id|nct_id|result_group_id|ctgov_group_code|period|reason|count
7306439|NCT00642707|11530409|FG000|Overall Study|Adverse Event|0
7388253|NCT01218204|11647021|FG000|Part B Washout|Adverse Event|0
7388254|NCT01218204|11647022|FG001|Part B Washout|Adverse Event|1
7388255|NCT01218204|11647023|FG002|Part B Washout|Adverse Event|0
7388256|NCT01218204|11647024|FG003|Part B Washout|Adverse Event|0
7388257|NCT01218204|11647021|FG000|Part B Washout|Lost to Follow-up|0
7388258|NCT01218204|11647022|FG001|Part B Washout|Lost to Follow-up|2
7388259|NCT01218204|11647023|FG002|Part B Washout|Lost to Follow-up|0
7388260|NCT01218204|11647024|FG003|Part B Washout|Lost to Follow-up|0
7388261|NCT01218204|11647021|FG000|Part B Washout|Physician Decision|0
7388262|NCT01218204|11647022|FG001|Part B Washout|Physician Decision|14
7388263|NCT01218204|11647023|FG002|Part B Washout|Physician Decision|0
7388264|NCT01218204|11647024|FG003|Part B Washout|Physician Decision|0
7388265|NCT01218204|11647021|FG000|Part B Washout|Withdrawal by Subject|0
7388266|NCT01218204|11647022|FG001|Part B Washout|Withdrawal by Subject|14
7388267|NCT01218204|11647023|FG002|Part B Washout|Withdrawal by Subject|0
7388268|NCT01218204|11647024|FG003|Part B Washout|Withdrawal by Subject|0
7388269|NCT01218204|11647021|FG000|Part B Washout|Reached defined stopping criteria|0
7388270|NCT01218204|11647022|FG001|Part B Washout|Reached defined stopping criteria|2
7388271|NCT01218204|11647023|FG002|Part B Washout|Reached defined stopping criteria|0
7388272|NCT01218204|11647024|FG003|Part B Washout|Reached defined stopping criteria|0
7388273|NCT01218204|11647021|FG000|Part B Washout|Did not meet continuation criteria|0
7388274|NCT01218204|11647022|FG001|Part B Washout|Did not meet continuation criteria|112
7388275|NCT01218204|11647023|FG002|Part B Washout|Did not meet continuation criteria|0
7388276|NCT01218204|11647024|FG003|Part B Washout|Did not meet continuation criteria|0
7388277|NCT01218204|11647021|FG000|Part B Run-in|Adverse Event|0
7388278|NCT01218204|11647022|FG001|Part B Run-in|Adverse Event|0
7388279|NCT01218204|11647023|FG002|Part B Run-in|Adverse Event|1
7388280|NCT01218204|11647024|FG003|Part B Run-in|Adverse Event|0
7388281|NCT01218204|11647021|FG000|Part B Run-in|Protocol Violation|0
7388282|NCT01218204|11647022|FG001|Part B Run-in|Protocol Violation|0
7388283|NCT01218204|11647023|FG002|Part B Run-in|Protocol Violation|2
7388284|NCT01218204|11647024|FG003|Part B Run-in|Protocol Violation|0
7388285|NCT01218204|11647021|FG000|Part B Run-in|Withdrawal by Subject|0
7388286|NCT01218204|11647022|FG001|Part B Run-in|Withdrawal by Subject|0
7388287|NCT01218204|11647023|FG002|Part B Run-in|Withdrawal by Subject|3
7388288|NCT01218204|11647024|FG003|Part B Run-in|Withdrawal by Subject|0
7388289|NCT01218204|11647021|FG000|Part B Pooled Treatment Arm|Adverse Event|0
7388290|NCT01218204|11647022|FG001|Part B Pooled Treatment Arm|Adverse Event|0
7388291|NCT01218204|11647023|FG002|Part B Pooled Treatment Arm|Adverse Event|0
7388292|NCT01218204|11647024|FG003|Part B Pooled Treatment Arm|Adverse Event|2
7388293|NCT01218204|11647021|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
7388294|NCT01218204|11647022|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
7388295|NCT01218204|11647023|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
7388296|NCT01218204|11647024|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
7388297|NCT01218243|11647073|FG000|Overall Study|Lack of Efficacy|1
7388298|NCT01218243|11647074|FG001|Overall Study|Lack of Efficacy|1
7388299|NCT01218243|11647073|FG000|Overall Study|Lost to Follow-up|3
7388300|NCT01218243|11647074|FG001|Overall Study|Lost to Follow-up|3
7388301|NCT01218243|11647073|FG000|Overall Study|Protocol Violation|5
7388302|NCT01218243|11647074|FG001|Overall Study|Protocol Violation|10
7388303|NCT01218308|11647082|FG000|Overall Study|Adverse Event|1
7388304|NCT01218308|11647083|FG001|Overall Study|Adverse Event|2
7388305|NCT01218308|11647082|FG000|Overall Study|Protocol Violation|0
7388306|NCT01218308|11647083|FG001|Overall Study|Protocol Violation|2
7388307|NCT01218308|11647082|FG000|Overall Study|Withdrawal by Subject|61
7388308|NCT01218308|11647083|FG001|Overall Study|Withdrawal by Subject|64
7388309|NCT01218308|11647082|FG000|Overall Study|Lost to Follow-up|27
7388310|NCT01218308|11647083|FG001|Overall Study|Lost to Follow-up|31
7388311|NCT01218308|11647082|FG000|Overall Study|Other|14
7388312|NCT01218308|11647083|FG001|Overall Study|Other|21
7388313|NCT01218438|11647098|FG000|Epoch 1|Physician Decision|2
7388314|NCT01218438|11647098|FG000|Epoch 1|Adverse Event|1
7388315|NCT01218438|11647098|FG000|Epoch 3|Withdrawal by Subject|3
7388316|NCT01218438|11647098|FG000|Epoch 3|Adverse Event|1
7388317|NCT01218438|11647098|FG000|Epoch 4|Physician Decision|1
7388318|NCT01218438|11647098|FG000|Epoch 4|Withdrawal by Subject|2
7388319|NCT01218477|11647176|FG000|Overall Study|Disease progression|2
7388320|NCT01218477|11647177|FG001|Overall Study|Disease progression|3
7388321|NCT01218477|11647178|FG002|Overall Study|Disease progression|6
7388322|NCT01218477|11647179|FG003|Overall Study|Disease progression|2
7388323|NCT01218477|11647176|FG000|Overall Study|Study drug toxicity|0
7388324|NCT01218477|11647177|FG001|Overall Study|Study drug toxicity|2
7388325|NCT01218477|11647178|FG002|Overall Study|Study drug toxicity|5
7388326|NCT01218477|11647179|FG003|Overall Study|Study drug toxicity|0
7388327|NCT01218477|11647176|FG000|Overall Study|No longer meets study criteria|1
7388328|NCT01218477|11647177|FG001|Overall Study|No longer meets study criteria|0
7388329|NCT01218477|11647178|FG002|Overall Study|No longer meets study criteria|0
7388330|NCT01218477|11647179|FG003|Overall Study|No longer meets study criteria|0
7306440|NCT00642707|11530410|FG001|Overall Study|Adverse Event|0
7388331|NCT01218477|11647176|FG000|Overall Study|Withdrawal by Subject|0
7388332|NCT01218477|11647177|FG001|Overall Study|Withdrawal by Subject|0
7388333|NCT01218477|11647178|FG002|Overall Study|Withdrawal by Subject|1
7306441|NCT00642707|11530411|FG002|Overall Study|Adverse Event|0
7306442|NCT00642707|11530412|FG003|Overall Study|Adverse Event|2
7306443|NCT00642707|11530409|FG000|Overall Study|Withdrawal by Subject|1
7306444|NCT00642707|11530410|FG001|Overall Study|Withdrawal by Subject|0
7306445|NCT00642707|11530411|FG002|Overall Study|Withdrawal by Subject|0
7306446|NCT00642707|11530412|FG003|Overall Study|Withdrawal by Subject|0
7306447|NCT00642746|11530424|FG000|Overall Study|Patient unevaluable|1
7388334|NCT01218477|11647179|FG003|Overall Study|Withdrawal by Subject|0
7388335|NCT01218477|11647176|FG000|Overall Study|Prepared for cell transplantation|0
7552359|NCT02989389|11912491|FG000|Period 1|Lost to Follow-up|0
7552360|NCT02989389|11912492|FG001|Period 1|Lost to Follow-up|1
7552361|NCT02989389|11912493|FG002|Period 1|Lost to Follow-up|0
7552362|NCT02989389|11912494|FG003|Period 1|Lost to Follow-up|0
7552363|NCT02989389|11912495|FG004|Period 1|Lost to Follow-up|0
7552364|NCT02989389|11912496|FG005|Period 1|Lost to Follow-up|0
7552365|NCT02989389|11912497|FG006|Period 1|Lost to Follow-up|0
7552366|NCT02989389|11912498|FG007|Period 1|Lost to Follow-up|0
7552367|NCT02989389|11912499|FG008|Period 1|Lost to Follow-up|0
7552368|NCT02989389|11912500|FG009|Period 1|Lost to Follow-up|0
7552369|NCT02989389|11912491|FG000|Period 1|Physician Decision|0
7552370|NCT02989389|11912492|FG001|Period 1|Physician Decision|0
7552371|NCT02989389|11912493|FG002|Period 1|Physician Decision|0
7552372|NCT02989389|11912494|FG003|Period 1|Physician Decision|0
7552373|NCT02989389|11912495|FG004|Period 1|Physician Decision|0
7552374|NCT02989389|11912496|FG005|Period 1|Physician Decision|0
7552375|NCT02989389|11912497|FG006|Period 1|Physician Decision|0
7552376|NCT02989389|11912498|FG007|Period 1|Physician Decision|0
7388336|NCT01218477|11647177|FG001|Overall Study|Prepared for cell transplantation|1
7388337|NCT01218477|11647178|FG002|Overall Study|Prepared for cell transplantation|1
7388338|NCT01218477|11647179|FG003|Overall Study|Prepared for cell transplantation|0
7388339|NCT01218477|11647176|FG000|Overall Study|Administrative reason by sponsor|0
7388340|NCT01218477|11647177|FG001|Overall Study|Administrative reason by sponsor|0
7388341|NCT01218477|11647178|FG002|Overall Study|Administrative reason by sponsor|1
7388342|NCT01218477|11647179|FG003|Overall Study|Administrative reason by sponsor|0
7388343|NCT01218477|11647176|FG000|Overall Study|Maximum clinical benefit|0
7388344|NCT01218477|11647177|FG001|Overall Study|Maximum clinical benefit|2
7388345|NCT01218477|11647178|FG002|Overall Study|Maximum clinical benefit|0
7388346|NCT01218477|11647179|FG003|Overall Study|Maximum clinical benefit|0
7388347|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Death|2
7388348|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Death|1
7388349|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Death|0
7388350|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Death|0
7388351|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7388352|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
7388353|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7388354|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
7388355|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7388356|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
7388357|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7388358|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
7388359|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
7388360|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7388361|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7388362|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
7388363|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
7388364|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
7388365|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7388366|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
7388367|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7388368|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
7388369|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7388370|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
7388371|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7388372|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
7388373|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7388374|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
7465067|NCT01877421|11764012|FG001|Phase 2|Protocol Violation|0
7470105|NCT01928940|11772050|FG000|Overall Study|Adverse Event|0
7470106|NCT01928940|11772051|FG001|Overall Study|Adverse Event|1
7552377|NCT02989389|11912499|FG008|Period 1|Physician Decision|1
7552378|NCT02989389|11912500|FG009|Period 1|Physician Decision|0
7552379|NCT02989610|11912557|FG000|Overall Study|Withdrawal/Other reasons|39
7552380|NCT02989649|11912561|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
7552381|NCT02989649|11912561|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
7552382|NCT02989649|11912561|FG000|Overall Study|Lost For Observation During Study|3
7552383|NCT02989649|11912561|FG000|Overall Study|Reason Not Specified|13
7388453|NCT01218867|11647286|FG010|Overall Study|Death during treatment|0
7388375|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7388376|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
7388377|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7388378|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
7388379|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Other|3
7388380|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Other|4
7388381|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Other|0
7388382|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Other|0
7388383|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7388384|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
7388385|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7388386|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
7388387|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
7388388|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
7388389|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7388390|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
7388391|NCT01218516|11647195|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7388392|NCT01218516|11647196|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
7388393|NCT01218516|11647197|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7388394|NCT01218516|11647198|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
7388395|NCT01218594|11647213|FG000|Overall Study|Death|1
7388396|NCT01218594|11647213|FG000|Overall Study|Withdrawal by Subject|3
7388397|NCT01218594|11647213|FG000|Overall Study|Adverse Event|2
7388398|NCT01218594|11647213|FG000|Overall Study|Physician Decision|6
7388399|NCT01218646|11647221|FG000|Overall Study|Adverse Event|0
7388400|NCT01218646|11647222|FG001|Overall Study|Adverse Event|0
7388401|NCT01218646|11647223|FG002|Overall Study|Adverse Event|1
7388402|NCT01218646|11647224|FG003|Overall Study|Adverse Event|0
7388403|NCT01218646|11647221|FG000|Overall Study|Lost to Follow-up|1
7388404|NCT01218646|11647222|FG001|Overall Study|Lost to Follow-up|0
7388405|NCT01218646|11647223|FG002|Overall Study|Lost to Follow-up|0
7388406|NCT01218646|11647224|FG003|Overall Study|Lost to Follow-up|0
7388407|NCT01218646|11647221|FG000|Overall Study|Protocol Violation|0
7388408|NCT01218646|11647222|FG001|Overall Study|Protocol Violation|0
7388409|NCT01218646|11647223|FG002|Overall Study|Protocol Violation|1
7388410|NCT01218646|11647224|FG003|Overall Study|Protocol Violation|1
7388411|NCT01218659|11647236|FG000|18-Month Randomized Period|Withdrawal by Subject|2
7388412|NCT01218659|11647237|FG001|18-Month Randomized Period|Withdrawal by Subject|3
7388413|NCT01218659|11647238|FG002|18-Month Randomized Period|Withdrawal by Subject|0
7388414|NCT01218659|11647236|FG000|18-Month Randomized Period|Did not receive study drug|0
7388415|NCT01218659|11647237|FG001|18-Month Randomized Period|Did not receive study drug|3
7388416|NCT01218659|11647238|FG002|18-Month Randomized Period|Did not receive study drug|0
7388417|NCT01218659|11647236|FG000|12-Month OLE|Withdrawal by Subject|0
7388418|NCT01218659|11647237|FG001|12-Month OLE|Withdrawal by Subject|0
7388419|NCT01218659|11647238|FG002|12-Month OLE|Withdrawal by Subject|2
7388420|NCT01218659|11647236|FG000|12-Month OLE|Physician Decision|0
7388421|NCT01218659|11647237|FG001|12-Month OLE|Physician Decision|0
7388422|NCT01218659|11647238|FG002|12-Month OLE|Physician Decision|1
7388423|NCT01218659|11647236|FG000|12-Month OLE|Lost to Follow-up|0
7388424|NCT01218659|11647237|FG001|12-Month OLE|Lost to Follow-up|0
7388425|NCT01218659|11647238|FG002|12-Month OLE|Lost to Follow-up|1
7388426|NCT01218659|11647236|FG000|12-Month OLE|Pregnancy|0
7388427|NCT01218659|11647237|FG001|12-Month OLE|Pregnancy|0
7388428|NCT01218659|11647238|FG002|12-Month OLE|Pregnancy|1
7388429|NCT01218659|11647236|FG000|12-Month OLE|Lack of Efficacy|0
7388430|NCT01218659|11647237|FG001|12-Month OLE|Lack of Efficacy|0
7388431|NCT01218659|11647238|FG002|12-Month OLE|Lack of Efficacy|1
7388432|NCT01218659|11647236|FG000|12-Month OLE|Declined to participate in the OLE|0
7388433|NCT01218659|11647237|FG001|12-Month OLE|Declined to participate in the OLE|0
7388434|NCT01218659|11647238|FG002|12-Month OLE|Declined to participate in the OLE|4
7388435|NCT01218802|11647258|FG000|Overall Study|Lost to Follow-up|5
7388436|NCT01218802|11647259|FG001|Overall Study|Lost to Follow-up|6
7388437|NCT01218802|11647258|FG000|Overall Study|Withdrawal by Subject|3
7388438|NCT01218802|11647259|FG001|Overall Study|Withdrawal by Subject|10
7388439|NCT01218802|11647258|FG000|Overall Study|Adverse Event|0
7388440|NCT01218802|11647259|FG001|Overall Study|Adverse Event|2
7388441|NCT01218802|11647258|FG000|Overall Study|Incarcerated|2
7388442|NCT01218802|11647259|FG001|Overall Study|Incarcerated|0
7388443|NCT01218867|11647276|FG000|Overall Study|Death during treatment|0
7388444|NCT01218867|11647277|FG001|Overall Study|Death during treatment|0
7388445|NCT01218867|11647278|FG002|Overall Study|Death during treatment|0
7388446|NCT01218867|11647279|FG003|Overall Study|Death during treatment|0
7388447|NCT01218867|11647280|FG004|Overall Study|Death during treatment|0
7388448|NCT01218867|11647281|FG005|Overall Study|Death during treatment|0
7388449|NCT01218867|11647282|FG006|Overall Study|Death during treatment|1
7388450|NCT01218867|11647283|FG007|Overall Study|Death during treatment|0
7388451|NCT01218867|11647284|FG008|Overall Study|Death during treatment|0
7388452|NCT01218867|11647285|FG009|Overall Study|Death during treatment|0
7465068|NCT01877421|11764013|FG002|Phase 2|Protocol Violation|0
7465069|NCT01877421|11764014|FG003|Phase 2|Protocol Violation|0
7465070|NCT01877421|11764015|FG004|Phase 2|Protocol Violation|0
7465071|NCT01877421|11764016|FG005|Phase 2|Protocol Violation|0
7470107|NCT01929018|11772060|FG000|Overall Study|Lost to Follow-up|1
7470108|NCT01929018|11772061|FG001|Overall Study|Lost to Follow-up|0
7470109|NCT01929018|11772060|FG000|Overall Study|Hospitalization|0
7470110|NCT01929018|11772061|FG001|Overall Study|Hospitalization|1
7470111|NCT01929031|11772071|FG000|Overall Study|Adverse Event|3
7470112|NCT01929031|11772072|FG001|Overall Study|Adverse Event|1
7470113|NCT01929031|11772073|FG002|Overall Study|Adverse Event|1
7470114|NCT01929031|11772074|FG003|Overall Study|Adverse Event|0
7470115|NCT01929031|11772075|FG004|Overall Study|Adverse Event|0
7470116|NCT01929031|11772076|FG005|Overall Study|Adverse Event|0
7470117|NCT01929031|11772071|FG000|Overall Study|Protocol Violation|1
7470118|NCT01929031|11772072|FG001|Overall Study|Protocol Violation|0
7470119|NCT01929031|11772073|FG002|Overall Study|Protocol Violation|0
7470120|NCT01929031|11772074|FG003|Overall Study|Protocol Violation|0
7470121|NCT01929031|11772075|FG004|Overall Study|Protocol Violation|0
7470122|NCT01929031|11772076|FG005|Overall Study|Protocol Violation|1
7470123|NCT01929031|11772071|FG000|Overall Study|Reason other than specified above|0
7470124|NCT01929031|11772072|FG001|Overall Study|Reason other than specified above|1
7470125|NCT01929031|11772073|FG002|Overall Study|Reason other than specified above|0
7470126|NCT01929031|11772074|FG003|Overall Study|Reason other than specified above|0
7470127|NCT01929031|11772075|FG004|Overall Study|Reason other than specified above|1
7470128|NCT01929031|11772076|FG005|Overall Study|Reason other than specified above|0
7470129|NCT01929044|11772088|FG000|Overall Study|Adverse Event|1
7470130|NCT01929044|11772089|FG001|Overall Study|Adverse Event|0
7470131|NCT01929044|11772088|FG000|Overall Study|Protocol Violation|9
7470132|NCT01929044|11772089|FG001|Overall Study|Protocol Violation|14
7470133|NCT01929044|11772088|FG000|Overall Study|Not Treated|1
7470134|NCT01929044|11772089|FG001|Overall Study|Not Treated|3
7470135|NCT01929083|11772106|FG000|Intervention 1|Lost to Follow-up|2
7470136|NCT01929083|11772107|FG001|Intervention 1|Lost to Follow-up|0
7470137|NCT01929083|11772106|FG000|Intervention 1|Nonadherent to study medications|1
7470138|NCT01929083|11772107|FG001|Intervention 1|Nonadherent to study medications|0
7470139|NCT01929083|11772106|FG000|Intervention 2|Adverse Event|0
7470140|NCT01929083|11772107|FG001|Intervention 2|Adverse Event|1
7470141|NCT01929109|11772118|FG000|Period 1 (All Groups)|Deviation from protocol|0
7470142|NCT01929109|11772119|FG001|Period 1 (All Groups)|Deviation from protocol|0
7470143|NCT01929109|11772120|FG002|Period 1 (All Groups)|Deviation from protocol|1
7470144|NCT01929109|11772121|FG003|Period 1 (All Groups)|Deviation from protocol|0
7470145|NCT01929109|11772122|FG004|Period 1 (All Groups)|Deviation from protocol|0
7470146|NCT01929135|11772139|FG000|Overall Study|Lost to Follow-up|1
7470147|NCT01929135|11772140|FG001|Overall Study|Lost to Follow-up|1
7470148|NCT01929226|11772150|FG000|Overall Study|Lost to Follow-up|4
7470149|NCT01929226|11772151|FG001|Overall Study|Lost to Follow-up|0
7470150|NCT01929226|11772150|FG000|Overall Study|Withdrawal by Subject|1
7470151|NCT01929226|11772151|FG001|Overall Study|Withdrawal by Subject|1
7470152|NCT01929317|11772164|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
7470153|NCT01929317|11772165|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
7470154|NCT01929317|11772164|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
7470155|NCT01929317|11772165|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
7470156|NCT01929317|11772164|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
7470157|NCT01929317|11772165|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
7470158|NCT01929317|11772164|FG000|Long-term Phase|Adverse Event|5
7470159|NCT01929317|11772165|FG001|Long-term Phase|Adverse Event|1
7470160|NCT01929317|11772164|FG000|Long-term Phase|Physician Decision|3
7470161|NCT01929317|11772165|FG001|Long-term Phase|Physician Decision|0
7470162|NCT01929317|11772164|FG000|Long-term Phase|Withdrawal by Subject|4
7470163|NCT01929317|11772165|FG001|Long-term Phase|Withdrawal by Subject|0
7470164|NCT01929317|11772164|FG000|Long-term Phase|Protocol Violation|1
7470165|NCT01929317|11772165|FG001|Long-term Phase|Protocol Violation|0
7470166|NCT01929317|11772164|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
7470167|NCT01929317|11772165|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
7470168|NCT01929317|11772164|FG000|Long-term Phase|Study Closed/Terminated|5
7470169|NCT01929317|11772165|FG001|Long-term Phase|Study Closed/Terminated|3
7470170|NCT01929343|11772180|FG000|Overall Study|Physician Decision|0
7470171|NCT01929343|11772181|FG001|Overall Study|Physician Decision|2
7470172|NCT01929343|11772182|FG002|Overall Study|Physician Decision|0
7470173|NCT01929343|11772180|FG000|Overall Study|Withdrawal by Subject|1
7470174|NCT01929343|11772181|FG001|Overall Study|Withdrawal by Subject|0
7470175|NCT01929343|11772182|FG002|Overall Study|Withdrawal by Subject|0
7470176|NCT01929395|11772193|FG000|Overall Study|Did not complete - non-related toxicity|1
7470177|NCT01929395|11772194|FG001|Overall Study|Did not complete - non-related toxicity|0
7470178|NCT01929395|11772195|FG002|Overall Study|Did not complete - non-related toxicity|0
7552384|NCT02989805|11912587|FG000|Overall Study|invalid consent|6
7465072|NCT01877421|11764017|FG006|Phase 2|Protocol Violation|0
7465073|NCT01877421|11764018|FG007|Phase 2|Protocol Violation|0
7388454|NCT01219933|11647416|FG000|Overall Study|Adverse Event|8
7388455|NCT01219933|11647416|FG000|Overall Study|No LDA reached|5
7388456|NCT01219933|11647416|FG000|Overall Study|No LDA maintained|7
7388457|NCT01219933|11647416|FG000|Overall Study|Lost to Follow-up|3
7388458|NCT01219933|11647416|FG000|Overall Study|GC free|1
7388459|NCT01219933|11647416|FG000|Overall Study|Withdrawal by Subject|5
7388460|NCT01219933|11647416|FG000|Overall Study|Protocol Violation|8
7388461|NCT01219933|11647416|FG000|Overall Study|Lack of Efficacy|1
7388462|NCT01219959|11647423|FG000|Overall Study|Adverse Event|6
7388463|NCT01219959|11647424|FG001|Overall Study|Adverse Event|14
7388464|NCT01219959|11647423|FG000|Overall Study|Physician Decision|0
7388465|NCT01219959|11647424|FG001|Overall Study|Physician Decision|4
7388466|NCT01219959|11647423|FG000|Overall Study|Withdrawal by Subject|0
7388467|NCT01219959|11647424|FG001|Overall Study|Withdrawal by Subject|2
7388468|NCT01219959|11647423|FG000|Overall Study|Renal Transplantation|0
7388469|NCT01219959|11647424|FG001|Overall Study|Renal Transplantation|3
7388470|NCT01219959|11647423|FG000|Overall Study|Other|1
7388471|NCT01219959|11647424|FG001|Overall Study|Other|0
7388472|NCT01219985|11647430|FG000|Overall Study|Physician Decision|20
7388473|NCT01220024|11647438|FG000|Overall Study|Lost to Follow-up|1
7388474|NCT01220024|11647439|FG001|Overall Study|Lost to Follow-up|1
7388475|NCT01220128|11647452|FG000|Overall Study|Progressive disease|0
7388476|NCT01220128|11647453|FG001|Overall Study|Progressive disease|0
7388477|NCT01220128|11647454|FG002|Overall Study|Progressive disease|2
7388478|NCT01220128|11647455|FG003|Overall Study|Progressive disease|0
7388479|NCT01220128|11647456|FG004|Overall Study|Progressive disease|0
7388480|NCT01220128|11647457|FG005|Overall Study|Progressive disease|0
7388481|NCT01220128|11647458|FG006|Overall Study|Progressive disease|0
7388482|NCT01220128|11647452|FG000|Overall Study|Sponsor study termination|0
7388483|NCT01220128|11647453|FG001|Overall Study|Sponsor study termination|1
7388484|NCT01220128|11647454|FG002|Overall Study|Sponsor study termination|0
7388485|NCT01220128|11647455|FG003|Overall Study|Sponsor study termination|0
7388486|NCT01220128|11647456|FG004|Overall Study|Sponsor study termination|0
7388487|NCT01220128|11647457|FG005|Overall Study|Sponsor study termination|0
7388488|NCT01220128|11647458|FG006|Overall Study|Sponsor study termination|1
7388489|NCT01220128|11647452|FG000|Overall Study|Adverse event, serious fatal|2
7388490|NCT01220128|11647453|FG001|Overall Study|Adverse event, serious fatal|0
7388491|NCT01220128|11647454|FG002|Overall Study|Adverse event, serious fatal|0
7388492|NCT01220128|11647455|FG003|Overall Study|Adverse event, serious fatal|0
7388493|NCT01220128|11647456|FG004|Overall Study|Adverse event, serious fatal|0
7388494|NCT01220128|11647457|FG005|Overall Study|Adverse event, serious fatal|0
7388495|NCT01220128|11647458|FG006|Overall Study|Adverse event, serious fatal|1
7388496|NCT01220128|11647452|FG000|Overall Study|Adverse event, non-fatal|1
7388497|NCT01220128|11647453|FG001|Overall Study|Adverse event, non-fatal|0
7388498|NCT01220128|11647454|FG002|Overall Study|Adverse event, non-fatal|0
7388499|NCT01220128|11647455|FG003|Overall Study|Adverse event, non-fatal|0
7388500|NCT01220128|11647456|FG004|Overall Study|Adverse event, non-fatal|0
7388501|NCT01220128|11647457|FG005|Overall Study|Adverse event, non-fatal|0
7388502|NCT01220128|11647458|FG006|Overall Study|Adverse event, non-fatal|3
7388503|NCT01220128|11647452|FG000|Overall Study|Other|0
7388504|NCT01220128|11647453|FG001|Overall Study|Other|0
7388505|NCT01220128|11647454|FG002|Overall Study|Other|1
7388506|NCT01220128|11647455|FG003|Overall Study|Other|0
7388507|NCT01220128|11647456|FG004|Overall Study|Other|0
7388508|NCT01220128|11647457|FG005|Overall Study|Other|0
7388509|NCT01220128|11647458|FG006|Overall Study|Other|0
7388510|NCT01220128|11647452|FG000|Overall Study|Consent withdrawn by subject|1
7388511|NCT01220128|11647453|FG001|Overall Study|Consent withdrawn by subject|0
7388512|NCT01220128|11647454|FG002|Overall Study|Consent withdrawn by subject|0
7388513|NCT01220128|11647455|FG003|Overall Study|Consent withdrawn by subject|0
7388514|NCT01220128|11647456|FG004|Overall Study|Consent withdrawn by subject|0
7388515|NCT01220128|11647457|FG005|Overall Study|Consent withdrawn by subject|0
7388516|NCT01220128|11647458|FG006|Overall Study|Consent withdrawn by subject|0
7388517|NCT01220167|11647478|FG000|Period 3|Urine positive for substance abuse|0
7388518|NCT01220167|11647479|FG001|Period 3|Urine positive for substance abuse|1
7388519|NCT01220167|11647480|FG002|Period 3|Urine positive for substance abuse|0
7388520|NCT01220180|11647489|FG000|Overall Study|Lost to Follow-up|76
7388521|NCT01220180|11647489|FG000|Overall Study|Other|72
7388522|NCT01220180|11647489|FG000|Overall Study|Adverse Event|35
7388523|NCT01220180|11647489|FG000|Overall Study|Lack of Efficacy|22
7388524|NCT01220180|11647489|FG000|Overall Study|Death|1
7388525|NCT01220180|11647489|FG000|Overall Study|Randomized but not treated|1
7388526|NCT01220297|11647495|FG000|Overall Study|Death|2
7388527|NCT01220297|11647495|FG000|Overall Study|Lost to Follow-up|1
7388528|NCT01220401|11647501|FG000|Overall Study|Withdrawal by Subject|2
7388529|NCT01220401|11647501|FG000|Overall Study|Protocol Violation|1
7388530|NCT01220414|11647507|FG000|Overall Study|Withdrawal by Subject|1
7388531|NCT01220414|11647508|FG001|Overall Study|Withdrawal by Subject|0
7388532|NCT01220414|11647509|FG002|Overall Study|Withdrawal by Subject|0
7388533|NCT01220414|11647510|FG003|Overall Study|Withdrawal by Subject|1
7388534|NCT01220557|11647532|FG000|Overall Study|Lost to Follow-up|5
7388535|NCT01220557|11647533|FG001|Overall Study|Lost to Follow-up|3
7388536|NCT01220557|11647532|FG000|Overall Study|attended less than 6 lessons|1
7388537|NCT01220557|11647533|FG001|Overall Study|attended less than 6 lessons|2
7388538|NCT01220609|11647539|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
7388539|NCT01220609|11647539|FG000|Overall Study|Ineligible- Wrong cell type|1
7388540|NCT01220609|11647539|FG000|Overall Study|Ineligible-Never treated|1
7388541|NCT01220856|11647578|FG000|Overall Study|graft loss|3
7388542|NCT01220856|11647579|FG001|Overall Study|graft loss|3
7388543|NCT01220856|11647578|FG000|Overall Study|Lost to Follow-up|1
7388544|NCT01220856|11647579|FG001|Overall Study|Lost to Follow-up|0
7470179|NCT01929395|11772193|FG000|Overall Study|Withdrawal by Subject|0
7470180|NCT01929395|11772194|FG001|Overall Study|Withdrawal by Subject|1
7470181|NCT01929395|11772195|FG002|Overall Study|Withdrawal by Subject|0
7470182|NCT01929395|11772193|FG000|Overall Study|Screen Fail|0
7470183|NCT01929395|11772194|FG001|Overall Study|Screen Fail|0
7470184|NCT01929395|11772195|FG002|Overall Study|Screen Fail|1
7470185|NCT01929408|11772203|FG000|Overall Study|received HCT as initial treatment|8
7470186|NCT01929681|11772228|FG000|Overall Study|Withdrawal by Subject|1
7470187|NCT01929681|11772229|FG001|Overall Study|Withdrawal by Subject|0
7470188|NCT01929681|11772228|FG000|Overall Study|Physician Decision|1
7470189|NCT01929681|11772229|FG001|Overall Study|Physician Decision|1
7470190|NCT01929707|11772235|FG000|Intervention Period 1|Lost to Follow-up|0
7470191|NCT01929707|11772236|FG001|Intervention Period 1|Lost to Follow-up|0
7470192|NCT01929707|11772237|FG002|Intervention Period 1|Lost to Follow-up|0
7470193|NCT01929707|11772238|FG003|Intervention Period 1|Lost to Follow-up|1
7470194|NCT01929707|11772239|FG004|Intervention Period 1|Lost to Follow-up|0
7470195|NCT01929707|11772240|FG005|Intervention Period 1|Lost to Follow-up|0
7470196|NCT01929707|11772241|FG006|Intervention Period 1|Lost to Follow-up|0
7470197|NCT01929707|11772242|FG007|Intervention Period 1|Lost to Follow-up|0
7470198|NCT01929707|11772235|FG000|Intervention Period 1|Withdrawal by Subject|0
7470199|NCT01929707|11772236|FG001|Intervention Period 1|Withdrawal by Subject|0
7470200|NCT01929707|11772237|FG002|Intervention Period 1|Withdrawal by Subject|0
7470201|NCT01929707|11772238|FG003|Intervention Period 1|Withdrawal by Subject|2
7470202|NCT01929707|11772239|FG004|Intervention Period 1|Withdrawal by Subject|0
7470203|NCT01929707|11772240|FG005|Intervention Period 1|Withdrawal by Subject|0
7470204|NCT01929707|11772241|FG006|Intervention Period 1|Withdrawal by Subject|0
7470205|NCT01929707|11772242|FG007|Intervention Period 1|Withdrawal by Subject|0
7470206|NCT01929707|11772235|FG000|Intervention Period 2|Withdrawal by Subject|0
7470207|NCT01929707|11772236|FG001|Intervention Period 2|Withdrawal by Subject|0
7470208|NCT01929707|11772237|FG002|Intervention Period 2|Withdrawal by Subject|0
7470209|NCT01929707|11772238|FG003|Intervention Period 2|Withdrawal by Subject|0
7470210|NCT01929707|11772239|FG004|Intervention Period 2|Withdrawal by Subject|0
7470211|NCT01929707|11772240|FG005|Intervention Period 2|Withdrawal by Subject|2
7470212|NCT01929707|11772241|FG006|Intervention Period 2|Withdrawal by Subject|0
7470213|NCT01929707|11772242|FG007|Intervention Period 2|Withdrawal by Subject|0
7470214|NCT01929863|11772267|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
7470215|NCT01929863|11772268|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
7470216|NCT01929863|11772267|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
7470217|NCT01929863|11772268|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
7470218|NCT01929863|11772267|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
7470219|NCT01929863|11772268|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
7470220|NCT01929876|11772279|FG000|Period 2|Non-Compliance|1
7470221|NCT01929980|11772287|FG000|Overall Study|Physician Decision|1
7470222|NCT01929993|11772293|FG000|Overall Study|Protocol Violation|4
7470223|NCT01929993|11772294|FG001|Overall Study|Protocol Violation|6
7470224|NCT01929993|11772293|FG000|Overall Study|Absent CIN, invasion present or artifact|26
7470225|NCT01929993|11772294|FG001|Overall Study|Absent CIN, invasion present or artifact|22
7470226|NCT01930045|11772300|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
7470227|NCT01930045|11772301|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
7470228|NCT01930045|11772302|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
7470229|NCT01930045|11772303|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
7470230|NCT01930045|11772304|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
7470231|NCT01930045|11772305|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
7470232|NCT01930045|11772300|FG000|Pause (up to 37 Days)|Protocol Violation|0
7470233|NCT01930045|11772301|FG001|Pause (up to 37 Days)|Protocol Violation|0
7470234|NCT01930045|11772302|FG002|Pause (up to 37 Days)|Protocol Violation|0
7470235|NCT01930045|11772303|FG003|Pause (up to 37 Days)|Protocol Violation|0
7470236|NCT01930045|11772304|FG004|Pause (up to 37 Days)|Protocol Violation|0
7470237|NCT01930045|11772305|FG005|Pause (up to 37 Days)|Protocol Violation|1
7470238|NCT01930162|11772329|FG000|Overall Study|Abnormal test procedure result(s)|4
7470239|NCT01930162|11772329|FG000|Overall Study|Death|1
7470240|NCT01930175|11772337|FG000|Core Study|Lost to Follow-up|0
7470241|NCT01930175|11772338|FG001|Core Study|Lost to Follow-up|1
7470242|NCT01930175|11772339|FG002|Core Study|Lost to Follow-up|0
7470243|NCT01930175|11772337|FG000|Core Study|Adverse Event|0
7470244|NCT01930175|11772338|FG001|Core Study|Adverse Event|0
7470245|NCT01930175|11772339|FG002|Core Study|Adverse Event|1
7470246|NCT01930188|11772351|FG000|Overall Study|unclassified|4
7470247|NCT01930188|11772352|FG001|Overall Study|unclassified|5
7470248|NCT01930188|11772353|FG002|Overall Study|unclassified|3
7470249|NCT01930188|11772351|FG000|Overall Study|Missing follow-up information|2
7470250|NCT01930188|11772352|FG001|Overall Study|Missing follow-up information|2
7388545|NCT01220999|11647601|FG000|Overall Study|Progressive disease|0
7388546|NCT01220999|11647602|FG001|Overall Study|Progressive disease|0
7388547|NCT01220999|11647603|FG002|Overall Study|Progressive disease|1
7388548|NCT01220999|11647604|FG003|Overall Study|Progressive disease|0
7388549|NCT01220999|11647605|FG004|Overall Study|Progressive disease|0
7388550|NCT01221090|11647621|FG000|Overall Study|Non-Compliant or Unable to Contact|15
7388551|NCT01221090|11647622|FG001|Overall Study|Non-Compliant or Unable to Contact|12
7388552|NCT01221090|11647623|FG002|Overall Study|Non-Compliant or Unable to Contact|15
7388553|NCT01221090|11647624|FG003|Overall Study|Non-Compliant or Unable to Contact|20
7388554|NCT01221090|11647621|FG000|Overall Study|Withdrawal by Subject|0
7388555|NCT01221090|11647622|FG001|Overall Study|Withdrawal by Subject|22
7388556|NCT01221090|11647623|FG002|Overall Study|Withdrawal by Subject|27
7388557|NCT01221090|11647624|FG003|Overall Study|Withdrawal by Subject|2
7388558|NCT01221181|11647634|FG000|Overall Study|Lost to Follow-up|1
7388559|NCT01221233|11647662|FG000|Overall Study|Withdrawal by Subject|3
7388560|NCT01221233|11647663|FG001|Overall Study|Withdrawal by Subject|1
7388561|NCT01221272|11647669|FG000|Period 1|Adverse Event|2
7388562|NCT01221272|11647670|FG001|Period 1|Adverse Event|0
7388563|NCT01221272|11647669|FG000|Period 1|Consent Withdrawal|0
7388564|NCT01221272|11647670|FG001|Period 1|Consent Withdrawal|1
7388565|NCT01221272|11647669|FG000|Period 1|Significant Dosing Noncompliance|0
7388566|NCT01221272|11647670|FG001|Period 1|Significant Dosing Noncompliance|1
7388567|NCT01221272|11647669|FG000|Period 2|Adverse Event|0
7388568|NCT01221272|11647670|FG001|Period 2|Adverse Event|2
7388569|NCT01221285|11647679|FG000|Overall Study|Withdrawal by Subject|1
7388570|NCT01221350|11647698|FG000|Overall Study|Discontinued intervention (GERD)|1
7388571|NCT01221350|11647699|FG001|Overall Study|Discontinued intervention (GERD)|0
7388572|NCT01221350|11647698|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
7388573|NCT01221350|11647699|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
7388574|NCT01221350|11647698|FG000|Overall Study|Withdrawal by Subject|4
7388575|NCT01221350|11647699|FG001|Overall Study|Withdrawal by Subject|2
7388576|NCT01221363|11647709|FG000|Overall Study|Pregnancy|1
7388577|NCT01221363|11647710|FG001|Overall Study|Pregnancy|0
7388578|NCT01221363|11647709|FG000|Overall Study|Withdrawal by Subject|11
7388579|NCT01221363|11647710|FG001|Overall Study|Withdrawal by Subject|5
7388580|NCT01221597|11647727|FG000|Overall Study|Adverse Event|4
7388581|NCT01221597|11647728|FG001|Overall Study|Adverse Event|1
7388582|NCT01221597|11647727|FG000|Overall Study|Withdrawal by Subject|20
7388583|NCT01221597|11647728|FG001|Overall Study|Withdrawal by Subject|6
7388584|NCT01221597|11647727|FG000|Overall Study|Lost to Follow-up|6
7388585|NCT01221597|11647728|FG001|Overall Study|Lost to Follow-up|5
7388586|NCT01221597|11647727|FG000|Overall Study|Protocol Violation|1
7388587|NCT01221597|11647728|FG001|Overall Study|Protocol Violation|0
7388588|NCT01221597|11647727|FG000|Overall Study|Other|3
7388589|NCT01221597|11647728|FG001|Overall Study|Other|4
7388590|NCT01221597|11647727|FG000|Overall Study|Death|2
7388591|NCT01221597|11647728|FG001|Overall Study|Death|0
7388592|NCT01221623|11647737|FG000|Overall Study|Withdrawal by Subject|19
7388593|NCT01221623|11647738|FG001|Overall Study|Withdrawal by Subject|8
7388594|NCT01221623|11647737|FG000|Overall Study|Lost to Follow-up|7
7388595|NCT01221623|11647738|FG001|Overall Study|Lost to Follow-up|1
7388596|NCT01221623|11647737|FG000|Overall Study|Adverse Event|6
7388597|NCT01221623|11647738|FG001|Overall Study|Adverse Event|3
7470251|NCT01930188|11772353|FG002|Overall Study|Missing follow-up information|3
7470252|NCT01930188|11772351|FG000|Overall Study|Lost to Follow-up|5
7470253|NCT01930188|11772352|FG001|Overall Study|Lost to Follow-up|2
7470254|NCT01930188|11772353|FG002|Overall Study|Lost to Follow-up|2
7470255|NCT01930188|11772351|FG000|Overall Study|Death|2
7470256|NCT01930188|11772352|FG001|Overall Study|Death|1
7470257|NCT01930188|11772353|FG002|Overall Study|Death|3
7470258|NCT01930188|11772351|FG000|Overall Study|Withdrawal by Subject|9
7470259|NCT01930188|11772352|FG001|Overall Study|Withdrawal by Subject|11
7470260|NCT01930188|11772353|FG002|Overall Study|Withdrawal by Subject|8
7470261|NCT01930214|11772365|FG000|Overall Study|Death|4
7470262|NCT01930214|11772366|FG001|Overall Study|Death|4
7470263|NCT01930214|11772367|FG002|Overall Study|Death|11
7470264|NCT01930214|11772365|FG000|Overall Study|Lost to Follow-up|12
7470265|NCT01930214|11772366|FG001|Overall Study|Lost to Follow-up|13
7470266|NCT01930214|11772367|FG002|Overall Study|Lost to Follow-up|12
7470267|NCT01930214|11772365|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
7470268|NCT01930214|11772366|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
7470269|NCT01930214|11772367|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
7470270|NCT01930214|11772365|FG000|Overall Study|Physician Decision|2
7470271|NCT01930214|11772366|FG001|Overall Study|Physician Decision|0
7470272|NCT01930214|11772367|FG002|Overall Study|Physician Decision|0
7470273|NCT01930799|11772409|FG000|Overall Study|Withdrawal by Subject|3
7470274|NCT01930799|11772409|FG000|Overall Study|Lost to Follow-up|5
7388598|NCT01221623|11647737|FG000|Overall Study|Death|1
7388599|NCT01221623|11647738|FG001|Overall Study|Death|0
7388600|NCT01221623|11647737|FG000|Overall Study|Other|5
7388601|NCT01221623|11647738|FG001|Overall Study|Other|2
7388602|NCT01221727|11647746|FG000|Overall Study|Physician Decision|2
7388603|NCT01221727|11647747|FG001|Overall Study|Physician Decision|0
7388604|NCT01221727|11647746|FG000|Overall Study|Withdrawal by Subject|1
7388605|NCT01221727|11647747|FG001|Overall Study|Withdrawal by Subject|1
7388606|NCT01221753|11647759|FG000|Overall Study|Adverse Event|1
7470275|NCT01930890|11772417|FG000|Overall Study|Study Termination|14
7470276|NCT01930890|11772418|FG001|Overall Study|Study Termination|28
7470277|NCT01930890|11772419|FG002|Overall Study|Study Termination|13
7470278|NCT01930890|11772420|FG003|Overall Study|Study Termination|25
7470279|NCT01930890|11772417|FG000|Overall Study|Death|0
7470280|NCT01930890|11772418|FG001|Overall Study|Death|0
7470281|NCT01930890|11772419|FG002|Overall Study|Death|0
7470282|NCT01930890|11772420|FG003|Overall Study|Death|1
7470283|NCT01930890|11772417|FG000|Overall Study|Investigator Decision|0
7470284|NCT01930890|11772418|FG001|Overall Study|Investigator Decision|1
7470285|NCT01930890|11772419|FG002|Overall Study|Investigator Decision|0
7470286|NCT01930890|11772420|FG003|Overall Study|Investigator Decision|0
7470287|NCT01930890|11772417|FG000|Overall Study|Consent Withdrawn|0
7470288|NCT01930890|11772418|FG001|Overall Study|Consent Withdrawn|3
7470289|NCT01930890|11772419|FG002|Overall Study|Consent Withdrawn|0
7470290|NCT01930890|11772420|FG003|Overall Study|Consent Withdrawn|1
7470291|NCT01930890|11772417|FG000|Overall Study|Adverse Event|0
7470292|NCT01930890|11772418|FG001|Overall Study|Adverse Event|1
7470293|NCT01930890|11772419|FG002|Overall Study|Adverse Event|0
7470294|NCT01930890|11772420|FG003|Overall Study|Adverse Event|0
7470295|NCT01931059|11772432|FG000|Day 1|Pregnancy|0
7470296|NCT01931059|11772433|FG001|Day 1|Pregnancy|1
7470297|NCT01931059|11772432|FG000|Day3|Lost to Follow-up|1
7470298|NCT01931059|11772433|FG001|Day3|Lost to Follow-up|0
7470299|NCT01931150|11772447|FG000|Overall Study|Withdrawal by Subject|1
7470300|NCT01931150|11772448|FG001|Overall Study|Withdrawal by Subject|2
7470301|NCT01931202|11772461|FG000|Overall Study|Withdrawal by Subject|0
7470302|NCT01931202|11772462|FG001|Overall Study|Withdrawal by Subject|0
7470303|NCT01931202|11772463|FG002|Overall Study|Withdrawal by Subject|2
7470304|NCT01931202|11772461|FG000|Overall Study|Lost to Follow-up|0
7470305|NCT01931202|11772462|FG001|Overall Study|Lost to Follow-up|5
7470306|NCT01931202|11772463|FG002|Overall Study|Lost to Follow-up|2
7470307|NCT01931397|11772474|FG000|Overall Study|Physician Decision|2
7470308|NCT01931397|11772474|FG000|Overall Study|Withdrawal by Subject|8
7470309|NCT01931397|11772474|FG000|Overall Study|moved out of state|1
7470310|NCT01931462|11772482|FG000|Overall Study|Withdrawal by Subject|1
7470311|NCT01931475|11772488|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
7470312|NCT01931475|11772489|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
7470313|NCT01931475|11772488|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
7470314|NCT01931475|11772489|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
7470315|NCT01931475|11772488|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
7470316|NCT01931475|11772489|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
7470317|NCT01931475|11772488|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
7470318|NCT01931475|11772489|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
7470319|NCT01931475|11772488|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
7470320|NCT01931475|11772489|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
7470321|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
7470322|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
7470323|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
7470324|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
7470325|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
7552385|NCT02989805|11912588|FG001|Overall Study|invalid consent|4
7552386|NCT02990000|11912596|FG000|Overall Study|Failed to provide data beyond baseline|36
7552387|NCT02990000|11912597|FG001|Overall Study|Failed to provide data beyond baseline|34
7552388|NCT02990910|11912605|FG000|Overall Study|Lack of Efficacy|6
7552389|NCT02990910|11912606|FG001|Overall Study|Lack of Efficacy|10
7552390|NCT02991040|11912612|FG000|Overall Study|Withdrawal by Subject|2
7552391|NCT02991040|11912612|FG000|Overall Study|Lost to Follow-up|2
7470326|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
7470327|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
7470328|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
7470329|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
7470330|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
7470331|NCT01931475|11772488|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7470332|NCT01931475|11772489|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
7470333|NCT01931566|11772516|FG000|Overall Study|Randomized But Not Treated|6
7470334|NCT01931566|11772517|FG001|Overall Study|Randomized But Not Treated|9
7470335|NCT01931566|11772518|FG002|Overall Study|Randomized But Not Treated|14
7470336|NCT01931566|11772516|FG000|Overall Study|Adverse Event|37
7470337|NCT01931566|11772517|FG001|Overall Study|Adverse Event|167
7470338|NCT01931566|11772518|FG002|Overall Study|Adverse Event|132
7470339|NCT01931566|11772516|FG000|Overall Study|Major Protocol Deviation|5
7470340|NCT01931566|11772517|FG001|Overall Study|Major Protocol Deviation|14
7470341|NCT01931566|11772518|FG002|Overall Study|Major Protocol Deviation|21
7470342|NCT01931566|11772516|FG000|Overall Study|Lost to Follow-up|3
7470343|NCT01931566|11772517|FG001|Overall Study|Lost to Follow-up|26
7470344|NCT01931566|11772518|FG002|Overall Study|Lost to Follow-up|23
7470345|NCT01931566|11772516|FG000|Overall Study|Voluntary Withdrawal|78
7470346|NCT01931566|11772517|FG001|Overall Study|Voluntary Withdrawal|245
7470347|NCT01931566|11772518|FG002|Overall Study|Voluntary Withdrawal|225
7470348|NCT01931566|11772516|FG000|Overall Study|Study Termination|289
7470349|NCT01931566|11772517|FG001|Overall Study|Study Termination|968
7470350|NCT01931566|11772518|FG002|Overall Study|Study Termination|1037
7470351|NCT01931566|11772516|FG000|Overall Study|Reason Not Specified|11
7470352|NCT01931566|11772517|FG001|Overall Study|Reason Not Specified|47
7470353|NCT01931566|11772518|FG002|Overall Study|Reason Not Specified|53
7470354|NCT01931566|11772516|FG000|Overall Study|Missing|0
7470355|NCT01931566|11772517|FG001|Overall Study|Missing|0
7470356|NCT01931566|11772518|FG002|Overall Study|Missing|1
7470357|NCT01931670|11772530|FG000|Treatment Period|Exclusionary Medication Received|1
7470358|NCT01931670|11772531|FG001|Treatment Period|Exclusionary Medication Received|1
7470359|NCT01931670|11772532|FG002|Treatment Period|Exclusionary Medication Received|1
7470360|NCT01931670|11772530|FG000|Treatment Period|Surgery/Invasive Intervention|4
7470361|NCT01931670|11772531|FG001|Treatment Period|Surgery/Invasive Intervention|2
7470362|NCT01931670|11772532|FG002|Treatment Period|Surgery/Invasive Intervention|0
7470363|NCT01931670|11772530|FG000|Treatment Period|Subject Noncompliant|4
7470364|NCT01931670|11772531|FG001|Treatment Period|Subject Noncompliant|9
7470365|NCT01931670|11772532|FG002|Treatment Period|Subject Noncompliant|5
7470366|NCT01931670|11772530|FG000|Treatment Period|Adverse Event|19
7470367|NCT01931670|11772531|FG001|Treatment Period|Adverse Event|8
7470368|NCT01931670|11772532|FG002|Treatment Period|Adverse Event|21
7470369|NCT01931670|11772530|FG000|Treatment Period|Lack of Efficacy|11
7470370|NCT01931670|11772531|FG001|Treatment Period|Lack of Efficacy|2
7470371|NCT01931670|11772532|FG002|Treatment Period|Lack of Efficacy|2
7470372|NCT01931670|11772530|FG000|Treatment Period|Pregnancy|7
7470373|NCT01931670|11772531|FG001|Treatment Period|Pregnancy|2
7470374|NCT01931670|11772532|FG002|Treatment Period|Pregnancy|0
7470375|NCT01931670|11772530|FG000|Treatment Period|Other|8
7470376|NCT01931670|11772531|FG001|Treatment Period|Other|7
7470377|NCT01931670|11772532|FG002|Treatment Period|Other|2
7470378|NCT01931670|11772530|FG000|Treatment Period|Consent Withdrawn by Subject|17
7470379|NCT01931670|11772531|FG001|Treatment Period|Consent Withdrawn by Subject|12
7470380|NCT01931670|11772532|FG002|Treatment Period|Consent Withdrawn by Subject|7
7470381|NCT01931670|11772530|FG000|Treatment Period|Lost to Follow-up|19
7306448|NCT00642746|11530425|FG001|Overall Study|Patient unevaluable|0
7306449|NCT00642759|11530431|FG000|Overall Study|Protocol Violation|1
7470382|NCT01931670|11772531|FG001|Treatment Period|Lost to Follow-up|5
7470383|NCT01931670|11772532|FG002|Treatment Period|Lost to Follow-up|7
7470384|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
7470385|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7470386|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
7470387|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
7470388|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
7470389|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
7470390|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7470391|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
7470392|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
7470393|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
7470394|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
7470395|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
7470396|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
7470397|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
7470398|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
7470399|NCT01931670|11772530|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7470400|NCT01931670|11772531|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
7470401|NCT01931670|11772532|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
7470402|NCT01931735|11772544|FG000|Randomized Phase|Lost to Follow-up|2
7470403|NCT01931735|11772545|FG001|Randomized Phase|Lost to Follow-up|2
7470404|NCT01931735|11772546|FG002|Randomized Phase|Lost to Follow-up|5
7470405|NCT01931735|11772547|FG003|Randomized Phase|Lost to Follow-up|0
7470406|NCT01931735|11772544|FG000|Observational Non-Randomized Phase|Adverse Event|0
7470407|NCT01931735|11772545|FG001|Observational Non-Randomized Phase|Adverse Event|0
7470408|NCT01931735|11772546|FG002|Observational Non-Randomized Phase|Adverse Event|0
7470409|NCT01931735|11772547|FG003|Observational Non-Randomized Phase|Adverse Event|1
7470410|NCT01931735|11772544|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
7470411|NCT01931735|11772545|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
7470412|NCT01931735|11772546|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
7470413|NCT01931735|11772547|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
7470414|NCT01931839|11772564|FG000|Overall Study|Death|0
7470415|NCT01931839|11772565|FG001|Overall Study|Death|1
7470416|NCT01931839|11772566|FG002|Overall Study|Death|2
7470417|NCT01931839|11772567|FG003|Overall Study|Death|0
7470418|NCT01931839|11772568|FG004|Overall Study|Death|0
7470419|NCT01931839|11772569|FG005|Overall Study|Death|0
7470420|NCT01931839|11772570|FG006|Overall Study|Death|0
7470421|NCT01931839|11772564|FG000|Overall Study|Physician Decision|1
7470422|NCT01931839|11772565|FG001|Overall Study|Physician Decision|0
7470423|NCT01931839|11772566|FG002|Overall Study|Physician Decision|1
7470424|NCT01931839|11772567|FG003|Overall Study|Physician Decision|0
7470425|NCT01931839|11772568|FG004|Overall Study|Physician Decision|0
7470426|NCT01931839|11772569|FG005|Overall Study|Physician Decision|0
7470427|NCT01931839|11772570|FG006|Overall Study|Physician Decision|1
7470428|NCT01931839|11772564|FG000|Overall Study|Withdrawal of consent|0
7470429|NCT01931839|11772565|FG001|Overall Study|Withdrawal of consent|0
7470430|NCT01931839|11772566|FG002|Overall Study|Withdrawal of consent|0
7552392|NCT02991118|11912620|FG000|Overall Study|Death|3
7552393|NCT02991118|11912621|FG001|Overall Study|Death|8
7552394|NCT02991118|11912620|FG000|Overall Study|Protocol Violation|0
7552395|NCT02991118|11912621|FG001|Overall Study|Protocol Violation|3
7552396|NCT02991118|11912620|FG000|Overall Study|Physician Decision|0
7552397|NCT02991118|11912621|FG001|Overall Study|Physician Decision|1
7552398|NCT02991118|11912620|FG000|Overall Study|Moved out of the country|0
7552399|NCT02991118|11912621|FG001|Overall Study|Moved out of the country|1
7552400|NCT02991118|11912620|FG000|Overall Study|Adverse Event|2
7552401|NCT02991118|11912621|FG001|Overall Study|Adverse Event|2
7552402|NCT02991118|11912620|FG000|Overall Study|Withdrawal by Subject|1
7552403|NCT02991118|11912621|FG001|Overall Study|Withdrawal by Subject|7
7552404|NCT02991118|11912620|FG000|Overall Study|Could not attend study visits|0
7552405|NCT02991118|11912621|FG001|Overall Study|Could not attend study visits|1
7552406|NCT02991118|11912620|FG000|Overall Study|Lost to Follow-up|1
7552407|NCT02991118|11912621|FG001|Overall Study|Lost to Follow-up|9
7552408|NCT02991859|11912666|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552409|NCT02991859|11912667|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7552410|NCT02991859|11912668|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7470431|NCT01931839|11772567|FG003|Overall Study|Withdrawal of consent|0
7470432|NCT01931839|11772568|FG004|Overall Study|Withdrawal of consent|1
7470433|NCT01931839|11772569|FG005|Overall Study|Withdrawal of consent|0
7470434|NCT01931839|11772570|FG006|Overall Study|Withdrawal of consent|0
7470435|NCT01931839|11772564|FG000|Overall Study|Adverse Event|9
7470436|NCT01931839|11772565|FG001|Overall Study|Adverse Event|4
7470437|NCT01931839|11772566|FG002|Overall Study|Adverse Event|1
7470438|NCT01931839|11772567|FG003|Overall Study|Adverse Event|3
7470439|NCT01931839|11772568|FG004|Overall Study|Adverse Event|0
7470440|NCT01931839|11772569|FG005|Overall Study|Adverse Event|0
7470441|NCT01931839|11772570|FG006|Overall Study|Adverse Event|1
7470442|NCT01931839|11772564|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
7470443|NCT01931839|11772565|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
7470444|NCT01931839|11772566|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
7470445|NCT01931839|11772567|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
7470446|NCT01931839|11772568|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
7470447|NCT01931839|11772569|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
7470448|NCT01931839|11772570|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
7470449|NCT01931839|11772564|FG000|Overall Study|Other non-compliance|15
7470450|NCT01931839|11772565|FG001|Overall Study|Other non-compliance|9
7470451|NCT01931839|11772566|FG002|Overall Study|Other non-compliance|12
7470452|NCT01931839|11772567|FG003|Overall Study|Other non-compliance|3
7470453|NCT01931839|11772568|FG004|Overall Study|Other non-compliance|0
7470454|NCT01931839|11772569|FG005|Overall Study|Other non-compliance|3
7470455|NCT01931839|11772570|FG006|Overall Study|Other non-compliance|0
7470456|NCT01931839|11772564|FG000|Overall Study|Lost to Follow-up|1
7470457|NCT01931839|11772565|FG001|Overall Study|Lost to Follow-up|2
7470458|NCT01931839|11772566|FG002|Overall Study|Lost to Follow-up|4
7470459|NCT01931839|11772567|FG003|Overall Study|Lost to Follow-up|5
7470460|NCT01931839|11772568|FG004|Overall Study|Lost to Follow-up|0
7552411|NCT02991859|11912669|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7470461|NCT01931839|11772569|FG005|Overall Study|Lost to Follow-up|0
7470462|NCT01931839|11772570|FG006|Overall Study|Lost to Follow-up|0
7470463|NCT01931839|11772564|FG000|Overall Study|Other|4
7470464|NCT01931839|11772565|FG001|Overall Study|Other|2
7470465|NCT01931839|11772566|FG002|Overall Study|Other|6
7470466|NCT01931839|11772567|FG003|Overall Study|Other|0
7470467|NCT01931839|11772568|FG004|Overall Study|Other|0
7470468|NCT01931839|11772569|FG005|Overall Study|Other|0
7470469|NCT01931839|11772570|FG006|Overall Study|Other|0
7470470|NCT01931865|11772590|FG000|Overall Study|Lost to Follow-up|2
7552412|NCT02991859|11912670|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
7552413|NCT02991859|11912671|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7470471|NCT01931865|11772590|FG000|Overall Study|Withdrawal by Subject|2
7470472|NCT01931956|11772610|FG000|Overall Study|Death|42
7470473|NCT01931956|11772611|FG001|Overall Study|Death|7
7470474|NCT01931956|11772612|FG002|Overall Study|Death|379
7552414|NCT02991859|11912672|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552415|NCT02991859|11912673|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552416|NCT02991859|11912674|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552417|NCT02991859|11912675|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552418|NCT02991859|11912676|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552419|NCT02991859|11912677|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552420|NCT02991859|11912678|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552421|NCT02991859|11912679|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552422|NCT02991859|11912680|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552423|NCT02991859|11912681|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552424|NCT02991859|11912682|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
7552425|NCT02991859|11912666|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552426|NCT02991859|11912667|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552427|NCT02991859|11912668|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552428|NCT02991859|11912669|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552429|NCT02991859|11912670|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552430|NCT02991859|11912671|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552431|NCT02991859|11912672|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552432|NCT02991859|11912673|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552433|NCT02991859|11912674|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552434|NCT02991859|11912675|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552435|NCT02991859|11912676|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552436|NCT02991859|11912677|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552437|NCT02991859|11912678|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7552438|NCT02991859|11912679|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
7552439|NCT02991859|11912680|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552440|NCT02991859|11912681|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552441|NCT02991859|11912682|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
7552442|NCT02991859|11912666|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552443|NCT02991859|11912667|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552444|NCT02991859|11912668|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552445|NCT02991859|11912669|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552446|NCT02991859|11912670|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552447|NCT02991859|11912671|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
7552448|NCT02991859|11912672|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552449|NCT02991859|11912673|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552450|NCT02991859|11912674|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552451|NCT02991859|11912675|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
7224516|NCT00054275|11433727|FG000|Overall Study|Withdrawal by Subject|4
7224517|NCT00054275|11433727|FG000|Overall Study|Adverse Event|5
7224518|NCT00054275|11433727|FG000|Overall Study|Progressive disease in cycle 1|1
7224519|NCT00054275|11433727|FG000|Overall Study|Physician Decision|1
7224520|NCT00054327|11433737|FG000|Overall Study|Engraftment failure|1
7224521|NCT00054327|11433738|FG001|Overall Study|Engraftment failure|0
7224522|NCT00054327|11433739|FG002|Overall Study|Engraftment failure|0
7224523|NCT00054327|11433740|FG003|Overall Study|Engraftment failure|0
7224524|NCT00054327|11433741|FG004|Overall Study|Engraftment failure|0
7224525|NCT00054327|11433742|FG005|Overall Study|Engraftment failure|0
7255444|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Protocol Violation|4
7255445|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Protocol Violation|4
7255446|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Protocol Violation|4
7255447|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Protocol Violation|5
7255448|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Lost to follow up|0
7255449|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Lost to follow up|1
7255450|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Lost to follow up|0
7255451|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Lost to follow up|0
7255452|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Lost to follow up|0
7255453|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7255454|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
7255455|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7255456|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7255457|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
7255458|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Consent withdrawn|0
7255459|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Consent withdrawn|3
7255460|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Consent withdrawn|4
7255461|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Consent withdrawn|10
7255462|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Consent withdrawn|4
7255463|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7470475|NCT01931956|11772613|FG003|Overall Study|Death|96
7470476|NCT01931956|11772610|FG000|Overall Study|Withdrawal by Subject|5
7470477|NCT01931956|11772611|FG001|Overall Study|Withdrawal by Subject|0
7470478|NCT01931956|11772612|FG002|Overall Study|Withdrawal by Subject|70
7470479|NCT01931956|11772613|FG003|Overall Study|Withdrawal by Subject|30
7470480|NCT01931956|11772610|FG000|Overall Study|Lost to Follow-up|2
7470481|NCT01931956|11772611|FG001|Overall Study|Lost to Follow-up|0
7470482|NCT01931956|11772612|FG002|Overall Study|Lost to Follow-up|11
7470483|NCT01931956|11772613|FG003|Overall Study|Lost to Follow-up|7
7470484|NCT01931956|11772610|FG000|Overall Study|Expected|2
7470485|NCT01931956|11772611|FG001|Overall Study|Expected|0
7470486|NCT01931956|11772612|FG002|Overall Study|Expected|6
7470487|NCT01931956|11772613|FG003|Overall Study|Expected|0
7470488|NCT01931956|11772610|FG000|Overall Study|Not due|0
7552452|NCT02991859|11912676|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552453|NCT02991859|11912677|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552454|NCT02991859|11912678|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552455|NCT02991859|11912679|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552456|NCT02991859|11912680|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
7306450|NCT00642772|11530436|FG000|Overall Study|Lost to Follow-up|3
7306451|NCT00642772|11530436|FG000|Overall Study|Withdrawal by Subject|7
7306452|NCT00642811|11530446|FG000|Overall Study|Adverse Event|2
7306453|NCT00642811|11530447|FG001|Overall Study|Adverse Event|3
7306454|NCT00642811|11530448|FG002|Overall Study|Adverse Event|0
7306455|NCT00642811|11530449|FG003|Overall Study|Adverse Event|0
7306456|NCT00642811|11530450|FG004|Overall Study|Adverse Event|0
7306457|NCT00642811|11530451|FG005|Overall Study|Adverse Event|1
7306458|NCT00642811|11530446|FG000|Overall Study|Developement of discontinuation criteria|0
7306459|NCT00642811|11530447|FG001|Overall Study|Developement of discontinuation criteria|0
7306460|NCT00642811|11530448|FG002|Overall Study|Developement of discontinuation criteria|0
7306461|NCT00642811|11530449|FG003|Overall Study|Developement of discontinuation criteria|0
7306462|NCT00642811|11530450|FG004|Overall Study|Developement of discontinuation criteria|1
7306463|NCT00642811|11530451|FG005|Overall Study|Developement of discontinuation criteria|0
7306464|NCT00642811|11530446|FG000|Overall Study|Severe Non-compliance to protocol|1
7306465|NCT00642811|11530447|FG001|Overall Study|Severe Non-compliance to protocol|0
7306466|NCT00642811|11530448|FG002|Overall Study|Severe Non-compliance to protocol|0
7306467|NCT00642811|11530449|FG003|Overall Study|Severe Non-compliance to protocol|0
7306468|NCT00642811|11530450|FG004|Overall Study|Severe Non-compliance to protocol|0
7306469|NCT00642811|11530451|FG005|Overall Study|Severe Non-compliance to protocol|0
7306470|NCT00642811|11530446|FG000|Overall Study|Other|0
7306471|NCT00642811|11530447|FG001|Overall Study|Other|1
7306472|NCT00642811|11530448|FG002|Overall Study|Other|0
7306473|NCT00642811|11530449|FG003|Overall Study|Other|1
7306474|NCT00642811|11530450|FG004|Overall Study|Other|0
7306475|NCT00642811|11530451|FG005|Overall Study|Other|0
7306476|NCT00642850|11530465|FG000|Overall Study|Death|7
7306477|NCT00642850|11530465|FG000|Overall Study|Adverse Event|2
7306478|NCT00642850|11530465|FG000|Overall Study|Lack of Efficacy|1
7306479|NCT00642850|11530465|FG000|Overall Study|Protocol Violation|2
7306480|NCT00642850|11530465|FG000|Overall Study|Kidney transplantation|8
7306481|NCT00642850|11530465|FG000|Overall Study|Blood transfusion|6
7306482|NCT00642850|11530465|FG000|Overall Study|Other reasons|7
7306483|NCT00642902|11530473|FG000|Overall Study|Adverse Event|0
7306484|NCT00642902|11530474|FG001|Overall Study|Adverse Event|1
7306485|NCT00642902|11530475|FG002|Overall Study|Adverse Event|3
7306486|NCT00642902|11530476|FG003|Overall Study|Adverse Event|1
7306487|NCT00642902|11530473|FG000|Overall Study|Lost to Follow-up|1
7306488|NCT00642902|11530474|FG001|Overall Study|Lost to Follow-up|1
7306489|NCT00642902|11530475|FG002|Overall Study|Lost to Follow-up|0
7306490|NCT00642902|11530476|FG003|Overall Study|Lost to Follow-up|0
7306491|NCT00642902|11530473|FG000|Overall Study|Lack of Efficacy|0
7306492|NCT00642902|11530474|FG001|Overall Study|Lack of Efficacy|3
7306493|NCT00642902|11530475|FG002|Overall Study|Lack of Efficacy|3
7306494|NCT00642902|11530476|FG003|Overall Study|Lack of Efficacy|0
7306495|NCT00642902|11530473|FG000|Overall Study|Death|1
7306496|NCT00642902|11530474|FG001|Overall Study|Death|0
7306497|NCT00642902|11530475|FG002|Overall Study|Death|0
7306498|NCT00642902|11530476|FG003|Overall Study|Death|0
7306499|NCT00642902|11530473|FG000|Overall Study|Premature termination of clinical trial|37
7306500|NCT00642902|11530474|FG001|Overall Study|Premature termination of clinical trial|32
7306501|NCT00642902|11530475|FG002|Overall Study|Premature termination of clinical trial|35
7306502|NCT00642902|11530476|FG003|Overall Study|Premature termination of clinical trial|35
7306503|NCT00642902|11530473|FG000|Overall Study|Randomized, but not treated|0
7306504|NCT00642902|11530474|FG001|Overall Study|Randomized, but not treated|0
7306505|NCT00642902|11530475|FG002|Overall Study|Randomized, but not treated|1
7306506|NCT00642902|11530476|FG003|Overall Study|Randomized, but not treated|0
7306507|NCT00642902|11530473|FG000|Overall Study|Other|1
7306508|NCT00642902|11530474|FG001|Overall Study|Other|5
7306509|NCT00642902|11530475|FG002|Overall Study|Other|1
7306510|NCT00642902|11530476|FG003|Overall Study|Other|4
7306511|NCT00642941|11530498|FG000|Overall Study|Physician Decision|3
7306512|NCT00642941|11530499|FG001|Overall Study|Physician Decision|1
7306513|NCT00642941|11530500|FG002|Overall Study|Physician Decision|0
7306514|NCT00642941|11530501|FG003|Overall Study|Physician Decision|0
7470489|NCT01931956|11772611|FG001|Overall Study|Not due|0
7470490|NCT01931956|11772612|FG002|Overall Study|Not due|21
7552457|NCT02991859|11912681|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552458|NCT02991859|11912682|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
7552459|NCT02991859|11912666|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
7552460|NCT02991859|11912667|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
7552461|NCT02991859|11912668|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
7552462|NCT02991859|11912669|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
7552463|NCT02991859|11912670|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
7552464|NCT02991859|11912671|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
7552465|NCT02991859|11912672|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
7552466|NCT02991859|11912673|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
7552467|NCT02991859|11912674|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
7552468|NCT02991859|11912675|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
7552469|NCT02991859|11912676|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
7552470|NCT02991859|11912677|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
7552471|NCT02991859|11912678|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
7552472|NCT02991859|11912679|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
7552473|NCT02991859|11912680|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
7552474|NCT02991859|11912681|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
7552475|NCT02991859|11912682|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
7552476|NCT02991859|11912666|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552477|NCT02991859|11912667|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552478|NCT02991859|11912668|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552479|NCT02991859|11912669|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552480|NCT02991859|11912670|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552481|NCT02991859|11912671|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552482|NCT02991859|11912672|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552483|NCT02991859|11912673|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552484|NCT02991859|11912674|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
7552485|NCT02991859|11912675|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552486|NCT02991859|11912676|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552487|NCT02991859|11912677|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552488|NCT02991859|11912678|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552489|NCT02991859|11912679|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552490|NCT02991859|11912680|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552491|NCT02991859|11912681|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552492|NCT02991859|11912682|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
7552493|NCT02992132|11912768|FG000|Overall Study|Adverse Event|4
7552494|NCT02992132|11912769|FG001|Overall Study|Adverse Event|1
7552495|NCT02992132|11912770|FG002|Overall Study|Adverse Event|3
7552496|NCT02992132|11912768|FG000|Overall Study|Lack of Efficacy|2
7552497|NCT02992132|11912769|FG001|Overall Study|Lack of Efficacy|0
7552498|NCT02992132|11912770|FG002|Overall Study|Lack of Efficacy|0
7552499|NCT02992132|11912768|FG000|Overall Study|Non-compliance with study drug|2
7552500|NCT02992132|11912769|FG001|Overall Study|Non-compliance with study drug|0
7552501|NCT02992132|11912770|FG002|Overall Study|Non-compliance with study drug|0
7552502|NCT02992132|11912768|FG000|Overall Study|Progressive disease|1
7552503|NCT02992132|11912769|FG001|Overall Study|Progressive disease|0
7552504|NCT02992132|11912770|FG002|Overall Study|Progressive disease|0
7552505|NCT02992132|11912768|FG000|Overall Study|Protocol Violation|2
7552506|NCT02992132|11912769|FG001|Overall Study|Protocol Violation|2
7552507|NCT02992132|11912770|FG002|Overall Study|Protocol Violation|0
7552508|NCT02992132|11912768|FG000|Overall Study|Caregiver withdrew consent|2
7552509|NCT02992132|11912769|FG001|Overall Study|Caregiver withdrew consent|3
7552510|NCT02992132|11912770|FG002|Overall Study|Caregiver withdrew consent|2
7552511|NCT02992132|11912768|FG000|Overall Study|Withdrawal by Subject|0
7552512|NCT02992132|11912769|FG001|Overall Study|Withdrawal by Subject|2
7552513|NCT02992132|11912770|FG002|Overall Study|Withdrawal by Subject|1
7552514|NCT02992132|11912768|FG000|Overall Study|Physician Decision|0
7552515|NCT02992132|11912769|FG001|Overall Study|Physician Decision|0
7552516|NCT02992132|11912770|FG002|Overall Study|Physician Decision|1
7552517|NCT02992288|11912804|FG000|Overall Study|Adverse Event|8
7552518|NCT02992288|11912805|FG001|Overall Study|Adverse Event|2
7552519|NCT02992288|11912806|FG002|Overall Study|Adverse Event|2
7552520|NCT02992288|11912807|FG003|Overall Study|Adverse Event|2
7552521|NCT02992288|11912808|FG004|Overall Study|Adverse Event|2
7552522|NCT02992288|11912809|FG005|Overall Study|Adverse Event|7
7552523|NCT02992288|11912804|FG000|Overall Study|Non-compliance with study drug|0
7552524|NCT02992288|11912805|FG001|Overall Study|Non-compliance with study drug|1
7552525|NCT02992288|11912806|FG002|Overall Study|Non-compliance with study drug|1
7552526|NCT02992288|11912807|FG003|Overall Study|Non-compliance with study drug|0
7552527|NCT02992288|11912808|FG004|Overall Study|Non-compliance with study drug|1
7552528|NCT02992288|11912809|FG005|Overall Study|Non-compliance with study drug|0
7552529|NCT02992288|11912804|FG000|Overall Study|Physician Decision|3
7552530|NCT02992288|11912805|FG001|Overall Study|Physician Decision|0
7552531|NCT02992288|11912806|FG002|Overall Study|Physician Decision|1
7552532|NCT02992288|11912807|FG003|Overall Study|Physician Decision|0
7552533|NCT02992288|11912808|FG004|Overall Study|Physician Decision|0
7552534|NCT02992288|11912809|FG005|Overall Study|Physician Decision|1
7552535|NCT02992288|11912804|FG000|Overall Study|Death|2
7552536|NCT02992288|11912805|FG001|Overall Study|Death|0
7552537|NCT02992288|11912806|FG002|Overall Study|Death|2
7552538|NCT02992288|11912807|FG003|Overall Study|Death|1
7552539|NCT02992288|11912808|FG004|Overall Study|Death|2
7552540|NCT02992288|11912809|FG005|Overall Study|Death|0
7552541|NCT02992288|11912804|FG000|Overall Study|Lost to Follow-up|0
7552542|NCT02992288|11912805|FG001|Overall Study|Lost to Follow-up|0
7552543|NCT02992288|11912806|FG002|Overall Study|Lost to Follow-up|0
7552544|NCT02992288|11912807|FG003|Overall Study|Lost to Follow-up|1
7552545|NCT02992288|11912808|FG004|Overall Study|Lost to Follow-up|0
7552546|NCT02992288|11912809|FG005|Overall Study|Lost to Follow-up|0
7552547|NCT02992288|11912804|FG000|Overall Study|Protocol Violation|0
7552548|NCT02992288|11912805|FG001|Overall Study|Protocol Violation|0
7552549|NCT02992288|11912806|FG002|Overall Study|Protocol Violation|0
7552550|NCT02992288|11912807|FG003|Overall Study|Protocol Violation|0
7552551|NCT02992288|11912808|FG004|Overall Study|Protocol Violation|0
7552552|NCT02992288|11912809|FG005|Overall Study|Protocol Violation|1
7552553|NCT02992288|11912804|FG000|Overall Study|Withdrawal by Subject|4
7552554|NCT02992288|11912805|FG001|Overall Study|Withdrawal by Subject|2
7552555|NCT02992288|11912806|FG002|Overall Study|Withdrawal by Subject|1
7552556|NCT02992288|11912807|FG003|Overall Study|Withdrawal by Subject|5
7552557|NCT02992288|11912808|FG004|Overall Study|Withdrawal by Subject|3
7552558|NCT02992288|11912809|FG005|Overall Study|Withdrawal by Subject|4
7552559|NCT02992691|11912823|FG000|Overall Study|Adverse Event|2
7552560|NCT02992691|11912823|FG000|Overall Study|Withdrawal by Subject|1
7552561|NCT02992899|11912840|FG000|Overall Study|Withdrawal by Subject|1
7552562|NCT02992899|11912841|FG001|Overall Study|Withdrawal by Subject|0
7552563|NCT02992899|11912840|FG000|Overall Study|Lost to Follow-up|1
7552564|NCT02992899|11912841|FG001|Overall Study|Lost to Follow-up|3
7552565|NCT02993224|11912847|FG000|Core Phase - Period 1|Adverse Event|4
7552566|NCT02993224|11912847|FG000|Core Phase - Period 1|Withdrawal by Subject|1
7552567|NCT02993224|11912847|FG000|Core Phase - Period 1|Lost to Follow-up|3
7552568|NCT02993224|11912847|FG000|Core Phase- Period 2|Adverse Event|1
7552569|NCT02993224|11912847|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
7552570|NCT02993224|11912847|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1
7552571|NCT02993224|11912847|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
7552572|NCT02993224|11912847|FG000|Extension Phase|Adverse Event|3
7552573|NCT02993224|11912847|FG000|Extension Phase|Withdrawal by Subject|3
7552574|NCT02993224|11912847|FG000|Extension Phase|Lost to Follow-up|2
7552575|NCT02993224|11912847|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27
7552576|NCT02993250|11912855|FG000|Overall Study|Lost to Follow-up|0
7552577|NCT02993250|11912856|FG001|Overall Study|Lost to Follow-up|1
7552578|NCT02993471|11912880|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
7552579|NCT02993471|11912880|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
7552580|NCT02993783|11912904|FG000|Overall Study|Reason not Specified|6
7552581|NCT02993783|11912905|FG001|Overall Study|Reason not Specified|9
7552582|NCT02994056|11912911|FG000|Overall Study|Death|8
7552583|NCT02994056|11912911|FG000|Overall Study|Withdrew Consent|1
7552584|NCT02994108|11912926|FG000|Intervention Messages|Withdrawal by Subject|2
7552585|NCT02994108|11912927|FG001|Intervention Messages|Withdrawal by Subject|0
7552586|NCT02994108|11912926|FG000|Phase 1 Assessment|Lost to Follow-up|5
7552587|NCT02994108|11912927|FG001|Phase 1 Assessment|Lost to Follow-up|3
7552588|NCT02994108|11912926|FG000|Phase 2 Assessment|Lost to Follow-up|8
7552589|NCT02994108|11912927|FG001|Phase 2 Assessment|Lost to Follow-up|7
7552590|NCT02994108|11912926|FG000|Phase 2 Assessment|Withdrawal by Subject|1
7552591|NCT02994108|11912927|FG001|Phase 2 Assessment|Withdrawal by Subject|0
7552592|NCT02994394|11912945|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
7552593|NCT02994394|11912946|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
7552594|NCT02994394|11912947|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
7552595|NCT02994394|11912948|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
7552596|NCT02994394|11912949|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
7552597|NCT02994394|11912950|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
7552598|NCT02994394|11912945|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
7552599|NCT02994394|11912946|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
7552600|NCT02994394|11912947|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
7552601|NCT02994394|11912948|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
7552602|NCT02994394|11912949|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
7552603|NCT02994394|11912950|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
7552604|NCT02994654|11912964|FG000|Overall Study|Lost to Follow-up|1
7552605|NCT02994940|11912976|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
7552606|NCT02994940|11912977|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
7552607|NCT02994940|11912976|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
7552608|NCT02994940|11912977|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
7552609|NCT02994940|11912976|FG000|Overall Study|Did not receive study medications: red dye allergy|0
7552610|NCT02994940|11912977|FG001|Overall Study|Did not receive study medications: red dye allergy|1
7552611|NCT02995980|11913001|FG000|Overall Study|Lost to Follow-up|14
7552612|NCT02996097|11913006|FG000|Overall Study|Lost to Follow-up|11
7552613|NCT02996097|11913007|FG001|Overall Study|Lost to Follow-up|11
7552614|NCT02996448|11913012|FG000|Overall Study|Study terminated due to adverse effects|3
7552615|NCT02996474|11913017|FG000|Overall Study|Physician Decision|5
7552616|NCT02996500|11913027|FG000|Overall Study|Adverse Event|1
7552617|NCT02996500|11913028|FG001|Overall Study|Adverse Event|1
7552618|NCT02996500|11913029|FG002|Overall Study|Adverse Event|4
7552619|NCT02996500|11913030|FG003|Overall Study|Adverse Event|3
7552620|NCT02996500|11913031|FG004|Overall Study|Adverse Event|1
7552621|NCT02996500|11913032|FG005|Overall Study|Adverse Event|2
7552622|NCT02996500|11913027|FG000|Overall Study|Lack of Efficacy|0
7552623|NCT02996500|11913028|FG001|Overall Study|Lack of Efficacy|0
7552624|NCT02996500|11913029|FG002|Overall Study|Lack of Efficacy|0
7552625|NCT02996500|11913030|FG003|Overall Study|Lack of Efficacy|0
7552626|NCT02996500|11913031|FG004|Overall Study|Lack of Efficacy|2
7552627|NCT02996500|11913032|FG005|Overall Study|Lack of Efficacy|0
7552628|NCT02996500|11913027|FG000|Overall Study|Lost to Follow-up|1
7552629|NCT02996500|11913028|FG001|Overall Study|Lost to Follow-up|0
7552630|NCT02996500|11913029|FG002|Overall Study|Lost to Follow-up|0
7552631|NCT02996500|11913030|FG003|Overall Study|Lost to Follow-up|0
7552632|NCT02996500|11913031|FG004|Overall Study|Lost to Follow-up|0
7552633|NCT02996500|11913032|FG005|Overall Study|Lost to Follow-up|1
7552634|NCT02996500|11913027|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7552635|NCT02996500|11913028|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7552636|NCT02996500|11913029|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7552637|NCT02996500|11913030|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7552638|NCT02996500|11913031|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7552639|NCT02996500|11913032|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7552640|NCT02996500|11913027|FG000|Overall Study|Non-Compliance With Study Drug|0
7552641|NCT02996500|11913028|FG001|Overall Study|Non-Compliance With Study Drug|0
7552642|NCT02996500|11913029|FG002|Overall Study|Non-Compliance With Study Drug|0
7552643|NCT02996500|11913030|FG003|Overall Study|Non-Compliance With Study Drug|0
7552644|NCT02996500|11913031|FG004|Overall Study|Non-Compliance With Study Drug|0
7552645|NCT02996500|11913032|FG005|Overall Study|Non-Compliance With Study Drug|1
7552646|NCT02996500|11913027|FG000|Overall Study|Progressive Disease|1
7552647|NCT02996500|11913028|FG001|Overall Study|Progressive Disease|0
7552648|NCT02996500|11913029|FG002|Overall Study|Progressive Disease|0
7552649|NCT02996500|11913030|FG003|Overall Study|Progressive Disease|0
7552650|NCT02996500|11913031|FG004|Overall Study|Progressive Disease|0
7552651|NCT02996500|11913032|FG005|Overall Study|Progressive Disease|0
7552652|NCT02996500|11913027|FG000|Overall Study|Other|2
7552653|NCT02996500|11913028|FG001|Overall Study|Other|0
7552654|NCT02996500|11913029|FG002|Overall Study|Other|2
7552655|NCT02996500|11913030|FG003|Overall Study|Other|0
7552656|NCT02996500|11913031|FG004|Overall Study|Other|0
7552657|NCT02996500|11913032|FG005|Overall Study|Other|0
7552658|NCT02996500|11913027|FG000|Overall Study|Protocol Violation|0
7552659|NCT02996500|11913028|FG001|Overall Study|Protocol Violation|0
7552660|NCT02996500|11913029|FG002|Overall Study|Protocol Violation|0
7552661|NCT02996500|11913030|FG003|Overall Study|Protocol Violation|1
7552662|NCT02996500|11913031|FG004|Overall Study|Protocol Violation|0
7552663|NCT02996500|11913032|FG005|Overall Study|Protocol Violation|0
7552664|NCT02996500|11913027|FG000|Overall Study|Withdrawal by Subject|3
7552665|NCT02996500|11913028|FG001|Overall Study|Withdrawal by Subject|0
7552666|NCT02996500|11913029|FG002|Overall Study|Withdrawal by Subject|3
7552667|NCT02996500|11913030|FG003|Overall Study|Withdrawal by Subject|0
7552668|NCT02996500|11913031|FG004|Overall Study|Withdrawal by Subject|2
7552669|NCT02996500|11913032|FG005|Overall Study|Withdrawal by Subject|0
7552670|NCT02996682|11913061|FG000|Overall Study|Death|0
7552671|NCT02996682|11913062|FG001|Overall Study|Death|3
7552672|NCT02996968|11913079|FG000|Overall Study|Withdrawal by Subject|1
7552673|NCT02996968|11913080|FG001|Overall Study|Withdrawal by Subject|0
7552674|NCT02997163|11913102|FG000|Overall Study|Adverse Event|1
7552675|NCT02997163|11913103|FG001|Overall Study|Adverse Event|0
7552676|NCT02997163|11913104|FG002|Overall Study|Adverse Event|0
7552677|NCT02997163|11913105|FG003|Overall Study|Adverse Event|1
7552678|NCT02997176|11913119|FG000|Overall Study|Adverse Event|0
7552679|NCT02997176|11913120|FG001|Overall Study|Adverse Event|0
7552680|NCT02997176|11913121|FG002|Overall Study|Adverse Event|0
7552681|NCT02997176|11913122|FG003|Overall Study|Adverse Event|8
7552682|NCT02997176|11913119|FG000|Overall Study|Progressive Disease|1
7552683|NCT02997176|11913120|FG001|Overall Study|Progressive Disease|0
7552684|NCT02997176|11913121|FG002|Overall Study|Progressive Disease|1
7552685|NCT02997176|11913122|FG003|Overall Study|Progressive Disease|1
7552686|NCT02997176|11913119|FG000|Overall Study|Death|0
7552687|NCT02997176|11913120|FG001|Overall Study|Death|0
7552688|NCT02997176|11913121|FG002|Overall Study|Death|1
7552689|NCT02997176|11913122|FG003|Overall Study|Death|1
7552690|NCT02997176|11913119|FG000|Overall Study|Withdrawal by Subject|0
7552691|NCT02997176|11913120|FG001|Overall Study|Withdrawal by Subject|2
7552692|NCT02997176|11913121|FG002|Overall Study|Withdrawal by Subject|0
7552693|NCT02997176|11913122|FG003|Overall Study|Withdrawal by Subject|1
7574504|NCT03682120|11957410|FG002|Overall Study|Withdrawal by Subject|3
7574505|NCT03682120|11957411|FG003|Overall Study|Withdrawal by Subject|0
7574506|NCT03682120|11957408|FG000|Overall Study|Death|0
7574507|NCT03682120|11957409|FG001|Overall Study|Death|1
7574508|NCT03682120|11957410|FG002|Overall Study|Death|0
7552694|NCT02998021|11913165|FG000|Overall Study|Withdrawal by Subject|3
7552695|NCT02998021|11913166|FG001|Overall Study|Withdrawal by Subject|1
7552696|NCT02998021|11913165|FG000|Overall Study|unsafe home|0
7552697|NCT02998021|11913166|FG001|Overall Study|unsafe home|1
7552698|NCT02998151|11913172|FG000|Overall Study|Withdrawal by Subject|3
7552699|NCT02998151|11913172|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
7552700|NCT02998151|11913172|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
7552701|NCT02998541|11913187|FG000|Overall Study|Adverse Event|4
7552702|NCT02998541|11913188|FG001|Overall Study|Adverse Event|5
7552703|NCT02998541|11913189|FG002|Overall Study|Adverse Event|1
7552704|NCT02998541|11913187|FG000|Overall Study|Protocol Violation|1
7552705|NCT02998541|11913188|FG001|Overall Study|Protocol Violation|0
7552706|NCT02998541|11913189|FG002|Overall Study|Protocol Violation|0
7552707|NCT02998541|11913187|FG000|Overall Study|Withdrawal by Subject|3
7552708|NCT02998541|11913188|FG001|Overall Study|Withdrawal by Subject|1
7552709|NCT02998541|11913189|FG002|Overall Study|Withdrawal by Subject|0
7552710|NCT02998541|11913187|FG000|Overall Study|Lost to Follow-up|0
7552711|NCT02998541|11913188|FG001|Overall Study|Lost to Follow-up|3
7552712|NCT02998541|11913189|FG002|Overall Study|Lost to Follow-up|1
7552713|NCT02998541|11913187|FG000|Overall Study|Physician Decision|0
7552714|NCT02998541|11913188|FG001|Overall Study|Physician Decision|0
7552715|NCT02998541|11913189|FG002|Overall Study|Physician Decision|3
7552716|NCT02998541|11913187|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7552717|NCT02998541|11913188|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7552718|NCT02998541|11913189|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7552719|NCT02998554|11913199|FG000|Overall Study|Adverse Event|8
7552720|NCT02998554|11913200|FG001|Overall Study|Adverse Event|3
7552721|NCT02998554|11913199|FG000|Overall Study|Protocol deviation|1
7552722|NCT02998554|11913200|FG001|Overall Study|Protocol deviation|0
7552723|NCT02998554|11913199|FG000|Overall Study|Withdrawal by Subject|2
7552724|NCT02998554|11913200|FG001|Overall Study|Withdrawal by Subject|6
7552725|NCT02998554|11913199|FG000|Overall Study|Lost to Follow-up|0
7552726|NCT02998554|11913200|FG001|Overall Study|Lost to Follow-up|1
7552727|NCT02998554|11913199|FG000|Overall Study|Lack of Efficacy|0
7552728|NCT02998554|11913200|FG001|Overall Study|Lack of Efficacy|1
7552729|NCT02998996|11913223|FG000|Overall Study|Lost to Follow-up|0
7552730|NCT02998996|11913224|FG001|Overall Study|Lost to Follow-up|0
7552731|NCT02998996|11913225|FG002|Overall Study|Lost to Follow-up|1
7552732|NCT02998996|11913226|FG003|Overall Study|Lost to Follow-up|0
7552733|NCT02998996|11913227|FG004|Overall Study|Lost to Follow-up|0
7552734|NCT02998996|11913228|FG005|Overall Study|Lost to Follow-up|0
7306515|NCT00642941|11530502|FG004|Overall Study|Physician Decision|0
7306516|NCT00642941|11530503|FG005|Overall Study|Physician Decision|0
7306517|NCT00642941|11530504|FG006|Overall Study|Physician Decision|1
7306518|NCT00642941|11530505|FG007|Overall Study|Physician Decision|0
7388607|NCT01221948|11647771|FG000|Overall Study|Physician Decision|5
7388608|NCT01221948|11647771|FG000|Overall Study|Withdrawal by Subject|2
7388609|NCT01221948|11647771|FG000|Overall Study|not disclosed|2
7388610|NCT01221948|11647771|FG000|Overall Study|Death|1
7388611|NCT01221948|11647771|FG000|Overall Study|Protocol Violation|4
7388612|NCT01222078|11647775|FG000|Overall Study|Early termination of the study|1
7388613|NCT01222104|11647787|FG000|Overall Study|Lost to Follow-up|37
7388614|NCT01222104|11647787|FG000|Overall Study|Death|10
7388615|NCT01222403|11647900|FG000|Overall Study|Inappropriate enrollment|0
7388616|NCT01222403|11647901|FG001|Overall Study|Inappropriate enrollment|2
7388617|NCT01222416|11647909|FG000|Overall Study|ineligible;metastasis|3
7388618|NCT01222416|11647910|FG001|Overall Study|ineligible;metastasis|0
7388619|NCT01222416|11647909|FG000|Overall Study|Adverse Event|4
7388620|NCT01222416|11647910|FG001|Overall Study|Adverse Event|0
7388621|NCT01222416|11647909|FG000|Overall Study|Withdrawal by Subject|5
7388622|NCT01222416|11647910|FG001|Overall Study|Withdrawal by Subject|0
7388623|NCT01222416|11647909|FG000|Overall Study|scheduling|6
7388624|NCT01222416|11647910|FG001|Overall Study|scheduling|0
7388625|NCT01222416|11647909|FG000|Overall Study|missed view/scan|1
7388626|NCT01222416|11647910|FG001|Overall Study|missed view/scan|0
7388627|NCT01222416|11647909|FG000|Overall Study|Death|1
7388628|NCT01222416|11647910|FG001|Overall Study|Death|0
7388629|NCT01222507|11647929|FG000|Overall Study|Physician Decision|1
7388630|NCT01222507|11647929|FG000|Overall Study|Withdrawal by Subject|1
7388631|NCT01222520|11647935|FG000|Open-label run-in Period|Withdrawal by Subject|0
7552735|NCT02998996|11913223|FG000|Overall Study|Pregnancy|0
7552736|NCT02998996|11913224|FG001|Overall Study|Pregnancy|1
7552737|NCT02998996|11913225|FG002|Overall Study|Pregnancy|0
7552738|NCT02998996|11913226|FG003|Overall Study|Pregnancy|0
7552739|NCT02998996|11913227|FG004|Overall Study|Pregnancy|0
7552740|NCT02998996|11913228|FG005|Overall Study|Pregnancy|0
7306519|NCT00642941|11530506|FG008|Overall Study|Physician Decision|0
7306520|NCT00642941|11530507|FG009|Overall Study|Physician Decision|1
7388632|NCT01222520|11647936|FG001|Open-label run-in Period|Withdrawal by Subject|2
7388633|NCT01222520|11647935|FG000|Open-label run-in Period|Blood pressure criteria not met|0
7388634|NCT01222520|11647936|FG001|Open-label run-in Period|Blood pressure criteria not met|18
7388635|NCT01222520|11647935|FG000|Open-label run-in Period|Number of patients fulfilled|0
7552741|NCT02998996|11913223|FG000|Overall Study|Family reasons|0
7552742|NCT02998996|11913224|FG001|Overall Study|Family reasons|0
7552743|NCT02998996|11913225|FG002|Overall Study|Family reasons|0
7552744|NCT02998996|11913226|FG003|Overall Study|Family reasons|0
7552745|NCT02998996|11913227|FG004|Overall Study|Family reasons|1
7552746|NCT02998996|11913228|FG005|Overall Study|Family reasons|0
7552747|NCT02999100|11913248|FG000|Part 1 (up to 15 Days)|Adverse Event|0
7552748|NCT02999100|11913249|FG001|Part 1 (up to 15 Days)|Adverse Event|1
7552749|NCT02999100|11913250|FG002|Part 1 (up to 15 Days)|Adverse Event|0
7552750|NCT02999100|11913251|FG003|Part 1 (up to 15 Days)|Adverse Event|0
7552751|NCT02999100|11913252|FG004|Part 1 (up to 15 Days)|Adverse Event|0
7552752|NCT02999100|11913253|FG005|Part 1 (up to 15 Days)|Adverse Event|0
7552753|NCT02999100|11913248|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7552754|NCT02999100|11913249|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7552755|NCT02999100|11913250|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7552756|NCT02999100|11913251|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7552757|NCT02999100|11913252|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
7552758|NCT02999100|11913253|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
7552759|NCT02999100|11913248|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7552760|NCT02999100|11913249|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7552761|NCT02999100|11913250|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
7552762|NCT02999100|11913251|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7552763|NCT02999100|11913252|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7552764|NCT02999100|11913253|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
7552765|NCT02999178|11913277|FG000|Overall Study|Adverse Event|85
7552766|NCT02999178|11913278|FG001|Overall Study|Adverse Event|62
7552767|NCT02999178|11913277|FG000|Overall Study|Protocol Violation|1
7552768|NCT02999178|11913278|FG001|Overall Study|Protocol Violation|2
7552769|NCT02999178|11913277|FG000|Overall Study|Lost to Follow-up|0
7552770|NCT02999178|11913278|FG001|Overall Study|Lost to Follow-up|2
7552771|NCT02999178|11913277|FG000|Overall Study|Withdrawal by Subject|21
7552772|NCT02999178|11913278|FG001|Overall Study|Withdrawal by Subject|21
7552773|NCT02999178|11913277|FG000|Overall Study|Other reason not defined above|7
7552774|NCT02999178|11913278|FG001|Overall Study|Other reason not defined above|13
7552775|NCT02999191|11913287|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
7552776|NCT02999191|11913288|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
7552777|NCT02999191|11913289|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
7552778|NCT02999672|11913299|FG000|Overall Study|Death|0
7552779|NCT02999672|11913300|FG001|Overall Study|Death|1
7552780|NCT02999672|11913299|FG000|Overall Study|Study Terminated by Sponsor|0
7552781|NCT02999672|11913300|FG001|Overall Study|Study Terminated by Sponsor|1
7552782|NCT02999672|11913299|FG000|Overall Study|Progressive Disease|9
7552783|NCT02999672|11913300|FG001|Overall Study|Progressive Disease|5
7552784|NCT02999672|11913299|FG000|Overall Study|Adverse Event|4
7552785|NCT02999672|11913300|FG001|Overall Study|Adverse Event|0
7552786|NCT03000075|11913322|FG000|Part A|Adverse Event|4
7552787|NCT03000075|11913323|FG001|Part A|Adverse Event|0
7552788|NCT03000075|11913324|FG002|Part A|Adverse Event|0
7552789|NCT03000075|11913325|FG003|Part A|Adverse Event|0
7552790|NCT03000075|11913326|FG004|Part A|Adverse Event|0
7552791|NCT03000075|11913327|FG005|Part A|Adverse Event|0
7552792|NCT03000075|11913328|FG006|Part A|Adverse Event|0
7552793|NCT03000075|11913322|FG000|Part B|Not dosed due to AE|0
7552794|NCT03000075|11913323|FG001|Part B|Not dosed due to AE|0
7552795|NCT03000075|11913324|FG002|Part B|Not dosed due to AE|0
7552796|NCT03000075|11913325|FG003|Part B|Not dosed due to AE|0
7552797|NCT03000075|11913326|FG004|Part B|Not dosed due to AE|0
7552798|NCT03000075|11913327|FG005|Part B|Not dosed due to AE|2
7552799|NCT03000075|11913328|FG006|Part B|Not dosed due to AE|1
7552800|NCT03000075|11913322|FG000|Part B|Adverse Event|0
7552801|NCT03000075|11913323|FG001|Part B|Adverse Event|0
7552802|NCT03000075|11913324|FG002|Part B|Adverse Event|0
7552803|NCT03000075|11913325|FG003|Part B|Adverse Event|0
7552804|NCT03000075|11913326|FG004|Part B|Adverse Event|1
7552805|NCT03000075|11913327|FG005|Part B|Adverse Event|0
7552806|NCT03000075|11913328|FG006|Part B|Adverse Event|0
7552807|NCT03000348|11913377|FG000|Overall Study|Adverse Event|1
7552808|NCT03000348|11913378|FG001|Overall Study|Adverse Event|1
7552809|NCT03000348|11913379|FG002|Overall Study|Adverse Event|1
7552810|NCT03000348|11913380|FG003|Overall Study|Adverse Event|1
7552811|NCT03000348|11913381|FG004|Overall Study|Adverse Event|1
7552812|NCT03000348|11913382|FG005|Overall Study|Adverse Event|1
7552813|NCT03000348|11913377|FG000|Overall Study|Lost to Follow-up|0
7552814|NCT03000348|11913378|FG001|Overall Study|Lost to Follow-up|0
7552815|NCT03000348|11913379|FG002|Overall Study|Lost to Follow-up|1
7552816|NCT03000348|11913380|FG003|Overall Study|Lost to Follow-up|0
7552817|NCT03000348|11913381|FG004|Overall Study|Lost to Follow-up|0
7552818|NCT03000348|11913382|FG005|Overall Study|Lost to Follow-up|0
7552819|NCT03000348|11913377|FG000|Overall Study|Withdrawal by Subject|0
7465074|NCT01877421|11764019|FG008|Phase 2|Protocol Violation|0
7224526|NCT00054639|11433769|FG000|Overall Study|Lack of Efficacy|1
7552820|NCT03000348|11913378|FG001|Overall Study|Withdrawal by Subject|1
7552821|NCT03000348|11913379|FG002|Overall Study|Withdrawal by Subject|0
7552822|NCT03000348|11913380|FG003|Overall Study|Withdrawal by Subject|0
7552823|NCT03000348|11913381|FG004|Overall Study|Withdrawal by Subject|0
7552824|NCT03000348|11913382|FG005|Overall Study|Withdrawal by Subject|0
7552825|NCT03000348|11913377|FG000|Overall Study|Consent|0
7552826|NCT03000348|11913378|FG001|Overall Study|Consent|0
7552827|NCT03000348|11913379|FG002|Overall Study|Consent|0
7552828|NCT03000348|11913380|FG003|Overall Study|Consent|0
7552829|NCT03000348|11913381|FG004|Overall Study|Consent|1
7552830|NCT03000348|11913382|FG005|Overall Study|Consent|0
7552831|NCT03000348|11913377|FG000|Overall Study|Failure to expectorate sputum|1
7552832|NCT03000348|11913378|FG001|Overall Study|Failure to expectorate sputum|0
7552833|NCT03000348|11913379|FG002|Overall Study|Failure to expectorate sputum|1
7552834|NCT03000348|11913380|FG003|Overall Study|Failure to expectorate sputum|0
7552835|NCT03000348|11913381|FG004|Overall Study|Failure to expectorate sputum|1
7552836|NCT03000348|11913382|FG005|Overall Study|Failure to expectorate sputum|0
7552837|NCT03000348|11913377|FG000|Overall Study|No gram negative|1
7552838|NCT03000348|11913378|FG001|Overall Study|No gram negative|2
7552839|NCT03000348|11913379|FG002|Overall Study|No gram negative|1
7552840|NCT03000348|11913380|FG003|Overall Study|No gram negative|1
7552841|NCT03000348|11913381|FG004|Overall Study|No gram negative|1
7552842|NCT03000348|11913382|FG005|Overall Study|No gram negative|1
7552843|NCT03000348|11913377|FG000|Overall Study|Patient had no transport|0
7552844|NCT03000348|11913378|FG001|Overall Study|Patient had no transport|0
7552845|NCT03000348|11913379|FG002|Overall Study|Patient had no transport|0
7552846|NCT03000348|11913380|FG003|Overall Study|Patient had no transport|1
7552847|NCT03000348|11913381|FG004|Overall Study|Patient had no transport|0
7552848|NCT03000348|11913382|FG005|Overall Study|Patient had no transport|0
7552849|NCT03000348|11913377|FG000|Overall Study|Dosing|0
7552850|NCT03000348|11913378|FG001|Overall Study|Dosing|0
7552851|NCT03000348|11913379|FG002|Overall Study|Dosing|0
7552852|NCT03000348|11913380|FG003|Overall Study|Dosing|0
7552853|NCT03000348|11913381|FG004|Overall Study|Dosing|1
7552854|NCT03000348|11913382|FG005|Overall Study|Dosing|0
7552855|NCT03000452|11913399|FG000|Treatment Period|Death|1
7552856|NCT03000452|11913399|FG000|Treatment Period|Progressive Disease (PD)|14
7552857|NCT03000452|11913399|FG000|Treatment Period|Physician Decision|1
7552858|NCT03000452|11913399|FG000|Treatment Period|Miscellaneous|2
7552859|NCT03000452|11913399|FG000|Follow-Up Period|Study Terminated by Sponsor|1
7552860|NCT03000452|11913399|FG000|Follow-Up Period|Death|3
7552861|NCT03000452|11913399|FG000|Follow-Up Period|Withdrawal by Subject|3
7552862|NCT03000673|11913416|FG000|Overall Study|Withdrawal by Subject|1
7552863|NCT03000673|11913417|FG001|Overall Study|Withdrawal by Subject|0
7552864|NCT03000673|11913418|FG002|Overall Study|Withdrawal by Subject|0
7552865|NCT03000673|11913419|FG003|Overall Study|Withdrawal by Subject|0
7552866|NCT03000686|11913432|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
7552867|NCT03000686|11913433|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
7552868|NCT03000686|11913434|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
7552869|NCT03000686|11913435|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
7552870|NCT03001076|11913449|FG000|Overall Study|Withdrawal by patient|2
7552871|NCT03001076|11913450|FG001|Overall Study|Withdrawal by patient|0
7552872|NCT03001076|11913449|FG000|Overall Study|Other|1
7552873|NCT03001076|11913450|FG001|Overall Study|Other|0
7552874|NCT03001076|11913449|FG000|Overall Study|Adverse Event|3
7552875|NCT03001076|11913450|FG001|Overall Study|Adverse Event|3
7552876|NCT03001076|11913449|FG000|Overall Study|Sponsor decision|1
7552877|NCT03001076|11913450|FG001|Overall Study|Sponsor decision|0
7552878|NCT03001076|11913449|FG000|Overall Study|Lost to Follow-up|0
7552879|NCT03001076|11913450|FG001|Overall Study|Lost to Follow-up|2
7552880|NCT03001219|11913458|FG000|Proof of Concept|Study Termination by Sponsor|0
7552881|NCT03001219|11913459|FG001|Proof of Concept|Study Termination by Sponsor|1
7552882|NCT03001219|11913458|FG000|Proof of Concept|Withdrawal by Subject|0
7552883|NCT03001219|11913459|FG001|Proof of Concept|Withdrawal by Subject|4
7552884|NCT03001219|11913458|FG000|Proof of Concept|Protocol Deviation|0
7552885|NCT03001219|11913459|FG001|Proof of Concept|Protocol Deviation|1
7552886|NCT03001219|11913458|FG000|Proof of Concept|Adverse Event|1
7552887|NCT03001219|11913459|FG001|Proof of Concept|Adverse Event|1
7552888|NCT03001219|11913458|FG000|Proof of Concept|Physician Decision|1
7552889|NCT03001219|11913459|FG001|Proof of Concept|Physician Decision|0
7552890|NCT03001219|11913458|FG000|Extension Period Analysis|Study Termination by Sponsor|0
7552891|NCT03001219|11913459|FG001|Extension Period Analysis|Study Termination by Sponsor|36
7552892|NCT03001219|11913458|FG000|Extension Period Analysis|Participant Non-Compliance|0
7552893|NCT03001219|11913459|FG001|Extension Period Analysis|Participant Non-Compliance|1
7552894|NCT03001219|11913458|FG000|Extension Period Analysis|Physician Decision|0
7552895|NCT03001219|11913459|FG001|Extension Period Analysis|Physician Decision|1
7552896|NCT03001219|11913458|FG000|Extension Period Analysis|Adverse Event|1
7306521|NCT00642941|11530508|FG010|Overall Study|Physician Decision|0
7306522|NCT00642941|11530509|FG011|Overall Study|Physician Decision|1
7552897|NCT03001219|11913459|FG001|Extension Period Analysis|Adverse Event|1
7552898|NCT03001219|11913458|FG000|Extension Period Analysis|Protocol Deviation|0
7552899|NCT03001219|11913459|FG001|Extension Period Analysis|Protocol Deviation|1
7552900|NCT03001219|11913458|FG000|Extension Period Analysis|Withdrawal by Subject|4
7552901|NCT03001219|11913459|FG001|Extension Period Analysis|Withdrawal by Subject|5
7552902|NCT03001557|11913497|FG000|Core Phase|Randomized but not treated|0
7552903|NCT03001557|11913498|FG001|Core Phase|Randomized but not treated|0
7552904|NCT03001557|11913499|FG002|Core Phase|Randomized but not treated|1
7552905|NCT03001557|11913500|FG003|Core Phase|Randomized but not treated|0
7552906|NCT03001557|11913501|FG004|Core Phase|Randomized but not treated|0
7552907|NCT03001557|11913502|FG005|Core Phase|Randomized but not treated|0
7552908|NCT03001557|11913503|FG006|Core Phase|Randomized but not treated|0
7552909|NCT03001557|11913504|FG007|Core Phase|Randomized but not treated|0
7552910|NCT03001557|11913497|FG000|Extension Phase|Adverse Event|0
7552911|NCT03001557|11913498|FG001|Extension Phase|Adverse Event|0
7552912|NCT03001557|11913499|FG002|Extension Phase|Adverse Event|0
7552913|NCT03001557|11913500|FG003|Extension Phase|Adverse Event|0
7552914|NCT03001557|11913501|FG004|Extension Phase|Adverse Event|0
7552915|NCT03001557|11913502|FG005|Extension Phase|Adverse Event|2
7552916|NCT03001557|11913503|FG006|Extension Phase|Adverse Event|0
7552917|NCT03001557|11913504|FG007|Extension Phase|Adverse Event|0
7552918|NCT03001557|11913497|FG000|Extension Phase|Withdrawal by Subject|0
7552919|NCT03001557|11913498|FG001|Extension Phase|Withdrawal by Subject|0
7552920|NCT03001557|11913499|FG002|Extension Phase|Withdrawal by Subject|0
7552921|NCT03001557|11913500|FG003|Extension Phase|Withdrawal by Subject|0
7552922|NCT03001557|11913501|FG004|Extension Phase|Withdrawal by Subject|0
7552923|NCT03001557|11913502|FG005|Extension Phase|Withdrawal by Subject|1
7552924|NCT03001557|11913503|FG006|Extension Phase|Withdrawal by Subject|5
7552925|NCT03001557|11913504|FG007|Extension Phase|Withdrawal by Subject|2
7552926|NCT03001557|11913497|FG000|Extension Phase|Lost to Follow-up|0
7552927|NCT03001557|11913498|FG001|Extension Phase|Lost to Follow-up|0
7552928|NCT03001557|11913499|FG002|Extension Phase|Lost to Follow-up|0
7552929|NCT03001557|11913500|FG003|Extension Phase|Lost to Follow-up|0
7552930|NCT03001557|11913501|FG004|Extension Phase|Lost to Follow-up|0
7306523|NCT00642941|11530498|FG000|Overall Study|Death|4
7306524|NCT00642941|11530499|FG001|Overall Study|Death|0
7306525|NCT00642941|11530500|FG002|Overall Study|Death|1
7306526|NCT00642941|11530501|FG003|Overall Study|Death|1
7306527|NCT00642941|11530502|FG004|Overall Study|Death|2
7306528|NCT00642941|11530503|FG005|Overall Study|Death|1
7306529|NCT00642941|11530504|FG006|Overall Study|Death|0
7306530|NCT00642941|11530505|FG007|Overall Study|Death|0
7306531|NCT00642941|11530506|FG008|Overall Study|Death|0
7306532|NCT00642941|11530507|FG009|Overall Study|Death|0
7306533|NCT00642941|11530508|FG010|Overall Study|Death|0
7306534|NCT00642941|11530509|FG011|Overall Study|Death|1
7306535|NCT00642941|11530498|FG000|Overall Study|Study closed by Sponsor|0
7388636|NCT01222520|11647936|FG001|Open-label run-in Period|Number of patients fulfilled|3
7388637|NCT01222520|11647935|FG000|Double-blind Period|Adverse Event|0
7388638|NCT01222520|11647936|FG001|Double-blind Period|Adverse Event|1
7388639|NCT01222520|11647935|FG000|Double-blind Period|Lack of Efficacy|0
7388640|NCT01222520|11647936|FG001|Double-blind Period|Lack of Efficacy|1
7388641|NCT01222520|11647935|FG000|Double-blind Period|Study medication stolen|1
7388642|NCT01222520|11647936|FG001|Double-blind Period|Study medication stolen|0
7388643|NCT01222533|11647942|FG000|Overall Study|Adverse Event|5
7388644|NCT01222533|11647942|FG000|Overall Study|Withdrawal by Subject|5
7388645|NCT01222533|11647942|FG000|Overall Study|Other|4
7388646|NCT01222715|11647970|FG000|Overall Study|Adverse Event|0
7388647|NCT01222715|11647971|FG001|Overall Study|Adverse Event|4
7388648|NCT01222715|11647970|FG000|Overall Study|Death|0
7388649|NCT01222715|11647971|FG001|Overall Study|Death|1
7388650|NCT01222715|11647970|FG000|Overall Study|Lack of Efficacy|22
7388651|NCT01222715|11647971|FG001|Overall Study|Lack of Efficacy|14
7388652|NCT01222715|11647970|FG000|Overall Study|Physician Decision|12
7388653|NCT01222715|11647971|FG001|Overall Study|Physician Decision|2
7388654|NCT01222715|11647970|FG000|Overall Study|Refusal of further protocol therapy|0
7388655|NCT01222715|11647971|FG001|Overall Study|Refusal of further protocol therapy|4
7388656|NCT01222715|11647970|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
7388657|NCT01222715|11647971|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
7388658|NCT01222715|11647970|FG000|Overall Study|Ineligible|0
7388659|NCT01222715|11647971|FG001|Overall Study|Ineligible|1
7388660|NCT01222715|11647970|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
7388661|NCT01222715|11647971|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
7388662|NCT01222767|11647977|FG000|Overall Study|Progressive disease|13
7388663|NCT01222767|11647977|FG000|Overall Study|Adverse Event|2
7388664|NCT01222767|11647977|FG000|Overall Study|Surgical resection|1
7388665|NCT01222767|11647977|FG000|Overall Study|Never treated|1
7388666|NCT01223027|11648001|FG000|Overall Study|Adverse Event|20
7388667|NCT01223027|11648002|FG001|Overall Study|Adverse Event|10
7388668|NCT01223027|11648001|FG000|Overall Study|Death|42
7388669|NCT01223027|11648002|FG001|Overall Study|Death|42
7388670|NCT01223027|11648001|FG000|Overall Study|Lost to Follow-up|2
7388671|NCT01223027|11648002|FG001|Overall Study|Lost to Follow-up|1
7388672|NCT01223027|11648001|FG000|Overall Study|Physician Decision|4
7388673|NCT01223027|11648002|FG001|Overall Study|Physician Decision|8
7388674|NCT01223027|11648001|FG000|Overall Study|Progressive Disease|167
7388675|NCT01223027|11648002|FG001|Overall Study|Progressive Disease|183
7388676|NCT01223027|11648001|FG000|Overall Study|Protocol Violation|2
7552931|NCT03001557|11913502|FG005|Extension Phase|Lost to Follow-up|0
7552932|NCT03001557|11913503|FG006|Extension Phase|Lost to Follow-up|2
7552933|NCT03001557|11913504|FG007|Extension Phase|Lost to Follow-up|1
7306536|NCT00642941|11530499|FG001|Overall Study|Study closed by Sponsor|1
7306537|NCT00642941|11530500|FG002|Overall Study|Study closed by Sponsor|0
7306538|NCT00642941|11530501|FG003|Overall Study|Study closed by Sponsor|0
7388677|NCT01223027|11648002|FG001|Overall Study|Protocol Violation|1
7388678|NCT01223027|11648001|FG000|Overall Study|Subject/guardian decicion|18
7388679|NCT01223027|11648002|FG001|Overall Study|Subject/guardian decicion|16
7306539|NCT00642941|11530502|FG004|Overall Study|Study closed by Sponsor|0
7306540|NCT00642941|11530503|FG005|Overall Study|Study closed by Sponsor|0
7306541|NCT00642941|11530504|FG006|Overall Study|Study closed by Sponsor|0
7306542|NCT00642941|11530505|FG007|Overall Study|Study closed by Sponsor|0
7306543|NCT00642941|11530506|FG008|Overall Study|Study closed by Sponsor|0
7306544|NCT00642941|11530507|FG009|Overall Study|Study closed by Sponsor|0
7306545|NCT00642941|11530508|FG010|Overall Study|Study closed by Sponsor|0
7306546|NCT00642941|11530509|FG011|Overall Study|Study closed by Sponsor|0
7306547|NCT00642941|11530498|FG000|Overall Study|Withdrawal by Subject|1
7306548|NCT00642941|11530499|FG001|Overall Study|Withdrawal by Subject|0
7306549|NCT00642941|11530500|FG002|Overall Study|Withdrawal by Subject|0
7306550|NCT00642941|11530501|FG003|Overall Study|Withdrawal by Subject|2
7306551|NCT00642941|11530502|FG004|Overall Study|Withdrawal by Subject|0
7306552|NCT00642941|11530503|FG005|Overall Study|Withdrawal by Subject|0
7306553|NCT00642941|11530504|FG006|Overall Study|Withdrawal by Subject|2
7306554|NCT00642941|11530505|FG007|Overall Study|Withdrawal by Subject|0
7306555|NCT00642941|11530506|FG008|Overall Study|Withdrawal by Subject|1
7306556|NCT00642941|11530507|FG009|Overall Study|Withdrawal by Subject|0
7306557|NCT00642941|11530508|FG010|Overall Study|Withdrawal by Subject|0
7306558|NCT00642941|11530509|FG011|Overall Study|Withdrawal by Subject|1
7306559|NCT00642941|11530498|FG000|Overall Study|Protocol Violation|0
7306560|NCT00642941|11530499|FG001|Overall Study|Protocol Violation|0
7306561|NCT00642941|11530500|FG002|Overall Study|Protocol Violation|0
7306562|NCT00642941|11530501|FG003|Overall Study|Protocol Violation|0
7306563|NCT00642941|11530502|FG004|Overall Study|Protocol Violation|0
7306564|NCT00642941|11530503|FG005|Overall Study|Protocol Violation|0
7306565|NCT00642941|11530504|FG006|Overall Study|Protocol Violation|1
7306566|NCT00642941|11530505|FG007|Overall Study|Protocol Violation|0
7306567|NCT00642941|11530506|FG008|Overall Study|Protocol Violation|0
7306568|NCT00642941|11530507|FG009|Overall Study|Protocol Violation|0
7306569|NCT00642941|11530508|FG010|Overall Study|Protocol Violation|0
7306570|NCT00642941|11530509|FG011|Overall Study|Protocol Violation|0
7306571|NCT00642941|11530498|FG000|Overall Study|Adverse Event|1
7306572|NCT00642941|11530499|FG001|Overall Study|Adverse Event|1
7306573|NCT00642941|11530500|FG002|Overall Study|Adverse Event|0
7306574|NCT00642941|11530501|FG003|Overall Study|Adverse Event|0
7306575|NCT00642941|11530502|FG004|Overall Study|Adverse Event|0
7306576|NCT00642941|11530503|FG005|Overall Study|Adverse Event|0
7306577|NCT00642941|11530504|FG006|Overall Study|Adverse Event|1
7306578|NCT00642941|11530505|FG007|Overall Study|Adverse Event|1
7306579|NCT00642941|11530506|FG008|Overall Study|Adverse Event|0
7306580|NCT00642941|11530507|FG009|Overall Study|Adverse Event|1
7306581|NCT00642941|11530508|FG010|Overall Study|Adverse Event|0
7306582|NCT00642941|11530509|FG011|Overall Study|Adverse Event|0
7306583|NCT00642941|11530498|FG000|Overall Study|Other|1
7306584|NCT00642941|11530499|FG001|Overall Study|Other|1
7306585|NCT00642941|11530500|FG002|Overall Study|Other|1
7306586|NCT00642941|11530501|FG003|Overall Study|Other|1
7306587|NCT00642941|11530502|FG004|Overall Study|Other|0
7306588|NCT00642941|11530503|FG005|Overall Study|Other|1
7306589|NCT00642941|11530504|FG006|Overall Study|Other|0
7306590|NCT00642941|11530505|FG007|Overall Study|Other|1
7306591|NCT00642941|11530506|FG008|Overall Study|Other|0
7306592|NCT00642941|11530507|FG009|Overall Study|Other|0
7306593|NCT00642941|11530508|FG010|Overall Study|Other|0
7306594|NCT00642941|11530509|FG011|Overall Study|Other|1
7306595|NCT00642941|11530498|FG000|Overall Study|Disease progression|60
7306596|NCT00642941|11530499|FG001|Overall Study|Disease progression|50
7306597|NCT00642941|11530500|FG002|Overall Study|Disease progression|5
7306598|NCT00642941|11530501|FG003|Overall Study|Disease progression|36
7306599|NCT00642941|11530502|FG004|Overall Study|Disease progression|23
7306600|NCT00642941|11530503|FG005|Overall Study|Disease progression|39
7306601|NCT00642941|11530504|FG006|Overall Study|Disease progression|18
7306602|NCT00642941|11530505|FG007|Overall Study|Disease progression|12
7306603|NCT00642941|11530506|FG008|Overall Study|Disease progression|10
7306604|NCT00642941|11530507|FG009|Overall Study|Disease progression|7
7306605|NCT00642941|11530508|FG010|Overall Study|Disease progression|12
7306606|NCT00642941|11530509|FG011|Overall Study|Disease progression|7
7306607|NCT00642954|11530561|FG000|Overall Study|Progressive Disease|3
7306608|NCT00642954|11530562|FG001|Overall Study|Progressive Disease|3
7306609|NCT00642954|11530563|FG002|Overall Study|Progressive Disease|3
7306610|NCT00642954|11530564|FG003|Overall Study|Progressive Disease|3
7306611|NCT00642954|11530565|FG004|Overall Study|Progressive Disease|9
7306612|NCT00642954|11530561|FG000|Overall Study|Withdrawal by Subject|0
7306613|NCT00642954|11530562|FG001|Overall Study|Withdrawal by Subject|0
7306614|NCT00642954|11530563|FG002|Overall Study|Withdrawal by Subject|0
7306615|NCT00642954|11530564|FG003|Overall Study|Withdrawal by Subject|0
7306616|NCT00642954|11530565|FG004|Overall Study|Withdrawal by Subject|1
7306617|NCT00642954|11530561|FG000|Overall Study|Adverse Event|1
7306618|NCT00642954|11530562|FG001|Overall Study|Adverse Event|1
7306619|NCT00642954|11530563|FG002|Overall Study|Adverse Event|0
7306620|NCT00642954|11530564|FG003|Overall Study|Adverse Event|0
7306621|NCT00642954|11530565|FG004|Overall Study|Adverse Event|6
7306622|NCT00642993|11530579|FG000|Overall Study|Adverse Event|85
7306623|NCT00642993|11530580|FG001|Overall Study|Adverse Event|4
7306624|NCT00642993|11530579|FG000|Overall Study|Lost to Follow-up|8
7306625|NCT00642993|11530580|FG001|Overall Study|Lost to Follow-up|4
7306626|NCT00642993|11530579|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
7388680|NCT01223027|11648001|FG000|Overall Study|New therapy for study indication|17
7388681|NCT01223027|11648002|FG001|Overall Study|New therapy for study indication|8
7388682|NCT01223027|11648001|FG000|Overall Study|Study terminated by sponsor|2
7388683|NCT01223027|11648002|FG001|Overall Study|Study terminated by sponsor|8
7388684|NCT01223183|11648010|FG000|Imaging Day 1|Physician Decision|0
7388685|NCT01223183|11648011|FG001|Imaging Day 1|Physician Decision|1
7388686|NCT01223183|11648010|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
7388687|NCT01223183|11648011|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
7388688|NCT01223183|11648010|FG000|Washout Period (5-24 Days)|Physician Decision|1
7388689|NCT01223183|11648011|FG001|Washout Period (5-24 Days)|Physician Decision|0
7388690|NCT01223196|11648020|FG000|Overall Study|Lost to Follow-up|2
7388691|NCT01223196|11648021|FG001|Overall Study|Lost to Follow-up|0
7388692|NCT01223196|11648020|FG000|Overall Study|Physician Decision|1
7388693|NCT01223196|11648021|FG001|Overall Study|Physician Decision|0
7388694|NCT01223196|11648020|FG000|Overall Study|Withdrawal by Subject|1
7388695|NCT01223196|11648021|FG001|Overall Study|Withdrawal by Subject|0
7388696|NCT01223235|11648029|FG000|Overall Study|Withdrawal by Subject|1
7465075|NCT01877421|11764020|FG009|Phase 2|Protocol Violation|0
7465076|NCT01877421|11764021|FG010|Phase 2|Protocol Violation|1
7465077|NCT01877421|11764022|FG011|Phase 2|Protocol Violation|0
7465078|NCT01877421|11764023|FG012|Phase 2|Protocol Violation|0
7465079|NCT01877421|11764024|FG013|Phase 2|Protocol Violation|0
7465080|NCT01877421|11764025|FG014|Phase 2|Protocol Violation|0
7465081|NCT01877421|11764026|FG015|Phase 2|Protocol Violation|0
7465082|NCT01877421|11764027|FG016|Phase 2|Protocol Violation|0
7465083|NCT01877421|11764028|FG017|Phase 2|Protocol Violation|0
7465084|NCT01877551|11764114|FG000|Overall Study|Physician Decision|0
7465085|NCT01877551|11764115|FG001|Overall Study|Physician Decision|1
7465086|NCT01877668|11764143|FG000|Overall Study|Death|0
7465087|NCT01877668|11764144|FG001|Overall Study|Death|0
7465088|NCT01877668|11764145|FG002|Overall Study|Death|0
7465089|NCT01877668|11764146|FG003|Overall Study|Death|1
7465090|NCT01877668|11764147|FG004|Overall Study|Death|0
7465091|NCT01877668|11764143|FG000|Overall Study|No longer met study criteria|1
7465092|NCT01877668|11764144|FG001|Overall Study|No longer met study criteria|0
7465093|NCT01877668|11764145|FG002|Overall Study|No longer met study criteria|1
7465094|NCT01877668|11764146|FG003|Overall Study|No longer met study criteria|0
7465095|NCT01877668|11764147|FG004|Overall Study|No longer met study criteria|0
7465096|NCT01877668|11764143|FG000|Overall Study|Insufficient clinical response|0
7465097|NCT01877668|11764144|FG001|Overall Study|Insufficient clinical response|1
7465098|NCT01877668|11764145|FG002|Overall Study|Insufficient clinical response|2
7465099|NCT01877668|11764146|FG003|Overall Study|Insufficient clinical response|2
7465100|NCT01877668|11764147|FG004|Overall Study|Insufficient clinical response|0
7465101|NCT01877668|11764143|FG000|Overall Study|Lost to Follow-up|0
7465102|NCT01877668|11764144|FG001|Overall Study|Lost to Follow-up|2
7465103|NCT01877668|11764145|FG002|Overall Study|Lost to Follow-up|1
7465104|NCT01877668|11764146|FG003|Overall Study|Lost to Follow-up|0
7465105|NCT01877668|11764147|FG004|Overall Study|Lost to Follow-up|0
7465106|NCT01877668|11764143|FG000|Overall Study|Withdrawal by Subject|2
7465107|NCT01877668|11764144|FG001|Overall Study|Withdrawal by Subject|0
7465108|NCT01877668|11764145|FG002|Overall Study|Withdrawal by Subject|3
7465109|NCT01877668|11764146|FG003|Overall Study|Withdrawal by Subject|2
7465110|NCT01877668|11764147|FG004|Overall Study|Withdrawal by Subject|2
7465111|NCT01877668|11764143|FG000|Overall Study|Other|1
7465112|NCT01877668|11764144|FG001|Overall Study|Other|1
7465113|NCT01877668|11764145|FG002|Overall Study|Other|1
7465114|NCT01877668|11764146|FG003|Overall Study|Other|1
7465115|NCT01877668|11764147|FG004|Overall Study|Other|3
7465116|NCT01877668|11764143|FG000|Overall Study|Protocol Violation|1
7465117|NCT01877668|11764144|FG001|Overall Study|Protocol Violation|1
7465118|NCT01877668|11764145|FG002|Overall Study|Protocol Violation|0
7465119|NCT01877668|11764146|FG003|Overall Study|Protocol Violation|0
7465120|NCT01877668|11764147|FG004|Overall Study|Protocol Violation|3
7465121|NCT01877668|11764143|FG000|Overall Study|Adverse event related to study drug|2
7465122|NCT01877668|11764144|FG001|Overall Study|Adverse event related to study drug|2
7465123|NCT01877668|11764145|FG002|Overall Study|Adverse event related to study drug|2
7465124|NCT01877668|11764146|FG003|Overall Study|Adverse event related to study drug|2
7465125|NCT01877668|11764147|FG004|Overall Study|Adverse event related to study drug|1
7465126|NCT01877668|11764143|FG000|Overall Study|Adverse event unrelated to study drug|4
7465127|NCT01877668|11764144|FG001|Overall Study|Adverse event unrelated to study drug|1
7465128|NCT01877668|11764145|FG002|Overall Study|Adverse event unrelated to study drug|2
7465129|NCT01877668|11764146|FG003|Overall Study|Adverse event unrelated to study drug|0
7465130|NCT01877668|11764147|FG004|Overall Study|Adverse event unrelated to study drug|1
7465131|NCT01877720|11764163|FG000|Overall Study|Adverse Event|1
7465132|NCT01877720|11764164|FG001|Overall Study|Adverse Event|0
7465133|NCT01877915|11764172|FG000|Overall Study|Lost to Follow-up|10
7465134|NCT01877915|11764173|FG001|Overall Study|Lost to Follow-up|9
7465135|NCT01877915|11764172|FG000|Overall Study|Withdrawal by Subject|42
7465136|NCT01877915|11764173|FG001|Overall Study|Withdrawal by Subject|55
7465137|NCT01877915|11764172|FG000|Overall Study|Other|2
7465138|NCT01877915|11764173|FG001|Overall Study|Other|4
7465139|NCT01878084|11764191|FG000|Overall Study|Physician Decision|2
7306627|NCT00642993|11530580|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
7306628|NCT00642993|11530579|FG000|Overall Study|Protocol Violation|1
7306629|NCT00642993|11530580|FG001|Overall Study|Protocol Violation|4
7306630|NCT00642993|11530579|FG000|Overall Study|Did not meet protocol eligibility|0
7306631|NCT00642993|11530580|FG001|Overall Study|Did not meet protocol eligibility|1
7306632|NCT00642993|11530579|FG000|Overall Study|Administrative|1
7306633|NCT00642993|11530580|FG001|Overall Study|Administrative|0
7306634|NCT00643006|11530588|FG000|Overall Study|Lost to Follow-up|5
7306635|NCT00643006|11530589|FG001|Overall Study|Lost to Follow-up|4
7306636|NCT00643123|11530612|FG000|Overall Study|Lost to Follow-up|4
7306637|NCT00643123|11530613|FG001|Overall Study|Lost to Follow-up|0
7306638|NCT00643123|11530612|FG000|Overall Study|Withdrawal by Subject|1
7306639|NCT00643123|11530613|FG001|Overall Study|Withdrawal by Subject|1
7306640|NCT00643162|11530621|FG000|Overall Study|Withdrawal by Subject|1
7306641|NCT00643162|11530622|FG001|Overall Study|Withdrawal by Subject|1
7306642|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Death|20
7306643|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Death|26
7306644|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
7306645|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
7306646|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7306647|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
7306648|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7306649|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
7306650|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
7306651|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
7306652|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
7306653|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
7306654|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
7306655|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
7306656|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
7306657|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
7306658|NCT00643201|11530630|FG000|Randomized, Completed 6 Months of Study|Other|107
7306659|NCT00643201|11530631|FG001|Randomized, Completed 6 Months of Study|Other|107
7306660|NCT00643201|11530630|FG000|Completed Study Follow Up|Death|28
7306661|NCT00643201|11530631|FG001|Completed Study Follow Up|Death|34
7306662|NCT00643201|11530630|FG000|Completed Study Follow Up|Withdrawal by Subject|23
7306663|NCT00643201|11530631|FG001|Completed Study Follow Up|Withdrawal by Subject|29
7306664|NCT00643201|11530630|FG000|Completed Study Follow Up|Lost to Follow-up|18
7306665|NCT00643201|11530631|FG001|Completed Study Follow Up|Lost to Follow-up|16
7306666|NCT00643201|11530630|FG000|Completed Study Follow Up|non-specified|1
7306667|NCT00643201|11530631|FG001|Completed Study Follow Up|non-specified|0
7306668|NCT00643279|11530641|FG000|Overall Study|Death|13
7306669|NCT00643279|11530642|FG001|Overall Study|Death|11
7306670|NCT00643279|11530641|FG000|Overall Study|Withdrawal by Subject|3
7306671|NCT00643279|11530642|FG001|Overall Study|Withdrawal by Subject|0
7306672|NCT00643279|11530641|FG000|Overall Study|Lost to Follow-up|0
7306673|NCT00643279|11530642|FG001|Overall Study|Lost to Follow-up|1
7306674|NCT00643279|11530641|FG000|Overall Study|Physician Decision|0
7306675|NCT00643279|11530642|FG001|Overall Study|Physician Decision|1
7306676|NCT00643448|11530653|FG000|Overall Study|Lack of Efficacy|2
7306677|NCT00643448|11530654|FG001|Overall Study|Lack of Efficacy|0
7306678|NCT00643448|11530655|FG002|Overall Study|Lack of Efficacy|4
7306679|NCT00643448|11530653|FG000|Overall Study|Adverse Event|2
7306680|NCT00643448|11530654|FG001|Overall Study|Adverse Event|2
7306681|NCT00643448|11530655|FG002|Overall Study|Adverse Event|2
7306682|NCT00643448|11530653|FG000|Overall Study|QTcF>550 ms|0
7306683|NCT00643448|11530654|FG001|Overall Study|QTcF>550 ms|3
7306684|NCT00643448|11530655|FG002|Overall Study|QTcF>550 ms|0
7306685|NCT00643487|11530665|FG000|Overall Study|Technical difficulty|3
7306686|NCT00643565|11530671|FG000|Overall Study|Death|12
7306687|NCT00643565|11530672|FG001|Overall Study|Death|11
7306688|NCT00643565|11530671|FG000|Overall Study|Withdrawal by Subject|4
7306689|NCT00643565|11530672|FG001|Overall Study|Withdrawal by Subject|1
7306690|NCT00643565|11530671|FG000|Overall Study|Lost to Follow-up|0
7306691|NCT00643565|11530672|FG001|Overall Study|Lost to Follow-up|6
7306692|NCT00643565|11530671|FG000|Overall Study|Other|7
7306693|NCT00643565|11530672|FG001|Overall Study|Other|8
7306694|NCT00643565|11530671|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
7306695|NCT00643565|11530672|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
7306696|NCT00643565|11530671|FG000|Overall Study|Recurrence of Disease|2
7306697|NCT00643565|11530672|FG001|Overall Study|Recurrence of Disease|1
7306698|NCT00643565|11530671|FG000|Overall Study|Progression of Disease|18
7306699|NCT00643565|11530672|FG001|Overall Study|Progression of Disease|14
7306700|NCT00643565|11530671|FG000|Overall Study|Protocol Violation|3
7306701|NCT00643565|11530672|FG001|Overall Study|Protocol Violation|0
7306702|NCT00643565|11530671|FG000|Overall Study|Did Not Cooperate|0
7306703|NCT00643565|11530672|FG001|Overall Study|Did Not Cooperate|1
7306704|NCT00643565|11530671|FG000|Overall Study|Administrative|22
7306705|NCT00643565|11530672|FG001|Overall Study|Administrative|16
7306706|NCT00643565|11530671|FG000|Overall Study|Adverse Event|5
7306707|NCT00643565|11530672|FG001|Overall Study|Adverse Event|8
7306708|NCT00643604|11530688|FG000|Overall Study|Death|1
7306709|NCT00643682|11530694|FG000|Overall Study|did not keep appointment|522
7306710|NCT00643682|11530695|FG001|Overall Study|did not keep appointment|509
7306711|NCT00643760|11530706|FG000|Overall Study|Adverse Event|11
7306712|NCT00643760|11530707|FG001|Overall Study|Adverse Event|5
7306713|NCT00643760|11530708|FG002|Overall Study|Adverse Event|12
7306714|NCT00643760|11530709|FG003|Overall Study|Adverse Event|21
7306715|NCT00643760|11530710|FG004|Overall Study|Adverse Event|6
7306716|NCT00643760|11530706|FG000|Overall Study|Lack of Efficacy|3
7306717|NCT00643760|11530707|FG001|Overall Study|Lack of Efficacy|1
7306718|NCT00643760|11530708|FG002|Overall Study|Lack of Efficacy|0
7306719|NCT00643760|11530709|FG003|Overall Study|Lack of Efficacy|4
7306720|NCT00643760|11530710|FG004|Overall Study|Lack of Efficacy|3
7306721|NCT00643760|11530706|FG000|Overall Study|Protocol Violation|7
7306722|NCT00643760|11530707|FG001|Overall Study|Protocol Violation|6
7306723|NCT00643760|11530708|FG002|Overall Study|Protocol Violation|4
7306724|NCT00643760|11530709|FG003|Overall Study|Protocol Violation|4
7306725|NCT00643760|11530710|FG004|Overall Study|Protocol Violation|6
7306726|NCT00643760|11530706|FG000|Overall Study|Lost to Follow-up|6
7306727|NCT00643760|11530707|FG001|Overall Study|Lost to Follow-up|2
7306728|NCT00643760|11530708|FG002|Overall Study|Lost to Follow-up|1
7306729|NCT00643760|11530709|FG003|Overall Study|Lost to Follow-up|3
7306730|NCT00643760|11530710|FG004|Overall Study|Lost to Follow-up|3
7306731|NCT00643760|11530706|FG000|Overall Study|Investigator Discretion|0
7306732|NCT00643760|11530707|FG001|Overall Study|Investigator Discretion|0
7306733|NCT00643760|11530708|FG002|Overall Study|Investigator Discretion|0
7306734|NCT00643760|11530709|FG003|Overall Study|Investigator Discretion|2
7388697|NCT01223365|11648048|FG000|Open-label Titration Period|Enrolled but not treated|1
7388698|NCT01223365|11648048|FG000|Open-label Titration Period|Adverse Event|23
7388699|NCT01223365|11648048|FG000|Open-label Titration Period|Lack of Efficacy|3
7388700|NCT01223365|11648048|FG000|Open-label Titration Period|Withdrawal by Subject|5
7388701|NCT01223365|11648048|FG000|Open-label Titration Period|Protocol Violation|1
7388702|NCT01223365|11648048|FG000|Open-label Titration Period|Lost to Follow-up|2
7388703|NCT01223365|11648048|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
7388704|NCT01223365|11648048|FG000|Open-label Titration Period|Noncompliance with study procedures|2
7388705|NCT01223365|11648048|FG000|Open-label Titration Period|Starting physical therapy|1
7388706|NCT01223365|11648048|FG000|Open-label Treatment Period|Adverse Event|39
7388707|NCT01223365|11648048|FG000|Open-label Treatment Period|Lack of Efficacy|2
7388708|NCT01223365|11648048|FG000|Open-label Treatment Period|Withdrawal by Subject|19
7388709|NCT01223365|11648048|FG000|Open-label Treatment Period|Protocol Violation|15
7388710|NCT01223365|11648048|FG000|Open-label Treatment Period|Lost to Follow-up|7
7388711|NCT01223365|11648048|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
7388712|NCT01223365|11648048|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
7388713|NCT01223365|11648048|FG000|Open-label Treatment Period|Moved out of area|2
7388714|NCT01223365|11648048|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
7388715|NCT01223365|11648048|FG000|Open-label Treatment Period|"Out of window"|1
7388716|NCT01223365|11648048|FG000|Open-label Treatment Period|Starting physical therapy|1
7388717|NCT01223365|11648048|FG000|Open-label Treatment Period|Physician Decision|2
7388718|NCT01223404|11648078|FG000|First Intervention (1 Day)|Adverse Event|0
7388719|NCT01223404|11648079|FG001|First Intervention (1 Day)|Adverse Event|0
7388720|NCT01223404|11648080|FG002|First Intervention (1 Day)|Adverse Event|0
7388721|NCT01223404|11648081|FG003|First Intervention (1 Day)|Adverse Event|1
7388722|NCT01223404|11648082|FG004|First Intervention (1 Day)|Adverse Event|0
7388723|NCT01223404|11648083|FG005|First Intervention (1 Day)|Adverse Event|0
7388724|NCT01223404|11648078|FG000|Second Intervention (1 Day)|Adverse Event|1
7388725|NCT01223404|11648079|FG001|Second Intervention (1 Day)|Adverse Event|0
7388726|NCT01223404|11648080|FG002|Second Intervention (1 Day)|Adverse Event|0
7388727|NCT01223404|11648081|FG003|Second Intervention (1 Day)|Adverse Event|0
7388728|NCT01223404|11648082|FG004|Second Intervention (1 Day)|Adverse Event|0
7388729|NCT01223404|11648083|FG005|Second Intervention (1 Day)|Adverse Event|0
7388730|NCT01223404|11648078|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
7388731|NCT01223404|11648079|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
7388732|NCT01223404|11648080|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
7388733|NCT01223404|11648081|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
7388734|NCT01223404|11648082|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
7388735|NCT01223404|11648083|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
7388736|NCT01223937|11648119|FG000|Overall Study|Withdrawal by Subject|3
7388737|NCT01223937|11648120|FG001|Overall Study|Withdrawal by Subject|2
7388738|NCT01223937|11648119|FG000|Overall Study|Lost to Follow-up|1
7388739|NCT01223937|11648120|FG001|Overall Study|Lost to Follow-up|4
7388740|NCT01223937|11648119|FG000|Overall Study|Adverse Event|1
7388741|NCT01223937|11648120|FG001|Overall Study|Adverse Event|4
7388742|NCT01223937|11648119|FG000|Overall Study|Protocol Violation|8
7388743|NCT01223937|11648120|FG001|Overall Study|Protocol Violation|7
7388744|NCT01223937|11648119|FG000|Overall Study|Other|4
7388745|NCT01223937|11648120|FG001|Overall Study|Other|1
7388746|NCT01224158|11648151|FG000|Overall Study|Withdrawal by Subject|1
7388747|NCT01224158|11648152|FG001|Overall Study|Withdrawal by Subject|0
7388748|NCT01224171|11648160|FG000|Overall Study|Adverse Event|8
7388749|NCT01224171|11648161|FG001|Overall Study|Adverse Event|4
7306735|NCT00643760|11530710|FG004|Overall Study|Investigator Discretion|0
7306736|NCT00643760|11530706|FG000|Overall Study|Withdrawal by Subject|3
7306737|NCT00643760|11530707|FG001|Overall Study|Withdrawal by Subject|1
7306738|NCT00643760|11530708|FG002|Overall Study|Withdrawal by Subject|2
7306739|NCT00643760|11530709|FG003|Overall Study|Withdrawal by Subject|4
7306740|NCT00643760|11530710|FG004|Overall Study|Withdrawal by Subject|1
7306741|NCT00643851|11530725|FG000|Overall Study|Death|0
7306742|NCT00643851|11530726|FG001|Overall Study|Death|1
7306743|NCT00643851|11530727|FG002|Overall Study|Death|0
7306744|NCT00643851|11530725|FG000|Overall Study|Lack of Efficacy|0
7306745|NCT00643851|11530726|FG001|Overall Study|Lack of Efficacy|1
7306746|NCT00643851|11530727|FG002|Overall Study|Lack of Efficacy|0
7306747|NCT00643851|11530725|FG000|Overall Study|Adverse Event|2
7306748|NCT00643851|11530726|FG001|Overall Study|Adverse Event|6
7306749|NCT00643851|11530727|FG002|Overall Study|Adverse Event|6
7306750|NCT00643851|11530725|FG000|Overall Study|Lost to Follow-up|4
7306751|NCT00643851|11530726|FG001|Overall Study|Lost to Follow-up|6
7306752|NCT00643851|11530727|FG002|Overall Study|Lost to Follow-up|9
7306753|NCT00643851|11530725|FG000|Overall Study|Withdrawal by Subject|8
7306754|NCT00643851|11530726|FG001|Overall Study|Withdrawal by Subject|15
7306755|NCT00643851|11530727|FG002|Overall Study|Withdrawal by Subject|9
7306756|NCT00643851|11530725|FG000|Overall Study|Non-compl., not met criteria, etc.|3
7306757|NCT00643851|11530726|FG001|Overall Study|Non-compl., not met criteria, etc.|4
7306758|NCT00643851|11530727|FG002|Overall Study|Non-compl., not met criteria, etc.|6
7306759|NCT00643916|11530741|FG000|Overall Study|Protocol Violation|0
7306760|NCT00643916|11530742|FG001|Overall Study|Protocol Violation|1
7306761|NCT00643916|11530743|FG002|Overall Study|Protocol Violation|1
7306762|NCT00643916|11530744|FG003|Overall Study|Protocol Violation|1
7306763|NCT00643916|11530745|FG004|Overall Study|Protocol Violation|0
7306764|NCT00643916|11530746|FG005|Overall Study|Protocol Violation|0
7306765|NCT00643916|11530741|FG000|Overall Study|Lost to Follow-up|0
7306766|NCT00643916|11530742|FG001|Overall Study|Lost to Follow-up|1
7306767|NCT00643916|11530743|FG002|Overall Study|Lost to Follow-up|0
7306768|NCT00643916|11530744|FG003|Overall Study|Lost to Follow-up|0
7306769|NCT00643916|11530745|FG004|Overall Study|Lost to Follow-up|0
7306770|NCT00643916|11530746|FG005|Overall Study|Lost to Follow-up|0
7306771|NCT00643916|11530741|FG000|Overall Study|Withdrawal by Subject|2
7306772|NCT00643916|11530742|FG001|Overall Study|Withdrawal by Subject|2
7306773|NCT00643916|11530743|FG002|Overall Study|Withdrawal by Subject|2
7306774|NCT00643916|11530744|FG003|Overall Study|Withdrawal by Subject|1
7306775|NCT00643916|11530745|FG004|Overall Study|Withdrawal by Subject|0
7306776|NCT00643916|11530746|FG005|Overall Study|Withdrawal by Subject|1
7306777|NCT00643916|11530741|FG000|Overall Study|Not Vaccinated|2
7306778|NCT00643916|11530742|FG001|Overall Study|Not Vaccinated|2
7306779|NCT00643916|11530743|FG002|Overall Study|Not Vaccinated|3
7306780|NCT00643916|11530744|FG003|Overall Study|Not Vaccinated|0
7306781|NCT00643916|11530745|FG004|Overall Study|Not Vaccinated|2
7306782|NCT00643916|11530746|FG005|Overall Study|Not Vaccinated|0
7306783|NCT00644059|11530763|FG000|Overall Study|Lost to Follow-up|37
7306784|NCT00644059|11530764|FG001|Overall Study|Lost to Follow-up|34
7306785|NCT00644059|11530765|FG002|Overall Study|Lost to Follow-up|16
7306786|NCT00644059|11530763|FG000|Overall Study|Withdrawal by Subject|52
7306787|NCT00644059|11530764|FG001|Overall Study|Withdrawal by Subject|60
7306788|NCT00644059|11530765|FG002|Overall Study|Withdrawal by Subject|30
7306789|NCT00644059|11530763|FG000|Overall Study|Adverse Event|8
7306790|NCT00644059|11530764|FG001|Overall Study|Adverse Event|5
7306791|NCT00644059|11530765|FG002|Overall Study|Adverse Event|1
7306792|NCT00644059|11530763|FG000|Overall Study|Inappropriate Enrollment|1
7306793|NCT00644059|11530764|FG001|Overall Study|Inappropriate Enrollment|3
7306794|NCT00644059|11530765|FG002|Overall Study|Inappropriate Enrollment|0
7306795|NCT00644059|11530763|FG000|Overall Study|Protocol Deviation/violation|20
7306796|NCT00644059|11530764|FG001|Overall Study|Protocol Deviation/violation|19
7306797|NCT00644059|11530765|FG002|Overall Study|Protocol Deviation/violation|15
7306798|NCT00644059|11530763|FG000|Overall Study|Unable to classify|6
7306799|NCT00644059|11530764|FG001|Overall Study|Unable to classify|2
7306800|NCT00644059|11530765|FG002|Overall Study|Unable to classify|3
7306801|NCT00644332|11530832|FG000|Overall Study|Adverse Event|11
7306802|NCT00644332|11530832|FG000|Overall Study|Withdrawal by Subject|6
7306803|NCT00644332|11530832|FG000|Overall Study|Completion Status Unknown|2
7306804|NCT00644332|11530832|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
7306805|NCT00644332|11530832|FG000|Overall Study|Could Not Attend Scheduled Visits|1
7306806|NCT00644358|11530836|FG000|Overall Study|Adverse Event|124
7306807|NCT00644358|11530836|FG000|Overall Study|Lost to Follow-up|105
7306808|NCT00644358|11530836|FG000|Overall Study|Consent Withdrawal|64
7306809|NCT00644358|11530836|FG000|Overall Study|Lack of Effectiveness|39
7306810|NCT00644358|11530836|FG000|Overall Study|Protocol Violation|5
7306811|NCT00644358|11530836|FG000|Overall Study|Noncompliance|14
7306812|NCT00644358|11530836|FG000|Overall Study|Other Unspecified|11
7306813|NCT00644423|11530842|FG000|Overall Study|Lost to Follow-up|1
7306814|NCT00644423|11530843|FG001|Overall Study|Lost to Follow-up|1
7306815|NCT00644787|11530862|FG000|Period 1: Titration Phase|Adverse Event|11
7306816|NCT00644787|11530863|FG001|Period 1: Titration Phase|Adverse Event|0
7306817|NCT00644787|11530864|FG002|Period 1: Titration Phase|Adverse Event|0
7306818|NCT00644787|11530862|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
7306819|NCT00644787|11530863|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
7306820|NCT00644787|11530864|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
7306821|NCT00644787|11530862|FG000|Period 1: Titration Phase|Physician Decision|1
7306822|NCT00644787|11530863|FG001|Period 1: Titration Phase|Physician Decision|0
7306823|NCT00644787|11530864|FG002|Period 1: Titration Phase|Physician Decision|0
7306824|NCT00644787|11530862|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
7306825|NCT00644787|11530863|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
7306826|NCT00644787|11530864|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
7306827|NCT00644787|11530862|FG000|Period 1: Titration Phase|Worsening of complications|1
7306828|NCT00644787|11530863|FG001|Period 1: Titration Phase|Worsening of complications|0
7306829|NCT00644787|11530864|FG002|Period 1: Titration Phase|Worsening of complications|0
7306830|NCT00644787|11530862|FG000|Period 1: Titration Phase|Worsening of symptoms|1
7306831|NCT00644787|11530863|FG001|Period 1: Titration Phase|Worsening of symptoms|0
7306832|NCT00644787|11530864|FG002|Period 1: Titration Phase|Worsening of symptoms|0
7306833|NCT00644787|11530862|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
7306834|NCT00644787|11530863|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7306835|NCT00644787|11530864|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
7306836|NCT00644787|11530862|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
7306837|NCT00644787|11530863|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
7306838|NCT00644787|11530864|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
7306839|NCT00644787|11530862|FG000|Period 2: Double Blind Phase|Adverse Event|0
7306840|NCT00644787|11530863|FG001|Period 2: Double Blind Phase|Adverse Event|2
7306841|NCT00644787|11530864|FG002|Period 2: Double Blind Phase|Adverse Event|4
7306842|NCT00644787|11530862|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
7306843|NCT00644787|11530863|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
7306844|NCT00644787|11530864|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
7306845|NCT00644787|11530862|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
7306846|NCT00644787|11530863|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
7306847|NCT00644787|11530864|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
7306848|NCT00644787|11530862|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
7306849|NCT00644787|11530863|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
7306850|NCT00644787|11530864|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
7306851|NCT00644878|11530872|FG000|Overall Study|Adverse Event|2
7306852|NCT00644878|11530872|FG000|Overall Study|Abnormal laboratory value|3
7306853|NCT00644878|11530872|FG000|Overall Study|Protocol deviation|2
7306854|NCT00644878|11530872|FG000|Overall Study|Treatment duration completed as per protocol|11
7306855|NCT00644917|11530876|FG000|Overall Study|Withdrawal by Subject|2
7306856|NCT00644969|11530886|FG000|Treatment Phase|Randomized, not treated|1
7306857|NCT00644969|11530887|FG001|Treatment Phase|Randomized, not treated|0
7306858|NCT00644969|11530886|FG000|Treatment Phase|Adverse Event|3
7306859|NCT00644969|11530887|FG001|Treatment Phase|Adverse Event|0
7306860|NCT00644969|11530886|FG000|Treatment Phase|Withdrawal by Subject|4
7306861|NCT00644969|11530887|FG001|Treatment Phase|Withdrawal by Subject|0
7306862|NCT00644969|11530886|FG000|Treatment Phase|Lost to Follow-up|2
7306863|NCT00644969|11530887|FG001|Treatment Phase|Lost to Follow-up|2
7306864|NCT00644969|11530886|FG000|Treatment Phase|Other|4
7306865|NCT00644969|11530887|FG001|Treatment Phase|Other|1
7306866|NCT00644969|11530886|FG000|Post Treatment Phase|Death|1
7306867|NCT00644969|11530887|FG001|Post Treatment Phase|Death|0
7306868|NCT00644969|11530886|FG000|Post Treatment Phase|Withdrawal by Subject|4
7306869|NCT00644969|11530887|FG001|Post Treatment Phase|Withdrawal by Subject|2
7306870|NCT00644969|11530886|FG000|Post Treatment Phase|Lost to Follow-up|4
7306871|NCT00644969|11530887|FG001|Post Treatment Phase|Lost to Follow-up|1
7306872|NCT00644969|11530886|FG000|Post Treatment Phase|Other|1
7306873|NCT00644969|11530887|FG001|Post Treatment Phase|Other|0
7306874|NCT00644995|11530895|FG000|Overall Study|Lost to Follow-up|1
7306875|NCT00644995|11530896|FG001|Overall Study|Lost to Follow-up|4
7306876|NCT00644995|11530895|FG000|Overall Study|Refused|1
7306877|NCT00644995|11530896|FG001|Overall Study|Refused|0
7306878|NCT00645099|11530915|FG000|Overall Study|Lack of Efficacy|15
7306879|NCT00645099|11530916|FG001|Overall Study|Lack of Efficacy|6
7306880|NCT00645099|11530915|FG000|Overall Study|Withdrawal by Subject|30
7306881|NCT00645099|11530916|FG001|Overall Study|Withdrawal by Subject|22
7306882|NCT00645099|11530915|FG000|Overall Study|Lost to Follow-up|6
7306883|NCT00645099|11530916|FG001|Overall Study|Lost to Follow-up|4
7306884|NCT00645099|11530915|FG000|Overall Study|Adverse Event|11
7306885|NCT00645099|11530916|FG001|Overall Study|Adverse Event|5
7306886|NCT00645099|11530915|FG000|Overall Study|Other|9
7306887|NCT00645099|11530916|FG001|Overall Study|Other|5
7306888|NCT00645164|11530922|FG000|Overall Study|Lost to Follow-up|2
7306889|NCT00645164|11530922|FG000|Overall Study|Withdrawal by Subject|4
7306890|NCT00645164|11530922|FG000|Overall Study|Protocol Violation|1
7306891|NCT00645411|11530934|FG000|Overall Study|Adverse Event|0
7306892|NCT00645411|11530935|FG001|Overall Study|Adverse Event|0
7306893|NCT00645411|11530936|FG002|Overall Study|Adverse Event|0
7306894|NCT00645411|11530937|FG003|Overall Study|Adverse Event|2
7306895|NCT00645411|11530934|FG000|Overall Study|Withdrawal by Subject|2
7306896|NCT00645411|11530935|FG001|Overall Study|Withdrawal by Subject|1
7306897|NCT00645411|11530936|FG002|Overall Study|Withdrawal by Subject|19
7306898|NCT00645411|11530937|FG003|Overall Study|Withdrawal by Subject|21
7306899|NCT00645411|11530934|FG000|Overall Study|Lost to Follow-up|10
7306900|NCT00645411|11530935|FG001|Overall Study|Lost to Follow-up|5
7306901|NCT00645411|11530936|FG002|Overall Study|Lost to Follow-up|124
7306902|NCT00645411|11530937|FG003|Overall Study|Lost to Follow-up|75
7306903|NCT00645411|11530934|FG000|Overall Study|Protocol Violation|1
7306904|NCT00645411|11530935|FG001|Overall Study|Protocol Violation|0
7306905|NCT00645411|11530936|FG002|Overall Study|Protocol Violation|1
7306906|NCT00645411|11530937|FG003|Overall Study|Protocol Violation|0
7306907|NCT00645411|11530934|FG000|Overall Study|Inappropriate enrollment|0
7306908|NCT00645411|11530935|FG001|Overall Study|Inappropriate enrollment|0
7306909|NCT00645411|11530936|FG002|Overall Study|Inappropriate enrollment|4
7306910|NCT00645411|11530937|FG003|Overall Study|Inappropriate enrollment|1
7388750|NCT01224171|11648160|FG000|Overall Study|Protocol Violation|0
7388751|NCT01224171|11648161|FG001|Overall Study|Protocol Violation|1
7388752|NCT01224171|11648160|FG000|Overall Study|Lack of Efficacy|5
7388753|NCT01224171|11648161|FG001|Overall Study|Lack of Efficacy|1
7388754|NCT01224171|11648160|FG000|Overall Study|Withdrawal of Consent|2
7388755|NCT01224171|11648161|FG001|Overall Study|Withdrawal of Consent|4
7388756|NCT01224171|11648160|FG000|Overall Study|Lost to Follow-up|0
7388757|NCT01224171|11648161|FG001|Overall Study|Lost to Follow-up|3
7388758|NCT01224431|11648183|FG000|Overall Study|not randomized|0
7388759|NCT01224431|11648184|FG001|Overall Study|not randomized|4
7388760|NCT01224431|11648183|FG000|Overall Study|no video record|0
7388761|NCT01224431|11648184|FG001|Overall Study|no video record|1
7388762|NCT01224639|11648208|FG000|Overall Study|Withdrawal by Subject|0
7388763|NCT01224639|11648209|FG001|Overall Study|Withdrawal by Subject|0
7388764|NCT01224639|11648210|FG002|Overall Study|Withdrawal by Subject|0
7388765|NCT01224639|11648211|FG003|Overall Study|Withdrawal by Subject|0
7388766|NCT01224639|11648212|FG004|Overall Study|Withdrawal by Subject|2
7388767|NCT01224639|11648213|FG005|Overall Study|Withdrawal by Subject|0
7388768|NCT01224639|11648214|FG006|Overall Study|Withdrawal by Subject|1
7388769|NCT01224639|11648215|FG007|Overall Study|Withdrawal by Subject|1
7388770|NCT01224639|11648208|FG000|Overall Study|Adverse Event|0
7388771|NCT01224639|11648209|FG001|Overall Study|Adverse Event|0
7388772|NCT01224639|11648210|FG002|Overall Study|Adverse Event|0
7388773|NCT01224639|11648211|FG003|Overall Study|Adverse Event|0
7388774|NCT01224639|11648212|FG004|Overall Study|Adverse Event|0
7388775|NCT01224639|11648213|FG005|Overall Study|Adverse Event|0
7388776|NCT01224639|11648214|FG006|Overall Study|Adverse Event|0
7388777|NCT01224639|11648215|FG007|Overall Study|Adverse Event|1
7388778|NCT01224782|11648242|FG000|Overall Study|Lost to Follow-up|177
7388779|NCT01224782|11648242|FG000|Overall Study|Withdrawal by Subject|16
7388780|NCT01224782|11648242|FG000|Overall Study|Death|14
7388781|NCT01224782|11648242|FG000|Overall Study|Improvement|13
7388782|NCT01224782|11648242|FG000|Overall Study|Adverse Event|12
7388783|NCT01224782|11648242|FG000|Overall Study|Adverse Reaction|11
7388784|NCT01224782|11648242|FG000|Overall Study|Noncompliance|10
7388785|NCT01224782|11648242|FG000|Overall Study|Other|4
7388786|NCT01224782|11648242|FG000|Overall Study|Start of Dialysis|3
7388787|NCT01224782|11648242|FG000|Overall Study|Change of Treatment|1
7388788|NCT01224782|11648242|FG000|Overall Study|Financial Reasons|1
7388789|NCT01224782|11648242|FG000|Overall Study|Deterioration|1
7388790|NCT01224782|11648242|FG000|Overall Study|Transplantation|1
7388791|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
7388792|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
7388793|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
7388794|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7388795|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
7388796|NCT01224821|11648246|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
7388797|NCT01224821|11648246|FG000|Long-Term Follow-Up|Death|2
7388798|NCT01224821|11648246|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
7388799|NCT01224925|11648252|FG000|Overall Study|Lost to Follow-up|3
7388800|NCT01224925|11648253|FG001|Overall Study|Lost to Follow-up|2
7388801|NCT01225146|11648294|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
7388802|NCT01225146|11648295|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
7388803|NCT01225159|11648305|FG000|Overall Study|Change operation|1
7388804|NCT01225159|11648306|FG001|Overall Study|Change operation|0
7388805|NCT01225172|11648314|FG000|Overall Study|Subject decision to stop|1
7388806|NCT01225172|11648315|FG001|Overall Study|Subject decision to stop|0
7388807|NCT01225172|11648314|FG000|Overall Study|Subject request to discontinue treatment|3
7388808|NCT01225172|11648315|FG001|Overall Study|Subject request to discontinue treatment|1
7388809|NCT01225172|11648314|FG000|Overall Study|Subject no longer meets study criteria|1
7388810|NCT01225172|11648315|FG001|Overall Study|Subject no longer meets study criteria|0
7306911|NCT00645411|11530934|FG000|Overall Study|Unable to classify|0
7388811|NCT01225172|11648314|FG000|Overall Study|Withdrawal by Subject|1
7388812|NCT01225172|11648315|FG001|Overall Study|Withdrawal by Subject|0
7388813|NCT01225211|11648331|FG000|Overall Study|Adverse Event|0
7388814|NCT01225211|11648332|FG001|Overall Study|Adverse Event|0
7388815|NCT01225211|11648333|FG002|Overall Study|Adverse Event|1
7388816|NCT01225211|11648334|FG003|Overall Study|Adverse Event|0
7388817|NCT01225211|11648335|FG004|Overall Study|Adverse Event|0
7306912|NCT00645411|11530935|FG001|Overall Study|Unable to classify|0
7306913|NCT00645411|11530936|FG002|Overall Study|Unable to classify|3
7306914|NCT00645411|11530937|FG003|Overall Study|Unable to classify|4
7306915|NCT00645528|11530963|FG000|Overall Study|Did not show up for Visit 2|7
7306916|NCT00645593|11530969|FG000|Overall Study|Later found to be ineligible|1
7306917|NCT00645593|11530970|FG001|Overall Study|Later found to be ineligible|0
7306918|NCT00645671|11530978|FG000|Overall Study|Protocol Violation|1
7306919|NCT00645671|11530979|FG001|Overall Study|Protocol Violation|0
7306920|NCT00645671|11530978|FG000|Overall Study|Withdrawal by Subject|0
7306921|NCT00645671|11530979|FG001|Overall Study|Withdrawal by Subject|4
7306922|NCT00645671|11530978|FG000|Overall Study|Adverse Event|0
7306923|NCT00645671|11530979|FG001|Overall Study|Adverse Event|1
7306924|NCT00645671|11530978|FG000|Overall Study|Physician Decision|0
7306925|NCT00645671|11530979|FG001|Overall Study|Physician Decision|1
7306926|NCT00645788|11531009|FG000|Overall Study|Did not receive study drug|1
7306927|NCT00645788|11531010|FG001|Overall Study|Did not receive study drug|1
7306928|NCT00645788|11531011|FG002|Overall Study|Did not receive study drug|0
7306929|NCT00645788|11531012|FG003|Overall Study|Did not receive study drug|0
7306930|NCT00645788|11531009|FG000|Overall Study|Adverse Event|4
7306931|NCT00645788|11531010|FG001|Overall Study|Adverse Event|9
7306932|NCT00645788|11531011|FG002|Overall Study|Adverse Event|5
7306933|NCT00645788|11531012|FG003|Overall Study|Adverse Event|3
7306934|NCT00645788|11531009|FG000|Overall Study|Lost to Follow-up|1
7306935|NCT00645788|11531010|FG001|Overall Study|Lost to Follow-up|0
7306936|NCT00645788|11531011|FG002|Overall Study|Lost to Follow-up|0
7306937|NCT00645788|11531012|FG003|Overall Study|Lost to Follow-up|0
7306938|NCT00645788|11531009|FG000|Overall Study|Protocol Violation|1
7306939|NCT00645788|11531010|FG001|Overall Study|Protocol Violation|0
7306940|NCT00645788|11531011|FG002|Overall Study|Protocol Violation|2
7306941|NCT00645788|11531012|FG003|Overall Study|Protocol Violation|0
7306942|NCT00645788|11531009|FG000|Overall Study|Withdrawal by Subject|0
7306943|NCT00645788|11531010|FG001|Overall Study|Withdrawal by Subject|1
7306944|NCT00645788|11531011|FG002|Overall Study|Withdrawal by Subject|0
7306945|NCT00645788|11531012|FG003|Overall Study|Withdrawal by Subject|2
7306946|NCT00645788|11531009|FG000|Overall Study|Pulmonary exacerbation|13
7306947|NCT00645788|11531010|FG001|Overall Study|Pulmonary exacerbation|16
7306948|NCT00645788|11531011|FG002|Overall Study|Pulmonary exacerbation|11
7306949|NCT00645788|11531012|FG003|Overall Study|Pulmonary exacerbation|9
7306950|NCT00645840|11531031|FG000|Overall Study|Protocol Violation|3
7306951|NCT00645853|11531037|FG000|Overall Study|Adverse Event|18
7306952|NCT00645853|11531038|FG001|Overall Study|Adverse Event|7
7306953|NCT00645853|11531037|FG000|Overall Study|AZ study closure in Hungary|60
7306954|NCT00645853|11531038|FG001|Overall Study|AZ study closure in Hungary|40
7306955|NCT00645853|11531037|FG000|Overall Study|Withdrawal by Subject|5
7306956|NCT00645853|11531038|FG001|Overall Study|Withdrawal by Subject|2
7306957|NCT00645853|11531037|FG000|Overall Study|Protocol Violation|0
7306958|NCT00645853|11531038|FG001|Overall Study|Protocol Violation|2
7306959|NCT00645853|11531037|FG000|Overall Study|Discontinuation criteria|2
7306960|NCT00645853|11531038|FG001|Overall Study|Discontinuation criteria|2
7306961|NCT00645853|11531037|FG000|Overall Study|recall of ICF, planned operation, death|7
7306962|NCT00645853|11531038|FG001|Overall Study|recall of ICF, planned operation, death|4
7306963|NCT00645944|11531046|FG000|Randomized|Withdrawal by Subject|1
7306964|NCT00645944|11531047|FG001|Randomized|Withdrawal by Subject|2
7306965|NCT00645944|11531046|FG000|Received Medication|Adverse Event|2
7306966|NCT00645944|11531047|FG001|Received Medication|Adverse Event|1
7306967|NCT00645944|11531046|FG000|Received Medication|Withdrawal by Subject|1
7306968|NCT00645944|11531047|FG001|Received Medication|Withdrawal by Subject|1
7306969|NCT00645944|11531046|FG000|Received Medication|Lost to Follow-up|1
7306970|NCT00645944|11531047|FG001|Received Medication|Lost to Follow-up|0
7306971|NCT00645944|11531046|FG000|Received Medication|Protocol Violation|2
7306972|NCT00645944|11531047|FG001|Received Medication|Protocol Violation|1
7306973|NCT00646113|11531066|FG000|Overall Study|Lost to Follow-up|5
7306974|NCT00646113|11531066|FG000|Overall Study|Adverse Event|3
7306975|NCT00646399|11531072|FG000|Overall Study|Death|63
7306976|NCT00646399|11531073|FG001|Overall Study|Death|53
7306977|NCT00646399|11531072|FG000|Overall Study|Withdrawal by Subject|9
7306978|NCT00646399|11531073|FG001|Overall Study|Withdrawal by Subject|10
7306979|NCT00646399|11531072|FG000|Overall Study|Other Reason|11
7306980|NCT00646399|11531073|FG001|Overall Study|Other Reason|11
7306981|NCT00646451|11531079|FG000|Overall Study|Adverse Event|3
7306982|NCT00646451|11531080|FG001|Overall Study|Adverse Event|0
7306983|NCT00646451|11531079|FG000|Overall Study|Exacerbation of pre-existing condition|1
7306984|NCT00646451|11531080|FG001|Overall Study|Exacerbation of pre-existing condition|0
7306985|NCT00646776|11531125|FG000|Overall Study|Adverse Event|1
7306986|NCT00646776|11531126|FG001|Overall Study|Adverse Event|9
7306987|NCT00646776|11531125|FG000|Overall Study|Investigator discretion|0
7306988|NCT00646776|11531126|FG001|Overall Study|Investigator discretion|4
7306989|NCT00646906|11531139|FG000|Crossover Period 1|Withdrawal by Subject|1
7306990|NCT00646906|11531140|FG001|Crossover Period 1|Withdrawal by Subject|0
7306991|NCT00646906|11531141|FG002|Crossover Period 1|Withdrawal by Subject|0
7306992|NCT00646906|11531142|FG003|Crossover Period 1|Withdrawal by Subject|0
7306993|NCT00646906|11531143|FG004|Crossover Period 1|Withdrawal by Subject|0
7306994|NCT00646906|11531144|FG005|Crossover Period 1|Withdrawal by Subject|1
7306995|NCT00646906|11531145|FG006|Crossover Period 1|Withdrawal by Subject|0
7306996|NCT00646906|11531139|FG000|Crossover Period 2|Withdrawal by Subject|0
7306997|NCT00646906|11531140|FG001|Crossover Period 2|Withdrawal by Subject|1
7306998|NCT00646906|11531141|FG002|Crossover Period 2|Withdrawal by Subject|2
7306999|NCT00646906|11531142|FG003|Crossover Period 2|Withdrawal by Subject|1
7307000|NCT00646906|11531143|FG004|Crossover Period 2|Withdrawal by Subject|0
7307001|NCT00646906|11531144|FG005|Crossover Period 2|Withdrawal by Subject|0
7307002|NCT00646906|11531145|FG006|Crossover Period 2|Withdrawal by Subject|0
7307003|NCT00646906|11531139|FG000|Crossover Period 2|Physician Decision|0
7307004|NCT00646906|11531140|FG001|Crossover Period 2|Physician Decision|0
7307005|NCT00646906|11531141|FG002|Crossover Period 2|Physician Decision|0
7307006|NCT00646906|11531142|FG003|Crossover Period 2|Physician Decision|0
7307007|NCT00646906|11531143|FG004|Crossover Period 2|Physician Decision|0
7307008|NCT00646906|11531144|FG005|Crossover Period 2|Physician Decision|0
7307009|NCT00646906|11531145|FG006|Crossover Period 2|Physician Decision|1
7307010|NCT00646958|11531161|FG000|Overall Study|Lack of Efficacy|1
7307011|NCT00646958|11531162|FG001|Overall Study|Lack of Efficacy|0
7307012|NCT00646958|11531163|FG002|Overall Study|Lack of Efficacy|0
7307013|NCT00646958|11531161|FG000|Overall Study|Adverse Event|4
7307014|NCT00646958|11531162|FG001|Overall Study|Adverse Event|0
7307015|NCT00646958|11531163|FG002|Overall Study|Adverse Event|0
7307016|NCT00646958|11531161|FG000|Overall Study|Lost to Follow-up|1
7307017|NCT00646958|11531162|FG001|Overall Study|Lost to Follow-up|5
7307018|NCT00646958|11531163|FG002|Overall Study|Lost to Follow-up|7
7307019|NCT00646958|11531161|FG000|Overall Study|Protocol Violation|1
7307020|NCT00646958|11531162|FG001|Overall Study|Protocol Violation|1
7307021|NCT00646958|11531163|FG002|Overall Study|Protocol Violation|0
7307022|NCT00646958|11531161|FG000|Overall Study|Abnormal screening lab tests|1
7307023|NCT00646958|11531162|FG001|Overall Study|Abnormal screening lab tests|1
7307024|NCT00646958|11531163|FG002|Overall Study|Abnormal screening lab tests|0
7307025|NCT00646958|11531161|FG000|Overall Study|Withdrawal by Subject|1
7307026|NCT00646958|11531162|FG001|Overall Study|Withdrawal by Subject|2
7307027|NCT00646958|11531163|FG002|Overall Study|Withdrawal by Subject|0
7307028|NCT00646958|11531161|FG000|Overall Study|Did not receive study drug|2
7307029|NCT00646958|11531162|FG001|Overall Study|Did not receive study drug|0
7307030|NCT00646958|11531163|FG002|Overall Study|Did not receive study drug|2
7307031|NCT00647270|11531174|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
7307032|NCT00647270|11531175|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7307033|NCT00647270|11531176|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
7307034|NCT00647270|11531174|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
7307035|NCT00647270|11531175|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7307036|NCT00647270|11531176|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
7307037|NCT00647270|11531174|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
7307038|NCT00647270|11531175|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
7307039|NCT00647270|11531176|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
7307040|NCT00647270|11531174|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
7307041|NCT00647270|11531175|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
7307042|NCT00647270|11531176|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
7307043|NCT00647270|11531174|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
7307044|NCT00647270|11531175|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7307045|NCT00647270|11531176|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
7307046|NCT00647270|11531174|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7307047|NCT00647270|11531175|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
7307048|NCT00647270|11531176|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
7307049|NCT00647270|11531174|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
7307050|NCT00647270|11531175|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
7307051|NCT00647270|11531176|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
7307052|NCT00647296|11531191|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7307053|NCT00647296|11531192|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7307054|NCT00647296|11531193|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
7307055|NCT00647296|11531194|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
7307056|NCT00647296|11531191|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7307057|NCT00647296|11531192|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7307058|NCT00647296|11531193|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
7307059|NCT00647296|11531194|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
7307060|NCT00647296|11531191|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7307061|NCT00647296|11531192|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
7307062|NCT00647296|11531193|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7307063|NCT00647296|11531194|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
7307064|NCT00647296|11531191|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
7307065|NCT00647296|11531192|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7307066|NCT00647296|11531193|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7307067|NCT00647296|11531194|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
7307068|NCT00647296|11531191|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
7307069|NCT00647296|11531192|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7307070|NCT00647296|11531193|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7307071|NCT00647296|11531194|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
7307072|NCT00647296|11531191|FG000|Part 2: 4-week Placebo Washout|Death|3
7307073|NCT00647296|11531192|FG001|Part 2: 4-week Placebo Washout|Death|0
7307074|NCT00647296|11531193|FG002|Part 2: 4-week Placebo Washout|Death|0
7307075|NCT00647296|11531194|FG003|Part 2: 4-week Placebo Washout|Death|0
7307076|NCT00647296|11531191|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7307077|NCT00647296|11531192|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
7307078|NCT00647296|11531193|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
7307079|NCT00647296|11531194|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
7307080|NCT00647296|11531191|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7307081|NCT00647296|11531192|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
7307082|NCT00647296|11531193|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
7307083|NCT00647296|11531194|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
7307084|NCT00647296|11531191|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7307085|NCT00647296|11531192|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
7307086|NCT00647296|11531193|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7307087|NCT00647296|11531194|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
7307088|NCT00647296|11531191|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
7307089|NCT00647296|11531192|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
7307090|NCT00647296|11531193|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
7307091|NCT00647296|11531194|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
7307092|NCT00647296|11531191|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7307093|NCT00647296|11531192|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7307094|NCT00647296|11531193|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
7307095|NCT00647296|11531194|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
7307096|NCT00647348|11531218|FG000|Overall Study|Lost to Follow-up|3
7307097|NCT00647348|11531219|FG001|Overall Study|Lost to Follow-up|6
7384041|NCT01192191|11641157|FG001|Overall Study|Participants Reached Stopping Criteria|2
7384042|NCT01192191|11641156|FG000|Overall Study|Lost to Follow-up|0
7384043|NCT01192191|11641157|FG001|Overall Study|Lost to Follow-up|1
7384044|NCT01192191|11641156|FG000|Overall Study|Withdrawal by Subject|1
7384045|NCT01192191|11641157|FG001|Overall Study|Withdrawal by Subject|6
7384046|NCT01192204|11641165|FG000|Overall Study|could not keep recall appointments|1
7384047|NCT01192204|11641166|FG001|Overall Study|could not keep recall appointments|0
7388818|NCT01225211|11648336|FG005|Overall Study|Adverse Event|0
7388819|NCT01225211|11648337|FG006|Overall Study|Adverse Event|0
7388820|NCT01225211|11648338|FG007|Overall Study|Adverse Event|0
7388821|NCT01225211|11648339|FG008|Overall Study|Adverse Event|0
7388822|NCT01225211|11648340|FG009|Overall Study|Adverse Event|1
7388823|NCT01225211|11648331|FG000|Overall Study|Withdrawal by Subject|0
7388824|NCT01225211|11648332|FG001|Overall Study|Withdrawal by Subject|0
7388825|NCT01225211|11648333|FG002|Overall Study|Withdrawal by Subject|0
7388826|NCT01225211|11648334|FG003|Overall Study|Withdrawal by Subject|0
7388827|NCT01225211|11648335|FG004|Overall Study|Withdrawal by Subject|0
7388828|NCT01225211|11648336|FG005|Overall Study|Withdrawal by Subject|0
7388829|NCT01225211|11648337|FG006|Overall Study|Withdrawal by Subject|1
7388830|NCT01225211|11648338|FG007|Overall Study|Withdrawal by Subject|0
7388831|NCT01225211|11648339|FG008|Overall Study|Withdrawal by Subject|1
7388832|NCT01225211|11648340|FG009|Overall Study|Withdrawal by Subject|3
7388833|NCT01225211|11648331|FG000|Overall Study|Other|0
7388834|NCT01225211|11648332|FG001|Overall Study|Other|0
7388835|NCT01225211|11648333|FG002|Overall Study|Other|0
7388836|NCT01225211|11648334|FG003|Overall Study|Other|0
7388837|NCT01225211|11648335|FG004|Overall Study|Other|0
7388838|NCT01225211|11648336|FG005|Overall Study|Other|0
7388839|NCT01225211|11648337|FG006|Overall Study|Other|0
7388840|NCT01225211|11648338|FG007|Overall Study|Other|0
7388841|NCT01225211|11648339|FG008|Overall Study|Other|0
7388842|NCT01225211|11648340|FG009|Overall Study|Other|1
7388843|NCT01225549|11648430|FG000|Period 4 - Washout|Disallowed medication|0
7388844|NCT01225549|11648431|FG001|Period 4 - Washout|Disallowed medication|1
7388845|NCT01225549|11648432|FG002|Period 4 - Washout|Disallowed medication|0
7388846|NCT01225549|11648433|FG003|Period 4 - Washout|Disallowed medication|0
7388847|NCT01225549|11648434|FG004|Period 4 - Washout|Disallowed medication|0
7388848|NCT01225549|11648435|FG005|Period 4 - Washout|Disallowed medication|0
7388849|NCT01225549|11648436|FG006|Period 4 - Washout|Disallowed medication|0
7388850|NCT01225549|11648437|FG007|Period 4 - Washout|Disallowed medication|0
7388851|NCT01225549|11648438|FG008|Period 4 - Washout|Disallowed medication|0
7384048|NCT01192295|11641191|FG000|Overall Study|Adverse Event|3
7384049|NCT01192295|11641192|FG001|Overall Study|Adverse Event|7
7384050|NCT01192295|11641191|FG000|Overall Study|Withdrawal by Subject|3
7384051|NCT01192295|11641192|FG001|Overall Study|Withdrawal by Subject|4
7388852|NCT01225549|11648439|FG009|Period 4 - Washout|Disallowed medication|0
7388853|NCT01225549|11648430|FG000|Period 6 - Washout|Disallowed medication|0
7388854|NCT01225549|11648431|FG001|Period 6 - Washout|Disallowed medication|0
7388855|NCT01225549|11648432|FG002|Period 6 - Washout|Disallowed medication|0
7388856|NCT01225549|11648433|FG003|Period 6 - Washout|Disallowed medication|1
7388857|NCT01225549|11648434|FG004|Period 6 - Washout|Disallowed medication|0
7388858|NCT01225549|11648435|FG005|Period 6 - Washout|Disallowed medication|0
7307108|NCT00647699|11531245|FG000|Overall Study|Lost to Follow-up|5
7307109|NCT00647699|11531246|FG001|Overall Study|Lost to Follow-up|4
7307110|NCT00647699|11531245|FG000|Overall Study|Withdrawal by Subject|3
7307111|NCT00647699|11531246|FG001|Overall Study|Withdrawal by Subject|8
7307112|NCT00648037|11531263|FG000|Overall Study|Not Treated|1
7307113|NCT00648037|11531263|FG000|Overall Study|Withdrawal by Subject|1
7307114|NCT00648037|11531263|FG000|Overall Study|Adverse Event|11
7307115|NCT00648037|11531263|FG000|Overall Study|Relapse|2
7307116|NCT00648037|11531263|FG000|Overall Study|Other|1
7307117|NCT00648167|11531280|FG000|Overall Study|Adverse Event|6
7307118|NCT00648167|11531280|FG000|Overall Study|unable to swallow tablets|1
7307119|NCT00648739|11531406|FG000|Overall Study|Adverse Event|1
7307120|NCT00648739|11531407|FG001|Overall Study|Adverse Event|0
7307121|NCT00648739|11531408|FG002|Overall Study|Adverse Event|1
7307122|NCT00648739|11531409|FG003|Overall Study|Adverse Event|2
7307123|NCT00648739|11531410|FG004|Overall Study|Adverse Event|1
7307124|NCT00648739|11531411|FG005|Overall Study|Adverse Event|0
7307125|NCT00648739|11531412|FG006|Overall Study|Adverse Event|0
7307126|NCT00648739|11531406|FG000|Overall Study|Withdrawal by Subject|1
7307127|NCT00648739|11531407|FG001|Overall Study|Withdrawal by Subject|0
7307128|NCT00648739|11531408|FG002|Overall Study|Withdrawal by Subject|1
7307129|NCT00648739|11531409|FG003|Overall Study|Withdrawal by Subject|0
7307130|NCT00648739|11531410|FG004|Overall Study|Withdrawal by Subject|0
7307131|NCT00648739|11531411|FG005|Overall Study|Withdrawal by Subject|2
7307132|NCT00648739|11531412|FG006|Overall Study|Withdrawal by Subject|0
7307133|NCT00648739|11531406|FG000|Overall Study|Lack of Efficacy|0
7307134|NCT00648739|11531407|FG001|Overall Study|Lack of Efficacy|0
7307135|NCT00648739|11531408|FG002|Overall Study|Lack of Efficacy|0
7307136|NCT00648739|11531409|FG003|Overall Study|Lack of Efficacy|0
7307137|NCT00648739|11531410|FG004|Overall Study|Lack of Efficacy|1
7307138|NCT00648739|11531411|FG005|Overall Study|Lack of Efficacy|2
7307139|NCT00648739|11531412|FG006|Overall Study|Lack of Efficacy|0
7307140|NCT00648739|11531406|FG000|Overall Study|Investigator Considered it Advisable|0
7307141|NCT00648739|11531407|FG001|Overall Study|Investigator Considered it Advisable|0
7307142|NCT00648739|11531408|FG002|Overall Study|Investigator Considered it Advisable|0
7307143|NCT00648739|11531409|FG003|Overall Study|Investigator Considered it Advisable|0
7307144|NCT00648739|11531410|FG004|Overall Study|Investigator Considered it Advisable|0
7307145|NCT00648739|11531411|FG005|Overall Study|Investigator Considered it Advisable|1
7307146|NCT00648739|11531412|FG006|Overall Study|Investigator Considered it Advisable|1
7307147|NCT00648739|11531406|FG000|Overall Study|Death|0
7307148|NCT00648739|11531407|FG001|Overall Study|Death|1
7307149|NCT00648739|11531408|FG002|Overall Study|Death|0
7307150|NCT00648739|11531409|FG003|Overall Study|Death|0
7307151|NCT00648739|11531410|FG004|Overall Study|Death|0
7307152|NCT00648739|11531411|FG005|Overall Study|Death|0
7307153|NCT00648739|11531412|FG006|Overall Study|Death|0
7307154|NCT00648739|11531406|FG000|Overall Study|Positive Human Anti-human Antibody|0
7307155|NCT00648739|11531407|FG001|Overall Study|Positive Human Anti-human Antibody|0
7307156|NCT00648739|11531408|FG002|Overall Study|Positive Human Anti-human Antibody|1
7307157|NCT00648739|11531409|FG003|Overall Study|Positive Human Anti-human Antibody|0
7307158|NCT00648739|11531410|FG004|Overall Study|Positive Human Anti-human Antibody|0
7307159|NCT00648739|11531411|FG005|Overall Study|Positive Human Anti-human Antibody|0
7307160|NCT00648739|11531412|FG006|Overall Study|Positive Human Anti-human Antibody|0
7307161|NCT00648739|11531406|FG000|Overall Study|Follow-up Visits Not Completed|0
7307162|NCT00648739|11531407|FG001|Overall Study|Follow-up Visits Not Completed|1
7307163|NCT00648739|11531408|FG002|Overall Study|Follow-up Visits Not Completed|0
7307164|NCT00648739|11531409|FG003|Overall Study|Follow-up Visits Not Completed|0
7307165|NCT00648739|11531410|FG004|Overall Study|Follow-up Visits Not Completed|0
7307166|NCT00648739|11531411|FG005|Overall Study|Follow-up Visits Not Completed|0
7307167|NCT00648739|11531412|FG006|Overall Study|Follow-up Visits Not Completed|0
7307168|NCT00649220|11531438|FG000|Overall Study|Adverse Event|2
7307169|NCT00649220|11531438|FG000|Overall Study|Withdrawal by Subject|1
7307170|NCT00649389|11531446|FG000|Overall Study|Adverse Event|22
7307171|NCT00649389|11531447|FG001|Overall Study|Adverse Event|46
7307172|NCT00649389|11531448|FG002|Overall Study|Adverse Event|38
7307173|NCT00649389|11531449|FG003|Overall Study|Adverse Event|48
7307174|NCT00649389|11531446|FG000|Overall Study|Lost to Follow-up|15
7307175|NCT00649389|11531447|FG001|Overall Study|Lost to Follow-up|17
7307176|NCT00649389|11531448|FG002|Overall Study|Lost to Follow-up|21
7307177|NCT00649389|11531449|FG003|Overall Study|Lost to Follow-up|26
7307178|NCT00649389|11531446|FG000|Overall Study|Protocol Violation|11
7307179|NCT00649389|11531447|FG001|Overall Study|Protocol Violation|13
7307180|NCT00649389|11531448|FG002|Overall Study|Protocol Violation|9
7307181|NCT00649389|11531449|FG003|Overall Study|Protocol Violation|8
7307182|NCT00649389|11531446|FG000|Overall Study|Withdrawal by Subject|20
7307183|NCT00649389|11531447|FG001|Overall Study|Withdrawal by Subject|21
7307184|NCT00649389|11531448|FG002|Overall Study|Withdrawal by Subject|19
7307185|NCT00649389|11531449|FG003|Overall Study|Withdrawal by Subject|23
7307186|NCT00649389|11531446|FG000|Overall Study|Other|3
7307187|NCT00649389|11531447|FG001|Overall Study|Other|9
7307188|NCT00649389|11531448|FG002|Overall Study|Other|1
7307189|NCT00649389|11531449|FG003|Overall Study|Other|6
7307190|NCT00649428|11531461|FG000|Overall Study|Adverse Event|2
7307191|NCT00649428|11531462|FG001|Overall Study|Adverse Event|2
7307192|NCT00649428|11531461|FG000|Overall Study|Withdrawal by Subject|6
7307193|NCT00649428|11531462|FG001|Overall Study|Withdrawal by Subject|6
7307194|NCT00649428|11531461|FG000|Overall Study|Lost to Follow-up|1
7307195|NCT00649428|11531462|FG001|Overall Study|Lost to Follow-up|3
7307196|NCT00649428|11531461|FG000|Overall Study|Insufficient manufacturing yield|5
7307197|NCT00649428|11531462|FG001|Overall Study|Insufficient manufacturing yield|1
7307198|NCT00649428|11531461|FG000|Overall Study|Protocol Violation|6
7307199|NCT00649428|11531462|FG001|Overall Study|Protocol Violation|2
7307200|NCT00649428|11531461|FG000|Overall Study|Physician Decision|0
7307201|NCT00649428|11531462|FG001|Overall Study|Physician Decision|1
7307202|NCT00650091|11531488|FG000|Amended Study Design|Withdrawal by Subject|12
7307203|NCT00650091|11531489|FG001|Amended Study Design|Withdrawal by Subject|11
7307204|NCT00650091|11531490|FG002|Amended Study Design|Withdrawal by Subject|0
7307205|NCT00650091|11531488|FG000|Amended Study Design|Physician Decision|5
7307206|NCT00650091|11531489|FG001|Amended Study Design|Physician Decision|0
7307207|NCT00650091|11531490|FG002|Amended Study Design|Physician Decision|0
7307208|NCT00650091|11531488|FG000|Amended Study Design|Adverse Event|1
7307209|NCT00650091|11531489|FG001|Amended Study Design|Adverse Event|4
7307210|NCT00650091|11531490|FG002|Amended Study Design|Adverse Event|0
7307211|NCT00650091|11531488|FG000|Amended Study Design|Lung transplantation|4
7307212|NCT00650091|11531489|FG001|Amended Study Design|Lung transplantation|2
7307213|NCT00650091|11531490|FG002|Amended Study Design|Lung transplantation|0
7307214|NCT00650091|11531488|FG000|Amended Study Design|Other|1
7307215|NCT00650091|11531489|FG001|Amended Study Design|Other|3
7307216|NCT00650091|11531490|FG002|Amended Study Design|Other|0
7307217|NCT00650104|11531498|FG000|Overall Study|Adverse Event|17
7307218|NCT00650104|11531498|FG000|Overall Study|Death|2
7307219|NCT00650104|11531498|FG000|Overall Study|Withdrawal by Subject|11
7307220|NCT00650104|11531498|FG000|Overall Study|Physician Decision|7
7307221|NCT00650104|11531498|FG000|Overall Study|Lost to Follow-up|1
7307222|NCT00650104|11531498|FG000|Overall Study|Non-compliance|2
7307223|NCT00650104|11531498|FG000|Overall Study|Sponsor Terminated Dosing|1
7307224|NCT00650585|11531518|FG000|Overall Study|Lost to Follow-up|505
7307225|NCT00650585|11531519|FG001|Overall Study|Lost to Follow-up|482
7307226|NCT00650585|11531518|FG000|Overall Study|No parental consent|935
7307227|NCT00650585|11531519|FG001|Overall Study|No parental consent|866
7307228|NCT00650585|11531518|FG000|Overall Study|Excluded/ruled ineligible|357
7307229|NCT00650585|11531519|FG001|Overall Study|Excluded/ruled ineligible|129
7307230|NCT00650767|11531529|FG000|Overall Study|Adverse Event|0
7307231|NCT00650767|11531530|FG001|Overall Study|Adverse Event|3
7307232|NCT00650767|11531531|FG002|Overall Study|Adverse Event|10
7307233|NCT00650767|11531532|FG003|Overall Study|Adverse Event|8
7307234|NCT00650767|11531529|FG000|Overall Study|Death|1
7307235|NCT00650767|11531530|FG001|Overall Study|Death|0
7307236|NCT00650767|11531531|FG002|Overall Study|Death|0
7307237|NCT00650767|11531532|FG003|Overall Study|Death|0
7307238|NCT00650767|11531529|FG000|Overall Study|Withdrawal by Subject|2
7307239|NCT00650767|11531530|FG001|Overall Study|Withdrawal by Subject|4
7307240|NCT00650767|11531531|FG002|Overall Study|Withdrawal by Subject|3
7307241|NCT00650767|11531532|FG003|Overall Study|Withdrawal by Subject|3
7307242|NCT00650767|11531529|FG000|Overall Study|Lost to Follow-up|1
7307243|NCT00650767|11531530|FG001|Overall Study|Lost to Follow-up|1
7307244|NCT00650767|11531531|FG002|Overall Study|Lost to Follow-up|1
7307245|NCT00650767|11531532|FG003|Overall Study|Lost to Follow-up|0
7307246|NCT00650767|11531529|FG000|Overall Study|Other|1
7307247|NCT00650767|11531530|FG001|Overall Study|Other|1
7307248|NCT00650767|11531531|FG002|Overall Study|Other|0
7307249|NCT00650767|11531532|FG003|Overall Study|Other|0
7307250|NCT00650806|11531546|FG000|Overall Study|Adverse Event|0
7307251|NCT00650806|11531547|FG001|Overall Study|Adverse Event|5
7307252|NCT00650806|11531548|FG002|Overall Study|Adverse Event|3
7307253|NCT00650806|11531549|FG003|Overall Study|Adverse Event|4
7307254|NCT00650806|11531546|FG000|Overall Study|Lost to Follow-up|7
7307255|NCT00650806|11531547|FG001|Overall Study|Lost to Follow-up|6
7307256|NCT00650806|11531548|FG002|Overall Study|Lost to Follow-up|11
7307257|NCT00650806|11531549|FG003|Overall Study|Lost to Follow-up|10
7307258|NCT00650806|11531546|FG000|Overall Study|Protocol Violation|0
7307259|NCT00650806|11531547|FG001|Overall Study|Protocol Violation|0
7307260|NCT00650806|11531548|FG002|Overall Study|Protocol Violation|0
7307261|NCT00650806|11531549|FG003|Overall Study|Protocol Violation|1
7307262|NCT00650806|11531546|FG000|Overall Study|Pregnancy|0
7307263|NCT00650806|11531547|FG001|Overall Study|Pregnancy|0
7307264|NCT00650806|11531548|FG002|Overall Study|Pregnancy|0
7307265|NCT00650806|11531549|FG003|Overall Study|Pregnancy|1
7307266|NCT00650806|11531546|FG000|Overall Study|Withdrawal by Subject|7
7307267|NCT00650806|11531547|FG001|Overall Study|Withdrawal by Subject|5
7307268|NCT00650806|11531548|FG002|Overall Study|Withdrawal by Subject|8
7307269|NCT00650806|11531549|FG003|Overall Study|Withdrawal by Subject|6
7307270|NCT00650806|11531546|FG000|Overall Study|Noncompliance with study drug regimen|1
7307271|NCT00650806|11531547|FG001|Overall Study|Noncompliance with study drug regimen|1
7307272|NCT00650806|11531548|FG002|Overall Study|Noncompliance with study drug regimen|0
7307273|NCT00650806|11531549|FG003|Overall Study|Noncompliance with study drug regimen|0
7307274|NCT00650806|11531546|FG000|Overall Study|Study terminated by sponsor|2
7307275|NCT00650806|11531547|FG001|Overall Study|Study terminated by sponsor|3
7307276|NCT00650806|11531548|FG002|Overall Study|Study terminated by sponsor|5
7307277|NCT00650806|11531549|FG003|Overall Study|Study terminated by sponsor|4
7307278|NCT00650806|11531546|FG000|Overall Study|Other|1
7307279|NCT00650806|11531547|FG001|Overall Study|Other|1
7307280|NCT00650806|11531548|FG002|Overall Study|Other|2
7307281|NCT00650806|11531549|FG003|Overall Study|Other|0
7307282|NCT00650845|11531563|FG000|Overall Study|Withdrawal by Subject|5
7307283|NCT00650845|11531564|FG001|Overall Study|Withdrawal by Subject|0
7307284|NCT00650845|11531563|FG000|Overall Study|Protocol Violation|0
7307285|NCT00650845|11531564|FG001|Overall Study|Protocol Violation|13
7307286|NCT00651118|11531601|FG000|Overall Study|Adverse Event|4
7307287|NCT00651118|11531602|FG001|Overall Study|Adverse Event|0
7307288|NCT00651118|11531603|FG002|Overall Study|Adverse Event|1
7307289|NCT00651118|11531604|FG003|Overall Study|Adverse Event|1
7307290|NCT00651118|11531601|FG000|Overall Study|Protocol Violation|2
7307291|NCT00651118|11531602|FG001|Overall Study|Protocol Violation|2
7307292|NCT00651118|11531603|FG002|Overall Study|Protocol Violation|6
7307293|NCT00651118|11531604|FG003|Overall Study|Protocol Violation|2
7307294|NCT00651118|11531601|FG000|Overall Study|Lost to Follow-up|2
7307295|NCT00651118|11531602|FG001|Overall Study|Lost to Follow-up|0
7307296|NCT00651118|11531603|FG002|Overall Study|Lost to Follow-up|1
7307297|NCT00651118|11531604|FG003|Overall Study|Lost to Follow-up|2
7307298|NCT00651118|11531601|FG000|Overall Study|administrative|1
7307299|NCT00651118|11531602|FG001|Overall Study|administrative|4
7307300|NCT00651118|11531603|FG002|Overall Study|administrative|2
7307301|NCT00651118|11531604|FG003|Overall Study|administrative|1
7307302|NCT00651118|11531601|FG000|Overall Study|Withdrawal by Subject|0
7307303|NCT00651118|11531602|FG001|Overall Study|Withdrawal by Subject|1
7307304|NCT00651118|11531603|FG002|Overall Study|Withdrawal by Subject|1
7307305|NCT00651118|11531604|FG003|Overall Study|Withdrawal by Subject|1
7307306|NCT00651157|11531617|FG000|Overall Study|Death|1
7307307|NCT00651157|11531617|FG000|Overall Study|Protocol Violation|1
7307308|NCT00651183|11531623|FG000|Overall Study|Lack of Efficacy|1
7307309|NCT00651183|11531624|FG001|Overall Study|Lack of Efficacy|0
7307310|NCT00651183|11531623|FG000|Overall Study|Efficacy insufficient + patients wish|0
7307311|NCT00651183|11531624|FG001|Overall Study|Efficacy insufficient + patients wish|1
7307312|NCT00651183|11531623|FG000|Overall Study|Tolerability insufficient|5
7307313|NCT00651183|11531624|FG001|Overall Study|Tolerability insufficient|2
7307314|NCT00651183|11531623|FG000|Overall Study|Tolerability insufficient +Patients wish|0
7307315|NCT00651183|11531624|FG001|Overall Study|Tolerability insufficient +Patients wish|1
7307316|NCT00651183|11531623|FG000|Overall Study|Withdrawal by Subject|6
7307317|NCT00651183|11531624|FG001|Overall Study|Withdrawal by Subject|3
7307318|NCT00651183|11531623|FG000|Overall Study|Lost to Follow-up|3
7307319|NCT00651183|11531624|FG001|Overall Study|Lost to Follow-up|1
7307320|NCT00651183|11531623|FG000|Overall Study|Other reasons|4
7307321|NCT00651183|11531624|FG001|Overall Study|Other reasons|2
7307322|NCT00651183|11531623|FG000|Overall Study|missing|1
7307323|NCT00651183|11531624|FG001|Overall Study|missing|0
7307324|NCT00651261|11531632|FG000|Overall Study|Adverse Event|32
7307325|NCT00651261|11531633|FG001|Overall Study|Adverse Event|22
7307326|NCT00651261|11531632|FG000|Overall Study|Death|18
7307327|NCT00651261|11531633|FG001|Overall Study|Death|18
7307328|NCT00651261|11531632|FG000|Overall Study|Withdrawal by Subject|22
7307329|NCT00651261|11531633|FG001|Overall Study|Withdrawal by Subject|40
7307330|NCT00651261|11531632|FG000|Overall Study|Induction failure|24
7307331|NCT00651261|11531633|FG001|Overall Study|Induction failure|35
7307332|NCT00651261|11531632|FG000|Overall Study|Disease progression|58
7307333|NCT00651261|11531633|FG001|Overall Study|Disease progression|58
7307334|NCT00651261|11531632|FG000|Overall Study|Alternative therapy|109
7307335|NCT00651261|11531633|FG001|Overall Study|Alternative therapy|107
7307336|NCT00651261|11531632|FG000|Overall Study|Other disease or participant decisions|23
7307337|NCT00651261|11531633|FG001|Overall Study|Other disease or participant decisions|23
7307338|NCT00651261|11531632|FG000|Overall Study|Never treated|5
7307339|NCT00651261|11531633|FG001|Overall Study|Never treated|3
7384052|NCT01192295|11641191|FG000|Overall Study|Lost to Follow-up|0
7384053|NCT01192295|11641192|FG001|Overall Study|Lost to Follow-up|1
7384054|NCT01192295|11641191|FG000|Overall Study|Lack of Efficacy|0
7384055|NCT01192295|11641192|FG001|Overall Study|Lack of Efficacy|5
7384056|NCT01192295|11641191|FG000|Overall Study|Administrative|4
7384057|NCT01192295|11641192|FG001|Overall Study|Administrative|6
7384058|NCT01192347|11641200|FG000|Overall Study|Death|3
7384059|NCT01192347|11641200|FG000|Overall Study|Lost to Follow-up|3
7384060|NCT01192347|11641200|FG000|Overall Study|Withdrawal by Subject|1
7384061|NCT01192347|11641200|FG000|Overall Study|Adverse Event|1
7384062|NCT01192347|11641200|FG000|Overall Study|Suspected serious adverse drug reaction|1
7384063|NCT01192347|11641200|FG000|Overall Study|Patient seen in different hospital|1
7307340|NCT00651313|11531641|FG000|Overall Study|Adverse Event|0
7307341|NCT00651313|11531642|FG001|Overall Study|Adverse Event|1
7307342|NCT00651313|11531641|FG000|Overall Study|Withdrawal by Subject|3
7307343|NCT00651313|11531642|FG001|Overall Study|Withdrawal by Subject|1
7307344|NCT00651313|11531641|FG000|Overall Study|Lost to Follow-up|1
7307345|NCT00651313|11531642|FG001|Overall Study|Lost to Follow-up|1
7307346|NCT00651313|11531641|FG000|Overall Study|Adminstrative Discontinuation|2
7307347|NCT00651313|11531642|FG001|Overall Study|Adminstrative Discontinuation|3
7307348|NCT00651664|11531681|FG000|Overall Study|Occurrence of Adverse Event(s)|0
7307349|NCT00651664|11531682|FG001|Overall Study|Occurrence of Adverse Event(s)|0
7307350|NCT00651664|11531683|FG002|Overall Study|Occurrence of Adverse Event(s)|0
7307351|NCT00651664|11531684|FG003|Overall Study|Occurrence of Adverse Event(s)|0
7307352|NCT00651664|11531685|FG004|Overall Study|Occurrence of Adverse Event(s)|0
7307353|NCT00651664|11531686|FG005|Overall Study|Occurrence of Adverse Event(s)|0
7307354|NCT00651664|11531687|FG006|Overall Study|Occurrence of Adverse Event(s)|1
7307355|NCT00651664|11531688|FG007|Overall Study|Occurrence of Adverse Event(s)|0
7307356|NCT00651664|11531689|FG008|Overall Study|Occurrence of Adverse Event(s)|1
7307357|NCT00651664|11531690|FG009|Overall Study|Occurrence of Adverse Event(s)|0
7307358|NCT00651664|11531681|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
7388859|NCT01225549|11648436|FG006|Period 6 - Washout|Disallowed medication|0
7388860|NCT01225549|11648437|FG007|Period 6 - Washout|Disallowed medication|0
7388861|NCT01225549|11648438|FG008|Period 6 - Washout|Disallowed medication|0
7388862|NCT01225549|11648439|FG009|Period 6 - Washout|Disallowed medication|0
7388863|NCT01225562|11648452|FG000|Overall Study|Withdrawal by Subject|52
7388864|NCT01225562|11648453|FG001|Overall Study|Withdrawal by Subject|50
7388865|NCT01225562|11648454|FG002|Overall Study|Withdrawal by Subject|52
7388866|NCT01225562|11648452|FG000|Overall Study|Lost to Follow-up|3
7388867|NCT01225562|11648453|FG001|Overall Study|Lost to Follow-up|6
7388868|NCT01225562|11648454|FG002|Overall Study|Lost to Follow-up|1
7388869|NCT01225731|11648467|FG000|Part 1|Did not meet eligibility criteria|1
7388870|NCT01225731|11648468|FG001|Part 1|Did not meet eligibility criteria|0
7388871|NCT01225731|11648469|FG002|Part 1|Did not meet eligibility criteria|0
7388872|NCT01225731|11648470|FG003|Part 1|Did not meet eligibility criteria|0
7388873|NCT01225731|11648471|FG004|Part 1|Did not meet eligibility criteria|1
7388874|NCT01225731|11648472|FG005|Part 1|Did not meet eligibility criteria|0
7388875|NCT01225731|11648473|FG006|Part 1|Did not meet eligibility criteria|0
7388876|NCT01225731|11648474|FG007|Part 1|Did not meet eligibility criteria|0
7388877|NCT01225731|11648475|FG008|Part 1|Did not meet eligibility criteria|0
7388878|NCT01225731|11648476|FG009|Part 1|Did not meet eligibility criteria|0
7388879|NCT01225731|11648477|FG010|Part 1|Did not meet eligibility criteria|0
7388880|NCT01225731|11648478|FG011|Part 1|Did not meet eligibility criteria|0
7388881|NCT01225731|11648479|FG012|Part 1|Did not meet eligibility criteria|0
7388882|NCT01225731|11648467|FG000|Part 1|Adverse Event|1
7388883|NCT01225731|11648468|FG001|Part 1|Adverse Event|2
7388884|NCT01225731|11648469|FG002|Part 1|Adverse Event|1
7388885|NCT01225731|11648470|FG003|Part 1|Adverse Event|1
7388886|NCT01225731|11648471|FG004|Part 1|Adverse Event|1
7388887|NCT01225731|11648472|FG005|Part 1|Adverse Event|0
7388888|NCT01225731|11648473|FG006|Part 1|Adverse Event|0
7388889|NCT01225731|11648474|FG007|Part 1|Adverse Event|0
7388890|NCT01225731|11648475|FG008|Part 1|Adverse Event|0
7388891|NCT01225731|11648476|FG009|Part 1|Adverse Event|0
7388892|NCT01225731|11648477|FG010|Part 1|Adverse Event|0
7388893|NCT01225731|11648478|FG011|Part 1|Adverse Event|0
7388894|NCT01225731|11648479|FG012|Part 1|Adverse Event|0
7388895|NCT01225731|11648467|FG000|Part 1|Withdrawal by Subject|0
7388896|NCT01225731|11648468|FG001|Part 1|Withdrawal by Subject|3
7388897|NCT01225731|11648469|FG002|Part 1|Withdrawal by Subject|0
7388898|NCT01225731|11648470|FG003|Part 1|Withdrawal by Subject|0
7388899|NCT01225731|11648471|FG004|Part 1|Withdrawal by Subject|4
7388900|NCT01225731|11648472|FG005|Part 1|Withdrawal by Subject|0
7388901|NCT01225731|11648473|FG006|Part 1|Withdrawal by Subject|0
7388902|NCT01225731|11648474|FG007|Part 1|Withdrawal by Subject|0
7388903|NCT01225731|11648475|FG008|Part 1|Withdrawal by Subject|0
7388904|NCT01225731|11648476|FG009|Part 1|Withdrawal by Subject|0
7388905|NCT01225731|11648477|FG010|Part 1|Withdrawal by Subject|0
7388906|NCT01225731|11648478|FG011|Part 1|Withdrawal by Subject|0
7388907|NCT01225731|11648479|FG012|Part 1|Withdrawal by Subject|0
7388908|NCT01225731|11648467|FG000|Part 1|Protocol Violation|0
7388909|NCT01225731|11648468|FG001|Part 1|Protocol Violation|0
7388910|NCT01225731|11648469|FG002|Part 1|Protocol Violation|0
7388911|NCT01225731|11648470|FG003|Part 1|Protocol Violation|1
7388912|NCT01225731|11648471|FG004|Part 1|Protocol Violation|0
7388913|NCT01225731|11648472|FG005|Part 1|Protocol Violation|0
7388914|NCT01225731|11648473|FG006|Part 1|Protocol Violation|0
7388915|NCT01225731|11648474|FG007|Part 1|Protocol Violation|0
7388916|NCT01225731|11648475|FG008|Part 1|Protocol Violation|0
7388917|NCT01225731|11648476|FG009|Part 1|Protocol Violation|0
7388918|NCT01225731|11648477|FG010|Part 1|Protocol Violation|0
7388919|NCT01225731|11648478|FG011|Part 1|Protocol Violation|0
7388920|NCT01225731|11648479|FG012|Part 1|Protocol Violation|0
7388921|NCT01225731|11648467|FG000|Part 2|Protocol Violation|0
7388922|NCT01225731|11648468|FG001|Part 2|Protocol Violation|0
7388923|NCT01225731|11648469|FG002|Part 2|Protocol Violation|0
7388924|NCT01225731|11648470|FG003|Part 2|Protocol Violation|0
7388925|NCT01225731|11648471|FG004|Part 2|Protocol Violation|0
7388926|NCT01225731|11648472|FG005|Part 2|Protocol Violation|1
7388927|NCT01225731|11648473|FG006|Part 2|Protocol Violation|0
7388928|NCT01225731|11648474|FG007|Part 2|Protocol Violation|0
7388929|NCT01225731|11648475|FG008|Part 2|Protocol Violation|1
7388930|NCT01225731|11648476|FG009|Part 2|Protocol Violation|0
7388931|NCT01225731|11648477|FG010|Part 2|Protocol Violation|0
7388932|NCT01225731|11648478|FG011|Part 2|Protocol Violation|0
7388933|NCT01225731|11648479|FG012|Part 2|Protocol Violation|0
7388934|NCT01225731|11648467|FG000|Part 2|Adverse Event|0
7388935|NCT01225731|11648468|FG001|Part 2|Adverse Event|0
7388936|NCT01225731|11648469|FG002|Part 2|Adverse Event|0
7388937|NCT01225731|11648470|FG003|Part 2|Adverse Event|0
7388938|NCT01225731|11648471|FG004|Part 2|Adverse Event|0
7388939|NCT01225731|11648472|FG005|Part 2|Adverse Event|0
7388940|NCT01225731|11648473|FG006|Part 2|Adverse Event|4
7388941|NCT01225731|11648474|FG007|Part 2|Adverse Event|4
7388942|NCT01225731|11648475|FG008|Part 2|Adverse Event|2
7388943|NCT01225731|11648476|FG009|Part 2|Adverse Event|0
7388944|NCT01225731|11648477|FG010|Part 2|Adverse Event|0
7388945|NCT01225731|11648478|FG011|Part 2|Adverse Event|0
7388946|NCT01225731|11648479|FG012|Part 2|Adverse Event|0
7388947|NCT01225731|11648467|FG000|Part 2|Lack of Efficacy|0
7388948|NCT01225731|11648468|FG001|Part 2|Lack of Efficacy|0
7388949|NCT01225731|11648469|FG002|Part 2|Lack of Efficacy|0
7388950|NCT01225731|11648470|FG003|Part 2|Lack of Efficacy|0
7388951|NCT01225731|11648471|FG004|Part 2|Lack of Efficacy|0
7388952|NCT01225731|11648472|FG005|Part 2|Lack of Efficacy|1
7388953|NCT01225731|11648473|FG006|Part 2|Lack of Efficacy|0
7388954|NCT01225731|11648474|FG007|Part 2|Lack of Efficacy|12
7388955|NCT01225731|11648475|FG008|Part 2|Lack of Efficacy|3
7388956|NCT01225731|11648476|FG009|Part 2|Lack of Efficacy|0
7388957|NCT01225731|11648477|FG010|Part 2|Lack of Efficacy|0
7388958|NCT01225731|11648478|FG011|Part 2|Lack of Efficacy|0
7388959|NCT01225731|11648479|FG012|Part 2|Lack of Efficacy|0
7388960|NCT01225731|11648467|FG000|Part 2|Pregnancy|0
7388961|NCT01225731|11648468|FG001|Part 2|Pregnancy|0
7388962|NCT01225731|11648469|FG002|Part 2|Pregnancy|0
7388963|NCT01225731|11648470|FG003|Part 2|Pregnancy|0
7388964|NCT01225731|11648471|FG004|Part 2|Pregnancy|0
7388965|NCT01225731|11648472|FG005|Part 2|Pregnancy|0
7388966|NCT01225731|11648473|FG006|Part 2|Pregnancy|1
7388967|NCT01225731|11648474|FG007|Part 2|Pregnancy|0
7388968|NCT01225731|11648475|FG008|Part 2|Pregnancy|1
7388969|NCT01225731|11648476|FG009|Part 2|Pregnancy|0
7388970|NCT01225731|11648477|FG010|Part 2|Pregnancy|0
7388971|NCT01225731|11648478|FG011|Part 2|Pregnancy|0
7388972|NCT01225731|11648479|FG012|Part 2|Pregnancy|0
7388973|NCT01225731|11648467|FG000|Part 2|Lost to Follow-up|0
7388974|NCT01225731|11648468|FG001|Part 2|Lost to Follow-up|0
7388975|NCT01225731|11648469|FG002|Part 2|Lost to Follow-up|0
7388976|NCT01225731|11648470|FG003|Part 2|Lost to Follow-up|0
7388977|NCT01225731|11648471|FG004|Part 2|Lost to Follow-up|0
7388978|NCT01225731|11648472|FG005|Part 2|Lost to Follow-up|0
7388979|NCT01225731|11648473|FG006|Part 2|Lost to Follow-up|0
7388980|NCT01225731|11648474|FG007|Part 2|Lost to Follow-up|3
7388981|NCT01225731|11648475|FG008|Part 2|Lost to Follow-up|1
7388982|NCT01225731|11648476|FG009|Part 2|Lost to Follow-up|0
7388983|NCT01225731|11648477|FG010|Part 2|Lost to Follow-up|0
7388984|NCT01225731|11648478|FG011|Part 2|Lost to Follow-up|0
7388985|NCT01225731|11648479|FG012|Part 2|Lost to Follow-up|0
7388986|NCT01225731|11648467|FG000|Part 2|Physician Decision|0
7388987|NCT01225731|11648468|FG001|Part 2|Physician Decision|0
7388988|NCT01225731|11648469|FG002|Part 2|Physician Decision|0
7388989|NCT01225731|11648470|FG003|Part 2|Physician Decision|0
7388990|NCT01225731|11648471|FG004|Part 2|Physician Decision|0
7388991|NCT01225731|11648472|FG005|Part 2|Physician Decision|0
7388992|NCT01225731|11648473|FG006|Part 2|Physician Decision|0
7388993|NCT01225731|11648474|FG007|Part 2|Physician Decision|2
7388994|NCT01225731|11648475|FG008|Part 2|Physician Decision|2
7388995|NCT01225731|11648476|FG009|Part 2|Physician Decision|0
7388996|NCT01225731|11648477|FG010|Part 2|Physician Decision|0
7388997|NCT01225731|11648478|FG011|Part 2|Physician Decision|0
7388998|NCT01225731|11648479|FG012|Part 2|Physician Decision|0
7388999|NCT01225731|11648467|FG000|Part 2|Withdrawal by Subject|0
7389000|NCT01225731|11648468|FG001|Part 2|Withdrawal by Subject|0
7389001|NCT01225731|11648469|FG002|Part 2|Withdrawal by Subject|0
7389002|NCT01225731|11648470|FG003|Part 2|Withdrawal by Subject|0
7389003|NCT01225731|11648471|FG004|Part 2|Withdrawal by Subject|0
7389004|NCT01225731|11648472|FG005|Part 2|Withdrawal by Subject|1
7389005|NCT01225731|11648473|FG006|Part 2|Withdrawal by Subject|3
7389006|NCT01225731|11648474|FG007|Part 2|Withdrawal by Subject|4
7389007|NCT01225731|11648475|FG008|Part 2|Withdrawal by Subject|1
7389008|NCT01225731|11648476|FG009|Part 2|Withdrawal by Subject|0
7389009|NCT01225731|11648477|FG010|Part 2|Withdrawal by Subject|0
7389010|NCT01225731|11648478|FG011|Part 2|Withdrawal by Subject|0
7389011|NCT01225731|11648479|FG012|Part 2|Withdrawal by Subject|0
7389012|NCT01225731|11648467|FG000|Part 3|Adverse Event|0
7389013|NCT01225731|11648468|FG001|Part 3|Adverse Event|0
7389014|NCT01225731|11648469|FG002|Part 3|Adverse Event|0
7389015|NCT01225731|11648470|FG003|Part 3|Adverse Event|0
7389016|NCT01225731|11648471|FG004|Part 3|Adverse Event|0
7389017|NCT01225731|11648472|FG005|Part 3|Adverse Event|0
7389018|NCT01225731|11648473|FG006|Part 3|Adverse Event|0
7389019|NCT01225731|11648474|FG007|Part 3|Adverse Event|0
7389020|NCT01225731|11648475|FG008|Part 3|Adverse Event|0
7389021|NCT01225731|11648476|FG009|Part 3|Adverse Event|0
7389022|NCT01225731|11648477|FG010|Part 3|Adverse Event|1
7389023|NCT01225731|11648478|FG011|Part 3|Adverse Event|1
7389024|NCT01225731|11648479|FG012|Part 3|Adverse Event|0
7389025|NCT01225731|11648467|FG000|Part 3|Lost to Follow-up|0
7389026|NCT01225731|11648468|FG001|Part 3|Lost to Follow-up|0
7389027|NCT01225731|11648469|FG002|Part 3|Lost to Follow-up|0
7389028|NCT01225731|11648470|FG003|Part 3|Lost to Follow-up|0
7389029|NCT01225731|11648471|FG004|Part 3|Lost to Follow-up|0
7389030|NCT01225731|11648472|FG005|Part 3|Lost to Follow-up|0
7389031|NCT01225731|11648473|FG006|Part 3|Lost to Follow-up|0
7307359|NCT00651664|11531682|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7307360|NCT00651664|11531683|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7307361|NCT00651664|11531684|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7307362|NCT00651664|11531685|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
7307363|NCT00651664|11531686|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
7307364|NCT00651664|11531687|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7307365|NCT00651664|11531688|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
7307366|NCT00651664|11531689|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
7307367|NCT00651664|11531690|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
7307368|NCT00651664|11531681|FG000|Overall Study|Progressive Disease|3
7307369|NCT00651664|11531682|FG001|Overall Study|Progressive Disease|3
7307370|NCT00651664|11531683|FG002|Overall Study|Progressive Disease|3
7307371|NCT00651664|11531684|FG003|Overall Study|Progressive Disease|12
7307372|NCT00651664|11531685|FG004|Overall Study|Progressive Disease|4
7307373|NCT00651664|11531686|FG005|Overall Study|Progressive Disease|1
7307374|NCT00651664|11531687|FG006|Overall Study|Progressive Disease|3
7307375|NCT00651664|11531688|FG007|Overall Study|Progressive Disease|6
7307376|NCT00651664|11531689|FG008|Overall Study|Progressive Disease|5
7307377|NCT00651664|11531690|FG009|Overall Study|Progressive Disease|5
7307378|NCT00651664|11531681|FG000|Overall Study|Patient Declined Further Treatment|0
7307379|NCT00651664|11531682|FG001|Overall Study|Patient Declined Further Treatment|0
7307380|NCT00651664|11531683|FG002|Overall Study|Patient Declined Further Treatment|0
7307381|NCT00651664|11531684|FG003|Overall Study|Patient Declined Further Treatment|1
7307382|NCT00651664|11531685|FG004|Overall Study|Patient Declined Further Treatment|1
7307383|NCT00651664|11531686|FG005|Overall Study|Patient Declined Further Treatment|1
7307384|NCT00651664|11531687|FG006|Overall Study|Patient Declined Further Treatment|0
7307385|NCT00651664|11531688|FG007|Overall Study|Patient Declined Further Treatment|0
7307386|NCT00651664|11531689|FG008|Overall Study|Patient Declined Further Treatment|0
7307387|NCT00651664|11531690|FG009|Overall Study|Patient Declined Further Treatment|1
7307388|NCT00651664|11531681|FG000|Overall Study|Symptomatic Deterioration|0
7307389|NCT00651664|11531682|FG001|Overall Study|Symptomatic Deterioration|0
7307390|NCT00651664|11531683|FG002|Overall Study|Symptomatic Deterioration|0
7307391|NCT00651664|11531684|FG003|Overall Study|Symptomatic Deterioration|1
7307392|NCT00651664|11531685|FG004|Overall Study|Symptomatic Deterioration|0
7307393|NCT00651664|11531686|FG005|Overall Study|Symptomatic Deterioration|0
7307394|NCT00651664|11531687|FG006|Overall Study|Symptomatic Deterioration|1
7307395|NCT00651664|11531688|FG007|Overall Study|Symptomatic Deterioration|0
7307396|NCT00651664|11531689|FG008|Overall Study|Symptomatic Deterioration|1
7307397|NCT00651664|11531690|FG009|Overall Study|Symptomatic Deterioration|0
7307398|NCT00651664|11531681|FG000|Overall Study|Reason not Specified|0
7307399|NCT00651664|11531682|FG001|Overall Study|Reason not Specified|0
7307400|NCT00651664|11531683|FG002|Overall Study|Reason not Specified|0
7307401|NCT00651664|11531684|FG003|Overall Study|Reason not Specified|0
7307402|NCT00651664|11531685|FG004|Overall Study|Reason not Specified|0
7307403|NCT00651664|11531686|FG005|Overall Study|Reason not Specified|0
7307404|NCT00651664|11531687|FG006|Overall Study|Reason not Specified|1
7307405|NCT00651664|11531688|FG007|Overall Study|Reason not Specified|0
7307406|NCT00651664|11531689|FG008|Overall Study|Reason not Specified|0
7307407|NCT00651664|11531690|FG009|Overall Study|Reason not Specified|0
7307408|NCT00651755|11531716|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
7307409|NCT00651755|11531717|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
7307410|NCT00651755|11531716|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
7307411|NCT00651755|11531717|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
7307412|NCT00651820|11531737|FG000|Overall Study|Lost to Follow-up|2
7307413|NCT00651924|11531745|FG000|Overall Study|Withdrawal by PI|0
7307414|NCT00651924|11531746|FG001|Overall Study|Withdrawal by PI|2
7307415|NCT00651924|11531745|FG000|Overall Study|Withdrawal by Subject|0
7307416|NCT00651924|11531746|FG001|Overall Study|Withdrawal by Subject|5
7307417|NCT00651937|11531754|FG000|Overall Study|Withdrawal by Subject|4
7307418|NCT00651937|11531755|FG001|Overall Study|Withdrawal by Subject|1
7307419|NCT00652028|11531765|FG000|Overall Study|Adverse Event|1
7307420|NCT00652028|11531766|FG001|Overall Study|Adverse Event|0
7307421|NCT00652028|11531767|FG002|Overall Study|Adverse Event|0
7307422|NCT00652028|11531768|FG003|Overall Study|Adverse Event|0
7307423|NCT00652028|11531765|FG000|Overall Study|No Longer Meets Entry Criteria|0
7307424|NCT00652028|11531766|FG001|Overall Study|No Longer Meets Entry Criteria|1
7307425|NCT00652028|11531767|FG002|Overall Study|No Longer Meets Entry Criteria|0
7307426|NCT00652028|11531768|FG003|Overall Study|No Longer Meets Entry Criteria|0
7307427|NCT00652028|11531765|FG000|Overall Study|Physician Decision|0
7307428|NCT00652028|11531766|FG001|Overall Study|Physician Decision|0
7307429|NCT00652028|11531767|FG002|Overall Study|Physician Decision|1
7307430|NCT00652028|11531768|FG003|Overall Study|Physician Decision|0
7307431|NCT00652093|11531790|FG000|Overall Study|Withdrawal by Subject|0
7389032|NCT01225731|11648474|FG007|Part 3|Lost to Follow-up|0
7307432|NCT00652093|11531791|FG001|Overall Study|Withdrawal by Subject|0
7307433|NCT00652093|11531792|FG002|Overall Study|Withdrawal by Subject|1
7307434|NCT00652093|11531793|FG003|Overall Study|Withdrawal by Subject|0
7307435|NCT00652093|11531794|FG004|Overall Study|Withdrawal by Subject|1
7389033|NCT01225731|11648475|FG008|Part 3|Lost to Follow-up|0
7389034|NCT01225731|11648476|FG009|Part 3|Lost to Follow-up|0
7389035|NCT01225731|11648477|FG010|Part 3|Lost to Follow-up|1
7389036|NCT01225731|11648478|FG011|Part 3|Lost to Follow-up|2
7389037|NCT01225731|11648479|FG012|Part 3|Lost to Follow-up|1
7389038|NCT01225731|11648467|FG000|Part 3|Physician Decision|0
7389039|NCT01225731|11648468|FG001|Part 3|Physician Decision|0
7389040|NCT01225731|11648469|FG002|Part 3|Physician Decision|0
7389041|NCT01225731|11648470|FG003|Part 3|Physician Decision|0
7389042|NCT01225731|11648471|FG004|Part 3|Physician Decision|0
7389043|NCT01225731|11648472|FG005|Part 3|Physician Decision|0
7389044|NCT01225731|11648473|FG006|Part 3|Physician Decision|0
7389045|NCT01225731|11648474|FG007|Part 3|Physician Decision|0
7389046|NCT01225731|11648475|FG008|Part 3|Physician Decision|0
7389047|NCT01225731|11648476|FG009|Part 3|Physician Decision|0
7389048|NCT01225731|11648477|FG010|Part 3|Physician Decision|0
7389049|NCT01225731|11648478|FG011|Part 3|Physician Decision|1
7389050|NCT01225731|11648479|FG012|Part 3|Physician Decision|2
7389051|NCT01225731|11648467|FG000|Part 3|Withdrawal by Subject|0
7389052|NCT01225731|11648468|FG001|Part 3|Withdrawal by Subject|0
7389053|NCT01225731|11648469|FG002|Part 3|Withdrawal by Subject|0
7389054|NCT01225731|11648470|FG003|Part 3|Withdrawal by Subject|0
7389055|NCT01225731|11648471|FG004|Part 3|Withdrawal by Subject|0
7389056|NCT01225731|11648472|FG005|Part 3|Withdrawal by Subject|0
7389057|NCT01225731|11648473|FG006|Part 3|Withdrawal by Subject|0
7389058|NCT01225731|11648474|FG007|Part 3|Withdrawal by Subject|0
7389059|NCT01225731|11648475|FG008|Part 3|Withdrawal by Subject|0
7389060|NCT01225731|11648476|FG009|Part 3|Withdrawal by Subject|0
7389061|NCT01225731|11648477|FG010|Part 3|Withdrawal by Subject|4
7389062|NCT01225731|11648478|FG011|Part 3|Withdrawal by Subject|6
7389063|NCT01225731|11648479|FG012|Part 3|Withdrawal by Subject|4
7389064|NCT01225822|11648513|FG000|Overall Study|Adverse Event|13
7389065|NCT01225822|11648514|FG001|Overall Study|Adverse Event|31
7389066|NCT01225822|11648515|FG002|Overall Study|Adverse Event|18
7389067|NCT01225822|11648516|FG003|Overall Study|Adverse Event|23
7389068|NCT01225822|11648517|FG004|Overall Study|Adverse Event|14
7389069|NCT01225822|11648513|FG000|Overall Study|Protocol Violation|6
7389070|NCT01225822|11648514|FG001|Overall Study|Protocol Violation|8
7389071|NCT01225822|11648515|FG002|Overall Study|Protocol Violation|6
7389072|NCT01225822|11648516|FG003|Overall Study|Protocol Violation|7
7389073|NCT01225822|11648517|FG004|Overall Study|Protocol Violation|4
7389074|NCT01225822|11648513|FG000|Overall Study|Lost to Follow-up|0
7389075|NCT01225822|11648514|FG001|Overall Study|Lost to Follow-up|0
7389076|NCT01225822|11648515|FG002|Overall Study|Lost to Follow-up|0
7389077|NCT01225822|11648516|FG003|Overall Study|Lost to Follow-up|1
7389078|NCT01225822|11648517|FG004|Overall Study|Lost to Follow-up|0
7389079|NCT01225822|11648513|FG000|Overall Study|Withdrawal by Subject|6
7389080|NCT01225822|11648514|FG001|Overall Study|Withdrawal by Subject|7
7307436|NCT00652093|11531795|FG005|Overall Study|Withdrawal by Subject|0
7307437|NCT00652093|11531790|FG000|Overall Study|Physician Decision|0
7307438|NCT00652093|11531791|FG001|Overall Study|Physician Decision|0
7307439|NCT00652093|11531792|FG002|Overall Study|Physician Decision|0
7307440|NCT00652093|11531793|FG003|Overall Study|Physician Decision|0
7307441|NCT00652093|11531794|FG004|Overall Study|Physician Decision|1
7307442|NCT00652093|11531795|FG005|Overall Study|Physician Decision|0
7307443|NCT00652340|11531831|FG000|Overall Study|Had not progressed.|4
7307444|NCT00652340|11531832|FG001|Overall Study|Had not progressed.|3
7307445|NCT00652366|11531843|FG000|Overall Study|Adverse Event|8
7307446|NCT00652366|11531844|FG001|Overall Study|Adverse Event|4
7307447|NCT00652366|11531845|FG002|Overall Study|Adverse Event|7
7307448|NCT00652366|11531846|FG003|Overall Study|Adverse Event|17
7307449|NCT00652366|11531847|FG004|Overall Study|Adverse Event|13
7307450|NCT00652366|11531843|FG000|Overall Study|Death|5
7307451|NCT00652366|11531844|FG001|Overall Study|Death|4
7307452|NCT00652366|11531845|FG002|Overall Study|Death|1
7307453|NCT00652366|11531846|FG003|Overall Study|Death|8
7307454|NCT00652366|11531847|FG004|Overall Study|Death|5
7307455|NCT00652366|11531843|FG000|Overall Study|Lack of Efficacy|84
7307456|NCT00652366|11531844|FG001|Overall Study|Lack of Efficacy|58
7307457|NCT00652366|11531845|FG002|Overall Study|Lack of Efficacy|53
7307458|NCT00652366|11531846|FG003|Overall Study|Lack of Efficacy|133
7307459|NCT00652366|11531847|FG004|Overall Study|Lack of Efficacy|13
7307460|NCT00652366|11531843|FG000|Overall Study|Violation of Selection Criteria|0
7307461|NCT00652366|11531844|FG001|Overall Study|Violation of Selection Criteria|0
7307462|NCT00652366|11531845|FG002|Overall Study|Violation of Selection Criteria|1
7307463|NCT00652366|11531846|FG003|Overall Study|Violation of Selection Criteria|0
7307464|NCT00652366|11531847|FG004|Overall Study|Violation of Selection Criteria|0
7307465|NCT00652366|11531843|FG000|Overall Study|Protocol Violation|1
7307466|NCT00652366|11531844|FG001|Overall Study|Protocol Violation|0
7307467|NCT00652366|11531845|FG002|Overall Study|Protocol Violation|0
7307468|NCT00652366|11531846|FG003|Overall Study|Protocol Violation|0
7307469|NCT00652366|11531847|FG004|Overall Study|Protocol Violation|0
7307470|NCT00652366|11531843|FG000|Overall Study|Refused treatment|3
7307471|NCT00652366|11531844|FG001|Overall Study|Refused treatment|7
7307472|NCT00652366|11531845|FG002|Overall Study|Refused treatment|6
7307473|NCT00652366|11531846|FG003|Overall Study|Refused treatment|17
7307474|NCT00652366|11531847|FG004|Overall Study|Refused treatment|5
7307475|NCT00652366|11531843|FG000|Overall Study|Other|5
7307476|NCT00652366|11531844|FG001|Overall Study|Other|2
7307477|NCT00652366|11531845|FG002|Overall Study|Other|3
7307478|NCT00652366|11531846|FG003|Overall Study|Other|4
7307479|NCT00652366|11531847|FG004|Overall Study|Other|0
7307480|NCT00652626|11531868|FG000|Initial Treatment Phase|Adverse Event|0
7307481|NCT00652626|11531869|FG001|Initial Treatment Phase|Adverse Event|0
7307482|NCT00652626|11531870|FG002|Initial Treatment Phase|Adverse Event|0
7307483|NCT00652626|11531871|FG003|Initial Treatment Phase|Adverse Event|0
7307484|NCT00652626|11531872|FG004|Initial Treatment Phase|Adverse Event|1
7307485|NCT00652626|11531873|FG005|Initial Treatment Phase|Adverse Event|0
7307486|NCT00652626|11531874|FG006|Initial Treatment Phase|Adverse Event|0
7307487|NCT00652626|11531868|FG000|Initial Treatment Phase|Protocol Violation|0
7307488|NCT00652626|11531869|FG001|Initial Treatment Phase|Protocol Violation|0
7307489|NCT00652626|11531870|FG002|Initial Treatment Phase|Protocol Violation|0
7307490|NCT00652626|11531871|FG003|Initial Treatment Phase|Protocol Violation|1
7307491|NCT00652626|11531872|FG004|Initial Treatment Phase|Protocol Violation|0
7307492|NCT00652626|11531873|FG005|Initial Treatment Phase|Protocol Violation|0
7307493|NCT00652626|11531874|FG006|Initial Treatment Phase|Protocol Violation|0
7307494|NCT00652626|11531868|FG000|Initial Treatment Phase|Physician Decision|0
7307495|NCT00652626|11531869|FG001|Initial Treatment Phase|Physician Decision|0
7307496|NCT00652626|11531870|FG002|Initial Treatment Phase|Physician Decision|0
7307497|NCT00652626|11531871|FG003|Initial Treatment Phase|Physician Decision|0
7307498|NCT00652626|11531872|FG004|Initial Treatment Phase|Physician Decision|1
7307499|NCT00652626|11531873|FG005|Initial Treatment Phase|Physician Decision|0
7307500|NCT00652626|11531874|FG006|Initial Treatment Phase|Physician Decision|0
7307501|NCT00652626|11531868|FG000|Initial Treatment Phase|Sponsor Request|0
7307502|NCT00652626|11531869|FG001|Initial Treatment Phase|Sponsor Request|0
7307503|NCT00652626|11531870|FG002|Initial Treatment Phase|Sponsor Request|1
7307504|NCT00652626|11531871|FG003|Initial Treatment Phase|Sponsor Request|0
7307505|NCT00652626|11531872|FG004|Initial Treatment Phase|Sponsor Request|0
7307506|NCT00652626|11531873|FG005|Initial Treatment Phase|Sponsor Request|0
7307507|NCT00652626|11531874|FG006|Initial Treatment Phase|Sponsor Request|0
7307508|NCT00652626|11531868|FG000|Initial Treatment Phase|Lost to Follow-up|0
7307509|NCT00652626|11531869|FG001|Initial Treatment Phase|Lost to Follow-up|0
7307510|NCT00652626|11531870|FG002|Initial Treatment Phase|Lost to Follow-up|0
7307511|NCT00652626|11531871|FG003|Initial Treatment Phase|Lost to Follow-up|0
7307512|NCT00652626|11531872|FG004|Initial Treatment Phase|Lost to Follow-up|1
7307513|NCT00652626|11531873|FG005|Initial Treatment Phase|Lost to Follow-up|0
7307514|NCT00652626|11531874|FG006|Initial Treatment Phase|Lost to Follow-up|0
7307515|NCT00652626|11531868|FG000|Extension Phase|Withdrawal by Subject|0
7307516|NCT00652626|11531869|FG001|Extension Phase|Withdrawal by Subject|0
7307517|NCT00652626|11531870|FG002|Extension Phase|Withdrawal by Subject|0
7307518|NCT00652626|11531871|FG003|Extension Phase|Withdrawal by Subject|0
7307519|NCT00652626|11531872|FG004|Extension Phase|Withdrawal by Subject|0
7307520|NCT00652626|11531873|FG005|Extension Phase|Withdrawal by Subject|2
7307521|NCT00652626|11531874|FG006|Extension Phase|Withdrawal by Subject|0
7307522|NCT00652626|11531868|FG000|Extension Phase|Adverse Event|0
7307523|NCT00652626|11531869|FG001|Extension Phase|Adverse Event|0
7307524|NCT00652626|11531870|FG002|Extension Phase|Adverse Event|0
7307525|NCT00652626|11531871|FG003|Extension Phase|Adverse Event|0
7307526|NCT00652626|11531872|FG004|Extension Phase|Adverse Event|0
7307527|NCT00652626|11531873|FG005|Extension Phase|Adverse Event|2
7307528|NCT00652626|11531874|FG006|Extension Phase|Adverse Event|1
7307529|NCT00652626|11531868|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
7307530|NCT00652626|11531869|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
7307531|NCT00652626|11531870|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
7307532|NCT00652626|11531871|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
7307533|NCT00652626|11531872|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
7307534|NCT00652626|11531873|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
7307535|NCT00652626|11531874|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
7307536|NCT00652626|11531868|FG000|Extension Phase|Physician Decision|0
7307537|NCT00652626|11531869|FG001|Extension Phase|Physician Decision|0
7307538|NCT00652626|11531870|FG002|Extension Phase|Physician Decision|0
7307539|NCT00652626|11531871|FG003|Extension Phase|Physician Decision|0
7307540|NCT00652626|11531872|FG004|Extension Phase|Physician Decision|0
7307541|NCT00652626|11531873|FG005|Extension Phase|Physician Decision|1
7307542|NCT00652626|11531874|FG006|Extension Phase|Physician Decision|1
7307543|NCT00652626|11531868|FG000|Extension Phase|Death|0
7307544|NCT00652626|11531869|FG001|Extension Phase|Death|0
7307545|NCT00652626|11531870|FG002|Extension Phase|Death|0
7307546|NCT00652626|11531871|FG003|Extension Phase|Death|0
7307547|NCT00652626|11531872|FG004|Extension Phase|Death|0
7307548|NCT00652626|11531873|FG005|Extension Phase|Death|1
7307549|NCT00652626|11531874|FG006|Extension Phase|Death|1
7307550|NCT00652743|11531895|FG000|Months 12-18|Lost to Follow-up|1
7307551|NCT00652743|11531896|FG001|Months 12-18|Lost to Follow-up|2
7307552|NCT00652743|11531897|FG002|Months 12-18|Lost to Follow-up|7
7307553|NCT00652743|11531895|FG000|Months 24-30|Other|5
7307554|NCT00652743|11531896|FG001|Months 24-30|Other|1
7307555|NCT00652743|11531897|FG002|Months 24-30|Other|11
7307556|NCT00652743|11531895|FG000|Months 36-42|Serious Adverse Events|0
7307557|NCT00652743|11531896|FG001|Months 36-42|Serious Adverse Events|1
7307558|NCT00652743|11531897|FG002|Months 36-42|Serious Adverse Events|1
7307559|NCT00652743|11531895|FG000|Months 36-42|Withdrawal by Subject|1
7307560|NCT00652743|11531896|FG001|Months 36-42|Withdrawal by Subject|1
7307561|NCT00652743|11531897|FG002|Months 36-42|Withdrawal by Subject|0
7307562|NCT00652743|11531895|FG000|Months 36-42|Lost to Follow-up|0
7307563|NCT00652743|11531896|FG001|Months 36-42|Lost to Follow-up|1
7307564|NCT00652743|11531897|FG002|Months 36-42|Lost to Follow-up|0
7307565|NCT00652743|11531895|FG000|Months 36-42|Migrated/moved from study area|1
7307566|NCT00652743|11531896|FG001|Months 36-42|Migrated/moved from study area|0
7307567|NCT00652743|11531897|FG002|Months 36-42|Migrated/moved from study area|0
7307568|NCT00652743|11531895|FG000|Months 36-42|Other|4
7307569|NCT00652743|11531896|FG001|Months 36-42|Other|2
7307570|NCT00652743|11531897|FG002|Months 36-42|Other|8
7307571|NCT00652834|11531908|FG000|Overall Study|Withdrawal by Subject|3
7307572|NCT00652834|11531908|FG000|Overall Study|Lost to Follow-up|2
7307573|NCT00652899|11531912|FG000|Overall Study|Death|1
7307574|NCT00652899|11531912|FG000|Overall Study|Treating physician decision|1
7307575|NCT00652938|11531923|FG000|Overall Study|Adverse Event|1
7307576|NCT00652938|11531924|FG001|Overall Study|Adverse Event|0
7307577|NCT00652938|11531925|FG002|Overall Study|Adverse Event|2
7307578|NCT00652938|11531923|FG000|Overall Study|Withdrawal by Subject|0
7307579|NCT00652938|11531924|FG001|Overall Study|Withdrawal by Subject|6
7307580|NCT00652938|11531925|FG002|Overall Study|Withdrawal by Subject|1
7307581|NCT00652938|11531923|FG000|Overall Study|Lost to Follow-up|0
7307582|NCT00652938|11531924|FG001|Overall Study|Lost to Follow-up|0
7307583|NCT00652938|11531925|FG002|Overall Study|Lost to Follow-up|2
7307584|NCT00652938|11531923|FG000|Overall Study|fear of blood sampling|0
7307585|NCT00652938|11531924|FG001|Overall Study|fear of blood sampling|1
7307586|NCT00652938|11531925|FG002|Overall Study|fear of blood sampling|0
7307587|NCT00652951|11531936|FG000|Booster Phase|Adverse event, non-fatal|0
7307588|NCT00652951|11531937|FG001|Booster Phase|Adverse event, non-fatal|1
7307589|NCT00652951|11531938|FG002|Booster Phase|Adverse event, non-fatal|0
7307590|NCT00652951|11531936|FG000|Booster Phase|Other|1
7307591|NCT00652951|11531937|FG001|Booster Phase|Other|0
7307592|NCT00652951|11531938|FG002|Booster Phase|Other|0
7307593|NCT00653159|11531957|FG000|Overall Study|Adverse Event|4
7307594|NCT00653159|11531958|FG001|Overall Study|Adverse Event|1
7307595|NCT00653159|11531957|FG000|Overall Study|Lost to Follow-up|1
7307596|NCT00653159|11531958|FG001|Overall Study|Lost to Follow-up|2
7307597|NCT00653224|11531966|FG000|Overall Study|Adverse Event|2
7307598|NCT00653224|11531967|FG001|Overall Study|Adverse Event|1
7307599|NCT00653224|11531966|FG000|Overall Study|Lack of Efficacy|1
7307600|NCT00653224|11531967|FG001|Overall Study|Lack of Efficacy|2
7307601|NCT00653224|11531966|FG000|Overall Study|Loss of efficacy|1
7307602|NCT00653224|11531967|FG001|Overall Study|Loss of efficacy|0
7307603|NCT00653224|11531966|FG000|Overall Study|Lost to Follow-up|1
7307604|NCT00653224|11531967|FG001|Overall Study|Lost to Follow-up|0
7307605|NCT00653224|11531966|FG000|Overall Study|Other|2
7307606|NCT00653224|11531967|FG001|Overall Study|Other|4
7307607|NCT00653263|11531973|FG000|Overall Study|Withdrawal by Subject|1
7307608|NCT00653263|11531973|FG000|Overall Study|Physician Decision|1
7307609|NCT00653328|11531977|FG000|Overall Study|Withdrawal by Subject|1
7307610|NCT00653328|11531977|FG000|Overall Study|Adverse Event|2
7307611|NCT00653328|11531977|FG000|Overall Study|Disease progression|10
7389081|NCT01225822|11648515|FG002|Overall Study|Withdrawal by Subject|7
7389082|NCT01225822|11648516|FG003|Overall Study|Withdrawal by Subject|11
7389083|NCT01225822|11648517|FG004|Overall Study|Withdrawal by Subject|6
7389084|NCT01225822|11648513|FG000|Overall Study|Other|13
7389085|NCT01225822|11648514|FG001|Overall Study|Other|10
7389086|NCT01225822|11648515|FG002|Overall Study|Other|7
7389087|NCT01225822|11648516|FG003|Overall Study|Other|10
7389088|NCT01225822|11648517|FG004|Overall Study|Other|7
7307612|NCT00653328|11531977|FG000|Overall Study|Drug manufacturer no longing making drug|2
7307613|NCT00653432|11531983|FG000|Overall Study|Adverse Event|4
7307614|NCT00653432|11531984|FG001|Overall Study|Adverse Event|1
7307615|NCT00653432|11531983|FG000|Overall Study|Withdrawal by Subject|4
7307616|NCT00653432|11531984|FG001|Overall Study|Withdrawal by Subject|5
7307617|NCT00653432|11531983|FG000|Overall Study|Lost to Follow-up|7
7307618|NCT00653432|11531984|FG001|Overall Study|Lost to Follow-up|6
7307619|NCT00653432|11531983|FG000|Overall Study|Use/Need of Con Therapy|2
7307620|NCT00653432|11531984|FG001|Overall Study|Use/Need of Con Therapy|1
7307621|NCT00653432|11531983|FG000|Overall Study|Other - Reason Not Provided|5
7307622|NCT00653432|11531984|FG001|Overall Study|Other - Reason Not Provided|3
7307623|NCT00653939|11532001|FG000|Overall Study|Adverse Event|1
7307624|NCT00653939|11532002|FG001|Overall Study|Adverse Event|3
7307625|NCT00653939|11532001|FG000|Overall Study|Withdrawal by Subject|3
7307626|NCT00653939|11532002|FG001|Overall Study|Withdrawal by Subject|3
7307627|NCT00653939|11532001|FG000|Overall Study|Physician Decision|4
7307628|NCT00653939|11532002|FG001|Overall Study|Physician Decision|0
7307629|NCT00653939|11532001|FG000|Overall Study|Disease Progression|2
7307630|NCT00653939|11532002|FG001|Overall Study|Disease Progression|3
7307631|NCT00653939|11532001|FG000|Overall Study|Other|2
7307632|NCT00653939|11532002|FG001|Overall Study|Other|6
7307633|NCT00653991|11532012|FG000|3 Month Follow-up|Participant would not respond|150
7307634|NCT00653991|11532013|FG001|3 Month Follow-up|Participant would not respond|157
7307635|NCT00653991|11532012|FG000|6 Month Follow-up|Participant would not respond|133
7307636|NCT00653991|11532013|FG001|6 Month Follow-up|Participant would not respond|141
7307637|NCT00654004|11532023|FG000|Overall Study|Lost to Follow-up|1
7307638|NCT00654004|11532024|FG001|Overall Study|Lost to Follow-up|0
7307639|NCT00654186|11532056|FG000|Overall Study|Withdrawal by Subject|5
7307640|NCT00654238|11532060|FG000|Overall Study|Screen Failures|4
7307641|NCT00654355|11532084|FG000|Overall Study|Lost to Follow-up|2
7307642|NCT00654355|11532085|FG001|Overall Study|Lost to Follow-up|2
7307643|NCT00654368|11532094|FG000|Overall Study|Ineligibility determined|6
7307644|NCT00654368|11532095|FG001|Overall Study|Ineligibility determined|0
7307645|NCT00654368|11532096|FG002|Overall Study|Ineligibility determined|0
7307646|NCT00654368|11532094|FG000|Overall Study|Protocol deviation|3
7307647|NCT00654368|11532095|FG001|Overall Study|Protocol deviation|2
7307648|NCT00654368|11532096|FG002|Overall Study|Protocol deviation|1
7307649|NCT00654368|11532094|FG000|Overall Study|Non-compliance|2
7307650|NCT00654368|11532095|FG001|Overall Study|Non-compliance|1
7307651|NCT00654368|11532096|FG002|Overall Study|Non-compliance|2
7307652|NCT00654368|11532094|FG000|Overall Study|Withdrawal by Subject|5
7307653|NCT00654368|11532095|FG001|Overall Study|Withdrawal by Subject|2
7307654|NCT00654368|11532096|FG002|Overall Study|Withdrawal by Subject|2
7307655|NCT00654368|11532094|FG000|Overall Study|Disease progression|21
7307656|NCT00654368|11532095|FG001|Overall Study|Disease progression|31
7307657|NCT00654368|11532096|FG002|Overall Study|Disease progression|13
7307658|NCT00654368|11532094|FG000|Overall Study|Requirement for alternative therapy|1
7307659|NCT00654368|11532095|FG001|Overall Study|Requirement for alternative therapy|1
7307660|NCT00654368|11532096|FG002|Overall Study|Requirement for alternative therapy|1
7307661|NCT00654368|11532094|FG000|Overall Study|Physician Decision|0
7307662|NCT00654368|11532095|FG001|Overall Study|Physician Decision|0
7307663|NCT00654368|11532096|FG002|Overall Study|Physician Decision|2
7307664|NCT00654368|11532094|FG000|Overall Study|Death|1
7307665|NCT00654368|11532095|FG001|Overall Study|Death|0
7307666|NCT00654368|11532096|FG002|Overall Study|Death|0
7307667|NCT00654368|11532094|FG000|Overall Study|Pregnancy|0
7307668|NCT00654368|11532095|FG001|Overall Study|Pregnancy|0
7307669|NCT00654368|11532096|FG002|Overall Study|Pregnancy|2
7307670|NCT00654368|11532094|FG000|Overall Study|Other|0
7307671|NCT00654368|11532095|FG001|Overall Study|Other|2
7307672|NCT00654368|11532096|FG002|Overall Study|Other|3
7307673|NCT00654368|11532094|FG000|Overall Study|Adverse Event|14
7307674|NCT00654368|11532095|FG001|Overall Study|Adverse Event|9
7307675|NCT00654368|11532096|FG002|Overall Study|Adverse Event|6
7307676|NCT00654381|11532107|FG000|1st Stage|Adverse Event|3
7307677|NCT00654381|11532108|FG001|1st Stage|Adverse Event|3
7307678|NCT00654381|11532109|FG002|1st Stage|Adverse Event|3
7307679|NCT00654381|11532110|FG003|1st Stage|Adverse Event|3
7307680|NCT00654381|11532111|FG004|1st Stage|Adverse Event|2
7307681|NCT00654381|11532112|FG005|1st Stage|Adverse Event|1
7307682|NCT00654381|11532107|FG000|1st Stage|Withdrawal by Subject|0
7307683|NCT00654381|11532108|FG001|1st Stage|Withdrawal by Subject|0
7307684|NCT00654381|11532109|FG002|1st Stage|Withdrawal by Subject|0
7307685|NCT00654381|11532110|FG003|1st Stage|Withdrawal by Subject|1
7307686|NCT00654381|11532111|FG004|1st Stage|Withdrawal by Subject|0
7307687|NCT00654381|11532112|FG005|1st Stage|Withdrawal by Subject|1
7307688|NCT00654381|11532107|FG000|1st Stage|Investigator's decision|0
7307689|NCT00654381|11532108|FG001|1st Stage|Investigator's decision|0
7307690|NCT00654381|11532109|FG002|1st Stage|Investigator's decision|0
7307691|NCT00654381|11532110|FG003|1st Stage|Investigator's decision|1
7307692|NCT00654381|11532111|FG004|1st Stage|Investigator's decision|0
7307693|NCT00654381|11532112|FG005|1st Stage|Investigator's decision|0
7307694|NCT00654381|11532107|FG000|2nd Stage|Adverse Event|2
7307695|NCT00654381|11532108|FG001|2nd Stage|Adverse Event|0
7307696|NCT00654381|11532109|FG002|2nd Stage|Adverse Event|2
7307697|NCT00654381|11532110|FG003|2nd Stage|Adverse Event|3
7307698|NCT00654381|11532111|FG004|2nd Stage|Adverse Event|7
7307699|NCT00654381|11532112|FG005|2nd Stage|Adverse Event|2
7307700|NCT00654381|11532107|FG000|2nd Stage|Withdrawal by Subject|0
7307701|NCT00654381|11532108|FG001|2nd Stage|Withdrawal by Subject|0
7307702|NCT00654381|11532109|FG002|2nd Stage|Withdrawal by Subject|0
7307703|NCT00654381|11532110|FG003|2nd Stage|Withdrawal by Subject|0
7307704|NCT00654381|11532111|FG004|2nd Stage|Withdrawal by Subject|1
7307705|NCT00654381|11532112|FG005|2nd Stage|Withdrawal by Subject|1
7307706|NCT00654381|11532107|FG000|2nd Stage|Investigator's decision|0
7307707|NCT00654381|11532108|FG001|2nd Stage|Investigator's decision|0
7307708|NCT00654381|11532109|FG002|2nd Stage|Investigator's decision|1
7307709|NCT00654381|11532110|FG003|2nd Stage|Investigator's decision|1
7307710|NCT00654381|11532111|FG004|2nd Stage|Investigator's decision|0
7307711|NCT00654381|11532112|FG005|2nd Stage|Investigator's decision|0
7307712|NCT00654381|11532107|FG000|Extension Stage|Adverse Event|1
7307713|NCT00654381|11532108|FG001|Extension Stage|Adverse Event|2
7307714|NCT00654381|11532109|FG002|Extension Stage|Adverse Event|9
7307715|NCT00654381|11532110|FG003|Extension Stage|Adverse Event|7
7307716|NCT00654381|11532111|FG004|Extension Stage|Adverse Event|1
7307717|NCT00654381|11532112|FG005|Extension Stage|Adverse Event|1
7307718|NCT00654381|11532107|FG000|Extension Stage|Protocol Violation|0
7307719|NCT00654381|11532108|FG001|Extension Stage|Protocol Violation|0
7307720|NCT00654381|11532109|FG002|Extension Stage|Protocol Violation|0
7307721|NCT00654381|11532110|FG003|Extension Stage|Protocol Violation|1
7307722|NCT00654381|11532111|FG004|Extension Stage|Protocol Violation|0
7307723|NCT00654381|11532112|FG005|Extension Stage|Protocol Violation|0
7307724|NCT00654381|11532107|FG000|Extension Stage|Lack of Efficacy|0
7307725|NCT00654381|11532108|FG001|Extension Stage|Lack of Efficacy|0
7307726|NCT00654381|11532109|FG002|Extension Stage|Lack of Efficacy|1
7307727|NCT00654381|11532110|FG003|Extension Stage|Lack of Efficacy|0
7307728|NCT00654381|11532111|FG004|Extension Stage|Lack of Efficacy|0
7307729|NCT00654381|11532112|FG005|Extension Stage|Lack of Efficacy|0
7307730|NCT00654381|11532107|FG000|Extension Stage|Withdrawal by Subject|0
7307731|NCT00654381|11532108|FG001|Extension Stage|Withdrawal by Subject|0
7307732|NCT00654381|11532109|FG002|Extension Stage|Withdrawal by Subject|1
7307733|NCT00654381|11532110|FG003|Extension Stage|Withdrawal by Subject|1
7307734|NCT00654381|11532111|FG004|Extension Stage|Withdrawal by Subject|1
7307735|NCT00654381|11532112|FG005|Extension Stage|Withdrawal by Subject|1
7307736|NCT00654381|11532107|FG000|Extension Stage|Closure of the trial site|0
7307737|NCT00654381|11532108|FG001|Extension Stage|Closure of the trial site|0
7307738|NCT00654381|11532109|FG002|Extension Stage|Closure of the trial site|0
7307739|NCT00654381|11532110|FG003|Extension Stage|Closure of the trial site|0
7389089|NCT01225835|11648534|FG000|Overall Study|Completed protocol|2
7389090|NCT01225835|11648535|FG001|Overall Study|Completed protocol|1
7389091|NCT01225835|11648534|FG000|Overall Study|Did not meet hCG criterion|2
7389092|NCT01225835|11648535|FG001|Overall Study|Did not meet hCG criterion|0
7389093|NCT01225835|11648534|FG000|Overall Study|Adverse Event|2
7389094|NCT01225835|11648535|FG001|Overall Study|Adverse Event|1
7389095|NCT01225835|11648534|FG000|Overall Study|Other|1
7389096|NCT01225835|11648535|FG001|Overall Study|Other|1
7389097|NCT01225887|11648547|FG000|Overall Study|Ineligible:required test not done|2
7389098|NCT01225887|11648547|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
7389099|NCT01225887|11648547|FG000|Overall Study|Ineligible:inadequate pathology|2
7389100|NCT01225952|11648563|FG000|Overall Study|Lost to Follow-up|1
7389101|NCT01225952|11648564|FG001|Overall Study|Lost to Follow-up|0
7389102|NCT01225952|11648565|FG002|Overall Study|Lost to Follow-up|0
7389103|NCT01225952|11648563|FG000|Overall Study|Study Eye Explanted|0
7389104|NCT01225952|11648564|FG001|Overall Study|Study Eye Explanted|0
7389105|NCT01225952|11648565|FG002|Overall Study|Study Eye Explanted|1
7389106|NCT01225952|11648563|FG000|Overall Study|Withdrawal by Subject|4
7389107|NCT01225952|11648564|FG001|Overall Study|Withdrawal by Subject|4
7389108|NCT01225952|11648565|FG002|Overall Study|Withdrawal by Subject|5
7389109|NCT01225952|11648563|FG000|Overall Study|Surgical complications|1
7389110|NCT01225952|11648564|FG001|Overall Study|Surgical complications|0
7389111|NCT01225952|11648565|FG002|Overall Study|Surgical complications|0
7389112|NCT01225991|11648573|FG000|Overall Study|Withdrawal by Subject|6
7389113|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
7389114|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
7389115|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
7389116|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
7389117|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7389118|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
7389119|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7389120|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
7389121|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
7389122|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7389123|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7389124|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
7389125|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
7389126|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
7389127|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
7389128|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
7389129|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7389130|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
7389131|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7389132|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
7389133|NCT01226043|11648579|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
7389134|NCT01226043|11648580|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
7389135|NCT01226043|11648581|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
7389136|NCT01226043|11648582|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
7389137|NCT01226043|11648579|FG000|6-week Re-randomization Phase|Adverse Event|0
7389138|NCT01226043|11648580|FG001|6-week Re-randomization Phase|Adverse Event|0
7389139|NCT01226043|11648581|FG002|6-week Re-randomization Phase|Adverse Event|1
7389140|NCT01226043|11648582|FG003|6-week Re-randomization Phase|Adverse Event|1
7389141|NCT01226043|11648579|FG000|6-week Re-randomization Phase|Protocol Violation|0
7307740|NCT00654381|11532111|FG004|Extension Stage|Closure of the trial site|1
7389142|NCT01226043|11648580|FG001|6-week Re-randomization Phase|Protocol Violation|0
7389143|NCT01226043|11648581|FG002|6-week Re-randomization Phase|Protocol Violation|1
7389144|NCT01226043|11648582|FG003|6-week Re-randomization Phase|Protocol Violation|1
7307741|NCT00654381|11532112|FG005|Extension Stage|Closure of the trial site|1
7307742|NCT00654420|11532133|FG000|Phase I (Dose Escalation)|Adverse Event|0
7307743|NCT00654420|11532134|FG001|Phase I (Dose Escalation)|Adverse Event|1
7307744|NCT00654420|11532135|FG002|Phase I (Dose Escalation)|Adverse Event|0
7307745|NCT00654420|11532136|FG003|Phase I (Dose Escalation)|Adverse Event|0
7307746|NCT00654420|11532133|FG000|Phase I (Dose Escalation)|Progressive Disease|4
7307747|NCT00654420|11532134|FG001|Phase I (Dose Escalation)|Progressive Disease|15
7307748|NCT00654420|11532135|FG002|Phase I (Dose Escalation)|Progressive Disease|0
7307749|NCT00654420|11532136|FG003|Phase I (Dose Escalation)|Progressive Disease|0
7307750|NCT00654420|11532133|FG000|Phase II|Adverse Event|0
7307751|NCT00654420|11532134|FG001|Phase II|Adverse Event|0
7307752|NCT00654420|11532135|FG002|Phase II|Adverse Event|3
7307753|NCT00654420|11532136|FG003|Phase II|Adverse Event|3
7307754|NCT00654420|11532133|FG000|Phase II|Lost to Follow-up|0
7307755|NCT00654420|11532134|FG001|Phase II|Lost to Follow-up|0
7307756|NCT00654420|11532135|FG002|Phase II|Lost to Follow-up|0
7307757|NCT00654420|11532136|FG003|Phase II|Lost to Follow-up|1
7307758|NCT00654420|11532133|FG000|Phase II|Physician Decision|0
7307759|NCT00654420|11532134|FG001|Phase II|Physician Decision|0
7307760|NCT00654420|11532135|FG002|Phase II|Physician Decision|0
7307761|NCT00654420|11532136|FG003|Phase II|Physician Decision|4
7307762|NCT00654420|11532133|FG000|Phase II|Progressive Disease|0
7307763|NCT00654420|11532134|FG001|Phase II|Progressive Disease|0
7307764|NCT00654420|11532135|FG002|Phase II|Progressive Disease|29
7307765|NCT00654420|11532136|FG003|Phase II|Progressive Disease|29
7307766|NCT00654420|11532133|FG000|Phase II|Withdrawal by Subject|0
7307767|NCT00654420|11532134|FG001|Phase II|Withdrawal by Subject|0
7307768|NCT00654420|11532135|FG002|Phase II|Withdrawal by Subject|4
7307769|NCT00654420|11532136|FG003|Phase II|Withdrawal by Subject|1
7307770|NCT00654420|11532133|FG000|Phase II|Missing Disposition Record|0
7307771|NCT00654420|11532134|FG001|Phase II|Missing Disposition Record|0
7307772|NCT00654420|11532135|FG002|Phase II|Missing Disposition Record|1
7307773|NCT00654420|11532136|FG003|Phase II|Missing Disposition Record|0
7307774|NCT00654498|11532148|FG000|Overall Study|Not Treated|1
7307775|NCT00654498|11532149|FG001|Overall Study|Not Treated|0
7307776|NCT00654498|11532148|FG000|Overall Study|Adverse Event|6
7307777|NCT00654498|11532149|FG001|Overall Study|Adverse Event|1
7307778|NCT00654498|11532148|FG000|Overall Study|Protocol Violation|1
7307779|NCT00654498|11532149|FG001|Overall Study|Protocol Violation|1
7307780|NCT00654498|11532148|FG000|Overall Study|Lost to Follow-up|1
7307781|NCT00654498|11532149|FG001|Overall Study|Lost to Follow-up|5
7307782|NCT00654498|11532148|FG000|Overall Study|Withdrawal by Subject|1
7307783|NCT00654498|11532149|FG001|Overall Study|Withdrawal by Subject|0
7307784|NCT00654498|11532148|FG000|Overall Study|Other reason not defined above|4
7307785|NCT00654498|11532149|FG001|Overall Study|Other reason not defined above|5
7307786|NCT00654641|11532187|FG000|Overall Study|Lost to Follow-up|2
7307787|NCT00654641|11532188|FG001|Overall Study|Lost to Follow-up|3
7307788|NCT00654732|11532200|FG000|Overall Study|Adverse Event|4
7307789|NCT00654732|11532201|FG001|Overall Study|Adverse Event|6
7307790|NCT00654745|11532207|FG000|Overall Study|Adverse Event|12
7307791|NCT00654745|11532207|FG000|Overall Study|Lost to Follow-up|7
7307792|NCT00654745|11532207|FG000|Overall Study|Protocol Violation|11
7307793|NCT00654745|11532207|FG000|Overall Study|Withdrawal by Subject|10
7307794|NCT00654745|11532207|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
7307795|NCT00654875|11532232|FG000|Overall Study|Adverse Event|5
7307796|NCT00654875|11532233|FG001|Overall Study|Adverse Event|5
7307797|NCT00654875|11532232|FG000|Overall Study|Withdrawal by Subject|4
7307798|NCT00654875|11532233|FG001|Overall Study|Withdrawal by Subject|4
7307799|NCT00654875|11532232|FG000|Overall Study|Protocol Violation|3
7307800|NCT00654875|11532233|FG001|Overall Study|Protocol Violation|3
7307801|NCT00654875|11532232|FG000|Overall Study|Lack of Efficacy|2
7307802|NCT00654875|11532233|FG001|Overall Study|Lack of Efficacy|2
7307803|NCT00654875|11532232|FG000|Overall Study|Lost to Follow-up|1
7307804|NCT00654875|11532233|FG001|Overall Study|Lost to Follow-up|3
7307805|NCT00654875|11532232|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7307806|NCT00654875|11532233|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7307807|NCT00654875|11532232|FG000|Overall Study|Administrative Problems|1
7307808|NCT00654875|11532233|FG001|Overall Study|Administrative Problems|0
7307809|NCT00654901|11532243|FG000|Overall Study|Lost to Follow-up|1
7307810|NCT00654901|11532244|FG001|Overall Study|Lost to Follow-up|0
7307811|NCT00654901|11532245|FG002|Overall Study|Lost to Follow-up|1
7307812|NCT00654901|11532246|FG003|Overall Study|Lost to Follow-up|0
7307813|NCT00654901|11532243|FG000|Overall Study|Withdrawal by Subject|3
7307814|NCT00654901|11532244|FG001|Overall Study|Withdrawal by Subject|0
7307815|NCT00654901|11532245|FG002|Overall Study|Withdrawal by Subject|1
7307816|NCT00654901|11532246|FG003|Overall Study|Withdrawal by Subject|0
7307817|NCT00654940|11532262|FG000|Period 1|Adverse Event|0
7307818|NCT00654940|11532263|FG001|Period 1|Adverse Event|1
7307819|NCT00654940|11532262|FG000|Period 1|Intolerable Pain Level|1
7307820|NCT00654940|11532263|FG001|Period 1|Intolerable Pain Level|0
7307821|NCT00655356|11532299|FG000|Overall Study|Withdrawal by Subject|3
7307822|NCT00655356|11532300|FG001|Overall Study|Withdrawal by Subject|4
7307823|NCT00655356|11532299|FG000|Overall Study|Sponsor Request|10
7307824|NCT00655356|11532300|FG001|Overall Study|Sponsor Request|4
7307825|NCT00655356|11532299|FG000|Overall Study|Adverse Event|1
7307826|NCT00655356|11532300|FG001|Overall Study|Adverse Event|1
7307827|NCT00655356|11532299|FG000|Overall Study|Protocol Violation|2
7307828|NCT00655356|11532300|FG001|Overall Study|Protocol Violation|1
7307829|NCT00655356|11532299|FG000|Overall Study|Other Reason|1
7307830|NCT00655356|11532300|FG001|Overall Study|Other Reason|0
7307831|NCT00655486|11532315|FG000|Overall Study|Adverse Event|10
7307832|NCT00655486|11532315|FG000|Overall Study|Lack of Efficacy|8
7307833|NCT00655486|11532315|FG000|Overall Study|Withdrawal by Subject|4
7307834|NCT00655486|11532315|FG000|Overall Study|Protocol Violation|1
7389145|NCT01226043|11648579|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
7389146|NCT01226043|11648580|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
7389147|NCT01226043|11648581|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
7389148|NCT01226043|11648582|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
7389149|NCT01226043|11648579|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
7389150|NCT01226043|11648580|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
7389151|NCT01226043|11648581|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
7389152|NCT01226043|11648582|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
7389153|NCT01226043|11648579|FG000|6-week Re-randomization Phase|Physician Decision|0
7389154|NCT01226043|11648580|FG001|6-week Re-randomization Phase|Physician Decision|0
7389155|NCT01226043|11648581|FG002|6-week Re-randomization Phase|Physician Decision|3
7389156|NCT01226043|11648582|FG003|6-week Re-randomization Phase|Physician Decision|2
7389157|NCT01226043|11648579|FG000|6-week Re-randomization Phase|completed in error|0
7389158|NCT01226043|11648580|FG001|6-week Re-randomization Phase|completed in error|0
7389159|NCT01226043|11648581|FG002|6-week Re-randomization Phase|completed in error|0
7389160|NCT01226043|11648582|FG003|6-week Re-randomization Phase|completed in error|1
7389161|NCT01226043|11648579|FG000|30-week Observational Phase|Adverse Event|0
7389162|NCT01226043|11648580|FG001|30-week Observational Phase|Adverse Event|0
7389163|NCT01226043|11648581|FG002|30-week Observational Phase|Adverse Event|1
7389164|NCT01226043|11648582|FG003|30-week Observational Phase|Adverse Event|1
7389165|NCT01226043|11648579|FG000|30-week Observational Phase|Protocol Violation|0
7389166|NCT01226043|11648580|FG001|30-week Observational Phase|Protocol Violation|0
7389167|NCT01226043|11648581|FG002|30-week Observational Phase|Protocol Violation|0
7389168|NCT01226043|11648582|FG003|30-week Observational Phase|Protocol Violation|1
7389169|NCT01226043|11648579|FG000|30-week Observational Phase|Lost to Follow-up|0
7389170|NCT01226043|11648580|FG001|30-week Observational Phase|Lost to Follow-up|0
7389171|NCT01226043|11648581|FG002|30-week Observational Phase|Lost to Follow-up|2
7389172|NCT01226043|11648582|FG003|30-week Observational Phase|Lost to Follow-up|2
7389173|NCT01226043|11648579|FG000|30-week Observational Phase|Withdrawal by Subject|0
7389174|NCT01226043|11648580|FG001|30-week Observational Phase|Withdrawal by Subject|0
7389175|NCT01226043|11648581|FG002|30-week Observational Phase|Withdrawal by Subject|1
7389176|NCT01226043|11648582|FG003|30-week Observational Phase|Withdrawal by Subject|7
7389177|NCT01226043|11648579|FG000|30-week Observational Phase|Physician Decision|0
7389178|NCT01226043|11648580|FG001|30-week Observational Phase|Physician Decision|0
7389179|NCT01226043|11648581|FG002|30-week Observational Phase|Physician Decision|2
7389180|NCT01226043|11648582|FG003|30-week Observational Phase|Physician Decision|2
7389181|NCT01226095|11648612|FG000|Overall Study|Poor compliance|1
7389182|NCT01226121|11648626|FG000|Overall Study|Lost to Follow-up|2
7389183|NCT01226121|11648627|FG001|Overall Study|Lost to Follow-up|0
7389184|NCT01226121|11648628|FG002|Overall Study|Lost to Follow-up|1
7389185|NCT01226459|11648642|FG000|Overall Study|Adverse Event|2
7389186|NCT01226459|11648643|FG001|Overall Study|Adverse Event|8
7389187|NCT01226459|11648642|FG000|Overall Study|Protocol Violation|4
7389188|NCT01226459|11648643|FG001|Overall Study|Protocol Violation|3
7389189|NCT01226459|11648642|FG000|Overall Study|Withdrawal by Subject|10
7389190|NCT01226459|11648643|FG001|Overall Study|Withdrawal by Subject|13
7389191|NCT01226459|11648642|FG000|Overall Study|Lost to Follow-up|4
7389192|NCT01226459|11648643|FG001|Overall Study|Lost to Follow-up|8
7389193|NCT01226459|11648642|FG000|Overall Study|Pregnancy|1
7389194|NCT01226459|11648643|FG001|Overall Study|Pregnancy|0
7389195|NCT01226472|11648649|FG000|Overall Study|Progressive Disease|1
7389196|NCT01226511|11648692|FG000|Acute Treatment Period|Adverse Event|7
7389197|NCT01226511|11648693|FG001|Acute Treatment Period|Adverse Event|6
7389198|NCT01226511|11648692|FG000|Acute Treatment Period|Lack of Efficacy|2
7389199|NCT01226511|11648693|FG001|Acute Treatment Period|Lack of Efficacy|1
7389200|NCT01226511|11648692|FG000|Acute Treatment Period|Lost to Follow-up|3
7389201|NCT01226511|11648693|FG001|Acute Treatment Period|Lost to Follow-up|6
7389202|NCT01226511|11648692|FG000|Acute Treatment Period|Parent/caregiver decision|5
7389203|NCT01226511|11648693|FG001|Acute Treatment Period|Parent/caregiver decision|7
7389204|NCT01226511|11648692|FG000|Acute Treatment Period|Protocol Violation|5
7389205|NCT01226511|11648693|FG001|Acute Treatment Period|Protocol Violation|5
7389206|NCT01226511|11648692|FG000|Acute Treatment Period|Withdrawal by Subject|10
7389207|NCT01226511|11648693|FG001|Acute Treatment Period|Withdrawal by Subject|6
7389208|NCT01226511|11648692|FG000|Extension Treatment Period|Adverse Event|8
7389209|NCT01226511|11648693|FG001|Extension Treatment Period|Adverse Event|8
7389210|NCT01226511|11648692|FG000|Extension Treatment Period|Lack of Efficacy|3
7389211|NCT01226511|11648693|FG001|Extension Treatment Period|Lack of Efficacy|2
7389212|NCT01226511|11648692|FG000|Extension Treatment Period|Lost to Follow-up|4
7389213|NCT01226511|11648693|FG001|Extension Treatment Period|Lost to Follow-up|3
7389214|NCT01226511|11648692|FG000|Extension Treatment Period|Protocol Violation|2
7307835|NCT00655486|11532315|FG000|Overall Study|Unsatisfactory compliance|2
7307836|NCT00655486|11532315|FG000|Overall Study|Other: Pregnancy|1
7307837|NCT00655486|11532315|FG000|Overall Study|Other: Could not tolerate BID dosing|1
7307838|NCT00655486|11532315|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
7307839|NCT00655499|11532319|FG000|Overall Study|not eligible|4
7307840|NCT00655551|11532336|FG000|All Periods Combined|Adverse Event|0
7307841|NCT00655551|11532337|FG001|All Periods Combined|Adverse Event|3
7307842|NCT00655551|11532338|FG002|All Periods Combined|Adverse Event|4
7307843|NCT00655551|11532336|FG000|Period 2 (up to 7 Days)|Adverse Event|0
7307844|NCT00655551|11532337|FG001|Period 2 (up to 7 Days)|Adverse Event|1
7307845|NCT00655551|11532338|FG002|Period 2 (up to 7 Days)|Adverse Event|0
7307846|NCT00655551|11532336|FG000|Period 3 (up to 7 Days)|Adverse Event|0
7307847|NCT00655551|11532337|FG001|Period 3 (up to 7 Days)|Adverse Event|0
7307848|NCT00655551|11532338|FG002|Period 3 (up to 7 Days)|Adverse Event|4
7307849|NCT00655551|11532336|FG000|Period 4 (up to 7 Days)|Adverse Event|0
7307850|NCT00655551|11532337|FG001|Period 4 (up to 7 Days)|Adverse Event|2
7307851|NCT00655551|11532338|FG002|Period 4 (up to 7 Days)|Adverse Event|0
7307852|NCT00655564|11532346|FG000|Overall Study|Adverse Event|1
7307853|NCT00655564|11532346|FG000|Overall Study|Lost to Follow-up|1
7307854|NCT00655564|11532346|FG000|Overall Study|Desired Alternate Therapy|1
7307855|NCT00655629|11532353|FG000|Overall Study|Adverse Event|4
7307856|NCT00655629|11532354|FG001|Overall Study|Adverse Event|1
7307857|NCT00655629|11532353|FG000|Overall Study|Lack of Efficacy|2
7307858|NCT00655629|11532354|FG001|Overall Study|Lack of Efficacy|12
7307859|NCT00655629|11532353|FG000|Overall Study|Lost to Follow-up|4
7307860|NCT00655629|11532354|FG001|Overall Study|Lost to Follow-up|3
7307861|NCT00655629|11532353|FG000|Overall Study|Protocol Violation|5
7307862|NCT00655629|11532354|FG001|Overall Study|Protocol Violation|3
7307863|NCT00655629|11532353|FG000|Overall Study|consent withdrawn|6
7307864|NCT00655629|11532354|FG001|Overall Study|consent withdrawn|4
7307865|NCT00655668|11532377|FG000|Overall Study|Adverse Event|6
7307866|NCT00655668|11532377|FG000|Overall Study|Death|5
7307867|NCT00655668|11532377|FG000|Overall Study|Disease Progression|27
7307868|NCT00655668|11532377|FG000|Overall Study|Study Terminated|9
7307869|NCT00655668|11532377|FG000|Overall Study|Other|1
7307870|NCT00655668|11532377|FG000|Overall Study|New Lymphoma Treatment Started|4
7307871|NCT00655668|11532377|FG000|Overall Study|Withdrawal by Subject|2
7307872|NCT00655733|11532388|FG000|Overall Study|Lost to Follow-up|2
7307873|NCT00655733|11532389|FG001|Overall Study|Lost to Follow-up|2
7307874|NCT00655733|11532388|FG000|Overall Study|Adverse Event|2
7307875|NCT00655733|11532389|FG001|Overall Study|Adverse Event|2
7307876|NCT00655733|11532388|FG000|Overall Study|Withdrawal by Subject|3
7307877|NCT00655733|11532389|FG001|Overall Study|Withdrawal by Subject|3
7307878|NCT00655733|11532388|FG000|Overall Study|Physician Decision|0
7307879|NCT00655733|11532389|FG001|Overall Study|Physician Decision|1
7307880|NCT00655746|11532397|FG000|Overall Study|Withdrawal by Subject|1
7307881|NCT00655850|11532415|FG000|Overall Study|Death|2
7307882|NCT00655850|11532415|FG000|Overall Study|Withdrawal by Subject|1
7307883|NCT00655863|11532424|FG000|Overall Study|Lost to Follow-up|0
7307884|NCT00655863|11532425|FG001|Overall Study|Lost to Follow-up|0
7389215|NCT01226511|11648693|FG001|Extension Treatment Period|Protocol Violation|2
7307885|NCT00655863|11532426|FG002|Overall Study|Lost to Follow-up|1
7307886|NCT00655889|11532434|FG000|Overall Study|Inadequate cell growth|1
7307887|NCT00655889|11532434|FG000|Overall Study|Protocol Violation|1
7307888|NCT00655928|11532440|FG000|Overall Study|Withdrawal by Subject|2
7307889|NCT00655928|11532441|FG001|Overall Study|Withdrawal by Subject|1
7307890|NCT00655928|11532440|FG000|Overall Study|Physician Decision|1
7307891|NCT00655928|11532441|FG001|Overall Study|Physician Decision|1
7307892|NCT00655980|11532450|FG000|Overall Study|surgery canceled; or subject or anesthes|26
7307893|NCT00655980|11532451|FG001|Overall Study|surgery canceled; or subject or anesthes|31
7307894|NCT00655980|11532452|FG002|Overall Study|surgery canceled; or subject or anesthes|5
7389216|NCT01226511|11648692|FG000|Extension Treatment Period|Withdrawal by Subject|1
7389217|NCT01226511|11648693|FG001|Extension Treatment Period|Withdrawal by Subject|3
7389218|NCT01226511|11648692|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
7389219|NCT01226511|11648693|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
7389220|NCT01226511|11648692|FG000|Extension Treatment Period|Sponsor Decision|1
7389221|NCT01226511|11648693|FG001|Extension Treatment Period|Sponsor Decision|1
7389222|NCT01226511|11648692|FG000|Taper Period|Adverse Event|1
7389223|NCT01226511|11648693|FG001|Taper Period|Adverse Event|0
7389224|NCT01226511|11648692|FG000|Taper Period|Lost to Follow-up|2
7389225|NCT01226511|11648693|FG001|Taper Period|Lost to Follow-up|2
7307895|NCT00656019|11532467|FG000|Overall Study|Not Eligible|10
7307896|NCT00656019|11532468|FG001|Overall Study|Not Eligible|0
7307897|NCT00656019|11532469|FG002|Overall Study|Not Eligible|0
7307898|NCT00656019|11532470|FG003|Overall Study|Not Eligible|0
7307899|NCT00656019|11532467|FG000|Overall Study|Withdrawal by Subject|2
7307900|NCT00656019|11532468|FG001|Overall Study|Withdrawal by Subject|0
7307901|NCT00656019|11532469|FG002|Overall Study|Withdrawal by Subject|0
7389226|NCT01226511|11648692|FG000|Taper Period|Protocol Violation|1
7307902|NCT00656019|11532470|FG003|Overall Study|Withdrawal by Subject|0
7307903|NCT00656019|11532467|FG000|Overall Study|Lost to Follow-up|2
7307904|NCT00656019|11532468|FG001|Overall Study|Lost to Follow-up|1
7307905|NCT00656019|11532469|FG002|Overall Study|Lost to Follow-up|0
7307906|NCT00656019|11532470|FG003|Overall Study|Lost to Follow-up|0
7307907|NCT00656058|11532480|FG000|Overall Study|Withdrawal by Subject|2
7307908|NCT00656058|11532480|FG000|Overall Study|Withdrawal by Subject|4
7307909|NCT00656084|11532484|FG000|Overall Study|Adverse Event|4
7307910|NCT00656084|11532484|FG000|Overall Study|Withdrawal by Subject|1
7307911|NCT00656084|11532484|FG000|Overall Study|Patient Request|1
7307912|NCT00656084|11532484|FG000|Overall Study|Investigator Request|1
7307913|NCT00656136|11532490|FG000|Overall Study|Progressive disease|177
7307914|NCT00656136|11532491|FG001|Overall Study|Progressive disease|322
7307915|NCT00656136|11532490|FG000|Overall Study|Other Adverse Event|5
7307916|NCT00656136|11532491|FG001|Overall Study|Other Adverse Event|51
7307917|NCT00656136|11532490|FG000|Overall Study|Protocol Violation|2
7307918|NCT00656136|11532491|FG001|Overall Study|Protocol Violation|3
7307919|NCT00656136|11532490|FG000|Overall Study|Patient refused to take study medication|7
7307920|NCT00656136|11532491|FG001|Overall Study|Patient refused to take study medication|10
7307921|NCT00656136|11532490|FG000|Overall Study|Unknown and others|4
7307922|NCT00656136|11532491|FG001|Overall Study|Unknown and others|4
7307923|NCT00656175|11532499|FG000|Overall Study|Adverse Event|1
7307924|NCT00656175|11532500|FG001|Overall Study|Adverse Event|0
7307925|NCT00656175|11532499|FG000|Overall Study|Transportation issues|0
7307926|NCT00656175|11532500|FG001|Overall Study|Transportation issues|1
7307927|NCT00656292|11532517|FG000|Overall Study|Withdrawal by Subject|2
7307928|NCT00656292|11532518|FG001|Overall Study|Withdrawal by Subject|3
7307929|NCT00656292|11532517|FG000|Overall Study|Screen failure|1
7307930|NCT00656292|11532518|FG001|Overall Study|Screen failure|2
7307931|NCT00656370|11532533|FG000|Overall Study|Screen Failures|7
7307932|NCT00656370|11532533|FG000|Overall Study|Alternates|3
7307933|NCT00656474|11532549|FG000|Overall Study|Other Reason|1
7307934|NCT00656513|11532570|FG000|Overall Study|Protocol Violation|1
7307935|NCT00656513|11532571|FG001|Overall Study|Protocol Violation|0
7307936|NCT00656513|11532572|FG002|Overall Study|Protocol Violation|2
7307937|NCT00656513|11532570|FG000|Overall Study|Withdrawal by Subject|0
7307938|NCT00656513|11532571|FG001|Overall Study|Withdrawal by Subject|11
7307939|NCT00656513|11532572|FG002|Overall Study|Withdrawal by Subject|4
7307940|NCT00656513|11532570|FG000|Overall Study|Death|0
7307941|NCT00656513|11532571|FG001|Overall Study|Death|0
7307942|NCT00656513|11532572|FG002|Overall Study|Death|1
7307943|NCT00656513|11532570|FG000|Overall Study|Missing data|0
7307944|NCT00656513|11532571|FG001|Overall Study|Missing data|11
7307945|NCT00656513|11532572|FG002|Overall Study|Missing data|9
7307946|NCT00656513|11532570|FG000|Overall Study|Incomplete treatment|3
7307947|NCT00656513|11532571|FG001|Overall Study|Incomplete treatment|0
7307948|NCT00656513|11532572|FG002|Overall Study|Incomplete treatment|0
7307949|NCT00656513|11532570|FG000|Overall Study|Treatment completed outside of timeframe|0
7307950|NCT00656513|11532571|FG001|Overall Study|Treatment completed outside of timeframe|3
7307951|NCT00656513|11532572|FG002|Overall Study|Treatment completed outside of timeframe|1
7307952|NCT00656513|11532570|FG000|Overall Study|Missing baseline form|0
7307953|NCT00656513|11532571|FG001|Overall Study|Missing baseline form|5
7307954|NCT00656513|11532572|FG002|Overall Study|Missing baseline form|5
7307955|NCT00656617|11532580|FG000|Overall Study|Adverse Event|1
7307956|NCT00656617|11532580|FG000|Overall Study|Death|2
7307957|NCT00656617|11532580|FG000|Overall Study|Insurance Issues|2
7307958|NCT00656617|11532580|FG000|Overall Study|Move to different clinical trial|2
7307959|NCT00656669|11532602|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
7307960|NCT00656669|11532602|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
7307961|NCT00656669|11532602|FG000|AC (Cycles 6-9)|Adverse Event|1
7307962|NCT00656669|11532602|FG000|AC (Cycles 6-9)|Did not start segment 3|1
7307963|NCT00656799|11532611|FG000|Overall Study|Death|2
7307964|NCT00656851|11532617|FG000|Overall Study|Withdrawal by Subject|0
7307965|NCT00656851|11532618|FG001|Overall Study|Withdrawal by Subject|4
7307966|NCT00657020|11532633|FG000|PERIOD 1|Adverse Event|0
7307967|NCT00657020|11532634|FG001|PERIOD 1|Adverse Event|1
7307968|NCT00657046|11532649|FG000|Overall Study|Adverse Event|1
7307969|NCT00657046|11532650|FG001|Overall Study|Adverse Event|1
7307970|NCT00657046|11532651|FG002|Overall Study|Adverse Event|0
7307971|NCT00657046|11532649|FG000|Overall Study|Protocol Violation|2
7307972|NCT00657046|11532650|FG001|Overall Study|Protocol Violation|2
7307973|NCT00657046|11532651|FG002|Overall Study|Protocol Violation|0
7307974|NCT00657046|11532649|FG000|Overall Study|Withdrawal by Subject|1
7307975|NCT00657046|11532650|FG001|Overall Study|Withdrawal by Subject|0
7307976|NCT00657046|11532651|FG002|Overall Study|Withdrawal by Subject|0
7307977|NCT00657046|11532649|FG000|Overall Study|Death|0
7307978|NCT00657046|11532650|FG001|Overall Study|Death|0
7307979|NCT00657046|11532651|FG002|Overall Study|Death|1
7307980|NCT00657046|11532649|FG000|Overall Study|Surgery|0
7307981|NCT00657046|11532650|FG001|Overall Study|Surgery|0
7307982|NCT00657046|11532651|FG002|Overall Study|Surgery|1
7307983|NCT00657150|11532661|FG000|Overall Study|Adverse Event|19
7307984|NCT00657150|11532662|FG001|Overall Study|Adverse Event|10
7307985|NCT00657150|11532661|FG000|Overall Study|Non-compliant with protocol|5
7307986|NCT00657150|11532662|FG001|Overall Study|Non-compliant with protocol|9
7307987|NCT00657150|11532661|FG000|Overall Study|Lost to Follow-up|2
7307988|NCT00657150|11532662|FG001|Overall Study|Lost to Follow-up|0
7307989|NCT00657150|11532661|FG000|Overall Study|Withdrawal by Subject|51
7307990|NCT00657150|11532662|FG001|Overall Study|Withdrawal by Subject|36
7307991|NCT00657150|11532661|FG000|Overall Study|Other|38
7307992|NCT00657150|11532662|FG001|Overall Study|Other|38
7307993|NCT00657150|11532661|FG000|Treatment|Adverse Event|60
7307994|NCT00657150|11532662|FG001|Treatment|Adverse Event|53
7307995|NCT00657150|11532661|FG000|Treatment|Non-compliant with protocol|10
7307996|NCT00657150|11532662|FG001|Treatment|Non-compliant with protocol|9
7307997|NCT00657150|11532661|FG000|Treatment|Lost to Follow-up|1
7307998|NCT00657150|11532662|FG001|Treatment|Lost to Follow-up|0
7307999|NCT00657150|11532661|FG000|Treatment|Withdrawal by Subject|23
7308000|NCT00657150|11532662|FG001|Treatment|Withdrawal by Subject|20
7308001|NCT00657150|11532661|FG000|Treatment|Other|13
7308002|NCT00657150|11532662|FG001|Treatment|Other|15
7384064|NCT01192347|11641200|FG000|Overall Study|Patient not visiting hospital regularly|1
7384065|NCT01192347|11641200|FG000|Overall Study|Patient did not show up for visits|1
7384066|NCT01192399|11641204|FG000|Overall Study|Lack of Efficacy|2
7384067|NCT01192412|11641210|FG000|Overall Study|Lost to Follow-up|2
7384068|NCT01192412|11641211|FG001|Overall Study|Lost to Follow-up|1
7384069|NCT01192412|11641210|FG000|Overall Study|Withdrawal by Subject|2
7384070|NCT01192412|11641211|FG001|Overall Study|Withdrawal by Subject|1
7384071|NCT01192516|11641220|FG000|Overall Study|Lost to Follow-up|7
7384072|NCT01192516|11641221|FG001|Overall Study|Lost to Follow-up|10
7384073|NCT01192516|11641222|FG002|Overall Study|Lost to Follow-up|7
7384074|NCT01192516|11641220|FG000|Overall Study|Withdrawal by Subject|4
7384075|NCT01192516|11641221|FG001|Overall Study|Withdrawal by Subject|4
7389227|NCT01226511|11648693|FG001|Taper Period|Protocol Violation|0
7389228|NCT01226511|11648692|FG000|Taper Period|Parent/Caregiver Decision|1
7389229|NCT01226511|11648693|FG001|Taper Period|Parent/Caregiver Decision|1
7389230|NCT01226745|11648726|FG000|Overall Study|Did not complete schedule of assessments|8
7308031|NCT00657709|11532717|FG004|Overall Study|Lost to Follow-up|21
7389231|NCT01226745|11648727|FG001|Overall Study|Did not complete schedule of assessments|3
7389232|NCT01226745|11648728|FG002|Overall Study|Did not complete schedule of assessments|6
7389233|NCT01226745|11648729|FG003|Overall Study|Did not complete schedule of assessments|0
7389234|NCT01226745|11648730|FG004|Overall Study|Did not complete schedule of assessments|0
7389235|NCT01226745|11648731|FG005|Overall Study|Did not complete schedule of assessments|1
7389236|NCT01226745|11648726|FG000|Overall Study|Lost to Follow-up|2
7389237|NCT01226745|11648727|FG001|Overall Study|Lost to Follow-up|6
7389238|NCT01226745|11648728|FG002|Overall Study|Lost to Follow-up|6
7389239|NCT01226745|11648729|FG003|Overall Study|Lost to Follow-up|1
7389240|NCT01226745|11648730|FG004|Overall Study|Lost to Follow-up|1
7389241|NCT01226745|11648731|FG005|Overall Study|Lost to Follow-up|2
7389242|NCT01226745|11648726|FG000|Overall Study|Death|1
7389243|NCT01226745|11648727|FG001|Overall Study|Death|0
7389244|NCT01226745|11648728|FG002|Overall Study|Death|0
7389245|NCT01226745|11648729|FG003|Overall Study|Death|0
7389246|NCT01226745|11648730|FG004|Overall Study|Death|0
7389247|NCT01226745|11648731|FG005|Overall Study|Death|1
7389248|NCT01226745|11648726|FG000|Overall Study|Other|6
7389249|NCT01226745|11648727|FG001|Overall Study|Other|7
7389250|NCT01226745|11648728|FG002|Overall Study|Other|8
7389251|NCT01226745|11648729|FG003|Overall Study|Other|4
7389252|NCT01226745|11648730|FG004|Overall Study|Other|3
7389253|NCT01226745|11648731|FG005|Overall Study|Other|1
7389254|NCT01227018|11648769|FG000|Overall Study|Disease progression|9
7389255|NCT01227018|11648769|FG000|Overall Study|Toxicity|2
7389256|NCT01227018|11648769|FG000|Overall Study|Withdrew after beginning treatment|4
7389257|NCT01227044|11648775|FG000|Overall Study|Lost to Follow-up|5
7389258|NCT01227044|11648776|FG001|Overall Study|Lost to Follow-up|7
7389259|NCT01227044|11648775|FG000|Overall Study|Discontinued Intervention|1
7389260|NCT01227044|11648776|FG001|Overall Study|Discontinued Intervention|2
7389261|NCT01227252|11648796|FG000|Overall Study|Sponsor Decision|0
7389262|NCT01227252|11648797|FG001|Overall Study|Sponsor Decision|1
7389263|NCT01227252|11648798|FG002|Overall Study|Sponsor Decision|0
7389264|NCT01227252|11648799|FG003|Overall Study|Sponsor Decision|0
7389265|NCT01227252|11648796|FG000|Overall Study|Lost to Follow-up|0
7389266|NCT01227252|11648797|FG001|Overall Study|Lost to Follow-up|1
7389267|NCT01227252|11648798|FG002|Overall Study|Lost to Follow-up|0
7389268|NCT01227252|11648799|FG003|Overall Study|Lost to Follow-up|0
7389269|NCT01227252|11648796|FG000|Overall Study|Withdrawal by Subject|0
7389270|NCT01227252|11648797|FG001|Overall Study|Withdrawal by Subject|1
7389271|NCT01227252|11648798|FG002|Overall Study|Withdrawal by Subject|0
7389272|NCT01227252|11648799|FG003|Overall Study|Withdrawal by Subject|0
7389273|NCT01227265|11648815|FG000|Overall Study|Did Not Receive Treatment|1
7389274|NCT01227265|11648816|FG001|Overall Study|Did Not Receive Treatment|2
7389275|NCT01227265|11648817|FG002|Overall Study|Did Not Receive Treatment|0
7389276|NCT01227265|11648815|FG000|Overall Study|Administrative|1
7389277|NCT01227265|11648816|FG001|Overall Study|Administrative|0
7389278|NCT01227265|11648817|FG002|Overall Study|Administrative|2
7389279|NCT01227265|11648815|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7389280|NCT01227265|11648816|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7389281|NCT01227265|11648817|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
7389282|NCT01227265|11648815|FG000|Overall Study|Protocol Violation|2
7389283|NCT01227265|11648816|FG001|Overall Study|Protocol Violation|1
7384076|NCT01192516|11641222|FG002|Overall Study|Withdrawal by Subject|1
7384077|NCT01192516|11641220|FG000|Overall Study|started new treatment|5
7384078|NCT01192516|11641221|FG001|Overall Study|started new treatment|1
7384079|NCT01192516|11641222|FG002|Overall Study|started new treatment|0
7308003|NCT00657267|11532668|FG000|Overall Study|Progressive disease|45
7308004|NCT00657267|11532668|FG000|Overall Study|Adverse Event|9
7308005|NCT00657358|11532678|FG000|Overall Study|Lack of Efficacy|6
7308006|NCT00657371|11532683|FG000|Overall Study|Poor bowel preparation|15
7308007|NCT00657371|11532683|FG000|Overall Study|Unable to intubate the cecum|5
7308008|NCT00657371|11532683|FG000|Overall Study|Protocol Violation|2
7308009|NCT00657371|11532683|FG000|Overall Study|Device- related reasons|13
7308010|NCT00657371|11532683|FG000|Overall Study|Pre-existing medical condition|4
7308011|NCT00657540|11532689|FG000|Overall Study|Lost to Follow-up|1
7308012|NCT00657540|11532690|FG001|Overall Study|Lost to Follow-up|4
7308013|NCT00657618|11532700|FG000|Overall Study|Adverse Event|32
7308014|NCT00657618|11532700|FG000|Overall Study|Withdrawal by Subject|8
7308015|NCT00657618|11532700|FG000|Overall Study|negative for leishmaniasis|2
7308016|NCT00657618|11532700|FG000|Overall Study|didn't start due to schedule conflicts|1
7308017|NCT00657709|11532713|FG000|Overall Study|AE or Death|7
7308018|NCT00657709|11532714|FG001|Overall Study|AE or Death|7
7308019|NCT00657709|11532715|FG002|Overall Study|AE or Death|6
7308020|NCT00657709|11532716|FG003|Overall Study|AE or Death|7
7308021|NCT00657709|11532717|FG004|Overall Study|AE or Death|1
7308022|NCT00657709|11532713|FG000|Overall Study|Withdrawal by Subject|7
7308023|NCT00657709|11532714|FG001|Overall Study|Withdrawal by Subject|15
7308024|NCT00657709|11532715|FG002|Overall Study|Withdrawal by Subject|15
7308025|NCT00657709|11532716|FG003|Overall Study|Withdrawal by Subject|5
7308026|NCT00657709|11532717|FG004|Overall Study|Withdrawal by Subject|9
7308027|NCT00657709|11532713|FG000|Overall Study|Lost to Follow-up|9
7308028|NCT00657709|11532714|FG001|Overall Study|Lost to Follow-up|9
7308029|NCT00657709|11532715|FG002|Overall Study|Lost to Follow-up|7
7308030|NCT00657709|11532716|FG003|Overall Study|Lost to Follow-up|1
7308032|NCT00657709|11532713|FG000|Overall Study|Protocol Violation|0
7308033|NCT00657709|11532714|FG001|Overall Study|Protocol Violation|2
7308034|NCT00657709|11532715|FG002|Overall Study|Protocol Violation|0
7308035|NCT00657709|11532716|FG003|Overall Study|Protocol Violation|1
7308036|NCT00657709|11532717|FG004|Overall Study|Protocol Violation|2
7308037|NCT00658021|11532746|FG000|28-Week Treatment Period|Adverse Event|3
7308038|NCT00658021|11532747|FG001|28-Week Treatment Period|Adverse Event|1
7308039|NCT00658021|11532748|FG002|28-Week Treatment Period|Adverse Event|0
7308040|NCT00658021|11532746|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
7308041|NCT00658021|11532747|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
7308042|NCT00658021|11532748|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
7308043|NCT00658021|11532746|FG000|28-Week Treatment Period|Protocol Violation|0
7308044|NCT00658021|11532747|FG001|28-Week Treatment Period|Protocol Violation|2
7308045|NCT00658021|11532748|FG002|28-Week Treatment Period|Protocol Violation|1
7308046|NCT00658021|11532746|FG000|28-Week Treatment Period|Withdrawal by Subject|1
7308047|NCT00658021|11532747|FG001|28-Week Treatment Period|Withdrawal by Subject|1
7308048|NCT00658021|11532748|FG002|28-Week Treatment Period|Withdrawal by Subject|3
7308049|NCT00658021|11532746|FG000|28-Week Treatment Period|Physician Decision|1
7308050|NCT00658021|11532747|FG001|28-Week Treatment Period|Physician Decision|2
7308051|NCT00658021|11532748|FG002|28-Week Treatment Period|Physician Decision|1
7308052|NCT00658021|11532746|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
7308053|NCT00658021|11532747|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
7308054|NCT00658021|11532748|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
7308055|NCT00658021|11532746|FG000|28-Week Treatment Period|Loss of glucose control|1
7308056|NCT00658021|11532747|FG001|28-Week Treatment Period|Loss of glucose control|1
7308057|NCT00658021|11532748|FG002|28-Week Treatment Period|Loss of glucose control|10
7308058|NCT00658021|11532746|FG000|28-Week Treatment Period|Other|2
7308059|NCT00658021|11532747|FG001|28-Week Treatment Period|Other|3
7308060|NCT00658021|11532748|FG002|28-Week Treatment Period|Other|1
7308061|NCT00658021|11532746|FG000|28-Week Treatment Period|Did not receive treatment|2
7308062|NCT00658021|11532747|FG001|28-Week Treatment Period|Did not receive treatment|0
7308063|NCT00658021|11532748|FG002|28-Week Treatment Period|Did not receive treatment|0
7308064|NCT00658021|11532746|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7308065|NCT00658021|11532747|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
7308066|NCT00658021|11532748|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
7308067|NCT00658021|11532746|FG000|Long-term Safety Follow-up Period|Physician Decision|0
7308068|NCT00658021|11532747|FG001|Long-term Safety Follow-up Period|Physician Decision|2
7308069|NCT00658021|11532748|FG002|Long-term Safety Follow-up Period|Physician Decision|0
7308070|NCT00658320|11532769|FG000|Core Study: 12 Months|Subject withdrew consent|5
7308071|NCT00658320|11532770|FG001|Core Study: 12 Months|Subject withdrew consent|3
7308072|NCT00658320|11532769|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
7308073|NCT00658320|11532770|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
7308074|NCT00658320|11532769|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
7308075|NCT00658320|11532770|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
7308076|NCT00658320|11532769|FG000|Extension Study: After Month 24|Subject withdrew consent|2
7308077|NCT00658320|11532770|FG001|Extension Study: After Month 24|Subject withdrew consent|0
7308078|NCT00658333|11532780|FG000|Overall Study|Adverse Event|2
7308079|NCT00658333|11532781|FG001|Overall Study|Adverse Event|1
7308080|NCT00658359|11532790|FG000|Overall Study|Death|3
7308081|NCT00658359|11532791|FG001|Overall Study|Death|1
7308082|NCT00658359|11532792|FG002|Overall Study|Death|2
7308083|NCT00658359|11532790|FG000|Overall Study|Adverse Event|13
7308084|NCT00658359|11532791|FG001|Overall Study|Adverse Event|6
7308085|NCT00658359|11532792|FG002|Overall Study|Adverse Event|9
7308086|NCT00658359|11532790|FG000|Overall Study|Protocol Violation|1
7308087|NCT00658359|11532791|FG001|Overall Study|Protocol Violation|0
7308088|NCT00658359|11532792|FG002|Overall Study|Protocol Violation|0
7308089|NCT00658359|11532790|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
7308090|NCT00658359|11532791|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
7308091|NCT00658359|11532792|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
7308092|NCT00658359|11532790|FG000|Overall Study|Withdrawal by Subject|7
7308093|NCT00658359|11532791|FG001|Overall Study|Withdrawal by Subject|4
7308094|NCT00658359|11532792|FG002|Overall Study|Withdrawal by Subject|2
7308095|NCT00658359|11532790|FG000|Overall Study|Lost to Follow-up|2
7308096|NCT00658359|11532791|FG001|Overall Study|Lost to Follow-up|2
7308097|NCT00658359|11532792|FG002|Overall Study|Lost to Follow-up|4
7308098|NCT00658359|11532790|FG000|Overall Study|Lack of Efficacy|0
7308099|NCT00658359|11532791|FG001|Overall Study|Lack of Efficacy|1
7308100|NCT00658359|11532792|FG002|Overall Study|Lack of Efficacy|0
7308101|NCT00658528|11532825|FG000|Overall Study|Adverse Event|5
7308102|NCT00658528|11532826|FG001|Overall Study|Adverse Event|7
7308103|NCT00658528|11532825|FG000|Overall Study|Lost to Follow-up|14
7308104|NCT00658528|11532826|FG001|Overall Study|Lost to Follow-up|22
7308105|NCT00658528|11532825|FG000|Overall Study|Withdrawal by Subject|8
7389284|NCT01227265|11648817|FG002|Overall Study|Protocol Violation|0
7389285|NCT01227265|11648815|FG000|Overall Study|Withdrawal by Subject|7
7389286|NCT01227265|11648816|FG001|Overall Study|Withdrawal by Subject|7
7389287|NCT01227265|11648817|FG002|Overall Study|Withdrawal by Subject|3
7389288|NCT01227265|11648815|FG000|Overall Study|Lost to Follow-up|2
7389289|NCT01227265|11648816|FG001|Overall Study|Lost to Follow-up|0
7389290|NCT01227265|11648817|FG002|Overall Study|Lost to Follow-up|3
7389291|NCT01227265|11648815|FG000|Overall Study|Adverse Event|6
7389292|NCT01227265|11648816|FG001|Overall Study|Adverse Event|10
7389293|NCT01227265|11648817|FG002|Overall Study|Adverse Event|5
7389294|NCT01227278|11648827|FG000|Overall Study|Withdrawal by Subject|4
7389295|NCT01227278|11648828|FG001|Overall Study|Withdrawal by Subject|4
7389296|NCT01227278|11648827|FG000|Overall Study|Death|0
7389297|NCT01227278|11648828|FG001|Overall Study|Death|2
7389298|NCT01227278|11648827|FG000|Overall Study|Other|1
7389299|NCT01227278|11648828|FG001|Overall Study|Other|2
7389300|NCT01227395|11648842|FG000|Overall Study|Protocol Violation|0
7389301|NCT01227395|11648843|FG001|Overall Study|Protocol Violation|1
7389302|NCT01227421|11648871|FG000|Overall Study|Lost to Follow-up|6
7389303|NCT01227421|11648872|FG001|Overall Study|Lost to Follow-up|7
7389304|NCT01227421|11648873|FG002|Overall Study|Lost to Follow-up|5
7389305|NCT01227421|11648871|FG000|Overall Study|Adverse Event|2
7389306|NCT01227421|11648872|FG001|Overall Study|Adverse Event|7
7389307|NCT01227421|11648873|FG002|Overall Study|Adverse Event|2
7389308|NCT01227421|11648871|FG000|Overall Study|Withdrawal by Subject|1
7389309|NCT01227421|11648872|FG001|Overall Study|Withdrawal by Subject|2
7389310|NCT01227421|11648873|FG002|Overall Study|Withdrawal by Subject|1
7389311|NCT01227421|11648871|FG000|Overall Study|Protocol Violation|1
7389312|NCT01227421|11648872|FG001|Overall Study|Protocol Violation|1
7389313|NCT01227421|11648873|FG002|Overall Study|Protocol Violation|2
7389314|NCT01227421|11648871|FG000|Overall Study|Randomized in error|1
7389315|NCT01227421|11648872|FG001|Overall Study|Randomized in error|1
7389316|NCT01227421|11648873|FG002|Overall Study|Randomized in error|0
7389317|NCT01227512|11648893|FG000|Overall Study|Physician Decision|6
7389318|NCT01227512|11648894|FG001|Overall Study|Physician Decision|6
7389319|NCT01227512|11648893|FG000|Overall Study|Adverse Event|4
7389320|NCT01227512|11648894|FG001|Overall Study|Adverse Event|3
7389321|NCT01227512|11648893|FG000|Overall Study|Withdrawal by Subject|3
7389322|NCT01227512|11648894|FG001|Overall Study|Withdrawal by Subject|0
7389323|NCT01227512|11648893|FG000|Overall Study|Participant met withdrawal criteria|0
7389324|NCT01227512|11648894|FG001|Overall Study|Participant met withdrawal criteria|1
7389325|NCT01227564|11648909|FG000|Overall Study|No Longer Willing to Participate|4
7389326|NCT01227564|11648910|FG001|Overall Study|No Longer Willing to Participate|2
7389327|NCT01227564|11648911|FG002|Overall Study|No Longer Willing to Participate|5
7389328|NCT01227564|11648909|FG000|Overall Study|Participant moved to another town|0
7389329|NCT01227564|11648910|FG001|Overall Study|Participant moved to another town|0
7389330|NCT01227564|11648911|FG002|Overall Study|Participant moved to another town|1
7389331|NCT01227577|11648921|FG000|Overall Study|Protocol deviation|3
7389332|NCT01227577|11648921|FG000|Overall Study|Death|3
7389333|NCT01227577|11648921|FG000|Overall Study|Administrative problems|2
7389334|NCT01227577|11648921|FG000|Overall Study|Lost to Follow-up|1
7389335|NCT01227577|11648921|FG000|Overall Study|Withdrawal by Subject|4
7308106|NCT00658528|11532826|FG001|Overall Study|Withdrawal by Subject|6
7308107|NCT00658528|11532825|FG000|Overall Study|Withdrawal of consent|5
7308108|NCT00658528|11532826|FG001|Overall Study|Withdrawal of consent|6
7389336|NCT01227577|11648921|FG000|Overall Study|Lack of Efficacy|5
7389337|NCT01227577|11648921|FG000|Overall Study|Adverse Event|17
7389338|NCT01227629|11648935|FG000|Overall Study|Adverse Event|2
7389339|NCT01227629|11648936|FG001|Overall Study|Adverse Event|2
7308109|NCT00658528|11532825|FG000|Overall Study|Other|8
7308110|NCT00658528|11532826|FG001|Overall Study|Other|4
7308111|NCT00658541|11532832|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7308112|NCT00658541|11532833|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7308113|NCT00658541|11532832|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7308114|NCT00658541|11532833|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7308115|NCT00658567|11532842|FG000|Overall Study|Adverse Event|5
7308116|NCT00658567|11532843|FG001|Overall Study|Adverse Event|2
7308117|NCT00658567|11532844|FG002|Overall Study|Adverse Event|3
7308118|NCT00658567|11532842|FG000|Overall Study|Voluntary Withdrawal of Consent|2
7308119|NCT00658567|11532843|FG001|Overall Study|Voluntary Withdrawal of Consent|0
7308120|NCT00658567|11532844|FG002|Overall Study|Voluntary Withdrawal of Consent|2
7308121|NCT00658567|11532842|FG000|Overall Study|Physician Decision|0
7308122|NCT00658567|11532843|FG001|Overall Study|Physician Decision|1
7308123|NCT00658567|11532844|FG002|Overall Study|Physician Decision|0
7308124|NCT00658567|11532842|FG000|Overall Study|At Discretion of Sponsor|1
7308125|NCT00658567|11532843|FG001|Overall Study|At Discretion of Sponsor|1
7308126|NCT00658567|11532844|FG002|Overall Study|At Discretion of Sponsor|1
7308127|NCT00658606|11532854|FG000|Overall Study|Adverse Event|2
7308128|NCT00658606|11532855|FG001|Overall Study|Adverse Event|1
7308129|NCT00658606|11532854|FG000|Overall Study|Lack of Efficacy|6
7308130|NCT00658606|11532855|FG001|Overall Study|Lack of Efficacy|3
7308131|NCT00658606|11532854|FG000|Overall Study|Lost to Follow-up|1
7308132|NCT00658606|11532855|FG001|Overall Study|Lost to Follow-up|0
7308133|NCT00658606|11532854|FG000|Overall Study|Withdrawal by Subject|7
7308134|NCT00658606|11532855|FG001|Overall Study|Withdrawal by Subject|16
7308135|NCT00658606|11532854|FG000|Overall Study|Lack of Compliance|0
7308136|NCT00658606|11532855|FG001|Overall Study|Lack of Compliance|3
7308137|NCT00658632|11532881|FG000|Overall Study|Adverse Event|13
7308138|NCT00658632|11532882|FG001|Overall Study|Adverse Event|11
7308139|NCT00658632|11532881|FG000|Overall Study|Lost to Follow-up|25
7308140|NCT00658632|11532882|FG001|Overall Study|Lost to Follow-up|23
7308141|NCT00658632|11532881|FG000|Overall Study|Withdrawal by Subject|10
7308142|NCT00658632|11532882|FG001|Overall Study|Withdrawal by Subject|7
7308143|NCT00658632|11532881|FG000|Overall Study|Lack of Efficacy|0
7308144|NCT00658632|11532882|FG001|Overall Study|Lack of Efficacy|1
7308145|NCT00658632|11532881|FG000|Overall Study|Withdrawal of consent|8
7308146|NCT00658632|11532882|FG001|Overall Study|Withdrawal of consent|14
7308147|NCT00658632|11532881|FG000|Overall Study|Pregnancy|1
7308148|NCT00658632|11532882|FG001|Overall Study|Pregnancy|1
7308149|NCT00658632|11532881|FG000|Overall Study|Other|7
7308150|NCT00658632|11532882|FG001|Overall Study|Other|8
7308151|NCT00658658|11532893|FG000|Overall Study|Withdrawal by Subject|0
7308152|NCT00658658|11532894|FG001|Overall Study|Withdrawal by Subject|1
7308153|NCT00658658|11532895|FG002|Overall Study|Withdrawal by Subject|0
7308154|NCT00658658|11532896|FG003|Overall Study|Withdrawal by Subject|0
7308155|NCT00658658|11532897|FG004|Overall Study|Withdrawal by Subject|0
7308156|NCT00658658|11532893|FG000|Overall Study|Death|4
7308157|NCT00658658|11532894|FG001|Overall Study|Death|0
7308158|NCT00658658|11532895|FG002|Overall Study|Death|0
7308159|NCT00658658|11532896|FG003|Overall Study|Death|1
7308160|NCT00658658|11532897|FG004|Overall Study|Death|1
7308161|NCT00658658|11532893|FG000|Overall Study|Disease Progression|0
7308162|NCT00658658|11532894|FG001|Overall Study|Disease Progression|1
7308163|NCT00658658|11532895|FG002|Overall Study|Disease Progression|0
7308164|NCT00658658|11532896|FG003|Overall Study|Disease Progression|1
7308165|NCT00658658|11532897|FG004|Overall Study|Disease Progression|3
7308166|NCT00658658|11532893|FG000|Overall Study|Protocol-specified Criteria|1
7308167|NCT00658658|11532894|FG001|Overall Study|Protocol-specified Criteria|0
7308168|NCT00658658|11532895|FG002|Overall Study|Protocol-specified Criteria|0
7308169|NCT00658658|11532896|FG003|Overall Study|Protocol-specified Criteria|0
7308170|NCT00658658|11532897|FG004|Overall Study|Protocol-specified Criteria|0
7308171|NCT00658658|11532893|FG000|Overall Study|Other|0
7308172|NCT00658658|11532894|FG001|Overall Study|Other|0
7308173|NCT00658658|11532895|FG002|Overall Study|Other|0
7308174|NCT00658658|11532896|FG003|Overall Study|Other|0
7308175|NCT00658658|11532897|FG004|Overall Study|Other|1
7308176|NCT00658684|11532912|FG000|Overall Study|Adverse Event|10
7308177|NCT00658684|11532913|FG001|Overall Study|Adverse Event|8
7308178|NCT00658684|11532914|FG002|Overall Study|Adverse Event|2
7308179|NCT00658684|11532915|FG003|Overall Study|Adverse Event|0
7308180|NCT00658684|11532912|FG000|Overall Study|Withdrawal by Subject|6
7308181|NCT00658684|11532913|FG001|Overall Study|Withdrawal by Subject|4
7308182|NCT00658684|11532914|FG002|Overall Study|Withdrawal by Subject|1
7308183|NCT00658684|11532915|FG003|Overall Study|Withdrawal by Subject|1
7308184|NCT00658684|11532912|FG000|Overall Study|Lack of Efficacy|1
7308185|NCT00658684|11532913|FG001|Overall Study|Lack of Efficacy|1
7308186|NCT00658684|11532914|FG002|Overall Study|Lack of Efficacy|0
7308187|NCT00658684|11532915|FG003|Overall Study|Lack of Efficacy|0
7308188|NCT00658684|11532912|FG000|Overall Study|Protocol Violation|1
7308189|NCT00658684|11532913|FG001|Overall Study|Protocol Violation|1
7308190|NCT00658684|11532914|FG002|Overall Study|Protocol Violation|0
7308191|NCT00658684|11532915|FG003|Overall Study|Protocol Violation|0
7308192|NCT00658684|11532912|FG000|Overall Study|Pregnancy|1
7308193|NCT00658684|11532913|FG001|Overall Study|Pregnancy|1
7308194|NCT00658684|11532914|FG002|Overall Study|Pregnancy|0
7308195|NCT00658684|11532915|FG003|Overall Study|Pregnancy|0
7308196|NCT00658723|11532933|FG000|Overall Study|Lost to Follow-up|0
7308197|NCT00658723|11532934|FG001|Overall Study|Lost to Follow-up|2
7308198|NCT00658723|11532935|FG002|Overall Study|Lost to Follow-up|2
7308199|NCT00658723|11532933|FG000|Overall Study|Death|2
7308200|NCT00658723|11532934|FG001|Overall Study|Death|1
7308201|NCT00658723|11532935|FG002|Overall Study|Death|4
7308202|NCT00658723|11532933|FG000|Overall Study|Scheduling Issue|1
7308203|NCT00658723|11532934|FG001|Overall Study|Scheduling Issue|1
7308204|NCT00658723|11532935|FG002|Overall Study|Scheduling Issue|0
7308205|NCT00658723|11532933|FG000|Overall Study|Withdrawal by Subject|1
7308206|NCT00658723|11532934|FG001|Overall Study|Withdrawal by Subject|0
7308207|NCT00658723|11532935|FG002|Overall Study|Withdrawal by Subject|1
7308208|NCT00658775|11532957|FG000|Overall Study|Adverse Event|4
7308209|NCT00658775|11532958|FG001|Overall Study|Adverse Event|6
7308210|NCT00658775|11532957|FG000|Overall Study|Lost to Follow-up|17
7308211|NCT00658775|11532958|FG001|Overall Study|Lost to Follow-up|18
7308212|NCT00658775|11532957|FG000|Overall Study|Withdrawal by Subject|6
7308213|NCT00658775|11532958|FG001|Overall Study|Withdrawal by Subject|4
7308214|NCT00658775|11532957|FG000|Overall Study|Withdrawal of consent|8
7308215|NCT00658775|11532958|FG001|Overall Study|Withdrawal of consent|7
7308216|NCT00658775|11532957|FG000|Overall Study|Other|7
7308217|NCT00658775|11532958|FG001|Overall Study|Other|8
7308222|NCT00658879|11532977|FG000|Overall Study|Protocol Violation|1
7308223|NCT00658996|11532981|FG000|First Intervention|Positive slit lamp finding|1
7308224|NCT00658996|11532982|FG001|First Intervention|Positive slit lamp finding|0
7308225|NCT00658996|11532981|FG000|First Intervention|Lack of lenses|0
7308226|NCT00658996|11532982|FG001|First Intervention|Lack of lenses|1
7308227|NCT00658996|11532981|FG000|Crossover Period|Physician Decision|1
7308228|NCT00658996|11532982|FG001|Crossover Period|Physician Decision|0
7308229|NCT00658996|11532981|FG000|Crossover Period|Ineligible|1
7308230|NCT00658996|11532982|FG001|Crossover Period|Ineligible|1
7308231|NCT00658996|11532981|FG000|Second Intervention|Developed a stye on upper lid|1
7308232|NCT00658996|11532982|FG001|Second Intervention|Developed a stye on upper lid|0
7308233|NCT00658996|11532981|FG000|Second Intervention|Positive slit lamp finding|0
7308234|NCT00658996|11532982|FG001|Second Intervention|Positive slit lamp finding|1
7308235|NCT00659230|11532999|FG000|Overall Study|Lost to Follow-up|2
7308236|NCT00659230|11533000|FG001|Overall Study|Lost to Follow-up|5
7308237|NCT00659230|11532999|FG000|Overall Study|Lost source documentation|5
7308238|NCT00659230|11533000|FG001|Overall Study|Lost source documentation|4
7308239|NCT00659230|11532999|FG000|Overall Study|Did not return post-randomization|2
7308240|NCT00659230|11533000|FG001|Overall Study|Did not return post-randomization|3
7308241|NCT00659269|11533008|FG000|Overall Study|Physician Decision|1
7308242|NCT00659269|11533009|FG001|Overall Study|Physician Decision|1
7308243|NCT00659334|11533040|FG000|Overall Study|Screen Failure|8
7308244|NCT00659334|11533041|FG001|Overall Study|Screen Failure|5
7308245|NCT00659334|11533042|FG002|Overall Study|Screen Failure|0
7308246|NCT00659334|11533043|FG003|Overall Study|Screen Failure|0
7308247|NCT00659334|11533044|FG004|Overall Study|Screen Failure|0
7308248|NCT00659334|11533045|FG005|Overall Study|Screen Failure|0
7308249|NCT00659334|11533046|FG006|Overall Study|Screen Failure|1
7308250|NCT00659373|11533070|FG000|Overall Study|Withdrawal by Subject|3
7308251|NCT00659373|11533071|FG001|Overall Study|Withdrawal by Subject|5
7308252|NCT00659373|11533070|FG000|Overall Study|Assessment Missed|2
7308253|NCT00659373|11533071|FG001|Overall Study|Assessment Missed|2
7308254|NCT00659425|11533087|FG000|Overall Study|Disease progression|1
7308255|NCT00659425|11533088|FG001|Overall Study|Disease progression|0
7308256|NCT00659425|11533089|FG002|Overall Study|Disease progression|0
7308257|NCT00659425|11533090|FG003|Overall Study|Disease progression|1
7308258|NCT00659425|11533091|FG004|Overall Study|Disease progression|0
7308259|NCT00659425|11533092|FG005|Overall Study|Disease progression|2
7308260|NCT00659425|11533093|FG006|Overall Study|Disease progression|4
7308261|NCT00659425|11533094|FG007|Overall Study|Disease progression|3
7308262|NCT00659425|11533095|FG008|Overall Study|Disease progression|5
7308263|NCT00659425|11533096|FG009|Overall Study|Disease progression|3
7308264|NCT00659425|11533087|FG000|Overall Study|Death|0
7308265|NCT00659425|11533088|FG001|Overall Study|Death|0
7308266|NCT00659425|11533089|FG002|Overall Study|Death|0
7308267|NCT00659425|11533090|FG003|Overall Study|Death|1
7308268|NCT00659425|11533091|FG004|Overall Study|Death|0
7308269|NCT00659425|11533092|FG005|Overall Study|Death|0
7308270|NCT00659425|11533093|FG006|Overall Study|Death|1
7308271|NCT00659425|11533094|FG007|Overall Study|Death|0
7308272|NCT00659425|11533095|FG008|Overall Study|Death|0
7308273|NCT00659425|11533096|FG009|Overall Study|Death|0
7308274|NCT00659425|11533087|FG000|Overall Study|Adverse Event|0
7308275|NCT00659425|11533088|FG001|Overall Study|Adverse Event|0
7308276|NCT00659425|11533089|FG002|Overall Study|Adverse Event|0
7308277|NCT00659425|11533090|FG003|Overall Study|Adverse Event|0
7308278|NCT00659425|11533091|FG004|Overall Study|Adverse Event|0
7308279|NCT00659425|11533092|FG005|Overall Study|Adverse Event|1
7308280|NCT00659425|11533093|FG006|Overall Study|Adverse Event|0
7308281|NCT00659425|11533094|FG007|Overall Study|Adverse Event|3
7308282|NCT00659425|11533095|FG008|Overall Study|Adverse Event|1
7308283|NCT00659425|11533096|FG009|Overall Study|Adverse Event|4
7308284|NCT00659425|11533087|FG000|Overall Study|Investigator Discretion|0
7308285|NCT00659425|11533088|FG001|Overall Study|Investigator Discretion|0
7308286|NCT00659425|11533089|FG002|Overall Study|Investigator Discretion|0
7308287|NCT00659425|11533090|FG003|Overall Study|Investigator Discretion|0
7308288|NCT00659425|11533091|FG004|Overall Study|Investigator Discretion|0
7308289|NCT00659425|11533092|FG005|Overall Study|Investigator Discretion|1
7308290|NCT00659425|11533093|FG006|Overall Study|Investigator Discretion|0
7308291|NCT00659425|11533094|FG007|Overall Study|Investigator Discretion|3
7308292|NCT00659425|11533095|FG008|Overall Study|Investigator Discretion|0
7308293|NCT00659425|11533096|FG009|Overall Study|Investigator Discretion|0
7308294|NCT00659425|11533087|FG000|Overall Study|Other|0
7308295|NCT00659425|11533088|FG001|Overall Study|Other|1
7308296|NCT00659425|11533089|FG002|Overall Study|Other|1
7308297|NCT00659425|11533090|FG003|Overall Study|Other|2
7308298|NCT00659425|11533091|FG004|Overall Study|Other|4
7308299|NCT00659425|11533092|FG005|Overall Study|Other|0
7308300|NCT00659425|11533093|FG006|Overall Study|Other|3
7308301|NCT00659425|11533094|FG007|Overall Study|Other|2
7308302|NCT00659425|11533095|FG008|Overall Study|Other|0
7308303|NCT00659425|11533096|FG009|Overall Study|Other|6
7308304|NCT00659438|11533133|FG000|Overall Study|Withdrawal by Subject|2
7308305|NCT00659438|11533134|FG001|Overall Study|Withdrawal by Subject|2
7308306|NCT00659438|11533133|FG000|Overall Study|Death|11
7308307|NCT00659438|11533134|FG001|Overall Study|Death|6
7308308|NCT00659438|11533133|FG000|Overall Study|Lost to Follow-up|1
7389340|NCT01227629|11648937|FG002|Overall Study|Adverse Event|1
7389341|NCT01227629|11648938|FG003|Overall Study|Adverse Event|6
7389342|NCT01227629|11648939|FG004|Overall Study|Adverse Event|1
7389343|NCT01227629|11648940|FG005|Overall Study|Adverse Event|1
7389344|NCT01227629|11648941|FG006|Overall Study|Adverse Event|6
7389345|NCT01227629|11648942|FG007|Overall Study|Adverse Event|6
7389346|NCT01227629|11648943|FG008|Overall Study|Adverse Event|4
7389347|NCT01227629|11648944|FG009|Overall Study|Adverse Event|0
7389348|NCT01227629|11648935|FG000|Overall Study|Protocol Violation|0
7389349|NCT01227629|11648936|FG001|Overall Study|Protocol Violation|0
7389350|NCT01227629|11648937|FG002|Overall Study|Protocol Violation|0
7389351|NCT01227629|11648938|FG003|Overall Study|Protocol Violation|1
7389352|NCT01227629|11648939|FG004|Overall Study|Protocol Violation|0
7389353|NCT01227629|11648940|FG005|Overall Study|Protocol Violation|0
7389354|NCT01227629|11648941|FG006|Overall Study|Protocol Violation|0
7389355|NCT01227629|11648942|FG007|Overall Study|Protocol Violation|0
7389356|NCT01227629|11648943|FG008|Overall Study|Protocol Violation|0
7389357|NCT01227629|11648944|FG009|Overall Study|Protocol Violation|0
7389358|NCT01227629|11648935|FG000|Overall Study|Lost to Follow-up|0
7389359|NCT01227629|11648936|FG001|Overall Study|Lost to Follow-up|0
7389360|NCT01227629|11648937|FG002|Overall Study|Lost to Follow-up|0
7389361|NCT01227629|11648938|FG003|Overall Study|Lost to Follow-up|0
7389362|NCT01227629|11648939|FG004|Overall Study|Lost to Follow-up|1
7389363|NCT01227629|11648940|FG005|Overall Study|Lost to Follow-up|0
7389364|NCT01227629|11648941|FG006|Overall Study|Lost to Follow-up|0
7389365|NCT01227629|11648942|FG007|Overall Study|Lost to Follow-up|0
7389366|NCT01227629|11648943|FG008|Overall Study|Lost to Follow-up|0
7389367|NCT01227629|11648944|FG009|Overall Study|Lost to Follow-up|0
7389368|NCT01227629|11648935|FG000|Overall Study|Withdrawal by Subject|0
7389369|NCT01227629|11648936|FG001|Overall Study|Withdrawal by Subject|0
7389370|NCT01227629|11648937|FG002|Overall Study|Withdrawal by Subject|0
7389371|NCT01227629|11648938|FG003|Overall Study|Withdrawal by Subject|0
7389372|NCT01227629|11648939|FG004|Overall Study|Withdrawal by Subject|0
7389373|NCT01227629|11648940|FG005|Overall Study|Withdrawal by Subject|0
7389374|NCT01227629|11648941|FG006|Overall Study|Withdrawal by Subject|2
7389375|NCT01227629|11648942|FG007|Overall Study|Withdrawal by Subject|0
7389376|NCT01227629|11648943|FG008|Overall Study|Withdrawal by Subject|0
7389377|NCT01227629|11648944|FG009|Overall Study|Withdrawal by Subject|1
7389378|NCT01227629|11648935|FG000|Overall Study|Other|0
7389379|NCT01227629|11648936|FG001|Overall Study|Other|0
7389380|NCT01227629|11648937|FG002|Overall Study|Other|0
7389381|NCT01227629|11648938|FG003|Overall Study|Other|1
7389382|NCT01227629|11648939|FG004|Overall Study|Other|0
7389383|NCT01227629|11648940|FG005|Overall Study|Other|0
7389384|NCT01227629|11648941|FG006|Overall Study|Other|0
7389385|NCT01227629|11648942|FG007|Overall Study|Other|0
7389386|NCT01227629|11648943|FG008|Overall Study|Other|2
7389387|NCT01227629|11648944|FG009|Overall Study|Other|1
7389388|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
7389389|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
7389390|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
7389391|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
7389392|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
7389393|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
7308309|NCT00659438|11533134|FG001|Overall Study|Lost to Follow-up|0
7308310|NCT00659490|11533143|FG000|Overall Study|Lost to Follow-up|2
7389394|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
7389395|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
7389396|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
7308311|NCT00659490|11533144|FG001|Overall Study|Lost to Follow-up|0
7308312|NCT00659490|11533145|FG002|Overall Study|Lost to Follow-up|1
7308313|NCT00659529|11533153|FG000|Overall Study|Withdrawal by Subject|4
7308314|NCT00659529|11533153|FG000|Overall Study|Protocol Violation|3
7308315|NCT00659529|11533153|FG000|Overall Study|Screen failure|9
7308316|NCT00659581|11533157|FG000|Overall Study|Adverse Event|1006
7308317|NCT00659581|11533157|FG000|Overall Study|Lack of Efficacy|1183
7308318|NCT00659581|11533157|FG000|Overall Study|Other|6393
7308319|NCT00659607|11533161|FG000|Overall Study|No blood pressure recorded|147
7308320|NCT00659607|11533161|FG000|Overall Study|Unknown measuring date of blood pressure|85
7308321|NCT00659607|11533161|FG000|Overall Study|'Unable to evaluate' for the final asses|67
7308322|NCT00659607|11533161|FG000|Overall Study|No recorded efficacy data|15
7308323|NCT00659607|11533161|FG000|Overall Study|Inconsistent BP measuring date|2
7308324|NCT00659815|11533210|FG000|Overall Study|Study related symptoms and complaints|2
7308325|NCT00659815|11533211|FG001|Overall Study|Study related symptoms and complaints|1
7308326|NCT00659815|11533210|FG000|Overall Study|Inability to maintain wearing schedule|1
7308327|NCT00659815|11533211|FG001|Overall Study|Inability to maintain wearing schedule|2
7308328|NCT00659815|11533210|FG000|Overall Study|Withdrawal by Subject|1
7308329|NCT00659815|11533211|FG001|Overall Study|Withdrawal by Subject|1
7308330|NCT00659880|11533221|FG000|Overall Study|Lost to Follow-up|5
7308331|NCT00659984|11533235|FG000|Overall Study|Adverse Event|1
7308332|NCT00660010|11533245|FG000|Overall Study|Withdrawal by Subject|2
7308333|NCT00660010|11533245|FG000|Overall Study|Lost to Follow-up|3
7308334|NCT00660010|11533245|FG000|Overall Study|Adverse Event|1
7308335|NCT00660010|11533245|FG000|Overall Study|Noncompliance with visit schedule|3
7308336|NCT00660023|11533249|FG000|Overall Study|Adverse Event|2
7308337|NCT00660023|11533249|FG000|Overall Study|Death|8
7308338|NCT00660023|11533249|FG000|Overall Study|Blood Transfusion|5
7308339|NCT00660023|11533249|FG000|Overall Study|Renal Transplantation|3
7308340|NCT00660023|11533249|FG000|Overall Study|Withdrawal by Subject|1
7308341|NCT00660023|11533249|FG000|Overall Study|Missed Pregnancy Test|1
7308342|NCT00660023|11533249|FG000|Overall Study|Other Screening Failure|9
7308343|NCT00660179|11533269|FG000|Overall Study|Death|44
7308344|NCT00660179|11533270|FG001|Overall Study|Death|47
7308345|NCT00660179|11533271|FG002|Overall Study|Death|34
7308346|NCT00660179|11533269|FG000|Overall Study|Withdrawal of consent|4
7308347|NCT00660179|11533270|FG001|Overall Study|Withdrawal of consent|6
7308348|NCT00660179|11533271|FG002|Overall Study|Withdrawal of consent|4
7308349|NCT00660179|11533269|FG000|Overall Study|Lost to Follow-up|7
7308350|NCT00660179|11533270|FG001|Overall Study|Lost to Follow-up|5
7308351|NCT00660179|11533271|FG002|Overall Study|Lost to Follow-up|2
7308352|NCT00660179|11533269|FG000|Overall Study|Administrative reason|0
7308353|NCT00660179|11533270|FG001|Overall Study|Administrative reason|0
7308354|NCT00660179|11533271|FG002|Overall Study|Administrative reason|1
7308355|NCT00660179|11533269|FG000|Overall Study|Incorrect randomization|1
7308356|NCT00660179|11533270|FG001|Overall Study|Incorrect randomization|0
7308357|NCT00660179|11533271|FG002|Overall Study|Incorrect randomization|0
7308358|NCT00660192|11533281|FG000|Overall Study|Lost to Follow-up|2
7308359|NCT00660192|11533282|FG001|Overall Study|Lost to Follow-up|3
7308360|NCT00660309|11533290|FG000|Overall Study|Adverse Event|2
7308361|NCT00660309|11533291|FG001|Overall Study|Adverse Event|0
7308362|NCT00660309|11533290|FG000|Overall Study|Withdrawal by Subject|0
7308363|NCT00660309|11533291|FG001|Overall Study|Withdrawal by Subject|3
7308364|NCT00660387|11533300|FG000|Overall Study|Adverse Event|1
7308365|NCT00660387|11533301|FG001|Overall Study|Adverse Event|2
7389397|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
7389398|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
7389399|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
7389400|NCT01227668|11649005|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
7389401|NCT01227668|11649006|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
7389402|NCT01227668|11649005|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
7389403|NCT01227668|11649006|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
7389404|NCT01227668|11649005|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
7389405|NCT01227668|11649006|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
7389406|NCT01227668|11649005|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
7389407|NCT01227668|11649006|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
7389408|NCT01227668|11649005|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
7389409|NCT01227668|11649006|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
7389410|NCT01227668|11649005|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
7389411|NCT01227668|11649006|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
7389412|NCT01227707|11649025|FG000|Overall Study|Adverse Event|10
7389413|NCT01227707|11649025|FG000|Overall Study|Progression of disease|3
7389414|NCT01227707|11649025|FG000|Overall Study|Withdrawal by Subject|1
7389415|NCT01227707|11649025|FG000|Overall Study|Patient non-compliance|3
7389416|NCT01227707|11649025|FG000|Overall Study|Medical decision|6
7389417|NCT01227707|11649025|FG000|Overall Study|Death|1
7308366|NCT00660387|11533300|FG000|Overall Study|Lack of Efficacy|0
7308367|NCT00660387|11533301|FG001|Overall Study|Lack of Efficacy|1
7308368|NCT00660387|11533300|FG000|Overall Study|Protocol Violation|1
7389418|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
7389419|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
7308369|NCT00660387|11533301|FG001|Overall Study|Protocol Violation|0
7308370|NCT00660400|11533307|FG000|Overall Study|Lack of insurance approval|1
7308371|NCT00660400|11533307|FG000|Overall Study|Suboptimal organ function|1
7308372|NCT00660400|11533307|FG000|Overall Study|Intracranial hemorrhage|1
7308373|NCT00660400|11533307|FG000|Overall Study|Withdrawal by Subject|1
7308374|NCT00660660|11533355|FG000|Overall Study|Adverse Event|1
7308375|NCT00660660|11533356|FG001|Overall Study|Adverse Event|0
7308376|NCT00660660|11533355|FG000|Overall Study|Lost to Follow-up|0
7308377|NCT00660660|11533356|FG001|Overall Study|Lost to Follow-up|6
7308378|NCT00660660|11533355|FG000|Overall Study|Lack of Efficacy|0
7308379|NCT00660660|11533356|FG001|Overall Study|Lack of Efficacy|2
7308380|NCT00660660|11533355|FG000|Overall Study|Withdrawal by Subject|3
7308381|NCT00660660|11533356|FG001|Overall Study|Withdrawal by Subject|0
7308382|NCT00660660|11533355|FG000|Overall Study|Incorrect enrollment and other|0
7308383|NCT00660660|11533356|FG001|Overall Study|Incorrect enrollment and other|1
7308384|NCT00660660|11533355|FG000|Overall Study|New medication after randomization|1
7308385|NCT00660660|11533356|FG001|Overall Study|New medication after randomization|0
7308386|NCT00660699|11533362|FG000|Overall Study|Withdrawal by Subject|2
7308387|NCT00660790|11533366|FG000|Baseline to 3 Months|Death|1
7308388|NCT00660790|11533366|FG000|Baseline to 3 Months|Withdrawal by Subject|2
7308389|NCT00660790|11533366|FG000|3 Months to 2 Years|Withdrawal by Subject|17
7308390|NCT00660816|11533372|FG000|Overall Study|Adverse Event|1
7308391|NCT00660816|11533373|FG001|Overall Study|Adverse Event|2
7308392|NCT00660816|11533372|FG000|Overall Study|Withdrawal by Subject|1
7308393|NCT00660816|11533373|FG001|Overall Study|Withdrawal by Subject|0
7308394|NCT00660816|11533372|FG000|Overall Study|Death|0
7308395|NCT00660816|11533373|FG001|Overall Study|Death|2
7308396|NCT00660816|11533372|FG000|Overall Study|Lack of Efficacy|1
7308397|NCT00660816|11533373|FG001|Overall Study|Lack of Efficacy|0
7308398|NCT00660816|11533372|FG000|Overall Study|Physician Decision|0
7308399|NCT00660816|11533373|FG001|Overall Study|Physician Decision|2
7308400|NCT00660816|11533372|FG000|Overall Study|Protocol Violation|1
7308401|NCT00660816|11533373|FG001|Overall Study|Protocol Violation|0
7308402|NCT00660816|11533372|FG000|Overall Study|Disease Progression|16
7308403|NCT00660816|11533373|FG001|Overall Study|Disease Progression|12
7308404|NCT00660816|11533372|FG000|Overall Study|Complicating Disease|0
7308405|NCT00660816|11533373|FG001|Overall Study|Complicating Disease|1
7308406|NCT00660829|11533381|FG000|Overall Study|Adverse Event|3
7308407|NCT00660829|11533382|FG001|Overall Study|Adverse Event|4
7308408|NCT00660829|11533381|FG000|Overall Study|Lack of Efficacy|2
7308409|NCT00660829|11533382|FG001|Overall Study|Lack of Efficacy|3
7308410|NCT00660829|11533381|FG000|Overall Study|Non-Compliance|0
7308411|NCT00660829|11533382|FG001|Overall Study|Non-Compliance|4
7308412|NCT00660829|11533381|FG000|Overall Study|Withdrawal by Subject|1
7308413|NCT00660829|11533382|FG001|Overall Study|Withdrawal by Subject|2
7308414|NCT00660829|11533381|FG000|Overall Study|Lost to Follow-up|3
7308415|NCT00660829|11533382|FG001|Overall Study|Lost to Follow-up|2
7308416|NCT00660829|11533381|FG000|Overall Study|Other|9
7308417|NCT00660829|11533382|FG001|Overall Study|Other|4
7308418|NCT00660907|11533390|FG000|Overall Study|Incorrect Enrollment|1
7308419|NCT00660907|11533391|FG001|Overall Study|Incorrect Enrollment|1
7308420|NCT00660907|11533390|FG000|Overall Study|Adverse Event|33
7308421|NCT00660907|11533391|FG001|Overall Study|Adverse Event|19
7308422|NCT00660907|11533390|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
7308423|NCT00660907|11533391|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
7308424|NCT00660907|11533390|FG000|Overall Study|Withdrawal by Subject|23
7308425|NCT00660907|11533391|FG001|Overall Study|Withdrawal by Subject|32
7308426|NCT00660907|11533390|FG000|Overall Study|Lost to Follow-up|3
7308427|NCT00660907|11533391|FG001|Overall Study|Lost to Follow-up|3
7308428|NCT00660907|11533390|FG000|Overall Study|Poor/Non-Compliance|5
7308429|NCT00660907|11533391|FG001|Overall Study|Poor/Non-Compliance|1
7308430|NCT00660907|11533390|FG000|Overall Study|Safety|1
7308431|NCT00660907|11533391|FG001|Overall Study|Safety|0
7308432|NCT00660907|11533390|FG000|Overall Study|Death|1
7308433|NCT00660907|11533391|FG001|Overall Study|Death|3
7308434|NCT00660907|11533390|FG000|Overall Study|Various|11
7308435|NCT00660907|11533391|FG001|Overall Study|Various|8
7308436|NCT00661089|11533419|FG000|Overall Study|1 subject withdrawal|0
7308437|NCT00661089|11533420|FG001|Overall Study|1 subject withdrawal|1
7308438|NCT00661089|11533419|FG000|Overall Study|death at 8 weeks due to new stroke|0
7308439|NCT00661089|11533420|FG001|Overall Study|death at 8 weeks due to new stroke|1
7308440|NCT00661193|11533456|FG000|Overall Study|Adverse Event|2
7308441|NCT00661193|11533457|FG001|Overall Study|Adverse Event|1
7308442|NCT00661193|11533456|FG000|Overall Study|Withdrawal by Subject|3
7308443|NCT00661193|11533457|FG001|Overall Study|Withdrawal by Subject|1
7308444|NCT00661193|11533456|FG000|Overall Study|Progression|27
7308445|NCT00661193|11533457|FG001|Overall Study|Progression|24
7308446|NCT00661193|11533456|FG000|Overall Study|Not protocol specified|1
7308447|NCT00661193|11533457|FG001|Overall Study|Not protocol specified|0
7308448|NCT00661258|11533465|FG000|Overall Study|Death|1
7308449|NCT00661258|11533466|FG001|Overall Study|Death|0
7308450|NCT00661258|11533465|FG000|Overall Study|caught by police and in detox center|2
7308451|NCT00661258|11533466|FG001|Overall Study|caught by police and in detox center|1
7308452|NCT00661271|11533474|FG000|Overall Study|Lost to Follow-up|28
7308453|NCT00661271|11533475|FG001|Overall Study|Lost to Follow-up|25
7308454|NCT00661362|11533483|FG000|Overall Study|Adverse Event|5
7308455|NCT00661362|11533484|FG001|Overall Study|Adverse Event|4
7308456|NCT00661362|11533483|FG000|Overall Study|Incorrect enrollment|2
7308457|NCT00661362|11533484|FG001|Overall Study|Incorrect enrollment|0
7308458|NCT00661362|11533483|FG000|Overall Study|Study specific discontinuation criteria|4
7308459|NCT00661362|11533484|FG001|Overall Study|Study specific discontinuation criteria|11
7308460|NCT00661362|11533483|FG000|Overall Study|Withdrawal by Subject|13
7308461|NCT00661362|11533484|FG001|Overall Study|Withdrawal by Subject|23
7308462|NCT00661362|11533483|FG000|Overall Study|Lost to Follow-up|3
7308463|NCT00661362|11533484|FG001|Overall Study|Lost to Follow-up|1
7308464|NCT00661362|11533483|FG000|Overall Study|Severe non-compliance to protocol|0
7308465|NCT00661362|11533484|FG001|Overall Study|Severe non-compliance to protocol|1
7308466|NCT00661362|11533483|FG000|Overall Study|Safety reasons|1
7308467|NCT00661362|11533484|FG001|Overall Study|Safety reasons|0
7308468|NCT00661362|11533483|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
7308469|NCT00661362|11533484|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
7308470|NCT00661388|11533490|FG000|Overall Study|Adverse Event|14
7308471|NCT00661388|11533490|FG000|Overall Study|Protocol Violation|7
7308472|NCT00661388|11533490|FG000|Overall Study|Renal transplantation|1
7308473|NCT00661388|11533490|FG000|Overall Study|Dialysis initiation|1
7308474|NCT00661388|11533490|FG000|Overall Study|Administrative reasons|1
7308475|NCT00661427|11533496|FG000|Overall Study|Adverse Event|5
7308476|NCT00661427|11533497|FG001|Overall Study|Adverse Event|5
7308477|NCT00661427|11533496|FG000|Overall Study|Patient not treated|0
7308478|NCT00661427|11533497|FG001|Overall Study|Patient not treated|2
7308479|NCT00661492|11533525|FG000|Overall Study|Adverse Event|16
7308480|NCT00661492|11533526|FG001|Overall Study|Adverse Event|13
7308481|NCT00661492|11533525|FG000|Overall Study|Disease Progression|44
7308482|NCT00661492|11533526|FG001|Overall Study|Disease Progression|14
7308483|NCT00661492|11533525|FG000|Overall Study|Patient Request|6
7308484|NCT00661492|11533526|FG001|Overall Study|Patient Request|1
7308485|NCT00661492|11533525|FG000|Overall Study|Investigator Request|1
7308486|NCT00661492|11533526|FG001|Overall Study|Investigator Request|0
7308487|NCT00661492|11533525|FG000|Overall Study|Lost to Follow-up|0
7308488|NCT00661492|11533526|FG001|Overall Study|Lost to Follow-up|1
7308489|NCT00661492|11533525|FG000|Overall Study|Other|1
7308490|NCT00661492|11533526|FG001|Overall Study|Other|0
7308491|NCT00661505|11533532|FG000|Overall Study|Adverse Event|3
7308492|NCT00661505|11533532|FG000|Overall Study|Protocol Violation|14
7308493|NCT00661505|11533532|FG000|Overall Study|Withdrawal by Subject|8
7308494|NCT00661505|11533532|FG000|Overall Study|Lost to Follow-up|3
7308495|NCT00661505|11533532|FG000|Overall Study|Other|2
7308496|NCT00661531|11533537|FG000|Overall Study|Withdrawal by Subject|3
7308497|NCT00661609|11533571|FG000|Overall Study|Adverse Event|4
7308498|NCT00661609|11533571|FG000|Overall Study|Death|20
7308499|NCT00661609|11533571|FG000|Overall Study|Withdrawal by Subject|2
7308500|NCT00661609|11533571|FG000|Overall Study|PI Decision|1
7308501|NCT00661609|11533571|FG000|Overall Study|Survival follow up stage discontinued|11
7308502|NCT00661609|11533571|FG000|Overall Study|Disease progression|3
7308503|NCT00661622|11533577|FG000|Overall Study|Protocol Violation|1
7308504|NCT00661622|11533578|FG001|Overall Study|Protocol Violation|0
7308505|NCT00661661|11533587|FG000|Overall Study|Adverse Event|99
7308506|NCT00661661|11533588|FG001|Overall Study|Adverse Event|24
7308507|NCT00661661|11533587|FG000|Overall Study|Lack of Efficacy|3
7308508|NCT00661661|11533588|FG001|Overall Study|Lack of Efficacy|2
7308509|NCT00661661|11533587|FG000|Overall Study|Lost to Follow-up|0
7308510|NCT00661661|11533588|FG001|Overall Study|Lost to Follow-up|1
7308511|NCT00661661|11533587|FG000|Overall Study|Withdrawal by Subject|15
7308512|NCT00661661|11533588|FG001|Overall Study|Withdrawal by Subject|5
7308513|NCT00661661|11533587|FG000|Overall Study|Other|22
7308514|NCT00661661|11533588|FG001|Overall Study|Other|7
7308515|NCT00661661|11533587|FG000|Overall Study|Not assigned treatment|1
7308516|NCT00661661|11533588|FG001|Overall Study|Not assigned treatment|0
7308517|NCT00661687|11533609|FG000|Overall Study|Study related symptoms and complaints|5
7308518|NCT00661687|11533609|FG000|Overall Study|Positive slit lamp findings|4
7308519|NCT00661687|11533609|FG000|Overall Study|Inability to maintain wearing schedule|3
7308520|NCT00661687|11533609|FG000|Overall Study|Physician Decision|1
7308521|NCT00661687|11533609|FG000|Overall Study|Adverse Event|2
7384080|NCT01192516|11641220|FG000|Overall Study|Unable to follow Actiwatch instructions|4
7384081|NCT01192516|11641221|FG001|Overall Study|Unable to follow Actiwatch instructions|2
7384082|NCT01192516|11641222|FG002|Overall Study|Unable to follow Actiwatch instructions|0
7384083|NCT01192815|11641243|FG000|Overall Study|Withdrawal by Subject|1
7384084|NCT01192815|11641243|FG000|Overall Study|Lack of Efficacy|1
7384085|NCT01193101|11641273|FG000|Overall Study|Adverse Event|0
7384086|NCT01193101|11641274|FG001|Overall Study|Adverse Event|1
7384087|NCT01193101|11641275|FG002|Overall Study|Adverse Event|1
7384088|NCT01193101|11641276|FG003|Overall Study|Adverse Event|3
7384089|NCT01193101|11641273|FG000|Overall Study|Lack of Efficacy|3
7384090|NCT01193101|11641274|FG001|Overall Study|Lack of Efficacy|1
7384091|NCT01193101|11641275|FG002|Overall Study|Lack of Efficacy|0
7384092|NCT01193101|11641276|FG003|Overall Study|Lack of Efficacy|8
7384093|NCT01193101|11641273|FG000|Overall Study|Withdrawal by Subject|2
7384094|NCT01193101|11641274|FG001|Overall Study|Withdrawal by Subject|4
7384095|NCT01193101|11641275|FG002|Overall Study|Withdrawal by Subject|1
7308522|NCT00661713|11533623|FG000|Overall Study|Death|1
7308523|NCT00661713|11533624|FG001|Overall Study|Death|0
7308524|NCT00661713|11533625|FG002|Overall Study|Death|0
7308525|NCT00661713|11533626|FG003|Overall Study|Death|0
7308526|NCT00661713|11533627|FG004|Overall Study|Death|1
7308527|NCT00661713|11533628|FG005|Overall Study|Death|0
7308528|NCT00661713|11533629|FG006|Overall Study|Death|0
7308529|NCT00661713|11533630|FG007|Overall Study|Death|0
7308530|NCT00661713|11533623|FG000|Overall Study|Unable to Classify|1
7308531|NCT00661713|11533624|FG001|Overall Study|Unable to Classify|0
7308532|NCT00661713|11533625|FG002|Overall Study|Unable to Classify|0
7308533|NCT00661713|11533626|FG003|Overall Study|Unable to Classify|0
7308534|NCT00661713|11533627|FG004|Overall Study|Unable to Classify|0
7308535|NCT00661713|11533628|FG005|Overall Study|Unable to Classify|0
7308536|NCT00661713|11533629|FG006|Overall Study|Unable to Classify|0
7308537|NCT00661713|11533630|FG007|Overall Study|Unable to Classify|0
7308538|NCT00661713|11533623|FG000|Overall Study|Protocol Violation|1
7308539|NCT00661713|11533624|FG001|Overall Study|Protocol Violation|6
7308540|NCT00661713|11533625|FG002|Overall Study|Protocol Violation|3
7308541|NCT00661713|11533626|FG003|Overall Study|Protocol Violation|3
7308542|NCT00661713|11533627|FG004|Overall Study|Protocol Violation|0
7308543|NCT00661713|11533628|FG005|Overall Study|Protocol Violation|2
7308544|NCT00661713|11533629|FG006|Overall Study|Protocol Violation|2
7308545|NCT00661713|11533630|FG007|Overall Study|Protocol Violation|1
7308546|NCT00661713|11533623|FG000|Overall Study|Withdrawal by Subject|11
7308547|NCT00661713|11533624|FG001|Overall Study|Withdrawal by Subject|25
7308548|NCT00661713|11533625|FG002|Overall Study|Withdrawal by Subject|12
7308549|NCT00661713|11533626|FG003|Overall Study|Withdrawal by Subject|21
7308550|NCT00661713|11533627|FG004|Overall Study|Withdrawal by Subject|12
7308551|NCT00661713|11533628|FG005|Overall Study|Withdrawal by Subject|26
7308552|NCT00661713|11533629|FG006|Overall Study|Withdrawal by Subject|45
7308553|NCT00661713|11533630|FG007|Overall Study|Withdrawal by Subject|9
7308554|NCT00661713|11533623|FG000|Overall Study|Lost to Follow-up|2
7308555|NCT00661713|11533624|FG001|Overall Study|Lost to Follow-up|7
7308556|NCT00661713|11533625|FG002|Overall Study|Lost to Follow-up|2
7308557|NCT00661713|11533626|FG003|Overall Study|Lost to Follow-up|2
7308558|NCT00661713|11533627|FG004|Overall Study|Lost to Follow-up|5
7308559|NCT00661713|11533628|FG005|Overall Study|Lost to Follow-up|7
7308560|NCT00661713|11533629|FG006|Overall Study|Lost to Follow-up|14
7308561|NCT00661713|11533630|FG007|Overall Study|Lost to Follow-up|1
7308562|NCT00661713|11533623|FG000|Overall Study|Administrative Reason|0
7308563|NCT00661713|11533624|FG001|Overall Study|Administrative Reason|1
7308564|NCT00661713|11533625|FG002|Overall Study|Administrative Reason|0
7308565|NCT00661713|11533626|FG003|Overall Study|Administrative Reason|2
7308566|NCT00661713|11533627|FG004|Overall Study|Administrative Reason|2
7308567|NCT00661713|11533628|FG005|Overall Study|Administrative Reason|2
7308568|NCT00661713|11533629|FG006|Overall Study|Administrative Reason|1
7308569|NCT00661713|11533630|FG007|Overall Study|Administrative Reason|0
7308570|NCT00661713|11533623|FG000|Overall Study|Adverse Event|0
7308571|NCT00661713|11533624|FG001|Overall Study|Adverse Event|0
7308572|NCT00661713|11533625|FG002|Overall Study|Adverse Event|0
7308573|NCT00661713|11533626|FG003|Overall Study|Adverse Event|0
7308574|NCT00661713|11533627|FG004|Overall Study|Adverse Event|0
7308575|NCT00661713|11533628|FG005|Overall Study|Adverse Event|0
7308576|NCT00661713|11533629|FG006|Overall Study|Adverse Event|1
7308577|NCT00661713|11533630|FG007|Overall Study|Adverse Event|0
7308578|NCT00661713|11533623|FG000|Overall Study|Inappropriate Enrollment|0
7308579|NCT00661713|11533624|FG001|Overall Study|Inappropriate Enrollment|0
7308580|NCT00661713|11533625|FG002|Overall Study|Inappropriate Enrollment|0
7308581|NCT00661713|11533626|FG003|Overall Study|Inappropriate Enrollment|0
7308582|NCT00661713|11533627|FG004|Overall Study|Inappropriate Enrollment|0
7308583|NCT00661713|11533628|FG005|Overall Study|Inappropriate Enrollment|0
7308584|NCT00661713|11533629|FG006|Overall Study|Inappropriate Enrollment|1
7308585|NCT00661713|11533630|FG007|Overall Study|Inappropriate Enrollment|0
7308586|NCT00661726|11533650|FG000|Overall Study|Adverse Event|1
7308587|NCT00661778|11533654|FG000|Overall Study|Disease Progression|23
7308588|NCT00661778|11533654|FG000|Overall Study|Adverse Event|18
7308589|NCT00661778|11533654|FG000|Overall Study|Reason not Specified|6
7308590|NCT00661778|11533654|FG000|Overall Study|Protocol Violation|2
7308591|NCT00661778|11533654|FG000|Overall Study|Withdrawal of Consent|1
7308592|NCT00661830|11533660|FG000|Overall Study|Death|37
7308593|NCT00661830|11533661|FG001|Overall Study|Death|33
7308594|NCT00661830|11533660|FG000|Overall Study|Lost to Follow-up|1
7308595|NCT00661830|11533661|FG001|Overall Study|Lost to Follow-up|3
7308596|NCT00661830|11533660|FG000|Overall Study|Withdrawal by Subject|1
7308597|NCT00661830|11533661|FG001|Overall Study|Withdrawal by Subject|1
7308598|NCT00661830|11533660|FG000|Overall Study|Other reason|1
7308599|NCT00661830|11533661|FG001|Overall Study|Other reason|5
7308600|NCT00661999|11533692|FG000|Overall Study|Adverse Event|11
7308601|NCT00661999|11533693|FG001|Overall Study|Adverse Event|5
7308602|NCT00661999|11533694|FG002|Overall Study|Adverse Event|8
7308603|NCT00661999|11533692|FG000|Overall Study|Death|8
7308604|NCT00661999|11533693|FG001|Overall Study|Death|6
7308605|NCT00661999|11533694|FG002|Overall Study|Death|3
7308606|NCT00661999|11533692|FG000|Overall Study|Other Reasons|5
7308607|NCT00661999|11533693|FG001|Overall Study|Other Reasons|12
7308608|NCT00661999|11533694|FG002|Overall Study|Other Reasons|23
7308609|NCT00661999|11533692|FG000|Overall Study|Withdrawal by Subject|30
7308610|NCT00661999|11533693|FG001|Overall Study|Withdrawal by Subject|23
7308611|NCT00661999|11533694|FG002|Overall Study|Withdrawal by Subject|14
7308612|NCT00661999|11533692|FG000|Overall Study|Alternative Treatment|1
7308613|NCT00661999|11533693|FG001|Overall Study|Alternative Treatment|0
7308614|NCT00661999|11533694|FG002|Overall Study|Alternative Treatment|0
7308615|NCT00661999|11533692|FG000|Overall Study|Other Medical Problems|4
7308616|NCT00661999|11533693|FG001|Overall Study|Other Medical Problems|4
7308617|NCT00661999|11533694|FG002|Overall Study|Other Medical Problems|9
7308618|NCT00662012|11533702|FG000|Overall Study|Lost to Follow-up|85
7308619|NCT00662012|11533702|FG000|Overall Study|Death|1
7308620|NCT00662012|11533702|FG000|Overall Study|Withdrawal by Subject|1
7308621|NCT00662025|11533706|FG000|Overall Study|Objective progression or relapse|51
7308622|NCT00662025|11533706|FG000|Overall Study|Adverse Event|7
7308623|NCT00662025|11533706|FG000|Overall Study|Withdrawal by Subject|1
7308624|NCT00662025|11533706|FG000|Overall Study|Results of other clinical study|2
7308625|NCT00662025|11533706|FG000|Overall Study|Target lesion cannot be evaluated|1
7308626|NCT00662025|11533706|FG000|Overall Study|Domestic circumstances|1
7308627|NCT00662038|11533710|FG000|Overall Study|Reason not specified|3
7308628|NCT00662038|11533710|FG000|Overall Study|Withdrawn consent|22
7308629|NCT00662038|11533710|FG000|Overall Study|Withdrawal by Subject|83
7308630|NCT00662038|11533710|FG000|Overall Study|Sponsor decision|1
7308631|NCT00662038|11533710|FG000|Overall Study|Physician Decision|19
7308632|NCT00662038|11533710|FG000|Overall Study|Lung transplantation|44
7308633|NCT00662038|11533710|FG000|Overall Study|Lost to Follow-up|1
7308634|NCT00662038|11533710|FG000|Overall Study|Death|95
7308635|NCT00662038|11533710|FG000|Overall Study|Adverse Event|358
7308636|NCT00662038|11533710|FG000|Overall Study|Continued treatment|5
7308637|NCT00662129|11533714|FG000|Overall Study|Protocol Violation|1
7308638|NCT00662129|11533714|FG000|Overall Study|Cancel prior to beginning treatment|1
7308639|NCT00662129|11533714|FG000|Overall Study|Ineligible|1
7308640|NCT00662259|11533741|FG000|Overall Study|Adverse Event|2
7308641|NCT00662259|11533742|FG001|Overall Study|Adverse Event|0
7308642|NCT00662311|11533755|FG000|Overall Study|Respiratory Infection|1
7308643|NCT00662311|11533756|FG001|Overall Study|Respiratory Infection|0
7308644|NCT00662311|11533757|FG002|Overall Study|Respiratory Infection|0
7308645|NCT00662363|11533767|FG000|Overall Study|Withdrawal by Subject|6
7308646|NCT00662363|11533768|FG001|Overall Study|Withdrawal by Subject|5
7308647|NCT00662363|11533767|FG000|Overall Study|Adverse Event|0
7308648|NCT00662363|11533768|FG001|Overall Study|Adverse Event|3
7308649|NCT00662363|11533767|FG000|Overall Study|Discharged early from rehab|4
7308650|NCT00662363|11533768|FG001|Overall Study|Discharged early from rehab|1
7308651|NCT00662363|11533767|FG000|Overall Study|Protocol Violation|1
7308652|NCT00662363|11533768|FG001|Overall Study|Protocol Violation|1
7308653|NCT00662532|11533778|FG000|Overall Study|Adverse Event|0
7308654|NCT00662532|11533779|FG001|Overall Study|Adverse Event|1
7308655|NCT00662532|11533778|FG000|Overall Study|Lost to Follow-up|0
7308656|NCT00662532|11533779|FG001|Overall Study|Lost to Follow-up|1
7308657|NCT00662558|11533796|FG000|Overall Study|Adverse Event|21
7308658|NCT00662558|11533797|FG001|Overall Study|Adverse Event|59
7308659|NCT00662558|11533796|FG000|Overall Study|Lack of Efficacy|4
7308660|NCT00662558|11533797|FG001|Overall Study|Lack of Efficacy|7
7308661|NCT00662558|11533796|FG000|Overall Study|Lost to Follow-up|13
7308662|NCT00662558|11533797|FG001|Overall Study|Lost to Follow-up|10
7308663|NCT00662558|11533796|FG000|Overall Study|Other|9
7308664|NCT00662558|11533797|FG001|Overall Study|Other|14
7308665|NCT00662558|11533796|FG000|Overall Study|Withdrawal by Subject|7
7308666|NCT00662558|11533797|FG001|Overall Study|Withdrawal by Subject|12
7308667|NCT00662558|11533796|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
7308668|NCT00662558|11533797|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
7308669|NCT00662649|11533807|FG000|Core Study (24 Months)|Withdrawal by Subject|31
7308670|NCT00662649|11533808|FG001|Core Study (24 Months)|Withdrawal by Subject|17
7308671|NCT00662649|11533809|FG002|Core Study (24 Months)|Withdrawal by Subject|28
7308672|NCT00662649|11533810|FG003|Core Study (24 Months)|Withdrawal by Subject|0
7308673|NCT00662649|11533811|FG004|Core Study (24 Months)|Withdrawal by Subject|0
7308674|NCT00662649|11533807|FG000|Core Study (24 Months)|Adverse Event|22
7308675|NCT00662649|11533808|FG001|Core Study (24 Months)|Adverse Event|13
7308676|NCT00662649|11533809|FG002|Core Study (24 Months)|Adverse Event|18
7308677|NCT00662649|11533810|FG003|Core Study (24 Months)|Adverse Event|0
7308678|NCT00662649|11533811|FG004|Core Study (24 Months)|Adverse Event|0
7308679|NCT00662649|11533807|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
7308680|NCT00662649|11533808|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
7308681|NCT00662649|11533809|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
7308682|NCT00662649|11533810|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7308683|NCT00662649|11533811|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
7308684|NCT00662649|11533807|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
7308685|NCT00662649|11533808|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
7308686|NCT00662649|11533809|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
7308687|NCT00662649|11533810|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
7308688|NCT00662649|11533811|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
7308689|NCT00662649|11533807|FG000|Core Study (24 Months)|Lost to Follow-up|3
7308690|NCT00662649|11533808|FG001|Core Study (24 Months)|Lost to Follow-up|5
7308691|NCT00662649|11533809|FG002|Core Study (24 Months)|Lost to Follow-up|7
7308692|NCT00662649|11533810|FG003|Core Study (24 Months)|Lost to Follow-up|0
7308693|NCT00662649|11533811|FG004|Core Study (24 Months)|Lost to Follow-up|0
7308694|NCT00662649|11533807|FG000|Core Study (24 Months)|Protocol Violation|5
7308695|NCT00662649|11533808|FG001|Core Study (24 Months)|Protocol Violation|5
7308696|NCT00662649|11533809|FG002|Core Study (24 Months)|Protocol Violation|4
7308697|NCT00662649|11533810|FG003|Core Study (24 Months)|Protocol Violation|0
7308698|NCT00662649|11533811|FG004|Core Study (24 Months)|Protocol Violation|0
7308699|NCT00662649|11533807|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
7308700|NCT00662649|11533808|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
7308701|NCT00662649|11533809|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
7308702|NCT00662649|11533810|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
7308703|NCT00662649|11533811|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
7308704|NCT00662649|11533807|FG000|Core Study (24 Months)|Death|1
7308705|NCT00662649|11533808|FG001|Core Study (24 Months)|Death|0
7308706|NCT00662649|11533809|FG002|Core Study (24 Months)|Death|2
7308707|NCT00662649|11533810|FG003|Core Study (24 Months)|Death|0
7308708|NCT00662649|11533811|FG004|Core Study (24 Months)|Death|0
7384096|NCT01193101|11641276|FG003|Overall Study|Withdrawal by Subject|1
7384097|NCT01193101|11641273|FG000|Overall Study|Administrative problems|0
7384098|NCT01193101|11641274|FG001|Overall Study|Administrative problems|0
7384099|NCT01193101|11641275|FG002|Overall Study|Administrative problems|1
7384100|NCT01193101|11641276|FG003|Overall Study|Administrative problems|0
7384101|NCT01193101|11641273|FG000|Overall Study|Abnormal test procedure results|0
7384102|NCT01193101|11641274|FG001|Overall Study|Abnormal test procedure results|1
7384103|NCT01193101|11641275|FG002|Overall Study|Abnormal test procedure results|0
7384104|NCT01193101|11641276|FG003|Overall Study|Abnormal test procedure results|0
7384105|NCT01193127|11641299|FG000|Randomized|Surgery Cancelled|0
7384106|NCT01193127|11641300|FG001|Randomized|Surgery Cancelled|0
7384107|NCT01193127|11641301|FG002|Randomized|Surgery Cancelled|0
7384108|NCT01193127|11641302|FG003|Randomized|Surgery Cancelled|1
7384109|NCT01193127|11641299|FG000|Treated|Withdrawal by Subject|0
7384110|NCT01193127|11641300|FG001|Treated|Withdrawal by Subject|0
7384111|NCT01193127|11641301|FG002|Treated|Withdrawal by Subject|0
7384112|NCT01193127|11641302|FG003|Treated|Withdrawal by Subject|1
7384113|NCT01193153|11641314|FG000|Open-label Lead in Period|Lost to Follow-up|32
7384114|NCT01193153|11641315|FG001|Open-label Lead in Period|Lost to Follow-up|0
7384115|NCT01193153|11641314|FG000|Open-label Lead in Period|Pregnancy|1
7384116|NCT01193153|11641315|FG001|Open-label Lead in Period|Pregnancy|0
7384117|NCT01193153|11641314|FG000|Open-label Lead in Period|Withdrawal by Subject|69
7384118|NCT01193153|11641315|FG001|Open-label Lead in Period|Withdrawal by Subject|0
7384119|NCT01193153|11641314|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
7384120|NCT01193153|11641315|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
7384121|NCT01193153|11641314|FG000|Open-label Lead in Period|Other|14
7384122|NCT01193153|11641315|FG001|Open-label Lead in Period|Other|0
7384123|NCT01193153|11641314|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
7384124|NCT01193153|11641315|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
7384125|NCT01193153|11641314|FG000|Open-label Lead in Period|Adverse Event|41
7384126|NCT01193153|11641315|FG001|Open-label Lead in Period|Adverse Event|0
7384127|NCT01193153|11641314|FG000|Open-label Lead in Period|Death|1
7384128|NCT01193153|11641315|FG001|Open-label Lead in Period|Death|0
7384129|NCT01193153|11641314|FG000|Open-label Lead in Period|Lack of Efficacy|26
7384130|NCT01193153|11641315|FG001|Open-label Lead in Period|Lack of Efficacy|0
7384131|NCT01193153|11641314|FG000|Open-label Stabilization Period|Adverse Event|9
7384132|NCT01193153|11641315|FG001|Open-label Stabilization Period|Adverse Event|0
7384133|NCT01193153|11641314|FG000|Open-label Stabilization Period|Death|2
7384134|NCT01193153|11641315|FG001|Open-label Stabilization Period|Death|0
7384135|NCT01193153|11641314|FG000|Open-label Stabilization Period|Lost to Follow-up|10
7384136|NCT01193153|11641315|FG001|Open-label Stabilization Period|Lost to Follow-up|0
7384137|NCT01193153|11641314|FG000|Open-label Stabilization Period|Lack of Efficacy|5
7384138|NCT01193153|11641315|FG001|Open-label Stabilization Period|Lack of Efficacy|0
7384139|NCT01193153|11641314|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
7384140|NCT01193153|11641315|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
7384141|NCT01193153|11641314|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
7384142|NCT01193153|11641315|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
7384143|NCT01193153|11641314|FG000|Open-label Stabilization Period|Other|8
7384144|NCT01193153|11641315|FG001|Open-label Stabilization Period|Other|0
7384145|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Other|2
7384146|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Other|3
7384147|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
7384148|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
7384149|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Death|2
7384150|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Death|0
7384151|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
7308709|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
7308710|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
7308711|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
7308712|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
7308713|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
7308714|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7308715|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7308716|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
7308717|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
7308718|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
7308719|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
7308720|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
7308721|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
7308722|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
7308723|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
7308724|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
7308725|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
7308726|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
7308727|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
7308728|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
7308729|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
7308730|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7308731|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
7308732|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7308733|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
7308734|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
7308735|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
7308736|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
7308737|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
7308738|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
7308739|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
7308740|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
7308741|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
7308742|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
7308743|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
7308744|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7308745|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
7308746|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7308747|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7308748|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
7308749|NCT00662649|11533807|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7308750|NCT00662649|11533808|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7308751|NCT00662649|11533809|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
7308752|NCT00662649|11533810|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
7308753|NCT00662649|11533811|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
7308754|NCT00662831|11533847|FG000|Overall Study|Death|4
7308755|NCT00662831|11533848|FG001|Overall Study|Death|1
7308756|NCT00662831|11533847|FG000|Overall Study|Lack of Efficacy|6
7308757|NCT00662831|11533848|FG001|Overall Study|Lack of Efficacy|6
7308758|NCT00662831|11533847|FG000|Overall Study|Lost to Follow-up|1
7308759|NCT00662831|11533848|FG001|Overall Study|Lost to Follow-up|0
7308760|NCT00662831|11533847|FG000|Overall Study|Withdrawal by Subject|2
7308761|NCT00662831|11533848|FG001|Overall Study|Withdrawal by Subject|1
7308762|NCT00662831|11533847|FG000|Overall Study|Other|62
7308763|NCT00662831|11533848|FG001|Overall Study|Other|31
7308764|NCT00662831|11533847|FG000|Overall Study|Protocol Violation|8
7308765|NCT00662831|11533848|FG001|Overall Study|Protocol Violation|4
7308766|NCT00662831|11533847|FG000|Overall Study|Adverse Event|23
7308767|NCT00662831|11533848|FG001|Overall Study|Adverse Event|16
7308768|NCT00662857|11533854|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
7308769|NCT00662857|11533855|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
7308770|NCT00662857|11533854|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
7308771|NCT00662857|11533855|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
7308772|NCT00662857|11533854|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
7308773|NCT00662857|11533855|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
7308774|NCT00662909|11533867|FG000|Overall Study|Adverse Event|17
7308775|NCT00662909|11533868|FG001|Overall Study|Adverse Event|18
7308776|NCT00662909|11533869|FG002|Overall Study|Adverse Event|19
7308777|NCT00662909|11533867|FG000|Overall Study|Lack of Efficacy|9
7308778|NCT00662909|11533868|FG001|Overall Study|Lack of Efficacy|1
7308779|NCT00662909|11533869|FG002|Overall Study|Lack of Efficacy|5
7308780|NCT00662909|11533867|FG000|Overall Study|Withdrawal by Subject|29
7308781|NCT00662909|11533868|FG001|Overall Study|Withdrawal by Subject|22
7308782|NCT00662909|11533869|FG002|Overall Study|Withdrawal by Subject|16
7308783|NCT00662909|11533867|FG000|Overall Study|Lost to Follow-up|2
7308784|NCT00662909|11533868|FG001|Overall Study|Lost to Follow-up|9
7308785|NCT00662909|11533869|FG002|Overall Study|Lost to Follow-up|3
7308786|NCT00662909|11533867|FG000|Overall Study|Protocol Violation|7
7308787|NCT00662909|11533868|FG001|Overall Study|Protocol Violation|4
7308788|NCT00662909|11533869|FG002|Overall Study|Protocol Violation|5
7308789|NCT00662909|11533867|FG000|Overall Study|Randomized- never received study drug|1
7308790|NCT00662909|11533868|FG001|Overall Study|Randomized- never received study drug|0
7308791|NCT00662909|11533869|FG002|Overall Study|Randomized- never received study drug|0
7308792|NCT00662909|11533867|FG000|Overall Study|Non-compliance with study procedures|3
7308793|NCT00662909|11533868|FG001|Overall Study|Non-compliance with study procedures|3
7308794|NCT00662909|11533869|FG002|Overall Study|Non-compliance with study procedures|2
7308795|NCT00662909|11533867|FG000|Overall Study|Physician Decision|1
7308796|NCT00662909|11533868|FG001|Overall Study|Physician Decision|1
7308797|NCT00662909|11533869|FG002|Overall Study|Physician Decision|2
7308798|NCT00662909|11533867|FG000|Overall Study|Eligibility criterion not met|0
7308799|NCT00662909|11533868|FG001|Overall Study|Eligibility criterion not met|1
7308800|NCT00662909|11533869|FG002|Overall Study|Eligibility criterion not met|1
7308801|NCT00663026|11533880|FG000|Overall Study|Lost to Follow-up|1
7308802|NCT00663026|11533881|FG001|Overall Study|Lost to Follow-up|0
7308803|NCT00663026|11533882|FG002|Overall Study|Lost to Follow-up|0
7308804|NCT00663026|11533880|FG000|Overall Study|Other|1
7308805|NCT00663026|11533881|FG001|Overall Study|Other|2
7308806|NCT00663026|11533882|FG002|Overall Study|Other|0
7308807|NCT00663026|11533880|FG000|Overall Study|Adverse Event|0
7308808|NCT00663026|11533881|FG001|Overall Study|Adverse Event|2
7308809|NCT00663026|11533882|FG002|Overall Study|Adverse Event|3
7308810|NCT00663026|11533880|FG000|Overall Study|Caregiver Request|0
7308811|NCT00663026|11533881|FG001|Overall Study|Caregiver Request|2
7308812|NCT00663026|11533882|FG002|Overall Study|Caregiver Request|0
7308813|NCT00663026|11533880|FG000|Overall Study|Withdrawal by Subject|0
7308814|NCT00663026|11533881|FG001|Overall Study|Withdrawal by Subject|0
7308815|NCT00663026|11533882|FG002|Overall Study|Withdrawal by Subject|1
7308816|NCT00663117|11533901|FG000|Overall Study|Lack of Efficacy|1
7308817|NCT00663117|11533902|FG001|Overall Study|Lack of Efficacy|0
7308818|NCT00663208|11533930|FG000|Treatment Period|Lost to Follow-up|0
7308819|NCT00663208|11533931|FG001|Treatment Period|Lost to Follow-up|1
7389420|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
7389421|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
7389422|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
7389423|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
7389424|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
7389425|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
7389426|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
7389427|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
7389428|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
7389429|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
7389430|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
7389431|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
7389432|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
7389433|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
7389434|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
7389435|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
7389436|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
7389437|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
7389438|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
7389439|NCT01227824|11649042|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
7389440|NCT01227824|11649043|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7389441|NCT01227824|11649044|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
7389442|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
7389443|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
7389444|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
7308820|NCT00663208|11533932|FG002|Treatment Period|Lost to Follow-up|0
7308821|NCT00663208|11533933|FG003|Treatment Period|Lost to Follow-up|0
7308822|NCT00663208|11533934|FG004|Treatment Period|Lost to Follow-up|0
7308823|NCT00663208|11533935|FG005|Treatment Period|Lost to Follow-up|0
7308824|NCT00663208|11533936|FG006|Treatment Period|Lost to Follow-up|0
7308825|NCT00663208|11533930|FG000|Follow-up Period|Lost to Follow-up|2
7308826|NCT00663208|11533931|FG001|Follow-up Period|Lost to Follow-up|0
7308827|NCT00663208|11533932|FG002|Follow-up Period|Lost to Follow-up|3
7308828|NCT00663208|11533933|FG003|Follow-up Period|Lost to Follow-up|2
7308829|NCT00663208|11533934|FG004|Follow-up Period|Lost to Follow-up|0
7308830|NCT00663208|11533935|FG005|Follow-up Period|Lost to Follow-up|0
7308831|NCT00663208|11533936|FG006|Follow-up Period|Lost to Follow-up|0
7308832|NCT00663208|11533930|FG000|Follow-up Period|Other reason|1
7308833|NCT00663208|11533931|FG001|Follow-up Period|Other reason|0
7308834|NCT00663208|11533932|FG002|Follow-up Period|Other reason|0
7308835|NCT00663208|11533933|FG003|Follow-up Period|Other reason|0
7308836|NCT00663208|11533934|FG004|Follow-up Period|Other reason|0
7308837|NCT00663208|11533935|FG005|Follow-up Period|Other reason|0
7308838|NCT00663208|11533936|FG006|Follow-up Period|Other reason|1
7308839|NCT00663234|11533954|FG000|Overall Study|Not willing to adhere to requirements|1
7308840|NCT00663260|11533965|FG000|Overall Study|Lack of Efficacy|2
7308841|NCT00663260|11533966|FG001|Overall Study|Lack of Efficacy|0
7308842|NCT00663260|11533967|FG002|Overall Study|Lack of Efficacy|0
7308843|NCT00663260|11533965|FG000|Overall Study|Adverse Event|12
7308844|NCT00663260|11533966|FG001|Overall Study|Adverse Event|7
7308845|NCT00663260|11533967|FG002|Overall Study|Adverse Event|6
7308846|NCT00663260|11533965|FG000|Overall Study|Withdrawal by Subject|3
7308847|NCT00663260|11533966|FG001|Overall Study|Withdrawal by Subject|1
7308848|NCT00663260|11533967|FG002|Overall Study|Withdrawal by Subject|6
7308849|NCT00663260|11533965|FG000|Overall Study|Death|1
7308850|NCT00663260|11533966|FG001|Overall Study|Death|0
7308851|NCT00663260|11533967|FG002|Overall Study|Death|1
7308852|NCT00663260|11533965|FG000|Overall Study|Lost to Follow-up|0
7308853|NCT00663260|11533966|FG001|Overall Study|Lost to Follow-up|1
7308854|NCT00663260|11533967|FG002|Overall Study|Lost to Follow-up|0
7308855|NCT00663260|11533965|FG000|Overall Study|non-compliance, not met criteria, etc.|3
7308856|NCT00663260|11533966|FG001|Overall Study|non-compliance, not met criteria, etc.|2
7308857|NCT00663260|11533967|FG002|Overall Study|non-compliance, not met criteria, etc.|3
7308858|NCT00663702|11533981|FG000|Overall Study|Adverse Event|8
7308859|NCT00663702|11533982|FG001|Overall Study|Adverse Event|4
7308860|NCT00663702|11533981|FG000|Overall Study|Withdrawal by Subject|3
7308861|NCT00663702|11533982|FG001|Overall Study|Withdrawal by Subject|1
7308862|NCT00663702|11533981|FG000|Overall Study|Pregnancy|0
7308863|NCT00663702|11533982|FG001|Overall Study|Pregnancy|1
7308864|NCT00663702|11533981|FG000|Overall Study|Lost to Follow-up|3
7308865|NCT00663702|11533982|FG001|Overall Study|Lost to Follow-up|0
7308866|NCT00663702|11533981|FG000|Overall Study|Death|1
7308867|NCT00663702|11533982|FG001|Overall Study|Death|1
7308868|NCT00663702|11533981|FG000|Overall Study|Lack of Efficacy|3
7308869|NCT00663702|11533982|FG001|Overall Study|Lack of Efficacy|3
7308870|NCT00663858|11534011|FG000|Overall Study|Adverse Event|9
7308871|NCT00663858|11534012|FG001|Overall Study|Adverse Event|1
7308872|NCT00663858|11534013|FG002|Overall Study|Adverse Event|6
7308873|NCT00663858|11534011|FG000|Overall Study|Lack of Efficacy|5
7308874|NCT00663858|11534012|FG001|Overall Study|Lack of Efficacy|1
7308875|NCT00663858|11534013|FG002|Overall Study|Lack of Efficacy|3
7308876|NCT00663858|11534011|FG000|Overall Study|Withdrawal by Subject|7
7308877|NCT00663858|11534012|FG001|Overall Study|Withdrawal by Subject|3
7308878|NCT00663858|11534013|FG002|Overall Study|Withdrawal by Subject|3
7308879|NCT00663858|11534011|FG000|Overall Study|Protocol Violation|5
7308880|NCT00663858|11534012|FG001|Overall Study|Protocol Violation|3
7308881|NCT00663858|11534013|FG002|Overall Study|Protocol Violation|4
7308882|NCT00663858|11534011|FG000|Overall Study|Other|8
7308883|NCT00663858|11534012|FG001|Overall Study|Other|2
7308884|NCT00663858|11534013|FG002|Overall Study|Other|4
7308885|NCT00663871|11534023|FG000|Overall Study|Lost to Follow-up|5
7308886|NCT00663871|11534024|FG001|Overall Study|Lost to Follow-up|5
7308887|NCT00663871|11534023|FG000|Overall Study|Withdrawal by Subject|5
7308888|NCT00663871|11534024|FG001|Overall Study|Withdrawal by Subject|2
7308889|NCT00663923|11534032|FG000|Overall Study|Lost to Follow-up|2
7308890|NCT00663962|11534040|FG000|Overall Study|somnolence|1
7308891|NCT00663962|11534041|FG001|Overall Study|somnolence|0
7308892|NCT00664105|11534047|FG000|Overall Study|Death|3
7308893|NCT00664105|11534047|FG000|Overall Study|Withdrawal by Subject|5
7308894|NCT00664105|11534047|FG000|Overall Study|Adverse Event|9
7308895|NCT00664105|11534047|FG000|Overall Study|Disease progression|7
7308896|NCT00664209|11534052|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
7308897|NCT00664209|11534052|FG000|Study Treatment Period|Physician Decision|4
7308898|NCT00664209|11534052|FG000|Study Treatment Period|Withdrawal by Subject|2
7308899|NCT00664326|11534057|FG000|Overall Study|Adverse Event|14
7308900|NCT00664326|11534057|FG000|Overall Study|Noncompliance with study medication|3
7308901|NCT00664326|11534057|FG000|Overall Study|Withdrawal by Subject|1
7308902|NCT00664326|11534057|FG000|Overall Study|Physician Decision|1
7308903|NCT00664326|11534057|FG000|Overall Study|Other Reasons|3
7308904|NCT00664326|11534057|FG000|Overall Study|Death|2
7308905|NCT00664326|11534057|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
7308906|NCT00664521|11534067|FG000|Overall Study|Adverse Event|4
7308907|NCT00664521|11534068|FG001|Overall Study|Adverse Event|1
7308908|NCT00664521|11534067|FG000|Overall Study|Lost to Follow-up|1
7308909|NCT00664521|11534068|FG001|Overall Study|Lost to Follow-up|0
7308910|NCT00664521|11534067|FG000|Overall Study|Other|1
7308911|NCT00664521|11534068|FG001|Overall Study|Other|0
7308912|NCT00664534|11534076|FG000|Overall Study|Adverse Event|2
7308913|NCT00664534|11534077|FG001|Overall Study|Adverse Event|3
7308914|NCT00664534|11534076|FG000|Overall Study|Lost to Follow-up|6
7308915|NCT00664534|11534077|FG001|Overall Study|Lost to Follow-up|10
7308916|NCT00664534|11534076|FG000|Overall Study|Protocol Violation|10
7308917|NCT00664534|11534077|FG001|Overall Study|Protocol Violation|8
7308918|NCT00664534|11534076|FG000|Overall Study|Withdrawal by Subject|7
7308919|NCT00664534|11534077|FG001|Overall Study|Withdrawal by Subject|6
7308920|NCT00664534|11534076|FG000|Overall Study|Physician Decision|8
7308921|NCT00664534|11534077|FG001|Overall Study|Physician Decision|0
7308922|NCT00664534|11534076|FG000|Overall Study|Sponsor decision|8
7308923|NCT00664534|11534077|FG001|Overall Study|Sponsor decision|6
7308924|NCT00664560|11534086|FG000|Overall Study|Adverse Event|19
7308925|NCT00664560|11534087|FG001|Overall Study|Adverse Event|16
7308926|NCT00664560|11534088|FG002|Overall Study|Adverse Event|7
7308927|NCT00664560|11534086|FG000|Overall Study|Withdrawal by Subject|9
7389445|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7389446|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
7389447|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
7389448|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7389449|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
7389450|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
7389451|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7389452|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
7389453|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
7389454|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7389455|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
7389456|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
7389457|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7389458|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
7389459|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
7389460|NCT01227824|11649042|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
7389461|NCT01227824|11649043|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
7389462|NCT01227824|11649044|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
7389463|NCT01227889|11649053|FG000|Randomized Phase (RP)|Adverse Event|13
7389464|NCT01227889|11649054|FG001|Randomized Phase (RP)|Adverse Event|0
7389465|NCT01227889|11649053|FG000|Randomized Phase (RP)|Physician Decision|13
7389466|NCT01227889|11649054|FG001|Randomized Phase (RP)|Physician Decision|5
7389467|NCT01227889|11649053|FG000|Randomized Phase (RP)|Progressive Disease|135
7389468|NCT01227889|11649054|FG001|Randomized Phase (RP)|Progressive Disease|52
7389469|NCT01227889|11649053|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
7389470|NCT01227889|11649054|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
7389471|NCT01227889|11649053|FG000|Randomized Phase (RP)|Missing|1
7389472|NCT01227889|11649054|FG001|Randomized Phase (RP)|Missing|3
7389473|NCT01227889|11649053|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
7389474|NCT01227889|11649054|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
7389475|NCT01227889|11649053|FG000|Crossover Phase|Adverse Event|0
7389476|NCT01227889|11649054|FG001|Crossover Phase|Adverse Event|1
7389477|NCT01227889|11649053|FG000|Crossover Phase|Physician Decision|0
7389478|NCT01227889|11649054|FG001|Crossover Phase|Physician Decision|3
7389479|NCT01227889|11649053|FG000|Crossover Phase|Progressive Disease|0
7389480|NCT01227889|11649054|FG001|Crossover Phase|Progressive Disease|31
7389481|NCT01227889|11649053|FG000|Crossover Phase|Study Terminated By Sponsor|0
7389482|NCT01227889|11649054|FG001|Crossover Phase|Study Terminated By Sponsor|1
7389483|NCT01227889|11649053|FG000|Crossover Phase|Withdrawal by Subject|0
7389484|NCT01227889|11649054|FG001|Crossover Phase|Withdrawal by Subject|1
7389485|NCT01227902|11649072|FG000|Overall Study|Adverse Event|12
7389486|NCT01227902|11649073|FG001|Overall Study|Adverse Event|8
7389487|NCT01227902|11649074|FG002|Overall Study|Adverse Event|11
7389488|NCT01227902|11649075|FG003|Overall Study|Adverse Event|4
7389489|NCT01227902|11649072|FG000|Overall Study|Lack of Efficacy|1
7389490|NCT01227902|11649073|FG001|Overall Study|Lack of Efficacy|2
7389491|NCT01227902|11649074|FG002|Overall Study|Lack of Efficacy|2
7389492|NCT01227902|11649075|FG003|Overall Study|Lack of Efficacy|1
7389493|NCT01227902|11649072|FG000|Overall Study|Protocol Violation|1
7389494|NCT01227902|11649073|FG001|Overall Study|Protocol Violation|0
7389495|NCT01227902|11649074|FG002|Overall Study|Protocol Violation|0
7389496|NCT01227902|11649075|FG003|Overall Study|Protocol Violation|0
7389497|NCT01227902|11649072|FG000|Overall Study|Lost to Follow-up|0
7389498|NCT01227902|11649073|FG001|Overall Study|Lost to Follow-up|0
7389499|NCT01227902|11649074|FG002|Overall Study|Lost to Follow-up|1
7389500|NCT01227902|11649075|FG003|Overall Study|Lost to Follow-up|2
7389501|NCT01227902|11649072|FG000|Overall Study|Physician Decision|0
7389502|NCT01227902|11649073|FG001|Overall Study|Physician Decision|1
7389503|NCT01227902|11649074|FG002|Overall Study|Physician Decision|1
7389504|NCT01227902|11649075|FG003|Overall Study|Physician Decision|0
7389505|NCT01227902|11649072|FG000|Overall Study|Withdrawal by Subject|4
7389506|NCT01227902|11649073|FG001|Overall Study|Withdrawal by Subject|2
7389507|NCT01227902|11649074|FG002|Overall Study|Withdrawal by Subject|4
7389508|NCT01227902|11649075|FG003|Overall Study|Withdrawal by Subject|3
7389509|NCT01227928|11649088|FG000|Overall Study|Lost to Follow-up|4
7389510|NCT01227928|11649089|FG001|Overall Study|Lost to Follow-up|2
7389511|NCT01227928|11649088|FG000|Overall Study|Withdrawal by Subject|4
7308928|NCT00664560|11534087|FG001|Overall Study|Withdrawal by Subject|13
7308929|NCT00664560|11534088|FG002|Overall Study|Withdrawal by Subject|7
7308930|NCT00664560|11534086|FG000|Overall Study|Lost to Follow-up|0
7308931|NCT00664560|11534087|FG001|Overall Study|Lost to Follow-up|2
7308932|NCT00664560|11534088|FG002|Overall Study|Lost to Follow-up|0
7308933|NCT00664560|11534086|FG000|Overall Study|Other|11
7308934|NCT00664560|11534087|FG001|Overall Study|Other|4
7308935|NCT00664560|11534088|FG002|Overall Study|Other|5
7308936|NCT00664742|11534096|FG000|Overall Study|Withdrawn due to adverse events|3
7308937|NCT00664742|11534096|FG000|Overall Study|Withdrawal by Subject|31
7308938|NCT00664742|11534096|FG000|Overall Study|Lost to Follow-up|92
7308939|NCT00664859|11534112|FG000|Overall Study|Adverse Event|2
7308940|NCT00664859|11534113|FG001|Overall Study|Adverse Event|1
7308941|NCT00664859|11534114|FG002|Overall Study|Adverse Event|3
7308942|NCT00664859|11534112|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
7308943|NCT00664859|11534113|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7308944|NCT00664859|11534114|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
7308945|NCT00664859|11534112|FG000|Overall Study|Noncompliance with protocol|1
7308946|NCT00664859|11534113|FG001|Overall Study|Noncompliance with protocol|0
7389512|NCT01227928|11649089|FG001|Overall Study|Withdrawal by Subject|3
7389513|NCT01227928|11649088|FG000|Overall Study|Death|14
7389514|NCT01227928|11649089|FG001|Overall Study|Death|12
7389515|NCT01227954|11649095|FG000|Overall Study|Protocol Violation|6
7389516|NCT01227954|11649095|FG000|Overall Study|No protocol treatment|7
7389517|NCT01227967|11649101|FG000|Overall Study|Protocol Violation|3
7389518|NCT01227967|11649102|FG001|Overall Study|Protocol Violation|1
7389519|NCT01227967|11649101|FG000|Overall Study|Death|0
7389520|NCT01227967|11649102|FG001|Overall Study|Death|1
7389521|NCT01227967|11649101|FG000|Overall Study|Lost to Follow-up|8
7389522|NCT01227967|11649102|FG001|Overall Study|Lost to Follow-up|3
7389523|NCT01227967|11649101|FG000|Overall Study|Withdrawal by Subject|4
7389524|NCT01227967|11649102|FG001|Overall Study|Withdrawal by Subject|3
7389525|NCT01227967|11649101|FG000|Overall Study|Physician Decision|0
7389526|NCT01227967|11649102|FG001|Overall Study|Physician Decision|1
7389527|NCT01227967|11649101|FG000|Overall Study|Never Started Treatment|0
7389528|NCT01227967|11649102|FG001|Overall Study|Never Started Treatment|4
7389529|NCT01227967|11649101|FG000|Overall Study|Taking Additional Antiviral Drug|1
7389530|NCT01227967|11649102|FG001|Overall Study|Taking Additional Antiviral Drug|0
7389531|NCT01228019|11649121|FG000|Overall Study|Dose Violation|70
7389532|NCT01228019|11649121|FG000|Overall Study|Duplicate enrollment|1
7389533|NCT01228019|11649121|FG000|Overall Study|Missing pre-treatment data|72
7389534|NCT01228019|11649121|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
7389535|NCT01228019|11649121|FG000|Overall Study|Violation of Entry Criterion|9
7389536|NCT01228071|11649125|FG000|Overall Study|Protocol Violation|1
7389537|NCT01228071|11649125|FG000|Overall Study|Withdrawal by Subject|1
7389538|NCT01228175|11649147|FG000|Overall Study|Lost to Follow-up|64
7389539|NCT01228175|11649148|FG001|Overall Study|Lost to Follow-up|50
7389540|NCT01228175|11649147|FG000|Overall Study|Withdrawal by Subject|1
7389541|NCT01228175|11649148|FG001|Overall Study|Withdrawal by Subject|2
7389542|NCT01228175|11649147|FG000|Overall Study|Physician Decision|1
7389543|NCT01228175|11649148|FG001|Overall Study|Physician Decision|1
7389544|NCT01228318|11649156|FG000|Overall Study|Clinic no show to receive intervention|1
7389545|NCT01228318|11649157|FG001|Overall Study|Clinic no show to receive intervention|0
7389546|NCT01228318|11649156|FG000|Overall Study|Unable to contact|2
7389547|NCT01228318|11649157|FG001|Overall Study|Unable to contact|5
7389548|NCT01228318|11649156|FG000|Overall Study|Moved|0
7389549|NCT01228318|11649157|FG001|Overall Study|Moved|2
7389550|NCT01228318|11649156|FG000|Overall Study|Incarcerated|1
7389551|NCT01228318|11649157|FG001|Overall Study|Incarcerated|0
7389552|NCT01228591|11649172|FG000|Baseline|Lack of Efficacy|1
7389553|NCT01228591|11649173|FG001|Baseline|Lack of Efficacy|2
7389554|NCT01228734|11649185|FG000|Overall Study|Randomized, but not treated|0
7389555|NCT01228734|11649186|FG001|Overall Study|Randomized, but not treated|4
7389556|NCT01228747|11649194|FG000|Overall Study|Adverse Event|8
7389557|NCT01228747|11649195|FG001|Overall Study|Adverse Event|4
7389558|NCT01228747|11649194|FG000|Overall Study|Lack of Efficacy|40
7389559|NCT01228747|11649195|FG001|Overall Study|Lack of Efficacy|27
7389560|NCT01228747|11649194|FG000|Overall Study|Protocol Violation|6
7389561|NCT01228747|11649195|FG001|Overall Study|Protocol Violation|5
7389562|NCT01228747|11649194|FG000|Overall Study|Lost to Follow-up|4
7389563|NCT01228747|11649195|FG001|Overall Study|Lost to Follow-up|3
7389564|NCT01228747|11649194|FG000|Overall Study|Withdrawal by Subject|5
7389565|NCT01228747|11649195|FG001|Overall Study|Withdrawal by Subject|1
7389566|NCT01228747|11649194|FG000|Overall Study|Other Reason|2
7389567|NCT01228747|11649195|FG001|Overall Study|Other Reason|5
7389568|NCT01229111|11649227|FG000|Overall Study|Death|1
7389569|NCT01229150|11649235|FG000|Overall Study|Toxicity|2
7389570|NCT01229150|11649236|FG001|Overall Study|Toxicity|2
7389571|NCT01229150|11649237|FG002|Overall Study|Toxicity|0
7389572|NCT01229150|11649238|FG003|Overall Study|Toxicity|0
7389573|NCT01229176|11649260|FG000|Overall Study|Withdrawal by Subject|0
7389574|NCT01229176|11649261|FG001|Overall Study|Withdrawal by Subject|0
7389575|NCT01229176|11649262|FG002|Overall Study|Withdrawal by Subject|0
7389576|NCT01229176|11649263|FG003|Overall Study|Withdrawal by Subject|1
7389577|NCT01229176|11649264|FG004|Overall Study|Withdrawal by Subject|1
7389578|NCT01229176|11649265|FG005|Overall Study|Withdrawal by Subject|1
7389579|NCT01229176|11649266|FG006|Overall Study|Withdrawal by Subject|0
7308947|NCT00664859|11534114|FG002|Overall Study|Noncompliance with protocol|4
7308948|NCT00664859|11534112|FG000|Overall Study|Laboratory abnormality|2
7308949|NCT00664859|11534113|FG001|Overall Study|Laboratory abnormality|1
7308950|NCT00664859|11534114|FG002|Overall Study|Laboratory abnormality|4
7308951|NCT00664859|11534112|FG000|Overall Study|Withdrawal by Subject|4
7308952|NCT00664859|11534113|FG001|Overall Study|Withdrawal by Subject|1
7308953|NCT00664859|11534114|FG002|Overall Study|Withdrawal by Subject|3
7308954|NCT00664859|11534112|FG000|Overall Study|Lost to Follow-up|2
7308955|NCT00664859|11534113|FG001|Overall Study|Lost to Follow-up|2
7308956|NCT00664859|11534114|FG002|Overall Study|Lost to Follow-up|1
7308957|NCT00664859|11534112|FG000|Overall Study|Other|0
7308958|NCT00664859|11534113|FG001|Overall Study|Other|1
7308959|NCT00664859|11534114|FG002|Overall Study|Other|2
7308960|NCT00665002|11534122|FG000|Overall Study|Progression/relapse during treatment|11
7308961|NCT00665002|11534122|FG000|Overall Study|Cytogenetic resistance|1
7308962|NCT00665353|11534130|FG000|Study Step 1|Adverse Event|1
7308963|NCT00665353|11534130|FG000|Study Step 1|Withdrawal by Subject|2
7308964|NCT00665353|11534130|FG000|Study Step 2|Lost to Follow-up|2
7308965|NCT00665353|11534130|FG000|Study Step 2|Lack of Efficacy|12
7308966|NCT00665366|11534136|FG000|Overall Study|Lack of Efficacy|11
7308967|NCT00665366|11534137|FG001|Overall Study|Lack of Efficacy|10
7308968|NCT00665366|11534136|FG000|Overall Study|Adverse Event|25
7308969|NCT00665366|11534137|FG001|Overall Study|Adverse Event|23
7308970|NCT00665366|11534136|FG000|Overall Study|Withdrawal by Subject|11
7308971|NCT00665366|11534137|FG001|Overall Study|Withdrawal by Subject|14
7308972|NCT00665366|11534136|FG000|Overall Study|Lost to Follow-up|3
7308973|NCT00665366|11534137|FG001|Overall Study|Lost to Follow-up|5
7308974|NCT00665366|11534136|FG000|Overall Study|Poor compliance/noncompliance|3
7308975|NCT00665366|11534137|FG001|Overall Study|Poor compliance/noncompliance|5
7308976|NCT00665366|11534136|FG000|Overall Study|Pregnancy|1
7308977|NCT00665366|11534137|FG001|Overall Study|Pregnancy|0
7308978|NCT00665366|11534136|FG000|Overall Study|No longer meets study criteria|0
7308979|NCT00665366|11534137|FG001|Overall Study|No longer meets study criteria|1
7308980|NCT00665366|11534136|FG000|Overall Study|Other reasons|4
7308981|NCT00665366|11534137|FG001|Overall Study|Other reasons|1
7308982|NCT00665392|11534143|FG000|Overall Study|not treated|1
7308983|NCT00665431|11534151|FG000|Overall Study|Adverse Event|16
7308984|NCT00665431|11534152|FG001|Overall Study|Adverse Event|22
7308985|NCT00665431|11534153|FG002|Overall Study|Adverse Event|6
7308986|NCT00665431|11534151|FG000|Overall Study|Withdrawal by Subject|17
7308987|NCT00665431|11534152|FG001|Overall Study|Withdrawal by Subject|25
7308988|NCT00665431|11534153|FG002|Overall Study|Withdrawal by Subject|15
7308989|NCT00665431|11534151|FG000|Overall Study|Lost to Follow-up|3
7308990|NCT00665431|11534152|FG001|Overall Study|Lost to Follow-up|3
7308991|NCT00665431|11534153|FG002|Overall Study|Lost to Follow-up|1
7308992|NCT00665431|11534151|FG000|Overall Study|Other|4
7308993|NCT00665431|11534152|FG001|Overall Study|Other|7
7308994|NCT00665431|11534153|FG002|Overall Study|Other|2
7308995|NCT00665561|11534176|FG000|Overall Study|Death recorded on subject summary pages|75
7308996|NCT00665561|11534177|FG001|Overall Study|Death recorded on subject summary pages|75
7308997|NCT00665561|11534176|FG000|Overall Study|Does not meet entrance criteria|19
7308998|NCT00665561|11534177|FG001|Overall Study|Does not meet entrance criteria|21
7308999|NCT00665561|11534176|FG000|Overall Study|Lost to Follow-up|203
7309000|NCT00665561|11534177|FG001|Overall Study|Lost to Follow-up|264
7309001|NCT00665561|11534176|FG000|Overall Study|Withdrawal by Subject|74
7309002|NCT00665561|11534177|FG001|Overall Study|Withdrawal by Subject|65
7309003|NCT00665561|11534176|FG000|Overall Study|Other|123
7309004|NCT00665561|11534177|FG001|Overall Study|Other|108
7309005|NCT00665561|11534176|FG000|Overall Study|Site closed|8
7309006|NCT00665561|11534177|FG001|Overall Study|Site closed|0
7309007|NCT00665561|11534176|FG000|Overall Study|Withdrawn due to pregnancy|0
7309008|NCT00665561|11534177|FG001|Overall Study|Withdrawn due to pregnancy|1
7309009|NCT00665626|11534185|FG000|Overall Study|Lack of Efficacy|8
7309010|NCT00665626|11534186|FG001|Overall Study|Lack of Efficacy|5
7309011|NCT00665626|11534185|FG000|Overall Study|Lost to Follow-up|0
7309012|NCT00665626|11534186|FG001|Overall Study|Lost to Follow-up|2
7309013|NCT00665626|11534185|FG000|Overall Study|Withdrawal by Subject|0
7309014|NCT00665626|11534186|FG001|Overall Study|Withdrawal by Subject|1
7309015|NCT00665626|11534185|FG000|Overall Study|Protocol Violation|0
7309016|NCT00665626|11534186|FG001|Overall Study|Protocol Violation|2
7309017|NCT00665626|11534185|FG000|Overall Study|Adverse Event|1
7309018|NCT00665626|11534186|FG001|Overall Study|Adverse Event|9
7309019|NCT00665626|11534185|FG000|Overall Study|Due to exclusion criteria|0
7309020|NCT00665626|11534186|FG001|Overall Study|Due to exclusion criteria|1
7309021|NCT00665626|11534185|FG000|Overall Study|Did not fulfil inclusion criteria|0
7309022|NCT00665626|11534186|FG001|Overall Study|Did not fulfil inclusion criteria|1
7309023|NCT00665626|11534185|FG000|Overall Study|Unably to comply with dosing regimen|0
7309024|NCT00665626|11534186|FG001|Overall Study|Unably to comply with dosing regimen|1
7309025|NCT00665626|11534185|FG000|Overall Study|Death|1
7309026|NCT00665626|11534186|FG001|Overall Study|Death|0
7309027|NCT00665652|11534192|FG000|Overall Study|Adverse Event|4
7309028|NCT00665652|11534192|FG000|Overall Study|Death|1
7309029|NCT00665652|11534192|FG000|Overall Study|No longer met inclusion criteria.|1
7309030|NCT00665847|11534200|FG000|Overall Study|Adverse Event|8
7309031|NCT00665847|11534200|FG000|Overall Study|Withdrawal by Subject|2
7309032|NCT00665847|11534200|FG000|Overall Study|Subject non-compliant|8
7309033|NCT00665847|11534200|FG000|Overall Study|Subject reached a virologic endpoint|4
7309034|NCT00665847|11534200|FG000|Overall Study|Resistance to TMC125|1
7309035|NCT00665847|11534200|FG000|Overall Study|Subject ineligible to continue the trial|1
7309036|NCT00665847|11534200|FG000|Overall Study|Switch to Commercial Medication|1
7309037|NCT00665925|11534208|FG000|Overall Study|Lack of Efficacy|10
7309038|NCT00665925|11534209|FG001|Overall Study|Lack of Efficacy|8
7309039|NCT00665925|11534210|FG002|Overall Study|Lack of Efficacy|9
7309040|NCT00665925|11534211|FG003|Overall Study|Lack of Efficacy|8
7309041|NCT00665925|11534208|FG000|Overall Study|Lost to Follow-up|1
7309042|NCT00665925|11534209|FG001|Overall Study|Lost to Follow-up|2
7309043|NCT00665925|11534210|FG002|Overall Study|Lost to Follow-up|2
7309044|NCT00665925|11534211|FG003|Overall Study|Lost to Follow-up|2
7309045|NCT00665925|11534208|FG000|Overall Study|Withdrawal by Subject|2
7389580|NCT01229176|11649267|FG007|Overall Study|Withdrawal by Subject|1
7389581|NCT01229176|11649260|FG000|Overall Study|Lost to Follow-up|0
7389582|NCT01229176|11649261|FG001|Overall Study|Lost to Follow-up|3
7389583|NCT01229176|11649262|FG002|Overall Study|Lost to Follow-up|0
7389584|NCT01229176|11649263|FG003|Overall Study|Lost to Follow-up|0
7389585|NCT01229176|11649264|FG004|Overall Study|Lost to Follow-up|1
7309046|NCT00665925|11534209|FG001|Overall Study|Withdrawal by Subject|2
7309047|NCT00665925|11534210|FG002|Overall Study|Withdrawal by Subject|3
7309048|NCT00665925|11534211|FG003|Overall Study|Withdrawal by Subject|2
7309049|NCT00665925|11534208|FG000|Overall Study|Physician Decision|0
7309050|NCT00665925|11534209|FG001|Overall Study|Physician Decision|0
7309051|NCT00665925|11534210|FG002|Overall Study|Physician Decision|1
7309052|NCT00665925|11534211|FG003|Overall Study|Physician Decision|2
7309053|NCT00665925|11534208|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7309054|NCT00665925|11534209|FG001|Overall Study|Severe Non-Compliance to Protocol|0
7309055|NCT00665925|11534210|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7309056|NCT00665925|11534211|FG003|Overall Study|Severe Non-Compliance to Protocol|1
7309057|NCT00665925|11534208|FG000|Overall Study|Adverse Event|1
7309058|NCT00665925|11534209|FG001|Overall Study|Adverse Event|5
7309059|NCT00665925|11534210|FG002|Overall Study|Adverse Event|10
7309060|NCT00665925|11534211|FG003|Overall Study|Adverse Event|5
7309061|NCT00665925|11534208|FG000|Overall Study|Enrolled by mistake|0
7309062|NCT00665925|11534209|FG001|Overall Study|Enrolled by mistake|0
7309063|NCT00665925|11534210|FG002|Overall Study|Enrolled by mistake|0
7309064|NCT00665925|11534211|FG003|Overall Study|Enrolled by mistake|1
7309065|NCT00665925|11534208|FG000|Overall Study|Due to exclusion criteria|1
7309066|NCT00665925|11534209|FG001|Overall Study|Due to exclusion criteria|0
7309067|NCT00665925|11534210|FG002|Overall Study|Due to exclusion criteria|0
7309068|NCT00665925|11534211|FG003|Overall Study|Due to exclusion criteria|0
7309069|NCT00666198|11534232|FG000|Overall Study|Protocol Violation|10
7309070|NCT00666198|11534232|FG000|Overall Study|No Visit After First Day of Treatment|13
7309071|NCT00666198|11534232|FG000|Overall Study|Safety Not Assessable|6
7309072|NCT00666198|11534232|FG000|Overall Study|No Drug Administration|4
7309073|NCT00666211|11534238|FG000|Overall Study|Withdrawal by Subject|10
7309074|NCT00666211|11534239|FG001|Overall Study|Withdrawal by Subject|13
7309075|NCT00666211|11534238|FG000|Overall Study|went off medication, no more pain|1
7309076|NCT00666211|11534239|FG001|Overall Study|went off medication, no more pain|0
7309077|NCT00666211|11534238|FG000|Overall Study|patient non-compliant|6
7309078|NCT00666211|11534239|FG001|Overall Study|patient non-compliant|6
7309079|NCT00666211|11534238|FG000|Overall Study|disease progression|1
7309080|NCT00666211|11534239|FG001|Overall Study|disease progression|8
7309081|NCT00666211|11534238|FG000|Overall Study|Lost to Follow-up|2
7309082|NCT00666211|11534239|FG001|Overall Study|Lost to Follow-up|0
7309083|NCT00666211|11534238|FG000|Overall Study|toxicity|0
7309084|NCT00666211|11534239|FG001|Overall Study|toxicity|2
7309085|NCT00666211|11534238|FG000|Overall Study|hospital admission|0
7309086|NCT00666211|11534239|FG001|Overall Study|hospital admission|5
7309087|NCT00666211|11534238|FG000|Overall Study|Death|0
7309088|NCT00666211|11534239|FG001|Overall Study|Death|2
7309089|NCT00666211|11534238|FG000|Overall Study|off tx for other complicating disease|0
7309090|NCT00666211|11534239|FG001|Overall Study|off tx for other complicating disease|1
7309091|NCT00666211|11534238|FG000|Overall Study|Physician Decision|0
7309092|NCT00666211|11534239|FG001|Overall Study|Physician Decision|1
7309093|NCT00666224|11534247|FG000|Double-Blind|Adverse Event|15
7309094|NCT00666224|11534248|FG001|Double-Blind|Adverse Event|5
7309095|NCT00666224|11534247|FG000|Double-Blind|Lost to Follow-up|2
7309096|NCT00666224|11534248|FG001|Double-Blind|Lost to Follow-up|2
7309097|NCT00666224|11534247|FG000|Double-Blind|Withdrawal by Subject|18
7309098|NCT00666224|11534248|FG001|Double-Blind|Withdrawal by Subject|14
7309099|NCT00666224|11534247|FG000|Double-Blind|Physician Decision|0
7309100|NCT00666224|11534248|FG001|Double-Blind|Physician Decision|3
7309101|NCT00666224|11534247|FG000|Double-Blind|Sponsor decision|1
7309102|NCT00666224|11534248|FG001|Double-Blind|Sponsor decision|0
7309103|NCT00666224|11534247|FG000|Double-Blind|Pregnancy|3
7309104|NCT00666224|11534248|FG001|Double-Blind|Pregnancy|2
7309105|NCT00666224|11534247|FG000|Double-Blind|Noncompliance|1
7309106|NCT00666224|11534248|FG001|Double-Blind|Noncompliance|0
7389586|NCT01229176|11649265|FG005|Overall Study|Lost to Follow-up|1
7309107|NCT00666224|11534247|FG000|Double-Blind|Death|1
7309108|NCT00666224|11534248|FG001|Double-Blind|Death|0
7309109|NCT00666224|11534247|FG000|Double-Blind|Undefined/Unknown|4
7309110|NCT00666224|11534248|FG001|Double-Blind|Undefined/Unknown|1
7309111|NCT00666224|11534247|FG000|Open-Label|Adverse Event|8
7309112|NCT00666224|11534248|FG001|Open-Label|Adverse Event|43
7309113|NCT00666224|11534247|FG000|Open-Label|Lost to Follow-up|4
7309114|NCT00666224|11534248|FG001|Open-Label|Lost to Follow-up|5
7309115|NCT00666224|11534247|FG000|Open-Label|Withdrawal by Subject|12
7309116|NCT00666224|11534248|FG001|Open-Label|Withdrawal by Subject|25
7309117|NCT00666224|11534247|FG000|Open-Label|Physician Decision|7
7309118|NCT00666224|11534248|FG001|Open-Label|Physician Decision|5
7309119|NCT00666224|11534247|FG000|Open-Label|Pregnancy|1
7309120|NCT00666224|11534248|FG001|Open-Label|Pregnancy|5
7309121|NCT00666224|11534247|FG000|Open-Label|Noncompliance|2
7309122|NCT00666224|11534248|FG001|Open-Label|Noncompliance|1
7309123|NCT00666224|11534247|FG000|Open-Label|Undefined/Unknown|1
7309124|NCT00666224|11534248|FG001|Open-Label|Undefined/Unknown|1
7309125|NCT00666263|11534255|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
7309126|NCT00666263|11534256|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
7309127|NCT00666263|11534255|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
7309128|NCT00666263|11534256|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
7309129|NCT00666263|11534255|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
7309130|NCT00666263|11534256|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
7309131|NCT00666276|11534301|FG000|Overall Study|Protocol Violation|34
7309132|NCT00666328|11534324|FG000|Overall Study|Death|2
7309133|NCT00666328|11534324|FG000|Overall Study|Lost to Follow-up|2
7309134|NCT00666328|11534324|FG000|Overall Study|No longer met eligibility criteria|1
7309135|NCT00666458|11534338|FG000|Overall Study|Adverse Event|8
7309136|NCT00666458|11534339|FG001|Overall Study|Adverse Event|7
7309137|NCT00666458|11534338|FG000|Overall Study|Withdrawal by Subject|5
7309138|NCT00666458|11534339|FG001|Overall Study|Withdrawal by Subject|4
7309139|NCT00666458|11534338|FG000|Overall Study|Lost to Follow-up|0
7309140|NCT00666458|11534339|FG001|Overall Study|Lost to Follow-up|3
7309141|NCT00666458|11534338|FG000|Overall Study|Administrative reason by sponsor|1
7309142|NCT00666458|11534339|FG001|Overall Study|Administrative reason by sponsor|1
7309143|NCT00666458|11534338|FG000|Overall Study|Incorrect enrollment|7
7309144|NCT00666458|11534339|FG001|Overall Study|Incorrect enrollment|1
7309145|NCT00666458|11534338|FG000|Overall Study|Study specific discontinuation criteria|14
7309146|NCT00666458|11534339|FG001|Overall Study|Study specific discontinuation criteria|7
7309147|NCT00666458|11534338|FG000|Overall Study|Severe non-compliance to the protocol|1
7309148|NCT00666458|11534339|FG001|Overall Study|Severe non-compliance to the protocol|1
7309149|NCT00666458|11534338|FG000|Overall Study|Safety reasons|1
7389587|NCT01229176|11649266|FG006|Overall Study|Lost to Follow-up|0
7389588|NCT01229176|11649267|FG007|Overall Study|Lost to Follow-up|2
7465140|NCT01878097|11764198|FG000|Baseline|Surveys not fully completed|2497
7465141|NCT01878097|11764199|FG001|Baseline|Surveys not fully completed|1800
7465142|NCT01878097|11764198|FG000|Implementation Year 1|Surveys not fully completed|3202
7465143|NCT01878097|11764199|FG001|Implementation Year 1|Surveys not fully completed|2549
7465144|NCT01878097|11764198|FG000|Implementation Year 2|Surveys not fully completed|3281
7465145|NCT01878097|11764199|FG001|Implementation Year 2|Surveys not fully completed|2841
7465146|NCT01878097|11764198|FG000|Implementation Year 3|Surveys not fully completed|3494
7465147|NCT01878097|11764199|FG001|Implementation Year 3|Surveys not fully completed|2980
7465148|NCT01878097|11764198|FG000|Implementation Year 4|Surveys not fully completed|3604
7465149|NCT01878097|11764199|FG001|Implementation Year 4|Surveys not fully completed|3007
7465150|NCT01878149|11764207|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
7465151|NCT01878149|11764208|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
7465152|NCT01878175|11764214|FG000|Overall Study|Developed contraindicated health problem|2
7465153|NCT01878214|11764221|FG000|Overall Study|Withdrawal by Subject|18
7465154|NCT01878214|11764222|FG001|Overall Study|Withdrawal by Subject|7
7465155|NCT01878214|11764221|FG000|Overall Study|Death|0
7465156|NCT01878214|11764222|FG001|Overall Study|Death|1
7465157|NCT01878214|11764221|FG000|Overall Study|Lost to Follow-up|35
7465158|NCT01878214|11764222|FG001|Overall Study|Lost to Follow-up|36
7465159|NCT01878253|11764228|FG000|Overall Study|Death|1
7465160|NCT01878253|11764228|FG000|Overall Study|SIdus System Removal|3
7465161|NCT01878253|11764228|FG000|Overall Study|Withdrawal by Subject|1
7465162|NCT01878253|11764228|FG000|Overall Study|Lost to Follow-up|2
7465163|NCT01878253|11764228|FG000|Overall Study|Completed Study w/o Follow-up Data|2
7465164|NCT01878292|11764240|FG000|Randomized|Protocol Violation|1
7465165|NCT01878292|11764241|FG001|Randomized|Protocol Violation|0
7465166|NCT01878292|11764242|FG002|Randomized|Protocol Violation|0
7465167|NCT01878292|11764240|FG000|Randomized|Lost to Follow-up|1
7465168|NCT01878292|11764241|FG001|Randomized|Lost to Follow-up|0
7465169|NCT01878292|11764242|FG002|Randomized|Lost to Follow-up|0
7465170|NCT01878292|11764240|FG000|Randomized|Adverse Event|1
7465171|NCT01878292|11764241|FG001|Randomized|Adverse Event|0
7465172|NCT01878292|11764242|FG002|Randomized|Adverse Event|0
7465173|NCT01878292|11764240|FG000|Double-blind Treatment Period|Other Reasons|2
7465174|NCT01878292|11764241|FG001|Double-blind Treatment Period|Other Reasons|0
7465175|NCT01878292|11764242|FG002|Double-blind Treatment Period|Other Reasons|0
7465176|NCT01878292|11764240|FG000|Double-blind Treatment Period|Lost to Follow-up|6
7309150|NCT00666458|11534339|FG001|Overall Study|Safety reasons|0
7309151|NCT00666458|11534338|FG000|Overall Study|Medical history of anemia|1
7309152|NCT00666458|11534339|FG001|Overall Study|Medical history of anemia|0
7309153|NCT00666536|11534347|FG000|Overall Study|Adverse Event|9
7309154|NCT00666536|11534348|FG001|Overall Study|Adverse Event|19
7309155|NCT00666536|11534347|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7309156|NCT00666536|11534348|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7309157|NCT00666536|11534347|FG000|Overall Study|Protocol deviation(s)|8
7309158|NCT00666536|11534348|FG001|Overall Study|Protocol deviation(s)|6
7309159|NCT00666536|11534347|FG000|Overall Study|Withdrawal by Subject|10
7309160|NCT00666536|11534348|FG001|Overall Study|Withdrawal by Subject|9
7309161|NCT00666536|11534347|FG000|Overall Study|Lost to Follow-up|4
7309162|NCT00666536|11534348|FG001|Overall Study|Lost to Follow-up|3
7309163|NCT00666562|11534357|FG000|Overall Study|Withdrawal by Subject|0
7309164|NCT00666562|11534358|FG001|Overall Study|Withdrawal by Subject|1
7309165|NCT00666562|11534359|FG002|Overall Study|Withdrawal by Subject|0
7309166|NCT00666562|11534357|FG000|Overall Study|Concomitant Medication|0
7309167|NCT00666562|11534358|FG001|Overall Study|Concomitant Medication|1
7309168|NCT00666562|11534359|FG002|Overall Study|Concomitant Medication|0
7309169|NCT00666588|11534378|FG000|Overall Study|ineligible|2
7309170|NCT00666588|11534379|FG001|Overall Study|ineligible|0
7309171|NCT00666588|11534380|FG002|Overall Study|ineligible|0
7309172|NCT00666588|11534381|FG003|Overall Study|ineligible|2
7309173|NCT00666588|11534378|FG000|Overall Study|inevaluable|2
7309174|NCT00666588|11534379|FG001|Overall Study|inevaluable|0
7309175|NCT00666588|11534380|FG002|Overall Study|inevaluable|0
7389589|NCT01229254|11649309|FG000|Overall Study|Not Continuing Into Safety Extension|3
7389590|NCT01229254|11649310|FG001|Overall Study|Not Continuing Into Safety Extension|1
7389591|NCT01229254|11649311|FG002|Overall Study|Not Continuing Into Safety Extension|1
7389592|NCT01229254|11649309|FG000|Overall Study|Adverse Event|4
7389593|NCT01229254|11649310|FG001|Overall Study|Adverse Event|5
7389594|NCT01229254|11649311|FG002|Overall Study|Adverse Event|3
7389595|NCT01229254|11649309|FG000|Overall Study|Lost to Follow-up|3
7389596|NCT01229254|11649310|FG001|Overall Study|Lost to Follow-up|0
7389597|NCT01229254|11649311|FG002|Overall Study|Lost to Follow-up|1
7389598|NCT01229254|11649309|FG000|Overall Study|Physician Decision|0
7389599|NCT01229254|11649310|FG001|Overall Study|Physician Decision|3
7389600|NCT01229254|11649311|FG002|Overall Study|Physician Decision|0
7389601|NCT01229254|11649309|FG000|Overall Study|Protocol Violation|4
7389602|NCT01229254|11649310|FG001|Overall Study|Protocol Violation|6
7389603|NCT01229254|11649311|FG002|Overall Study|Protocol Violation|5
7389604|NCT01229254|11649309|FG000|Overall Study|Withdrawal by Subject|1
7389605|NCT01229254|11649310|FG001|Overall Study|Withdrawal by Subject|0
7389606|NCT01229254|11649311|FG002|Overall Study|Withdrawal by Subject|1
7389607|NCT01229254|11649309|FG000|Overall Study|Non-compliance with Study Drug|0
7389608|NCT01229254|11649310|FG001|Overall Study|Non-compliance with Study Drug|1
7389609|NCT01229254|11649311|FG002|Overall Study|Non-compliance with Study Drug|1
7389610|NCT01229267|11649325|FG000|Overall Study|Adverse Event|4
7389611|NCT01229267|11649326|FG001|Overall Study|Adverse Event|6
7389612|NCT01229267|11649327|FG002|Overall Study|Adverse Event|3
7389613|NCT01229267|11649328|FG003|Overall Study|Adverse Event|2
7389614|NCT01229267|11649329|FG004|Overall Study|Adverse Event|10
7389615|NCT01229267|11649325|FG000|Overall Study|Death|40
7389616|NCT01229267|11649326|FG001|Overall Study|Death|37
7389617|NCT01229267|11649327|FG002|Overall Study|Death|35
7389618|NCT01229267|11649328|FG003|Overall Study|Death|13
7389619|NCT01229267|11649329|FG004|Overall Study|Death|103
7389620|NCT01229267|11649325|FG000|Overall Study|Withdrawal by Subject|23
7389621|NCT01229267|11649326|FG001|Overall Study|Withdrawal by Subject|22
7389622|NCT01229267|11649327|FG002|Overall Study|Withdrawal by Subject|32
7389623|NCT01229267|11649328|FG003|Overall Study|Withdrawal by Subject|14
7389624|NCT01229267|11649329|FG004|Overall Study|Withdrawal by Subject|59
7389625|NCT01229267|11649325|FG000|Overall Study|Protocol Violation|0
7389626|NCT01229267|11649326|FG001|Overall Study|Protocol Violation|1
7389627|NCT01229267|11649327|FG002|Overall Study|Protocol Violation|0
7389628|NCT01229267|11649328|FG003|Overall Study|Protocol Violation|0
7389629|NCT01229267|11649329|FG004|Overall Study|Protocol Violation|0
7389630|NCT01229267|11649325|FG000|Overall Study|Progressive disease|0
7389631|NCT01229267|11649326|FG001|Overall Study|Progressive disease|0
7389632|NCT01229267|11649327|FG002|Overall Study|Progressive disease|0
7389633|NCT01229267|11649328|FG003|Overall Study|Progressive disease|0
7389634|NCT01229267|11649329|FG004|Overall Study|Progressive disease|1
7389635|NCT01229267|11649325|FG000|Overall Study|Physician Decision|8
7389636|NCT01229267|11649326|FG001|Overall Study|Physician Decision|11
7389637|NCT01229267|11649327|FG002|Overall Study|Physician Decision|8
7389638|NCT01229267|11649328|FG003|Overall Study|Physician Decision|3
7389639|NCT01229267|11649329|FG004|Overall Study|Physician Decision|25
7389640|NCT01229267|11649325|FG000|Overall Study|Lost to Follow-up|6
7389641|NCT01229267|11649326|FG001|Overall Study|Lost to Follow-up|5
7389642|NCT01229267|11649327|FG002|Overall Study|Lost to Follow-up|8
7389643|NCT01229267|11649328|FG003|Overall Study|Lost to Follow-up|3
7389644|NCT01229267|11649329|FG004|Overall Study|Lost to Follow-up|22
7309176|NCT00666588|11534381|FG003|Overall Study|inevaluable|0
7309177|NCT00666679|11534397|FG000|First Intervention|Lost to Follow-up|1
7389645|NCT01229371|11649340|FG000|Overall Study|Withdrawal by Subject|0
7389646|NCT01229371|11649341|FG001|Overall Study|Withdrawal by Subject|1
7309178|NCT00666679|11534398|FG001|First Intervention|Lost to Follow-up|0
7309179|NCT00666679|11534397|FG000|First Intervention|Protocol Violation|1
7309180|NCT00666679|11534398|FG001|First Intervention|Protocol Violation|0
7309181|NCT00666679|11534397|FG000|First Intervention|Withdrawal by Subject|1
7309182|NCT00666679|11534398|FG001|First Intervention|Withdrawal by Subject|0
7309183|NCT00666679|11534397|FG000|First Intervention|Randomized did not start treatment|1
7309184|NCT00666679|11534398|FG001|First Intervention|Randomized did not start treatment|1
7309185|NCT00666679|11534397|FG000|Washout Period of 1 Week|Lost to Follow-up|0
7309186|NCT00666679|11534398|FG001|Washout Period of 1 Week|Lost to Follow-up|1
7309187|NCT00666679|11534397|FG000|Washout Period of 1 Week|Protocol Violation|0
7309188|NCT00666679|11534398|FG001|Washout Period of 1 Week|Protocol Violation|1
7309189|NCT00666679|11534397|FG000|Second Intervention|Adverse Event|1
7309190|NCT00666679|11534398|FG001|Second Intervention|Adverse Event|0
7309191|NCT00666679|11534397|FG000|Second Intervention|Death|0
7309192|NCT00666679|11534398|FG001|Second Intervention|Death|1
7309193|NCT00666705|11534404|FG000|Overall Study|Withdrawal by Subject|1
7309194|NCT00666718|11534415|FG000|Overall Study|Adverse Event|0
7309195|NCT00666718|11534416|FG001|Overall Study|Adverse Event|1
7309196|NCT00666718|11534415|FG000|Overall Study|Death|1
7309197|NCT00666718|11534416|FG001|Overall Study|Death|0
7309198|NCT00666718|11534415|FG000|Overall Study|Lost to Follow-up|1
7309199|NCT00666718|11534416|FG001|Overall Study|Lost to Follow-up|0
7309200|NCT00666718|11534415|FG000|Overall Study|Entry Criteria Not Met|2
7309201|NCT00666718|11534416|FG001|Overall Study|Entry Criteria Not Met|0
7309202|NCT00666718|11534415|FG000|Overall Study|Protocol Violation|1
7309203|NCT00666718|11534416|FG001|Overall Study|Protocol Violation|3
7309204|NCT00666718|11534415|FG000|Overall Study|Withdrawal by Subject|7
7309205|NCT00666718|11534416|FG001|Overall Study|Withdrawal by Subject|12
7309206|NCT00666718|11534415|FG000|Overall Study|Physician Decision|0
7309207|NCT00666718|11534416|FG001|Overall Study|Physician Decision|2
7309208|NCT00666757|11534424|FG000|Overall Study|Lost to Follow-up|39
7309209|NCT00666757|11534425|FG001|Overall Study|Lost to Follow-up|35
7309210|NCT00666757|11534424|FG000|Overall Study|Protocol Violation|23
7309211|NCT00666757|11534425|FG001|Overall Study|Protocol Violation|24
7309212|NCT00666757|11534424|FG000|Overall Study|Adverse Event|22
7309213|NCT00666757|11534425|FG001|Overall Study|Adverse Event|12
7309214|NCT00666757|11534424|FG000|Overall Study|Withdrawal by Subject|13
7309215|NCT00666757|11534425|FG001|Overall Study|Withdrawal by Subject|17
7309216|NCT00666757|11534424|FG000|Overall Study|Lack of Efficacy|3
7309217|NCT00666757|11534425|FG001|Overall Study|Lack of Efficacy|6
7309218|NCT00666757|11534424|FG000|Overall Study|Physician Decision|0
7309219|NCT00666757|11534425|FG001|Overall Study|Physician Decision|2
7309220|NCT00666757|11534424|FG000|Overall Study|Sponsor decision|0
7309221|NCT00666757|11534425|FG001|Overall Study|Sponsor decision|1
7309222|NCT00666835|11534436|FG000|Overall Study|Withdrawal by Subject|5
7309223|NCT00666835|11534437|FG001|Overall Study|Withdrawal by Subject|2
7309224|NCT00666835|11534436|FG000|Overall Study|Lack of Efficacy|0
7309225|NCT00666835|11534437|FG001|Overall Study|Lack of Efficacy|1
7309226|NCT00666835|11534436|FG000|Overall Study|Incl./excl. not fulfilled|7
7309227|NCT00666835|11534437|FG001|Overall Study|Incl./excl. not fulfilled|2
7309228|NCT00666835|11534436|FG000|Overall Study|Adverse Event|7
7309229|NCT00666835|11534437|FG001|Overall Study|Adverse Event|6
7309230|NCT00666835|11534436|FG000|Overall Study|Protocol Violation|2
7309231|NCT00666835|11534437|FG001|Overall Study|Protocol Violation|0
7309232|NCT00666835|11534436|FG000|Overall Study|Death|15
7309233|NCT00666835|11534437|FG001|Overall Study|Death|4
7309234|NCT00666835|11534436|FG000|Overall Study|Kidney Transplantation (NTX)|10
7309235|NCT00666835|11534437|FG001|Overall Study|Kidney Transplantation (NTX)|2
7309236|NCT00666835|11534436|FG000|Overall Study|Hemoglobulin concentration|4
7309237|NCT00666835|11534437|FG001|Overall Study|Hemoglobulin concentration|3
7309238|NCT00666835|11534436|FG000|Overall Study|Planned operation|2
7309239|NCT00666835|11534437|FG001|Overall Study|Planned operation|0
7309240|NCT00666835|11534436|FG000|Overall Study|Physician Decision|1
7309241|NCT00666835|11534437|FG001|Overall Study|Physician Decision|2
7309242|NCT00666926|11534457|FG000|Overall Study|Adverse Event|0
7309243|NCT00666926|11534458|FG001|Overall Study|Adverse Event|0
7309244|NCT00666926|11534459|FG002|Overall Study|Adverse Event|0
7309245|NCT00666926|11534460|FG003|Overall Study|Adverse Event|0
7309246|NCT00666926|11534461|FG004|Overall Study|Adverse Event|0
7309247|NCT00666926|11534462|FG005|Overall Study|Adverse Event|0
7309248|NCT00666926|11534463|FG006|Overall Study|Adverse Event|0
7309249|NCT00666926|11534464|FG007|Overall Study|Adverse Event|0
7309250|NCT00666926|11534465|FG008|Overall Study|Adverse Event|0
7309251|NCT00666926|11534466|FG009|Overall Study|Adverse Event|2
7309252|NCT00666926|11534467|FG010|Overall Study|Adverse Event|2
7309253|NCT00666926|11534468|FG011|Overall Study|Adverse Event|2
7309254|NCT00666926|11534469|FG012|Overall Study|Adverse Event|0
7389647|NCT01229371|11649342|FG002|Overall Study|Withdrawal by Subject|0
7309255|NCT00666926|11534470|FG013|Overall Study|Adverse Event|1
7309256|NCT00666926|11534471|FG014|Overall Study|Adverse Event|0
7309257|NCT00666926|11534472|FG015|Overall Study|Adverse Event|0
7309258|NCT00666926|11534457|FG000|Overall Study|Laboratory abnormality|0
7309259|NCT00666926|11534458|FG001|Overall Study|Laboratory abnormality|0
7309260|NCT00666926|11534459|FG002|Overall Study|Laboratory abnormality|0
7309261|NCT00666926|11534460|FG003|Overall Study|Laboratory abnormality|0
7309262|NCT00666926|11534461|FG004|Overall Study|Laboratory abnormality|0
7309263|NCT00666926|11534462|FG005|Overall Study|Laboratory abnormality|0
7309264|NCT00666926|11534463|FG006|Overall Study|Laboratory abnormality|0
7309265|NCT00666926|11534464|FG007|Overall Study|Laboratory abnormality|0
7309266|NCT00666926|11534465|FG008|Overall Study|Laboratory abnormality|0
7309267|NCT00666926|11534466|FG009|Overall Study|Laboratory abnormality|0
7309268|NCT00666926|11534467|FG010|Overall Study|Laboratory abnormality|1
7309269|NCT00666926|11534468|FG011|Overall Study|Laboratory abnormality|0
7309270|NCT00666926|11534469|FG012|Overall Study|Laboratory abnormality|0
7309271|NCT00666926|11534470|FG013|Overall Study|Laboratory abnormality|0
7309272|NCT00666926|11534471|FG014|Overall Study|Laboratory abnormality|0
7309273|NCT00666926|11534472|FG015|Overall Study|Laboratory abnormality|1
7309274|NCT00666926|11534457|FG000|Overall Study|Lack of Efficacy|0
7309275|NCT00666926|11534458|FG001|Overall Study|Lack of Efficacy|0
7309276|NCT00666926|11534459|FG002|Overall Study|Lack of Efficacy|0
7309277|NCT00666926|11534460|FG003|Overall Study|Lack of Efficacy|0
7309278|NCT00666926|11534461|FG004|Overall Study|Lack of Efficacy|0
7309279|NCT00666926|11534462|FG005|Overall Study|Lack of Efficacy|1
7309280|NCT00666926|11534463|FG006|Overall Study|Lack of Efficacy|0
7309281|NCT00666926|11534464|FG007|Overall Study|Lack of Efficacy|0
7309282|NCT00666926|11534465|FG008|Overall Study|Lack of Efficacy|0
7309283|NCT00666926|11534466|FG009|Overall Study|Lack of Efficacy|0
7309284|NCT00666926|11534467|FG010|Overall Study|Lack of Efficacy|0
7309285|NCT00666926|11534468|FG011|Overall Study|Lack of Efficacy|1
7309286|NCT00666926|11534469|FG012|Overall Study|Lack of Efficacy|0
7309287|NCT00666926|11534470|FG013|Overall Study|Lack of Efficacy|0
7309288|NCT00666926|11534471|FG014|Overall Study|Lack of Efficacy|0
7309289|NCT00666926|11534472|FG015|Overall Study|Lack of Efficacy|0
7309290|NCT00666926|11534457|FG000|Overall Study|Lost to Follow-up|0
7309291|NCT00666926|11534458|FG001|Overall Study|Lost to Follow-up|0
7309292|NCT00666926|11534459|FG002|Overall Study|Lost to Follow-up|0
7309293|NCT00666926|11534460|FG003|Overall Study|Lost to Follow-up|1
7309294|NCT00666926|11534461|FG004|Overall Study|Lost to Follow-up|0
7309295|NCT00666926|11534462|FG005|Overall Study|Lost to Follow-up|0
7309296|NCT00666926|11534463|FG006|Overall Study|Lost to Follow-up|0
7309297|NCT00666926|11534464|FG007|Overall Study|Lost to Follow-up|0
7309298|NCT00666926|11534465|FG008|Overall Study|Lost to Follow-up|0
7309299|NCT00666926|11534466|FG009|Overall Study|Lost to Follow-up|0
7309300|NCT00666926|11534467|FG010|Overall Study|Lost to Follow-up|0
7309301|NCT00666926|11534468|FG011|Overall Study|Lost to Follow-up|0
7309302|NCT00666926|11534469|FG012|Overall Study|Lost to Follow-up|0
7309303|NCT00666926|11534470|FG013|Overall Study|Lost to Follow-up|0
7309304|NCT00666926|11534471|FG014|Overall Study|Lost to Follow-up|0
7309305|NCT00666926|11534472|FG015|Overall Study|Lost to Follow-up|0
7309306|NCT00666926|11534457|FG000|Overall Study|Other|2
7309307|NCT00666926|11534458|FG001|Overall Study|Other|4
7309308|NCT00666926|11534459|FG002|Overall Study|Other|3
7309309|NCT00666926|11534460|FG003|Overall Study|Other|3
7309310|NCT00666926|11534461|FG004|Overall Study|Other|3
7309311|NCT00666926|11534462|FG005|Overall Study|Other|3
7309312|NCT00666926|11534463|FG006|Overall Study|Other|4
7309313|NCT00666926|11534464|FG007|Overall Study|Other|0
7309314|NCT00666926|11534465|FG008|Overall Study|Other|3
7309315|NCT00666926|11534466|FG009|Overall Study|Other|5
7309316|NCT00666926|11534467|FG010|Overall Study|Other|3
7309317|NCT00666926|11534468|FG011|Overall Study|Other|26
7309318|NCT00666926|11534469|FG012|Overall Study|Other|3
7309319|NCT00666926|11534470|FG013|Overall Study|Other|2
7309320|NCT00666926|11534471|FG014|Overall Study|Other|4
7309321|NCT00666926|11534472|FG015|Overall Study|Other|4
7309322|NCT00666926|11534457|FG000|Overall Study|Withdrawal by Subject|0
7309323|NCT00666926|11534458|FG001|Overall Study|Withdrawal by Subject|0
7309324|NCT00666926|11534459|FG002|Overall Study|Withdrawal by Subject|0
7309325|NCT00666926|11534460|FG003|Overall Study|Withdrawal by Subject|0
7309326|NCT00666926|11534461|FG004|Overall Study|Withdrawal by Subject|0
7309327|NCT00666926|11534462|FG005|Overall Study|Withdrawal by Subject|0
7309328|NCT00666926|11534463|FG006|Overall Study|Withdrawal by Subject|0
7309329|NCT00666926|11534464|FG007|Overall Study|Withdrawal by Subject|1
7309330|NCT00666926|11534465|FG008|Overall Study|Withdrawal by Subject|0
7309331|NCT00666926|11534466|FG009|Overall Study|Withdrawal by Subject|3
7309332|NCT00666926|11534467|FG010|Overall Study|Withdrawal by Subject|0
7309333|NCT00666926|11534468|FG011|Overall Study|Withdrawal by Subject|3
7309334|NCT00666926|11534469|FG012|Overall Study|Withdrawal by Subject|0
7309335|NCT00666926|11534470|FG013|Overall Study|Withdrawal by Subject|1
7309336|NCT00666926|11534471|FG014|Overall Study|Withdrawal by Subject|3
7309337|NCT00666926|11534472|FG015|Overall Study|Withdrawal by Subject|3
7309338|NCT00666926|11534457|FG000|Overall Study|Death|0
7309339|NCT00666926|11534458|FG001|Overall Study|Death|0
7309340|NCT00666926|11534459|FG002|Overall Study|Death|0
7309341|NCT00666926|11534460|FG003|Overall Study|Death|0
7309342|NCT00666926|11534461|FG004|Overall Study|Death|0
7309343|NCT00666926|11534462|FG005|Overall Study|Death|0
7309344|NCT00666926|11534463|FG006|Overall Study|Death|0
7309345|NCT00666926|11534464|FG007|Overall Study|Death|0
7309346|NCT00666926|11534465|FG008|Overall Study|Death|0
7309347|NCT00666926|11534466|FG009|Overall Study|Death|0
7309348|NCT00666926|11534467|FG010|Overall Study|Death|0
7309349|NCT00666926|11534468|FG011|Overall Study|Death|1
7309350|NCT00666926|11534469|FG012|Overall Study|Death|0
7309351|NCT00666926|11534470|FG013|Overall Study|Death|0
7309352|NCT00666926|11534471|FG014|Overall Study|Death|0
7309353|NCT00666926|11534472|FG015|Overall Study|Death|0
7309354|NCT00666965|11534527|FG000|Overall Study|Adverse Event|0
7309355|NCT00666965|11534528|FG001|Overall Study|Adverse Event|2
7309356|NCT00666965|11534529|FG002|Overall Study|Adverse Event|1
7309357|NCT00666965|11534530|FG003|Overall Study|Adverse Event|9
7309358|NCT00666965|11534527|FG000|Overall Study|Lack of Efficacy|1
7309359|NCT00666965|11534528|FG001|Overall Study|Lack of Efficacy|1
7309360|NCT00666965|11534529|FG002|Overall Study|Lack of Efficacy|0
7309361|NCT00666965|11534530|FG003|Overall Study|Lack of Efficacy|0
7309362|NCT00666965|11534527|FG000|Overall Study|Protocol Violation|0
7309363|NCT00666965|11534528|FG001|Overall Study|Protocol Violation|0
7309364|NCT00666965|11534529|FG002|Overall Study|Protocol Violation|0
7309365|NCT00666965|11534530|FG003|Overall Study|Protocol Violation|2
7309366|NCT00666965|11534527|FG000|Overall Study|Discontinuation criteria|2
7309367|NCT00666965|11534528|FG001|Overall Study|Discontinuation criteria|1
7309368|NCT00666965|11534529|FG002|Overall Study|Discontinuation criteria|1
7309369|NCT00666965|11534530|FG003|Overall Study|Discontinuation criteria|2
7309370|NCT00666965|11534527|FG000|Overall Study|Withdrawal by Subject|0
7309371|NCT00666965|11534528|FG001|Overall Study|Withdrawal by Subject|0
7309372|NCT00666965|11534529|FG002|Overall Study|Withdrawal by Subject|0
7309373|NCT00666965|11534530|FG003|Overall Study|Withdrawal by Subject|2
7309374|NCT00667095|11534562|FG000|Overall Study|Withdrawal by Subject|0
7309375|NCT00667095|11534563|FG001|Overall Study|Withdrawal by Subject|1
7309376|NCT00667225|11534580|FG000|Overall Study|Subject had no more lesions to treat.|1
7309377|NCT00667225|11534581|FG001|Overall Study|Subject had no more lesions to treat.|0
7309378|NCT00667225|11534580|FG000|Overall Study|Lost to Follow-up|0
7309379|NCT00667225|11534581|FG001|Overall Study|Lost to Follow-up|1
7309380|NCT00667277|11534587|FG000|Overall Study|Withdrawal by Subject|2
7309381|NCT00667342|11534594|FG000|Overall Study|Protocol Violation|1
7309382|NCT00667342|11534595|FG001|Overall Study|Protocol Violation|0
7309383|NCT00667342|11534596|FG002|Overall Study|Protocol Violation|0
7309384|NCT00667342|11534594|FG000|Overall Study|Withdrawal by Subject|1
7309385|NCT00667342|11534595|FG001|Overall Study|Withdrawal by Subject|0
7309386|NCT00667342|11534596|FG002|Overall Study|Withdrawal by Subject|0
7309387|NCT00667342|11534594|FG000|Overall Study|Physician Decision|3
7309388|NCT00667342|11534595|FG001|Overall Study|Physician Decision|0
7309389|NCT00667342|11534596|FG002|Overall Study|Physician Decision|0
7309390|NCT00667342|11534594|FG000|Overall Study|Relapse or tumor progression|9
7309391|NCT00667342|11534595|FG001|Overall Study|Relapse or tumor progression|0
7389683|NCT01229735|11649442|FG001|Overall Study|SAE, non-fatal|4
7309392|NCT00667342|11534596|FG002|Overall Study|Relapse or tumor progression|7
7309393|NCT00667342|11534594|FG000|Overall Study|Adverse Event|0
7309394|NCT00667342|11534595|FG001|Overall Study|Adverse Event|0
7309395|NCT00667342|11534596|FG002|Overall Study|Adverse Event|1
7309396|NCT00667342|11534594|FG000|Overall Study|Ineligible|0
7309397|NCT00667342|11534595|FG001|Overall Study|Ineligible|0
7309398|NCT00667342|11534596|FG002|Overall Study|Ineligible|1
7309399|NCT00667355|11534610|FG000|Overall Study|Adverse Event|5
7309400|NCT00667355|11534610|FG000|Overall Study|Lost to Follow-up|1
7309401|NCT00667355|11534610|FG000|Overall Study|Other reason was not specified|5
7309402|NCT00667368|11534616|FG000|Overall Study|Lost to Follow-up|176
7309403|NCT00667368|11534617|FG001|Overall Study|Lost to Follow-up|155
7309404|NCT00667368|11534616|FG000|Overall Study|Discontinued early|24
7309405|NCT00667368|11534617|FG001|Overall Study|Discontinued early|17
7309406|NCT00667394|11534634|FG000|Overall Study|Adverse Event|3
7309407|NCT00667394|11534635|FG001|Overall Study|Adverse Event|0
7309408|NCT00667394|11534634|FG000|Overall Study|Progressive disease|1
7309409|NCT00667394|11534635|FG001|Overall Study|Progressive disease|0
7309410|NCT00667420|11534641|FG000|Overall Study|Adverse Event|2
7309411|NCT00667420|11534641|FG000|Overall Study|Lack of Efficacy|5
7309412|NCT00667420|11534641|FG000|Overall Study|Physician Decision|1
7309413|NCT00667420|11534641|FG000|Overall Study|Withdrawal by Subject|2
7309414|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
7309415|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
7309416|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Other|2
7309417|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Other|2
7309418|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Personal reasons|2
7309419|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Personal reasons|2
7309420|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
7309421|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
7309422|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
7309423|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
7309424|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
7309425|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
7309426|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Protocol Violation|1
7309427|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Protocol Violation|1
7309428|NCT00667446|11534648|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
7309429|NCT00667446|11534649|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
7309430|NCT00667446|11534648|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
7309431|NCT00667446|11534649|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
7309432|NCT00667459|11534657|FG000|Overall Study|Death|0
7309433|NCT00667459|11534658|FG001|Overall Study|Death|2
7309434|NCT00667459|11534657|FG000|Overall Study|Lost to Follow-up|8
7309435|NCT00667459|11534658|FG001|Overall Study|Lost to Follow-up|43
7384152|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
7384153|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
7384154|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
7389648|NCT01229371|11649343|FG003|Overall Study|Withdrawal by Subject|0
7389649|NCT01229397|11649355|FG000|Overall Study|Withdrawal by Subject|3
7389650|NCT01229397|11649356|FG001|Overall Study|Withdrawal by Subject|3
7389651|NCT01229397|11649355|FG000|Overall Study|Lost to Follow-up|7
7389652|NCT01229397|11649356|FG001|Overall Study|Lost to Follow-up|6
7389653|NCT01229397|11649355|FG000|Overall Study|Migrated/moved from study area|1
7389654|NCT01229397|11649356|FG001|Overall Study|Migrated/moved from study area|0
7389655|NCT01229436|11649379|FG000|Overall Study|Withdrawal by Subject|2
7389656|NCT01229436|11649379|FG000|Overall Study|Lost to Follow-up|3
7389657|NCT01229449|11649388|FG000|Overall Study|Withdrawal by Subject|0
7389658|NCT01229449|11649389|FG001|Overall Study|Withdrawal by Subject|3
7389659|NCT01229449|11649390|FG002|Overall Study|Withdrawal by Subject|0
7389660|NCT01229449|11649391|FG003|Overall Study|Withdrawal by Subject|1
7389661|NCT01229449|11649392|FG004|Overall Study|Withdrawal by Subject|1
7389662|NCT01229449|11649388|FG000|Overall Study|Lost to Follow-up|1
7389663|NCT01229449|11649389|FG001|Overall Study|Lost to Follow-up|1
7389664|NCT01229449|11649390|FG002|Overall Study|Lost to Follow-up|1
7389665|NCT01229449|11649391|FG003|Overall Study|Lost to Follow-up|0
7389666|NCT01229449|11649392|FG004|Overall Study|Lost to Follow-up|0
7389667|NCT01229449|11649388|FG000|Overall Study|Physician Decision|0
7389668|NCT01229449|11649389|FG001|Overall Study|Physician Decision|0
7389669|NCT01229449|11649390|FG002|Overall Study|Physician Decision|1
7389670|NCT01229449|11649391|FG003|Overall Study|Physician Decision|0
7389671|NCT01229449|11649392|FG004|Overall Study|Physician Decision|0
7389672|NCT01229735|11649441|FG000|Overall Study|Lack of Efficacy|8
7389673|NCT01229735|11649442|FG001|Overall Study|Lack of Efficacy|8
7389674|NCT01229735|11649441|FG000|Overall Study|Protocol Violation|13
7389675|NCT01229735|11649442|FG001|Overall Study|Protocol Violation|8
7389676|NCT01229735|11649441|FG000|Overall Study|Lost to Follow-up|0
7389677|NCT01229735|11649442|FG001|Overall Study|Lost to Follow-up|2
7389678|NCT01229735|11649441|FG000|Overall Study|Withdrawal by Subject|18
7389679|NCT01229735|11649442|FG001|Overall Study|Withdrawal by Subject|17
7389680|NCT01229735|11649441|FG000|Overall Study|Other Reason|13
7389681|NCT01229735|11649442|FG001|Overall Study|Other Reason|10
7389682|NCT01229735|11649441|FG000|Overall Study|SAE, non-fatal|0
7389684|NCT01229735|11649441|FG000|Overall Study|AE, non-serious non-fatal|13
7389685|NCT01229735|11649442|FG001|Overall Study|AE, non-serious non-fatal|17
7468553|NCT01912287|11769441|FG001|Overall Study|Missed Assesment|1
7470491|NCT01931956|11772613|FG003|Overall Study|Not due|0
7384155|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
7384156|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
7384157|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
7384158|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
7384159|NCT01193153|11641314|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
7384160|NCT01193153|11641315|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
7384161|NCT01193218|11641329|FG000|0-12 Weeks|Adverse Event|6
7384162|NCT01193218|11641330|FG001|0-12 Weeks|Adverse Event|0
7384163|NCT01193218|11641331|FG002|0-12 Weeks|Adverse Event|1
7384164|NCT01193218|11641332|FG003|0-12 Weeks|Adverse Event|0
7384165|NCT01193218|11641333|FG004|0-12 Weeks|Adverse Event|0
7384166|NCT01193218|11641334|FG005|0-12 Weeks|Adverse Event|2
7384167|NCT01193218|11641335|FG006|0-12 Weeks|Adverse Event|2
7384168|NCT01193218|11641336|FG007|0-12 Weeks|Adverse Event|0
7384169|NCT01193218|11641329|FG000|0-12 Weeks|Protocol Violation|0
7384170|NCT01193218|11641330|FG001|0-12 Weeks|Protocol Violation|0
7384171|NCT01193218|11641331|FG002|0-12 Weeks|Protocol Violation|0
7384172|NCT01193218|11641332|FG003|0-12 Weeks|Protocol Violation|0
7384173|NCT01193218|11641333|FG004|0-12 Weeks|Protocol Violation|1
7384174|NCT01193218|11641334|FG005|0-12 Weeks|Protocol Violation|1
7384175|NCT01193218|11641335|FG006|0-12 Weeks|Protocol Violation|0
7384176|NCT01193218|11641336|FG007|0-12 Weeks|Protocol Violation|0
7384177|NCT01193218|11641329|FG000|0-12 Weeks|Withdrawal by Subject|3
7384178|NCT01193218|11641330|FG001|0-12 Weeks|Withdrawal by Subject|0
7384179|NCT01193218|11641331|FG002|0-12 Weeks|Withdrawal by Subject|2
7384180|NCT01193218|11641332|FG003|0-12 Weeks|Withdrawal by Subject|0
7384181|NCT01193218|11641333|FG004|0-12 Weeks|Withdrawal by Subject|0
7384182|NCT01193218|11641334|FG005|0-12 Weeks|Withdrawal by Subject|0
7384183|NCT01193218|11641335|FG006|0-12 Weeks|Withdrawal by Subject|1
7384184|NCT01193218|11641336|FG007|0-12 Weeks|Withdrawal by Subject|0
7384185|NCT01193218|11641329|FG000|12-52 Weeks|Adverse Event|1
7384186|NCT01193218|11641330|FG001|12-52 Weeks|Adverse Event|0
7384187|NCT01193218|11641331|FG002|12-52 Weeks|Adverse Event|1
7384188|NCT01193218|11641332|FG003|12-52 Weeks|Adverse Event|2
7384189|NCT01193218|11641333|FG004|12-52 Weeks|Adverse Event|3
7384190|NCT01193218|11641334|FG005|12-52 Weeks|Adverse Event|3
7384191|NCT01193218|11641335|FG006|12-52 Weeks|Adverse Event|1
7309436|NCT00667563|11534670|FG000|Overall Study|Protocol Violation|24
7309437|NCT00667576|11534679|FG000|Overall Study|Withdrawal by Subject|1
7309438|NCT00667576|11534680|FG001|Overall Study|Withdrawal by Subject|0
7309439|NCT00667576|11534681|FG002|Overall Study|Withdrawal by Subject|1
7309440|NCT00667576|11534682|FG003|Overall Study|Withdrawal by Subject|1
7309441|NCT00667576|11534683|FG004|Overall Study|Withdrawal by Subject|1
7309442|NCT00667576|11534679|FG000|Overall Study|Adverse Event|1
7309443|NCT00667576|11534680|FG001|Overall Study|Adverse Event|1
7309444|NCT00667576|11534681|FG002|Overall Study|Adverse Event|0
7309445|NCT00667576|11534682|FG003|Overall Study|Adverse Event|0
7309446|NCT00667576|11534683|FG004|Overall Study|Adverse Event|0
7309447|NCT00667576|11534679|FG000|Overall Study|Lost to Follow-up|0
7309448|NCT00667576|11534680|FG001|Overall Study|Lost to Follow-up|0
7309449|NCT00667576|11534681|FG002|Overall Study|Lost to Follow-up|1
7309450|NCT00667576|11534682|FG003|Overall Study|Lost to Follow-up|0
7309451|NCT00667576|11534683|FG004|Overall Study|Lost to Follow-up|0
7309452|NCT00667576|11534679|FG000|Overall Study|Protocol Violation|0
7309453|NCT00667576|11534680|FG001|Overall Study|Protocol Violation|0
7309454|NCT00667576|11534681|FG002|Overall Study|Protocol Violation|0
7309455|NCT00667576|11534682|FG003|Overall Study|Protocol Violation|1
7309456|NCT00667576|11534683|FG004|Overall Study|Protocol Violation|0
7309457|NCT00667576|11534679|FG000|Overall Study|Physician Decision|0
7309458|NCT00667576|11534680|FG001|Overall Study|Physician Decision|0
7309459|NCT00667576|11534681|FG002|Overall Study|Physician Decision|0
7309460|NCT00667576|11534682|FG003|Overall Study|Physician Decision|1
7309461|NCT00667576|11534683|FG004|Overall Study|Physician Decision|0
7309462|NCT00667576|11534679|FG000|Overall Study|Missed Visit|0
7309463|NCT00667576|11534680|FG001|Overall Study|Missed Visit|0
7309464|NCT00667576|11534681|FG002|Overall Study|Missed Visit|0
7309465|NCT00667576|11534682|FG003|Overall Study|Missed Visit|1
7309466|NCT00667576|11534683|FG004|Overall Study|Missed Visit|0
7309467|NCT00667602|11534715|FG000|Overall Study|Withdrawal by Subject|4
7309468|NCT00667602|11534716|FG001|Overall Study|Withdrawal by Subject|9
7309469|NCT00667602|11534717|FG002|Overall Study|Withdrawal by Subject|10
7309470|NCT00667602|11534715|FG000|Overall Study|Lost to Follow-up|4
7309471|NCT00667602|11534716|FG001|Overall Study|Lost to Follow-up|5
7309472|NCT00667602|11534717|FG002|Overall Study|Lost to Follow-up|6
7309473|NCT00667602|11534715|FG000|Overall Study|Administrative reason|0
7309474|NCT00667602|11534716|FG001|Overall Study|Administrative reason|0
7309475|NCT00667602|11534717|FG002|Overall Study|Administrative reason|2
7309476|NCT00667602|11534715|FG000|Overall Study|Protocol Violation|0
7309477|NCT00667602|11534716|FG001|Overall Study|Protocol Violation|1
7309478|NCT00667602|11534717|FG002|Overall Study|Protocol Violation|0
7309479|NCT00667719|11534743|FG000|Overall Study|Adverse Event|39
7309480|NCT00667719|11534743|FG000|Overall Study|Abnormal Test Procedure|1
7309481|NCT00667719|11534743|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7309482|NCT00667719|11534743|FG000|Overall Study|Protocol Violation|3
7309483|NCT00667719|11534743|FG000|Overall Study|Withdrawal by Subject|17
7309484|NCT00667719|11534743|FG000|Overall Study|Lost to Follow-up|8
7309485|NCT00667732|11534754|FG000|Run -In (8 Weeks)|Adverse Event|4
7309486|NCT00667732|11534755|FG001|Run -In (8 Weeks)|Adverse Event|0
7309487|NCT00667732|11534756|FG002|Run -In (8 Weeks)|Adverse Event|0
7309488|NCT00667732|11534754|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
7309489|NCT00667732|11534755|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
7309490|NCT00667732|11534756|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
7309491|NCT00667732|11534754|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
7309492|NCT00667732|11534755|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
7309493|NCT00667732|11534756|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
7309494|NCT00667810|11534780|FG000|Overall Study|Adverse Event|13
7309495|NCT00667810|11534781|FG001|Overall Study|Adverse Event|14
7309496|NCT00667810|11534782|FG002|Overall Study|Adverse Event|19
7309497|NCT00667810|11534783|FG003|Overall Study|Adverse Event|1
7309498|NCT00667810|11534780|FG000|Overall Study|Death|1
7309499|NCT00667810|11534781|FG001|Overall Study|Death|1
7309500|NCT00667810|11534782|FG002|Overall Study|Death|3
7309501|NCT00667810|11534783|FG003|Overall Study|Death|0
7309502|NCT00667810|11534780|FG000|Overall Study|Lack of Efficacy|1
7309503|NCT00667810|11534781|FG001|Overall Study|Lack of Efficacy|0
7309504|NCT00667810|11534782|FG002|Overall Study|Lack of Efficacy|2
7309505|NCT00667810|11534783|FG003|Overall Study|Lack of Efficacy|0
7309506|NCT00667810|11534780|FG000|Overall Study|Lost to Follow-up|1
7309507|NCT00667810|11534781|FG001|Overall Study|Lost to Follow-up|4
7309508|NCT00667810|11534782|FG002|Overall Study|Lost to Follow-up|2
7309509|NCT00667810|11534783|FG003|Overall Study|Lost to Follow-up|0
7309510|NCT00667810|11534780|FG000|Overall Study|Physician Decision|1
7309511|NCT00667810|11534781|FG001|Overall Study|Physician Decision|1
7309512|NCT00667810|11534782|FG002|Overall Study|Physician Decision|2
7309513|NCT00667810|11534783|FG003|Overall Study|Physician Decision|0
7309514|NCT00667810|11534780|FG000|Overall Study|Protocol Violation|0
7309515|NCT00667810|11534781|FG001|Overall Study|Protocol Violation|2
7309516|NCT00667810|11534782|FG002|Overall Study|Protocol Violation|0
7309517|NCT00667810|11534783|FG003|Overall Study|Protocol Violation|0
7309518|NCT00667810|11534780|FG000|Overall Study|Withdrawal by Subject|14
7309519|NCT00667810|11534781|FG001|Overall Study|Withdrawal by Subject|20
7309520|NCT00667810|11534782|FG002|Overall Study|Withdrawal by Subject|29
7309521|NCT00667810|11534783|FG003|Overall Study|Withdrawal by Subject|1
7309522|NCT00667810|11534780|FG000|Overall Study|Discontinuation of Study by Sponsor|130
7309523|NCT00667810|11534781|FG001|Overall Study|Discontinuation of Study by Sponsor|118
7309524|NCT00667810|11534782|FG002|Overall Study|Discontinuation of Study by Sponsor|155
7309525|NCT00667810|11534783|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7309526|NCT00667810|11534780|FG000|Overall Study|Failed to Return|0
7309527|NCT00667810|11534781|FG001|Overall Study|Failed to Return|0
7309528|NCT00667810|11534782|FG002|Overall Study|Failed to Return|2
7309529|NCT00667810|11534783|FG003|Overall Study|Failed to Return|0
7309530|NCT00667810|11534780|FG000|Overall Study|Loss of Caregiver|0
7309531|NCT00667810|11534781|FG001|Overall Study|Loss of Caregiver|1
7309532|NCT00667810|11534782|FG002|Overall Study|Loss of Caregiver|3
7309533|NCT00667810|11534783|FG003|Overall Study|Loss of Caregiver|0
7309534|NCT00667810|11534780|FG000|Overall Study|Vasogenic Edema Recurrence|0
7309535|NCT00667810|11534781|FG001|Overall Study|Vasogenic Edema Recurrence|3
7309536|NCT00667810|11534782|FG002|Overall Study|Vasogenic Edema Recurrence|0
7309537|NCT00667810|11534783|FG003|Overall Study|Vasogenic Edema Recurrence|0
7309538|NCT00667810|11534780|FG000|Overall Study|Other|6
7309539|NCT00667810|11534781|FG001|Overall Study|Other|6
7309540|NCT00667810|11534782|FG002|Overall Study|Other|5
7309541|NCT00667810|11534783|FG003|Overall Study|Other|0
7309542|NCT00667862|11534810|FG000|Overall Study|Adverse Event|9
7309543|NCT00667862|11534810|FG000|Overall Study|Death|1
7309544|NCT00667862|11534810|FG000|Overall Study|Disease Progression|22
7309545|NCT00667862|11534810|FG000|Overall Study|Withdrawal by Subject|3
7309546|NCT00667875|11534817|FG000|Overall Study|Adverse Event|0
7309547|NCT00667875|11534818|FG001|Overall Study|Adverse Event|2
7309548|NCT00667875|11534819|FG002|Overall Study|Adverse Event|6
7309549|NCT00667875|11534817|FG000|Overall Study|Withdrawal by Subject|10
7309550|NCT00667875|11534818|FG001|Overall Study|Withdrawal by Subject|9
7309551|NCT00667875|11534819|FG002|Overall Study|Withdrawal by Subject|7
7309552|NCT00667888|11534835|FG000|Overall Study|Death|1
7309553|NCT00667888|11534836|FG001|Overall Study|Death|1
7309554|NCT00667888|11534835|FG000|Overall Study|Withdrawal by Subject|6
7309555|NCT00667888|11534836|FG001|Overall Study|Withdrawal by Subject|3
7309556|NCT00667888|11534835|FG000|Overall Study|Proceed with other treatment|3
7309557|NCT00667888|11534836|FG001|Overall Study|Proceed with other treatment|3
7309558|NCT00667888|11534835|FG000|Overall Study|Ineligible after SIM|0
7309559|NCT00667888|11534836|FG001|Overall Study|Ineligible after SIM|2
7309560|NCT00667992|11534844|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
7309561|NCT00667992|11534845|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
7309562|NCT00667992|11534844|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
7309563|NCT00667992|11534845|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7309564|NCT00667992|11534844|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7309565|NCT00667992|11534845|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7309566|NCT00667992|11534844|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
7309567|NCT00667992|11534845|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
7309568|NCT00667992|11534844|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
7309569|NCT00667992|11534845|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
7309570|NCT00667992|11534844|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
7309571|NCT00667992|11534845|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
7309572|NCT00667992|11534844|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
7309573|NCT00667992|11534845|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
7309574|NCT00667992|11534844|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
7309575|NCT00667992|11534845|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
7309576|NCT00667992|11534844|FG000|Wash-out|Not within one doubling dilution|4
7309577|NCT00667992|11534845|FG001|Wash-out|Not within one doubling dilution|3
7309578|NCT00667992|11534844|FG000|Wash-out|Failure to wash-out|2
7309579|NCT00667992|11534845|FG001|Wash-out|Failure to wash-out|2
7309580|NCT00667992|11534844|FG000|Wash-out|Withdrawal by Subject|1
7309581|NCT00667992|11534845|FG001|Wash-out|Withdrawal by Subject|0
7309582|NCT00667992|11534844|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
7309583|NCT00667992|11534845|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
7309584|NCT00667992|11534844|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
7309585|NCT00667992|11534845|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
7309586|NCT00668148|11534861|FG000|Overall Study|Adverse Event|5
7309587|NCT00668148|11534861|FG000|Overall Study|Subject Non-compliance|1
7309588|NCT00668148|11534861|FG000|Overall Study|Progressive Disease Before Treatment|2
7309589|NCT00668148|11534861|FG000|Overall Study|Withdrawal of Consent|2
7309590|NCT00668200|11534876|FG000|Overall Study|Withdrawal by Subject|2
7309591|NCT00668200|11534876|FG000|Overall Study|Lost to Follow-up|1
7309592|NCT00668317|11534880|FG000|Overall Study|Adverse Event|2
7309593|NCT00668395|11534891|FG000|Overall Study|Withdrawal by Subject|4
7309594|NCT00668395|11534892|FG001|Overall Study|Withdrawal by Subject|4
7309595|NCT00668395|11534893|FG002|Overall Study|Withdrawal by Subject|1
7309596|NCT00668395|11534891|FG000|Overall Study|Adverse Event|1
7309597|NCT00668395|11534892|FG001|Overall Study|Adverse Event|1
7309598|NCT00668395|11534893|FG002|Overall Study|Adverse Event|0
7309599|NCT00668395|11534891|FG000|Overall Study|Physician Decision|1
7309600|NCT00668395|11534892|FG001|Overall Study|Physician Decision|1
7309601|NCT00668395|11534893|FG002|Overall Study|Physician Decision|0
7309602|NCT00668707|11534929|FG000|Overall Study|Cancer Recurrence|58
7309603|NCT00668707|11534930|FG001|Overall Study|Cancer Recurrence|58
7309604|NCT00668707|11534929|FG000|Overall Study|Withdrawal by Subject|117
7309605|NCT00668707|11534930|FG001|Overall Study|Withdrawal by Subject|100
7309606|NCT00668707|11534929|FG000|Overall Study|Lost to Follow-up|3
7309607|NCT00668707|11534930|FG001|Overall Study|Lost to Follow-up|6
7309608|NCT00668707|11534929|FG000|Overall Study|Protocol Violation|10
7309609|NCT00668707|11534930|FG001|Overall Study|Protocol Violation|12
7309610|NCT00668707|11534929|FG000|Overall Study|Death|11
7309611|NCT00668707|11534930|FG001|Overall Study|Death|4
7309612|NCT00668733|11534943|FG000|Overall Study|Lost to Follow-up|2
7309613|NCT00668733|11534944|FG001|Overall Study|Lost to Follow-up|3
7309614|NCT00668733|11534943|FG000|Overall Study|Withdrawal by Subject|0
7309615|NCT00668733|11534944|FG001|Overall Study|Withdrawal by Subject|4
7309616|NCT00668746|11534952|FG000|Overall Study|Lost to Follow-up|2
7309617|NCT00668746|11534953|FG001|Overall Study|Lost to Follow-up|1
7309618|NCT00668863|11534973|FG000|Overall Study|Objective Progression or Relapse|42
7309619|NCT00668863|11534973|FG000|Overall Study|Adverse Event|13
7309620|NCT00668863|11534973|FG000|Overall Study|Study Terminated by Sponsor|8
7309621|NCT00668863|11534973|FG000|Overall Study|Global Deterioration of Health Status|4
7309622|NCT00668863|11534973|FG000|Overall Study|Withdrawal by Subject|1
7309623|NCT00668863|11534973|FG000|Overall Study|Surgery|1
7309624|NCT00668863|11534973|FG000|Overall Study|Subject's work scheduling problem|1
7309625|NCT00668863|11534973|FG000|Overall Study|Physician Decision|1
7309626|NCT00669032|11534996|FG000|Overall Study|Lost to Follow-up|6
7309627|NCT00669032|11534997|FG001|Overall Study|Lost to Follow-up|5
7309628|NCT00669032|11534996|FG000|Overall Study|Lack of Efficacy|8
7309629|NCT00669032|11534997|FG001|Overall Study|Lack of Efficacy|19
7309630|NCT00669032|11534996|FG000|Overall Study|Withdrawal by Subject|12
7309631|NCT00669032|11534997|FG001|Overall Study|Withdrawal by Subject|13
7309632|NCT00669032|11534996|FG000|Overall Study|Adverse Event|12
7309633|NCT00669032|11534997|FG001|Overall Study|Adverse Event|16
7309634|NCT00669032|11534996|FG000|Overall Study|Physician Decision|1
7309635|NCT00669032|11534997|FG001|Overall Study|Physician Decision|1
7309636|NCT00669032|11534996|FG000|Overall Study|No fulfilment of the selection criteria|5
7309637|NCT00669032|11534997|FG001|Overall Study|No fulfilment of the selection criteria|5
7309640|NCT00669110|11535011|FG000|Overall Study|Adverse Event|4
7309641|NCT00669110|11535012|FG001|Overall Study|Adverse Event|3
7309642|NCT00669110|11535011|FG000|Overall Study|Caregiver request|3
7309643|NCT00669110|11535012|FG001|Overall Study|Caregiver request|2
7309644|NCT00669110|11535011|FG000|Overall Study|Physician Decision|0
7309645|NCT00669110|11535012|FG001|Overall Study|Physician Decision|1
7309646|NCT00669110|11535011|FG000|Overall Study|Lost to Follow-up|1
7309647|NCT00669110|11535012|FG001|Overall Study|Lost to Follow-up|0
7309648|NCT00669110|11535011|FG000|Overall Study|Protocol Violation|0
7309649|NCT00669110|11535012|FG001|Overall Study|Protocol Violation|5
7309650|NCT00669110|11535011|FG000|Overall Study|Withdrawal by Subject|0
7309651|NCT00669110|11535012|FG001|Overall Study|Withdrawal by Subject|2
7309652|NCT00669162|11535018|FG000|Overall Study|Withdrawal by Subject|1
7309653|NCT00669240|11535035|FG000|Overall Study|Lack of Efficacy|33
7309654|NCT00669240|11535035|FG000|Overall Study|Withdrawal by Subject|42
7309655|NCT00669240|11535035|FG000|Overall Study|Lost to Follow-up|34
7309656|NCT00669240|11535035|FG000|Overall Study|Adverse Event|21
7309657|NCT00669240|11535035|FG000|Overall Study|Other|19
7309658|NCT00669240|11535035|FG000|Overall Study|Enrolled but not treated|15
7309659|NCT00669240|11535035|FG000|Overall Study|Enrolled but no dosing record|1
7309660|NCT00669318|11535048|FG000|Overall Study|Withdrawal by Subject|2
7309661|NCT00669331|11535054|FG000|Randomisation to First Dose|Adverse Event|1
7309662|NCT00669331|11535055|FG001|Randomisation to First Dose|Adverse Event|0
7309663|NCT00669331|11535054|FG000|Randomisation to First Dose|Protocol Violation|1
7309664|NCT00669331|11535055|FG001|Randomisation to First Dose|Protocol Violation|0
7309665|NCT00669331|11535054|FG000|Randomisation to First Dose|Withdrawal by Subject|3
7309666|NCT00669331|11535055|FG001|Randomisation to First Dose|Withdrawal by Subject|2
7309667|NCT00669331|11535054|FG000|Randomisation to First Dose|Lost to Follow-up|2
7309668|NCT00669331|11535055|FG001|Randomisation to First Dose|Lost to Follow-up|0
7309669|NCT00669331|11535054|FG000|Randomisation to First Dose|Death|1
7309670|NCT00669331|11535055|FG001|Randomisation to First Dose|Death|0
7309671|NCT00669331|11535054|FG000|Randomisation to First Dose|Sponsor decision|0
7309672|NCT00669331|11535055|FG001|Randomisation to First Dose|Sponsor decision|1
7309673|NCT00669331|11535054|FG000|Randomisation to First Dose|Randomised in error|3
7309674|NCT00669331|11535055|FG001|Randomisation to First Dose|Randomised in error|10
7309675|NCT00669331|11535054|FG000|Blinded Treatment Period|Adverse Event|16
7309676|NCT00669331|11535055|FG001|Blinded Treatment Period|Adverse Event|10
7309677|NCT00669331|11535054|FG000|Blinded Treatment Period|Protocol Violation|1
7309678|NCT00669331|11535055|FG001|Blinded Treatment Period|Protocol Violation|1
7309679|NCT00669331|11535054|FG000|Blinded Treatment Period|Withdrawal by Subject|17
7309680|NCT00669331|11535055|FG001|Blinded Treatment Period|Withdrawal by Subject|19
7309681|NCT00669331|11535054|FG000|Blinded Treatment Period|Lost to Follow-up|3
7309682|NCT00669331|11535055|FG001|Blinded Treatment Period|Lost to Follow-up|2
7309683|NCT00669331|11535054|FG000|Blinded Treatment Period|Death|0
7309684|NCT00669331|11535055|FG001|Blinded Treatment Period|Death|2
7309685|NCT00669331|11535054|FG000|Blinded Treatment Period|Physician Decision|3
7309686|NCT00669331|11535055|FG001|Blinded Treatment Period|Physician Decision|3
7309687|NCT00669331|11535054|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7309688|NCT00669331|11535055|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
7309689|NCT00669396|11535074|FG000|Overall Study|Lost to Follow-up|10
7309690|NCT00669396|11535075|FG001|Overall Study|Lost to Follow-up|12
7309691|NCT00669409|11535087|FG000|Part 2|Withdrawal by Subject|0
7309692|NCT00669409|11535088|FG001|Part 2|Withdrawal by Subject|0
7309693|NCT00669409|11535089|FG002|Part 2|Withdrawal by Subject|0
7309694|NCT00669409|11535090|FG003|Part 2|Withdrawal by Subject|0
7309695|NCT00669409|11535091|FG004|Part 2|Withdrawal by Subject|0
7309696|NCT00669409|11535092|FG005|Part 2|Withdrawal by Subject|0
7309697|NCT00669409|11535093|FG006|Part 2|Withdrawal by Subject|0
7309698|NCT00669409|11535094|FG007|Part 2|Withdrawal by Subject|0
7309699|NCT00669409|11535095|FG008|Part 2|Withdrawal by Subject|0
7309700|NCT00669409|11535096|FG009|Part 2|Withdrawal by Subject|1
7309701|NCT00669409|11535097|FG010|Part 2|Withdrawal by Subject|0
7309702|NCT00669617|11535147|FG000|Period 1|Withdrawal by Subject|0
7309703|NCT00669617|11535148|FG001|Period 1|Withdrawal by Subject|0
7309704|NCT00669617|11535149|FG002|Period 1|Withdrawal by Subject|1
7309705|NCT00669617|11535150|FG003|Period 1|Withdrawal by Subject|0
7309706|NCT00669617|11535151|FG004|Period 1|Withdrawal by Subject|0
7309707|NCT00669617|11535147|FG000|Period 1|Protocol Deviation|0
7309708|NCT00669617|11535148|FG001|Period 1|Protocol Deviation|0
7309709|NCT00669617|11535149|FG002|Period 1|Protocol Deviation|0
7309710|NCT00669617|11535150|FG003|Period 1|Protocol Deviation|0
7309711|NCT00669617|11535151|FG004|Period 1|Protocol Deviation|1
7309712|NCT00669617|11535147|FG000|Period 3|Lost to Follow-up|1
7389686|NCT01229735|11649441|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7389687|NCT01229735|11649442|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7389688|NCT01230060|11649467|FG000|Overall Study|Withdrawal by Subject|1
7389689|NCT01230554|11649512|FG000|Overall Study|Lost to Follow-up|2
7389690|NCT01230554|11649512|FG000|Overall Study|Inability to maintain visit schedule|1
7389691|NCT01230710|11649529|FG000|Overall Study|Disease Progression|41
7389692|NCT01230710|11649529|FG000|Overall Study|Lost to Follow-up|3
7389693|NCT01230710|11649529|FG000|Overall Study|Death|4
7389694|NCT01230710|11649529|FG000|Overall Study|Withdrawal of Consent|1
7389695|NCT01230749|11649537|FG000|Overall Study|Adverse Event|0
7389696|NCT01230749|11649538|FG001|Overall Study|Adverse Event|0
7389697|NCT01230749|11649539|FG002|Overall Study|Adverse Event|0
7389698|NCT01230749|11649540|FG003|Overall Study|Adverse Event|1
7389699|NCT01230749|11649537|FG000|Overall Study|Physician Decision|0
7389700|NCT01230749|11649538|FG001|Overall Study|Physician Decision|0
7389701|NCT01230749|11649539|FG002|Overall Study|Physician Decision|1
7389702|NCT01230749|11649540|FG003|Overall Study|Physician Decision|0
7389703|NCT01230749|11649537|FG000|Overall Study|Withdrawal by Subject|0
7389704|NCT01230749|11649538|FG001|Overall Study|Withdrawal by Subject|1
7389705|NCT01230749|11649539|FG002|Overall Study|Withdrawal by Subject|0
7389706|NCT01230749|11649540|FG003|Overall Study|Withdrawal by Subject|0
7389707|NCT01230749|11649537|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
7389708|NCT01230749|11649538|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
7389709|NCT01230749|11649539|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
7389710|NCT01230749|11649540|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
7389711|NCT01230814|11649571|FG000|Overall Study|Lost to Follow-up|11
7389712|NCT01230814|11649572|FG001|Overall Study|Lost to Follow-up|3
7389713|NCT01230814|11649571|FG000|Overall Study|Discontinued (not due to adverse event)|2
7389714|NCT01230814|11649572|FG001|Overall Study|Discontinued (not due to adverse event)|1
7389715|NCT01230827|11649582|FG000|Overall Study|Lost to Follow-up|0
7389716|NCT01230827|11649583|FG001|Overall Study|Lost to Follow-up|0
7389717|NCT01230827|11649584|FG002|Overall Study|Lost to Follow-up|1
7389718|NCT01230827|11649585|FG003|Overall Study|Lost to Follow-up|3
7389719|NCT01230827|11649582|FG000|Overall Study|Withdrawal by Subject|1
7389720|NCT01230827|11649583|FG001|Overall Study|Withdrawal by Subject|0
7389721|NCT01230827|11649584|FG002|Overall Study|Withdrawal by Subject|3
7389722|NCT01230827|11649585|FG003|Overall Study|Withdrawal by Subject|2
7389723|NCT01230827|11649582|FG000|Overall Study|Lack of Efficacy|14
7389724|NCT01230827|11649583|FG001|Overall Study|Lack of Efficacy|1
7389725|NCT01230827|11649584|FG002|Overall Study|Lack of Efficacy|2
7389726|NCT01230827|11649585|FG003|Overall Study|Lack of Efficacy|3
7389727|NCT01230827|11649582|FG000|Overall Study|Adverse Event|4
7389728|NCT01230827|11649583|FG001|Overall Study|Adverse Event|2
7389729|NCT01230827|11649584|FG002|Overall Study|Adverse Event|3
7389730|NCT01230827|11649585|FG003|Overall Study|Adverse Event|7
7389731|NCT01230827|11649582|FG000|Overall Study|Recovery|0
7309713|NCT00669617|11535148|FG001|Period 3|Lost to Follow-up|0
7309714|NCT00669617|11535149|FG002|Period 3|Lost to Follow-up|0
7309715|NCT00669617|11535150|FG003|Period 3|Lost to Follow-up|0
7309716|NCT00669617|11535151|FG004|Period 3|Lost to Follow-up|0
7309717|NCT00669864|11535168|FG000|Overall Study|Lost to Follow-up|2
7309718|NCT00669864|11535168|FG000|Overall Study|Protocol Violation|2
7309719|NCT00669864|11535168|FG000|Overall Study|Withdrawal by Subject|3
7389732|NCT01230827|11649583|FG001|Overall Study|Recovery|6
7389733|NCT01230827|11649584|FG002|Overall Study|Recovery|0
7309720|NCT00669864|11535168|FG000|Overall Study|Other|2
7309721|NCT00669877|11535172|FG000|Overall Study|Disease Progression/Death|4
7309722|NCT00669903|11535180|FG000|Overall Study|Adverse Event|0
7309723|NCT00669903|11535181|FG001|Overall Study|Adverse Event|1
7309724|NCT00669903|11535182|FG002|Overall Study|Adverse Event|3
7309725|NCT00669903|11535183|FG003|Overall Study|Adverse Event|1
7309726|NCT00669903|11535180|FG000|Overall Study|Withdrawal by Subject|0
7309727|NCT00669903|11535181|FG001|Overall Study|Withdrawal by Subject|2
7309728|NCT00669903|11535182|FG002|Overall Study|Withdrawal by Subject|2
7309729|NCT00669903|11535183|FG003|Overall Study|Withdrawal by Subject|2
7309730|NCT00669903|11535180|FG000|Overall Study|Lost to Follow-up|1
7309731|NCT00669903|11535181|FG001|Overall Study|Lost to Follow-up|1
7309732|NCT00669903|11535182|FG002|Overall Study|Lost to Follow-up|0
7309733|NCT00669903|11535183|FG003|Overall Study|Lost to Follow-up|1
7309734|NCT00669903|11535180|FG000|Overall Study|Protocol Violation|0
7309735|NCT00669903|11535181|FG001|Overall Study|Protocol Violation|1
7309736|NCT00669903|11535182|FG002|Overall Study|Protocol Violation|0
7309737|NCT00669903|11535183|FG003|Overall Study|Protocol Violation|0
7309738|NCT00669942|11535214|FG000|Parts 2 and 3|Adverse Event|0
7309739|NCT00669942|11535215|FG001|Parts 2 and 3|Adverse Event|0
7309740|NCT00669942|11535216|FG002|Parts 2 and 3|Adverse Event|0
7309741|NCT00669942|11535217|FG003|Parts 2 and 3|Adverse Event|0
7309742|NCT00669942|11535218|FG004|Parts 2 and 3|Adverse Event|0
7309743|NCT00669942|11535219|FG005|Parts 2 and 3|Adverse Event|0
7309744|NCT00669942|11535220|FG006|Parts 2 and 3|Adverse Event|0
7309745|NCT00669942|11535221|FG007|Parts 2 and 3|Adverse Event|2
7309746|NCT00669942|11535222|FG008|Parts 2 and 3|Adverse Event|1
7309747|NCT00669942|11535223|FG009|Parts 2 and 3|Adverse Event|0
7309748|NCT00669942|11535224|FG010|Parts 2 and 3|Adverse Event|0
7309749|NCT00669942|11535225|FG011|Parts 2 and 3|Adverse Event|0
7309750|NCT00669942|11535214|FG000|Parts 2 and 3|Withdrawal by Subject|0
7309751|NCT00669942|11535215|FG001|Parts 2 and 3|Withdrawal by Subject|0
7309752|NCT00669942|11535216|FG002|Parts 2 and 3|Withdrawal by Subject|0
7309753|NCT00669942|11535217|FG003|Parts 2 and 3|Withdrawal by Subject|0
7389734|NCT01230827|11649585|FG003|Overall Study|Recovery|0
7389735|NCT01230827|11649582|FG000|Overall Study|Study terminated by Sponsor|0
7389736|NCT01230827|11649583|FG001|Overall Study|Study terminated by Sponsor|2
7389737|NCT01230827|11649584|FG002|Overall Study|Study terminated by Sponsor|56
7389738|NCT01230827|11649585|FG003|Overall Study|Study terminated by Sponsor|63
7389739|NCT01230892|11649595|FG000|Overall Study|Withdrawal by Subject|1
7389740|NCT01230892|11649596|FG001|Overall Study|Withdrawal by Subject|1
7389741|NCT01230892|11649595|FG000|Overall Study|Lost to Follow-up|2
7389742|NCT01230892|11649596|FG001|Overall Study|Lost to Follow-up|0
7389743|NCT01231321|11649622|FG000|Overall Study|Adverse Event|3
7389744|NCT01231321|11649622|FG000|Overall Study|Lack of Efficacy|2
7389745|NCT01231373|11649645|FG000|Overall Study|Withdrew consent prior to randomization|2
7389746|NCT01231373|11649646|FG001|Overall Study|Withdrew consent prior to randomization|1
7389747|NCT01231373|11649647|FG002|Overall Study|Withdrew consent prior to randomization|0
7389748|NCT01231373|11649648|FG003|Overall Study|Withdrew consent prior to randomization|0
7389749|NCT01231373|11649645|FG000|Overall Study|Lost to Follow-up|0
7389750|NCT01231373|11649646|FG001|Overall Study|Lost to Follow-up|0
7389751|NCT01231373|11649647|FG002|Overall Study|Lost to Follow-up|0
7389752|NCT01231373|11649648|FG003|Overall Study|Lost to Follow-up|1
7389753|NCT01231373|11649645|FG000|Overall Study|Withdrew Consent|1
7389754|NCT01231373|11649646|FG001|Overall Study|Withdrew Consent|0
7389755|NCT01231373|11649647|FG002|Overall Study|Withdrew Consent|0
7389756|NCT01231373|11649648|FG003|Overall Study|Withdrew Consent|0
7389757|NCT01231464|11649680|FG000|Overall Study|Adverse Event|0
7389758|NCT01231464|11649681|FG001|Overall Study|Adverse Event|1
7389759|NCT01231464|11649680|FG000|Overall Study|Protocol Violation|1
7389760|NCT01231464|11649681|FG001|Overall Study|Protocol Violation|2
7389761|NCT01231464|11649680|FG000|Overall Study|Lost to Follow-up|1
7389762|NCT01231464|11649681|FG001|Overall Study|Lost to Follow-up|2
7389763|NCT01231464|11649680|FG000|Overall Study|Withdrawal by Subject|3
7389764|NCT01231464|11649681|FG001|Overall Study|Withdrawal by Subject|2
7389765|NCT01231503|11649697|FG000|Overall Study|Adverse Event|0
7389766|NCT01231503|11649698|FG001|Overall Study|Adverse Event|0
7389767|NCT01231503|11649699|FG002|Overall Study|Adverse Event|0
7389768|NCT01231503|11649700|FG003|Overall Study|Adverse Event|0
7389769|NCT01231503|11649701|FG004|Overall Study|Adverse Event|0
7389770|NCT01231503|11649702|FG005|Overall Study|Adverse Event|1
7309754|NCT00669942|11535218|FG004|Parts 2 and 3|Withdrawal by Subject|0
7309755|NCT00669942|11535219|FG005|Parts 2 and 3|Withdrawal by Subject|1
7309756|NCT00669942|11535220|FG006|Parts 2 and 3|Withdrawal by Subject|0
7309757|NCT00669942|11535221|FG007|Parts 2 and 3|Withdrawal by Subject|0
7309758|NCT00669942|11535222|FG008|Parts 2 and 3|Withdrawal by Subject|2
7309759|NCT00669942|11535223|FG009|Parts 2 and 3|Withdrawal by Subject|0
7309760|NCT00669942|11535224|FG010|Parts 2 and 3|Withdrawal by Subject|0
7309761|NCT00669942|11535225|FG011|Parts 2 and 3|Withdrawal by Subject|0
7309762|NCT00669942|11535214|FG000|Parts 2 and 3|Protocol Violation|0
7389771|NCT01231503|11649703|FG006|Overall Study|Adverse Event|0
7389772|NCT01231503|11649704|FG007|Overall Study|Adverse Event|0
7389773|NCT01231503|11649697|FG000|Overall Study|Adverse event, serious fatal|0
7389774|NCT01231503|11649698|FG001|Overall Study|Adverse event, serious fatal|0
7309763|NCT00669942|11535215|FG001|Parts 2 and 3|Protocol Violation|0
7309764|NCT00669942|11535216|FG002|Parts 2 and 3|Protocol Violation|0
7309765|NCT00669942|11535217|FG003|Parts 2 and 3|Protocol Violation|0
7309766|NCT00669942|11535218|FG004|Parts 2 and 3|Protocol Violation|0
7309767|NCT00669942|11535219|FG005|Parts 2 and 3|Protocol Violation|1
7309768|NCT00669942|11535220|FG006|Parts 2 and 3|Protocol Violation|0
7309769|NCT00669942|11535221|FG007|Parts 2 and 3|Protocol Violation|0
7309770|NCT00669942|11535222|FG008|Parts 2 and 3|Protocol Violation|0
7309771|NCT00669942|11535223|FG009|Parts 2 and 3|Protocol Violation|0
7309772|NCT00669942|11535224|FG010|Parts 2 and 3|Protocol Violation|0
7309773|NCT00669942|11535225|FG011|Parts 2 and 3|Protocol Violation|0
7309774|NCT00669955|11535250|FG000|Overall Study|Adverse Event|3
7309775|NCT00669955|11535251|FG001|Overall Study|Adverse Event|5
7309776|NCT00669955|11535250|FG000|Overall Study|Death|0
7309777|NCT00669955|11535251|FG001|Overall Study|Death|1
7309778|NCT00669955|11535250|FG000|Overall Study|Withdrawal by Subject|2
7309779|NCT00669955|11535251|FG001|Overall Study|Withdrawal by Subject|3
7309780|NCT00669955|11535250|FG000|Overall Study|Lost to Follow-up|5
7309781|NCT00669955|11535251|FG001|Overall Study|Lost to Follow-up|7
7309782|NCT00669955|11535250|FG000|Overall Study|Protocol Violation|2
7309783|NCT00669955|11535251|FG001|Overall Study|Protocol Violation|7
7309784|NCT00669955|11535250|FG000|Overall Study|Investigator Sponsor Judgement|0
7309785|NCT00669955|11535251|FG001|Overall Study|Investigator Sponsor Judgement|1
7309786|NCT00669955|11535250|FG000|Overall Study|not compliant with study drug/visit|2
7309787|NCT00669955|11535251|FG001|Overall Study|not compliant with study drug/visit|3
7309788|NCT00670007|11535257|FG000|Overall Study|Drug abuse|1
7309789|NCT00670007|11535257|FG000|Overall Study|Lung transplant|1
7309790|NCT00670007|11535257|FG000|Overall Study|Travel/Vacation|1
7309791|NCT00670007|11535257|FG000|Overall Study|Adverse event, serious fatal|1
7309792|NCT00670007|11535257|FG000|Overall Study|Adverse Event|1
7309793|NCT00670007|11535257|FG000|Overall Study|Withdrawal by Subject|4
7309794|NCT00670046|11535264|FG000|Overall Study|Lost to Follow-up|1
7309795|NCT00670046|11535265|FG001|Overall Study|Lost to Follow-up|1
7309796|NCT00670046|11535264|FG000|Overall Study|Withdrawal by Subject|0
7309797|NCT00670046|11535265|FG001|Overall Study|Withdrawal by Subject|1
7309798|NCT00670111|11535274|FG000|Enrollment to One Month|Testing Failure|0
7309799|NCT00670111|11535275|FG001|Enrollment to One Month|Testing Failure|0
7309800|NCT00670111|11535276|FG002|Enrollment to One Month|Testing Failure|13
7309801|NCT00670111|11535274|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7309802|NCT00670111|11535275|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
7309803|NCT00670111|11535276|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
7309804|NCT00670111|11535274|FG000|Enrollment to One Month|Physician Decision|1
7309805|NCT00670111|11535275|FG001|Enrollment to One Month|Physician Decision|0
7309806|NCT00670111|11535276|FG002|Enrollment to One Month|Physician Decision|0
7309807|NCT00670228|11535295|FG000|Overall Study|Adverse Event|1
7309808|NCT00670228|11535296|FG001|Overall Study|Adverse Event|0
7309809|NCT00670228|11535295|FG000|Overall Study|Death or MACE|0
7309810|NCT00670228|11535296|FG001|Overall Study|Death or MACE|1
7309811|NCT00670228|11535295|FG000|Overall Study|Not treated|2
7309812|NCT00670228|11535296|FG001|Overall Study|Not treated|2
7309813|NCT00670228|11535295|FG000|Overall Study|Not meeting the selection criteria|2
7309814|NCT00670228|11535296|FG001|Overall Study|Not meeting the selection criteria|0
7309815|NCT00670306|11535321|FG000|Overall Study|Adverse Event|8
7309816|NCT00670306|11535321|FG000|Overall Study|Lack of Efficacy|10
7309817|NCT00670306|11535321|FG000|Overall Study|Withdrawal by Subject|9
7309818|NCT00670306|11535321|FG000|Overall Study|Physician Decision|1
7309819|NCT00670306|11535321|FG000|Overall Study|Lost to Follow-up|8
7309820|NCT00670306|11535321|FG000|Overall Study|incl/excl criterias did not meet|19
7309821|NCT00670449|11535329|FG000|Overall Study|Adverse Event|6
7309822|NCT00670449|11535330|FG001|Overall Study|Adverse Event|2
7309823|NCT00670449|11535331|FG002|Overall Study|Adverse Event|8
7309824|NCT00670449|11535332|FG003|Overall Study|Adverse Event|5
7309825|NCT00670449|11535329|FG000|Overall Study|Protocol Deviation|1
7309826|NCT00670449|11535330|FG001|Overall Study|Protocol Deviation|2
7309827|NCT00670449|11535331|FG002|Overall Study|Protocol Deviation|0
7309828|NCT00670449|11535332|FG003|Overall Study|Protocol Deviation|1
7309829|NCT00670449|11535329|FG000|Overall Study|Administrative Problems|0
7309830|NCT00670449|11535330|FG001|Overall Study|Administrative Problems|2
7309831|NCT00670449|11535331|FG002|Overall Study|Administrative Problems|0
7309832|NCT00670449|11535332|FG003|Overall Study|Administrative Problems|1
7309833|NCT00670449|11535329|FG000|Overall Study|Subject Withdrew Consent|0
7309834|NCT00670449|11535330|FG001|Overall Study|Subject Withdrew Consent|2
7309835|NCT00670449|11535331|FG002|Overall Study|Subject Withdrew Consent|0
7309836|NCT00670449|11535332|FG003|Overall Study|Subject Withdrew Consent|1
7309837|NCT00670449|11535329|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
7309838|NCT00670449|11535330|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7309839|NCT00670449|11535331|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
7309840|NCT00670449|11535332|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
7309841|NCT00670449|11535329|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7309842|NCT00670449|11535330|FG001|Overall Study|Abnormal Laboratory Value(s)|2
7309843|NCT00670449|11535331|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7309844|NCT00670449|11535332|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7309845|NCT00670488|11535362|FG000|Overall Study|Adverse Event|0
7309846|NCT00670488|11535363|FG001|Overall Study|Adverse Event|7
7309847|NCT00670488|11535364|FG002|Overall Study|Adverse Event|0
7309848|NCT00670488|11535365|FG003|Overall Study|Adverse Event|3
7309849|NCT00670488|11535366|FG004|Overall Study|Adverse Event|1
7309850|NCT00670488|11535367|FG005|Overall Study|Adverse Event|1
7309851|NCT00670488|11535368|FG006|Overall Study|Adverse Event|5
7309852|NCT00670488|11535369|FG007|Overall Study|Adverse Event|1
7309853|NCT00670488|11535370|FG008|Overall Study|Adverse Event|0
7309854|NCT00670488|11535371|FG009|Overall Study|Adverse Event|1
7309855|NCT00670488|11535362|FG000|Overall Study|Physician Decision|1
7309856|NCT00670488|11535363|FG001|Overall Study|Physician Decision|9
7309857|NCT00670488|11535364|FG002|Overall Study|Physician Decision|0
7309858|NCT00670488|11535365|FG003|Overall Study|Physician Decision|1
7309859|NCT00670488|11535366|FG004|Overall Study|Physician Decision|0
7309860|NCT00670488|11535367|FG005|Overall Study|Physician Decision|0
7309861|NCT00670488|11535368|FG006|Overall Study|Physician Decision|0
7309862|NCT00670488|11535369|FG007|Overall Study|Physician Decision|0
7309863|NCT00670488|11535370|FG008|Overall Study|Physician Decision|0
7309864|NCT00670488|11535371|FG009|Overall Study|Physician Decision|0
7309865|NCT00670488|11535362|FG000|Overall Study|Progressive Disease|2
7309866|NCT00670488|11535363|FG001|Overall Study|Progressive Disease|41
7309867|NCT00670488|11535364|FG002|Overall Study|Progressive Disease|3
7309868|NCT00670488|11535365|FG003|Overall Study|Progressive Disease|2
7309869|NCT00670488|11535366|FG004|Overall Study|Progressive Disease|2
7309870|NCT00670488|11535367|FG005|Overall Study|Progressive Disease|4
7309871|NCT00670488|11535368|FG006|Overall Study|Progressive Disease|11
7309872|NCT00670488|11535369|FG007|Overall Study|Progressive Disease|2
7309873|NCT00670488|11535370|FG008|Overall Study|Progressive Disease|2
7309874|NCT00670488|11535371|FG009|Overall Study|Progressive Disease|1
7309875|NCT00670488|11535362|FG000|Overall Study|Withdrawal by Subject|0
7309876|NCT00670488|11535363|FG001|Overall Study|Withdrawal by Subject|1
7309877|NCT00670488|11535364|FG002|Overall Study|Withdrawal by Subject|0
7309878|NCT00670488|11535365|FG003|Overall Study|Withdrawal by Subject|1
7309879|NCT00670488|11535366|FG004|Overall Study|Withdrawal by Subject|0
7309880|NCT00670488|11535367|FG005|Overall Study|Withdrawal by Subject|0
7309881|NCT00670488|11535368|FG006|Overall Study|Withdrawal by Subject|1
7309882|NCT00670488|11535369|FG007|Overall Study|Withdrawal by Subject|0
7309883|NCT00670488|11535370|FG008|Overall Study|Withdrawal by Subject|1
7309884|NCT00670488|11535371|FG009|Overall Study|Withdrawal by Subject|0
7309885|NCT00670540|11535393|FG000|Overall Study|ineligible|17
7309886|NCT00670540|11535393|FG000|Overall Study|not living in France|348
7309887|NCT00670540|11535393|FG000|Overall Study|refused to participate|189
7309888|NCT00670540|11535393|FG000|Overall Study|controls randomised for no follow up|2770
7309889|NCT00670540|11535393|FG000|Overall Study|missing information inclusion criteria|1
7309890|NCT00670748|11535410|FG000|Overall Study|Death during treatment|1
7309891|NCT00670748|11535411|FG001|Overall Study|Death during treatment|1
7309892|NCT00670748|11535412|FG002|Overall Study|Death during treatment|1
7309893|NCT00670748|11535413|FG003|Overall Study|Death during treatment|0
7309894|NCT00670748|11535410|FG000|Overall Study|Not off study|2
7309895|NCT00670748|11535411|FG001|Overall Study|Not off study|1
7309896|NCT00670748|11535412|FG002|Overall Study|Not off study|1
7309897|NCT00670748|11535413|FG003|Overall Study|Not off study|1
7309898|NCT00670800|11535429|FG000|Overall Study|2 controls were insulin resistant|0
7309899|NCT00670800|11535430|FG001|Overall Study|2 controls were insulin resistant|2
7309900|NCT00670930|11535440|FG000|Overall Study|Adminstrative Problem|0
7309901|NCT00670930|11535441|FG001|Overall Study|Adminstrative Problem|1
7309902|NCT00670930|11535440|FG000|Overall Study|Lost to Follow-up|1
7309903|NCT00670930|11535441|FG001|Overall Study|Lost to Follow-up|0
7309904|NCT00671034|11535462|FG000|Overall Study|Adverse Event|5
7309905|NCT00671034|11535463|FG001|Overall Study|Adverse Event|7
7309906|NCT00671034|11535464|FG002|Overall Study|Adverse Event|1
7309907|NCT00671034|11535462|FG000|Overall Study|Death|3
7309908|NCT00671034|11535463|FG001|Overall Study|Death|2
7309909|NCT00671034|11535464|FG002|Overall Study|Death|1
7309910|NCT00671034|11535462|FG000|Overall Study|Physician Decision|12
7309911|NCT00671034|11535463|FG001|Overall Study|Physician Decision|4
7309912|NCT00671034|11535464|FG002|Overall Study|Physician Decision|5
7309913|NCT00671034|11535462|FG000|Overall Study|VHR ALL feature|8
7309914|NCT00671034|11535463|FG001|Overall Study|VHR ALL feature|3
7309915|NCT00671034|11535464|FG002|Overall Study|VHR ALL feature|5
7309916|NCT00671034|11535462|FG000|Overall Study|Refusal|5
7309917|NCT00671034|11535463|FG001|Overall Study|Refusal|3
7309918|NCT00671034|11535464|FG002|Overall Study|Refusal|5
7309919|NCT00671034|11535462|FG000|Overall Study|includes Alternative therapy, etc.|6
7309920|NCT00671034|11535463|FG001|Overall Study|includes Alternative therapy, etc.|1
7309921|NCT00671034|11535464|FG002|Overall Study|includes Alternative therapy, etc.|7
7309922|NCT00671060|11535475|FG000|Overall Study|Protocol Violation|1
7309923|NCT00671060|11535476|FG001|Overall Study|Protocol Violation|0
7309924|NCT00671060|11535475|FG000|Overall Study|Physician Decision|0
7309925|NCT00671060|11535476|FG001|Overall Study|Physician Decision|1
7309926|NCT00671437|11535491|FG000|Overall Study|Progressive disease before C1 week 8|8
7309927|NCT00671437|11535491|FG000|Overall Study|Cutaneous SCC of head and neck|3
7309928|NCT00671437|11535491|FG000|Overall Study|Adverse Event|3
7309929|NCT00671437|11535491|FG000|Overall Study|Ineligible post-hoc|1
7309930|NCT00671554|11535520|FG000|Overall Study|Disease progression|3
7309931|NCT00671658|11535525|FG000|Overall Study|Physician Decision|5
7309936|NCT00671788|11535556|FG000|Overall Study|Adverse Event|8
7309937|NCT00671788|11535556|FG000|Overall Study|Refused further treatment|3
7309938|NCT00671788|11535556|FG000|Overall Study|Ineligible|1
7309939|NCT00671788|11535556|FG000|Overall Study|MD Decision|1
7309940|NCT00671788|11535556|FG000|Overall Study|Other|1
7309941|NCT00671853|11535562|FG000|Overall Study|Lack of Efficacy|3
7309942|NCT00671853|11535563|FG001|Overall Study|Lack of Efficacy|7
7309943|NCT00671853|11535562|FG000|Overall Study|Adverse Event|7
7309944|NCT00671853|11535563|FG001|Overall Study|Adverse Event|1
7309945|NCT00671853|11535562|FG000|Overall Study|Withdrawal by Subject|1
7309946|NCT00671853|11535563|FG001|Overall Study|Withdrawal by Subject|5
7309947|NCT00671853|11535562|FG000|Overall Study|Lost to Follow-up|8
7309948|NCT00671853|11535563|FG001|Overall Study|Lost to Follow-up|8
7309949|NCT00671853|11535562|FG000|Overall Study|Physician Decision|0
7309950|NCT00671853|11535563|FG001|Overall Study|Physician Decision|2
7309951|NCT00671853|11535562|FG000|Overall Study|Non-adherence with study procedures|1
7309952|NCT00671853|11535563|FG001|Overall Study|Non-adherence with study procedures|4
7309953|NCT00671879|11535574|FG000|Overall Study|Withdrawal by Subject|0
7309954|NCT00671879|11535575|FG001|Overall Study|Withdrawal by Subject|4
7309955|NCT00671879|11535576|FG002|Overall Study|Withdrawal by Subject|6
7309956|NCT00671931|11535595|FG000|Overall Study|Physician Decision|1
7309957|NCT00671931|11535596|FG001|Overall Study|Physician Decision|0
7309958|NCT00671931|11535597|FG002|Overall Study|Physician Decision|0
7309959|NCT00671931|11535598|FG003|Overall Study|Physician Decision|2
7309960|NCT00671931|11535599|FG004|Overall Study|Physician Decision|1
7309961|NCT00672139|11535651|FG000|Overall Study|Death|14
7309962|NCT00672139|11535652|FG001|Overall Study|Death|23
7309963|NCT00672139|11535651|FG000|Overall Study|Withdrawal by Subject|2
7309964|NCT00672139|11535652|FG001|Overall Study|Withdrawal by Subject|11
7309965|NCT00672139|11535651|FG000|Overall Study|Adverse Event|4
7309966|NCT00672139|11535652|FG001|Overall Study|Adverse Event|7
7309967|NCT00672139|11535651|FG000|Overall Study|Physician Decision|2
7309968|NCT00672139|11535652|FG001|Overall Study|Physician Decision|0
7309969|NCT00672139|11535651|FG000|Overall Study|Lack of Efficacy|4
7309970|NCT00672139|11535652|FG001|Overall Study|Lack of Efficacy|1
7309971|NCT00672139|11535651|FG000|Overall Study|Protocol Violation|1
7309972|NCT00672139|11535652|FG001|Overall Study|Protocol Violation|1
7309973|NCT00672139|11535651|FG000|Overall Study|hospice discharge, caregiver requests|3
7309974|NCT00672139|11535652|FG001|Overall Study|hospice discharge, caregiver requests|2
7309975|NCT00672256|11535667|FG000|Overall Study|PI dropped, bad data|44
7309976|NCT00672477|11535691|FG000|Overall Study|Adverse Event|10
7309977|NCT00672477|11535692|FG001|Overall Study|Adverse Event|7
7309978|NCT00672477|11535691|FG000|Overall Study|Death|7
7309979|NCT00672477|11535692|FG001|Overall Study|Death|11
7309980|NCT00672477|11535691|FG000|Overall Study|Physician Decision|2
7309981|NCT00672477|11535692|FG001|Overall Study|Physician Decision|0
7309982|NCT00672477|11535691|FG000|Overall Study|Protocol Violation|1
7309983|NCT00672477|11535692|FG001|Overall Study|Protocol Violation|1
7309984|NCT00672477|11535691|FG000|Overall Study|Withdrawal by Subject|5
7309985|NCT00672477|11535692|FG001|Overall Study|Withdrawal by Subject|3
7309986|NCT00672477|11535691|FG000|Overall Study|Lack of Efficacy|1
7309987|NCT00672477|11535692|FG001|Overall Study|Lack of Efficacy|1
7309988|NCT00672477|11535691|FG000|Overall Study|no study drug for low GFR, health cond.|1
7309989|NCT00672477|11535692|FG001|Overall Study|no study drug for low GFR, health cond.|3
7309990|NCT00672490|11535700|FG000|Overall Study|Withdrawal by Subject|8
7309991|NCT00672490|11535701|FG001|Overall Study|Withdrawal by Subject|8
7309992|NCT00672490|11535700|FG000|Overall Study|Lack of Compliance|2
7309993|NCT00672490|11535701|FG001|Overall Study|Lack of Compliance|7
7309994|NCT00672490|11535700|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
7309995|NCT00672490|11535701|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
7309996|NCT00672490|11535700|FG000|Overall Study|Adverse Event|5
7309997|NCT00672490|11535701|FG001|Overall Study|Adverse Event|8
7309998|NCT00672490|11535700|FG000|Overall Study|Violation of Concomitant Medicine|1
7309999|NCT00672490|11535701|FG001|Overall Study|Violation of Concomitant Medicine|0
7310000|NCT00672490|11535700|FG000|Overall Study|Intolerance|0
7310001|NCT00672490|11535701|FG001|Overall Study|Intolerance|2
7310002|NCT00672490|11535700|FG000|Overall Study|Lost to Follow-up|1
7310003|NCT00672490|11535701|FG001|Overall Study|Lost to Follow-up|5
7310004|NCT00672490|11535700|FG000|Overall Study|No reason was provided|6
7310005|NCT00672490|11535701|FG001|Overall Study|No reason was provided|2
7310006|NCT00672555|11535707|FG000|Overall Study|Lost to Follow-up|4
7310007|NCT00672555|11535707|FG000|Overall Study|Did not want to answer questionnaire|2
7384192|NCT01193218|11641336|FG007|12-52 Weeks|Adverse Event|2
7384193|NCT01193218|11641329|FG000|12-52 Weeks|Lack of Efficacy|0
7384194|NCT01193218|11641330|FG001|12-52 Weeks|Lack of Efficacy|0
7384195|NCT01193218|11641331|FG002|12-52 Weeks|Lack of Efficacy|0
7384196|NCT01193218|11641332|FG003|12-52 Weeks|Lack of Efficacy|0
7384197|NCT01193218|11641333|FG004|12-52 Weeks|Lack of Efficacy|0
7384198|NCT01193218|11641334|FG005|12-52 Weeks|Lack of Efficacy|0
7384199|NCT01193218|11641335|FG006|12-52 Weeks|Lack of Efficacy|1
7310008|NCT00672620|11535719|FG000|Overall Study|Adverse Event|7
7310009|NCT00672620|11535720|FG001|Overall Study|Adverse Event|7
7310010|NCT00672620|11535721|FG002|Overall Study|Adverse Event|12
7310011|NCT00672620|11535722|FG003|Overall Study|Adverse Event|17
7310012|NCT00672620|11535719|FG000|Overall Study|Lack of Efficacy|1
7310013|NCT00672620|11535720|FG001|Overall Study|Lack of Efficacy|2
7310014|NCT00672620|11535721|FG002|Overall Study|Lack of Efficacy|2
7310015|NCT00672620|11535722|FG003|Overall Study|Lack of Efficacy|0
7310016|NCT00672620|11535719|FG000|Overall Study|Noncompliance with Study Drug|3
7310017|NCT00672620|11535720|FG001|Overall Study|Noncompliance with Study Drug|4
7310018|NCT00672620|11535721|FG002|Overall Study|Noncompliance with Study Drug|0
7310019|NCT00672620|11535722|FG003|Overall Study|Noncompliance with Study Drug|2
7310020|NCT00672620|11535719|FG000|Overall Study|Protocol Deviations|5
7310021|NCT00672620|11535720|FG001|Overall Study|Protocol Deviations|7
7310022|NCT00672620|11535721|FG002|Overall Study|Protocol Deviations|2
7310023|NCT00672620|11535722|FG003|Overall Study|Protocol Deviations|5
7310024|NCT00672620|11535719|FG000|Overall Study|Withdrawal of Consent|6
7310025|NCT00672620|11535720|FG001|Overall Study|Withdrawal of Consent|12
7310026|NCT00672620|11535721|FG002|Overall Study|Withdrawal of Consent|5
7310027|NCT00672620|11535722|FG003|Overall Study|Withdrawal of Consent|6
7310028|NCT00672620|11535719|FG000|Overall Study|Lost to Follow-up|8
7310029|NCT00672620|11535720|FG001|Overall Study|Lost to Follow-up|19
7310030|NCT00672620|11535721|FG002|Overall Study|Lost to Follow-up|8
7310031|NCT00672620|11535722|FG003|Overall Study|Lost to Follow-up|11
7310032|NCT00672620|11535719|FG000|Overall Study|Reason not Specified|3
7310033|NCT00672620|11535720|FG001|Overall Study|Reason not Specified|3
7310034|NCT00672620|11535721|FG002|Overall Study|Reason not Specified|2
7310035|NCT00672620|11535722|FG003|Overall Study|Reason not Specified|1
7310036|NCT00672633|11535734|FG000|Overall Study|Withdrawal by Subject|0
7310037|NCT00672633|11535735|FG001|Overall Study|Withdrawal by Subject|1
7310038|NCT00672646|11535744|FG000|Overall Study|Lost to Follow-up|0
7310039|NCT00672646|11535745|FG001|Overall Study|Lost to Follow-up|1
7310040|NCT00672646|11535746|FG002|Overall Study|Lost to Follow-up|2
7310041|NCT00672646|11535744|FG000|Overall Study|Withdrawal by Subject|0
7310042|NCT00672646|11535745|FG001|Overall Study|Withdrawal by Subject|0
7310043|NCT00672646|11535746|FG002|Overall Study|Withdrawal by Subject|1
7310044|NCT00672841|11535761|FG000|Overall Study|Comfort care|1
7310045|NCT00672841|11535762|FG001|Overall Study|Comfort care|4
7310046|NCT00672841|11535761|FG000|Overall Study|icteric specimens|0
7310047|NCT00672841|11535762|FG001|Overall Study|icteric specimens|3
7310048|NCT00672841|11535761|FG000|Overall Study|Antifungal therapy, negative glucan|0
7310049|NCT00672841|11535762|FG001|Overall Study|Antifungal therapy, negative glucan|4
7310050|NCT00672841|11535761|FG000|Overall Study|Adverse Event|0
7310051|NCT00672841|11535762|FG001|Overall Study|Adverse Event|3
7310052|NCT00672841|11535761|FG000|Overall Study|Pregnancy|0
7310053|NCT00672841|11535762|FG001|Overall Study|Pregnancy|1
7310054|NCT00672958|11535793|FG000|Overall Study|Adverse Event|11
7310055|NCT00672958|11535794|FG001|Overall Study|Adverse Event|9
7310056|NCT00672958|11535793|FG000|Overall Study|Lack of Efficacy|6
7310057|NCT00672958|11535794|FG001|Overall Study|Lack of Efficacy|11
7310058|NCT00672958|11535793|FG000|Overall Study|Non-compliance with study drug|2
7310059|NCT00672958|11535794|FG001|Overall Study|Non-compliance with study drug|3
7310060|NCT00672958|11535793|FG000|Overall Study|Protocol deviations|11
7310061|NCT00672958|11535794|FG001|Overall Study|Protocol deviations|5
7310062|NCT00672958|11535793|FG000|Overall Study|Voluntary withdrawal|12
7310063|NCT00672958|11535794|FG001|Overall Study|Voluntary withdrawal|8
7310064|NCT00672958|11535793|FG000|Overall Study|Lost to Follow-up|22
7310065|NCT00672958|11535794|FG001|Overall Study|Lost to Follow-up|17
7310066|NCT00672958|11535793|FG000|Overall Study|Reason not specified|0
7310067|NCT00672958|11535794|FG001|Overall Study|Reason not specified|3
7310068|NCT00672984|11535803|FG000|First Intervention|Adverse Event|5
7310069|NCT00672984|11535804|FG001|First Intervention|Adverse Event|0
7310070|NCT00672984|11535805|FG002|First Intervention|Adverse Event|0
7310071|NCT00672984|11535803|FG000|First Intervention|Withdrawal by Subject|1
7310072|NCT00672984|11535804|FG001|First Intervention|Withdrawal by Subject|2
7310073|NCT00672984|11535805|FG002|First Intervention|Withdrawal by Subject|2
7310074|NCT00672984|11535803|FG000|First Intervention|Sponsor decision|3
7468554|NCT01912287|11769442|FG002|Overall Study|Missed Assesment|1
7310075|NCT00672984|11535804|FG001|First Intervention|Sponsor decision|0
7310076|NCT00672984|11535805|FG002|First Intervention|Sponsor decision|0
7310077|NCT00672984|11535803|FG000|Second Intervention|Non-compliance with facility policies|0
7310078|NCT00672984|11535804|FG001|Second Intervention|Non-compliance with facility policies|2
7310079|NCT00672984|11535805|FG002|Second Intervention|Non-compliance with facility policies|0
7310080|NCT00672984|11535803|FG000|Second Intervention|Withdrawal by Subject|0
7310081|NCT00672984|11535804|FG001|Second Intervention|Withdrawal by Subject|3
7310082|NCT00672984|11535805|FG002|Second Intervention|Withdrawal by Subject|0
7310083|NCT00672984|11535803|FG000|Second Intervention|Protocol Violation|0
7310084|NCT00672984|11535804|FG001|Second Intervention|Protocol Violation|1
7310085|NCT00672984|11535805|FG002|Second Intervention|Protocol Violation|1
7310086|NCT00672984|11535803|FG000|Third Intervention|Adverse Event|1
7310087|NCT00672984|11535804|FG001|Third Intervention|Adverse Event|0
7310088|NCT00672984|11535805|FG002|Third Intervention|Adverse Event|1
7384200|NCT01193218|11641336|FG007|12-52 Weeks|Lack of Efficacy|0
7384201|NCT01193218|11641329|FG000|12-52 Weeks|Withdrawal by Subject|3
7310089|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Randomized but not treated|3
7310090|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Randomized but not treated|1
7310091|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Randomized but not treated|0
7310092|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Randomized but not treated|0
7310093|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Death|235
7310094|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Death|167
7310095|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Death|1
7310096|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Death|0
7310097|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
7310098|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
7310099|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
7310100|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
7310101|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
7310102|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
7310103|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
7310104|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
7310105|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Other|1
7310106|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Other|2
7310107|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Other|0
7310108|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Other|0
7310109|NCT00673049|11535817|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
7310110|NCT00673049|11535818|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
7310111|NCT00673049|11535819|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
7310112|NCT00673049|11535820|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
7310113|NCT00673049|11535817|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
7310114|NCT00673049|11535818|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
7310115|NCT00673049|11535819|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
7310116|NCT00673049|11535820|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
7310117|NCT00673049|11535817|FG000|After Progression on Erlotinib|Death|0
7310118|NCT00673049|11535818|FG001|After Progression on Erlotinib|Death|0
7310119|NCT00673049|11535819|FG002|After Progression on Erlotinib|Death|0
7310120|NCT00673049|11535820|FG003|After Progression on Erlotinib|Death|71
7310121|NCT00673049|11535817|FG000|After Progression on Erlotinib|Lost to Follow-up|0
7310122|NCT00673049|11535818|FG001|After Progression on Erlotinib|Lost to Follow-up|0
7310123|NCT00673049|11535819|FG002|After Progression on Erlotinib|Lost to Follow-up|0
7310124|NCT00673049|11535820|FG003|After Progression on Erlotinib|Lost to Follow-up|3
7310125|NCT00673049|11535817|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
7310126|NCT00673049|11535818|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
7310127|NCT00673049|11535819|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
7310128|NCT00673049|11535820|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
7310129|NCT00673049|11535817|FG000|After Progression on Erlotinib|study terminated by sponsor|0
7310130|NCT00673049|11535818|FG001|After Progression on Erlotinib|study terminated by sponsor|0
7310131|NCT00673049|11535819|FG002|After Progression on Erlotinib|study terminated by sponsor|0
7310132|NCT00673049|11535820|FG003|After Progression on Erlotinib|study terminated by sponsor|4
7310133|NCT00673231|11535856|FG000|Overall Study|Withdrawal by Subject|14
7310134|NCT00673231|11535857|FG001|Overall Study|Withdrawal by Subject|10
7310135|NCT00673231|11535858|FG002|Overall Study|Withdrawal by Subject|8
7310136|NCT00673231|11535859|FG003|Overall Study|Withdrawal by Subject|6
7310137|NCT00673231|11535856|FG000|Overall Study|Adverse Event|6
7310138|NCT00673231|11535857|FG001|Overall Study|Adverse Event|5
7310139|NCT00673231|11535858|FG002|Overall Study|Adverse Event|9
7310140|NCT00673231|11535859|FG003|Overall Study|Adverse Event|6
7310141|NCT00673231|11535856|FG000|Overall Study|Lost to Follow-up|1
7310142|NCT00673231|11535857|FG001|Overall Study|Lost to Follow-up|2
7310143|NCT00673231|11535858|FG002|Overall Study|Lost to Follow-up|1
7310144|NCT00673231|11535859|FG003|Overall Study|Lost to Follow-up|2
7310145|NCT00673231|11535856|FG000|Overall Study|Death|0
7310146|NCT00673231|11535857|FG001|Overall Study|Death|0
7310147|NCT00673231|11535858|FG002|Overall Study|Death|1
7310148|NCT00673231|11535859|FG003|Overall Study|Death|0
7310149|NCT00673231|11535856|FG000|Overall Study|Study criteria,compliance,safety, other|8
7310150|NCT00673231|11535857|FG001|Overall Study|Study criteria,compliance,safety, other|5
7310151|NCT00673231|11535858|FG002|Overall Study|Study criteria,compliance,safety, other|7
7310152|NCT00673231|11535859|FG003|Overall Study|Study criteria,compliance,safety, other|4
7310153|NCT00673257|11535878|FG000|Overall Study|Withdrawal by Subject|4
7310154|NCT00673257|11535878|FG000|Overall Study|Unable to obtain specimen|1
7310155|NCT00673387|11535890|FG000|Overall Study|Withdrawal by Subject|15
7310156|NCT00673387|11535891|FG001|Overall Study|Withdrawal by Subject|16
7310157|NCT00673387|11535892|FG002|Overall Study|Withdrawal by Subject|20
7310158|NCT00673387|11535893|FG003|Overall Study|Withdrawal by Subject|16
7310159|NCT00673387|11535894|FG004|Overall Study|Withdrawal by Subject|18
7310160|NCT00673387|11535895|FG005|Overall Study|Withdrawal by Subject|21
7310161|NCT00673387|11535896|FG006|Overall Study|Withdrawal by Subject|15
7310162|NCT00673387|11535897|FG007|Overall Study|Withdrawal by Subject|21
7310163|NCT00673387|11535890|FG000|Overall Study|Adverse Event|3
7310164|NCT00673387|11535891|FG001|Overall Study|Adverse Event|1
7310165|NCT00673387|11535892|FG002|Overall Study|Adverse Event|5
7310166|NCT00673387|11535893|FG003|Overall Study|Adverse Event|2
7310167|NCT00673387|11535894|FG004|Overall Study|Adverse Event|6
7310168|NCT00673387|11535895|FG005|Overall Study|Adverse Event|2
7310169|NCT00673387|11535896|FG006|Overall Study|Adverse Event|5
7310170|NCT00673387|11535897|FG007|Overall Study|Adverse Event|5
7310171|NCT00673387|11535890|FG000|Overall Study|Physician Decision|0
7310172|NCT00673387|11535891|FG001|Overall Study|Physician Decision|0
7310173|NCT00673387|11535892|FG002|Overall Study|Physician Decision|0
7310174|NCT00673387|11535893|FG003|Overall Study|Physician Decision|0
7310175|NCT00673387|11535894|FG004|Overall Study|Physician Decision|0
7310176|NCT00673387|11535895|FG005|Overall Study|Physician Decision|5
7310177|NCT00673387|11535896|FG006|Overall Study|Physician Decision|1
7310178|NCT00673387|11535897|FG007|Overall Study|Physician Decision|1
7310179|NCT00673387|11535890|FG000|Overall Study|Protocol Violation|3
7310180|NCT00673387|11535891|FG001|Overall Study|Protocol Violation|0
7310181|NCT00673387|11535892|FG002|Overall Study|Protocol Violation|1
7310182|NCT00673387|11535893|FG003|Overall Study|Protocol Violation|2
7310183|NCT00673387|11535894|FG004|Overall Study|Protocol Violation|0
7310184|NCT00673387|11535895|FG005|Overall Study|Protocol Violation|1
7310185|NCT00673387|11535896|FG006|Overall Study|Protocol Violation|1
7310186|NCT00673387|11535897|FG007|Overall Study|Protocol Violation|3
7310187|NCT00673387|11535890|FG000|Overall Study|Lost to Follow-up|8
7310188|NCT00673387|11535891|FG001|Overall Study|Lost to Follow-up|6
7310189|NCT00673387|11535892|FG002|Overall Study|Lost to Follow-up|5
7310190|NCT00673387|11535893|FG003|Overall Study|Lost to Follow-up|6
7310191|NCT00673387|11535894|FG004|Overall Study|Lost to Follow-up|6
7310192|NCT00673387|11535895|FG005|Overall Study|Lost to Follow-up|5
7310193|NCT00673387|11535896|FG006|Overall Study|Lost to Follow-up|8
7310194|NCT00673387|11535897|FG007|Overall Study|Lost to Follow-up|5
7310195|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Adverse Event|41
7310196|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Adverse Event|24
7310197|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
7310198|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
7310199|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
7310200|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
7310201|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Physician Decision|0
7310202|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Physician Decision|6
7310203|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Protocol Violation|5
7310204|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Protocol Violation|3
7310205|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Sponsor Decision|0
7310206|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Sponsor Decision|1
7310207|NCT00673452|11535942|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
7310208|NCT00673452|11535943|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
7310209|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Adverse Event|5
7310210|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Adverse Event|13
7389775|NCT01231503|11649699|FG002|Overall Study|Adverse event, serious fatal|1
7389776|NCT01231503|11649700|FG003|Overall Study|Adverse event, serious fatal|1
7389777|NCT01231503|11649701|FG004|Overall Study|Adverse event, serious fatal|0
7389778|NCT01231503|11649702|FG005|Overall Study|Adverse event, serious fatal|1
7389779|NCT01231503|11649703|FG006|Overall Study|Adverse event, serious fatal|0
7389780|NCT01231503|11649704|FG007|Overall Study|Adverse event, serious fatal|0
7389781|NCT01231503|11649697|FG000|Overall Study|Withdrawal by Subject|6
7389782|NCT01231503|11649698|FG001|Overall Study|Withdrawal by Subject|3
7389783|NCT01231503|11649699|FG002|Overall Study|Withdrawal by Subject|3
7389784|NCT01231503|11649700|FG003|Overall Study|Withdrawal by Subject|1
7389785|NCT01231503|11649701|FG004|Overall Study|Withdrawal by Subject|3
7389786|NCT01231503|11649702|FG005|Overall Study|Withdrawal by Subject|5
7389787|NCT01231503|11649703|FG006|Overall Study|Withdrawal by Subject|1
7389788|NCT01231503|11649704|FG007|Overall Study|Withdrawal by Subject|2
7389789|NCT01231503|11649697|FG000|Overall Study|Lost to Follow-up|8
7389790|NCT01231503|11649698|FG001|Overall Study|Lost to Follow-up|10
7389791|NCT01231503|11649699|FG002|Overall Study|Lost to Follow-up|8
7389792|NCT01231503|11649700|FG003|Overall Study|Lost to Follow-up|5
7389793|NCT01231503|11649701|FG004|Overall Study|Lost to Follow-up|7
7389794|NCT01231503|11649702|FG005|Overall Study|Lost to Follow-up|9
7389795|NCT01231503|11649703|FG006|Overall Study|Lost to Follow-up|6
7389796|NCT01231503|11649704|FG007|Overall Study|Lost to Follow-up|6
7389797|NCT01231503|11649697|FG000|Overall Study|Protocol Violation|0
7389798|NCT01231503|11649698|FG001|Overall Study|Protocol Violation|0
7389799|NCT01231503|11649699|FG002|Overall Study|Protocol Violation|0
7310211|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
7310212|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
7310213|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
7310214|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
7310215|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
7310216|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
7310217|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Protocol Violation|2
7310218|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Protocol Violation|3
7310219|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
7310220|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
7310221|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Physician Decision|2
7310222|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Physician Decision|0
7310223|NCT00673452|11535942|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
7389800|NCT01231503|11649700|FG003|Overall Study|Protocol Violation|1
7389801|NCT01231503|11649701|FG004|Overall Study|Protocol Violation|0
7389802|NCT01231503|11649702|FG005|Overall Study|Protocol Violation|0
7389803|NCT01231503|11649703|FG006|Overall Study|Protocol Violation|0
7389804|NCT01231503|11649704|FG007|Overall Study|Protocol Violation|0
7389805|NCT01231555|11649735|FG000|Overall Study|Study terminated|8
7389806|NCT01231555|11649736|FG001|Overall Study|Study terminated|5
7389807|NCT01231555|11649737|FG002|Overall Study|Study terminated|8
7389808|NCT01231555|11649735|FG000|Overall Study|Withdrawal by Subject|0
7389809|NCT01231555|11649736|FG001|Overall Study|Withdrawal by Subject|2
7389810|NCT01231555|11649737|FG002|Overall Study|Withdrawal by Subject|0
7389811|NCT01231581|11649747|FG000|Overall Study|Lost to Follow-up|2
7389812|NCT01231581|11649748|FG001|Overall Study|Lost to Follow-up|2
7389813|NCT01231581|11649747|FG000|Overall Study|Withdrawal by Subject|6
7389814|NCT01231581|11649748|FG001|Overall Study|Withdrawal by Subject|9
7389815|NCT01231581|11649747|FG000|Overall Study|Study Closed/Terminated|6
7389816|NCT01231581|11649748|FG001|Overall Study|Study Closed/Terminated|5
7389817|NCT01231581|11649747|FG000|Overall Study|Death|65
7389818|NCT01231581|11649748|FG001|Overall Study|Death|64
7389819|NCT01231581|11649747|FG000|Overall Study|Ongoing|1
7389820|NCT01231581|11649748|FG001|Overall Study|Ongoing|0
7389821|NCT01231607|11649759|FG000|Overall Study|Adverse Event|0
7389822|NCT01231607|11649760|FG001|Overall Study|Adverse Event|8
7389823|NCT01231607|11649761|FG002|Overall Study|Adverse Event|4
7389824|NCT01231607|11649762|FG003|Overall Study|Adverse Event|4
7389825|NCT01231607|11649763|FG004|Overall Study|Adverse Event|5
7389826|NCT01231607|11649759|FG000|Overall Study|Lost to Follow-up|13
7389827|NCT01231607|11649760|FG001|Overall Study|Lost to Follow-up|11
7389828|NCT01231607|11649761|FG002|Overall Study|Lost to Follow-up|10
7389829|NCT01231607|11649762|FG003|Overall Study|Lost to Follow-up|10
7389830|NCT01231607|11649763|FG004|Overall Study|Lost to Follow-up|4
7389831|NCT01231607|11649759|FG000|Overall Study|Physician Decision|4
7389832|NCT01231607|11649760|FG001|Overall Study|Physician Decision|4
7389833|NCT01231607|11649761|FG002|Overall Study|Physician Decision|3
7389834|NCT01231607|11649762|FG003|Overall Study|Physician Decision|5
7389835|NCT01231607|11649763|FG004|Overall Study|Physician Decision|4
7389836|NCT01231607|11649759|FG000|Overall Study|Protocol Violation|3
7389837|NCT01231607|11649760|FG001|Overall Study|Protocol Violation|2
7389838|NCT01231607|11649761|FG002|Overall Study|Protocol Violation|0
7389839|NCT01231607|11649762|FG003|Overall Study|Protocol Violation|2
7389840|NCT01231607|11649763|FG004|Overall Study|Protocol Violation|2
7389841|NCT01231607|11649759|FG000|Overall Study|Withdrawal by Subject|9
7389842|NCT01231607|11649760|FG001|Overall Study|Withdrawal by Subject|9
7389843|NCT01231607|11649761|FG002|Overall Study|Withdrawal by Subject|14
7389844|NCT01231607|11649762|FG003|Overall Study|Withdrawal by Subject|17
7389845|NCT01231607|11649763|FG004|Overall Study|Withdrawal by Subject|9
7389846|NCT01231620|11649781|FG000|Overall Study|Physician Decision|3
7389847|NCT01231620|11649782|FG001|Overall Study|Physician Decision|5
7389848|NCT01231620|11649783|FG002|Overall Study|Physician Decision|10
7389849|NCT01231620|11649781|FG000|Overall Study|Death|12
7389850|NCT01231620|11649782|FG001|Overall Study|Death|14
7389851|NCT01231620|11649783|FG002|Overall Study|Death|11
7389852|NCT01231620|11649781|FG000|Overall Study|Adverse Event|2
7389853|NCT01231620|11649782|FG001|Overall Study|Adverse Event|2
7389854|NCT01231620|11649783|FG002|Overall Study|Adverse Event|1
7389855|NCT01231620|11649781|FG000|Overall Study|Withdrawal by Subject|6
7389856|NCT01231620|11649782|FG001|Overall Study|Withdrawal by Subject|6
7389857|NCT01231620|11649783|FG002|Overall Study|Withdrawal by Subject|8
7389858|NCT01231620|11649781|FG000|Overall Study|Lost to Follow-up|3
7389859|NCT01231620|11649782|FG001|Overall Study|Lost to Follow-up|4
7389860|NCT01231620|11649783|FG002|Overall Study|Lost to Follow-up|9
7389861|NCT01231659|11649811|FG000|Overall Study|Adverse Event|9
7389862|NCT01231659|11649811|FG000|Overall Study|Disease Progression|48
7389863|NCT01231659|11649811|FG000|Overall Study|Death|2
7389864|NCT01231659|11649811|FG000|Overall Study|Patient refused to complete study visit|1
7389865|NCT01231659|11649811|FG000|Overall Study|Other protocol defined criteria|12
7389866|NCT01231984|11649821|FG000|Study Period 1|Withdrawal by Subject|0
7389867|NCT01231984|11649822|FG001|Study Period 1|Withdrawal by Subject|0
7389868|NCT01231984|11649823|FG002|Study Period 1|Withdrawal by Subject|0
7389869|NCT01231984|11649824|FG003|Study Period 1|Withdrawal by Subject|1
7389870|NCT01231984|11649821|FG000|Study Period 1|Lost to Follow-up|1
7310224|NCT00673452|11535943|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
7310225|NCT00673465|11535949|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
7310226|NCT00673465|11535950|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
7310227|NCT00673465|11535951|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
7310228|NCT00673465|11535952|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
7310229|NCT00673465|11535953|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
7310230|NCT00673465|11535954|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
7310231|NCT00673465|11535955|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
7310232|NCT00673465|11535956|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
7310233|NCT00673465|11535957|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
7310234|NCT00673465|11535958|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
7310235|NCT00673465|11535959|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
7310236|NCT00673465|11535960|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
7310237|NCT00673465|11535949|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
7310238|NCT00673465|11535950|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
7310239|NCT00673465|11535951|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
7310240|NCT00673465|11535952|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
7310241|NCT00673465|11535953|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
7310242|NCT00673465|11535954|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
7310243|NCT00673465|11535955|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
7310244|NCT00673465|11535956|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
7310245|NCT00673465|11535957|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
7310246|NCT00673465|11535958|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
7310247|NCT00673465|11535959|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
7310248|NCT00673465|11535960|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
7310249|NCT00673660|11535968|FG000|Overall Study|Lost to Follow-up|107
7310250|NCT00673673|11535977|FG000|Overall Study|Progressive disease|27
7310251|NCT00673673|11535977|FG000|Overall Study|Adverse Event|4
7310252|NCT00673673|11535977|FG000|Overall Study|Withdrawal by Subject|3
7310253|NCT00673673|11535977|FG000|Overall Study|Investigators' discretion|2
7310254|NCT00673790|11536004|FG000|Overall Study|Adverse Event|23
7310255|NCT00673790|11536005|FG001|Overall Study|Adverse Event|14
7310256|NCT00673790|11536006|FG002|Overall Study|Adverse Event|2
7310257|NCT00673790|11536004|FG000|Overall Study|Lack of Efficacy|2
7310258|NCT00673790|11536005|FG001|Overall Study|Lack of Efficacy|2
7310259|NCT00673790|11536006|FG002|Overall Study|Lack of Efficacy|2
7310260|NCT00673790|11536004|FG000|Overall Study|Protocol Violation|6
7389871|NCT01231984|11649822|FG001|Study Period 1|Lost to Follow-up|1
7389872|NCT01231984|11649823|FG002|Study Period 1|Lost to Follow-up|1
7389873|NCT01231984|11649824|FG003|Study Period 1|Lost to Follow-up|0
7389874|NCT01231984|11649821|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
7389875|NCT01231984|11649822|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
7389876|NCT01231984|11649823|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
7389877|NCT01231984|11649824|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
7389878|NCT01231984|11649821|FG000|Study Period 1|Screen Failure|0
7389879|NCT01231984|11649822|FG001|Study Period 1|Screen Failure|0
7389880|NCT01231984|11649823|FG002|Study Period 1|Screen Failure|0
7389881|NCT01231984|11649824|FG003|Study Period 1|Screen Failure|1
7389882|NCT01231984|11649821|FG000|Study Period 1|Non-compliance with study requirements|5
7389883|NCT01231984|11649822|FG001|Study Period 1|Non-compliance with study requirements|0
7389884|NCT01231984|11649823|FG002|Study Period 1|Non-compliance with study requirements|2
7389885|NCT01231984|11649824|FG003|Study Period 1|Non-compliance with study requirements|1
7389886|NCT01231984|11649821|FG000|Study Period 1|Protocol Violation|3
7389887|NCT01231984|11649822|FG001|Study Period 1|Protocol Violation|4
7389888|NCT01231984|11649823|FG002|Study Period 1|Protocol Violation|2
7389889|NCT01231984|11649824|FG003|Study Period 1|Protocol Violation|3
7389890|NCT01231984|11649821|FG000|Study Period 1|Adverse Event|1
7389891|NCT01231984|11649822|FG001|Study Period 1|Adverse Event|0
7389892|NCT01231984|11649823|FG002|Study Period 1|Adverse Event|0
7389893|NCT01231984|11649824|FG003|Study Period 1|Adverse Event|0
7389894|NCT01231984|11649821|FG000|Study Period 1|Other|0
7389895|NCT01231984|11649822|FG001|Study Period 1|Other|0
7389896|NCT01231984|11649823|FG002|Study Period 1|Other|0
7389897|NCT01231984|11649824|FG003|Study Period 1|Other|1
7389898|NCT01231984|11649821|FG000|Study Period 2|Withdrawal by Subject|1
7389899|NCT01231984|11649822|FG001|Study Period 2|Withdrawal by Subject|1
7389900|NCT01231984|11649823|FG002|Study Period 2|Withdrawal by Subject|0
7389901|NCT01231984|11649824|FG003|Study Period 2|Withdrawal by Subject|0
7389902|NCT01231984|11649821|FG000|Study Period 2|Lost to Follow-up|1
7389903|NCT01231984|11649822|FG001|Study Period 2|Lost to Follow-up|0
7389904|NCT01231984|11649823|FG002|Study Period 2|Lost to Follow-up|0
7389905|NCT01231984|11649824|FG003|Study Period 2|Lost to Follow-up|3
7389906|NCT01231984|11649821|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
7389907|NCT01231984|11649822|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
7389908|NCT01231984|11649823|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
7389909|NCT01231984|11649824|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
7389910|NCT01232127|11649842|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
7389911|NCT01232127|11649843|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
7389912|NCT01232127|11649844|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
7389913|NCT01232296|11649867|FG000|Overall Study|Adverse Event|24
7389914|NCT01232296|11649868|FG001|Overall Study|Adverse Event|12
7389915|NCT01232296|11649867|FG000|Overall Study|Physician Decision|1
7389916|NCT01232296|11649868|FG001|Overall Study|Physician Decision|1
7310261|NCT00673790|11536005|FG001|Overall Study|Protocol Violation|9
7310262|NCT00673790|11536006|FG002|Overall Study|Protocol Violation|1
7389917|NCT01232296|11649867|FG000|Overall Study|Progressive disease|43
7310263|NCT00673790|11536004|FG000|Overall Study|Withdrawal by Subject|7
7310264|NCT00673790|11536005|FG001|Overall Study|Withdrawal by Subject|4
7310265|NCT00673790|11536006|FG002|Overall Study|Withdrawal by Subject|1
7310266|NCT00673790|11536004|FG000|Overall Study|Lost to Follow-up|6
7310267|NCT00673790|11536005|FG001|Overall Study|Lost to Follow-up|6
7310268|NCT00673790|11536006|FG002|Overall Study|Lost to Follow-up|5
7310269|NCT00673790|11536004|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
7310270|NCT00673790|11536005|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
7310271|NCT00673790|11536006|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
7310272|NCT00673790|11536004|FG000|Overall Study|Poor compliance|1
7310273|NCT00673790|11536005|FG001|Overall Study|Poor compliance|0
7310274|NCT00673790|11536006|FG002|Overall Study|Poor compliance|0
7310275|NCT00673790|11536004|FG000|Overall Study|Participated in two Nebivolol studies|0
7310276|NCT00673790|11536005|FG001|Overall Study|Participated in two Nebivolol studies|0
7310277|NCT00673790|11536006|FG002|Overall Study|Participated in two Nebivolol studies|1
7310278|NCT00673790|11536004|FG000|Overall Study|Unconfirmed pregnancy|0
7310279|NCT00673790|11536005|FG001|Overall Study|Unconfirmed pregnancy|1
7310280|NCT00673790|11536006|FG002|Overall Study|Unconfirmed pregnancy|0
7310281|NCT00673790|11536004|FG000|Overall Study|Randomization criteria not met|0
7310282|NCT00673790|11536005|FG001|Overall Study|Randomization criteria not met|1
7310283|NCT00673790|11536006|FG002|Overall Study|Randomization criteria not met|0
7310284|NCT00673816|11536015|FG000|Overall Study|Adverse Event|1
7310285|NCT00673816|11536015|FG000|Overall Study|Withdrawal by Subject|1
7310286|NCT00673881|11536027|FG000|Overall Study|Withdrawal by Subject|1
7310287|NCT00673894|11536033|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
7310288|NCT00673894|11536034|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
7389918|NCT01232296|11649868|FG001|Overall Study|Progressive disease|61
7389919|NCT01232296|11649867|FG000|Overall Study|Study terminated by sponsor|0
7389920|NCT01232296|11649868|FG001|Overall Study|Study terminated by sponsor|1
7389921|NCT01232296|11649867|FG000|Overall Study|Technical problems|3
7389922|NCT01232296|11649868|FG001|Overall Study|Technical problems|0
7389923|NCT01232296|11649867|FG000|Overall Study|Subject/guardian decision|10
7389924|NCT01232296|11649868|FG001|Overall Study|Subject/guardian decision|2
7389925|NCT01232296|11649867|FG000|Overall Study|Death|1
7389926|NCT01232296|11649868|FG001|Overall Study|Death|6
7389927|NCT01232452|11649876|FG000|Overall Study|Adverse Event|17
7389928|NCT01232452|11649877|FG001|Overall Study|Adverse Event|15
7389929|NCT01232452|11649876|FG000|Overall Study|Withdrawal by Subject|11
7389930|NCT01232452|11649877|FG001|Overall Study|Withdrawal by Subject|8
7389931|NCT01232452|11649876|FG000|Overall Study|Physician Decision|8
7389932|NCT01232452|11649877|FG001|Overall Study|Physician Decision|12
7389933|NCT01232452|11649876|FG000|Overall Study|Protocol entry criterion not met|0
7389934|NCT01232452|11649877|FG001|Overall Study|Protocol entry criterion not met|2
7389935|NCT01232452|11649876|FG000|Overall Study|Sponsor Decision|3
7389936|NCT01232452|11649877|FG001|Overall Study|Sponsor Decision|1
7389937|NCT01232452|11649876|FG000|Overall Study|Protocol Violation|0
7389938|NCT01232452|11649877|FG001|Overall Study|Protocol Violation|1
7389939|NCT01232491|11649894|FG000|Overall Study|Adverse Event|13
7389940|NCT01232491|11649895|FG001|Overall Study|Adverse Event|8
7389941|NCT01232491|11649894|FG000|Overall Study|Lack of Efficacy|1
7389942|NCT01232491|11649895|FG001|Overall Study|Lack of Efficacy|5
7389943|NCT01232491|11649894|FG000|Overall Study|Protocol Violation|13
7389944|NCT01232491|11649895|FG001|Overall Study|Protocol Violation|11
7389945|NCT01232491|11649894|FG000|Overall Study|Withdrawal Criteria|12
7389946|NCT01232491|11649895|FG001|Overall Study|Withdrawal Criteria|21
7389947|NCT01232491|11649894|FG000|Overall Study|Other|21
7389948|NCT01232491|11649895|FG001|Overall Study|Other|18
7389949|NCT01232556|11649924|FG000|Overall Study|Withdrawal by Subject|21
7389950|NCT01232556|11649925|FG001|Overall Study|Withdrawal by Subject|17
7389951|NCT01232556|11649924|FG000|Overall Study|Death|97
7389952|NCT01232556|11649925|FG001|Overall Study|Death|97
7389953|NCT01232556|11649924|FG000|Overall Study|Lost to Follow-up|0
7389954|NCT01232556|11649925|FG001|Overall Study|Lost to Follow-up|2
7389955|NCT01232556|11649924|FG000|Overall Study|Terminated by Sponsor|35
7389956|NCT01232556|11649925|FG001|Overall Study|Terminated by Sponsor|51
7389957|NCT01232556|11649924|FG000|Overall Study|Other|6
7389958|NCT01232556|11649925|FG001|Overall Study|Other|4
7389959|NCT01232569|11649933|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
7389960|NCT01232569|11649934|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7389961|NCT01232569|11649935|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7389962|NCT01232569|11649936|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
7389963|NCT01232569|11649933|FG000|Double-blind Treatment Period|Escape|2
7389964|NCT01232569|11649934|FG001|Double-blind Treatment Period|Escape|2
7389965|NCT01232569|11649935|FG002|Double-blind Treatment Period|Escape|0
7389966|NCT01232569|11649936|FG003|Double-blind Treatment Period|Escape|0
7389967|NCT01232569|11649933|FG000|Double-blind Treatment Period|Lost to Follow-up|4
7389968|NCT01232569|11649934|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7389969|NCT01232569|11649935|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7389970|NCT01232569|11649936|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7389971|NCT01232569|11649933|FG000|Double-blind Treatment Period|Lack of Efficacy|1
7389972|NCT01232569|11649934|FG001|Double-blind Treatment Period|Lack of Efficacy|2
7389973|NCT01232569|11649935|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7389974|NCT01232569|11649936|FG003|Double-blind Treatment Period|Lack of Efficacy|0
7389975|NCT01232569|11649933|FG000|Double-blind Treatment Period|Physician Decision|1
7310289|NCT00673894|11536033|FG000|First Intervention 4 Weeks|Adverse Event|1
7310290|NCT00673894|11536034|FG001|First Intervention 4 Weeks|Adverse Event|0
7310291|NCT00673920|11536048|FG000|Baseline up to Week 48|Withdrew consent|1
7310292|NCT00673920|11536049|FG001|Baseline up to Week 48|Withdrew consent|0
7310293|NCT00673920|11536050|FG002|Baseline up to Week 48|Withdrew consent|2
7310294|NCT00673920|11536051|FG003|Baseline up to Week 48|Withdrew consent|0
7310295|NCT00673920|11536052|FG004|Baseline up to Week 48|Withdrew consent|0
7310296|NCT00673920|11536053|FG005|Baseline up to Week 48|Withdrew consent|0
7310297|NCT00673920|11536054|FG006|Baseline up to Week 48|Withdrew consent|0
7310298|NCT00673920|11536055|FG007|Baseline up to Week 48|Withdrew consent|0
7310299|NCT00673920|11536048|FG000|Baseline up to Week 48|Refused treatment|1
7310300|NCT00673920|11536049|FG001|Baseline up to Week 48|Refused treatment|0
7310301|NCT00673920|11536050|FG002|Baseline up to Week 48|Refused treatment|0
7310302|NCT00673920|11536051|FG003|Baseline up to Week 48|Refused treatment|0
7310303|NCT00673920|11536052|FG004|Baseline up to Week 48|Refused treatment|0
7310304|NCT00673920|11536053|FG005|Baseline up to Week 48|Refused treatment|0
7310305|NCT00673920|11536054|FG006|Baseline up to Week 48|Refused treatment|0
7310306|NCT00673920|11536055|FG007|Baseline up to Week 48|Refused treatment|0
7310307|NCT00673920|11536048|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
7310308|NCT00673920|11536049|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
7310309|NCT00673920|11536050|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
7310310|NCT00673920|11536051|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
7310311|NCT00673920|11536052|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
7310312|NCT00673920|11536053|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
7310313|NCT00673920|11536054|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
7310314|NCT00673920|11536055|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
7310315|NCT00673920|11536048|FG000|Baseline up to Week 48|Protocol Violation|0
7310316|NCT00673920|11536049|FG001|Baseline up to Week 48|Protocol Violation|0
7310317|NCT00673920|11536050|FG002|Baseline up to Week 48|Protocol Violation|1
7310318|NCT00673920|11536051|FG003|Baseline up to Week 48|Protocol Violation|0
7310319|NCT00673920|11536052|FG004|Baseline up to Week 48|Protocol Violation|0
7310320|NCT00673920|11536053|FG005|Baseline up to Week 48|Protocol Violation|0
7310321|NCT00673920|11536054|FG006|Baseline up to Week 48|Protocol Violation|0
7310322|NCT00673920|11536055|FG007|Baseline up to Week 48|Protocol Violation|0
7310323|NCT00673920|11536048|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
7310324|NCT00673920|11536049|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
7310325|NCT00673920|11536050|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
7310326|NCT00673920|11536051|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
7310327|NCT00673920|11536052|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
7310328|NCT00673920|11536053|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
7310329|NCT00673920|11536054|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
7310330|NCT00673920|11536055|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
7310331|NCT00673920|11536048|FG000|Baseline up to Week 48|Administrative/Other|0
7310332|NCT00673920|11536049|FG001|Baseline up to Week 48|Administrative/Other|1
7310333|NCT00673920|11536050|FG002|Baseline up to Week 48|Administrative/Other|2
7310334|NCT00673920|11536051|FG003|Baseline up to Week 48|Administrative/Other|0
7310335|NCT00673920|11536052|FG004|Baseline up to Week 48|Administrative/Other|0
7310336|NCT00673920|11536053|FG005|Baseline up to Week 48|Administrative/Other|0
7310337|NCT00673920|11536054|FG006|Baseline up to Week 48|Administrative/Other|0
7310338|NCT00673920|11536055|FG007|Baseline up to Week 48|Administrative/Other|0
7310339|NCT00673920|11536048|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
7310340|NCT00673920|11536049|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
7310341|NCT00673920|11536050|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
7310342|NCT00673920|11536051|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
7310343|NCT00673920|11536052|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
7310344|NCT00673920|11536053|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
7384202|NCT01193218|11641330|FG001|12-52 Weeks|Withdrawal by Subject|0
7384203|NCT01193218|11641331|FG002|12-52 Weeks|Withdrawal by Subject|3
7384204|NCT01193218|11641332|FG003|12-52 Weeks|Withdrawal by Subject|0
7384205|NCT01193218|11641333|FG004|12-52 Weeks|Withdrawal by Subject|0
7384206|NCT01193218|11641334|FG005|12-52 Weeks|Withdrawal by Subject|2
7384207|NCT01193218|11641335|FG006|12-52 Weeks|Withdrawal by Subject|1
7384208|NCT01193218|11641336|FG007|12-52 Weeks|Withdrawal by Subject|2
7384209|NCT01193218|11641329|FG000|12-52 Weeks|Other reason than above|1
7384210|NCT01193218|11641330|FG001|12-52 Weeks|Other reason than above|0
7384211|NCT01193218|11641331|FG002|12-52 Weeks|Other reason than above|0
7384212|NCT01193218|11641332|FG003|12-52 Weeks|Other reason than above|1
7384213|NCT01193218|11641333|FG004|12-52 Weeks|Other reason than above|1
7384214|NCT01193218|11641334|FG005|12-52 Weeks|Other reason than above|0
7384215|NCT01193218|11641335|FG006|12-52 Weeks|Other reason than above|0
7384216|NCT01193218|11641336|FG007|12-52 Weeks|Other reason than above|0
7384217|NCT01193244|11641354|FG000|Overall Study|Withdrawal by Subject|79
7384218|NCT01193244|11641355|FG001|Overall Study|Withdrawal by Subject|97
7384219|NCT01193244|11641354|FG000|Overall Study|Other|303
7384220|NCT01193244|11641355|FG001|Overall Study|Other|278
7384221|NCT01193244|11641354|FG000|Overall Study|Lost to Follow-up|6
7384222|NCT01193244|11641355|FG001|Overall Study|Lost to Follow-up|15
7384223|NCT01193257|11641363|FG000|Overall Study|Death|202
7384224|NCT01193257|11641364|FG001|Overall Study|Death|391
7310345|NCT00673920|11536054|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
7310346|NCT00673920|11536055|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
7310347|NCT00673920|11536048|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310348|NCT00673920|11536049|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310349|NCT00673920|11536050|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310350|NCT00673920|11536051|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310351|NCT00673920|11536052|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310352|NCT00673920|11536053|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310353|NCT00673920|11536054|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
7310354|NCT00673920|11536055|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
7310355|NCT00673920|11536048|FG000|Week 24 to Week 48|Failure to return|0
7310356|NCT00673920|11536049|FG001|Week 24 to Week 48|Failure to return|0
7310357|NCT00673920|11536050|FG002|Week 24 to Week 48|Failure to return|0
7310358|NCT00673920|11536051|FG003|Week 24 to Week 48|Failure to return|0
7310359|NCT00673920|11536052|FG004|Week 24 to Week 48|Failure to return|0
7310360|NCT00673920|11536053|FG005|Week 24 to Week 48|Failure to return|1
7310361|NCT00673920|11536054|FG006|Week 24 to Week 48|Failure to return|0
7310362|NCT00673920|11536055|FG007|Week 24 to Week 48|Failure to return|0
7310363|NCT00673920|11536048|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
7310364|NCT00673920|11536049|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
7310365|NCT00673920|11536050|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
7310366|NCT00673920|11536051|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
7310367|NCT00673920|11536052|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
7310368|NCT00673920|11536053|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
7310369|NCT00673920|11536054|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
7310370|NCT00673920|11536055|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
7310371|NCT00673920|11536048|FG000|Week 24 to Week 48|Death|0
7310372|NCT00673920|11536049|FG001|Week 24 to Week 48|Death|0
7310373|NCT00673920|11536050|FG002|Week 24 to Week 48|Death|0
7310374|NCT00673920|11536051|FG003|Week 24 to Week 48|Death|0
7389976|NCT01232569|11649934|FG001|Double-blind Treatment Period|Physician Decision|0
7389977|NCT01232569|11649935|FG002|Double-blind Treatment Period|Physician Decision|0
7389978|NCT01232569|11649936|FG003|Double-blind Treatment Period|Physician Decision|0
7389979|NCT01232569|11649933|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
7389980|NCT01232569|11649934|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
7389981|NCT01232569|11649935|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7389982|NCT01232569|11649936|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
7389983|NCT01232569|11649933|FG000|Double-blind Treatment Period|Death|2
7389984|NCT01232569|11649934|FG001|Double-blind Treatment Period|Death|0
7389985|NCT01232569|11649935|FG002|Double-blind Treatment Period|Death|0
7389986|NCT01232569|11649936|FG003|Double-blind Treatment Period|Death|0
7389987|NCT01232738|11649945|FG000|Overall Study|Death|3
7389988|NCT01232738|11649945|FG000|Overall Study|Physician Decision|2
7389989|NCT01232738|11649945|FG000|Overall Study|Lost to Follow-up|1
7389990|NCT01232738|11649945|FG000|Overall Study|Withdrawal by Subject|2
7389991|NCT01232738|11649945|FG000|Overall Study|Adverse Event|5
7389992|NCT01232790|11649953|FG000|Randomization|Withdrawal by Subject|2
7389993|NCT01232790|11649954|FG001|Randomization|Withdrawal by Subject|0
7389994|NCT01232790|11649953|FG000|Randomization|Protocol Violation|0
7389995|NCT01232790|11649954|FG001|Randomization|Protocol Violation|1
7389996|NCT01232790|11649953|FG000|Randomization|Physician Decision|0
7389997|NCT01232790|11649954|FG001|Randomization|Physician Decision|1
7389998|NCT01232790|11649953|FG000|Initial Assessment|Withdrawal by Subject|0
7389999|NCT01232790|11649954|FG001|Initial Assessment|Withdrawal by Subject|1
7390000|NCT01232790|11649953|FG000|First Crossover|Withdrawal by Subject|1
7390001|NCT01232790|11649954|FG001|First Crossover|Withdrawal by Subject|0
7390002|NCT01232790|11649953|FG000|Second Crossover|Withdrawal by Subject|1
7390003|NCT01232790|11649954|FG001|Second Crossover|Withdrawal by Subject|2
7390004|NCT01232868|11649976|FG000|Overall Study|Lost to Follow-up|2
7390005|NCT01232868|11649977|FG001|Overall Study|Lost to Follow-up|4
7390006|NCT01232894|11649985|FG000|Overall Study|Lost to Follow-up|0
7390007|NCT01232894|11649986|FG001|Overall Study|Lost to Follow-up|1
7390008|NCT01232894|11649985|FG000|Overall Study|Death|1
7390009|NCT01232894|11649986|FG001|Overall Study|Death|0
7390010|NCT01232894|11649985|FG000|Overall Study|Protocol Violation|1
7390011|NCT01232894|11649986|FG001|Overall Study|Protocol Violation|1
7390012|NCT01232894|11649985|FG000|Overall Study|Withdrawal by Subject|8
7390013|NCT01232894|11649986|FG001|Overall Study|Withdrawal by Subject|5
7390014|NCT01232894|11649985|FG000|Overall Study|Physician Decision|2
7390015|NCT01232894|11649986|FG001|Overall Study|Physician Decision|1
7390016|NCT01233050|11650016|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
7390017|NCT01233050|11650017|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
7310375|NCT00673920|11536052|FG004|Week 24 to Week 48|Death|0
7310376|NCT00673920|11536053|FG005|Week 24 to Week 48|Death|1
7390018|NCT01233076|11650023|FG000|Period 2, One Week|Lost to Follow-up|1
7390019|NCT01233076|11650024|FG001|Period 2, One Week|Lost to Follow-up|0
7310377|NCT00673920|11536054|FG006|Week 24 to Week 48|Death|0
7310378|NCT00673920|11536055|FG007|Week 24 to Week 48|Death|0
7310379|NCT00673920|11536048|FG000|Week 24 to Week 48|Adminstrative/Other|0
7310380|NCT00673920|11536049|FG001|Week 24 to Week 48|Adminstrative/Other|0
7310381|NCT00673920|11536050|FG002|Week 24 to Week 48|Adminstrative/Other|0
7310382|NCT00673920|11536051|FG003|Week 24 to Week 48|Adminstrative/Other|1
7310383|NCT00673920|11536052|FG004|Week 24 to Week 48|Adminstrative/Other|0
7310384|NCT00673920|11536053|FG005|Week 24 to Week 48|Adminstrative/Other|0
7310385|NCT00673920|11536054|FG006|Week 24 to Week 48|Adminstrative/Other|0
7310386|NCT00673920|11536055|FG007|Week 24 to Week 48|Adminstrative/Other|0
7310387|NCT00673933|11536077|FG000|Overall Study|Withdrawal by Subject|2
7310388|NCT00673933|11536077|FG000|Overall Study|Lost to Follow-up|1
7310389|NCT00674128|11536104|FG000|Overall Study|Withdrawal by Subject|25
7310390|NCT00674128|11536105|FG001|Overall Study|Withdrawal by Subject|23
7310391|NCT00674154|11536113|FG000|Overall Study|Withdrawal by Subject|3
7310392|NCT00674154|11536114|FG001|Overall Study|Withdrawal by Subject|1
7310393|NCT00674154|11536113|FG000|Overall Study|Did not want parathyroidectomy|0
7310394|NCT00674154|11536114|FG001|Overall Study|Did not want parathyroidectomy|2
7310395|NCT00674323|11536146|FG000|Overall Study|Adverse Event|0
7310396|NCT00674323|11536147|FG001|Overall Study|Adverse Event|1
7310397|NCT00674323|11536148|FG002|Overall Study|Adverse Event|0
7310398|NCT00674323|11536146|FG000|Overall Study|Protocol Violation|1
7310399|NCT00674323|11536147|FG001|Overall Study|Protocol Violation|0
7310400|NCT00674323|11536148|FG002|Overall Study|Protocol Violation|0
7310401|NCT00674362|11536158|FG000|Double Blind|Adverse Event|6
7310402|NCT00674362|11536159|FG001|Double Blind|Adverse Event|6
7310403|NCT00674362|11536158|FG000|Double Blind|Lack of Efficacy|2
7310404|NCT00674362|11536159|FG001|Double Blind|Lack of Efficacy|6
7310405|NCT00674362|11536158|FG000|Double Blind|Loss of efficacy|0
7310406|NCT00674362|11536159|FG001|Double Blind|Loss of efficacy|1
7390020|NCT01233232|11650033|FG000|Overall Study|Voluntary Discontinuation by Subject|1
7390021|NCT01233232|11650034|FG001|Overall Study|Voluntary Discontinuation by Subject|0
7390022|NCT01233232|11650035|FG002|Overall Study|Voluntary Discontinuation by Subject|0
7390023|NCT01233258|11650048|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
7390024|NCT01233258|11650049|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
7390025|NCT01233258|11650050|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
7390026|NCT01233258|11650051|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
7390027|NCT01233258|11650052|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
7390028|NCT01233258|11650053|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
7390029|NCT01233258|11650048|FG000|First Intervention (6 Months)|Protocol Violation|0
7390030|NCT01233258|11650049|FG001|First Intervention (6 Months)|Protocol Violation|0
7390031|NCT01233258|11650050|FG002|First Intervention (6 Months)|Protocol Violation|1
7390032|NCT01233258|11650051|FG003|First Intervention (6 Months)|Protocol Violation|0
7390033|NCT01233258|11650052|FG004|First Intervention (6 Months)|Protocol Violation|0
7390034|NCT01233258|11650053|FG005|First Intervention (6 Months)|Protocol Violation|0
7390035|NCT01233258|11650048|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
7390036|NCT01233258|11650049|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
7390037|NCT01233258|11650050|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
7390038|NCT01233258|11650051|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
7390039|NCT01233258|11650052|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
7390040|NCT01233258|11650053|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
7390041|NCT01233284|11650068|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
7390042|NCT01233284|11650069|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
7390043|NCT01233284|11650070|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
7390044|NCT01233284|11650071|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
7390045|NCT01233284|11650072|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
7390046|NCT01233284|11650068|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
7390047|NCT01233284|11650069|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
7390048|NCT01233284|11650070|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
7390049|NCT01233284|11650071|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
7390050|NCT01233284|11650072|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
7390051|NCT01233284|11650068|FG000|Period 1 (4 Weeks)|Other|0
7390052|NCT01233284|11650069|FG001|Period 1 (4 Weeks)|Other|0
7390053|NCT01233284|11650070|FG002|Period 1 (4 Weeks)|Other|1
7390054|NCT01233284|11650071|FG003|Period 1 (4 Weeks)|Other|0
7390055|NCT01233284|11650072|FG004|Period 1 (4 Weeks)|Other|0
7390056|NCT01233284|11650068|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
7390057|NCT01233284|11650069|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
7390058|NCT01233284|11650070|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
7390059|NCT01233284|11650071|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
7390060|NCT01233284|11650072|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
7390061|NCT01233284|11650068|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
7390062|NCT01233284|11650069|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
7390063|NCT01233284|11650070|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
7390064|NCT01233284|11650071|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
7390065|NCT01233284|11650072|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
7390066|NCT01233284|11650068|FG000|Period 3 (4 Weeks)|Other|0
7390067|NCT01233284|11650069|FG001|Period 3 (4 Weeks)|Other|0
7533849|NCT02689206|11880195|FG001|Overall Study|Physician Decision|0
7390068|NCT01233284|11650070|FG002|Period 3 (4 Weeks)|Other|0
7390069|NCT01233284|11650071|FG003|Period 3 (4 Weeks)|Other|1
7390070|NCT01233284|11650072|FG004|Period 3 (4 Weeks)|Other|0
7390071|NCT01233284|11650068|FG000|Period 4 (4 Weeks)|Adverse Event|0
7310407|NCT00674362|11536158|FG000|Double Blind|Withdrawal by Subject|4
7310408|NCT00674362|11536159|FG001|Double Blind|Withdrawal by Subject|3
7310409|NCT00674362|11536158|FG000|Double Blind|Other: Loss of Patient Compliance|0
7310410|NCT00674362|11536159|FG001|Double Blind|Other: Loss of Patient Compliance|1
7310411|NCT00674362|11536158|FG000|Double Blind|Other: Surgery|0
7310412|NCT00674362|11536159|FG001|Double Blind|Other: Surgery|1
7310413|NCT00674362|11536158|FG000|Open Label|Adverse Event|1
7310414|NCT00674362|11536159|FG001|Open Label|Adverse Event|0
7310415|NCT00674362|11536158|FG000|Open Label|Other: Subject moved to extension study|1
7310416|NCT00674362|11536159|FG001|Open Label|Other: Subject moved to extension study|0
7310417|NCT00674570|11536190|FG000|Overall Study|Withdrawal by Subject|0
7310418|NCT00674570|11536191|FG001|Overall Study|Withdrawal by Subject|2
7310419|NCT00674570|11536192|FG002|Overall Study|Withdrawal by Subject|0
7310420|NCT00674661|11536241|FG000|Overall Study|Other|5
7310421|NCT00674661|11536242|FG001|Overall Study|Other|7
7310422|NCT00674661|11536241|FG000|Overall Study|Lost to Follow-up|6
7310423|NCT00674661|11536242|FG001|Overall Study|Lost to Follow-up|3
7310424|NCT00674661|11536241|FG000|Overall Study|Withdrawal by Subject|0
7310425|NCT00674661|11536242|FG001|Overall Study|Withdrawal by Subject|5
7310426|NCT00674700|11536251|FG000|Year 1|Adverse Event|17
7310427|NCT00674700|11536252|FG001|Year 1|Adverse Event|20
7310428|NCT00674700|11536253|FG002|Year 1|Adverse Event|5
7310429|NCT00674700|11536251|FG000|Year 1|Withdrawal by Subject|7
7310430|NCT00674700|11536252|FG001|Year 1|Withdrawal by Subject|7
7310431|NCT00674700|11536253|FG002|Year 1|Withdrawal by Subject|6
7310432|NCT00674700|11536251|FG000|Year 1|Any other reason not above-mentioned|7
7310433|NCT00674700|11536252|FG001|Year 1|Any other reason not above-mentioned|7
7310434|NCT00674700|11536253|FG002|Year 1|Any other reason not above-mentioned|6
7310435|NCT00674700|11536251|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
7310436|NCT00674700|11536252|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
7310437|NCT00674700|11536253|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
7310438|NCT00674700|11536251|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7310439|NCT00674700|11536252|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
7310440|NCT00674700|11536253|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
7310441|NCT00674700|11536251|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
7310442|NCT00674700|11536252|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
7310443|NCT00674700|11536253|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
7310444|NCT00674817|11536283|FG000|Period 1|Withdrawal by Subject|2
7310445|NCT00674817|11536283|FG000|Period 1|Protocol Violation|1
7310446|NCT00674817|11536283|FG000|Period 3|Adverse Event|1
7310447|NCT00674817|11536283|FG000|Period 3|Protocol Violation|1
7310448|NCT00674817|11536283|FG000|Period 4|Adverse Event|1
7310449|NCT00674973|11536299|FG000|Overall Study|Insufficient Therapeutic Response|77
7310450|NCT00674973|11536300|FG001|Overall Study|Insufficient Therapeutic Response|72
7310451|NCT00674973|11536299|FG000|Overall Study|Refused Treatment|1
7310452|NCT00674973|11536300|FG001|Overall Study|Refused Treatment|5
7310453|NCT00674973|11536299|FG000|Overall Study|Failure to Return|1
7310454|NCT00674973|11536300|FG001|Overall Study|Failure to Return|0
7310455|NCT00674973|11536299|FG000|Overall Study|Adverse Event|2
7310456|NCT00674973|11536300|FG001|Overall Study|Adverse Event|9
7310457|NCT00674973|11536299|FG000|Overall Study|Death|19
7310458|NCT00674973|11536300|FG001|Overall Study|Death|15
7310459|NCT00674973|11536299|FG000|Overall Study|Protocol Violation|0
7310460|NCT00674973|11536300|FG001|Overall Study|Protocol Violation|1
7310461|NCT00674986|11536308|FG000|Overall Study|Adverse Event|2
7310462|NCT00674986|11536309|FG001|Overall Study|Adverse Event|1
7310463|NCT00674986|11536308|FG000|Overall Study|Subject withdrew consent|12
7310464|NCT00674986|11536309|FG001|Overall Study|Subject withdrew consent|19
7310465|NCT00674986|11536308|FG000|Overall Study|Lost to Follow-up|25
7310466|NCT00674986|11536309|FG001|Overall Study|Lost to Follow-up|53
7310467|NCT00674986|11536308|FG000|Overall Study|Other reasons|4
7310468|NCT00674986|11536309|FG001|Overall Study|Other reasons|8
7310469|NCT00675025|11536318|FG000|Overall Study|Study Terminated by Sponsor|38
7310470|NCT00675025|11536319|FG001|Overall Study|Study Terminated by Sponsor|42
7310471|NCT00675025|11536318|FG000|Overall Study|Adverse Event|6
7310472|NCT00675025|11536319|FG001|Overall Study|Adverse Event|11
7310473|NCT00675025|11536318|FG000|Overall Study|Lost to Follow-up|6
7310474|NCT00675025|11536319|FG001|Overall Study|Lost to Follow-up|4
7310475|NCT00675025|11536318|FG000|Overall Study|Withdrawal by Subject|4
7310476|NCT00675025|11536319|FG001|Overall Study|Withdrawal by Subject|6
7310477|NCT00675103|11536325|FG000|Overall Study|Lack of Efficacy|2
7310478|NCT00675103|11536325|FG000|Overall Study|Adverse Event|1
7310479|NCT00675428|11536348|FG000|Overall Study|Disease Progression|2
7310480|NCT00675428|11536349|FG001|Overall Study|Disease Progression|2
7310481|NCT00675428|11536348|FG000|Overall Study|No Disease Response After Cycle 6|0
7310482|NCT00675428|11536349|FG001|Overall Study|No Disease Response After Cycle 6|1
7310483|NCT00675428|11536348|FG000|Overall Study|Physician Decision|1
7310484|NCT00675428|11536349|FG001|Overall Study|Physician Decision|0
7310485|NCT00675441|11536355|FG000|Overall Study|Withdrawal by Subject|2
7310486|NCT00675441|11536355|FG000|Overall Study|Death|1
7310487|NCT00675506|11536361|FG000|Overall Study|Lost to Follow-up|1
7310488|NCT00675506|11536362|FG001|Overall Study|Lost to Follow-up|5
7310489|NCT00675506|11536361|FG000|Overall Study|Lost interest|3
7310490|NCT00675506|11536362|FG001|Overall Study|Lost interest|5
7390072|NCT01233284|11650069|FG001|Period 4 (4 Weeks)|Adverse Event|1
7390073|NCT01233284|11650070|FG002|Period 4 (4 Weeks)|Adverse Event|0
7390074|NCT01233284|11650071|FG003|Period 4 (4 Weeks)|Adverse Event|0
7390075|NCT01233284|11650072|FG004|Period 4 (4 Weeks)|Adverse Event|0
7390076|NCT01233284|11650068|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
7390077|NCT01233284|11650069|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
7390078|NCT01233284|11650070|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
7390079|NCT01233284|11650071|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
7390080|NCT01233284|11650072|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
7390081|NCT01233609|11650089|FG000|Overall Study|Death|1
7390082|NCT01233609|11650090|FG001|Overall Study|Death|0
7390083|NCT01233609|11650089|FG000|Overall Study|Lost to Follow-up|3
7390084|NCT01233609|11650090|FG001|Overall Study|Lost to Follow-up|1
7390085|NCT01233609|11650089|FG000|Overall Study|Adverse Event|2
7390086|NCT01233609|11650090|FG001|Overall Study|Adverse Event|1
7390087|NCT01233609|11650089|FG000|Overall Study|Withdrawal by Subject|3
7390088|NCT01233609|11650090|FG001|Overall Study|Withdrawal by Subject|0
7390089|NCT01233687|11650104|FG000|Phase II AMG 102 + Erlotinib|Death|1
7390090|NCT01233687|11650104|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
7390091|NCT01233687|11650104|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
7390092|NCT01233817|11650124|FG000|Overall Study|Lost to Follow-up|1
7390093|NCT01233817|11650124|FG000|Overall Study|Withdrawal by Subject|2
7390094|NCT01233869|11650132|FG000|Initial Treatment Period (24 Months)|Death|1
7390095|NCT01233869|11650133|FG001|Initial Treatment Period (24 Months)|Death|0
7390096|NCT01233869|11650134|FG002|Initial Treatment Period (24 Months)|Death|0
7390097|NCT01233869|11650135|FG003|Initial Treatment Period (24 Months)|Death|0
7390098|NCT01233869|11650132|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
7390099|NCT01233869|11650133|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
7390100|NCT01233869|11650134|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
7390101|NCT01233869|11650135|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
7390102|NCT01233869|11650132|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
7390103|NCT01233869|11650133|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
7390104|NCT01233869|11650134|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
7390105|NCT01233869|11650135|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
7390106|NCT01233869|11650132|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7390107|NCT01233869|11650133|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7390108|NCT01233869|11650134|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
7390109|NCT01233869|11650135|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
7390110|NCT01233869|11650132|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
7390111|NCT01233869|11650133|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
7390112|NCT01233869|11650134|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
7390113|NCT01233869|11650135|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
7390114|NCT01233869|11650132|FG000|Extended Treatment Period (46 Months)|Other|3
7390115|NCT01233869|11650133|FG001|Extended Treatment Period (46 Months)|Other|0
7310542|NCT00676052|11536473|FG000|Overall Study|Protocol Violation|5
7390116|NCT01233869|11650134|FG002|Extended Treatment Period (46 Months)|Other|0
7390117|NCT01233869|11650135|FG003|Extended Treatment Period (46 Months)|Other|3
7390118|NCT01233869|11650132|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
7390119|NCT01233869|11650133|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
7390120|NCT01233869|11650134|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
7390121|NCT01233869|11650135|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
7390122|NCT01233999|11650154|FG000|Overall Study|Withdrawal by Subject|1
7390123|NCT01233999|11650154|FG000|Overall Study|Lost to Follow-up|1
7390124|NCT01234337|11650169|FG000|Overall Study|Adverse Event|58
7390125|NCT01234337|11650170|FG001|Overall Study|Adverse Event|21
7390126|NCT01234337|11650169|FG000|Overall Study|Disease progression/recurrence/relapse|181
7390127|NCT01234337|11650170|FG001|Overall Study|Disease progression/recurrence/relapse|223
7390128|NCT01234337|11650169|FG000|Overall Study|Investi. decision not protocol driven|5
7390129|NCT01234337|11650170|FG001|Overall Study|Investi. decision not protocol driven|6
7390130|NCT01234337|11650169|FG000|Overall Study|Non-compliant with study medication|3
7390131|NCT01234337|11650170|FG001|Overall Study|Non-compliant with study medication|2
7390132|NCT01234337|11650169|FG000|Overall Study|Randomized but not treated|6
7390133|NCT01234337|11650170|FG001|Overall Study|Randomized but not treated|4
7390134|NCT01234337|11650169|FG000|Overall Study|Lost to Follow-up|0
7390135|NCT01234337|11650170|FG001|Overall Study|Lost to Follow-up|1
7390136|NCT01234337|11650169|FG000|Overall Study|Protocol Violation|2
7390137|NCT01234337|11650170|FG001|Overall Study|Protocol Violation|3
7390138|NCT01234337|11650169|FG000|Overall Study|Withdrawal by Subject|11
7390139|NCT01234337|11650170|FG001|Overall Study|Withdrawal by Subject|9
7390140|NCT01234337|11650169|FG000|Overall Study|Death|0
7390141|NCT01234337|11650170|FG001|Overall Study|Death|1
7310491|NCT00675506|11536361|FG000|Overall Study|Elevated fasting glucose|2
7310492|NCT00675506|11536362|FG001|Overall Study|Elevated fasting glucose|1
7310493|NCT00675506|11536361|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
7310494|NCT00675506|11536362|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
7310495|NCT00675506|11536361|FG000|Overall Study|Elevated IGF-1|2
7310496|NCT00675506|11536362|FG001|Overall Study|Elevated IGF-1|0
7310497|NCT00675506|11536361|FG000|Overall Study|Hypersensitivity Reaction|1
7310498|NCT00675506|11536362|FG001|Overall Study|Hypersensitivity Reaction|0
7310499|NCT00675506|11536361|FG000|Overall Study|Disclosed history of cancer|1
7310500|NCT00675506|11536362|FG001|Overall Study|Disclosed history of cancer|0
7310501|NCT00675506|11536361|FG000|Overall Study|Declined participation|1
7310502|NCT00675506|11536362|FG001|Overall Study|Declined participation|0
7310503|NCT00675506|11536361|FG000|Overall Study|Schedule conflict|0
7310504|NCT00675506|11536362|FG001|Overall Study|Schedule conflict|1
7310505|NCT00675597|11536391|FG000|Overall Study|Withdrawal by Subject|3
7310506|NCT00675766|11536399|FG000|Overall Study|Lost to Follow-up|6
7310507|NCT00675766|11536400|FG001|Overall Study|Lost to Follow-up|5
7310508|NCT00675766|11536401|FG002|Overall Study|Lost to Follow-up|21
7310509|NCT00675766|11536402|FG003|Overall Study|Lost to Follow-up|26
7310510|NCT00675948|11536441|FG000|Overall Study|Adverse Event|23
7310511|NCT00675948|11536442|FG001|Overall Study|Adverse Event|1
7310512|NCT00675948|11536441|FG000|Overall Study|Lack of Efficacy|3
7310513|NCT00675948|11536442|FG001|Overall Study|Lack of Efficacy|0
7310514|NCT00675948|11536441|FG000|Overall Study|Withdrawal by Subject|7
7310515|NCT00675948|11536442|FG001|Overall Study|Withdrawal by Subject|0
7390142|NCT01234337|11650169|FG000|Overall Study|Switch to commercial drug|0
7390143|NCT01234337|11650170|FG001|Overall Study|Switch to commercial drug|1
7390144|NCT01234350|11650178|FG000|Overall Study|Adverse Event|277
7390145|NCT01234350|11650179|FG001|Overall Study|Adverse Event|92
7390146|NCT01234350|11650178|FG000|Overall Study|Withdrawal by Subject|61
7390147|NCT01234350|11650179|FG001|Overall Study|Withdrawal by Subject|36
7310516|NCT00675948|11536441|FG000|Overall Study|Lost to Follow-up|2
7310517|NCT00675948|11536442|FG001|Overall Study|Lost to Follow-up|0
7310518|NCT00675948|11536441|FG000|Overall Study|Protocol Violation|1
7310519|NCT00675948|11536442|FG001|Overall Study|Protocol Violation|0
7310520|NCT00675948|11536441|FG000|Overall Study|Pain under control|1
7310521|NCT00675948|11536442|FG001|Overall Study|Pain under control|0
7310522|NCT00675948|11536441|FG000|Overall Study|Sponsor decision|0
7310523|NCT00675948|11536442|FG001|Overall Study|Sponsor decision|1
7310524|NCT00675948|11536441|FG000|Overall Study|Patient died|1
7310525|NCT00675948|11536442|FG001|Overall Study|Patient died|0
7310526|NCT00675948|11536441|FG000|Overall Study|Patient unable to comply with diaries|1
7310527|NCT00675948|11536442|FG001|Overall Study|Patient unable to comply with diaries|0
7310528|NCT00675948|11536441|FG000|Overall Study|Patient feels unable to take medication|0
7310529|NCT00675948|11536442|FG001|Overall Study|Patient feels unable to take medication|1
7310530|NCT00676052|11536473|FG000|Overall Study|Adverse Event|0
7310531|NCT00676052|11536474|FG001|Overall Study|Adverse Event|1
7310532|NCT00676052|11536475|FG002|Overall Study|Adverse Event|1
7310533|NCT00676052|11536476|FG003|Overall Study|Adverse Event|2
7310534|NCT00676052|11536477|FG004|Overall Study|Adverse Event|2
7310535|NCT00676052|11536478|FG005|Overall Study|Adverse Event|2
7310536|NCT00676052|11536473|FG000|Overall Study|Lack of Efficacy|2
7310537|NCT00676052|11536474|FG001|Overall Study|Lack of Efficacy|2
7310538|NCT00676052|11536475|FG002|Overall Study|Lack of Efficacy|1
7310539|NCT00676052|11536476|FG003|Overall Study|Lack of Efficacy|1
7310540|NCT00676052|11536477|FG004|Overall Study|Lack of Efficacy|2
7310541|NCT00676052|11536478|FG005|Overall Study|Lack of Efficacy|1
7310543|NCT00676052|11536474|FG001|Overall Study|Protocol Violation|3
7310544|NCT00676052|11536475|FG002|Overall Study|Protocol Violation|2
7310545|NCT00676052|11536476|FG003|Overall Study|Protocol Violation|2
7310546|NCT00676052|11536477|FG004|Overall Study|Protocol Violation|1
7310547|NCT00676052|11536478|FG005|Overall Study|Protocol Violation|2
7310548|NCT00676052|11536473|FG000|Overall Study|Lost to Follow-up|0
7310549|NCT00676052|11536474|FG001|Overall Study|Lost to Follow-up|0
7310550|NCT00676052|11536475|FG002|Overall Study|Lost to Follow-up|0
7310551|NCT00676052|11536476|FG003|Overall Study|Lost to Follow-up|0
7310552|NCT00676052|11536477|FG004|Overall Study|Lost to Follow-up|1
7310553|NCT00676052|11536478|FG005|Overall Study|Lost to Follow-up|0
7310554|NCT00676052|11536473|FG000|Overall Study|Physician Decision|1
7310555|NCT00676052|11536474|FG001|Overall Study|Physician Decision|1
7310556|NCT00676052|11536475|FG002|Overall Study|Physician Decision|1
7310557|NCT00676052|11536476|FG003|Overall Study|Physician Decision|0
7310558|NCT00676052|11536477|FG004|Overall Study|Physician Decision|0
7310559|NCT00676052|11536478|FG005|Overall Study|Physician Decision|1
7310560|NCT00676052|11536473|FG000|Overall Study|Withdrawal by Subject|1
7310561|NCT00676052|11536474|FG001|Overall Study|Withdrawal by Subject|0
7310562|NCT00676052|11536475|FG002|Overall Study|Withdrawal by Subject|1
7310563|NCT00676052|11536476|FG003|Overall Study|Withdrawal by Subject|0
7310564|NCT00676052|11536477|FG004|Overall Study|Withdrawal by Subject|0
7310565|NCT00676052|11536478|FG005|Overall Study|Withdrawal by Subject|0
7310566|NCT00676091|11536507|FG000|Infant Series|Parent or legal guardian request|10
7390148|NCT01234350|11650178|FG000|Overall Study|Lost to Follow-up|115
7310567|NCT00676091|11536508|FG001|Infant Series|Parent or legal guardian request|8
7310568|NCT00676091|11536507|FG000|Infant Series|Protocol Violation|6
7310569|NCT00676091|11536508|FG001|Infant Series|Protocol Violation|3
7310570|NCT00676091|11536507|FG000|Infant Series|Adverse Event|2
7310571|NCT00676091|11536508|FG001|Infant Series|Adverse Event|3
7310572|NCT00676091|11536507|FG000|Infant Series|Failed to return|1
7310573|NCT00676091|11536508|FG001|Infant Series|Failed to return|3
7310574|NCT00676091|11536507|FG000|Infant Series|Lost to Follow-up|1
7310575|NCT00676091|11536508|FG001|Infant Series|Lost to Follow-up|0
7310576|NCT00676091|11536507|FG000|Infant Series|Died prior to receiving 7vPnC|0
7310577|NCT00676091|11536508|FG001|Infant Series|Died prior to receiving 7vPnC|1
7310578|NCT00676091|11536507|FG000|After Infant Series|Adverse Event|0
7310579|NCT00676091|11536508|FG001|After Infant Series|Adverse Event|1
7310580|NCT00676091|11536507|FG000|After Infant Series|Protocol Violation|0
7310581|NCT00676091|11536508|FG001|After Infant Series|Protocol Violation|1
7310582|NCT00676091|11536507|FG000|After Infant Series|Failed to return|1
7310583|NCT00676091|11536508|FG001|After Infant Series|Failed to return|1
7310584|NCT00676091|11536507|FG000|Toddler Dose|Failed to return|2
7310585|NCT00676091|11536508|FG001|Toddler Dose|Failed to return|0
7310586|NCT00676091|11536507|FG000|Toddler Dose|Parent or legal guardian request|1
7310587|NCT00676091|11536508|FG001|Toddler Dose|Parent or legal guardian request|0
7310588|NCT00676130|11536520|FG000|Overall Study|Lost to Follow-up|0
7310589|NCT00676130|11536521|FG001|Overall Study|Lost to Follow-up|1
7310590|NCT00676130|11536520|FG000|Overall Study|Found ineligible|3
7390149|NCT01234350|11650179|FG001|Overall Study|Lost to Follow-up|47
7390150|NCT01234350|11650178|FG000|Overall Study|Covers a diverse set of reasons|234
7390151|NCT01234350|11650179|FG001|Overall Study|Covers a diverse set of reasons|92
7390152|NCT01234402|11650190|FG000|Overall Study|Lost to Follow-up|0
7390153|NCT01234402|11650191|FG001|Overall Study|Lost to Follow-up|1
7390154|NCT01234402|11650192|FG002|Overall Study|Lost to Follow-up|3
7390155|NCT01234402|11650190|FG000|Overall Study|Withdrawal by Subject|1
7390156|NCT01234402|11650191|FG001|Overall Study|Withdrawal by Subject|3
7390157|NCT01234402|11650192|FG002|Overall Study|Withdrawal by Subject|4
7390158|NCT01234402|11650190|FG000|Overall Study|Never treated: Death|0
7390159|NCT01234402|11650191|FG001|Overall Study|Never treated: Death|0
7390160|NCT01234402|11650192|FG002|Overall Study|Never treated: Death|1
7390161|NCT01234402|11650190|FG000|Overall Study|Never treated: Withdrawal By Subject|0
7390162|NCT01234402|11650191|FG001|Overall Study|Never treated: Withdrawal By Subject|1
7390163|NCT01234402|11650192|FG002|Overall Study|Never treated: Withdrawal By Subject|0
7390164|NCT01234402|11650190|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
7390165|NCT01234402|11650191|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
7390166|NCT01234402|11650192|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
7390167|NCT01234467|11650202|FG000|Overall Study|Adverse Event|3
7390168|NCT01234467|11650202|FG000|Overall Study|Death|2
7390169|NCT01234467|11650202|FG000|Overall Study|Withdrawal by Subject|2
7390170|NCT01234467|11650202|FG000|Overall Study|Disease Progression|2
7390171|NCT01234467|11650202|FG000|Overall Study|Clinical deterioration|1
7390172|NCT01234467|11650202|FG000|Overall Study|Physician Decision|1
7390173|NCT01234467|11650202|FG000|Overall Study|Other complicating disease (stroke)|1
7390174|NCT01234480|11650206|FG000|Overall Study|Pregnancy|88
7390175|NCT01234480|11650206|FG000|Overall Study|>36/Normal History|50
7390176|NCT01234480|11650206|FG000|Overall Study|Age|3
7390177|NCT01234480|11650206|FG000|Overall Study|HPV Vaccine History|28
7390178|NCT01234480|11650206|FG000|Overall Study|HPV Vaccine after Enrollment|17
7390179|NCT01234480|11650206|FG000|Overall Study|Hysterectomy|2
7390180|NCT01234480|11650206|FG000|Overall Study|Hysterectomy post enrollment|1
7390181|NCT01234480|11650206|FG000|Overall Study|Inclusion/Exclusion Violation|3
7390182|NCT01234480|11650206|FG000|Overall Study|Informed Consent Form Violation|30
7390183|NCT01234480|11650206|FG000|Overall Study|Incorrect Visit|3
7390184|NCT01234480|11650206|FG000|Overall Study|No Florida Lab License|20
7390185|NCT01234480|11650206|FG000|Overall Study|Out of Window|42
7390186|NCT01234480|11650206|FG000|Overall Study|Sample Processing/Storage|92
7390187|NCT01234480|11650206|FG000|Overall Study|Site Amendment prohibited colposcopy|11
7390188|NCT01234480|11650206|FG000|Overall Study|Site/Subject non-compliance|44
7390189|NCT01234480|11650206|FG000|Overall Study|Missing Sample|9
7390190|NCT01234649|11650215|FG000|Overall Study|Withdrawal by Subject|32
7390191|NCT01234649|11650216|FG001|Overall Study|Withdrawal by Subject|26
7390192|NCT01234649|11650215|FG000|Overall Study|Pregnancy|6
7390193|NCT01234649|11650216|FG001|Overall Study|Pregnancy|6
7390194|NCT01234649|11650215|FG000|Overall Study|intolerant to side effects|4
7390195|NCT01234649|11650216|FG001|Overall Study|intolerant to side effects|3
7390196|NCT01234649|11650215|FG000|Overall Study|Allergic reaction|1
7390197|NCT01234649|11650216|FG001|Overall Study|Allergic reaction|0
7390198|NCT01234649|11650215|FG000|Overall Study|Lack of Efficacy|0
7390199|NCT01234649|11650216|FG001|Overall Study|Lack of Efficacy|3
7390200|NCT01234675|11650222|FG000|First Intervention (6 Weeks)|Adverse Event|0
7390201|NCT01234675|11650223|FG001|First Intervention (6 Weeks)|Adverse Event|1
7390202|NCT01234675|11650222|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
7390203|NCT01234675|11650223|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
7390204|NCT01234883|11650257|FG000|Overall Study|Early treatment release|8
7390205|NCT01234883|11650258|FG001|Overall Study|Early treatment release|10
7390206|NCT01234883|11650257|FG000|Overall Study|Parent/guardian withdrew consent|1
7390207|NCT01234883|11650258|FG001|Overall Study|Parent/guardian withdrew consent|2
7390208|NCT01234883|11650257|FG000|Overall Study|Technical difficulties with IV infusion|0
7390209|NCT01234883|11650258|FG001|Overall Study|Technical difficulties with IV infusion|1
7390210|NCT01234883|11650257|FG000|Overall Study|Inclusion/exclusion failure|1
7310591|NCT00676130|11536521|FG001|Overall Study|Found ineligible|2
7310592|NCT00676130|11536520|FG000|Overall Study|Withdrawal by Subject|0
7310593|NCT00676130|11536521|FG001|Overall Study|Withdrawal by Subject|1
7310594|NCT00676143|11536529|FG000|Overall Study|Adverse Event|34
7310595|NCT00676143|11536530|FG001|Overall Study|Adverse Event|60
7310596|NCT00676143|11536529|FG000|Overall Study|Death|4
7310597|NCT00676143|11536530|FG001|Overall Study|Death|4
7310598|NCT00676143|11536529|FG000|Overall Study|Lack of Efficacy|0
7310599|NCT00676143|11536530|FG001|Overall Study|Lack of Efficacy|6
7310600|NCT00676143|11536529|FG000|Overall Study|Lost to Follow-up|0
7310601|NCT00676143|11536530|FG001|Overall Study|Lost to Follow-up|13
7310602|NCT00676143|11536529|FG000|Overall Study|Physician Decision|5
7310603|NCT00676143|11536530|FG001|Overall Study|Physician Decision|8
7310604|NCT00676143|11536529|FG000|Overall Study|Protocol Violation|4
7310605|NCT00676143|11536530|FG001|Overall Study|Protocol Violation|8
7310606|NCT00676143|11536529|FG000|Overall Study|Withdrawal by Subject|24
7310607|NCT00676143|11536530|FG001|Overall Study|Withdrawal by Subject|42
7310608|NCT00676143|11536529|FG000|Overall Study|Discontinuation of study by sponsor|65
7310609|NCT00676143|11536530|FG001|Overall Study|Discontinuation of study by sponsor|88
7310610|NCT00676143|11536529|FG000|Overall Study|Failed to return|2
7310611|NCT00676143|11536530|FG001|Overall Study|Failed to return|1
7310612|NCT00676143|11536529|FG000|Overall Study|Loss of caregiver|5
7310613|NCT00676143|11536530|FG001|Overall Study|Loss of caregiver|3
7310614|NCT00676143|11536529|FG000|Overall Study|Other|11
7310615|NCT00676143|11536530|FG001|Overall Study|Other|20
7310616|NCT00676143|11536529|FG000|Overall Study|Participant participation unknown|1
7310617|NCT00676143|11536530|FG001|Overall Study|Participant participation unknown|4
7310618|NCT00676143|11536529|FG000|Overall Study|Vasogenic edema recurrence|1
7310619|NCT00676143|11536530|FG001|Overall Study|Vasogenic edema recurrence|3
7310620|NCT00676195|11536549|FG000|Overall Study|Lost to Follow-up|1
7310621|NCT00676195|11536549|FG000|Overall Study|Adverse Event|1
7310622|NCT00676195|11536549|FG000|Overall Study|Physician Decision|1
7310623|NCT00676208|11536556|FG000|Overall Study|Lost to Follow-up|0
7310624|NCT00676208|11536557|FG001|Overall Study|Lost to Follow-up|2
7310625|NCT00676208|11536556|FG000|Overall Study|Incomplete data|2
7310626|NCT00676208|11536557|FG001|Overall Study|Incomplete data|4
7310627|NCT00676338|11536569|FG000|Overall Study|Adverse Event|6
7390211|NCT01234883|11650258|FG001|Overall Study|Inclusion/exclusion failure|0
7390212|NCT01235338|11650290|FG000|Overall Study|Adverse Event|3
7390213|NCT01235338|11650291|FG001|Overall Study|Adverse Event|2
7390214|NCT01235338|11650290|FG000|Overall Study|Protocol Violation|1
7390215|NCT01235338|11650291|FG001|Overall Study|Protocol Violation|1
7390216|NCT01235338|11650290|FG000|Overall Study|Withdrawal by Subject|5
7390217|NCT01235338|11650291|FG001|Overall Study|Withdrawal by Subject|0
7390218|NCT01235338|11650290|FG000|Overall Study|Exclusion criteria violations|1
7310628|NCT00676338|11536570|FG001|Overall Study|Adverse Event|6
7310629|NCT00676338|11536571|FG002|Overall Study|Adverse Event|5
7310630|NCT00676338|11536572|FG003|Overall Study|Adverse Event|1
7310631|NCT00676338|11536569|FG000|Overall Study|Lost to Follow-up|4
7310632|NCT00676338|11536570|FG001|Overall Study|Lost to Follow-up|1
7310633|NCT00676338|11536571|FG002|Overall Study|Lost to Follow-up|3
7310634|NCT00676338|11536572|FG003|Overall Study|Lost to Follow-up|4
7310635|NCT00676338|11536569|FG000|Overall Study|Physician Decision|3
7310636|NCT00676338|11536570|FG001|Overall Study|Physician Decision|3
7310637|NCT00676338|11536571|FG002|Overall Study|Physician Decision|2
7310638|NCT00676338|11536572|FG003|Overall Study|Physician Decision|3
7310639|NCT00676338|11536569|FG000|Overall Study|Protocol Violation|5
7310640|NCT00676338|11536570|FG001|Overall Study|Protocol Violation|9
7310641|NCT00676338|11536571|FG002|Overall Study|Protocol Violation|2
7310642|NCT00676338|11536572|FG003|Overall Study|Protocol Violation|5
7310643|NCT00676338|11536569|FG000|Overall Study|Withdrawal by Subject|17
7310644|NCT00676338|11536570|FG001|Overall Study|Withdrawal by Subject|9
7310645|NCT00676338|11536571|FG002|Overall Study|Withdrawal by Subject|12
7390219|NCT01235338|11650291|FG001|Overall Study|Exclusion criteria violations|1
7390220|NCT01235338|11650290|FG000|Overall Study|Positive drug screen|0
7390221|NCT01235338|11650291|FG001|Overall Study|Positive drug screen|1
7390222|NCT01235338|11650290|FG000|Overall Study|Prohibited meds|1
7390223|NCT01235338|11650291|FG001|Overall Study|Prohibited meds|0
7390224|NCT01235351|11650301|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
7390225|NCT01235351|11650302|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
7390226|NCT01235403|11650321|FG000|Overall Study|Adverse Event|14
7390227|NCT01235403|11650321|FG000|Overall Study|Lost to Follow-up|2
7390228|NCT01235403|11650321|FG000|Overall Study|Withdrawal by Subject|4
7390229|NCT01235403|11650321|FG000|Overall Study|Lack of Efficacy|2
7390230|NCT01235403|11650321|FG000|Overall Study|Other reasons for premature termination|4
7390231|NCT01235442|11650327|FG000|Overall Study|Lost to Follow-up|12
7390232|NCT01235442|11650328|FG001|Overall Study|Lost to Follow-up|10
7390233|NCT01235442|11650327|FG000|Overall Study|Death|0
7310646|NCT00676338|11536572|FG003|Overall Study|Withdrawal by Subject|6
7390234|NCT01235442|11650328|FG001|Overall Study|Death|2
7390235|NCT01235442|11650327|FG000|Overall Study|Pregnancy|1
7390236|NCT01235442|11650328|FG001|Overall Study|Pregnancy|1
7390237|NCT01235442|11650327|FG000|Overall Study|Ineligibility determined|5
7390238|NCT01235442|11650328|FG001|Overall Study|Ineligibility determined|4
7390239|NCT01235442|11650327|FG000|Overall Study|Protocol Violation|3
7310647|NCT00676338|11536569|FG000|Overall Study|Entry Criteria Not Met|0
7310648|NCT00676338|11536570|FG001|Overall Study|Entry Criteria Not Met|2
7310649|NCT00676338|11536571|FG002|Overall Study|Entry Criteria Not Met|1
7310650|NCT00676338|11536572|FG003|Overall Study|Entry Criteria Not Met|1
7310651|NCT00676338|11536569|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7310652|NCT00676338|11536570|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7310653|NCT00676338|11536571|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
7310654|NCT00676338|11536572|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
7310655|NCT00676403|11536599|FG000|Overall Study|Adverse Event|1
7310656|NCT00676403|11536600|FG001|Overall Study|Adverse Event|2
7310657|NCT00676403|11536601|FG002|Overall Study|Adverse Event|0
7310658|NCT00676403|11536602|FG003|Overall Study|Adverse Event|5
7310659|NCT00676403|11536603|FG004|Overall Study|Adverse Event|1
7310660|NCT00676403|11536604|FG005|Overall Study|Adverse Event|2
7310661|NCT00676403|11536599|FG000|Overall Study|Lost to Follow-up|0
7310662|NCT00676403|11536600|FG001|Overall Study|Lost to Follow-up|0
7310663|NCT00676403|11536601|FG002|Overall Study|Lost to Follow-up|0
7310664|NCT00676403|11536602|FG003|Overall Study|Lost to Follow-up|0
7310665|NCT00676403|11536603|FG004|Overall Study|Lost to Follow-up|0
7310666|NCT00676403|11536604|FG005|Overall Study|Lost to Follow-up|1
7310667|NCT00676403|11536599|FG000|Overall Study|Reason Unspecified|1
7310668|NCT00676403|11536600|FG001|Overall Study|Reason Unspecified|0
7310669|NCT00676403|11536601|FG002|Overall Study|Reason Unspecified|1
7310670|NCT00676403|11536602|FG003|Overall Study|Reason Unspecified|0
7310671|NCT00676403|11536603|FG004|Overall Study|Reason Unspecified|0
7310672|NCT00676403|11536604|FG005|Overall Study|Reason Unspecified|1
7310673|NCT00676403|11536599|FG000|Overall Study|Withdrawal by Subject|0
7310674|NCT00676403|11536600|FG001|Overall Study|Withdrawal by Subject|0
7310675|NCT00676403|11536601|FG002|Overall Study|Withdrawal by Subject|0
7310676|NCT00676403|11536602|FG003|Overall Study|Withdrawal by Subject|0
7310677|NCT00676403|11536603|FG004|Overall Study|Withdrawal by Subject|0
7310678|NCT00676403|11536604|FG005|Overall Study|Withdrawal by Subject|1
7310679|NCT00676520|11536624|FG000|Overall Study|Withdrawal by Subject|163
7310680|NCT00676520|11536624|FG000|Overall Study|Lost to Follow-up|162
7310681|NCT00676520|11536624|FG000|Overall Study|Death|159
7310682|NCT00676520|11536624|FG000|Overall Study|Physician Decision|20
7310683|NCT00676520|11536624|FG000|Overall Study|Ineligible for Randomization to DAPT|209
7310684|NCT00676520|11536624|FG000|Overall Study|Other Reason|18
7310685|NCT00676650|11536653|FG000|Overall Study|Death|45
7310686|NCT00676650|11536654|FG001|Overall Study|Death|14
7310687|NCT00676650|11536653|FG000|Overall Study|Adverse Event|159
7310688|NCT00676650|11536654|FG001|Overall Study|Adverse Event|21
7310689|NCT00676650|11536653|FG000|Overall Study|Global deterioration of health status|66
7310690|NCT00676650|11536654|FG001|Overall Study|Global deterioration of health status|31
7310691|NCT00676650|11536653|FG000|Overall Study|Lost to Follow-up|0
7310692|NCT00676650|11536654|FG001|Overall Study|Lost to Follow-up|1
7310693|NCT00676650|11536653|FG000|Overall Study|Objective progression or relapse|189
7310694|NCT00676650|11536654|FG001|Overall Study|Objective progression or relapse|140
7310695|NCT00676650|11536653|FG000|Overall Study|Other|14
7310696|NCT00676650|11536654|FG001|Overall Study|Other|10
7310697|NCT00676650|11536653|FG000|Overall Study|Protocol Violation|3
7310698|NCT00676650|11536654|FG001|Overall Study|Protocol Violation|1
7310699|NCT00676650|11536653|FG000|Overall Study|Study terminated by sponsor|57
7310700|NCT00676650|11536654|FG001|Overall Study|Study terminated by sponsor|43
7310701|NCT00676650|11536653|FG000|Overall Study|Withdrawal by Subject|48
7310702|NCT00676650|11536654|FG001|Overall Study|Withdrawal by Subject|24
7310703|NCT00676650|11536653|FG000|Overall Study|Randomized but not treated|3
7310704|NCT00676650|11536654|FG001|Overall Study|Randomized but not treated|4
7310705|NCT00676689|11536664|FG000|Overall Study|Screen Failure|2
7310706|NCT00676689|11536664|FG000|Overall Study|Death|2
7310707|NCT00676689|11536664|FG000|Overall Study|Lost to Follow-up|4
7310708|NCT00676689|11536664|FG000|Overall Study|Physician Decision|1
7310709|NCT00676689|11536664|FG000|Overall Study|Withdrawal by Subject|3
7310710|NCT00676689|11536664|FG000|Overall Study|Continuing FU|49
7310711|NCT00677014|11536704|FG000|Overall Study|Lost to Follow-up|20
7310712|NCT00677014|11536705|FG001|Overall Study|Lost to Follow-up|12
7310713|NCT00677014|11536706|FG002|Overall Study|Lost to Follow-up|24
7310714|NCT00677014|11536704|FG000|Overall Study|Death|6
7310715|NCT00677014|11536705|FG001|Overall Study|Death|15
7310716|NCT00677014|11536706|FG002|Overall Study|Death|7
7310717|NCT00677014|11536704|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
7310718|NCT00677014|11536705|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
7310719|NCT00677014|11536706|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
7310720|NCT00677092|11536719|FG000|Overall Study|Adverse Event|1
7310721|NCT00677092|11536719|FG000|Overall Study|Lost to Follow-up|1
7310722|NCT00677092|11536719|FG000|Overall Study|Withdrawal by Subject|3
7310723|NCT00677092|11536719|FG000|Overall Study|Death Prior to Receiving Treatment|1
7310724|NCT00677235|11536726|FG000|Overall Study|Withdrawal by Subject|1
7310725|NCT00677235|11536727|FG001|Overall Study|Withdrawal by Subject|1
7310726|NCT00677235|11536726|FG000|Overall Study|Lost to Follow-up|2
7310727|NCT00677235|11536727|FG001|Overall Study|Lost to Follow-up|1
7310728|NCT00677235|11536726|FG000|Overall Study|Death|37
7310729|NCT00677235|11536727|FG001|Overall Study|Death|36
7310730|NCT00677235|11536726|FG000|Overall Study|Adverse Experience|1
7310731|NCT00677235|11536727|FG001|Overall Study|Adverse Experience|0
7384225|NCT01193257|11641363|FG000|Overall Study|Study termination by sponsor|0
7310732|NCT00677352|11536735|FG000|Treatment Phase|Adverse Event|14
7310733|NCT00677352|11536736|FG001|Treatment Phase|Adverse Event|22
7310734|NCT00677352|11536735|FG000|Treatment Phase|Lack of Efficacy|2
7310735|NCT00677352|11536736|FG001|Treatment Phase|Lack of Efficacy|3
7310736|NCT00677352|11536735|FG000|Treatment Phase|Lost to Follow-up|0
7310737|NCT00677352|11536736|FG001|Treatment Phase|Lost to Follow-up|1
7310738|NCT00677352|11536735|FG000|Treatment Phase|Withdrawal by Subject|7
7310739|NCT00677352|11536736|FG001|Treatment Phase|Withdrawal by Subject|7
7310740|NCT00677352|11536735|FG000|Treatment Phase|Physician Decision|1
7310741|NCT00677352|11536736|FG001|Treatment Phase|Physician Decision|0
7310742|NCT00677352|11536735|FG000|Treatment Phase|Pregnancy|0
7310743|NCT00677352|11536736|FG001|Treatment Phase|Pregnancy|1
7310744|NCT00677352|11536735|FG000|Treatment Phase|Protocol Violation|1
7310745|NCT00677352|11536736|FG001|Treatment Phase|Protocol Violation|1
7310746|NCT00677352|11536735|FG000|Treatment Phase|Transference or work related matter|0
7310747|NCT00677352|11536736|FG001|Treatment Phase|Transference or work related matter|5
7310748|NCT00677352|11536735|FG000|Treatment Phase|Not treated|0
7310749|NCT00677352|11536736|FG001|Treatment Phase|Not treated|2
7310750|NCT00677352|11536735|FG000|Tapering Phase|Adverse Event|1
7310751|NCT00677352|11536736|FG001|Tapering Phase|Adverse Event|5
7310752|NCT00677352|11536735|FG000|Tapering Phase|Withdrawal by Subject|5
7310753|NCT00677352|11536736|FG001|Tapering Phase|Withdrawal by Subject|3
7310754|NCT00677352|11536735|FG000|Tapering Phase|Pregnancy|0
7310755|NCT00677352|11536736|FG001|Tapering Phase|Pregnancy|1
7310756|NCT00677352|11536735|FG000|Tapering Phase|Job transfer|0
7310757|NCT00677352|11536736|FG001|Tapering Phase|Job transfer|1
7310758|NCT00677365|11536746|FG000|Overall Study|Adverse Event|2
7310759|NCT00677365|11536747|FG001|Overall Study|Adverse Event|1
7310760|NCT00677365|11536748|FG002|Overall Study|Adverse Event|1
7310761|NCT00677365|11536749|FG003|Overall Study|Adverse Event|2
7310762|NCT00677365|11536746|FG000|Overall Study|Withdrawal by Subject|0
7310763|NCT00677365|11536747|FG001|Overall Study|Withdrawal by Subject|0
7310764|NCT00677365|11536748|FG002|Overall Study|Withdrawal by Subject|1
7310765|NCT00677365|11536749|FG003|Overall Study|Withdrawal by Subject|0
7310766|NCT00677365|11536746|FG000|Overall Study|Other reason|0
7310767|NCT00677365|11536747|FG001|Overall Study|Other reason|0
7310768|NCT00677365|11536748|FG002|Overall Study|Other reason|0
7310769|NCT00677365|11536749|FG003|Overall Study|Other reason|1
7310770|NCT00677534|11536759|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
7310771|NCT00677534|11536759|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
7310772|NCT00677534|11536759|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
7310773|NCT00677807|11536775|FG000|Overall Study|Adverse Event|4
7310774|NCT00677807|11536776|FG001|Overall Study|Adverse Event|1
7310775|NCT00677807|11536777|FG002|Overall Study|Adverse Event|6
7310776|NCT00677807|11536775|FG000|Overall Study|Lack of Efficacy|0
7310777|NCT00677807|11536776|FG001|Overall Study|Lack of Efficacy|0
7310778|NCT00677807|11536777|FG002|Overall Study|Lack of Efficacy|2
7310779|NCT00677807|11536775|FG000|Overall Study|Participant no longer needs study drug|0
7310780|NCT00677807|11536776|FG001|Overall Study|Participant no longer needs study drug|0
7310781|NCT00677807|11536777|FG002|Overall Study|Participant no longer needs study drug|1
7310782|NCT00677807|11536775|FG000|Overall Study|Withdrawal by Subject|10
7310783|NCT00677807|11536776|FG001|Overall Study|Withdrawal by Subject|3
7310784|NCT00677807|11536777|FG002|Overall Study|Withdrawal by Subject|6
7310785|NCT00677807|11536775|FG000|Overall Study|Lost to Follow-up|2
7310786|NCT00677807|11536776|FG001|Overall Study|Lost to Follow-up|2
7310787|NCT00677807|11536777|FG002|Overall Study|Lost to Follow-up|2
7310788|NCT00677807|11536775|FG000|Overall Study|Administrative problems|1
7310789|NCT00677807|11536776|FG001|Overall Study|Administrative problems|1
7310790|NCT00677807|11536777|FG002|Overall Study|Administrative problems|2
7310791|NCT00677807|11536775|FG000|Overall Study|Death|0
7310792|NCT00677807|11536776|FG001|Overall Study|Death|1
7310793|NCT00677807|11536777|FG002|Overall Study|Death|1
7310794|NCT00677807|11536775|FG000|Overall Study|Protocol Deviation|1
7310795|NCT00677807|11536776|FG001|Overall Study|Protocol Deviation|3
7310796|NCT00677807|11536777|FG002|Overall Study|Protocol Deviation|0
7310797|NCT00677820|11536787|FG000|Overall Study|Lost to Follow-up|1
7310798|NCT00677820|11536788|FG001|Overall Study|Lost to Follow-up|0
7310799|NCT00677833|11536798|FG000|Overall Study|Withdrawal by Subject|4
7310800|NCT00677833|11536799|FG001|Overall Study|Withdrawal by Subject|0
7310801|NCT00677833|11536800|FG002|Overall Study|Withdrawal by Subject|1
7310802|NCT00677833|11536801|FG003|Overall Study|Withdrawal by Subject|3
7310803|NCT00677833|11536798|FG000|Overall Study|Lost to Follow-up|0
7310804|NCT00677833|11536799|FG001|Overall Study|Lost to Follow-up|0
7310805|NCT00677833|11536800|FG002|Overall Study|Lost to Follow-up|1
7310806|NCT00677833|11536801|FG003|Overall Study|Lost to Follow-up|0
7310807|NCT00678080|11536833|FG000|Overall Study|Physician Decision|2
7310808|NCT00678080|11536834|FG001|Overall Study|Physician Decision|0
7310809|NCT00678080|11536833|FG000|Overall Study|Lost to Follow-up|1
7310810|NCT00678080|11536834|FG001|Overall Study|Lost to Follow-up|0
7310811|NCT00678080|11536833|FG000|Overall Study|Withdrawal by Subject|0
7310812|NCT00678080|11536834|FG001|Overall Study|Withdrawal by Subject|1
7310813|NCT00678210|11536844|FG000|Overall Study|Adverse Event|1
7310814|NCT00678210|11536845|FG001|Overall Study|Adverse Event|2
7310815|NCT00678210|11536846|FG002|Overall Study|Adverse Event|3
7310816|NCT00678210|11536847|FG003|Overall Study|Adverse Event|3
7310817|NCT00678210|11536844|FG000|Overall Study|Lack of Efficacy|2
7310818|NCT00678210|11536845|FG001|Overall Study|Lack of Efficacy|3
7310819|NCT00678210|11536846|FG002|Overall Study|Lack of Efficacy|1
7310820|NCT00678210|11536847|FG003|Overall Study|Lack of Efficacy|9
7310821|NCT00678210|11536844|FG000|Overall Study|Lost to Follow-up|4
7310822|NCT00678210|11536845|FG001|Overall Study|Lost to Follow-up|2
7310823|NCT00678210|11536846|FG002|Overall Study|Lost to Follow-up|0
7310824|NCT00678210|11536847|FG003|Overall Study|Lost to Follow-up|1
7390240|NCT01235442|11650328|FG001|Overall Study|Protocol Violation|3
7390241|NCT01235442|11650327|FG000|Overall Study|Adverse Event|4
7390242|NCT01235442|11650328|FG001|Overall Study|Adverse Event|6
7390243|NCT01235442|11650327|FG000|Overall Study|Withdrawal by Subject|15
7390244|NCT01235442|11650328|FG001|Overall Study|Withdrawal by Subject|9
7390245|NCT01235442|11650327|FG000|Overall Study|Lack of Efficacy|1
7390246|NCT01235442|11650328|FG001|Overall Study|Lack of Efficacy|3
7390247|NCT01235442|11650327|FG000|Overall Study|Noncompliance|1
7310825|NCT00678210|11536844|FG000|Overall Study|Withdrawal by Subject|3
7310826|NCT00678210|11536845|FG001|Overall Study|Withdrawal by Subject|4
7310827|NCT00678210|11536846|FG002|Overall Study|Withdrawal by Subject|1
7310828|NCT00678210|11536847|FG003|Overall Study|Withdrawal by Subject|7
7310829|NCT00678210|11536844|FG000|Overall Study|Other|1
7310830|NCT00678210|11536845|FG001|Overall Study|Other|0
7310831|NCT00678210|11536846|FG002|Overall Study|Other|1
7310832|NCT00678210|11536847|FG003|Overall Study|Other|0
7310833|NCT00678301|11536872|FG000|Overall Study|Non-compliance with study procedures|0
7310834|NCT00678301|11536873|FG001|Overall Study|Non-compliance with study procedures|1
7310835|NCT00678301|11536872|FG000|Overall Study|Adverse Event|1
7310836|NCT00678301|11536873|FG001|Overall Study|Adverse Event|0
7310837|NCT00678301|11536872|FG000|Overall Study|Withdrawal by Subject|4
7310838|NCT00678301|11536873|FG001|Overall Study|Withdrawal by Subject|0
7310839|NCT00678301|11536872|FG000|Overall Study|Lost to Follow-up|3
7310840|NCT00678301|11536873|FG001|Overall Study|Lost to Follow-up|1
7310841|NCT00678379|11536882|FG000|Overall Study|Injection performed after tonsillectomy|2
7310842|NCT00678379|11536883|FG001|Overall Study|Injection performed after tonsillectomy|0
7310843|NCT00678379|11536884|FG002|Overall Study|Injection performed after tonsillectomy|1
7310844|NCT00678379|11536882|FG000|Overall Study|Incomplete Data|4
7310845|NCT00678379|11536883|FG001|Overall Study|Incomplete Data|3
7310846|NCT00678379|11536884|FG002|Overall Study|Incomplete Data|3
7310847|NCT00678392|11536894|FG000|Overall Study|Adverse Event|0
7310848|NCT00678392|11536895|FG001|Overall Study|Adverse Event|6
7310849|NCT00678392|11536894|FG000|Overall Study|Death|280
7310850|NCT00678392|11536895|FG001|Overall Study|Death|269
7310851|NCT00678392|11536894|FG000|Overall Study|Lost to Follow-up|15
7310852|NCT00678392|11536895|FG001|Overall Study|Lost to Follow-up|13
7310853|NCT00678392|11536894|FG000|Overall Study|Objective Progression or Relapse|3
7310854|NCT00678392|11536895|FG001|Overall Study|Objective Progression or Relapse|8
7310855|NCT00678392|11536894|FG000|Overall Study|Sponsor's Decision|1
7310856|NCT00678392|11536895|FG001|Overall Study|Sponsor's Decision|2
7310857|NCT00678392|11536894|FG000|Overall Study|Withdrawal by Subject|4
7310858|NCT00678392|11536895|FG001|Overall Study|Withdrawal by Subject|4
7310859|NCT00678392|11536894|FG000|Overall Study|Randomized But Not Treated|2
7310860|NCT00678392|11536895|FG001|Overall Study|Randomized But Not Treated|7
7390248|NCT01235442|11650328|FG001|Overall Study|Noncompliance|2
7390249|NCT01235442|11650327|FG000|Overall Study|Administrative decision|1
7390250|NCT01235442|11650328|FG001|Overall Study|Administrative decision|2
7390251|NCT01235442|11650327|FG000|Overall Study|Other unspecified|1
7390252|NCT01235442|11650328|FG001|Overall Study|Other unspecified|2
7390253|NCT01235507|11650334|FG000|Overall Study|Adverse Event|1
7390254|NCT01235507|11650334|FG000|Overall Study|Withdrawal by Subject|1
7390255|NCT01235546|11650340|FG000|Overall Study|Staff error, medication not administered|1
7390256|NCT01235546|11650341|FG001|Overall Study|Staff error, medication not administered|0
7390257|NCT01235546|11650340|FG000|Overall Study|Protocol Violation|1
7390258|NCT01235546|11650341|FG001|Overall Study|Protocol Violation|1
7390259|NCT01235598|11650358|FG000|Overall Study|Adverse Event|0
7390260|NCT01235598|11650359|FG001|Overall Study|Adverse Event|3
7390261|NCT01235598|11650358|FG000|Overall Study|Lack of Efficacy|0
7390262|NCT01235598|11650359|FG001|Overall Study|Lack of Efficacy|1
7390263|NCT01235598|11650358|FG000|Overall Study|Withdrawal by Subject|1
7390264|NCT01235598|11650359|FG001|Overall Study|Withdrawal by Subject|0
7390265|NCT01235689|11650368|FG000|Overall Study|Adverse Event|12
7390266|NCT01235689|11650369|FG001|Overall Study|Adverse Event|16
7390267|NCT01235689|11650368|FG000|Overall Study|Lack of Efficacy|12
7390268|NCT01235689|11650369|FG001|Overall Study|Lack of Efficacy|5
7390269|NCT01235689|11650368|FG000|Overall Study|Withdrawal by Subject|3
7390270|NCT01235689|11650369|FG001|Overall Study|Withdrawal by Subject|4
7390271|NCT01235689|11650368|FG000|Overall Study|Lost to Follow-up|1
7390272|NCT01235689|11650369|FG001|Overall Study|Lost to Follow-up|2
7390273|NCT01235689|11650368|FG000|Overall Study|Miscellaneous|1
7390274|NCT01235689|11650369|FG001|Overall Study|Miscellaneous|5
7390275|NCT01235715|11650377|FG000|Overall Study|Physician Decision|0
7390276|NCT01235715|11650378|FG001|Overall Study|Physician Decision|2
7390277|NCT01235728|11650385|FG000|Overall Study|Protocol Violation|0
7390278|NCT01235728|11650386|FG001|Overall Study|Protocol Violation|0
7310861|NCT00678392|11536894|FG000|Overall Study|Other|56
7390279|NCT01235728|11650387|FG002|Overall Study|Protocol Violation|0
7310862|NCT00678392|11536895|FG001|Overall Study|Other|53
7310863|NCT00678561|11536951|FG000|Overall Study|Adverse Event|0
7310864|NCT00678561|11536952|FG001|Overall Study|Adverse Event|1
7310865|NCT00678561|11536953|FG002|Overall Study|Adverse Event|1
7310866|NCT00678561|11536954|FG003|Overall Study|Adverse Event|0
7310867|NCT00678561|11536955|FG004|Overall Study|Adverse Event|1
7310868|NCT00678561|11536956|FG005|Overall Study|Adverse Event|0
7310869|NCT00678561|11536957|FG006|Overall Study|Adverse Event|0
7310870|NCT00678561|11536958|FG007|Overall Study|Adverse Event|0
7310871|NCT00678561|11536951|FG000|Overall Study|Protocol Violation|0
7310872|NCT00678561|11536952|FG001|Overall Study|Protocol Violation|0
7310873|NCT00678561|11536953|FG002|Overall Study|Protocol Violation|0
7310874|NCT00678561|11536954|FG003|Overall Study|Protocol Violation|0
7310875|NCT00678561|11536955|FG004|Overall Study|Protocol Violation|1
7310876|NCT00678561|11536956|FG005|Overall Study|Protocol Violation|1
7310877|NCT00678561|11536957|FG006|Overall Study|Protocol Violation|0
7310878|NCT00678561|11536958|FG007|Overall Study|Protocol Violation|0
7310879|NCT00678561|11536951|FG000|Overall Study|Withdrawal by Subject|0
7310880|NCT00678561|11536952|FG001|Overall Study|Withdrawal by Subject|0
7310881|NCT00678561|11536953|FG002|Overall Study|Withdrawal by Subject|0
7310882|NCT00678561|11536954|FG003|Overall Study|Withdrawal by Subject|0
7310883|NCT00678561|11536955|FG004|Overall Study|Withdrawal by Subject|0
7310884|NCT00678561|11536956|FG005|Overall Study|Withdrawal by Subject|0
7310885|NCT00678561|11536957|FG006|Overall Study|Withdrawal by Subject|0
7310886|NCT00678561|11536958|FG007|Overall Study|Withdrawal by Subject|1
7310887|NCT00678587|11536985|FG000|Overall Study|Adverse Event|3
7310888|NCT00678587|11536986|FG001|Overall Study|Adverse Event|3
7390280|NCT01235728|11650388|FG003|Overall Study|Protocol Violation|1
7390281|NCT01235728|11650389|FG004|Overall Study|Protocol Violation|0
7390282|NCT01235728|11650390|FG005|Overall Study|Protocol Violation|0
7390283|NCT01235728|11650391|FG006|Overall Study|Protocol Violation|0
7390284|NCT01235728|11650392|FG007|Overall Study|Protocol Violation|0
7465177|NCT01878292|11764241|FG001|Double-blind Treatment Period|Lost to Follow-up|3
7465178|NCT01878292|11764242|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7465179|NCT01878292|11764240|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
7465180|NCT01878292|11764241|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
7465181|NCT01878292|11764242|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
7465182|NCT01878292|11764240|FG000|Double-blind Treatment Period|Protocol Violation|3
7465183|NCT01878292|11764241|FG001|Double-blind Treatment Period|Protocol Violation|4
7465184|NCT01878292|11764242|FG002|Double-blind Treatment Period|Protocol Violation|2
7465185|NCT01878292|11764240|FG000|Double-blind Treatment Period|Lack of Efficacy|5
7465186|NCT01878292|11764241|FG001|Double-blind Treatment Period|Lack of Efficacy|3
7465187|NCT01878292|11764242|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7465188|NCT01878292|11764240|FG000|Double-blind Treatment Period|Adverse Event|4
7465189|NCT01878292|11764241|FG001|Double-blind Treatment Period|Adverse Event|9
7465190|NCT01878292|11764242|FG002|Double-blind Treatment Period|Adverse Event|8
7465191|NCT01878292|11764240|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
7465192|NCT01878292|11764241|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
7465193|NCT01878292|11764242|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
7465194|NCT01878383|11764252|FG000|Overall Study|Lost to Follow-up|0
7465195|NCT01878383|11764253|FG001|Overall Study|Lost to Follow-up|1499
7465196|NCT01878890|11764323|FG000|Overall Study|Protocol Violation|0
7465197|NCT01878890|11764324|FG001|Overall Study|Protocol Violation|1
7465198|NCT01878890|11764325|FG002|Overall Study|Protocol Violation|0
7465199|NCT01878890|11764326|FG003|Overall Study|Protocol Violation|0
7465200|NCT01879072|11764341|FG000|Overall Study|Withdrawal by Subject|121
7465201|NCT01879072|11764341|FG000|Overall Study|Not Transplanted|30
7465202|NCT01879319|11764356|FG000|Overall Study|Withdrawal by Subject|1
7465203|NCT01879319|11764357|FG001|Overall Study|Withdrawal by Subject|0
7465204|NCT01879319|11764356|FG000|Overall Study|Lost to Follow-up|1
7465205|NCT01879319|11764357|FG001|Overall Study|Lost to Follow-up|5
7468555|NCT01912287|11769440|FG000|Overall Study|Scheduling/change in availability|17
7468556|NCT01912287|11769441|FG001|Overall Study|Scheduling/change in availability|10
7468557|NCT01912287|11769442|FG002|Overall Study|Scheduling/change in availability|8
7468558|NCT01912339|11769452|FG000|Blinded (0 to 3 Months)|Declined to participate|1
7468559|NCT01912339|11769453|FG001|Blinded (0 to 3 Months)|Declined to participate|0
7468560|NCT01912339|11769454|FG002|Blinded (0 to 3 Months)|Declined to participate|0
7468561|NCT01912339|11769452|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
7468562|NCT01912339|11769453|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
7468563|NCT01912339|11769454|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
7468564|NCT01912339|11769452|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
7468565|NCT01912339|11769453|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7468566|NCT01912339|11769454|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
7468567|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
7468568|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7468569|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
7468570|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
7468571|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7468572|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
7310889|NCT00678587|11536985|FG000|Overall Study|Lack of Efficacy|1
7310890|NCT00678587|11536986|FG001|Overall Study|Lack of Efficacy|0
7310891|NCT00678587|11536985|FG000|Overall Study|Protocol Violation|2
7310892|NCT00678587|11536986|FG001|Overall Study|Protocol Violation|1
7310893|NCT00678587|11536985|FG000|Overall Study|Study Closed/Terminated|1
7310894|NCT00678587|11536986|FG001|Overall Study|Study Closed/Terminated|0
7310895|NCT00678587|11536985|FG000|Overall Study|Lost to Follow-up|3
7310896|NCT00678587|11536986|FG001|Overall Study|Lost to Follow-up|5
7310897|NCT00678587|11536985|FG000|Overall Study|Investigator Discretion|2
7310898|NCT00678587|11536986|FG001|Overall Study|Investigator Discretion|6
7310899|NCT00678587|11536985|FG000|Overall Study|Withdrew Consent|8
7310900|NCT00678587|11536986|FG001|Overall Study|Withdrew Consent|3
7310901|NCT00678639|11536995|FG000|Overall Study|Lost to Follow-up at 30 days|2
7310902|NCT00678639|11536996|FG001|Overall Study|Lost to Follow-up at 30 days|0
7310903|NCT00678652|11537007|FG000|Overall Study|Protocol Violation|2
7310904|NCT00678652|11537008|FG001|Overall Study|Protocol Violation|0
7310905|NCT00678652|11537009|FG002|Overall Study|Protocol Violation|0
7310906|NCT00678652|11537010|FG003|Overall Study|Protocol Violation|0
7310907|NCT00678652|11537007|FG000|Overall Study|Pregnancy|0
7310908|NCT00678652|11537008|FG001|Overall Study|Pregnancy|0
7310909|NCT00678652|11537009|FG002|Overall Study|Pregnancy|1
7310910|NCT00678652|11537010|FG003|Overall Study|Pregnancy|0
7310911|NCT00678652|11537007|FG000|Overall Study|Relocation|1
7310912|NCT00678652|11537008|FG001|Overall Study|Relocation|0
7310913|NCT00678652|11537009|FG002|Overall Study|Relocation|0
7310914|NCT00678652|11537010|FG003|Overall Study|Relocation|0
7310915|NCT00678691|11537022|FG000|Overall Study|Adverse Event|6
7310916|NCT00678691|11537023|FG001|Overall Study|Adverse Event|4
7310917|NCT00678795|11537031|FG000|Overall Study|Adverse Event|7
7310918|NCT00678795|11537032|FG001|Overall Study|Adverse Event|3
7310919|NCT00678795|11537031|FG000|Overall Study|Withdrawal by Subject|3
7310920|NCT00678795|11537032|FG001|Overall Study|Withdrawal by Subject|0
7310921|NCT00678795|11537031|FG000|Overall Study|Protocol Violation|0
7310922|NCT00678795|11537032|FG001|Overall Study|Protocol Violation|1
7310923|NCT00678795|11537031|FG000|Overall Study|Lost to Follow-up|0
7310924|NCT00678795|11537032|FG001|Overall Study|Lost to Follow-up|1
7310925|NCT00678795|11537031|FG000|Overall Study|Lack of Efficacy|1
7310926|NCT00678795|11537032|FG001|Overall Study|Lack of Efficacy|1
7390285|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
7390286|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7390287|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
7390288|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
7390289|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7390290|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
7390291|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
7390292|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7390293|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
7390294|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
7390295|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7390296|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
7390297|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
7390298|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7390299|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
7390300|NCT01235741|11650403|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
7390301|NCT01235741|11650404|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7390302|NCT01235741|11650405|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
7390303|NCT01235741|11650403|FG000|Randomized to Treatment|Withdrawal by Subject|0
7390304|NCT01235741|11650404|FG001|Randomized to Treatment|Withdrawal by Subject|0
7390305|NCT01235741|11650405|FG002|Randomized to Treatment|Withdrawal by Subject|1
7390306|NCT01235741|11650403|FG000|Randomized to Treatment|Adverse Event|0
7390307|NCT01235741|11650404|FG001|Randomized to Treatment|Adverse Event|1
7390308|NCT01235741|11650405|FG002|Randomized to Treatment|Adverse Event|1
7390309|NCT01235741|11650403|FG000|Randomized to Treatment|Sponsor terminated study|0
7390310|NCT01235741|11650404|FG001|Randomized to Treatment|Sponsor terminated study|35
7390311|NCT01235741|11650405|FG002|Randomized to Treatment|Sponsor terminated study|34
7390312|NCT01235741|11650403|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
7390313|NCT01235741|11650404|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
7390314|NCT01235741|11650405|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
7390315|NCT01235741|11650403|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
7390316|NCT01235741|11650404|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
7390317|NCT01235741|11650405|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
7390318|NCT01235741|11650403|FG000|Follow-Up Post Treatment up to Month 6|Other|0
7390319|NCT01235741|11650404|FG001|Follow-Up Post Treatment up to Month 6|Other|1
7390320|NCT01235741|11650405|FG002|Follow-Up Post Treatment up to Month 6|Other|0
7390321|NCT01235793|11650417|FG000|Overall Study|Death|6
7310927|NCT00678886|11537063|FG000|Overall Study|Withdrawal by Subject|0
7310928|NCT00678886|11537064|FG001|Overall Study|Withdrawal by Subject|0
7310929|NCT00678886|11537065|FG002|Overall Study|Withdrawal by Subject|4
7310930|NCT00678886|11537066|FG003|Overall Study|Withdrawal by Subject|6
7310931|NCT00678886|11537063|FG000|Overall Study|Physician Decision|0
7310932|NCT00678886|11537064|FG001|Overall Study|Physician Decision|0
7310933|NCT00678886|11537065|FG002|Overall Study|Physician Decision|1
7310934|NCT00678886|11537066|FG003|Overall Study|Physician Decision|1
7310935|NCT00678886|11537063|FG000|Overall Study|Lost to Follow-up|0
7310936|NCT00678886|11537064|FG001|Overall Study|Lost to Follow-up|0
7310937|NCT00678886|11537065|FG002|Overall Study|Lost to Follow-up|3
7310938|NCT00678886|11537066|FG003|Overall Study|Lost to Follow-up|2
7310939|NCT00678886|11537063|FG000|Overall Study|Other|0
7310940|NCT00678886|11537064|FG001|Overall Study|Other|0
7310941|NCT00678886|11537065|FG002|Overall Study|Other|1
7310942|NCT00678886|11537066|FG003|Overall Study|Other|0
7310943|NCT00678899|11537075|FG000|Overall Study|Adverse Event|1
7310944|NCT00679029|11537080|FG000|Overall Study|Adverse Event|3
7310945|NCT00679029|11537080|FG000|Overall Study|Withdrawal by Subject|1
7310946|NCT00679029|11537080|FG000|Overall Study|Lost to Follow-up|1
7390322|NCT01235949|11650449|FG000|Primary Phase|Migrated/moved from study area|1
7390323|NCT01235949|11650450|FG001|Primary Phase|Migrated/moved from study area|1
7390324|NCT01235949|11650451|FG002|Primary Phase|Migrated/moved from study area|0
7310952|NCT00679055|11537090|FG000|Overall Study|Adverse Event|0
7310953|NCT00679055|11537091|FG001|Overall Study|Adverse Event|1
7310954|NCT00679055|11537090|FG000|Overall Study|Other|0
7310955|NCT00679055|11537091|FG001|Overall Study|Other|3
7310956|NCT00679055|11537090|FG000|Overall Study|Study Terminated|2
7310957|NCT00679055|11537091|FG001|Overall Study|Study Terminated|1
7310958|NCT00679081|11537097|FG000|Overall Study|Lost to Follow-up|1
7310959|NCT00679172|11537110|FG000|Overall Study|Non-compliance|1
7310960|NCT00679172|11537111|FG001|Overall Study|Non-compliance|1
7310961|NCT00679172|11537112|FG002|Overall Study|Non-compliance|0
7310962|NCT00679172|11537113|FG003|Overall Study|Non-compliance|1
7310963|NCT00679172|11537114|FG004|Overall Study|Non-compliance|0
7310964|NCT00679172|11537110|FG000|Overall Study|Other not specified|0
7310965|NCT00679172|11537111|FG001|Overall Study|Other not specified|0
7310966|NCT00679172|11537112|FG002|Overall Study|Other not specified|1
7310967|NCT00679172|11537113|FG003|Overall Study|Other not specified|0
7310968|NCT00679172|11537114|FG004|Overall Study|Other not specified|0
7310969|NCT00679211|11537129|FG000|Overall Study|Progressive disease|82
7310970|NCT00679211|11537129|FG000|Overall Study|Adverse Event|7
7390325|NCT01235949|11650452|FG003|Primary Phase|Migrated/moved from study area|0
7390326|NCT01235949|11650453|FG004|Primary Phase|Migrated/moved from study area|1
7390327|NCT01235949|11650454|FG005|Primary Phase|Migrated/moved from study area|2
7390328|NCT01235949|11650455|FG006|Primary Phase|Migrated/moved from study area|0
7390329|NCT01235949|11650456|FG007|Primary Phase|Migrated/moved from study area|0
7390330|NCT01235949|11650457|FG008|Primary Phase|Migrated/moved from study area|0
7390331|NCT01235949|11650458|FG009|Primary Phase|Migrated/moved from study area|0
7390332|NCT01235949|11650459|FG010|Primary Phase|Migrated/moved from study area|0
7390333|NCT01235949|11650460|FG011|Primary Phase|Migrated/moved from study area|0
7390334|NCT01235949|11650461|FG012|Primary Phase|Migrated/moved from study area|0
7390335|NCT01235949|11650462|FG013|Primary Phase|Migrated/moved from study area|0
7390336|NCT01235949|11650463|FG014|Primary Phase|Migrated/moved from study area|0
7390337|NCT01235949|11650464|FG015|Primary Phase|Migrated/moved from study area|0
7390338|NCT01235949|11650465|FG016|Primary Phase|Migrated/moved from study area|0
7390339|NCT01235949|11650466|FG017|Primary Phase|Migrated/moved from study area|0
7390340|NCT01235949|11650449|FG000|Primary Phase|Adverse Event|0
7390341|NCT01235949|11650450|FG001|Primary Phase|Adverse Event|0
7390342|NCT01235949|11650451|FG002|Primary Phase|Adverse Event|0
7390343|NCT01235949|11650452|FG003|Primary Phase|Adverse Event|1
7390344|NCT01235949|11650453|FG004|Primary Phase|Adverse Event|0
7390345|NCT01235949|11650454|FG005|Primary Phase|Adverse Event|0
7390346|NCT01235949|11650455|FG006|Primary Phase|Adverse Event|0
7390347|NCT01235949|11650456|FG007|Primary Phase|Adverse Event|0
7390348|NCT01235949|11650457|FG008|Primary Phase|Adverse Event|0
7390349|NCT01235949|11650458|FG009|Primary Phase|Adverse Event|0
7390350|NCT01235949|11650459|FG010|Primary Phase|Adverse Event|0
7390351|NCT01235949|11650460|FG011|Primary Phase|Adverse Event|0
7390352|NCT01235949|11650461|FG012|Primary Phase|Adverse Event|0
7390353|NCT01235949|11650462|FG013|Primary Phase|Adverse Event|0
7390354|NCT01235949|11650463|FG014|Primary Phase|Adverse Event|0
7390355|NCT01235949|11650464|FG015|Primary Phase|Adverse Event|0
7390356|NCT01235949|11650465|FG016|Primary Phase|Adverse Event|0
7390357|NCT01235949|11650466|FG017|Primary Phase|Adverse Event|0
7390358|NCT01235949|11650449|FG000|Primary Phase|Withdrawal by Subject|3
7390359|NCT01235949|11650450|FG001|Primary Phase|Withdrawal by Subject|2
7310971|NCT00679211|11537129|FG000|Overall Study|Withdrawal by Subject|2
7310972|NCT00679211|11537129|FG000|Overall Study|Physician Decision|5
7310973|NCT00679211|11537129|FG000|Overall Study|Refused to undergo protocol procedures|1
7390360|NCT01235949|11650451|FG002|Primary Phase|Withdrawal by Subject|2
7390361|NCT01235949|11650452|FG003|Primary Phase|Withdrawal by Subject|0
7390362|NCT01235949|11650453|FG004|Primary Phase|Withdrawal by Subject|0
7390363|NCT01235949|11650454|FG005|Primary Phase|Withdrawal by Subject|3
7390364|NCT01235949|11650455|FG006|Primary Phase|Withdrawal by Subject|0
7390365|NCT01235949|11650456|FG007|Primary Phase|Withdrawal by Subject|0
7390366|NCT01235949|11650457|FG008|Primary Phase|Withdrawal by Subject|0
7390367|NCT01235949|11650458|FG009|Primary Phase|Withdrawal by Subject|0
7390368|NCT01235949|11650459|FG010|Primary Phase|Withdrawal by Subject|0
7310974|NCT00679211|11537129|FG000|Overall Study|Transferred to extension study TDM4529g|12
7310975|NCT00679211|11537129|FG000|Overall Study|Other|1
7310976|NCT00679263|11537138|FG000|Visit 2/Dose 1|Adverse Event|1
7310977|NCT00679263|11537139|FG001|Visit 2/Dose 1|Adverse Event|0
7310978|NCT00679263|11537140|FG002|Visit 2/Dose 1|Adverse Event|0
7310979|NCT00679263|11537138|FG000|Visit 2/Dose 1|subject not compliance|1
7310980|NCT00679263|11537139|FG001|Visit 2/Dose 1|subject not compliance|1
7310981|NCT00679263|11537140|FG002|Visit 2/Dose 1|subject not compliance|0
7310982|NCT00679289|11537151|FG000|Overall Study|Progressive disease|4
7310983|NCT00679289|11537152|FG001|Overall Study|Progressive disease|5
7310984|NCT00679289|11537153|FG002|Overall Study|Progressive disease|18
7310985|NCT00679289|11537151|FG000|Overall Study|Withdrawal by Subject|0
7310986|NCT00679289|11537152|FG001|Overall Study|Withdrawal by Subject|1
7310987|NCT00679289|11537153|FG002|Overall Study|Withdrawal by Subject|1
7310988|NCT00679289|11537151|FG000|Overall Study|Adverse Event|0
7310989|NCT00679289|11537152|FG001|Overall Study|Adverse Event|0
7310990|NCT00679289|11537153|FG002|Overall Study|Adverse Event|3
7310991|NCT00679289|11537151|FG000|Overall Study|Physician Decision|1
7310992|NCT00679289|11537152|FG001|Overall Study|Physician Decision|0
7310993|NCT00679289|11537153|FG002|Overall Study|Physician Decision|1
7310994|NCT00679302|11537165|FG000|Overall Study|Lost to Follow-up|8
7310995|NCT00679302|11537166|FG001|Overall Study|Lost to Follow-up|4
7310996|NCT00679341|11537174|FG000|Overall Study|Disease progression|42
7310997|NCT00679341|11537175|FG001|Overall Study|Disease progression|36
7310998|NCT00679341|11537174|FG000|Overall Study|Adverse Event|5
7310999|NCT00679341|11537175|FG001|Overall Study|Adverse Event|6
7311000|NCT00679341|11537174|FG000|Overall Study|Subject/guardian decision to discontinue|3
7311001|NCT00679341|11537175|FG001|Overall Study|Subject/guardian decision to discontinue|0
7311002|NCT00679341|11537174|FG000|Overall Study|Death|1
7311003|NCT00679341|11537175|FG001|Overall Study|Death|1
7311004|NCT00679341|11537174|FG000|Overall Study|Other|1
7311005|NCT00679341|11537175|FG001|Overall Study|Other|0
7311006|NCT00679341|11537174|FG000|Overall Study|Physician Decision|1
7311007|NCT00679341|11537175|FG001|Overall Study|Physician Decision|0
7311008|NCT00679341|11537174|FG000|Overall Study|Not treated|0
7311009|NCT00679341|11537175|FG001|Overall Study|Not treated|2
7311010|NCT00679341|11537174|FG000|Overall Study|Physician/patient decision to withdraw|0
7390369|NCT01235949|11650460|FG011|Primary Phase|Withdrawal by Subject|0
7390370|NCT01235949|11650461|FG012|Primary Phase|Withdrawal by Subject|0
7390371|NCT01235949|11650462|FG013|Primary Phase|Withdrawal by Subject|0
7390372|NCT01235949|11650463|FG014|Primary Phase|Withdrawal by Subject|0
7390373|NCT01235949|11650464|FG015|Primary Phase|Withdrawal by Subject|0
7390374|NCT01235949|11650465|FG016|Primary Phase|Withdrawal by Subject|0
7390375|NCT01235949|11650466|FG017|Primary Phase|Withdrawal by Subject|0
7390376|NCT01235949|11650449|FG000|Primary Phase|Lost to Follow-up|0
7390377|NCT01235949|11650450|FG001|Primary Phase|Lost to Follow-up|0
7390378|NCT01235949|11650451|FG002|Primary Phase|Lost to Follow-up|1
7390379|NCT01235949|11650452|FG003|Primary Phase|Lost to Follow-up|1
7390380|NCT01235949|11650453|FG004|Primary Phase|Lost to Follow-up|0
7390381|NCT01235949|11650454|FG005|Primary Phase|Lost to Follow-up|2
7390382|NCT01235949|11650455|FG006|Primary Phase|Lost to Follow-up|0
7390383|NCT01235949|11650456|FG007|Primary Phase|Lost to Follow-up|0
7390384|NCT01235949|11650457|FG008|Primary Phase|Lost to Follow-up|0
7390385|NCT01235949|11650458|FG009|Primary Phase|Lost to Follow-up|0
7390386|NCT01235949|11650459|FG010|Primary Phase|Lost to Follow-up|0
7390387|NCT01235949|11650460|FG011|Primary Phase|Lost to Follow-up|0
7390388|NCT01235949|11650461|FG012|Primary Phase|Lost to Follow-up|0
7390389|NCT01235949|11650462|FG013|Primary Phase|Lost to Follow-up|0
7390390|NCT01235949|11650463|FG014|Primary Phase|Lost to Follow-up|0
7390391|NCT01235949|11650464|FG015|Primary Phase|Lost to Follow-up|0
7390392|NCT01235949|11650465|FG016|Primary Phase|Lost to Follow-up|0
7390393|NCT01235949|11650466|FG017|Primary Phase|Lost to Follow-up|0
7390394|NCT01235949|11650449|FG000|Booster Phase|Migrated/moved from study area|0
7311011|NCT00679341|11537175|FG001|Overall Study|Physician/patient decision to withdraw|6
7311012|NCT00679354|11537182|FG000|Overall Study|Death|3
7311013|NCT00679354|11537182|FG000|Overall Study|Lack of Efficacy|22
7311014|NCT00679354|11537182|FG000|Overall Study|Physician Decision|4
7311015|NCT00679354|11537182|FG000|Overall Study|Ineligible|1
7311016|NCT00679367|11537187|FG000|Overall Study|Adverse Event|7
7311017|NCT00679367|11537187|FG000|Overall Study|inability to swallow oral drugs|1
7311018|NCT00679367|11537187|FG000|Overall Study|Lack of Efficacy|3
7311019|NCT00679367|11537187|FG000|Overall Study|Withdrawal by Subject|1
7311020|NCT00679432|11537213|FG000|Overall Study|Adverse Event|5
7390395|NCT01235949|11650450|FG001|Booster Phase|Migrated/moved from study area|0
7390396|NCT01235949|11650451|FG002|Booster Phase|Migrated/moved from study area|0
7390397|NCT01235949|11650452|FG003|Booster Phase|Migrated/moved from study area|0
7390398|NCT01235949|11650453|FG004|Booster Phase|Migrated/moved from study area|0
7390399|NCT01235949|11650454|FG005|Booster Phase|Migrated/moved from study area|0
7390400|NCT01235949|11650455|FG006|Booster Phase|Migrated/moved from study area|0
7390401|NCT01235949|11650456|FG007|Booster Phase|Migrated/moved from study area|0
7390402|NCT01235949|11650457|FG008|Booster Phase|Migrated/moved from study area|0
7390403|NCT01235949|11650458|FG009|Booster Phase|Migrated/moved from study area|0
7311021|NCT00679432|11537214|FG001|Overall Study|Adverse Event|6
7311022|NCT00679432|11537215|FG002|Overall Study|Adverse Event|10
7311023|NCT00679432|11537216|FG003|Overall Study|Adverse Event|7
7311024|NCT00679432|11537213|FG000|Overall Study|Protocol Violation|1
7311025|NCT00679432|11537214|FG001|Overall Study|Protocol Violation|1
7311026|NCT00679432|11537215|FG002|Overall Study|Protocol Violation|2
7311027|NCT00679432|11537216|FG003|Overall Study|Protocol Violation|1
7311028|NCT00679432|11537213|FG000|Overall Study|Withdrawal by Subject|8
7311029|NCT00679432|11537214|FG001|Overall Study|Withdrawal by Subject|11
7311030|NCT00679432|11537215|FG002|Overall Study|Withdrawal by Subject|10
7311031|NCT00679432|11537216|FG003|Overall Study|Withdrawal by Subject|9
7311032|NCT00679432|11537213|FG000|Overall Study|Lost to Follow-up|1
7311033|NCT00679432|11537214|FG001|Overall Study|Lost to Follow-up|5
7311034|NCT00679432|11537215|FG002|Overall Study|Lost to Follow-up|4
7311035|NCT00679432|11537216|FG003|Overall Study|Lost to Follow-up|2
7311036|NCT00679432|11537213|FG000|Overall Study|Physician Decision|3
7311037|NCT00679432|11537214|FG001|Overall Study|Physician Decision|2
7311038|NCT00679432|11537215|FG002|Overall Study|Physician Decision|2
7311039|NCT00679432|11537216|FG003|Overall Study|Physician Decision|2
7311040|NCT00679432|11537213|FG000|Overall Study|Sponsor decision|1
7311041|NCT00679432|11537214|FG001|Overall Study|Sponsor decision|0
7311042|NCT00679432|11537215|FG002|Overall Study|Sponsor decision|0
7311043|NCT00679432|11537216|FG003|Overall Study|Sponsor decision|0
7311044|NCT00679432|11537213|FG000|Overall Study|Lack of Efficacy|13
7311045|NCT00679432|11537214|FG001|Overall Study|Lack of Efficacy|9
7311046|NCT00679432|11537215|FG002|Overall Study|Lack of Efficacy|14
7311047|NCT00679432|11537216|FG003|Overall Study|Lack of Efficacy|8
7311048|NCT00679432|11537213|FG000|Overall Study|Infectious colitis, normal histology|5
7311049|NCT00679432|11537214|FG001|Overall Study|Infectious colitis, normal histology|4
7311050|NCT00679432|11537215|FG002|Overall Study|Infectious colitis, normal histology|8
7311051|NCT00679432|11537216|FG003|Overall Study|Infectious colitis, normal histology|3
7311052|NCT00679432|11537213|FG000|Overall Study|Randomization error, return to prior Rx|0
7311053|NCT00679432|11537214|FG001|Overall Study|Randomization error, return to prior Rx|0
7311054|NCT00679432|11537215|FG002|Overall Study|Randomization error, return to prior Rx|3
7311055|NCT00679432|11537216|FG003|Overall Study|Randomization error, return to prior Rx|0
7311056|NCT00679549|11537228|FG000|Overall Study|dropout|2
7311057|NCT00679549|11537229|FG001|Overall Study|dropout|4
7311058|NCT00679549|11537228|FG000|Overall Study|missing outcome echocardiograms|4
7311059|NCT00679549|11537229|FG001|Overall Study|missing outcome echocardiograms|5
7311060|NCT00679627|11537237|FG000|Overall Study|Death|41
7311061|NCT00679627|11537238|FG001|Overall Study|Death|29
7311062|NCT00679627|11537237|FG000|Overall Study|Adverse Event|43
7311063|NCT00679627|11537238|FG001|Overall Study|Adverse Event|53
7311064|NCT00679627|11537237|FG000|Overall Study|Withdrawal by Subject|168
7311065|NCT00679627|11537238|FG001|Overall Study|Withdrawal by Subject|172
7311066|NCT00679627|11537237|FG000|Overall Study|Lost to Follow-up|22
7311067|NCT00679627|11537238|FG001|Overall Study|Lost to Follow-up|26
7311068|NCT00679627|11537237|FG000|Overall Study|Early Study Closure|425
7311069|NCT00679627|11537238|FG001|Overall Study|Early Study Closure|405
7311070|NCT00679913|11537246|FG000|Overall Study|Protocol Violation|18
7311071|NCT00679913|11537247|FG001|Overall Study|Protocol Violation|13
7311072|NCT00679939|11537256|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
7311073|NCT00679939|11537257|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
7311074|NCT00679939|11537256|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
7311075|NCT00679939|11537257|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
7311076|NCT00679939|11537256|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
7311077|NCT00679939|11537257|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
7311078|NCT00679939|11537256|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
7311079|NCT00679939|11537257|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
7311080|NCT00679939|11537256|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7311081|NCT00679939|11537257|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
7311082|NCT00679939|11537256|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
7311083|NCT00679939|11537257|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
7311084|NCT00679939|11537256|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
7311085|NCT00679939|11537257|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
7311086|NCT00679939|11537256|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
7311087|NCT00679939|11537257|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
7311088|NCT00679939|11537256|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
7311089|NCT00679939|11537257|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
7311090|NCT00679939|11537256|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
7311091|NCT00679939|11537257|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
7311092|NCT00680017|11537278|FG000|Overall Study|Adverse Event|13
7311093|NCT00680017|11537279|FG001|Overall Study|Adverse Event|7
7311094|NCT00680017|11537278|FG000|Overall Study|Withdrawal by Subject|2
7311095|NCT00680017|11537279|FG001|Overall Study|Withdrawal by Subject|5
7311096|NCT00680017|11537278|FG000|Overall Study|Lost to Follow-up|2
7311097|NCT00680017|11537279|FG001|Overall Study|Lost to Follow-up|0
7311098|NCT00680043|11537288|FG000|Overall Study|Withdrawal by Subject|1
7311099|NCT00680043|11537289|FG001|Overall Study|Withdrawal by Subject|0
7311100|NCT00680043|11537290|FG002|Overall Study|Withdrawal by Subject|0
7311101|NCT00680043|11537288|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
7311102|NCT00680043|11537289|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
7311103|NCT00680043|11537290|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
7311104|NCT00680043|11537288|FG000|Overall Study|Renal Transplant|1
7311105|NCT00680043|11537289|FG001|Overall Study|Renal Transplant|0
7311106|NCT00680043|11537290|FG002|Overall Study|Renal Transplant|4
7311107|NCT00680056|11537300|FG000|First Intervention|Mainly Exacerbation of COPD|1
7311108|NCT00680056|11537301|FG001|First Intervention|Mainly Exacerbation of COPD|2
7311109|NCT00680056|11537300|FG000|Second Intervention|Protocol Violation|3
7311110|NCT00680056|11537301|FG001|Second Intervention|Protocol Violation|1
7311111|NCT00680121|11537310|FG000|Overall Study|Lost to Follow-up|27
7311112|NCT00680121|11537311|FG001|Overall Study|Lost to Follow-up|23
7311113|NCT00680186|11537319|FG000|Overall Study|Adverse Event|47
7311114|NCT00680186|11537320|FG001|Overall Study|Adverse Event|44
7311115|NCT00680186|11537319|FG000|Overall Study|Protocol Violation|31
7311116|NCT00680186|11537320|FG001|Overall Study|Protocol Violation|26
7311117|NCT00680186|11537319|FG000|Overall Study|Lost to Follow-up|11
7311118|NCT00680186|11537320|FG001|Overall Study|Lost to Follow-up|6
7311119|NCT00680186|11537319|FG000|Overall Study|Withdrawal by Subject|32
7311120|NCT00680186|11537320|FG001|Overall Study|Withdrawal by Subject|39
7311121|NCT00680186|11537319|FG000|Overall Study|Other|4
7311122|NCT00680186|11537320|FG001|Overall Study|Other|1
7311123|NCT00680368|11537330|FG000|Overall Study|not supervised, not eligible|15
7311124|NCT00680407|11537339|FG000|Overall Study|Lost to Follow-up|3
7311125|NCT00680407|11537340|FG001|Overall Study|Lost to Follow-up|3
7311126|NCT00680407|11537341|FG002|Overall Study|Lost to Follow-up|1
7311127|NCT00680407|11537339|FG000|Overall Study|Withdrawal by Subject|5
7311128|NCT00680407|11537340|FG001|Overall Study|Withdrawal by Subject|2
7311129|NCT00680407|11537341|FG002|Overall Study|Withdrawal by Subject|2
7311130|NCT00680745|11537384|FG000|Overall Study|Withdrawal by Subject|8
7311131|NCT00680745|11537385|FG001|Overall Study|Withdrawal by Subject|3
7311132|NCT00680745|11537386|FG002|Overall Study|Withdrawal by Subject|2
7311133|NCT00680745|11537387|FG003|Overall Study|Withdrawal by Subject|8
7311134|NCT00680745|11537384|FG000|Overall Study|Lost to Follow-up|0
7311135|NCT00680745|11537385|FG001|Overall Study|Lost to Follow-up|1
7311136|NCT00680745|11537386|FG002|Overall Study|Lost to Follow-up|1
7311137|NCT00680745|11537387|FG003|Overall Study|Lost to Follow-up|0
7311138|NCT00680745|11537384|FG000|Overall Study|Death|1
7311139|NCT00680745|11537385|FG001|Overall Study|Death|0
7311140|NCT00680745|11537386|FG002|Overall Study|Death|1
7311141|NCT00680745|11537387|FG003|Overall Study|Death|0
7311142|NCT00680745|11537384|FG000|Overall Study|Adverse Event|5
7390404|NCT01235949|11650459|FG010|Booster Phase|Migrated/moved from study area|0
7390405|NCT01235949|11650460|FG011|Booster Phase|Migrated/moved from study area|1
7390406|NCT01235949|11650461|FG012|Booster Phase|Migrated/moved from study area|1
7390407|NCT01235949|11650462|FG013|Booster Phase|Migrated/moved from study area|0
7390408|NCT01235949|11650463|FG014|Booster Phase|Migrated/moved from study area|0
7390409|NCT01235949|11650464|FG015|Booster Phase|Migrated/moved from study area|0
7390410|NCT01235949|11650465|FG016|Booster Phase|Migrated/moved from study area|0
7390411|NCT01235949|11650466|FG017|Booster Phase|Migrated/moved from study area|1
7390412|NCT01235949|11650449|FG000|Booster Phase|Adverse Event|0
7390413|NCT01235949|11650450|FG001|Booster Phase|Adverse Event|0
7390414|NCT01235949|11650451|FG002|Booster Phase|Adverse Event|0
7390415|NCT01235949|11650452|FG003|Booster Phase|Adverse Event|0
7390416|NCT01235949|11650453|FG004|Booster Phase|Adverse Event|0
7390417|NCT01235949|11650454|FG005|Booster Phase|Adverse Event|0
7390418|NCT01235949|11650455|FG006|Booster Phase|Adverse Event|0
7390419|NCT01235949|11650456|FG007|Booster Phase|Adverse Event|0
7390420|NCT01235949|11650457|FG008|Booster Phase|Adverse Event|0
7390421|NCT01235949|11650458|FG009|Booster Phase|Adverse Event|0
7390422|NCT01235949|11650459|FG010|Booster Phase|Adverse Event|0
7390423|NCT01235949|11650460|FG011|Booster Phase|Adverse Event|0
7390424|NCT01235949|11650461|FG012|Booster Phase|Adverse Event|0
7390425|NCT01235949|11650462|FG013|Booster Phase|Adverse Event|0
7390426|NCT01235949|11650463|FG014|Booster Phase|Adverse Event|0
7390427|NCT01235949|11650464|FG015|Booster Phase|Adverse Event|1
7390428|NCT01235949|11650465|FG016|Booster Phase|Adverse Event|0
7390429|NCT01235949|11650466|FG017|Booster Phase|Adverse Event|0
7390430|NCT01235949|11650449|FG000|Booster Phase|Withdrawal by Subject|0
7390431|NCT01235949|11650450|FG001|Booster Phase|Withdrawal by Subject|0
7390432|NCT01235949|11650451|FG002|Booster Phase|Withdrawal by Subject|0
7311143|NCT00680745|11537385|FG001|Overall Study|Adverse Event|3
7311144|NCT00680745|11537386|FG002|Overall Study|Adverse Event|3
7311145|NCT00680745|11537387|FG003|Overall Study|Adverse Event|3
7311146|NCT00680745|11537384|FG000|Overall Study|Poor/Non-compliance|0
7311147|NCT00680745|11537385|FG001|Overall Study|Poor/Non-compliance|3
7311148|NCT00680745|11537386|FG002|Overall Study|Poor/Non-compliance|0
7311149|NCT00680745|11537387|FG003|Overall Study|Poor/Non-compliance|0
7311150|NCT00680745|11537384|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7311151|NCT00680745|11537385|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7311152|NCT00680745|11537386|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7311153|NCT00680745|11537387|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
7311154|NCT00680745|11537384|FG000|Overall Study|False Treatment|0
7311155|NCT00680745|11537385|FG001|Overall Study|False Treatment|1
7311156|NCT00680745|11537386|FG002|Overall Study|False Treatment|3
7311157|NCT00680745|11537387|FG003|Overall Study|False Treatment|0
7311158|NCT00680771|11537400|FG000|Overall Study|Withdrawal by Subject|1
7311159|NCT00680771|11537401|FG001|Overall Study|Withdrawal by Subject|0
7311160|NCT00680771|11537400|FG000|Overall Study|Sleep Apnea suspected after PSG|1
7311161|NCT00680771|11537401|FG001|Overall Study|Sleep Apnea suspected after PSG|0
7311162|NCT00680771|11537400|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
7311163|NCT00680771|11537401|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
7311164|NCT00680836|11537439|FG000|Overall Study|Withdrawal by Subject|3
7311165|NCT00680836|11537440|FG001|Overall Study|Withdrawal by Subject|0
7311166|NCT00680836|11537439|FG000|Overall Study|Lost to Follow-up|3
7311167|NCT00680836|11537440|FG001|Overall Study|Lost to Follow-up|1
7311168|NCT00680836|11537439|FG000|Overall Study|Physician Decision|2
7311169|NCT00680836|11537440|FG001|Overall Study|Physician Decision|1
7311170|NCT00680914|11537453|FG000|Overall Study|Consent withdrawal|6
7311171|NCT00680914|11537454|FG001|Overall Study|Consent withdrawal|3
7311172|NCT00680914|11537453|FG000|Overall Study|Lost to Follow-up|4
7311173|NCT00680914|11537454|FG001|Overall Study|Lost to Follow-up|0
7311174|NCT00680914|11537453|FG000|Overall Study|serious adverse event (SAE)|0
7311175|NCT00680914|11537454|FG001|Overall Study|serious adverse event (SAE)|1
7311215|NCT00681109|11537501|FG000|Overall Study|Lost to Follow-up|2
7311216|NCT00681109|11537502|FG001|Overall Study|Lost to Follow-up|6
7311217|NCT00681109|11537503|FG002|Overall Study|Lost to Follow-up|0
7311218|NCT00681187|11537516|FG000|Overall Study|Withdrawal by Subject|1
7311219|NCT00681187|11537517|FG001|Overall Study|Withdrawal by Subject|0
7311220|NCT00681187|11537516|FG000|Overall Study|Death|0
7311221|NCT00681187|11537517|FG001|Overall Study|Death|1
7311222|NCT00681187|11537516|FG000|Overall Study|Adverse Event|0
7311223|NCT00681187|11537517|FG001|Overall Study|Adverse Event|1
7311224|NCT00681564|11537566|FG000|Overall Study|Lost to Follow-up|6
7311225|NCT00681564|11537567|FG001|Overall Study|Lost to Follow-up|6
7311226|NCT00681564|11537566|FG000|Overall Study|Withdrawal by Subject|0
7311227|NCT00681564|11537567|FG001|Overall Study|Withdrawal by Subject|1
7311228|NCT00681564|11537566|FG000|Overall Study|Death|0
7311229|NCT00681564|11537567|FG001|Overall Study|Death|1
7311230|NCT00681590|11537575|FG000|Overall Study|Withdrawal by Subject|2
7311231|NCT00681590|11537576|FG001|Overall Study|Withdrawal by Subject|12
7311232|NCT00681668|11537582|FG000|Overall Study|Protocol Violation|1
7311233|NCT00681668|11537582|FG000|Overall Study|Withdrawal by Subject|1
7311234|NCT00681811|11537588|FG000|Overall Study|Adverse Event|1
7311235|NCT00681811|11537589|FG001|Overall Study|Adverse Event|1
7311236|NCT00681811|11537588|FG000|Overall Study|Withdrawal by Subject|2
7311237|NCT00681811|11537589|FG001|Overall Study|Withdrawal by Subject|2
7311238|NCT00681811|11537588|FG000|Overall Study|Non-compliance|0
7311239|NCT00681811|11537589|FG001|Overall Study|Non-compliance|1
7311240|NCT00681824|11537609|FG000|Overall Study|withdrawn by investigator|0
7311241|NCT00681824|11537610|FG001|Overall Study|withdrawn by investigator|0
7311242|NCT00681824|11537611|FG002|Overall Study|withdrawn by investigator|1
7311243|NCT00681824|11537609|FG000|Overall Study|scheduling conflict|1
7311244|NCT00681824|11537610|FG001|Overall Study|scheduling conflict|0
7311245|NCT00681824|11537611|FG002|Overall Study|scheduling conflict|0
7311246|NCT00681824|11537609|FG000|Overall Study|Death|0
7311247|NCT00681824|11537610|FG001|Overall Study|Death|1
7311248|NCT00681824|11537611|FG002|Overall Study|Death|0
7311249|NCT00681863|11537619|FG000|Overall Study|Adverse Event|1
7311250|NCT00681863|11537619|FG000|Overall Study|Lost to Follow-up|2
7311251|NCT00681863|11537619|FG000|Overall Study|Lack of Efficacy|2
7311252|NCT00681863|11537619|FG000|Overall Study|Other|18
7311253|NCT00682435|11537640|FG000|Overall Study|Insufficient data|5
7311254|NCT00682435|11537640|FG000|Overall Study|Erroneously enrolled twice|2
7311255|NCT00682448|11537646|FG000|Overall Study|Adverse Event|1
7311256|NCT00682448|11537647|FG001|Overall Study|Adverse Event|2
7311257|NCT00682448|11537646|FG000|Overall Study|Lack of Efficacy|1
7390433|NCT01235949|11650452|FG003|Booster Phase|Withdrawal by Subject|0
7390434|NCT01235949|11650453|FG004|Booster Phase|Withdrawal by Subject|0
7390435|NCT01235949|11650454|FG005|Booster Phase|Withdrawal by Subject|0
7390436|NCT01235949|11650455|FG006|Booster Phase|Withdrawal by Subject|0
7390437|NCT01235949|11650456|FG007|Booster Phase|Withdrawal by Subject|1
7390438|NCT01235949|11650457|FG008|Booster Phase|Withdrawal by Subject|1
7390439|NCT01235949|11650458|FG009|Booster Phase|Withdrawal by Subject|0
7390440|NCT01235949|11650459|FG010|Booster Phase|Withdrawal by Subject|1
7390441|NCT01235949|11650460|FG011|Booster Phase|Withdrawal by Subject|1
7390442|NCT01235949|11650461|FG012|Booster Phase|Withdrawal by Subject|2
7390443|NCT01235949|11650462|FG013|Booster Phase|Withdrawal by Subject|0
7390444|NCT01235949|11650463|FG014|Booster Phase|Withdrawal by Subject|2
7390445|NCT01235949|11650464|FG015|Booster Phase|Withdrawal by Subject|0
7390446|NCT01235949|11650465|FG016|Booster Phase|Withdrawal by Subject|0
7390447|NCT01235949|11650466|FG017|Booster Phase|Withdrawal by Subject|0
7390448|NCT01235949|11650449|FG000|Booster Phase|Lost to Follow-up|0
7390449|NCT01235949|11650450|FG001|Booster Phase|Lost to Follow-up|0
7390450|NCT01235949|11650451|FG002|Booster Phase|Lost to Follow-up|0
7390451|NCT01235949|11650452|FG003|Booster Phase|Lost to Follow-up|0
7390452|NCT01235949|11650453|FG004|Booster Phase|Lost to Follow-up|0
7390453|NCT01235949|11650454|FG005|Booster Phase|Lost to Follow-up|0
7390454|NCT01235949|11650455|FG006|Booster Phase|Lost to Follow-up|0
7390455|NCT01235949|11650456|FG007|Booster Phase|Lost to Follow-up|0
7390456|NCT01235949|11650457|FG008|Booster Phase|Lost to Follow-up|1
7390457|NCT01235949|11650458|FG009|Booster Phase|Lost to Follow-up|1
7390458|NCT01235949|11650459|FG010|Booster Phase|Lost to Follow-up|1
7390459|NCT01235949|11650460|FG011|Booster Phase|Lost to Follow-up|1
7390460|NCT01235949|11650461|FG012|Booster Phase|Lost to Follow-up|0
7390461|NCT01235949|11650462|FG013|Booster Phase|Lost to Follow-up|0
7390462|NCT01235949|11650463|FG014|Booster Phase|Lost to Follow-up|0
7390463|NCT01235949|11650464|FG015|Booster Phase|Lost to Follow-up|0
7390464|NCT01235949|11650465|FG016|Booster Phase|Lost to Follow-up|0
7390465|NCT01235949|11650466|FG017|Booster Phase|Lost to Follow-up|1
7390466|NCT01235975|11650506|FG000|Overall Study|Serious Adverse Event|0
7390467|NCT01235975|11650507|FG001|Overall Study|Serious Adverse Event|1
7390468|NCT01235975|11650506|FG000|Overall Study|Withdrawal by Subject|8
7390469|NCT01235975|11650507|FG001|Overall Study|Withdrawal by Subject|2
7390470|NCT01235975|11650506|FG000|Overall Study|Migrated/moved from study area|2
7390471|NCT01235975|11650507|FG001|Overall Study|Migrated/moved from study area|1
7390472|NCT01235975|11650506|FG000|Overall Study|Lost to Follow-up|7
7390473|NCT01235975|11650507|FG001|Overall Study|Lost to Follow-up|3
7390474|NCT01236001|11650515|FG000|Overall Study|Adverse Event|5
7390475|NCT01236001|11650516|FG001|Overall Study|Adverse Event|14
7390476|NCT01236001|11650515|FG000|Overall Study|Lack of Efficacy|6
7390477|NCT01236001|11650516|FG001|Overall Study|Lack of Efficacy|6
7390478|NCT01236001|11650515|FG000|Overall Study|Lost to Follow-up|6
7390479|NCT01236001|11650516|FG001|Overall Study|Lost to Follow-up|1
7390480|NCT01236001|11650515|FG000|Overall Study|Incompliance|1
7390481|NCT01236001|11650516|FG001|Overall Study|Incompliance|0
7390482|NCT01236001|11650515|FG000|Overall Study|Planned Visit After End of Study|0
7311258|NCT00682448|11537647|FG001|Overall Study|Lack of Efficacy|0
7311259|NCT00682448|11537646|FG000|Overall Study|Lost to Follow-up|1
7390483|NCT01236001|11650516|FG001|Overall Study|Planned Visit After End of Study|1
7390484|NCT01236118|11650626|FG000|Overall Study|Adverse Event|2
7390485|NCT01236118|11650627|FG001|Overall Study|Adverse Event|0
7390486|NCT01236118|11650628|FG002|Overall Study|Adverse Event|2
7390487|NCT01236118|11650626|FG000|Overall Study|Physician Decision|0
7390488|NCT01236118|11650627|FG001|Overall Study|Physician Decision|1
7311260|NCT00682448|11537647|FG001|Overall Study|Lost to Follow-up|3
7311261|NCT00682448|11537646|FG000|Overall Study|Pregnancy|0
7311262|NCT00682448|11537647|FG001|Overall Study|Pregnancy|1
7311263|NCT00682448|11537646|FG000|Overall Study|Withdrawal by Subject|2
7311264|NCT00682448|11537647|FG001|Overall Study|Withdrawal by Subject|0
7311265|NCT00682539|11537656|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
7311266|NCT00682539|11537657|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
7311267|NCT00682539|11537658|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
7311268|NCT00682539|11537656|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
7311269|NCT00682539|11537657|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
7311270|NCT00682539|11537658|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
7311271|NCT00682461|11537682|FG000|Overall Study|Adverse Event|5
7311272|NCT00682461|11537683|FG001|Overall Study|Adverse Event|7
7311273|NCT00682461|11537682|FG000|Overall Study|Lost to Follow-up|8
7311274|NCT00682461|11537683|FG001|Overall Study|Lost to Follow-up|5
7311275|NCT00682461|11537682|FG000|Overall Study|Withdrawal by Subject|12
7311276|NCT00682461|11537683|FG001|Overall Study|Withdrawal by Subject|19
7311277|NCT00682643|11537701|FG000|Overall Study|Adverse Event|12
7390489|NCT01236118|11650628|FG002|Overall Study|Physician Decision|0
7390490|NCT01236118|11650626|FG000|Overall Study|Withdrawal by Subject|0
7390491|NCT01236118|11650627|FG001|Overall Study|Withdrawal by Subject|0
7390492|NCT01236118|11650628|FG002|Overall Study|Withdrawal by Subject|1
7390493|NCT01236339|11650665|FG000|Overall Study|Termination of study by sponsor|11
7390494|NCT01236339|11650666|FG001|Overall Study|Termination of study by sponsor|13
7390495|NCT01236352|11650684|FG000|Overall Study|Death|0
7390496|NCT01236352|11650685|FG001|Overall Study|Death|0
7390497|NCT01236352|11650686|FG002|Overall Study|Death|0
7390498|NCT01236352|11650687|FG003|Overall Study|Death|0
7390499|NCT01236352|11650688|FG004|Overall Study|Death|0
7390500|NCT01236352|11650689|FG005|Overall Study|Death|0
7390501|NCT01236352|11650690|FG006|Overall Study|Death|0
7390502|NCT01236352|11650691|FG007|Overall Study|Death|1
7390503|NCT01236352|11650692|FG008|Overall Study|Death|0
7390504|NCT01236352|11650693|FG009|Overall Study|Death|0
7390505|NCT01236352|11650694|FG010|Overall Study|Death|0
7390506|NCT01236352|11650684|FG000|Overall Study|Withdrawal by Subject|0
7390507|NCT01236352|11650685|FG001|Overall Study|Withdrawal by Subject|0
7390508|NCT01236352|11650686|FG002|Overall Study|Withdrawal by Subject|0
7390509|NCT01236352|11650687|FG003|Overall Study|Withdrawal by Subject|0
7390510|NCT01236352|11650688|FG004|Overall Study|Withdrawal by Subject|0
7390511|NCT01236352|11650689|FG005|Overall Study|Withdrawal by Subject|0
7390512|NCT01236352|11650690|FG006|Overall Study|Withdrawal by Subject|0
7390513|NCT01236352|11650691|FG007|Overall Study|Withdrawal by Subject|0
7390514|NCT01236352|11650692|FG008|Overall Study|Withdrawal by Subject|0
7390515|NCT01236352|11650693|FG009|Overall Study|Withdrawal by Subject|2
7390516|NCT01236352|11650694|FG010|Overall Study|Withdrawal by Subject|1
7390517|NCT01236352|11650684|FG000|Overall Study|Adverse Event|0
7390518|NCT01236352|11650685|FG001|Overall Study|Adverse Event|0
7390519|NCT01236352|11650686|FG002|Overall Study|Adverse Event|0
7390520|NCT01236352|11650687|FG003|Overall Study|Adverse Event|0
7390521|NCT01236352|11650688|FG004|Overall Study|Adverse Event|0
7390522|NCT01236352|11650689|FG005|Overall Study|Adverse Event|0
7390523|NCT01236352|11650690|FG006|Overall Study|Adverse Event|2
7390524|NCT01236352|11650691|FG007|Overall Study|Adverse Event|0
7390525|NCT01236352|11650692|FG008|Overall Study|Adverse Event|0
7390526|NCT01236352|11650693|FG009|Overall Study|Adverse Event|4
7390527|NCT01236352|11650694|FG010|Overall Study|Adverse Event|1
7390528|NCT01236352|11650684|FG000|Overall Study|Study drug toxicity|0
7390529|NCT01236352|11650685|FG001|Overall Study|Study drug toxicity|0
7390530|NCT01236352|11650686|FG002|Overall Study|Study drug toxicity|0
7390531|NCT01236352|11650687|FG003|Overall Study|Study drug toxicity|0
7390532|NCT01236352|11650688|FG004|Overall Study|Study drug toxicity|0
7390533|NCT01236352|11650689|FG005|Overall Study|Study drug toxicity|1
7390534|NCT01236352|11650690|FG006|Overall Study|Study drug toxicity|1
7390535|NCT01236352|11650691|FG007|Overall Study|Study drug toxicity|0
7390536|NCT01236352|11650692|FG008|Overall Study|Study drug toxicity|0
7390537|NCT01236352|11650693|FG009|Overall Study|Study drug toxicity|2
7390538|NCT01236352|11650694|FG010|Overall Study|Study drug toxicity|2
7390539|NCT01236352|11650684|FG000|Overall Study|Disease progression|1
7390540|NCT01236352|11650685|FG001|Overall Study|Disease progression|2
7311278|NCT00682643|11537702|FG001|Overall Study|Adverse Event|23
7311279|NCT00682643|11537701|FG000|Overall Study|Lack of Efficacy|2
7311280|NCT00682643|11537702|FG001|Overall Study|Lack of Efficacy|0
7311281|NCT00682643|11537701|FG000|Overall Study|Protocol Violation|38
7390541|NCT01236352|11650686|FG002|Overall Study|Disease progression|1
7390542|NCT01236352|11650687|FG003|Overall Study|Disease progression|2
7390543|NCT01236352|11650688|FG004|Overall Study|Disease progression|2
7390544|NCT01236352|11650689|FG005|Overall Study|Disease progression|2
7390545|NCT01236352|11650690|FG006|Overall Study|Disease progression|1
7390546|NCT01236352|11650691|FG007|Overall Study|Disease progression|3
7390547|NCT01236352|11650692|FG008|Overall Study|Disease progression|2
7390548|NCT01236352|11650693|FG009|Overall Study|Disease progression|2
7390549|NCT01236352|11650694|FG010|Overall Study|Disease progression|2
7390550|NCT01236352|11650684|FG000|Overall Study|Poor/Non-compliance|1
7390551|NCT01236352|11650685|FG001|Overall Study|Poor/Non-compliance|0
7390552|NCT01236352|11650686|FG002|Overall Study|Poor/Non-compliance|0
7311282|NCT00682643|11537702|FG001|Overall Study|Protocol Violation|76
7311283|NCT00682643|11537701|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
7311284|NCT00682643|11537702|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
7311285|NCT00682643|11537701|FG000|Overall Study|Lost to Follow-up|1
7311286|NCT00682643|11537702|FG001|Overall Study|Lost to Follow-up|6
7311287|NCT00682643|11537701|FG000|Overall Study|Physician Decision|2
7311288|NCT00682643|11537702|FG001|Overall Study|Physician Decision|6
7311289|NCT00682643|11537701|FG000|Overall Study|Withdrawal by Subject|19
7311290|NCT00682643|11537702|FG001|Overall Study|Withdrawal by Subject|53
7311291|NCT00682643|11537701|FG000|Overall Study|Did Not Receive Study Drug|1
7311292|NCT00682643|11537702|FG001|Overall Study|Did Not Receive Study Drug|1
7311293|NCT00682786|11537724|FG000|Overall Study|Withdrawal by Subject|2
7311294|NCT00682786|11537725|FG001|Overall Study|Withdrawal by Subject|2
7311295|NCT00682786|11537724|FG000|Overall Study|Did not receive irinotecan|0
7311296|NCT00682786|11537725|FG001|Overall Study|Did not receive irinotecan|1
7311297|NCT00682890|11537765|FG000|Overall Study|Lost to Follow-up|1
7311298|NCT00682890|11537766|FG001|Overall Study|Lost to Follow-up|1
7311299|NCT00682890|11537765|FG000|Overall Study|subject moved away|0
7311300|NCT00682890|11537766|FG001|Overall Study|subject moved away|1
7311301|NCT00682890|11537765|FG000|Overall Study|heavy menstrual bleeding|1
7311302|NCT00682890|11537766|FG001|Overall Study|heavy menstrual bleeding|0
7311303|NCT00682929|11537775|FG000|Overall Study|Adverse Event|4
7311304|NCT00682929|11537776|FG001|Overall Study|Adverse Event|1
7311305|NCT00682929|11537777|FG002|Overall Study|Adverse Event|1
7311306|NCT00682929|11537775|FG000|Overall Study|Withdrawal by Subject|1
7311307|NCT00682929|11537776|FG001|Overall Study|Withdrawal by Subject|2
7311308|NCT00682929|11537777|FG002|Overall Study|Withdrawal by Subject|1
7311309|NCT00682929|11537775|FG000|Overall Study|dosing compliance < 80%|0
7311310|NCT00682929|11537776|FG001|Overall Study|dosing compliance < 80%|2
7311311|NCT00682929|11537777|FG002|Overall Study|dosing compliance < 80%|0
7311312|NCT00682929|11537775|FG000|Overall Study|lag in DEA renewal|1
7311313|NCT00682929|11537776|FG001|Overall Study|lag in DEA renewal|0
7311314|NCT00682929|11537777|FG002|Overall Study|lag in DEA renewal|0
7384226|NCT01193257|11641364|FG001|Overall Study|Study termination by sponsor|3
7384227|NCT01193257|11641363|FG000|Overall Study|Withdrawal by Subject|26
7384228|NCT01193257|11641364|FG001|Overall Study|Withdrawal by Subject|86
7384229|NCT01193257|11641363|FG000|Overall Study|Lost to Follow-up|2
7384230|NCT01193257|11641364|FG001|Overall Study|Lost to Follow-up|3
7384231|NCT01193257|11641363|FG000|Overall Study|Unblinded due to futility|135
7384232|NCT01193257|11641364|FG001|Overall Study|Unblinded due to futility|251
7384233|NCT01193283|11641370|FG000|Overall Study|Death|1
7384234|NCT01193335|11641376|FG000|After Infant Series|Lost to Follow-up|1
7384235|NCT01193335|11641377|FG001|After Infant Series|Lost to Follow-up|2
7384236|NCT01193335|11641376|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
7384237|NCT01193335|11641377|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
7384238|NCT01193335|11641376|FG000|1-Year Follow-up|No Longer Willing to Participate|7
7384239|NCT01193335|11641377|FG001|1-Year Follow-up|No Longer Willing to Participate|9
7384240|NCT01193335|11641376|FG000|1-Year Follow-up|Lost to Follow-up|4
7384241|NCT01193335|11641377|FG001|1-Year Follow-up|Lost to Follow-up|0
7384242|NCT01193335|11641376|FG000|2-Year Follow-up|No Longer Willing to Participate|5
7384243|NCT01193335|11641377|FG001|2-Year Follow-up|No Longer Willing to Participate|6
7384244|NCT01193335|11641376|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7384245|NCT01193335|11641377|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
7384246|NCT01193348|11641399|FG000|Screening Period|Screen Failure|5
7384247|NCT01193348|11641399|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
7384248|NCT01193348|11641399|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
7384249|NCT01193348|11641399|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
7384250|NCT01193348|11641399|FG000|Extension Treatment Period|Physician Decision|1
7384251|NCT01193348|11641399|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
7384252|NCT01193517|11641411|FG000|Overall Study|Early Progression|1
7384253|NCT01193517|11641412|FG001|Overall Study|Early Progression|0
7384254|NCT01193517|11641413|FG002|Overall Study|Early Progression|0
7384255|NCT01193582|11641426|FG000|Vaccination Series|Withdrawal by Subject|11
7384256|NCT01193582|11641427|FG001|Vaccination Series|Withdrawal by Subject|13
7384257|NCT01193582|11641428|FG002|Vaccination Series|Withdrawal by Subject|8
7384258|NCT01193582|11641429|FG003|Vaccination Series|Withdrawal by Subject|3
7384259|NCT01193582|11641426|FG000|12 Month Follow-up|Death|0
7384260|NCT01193582|11641427|FG001|12 Month Follow-up|Death|0
7384261|NCT01193582|11641428|FG002|12 Month Follow-up|Death|1
7384262|NCT01193582|11641429|FG003|12 Month Follow-up|Death|0
7384263|NCT01193582|11641426|FG000|12 Month Follow-up|Withdrawal by Subject|6
7384264|NCT01193582|11641427|FG001|12 Month Follow-up|Withdrawal by Subject|0
7384265|NCT01193582|11641428|FG002|12 Month Follow-up|Withdrawal by Subject|3
7384266|NCT01193582|11641429|FG003|12 Month Follow-up|Withdrawal by Subject|11
7384267|NCT01193608|11641447|FG000|Overall Study|Other|0
7384268|NCT01193608|11641448|FG001|Overall Study|Other|1
7384269|NCT01193608|11641449|FG002|Overall Study|Other|0
7384270|NCT01193608|11641450|FG003|Overall Study|Other|0
7384271|NCT01193608|11641451|FG004|Overall Study|Other|0
7384272|NCT01193608|11641452|FG005|Overall Study|Other|0
7384273|NCT01193608|11641447|FG000|Overall Study|Withdrawal by Subject|0
7384274|NCT01193608|11641448|FG001|Overall Study|Withdrawal by Subject|1
7311315|NCT00683293|11537813|FG000|Overall Study|Withdrawal by Subject|2
7311316|NCT00683293|11537814|FG001|Overall Study|Withdrawal by Subject|3
7311317|NCT00683384|11537824|FG000|Overall Study|Death|1
7311318|NCT00683384|11537824|FG000|Overall Study|Adverse Event|1
7390553|NCT01236352|11650687|FG003|Overall Study|Poor/Non-compliance|0
7390554|NCT01236352|11650688|FG004|Overall Study|Poor/Non-compliance|0
7390555|NCT01236352|11650689|FG005|Overall Study|Poor/Non-compliance|0
7390556|NCT01236352|11650690|FG006|Overall Study|Poor/Non-compliance|0
7390557|NCT01236352|11650691|FG007|Overall Study|Poor/Non-compliance|0
7390558|NCT01236352|11650692|FG008|Overall Study|Poor/Non-compliance|0
7390559|NCT01236352|11650693|FG009|Overall Study|Poor/Non-compliance|0
7390560|NCT01236352|11650694|FG010|Overall Study|Poor/Non-compliance|0
7390561|NCT01236352|11650684|FG000|Overall Study|Maximum clinical benefit|1
7390562|NCT01236352|11650685|FG001|Overall Study|Maximum clinical benefit|1
7390563|NCT01236352|11650686|FG002|Overall Study|Maximum clinical benefit|1
7390564|NCT01236352|11650687|FG003|Overall Study|Maximum clinical benefit|0
7390565|NCT01236352|11650688|FG004|Overall Study|Maximum clinical benefit|2
7390566|NCT01236352|11650689|FG005|Overall Study|Maximum clinical benefit|0
7390567|NCT01236352|11650690|FG006|Overall Study|Maximum clinical benefit|3
7390568|NCT01236352|11650691|FG007|Overall Study|Maximum clinical benefit|1
7390569|NCT01236352|11650692|FG008|Overall Study|Maximum clinical benefit|1
7390570|NCT01236352|11650693|FG009|Overall Study|Maximum clinical benefit|4
7390571|NCT01236352|11650694|FG010|Overall Study|Maximum clinical benefit|2
7390572|NCT01236352|11650684|FG000|Overall Study|Subject request to discontinue treatment|0
7390573|NCT01236352|11650685|FG001|Overall Study|Subject request to discontinue treatment|0
7390574|NCT01236352|11650686|FG002|Overall Study|Subject request to discontinue treatment|1
7390575|NCT01236352|11650687|FG003|Overall Study|Subject request to discontinue treatment|1
7390576|NCT01236352|11650688|FG004|Overall Study|Subject request to discontinue treatment|0
7390577|NCT01236352|11650689|FG005|Overall Study|Subject request to discontinue treatment|1
7390578|NCT01236352|11650690|FG006|Overall Study|Subject request to discontinue treatment|0
7390579|NCT01236352|11650691|FG007|Overall Study|Subject request to discontinue treatment|0
7390580|NCT01236352|11650692|FG008|Overall Study|Subject request to discontinue treatment|0
7390581|NCT01236352|11650693|FG009|Overall Study|Subject request to discontinue treatment|1
7390582|NCT01236352|11650694|FG010|Overall Study|Subject request to discontinue treatment|4
7390583|NCT01236352|11650684|FG000|Overall Study|Subject to receive drug via EAP|1
7390584|NCT01236352|11650685|FG001|Overall Study|Subject to receive drug via EAP|1
7390585|NCT01236352|11650686|FG002|Overall Study|Subject to receive drug via EAP|1
7390586|NCT01236352|11650687|FG003|Overall Study|Subject to receive drug via EAP|0
7390587|NCT01236352|11650688|FG004|Overall Study|Subject to receive drug via EAP|0
7390588|NCT01236352|11650689|FG005|Overall Study|Subject to receive drug via EAP|0
7390589|NCT01236352|11650690|FG006|Overall Study|Subject to receive drug via EAP|0
7390590|NCT01236352|11650691|FG007|Overall Study|Subject to receive drug via EAP|2
7390591|NCT01236352|11650692|FG008|Overall Study|Subject to receive drug via EAP|0
7390592|NCT01236352|11650693|FG009|Overall Study|Subject to receive drug via EAP|4
7390593|NCT01236352|11650694|FG010|Overall Study|Subject to receive drug via EAP|0
7390594|NCT01236352|11650684|FG000|Overall Study|Patient moving to allogeneic transplant|0
7390595|NCT01236352|11650685|FG001|Overall Study|Patient moving to allogeneic transplant|0
7390596|NCT01236352|11650686|FG002|Overall Study|Patient moving to allogeneic transplant|0
7390597|NCT01236352|11650687|FG003|Overall Study|Patient moving to allogeneic transplant|0
7390598|NCT01236352|11650688|FG004|Overall Study|Patient moving to allogeneic transplant|0
7390599|NCT01236352|11650689|FG005|Overall Study|Patient moving to allogeneic transplant|0
7390600|NCT01236352|11650690|FG006|Overall Study|Patient moving to allogeneic transplant|1
7390601|NCT01236352|11650691|FG007|Overall Study|Patient moving to allogeneic transplant|0
7390602|NCT01236352|11650692|FG008|Overall Study|Patient moving to allogeneic transplant|0
7390603|NCT01236352|11650693|FG009|Overall Study|Patient moving to allogeneic transplant|0
7390604|NCT01236352|11650694|FG010|Overall Study|Patient moving to allogeneic transplant|0
7311389|NCT00683774|11537926|FG000|Overall Study|Physician Decision|3
7390605|NCT01236352|11650684|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
7390606|NCT01236352|11650685|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
7390607|NCT01236352|11650686|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
7390608|NCT01236352|11650687|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
7390609|NCT01236352|11650688|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
7390610|NCT01236352|11650689|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
7390611|NCT01236352|11650690|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
7390612|NCT01236352|11650691|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
7390613|NCT01236352|11650692|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
7390614|NCT01236352|11650693|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
7311319|NCT00683449|11537837|FG000|Overall Study|Lost to Follow-up|0
7311320|NCT00683449|11537838|FG001|Overall Study|Lost to Follow-up|1
7311321|NCT00683449|11537839|FG002|Overall Study|Lost to Follow-up|0
7311322|NCT00683449|11537840|FG003|Overall Study|Lost to Follow-up|0
7311323|NCT00683449|11537841|FG004|Overall Study|Lost to Follow-up|0
7311324|NCT00683475|11537860|FG000|Overall Study|Withdrawal by Subject|1
7311325|NCT00683475|11537861|FG001|Overall Study|Withdrawal by Subject|0
7311326|NCT00683475|11537860|FG000|Overall Study|Never Treated: Adverse Event|2
7311327|NCT00683475|11537861|FG001|Overall Study|Never Treated: Adverse Event|3
7311328|NCT00683475|11537860|FG000|Overall Study|Never Treated: Progressive Disease|1
7311329|NCT00683475|11537861|FG001|Overall Study|Never Treated: Progressive Disease|0
7311330|NCT00683592|11537870|FG000|Overall Study|Adverse Event|12
7311331|NCT00683592|11537871|FG001|Overall Study|Adverse Event|4
7311332|NCT00683592|11537870|FG000|Overall Study|Withdrawal by Subject|11
7311333|NCT00683592|11537871|FG001|Overall Study|Withdrawal by Subject|11
7311334|NCT00683592|11537870|FG000|Overall Study|Lost to Follow-up|17
7311335|NCT00683592|11537871|FG001|Overall Study|Lost to Follow-up|17
7311336|NCT00683592|11537870|FG000|Overall Study|Lack of Efficacy|3
7311337|NCT00683592|11537871|FG001|Overall Study|Lack of Efficacy|7
7311338|NCT00683592|11537870|FG000|Overall Study|Physician Decision|0
7311339|NCT00683592|11537871|FG001|Overall Study|Physician Decision|1
7311340|NCT00683592|11537870|FG000|Overall Study|Non-compliance|3
7311341|NCT00683592|11537871|FG001|Overall Study|Non-compliance|5
7311342|NCT00683592|11537870|FG000|Overall Study|Other|1
7311343|NCT00683592|11537871|FG001|Overall Study|Other|1
7311344|NCT00683618|11537880|FG000|Randomised Treatment Period|Withdrawal by Subject|4
7311345|NCT00683618|11537881|FG001|Randomised Treatment Period|Withdrawal by Subject|1
7311346|NCT00683618|11537882|FG002|Randomised Treatment Period|Withdrawal by Subject|2
7311347|NCT00683618|11537880|FG000|Randomised Treatment Period|Protocol Violation|0
7311348|NCT00683618|11537881|FG001|Randomised Treatment Period|Protocol Violation|1
7311349|NCT00683618|11537882|FG002|Randomised Treatment Period|Protocol Violation|0
7311350|NCT00683618|11537880|FG000|Randomised Treatment Period|Adverse Event|2
7311351|NCT00683618|11537881|FG001|Randomised Treatment Period|Adverse Event|0
7311352|NCT00683618|11537882|FG002|Randomised Treatment Period|Adverse Event|2
7311353|NCT00683618|11537880|FG000|Randomised Treatment Period|Reason not provided|0
7311354|NCT00683618|11537881|FG001|Randomised Treatment Period|Reason not provided|0
7311355|NCT00683618|11537882|FG002|Randomised Treatment Period|Reason not provided|2
7311356|NCT00683618|11537880|FG000|Extension Treatment Period|Withdrawal by Subject|1
7311357|NCT00683618|11537881|FG001|Extension Treatment Period|Withdrawal by Subject|0
7311358|NCT00683618|11537882|FG002|Extension Treatment Period|Withdrawal by Subject|0
7311359|NCT00683618|11537880|FG000|Extension Treatment Period|Adverse Event|1
7311360|NCT00683618|11537881|FG001|Extension Treatment Period|Adverse Event|0
7311361|NCT00683618|11537882|FG002|Extension Treatment Period|Adverse Event|0
7311362|NCT00683618|11537880|FG000|Extension Treatment Period|Protocol Violation|1
7311363|NCT00683618|11537881|FG001|Extension Treatment Period|Protocol Violation|0
7311364|NCT00683618|11537882|FG002|Extension Treatment Period|Protocol Violation|0
7311365|NCT00683644|11537894|FG000|Overall Study|Withdrawal by Subject|4
7311366|NCT00683644|11537895|FG001|Overall Study|Withdrawal by Subject|2
7311367|NCT00683644|11537894|FG000|Overall Study|Lost to Follow-up|1
7311368|NCT00683644|11537895|FG001|Overall Study|Lost to Follow-up|4
7311369|NCT00683644|11537894|FG000|Overall Study|Adverse Event|1
7311370|NCT00683644|11537895|FG001|Overall Study|Adverse Event|2
7311371|NCT00683644|11537894|FG000|Overall Study|Low copper, other health problems,|7
7311372|NCT00683644|11537895|FG001|Overall Study|Low copper, other health problems,|6
7311373|NCT00683657|11537907|FG000|Overall Study|Adverse Event|0
7311374|NCT00683657|11537908|FG001|Overall Study|Adverse Event|1
7311375|NCT00683657|11537907|FG000|Overall Study|Subject Withdrew Consent|1
7311376|NCT00683657|11537908|FG001|Overall Study|Subject Withdrew Consent|0
7311377|NCT00683696|11537916|FG000|Overall Study|Withdrawn due to study closure|337
7311378|NCT00683696|11537917|FG001|Overall Study|Withdrawn due to study closure|338
7311379|NCT00683696|11537916|FG000|Overall Study|Withdrawn prior to study closure|13
7311380|NCT00683696|11537917|FG001|Overall Study|Withdrawn prior to study closure|28
7311381|NCT00683696|11537916|FG000|Overall Study|Lost to Follow-up|5
7311382|NCT00683696|11537917|FG001|Overall Study|Lost to Follow-up|6
7311383|NCT00683696|11537916|FG000|Overall Study|Vital status follow-up only|3
7311384|NCT00683696|11537917|FG001|Overall Study|Vital status follow-up only|3
7311385|NCT00683696|11537916|FG000|Overall Study|Death|46
7311386|NCT00683696|11537917|FG001|Overall Study|Death|30
7311387|NCT00683774|11537926|FG000|Overall Study|Withdrawal by Subject|0
7311388|NCT00683774|11537927|FG001|Overall Study|Withdrawal by Subject|1
7311390|NCT00683774|11537927|FG001|Overall Study|Physician Decision|0
7311391|NCT00683800|11537935|FG000|Overall Study|Adverse Event|195
7311392|NCT00683800|11537936|FG001|Overall Study|Adverse Event|102
7311393|NCT00683800|11537935|FG000|Overall Study|Death|0
7311394|NCT00683800|11537936|FG001|Overall Study|Death|1
7311395|NCT00683800|11537935|FG000|Overall Study|Lost to Follow-up|57
7311396|NCT00683800|11537936|FG001|Overall Study|Lost to Follow-up|44
7311397|NCT00683800|11537935|FG000|Overall Study|Other|5
7311398|NCT00683800|11537936|FG001|Overall Study|Other|2
7311399|NCT00683800|11537935|FG000|Overall Study|Protocol Violation|13
7311400|NCT00683800|11537936|FG001|Overall Study|Protocol Violation|16
7311401|NCT00683800|11537935|FG000|Overall Study|Withdrawal by Subject|66
7311402|NCT00683800|11537936|FG001|Overall Study|Withdrawal by Subject|64
7311403|NCT00683800|11537935|FG000|Overall Study|Lack of Efficacy|61
7311404|NCT00683800|11537936|FG001|Overall Study|Lack of Efficacy|104
7311405|NCT00683800|11537935|FG000|Overall Study|Randomized, not treated|35
7311406|NCT00683800|11537936|FG001|Overall Study|Randomized, not treated|33
7311407|NCT00683878|11537975|FG000|Overall Study|Lack of Efficacy|3
7311408|NCT00683878|11537976|FG001|Overall Study|Lack of Efficacy|0
7311409|NCT00683878|11537977|FG002|Overall Study|Lack of Efficacy|1
7311410|NCT00683878|11537975|FG000|Overall Study|Adverse Event|4
7311411|NCT00683878|11537976|FG001|Overall Study|Adverse Event|3
7311412|NCT00683878|11537977|FG002|Overall Study|Adverse Event|3
7311413|NCT00683878|11537975|FG000|Overall Study|Withdrawal by Subject|9
7311414|NCT00683878|11537976|FG001|Overall Study|Withdrawal by Subject|8
7311415|NCT00683878|11537977|FG002|Overall Study|Withdrawal by Subject|6
7311416|NCT00683878|11537975|FG000|Overall Study|Death|0
7311417|NCT00683878|11537976|FG001|Overall Study|Death|1
7311418|NCT00683878|11537977|FG002|Overall Study|Death|0
7311419|NCT00683878|11537975|FG000|Overall Study|Lost to Follow-up|4
7311420|NCT00683878|11537976|FG001|Overall Study|Lost to Follow-up|2
7311421|NCT00683878|11537977|FG002|Overall Study|Lost to Follow-up|4
7311422|NCT00683878|11537975|FG000|Overall Study|Non-compliance, not met criteria etc.|3
7311423|NCT00683878|11537976|FG001|Overall Study|Non-compliance, not met criteria etc.|2
7311424|NCT00683878|11537977|FG002|Overall Study|Non-compliance, not met criteria etc.|0
7311425|NCT00683904|11537987|FG000|Dose Level 1|Disease progression|2
7311426|NCT00683904|11537988|FG001|Dose Level 1|Disease progression|0
7311427|NCT00683904|11537987|FG000|Dose Level 1|Adverse Event|1
7311428|NCT00683904|11537988|FG001|Dose Level 1|Adverse Event|0
7311429|NCT00683904|11537987|FG000|Dose Level 2|Adverse Event|0
7311430|NCT00683904|11537988|FG001|Dose Level 2|Adverse Event|2
7311431|NCT00684021|11538018|FG000|Overall Study|MRI Contraindicated|1
7311432|NCT00684021|11538019|FG001|Overall Study|MRI Contraindicated|1
7311433|NCT00684021|11538020|FG002|Overall Study|MRI Contraindicated|1
7311434|NCT00684021|11538021|FG003|Overall Study|MRI Contraindicated|0
7311435|NCT00684021|11538018|FG000|Overall Study|MRI not performed|0
7311436|NCT00684021|11538019|FG001|Overall Study|MRI not performed|1
7311437|NCT00684021|11538020|FG002|Overall Study|MRI not performed|1
7311438|NCT00684021|11538021|FG003|Overall Study|MRI not performed|2
7311439|NCT00684021|11538018|FG000|Overall Study|Death|1
7311440|NCT00684021|11538019|FG001|Overall Study|Death|0
7311441|NCT00684021|11538020|FG002|Overall Study|Death|0
7311442|NCT00684021|11538021|FG003|Overall Study|Death|0
7311443|NCT00684060|11538046|FG000|Overall Study|Lost to Follow-up|1
7311444|NCT00684060|11538047|FG001|Overall Study|Lost to Follow-up|0
7311445|NCT00684060|11538046|FG000|Overall Study|New stenosis identified|1
7311446|NCT00684060|11538047|FG001|Overall Study|New stenosis identified|0
7311447|NCT00684060|11538046|FG000|Overall Study|Unable to collect MRI|1
7311448|NCT00684060|11538047|FG001|Overall Study|Unable to collect MRI|2
7311449|NCT00684060|11538046|FG000|Overall Study|Death|0
7311450|NCT00684060|11538047|FG001|Overall Study|Death|1
7311451|NCT00684073|11538053|FG000|Selection|Selection/non-selection criteria|3
7311452|NCT00684073|11538053|FG000|Selection|Death|1
7311453|NCT00684073|11538053|FG000|Selection|noncompliance|1
7311454|NCT00684073|11538053|FG000|Selection|Lost to Follow-up|1
7311455|NCT00684073|11538053|FG000|Selection|request of the sponsor|1
7311456|NCT00684073|11538053|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
7311457|NCT00684177|11538074|FG000|Overall Study|Adverse Event|4
7311458|NCT00684177|11538075|FG001|Overall Study|Adverse Event|3
7311459|NCT00684177|11538074|FG000|Overall Study|Lack of Efficacy|10
7311460|NCT00684177|11538075|FG001|Overall Study|Lack of Efficacy|15
7311461|NCT00684177|11538074|FG000|Overall Study|Protocol Violation|1
7311462|NCT00684177|11538075|FG001|Overall Study|Protocol Violation|0
7311463|NCT00684177|11538074|FG000|Overall Study|Lost to Follow-up|2
7311464|NCT00684177|11538075|FG001|Overall Study|Lost to Follow-up|1
7311465|NCT00684177|11538074|FG000|Overall Study|Physician Decision|2
7311466|NCT00684177|11538075|FG001|Overall Study|Physician Decision|0
7311467|NCT00684177|11538074|FG000|Overall Study|Withdrawal by Subject|1
7311468|NCT00684177|11538075|FG001|Overall Study|Withdrawal by Subject|2
7311469|NCT00684177|11538074|FG000|Overall Study|Other|1
7311470|NCT00684177|11538075|FG001|Overall Study|Other|2
7311471|NCT00684203|11538087|FG000|Overall Study|Adverse Event|6
7311472|NCT00684203|11538088|FG001|Overall Study|Adverse Event|4
7311473|NCT00684203|11538089|FG002|Overall Study|Adverse Event|8
7311474|NCT00684203|11538090|FG003|Overall Study|Adverse Event|0
7311475|NCT00684203|11538091|FG004|Overall Study|Adverse Event|0
7311476|NCT00684203|11538092|FG005|Overall Study|Adverse Event|0
7390615|NCT01236352|11650694|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
7390616|NCT01236352|11650684|FG000|Overall Study|Lack of response to drug|0
7390617|NCT01236352|11650685|FG001|Overall Study|Lack of response to drug|0
7390618|NCT01236352|11650686|FG002|Overall Study|Lack of response to drug|0
7390619|NCT01236352|11650687|FG003|Overall Study|Lack of response to drug|0
7390620|NCT01236352|11650688|FG004|Overall Study|Lack of response to drug|0
7390621|NCT01236352|11650689|FG005|Overall Study|Lack of response to drug|0
7390622|NCT01236352|11650690|FG006|Overall Study|Lack of response to drug|0
7390623|NCT01236352|11650691|FG007|Overall Study|Lack of response to drug|0
7390624|NCT01236352|11650692|FG008|Overall Study|Lack of response to drug|0
7390625|NCT01236352|11650693|FG009|Overall Study|Lack of response to drug|1
7390626|NCT01236352|11650694|FG010|Overall Study|Lack of response to drug|1
7390627|NCT01236352|11650684|FG000|Overall Study|Patient transferred to IST|0
7390628|NCT01236352|11650685|FG001|Overall Study|Patient transferred to IST|0
7311477|NCT00684203|11538087|FG000|Overall Study|Protocol-defined clinical event|3
7311478|NCT00684203|11538088|FG001|Overall Study|Protocol-defined clinical event|1
7311479|NCT00684203|11538089|FG002|Overall Study|Protocol-defined clinical event|0
7390629|NCT01236352|11650686|FG002|Overall Study|Patient transferred to IST|0
7311480|NCT00684203|11538090|FG003|Overall Study|Protocol-defined clinical event|0
7311481|NCT00684203|11538091|FG004|Overall Study|Protocol-defined clinical event|0
7311482|NCT00684203|11538092|FG005|Overall Study|Protocol-defined clinical event|0
7390630|NCT01236352|11650687|FG003|Overall Study|Patient transferred to IST|0
7390631|NCT01236352|11650688|FG004|Overall Study|Patient transferred to IST|0
7390632|NCT01236352|11650689|FG005|Overall Study|Patient transferred to IST|0
7390633|NCT01236352|11650690|FG006|Overall Study|Patient transferred to IST|0
7390634|NCT01236352|11650691|FG007|Overall Study|Patient transferred to IST|0
7390635|NCT01236352|11650692|FG008|Overall Study|Patient transferred to IST|0
7390636|NCT01236352|11650693|FG009|Overall Study|Patient transferred to IST|2
7390637|NCT01236352|11650694|FG010|Overall Study|Patient transferred to IST|6
7390638|NCT01236365|11650720|FG000|Overall Study|Lost to Follow-up|0
7390639|NCT01236365|11650721|FG001|Overall Study|Lost to Follow-up|2
7390640|NCT01236365|11650720|FG000|Overall Study|Moved Out of State|1
7390641|NCT01236365|11650721|FG001|Overall Study|Moved Out of State|0
7390642|NCT01236365|11650720|FG000|Overall Study|Dropped at Randomization due to high LFT|1
7390643|NCT01236365|11650721|FG001|Overall Study|Dropped at Randomization due to high LFT|0
7390644|NCT01236534|11650752|FG000|Overall Study|Adverse Event|3
7390645|NCT01236534|11650753|FG001|Overall Study|Adverse Event|0
7390646|NCT01236573|11650770|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390647|NCT01236573|11650771|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390648|NCT01236573|11650772|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390649|NCT01236573|11650773|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390650|NCT01236573|11650774|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390651|NCT01236573|11650775|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390652|NCT01236573|11650776|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7390653|NCT01236573|11650777|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390654|NCT01236573|11650778|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7390655|NCT01236573|11650779|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
7390656|NCT01236573|11650780|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
7390657|NCT01236573|11650770|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390658|NCT01236573|11650771|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390659|NCT01236573|11650772|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390660|NCT01236573|11650773|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390661|NCT01236573|11650774|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390662|NCT01236573|11650775|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390663|NCT01236573|11650776|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390664|NCT01236573|11650777|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390665|NCT01236573|11650778|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
7390666|NCT01236573|11650779|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390667|NCT01236573|11650780|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
7390668|NCT01236573|11650770|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390669|NCT01236573|11650771|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390670|NCT01236573|11650772|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390671|NCT01236573|11650773|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390672|NCT01236573|11650774|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390673|NCT01236573|11650775|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390674|NCT01236573|11650776|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390675|NCT01236573|11650777|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7311483|NCT00684203|11538087|FG000|Overall Study|Withdrawal by Subject|0
7311484|NCT00684203|11538088|FG001|Overall Study|Withdrawal by Subject|2
7311485|NCT00684203|11538089|FG002|Overall Study|Withdrawal by Subject|1
7311486|NCT00684203|11538090|FG003|Overall Study|Withdrawal by Subject|0
7311487|NCT00684203|11538091|FG004|Overall Study|Withdrawal by Subject|0
7311488|NCT00684203|11538092|FG005|Overall Study|Withdrawal by Subject|0
7311489|NCT00684203|11538087|FG000|Overall Study|Did not meet protocol eligibility|0
7311490|NCT00684203|11538088|FG001|Overall Study|Did not meet protocol eligibility|1
7311491|NCT00684203|11538089|FG002|Overall Study|Did not meet protocol eligibility|0
7311492|NCT00684203|11538090|FG003|Overall Study|Did not meet protocol eligibility|0
7311493|NCT00684203|11538091|FG004|Overall Study|Did not meet protocol eligibility|0
7311494|NCT00684203|11538092|FG005|Overall Study|Did not meet protocol eligibility|0
7311495|NCT00684307|11538122|FG000|Overall Study|Adverse Event|11
7311496|NCT00684307|11538123|FG001|Overall Study|Adverse Event|6
7311497|NCT00684307|11538124|FG002|Overall Study|Adverse Event|15
7311498|NCT00684307|11538125|FG003|Overall Study|Adverse Event|16
7311499|NCT00684307|11538126|FG004|Overall Study|Adverse Event|8
7311500|NCT00684307|11538122|FG000|Overall Study|Development of increasing Liver Function|0
7311501|NCT00684307|11538123|FG001|Overall Study|Development of increasing Liver Function|2
7311502|NCT00684307|11538124|FG002|Overall Study|Development of increasing Liver Function|0
7311503|NCT00684307|11538125|FG003|Overall Study|Development of increasing Liver Function|1
7311504|NCT00684307|11538126|FG004|Overall Study|Development of increasing Liver Function|0
7311505|NCT00684307|11538122|FG000|Overall Study|Fullfillment of exclusion criteria|1
7311506|NCT00684307|11538123|FG001|Overall Study|Fullfillment of exclusion criteria|0
7311507|NCT00684307|11538124|FG002|Overall Study|Fullfillment of exclusion criteria|0
7311508|NCT00684307|11538125|FG003|Overall Study|Fullfillment of exclusion criteria|3
7311509|NCT00684307|11538126|FG004|Overall Study|Fullfillment of exclusion criteria|1
7311510|NCT00684307|11538122|FG000|Overall Study|Incorrect enrolment or randomization|4
7311511|NCT00684307|11538123|FG001|Overall Study|Incorrect enrolment or randomization|0
7311512|NCT00684307|11538124|FG002|Overall Study|Incorrect enrolment or randomization|0
7311513|NCT00684307|11538125|FG003|Overall Study|Incorrect enrolment or randomization|0
7311514|NCT00684307|11538126|FG004|Overall Study|Incorrect enrolment or randomization|0
7311515|NCT00684307|11538122|FG000|Overall Study|Interupted IP for more than 7 days|0
7311516|NCT00684307|11538123|FG001|Overall Study|Interupted IP for more than 7 days|4
7311517|NCT00684307|11538124|FG002|Overall Study|Interupted IP for more than 7 days|1
7311518|NCT00684307|11538125|FG003|Overall Study|Interupted IP for more than 7 days|3
7311519|NCT00684307|11538126|FG004|Overall Study|Interupted IP for more than 7 days|3
7311520|NCT00684307|11538122|FG000|Overall Study|Severe non compliance to protocol|1
7311521|NCT00684307|11538123|FG001|Overall Study|Severe non compliance to protocol|0
7311522|NCT00684307|11538124|FG002|Overall Study|Severe non compliance to protocol|0
7311523|NCT00684307|11538125|FG003|Overall Study|Severe non compliance to protocol|1
7311524|NCT00684307|11538126|FG004|Overall Study|Severe non compliance to protocol|2
7311525|NCT00684307|11538122|FG000|Overall Study|Participant not willing to continue|7
7311526|NCT00684307|11538123|FG001|Overall Study|Participant not willing to continue|10
7311527|NCT00684307|11538124|FG002|Overall Study|Participant not willing to continue|11
7311528|NCT00684307|11538125|FG003|Overall Study|Participant not willing to continue|5
7311529|NCT00684307|11538126|FG004|Overall Study|Participant not willing to continue|8
7311530|NCT00684307|11538122|FG000|Overall Study|Criteria from the CSR|0
7311531|NCT00684307|11538123|FG001|Overall Study|Criteria from the CSR|0
7311532|NCT00684307|11538124|FG002|Overall Study|Criteria from the CSR|1
7311533|NCT00684307|11538125|FG003|Overall Study|Criteria from the CSR|3
7311534|NCT00684307|11538126|FG004|Overall Study|Criteria from the CSR|3
7311535|NCT00684411|11538147|FG000|Overall Study|New Primary Cancer|1
7311536|NCT00684411|11538147|FG000|Overall Study|Disease Progression|10
7311537|NCT00684411|11538147|FG000|Overall Study|Adverse Event|1
7311538|NCT00684424|11538151|FG000|Overall Study|Adverse Event|1
7311539|NCT00684424|11538151|FG000|Overall Study|Lost to Follow-up|2
7311540|NCT00684424|11538151|FG000|Overall Study|Other|2
7311541|NCT00684515|11538159|FG000|Overall Study|Adverse Event|3
7311542|NCT00684515|11538160|FG001|Overall Study|Adverse Event|3
7311543|NCT00684515|11538161|FG002|Overall Study|Adverse Event|1
7311544|NCT00684515|11538159|FG000|Overall Study|Protocol-Defined Clinical Event|1
7311545|NCT00684515|11538160|FG001|Overall Study|Protocol-Defined Clinical Event|0
7311546|NCT00684515|11538161|FG002|Overall Study|Protocol-Defined Clinical Event|0
7311547|NCT00684567|11538188|FG000|Concomitant Radiotherapy Period|Adverse Event|2
7311548|NCT00684567|11538188|FG000|Monotherapy Period|Adverse Event|2
7311549|NCT00684567|11538188|FG000|Monotherapy Period|Death|1
7311550|NCT00684567|11538188|FG000|Monotherapy Period|Progression of primary disease|11
7311551|NCT00684593|11538194|FG000|Overall Study|Adverse Event|0
7311552|NCT00684593|11538195|FG001|Overall Study|Adverse Event|2
7311553|NCT00684645|11538201|FG000|Overall Study|Death|2
7311554|NCT00684645|11538201|FG000|Overall Study|Progressive disease|67
7311555|NCT00684645|11538201|FG000|Overall Study|Adverse Event|27
7311556|NCT00684645|11538201|FG000|Overall Study|Lost to Follow-up|3
7311557|NCT00684645|11538201|FG000|Overall Study|Other|15
7311558|NCT00684671|11538208|FG000|Overall Study|Adverse Event|1
7311559|NCT00684671|11538209|FG001|Overall Study|Adverse Event|0
7311560|NCT00684671|11538210|FG002|Overall Study|Adverse Event|0
7311561|NCT00684671|11538208|FG000|Overall Study|Lost to Follow-up|1
7311562|NCT00684671|11538209|FG001|Overall Study|Lost to Follow-up|0
7311563|NCT00684671|11538210|FG002|Overall Study|Lost to Follow-up|0
7311564|NCT00684671|11538208|FG000|Overall Study|Alcoholic dependance|1
7311565|NCT00684671|11538209|FG001|Overall Study|Alcoholic dependance|0
7311566|NCT00684671|11538210|FG002|Overall Study|Alcoholic dependance|0
7311567|NCT00684762|11538229|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
7311568|NCT00684762|11538230|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7311569|NCT00684814|11538268|FG000|Washout Period of 7 Days|Adverse Event|1
7311570|NCT00684814|11538269|FG001|Washout Period of 7 Days|Adverse Event|2
7311571|NCT00684814|11538268|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7311572|NCT00684814|11538269|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7311573|NCT00684814|11538268|FG000|Second Intervention|Adverse Event|1
7311574|NCT00684814|11538269|FG001|Second Intervention|Adverse Event|0
7311575|NCT00684996|11538286|FG000|Overall Study|Adverse Event|1
7311576|NCT00684996|11538286|FG000|Overall Study|Refusal unrelated to adverse event|1
7311577|NCT00684996|11538286|FG000|Overall Study|Progression/relapse|2
7311578|NCT00684996|11538286|FG000|Overall Study|Other reasons not protocol specified|1
7311579|NCT00685035|11538293|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
7311580|NCT00685035|11538294|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
7311581|NCT00685165|11538325|FG000|Washout Period of 14 Days|Adverse Event|1
7311582|NCT00685165|11538326|FG001|Washout Period of 14 Days|Adverse Event|0
7311583|NCT00685178|11538336|FG000|Overall Study|Adverse Event|1
7311584|NCT00685178|11538337|FG001|Overall Study|Adverse Event|5
7311585|NCT00685178|11538338|FG002|Overall Study|Adverse Event|2
7311586|NCT00685178|11538339|FG003|Overall Study|Adverse Event|4
7311587|NCT00685178|11538336|FG000|Overall Study|missed 3 consecutive methadone clin days|7
7311588|NCT00685178|11538337|FG001|Overall Study|missed 3 consecutive methadone clin days|5
7311589|NCT00685178|11538338|FG002|Overall Study|missed 3 consecutive methadone clin days|2
7311590|NCT00685178|11538339|FG003|Overall Study|missed 3 consecutive methadone clin days|6
7311591|NCT00685178|11538336|FG000|Overall Study|voluntary study discharge|4
7311592|NCT00685178|11538337|FG001|Overall Study|voluntary study discharge|5
7311593|NCT00685178|11538338|FG002|Overall Study|voluntary study discharge|1
7311594|NCT00685178|11538339|FG003|Overall Study|voluntary study discharge|1
7311595|NCT00685178|11538336|FG000|Overall Study|incarcerated|1
7390676|NCT01236573|11650778|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390677|NCT01236573|11650779|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
7390678|NCT01236573|11650780|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
7390679|NCT01236755|11650818|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
7390680|NCT01236755|11650818|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
7390681|NCT01236755|11650818|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
7390682|NCT01236755|11650818|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
7390683|NCT01237054|11650852|FG000|Overall Study|imaging 10C0096|1
7390684|NCT01237223|11650883|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
7390685|NCT01237223|11650884|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7390686|NCT01237223|11650885|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7390687|NCT01237223|11650886|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7390688|NCT01237223|11650887|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7390689|NCT01237223|11650888|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
7390690|NCT01237223|11650883|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
7390691|NCT01237223|11650884|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7390692|NCT01237223|11650885|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7390693|NCT01237223|11650886|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7390694|NCT01237223|11650887|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7390695|NCT01237223|11650888|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
7390696|NCT01237223|11650883|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
7390697|NCT01237223|11650884|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7390698|NCT01237223|11650885|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7390699|NCT01237223|11650886|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7390700|NCT01237223|11650887|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7390701|NCT01237223|11650888|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
7390702|NCT01237223|11650883|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
7390703|NCT01237223|11650884|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7390704|NCT01237223|11650885|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7390705|NCT01237223|11650886|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7390706|NCT01237223|11650887|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7390707|NCT01237223|11650888|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
7390708|NCT01237223|11650883|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
7390709|NCT01237223|11650884|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7390710|NCT01237223|11650885|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7390711|NCT01237223|11650886|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7390712|NCT01237223|11650887|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7390713|NCT01237223|11650888|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
7390714|NCT01237223|11650883|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
7390715|NCT01237223|11650884|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
7390716|NCT01237223|11650885|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
7390717|NCT01237223|11650886|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7390718|NCT01237223|11650887|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
7390719|NCT01237223|11650888|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
7390720|NCT01237223|11650883|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
7390721|NCT01237223|11650884|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
7390722|NCT01237223|11650885|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
7390723|NCT01237223|11650886|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7390724|NCT01237223|11650887|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
7390725|NCT01237223|11650888|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
7390726|NCT01237223|11650883|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7390727|NCT01237223|11650884|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7390728|NCT01237223|11650885|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
7390729|NCT01237223|11650886|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
7390730|NCT01237223|11650887|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7390731|NCT01237223|11650888|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
7390732|NCT01237223|11650883|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7390733|NCT01237223|11650884|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7311596|NCT00685178|11538337|FG001|Overall Study|incarcerated|3
7311597|NCT00685178|11538338|FG002|Overall Study|incarcerated|7
7311598|NCT00685178|11538339|FG003|Overall Study|incarcerated|0
7311599|NCT00685178|11538336|FG000|Overall Study|administrative (disciplinary) discharge|0
7311600|NCT00685178|11538337|FG001|Overall Study|administrative (disciplinary) discharge|1
7311601|NCT00685178|11538338|FG002|Overall Study|administrative (disciplinary) discharge|0
7311602|NCT00685178|11538339|FG003|Overall Study|administrative (disciplinary) discharge|2
7311603|NCT00685178|11538336|FG000|Overall Study|Pregnancy|0
7311604|NCT00685178|11538337|FG001|Overall Study|Pregnancy|0
7311605|NCT00685178|11538338|FG002|Overall Study|Pregnancy|0
7311606|NCT00685178|11538339|FG003|Overall Study|Pregnancy|1
7311607|NCT00685334|11538362|FG000|Overall Study|Withdrawal by Subject|5
7311608|NCT00685334|11538363|FG001|Overall Study|Withdrawal by Subject|6
7311609|NCT00685334|11538362|FG000|Overall Study|Lost to Follow-up|4
7311610|NCT00685334|11538363|FG001|Overall Study|Lost to Follow-up|0
7311611|NCT00685334|11538362|FG000|Overall Study|Chose to enter hospital|1
7311612|NCT00685334|11538363|FG001|Overall Study|Chose to enter hospital|1
7311613|NCT00685373|11538369|FG000|Overall Study|Adverse Event|3
7311614|NCT00685373|11538369|FG000|Overall Study|Withdrawal by Subject|5
7311615|NCT00685373|11538369|FG000|Overall Study|Lack of Efficacy|3
7311616|NCT00685373|11538369|FG000|Overall Study|Condition no longer requires study drug|1
7311617|NCT00685373|11538369|FG000|Overall Study|Lost to Follow-up|2
7311618|NCT00685373|11538369|FG000|Overall Study|Protocol Violation|1
7311619|NCT00685399|11538380|FG000|Treatment Period 1|Withdrawal by Subject|2
7311620|NCT00685399|11538381|FG001|Treatment Period 1|Withdrawal by Subject|0
7311621|NCT00685399|11538382|FG002|Treatment Period 1|Withdrawal by Subject|0
7311622|NCT00685399|11538383|FG003|Treatment Period 1|Withdrawal by Subject|0
7311623|NCT00685399|11538384|FG004|Treatment Period 1|Withdrawal by Subject|0
7311624|NCT00685399|11538385|FG005|Treatment Period 1|Withdrawal by Subject|0
7311625|NCT00685399|11538386|FG006|Treatment Period 1|Withdrawal by Subject|0
7311626|NCT00685399|11538387|FG007|Treatment Period 1|Withdrawal by Subject|0
7311627|NCT00685399|11538380|FG000|Treatment Period 1|Protocol Violation|1
7311628|NCT00685399|11538381|FG001|Treatment Period 1|Protocol Violation|0
7311629|NCT00685399|11538382|FG002|Treatment Period 1|Protocol Violation|0
7311630|NCT00685399|11538383|FG003|Treatment Period 1|Protocol Violation|0
7311631|NCT00685399|11538384|FG004|Treatment Period 1|Protocol Violation|0
7311632|NCT00685399|11538385|FG005|Treatment Period 1|Protocol Violation|0
7311633|NCT00685399|11538386|FG006|Treatment Period 1|Protocol Violation|0
7311634|NCT00685399|11538387|FG007|Treatment Period 1|Protocol Violation|0
7311635|NCT00685399|11538380|FG000|Treatment Period 1|Administrative|2
7311636|NCT00685399|11538381|FG001|Treatment Period 1|Administrative|0
7311637|NCT00685399|11538382|FG002|Treatment Period 1|Administrative|0
7311638|NCT00685399|11538383|FG003|Treatment Period 1|Administrative|0
7311639|NCT00685399|11538384|FG004|Treatment Period 1|Administrative|0
7311640|NCT00685399|11538385|FG005|Treatment Period 1|Administrative|0
7311641|NCT00685399|11538386|FG006|Treatment Period 1|Administrative|0
7311642|NCT00685399|11538387|FG007|Treatment Period 1|Administrative|0
7311643|NCT00685399|11538380|FG000|Treatment Period 1|Lack of Efficacy|1
7311644|NCT00685399|11538381|FG001|Treatment Period 1|Lack of Efficacy|0
7311645|NCT00685399|11538382|FG002|Treatment Period 1|Lack of Efficacy|0
7311646|NCT00685399|11538383|FG003|Treatment Period 1|Lack of Efficacy|0
7311647|NCT00685399|11538384|FG004|Treatment Period 1|Lack of Efficacy|0
7311648|NCT00685399|11538385|FG005|Treatment Period 1|Lack of Efficacy|0
7311649|NCT00685399|11538386|FG006|Treatment Period 1|Lack of Efficacy|0
7311650|NCT00685399|11538387|FG007|Treatment Period 1|Lack of Efficacy|0
7311651|NCT00685399|11538380|FG000|Treatment Period 2|Administrative Problems|0
7311652|NCT00685399|11538381|FG001|Treatment Period 2|Administrative Problems|2
7311653|NCT00685399|11538382|FG002|Treatment Period 2|Administrative Problems|1
7311654|NCT00685399|11538383|FG003|Treatment Period 2|Administrative Problems|0
7311655|NCT00685399|11538384|FG004|Treatment Period 2|Administrative Problems|0
7311656|NCT00685399|11538385|FG005|Treatment Period 2|Administrative Problems|0
7311657|NCT00685399|11538386|FG006|Treatment Period 2|Administrative Problems|0
7311658|NCT00685399|11538387|FG007|Treatment Period 2|Administrative Problems|0
7311659|NCT00685399|11538380|FG000|Treatment Period 2|Withdrawal by Subject|0
7311660|NCT00685399|11538381|FG001|Treatment Period 2|Withdrawal by Subject|0
7311661|NCT00685399|11538382|FG002|Treatment Period 2|Withdrawal by Subject|0
7311662|NCT00685399|11538383|FG003|Treatment Period 2|Withdrawal by Subject|0
7311663|NCT00685399|11538384|FG004|Treatment Period 2|Withdrawal by Subject|0
7311664|NCT00685399|11538385|FG005|Treatment Period 2|Withdrawal by Subject|0
7311665|NCT00685399|11538386|FG006|Treatment Period 2|Withdrawal by Subject|0
7311666|NCT00685399|11538387|FG007|Treatment Period 2|Withdrawal by Subject|2
7311667|NCT00685399|11538380|FG000|Treatment Period 2|Adverse Event|0
7311668|NCT00685399|11538381|FG001|Treatment Period 2|Adverse Event|0
7311669|NCT00685399|11538382|FG002|Treatment Period 2|Adverse Event|0
7311670|NCT00685399|11538383|FG003|Treatment Period 2|Adverse Event|0
7311671|NCT00685399|11538384|FG004|Treatment Period 2|Adverse Event|0
7311672|NCT00685399|11538385|FG005|Treatment Period 2|Adverse Event|1
7311673|NCT00685399|11538386|FG006|Treatment Period 2|Adverse Event|0
7311674|NCT00685399|11538387|FG007|Treatment Period 2|Adverse Event|0
7311675|NCT00685399|11538380|FG000|Treatment Period 2|Lack of Efficacy|0
7311676|NCT00685399|11538381|FG001|Treatment Period 2|Lack of Efficacy|10
7311677|NCT00685399|11538382|FG002|Treatment Period 2|Lack of Efficacy|2
7311678|NCT00685399|11538383|FG003|Treatment Period 2|Lack of Efficacy|0
7311679|NCT00685399|11538384|FG004|Treatment Period 2|Lack of Efficacy|0
7311680|NCT00685399|11538385|FG005|Treatment Period 2|Lack of Efficacy|1
7311681|NCT00685399|11538386|FG006|Treatment Period 2|Lack of Efficacy|0
7311682|NCT00685399|11538387|FG007|Treatment Period 2|Lack of Efficacy|0
7311683|NCT00685399|11538380|FG000|Extension|Administrative Issues|0
7311684|NCT00685399|11538381|FG001|Extension|Administrative Issues|0
7311685|NCT00685399|11538382|FG002|Extension|Administrative Issues|0
7311686|NCT00685399|11538383|FG003|Extension|Administrative Issues|1
7311687|NCT00685399|11538384|FG004|Extension|Administrative Issues|0
7311688|NCT00685399|11538385|FG005|Extension|Administrative Issues|0
7311689|NCT00685399|11538386|FG006|Extension|Administrative Issues|0
7311690|NCT00685399|11538387|FG007|Extension|Administrative Issues|0
7311691|NCT00685399|11538380|FG000|Extension|Withdrawal by Subject|0
7311692|NCT00685399|11538381|FG001|Extension|Withdrawal by Subject|0
7311693|NCT00685399|11538382|FG002|Extension|Withdrawal by Subject|0
7311694|NCT00685399|11538383|FG003|Extension|Withdrawal by Subject|1
7311695|NCT00685399|11538384|FG004|Extension|Withdrawal by Subject|0
7311696|NCT00685399|11538385|FG005|Extension|Withdrawal by Subject|0
7311697|NCT00685399|11538386|FG006|Extension|Withdrawal by Subject|0
7311698|NCT00685399|11538387|FG007|Extension|Withdrawal by Subject|0
7311699|NCT00685399|11538380|FG000|Extension|Protocol Violation|0
7311700|NCT00685399|11538381|FG001|Extension|Protocol Violation|0
7311701|NCT00685399|11538382|FG002|Extension|Protocol Violation|0
7311702|NCT00685399|11538383|FG003|Extension|Protocol Violation|1
7311703|NCT00685399|11538384|FG004|Extension|Protocol Violation|0
7311704|NCT00685399|11538385|FG005|Extension|Protocol Violation|0
7311705|NCT00685399|11538386|FG006|Extension|Protocol Violation|0
7311706|NCT00685399|11538387|FG007|Extension|Protocol Violation|0
7311707|NCT00685399|11538380|FG000|Extension|Lack of Efficacy|0
7311708|NCT00685399|11538381|FG001|Extension|Lack of Efficacy|0
7311709|NCT00685399|11538382|FG002|Extension|Lack of Efficacy|0
7311710|NCT00685399|11538383|FG003|Extension|Lack of Efficacy|2
7311711|NCT00685399|11538384|FG004|Extension|Lack of Efficacy|0
7311712|NCT00685399|11538385|FG005|Extension|Lack of Efficacy|0
7311713|NCT00685399|11538386|FG006|Extension|Lack of Efficacy|0
7311714|NCT00685399|11538387|FG007|Extension|Lack of Efficacy|0
7311715|NCT00685399|11538380|FG000|Extension|Adverse Event|0
7311716|NCT00685399|11538381|FG001|Extension|Adverse Event|0
7311717|NCT00685399|11538382|FG002|Extension|Adverse Event|0
7311718|NCT00685399|11538383|FG003|Extension|Adverse Event|2
7311719|NCT00685399|11538384|FG004|Extension|Adverse Event|0
7311720|NCT00685399|11538385|FG005|Extension|Adverse Event|0
7311721|NCT00685399|11538386|FG006|Extension|Adverse Event|0
7311722|NCT00685399|11538387|FG007|Extension|Adverse Event|0
7311723|NCT00685685|11538457|FG000|Washout Period of 7 Days|Adverse Event|2
7311724|NCT00685685|11538458|FG001|Washout Period of 7 Days|Adverse Event|0
7311725|NCT00685685|11538457|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7311726|NCT00685685|11538458|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7311727|NCT00685698|11538464|FG000|Overall Study|Withdrawal by Subject|1
7311728|NCT00685698|11538464|FG000|Overall Study|Protocol Violation|6
7311729|NCT00685698|11538464|FG000|Overall Study|Adverse Event|3
7311730|NCT00685698|11538464|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
7311731|NCT00685698|11538464|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
7311732|NCT00685698|11538464|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
7311733|NCT00685750|11538487|FG000|Overall Study|Tumor sampling failure|0
7311734|NCT00685750|11538488|FG001|Overall Study|Tumor sampling failure|0
7311735|NCT00685750|11538489|FG002|Overall Study|Tumor sampling failure|1
7311736|NCT00685750|11538490|FG003|Overall Study|Tumor sampling failure|0
7311737|NCT00685750|11538491|FG004|Overall Study|Tumor sampling failure|0
7311738|NCT00685750|11538492|FG005|Overall Study|Tumor sampling failure|0
7311739|NCT00685750|11538493|FG006|Overall Study|Tumor sampling failure|0
7311740|NCT00685750|11538487|FG000|Overall Study|Patient didn't receive the treatment|0
7311741|NCT00685750|11538488|FG001|Overall Study|Patient didn't receive the treatment|0
7311742|NCT00685750|11538489|FG002|Overall Study|Patient didn't receive the treatment|0
7311743|NCT00685750|11538490|FG003|Overall Study|Patient didn't receive the treatment|0
7311744|NCT00685750|11538491|FG004|Overall Study|Patient didn't receive the treatment|0
7311745|NCT00685750|11538492|FG005|Overall Study|Patient didn't receive the treatment|0
7311746|NCT00685750|11538493|FG006|Overall Study|Patient didn't receive the treatment|1
7311747|NCT00685750|11538487|FG000|Overall Study|Eligibility criteria not fulfilled|0
7311748|NCT00685750|11538488|FG001|Overall Study|Eligibility criteria not fulfilled|0
7311749|NCT00685750|11538489|FG002|Overall Study|Eligibility criteria not fulfilled|1
7311750|NCT00685750|11538490|FG003|Overall Study|Eligibility criteria not fulfilled|0
7311751|NCT00685750|11538491|FG004|Overall Study|Eligibility criteria not fulfilled|0
7311752|NCT00685750|11538492|FG005|Overall Study|Eligibility criteria not fulfilled|0
7311753|NCT00685750|11538493|FG006|Overall Study|Eligibility criteria not fulfilled|0
7311754|NCT00685763|11538513|FG000|Overall Study|Intercurrent death-incomplete treatment|1
7311755|NCT00685763|11538513|FG000|Overall Study|Protocol Violation|1
7311756|NCT00685802|11538517|FG000|Washout Period of 7 Days|Protocol Violation|2
7311757|NCT00685802|11538518|FG001|Washout Period of 7 Days|Protocol Violation|0
7311758|NCT00685802|11538517|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7311759|NCT00685802|11538518|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7311760|NCT00685945|11538533|FG000|L-NMMA + Bradykinin|Physician Decision|1
7311761|NCT00686075|11538553|FG000|Overall Study|Withdrawal by Subject|4
7311762|NCT00686075|11538554|FG001|Overall Study|Withdrawal by Subject|3
7311763|NCT00686075|11538555|FG002|Overall Study|Withdrawal by Subject|3
7311764|NCT00686075|11538556|FG003|Overall Study|Withdrawal by Subject|7
7311765|NCT00686075|11538557|FG004|Overall Study|Withdrawal by Subject|1
7311766|NCT00686075|11538558|FG005|Overall Study|Withdrawal by Subject|0
7311767|NCT00686075|11538559|FG006|Overall Study|Withdrawal by Subject|0
7311768|NCT00686075|11538560|FG007|Overall Study|Withdrawal by Subject|2
7311769|NCT00686075|11538561|FG008|Overall Study|Withdrawal by Subject|4
7311770|NCT00686075|11538562|FG009|Overall Study|Withdrawal by Subject|6
7311771|NCT00686075|11538553|FG000|Overall Study|Lost to Follow-up|3
7311772|NCT00686075|11538554|FG001|Overall Study|Lost to Follow-up|6
7311773|NCT00686075|11538555|FG002|Overall Study|Lost to Follow-up|3
7311774|NCT00686075|11538556|FG003|Overall Study|Lost to Follow-up|2
7311775|NCT00686075|11538557|FG004|Overall Study|Lost to Follow-up|3
7311776|NCT00686075|11538558|FG005|Overall Study|Lost to Follow-up|3
7311777|NCT00686075|11538559|FG006|Overall Study|Lost to Follow-up|0
7311778|NCT00686075|11538560|FG007|Overall Study|Lost to Follow-up|0
7311779|NCT00686075|11538561|FG008|Overall Study|Lost to Follow-up|2
7311780|NCT00686075|11538562|FG009|Overall Study|Lost to Follow-up|3
7311781|NCT00686075|11538553|FG000|Overall Study|Other|1
7311782|NCT00686075|11538554|FG001|Overall Study|Other|1
7311783|NCT00686075|11538555|FG002|Overall Study|Other|0
7311784|NCT00686075|11538556|FG003|Overall Study|Other|0
7311785|NCT00686075|11538557|FG004|Overall Study|Other|0
7311786|NCT00686075|11538558|FG005|Overall Study|Other|0
7311787|NCT00686075|11538559|FG006|Overall Study|Other|0
7311788|NCT00686075|11538560|FG007|Overall Study|Other|0
7311789|NCT00686075|11538561|FG008|Overall Study|Other|0
7311790|NCT00686075|11538562|FG009|Overall Study|Other|1
7390734|NCT01237223|11650885|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7390735|NCT01237223|11650886|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7390736|NCT01237223|11650887|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
7390737|NCT01237223|11650888|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
7390738|NCT01237223|11650883|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
7390739|NCT01237223|11650884|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7390740|NCT01237223|11650885|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7390741|NCT01237223|11650886|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
7390742|NCT01237223|11650887|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7390743|NCT01237223|11650888|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
7390744|NCT01237327|11650917|FG000|Overall Study|Protocol Violation: Core Study|1
7390745|NCT01237327|11650918|FG001|Overall Study|Protocol Violation: Core Study|0
7390746|NCT01237327|11650917|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
7390747|NCT01237327|11650918|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
7390748|NCT01237327|11650917|FG000|Overall Study|Progression of Disease: Core Study|18
7390749|NCT01237327|11650918|FG001|Overall Study|Progression of Disease: Core Study|22
7390750|NCT01237327|11650917|FG000|Overall Study|Progression of Disease: Extension Study|15
7390751|NCT01237327|11650918|FG001|Overall Study|Progression of Disease: Extension Study|13
7390752|NCT01237327|11650917|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
7390753|NCT01237327|11650918|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
7390754|NCT01237327|11650917|FG000|Overall Study|Withdrawal by Subject|1
7390755|NCT01237327|11650918|FG001|Overall Study|Withdrawal by Subject|3
7390756|NCT01237327|11650917|FG000|Overall Study|Lost to Follow-up|3
7390757|NCT01237327|11650918|FG001|Overall Study|Lost to Follow-up|0
7390758|NCT01237340|11650924|FG000|Overall Study|Adverse Event|3
7390759|NCT01237340|11650924|FG000|Overall Study|Withdrawal by Subject|1
7390760|NCT01237340|11650924|FG000|Overall Study|Early termination of the trial|36
7390761|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
7390762|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
7390763|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
7390764|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
7390765|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
7390766|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
7390767|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
7390768|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
7390769|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
7390770|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
7390771|NCT01237587|11650937|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
7390772|NCT01237587|11650938|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
7390773|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
7390774|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
7390775|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
7311791|NCT00686127|11538586|FG000|Overall Study|Withdrawal by Subject|14
7311792|NCT00686127|11538587|FG001|Overall Study|Withdrawal by Subject|6
7311793|NCT00686166|11538593|FG000|Overall Study|Adverse Event|7
7311794|NCT00686166|11538593|FG000|Overall Study|Withdrawal by Subject|1
7311795|NCT00686166|11538593|FG000|Overall Study|Progression/Relapse|1
7311796|NCT00686166|11538593|FG000|Overall Study|Death|1
7311797|NCT00686166|11538593|FG000|Overall Study|Not Protocol Specified|1
7311798|NCT00686166|11538593|FG000|Overall Study|Ineligible|5
7311799|NCT00686166|11538593|FG000|Overall Study|Did not begin protocol therapy|4
7311800|NCT00686205|11538604|FG000|Overall Study|Protocol Violation|127
7311801|NCT00686205|11538605|FG001|Overall Study|Protocol Violation|0
7311802|NCT00686205|11538604|FG000|Overall Study|Withdrawal by Subject|2
7311803|NCT00686205|11538605|FG001|Overall Study|Withdrawal by Subject|0
7311804|NCT00686205|11538604|FG000|Overall Study|Specimen handling procedure altered|5878
7311805|NCT00686205|11538605|FG001|Overall Study|Specimen handling procedure altered|0
7311806|NCT00686205|11538604|FG000|Overall Study|Specimens not confirmed HIV positive|0
7311807|NCT00686205|11538605|FG001|Overall Study|Specimens not confirmed HIV positive|981
7311808|NCT00686335|11538635|FG000|Run-in Period|Adverse Event|1
7311809|NCT00686335|11538635|FG000|Run-in Period|asthma exacerbation|1
7311810|NCT00686335|11538635|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
7311811|NCT00686517|11538644|FG000|Treatment|Serious Adverse Event|1
7311812|NCT00686517|11538645|FG001|Treatment|Serious Adverse Event|2
7311813|NCT00686517|11538646|FG002|Treatment|Serious Adverse Event|1
7311814|NCT00686517|11538644|FG000|Treatment|Adverse Event|2
7311815|NCT00686517|11538645|FG001|Treatment|Adverse Event|0
7390776|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
7390777|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
7390778|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
7390779|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
7390780|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
7390781|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
7390782|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
7390783|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
7390784|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
7390785|NCT01237587|11650937|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
7390786|NCT01237587|11650938|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
7390787|NCT01237587|11650937|FG000|Taper Phase|Adverse Event|0
7390788|NCT01237587|11650938|FG001|Taper Phase|Adverse Event|2
7390789|NCT01237587|11650937|FG000|Taper Phase|Protocol Violation|2
7390790|NCT01237587|11650938|FG001|Taper Phase|Protocol Violation|0
7390791|NCT01237587|11650937|FG000|Taper Phase|Lack of Efficacy|2
7390792|NCT01237587|11650938|FG001|Taper Phase|Lack of Efficacy|5
7390793|NCT01237587|11650937|FG000|Taper Phase|Parent/Guardian Decision|0
7390794|NCT01237587|11650938|FG001|Taper Phase|Parent/Guardian Decision|2
7390795|NCT01237587|11650937|FG000|Taper Phase|Sponsor Decision|1
7390796|NCT01237587|11650938|FG001|Taper Phase|Sponsor Decision|0
7390797|NCT01237587|11650937|FG000|Taper Phase|Withdrawal by Subject|0
7390798|NCT01237587|11650938|FG001|Taper Phase|Withdrawal by Subject|1
7390799|NCT01237678|11650954|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
7390800|NCT01237678|11650955|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7390801|NCT01237678|11650956|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
7390802|NCT01237678|11650954|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
7390803|NCT01237678|11650955|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7390804|NCT01237678|11650956|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
7390805|NCT01237678|11650954|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
7390806|NCT01237678|11650955|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7390807|NCT01237678|11650956|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
7390808|NCT01237678|11650954|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
7390809|NCT01237678|11650955|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7390810|NCT01237678|11650956|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
7390811|NCT01237678|11650954|FG000|Phase II|Adverse Event|0
7390812|NCT01237678|11650955|FG001|Phase II|Adverse Event|39
7390813|NCT01237678|11650956|FG002|Phase II|Adverse Event|9
7390814|NCT01237678|11650954|FG000|Phase II|Death|0
7390815|NCT01237678|11650955|FG001|Phase II|Death|0
7390816|NCT01237678|11650956|FG002|Phase II|Death|2
7390817|NCT01237678|11650954|FG000|Phase II|Lack of Efficacy|0
7390818|NCT01237678|11650955|FG001|Phase II|Lack of Efficacy|25
7390819|NCT01237678|11650956|FG002|Phase II|Lack of Efficacy|3
7390820|NCT01237678|11650954|FG000|Phase II|Withdrawal by Subject|0
7390821|NCT01237678|11650955|FG001|Phase II|Withdrawal by Subject|1
7390822|NCT01237678|11650956|FG002|Phase II|Withdrawal by Subject|5
7390823|NCT01237678|11650954|FG000|Phase II|Completed Cycles 4-6|0
7390824|NCT01237678|11650955|FG001|Phase II|Completed Cycles 4-6|11
7390825|NCT01237678|11650956|FG002|Phase II|Completed Cycles 4-6|21
7390826|NCT01237678|11650954|FG000|Phase II|Sponsor Decision/Study Closed|0
7390827|NCT01237678|11650955|FG001|Phase II|Sponsor Decision/Study Closed|18
7390828|NCT01237678|11650956|FG002|Phase II|Sponsor Decision/Study Closed|7
7390829|NCT01237678|11650954|FG000|Phase II|Randomized but were not treated|0
7390830|NCT01237678|11650955|FG001|Phase II|Randomized but were not treated|4
7390831|NCT01237678|11650956|FG002|Phase II|Randomized but were not treated|3
7390832|NCT01237899|11650991|FG000|Washout Period of at Least 7 Days|Adverse Event|0
7311816|NCT00686517|11538646|FG002|Treatment|Adverse Event|0
7311817|NCT00686517|11538644|FG000|Treatment|Poor Protocol Compliance|1
7311818|NCT00686517|11538645|FG001|Treatment|Poor Protocol Compliance|0
7311819|NCT00686517|11538646|FG002|Treatment|Poor Protocol Compliance|0
7311820|NCT00686517|11538644|FG000|Treatment|Protocol Violation|2
7311821|NCT00686517|11538645|FG001|Treatment|Protocol Violation|1
7311822|NCT00686517|11538646|FG002|Treatment|Protocol Violation|0
7311823|NCT00686543|11538658|FG000|Overall Study|Adverse Event|9
7311824|NCT00686543|11538659|FG001|Overall Study|Adverse Event|1
7311825|NCT00686543|11538660|FG002|Overall Study|Adverse Event|3
7311826|NCT00686543|11538661|FG003|Overall Study|Adverse Event|2
7311827|NCT00686543|11538658|FG000|Overall Study|Withdrawal by Subject|2
7311828|NCT00686543|11538659|FG001|Overall Study|Withdrawal by Subject|0
7311829|NCT00686543|11538660|FG002|Overall Study|Withdrawal by Subject|0
7311830|NCT00686543|11538661|FG003|Overall Study|Withdrawal by Subject|0
7311831|NCT00686543|11538658|FG000|Overall Study|Protocol Violation|3
7311832|NCT00686543|11538659|FG001|Overall Study|Protocol Violation|0
7311833|NCT00686543|11538660|FG002|Overall Study|Protocol Violation|2
7311834|NCT00686543|11538661|FG003|Overall Study|Protocol Violation|1
7311835|NCT00686595|11538682|FG000|Overall Study|Adverse Event|3
7311836|NCT00686595|11538682|FG000|Overall Study|Protocol Violation|1
7311837|NCT00686595|11538682|FG000|Overall Study|Lost to Follow-up|1
7311838|NCT00686595|11538682|FG000|Overall Study|Lack of Efficacy|1
7311839|NCT00686595|11538682|FG000|Overall Study|Poor Compliance|1
7311840|NCT00686634|11538686|FG000|Overall Study|Protocol Violation|6
7311841|NCT00686647|11538691|FG000|Overall Study|Lost to Follow-up|1
7311842|NCT00686647|11538691|FG000|Overall Study|Death|1
7311843|NCT00686686|11538696|FG000|Overall Study|Non-compliance|1
7311844|NCT00686686|11538696|FG000|Overall Study|Adverse Event|2
7311845|NCT00686686|11538696|FG000|Overall Study|Lost to Follow-up|3
7311846|NCT00686699|11538702|FG000|Treatment Period 1|Adverse Event|0
7311847|NCT00686699|11538703|FG001|Treatment Period 1|Adverse Event|2
7311848|NCT00686712|11538712|FG000|Overall Study|Protocol Violation|8
7311849|NCT00686712|11538713|FG001|Overall Study|Protocol Violation|8
7311850|NCT00686712|11538714|FG002|Overall Study|Protocol Violation|10
7311851|NCT00686712|11538712|FG000|Overall Study|Lost to Follow-up|1
7311852|NCT00686712|11538713|FG001|Overall Study|Lost to Follow-up|2
7311853|NCT00686712|11538714|FG002|Overall Study|Lost to Follow-up|3
7311854|NCT00686712|11538712|FG000|Overall Study|Adverse Event|1
7311855|NCT00686712|11538713|FG001|Overall Study|Adverse Event|1
7311856|NCT00686712|11538714|FG002|Overall Study|Adverse Event|0
7311857|NCT00686725|11538727|FG000|Overall Study|Adverse Event|1
7311858|NCT00686725|11538728|FG001|Overall Study|Adverse Event|1
7311859|NCT00686725|11538727|FG000|Overall Study|Progressive Disease|17
7311860|NCT00686725|11538728|FG001|Overall Study|Progressive Disease|23
7311861|NCT00686725|11538727|FG000|Overall Study|Lost to Follow-up|7
7311862|NCT00686725|11538728|FG001|Overall Study|Lost to Follow-up|5
7311863|NCT00686725|11538727|FG000|Overall Study|Death|6
7311864|NCT00686725|11538728|FG001|Overall Study|Death|3
7311865|NCT00686725|11538727|FG000|Overall Study|Withdrawal by Subject|13
7311866|NCT00686725|11538728|FG001|Overall Study|Withdrawal by Subject|4
7311867|NCT00686725|11538727|FG000|Overall Study|Protocol Violation|1
7311868|NCT00686725|11538728|FG001|Overall Study|Protocol Violation|3
7311869|NCT00686725|11538727|FG000|Overall Study|Other|1
7311870|NCT00686725|11538728|FG001|Overall Study|Other|3
7311871|NCT00686777|11538734|FG000|Overall Study|Adverse Event|2
7311872|NCT00686777|11538734|FG000|Overall Study|Pregnancy|1
7311873|NCT00686777|11538734|FG000|Overall Study|Withdrawal by Subject|2
7311874|NCT00686777|11538734|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
7311875|NCT00686777|11538734|FG000|Overall Study|No Visit|1
7311876|NCT00686790|11538738|FG000|Overall Study|Adverse Event|2
7311877|NCT00686790|11538738|FG000|Overall Study|Withdrawal by Subject|1
7311878|NCT00686790|11538738|FG000|Overall Study|Death|1
7311879|NCT00686790|11538738|FG000|Overall Study|Lost to Follow-up|12
7311880|NCT00686829|11538755|FG000|Overall Study|Adverse Event|5
7311881|NCT00686829|11538755|FG000|Overall Study|Lack of Efficacy|6
7311882|NCT00686829|11538755|FG000|Overall Study|Lost to Follow-up|4
7311883|NCT00686829|11538755|FG000|Overall Study|Withdrawal by Subject|14
7311884|NCT00686829|11538755|FG000|Overall Study|Protocol Violation|3
7311885|NCT00686829|11538755|FG000|Overall Study|Sponsor discontinued VCV|47
7311886|NCT00686855|11538765|FG000|Overall Study|Lost to Follow-up|1
7311887|NCT00686855|11538766|FG001|Overall Study|Lost to Follow-up|0
7311888|NCT00686855|11538765|FG000|Overall Study|Progressive GVHD|0
7311889|NCT00686855|11538766|FG001|Overall Study|Progressive GVHD|1
7311890|NCT00686881|11538774|FG000|Overall Study|Withdrawal by Subject|11
7311891|NCT00686881|11538775|FG001|Overall Study|Withdrawal by Subject|18
7311892|NCT00686881|11538774|FG000|Overall Study|Lost to Follow-up|0
7311893|NCT00686881|11538775|FG001|Overall Study|Lost to Follow-up|1
7311894|NCT00686881|11538774|FG000|Overall Study|Treatment-related adverse event|10
7311895|NCT00686881|11538775|FG001|Overall Study|Treatment-related adverse event|9
7311896|NCT00686881|11538774|FG000|Overall Study|Met discontinuation criteria|5
7311897|NCT00686881|11538775|FG001|Overall Study|Met discontinuation criteria|0
7311898|NCT00686881|11538774|FG000|Overall Study|Onset of malignant tumor|11
7311899|NCT00686881|11538775|FG001|Overall Study|Onset of malignant tumor|11
7311900|NCT00686881|11538774|FG000|Overall Study|Lack of Efficacy|4
7311901|NCT00686881|11538775|FG001|Overall Study|Lack of Efficacy|3
7311902|NCT00686881|11538774|FG000|Overall Study|Physician Decision|1
7311903|NCT00686881|11538775|FG001|Overall Study|Physician Decision|0
7311904|NCT00686881|11538774|FG000|Overall Study|Circumstances of site|1
7311905|NCT00686881|11538775|FG001|Overall Study|Circumstances of site|1
7311906|NCT00686881|11538774|FG000|Overall Study|Did not meet protocol eligibility|1
7311907|NCT00686881|11538775|FG001|Overall Study|Did not meet protocol eligibility|0
7311908|NCT00686881|11538774|FG000|Overall Study|Irregular visits|1
7311909|NCT00686881|11538775|FG001|Overall Study|Irregular visits|0
7311910|NCT00686881|11538774|FG000|Overall Study|Study discontinuation|35
7311911|NCT00686881|11538775|FG001|Overall Study|Study discontinuation|32
7311912|NCT00686881|11538774|FG000|Overall Study|Never received study drug|2
7311913|NCT00686881|11538775|FG001|Overall Study|Never received study drug|6
7311914|NCT00686894|11538783|FG000|Overall Study|Relapse|2
7311915|NCT00686894|11538783|FG000|Overall Study|Protocol Violation|4
7311916|NCT00686920|11538789|FG000|Overall Study|Death|45
7311917|NCT00686920|11538790|FG001|Overall Study|Death|14
7311918|NCT00686920|11538789|FG000|Overall Study|Liver Transplant|23
7311919|NCT00686920|11538790|FG001|Overall Study|Liver Transplant|8
7311920|NCT00686920|11538789|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
7311921|NCT00686920|11538790|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
7311922|NCT00686920|11538789|FG000|Overall Study|Withdrawal by Subject|23
7311923|NCT00686920|11538790|FG001|Overall Study|Withdrawal by Subject|5
7311924|NCT00686920|11538789|FG000|Overall Study|Protocol Violation|2
7311925|NCT00686920|11538790|FG001|Overall Study|Protocol Violation|1
7311926|NCT00686920|11538789|FG000|Overall Study|Adverse Event|10
7311927|NCT00686920|11538790|FG001|Overall Study|Adverse Event|2
7311928|NCT00686920|11538789|FG000|Overall Study|Personal Reason|0
7311929|NCT00686920|11538790|FG001|Overall Study|Personal Reason|1
7311930|NCT00686920|11538789|FG000|Overall Study|Lost to Follow-up|15
7311931|NCT00686920|11538790|FG001|Overall Study|Lost to Follow-up|3
7311932|NCT00686920|11538789|FG000|Overall Study|Moved to Another State|1
7311933|NCT00686920|11538790|FG001|Overall Study|Moved to Another State|0
7311934|NCT00686920|11538789|FG000|Overall Study|Transferred to Nursing Home|1
7311935|NCT00686920|11538790|FG001|Overall Study|Transferred to Nursing Home|0
7311936|NCT00686920|11538789|FG000|Overall Study|Noncompliance|9
7311937|NCT00686920|11538790|FG001|Overall Study|Noncompliance|0
7390833|NCT01237899|11650992|FG001|Washout Period of at Least 7 Days|Adverse Event|0
7390834|NCT01237899|11650993|FG002|Washout Period of at Least 7 Days|Adverse Event|1
7390835|NCT01237899|11650994|FG003|Washout Period of at Least 7 Days|Adverse Event|0
7390836|NCT01237899|11650995|FG004|Washout Period of at Least 7 Days|Adverse Event|0
7390837|NCT01237899|11650996|FG005|Washout Period of at Least 7 Days|Adverse Event|0
7390838|NCT01237899|11650997|FG006|Washout Period of at Least 7 Days|Adverse Event|0
7390839|NCT01237899|11650998|FG007|Washout Period of at Least 7 Days|Adverse Event|0
7390840|NCT01237899|11650999|FG008|Washout Period of at Least 7 Days|Adverse Event|0
7390841|NCT01237899|11651000|FG009|Washout Period of at Least 7 Days|Adverse Event|0
7390842|NCT01237899|11651001|FG010|Washout Period of at Least 7 Days|Adverse Event|0
7390843|NCT01237951|11651019|FG000|Overall Study|Death|1
7390844|NCT01238120|11651027|FG000|Overall Study|Withdrawal by Subject|4
7390845|NCT01238120|11651028|FG001|Overall Study|Withdrawal by Subject|1
7390846|NCT01238120|11651029|FG002|Overall Study|Withdrawal by Subject|2
7390847|NCT01238120|11651030|FG003|Overall Study|Withdrawal by Subject|5
7390848|NCT01238120|11651027|FG000|Overall Study|Lost to Follow-up|2
7390849|NCT01238120|11651028|FG001|Overall Study|Lost to Follow-up|0
7390850|NCT01238120|11651029|FG002|Overall Study|Lost to Follow-up|1
7390851|NCT01238120|11651030|FG003|Overall Study|Lost to Follow-up|1
7390852|NCT01238120|11651027|FG000|Overall Study|Withdrawn due to Medical Problem|2
7390853|NCT01238120|11651028|FG001|Overall Study|Withdrawn due to Medical Problem|0
7390854|NCT01238120|11651029|FG002|Overall Study|Withdrawn due to Medical Problem|1
7390855|NCT01238120|11651030|FG003|Overall Study|Withdrawn due to Medical Problem|0
7390856|NCT01238172|11651042|FG000|Overall Study|Ineligible: based on Eligibility Review|2
7390857|NCT01238172|11651043|FG001|Overall Study|Ineligible: based on Eligibility Review|5
7390858|NCT01238172|11651042|FG000|Overall Study|Ineligible: based on Central Path Review|9
7390859|NCT01238172|11651043|FG001|Overall Study|Ineligible: based on Central Path Review|19
7390860|NCT01238575|11651079|FG000|Overall Study|Lack of Efficacy|2
7390861|NCT01238575|11651080|FG001|Overall Study|Lack of Efficacy|4
7390862|NCT01238575|11651079|FG000|Overall Study|Adverse Event|2
7390863|NCT01238575|11651080|FG001|Overall Study|Adverse Event|0
7390864|NCT01238588|11651086|FG000|Overall Study|Withdrawal by Subject|1
7390865|NCT01238588|11651086|FG000|Overall Study|Physician Decision|2
7390866|NCT01238822|11651098|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
7390867|NCT01238835|11651108|FG000|Overall Study|Death|124
7390868|NCT01238835|11651108|FG000|Overall Study|Withdrawal by Subject|9
7390869|NCT01238835|11651108|FG000|Overall Study|Lost to Follow-up|1
7390870|NCT01238835|11651108|FG000|Overall Study|Site early discontinuation|2
7390871|NCT01238848|11651114|FG000|Overall Study|Physician Decision|13
7390872|NCT01238848|11651115|FG001|Overall Study|Physician Decision|5
7390873|NCT01238861|11651127|FG000|Overall Study|Lost to Follow-up|4
7390874|NCT01238861|11651128|FG001|Overall Study|Lost to Follow-up|2
7390875|NCT01238861|11651129|FG002|Overall Study|Lost to Follow-up|3
7390876|NCT01238861|11651130|FG003|Overall Study|Lost to Follow-up|1
7390877|NCT01238861|11651131|FG004|Overall Study|Lost to Follow-up|1
7311938|NCT00686920|11538789|FG000|Overall Study|Principal Investigator Decision|2
7311939|NCT00686920|11538790|FG001|Overall Study|Principal Investigator Decision|0
7311940|NCT00686959|11538798|FG000|Overall Study|Participants censored (no death events)|124
7311941|NCT00686959|11538799|FG001|Overall Study|Participants censored (no death events)|117
7311942|NCT00686998|11538808|FG000|Overall Study|Adverse Event|3
7311943|NCT00686998|11538809|FG001|Overall Study|Adverse Event|2
7311944|NCT00686998|11538810|FG002|Overall Study|Adverse Event|1
7311945|NCT00686998|11538808|FG000|Overall Study|Withdrawal by Subject|2
7311946|NCT00686998|11538809|FG001|Overall Study|Withdrawal by Subject|1
7311947|NCT00686998|11538810|FG002|Overall Study|Withdrawal by Subject|2
7311948|NCT00686998|11538808|FG000|Overall Study|Lack of Efficacy|7
7311949|NCT00686998|11538809|FG001|Overall Study|Lack of Efficacy|5
7311950|NCT00686998|11538810|FG002|Overall Study|Lack of Efficacy|0
7311951|NCT00686998|11538808|FG000|Overall Study|Other|0
7311952|NCT00686998|11538809|FG001|Overall Study|Other|0
7311953|NCT00686998|11538810|FG002|Overall Study|Other|1
7311954|NCT00686998|11538808|FG000|Overall Study|Safety Reasons|1
7311955|NCT00686998|11538809|FG001|Overall Study|Safety Reasons|0
7311956|NCT00686998|11538810|FG002|Overall Study|Safety Reasons|0
7311957|NCT00687193|11538849|FG000|Overall Study|Adverse Event|0
7311958|NCT00687193|11538850|FG001|Overall Study|Adverse Event|1
7390878|NCT01238861|11651132|FG005|Overall Study|Lost to Follow-up|2
7390879|NCT01238861|11651127|FG000|Overall Study|Unplanned surgery|1
7390880|NCT01238861|11651128|FG001|Overall Study|Unplanned surgery|0
7390881|NCT01238861|11651129|FG002|Overall Study|Unplanned surgery|0
7390882|NCT01238861|11651130|FG003|Overall Study|Unplanned surgery|0
7390883|NCT01238861|11651131|FG004|Overall Study|Unplanned surgery|0
7390884|NCT01238861|11651132|FG005|Overall Study|Unplanned surgery|0
7390885|NCT01238861|11651127|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
7390886|NCT01238861|11651128|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
7390887|NCT01238861|11651129|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
7390888|NCT01238861|11651130|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
7390889|NCT01238861|11651131|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
7390890|NCT01238861|11651132|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
7390891|NCT01238861|11651127|FG000|Overall Study|Incorrect enrollment/randomization|0
7390892|NCT01238861|11651128|FG001|Overall Study|Incorrect enrollment/randomization|0
7390893|NCT01238861|11651129|FG002|Overall Study|Incorrect enrollment/randomization|1
7390894|NCT01238861|11651130|FG003|Overall Study|Incorrect enrollment/randomization|0
7390895|NCT01238861|11651131|FG004|Overall Study|Incorrect enrollment/randomization|1
7390896|NCT01238861|11651132|FG005|Overall Study|Incorrect enrollment/randomization|0
7390897|NCT01238861|11651127|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
7390898|NCT01238861|11651128|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
7390899|NCT01238861|11651129|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
7390900|NCT01238861|11651130|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
7390901|NCT01238861|11651131|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
7390902|NCT01238861|11651132|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
7390903|NCT01238861|11651127|FG000|Overall Study|Subject moved out of state/area|0
7390904|NCT01238861|11651128|FG001|Overall Study|Subject moved out of state/area|0
7390905|NCT01238861|11651129|FG002|Overall Study|Subject moved out of state/area|1
7390906|NCT01238861|11651130|FG003|Overall Study|Subject moved out of state/area|1
7390907|NCT01238861|11651131|FG004|Overall Study|Subject moved out of state/area|0
7390908|NCT01238861|11651132|FG005|Overall Study|Subject moved out of state/area|0
7390909|NCT01238861|11651127|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
7390910|NCT01238861|11651128|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
7390911|NCT01238861|11651129|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
7390912|NCT01238861|11651130|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
7390913|NCT01238861|11651131|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
7390914|NCT01238861|11651132|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
7390915|NCT01238861|11651127|FG000|Overall Study|Personal problems|0
7390916|NCT01238861|11651128|FG001|Overall Study|Personal problems|0
7390917|NCT01238861|11651129|FG002|Overall Study|Personal problems|0
7390918|NCT01238861|11651130|FG003|Overall Study|Personal problems|1
7390919|NCT01238861|11651131|FG004|Overall Study|Personal problems|0
7390920|NCT01238861|11651132|FG005|Overall Study|Personal problems|0
7390921|NCT01238861|11651127|FG000|Overall Study|Unable to continue visits|0
7390922|NCT01238861|11651128|FG001|Overall Study|Unable to continue visits|0
7390923|NCT01238861|11651129|FG002|Overall Study|Unable to continue visits|0
7390924|NCT01238861|11651130|FG003|Overall Study|Unable to continue visits|1
7390925|NCT01238861|11651131|FG004|Overall Study|Unable to continue visits|0
7390926|NCT01238861|11651132|FG005|Overall Study|Unable to continue visits|1
7390927|NCT01238861|11651127|FG000|Overall Study|Serious adverse event|0
7390928|NCT01238861|11651128|FG001|Overall Study|Serious adverse event|0
7390929|NCT01238861|11651129|FG002|Overall Study|Serious adverse event|0
7390930|NCT01238861|11651130|FG003|Overall Study|Serious adverse event|0
7390931|NCT01238861|11651131|FG004|Overall Study|Serious adverse event|0
7390932|NCT01238861|11651132|FG005|Overall Study|Serious adverse event|1
7390933|NCT01238861|11651127|FG000|Overall Study|Lack of compliance|0
7390934|NCT01238861|11651128|FG001|Overall Study|Lack of compliance|0
7390935|NCT01238861|11651129|FG002|Overall Study|Lack of compliance|0
7390936|NCT01238861|11651130|FG003|Overall Study|Lack of compliance|0
7311959|NCT00687193|11538851|FG002|Overall Study|Adverse Event|2
7311960|NCT00687193|11538852|FG003|Overall Study|Adverse Event|3
7311961|NCT00687193|11538853|FG004|Overall Study|Adverse Event|0
7311962|NCT00687193|11538854|FG005|Overall Study|Adverse Event|2
7311963|NCT00687193|11538849|FG000|Overall Study|Lack of Efficacy|1
7390937|NCT01238861|11651131|FG004|Overall Study|Lack of compliance|0
7533850|NCT02689206|11880196|FG002|Overall Study|Physician Decision|0
7311964|NCT00687193|11538850|FG001|Overall Study|Lack of Efficacy|1
7390938|NCT01238861|11651132|FG005|Overall Study|Lack of compliance|1
7390939|NCT01238861|11651127|FG000|Overall Study|Adverse Event|0
7390940|NCT01238861|11651128|FG001|Overall Study|Adverse Event|1
7390941|NCT01238861|11651129|FG002|Overall Study|Adverse Event|0
7390942|NCT01238861|11651130|FG003|Overall Study|Adverse Event|0
7390943|NCT01238861|11651131|FG004|Overall Study|Adverse Event|0
7390944|NCT01238861|11651132|FG005|Overall Study|Adverse Event|0
7390945|NCT01238861|11651127|FG000|Overall Study|Withdrawal by Subject|6
7390946|NCT01238861|11651128|FG001|Overall Study|Withdrawal by Subject|5
7390947|NCT01238861|11651129|FG002|Overall Study|Withdrawal by Subject|4
7390948|NCT01238861|11651130|FG003|Overall Study|Withdrawal by Subject|8
7390949|NCT01238861|11651131|FG004|Overall Study|Withdrawal by Subject|10
7390950|NCT01238861|11651132|FG005|Overall Study|Withdrawal by Subject|9
7390951|NCT01238900|11651153|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
7390952|NCT01238900|11651153|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
7390953|NCT01238991|11651168|FG000|Overall Study|Adverse Event|1
7390954|NCT01238991|11651169|FG001|Overall Study|Adverse Event|0
7390955|NCT01238991|11651170|FG002|Overall Study|Adverse Event|3
7390956|NCT01238991|11651171|FG003|Overall Study|Adverse Event|1
7390957|NCT01238991|11651172|FG004|Overall Study|Adverse Event|1
7390958|NCT01238991|11651173|FG005|Overall Study|Adverse Event|0
7390959|NCT01238991|11651174|FG006|Overall Study|Adverse Event|1
7390960|NCT01238991|11651175|FG007|Overall Study|Adverse Event|1
7390961|NCT01238991|11651176|FG008|Overall Study|Adverse Event|0
7390962|NCT01238991|11651177|FG009|Overall Study|Adverse Event|0
7390963|NCT01238991|11651168|FG000|Overall Study|Death|0
7390964|NCT01238991|11651169|FG001|Overall Study|Death|0
7390965|NCT01238991|11651170|FG002|Overall Study|Death|0
7390966|NCT01238991|11651171|FG003|Overall Study|Death|1
7390967|NCT01238991|11651172|FG004|Overall Study|Death|0
7390968|NCT01238991|11651173|FG005|Overall Study|Death|0
7390969|NCT01238991|11651174|FG006|Overall Study|Death|0
7390970|NCT01238991|11651175|FG007|Overall Study|Death|0
7390971|NCT01238991|11651176|FG008|Overall Study|Death|0
7390972|NCT01238991|11651177|FG009|Overall Study|Death|0
7390973|NCT01238991|11651168|FG000|Overall Study|Lack of Efficacy|0
7390974|NCT01238991|11651169|FG001|Overall Study|Lack of Efficacy|0
7390975|NCT01238991|11651170|FG002|Overall Study|Lack of Efficacy|1
7390976|NCT01238991|11651171|FG003|Overall Study|Lack of Efficacy|0
7390977|NCT01238991|11651172|FG004|Overall Study|Lack of Efficacy|0
7390978|NCT01238991|11651173|FG005|Overall Study|Lack of Efficacy|0
7390979|NCT01238991|11651174|FG006|Overall Study|Lack of Efficacy|0
7390980|NCT01238991|11651175|FG007|Overall Study|Lack of Efficacy|0
7390981|NCT01238991|11651176|FG008|Overall Study|Lack of Efficacy|1
7390982|NCT01238991|11651177|FG009|Overall Study|Lack of Efficacy|0
7390983|NCT01238991|11651168|FG000|Overall Study|Withdrawal by Subject|0
7390984|NCT01238991|11651169|FG001|Overall Study|Withdrawal by Subject|0
7390985|NCT01238991|11651170|FG002|Overall Study|Withdrawal by Subject|1
7390986|NCT01238991|11651171|FG003|Overall Study|Withdrawal by Subject|0
7390987|NCT01238991|11651172|FG004|Overall Study|Withdrawal by Subject|0
7390988|NCT01238991|11651173|FG005|Overall Study|Withdrawal by Subject|0
7390989|NCT01238991|11651174|FG006|Overall Study|Withdrawal by Subject|0
7390990|NCT01238991|11651175|FG007|Overall Study|Withdrawal by Subject|0
7390991|NCT01238991|11651176|FG008|Overall Study|Withdrawal by Subject|0
7390992|NCT01238991|11651177|FG009|Overall Study|Withdrawal by Subject|0
7390993|NCT01238991|11651168|FG000|Overall Study|Study Terminated by Sponsor|0
7390994|NCT01238991|11651169|FG001|Overall Study|Study Terminated by Sponsor|0
7390995|NCT01238991|11651170|FG002|Overall Study|Study Terminated by Sponsor|0
7390996|NCT01238991|11651171|FG003|Overall Study|Study Terminated by Sponsor|0
7390997|NCT01238991|11651172|FG004|Overall Study|Study Terminated by Sponsor|1
7390998|NCT01238991|11651173|FG005|Overall Study|Study Terminated by Sponsor|0
7390999|NCT01238991|11651174|FG006|Overall Study|Study Terminated by Sponsor|7
7391000|NCT01238991|11651175|FG007|Overall Study|Study Terminated by Sponsor|4
7391001|NCT01238991|11651176|FG008|Overall Study|Study Terminated by Sponsor|2
7391002|NCT01238991|11651177|FG009|Overall Study|Study Terminated by Sponsor|2
7391003|NCT01238991|11651168|FG000|Overall Study|Caregiver's request|0
7311965|NCT00687193|11538851|FG002|Overall Study|Lack of Efficacy|0
7311966|NCT00687193|11538852|FG003|Overall Study|Lack of Efficacy|0
7311967|NCT00687193|11538853|FG004|Overall Study|Lack of Efficacy|0
7311968|NCT00687193|11538854|FG005|Overall Study|Lack of Efficacy|2
7311969|NCT00687193|11538849|FG000|Overall Study|Protocol Violation|1
7311970|NCT00687193|11538850|FG001|Overall Study|Protocol Violation|2
7311971|NCT00687193|11538851|FG002|Overall Study|Protocol Violation|0
7311972|NCT00687193|11538852|FG003|Overall Study|Protocol Violation|1
7311973|NCT00687193|11538853|FG004|Overall Study|Protocol Violation|2
7311974|NCT00687193|11538854|FG005|Overall Study|Protocol Violation|0
7311975|NCT00687219|11538871|FG000|Overall Study|Adverse Event|8
7311976|NCT00687219|11538871|FG000|Overall Study|Discontinuance criteria met|7
7311977|NCT00687219|11538871|FG000|Overall Study|HCV-RNA positive conversion|34
7311978|NCT00687219|11538871|FG000|Overall Study|Withdrawal by Subject|1
7311979|NCT00687219|11538871|FG000|Overall Study|Lack of Efficacy|1
7311980|NCT00687271|11538879|FG000|Overall Study|Adverse Event|1
7311981|NCT00687271|11538880|FG001|Overall Study|Adverse Event|3
7311982|NCT00687271|11538881|FG002|Overall Study|Adverse Event|1
7311983|NCT00687271|11538882|FG003|Overall Study|Adverse Event|0
7311984|NCT00687271|11538879|FG000|Overall Study|Lost to Follow-up|0
7311985|NCT00687271|11538880|FG001|Overall Study|Lost to Follow-up|1
7311986|NCT00687271|11538881|FG002|Overall Study|Lost to Follow-up|0
7311987|NCT00687271|11538882|FG003|Overall Study|Lost to Follow-up|0
7311988|NCT00687271|11538879|FG000|Overall Study|Protocol Violation|2
7311989|NCT00687271|11538880|FG001|Overall Study|Protocol Violation|1
7311990|NCT00687271|11538881|FG002|Overall Study|Protocol Violation|1
7311991|NCT00687271|11538882|FG003|Overall Study|Protocol Violation|0
7311992|NCT00687271|11538879|FG000|Overall Study|Withdrawal by Subject|0
7311993|NCT00687271|11538880|FG001|Overall Study|Withdrawal by Subject|1
7311994|NCT00687271|11538881|FG002|Overall Study|Withdrawal by Subject|3
7311995|NCT00687271|11538882|FG003|Overall Study|Withdrawal by Subject|0
7384275|NCT01193608|11641449|FG002|Overall Study|Withdrawal by Subject|2
7384276|NCT01193608|11641450|FG003|Overall Study|Withdrawal by Subject|3
7384277|NCT01193608|11641451|FG004|Overall Study|Withdrawal by Subject|3
7384278|NCT01193608|11641452|FG005|Overall Study|Withdrawal by Subject|0
7384279|NCT01193608|11641447|FG000|Overall Study|Lost to Follow-up|0
7384280|NCT01193608|11641448|FG001|Overall Study|Lost to Follow-up|0
7384281|NCT01193608|11641449|FG002|Overall Study|Lost to Follow-up|0
7384282|NCT01193608|11641450|FG003|Overall Study|Lost to Follow-up|0
7384283|NCT01193608|11641451|FG004|Overall Study|Lost to Follow-up|1
7384284|NCT01193608|11641452|FG005|Overall Study|Lost to Follow-up|2
7384285|NCT01193608|11641447|FG000|Overall Study|Adverse Event|0
7384286|NCT01193608|11641448|FG001|Overall Study|Adverse Event|0
7384287|NCT01193608|11641449|FG002|Overall Study|Adverse Event|0
7384288|NCT01193608|11641450|FG003|Overall Study|Adverse Event|0
7384289|NCT01193608|11641451|FG004|Overall Study|Adverse Event|1
7384290|NCT01193608|11641452|FG005|Overall Study|Adverse Event|0
7384291|NCT01193660|11641474|FG000|Overall Study|Withdrawal by Subject|2
7384292|NCT01193660|11641475|FG001|Overall Study|Withdrawal by Subject|3
7384293|NCT01193660|11641476|FG002|Overall Study|Withdrawal by Subject|1
7384294|NCT01193660|11641474|FG000|Overall Study|Death|1
7384295|NCT01193660|11641475|FG001|Overall Study|Death|0
7384296|NCT01193660|11641476|FG002|Overall Study|Death|0
7384297|NCT01193660|11641474|FG000|Overall Study|Physician Decision|1
7384298|NCT01193660|11641475|FG001|Overall Study|Physician Decision|0
7384299|NCT01193660|11641476|FG002|Overall Study|Physician Decision|1
7384300|NCT01193686|11641486|FG000|Overall Study|Withdrawal by Subject|4
7384301|NCT01193686|11641487|FG001|Overall Study|Withdrawal by Subject|1
7384302|NCT01193686|11641486|FG000|Overall Study|Removed by Investigators; unable to matc|3
7384303|NCT01193686|11641487|FG001|Overall Study|Removed by Investigators; unable to matc|0
7384304|NCT01193920|11641525|FG000|Overall Study|Withdrawal by Subject|1
7384305|NCT01193920|11641526|FG001|Overall Study|Withdrawal by Subject|0
7384306|NCT01193920|11641527|FG002|Overall Study|Withdrawal by Subject|5
7384307|NCT01193920|11641528|FG003|Overall Study|Withdrawal by Subject|1
7384308|NCT01193920|11641529|FG004|Overall Study|Withdrawal by Subject|3
7384309|NCT01193920|11641530|FG005|Overall Study|Withdrawal by Subject|1
7384310|NCT01193920|11641531|FG006|Overall Study|Withdrawal by Subject|3
7384311|NCT01193920|11641532|FG007|Overall Study|Withdrawal by Subject|0
7384312|NCT01193920|11641533|FG008|Overall Study|Withdrawal by Subject|1
7384313|NCT01193920|11641534|FG009|Overall Study|Withdrawal by Subject|0
7384314|NCT01193920|11641525|FG000|Overall Study|Lost to Follow-up|1
7384315|NCT01193920|11641526|FG001|Overall Study|Lost to Follow-up|0
7384316|NCT01193920|11641527|FG002|Overall Study|Lost to Follow-up|1
7384317|NCT01193920|11641528|FG003|Overall Study|Lost to Follow-up|1
7384318|NCT01193920|11641529|FG004|Overall Study|Lost to Follow-up|3
7384319|NCT01193920|11641530|FG005|Overall Study|Lost to Follow-up|3
7384320|NCT01193920|11641531|FG006|Overall Study|Lost to Follow-up|1
7384321|NCT01193920|11641532|FG007|Overall Study|Lost to Follow-up|0
7384322|NCT01193920|11641533|FG008|Overall Study|Lost to Follow-up|2
7384323|NCT01193920|11641534|FG009|Overall Study|Lost to Follow-up|3
7384324|NCT01193920|11641525|FG000|Overall Study|Protocol Violation|1
7384325|NCT01193920|11641526|FG001|Overall Study|Protocol Violation|0
7384326|NCT01193920|11641527|FG002|Overall Study|Protocol Violation|0
7384327|NCT01193920|11641528|FG003|Overall Study|Protocol Violation|0
7384328|NCT01193920|11641529|FG004|Overall Study|Protocol Violation|0
7384329|NCT01193920|11641530|FG005|Overall Study|Protocol Violation|0
7384330|NCT01193920|11641531|FG006|Overall Study|Protocol Violation|0
7384331|NCT01193920|11641532|FG007|Overall Study|Protocol Violation|0
7384332|NCT01193920|11641533|FG008|Overall Study|Protocol Violation|0
7384333|NCT01193920|11641534|FG009|Overall Study|Protocol Violation|0
7384334|NCT01193920|11641525|FG000|Overall Study|Death|0
7384335|NCT01193920|11641526|FG001|Overall Study|Death|0
7384336|NCT01193920|11641527|FG002|Overall Study|Death|0
7384337|NCT01193920|11641528|FG003|Overall Study|Death|1
7384338|NCT01193920|11641529|FG004|Overall Study|Death|0
7384339|NCT01193920|11641530|FG005|Overall Study|Death|0
7384340|NCT01193920|11641531|FG006|Overall Study|Death|2
7384341|NCT01193920|11641532|FG007|Overall Study|Death|3
7384342|NCT01193920|11641533|FG008|Overall Study|Death|2
7384343|NCT01193920|11641534|FG009|Overall Study|Death|4
7384344|NCT01193920|11641525|FG000|Overall Study|Unable to classify|0
7384345|NCT01193920|11641526|FG001|Overall Study|Unable to classify|0
7311996|NCT00687297|11538894|FG000|Randomization|Withdrawal by Subject|2
7311997|NCT00687297|11538895|FG001|Randomization|Withdrawal by Subject|0
7311998|NCT00687297|11538894|FG000|Randomization|Withdrew before treatment, ineligible|1
7311999|NCT00687297|11538895|FG001|Randomization|Withdrew before treatment, ineligible|1
7312000|NCT00687297|11538894|FG000|Induction|Withdrawal by Subject|4
7312001|NCT00687297|11538895|FG001|Induction|Withdrawal by Subject|4
7312002|NCT00687297|11538894|FG000|Induction|Adverse Event|16
7312003|NCT00687297|11538895|FG001|Induction|Adverse Event|15
7312004|NCT00687297|11538894|FG000|Induction|Death|7
7312005|NCT00687297|11538895|FG001|Induction|Death|11
7312006|NCT00687297|11538894|FG000|Induction|Lack of Efficacy|17
7312007|NCT00687297|11538895|FG001|Induction|Lack of Efficacy|21
7312008|NCT00687297|11538894|FG000|Induction|Ineligible|0
7312009|NCT00687297|11538895|FG001|Induction|Ineligible|1
7312010|NCT00687297|11538894|FG000|Induction|Patient Noncompliance|1
7312011|NCT00687297|11538895|FG001|Induction|Patient Noncompliance|0
7312012|NCT00687297|11538894|FG000|Induction|Physician Decision|0
7312013|NCT00687297|11538895|FG001|Induction|Physician Decision|2
7312014|NCT00687297|11538894|FG000|Induction|Other|0
7312015|NCT00687297|11538895|FG001|Induction|Other|1
7312016|NCT00687323|11538903|FG000|Overall Study|Death|25
7312017|NCT00687323|11538903|FG000|Overall Study|Withdrawal by Subject|1
7312018|NCT00687323|11538903|FG000|Overall Study|Excluded from efficacy evaluations|6
7391004|NCT01238991|11651169|FG001|Overall Study|Caregiver's request|0
7391005|NCT01238991|11651170|FG002|Overall Study|Caregiver's request|0
7391006|NCT01238991|11651171|FG003|Overall Study|Caregiver's request|0
7391007|NCT01238991|11651172|FG004|Overall Study|Caregiver's request|0
7391008|NCT01238991|11651173|FG005|Overall Study|Caregiver's request|0
7391009|NCT01238991|11651174|FG006|Overall Study|Caregiver's request|0
7391010|NCT01238991|11651175|FG007|Overall Study|Caregiver's request|0
7391011|NCT01238991|11651176|FG008|Overall Study|Caregiver's request|1
7391012|NCT01238991|11651177|FG009|Overall Study|Caregiver's request|0
7391013|NCT01238991|11651168|FG000|Overall Study|Admission to a nursing home|1
7391014|NCT01238991|11651169|FG001|Overall Study|Admission to a nursing home|0
7391015|NCT01238991|11651170|FG002|Overall Study|Admission to a nursing home|1
7391016|NCT01238991|11651171|FG003|Overall Study|Admission to a nursing home|0
7391017|NCT01238991|11651172|FG004|Overall Study|Admission to a nursing home|0
7391018|NCT01238991|11651173|FG005|Overall Study|Admission to a nursing home|0
7391019|NCT01238991|11651174|FG006|Overall Study|Admission to a nursing home|0
7391020|NCT01238991|11651175|FG007|Overall Study|Admission to a nursing home|0
7391021|NCT01238991|11651176|FG008|Overall Study|Admission to a nursing home|0
7391022|NCT01238991|11651177|FG009|Overall Study|Admission to a nursing home|0
7391023|NCT01239043|11651204|FG000|Overall Study|Protocol Violation|2
7391024|NCT01239043|11651205|FG001|Overall Study|Protocol Violation|1
7391025|NCT01239121|11651219|FG000|Overall Study|Withdrawal by Subject|2
7391026|NCT01239121|11651220|FG001|Overall Study|Withdrawal by Subject|4
7391027|NCT01239121|11651221|FG002|Overall Study|Withdrawal by Subject|0
7391028|NCT01239160|11651231|FG000|Overall Study|Lost to Follow-up|3
7391029|NCT01239160|11651232|FG001|Overall Study|Lost to Follow-up|5
7391030|NCT01239160|11651233|FG002|Overall Study|Lost to Follow-up|0
7391031|NCT01239160|11651231|FG000|Overall Study|Withdrawal by Subject|17
7391032|NCT01239160|11651232|FG001|Overall Study|Withdrawal by Subject|6
7391033|NCT01239160|11651233|FG002|Overall Study|Withdrawal by Subject|2
7391034|NCT01239160|11651231|FG000|Overall Study|Physician Decision|5
7391035|NCT01239160|11651232|FG001|Overall Study|Physician Decision|7
7391036|NCT01239160|11651233|FG002|Overall Study|Physician Decision|2
7391037|NCT01239160|11651231|FG000|Overall Study|Early Termination Due to Study Closure|0
7391038|NCT01239160|11651232|FG001|Overall Study|Early Termination Due to Study Closure|1
7391039|NCT01239160|11651233|FG002|Overall Study|Early Termination Due to Study Closure|6
7391040|NCT01239316|11651243|FG000|Overall Study|Progression/Relapse|11
7391041|NCT01239316|11651243|FG000|Overall Study|Adverse Event|1
7391042|NCT01239342|11651249|FG000|Overall Study|Adverse Event|1
7391043|NCT01239342|11651250|FG001|Overall Study|Adverse Event|0
7391044|NCT01239342|11651249|FG000|Overall Study|Withdrawal by Subject|1
7391045|NCT01239342|11651250|FG001|Overall Study|Withdrawal by Subject|5
7391046|NCT01239342|11651249|FG000|Overall Study|Reason Unknown|1
7391047|NCT01239342|11651250|FG001|Overall Study|Reason Unknown|1
7391048|NCT01239381|11651260|FG000|Overall Study|Protocol Violation|1
7391049|NCT01239381|11651260|FG000|Overall Study|Withdrawal by Subject|1
7391050|NCT01239394|11651265|FG000|Overall Study|Adverse Event|1
7391051|NCT01239472|11651271|FG000|Overall Study|Withdrawal by Subject|5
7391052|NCT01239472|11651272|FG001|Overall Study|Withdrawal by Subject|1
7391053|NCT01239472|11651271|FG000|Overall Study|Adverse Event|0
7391054|NCT01239472|11651272|FG001|Overall Study|Adverse Event|1
7391055|NCT01239472|11651271|FG000|Overall Study|Lack of Efficacy|0
7391056|NCT01239472|11651272|FG001|Overall Study|Lack of Efficacy|1
7391057|NCT01239732|11651297|FG000|Overall Study|Termination of study per protocol|667
7391058|NCT01239732|11651297|FG000|Overall Study|Death|226
7391059|NCT01239732|11651297|FG000|Overall Study|Withdrawal by Subject|87
7391060|NCT01239732|11651297|FG000|Overall Study|Adverse Event|6
7391061|NCT01239732|11651297|FG000|Overall Study|Protocol Violation|3
7391062|NCT01239732|11651297|FG000|Overall Study|Participant non compliance|5
7391063|NCT01239732|11651297|FG000|Overall Study|Study termination by sponsor|2
7312019|NCT00687323|11538903|FG000|Overall Study|Screen failure|148
7312020|NCT00687362|11538907|FG000|Overall Study|Protocol Violation|2
7312021|NCT00687362|11538907|FG000|Overall Study|Withdrawal by Subject|1
7312022|NCT00687401|11538911|FG000|Overall Study|Protocol Violation|7
7312023|NCT00687401|11538911|FG000|Overall Study|Adverse Event|6
7312024|NCT00687401|11538911|FG000|Overall Study|Lack of Efficacy|6
7312025|NCT00687401|11538911|FG000|Overall Study|Withdrawal by Subject|4
7312026|NCT00687401|11538911|FG000|Overall Study|Did not return for visit|3
7312027|NCT00687401|11538911|FG000|Overall Study|For reasons different from those above|4
7312028|NCT00687440|11538916|FG000|Overall Study|Adverse Event|3
7312029|NCT00687440|11538916|FG000|Overall Study|Lost to Follow-up|3
7312030|NCT00687440|11538916|FG000|Overall Study|Lack of Efficacy|2
7312031|NCT00687440|11538916|FG000|Overall Study|Death|2
7312032|NCT00687440|11538916|FG000|Overall Study|Other|1
7312033|NCT00687440|11538916|FG000|Overall Study|Missing|1
7312034|NCT00687609|11538933|FG000|Overall Study|Physician Decision|1
7312035|NCT00687609|11538933|FG000|Overall Study|Withdrawal by Subject|2
7312036|NCT00687739|11538956|FG000|Overall Study|Lost to Follow-up|2
7312037|NCT00687739|11538957|FG001|Overall Study|Lost to Follow-up|2
7312038|NCT00687739|11538958|FG002|Overall Study|Lost to Follow-up|1
7312039|NCT00687739|11538959|FG003|Overall Study|Lost to Follow-up|2
7312040|NCT00687739|11538956|FG000|Overall Study|Adverse Event|0
7312041|NCT00687739|11538957|FG001|Overall Study|Adverse Event|1
7312042|NCT00687739|11538958|FG002|Overall Study|Adverse Event|1
7312043|NCT00687739|11538959|FG003|Overall Study|Adverse Event|0
7312044|NCT00687804|11538974|FG000|Core Study|Adverse Event|5
7312045|NCT00687804|11538975|FG001|Core Study|Adverse Event|3
7312046|NCT00687804|11538976|FG002|Core Study|Adverse Event|3
7312047|NCT00687804|11538974|FG000|Core Study|Abnormal laboratory value(s)|1
7312048|NCT00687804|11538975|FG001|Core Study|Abnormal laboratory value(s)|0
7312049|NCT00687804|11538976|FG002|Core Study|Abnormal laboratory value(s)|0
7312050|NCT00687804|11538974|FG000|Core Study|Lack of Efficacy|1
7312051|NCT00687804|11538975|FG001|Core Study|Lack of Efficacy|1
7312052|NCT00687804|11538976|FG002|Core Study|Lack of Efficacy|1
7312053|NCT00687804|11538974|FG000|Core Study|Withdrawal by Subject|4
7312054|NCT00687804|11538975|FG001|Core Study|Withdrawal by Subject|7
7312055|NCT00687804|11538976|FG002|Core Study|Withdrawal by Subject|7
7312056|NCT00687804|11538974|FG000|Core Study|Lost to Follow-up|0
7312057|NCT00687804|11538975|FG001|Core Study|Lost to Follow-up|1
7312058|NCT00687804|11538976|FG002|Core Study|Lost to Follow-up|0
7312059|NCT00687804|11538974|FG000|Core Study|Death|2
7312060|NCT00687804|11538975|FG001|Core Study|Death|2
7312061|NCT00687804|11538976|FG002|Core Study|Death|2
7312062|NCT00687804|11538974|FG000|Core Study|Protocol Violation|1
7312063|NCT00687804|11538975|FG001|Core Study|Protocol Violation|1
7312064|NCT00687804|11538976|FG002|Core Study|Protocol Violation|0
7312065|NCT00687804|11538974|FG000|Open-Label Extension Study|Adverse Event|2
7312066|NCT00687804|11538975|FG001|Open-Label Extension Study|Adverse Event|2
7312067|NCT00687804|11538976|FG002|Open-Label Extension Study|Adverse Event|2
7312068|NCT00687804|11538974|FG000|Open-Label Extension Study|Subject withdrew consent|3
7312069|NCT00687804|11538975|FG001|Open-Label Extension Study|Subject withdrew consent|4
7312070|NCT00687804|11538976|FG002|Open-Label Extension Study|Subject withdrew consent|4
7312071|NCT00687804|11538974|FG000|Open-Label Extension Study|Lost to Follow-up|2
7312072|NCT00687804|11538975|FG001|Open-Label Extension Study|Lost to Follow-up|1
7312073|NCT00687804|11538976|FG002|Open-Label Extension Study|Lost to Follow-up|2
7312074|NCT00687804|11538974|FG000|Open-Label Extension Study|Administrative problems|1
7312075|NCT00687804|11538975|FG001|Open-Label Extension Study|Administrative problems|1
7312076|NCT00687804|11538976|FG002|Open-Label Extension Study|Administrative problems|0
7312077|NCT00687804|11538974|FG000|Open-Label Extension Study|Death|2
7312078|NCT00687804|11538975|FG001|Open-Label Extension Study|Death|3
7312079|NCT00687804|11538976|FG002|Open-Label Extension Study|Death|3
7312080|NCT00687973|11539014|FG000|Overall Study|Adverse Event|18
7312081|NCT00687973|11539015|FG001|Overall Study|Adverse Event|28
7312082|NCT00687973|11539014|FG000|Overall Study|Lack of Efficacy|2
7312083|NCT00687973|11539015|FG001|Overall Study|Lack of Efficacy|3
7312084|NCT00687973|11539014|FG000|Overall Study|Protocol Violation|1
7312085|NCT00687973|11539015|FG001|Overall Study|Protocol Violation|2
7312086|NCT00687973|11539014|FG000|Overall Study|Administrative Reasons|0
7312087|NCT00687973|11539015|FG001|Overall Study|Administrative Reasons|2
7312088|NCT00687973|11539014|FG000|Overall Study|Withdrawal by Subject|3
7312089|NCT00687973|11539015|FG001|Overall Study|Withdrawal by Subject|3
7312090|NCT00688064|11539024|FG000|Overall Study|Protocol Violation|0
7312091|NCT00688064|11539025|FG001|Overall Study|Protocol Violation|1
7312092|NCT00688064|11539024|FG000|Overall Study|Adverse Event|2
7312093|NCT00688064|11539025|FG001|Overall Study|Adverse Event|4
7312094|NCT00688064|11539024|FG000|Overall Study|Withdrawal by Subject|7
7312095|NCT00688064|11539025|FG001|Overall Study|Withdrawal by Subject|7
7312096|NCT00688064|11539024|FG000|Overall Study|Lost to Follow-up|10
7312097|NCT00688064|11539025|FG001|Overall Study|Lost to Follow-up|10
7312098|NCT00688064|11539024|FG000|Overall Study|Lack of Efficacy|0
7312099|NCT00688064|11539025|FG001|Overall Study|Lack of Efficacy|1
7312100|NCT00688064|11539024|FG000|Overall Study|Pregnancy|1
7312101|NCT00688064|11539025|FG001|Overall Study|Pregnancy|0
7312102|NCT00688064|11539024|FG000|Overall Study|Any other reasons|1
7312103|NCT00688064|11539025|FG001|Overall Study|Any other reasons|3
7312104|NCT00688103|11539033|FG000|Overall Study|Adverse Event|4
7312105|NCT00688103|11539034|FG001|Overall Study|Adverse Event|1
7312106|NCT00688103|11539033|FG000|Overall Study|Lack of Efficacy|11
7312107|NCT00688103|11539034|FG001|Overall Study|Lack of Efficacy|1
7312108|NCT00688103|11539033|FG000|Overall Study|Withdrawal by Subject|4
7312109|NCT00688103|11539034|FG001|Overall Study|Withdrawal by Subject|2
7312110|NCT00688103|11539033|FG000|Overall Study|complex reasons|11
7312111|NCT00688103|11539034|FG001|Overall Study|complex reasons|9
7391064|NCT01239732|11651297|FG000|Overall Study|Investigator's decision|4
7391065|NCT01239732|11651297|FG000|Overall Study|Treatment failure|2
7391066|NCT01239732|11651297|FG000|Overall Study|Other|19
7391067|NCT01239745|11651301|FG000|Overall Study|Study terminated by sponsor|45
7391068|NCT01239745|11651301|FG000|Overall Study|Adverse Event|1
7391069|NCT01239992|11651305|FG000|Overall Study|Withdrawal by Subject|2
7391070|NCT01240135|11651320|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7391071|NCT01240135|11651321|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
7391072|NCT01240135|11651320|FG000|Period Two, 14 Days of Wear|Adverse Event|0
7391073|NCT01240135|11651321|FG001|Period Two, 14 Days of Wear|Adverse Event|1
7391074|NCT01240200|11651329|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
7391075|NCT01240200|11651330|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
7391076|NCT01240356|11651345|FG000|Overall Study|Withdrawal by Subject|2
7391077|NCT01240356|11651346|FG001|Overall Study|Withdrawal by Subject|0
7391078|NCT01240356|11651345|FG000|Overall Study|MRI contraindication|1
7391079|NCT01240356|11651346|FG001|Overall Study|MRI contraindication|0
7391080|NCT01240382|11651357|FG000|Overall Study|Adverse Event|2
7391081|NCT01240382|11651358|FG001|Overall Study|Adverse Event|1
7391082|NCT01240382|11651357|FG000|Overall Study|Lack of Efficacy|0
7391083|NCT01240382|11651358|FG001|Overall Study|Lack of Efficacy|2
7391084|NCT01240382|11651357|FG000|Overall Study|Fear of adverse events|0
7391085|NCT01240382|11651358|FG001|Overall Study|Fear of adverse events|1
7391086|NCT01240551|11651366|FG000|Overall Study|Refused further treatment|3
7391087|NCT01240551|11651367|FG001|Overall Study|Refused further treatment|2
7391088|NCT01240551|11651366|FG000|Overall Study|Lost to Follow-up|1
7391089|NCT01240551|11651367|FG001|Overall Study|Lost to Follow-up|1
7391090|NCT01240590|11651378|FG000|Phase I|Refused further treatment|0
7391091|NCT01240590|11651379|FG001|Phase I|Refused further treatment|0
7391092|NCT01240590|11651380|FG002|Phase I|Refused further treatment|3
7391093|NCT01240590|11651381|FG003|Phase I|Refused further treatment|0
7391094|NCT01240590|11651382|FG004|Phase I|Refused further treatment|0
7391095|NCT01240590|11651378|FG000|Phase II|Refused further treatment|0
7391096|NCT01240590|11651379|FG001|Phase II|Refused further treatment|0
7391097|NCT01240590|11651380|FG002|Phase II|Refused further treatment|0
7391098|NCT01240590|11651381|FG003|Phase II|Refused further treatment|2
7391099|NCT01240590|11651382|FG004|Phase II|Refused further treatment|1
7391100|NCT01240746|11651411|FG000|Overall Study|Adverse Event|2
7391101|NCT01240746|11651412|FG001|Overall Study|Adverse Event|0
7391102|NCT01240746|11651413|FG002|Overall Study|Adverse Event|10
7391103|NCT01240746|11651411|FG000|Overall Study|Lost to Follow-up|23
7391104|NCT01240746|11651412|FG001|Overall Study|Lost to Follow-up|20
7391105|NCT01240746|11651413|FG002|Overall Study|Lost to Follow-up|102
7391106|NCT01240746|11651411|FG000|Overall Study|Protocol Violation|24
7391107|NCT01240746|11651412|FG001|Overall Study|Protocol Violation|15
7391108|NCT01240746|11651413|FG002|Overall Study|Protocol Violation|72
7391109|NCT01240746|11651411|FG000|Overall Study|Withdrawal by Subject|10
7391110|NCT01240746|11651412|FG001|Overall Study|Withdrawal by Subject|13
7391111|NCT01240746|11651413|FG002|Overall Study|Withdrawal by Subject|59
7391112|NCT01240785|11651423|FG000|Overall Study|Lost to Follow-up|1
7391113|NCT01240785|11651424|FG001|Overall Study|Lost to Follow-up|0
7391114|NCT01240785|11651423|FG000|Overall Study|Protocol Violation|0
7391115|NCT01240785|11651424|FG001|Overall Study|Protocol Violation|3
7391116|NCT01240811|11651433|FG000|Overall Study|Physician Decision|0
7391117|NCT01240811|11651434|FG001|Overall Study|Physician Decision|1
7391118|NCT01240811|11651435|FG002|Overall Study|Physician Decision|0
7391119|NCT01240811|11651433|FG000|Overall Study|Withdrawal by Subject|0
7391120|NCT01240811|11651434|FG001|Overall Study|Withdrawal by Subject|0
7312112|NCT00688155|11539046|FG000|Overall Study|Withdrawal by Subject|2
7312113|NCT00688155|11539047|FG001|Overall Study|Withdrawal by Subject|2
7312114|NCT00688155|11539048|FG002|Overall Study|Withdrawal by Subject|1
7312115|NCT00688155|11539049|FG003|Overall Study|Withdrawal by Subject|1
7312116|NCT00688181|11539059|FG000|Overall Study|Lost to Follow-up|17
7312117|NCT00688181|11539059|FG000|Overall Study|Unknown Reason|4
7312118|NCT00688181|11539059|FG000|Overall Study|Non-clinical Reason|2
7312119|NCT00688259|11539067|FG000|Overall Study|Lost to Follow-up|2
7312120|NCT00688259|11539068|FG001|Overall Study|Lost to Follow-up|4
7312121|NCT00688259|11539067|FG000|Overall Study|Physician Decision|1
7312122|NCT00688259|11539068|FG001|Overall Study|Physician Decision|0
7312123|NCT00688259|11539067|FG000|Overall Study|Withdrawal by Subject|2
7312124|NCT00688259|11539068|FG001|Overall Study|Withdrawal by Subject|0
7312125|NCT00688259|11539067|FG000|Overall Study|Declined Interview|2
7312126|NCT00688259|11539068|FG001|Overall Study|Declined Interview|3
7312127|NCT00688259|11539067|FG000|Overall Study|Hospitalized at Follow-up|0
7312128|NCT00688259|11539068|FG001|Overall Study|Hospitalized at Follow-up|1
7312129|NCT00688324|11539074|FG000|Overall Study|Withdrawal by Subject|2
7312130|NCT00688324|11539074|FG000|Overall Study|Physician Decision|5
7312131|NCT00688324|11539074|FG000|Overall Study|Lost to Follow-up|1
7312132|NCT00688467|11539081|FG000|Treatment Period 1|Adverse Event|2
7312133|NCT00688467|11539082|FG001|Treatment Period 1|Adverse Event|1
7312134|NCT00688467|11539081|FG000|Treatment Period 1|Did not meet protocol eligibility|0
7312135|NCT00688467|11539082|FG001|Treatment Period 1|Did not meet protocol eligibility|1
7312136|NCT00688467|11539081|FG000|Treatment Period 2|Protocol Violation|0
7312137|NCT00688467|11539082|FG001|Treatment Period 2|Protocol Violation|1
7312138|NCT00688467|11539081|FG000|Treatment Period 2|Adverse Event|0
7312139|NCT00688467|11539082|FG001|Treatment Period 2|Adverse Event|1
7312140|NCT00688519|11539090|FG000|Overall Study|Adverse Event|2
7312141|NCT00688519|11539091|FG001|Overall Study|Adverse Event|3
7312142|NCT00688519|11539090|FG000|Overall Study|Lost to Follow-up|3
7312143|NCT00688519|11539091|FG001|Overall Study|Lost to Follow-up|3
7312144|NCT00688519|11539090|FG000|Overall Study|Lack of Efficacy|3
7312145|NCT00688519|11539091|FG001|Overall Study|Lack of Efficacy|1
7312146|NCT00688519|11539090|FG000|Overall Study|Withdrawal by Subject|7
7312147|NCT00688519|11539091|FG001|Overall Study|Withdrawal by Subject|6
7312148|NCT00688519|11539090|FG000|Overall Study|Prohibited medication|1
7312149|NCT00688519|11539091|FG001|Overall Study|Prohibited medication|0
7312150|NCT00688519|11539090|FG000|Overall Study|Non-compliance|0
7312151|NCT00688519|11539091|FG001|Overall Study|Non-compliance|1
7312152|NCT00688519|11539090|FG000|Overall Study|Subject moved out of state|1
7312153|NCT00688519|11539091|FG001|Overall Study|Subject moved out of state|0
7312154|NCT00688519|11539090|FG000|Overall Study|Investigator decision|1
7312155|NCT00688519|11539091|FG001|Overall Study|Investigator decision|0
7312156|NCT00688519|11539090|FG000|Overall Study|Subject moved out of area|1
7312157|NCT00688519|11539091|FG001|Overall Study|Subject moved out of area|0
7312158|NCT00688519|11539090|FG000|Overall Study|Pregnancy|0
7312159|NCT00688519|11539091|FG001|Overall Study|Pregnancy|1
7312160|NCT00688545|11539099|FG000|Overall Study|Lost to Follow-up|1
7312161|NCT00688545|11539100|FG001|Overall Study|Lost to Follow-up|4
7312162|NCT00688545|11539099|FG000|Overall Study|Insurance/cost of drug|0
7312163|NCT00688545|11539100|FG001|Overall Study|Insurance/cost of drug|1
7312164|NCT00688545|11539099|FG000|Overall Study|Withdrawal by Subject|2
7312165|NCT00688545|11539100|FG001|Overall Study|Withdrawal by Subject|3
7312166|NCT00688545|11539099|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
7312167|NCT00688545|11539100|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
7312168|NCT00688597|11539111|FG000|Overall Study|Adverse Event|2
7312169|NCT00688597|11539112|FG001|Overall Study|Adverse Event|0
7312170|NCT00688597|11539113|FG002|Overall Study|Adverse Event|0
7312171|NCT00688597|11539111|FG000|Overall Study|Physician Decision|1
7312172|NCT00688597|11539112|FG001|Overall Study|Physician Decision|0
7312173|NCT00688597|11539113|FG002|Overall Study|Physician Decision|0
7312174|NCT00688623|11539121|FG000|Overall Study|Adverse Event|22
7312175|NCT00688623|11539121|FG000|Overall Study|abnormal lab value|1
7312176|NCT00688623|11539121|FG000|Overall Study|Withdrawal by Subject|4
7312177|NCT00688623|11539121|FG000|Overall Study|Death|3
7312178|NCT00688623|11539121|FG000|Overall Study|disease progression|23
7312179|NCT00688623|11539121|FG000|Overall Study|Protocol Violation|2
7312180|NCT00688636|11539127|FG000|Overall Study|Adverse Event|2
7312181|NCT00688636|11539128|FG001|Overall Study|Adverse Event|1
7312182|NCT00688688|11539147|FG000|Overall Study|Eligibility criterion not met|7
7312183|NCT00688688|11539148|FG001|Overall Study|Eligibility criterion not met|7
7312184|NCT00688688|11539149|FG002|Overall Study|Eligibility criterion not met|10
7312185|NCT00688688|11539147|FG000|Overall Study|Adverse Event|52
7312186|NCT00688688|11539148|FG001|Overall Study|Adverse Event|51
7312187|NCT00688688|11539149|FG002|Overall Study|Adverse Event|50
7312188|NCT00688688|11539147|FG000|Overall Study|Lack of Efficacy|34
7312189|NCT00688688|11539148|FG001|Overall Study|Lack of Efficacy|25
7312190|NCT00688688|11539149|FG002|Overall Study|Lack of Efficacy|45
7312191|NCT00688688|11539147|FG000|Overall Study|Withdrawal by Subject|66
7312192|NCT00688688|11539148|FG001|Overall Study|Withdrawal by Subject|75
7312193|NCT00688688|11539149|FG002|Overall Study|Withdrawal by Subject|65
7312194|NCT00688688|11539147|FG000|Overall Study|Lost to Follow-up|14
7312195|NCT00688688|11539148|FG001|Overall Study|Lost to Follow-up|7
7312196|NCT00688688|11539149|FG002|Overall Study|Lost to Follow-up|7
7312197|NCT00688688|11539147|FG000|Overall Study|Protocol Violation|6
7312198|NCT00688688|11539148|FG001|Overall Study|Protocol Violation|9
7312199|NCT00688688|11539149|FG002|Overall Study|Protocol Violation|11
7312200|NCT00688688|11539147|FG000|Overall Study|Randomized but never received study drug|1
7312201|NCT00688688|11539148|FG001|Overall Study|Randomized but never received study drug|0
7312202|NCT00688688|11539149|FG002|Overall Study|Randomized but never received study drug|0
7312203|NCT00688688|11539147|FG000|Overall Study|Non-compliance with study procedures|5
7312204|NCT00688688|11539148|FG001|Overall Study|Non-compliance with study procedures|3
7312205|NCT00688688|11539149|FG002|Overall Study|Non-compliance with study procedures|4
7312206|NCT00688688|11539147|FG000|Overall Study|Taking exclusionary medications|1
7312207|NCT00688688|11539148|FG001|Overall Study|Taking exclusionary medications|0
7312208|NCT00688688|11539149|FG002|Overall Study|Taking exclusionary medications|0
7312209|NCT00688688|11539147|FG000|Overall Study|Site closure|0
7312210|NCT00688688|11539148|FG001|Overall Study|Site closure|1
7312211|NCT00688688|11539149|FG002|Overall Study|Site closure|0
7312212|NCT00688688|11539147|FG000|Overall Study|Violation of exclusion criterion|0
7312213|NCT00688688|11539148|FG001|Overall Study|Violation of exclusion criterion|1
7312214|NCT00688688|11539149|FG002|Overall Study|Violation of exclusion criterion|0
7312215|NCT00688701|11539160|FG000|Overall Study|Adverse Event|1
7312216|NCT00688701|11539161|FG001|Overall Study|Adverse Event|0
7312217|NCT00688701|11539162|FG002|Overall Study|Adverse Event|5
7312218|NCT00688701|11539163|FG003|Overall Study|Adverse Event|3
7312219|NCT00688701|11539160|FG000|Overall Study|Lack of Efficacy|0
7312220|NCT00688701|11539161|FG001|Overall Study|Lack of Efficacy|1
7312221|NCT00688701|11539162|FG002|Overall Study|Lack of Efficacy|0
7312222|NCT00688701|11539163|FG003|Overall Study|Lack of Efficacy|0
7312223|NCT00688701|11539160|FG000|Overall Study|Withdrawal by Subject|3
7312224|NCT00688701|11539161|FG001|Overall Study|Withdrawal by Subject|3
7312225|NCT00688701|11539162|FG002|Overall Study|Withdrawal by Subject|4
7312226|NCT00688701|11539163|FG003|Overall Study|Withdrawal by Subject|8
7312227|NCT00688701|11539160|FG000|Overall Study|Poor compliance to protocol|0
7312228|NCT00688701|11539161|FG001|Overall Study|Poor compliance to protocol|1
7312229|NCT00688701|11539162|FG002|Overall Study|Poor compliance to protocol|1
7312230|NCT00688701|11539163|FG003|Overall Study|Poor compliance to protocol|0
7312231|NCT00688740|11539176|FG000|Overall Study|Adverse Event|45
7312232|NCT00688740|11539177|FG001|Overall Study|Adverse Event|8
7312233|NCT00688740|11539176|FG000|Overall Study|Death|2
7312234|NCT00688740|11539177|FG001|Overall Study|Death|2
7312235|NCT00688740|11539176|FG000|Overall Study|Lost to Follow-up|0
7312236|NCT00688740|11539177|FG001|Overall Study|Lost to Follow-up|1
7312237|NCT00688740|11539176|FG000|Overall Study|Consent Withdrawn|17
7312238|NCT00688740|11539177|FG001|Overall Study|Consent Withdrawn|17
7312239|NCT00688740|11539176|FG000|Overall Study|Breast Cancer Relapse|1
7312240|NCT00688740|11539177|FG001|Overall Study|Breast Cancer Relapse|4
7312241|NCT00688740|11539176|FG000|Overall Study|Violation of Inclusion Criteria|1
7312242|NCT00688740|11539177|FG001|Overall Study|Violation of Inclusion Criteria|3
7312243|NCT00688753|11539183|FG000|Overall Study|Disease progression|55
7312244|NCT00688753|11539183|FG000|Overall Study|Missing|1
7312245|NCT00688753|11539183|FG000|Overall Study|Death|9
7312246|NCT00688753|11539183|FG000|Overall Study|Withdrawal by Subject|3
7312247|NCT00688753|11539183|FG000|Overall Study|Adverse Event|20
7312248|NCT00688753|11539183|FG000|Overall Study|Protocol Violation|1
7312249|NCT00688753|11539183|FG000|Overall Study|Lost to Follow-up|3
7312250|NCT00688844|11539187|FG000|Overall Study|Lost to Follow-up|10
7312251|NCT00688870|11539193|FG000|Infant Series|Parent or legal guardian request|4
7312252|NCT00688870|11539194|FG001|Infant Series|Parent or legal guardian request|0
7312253|NCT00688909|11539204|FG000|Overall Study|Adverse Event|28
7312254|NCT00688909|11539204|FG000|Overall Study|Patient withdrew consent|2
7312255|NCT00688909|11539204|FG000|Overall Study|Administrative problems|1
7312256|NCT00688909|11539204|FG000|Overall Study|Protocol Violation|2
7312257|NCT00689026|11539211|FG000|Overall Study|Withdrawal by Subject|13
7312258|NCT00689026|11539212|FG001|Overall Study|Withdrawal by Subject|6
7312259|NCT00689104|11539252|FG000|Overall Study|Eligibility criterion not met|5
7312260|NCT00689104|11539253|FG001|Overall Study|Eligibility criterion not met|8
7312261|NCT00689104|11539254|FG002|Overall Study|Eligibility criterion not met|0
7312262|NCT00689104|11539255|FG003|Overall Study|Eligibility criterion not met|4
7312263|NCT00689104|11539252|FG000|Overall Study|Adverse Event|13
7312264|NCT00689104|11539253|FG001|Overall Study|Adverse Event|25
7312265|NCT00689104|11539254|FG002|Overall Study|Adverse Event|16
7312266|NCT00689104|11539255|FG003|Overall Study|Adverse Event|24
7312267|NCT00689104|11539252|FG000|Overall Study|Lack of Efficacy|5
7312268|NCT00689104|11539253|FG001|Overall Study|Lack of Efficacy|6
7312269|NCT00689104|11539254|FG002|Overall Study|Lack of Efficacy|2
7312270|NCT00689104|11539255|FG003|Overall Study|Lack of Efficacy|3
7312271|NCT00689104|11539252|FG000|Overall Study|Withdrawal by Subject|12
7312272|NCT00689104|11539253|FG001|Overall Study|Withdrawal by Subject|11
7312273|NCT00689104|11539254|FG002|Overall Study|Withdrawal by Subject|18
7312274|NCT00689104|11539255|FG003|Overall Study|Withdrawal by Subject|11
7312275|NCT00689104|11539252|FG000|Overall Study|Lost to Follow-up|4
7312276|NCT00689104|11539253|FG001|Overall Study|Lost to Follow-up|3
7312277|NCT00689104|11539254|FG002|Overall Study|Lost to Follow-up|2
7312278|NCT00689104|11539255|FG003|Overall Study|Lost to Follow-up|5
7312279|NCT00689104|11539252|FG000|Overall Study|Protocol Violation|2
7312280|NCT00689104|11539253|FG001|Overall Study|Protocol Violation|3
7312281|NCT00689104|11539254|FG002|Overall Study|Protocol Violation|5
7312282|NCT00689104|11539255|FG003|Overall Study|Protocol Violation|3
7312283|NCT00689104|11539252|FG000|Overall Study|Randomized but never received study drug|2
7312284|NCT00689104|11539253|FG001|Overall Study|Randomized but never received study drug|1
7312285|NCT00689104|11539254|FG002|Overall Study|Randomized but never received study drug|1
7312286|NCT00689104|11539255|FG003|Overall Study|Randomized but never received study drug|0
7312287|NCT00689104|11539252|FG000|Overall Study|Physician Decision|1
7312288|NCT00689104|11539253|FG001|Overall Study|Physician Decision|0
7312289|NCT00689104|11539254|FG002|Overall Study|Physician Decision|0
7312290|NCT00689104|11539255|FG003|Overall Study|Physician Decision|0
7312291|NCT00689104|11539252|FG000|Overall Study|Non-compliance with study procedures|0
7312292|NCT00689104|11539253|FG001|Overall Study|Non-compliance with study procedures|0
7312293|NCT00689104|11539254|FG002|Overall Study|Non-compliance with study procedures|1
7312294|NCT00689104|11539255|FG003|Overall Study|Non-compliance with study procedures|0
7312295|NCT00689117|11539269|FG000|Overall Study|Adverse Event|6
7312296|NCT00689117|11539270|FG001|Overall Study|Adverse Event|0
7312297|NCT00689117|11539271|FG002|Overall Study|Adverse Event|5
7312298|NCT00689117|11539272|FG003|Overall Study|Adverse Event|0
7470492|NCT01931995|11772638|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
7312299|NCT00689117|11539269|FG000|Overall Study|Lost to Follow-up|26
7312300|NCT00689117|11539270|FG001|Overall Study|Lost to Follow-up|19
7312301|NCT00689117|11539271|FG002|Overall Study|Lost to Follow-up|17
7312302|NCT00689117|11539272|FG003|Overall Study|Lost to Follow-up|11
7312303|NCT00689117|11539269|FG000|Overall Study|Lack of Efficacy|1
7312304|NCT00689117|11539270|FG001|Overall Study|Lack of Efficacy|2
7312305|NCT00689117|11539271|FG002|Overall Study|Lack of Efficacy|2
7312306|NCT00689117|11539272|FG003|Overall Study|Lack of Efficacy|2
7312307|NCT00689117|11539269|FG000|Overall Study|Non-Compliance with Study Treatment|3
7312308|NCT00689117|11539270|FG001|Overall Study|Non-Compliance with Study Treatment|3
7312309|NCT00689117|11539271|FG002|Overall Study|Non-Compliance with Study Treatment|3
7312310|NCT00689117|11539272|FG003|Overall Study|Non-Compliance with Study Treatment|1
7312311|NCT00689117|11539269|FG000|Overall Study|Withdrawal by Subject|19
7312312|NCT00689117|11539270|FG001|Overall Study|Withdrawal by Subject|18
7312313|NCT00689117|11539271|FG002|Overall Study|Withdrawal by Subject|26
7312314|NCT00689117|11539272|FG003|Overall Study|Withdrawal by Subject|13
7312315|NCT00689117|11539269|FG000|Overall Study|Unable to Comply with Visit Schedule|0
7312316|NCT00689117|11539270|FG001|Overall Study|Unable to Comply with Visit Schedule|0
7312317|NCT00689117|11539271|FG002|Overall Study|Unable to Comply with Visit Schedule|1
7312318|NCT00689117|11539272|FG003|Overall Study|Unable to Comply with Visit Schedule|1
7312319|NCT00689117|11539269|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7312320|NCT00689117|11539270|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7312321|NCT00689117|11539271|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7312322|NCT00689117|11539272|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7312323|NCT00689117|11539269|FG000|Overall Study|Non-compliance with Treatment Regimen|0
7312324|NCT00689117|11539270|FG001|Overall Study|Non-compliance with Treatment Regimen|1
7312325|NCT00689117|11539271|FG002|Overall Study|Non-compliance with Treatment Regimen|0
7312326|NCT00689117|11539272|FG003|Overall Study|Non-compliance with Treatment Regimen|0
7312327|NCT00689117|11539269|FG000|Overall Study|Change/Discontinuation of Birth Control|1
7312328|NCT00689117|11539270|FG001|Overall Study|Change/Discontinuation of Birth Control|1
7312329|NCT00689117|11539271|FG002|Overall Study|Change/Discontinuation of Birth Control|1
7312330|NCT00689117|11539272|FG003|Overall Study|Change/Discontinuation of Birth Control|0
7312331|NCT00689117|11539269|FG000|Overall Study|Use of Prohibitive Medication|2
7312332|NCT00689117|11539270|FG001|Overall Study|Use of Prohibitive Medication|1
7312333|NCT00689117|11539271|FG002|Overall Study|Use of Prohibitive Medication|3
7312334|NCT00689117|11539272|FG003|Overall Study|Use of Prohibitive Medication|0
7312335|NCT00689117|11539269|FG000|Overall Study|Pregnancy|0
7312336|NCT00689117|11539270|FG001|Overall Study|Pregnancy|2
7312337|NCT00689117|11539271|FG002|Overall Study|Pregnancy|0
7312338|NCT00689117|11539272|FG003|Overall Study|Pregnancy|2
7312339|NCT00689117|11539269|FG000|Overall Study|Incarceration|2
7312340|NCT00689117|11539270|FG001|Overall Study|Incarceration|0
7312341|NCT00689117|11539271|FG002|Overall Study|Incarceration|0
7312342|NCT00689117|11539272|FG003|Overall Study|Incarceration|0
7312343|NCT00689117|11539269|FG000|Overall Study|Fear of Birth Defects|0
7312344|NCT00689117|11539270|FG001|Overall Study|Fear of Birth Defects|0
7312345|NCT00689117|11539271|FG002|Overall Study|Fear of Birth Defects|1
7312346|NCT00689117|11539272|FG003|Overall Study|Fear of Birth Defects|0
7312347|NCT00689117|11539269|FG000|Overall Study|Transportation|1
7312348|NCT00689117|11539270|FG001|Overall Study|Transportation|0
7312349|NCT00689117|11539271|FG002|Overall Study|Transportation|0
7312350|NCT00689117|11539272|FG003|Overall Study|Transportation|0
7312351|NCT00689117|11539269|FG000|Overall Study|Patient Withdrew from Study|0
7312352|NCT00689117|11539270|FG001|Overall Study|Patient Withdrew from Study|0
7312353|NCT00689117|11539271|FG002|Overall Study|Patient Withdrew from Study|0
7312354|NCT00689117|11539272|FG003|Overall Study|Patient Withdrew from Study|1
7312355|NCT00689117|11539269|FG000|Overall Study|Personal Reason|0
7312356|NCT00689117|11539270|FG001|Overall Study|Personal Reason|1
7312357|NCT00689117|11539271|FG002|Overall Study|Personal Reason|0
7312358|NCT00689117|11539272|FG003|Overall Study|Personal Reason|0
7312359|NCT00689117|11539269|FG000|Overall Study|Dispensing Error|0
7312360|NCT00689117|11539270|FG001|Overall Study|Dispensing Error|1
7312361|NCT00689117|11539271|FG002|Overall Study|Dispensing Error|0
7312362|NCT00689117|11539272|FG003|Overall Study|Dispensing Error|0
7312363|NCT00689221|11539284|FG000|Overall Study|Ongoing at cut-off date|39
7312364|NCT00689221|11539285|FG001|Overall Study|Ongoing at cut-off date|36
7312365|NCT00689273|11539305|FG000|Overall Study|Adverse Event|3
7312366|NCT00689273|11539306|FG001|Overall Study|Adverse Event|1
7312367|NCT00689273|11539305|FG000|Overall Study|Lack of Efficacy|3
7312368|NCT00689273|11539306|FG001|Overall Study|Lack of Efficacy|0
7312369|NCT00689273|11539305|FG000|Overall Study|Lost to Follow-up|0
7312370|NCT00689273|11539306|FG001|Overall Study|Lost to Follow-up|2
7312371|NCT00689273|11539305|FG000|Overall Study|Other|6
7312372|NCT00689273|11539306|FG001|Overall Study|Other|2
7312373|NCT00689273|11539305|FG000|Overall Study|Randomized but not Treated|1
7312374|NCT00689273|11539306|FG001|Overall Study|Randomized but not Treated|0
7312375|NCT00689299|11539315|FG000|Overall Study|Adverse Event|2
7312376|NCT00689299|11539316|FG001|Overall Study|Adverse Event|1
7312377|NCT00689299|11539317|FG002|Overall Study|Adverse Event|1
7312378|NCT00689299|11539315|FG000|Overall Study|Lost to Follow-up|0
7312379|NCT00689299|11539316|FG001|Overall Study|Lost to Follow-up|1
7312380|NCT00689299|11539317|FG002|Overall Study|Lost to Follow-up|1
7312381|NCT00689299|11539315|FG000|Overall Study|Withdrawal by Subject|4
7312382|NCT00689299|11539316|FG001|Overall Study|Withdrawal by Subject|1
7312383|NCT00689299|11539317|FG002|Overall Study|Withdrawal by Subject|3
7312384|NCT00689299|11539315|FG000|Overall Study|Protocol Violation|1
7312385|NCT00689299|11539316|FG001|Overall Study|Protocol Violation|0
7312386|NCT00689299|11539317|FG002|Overall Study|Protocol Violation|0
7312387|NCT00689338|11539325|FG000|Overall Study|Death|65
7312388|NCT00689338|11539325|FG000|Overall Study|Adverse Event|13
7312389|NCT00689338|11539325|FG000|Overall Study|Insufficient Clinical Response|1
7312390|NCT00689338|11539325|FG000|Overall Study|Lack of Efficacy|6
7312391|NCT00689338|11539325|FG000|Overall Study|Other|8
7312392|NCT00689338|11539325|FG000|Overall Study|Did not Meet Entrance Criteria|27
7312393|NCT00689338|11539325|FG000|Overall Study|Lost to Follow-up|5
7312394|NCT00689338|11539325|FG000|Overall Study|Withdrawal by Subject|3
7312395|NCT00689338|11539325|FG000|Overall Study|Protocol Violation|15
7312396|NCT00689351|11539331|FG000|Infant Series of Dosing|Parent/legal guardian request|5
7312397|NCT00689351|11539332|FG001|Infant Series of Dosing|Parent/legal guardian request|0
7312398|NCT00689351|11539331|FG000|Infant Series of Dosing|Adverse Event|1
7312399|NCT00689351|11539332|FG001|Infant Series of Dosing|Adverse Event|0
7312400|NCT00689351|11539331|FG000|Infant Series of Dosing|Lost to Follow-up|0
7312401|NCT00689351|11539332|FG001|Infant Series of Dosing|Lost to Follow-up|1
7312402|NCT00689351|11539331|FG000|After Infant Series|Parent/legal guardian request|1
7312403|NCT00689351|11539332|FG001|After Infant Series|Parent/legal guardian request|0
7312404|NCT00689390|11539344|FG000|Overall Study|Adverse Event|19
7312405|NCT00689390|11539345|FG001|Overall Study|Adverse Event|0
7312406|NCT00689390|11539344|FG000|Overall Study|Lost to Follow-up|179
7312407|NCT00689390|11539345|FG001|Overall Study|Lost to Follow-up|7
7312408|NCT00689390|11539344|FG000|Overall Study|Withdrawal by Subject|117
7312409|NCT00689390|11539345|FG001|Overall Study|Withdrawal by Subject|3
7312410|NCT00689390|11539344|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
7312411|NCT00689390|11539345|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
7312412|NCT00689390|11539344|FG000|Overall Study|Non-Compliance With Protocol|21
7312413|NCT00689390|11539345|FG001|Overall Study|Non-Compliance With Protocol|0
7312414|NCT00689390|11539344|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7312415|NCT00689390|11539345|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7312416|NCT00689390|11539344|FG000|Overall Study|Administrative|37
7312417|NCT00689390|11539345|FG001|Overall Study|Administrative|0
7312418|NCT00689481|11539358|FG000|Overall Study|Adverse Event|7
7312419|NCT00689481|11539359|FG001|Overall Study|Adverse Event|1
7312420|NCT00689481|11539358|FG000|Overall Study|Lost to Follow-up|4
7312421|NCT00689481|11539359|FG001|Overall Study|Lost to Follow-up|3
7312422|NCT00689481|11539358|FG000|Overall Study|Lack of Efficacy|4
7312423|NCT00689481|11539359|FG001|Overall Study|Lack of Efficacy|3
7312424|NCT00689481|11539358|FG000|Overall Study|Non-compliance with study treatment|1
7312425|NCT00689481|11539359|FG001|Overall Study|Non-compliance with study treatment|1
7312426|NCT00689481|11539358|FG000|Overall Study|Withdrawal by Subject|8
7312427|NCT00689481|11539359|FG001|Overall Study|Withdrawal by Subject|4
7312428|NCT00689481|11539358|FG000|Overall Study|Excluded medication started during study|0
7312429|NCT00689481|11539359|FG001|Overall Study|Excluded medication started during study|1
7312430|NCT00689481|11539358|FG000|Overall Study|Subject early term, left on vacation|0
7312431|NCT00689481|11539359|FG001|Overall Study|Subject early term, left on vacation|1
7312432|NCT00689611|11539376|FG000|Overall Study|Death|6
7312433|NCT00689611|11539377|FG001|Overall Study|Death|9
7312434|NCT00689611|11539376|FG000|Overall Study|Withdrawal by Subject|8
7312435|NCT00689611|11539377|FG001|Overall Study|Withdrawal by Subject|9
7312436|NCT00689611|11539376|FG000|Overall Study|Lost to Follow-up|27
7312437|NCT00689611|11539377|FG001|Overall Study|Lost to Follow-up|28
7312438|NCT00689728|11539386|FG000|Double-Blind Treatment|Adverse Event|1
7312439|NCT00689728|11539387|FG001|Double-Blind Treatment|Adverse Event|0
7312440|NCT00689728|11539388|FG002|Double-Blind Treatment|Adverse Event|0
7312441|NCT00689728|11539386|FG000|Double-Blind Treatment|Protocol Violation|0
7312442|NCT00689728|11539387|FG001|Double-Blind Treatment|Protocol Violation|0
7312443|NCT00689728|11539388|FG002|Double-Blind Treatment|Protocol Violation|1
7312444|NCT00689728|11539386|FG000|Double-Blind Treatment|Withdrawal by Subject|3
7312445|NCT00689728|11539387|FG001|Double-Blind Treatment|Withdrawal by Subject|3
7312446|NCT00689728|11539388|FG002|Double-Blind Treatment|Withdrawal by Subject|2
7312447|NCT00689728|11539386|FG000|Double-Blind Treatment|Lack of Efficacy|0
7312448|NCT00689728|11539387|FG001|Double-Blind Treatment|Lack of Efficacy|1
7312449|NCT00689728|11539388|FG002|Double-Blind Treatment|Lack of Efficacy|2
7312450|NCT00689728|11539386|FG000|Rescue|Adverse Event|0
7312451|NCT00689728|11539387|FG001|Rescue|Adverse Event|1
7312452|NCT00689728|11539388|FG002|Rescue|Adverse Event|0
7312453|NCT00689728|11539386|FG000|Rescue|Withdrawal by Subject|1
7312454|NCT00689728|11539387|FG001|Rescue|Withdrawal by Subject|1
7312455|NCT00689728|11539388|FG002|Rescue|Withdrawal by Subject|1
7312456|NCT00689728|11539386|FG000|Optional Follow-Up|Adverse Event|1
7312457|NCT00689728|11539387|FG001|Optional Follow-Up|Adverse Event|0
7312458|NCT00689728|11539388|FG002|Optional Follow-Up|Adverse Event|0
7312459|NCT00689728|11539386|FG000|Optional Follow-Up|Lack of Efficacy|0
7312460|NCT00689728|11539387|FG001|Optional Follow-Up|Lack of Efficacy|1
7312461|NCT00689728|11539388|FG002|Optional Follow-Up|Lack of Efficacy|1
7312462|NCT00689728|11539386|FG000|Optional Follow-Up|Lost to Follow-up|0
7312463|NCT00689728|11539387|FG001|Optional Follow-Up|Lost to Follow-up|1
7312464|NCT00689728|11539388|FG002|Optional Follow-Up|Lost to Follow-up|1
7312465|NCT00689728|11539386|FG000|Optional Follow-Up|Protocol Violation|0
7312466|NCT00689728|11539387|FG001|Optional Follow-Up|Protocol Violation|0
7312467|NCT00689728|11539388|FG002|Optional Follow-Up|Protocol Violation|1
7312468|NCT00689728|11539386|FG000|Optional Follow-Up|Withdrawal by Subject|2
7312469|NCT00689728|11539387|FG001|Optional Follow-Up|Withdrawal by Subject|4
7312470|NCT00689728|11539388|FG002|Optional Follow-Up|Withdrawal by Subject|3
7312471|NCT00689793|11539419|FG000|Overall Study|Lost to Follow-up|4
7312472|NCT00689793|11539420|FG001|Overall Study|Lost to Follow-up|5
7312473|NCT00689871|11539441|FG000|Overall Study|Lost to Follow-up|123
7312474|NCT00689871|11539442|FG001|Overall Study|Lost to Follow-up|13
7312475|NCT00689871|11539443|FG002|Overall Study|Lost to Follow-up|37
7312476|NCT00689871|11539444|FG003|Overall Study|Lost to Follow-up|1
7312477|NCT00689871|11539441|FG000|Overall Study|Explanted of All Study Devices|36
7312478|NCT00689871|11539442|FG001|Overall Study|Explanted of All Study Devices|25
7312479|NCT00689871|11539443|FG002|Overall Study|Explanted of All Study Devices|29
7312480|NCT00689871|11539444|FG003|Overall Study|Explanted of All Study Devices|3
7312481|NCT00689871|11539441|FG000|Overall Study|Withdrawal by Subject|13
7312482|NCT00689871|11539442|FG001|Overall Study|Withdrawal by Subject|3
7312483|NCT00689871|11539443|FG002|Overall Study|Withdrawal by Subject|4
7312484|NCT00689871|11539444|FG003|Overall Study|Withdrawal by Subject|1
7312485|NCT00689871|11539441|FG000|Overall Study|Death|1
7312486|NCT00689871|11539442|FG001|Overall Study|Death|10
7312487|NCT00689871|11539443|FG002|Overall Study|Death|2
7312488|NCT00689871|11539444|FG003|Overall Study|Death|2
7312489|NCT00689871|11539441|FG000|Overall Study|Physician Decision|2
7312490|NCT00689871|11539442|FG001|Overall Study|Physician Decision|1
7312491|NCT00689871|11539443|FG002|Overall Study|Physician Decision|1
7312492|NCT00689871|11539444|FG003|Overall Study|Physician Decision|0
7312493|NCT00689936|11539457|FG000|Active Treatment Phase|Adverse Event|68
7312494|NCT00689936|11539458|FG001|Active Treatment Phase|Adverse Event|71
7312495|NCT00689936|11539459|FG002|Active Treatment Phase|Adverse Event|76
7312496|NCT00689936|11539457|FG000|Active Treatment Phase|Disease Progression|273
7312497|NCT00689936|11539458|FG001|Active Treatment Phase|Disease Progression|362
7312498|NCT00689936|11539459|FG002|Active Treatment Phase|Disease Progression|339
7312499|NCT00689936|11539457|FG000|Active Treatment Phase|Withdrawal by Subject|16
7312500|NCT00689936|11539458|FG001|Active Treatment Phase|Withdrawal by Subject|16
7312501|NCT00689936|11539459|FG002|Active Treatment Phase|Withdrawal by Subject|21
7312502|NCT00689936|11539457|FG000|Active Treatment Phase|Death|60
7312503|NCT00689936|11539458|FG001|Active Treatment Phase|Death|28
7312504|NCT00689936|11539459|FG002|Active Treatment Phase|Death|37
7312505|NCT00689936|11539457|FG000|Active Treatment Phase|Lost to Follow-up|0
7312506|NCT00689936|11539458|FG001|Active Treatment Phase|Lost to Follow-up|2
7312507|NCT00689936|11539459|FG002|Active Treatment Phase|Lost to Follow-up|2
7312508|NCT00689936|11539457|FG000|Active Treatment Phase|Protocol Violation|2
7312509|NCT00689936|11539458|FG001|Active Treatment Phase|Protocol Violation|2
7312510|NCT00689936|11539459|FG002|Active Treatment Phase|Protocol Violation|4
7312511|NCT00689936|11539457|FG000|Active Treatment Phase|Study Close Out|64
7312512|NCT00689936|11539458|FG001|Active Treatment Phase|Study Close Out|26
7312513|NCT00689936|11539459|FG002|Active Treatment Phase|Study Close Out|21
7312514|NCT00689936|11539457|FG000|Active Treatment Phase|Miscellaneous|52
7312515|NCT00689936|11539458|FG001|Active Treatment Phase|Miscellaneous|34
7312516|NCT00689936|11539459|FG002|Active Treatment Phase|Miscellaneous|47
7312517|NCT00689936|11539457|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
7312518|NCT00689936|11539458|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
7312519|NCT00689936|11539459|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
7312520|NCT00690378|11539513|FG000|Overall Study|Adverse Event|1
7312521|NCT00690378|11539514|FG001|Overall Study|Adverse Event|0
7312522|NCT00690378|11539513|FG000|Overall Study|Withdrawal by Subject|2
7312523|NCT00690378|11539514|FG001|Overall Study|Withdrawal by Subject|0
7312524|NCT00690378|11539513|FG000|Overall Study|Protocol Violation|1
7312525|NCT00690378|11539514|FG001|Overall Study|Protocol Violation|0
7312526|NCT00690378|11539513|FG000|Overall Study|Lost to Follow-up|2
7312527|NCT00690378|11539514|FG001|Overall Study|Lost to Follow-up|3
7312528|NCT00690378|11539513|FG000|Overall Study|Did not meet inc/exc criteria|13
7312529|NCT00690378|11539514|FG001|Overall Study|Did not meet inc/exc criteria|11
7312530|NCT00690378|11539513|FG000|Overall Study|Social problem|1
7312531|NCT00690378|11539514|FG001|Overall Study|Social problem|0
7312532|NCT00690430|11539522|FG000|Core Phase|Abnormal Laboratory value|0
7312533|NCT00690430|11539523|FG001|Core Phase|Abnormal Laboratory value|1
7312534|NCT00690430|11539524|FG002|Core Phase|Abnormal Laboratory value|0
7312535|NCT00690430|11539522|FG000|Core Phase|Adverse Event|5
7312536|NCT00690430|11539523|FG001|Core Phase|Adverse Event|1
7312537|NCT00690430|11539524|FG002|Core Phase|Adverse Event|0
7312538|NCT00690430|11539522|FG000|Core Phase|Death|0
7312539|NCT00690430|11539523|FG001|Core Phase|Death|2
7312540|NCT00690430|11539524|FG002|Core Phase|Death|0
7312541|NCT00690430|11539522|FG000|Core Phase|Protocol Violation|1
7312542|NCT00690430|11539523|FG001|Core Phase|Protocol Violation|0
7312543|NCT00690430|11539524|FG002|Core Phase|Protocol Violation|0
7312544|NCT00690430|11539522|FG000|Core Phase|Withdrawal by Subject|3
7312545|NCT00690430|11539523|FG001|Core Phase|Withdrawal by Subject|3
7312546|NCT00690430|11539524|FG002|Core Phase|Withdrawal by Subject|0
7312547|NCT00690430|11539522|FG000|Core Phase|Subject no longer requires study drug|1
7312548|NCT00690430|11539523|FG001|Core Phase|Subject no longer requires study drug|0
7312549|NCT00690430|11539524|FG002|Core Phase|Subject no longer requires study drug|0
7312550|NCT00690430|11539522|FG000|Core Phase|Lack of Efficacy|8
7312551|NCT00690430|11539523|FG001|Core Phase|Lack of Efficacy|10
7312552|NCT00690430|11539524|FG002|Core Phase|Lack of Efficacy|0
7312553|NCT00690430|11539522|FG000|Core Phase|Administrative Problems|0
7312554|NCT00690430|11539523|FG001|Core Phase|Administrative Problems|1
7312555|NCT00690430|11539524|FG002|Core Phase|Administrative Problems|0
7312556|NCT00690430|11539522|FG000|Core Phase|Early Termination|0
7312557|NCT00690430|11539523|FG001|Core Phase|Early Termination|5
7312558|NCT00690430|11539524|FG002|Core Phase|Early Termination|0
7312559|NCT00690430|11539522|FG000|Extension Phase|Lack of Efficacy|3
7312560|NCT00690430|11539523|FG001|Extension Phase|Lack of Efficacy|1
7312561|NCT00690430|11539524|FG002|Extension Phase|Lack of Efficacy|4
7312562|NCT00690430|11539522|FG000|Extension Phase|Abnormal Lab Values|1
7312563|NCT00690430|11539523|FG001|Extension Phase|Abnormal Lab Values|0
7312564|NCT00690430|11539524|FG002|Extension Phase|Abnormal Lab Values|0
7312565|NCT00690430|11539522|FG000|Extension Phase|Abnormal test procedure results|1
7312566|NCT00690430|11539523|FG001|Extension Phase|Abnormal test procedure results|0
7312567|NCT00690430|11539524|FG002|Extension Phase|Abnormal test procedure results|0
7312568|NCT00690430|11539522|FG000|Extension Phase|Administrative Problems|0
7312569|NCT00690430|11539523|FG001|Extension Phase|Administrative Problems|1
7312570|NCT00690430|11539524|FG002|Extension Phase|Administrative Problems|1
7312571|NCT00690430|11539522|FG000|Extension Phase|Adverse Event|2
7312572|NCT00690430|11539523|FG001|Extension Phase|Adverse Event|1
7312573|NCT00690430|11539524|FG002|Extension Phase|Adverse Event|2
7312574|NCT00690430|11539522|FG000|Extension Phase|Death|1
7312575|NCT00690430|11539523|FG001|Extension Phase|Death|1
7312576|NCT00690430|11539524|FG002|Extension Phase|Death|1
7312577|NCT00690430|11539522|FG000|Extension Phase|Withdrawal by Subject|0
7312578|NCT00690430|11539523|FG001|Extension Phase|Withdrawal by Subject|0
7312579|NCT00690430|11539524|FG002|Extension Phase|Withdrawal by Subject|2
7312580|NCT00690430|11539522|FG000|Extension Phase|Early Termination|10
7312581|NCT00690430|11539523|FG001|Extension Phase|Early Termination|1
7312582|NCT00690430|11539524|FG002|Extension Phase|Early Termination|3
7391121|NCT01240811|11651435|FG002|Overall Study|Withdrawal by Subject|1
7391122|NCT01240863|11651447|FG000|Open-label Titration Period|Adverse Event|47
7391123|NCT01240863|11651448|FG001|Open-label Titration Period|Adverse Event|0
7391124|NCT01240863|11651449|FG002|Open-label Titration Period|Adverse Event|0
7391125|NCT01240863|11651447|FG000|Open-label Titration Period|Lack of Efficacy|19
7391126|NCT01240863|11651448|FG001|Open-label Titration Period|Lack of Efficacy|0
7391127|NCT01240863|11651449|FG002|Open-label Titration Period|Lack of Efficacy|0
7391128|NCT01240863|11651447|FG000|Open-label Titration Period|Withdrawal by Subject|9
7391129|NCT01240863|11651448|FG001|Open-label Titration Period|Withdrawal by Subject|0
7391130|NCT01240863|11651449|FG002|Open-label Titration Period|Withdrawal by Subject|0
7391131|NCT01240863|11651447|FG000|Open-label Titration Period|Protocol Violation|7
7391132|NCT01240863|11651448|FG001|Open-label Titration Period|Protocol Violation|0
7391133|NCT01240863|11651449|FG002|Open-label Titration Period|Protocol Violation|0
7391134|NCT01240863|11651447|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
7391135|NCT01240863|11651448|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
7391136|NCT01240863|11651449|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
7391137|NCT01240863|11651447|FG000|Open-label Titration Period|Noncompliance to study procedures|3
7391138|NCT01240863|11651448|FG001|Open-label Titration Period|Noncompliance to study procedures|0
7391139|NCT01240863|11651449|FG002|Open-label Titration Period|Noncompliance to study procedures|0
7391140|NCT01240863|11651447|FG000|Open-label Titration Period|Dropped out prior to dosing|2
7391141|NCT01240863|11651448|FG001|Open-label Titration Period|Dropped out prior to dosing|0
7391142|NCT01240863|11651449|FG002|Open-label Titration Period|Dropped out prior to dosing|0
7391143|NCT01240863|11651447|FG000|Open-label Titration Period|Other|7
7391144|NCT01240863|11651448|FG001|Open-label Titration Period|Other|0
7391145|NCT01240863|11651449|FG002|Open-label Titration Period|Other|0
7391146|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7391147|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
7391148|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
7391149|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7391150|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7391151|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7391152|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7391153|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
7391154|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
7391155|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7312583|NCT00690443|11539535|FG000|Overall Study|Adverse Event|1
7312584|NCT00690443|11539536|FG001|Overall Study|Adverse Event|2
7312585|NCT00690482|11539544|FG000|Overall Study|Adverse Event|2
7312586|NCT00690482|11539545|FG001|Overall Study|Adverse Event|1
7312587|NCT00690482|11539544|FG000|Overall Study|Incorrect enrolment|0
7312588|NCT00690482|11539545|FG001|Overall Study|Incorrect enrolment|1
7312589|NCT00690482|11539544|FG000|Overall Study|Study-specific discontinuation criteria|1
7312590|NCT00690482|11539545|FG001|Overall Study|Study-specific discontinuation criteria|0
7312591|NCT00690482|11539544|FG000|Overall Study|Intake of prohibited medicine|1
7312592|NCT00690482|11539545|FG001|Overall Study|Intake of prohibited medicine|0
7312593|NCT00690482|11539544|FG000|Overall Study|withdrew consent at rand.day|0
7312594|NCT00690482|11539545|FG001|Overall Study|withdrew consent at rand.day|1
7312595|NCT00690573|11539560|FG000|Overall Study|Lack of Efficacy|8
7312596|NCT00690573|11539560|FG000|Overall Study|Withdrawal by Subject|1
7312597|NCT00690612|11539564|FG000|Overall Study|Adverse Event|1
7312598|NCT00690612|11539564|FG000|Overall Study|Withdrawal by Subject|2
7312599|NCT00690755|11539575|FG000|Overall Study|Physician Decision|2
7312600|NCT00690755|11539576|FG001|Overall Study|Physician Decision|0
7312601|NCT00690755|11539577|FG002|Overall Study|Physician Decision|46
7312602|NCT00690755|11539578|FG003|Overall Study|Physician Decision|5
7312603|NCT00690755|11539579|FG004|Overall Study|Physician Decision|0
7312604|NCT00690755|11539580|FG005|Overall Study|Physician Decision|4
7312605|NCT00690755|11539581|FG006|Overall Study|Physician Decision|0
7312606|NCT00690794|11539599|FG000|Overall Study|Adverse Event|12
7312607|NCT00690794|11539600|FG001|Overall Study|Adverse Event|10
7312608|NCT00690794|11539599|FG000|Overall Study|Lost to Follow-up|1
7312609|NCT00690794|11539600|FG001|Overall Study|Lost to Follow-up|4
7312610|NCT00690794|11539599|FG000|Overall Study|Withdrawal by Subject|0
7312611|NCT00690794|11539600|FG001|Overall Study|Withdrawal by Subject|9
7312612|NCT00690794|11539599|FG000|Overall Study|Protocol Violation|6
7312613|NCT00690794|11539600|FG001|Overall Study|Protocol Violation|7
7312614|NCT00690794|11539599|FG000|Overall Study|Noncompliance|1
7312615|NCT00690794|11539600|FG001|Overall Study|Noncompliance|2
7391156|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7391157|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
7391158|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7391159|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
7391160|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
7391161|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
7391162|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7391163|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
7391164|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
7391165|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
7391166|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
7391167|NCT01240863|11651447|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7391168|NCT01240863|11651448|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
7391169|NCT01240863|11651449|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
7391170|NCT01240915|11651469|FG000|Overall Study|Adverse Event|0
7391171|NCT01240915|11651470|FG001|Overall Study|Adverse Event|0
7391172|NCT01240915|11651471|FG002|Overall Study|Adverse Event|0
7391173|NCT01240915|11651472|FG003|Overall Study|Adverse Event|1
7391174|NCT01240915|11651473|FG004|Overall Study|Adverse Event|0
7391175|NCT01240915|11651474|FG005|Overall Study|Adverse Event|2
7391176|NCT01240915|11651475|FG006|Overall Study|Adverse Event|0
7391177|NCT01240915|11651476|FG007|Overall Study|Adverse Event|0
7391178|NCT01240915|11651477|FG008|Overall Study|Adverse Event|1
7391179|NCT01240915|11651469|FG000|Overall Study|Lost to Follow-up|0
7391180|NCT01240915|11651470|FG001|Overall Study|Lost to Follow-up|0
7391181|NCT01240915|11651471|FG002|Overall Study|Lost to Follow-up|0
7391182|NCT01240915|11651472|FG003|Overall Study|Lost to Follow-up|0
7391183|NCT01240915|11651473|FG004|Overall Study|Lost to Follow-up|1
7391184|NCT01240915|11651474|FG005|Overall Study|Lost to Follow-up|1
7391185|NCT01240915|11651475|FG006|Overall Study|Lost to Follow-up|0
7391186|NCT01240915|11651476|FG007|Overall Study|Lost to Follow-up|1
7391187|NCT01240915|11651477|FG008|Overall Study|Lost to Follow-up|1
7391188|NCT01240915|11651469|FG000|Overall Study|Withdrawal by Subject|2
7391189|NCT01240915|11651470|FG001|Overall Study|Withdrawal by Subject|1
7391190|NCT01240915|11651471|FG002|Overall Study|Withdrawal by Subject|0
7391191|NCT01240915|11651472|FG003|Overall Study|Withdrawal by Subject|2
7391192|NCT01240915|11651473|FG004|Overall Study|Withdrawal by Subject|0
7391193|NCT01240915|11651474|FG005|Overall Study|Withdrawal by Subject|4
7391194|NCT01240915|11651475|FG006|Overall Study|Withdrawal by Subject|2
7391195|NCT01240915|11651476|FG007|Overall Study|Withdrawal by Subject|3
7391196|NCT01240915|11651477|FG008|Overall Study|Withdrawal by Subject|3
7391197|NCT01240915|11651469|FG000|Overall Study|Other|0
7391198|NCT01240915|11651470|FG001|Overall Study|Other|0
7391199|NCT01240915|11651471|FG002|Overall Study|Other|0
7470493|NCT01931995|11772639|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
7470494|NCT01931995|11772638|FG000|First Intervention (1 Day)|Physician Decision|1
7470495|NCT01931995|11772639|FG001|First Intervention (1 Day)|Physician Decision|1
7470496|NCT01931995|11772638|FG000|First Intervention (1 Day)|Lost to Follow-up|1
7312616|NCT00690794|11539599|FG000|Overall Study|Other not specified|1
7391200|NCT01240915|11651472|FG003|Overall Study|Other|0
7391201|NCT01240915|11651473|FG004|Overall Study|Other|2
7470497|NCT01931995|11772639|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7470498|NCT01932294|11772671|FG000|Overall Study|Death|43
7470499|NCT01932294|11772671|FG000|Overall Study|Lost to Follow-up|8
7470500|NCT01932294|11772671|FG000|Overall Study|VAD Implantation|20
7470501|NCT01932294|11772671|FG000|Overall Study|Heart Transplantation|16
7470502|NCT01932294|11772671|FG000|Overall Study|Transferred to other hospitals|12
7470503|NCT01932437|11772678|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7470504|NCT01932437|11772679|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7470505|NCT01932437|11772680|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7470506|NCT01932437|11772681|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7470507|NCT01932437|11772682|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
7470508|NCT01932437|11772683|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
7470509|NCT01932697|11772715|FG000|Overall Study|Received a different amount of tx|1
7470510|NCT01932697|11772716|FG001|Overall Study|Received a different amount of tx|0
7312617|NCT00690794|11539600|FG001|Overall Study|Other not specified|3
7312618|NCT00690820|11539608|FG000|Period 1|Withdrawal by Subject|0
7312619|NCT00690820|11539609|FG001|Period 1|Withdrawal by Subject|1
7312620|NCT00690898|11539619|FG000|SCREENING|Screen failure|18
7312621|NCT00690898|11539619|FG000|TREATMENT|Adverse Event|3
7312622|NCT00690898|11539619|FG000|TREATMENT|Lack of Efficacy|18
7312623|NCT00690898|11539619|FG000|TREATMENT|Withdrawal by Subject|4
7312624|NCT00690898|11539619|FG000|TREATMENT|Other (not otherwise specified)|1
7312625|NCT00691015|11539646|FG000|Overall Study|Refused further treatment|1
7312626|NCT00691028|11539653|FG000|Open-label Period|Adverse Event|0
7312627|NCT00691028|11539654|FG001|Open-label Period|Adverse Event|0
7312628|NCT00691028|11539655|FG002|Open-label Period|Adverse Event|0
7312629|NCT00691028|11539656|FG003|Open-label Period|Adverse Event|16
7312630|NCT00691028|11539653|FG000|Open-label Period|Withdrawal by Subject|0
7312631|NCT00691028|11539654|FG001|Open-label Period|Withdrawal by Subject|0
7312632|NCT00691028|11539655|FG002|Open-label Period|Withdrawal by Subject|0
7312633|NCT00691028|11539656|FG003|Open-label Period|Withdrawal by Subject|3
7312634|NCT00691028|11539653|FG000|Open-label Period|not come to a hospital|0
7312635|NCT00691028|11539654|FG001|Open-label Period|not come to a hospital|0
7312636|NCT00691028|11539655|FG002|Open-label Period|not come to a hospital|0
7312637|NCT00691028|11539656|FG003|Open-label Period|not come to a hospital|1
7312638|NCT00691028|11539653|FG000|Double-blind Period|Adverse Event|8
7312639|NCT00691028|11539654|FG001|Double-blind Period|Adverse Event|9
7312640|NCT00691028|11539655|FG002|Double-blind Period|Adverse Event|6
7312641|NCT00691028|11539656|FG003|Double-blind Period|Adverse Event|0
7312642|NCT00691028|11539653|FG000|Double-blind Period|Lack of Efficacy|4
7312643|NCT00691028|11539654|FG001|Double-blind Period|Lack of Efficacy|3
7312644|NCT00691028|11539655|FG002|Double-blind Period|Lack of Efficacy|2
7312645|NCT00691028|11539656|FG003|Double-blind Period|Lack of Efficacy|0
7312646|NCT00691028|11539653|FG000|Double-blind Period|Withdrawal by Subject|1
7312647|NCT00691028|11539654|FG001|Double-blind Period|Withdrawal by Subject|0
7312648|NCT00691028|11539655|FG002|Double-blind Period|Withdrawal by Subject|1
7312649|NCT00691028|11539656|FG003|Double-blind Period|Withdrawal by Subject|0
7312650|NCT00691028|11539653|FG000|Double-blind Period|not come to a hospital.|0
7312651|NCT00691028|11539654|FG001|Double-blind Period|not come to a hospital.|1
7391202|NCT01240915|11651474|FG005|Overall Study|Other|0
7391203|NCT01240915|11651475|FG006|Overall Study|Other|0
7391204|NCT01240915|11651476|FG007|Overall Study|Other|0
7391205|NCT01240915|11651477|FG008|Overall Study|Other|0
7391206|NCT01240915|11651469|FG000|Overall Study|Insufficient Clinical Response|0
7391207|NCT01240915|11651470|FG001|Overall Study|Insufficient Clinical Response|0
7391208|NCT01240915|11651471|FG002|Overall Study|Insufficient Clinical Response|0
7391209|NCT01240915|11651472|FG003|Overall Study|Insufficient Clinical Response|0
7391210|NCT01240915|11651473|FG004|Overall Study|Insufficient Clinical Response|1
7391211|NCT01240915|11651474|FG005|Overall Study|Insufficient Clinical Response|3
7391212|NCT01240915|11651475|FG006|Overall Study|Insufficient Clinical Response|6
7391213|NCT01240915|11651476|FG007|Overall Study|Insufficient Clinical Response|0
7391214|NCT01240915|11651477|FG008|Overall Study|Insufficient Clinical Response|3
7391215|NCT01241240|11651501|FG000|Overall Study|Adverse Event|5
7391216|NCT01241240|11651502|FG001|Overall Study|Adverse Event|4
7391217|NCT01241240|11651501|FG000|Overall Study|Lost to Follow-up|2
7391218|NCT01241240|11651502|FG001|Overall Study|Lost to Follow-up|4
7391219|NCT01241240|11651501|FG000|Overall Study|Personal Reasons|1
7391220|NCT01241240|11651502|FG001|Overall Study|Personal Reasons|1
7391221|NCT01241292|11651510|FG000|Overall Study|Administrative Reason by Sponsor|1
7391222|NCT01241292|11651511|FG001|Overall Study|Administrative Reason by Sponsor|0
7391223|NCT01241292|11651510|FG000|Overall Study|Disease Progression|2
7391224|NCT01241292|11651511|FG001|Overall Study|Disease Progression|0
7391225|NCT01241292|11651510|FG000|Overall Study|Study Drug Toxicity|0
7391226|NCT01241292|11651511|FG001|Overall Study|Study Drug Toxicity|1
7391227|NCT01241292|11651510|FG000|Overall Study|Participant Discontinued Treatment|0
7391228|NCT01241292|11651511|FG001|Overall Study|Participant Discontinued Treatment|2
7391229|NCT01241318|11651523|FG000|Overall Study|Woman: false pregnancies|27
7391230|NCT01241318|11651524|FG001|Overall Study|Woman: false pregnancies|15
7391231|NCT01241318|11651523|FG000|Overall Study|Woman: miscarriage/abortion|46
7391232|NCT01241318|11651524|FG001|Overall Study|Woman: miscarriage/abortion|38
7470511|NCT01932697|11772715|FG000|Overall Study|Ineligible|1
7552934|NCT03001557|11913497|FG000|Extension Phase|Administrative Reason|0
7312652|NCT00691028|11539655|FG002|Double-blind Period|not come to a hospital.|0
7312653|NCT00691028|11539656|FG003|Double-blind Period|not come to a hospital.|0
7312654|NCT00691054|11539668|FG000|Overall Study|Withdrawal by Subject|1
7312655|NCT00691093|11539674|FG000|Overall Study|Adverse Event|1
7312656|NCT00691093|11539674|FG000|Overall Study|Lost to Follow-up|1
7312657|NCT00691093|11539674|FG000|Overall Study|Lack of Efficacy|1
7312658|NCT00691093|11539674|FG000|Overall Study|Ongoing at Date of Cut-Off|4
7312659|NCT00691132|11539685|FG000|Overall Study|Adverse Event|2
7312660|NCT00691132|11539686|FG001|Overall Study|Adverse Event|3
7312661|NCT00691132|11539685|FG000|Overall Study|Withdrawal by Subject|10
7312662|NCT00691132|11539686|FG001|Overall Study|Withdrawal by Subject|10
7312663|NCT00691210|11539719|FG000|Overall Study|Progression of Disease|0
7312664|NCT00691210|11539720|FG001|Overall Study|Progression of Disease|0
7312665|NCT00691210|11539721|FG002|Overall Study|Progression of Disease|0
7312666|NCT00691210|11539722|FG003|Overall Study|Progression of Disease|2
7312667|NCT00691210|11539723|FG004|Overall Study|Progression of Disease|0
7312668|NCT00691210|11539724|FG005|Overall Study|Progression of Disease|0
7312669|NCT00691210|11539725|FG006|Overall Study|Progression of Disease|0
7312670|NCT00691210|11539726|FG007|Overall Study|Progression of Disease|0
7312671|NCT00691210|11539719|FG000|Overall Study|Lack of Efficacy|0
7312672|NCT00691210|11539720|FG001|Overall Study|Lack of Efficacy|0
7312673|NCT00691210|11539721|FG002|Overall Study|Lack of Efficacy|0
7312674|NCT00691210|11539722|FG003|Overall Study|Lack of Efficacy|1
7312675|NCT00691210|11539723|FG004|Overall Study|Lack of Efficacy|0
7312676|NCT00691210|11539724|FG005|Overall Study|Lack of Efficacy|1
7312677|NCT00691210|11539725|FG006|Overall Study|Lack of Efficacy|0
7312678|NCT00691210|11539726|FG007|Overall Study|Lack of Efficacy|0
7312679|NCT00691301|11539744|FG000|Overall Study|Adverse Event|10
7312680|NCT00691301|11539744|FG000|Overall Study|Death|2
7312681|NCT00691301|11539744|FG000|Overall Study|Lack of Efficacy|32
7312682|NCT00691301|11539744|FG000|Overall Study|Withdrawal by Subject|4
7312683|NCT00691301|11539744|FG000|Overall Study|Concurrent illness|2
7312684|NCT00691301|11539744|FG000|Overall Study|other reason|3
7312685|NCT00691301|11539744|FG000|Overall Study|Did not initiate study treatment|1
7312686|NCT00691483|11539765|FG000|Overall Study|Adverse Event|14
7312687|NCT00691483|11539766|FG001|Overall Study|Adverse Event|6
7312688|NCT00691483|11539765|FG000|Overall Study|Lost to Follow-up|17
7312689|NCT00691483|11539766|FG001|Overall Study|Lost to Follow-up|10
7312690|NCT00691483|11539765|FG000|Overall Study|Withdrawal by Subject|24
7312691|NCT00691483|11539766|FG001|Overall Study|Withdrawal by Subject|7
7312692|NCT00691483|11539765|FG000|Overall Study|Other known cause|6
7312693|NCT00691483|11539766|FG001|Overall Study|Other known cause|1
7312694|NCT00691483|11539765|FG000|Overall Study|Randomized by not treated|7
7312695|NCT00691483|11539766|FG001|Overall Study|Randomized by not treated|1
7312696|NCT00691704|11539790|FG000|Induction Therapy|Disease Progression|1
7312697|NCT00691704|11539790|FG000|Induction Therapy|Active Hepatitis|1
7312698|NCT00691704|11539790|FG000|Two Years of Maintenance Therapy|Disease Progression|8
7312699|NCT00691704|11539790|FG000|Two Years of Maintenance Therapy|Physician Decision|4
7312700|NCT00691704|11539790|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
7312701|NCT00691938|11539814|FG000|Overall Study|QTc prolongation|1
7312702|NCT00691938|11539815|FG001|Overall Study|QTc prolongation|0
7312703|NCT00691938|11539816|FG002|Overall Study|QTc prolongation|0
7312704|NCT00691938|11539817|FG003|Overall Study|QTc prolongation|0
7312705|NCT00691938|11539818|FG004|Overall Study|QTc prolongation|0
7312706|NCT00691938|11539819|FG005|Overall Study|QTc prolongation|0
7312707|NCT00691938|11539820|FG006|Overall Study|QTc prolongation|0
7312708|NCT00692237|11539863|FG000|Overall Study|Withdrawal by Subject|1
7312709|NCT00692237|11539864|FG001|Overall Study|Withdrawal by Subject|3
7312710|NCT00692237|11539863|FG000|Overall Study|Adverse Event|0
7312711|NCT00692237|11539864|FG001|Overall Study|Adverse Event|1
7312712|NCT00692406|11539892|FG000|Overall Study|PI dropped, bad data|57
7312713|NCT00692770|11539918|FG000|Overall Study|Protocol Violation|2
7312714|NCT00692770|11539919|FG001|Overall Study|Protocol Violation|7
7312715|NCT00692770|11539918|FG000|Overall Study|Withdrawal by Subject|97
7312716|NCT00692770|11539919|FG001|Overall Study|Withdrawal by Subject|36
7312717|NCT00692770|11539918|FG000|Overall Study|Adverse Event|136
7312718|NCT00692770|11539919|FG001|Overall Study|Adverse Event|41
7312719|NCT00692770|11539918|FG000|Overall Study|Death|10
7312720|NCT00692770|11539919|FG001|Overall Study|Death|5
7312721|NCT00692770|11539918|FG000|Overall Study|Lost to Follow-up|7
7312722|NCT00692770|11539919|FG001|Overall Study|Lost to Follow-up|3
7312723|NCT00692770|11539918|FG000|Overall Study|Non-compliant with study medication|11
7312724|NCT00692770|11539919|FG001|Overall Study|Non-compliant with study medication|5
7312725|NCT00692770|11539918|FG000|Overall Study|Progression by clinical judgment|2
7312726|NCT00692770|11539919|FG001|Overall Study|Progression by clinical judgment|3
7312727|NCT00692770|11539918|FG000|Overall Study|Physician decision not protocol driven|10
7312728|NCT00692770|11539919|FG001|Overall Study|Physician decision not protocol driven|14
7312729|NCT00692770|11539918|FG000|Overall Study|Disease progression, recurrence/relapse|170
7312730|NCT00692770|11539919|FG001|Overall Study|Disease progression, recurrence/relapse|279
7312731|NCT00692770|11539918|FG000|Overall Study|Protocol driven decision point|3
7312732|NCT00692770|11539919|FG001|Overall Study|Protocol driven decision point|7
7312733|NCT00692770|11539918|FG000|Overall Study|Completed all planned assessments|79
7312734|NCT00692770|11539919|FG001|Overall Study|Completed all planned assessments|101
7312735|NCT00692770|11539918|FG000|Overall Study|Radiological and clinical progression|8
7312736|NCT00692770|11539919|FG001|Overall Study|Radiological and clinical progression|8
7312737|NCT00692770|11539918|FG000|Overall Study|Clinical endpoint reached|16
7312738|NCT00692770|11539919|FG001|Overall Study|Clinical endpoint reached|43
7312739|NCT00692770|11539918|FG000|Overall Study|Study terminated by sponsor|2
7312740|NCT00692770|11539919|FG001|Overall Study|Study terminated by sponsor|2
7312741|NCT00692770|11539918|FG000|Overall Study|Randomized but not treated|3
7312742|NCT00692770|11539919|FG001|Overall Study|Randomized but not treated|4
7384346|NCT01193920|11641527|FG002|Overall Study|Unable to classify|0
7384347|NCT01193920|11641528|FG003|Overall Study|Unable to classify|1
7384348|NCT01193920|11641529|FG004|Overall Study|Unable to classify|0
7384349|NCT01193920|11641530|FG005|Overall Study|Unable to classify|0
7384350|NCT01193920|11641531|FG006|Overall Study|Unable to classify|0
7384351|NCT01193920|11641532|FG007|Overall Study|Unable to classify|1
7384352|NCT01193920|11641533|FG008|Overall Study|Unable to classify|0
7384353|NCT01193920|11641534|FG009|Overall Study|Unable to classify|0
7384354|NCT01194154|11641568|FG000|Overall Study|Adverse Event|12
7384355|NCT01194154|11641569|FG001|Overall Study|Adverse Event|7
7384356|NCT01194154|11641568|FG000|Overall Study|Lost to Follow-up|2
7384357|NCT01194154|11641569|FG001|Overall Study|Lost to Follow-up|3
7384358|NCT01194154|11641568|FG000|Overall Study|Protocol Violation|0
7384359|NCT01194154|11641569|FG001|Overall Study|Protocol Violation|1
7384360|NCT01194154|11641568|FG000|Overall Study|Withdrawal by Subject|5
7384361|NCT01194154|11641569|FG001|Overall Study|Withdrawal by Subject|6
7384362|NCT01194154|11641568|FG000|Overall Study|Blood pressure increase|5
7384363|NCT01194154|11641569|FG001|Overall Study|Blood pressure increase|3
7384364|NCT01194154|11641568|FG000|Overall Study|Hemoglobin decrease|0
7384365|NCT01194154|11641569|FG001|Overall Study|Hemoglobin decrease|1
7384366|NCT01194154|11641568|FG000|Overall Study|Hemoglobin increase|12
7384367|NCT01194154|11641569|FG001|Overall Study|Hemoglobin increase|3
7384368|NCT01194154|11641568|FG000|Overall Study|Skipping of CERA treatment at two visits|3
7384369|NCT01194154|11641569|FG001|Overall Study|Skipping of CERA treatment at two visits|0
7384370|NCT01194154|11641568|FG000|Overall Study|Treatment with prohibited medication|4
7384371|NCT01194154|11641569|FG001|Overall Study|Treatment with prohibited medication|5
7384372|NCT01194154|11641568|FG000|Overall Study|Other|4
7384373|NCT01194154|11641569|FG001|Overall Study|Other|0
7384374|NCT01194154|11641568|FG000|Overall Study|Did not receive study medication|2
7384375|NCT01194154|11641569|FG001|Overall Study|Did not receive study medication|4
7384376|NCT01194245|11641582|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
7384377|NCT01194245|11641583|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7384378|NCT01194245|11641584|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7384379|NCT01194245|11641585|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7384380|NCT01194245|11641586|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
7384381|NCT01194245|11641582|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
7384382|NCT01194245|11641583|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
7384383|NCT01194245|11641584|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
7384384|NCT01194245|11641585|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
7384385|NCT01194245|11641586|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
7384386|NCT01194245|11641582|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
7384387|NCT01194245|11641583|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
7384388|NCT01194245|11641584|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
7384389|NCT01194245|11641585|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
7384390|NCT01194245|11641586|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
7384391|NCT01194245|11641582|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
7384392|NCT01194245|11641583|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7384393|NCT01194245|11641584|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7384394|NCT01194245|11641585|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7384395|NCT01194245|11641586|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
7384396|NCT01194245|11641582|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7384397|NCT01194245|11641583|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7384398|NCT01194245|11641584|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7384399|NCT01194245|11641585|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7384400|NCT01194245|11641586|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7384401|NCT01194245|11641582|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7384402|NCT01194245|11641583|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7384403|NCT01194245|11641584|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7384404|NCT01194245|11641585|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7384405|NCT01194245|11641586|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
7384406|NCT01194258|11641595|FG000|Titration Period|Withdrawal by Subject|6
7384407|NCT01194258|11641596|FG001|Titration Period|Withdrawal by Subject|0
7384408|NCT01194258|11641597|FG002|Titration Period|Withdrawal by Subject|0
7384409|NCT01194258|11641598|FG003|Titration Period|Withdrawal by Subject|0
7384410|NCT01194258|11641599|FG004|Titration Period|Withdrawal by Subject|0
7384411|NCT01194258|11641595|FG000|Titration Period|Lost to Follow-up|2
7384412|NCT01194258|11641596|FG001|Titration Period|Lost to Follow-up|0
7312743|NCT00693225|11539963|FG000|Overall Study|Lost to Follow-up|1
7312744|NCT00693225|11539964|FG001|Overall Study|Lost to Follow-up|2
7312745|NCT00693225|11539963|FG000|Overall Study|Adverse Event|1
7312746|NCT00693225|11539964|FG001|Overall Study|Adverse Event|3
7312747|NCT00693420|11539976|FG000|Overall Study|Adverse Event|4
7312748|NCT00693420|11539977|FG001|Overall Study|Adverse Event|4
7312749|NCT00693420|11539976|FG000|Overall Study|Lost to Follow-up|0
7312750|NCT00693420|11539977|FG001|Overall Study|Lost to Follow-up|3
7312751|NCT00693420|11539976|FG000|Overall Study|Withdrawal by Subject|1
7312752|NCT00693420|11539977|FG001|Overall Study|Withdrawal by Subject|0
7312753|NCT00693420|11539976|FG000|Overall Study|Protocol Violation|0
7312754|NCT00693420|11539977|FG001|Overall Study|Protocol Violation|2
7312755|NCT00693420|11539976|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
7312756|NCT00693420|11539977|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
7312757|NCT00693420|11539976|FG000|Overall Study|Personal Reasons|1
7312758|NCT00693420|11539977|FG001|Overall Study|Personal Reasons|4
7312759|NCT00693472|11539987|FG000|Part 1|Adverse Event|1
7312760|NCT00693472|11539988|FG001|Part 1|Adverse Event|1
7312761|NCT00693472|11539989|FG002|Part 1|Adverse Event|0
7312762|NCT00693472|11539990|FG003|Part 1|Adverse Event|0
7312763|NCT00693472|11539987|FG000|Part 1|Lost to Follow-up|0
7312764|NCT00693472|11539988|FG001|Part 1|Lost to Follow-up|1
7312765|NCT00693472|11539989|FG002|Part 1|Lost to Follow-up|0
7312766|NCT00693472|11539990|FG003|Part 1|Lost to Follow-up|0
7312767|NCT00693472|11539987|FG000|Part 1|Withdrew - reason unrelated to treatment|5
7312768|NCT00693472|11539988|FG001|Part 1|Withdrew - reason unrelated to treatment|2
7312769|NCT00693472|11539989|FG002|Part 1|Withdrew - reason unrelated to treatment|0
7312770|NCT00693472|11539990|FG003|Part 1|Withdrew - reason unrelated to treatment|0
7312771|NCT00693472|11539987|FG000|Part 2|Adverse Event|0
7312772|NCT00693472|11539988|FG001|Part 2|Adverse Event|0
7312773|NCT00693472|11539989|FG002|Part 2|Adverse Event|1
7312774|NCT00693472|11539990|FG003|Part 2|Adverse Event|0
7312775|NCT00693472|11539987|FG000|Part 2|Withdrew - reason unrelated to treatment|0
7312776|NCT00693472|11539988|FG001|Part 2|Withdrew - reason unrelated to treatment|0
7312777|NCT00693472|11539989|FG002|Part 2|Withdrew - reason unrelated to treatment|1
7312778|NCT00693472|11539990|FG003|Part 2|Withdrew - reason unrelated to treatment|2
7312779|NCT00693693|11540035|FG000|Overall Study|Lost to Follow-up|1
7312780|NCT00693693|11540036|FG001|Overall Study|Lost to Follow-up|1
7312781|NCT00693693|11540037|FG002|Overall Study|Lost to Follow-up|2
7312782|NCT00693706|11540047|FG000|Overall Study|Protocol Violation|0
7312783|NCT00693706|11540048|FG001|Overall Study|Protocol Violation|1
7312784|NCT00693784|11540058|FG000|Overall Study|Lost to Follow-up|2
7312785|NCT00693784|11540058|FG000|Overall Study|Withdrawal by Subject|2
7312786|NCT00694096|11540084|FG000|Overall Study|Withdrawal by Subject|5
7312787|NCT00694109|11540088|FG000|Overall Study|Physician Decision|3
7312788|NCT00694109|11540088|FG000|Overall Study|Adverse Event|74
7312789|NCT00694109|11540088|FG000|Overall Study|Not consent of more 2 years of treatment|18
7312790|NCT00694109|11540088|FG000|Overall Study|Lack of Efficacy|2
7312791|NCT00694109|11540088|FG000|Overall Study|Withdrawal by Subject|13
7312792|NCT00694109|11540088|FG000|Overall Study|Pregnancy|1
7312793|NCT00694109|11540088|FG000|Overall Study|Enrolled but not treated|1
7312794|NCT00694109|11540088|FG000|Overall Study|Other|2
7312795|NCT00694109|11540088|FG000|Overall Study|Consented but no additional treatment|3
7312796|NCT00694122|11540093|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
7312797|NCT00694122|11540094|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
7312798|NCT00694122|11540093|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7312799|NCT00694122|11540094|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
7312800|NCT00694122|11540093|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
7312801|NCT00694122|11540094|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
7312802|NCT00694161|11540105|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
7312803|NCT00694161|11540105|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
7312804|NCT00694161|11540105|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
7312805|NCT00694304|11540109|FG000|Overall Study|Adverse Event|42
7312806|NCT00694304|11540109|FG000|Overall Study|Lack of Efficacy|35
7312807|NCT00694304|11540109|FG000|Overall Study|Non-compliance With Study Product|16
7312808|NCT00694304|11540109|FG000|Overall Study|Protocol Violation|6
7312809|NCT00694304|11540109|FG000|Overall Study|Withdrawal of Consent|61
7312810|NCT00694304|11540109|FG000|Overall Study|Lost to Follow-up|15
7312811|NCT00694304|11540109|FG000|Overall Study|Administrative or Other Reasons|32
7312812|NCT00694356|11540116|FG000|Overall Study|Adverse Event|1
7312813|NCT00694356|11540117|FG001|Overall Study|Adverse Event|0
7312814|NCT00694356|11540118|FG002|Overall Study|Adverse Event|0
7312815|NCT00694356|11540116|FG000|Overall Study|Progressive Disease|2
7312816|NCT00694356|11540117|FG001|Overall Study|Progressive Disease|6
7312817|NCT00694356|11540118|FG002|Overall Study|Progressive Disease|6
7312818|NCT00694551|11540133|FG000|Overall Study|Disease Progression|1
7312819|NCT00694551|11540134|FG001|Overall Study|Disease Progression|0
7312820|NCT00694551|11540135|FG002|Overall Study|Disease Progression|1
7312821|NCT00694707|11540157|FG000|Overall Study|Did Not Receive Treatment|0
7312822|NCT00694707|11540158|FG001|Overall Study|Did Not Receive Treatment|0
7312823|NCT00694707|11540159|FG002|Overall Study|Did Not Receive Treatment|1
7312824|NCT00694707|11540160|FG003|Overall Study|Did Not Receive Treatment|1
7312825|NCT00694707|11540161|FG004|Overall Study|Did Not Receive Treatment|1
7312826|NCT00694707|11540157|FG000|Overall Study|Adverse Event|22
7312827|NCT00694707|11540158|FG001|Overall Study|Adverse Event|14
7312828|NCT00694707|11540159|FG002|Overall Study|Adverse Event|8
7312829|NCT00694707|11540160|FG003|Overall Study|Adverse Event|12
7312830|NCT00694707|11540161|FG004|Overall Study|Adverse Event|13
7312831|NCT00694707|11540157|FG000|Overall Study|Insufficient Therapeutic Response|33
7312832|NCT00694707|11540158|FG001|Overall Study|Insufficient Therapeutic Response|18
7312833|NCT00694707|11540159|FG002|Overall Study|Insufficient Therapeutic Response|17
7312834|NCT00694707|11540160|FG003|Overall Study|Insufficient Therapeutic Response|15
7312835|NCT00694707|11540161|FG004|Overall Study|Insufficient Therapeutic Response|10
7312836|NCT00694707|11540157|FG000|Overall Study|Protocol Violation|1
7312837|NCT00694707|11540158|FG001|Overall Study|Protocol Violation|2
7312838|NCT00694707|11540159|FG002|Overall Study|Protocol Violation|1
7312839|NCT00694707|11540160|FG003|Overall Study|Protocol Violation|3
7312840|NCT00694707|11540161|FG004|Overall Study|Protocol Violation|1
7312841|NCT00694707|11540157|FG000|Overall Study|Withdrawal of Consent|14
7312842|NCT00694707|11540158|FG001|Overall Study|Withdrawal of Consent|18
7312843|NCT00694707|11540159|FG002|Overall Study|Withdrawal of Consent|22
7312844|NCT00694707|11540160|FG003|Overall Study|Withdrawal of Consent|16
7312845|NCT00694707|11540161|FG004|Overall Study|Withdrawal of Consent|15
7312846|NCT00694707|11540157|FG000|Overall Study|Lost to Follow-up|0
7312847|NCT00694707|11540158|FG001|Overall Study|Lost to Follow-up|1
7312848|NCT00694707|11540159|FG002|Overall Study|Lost to Follow-up|2
7312849|NCT00694707|11540160|FG003|Overall Study|Lost to Follow-up|0
7312850|NCT00694707|11540161|FG004|Overall Study|Lost to Follow-up|0
7312851|NCT00694707|11540157|FG000|Overall Study|Jeopardizing Parole Status|1
7312852|NCT00694707|11540158|FG001|Overall Study|Jeopardizing Parole Status|0
7312853|NCT00694707|11540159|FG002|Overall Study|Jeopardizing Parole Status|0
7312854|NCT00694707|11540160|FG003|Overall Study|Jeopardizing Parole Status|0
7312855|NCT00694707|11540161|FG004|Overall Study|Jeopardizing Parole Status|0
7312856|NCT00694707|11540157|FG000|Overall Study|Death in the Family|1
7312857|NCT00694707|11540158|FG001|Overall Study|Death in the Family|0
7312858|NCT00694707|11540159|FG002|Overall Study|Death in the Family|0
7312859|NCT00694707|11540160|FG003|Overall Study|Death in the Family|0
7312860|NCT00694707|11540161|FG004|Overall Study|Death in the Family|0
7312861|NCT00694707|11540157|FG000|Overall Study|Arrest by Police|0
7312862|NCT00694707|11540158|FG001|Overall Study|Arrest by Police|1
7312863|NCT00694707|11540159|FG002|Overall Study|Arrest by Police|0
7312864|NCT00694707|11540160|FG003|Overall Study|Arrest by Police|0
7312865|NCT00694707|11540161|FG004|Overall Study|Arrest by Police|0
7312866|NCT00694707|11540157|FG000|Overall Study|Administrative Reasons|0
7312867|NCT00694707|11540158|FG001|Overall Study|Administrative Reasons|1
7312868|NCT00694707|11540159|FG002|Overall Study|Administrative Reasons|0
7312869|NCT00694707|11540160|FG003|Overall Study|Administrative Reasons|2
7312870|NCT00694707|11540161|FG004|Overall Study|Administrative Reasons|0
7312871|NCT00694707|11540157|FG000|Overall Study|Notification of Past Head Injury|0
7312872|NCT00694707|11540158|FG001|Overall Study|Notification of Past Head Injury|0
7312873|NCT00694707|11540159|FG002|Overall Study|Notification of Past Head Injury|0
7312874|NCT00694707|11540160|FG003|Overall Study|Notification of Past Head Injury|1
7312875|NCT00694707|11540161|FG004|Overall Study|Notification of Past Head Injury|0
7312876|NCT00695019|11540176|FG000|Overall Study|Withdrawal by Subject|8
7312877|NCT00695019|11540177|FG001|Overall Study|Withdrawal by Subject|6
7312878|NCT00695019|11540178|FG002|Overall Study|Withdrawal by Subject|4
7312879|NCT00695019|11540176|FG000|Overall Study|Protocol Violation|1
7312880|NCT00695019|11540177|FG001|Overall Study|Protocol Violation|3
7312881|NCT00695019|11540178|FG002|Overall Study|Protocol Violation|1
7312882|NCT00695019|11540176|FG000|Overall Study|Lack of Efficacy|0
7312883|NCT00695019|11540177|FG001|Overall Study|Lack of Efficacy|0
7312884|NCT00695019|11540178|FG002|Overall Study|Lack of Efficacy|1
7312885|NCT00695019|11540176|FG000|Overall Study|Various|4
7312886|NCT00695019|11540177|FG001|Overall Study|Various|5
7312887|NCT00695019|11540178|FG002|Overall Study|Various|4
7312888|NCT00695110|11540195|FG000|Treatment Period 1|Adverse Event|1
7312889|NCT00695110|11540195|FG000|Treatment Period 1|Withdrawal by Subject|2
7312890|NCT00695110|11540195|FG000|Treatment Period 3|Withdrawal by Subject|1
7312891|NCT00695110|11540195|FG000|Treatment Period 4|Adverse Event|1
7312892|NCT00695136|11540202|FG000|Overall Study|Withdrawal by Subject|1
7312893|NCT00695136|11540202|FG000|Overall Study|unrelated adverse event|1
7312894|NCT00695318|11540226|FG000|Overall Study|Lost to Follow-up|1
7312895|NCT00695318|11540227|FG001|Overall Study|Lost to Follow-up|0
7312896|NCT00695318|11540226|FG000|Overall Study|Withdrawal by Subject|2
7312897|NCT00695318|11540227|FG001|Overall Study|Withdrawal by Subject|0
7312898|NCT00695318|11540226|FG000|Overall Study|Death|1
7312899|NCT00695318|11540227|FG001|Overall Study|Death|1
7312900|NCT00695318|11540226|FG000|Overall Study|Study Terminated|1
7312901|NCT00695318|11540227|FG001|Overall Study|Study Terminated|0
7312902|NCT00695396|11540241|FG000|Overall Study|Study Closed Prematurely|5
7312903|NCT00695396|11540242|FG001|Overall Study|Study Closed Prematurely|6
7312904|NCT00695396|11540243|FG002|Overall Study|Study Closed Prematurely|8
7312905|NCT00695396|11540241|FG000|Overall Study|Withdrawal by Subject|2
7312906|NCT00695396|11540242|FG001|Overall Study|Withdrawal by Subject|2
7312907|NCT00695396|11540243|FG002|Overall Study|Withdrawal by Subject|0
7312908|NCT00695565|11540277|FG000|Overall Study|Lost to Follow-up|4
7312909|NCT00695565|11540278|FG001|Overall Study|Lost to Follow-up|4
7312910|NCT00695565|11540277|FG000|Overall Study|Adverse Event|3
7312911|NCT00695565|11540278|FG001|Overall Study|Adverse Event|1
7312912|NCT00695565|11540277|FG000|Overall Study|Protocol Violation|3
7312913|NCT00695565|11540278|FG001|Overall Study|Protocol Violation|1
7312914|NCT00695565|11540277|FG000|Overall Study|Withdrawal by Subject|1
7312915|NCT00695565|11540278|FG001|Overall Study|Withdrawal by Subject|1
7312916|NCT00695565|11540277|FG000|Overall Study|Lack of Efficacy|1
7312917|NCT00695565|11540278|FG001|Overall Study|Lack of Efficacy|1
7312918|NCT00695565|11540277|FG000|Overall Study|Subject did not follow instructions|1
7312919|NCT00695565|11540278|FG001|Overall Study|Subject did not follow instructions|1
7312920|NCT00695669|11540297|FG000|Overall Study|Adverse Event|0
7312921|NCT00695669|11540298|FG001|Overall Study|Adverse Event|0
7312922|NCT00695669|11540299|FG002|Overall Study|Adverse Event|2
7312923|NCT00695669|11540300|FG003|Overall Study|Adverse Event|0
7312924|NCT00695669|11540297|FG000|Overall Study|Lost to Follow-up|4
7312925|NCT00695669|11540298|FG001|Overall Study|Lost to Follow-up|4
7312926|NCT00695669|11540299|FG002|Overall Study|Lost to Follow-up|1
7312927|NCT00695669|11540300|FG003|Overall Study|Lost to Follow-up|4
7312928|NCT00695786|11540317|FG000|Overall Study|Adverse Event|0
7312929|NCT00695786|11540318|FG001|Overall Study|Adverse Event|3
7312930|NCT00695786|11540319|FG002|Overall Study|Adverse Event|4
7312931|NCT00695786|11540320|FG003|Overall Study|Adverse Event|2
7312932|NCT00695786|11540317|FG000|Overall Study|Lost to Follow-up|0
7312933|NCT00695786|11540318|FG001|Overall Study|Lost to Follow-up|5
7312934|NCT00695786|11540319|FG002|Overall Study|Lost to Follow-up|1
7312935|NCT00695786|11540320|FG003|Overall Study|Lost to Follow-up|1
7312936|NCT00695786|11540317|FG000|Overall Study|Withdrawal by Subject|0
7312937|NCT00695786|11540318|FG001|Overall Study|Withdrawal by Subject|4
7391233|NCT01241318|11651523|FG000|Overall Study|Withdrawal by Subject|175
7391234|NCT01241318|11651524|FG001|Overall Study|Withdrawal by Subject|46
7391235|NCT01241318|11651523|FG000|Overall Study|Lost to Follow-up|740
7391236|NCT01241318|11651524|FG001|Overall Study|Lost to Follow-up|455
7391237|NCT01241318|11651523|FG000|Overall Study|Death|2
7391238|NCT01241318|11651524|FG001|Overall Study|Death|4
7391239|NCT01241318|11651523|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
7391240|NCT01241318|11651524|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
7391241|NCT01241318|11651523|FG000|Overall Study|Woman: Stillborn infant|129
7391242|NCT01241318|11651524|FG001|Overall Study|Woman: Stillborn infant|146
7391243|NCT01241448|11651570|FG000|Overall Study|Adverse Event|1
7391244|NCT01241448|11651571|FG001|Overall Study|Adverse Event|0
7391245|NCT01241448|11651572|FG002|Overall Study|Adverse Event|2
7391246|NCT01241448|11651573|FG003|Overall Study|Adverse Event|2
7391247|NCT01241448|11651570|FG000|Overall Study|Lost to Follow-up|2
7391248|NCT01241448|11651571|FG001|Overall Study|Lost to Follow-up|1
7391249|NCT01241448|11651572|FG002|Overall Study|Lost to Follow-up|1
7391250|NCT01241448|11651573|FG003|Overall Study|Lost to Follow-up|1
7391251|NCT01241448|11651570|FG000|Overall Study|Physician Decision|0
7391252|NCT01241448|11651571|FG001|Overall Study|Physician Decision|2
7391253|NCT01241448|11651572|FG002|Overall Study|Physician Decision|0
7391254|NCT01241448|11651573|FG003|Overall Study|Physician Decision|0
7391255|NCT01241448|11651570|FG000|Overall Study|Protocol Violation|10
7391256|NCT01241448|11651571|FG001|Overall Study|Protocol Violation|5
7391257|NCT01241448|11651572|FG002|Overall Study|Protocol Violation|3
7391258|NCT01241448|11651573|FG003|Overall Study|Protocol Violation|6
7391259|NCT01241448|11651570|FG000|Overall Study|Sponsor Decision|17
7391260|NCT01241448|11651571|FG001|Overall Study|Sponsor Decision|14
7391261|NCT01241448|11651572|FG002|Overall Study|Sponsor Decision|12
7391262|NCT01241448|11651573|FG003|Overall Study|Sponsor Decision|6
7391263|NCT01241448|11651570|FG000|Overall Study|Withdrawal by Subject|4
7391264|NCT01241448|11651571|FG001|Overall Study|Withdrawal by Subject|5
7391265|NCT01241448|11651572|FG002|Overall Study|Withdrawal by Subject|3
7391266|NCT01241448|11651573|FG003|Overall Study|Withdrawal by Subject|6
7391267|NCT01241448|11651570|FG000|Overall Study|Excluded due to data integrity issues|3
7391268|NCT01241448|11651571|FG001|Overall Study|Excluded due to data integrity issues|2
7391269|NCT01241448|11651572|FG002|Overall Study|Excluded due to data integrity issues|2
7391270|NCT01241448|11651573|FG003|Overall Study|Excluded due to data integrity issues|2
7391271|NCT01241461|11651586|FG000|Overall Study|Progressive Disease|3
7391272|NCT01241461|11651587|FG001|Overall Study|Progressive Disease|6
7391273|NCT01241552|11651615|FG000|Overall Study|Lack of Efficacy|1
7391274|NCT01241552|11651616|FG001|Overall Study|Lack of Efficacy|0
7391275|NCT01241552|11651617|FG002|Overall Study|Lack of Efficacy|0
7391276|NCT01241552|11651618|FG003|Overall Study|Lack of Efficacy|0
7391277|NCT01241552|11651615|FG000|Overall Study|Death|26
7391278|NCT01241552|11651616|FG001|Overall Study|Death|30
7391279|NCT01241552|11651617|FG002|Overall Study|Death|20
7391280|NCT01241552|11651618|FG003|Overall Study|Death|25
7391281|NCT01241552|11651615|FG000|Overall Study|Adverse Event|1
7391282|NCT01241552|11651616|FG001|Overall Study|Adverse Event|1
7391283|NCT01241552|11651617|FG002|Overall Study|Adverse Event|0
7391284|NCT01241552|11651618|FG003|Overall Study|Adverse Event|0
7391285|NCT01241552|11651615|FG000|Overall Study|Technical Problems|2
7312938|NCT00695786|11540319|FG002|Overall Study|Withdrawal by Subject|3
7312939|NCT00695786|11540320|FG003|Overall Study|Withdrawal by Subject|1
7312940|NCT00695786|11540317|FG000|Overall Study|Deemed Ineligible|1
7312941|NCT00695786|11540318|FG001|Overall Study|Deemed Ineligible|0
7312942|NCT00695786|11540319|FG002|Overall Study|Deemed Ineligible|0
7312943|NCT00695786|11540320|FG003|Overall Study|Deemed Ineligible|0
7312944|NCT00695786|11540317|FG000|Overall Study|Lack of Efficacy|0
7312945|NCT00695786|11540318|FG001|Overall Study|Lack of Efficacy|0
7312946|NCT00695786|11540319|FG002|Overall Study|Lack of Efficacy|0
7312947|NCT00695786|11540320|FG003|Overall Study|Lack of Efficacy|4
7312948|NCT00695864|11540330|FG000|Placebo|Withdrawal by Subject|1
7312949|NCT00695864|11540330|FG000|Placebo|Physician Decision|4
7312950|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
7312951|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
7312952|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7312953|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
7312954|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
7312955|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
7312956|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7312957|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
7312958|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
7312959|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
7312960|NCT00695903|11540338|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
7312961|NCT00695903|11540339|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
7312962|NCT00695903|11540338|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
7312963|NCT00695903|11540339|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
7312964|NCT00695903|11540338|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
7312965|NCT00695903|11540339|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
7312966|NCT00695903|11540338|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
7312967|NCT00695903|11540339|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
7312968|NCT00695955|11540345|FG000|Cohort 1|Adverse Event|26
7312969|NCT00695955|11540345|FG000|Cohort 1|Protocol Violation|2
7312970|NCT00695955|11540345|FG000|Cohort 1|Lost to Follow-up|30
7312971|NCT00695955|11540345|FG000|Cohort 1|Withdrawal by Subject|25
7312972|NCT00695955|11540345|FG000|Cohort 1|Lack of Efficacy|3
7312973|NCT00695955|11540345|FG000|Cohort 1|Other|16
7312974|NCT00695955|11540345|FG000|Cohort 2|Adverse Event|24
7312975|NCT00695955|11540345|FG000|Cohort 2|Protocol Violation|5
7312976|NCT00695955|11540345|FG000|Cohort 2|Lost to Follow-up|38
7312977|NCT00695955|11540345|FG000|Cohort 2|Withdrawal by Subject|28
7312978|NCT00695955|11540345|FG000|Cohort 2|Lack of Efficacy|4
7312979|NCT00695955|11540345|FG000|Cohort 2|Other|5
7312980|NCT00696020|11540355|FG000|Overall Study|Adverse Event|3
7312981|NCT00696020|11540356|FG001|Overall Study|Adverse Event|1
7312982|NCT00696020|11540357|FG002|Overall Study|Adverse Event|2
7312983|NCT00696020|11540358|FG003|Overall Study|Adverse Event|1
7312984|NCT00696020|11540355|FG000|Overall Study|Lack of Efficacy|1
7312985|NCT00696020|11540356|FG001|Overall Study|Lack of Efficacy|0
7312986|NCT00696020|11540357|FG002|Overall Study|Lack of Efficacy|0
7312987|NCT00696020|11540358|FG003|Overall Study|Lack of Efficacy|0
7312988|NCT00696020|11540355|FG000|Overall Study|Protocol Violation|0
7312989|NCT00696020|11540356|FG001|Overall Study|Protocol Violation|0
7312990|NCT00696020|11540357|FG002|Overall Study|Protocol Violation|0
7312991|NCT00696020|11540358|FG003|Overall Study|Protocol Violation|1
7312992|NCT00696020|11540355|FG000|Overall Study|Withdrawal by Subject|0
7312993|NCT00696020|11540356|FG001|Overall Study|Withdrawal by Subject|1
7312994|NCT00696020|11540357|FG002|Overall Study|Withdrawal by Subject|0
7312995|NCT00696020|11540358|FG003|Overall Study|Withdrawal by Subject|1
7312996|NCT00696020|11540355|FG000|Overall Study|Other not stated above|0
7312997|NCT00696020|11540356|FG001|Overall Study|Other not stated above|0
7312998|NCT00696020|11540357|FG002|Overall Study|Other not stated above|1
7312999|NCT00696020|11540358|FG003|Overall Study|Other not stated above|1
7313000|NCT00696072|11540372|FG000|Overall Study|continuing active treatment|10
7313001|NCT00696072|11540373|FG001|Overall Study|continuing active treatment|13
7313002|NCT00696072|11540372|FG000|Overall Study|Adverse Event|10
7313003|NCT00696072|11540373|FG001|Overall Study|Adverse Event|6
7313004|NCT00696072|11540372|FG000|Overall Study|Patient Request|3
7313005|NCT00696072|11540373|FG001|Overall Study|Patient Request|7
7313006|NCT00696072|11540372|FG000|Overall Study|Investigator Request|1
7313007|NCT00696072|11540373|FG001|Overall Study|Investigator Request|4
7313008|NCT00696072|11540372|FG000|Overall Study|Sponsor Request|0
7313009|NCT00696072|11540373|FG001|Overall Study|Sponsor Request|1
7313010|NCT00696072|11540372|FG000|Overall Study|Disease Progression|32
7313011|NCT00696072|11540373|FG001|Overall Study|Disease Progression|30
7313012|NCT00696072|11540372|FG000|Overall Study|Non-specified|1
7313013|NCT00696072|11540373|FG001|Overall Study|Non-specified|2
7313014|NCT00696137|11540380|FG000|Overall Study|Withdrawal by Subject|2
7313015|NCT00696241|11540389|FG000|Overall Study|Adverse Event|11
7313016|NCT00696241|11540390|FG001|Overall Study|Adverse Event|3
7313017|NCT00696241|11540391|FG002|Overall Study|Adverse Event|6
7313018|NCT00696241|11540392|FG003|Overall Study|Adverse Event|4
7313019|NCT00696241|11540393|FG004|Overall Study|Adverse Event|5
7313020|NCT00696241|11540389|FG000|Overall Study|Protocol Violation|1
7313021|NCT00696241|11540390|FG001|Overall Study|Protocol Violation|1
7313022|NCT00696241|11540391|FG002|Overall Study|Protocol Violation|2
7313023|NCT00696241|11540392|FG003|Overall Study|Protocol Violation|0
7313024|NCT00696241|11540393|FG004|Overall Study|Protocol Violation|3
7313025|NCT00696241|11540389|FG000|Overall Study|Lost to Follow-up|1
7313026|NCT00696241|11540390|FG001|Overall Study|Lost to Follow-up|4
7313027|NCT00696241|11540391|FG002|Overall Study|Lost to Follow-up|1
7313028|NCT00696241|11540392|FG003|Overall Study|Lost to Follow-up|2
7313029|NCT00696241|11540393|FG004|Overall Study|Lost to Follow-up|0
7313030|NCT00696241|11540389|FG000|Overall Study|Withdrawal by Subject|4
7313031|NCT00696241|11540390|FG001|Overall Study|Withdrawal by Subject|8
7313032|NCT00696241|11540391|FG002|Overall Study|Withdrawal by Subject|6
7313033|NCT00696241|11540392|FG003|Overall Study|Withdrawal by Subject|1
7313034|NCT00696241|11540393|FG004|Overall Study|Withdrawal by Subject|0
7313035|NCT00696241|11540389|FG000|Overall Study|Lack of Efficacy|1
7313036|NCT00696241|11540390|FG001|Overall Study|Lack of Efficacy|5
7313037|NCT00696241|11540391|FG002|Overall Study|Lack of Efficacy|4
7313038|NCT00696241|11540392|FG003|Overall Study|Lack of Efficacy|5
7313039|NCT00696241|11540393|FG004|Overall Study|Lack of Efficacy|3
7313040|NCT00696241|11540389|FG000|Overall Study|Other|6
7313041|NCT00696241|11540390|FG001|Overall Study|Other|1
7313042|NCT00696241|11540391|FG002|Overall Study|Other|5
7313043|NCT00696241|11540392|FG003|Overall Study|Other|2
7313044|NCT00696241|11540393|FG004|Overall Study|Other|1
7313045|NCT00696384|11540410|FG000|Open Label Phase|Adverse Event|27
7313046|NCT00696384|11540411|FG001|Open Label Phase|Adverse Event|0
7313047|NCT00696384|11540412|FG002|Open Label Phase|Adverse Event|0
7313048|NCT00696384|11540410|FG000|Open Label Phase|Protocol Violation|18
7313049|NCT00696384|11540411|FG001|Open Label Phase|Protocol Violation|0
7313050|NCT00696384|11540412|FG002|Open Label Phase|Protocol Violation|0
7313051|NCT00696384|11540410|FG000|Open Label Phase|Lost to Follow-up|24
7313052|NCT00696384|11540411|FG001|Open Label Phase|Lost to Follow-up|0
7313053|NCT00696384|11540412|FG002|Open Label Phase|Lost to Follow-up|0
7313054|NCT00696384|11540410|FG000|Open Label Phase|Withdrawal by Subject|37
7313055|NCT00696384|11540411|FG001|Open Label Phase|Withdrawal by Subject|0
7313056|NCT00696384|11540412|FG002|Open Label Phase|Withdrawal by Subject|0
7313057|NCT00696384|11540410|FG000|Open Label Phase|Other|6
7313058|NCT00696384|11540411|FG001|Open Label Phase|Other|0
7313059|NCT00696384|11540412|FG002|Open Label Phase|Other|0
7313060|NCT00696384|11540410|FG000|Open Label Phase|Lack of Efficacy|3
7313061|NCT00696384|11540411|FG001|Open Label Phase|Lack of Efficacy|0
7313062|NCT00696384|11540412|FG002|Open Label Phase|Lack of Efficacy|0
7313063|NCT00696384|11540410|FG000|Open Label Phase|Physician Decision|4
7313064|NCT00696384|11540411|FG001|Open Label Phase|Physician Decision|0
7313065|NCT00696384|11540412|FG002|Open Label Phase|Physician Decision|0
7313066|NCT00696384|11540410|FG000|Double Blind Phase|Adverse Event|0
7313067|NCT00696384|11540411|FG001|Double Blind Phase|Adverse Event|2
7313068|NCT00696384|11540412|FG002|Double Blind Phase|Adverse Event|2
7313069|NCT00696384|11540410|FG000|Double Blind Phase|Lost to Follow-up|0
7313070|NCT00696384|11540411|FG001|Double Blind Phase|Lost to Follow-up|2
7313071|NCT00696384|11540412|FG002|Double Blind Phase|Lost to Follow-up|1
7313072|NCT00696384|11540410|FG000|Double Blind Phase|Withdrawal by Subject|0
7313073|NCT00696384|11540411|FG001|Double Blind Phase|Withdrawal by Subject|4
7313074|NCT00696384|11540412|FG002|Double Blind Phase|Withdrawal by Subject|3
7313075|NCT00696384|11540410|FG000|Double Blind Phase|Lack of Efficacy|0
7313076|NCT00696384|11540411|FG001|Double Blind Phase|Lack of Efficacy|1
7313077|NCT00696384|11540412|FG002|Double Blind Phase|Lack of Efficacy|0
7313078|NCT00696384|11540410|FG000|Double Blind Phase|Physician Decision|0
7313079|NCT00696384|11540411|FG001|Double Blind Phase|Physician Decision|2
7313080|NCT00696384|11540412|FG002|Double Blind Phase|Physician Decision|0
7313081|NCT00696410|11540423|FG000|Overall Study|Lost to Follow-up|2
7313082|NCT00696410|11540424|FG001|Overall Study|Lost to Follow-up|0
7313083|NCT00696410|11540423|FG000|Overall Study|Withdrawal by Subject|8
7313084|NCT00696410|11540424|FG001|Overall Study|Withdrawal by Subject|0
7313085|NCT00696410|11540423|FG000|Overall Study|Physician Decision|3
7313086|NCT00696410|11540424|FG001|Overall Study|Physician Decision|0
7313087|NCT00696423|11540437|FG000|Overall Study|Lost to Follow-up|0
7313088|NCT00696423|11540438|FG001|Overall Study|Lost to Follow-up|5
7313089|NCT00696436|11540449|FG000|Overall Study|Adverse Event|7
7313090|NCT00696436|11540450|FG001|Overall Study|Adverse Event|9
7313091|NCT00696436|11540451|FG002|Overall Study|Adverse Event|8
7313092|NCT00696436|11540452|FG003|Overall Study|Adverse Event|6
7313093|NCT00696436|11540453|FG004|Overall Study|Adverse Event|4
7313094|NCT00696436|11540449|FG000|Overall Study|Protocol Violation|3
7313095|NCT00696436|11540450|FG001|Overall Study|Protocol Violation|2
7313096|NCT00696436|11540451|FG002|Overall Study|Protocol Violation|2
7313097|NCT00696436|11540452|FG003|Overall Study|Protocol Violation|0
7313098|NCT00696436|11540453|FG004|Overall Study|Protocol Violation|1
7313099|NCT00696436|11540449|FG000|Overall Study|Lost to Follow-up|1
7313100|NCT00696436|11540450|FG001|Overall Study|Lost to Follow-up|6
7313101|NCT00696436|11540451|FG002|Overall Study|Lost to Follow-up|2
7313102|NCT00696436|11540452|FG003|Overall Study|Lost to Follow-up|4
7313103|NCT00696436|11540453|FG004|Overall Study|Lost to Follow-up|3
7313104|NCT00696436|11540449|FG000|Overall Study|Withdrawal by Subject|4
7313105|NCT00696436|11540450|FG001|Overall Study|Withdrawal by Subject|11
7313106|NCT00696436|11540451|FG002|Overall Study|Withdrawal by Subject|5
7313107|NCT00696436|11540452|FG003|Overall Study|Withdrawal by Subject|7
7313108|NCT00696436|11540453|FG004|Overall Study|Withdrawal by Subject|1
7313109|NCT00696436|11540449|FG000|Overall Study|Lack of Efficacy|3
7313110|NCT00696436|11540450|FG001|Overall Study|Lack of Efficacy|1
7313111|NCT00696436|11540451|FG002|Overall Study|Lack of Efficacy|5
7313112|NCT00696436|11540452|FG003|Overall Study|Lack of Efficacy|2
7313113|NCT00696436|11540453|FG004|Overall Study|Lack of Efficacy|4
7313114|NCT00696436|11540449|FG000|Overall Study|Participant Unavailability|2
7313115|NCT00696436|11540450|FG001|Overall Study|Participant Unavailability|0
7313116|NCT00696436|11540451|FG002|Overall Study|Participant Unavailability|2
7313117|NCT00696436|11540452|FG003|Overall Study|Participant Unavailability|1
7313118|NCT00696436|11540453|FG004|Overall Study|Participant Unavailability|0
7313119|NCT00696436|11540449|FG000|Overall Study|Administrative Error|2
7313120|NCT00696436|11540450|FG001|Overall Study|Administrative Error|0
7313121|NCT00696436|11540451|FG002|Overall Study|Administrative Error|2
7313122|NCT00696436|11540452|FG003|Overall Study|Administrative Error|0
7313123|NCT00696436|11540453|FG004|Overall Study|Administrative Error|0
7313124|NCT00696436|11540449|FG000|Overall Study|Participant Non-compliance|0
7313125|NCT00696436|11540450|FG001|Overall Study|Participant Non-compliance|0
7313126|NCT00696436|11540451|FG002|Overall Study|Participant Non-compliance|1
7313127|NCT00696436|11540452|FG003|Overall Study|Participant Non-compliance|2
7313128|NCT00696436|11540453|FG004|Overall Study|Participant Non-compliance|0
7313129|NCT00696436|11540449|FG000|Overall Study|Administrative Decision|1
7313130|NCT00696436|11540450|FG001|Overall Study|Administrative Decision|0
7313131|NCT00696436|11540451|FG002|Overall Study|Administrative Decision|0
7313132|NCT00696436|11540452|FG003|Overall Study|Administrative Decision|0
7313133|NCT00696436|11540453|FG004|Overall Study|Administrative Decision|0
7313134|NCT00696436|11540449|FG000|Overall Study|Missing|0
7313135|NCT00696436|11540450|FG001|Overall Study|Missing|1
7313136|NCT00696436|11540451|FG002|Overall Study|Missing|1
7313137|NCT00696436|11540452|FG003|Overall Study|Missing|0
7313138|NCT00696436|11540453|FG004|Overall Study|Missing|0
7313139|NCT00696657|11540508|FG000|Overall Study|Protocol Violation|0
7313140|NCT00696657|11540509|FG001|Overall Study|Protocol Violation|0
7313141|NCT00696657|11540510|FG002|Overall Study|Protocol Violation|0
7313142|NCT00696657|11540511|FG003|Overall Study|Protocol Violation|0
7313143|NCT00696657|11540512|FG004|Overall Study|Protocol Violation|0
7313144|NCT00696657|11540513|FG005|Overall Study|Protocol Violation|1
7313145|NCT00696657|11540514|FG006|Overall Study|Protocol Violation|0
7313146|NCT00696657|11540515|FG007|Overall Study|Protocol Violation|0
7313147|NCT00696657|11540516|FG008|Overall Study|Protocol Violation|1
7313148|NCT00696657|11540508|FG000|Overall Study|Lack of Efficacy|0
7313149|NCT00696657|11540509|FG001|Overall Study|Lack of Efficacy|1
7313150|NCT00696657|11540510|FG002|Overall Study|Lack of Efficacy|0
7313151|NCT00696657|11540511|FG003|Overall Study|Lack of Efficacy|0
7313152|NCT00696657|11540512|FG004|Overall Study|Lack of Efficacy|0
7313153|NCT00696657|11540513|FG005|Overall Study|Lack of Efficacy|0
7313154|NCT00696657|11540514|FG006|Overall Study|Lack of Efficacy|0
7313155|NCT00696657|11540515|FG007|Overall Study|Lack of Efficacy|0
7313156|NCT00696657|11540516|FG008|Overall Study|Lack of Efficacy|0
7313157|NCT00696657|11540508|FG000|Overall Study|Withdrawal criteria|1
7313158|NCT00696657|11540509|FG001|Overall Study|Withdrawal criteria|3
7313159|NCT00696657|11540510|FG002|Overall Study|Withdrawal criteria|2
7313160|NCT00696657|11540511|FG003|Overall Study|Withdrawal criteria|2
7313161|NCT00696657|11540512|FG004|Overall Study|Withdrawal criteria|0
7313162|NCT00696657|11540513|FG005|Overall Study|Withdrawal criteria|0
7313163|NCT00696657|11540514|FG006|Overall Study|Withdrawal criteria|1
7313164|NCT00696657|11540515|FG007|Overall Study|Withdrawal criteria|1
7313165|NCT00696657|11540516|FG008|Overall Study|Withdrawal criteria|2
7313166|NCT00696657|11540508|FG000|Overall Study|Unclassified|0
7313167|NCT00696657|11540509|FG001|Overall Study|Unclassified|1
7391286|NCT01241552|11651616|FG001|Overall Study|Technical Problems|0
7391287|NCT01241552|11651617|FG002|Overall Study|Technical Problems|2
7391288|NCT01241552|11651618|FG003|Overall Study|Technical Problems|2
7391289|NCT01241552|11651615|FG000|Overall Study|Progressive Disease|0
7391290|NCT01241552|11651616|FG001|Overall Study|Progressive Disease|0
7391291|NCT01241552|11651617|FG002|Overall Study|Progressive Disease|1
7391292|NCT01241552|11651618|FG003|Overall Study|Progressive Disease|2
7391293|NCT01241552|11651615|FG000|Overall Study|Protocol Violation|0
7391294|NCT01241552|11651616|FG001|Overall Study|Protocol Violation|2
7391295|NCT01241552|11651617|FG002|Overall Study|Protocol Violation|6
7391296|NCT01241552|11651618|FG003|Overall Study|Protocol Violation|1
7391297|NCT01241552|11651615|FG000|Overall Study|Withdrawal by Subject|7
7391298|NCT01241552|11651616|FG001|Overall Study|Withdrawal by Subject|15
7391299|NCT01241552|11651617|FG002|Overall Study|Withdrawal by Subject|14
7391300|NCT01241552|11651618|FG003|Overall Study|Withdrawal by Subject|15
7391301|NCT01241552|11651615|FG000|Overall Study|Physician Decision|2
7391302|NCT01241552|11651616|FG001|Overall Study|Physician Decision|4
7391303|NCT01241552|11651617|FG002|Overall Study|Physician Decision|2
7391304|NCT01241552|11651618|FG003|Overall Study|Physician Decision|3
7391305|NCT01241552|11651615|FG000|Overall Study|Lost to Follow-up|2
7391306|NCT01241552|11651616|FG001|Overall Study|Lost to Follow-up|11
7391307|NCT01241552|11651617|FG002|Overall Study|Lost to Follow-up|15
7391308|NCT01241552|11651618|FG003|Overall Study|Lost to Follow-up|16
7391309|NCT01241591|11651637|FG000|Overall Study|Lack of Efficacy|5
7391310|NCT01241591|11651638|FG001|Overall Study|Lack of Efficacy|2
7391311|NCT01241591|11651639|FG002|Overall Study|Lack of Efficacy|2
7313168|NCT00696657|11540510|FG002|Overall Study|Unclassified|3
7391312|NCT01241591|11651640|FG003|Overall Study|Lack of Efficacy|3
7391313|NCT01241591|11651637|FG000|Overall Study|Protocol Violation|5
7313169|NCT00696657|11540511|FG003|Overall Study|Unclassified|2
7313170|NCT00696657|11540512|FG004|Overall Study|Unclassified|4
7313171|NCT00696657|11540513|FG005|Overall Study|Unclassified|2
7313172|NCT00696657|11540514|FG006|Overall Study|Unclassified|0
7313173|NCT00696657|11540515|FG007|Overall Study|Unclassified|0
7313174|NCT00696657|11540516|FG008|Overall Study|Unclassified|1
7313175|NCT00696657|11540508|FG000|Overall Study|Adverse Event|0
7313176|NCT00696657|11540509|FG001|Overall Study|Adverse Event|0
7313177|NCT00696657|11540510|FG002|Overall Study|Adverse Event|3
7313178|NCT00696657|11540511|FG003|Overall Study|Adverse Event|7
7313179|NCT00696657|11540512|FG004|Overall Study|Adverse Event|6
7313180|NCT00696657|11540513|FG005|Overall Study|Adverse Event|9
7313181|NCT00696657|11540514|FG006|Overall Study|Adverse Event|14
7313182|NCT00696657|11540515|FG007|Overall Study|Adverse Event|2
7313183|NCT00696657|11540516|FG008|Overall Study|Adverse Event|5
7313184|NCT00696696|11540536|FG000|Overall Study|Adverse Event|5
7313185|NCT00696696|11540536|FG000|Overall Study|Withdrawal by Subject|8
7313186|NCT00696696|11540536|FG000|Overall Study|Physician Decision|2
7313187|NCT00696696|11540536|FG000|Overall Study|Death|3
7313188|NCT00696709|11540545|FG000|Overall Study|Withdrawal by Subject|1
7313189|NCT00696709|11540546|FG001|Overall Study|Withdrawal by Subject|2
7313190|NCT00696709|11540547|FG002|Overall Study|Withdrawal by Subject|1
7313191|NCT00696709|11540548|FG003|Overall Study|Withdrawal by Subject|4
7313192|NCT00696709|11540549|FG004|Overall Study|Withdrawal by Subject|3
7313193|NCT00696709|11540545|FG000|Overall Study|Protocol Violation|1
7313194|NCT00696709|11540546|FG001|Overall Study|Protocol Violation|0
7313195|NCT00696709|11540547|FG002|Overall Study|Protocol Violation|0
7313196|NCT00696709|11540548|FG003|Overall Study|Protocol Violation|0
7313197|NCT00696709|11540549|FG004|Overall Study|Protocol Violation|0
7313198|NCT00696709|11540545|FG000|Overall Study|Lost to Follow-up|1
7313199|NCT00696709|11540546|FG001|Overall Study|Lost to Follow-up|1
7313200|NCT00696709|11540547|FG002|Overall Study|Lost to Follow-up|0
7313201|NCT00696709|11540548|FG003|Overall Study|Lost to Follow-up|0
7313202|NCT00696709|11540549|FG004|Overall Study|Lost to Follow-up|0
7313203|NCT00696709|11540545|FG000|Overall Study|Adverse Event|0
7313204|NCT00696709|11540546|FG001|Overall Study|Adverse Event|0
7313205|NCT00696709|11540547|FG002|Overall Study|Adverse Event|0
7313206|NCT00696709|11540548|FG003|Overall Study|Adverse Event|1
7313207|NCT00696709|11540549|FG004|Overall Study|Adverse Event|0
7313208|NCT00696774|11540593|FG000|Period II|Adverse Event|0
7313209|NCT00696774|11540594|FG001|Period II|Adverse Event|0
7313210|NCT00696774|11540595|FG002|Period II|Adverse Event|15
7313211|NCT00696774|11540593|FG000|Period II|Lost to Follow-up|0
7313212|NCT00696774|11540594|FG001|Period II|Lost to Follow-up|0
7313213|NCT00696774|11540595|FG002|Period II|Lost to Follow-up|4
7313214|NCT00696774|11540593|FG000|Period II|Protocol Violation|0
7313215|NCT00696774|11540594|FG001|Period II|Protocol Violation|0
7313216|NCT00696774|11540595|FG002|Period II|Protocol Violation|11
7313217|NCT00696774|11540593|FG000|Period II|Withdrawal by Subject|0
7313218|NCT00696774|11540594|FG001|Period II|Withdrawal by Subject|0
7313219|NCT00696774|11540595|FG002|Period II|Withdrawal by Subject|4
7313220|NCT00696774|11540593|FG000|Period II|Sponsor Decision|0
7313221|NCT00696774|11540594|FG001|Period II|Sponsor Decision|0
7313222|NCT00696774|11540595|FG002|Period II|Sponsor Decision|0
7313223|NCT00696774|11540593|FG000|Period II|Lack of Efficacy|0
7313224|NCT00696774|11540594|FG001|Period II|Lack of Efficacy|0
7313225|NCT00696774|11540595|FG002|Period II|Lack of Efficacy|2
7313226|NCT00696774|11540593|FG000|Period III|Adverse Event|1
7313227|NCT00696774|11540594|FG001|Period III|Adverse Event|1
7313228|NCT00696774|11540595|FG002|Period III|Adverse Event|0
7313229|NCT00696774|11540593|FG000|Period III|Lost to Follow-up|2
7313230|NCT00696774|11540594|FG001|Period III|Lost to Follow-up|1
7313231|NCT00696774|11540595|FG002|Period III|Lost to Follow-up|0
7313232|NCT00696774|11540593|FG000|Period III|Protocol Violation|1
7313233|NCT00696774|11540594|FG001|Period III|Protocol Violation|1
7313234|NCT00696774|11540595|FG002|Period III|Protocol Violation|0
7313235|NCT00696774|11540593|FG000|Period III|Withdrawal by Subject|1
7313236|NCT00696774|11540594|FG001|Period III|Withdrawal by Subject|2
7313237|NCT00696774|11540595|FG002|Period III|Withdrawal by Subject|0
7313238|NCT00696774|11540593|FG000|Period III|Sponsor Decision|2
7313239|NCT00696774|11540594|FG001|Period III|Sponsor Decision|0
7313240|NCT00696774|11540595|FG002|Period III|Sponsor Decision|0
7313241|NCT00696774|11540593|FG000|Period III|Lack of Efficacy|0
7313242|NCT00696774|11540594|FG001|Period III|Lack of Efficacy|2
7313243|NCT00696774|11540595|FG002|Period III|Lack of Efficacy|0
7313244|NCT00696787|11540606|FG000|Overall Study|Adverse Event|1
7313245|NCT00696787|11540607|FG001|Overall Study|Adverse Event|0
7313246|NCT00696787|11540608|FG002|Overall Study|Adverse Event|6
7313247|NCT00696787|11540606|FG000|Overall Study|Discontinuation by Sponsor|9
7313248|NCT00696787|11540607|FG001|Overall Study|Discontinuation by Sponsor|13
7313249|NCT00696787|11540608|FG002|Overall Study|Discontinuation by Sponsor|14
7313250|NCT00696787|11540606|FG000|Overall Study|Lack of Efficacy|0
7313251|NCT00696787|11540607|FG001|Overall Study|Lack of Efficacy|1
7313252|NCT00696787|11540608|FG002|Overall Study|Lack of Efficacy|0
7313253|NCT00696787|11540606|FG000|Overall Study|Lost to Follow-up|4
7313254|NCT00696787|11540607|FG001|Overall Study|Lost to Follow-up|0
7313255|NCT00696787|11540608|FG002|Overall Study|Lost to Follow-up|3
7313256|NCT00696787|11540606|FG000|Overall Study|Withdrawal by Subject|0
7313257|NCT00696787|11540607|FG001|Overall Study|Withdrawal by Subject|3
7313258|NCT00696787|11540608|FG002|Overall Study|Withdrawal by Subject|2
7313259|NCT00696787|11540606|FG000|Overall Study|Failed to return|1
7313260|NCT00696787|11540607|FG001|Overall Study|Failed to return|3
7313261|NCT00696787|11540608|FG002|Overall Study|Failed to return|1
7313262|NCT00697073|11540616|FG000|Overall Study|Withdrawal by Subject|2
7313263|NCT00697073|11540616|FG000|Overall Study|Pregnancy|1
7313264|NCT00697073|11540616|FG000|Overall Study|non compliance and other|6
7313265|NCT00697112|11540620|FG000|Overall Study|Adverse Event|8
7313266|NCT00697112|11540620|FG000|Overall Study|Lost to Follow-up|1
7313267|NCT00697112|11540620|FG000|Overall Study|Did not meet inclusion criteria|1
7313268|NCT00697346|11540655|FG000|Overall Study|Adverse Event|4
7313269|NCT00697346|11540656|FG001|Overall Study|Adverse Event|5
7313270|NCT00697346|11540657|FG002|Overall Study|Adverse Event|0
7313271|NCT00697346|11540655|FG000|Overall Study|Progressive Disease|19
7313272|NCT00697346|11540656|FG001|Overall Study|Progressive Disease|18
7313273|NCT00697346|11540657|FG002|Overall Study|Progressive Disease|0
7313274|NCT00697346|11540655|FG000|Overall Study|Symptomatic Deterioration|0
7313275|NCT00697346|11540656|FG001|Overall Study|Symptomatic Deterioration|1
7313276|NCT00697346|11540657|FG002|Overall Study|Symptomatic Deterioration|0
7313277|NCT00697346|11540655|FG000|Overall Study|Withdrawal by Subject|2
7313278|NCT00697346|11540656|FG001|Overall Study|Withdrawal by Subject|2
7313279|NCT00697346|11540657|FG002|Overall Study|Withdrawal by Subject|0
7313280|NCT00697346|11540655|FG000|Overall Study|Reason not Specified|3
7313281|NCT00697346|11540656|FG001|Overall Study|Reason not Specified|0
7313282|NCT00697346|11540657|FG002|Overall Study|Reason not Specified|1
7313283|NCT00697463|11540684|FG000|Overall Study|Withdrawal by Subject|1
7313284|NCT00697515|11540688|FG000|Dose Optimization Period|Adverse Event|4
7313285|NCT00697515|11540689|FG001|Dose Optimization Period|Adverse Event|0
7313286|NCT00697515|11540688|FG000|Dose Optimization Period|Withdrawal by Subject|5
7313287|NCT00697515|11540689|FG001|Dose Optimization Period|Withdrawal by Subject|0
7313288|NCT00697515|11540688|FG000|Dose Optimization Period|Lost to Follow-up|2
7313289|NCT00697515|11540689|FG001|Dose Optimization Period|Lost to Follow-up|0
7313290|NCT00697515|11540688|FG000|Dose Optimization Period|sponsor request|2
7313291|NCT00697515|11540689|FG001|Dose Optimization Period|sponsor request|0
7313292|NCT00697515|11540688|FG000|Dose Optimization Period|called to active duty|1
7313293|NCT00697515|11540689|FG001|Dose Optimization Period|called to active duty|0
7313294|NCT00697515|11540688|FG000|Dose Optimization Period|elevated QTc|1
7313295|NCT00697515|11540689|FG001|Dose Optimization Period|elevated QTc|0
7313296|NCT00697515|11540688|FG000|First Intervention (Crossover Period)|Natural disaster|8
7313297|NCT00697515|11540689|FG001|First Intervention (Crossover Period)|Natural disaster|9
7313298|NCT00697515|11540688|FG000|First Intervention (Crossover Period)|Adverse Event|0
7313299|NCT00697515|11540689|FG001|First Intervention (Crossover Period)|Adverse Event|2
7313300|NCT00697515|11540688|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
7313301|NCT00697515|11540689|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
7313302|NCT00697515|11540688|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7313303|NCT00697515|11540689|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
7313304|NCT00697593|11540705|FG000|Overall Study|Adverse Event|3
7313305|NCT00697593|11540705|FG000|Overall Study|Protocol Violation|1
7313306|NCT00697593|11540705|FG000|Overall Study|Lack of Efficacy|3
7313307|NCT00697593|11540705|FG000|Overall Study|Suspension of the study by sponsor|12
7313308|NCT00697619|11540711|FG000|Overall Study|Lack of Efficacy|2
7313309|NCT00697619|11540712|FG001|Overall Study|Lack of Efficacy|2
7313310|NCT00697619|11540711|FG000|Overall Study|Adverse Event|4
7313311|NCT00697619|11540712|FG001|Overall Study|Adverse Event|6
7313312|NCT00697788|11540727|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313313|NCT00697788|11540728|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
7313314|NCT00697788|11540729|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313315|NCT00697788|11540730|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313316|NCT00697788|11540731|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313317|NCT00697788|11540732|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313318|NCT00697788|11540733|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313319|NCT00697788|11540734|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
7313320|NCT00697788|11540727|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313321|NCT00697788|11540728|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313322|NCT00697788|11540729|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313323|NCT00697788|11540730|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313324|NCT00697788|11540731|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
7313325|NCT00697788|11540732|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313326|NCT00697788|11540733|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313327|NCT00697788|11540734|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
7313328|NCT00697827|11540776|FG000|Overall Study|enrolled but not treated|2
7313329|NCT00697827|11540777|FG001|Overall Study|enrolled but not treated|1
7313330|NCT00698204|11540810|FG000|Overall Study|Withdrawal by Subject|1
7313331|NCT00698204|11540811|FG001|Overall Study|Withdrawal by Subject|0
7313332|NCT00698451|11540819|FG000|Overall Study|Adverse Event|22
7313333|NCT00698451|11540819|FG000|Overall Study|Physician Decision|2
7313334|NCT00698451|11540819|FG000|Overall Study|Protocol Violation|6
7313335|NCT00698451|11540819|FG000|Overall Study|Withdrawal by Subject|6
7313336|NCT00698451|11540819|FG000|Overall Study|Disease progression|3
7391314|NCT01241591|11651638|FG001|Overall Study|Protocol Violation|2
7391315|NCT01241591|11651639|FG002|Overall Study|Protocol Violation|3
7391316|NCT01241591|11651640|FG003|Overall Study|Protocol Violation|0
7391317|NCT01241591|11651637|FG000|Overall Study|Lost to Follow-up|1
7391318|NCT01241591|11651638|FG001|Overall Study|Lost to Follow-up|2
7391319|NCT01241591|11651639|FG002|Overall Study|Lost to Follow-up|2
7391320|NCT01241591|11651640|FG003|Overall Study|Lost to Follow-up|2
7391321|NCT01241591|11651637|FG000|Overall Study|Screen Failure|3
7391322|NCT01241591|11651638|FG001|Overall Study|Screen Failure|2
7391323|NCT01241591|11651639|FG002|Overall Study|Screen Failure|1
7391324|NCT01241591|11651640|FG003|Overall Study|Screen Failure|0
7391325|NCT01241591|11651637|FG000|Overall Study|Withdrawal by Subject|6
7391326|NCT01241591|11651638|FG001|Overall Study|Withdrawal by Subject|4
7391327|NCT01241591|11651639|FG002|Overall Study|Withdrawal by Subject|2
7391328|NCT01241591|11651640|FG003|Overall Study|Withdrawal by Subject|2
7391329|NCT01241591|11651637|FG000|Overall Study|Other|0
7391330|NCT01241591|11651638|FG001|Overall Study|Other|1
7391331|NCT01241591|11651639|FG002|Overall Study|Other|0
7391332|NCT01241591|11651640|FG003|Overall Study|Other|1
7391333|NCT01241591|11651637|FG000|Overall Study|Adverse Event|3
7391334|NCT01241591|11651638|FG001|Overall Study|Adverse Event|11
7391335|NCT01241591|11651639|FG002|Overall Study|Adverse Event|12
7391336|NCT01241591|11651640|FG003|Overall Study|Adverse Event|4
7391337|NCT01241604|11651650|FG000|Screening Period|Screen Failure|3
7391338|NCT01241604|11651651|FG001|Screening Period|Screen Failure|0
7391339|NCT01241604|11651652|FG002|Screening Period|Screen Failure|0
7391340|NCT01241760|11651661|FG000|Overall Study|Adverse Event|1
7391341|NCT01241760|11651662|FG001|Overall Study|Adverse Event|0
7391342|NCT01241760|11651661|FG000|Overall Study|Lost to Follow-up|18
7391343|NCT01241760|11651662|FG001|Overall Study|Lost to Follow-up|22
7391344|NCT01241760|11651661|FG000|Overall Study|Withdrawal by Subject|13
7391345|NCT01241760|11651662|FG001|Overall Study|Withdrawal by Subject|13
7391346|NCT01241760|11651661|FG000|Overall Study|Switch To Commercially Available Medicat|1
7391347|NCT01241760|11651662|FG001|Overall Study|Switch To Commercially Available Medicat|4
7391348|NCT01241760|11651661|FG000|Overall Study|Other|1
7391349|NCT01241760|11651662|FG001|Overall Study|Other|1
7391350|NCT01242085|11651690|FG000|Overall Study|Withdrawal by Subject|4
7391351|NCT01242085|11651691|FG001|Overall Study|Withdrawal by Subject|2
7391352|NCT01242085|11651692|FG002|Overall Study|Withdrawal by Subject|0
7391353|NCT01242085|11651690|FG000|Overall Study|medically unable to have surgery|4
7313337|NCT00698516|11540823|FG000|Overall Study|Study Termination|2
7313338|NCT00698516|11540823|FG000|Overall Study|Withdrawal by Subject|3
7313339|NCT00698581|11540833|FG000|Overall Study|Lack of Efficacy|23
7313340|NCT00698581|11540834|FG001|Overall Study|Lack of Efficacy|11
7313341|NCT00698581|11540833|FG000|Overall Study|Withdrawal by Subject|6
7313342|NCT00698581|11540834|FG001|Overall Study|Withdrawal by Subject|0
7313343|NCT00698581|11540833|FG000|Overall Study|Other reason|9
7313344|NCT00698581|11540834|FG001|Overall Study|Other reason|1
7313345|NCT00698581|11540833|FG000|Overall Study|SAE, non-fatal|1
7313346|NCT00698581|11540834|FG001|Overall Study|SAE, non-fatal|0
7313347|NCT00698581|11540833|FG000|Overall Study|AE, non-serious non-fatal|4
7313348|NCT00698581|11540834|FG001|Overall Study|AE, non-serious non-fatal|0
7313349|NCT00698581|11540833|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7313350|NCT00698581|11540834|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7313351|NCT00698581|11540833|FG000|Overall Study|AE of unknown type|1
7313352|NCT00698581|11540834|FG001|Overall Study|AE of unknown type|0
7313353|NCT00698646|11540844|FG000|Overall Study|Adverse Event|8
7313354|NCT00698646|11540845|FG001|Overall Study|Adverse Event|7
7313355|NCT00698646|11540846|FG002|Overall Study|Adverse Event|8
7313356|NCT00698646|11540844|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
7313357|NCT00698646|11540845|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
7313358|NCT00698646|11540846|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
7313359|NCT00698646|11540844|FG000|Overall Study|Protocol Deviation|6
7313360|NCT00698646|11540845|FG001|Overall Study|Protocol Deviation|2
7313361|NCT00698646|11540846|FG002|Overall Study|Protocol Deviation|3
7313362|NCT00698646|11540844|FG000|Overall Study|Withdrawal by Subject|10
7313363|NCT00698646|11540845|FG001|Overall Study|Withdrawal by Subject|11
7313364|NCT00698646|11540846|FG002|Overall Study|Withdrawal by Subject|8
7313365|NCT00698646|11540844|FG000|Overall Study|Lost to Follow-up|0
7313366|NCT00698646|11540845|FG001|Overall Study|Lost to Follow-up|0
7313367|NCT00698646|11540846|FG002|Overall Study|Lost to Follow-up|2
7313368|NCT00698646|11540844|FG000|Overall Study|Administrative problems|1
7313369|NCT00698646|11540845|FG001|Overall Study|Administrative problems|0
7313370|NCT00698646|11540846|FG002|Overall Study|Administrative problems|1
7313371|NCT00698685|11540854|FG000|Overall Study|Sister withdrew as donor|1
7313372|NCT00698685|11540854|FG000|Overall Study|Off study pre transplant by clinic MD|1
7313373|NCT00698841|11540858|FG000|Overall Study|Withdrawal by Subject|2
7313374|NCT00698841|11540858|FG000|Overall Study|Adverse Event|3
7313375|NCT00698841|11540858|FG000|Overall Study|Disease progression|7
7313376|NCT00698841|11540858|FG000|Overall Study|Failure to meet eligibility criteria|2
7313377|NCT00698841|11540858|FG000|Overall Study|Study drug toxicity|2
7313378|NCT00698841|11540858|FG000|Overall Study|Other|2
7313379|NCT00698932|11540868|FG000|Overall Study|Adverse Event|0
7313380|NCT00698932|11540869|FG001|Overall Study|Adverse Event|2
7313381|NCT00698932|11540868|FG000|Overall Study|Incorrect enrollment|0
7313382|NCT00698932|11540869|FG001|Overall Study|Incorrect enrollment|2
7313383|NCT00698932|11540868|FG000|Overall Study|Study specific discontinuation criteria|3
7313384|NCT00698932|11540869|FG001|Overall Study|Study specific discontinuation criteria|4
7313385|NCT00698932|11540868|FG000|Overall Study|Withdrawal by Subject|11
7313386|NCT00698932|11540869|FG001|Overall Study|Withdrawal by Subject|23
7313387|NCT00698932|11540868|FG000|Overall Study|Lost to Follow-up|6
7313388|NCT00698932|11540869|FG001|Overall Study|Lost to Follow-up|1
7313389|NCT00698932|11540868|FG000|Overall Study|Severe non-compliance to protocol|1
7313390|NCT00698932|11540869|FG001|Overall Study|Severe non-compliance to protocol|2
7313391|NCT00698932|11540868|FG000|Overall Study|Safety reasons|0
7313392|NCT00698932|11540869|FG001|Overall Study|Safety reasons|2
7313393|NCT00698932|11540868|FG000|Overall Study|Death|1
7313394|NCT00698932|11540869|FG001|Overall Study|Death|0
7313395|NCT00698997|11540877|FG000|Overall Study|Lost to Follow-up|3
7313396|NCT00698997|11540878|FG001|Overall Study|Lost to Follow-up|0
7313397|NCT00698997|11540877|FG000|Overall Study|Withdrawal by Subject|7
7313398|NCT00698997|11540878|FG001|Overall Study|Withdrawal by Subject|27
7313399|NCT00699153|11540904|FG000|Overall Study|Lost to Follow-up|1
7313400|NCT00699153|11540905|FG001|Overall Study|Lost to Follow-up|0
7313401|NCT00699153|11540904|FG000|Overall Study|Adverse Event|0
7313402|NCT00699153|11540905|FG001|Overall Study|Adverse Event|2
7313403|NCT00699153|11540904|FG000|Overall Study|Protocol Violation|1
7313404|NCT00699153|11540905|FG001|Overall Study|Protocol Violation|0
7313405|NCT00699153|11540904|FG000|Overall Study|Travel Problem|1
7313406|NCT00699153|11540905|FG001|Overall Study|Travel Problem|0
7313407|NCT00699192|11540914|FG000|Overall Study|Missing|1
7313408|NCT00699192|11540915|FG001|Overall Study|Missing|1
7313409|NCT00699192|11540916|FG002|Overall Study|Missing|1
7313410|NCT00699192|11540914|FG000|Overall Study|Adverse Event|9
7313411|NCT00699192|11540915|FG001|Overall Study|Adverse Event|4
7313412|NCT00699192|11540916|FG002|Overall Study|Adverse Event|3
7313413|NCT00699192|11540914|FG000|Overall Study|Abnormal test procedure result(s)|0
7313414|NCT00699192|11540915|FG001|Overall Study|Abnormal test procedure result(s)|0
7313415|NCT00699192|11540916|FG002|Overall Study|Abnormal test procedure result(s)|1
7313416|NCT00699192|11540914|FG000|Overall Study|Lack of Efficacy|0
7313417|NCT00699192|11540915|FG001|Overall Study|Lack of Efficacy|0
7313418|NCT00699192|11540916|FG002|Overall Study|Lack of Efficacy|1
7313419|NCT00699192|11540914|FG000|Overall Study|Withdrawal by Subject|3
7313420|NCT00699192|11540915|FG001|Overall Study|Withdrawal by Subject|2
7313421|NCT00699192|11540916|FG002|Overall Study|Withdrawal by Subject|4
7313422|NCT00699192|11540914|FG000|Overall Study|Administrative problems|1
7313423|NCT00699192|11540915|FG001|Overall Study|Administrative problems|3
7313424|NCT00699192|11540916|FG002|Overall Study|Administrative problems|1
7313425|NCT00699192|11540914|FG000|Overall Study|Protocol Violation|2
7313426|NCT00699192|11540915|FG001|Overall Study|Protocol Violation|2
7313427|NCT00699192|11540916|FG002|Overall Study|Protocol Violation|0
7313428|NCT00699283|11540930|FG000|Overall Study|Lack of Efficacy|15
7313429|NCT00699283|11540931|FG001|Overall Study|Lack of Efficacy|5
7313430|NCT00699283|11540930|FG000|Overall Study|Lost to Follow-up|2
7313431|NCT00699283|11540931|FG001|Overall Study|Lost to Follow-up|0
7313432|NCT00699283|11540930|FG000|Overall Study|Withdrawal by Subject|1
7313433|NCT00699283|11540931|FG001|Overall Study|Withdrawal by Subject|0
7313434|NCT00699283|11540930|FG000|Overall Study|Other Reason|5
7313435|NCT00699283|11540931|FG001|Overall Study|Other Reason|1
7313436|NCT00699283|11540930|FG000|Overall Study|SAE, non-fatal|1
7313437|NCT00699283|11540931|FG001|Overall Study|SAE, non-fatal|1
7313438|NCT00699283|11540930|FG000|Overall Study|AE, non-serious non-fatal|8
7313439|NCT00699283|11540931|FG001|Overall Study|AE, non-serious non-fatal|1
7313440|NCT00699283|11540930|FG000|Overall Study|AE of unknown type|1
7313441|NCT00699283|11540931|FG001|Overall Study|AE of unknown type|0
7313442|NCT00699335|11540936|FG000|Overall Study|Combination of multiple reasons|176
7313443|NCT00699335|11540936|FG000|Overall Study|Missing data|52
7313444|NCT00699348|11540943|FG000|Overall Study|Death|6
7313445|NCT00699348|11540943|FG000|Overall Study|Adverse Event|15
7313446|NCT00699348|11540943|FG000|Overall Study|Withdrawal by Subject|11
7313447|NCT00699348|11540943|FG000|Overall Study|Protocol Violation|10
7313448|NCT00699348|11540943|FG000|Overall Study|Lack of Efficacy|8
7313449|NCT00699348|11540943|FG000|Overall Study|Failure to return|1
7313450|NCT00699348|11540943|FG000|Overall Study|Blood transfusion|24
7313451|NCT00699348|11540943|FG000|Overall Study|Renal transplantation|10
7313452|NCT00699348|11540943|FG000|Overall Study|Other|5
7313453|NCT00699374|11540949|FG000|Overall Study|Death|93
7313454|NCT00699374|11540950|FG001|Overall Study|Death|83
7313455|NCT00699374|11540949|FG000|Overall Study|Adverse Event|70
7313456|NCT00699374|11540950|FG001|Overall Study|Adverse Event|67
7313457|NCT00699374|11540949|FG000|Overall Study|Global deterioration of health status|7
7313458|NCT00699374|11540950|FG001|Overall Study|Global deterioration of health status|8
7313459|NCT00699374|11540949|FG000|Overall Study|Lost to Follow-up|3
7313460|NCT00699374|11540950|FG001|Overall Study|Lost to Follow-up|5
7313461|NCT00699374|11540949|FG000|Overall Study|Withdrawal by Subject|34
7313462|NCT00699374|11540950|FG001|Overall Study|Withdrawal by Subject|44
7313463|NCT00699374|11540949|FG000|Overall Study|Objective progression or relapse|281
7313464|NCT00699374|11540950|FG001|Overall Study|Objective progression or relapse|277
7313465|NCT00699374|11540949|FG000|Overall Study|Other|18
7313466|NCT00699374|11540950|FG001|Overall Study|Other|15
7313467|NCT00699374|11540949|FG000|Overall Study|Protocol Violation|2
7313468|NCT00699374|11540950|FG001|Overall Study|Protocol Violation|6
7313469|NCT00699374|11540949|FG000|Overall Study|Study terminated by sponsor|13
7313470|NCT00699374|11540950|FG001|Overall Study|Study terminated by sponsor|28
7313471|NCT00699374|11540949|FG000|Overall Study|Randomized but not treated|4
7313472|NCT00699374|11540950|FG001|Overall Study|Randomized but not treated|2
7313473|NCT00699374|11540949|FG000|Overall Study|Died 28 days after last dose|5
7313474|NCT00699374|11540950|FG001|Overall Study|Died 28 days after last dose|9
7384413|NCT01194258|11641597|FG002|Titration Period|Lost to Follow-up|0
7384414|NCT01194258|11641598|FG003|Titration Period|Lost to Follow-up|0
7384415|NCT01194258|11641599|FG004|Titration Period|Lost to Follow-up|0
7384416|NCT01194258|11641595|FG000|Titration Period|Titration failure|3
7384417|NCT01194258|11641596|FG001|Titration Period|Titration failure|0
7384418|NCT01194258|11641597|FG002|Titration Period|Titration failure|0
7384419|NCT01194258|11641598|FG003|Titration Period|Titration failure|0
7384420|NCT01194258|11641599|FG004|Titration Period|Titration failure|0
7384421|NCT01194258|11641595|FG000|Period 1 (12 Weeks)|Death|0
7384422|NCT01194258|11641596|FG001|Period 1 (12 Weeks)|Death|0
7391354|NCT01242085|11651691|FG001|Overall Study|medically unable to have surgery|5
7391355|NCT01242085|11651692|FG002|Overall Study|medically unable to have surgery|0
7391356|NCT01242111|11651698|FG000|Overall Study|Adverse Event|1
7391357|NCT01242111|11651698|FG000|Overall Study|Withdrawal by Subject|1
7391358|NCT01242111|11651698|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
7391359|NCT01242176|11651702|FG000|Washout Period of 7 Days|Adverse Event|0
7391360|NCT01242176|11651703|FG001|Washout Period of 7 Days|Adverse Event|2
7391361|NCT01242176|11651702|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
7391362|NCT01242176|11651703|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
7465206|NCT01879410|11764412|FG000|Overall Study|Adverse Event|9
7465207|NCT01879410|11764413|FG001|Overall Study|Adverse Event|14
7465208|NCT01879410|11764412|FG000|Overall Study|Lack of Efficacy|4
7465209|NCT01879410|11764413|FG001|Overall Study|Lack of Efficacy|6
7465210|NCT01879410|11764412|FG000|Overall Study|Protocol Violation|1
7465211|NCT01879410|11764413|FG001|Overall Study|Protocol Violation|7
7465212|NCT01879410|11764412|FG000|Overall Study|Lost to Follow-up|2
7465213|NCT01879410|11764413|FG001|Overall Study|Lost to Follow-up|1
7465214|NCT01879410|11764412|FG000|Overall Study|Withdrawal by Subject|7
7465215|NCT01879410|11764413|FG001|Overall Study|Withdrawal by Subject|8
7465216|NCT01879410|11764412|FG000|Overall Study|Randomised in Error|1
7465217|NCT01879410|11764413|FG001|Overall Study|Randomised in Error|2
7465218|NCT01879553|11764425|FG000|Overall Study|Withdrawal by Subject|1
7465219|NCT01879553|11764426|FG001|Overall Study|Withdrawal by Subject|0
7465220|NCT01879579|11764435|FG000|Overall Study|Phone incompatible with texting platform|3
7465221|NCT01879579|11764436|FG001|Overall Study|Phone incompatible with texting platform|0
7465222|NCT01879579|11764435|FG000|Overall Study|Did not enroll in texting platform|1
7465223|NCT01879579|11764436|FG001|Overall Study|Did not enroll in texting platform|0
7465224|NCT01879579|11764435|FG000|Overall Study|Did not initiate insulin treatment|1
7465225|NCT01879579|11764436|FG001|Overall Study|Did not initiate insulin treatment|0
7465226|NCT01879579|11764435|FG000|Overall Study|Phenotypic type 1 diabetes|0
7465227|NCT01879579|11764436|FG001|Overall Study|Phenotypic type 1 diabetes|1
7465228|NCT01879579|11764435|FG000|Overall Study|Discontinued insulin - possible allergy|0
7465229|NCT01879579|11764436|FG001|Overall Study|Discontinued insulin - possible allergy|1
7465230|NCT01879618|11764445|FG000|Overall Study|Does not meet entrance criteria|1
7465231|NCT01879618|11764445|FG000|Overall Study|Withdrawal by Subject|1
7465232|NCT01879618|11764445|FG000|Overall Study|Surgery;changed schedule; not available|8
7465233|NCT01879618|11764445|FG000|Overall Study|Protocol Violation|6
7465234|NCT01879618|11764445|FG000|Overall Study|Adverse Event|5
7465235|NCT01879683|11764449|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
7465236|NCT01879722|11764463|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7465237|NCT01879722|11764464|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7465238|NCT01879722|11764465|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7465239|NCT01879722|11764466|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7465240|NCT01879722|11764467|FG004|Overall Study|Pretreatment Event/Adverse Event|1
7465241|NCT01879722|11764468|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7465242|NCT01879722|11764469|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7465243|NCT01879722|11764470|FG007|Overall Study|Pretreatment Event/Adverse Event|1
7384423|NCT01194258|11641597|FG002|Period 1 (12 Weeks)|Death|0
7384424|NCT01194258|11641598|FG003|Period 1 (12 Weeks)|Death|0
7384425|NCT01194258|11641599|FG004|Period 1 (12 Weeks)|Death|1
7384426|NCT01194258|11641595|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
7465244|NCT01879722|11764471|FG008|Overall Study|Pretreatment Event/Adverse Event|1
7465245|NCT01879722|11764472|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7465246|NCT01879722|11764463|FG000|Overall Study|Voluntary Withdrawal|0
7465247|NCT01879722|11764464|FG001|Overall Study|Voluntary Withdrawal|0
7465248|NCT01879722|11764465|FG002|Overall Study|Voluntary Withdrawal|0
7465249|NCT01879722|11764466|FG003|Overall Study|Voluntary Withdrawal|0
7465250|NCT01879722|11764467|FG004|Overall Study|Voluntary Withdrawal|0
7313475|NCT00699582|11541008|FG000|Overall Study|Adverse Event|4
7313476|NCT00699582|11541009|FG001|Overall Study|Adverse Event|11
7313477|NCT00699582|11541010|FG002|Overall Study|Adverse Event|23
7313478|NCT00699582|11541008|FG000|Overall Study|Withdrawal by Subject|6
7313479|NCT00699582|11541009|FG001|Overall Study|Withdrawal by Subject|7
7313480|NCT00699582|11541010|FG002|Overall Study|Withdrawal by Subject|4
7313481|NCT00699582|11541008|FG000|Overall Study|Lack of Efficacy|1
7313482|NCT00699582|11541009|FG001|Overall Study|Lack of Efficacy|0
7313483|NCT00699582|11541010|FG002|Overall Study|Lack of Efficacy|1
7313484|NCT00699582|11541008|FG000|Overall Study|Progressive Disease|1
7313485|NCT00699582|11541009|FG001|Overall Study|Progressive Disease|0
7313486|NCT00699582|11541010|FG002|Overall Study|Progressive Disease|0
7313487|NCT00699582|11541008|FG000|Overall Study|Administrative/Other|4
7313488|NCT00699582|11541009|FG001|Overall Study|Administrative/Other|3
7313489|NCT00699582|11541010|FG002|Overall Study|Administrative/Other|0
7313490|NCT00699582|11541008|FG000|Overall Study|Randomized, Not Treated|2
7313491|NCT00699582|11541009|FG001|Overall Study|Randomized, Not Treated|1
7313492|NCT00699582|11541010|FG002|Overall Study|Randomized, Not Treated|0
7313493|NCT00699608|11541018|FG000|First Intervention|Withdrawal by Subject|0
7313494|NCT00699608|11541019|FG001|First Intervention|Withdrawal by Subject|0
7313495|NCT00699608|11541020|FG002|First Intervention|Withdrawal by Subject|1
7313496|NCT00699608|11541021|FG003|First Intervention|Withdrawal by Subject|0
7313497|NCT00699608|11541022|FG004|First Intervention|Withdrawal by Subject|0
7313498|NCT00699608|11541023|FG005|First Intervention|Withdrawal by Subject|0
7313499|NCT00699608|11541018|FG000|First Intervention|Protocol Violation|0
7313500|NCT00699608|11541019|FG001|First Intervention|Protocol Violation|0
7313501|NCT00699608|11541020|FG002|First Intervention|Protocol Violation|0
7313502|NCT00699608|11541021|FG003|First Intervention|Protocol Violation|0
7313503|NCT00699608|11541022|FG004|First Intervention|Protocol Violation|1
7313504|NCT00699608|11541023|FG005|First Intervention|Protocol Violation|0
7313505|NCT00699608|11541018|FG000|Second Intervention|Adverse Event|0
7313506|NCT00699608|11541019|FG001|Second Intervention|Adverse Event|0
7313507|NCT00699608|11541020|FG002|Second Intervention|Adverse Event|1
7391363|NCT01242371|11651720|FG000|Overall Study|Withdrawal by Subject|2
7391364|NCT01242371|11651721|FG001|Overall Study|Withdrawal by Subject|2
7391365|NCT01242371|11651720|FG000|Overall Study|Protocol Violation|0
7391366|NCT01242371|11651721|FG001|Overall Study|Protocol Violation|3
7391367|NCT01242514|11651730|FG000|Overall Study|e.g., project closure|1042
7391368|NCT01242514|11651731|FG001|Overall Study|e.g., project closure|305
7391369|NCT01242514|11651732|FG002|Overall Study|e.g., project closure|171
7391370|NCT01242514|11651730|FG000|Overall Study|Subject decision|33
7391371|NCT01242514|11651731|FG001|Overall Study|Subject decision|8
7391372|NCT01242514|11651732|FG002|Overall Study|Subject decision|2
7391373|NCT01242514|11651730|FG000|Overall Study|Severe non-compliance to protocol|5
7391374|NCT01242514|11651731|FG001|Overall Study|Severe non-compliance to protocol|2
7391375|NCT01242514|11651732|FG002|Overall Study|Severe non-compliance to protocol|1
7391376|NCT01242514|11651730|FG000|Overall Study|Lack of therapeutic response|99
7391377|NCT01242514|11651731|FG001|Overall Study|Lack of therapeutic response|16
7391378|NCT01242514|11651732|FG002|Overall Study|Lack of therapeutic response|10
7391379|NCT01242514|11651730|FG000|Overall Study|Dev. of study specific discont. criteria|21
7391380|NCT01242514|11651731|FG001|Overall Study|Dev. of study specific discont. criteria|3
7391381|NCT01242514|11651732|FG002|Overall Study|Dev. of study specific discont. criteria|5
7391382|NCT01242514|11651730|FG000|Overall Study|Lost to Follow-up|14
7391383|NCT01242514|11651731|FG001|Overall Study|Lost to Follow-up|5
7391384|NCT01242514|11651732|FG002|Overall Study|Lost to Follow-up|4
7391385|NCT01242514|11651730|FG000|Overall Study|Adverse Event|129
7391386|NCT01242514|11651731|FG001|Overall Study|Adverse Event|18
7391387|NCT01242514|11651732|FG002|Overall Study|Adverse Event|19
7391388|NCT01242748|11651772|FG000|Overall Study|Adverse Event|10
7391389|NCT01242748|11651773|FG001|Overall Study|Adverse Event|5
7391390|NCT01242748|11651772|FG000|Overall Study|Lost to Follow-up|6
7391391|NCT01242748|11651773|FG001|Overall Study|Lost to Follow-up|2
7391392|NCT01242748|11651772|FG000|Overall Study|Physician Decision|3
7391393|NCT01242748|11651773|FG001|Overall Study|Physician Decision|2
7391394|NCT01242748|11651772|FG000|Overall Study|Protocol Violation|1
7391395|NCT01242748|11651773|FG001|Overall Study|Protocol Violation|0
7391396|NCT01242748|11651772|FG000|Overall Study|Withdrawal by Subject|10
7391397|NCT01242748|11651773|FG001|Overall Study|Withdrawal by Subject|2
7391398|NCT01242748|11651772|FG000|Overall Study|Miscellaneous reasons|8
7391399|NCT01242748|11651773|FG001|Overall Study|Miscellaneous reasons|3
7391400|NCT01242813|11651779|FG000|Overall Study|Lost to Follow-up|2
7391401|NCT01243151|11651792|FG000|Overall Study|Adverse Event|0
7391402|NCT01243151|11651793|FG001|Overall Study|Adverse Event|1
7391403|NCT01243151|11651794|FG002|Overall Study|Adverse Event|0
7391404|NCT01243151|11651795|FG003|Overall Study|Adverse Event|0
7391405|NCT01243151|11651796|FG004|Overall Study|Adverse Event|0
7313508|NCT00699608|11541021|FG003|Second Intervention|Adverse Event|0
7391406|NCT01243151|11651792|FG000|Overall Study|Protocol Violation|0
7391407|NCT01243151|11651793|FG001|Overall Study|Protocol Violation|0
7391408|NCT01243151|11651794|FG002|Overall Study|Protocol Violation|1
7391409|NCT01243151|11651795|FG003|Overall Study|Protocol Violation|0
7391410|NCT01243151|11651796|FG004|Overall Study|Protocol Violation|0
7391411|NCT01243151|11651792|FG000|Overall Study|Other|0
7391412|NCT01243151|11651793|FG001|Overall Study|Other|0
7313509|NCT00699608|11541022|FG004|Second Intervention|Adverse Event|0
7313510|NCT00699608|11541023|FG005|Second Intervention|Adverse Event|0
7313511|NCT00699608|11541018|FG000|Second Intervention|Withdrawal by Subject|0
7313512|NCT00699608|11541019|FG001|Second Intervention|Withdrawal by Subject|0
7313513|NCT00699608|11541020|FG002|Second Intervention|Withdrawal by Subject|0
7313514|NCT00699608|11541021|FG003|Second Intervention|Withdrawal by Subject|1
7313515|NCT00699608|11541022|FG004|Second Intervention|Withdrawal by Subject|0
7313516|NCT00699608|11541023|FG005|Second Intervention|Withdrawal by Subject|0
7313517|NCT00699660|11541033|FG000|Overall Study|Lost to Follow-up|4
7313518|NCT00699660|11541034|FG001|Overall Study|Lost to Follow-up|2
7313519|NCT00699660|11541033|FG000|Overall Study|missing reports and recording failures|10
7313520|NCT00699660|11541034|FG001|Overall Study|missing reports and recording failures|6
7313521|NCT00699699|11541040|FG000|Overall Study|Adverse Event|36
7313522|NCT00699699|11541040|FG000|Overall Study|Individual different reasons|21
7313523|NCT00699751|11541046|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
7313524|NCT00699751|11541047|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
7313525|NCT00699751|11541046|FG000|Period 1: Without/Before Drug Switch|Death|28
7313526|NCT00699751|11541047|FG001|Period 1: Without/Before Drug Switch|Death|29
7313527|NCT00699751|11541046|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
7313528|NCT00699751|11541047|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
7313529|NCT00699751|11541046|FG000|Period 1: Without/Before Drug Switch|Other|30
7313530|NCT00699751|11541047|FG001|Period 1: Without/Before Drug Switch|Other|20
7313531|NCT00699751|11541046|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
7313532|NCT00699751|11541047|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
7313533|NCT00699751|11541046|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
7313534|NCT00699751|11541047|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
7313535|NCT00699751|11541046|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
7313536|NCT00699751|11541047|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
7313537|NCT00699751|11541046|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
7313538|NCT00699751|11541047|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
7313539|NCT00699816|11541065|FG000|Overall Study|Protocol Violation|1
7313540|NCT00699816|11541066|FG001|Overall Study|Protocol Violation|3
7313541|NCT00699907|11541075|FG000|Overall Study|Withdrawal by Subject|2
7313542|NCT00699907|11541076|FG001|Overall Study|Withdrawal by Subject|1
7313543|NCT00699907|11541077|FG002|Overall Study|Withdrawal by Subject|0
7313544|NCT00699907|11541075|FG000|Overall Study|No usable sample|0
7313545|NCT00699907|11541076|FG001|Overall Study|No usable sample|9
7313546|NCT00699907|11541077|FG002|Overall Study|No usable sample|8
7313547|NCT00699972|11541088|FG000|Overall Study|Adverse Event|7
7313548|NCT00699972|11541089|FG001|Overall Study|Adverse Event|9
7313549|NCT00699972|11541090|FG002|Overall Study|Adverse Event|24
7313550|NCT00699972|11541088|FG000|Overall Study|Lost to Follow-up|0
7313551|NCT00699972|11541089|FG001|Overall Study|Lost to Follow-up|2
7313552|NCT00699972|11541090|FG002|Overall Study|Lost to Follow-up|0
7313553|NCT00699972|11541088|FG000|Overall Study|Withdrawal by Subject|3
7313554|NCT00699972|11541089|FG001|Overall Study|Withdrawal by Subject|7
7313555|NCT00699972|11541090|FG002|Overall Study|Withdrawal by Subject|4
7313556|NCT00699972|11541088|FG000|Overall Study|Lack of Efficacy|2
7313557|NCT00699972|11541089|FG001|Overall Study|Lack of Efficacy|0
7313558|NCT00699972|11541090|FG002|Overall Study|Lack of Efficacy|2
7313559|NCT00699972|11541088|FG000|Overall Study|Administrative/Other|3
7313560|NCT00699972|11541089|FG001|Overall Study|Administrative/Other|1
7313561|NCT00699972|11541090|FG002|Overall Study|Administrative/Other|4
7313562|NCT00699972|11541088|FG000|Overall Study|Randomized, Not Treated|1
7313563|NCT00699972|11541089|FG001|Overall Study|Randomized, Not Treated|0
7313564|NCT00699972|11541090|FG002|Overall Study|Randomized, Not Treated|1
7313565|NCT00699998|11541102|FG000|Overall Study|Withdrawal by Subject|194
7313566|NCT00699998|11541103|FG001|Overall Study|Withdrawal by Subject|83
7313567|NCT00699998|11541104|FG002|Overall Study|Withdrawal by Subject|202
7313568|NCT00699998|11541105|FG003|Overall Study|Withdrawal by Subject|80
7313569|NCT00699998|11541102|FG000|Overall Study|Physician Decision|3
7313570|NCT00699998|11541103|FG001|Overall Study|Physician Decision|2
7313571|NCT00699998|11541104|FG002|Overall Study|Physician Decision|1
7313572|NCT00699998|11541105|FG003|Overall Study|Physician Decision|1
7313573|NCT00699998|11541102|FG000|Overall Study|Lost to Follow-up|2
7313574|NCT00699998|11541103|FG001|Overall Study|Lost to Follow-up|1
7313575|NCT00699998|11541104|FG002|Overall Study|Lost to Follow-up|3
7313576|NCT00699998|11541105|FG003|Overall Study|Lost to Follow-up|1
7313577|NCT00700011|11541122|FG000|Overall Study|Death|0
7313578|NCT00700011|11541123|FG001|Overall Study|Death|1
7313579|NCT00700102|11541164|FG000|Overall Study|Died|394
7313580|NCT00700102|11541165|FG001|Overall Study|Died|385
7313581|NCT00700102|11541164|FG000|Overall Study|Lost to Follow-up|8
7313582|NCT00700102|11541165|FG001|Overall Study|Lost to Follow-up|10
7313583|NCT00700115|11541173|FG000|Overall Study|Withdrawal by Subject|1
7313584|NCT00700115|11541174|FG001|Overall Study|Withdrawal by Subject|0
7313585|NCT00700115|11541173|FG000|Overall Study|Lost to Follow-up|0
7313586|NCT00700115|11541174|FG001|Overall Study|Lost to Follow-up|1
7313587|NCT00700180|11541186|FG000|Overall Study|Death|99
7313588|NCT00700180|11541187|FG001|Overall Study|Death|114
7313589|NCT00700180|11541186|FG000|Overall Study|Alive on treatment|5
7313590|NCT00700180|11541187|FG001|Overall Study|Alive on treatment|3
7313591|NCT00700180|11541186|FG000|Overall Study|Alive in follow-up|46
7313592|NCT00700180|11541187|FG001|Overall Study|Alive in follow-up|27
7313593|NCT00700180|11541186|FG000|Overall Study|Lost to Follow-up|4
7313594|NCT00700180|11541187|FG001|Overall Study|Lost to Follow-up|5
7313595|NCT00700271|11541195|FG000|Overall Study|Adverse Event|4
7313596|NCT00700271|11541196|FG001|Overall Study|Adverse Event|6
7313597|NCT00700271|11541195|FG000|Overall Study|Protocol Violation|1
7313598|NCT00700271|11541196|FG001|Overall Study|Protocol Violation|0
7313599|NCT00700271|11541195|FG000|Overall Study|Administrative Reasons|1
7313600|NCT00700271|11541196|FG001|Overall Study|Administrative Reasons|0
7313601|NCT00700271|11541195|FG000|Overall Study|Withdrawal by Subject|6
7313602|NCT00700271|11541196|FG001|Overall Study|Withdrawal by Subject|4
7313603|NCT00700271|11541195|FG000|Overall Study|Lost to Follow-up|2
7313604|NCT00700271|11541196|FG001|Overall Study|Lost to Follow-up|2
7313605|NCT00700310|11541206|FG000|Overall Study|Adverse Event|6
7313606|NCT00700310|11541207|FG001|Overall Study|Adverse Event|10
7313607|NCT00700310|11541208|FG002|Overall Study|Adverse Event|5
7313608|NCT00700310|11541209|FG003|Overall Study|Adverse Event|11
7313609|NCT00700310|11541206|FG000|Overall Study|Lost to Follow-up|4
7313610|NCT00700310|11541207|FG001|Overall Study|Lost to Follow-up|1
7313611|NCT00700310|11541208|FG002|Overall Study|Lost to Follow-up|0
7313612|NCT00700310|11541209|FG003|Overall Study|Lost to Follow-up|1
7313613|NCT00700310|11541206|FG000|Overall Study|Withdrawal by Subject|8
7313614|NCT00700310|11541207|FG001|Overall Study|Withdrawal by Subject|9
7313615|NCT00700310|11541208|FG002|Overall Study|Withdrawal by Subject|8
7313616|NCT00700310|11541209|FG003|Overall Study|Withdrawal by Subject|8
7313617|NCT00700310|11541206|FG000|Overall Study|Lack of Efficacy|0
7391413|NCT01243151|11651794|FG002|Overall Study|Other|0
7391414|NCT01243151|11651795|FG003|Overall Study|Other|1
7391415|NCT01243151|11651796|FG004|Overall Study|Other|0
7391416|NCT01243151|11651792|FG000|Overall Study|Randomized but not treated|0
7391417|NCT01243151|11651793|FG001|Overall Study|Randomized but not treated|0
7391418|NCT01243151|11651794|FG002|Overall Study|Randomized but not treated|0
7391419|NCT01243151|11651795|FG003|Overall Study|Randomized but not treated|1
7391420|NCT01243151|11651796|FG004|Overall Study|Randomized but not treated|0
7391421|NCT01243177|11651814|FG000|Overall Study|Lack of Efficacy|47
7391422|NCT01243177|11651815|FG001|Overall Study|Lack of Efficacy|31
7391423|NCT01243177|11651814|FG000|Overall Study|Protocol Violation|11
7391424|NCT01243177|11651815|FG001|Overall Study|Protocol Violation|10
7391425|NCT01243177|11651814|FG000|Overall Study|Lost to Follow-up|15
7391426|NCT01243177|11651815|FG001|Overall Study|Lost to Follow-up|18
7391427|NCT01243177|11651814|FG000|Overall Study|Withdrawal by Subject|46
7391428|NCT01243177|11651815|FG001|Overall Study|Withdrawal by Subject|38
7391429|NCT01243177|11651814|FG000|Overall Study|AE, serious fatal|0
7391430|NCT01243177|11651815|FG001|Overall Study|AE, serious fatal|1
7391431|NCT01243177|11651814|FG000|Overall Study|SAE, non-fatal|7
7391432|NCT01243177|11651815|FG001|Overall Study|SAE, non-fatal|9
7391433|NCT01243177|11651814|FG000|Overall Study|AE, non-serious non-fatal|40
7391434|NCT01243177|11651815|FG001|Overall Study|AE, non-serious non-fatal|58
7391435|NCT01243177|11651814|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
7391436|NCT01243177|11651815|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
7391437|NCT01243177|11651814|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7391438|NCT01243177|11651815|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7391439|NCT01243177|11651814|FG000|Overall Study|Other Reason|11
7391440|NCT01243177|11651815|FG001|Overall Study|Other Reason|12
7391441|NCT01243242|11651823|FG000|Overall Study|Adverse Event|1
7391442|NCT01243242|11651824|FG001|Overall Study|Adverse Event|1
7391443|NCT01243242|11651823|FG000|Overall Study|Withdrawal by Subject|1
7391444|NCT01243242|11651824|FG001|Overall Study|Withdrawal by Subject|1
7391445|NCT01243242|11651823|FG000|Overall Study|Physician Decision|0
7391446|NCT01243242|11651824|FG001|Overall Study|Physician Decision|1
7391447|NCT01243242|11651823|FG000|Overall Study|sponsor decision|0
7391448|NCT01243242|11651824|FG001|Overall Study|sponsor decision|1
7391449|NCT01243242|11651823|FG000|Overall Study|non compliance|1
7391450|NCT01243242|11651824|FG001|Overall Study|non compliance|0
7391451|NCT01243268|11651830|FG000|Overall Study|Lost to Follow-up|4
7391452|NCT01243268|11651830|FG000|Overall Study|Protocol Violation|51
7391453|NCT01243268|11651830|FG000|Overall Study|Deviation with contract date|7
7391454|NCT01243268|11651830|FG000|Overall Study|Duplicate subject|2
7391455|NCT01243411|11651851|FG000|Overall Study|Withdrawal by Subject|18
7391456|NCT01243411|11651851|FG000|Overall Study|Lost to Follow-up|10
7391457|NCT01243411|11651851|FG000|Overall Study|Adverse Event|5
7391458|NCT01243411|11651851|FG000|Overall Study|Other|8
7391459|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
7391460|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
7391461|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
7391462|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
7391463|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
7391464|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
7313618|NCT00700310|11541207|FG001|Overall Study|Lack of Efficacy|3
7313619|NCT00700310|11541208|FG002|Overall Study|Lack of Efficacy|0
7313620|NCT00700310|11541209|FG003|Overall Study|Lack of Efficacy|1
7313621|NCT00700310|11541206|FG000|Overall Study|Administrative/Other|1
7313622|NCT00700310|11541207|FG001|Overall Study|Administrative/Other|3
7313623|NCT00700310|11541208|FG002|Overall Study|Administrative/Other|1
7313624|NCT00700310|11541209|FG003|Overall Study|Administrative/Other|3
7313625|NCT00700310|11541206|FG000|Overall Study|Randomized, Not Treated|2
7313626|NCT00700310|11541207|FG001|Overall Study|Randomized, Not Treated|0
7313627|NCT00700310|11541208|FG002|Overall Study|Randomized, Not Treated|2
7313628|NCT00700310|11541209|FG003|Overall Study|Randomized, Not Treated|2
7313629|NCT00700401|11541240|FG000|Overall Study|Detectable HCV RNA after Week 4|82
7313630|NCT00700401|11541240|FG000|Overall Study|Adverse Event|5
7313631|NCT00700401|11541240|FG000|Overall Study|Refused Treatment|2
7313632|NCT00700401|11541240|FG000|Overall Study|Lost to Follow-up|1
7313633|NCT00700401|11541240|FG000|Overall Study|Treatment never started|1
7313634|NCT00700401|11541240|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
7313635|NCT00700401|11541240|FG000|Overall Study|Withdrawal by Subject|2
7313636|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
7313637|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7313638|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7313639|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7313640|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
7313641|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
7313642|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7313643|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7313644|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7313645|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
7313646|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
7313647|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7313648|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7313649|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7313650|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
7313651|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
7313652|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7313653|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7313654|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7313655|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
7313656|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
7313657|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7313658|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7313659|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7313660|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
7313661|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
7313662|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7313663|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7313664|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7313665|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
7313666|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
7313667|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7313668|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7313669|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7313670|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
7313671|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
7313672|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7313673|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7313674|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7313675|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
7313676|NCT00700427|11541244|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
7313677|NCT00700427|11541245|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7313678|NCT00700427|11541246|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7313679|NCT00700427|11541247|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7313680|NCT00700427|11541248|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
7313681|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7313682|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
7313683|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7313684|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7313685|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
7313686|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7313687|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
7313688|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7313689|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7384427|NCT01194258|11641596|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
7313690|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
7313691|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7313692|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
7313693|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7313694|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7313695|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
7313696|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7313697|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
7313698|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7313699|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7313700|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
7313701|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7313702|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
7313703|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7313704|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7313705|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
7313706|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7313707|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
7313708|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7313709|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7313710|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
7313711|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7313712|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
7313713|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7313714|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7313715|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
7313716|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7313717|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
7313718|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7313719|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7313720|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
7313721|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7313722|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
7313723|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7313724|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7313725|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
7313726|NCT00700427|11541244|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7313727|NCT00700427|11541245|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
7313728|NCT00700427|11541246|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7313729|NCT00700427|11541247|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7313730|NCT00700427|11541248|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
7313731|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7313732|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7313733|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
7313734|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
7313735|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
7313736|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7313737|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7313738|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
7313739|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
7313740|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
7313741|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7313742|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7313743|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
7313744|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
7313745|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
7313746|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7313747|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7313748|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
7313749|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
7313750|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
7313751|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7313752|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7313753|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
7313754|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
7313755|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
7313756|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7313757|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7313758|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7313759|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
7313760|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
7313761|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7313762|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7313763|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7313764|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
7313765|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
7313766|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
7313767|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
7313768|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
7313769|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
7313770|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
7313771|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7313772|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7313773|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
7313774|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7313775|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
7313776|NCT00700427|11541244|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
7313777|NCT00700427|11541245|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
7313778|NCT00700427|11541246|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
7313779|NCT00700427|11541247|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
7313780|NCT00700427|11541248|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
7313781|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
7313782|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
7313783|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
7313784|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
7313785|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
7313786|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Death|0
7313787|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Death|0
7313788|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Death|0
7313789|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Death|0
7313790|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Death|1
7313791|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7313792|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7313793|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7313794|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
7313795|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
7313796|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7313797|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7313798|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7313799|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
7313800|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
7313801|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
7313802|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
7313803|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
7313804|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
7313805|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
7313806|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7313807|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7313808|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7313809|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
7313810|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
7313811|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7313812|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7313813|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7313814|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
7313815|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
7313816|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7313817|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7313818|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7313819|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
7313820|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
7313821|NCT00700427|11541244|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7313822|NCT00700427|11541245|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7313823|NCT00700427|11541246|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7313824|NCT00700427|11541247|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
7313825|NCT00700427|11541248|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
7313826|NCT00700570|11541262|FG000|Overall Study|Adverse Event|2
7313827|NCT00700570|11541263|FG001|Overall Study|Adverse Event|6
7313828|NCT00700570|11541262|FG000|Overall Study|Discretion of Investigator or Sponsor|0
7313829|NCT00700570|11541263|FG001|Overall Study|Discretion of Investigator or Sponsor|3
7313830|NCT00700570|11541262|FG000|Overall Study|Disease Progression|8
7313831|NCT00700570|11541263|FG001|Overall Study|Disease Progression|11
7313832|NCT00700570|11541262|FG000|Overall Study|Withdrawal by Subject|1
7313833|NCT00700570|11541263|FG001|Overall Study|Withdrawal by Subject|6
7313834|NCT00700622|11541271|FG000|Overall Study|Adverse Event|4
7313835|NCT00700622|11541272|FG001|Overall Study|Adverse Event|0
7313836|NCT00700622|11541271|FG000|Overall Study|Lost to Follow-up|0
7313837|NCT00700622|11541272|FG001|Overall Study|Lost to Follow-up|1
7313838|NCT00700622|11541271|FG000|Overall Study|Physician Decision|2
7313839|NCT00700622|11541272|FG001|Overall Study|Physician Decision|1
7313840|NCT00700622|11541271|FG000|Overall Study|Protocol Violation|0
7313841|NCT00700622|11541272|FG001|Overall Study|Protocol Violation|1
7313842|NCT00700622|11541271|FG000|Overall Study|Withdrawal by Subject|4
7313843|NCT00700622|11541272|FG001|Overall Study|Withdrawal by Subject|1
7313844|NCT00700622|11541271|FG000|Overall Study|Other|3
7313845|NCT00700622|11541272|FG001|Overall Study|Other|1
7313846|NCT00700635|11541281|FG000|Overall Study|Adverse Event|1
7313847|NCT00700635|11541282|FG001|Overall Study|Adverse Event|0
7313848|NCT00700635|11541283|FG002|Overall Study|Adverse Event|0
7313849|NCT00700635|11541281|FG000|Overall Study|Lost to Follow-up|1
7313850|NCT00700635|11541282|FG001|Overall Study|Lost to Follow-up|3
7313851|NCT00700635|11541283|FG002|Overall Study|Lost to Follow-up|0
7313852|NCT00700635|11541281|FG000|Overall Study|Protocol Violation|2
7313853|NCT00700635|11541282|FG001|Overall Study|Protocol Violation|2
7313854|NCT00700635|11541283|FG002|Overall Study|Protocol Violation|0
7313855|NCT00700635|11541281|FG000|Overall Study|Withdrawal by Subject|7
7313856|NCT00700635|11541282|FG001|Overall Study|Withdrawal by Subject|3
7313857|NCT00700635|11541283|FG002|Overall Study|Withdrawal by Subject|1
7313858|NCT00700713|11541294|FG000|Overall Study|Protocol Violation|1
7313859|NCT00700713|11541295|FG001|Overall Study|Protocol Violation|0
7313860|NCT00700713|11541296|FG002|Overall Study|Protocol Violation|1
7313861|NCT00700713|11541294|FG000|Overall Study|Withdrawal by Subject|0
7313862|NCT00700713|11541295|FG001|Overall Study|Withdrawal by Subject|0
7313863|NCT00700713|11541296|FG002|Overall Study|Withdrawal by Subject|1
7313864|NCT00700739|11541306|FG000|Overall Study|Lost to Follow-up|4
7313865|NCT00700739|11541307|FG001|Overall Study|Lost to Follow-up|4
7313866|NCT00700752|11541314|FG000|First Intervention|Withdrawal by Subject|0
7313867|NCT00700752|11541315|FG001|First Intervention|Withdrawal by Subject|2
7313868|NCT00700804|11541323|FG000|Overall Study|Withdrawal by Subject|1
7313869|NCT00700804|11541324|FG001|Overall Study|Withdrawal by Subject|2
7313870|NCT00700804|11541323|FG000|Overall Study|Protocol Violation|1
7313871|NCT00700804|11541324|FG001|Overall Study|Protocol Violation|1
7313872|NCT00700804|11541323|FG000|Overall Study|Loose Stools|1
7313873|NCT00700804|11541324|FG001|Overall Study|Loose Stools|1
7313874|NCT00700817|11541335|FG000|Week 0-26 (Main Period)|Adverse Event|14
7313875|NCT00700817|11541336|FG001|Week 0-26 (Main Period)|Adverse Event|15
7313876|NCT00700817|11541337|FG002|Week 0-26 (Main Period)|Adverse Event|4
7313877|NCT00700817|11541338|FG003|Week 0-26 (Main Period)|Adverse Event|0
7313878|NCT00700817|11541339|FG004|Week 0-26 (Main Period)|Adverse Event|0
7313879|NCT00700817|11541335|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
7313880|NCT00700817|11541336|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
7313881|NCT00700817|11541337|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
7313882|NCT00700817|11541338|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
7313883|NCT00700817|11541339|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
7313884|NCT00700817|11541335|FG000|Week 0-26 (Main Period)|Protocol Violation|14
7313885|NCT00700817|11541336|FG001|Week 0-26 (Main Period)|Protocol Violation|4
7313886|NCT00700817|11541337|FG002|Week 0-26 (Main Period)|Protocol Violation|4
7313887|NCT00700817|11541338|FG003|Week 0-26 (Main Period)|Protocol Violation|0
7313888|NCT00700817|11541339|FG004|Week 0-26 (Main Period)|Protocol Violation|0
7313889|NCT00700817|11541335|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
7313890|NCT00700817|11541336|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
7313891|NCT00700817|11541337|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
7313892|NCT00700817|11541338|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
7313893|NCT00700817|11541339|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
7313894|NCT00700817|11541335|FG000|Week 0-26 (Main Period)|Unclassified|14
7313895|NCT00700817|11541336|FG001|Week 0-26 (Main Period)|Unclassified|4
7313896|NCT00700817|11541337|FG002|Week 0-26 (Main Period)|Unclassified|8
7313897|NCT00700817|11541338|FG003|Week 0-26 (Main Period)|Unclassified|0
7313898|NCT00700817|11541339|FG004|Week 0-26 (Main Period)|Unclassified|0
7313899|NCT00700817|11541335|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
7313900|NCT00700817|11541336|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
7313901|NCT00700817|11541337|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
7313902|NCT00700817|11541338|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
7313903|NCT00700817|11541339|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
7313904|NCT00700817|11541335|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
7313905|NCT00700817|11541336|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
7313906|NCT00700817|11541337|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
7384428|NCT01194258|11641597|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
7313907|NCT00700817|11541338|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
7313908|NCT00700817|11541339|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
7313909|NCT00700817|11541335|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
7313910|NCT00700817|11541336|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
7313911|NCT00700817|11541337|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
7313912|NCT00700817|11541338|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7313913|NCT00700817|11541339|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
7313914|NCT00700817|11541335|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
7313915|NCT00700817|11541336|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
7313916|NCT00700817|11541337|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
7313917|NCT00700817|11541338|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7313918|NCT00700817|11541339|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
7313919|NCT00700817|11541335|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
7313920|NCT00700817|11541336|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
7313921|NCT00700817|11541337|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
7313922|NCT00700817|11541338|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
7313923|NCT00700817|11541339|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
7313924|NCT00700817|11541335|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
7313925|NCT00700817|11541336|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
7313926|NCT00700817|11541337|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
7313927|NCT00700817|11541338|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
7313928|NCT00700817|11541339|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
7313929|NCT00700817|11541335|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
7313930|NCT00700817|11541336|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
7313931|NCT00700817|11541337|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
7313932|NCT00700817|11541338|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
7313933|NCT00700817|11541339|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
7313934|NCT00700817|11541335|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7313935|NCT00700817|11541336|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
7313936|NCT00700817|11541337|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7313937|NCT00700817|11541338|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7313938|NCT00700817|11541339|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
7313939|NCT00700817|11541335|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
7313940|NCT00700817|11541336|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7313941|NCT00700817|11541337|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
7313942|NCT00700817|11541338|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
7313943|NCT00700817|11541339|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
7313944|NCT00700817|11541335|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
7313945|NCT00700817|11541336|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
7313946|NCT00700817|11541337|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
7313947|NCT00700817|11541338|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
7313948|NCT00700817|11541339|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
7313949|NCT00700999|11541360|FG000|Overall Study|Lost to Follow-up|7
7313950|NCT00700999|11541361|FG001|Overall Study|Lost to Follow-up|7
7313951|NCT00700999|11541360|FG000|Overall Study|Excluded - did not meet study criteria|0
7313952|NCT00700999|11541361|FG001|Overall Study|Excluded - did not meet study criteria|1
7313953|NCT00700999|11541360|FG000|Overall Study|Withdrawal by Subject|8
7313954|NCT00700999|11541361|FG001|Overall Study|Withdrawal by Subject|1
7313955|NCT00701038|11541369|FG000|Overall Study|study amended pilot group of patients|4
7313956|NCT00701038|11541370|FG001|Overall Study|study amended pilot group of patients|4
7313957|NCT00701051|11541378|FG000|Screening|Failed Screening|40
7313958|NCT00701051|11541379|FG001|Screening|Failed Screening|0
7313959|NCT00701051|11541380|FG002|Screening|Failed Screening|0
7313960|NCT00701051|11541378|FG000|Screening|Time conflicts|19
7313961|NCT00701051|11541379|FG001|Screening|Time conflicts|0
7313962|NCT00701051|11541380|FG002|Screening|Time conflicts|0
7313963|NCT00701051|11541378|FG000|Exercise Intervention|time conflict; non-study related illness|0
7313964|NCT00701051|11541379|FG001|Exercise Intervention|time conflict; non-study related illness|5
7313965|NCT00701051|11541380|FG002|Exercise Intervention|time conflict; non-study related illness|3
7313966|NCT00701064|11541388|FG000|Overall Study|Protocol Violation|1
7313967|NCT00701064|11541389|FG001|Overall Study|Protocol Violation|1
7313968|NCT00701064|11541388|FG000|Overall Study|Withdrawal by Subject|1
7313969|NCT00701064|11541389|FG001|Overall Study|Withdrawal by Subject|1
7313970|NCT00701064|11541388|FG000|Overall Study|initiated other PTSD treatment|2
7313971|NCT00701064|11541389|FG001|Overall Study|initiated other PTSD treatment|2
7313972|NCT00701090|11541397|FG000|Overall Study|Adverse Event|11
7313973|NCT00701090|11541398|FG001|Overall Study|Adverse Event|2
7313974|NCT00701090|11541397|FG000|Overall Study|Death|0
7313975|NCT00701090|11541398|FG001|Overall Study|Death|1
7313976|NCT00701090|11541397|FG000|Overall Study|Lack of Efficacy|5
7470512|NCT01932697|11772716|FG001|Overall Study|Ineligible|0
7313977|NCT00701090|11541398|FG001|Overall Study|Lack of Efficacy|4
7313978|NCT00701090|11541397|FG000|Overall Study|Lost to Follow-up|9
7313979|NCT00701090|11541398|FG001|Overall Study|Lost to Follow-up|9
7313980|NCT00701090|11541397|FG000|Overall Study|Physician Decision|3
7313981|NCT00701090|11541398|FG001|Overall Study|Physician Decision|4
7470513|NCT01932762|11772728|FG000|Overall Study|Withdrawal by Subject|1
7313982|NCT00701090|11541397|FG000|Overall Study|Protocol Violation|2
7313983|NCT00701090|11541398|FG001|Overall Study|Protocol Violation|3
7313984|NCT00701090|11541397|FG000|Overall Study|Withdrawal by Subject|11
7313985|NCT00701090|11541398|FG001|Overall Study|Withdrawal by Subject|16
7313986|NCT00701090|11541397|FG000|Overall Study|Other|7
7313987|NCT00701090|11541398|FG001|Overall Study|Other|12
7313988|NCT00701103|11541415|FG000|Overall Study|Adverse Event|0
7313989|NCT00701103|11541416|FG001|Overall Study|Adverse Event|0
7313990|NCT00701103|11541417|FG002|Overall Study|Adverse Event|1
7313991|NCT00701103|11541418|FG003|Overall Study|Adverse Event|1
7391465|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
7391466|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
7391467|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
7391468|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
7391469|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7391470|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
7391471|NCT01243424|11651857|FG000|Discontinuation From Study (Treated Set)|Not treated|5
7391472|NCT01243424|11651858|FG001|Discontinuation From Study (Treated Set)|Not treated|4
7391473|NCT01243424|11651857|FG000|Discontinuation From Treatment|Not treated|5
7391474|NCT01243424|11651858|FG001|Discontinuation From Treatment|Not treated|4
7391475|NCT01243424|11651857|FG000|Discontinuation From Treatment|Adverse Event|457
7391476|NCT01243424|11651858|FG001|Discontinuation From Treatment|Adverse Event|523
7391477|NCT01243424|11651857|FG000|Discontinuation From Treatment|Lack of Efficacy|61
7391478|NCT01243424|11651858|FG001|Discontinuation From Treatment|Lack of Efficacy|41
7391479|NCT01243424|11651857|FG000|Discontinuation From Treatment|Protocol Violation|46
7391480|NCT01243424|11651858|FG001|Discontinuation From Treatment|Protocol Violation|47
7391481|NCT01243424|11651857|FG000|Discontinuation From Treatment|Lost to Follow-up|24
7391482|NCT01243424|11651858|FG001|Discontinuation From Treatment|Lost to Follow-up|28
7391483|NCT01243424|11651857|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
7391484|NCT01243424|11651858|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
7391485|NCT01243424|11651857|FG000|Discontinuation From Treatment|Other than listed above|230
7391486|NCT01243424|11651858|FG001|Discontinuation From Treatment|Other than listed above|211
7391487|NCT01243671|11651911|FG000|Overall Study|Adverse Event|3
7391488|NCT01243671|11651911|FG000|Overall Study|Anti-adalimumab antibody positive|1
7391489|NCT01243671|11651911|FG000|Overall Study|Other|1
7391490|NCT01243762|11651922|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7391491|NCT01243762|11651923|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
7391492|NCT01243762|11651924|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7391493|NCT01243762|11651925|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7391494|NCT01243762|11651926|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7391495|NCT01243762|11651927|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
7391496|NCT01243762|11651928|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
7391497|NCT01243762|11651922|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7391498|NCT01243762|11651923|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7391499|NCT01243762|11651924|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7391500|NCT01243762|11651925|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
7391501|NCT01243762|11651926|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7391502|NCT01243762|11651927|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7391503|NCT01243762|11651928|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
7391504|NCT01243762|11651922|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7391505|NCT01243762|11651923|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7391506|NCT01243762|11651924|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
7391507|NCT01243762|11651925|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7470514|NCT01932762|11772729|FG001|Overall Study|Withdrawal by Subject|2
7470515|NCT01932762|11772730|FG002|Overall Study|Withdrawal by Subject|0
7470516|NCT01932762|11772731|FG003|Overall Study|Withdrawal by Subject|0
7470517|NCT01932762|11772728|FG000|Overall Study|Lost to Follow-up|4
7470518|NCT01932762|11772729|FG001|Overall Study|Lost to Follow-up|0
7470519|NCT01932762|11772730|FG002|Overall Study|Lost to Follow-up|0
7470520|NCT01932762|11772731|FG003|Overall Study|Lost to Follow-up|1
7470521|NCT01932762|11772728|FG000|Overall Study|Physician Decision|1
7470522|NCT01932762|11772729|FG001|Overall Study|Physician Decision|0
7470523|NCT01932762|11772730|FG002|Overall Study|Physician Decision|0
7470524|NCT01932762|11772731|FG003|Overall Study|Physician Decision|0
7470525|NCT01932788|11772743|FG000|Overall Study|Protocol Violation|18
7470526|NCT01932788|11772744|FG001|Overall Study|Protocol Violation|0
7470527|NCT01932788|11772743|FG000|Overall Study|Lost to Follow-up|18
7470528|NCT01932788|11772744|FG001|Overall Study|Lost to Follow-up|46
7470529|NCT01932788|11772743|FG000|Overall Study|Lack of Efficacy|2
7470530|NCT01932788|11772744|FG001|Overall Study|Lack of Efficacy|0
7470531|NCT01932788|11772743|FG000|Overall Study|Withdrawal by Subject|0
7470532|NCT01932788|11772744|FG001|Overall Study|Withdrawal by Subject|5
7470533|NCT01932970|11772750|FG000|Overall Study|Withdrawal by Subject|5
7470534|NCT01932970|11772750|FG000|Overall Study|Death|1
7470535|NCT01932970|11772750|FG000|Overall Study|Lost to Follow-up|2
7313992|NCT00701103|11541419|FG004|Overall Study|Adverse Event|0
7313993|NCT00701103|11541420|FG005|Overall Study|Adverse Event|1
7313994|NCT00701103|11541421|FG006|Overall Study|Adverse Event|1
7313995|NCT00701103|11541422|FG007|Overall Study|Adverse Event|0
7313996|NCT00701103|11541423|FG008|Overall Study|Adverse Event|0
7313997|NCT00701103|11541424|FG009|Overall Study|Adverse Event|2
7313998|NCT00701103|11541425|FG010|Overall Study|Adverse Event|0
7313999|NCT00701103|11541415|FG000|Overall Study|Progressive Disease|5
7314000|NCT00701103|11541416|FG001|Overall Study|Progressive Disease|2
7314001|NCT00701103|11541417|FG002|Overall Study|Progressive Disease|6
7314002|NCT00701103|11541418|FG003|Overall Study|Progressive Disease|5
7314003|NCT00701103|11541419|FG004|Overall Study|Progressive Disease|6
7314004|NCT00701103|11541420|FG005|Overall Study|Progressive Disease|5
7314005|NCT00701103|11541421|FG006|Overall Study|Progressive Disease|7
7314006|NCT00701103|11541422|FG007|Overall Study|Progressive Disease|7
7314007|NCT00701103|11541423|FG008|Overall Study|Progressive Disease|8
7314008|NCT00701103|11541424|FG009|Overall Study|Progressive Disease|8
7314009|NCT00701103|11541425|FG010|Overall Study|Progressive Disease|11
7314010|NCT00701103|11541415|FG000|Overall Study|Withdrawal by Subject|0
7314011|NCT00701103|11541416|FG001|Overall Study|Withdrawal by Subject|1
7314012|NCT00701103|11541417|FG002|Overall Study|Withdrawal by Subject|1
7314013|NCT00701103|11541418|FG003|Overall Study|Withdrawal by Subject|0
7314014|NCT00701103|11541419|FG004|Overall Study|Withdrawal by Subject|0
7314015|NCT00701103|11541420|FG005|Overall Study|Withdrawal by Subject|0
7314016|NCT00701103|11541421|FG006|Overall Study|Withdrawal by Subject|0
7314017|NCT00701103|11541422|FG007|Overall Study|Withdrawal by Subject|0
7314018|NCT00701103|11541423|FG008|Overall Study|Withdrawal by Subject|0
7391508|NCT01243762|11651926|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
7391509|NCT01243762|11651927|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
7391510|NCT01243762|11651928|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
7391511|NCT01243762|11651922|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391512|NCT01243762|11651923|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
7391513|NCT01243762|11651924|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391514|NCT01243762|11651925|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391515|NCT01243762|11651926|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391516|NCT01243762|11651927|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391517|NCT01243762|11651928|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
7391518|NCT01243762|11651922|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7391519|NCT01243762|11651923|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
7391520|NCT01243762|11651924|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7391521|NCT01243762|11651925|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7391522|NCT01243762|11651926|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7391523|NCT01243762|11651927|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
7391524|NCT01243762|11651928|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
7391525|NCT01243762|11651922|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7391526|NCT01243762|11651923|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7391527|NCT01243762|11651924|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7391528|NCT01243762|11651925|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
7391529|NCT01243762|11651926|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
7391530|NCT01243762|11651927|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
7391531|NCT01243762|11651928|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
7391532|NCT01243762|11651922|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7391533|NCT01243762|11651923|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7391534|NCT01243762|11651924|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7391535|NCT01243762|11651925|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7391536|NCT01243762|11651926|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
7391537|NCT01243762|11651927|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7391538|NCT01243762|11651928|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
7391539|NCT01243762|11651922|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7470536|NCT01932970|11772750|FG000|Overall Study|Protocol Specified Criteria|10
7470537|NCT01932996|11772756|FG000|Overall Study|Protocol Violation|2
7470538|NCT01932996|11772757|FG001|Overall Study|Protocol Violation|0
7470539|NCT01933048|11772765|FG000|Overall Study|Lost to Follow-up|15
7470540|NCT01933048|11772766|FG001|Overall Study|Lost to Follow-up|18
7470541|NCT01933048|11772765|FG000|Overall Study|personal reasons|1
7470542|NCT01933048|11772766|FG001|Overall Study|personal reasons|1
7470543|NCT01933048|11772765|FG000|Overall Study|Protocol Violation|7
7470544|NCT01933048|11772766|FG001|Overall Study|Protocol Violation|8
7470545|NCT01933048|11772765|FG000|Overall Study|Physician Decision|1
7470546|NCT01933048|11772766|FG001|Overall Study|Physician Decision|0
7470547|NCT01933048|11772765|FG000|Overall Study|unknown reasons|1
7470548|NCT01933048|11772766|FG001|Overall Study|unknown reasons|1
7314019|NCT00701103|11541424|FG009|Overall Study|Withdrawal by Subject|0
7314020|NCT00701103|11541425|FG010|Overall Study|Withdrawal by Subject|0
7314021|NCT00701103|11541415|FG000|Overall Study|Other|0
7314022|NCT00701103|11541416|FG001|Overall Study|Other|0
7314023|NCT00701103|11541417|FG002|Overall Study|Other|0
7314024|NCT00701103|11541418|FG003|Overall Study|Other|0
7314025|NCT00701103|11541419|FG004|Overall Study|Other|0
7314026|NCT00701103|11541420|FG005|Overall Study|Other|0
7314027|NCT00701103|11541421|FG006|Overall Study|Other|0
7314028|NCT00701103|11541422|FG007|Overall Study|Other|0
7314029|NCT00701103|11541423|FG008|Overall Study|Other|1
7314030|NCT00701103|11541424|FG009|Overall Study|Other|1
7314031|NCT00701103|11541425|FG010|Overall Study|Other|0
7314032|NCT00701129|11541453|FG000|Overall Study|Death|2
7314033|NCT00701311|11541457|FG000|Overall Study|Lack of Efficacy|3
7314034|NCT00701311|11541457|FG000|Overall Study|Adverse Event|3
7314035|NCT00701311|11541457|FG000|Overall Study|Withdrawal by Subject|2
7314036|NCT00701363|11541465|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
7314037|NCT00701363|11541466|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7314038|NCT00701363|11541467|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7314039|NCT00701363|11541468|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
7314040|NCT00701363|11541465|FG000|Treatment Phase 1|Does not meet entry Criteria|1
7314041|NCT00701363|11541466|FG001|Treatment Phase 1|Does not meet entry Criteria|0
7314042|NCT00701363|11541467|FG002|Treatment Phase 1|Does not meet entry Criteria|0
7314043|NCT00701363|11541468|FG003|Treatment Phase 1|Does not meet entry Criteria|0
7314044|NCT00701363|11541465|FG000|Treatment Phase 1|Adverse Event|7
7314045|NCT00701363|11541466|FG001|Treatment Phase 1|Adverse Event|0
7314046|NCT00701363|11541467|FG002|Treatment Phase 1|Adverse Event|0
7470549|NCT01933113|11772775|FG000|Overall Study|Fractured nonfunctioning lead.|1
7470550|NCT01933217|11772781|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
7470551|NCT01933217|11772782|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
7470552|NCT01933217|11772781|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
7470553|NCT01933217|11772782|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
7470554|NCT01933334|11772805|FG000|Overall Study|Adverse Event|5
7470555|NCT01933334|11772806|FG001|Overall Study|Adverse Event|1
7470556|NCT01933334|11772805|FG000|Overall Study|Withdrawal by Subject|0
7470557|NCT01933334|11772806|FG001|Overall Study|Withdrawal by Subject|1
7470558|NCT01933594|11772849|FG000|Overall Study|Lost to Follow-up|1
7470559|NCT01933594|11772850|FG001|Overall Study|Lost to Follow-up|0
7470560|NCT01933594|11772851|FG002|Overall Study|Lost to Follow-up|0
7470561|NCT01933594|11772852|FG003|Overall Study|Lost to Follow-up|0
7470562|NCT01933594|11772853|FG004|Overall Study|Lost to Follow-up|1
7470563|NCT01933594|11772854|FG005|Overall Study|Lost to Follow-up|0
7470564|NCT01933594|11772849|FG000|Overall Study|Ineligible for subsequent study step|0
7470565|NCT01933594|11772850|FG001|Overall Study|Ineligible for subsequent study step|0
7470566|NCT01933594|11772851|FG002|Overall Study|Ineligible for subsequent study step|0
7470567|NCT01933594|11772852|FG003|Overall Study|Ineligible for subsequent study step|0
7470568|NCT01933594|11772853|FG004|Overall Study|Ineligible for subsequent study step|1
7470569|NCT01933594|11772854|FG005|Overall Study|Ineligible for subsequent study step|0
7470570|NCT01933672|11772872|FG000|Metformin Run-in Period|Adverse Event|1
7470571|NCT01933672|11772873|FG001|Metformin Run-in Period|Adverse Event|0
7470572|NCT01933672|11772874|FG002|Metformin Run-in Period|Adverse Event|0
7470573|NCT01933672|11772875|FG003|Metformin Run-in Period|Adverse Event|0
7470574|NCT01933672|11772876|FG004|Metformin Run-in Period|Adverse Event|0
7470575|NCT01933672|11772877|FG005|Metformin Run-in Period|Adverse Event|0
7470576|NCT01933672|11772878|FG006|Metformin Run-in Period|Adverse Event|0
7470577|NCT01933672|11772872|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
7470578|NCT01933672|11772873|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
7470579|NCT01933672|11772874|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
7470580|NCT01933672|11772875|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
7470581|NCT01933672|11772876|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
7552935|NCT03001557|11913498|FG001|Extension Phase|Administrative Reason|0
7552936|NCT03001557|11913499|FG002|Extension Phase|Administrative Reason|0
7552937|NCT03001557|11913500|FG003|Extension Phase|Administrative Reason|0
7552938|NCT03001557|11913501|FG004|Extension Phase|Administrative Reason|0
7552939|NCT03001557|11913502|FG005|Extension Phase|Administrative Reason|1
7552940|NCT03001557|11913503|FG006|Extension Phase|Administrative Reason|3
7552941|NCT03001557|11913504|FG007|Extension Phase|Administrative Reason|3
7552942|NCT03001557|11913497|FG000|Extension Phase|Loss of caregiver|0
7552943|NCT03001557|11913498|FG001|Extension Phase|Loss of caregiver|0
7552944|NCT03001557|11913499|FG002|Extension Phase|Loss of caregiver|0
7552945|NCT03001557|11913500|FG003|Extension Phase|Loss of caregiver|0
7552946|NCT03001557|11913501|FG004|Extension Phase|Loss of caregiver|0
7552947|NCT03001557|11913502|FG005|Extension Phase|Loss of caregiver|0
7552948|NCT03001557|11913503|FG006|Extension Phase|Loss of caregiver|1
7552949|NCT03001557|11913504|FG007|Extension Phase|Loss of caregiver|0
7552950|NCT03001557|11913497|FG000|Extension Phase|Others|0
7552951|NCT03001557|11913498|FG001|Extension Phase|Others|0
7552952|NCT03001557|11913499|FG002|Extension Phase|Others|0
7552953|NCT03001557|11913500|FG003|Extension Phase|Others|0
7552954|NCT03001557|11913501|FG004|Extension Phase|Others|0
7552955|NCT03001557|11913502|FG005|Extension Phase|Others|1
7552956|NCT03001557|11913503|FG006|Extension Phase|Others|3
7552957|NCT03001557|11913504|FG007|Extension Phase|Others|0
7552958|NCT03002038|11913564|FG000|Overall Study|Adverse Event|3
7552959|NCT03002038|11913565|FG001|Overall Study|Adverse Event|1
7314047|NCT00701363|11541468|FG003|Treatment Phase 1|Adverse Event|0
7552960|NCT03002038|11913564|FG000|Overall Study|Withdrawal by Subject|8
7552961|NCT03002038|11913565|FG001|Overall Study|Withdrawal by Subject|4
7552962|NCT03002038|11913564|FG000|Overall Study|Immigration to another region|0
7314048|NCT00701363|11541465|FG000|Treatment Phase 1|Protocol Violation|1
7314049|NCT00701363|11541466|FG001|Treatment Phase 1|Protocol Violation|0
7314050|NCT00701363|11541467|FG002|Treatment Phase 1|Protocol Violation|0
7314051|NCT00701363|11541468|FG003|Treatment Phase 1|Protocol Violation|0
7314052|NCT00701363|11541465|FG000|Treatment Phase 1|Withdrawal by Subject|5
7314053|NCT00701363|11541466|FG001|Treatment Phase 1|Withdrawal by Subject|0
7314054|NCT00701363|11541467|FG002|Treatment Phase 1|Withdrawal by Subject|0
7314055|NCT00701363|11541468|FG003|Treatment Phase 1|Withdrawal by Subject|0
7314056|NCT00701363|11541465|FG000|Treatment Phase 1|Lack of Efficacy|1
7314057|NCT00701363|11541466|FG001|Treatment Phase 1|Lack of Efficacy|0
7314058|NCT00701363|11541467|FG002|Treatment Phase 1|Lack of Efficacy|0
7314059|NCT00701363|11541468|FG003|Treatment Phase 1|Lack of Efficacy|0
7314060|NCT00701363|11541465|FG000|Treatment Phase 2|Adverse Event|0
7314061|NCT00701363|11541466|FG001|Treatment Phase 2|Adverse Event|0
7314062|NCT00701363|11541467|FG002|Treatment Phase 2|Adverse Event|1
7314063|NCT00701363|11541468|FG003|Treatment Phase 2|Adverse Event|0
7391540|NCT01243762|11651923|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7391541|NCT01243762|11651924|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7391542|NCT01243762|11651925|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7391543|NCT01243762|11651926|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
7391544|NCT01243762|11651927|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7391545|NCT01243762|11651928|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
7391546|NCT01243775|11651947|FG000|Overall Study|Withdrawal by Subject|2
7391547|NCT01243944|11651953|FG000|Overall Study|Adverse Event|15
7391548|NCT01243944|11651954|FG001|Overall Study|Adverse Event|13
7391549|NCT01243944|11651953|FG000|Overall Study|Lost to Follow-up|2
7391550|NCT01243944|11651954|FG001|Overall Study|Lost to Follow-up|1
7391551|NCT01243944|11651953|FG000|Overall Study|Physician Decision|2
7391552|NCT01243944|11651954|FG001|Overall Study|Physician Decision|7
7391553|NCT01243944|11651953|FG000|Overall Study|Disease progression|12
7391554|NCT01243944|11651954|FG001|Overall Study|Disease progression|11
7391555|NCT01243944|11651953|FG000|Overall Study|Protocol deviation|1
7391556|NCT01243944|11651954|FG001|Overall Study|Protocol deviation|1
7391557|NCT01243944|11651953|FG000|Overall Study|Participant decision|10
7391558|NCT01243944|11651954|FG001|Overall Study|Participant decision|15
7391559|NCT01243944|11651953|FG000|Overall Study|Death|2
7391560|NCT01243944|11651954|FG001|Overall Study|Death|3
7391561|NCT01243944|11651953|FG000|Overall Study|Non-compliance with study treatment|1
7391562|NCT01243944|11651954|FG001|Overall Study|Non-compliance with study treatment|0
7391563|NCT01244035|11651967|FG000|Part 1: Period 1|Adverse Event|0
7391564|NCT01244035|11651968|FG001|Part 1: Period 1|Adverse Event|0
7391565|NCT01244035|11651969|FG002|Part 1: Period 1|Adverse Event|0
7391566|NCT01244035|11651970|FG003|Part 1: Period 1|Adverse Event|0
7470582|NCT01933672|11772877|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
7470583|NCT01933672|11772878|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
7470584|NCT01933672|11772872|FG000|Metformin Run-in Period|Other|5
7470585|NCT01933672|11772873|FG001|Metformin Run-in Period|Other|0
7470586|NCT01933672|11772874|FG002|Metformin Run-in Period|Other|0
7470587|NCT01933672|11772875|FG003|Metformin Run-in Period|Other|0
7470588|NCT01933672|11772876|FG004|Metformin Run-in Period|Other|0
7470589|NCT01933672|11772877|FG005|Metformin Run-in Period|Other|0
7470590|NCT01933672|11772878|FG006|Metformin Run-in Period|Other|0
7470591|NCT01933672|11772872|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470592|NCT01933672|11772873|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470593|NCT01933672|11772874|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470594|NCT01933672|11772875|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470595|NCT01933672|11772876|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
7470596|NCT01933672|11772877|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470597|NCT01933672|11772878|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
7470598|NCT01933672|11772872|FG000|First Intervention Period (12-16 Days)|Other|0
7470599|NCT01933672|11772873|FG001|First Intervention Period (12-16 Days)|Other|0
7391567|NCT01244035|11651971|FG004|Part 1: Period 1|Adverse Event|0
7391568|NCT01244035|11651972|FG005|Part 1: Period 1|Adverse Event|1
7391569|NCT01244035|11651967|FG000|Part 1: Period 1|Withdrawal by Subject|0
7391570|NCT01244035|11651968|FG001|Part 1: Period 1|Withdrawal by Subject|2
7391571|NCT01244035|11651969|FG002|Part 1: Period 1|Withdrawal by Subject|0
7391572|NCT01244035|11651970|FG003|Part 1: Period 1|Withdrawal by Subject|0
7391573|NCT01244035|11651971|FG004|Part 1: Period 1|Withdrawal by Subject|0
7391574|NCT01244035|11651972|FG005|Part 1: Period 1|Withdrawal by Subject|0
7391575|NCT01244035|11651967|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
7391576|NCT01244035|11651968|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
7391577|NCT01244035|11651969|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
7391578|NCT01244035|11651970|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
7470600|NCT01933672|11772874|FG002|First Intervention Period (12-16 Days)|Other|1
7470601|NCT01933672|11772875|FG003|First Intervention Period (12-16 Days)|Other|0
7470602|NCT01933672|11772876|FG004|First Intervention Period (12-16 Days)|Other|0
7470603|NCT01933672|11772877|FG005|First Intervention Period (12-16 Days)|Other|1
7470604|NCT01933672|11772878|FG006|First Intervention Period (12-16 Days)|Other|0
7470605|NCT01933672|11772872|FG000|Second Intervention Period (12-16 Days)|Other|0
7391579|NCT01244035|11651971|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
7391580|NCT01244035|11651972|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
7314064|NCT00701363|11541465|FG000|Treatment Phase 2|Withdrawal by Subject|0
7314065|NCT00701363|11541466|FG001|Treatment Phase 2|Withdrawal by Subject|0
7314066|NCT00701363|11541467|FG002|Treatment Phase 2|Withdrawal by Subject|1
7314067|NCT00701363|11541468|FG003|Treatment Phase 2|Withdrawal by Subject|0
7314068|NCT00701415|11541512|FG000|Overall Study|Adverse Event|0
7314069|NCT00701415|11541513|FG001|Overall Study|Adverse Event|1
7314070|NCT00701415|11541512|FG000|Overall Study|Social/family issues and needle phobia|1
7314071|NCT00701415|11541513|FG001|Overall Study|Social/family issues and needle phobia|0
7314072|NCT00701441|11541521|FG000|Overall Study|failure in cpap compliance|0
7314073|NCT00701441|11541522|FG001|Overall Study|failure in cpap compliance|4
7314074|NCT00701558|11541532|FG000|Overall Study|Death|7
7314075|NCT00701558|11541532|FG000|Overall Study|Lost to Follow-up|8
7314076|NCT00701662|11541544|FG000|Overall Study|Lack of Efficacy|1
7314077|NCT00701701|11541563|FG000|Overall Study|Withdrawal by Subject|0
7314078|NCT00701701|11541564|FG001|Overall Study|Withdrawal by Subject|1
7314079|NCT00701701|11541563|FG000|Overall Study|Adverse Event|0
7314080|NCT00701701|11541564|FG001|Overall Study|Adverse Event|1
7314081|NCT00701727|11541584|FG000|First Treatment Period|Adverse Event|0
7314082|NCT00701727|11541585|FG001|First Treatment Period|Adverse Event|0
7314083|NCT00701727|11541584|FG000|First Treatment Period|Withdrawal by Subject|1
7314084|NCT00701727|11541585|FG001|First Treatment Period|Withdrawal by Subject|0
7314085|NCT00701727|11541584|FG000|First Treatment Period|sponsor decision|0
7314086|NCT00701727|11541585|FG001|First Treatment Period|sponsor decision|1
7314087|NCT00701727|11541584|FG000|First Treatment Period|Lost to Follow-up|0
7314088|NCT00701727|11541585|FG001|First Treatment Period|Lost to Follow-up|1
7314089|NCT00701727|11541584|FG000|Second Treatment Period|Withdrawal by Subject|2
7314090|NCT00701727|11541585|FG001|Second Treatment Period|Withdrawal by Subject|0
7314091|NCT00701779|11541591|FG000|Overall Study|Adverse Event|6
7314092|NCT00701779|11541591|FG000|Overall Study|Lost to Follow-up|1
7314093|NCT00701779|11541591|FG000|Overall Study|Withdrawal by Subject|2
7314094|NCT00701805|11541599|FG000|Overall Study|Withdrawal by Subject|3
7314095|NCT00701805|11541600|FG001|Overall Study|Withdrawal by Subject|1
7314096|NCT00701805|11541601|FG002|Overall Study|Withdrawal by Subject|4
7314097|NCT00701805|11541602|FG003|Overall Study|Withdrawal by Subject|3
7314098|NCT00701805|11541599|FG000|Overall Study|Adverse Event|0
7314099|NCT00701805|11541600|FG001|Overall Study|Adverse Event|1
7314100|NCT00701805|11541601|FG002|Overall Study|Adverse Event|1
7314101|NCT00701805|11541602|FG003|Overall Study|Adverse Event|0
7314102|NCT00701805|11541599|FG000|Overall Study|Missed 7 consecutive doses|0
7314103|NCT00701805|11541600|FG001|Overall Study|Missed 7 consecutive doses|1
7314104|NCT00701805|11541601|FG002|Overall Study|Missed 7 consecutive doses|0
7314105|NCT00701805|11541602|FG003|Overall Study|Missed 7 consecutive doses|0
7314106|NCT00701805|11541599|FG000|Overall Study|Admitted to hospital for 2 weeks|0
7314107|NCT00701805|11541600|FG001|Overall Study|Admitted to hospital for 2 weeks|0
7314108|NCT00701805|11541601|FG002|Overall Study|Admitted to hospital for 2 weeks|1
7314109|NCT00701805|11541602|FG003|Overall Study|Admitted to hospital for 2 weeks|0
7314110|NCT00701805|11541599|FG000|Overall Study|Physician decision, change of therapy|0
7314111|NCT00701805|11541600|FG001|Overall Study|Physician decision, change of therapy|0
7314112|NCT00701805|11541601|FG002|Overall Study|Physician decision, change of therapy|0
7314113|NCT00701805|11541602|FG003|Overall Study|Physician decision, change of therapy|1
7314114|NCT00701805|11541599|FG000|Overall Study|Difficult to travel to dialysis site|0
7314115|NCT00701805|11541600|FG001|Overall Study|Difficult to travel to dialysis site|0
7314116|NCT00701805|11541601|FG002|Overall Study|Difficult to travel to dialysis site|1
7314117|NCT00701805|11541602|FG003|Overall Study|Difficult to travel to dialysis site|0
7314118|NCT00701805|11541599|FG000|Overall Study|Resumption criteria were not met|0
7314119|NCT00701805|11541600|FG001|Overall Study|Resumption criteria were not met|1
7314120|NCT00701805|11541601|FG002|Overall Study|Resumption criteria were not met|0
7314121|NCT00701805|11541602|FG003|Overall Study|Resumption criteria were not met|0
7314122|NCT00702052|11541630|FG000|Overall Study|Adverse Event|23
7470606|NCT01933672|11772873|FG001|Second Intervention Period (12-16 Days)|Other|1
7470607|NCT01933672|11772874|FG002|Second Intervention Period (12-16 Days)|Other|1
7314123|NCT00702052|11541630|FG000|Overall Study|Disease Progression|30
7314124|NCT00702052|11541630|FG000|Overall Study|Withdrawal by Subject|5
7314125|NCT00702143|11541637|FG000|Overall Study|Lost to Follow-up|0
7314126|NCT00702143|11541638|FG001|Overall Study|Lost to Follow-up|0
7314127|NCT00702143|11541639|FG002|Overall Study|Lost to Follow-up|1
7314128|NCT00702208|11541645|FG000|Overall Study|Lost to Follow-up|28
7314129|NCT00702208|11541645|FG000|Overall Study|Did not self-lavage|1
7314130|NCT00702208|11541645|FG000|Overall Study|Unsatisfactory colposcopy|2
7314131|NCT00702221|11541652|FG000|Overall Study|Adverse Event|4
7314132|NCT00702221|11541653|FG001|Overall Study|Adverse Event|3
7391581|NCT01244035|11651967|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
7391582|NCT01244035|11651968|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
7391583|NCT01244035|11651969|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
7391584|NCT01244035|11651970|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
7391585|NCT01244035|11651971|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
7391586|NCT01244035|11651972|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
7391587|NCT01244035|11651967|FG000|Part 1: Period 3|Adverse Event|0
7391588|NCT01244035|11651968|FG001|Part 1: Period 3|Adverse Event|0
7391589|NCT01244035|11651969|FG002|Part 1: Period 3|Adverse Event|0
7314133|NCT00702325|11541668|FG000|Overall Study|Adverse Event|1
7314134|NCT00702325|11541669|FG001|Overall Study|Adverse Event|0
7314135|NCT00702325|11541668|FG000|Overall Study|Withdrawal by Subject|7
7314136|NCT00702325|11541669|FG001|Overall Study|Withdrawal by Subject|7
7314137|NCT00702325|11541668|FG000|Overall Study|Lost to Follow-up|3
7314138|NCT00702325|11541669|FG001|Overall Study|Lost to Follow-up|4
7314139|NCT00702325|11541668|FG000|Overall Study|Incorrect enrollment|5
7314140|NCT00702325|11541669|FG001|Overall Study|Incorrect enrollment|7
7314141|NCT00702325|11541668|FG000|Overall Study|Developed study discontinuation criteria|18
7314142|NCT00702325|11541669|FG001|Overall Study|Developed study discontinuation criteria|28
7314143|NCT00702325|11541668|FG000|Overall Study|Severe noncompliance to protocol|3
7314144|NCT00702325|11541669|FG001|Overall Study|Severe noncompliance to protocol|3
7314145|NCT00702325|11541668|FG000|Overall Study|Termination due to lab results|1
7314146|NCT00702325|11541669|FG001|Overall Study|Termination due to lab results|0
7314147|NCT00702325|11541668|FG000|Overall Study|Didn't follow study medication dosage|0
7314148|NCT00702325|11541669|FG001|Overall Study|Didn't follow study medication dosage|2
7314149|NCT00702325|11541668|FG000|Overall Study|Withdrew consent|0
7314150|NCT00702325|11541669|FG001|Overall Study|Withdrew consent|1
7314151|NCT00702325|11541668|FG000|Overall Study|Incorrectly Discontinued|0
7314152|NCT00702325|11541669|FG001|Overall Study|Incorrectly Discontinued|1
7314153|NCT00702403|11541693|FG000|From Consent to Engraftment|Progressive leukemia|6
7314154|NCT00702403|11541693|FG000|From Consent to Engraftment|Critically ill|2
7314155|NCT00702403|11541693|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
7314156|NCT00702403|11541693|FG000|From Consent to Engraftment|Myocardial infarction|1
7314157|NCT00702403|11541693|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
7314158|NCT00702403|11541693|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
7314159|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
7314160|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
7314161|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Non-compliance|2
7314162|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
7314163|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Liver GVHD|1
7314164|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Suicide|1
7314165|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
7314166|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
7314167|NCT00702403|11541693|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
7314168|NCT00702507|11541709|FG000|Initial Treatment Phase|Adverse Event|2
7314169|NCT00702507|11541709|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
7314170|NCT00702507|11541709|FG000|Initial Treatment Phase|Lost to Follow-up|2
7314171|NCT00702507|11541709|FG000|Initial Treatment Phase|Negative Candida Culture|34
7314172|NCT00702507|11541709|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
7314173|NCT00702507|11541709|FG000|Follow-up Phase|Protocol Violation|2
7314174|NCT00702507|11541709|FG000|Follow-up Phase|Lost to Follow-up|23
7314175|NCT00702507|11541709|FG000|Follow-up Phase|Late Enrollment|1
7314176|NCT00702650|11541714|FG000|Overall Study|Withdrawal by Subject|9
7314177|NCT00702650|11541714|FG000|Overall Study|Non-Compliance of Study Drug|3
7314178|NCT00702650|11541714|FG000|Overall Study|Lost to Follow-up|2
7314179|NCT00702650|11541714|FG000|Overall Study|Non-Compliance with Site Directives|1
7314180|NCT00702650|11541714|FG000|Overall Study|Sponsor Request|1
7314181|NCT00702650|11541714|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
7314182|NCT00702650|11541714|FG000|Overall Study|Adverse Event|3
7314183|NCT00702689|11541718|FG000|Overall Study|Withdrawal by Subject|4
7314184|NCT00702689|11541718|FG000|Overall Study|Recurrent malignancy|1
7314185|NCT00702689|11541718|FG000|Overall Study|Adverse Event|1
7314186|NCT00702715|11541724|FG000|Overall Study|Lost to Follow-up|1
7314187|NCT00702715|11541725|FG001|Overall Study|Lost to Follow-up|0
7314188|NCT00702923|11541751|FG000|Overall Study|Adverse Event|1
7314189|NCT00702949|11541759|FG000|Overall Study|Refusal|3
7314190|NCT00702949|11541760|FG001|Overall Study|Refusal|2
7314191|NCT00702949|11541761|FG002|Overall Study|Refusal|2
7314192|NCT00702949|11541759|FG000|Overall Study|Adverse Event|1
7314193|NCT00702949|11541760|FG001|Overall Study|Adverse Event|6
7470608|NCT01933672|11772875|FG003|Second Intervention Period (12-16 Days)|Other|0
7470609|NCT01933672|11772876|FG004|Second Intervention Period (12-16 Days)|Other|0
7470610|NCT01933672|11772877|FG005|Second Intervention Period (12-16 Days)|Other|0
7470611|NCT01933672|11772878|FG006|Second Intervention Period (12-16 Days)|Other|0
7470612|NCT01933672|11772872|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7470613|NCT01933672|11772873|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7470614|NCT01933672|11772874|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7470615|NCT01933672|11772875|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
7470616|NCT01933672|11772876|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7470617|NCT01933672|11772877|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7314194|NCT00702949|11541761|FG002|Overall Study|Adverse Event|3
7314195|NCT00702949|11541759|FG000|Overall Study|Other Medical Reason/unknown|1
7314196|NCT00702949|11541760|FG001|Overall Study|Other Medical Reason/unknown|1
7314197|NCT00702949|11541761|FG002|Overall Study|Other Medical Reason/unknown|3
7314198|NCT00703118|11541813|FG000|Overall Study|Adverse Event|1
7470618|NCT01933672|11772878|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
7314279|NCT00704184|11541994|FG004|Open-Label Treatment|Physician Decision|1
7470619|NCT01933672|11772872|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470620|NCT01933672|11772873|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
7314199|NCT00703118|11541814|FG001|Overall Study|Adverse Event|2
7314200|NCT00703118|11541815|FG002|Overall Study|Adverse Event|2
7314201|NCT00703118|11541813|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
7314202|NCT00703118|11541814|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
7314203|NCT00703118|11541815|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
7314204|NCT00703118|11541813|FG000|Overall Study|Lost to Follow-up|6
7314205|NCT00703118|11541814|FG001|Overall Study|Lost to Follow-up|4
7314206|NCT00703118|11541815|FG002|Overall Study|Lost to Follow-up|4
7314207|NCT00703118|11541813|FG000|Overall Study|Withdrawal by Subject|8
7314208|NCT00703118|11541814|FG001|Overall Study|Withdrawal by Subject|7
7314209|NCT00703118|11541815|FG002|Overall Study|Withdrawal by Subject|13
7314210|NCT00703118|11541813|FG000|Overall Study|Other|0
7314211|NCT00703118|11541814|FG001|Overall Study|Other|0
7314212|NCT00703118|11541815|FG002|Overall Study|Other|1
7314213|NCT00703157|11541828|FG000|Overall Study|Lost to Follow-up|0
7314214|NCT00703157|11541829|FG001|Overall Study|Lost to Follow-up|1
7314215|NCT00703157|11541828|FG000|Overall Study|source data permanently lost/ other|4
7314216|NCT00703157|11541829|FG001|Overall Study|source data permanently lost/ other|1
7314217|NCT00703677|11541875|FG000|Overall Study|Dropout-withdrawal not related to drug|3
7314218|NCT00703781|11541890|FG000|Overall Study|Withdrawal by Subject|1
7314219|NCT00703781|11541891|FG001|Overall Study|Withdrawal by Subject|2
7314220|NCT00703781|11541890|FG000|Overall Study|Cancelled surgery|1
7314221|NCT00703781|11541891|FG001|Overall Study|Cancelled surgery|0
7314222|NCT00703820|11541899|FG000|Overall Study|Adverse Event|12
7314223|NCT00703820|11541900|FG001|Overall Study|Adverse Event|17
7314224|NCT00703820|11541899|FG000|Overall Study|Death|5
7314225|NCT00703820|11541900|FG001|Overall Study|Death|0
7314226|NCT00703820|11541899|FG000|Overall Study|Lack of Efficacy|11
7314227|NCT00703820|11541900|FG001|Overall Study|Lack of Efficacy|11
7314228|NCT00703820|11541899|FG000|Overall Study|Received non-protocol therapy|1
7314229|NCT00703820|11541900|FG001|Overall Study|Received non-protocol therapy|0
7314230|NCT00703820|11541899|FG000|Overall Study|Physician Decision|4
7314231|NCT00703820|11541900|FG001|Overall Study|Physician Decision|5
7314232|NCT00703820|11541899|FG000|Overall Study|Withdrawal by Subject|2
7314233|NCT00703820|11541900|FG001|Overall Study|Withdrawal by Subject|1
7314234|NCT00703846|11541908|FG000|Overall Study|Adverse Event|8
7314235|NCT00703846|11541908|FG000|Overall Study|Lost to Follow-up|55
7314236|NCT00703846|11541908|FG000|Overall Study|Lack of Efficacy|15
7314237|NCT00703846|11541908|FG000|Overall Study|Noncompliance with Study Treatment|2
7314238|NCT00703846|11541908|FG000|Overall Study|Withdrawal by Subject|40
7314239|NCT00703846|11541908|FG000|Overall Study|Death|1
7314240|NCT00703846|11541908|FG000|Overall Study|Other|14
7314241|NCT00703846|11541908|FG000|Overall Study|Did Not Receive Study Drug|2
7314242|NCT00703911|11541912|FG000|Overall Study|Death|1
7314243|NCT00703911|11541912|FG000|Overall Study|Physician Decision|6
7314244|NCT00703911|11541912|FG000|Overall Study|Lost to Follow-up|1
7314245|NCT00703911|11541912|FG000|Overall Study|Withdrawal by Subject|2
7314246|NCT00703924|11541918|FG000|Overall Study|Withdrawal by Subject|1
7314247|NCT00703924|11541919|FG001|Overall Study|Withdrawal by Subject|1
7314248|NCT00703963|11541940|FG000|Overall Study|Withdrawal by Subject|7
7314249|NCT00703963|11541941|FG001|Overall Study|Withdrawal by Subject|13
7314250|NCT00703963|11541940|FG000|Overall Study|Physician Decision|0
7314251|NCT00703963|11541941|FG001|Overall Study|Physician Decision|1
7314252|NCT00704132|11541969|FG000|Overall Study|Clinical Adverse Experience|1
7314253|NCT00704132|11541970|FG001|Overall Study|Clinical Adverse Experience|0
7314254|NCT00704132|11541969|FG000|Overall Study|Lack of Efficacy|0
7314255|NCT00704132|11541970|FG001|Overall Study|Lack of Efficacy|1
7314256|NCT00704132|11541969|FG000|Overall Study|Withdrawal by Subject|0
7314257|NCT00704132|11541970|FG001|Overall Study|Withdrawal by Subject|1
7314258|NCT00704171|11541978|FG000|Overall Study|Withdrawal by Subject|1
7314259|NCT00704171|11541979|FG001|Overall Study|Withdrawal by Subject|0
7314260|NCT00704184|11541990|FG000|Double-Blind Treatment|Withdrawal by Subject|1
7314261|NCT00704184|11541991|FG001|Double-Blind Treatment|Withdrawal by Subject|0
7314262|NCT00704184|11541992|FG002|Double-Blind Treatment|Withdrawal by Subject|0
7314263|NCT00704184|11541993|FG003|Double-Blind Treatment|Withdrawal by Subject|0
7314264|NCT00704184|11541994|FG004|Double-Blind Treatment|Withdrawal by Subject|0
7314265|NCT00704184|11541990|FG000|Open-Label Treatment|Adverse Event|0
7314266|NCT00704184|11541991|FG001|Open-Label Treatment|Adverse Event|0
7314267|NCT00704184|11541992|FG002|Open-Label Treatment|Adverse Event|2
7314268|NCT00704184|11541993|FG003|Open-Label Treatment|Adverse Event|0
7314269|NCT00704184|11541994|FG004|Open-Label Treatment|Adverse Event|1
7314270|NCT00704184|11541990|FG000|Open-Label Treatment|Lack of Efficacy|0
7314271|NCT00704184|11541991|FG001|Open-Label Treatment|Lack of Efficacy|2
7314272|NCT00704184|11541992|FG002|Open-Label Treatment|Lack of Efficacy|2
7314273|NCT00704184|11541993|FG003|Open-Label Treatment|Lack of Efficacy|2
7314274|NCT00704184|11541994|FG004|Open-Label Treatment|Lack of Efficacy|1
7314275|NCT00704184|11541990|FG000|Open-Label Treatment|Physician Decision|0
7314276|NCT00704184|11541991|FG001|Open-Label Treatment|Physician Decision|0
7314277|NCT00704184|11541992|FG002|Open-Label Treatment|Physician Decision|0
7314278|NCT00704184|11541993|FG003|Open-Label Treatment|Physician Decision|0
7314280|NCT00704184|11541990|FG000|Open-Label Treatment|Withdrawal by Subject|1
7314281|NCT00704184|11541991|FG001|Open-Label Treatment|Withdrawal by Subject|0
7314282|NCT00704184|11541992|FG002|Open-Label Treatment|Withdrawal by Subject|0
7314283|NCT00704184|11541993|FG003|Open-Label Treatment|Withdrawal by Subject|3
7314284|NCT00704184|11541994|FG004|Open-Label Treatment|Withdrawal by Subject|0
7314285|NCT00704340|11542012|FG000|Overall Study|Lost to Follow-up|2
7470621|NCT01933672|11772874|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470622|NCT01933672|11772875|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470623|NCT01933672|11772876|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470624|NCT01933672|11772877|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470625|NCT01933672|11772878|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
7470626|NCT01933789|11772909|FG000|Overall Study|Death|0
7470627|NCT01933789|11772910|FG001|Overall Study|Death|0
7470628|NCT01933789|11772911|FG002|Overall Study|Death|0
7470629|NCT01933789|11772912|FG003|Overall Study|Death|0
7470630|NCT01933789|11772913|FG004|Overall Study|Death|21
7470631|NCT01933789|11772914|FG005|Overall Study|Death|32
7314286|NCT00704340|11542013|FG001|Overall Study|Lost to Follow-up|1
7314287|NCT00704340|11542012|FG000|Overall Study|Death|0
7314288|NCT00704340|11542013|FG001|Overall Study|Death|1
7384429|NCT01194258|11641598|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
7470632|NCT01933789|11772915|FG006|Overall Study|Death|0
7470633|NCT01933789|11772916|FG007|Overall Study|Death|0
7470634|NCT01933789|11772917|FG008|Overall Study|Death|0
7470635|NCT01933789|11772909|FG000|Overall Study|Lost to Follow-up|0
7470636|NCT01933789|11772910|FG001|Overall Study|Lost to Follow-up|0
7470637|NCT01933789|11772911|FG002|Overall Study|Lost to Follow-up|0
7470638|NCT01933789|11772912|FG003|Overall Study|Lost to Follow-up|1
7470639|NCT01933789|11772913|FG004|Overall Study|Lost to Follow-up|8
7470640|NCT01933789|11772914|FG005|Overall Study|Lost to Follow-up|9
7470641|NCT01933789|11772915|FG006|Overall Study|Lost to Follow-up|1
7470642|NCT01933789|11772916|FG007|Overall Study|Lost to Follow-up|4
7470643|NCT01933789|11772917|FG008|Overall Study|Lost to Follow-up|0
7470644|NCT01933789|11772909|FG000|Overall Study|Withdrawal by Subject|2
7470645|NCT01933789|11772910|FG001|Overall Study|Withdrawal by Subject|1
7470646|NCT01933789|11772911|FG002|Overall Study|Withdrawal by Subject|0
7470647|NCT01933789|11772912|FG003|Overall Study|Withdrawal by Subject|0
7470648|NCT01933789|11772913|FG004|Overall Study|Withdrawal by Subject|17
7470649|NCT01933789|11772914|FG005|Overall Study|Withdrawal by Subject|16
7470650|NCT01933789|11772915|FG006|Overall Study|Withdrawal by Subject|1
7470651|NCT01933789|11772916|FG007|Overall Study|Withdrawal by Subject|4
7470652|NCT01933789|11772917|FG008|Overall Study|Withdrawal by Subject|0
7470653|NCT01933789|11772909|FG000|Overall Study|Became Ineligible|4
7470654|NCT01933789|11772910|FG001|Overall Study|Became Ineligible|0
7470655|NCT01933789|11772911|FG002|Overall Study|Became Ineligible|0
7470656|NCT01933789|11772912|FG003|Overall Study|Became Ineligible|0
7470657|NCT01933789|11772913|FG004|Overall Study|Became Ineligible|13
7470658|NCT01933789|11772914|FG005|Overall Study|Became Ineligible|10
7470659|NCT01933789|11772915|FG006|Overall Study|Became Ineligible|13
7470660|NCT01933789|11772916|FG007|Overall Study|Became Ineligible|6
7470661|NCT01933789|11772917|FG008|Overall Study|Became Ineligible|0
7470662|NCT01933880|11772939|FG000|Overall Study|Withdrawal by Subject|5
7470663|NCT01933880|11772940|FG001|Overall Study|Withdrawal by Subject|0
7470664|NCT01933880|11772939|FG000|Overall Study|Lack of Efficacy|1
7470665|NCT01933880|11772940|FG001|Overall Study|Lack of Efficacy|0
7470666|NCT01933880|11772939|FG000|Overall Study|Concomitant medication Interference|0
7470667|NCT01933880|11772940|FG001|Overall Study|Concomitant medication Interference|1
7470668|NCT01933880|11772939|FG000|Overall Study|Followup exceeded 4 days to visit window|19
7470669|NCT01933880|11772940|FG001|Overall Study|Followup exceeded 4 days to visit window|0
7470670|NCT01933880|11772939|FG000|Overall Study|Other|4
7470671|NCT01933880|11772940|FG001|Overall Study|Other|0
7470672|NCT01933880|11772939|FG000|Overall Study|Protocol Violation|1
7470673|NCT01933880|11772940|FG001|Overall Study|Protocol Violation|0
7470674|NCT01933919|11772953|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
7470675|NCT01933919|11772954|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
7470676|NCT01933919|11772953|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
7470677|NCT01933919|11772954|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
7470678|NCT01933919|11772953|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
7470679|NCT01933919|11772954|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
7470680|NCT01933919|11772953|FG000|Open-label Long-term Phase|Adverse Event|2
7470681|NCT01933919|11772954|FG001|Open-label Long-term Phase|Adverse Event|0
7470682|NCT01933919|11772953|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
7384430|NCT01194258|11641599|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
7384431|NCT01194258|11641595|FG000|Period 2 (12 Weeks)|Adverse Event|0
7384432|NCT01194258|11641596|FG001|Period 2 (12 Weeks)|Adverse Event|1
7384433|NCT01194258|11641597|FG002|Period 2 (12 Weeks)|Adverse Event|0
7384434|NCT01194258|11641598|FG003|Period 2 (12 Weeks)|Adverse Event|0
7470683|NCT01933919|11772954|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
7470684|NCT01933919|11772953|FG000|Open-label Long-term Phase|Lost to Follow-up|1
7574509|NCT03682120|11957411|FG003|Overall Study|Death|0
7314289|NCT00704405|11542044|FG000|Overall Study (NC Population)|Adverse Event|1
7314290|NCT00704405|11542045|FG001|Overall Study (NC Population)|Adverse Event|0
7314291|NCT00704405|11542046|FG002|Overall Study (NC Population)|Adverse Event|0
7314292|NCT00704405|11542047|FG003|Overall Study (NC Population)|Adverse Event|0
7314293|NCT00704405|11542048|FG004|Overall Study (NC Population)|Adverse Event|0
7314294|NCT00704405|11542044|FG000|Overall Study (NC Population)|Lost to Follow-up|2
7314295|NCT00704405|11542045|FG001|Overall Study (NC Population)|Lost to Follow-up|1
7314296|NCT00704405|11542046|FG002|Overall Study (NC Population)|Lost to Follow-up|1
7314297|NCT00704405|11542047|FG003|Overall Study (NC Population)|Lost to Follow-up|2
7314298|NCT00704405|11542048|FG004|Overall Study (NC Population)|Lost to Follow-up|2
7314299|NCT00704405|11542044|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
7314300|NCT00704405|11542045|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
7314301|NCT00704405|11542046|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
7314302|NCT00704405|11542047|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
7314303|NCT00704405|11542048|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
7314304|NCT00704405|11542044|FG000|Overall Study (NC Population)|Other|0
7314305|NCT00704405|11542045|FG001|Overall Study (NC Population)|Other|0
7314306|NCT00704405|11542046|FG002|Overall Study (NC Population)|Other|0
7314307|NCT00704405|11542047|FG003|Overall Study (NC Population)|Other|0
7314308|NCT00704405|11542048|FG004|Overall Study (NC Population)|Other|1
7314309|NCT00704405|11542044|FG000|Overall Study (C Population)|Withdrawal by Subject|1
7314310|NCT00704405|11542045|FG001|Overall Study (C Population)|Withdrawal by Subject|1
7314311|NCT00704405|11542046|FG002|Overall Study (C Population)|Withdrawal by Subject|1
7314312|NCT00704405|11542047|FG003|Overall Study (C Population)|Withdrawal by Subject|1
7314313|NCT00704405|11542048|FG004|Overall Study (C Population)|Withdrawal by Subject|0
7314314|NCT00704405|11542044|FG000|Overall Study (C Population)|Lost to Follow-up|0
7314315|NCT00704405|11542045|FG001|Overall Study (C Population)|Lost to Follow-up|2
7314316|NCT00704405|11542046|FG002|Overall Study (C Population)|Lost to Follow-up|0
7314317|NCT00704405|11542047|FG003|Overall Study (C Population)|Lost to Follow-up|0
7314318|NCT00704405|11542048|FG004|Overall Study (C Population)|Lost to Follow-up|0
7314319|NCT00704418|11542068|FG000|Overall Study|Withdrawal by Subject|2
7314320|NCT00704418|11542069|FG001|Overall Study|Withdrawal by Subject|0
7314321|NCT00704418|11542068|FG000|Overall Study|Over-enrolled/surgery postponed|3
7470685|NCT01933919|11772954|FG001|Open-label Long-term Phase|Lost to Follow-up|0
7470686|NCT01933919|11772953|FG000|Open-label Long-term Phase|Other|1
7470687|NCT01933919|11772954|FG001|Open-label Long-term Phase|Other|2
7470688|NCT01934010|11772988|FG000|Overall Study|Adverse Event|1
7314322|NCT00704418|11542069|FG001|Overall Study|Over-enrolled/surgery postponed|6
7314323|NCT00704522|11542077|FG000|Overall Study|Lack of Efficacy|65
7314324|NCT00704522|11542078|FG001|Overall Study|Lack of Efficacy|17
7314325|NCT00704522|11542077|FG000|Overall Study|Failure to appear again at hospital|56
7314326|NCT00704522|11542078|FG001|Overall Study|Failure to appear again at hospital|10
7314327|NCT00704522|11542077|FG000|Overall Study|Withdrawal by Subject|17
7314328|NCT00704522|11542078|FG001|Overall Study|Withdrawal by Subject|8
7314329|NCT00704522|11542077|FG000|Overall Study|Adverse Event|9
7314330|NCT00704522|11542078|FG001|Overall Study|Adverse Event|1
7314331|NCT00704522|11542077|FG000|Overall Study|Undefined causes|9
7314332|NCT00704522|11542078|FG001|Overall Study|Undefined causes|7
7314333|NCT00704522|11542077|FG000|Overall Study|No information on therapy end|27
7314334|NCT00704522|11542078|FG001|Overall Study|No information on therapy end|2
7314335|NCT00704730|11542089|FG000|Overall Study|Adverse Event|35
7314336|NCT00704730|11542090|FG001|Overall Study|Adverse Event|9
7314337|NCT00704730|11542089|FG000|Overall Study|Death|11
7314338|NCT00704730|11542090|FG001|Overall Study|Death|5
7314339|NCT00704730|11542089|FG000|Overall Study|Physician Decision|2
7314340|NCT00704730|11542090|FG001|Overall Study|Physician Decision|0
7314341|NCT00704730|11542089|FG000|Overall Study|Did not receive drug|5
7314342|NCT00704730|11542090|FG001|Overall Study|Did not receive drug|2
7314343|NCT00704730|11542089|FG000|Overall Study|Disease progression per PI|58
7314344|NCT00704730|11542090|FG001|Overall Study|Disease progression per PI|67
7314345|NCT00704730|11542089|FG000|Overall Study|data unavailable|1
7314346|NCT00704730|11542090|FG001|Overall Study|data unavailable|0
7314347|NCT00704730|11542089|FG000|Overall Study|Withdrawal by Subject|9
7314348|NCT00704730|11542090|FG001|Overall Study|Withdrawal by Subject|13
7314349|NCT00704808|11542097|FG000|Overall Study|Discontinued prior to starting treatment|14
7314350|NCT00704808|11542097|FG000|Overall Study|Death|7
7314351|NCT00704808|11542097|FG000|Overall Study|Tumor progression|80
7314352|NCT00704808|11542097|FG000|Overall Study|Patient's decision|11
7314353|NCT00704808|11542097|FG000|Overall Study|Early therapy discontinuation|16
7314354|NCT00704808|11542097|FG000|Overall Study|Adverse Event|1
7314355|NCT00704808|11542097|FG000|Overall Study|Lost to Follow-up|1
7314356|NCT00704808|11542097|FG000|Overall Study|Treatment change|1
7314357|NCT00704964|11542132|FG000|Overall Study|Not completed on time|328
7314358|NCT00705016|11542153|FG000|Overall Study|Adverse Event|6
7314359|NCT00705016|11542154|FG001|Overall Study|Adverse Event|11
7314360|NCT00705016|11542155|FG002|Overall Study|Adverse Event|10
7314361|NCT00705016|11542153|FG000|Overall Study|Death|5
7314362|NCT00705016|11542154|FG001|Overall Study|Death|7
7314363|NCT00705016|11542155|FG002|Overall Study|Death|5
7314364|NCT00705016|11542153|FG000|Overall Study|Protocol Violation|0
7314365|NCT00705016|11542154|FG001|Overall Study|Protocol Violation|1
7314366|NCT00705016|11542155|FG002|Overall Study|Protocol Violation|1
7314367|NCT00705016|11542153|FG000|Overall Study|Withdrawal by Subject|4
7314368|NCT00705016|11542154|FG001|Overall Study|Withdrawal by Subject|3
7314369|NCT00705016|11542155|FG002|Overall Study|Withdrawal by Subject|2
7314370|NCT00705016|11542153|FG000|Overall Study|Progressive Disease|33
7314371|NCT00705016|11542154|FG001|Overall Study|Progressive Disease|29
7314372|NCT00705016|11542155|FG002|Overall Study|Progressive Disease|33
7314373|NCT00705016|11542153|FG000|Overall Study|Symptomatic Deterioration|3
7314374|NCT00705016|11542154|FG001|Overall Study|Symptomatic Deterioration|1
7314375|NCT00705016|11542155|FG002|Overall Study|Symptomatic Deterioration|1
7314376|NCT00705016|11542153|FG000|Overall Study|Other|9
7314377|NCT00705016|11542154|FG001|Overall Study|Other|6
7314378|NCT00705016|11542155|FG002|Overall Study|Other|6
7314379|NCT00705146|11542173|FG000|Overall Study|Lost to Follow-up|1
7314380|NCT00705146|11542174|FG001|Overall Study|Lost to Follow-up|1
7314381|NCT00705159|11542184|FG000|Overall Study|Withdrawal by Subject|0
7314382|NCT00705159|11542185|FG001|Overall Study|Withdrawal by Subject|1
7314383|NCT00705159|11542186|FG002|Overall Study|Withdrawal by Subject|1
7470689|NCT01934010|11772989|FG001|Overall Study|Adverse Event|1
7470690|NCT01934010|11772990|FG002|Overall Study|Adverse Event|0
7470691|NCT01934010|11772988|FG000|Overall Study|Withdrawal by Subject|15
7470692|NCT01934010|11772989|FG001|Overall Study|Withdrawal by Subject|6
7470693|NCT01934010|11772990|FG002|Overall Study|Withdrawal by Subject|2
7470694|NCT01934010|11772988|FG000|Overall Study|Lost to Follow-up|7
7470695|NCT01934010|11772989|FG001|Overall Study|Lost to Follow-up|4
7470696|NCT01934010|11772990|FG002|Overall Study|Lost to Follow-up|0
7470697|NCT01934140|11773009|FG000|Persistence Phase (Year 6-10)|Other|24
7470698|NCT01934140|11773010|FG001|Persistence Phase (Year 6-10)|Other|6
7470699|NCT01934140|11773009|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
7470700|NCT01934140|11773010|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
7470701|NCT01934140|11773009|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
7470702|NCT01934140|11773010|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
7470703|NCT01934140|11773009|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
7470704|NCT01934140|11773010|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
7470705|NCT01934140|11773009|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
7470706|NCT01934140|11773010|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
7470707|NCT01934140|11773009|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
7470708|NCT01934140|11773010|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
7470709|NCT01934140|11773009|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
7470710|NCT01934140|11773010|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
7470711|NCT01934140|11773009|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
7470712|NCT01934140|11773010|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
7470713|NCT01934192|11773022|FG000|Overall Study|Protocol Violation|0
7470714|NCT01934192|11773023|FG001|Overall Study|Protocol Violation|0
7470715|NCT01934192|11773024|FG002|Overall Study|Protocol Violation|0
7470716|NCT01934192|11773025|FG003|Overall Study|Protocol Violation|1
7470717|NCT01934192|11773022|FG000|Overall Study|Other: reached stopping criteria|6
7470718|NCT01934192|11773023|FG001|Overall Study|Other: reached stopping criteria|5
7470719|NCT01934192|11773024|FG002|Overall Study|Other: reached stopping criteria|1
7470720|NCT01934192|11773025|FG003|Overall Study|Other: reached stopping criteria|0
7470721|NCT01934192|11773022|FG000|Overall Study|Physician Decision|3
7470722|NCT01934192|11773023|FG001|Overall Study|Physician Decision|2
7470723|NCT01934192|11773024|FG002|Overall Study|Physician Decision|0
7470724|NCT01934192|11773025|FG003|Overall Study|Physician Decision|0
7533851|NCT02689206|11880197|FG003|Overall Study|Physician Decision|0
7533852|NCT02689206|11880198|FG004|Overall Study|Physician Decision|0
7314384|NCT00705159|11542187|FG003|Overall Study|Withdrawal by Subject|1
7314385|NCT00705159|11542184|FG000|Overall Study|Protocol Violation|0
7314386|NCT00705159|11542185|FG001|Overall Study|Protocol Violation|1
7314387|NCT00705159|11542186|FG002|Overall Study|Protocol Violation|0
7314388|NCT00705159|11542187|FG003|Overall Study|Protocol Violation|0
7314389|NCT00705159|11542184|FG000|Overall Study|Adverse Event|0
7314390|NCT00705159|11542185|FG001|Overall Study|Adverse Event|0
7391590|NCT01244035|11651970|FG003|Part 1: Period 3|Adverse Event|0
7391591|NCT01244035|11651971|FG004|Part 1: Period 3|Adverse Event|0
7391592|NCT01244035|11651972|FG005|Part 1: Period 3|Adverse Event|1
7391593|NCT01244035|11651967|FG000|Part 1: Period 3|Withdrawal by Subject|0
7391594|NCT01244035|11651968|FG001|Part 1: Period 3|Withdrawal by Subject|0
7391595|NCT01244035|11651969|FG002|Part 1: Period 3|Withdrawal by Subject|0
7391596|NCT01244035|11651970|FG003|Part 1: Period 3|Withdrawal by Subject|0
7391597|NCT01244035|11651971|FG004|Part 1: Period 3|Withdrawal by Subject|1
7391598|NCT01244035|11651972|FG005|Part 1: Period 3|Withdrawal by Subject|0
7391599|NCT01244035|11651967|FG000|Part 1: Period 3|Protocol Deviation|0
7391600|NCT01244035|11651968|FG001|Part 1: Period 3|Protocol Deviation|1
7391601|NCT01244035|11651969|FG002|Part 1: Period 3|Protocol Deviation|0
7391602|NCT01244035|11651970|FG003|Part 1: Period 3|Protocol Deviation|0
7391603|NCT01244035|11651971|FG004|Part 1: Period 3|Protocol Deviation|0
7391604|NCT01244035|11651972|FG005|Part 1: Period 3|Protocol Deviation|0
7391605|NCT01244061|11651994|FG000|Overall Study|Death|1
7391606|NCT01244061|11651995|FG001|Overall Study|Death|0
7314391|NCT00705159|11542186|FG002|Overall Study|Adverse Event|1
7314392|NCT00705159|11542187|FG003|Overall Study|Adverse Event|0
7314393|NCT00705159|11542184|FG000|Overall Study|Lost to Follow-up|0
7314394|NCT00705159|11542185|FG001|Overall Study|Lost to Follow-up|0
7314395|NCT00705159|11542186|FG002|Overall Study|Lost to Follow-up|3
7314396|NCT00705159|11542187|FG003|Overall Study|Lost to Follow-up|2
7314397|NCT00705159|11542184|FG000|Overall Study|Screen Failure|0
7314398|NCT00705159|11542185|FG001|Overall Study|Screen Failure|0
7314399|NCT00705159|11542186|FG002|Overall Study|Screen Failure|0
7314400|NCT00705159|11542187|FG003|Overall Study|Screen Failure|1
7314401|NCT00705224|11542197|FG000|Overall Study|Adverse Event|1
7391607|NCT01244061|11651994|FG000|Overall Study|Did not meet entrance criteria|1
7391608|NCT01244061|11651995|FG001|Overall Study|Did not meet entrance criteria|0
7391609|NCT01244061|11651994|FG000|Overall Study|Lack of Efficacy|1
7391610|NCT01244061|11651995|FG001|Overall Study|Lack of Efficacy|3
7391611|NCT01244061|11651994|FG000|Overall Study|Lost to Follow-up|34
7391612|NCT01244061|11651995|FG001|Overall Study|Lost to Follow-up|30
7391613|NCT01244061|11651994|FG000|Overall Study|Withdrawal by Subject|29
7391614|NCT01244061|11651995|FG001|Overall Study|Withdrawal by Subject|46
7391615|NCT01244061|11651994|FG000|Overall Study|Other|8
7391616|NCT01244061|11651995|FG001|Overall Study|Other|19
7391617|NCT01244061|11651994|FG000|Overall Study|Protocol Violation|1
7391618|NCT01244061|11651995|FG001|Overall Study|Protocol Violation|1
7391619|NCT01244061|11651994|FG000|Overall Study|Adverse Event|5
7391620|NCT01244061|11651995|FG001|Overall Study|Adverse Event|2
7391621|NCT01244061|11651994|FG000|Overall Study|Randomized but not treated|2
7391622|NCT01244061|11651995|FG001|Overall Study|Randomized but not treated|2
7391623|NCT01244126|11652004|FG000|Overall Study|Protocol Violation|3
7391624|NCT01244126|11652005|FG001|Overall Study|Protocol Violation|3
7391625|NCT01244126|11652006|FG002|Overall Study|Protocol Violation|9
7391626|NCT01244191|11652016|FG000|Overall Study|Progressive disease|295
7391627|NCT01244191|11652017|FG001|Overall Study|Progressive disease|350
7391628|NCT01244191|11652016|FG000|Overall Study|Clinical disease progression|54
7470725|NCT01934218|11773048|FG000|Double-blind Phase|Adverse Event|8
7470726|NCT01934218|11773049|FG001|Double-blind Phase|Adverse Event|8
7470727|NCT01934218|11773048|FG000|Double-blind Phase|Lack of Efficacy|6
7470728|NCT01934218|11773049|FG001|Double-blind Phase|Lack of Efficacy|7
7470729|NCT01934218|11773048|FG000|Double-blind Phase|Lost to Follow-up|7
7391629|NCT01244191|11652017|FG001|Overall Study|Clinical disease progression|36
7391630|NCT01244191|11652016|FG000|Overall Study|Adverse Event|65
7391631|NCT01244191|11652017|FG001|Overall Study|Adverse Event|48
7391632|NCT01244191|11652016|FG000|Overall Study|Death|22
7391633|NCT01244191|11652017|FG001|Overall Study|Death|29
7391634|NCT01244191|11652016|FG000|Overall Study|Lost to Follow-up|0
7391635|NCT01244191|11652017|FG001|Overall Study|Lost to Follow-up|2
7391636|NCT01244191|11652016|FG000|Overall Study|Protocol Violation|1
7391637|NCT01244191|11652017|FG001|Overall Study|Protocol Violation|2
7391638|NCT01244191|11652016|FG000|Overall Study|Withdrawal by Subject|31
7391639|NCT01244191|11652017|FG001|Overall Study|Withdrawal by Subject|23
7391640|NCT01244191|11652016|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
7391641|NCT01244191|11652017|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
7391642|NCT01244425|11652033|FG000|Overall Study|Withdrawal by Subject|2
7391643|NCT01244425|11652034|FG001|Overall Study|Withdrawal by Subject|2
7391644|NCT01244425|11652033|FG000|Overall Study|Adverse Event|1
7391645|NCT01244425|11652034|FG001|Overall Study|Adverse Event|1
7391646|NCT01244490|11652067|FG000|Overall Study|Lack of Efficacy|14
7391647|NCT01244490|11652068|FG001|Overall Study|Lack of Efficacy|5
7391648|NCT01244490|11652069|FG002|Overall Study|Lack of Efficacy|5
7391649|NCT01244490|11652067|FG000|Overall Study|Withdrawal by Subject|4
7391650|NCT01244490|11652068|FG001|Overall Study|Withdrawal by Subject|4
7391651|NCT01244490|11652069|FG002|Overall Study|Withdrawal by Subject|9
7391652|NCT01244490|11652067|FG000|Overall Study|Adverse Event|1
7391653|NCT01244490|11652068|FG001|Overall Study|Adverse Event|9
7391654|NCT01244490|11652069|FG002|Overall Study|Adverse Event|5
7391655|NCT01244490|11652067|FG000|Overall Study|Lost to Follow-up|0
7391656|NCT01244490|11652068|FG001|Overall Study|Lost to Follow-up|6
7391657|NCT01244490|11652069|FG002|Overall Study|Lost to Follow-up|3
7391658|NCT01244490|11652067|FG000|Overall Study|Other|0
7391659|NCT01244490|11652068|FG001|Overall Study|Other|0
7391660|NCT01244490|11652069|FG002|Overall Study|Other|1
7391661|NCT01244516|11652084|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
7391662|NCT01244516|11652085|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
7391663|NCT01244516|11652086|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
7391664|NCT01244516|11652084|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7391665|NCT01244516|11652085|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
7391666|NCT01244516|11652086|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
7391667|NCT01244516|11652084|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7391668|NCT01244516|11652085|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
7314402|NCT00705224|11542197|FG000|Overall Study|Lack of Efficacy|2
7391669|NCT01244516|11652086|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
7391670|NCT01244516|11652084|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
7391671|NCT01244516|11652085|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7391672|NCT01244516|11652086|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
7465251|NCT01879722|11764468|FG005|Overall Study|Voluntary Withdrawal|0
7314403|NCT00705224|11542197|FG000|Overall Study|Withdrawal by Subject|3
7314404|NCT00705224|11542197|FG000|Overall Study|Lost to Follow-up|5
7314405|NCT00705250|11542204|FG000|Overall Study|Withdrawal by Subject|1
7314406|NCT00705250|11542204|FG000|Overall Study|Patient died in car accident|1
7314407|NCT00705263|11542208|FG000|Overall Study|Withdrawal by Subject|2
7314408|NCT00705289|11542212|FG000|Overall Study|Subject or treating physician's choice|131
7314409|NCT00705341|11542235|FG000|Phase 2: Trial|Withdrawal by Subject|0
7314410|NCT00705341|11542236|FG001|Phase 2: Trial|Withdrawal by Subject|0
7314411|NCT00705341|11542237|FG002|Phase 2: Trial|Withdrawal by Subject|6
7314412|NCT00705341|11542238|FG003|Phase 2: Trial|Withdrawal by Subject|4
7314413|NCT00705341|11542235|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
7314414|NCT00705341|11542236|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
7314415|NCT00705341|11542237|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
7314416|NCT00705341|11542238|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
7470730|NCT01934218|11773049|FG001|Double-blind Phase|Lost to Follow-up|14
7470731|NCT01934218|11773048|FG000|Double-blind Phase|Physician Decision|1
7470732|NCT01934218|11773049|FG001|Double-blind Phase|Physician Decision|2
7470733|NCT01934218|11773048|FG000|Double-blind Phase|Protocol Violation|4
7470734|NCT01934218|11773049|FG001|Double-blind Phase|Protocol Violation|0
7470735|NCT01934218|11773048|FG000|Double-blind Phase|Withdrawal by Subject|16
7470736|NCT01934218|11773049|FG001|Double-blind Phase|Withdrawal by Subject|13
7470737|NCT01934218|11773048|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
7470738|NCT01934218|11773049|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
7314417|NCT00705367|11542248|FG000|Long-term Extension Period|Adverse Event|2
7314418|NCT00705367|11542249|FG001|Long-term Extension Period|Adverse Event|0
7314419|NCT00705367|11542248|FG000|Long-term Extension Period|Withdrawal by Subject|2
7314420|NCT00705367|11542249|FG001|Long-term Extension Period|Withdrawal by Subject|0
7314421|NCT00705367|11542248|FG000|Long-term Extension Period|Lack of Efficacy|1
7314422|NCT00705367|11542249|FG001|Long-term Extension Period|Lack of Efficacy|0
7314423|NCT00705367|11542248|FG000|Long-term Extension Period|No longer met study criteria|1
7314424|NCT00705367|11542249|FG001|Long-term Extension Period|No longer met study criteria|0
7314425|NCT00705367|11542248|FG000|Long-term Extension Period|Administrative reason by sponsor|3
7314426|NCT00705367|11542249|FG001|Long-term Extension Period|Administrative reason by sponsor|0
7314427|NCT00705406|11542259|FG000|Overall Study|Lost to Follow-up|3
7314428|NCT00705406|11542260|FG001|Overall Study|Lost to Follow-up|3
7314429|NCT00705406|11542259|FG000|Overall Study|Did not receive study drug|1
7314430|NCT00705406|11542260|FG001|Overall Study|Did not receive study drug|2
7470739|NCT01934218|11773048|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
7470740|NCT01934218|11773049|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
7470741|NCT01934218|11773048|FG000|Open-Label Phase|Adverse Event|2
7470742|NCT01934218|11773049|FG001|Open-Label Phase|Adverse Event|4
7470743|NCT01934218|11773048|FG000|Open-Label Phase|Lack of Efficacy|1
7470744|NCT01934218|11773049|FG001|Open-Label Phase|Lack of Efficacy|4
7470745|NCT01934218|11773048|FG000|Open-Label Phase|Lost to Follow-up|4
7470746|NCT01934218|11773049|FG001|Open-Label Phase|Lost to Follow-up|2
7470747|NCT01934218|11773048|FG000|Open-Label Phase|Physician Decision|1
7470748|NCT01934218|11773049|FG001|Open-Label Phase|Physician Decision|0
7470749|NCT01934218|11773048|FG000|Open-Label Phase|Protocol Violation|1
7470750|NCT01934218|11773049|FG001|Open-Label Phase|Protocol Violation|0
7470751|NCT01934218|11773048|FG000|Open-Label Phase|Withdrawal by Subject|13
7470752|NCT01934218|11773049|FG001|Open-Label Phase|Withdrawal by Subject|11
7470753|NCT01934218|11773048|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
7470754|NCT01934218|11773049|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
7470755|NCT01934218|11773048|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
7470756|NCT01934218|11773049|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
7470757|NCT01934335|11773061|FG000|Overall Study|Withdrawal by Subject|1
7470758|NCT01934335|11773062|FG001|Overall Study|Withdrawal by Subject|1
7470759|NCT01934556|11773079|FG000|Overall Study|Withdrawal by Subject|0
7314431|NCT00705432|11542273|FG000|Treatment Period|Adverse Event|45
7314432|NCT00705432|11542274|FG001|Treatment Period|Adverse Event|37
7314433|NCT00705432|11542275|FG002|Treatment Period|Adverse Event|51
7314434|NCT00705432|11542276|FG003|Treatment Period|Adverse Event|12
7314435|NCT00705432|11542277|FG004|Treatment Period|Adverse Event|8
7314436|NCT00705432|11542278|FG005|Treatment Period|Adverse Event|9
7314437|NCT00705432|11542273|FG000|Treatment Period|Treatment failure|92
7314438|NCT00705432|11542274|FG001|Treatment Period|Treatment failure|42
7314439|NCT00705432|11542275|FG002|Treatment Period|Treatment failure|33
7314440|NCT00705432|11542276|FG003|Treatment Period|Treatment failure|25
7314441|NCT00705432|11542277|FG004|Treatment Period|Treatment failure|13
7314442|NCT00705432|11542278|FG005|Treatment Period|Treatment failure|14
7314443|NCT00705432|11542273|FG000|Treatment Period|Non medical reason|26
7314444|NCT00705432|11542274|FG001|Treatment Period|Non medical reason|32
7314445|NCT00705432|11542275|FG002|Treatment Period|Non medical reason|37
7465252|NCT01879722|11764469|FG006|Overall Study|Voluntary Withdrawal|0
7314446|NCT00705432|11542276|FG003|Treatment Period|Non medical reason|4
7314447|NCT00705432|11542277|FG004|Treatment Period|Non medical reason|7
7314448|NCT00705432|11542278|FG005|Treatment Period|Non medical reason|7
7314449|NCT00705432|11542273|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
7314450|NCT00705432|11542274|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
7314451|NCT00705432|11542275|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
7314452|NCT00705432|11542276|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
7314453|NCT00705432|11542277|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
7314454|NCT00705432|11542278|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
7314455|NCT00705432|11542273|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
7314456|NCT00705432|11542274|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
7314457|NCT00705432|11542275|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
7314458|NCT00705432|11542276|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
7314459|NCT00705432|11542277|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
7314460|NCT00705432|11542278|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
7470760|NCT01934556|11773080|FG001|Overall Study|Withdrawal by Subject|1
7470761|NCT01934556|11773081|FG002|Overall Study|Withdrawal by Subject|1
7470762|NCT01934556|11773079|FG000|Overall Study|Lost to Follow-up|4
7470763|NCT01934556|11773080|FG001|Overall Study|Lost to Follow-up|10
7470764|NCT01934556|11773081|FG002|Overall Study|Lost to Follow-up|7
7470765|NCT01934556|11773079|FG000|Overall Study|Death|1
7470766|NCT01934556|11773080|FG001|Overall Study|Death|5
7470767|NCT01934556|11773081|FG002|Overall Study|Death|2
7470768|NCT01934790|11773095|FG000|Treatment|Adverse Event|3
7470769|NCT01934790|11773095|FG000|Treatment|Clinical progression|6
7314461|NCT00705484|11542291|FG000|Overall Study|Adverse Event|28
7314462|NCT00705484|11542292|FG001|Overall Study|Adverse Event|27
7314463|NCT00705484|11542291|FG000|Overall Study|Lost to Follow-up|169
7314464|NCT00705484|11542292|FG001|Overall Study|Lost to Follow-up|250
7314465|NCT00705484|11542291|FG000|Overall Study|Withdrawal by Subject|96
7314466|NCT00705484|11542292|FG001|Overall Study|Withdrawal by Subject|72
7314467|NCT00705484|11542291|FG000|Overall Study|Administrative|89
7314468|NCT00705484|11542292|FG001|Overall Study|Administrative|59
7314469|NCT00705523|11542302|FG000|Overall Study|Lost to Follow-up|2
7314470|NCT00705523|11542303|FG001|Overall Study|Lost to Follow-up|3
7314471|NCT00705536|11542311|FG000|Start Period 1|Withdrawal by Subject|0
7314472|NCT00705536|11542312|FG001|Start Period 1|Withdrawal by Subject|0
7314473|NCT00705536|11542313|FG002|Start Period 1|Withdrawal by Subject|0
7314474|NCT00705536|11542314|FG003|Start Period 1|Withdrawal by Subject|1
7314475|NCT00705575|11542335|FG000|Overall Study|Abnormal laboratory value(s)|0
7314476|NCT00705575|11542336|FG001|Overall Study|Abnormal laboratory value(s)|3
7314477|NCT00705575|11542335|FG000|Overall Study|Abnormal test procedure result(s)|2
7314478|NCT00705575|11542336|FG001|Overall Study|Abnormal test procedure result(s)|12
7314479|NCT00705575|11542335|FG000|Overall Study|Adverse Event|11
7314480|NCT00705575|11542336|FG001|Overall Study|Adverse Event|15
7470770|NCT01934790|11773095|FG000|Treatment|Radiological progression|4
7314481|NCT00705575|11542335|FG000|Overall Study|Lost to Follow-up|3
7470771|NCT01934790|11773095|FG000|Treatment|Withdrawal by Subject|2
7314482|NCT00705575|11542336|FG001|Overall Study|Lost to Follow-up|4
7314483|NCT00705575|11542335|FG000|Overall Study|Protocol Violation|2
7314484|NCT00705575|11542336|FG001|Overall Study|Protocol Violation|2
7314485|NCT00705575|11542335|FG000|Overall Study|Withdrawal by Subject|5
7314486|NCT00705575|11542336|FG001|Overall Study|Withdrawal by Subject|10
7470772|NCT01934790|11773095|FG000|Treatment|Study drug never administered|1
7314487|NCT00705614|11542344|FG000|Initial Intervention|Adverse Event|40
7314488|NCT00705614|11542345|FG001|Initial Intervention|Adverse Event|21
7314489|NCT00705614|11542344|FG000|Initial Intervention|Lost to Follow-up|310
7314490|NCT00705614|11542345|FG001|Initial Intervention|Lost to Follow-up|191
7314491|NCT00705614|11542344|FG000|Initial Intervention|Withdrawal by Subject|114
7314492|NCT00705614|11542345|FG001|Initial Intervention|Withdrawal by Subject|71
7314493|NCT00705614|11542344|FG000|Initial Intervention|Administrative Reason|51
7470773|NCT01934790|11773095|FG000|Active Follow up|Death|20
7470774|NCT01934790|11773095|FG000|Active Follow up|Physician Decision|2
7470775|NCT01934790|11773095|FG000|Active Follow up|Progressive disease|1
7470776|NCT01934790|11773095|FG000|Active Follow up|Other reason|1
7470777|NCT01934894|11773101|FG000|Overall Study|Adverse Event|1
7470778|NCT01934894|11773102|FG001|Overall Study|Adverse Event|2
7470779|NCT01934894|11773101|FG000|Overall Study|Death|2
7470780|NCT01934894|11773102|FG001|Overall Study|Death|0
7470781|NCT01934894|11773101|FG000|Overall Study|Withdrawal by Subject|0
7470782|NCT01934894|11773102|FG001|Overall Study|Withdrawal by Subject|1
7470783|NCT01934894|11773101|FG000|Overall Study|Progressive Disease|3
7470784|NCT01934894|11773102|FG001|Overall Study|Progressive Disease|2
7470785|NCT01934972|11773113|FG000|Overall Study|Withdrawal by Subject|9
7470786|NCT01934972|11773114|FG001|Overall Study|Withdrawal by Subject|6
7470787|NCT01935700|11773144|FG000|Overall Study|Withdrawal by Subject|1
7470788|NCT01935700|11773145|FG001|Overall Study|Withdrawal by Subject|0
7470789|NCT01935700|11773144|FG000|Overall Study|Physician Decision|4
7470790|NCT01935700|11773145|FG001|Overall Study|Physician Decision|0
7470791|NCT01936181|11773177|FG000|Randomised, Double-blind|Adverse Event|27
7470792|NCT01936181|11773178|FG001|Randomised, Double-blind|Adverse Event|21
7470793|NCT01936181|11773179|FG002|Randomised, Double-blind|Adverse Event|0
7314494|NCT00705614|11542345|FG001|Initial Intervention|Administrative Reason|38
7470794|NCT01936181|11773180|FG003|Randomised, Double-blind|Adverse Event|0
7470795|NCT01936181|11773177|FG000|Randomised, Double-blind|Protocol Violation|1
7314495|NCT00705614|11542344|FG000|Initial Intervention|Status completion unknown|3
7314496|NCT00705614|11542345|FG001|Initial Intervention|Status completion unknown|0
7314497|NCT00705614|11542344|FG000|Switch to Remicade|Adverse Event|0
7314498|NCT00705614|11542345|FG001|Switch to Remicade|Adverse Event|5
7314499|NCT00705614|11542344|FG000|Switch to Remicade|Lost to Follow-up|0
7314500|NCT00705614|11542345|FG001|Switch to Remicade|Lost to Follow-up|23
7314501|NCT00705614|11542344|FG000|Switch to Remicade|Withdrawal by Subject|0
7470796|NCT01936181|11773178|FG001|Randomised, Double-blind|Protocol Violation|5
7470797|NCT01936181|11773179|FG002|Randomised, Double-blind|Protocol Violation|0
7470798|NCT01936181|11773180|FG003|Randomised, Double-blind|Protocol Violation|0
7470799|NCT01936181|11773177|FG000|Randomised, Double-blind|Lack of Efficacy|5
7470800|NCT01936181|11773178|FG001|Randomised, Double-blind|Lack of Efficacy|6
7470801|NCT01936181|11773179|FG002|Randomised, Double-blind|Lack of Efficacy|0
7470802|NCT01936181|11773180|FG003|Randomised, Double-blind|Lack of Efficacy|0
7470803|NCT01936181|11773177|FG000|Randomised, Double-blind|Lost to Follow-up|0
7470804|NCT01936181|11773178|FG001|Randomised, Double-blind|Lost to Follow-up|1
7470805|NCT01936181|11773179|FG002|Randomised, Double-blind|Lost to Follow-up|0
7470806|NCT01936181|11773180|FG003|Randomised, Double-blind|Lost to Follow-up|0
7470807|NCT01936181|11773177|FG000|Randomised, Double-blind|Pregnancy|0
7470808|NCT01936181|11773178|FG001|Randomised, Double-blind|Pregnancy|1
7470809|NCT01936181|11773179|FG002|Randomised, Double-blind|Pregnancy|0
7314502|NCT00705614|11542345|FG001|Switch to Remicade|Withdrawal by Subject|12
7314503|NCT00705614|11542344|FG000|Switch to Remicade|Administrative Reason|0
7314504|NCT00705614|11542345|FG001|Switch to Remicade|Administrative Reason|9
7314505|NCT00705666|11542357|FG000|Overall Study|No post-treatment questionnaire|279
7314506|NCT00705666|11542357|FG000|Overall Study|Withdrawal by Subject|21
7314507|NCT00705666|11542357|FG000|Overall Study|Physician Decision|7
7314508|NCT00705666|11542357|FG000|Overall Study|Lost to Follow-up|5
7314509|NCT00705666|11542357|FG000|Overall Study|Death|1
7314510|NCT00705666|11542357|FG000|Overall Study|Adverse Event|4
7314511|NCT00705666|11542357|FG000|Overall Study|Other|12
7314512|NCT00705666|11542357|FG000|Overall Study|Other|2
7314513|NCT00705666|11542357|FG000|Overall Study|Lack of data|3
7314514|NCT00705666|11542357|FG000|Overall Study|Untreated|5
7470810|NCT01936181|11773180|FG003|Randomised, Double-blind|Pregnancy|0
7470811|NCT01936181|11773177|FG000|Randomised, Double-blind|Physician Decision|4
7470812|NCT01936181|11773178|FG001|Randomised, Double-blind|Physician Decision|4
7470813|NCT01936181|11773179|FG002|Randomised, Double-blind|Physician Decision|0
7470814|NCT01936181|11773180|FG003|Randomised, Double-blind|Physician Decision|0
7470815|NCT01936181|11773177|FG000|Randomised, Double-blind|Withdrawal by Subject|23
7470816|NCT01936181|11773178|FG001|Randomised, Double-blind|Withdrawal by Subject|26
7470817|NCT01936181|11773179|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7470818|NCT01936181|11773180|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7470819|NCT01936181|11773177|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7470820|NCT01936181|11773178|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
7470821|NCT01936181|11773179|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7470822|NCT01936181|11773180|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
7470823|NCT01936181|11773177|FG000|Transition-extension|Adverse Event|3
7470824|NCT01936181|11773178|FG001|Transition-extension|Adverse Event|0
7470825|NCT01936181|11773179|FG002|Transition-extension|Adverse Event|3
7470826|NCT01936181|11773180|FG003|Transition-extension|Adverse Event|1
7470827|NCT01936181|11773177|FG000|Transition-extension|Lost to Follow-up|3
7470828|NCT01936181|11773178|FG001|Transition-extension|Lost to Follow-up|0
7470829|NCT01936181|11773179|FG002|Transition-extension|Lost to Follow-up|1
7470830|NCT01936181|11773180|FG003|Transition-extension|Lost to Follow-up|2
7470831|NCT01936181|11773177|FG000|Transition-extension|Physician Decision|2
7470832|NCT01936181|11773178|FG001|Transition-extension|Physician Decision|0
7470833|NCT01936181|11773179|FG002|Transition-extension|Physician Decision|0
7470834|NCT01936181|11773180|FG003|Transition-extension|Physician Decision|1
7470835|NCT01936181|11773177|FG000|Transition-extension|Withdrawal by Subject|7
7470836|NCT01936181|11773178|FG001|Transition-extension|Withdrawal by Subject|0
7470837|NCT01936181|11773179|FG002|Transition-extension|Withdrawal by Subject|2
7470838|NCT01936181|11773180|FG003|Transition-extension|Withdrawal by Subject|1
7470839|NCT01936623|11773257|FG000|Overall Study|Lost to Follow-up|0
7470840|NCT01936623|11773258|FG001|Overall Study|Lost to Follow-up|5
7470841|NCT01936649|11773264|FG000|Overall Study|Withdrawal by Subject|4
7470842|NCT01936649|11773264|FG000|Overall Study|Physician Decision|2
7470843|NCT01936649|11773264|FG000|Overall Study|Protocol Violation|2
7470844|NCT01936649|11773264|FG000|Overall Study|Other than specified above|5
7314515|NCT00705679|11542366|FG000|Overall Study|Adverse Event|1
7314516|NCT00705679|11542367|FG001|Overall Study|Adverse Event|1
7314517|NCT00705679|11542368|FG002|Overall Study|Adverse Event|0
7314518|NCT00705679|11542369|FG003|Overall Study|Adverse Event|0
7314519|NCT00705679|11542370|FG004|Overall Study|Adverse Event|0
7470845|NCT01936870|11773288|FG000|Overall Study|No Visit After Treatment|176
7470846|NCT01936870|11773288|FG000|Overall Study|Protocol Violation|12
7470847|NCT01936870|11773288|FG000|Overall Study|No Drug Administration|1
7314520|NCT00705679|11542366|FG000|Overall Study|Death|0
7314521|NCT00705679|11542367|FG001|Overall Study|Death|0
7314522|NCT00705679|11542368|FG002|Overall Study|Death|3
7314523|NCT00705679|11542369|FG003|Overall Study|Death|2
7314524|NCT00705679|11542370|FG004|Overall Study|Death|1
7314525|NCT00705679|11542366|FG000|Overall Study|Lost to Follow-up|32
7314526|NCT00705679|11542367|FG001|Overall Study|Lost to Follow-up|60
7314527|NCT00705679|11542368|FG002|Overall Study|Lost to Follow-up|44
7314528|NCT00705679|11542369|FG003|Overall Study|Lost to Follow-up|30
7314529|NCT00705679|11542370|FG004|Overall Study|Lost to Follow-up|35
7314530|NCT00705679|11542366|FG000|Overall Study|Physician Decision|0
7314531|NCT00705679|11542367|FG001|Overall Study|Physician Decision|1
7314532|NCT00705679|11542368|FG002|Overall Study|Physician Decision|0
7314533|NCT00705679|11542369|FG003|Overall Study|Physician Decision|1
7314534|NCT00705679|11542370|FG004|Overall Study|Physician Decision|0
7314535|NCT00705679|11542366|FG000|Overall Study|Withdrawal by Subject|32
7314536|NCT00705679|11542367|FG001|Overall Study|Withdrawal by Subject|77
7314537|NCT00705679|11542368|FG002|Overall Study|Withdrawal by Subject|68
7314538|NCT00705679|11542369|FG003|Overall Study|Withdrawal by Subject|47
7314539|NCT00705679|11542370|FG004|Overall Study|Withdrawal by Subject|33
7314540|NCT00705718|11542389|FG000|Overall Study|Death|6
7314541|NCT00705718|11542390|FG001|Overall Study|Death|6
7470848|NCT01936948|11773313|FG000|Overall Study|no 30-day follow-up data|0
7470849|NCT01936948|11773314|FG001|Overall Study|no 30-day follow-up data|3
7470850|NCT01936948|11773315|FG002|Overall Study|no 30-day follow-up data|3
7470851|NCT01936948|11773316|FG003|Overall Study|no 30-day follow-up data|3
7470852|NCT01937117|11773331|FG000|Overall Study|Disease Progression|7
7470853|NCT01937117|11773331|FG000|Overall Study|Physician Decision|4
7470854|NCT01937117|11773331|FG000|Overall Study|Adverse Event|2
7470855|NCT01937130|11773339|FG000|Overall Study|Withdrawal by Subject|0
7470856|NCT01937130|11773340|FG001|Overall Study|Withdrawal by Subject|0
7470857|NCT01937130|11773341|FG002|Overall Study|Withdrawal by Subject|0
7470858|NCT01937130|11773342|FG003|Overall Study|Withdrawal by Subject|1
7470859|NCT01937130|11773339|FG000|Overall Study|Adverse Event|0
7470860|NCT01937130|11773340|FG001|Overall Study|Adverse Event|1
7470861|NCT01937130|11773341|FG002|Overall Study|Adverse Event|0
7470862|NCT01937130|11773342|FG003|Overall Study|Adverse Event|1
7470863|NCT01937130|11773339|FG000|Overall Study|Death|1
7470864|NCT01937130|11773340|FG001|Overall Study|Death|1
7470865|NCT01937130|11773341|FG002|Overall Study|Death|1
7470866|NCT01937130|11773342|FG003|Overall Study|Death|0
7470867|NCT01937130|11773339|FG000|Overall Study|Lost to Follow-up|2
7470868|NCT01937130|11773340|FG001|Overall Study|Lost to Follow-up|0
7470869|NCT01937130|11773341|FG002|Overall Study|Lost to Follow-up|2
7470870|NCT01937130|11773342|FG003|Overall Study|Lost to Follow-up|0
7470871|NCT01937130|11773339|FG000|Overall Study|Physician Decision|0
7470872|NCT01937130|11773340|FG001|Overall Study|Physician Decision|1
7470873|NCT01937130|11773341|FG002|Overall Study|Physician Decision|0
7470874|NCT01937130|11773342|FG003|Overall Study|Physician Decision|0
7470875|NCT01937130|11773339|FG000|Overall Study|Patients unable to swallow|0
7470876|NCT01937130|11773340|FG001|Overall Study|Patients unable to swallow|1
7470877|NCT01937130|11773341|FG002|Overall Study|Patients unable to swallow|0
7314542|NCT00705718|11542389|FG000|Overall Study|Not due for Visit|0
7314543|NCT00705718|11542390|FG001|Overall Study|Not due for Visit|12
7314544|NCT00705718|11542389|FG000|Overall Study|Follow up not done|1
7314545|NCT00705718|11542390|FG001|Overall Study|Follow up not done|4
7314546|NCT00705757|11542399|FG000|Overall Study|Lack of Efficacy|5
7314547|NCT00705757|11542400|FG001|Overall Study|Lack of Efficacy|1
7314548|NCT00705757|11542401|FG002|Overall Study|Lack of Efficacy|3
7314549|NCT00705757|11542399|FG000|Overall Study|Lost to Follow-up|7
7314550|NCT00705757|11542400|FG001|Overall Study|Lost to Follow-up|6
7314551|NCT00705757|11542401|FG002|Overall Study|Lost to Follow-up|6
7314552|NCT00705757|11542399|FG000|Overall Study|Withdrawal by Subject|1
7314553|NCT00705757|11542400|FG001|Overall Study|Withdrawal by Subject|1
7314554|NCT00705757|11542401|FG002|Overall Study|Withdrawal by Subject|2
7314555|NCT00705783|11542411|FG000|Conversion Phase|Sponsor Discontinued Study|54
7314556|NCT00705783|11542412|FG001|Conversion Phase|Sponsor Discontinued Study|0
7314557|NCT00705783|11542413|FG002|Conversion Phase|Sponsor Discontinued Study|0
7314558|NCT00705783|11542411|FG000|Conversion Phase|Lost to Follow-up|13
7314559|NCT00705783|11542412|FG001|Conversion Phase|Lost to Follow-up|0
7314560|NCT00705783|11542413|FG002|Conversion Phase|Lost to Follow-up|0
7314561|NCT00705783|11542411|FG000|Conversion Phase|Met Withdrawal Criteria|4
7314562|NCT00705783|11542412|FG001|Conversion Phase|Met Withdrawal Criteria|0
7314563|NCT00705783|11542413|FG002|Conversion Phase|Met Withdrawal Criteria|0
7314564|NCT00705783|11542411|FG000|Conversion Phase|Withdrawn by Investigator|4
7314565|NCT00705783|11542412|FG001|Conversion Phase|Withdrawn by Investigator|0
7314566|NCT00705783|11542413|FG002|Conversion Phase|Withdrawn by Investigator|0
7314567|NCT00705783|11542411|FG000|Conversion Phase|Withdrew Consent|24
7314568|NCT00705783|11542412|FG001|Conversion Phase|Withdrew Consent|0
7314569|NCT00705783|11542413|FG002|Conversion Phase|Withdrew Consent|0
7314570|NCT00705783|11542411|FG000|Conversion Phase|Protocol Deviation|2
7470878|NCT01937130|11773342|FG003|Overall Study|Patients unable to swallow|0
7470879|NCT01937130|11773339|FG000|Overall Study|Patient lost to FU due to death|2
7314571|NCT00705783|11542412|FG001|Conversion Phase|Protocol Deviation|0
7314572|NCT00705783|11542413|FG002|Conversion Phase|Protocol Deviation|0
7314573|NCT00705783|11542411|FG000|Conversion Phase|Adverse Event|11
7470880|NCT01937130|11773340|FG001|Overall Study|Patient lost to FU due to death|0
7470881|NCT01937130|11773341|FG002|Overall Study|Patient lost to FU due to death|0
7470882|NCT01937130|11773342|FG003|Overall Study|Patient lost to FU due to death|0
7314574|NCT00705783|11542412|FG001|Conversion Phase|Adverse Event|0
7314575|NCT00705783|11542413|FG002|Conversion Phase|Adverse Event|0
7314576|NCT00705783|11542411|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
7314577|NCT00705783|11542412|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
7314578|NCT00705783|11542413|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
7314579|NCT00705783|11542411|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
7314580|NCT00705783|11542412|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
7314581|NCT00705783|11542413|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
7314582|NCT00705783|11542411|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
7314583|NCT00705783|11542412|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
7314584|NCT00705783|11542413|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
7314585|NCT00705783|11542411|FG000|Oral Stabilization Phase|Lost to Follow-up|7
7314586|NCT00705783|11542412|FG001|Oral Stabilization Phase|Lost to Follow-up|0
7314587|NCT00705783|11542413|FG002|Oral Stabilization Phase|Lost to Follow-up|0
7314588|NCT00705783|11542411|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
7314589|NCT00705783|11542412|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
7470883|NCT01937299|11773367|FG000|Overall Study|Adverse Event|13
7470884|NCT01937299|11773368|FG001|Overall Study|Adverse Event|0
7470885|NCT01937299|11773367|FG000|Overall Study|Lack of Efficacy|0
7470886|NCT01937299|11773368|FG001|Overall Study|Lack of Efficacy|4
7470887|NCT01937299|11773367|FG000|Overall Study|Withdrawal by Subject|1
7470888|NCT01937299|11773368|FG001|Overall Study|Withdrawal by Subject|0
7470889|NCT01937312|11773377|FG000|Overall Study|Adverse Event|10
7470890|NCT01937312|11773378|FG001|Overall Study|Adverse Event|1
7470891|NCT01937312|11773377|FG000|Overall Study|Lack of Efficacy|0
7470892|NCT01937312|11773378|FG001|Overall Study|Lack of Efficacy|1
7470893|NCT01937312|11773377|FG000|Overall Study|Withdrawal of subject prior to treatment|1
7470894|NCT01937312|11773378|FG001|Overall Study|Withdrawal of subject prior to treatment|1
7470895|NCT01937351|11773387|FG000|Overall Study|Withdrawal by Subject|4
7470896|NCT01937351|11773388|FG001|Overall Study|Withdrawal by Subject|2
7470897|NCT01937351|11773387|FG000|Overall Study|Death|1
7470898|NCT01937351|11773388|FG001|Overall Study|Death|0
7470899|NCT01937351|11773387|FG000|Overall Study|Not treated w device, per protocol fail|4
7470900|NCT01937351|11773388|FG001|Overall Study|Not treated w device, per protocol fail|0
7470901|NCT01937364|11773395|FG000|Overall Study|Adverse Event|2
7470902|NCT01937364|11773396|FG001|Overall Study|Adverse Event|1
7470903|NCT01937390|11773402|FG000|Overall Study|Death|2
7470904|NCT01937390|11773402|FG000|Overall Study|Lost to Follow-up|7
7470905|NCT01937390|11773402|FG000|Overall Study|Withdrawal by Subject|5
7470906|NCT01937390|11773402|FG000|Overall Study|Fail to return|21
7470907|NCT01937559|11773419|FG000|Overall Study|Physician Decision|3
7470908|NCT01937559|11773420|FG001|Overall Study|Physician Decision|3
7470909|NCT01937559|11773421|FG002|Overall Study|Physician Decision|0
7470910|NCT01937559|11773419|FG000|Overall Study|Withdrawal by Subject|6
7470911|NCT01937559|11773420|FG001|Overall Study|Withdrawal by Subject|4
7314590|NCT00705783|11542413|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
7314591|NCT00705783|11542411|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
7314592|NCT00705783|11542412|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
7314593|NCT00705783|11542413|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
7314594|NCT00705783|11542411|FG000|Oral Stabilization Phase|Withdrew Consent|29
7314595|NCT00705783|11542412|FG001|Oral Stabilization Phase|Withdrew Consent|0
7314596|NCT00705783|11542413|FG002|Oral Stabilization Phase|Withdrew Consent|0
7314597|NCT00705783|11542411|FG000|Oral Stabilization Phase|Adverse Event|14
7314598|NCT00705783|11542412|FG001|Oral Stabilization Phase|Adverse Event|0
7314599|NCT00705783|11542413|FG002|Oral Stabilization Phase|Adverse Event|0
7314600|NCT00705783|11542411|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
7314601|NCT00705783|11542412|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314602|NCT00705783|11542413|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314603|NCT00705783|11542411|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
7314604|NCT00705783|11542412|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7391673|NCT01244516|11652084|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7391674|NCT01244516|11652085|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
7391675|NCT01244516|11652086|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
7391676|NCT01244516|11652084|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7391677|NCT01244516|11652085|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
7391678|NCT01244516|11652086|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
7391679|NCT01244516|11652084|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7391680|NCT01244516|11652085|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
7391681|NCT01244516|11652086|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
7391682|NCT01244893|11652123|FG000|Baseline|Protocol Violation|0
7470912|NCT01937559|11773421|FG002|Overall Study|Withdrawal by Subject|0
7470913|NCT01937559|11773419|FG000|Overall Study|screen fail|2
7470914|NCT01937559|11773420|FG001|Overall Study|screen fail|4
7470915|NCT01937559|11773421|FG002|Overall Study|screen fail|0
7470916|NCT01937715|11773449|FG000|Overall Study|Death|0
7470917|NCT01937715|11773450|FG001|Overall Study|Death|0
7470918|NCT01937715|11773451|FG002|Overall Study|Death|0
7470919|NCT01937715|11773452|FG003|Overall Study|Death|1
7470920|NCT01937715|11773453|FG004|Overall Study|Death|0
7314605|NCT00705783|11542413|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314606|NCT00705783|11542411|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
7314607|NCT00705783|11542412|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
7314608|NCT00705783|11542413|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
7314609|NCT00705783|11542411|FG000|Depot Stabilization Phase|Lost to Follow-up|11
7314610|NCT00705783|11542412|FG001|Depot Stabilization Phase|Lost to Follow-up|0
7314611|NCT00705783|11542413|FG002|Depot Stabilization Phase|Lost to Follow-up|0
7314612|NCT00705783|11542411|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
7314613|NCT00705783|11542412|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
7314614|NCT00705783|11542413|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
7314615|NCT00705783|11542411|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
7470921|NCT01937715|11773449|FG000|Overall Study|Withdrawal by Subject|0
7470922|NCT01937715|11773450|FG001|Overall Study|Withdrawal by Subject|1
7470923|NCT01937715|11773451|FG002|Overall Study|Withdrawal by Subject|0
7470924|NCT01937715|11773452|FG003|Overall Study|Withdrawal by Subject|0
7314616|NCT00705783|11542412|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
7470925|NCT01937715|11773453|FG004|Overall Study|Withdrawal by Subject|2
7470926|NCT01937715|11773449|FG000|Overall Study|Other|0
7470927|NCT01937715|11773450|FG001|Overall Study|Other|0
7470928|NCT01937715|11773451|FG002|Overall Study|Other|0
7470929|NCT01937715|11773452|FG003|Overall Study|Other|3
7470930|NCT01937715|11773453|FG004|Overall Study|Other|0
7470931|NCT01937871|11773468|FG000|Overall Study|Adverse Event|6
7470932|NCT01937871|11773469|FG001|Overall Study|Adverse Event|6
7470933|NCT01937871|11773470|FG002|Overall Study|Adverse Event|2
7470934|NCT01937871|11773468|FG000|Overall Study|Lost to Follow-up|8
7470935|NCT01937871|11773469|FG001|Overall Study|Lost to Follow-up|2
7470936|NCT01937871|11773470|FG002|Overall Study|Lost to Follow-up|4
7470937|NCT01937871|11773468|FG000|Overall Study|Withdrawal by Subject|9
7470938|NCT01937871|11773469|FG001|Overall Study|Withdrawal by Subject|6
7470939|NCT01937871|11773470|FG002|Overall Study|Withdrawal by Subject|4
7470940|NCT01937871|11773468|FG000|Overall Study|Physician Decision|0
7470941|NCT01937871|11773469|FG001|Overall Study|Physician Decision|1
7470942|NCT01937871|11773470|FG002|Overall Study|Physician Decision|0
7470943|NCT01937871|11773468|FG000|Overall Study|Entry Criteria Not Met|1
7470944|NCT01937871|11773469|FG001|Overall Study|Entry Criteria Not Met|2
7314617|NCT00705783|11542413|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
7314618|NCT00705783|11542411|FG000|Depot Stabilization Phase|Withdrew Consent|29
7314619|NCT00705783|11542412|FG001|Depot Stabilization Phase|Withdrew Consent|0
7314620|NCT00705783|11542413|FG002|Depot Stabilization Phase|Withdrew Consent|0
7314621|NCT00705783|11542411|FG000|Depot Stabilization Phase|Adverse Event|17
7314622|NCT00705783|11542412|FG001|Depot Stabilization Phase|Adverse Event|0
7314623|NCT00705783|11542413|FG002|Depot Stabilization Phase|Adverse Event|0
7314624|NCT00705783|11542411|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
7314625|NCT00705783|11542412|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314626|NCT00705783|11542413|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314627|NCT00705783|11542411|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
7314628|NCT00705783|11542412|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314629|NCT00705783|11542413|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314630|NCT00705783|11542411|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
7314631|NCT00705783|11542412|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
7314632|NCT00705783|11542413|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
7314633|NCT00705783|11542411|FG000|Depot Maintenance Phase|Lost to Follow-up|0
7314634|NCT00705783|11542412|FG001|Depot Maintenance Phase|Lost to Follow-up|5
7314635|NCT00705783|11542413|FG002|Depot Maintenance Phase|Lost to Follow-up|3
7314636|NCT00705783|11542411|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
7314637|NCT00705783|11542412|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
7314638|NCT00705783|11542413|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
7314639|NCT00705783|11542411|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
7314640|NCT00705783|11542412|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
7314641|NCT00705783|11542413|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
7314642|NCT00705783|11542411|FG000|Depot Maintenance Phase|Withdrew Consent|0
7314643|NCT00705783|11542412|FG001|Depot Maintenance Phase|Withdrew Consent|14
7314644|NCT00705783|11542413|FG002|Depot Maintenance Phase|Withdrew Consent|4
7314645|NCT00705783|11542411|FG000|Depot Maintenance Phase|Protocol Deviation|0
7314646|NCT00705783|11542412|FG001|Depot Maintenance Phase|Protocol Deviation|2
7314647|NCT00705783|11542413|FG002|Depot Maintenance Phase|Protocol Deviation|0
7391683|NCT01244893|11652124|FG001|Baseline|Protocol Violation|1
7391684|NCT01244893|11652123|FG000|1-Week Follow Up|Lost to Follow-up|1
7391685|NCT01244893|11652124|FG001|1-Week Follow Up|Lost to Follow-up|0
7391686|NCT01244906|11652135|FG000|Overall Study|Death|2
7470945|NCT01937871|11773470|FG002|Overall Study|Entry Criteria Not Met|1
7470946|NCT01937884|11773483|FG000|Overall Study|Withdrawal by Subject|1
7470947|NCT01937884|11773484|FG001|Overall Study|Withdrawal by Subject|0
7470948|NCT01938391|11773567|FG000|6 Month Follow up|Withdrawal by Subject|1
7470949|NCT01938391|11773567|FG000|12 Month Follow up|Physician Decision|1
7470950|NCT01938391|11773567|FG000|12 Month Follow up|Withdrawal by Subject|1
7314648|NCT00705783|11542411|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7314649|NCT00705783|11542412|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
7314650|NCT00705783|11542413|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
7314651|NCT00705783|11542411|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7314652|NCT00705783|11542412|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
7314653|NCT00705783|11542413|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7314654|NCT00705783|11542411|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7314655|NCT00705783|11542412|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
7470951|NCT01938430|11773585|FG000|Overall Study|Randomized but Not Treated|0
7470952|NCT01938430|11773586|FG001|Overall Study|Randomized but Not Treated|0
7470953|NCT01938430|11773587|FG002|Overall Study|Randomized but Not Treated|0
7470954|NCT01938430|11773588|FG003|Overall Study|Randomized but Not Treated|0
7470955|NCT01938430|11773589|FG004|Overall Study|Randomized but Not Treated|0
7470956|NCT01938430|11773590|FG005|Overall Study|Randomized but Not Treated|0
7470957|NCT01938430|11773591|FG006|Overall Study|Randomized but Not Treated|0
7470958|NCT01938430|11773592|FG007|Overall Study|Randomized but Not Treated|0
7470959|NCT01938430|11773593|FG008|Overall Study|Randomized but Not Treated|0
7470960|NCT01938430|11773594|FG009|Overall Study|Randomized but Not Treated|0
7470961|NCT01938430|11773595|FG010|Overall Study|Randomized but Not Treated|1
7470962|NCT01938430|11773596|FG011|Overall Study|Randomized but Not Treated|0
7470963|NCT01938430|11773597|FG012|Overall Study|Randomized but Not Treated|0
7470964|NCT01938430|11773598|FG013|Overall Study|Randomized but Not Treated|1
7470965|NCT01938430|11773585|FG000|Overall Study|Adverse Event|0
7470966|NCT01938430|11773586|FG001|Overall Study|Adverse Event|0
7470967|NCT01938430|11773587|FG002|Overall Study|Adverse Event|0
7470968|NCT01938430|11773588|FG003|Overall Study|Adverse Event|0
7470969|NCT01938430|11773589|FG004|Overall Study|Adverse Event|0
7470970|NCT01938430|11773590|FG005|Overall Study|Adverse Event|0
7470971|NCT01938430|11773591|FG006|Overall Study|Adverse Event|1
7470972|NCT01938430|11773592|FG007|Overall Study|Adverse Event|0
7470973|NCT01938430|11773593|FG008|Overall Study|Adverse Event|0
7470974|NCT01938430|11773594|FG009|Overall Study|Adverse Event|0
7470975|NCT01938430|11773595|FG010|Overall Study|Adverse Event|0
7470976|NCT01938430|11773596|FG011|Overall Study|Adverse Event|0
7470977|NCT01938430|11773597|FG012|Overall Study|Adverse Event|0
7470978|NCT01938430|11773598|FG013|Overall Study|Adverse Event|0
7470979|NCT01938430|11773585|FG000|Overall Study|Death|1
7470980|NCT01938430|11773586|FG001|Overall Study|Death|2
7470981|NCT01938430|11773587|FG002|Overall Study|Death|2
7470982|NCT01938430|11773588|FG003|Overall Study|Death|1
7470983|NCT01938430|11773589|FG004|Overall Study|Death|0
7470984|NCT01938430|11773590|FG005|Overall Study|Death|0
7470985|NCT01938430|11773591|FG006|Overall Study|Death|1
7470986|NCT01938430|11773592|FG007|Overall Study|Death|1
7470987|NCT01938430|11773593|FG008|Overall Study|Death|2
7470988|NCT01938430|11773594|FG009|Overall Study|Death|3
7470989|NCT01938430|11773595|FG010|Overall Study|Death|0
7470990|NCT01938430|11773596|FG011|Overall Study|Death|0
7470991|NCT01938430|11773597|FG012|Overall Study|Death|0
7470992|NCT01938430|11773598|FG013|Overall Study|Death|0
7470993|NCT01938430|11773585|FG000|Overall Study|Investigator's Discretion|0
7470994|NCT01938430|11773586|FG001|Overall Study|Investigator's Discretion|0
7470995|NCT01938430|11773587|FG002|Overall Study|Investigator's Discretion|1
7470996|NCT01938430|11773588|FG003|Overall Study|Investigator's Discretion|0
7470997|NCT01938430|11773589|FG004|Overall Study|Investigator's Discretion|0
7470998|NCT01938430|11773590|FG005|Overall Study|Investigator's Discretion|0
7470999|NCT01938430|11773591|FG006|Overall Study|Investigator's Discretion|0
7471000|NCT01938430|11773592|FG007|Overall Study|Investigator's Discretion|0
7471001|NCT01938430|11773593|FG008|Overall Study|Investigator's Discretion|0
7471002|NCT01938430|11773594|FG009|Overall Study|Investigator's Discretion|0
7471003|NCT01938430|11773595|FG010|Overall Study|Investigator's Discretion|0
7471004|NCT01938430|11773596|FG011|Overall Study|Investigator's Discretion|0
7471005|NCT01938430|11773597|FG012|Overall Study|Investigator's Discretion|0
7471006|NCT01938430|11773598|FG013|Overall Study|Investigator's Discretion|0
7471007|NCT01938430|11773585|FG000|Overall Study|Lack of Efficacy|3
7471008|NCT01938430|11773586|FG001|Overall Study|Lack of Efficacy|1
7471009|NCT01938430|11773587|FG002|Overall Study|Lack of Efficacy|1
7471010|NCT01938430|11773588|FG003|Overall Study|Lack of Efficacy|1
7314656|NCT00705783|11542413|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
7314657|NCT00705939|11542454|FG000|Overall Study|Protocol Violation|0
7471011|NCT01938430|11773589|FG004|Overall Study|Lack of Efficacy|0
7471012|NCT01938430|11773590|FG005|Overall Study|Lack of Efficacy|0
7471013|NCT01938430|11773591|FG006|Overall Study|Lack of Efficacy|0
7471014|NCT01938430|11773592|FG007|Overall Study|Lack of Efficacy|0
7314658|NCT00705939|11542455|FG001|Overall Study|Protocol Violation|0
7471015|NCT01938430|11773593|FG008|Overall Study|Lack of Efficacy|1
7471016|NCT01938430|11773594|FG009|Overall Study|Lack of Efficacy|0
7471017|NCT01938430|11773595|FG010|Overall Study|Lack of Efficacy|2
7471018|NCT01938430|11773596|FG011|Overall Study|Lack of Efficacy|1
7471019|NCT01938430|11773597|FG012|Overall Study|Lack of Efficacy|0
7471020|NCT01938430|11773598|FG013|Overall Study|Lack of Efficacy|0
7471021|NCT01938430|11773585|FG000|Overall Study|Lost to Follow-up|0
7471022|NCT01938430|11773586|FG001|Overall Study|Lost to Follow-up|0
7471023|NCT01938430|11773587|FG002|Overall Study|Lost to Follow-up|1
7314659|NCT00705939|11542456|FG002|Overall Study|Protocol Violation|1
7314660|NCT00705939|11542454|FG000|Overall Study|Withdrawal by Subject|0
7314661|NCT00705939|11542455|FG001|Overall Study|Withdrawal by Subject|1
7391687|NCT01244906|11652135|FG000|Overall Study|Progression of disease post treatment|6
7391688|NCT01244984|11652142|FG000|Overall Study|Adverse Event|2
7391689|NCT01244984|11652143|FG001|Overall Study|Adverse Event|11
7391690|NCT01244984|11652144|FG002|Overall Study|Adverse Event|2
7391691|NCT01244984|11652142|FG000|Overall Study|Protocol Violation|1
7391692|NCT01244984|11652143|FG001|Overall Study|Protocol Violation|0
7391693|NCT01244984|11652144|FG002|Overall Study|Protocol Violation|0
7391694|NCT01244984|11652142|FG000|Overall Study|Protocol Defined Stopping Criteria|1
7391695|NCT01244984|11652143|FG001|Overall Study|Protocol Defined Stopping Criteria|1
7391696|NCT01244984|11652144|FG002|Overall Study|Protocol Defined Stopping Criteria|0
7471024|NCT01938430|11773588|FG003|Overall Study|Lost to Follow-up|0
7471025|NCT01938430|11773589|FG004|Overall Study|Lost to Follow-up|0
7471026|NCT01938430|11773590|FG005|Overall Study|Lost to Follow-up|1
7471027|NCT01938430|11773591|FG006|Overall Study|Lost to Follow-up|0
7471028|NCT01938430|11773592|FG007|Overall Study|Lost to Follow-up|0
7471029|NCT01938430|11773593|FG008|Overall Study|Lost to Follow-up|0
7471030|NCT01938430|11773594|FG009|Overall Study|Lost to Follow-up|0
7471031|NCT01938430|11773595|FG010|Overall Study|Lost to Follow-up|0
7471032|NCT01938430|11773596|FG011|Overall Study|Lost to Follow-up|0
7471033|NCT01938430|11773597|FG012|Overall Study|Lost to Follow-up|0
7471034|NCT01938430|11773598|FG013|Overall Study|Lost to Follow-up|0
7471035|NCT01938430|11773585|FG000|Overall Study|Withdrew Consent|0
7471036|NCT01938430|11773586|FG001|Overall Study|Withdrew Consent|0
7471037|NCT01938430|11773587|FG002|Overall Study|Withdrew Consent|0
7471038|NCT01938430|11773588|FG003|Overall Study|Withdrew Consent|0
7471039|NCT01938430|11773589|FG004|Overall Study|Withdrew Consent|0
7471040|NCT01938430|11773590|FG005|Overall Study|Withdrew Consent|0
7471041|NCT01938430|11773591|FG006|Overall Study|Withdrew Consent|0
7471042|NCT01938430|11773592|FG007|Overall Study|Withdrew Consent|0
7471043|NCT01938430|11773593|FG008|Overall Study|Withdrew Consent|1
7471044|NCT01938430|11773594|FG009|Overall Study|Withdrew Consent|0
7391697|NCT01244984|11652142|FG000|Overall Study|Withdrawal by Subject|1
7391698|NCT01244984|11652143|FG001|Overall Study|Withdrawal by Subject|2
7391699|NCT01244984|11652144|FG002|Overall Study|Withdrawal by Subject|2
7391700|NCT01245049|11652155|FG000|Overall Study|Migrated/moved from study area|0
7391701|NCT01245049|11652156|FG001|Overall Study|Migrated/moved from study area|1
7391702|NCT01245049|11652155|FG000|Overall Study|Withdrawal by Subject|0
7391703|NCT01245049|11652156|FG001|Overall Study|Withdrawal by Subject|1
7391704|NCT01245049|11652155|FG000|Overall Study|Lost to Follow-up|1
7391705|NCT01245049|11652156|FG001|Overall Study|Lost to Follow-up|2
7391706|NCT01245062|11652164|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
7391707|NCT01245062|11652165|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
7391708|NCT01245062|11652166|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
7391709|NCT01245062|11652164|FG000|Randomization and Crossover Phase|Physician Decision|2
7391710|NCT01245062|11652165|FG001|Randomization and Crossover Phase|Physician Decision|4
7391711|NCT01245062|11652166|FG002|Randomization and Crossover Phase|Physician Decision|0
7391712|NCT01245062|11652164|FG000|Randomization and Crossover Phase|Withdrew Consent|12
7391713|NCT01245062|11652165|FG001|Randomization and Crossover Phase|Withdrew Consent|11
7391714|NCT01245062|11652166|FG002|Randomization and Crossover Phase|Withdrew Consent|0
7391715|NCT01245062|11652164|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
7391716|NCT01245062|11652165|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
7391717|NCT01245062|11652166|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
7391718|NCT01245062|11652164|FG000|Cross-over Phase|Lost to Follow-up|0
7391719|NCT01245062|11652165|FG001|Cross-over Phase|Lost to Follow-up|0
7391720|NCT01245062|11652166|FG002|Cross-over Phase|Lost to Follow-up|1
7391721|NCT01245062|11652164|FG000|Cross-over Phase|Physician Decision|0
7391722|NCT01245062|11652165|FG001|Cross-over Phase|Physician Decision|0
7391723|NCT01245062|11652166|FG002|Cross-over Phase|Physician Decision|1
7391724|NCT01245062|11652164|FG000|Cross-over Phase|Withdrew Consent|0
7471045|NCT01938430|11773595|FG010|Overall Study|Withdrew Consent|0
7471046|NCT01938430|11773596|FG011|Overall Study|Withdrew Consent|0
7471047|NCT01938430|11773597|FG012|Overall Study|Withdrew Consent|0
7471048|NCT01938430|11773598|FG013|Overall Study|Withdrew Consent|0
7471049|NCT01938573|11773653|FG000|Overall Study|Lack of Efficacy|1
7471050|NCT01938573|11773654|FG001|Overall Study|Lack of Efficacy|0
7314662|NCT00705939|11542456|FG002|Overall Study|Withdrawal by Subject|3
7314663|NCT00705939|11542454|FG000|Overall Study|Physician Decision|0
7314664|NCT00705939|11542455|FG001|Overall Study|Physician Decision|1
7314665|NCT00705939|11542456|FG002|Overall Study|Physician Decision|0
7314666|NCT00706004|11542465|FG000|Overall Study|Did not meet eligibility criteria|2
7314667|NCT00706030|11542474|FG000|Overall Study|Disease Progression|4
7314668|NCT00706030|11542475|FG001|Overall Study|Disease Progression|6
7314669|NCT00706030|11542476|FG002|Overall Study|Disease Progression|46
7314670|NCT00706030|11542477|FG003|Overall Study|Disease Progression|12
7314671|NCT00706030|11542474|FG000|Overall Study|Adverse Event|1
7314672|NCT00706030|11542475|FG001|Overall Study|Adverse Event|0
7314673|NCT00706030|11542476|FG002|Overall Study|Adverse Event|4
7314674|NCT00706030|11542477|FG003|Overall Study|Adverse Event|2
7314675|NCT00706030|11542474|FG000|Overall Study|Withdrawal by Subject|1
7314676|NCT00706030|11542475|FG001|Overall Study|Withdrawal by Subject|0
7314677|NCT00706030|11542476|FG002|Overall Study|Withdrawal by Subject|2
7314678|NCT00706030|11542477|FG003|Overall Study|Withdrawal by Subject|0
7314679|NCT00706030|11542474|FG000|Overall Study|Physician Decision|0
7314680|NCT00706030|11542475|FG001|Overall Study|Physician Decision|0
7314681|NCT00706030|11542476|FG002|Overall Study|Physician Decision|2
7314682|NCT00706030|11542477|FG003|Overall Study|Physician Decision|0
7314683|NCT00706030|11542474|FG000|Overall Study|Not recorded|0
7552963|NCT03002038|11913565|FG001|Overall Study|Immigration to another region|2
7314684|NCT00706030|11542475|FG001|Overall Study|Not recorded|0
7314685|NCT00706030|11542476|FG002|Overall Study|Not recorded|2
7314686|NCT00706030|11542477|FG003|Overall Study|Not recorded|0
7314687|NCT00706030|11542474|FG000|Overall Study|Protocol Violation|0
7314688|NCT00706030|11542475|FG001|Overall Study|Protocol Violation|0
7314689|NCT00706030|11542476|FG002|Overall Study|Protocol Violation|1
7314690|NCT00706030|11542477|FG003|Overall Study|Protocol Violation|1
7314691|NCT00706030|11542474|FG000|Overall Study|Failed to return|0
7314692|NCT00706030|11542475|FG001|Overall Study|Failed to return|0
7314693|NCT00706030|11542476|FG002|Overall Study|Failed to return|1
7314694|NCT00706030|11542477|FG003|Overall Study|Failed to return|0
7314695|NCT00706030|11542474|FG000|Overall Study|Symptomatic Deterioration|0
7314696|NCT00706030|11542475|FG001|Overall Study|Symptomatic Deterioration|0
7314697|NCT00706030|11542476|FG002|Overall Study|Symptomatic Deterioration|1
7314698|NCT00706030|11542477|FG003|Overall Study|Symptomatic Deterioration|0
7314699|NCT00706030|11542474|FG000|Overall Study|No treatment received|0
7314700|NCT00706030|11542475|FG001|Overall Study|No treatment received|0
7314701|NCT00706030|11542476|FG002|Overall Study|No treatment received|0
7314702|NCT00706030|11542477|FG003|Overall Study|No treatment received|1
7314703|NCT00706030|11542474|FG000|Overall Study|Death|0
7314704|NCT00706030|11542475|FG001|Overall Study|Death|0
7314705|NCT00706030|11542476|FG002|Overall Study|Death|1
7314706|NCT00706030|11542477|FG003|Overall Study|Death|0
7314707|NCT00706095|11542491|FG000|Overall Study|Progressive Disease|4
7314708|NCT00706095|11542492|FG001|Overall Study|Progressive Disease|5
7314709|NCT00706095|11542493|FG002|Overall Study|Progressive Disease|3
7314710|NCT00706095|11542491|FG000|Overall Study|Clinical Progression|1
7314711|NCT00706095|11542492|FG001|Overall Study|Clinical Progression|2
7314712|NCT00706095|11542493|FG002|Overall Study|Clinical Progression|2
7314713|NCT00706095|11542491|FG000|Overall Study|Withdrawal by Subject|1
7314714|NCT00706095|11542492|FG001|Overall Study|Withdrawal by Subject|0
7314715|NCT00706095|11542493|FG002|Overall Study|Withdrawal by Subject|0
7314716|NCT00706134|11542530|FG000|Overall Study|Adverse Event|8
7314717|NCT00706134|11542531|FG001|Overall Study|Adverse Event|7
7314718|NCT00706134|11542532|FG002|Overall Study|Adverse Event|2
7314719|NCT00706134|11542533|FG003|Overall Study|Adverse Event|3
7314720|NCT00706134|11542530|FG000|Overall Study|Lost to Follow-up|0
7314721|NCT00706134|11542531|FG001|Overall Study|Lost to Follow-up|1
7314722|NCT00706134|11542532|FG002|Overall Study|Lost to Follow-up|0
7314723|NCT00706134|11542533|FG003|Overall Study|Lost to Follow-up|0
7314724|NCT00706134|11542530|FG000|Overall Study|Protocol Violation|0
7314725|NCT00706134|11542531|FG001|Overall Study|Protocol Violation|6
7314726|NCT00706134|11542532|FG002|Overall Study|Protocol Violation|0
7314727|NCT00706134|11542533|FG003|Overall Study|Protocol Violation|3
7314728|NCT00706134|11542530|FG000|Overall Study|Withdrawal by Subject|1
7314729|NCT00706134|11542531|FG001|Overall Study|Withdrawal by Subject|2
7314730|NCT00706134|11542532|FG002|Overall Study|Withdrawal by Subject|1
7314731|NCT00706134|11542533|FG003|Overall Study|Withdrawal by Subject|0
7314732|NCT00706134|11542530|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7314733|NCT00706134|11542531|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7314734|NCT00706134|11542532|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7314735|NCT00706134|11542533|FG003|Overall Study|Unsatisfactory therapeutic effect|5
7314736|NCT00706134|11542530|FG000|Overall Study|Did not meet study criteria|2
7314737|NCT00706134|11542531|FG001|Overall Study|Did not meet study criteria|0
7314738|NCT00706134|11542532|FG002|Overall Study|Did not meet study criteria|0
7314739|NCT00706134|11542533|FG003|Overall Study|Did not meet study criteria|0
7314740|NCT00706238|11542543|FG000|Overall Study|Disease progression|4
7314741|NCT00706238|11542543|FG000|Overall Study|Other|1
7314742|NCT00706342|11542558|FG000|Overall Study|Adverse Event|3
7314743|NCT00706342|11542558|FG000|Overall Study|Not responding to treatment|2
7314744|NCT00706342|11542558|FG000|Overall Study|Withdrawn due to failure to respond|1
7314745|NCT00706342|11542558|FG000|Overall Study|Death|1
7314746|NCT00706342|11542558|FG000|Overall Study|Withdrew from the study on his own.|1
7314747|NCT00706342|11542558|FG000|Overall Study|Investigator discretion|2
7314748|NCT00706342|11542558|FG000|Overall Study|Non-responder Week 12|1
7314749|NCT00706342|11542558|FG000|Overall Study|Ongoing|6
7314750|NCT00706342|11542558|FG000|Overall Study|WIthdrawal of consent|1
7314751|NCT00706355|11542566|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
7314752|NCT00706355|11542567|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7314753|NCT00706355|11542568|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7314754|NCT00706355|11542569|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
7314755|NCT00706355|11542566|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
7314756|NCT00706355|11542567|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7314757|NCT00706355|11542568|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7314758|NCT00706355|11542569|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
7314759|NCT00706355|11542566|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7314760|NCT00706355|11542567|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
7314761|NCT00706355|11542568|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7314762|NCT00706355|11542569|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
7314763|NCT00706355|11542566|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7314764|NCT00706355|11542567|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
7314798|NCT00706433|11542621|FG003|Overall Study|Withdrawal by Subject|1
7314765|NCT00706355|11542568|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7314766|NCT00706355|11542569|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
7314767|NCT00706355|11542566|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7314768|NCT00706355|11542567|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
7314769|NCT00706355|11542568|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7314770|NCT00706355|11542569|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
7391725|NCT01245062|11652165|FG001|Cross-over Phase|Withdrew Consent|0
7391726|NCT01245062|11652166|FG002|Cross-over Phase|Withdrew Consent|4
7391727|NCT01245062|11652164|FG000|Cross-over Phase|Study closed/ terminated|0
7391728|NCT01245062|11652165|FG001|Cross-over Phase|Study closed/ terminated|0
7471051|NCT01938573|11773653|FG000|Overall Study|Operation at other hospital|1
7471052|NCT01938573|11773654|FG001|Overall Study|Operation at other hospital|0
7471053|NCT01938625|11773661|FG000|Overall Study|Withdrawal by Subject|0
7471054|NCT01938625|11773662|FG001|Overall Study|Withdrawal by Subject|1
7471055|NCT01938625|11773661|FG000|Overall Study|Adverse Event|0
7471056|NCT01938625|11773662|FG001|Overall Study|Adverse Event|1
7471057|NCT01938846|11773680|FG000|Overall Study|Progressive disease|26
7471058|NCT01938846|11773681|FG001|Overall Study|Progressive disease|18
7471059|NCT01938846|11773682|FG002|Overall Study|Progressive disease|16
7471060|NCT01938846|11773680|FG000|Overall Study|Adverse Event|8
7471061|NCT01938846|11773681|FG001|Overall Study|Adverse Event|4
7471062|NCT01938846|11773682|FG002|Overall Study|Adverse Event|3
7471063|NCT01938846|11773680|FG000|Overall Study|Withdrawal by Subject|2
7471064|NCT01938846|11773681|FG001|Overall Study|Withdrawal by Subject|2
7471065|NCT01938846|11773682|FG002|Overall Study|Withdrawal by Subject|1
7471066|NCT01938846|11773680|FG000|Overall Study|Other than listed|5
7391729|NCT01245062|11652166|FG002|Cross-over Phase|Study closed/ terminated|11
7391730|NCT01245101|11652176|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
7391731|NCT01245101|11652177|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
7391732|NCT01245101|11652176|FG000|Period 2 (Washout)|Withdrawal by Subject|1
7391733|NCT01245101|11652177|FG001|Period 2 (Washout)|Withdrawal by Subject|0
7391734|NCT01245101|11652176|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
7391735|NCT01245101|11652177|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
7391736|NCT01245140|11652185|FG000|Overall Study|Adverse Event|1
7391737|NCT01245140|11652186|FG001|Overall Study|Adverse Event|3
7391738|NCT01245140|11652185|FG000|Overall Study|Lack of Efficacy|2
7471067|NCT01938846|11773681|FG001|Overall Study|Other than listed|1
7471068|NCT01938846|11773682|FG002|Overall Study|Other than listed|4
7471069|NCT01939002|11773732|FG000|Overall Study|Adverse Event|13
7471070|NCT01939002|11773733|FG001|Overall Study|Adverse Event|13
7471071|NCT01939002|11773732|FG000|Overall Study|Withdrawal by Subject|5
7471072|NCT01939002|11773733|FG001|Overall Study|Withdrawal by Subject|3
7471073|NCT01939002|11773732|FG000|Overall Study|Other|1
7471074|NCT01939002|11773733|FG001|Overall Study|Other|2
7471075|NCT01939028|11773744|FG000|Overall Study|Withdrawal by Subject|5
7471076|NCT01939028|11773744|FG000|Overall Study|Physician Decision|7
7471077|NCT01939158|11773761|FG000|Overall Study|Adverse Event|1
7471078|NCT01939158|11773762|FG001|Overall Study|Adverse Event|0
7471079|NCT01939158|11773763|FG002|Overall Study|Adverse Event|0
7471080|NCT01939158|11773764|FG003|Overall Study|Adverse Event|0
7471081|NCT01939158|11773761|FG000|Overall Study|Withdrawal by Subject|22
7471082|NCT01939158|11773762|FG001|Overall Study|Withdrawal by Subject|25
7471083|NCT01939158|11773763|FG002|Overall Study|Withdrawal by Subject|15
7471084|NCT01939158|11773764|FG003|Overall Study|Withdrawal by Subject|17
7471085|NCT01939158|11773761|FG000|Overall Study|Migrated/moved from study area|5
7471086|NCT01939158|11773762|FG001|Overall Study|Migrated/moved from study area|7
7471087|NCT01939158|11773763|FG002|Overall Study|Migrated/moved from study area|3
7471088|NCT01939158|11773764|FG003|Overall Study|Migrated/moved from study area|6
7471089|NCT01939158|11773761|FG000|Overall Study|Lost to Follow-up|18
7471090|NCT01939158|11773762|FG001|Overall Study|Lost to Follow-up|17
7471091|NCT01939158|11773763|FG002|Overall Study|Lost to Follow-up|17
7391739|NCT01245140|11652186|FG001|Overall Study|Lack of Efficacy|4
7471092|NCT01939158|11773764|FG003|Overall Study|Lost to Follow-up|17
7471093|NCT01939158|11773761|FG000|Overall Study|Death|0
7471094|NCT01939158|11773762|FG001|Overall Study|Death|0
7471095|NCT01939158|11773763|FG002|Overall Study|Death|1
7471096|NCT01939158|11773764|FG003|Overall Study|Death|1
7471097|NCT01939158|11773761|FG000|Overall Study|No longer meets eligibility criteria|0
7471098|NCT01939158|11773762|FG001|Overall Study|No longer meets eligibility criteria|0
7471099|NCT01939158|11773763|FG002|Overall Study|No longer meets eligibility criteria|1
7471100|NCT01939158|11773764|FG003|Overall Study|No longer meets eligibility criteria|0
7471101|NCT01939158|11773761|FG000|Overall Study|Other|1
7314771|NCT00706355|11542566|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
7314772|NCT00706355|11542567|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
7314773|NCT00706355|11542568|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
7314774|NCT00706355|11542569|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
7314775|NCT00706355|11542566|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7314776|NCT00706355|11542567|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7314777|NCT00706355|11542568|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
7314778|NCT00706355|11542569|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
7314779|NCT00706355|11542566|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
7314780|NCT00706355|11542567|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
7314781|NCT00706355|11542568|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
7314782|NCT00706355|11542569|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
7314783|NCT00706355|11542566|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7314784|NCT00706355|11542567|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7471102|NCT01939158|11773762|FG001|Overall Study|Other|3
7471103|NCT01939158|11773763|FG002|Overall Study|Other|4
7471104|NCT01939158|11773764|FG003|Overall Study|Other|3
7471105|NCT01939197|11773785|FG000|Overall Study|Withdrawal by Subject|1
7471106|NCT01939197|11773786|FG001|Overall Study|Withdrawal by Subject|0
7471107|NCT01939197|11773787|FG002|Overall Study|Withdrawal by Subject|0
7471108|NCT01939197|11773788|FG003|Overall Study|Withdrawal by Subject|0
7471109|NCT01939197|11773789|FG004|Overall Study|Withdrawal by Subject|1
7471110|NCT01939197|11773790|FG005|Overall Study|Withdrawal by Subject|0
7471111|NCT01939197|11773791|FG006|Overall Study|Withdrawal by Subject|0
7552964|NCT03002077|11913571|FG000|Overall Study|Non-compliance with Study Drug|4
7552965|NCT03002077|11913571|FG000|Overall Study|Non-compliance w/Background ADT|1
7552966|NCT03002077|11913571|FG000|Overall Study|Study Terminated by Sponsor|257
7552967|NCT03002077|11913571|FG000|Overall Study|Site Terminated by Sponsor|5
7552968|NCT03002077|11913571|FG000|Overall Study|Miscellaneous Reasons|10
7552969|NCT03002077|11913571|FG000|Overall Study|Adverse Event|23
7552970|NCT03002077|11913571|FG000|Overall Study|Lack of Efficacy|20
7552971|NCT03002077|11913571|FG000|Overall Study|Withdrawal by Subject|72
7552972|NCT03002077|11913571|FG000|Overall Study|Lost to Follow-up|21
7552973|NCT03002077|11913571|FG000|Overall Study|Pregnancy|4
7552974|NCT03002077|11913571|FG000|Overall Study|Protocol Violation|21
7552975|NCT03002194|11913575|FG000|Overall Study|Lost to Follow-up|6
7552976|NCT03002194|11913575|FG000|Overall Study|Adverse Event|1
7552977|NCT03002194|11913575|FG000|Overall Study|Lack of Efficacy|1
7552978|NCT03002194|11913575|FG000|Overall Study|Withdrawal by Subject|2
7552979|NCT03002311|11913581|FG000|Overall Study|Lost to Follow-up|13
7552980|NCT03002311|11913582|FG001|Overall Study|Lost to Follow-up|26
7552981|NCT03002311|11913581|FG000|Overall Study|Referral provider called to schedule app|3
7552982|NCT03002311|11913582|FG001|Overall Study|Referral provider called to schedule app|3
7552983|NCT03002311|11913581|FG000|Overall Study|Physician Decision|3
7552984|NCT03002311|11913582|FG001|Overall Study|Physician Decision|1
7552985|NCT03002610|11913600|FG000|Overall Study|Withdrawal by Subject|6
7552986|NCT03002610|11913601|FG001|Overall Study|Withdrawal by Subject|25
7552987|NCT03002610|11913602|FG002|Overall Study|Withdrawal by Subject|13
7552988|NCT03002623|11913612|FG000|Overall Study|Lost to Follow-up|1
7552989|NCT03002623|11913613|FG001|Overall Study|Lost to Follow-up|0
7552990|NCT03002623|11913612|FG000|Overall Study|Physician Decision|1
7552991|NCT03002623|11913613|FG001|Overall Study|Physician Decision|1
7552992|NCT03002818|11913633|FG000|Overall Study|Decision of the investigator|1
7552993|NCT03003000|11913653|FG000|Overall Study|Adverse Event|1
7552994|NCT03003000|11913654|FG001|Overall Study|Adverse Event|2
7552995|NCT03003000|11913655|FG002|Overall Study|Adverse Event|3
7552996|NCT03003000|11913653|FG000|Overall Study|Lack of Efficacy|1
7552997|NCT03003000|11913654|FG001|Overall Study|Lack of Efficacy|0
7552998|NCT03003000|11913655|FG002|Overall Study|Lack of Efficacy|0
7552999|NCT03003000|11913653|FG000|Overall Study|Non-compliant with protocol|0
7553000|NCT03003000|11913654|FG001|Overall Study|Non-compliant with protocol|1
7553001|NCT03003000|11913655|FG002|Overall Study|Non-compliant with protocol|1
7553002|NCT03003000|11913653|FG000|Overall Study|Refused to continue medication|2
7553003|NCT03003000|11913654|FG001|Overall Study|Refused to continue medication|0
7553004|NCT03003000|11913655|FG002|Overall Study|Refused to continue medication|0
7553005|NCT03003000|11913653|FG000|Overall Study|Other than listed|1
7553006|NCT03003000|11913654|FG001|Overall Study|Other than listed|1
7314785|NCT00706355|11542568|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
7314786|NCT00706355|11542569|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
7553007|NCT03003000|11913655|FG002|Overall Study|Other than listed|1
7553008|NCT03003390|11913674|FG000|Overall Study|Physician Decision|2
7224527|NCT00054639|11433769|FG000|Overall Study|Physician Decision|1
7553009|NCT03003390|11913675|FG001|Overall Study|Physician Decision|0
7553010|NCT03003390|11913674|FG000|Overall Study|Parent refused intervention|2
7553011|NCT03003390|11913675|FG001|Overall Study|Parent refused intervention|0
7553012|NCT03003494|11913686|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
7553013|NCT03003676|11913692|FG000|Overall Study|Lack of Efficacy|5
7553014|NCT03003676|11913693|FG001|Overall Study|Lack of Efficacy|7
7553015|NCT03003676|11913692|FG000|Overall Study|Withdrawal by Subject|0
7553016|NCT03003676|11913693|FG001|Overall Study|Withdrawal by Subject|1
7553017|NCT03003676|11913692|FG000|Overall Study|Hepatitis B infection|1
7314787|NCT00706381|11542585|FG000|Overall Study|Lost to Follow-up|0
7314788|NCT00706381|11542586|FG001|Overall Study|Lost to Follow-up|1
7314789|NCT00706381|11542587|FG002|Overall Study|Lost to Follow-up|1
7314790|NCT00706381|11542588|FG003|Overall Study|Lost to Follow-up|0
7314791|NCT00706433|11542618|FG000|Overall Study|Lost to Follow-up|3
7314792|NCT00706433|11542619|FG001|Overall Study|Lost to Follow-up|1
7314793|NCT00706433|11542620|FG002|Overall Study|Lost to Follow-up|6
7314794|NCT00706433|11542621|FG003|Overall Study|Lost to Follow-up|0
7314795|NCT00706433|11542618|FG000|Overall Study|Withdrawal by Subject|1
7314796|NCT00706433|11542619|FG001|Overall Study|Withdrawal by Subject|2
7314797|NCT00706433|11542620|FG002|Overall Study|Withdrawal by Subject|3
7314799|NCT00706433|11542618|FG000|Overall Study|Adverse Event|0
7314800|NCT00706433|11542619|FG001|Overall Study|Adverse Event|0
7314801|NCT00706433|11542620|FG002|Overall Study|Adverse Event|1
7314802|NCT00706433|11542621|FG003|Overall Study|Adverse Event|0
7314803|NCT00706433|11542618|FG000|Overall Study|Protocol Violation|1
7314804|NCT00706433|11542619|FG001|Overall Study|Protocol Violation|0
7314805|NCT00706433|11542620|FG002|Overall Study|Protocol Violation|0
7314806|NCT00706433|11542621|FG003|Overall Study|Protocol Violation|0
7314807|NCT00706433|11542618|FG000|Overall Study|new job|0
7314808|NCT00706433|11542619|FG001|Overall Study|new job|0
7314809|NCT00706433|11542620|FG002|Overall Study|new job|0
7314810|NCT00706433|11542621|FG003|Overall Study|new job|1
7314811|NCT00706511|11542664|FG000|Overall Study|Withdrawal by Subject|1
7314812|NCT00706511|11542665|FG001|Overall Study|Withdrawal by Subject|0
7314813|NCT00706511|11542666|FG002|Overall Study|Withdrawal by Subject|0
7314814|NCT00706511|11542667|FG003|Overall Study|Withdrawal by Subject|0
7314815|NCT00706628|11542707|FG000|Overall Study|Other Adverse Event|16
7391740|NCT01245140|11652185|FG000|Overall Study|Protocol Violation|0
7391741|NCT01245140|11652186|FG001|Overall Study|Protocol Violation|1
7391742|NCT01245140|11652185|FG000|Overall Study|Withdrawal by Subject|0
7553018|NCT03003676|11913693|FG001|Overall Study|Hepatitis B infection|0
7553019|NCT03004469|11913722|FG000|Overall Study|Adverse Event|6
7553020|NCT03004469|11913723|FG001|Overall Study|Adverse Event|4
7553021|NCT03004469|11913724|FG002|Overall Study|Adverse Event|6
7553022|NCT03004469|11913722|FG000|Overall Study|Lack of Efficacy|1
7553023|NCT03004469|11913723|FG001|Overall Study|Lack of Efficacy|0
7553024|NCT03004469|11913724|FG002|Overall Study|Lack of Efficacy|1
7553025|NCT03004469|11913722|FG000|Overall Study|Lost to Follow-up|23
7553026|NCT03004469|11913723|FG001|Overall Study|Lost to Follow-up|14
7553027|NCT03004469|11913724|FG002|Overall Study|Lost to Follow-up|6
7553028|NCT03004469|11913722|FG000|Overall Study|Non-Compliance with Study Drug|2
7553029|NCT03004469|11913723|FG001|Overall Study|Non-Compliance with Study Drug|0
7553030|NCT03004469|11913724|FG002|Overall Study|Non-Compliance with Study Drug|0
7553031|NCT03004469|11913722|FG000|Overall Study|Protocol Violation|0
7553032|NCT03004469|11913723|FG001|Overall Study|Protocol Violation|0
7553033|NCT03004469|11913724|FG002|Overall Study|Protocol Violation|1
7391743|NCT01245140|11652186|FG001|Overall Study|Withdrawal by Subject|1
7391744|NCT01245140|11652185|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
7314816|NCT00706628|11542708|FG001|Overall Study|Other Adverse Event|5
7314817|NCT00706628|11542709|FG002|Overall Study|Other Adverse Event|5
7314818|NCT00706628|11542710|FG003|Overall Study|Other Adverse Event|2
7314819|NCT00706628|11542707|FG000|Overall Study|Non compliant with protocol|0
7314820|NCT00706628|11542708|FG001|Overall Study|Non compliant with protocol|1
7391745|NCT01245140|11652186|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
7314821|NCT00706628|11542709|FG002|Overall Study|Non compliant with protocol|0
7314822|NCT00706628|11542710|FG003|Overall Study|Non compliant with protocol|0
7314823|NCT00706628|11542707|FG000|Overall Study|Consent withdrawn|6
7314824|NCT00706628|11542708|FG001|Overall Study|Consent withdrawn|1
7314825|NCT00706628|11542709|FG002|Overall Study|Consent withdrawn|3
7314826|NCT00706628|11542710|FG003|Overall Study|Consent withdrawn|0
7314827|NCT00706628|11542707|FG000|Overall Study|Progressive disease|20
7314828|NCT00706628|11542708|FG001|Overall Study|Progressive disease|13
7314829|NCT00706628|11542709|FG002|Overall Study|Progressive disease|8
7314830|NCT00706628|11542710|FG003|Overall Study|Progressive disease|1
7314831|NCT00706628|11542707|FG000|Overall Study|Other than those stated above|4
7314832|NCT00706628|11542708|FG001|Overall Study|Other than those stated above|0
7314833|NCT00706628|11542709|FG002|Overall Study|Other than those stated above|0
7314834|NCT00706628|11542710|FG003|Overall Study|Other than those stated above|0
7314835|NCT00706628|11542707|FG000|Overall Study|Not treated|1
7314836|NCT00706628|11542708|FG001|Overall Study|Not treated|1
7314837|NCT00706628|11542709|FG002|Overall Study|Not treated|0
7314838|NCT00706628|11542710|FG003|Overall Study|Not treated|0
7314839|NCT00706641|11542723|FG000|Dasatinib Administration|Withdrawal by Subject|1
7314840|NCT00706641|11542723|FG000|Dasatinib Administration|Ineligible after start of therapy|1
7314841|NCT00706641|11542723|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
7314842|NCT00706654|11542730|FG000|Conversion Phase|Lost to Follow-up|4
7314843|NCT00706654|11542731|FG001|Conversion Phase|Lost to Follow-up|0
7314844|NCT00706654|11542732|FG002|Conversion Phase|Lost to Follow-up|0
7314845|NCT00706654|11542733|FG003|Conversion Phase|Lost to Follow-up|0
7314846|NCT00706654|11542730|FG000|Conversion Phase|Sponsor Discontinued Trial|8
7314847|NCT00706654|11542731|FG001|Conversion Phase|Sponsor Discontinued Trial|0
7314848|NCT00706654|11542732|FG002|Conversion Phase|Sponsor Discontinued Trial|0
7314849|NCT00706654|11542733|FG003|Conversion Phase|Sponsor Discontinued Trial|0
7314850|NCT00706654|11542730|FG000|Conversion Phase|Met Withdrawal Criteria|2
7314851|NCT00706654|11542731|FG001|Conversion Phase|Met Withdrawal Criteria|0
7314852|NCT00706654|11542732|FG002|Conversion Phase|Met Withdrawal Criteria|0
7314853|NCT00706654|11542733|FG003|Conversion Phase|Met Withdrawal Criteria|0
7314854|NCT00706654|11542730|FG000|Conversion Phase|Withdrawn by Investigator|14
7314855|NCT00706654|11542731|FG001|Conversion Phase|Withdrawn by Investigator|0
7314856|NCT00706654|11542732|FG002|Conversion Phase|Withdrawn by Investigator|0
7314857|NCT00706654|11542733|FG003|Conversion Phase|Withdrawn by Investigator|0
7314858|NCT00706654|11542730|FG000|Conversion Phase|Withdrew Consent|38
7314859|NCT00706654|11542731|FG001|Conversion Phase|Withdrew Consent|0
7314860|NCT00706654|11542732|FG002|Conversion Phase|Withdrew Consent|0
7314861|NCT00706654|11542733|FG003|Conversion Phase|Withdrew Consent|0
7314862|NCT00706654|11542730|FG000|Conversion Phase|Adverse Event|18
7314863|NCT00706654|11542731|FG001|Conversion Phase|Adverse Event|0
7314864|NCT00706654|11542732|FG002|Conversion Phase|Adverse Event|0
7314865|NCT00706654|11542733|FG003|Conversion Phase|Adverse Event|0
7314866|NCT00706654|11542730|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
7314867|NCT00706654|11542731|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
7314868|NCT00706654|11542732|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
7391746|NCT01245283|11652206|FG000|Overall Study|Lost to Follow-up|14
7391747|NCT01245283|11652207|FG001|Overall Study|Lost to Follow-up|11
7391748|NCT01245283|11652208|FG002|Overall Study|Lost to Follow-up|11
7391749|NCT01245374|11652219|FG000|Overall Study|Protocol Violation|1
7391750|NCT01245374|11652219|FG000|Overall Study|Withdrawal by Subject|3
7391751|NCT01245387|11652224|FG000|Overall Study|Lost to Follow-up|106
7391752|NCT01245387|11652224|FG000|Overall Study|Lack of Efficacy|195
7391753|NCT01245387|11652224|FG000|Overall Study|Adverse Event|9
7391754|NCT01245387|11652224|FG000|Overall Study|Death|3
7314869|NCT00706654|11542733|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
7314870|NCT00706654|11542730|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
7314871|NCT00706654|11542731|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
7314872|NCT00706654|11542732|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
7314873|NCT00706654|11542733|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
7314874|NCT00706654|11542730|FG000|Oral Stabilization Phase|Lost to Follow-up|17
7314875|NCT00706654|11542731|FG001|Oral Stabilization Phase|Lost to Follow-up|0
7314876|NCT00706654|11542732|FG002|Oral Stabilization Phase|Lost to Follow-up|0
7314877|NCT00706654|11542733|FG003|Oral Stabilization Phase|Lost to Follow-up|0
7314878|NCT00706654|11542730|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
7314879|NCT00706654|11542731|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7314880|NCT00706654|11542732|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7314881|NCT00706654|11542733|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
7314882|NCT00706654|11542730|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
7314883|NCT00706654|11542731|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
7314884|NCT00706654|11542732|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
7391755|NCT01245387|11652224|FG000|Overall Study|Other|131
7314885|NCT00706654|11542733|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
7314886|NCT00706654|11542730|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
7314887|NCT00706654|11542731|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
7314888|NCT00706654|11542732|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
7314889|NCT00706654|11542733|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
7314890|NCT00706654|11542730|FG000|Oral Stabilization Phase|Withdrew consent|55
7314891|NCT00706654|11542731|FG001|Oral Stabilization Phase|Withdrew consent|0
7314892|NCT00706654|11542732|FG002|Oral Stabilization Phase|Withdrew consent|0
7314893|NCT00706654|11542733|FG003|Oral Stabilization Phase|Withdrew consent|0
7314894|NCT00706654|11542730|FG000|Oral Stabilization Phase|Protocol Deviation|2
7314895|NCT00706654|11542731|FG001|Oral Stabilization Phase|Protocol Deviation|0
7314896|NCT00706654|11542732|FG002|Oral Stabilization Phase|Protocol Deviation|0
7314897|NCT00706654|11542733|FG003|Oral Stabilization Phase|Protocol Deviation|0
7314898|NCT00706654|11542730|FG000|Oral Stabilization Phase|Adverse Event|21
7314899|NCT00706654|11542731|FG001|Oral Stabilization Phase|Adverse Event|0
7314900|NCT00706654|11542732|FG002|Oral Stabilization Phase|Adverse Event|0
7391756|NCT01245387|11652224|FG000|Overall Study|Missing discontinuation status|369
7391757|NCT01245673|11652259|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
7314901|NCT00706654|11542733|FG003|Oral Stabilization Phase|Adverse Event|0
7314902|NCT00706654|11542730|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
7314903|NCT00706654|11542731|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314904|NCT00706654|11542732|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314905|NCT00706654|11542733|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
7314906|NCT00706654|11542730|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
7314907|NCT00706654|11542731|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314908|NCT00706654|11542732|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314909|NCT00706654|11542733|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
7314910|NCT00706654|11542730|FG000|Depot Maintenance Phase|Lost to Follow-up|0
7314911|NCT00706654|11542731|FG001|Depot Maintenance Phase|Lost to Follow-up|4
7314912|NCT00706654|11542732|FG002|Depot Maintenance Phase|Lost to Follow-up|10
7314913|NCT00706654|11542733|FG003|Depot Maintenance Phase|Lost to Follow-up|6
7314914|NCT00706654|11542730|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
7314915|NCT00706654|11542731|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
7314916|NCT00706654|11542732|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
7314917|NCT00706654|11542733|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
7314918|NCT00706654|11542730|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
7314919|NCT00706654|11542731|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
7314920|NCT00706654|11542732|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
7314921|NCT00706654|11542733|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
7314922|NCT00706654|11542730|FG000|Depot Maintenance Phase|Withdrew Consent|0
7314923|NCT00706654|11542731|FG001|Depot Maintenance Phase|Withdrew Consent|21
7314924|NCT00706654|11542732|FG002|Depot Maintenance Phase|Withdrew Consent|29
7314925|NCT00706654|11542733|FG003|Depot Maintenance Phase|Withdrew Consent|14
7314926|NCT00706654|11542730|FG000|Depot Maintenance Phase|Protocol Deviation|0
7314927|NCT00706654|11542731|FG001|Depot Maintenance Phase|Protocol Deviation|2
7314928|NCT00706654|11542732|FG002|Depot Maintenance Phase|Protocol Deviation|3
7314929|NCT00706654|11542733|FG003|Depot Maintenance Phase|Protocol Deviation|1
7314930|NCT00706654|11542730|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
7314931|NCT00706654|11542731|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
7314932|NCT00706654|11542732|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7314933|NCT00706654|11542733|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
7314934|NCT00706654|11542730|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
7314935|NCT00706654|11542731|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
7314936|NCT00706654|11542732|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
7314937|NCT00706654|11542733|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
7314938|NCT00706654|11542730|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
7314939|NCT00706654|11542731|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7314940|NCT00706654|11542732|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
7314941|NCT00706654|11542733|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
7314942|NCT00706706|11542743|FG000|Overall Study|Death|53
7314943|NCT00706706|11542743|FG000|Overall Study|Lost to Follow-up|7
7314944|NCT00706706|11542743|FG000|Overall Study|Study endpoint had reached|45
7314945|NCT00706849|11542792|FG000|Treatment Period|Adverse Event|0
7314946|NCT00706849|11542793|FG001|Treatment Period|Adverse Event|9
7314947|NCT00706849|11542792|FG000|Treatment Period|Other|0
7314948|NCT00706849|11542793|FG001|Treatment Period|Other|1
7314949|NCT00706849|11542792|FG000|Follow-up Period|Withdrawal by Subject|0
7314950|NCT00706849|11542793|FG001|Follow-up Period|Withdrawal by Subject|2
7314951|NCT00706849|11542792|FG000|Follow-up Period|Protocol non-compliance|0
7314952|NCT00706849|11542793|FG001|Follow-up Period|Protocol non-compliance|1
7314953|NCT00706901|11542802|FG000|Overall Study|Lost to Follow-up|2
7314954|NCT00706901|11542803|FG001|Overall Study|Lost to Follow-up|3
7314955|NCT00706901|11542804|FG002|Overall Study|Lost to Follow-up|2
7314956|NCT00706901|11542802|FG000|Overall Study|Withdrawal by Subject|4
7314957|NCT00706901|11542803|FG001|Overall Study|Withdrawal by Subject|2
7314958|NCT00706901|11542804|FG002|Overall Study|Withdrawal by Subject|5
7314959|NCT00706901|11542802|FG000|Overall Study|In Jail|1
7314960|NCT00706901|11542803|FG001|Overall Study|In Jail|0
7314961|NCT00706901|11542804|FG002|Overall Study|In Jail|1
7314962|NCT00706901|11542802|FG000|Overall Study|Death|1
7314963|NCT00706901|11542803|FG001|Overall Study|Death|0
7314964|NCT00706901|11542804|FG002|Overall Study|Death|0
7314965|NCT00706914|11542816|FG000|Overall Study|Lack of Efficacy|0
7314966|NCT00706914|11542817|FG001|Overall Study|Lack of Efficacy|1
7314967|NCT00706914|11542818|FG002|Overall Study|Lack of Efficacy|0
7314968|NCT00706914|11542816|FG000|Overall Study|Lost to Follow-up|1
7314969|NCT00706914|11542817|FG001|Overall Study|Lost to Follow-up|0
7314970|NCT00706914|11542818|FG002|Overall Study|Lost to Follow-up|0
7314971|NCT00706914|11542816|FG000|Overall Study|Adverse Event|2
7314972|NCT00706914|11542817|FG001|Overall Study|Adverse Event|2
7314973|NCT00706914|11542818|FG002|Overall Study|Adverse Event|0
7314974|NCT00706914|11542816|FG000|Overall Study|Protocol Violation|3
7314975|NCT00706914|11542817|FG001|Overall Study|Protocol Violation|1
7314976|NCT00706914|11542818|FG002|Overall Study|Protocol Violation|1
7314977|NCT00706966|11542826|FG000|Overall Study|Adverse Event|1
7314978|NCT00706992|11542874|FG000|Overall Study|Study termination|5
7314979|NCT00706992|11542875|FG001|Overall Study|Study termination|5
7314980|NCT00706992|11542876|FG002|Overall Study|Study termination|6
7314981|NCT00706992|11542877|FG003|Overall Study|Study termination|2
7314982|NCT00706992|11542878|FG004|Overall Study|Study termination|3
7314983|NCT00706992|11542879|FG005|Overall Study|Study termination|2
7314984|NCT00706992|11542880|FG006|Overall Study|Study termination|3
7314985|NCT00706992|11542874|FG000|Overall Study|Disease progression before treatment|0
7314986|NCT00706992|11542875|FG001|Overall Study|Disease progression before treatment|0
7314987|NCT00706992|11542876|FG002|Overall Study|Disease progression before treatment|0
7314988|NCT00706992|11542877|FG003|Overall Study|Disease progression before treatment|0
7314989|NCT00706992|11542878|FG004|Overall Study|Disease progression before treatment|1
7314990|NCT00706992|11542879|FG005|Overall Study|Disease progression before treatment|0
7314991|NCT00706992|11542880|FG006|Overall Study|Disease progression before treatment|0
7391758|NCT01245751|11652281|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
7391759|NCT01245751|11652282|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
7391760|NCT01245751|11652283|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7391761|NCT01245751|11652284|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
7391762|NCT01245751|11652281|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7391763|NCT01245751|11652282|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7391764|NCT01245751|11652283|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
7391765|NCT01245751|11652284|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
7391766|NCT01245751|11652281|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7391767|NCT01245751|11652282|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
7391768|NCT01245751|11652283|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7391769|NCT01245751|11652284|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
7391770|NCT01245764|11652299|FG000|Study Phase A|Other|3
7391771|NCT01245764|11652300|FG001|Study Phase A|Other|2
7391772|NCT01245764|11652301|FG002|Study Phase A|Other|3
7391773|NCT01245764|11652302|FG003|Study Phase A|Other|1
7391774|NCT01245764|11652299|FG000|Study Phase A|Protocol Violation|6
7391775|NCT01245764|11652300|FG001|Study Phase A|Protocol Violation|3
7391776|NCT01245764|11652301|FG002|Study Phase A|Protocol Violation|2
7391777|NCT01245764|11652302|FG003|Study Phase A|Protocol Violation|2
7391778|NCT01245764|11652299|FG000|Study Phase A|Lost to Follow-up|0
7391779|NCT01245764|11652300|FG001|Study Phase A|Lost to Follow-up|0
7391780|NCT01245764|11652301|FG002|Study Phase A|Lost to Follow-up|5
7391781|NCT01245764|11652302|FG003|Study Phase A|Lost to Follow-up|0
7391782|NCT01246206|11652375|FG000|Overall Study|Patient did not receive study regiments.|1
7391783|NCT01246466|11652404|FG000|Overall Study|Death|1
7391784|NCT01246466|11652404|FG000|Overall Study|Withdrawal by Subject|1
7391785|NCT01246583|11652417|FG000|Overall Study|Lost to Follow-up|0
7391786|NCT01246583|11652418|FG001|Overall Study|Lost to Follow-up|0
7391787|NCT01246583|11652419|FG002|Overall Study|Lost to Follow-up|0
7391788|NCT01246583|11652420|FG003|Overall Study|Lost to Follow-up|1
7391789|NCT01246583|11652417|FG000|Overall Study|Protocol Violation|0
7391790|NCT01246583|11652418|FG001|Overall Study|Protocol Violation|0
7391791|NCT01246583|11652419|FG002|Overall Study|Protocol Violation|1
7314992|NCT00707031|11542899|FG000|Overall Study|Adverse Event|45
7314993|NCT00707031|11542900|FG001|Overall Study|Adverse Event|45
7314994|NCT00707031|11542899|FG000|Overall Study|Lack of Efficacy|19
7314995|NCT00707031|11542900|FG001|Overall Study|Lack of Efficacy|6
7314996|NCT00707031|11542899|FG000|Overall Study|Lost to Follow-up|2
7314997|NCT00707031|11542900|FG001|Overall Study|Lost to Follow-up|1
7314998|NCT00707031|11542899|FG000|Overall Study|Protocol Violation|1
7314999|NCT00707031|11542900|FG001|Overall Study|Protocol Violation|0
7391792|NCT01246583|11652420|FG003|Overall Study|Protocol Violation|0
7315000|NCT00707031|11542899|FG000|Overall Study|Withdrawal by Subject|7
7315001|NCT00707031|11542900|FG001|Overall Study|Withdrawal by Subject|8
7315002|NCT00707031|11542899|FG000|Overall Study|Poor Compliance to Protocol|7
7315003|NCT00707031|11542900|FG001|Overall Study|Poor Compliance to Protocol|13
7315004|NCT00707031|11542899|FG000|Overall Study|Familial or Personal Reasons|12
7315005|NCT00707031|11542900|FG001|Overall Study|Familial or Personal Reasons|15
7315006|NCT00707031|11542899|FG000|Overall Study|Serious Noncompliance|2
7315007|NCT00707031|11542900|FG001|Overall Study|Serious Noncompliance|3
7315008|NCT00707031|11542899|FG000|Overall Study|Sponsor Decision|9
7315009|NCT00707031|11542900|FG001|Overall Study|Sponsor Decision|8
7315010|NCT00707057|11542909|FG000|Overall Study|Withdrawal by Subject|8
7315011|NCT00707057|11542910|FG001|Overall Study|Withdrawal by Subject|3
7315012|NCT00707057|11542909|FG000|Overall Study|Dosed incorrectly|0
7315013|NCT00707057|11542910|FG001|Overall Study|Dosed incorrectly|1
7315014|NCT00707174|11542918|FG000|Overall Study|Adverse Event|1
7315015|NCT00707174|11542919|FG001|Overall Study|Adverse Event|6
7315016|NCT00707174|11542918|FG000|Overall Study|Withdrawal by Subject|4
7315017|NCT00707174|11542919|FG001|Overall Study|Withdrawal by Subject|1
7315018|NCT00707239|11542928|FG000|Overall Study|Adverse Event|5
7315019|NCT00707239|11542929|FG001|Overall Study|Adverse Event|3
7315020|NCT00707239|11542930|FG002|Overall Study|Adverse Event|2
7315021|NCT00707239|11542928|FG000|Overall Study|Death|3
7315022|NCT00707239|11542929|FG001|Overall Study|Death|1
7315023|NCT00707239|11542930|FG002|Overall Study|Death|3
7315024|NCT00707239|11542928|FG000|Overall Study|Physician Decision|1
7315025|NCT00707239|11542929|FG001|Overall Study|Physician Decision|1
7315026|NCT00707239|11542930|FG002|Overall Study|Physician Decision|2
7315027|NCT00707239|11542928|FG000|Overall Study|Protocol Violation|0
7315028|NCT00707239|11542929|FG001|Overall Study|Protocol Violation|0
7315029|NCT00707239|11542930|FG002|Overall Study|Protocol Violation|1
7315030|NCT00707239|11542928|FG000|Overall Study|Lack of Efficacy|1
7315031|NCT00707239|11542929|FG001|Overall Study|Lack of Efficacy|2
7315032|NCT00707239|11542930|FG002|Overall Study|Lack of Efficacy|0
7315033|NCT00707239|11542928|FG000|Overall Study|Randomized, but not treated|1
7315034|NCT00707239|11542929|FG001|Overall Study|Randomized, but not treated|1
7315035|NCT00707239|11542930|FG002|Overall Study|Randomized, but not treated|1
7315036|NCT00707239|11542928|FG000|Overall Study|Other|8
7315037|NCT00707239|11542929|FG001|Overall Study|Other|3
7315038|NCT00707239|11542930|FG002|Overall Study|Other|5
7224528|NCT00054691|11433782|FG000|Overall Study|Unmeasurable Disease|2
7315039|NCT00707486|11542954|FG000|Overall Study|Withdrawal by Subject|1
7315040|NCT00707577|11542962|FG000|Overall Study|Withdrawal by Subject|3
7315041|NCT00707577|11542963|FG001|Overall Study|Withdrawal by Subject|2
7315042|NCT00707577|11542962|FG000|Overall Study|Lost to Follow-up|34
7315043|NCT00707577|11542963|FG001|Overall Study|Lost to Follow-up|25
7315044|NCT00707577|11542962|FG000|Overall Study|Left employment|13
7315045|NCT00707577|11542963|FG001|Overall Study|Left employment|10
7315046|NCT00707577|11542962|FG000|Overall Study|Pregnancy|4
7315047|NCT00707577|11542963|FG001|Overall Study|Pregnancy|1
7315048|NCT00707746|11542982|FG000|Treatment Period|Adverse Event|2
7224529|NCT00054691|11433782|FG000|Overall Study|Noncompliant|1
7224530|NCT00054704|11433788|FG000|Overall Study|Lack of Efficacy|2
7224531|NCT00054704|11433789|FG001|Overall Study|Lack of Efficacy|3
7224532|NCT00054704|11433788|FG000|Overall Study|Adverse Event|3
7224533|NCT00054704|11433789|FG001|Overall Study|Adverse Event|1
7224534|NCT00054704|11433788|FG000|Overall Study|Lost to Follow-up|0
7224535|NCT00054704|11433789|FG001|Overall Study|Lost to Follow-up|1
7224536|NCT00054717|11433797|FG000|Overall Study|Randomized but not treated|2
7224537|NCT00054717|11433798|FG001|Overall Study|Randomized but not treated|8
7224538|NCT00054717|11433797|FG000|Overall Study|Adverse Event|70
7224539|NCT00054717|11433798|FG001|Overall Study|Adverse Event|22
7224540|NCT00054717|11433797|FG000|Overall Study|Protocol Violation|18
7224541|NCT00054717|11433798|FG001|Overall Study|Protocol Violation|19
7224542|NCT00054717|11433797|FG000|Overall Study|Lost to Follow-up|23
7224543|NCT00054717|11433798|FG001|Overall Study|Lost to Follow-up|13
7224544|NCT00054717|11433797|FG000|Overall Study|Withdrawal by Subject|32
7224545|NCT00054717|11433798|FG001|Overall Study|Withdrawal by Subject|20
7224546|NCT00054717|11433797|FG000|Overall Study|Other reason not defined above|117
7224547|NCT00054717|11433798|FG001|Overall Study|Other reason not defined above|217
7224548|NCT00055471|11433832|FG000|Period 1: Dose Escalation Period|Adverse Event|0
7224549|NCT00055471|11433833|FG001|Period 1: Dose Escalation Period|Adverse Event|1
7224550|NCT00055471|11433834|FG002|Period 1: Dose Escalation Period|Adverse Event|2
7224551|NCT00055471|11433832|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7224552|NCT00055471|11433833|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
7224553|NCT00055471|11433834|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
7224554|NCT00055471|11433832|FG000|Period 1: Dose Escalation Period|Disease progression|0
7224555|NCT00055471|11433833|FG001|Period 1: Dose Escalation Period|Disease progression|1
7256764|NCT00325468|11468504|FG004|Overall Study|Lost to Follow-up|2
7553034|NCT03004469|11913722|FG000|Overall Study|Withdrawal by Subject|29
7553035|NCT03004469|11913723|FG001|Overall Study|Withdrawal by Subject|27
7553036|NCT03004469|11913724|FG002|Overall Study|Withdrawal by Subject|10
7553037|NCT03004469|11913722|FG000|Overall Study|Other unspecified reason|0
7553038|NCT03004469|11913723|FG001|Overall Study|Other unspecified reason|4
7553039|NCT03004469|11913724|FG002|Overall Study|Other unspecified reason|1
7553040|NCT03004924|11913792|FG000|Overall Study|Adverse Event|6
7553041|NCT03004924|11913793|FG001|Overall Study|Adverse Event|5
7553042|NCT03004924|11913794|FG002|Overall Study|Adverse Event|10
7553043|NCT03004924|11913792|FG000|Overall Study|Protocol Violation|4
7553044|NCT03004924|11913793|FG001|Overall Study|Protocol Violation|0
7553045|NCT03004924|11913794|FG002|Overall Study|Protocol Violation|1
7553046|NCT03004924|11913792|FG000|Overall Study|Withdrawal by Subject|5
7553047|NCT03004924|11913793|FG001|Overall Study|Withdrawal by Subject|3
7553048|NCT03004924|11913794|FG002|Overall Study|Withdrawal by Subject|5
7553049|NCT03004924|11913792|FG000|Overall Study|Lost to Follow-up|6
7553050|NCT03004924|11913793|FG001|Overall Study|Lost to Follow-up|1
7553051|NCT03004924|11913794|FG002|Overall Study|Lost to Follow-up|4
7553052|NCT03004924|11913792|FG000|Overall Study|Lack of Efficacy|2
7553053|NCT03004924|11913793|FG001|Overall Study|Lack of Efficacy|4
7553054|NCT03004924|11913794|FG002|Overall Study|Lack of Efficacy|2
7553055|NCT03004924|11913792|FG000|Overall Study|Physician Decision|1
7553056|NCT03004924|11913793|FG001|Overall Study|Physician Decision|0
7553057|NCT03004924|11913794|FG002|Overall Study|Physician Decision|1
7553058|NCT03004924|11913792|FG000|Overall Study|Withdrawal by parent/guardian|1
7553059|NCT03004924|11913793|FG001|Overall Study|Withdrawal by parent/guardian|0
7553060|NCT03004924|11913794|FG002|Overall Study|Withdrawal by parent/guardian|2
7553061|NCT03004924|11913792|FG000|Overall Study|Screen Failure|1
7553062|NCT03004924|11913793|FG001|Overall Study|Screen Failure|0
7553063|NCT03004924|11913794|FG002|Overall Study|Screen Failure|0
7553064|NCT03004924|11913792|FG000|Overall Study|Pregnancy|0
7553065|NCT03004924|11913793|FG001|Overall Study|Pregnancy|1
7553066|NCT03004924|11913794|FG002|Overall Study|Pregnancy|0
7553067|NCT03004924|11913792|FG000|Overall Study|Terminated by Sponsor|0
7553068|NCT03004924|11913793|FG001|Overall Study|Terminated by Sponsor|0
7553069|NCT03004924|11913794|FG002|Overall Study|Terminated by Sponsor|1
7553070|NCT03004924|11913792|FG000|Overall Study|Missed Study Visit|0
7315049|NCT00707746|11542983|FG001|Treatment Period|Adverse Event|4
7553071|NCT03004924|11913793|FG001|Overall Study|Missed Study Visit|0
7553072|NCT03004924|11913794|FG002|Overall Study|Missed Study Visit|2
7315050|NCT00707746|11542982|FG000|Treatment Period|Ineligibility|0
7315051|NCT00707746|11542983|FG001|Treatment Period|Ineligibility|1
7315052|NCT00707954|11543016|FG000|Overall Study|Physician Decision|0
7315053|NCT00707954|11543017|FG001|Overall Study|Physician Decision|0
7391793|NCT01246583|11652417|FG000|Overall Study|Withdrawal by Subject|1
7391794|NCT01246583|11652418|FG001|Overall Study|Withdrawal by Subject|0
7391795|NCT01246583|11652419|FG002|Overall Study|Withdrawal by Subject|0
7391796|NCT01246583|11652420|FG003|Overall Study|Withdrawal by Subject|0
7391797|NCT01246960|11652455|FG000|Overall Study|Lost to Follow-up|3
7391798|NCT01246960|11652456|FG001|Overall Study|Lost to Follow-up|1
7391799|NCT01246960|11652455|FG000|Overall Study|Withdrawal (by participant or physician)|3
7391800|NCT01246960|11652456|FG001|Overall Study|Withdrawal (by participant or physician)|3
7391801|NCT01246973|11652464|FG000|Overall Study|Other|38
7391802|NCT01246973|11652465|FG001|Overall Study|Other|25
7391803|NCT01246973|11652464|FG000|Overall Study|Adverse Event|16
7391804|NCT01246973|11652465|FG001|Overall Study|Adverse Event|9
7315054|NCT00707954|11543018|FG002|Overall Study|Physician Decision|0
7315055|NCT00707954|11543019|FG003|Overall Study|Physician Decision|0
7315056|NCT00707954|11543020|FG004|Overall Study|Physician Decision|1
7315057|NCT00707980|11543045|FG000|Overall Study|Adverse Event|49
7315058|NCT00707980|11543045|FG000|Overall Study|Lack of Efficacy|35
7315059|NCT00707980|11543045|FG000|Overall Study|Non-Compliance with Study Drug|28
7315060|NCT00707980|11543045|FG000|Overall Study|Protocol Deviations|19
7315061|NCT00707980|11543045|FG000|Overall Study|Withdrawal of Consent|81
7315062|NCT00707980|11543045|FG000|Overall Study|Lost to Follow-up|59
7315063|NCT00707980|11543045|FG000|Overall Study|Other|39
7315064|NCT00707993|11543051|FG000|Overall Study|Adverse Event|16
7315065|NCT00707993|11543052|FG001|Overall Study|Adverse Event|20
7315066|NCT00707993|11543051|FG000|Overall Study|Protocol Violation|4
7315067|NCT00707993|11543052|FG001|Overall Study|Protocol Violation|7
7315068|NCT00707993|11543051|FG000|Overall Study|Lost to Follow-up|0
7315069|NCT00707993|11543052|FG001|Overall Study|Lost to Follow-up|4
7315070|NCT00707993|11543051|FG000|Overall Study|Withdrawal by Subject|12
7315071|NCT00707993|11543052|FG001|Overall Study|Withdrawal by Subject|16
7315072|NCT00707993|11543051|FG000|Overall Study|Hyperglycemic Rescue|55
7315073|NCT00707993|11543052|FG001|Overall Study|Hyperglycemic Rescue|47
7315074|NCT00707993|11543051|FG000|Overall Study|Other|2
7315075|NCT00707993|11543052|FG001|Overall Study|Other|0
7315076|NCT00708032|11543069|FG000|Overall Study|Adverse Event|0
7315077|NCT00708032|11543070|FG001|Overall Study|Adverse Event|2
7315078|NCT00708032|11543069|FG000|Overall Study|Lost to Follow-up|1
7315079|NCT00708032|11543070|FG001|Overall Study|Lost to Follow-up|2
7315080|NCT00708032|11543069|FG000|Overall Study|Pregnancy|0
7315081|NCT00708032|11543070|FG001|Overall Study|Pregnancy|1
7315082|NCT00708032|11543069|FG000|Overall Study|Poor vision|0
7315083|NCT00708032|11543070|FG001|Overall Study|Poor vision|6
7315084|NCT00708032|11543069|FG000|Overall Study|Visit out of range at month 12|4
7315085|NCT00708032|11543070|FG001|Overall Study|Visit out of range at month 12|1
7315086|NCT00708032|11543069|FG000|Overall Study|Did not meet protocol criteria|1
7315087|NCT00708032|11543070|FG001|Overall Study|Did not meet protocol criteria|2
7315088|NCT00708032|11543069|FG000|Overall Study|Protocol Violation|4
7315089|NCT00708032|11543070|FG001|Overall Study|Protocol Violation|1
7315090|NCT00708032|11543069|FG000|Overall Study|Withdrawal by Subject|0
7315091|NCT00708032|11543070|FG001|Overall Study|Withdrawal by Subject|1
7315092|NCT00708097|11543110|FG000|Period 1|Protocol Violation|0
7315093|NCT00708097|11543111|FG001|Period 1|Protocol Violation|1
7315094|NCT00708097|11543112|FG002|Period 1|Protocol Violation|0
7315095|NCT00708097|11543113|FG003|Period 1|Protocol Violation|2
7315096|NCT00708097|11543114|FG004|Period 1|Protocol Violation|0
7315097|NCT00708097|11543110|FG000|Period 1|Other Reason|0
7315098|NCT00708097|11543111|FG001|Period 1|Other Reason|0
7315099|NCT00708097|11543112|FG002|Period 1|Other Reason|0
7315100|NCT00708097|11543113|FG003|Period 1|Other Reason|0
7315101|NCT00708097|11543114|FG004|Period 1|Other Reason|1
7315102|NCT00708097|11543110|FG000|Period 2|Protocol Violation|0
7315103|NCT00708097|11543111|FG001|Period 2|Protocol Violation|1
7315104|NCT00708097|11543112|FG002|Period 2|Protocol Violation|1
7315105|NCT00708097|11543113|FG003|Period 2|Protocol Violation|1
7315106|NCT00708097|11543114|FG004|Period 2|Protocol Violation|0
7315107|NCT00708123|11543148|FG000|Period 1|Protocol Violation|0
7315108|NCT00708123|11543149|FG001|Period 1|Protocol Violation|1
7315109|NCT00708123|11543150|FG002|Period 1|Protocol Violation|0
7315110|NCT00708123|11543151|FG003|Period 1|Protocol Violation|1
7315111|NCT00708123|11543152|FG004|Period 1|Protocol Violation|0
7315112|NCT00708123|11543148|FG000|Period 1|Adverse Event|0
7315113|NCT00708123|11543149|FG001|Period 1|Adverse Event|0
7315114|NCT00708123|11543150|FG002|Period 1|Adverse Event|1
7315115|NCT00708123|11543151|FG003|Period 1|Adverse Event|0
7315116|NCT00708123|11543152|FG004|Period 1|Adverse Event|0
7315117|NCT00708123|11543148|FG000|Period 2|Protocol Violation|0
7315118|NCT00708123|11543149|FG001|Period 2|Protocol Violation|0
7315119|NCT00708123|11543150|FG002|Period 2|Protocol Violation|0
7315120|NCT00708123|11543151|FG003|Period 2|Protocol Violation|1
7315121|NCT00708123|11543152|FG004|Period 2|Protocol Violation|0
7315122|NCT00708123|11543148|FG000|Period 2|Other Reason|1
7315123|NCT00708123|11543149|FG001|Period 2|Other Reason|0
7315124|NCT00708123|11543150|FG002|Period 2|Other Reason|0
7315125|NCT00708123|11543151|FG003|Period 2|Other Reason|0
7315126|NCT00708123|11543152|FG004|Period 2|Other Reason|0
7315127|NCT00708123|11543148|FG000|Period 3|Lost to Follow-up|0
7315128|NCT00708123|11543149|FG001|Period 3|Lost to Follow-up|0
7315129|NCT00708123|11543150|FG002|Period 3|Lost to Follow-up|1
7315130|NCT00708123|11543151|FG003|Period 3|Lost to Follow-up|1
7315131|NCT00708123|11543152|FG004|Period 3|Lost to Follow-up|0
7315132|NCT00708123|11543148|FG000|Period 4|Protocol Violation|0
7315133|NCT00708123|11543149|FG001|Period 4|Protocol Violation|1
7315134|NCT00708123|11543150|FG002|Period 4|Protocol Violation|0
7315135|NCT00708123|11543151|FG003|Period 4|Protocol Violation|0
7315136|NCT00708123|11543152|FG004|Period 4|Protocol Violation|0
7315137|NCT00708162|11543170|FG000|Randomized Phase|Randomized but Not Treated|7
7315138|NCT00708162|11543171|FG001|Randomized Phase|Randomized but Not Treated|5
7315139|NCT00708162|11543170|FG000|Randomized Phase|Participant Noncompliance|40
7315140|NCT00708162|11543171|FG001|Randomized Phase|Participant Noncompliance|32
7315141|NCT00708162|11543170|FG000|Randomized Phase|Lost to Follow-up|34
7315142|NCT00708162|11543171|FG001|Randomized Phase|Lost to Follow-up|34
7315143|NCT00708162|11543170|FG000|Randomized Phase|Withdrew Consent|31
7315144|NCT00708162|11543171|FG001|Randomized Phase|Withdrew Consent|22
7315145|NCT00708162|11543170|FG000|Randomized Phase|Lack of Efficacy|14
7315146|NCT00708162|11543171|FG001|Randomized Phase|Lack of Efficacy|19
7315147|NCT00708162|11543170|FG000|Randomized Phase|Protocol Violation|10
7315148|NCT00708162|11543171|FG001|Randomized Phase|Protocol Violation|11
7315149|NCT00708162|11543170|FG000|Randomized Phase|Adverse Event|8
7315150|NCT00708162|11543171|FG001|Randomized Phase|Adverse Event|12
7315151|NCT00708162|11543170|FG000|Randomized Phase|Investigator's Discretion|7
7315152|NCT00708162|11543171|FG001|Randomized Phase|Investigator's Discretion|10
7315153|NCT00708162|11543170|FG000|Randomized Phase|Death|2
7315154|NCT00708162|11543171|FG001|Randomized Phase|Death|9
7315155|NCT00708162|11543170|FG000|Randomized Phase|Pregnancy|3
7315156|NCT00708162|11543171|FG001|Randomized Phase|Pregnancy|0
7315157|NCT00708162|11543170|FG000|Open-Label Phase|Lost to Follow-up|10
7315158|NCT00708162|11543171|FG001|Open-Label Phase|Lost to Follow-up|8
7315159|NCT00708162|11543170|FG000|Open-Label Phase|Withdrew Consent|12
7315160|NCT00708162|11543171|FG001|Open-Label Phase|Withdrew Consent|6
7315161|NCT00708162|11543170|FG000|Open-Label Phase|Participant Noncompliance|7
7315162|NCT00708162|11543171|FG001|Open-Label Phase|Participant Noncompliance|7
7315163|NCT00708162|11543170|FG000|Open-Label Phase|Lack of Efficacy|7
7315164|NCT00708162|11543171|FG001|Open-Label Phase|Lack of Efficacy|4
7315165|NCT00708162|11543170|FG000|Open-Label Phase|Investigator's Discretion|3
7315166|NCT00708162|11543171|FG001|Open-Label Phase|Investigator's Discretion|2
7315167|NCT00708162|11543170|FG000|Open-Label Phase|Death|3
7315168|NCT00708162|11543171|FG001|Open-Label Phase|Death|1
7315169|NCT00708162|11543170|FG000|Open-Label Phase|Adverse Event|1
7315170|NCT00708162|11543171|FG001|Open-Label Phase|Adverse Event|2
7315171|NCT00708162|11543170|FG000|Open-Label Phase|Other|1
7315172|NCT00708162|11543171|FG001|Open-Label Phase|Other|0
7315173|NCT00708175|11543180|FG000|Overall Study|Adverse Event|4
7315174|NCT00708175|11543181|FG001|Overall Study|Adverse Event|5
7315175|NCT00708175|11543180|FG000|Overall Study|Protocol Violation|2
7315176|NCT00708175|11543181|FG001|Overall Study|Protocol Violation|3
7315177|NCT00708175|11543180|FG000|Overall Study|Lost to Follow-up|5
7315178|NCT00708175|11543181|FG001|Overall Study|Lost to Follow-up|3
7315179|NCT00708175|11543180|FG000|Overall Study|Withdrawal by Subject|5
7315180|NCT00708175|11543181|FG001|Overall Study|Withdrawal by Subject|7
7315181|NCT00708175|11543180|FG000|Overall Study|BMD loss >7%|2
7315182|NCT00708175|11543181|FG001|Overall Study|BMD loss >7%|3
7315183|NCT00708201|11543189|FG000|Overall Study|Adverse Event|4
7315184|NCT00708201|11543190|FG001|Overall Study|Adverse Event|4
7315185|NCT00708201|11543189|FG000|Overall Study|Withdrawal by Subject|1
7315186|NCT00708201|11543190|FG001|Overall Study|Withdrawal by Subject|1
7315187|NCT00708201|11543189|FG000|Overall Study|Lost to Follow-up|2
7315188|NCT00708201|11543190|FG001|Overall Study|Lost to Follow-up|0
7315189|NCT00708201|11543189|FG000|Overall Study|Protocol Violation|0
7315190|NCT00708201|11543190|FG001|Overall Study|Protocol Violation|1
7315191|NCT00708214|11543199|FG000|Overall Study|Other Adverse Event|3
7315192|NCT00708214|11543200|FG001|Overall Study|Other Adverse Event|6
7315193|NCT00708214|11543201|FG002|Overall Study|Other Adverse Event|2
7315194|NCT00708214|11543199|FG000|Overall Study|Other|0
7315195|NCT00708214|11543200|FG001|Overall Study|Other|1
7315196|NCT00708214|11543201|FG002|Overall Study|Other|1
7315197|NCT00708214|11543199|FG000|Overall Study|Progressive Disease|4
7315198|NCT00708214|11543200|FG001|Overall Study|Progressive Disease|6
7315199|NCT00708214|11543201|FG002|Overall Study|Progressive Disease|5
7315200|NCT00708227|11543218|FG000|Overall Study|Physician Decision|0
7315201|NCT00708227|11543219|FG001|Overall Study|Physician Decision|3
7315202|NCT00708227|11543220|FG002|Overall Study|Physician Decision|1
7315203|NCT00708227|11543221|FG003|Overall Study|Physician Decision|2
7315204|NCT00708227|11543218|FG000|Overall Study|Withdrawal by Subject|1
7315205|NCT00708227|11543219|FG001|Overall Study|Withdrawal by Subject|2
7315206|NCT00708227|11543220|FG002|Overall Study|Withdrawal by Subject|0
7315207|NCT00708227|11543221|FG003|Overall Study|Withdrawal by Subject|1
7384435|NCT01194258|11641599|FG004|Period 2 (12 Weeks)|Adverse Event|0
7384436|NCT01194258|11641595|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
7384437|NCT01194258|11641596|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
7384438|NCT01194258|11641597|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
7384439|NCT01194258|11641598|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
7384440|NCT01194258|11641599|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
7384441|NCT01194271|11641610|FG000|Overall Study|Withdrawal by Subject|1
7384442|NCT01194271|11641610|FG000|Overall Study|Ineligible, Screen Failure|1
7384443|NCT01194271|11641610|FG000|Overall Study|Death|1
7384444|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
7384445|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
7384446|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7384447|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
7384448|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
7384449|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
7384450|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7384451|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
7384452|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Protocol Violation|5
7384453|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Protocol Violation|3
7384454|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Protocol Violation|0
7384455|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Protocol Violation|0
7384456|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7384457|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
7384458|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7384459|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
7384460|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Pregnancy|2
7384461|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Pregnancy|2
7384462|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Pregnancy|0
7384463|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Pregnancy|0
7384464|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
7315208|NCT00708305|11543251|FG000|Period 1|Protocol Violation|1
7315209|NCT00708305|11543252|FG001|Period 1|Protocol Violation|0
7315210|NCT00708305|11543253|FG002|Period 1|Protocol Violation|1
7315211|NCT00708305|11543254|FG003|Period 1|Protocol Violation|0
7315212|NCT00708305|11543251|FG000|Period 1|Other Reason|0
7315213|NCT00708305|11543252|FG001|Period 1|Other Reason|0
7315214|NCT00708305|11543253|FG002|Period 1|Other Reason|0
7315215|NCT00708305|11543254|FG003|Period 1|Other Reason|2
7315216|NCT00708305|11543251|FG000|Period 2|Lost to Follow-up|0
7315217|NCT00708305|11543252|FG001|Period 2|Lost to Follow-up|1
7315218|NCT00708305|11543253|FG002|Period 2|Lost to Follow-up|0
7315219|NCT00708305|11543254|FG003|Period 2|Lost to Follow-up|0
7315220|NCT00708305|11543251|FG000|Period 2|Protocol Violation|0
7315221|NCT00708305|11543252|FG001|Period 2|Protocol Violation|1
7315222|NCT00708305|11543253|FG002|Period 2|Protocol Violation|0
7315223|NCT00708305|11543254|FG003|Period 2|Protocol Violation|0
7315224|NCT00708305|11543251|FG000|Period 2|Other Reason|1
7315225|NCT00708305|11543252|FG001|Period 2|Other Reason|0
7315226|NCT00708305|11543253|FG002|Period 2|Other Reason|0
7315227|NCT00708305|11543254|FG003|Period 2|Other Reason|1
7315228|NCT00708305|11543251|FG000|Period 3|Protocol Violation|0
7315229|NCT00708305|11543252|FG001|Period 3|Protocol Violation|2
7315230|NCT00708305|11543253|FG002|Period 3|Protocol Violation|0
7315231|NCT00708305|11543254|FG003|Period 3|Protocol Violation|0
7315232|NCT00708305|11543251|FG000|Period 3|Other Reason|1
7315233|NCT00708305|11543252|FG001|Period 3|Other Reason|0
7315234|NCT00708305|11543253|FG002|Period 3|Other Reason|0
7315235|NCT00708305|11543254|FG003|Period 3|Other Reason|0
7315236|NCT00708422|11543269|FG000|Overall Study|Adverse Event|3
7315237|NCT00708422|11543270|FG001|Overall Study|Adverse Event|1
7315238|NCT00708422|11543269|FG000|Overall Study|Withdrawal by Subject|1
7315239|NCT00708422|11543270|FG001|Overall Study|Withdrawal by Subject|0
7315240|NCT00708435|11543278|FG000|Overall Study|Death / Serious Adverse Event|10
7315241|NCT00708435|11543279|FG001|Overall Study|Death / Serious Adverse Event|5
7315242|NCT00708435|11543278|FG000|Overall Study|Lost to Follow-up|9
7315243|NCT00708435|11543279|FG001|Overall Study|Lost to Follow-up|4
7315244|NCT00708435|11543278|FG000|Overall Study|Withdrawal by Subject|3
7315245|NCT00708435|11543279|FG001|Overall Study|Withdrawal by Subject|7
7315246|NCT00708435|11543278|FG000|Overall Study|Adverse Event|1
7315247|NCT00708435|11543279|FG001|Overall Study|Adverse Event|0
7315248|NCT00708435|11543278|FG000|Overall Study|Protocol Violation|0
7315249|NCT00708435|11543279|FG001|Overall Study|Protocol Violation|1
7315250|NCT00708435|11543278|FG000|Overall Study|Intervention by primary care physician|1
7315251|NCT00708435|11543279|FG001|Overall Study|Intervention by primary care physician|0
7315252|NCT00708435|11543278|FG000|Overall Study|Refused hospitalization|1
7315253|NCT00708435|11543279|FG001|Overall Study|Refused hospitalization|0
7315254|NCT00708461|11543289|FG000|Overall Study|Lost to Follow-up|18
7315255|NCT00708461|11543290|FG001|Overall Study|Lost to Follow-up|11
7315256|NCT00708461|11543289|FG000|Overall Study|Withdrawal by Subject|8
7315257|NCT00708461|11543290|FG001|Overall Study|Withdrawal by Subject|9
7315258|NCT00708461|11543289|FG000|Overall Study|left workforce|115
7315259|NCT00708461|11543290|FG001|Overall Study|left workforce|180
7315260|NCT00708500|11543299|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7315261|NCT00708500|11543300|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
7315262|NCT00708500|11543301|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
7315263|NCT00708500|11543299|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
7315264|NCT00708500|11543300|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7315265|NCT00708500|11543301|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
7315266|NCT00708500|11543299|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7387511|NCT01214720|11646050|FG000|Overall Study|Lost to Follow-up|6
7315267|NCT00708500|11543300|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
7315268|NCT00708500|11543301|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
7315269|NCT00708500|11543299|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7315270|NCT00708500|11543300|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
7315271|NCT00708500|11543301|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
7315272|NCT00708500|11543299|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7315273|NCT00708500|11543300|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
7315274|NCT00708500|11543301|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
7315275|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
7315276|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
7315277|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
7315278|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
7315279|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
7315280|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
7315281|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7315282|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
7315283|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
7315284|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
7315285|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
7315286|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
7315287|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
7315288|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
7315289|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
7315290|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
7315291|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
7315292|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
7315293|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
7315294|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7315295|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
7224556|NCT00055471|11433834|FG002|Period 1: Dose Escalation Period|Disease progression|0
7315296|NCT00708500|11543299|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7315297|NCT00708500|11543300|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
7224557|NCT00055497|11433846|FG000|Overall Study|Adverse Event|1
7224558|NCT00055497|11433847|FG001|Overall Study|Adverse Event|1
7224559|NCT00055497|11433848|FG002|Overall Study|Adverse Event|1
7224560|NCT00055497|11433849|FG003|Overall Study|Adverse Event|28
7224561|NCT00055497|11433846|FG000|Overall Study|Withdrawal by Subject|3
7224562|NCT00055497|11433847|FG001|Overall Study|Withdrawal by Subject|1
7224563|NCT00055497|11433848|FG002|Overall Study|Withdrawal by Subject|1
7224564|NCT00055497|11433849|FG003|Overall Study|Withdrawal by Subject|15
7224565|NCT00055497|11433846|FG000|Overall Study|Lost to Follow-up|0
7224566|NCT00055497|11433847|FG001|Overall Study|Lost to Follow-up|1
7224567|NCT00055497|11433848|FG002|Overall Study|Lost to Follow-up|0
7224568|NCT00055497|11433849|FG003|Overall Study|Lost to Follow-up|5
7224569|NCT00055497|11433846|FG000|Overall Study|Protocol Violation|0
7224570|NCT00055497|11433847|FG001|Overall Study|Protocol Violation|0
7224571|NCT00055497|11433848|FG002|Overall Study|Protocol Violation|0
7224572|NCT00055497|11433849|FG003|Overall Study|Protocol Violation|3
7224573|NCT00055497|11433846|FG000|Overall Study|Lack of Efficacy|1
7224574|NCT00055497|11433847|FG001|Overall Study|Lack of Efficacy|0
7224575|NCT00055497|11433848|FG002|Overall Study|Lack of Efficacy|0
7224576|NCT00055497|11433849|FG003|Overall Study|Lack of Efficacy|27
7224577|NCT00055497|11433846|FG000|Overall Study|Administrative Reasons|0
7224578|NCT00055497|11433847|FG001|Overall Study|Administrative Reasons|0
7224579|NCT00055497|11433848|FG002|Overall Study|Administrative Reasons|0
7224580|NCT00055497|11433849|FG003|Overall Study|Administrative Reasons|1
7224581|NCT00055497|11433846|FG000|Overall Study|Other|0
7315298|NCT00708500|11543301|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
7315299|NCT00708500|11543299|FG000|FOLLOWUP|Adverse Event|0
7315300|NCT00708500|11543300|FG001|FOLLOWUP|Adverse Event|1
7315301|NCT00708500|11543301|FG002|FOLLOWUP|Adverse Event|0
7315302|NCT00708500|11543299|FG000|FOLLOWUP|Lost to Follow-up|1
7315303|NCT00708500|11543300|FG001|FOLLOWUP|Lost to Follow-up|6
7315304|NCT00708500|11543301|FG002|FOLLOWUP|Lost to Follow-up|4
7315305|NCT00708500|11543299|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
7315306|NCT00708500|11543300|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
7315307|NCT00708500|11543301|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
7315308|NCT00708500|11543299|FG000|FOLLOWUP|Subject withdrew consent|31
7315309|NCT00708500|11543300|FG001|FOLLOWUP|Subject withdrew consent|4
7315310|NCT00708500|11543301|FG002|FOLLOWUP|Subject withdrew consent|5
7315311|NCT00708500|11543299|FG000|FOLLOWUP|Non-compliance with protocol|5
7315312|NCT00708500|11543300|FG001|FOLLOWUP|Non-compliance with protocol|0
7315313|NCT00708500|11543301|FG002|FOLLOWUP|Non-compliance with protocol|1
7315314|NCT00708552|11543322|FG000|Overall Study|Adverse Event|10
7315315|NCT00708552|11543323|FG001|Overall Study|Adverse Event|3
7315316|NCT00708552|11543324|FG002|Overall Study|Adverse Event|4
7315317|NCT00708552|11543325|FG003|Overall Study|Adverse Event|6
7315318|NCT00708552|11543322|FG000|Overall Study|Lack of Efficacy|0
7315319|NCT00708552|11543323|FG001|Overall Study|Lack of Efficacy|4
7315320|NCT00708552|11543324|FG002|Overall Study|Lack of Efficacy|1
7315321|NCT00708552|11543325|FG003|Overall Study|Lack of Efficacy|0
7315322|NCT00708552|11543322|FG000|Overall Study|Protocol Violation|0
7315323|NCT00708552|11543323|FG001|Overall Study|Protocol Violation|0
7315324|NCT00708552|11543324|FG002|Overall Study|Protocol Violation|2
7315325|NCT00708552|11543325|FG003|Overall Study|Protocol Violation|4
7315326|NCT00708552|11543322|FG000|Overall Study|Lost to Follow-up|4
7315327|NCT00708552|11543323|FG001|Overall Study|Lost to Follow-up|2
7315328|NCT00708552|11543324|FG002|Overall Study|Lost to Follow-up|0
7315329|NCT00708552|11543325|FG003|Overall Study|Lost to Follow-up|1
7315330|NCT00708552|11543322|FG000|Overall Study|Physician Decision|1
7315331|NCT00708552|11543323|FG001|Overall Study|Physician Decision|2
7315332|NCT00708552|11543324|FG002|Overall Study|Physician Decision|0
7315333|NCT00708552|11543325|FG003|Overall Study|Physician Decision|0
7315334|NCT00708552|11543322|FG000|Overall Study|Withdrawal by Subject|12
7315335|NCT00708552|11543323|FG001|Overall Study|Withdrawal by Subject|7
7315336|NCT00708552|11543324|FG002|Overall Study|Withdrawal by Subject|8
7315337|NCT00708552|11543325|FG003|Overall Study|Withdrawal by Subject|10
7315338|NCT00708643|11543341|FG000|Overall Study|Adverse Event|0
7315339|NCT00708643|11543342|FG001|Overall Study|Adverse Event|1
7315340|NCT00708682|11543348|FG000|Infant Series|Adverse Event|1
7315341|NCT00708682|11543348|FG000|Infant Series|Lost to Follow-up|4
7315342|NCT00708682|11543348|FG000|Infant Series|Protocol Violation|1
7315343|NCT00708682|11543348|FG000|Infant Series|Parent/legal guardian request|6
7315344|NCT00708682|11543348|FG000|Infant Series|Failed to return|2
7315345|NCT00708682|11543348|FG000|Infant Series|Other|19
7315346|NCT00708682|11543348|FG000|After Infant Series|Parent/Legal Guardian Request|1
7315347|NCT00708682|11543348|FG000|Toddler Dose|Parent/Legal Guardian Request|1
7315348|NCT00708682|11543348|FG000|Toddler Dose|Lost to Follow-up|3
7315349|NCT00708682|11543348|FG000|Toddler Dose|Failed to Return|4
7315350|NCT00708708|11543354|FG000|Overall Study|Another therapy instead of Enbrel|141
7315351|NCT00708708|11543354|FG000|Overall Study|Lost to Follow-up|52
7315352|NCT00708708|11543354|FG000|Overall Study|Withdrawal by Subject|51
7315353|NCT00708708|11543354|FG000|Overall Study|Intolerance|42
7315354|NCT00708708|11543354|FG000|Overall Study|Another therapy along with Enbrel|15
7315355|NCT00708708|11543354|FG000|Overall Study|Other unspecified|11
7315356|NCT00708708|11543354|FG000|Overall Study|Good effectiveness|9
7315357|NCT00708708|11543354|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
7315358|NCT00708708|11543354|FG000|Overall Study|Administrative reasons|7
7315359|NCT00708708|11543354|FG000|Overall Study|Lack of effectiveness|4
7315360|NCT00708708|11543354|FG000|Overall Study|Lack of compliance|3
7315361|NCT00708708|11543354|FG000|Overall Study|Pregnancy|3
7315362|NCT00708708|11543354|FG000|Overall Study|Adverse Event|3
7391805|NCT01246973|11652464|FG000|Overall Study|Withdrawal by Subject|7
7315363|NCT00708708|11543354|FG000|Overall Study|Missing values|392
7315364|NCT00709059|11543406|FG000|Overall Study|Lost to Follow-up|34
7391806|NCT01246973|11652465|FG001|Overall Study|Withdrawal by Subject|13
7315365|NCT00709059|11543406|FG000|Overall Study|Withdrawal by Subject|19
7315366|NCT00709059|11543406|FG000|Overall Study|Physician Decision|7
7315367|NCT00709059|11543406|FG000|Overall Study|Disease complication|3
7315368|NCT00709059|11543406|FG000|Overall Study|Side effects|20
7315369|NCT00709059|11543406|FG000|Overall Study|Serious side effects|11
7315370|NCT00709098|11543413|FG000|Double-blind Period|Withdrawal of consent|3
7315371|NCT00709098|11543414|FG001|Double-blind Period|Withdrawal of consent|3
7315372|NCT00709098|11543415|FG002|Double-blind Period|Withdrawal of consent|0
7315373|NCT00709098|11543413|FG000|Double-blind Period|Administrative reason|1
7315374|NCT00709098|11543414|FG001|Double-blind Period|Administrative reason|3
7315375|NCT00709098|11543415|FG002|Double-blind Period|Administrative reason|0
7315376|NCT00709098|11543413|FG000|Double-blind Period|Death|1
7315377|NCT00709098|11543414|FG001|Double-blind Period|Death|1
7315378|NCT00709098|11543415|FG002|Double-blind Period|Death|0
7391807|NCT01246986|11652478|FG000|Overall Study|Lost to Follow-up|0
7391808|NCT01246986|11652479|FG001|Overall Study|Lost to Follow-up|1
7391809|NCT01246986|11652480|FG002|Overall Study|Lost to Follow-up|3
7315379|NCT00709098|11543413|FG000|Double-blind Period|Lost to Follow-up|1
7315380|NCT00709098|11543414|FG001|Double-blind Period|Lost to Follow-up|1
7315381|NCT00709098|11543415|FG002|Double-blind Period|Lost to Follow-up|0
7315382|NCT00709098|11543413|FG000|Open-label Period|Withdrawal of consent|0
7315383|NCT00709098|11543414|FG001|Open-label Period|Withdrawal of consent|0
7315384|NCT00709098|11543415|FG002|Open-label Period|Withdrawal of consent|7
7315385|NCT00709098|11543413|FG000|Open-label Period|Administrative reason|0
7315386|NCT00709098|11543414|FG001|Open-label Period|Administrative reason|0
7315387|NCT00709098|11543415|FG002|Open-label Period|Administrative reason|5
7315388|NCT00709098|11543413|FG000|Open-label Period|Death|0
7315389|NCT00709098|11543414|FG001|Open-label Period|Death|0
7315390|NCT00709098|11543415|FG002|Open-label Period|Death|1
7315391|NCT00709098|11543413|FG000|Open-label Period|Lost to Follow-up|0
7315392|NCT00709098|11543414|FG001|Open-label Period|Lost to Follow-up|0
7315393|NCT00709098|11543415|FG002|Open-label Period|Lost to Follow-up|1
7315394|NCT00709111|11543424|FG000|Overall Study|Withdrawal by Subject|1
7315395|NCT00709111|11543424|FG000|Overall Study|Unable to attend clinic visits|1
7315396|NCT00709124|11543430|FG000|Overall Study|Death|3
7315397|NCT00709124|11543431|FG001|Overall Study|Death|1
7315398|NCT00709124|11543430|FG000|Overall Study|encephalopathy; can't do assessment|1
7315399|NCT00709124|11543431|FG001|Overall Study|encephalopathy; can't do assessment|0
7315400|NCT00709202|11543443|FG000|Overall Study|Withdrawal by Subject|6
7315401|NCT00709202|11543444|FG001|Overall Study|Withdrawal by Subject|6
7315402|NCT00709228|11543451|FG000|Overall Study|Not treated|14
7315403|NCT00709228|11543451|FG000|Overall Study|Eligibility criteria not met|281
7315404|NCT00709228|11543451|FG000|Overall Study|Adverse events|2
7315405|NCT00709228|11543451|FG000|Overall Study|Discontinued treatment|14
7315406|NCT00709228|11543451|FG000|Overall Study|Did not enter follow-up|4
7315407|NCT00709228|11543451|FG000|Overall Study|Discontinued follow-up|5
7315408|NCT00709228|11543451|FG000|Overall Study|Disease progression|1
7315409|NCT00709228|11543451|FG000|Overall Study|Lost to Follow-up|6
7315410|NCT00709228|11543451|FG000|Overall Study|Non-compliance|5
7315411|NCT00709319|11543472|FG000|Overall Study|Death|4
7315412|NCT00709319|11543472|FG000|Overall Study|Withdrawal by Subject|2
7315413|NCT00709592|11543478|FG000|Overall Study|Unable to proceed to transplant|0
7315414|NCT00709592|11543479|FG001|Overall Study|Unable to proceed to transplant|1
7315415|NCT00709618|11543485|FG000|Overall Study|Withdrawal by Subject|4
7315416|NCT00709618|11543485|FG000|Overall Study|Lost to Follow-up|1
7315417|NCT00709618|11543485|FG000|Overall Study|Study Closed/Terminated|25
7315418|NCT00709722|11543498|FG000|Overall Study|Adverse Event|1
7315419|NCT00709735|11543504|FG000|Overall Study|Lost to Follow-up|1
7315420|NCT00709735|11543505|FG001|Overall Study|Lost to Follow-up|1
7315421|NCT00709735|11543504|FG000|Overall Study|Relapse into Opioid Abuse|0
7315422|NCT00709735|11543505|FG001|Overall Study|Relapse into Opioid Abuse|1
7315423|NCT00709735|11543504|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
7315424|NCT00709735|11543505|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
7315425|NCT00709761|11543511|FG000|Overall Study|Withdrawal by Subject|8
7315426|NCT00709761|11543511|FG000|Overall Study|study closed/terminated|17
7315427|NCT00709761|11543511|FG000|Overall Study|Lost to Follow-up|2
7315428|NCT00709852|11543524|FG000|Period 1|Adverse Event|2
7315429|NCT00709852|11543525|FG001|Period 1|Adverse Event|0
7315430|NCT00709852|11543524|FG000|Period 1|Withdrawal by Subject|4
7315431|NCT00709852|11543525|FG001|Period 1|Withdrawal by Subject|2
7315432|NCT00709852|11543524|FG000|Period 1|Protocol Violation|1
7315433|NCT00709852|11543525|FG001|Period 1|Protocol Violation|0
7315434|NCT00709852|11543524|FG000|Period 1|Defective scanner|0
7315435|NCT00709852|11543525|FG001|Period 1|Defective scanner|1
7315436|NCT00709852|11543524|FG000|Period 1|Lost to Follow-up|1
7315437|NCT00709852|11543525|FG001|Period 1|Lost to Follow-up|0
7315438|NCT00709852|11543524|FG000|Period 2|Protocol Violation|4
7315439|NCT00709852|11543525|FG001|Period 2|Protocol Violation|1
7315440|NCT00709852|11543524|FG000|Period 2|Adverse Event|1
7315441|NCT00709852|11543525|FG001|Period 2|Adverse Event|1
7315442|NCT00709852|11543524|FG000|Period 2|Lost to Follow-up|1
7315443|NCT00709852|11543525|FG001|Period 2|Lost to Follow-up|0
7315444|NCT00709852|11543524|FG000|Period 2|No 72-hour follow-up|3
7315445|NCT00709852|11543525|FG001|Period 2|No 72-hour follow-up|0
7315446|NCT00709956|11543563|FG000|Overall Study|Withdrawal by Subject|1
7315447|NCT00709956|11543564|FG001|Overall Study|Withdrawal by Subject|1
7315448|NCT00709956|11543563|FG000|Overall Study|Inclusion/exclusion criteria violation|2
7315449|NCT00709956|11543564|FG001|Overall Study|Inclusion/exclusion criteria violation|3
7315450|NCT00709995|11543574|FG000|Overall Study|Adverse Event|4
7315451|NCT00709995|11543575|FG001|Overall Study|Adverse Event|2
7315452|NCT00709995|11543574|FG000|Overall Study|Withdrawal by Subject|1
7315453|NCT00709995|11543575|FG001|Overall Study|Withdrawal by Subject|3
7391810|NCT01246986|11652481|FG003|Overall Study|Lost to Follow-up|0
7315454|NCT00710021|11543587|FG000|Overall Study|Lost to Follow-up|1
7315455|NCT00710021|11543588|FG001|Overall Study|Lost to Follow-up|0
7315456|NCT00710021|11543589|FG002|Overall Study|Lost to Follow-up|0
7315457|NCT00710021|11543587|FG000|Overall Study|Subject's Decision|0
7315458|NCT00710021|11543588|FG001|Overall Study|Subject's Decision|1
7315459|NCT00710021|11543589|FG002|Overall Study|Subject's Decision|0
7315460|NCT00710021|11543587|FG000|Overall Study|Subject misrandomized|0
7315461|NCT00710021|11543588|FG001|Overall Study|Subject misrandomized|1
7315462|NCT00710021|11543589|FG002|Overall Study|Subject misrandomized|1
7315463|NCT00710021|11543587|FG000|Overall Study|Physician Decision|0
7315464|NCT00710021|11543588|FG001|Overall Study|Physician Decision|1
7315465|NCT00710021|11543589|FG002|Overall Study|Physician Decision|0
7315466|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
7315467|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
7315468|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
7315469|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
7315470|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
7315471|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
7315472|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
7315473|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
7315474|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
7315475|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
7315476|NCT00710034|11543600|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
7315477|NCT00710034|11543601|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
7315478|NCT00710034|11543600|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
7315479|NCT00710034|11543601|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
7224582|NCT00055497|11433847|FG001|Overall Study|Other|0
7315480|NCT00710034|11543600|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
7315481|NCT00710034|11543601|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
7224583|NCT00055497|11433848|FG002|Overall Study|Other|0
7224584|NCT00055497|11433849|FG003|Overall Study|Other|11
7224585|NCT00055601|11433866|FG000|Overall Study|Protocol Violation|1
7224586|NCT00055601|11433867|FG001|Overall Study|Protocol Violation|1
7224587|NCT00055601|11433866|FG000|Overall Study|No protocol treatment received|1
7224588|NCT00055601|11433867|FG001|Overall Study|No protocol treatment received|1
7224589|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
7224590|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
7224591|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
7224592|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
7224593|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
7224594|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
7224595|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7224596|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
7224597|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Death|2
7224598|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Death|1
7224599|NCT00056160|11433881|FG000|Up to Unblinding (07 Jun 2005)|Other|8
7224600|NCT00056160|11433882|FG001|Up to Unblinding (07 Jun 2005)|Other|7
7224601|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
7224602|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
7224603|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
7224604|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
7224605|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
7224606|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
7224607|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
7224608|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
7224609|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
7224610|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
7224611|NCT00056160|11433881|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
7224612|NCT00056160|11433882|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
7224613|NCT00056160|11433881|FG000|Final Follow-up|Transferred into expanded access study.|3
7224614|NCT00056160|11433882|FG001|Final Follow-up|Transferred into expanded access study.|0
7224615|NCT00056160|11433881|FG000|Final Follow-up|Transferred into RevAssist Program|2
7256765|NCT00325468|11468500|FG000|Overall Study|Physician Decision|1
7256766|NCT00325468|11468501|FG001|Overall Study|Physician Decision|1
7315482|NCT00710034|11543600|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7315483|NCT00710034|11543601|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
7315484|NCT00710034|11543600|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
7387512|NCT01214720|11646051|FG001|Overall Study|Lost to Follow-up|2
7315485|NCT00710034|11543601|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
7315486|NCT00710034|11543600|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
7315487|NCT00710034|11543601|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
7315488|NCT00710385|11543617|FG000|Overall Study|Did not qualify|1
7315489|NCT00710385|11543617|FG000|Overall Study|Withdrawal by Subject|1
7315490|NCT00710385|11543617|FG000|Overall Study|Undisclosed back pain|1
7315491|NCT00710385|11543617|FG000|Overall Study|Physician Decision|1
7315492|NCT00710385|11543617|FG000|Overall Study|Undisclosed excessive methadone use|1
7315493|NCT00710424|11543629|FG000|Overall Study|Adverse Event|30
7315494|NCT00710424|11543630|FG001|Overall Study|Adverse Event|12
7315495|NCT00710424|11543629|FG000|Overall Study|Lack of Efficacy|4
7315496|NCT00710424|11543630|FG001|Overall Study|Lack of Efficacy|5
7315497|NCT00710424|11543629|FG000|Overall Study|Withdrawal by Subject|5
7315498|NCT00710424|11543630|FG001|Overall Study|Withdrawal by Subject|3
7315499|NCT00710424|11543629|FG000|Overall Study|Lost to Follow-up|0
7315500|NCT00710424|11543630|FG001|Overall Study|Lost to Follow-up|1
7315501|NCT00710424|11543629|FG000|Overall Study|Refused medication, no side effects|1
7315502|NCT00710424|11543630|FG001|Overall Study|Refused medication, no side effects|0
7315503|NCT00710424|11543629|FG000|Overall Study|Non-compliance with stable analgesia|1
7315504|NCT00710424|11543630|FG001|Overall Study|Non-compliance with stable analgesia|0
7315505|NCT00710424|11543629|FG000|Overall Study|Did not meet entry criteria at visit 1|1
7315506|NCT00710424|11543630|FG001|Overall Study|Did not meet entry criteria at visit 1|0
7315507|NCT00710424|11543629|FG000|Overall Study|Subject thought medication changed|1
7315508|NCT00710424|11543630|FG001|Overall Study|Subject thought medication changed|0
7315509|NCT00710424|11543629|FG000|Overall Study|Ceased treatment due to travel|1
7315510|NCT00710424|11543630|FG001|Overall Study|Ceased treatment due to travel|0
7315511|NCT00710424|11543629|FG000|Overall Study|Subject preferred paracetamol|0
7315512|NCT00710424|11543630|FG001|Overall Study|Subject preferred paracetamol|1
7315513|NCT00710424|11543629|FG000|Overall Study|Felt good so stopped treatment|0
7315514|NCT00710424|11543630|FG001|Overall Study|Felt good so stopped treatment|1
7315515|NCT00710554|11543638|FG000|Overall Study|Adverse Event|24
7315516|NCT00710554|11543639|FG001|Overall Study|Adverse Event|7
7315517|NCT00710554|11543638|FG000|Overall Study|Withdrawal by Subject|7
7315518|NCT00710554|11543639|FG001|Overall Study|Withdrawal by Subject|3
7315519|NCT00710554|11543638|FG000|Overall Study|Lost to Follow-up|7
7315520|NCT00710554|11543639|FG001|Overall Study|Lost to Follow-up|1
7315521|NCT00710554|11543638|FG000|Overall Study|Lack of Efficacy|11
7315522|NCT00710554|11543639|FG001|Overall Study|Lack of Efficacy|12
7315523|NCT00710554|11543638|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
7315524|NCT00710554|11543639|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
7315525|NCT00710593|11543647|FG000|Overall Study|Incarceration|1
7315526|NCT00710593|11543648|FG001|Overall Study|Incarceration|0
7315527|NCT00710593|11543647|FG000|Overall Study|Unable to complete Wk 48 within window|2
7315528|NCT00710593|11543648|FG001|Overall Study|Unable to complete Wk 48 within window|0
7315529|NCT00710593|11543647|FG000|Overall Study|Lost to Follow-up|3
7315530|NCT00710593|11543648|FG001|Overall Study|Lost to Follow-up|1
7315531|NCT00710593|11543647|FG000|Overall Study|Moved out of area|1
7315532|NCT00710593|11543648|FG001|Overall Study|Moved out of area|0
7315533|NCT00710593|11543647|FG000|Overall Study|Failure to adhere or complete study eval|1
7315534|NCT00710593|11543648|FG001|Overall Study|Failure to adhere or complete study eval|1
7315535|NCT00710593|11543647|FG000|Overall Study|Protocol Violation|1
7315536|NCT00710593|11543648|FG001|Overall Study|Protocol Violation|1
7315537|NCT00710593|11543647|FG000|Overall Study|Prem disc vaccine, completed all visits|6
7315538|NCT00710593|11543648|FG001|Overall Study|Prem disc vaccine, completed all visits|2
7315539|NCT00710606|11543672|FG000|Overall Study|Adverse Event|0
7315540|NCT00710606|11543673|FG001|Overall Study|Adverse Event|2
7315541|NCT00710684|11543684|FG000|Overall Study|Adverse Event|11
7315542|NCT00710684|11543685|FG001|Overall Study|Adverse Event|19
7315543|NCT00710684|11543686|FG002|Overall Study|Adverse Event|16
7315544|NCT00710684|11543684|FG000|Overall Study|Lack of Efficacy|4
7315545|NCT00710684|11543685|FG001|Overall Study|Lack of Efficacy|3
7315546|NCT00710684|11543686|FG002|Overall Study|Lack of Efficacy|5
7315547|NCT00710684|11543684|FG000|Overall Study|Protocol Violation|5
7315548|NCT00710684|11543685|FG001|Overall Study|Protocol Violation|5
7315549|NCT00710684|11543686|FG002|Overall Study|Protocol Violation|5
7315550|NCT00710684|11543684|FG000|Overall Study|Lost to Follow-up|4
7315551|NCT00710684|11543685|FG001|Overall Study|Lost to Follow-up|6
7315552|NCT00710684|11543686|FG002|Overall Study|Lost to Follow-up|7
7315553|NCT00710684|11543684|FG000|Overall Study|Physician Decision|0
7315554|NCT00710684|11543685|FG001|Overall Study|Physician Decision|2
7315555|NCT00710684|11543686|FG002|Overall Study|Physician Decision|4
7315556|NCT00710684|11543684|FG000|Overall Study|Withdrawal by Subject|24
7315557|NCT00710684|11543685|FG001|Overall Study|Withdrawal by Subject|18
7315558|NCT00710684|11543686|FG002|Overall Study|Withdrawal by Subject|11
7315559|NCT00710684|11543684|FG000|Overall Study|Missing|1
7315560|NCT00710684|11543685|FG001|Overall Study|Missing|0
7315561|NCT00710684|11543686|FG002|Overall Study|Missing|0
7315562|NCT00710684|11543684|FG000|Overall Study|Did not continue after week 24|25
7315563|NCT00710684|11543685|FG001|Overall Study|Did not continue after week 24|21
7315564|NCT00710684|11543686|FG002|Overall Study|Did not continue after week 24|16
7315565|NCT00710749|11543700|FG000|First Intervention|Withdrawal by Subject|1
7315566|NCT00710749|11543701|FG001|First Intervention|Withdrawal by Subject|0
7315567|NCT00710762|11543711|FG000|Overall Study|Progressive disease|27
7315568|NCT00710762|11543712|FG001|Overall Study|Progressive disease|30
7315569|NCT00710762|11543711|FG000|Overall Study|Adverse Event other disease worsening|2
7315570|NCT00710762|11543712|FG001|Overall Study|Adverse Event other disease worsening|1
7315571|NCT00710762|11543711|FG000|Overall Study|Other Adverse Event|7
7315572|NCT00710762|11543712|FG001|Overall Study|Other Adverse Event|7
7315573|NCT00710762|11543711|FG000|Overall Study|Lost to Follow-up|1
7315574|NCT00710762|11543712|FG001|Overall Study|Lost to Follow-up|0
7315575|NCT00710762|11543711|FG000|Overall Study|Reason other than listed above|2
7315576|NCT00710762|11543712|FG001|Overall Study|Reason other than listed above|2
7315577|NCT00710866|11543738|FG000|Overall Study|Protocol Violation|5
7315578|NCT00710866|11543739|FG001|Overall Study|Protocol Violation|4
7315579|NCT00710866|11543738|FG000|Overall Study|Withdrawal by Subject|2
7315580|NCT00710866|11543739|FG001|Overall Study|Withdrawal by Subject|1
7315581|NCT00710866|11543738|FG000|Overall Study|Lost to Follow-up|1
7315582|NCT00710866|11543739|FG001|Overall Study|Lost to Follow-up|0
7315583|NCT00710866|11543738|FG000|Overall Study|Failed to meet eligibility|1
7315584|NCT00710866|11543739|FG001|Overall Study|Failed to meet eligibility|1
7315585|NCT00710879|11543747|FG000|Overall Study|Lost to Follow-up|2
7315586|NCT00710879|11543748|FG001|Overall Study|Lost to Follow-up|1
7315587|NCT00710879|11543747|FG000|Overall Study|Protocol Violation|0
7315588|NCT00710879|11543748|FG001|Overall Study|Protocol Violation|3
7315589|NCT00711009|11543790|FG000|Overall Study|Adverse Event/HIV-Related Event|4
7315590|NCT00711009|11543791|FG001|Overall Study|Adverse Event/HIV-Related Event|5
7315591|NCT00711009|11543790|FG000|Overall Study|Withdrawal by Subject|4
7315592|NCT00711009|11543791|FG001|Overall Study|Withdrawal by Subject|2
7315593|NCT00711009|11543790|FG000|Overall Study|Lost to Follow-up|3
7315594|NCT00711009|11543791|FG001|Overall Study|Lost to Follow-up|9
7315595|NCT00711009|11543790|FG000|Overall Study|Participant Noncompliant|0
7315596|NCT00711009|11543791|FG001|Overall Study|Participant Noncompliant|1
7315597|NCT00711009|11543790|FG000|Overall Study|Virologic Failure|2
7315598|NCT00711009|11543791|FG001|Overall Study|Virologic Failure|1
7315599|NCT00711009|11543790|FG000|Overall Study|Pregnancy|1
7315600|NCT00711009|11543791|FG001|Overall Study|Pregnancy|0
7315601|NCT00711009|11543790|FG000|Overall Study|Site closing|0
7315602|NCT00711009|11543791|FG001|Overall Study|Site closing|1
7315603|NCT00711009|11543790|FG000|Overall Study|Dose adjustment|1
7315604|NCT00711009|11543791|FG001|Overall Study|Dose adjustment|0
7315605|NCT00711100|11543801|FG000|Overall Study|Lack of Efficacy|5
7315606|NCT00711100|11543801|FG000|Overall Study|Withdrawal by Subject|8
7315607|NCT00711113|11543817|FG000|Overall Study|Lost to Follow-up|9
7315608|NCT00711113|11543817|FG000|Overall Study|Implant lost|2
7315609|NCT00711191|11543824|FG000|Overall Study|Adverse Event|1
7315610|NCT00711191|11543825|FG001|Overall Study|Adverse Event|1
7315611|NCT00711191|11543826|FG002|Overall Study|Adverse Event|2
7315612|NCT00711191|11543824|FG000|Overall Study|Objective progression or relapse|2
7315613|NCT00711191|11543825|FG001|Overall Study|Objective progression or relapse|3
7315614|NCT00711191|11543826|FG002|Overall Study|Objective progression or relapse|7
7315615|NCT00711191|11543824|FG000|Overall Study|Withdrawal by Subject|0
7315616|NCT00711191|11543825|FG001|Overall Study|Withdrawal by Subject|1
7315617|NCT00711191|11543826|FG002|Overall Study|Withdrawal by Subject|3
7315618|NCT00711243|11543843|FG000|Registed and Started Treatment|Withdrawal by Subject|0
7315619|NCT00711243|11543844|FG001|Registed and Started Treatment|Withdrawal by Subject|0
7315620|NCT00711243|11543845|FG002|Registed and Started Treatment|Withdrawal by Subject|0
7315621|NCT00711243|11543846|FG003|Registed and Started Treatment|Withdrawal by Subject|0
7315622|NCT00711243|11543847|FG004|Registed and Started Treatment|Withdrawal by Subject|0
7315623|NCT00711243|11543848|FG005|Registed and Started Treatment|Withdrawal by Subject|1
7315624|NCT00711243|11543843|FG000|Reached First Response/4 Cycles|Death|0
7315625|NCT00711243|11543844|FG001|Reached First Response/4 Cycles|Death|0
7315626|NCT00711243|11543845|FG002|Reached First Response/4 Cycles|Death|0
7315627|NCT00711243|11543846|FG003|Reached First Response/4 Cycles|Death|0
7315628|NCT00711243|11543847|FG004|Reached First Response/4 Cycles|Death|0
7315629|NCT00711243|11543848|FG005|Reached First Response/4 Cycles|Death|2
7315630|NCT00711243|11543843|FG000|Reached First Response/4 Cycles|Progressive disease|0
7315631|NCT00711243|11543844|FG001|Reached First Response/4 Cycles|Progressive disease|0
7315632|NCT00711243|11543845|FG002|Reached First Response/4 Cycles|Progressive disease|0
7315633|NCT00711243|11543846|FG003|Reached First Response/4 Cycles|Progressive disease|1
7315634|NCT00711243|11543847|FG004|Reached First Response/4 Cycles|Progressive disease|0
7315635|NCT00711243|11543848|FG005|Reached First Response/4 Cycles|Progressive disease|0
7315636|NCT00711243|11543843|FG000|Treated Cycle 5 After First Response|Progressive disease|1
7315637|NCT00711243|11543844|FG001|Treated Cycle 5 After First Response|Progressive disease|2
7315638|NCT00711243|11543845|FG002|Treated Cycle 5 After First Response|Progressive disease|0
7315639|NCT00711243|11543846|FG003|Treated Cycle 5 After First Response|Progressive disease|0
7315640|NCT00711243|11543847|FG004|Treated Cycle 5 After First Response|Progressive disease|1
7315641|NCT00711243|11543848|FG005|Treated Cycle 5 After First Response|Progressive disease|1
7315642|NCT00711243|11543843|FG000|Treated Cycle 5 After First Response|Death|0
7315643|NCT00711243|11543844|FG001|Treated Cycle 5 After First Response|Death|0
7315644|NCT00711243|11543845|FG002|Treated Cycle 5 After First Response|Death|0
7315645|NCT00711243|11543846|FG003|Treated Cycle 5 After First Response|Death|0
7315646|NCT00711243|11543847|FG004|Treated Cycle 5 After First Response|Death|0
7315647|NCT00711243|11543848|FG005|Treated Cycle 5 After First Response|Death|2
7315648|NCT00711243|11543843|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
7315649|NCT00711243|11543844|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
7315650|NCT00711243|11543845|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
7315651|NCT00711243|11543846|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
7315652|NCT00711243|11543847|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
7315653|NCT00711243|11543848|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
7315654|NCT00711243|11543843|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7315655|NCT00711243|11543844|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7315656|NCT00711243|11543845|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7315657|NCT00711243|11543846|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7315658|NCT00711243|11543847|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
7315659|NCT00711243|11543848|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
7315660|NCT00711412|11543873|FG000|Induction Treatment|Death|2
7315661|NCT00711412|11543873|FG000|Induction Treatment|Adverse Event|1
7315662|NCT00711412|11543873|FG000|Induction Treatment|Other|1
7315663|NCT00711412|11543873|FG000|Evaluated for Combination Treatment|Adverse Event|2
7315664|NCT00711412|11543873|FG000|Evaluated for Combination Treatment|Death|1
7315665|NCT00711412|11543873|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
7315666|NCT00711412|11543873|FG000|Evaluated for Combination Treatment|Progressive disease|2
7315667|NCT00711412|11543873|FG000|Combination Treatment|Progressive Disease|1
7315668|NCT00711412|11543873|FG000|Evaluation for Response and Surgery|Progressive Disease|2
7315669|NCT00711412|11543873|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
7315670|NCT00711412|11543873|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
7315671|NCT00711412|11543873|FG000|Evaluation for Response and Surgery|Death|1
7315672|NCT00711412|11543873|FG000|Survival Follow up Until Death|Other|12
7315673|NCT00711425|11543878|FG000|Overall Study|Protocol Violation|1
7315674|NCT00711425|11543878|FG000|Overall Study|Death|2
7315675|NCT00711425|11543878|FG000|Overall Study|Lost to Follow-up|1
7315676|NCT00711477|11543894|FG000|Overall Study|Adverse Event|3
7315677|NCT00711477|11543895|FG001|Overall Study|Adverse Event|1
7315678|NCT00711477|11543894|FG000|Overall Study|Lost to Follow-up|0
7315679|NCT00711477|11543895|FG001|Overall Study|Lost to Follow-up|1
7315680|NCT00711477|11543894|FG000|Overall Study|Noncompliance|0
7315681|NCT00711477|11543895|FG001|Overall Study|Noncompliance|1
7315682|NCT00711516|11543910|FG000|Overall Study|Adverse Event|1
7315683|NCT00711516|11543911|FG001|Overall Study|Adverse Event|1
7315684|NCT00711516|11543910|FG000|Overall Study|Withdrawal by Subject|0
7315685|NCT00711516|11543911|FG001|Overall Study|Withdrawal by Subject|1
7315686|NCT00711516|11543910|FG000|Overall Study|Protocol Violation|0
7315687|NCT00711516|11543911|FG001|Overall Study|Protocol Violation|1
7315688|NCT00711529|11543919|FG000|Overall Study|Protocol Violation|2
7315689|NCT00711529|11543920|FG001|Overall Study|Protocol Violation|0
7315690|NCT00711529|11543919|FG000|Overall Study|Withdrawal by Subject|2
7315691|NCT00711529|11543920|FG001|Overall Study|Withdrawal by Subject|6
7315692|NCT00711594|11543930|FG000|Overall Study|Progressive disease|2
7315693|NCT00711594|11543931|FG001|Overall Study|Progressive disease|2
7315694|NCT00711594|11543932|FG002|Overall Study|Progressive disease|6
7315695|NCT00711594|11543933|FG003|Overall Study|Progressive disease|44
7315696|NCT00711594|11543930|FG000|Overall Study|Other Adverse Event|1
7315697|NCT00711594|11543931|FG001|Overall Study|Other Adverse Event|0
7315698|NCT00711594|11543932|FG002|Overall Study|Other Adverse Event|0
7315699|NCT00711594|11543933|FG003|Overall Study|Other Adverse Event|16
7315700|NCT00711594|11543930|FG000|Overall Study|Withdrawal by Subject|0
7315701|NCT00711594|11543931|FG001|Overall Study|Withdrawal by Subject|1
7315702|NCT00711594|11543932|FG002|Overall Study|Withdrawal by Subject|0
7315703|NCT00711594|11543933|FG003|Overall Study|Withdrawal by Subject|2
7315704|NCT00711646|11543947|FG000|Overall Study|Adverse Event|6
7315705|NCT00711646|11543948|FG001|Overall Study|Adverse Event|1
7315706|NCT00711646|11543947|FG000|Overall Study|Withdrawal by Subject|4
7315707|NCT00711646|11543948|FG001|Overall Study|Withdrawal by Subject|0
7315708|NCT00711646|11543947|FG000|Overall Study|Protocol Violation|0
7315709|NCT00711646|11543948|FG001|Overall Study|Protocol Violation|1
7315710|NCT00711646|11543947|FG000|Overall Study|Lost to Follow-up|1
7315711|NCT00711646|11543948|FG001|Overall Study|Lost to Follow-up|0
7315712|NCT00711646|11543947|FG000|Overall Study|administrative decision|0
7315713|NCT00711646|11543948|FG001|Overall Study|administrative decision|1
7315714|NCT00711646|11543947|FG000|Overall Study|patient non-compliance|1
7315715|NCT00711646|11543948|FG001|Overall Study|patient non-compliance|0
7315716|NCT00711802|11543973|FG000|Overall Study|Not treated (no further detail)|2
7315717|NCT00711802|11543974|FG001|Overall Study|Not treated (no further detail)|1
7315718|NCT00711802|11543975|FG002|Overall Study|Not treated (no further detail)|2
7315719|NCT00711802|11543976|FG003|Overall Study|Not treated (no further detail)|0
7315720|NCT00711802|11543977|FG004|Overall Study|Not treated (no further detail)|2
7315721|NCT00711802|11543978|FG005|Overall Study|Not treated (no further detail)|0
7315722|NCT00711802|11543979|FG006|Overall Study|Not treated (no further detail)|0
7315723|NCT00711802|11543980|FG007|Overall Study|Not treated (no further detail)|0
7315724|NCT00711802|11543973|FG000|Overall Study|Adverse Event|0
7315725|NCT00711802|11543974|FG001|Overall Study|Adverse Event|0
7315726|NCT00711802|11543975|FG002|Overall Study|Adverse Event|0
7315727|NCT00711802|11543976|FG003|Overall Study|Adverse Event|0
7315728|NCT00711802|11543977|FG004|Overall Study|Adverse Event|1
7315729|NCT00711802|11543978|FG005|Overall Study|Adverse Event|1
7315730|NCT00711802|11543979|FG006|Overall Study|Adverse Event|0
7315731|NCT00711802|11543980|FG007|Overall Study|Adverse Event|0
7315732|NCT00711802|11543973|FG000|Overall Study|Microbiological failure|0
7315733|NCT00711802|11543974|FG001|Overall Study|Microbiological failure|1
7315734|NCT00711802|11543975|FG002|Overall Study|Microbiological failure|0
7315735|NCT00711802|11543976|FG003|Overall Study|Microbiological failure|0
7315736|NCT00711802|11543977|FG004|Overall Study|Microbiological failure|0
7315737|NCT00711802|11543978|FG005|Overall Study|Microbiological failure|1
7315738|NCT00711802|11543979|FG006|Overall Study|Microbiological failure|0
7315739|NCT00711802|11543980|FG007|Overall Study|Microbiological failure|0
7315740|NCT00711802|11543973|FG000|Overall Study|Protocol Violation|0
7315741|NCT00711802|11543974|FG001|Overall Study|Protocol Violation|0
7315742|NCT00711802|11543975|FG002|Overall Study|Protocol Violation|0
7315743|NCT00711802|11543976|FG003|Overall Study|Protocol Violation|1
7315744|NCT00711802|11543977|FG004|Overall Study|Protocol Violation|0
7315745|NCT00711802|11543978|FG005|Overall Study|Protocol Violation|0
7315746|NCT00711802|11543979|FG006|Overall Study|Protocol Violation|0
7315747|NCT00711802|11543980|FG007|Overall Study|Protocol Violation|0
7315748|NCT00711802|11543973|FG000|Overall Study|Physician Decision|0
7315749|NCT00711802|11543974|FG001|Overall Study|Physician Decision|2
7315750|NCT00711802|11543975|FG002|Overall Study|Physician Decision|0
7315751|NCT00711802|11543976|FG003|Overall Study|Physician Decision|0
7315752|NCT00711802|11543977|FG004|Overall Study|Physician Decision|0
7315753|NCT00711802|11543978|FG005|Overall Study|Physician Decision|0
7315754|NCT00711802|11543979|FG006|Overall Study|Physician Decision|0
7315755|NCT00711802|11543980|FG007|Overall Study|Physician Decision|0
7315756|NCT00711802|11543973|FG000|Overall Study|Withdrawal by Subject|0
7315757|NCT00711802|11543974|FG001|Overall Study|Withdrawal by Subject|1
7315758|NCT00711802|11543975|FG002|Overall Study|Withdrawal by Subject|0
7315759|NCT00711802|11543976|FG003|Overall Study|Withdrawal by Subject|1
7315760|NCT00711802|11543977|FG004|Overall Study|Withdrawal by Subject|0
7315761|NCT00711802|11543978|FG005|Overall Study|Withdrawal by Subject|0
7315762|NCT00711802|11543979|FG006|Overall Study|Withdrawal by Subject|0
7315763|NCT00711802|11543980|FG007|Overall Study|Withdrawal by Subject|0
7315764|NCT00711802|11543973|FG000|Overall Study|Lost to Follow-up|0
7315765|NCT00711802|11543974|FG001|Overall Study|Lost to Follow-up|0
7315766|NCT00711802|11543975|FG002|Overall Study|Lost to Follow-up|3
7315767|NCT00711802|11543976|FG003|Overall Study|Lost to Follow-up|1
7315768|NCT00711802|11543977|FG004|Overall Study|Lost to Follow-up|10
7315769|NCT00711802|11543978|FG005|Overall Study|Lost to Follow-up|6
7315770|NCT00711802|11543979|FG006|Overall Study|Lost to Follow-up|4
7315771|NCT00711802|11543980|FG007|Overall Study|Lost to Follow-up|2
7315772|NCT00711802|11543973|FG000|Overall Study|Reason not reported|0
7315773|NCT00711802|11543974|FG001|Overall Study|Reason not reported|1
7315774|NCT00711802|11543975|FG002|Overall Study|Reason not reported|1
7315775|NCT00711802|11543976|FG003|Overall Study|Reason not reported|0
7315776|NCT00711802|11543977|FG004|Overall Study|Reason not reported|1
7315777|NCT00711802|11543978|FG005|Overall Study|Reason not reported|0
7315778|NCT00711802|11543979|FG006|Overall Study|Reason not reported|1
7315779|NCT00711802|11543980|FG007|Overall Study|Reason not reported|0
7315780|NCT00711880|11544016|FG000|Overall Study|Adverse Event|11
7315781|NCT00711880|11544017|FG001|Overall Study|Adverse Event|2
7315782|NCT00711880|11544016|FG000|Overall Study|Patient non-compliance|1
7315783|NCT00711880|11544017|FG001|Overall Study|Patient non-compliance|0
7315784|NCT00711880|11544016|FG000|Overall Study|Lack of Efficacy|1
7315785|NCT00711880|11544017|FG001|Overall Study|Lack of Efficacy|5
7315786|NCT00711958|11544025|FG000|Overall Study|Withdrawal by Subject|6
7315787|NCT00711958|11544026|FG001|Overall Study|Withdrawal by Subject|8
7315788|NCT00711958|11544025|FG000|Overall Study|Lack of Efficacy|3
7315789|NCT00711958|11544026|FG001|Overall Study|Lack of Efficacy|1
7315790|NCT00711958|11544025|FG000|Overall Study|Clinical deterioration|1
7315791|NCT00711958|11544026|FG001|Overall Study|Clinical deterioration|0
7315792|NCT00711958|11544025|FG000|Overall Study|Adverse Event|9
7315793|NCT00711958|11544026|FG001|Overall Study|Adverse Event|7
7315794|NCT00711958|11544025|FG000|Overall Study|Protocol Violation|1
7315795|NCT00711958|11544026|FG001|Overall Study|Protocol Violation|0
7315796|NCT00711958|11544025|FG000|Overall Study|Lost to Follow-up|2
7315797|NCT00711958|11544026|FG001|Overall Study|Lost to Follow-up|2
7315798|NCT00711958|11544025|FG000|Overall Study|Death|10
7315799|NCT00711958|11544026|FG001|Overall Study|Death|5
7315800|NCT00711958|11544025|FG000|Overall Study|Progression of disease|1
7315801|NCT00711958|11544026|FG001|Overall Study|Progression of disease|0
7315802|NCT00711971|11544035|FG000|Overall Study|Lost to Follow-up|3
7315803|NCT00711971|11544036|FG001|Overall Study|Lost to Follow-up|4
7315804|NCT00711971|11544037|FG002|Overall Study|Lost to Follow-up|1
7315805|NCT00712010|11544060|FG000|Washout (7 Days)|Withdrawal by Subject|1
7315806|NCT00712166|11544091|FG000|Overall Study|Noncompliance|0
7315807|NCT00712166|11544092|FG001|Overall Study|Noncompliance|1
7315808|NCT00712270|11544124|FG000|Overall Study|Withdrawal by Subject|11
7315809|NCT00712270|11544124|FG000|Overall Study|Screen Failure|3
7315810|NCT00712335|11544178|FG000|Overall Study|Withdrawal by Subject|0
7391811|NCT01246986|11652482|FG004|Overall Study|Lost to Follow-up|0
7391812|NCT01246986|11652483|FG005|Overall Study|Lost to Follow-up|1
7391813|NCT01246986|11652484|FG006|Overall Study|Lost to Follow-up|0
7391814|NCT01246986|11652478|FG000|Overall Study|Withdrawal by Subject|3
7391815|NCT01246986|11652479|FG001|Overall Study|Withdrawal by Subject|4
7391816|NCT01246986|11652480|FG002|Overall Study|Withdrawal by Subject|3
7391817|NCT01246986|11652481|FG003|Overall Study|Withdrawal by Subject|0
7391818|NCT01246986|11652482|FG004|Overall Study|Withdrawal by Subject|4
7391819|NCT01246986|11652483|FG005|Overall Study|Withdrawal by Subject|0
7391820|NCT01246986|11652484|FG006|Overall Study|Withdrawal by Subject|0
7391821|NCT01246999|11652519|FG000|Overall Study|Lost to Follow-up|0
7391822|NCT01246999|11652520|FG001|Overall Study|Lost to Follow-up|1
7391823|NCT01246999|11652521|FG002|Overall Study|Lost to Follow-up|0
7391824|NCT01246999|11652522|FG003|Overall Study|Lost to Follow-up|0
7391825|NCT01246999|11652519|FG000|Overall Study|Withdrawal by Subject|0
7391826|NCT01246999|11652520|FG001|Overall Study|Withdrawal by Subject|0
7391827|NCT01246999|11652521|FG002|Overall Study|Withdrawal by Subject|0
7391828|NCT01246999|11652522|FG003|Overall Study|Withdrawal by Subject|2
7391829|NCT01247090|11652547|FG000|Overall Study|Physician Decision|1
7391830|NCT01247090|11652548|FG001|Overall Study|Physician Decision|0
7391831|NCT01247090|11652549|FG002|Overall Study|Physician Decision|0
7391832|NCT01247090|11652547|FG000|Overall Study|Withdrawal by Subject|0
7391833|NCT01247090|11652548|FG001|Overall Study|Withdrawal by Subject|1
7391834|NCT01247090|11652549|FG002|Overall Study|Withdrawal by Subject|0
7391835|NCT01247350|11652594|FG000|Overall Study|Adverse Event|0
7391836|NCT01247350|11652595|FG001|Overall Study|Adverse Event|0
7391837|NCT01247350|11652596|FG002|Overall Study|Adverse Event|1
7391838|NCT01247350|11652597|FG003|Overall Study|Adverse Event|0
7391839|NCT01247350|11652598|FG004|Overall Study|Adverse Event|0
7391840|NCT01247350|11652594|FG000|Overall Study|Withdrawal by Subject|0
7391841|NCT01247350|11652595|FG001|Overall Study|Withdrawal by Subject|0
7391842|NCT01247350|11652596|FG002|Overall Study|Withdrawal by Subject|0
7391843|NCT01247350|11652597|FG003|Overall Study|Withdrawal by Subject|1
7391844|NCT01247350|11652598|FG004|Overall Study|Withdrawal by Subject|0
7391845|NCT01247350|11652594|FG000|Overall Study|Entry criteria not met|0
7391846|NCT01247350|11652595|FG001|Overall Study|Entry criteria not met|0
7391847|NCT01247350|11652596|FG002|Overall Study|Entry criteria not met|0
7391848|NCT01247350|11652597|FG003|Overall Study|Entry criteria not met|0
7391849|NCT01247350|11652598|FG004|Overall Study|Entry criteria not met|1
7391850|NCT01247922|11652666|FG000|Overall Study|Disease progression|4
7391851|NCT01248013|11652679|FG000|Overall Study|Withdrawal by Subject|14
7391852|NCT01248065|11652685|FG000|Overall Study|Lost to Follow-up|3
7391853|NCT01248065|11652686|FG001|Overall Study|Lost to Follow-up|5
7391854|NCT01248065|11652685|FG000|Overall Study|Withdrawal by Subject|14
7391855|NCT01248065|11652686|FG001|Overall Study|Withdrawal by Subject|11
7315811|NCT00712335|11544179|FG001|Overall Study|Withdrawal by Subject|7
7315812|NCT00712335|11544180|FG002|Overall Study|Withdrawal by Subject|2
7315813|NCT00712335|11544181|FG003|Overall Study|Withdrawal by Subject|3
7315814|NCT00712335|11544182|FG004|Overall Study|Withdrawal by Subject|0
7391856|NCT01248065|11652685|FG000|Overall Study|Adverse Event|3
7391857|NCT01248065|11652686|FG001|Overall Study|Adverse Event|0
7391858|NCT01248065|11652685|FG000|Overall Study|Third treatment failure event|3
7315897|NCT00712725|11544264|FG007|Overall Study|Physician Decision|0
7391859|NCT01248065|11652686|FG001|Overall Study|Third treatment failure event|1
7391860|NCT01248065|11652685|FG000|Overall Study|Other|3
7391861|NCT01248065|11652686|FG001|Overall Study|Other|5
7391862|NCT01248364|11652716|FG000|Overall Study|Adverse Event|0
7315815|NCT00712335|11544178|FG000|Overall Study|Lost to Follow-up|2
7315816|NCT00712335|11544179|FG001|Overall Study|Lost to Follow-up|5
7315817|NCT00712335|11544180|FG002|Overall Study|Lost to Follow-up|0
7315818|NCT00712335|11544181|FG003|Overall Study|Lost to Follow-up|1
7315819|NCT00712335|11544182|FG004|Overall Study|Lost to Follow-up|0
7315820|NCT00712335|11544178|FG000|Overall Study|Protocol Violation|1
7315821|NCT00712335|11544179|FG001|Overall Study|Protocol Violation|2
7315822|NCT00712335|11544180|FG002|Overall Study|Protocol Violation|1
7315823|NCT00712335|11544181|FG003|Overall Study|Protocol Violation|0
7315824|NCT00712335|11544182|FG004|Overall Study|Protocol Violation|0
7315825|NCT00712335|11544178|FG000|Overall Study|Lack of Efficacy|0
7315826|NCT00712335|11544179|FG001|Overall Study|Lack of Efficacy|0
7315827|NCT00712335|11544180|FG002|Overall Study|Lack of Efficacy|1
7315828|NCT00712335|11544181|FG003|Overall Study|Lack of Efficacy|1
7315829|NCT00712335|11544182|FG004|Overall Study|Lack of Efficacy|0
7315830|NCT00712335|11544178|FG000|Overall Study|Other Reason|0
7315831|NCT00712335|11544179|FG001|Overall Study|Other Reason|3
7315832|NCT00712335|11544180|FG002|Overall Study|Other Reason|1
7315833|NCT00712335|11544181|FG003|Overall Study|Other Reason|0
7315834|NCT00712335|11544182|FG004|Overall Study|Other Reason|0
7315835|NCT00712348|11544194|FG000|Overall Study|Withdrawal by Subject|1
7315836|NCT00712543|11544213|FG000|Day 8-14|Lost to Follow-up|0
7315837|NCT00712543|11544214|FG001|Day 8-14|Lost to Follow-up|2
7315838|NCT00712673|11544223|FG000|Overall Study|Adverse Event|3
7315839|NCT00712673|11544224|FG001|Overall Study|Adverse Event|3
7315840|NCT00712673|11544225|FG002|Overall Study|Adverse Event|21
7315841|NCT00712673|11544226|FG003|Overall Study|Adverse Event|26
7315842|NCT00712673|11544223|FG000|Overall Study|Lack of Efficacy|2
7315843|NCT00712673|11544224|FG001|Overall Study|Lack of Efficacy|8
7315844|NCT00712673|11544225|FG002|Overall Study|Lack of Efficacy|8
7315845|NCT00712673|11544226|FG003|Overall Study|Lack of Efficacy|6
7315846|NCT00712673|11544223|FG000|Overall Study|Poor Compliance to Protocol|3
7315847|NCT00712673|11544224|FG001|Overall Study|Poor Compliance to Protocol|3
7315848|NCT00712673|11544225|FG002|Overall Study|Poor Compliance to Protocol|4
7315849|NCT00712673|11544226|FG003|Overall Study|Poor Compliance to Protocol|16
7315850|NCT00712673|11544223|FG000|Overall Study|Lost to Follow-up|1
7315851|NCT00712673|11544224|FG001|Overall Study|Lost to Follow-up|0
7315852|NCT00712673|11544225|FG002|Overall Study|Lost to Follow-up|2
7315853|NCT00712673|11544226|FG003|Overall Study|Lost to Follow-up|0
7315854|NCT00712673|11544223|FG000|Overall Study|Withdrawal by Subject|6
7315855|NCT00712673|11544224|FG001|Overall Study|Withdrawal by Subject|7
7315856|NCT00712673|11544225|FG002|Overall Study|Withdrawal by Subject|15
7315857|NCT00712673|11544226|FG003|Overall Study|Withdrawal by Subject|20
7315858|NCT00712673|11544223|FG000|Overall Study|Familial and Personal Reasons|5
7315859|NCT00712673|11544224|FG001|Overall Study|Familial and Personal Reasons|0
7315860|NCT00712673|11544225|FG002|Overall Study|Familial and Personal Reasons|5
7315861|NCT00712673|11544226|FG003|Overall Study|Familial and Personal Reasons|2
7315862|NCT00712673|11544223|FG000|Overall Study|Investigator's Decision|1
7315863|NCT00712673|11544224|FG001|Overall Study|Investigator's Decision|0
7315864|NCT00712673|11544225|FG002|Overall Study|Investigator's Decision|0
7315865|NCT00712673|11544226|FG003|Overall Study|Investigator's Decision|0
7315866|NCT00712673|11544223|FG000|Overall Study|Protocol Violation|0
7315867|NCT00712673|11544224|FG001|Overall Study|Protocol Violation|0
7315868|NCT00712673|11544225|FG002|Overall Study|Protocol Violation|2
7315869|NCT00712673|11544226|FG003|Overall Study|Protocol Violation|0
7315870|NCT00712712|11544245|FG000|Overall Study|Protocol Violation|11
7315871|NCT00712712|11544245|FG000|Overall Study|Radiofrequency not done|3
7315872|NCT00712712|11544245|FG000|Overall Study|Death|8
7315873|NCT00712712|11544245|FG000|Overall Study|Withdrawal by Subject|1
7315874|NCT00712725|11544257|FG000|Overall Study|Adverse Event|1
7315875|NCT00712725|11544258|FG001|Overall Study|Adverse Event|0
7315876|NCT00712725|11544259|FG002|Overall Study|Adverse Event|0
7315877|NCT00712725|11544260|FG003|Overall Study|Adverse Event|1
7315878|NCT00712725|11544261|FG004|Overall Study|Adverse Event|0
7315879|NCT00712725|11544262|FG005|Overall Study|Adverse Event|0
7315880|NCT00712725|11544263|FG006|Overall Study|Adverse Event|0
7315881|NCT00712725|11544264|FG007|Overall Study|Adverse Event|0
7315882|NCT00712725|11544257|FG000|Overall Study|Lost to Follow-up|3
7315883|NCT00712725|11544258|FG001|Overall Study|Lost to Follow-up|2
7315884|NCT00712725|11544259|FG002|Overall Study|Lost to Follow-up|1
7315885|NCT00712725|11544260|FG003|Overall Study|Lost to Follow-up|1
7315886|NCT00712725|11544261|FG004|Overall Study|Lost to Follow-up|2
7315887|NCT00712725|11544262|FG005|Overall Study|Lost to Follow-up|2
7315888|NCT00712725|11544263|FG006|Overall Study|Lost to Follow-up|3
7315889|NCT00712725|11544264|FG007|Overall Study|Lost to Follow-up|1
7315890|NCT00712725|11544257|FG000|Overall Study|Physician Decision|2
7315891|NCT00712725|11544258|FG001|Overall Study|Physician Decision|0
7315892|NCT00712725|11544259|FG002|Overall Study|Physician Decision|0
7315893|NCT00712725|11544260|FG003|Overall Study|Physician Decision|0
7315894|NCT00712725|11544261|FG004|Overall Study|Physician Decision|1
7315895|NCT00712725|11544262|FG005|Overall Study|Physician Decision|0
7315896|NCT00712725|11544263|FG006|Overall Study|Physician Decision|2
7315898|NCT00712725|11544257|FG000|Overall Study|Pregnancy|0
7315899|NCT00712725|11544258|FG001|Overall Study|Pregnancy|1
7315900|NCT00712725|11544259|FG002|Overall Study|Pregnancy|0
7315901|NCT00712725|11544260|FG003|Overall Study|Pregnancy|0
7315902|NCT00712725|11544261|FG004|Overall Study|Pregnancy|1
7315903|NCT00712725|11544262|FG005|Overall Study|Pregnancy|0
7315904|NCT00712725|11544263|FG006|Overall Study|Pregnancy|2
7315905|NCT00712725|11544264|FG007|Overall Study|Pregnancy|0
7315906|NCT00712725|11544257|FG000|Overall Study|Protocol Violation|2
7315907|NCT00712725|11544258|FG001|Overall Study|Protocol Violation|0
7315908|NCT00712725|11544259|FG002|Overall Study|Protocol Violation|1
7315909|NCT00712725|11544260|FG003|Overall Study|Protocol Violation|3
7315910|NCT00712725|11544261|FG004|Overall Study|Protocol Violation|2
7315911|NCT00712725|11544262|FG005|Overall Study|Protocol Violation|0
7315912|NCT00712725|11544263|FG006|Overall Study|Protocol Violation|1
7315913|NCT00712725|11544264|FG007|Overall Study|Protocol Violation|1
7315914|NCT00712725|11544257|FG000|Overall Study|Withdrawal by Subject|2
7315915|NCT00712725|11544258|FG001|Overall Study|Withdrawal by Subject|1
7315916|NCT00712725|11544259|FG002|Overall Study|Withdrawal by Subject|1
7315917|NCT00712725|11544260|FG003|Overall Study|Withdrawal by Subject|2
7315918|NCT00712725|11544261|FG004|Overall Study|Withdrawal by Subject|1
7315919|NCT00712725|11544262|FG005|Overall Study|Withdrawal by Subject|1
7315920|NCT00712725|11544263|FG006|Overall Study|Withdrawal by Subject|1
7315921|NCT00712725|11544264|FG007|Overall Study|Withdrawal by Subject|2
7315922|NCT00712725|11544257|FG000|Overall Study|Lack of Qualifying Event|16
7315923|NCT00712725|11544258|FG001|Overall Study|Lack of Qualifying Event|2
7315924|NCT00712725|11544259|FG002|Overall Study|Lack of Qualifying Event|6
7315925|NCT00712725|11544260|FG003|Overall Study|Lack of Qualifying Event|8
7315926|NCT00712725|11544261|FG004|Overall Study|Lack of Qualifying Event|11
7315927|NCT00712725|11544262|FG005|Overall Study|Lack of Qualifying Event|13
7315928|NCT00712725|11544263|FG006|Overall Study|Lack of Qualifying Event|11
7315929|NCT00712725|11544264|FG007|Overall Study|Lack of Qualifying Event|6
7315930|NCT00712725|11544257|FG000|Overall Study|Protocol Specified Criteria|3
7315931|NCT00712725|11544258|FG001|Overall Study|Protocol Specified Criteria|0
7315932|NCT00712725|11544259|FG002|Overall Study|Protocol Specified Criteria|1
7315933|NCT00712725|11544260|FG003|Overall Study|Protocol Specified Criteria|2
7315934|NCT00712725|11544261|FG004|Overall Study|Protocol Specified Criteria|1
7315935|NCT00712725|11544262|FG005|Overall Study|Protocol Specified Criteria|0
7315936|NCT00712725|11544263|FG006|Overall Study|Protocol Specified Criteria|2
7315937|NCT00712725|11544264|FG007|Overall Study|Protocol Specified Criteria|1
7315938|NCT00712920|11544285|FG000|Overall Study|Adverse Event|3
7315939|NCT00712920|11544286|FG001|Overall Study|Adverse Event|4
7315940|NCT00712920|11544287|FG002|Overall Study|Adverse Event|7
7315941|NCT00712920|11544285|FG000|Overall Study|Withdrawal by Subject|4
7315942|NCT00712920|11544286|FG001|Overall Study|Withdrawal by Subject|2
7315943|NCT00712920|11544287|FG002|Overall Study|Withdrawal by Subject|1
7315944|NCT00712920|11544285|FG000|Overall Study|Lost to Follow-up|1
7315945|NCT00712920|11544286|FG001|Overall Study|Lost to Follow-up|4
7315946|NCT00712920|11544287|FG002|Overall Study|Lost to Follow-up|0
7315947|NCT00712920|11544285|FG000|Overall Study|Lack of Efficacy|1
7315948|NCT00712920|11544286|FG001|Overall Study|Lack of Efficacy|0
7315949|NCT00712920|11544287|FG002|Overall Study|Lack of Efficacy|1
7315950|NCT00712920|11544285|FG000|Overall Study|Other|5
7315951|NCT00712920|11544286|FG001|Overall Study|Other|7
7315952|NCT00712920|11544287|FG002|Overall Study|Other|3
7315953|NCT00712920|11544285|FG000|Overall Study|Non-compliance|3
7315954|NCT00712920|11544286|FG001|Overall Study|Non-compliance|0
7315955|NCT00712920|11544287|FG002|Overall Study|Non-compliance|0
7315956|NCT00712959|11544297|FG000|Overall Study|Protocol Violation|3
7315957|NCT00712959|11544298|FG001|Overall Study|Protocol Violation|1
7315958|NCT00712959|11544297|FG000|Overall Study|Lost to Follow-up|13
7315959|NCT00712959|11544298|FG001|Overall Study|Lost to Follow-up|2
7315960|NCT00712959|11544297|FG000|Overall Study|Withdrawal by Subject|3
7315961|NCT00712959|11544298|FG001|Overall Study|Withdrawal by Subject|0
7315962|NCT00712985|11544304|FG000|Overall Study|1 withdrew prior to start of drug|1
7315963|NCT00712985|11544304|FG000|Overall Study|1 patient moved out of state|1
7315964|NCT00712985|11544304|FG000|Overall Study|Lack of Efficacy|3
7315965|NCT00713219|11544308|FG000|Overall Study|Death|1
7315966|NCT00713219|11544308|FG000|Overall Study|Protocol Violation|1
7315967|NCT00713310|11544318|FG000|Overall Study|Adverse Event|5
7315968|NCT00713310|11544319|FG001|Overall Study|Adverse Event|2
7315969|NCT00713310|11544318|FG000|Overall Study|Lack of Efficacy|0
7315970|NCT00713310|11544319|FG001|Overall Study|Lack of Efficacy|2
7315971|NCT00713310|11544318|FG000|Overall Study|Withdrawal by Subject|0
7315972|NCT00713310|11544319|FG001|Overall Study|Withdrawal by Subject|2
7315973|NCT00713323|11544325|FG000|Overall Study|Adverse Event|75
7315974|NCT00713323|11544325|FG000|Overall Study|Withdrawal by Subject|15
7315975|NCT00713323|11544325|FG000|Overall Study|Lost to Follow-up|11
7315976|NCT00713323|11544325|FG000|Overall Study|Lack of Efficacy|36
7315977|NCT00713323|11544325|FG000|Overall Study|Low creatine clearance at screening|1
7315978|NCT00713323|11544325|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
7315979|NCT00713323|11544325|FG000|Overall Study|Surgery cured allodynic pain|1
7315980|NCT00713323|11544325|FG000|Overall Study|Pain free|1
7315981|NCT00713323|11544325|FG000|Overall Study|Non-compliance|1
7315982|NCT00713323|11544325|FG000|Overall Study|Pain resolved|1
7315983|NCT00713323|11544325|FG000|Overall Study|Subject travelling to USA|1
7315984|NCT00713323|11544325|FG000|Overall Study|Subject travelling to Dominica Republic|1
7315985|NCT00713323|11544325|FG000|Overall Study|Treatment that may interact with Sativex|1
7315986|NCT00713349|11544329|FG000|Overall Study|Protocol Violation|1
7384465|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
7384466|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
7384467|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
7384468|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Other|0
7384469|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Other|1
7384470|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Other|0
7384471|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Other|0
7384472|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Adverse Event|28
7384473|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Adverse Event|40
7384474|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Adverse Event|0
7384475|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Adverse Event|0
7384476|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
7384477|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
7384478|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7384479|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
7384480|NCT01194414|11641625|FG000|24 Weeks Double Blind Period|Death|0
7384481|NCT01194414|11641626|FG001|24 Weeks Double Blind Period|Death|1
7384482|NCT01194414|11641627|FG002|24 Weeks Double Blind Period|Death|0
7384483|NCT01194414|11641628|FG003|24 Weeks Double Blind Period|Death|0
7384484|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
7384485|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
7384486|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
7384487|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
7384488|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
7384489|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
7384490|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
7384491|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
7384492|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
7384493|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
7384494|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
7384495|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
7384496|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
7384497|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
7384498|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
7384499|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
7384500|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
7384501|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
7384502|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7384503|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
7384504|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Pregnancy|1
7384505|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Pregnancy|3
7384506|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Pregnancy|1
7384507|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Pregnancy|1
7384508|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Other|2
7384509|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Other|1
7384510|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Other|0
7384511|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Other|0
7384512|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Protocol Violation|0
7384513|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Protocol Violation|0
7384514|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Protocol Violation|0
7384515|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Protocol Violation|1
7384516|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Adverse Event|35
7384517|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Adverse Event|21
7384518|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Adverse Event|2
7384519|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Adverse Event|12
7384520|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7384521|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
7384522|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7384523|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
7384524|NCT01194414|11641625|FG000|72 Weeks Open Label Extension|Death|1
7384525|NCT01194414|11641626|FG001|72 Weeks Open Label Extension|Death|2
7384526|NCT01194414|11641627|FG002|72 Weeks Open Label Extension|Death|0
7384527|NCT01194414|11641628|FG003|72 Weeks Open Label Extension|Death|2
7384528|NCT01194440|11641640|FG000|Baseline (First Dose)|Reason not specified|4
7384529|NCT01194440|11641640|FG000|Baseline (First Dose)|Lack of Efficacy|1
7384530|NCT01194440|11641640|FG000|Baseline (First Dose)|Change in therapy|1
7384531|NCT01194440|11641640|FG000|Baseline (First Dose)|Adverse Event|1
7384532|NCT01194440|11641640|FG000|6-months (2nd Dose)|Change in therapy|4
7384533|NCT01194531|11641681|FG000|Overall Study|Withdrawal by Subject|1
7384534|NCT01194531|11641682|FG001|Overall Study|Withdrawal by Subject|0
7384535|NCT01194531|11641681|FG000|Overall Study|Protocol Violation|4
7315987|NCT00713544|11544354|FG000|Overall Study|Adverse Event|5
7315988|NCT00713544|11544355|FG001|Overall Study|Adverse Event|3
7315989|NCT00713544|11544356|FG002|Overall Study|Adverse Event|7
7315990|NCT00713544|11544357|FG003|Overall Study|Adverse Event|7
7315991|NCT00713544|11544358|FG004|Overall Study|Adverse Event|3
7315992|NCT00713544|11544359|FG005|Overall Study|Adverse Event|5
7315993|NCT00713544|11544354|FG000|Overall Study|Withdrawal by Subject|2
7315994|NCT00713544|11544355|FG001|Overall Study|Withdrawal by Subject|0
7315995|NCT00713544|11544356|FG002|Overall Study|Withdrawal by Subject|3
7315996|NCT00713544|11544357|FG003|Overall Study|Withdrawal by Subject|2
7315997|NCT00713544|11544358|FG004|Overall Study|Withdrawal by Subject|3
7315998|NCT00713544|11544359|FG005|Overall Study|Withdrawal by Subject|1
7315999|NCT00713544|11544354|FG000|Overall Study|Protocol Violation|0
7316000|NCT00713544|11544355|FG001|Overall Study|Protocol Violation|0
7316001|NCT00713544|11544356|FG002|Overall Study|Protocol Violation|0
7316002|NCT00713544|11544357|FG003|Overall Study|Protocol Violation|0
7316003|NCT00713544|11544358|FG004|Overall Study|Protocol Violation|0
7316004|NCT00713544|11544359|FG005|Overall Study|Protocol Violation|1
7316005|NCT00713544|11544354|FG000|Overall Study|Physician Decision|0
7316006|NCT00713544|11544355|FG001|Overall Study|Physician Decision|0
7316007|NCT00713544|11544356|FG002|Overall Study|Physician Decision|0
7316008|NCT00713544|11544357|FG003|Overall Study|Physician Decision|0
7316009|NCT00713544|11544358|FG004|Overall Study|Physician Decision|0
7316010|NCT00713544|11544359|FG005|Overall Study|Physician Decision|2
7316011|NCT00713544|11544354|FG000|Overall Study|Lack of Efficacy|0
7316012|NCT00713544|11544355|FG001|Overall Study|Lack of Efficacy|1
7316013|NCT00713544|11544356|FG002|Overall Study|Lack of Efficacy|0
7316014|NCT00713544|11544357|FG003|Overall Study|Lack of Efficacy|1
7316015|NCT00713544|11544358|FG004|Overall Study|Lack of Efficacy|1
7316016|NCT00713544|11544359|FG005|Overall Study|Lack of Efficacy|0
7316017|NCT00713544|11544354|FG000|Overall Study|Lost to Follow-up|0
7316018|NCT00713544|11544355|FG001|Overall Study|Lost to Follow-up|0
7316019|NCT00713544|11544356|FG002|Overall Study|Lost to Follow-up|1
7316020|NCT00713544|11544357|FG003|Overall Study|Lost to Follow-up|0
7316021|NCT00713544|11544358|FG004|Overall Study|Lost to Follow-up|0
7316022|NCT00713544|11544359|FG005|Overall Study|Lost to Follow-up|0
7316023|NCT00713544|11544354|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
7316024|NCT00713544|11544355|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
7316025|NCT00713544|11544356|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
7316026|NCT00713544|11544357|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
7316027|NCT00713544|11544358|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
7316028|NCT00713544|11544359|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
7316029|NCT00713544|11544354|FG000|Overall Study|Incorrect enrollment|0
7316030|NCT00713544|11544355|FG001|Overall Study|Incorrect enrollment|1
7316031|NCT00713544|11544356|FG002|Overall Study|Incorrect enrollment|0
7316032|NCT00713544|11544357|FG003|Overall Study|Incorrect enrollment|0
7316033|NCT00713544|11544358|FG004|Overall Study|Incorrect enrollment|0
7316034|NCT00713544|11544359|FG005|Overall Study|Incorrect enrollment|0
7316035|NCT00713544|11544354|FG000|Overall Study|Hepatotoxicity - not an AE|0
7316036|NCT00713544|11544355|FG001|Overall Study|Hepatotoxicity - not an AE|0
7316037|NCT00713544|11544356|FG002|Overall Study|Hepatotoxicity - not an AE|0
7316038|NCT00713544|11544357|FG003|Overall Study|Hepatotoxicity - not an AE|0
7316039|NCT00713544|11544358|FG004|Overall Study|Hepatotoxicity - not an AE|1
7316040|NCT00713544|11544359|FG005|Overall Study|Hepatotoxicity - not an AE|0
7316041|NCT00713609|11544388|FG000|Overall Study|Adverse Event|2
7316042|NCT00713609|11544389|FG001|Overall Study|Adverse Event|0
7316043|NCT00713609|11544390|FG002|Overall Study|Adverse Event|2
7316044|NCT00713609|11544391|FG003|Overall Study|Adverse Event|2
7316045|NCT00713609|11544392|FG004|Overall Study|Adverse Event|3
7316046|NCT00713609|11544393|FG005|Overall Study|Adverse Event|1
7316047|NCT00713609|11544388|FG000|Overall Study|Lost to Follow-up|5
7316048|NCT00713609|11544389|FG001|Overall Study|Lost to Follow-up|7
7316049|NCT00713609|11544390|FG002|Overall Study|Lost to Follow-up|5
7316050|NCT00713609|11544391|FG003|Overall Study|Lost to Follow-up|5
7316051|NCT00713609|11544392|FG004|Overall Study|Lost to Follow-up|7
7316052|NCT00713609|11544393|FG005|Overall Study|Lost to Follow-up|0
7316053|NCT00713609|11544388|FG000|Overall Study|Lack of Efficacy|1
7316054|NCT00713609|11544389|FG001|Overall Study|Lack of Efficacy|3
7316055|NCT00713609|11544390|FG002|Overall Study|Lack of Efficacy|0
7316056|NCT00713609|11544391|FG003|Overall Study|Lack of Efficacy|0
7316057|NCT00713609|11544392|FG004|Overall Study|Lack of Efficacy|1
7316058|NCT00713609|11544393|FG005|Overall Study|Lack of Efficacy|0
7316059|NCT00713609|11544388|FG000|Overall Study|Non-Compliance with Study Treatment|1
7316060|NCT00713609|11544389|FG001|Overall Study|Non-Compliance with Study Treatment|1
7316061|NCT00713609|11544390|FG002|Overall Study|Non-Compliance with Study Treatment|2
7316062|NCT00713609|11544391|FG003|Overall Study|Non-Compliance with Study Treatment|0
7316063|NCT00713609|11544392|FG004|Overall Study|Non-Compliance with Study Treatment|1
7316064|NCT00713609|11544393|FG005|Overall Study|Non-Compliance with Study Treatment|0
7316065|NCT00713609|11544388|FG000|Overall Study|Withdrawal by Subject|6
7316066|NCT00713609|11544389|FG001|Overall Study|Withdrawal by Subject|1
7316067|NCT00713609|11544390|FG002|Overall Study|Withdrawal by Subject|5
7316068|NCT00713609|11544391|FG003|Overall Study|Withdrawal by Subject|1
7316069|NCT00713609|11544392|FG004|Overall Study|Withdrawal by Subject|5
7316070|NCT00713609|11544393|FG005|Overall Study|Withdrawal by Subject|7
7316071|NCT00713609|11544388|FG000|Overall Study|Protocol Violation|6
7316072|NCT00713609|11544389|FG001|Overall Study|Protocol Violation|3
7316073|NCT00713609|11544390|FG002|Overall Study|Protocol Violation|1
7316074|NCT00713609|11544391|FG003|Overall Study|Protocol Violation|1
7316075|NCT00713609|11544392|FG004|Overall Study|Protocol Violation|2
7316076|NCT00713609|11544393|FG005|Overall Study|Protocol Violation|0
7316077|NCT00713648|11544407|FG000|Overall Study|Adverse Event|1
7316078|NCT00713648|11544407|FG000|Overall Study|Unclassified|2
7316079|NCT00713648|11544407|FG000|Overall Study|According to Protocol|2
7316080|NCT00713648|11544407|FG000|Overall Study|Development of antibodies|3
7316081|NCT00713700|11544428|FG000|Overall Study|Lost to Follow-up|3
7316082|NCT00713700|11544428|FG000|Overall Study|Withdrawal by Subject|1
7316083|NCT00713830|11544443|FG000|Overall Study|Adverse Event|23
7316084|NCT00713830|11544444|FG001|Overall Study|Adverse Event|71
7316085|NCT00713830|11544443|FG000|Overall Study|Lack of Efficacy|24
7316086|NCT00713830|11544444|FG001|Overall Study|Lack of Efficacy|16
7316087|NCT00713830|11544443|FG000|Overall Study|Lost to Follow-up|2
7316088|NCT00713830|11544444|FG001|Overall Study|Lost to Follow-up|9
7316089|NCT00713830|11544443|FG000|Overall Study|Withdrawal by Subject|13
7316090|NCT00713830|11544444|FG001|Overall Study|Withdrawal by Subject|23
7316091|NCT00713830|11544443|FG000|Overall Study|Poor Compliance to Protocol|7
7316092|NCT00713830|11544444|FG001|Overall Study|Poor Compliance to Protocol|14
7316093|NCT00713830|11544443|FG000|Overall Study|Familial and Personal Reasons|9
7316094|NCT00713830|11544444|FG001|Overall Study|Familial and Personal Reasons|34
7316095|NCT00713830|11544443|FG000|Overall Study|Sponsor Decision|4
7316096|NCT00713830|11544444|FG001|Overall Study|Sponsor Decision|10
7316097|NCT00714051|11544452|FG000|Overall Study|Withdrawal by Subject|1
7316098|NCT00714051|11544453|FG001|Overall Study|Withdrawal by Subject|0
7316099|NCT00714051|11544452|FG000|Overall Study|Death|0
7316100|NCT00714051|11544453|FG001|Overall Study|Death|1
7316101|NCT00714168|11544461|FG000|Overall Study|Pregnancy|5
7316102|NCT00714168|11544462|FG001|Overall Study|Pregnancy|4
7316103|NCT00714168|11544461|FG000|Overall Study|Lost to Follow-up|32
7316104|NCT00714168|11544462|FG001|Overall Study|Lost to Follow-up|50
7316105|NCT00714168|11544461|FG000|Overall Study|Relocation|4
7316106|NCT00714168|11544462|FG001|Overall Study|Relocation|3
7316107|NCT00714168|11544461|FG000|Overall Study|Non-study medical condition|3
7316108|NCT00714168|11544462|FG001|Overall Study|Non-study medical condition|2
7316109|NCT00714259|11544490|FG000|Overall Study|Death|2
7316110|NCT00714285|11544507|FG000|Overall Study|Lost to Follow-up|0
7316111|NCT00714285|11544508|FG001|Overall Study|Lost to Follow-up|2
7316112|NCT00714285|11544509|FG002|Overall Study|Lost to Follow-up|0
7316113|NCT00714285|11544510|FG003|Overall Study|Lost to Follow-up|1
7316114|NCT00714285|11544507|FG000|Overall Study|Migrated/moved from study area|0
7316115|NCT00714285|11544508|FG001|Overall Study|Migrated/moved from study area|1
7316116|NCT00714285|11544509|FG002|Overall Study|Migrated/moved from study area|0
7316117|NCT00714285|11544510|FG003|Overall Study|Migrated/moved from study area|0
7316118|NCT00714415|11544537|FG000|Overall Study|Lack of Efficacy|1
7316119|NCT00714415|11544538|FG001|Overall Study|Lack of Efficacy|0
7316120|NCT00714415|11544537|FG000|Overall Study|Death|1
7316121|NCT00714415|11544538|FG001|Overall Study|Death|0
7316122|NCT00714493|11544544|FG000|Overall Study|Adverse Event|11
7316123|NCT00714493|11544544|FG000|Overall Study|Death|3
7316124|NCT00714493|11544544|FG000|Overall Study|Lack of Efficacy|10
7316125|NCT00714493|11544544|FG000|Overall Study|Lost to Follow-up|3
7316126|NCT00714493|11544544|FG000|Overall Study|Protocol Violation|12
7316127|NCT00714493|11544544|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
7316128|NCT00714493|11544544|FG000|Overall Study|OTHER|2
7316129|NCT00714688|11544576|FG000|Overall Study|Lack of Efficacy|14
7316130|NCT00714688|11544577|FG001|Overall Study|Lack of Efficacy|1
7316131|NCT00714688|11544578|FG002|Overall Study|Lack of Efficacy|4
7316132|NCT00714688|11544576|FG000|Overall Study|Withdrawal by Subject|4
7316133|NCT00714688|11544577|FG001|Overall Study|Withdrawal by Subject|3
7316134|NCT00714688|11544578|FG002|Overall Study|Withdrawal by Subject|3
7316135|NCT00714688|11544576|FG000|Overall Study|Lost to Follow-up|5
7316136|NCT00714688|11544577|FG001|Overall Study|Lost to Follow-up|2
7316137|NCT00714688|11544578|FG002|Overall Study|Lost to Follow-up|0
7316138|NCT00714688|11544576|FG000|Overall Study|Adverse Event|2
7316139|NCT00714688|11544577|FG001|Overall Study|Adverse Event|15
7316140|NCT00714688|11544578|FG002|Overall Study|Adverse Event|19
7316141|NCT00714688|11544576|FG000|Overall Study|Subject Non-compliant|3
7391863|NCT01248364|11652717|FG001|Overall Study|Adverse Event|1
7316142|NCT00714688|11544577|FG001|Overall Study|Subject Non-compliant|5
7316143|NCT00714688|11544578|FG002|Overall Study|Subject Non-compliant|5
7316144|NCT00714688|11544576|FG000|Overall Study|Ineligible to Continue the Study|0
7316145|NCT00714688|11544577|FG001|Overall Study|Ineligible to Continue the Study|1
7316146|NCT00714688|11544578|FG002|Overall Study|Ineligible to Continue the Study|1
7316147|NCT00714688|11544576|FG000|Overall Study|Sponsor's Decision|0
7316148|NCT00714688|11544577|FG001|Overall Study|Sponsor's Decision|2
7316149|NCT00714688|11544578|FG002|Overall Study|Sponsor's Decision|0
7316150|NCT00714688|11544576|FG000|Overall Study|Other|1
7316151|NCT00714688|11544577|FG001|Overall Study|Other|6
7316152|NCT00714688|11544578|FG002|Overall Study|Other|5
7316153|NCT00714714|11544586|FG000|Overall Study|Adverse Event|1
7316154|NCT00714870|11544607|FG000|Overall Study|Lost to Follow-up|22
7316155|NCT00714870|11544608|FG001|Overall Study|Lost to Follow-up|5
7316156|NCT00714870|11544607|FG000|Overall Study|patient unable to come b/c back pain|1
7316157|NCT00714870|11544608|FG001|Overall Study|patient unable to come b/c back pain|0
7316158|NCT00714870|11544607|FG000|Overall Study|did not attend minimum of 4 sessions|4
7316159|NCT00714870|11544608|FG001|Overall Study|did not attend minimum of 4 sessions|0
7316160|NCT00715026|11544614|FG000|Overall Study|Withdrawal by Subject|5
7316161|NCT00715026|11544614|FG000|Overall Study|Lost to Follow-up|3
7316162|NCT00715026|11544614|FG000|Overall Study|Protocol Violation|1
7316163|NCT00715026|11544614|FG000|Overall Study|Surgery done on non-study consented hip|1
7316164|NCT00715078|11544621|FG000|Overall Study|Death|29
7316165|NCT00715078|11544622|FG001|Overall Study|Death|36
7316166|NCT00715078|11544623|FG002|Overall Study|Death|36
7316167|NCT00715078|11544621|FG000|Overall Study|Withdrawal by Subject|1
7316168|NCT00715078|11544622|FG001|Overall Study|Withdrawal by Subject|0
7316169|NCT00715078|11544623|FG002|Overall Study|Withdrawal by Subject|1
7316170|NCT00715078|11544621|FG000|Overall Study|Unable to start due to disease prog.|0
7316171|NCT00715078|11544622|FG001|Overall Study|Unable to start due to disease prog.|0
7316172|NCT00715078|11544623|FG002|Overall Study|Unable to start due to disease prog.|1
7316173|NCT00715117|11544680|FG000|Overall Study|Crohn's flare and rescue with steroids|0
7316174|NCT00715117|11544681|FG001|Overall Study|Crohn's flare and rescue with steroids|1
7316175|NCT00715208|11544694|FG000|Overall Study|Withdrawal by Subject|1
7316176|NCT00715208|11544695|FG001|Overall Study|Withdrawal by Subject|1
7316177|NCT00715208|11544694|FG000|Overall Study|Adverse Event|0
7316178|NCT00715208|11544695|FG001|Overall Study|Adverse Event|6
7316179|NCT00715208|11544694|FG000|Overall Study|Lack of Efficacy|0
7316180|NCT00715208|11544695|FG001|Overall Study|Lack of Efficacy|2
7316181|NCT00715299|11544701|FG000|Overall Study|Withdrawal by Subject|1
7316182|NCT00715299|11544701|FG000|Overall Study|Adverse Event|3
7316183|NCT00715299|11544701|FG000|Overall Study|failed the pre-screen exercise test|2
7316184|NCT00715403|11544716|FG000|Overall Study|Progressive disease|0
7316185|NCT00715403|11544717|FG001|Overall Study|Progressive disease|1
7316186|NCT00715403|11544718|FG002|Overall Study|Progressive disease|3
7316187|NCT00715403|11544719|FG003|Overall Study|Progressive disease|9
7316188|NCT00715403|11544720|FG004|Overall Study|Progressive disease|5
7316189|NCT00715403|11544721|FG005|Overall Study|Progressive disease|14
7316190|NCT00715403|11544722|FG006|Overall Study|Progressive disease|1
7316191|NCT00715403|11544716|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
7316192|NCT00715403|11544717|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
7316193|NCT00715403|11544718|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
7316194|NCT00715403|11544719|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
7316195|NCT00715403|11544720|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
7316196|NCT00715403|11544721|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
7316197|NCT00715403|11544722|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
7316198|NCT00715403|11544716|FG000|Overall Study|Other Adverse Event than DLT|1
7316199|NCT00715403|11544717|FG001|Overall Study|Other Adverse Event than DLT|0
7316200|NCT00715403|11544718|FG002|Overall Study|Other Adverse Event than DLT|0
7316201|NCT00715403|11544719|FG003|Overall Study|Other Adverse Event than DLT|0
7316202|NCT00715403|11544720|FG004|Overall Study|Other Adverse Event than DLT|0
7316203|NCT00715403|11544721|FG005|Overall Study|Other Adverse Event than DLT|2
7316204|NCT00715403|11544722|FG006|Overall Study|Other Adverse Event than DLT|0
7316205|NCT00715403|11544716|FG000|Overall Study|Protocol Violation|0
7316206|NCT00715403|11544717|FG001|Overall Study|Protocol Violation|0
7316207|NCT00715403|11544718|FG002|Overall Study|Protocol Violation|0
7316208|NCT00715403|11544719|FG003|Overall Study|Protocol Violation|0
7316209|NCT00715403|11544720|FG004|Overall Study|Protocol Violation|0
7316210|NCT00715403|11544721|FG005|Overall Study|Protocol Violation|1
7316211|NCT00715403|11544722|FG006|Overall Study|Protocol Violation|0
7316212|NCT00715403|11544716|FG000|Overall Study|Other reason not defined above|0
7316213|NCT00715403|11544717|FG001|Overall Study|Other reason not defined above|0
7316214|NCT00715403|11544718|FG002|Overall Study|Other reason not defined above|1
7316215|NCT00715403|11544719|FG003|Overall Study|Other reason not defined above|0
7316216|NCT00715403|11544720|FG004|Overall Study|Other reason not defined above|1
7316217|NCT00715403|11544721|FG005|Overall Study|Other reason not defined above|1
7316218|NCT00715403|11544722|FG006|Overall Study|Other reason not defined above|0
7316219|NCT00715429|11544740|FG000|Overall Study|Did not complete the study diary|0
7316220|NCT00715429|11544741|FG001|Overall Study|Did not complete the study diary|1
7316221|NCT00715520|11544750|FG000|Overall Study|Screen failure|8
7316222|NCT00715520|11544751|FG001|Overall Study|Screen failure|1
7316223|NCT00715520|11544752|FG002|Overall Study|Screen failure|1
7316224|NCT00715520|11544750|FG000|Overall Study|Withdrawal by Subject|2
7316225|NCT00715520|11544751|FG001|Overall Study|Withdrawal by Subject|0
7316226|NCT00715520|11544752|FG002|Overall Study|Withdrawal by Subject|1
7316227|NCT00715559|11544760|FG000|Overall Study|medication not tolerated - nausea|1
7316228|NCT00715624|11544766|FG000|Overall Study|Adverse Event|12
7316229|NCT00715624|11544767|FG001|Overall Study|Adverse Event|37
7316230|NCT00715624|11544766|FG000|Overall Study|Lack of Efficacy|11
7316231|NCT00715624|11544767|FG001|Overall Study|Lack of Efficacy|11
7316232|NCT00715624|11544766|FG000|Overall Study|Lost to Follow-up|1
7316233|NCT00715624|11544767|FG001|Overall Study|Lost to Follow-up|2
7316234|NCT00715624|11544766|FG000|Overall Study|Protocol Violation|1
7316235|NCT00715624|11544767|FG001|Overall Study|Protocol Violation|0
7316236|NCT00715624|11544766|FG000|Overall Study|Withdrawal by Subject|11
7316237|NCT00715624|11544767|FG001|Overall Study|Withdrawal by Subject|25
7316238|NCT00715624|11544766|FG000|Overall Study|Familial and personal reasons|10
7316239|NCT00715624|11544767|FG001|Overall Study|Familial and personal reasons|22
7316240|NCT00715624|11544766|FG000|Overall Study|Poor compliance|6
7316241|NCT00715624|11544767|FG001|Overall Study|Poor compliance|13
7316242|NCT00715624|11544766|FG000|Overall Study|Sponsor decision|0
7316243|NCT00715624|11544767|FG001|Overall Study|Sponsor decision|4
7316244|NCT00715624|11544766|FG000|Overall Study|Incorrect randomization (not treated)|0
7316245|NCT00715624|11544767|FG001|Overall Study|Incorrect randomization (not treated)|1
7316246|NCT00715624|11544766|FG000|Overall Study|Other|0
7316247|NCT00715624|11544767|FG001|Overall Study|Other|1
7316248|NCT00715676|11544785|FG000|Overall Study|Adverse Event|3
7316249|NCT00715676|11544786|FG001|Overall Study|Adverse Event|5
7316250|NCT00715676|11544787|FG002|Overall Study|Adverse Event|21
7316251|NCT00715676|11544785|FG000|Overall Study|Withdrawal by Subject|1
7316252|NCT00715676|11544786|FG001|Overall Study|Withdrawal by Subject|3
7316253|NCT00715676|11544787|FG002|Overall Study|Withdrawal by Subject|8
7316254|NCT00715676|11544785|FG000|Overall Study|Lost to Follow-up|1
7316255|NCT00715676|11544786|FG001|Overall Study|Lost to Follow-up|2
7316256|NCT00715676|11544787|FG002|Overall Study|Lost to Follow-up|1
7316257|NCT00715676|11544785|FG000|Overall Study|Terminated by Sponsor|1
7316258|NCT00715676|11544786|FG001|Overall Study|Terminated by Sponsor|0
7316259|NCT00715676|11544787|FG002|Overall Study|Terminated by Sponsor|0
7316260|NCT00715676|11544785|FG000|Overall Study|Did Not Meet Entry Criteria|0
7316261|NCT00715676|11544786|FG001|Overall Study|Did Not Meet Entry Criteria|0
7316262|NCT00715676|11544787|FG002|Overall Study|Did Not Meet Entry Criteria|1
7316263|NCT00715676|11544785|FG000|Overall Study|Use of Exclusionary Medication|0
7316264|NCT00715676|11544786|FG001|Overall Study|Use of Exclusionary Medication|0
7316265|NCT00715676|11544787|FG002|Overall Study|Use of Exclusionary Medication|1
7316266|NCT00715676|11544785|FG000|Overall Study|Elevated Blood Glucose|0
7316267|NCT00715676|11544786|FG001|Overall Study|Elevated Blood Glucose|1
7316268|NCT00715676|11544787|FG002|Overall Study|Elevated Blood Glucose|0
7316269|NCT00715793|11544827|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
7316270|NCT00715793|11544828|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
7316271|NCT00715793|11544827|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
7316272|NCT00715793|11544828|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
7316273|NCT00715910|11544848|FG000|Booster and ESFU Phase|Lost to Follow-up|0
7316274|NCT00715910|11544849|FG001|Booster and ESFU Phase|Lost to Follow-up|0
7316275|NCT00715910|11544850|FG002|Booster and ESFU Phase|Lost to Follow-up|0
7316276|NCT00715910|11544851|FG003|Booster and ESFU Phase|Lost to Follow-up|6
7316277|NCT00715910|11544852|FG004|Booster and ESFU Phase|Lost to Follow-up|1
7316278|NCT00715910|11544853|FG005|Booster and ESFU Phase|Lost to Follow-up|13
7316279|NCT00715910|11544848|FG000|Booster and ESFU Phase|Other|0
7316280|NCT00715910|11544849|FG001|Booster and ESFU Phase|Other|0
7316281|NCT00715910|11544850|FG002|Booster and ESFU Phase|Other|0
7316282|NCT00715910|11544851|FG003|Booster and ESFU Phase|Other|5
7316283|NCT00715910|11544852|FG004|Booster and ESFU Phase|Other|1
7316284|NCT00715910|11544853|FG005|Booster and ESFU Phase|Other|0
7316285|NCT00715949|11544869|FG000|Overall Study|could not finish first test|4
7316286|NCT00716092|11544895|FG000|Overall Study|Other incl. Lack of Efficacy|2
7316287|NCT00716092|11544896|FG001|Overall Study|Other incl. Lack of Efficacy|1
7316288|NCT00716092|11544897|FG002|Overall Study|Other incl. Lack of Efficacy|0
7316289|NCT00716144|11544909|FG000|Overall Study|Withdrawal by Subject|4
7316290|NCT00716144|11544910|FG001|Overall Study|Withdrawal by Subject|2
7316291|NCT00716144|11544911|FG002|Overall Study|Withdrawal by Subject|6
7316292|NCT00716144|11544912|FG003|Overall Study|Withdrawal by Subject|6
7316293|NCT00716144|11544909|FG000|Overall Study|Lost to Follow-up|2
7316294|NCT00716144|11544910|FG001|Overall Study|Lost to Follow-up|2
7316295|NCT00716144|11544911|FG002|Overall Study|Lost to Follow-up|1
7316296|NCT00716144|11544912|FG003|Overall Study|Lost to Follow-up|2
7316297|NCT00716144|11544909|FG000|Overall Study|Adverse Event|0
7316298|NCT00716144|11544910|FG001|Overall Study|Adverse Event|0
7316299|NCT00716144|11544911|FG002|Overall Study|Adverse Event|0
7316300|NCT00716144|11544912|FG003|Overall Study|Adverse Event|2
7316301|NCT00716144|11544909|FG000|Overall Study|Non-compliance|1
7316302|NCT00716144|11544910|FG001|Overall Study|Non-compliance|0
7316303|NCT00716144|11544911|FG002|Overall Study|Non-compliance|0
7316304|NCT00716144|11544912|FG003|Overall Study|Non-compliance|0
7316305|NCT00716144|11544909|FG000|Overall Study|Protocol Violation|2
7316306|NCT00716144|11544910|FG001|Overall Study|Protocol Violation|0
7316307|NCT00716144|11544911|FG002|Overall Study|Protocol Violation|1
7316308|NCT00716144|11544912|FG003|Overall Study|Protocol Violation|0
7316309|NCT00716144|11544909|FG000|Overall Study|Physician Decision|0
7316310|NCT00716144|11544910|FG001|Overall Study|Physician Decision|1
7316311|NCT00716144|11544911|FG002|Overall Study|Physician Decision|2
7316312|NCT00716144|11544912|FG003|Overall Study|Physician Decision|2
7316313|NCT00716144|11544909|FG000|Overall Study|Intercurrent illness|0
7316314|NCT00716144|11544910|FG001|Overall Study|Intercurrent illness|0
7316315|NCT00716144|11544911|FG002|Overall Study|Intercurrent illness|1
7316316|NCT00716144|11544912|FG003|Overall Study|Intercurrent illness|0
7384536|NCT01194531|11641682|FG001|Overall Study|Protocol Violation|1
7316317|NCT00716144|11544909|FG000|Overall Study|Withdrew consent, allowed use of data|0
7316318|NCT00716144|11544910|FG001|Overall Study|Withdrew consent, allowed use of data|0
7316319|NCT00716144|11544911|FG002|Overall Study|Withdrew consent, allowed use of data|1
7316320|NCT00716144|11544912|FG003|Overall Study|Withdrew consent, allowed use of data|0
7316321|NCT00716144|11544909|FG000|Overall Study|Adverse event: left foot pain|0
7316322|NCT00716144|11544910|FG001|Overall Study|Adverse event: left foot pain|1
7316323|NCT00716144|11544911|FG002|Overall Study|Adverse event: left foot pain|0
7316324|NCT00716144|11544912|FG003|Overall Study|Adverse event: left foot pain|0
7316325|NCT00716144|11544909|FG000|Overall Study|Clinical Depression|0
7316326|NCT00716144|11544910|FG001|Overall Study|Clinical Depression|1
7316327|NCT00716144|11544911|FG002|Overall Study|Clinical Depression|0
7316328|NCT00716144|11544912|FG003|Overall Study|Clinical Depression|0
7316329|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
7316330|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7316331|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7316332|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7316333|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7316334|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
7316335|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Protocol Violation|0
7316336|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Protocol Violation|3
7316337|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Protocol Violation|0
7316338|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Protocol Violation|0
7316339|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Protocol Violation|0
7316340|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Protocol Violation|1
7316341|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
7316342|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
7316343|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
7316344|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
7316345|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
7316346|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
7316347|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Physician Decision|3
7316348|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Physician Decision|1
7316349|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Physician Decision|0
7316350|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Physician Decision|0
7316351|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Physician Decision|0
7316352|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Physician Decision|1
7316353|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7316354|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
7316355|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7316356|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7316357|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7316358|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
7316359|NCT00716274|11544925|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
7316360|NCT00716274|11544926|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
7316361|NCT00716274|11544927|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
7316362|NCT00716274|11544928|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
7316363|NCT00716274|11544929|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
7316364|NCT00716274|11544930|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
7316365|NCT00716274|11544925|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
7316366|NCT00716274|11544926|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
7316367|NCT00716274|11544927|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
7316368|NCT00716274|11544928|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
7316369|NCT00716274|11544929|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
7316370|NCT00716274|11544930|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
7316371|NCT00716274|11544925|FG000|Study Period III (16-Weeks)|Physician Decision|0
7316372|NCT00716274|11544926|FG001|Study Period III (16-Weeks)|Physician Decision|0
7316373|NCT00716274|11544927|FG002|Study Period III (16-Weeks)|Physician Decision|0
7316374|NCT00716274|11544928|FG003|Study Period III (16-Weeks)|Physician Decision|0
7316375|NCT00716274|11544929|FG004|Study Period III (16-Weeks)|Physician Decision|1
7316376|NCT00716274|11544930|FG005|Study Period III (16-Weeks)|Physician Decision|0
7316377|NCT00716274|11544925|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7316378|NCT00716274|11544926|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7316379|NCT00716274|11544927|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7316380|NCT00716274|11544928|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7316381|NCT00716274|11544929|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
7316382|NCT00716274|11544930|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
7316383|NCT00716274|11544925|FG000|Study Period III (16-Weeks)|Adverse Event|0
7316384|NCT00716274|11544926|FG001|Study Period III (16-Weeks)|Adverse Event|0
7316385|NCT00716274|11544927|FG002|Study Period III (16-Weeks)|Adverse Event|0
7316386|NCT00716274|11544928|FG003|Study Period III (16-Weeks)|Adverse Event|0
7316387|NCT00716274|11544929|FG004|Study Period III (16-Weeks)|Adverse Event|1
7316388|NCT00716274|11544930|FG005|Study Period III (16-Weeks)|Adverse Event|0
7316389|NCT00716417|11544957|FG000|Overall Study|Adverse Event|0
7316390|NCT00716417|11544958|FG001|Overall Study|Adverse Event|0
7316391|NCT00716417|11544959|FG002|Overall Study|Adverse Event|2
7316392|NCT00716417|11544960|FG003|Overall Study|Adverse Event|1
7316393|NCT00716417|11544961|FG004|Overall Study|Adverse Event|0
7316394|NCT00716417|11544962|FG005|Overall Study|Adverse Event|0
7316395|NCT00716417|11544963|FG006|Overall Study|Adverse Event|3
7316396|NCT00716417|11544964|FG007|Overall Study|Adverse Event|1
7316397|NCT00716417|11544965|FG008|Overall Study|Adverse Event|0
7316398|NCT00716417|11544966|FG009|Overall Study|Adverse Event|3
7316399|NCT00716417|11544957|FG000|Overall Study|Withdrawal by Subject|0
7316400|NCT00716417|11544958|FG001|Overall Study|Withdrawal by Subject|1
7316401|NCT00716417|11544959|FG002|Overall Study|Withdrawal by Subject|0
7316402|NCT00716417|11544960|FG003|Overall Study|Withdrawal by Subject|2
7316403|NCT00716417|11544961|FG004|Overall Study|Withdrawal by Subject|0
7316404|NCT00716417|11544962|FG005|Overall Study|Withdrawal by Subject|0
7316405|NCT00716417|11544963|FG006|Overall Study|Withdrawal by Subject|1
7316406|NCT00716417|11544964|FG007|Overall Study|Withdrawal by Subject|0
7316407|NCT00716417|11544965|FG008|Overall Study|Withdrawal by Subject|0
7316408|NCT00716417|11544966|FG009|Overall Study|Withdrawal by Subject|0
7316409|NCT00716417|11544957|FG000|Overall Study|Progressive disease|3
7316410|NCT00716417|11544958|FG001|Overall Study|Progressive disease|5
7316411|NCT00716417|11544959|FG002|Overall Study|Progressive disease|3
7316412|NCT00716417|11544960|FG003|Overall Study|Progressive disease|8
7316413|NCT00716417|11544961|FG004|Overall Study|Progressive disease|0
7316414|NCT00716417|11544962|FG005|Overall Study|Progressive disease|3
7316415|NCT00716417|11544963|FG006|Overall Study|Progressive disease|3
7316416|NCT00716417|11544964|FG007|Overall Study|Progressive disease|1
7316417|NCT00716417|11544965|FG008|Overall Study|Progressive disease|5
7316418|NCT00716417|11544966|FG009|Overall Study|Progressive disease|0
7316419|NCT00716417|11544957|FG000|Overall Study|Dose limiting toxicity (DLT)|0
7316420|NCT00716417|11544958|FG001|Overall Study|Dose limiting toxicity (DLT)|0
7316421|NCT00716417|11544959|FG002|Overall Study|Dose limiting toxicity (DLT)|0
7316422|NCT00716417|11544960|FG003|Overall Study|Dose limiting toxicity (DLT)|0
7316423|NCT00716417|11544961|FG004|Overall Study|Dose limiting toxicity (DLT)|1
7316424|NCT00716417|11544962|FG005|Overall Study|Dose limiting toxicity (DLT)|0
7316425|NCT00716417|11544963|FG006|Overall Study|Dose limiting toxicity (DLT)|0
7316426|NCT00716417|11544964|FG007|Overall Study|Dose limiting toxicity (DLT)|0
7316427|NCT00716417|11544965|FG008|Overall Study|Dose limiting toxicity (DLT)|0
7316428|NCT00716417|11544966|FG009|Overall Study|Dose limiting toxicity (DLT)|0
7316429|NCT00716417|11544957|FG000|Overall Study|On patient request due to toxicities|0
7316430|NCT00716417|11544958|FG001|Overall Study|On patient request due to toxicities|0
7316431|NCT00716417|11544959|FG002|Overall Study|On patient request due to toxicities|0
7316432|NCT00716417|11544960|FG003|Overall Study|On patient request due to toxicities|0
7316433|NCT00716417|11544961|FG004|Overall Study|On patient request due to toxicities|0
7316434|NCT00716417|11544962|FG005|Overall Study|On patient request due to toxicities|0
7316435|NCT00716417|11544963|FG006|Overall Study|On patient request due to toxicities|0
7316436|NCT00716417|11544964|FG007|Overall Study|On patient request due to toxicities|1
7316437|NCT00716417|11544965|FG008|Overall Study|On patient request due to toxicities|0
7316438|NCT00716417|11544966|FG009|Overall Study|On patient request due to toxicities|0
7316439|NCT00716456|11544998|FG000|Overall Study|Adverse Event|0
7316440|NCT00716456|11544999|FG001|Overall Study|Adverse Event|2
7316441|NCT00716456|11545000|FG002|Overall Study|Adverse Event|0
7316442|NCT00716482|11545008|FG000|Overall Study|Lost to Follow-up|6
7316443|NCT00716482|11545008|FG000|Overall Study|Inadequate acquisition or analysis|50
7316444|NCT00716482|11545008|FG000|Overall Study|no pathology obtained|10
7316445|NCT00716482|11545008|FG000|Overall Study|technical/machine error|28
7316446|NCT00716482|11545008|FG000|Overall Study|inclusion/exclusion criteria not met|25
7316447|NCT00716625|11545023|FG000|Overall Study|Safety was not Assessable|1
7316448|NCT00716859|11545081|FG000|Overall Study|Adverse Event|4
7316449|NCT00716859|11545082|FG001|Overall Study|Adverse Event|1
7316450|NCT00716859|11545081|FG000|Overall Study|Lack of Efficacy|3
7316451|NCT00716859|11545082|FG001|Overall Study|Lack of Efficacy|0
7316452|NCT00716859|11545081|FG000|Overall Study|Withdrawal by Subject|1
7316453|NCT00716859|11545082|FG001|Overall Study|Withdrawal by Subject|3
7316454|NCT00716859|11545081|FG000|Overall Study|Not treated|1
7316455|NCT00716859|11545082|FG001|Overall Study|Not treated|1
7316456|NCT00716976|11545103|FG000|Overall Study|Adverse Event|2
7316457|NCT00716976|11545104|FG001|Overall Study|Adverse Event|0
7316458|NCT00716976|11545103|FG000|Overall Study|Death|1
7316459|NCT00716976|11545104|FG001|Overall Study|Death|0
7316460|NCT00716976|11545103|FG000|Overall Study|Physician Decision|2
7316461|NCT00716976|11545104|FG001|Overall Study|Physician Decision|2
7316462|NCT00716976|11545103|FG000|Overall Study|Withdrawal by Subject|5
7316463|NCT00716976|11545104|FG001|Overall Study|Withdrawal by Subject|1
7316464|NCT00716976|11545103|FG000|Overall Study|Premature discontinuation cisplatin|5
7316465|NCT00716976|11545104|FG001|Overall Study|Premature discontinuation cisplatin|4
7316466|NCT00716976|11545103|FG000|Overall Study|Radiation during protocol|1
7316467|NCT00716976|11545104|FG001|Overall Study|Radiation during protocol|0
7316468|NCT00716976|11545103|FG000|Overall Study|Ineligibles|4
7316469|NCT00716976|11545104|FG001|Overall Study|Ineligibles|2
7316470|NCT00717067|11545133|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7316471|NCT00717067|11545134|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7316472|NCT00717067|11545135|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
7316473|NCT00717067|11545136|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7316474|NCT00717067|11545137|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
7316475|NCT00717093|11545161|FG000|Overall Study|Adverse Event|19
7316476|NCT00717093|11545162|FG001|Overall Study|Adverse Event|9
7316477|NCT00717093|11545161|FG000|Overall Study|Lack of Efficacy|3
7316478|NCT00717093|11545162|FG001|Overall Study|Lack of Efficacy|13
7316479|NCT00717093|11545161|FG000|Overall Study|Lost to Follow-up|9
7316480|NCT00717093|11545162|FG001|Overall Study|Lost to Follow-up|6
7316481|NCT00717093|11545161|FG000|Overall Study|Withdrawal by Subject|12
7316482|NCT00717093|11545162|FG001|Overall Study|Withdrawal by Subject|19
7316483|NCT00717093|11545161|FG000|Overall Study|Other|0
7316484|NCT00717093|11545162|FG001|Overall Study|Other|1
7316485|NCT00717093|11545161|FG000|Overall Study|Randomized but not treated|1
7316486|NCT00717093|11545162|FG001|Overall Study|Randomized but not treated|0
7316487|NCT00717197|11545168|FG000|Overall Study|Unable to purchase study drug|5
7316488|NCT00717197|11545168|FG000|Overall Study|Tumor Progression|1
7316489|NCT00717197|11545168|FG000|Overall Study|Physician Decision|1
7316490|NCT00717236|11545174|FG000|Double-Blind Period|Adverse Event|33
7316491|NCT00717236|11545175|FG001|Double-Blind Period|Adverse Event|6
7316492|NCT00717236|11545174|FG000|Double-Blind Period|Lack of Efficacy|6
7316493|NCT00717236|11545175|FG001|Double-Blind Period|Lack of Efficacy|6
7316494|NCT00717236|11545174|FG000|Double-Blind Period|Lost to Follow-up|3
7316495|NCT00717236|11545175|FG001|Double-Blind Period|Lost to Follow-up|5
7316496|NCT00717236|11545174|FG000|Double-Blind Period|Withdrawal by Subject|10
7316497|NCT00717236|11545175|FG001|Double-Blind Period|Withdrawal by Subject|2
7316498|NCT00717236|11545174|FG000|Double-Blind Period|Loss of efficacy|3
7316499|NCT00717236|11545175|FG001|Double-Blind Period|Loss of efficacy|0
7316500|NCT00717236|11545174|FG000|Double-Blind Period|Other: Death|1
7316501|NCT00717236|11545175|FG001|Double-Blind Period|Other: Death|0
7316502|NCT00717236|11545174|FG000|Double-Blind Period|Other: Pregnancy|1
7316503|NCT00717236|11545175|FG001|Double-Blind Period|Other: Pregnancy|0
7316504|NCT00717236|11545174|FG000|Double-Blind Period|Other: Protocol Violation|2
7316505|NCT00717236|11545175|FG001|Double-Blind Period|Other: Protocol Violation|0
7316506|NCT00717236|11545174|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
7316507|NCT00717236|11545175|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
7316508|NCT00717236|11545174|FG000|Double-Blind Period|Other: Site withdrew|2
7316509|NCT00717236|11545175|FG001|Double-Blind Period|Other: Site withdrew|0
7316510|NCT00717236|11545174|FG000|Double-Blind Period|Other: Screening failure|1
7316511|NCT00717236|11545175|FG001|Double-Blind Period|Other: Screening failure|0
7316512|NCT00717236|11545174|FG000|Double-Blind Period|Other: subject withdrew consent|1
7316513|NCT00717236|11545175|FG001|Double-Blind Period|Other: subject withdrew consent|1
7316514|NCT00717236|11545174|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
7316515|NCT00717236|11545175|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
7316516|NCT00717236|11545174|FG000|Double-Blind Period|Other: History of adenoid grown|1
7316517|NCT00717236|11545175|FG001|Double-Blind Period|Other: History of adenoid grown|0
7316518|NCT00717236|11545174|FG000|Double-Blind Period|Other: History of cancer|1
7316519|NCT00717236|11545175|FG001|Double-Blind Period|Other: History of cancer|0
7316520|NCT00717236|11545174|FG000|Double-Blind Period|Other: Sponsor request|1
7316521|NCT00717236|11545175|FG001|Double-Blind Period|Other: Sponsor request|0
7316522|NCT00717236|11545174|FG000|Double-Blind Period|Other: Inappropriate randomization|1
7316523|NCT00717236|11545175|FG001|Double-Blind Period|Other: Inappropriate randomization|0
7316524|NCT00717236|11545174|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
7316525|NCT00717236|11545175|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
7316526|NCT00717236|11545174|FG000|Double-Blind Period|Other: Subject moved|1
7316527|NCT00717236|11545175|FG001|Double-Blind Period|Other: Subject moved|1
7316528|NCT00717236|11545174|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
7316529|NCT00717236|11545175|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
7316530|NCT00717236|11545174|FG000|Double-Blind Period|Other: Prohibited medication taken|2
7316531|NCT00717236|11545175|FG001|Double-Blind Period|Other: Prohibited medication taken|2
7316532|NCT00717236|11545174|FG000|Double-Blind Period|Other: Transportation problems|0
7316533|NCT00717236|11545175|FG001|Double-Blind Period|Other: Transportation problems|1
7316534|NCT00717236|11545174|FG000|Double-Blind Period|Other: Investigator Decision|0
7316535|NCT00717236|11545175|FG001|Double-Blind Period|Other: Investigator Decision|1
7316536|NCT00717236|11545174|FG000|Open-Label Period|Adverse Event|29
7316537|NCT00717236|11545175|FG001|Open-Label Period|Adverse Event|4
7316538|NCT00717236|11545174|FG000|Open-Label Period|Lack of Efficacy|30
7316539|NCT00717236|11545175|FG001|Open-Label Period|Lack of Efficacy|8
7316540|NCT00717236|11545174|FG000|Open-Label Period|Lost to Follow-up|28
7316541|NCT00717236|11545175|FG001|Open-Label Period|Lost to Follow-up|4
7316542|NCT00717236|11545174|FG000|Open-Label Period|Withdrawal by Subject|20
7316543|NCT00717236|11545175|FG001|Open-Label Period|Withdrawal by Subject|2
7316544|NCT00717236|11545174|FG000|Open-Label Period|Loss of Efficacy|6
7316545|NCT00717236|11545175|FG001|Open-Label Period|Loss of Efficacy|1
7316546|NCT00717236|11545174|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
7316547|NCT00717236|11545175|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
7316548|NCT00717236|11545174|FG000|Open-Label Period|Other: Lack of Compliance|1
7316549|NCT00717236|11545175|FG001|Open-Label Period|Other: Lack of Compliance|1
7316550|NCT00717236|11545174|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
7316551|NCT00717236|11545175|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
7316552|NCT00717236|11545174|FG000|Open-Label Period|Other: Moved|1
7316553|NCT00717236|11545175|FG001|Open-Label Period|Other: Moved|0
7316554|NCT00717236|11545174|FG000|Open-Label Period|Other: Investigator Decision|1
7316555|NCT00717236|11545175|FG001|Open-Label Period|Other: Investigator Decision|0
7316556|NCT00717236|11545174|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
7316557|NCT00717236|11545175|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
7316558|NCT00717236|11545174|FG000|Open-Label Period|Other: Sponsor Request|3
7316559|NCT00717236|11545175|FG001|Open-Label Period|Other: Sponsor Request|0
7316560|NCT00717236|11545174|FG000|Open-Label Period|Other: Cataract Surgery|1
7316561|NCT00717236|11545175|FG001|Open-Label Period|Other: Cataract Surgery|0
7316562|NCT00717236|11545174|FG000|Open-Label Period|Other: Administration of Golimumab|1
7316563|NCT00717236|11545175|FG001|Open-Label Period|Other: Administration of Golimumab|0
7316564|NCT00717236|11545174|FG000|Open-Label Period|Other: Completion Accidently Performed|1
7316565|NCT00717236|11545175|FG001|Open-Label Period|Other: Completion Accidently Performed|0
7316566|NCT00717236|11545174|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
7316567|NCT00717236|11545175|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
7316568|NCT00717249|11545185|FG000|Overall Study|Lens Discomfort|4
7316569|NCT00717249|11545186|FG001|Overall Study|Lens Discomfort|1
7316570|NCT00717249|11545185|FG000|Overall Study|Unsatisfactory visual Response|0
7316571|NCT00717249|11545186|FG001|Overall Study|Unsatisfactory visual Response|2
7316572|NCT00717249|11545185|FG000|Overall Study|Adverse Event|4
7316573|NCT00717249|11545186|FG001|Overall Study|Adverse Event|2
7316574|NCT00717249|11545185|FG000|Overall Study|Lost to Follow-up|2
7316575|NCT00717249|11545186|FG001|Overall Study|Lost to Follow-up|0
7316576|NCT00717249|11545185|FG000|Overall Study|Withdrawal by Subject|1
7316577|NCT00717249|11545186|FG001|Overall Study|Withdrawal by Subject|2
7316578|NCT00717249|11545185|FG000|Overall Study|Pregnancy|6
7316579|NCT00717249|11545186|FG001|Overall Study|Pregnancy|3
7316580|NCT00717249|11545185|FG000|Overall Study|Protocol Violation|0
7316581|NCT00717249|11545186|FG001|Overall Study|Protocol Violation|2
7316582|NCT00717249|11545185|FG000|Overall Study|Subject became Ineligible|1
7316583|NCT00717249|11545186|FG001|Overall Study|Subject became Ineligible|1
7316584|NCT00717249|11545185|FG000|Overall Study|Unsatisfactory Physiological Response|0
7316585|NCT00717249|11545186|FG001|Overall Study|Unsatisfactory Physiological Response|1
7316586|NCT00717249|11545185|FG000|Overall Study|Gastric Surgery|0
7316587|NCT00717249|11545186|FG001|Overall Study|Gastric Surgery|1
7316588|NCT00717249|11545185|FG000|Overall Study|Diagnosed with Diabetes|1
7316589|NCT00717249|11545186|FG001|Overall Study|Diagnosed with Diabetes|0
7316590|NCT00717249|11545185|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
7316591|NCT00717249|11545186|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
7316592|NCT00717249|11545185|FG000|Overall Study|Subject relocated|1
7316593|NCT00717249|11545186|FG001|Overall Study|Subject relocated|0
7316594|NCT00717249|11545185|FG000|Overall Study|Headaches|1
7316595|NCT00717249|11545186|FG001|Overall Study|Headaches|0
7316596|NCT00717314|11545213|FG000|Overall Study|Adverse Event|3
7316597|NCT00717314|11545214|FG001|Overall Study|Adverse Event|2
7316598|NCT00717314|11545213|FG000|Overall Study|Protocol Violation|1
7316599|NCT00717314|11545214|FG001|Overall Study|Protocol Violation|0
7316600|NCT00717314|11545213|FG000|Overall Study|Lost to Follow-up|1
7316601|NCT00717314|11545214|FG001|Overall Study|Lost to Follow-up|5
7316602|NCT00717314|11545213|FG000|Overall Study|Withdrawal by Subject|1
7316603|NCT00717314|11545214|FG001|Overall Study|Withdrawal by Subject|3
7316604|NCT00717366|11545222|FG000|Core Study Period (20 Weeks)|Renal transplant|4
7316605|NCT00717366|11545223|FG001|Core Study Period (20 Weeks)|Renal transplant|9
7316606|NCT00717366|11545222|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
7316607|NCT00717366|11545223|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
7316608|NCT00717366|11545222|FG000|Core Study Period (20 Weeks)|Death|0
7316609|NCT00717366|11545223|FG001|Core Study Period (20 Weeks)|Death|1
7316610|NCT00717366|11545222|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
7316611|NCT00717366|11545223|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
7316612|NCT00717366|11545222|FG000|Extension Period (52 Weeks)|Renal transplant|3
7316613|NCT00717366|11545223|FG001|Extension Period (52 Weeks)|Renal transplant|13
7316614|NCT00717366|11545222|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
7316615|NCT00717366|11545223|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
7316616|NCT00717366|11545222|FG000|Extension Period (52 Weeks)|Withdrew consent|1
7316617|NCT00717366|11545223|FG001|Extension Period (52 Weeks)|Withdrew consent|1
7316618|NCT00717522|11545244|FG000|Overall Study|Disease Progression|5
7316619|NCT00717522|11545244|FG000|Overall Study|Adverse Event|1
7316620|NCT00717522|11545244|FG000|Overall Study|Death|1
7316621|NCT00717756|11545261|FG000|Overall Study|Withdrawal by Subject|1
7316622|NCT00717769|11545268|FG000|Overall Study|Adverse Event|9
7316623|NCT00717769|11545269|FG001|Overall Study|Adverse Event|6
7316624|NCT00717769|11545270|FG002|Overall Study|Adverse Event|1
7316625|NCT00717769|11545268|FG000|Overall Study|Lack of compliance|0
7316626|NCT00717769|11545269|FG001|Overall Study|Lack of compliance|2
7391864|NCT01248364|11652718|FG002|Overall Study|Adverse Event|0
7316627|NCT00717769|11545270|FG002|Overall Study|Lack of compliance|0
7316628|NCT00717769|11545268|FG000|Overall Study|Lost to Follow-up|3
7316629|NCT00717769|11545269|FG001|Overall Study|Lost to Follow-up|4
7316630|NCT00717769|11545270|FG002|Overall Study|Lost to Follow-up|0
7316631|NCT00717769|11545268|FG000|Overall Study|Lack of Efficacy|1
7316632|NCT00717769|11545269|FG001|Overall Study|Lack of Efficacy|2
7316633|NCT00717769|11545270|FG002|Overall Study|Lack of Efficacy|0
7316634|NCT00717769|11545268|FG000|Overall Study|Protocol Violation|0
7316635|NCT00717769|11545269|FG001|Overall Study|Protocol Violation|2
7316636|NCT00717769|11545270|FG002|Overall Study|Protocol Violation|0
7316637|NCT00717769|11545268|FG000|Overall Study|Sponsor decision|1
7316638|NCT00717769|11545269|FG001|Overall Study|Sponsor decision|0
7316639|NCT00717769|11545270|FG002|Overall Study|Sponsor decision|10
7316640|NCT00717769|11545268|FG000|Overall Study|Withdrew consent|2
7316641|NCT00717769|11545269|FG001|Overall Study|Withdrew consent|2
7316642|NCT00717769|11545270|FG002|Overall Study|Withdrew consent|0
7316643|NCT00717860|11545282|FG000|Overall Study|Clinical adverse experience|5
7316644|NCT00717860|11545283|FG001|Overall Study|Clinical adverse experience|9
7316645|NCT00717860|11545282|FG000|Overall Study|Laboratory adverse experience|2
7316646|NCT00717860|11545283|FG001|Overall Study|Laboratory adverse experience|2
7316647|NCT00717860|11545282|FG000|Overall Study|Lack of Efficacy|7
7316648|NCT00717860|11545283|FG001|Overall Study|Lack of Efficacy|13
7316649|NCT00717860|11545282|FG000|Overall Study|Discontinued for other reason|6
7316650|NCT00717860|11545283|FG001|Overall Study|Discontinued for other reason|1
7316651|NCT00717860|11545282|FG000|Overall Study|Withdrew consent|7
7316652|NCT00717860|11545283|FG001|Overall Study|Withdrew consent|3
7316653|NCT00717886|11545298|FG000|Overall Study|Withdrawal by Subject|3
7316654|NCT00717886|11545298|FG000|Overall Study|Treatment Failure|1
7316655|NCT00718042|11545326|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7316656|NCT00718042|11545327|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7316657|NCT00718042|11545328|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7316658|NCT00718042|11545329|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7316659|NCT00718042|11545330|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
7316660|NCT00718042|11545331|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
7316661|NCT00718042|11545326|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
7316662|NCT00718042|11545327|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7316663|NCT00718042|11545328|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7316664|NCT00718042|11545329|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7316665|NCT00718042|11545330|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
7316666|NCT00718042|11545331|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
7316667|NCT00718042|11545326|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7316668|NCT00718042|11545327|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7316669|NCT00718042|11545328|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
7316670|NCT00718042|11545329|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7316671|NCT00718042|11545330|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7316672|NCT00718042|11545331|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
7316673|NCT00718042|11545326|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7316674|NCT00718042|11545327|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
7316675|NCT00718042|11545328|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7316676|NCT00718042|11545329|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7316677|NCT00718042|11545330|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7316678|NCT00718042|11545331|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
7316679|NCT00718042|11545326|FG000|Donor Follow-up|Lost to Follow-up|13
7316680|NCT00718042|11545327|FG001|Donor Follow-up|Lost to Follow-up|0
7316681|NCT00718042|11545328|FG002|Donor Follow-up|Lost to Follow-up|0
7316682|NCT00718042|11545329|FG003|Donor Follow-up|Lost to Follow-up|0
7316683|NCT00718042|11545330|FG004|Donor Follow-up|Lost to Follow-up|19
7316684|NCT00718042|11545331|FG005|Donor Follow-up|Lost to Follow-up|0
7316685|NCT00718081|11545346|FG000|Overall Study|Adverse Event|0
7316686|NCT00718081|11545347|FG001|Overall Study|Adverse Event|1
7316687|NCT00718081|11545348|FG002|Overall Study|Adverse Event|0
7316688|NCT00718081|11545346|FG000|Overall Study|Lack of Efficacy|7
7316689|NCT00718081|11545347|FG001|Overall Study|Lack of Efficacy|3
7316690|NCT00718081|11545348|FG002|Overall Study|Lack of Efficacy|21
7316691|NCT00718159|11545381|FG000|Overall Study|Progressive Disease|3
7316692|NCT00718159|11545382|FG001|Overall Study|Progressive Disease|3
7316693|NCT00718159|11545383|FG002|Overall Study|Progressive Disease|2
7316694|NCT00718159|11545384|FG003|Overall Study|Progressive Disease|0
7316695|NCT00718159|11545385|FG004|Overall Study|Progressive Disease|6
7316696|NCT00718159|11545386|FG005|Overall Study|Progressive Disease|0
7316697|NCT00718159|11545387|FG006|Overall Study|Progressive Disease|0
7316698|NCT00718159|11545381|FG000|Overall Study|Death due to Adverse Event|0
7316699|NCT00718159|11545382|FG001|Overall Study|Death due to Adverse Event|0
7316700|NCT00718159|11545383|FG002|Overall Study|Death due to Adverse Event|0
7316701|NCT00718159|11545384|FG003|Overall Study|Death due to Adverse Event|2
7316702|NCT00718159|11545385|FG004|Overall Study|Death due to Adverse Event|2
7316703|NCT00718159|11545386|FG005|Overall Study|Death due to Adverse Event|0
7316704|NCT00718159|11545387|FG006|Overall Study|Death due to Adverse Event|0
7316705|NCT00718159|11545381|FG000|Overall Study|Death due to Study Drug Toxicity|0
7316706|NCT00718159|11545382|FG001|Overall Study|Death due to Study Drug Toxicity|0
7316707|NCT00718159|11545383|FG002|Overall Study|Death due to Study Drug Toxicity|1
7316708|NCT00718159|11545384|FG003|Overall Study|Death due to Study Drug Toxicity|2
7316709|NCT00718159|11545385|FG004|Overall Study|Death due to Study Drug Toxicity|0
7316710|NCT00718159|11545386|FG005|Overall Study|Death due to Study Drug Toxicity|0
7316711|NCT00718159|11545387|FG006|Overall Study|Death due to Study Drug Toxicity|0
7316712|NCT00718159|11545381|FG000|Overall Study|Investigator Decision|0
7316713|NCT00718159|11545382|FG001|Overall Study|Investigator Decision|0
7316714|NCT00718159|11545383|FG002|Overall Study|Investigator Decision|0
7316715|NCT00718159|11545384|FG003|Overall Study|Investigator Decision|0
7316716|NCT00718159|11545385|FG004|Overall Study|Investigator Decision|0
7316717|NCT00718159|11545386|FG005|Overall Study|Investigator Decision|1
7316718|NCT00718159|11545387|FG006|Overall Study|Investigator Decision|1
7316719|NCT00718237|11545405|FG000|Overall Study|Adverse Event|1
7316720|NCT00718237|11545406|FG001|Overall Study|Adverse Event|3
7316721|NCT00718237|11545405|FG000|Overall Study|Lost to Follow-up|2
7316722|NCT00718237|11545406|FG001|Overall Study|Lost to Follow-up|2
7316723|NCT00718237|11545405|FG000|Overall Study|Physician Decision|1
7316724|NCT00718237|11545406|FG001|Overall Study|Physician Decision|0
7316725|NCT00718237|11545405|FG000|Overall Study|Withdrawal by Subject|9
7316726|NCT00718237|11545406|FG001|Overall Study|Withdrawal by Subject|10
7316727|NCT00718315|11545428|FG000|Overall Study|Adverse Event|1
7316728|NCT00718315|11545429|FG001|Overall Study|Adverse Event|2
7316729|NCT00718315|11545430|FG002|Overall Study|Adverse Event|3
7316730|NCT00718315|11545428|FG000|Overall Study|Death|6
7316731|NCT00718315|11545429|FG001|Overall Study|Death|6
7316732|NCT00718315|11545430|FG002|Overall Study|Death|5
7316733|NCT00718315|11545428|FG000|Overall Study|Lost to Follow-up|2
7316734|NCT00718315|11545429|FG001|Overall Study|Lost to Follow-up|3
7316735|NCT00718315|11545430|FG002|Overall Study|Lost to Follow-up|4
7316736|NCT00718315|11545428|FG000|Overall Study|Protocol Violation|5
7316737|NCT00718315|11545429|FG001|Overall Study|Protocol Violation|5
7316738|NCT00718315|11545430|FG002|Overall Study|Protocol Violation|3
7316739|NCT00718315|11545428|FG000|Overall Study|Erlotinib dose decreased|4
7316740|NCT00718315|11545429|FG001|Overall Study|Erlotinib dose decreased|3
7316741|NCT00718315|11545430|FG002|Overall Study|Erlotinib dose decreased|1
7316742|NCT00718315|11545428|FG000|Overall Study|Use of Minocyclin|1
7316743|NCT00718315|11545429|FG001|Overall Study|Use of Minocyclin|1
7316744|NCT00718315|11545430|FG002|Overall Study|Use of Minocyclin|1
7316745|NCT00718315|11545428|FG000|Overall Study|Disease progression|0
7316746|NCT00718315|11545429|FG001|Overall Study|Disease progression|1
7316747|NCT00718315|11545430|FG002|Overall Study|Disease progression|1
7316748|NCT00718315|11545428|FG000|Overall Study|Other|0
7316749|NCT00718315|11545429|FG001|Overall Study|Other|0
7316750|NCT00718315|11545430|FG002|Overall Study|Other|1
7316751|NCT00718315|11545428|FG000|Overall Study|Use of ATB and Corticoids|0
7316752|NCT00718315|11545429|FG001|Overall Study|Use of ATB and Corticoids|1
7316753|NCT00718315|11545430|FG002|Overall Study|Use of ATB and Corticoids|2
7316754|NCT00718328|11545440|FG000|Overall Study|Lost to Follow-up|1
7316755|NCT00718328|11545441|FG001|Overall Study|Lost to Follow-up|0
7316756|NCT00718419|11545449|FG000|Overall Study|Adverse Event|2
7316757|NCT00718419|11545450|FG001|Overall Study|Adverse Event|1
7316758|NCT00718419|11545449|FG000|Overall Study|Physician Decision|1
7316759|NCT00718419|11545450|FG001|Overall Study|Physician Decision|6
7316760|NCT00718419|11545449|FG000|Overall Study|Sponsor decision|0
7316761|NCT00718419|11545450|FG001|Overall Study|Sponsor decision|1
7316762|NCT00718419|11545449|FG000|Overall Study|Withdrawal by Subject|0
7316763|NCT00718419|11545450|FG001|Overall Study|Withdrawal by Subject|5
7316764|NCT00718419|11545449|FG000|Overall Study|Progressive Disease|7
7316765|NCT00718419|11545450|FG001|Overall Study|Progressive Disease|25
7316766|NCT00718419|11545449|FG000|Overall Study|Death Due to Progressive Disease|2
7316767|NCT00718419|11545450|FG001|Overall Study|Death Due to Progressive Disease|0
7316768|NCT00718419|11545449|FG000|Overall Study|Death Due to Study Drug Related|0
7316769|NCT00718419|11545450|FG001|Overall Study|Death Due to Study Drug Related|1
7316770|NCT00718419|11545449|FG000|Overall Study|Death Due to Adverse Events|1
7316771|NCT00718419|11545450|FG001|Overall Study|Death Due to Adverse Events|0
7316772|NCT00718510|11545458|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
7316773|NCT00718510|11545459|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7316774|NCT00718510|11545458|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7316775|NCT00718510|11545459|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7316776|NCT00718523|11545467|FG000|Overall Study|Withdrawal by Subject|5
7316777|NCT00718523|11545468|FG001|Overall Study|Withdrawal by Subject|7
7316778|NCT00718523|11545467|FG000|Overall Study|Death|13
7316779|NCT00718523|11545468|FG001|Overall Study|Death|17
7316780|NCT00718549|11545474|FG000|Induction Phase|Disease Progression|1
7316781|NCT00718549|11545475|FG001|Induction Phase|Disease Progression|0
7316782|NCT00718549|11545476|FG002|Induction Phase|Disease Progression|0
7316783|NCT00718549|11545474|FG000|Induction Phase|Eligibility Criteria Violation|2
7316784|NCT00718549|11545475|FG001|Induction Phase|Eligibility Criteria Violation|0
7316785|NCT00718549|11545476|FG002|Induction Phase|Eligibility Criteria Violation|0
7316786|NCT00718549|11545474|FG000|Induction Phase|Early Termination - No Additional Info|59
7316787|NCT00718549|11545475|FG001|Induction Phase|Early Termination - No Additional Info|0
7316788|NCT00718549|11545476|FG002|Induction Phase|Early Termination - No Additional Info|0
7316789|NCT00718549|11545474|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
7316790|NCT00718549|11545475|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
7316791|NCT00718549|11545476|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
7316792|NCT00718549|11545474|FG000|Maintenance/ Observation Phase|Death|0
7316793|NCT00718549|11545475|FG001|Maintenance/ Observation Phase|Death|1
7316794|NCT00718549|11545476|FG002|Maintenance/ Observation Phase|Death|2
7316795|NCT00718549|11545474|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
7316796|NCT00718549|11545475|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
7316797|NCT00718549|11545476|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
7316798|NCT00718549|11545474|FG000|Maintenance/ Observation Phase|Progression|0
7316799|NCT00718549|11545475|FG001|Maintenance/ Observation Phase|Progression|5
7316800|NCT00718549|11545476|FG002|Maintenance/ Observation Phase|Progression|14
7316801|NCT00718549|11545474|FG000|Maintenance/ Observation Phase|Relapse|0
7316802|NCT00718549|11545475|FG001|Maintenance/ Observation Phase|Relapse|3
7316803|NCT00718549|11545476|FG002|Maintenance/ Observation Phase|Relapse|2
7316804|NCT00718666|11545492|FG000|Booster Phase Year 5|No active participation request|0
7316805|NCT00718666|11545493|FG001|Booster Phase Year 5|No active participation request|0
7316806|NCT00718666|11545494|FG002|Booster Phase Year 5|No active participation request|1
7316807|NCT00718666|11545492|FG000|Booster Phase Year 5|Declined v-4 serology|1
7316808|NCT00718666|11545493|FG001|Booster Phase Year 5|Declined v-4 serology|0
7316809|NCT00718666|11545494|FG002|Booster Phase Year 5|Declined v-4 serology|0
7316810|NCT00718666|11545492|FG000|Booster Phase Year 5|Withdrawal by Subject|0
7316811|NCT00718666|11545493|FG001|Booster Phase Year 5|Withdrawal by Subject|0
7316812|NCT00718666|11545494|FG002|Booster Phase Year 5|Withdrawal by Subject|1
7316813|NCT00718666|11545492|FG000|Booster Phase Year 5|Lost to Follow-up|1
7316814|NCT00718666|11545493|FG001|Booster Phase Year 5|Lost to Follow-up|0
7316815|NCT00718666|11545494|FG002|Booster Phase Year 5|Lost to Follow-up|4
7316816|NCT00718718|11545519|FG000|Prior to Week 12|Adverse Event|0
7316817|NCT00718718|11545520|FG001|Prior to Week 12|Adverse Event|0
7316818|NCT00718718|11545521|FG002|Prior to Week 12|Adverse Event|0
7316819|NCT00718718|11545522|FG003|Prior to Week 12|Adverse Event|0
7316820|NCT00718718|11545523|FG004|Prior to Week 12|Adverse Event|0
7316821|NCT00718718|11545524|FG005|Prior to Week 12|Adverse Event|0
7316822|NCT00718718|11545525|FG006|Prior to Week 12|Adverse Event|0
7316823|NCT00718718|11545526|FG007|Prior to Week 12|Adverse Event|1
7316824|NCT00718718|11545527|FG008|Prior to Week 12|Adverse Event|1
7316825|NCT00718718|11545528|FG009|Prior to Week 12|Adverse Event|0
7316826|NCT00718718|11545519|FG000|Prior to Week 12|Withdrawal by Subject|0
7316827|NCT00718718|11545520|FG001|Prior to Week 12|Withdrawal by Subject|0
7316828|NCT00718718|11545521|FG002|Prior to Week 12|Withdrawal by Subject|0
7316829|NCT00718718|11545522|FG003|Prior to Week 12|Withdrawal by Subject|0
7316830|NCT00718718|11545523|FG004|Prior to Week 12|Withdrawal by Subject|3
7316831|NCT00718718|11545524|FG005|Prior to Week 12|Withdrawal by Subject|0
7316832|NCT00718718|11545525|FG006|Prior to Week 12|Withdrawal by Subject|1
7316833|NCT00718718|11545526|FG007|Prior to Week 12|Withdrawal by Subject|1
7316834|NCT00718718|11545527|FG008|Prior to Week 12|Withdrawal by Subject|1
7316835|NCT00718718|11545528|FG009|Prior to Week 12|Withdrawal by Subject|0
7316836|NCT00718718|11545519|FG000|Prior to Week 12|Other|1
7316837|NCT00718718|11545520|FG001|Prior to Week 12|Other|0
7316838|NCT00718718|11545521|FG002|Prior to Week 12|Other|1
7316839|NCT00718718|11545522|FG003|Prior to Week 12|Other|0
7316840|NCT00718718|11545523|FG004|Prior to Week 12|Other|0
7316841|NCT00718718|11545524|FG005|Prior to Week 12|Other|0
7316842|NCT00718718|11545525|FG006|Prior to Week 12|Other|0
7316843|NCT00718718|11545526|FG007|Prior to Week 12|Other|0
7316844|NCT00718718|11545527|FG008|Prior to Week 12|Other|0
7316845|NCT00718718|11545528|FG009|Prior to Week 12|Other|0
7316846|NCT00718718|11545519|FG000|Week 12 to End of Study|Adverse Event|0
7316847|NCT00718718|11545520|FG001|Week 12 to End of Study|Adverse Event|0
7316848|NCT00718718|11545521|FG002|Week 12 to End of Study|Adverse Event|0
7316849|NCT00718718|11545522|FG003|Week 12 to End of Study|Adverse Event|0
7316850|NCT00718718|11545523|FG004|Week 12 to End of Study|Adverse Event|0
7316851|NCT00718718|11545524|FG005|Week 12 to End of Study|Adverse Event|0
7316852|NCT00718718|11545525|FG006|Week 12 to End of Study|Adverse Event|0
7316853|NCT00718718|11545526|FG007|Week 12 to End of Study|Adverse Event|1
7316854|NCT00718718|11545527|FG008|Week 12 to End of Study|Adverse Event|0
7316855|NCT00718718|11545528|FG009|Week 12 to End of Study|Adverse Event|0
7316856|NCT00718718|11545519|FG000|Week 12 to End of Study|Death|0
7316857|NCT00718718|11545520|FG001|Week 12 to End of Study|Death|0
7316858|NCT00718718|11545521|FG002|Week 12 to End of Study|Death|0
7316859|NCT00718718|11545522|FG003|Week 12 to End of Study|Death|0
7316860|NCT00718718|11545523|FG004|Week 12 to End of Study|Death|0
7316861|NCT00718718|11545524|FG005|Week 12 to End of Study|Death|1
7316862|NCT00718718|11545525|FG006|Week 12 to End of Study|Death|0
7316863|NCT00718718|11545526|FG007|Week 12 to End of Study|Death|0
7316864|NCT00718718|11545527|FG008|Week 12 to End of Study|Death|0
7316865|NCT00718718|11545528|FG009|Week 12 to End of Study|Death|0
7316866|NCT00718718|11545519|FG000|Week 12 to End of Study|Withdrawal by Subject|0
7316867|NCT00718718|11545520|FG001|Week 12 to End of Study|Withdrawal by Subject|0
7316868|NCT00718718|11545521|FG002|Week 12 to End of Study|Withdrawal by Subject|0
7316869|NCT00718718|11545522|FG003|Week 12 to End of Study|Withdrawal by Subject|0
7316870|NCT00718718|11545523|FG004|Week 12 to End of Study|Withdrawal by Subject|0
7316871|NCT00718718|11545524|FG005|Week 12 to End of Study|Withdrawal by Subject|2
7316872|NCT00718718|11545525|FG006|Week 12 to End of Study|Withdrawal by Subject|1
7316873|NCT00718718|11545526|FG007|Week 12 to End of Study|Withdrawal by Subject|0
7316874|NCT00718718|11545527|FG008|Week 12 to End of Study|Withdrawal by Subject|0
7316875|NCT00718718|11545528|FG009|Week 12 to End of Study|Withdrawal by Subject|0
7316876|NCT00718718|11545519|FG000|Week 12 to End of Study|Lost to Follow-up|0
7316877|NCT00718718|11545520|FG001|Week 12 to End of Study|Lost to Follow-up|0
7316878|NCT00718718|11545521|FG002|Week 12 to End of Study|Lost to Follow-up|0
7316879|NCT00718718|11545522|FG003|Week 12 to End of Study|Lost to Follow-up|0
7316880|NCT00718718|11545523|FG004|Week 12 to End of Study|Lost to Follow-up|0
7316881|NCT00718718|11545524|FG005|Week 12 to End of Study|Lost to Follow-up|0
7316882|NCT00718718|11545525|FG006|Week 12 to End of Study|Lost to Follow-up|0
7316883|NCT00718718|11545526|FG007|Week 12 to End of Study|Lost to Follow-up|0
7316884|NCT00718718|11545527|FG008|Week 12 to End of Study|Lost to Follow-up|1
7316885|NCT00718718|11545528|FG009|Week 12 to End of Study|Lost to Follow-up|0
7316886|NCT00718718|11545519|FG000|Week 12 to End of Study|Other|0
7316887|NCT00718718|11545520|FG001|Week 12 to End of Study|Other|1
7316888|NCT00718718|11545521|FG002|Week 12 to End of Study|Other|0
7316889|NCT00718718|11545522|FG003|Week 12 to End of Study|Other|1
7316890|NCT00718718|11545523|FG004|Week 12 to End of Study|Other|0
7316891|NCT00718718|11545524|FG005|Week 12 to End of Study|Other|0
7316892|NCT00718718|11545525|FG006|Week 12 to End of Study|Other|1
7316893|NCT00718718|11545526|FG007|Week 12 to End of Study|Other|0
7316894|NCT00718718|11545527|FG008|Week 12 to End of Study|Other|0
7316895|NCT00718718|11545528|FG009|Week 12 to End of Study|Other|0
7316896|NCT00718770|11545554|FG000|Overall Study|Adverse Event|1
7316897|NCT00718770|11545554|FG000|Overall Study|Lack of Efficacy|1
7316898|NCT00718770|11545554|FG000|Overall Study|Lack of Efficacy|1
7316899|NCT00718770|11545554|FG000|Overall Study|Adverse Event|1
7316900|NCT00718770|11545554|FG000|Overall Study|Lack of Efficacy|1
7316901|NCT00718770|11545554|FG000|Overall Study|Adverse Event|1
7316902|NCT00718770|11545554|FG000|Overall Study|Lack of Efficacy|1
7316903|NCT00718770|11545554|FG000|Overall Study|Adverse Event|1
7384537|NCT01194531|11641681|FG000|Overall Study|Physician Decision|0
7384538|NCT01194531|11641682|FG001|Overall Study|Physician Decision|2
7384539|NCT01194804|11641693|FG000|Overall Study|Withdrawal by Subject|1
7384540|NCT01194830|11641699|FG000|Overall Study|Adverse Event|3
7384541|NCT01194830|11641700|FG001|Overall Study|Adverse Event|2
7384542|NCT01194830|11641699|FG000|Overall Study|Protocol Violation|5
7384543|NCT01194830|11641700|FG001|Overall Study|Protocol Violation|4
7384544|NCT01194830|11641699|FG000|Overall Study|Lost to Follow-up|9
7384545|NCT01194830|11641700|FG001|Overall Study|Lost to Follow-up|7
7384546|NCT01194830|11641699|FG000|Overall Study|Withdrawal by Subject|2
7384547|NCT01194830|11641700|FG001|Overall Study|Withdrawal by Subject|1
7384548|NCT01194830|11641699|FG000|Overall Study|Lack of Efficacy|1
7384549|NCT01194830|11641700|FG001|Overall Study|Lack of Efficacy|1
7384550|NCT01194830|11641699|FG000|Overall Study|Non-compliance issues|4
7384551|NCT01194830|11641700|FG001|Overall Study|Non-compliance issues|4
7384552|NCT01194830|11641699|FG000|Overall Study|Other Reason|12
7384553|NCT01194830|11641700|FG001|Overall Study|Other Reason|8
7384554|NCT01194869|11641706|FG000|Overall Study|Disease Progression|2
7384555|NCT01194869|11641706|FG000|Overall Study|Toxicity|2
7384556|NCT01194973|11641710|FG000|Screening Period|Screen Failure|3
7384557|NCT01194973|11641710|FG000|26 Week Treatment Period|Adverse Event|1
7384558|NCT01194973|11641710|FG000|26 Week Treatment Period|Lack of Efficacy|1
7384559|NCT01194973|11641710|FG000|26 Week Treatment Period|Pregnancy|1
7384560|NCT01194999|11641714|FG000|Overall Study|Lost to Follow-up|17
7384561|NCT01195090|11641730|FG000|Overall Study|Adverse Event|1
7384562|NCT01195090|11641731|FG001|Overall Study|Adverse Event|2
7384563|NCT01195090|11641730|FG000|Overall Study|Lost to Follow-up|2
7384564|NCT01195090|11641731|FG001|Overall Study|Lost to Follow-up|2
7384565|NCT01195090|11641730|FG000|Overall Study|Protocol Violation|3
7384566|NCT01195090|11641731|FG001|Overall Study|Protocol Violation|4
7384567|NCT01195103|11641740|FG000|Overall Study|Withdrawal by Subject|1
7384568|NCT01195103|11641741|FG001|Overall Study|Withdrawal by Subject|0
7384569|NCT01195103|11641742|FG002|Overall Study|Withdrawal by Subject|0
7384570|NCT01195272|11641759|FG000|Overall Study|Adverse Event|1
7384571|NCT01195272|11641759|FG000|Overall Study|Lack of Efficacy|3
7384572|NCT01195363|11641765|FG000|Overall Study|Lost to Follow-up|7
7384573|NCT01195363|11641766|FG001|Overall Study|Lost to Follow-up|4
7384574|NCT01195363|11641765|FG000|Overall Study|Adverse Event|3
7391865|NCT01248364|11652719|FG003|Overall Study|Adverse Event|0
7465253|NCT01879722|11764470|FG007|Overall Study|Voluntary Withdrawal|0
7384575|NCT01195363|11641766|FG001|Overall Study|Adverse Event|1
7384576|NCT01195363|11641765|FG000|Overall Study|Lack of Efficacy|0
7384577|NCT01195363|11641766|FG001|Overall Study|Lack of Efficacy|4
7465254|NCT01879722|11764471|FG008|Overall Study|Voluntary Withdrawal|1
7384578|NCT01195363|11641765|FG000|Overall Study|incarceration|1
7384579|NCT01195363|11641766|FG001|Overall Study|incarceration|0
7465255|NCT01879722|11764472|FG009|Overall Study|Voluntary Withdrawal|0
7384580|NCT01195415|11641772|FG000|Overall Study|No repeat biopsy due to progression|2
7384581|NCT01195545|11641780|FG000|Overall Study|Protocol Violation|4
7384582|NCT01195623|11641805|FG000|Overall Study|Lost to Follow-up|35
7384583|NCT01195623|11641806|FG001|Overall Study|Lost to Follow-up|37
7384584|NCT01195636|11641814|FG000|First Intervention (3 Weeks)|Adverse Event|2
7384585|NCT01195636|11641815|FG001|First Intervention (3 Weeks)|Adverse Event|3
7384586|NCT01195636|11641814|FG000|First Intervention (3 Weeks)|Protocol Violation|1
7384587|NCT01195636|11641815|FG001|First Intervention (3 Weeks)|Protocol Violation|0
7384588|NCT01195636|11641814|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7316904|NCT00718809|11545560|FG000|Overall Study|Disease progression|9
7316905|NCT00718809|11545561|FG001|Overall Study|Disease progression|7
7316906|NCT00718809|11545560|FG000|Overall Study|Adverse Event|1
7316907|NCT00718809|11545561|FG001|Overall Study|Adverse Event|1
7316908|NCT00718809|11545560|FG000|Overall Study|Withdrawal by Subject|0
7316909|NCT00718809|11545561|FG001|Overall Study|Withdrawal by Subject|1
7316910|NCT00718809|11545560|FG000|Overall Study|Lost to Follow-up|1
7316911|NCT00718809|11545561|FG001|Overall Study|Lost to Follow-up|0
7316912|NCT00718809|11545560|FG000|Overall Study|Noncompliance|1
7316913|NCT00718809|11545561|FG001|Overall Study|Noncompliance|0
7316914|NCT00718861|11545569|FG000|Overall Study|Withdrawal by Subject|15
7316915|NCT00718861|11545570|FG001|Overall Study|Withdrawal by Subject|10
7316916|NCT00718861|11545569|FG000|Overall Study|Adverse Event|2
7316917|NCT00718861|11545570|FG001|Overall Study|Adverse Event|1
7316918|NCT00718861|11545569|FG000|Overall Study|Lost to Follow-up|2
7316919|NCT00718861|11545570|FG001|Overall Study|Lost to Follow-up|1
7316920|NCT00718861|11545569|FG000|Overall Study|Administrative Problems|1
7316921|NCT00718861|11545570|FG001|Overall Study|Administrative Problems|1
7316922|NCT00718861|11545569|FG000|Overall Study|Death|1
7316923|NCT00718861|11545570|FG001|Overall Study|Death|5
7316924|NCT00718887|11545578|FG000|Overall Study|Withdrawal by Subject|3
7316925|NCT00718887|11545579|FG001|Overall Study|Withdrawal by Subject|2
7316926|NCT00718887|11545578|FG000|Overall Study|Not identified|2
7316927|NCT00718887|11545579|FG001|Overall Study|Not identified|7
7316928|NCT00719043|11545598|FG000|Overall Study|Adverse Event|5
7316929|NCT00719043|11545599|FG001|Overall Study|Adverse Event|1
7316930|NCT00719043|11545600|FG002|Overall Study|Adverse Event|2
7316931|NCT00719043|11545601|FG003|Overall Study|Adverse Event|2
7316932|NCT00719043|11545602|FG004|Overall Study|Adverse Event|1
7316933|NCT00719043|11545603|FG005|Overall Study|Adverse Event|4
7316934|NCT00719043|11545604|FG006|Overall Study|Adverse Event|4
7316935|NCT00719043|11545598|FG000|Overall Study|Lost to Follow-up|14
7316936|NCT00719043|11545599|FG001|Overall Study|Lost to Follow-up|10
7316937|NCT00719043|11545600|FG002|Overall Study|Lost to Follow-up|8
7316938|NCT00719043|11545601|FG003|Overall Study|Lost to Follow-up|9
7316939|NCT00719043|11545602|FG004|Overall Study|Lost to Follow-up|10
7316940|NCT00719043|11545603|FG005|Overall Study|Lost to Follow-up|9
7316941|NCT00719043|11545604|FG006|Overall Study|Lost to Follow-up|9
7316942|NCT00719043|11545598|FG000|Overall Study|Protocol Violation|0
7316943|NCT00719043|11545599|FG001|Overall Study|Protocol Violation|0
7316944|NCT00719043|11545600|FG002|Overall Study|Protocol Violation|0
7316945|NCT00719043|11545601|FG003|Overall Study|Protocol Violation|0
7316946|NCT00719043|11545602|FG004|Overall Study|Protocol Violation|0
7316947|NCT00719043|11545603|FG005|Overall Study|Protocol Violation|1
7316948|NCT00719043|11545604|FG006|Overall Study|Protocol Violation|0
7316949|NCT00719043|11545598|FG000|Overall Study|Other|1
7316950|NCT00719043|11545599|FG001|Overall Study|Other|0
7316951|NCT00719043|11545600|FG002|Overall Study|Other|1
7316952|NCT00719043|11545601|FG003|Overall Study|Other|2
7316953|NCT00719043|11545602|FG004|Overall Study|Other|0
7316954|NCT00719043|11545603|FG005|Overall Study|Other|2
7316955|NCT00719043|11545604|FG006|Overall Study|Other|1
7316956|NCT00719043|11545598|FG000|Overall Study|Withdrawal by Subject|12
7316957|NCT00719043|11545599|FG001|Overall Study|Withdrawal by Subject|14
7316958|NCT00719043|11545600|FG002|Overall Study|Withdrawal by Subject|9
7316959|NCT00719043|11545601|FG003|Overall Study|Withdrawal by Subject|10
7316960|NCT00719043|11545602|FG004|Overall Study|Withdrawal by Subject|16
7316961|NCT00719043|11545603|FG005|Overall Study|Withdrawal by Subject|18
7316962|NCT00719043|11545604|FG006|Overall Study|Withdrawal by Subject|14
7316963|NCT00719212|11545654|FG000|Overall Study|Death|41
7316964|NCT00719212|11545654|FG000|Overall Study|Lost to Follow-up|2
7316965|NCT00719212|11545654|FG000|Overall Study|Withdrawal by Subject|1
7316966|NCT00719264|11545660|FG000|Overall Study|Adverse Event|41
7316967|NCT00719264|11545661|FG001|Overall Study|Adverse Event|49
7316968|NCT00719264|11545660|FG000|Overall Study|Death|13
7316969|NCT00719264|11545661|FG001|Overall Study|Death|10
7316970|NCT00719264|11545660|FG000|Overall Study|Administrative Problems|6
7316971|NCT00719264|11545661|FG001|Overall Study|Administrative Problems|4
7316972|NCT00719264|11545660|FG000|Overall Study|Lost to Follow-up|1
7316973|NCT00719264|11545661|FG001|Overall Study|Lost to Follow-up|1
7316974|NCT00719264|11545660|FG000|Overall Study|Withdrawal by Subject|12
7316975|NCT00719264|11545661|FG001|Overall Study|Withdrawal by Subject|7
7316976|NCT00719264|11545660|FG000|Overall Study|Protocol Deviation|1
7316977|NCT00719264|11545661|FG001|Overall Study|Protocol Deviation|3
7316978|NCT00719264|11545660|FG000|Overall Study|New Cancer Therapy|4
7316979|NCT00719264|11545661|FG001|Overall Study|New Cancer Therapy|2
7316980|NCT00719264|11545660|FG000|Overall Study|Disease Progression|104
7316981|NCT00719264|11545661|FG001|Overall Study|Disease Progression|107
7316982|NCT00719355|11545685|FG000|Overall Study|Death|0
7316983|NCT00719355|11545686|FG001|Overall Study|Death|1
7316984|NCT00719355|11545685|FG000|Overall Study|Medical|14
7316985|NCT00719355|11545686|FG001|Overall Study|Medical|5
7316986|NCT00719355|11545685|FG000|Overall Study|Compliance|4
7316987|NCT00719355|11545686|FG001|Overall Study|Compliance|6
7316988|NCT00719355|11545685|FG000|Overall Study|Moved|0
7316989|NCT00719355|11545686|FG001|Overall Study|Moved|1
7316990|NCT00719472|11545692|FG000|Enrolled in Study|Physician decision to withdraw patient|1
7316991|NCT00719472|11545692|FG000|Enrolled in Study|Subject decision to withdraw|8
7316992|NCT00719472|11545692|FG000|Enrolled in Study|Various Reasons|17
7316993|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Adverse Event|8
7316994|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Death|5
7317059|NCT00719862|11545781|FG001|Overall Study|Lost to Follow-up|1
7316995|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
7316996|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
7316997|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
7316998|NCT00719472|11545692|FG000|Received Cycle 1 Treatment|Various Reasons|13
7316999|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Adverse Event|12
7317000|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Death|6
7317001|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Disease progression|3
7317002|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
7317003|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
7317004|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
7317005|NCT00719472|11545692|FG000|Received Cycle 2 Treatment|Various Reasons|25
7317006|NCT00719537|11545698|FG000|Overall Study|Withdrawal by Subject|1
7317007|NCT00719537|11545699|FG001|Overall Study|Withdrawal by Subject|0
7317008|NCT00719537|11545698|FG000|Overall Study|Lost to Follow-up|0
7317009|NCT00719537|11545699|FG001|Overall Study|Lost to Follow-up|1
7317010|NCT00719563|11545707|FG000|Overall Study|Adverse Event|16
7317011|NCT00719563|11545708|FG001|Overall Study|Adverse Event|13
7317012|NCT00719563|11545707|FG000|Overall Study|Medical condition changed|3
7317013|NCT00719563|11545708|FG001|Overall Study|Medical condition changed|5
7317014|NCT00719563|11545707|FG000|Overall Study|Lack of Efficacy|3
7317015|NCT00719563|11545708|FG001|Overall Study|Lack of Efficacy|7
7317016|NCT00719563|11545707|FG000|Overall Study|Personal reasons|6
7317017|NCT00719563|11545708|FG001|Overall Study|Personal reasons|7
7317018|NCT00719563|11545707|FG000|Overall Study|Unknown reasons|4
7317019|NCT00719563|11545708|FG001|Overall Study|Unknown reasons|6
7317020|NCT00719563|11545707|FG000|Overall Study|Noncompliant|1
7317021|NCT00719563|11545708|FG001|Overall Study|Noncompliant|1
7317022|NCT00719563|11545707|FG000|Overall Study|Lost to Follow-up|5
7317023|NCT00719563|11545708|FG001|Overall Study|Lost to Follow-up|3
7317024|NCT00719680|11545739|FG000|Overall Study|Adverse Event|1
7317025|NCT00719680|11545739|FG000|Overall Study|Lost to Follow-up|1
7317026|NCT00719680|11545739|FG000|Overall Study|Withdrawal by Subject|3
7317027|NCT00719706|11545745|FG000|Overall Study|Adverse Event|5
7317028|NCT00719706|11545746|FG001|Overall Study|Adverse Event|4
7317029|NCT00719706|11545745|FG000|Overall Study|Withdrawal by Subject|1
7317030|NCT00719706|11545746|FG001|Overall Study|Withdrawal by Subject|2
7317031|NCT00719706|11545745|FG000|Overall Study|Protocol Violation|3
7317032|NCT00719706|11545746|FG001|Overall Study|Protocol Violation|0
7317033|NCT00719732|11545752|FG000|Overall Study|Lost to Follow-up|20
7317034|NCT00719732|11545752|FG000|Overall Study|Unilateral (not bilateral) implantation|1
7317035|NCT00719732|11545752|FG000|Overall Study|Illness not associated with device|1
7317036|NCT00719810|11545759|FG000|Overall Study|Adverse Event|0
7317037|NCT00719810|11545760|FG001|Overall Study|Adverse Event|2
7317038|NCT00719810|11545761|FG002|Overall Study|Adverse Event|3
7317039|NCT00719810|11545759|FG000|Overall Study|Lost to Follow-up|2
7317040|NCT00719810|11545760|FG001|Overall Study|Lost to Follow-up|0
7317041|NCT00719810|11545761|FG002|Overall Study|Lost to Follow-up|3
7317042|NCT00719810|11545759|FG000|Overall Study|Physician Decision|0
7317043|NCT00719810|11545760|FG001|Overall Study|Physician Decision|1
7317044|NCT00719810|11545761|FG002|Overall Study|Physician Decision|0
7317045|NCT00719810|11545759|FG000|Overall Study|Withdrawal by Subject|1
7317046|NCT00719810|11545760|FG001|Overall Study|Withdrawal by Subject|1
7317047|NCT00719810|11545761|FG002|Overall Study|Withdrawal by Subject|2
7317048|NCT00719849|11545771|FG000|Overall Study|Death|0
7317049|NCT00719849|11545772|FG001|Overall Study|Death|1
7317050|NCT00719862|11545780|FG000|Overall Study|Adverse Event|1
7317051|NCT00719862|11545781|FG001|Overall Study|Adverse Event|2
7317052|NCT00719862|11545780|FG000|Overall Study|Lack of Efficacy|3
7317053|NCT00719862|11545781|FG001|Overall Study|Lack of Efficacy|0
7391866|NCT01248455|11652744|FG000|Overall Study|switched to alternate treatment|1
7391867|NCT01248468|11652751|FG000|Overall Study|Administrative problem|1
7391868|NCT01248468|11652752|FG001|Overall Study|Administrative problem|0
7391869|NCT01248468|11652753|FG002|Overall Study|Administrative problem|0
7391870|NCT01248468|11652751|FG000|Overall Study|Lost to Follow-up|9
7391871|NCT01248468|11652752|FG001|Overall Study|Lost to Follow-up|12
7391872|NCT01248468|11652753|FG002|Overall Study|Lost to Follow-up|4
7391873|NCT01248468|11652751|FG000|Overall Study|Pregnancy|1
7391874|NCT01248468|11652752|FG001|Overall Study|Pregnancy|0
7391875|NCT01248468|11652753|FG002|Overall Study|Pregnancy|0
7391876|NCT01248468|11652751|FG000|Overall Study|Withdrawal by Subject|4
7391877|NCT01248468|11652752|FG001|Overall Study|Withdrawal by Subject|2
7391878|NCT01248468|11652753|FG002|Overall Study|Withdrawal by Subject|0
7391879|NCT01248715|11652772|FG000|Overall Study|Not influenza positive|501
7391880|NCT01248715|11652773|FG001|Overall Study|Not influenza positive|510
7391881|NCT01248728|11652781|FG000|Overall Study|Adverse Event|1
7391882|NCT01248728|11652782|FG001|Overall Study|Adverse Event|1
7391883|NCT01248728|11652781|FG000|Overall Study|Withdrawal by Subject|2
7391884|NCT01248728|11652782|FG001|Overall Study|Withdrawal by Subject|1
7317054|NCT00719862|11545780|FG000|Overall Study|Non-Compliance|1
7317055|NCT00719862|11545781|FG001|Overall Study|Non-Compliance|0
7391885|NCT01248728|11652781|FG000|Overall Study|Lack of Efficacy|1
7317056|NCT00719862|11545780|FG000|Overall Study|Withdrawal by Subject|1
7317057|NCT00719862|11545781|FG001|Overall Study|Withdrawal by Subject|0
7317058|NCT00719862|11545780|FG000|Overall Study|Lost to Follow-up|0
7317060|NCT00719862|11545780|FG000|Overall Study|Other|2
7317061|NCT00719862|11545781|FG001|Overall Study|Other|3
7317062|NCT00719901|11545787|FG000|Overall Study|Adverse Event|5
7317063|NCT00719901|11545787|FG000|Overall Study|Withdrawal by Subject|1
7317064|NCT00719901|11545787|FG000|Overall Study|Alternate Treatment|1
7317065|NCT00719901|11545787|FG000|Overall Study|Disease Progression|3
7317066|NCT00719901|11545787|FG000|Overall Study|Availability of Study Drug|1
7317067|NCT00719953|11545791|FG000|Overall Study|Adverse Event|4
7317068|NCT00720057|11545797|FG000|Overall Study|Lost to Follow-up|0
7317069|NCT00720057|11545798|FG001|Overall Study|Lost to Follow-up|2
7317070|NCT00720057|11545797|FG000|Overall Study|Protocol Violation|1
7317071|NCT00720057|11545798|FG001|Overall Study|Protocol Violation|0
7317072|NCT00720057|11545797|FG000|Overall Study|Withdrawal by Subject|0
7317073|NCT00720057|11545798|FG001|Overall Study|Withdrawal by Subject|1
7317074|NCT00720096|11545806|FG000|Overall Study|Withdrawal by Subject|0
7317075|NCT00720096|11545807|FG001|Overall Study|Withdrawal by Subject|2
7317076|NCT00720109|11545813|FG000|Induction Period|Did not meet eligibility criteria|3
7317077|NCT00720109|11545814|FG001|Induction Period|Did not meet eligibility criteria|0
7317078|NCT00720109|11545815|FG002|Induction Period|Did not meet eligibility criteria|0
7317079|NCT00720109|11545813|FG000|Induction Period|Bone Marrow Transplant|2
7317080|NCT00720109|11545814|FG001|Induction Period|Bone Marrow Transplant|0
7317081|NCT00720109|11545815|FG002|Induction Period|Bone Marrow Transplant|0
7317082|NCT00720109|11545813|FG000|Induction Period|Physician Decision|1
7317083|NCT00720109|11545814|FG001|Induction Period|Physician Decision|0
7317084|NCT00720109|11545815|FG002|Induction Period|Physician Decision|0
7317085|NCT00720109|11545813|FG000|Risk Stratification Period|Adverse Event|0
7317086|NCT00720109|11545814|FG001|Risk Stratification Period|Adverse Event|1
7317087|NCT00720109|11545815|FG002|Risk Stratification Period|Adverse Event|0
7317088|NCT00720109|11545813|FG000|Risk Stratification Period|Physician Decision|0
7317089|NCT00720109|11545814|FG001|Risk Stratification Period|Physician Decision|2
7317090|NCT00720109|11545815|FG002|Risk Stratification Period|Physician Decision|1
7317091|NCT00720109|11545813|FG000|Risk Stratification Period|Bone marrow transplant|0
7317092|NCT00720109|11545814|FG001|Risk Stratification Period|Bone marrow transplant|9
7317093|NCT00720109|11545815|FG002|Risk Stratification Period|Bone marrow transplant|7
7317094|NCT00720109|11545813|FG000|Risk Stratification Period|Disease progression or relapse|0
7317095|NCT00720109|11545814|FG001|Risk Stratification Period|Disease progression or relapse|2
7317096|NCT00720109|11545815|FG002|Risk Stratification Period|Disease progression or relapse|0
7317097|NCT00720109|11545813|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
7317098|NCT00720109|11545814|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
7317099|NCT00720109|11545815|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
7317100|NCT00720122|11545824|FG000|Overall Study|Lost to Follow-up|1
7317101|NCT00720122|11545824|FG000|Overall Study|Physician Decision|1
7317102|NCT00720122|11545824|FG000|Overall Study|Withdrawal by Subject|7
7317103|NCT00720213|11545828|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
7317104|NCT00720213|11545829|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
7317105|NCT00720213|11545830|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
7317106|NCT00720226|11545840|FG000|Overall Study|Withdrawal by Subject|7
7317107|NCT00720226|11545841|FG001|Overall Study|Withdrawal by Subject|4
7317108|NCT00720278|11545850|FG000|Overall Study|Adverse Event|5
7317109|NCT00720278|11545851|FG001|Overall Study|Adverse Event|3
7317110|NCT00720278|11545852|FG002|Overall Study|Adverse Event|4
7317111|NCT00720278|11545850|FG000|Overall Study|Withdrawal by Subject|0
7317112|NCT00720278|11545851|FG001|Overall Study|Withdrawal by Subject|1
7317113|NCT00720278|11545852|FG002|Overall Study|Withdrawal by Subject|0
7317114|NCT00720278|11545850|FG000|Overall Study|Lost to Follow-up|0
7317115|NCT00720278|11545851|FG001|Overall Study|Lost to Follow-up|0
7317116|NCT00720278|11545852|FG002|Overall Study|Lost to Follow-up|1
7317117|NCT00720278|11545850|FG000|Overall Study|Non-compliance|1
7317118|NCT00720278|11545851|FG001|Overall Study|Non-compliance|0
7317119|NCT00720278|11545852|FG002|Overall Study|Non-compliance|0
7317120|NCT00720278|11545850|FG000|Overall Study|eligibility criteria violation|1
7317121|NCT00720278|11545851|FG001|Overall Study|eligibility criteria violation|0
7317122|NCT00720278|11545852|FG002|Overall Study|eligibility criteria violation|1
7317123|NCT00720356|11545873|FG000|Registration to Study|Determined to have methylated MGMT|67
7317124|NCT00720356|11545873|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
7317125|NCT00720356|11545873|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
7317126|NCT00720356|11545873|FG000|Went on to be Treated Cycle 3|Adverse Event|1
7317127|NCT00720356|11545873|FG000|Went on to be Treated Cycle 3|Physician Decision|1
7317128|NCT00720356|11545873|FG000|Follow up Until Death|Withdrawal by Subject|1
7317129|NCT00720356|11545873|FG000|Follow up Until Death|Alive at last data collection|4
7317130|NCT00720382|11545890|FG000|Overall Study|Adverse Event|54
7317131|NCT00720382|11545891|FG001|Overall Study|Adverse Event|17
7317132|NCT00720382|11545890|FG000|Overall Study|Lack of Efficacy|18
7317133|NCT00720382|11545891|FG001|Overall Study|Lack of Efficacy|7
7317134|NCT00720382|11545890|FG000|Overall Study|Non-Compliance|15
7317135|NCT00720382|11545891|FG001|Overall Study|Non-Compliance|5
7317136|NCT00720382|11545890|FG000|Overall Study|Withdrawal by Subject|47
7317137|NCT00720382|11545891|FG001|Overall Study|Withdrawal by Subject|11
7317138|NCT00720382|11545890|FG000|Overall Study|Lost to Follow-up|28
7317139|NCT00720382|11545891|FG001|Overall Study|Lost to Follow-up|14
7317140|NCT00720382|11545890|FG000|Overall Study|administrative|14
7317141|NCT00720382|11545891|FG001|Overall Study|administrative|5
7317142|NCT00720434|11545901|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7317143|NCT00720434|11545902|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
7317144|NCT00720434|11545903|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7317145|NCT00720434|11545904|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
7317146|NCT00720434|11545901|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
7317147|NCT00720434|11545902|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
7317148|NCT00720434|11545903|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
7317149|NCT00720434|11545904|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
7317150|NCT00720434|11545901|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
7317151|NCT00720434|11545902|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7317152|NCT00720434|11545903|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7317153|NCT00720434|11545904|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
7317154|NCT00720434|11545901|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7317155|NCT00720434|11545902|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7317156|NCT00720434|11545903|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
7317157|NCT00720434|11545904|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
7317158|NCT00720434|11545901|FG000|Open-Label Period (Week 5-72)|Other|4
7317159|NCT00720434|11545902|FG001|Open-Label Period (Week 5-72)|Other|3
7317160|NCT00720434|11545903|FG002|Open-Label Period (Week 5-72)|Other|3
7317161|NCT00720434|11545904|FG003|Open-Label Period (Week 5-72)|Other|2
7317162|NCT00720499|11545924|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
7317163|NCT00720499|11545925|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
7317164|NCT00720499|11545924|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
7317165|NCT00720499|11545925|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
7317166|NCT00720499|11545924|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
7317167|NCT00720499|11545925|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
7317168|NCT00720759|11545942|FG000|Overall Study|Lost to Follow-up|0
7317169|NCT00720759|11545943|FG001|Overall Study|Lost to Follow-up|1
7317170|NCT00720759|11545944|FG002|Overall Study|Lost to Follow-up|1
7317171|NCT00720759|11545945|FG003|Overall Study|Lost to Follow-up|0
7317172|NCT00720798|11545955|FG000|Overall Study|Adverse Event|304
7317173|NCT00720798|11545955|FG000|Overall Study|Death|39
7317174|NCT00720798|11545955|FG000|Overall Study|Insufficient Therapeutic Response|129
7317175|NCT00720798|11545955|FG000|Overall Study|Protocol Violation|4
7317176|NCT00720798|11545955|FG000|Overall Study|Refused Treatment|151
7317177|NCT00720798|11545955|FG000|Overall Study|Failure to Return|46
7317178|NCT00720798|11545955|FG000|Overall Study|Reason not Specified|83
7317179|NCT00720876|11545959|FG000|Overall Study|found to be ineligible after starting tx|2
7317180|NCT00720941|11545965|FG000|Overall Study|Death|334
7317181|NCT00720941|11545966|FG001|Overall Study|Death|335
7317182|NCT00720941|11545965|FG000|Overall Study|Protocol Violation|0
7317183|NCT00720941|11545966|FG001|Overall Study|Protocol Violation|2
7317184|NCT00720941|11545965|FG000|Overall Study|Lost to Follow-up|17
7317185|NCT00720941|11545966|FG001|Overall Study|Lost to Follow-up|15
7317186|NCT00720941|11545965|FG000|Overall Study|Physician Decision|1
7317187|NCT00720941|11545966|FG001|Overall Study|Physician Decision|5
7317188|NCT00720941|11545965|FG000|Overall Study|Withdrawal by Subject|27
7317189|NCT00720941|11545966|FG001|Overall Study|Withdrawal by Subject|35
7317190|NCT00720941|11545965|FG000|Overall Study|Ongoing|34
7317191|NCT00720941|11545966|FG001|Overall Study|Ongoing|23
7317192|NCT00721110|11545976|FG000|Overall Study|Ultram use|1
7317193|NCT00721110|11545977|FG001|Overall Study|Ultram use|0
7317194|NCT00721110|11545978|FG002|Overall Study|Ultram use|0
7317195|NCT00721110|11545979|FG003|Overall Study|Ultram use|0
7317196|NCT00721110|11545976|FG000|Overall Study|vertical incision|0
7317197|NCT00721110|11545977|FG001|Overall Study|vertical incision|0
7317198|NCT00721110|11545978|FG002|Overall Study|vertical incision|1
7317199|NCT00721110|11545979|FG003|Overall Study|vertical incision|0
7317200|NCT00721123|11545989|FG000|Overall Study|Adverse Event|96
7317201|NCT00721123|11545989|FG000|Overall Study|Death|10
7317202|NCT00721123|11545989|FG000|Overall Study|Insufficient Therapeutic Response|21
7317203|NCT00721123|11545989|FG000|Overall Study|Protocol Violation|1
7317204|NCT00721123|11545989|FG000|Overall Study|Refused Treatment|41
7317205|NCT00721123|11545989|FG000|Overall Study|Failure to Return|9
7317206|NCT00721123|11545989|FG000|Overall Study|Withdrawal by Subject|5
7317207|NCT00721149|11546030|FG000|Overall Study|Physician Decision|1
7317208|NCT00721214|11546051|FG000|Overall Study|Chose another center for transplant|1
7317209|NCT00721214|11546051|FG000|Overall Study|Death|3
7317210|NCT00721227|11546057|FG000|Overall Study|Lost to Follow-up|3
7317211|NCT00721227|11546058|FG001|Overall Study|Lost to Follow-up|0
7317212|NCT00721227|11546057|FG000|Overall Study|Noncompliance with scheduled visits.|1
7317213|NCT00721227|11546058|FG001|Overall Study|Noncompliance with scheduled visits.|0
7317214|NCT00721279|11546076|FG000|Overall Study|Lack of Efficacy|6
7317215|NCT00721279|11546077|FG001|Overall Study|Lack of Efficacy|3
7317216|NCT00721279|11546076|FG000|Overall Study|Tolerability insufficient|5
7317217|NCT00721279|11546077|FG001|Overall Study|Tolerability insufficient|2
7317218|NCT00721279|11546076|FG000|Overall Study|Withdrawal by Subject|13
7317219|NCT00721279|11546077|FG001|Overall Study|Withdrawal by Subject|3
7317220|NCT00721279|11546076|FG000|Overall Study|Other|12
7317221|NCT00721279|11546077|FG001|Overall Study|Other|16
7317222|NCT00721396|11546099|FG000|Overall Study|Adverse Event|4
7317223|NCT00721396|11546100|FG001|Overall Study|Adverse Event|7
7317224|NCT00721396|11546101|FG002|Overall Study|Adverse Event|2
7317225|NCT00721396|11546102|FG003|Overall Study|Adverse Event|0
7317226|NCT00721396|11546099|FG000|Overall Study|Withdrawal by Subject|12
7317227|NCT00721396|11546100|FG001|Overall Study|Withdrawal by Subject|15
7317228|NCT00721396|11546101|FG002|Overall Study|Withdrawal by Subject|3
7317229|NCT00721396|11546102|FG003|Overall Study|Withdrawal by Subject|7
7317230|NCT00721396|11546099|FG000|Overall Study|Lost to Follow-up|7
7317231|NCT00721396|11546100|FG001|Overall Study|Lost to Follow-up|9
7317232|NCT00721396|11546101|FG002|Overall Study|Lost to Follow-up|3
7317233|NCT00721396|11546102|FG003|Overall Study|Lost to Follow-up|3
7317234|NCT00721396|11546099|FG000|Overall Study|Protocol Violation|4
7317235|NCT00721396|11546100|FG001|Overall Study|Protocol Violation|3
7317236|NCT00721396|11546101|FG002|Overall Study|Protocol Violation|1
7317237|NCT00721396|11546102|FG003|Overall Study|Protocol Violation|0
7317238|NCT00721396|11546099|FG000|Overall Study|Inappropriate enrollment|0
7317239|NCT00721396|11546100|FG001|Overall Study|Inappropriate enrollment|2
7317240|NCT00721396|11546101|FG002|Overall Study|Inappropriate enrollment|0
7317241|NCT00721396|11546102|FG003|Overall Study|Inappropriate enrollment|0
7317242|NCT00721396|11546099|FG000|Overall Study|Administrative reason|3
7317243|NCT00721396|11546100|FG001|Overall Study|Administrative reason|0
7317244|NCT00721396|11546101|FG002|Overall Study|Administrative reason|1
7317245|NCT00721396|11546102|FG003|Overall Study|Administrative reason|0
7317246|NCT00721409|11546120|FG000|Overall Study|Global deterioration of health status|2
7317247|NCT00721409|11546121|FG001|Overall Study|Global deterioration of health status|6
7317248|NCT00721409|11546122|FG002|Overall Study|Global deterioration of health status|3
7317249|NCT00721409|11546120|FG000|Overall Study|Death|0
7317250|NCT00721409|11546121|FG001|Overall Study|Death|1
7317251|NCT00721409|11546122|FG002|Overall Study|Death|0
7317252|NCT00721409|11546120|FG000|Overall Study|Randomized not Treated|0
7317253|NCT00721409|11546121|FG001|Overall Study|Randomized not Treated|1
7317254|NCT00721409|11546122|FG002|Overall Study|Randomized not Treated|4
7317255|NCT00721409|11546120|FG000|Overall Study|Reason not specified|1
7317256|NCT00721409|11546121|FG001|Overall Study|Reason not specified|0
7317257|NCT00721409|11546122|FG002|Overall Study|Reason not specified|2
7317258|NCT00721409|11546120|FG000|Overall Study|Adverse Event|0
7317259|NCT00721409|11546121|FG001|Overall Study|Adverse Event|13
7317260|NCT00721409|11546122|FG002|Overall Study|Adverse Event|2
7317261|NCT00721409|11546120|FG000|Overall Study|Lost to Follow-up|0
7317262|NCT00721409|11546121|FG001|Overall Study|Lost to Follow-up|0
7317263|NCT00721409|11546122|FG002|Overall Study|Lost to Follow-up|1
7317264|NCT00721409|11546120|FG000|Overall Study|Withdrawal by Subject|1
7317265|NCT00721409|11546121|FG001|Overall Study|Withdrawal by Subject|6
7317266|NCT00721409|11546122|FG002|Overall Study|Withdrawal by Subject|5
7317267|NCT00721409|11546120|FG000|Overall Study|Objective progression or relapse|8
7317268|NCT00721409|11546121|FG001|Overall Study|Objective progression or relapse|55
7317269|NCT00721409|11546122|FG002|Overall Study|Objective progression or relapse|62
7317270|NCT00721578|11546169|FG000|Overall Study|Death|1
7317271|NCT00721578|11546170|FG001|Overall Study|Death|1
7317272|NCT00721578|11546169|FG000|Overall Study|Withdrawal by Subject|1
7317273|NCT00721578|11546170|FG001|Overall Study|Withdrawal by Subject|1
7317274|NCT00721630|11546181|FG000|Overall Study|Participant found to be ineligible|1
7317275|NCT00721734|11546190|FG000|Overall Study|Progressive Disease|3
7317276|NCT00721734|11546191|FG001|Overall Study|Progressive Disease|10
7317277|NCT00721734|11546192|FG002|Overall Study|Progressive Disease|4
7317278|NCT00721734|11546193|FG003|Overall Study|Progressive Disease|5
7317279|NCT00721734|11546194|FG004|Overall Study|Progressive Disease|2
7317280|NCT00721734|11546190|FG000|Overall Study|Adverse Event|3
7317281|NCT00721734|11546191|FG001|Overall Study|Adverse Event|1
7317282|NCT00721734|11546192|FG002|Overall Study|Adverse Event|4
7317283|NCT00721734|11546193|FG003|Overall Study|Adverse Event|0
7317284|NCT00721734|11546194|FG004|Overall Study|Adverse Event|3
7317285|NCT00721734|11546190|FG000|Overall Study|Withdrawal by Subject|2
7317286|NCT00721734|11546191|FG001|Overall Study|Withdrawal by Subject|1
7317287|NCT00721734|11546192|FG002|Overall Study|Withdrawal by Subject|0
7317288|NCT00721734|11546193|FG003|Overall Study|Withdrawal by Subject|0
7317289|NCT00721734|11546194|FG004|Overall Study|Withdrawal by Subject|1
7317290|NCT00721734|11546190|FG000|Overall Study|Other|0
7317291|NCT00721734|11546191|FG001|Overall Study|Other|0
7317292|NCT00721734|11546192|FG002|Overall Study|Other|0
7317293|NCT00721734|11546193|FG003|Overall Study|Other|1
7317294|NCT00721734|11546194|FG004|Overall Study|Other|0
7317295|NCT00721799|11546206|FG000|Overall Study|Withdrawal by Subject|7
7317296|NCT00721799|11546206|FG000|Overall Study|withdraw by subject after scan 1|1
7317297|NCT00721955|11546213|FG000|Overall Study|Adverse Event|0
7317298|NCT00721955|11546214|FG001|Overall Study|Adverse Event|0
7317299|NCT00721955|11546215|FG002|Overall Study|Adverse Event|2
7317300|NCT00721968|11546225|FG000|Overall Study|Lost to Follow-up|2
7317301|NCT00721968|11546226|FG001|Overall Study|Lost to Follow-up|0
7317302|NCT00722137|11546276|FG000|Overall Study|Overt Disease Progression|5
7317303|NCT00722137|11546277|FG001|Overall Study|Overt Disease Progression|4
7317304|NCT00722137|11546276|FG000|Overall Study|Adverse Event|17
7317305|NCT00722137|11546277|FG001|Overall Study|Adverse Event|21
7317306|NCT00722137|11546276|FG000|Overall Study|Death|12
7317307|NCT00722137|11546277|FG001|Overall Study|Death|7
7317308|NCT00722137|11546276|FG000|Overall Study|Withdrawal by Subject|6
7317309|NCT00722137|11546277|FG001|Overall Study|Withdrawal by Subject|9
7317310|NCT00722137|11546276|FG000|Overall Study|Other Reason Unknown|3
7317311|NCT00722137|11546277|FG001|Overall Study|Other Reason Unknown|4
7317312|NCT00722137|11546276|FG000|Overall Study|Randomized But Not Treated|2
7317313|NCT00722137|11546277|FG001|Overall Study|Randomized But Not Treated|3
7317314|NCT00722371|11546290|FG000|Overall Study|Adverse Event|6
7224616|NCT00056160|11433882|FG001|Final Follow-up|Transferred into RevAssist Program|0
7224617|NCT00056160|11433881|FG000|Final Follow-up|Adverse Event|1
7224618|NCT00056160|11433882|FG001|Final Follow-up|Adverse Event|0
7224619|NCT00056316|11433890|FG000|Overall Study|Withdrawal by Subject|2
7317315|NCT00722371|11546291|FG001|Overall Study|Adverse Event|13
7317316|NCT00722371|11546292|FG002|Overall Study|Adverse Event|9
7317317|NCT00722371|11546293|FG003|Overall Study|Adverse Event|10
7317318|NCT00722371|11546294|FG004|Overall Study|Adverse Event|6
7317319|NCT00722371|11546295|FG005|Overall Study|Adverse Event|8
7317320|NCT00722371|11546296|FG006|Overall Study|Adverse Event|4
7317321|NCT00722371|11546290|FG000|Overall Study|Contraindication|0
7317322|NCT00722371|11546291|FG001|Overall Study|Contraindication|0
7317323|NCT00722371|11546292|FG002|Overall Study|Contraindication|1
7317324|NCT00722371|11546293|FG003|Overall Study|Contraindication|0
7317325|NCT00722371|11546294|FG004|Overall Study|Contraindication|0
7317326|NCT00722371|11546295|FG005|Overall Study|Contraindication|0
7317327|NCT00722371|11546296|FG006|Overall Study|Contraindication|0
7317328|NCT00722371|11546290|FG000|Overall Study|Creatinine / Creatinine clearance|2
7317329|NCT00722371|11546291|FG001|Overall Study|Creatinine / Creatinine clearance|1
7317330|NCT00722371|11546292|FG002|Overall Study|Creatinine / Creatinine clearance|2
7317331|NCT00722371|11546293|FG003|Overall Study|Creatinine / Creatinine clearance|3
7317332|NCT00722371|11546294|FG004|Overall Study|Creatinine / Creatinine clearance|2
7317333|NCT00722371|11546295|FG005|Overall Study|Creatinine / Creatinine clearance|1
7317334|NCT00722371|11546296|FG006|Overall Study|Creatinine / Creatinine clearance|1
7317335|NCT00722371|11546290|FG000|Overall Study|Excluded medication|0
7317336|NCT00722371|11546291|FG001|Overall Study|Excluded medication|1
7317337|NCT00722371|11546292|FG002|Overall Study|Excluded medication|1
7317338|NCT00722371|11546293|FG003|Overall Study|Excluded medication|0
7317339|NCT00722371|11546294|FG004|Overall Study|Excluded medication|0
7317340|NCT00722371|11546295|FG005|Overall Study|Excluded medication|0
7317341|NCT00722371|11546296|FG006|Overall Study|Excluded medication|1
7317342|NCT00722371|11546290|FG000|Overall Study|Hyperglycemia|2
7317343|NCT00722371|11546291|FG001|Overall Study|Hyperglycemia|6
7317344|NCT00722371|11546292|FG002|Overall Study|Hyperglycemia|4
7317345|NCT00722371|11546293|FG003|Overall Study|Hyperglycemia|2
7317346|NCT00722371|11546294|FG004|Overall Study|Hyperglycemia|5
7317347|NCT00722371|11546295|FG005|Overall Study|Hyperglycemia|1
7317348|NCT00722371|11546296|FG006|Overall Study|Hyperglycemia|1
7317349|NCT00722371|11546290|FG000|Overall Study|Hypoglycemia|1
7317350|NCT00722371|11546291|FG001|Overall Study|Hypoglycemia|0
7317351|NCT00722371|11546292|FG002|Overall Study|Hypoglycemia|0
7317352|NCT00722371|11546293|FG003|Overall Study|Hypoglycemia|0
7317353|NCT00722371|11546294|FG004|Overall Study|Hypoglycemia|0
7317354|NCT00722371|11546295|FG005|Overall Study|Hypoglycemia|0
7317355|NCT00722371|11546296|FG006|Overall Study|Hypoglycemia|0
7317356|NCT00722371|11546290|FG000|Overall Study|Lack of Efficacy|4
7317357|NCT00722371|11546291|FG001|Overall Study|Lack of Efficacy|6
7317358|NCT00722371|11546292|FG002|Overall Study|Lack of Efficacy|6
7317359|NCT00722371|11546293|FG003|Overall Study|Lack of Efficacy|6
7317360|NCT00722371|11546294|FG004|Overall Study|Lack of Efficacy|2
7317361|NCT00722371|11546295|FG005|Overall Study|Lack of Efficacy|3
7317362|NCT00722371|11546296|FG006|Overall Study|Lack of Efficacy|0
7317363|NCT00722371|11546290|FG000|Overall Study|Lost to Follow-up|11
7317364|NCT00722371|11546291|FG001|Overall Study|Lost to Follow-up|14
7317365|NCT00722371|11546292|FG002|Overall Study|Lost to Follow-up|21
7317366|NCT00722371|11546293|FG003|Overall Study|Lost to Follow-up|13
7317367|NCT00722371|11546294|FG004|Overall Study|Lost to Follow-up|8
7317368|NCT00722371|11546295|FG005|Overall Study|Lost to Follow-up|16
7317369|NCT00722371|11546296|FG006|Overall Study|Lost to Follow-up|13
7317370|NCT00722371|11546290|FG000|Overall Study|Physician Decision|5
7317371|NCT00722371|11546291|FG001|Overall Study|Physician Decision|2
7317372|NCT00722371|11546292|FG002|Overall Study|Physician Decision|2
7317373|NCT00722371|11546293|FG003|Overall Study|Physician Decision|5
7317374|NCT00722371|11546294|FG004|Overall Study|Physician Decision|2
7317375|NCT00722371|11546295|FG005|Overall Study|Physician Decision|3
7317376|NCT00722371|11546296|FG006|Overall Study|Physician Decision|4
7317377|NCT00722371|11546290|FG000|Overall Study|Pregnancy|1
7317378|NCT00722371|11546291|FG001|Overall Study|Pregnancy|1
7317379|NCT00722371|11546292|FG002|Overall Study|Pregnancy|0
7317380|NCT00722371|11546293|FG003|Overall Study|Pregnancy|0
7317381|NCT00722371|11546294|FG004|Overall Study|Pregnancy|0
7317382|NCT00722371|11546295|FG005|Overall Study|Pregnancy|1
7317383|NCT00722371|11546296|FG006|Overall Study|Pregnancy|0
7317384|NCT00722371|11546290|FG000|Overall Study|Protocol Violation|6
7317385|NCT00722371|11546291|FG001|Overall Study|Protocol Violation|1
7317386|NCT00722371|11546292|FG002|Overall Study|Protocol Violation|0
7317387|NCT00722371|11546293|FG003|Overall Study|Protocol Violation|1
7317388|NCT00722371|11546294|FG004|Overall Study|Protocol Violation|4
7317389|NCT00722371|11546295|FG005|Overall Study|Protocol Violation|2
7317390|NCT00722371|11546296|FG006|Overall Study|Protocol Violation|1
7317391|NCT00722371|11546290|FG000|Overall Study|Withdrawal by Subject|18
7317392|NCT00722371|11546291|FG001|Overall Study|Withdrawal by Subject|27
7317393|NCT00722371|11546292|FG002|Overall Study|Withdrawal by Subject|19
7317394|NCT00722371|11546293|FG003|Overall Study|Withdrawal by Subject|23
7317395|NCT00722371|11546294|FG004|Overall Study|Withdrawal by Subject|19
7317396|NCT00722371|11546295|FG005|Overall Study|Withdrawal by Subject|18
7317397|NCT00722371|11546296|FG006|Overall Study|Withdrawal by Subject|26
7317398|NCT00722423|11546314|FG000|Overall Study|Protocol Violation|0
7317399|NCT00722423|11546315|FG001|Overall Study|Protocol Violation|1
7317400|NCT00722761|11546364|FG000|Overall Study|Lost to Follow-up|1
7317401|NCT00722761|11546365|FG001|Overall Study|Lost to Follow-up|4
7317402|NCT00722761|11546364|FG000|Overall Study|Withdrawal by Subject|5
7317403|NCT00722761|11546365|FG001|Overall Study|Withdrawal by Subject|2
7317404|NCT00722800|11546373|FG000|Overall Study|Withdrawal by Subject|1
7317405|NCT00722800|11546374|FG001|Overall Study|Withdrawal by Subject|0
7317406|NCT00722800|11546373|FG000|Overall Study|Physician Decision|1
7317407|NCT00722800|11546374|FG001|Overall Study|Physician Decision|0
7317408|NCT00723008|11546386|FG000|Enrollment|Lost to Follow-up|1
7317409|NCT00723008|11546387|FG001|Enrollment|Lost to Follow-up|0
7317410|NCT00723008|11546386|FG000|4-Week Double Blinded|Lack of Efficacy|0
7317411|NCT00723008|11546387|FG001|4-Week Double Blinded|Lack of Efficacy|1
7317412|NCT00723008|11546386|FG000|4-Week Double Blinded|Withdrawal by Subject|1
7317413|NCT00723008|11546387|FG001|4-Week Double Blinded|Withdrawal by Subject|1
7317414|NCT00723008|11546386|FG000|4-Week Double Blinded|Lost to Follow-up|4
7317415|NCT00723008|11546387|FG001|4-Week Double Blinded|Lost to Follow-up|3
7317416|NCT00723008|11546386|FG000|4-Week Unblinded Treatment|Adverse Event|1
7317417|NCT00723008|11546387|FG001|4-Week Unblinded Treatment|Adverse Event|0
7317418|NCT00723008|11546386|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
7317419|NCT00723008|11546387|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
7317420|NCT00723021|11546401|FG000|Intervention Period 4|Adverse Event|0
7317421|NCT00723021|11546402|FG001|Intervention Period 4|Adverse Event|0
7317422|NCT00723021|11546403|FG002|Intervention Period 4|Adverse Event|0
7317423|NCT00723021|11546404|FG003|Intervention Period 4|Adverse Event|0
7317424|NCT00723021|11546405|FG004|Intervention Period 4|Adverse Event|1
7317425|NCT00723125|11546440|FG000|Overall Study|Met Dx|1
7317426|NCT00723125|11546441|FG001|Overall Study|Met Dx|0
7317427|NCT00723125|11546440|FG000|Overall Study|Withdrawal by Subject|15
7317428|NCT00723125|11546441|FG001|Overall Study|Withdrawal by Subject|6
7317429|NCT00723125|11546440|FG000|Overall Study|Adverse Event|2
7317430|NCT00723125|11546441|FG001|Overall Study|Adverse Event|0
7317431|NCT00723190|11546466|FG000|Overall Study|Withdrawal by Subject|45
7317432|NCT00723190|11546466|FG000|Overall Study|Lost to Follow-up|37
7317433|NCT00723190|11546466|FG000|Overall Study|Adverse Event|18
7317434|NCT00723190|11546466|FG000|Overall Study|Lack of Efficacy|16
7317435|NCT00723190|11546466|FG000|Overall Study|Protocol Violation|15
7317436|NCT00723190|11546466|FG000|Overall Study|Other-Premature Discontinuation|9
7317437|NCT00723190|11546466|FG000|Overall Study|Other-Not included in safety population|2
7317438|NCT00723203|11546470|FG000|Overall Study|Withdrawal by Subject|3
7317439|NCT00723229|11546476|FG000|First Intervention|Lost to Follow-up|7
7317440|NCT00723229|11546477|FG001|First Intervention|Lost to Follow-up|3
7317441|NCT00723255|11546483|FG000|Overall Study|Ineligible: Inadequate pathology|1
7317442|NCT00723255|11546483|FG000|Overall Study|Ineligible: Second primary|1
7317443|NCT00723255|11546483|FG000|Overall Study|Ineligible: Wrong Primary|2
7317444|NCT00723294|11546499|FG000|Overall Study|Lobular histology|2
7317445|NCT00723294|11546499|FG000|Overall Study|>25% intraductal component|1
7317446|NCT00723294|11546499|FG000|Overall Study|No MRI tumor enhancement|1
7317447|NCT00723294|11546499|FG000|Overall Study|1.0-Tesla MRI|1
7317448|NCT00723294|11546499|FG000|Overall Study|No cryoabalation|2
7317449|NCT00723294|11546499|FG000|Overall Study|Did not undergo surgery|1
7317450|NCT00723294|11546499|FG000|Overall Study|Treated prior to registration|1
7317451|NCT00723294|11546499|FG000|Overall Study|Treated by non-credentialed surgeon|1
7317452|NCT00723294|11546499|FG000|Overall Study|Benign lesion|1
7317453|NCT00723294|11546499|FG000|Overall Study|Withdrawal by Subject|1
7317454|NCT00723294|11546499|FG000|Overall Study|No treatment due to probe failure|1
7317455|NCT00723398|11546508|FG000|Overall Study|Withdrawal by Subject|2
7317456|NCT00723398|11546509|FG001|Overall Study|Withdrawal by Subject|6
7317457|NCT00723398|11546510|FG002|Overall Study|Withdrawal by Subject|4
7317458|NCT00723398|11546511|FG003|Overall Study|Withdrawal by Subject|4
7317459|NCT00723398|11546512|FG004|Overall Study|Withdrawal by Subject|4
7317460|NCT00723398|11546508|FG000|Overall Study|Protocol Violation|2
7317461|NCT00723398|11546509|FG001|Overall Study|Protocol Violation|1
7317462|NCT00723398|11546510|FG002|Overall Study|Protocol Violation|5
7317463|NCT00723398|11546511|FG003|Overall Study|Protocol Violation|0
7317464|NCT00723398|11546512|FG004|Overall Study|Protocol Violation|0
7391886|NCT01248728|11652782|FG001|Overall Study|Lack of Efficacy|0
7391887|NCT01248780|11652796|FG000|Overall Study|Lack of Efficacy|2
7391888|NCT01248780|11652797|FG001|Overall Study|Lack of Efficacy|0
7391889|NCT01248780|11652796|FG000|Overall Study|Lost to Follow-up|0
7391890|NCT01248780|11652797|FG001|Overall Study|Lost to Follow-up|1
7391891|NCT01248780|11652796|FG000|Overall Study|Death|0
7391892|NCT01248780|11652797|FG001|Overall Study|Death|1
7391893|NCT01248780|11652796|FG000|Overall Study|Adverse Event|2
7391894|NCT01248780|11652797|FG001|Overall Study|Adverse Event|7
7391895|NCT01248780|11652796|FG000|Overall Study|Protocol Violation|1
7391896|NCT01248780|11652797|FG001|Overall Study|Protocol Violation|1
7391897|NCT01248780|11652796|FG000|Overall Study|Withdrawal by Subject|4
7391898|NCT01248780|11652797|FG001|Overall Study|Withdrawal by Subject|4
7391899|NCT01248780|11652796|FG000|Overall Study|Not treated|0
7391900|NCT01248780|11652797|FG001|Overall Study|Not treated|1
7391901|NCT01248793|11652805|FG000|Overall Study|Lost to Follow-up|0
7391902|NCT01248793|11652806|FG001|Overall Study|Lost to Follow-up|1
7391903|NCT01248793|11652805|FG000|Overall Study|Adverse Event|1
7391904|NCT01248793|11652806|FG001|Overall Study|Adverse Event|1
7391905|NCT01248793|11652805|FG000|Overall Study|Protocol Violation|0
7391906|NCT01248793|11652806|FG001|Overall Study|Protocol Violation|1
7391907|NCT01248793|11652805|FG000|Overall Study|Withdrawal by Subject|3
7391908|NCT01248793|11652806|FG001|Overall Study|Withdrawal by Subject|3
7391909|NCT01248884|11652815|FG000|Overall Study|Withdrawal by Subject|1
7391910|NCT01248884|11652816|FG001|Overall Study|Withdrawal by Subject|3
7391911|NCT01248884|11652817|FG002|Overall Study|Withdrawal by Subject|1
7391912|NCT01248884|11652815|FG000|Overall Study|Adverse Event|1
7391913|NCT01248884|11652816|FG001|Overall Study|Adverse Event|0
7391914|NCT01248884|11652817|FG002|Overall Study|Adverse Event|0
7391915|NCT01248936|11652827|FG000|Overall Study|Sponsor Decision|259
7391916|NCT01248936|11652827|FG000|Overall Study|Progression of Disease|50
7391917|NCT01248936|11652827|FG000|Overall Study|Death|26
7391918|NCT01248936|11652827|FG000|Overall Study|Withdrawal of Consent|20
7391919|NCT01248936|11652827|FG000|Overall Study|Adverse Event|8
7391920|NCT01248936|11652827|FG000|Overall Study|Lost to Follow-up|7
7391921|NCT01248936|11652827|FG000|Overall Study|Refused Treatment|1
7391922|NCT01248936|11652827|FG000|Overall Study|Other reason|3
7391923|NCT01248949|11652837|FG000|Overall Study|Lost to Follow-up|2
7391924|NCT01248949|11652838|FG001|Overall Study|Lost to Follow-up|2
7391925|NCT01248949|11652839|FG002|Overall Study|Lost to Follow-up|2
7391926|NCT01248949|11652840|FG003|Overall Study|Lost to Follow-up|1
7391927|NCT01248949|11652841|FG004|Overall Study|Lost to Follow-up|0
7391928|NCT01248949|11652837|FG000|Overall Study|Withdrawal by Subject|5
7391929|NCT01248949|11652838|FG001|Overall Study|Withdrawal by Subject|3
7391930|NCT01248949|11652839|FG002|Overall Study|Withdrawal by Subject|11
7391931|NCT01248949|11652840|FG003|Overall Study|Withdrawal by Subject|3
7391932|NCT01248949|11652841|FG004|Overall Study|Withdrawal by Subject|1
7391933|NCT01248949|11652837|FG000|Overall Study|Death|22
7391934|NCT01248949|11652838|FG001|Overall Study|Death|7
7391935|NCT01248949|11652839|FG002|Overall Study|Death|21
7391936|NCT01248949|11652840|FG003|Overall Study|Death|6
7391937|NCT01248949|11652841|FG004|Overall Study|Death|2
7391938|NCT01248949|11652837|FG000|Overall Study|Alternative Therapy|1
7391939|NCT01248949|11652838|FG001|Overall Study|Alternative Therapy|0
7391940|NCT01248949|11652839|FG002|Overall Study|Alternative Therapy|0
7391941|NCT01248949|11652840|FG003|Overall Study|Alternative Therapy|0
7391942|NCT01248949|11652841|FG004|Overall Study|Alternative Therapy|0
7391943|NCT01248949|11652837|FG000|Overall Study|Alternative Therapy.|1
7391944|NCT01248949|11652838|FG001|Overall Study|Alternative Therapy.|0
7391945|NCT01248949|11652839|FG002|Overall Study|Alternative Therapy.|0
7391946|NCT01248949|11652840|FG003|Overall Study|Alternative Therapy.|0
7391947|NCT01248949|11652841|FG004|Overall Study|Alternative Therapy.|0
7391948|NCT01248949|11652837|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
7391949|NCT01248949|11652838|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
7391950|NCT01248949|11652839|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
7391951|NCT01248949|11652840|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
7391952|NCT01248949|11652841|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
7391953|NCT01248949|11652837|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
7391954|NCT01248949|11652838|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
7391955|NCT01248949|11652839|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
7391956|NCT01248949|11652840|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
7391957|NCT01248949|11652841|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
7391958|NCT01248949|11652837|FG000|Overall Study|Participant Went To Hospice|0
7391959|NCT01248949|11652838|FG001|Overall Study|Participant Went To Hospice|0
7391960|NCT01248949|11652839|FG002|Overall Study|Participant Went To Hospice|1
7391961|NCT01248949|11652840|FG003|Overall Study|Participant Went To Hospice|0
7391962|NCT01248949|11652841|FG004|Overall Study|Participant Went To Hospice|0
7391963|NCT01248949|11652837|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
7391964|NCT01248949|11652838|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
7391965|NCT01248949|11652839|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
7391966|NCT01248949|11652840|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
7391967|NCT01248949|11652841|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
7391968|NCT01248949|11652837|FG000|Overall Study|Pi Decision Due To Declining Status|0
7391969|NCT01248949|11652838|FG001|Overall Study|Pi Decision Due To Declining Status|0
7391970|NCT01248949|11652839|FG002|Overall Study|Pi Decision Due To Declining Status|1
7391971|NCT01248949|11652840|FG003|Overall Study|Pi Decision Due To Declining Status|0
7391972|NCT01248949|11652841|FG004|Overall Study|Pi Decision Due To Declining Status|0
7391973|NCT01248949|11652837|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
7391974|NCT01248949|11652838|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
7391975|NCT01248949|11652839|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
7391976|NCT01248949|11652840|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
7391977|NCT01248949|11652841|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
7391978|NCT01248949|11652837|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7391979|NCT01248949|11652838|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7391980|NCT01248949|11652839|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
7391981|NCT01248949|11652840|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7391982|NCT01248949|11652841|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
7391983|NCT01248962|11652855|FG000|Overall Study|Withdrawal by Subject|1
7391984|NCT01248962|11652856|FG001|Overall Study|Withdrawal by Subject|1
7391985|NCT01248962|11652855|FG000|Overall Study|Adverse Event|2
7391986|NCT01248962|11652856|FG001|Overall Study|Adverse Event|1
7391987|NCT01248962|11652855|FG000|Overall Study|Complete Response after 4 Cycles|1
7391988|NCT01248962|11652856|FG001|Overall Study|Complete Response after 4 Cycles|0
7391989|NCT01248962|11652855|FG000|Overall Study|Complete Response after 3 Cycles|0
7391990|NCT01248962|11652856|FG001|Overall Study|Complete Response after 3 Cycles|1
7391991|NCT01248962|11652855|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
7391992|NCT01248962|11652856|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
7391993|NCT01249092|11652867|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
7391994|NCT01249092|11652867|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
7391995|NCT01249118|11652873|FG000|First Washout Period|Physician Decision|0
7391996|NCT01249118|11652874|FG001|First Washout Period|Physician Decision|1
7391997|NCT01249118|11652875|FG002|First Washout Period|Physician Decision|0
7391998|NCT01249131|11652882|FG000|Washout Period of 10 Days|Adverse Event|0
7391999|NCT01249131|11652883|FG001|Washout Period of 10 Days|Adverse Event|0
7392000|NCT01249131|11652884|FG002|Washout Period of 10 Days|Adverse Event|0
7392001|NCT01249131|11652885|FG003|Washout Period of 10 Days|Adverse Event|0
7392002|NCT01249131|11652886|FG004|Washout Period of 10 Days|Adverse Event|1
7392003|NCT01249131|11652887|FG005|Washout Period of 10 Days|Adverse Event|0
7392004|NCT01249261|11652897|FG000|Overall Study|Withdrawal by Subject|1
7392005|NCT01249261|11652898|FG001|Overall Study|Withdrawal by Subject|0
7392006|NCT01249274|11652906|FG000|Overall Study|Lost to Follow-up|3
7392007|NCT01249274|11652907|FG001|Overall Study|Lost to Follow-up|4
7392008|NCT01249274|11652906|FG000|Overall Study|Received inpatient substance treatment|1
7392009|NCT01249274|11652907|FG001|Overall Study|Received inpatient substance treatment|2
7392010|NCT01249365|11652915|FG000|Overall Study|Lost to Follow-up|1
7392047|NCT01249651|11652954|FG000|Overall Study|Withdrawal by Subject|4
7392048|NCT01249651|11652954|FG000|Overall Study|Adverse Event|1
7392049|NCT01249651|11652954|FG000|Overall Study|Protocol Violation|1
7392050|NCT01249651|11652954|FG000|Overall Study|Sponsor Decision|1
7392051|NCT01249664|11652960|FG000|Overall Study|Withdrawal by Subject|5
7392052|NCT01249664|11652961|FG001|Overall Study|Withdrawal by Subject|0
7392053|NCT01249664|11652960|FG000|Overall Study|Adverse Event|1
7392054|NCT01249664|11652961|FG001|Overall Study|Adverse Event|0
7392055|NCT01249833|11652971|FG000|Overall Study|Lost to Follow-up|0
7392056|NCT01249833|11652972|FG001|Overall Study|Lost to Follow-up|1
7392057|NCT01250002|11653013|FG000|Overall Study|Change to open surgical procedure|4
7392058|NCT01250002|11653014|FG001|Overall Study|Change to open surgical procedure|3
7392059|NCT01250054|11653020|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
7392060|NCT01250054|11653021|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
7392061|NCT01250119|11653027|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
7392062|NCT01250119|11653028|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
7392063|NCT01250119|11653027|FG000|Diagnostic Phase|Participants Not Tested|44
7392064|NCT01250119|11653028|FG001|Diagnostic Phase|Participants Not Tested|0
7392065|NCT01250119|11653027|FG000|Treatment Phase|Progressive Disease|0
7392066|NCT01250119|11653028|FG001|Treatment Phase|Progressive Disease|32
7392067|NCT01250119|11653027|FG000|Treatment Phase|Death|0
7392068|NCT01250119|11653028|FG001|Treatment Phase|Death|2
7392069|NCT01250119|11653027|FG000|Treatment Phase|Withdrawal by Subject|0
7392070|NCT01250119|11653028|FG001|Treatment Phase|Withdrawal by Subject|1
7392071|NCT01250119|11653027|FG000|Treatment Phase|Adverse Event|0
7392072|NCT01250119|11653028|FG001|Treatment Phase|Adverse Event|2
7392073|NCT01250119|11653027|FG000|Treatment Phase|Unknown reason|0
7392074|NCT01250119|11653028|FG001|Treatment Phase|Unknown reason|4
7392075|NCT01250145|11653037|FG000|Overall Study|Adverse Event|2
7392076|NCT01250145|11653038|FG001|Overall Study|Adverse Event|1
7392077|NCT01250145|11653037|FG000|Overall Study|Withdrawal by Subject|0
7392078|NCT01250145|11653038|FG001|Overall Study|Withdrawal by Subject|4
7392079|NCT01250171|11653061|FG000|Overall Study|Administrative reasons|1
7392080|NCT01250171|11653062|FG001|Overall Study|Administrative reasons|0
7392081|NCT01250171|11653063|FG002|Overall Study|Administrative reasons|0
7392082|NCT01250379|11653099|FG000|Overall Study|Death|141
7392083|NCT01250379|11653100|FG001|Overall Study|Death|148
7392084|NCT01250379|11653099|FG000|Overall Study|Withdrawal by Subject|32
7392085|NCT01250379|11653100|FG001|Overall Study|Withdrawal by Subject|20
7392086|NCT01250379|11653099|FG000|Overall Study|Physician Decision|11
7392087|NCT01250379|11653100|FG001|Overall Study|Physician Decision|3
7392088|NCT01250379|11653099|FG000|Overall Study|Protocol Violation|2
7392089|NCT01250379|11653100|FG001|Overall Study|Protocol Violation|8
7392090|NCT01250379|11653099|FG000|Overall Study|Lost to Follow-up|9
7392091|NCT01250379|11653100|FG001|Overall Study|Lost to Follow-up|6
7392092|NCT01250379|11653099|FG000|Overall Study|Adverse Event|5
7392093|NCT01250379|11653100|FG001|Overall Study|Adverse Event|4
7392094|NCT01250379|11653099|FG000|Overall Study|Other|0
7392095|NCT01250379|11653100|FG001|Overall Study|Other|4
7392096|NCT01250379|11653099|FG000|Overall Study|Participant noncompliance|2
7392097|NCT01250379|11653100|FG001|Overall Study|Participant noncompliance|0
7392098|NCT01250418|11653108|FG000|Overall Study|monitor data failure|1
7392099|NCT01250418|11653109|FG001|Overall Study|monitor data failure|1
7392100|NCT01250509|11653117|FG000|Overall Study|Lost to Follow-up|5
7392101|NCT01250509|11653118|FG001|Overall Study|Lost to Follow-up|2
7392102|NCT01250756|11653145|FG000|Infant Series|Withdrawal by Subject|4
7392103|NCT01250756|11653146|FG001|Infant Series|Withdrawal by Subject|5
7392104|NCT01250756|11653145|FG000|Infant Series|Randomized, Not Vaccinated|2
7392105|NCT01250756|11653146|FG001|Infant Series|Randomized, Not Vaccinated|2
7392106|NCT01250756|11653145|FG000|Infant Series|Other|22
7392107|NCT01250756|11653146|FG001|Infant Series|Other|0
7392108|NCT01250756|11653145|FG000|After Infant Series|Adverse Event|5
7392109|NCT01250756|11653146|FG001|After Infant Series|Adverse Event|2
7392110|NCT01250756|11653145|FG000|After Infant Series|Withdrawal by Subject|4
7392111|NCT01250756|11653146|FG001|After Infant Series|Withdrawal by Subject|1
7392112|NCT01250756|11653145|FG000|After Infant Series|Other|2
7392113|NCT01250756|11653146|FG001|After Infant Series|Other|1
7392114|NCT01250756|11653145|FG000|Toddler Dose|Adverse Event|0
7392115|NCT01250756|11653146|FG001|Toddler Dose|Adverse Event|1
7392116|NCT01250756|11653145|FG000|After Toddler Dose|Adverse Event|0
7392117|NCT01250756|11653146|FG001|After Toddler Dose|Adverse Event|1
7392118|NCT01250769|11653162|FG000|Overall Study|Withdrawal by Subject|0
7392119|NCT01250769|11653163|FG001|Overall Study|Withdrawal by Subject|1
7392120|NCT01250769|11653164|FG002|Overall Study|Withdrawal by Subject|1
7392121|NCT01250769|11653165|FG003|Overall Study|Withdrawal by Subject|0
7392122|NCT01250769|11653162|FG000|Overall Study|Adverse Event|0
7392123|NCT01250769|11653163|FG001|Overall Study|Adverse Event|0
7392124|NCT01250769|11653164|FG002|Overall Study|Adverse Event|1
7392125|NCT01250769|11653165|FG003|Overall Study|Adverse Event|0
7392126|NCT01250873|11653182|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
7465256|NCT04495829|11764506|FG000|Overall Study|Lost to Follow-up|2
7392127|NCT01250873|11653182|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
7392128|NCT01250925|11653198|FG000|Overall Study|Lost to Follow-up|1
7392129|NCT01250925|11653199|FG001|Overall Study|Lost to Follow-up|1
7392130|NCT01250925|11653200|FG002|Overall Study|Lost to Follow-up|0
7392131|NCT01250925|11653198|FG000|Overall Study|Withdrawal by Subject|2
7392132|NCT01250925|11653199|FG001|Overall Study|Withdrawal by Subject|0
7392133|NCT01250925|11653200|FG002|Overall Study|Withdrawal by Subject|0
7392134|NCT01250925|11653198|FG000|Overall Study|Protocol Violation|2
7392135|NCT01250925|11653199|FG001|Overall Study|Protocol Violation|0
7392136|NCT01250925|11653200|FG002|Overall Study|Protocol Violation|0
7392137|NCT01250925|11653198|FG000|Overall Study|Physician Decision|0
7392138|NCT01250925|11653199|FG001|Overall Study|Physician Decision|2
7392139|NCT01250925|11653200|FG002|Overall Study|Physician Decision|1
7392140|NCT01250925|11653198|FG000|Overall Study|Adverse Event|0
7392141|NCT01250925|11653199|FG001|Overall Study|Adverse Event|0
7392142|NCT01250925|11653200|FG002|Overall Study|Adverse Event|1
7392143|NCT01251146|11653237|FG000|Overall Study|Lost to Follow-up|3
7392144|NCT01251146|11653238|FG001|Overall Study|Lost to Follow-up|10
7392149|NCT01251354|11653282|FG000|Overall Study|Adverse Event|1
7392150|NCT01251354|11653282|FG000|Overall Study|Investigator's Decision|1
7392151|NCT01251354|11653282|FG000|Overall Study|Disease Progression|4
7392166|NCT01251614|11653343|FG000|Overall Study|Adverse Event|1
7392167|NCT01251614|11653344|FG001|Overall Study|Adverse Event|0
7392168|NCT01251614|11653345|FG002|Overall Study|Adverse Event|1
7392169|NCT01251614|11653343|FG000|Overall Study|Lack of Efficacy|1
7392170|NCT01251614|11653344|FG001|Overall Study|Lack of Efficacy|9
7392171|NCT01251614|11653345|FG002|Overall Study|Lack of Efficacy|4
7392172|NCT01251614|11653343|FG000|Overall Study|Clearing of Psoriatic Lesions|1
7392173|NCT01251614|11653344|FG001|Overall Study|Clearing of Psoriatic Lesions|0
7392174|NCT01251614|11653345|FG002|Overall Study|Clearing of Psoriatic Lesions|0
7392175|NCT01251614|11653343|FG000|Overall Study|Pregnancy|0
7392176|NCT01251614|11653344|FG001|Overall Study|Pregnancy|0
7392177|NCT01251614|11653345|FG002|Overall Study|Pregnancy|2
7392178|NCT01251614|11653343|FG000|Overall Study|Loss of Disease Control|0
7392179|NCT01251614|11653344|FG001|Overall Study|Loss of Disease Control|1
7392180|NCT01251614|11653345|FG002|Overall Study|Loss of Disease Control|0
7392181|NCT01251614|11653343|FG000|Overall Study|Withdrawal by Subject|0
7392182|NCT01251614|11653344|FG001|Overall Study|Withdrawal by Subject|2
7392183|NCT01251614|11653345|FG002|Overall Study|Withdrawal by Subject|1
7392184|NCT01251614|11653343|FG000|Overall Study|Lost to Follow-up|0
7392185|NCT01251614|11653344|FG001|Overall Study|Lost to Follow-up|1
7392186|NCT01251614|11653345|FG002|Overall Study|Lost to Follow-up|0
7392187|NCT01251653|11653372|FG000|Overall Study|Progressive Disease|1
7392188|NCT01251653|11653373|FG001|Overall Study|Progressive Disease|7
7392189|NCT01251653|11653374|FG002|Overall Study|Progressive Disease|16
7392190|NCT01251653|11653375|FG003|Overall Study|Progressive Disease|4
7392191|NCT01251653|11653376|FG004|Overall Study|Progressive Disease|0
7392192|NCT01251653|11653377|FG005|Overall Study|Progressive Disease|17
7392193|NCT01251653|11653378|FG006|Overall Study|Progressive Disease|14
7392194|NCT01251653|11653379|FG007|Overall Study|Progressive Disease|7
7392195|NCT01251653|11653380|FG008|Overall Study|Progressive Disease|5
7392196|NCT01251653|11653372|FG000|Overall Study|Dose-limiting toxicity|0
7392197|NCT01251653|11653373|FG001|Overall Study|Dose-limiting toxicity|1
7392198|NCT01251653|11653374|FG002|Overall Study|Dose-limiting toxicity|1
7392199|NCT01251653|11653375|FG003|Overall Study|Dose-limiting toxicity|1
7392200|NCT01251653|11653376|FG004|Overall Study|Dose-limiting toxicity|0
7392201|NCT01251653|11653377|FG005|Overall Study|Dose-limiting toxicity|0
7392202|NCT01251653|11653378|FG006|Overall Study|Dose-limiting toxicity|2
7392203|NCT01251653|11653379|FG007|Overall Study|Dose-limiting toxicity|0
7392204|NCT01251653|11653380|FG008|Overall Study|Dose-limiting toxicity|0
7392205|NCT01251653|11653372|FG000|Overall Study|Adverse Event|1
7392206|NCT01251653|11653373|FG001|Overall Study|Adverse Event|0
7392207|NCT01251653|11653374|FG002|Overall Study|Adverse Event|2
7392208|NCT01251653|11653375|FG003|Overall Study|Adverse Event|1
7392209|NCT01251653|11653376|FG004|Overall Study|Adverse Event|1
7392210|NCT01251653|11653377|FG005|Overall Study|Adverse Event|0
7392211|NCT01251653|11653378|FG006|Overall Study|Adverse Event|2
7392212|NCT01251653|11653379|FG007|Overall Study|Adverse Event|2
7392213|NCT01251653|11653380|FG008|Overall Study|Adverse Event|1
7392214|NCT01251653|11653372|FG000|Overall Study|Withdrawal by Subject|1
7392215|NCT01251653|11653373|FG001|Overall Study|Withdrawal by Subject|0
7392216|NCT01251653|11653374|FG002|Overall Study|Withdrawal by Subject|1
7392217|NCT01251653|11653375|FG003|Overall Study|Withdrawal by Subject|0
7392218|NCT01251653|11653376|FG004|Overall Study|Withdrawal by Subject|1
7392219|NCT01251653|11653377|FG005|Overall Study|Withdrawal by Subject|1
7392220|NCT01251653|11653378|FG006|Overall Study|Withdrawal by Subject|0
7392221|NCT01251653|11653379|FG007|Overall Study|Withdrawal by Subject|1
7392222|NCT01251653|11653380|FG008|Overall Study|Withdrawal by Subject|0
7392223|NCT01251653|11653372|FG000|Overall Study|Other reason not mentioned above|0
7392224|NCT01251653|11653373|FG001|Overall Study|Other reason not mentioned above|0
7392225|NCT01251653|11653374|FG002|Overall Study|Other reason not mentioned above|0
7392226|NCT01251653|11653375|FG003|Overall Study|Other reason not mentioned above|0
7392227|NCT01251653|11653376|FG004|Overall Study|Other reason not mentioned above|0
7392228|NCT01251653|11653377|FG005|Overall Study|Other reason not mentioned above|0
7392229|NCT01251653|11653378|FG006|Overall Study|Other reason not mentioned above|0
7392230|NCT01251653|11653379|FG007|Overall Study|Other reason not mentioned above|2
7392231|NCT01251653|11653380|FG008|Overall Study|Other reason not mentioned above|0
7392232|NCT01251744|11653418|FG000|Overall Study|Lost to Follow-up|1
7392233|NCT01251744|11653419|FG001|Overall Study|Lost to Follow-up|0
7392234|NCT01251770|11653451|FG000|Overall Study|Protocol Violation|13
7392235|NCT01251770|11653452|FG001|Overall Study|Protocol Violation|7
7392236|NCT01251887|11653461|FG000|Overall Study|Scheduling conflict|1
7392237|NCT01251887|11653462|FG001|Overall Study|Scheduling conflict|2
7392238|NCT01251887|11653463|FG002|Overall Study|Scheduling conflict|2
7392239|NCT01251887|11653461|FG000|Overall Study|Physician Decision|0
7392240|NCT01251887|11653462|FG001|Overall Study|Physician Decision|1
7392241|NCT01251887|11653463|FG002|Overall Study|Physician Decision|0
7392242|NCT01251965|11653474|FG000|Overall Study|Participant/physician decision|1
7392243|NCT01251965|11653475|FG001|Overall Study|Participant/physician decision|2
7392244|NCT01251965|11653476|FG002|Overall Study|Participant/physician decision|0
7392245|NCT01251965|11653474|FG000|Overall Study|Death|0
7392246|NCT01251965|11653475|FG001|Overall Study|Death|0
7392247|NCT01251965|11653476|FG002|Overall Study|Death|11
7392248|NCT01252095|11653496|FG000|Overall Study|Disease progression|1
7392249|NCT01252095|11653497|FG001|Overall Study|Disease progression|0
7392250|NCT01252134|11653503|FG000|Period 1, 8 Hours|Personal Reasons|0
7392251|NCT01252134|11653504|FG001|Period 1, 8 Hours|Personal Reasons|1
7392252|NCT01252134|11653505|FG002|Period 1, 8 Hours|Personal Reasons|1
7392253|NCT01252134|11653506|FG003|Period 1, 8 Hours|Personal Reasons|0
7392254|NCT01252134|11653507|FG004|Period 1, 8 Hours|Personal Reasons|0
7392255|NCT01252134|11653508|FG005|Period 1, 8 Hours|Personal Reasons|0
7392256|NCT01252186|11653523|FG000|Overall Study|Adverse Event|9
7392257|NCT01252186|11653524|FG001|Overall Study|Adverse Event|6
7392258|NCT01252186|11653525|FG002|Overall Study|Adverse Event|8
7392259|NCT01252186|11653523|FG000|Overall Study|Withdrawal by Subject|2
7392260|NCT01252186|11653524|FG001|Overall Study|Withdrawal by Subject|5
7392261|NCT01252186|11653525|FG002|Overall Study|Withdrawal by Subject|2
7392262|NCT01252186|11653523|FG000|Overall Study|Physician Decision|0
7392263|NCT01252186|11653524|FG001|Overall Study|Physician Decision|0
7392264|NCT01252186|11653525|FG002|Overall Study|Physician Decision|1
7392265|NCT01252186|11653523|FG000|Overall Study|Non-compliance|0
7392266|NCT01252186|11653524|FG001|Overall Study|Non-compliance|3
7392267|NCT01252186|11653525|FG002|Overall Study|Non-compliance|4
7392268|NCT01252186|11653523|FG000|Overall Study|Protocol Violation|0
7392269|NCT01252186|11653524|FG001|Overall Study|Protocol Violation|0
7392270|NCT01252186|11653525|FG002|Overall Study|Protocol Violation|1
7392271|NCT01252186|11653523|FG000|Overall Study|Pregnancy|2
7392272|NCT01252186|11653524|FG001|Overall Study|Pregnancy|2
7392273|NCT01252186|11653525|FG002|Overall Study|Pregnancy|0
7392274|NCT01252186|11653523|FG000|Overall Study|Sponsor Request|2
7392275|NCT01252186|11653524|FG001|Overall Study|Sponsor Request|1
7392276|NCT01252186|11653525|FG002|Overall Study|Sponsor Request|0
7392277|NCT01252186|11653523|FG000|Overall Study|Lost to Follow-up|10
7392278|NCT01252186|11653524|FG001|Overall Study|Lost to Follow-up|10
7392279|NCT01252186|11653525|FG002|Overall Study|Lost to Follow-up|11
7392280|NCT01252186|11653523|FG000|Overall Study|Other - Miscellaneous Reasons|5
7392281|NCT01252186|11653524|FG001|Overall Study|Other - Miscellaneous Reasons|5
7392282|NCT01252186|11653525|FG002|Overall Study|Other - Miscellaneous Reasons|7
7392283|NCT01252238|11653536|FG000|Overall Study|Sponsor terminated study|4
7392284|NCT01252238|11653537|FG001|Overall Study|Sponsor terminated study|4
7392285|NCT01252238|11653538|FG002|Overall Study|Sponsor terminated study|4
7392286|NCT01252251|11653549|FG000|Overall Study|Withdrawal by Subject|1
7392287|NCT01252290|11653558|FG000|Overall Study|Withdrawal by Subject|1
7392288|NCT01252355|11653565|FG000|Overall Study|Adverse Event|9
7392289|NCT01252355|11653566|FG001|Overall Study|Adverse Event|17
7392290|NCT01252355|11653567|FG002|Overall Study|Adverse Event|22
7392291|NCT01252355|11653565|FG000|Overall Study|Lack of Efficacy|6
7392292|NCT01252355|11653566|FG001|Overall Study|Lack of Efficacy|4
7392293|NCT01252355|11653567|FG002|Overall Study|Lack of Efficacy|2
7392294|NCT01252355|11653565|FG000|Overall Study|Lost to Follow-up|0
7392295|NCT01252355|11653566|FG001|Overall Study|Lost to Follow-up|0
7392296|NCT01252355|11653567|FG002|Overall Study|Lost to Follow-up|1
7392297|NCT01252355|11653565|FG000|Overall Study|Poor Compliance to Protocol|1
7392298|NCT01252355|11653566|FG001|Overall Study|Poor Compliance to Protocol|1
7392299|NCT01252355|11653567|FG002|Overall Study|Poor Compliance to Protocol|1
7392300|NCT01252355|11653565|FG000|Overall Study|Progressive Disease|2
7392301|NCT01252355|11653566|FG001|Overall Study|Progressive Disease|0
7392302|NCT01252355|11653567|FG002|Overall Study|Progressive Disease|0
7392303|NCT01252355|11653565|FG000|Overall Study|Sponsor Early Termination of Study|149
7392304|NCT01252355|11653566|FG001|Overall Study|Sponsor Early Termination of Study|149
7392305|NCT01252355|11653567|FG002|Overall Study|Sponsor Early Termination of Study|146
7392306|NCT01252355|11653565|FG000|Overall Study|Randomized but not Treated|2
7392307|NCT01252355|11653566|FG001|Overall Study|Randomized but not Treated|0
7392308|NCT01252355|11653567|FG002|Overall Study|Randomized but not Treated|0
7392309|NCT01252355|11653565|FG000|Overall Study|Other Than Above|8
7392310|NCT01252355|11653566|FG001|Overall Study|Other Than Above|7
7392311|NCT01252355|11653567|FG002|Overall Study|Other Than Above|7
7392312|NCT01252563|11653575|FG000|Overall Study|Contract Deviation|41
7392313|NCT01252563|11653575|FG000|Overall Study|Centralized Registration Deviation|30
7392314|NCT01252563|11653575|FG000|Overall Study|Lost to Follow-up|161
7392315|NCT01252563|11653575|FG000|Overall Study|No visit after first day of treatment|194
7392316|NCT01252563|11653575|FG000|Overall Study|No drug administration|6
7392317|NCT01252667|11653616|FG000|Overall Study|Transplant aborted post-conditioning|0
7392318|NCT01252667|11653617|FG001|Overall Study|Transplant aborted post-conditioning|0
7392319|NCT01252667|11653618|FG002|Overall Study|Transplant aborted post-conditioning|0
7392320|NCT01252667|11653619|FG003|Overall Study|Transplant aborted post-conditioning|0
7392321|NCT01252667|11653620|FG004|Overall Study|Transplant aborted post-conditioning|0
7392322|NCT01252667|11653621|FG005|Overall Study|Transplant aborted post-conditioning|1
7392323|NCT01252810|11653662|FG000|Overall Study|Withdrawal by Subject|4
7392324|NCT01252810|11653663|FG001|Overall Study|Withdrawal by Subject|1
7392325|NCT01252810|11653662|FG000|Overall Study|Lost to Follow-up|0
7392326|NCT01252810|11653663|FG001|Overall Study|Lost to Follow-up|1
7392327|NCT01252810|11653662|FG000|Overall Study|Physician Decision|2
7392328|NCT01252810|11653663|FG001|Overall Study|Physician Decision|1
7392329|NCT01252810|11653662|FG000|Overall Study|Various reasons|8
7392330|NCT01252810|11653663|FG001|Overall Study|Various reasons|0
7392331|NCT01252940|11653671|FG000|Main Study Phase|Randomized but not treated|4
7392332|NCT01252940|11653672|FG001|Main Study Phase|Randomized but not treated|2
7392333|NCT01252940|11653671|FG000|Main Study Phase|Adverse Event|3
7392334|NCT01252940|11653672|FG001|Main Study Phase|Adverse Event|1
7392335|NCT01252940|11653671|FG000|Main Study Phase|Lack of Efficacy|1
7392336|NCT01252940|11653672|FG001|Main Study Phase|Lack of Efficacy|0
7392337|NCT01252940|11653671|FG000|Main Study Phase|Lost to Follow-up|6
7392338|NCT01252940|11653672|FG001|Main Study Phase|Lost to Follow-up|1
7392339|NCT01252940|11653671|FG000|Main Study Phase|Physician Decision|1
7392340|NCT01252940|11653672|FG001|Main Study Phase|Physician Decision|0
7392341|NCT01252940|11653671|FG000|Main Study Phase|Protocol Violation|4
7392342|NCT01252940|11653672|FG001|Main Study Phase|Protocol Violation|2
7392343|NCT01252940|11653671|FG000|Main Study Phase|Withdrawal by Subject|6
7392344|NCT01252940|11653672|FG001|Main Study Phase|Withdrawal by Subject|5
7392345|NCT01252940|11653671|FG000|Main Study Phase|Subject Non-compliance|1
7392346|NCT01252940|11653672|FG001|Main Study Phase|Subject Non-compliance|1
7392347|NCT01252940|11653671|FG000|Extension Phase|Adverse Event|2
7392348|NCT01252940|11653672|FG001|Extension Phase|Adverse Event|1
7392349|NCT01252940|11653671|FG000|Extension Phase|Lack of Efficacy|1
7392350|NCT01252940|11653672|FG001|Extension Phase|Lack of Efficacy|0
7392351|NCT01252940|11653671|FG000|Extension Phase|Lost to Follow-up|5
7392352|NCT01252940|11653672|FG001|Extension Phase|Lost to Follow-up|0
7392353|NCT01252940|11653671|FG000|Extension Phase|Physician Decision|0
7392354|NCT01252940|11653672|FG001|Extension Phase|Physician Decision|1
7392355|NCT01252940|11653671|FG000|Extension Phase|Subject Non-compliance|1
7392356|NCT01252940|11653672|FG001|Extension Phase|Subject Non-compliance|0
7392357|NCT01252940|11653671|FG000|Extension Phase|Withdrawal by Subject|1
7392358|NCT01252940|11653672|FG001|Extension Phase|Withdrawal by Subject|1
7392359|NCT01252966|11653681|FG000|Overall Study|Lost to Follow-up|16
7392360|NCT01252966|11653682|FG001|Overall Study|Lost to Follow-up|10
7392361|NCT01252966|11653681|FG000|Overall Study|Withdrawal by Subject|7
7392362|NCT01252966|11653682|FG001|Overall Study|Withdrawal by Subject|3
7392363|NCT01253018|11653692|FG000|Overall Study|Lost to Follow-up|1
7392364|NCT01253018|11653693|FG001|Overall Study|Lost to Follow-up|1
7392365|NCT01253018|11653692|FG000|Overall Study|Robot Repair Issues|2
7392366|NCT01253018|11653693|FG001|Overall Study|Robot Repair Issues|0
7392367|NCT01253018|11653692|FG000|Overall Study|Withdrawal by Subject|1
7392368|NCT01253018|11653693|FG001|Overall Study|Withdrawal by Subject|1
7392369|NCT01253044|11653702|FG000|Overall Study|Lost to Follow-up|38
7392370|NCT01253044|11653703|FG001|Overall Study|Lost to Follow-up|29
7392371|NCT01253135|11653709|FG000|Original Protocol|Protocol Amendment|15
7392372|NCT01253135|11653709|FG000|Amended Protocol|Non-compliance|1
7392373|NCT01253174|11653721|FG000|Period 1|Randomized but not treated|0
7392374|NCT01253174|11653722|FG001|Period 1|Randomized but not treated|1
7392375|NCT01253174|11653723|FG002|Period 1|Randomized but not treated|1
7392376|NCT01253174|11653724|FG003|Period 1|Randomized but not treated|0
7392377|NCT01253174|11653725|FG004|Period 1|Randomized but not treated|1
7392378|NCT01253174|11653726|FG005|Period 1|Randomized but not treated|0
7392379|NCT01253174|11653721|FG000|Period 2|Adverse Event|0
7392380|NCT01253174|11653722|FG001|Period 2|Adverse Event|0
7392381|NCT01253174|11653723|FG002|Period 2|Adverse Event|1
7392382|NCT01253174|11653724|FG003|Period 2|Adverse Event|0
7392383|NCT01253174|11653725|FG004|Period 2|Adverse Event|0
7392384|NCT01253174|11653726|FG005|Period 2|Adverse Event|0
7392385|NCT01253174|11653721|FG000|Period 3|Withdrawal by Subject|0
7392386|NCT01253174|11653722|FG001|Period 3|Withdrawal by Subject|1
7392387|NCT01253174|11653723|FG002|Period 3|Withdrawal by Subject|0
7392388|NCT01253174|11653724|FG003|Period 3|Withdrawal by Subject|0
7392389|NCT01253174|11653725|FG004|Period 3|Withdrawal by Subject|1
7392390|NCT01253174|11653726|FG005|Period 3|Withdrawal by Subject|0
7392391|NCT01253174|11653721|FG000|Period 3|Pregnancy|0
7392392|NCT01253174|11653722|FG001|Period 3|Pregnancy|0
7392393|NCT01253174|11653723|FG002|Period 3|Pregnancy|1
7392394|NCT01253174|11653724|FG003|Period 3|Pregnancy|0
7392395|NCT01253174|11653725|FG004|Period 3|Pregnancy|0
7392396|NCT01253174|11653726|FG005|Period 3|Pregnancy|0
7392397|NCT01253187|11653735|FG000|Period 2|Withdrawal by Subject|0
7392398|NCT01253187|11653736|FG001|Period 2|Withdrawal by Subject|0
7392399|NCT01253187|11653737|FG002|Period 2|Withdrawal by Subject|0
7392400|NCT01253187|11653738|FG003|Period 2|Withdrawal by Subject|0
7392401|NCT01253187|11653739|FG004|Period 2|Withdrawal by Subject|1
7392402|NCT01253187|11653740|FG005|Period 2|Withdrawal by Subject|0
7392403|NCT01253187|11653735|FG000|Period 3|Pregnancy|1
7392404|NCT01253187|11653736|FG001|Period 3|Pregnancy|0
7392405|NCT01253187|11653737|FG002|Period 3|Pregnancy|0
7392406|NCT01253187|11653738|FG003|Period 3|Pregnancy|0
7392407|NCT01253187|11653739|FG004|Period 3|Pregnancy|0
7392408|NCT01253187|11653740|FG005|Period 3|Pregnancy|0
7392409|NCT01253187|11653735|FG000|Period 3|difficulty with blood sampling|0
7392410|NCT01253187|11653736|FG001|Period 3|difficulty with blood sampling|1
7392411|NCT01253187|11653737|FG002|Period 3|difficulty with blood sampling|0
7392412|NCT01253187|11653738|FG003|Period 3|difficulty with blood sampling|0
7392413|NCT01253187|11653739|FG004|Period 3|difficulty with blood sampling|0
7392414|NCT01253187|11653740|FG005|Period 3|difficulty with blood sampling|0
7392415|NCT01253187|11653735|FG000|Period 3|non-compliance|0
7392416|NCT01253187|11653736|FG001|Period 3|non-compliance|0
7392417|NCT01253187|11653737|FG002|Period 3|non-compliance|0
7392418|NCT01253187|11653738|FG003|Period 3|non-compliance|0
7392419|NCT01253187|11653739|FG004|Period 3|non-compliance|1
7392420|NCT01253187|11653740|FG005|Period 3|non-compliance|0
7392421|NCT01253200|11653756|FG000|Overall Study|Death|1
7392422|NCT01253200|11653757|FG001|Overall Study|Death|0
7392423|NCT01253200|11653758|FG002|Overall Study|Death|0
7392424|NCT01253200|11653759|FG003|Overall Study|Death|0
7392425|NCT01253200|11653760|FG004|Overall Study|Death|0
7392426|NCT01253200|11653756|FG000|Overall Study|Lost to Follow-up|1
7392427|NCT01253200|11653757|FG001|Overall Study|Lost to Follow-up|1
7392428|NCT01253200|11653758|FG002|Overall Study|Lost to Follow-up|0
7392429|NCT01253200|11653759|FG003|Overall Study|Lost to Follow-up|0
7392430|NCT01253200|11653760|FG004|Overall Study|Lost to Follow-up|0
7392431|NCT01253200|11653756|FG000|Overall Study|Withdrawal by Subject|2
7392432|NCT01253200|11653757|FG001|Overall Study|Withdrawal by Subject|0
7392433|NCT01253200|11653758|FG002|Overall Study|Withdrawal by Subject|0
7392434|NCT01253200|11653759|FG003|Overall Study|Withdrawal by Subject|0
7392435|NCT01253200|11653760|FG004|Overall Study|Withdrawal by Subject|0
7392436|NCT01253200|11653756|FG000|Overall Study|Protocol Violation|1
7392437|NCT01253200|11653757|FG001|Overall Study|Protocol Violation|4
7392438|NCT01253200|11653758|FG002|Overall Study|Protocol Violation|0
7392439|NCT01253200|11653759|FG003|Overall Study|Protocol Violation|0
7392440|NCT01253200|11653760|FG004|Overall Study|Protocol Violation|5
7392441|NCT01253200|11653756|FG000|Overall Study|intents|10
7392442|NCT01253200|11653757|FG001|Overall Study|intents|10
7392443|NCT01253200|11653758|FG002|Overall Study|intents|1
7392444|NCT01253200|11653759|FG003|Overall Study|intents|3
7392445|NCT01253200|11653760|FG004|Overall Study|intents|0
7392446|NCT01253200|11653756|FG000|Overall Study|Attempts|6
7392447|NCT01253200|11653757|FG001|Overall Study|Attempts|4
7392448|NCT01253200|11653758|FG002|Overall Study|Attempts|1
7392449|NCT01253200|11653759|FG003|Overall Study|Attempts|2
7392450|NCT01253200|11653760|FG004|Overall Study|Attempts|0
7392451|NCT01253226|11653774|FG000|Overall Study|Adverse Event|0
7392452|NCT01253226|11653775|FG001|Overall Study|Adverse Event|0
7392453|NCT01253226|11653776|FG002|Overall Study|Adverse Event|1
7392454|NCT01253226|11653777|FG003|Overall Study|Adverse Event|0
7392455|NCT01253226|11653778|FG004|Overall Study|Adverse Event|0
7392456|NCT01253226|11653774|FG000|Overall Study|Death|0
7392457|NCT01253226|11653775|FG001|Overall Study|Death|1
7392458|NCT01253226|11653776|FG002|Overall Study|Death|0
7392459|NCT01253226|11653777|FG003|Overall Study|Death|0
7392460|NCT01253226|11653778|FG004|Overall Study|Death|0
7392461|NCT01253226|11653774|FG000|Overall Study|Physician Decision|0
7392462|NCT01253226|11653775|FG001|Overall Study|Physician Decision|0
7392463|NCT01253226|11653776|FG002|Overall Study|Physician Decision|0
7392464|NCT01253226|11653777|FG003|Overall Study|Physician Decision|0
7392465|NCT01253226|11653778|FG004|Overall Study|Physician Decision|2
7392466|NCT01253226|11653774|FG000|Overall Study|Withdrawal by Subject|0
7392467|NCT01253226|11653775|FG001|Overall Study|Withdrawal by Subject|0
7392468|NCT01253226|11653776|FG002|Overall Study|Withdrawal by Subject|0
7392469|NCT01253226|11653777|FG003|Overall Study|Withdrawal by Subject|1
7392470|NCT01253226|11653778|FG004|Overall Study|Withdrawal by Subject|0
7392471|NCT01253265|11653795|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
7392472|NCT01253265|11653796|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
7392473|NCT01253265|11653797|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
7392474|NCT01253265|11653798|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
7392475|NCT01253265|11653799|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
7392476|NCT01253265|11653795|FG000|Overall Study|Withdrawal by Subject|0
7392477|NCT01253265|11653796|FG001|Overall Study|Withdrawal by Subject|0
7392478|NCT01253265|11653797|FG002|Overall Study|Withdrawal by Subject|0
7392479|NCT01253265|11653798|FG003|Overall Study|Withdrawal by Subject|0
7392480|NCT01253265|11653799|FG004|Overall Study|Withdrawal by Subject|1
7392481|NCT01253291|11653816|FG000|Overall Study|Withdrawal by Subject|1
7392482|NCT01253291|11653817|FG001|Overall Study|Withdrawal by Subject|1
7392483|NCT01253291|11653818|FG002|Overall Study|Withdrawal by Subject|0
7392484|NCT01253291|11653819|FG003|Overall Study|Withdrawal by Subject|0
7392485|NCT01253291|11653820|FG004|Overall Study|Withdrawal by Subject|0
7392486|NCT01253291|11653816|FG000|Overall Study|Adverse Event|0
7392487|NCT01253291|11653817|FG001|Overall Study|Adverse Event|1
7392488|NCT01253291|11653818|FG002|Overall Study|Adverse Event|0
7392489|NCT01253291|11653819|FG003|Overall Study|Adverse Event|0
7392490|NCT01253291|11653820|FG004|Overall Study|Adverse Event|0
7392491|NCT01253291|11653816|FG000|Overall Study|Lack of Efficacy|1
7392492|NCT01253291|11653817|FG001|Overall Study|Lack of Efficacy|0
7392493|NCT01253291|11653818|FG002|Overall Study|Lack of Efficacy|0
7392494|NCT01253291|11653819|FG003|Overall Study|Lack of Efficacy|0
7392495|NCT01253291|11653820|FG004|Overall Study|Lack of Efficacy|0
7392496|NCT01253291|11653816|FG000|Overall Study|Physician Decision|2
7392497|NCT01253291|11653817|FG001|Overall Study|Physician Decision|0
7392498|NCT01253291|11653818|FG002|Overall Study|Physician Decision|0
7392499|NCT01253291|11653819|FG003|Overall Study|Physician Decision|0
7392500|NCT01253291|11653820|FG004|Overall Study|Physician Decision|2
7392501|NCT01253304|11653837|FG000|Overall Study|Adverse Event|0
7392502|NCT01253304|11653838|FG001|Overall Study|Adverse Event|0
7392503|NCT01253304|11653839|FG002|Overall Study|Adverse Event|0
7392504|NCT01253304|11653840|FG003|Overall Study|Adverse Event|1
7392505|NCT01253317|11653850|FG000|Overall Study|Adverse Event|2
7392506|NCT01253369|11653883|FG000|Overall Study|Adverse Event|4
7392507|NCT01253369|11653883|FG000|Overall Study|Withdrawal by Subject|2
7392508|NCT01253369|11653883|FG000|Overall Study|Death|1
7392509|NCT01253369|11653883|FG000|Overall Study|Progressive disease|23
7392510|NCT01253369|11653883|FG000|Overall Study|Not Evaluable|3
7392511|NCT01253408|11653890|FG000|Overall Study|Adverse Event|0
7392512|NCT01253408|11653891|FG001|Overall Study|Adverse Event|1
7392513|NCT01253408|11653892|FG002|Overall Study|Adverse Event|0
7392514|NCT01253421|11653904|FG000|Assessment and Scheduling|Found to be Ineligible|74
7392515|NCT01253421|11653905|FG001|Assessment and Scheduling|Found to be Ineligible|0
7392516|NCT01253421|11653906|FG002|Assessment and Scheduling|Found to be Ineligible|0
7392517|NCT01253421|11653907|FG003|Assessment and Scheduling|Found to be Ineligible|0
7392518|NCT01253421|11653908|FG004|Assessment and Scheduling|Found to be Ineligible|0
7392519|NCT01253421|11653904|FG000|Assessment and Scheduling|Lost to Follow-up|17
7392520|NCT01253421|11653905|FG001|Assessment and Scheduling|Lost to Follow-up|0
7392521|NCT01253421|11653906|FG002|Assessment and Scheduling|Lost to Follow-up|0
7392522|NCT01253421|11653907|FG003|Assessment and Scheduling|Lost to Follow-up|0
7392523|NCT01253421|11653908|FG004|Assessment and Scheduling|Lost to Follow-up|0
7392524|NCT01253421|11653904|FG000|Assessment and Scheduling|Withdrawal by Subject|7
7392525|NCT01253421|11653905|FG001|Assessment and Scheduling|Withdrawal by Subject|0
7392526|NCT01253421|11653906|FG002|Assessment and Scheduling|Withdrawal by Subject|0
7392527|NCT01253421|11653907|FG003|Assessment and Scheduling|Withdrawal by Subject|0
7392528|NCT01253421|11653908|FG004|Assessment and Scheduling|Withdrawal by Subject|0
7392529|NCT01253421|11653904|FG000|Assessment and Scheduling|Physician Decision|1
7392530|NCT01253421|11653905|FG001|Assessment and Scheduling|Physician Decision|0
7392531|NCT01253421|11653906|FG002|Assessment and Scheduling|Physician Decision|0
7392532|NCT01253421|11653907|FG003|Assessment and Scheduling|Physician Decision|0
7392533|NCT01253421|11653908|FG004|Assessment and Scheduling|Physician Decision|0
7392534|NCT01253421|11653904|FG000|Drug+Scanning Visit|Physician Decision|0
7392535|NCT01253421|11653905|FG001|Drug+Scanning Visit|Physician Decision|0
7392536|NCT01253421|11653906|FG002|Drug+Scanning Visit|Physician Decision|0
7392537|NCT01253421|11653907|FG003|Drug+Scanning Visit|Physician Decision|0
7392538|NCT01253421|11653908|FG004|Drug+Scanning Visit|Physician Decision|1
7392539|NCT01253447|11653918|FG000|Overall Study|Adverse Event|2
7465257|NCT04495829|11764506|FG000|Overall Study|Inclusion criterion not met|3
7468573|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
7468574|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
7468575|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
7468576|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
7468577|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7468578|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
7468710|NCT01913405|11769618|FG000|Overall Study|Withdrawal by Subject|1
7392540|NCT01253564|11653931|FG000|Overall Study|Disease Progression|22
7392541|NCT01253564|11653931|FG000|Overall Study|Withdrawal by Subject|1
7392542|NCT01253564|11653931|FG000|Overall Study|Serious Adverse Event|1
7392543|NCT01253577|11653935|FG000|Overall Study|Lost to Follow-up|3
7392544|NCT01253811|11653946|FG000|Overall Study|Withdrawal criteria|1
7392545|NCT01254019|11653983|FG000|Overall Study|Adverse Event|0
7392546|NCT01254019|11653984|FG001|Overall Study|Adverse Event|2
7392547|NCT01254019|11653983|FG000|Overall Study|Protocol Violation|1
7392548|NCT01254019|11653984|FG001|Overall Study|Protocol Violation|0
7392549|NCT01254019|11653983|FG000|Overall Study|Withdrawal by Subject|0
7392550|NCT01254019|11653984|FG001|Overall Study|Withdrawal by Subject|2
7392551|NCT01254045|11653993|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
7392552|NCT01254045|11653994|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7392553|NCT01254045|11653995|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7392554|NCT01254045|11653996|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7392555|NCT01254045|11653997|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7392556|NCT01254045|11653998|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
7392557|NCT01254188|11654008|FG000|Overall Study|Disease Progression|6
7392558|NCT01254188|11654008|FG000|Overall Study|Protocol Violation|6
7392559|NCT01254188|11654008|FG000|Overall Study|Pregnancy|2
7392560|NCT01254188|11654008|FG000|Overall Study|Death|4
7392561|NCT01254188|11654008|FG000|Overall Study|Lost to Follow-up|5
7392562|NCT01254188|11654008|FG000|Overall Study|Withdrawal by Subject|7
7392563|NCT01254188|11654008|FG000|Overall Study|Adverse Event|43
7392564|NCT01254188|11654008|FG000|Overall Study|per investigator discretion|20
7392565|NCT01254227|11654021|FG000|Overall Study|Withdrawal by Subject|6
7392566|NCT01254227|11654021|FG000|Overall Study|Lost to Follow-up|6
7392567|NCT01254227|11654021|FG000|Overall Study|Adverse Event|5
7392568|NCT01254227|11654021|FG000|Overall Study|Abnormal test procedure result|5
7392569|NCT01254227|11654021|FG000|Overall Study|Administrative problems|2
7392570|NCT01254227|11654021|FG000|Overall Study|Death|1
7392571|NCT01254227|11654021|FG000|Overall Study|Protocol deviation|1
7392572|NCT01254292|11654027|FG000|Comparative Phase|Adverse Event|25
7392573|NCT01254292|11654028|FG001|Comparative Phase|Adverse Event|25
7392574|NCT01254292|11654027|FG000|Comparative Phase|Lost to Follow-up|3
7392575|NCT01254292|11654028|FG001|Comparative Phase|Lost to Follow-up|21
7392576|NCT01254292|11654027|FG000|Comparative Phase|Pregnancy|2
7392577|NCT01254292|11654028|FG001|Comparative Phase|Pregnancy|6
7392578|NCT01254292|11654027|FG000|Comparative Phase|Withdrawal by Subject|20
7392579|NCT01254292|11654028|FG001|Comparative Phase|Withdrawal by Subject|21
7392580|NCT01254292|11654027|FG000|Comparative Phase|Protocol Violation|1
7392581|NCT01254292|11654028|FG001|Comparative Phase|Protocol Violation|2
7392582|NCT01254292|11654027|FG000|Comparative Phase|Wish for pregnancy|4
7392583|NCT01254292|11654028|FG001|Comparative Phase|Wish for pregnancy|6
7392584|NCT01254292|11654027|FG000|LCS12 Extension Phase|Wish for pregnancy|14
7392585|NCT01254292|11654028|FG001|LCS12 Extension Phase|Wish for pregnancy|0
7392586|NCT01254292|11654027|FG000|LCS12 Extension Phase|Adverse Event|9
7392587|NCT01254292|11654028|FG001|LCS12 Extension Phase|Adverse Event|0
7392588|NCT01254292|11654027|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
7392589|NCT01254292|11654028|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
7392590|NCT01254292|11654027|FG000|LCS12 Extension Phase|Other unknown|4
7392591|NCT01254292|11654028|FG001|LCS12 Extension Phase|Other unknown|0
7392592|NCT01254292|11654027|FG000|LCS12 Extension Phase|Pregnancy|2
7392593|NCT01254292|11654028|FG001|LCS12 Extension Phase|Pregnancy|0
7392594|NCT01254292|11654027|FG000|LCS12 Extension Phase|Lost to Follow-up|1
7392595|NCT01254292|11654028|FG001|LCS12 Extension Phase|Lost to Follow-up|0
7392596|NCT01254305|11654038|FG000|Overall Study|Adverse Event|6
7392597|NCT01254305|11654039|FG001|Overall Study|Adverse Event|3
7392598|NCT01254305|11654040|FG002|Overall Study|Adverse Event|2
7392599|NCT01254305|11654038|FG000|Overall Study|Lack of Efficacy|1
7392600|NCT01254305|11654039|FG001|Overall Study|Lack of Efficacy|0
7392601|NCT01254305|11654040|FG002|Overall Study|Lack of Efficacy|1
7392602|NCT01254305|11654038|FG000|Overall Study|Protocol Violation|1
7392603|NCT01254305|11654039|FG001|Overall Study|Protocol Violation|7
7392604|NCT01254305|11654040|FG002|Overall Study|Protocol Violation|3
7392605|NCT01254305|11654038|FG000|Overall Study|Withdrawal by Subject|4
7392606|NCT01254305|11654039|FG001|Overall Study|Withdrawal by Subject|2
7392607|NCT01254305|11654040|FG002|Overall Study|Withdrawal by Subject|4
7392608|NCT01254305|11654038|FG000|Overall Study|Lost to Follow-up|10
7392609|NCT01254305|11654039|FG001|Overall Study|Lost to Follow-up|6
7392610|NCT01254305|11654040|FG002|Overall Study|Lost to Follow-up|5
7392611|NCT01254305|11654038|FG000|Overall Study|Other Reasons|0
7392612|NCT01254305|11654039|FG001|Overall Study|Other Reasons|0
7392613|NCT01254305|11654040|FG002|Overall Study|Other Reasons|2
7392614|NCT01254318|11654051|FG000|Overall Study|Lost to Follow-up|5
7392615|NCT01254318|11654051|FG000|Overall Study|Death|47
7392616|NCT01254331|11654055|FG000|Initial Phase|Adverse Event|3
7392617|NCT01254331|11654055|FG000|Initial Phase|Withdrawal by Subject|1
7392618|NCT01254331|11654055|FG000|Initial Phase|Pregnancy|1
7392619|NCT01254331|11654055|FG000|Extension Phase|Lack of Efficacy|1
7392620|NCT01254331|11654055|FG000|Extension Phase|Lost to Follow-up|3
7392621|NCT01254344|11654061|FG000|Overall Study|Adverse Event|2
7392622|NCT01254344|11654062|FG001|Overall Study|Adverse Event|5
7392623|NCT01254344|11654061|FG000|Overall Study|Physician Decision|7
7392624|NCT01254344|11654062|FG001|Overall Study|Physician Decision|4
7392625|NCT01254344|11654061|FG000|Overall Study|Protocol Violation|1
7392626|NCT01254344|11654062|FG001|Overall Study|Protocol Violation|4
7392627|NCT01254344|11654061|FG000|Overall Study|Withdrawal by Subject|3
7392628|NCT01254344|11654062|FG001|Overall Study|Withdrawal by Subject|6
7392629|NCT01254565|11654089|FG000|Overall Study|Non-compliance to Study Procedures|0
7392630|NCT01254565|11654090|FG001|Overall Study|Non-compliance to Study Procedures|0
7392631|NCT01254565|11654091|FG002|Overall Study|Non-compliance to Study Procedures|0
7392632|NCT01254565|11654092|FG003|Overall Study|Non-compliance to Study Procedures|0
7392718|NCT01254721|11654163|FG001|Overall Study|technical problum|0
7392633|NCT01254565|11654093|FG004|Overall Study|Non-compliance to Study Procedures|1
7392634|NCT01254565|11654094|FG005|Overall Study|Non-compliance to Study Procedures|0
7392635|NCT01254565|11654089|FG000|Overall Study|Did not Receive Treatment|1
7392636|NCT01254565|11654090|FG001|Overall Study|Did not Receive Treatment|1
7392637|NCT01254565|11654091|FG002|Overall Study|Did not Receive Treatment|0
7392638|NCT01254565|11654092|FG003|Overall Study|Did not Receive Treatment|0
7392639|NCT01254565|11654093|FG004|Overall Study|Did not Receive Treatment|3
7392640|NCT01254565|11654094|FG005|Overall Study|Did not Receive Treatment|4
7392641|NCT01254565|11654089|FG000|Overall Study|Other|0
7392642|NCT01254565|11654090|FG001|Overall Study|Other|0
7392643|NCT01254565|11654091|FG002|Overall Study|Other|0
7392644|NCT01254565|11654092|FG003|Overall Study|Other|1
7392645|NCT01254565|11654093|FG004|Overall Study|Other|0
7392646|NCT01254565|11654094|FG005|Overall Study|Other|0
7392647|NCT01254604|11654110|FG000|Overall Study|Lost to Follow-up|1
7392648|NCT01254604|11654111|FG001|Overall Study|Lost to Follow-up|1
7392649|NCT01254604|11654110|FG000|Overall Study|Protocol Violation|2
7392650|NCT01254604|11654111|FG001|Overall Study|Protocol Violation|2
7392651|NCT01254604|11654110|FG000|Overall Study|Withdrawal by Subject|2
7392652|NCT01254604|11654111|FG001|Overall Study|Withdrawal by Subject|4
7392653|NCT01254604|11654110|FG000|Overall Study|Adverse Event|3
7392654|NCT01254604|11654111|FG001|Overall Study|Adverse Event|2
7392655|NCT01254630|11654121|FG000|Overall Study|Adverse Event|36
7392656|NCT01254630|11654122|FG001|Overall Study|Adverse Event|15
7392657|NCT01254630|11654123|FG002|Overall Study|Adverse Event|40
7392658|NCT01254630|11654124|FG003|Overall Study|Adverse Event|8
7392659|NCT01254630|11654121|FG000|Overall Study|Death|461
7392660|NCT01254630|11654122|FG001|Overall Study|Death|151
7392661|NCT01254630|11654123|FG002|Overall Study|Death|478
7392662|NCT01254630|11654124|FG003|Overall Study|Death|139
7392663|NCT01254630|11654121|FG000|Overall Study|Lost to Follow-up|80
7392664|NCT01254630|11654122|FG001|Overall Study|Lost to Follow-up|26
7392665|NCT01254630|11654123|FG002|Overall Study|Lost to Follow-up|89
7392666|NCT01254630|11654124|FG003|Overall Study|Lost to Follow-up|32
7392667|NCT01254630|11654121|FG000|Overall Study|Physician Decision|24
7392668|NCT01254630|11654122|FG001|Overall Study|Physician Decision|8
7392669|NCT01254630|11654123|FG002|Overall Study|Physician Decision|16
7392670|NCT01254630|11654124|FG003|Overall Study|Physician Decision|7
7392671|NCT01254630|11654121|FG000|Overall Study|Withdrawal by Subject|201
7392672|NCT01254630|11654122|FG001|Overall Study|Withdrawal by Subject|94
7392673|NCT01254630|11654123|FG002|Overall Study|Withdrawal by Subject|188
7392674|NCT01254630|11654124|FG003|Overall Study|Withdrawal by Subject|89
7392675|NCT01254630|11654121|FG000|Overall Study|Study terminated by sponsor|0
7392676|NCT01254630|11654122|FG001|Overall Study|Study terminated by sponsor|994
7392677|NCT01254630|11654123|FG002|Overall Study|Study terminated by sponsor|0
7392678|NCT01254630|11654124|FG003|Overall Study|Study terminated by sponsor|1010
7392679|NCT01254630|11654121|FG000|Overall Study|Status not recorded|0
7392680|NCT01254630|11654122|FG001|Overall Study|Status not recorded|0
7392681|NCT01254630|11654123|FG002|Overall Study|Status not recorded|1
7392682|NCT01254630|11654124|FG003|Overall Study|Status not recorded|0
7392683|NCT01254643|11654132|FG000|Overall Study|Withdrawal by Subject|1
7392684|NCT01254656|11654139|FG000|Overall Study|Discontinued due to termination of study|40
7392685|NCT01254656|11654140|FG001|Overall Study|Discontinued due to termination of study|39
7392686|NCT01254656|11654141|FG002|Overall Study|Discontinued due to termination of study|13
7392687|NCT01254656|11654139|FG000|Overall Study|Lack of Efficacy|3
7392688|NCT01254656|11654140|FG001|Overall Study|Lack of Efficacy|0
7392689|NCT01254656|11654141|FG002|Overall Study|Lack of Efficacy|0
7392690|NCT01254656|11654139|FG000|Overall Study|Lost to Follow-up|1
7392691|NCT01254656|11654140|FG001|Overall Study|Lost to Follow-up|0
7392692|NCT01254656|11654141|FG002|Overall Study|Lost to Follow-up|2
7392693|NCT01254656|11654139|FG000|Overall Study|Withdrawal by Subject|2
7392694|NCT01254656|11654140|FG001|Overall Study|Withdrawal by Subject|2
7392695|NCT01254656|11654141|FG002|Overall Study|Withdrawal by Subject|1
7392696|NCT01254656|11654139|FG000|Overall Study|Pregnancy|0
7392697|NCT01254656|11654140|FG001|Overall Study|Pregnancy|0
7392698|NCT01254656|11654141|FG002|Overall Study|Pregnancy|2
7392699|NCT01254656|11654139|FG000|Overall Study|Adverse Event|1
7392700|NCT01254656|11654140|FG001|Overall Study|Adverse Event|1
7392701|NCT01254656|11654141|FG002|Overall Study|Adverse Event|0
7392702|NCT01254656|11654139|FG000|Overall Study|Death|0
7392703|NCT01254656|11654140|FG001|Overall Study|Death|1
7392704|NCT01254656|11654141|FG002|Overall Study|Death|0
7392705|NCT01254669|11654151|FG000|Overall Study|Withdrawal by Subject|0
7392706|NCT01254669|11654152|FG001|Overall Study|Withdrawal by Subject|1
7392707|NCT01254669|11654151|FG000|Overall Study|time constraint|2
7392708|NCT01254669|11654152|FG001|Overall Study|time constraint|2
7465258|NCT03861052|11764514|FG000|Overall Study|Adverse Event|1
7392709|NCT01254669|11654151|FG000|Overall Study|called to clinic during intervention|1
7392710|NCT01254669|11654152|FG001|Overall Study|called to clinic during intervention|1
7392711|NCT01254721|11654162|FG000|Overall Study|Lost to Follow-up|0
7392712|NCT01254721|11654163|FG001|Overall Study|Lost to Follow-up|4
7392713|NCT01254721|11654162|FG000|Overall Study|Lack of Efficacy|4
7392714|NCT01254721|11654163|FG001|Overall Study|Lack of Efficacy|2
7392715|NCT01254721|11654162|FG000|Overall Study|Death|0
7392716|NCT01254721|11654163|FG001|Overall Study|Death|1
7392717|NCT01254721|11654162|FG000|Overall Study|technical problum|1
7392719|NCT01254721|11654162|FG000|Overall Study|Adverse Event|2
7392720|NCT01254721|11654163|FG001|Overall Study|Adverse Event|3
7392721|NCT01254721|11654162|FG000|Overall Study|Withdrawal by Subject|8
7392722|NCT01254721|11654163|FG001|Overall Study|Withdrawal by Subject|11
7392723|NCT01254721|11654162|FG000|Overall Study|Wrongly randomization|0
7392724|NCT01254721|11654163|FG001|Overall Study|Wrongly randomization|1
7392725|NCT01254747|11654173|FG000|Overall Study|Unacceptable subjective vision|0
7392726|NCT01254747|11654174|FG001|Overall Study|Unacceptable subjective vision|0
7392727|NCT01254747|11654175|FG002|Overall Study|Unacceptable subjective vision|0
7392728|NCT01254747|11654176|FG003|Overall Study|Unacceptable subjective vision|2
7392729|NCT01254747|11654173|FG000|Overall Study|Difficult removal handling|0
7392730|NCT01254747|11654174|FG001|Overall Study|Difficult removal handling|0
7392731|NCT01254747|11654175|FG002|Overall Study|Difficult removal handling|1
7392732|NCT01254747|11654176|FG003|Overall Study|Difficult removal handling|0
7392733|NCT01254747|11654173|FG000|Overall Study|Symptoms and problems|0
7392734|NCT01254747|11654174|FG001|Overall Study|Symptoms and problems|2
7392735|NCT01254747|11654175|FG002|Overall Study|Symptoms and problems|1
7392736|NCT01254747|11654176|FG003|Overall Study|Symptoms and problems|0
7392737|NCT01254747|11654173|FG000|Overall Study|Lost to Follow-up|0
7392738|NCT01254747|11654174|FG001|Overall Study|Lost to Follow-up|0
7392739|NCT01254747|11654175|FG002|Overall Study|Lost to Follow-up|1
7392740|NCT01254747|11654176|FG003|Overall Study|Lost to Follow-up|0
7392741|NCT01254747|11654173|FG000|Overall Study|Biomicroscopy|0
7392742|NCT01254747|11654174|FG001|Overall Study|Biomicroscopy|0
7392743|NCT01254747|11654175|FG002|Overall Study|Biomicroscopy|1
7392744|NCT01254747|11654176|FG003|Overall Study|Biomicroscopy|0
7392745|NCT01254747|11654173|FG000|Overall Study|Discomfort|0
7392746|NCT01254747|11654174|FG001|Overall Study|Discomfort|4
7392747|NCT01254747|11654175|FG002|Overall Study|Discomfort|0
7392748|NCT01254747|11654176|FG003|Overall Study|Discomfort|0
7392749|NCT01254890|11654218|FG000|Overall Study|Ineligible|0
7392750|NCT01254890|11654219|FG001|Overall Study|Ineligible|3
7392751|NCT01254890|11654218|FG000|Overall Study|Withdrawal by Subject|1
7392752|NCT01254890|11654219|FG001|Overall Study|Withdrawal by Subject|2
7392753|NCT01254890|11654218|FG000|Overall Study|Disease Progression|0
7392754|NCT01254890|11654219|FG001|Overall Study|Disease Progression|5
7392755|NCT01255163|11654230|FG000|Overall Study|Withdrawal by Subject|1
7392756|NCT01255163|11654231|FG001|Overall Study|Withdrawal by Subject|0
7392757|NCT01255163|11654230|FG000|Overall Study|Lost to Follow-up|2
7392758|NCT01255163|11654231|FG001|Overall Study|Lost to Follow-up|0
7392759|NCT01255163|11654230|FG000|Overall Study|Adverse Event|0
7392760|NCT01255163|11654231|FG001|Overall Study|Adverse Event|2
7392761|NCT01255163|11654230|FG000|Overall Study|AstraZeneca stopped support of the study|1
7392762|NCT01255163|11654231|FG001|Overall Study|AstraZeneca stopped support of the study|3
7392763|NCT01255306|11654241|FG000|Overall Study|Physician Decision|1
7392764|NCT01255306|11654242|FG001|Overall Study|Physician Decision|1
7392765|NCT01255423|11654253|FG000|Overall Study|Abnormal Laboratory value|3
7392766|NCT01255423|11654254|FG001|Overall Study|Abnormal Laboratory value|2
7392767|NCT01255423|11654253|FG000|Overall Study|Use of prohibited medications|0
7392768|NCT01255423|11654254|FG001|Overall Study|Use of prohibited medications|1
7392769|NCT01255436|11654262|FG000|Overall Study|Lost to Follow-up|178
7392770|NCT01255436|11654263|FG001|Overall Study|Lost to Follow-up|191
7392771|NCT01255436|11654262|FG000|Overall Study|Death, stroke, or MI|4
7392772|NCT01255436|11654263|FG001|Overall Study|Death, stroke, or MI|3
7392773|NCT01255592|11654276|FG000|Overall Study|Adverse Event|5
7392774|NCT01255592|11654277|FG001|Overall Study|Adverse Event|0
7392775|NCT01255592|11654276|FG000|Overall Study|Withdrawal by Subject|1
7392776|NCT01255592|11654277|FG001|Overall Study|Withdrawal by Subject|0
7392777|NCT01255592|11654276|FG000|Overall Study|Other|0
7392778|NCT01255592|11654277|FG001|Overall Study|Other|1
7392779|NCT01255631|11654286|FG000|Overall Study|poor enrollment, no data analyzed|9
7392780|NCT01255631|11654287|FG001|Overall Study|poor enrollment, no data analyzed|6
7392781|NCT01255670|11654295|FG000|Overall Study|Adverse Event|10
7392782|NCT01255670|11654296|FG001|Overall Study|Adverse Event|10
7392783|NCT01255670|11654295|FG000|Overall Study|Lost to Follow-up|16
7392784|NCT01255670|11654296|FG001|Overall Study|Lost to Follow-up|10
7392785|NCT01255722|11654305|FG000|Overall Study|Adverse Event|0
7392786|NCT01255722|11654306|FG001|Overall Study|Adverse Event|1
7392787|NCT01255722|11654307|FG002|Overall Study|Adverse Event|1
7392788|NCT01255722|11654305|FG000|Overall Study|asymptomatic patient|1
7392789|NCT01255722|11654306|FG001|Overall Study|asymptomatic patient|0
7392790|NCT01255722|11654307|FG002|Overall Study|asymptomatic patient|0
7392791|NCT01255722|11654305|FG000|Overall Study|beta-blocker contraindicated|2
7392792|NCT01255722|11654306|FG001|Overall Study|beta-blocker contraindicated|0
7392793|NCT01255722|11654307|FG002|Overall Study|beta-blocker contraindicated|0
7392794|NCT01255761|11654318|FG000|Overall Study|Adverse Event|29
7392795|NCT01255761|11654319|FG001|Overall Study|Adverse Event|43
7392796|NCT01255761|11654318|FG000|Overall Study|Lack of Efficacy|86
7392797|NCT01255761|11654319|FG001|Overall Study|Lack of Efficacy|74
7392798|NCT01255761|11654318|FG000|Overall Study|Protocol Violation|9
7392799|NCT01255761|11654319|FG001|Overall Study|Protocol Violation|5
7392800|NCT01255761|11654318|FG000|Overall Study|Lost to Follow-up|10
7392801|NCT01255761|11654319|FG001|Overall Study|Lost to Follow-up|8
7392802|NCT01255761|11654318|FG000|Overall Study|Withdrawal by Subject|11
7392803|NCT01255761|11654319|FG001|Overall Study|Withdrawal by Subject|27
7392804|NCT01255761|11654318|FG000|Overall Study|Other Reasons|37
7392805|NCT01255761|11654319|FG001|Overall Study|Other Reasons|18
7392806|NCT01255787|11654329|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7392807|NCT01255787|11654330|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
7392808|NCT01255787|11654331|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7392809|NCT01255787|11654332|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
7392810|NCT01255787|11654329|FG000|Overall Study|Major Protocol Deviation|1
7392811|NCT01255787|11654330|FG001|Overall Study|Major Protocol Deviation|1
7392812|NCT01255787|11654331|FG002|Overall Study|Major Protocol Deviation|0
7392813|NCT01255787|11654332|FG003|Overall Study|Major Protocol Deviation|4
7392814|NCT01255787|11654329|FG000|Overall Study|Lost to Follow-up|1
7392815|NCT01255787|11654330|FG001|Overall Study|Lost to Follow-up|2
7392816|NCT01255787|11654331|FG002|Overall Study|Lost to Follow-up|4
7392817|NCT01255787|11654332|FG003|Overall Study|Lost to Follow-up|2
7392818|NCT01255787|11654329|FG000|Overall Study|Withdrawal of Consent|3
7392819|NCT01255787|11654330|FG001|Overall Study|Withdrawal of Consent|9
7392820|NCT01255787|11654331|FG002|Overall Study|Withdrawal of Consent|3
7392821|NCT01255787|11654332|FG003|Overall Study|Withdrawal of Consent|4
7392822|NCT01255787|11654329|FG000|Overall Study|Pregnancy|0
7392823|NCT01255787|11654330|FG001|Overall Study|Pregnancy|0
7392824|NCT01255787|11654331|FG002|Overall Study|Pregnancy|0
7392825|NCT01255787|11654332|FG003|Overall Study|Pregnancy|1
7392826|NCT01255787|11654329|FG000|Overall Study|Lack of Efficacy|2
7392827|NCT01255787|11654330|FG001|Overall Study|Lack of Efficacy|2
7392828|NCT01255787|11654331|FG002|Overall Study|Lack of Efficacy|2
7392829|NCT01255787|11654332|FG003|Overall Study|Lack of Efficacy|2
7392830|NCT01255787|11654329|FG000|Overall Study|Noncompliance with Study Drug|3
7392831|NCT01255787|11654330|FG001|Overall Study|Noncompliance with Study Drug|1
7392832|NCT01255787|11654331|FG002|Overall Study|Noncompliance with Study Drug|0
7392833|NCT01255787|11654332|FG003|Overall Study|Noncompliance with Study Drug|0
7392834|NCT01255904|11654373|FG000|Overall Study|Physician Decision|1
7392835|NCT01255904|11654374|FG001|Overall Study|Physician Decision|4
7392836|NCT01256008|11654383|FG000|Overall Study|Lost to Follow-up|6
7392837|NCT01256008|11654384|FG001|Overall Study|Lost to Follow-up|4
7392838|NCT01256008|11654385|FG002|Overall Study|Lost to Follow-up|11
7392839|NCT01256008|11654383|FG000|Overall Study|Withdrawal by Subject|2
7392840|NCT01256008|11654384|FG001|Overall Study|Withdrawal by Subject|3
7392841|NCT01256008|11654385|FG002|Overall Study|Withdrawal by Subject|10
7392842|NCT01256060|11654404|FG000|Overall Study|Lost to Follow-up|0
7392843|NCT01256060|11654405|FG001|Overall Study|Lost to Follow-up|1
7392844|NCT01256060|11654406|FG002|Overall Study|Lost to Follow-up|0
7392845|NCT01256060|11654407|FG003|Overall Study|Lost to Follow-up|0
7392846|NCT01256177|11654424|FG000|Overall Study|Withdrawal by Subject|23
7392847|NCT01256177|11654425|FG001|Overall Study|Withdrawal by Subject|22
7392848|NCT01256177|11654424|FG000|Overall Study|Lost to Follow-up|2
7392849|NCT01256177|11654425|FG001|Overall Study|Lost to Follow-up|2
7392850|NCT01256177|11654424|FG000|Overall Study|Adverse Event|8
7392851|NCT01256177|11654425|FG001|Overall Study|Adverse Event|9
7392852|NCT01256177|11654424|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7392853|NCT01256177|11654425|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7392854|NCT01256177|11654424|FG000|Overall Study|Condition under Investigation Worsened|1
7392855|NCT01256177|11654425|FG001|Overall Study|Condition under Investigation Worsened|0
7392856|NCT01256177|11654424|FG000|Overall Study|Lack of Efficacy|11
7392857|NCT01256177|11654425|FG001|Overall Study|Lack of Efficacy|2
7392858|NCT01256177|11654424|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
7392859|NCT01256177|11654425|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
7392860|NCT01256190|11654433|FG000|Overall Study|Lost to Follow-up|2
7392861|NCT01256190|11654434|FG001|Overall Study|Lost to Follow-up|0
7392862|NCT01256294|11654440|FG000|Overall Study|Adverse Event|1
7392863|NCT01256294|11654441|FG001|Overall Study|Adverse Event|0
7392864|NCT01256294|11654440|FG000|Overall Study|Withdrawal by Subject|1
7392865|NCT01256294|11654441|FG001|Overall Study|Withdrawal by Subject|1
7392866|NCT01256294|11654440|FG000|Overall Study|Protocol deviation|2
7392867|NCT01256294|11654441|FG001|Overall Study|Protocol deviation|1
7392868|NCT01256385|11654449|FG000|Overall Study|Physician Decision|1
7392869|NCT01256385|11654450|FG001|Overall Study|Physician Decision|1
7392870|NCT01256385|11654449|FG000|Overall Study|Withdrawal by Subject|2
7392871|NCT01256385|11654450|FG001|Overall Study|Withdrawal by Subject|2
7392872|NCT01256411|11654460|FG000|Extension by Maximum Treatment|Protocol deviation|0
7392873|NCT01256411|11654461|FG001|Extension by Maximum Treatment|Protocol deviation|0
7392874|NCT01256411|11654462|FG002|Extension by Maximum Treatment|Protocol deviation|1
7465259|NCT03861052|11764515|FG001|Overall Study|Adverse Event|1
7392875|NCT01256411|11654463|FG003|Extension by Maximum Treatment|Protocol deviation|0
7392876|NCT01256411|11654464|FG004|Extension by Maximum Treatment|Protocol deviation|0
7392877|NCT01256411|11654465|FG005|Extension by Maximum Treatment|Protocol deviation|0
7392878|NCT01256411|11654460|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
7392879|NCT01256411|11654461|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
7392880|NCT01256411|11654462|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
7392881|NCT01256411|11654463|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
7392882|NCT01256411|11654464|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
7392883|NCT01256411|11654465|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
7392884|NCT01256411|11654460|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
7392885|NCT01256411|11654461|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
7392886|NCT01256411|11654462|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
7392887|NCT01256411|11654463|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
7392888|NCT01256411|11654464|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
7392889|NCT01256411|11654465|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
7392890|NCT01256411|11654460|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
7392891|NCT01256411|11654461|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
7392892|NCT01256411|11654462|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
7392893|NCT01256411|11654463|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
7392894|NCT01256411|11654464|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
7392895|NCT01256411|11654465|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
7392896|NCT01256411|11654460|FG000|Extension by Maximum Treatment|Adverse Event|4
7392897|NCT01256411|11654461|FG001|Extension by Maximum Treatment|Adverse Event|2
7392898|NCT01256411|11654462|FG002|Extension by Maximum Treatment|Adverse Event|1
7392899|NCT01256411|11654463|FG003|Extension by Maximum Treatment|Adverse Event|0
7392900|NCT01256411|11654464|FG004|Extension by Maximum Treatment|Adverse Event|0
7392901|NCT01256411|11654465|FG005|Extension by Maximum Treatment|Adverse Event|0
7392902|NCT01256411|11654460|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
7392903|NCT01256411|11654461|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
7392904|NCT01256411|11654462|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
7392905|NCT01256411|11654463|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
7392906|NCT01256411|11654464|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
7392907|NCT01256411|11654465|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
7392908|NCT01256411|11654460|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
7392909|NCT01256411|11654461|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
7392910|NCT01256411|11654462|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
7392911|NCT01256411|11654463|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
7392912|NCT01256411|11654464|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
7392913|NCT01256411|11654465|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
7392914|NCT01256411|11654460|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7392915|NCT01256411|11654461|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7392916|NCT01256411|11654462|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7392917|NCT01256411|11654463|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7392918|NCT01256411|11654464|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
7392919|NCT01256411|11654465|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
7392920|NCT01256411|11654460|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7392921|NCT01256411|11654461|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7392922|NCT01256411|11654462|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7392923|NCT01256411|11654463|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
7392924|NCT01256411|11654464|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
7392925|NCT01256411|11654465|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
7392926|NCT01256411|11654460|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7392927|NCT01256411|11654461|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7392928|NCT01256411|11654462|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7392929|NCT01256411|11654463|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
7392930|NCT01256411|11654464|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7392931|NCT01256411|11654465|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
7392932|NCT01256450|11654499|FG000|Open-label Titration|Adverse Event|39
7392933|NCT01256450|11654500|FG001|Open-label Titration|Adverse Event|0
7392934|NCT01256450|11654501|FG002|Open-label Titration|Adverse Event|0
7392935|NCT01256450|11654499|FG000|Open-label Titration|Lost to Follow-up|7
7392936|NCT01256450|11654500|FG001|Open-label Titration|Lost to Follow-up|0
7392937|NCT01256450|11654501|FG002|Open-label Titration|Lost to Follow-up|0
7392938|NCT01256450|11654499|FG000|Open-label Titration|Lack of analgesic effect|30
7392939|NCT01256450|11654500|FG001|Open-label Titration|Lack of analgesic effect|0
7392940|NCT01256450|11654501|FG002|Open-label Titration|Lack of analgesic effect|0
7392941|NCT01256450|11654499|FG000|Open-label Titration|Non-compliance|9
7392942|NCT01256450|11654500|FG001|Open-label Titration|Non-compliance|0
7392943|NCT01256450|11654501|FG002|Open-label Titration|Non-compliance|0
7392944|NCT01256450|11654499|FG000|Open-label Titration|Screen failure|1
7392945|NCT01256450|11654500|FG001|Open-label Titration|Screen failure|0
7392946|NCT01256450|11654501|FG002|Open-label Titration|Screen failure|0
7392947|NCT01256450|11654499|FG000|Open-label Titration|Other|13
7392948|NCT01256450|11654500|FG001|Open-label Titration|Other|0
7392949|NCT01256450|11654501|FG002|Open-label Titration|Other|0
7392950|NCT01256450|11654499|FG000|Double-blind Treatment|Adverse Event|0
7392951|NCT01256450|11654500|FG001|Double-blind Treatment|Adverse Event|8
7392952|NCT01256450|11654501|FG002|Double-blind Treatment|Adverse Event|6
7392953|NCT01256450|11654499|FG000|Double-blind Treatment|Lost to Follow-up|0
7392954|NCT01256450|11654500|FG001|Double-blind Treatment|Lost to Follow-up|1
7392955|NCT01256450|11654501|FG002|Double-blind Treatment|Lost to Follow-up|7
7392956|NCT01256450|11654499|FG000|Double-blind Treatment|Withdrawal by Subject|0
7392957|NCT01256450|11654500|FG001|Double-blind Treatment|Withdrawal by Subject|0
7392958|NCT01256450|11654501|FG002|Double-blind Treatment|Withdrawal by Subject|1
7392959|NCT01256450|11654499|FG000|Double-blind Treatment|Lack of analgesic effect|0
7392960|NCT01256450|11654500|FG001|Double-blind Treatment|Lack of analgesic effect|5
7392961|NCT01256450|11654501|FG002|Double-blind Treatment|Lack of analgesic effect|6
7392962|NCT01256450|11654499|FG000|Double-blind Treatment|Non-compliance|0
7392963|NCT01256450|11654500|FG001|Double-blind Treatment|Non-compliance|5
7392964|NCT01256450|11654501|FG002|Double-blind Treatment|Non-compliance|4
7392965|NCT01256450|11654499|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
7392966|NCT01256450|11654500|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
7392967|NCT01256450|11654501|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
7392968|NCT01256450|11654499|FG000|Double-blind Treatment|Other|0
7392969|NCT01256450|11654500|FG001|Double-blind Treatment|Other|9
7392970|NCT01256450|11654501|FG002|Double-blind Treatment|Other|12
7392971|NCT01256476|11654510|FG000|Overall Study|Adverse Event|2
7392972|NCT01256476|11654511|FG001|Overall Study|Adverse Event|1
7392973|NCT01256476|11654510|FG000|Overall Study|Withdrawal by Subject|2
7392974|NCT01256476|11654511|FG001|Overall Study|Withdrawal by Subject|1
7392975|NCT01256476|11654510|FG000|Overall Study|Lost to Follow-up|1
7392976|NCT01256476|11654511|FG001|Overall Study|Lost to Follow-up|2
7392977|NCT01256476|11654510|FG000|Overall Study|Persistent ALT or AST elevation|1
7392978|NCT01256476|11654511|FG001|Overall Study|Persistent ALT or AST elevation|0
7392979|NCT01256476|11654510|FG000|Overall Study|Physician Decision|0
7392980|NCT01256476|11654511|FG001|Overall Study|Physician Decision|1
7392981|NCT01256476|11654510|FG000|Overall Study|Subject non-compliance|0
7392982|NCT01256476|11654511|FG001|Overall Study|Subject non-compliance|1
7392983|NCT01256476|11654510|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
7392984|NCT01256476|11654511|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
7392985|NCT01256502|11654517|FG000|Overall Study|Had scaffold removed|4
7392986|NCT01256502|11654517|FG000|Overall Study|Personal reasons|5
7392987|NCT01256502|11654517|FG000|Overall Study|Protocol deviation|1
7392988|NCT01256567|11654526|FG000|Overall Study|Withdrawal by Subject|1
7392989|NCT01256593|11654531|FG000|Overall Study|Protocol Violation|26
7392990|NCT01256593|11654531|FG000|Overall Study|No Drug Administration Information|2
7392991|NCT01256593|11654531|FG000|Overall Study|No Visit After Treatment|186
7392992|NCT01256658|11654537|FG000|Period 1|Lost to Follow-up|837
7392993|NCT01256658|11654538|FG001|Period 1|Lost to Follow-up|661
7392994|NCT01256658|11654537|FG000|Period 1|Withdrawal by Subject|35
7392995|NCT01256658|11654538|FG001|Period 1|Withdrawal by Subject|43
7392996|NCT01256658|11654537|FG000|Period 1|Death|48
7392997|NCT01256658|11654538|FG001|Period 1|Death|44
7392998|NCT01256671|11654547|FG000|Overall Study|Adverse Event|29
7392999|NCT01256671|11654547|FG000|Overall Study|Lost to Follow-up|16
7393000|NCT01256671|11654547|FG000|Overall Study|Withdrawal by Subject|31
7393001|NCT01256671|11654547|FG000|Overall Study|Physician Decision|3
7393002|NCT01256671|11654547|FG000|Overall Study|Lack of Efficacy|4
7393003|NCT01256671|11654547|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
7393004|NCT01256684|11654554|FG000|Overall Study|Adverse Event|1
7393005|NCT01256684|11654555|FG001|Overall Study|Adverse Event|4
7393006|NCT01256684|11654556|FG002|Overall Study|Adverse Event|2
7393007|NCT01256684|11654554|FG000|Overall Study|Withdrawal by Subject|4
7393008|NCT01256684|11654555|FG001|Overall Study|Withdrawal by Subject|0
7393009|NCT01256684|11654556|FG002|Overall Study|Withdrawal by Subject|2
7393010|NCT01256684|11654554|FG000|Overall Study|Physician Decision|0
7393011|NCT01256684|11654555|FG001|Overall Study|Physician Decision|1
7393012|NCT01256684|11654556|FG002|Overall Study|Physician Decision|0
7393013|NCT01256684|11654554|FG000|Overall Study|Lack of Efficacy|0
7393014|NCT01256684|11654555|FG001|Overall Study|Lack of Efficacy|1
7393015|NCT01256684|11654556|FG002|Overall Study|Lack of Efficacy|1
7393016|NCT01256684|11654554|FG000|Overall Study|Entry criteria not met/non-compliance|4
7393017|NCT01256684|11654555|FG001|Overall Study|Entry criteria not met/non-compliance|7
7393018|NCT01256684|11654556|FG002|Overall Study|Entry criteria not met/non-compliance|6
7393019|NCT01256788|11654567|FG000|Overall Study|Lost to Follow-up|5
7393020|NCT01256788|11654568|FG001|Overall Study|Lost to Follow-up|8
7393021|NCT01256788|11654569|FG002|Overall Study|Lost to Follow-up|3
7393022|NCT01256879|11654590|FG000|Overall Study|Withdrawal by Subject|1
7393023|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
7393024|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
7393025|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
7393026|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Adverse Event|3
7393027|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Adverse Event|1
7393028|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Adverse Event|2
7393029|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7393030|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
7393031|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7393032|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
7393033|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
7393034|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
7393035|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7393036|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
7393202|NCT01258738|11654960|FG000|Double-blind Period|Protocol Violation|1
7393037|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
7393038|NCT01257204|11654645|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
7393039|NCT01257204|11654646|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7393040|NCT01257204|11654647|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
7393041|NCT01257204|11654645|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
7393042|NCT01257204|11654646|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
7393043|NCT01257204|11654647|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
7393044|NCT01257204|11654645|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
7393045|NCT01257204|11654646|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7393046|NCT01257204|11654647|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
7393047|NCT01257204|11654645|FG000|Follow-up Period (up to Week 48)|Other|0
7393048|NCT01257204|11654646|FG001|Follow-up Period (up to Week 48)|Other|0
7393049|NCT01257204|11654647|FG002|Follow-up Period (up to Week 48)|Other|5
7393050|NCT01257230|11654683|FG000|Overall Study|Not Treated|0
7393051|NCT01257230|11654684|FG001|Overall Study|Not Treated|0
7393052|NCT01257230|11654685|FG002|Overall Study|Not Treated|1
7393053|NCT01257230|11654683|FG000|Overall Study|Adverse Event|2
7393054|NCT01257230|11654684|FG001|Overall Study|Adverse Event|0
7393055|NCT01257230|11654685|FG002|Overall Study|Adverse Event|0
7393056|NCT01257230|11654683|FG000|Overall Study|Lack of Efficacy|0
7393057|NCT01257230|11654684|FG001|Overall Study|Lack of Efficacy|1
7393058|NCT01257230|11654685|FG002|Overall Study|Lack of Efficacy|0
7393059|NCT01257230|11654683|FG000|Overall Study|Protocol Violation|3
7393060|NCT01257230|11654684|FG001|Overall Study|Protocol Violation|0
7393061|NCT01257230|11654685|FG002|Overall Study|Protocol Violation|1
7393062|NCT01257230|11654683|FG000|Overall Study|Withdrawal by Subject|0
7393063|NCT01257230|11654684|FG001|Overall Study|Withdrawal by Subject|4
7393064|NCT01257230|11654685|FG002|Overall Study|Withdrawal by Subject|1
7393065|NCT01257230|11654683|FG000|Overall Study|Other reason not defined above|1
7393066|NCT01257230|11654684|FG001|Overall Study|Other reason not defined above|5
7393067|NCT01257230|11654685|FG002|Overall Study|Other reason not defined above|3
7393068|NCT01257425|11654716|FG000|Overall Study|Lack of Efficacy|3
7393069|NCT01257425|11654717|FG001|Overall Study|Lack of Efficacy|3
7393070|NCT01257425|11654716|FG000|Overall Study|Adverse Event|1
7393071|NCT01257425|11654717|FG001|Overall Study|Adverse Event|1
7393072|NCT01257425|11654716|FG000|Overall Study|Protocol Violation|1
7393073|NCT01257425|11654717|FG001|Overall Study|Protocol Violation|1
7393074|NCT01257425|11654716|FG000|Overall Study|Withdrawal by Subject|0
7393075|NCT01257425|11654717|FG001|Overall Study|Withdrawal by Subject|1
7393076|NCT01257425|11654716|FG000|Overall Study|Death|1
7393077|NCT01257425|11654717|FG001|Overall Study|Death|0
7393078|NCT01257503|11654734|FG000|Overall Study|Lost to Follow-up|7
7393079|NCT01257503|11654735|FG001|Overall Study|Lost to Follow-up|10
7393080|NCT01257503|11654734|FG000|Overall Study|Over 5 years old at enrollment|0
7393081|NCT01257503|11654735|FG001|Overall Study|Over 5 years old at enrollment|1
7393082|NCT01257503|11654734|FG000|Overall Study|strep culture positive at enrollment|1
7393083|NCT01257503|11654735|FG001|Overall Study|strep culture positive at enrollment|0
7393084|NCT01257542|11654743|FG000|Overall Study|Protocol Violation|3
7393085|NCT01257542|11654744|FG001|Overall Study|Protocol Violation|5
7393086|NCT01257542|11654743|FG000|Overall Study|Withdrawal by Subject|0
7393087|NCT01257542|11654744|FG001|Overall Study|Withdrawal by Subject|2
7393088|NCT01257581|11654753|FG000|Overall Study|Early Termination|3
7393089|NCT01257581|11654754|FG001|Overall Study|Early Termination|1
7393090|NCT01257581|11654755|FG002|Overall Study|Early Termination|2
7393091|NCT01257581|11654753|FG000|Overall Study|Death|2
7393092|NCT01257581|11654754|FG001|Overall Study|Death|2
7393093|NCT01257581|11654755|FG002|Overall Study|Death|4
7393094|NCT01257698|11654765|FG000|Overall Study|Protocol Violation|4
7393095|NCT01257698|11654766|FG001|Overall Study|Protocol Violation|0
7393096|NCT01257737|11654774|FG000|Overall Study|Lost to Follow-up|1
7393097|NCT01257737|11654775|FG001|Overall Study|Lost to Follow-up|2
7393098|NCT01257737|11654774|FG000|Overall Study|Liver transplant|1
7393099|NCT01257737|11654775|FG001|Overall Study|Liver transplant|0
7393100|NCT01257737|11654774|FG000|Overall Study|Relocation out of the country|0
7393101|NCT01257737|11654775|FG001|Overall Study|Relocation out of the country|1
7393102|NCT01257737|11654774|FG000|Overall Study|Withdrew from study|0
7393103|NCT01257737|11654775|FG001|Overall Study|Withdrew from study|1
7393104|NCT01258075|11654817|FG000|Overall Study|Adverse Event|8
7393105|NCT01258075|11654818|FG001|Overall Study|Adverse Event|3
7393106|NCT01258075|11654817|FG000|Overall Study|Lost to Follow-up|11
7393107|NCT01258075|11654818|FG001|Overall Study|Lost to Follow-up|6
7393108|NCT01258075|11654817|FG000|Overall Study|Withdrawal by Subject|10
7393109|NCT01258075|11654818|FG001|Overall Study|Withdrawal by Subject|7
7393110|NCT01258075|11654817|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
7393111|NCT01258075|11654818|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
7393112|NCT01258075|11654817|FG000|Overall Study|Other|12
7393113|NCT01258075|11654818|FG001|Overall Study|Other|5
7393114|NCT01258101|11654828|FG000|Overall Study|Adverse Event|5
7393115|NCT01258101|11654829|FG001|Overall Study|Adverse Event|6
7393116|NCT01258101|11654830|FG002|Overall Study|Adverse Event|0
7393117|NCT01258101|11654831|FG003|Overall Study|Adverse Event|0
7393118|NCT01258101|11654828|FG000|Overall Study|Extra exclusion criterion amended|2
7393119|NCT01258101|11654829|FG001|Overall Study|Extra exclusion criterion amended|1
7393120|NCT01258101|11654830|FG002|Overall Study|Extra exclusion criterion amended|1
7393121|NCT01258101|11654831|FG003|Overall Study|Extra exclusion criterion amended|1
7393122|NCT01258101|11654828|FG000|Overall Study|Informed consent has been withdrawn|2
7393123|NCT01258101|11654829|FG001|Overall Study|Informed consent has been withdrawn|2
7393124|NCT01258101|11654830|FG002|Overall Study|Informed consent has been withdrawn|1
7393125|NCT01258101|11654831|FG003|Overall Study|Informed consent has been withdrawn|1
7393126|NCT01258101|11654828|FG000|Overall Study|Patient is not able to attend visits|8
7393127|NCT01258101|11654829|FG001|Overall Study|Patient is not able to attend visits|9
7393128|NCT01258101|11654830|FG002|Overall Study|Patient is not able to attend visits|7
7393129|NCT01258101|11654831|FG003|Overall Study|Patient is not able to attend visits|6
7393130|NCT01258101|11654828|FG000|Overall Study|Patient´s compliance|4
7393131|NCT01258101|11654829|FG001|Overall Study|Patient´s compliance|3
7393132|NCT01258101|11654830|FG002|Overall Study|Patient´s compliance|1
7393133|NCT01258101|11654831|FG003|Overall Study|Patient´s compliance|2
7393134|NCT01258101|11654828|FG000|Overall Study|Lost to Follow-up|5
7393135|NCT01258101|11654829|FG001|Overall Study|Lost to Follow-up|5
7393136|NCT01258101|11654830|FG002|Overall Study|Lost to Follow-up|0
7393137|NCT01258101|11654831|FG003|Overall Study|Lost to Follow-up|6
7393138|NCT01258101|11654828|FG000|Overall Study|PCR positive at week 24|0
7393139|NCT01258101|11654829|FG001|Overall Study|PCR positive at week 24|0
7393140|NCT01258101|11654830|FG002|Overall Study|PCR positive at week 24|0
7393141|NCT01258101|11654831|FG003|Overall Study|PCR positive at week 24|1
7393142|NCT01258101|11654828|FG000|Overall Study|Other reason|7
7393143|NCT01258101|11654829|FG001|Overall Study|Other reason|8
7393144|NCT01258101|11654830|FG002|Overall Study|Other reason|1
7393145|NCT01258101|11654831|FG003|Overall Study|Other reason|8
7393146|NCT01258348|11654856|FG000|Overall Study|Adverse Event|1
7393147|NCT01258348|11654857|FG001|Overall Study|Adverse Event|1
7393148|NCT01258348|11654858|FG002|Overall Study|Adverse Event|3
7393149|NCT01258348|11654859|FG003|Overall Study|Adverse Event|2
7393150|NCT01258348|11654860|FG004|Overall Study|Adverse Event|4
7393151|NCT01258348|11654856|FG000|Overall Study|Progressive Disease|0
7393152|NCT01258348|11654857|FG001|Overall Study|Progressive Disease|3
7393153|NCT01258348|11654858|FG002|Overall Study|Progressive Disease|0
7393154|NCT01258348|11654859|FG003|Overall Study|Progressive Disease|2
7393155|NCT01258348|11654860|FG004|Overall Study|Progressive Disease|2
7393156|NCT01258348|11654856|FG000|Overall Study|Physician Decision|0
7393157|NCT01258348|11654857|FG001|Overall Study|Physician Decision|0
7393158|NCT01258348|11654858|FG002|Overall Study|Physician Decision|0
7393159|NCT01258348|11654859|FG003|Overall Study|Physician Decision|2
7393160|NCT01258348|11654860|FG004|Overall Study|Physician Decision|0
7393161|NCT01258348|11654856|FG000|Overall Study|Withdrawal by Subject|0
7393162|NCT01258348|11654857|FG001|Overall Study|Withdrawal by Subject|1
7393163|NCT01258348|11654858|FG002|Overall Study|Withdrawal by Subject|0
7393164|NCT01258348|11654859|FG003|Overall Study|Withdrawal by Subject|0
7393165|NCT01258348|11654860|FG004|Overall Study|Withdrawal by Subject|0
7393166|NCT01258595|11654931|FG000|Overall Study|Lost to Follow-up|1
7393167|NCT01258595|11654932|FG001|Overall Study|Lost to Follow-up|0
7393168|NCT01258595|11654931|FG000|Overall Study|Withdrawal by Subject|0
7393169|NCT01258595|11654932|FG001|Overall Study|Withdrawal by Subject|1
7393170|NCT01258608|11654940|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
7393171|NCT01258608|11654941|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
7393172|NCT01258608|11654940|FG000|Overall Study|Clinical progression|1
7393173|NCT01258608|11654941|FG001|Overall Study|Clinical progression|0
7393174|NCT01258608|11654940|FG000|Overall Study|Sponsor decision|0
7393175|NCT01258608|11654941|FG001|Overall Study|Sponsor decision|1
7393176|NCT01258608|11654940|FG000|Overall Study|Physician Decision|6
7393177|NCT01258608|11654941|FG001|Overall Study|Physician Decision|1
7393178|NCT01258608|11654940|FG000|Overall Study|Lost to Follow-up|0
7393179|NCT01258608|11654941|FG001|Overall Study|Lost to Follow-up|1
7393180|NCT01258608|11654940|FG000|Overall Study|Lack of compliance|1
7393181|NCT01258608|11654941|FG001|Overall Study|Lack of compliance|0
7393182|NCT01258608|11654940|FG000|Overall Study|Lack of Efficacy|0
7393183|NCT01258608|11654941|FG001|Overall Study|Lack of Efficacy|1
7393184|NCT01258608|11654940|FG000|Overall Study|Adverse Event|6
7393185|NCT01258608|11654941|FG001|Overall Study|Adverse Event|10
7393186|NCT01258608|11654940|FG000|Overall Study|Withdrawal by Subject|6
7393187|NCT01258608|11654941|FG001|Overall Study|Withdrawal by Subject|5
7393188|NCT01258660|11654950|FG000|Overall Study|Adverse Event|2
7393189|NCT01258660|11654951|FG001|Overall Study|Adverse Event|4
7393190|NCT01258660|11654950|FG000|Overall Study|Withdrawal by Subject|3
7393191|NCT01258660|11654951|FG001|Overall Study|Withdrawal by Subject|0
7393192|NCT01258660|11654950|FG000|Overall Study|due to relocation|2
7393193|NCT01258660|11654951|FG001|Overall Study|due to relocation|0
7393194|NCT01258660|11654950|FG000|Overall Study|Protocol Violation|0
7393195|NCT01258660|11654951|FG001|Overall Study|Protocol Violation|1
7393196|NCT01258660|11654950|FG000|Overall Study|Invalid for primary analysis data set|4
7393197|NCT01258660|11654951|FG001|Overall Study|Invalid for primary analysis data set|6
7393198|NCT01258738|11654960|FG000|Double-blind Period|Did not meet inclusion criteria|3
7393199|NCT01258738|11654961|FG001|Double-blind Period|Did not meet inclusion criteria|3
7393200|NCT01258738|11654960|FG000|Double-blind Period|Withdrawal by Subject|2
7393201|NCT01258738|11654961|FG001|Double-blind Period|Withdrawal by Subject|2
7393203|NCT01258738|11654961|FG001|Double-blind Period|Protocol Violation|1
7393204|NCT01258738|11654960|FG000|Double-blind Period|Adverse Event|3
7393205|NCT01258738|11654961|FG001|Double-blind Period|Adverse Event|1
7393206|NCT01258738|11654960|FG000|Open-label Period|Did not meet inclusion criteria|0
7393207|NCT01258738|11654961|FG001|Open-label Period|Did not meet inclusion criteria|1
7393208|NCT01258738|11654960|FG000|Open-label Period|Insufficient clinical response|5
7393209|NCT01258738|11654961|FG001|Open-label Period|Insufficient clinical response|3
7393210|NCT01258738|11654960|FG000|Open-label Period|Lost to Follow-up|0
7393211|NCT01258738|11654961|FG001|Open-label Period|Lost to Follow-up|2
7317465|NCT00723398|11546508|FG000|Overall Study|Physician Decision|2
7317466|NCT00723398|11546509|FG001|Overall Study|Physician Decision|2
7317467|NCT00723398|11546510|FG002|Overall Study|Physician Decision|5
7317468|NCT00723398|11546511|FG003|Overall Study|Physician Decision|0
7317469|NCT00723398|11546512|FG004|Overall Study|Physician Decision|1
7317470|NCT00723398|11546508|FG000|Overall Study|Adverse Event|0
7317471|NCT00723398|11546509|FG001|Overall Study|Adverse Event|5
7317472|NCT00723398|11546510|FG002|Overall Study|Adverse Event|3
7317473|NCT00723398|11546511|FG003|Overall Study|Adverse Event|1
7317474|NCT00723398|11546512|FG004|Overall Study|Adverse Event|4
7317475|NCT00723398|11546508|FG000|Overall Study|Lost to Follow-up|0
7317476|NCT00723398|11546509|FG001|Overall Study|Lost to Follow-up|1
7317477|NCT00723398|11546510|FG002|Overall Study|Lost to Follow-up|0
7317478|NCT00723398|11546511|FG003|Overall Study|Lost to Follow-up|0
7317479|NCT00723398|11546512|FG004|Overall Study|Lost to Follow-up|0
7317480|NCT00723450|11546526|FG000|Open-Label Phase|Adverse Event|26
7317481|NCT00723450|11546527|FG001|Open-Label Phase|Adverse Event|0
7317482|NCT00723450|11546528|FG002|Open-Label Phase|Adverse Event|0
7317483|NCT00723450|11546526|FG000|Open-Label Phase|Lack of Efficacy|18
7317484|NCT00723450|11546527|FG001|Open-Label Phase|Lack of Efficacy|0
7317485|NCT00723450|11546528|FG002|Open-Label Phase|Lack of Efficacy|0
7317486|NCT00723450|11546526|FG000|Open-Label Phase|Protocol Violation|35
7317487|NCT00723450|11546527|FG001|Open-Label Phase|Protocol Violation|0
7317488|NCT00723450|11546528|FG002|Open-Label Phase|Protocol Violation|0
7317489|NCT00723450|11546526|FG000|Open-Label Phase|Lost to Follow-up|7
7317490|NCT00723450|11546527|FG001|Open-Label Phase|Lost to Follow-up|0
7317491|NCT00723450|11546528|FG002|Open-Label Phase|Lost to Follow-up|0
7393212|NCT01258738|11654960|FG000|Open-label Period|Withdrawal by Subject|5
7393213|NCT01258738|11654961|FG001|Open-label Period|Withdrawal by Subject|6
7393214|NCT01258738|11654960|FG000|Open-label Period|Protocol Violation|2
7393215|NCT01258738|11654961|FG001|Open-label Period|Protocol Violation|2
7393216|NCT01258738|11654960|FG000|Open-label Period|Adverse Event|4
7317492|NCT00723450|11546526|FG000|Open-Label Phase|Physician Decision|2
7317493|NCT00723450|11546527|FG001|Open-Label Phase|Physician Decision|0
7317494|NCT00723450|11546528|FG002|Open-Label Phase|Physician Decision|0
7317495|NCT00723450|11546526|FG000|Open-Label Phase|Withdrawal by Subject|37
7317496|NCT00723450|11546527|FG001|Open-Label Phase|Withdrawal by Subject|0
7317497|NCT00723450|11546528|FG002|Open-Label Phase|Withdrawal by Subject|0
7317498|NCT00723450|11546526|FG000|Randomized Phase|Adverse Event|0
7393217|NCT01258738|11654961|FG001|Open-label Period|Adverse Event|5
7393218|NCT01258738|11654960|FG000|Open-label Period|Other Reasons|0
7393219|NCT01258738|11654961|FG001|Open-label Period|Other Reasons|1
7393220|NCT01258738|11654960|FG000|Open-label Period|Withdrawn due to pregnancy|1
7393221|NCT01258738|11654961|FG001|Open-label Period|Withdrawn due to pregnancy|1
7465260|NCT03861052|11764516|FG002|Overall Study|Adverse Event|2
7465261|NCT03861052|11764517|FG003|Overall Study|Adverse Event|4
7465262|NCT03861052|11764514|FG000|Overall Study|Lost to Follow-up|0
7465263|NCT03861052|11764515|FG001|Overall Study|Lost to Follow-up|0
7465264|NCT03861052|11764516|FG002|Overall Study|Lost to Follow-up|0
7465265|NCT03861052|11764517|FG003|Overall Study|Lost to Follow-up|1
7465266|NCT03861052|11764514|FG000|Overall Study|Physician Decision|0
7465267|NCT03861052|11764515|FG001|Overall Study|Physician Decision|1
7465268|NCT03861052|11764516|FG002|Overall Study|Physician Decision|0
7465269|NCT03861052|11764517|FG003|Overall Study|Physician Decision|0
7465270|NCT03861052|11764514|FG000|Overall Study|Withdrawal by Subject|2
7465271|NCT03861052|11764515|FG001|Overall Study|Withdrawal by Subject|5
7465272|NCT03861052|11764516|FG002|Overall Study|Withdrawal by Subject|3
7465273|NCT03861052|11764517|FG003|Overall Study|Withdrawal by Subject|0
7465274|NCT03861052|11764514|FG000|Overall Study|Relocation to other city|1
7465275|NCT03861052|11764515|FG001|Overall Study|Relocation to other city|0
7465276|NCT03861052|11764516|FG002|Overall Study|Relocation to other city|0
7465277|NCT03861052|11764517|FG003|Overall Study|Relocation to other city|0
7465278|NCT03846453|11764534|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465
7465279|NCT03846453|11764535|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7465280|NCT03846453|11764536|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
7465281|NCT03846453|11764534|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3
7465282|NCT03846453|11764535|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7465283|NCT03846453|11764536|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0
7465284|NCT03846453|11764534|FG000|Placebo Run-in (14 Days)|Physician Decision|1
7465285|NCT03846453|11764535|FG001|Placebo Run-in (14 Days)|Physician Decision|0
7465286|NCT03846453|11764536|FG002|Placebo Run-in (14 Days)|Physician Decision|0
7465287|NCT03846453|11764534|FG000|Placebo Run-in (14 Days)|Other|2
7465288|NCT03846453|11764535|FG001|Placebo Run-in (14 Days)|Other|0
7465289|NCT03846453|11764536|FG002|Placebo Run-in (14 Days)|Other|0
7465290|NCT03846453|11764534|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0
7465291|NCT03846453|11764535|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16
7465292|NCT03846453|11764536|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8
7465293|NCT03846453|11764534|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0
7465294|NCT03846453|11764535|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6
7465295|NCT03846453|11764536|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5
7465296|NCT03846453|11764534|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0
7465297|NCT03846453|11764535|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2
7465298|NCT03846453|11764536|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4
7465299|NCT03846453|11764534|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0
7465300|NCT03846453|11764535|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2
7465301|NCT03846453|11764536|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4
7465302|NCT03846453|11764534|FG000|Randomized Treatment Period (Days 57±3)|Other|0
7465303|NCT03846453|11764535|FG001|Randomized Treatment Period (Days 57±3)|Other|1
7465304|NCT03846453|11764536|FG002|Randomized Treatment Period (Days 57±3)|Other|4
7468579|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
7468580|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7468581|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
7468582|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7468583|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
7468584|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
7468585|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7468586|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
7468587|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
7393222|NCT01258998|11654994|FG000|Overall Study|Ineligible|1
7393223|NCT01259089|11655013|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
7393224|NCT01259089|11655014|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
7393225|NCT01259089|11655015|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
7393226|NCT01259089|11655016|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
7393227|NCT01259089|11655017|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
7393228|NCT01259089|11655018|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
7393229|NCT01259089|11655013|FG000|Reached First Response at 4 Weeks|Adverse Event|0
7393230|NCT01259089|11655014|FG001|Reached First Response at 4 Weeks|Adverse Event|0
7393231|NCT01259089|11655015|FG002|Reached First Response at 4 Weeks|Adverse Event|0
7393232|NCT01259089|11655016|FG003|Reached First Response at 4 Weeks|Adverse Event|0
7393233|NCT01259089|11655017|FG004|Reached First Response at 4 Weeks|Adverse Event|0
7393234|NCT01259089|11655018|FG005|Reached First Response at 4 Weeks|Adverse Event|1
7393235|NCT01259089|11655013|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7393236|NCT01259089|11655014|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7393237|NCT01259089|11655015|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7393238|NCT01259089|11655016|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7393239|NCT01259089|11655017|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
7393240|NCT01259089|11655018|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
7393241|NCT01259089|11655013|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
7393242|NCT01259089|11655014|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
7393243|NCT01259089|11655015|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
7393244|NCT01259089|11655016|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
7393245|NCT01259089|11655017|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
7393246|NCT01259089|11655018|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
7393247|NCT01259089|11655013|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
7393248|NCT01259089|11655014|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
7393249|NCT01259089|11655015|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
7393250|NCT01259089|11655016|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
7393251|NCT01259089|11655017|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
7393252|NCT01259089|11655018|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
7393253|NCT01259089|11655013|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
7393254|NCT01259089|11655014|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7393255|NCT01259089|11655015|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7393256|NCT01259089|11655016|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7393257|NCT01259089|11655017|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7393258|NCT01259089|11655018|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
7393259|NCT01259089|11655013|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
7393260|NCT01259089|11655014|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
7393261|NCT01259089|11655015|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
7393262|NCT01259089|11655016|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
7393263|NCT01259089|11655017|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
7393264|NCT01259089|11655018|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
7393265|NCT01259089|11655013|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
7393266|NCT01259089|11655014|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
7393267|NCT01259089|11655015|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
7393268|NCT01259089|11655016|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
7393269|NCT01259089|11655017|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
7393270|NCT01259089|11655018|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
7393271|NCT01259089|11655013|FG000|Survival Follow up for Two Years|Death|3
7393272|NCT01259089|11655014|FG001|Survival Follow up for Two Years|Death|2
7393273|NCT01259089|11655015|FG002|Survival Follow up for Two Years|Death|2
7393274|NCT01259089|11655016|FG003|Survival Follow up for Two Years|Death|3
7393275|NCT01259089|11655017|FG004|Survival Follow up for Two Years|Death|6
7393276|NCT01259089|11655018|FG005|Survival Follow up for Two Years|Death|13
7393277|NCT01259089|11655013|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
7393278|NCT01259089|11655014|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
7393279|NCT01259089|11655015|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
7393280|NCT01259089|11655016|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
7393281|NCT01259089|11655017|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
7393282|NCT01259089|11655018|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
7393283|NCT01259089|11655013|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
7393284|NCT01259089|11655014|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
7393285|NCT01259089|11655015|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
7393286|NCT01259089|11655016|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
7393287|NCT01259089|11655017|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
7393288|NCT01259089|11655018|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
7393289|NCT01259102|11655037|FG000|Overall Study|Adverse Event|1
7393290|NCT01259102|11655038|FG001|Overall Study|Adverse Event|0
7393291|NCT01259102|11655039|FG002|Overall Study|Adverse Event|1
7393292|NCT01259102|11655040|FG003|Overall Study|Adverse Event|1
7393293|NCT01259102|11655041|FG004|Overall Study|Adverse Event|0
7393294|NCT01259102|11655037|FG000|Overall Study|Other|0
7393295|NCT01259102|11655038|FG001|Overall Study|Other|0
7393296|NCT01259102|11655039|FG002|Overall Study|Other|1
7393297|NCT01259102|11655040|FG003|Overall Study|Other|1
7393298|NCT01259102|11655041|FG004|Overall Study|Other|1
7393299|NCT01259115|11655053|FG000|Period 1|Adverse Event|1
7393300|NCT01259115|11655054|FG001|Period 1|Adverse Event|0
7393301|NCT01259115|11655053|FG000|Period 1|Protocol Violation|2
7393302|NCT01259115|11655054|FG001|Period 1|Protocol Violation|0
7393303|NCT01259115|11655053|FG000|Period 1|Lost to Follow-up|0
7393304|NCT01259115|11655054|FG001|Period 1|Lost to Follow-up|1
7393305|NCT01259115|11655053|FG000|Period 2|Adverse Event|1
7393306|NCT01259115|11655054|FG001|Period 2|Adverse Event|0
7393307|NCT01259245|11655076|FG000|Overall Study|Withdrawal by Subject|27
7393308|NCT01259245|11655077|FG001|Overall Study|Withdrawal by Subject|24
7393309|NCT01259245|11655076|FG000|Overall Study|Death|1
7393310|NCT01259245|11655077|FG001|Overall Study|Death|2
7393311|NCT01259297|11655093|FG000|Double Blind Randomized Period|Death|1
7393312|NCT01259297|11655094|FG001|Double Blind Randomized Period|Death|1
7393313|NCT01259297|11655095|FG002|Double Blind Randomized Period|Death|1
7393314|NCT01259297|11655096|FG003|Double Blind Randomized Period|Death|2
7393315|NCT01259297|11655097|FG004|Double Blind Randomized Period|Death|1
7393316|NCT01259297|11655098|FG005|Double Blind Randomized Period|Death|5
7393317|NCT01259297|11655099|FG006|Double Blind Randomized Period|Death|2
7393318|NCT01259297|11655100|FG007|Double Blind Randomized Period|Death|1
7393319|NCT01259297|11655093|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7393320|NCT01259297|11655094|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7393321|NCT01259297|11655095|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
7393322|NCT01259297|11655096|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7393323|NCT01259297|11655097|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
7393324|NCT01259297|11655098|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7393325|NCT01259297|11655099|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7393326|NCT01259297|11655100|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
7393327|NCT01259297|11655093|FG000|Double Blind Randomized Period|Other reasons|0
7393328|NCT01259297|11655094|FG001|Double Blind Randomized Period|Other reasons|1
7393329|NCT01259297|11655095|FG002|Double Blind Randomized Period|Other reasons|0
7393330|NCT01259297|11655096|FG003|Double Blind Randomized Period|Other reasons|0
7393331|NCT01259297|11655097|FG004|Double Blind Randomized Period|Other reasons|1
7393332|NCT01259297|11655098|FG005|Double Blind Randomized Period|Other reasons|2
7393333|NCT01259297|11655099|FG006|Double Blind Randomized Period|Other reasons|3
7393334|NCT01259297|11655100|FG007|Double Blind Randomized Period|Other reasons|1
7393335|NCT01259375|11655117|FG000|Overall Study|Adverse Event|1
7393336|NCT01259388|11655125|FG000|Overall Study|Adverse Event|3
7393337|NCT01259388|11655126|FG001|Overall Study|Adverse Event|0
7393338|NCT01259388|11655125|FG000|Overall Study|Withdrawal by Subject|1
7393339|NCT01259388|11655126|FG001|Overall Study|Withdrawal by Subject|1
7393340|NCT01259388|11655125|FG000|Overall Study|Physician Decision|1
7393341|NCT01259388|11655126|FG001|Overall Study|Physician Decision|0
7393342|NCT01259401|11655134|FG000|4-month Follow-up|Death|0
7393343|NCT01259401|11655135|FG001|4-month Follow-up|Death|1
7393344|NCT01259401|11655134|FG000|4-month Follow-up|Lost to Follow-up|0
7393345|NCT01259401|11655135|FG001|4-month Follow-up|Lost to Follow-up|1
7393346|NCT01259466|11655162|FG000|Overall Study|Withdrawal by Subject|1
7393347|NCT01259466|11655163|FG001|Overall Study|Withdrawal by Subject|9
7393348|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Adverse Event|13
7393349|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Adverse Event|18
7393350|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Adverse Event|26
7393351|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Adverse Event|3
7393352|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
7393353|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
7393354|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
7393355|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
7393356|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
7393357|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
7393358|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
7393359|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
7393360|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
7393361|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
7393362|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
7393363|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
7393364|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Administrative Problems|0
7393365|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Administrative Problems|1
7393366|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Administrative Problems|1
7393367|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Administrative Problems|2
7393368|NCT01259492|11655173|FG000|Period 1 (9 Weeks)|Protocol Violation|5
7393369|NCT01259492|11655174|FG001|Period 1 (9 Weeks)|Protocol Violation|6
7393370|NCT01259492|11655175|FG002|Period 1 (9 Weeks)|Protocol Violation|3
7393371|NCT01259492|11655176|FG003|Period 1 (9 Weeks)|Protocol Violation|1
7393372|NCT01259492|11655173|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
7393373|NCT01259492|11655174|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
7393374|NCT01259492|11655175|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
7393375|NCT01259492|11655176|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
7393376|NCT01259492|11655173|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7393377|NCT01259492|11655174|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7393378|NCT01259492|11655175|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
7393379|NCT01259492|11655176|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
7393380|NCT01259492|11655173|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
7393381|NCT01259492|11655174|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
7393382|NCT01259492|11655175|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
7393383|NCT01259492|11655176|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
7393384|NCT01259492|11655173|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7393385|NCT01259492|11655174|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7393386|NCT01259492|11655175|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
7393387|NCT01259492|11655176|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
7393388|NCT01259492|11655173|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7393389|NCT01259492|11655174|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
7393390|NCT01259492|11655175|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
7393391|NCT01259492|11655176|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
7393392|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7393393|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
7393394|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
7393395|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
7393396|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7393397|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7393398|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
7393399|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
7393400|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7393401|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7393402|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
7393403|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
7393404|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
7393405|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
7393406|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
7393407|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
7393408|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
7393409|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7393410|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7393411|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
7393412|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
7393413|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
7393414|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
7393415|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
7393416|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7393417|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
7393418|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
7393419|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
7393420|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7393421|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7393422|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
7393423|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
7393424|NCT01259492|11655173|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
7393425|NCT01259492|11655174|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
7393426|NCT01259492|11655175|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
7393427|NCT01259492|11655176|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
7393428|NCT01259713|11655198|FG000|Overall Study|Adverse Event|54
7393429|NCT01259713|11655199|FG001|Overall Study|Adverse Event|23
7393430|NCT01259713|11655198|FG000|Overall Study|Death Not Related to IFI|8
7393431|NCT01259713|11655199|FG001|Overall Study|Death Not Related to IFI|1
7393432|NCT01259713|11655198|FG000|Overall Study|Investigators Discretion|14
7393433|NCT01259713|11655199|FG001|Overall Study|Investigators Discretion|6
7393434|NCT01259713|11655198|FG000|Overall Study|Lack of Efficacy|2
7393435|NCT01259713|11655199|FG001|Overall Study|Lack of Efficacy|0
7393436|NCT01259713|11655198|FG000|Overall Study|Protocol Violation|5
7393437|NCT01259713|11655199|FG001|Overall Study|Protocol Violation|4
7393438|NCT01259713|11655198|FG000|Overall Study|Subject Withdrew Consent|12
7393439|NCT01259713|11655199|FG001|Overall Study|Subject Withdrew Consent|7
7393440|NCT01259726|11655209|FG000|Overall Study|Death|1
7393441|NCT01259726|11655210|FG001|Overall Study|Death|0
7393442|NCT01259726|11655211|FG002|Overall Study|Death|0
7393443|NCT01259726|11655212|FG003|Overall Study|Death|0
7393444|NCT01259726|11655209|FG000|Overall Study|Physician Decision|2
7393445|NCT01259726|11655210|FG001|Overall Study|Physician Decision|0
7393446|NCT01259726|11655211|FG002|Overall Study|Physician Decision|1
7393447|NCT01259726|11655212|FG003|Overall Study|Physician Decision|1
7393448|NCT01259726|11655209|FG000|Overall Study|Withdrawal by Subject|1
7393449|NCT01259726|11655210|FG001|Overall Study|Withdrawal by Subject|3
7393450|NCT01259726|11655211|FG002|Overall Study|Withdrawal by Subject|2
7393451|NCT01259726|11655212|FG003|Overall Study|Withdrawal by Subject|1
7393452|NCT01259726|11655209|FG000|Overall Study|Lost to Follow-up|1
7393453|NCT01259726|11655210|FG001|Overall Study|Lost to Follow-up|1
7393454|NCT01259726|11655211|FG002|Overall Study|Lost to Follow-up|1
7393455|NCT01259726|11655212|FG003|Overall Study|Lost to Follow-up|3
7393456|NCT01259856|11655224|FG000|Overall Study|Adverse Event|12
7393457|NCT01259856|11655225|FG001|Overall Study|Adverse Event|9
7393458|NCT01259856|11655224|FG000|Overall Study|Death|0
7393459|NCT01259856|11655225|FG001|Overall Study|Death|1
7393460|NCT01259856|11655224|FG000|Overall Study|Lack of Efficacy|3
7393461|NCT01259856|11655225|FG001|Overall Study|Lack of Efficacy|1
7393462|NCT01259856|11655224|FG000|Overall Study|Lost to Follow-up|1
7393463|NCT01259856|11655225|FG001|Overall Study|Lost to Follow-up|1
7393464|NCT01259856|11655224|FG000|Overall Study|Physician Decision|2
7393465|NCT01259856|11655225|FG001|Overall Study|Physician Decision|1
7393466|NCT01259856|11655224|FG000|Overall Study|Withdrawal by Subject|9
7393467|NCT01259856|11655225|FG001|Overall Study|Withdrawal by Subject|10
7393468|NCT01259856|11655224|FG000|Overall Study|Treatment never started|0
7393469|NCT01259856|11655225|FG001|Overall Study|Treatment never started|6
7393470|NCT01259856|11655224|FG000|Overall Study|Study closure by sponsor|40
7393471|NCT01259856|11655225|FG001|Overall Study|Study closure by sponsor|41
7393472|NCT01259856|11655224|FG000|Overall Study|Patient developed other disease|0
7393473|NCT01259856|11655225|FG001|Overall Study|Patient developed other disease|1
7393474|NCT01259856|11655224|FG000|Overall Study|Transfer to another study|0
7393475|NCT01259856|11655225|FG001|Overall Study|Transfer to another study|1
7393476|NCT01259856|11655224|FG000|Overall Study|Unknown/missing|2
7393477|NCT01259856|11655225|FG001|Overall Study|Unknown/missing|2
7393478|NCT01259869|11655231|FG000|Overall Study|Duplicated registration|1
7393479|NCT01260142|11655241|FG000|Treatment Period 1|Study on hold|1
7393480|NCT01260142|11655242|FG001|Treatment Period 1|Study on hold|1
7393481|NCT01260142|11655243|FG002|Treatment Period 1|Study on hold|0
7393482|NCT01260142|11655244|FG003|Treatment Period 1|Study on hold|0
7393483|NCT01260142|11655245|FG004|Treatment Period 1|Study on hold|1
7393484|NCT01260142|11655246|FG005|Treatment Period 1|Study on hold|2
7393485|NCT01260142|11655241|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
7393486|NCT01260142|11655242|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
7393487|NCT01260142|11655243|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
7393488|NCT01260142|11655244|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
7393489|NCT01260142|11655245|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
7393490|NCT01260142|11655246|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
7393491|NCT01260142|11655241|FG000|Treatment Period 1|Withdrawal by Subject|0
7393492|NCT01260142|11655242|FG001|Treatment Period 1|Withdrawal by Subject|0
7393493|NCT01260142|11655243|FG002|Treatment Period 1|Withdrawal by Subject|0
7393494|NCT01260142|11655244|FG003|Treatment Period 1|Withdrawal by Subject|0
7393495|NCT01260142|11655245|FG004|Treatment Period 1|Withdrawal by Subject|0
7393496|NCT01260142|11655246|FG005|Treatment Period 1|Withdrawal by Subject|1
7393497|NCT01260181|11655266|FG000|Overall Study|Decision of Investigator|1
7393498|NCT01260194|11655270|FG000|Overall Study|Withdrawal of Consent|1
7393499|NCT01260311|11655285|FG000|Overall Study|Adverse Event|11
7393500|NCT01260311|11655285|FG000|Overall Study|Lack of Efficacy|4
7393501|NCT01260311|11655285|FG000|Overall Study|Lost to Follow-up|25
7393502|NCT01260311|11655285|FG000|Overall Study|Withdrawal by Subject|6
7393503|NCT01260311|11655285|FG000|Overall Study|Financial Constraints|77
7393504|NCT01260311|11655285|FG000|Overall Study|Gone to Province|2
7393505|NCT01260311|11655285|FG000|Overall Study|Medication Stopped|1
7393506|NCT01260311|11655285|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
7393507|NCT01260350|11655318|FG000|Overall Study|Lack of Efficacy|0
7393508|NCT01260350|11655319|FG001|Overall Study|Lack of Efficacy|0
7393509|NCT01260350|11655320|FG002|Overall Study|Lack of Efficacy|0
7393510|NCT01260350|11655321|FG003|Overall Study|Lack of Efficacy|0
7393511|NCT01260350|11655322|FG004|Overall Study|Lack of Efficacy|0
7393512|NCT01260350|11655323|FG005|Overall Study|Lack of Efficacy|0
7393513|NCT01260350|11655324|FG006|Overall Study|Lack of Efficacy|0
7393514|NCT01260350|11655325|FG007|Overall Study|Lack of Efficacy|0
7393515|NCT01260350|11655326|FG008|Overall Study|Lack of Efficacy|0
7393516|NCT01260350|11655327|FG009|Overall Study|Lack of Efficacy|0
7393517|NCT01260350|11655328|FG010|Overall Study|Lack of Efficacy|0
7393518|NCT01260350|11655329|FG011|Overall Study|Lack of Efficacy|0
7393519|NCT01260350|11655330|FG012|Overall Study|Lack of Efficacy|0
7393520|NCT01260350|11655331|FG013|Overall Study|Lack of Efficacy|0
7393521|NCT01260350|11655332|FG014|Overall Study|Lack of Efficacy|0
7393522|NCT01260350|11655333|FG015|Overall Study|Lack of Efficacy|0
7393523|NCT01260350|11655334|FG016|Overall Study|Lack of Efficacy|0
7393524|NCT01260350|11655335|FG017|Overall Study|Lack of Efficacy|1
7393525|NCT01260350|11655336|FG018|Overall Study|Lack of Efficacy|0
7393526|NCT01260350|11655337|FG019|Overall Study|Lack of Efficacy|0
7393527|NCT01260350|11655338|FG020|Overall Study|Lack of Efficacy|3
7393528|NCT01260350|11655339|FG021|Overall Study|Lack of Efficacy|0
7393529|NCT01260350|11655318|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393530|NCT01260350|11655319|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393531|NCT01260350|11655320|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393532|NCT01260350|11655321|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393533|NCT01260350|11655322|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393534|NCT01260350|11655323|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393535|NCT01260350|11655324|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393536|NCT01260350|11655325|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393537|NCT01260350|11655326|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
7393538|NCT01260350|11655327|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393539|NCT01260350|11655328|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393540|NCT01260350|11655329|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393541|NCT01260350|11655330|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393542|NCT01260350|11655331|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393543|NCT01260350|11655332|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393544|NCT01260350|11655333|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393545|NCT01260350|11655334|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393546|NCT01260350|11655335|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393547|NCT01260350|11655336|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393548|NCT01260350|11655337|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393549|NCT01260350|11655338|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393550|NCT01260350|11655339|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
7393551|NCT01260467|11655397|FG000|Overall Study|Withdrawal by Subject|2
7393552|NCT01260584|11655416|FG000|Period 1|Protocol Violation|0
7393553|NCT01260584|11655417|FG001|Period 1|Protocol Violation|0
7393554|NCT01260584|11655418|FG002|Period 1|Protocol Violation|1
7393555|NCT01260584|11655419|FG003|Period 1|Protocol Violation|1
7393556|NCT01260584|11655416|FG000|Period 1|Adverse Event|0
7393557|NCT01260584|11655417|FG001|Period 1|Adverse Event|0
7393558|NCT01260584|11655418|FG002|Period 1|Adverse Event|1
7393559|NCT01260584|11655419|FG003|Period 1|Adverse Event|0
7393560|NCT01260584|11655416|FG000|Period 2|Protocol Violation|0
7393561|NCT01260584|11655417|FG001|Period 2|Protocol Violation|2
7393562|NCT01260584|11655418|FG002|Period 2|Protocol Violation|3
7393563|NCT01260584|11655419|FG003|Period 2|Protocol Violation|1
7393564|NCT01260584|11655416|FG000|Period 2|Adverse Event|1
7393565|NCT01260584|11655417|FG001|Period 2|Adverse Event|0
7393566|NCT01260584|11655418|FG002|Period 2|Adverse Event|2
7393567|NCT01260584|11655419|FG003|Period 2|Adverse Event|0
7393568|NCT01260584|11655416|FG000|Period 2|Withdrawal by Subject|0
7393569|NCT01260584|11655417|FG001|Period 2|Withdrawal by Subject|1
7393570|NCT01260584|11655418|FG002|Period 2|Withdrawal by Subject|0
7393571|NCT01260584|11655419|FG003|Period 2|Withdrawal by Subject|0
7393572|NCT01260701|11655463|FG000|Overall Study|Adverse Event|9
7393573|NCT01260701|11655463|FG000|Overall Study|Withdrawal by Subject|2
7393574|NCT01260701|11655463|FG000|Overall Study|Progression|53
7393575|NCT01260701|11655463|FG000|Overall Study|Death|2
7393576|NCT01260701|11655463|FG000|Overall Study|Not protocol specified|3
7393577|NCT01260701|11655463|FG000|Overall Study|Under review|1
7393578|NCT01260701|11655463|FG000|Overall Study|Ineligible|4
7393579|NCT01260701|11655463|FG000|Overall Study|Did not begin protocol therapy|1
7393580|NCT01260896|11655503|FG000|First Intervention|Withdrawn Due to Emesis|2
7393581|NCT01260896|11655504|FG001|First Intervention|Withdrawn Due to Emesis|0
7393582|NCT01260922|11655512|FG000|First Intervention|Withdrawal by Subject|0
7393583|NCT01260922|11655513|FG001|First Intervention|Withdrawal by Subject|1
7393584|NCT01260922|11655512|FG000|Washout of 28 Days|Withdrawal by Subject|4
7393585|NCT01260922|11655513|FG001|Washout of 28 Days|Withdrawal by Subject|2
7393586|NCT01260922|11655512|FG000|Second Intervention|Emesis|0
7393587|NCT01260922|11655513|FG001|Second Intervention|Emesis|2
7393588|NCT01260948|11655521|FG000|Washout of 28 Days|Withdrawal by Subject|1
7393589|NCT01260948|11655522|FG001|Washout of 28 Days|Withdrawal by Subject|3
7393590|NCT01260948|11655521|FG000|Second Intervention|Emesis|0
7393591|NCT01260948|11655522|FG001|Second Intervention|Emesis|1
7393592|NCT01261000|11655528|FG000|Overall Study|Screen failure|1
7393632|NCT01261338|11655555|FG000|Overall Study|Withdrawal by Subject|3
7393633|NCT01261338|11655556|FG001|Overall Study|Withdrawal by Subject|2
7393634|NCT01261390|11655566|FG000|Overall Study|Significant Concurrent Illness|1
7393635|NCT01261390|11655567|FG001|Overall Study|Significant Concurrent Illness|0
7393636|NCT01261390|11655568|FG002|Overall Study|Significant Concurrent Illness|1
7393637|NCT01261390|11655569|FG003|Overall Study|Significant Concurrent Illness|0
7393638|NCT01261390|11655566|FG000|Overall Study|Dissatisfaction with Treatment|2
7393639|NCT01261390|11655567|FG001|Overall Study|Dissatisfaction with Treatment|1
7393640|NCT01261390|11655568|FG002|Overall Study|Dissatisfaction with Treatment|1
7393641|NCT01261390|11655569|FG003|Overall Study|Dissatisfaction with Treatment|2
7393642|NCT01261390|11655566|FG000|Overall Study|Relocation|0
7393643|NCT01261390|11655567|FG001|Overall Study|Relocation|1
7393644|NCT01261390|11655568|FG002|Overall Study|Relocation|0
7393645|NCT01261390|11655569|FG003|Overall Study|Relocation|0
7393646|NCT01261390|11655566|FG000|Overall Study|Loss of Interest in the Study|3
7393647|NCT01261390|11655567|FG001|Overall Study|Loss of Interest in the Study|1
7393648|NCT01261390|11655568|FG002|Overall Study|Loss of Interest in the Study|0
7393649|NCT01261390|11655569|FG003|Overall Study|Loss of Interest in the Study|0
7393650|NCT01261390|11655566|FG000|Overall Study|Lost to Follow-up|1
7393651|NCT01261390|11655567|FG001|Overall Study|Lost to Follow-up|6
7393652|NCT01261390|11655568|FG002|Overall Study|Lost to Follow-up|5
7393653|NCT01261390|11655569|FG003|Overall Study|Lost to Follow-up|6
7393717|NCT01261624|11655620|FG000|Week 0 to Week 12|Disease Progression|1
7393718|NCT01261624|11655621|FG001|Week 0 to Week 12|Disease Progression|1
7393719|NCT01261624|11655620|FG000|Week 0 to Week 12|Insufficient Response|0
7393720|NCT01261624|11655621|FG001|Week 0 to Week 12|Insufficient Response|2
7393721|NCT01261624|11655620|FG000|Week 13 to Week 24|Insufficient Response|0
7393722|NCT01261624|11655621|FG001|Week 13 to Week 24|Insufficient Response|1
7393723|NCT01261780|11655635|FG000|Overall Study|Withdrawal by Subject|1
7393724|NCT01261780|11655636|FG001|Overall Study|Withdrawal by Subject|0
7393725|NCT01261780|11655635|FG000|Overall Study|Event not related to subject|1
7393726|NCT01261780|11655636|FG001|Overall Study|Event not related to subject|2
7393727|NCT01261793|11655645|FG000|Overall Study|Lack of Efficacy|44
7393728|NCT01261793|11655646|FG001|Overall Study|Lack of Efficacy|37
7393729|NCT01261793|11655647|FG002|Overall Study|Lack of Efficacy|32
7393730|NCT01261793|11655645|FG000|Overall Study|Protocol Violation|3
7393731|NCT01261793|11655646|FG001|Overall Study|Protocol Violation|5
7393732|NCT01261793|11655647|FG002|Overall Study|Protocol Violation|6
7393733|NCT01261793|11655645|FG000|Overall Study|Lost to Follow-up|10
7393734|NCT01261793|11655646|FG001|Overall Study|Lost to Follow-up|3
7393735|NCT01261793|11655647|FG002|Overall Study|Lost to Follow-up|7
7393736|NCT01261793|11655645|FG000|Overall Study|Withdrawal by Subject|12
7393737|NCT01261793|11655646|FG001|Overall Study|Withdrawal by Subject|14
7393738|NCT01261793|11655647|FG002|Overall Study|Withdrawal by Subject|14
7393739|NCT01261793|11655645|FG000|Overall Study|Death|3
7393740|NCT01261793|11655646|FG001|Overall Study|Death|1
7393741|NCT01261793|11655647|FG002|Overall Study|Death|0
7393742|NCT01261793|11655645|FG000|Overall Study|Adverse Event|9
7393743|NCT01261793|11655646|FG001|Overall Study|Adverse Event|24
7393744|NCT01261793|11655647|FG002|Overall Study|Adverse Event|19
7393745|NCT01261793|11655645|FG000|Overall Study|Patient non-availability|1
7393746|NCT01261793|11655646|FG001|Overall Study|Patient non-availability|1
7393747|NCT01261793|11655647|FG002|Overall Study|Patient non-availability|1
7393748|NCT01261793|11655645|FG000|Overall Study|Suspected pregnancy|1
7393749|NCT01261793|11655646|FG001|Overall Study|Suspected pregnancy|1
7393750|NCT01261793|11655647|FG002|Overall Study|Suspected pregnancy|0
7393751|NCT01261793|11655645|FG000|Overall Study|Patient non-compliance|1
7393752|NCT01261793|11655646|FG001|Overall Study|Patient non-compliance|0
7393753|NCT01261793|11655647|FG002|Overall Study|Patient non-compliance|1
7393754|NCT01261793|11655645|FG000|Overall Study|Patient pregnant|1
7393755|NCT01261793|11655646|FG001|Overall Study|Patient pregnant|0
7393756|NCT01261793|11655647|FG002|Overall Study|Patient pregnant|0
7393757|NCT01261793|11655645|FG000|Overall Study|Outside the study area|0
7393758|NCT01261793|11655646|FG001|Overall Study|Outside the study area|2
7393759|NCT01261793|11655647|FG002|Overall Study|Outside the study area|1
7393760|NCT01261793|11655645|FG000|Overall Study|Lack of efficacy & patient not available|0
7393761|NCT01261793|11655646|FG001|Overall Study|Lack of efficacy & patient not available|1
7393762|NCT01261793|11655647|FG002|Overall Study|Lack of efficacy & patient not available|0
7393763|NCT01261793|11655645|FG000|Overall Study|Patient withdrew after cardiology visit|0
7393764|NCT01261793|11655646|FG001|Overall Study|Patient withdrew after cardiology visit|1
7393765|NCT01261793|11655647|FG002|Overall Study|Patient withdrew after cardiology visit|0
7393766|NCT01261793|11655645|FG000|Overall Study|Randomization error|0
7393767|NCT01261793|11655646|FG001|Overall Study|Randomization error|1
7393768|NCT01261793|11655647|FG002|Overall Study|Randomization error|0
7393769|NCT01261793|11655645|FG000|Overall Study|Patient unable to start IV line|0
7393770|NCT01261793|11655646|FG001|Overall Study|Patient unable to start IV line|0
7393771|NCT01261793|11655647|FG002|Overall Study|Patient unable to start IV line|1
7393772|NCT01261975|11655664|FG000|Overall Study|Surgical complication|1
7393773|NCT01262027|11655671|FG000|Overall Study|Adverse Event|1
7393774|NCT01262027|11655671|FG000|Overall Study|Withdrawal by Subject|3
7393775|NCT01262027|11655671|FG000|Overall Study|Protocol Violation|1
7465305|NCT03605862|11764546|FG000|Overall Study|Withdrawal by Subject|12
7393776|NCT01262092|11655677|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
7393777|NCT01262092|11655678|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
7393778|NCT01262092|11655677|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
7393779|NCT01262092|11655678|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
7393780|NCT01262092|11655677|FG000|Buprenorphine Taper|noncompliance - missed medication|1
7393781|NCT01262092|11655678|FG001|Buprenorphine Taper|noncompliance - missed medication|1
7393782|NCT01262092|11655677|FG000|Gabapentin Taper|noncompliance - missed medications|1
7393783|NCT01262092|11655678|FG001|Gabapentin Taper|noncompliance - missed medications|0
7393784|NCT01262287|11655717|FG000|Overall Study|Lost to Follow-up|2
7393785|NCT01262287|11655718|FG001|Overall Study|Lost to Follow-up|1
7393786|NCT01262352|11655730|FG000|Period 1|Illness after randomization|1
7393787|NCT01262352|11655731|FG001|Period 1|Illness after randomization|0
7393788|NCT01262352|11655730|FG000|Washout|Adverse Event|1
7393789|NCT01262352|11655731|FG001|Washout|Adverse Event|1
7393790|NCT01262352|11655730|FG000|Washout|Extended Washout|0
7393791|NCT01262352|11655731|FG001|Washout|Extended Washout|1
7393792|NCT01262365|11655740|FG000|Overall Study|Lack of Efficacy|35
7393793|NCT01262365|11655741|FG001|Overall Study|Lack of Efficacy|30
7393794|NCT01262365|11655742|FG002|Overall Study|Lack of Efficacy|47
7393795|NCT01262365|11655740|FG000|Overall Study|Protocol Violation|3
7393796|NCT01262365|11655741|FG001|Overall Study|Protocol Violation|1
7393797|NCT01262365|11655742|FG002|Overall Study|Protocol Violation|1
7393798|NCT01262365|11655740|FG000|Overall Study|Lost to Follow-up|3
7393799|NCT01262365|11655741|FG001|Overall Study|Lost to Follow-up|7
7393800|NCT01262365|11655742|FG002|Overall Study|Lost to Follow-up|6
7393801|NCT01262365|11655740|FG000|Overall Study|Withdrawal by Subject|17
7393802|NCT01262365|11655741|FG001|Overall Study|Withdrawal by Subject|22
7393803|NCT01262365|11655742|FG002|Overall Study|Withdrawal by Subject|22
7393804|NCT01262365|11655740|FG000|Overall Study|Death|1
7393805|NCT01262365|11655741|FG001|Overall Study|Death|2
7393806|NCT01262365|11655742|FG002|Overall Study|Death|1
7393807|NCT01262365|11655740|FG000|Overall Study|Adverse Event|26
7393808|NCT01262365|11655741|FG001|Overall Study|Adverse Event|16
7393809|NCT01262365|11655742|FG002|Overall Study|Adverse Event|11
7393810|NCT01262365|11655740|FG000|Overall Study|sponsor decision|1
7393811|NCT01262365|11655741|FG001|Overall Study|sponsor decision|1
7393812|NCT01262365|11655742|FG002|Overall Study|sponsor decision|0
7393813|NCT01262365|11655740|FG000|Overall Study|Randomization error|1
7393814|NCT01262365|11655741|FG001|Overall Study|Randomization error|0
7393815|NCT01262365|11655742|FG002|Overall Study|Randomization error|2
7393816|NCT01262365|11655740|FG000|Overall Study|Non-compliance|1
7393817|NCT01262365|11655741|FG001|Overall Study|Non-compliance|0
7393818|NCT01262365|11655742|FG002|Overall Study|Non-compliance|2
7393819|NCT01262365|11655740|FG000|Overall Study|Suspected pregnancy|1
7393820|NCT01262365|11655741|FG001|Overall Study|Suspected pregnancy|0
7393821|NCT01262365|11655742|FG002|Overall Study|Suspected pregnancy|0
7393822|NCT01262365|11655740|FG000|Overall Study|Patient pregnant|1
7393823|NCT01262365|11655741|FG001|Overall Study|Patient pregnant|0
7393824|NCT01262365|11655742|FG002|Overall Study|Patient pregnant|1
7393825|NCT01262365|11655740|FG000|Overall Study|Toxicity related to study drug|0
7393826|NCT01262365|11655741|FG001|Overall Study|Toxicity related to study drug|1
7393827|NCT01262365|11655742|FG002|Overall Study|Toxicity related to study drug|0
7393828|NCT01262365|11655740|FG000|Overall Study|Cannot tolerate the protocol|0
7393829|NCT01262365|11655741|FG001|Overall Study|Cannot tolerate the protocol|1
7393830|NCT01262365|11655742|FG002|Overall Study|Cannot tolerate the protocol|0
7393831|NCT01262365|11655740|FG000|Overall Study|Patient unavailable|0
7393832|NCT01262365|11655741|FG001|Overall Study|Patient unavailable|0
7393833|NCT01262365|11655742|FG002|Overall Study|Patient unavailable|1
7393834|NCT01262456|11655753|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
7393835|NCT01262456|11655754|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
7393836|NCT01262456|11655755|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
7393837|NCT01262456|11655753|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
7393838|NCT01262456|11655754|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
7393839|NCT01262456|11655755|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
7393840|NCT01262456|11655753|FG000|3-Month Double-Blind Period|Adverse Event|6
7393841|NCT01262456|11655754|FG001|3-Month Double-Blind Period|Adverse Event|4
7393842|NCT01262456|11655755|FG002|3-Month Double-Blind Period|Adverse Event|8
7393843|NCT01262456|11655753|FG000|3-Month Double-Blind Period|Protocol Violation|3
7393844|NCT01262456|11655754|FG001|3-Month Double-Blind Period|Protocol Violation|6
7393845|NCT01262456|11655755|FG002|3-Month Double-Blind Period|Protocol Violation|6
7393846|NCT01262456|11655753|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7393847|NCT01262456|11655754|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7393848|NCT01262456|11655755|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
7393849|NCT01262456|11655753|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
7393850|NCT01262456|11655754|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
7393851|NCT01262456|11655755|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
7393852|NCT01262456|11655753|FG000|1-Month Open-Label Extension Period|Adverse Event|2
7393853|NCT01262456|11655754|FG001|1-Month Open-Label Extension Period|Adverse Event|0
7393854|NCT01262456|11655755|FG002|1-Month Open-Label Extension Period|Adverse Event|2
7393855|NCT01262456|11655753|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
7465306|NCT03605862|11764547|FG001|Overall Study|Withdrawal by Subject|9
7393856|NCT01262456|11655754|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
7393857|NCT01262456|11655755|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
7393858|NCT01262456|11655753|FG000|1-Month Open-Label Extension Period|Other Reason|0
7393859|NCT01262456|11655754|FG001|1-Month Open-Label Extension Period|Other Reason|1
7393860|NCT01262456|11655755|FG002|1-Month Open-Label Extension Period|Other Reason|0
7393861|NCT01262560|11655783|FG000|Overall Study|Protocol Violation|0
7393862|NCT01262560|11655784|FG001|Overall Study|Protocol Violation|1
7393863|NCT01262560|11655785|FG002|Overall Study|Protocol Violation|2
7393864|NCT01262573|11655795|FG000|Overall Study|Withdrawal by Subject|0
7393865|NCT01262573|11655796|FG001|Overall Study|Withdrawal by Subject|1
7393866|NCT01262638|11655817|FG000|Overall Study|Adverse Event|3
7393867|NCT01262638|11655818|FG001|Overall Study|Adverse Event|4
7393868|NCT01262638|11655819|FG002|Overall Study|Adverse Event|3
7393869|NCT01262638|11655820|FG003|Overall Study|Adverse Event|4
7393870|NCT01262638|11655817|FG000|Overall Study|Protocol Violation|1
7393871|NCT01262638|11655818|FG001|Overall Study|Protocol Violation|0
7393872|NCT01262638|11655819|FG002|Overall Study|Protocol Violation|0
7393873|NCT01262638|11655820|FG003|Overall Study|Protocol Violation|1
7393874|NCT01262638|11655817|FG000|Overall Study|Withdrawal by Subject|2
7393875|NCT01262638|11655818|FG001|Overall Study|Withdrawal by Subject|1
7393876|NCT01262638|11655819|FG002|Overall Study|Withdrawal by Subject|0
7393877|NCT01262638|11655820|FG003|Overall Study|Withdrawal by Subject|1
7393878|NCT01262638|11655817|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7393879|NCT01262638|11655818|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7393880|NCT01262638|11655819|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
7393881|NCT01262638|11655820|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7393882|NCT01262638|11655817|FG000|Overall Study|Lost to Follow-up|1
7393883|NCT01262638|11655818|FG001|Overall Study|Lost to Follow-up|1
7393884|NCT01262638|11655819|FG002|Overall Study|Lost to Follow-up|1
7393885|NCT01262638|11655820|FG003|Overall Study|Lost to Follow-up|1
7393886|NCT01262638|11655817|FG000|Overall Study|Participant Went Out of Town|0
7393887|NCT01262638|11655818|FG001|Overall Study|Participant Went Out of Town|0
7393888|NCT01262638|11655819|FG002|Overall Study|Participant Went Out of Town|1
7393889|NCT01262638|11655820|FG003|Overall Study|Participant Went Out of Town|0
7393890|NCT01262651|11655835|FG000|Overall Study|Adverse Event|40
7393891|NCT01262651|11655836|FG001|Overall Study|Adverse Event|35
7393892|NCT01262651|11655835|FG000|Overall Study|Withdrawal by Subject|15
7393893|NCT01262651|11655836|FG001|Overall Study|Withdrawal by Subject|11
7393894|NCT01262651|11655835|FG000|Overall Study|Withdrawal by Investigator|2
7393895|NCT01262651|11655836|FG001|Overall Study|Withdrawal by Investigator|2
7393896|NCT01262651|11655835|FG000|Overall Study|Met Withdrawal Criteria|1
7393897|NCT01262651|11655836|FG001|Overall Study|Met Withdrawal Criteria|0
7393898|NCT01262677|11655845|FG000|Overall Study|Does not meet entrance criteria|0
7393899|NCT01262677|11655846|FG001|Overall Study|Does not meet entrance criteria|2
7393900|NCT01262677|11655847|FG002|Overall Study|Does not meet entrance criteria|0
7393901|NCT01262677|11655845|FG000|Overall Study|Insufficient clinical response|0
7393902|NCT01262677|11655846|FG001|Overall Study|Insufficient clinical response|0
7393903|NCT01262677|11655847|FG002|Overall Study|Insufficient clinical response|1
7393904|NCT01262677|11655845|FG000|Overall Study|Lost to Follow-up|1
7393905|NCT01262677|11655846|FG001|Overall Study|Lost to Follow-up|0
7393906|NCT01262677|11655847|FG002|Overall Study|Lost to Follow-up|2
7393907|NCT01262677|11655845|FG000|Overall Study|No longer willing to participate|3
7393908|NCT01262677|11655846|FG001|Overall Study|No longer willing to participate|3
7393909|NCT01262677|11655847|FG002|Overall Study|No longer willing to participate|2
7393910|NCT01262677|11655845|FG000|Overall Study|Reason not provided|2
7393911|NCT01262677|11655846|FG001|Overall Study|Reason not provided|1
7393912|NCT01262677|11655847|FG002|Overall Study|Reason not provided|3
7393913|NCT01262677|11655845|FG000|Overall Study|Protocol Violation|0
7393914|NCT01262677|11655846|FG001|Overall Study|Protocol Violation|1
7393915|NCT01262677|11655847|FG002|Overall Study|Protocol Violation|1
7393916|NCT01262677|11655845|FG000|Overall Study|Adverse Event (AE) related to study drug|3
7393917|NCT01262677|11655846|FG001|Overall Study|Adverse Event (AE) related to study drug|8
7393918|NCT01262677|11655847|FG002|Overall Study|Adverse Event (AE) related to study drug|3
7393919|NCT01262820|11655859|FG000|Overall Study|Adverse Event|5
7393920|NCT01262820|11655859|FG000|Overall Study|Lack of Efficacy|9
7393921|NCT01262820|11655859|FG000|Overall Study|Drug held for 21+ days|1
7393922|NCT01262872|11655880|FG000|Step 2|Death|0
7393923|NCT01262872|11655881|FG001|Step 2|Death|0
7393924|NCT01262872|11655882|FG002|Step 2|Death|0
7393925|NCT01262872|11655883|FG003|Step 2|Death|1
7393926|NCT01262872|11655884|FG004|Step 2|Death|0
7393927|NCT01262872|11655885|FG005|Step 2|Death|2
7393928|NCT01262872|11655886|FG006|Step 2|Death|2
7393929|NCT01262872|11655887|FG007|Step 2|Death|1
7393930|NCT01262872|11655880|FG000|Step 2|Protocol Violation|0
7393931|NCT01262872|11655881|FG001|Step 2|Protocol Violation|0
7393932|NCT01262872|11655882|FG002|Step 2|Protocol Violation|1
7393933|NCT01262872|11655883|FG003|Step 2|Protocol Violation|0
7393934|NCT01262872|11655884|FG004|Step 2|Protocol Violation|0
7393935|NCT01262872|11655885|FG005|Step 2|Protocol Violation|0
7393936|NCT01262872|11655886|FG006|Step 2|Protocol Violation|3
7393937|NCT01262872|11655887|FG007|Step 2|Protocol Violation|1
7393938|NCT01262872|11655880|FG000|Step 2|Withdrawal by Subject|0
7393939|NCT01262872|11655881|FG001|Step 2|Withdrawal by Subject|0
7317499|NCT00723450|11546527|FG001|Randomized Phase|Adverse Event|26
7317500|NCT00723450|11546528|FG002|Randomized Phase|Adverse Event|17
7317501|NCT00723450|11546526|FG000|Randomized Phase|Lack of Efficacy|0
7317502|NCT00723450|11546527|FG001|Randomized Phase|Lack of Efficacy|11
7317503|NCT00723450|11546528|FG002|Randomized Phase|Lack of Efficacy|11
7317504|NCT00723450|11546526|FG000|Randomized Phase|Protocol Violation|0
7317505|NCT00723450|11546527|FG001|Randomized Phase|Protocol Violation|9
7317506|NCT00723450|11546528|FG002|Randomized Phase|Protocol Violation|13
7317507|NCT00723450|11546526|FG000|Randomized Phase|Lost to Follow-up|0
7317508|NCT00723450|11546527|FG001|Randomized Phase|Lost to Follow-up|2
7317509|NCT00723450|11546528|FG002|Randomized Phase|Lost to Follow-up|3
7317510|NCT00723450|11546526|FG000|Randomized Phase|Physician Decision|0
7317511|NCT00723450|11546527|FG001|Randomized Phase|Physician Decision|3
7317512|NCT00723450|11546528|FG002|Randomized Phase|Physician Decision|1
7317513|NCT00723450|11546526|FG000|Randomized Phase|Withdrawal by Subject|0
7317514|NCT00723450|11546527|FG001|Randomized Phase|Withdrawal by Subject|14
7317515|NCT00723450|11546528|FG002|Randomized Phase|Withdrawal by Subject|22
7317516|NCT00723489|11546541|FG000|Overall Study|Physician Decision|0
7317517|NCT00723489|11546542|FG001|Overall Study|Physician Decision|1
7317518|NCT00723489|11546543|FG002|Overall Study|Physician Decision|0
7317519|NCT00723489|11546544|FG003|Overall Study|Physician Decision|0
7317520|NCT00723489|11546541|FG000|Overall Study|Pregnancy|0
7317521|NCT00723489|11546542|FG001|Overall Study|Pregnancy|0
7317522|NCT00723489|11546543|FG002|Overall Study|Pregnancy|0
7317523|NCT00723489|11546544|FG003|Overall Study|Pregnancy|1
7317524|NCT00723489|11546541|FG000|Overall Study|Withdrawal by Subject|0
7317525|NCT00723489|11546542|FG001|Overall Study|Withdrawal by Subject|0
7317526|NCT00723489|11546543|FG002|Overall Study|Withdrawal by Subject|0
7317527|NCT00723489|11546544|FG003|Overall Study|Withdrawal by Subject|1
7317528|NCT00723489|11546541|FG000|Overall Study|Seropositive at baseline|1
7317529|NCT00723489|11546542|FG001|Overall Study|Seropositive at baseline|0
7317530|NCT00723489|11546543|FG002|Overall Study|Seropositive at baseline|0
7317531|NCT00723489|11546544|FG003|Overall Study|Seropositive at baseline|0
7317532|NCT00723489|11546541|FG000|Overall Study|Prohibited Medication|0
7317533|NCT00723489|11546542|FG001|Overall Study|Prohibited Medication|0
7317534|NCT00723489|11546543|FG002|Overall Study|Prohibited Medication|0
7317535|NCT00723489|11546544|FG003|Overall Study|Prohibited Medication|1
7317536|NCT00723489|11546541|FG000|Overall Study|Samples Collected Out of Window|0
7317537|NCT00723489|11546542|FG001|Overall Study|Samples Collected Out of Window|3
7317538|NCT00723489|11546543|FG002|Overall Study|Samples Collected Out of Window|0
7317539|NCT00723489|11546544|FG003|Overall Study|Samples Collected Out of Window|0
7317540|NCT00723528|11546557|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
7317541|NCT00723528|11546558|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
7317542|NCT00723528|11546559|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
7317543|NCT00723528|11546560|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
7317544|NCT00723528|11546561|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
7317545|NCT00723528|11546562|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
7317546|NCT00723528|11546563|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
7317547|NCT00723528|11546557|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
7317548|NCT00723528|11546558|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317549|NCT00723528|11546559|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317550|NCT00723528|11546560|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317551|NCT00723528|11546561|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317552|NCT00723528|11546562|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317553|NCT00723528|11546563|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
7317554|NCT00723528|11546557|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
7317555|NCT00723528|11546558|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
7317556|NCT00723528|11546559|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
7317557|NCT00723528|11546560|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
7317558|NCT00723528|11546561|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
7317559|NCT00723528|11546562|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
7317560|NCT00723528|11546563|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
7317561|NCT00723528|11546557|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317562|NCT00723528|11546558|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317563|NCT00723528|11546559|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
7317564|NCT00723528|11546560|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317565|NCT00723528|11546561|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317566|NCT00723528|11546562|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317567|NCT00723528|11546563|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
7317568|NCT00723528|11546557|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
7317569|NCT00723528|11546558|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7317570|NCT00723528|11546559|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
7317571|NCT00723528|11546560|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7317572|NCT00723528|11546561|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7317573|NCT00723528|11546562|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7393940|NCT01262872|11655882|FG002|Step 2|Withdrawal by Subject|4
7393941|NCT01262872|11655883|FG003|Step 2|Withdrawal by Subject|6
7393942|NCT01262872|11655884|FG004|Step 2|Withdrawal by Subject|3
7393943|NCT01262872|11655885|FG005|Step 2|Withdrawal by Subject|1
7393944|NCT01262872|11655886|FG006|Step 2|Withdrawal by Subject|2
7393945|NCT01262872|11655887|FG007|Step 2|Withdrawal by Subject|1
7393946|NCT01262872|11655880|FG000|Step 2|Migrated/moved from study area|0
7393947|NCT01262872|11655881|FG001|Step 2|Migrated/moved from study area|0
7393948|NCT01262872|11655882|FG002|Step 2|Migrated/moved from study area|4
7393949|NCT01262872|11655883|FG003|Step 2|Migrated/moved from study area|3
7393950|NCT01262872|11655884|FG004|Step 2|Migrated/moved from study area|2
7393951|NCT01262872|11655885|FG005|Step 2|Migrated/moved from study area|6
7393952|NCT01262872|11655886|FG006|Step 2|Migrated/moved from study area|2
7393953|NCT01262872|11655887|FG007|Step 2|Migrated/moved from study area|3
7393954|NCT01262898|11655925|FG000|Overall Study|Protocol Violation|1
7393955|NCT01262898|11655926|FG001|Overall Study|Protocol Violation|1
7393956|NCT01262898|11655927|FG002|Overall Study|Protocol Violation|0
7393957|NCT01262898|11655928|FG003|Overall Study|Protocol Violation|0
7393958|NCT01262898|11655925|FG000|Overall Study|Lost to Follow-up|1
7393959|NCT01262898|11655926|FG001|Overall Study|Lost to Follow-up|0
7393960|NCT01262898|11655927|FG002|Overall Study|Lost to Follow-up|0
7393961|NCT01262898|11655928|FG003|Overall Study|Lost to Follow-up|0
7393962|NCT01262898|11655925|FG000|Overall Study|Withdrawal by Subject|1
7393963|NCT01262898|11655926|FG001|Overall Study|Withdrawal by Subject|1
7393964|NCT01262898|11655927|FG002|Overall Study|Withdrawal by Subject|0
7393965|NCT01262898|11655928|FG003|Overall Study|Withdrawal by Subject|0
7393966|NCT01262976|11655947|FG000|Up to Month 2|Serious Adverse Event|0
7393967|NCT01262976|11655948|FG001|Up to Month 2|Serious Adverse Event|0
7393968|NCT01262976|11655949|FG002|Up to Month 2|Serious Adverse Event|1
7393969|NCT01262976|11655950|FG003|Up to Month 2|Serious Adverse Event|0
7393970|NCT01262976|11655951|FG004|Up to Month 2|Serious Adverse Event|0
7393971|NCT01262976|11655952|FG005|Up to Month 2|Serious Adverse Event|0
7393972|NCT01262976|11655947|FG000|Up to Month 2|Withdrawal by Subject|1
7393973|NCT01262976|11655948|FG001|Up to Month 2|Withdrawal by Subject|0
7393974|NCT01262976|11655949|FG002|Up to Month 2|Withdrawal by Subject|0
7393975|NCT01262976|11655950|FG003|Up to Month 2|Withdrawal by Subject|0
7393976|NCT01262976|11655951|FG004|Up to Month 2|Withdrawal by Subject|0
7393977|NCT01262976|11655952|FG005|Up to Month 2|Withdrawal by Subject|0
7393978|NCT01262976|11655947|FG000|Up to Month 2|Migrated/moved from study area|0
7393979|NCT01262976|11655948|FG001|Up to Month 2|Migrated/moved from study area|1
7393980|NCT01262976|11655949|FG002|Up to Month 2|Migrated/moved from study area|0
7393981|NCT01262976|11655950|FG003|Up to Month 2|Migrated/moved from study area|0
7393982|NCT01262976|11655951|FG004|Up to Month 2|Migrated/moved from study area|1
7393983|NCT01262976|11655952|FG005|Up to Month 2|Migrated/moved from study area|1
7393984|NCT01262976|11655947|FG000|Up to Month 2|Lost to Follow-up|1
7393985|NCT01262976|11655948|FG001|Up to Month 2|Lost to Follow-up|0
7393986|NCT01262976|11655949|FG002|Up to Month 2|Lost to Follow-up|0
7393987|NCT01262976|11655950|FG003|Up to Month 2|Lost to Follow-up|1
7393988|NCT01262976|11655951|FG004|Up to Month 2|Lost to Follow-up|1
7393989|NCT01262976|11655952|FG005|Up to Month 2|Lost to Follow-up|1
7393990|NCT01262976|11655947|FG000|Up to Month 2|Other|1
7393991|NCT01262976|11655948|FG001|Up to Month 2|Other|0
7393992|NCT01262976|11655949|FG002|Up to Month 2|Other|0
7393993|NCT01262976|11655950|FG003|Up to Month 2|Other|1
7393994|NCT01262976|11655951|FG004|Up to Month 2|Other|0
7393995|NCT01262976|11655952|FG005|Up to Month 2|Other|2
7393996|NCT01262976|11655947|FG000|Up to Month 7|Serious Adverse Event|0
7393997|NCT01262976|11655948|FG001|Up to Month 7|Serious Adverse Event|0
7393998|NCT01262976|11655949|FG002|Up to Month 7|Serious Adverse Event|2
7393999|NCT01262976|11655950|FG003|Up to Month 7|Serious Adverse Event|0
7394000|NCT01262976|11655951|FG004|Up to Month 7|Serious Adverse Event|0
7394001|NCT01262976|11655952|FG005|Up to Month 7|Serious Adverse Event|0
7394002|NCT01262976|11655947|FG000|Up to Month 7|Withdrawal by Subject|1
7394003|NCT01262976|11655948|FG001|Up to Month 7|Withdrawal by Subject|0
7394004|NCT01262976|11655949|FG002|Up to Month 7|Withdrawal by Subject|0
7394005|NCT01262976|11655950|FG003|Up to Month 7|Withdrawal by Subject|0
7394006|NCT01262976|11655951|FG004|Up to Month 7|Withdrawal by Subject|0
7394007|NCT01262976|11655952|FG005|Up to Month 7|Withdrawal by Subject|0
7394008|NCT01262976|11655947|FG000|Up to Month 7|Migrated/moved from study area|0
7394009|NCT01262976|11655948|FG001|Up to Month 7|Migrated/moved from study area|0
7394010|NCT01262976|11655949|FG002|Up to Month 7|Migrated/moved from study area|1
7394011|NCT01262976|11655950|FG003|Up to Month 7|Migrated/moved from study area|3
7394012|NCT01262976|11655951|FG004|Up to Month 7|Migrated/moved from study area|1
7394013|NCT01262976|11655952|FG005|Up to Month 7|Migrated/moved from study area|1
7394014|NCT01262976|11655947|FG000|Up to Month 7|Lost to Follow-up|1
7394015|NCT01262976|11655948|FG001|Up to Month 7|Lost to Follow-up|0
7394016|NCT01262976|11655949|FG002|Up to Month 7|Lost to Follow-up|1
7394017|NCT01262976|11655950|FG003|Up to Month 7|Lost to Follow-up|3
7394018|NCT01262976|11655951|FG004|Up to Month 7|Lost to Follow-up|1
7394019|NCT01262976|11655952|FG005|Up to Month 7|Lost to Follow-up|3
7394020|NCT01262976|11655947|FG000|Up to Month 7|Other|3
7394021|NCT01262976|11655948|FG001|Up to Month 7|Other|0
7394022|NCT01262976|11655949|FG002|Up to Month 7|Other|2
7394023|NCT01262976|11655950|FG003|Up to Month 7|Other|0
7394024|NCT01262976|11655951|FG004|Up to Month 7|Other|0
7394025|NCT01262976|11655952|FG005|Up to Month 7|Other|0
7394026|NCT01262976|11655947|FG000|Up to Year 1|Serious Adverse Event|0
7394027|NCT01262976|11655948|FG001|Up to Year 1|Serious Adverse Event|0
7394028|NCT01262976|11655949|FG002|Up to Year 1|Serious Adverse Event|2
7394029|NCT01262976|11655950|FG003|Up to Year 1|Serious Adverse Event|0
7394030|NCT01262976|11655951|FG004|Up to Year 1|Serious Adverse Event|0
7394031|NCT01262976|11655952|FG005|Up to Year 1|Serious Adverse Event|0
7394032|NCT01262976|11655947|FG000|Up to Year 1|Withdrawal by Subject|1
7394033|NCT01262976|11655948|FG001|Up to Year 1|Withdrawal by Subject|0
7394034|NCT01262976|11655949|FG002|Up to Year 1|Withdrawal by Subject|0
7394035|NCT01262976|11655950|FG003|Up to Year 1|Withdrawal by Subject|0
7394036|NCT01262976|11655951|FG004|Up to Year 1|Withdrawal by Subject|0
7394037|NCT01262976|11655952|FG005|Up to Year 1|Withdrawal by Subject|0
7394038|NCT01262976|11655947|FG000|Up to Year 1|Migrated/moved from study area|1
7394039|NCT01262976|11655948|FG001|Up to Year 1|Migrated/moved from study area|0
7394040|NCT01262976|11655949|FG002|Up to Year 1|Migrated/moved from study area|0
7394041|NCT01262976|11655950|FG003|Up to Year 1|Migrated/moved from study area|3
7394042|NCT01262976|11655951|FG004|Up to Year 1|Migrated/moved from study area|3
7394043|NCT01262976|11655952|FG005|Up to Year 1|Migrated/moved from study area|2
7394044|NCT01262976|11655947|FG000|Up to Year 1|Lost to Follow-up|4
7394045|NCT01262976|11655948|FG001|Up to Year 1|Lost to Follow-up|0
7394046|NCT01262976|11655949|FG002|Up to Year 1|Lost to Follow-up|0
7394047|NCT01262976|11655950|FG003|Up to Year 1|Lost to Follow-up|1
7394048|NCT01262976|11655951|FG004|Up to Year 1|Lost to Follow-up|6
7394049|NCT01262976|11655952|FG005|Up to Year 1|Lost to Follow-up|5
7394050|NCT01262976|11655947|FG000|Up to Year 1|Other|3
7394051|NCT01262976|11655948|FG001|Up to Year 1|Other|1
7394052|NCT01262976|11655949|FG002|Up to Year 1|Other|0
7394053|NCT01262976|11655950|FG003|Up to Year 1|Other|0
7394054|NCT01262976|11655951|FG004|Up to Year 1|Other|2
7394055|NCT01262976|11655952|FG005|Up to Year 1|Other|1
7394056|NCT01262976|11655947|FG000|Up to Year 1|Subjects with unknown completion status|0
7394057|NCT01262976|11655948|FG001|Up to Year 1|Subjects with unknown completion status|0
7394058|NCT01262976|11655949|FG002|Up to Year 1|Subjects with unknown completion status|1
7394059|NCT01262976|11655950|FG003|Up to Year 1|Subjects with unknown completion status|0
7394060|NCT01262976|11655951|FG004|Up to Year 1|Subjects with unknown completion status|0
7394061|NCT01262976|11655952|FG005|Up to Year 1|Subjects with unknown completion status|1
7394062|NCT01262976|11655947|FG000|Up to Year 2|Serious Adverse Event|0
7394063|NCT01262976|11655948|FG001|Up to Year 2|Serious Adverse Event|0
7394064|NCT01262976|11655949|FG002|Up to Year 2|Serious Adverse Event|2
7394065|NCT01262976|11655950|FG003|Up to Year 2|Serious Adverse Event|0
7394066|NCT01262976|11655951|FG004|Up to Year 2|Serious Adverse Event|0
7394067|NCT01262976|11655952|FG005|Up to Year 2|Serious Adverse Event|0
7394068|NCT01262976|11655947|FG000|Up to Year 2|Withdrawal by Subject|1
7394069|NCT01262976|11655948|FG001|Up to Year 2|Withdrawal by Subject|0
7394070|NCT01262976|11655949|FG002|Up to Year 2|Withdrawal by Subject|0
7394071|NCT01262976|11655950|FG003|Up to Year 2|Withdrawal by Subject|0
7394072|NCT01262976|11655951|FG004|Up to Year 2|Withdrawal by Subject|0
7394073|NCT01262976|11655952|FG005|Up to Year 2|Withdrawal by Subject|0
7394074|NCT01262976|11655947|FG000|Up to Year 2|Migrated/moved from study area|0
7394075|NCT01262976|11655948|FG001|Up to Year 2|Migrated/moved from study area|0
7394076|NCT01262976|11655949|FG002|Up to Year 2|Migrated/moved from study area|0
7394077|NCT01262976|11655950|FG003|Up to Year 2|Migrated/moved from study area|2
7394078|NCT01262976|11655951|FG004|Up to Year 2|Migrated/moved from study area|1
7394079|NCT01262976|11655952|FG005|Up to Year 2|Migrated/moved from study area|2
7394080|NCT01262976|11655947|FG000|Up to Year 2|Lost to Follow-up|1
7394081|NCT01262976|11655948|FG001|Up to Year 2|Lost to Follow-up|1
7394082|NCT01262976|11655949|FG002|Up to Year 2|Lost to Follow-up|2
7394083|NCT01262976|11655950|FG003|Up to Year 2|Lost to Follow-up|2
7394084|NCT01262976|11655951|FG004|Up to Year 2|Lost to Follow-up|3
7394085|NCT01262976|11655952|FG005|Up to Year 2|Lost to Follow-up|3
7394086|NCT01262976|11655947|FG000|Up to Year 2|Subjects with unknown completion status|0
7394087|NCT01262976|11655948|FG001|Up to Year 2|Subjects with unknown completion status|0
7394088|NCT01262976|11655949|FG002|Up to Year 2|Subjects with unknown completion status|1
7394089|NCT01262976|11655950|FG003|Up to Year 2|Subjects with unknown completion status|0
7394090|NCT01262976|11655951|FG004|Up to Year 2|Subjects with unknown completion status|0
7394091|NCT01262976|11655952|FG005|Up to Year 2|Subjects with unknown completion status|0
7394092|NCT01262976|11655947|FG000|Up to Year 2|Other|3
7394093|NCT01262976|11655948|FG001|Up to Year 2|Other|0
7394094|NCT01262976|11655949|FG002|Up to Year 2|Other|0
7394095|NCT01262976|11655950|FG003|Up to Year 2|Other|0
7394096|NCT01262976|11655951|FG004|Up to Year 2|Other|0
7394097|NCT01262976|11655952|FG005|Up to Year 2|Other|0
7394098|NCT01262976|11655947|FG000|Up to Year 3|Serious Adverse Event|0
7394099|NCT01262976|11655948|FG001|Up to Year 3|Serious Adverse Event|0
7394100|NCT01262976|11655949|FG002|Up to Year 3|Serious Adverse Event|2
7394101|NCT01262976|11655950|FG003|Up to Year 3|Serious Adverse Event|0
7394102|NCT01262976|11655951|FG004|Up to Year 3|Serious Adverse Event|0
7394103|NCT01262976|11655952|FG005|Up to Year 3|Serious Adverse Event|0
7394104|NCT01262976|11655947|FG000|Up to Year 3|Withdrawal by Subject|1
7394105|NCT01262976|11655948|FG001|Up to Year 3|Withdrawal by Subject|0
7394106|NCT01262976|11655949|FG002|Up to Year 3|Withdrawal by Subject|0
7394107|NCT01262976|11655950|FG003|Up to Year 3|Withdrawal by Subject|0
7394108|NCT01262976|11655951|FG004|Up to Year 3|Withdrawal by Subject|0
7394109|NCT01262976|11655952|FG005|Up to Year 3|Withdrawal by Subject|0
7394110|NCT01262976|11655947|FG000|Up to Year 3|Migrated/moved from study area|0
7394111|NCT01262976|11655948|FG001|Up to Year 3|Migrated/moved from study area|0
7394112|NCT01262976|11655949|FG002|Up to Year 3|Migrated/moved from study area|0
7394113|NCT01262976|11655950|FG003|Up to Year 3|Migrated/moved from study area|2
7394114|NCT01262976|11655951|FG004|Up to Year 3|Migrated/moved from study area|1
7394115|NCT01262976|11655952|FG005|Up to Year 3|Migrated/moved from study area|1
7394116|NCT01262976|11655947|FG000|Up to Year 3|Lost to Follow-up|2
7394117|NCT01262976|11655948|FG001|Up to Year 3|Lost to Follow-up|2
7394118|NCT01262976|11655949|FG002|Up to Year 3|Lost to Follow-up|4
7394119|NCT01262976|11655950|FG003|Up to Year 3|Lost to Follow-up|3
7394120|NCT01262976|11655951|FG004|Up to Year 3|Lost to Follow-up|1
7394121|NCT01262976|11655952|FG005|Up to Year 3|Lost to Follow-up|3
7394122|NCT01262976|11655947|FG000|Up to Year 3|Subjects with unknown completion status|0
7394123|NCT01262976|11655948|FG001|Up to Year 3|Subjects with unknown completion status|0
7394124|NCT01262976|11655949|FG002|Up to Year 3|Subjects with unknown completion status|1
7394125|NCT01262976|11655950|FG003|Up to Year 3|Subjects with unknown completion status|0
7394126|NCT01262976|11655951|FG004|Up to Year 3|Subjects with unknown completion status|0
7394127|NCT01262976|11655952|FG005|Up to Year 3|Subjects with unknown completion status|0
7394128|NCT01262976|11655947|FG000|Up to Year 3|Other|3
7394129|NCT01262976|11655948|FG001|Up to Year 3|Other|0
7394130|NCT01262976|11655949|FG002|Up to Year 3|Other|0
7394131|NCT01262976|11655950|FG003|Up to Year 3|Other|0
7394132|NCT01262976|11655951|FG004|Up to Year 3|Other|0
7394133|NCT01262976|11655952|FG005|Up to Year 3|Other|0
7394134|NCT01262989|11655967|FG000|Period 1|Lost to Follow-up|1
7394135|NCT01262989|11655968|FG001|Period 1|Lost to Follow-up|1
7394136|NCT01262989|11655967|FG000|Period 1|Intercurrent disease|0
7394137|NCT01262989|11655968|FG001|Period 1|Intercurrent disease|1
7394138|NCT01262989|11655967|FG000|Period 1|Positive answer for exclusion criteria|0
7394139|NCT01262989|11655968|FG001|Period 1|Positive answer for exclusion criteria|1
7394140|NCT01262989|11655967|FG000|Period 2|Intercurrent disease|0
7394141|NCT01262989|11655968|FG001|Period 2|Intercurrent disease|1
7394142|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
7394143|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
7394144|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
7394145|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
7394146|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
7394147|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
7394148|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
7394149|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
7394150|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
7394151|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
7394152|NCT01263015|11655976|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
7394153|NCT01263015|11655977|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
7394154|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
7394155|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
7394156|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
7394157|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
7394158|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
7394159|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
7394160|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7394161|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
7394162|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
7394163|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
7394164|NCT01263015|11655976|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
7394165|NCT01263015|11655977|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
7394166|NCT01263054|11655985|FG000|Overall Study|Death|1
7394167|NCT01263054|11655986|FG001|Overall Study|Death|0
7394168|NCT01263054|11655985|FG000|Overall Study|Lost to Follow-up|2
7394169|NCT01263054|11655986|FG001|Overall Study|Lost to Follow-up|2
7394170|NCT01263054|11655985|FG000|Overall Study|Withdrawal by Subject|1
7394171|NCT01263054|11655986|FG001|Overall Study|Withdrawal by Subject|3
7394172|NCT01263054|11655985|FG000|Overall Study|Qualification Violation|1
7394173|NCT01263054|11655986|FG001|Overall Study|Qualification Violation|0
7394174|NCT01263054|11655985|FG000|Overall Study|Other|0
7394175|NCT01263054|11655986|FG001|Overall Study|Other|1
7394176|NCT01263093|11655994|FG000|Washout|Physician Decision|1
7394177|NCT01263093|11655995|FG001|Washout|Physician Decision|0
7394178|NCT01263093|11655994|FG000|Period 2|Adverse Event|1
7394179|NCT01263093|11655995|FG001|Period 2|Adverse Event|0
7394180|NCT01263106|11656002|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
7394181|NCT01263106|11656003|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
7394182|NCT01263119|11656012|FG000|Period 1|Protocol Violation|2
7394183|NCT01263119|11656012|FG000|Period 2|Adverse Event|2
7394184|NCT01263197|11656031|FG000|First Intervention (Period 1)|Adverse Event|0
7394185|NCT01263197|11656032|FG001|First Intervention (Period 1)|Adverse Event|0
7394186|NCT01263197|11656033|FG002|First Intervention (Period 1)|Adverse Event|0
7394187|NCT01263197|11656034|FG003|First Intervention (Period 1)|Adverse Event|0
7394188|NCT01263197|11656035|FG004|First Intervention (Period 1)|Adverse Event|0
7394189|NCT01263197|11656036|FG005|First Intervention (Period 1)|Adverse Event|1
7394190|NCT01263197|11656031|FG000|Washout Period 1|Protocol Violation|0
7394191|NCT01263197|11656032|FG001|Washout Period 1|Protocol Violation|0
7394192|NCT01263197|11656033|FG002|Washout Period 1|Protocol Violation|0
7394193|NCT01263197|11656034|FG003|Washout Period 1|Protocol Violation|0
7394194|NCT01263197|11656035|FG004|Washout Period 1|Protocol Violation|1
7394195|NCT01263197|11656036|FG005|Washout Period 1|Protocol Violation|0
7394196|NCT01263197|11656031|FG000|Washout Period 2|Physician Decision|0
7394197|NCT01263197|11656032|FG001|Washout Period 2|Physician Decision|0
7394198|NCT01263197|11656033|FG002|Washout Period 2|Physician Decision|0
7394199|NCT01263197|11656034|FG003|Washout Period 2|Physician Decision|0
7394200|NCT01263197|11656035|FG004|Washout Period 2|Physician Decision|0
7394201|NCT01263197|11656036|FG005|Washout Period 2|Physician Decision|1
7394202|NCT01263197|11656031|FG000|Washout Period 2|Protocol Violation|0
7394203|NCT01263197|11656032|FG001|Washout Period 2|Protocol Violation|0
7394204|NCT01263197|11656033|FG002|Washout Period 2|Protocol Violation|0
7394205|NCT01263197|11656034|FG003|Washout Period 2|Protocol Violation|1
7394206|NCT01263197|11656035|FG004|Washout Period 2|Protocol Violation|0
7394207|NCT01263197|11656036|FG005|Washout Period 2|Protocol Violation|0
7394208|NCT01263197|11656031|FG000|Third Intervention (Period 3)|Adverse Event|0
7394209|NCT01263197|11656032|FG001|Third Intervention (Period 3)|Adverse Event|1
7394210|NCT01263197|11656033|FG002|Third Intervention (Period 3)|Adverse Event|0
7394211|NCT01263197|11656034|FG003|Third Intervention (Period 3)|Adverse Event|0
7394212|NCT01263197|11656035|FG004|Third Intervention (Period 3)|Adverse Event|0
7394213|NCT01263197|11656036|FG005|Third Intervention (Period 3)|Adverse Event|0
7394214|NCT01263223|11656050|FG000|Period 2|Withdrawal by Subject|0
7394215|NCT01263223|11656051|FG001|Period 2|Withdrawal by Subject|1
7394216|NCT01263223|11656050|FG000|7-day Follow-up|Withdrawal by Subject|0
7394217|NCT01263223|11656051|FG001|7-day Follow-up|Withdrawal by Subject|1
7394218|NCT01263223|11656050|FG000|7-day Follow-up|Lost to Follow-up|1
7394219|NCT01263223|11656051|FG001|7-day Follow-up|Lost to Follow-up|0
7394220|NCT01263444|11656108|FG000|Overall Study|Adverse Event|8
7394221|NCT01263444|11656108|FG000|Overall Study|Withdrawal by Subject|1
7394222|NCT01263444|11656108|FG000|Overall Study|Protocol Violation|1
7394223|NCT01263470|11656118|FG000|Overall Study|Adverse Event|2
7394224|NCT01263470|11656119|FG001|Overall Study|Adverse Event|2
7394225|NCT01263470|11656120|FG002|Overall Study|Adverse Event|1
7394226|NCT01263470|11656121|FG003|Overall Study|Adverse Event|1
7394227|NCT01263470|11656122|FG004|Overall Study|Adverse Event|2
7394228|NCT01263470|11656123|FG005|Overall Study|Adverse Event|2
7394229|NCT01263470|11656118|FG000|Overall Study|Protocol Violation|0
7394230|NCT01263470|11656119|FG001|Overall Study|Protocol Violation|1
7394231|NCT01263470|11656120|FG002|Overall Study|Protocol Violation|0
7394232|NCT01263470|11656121|FG003|Overall Study|Protocol Violation|0
7394233|NCT01263470|11656122|FG004|Overall Study|Protocol Violation|0
7394234|NCT01263470|11656123|FG005|Overall Study|Protocol Violation|1
7394235|NCT01263470|11656118|FG000|Overall Study|Withdrawal by Subject|0
7394236|NCT01263470|11656119|FG001|Overall Study|Withdrawal by Subject|1
7394237|NCT01263470|11656120|FG002|Overall Study|Withdrawal by Subject|1
7394238|NCT01263470|11656121|FG003|Overall Study|Withdrawal by Subject|2
7394239|NCT01263470|11656122|FG004|Overall Study|Withdrawal by Subject|0
7394240|NCT01263470|11656123|FG005|Overall Study|Withdrawal by Subject|2
7394241|NCT01263470|11656118|FG000|Overall Study|Lack of Efficacy|0
7394242|NCT01263470|11656119|FG001|Overall Study|Lack of Efficacy|0
7394243|NCT01263470|11656120|FG002|Overall Study|Lack of Efficacy|2
7394244|NCT01263470|11656121|FG003|Overall Study|Lack of Efficacy|0
7394245|NCT01263470|11656122|FG004|Overall Study|Lack of Efficacy|0
7394246|NCT01263470|11656123|FG005|Overall Study|Lack of Efficacy|0
7394247|NCT01263470|11656118|FG000|Overall Study|Participant Unavailability|0
7394248|NCT01263470|11656119|FG001|Overall Study|Participant Unavailability|1
7394249|NCT01263470|11656120|FG002|Overall Study|Participant Unavailability|0
7394250|NCT01263470|11656121|FG003|Overall Study|Participant Unavailability|0
7394251|NCT01263470|11656122|FG004|Overall Study|Participant Unavailability|0
7394252|NCT01263470|11656123|FG005|Overall Study|Participant Unavailability|0
7394253|NCT01263470|11656118|FG000|Overall Study|Study Drug Non-compliance|0
7394254|NCT01263470|11656119|FG001|Overall Study|Study Drug Non-compliance|0
7394255|NCT01263470|11656120|FG002|Overall Study|Study Drug Non-compliance|0
7394256|NCT01263470|11656121|FG003|Overall Study|Study Drug Non-compliance|0
7394257|NCT01263470|11656122|FG004|Overall Study|Study Drug Non-compliance|1
7394258|NCT01263470|11656123|FG005|Overall Study|Study Drug Non-compliance|0
7394259|NCT01263483|11656140|FG000|Overall Study|Adverse Event|4
7394260|NCT01263483|11656141|FG001|Overall Study|Adverse Event|0
7394261|NCT01263483|11656142|FG002|Overall Study|Adverse Event|3
7394262|NCT01263483|11656140|FG000|Overall Study|Withdrawal by Subject|1
7394263|NCT01263483|11656141|FG001|Overall Study|Withdrawal by Subject|0
7394264|NCT01263483|11656142|FG002|Overall Study|Withdrawal by Subject|0
7394265|NCT01263483|11656140|FG000|Overall Study|Lack of Efficacy|2
7394266|NCT01263483|11656141|FG001|Overall Study|Lack of Efficacy|0
7394267|NCT01263483|11656142|FG002|Overall Study|Lack of Efficacy|0
7394268|NCT01263483|11656140|FG000|Overall Study|Protocol Violation|0
7394269|NCT01263483|11656141|FG001|Overall Study|Protocol Violation|1
7394270|NCT01263483|11656142|FG002|Overall Study|Protocol Violation|1
7394271|NCT01263483|11656140|FG000|Overall Study|Participant Unavailability|0
7394272|NCT01263483|11656141|FG001|Overall Study|Participant Unavailability|1
7394273|NCT01263483|11656142|FG002|Overall Study|Participant Unavailability|1
7394274|NCT01263496|11656155|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
7394275|NCT01263496|11656156|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394276|NCT01263496|11656157|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394277|NCT01263496|11656158|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394278|NCT01263496|11656159|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394279|NCT01263496|11656160|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394280|NCT01263496|11656161|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394281|NCT01263496|11656162|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394282|NCT01263496|11656163|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
7394283|NCT01263496|11656155|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
7394284|NCT01263496|11656156|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7394285|NCT01263496|11656157|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
7394286|NCT01263496|11656158|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
7394287|NCT01263496|11656159|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
7394288|NCT01263496|11656160|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
7394289|NCT01263496|11656161|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
7394290|NCT01263496|11656162|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
7394291|NCT01263496|11656163|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
7394292|NCT01263496|11656155|FG000|Entered - Long-Term Extension Study|Adverse Event|0
7394293|NCT01263496|11656156|FG001|Entered - Long-Term Extension Study|Adverse Event|5
7394294|NCT01263496|11656157|FG002|Entered - Long-Term Extension Study|Adverse Event|6
7394295|NCT01263496|11656158|FG003|Entered - Long-Term Extension Study|Adverse Event|3
7394296|NCT01263496|11656159|FG004|Entered - Long-Term Extension Study|Adverse Event|1
7394297|NCT01263496|11656160|FG005|Entered - Long-Term Extension Study|Adverse Event|0
7394298|NCT01263496|11656161|FG006|Entered - Long-Term Extension Study|Adverse Event|0
7394299|NCT01263496|11656162|FG007|Entered - Long-Term Extension Study|Adverse Event|0
7394300|NCT01263496|11656163|FG008|Entered - Long-Term Extension Study|Adverse Event|1
7394301|NCT01263496|11656155|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394302|NCT01263496|11656156|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
7394303|NCT01263496|11656157|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394304|NCT01263496|11656158|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394305|NCT01263496|11656159|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394306|NCT01263496|11656160|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394307|NCT01263496|11656161|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394308|NCT01263496|11656162|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394309|NCT01263496|11656163|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
7394310|NCT01263496|11656155|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7394311|NCT01263496|11656156|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7394312|NCT01263496|11656157|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7394313|NCT01263496|11656158|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7394314|NCT01263496|11656159|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
7394315|NCT01263496|11656160|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7394316|NCT01263496|11656161|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7394317|NCT01263496|11656162|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7394318|NCT01263496|11656163|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7394319|NCT01263496|11656155|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
7394320|NCT01263496|11656156|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
7394321|NCT01263496|11656157|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
7394322|NCT01263496|11656158|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
7394323|NCT01263496|11656159|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
7394324|NCT01263496|11656160|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
7394325|NCT01263496|11656161|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
7394326|NCT01263496|11656162|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
7394327|NCT01263496|11656163|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
7394328|NCT01263496|11656155|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
7394329|NCT01263496|11656156|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
7394330|NCT01263496|11656157|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
7394331|NCT01263496|11656158|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
7394332|NCT01263496|11656159|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
7394333|NCT01263496|11656160|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
7394334|NCT01263496|11656161|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
7394335|NCT01263496|11656162|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
7394336|NCT01263496|11656163|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
7394337|NCT01263509|11656177|FG000|Entered - Long-Term Extension Study|Adverse Event|5
7394338|NCT01263509|11656178|FG001|Entered - Long-Term Extension Study|Adverse Event|5
7394339|NCT01263509|11656179|FG002|Entered - Long-Term Extension Study|Adverse Event|4
7394340|NCT01263509|11656180|FG003|Entered - Long-Term Extension Study|Adverse Event|1
7394341|NCT01263509|11656177|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
7394342|NCT01263509|11656178|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
7394343|NCT01263509|11656179|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
7394344|NCT01263509|11656180|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
7394345|NCT01263509|11656177|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7394346|NCT01263509|11656178|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7394347|NCT01263509|11656179|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7394348|NCT01263509|11656180|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7394349|NCT01263509|11656177|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
7394350|NCT01263509|11656178|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
7394351|NCT01263509|11656179|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
7394352|NCT01263509|11656180|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
7394353|NCT01263509|11656177|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7394354|NCT01263509|11656178|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7394355|NCT01263509|11656179|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
7394356|NCT01263509|11656180|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
7394357|NCT01263561|11656188|FG000|Overall Study|Death|1
7394358|NCT01263561|11656189|FG001|Overall Study|Death|2
7394359|NCT01263639|11656197|FG000|Overall Study|Lost to Follow-up|66
7394360|NCT01263639|11656198|FG001|Overall Study|Lost to Follow-up|70
7394361|NCT01263639|11656197|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
7394362|NCT01263639|11656198|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
7394363|NCT01263665|11656204|FG000|Overall Study|Withdrew Consent|1
7394364|NCT01263665|11656204|FG000|Overall Study|Lost to Follow-up|3
7394365|NCT01263665|11656204|FG000|Overall Study|Death|2
7394366|NCT01263665|11656204|FG000|Overall Study|Amputation above the ankle|1
7394367|NCT01263665|11656204|FG000|Overall Study|Surgical Bypass|2
7394368|NCT01263691|11656214|FG000|Overall Study|Lost to Follow-up|1
7394369|NCT01263691|11656215|FG001|Overall Study|Lost to Follow-up|0
7394370|NCT01263691|11656216|FG002|Overall Study|Lost to Follow-up|1
7394371|NCT01263691|11656217|FG003|Overall Study|Lost to Follow-up|1
7394372|NCT01263691|11656218|FG004|Overall Study|Lost to Follow-up|0
7394373|NCT01263691|11656219|FG005|Overall Study|Lost to Follow-up|0
7394374|NCT01263691|11656214|FG000|Overall Study|Withdrawal by Subject|1
7394375|NCT01263691|11656215|FG001|Overall Study|Withdrawal by Subject|0
7394376|NCT01263691|11656216|FG002|Overall Study|Withdrawal by Subject|0
7394377|NCT01263691|11656217|FG003|Overall Study|Withdrawal by Subject|0
7394378|NCT01263691|11656218|FG004|Overall Study|Withdrawal by Subject|0
7394379|NCT01263691|11656219|FG005|Overall Study|Withdrawal by Subject|0
7394380|NCT01263691|11656214|FG000|Overall Study|Adverse Event|1
7394381|NCT01263691|11656215|FG001|Overall Study|Adverse Event|0
7394382|NCT01263691|11656216|FG002|Overall Study|Adverse Event|0
7394383|NCT01263691|11656217|FG003|Overall Study|Adverse Event|0
7394384|NCT01263691|11656218|FG004|Overall Study|Adverse Event|0
7394385|NCT01263691|11656219|FG005|Overall Study|Adverse Event|0
7394386|NCT01263704|11656254|FG000|Overall Study|Progressive disease|18
7394387|NCT01263704|11656254|FG000|Overall Study|Adverse Event|3
7394388|NCT01263704|11656254|FG000|Overall Study|Death|2
7394389|NCT01263704|11656254|FG000|Overall Study|Patient withdrew consent|2
7394390|NCT01263704|11656254|FG000|Overall Study|Eligibility criteria not fulfilled|1
7394391|NCT01263704|11656254|FG000|Overall Study|Lost to Follow-up|1
7394392|NCT01263704|11656254|FG000|Overall Study|Colon metastases|1
7394393|NCT01263704|11656254|FG000|Overall Study|Principal Investigator (PI) decision|1
7394394|NCT01263782|11656271|FG000|Overall Study|Death|0
7394395|NCT01263782|11656272|FG001|Overall Study|Death|0
7394396|NCT01263782|11656273|FG002|Overall Study|Death|1
7394397|NCT01263782|11656274|FG003|Overall Study|Death|0
7394398|NCT01263782|11656271|FG000|Overall Study|Progressive disease|0
7394399|NCT01263782|11656272|FG001|Overall Study|Progressive disease|0
7394400|NCT01263782|11656273|FG002|Overall Study|Progressive disease|0
7394401|NCT01263782|11656274|FG003|Overall Study|Progressive disease|1
7394402|NCT01263782|11656271|FG000|Overall Study|Too early|0
7394403|NCT01263782|11656272|FG001|Overall Study|Too early|0
7394404|NCT01263782|11656273|FG002|Overall Study|Too early|1
7394405|NCT01263782|11656274|FG003|Overall Study|Too early|0
7394406|NCT01263782|11656271|FG000|Overall Study|Inevaluable|0
7394407|NCT01263782|11656272|FG001|Overall Study|Inevaluable|0
7394408|NCT01263782|11656273|FG002|Overall Study|Inevaluable|1
7394409|NCT01263782|11656274|FG003|Overall Study|Inevaluable|0
7394410|NCT01263873|11656286|FG000|Overall Study|One provider unable to complete numbers|1
7394411|NCT01263873|11656287|FG001|Overall Study|One provider unable to complete numbers|1
7394412|NCT01263925|11656295|FG000|Overall Study|Protocol Violation|1
7394413|NCT01263925|11656296|FG001|Overall Study|Protocol Violation|0
7394414|NCT01263925|11656295|FG000|Overall Study|Lack of Efficacy|0
7394415|NCT01263925|11656296|FG001|Overall Study|Lack of Efficacy|1
7394416|NCT01263925|11656295|FG000|Overall Study|Adverse Event|23
7394417|NCT01263925|11656296|FG001|Overall Study|Adverse Event|22
7394418|NCT01263925|11656295|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
7394419|NCT01263925|11656296|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
7394420|NCT01263925|11656295|FG000|Overall Study|Withdrawal by Subject|6
7394421|NCT01263925|11656296|FG001|Overall Study|Withdrawal by Subject|8
7394422|NCT01263925|11656295|FG000|Overall Study|Other|4
7394423|NCT01263925|11656296|FG001|Overall Study|Other|4
7394424|NCT01263925|11656295|FG000|Overall Study|Lost to Follow-up|3
7394425|NCT01263925|11656296|FG001|Overall Study|Lost to Follow-up|1
7394426|NCT01263925|11656295|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7394427|NCT01263925|11656296|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
7394428|NCT01263925|11656295|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
7394429|NCT01263925|11656296|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
7394430|NCT01263925|11656295|FG000|Overall Study|AE/ Withdrawal|1
7394431|NCT01263925|11656296|FG001|Overall Study|AE/ Withdrawal|4
7394432|NCT01263925|11656295|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7394433|NCT01263925|11656296|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
7394434|NCT01263925|11656295|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
7394435|NCT01263925|11656296|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
7394436|NCT01263925|11656295|FG000|Overall Study|Withdrawal/ Not specified|0
7394437|NCT01263925|11656296|FG001|Overall Study|Withdrawal/ Not specified|1
7465307|NCT03605862|11764546|FG000|Overall Study|Adverse Event|2
7465308|NCT03605862|11764547|FG001|Overall Study|Adverse Event|1
7465309|NCT03605862|11764546|FG000|Overall Study|Physician Decision|3
7465310|NCT03605862|11764547|FG001|Overall Study|Physician Decision|1
7465311|NCT03605862|11764546|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11
7465312|NCT03605862|11764547|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15
7465313|NCT03541252|11764554|FG000|Overall Study|Withdrawal by Subject|1
7465314|NCT03401112|11764563|FG000|Overall Study|Adverse Event|1
7465315|NCT03401112|11764564|FG001|Overall Study|Adverse Event|2
7465316|NCT03401112|11764565|FG002|Overall Study|Adverse Event|3
7465317|NCT03401112|11764566|FG003|Overall Study|Adverse Event|2
7465318|NCT03401112|11764567|FG004|Overall Study|Adverse Event|0
7465319|NCT03401112|11764563|FG000|Overall Study|Lost to Follow-up|1
7465320|NCT03401112|11764564|FG001|Overall Study|Lost to Follow-up|0
7465321|NCT03401112|11764565|FG002|Overall Study|Lost to Follow-up|0
7465322|NCT03401112|11764566|FG003|Overall Study|Lost to Follow-up|0
7465323|NCT03401112|11764567|FG004|Overall Study|Lost to Follow-up|0
7465324|NCT03401112|11764563|FG000|Overall Study|Noncompliance|1
7465325|NCT03401112|11764564|FG001|Overall Study|Noncompliance|2
7465326|NCT03401112|11764565|FG002|Overall Study|Noncompliance|3
7465327|NCT03401112|11764566|FG003|Overall Study|Noncompliance|0
7465328|NCT03401112|11764567|FG004|Overall Study|Noncompliance|0
7465329|NCT03401112|11764563|FG000|Overall Study|Did not Meet Inclusion Criteria|1
7465330|NCT03401112|11764564|FG001|Overall Study|Did not Meet Inclusion Criteria|0
7465331|NCT03401112|11764565|FG002|Overall Study|Did not Meet Inclusion Criteria|0
7465332|NCT03401112|11764566|FG003|Overall Study|Did not Meet Inclusion Criteria|0
7465333|NCT03401112|11764567|FG004|Overall Study|Did not Meet Inclusion Criteria|0
7465334|NCT03401112|11764563|FG000|Overall Study|Withdrawal by Subject|0
7465335|NCT03401112|11764564|FG001|Overall Study|Withdrawal by Subject|3
7465336|NCT03401112|11764565|FG002|Overall Study|Withdrawal by Subject|2
7465337|NCT03401112|11764566|FG003|Overall Study|Withdrawal by Subject|1
7465338|NCT03401112|11764567|FG004|Overall Study|Withdrawal by Subject|0
7465339|NCT03401112|11764563|FG000|Overall Study|Physician Decision|0
7465340|NCT03401112|11764564|FG001|Overall Study|Physician Decision|0
7465341|NCT03401112|11764565|FG002|Overall Study|Physician Decision|0
7465342|NCT03401112|11764566|FG003|Overall Study|Physician Decision|2
7465343|NCT03401112|11764567|FG004|Overall Study|Physician Decision|0
7394438|NCT01264016|11656307|FG000|Overall Study|Withdrawal by Subject|1
7394439|NCT01264016|11656307|FG000|Overall Study|Felt faint at sight of blood|1
7394440|NCT01264081|11656312|FG000|Participants Screened|Screening failures|30
7394441|NCT01264081|11656312|FG000|Started Treatment|Withdrawal by Subject|1
7394442|NCT01264081|11656312|FG000|Started Treatment|Not complete cycle 1 due to death|1
7394443|NCT01264380|11656316|FG000|Period C|Disease Progression|0
7394444|NCT01264380|11656317|FG001|Period C|Disease Progression|0
7394445|NCT01264380|11656318|FG002|Period C|Disease Progression|4
7394446|NCT01264380|11656316|FG000|Period C|Death|0
7394447|NCT01264380|11656317|FG001|Period C|Death|0
7394448|NCT01264380|11656318|FG002|Period C|Death|2
7394449|NCT01264380|11656316|FG000|Period C|Follow-up for survival status|0
7394450|NCT01264380|11656317|FG001|Period C|Follow-up for survival status|0
7394451|NCT01264380|11656318|FG002|Period C|Follow-up for survival status|6
7394452|NCT01264380|11656316|FG000|Period C|Withdrawal by Subject|0
7394453|NCT01264380|11656317|FG001|Period C|Withdrawal by Subject|0
7394454|NCT01264380|11656318|FG002|Period C|Withdrawal by Subject|1
7394455|NCT01264380|11656316|FG000|Period C|Adverse Event|0
7394456|NCT01264380|11656317|FG001|Period C|Adverse Event|0
7394457|NCT01264380|11656318|FG002|Period C|Adverse Event|1
7394458|NCT01264419|11656326|FG000|Overall Study|Lost to Follow-up|3
7394459|NCT01264718|11656366|FG000|Overall Study|Lost to Follow-up|3
7394460|NCT01264718|11656367|FG001|Overall Study|Lost to Follow-up|2
7394461|NCT01264718|11656366|FG000|Overall Study|Withdrawal by Subject|9
7394462|NCT01264718|11656367|FG001|Overall Study|Withdrawal by Subject|15
7394463|NCT01264718|11656366|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
7394464|NCT01264718|11656367|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
7394465|NCT01264770|11656379|FG000|Overall Study|Not reported|0
7394466|NCT01264770|11656380|FG001|Overall Study|Not reported|0
7394467|NCT01264770|11656381|FG002|Overall Study|Not reported|1
7394468|NCT01264770|11656382|FG003|Overall Study|Not reported|0
7394469|NCT01264770|11656383|FG004|Overall Study|Not reported|0
7394470|NCT01264770|11656384|FG005|Overall Study|Not reported|0
7394471|NCT01264770|11656379|FG000|Overall Study|e.g., change in circumstances|8
7394472|NCT01264770|11656380|FG001|Overall Study|e.g., change in circumstances|3
7394473|NCT01264770|11656381|FG002|Overall Study|e.g., change in circumstances|3
7394474|NCT01264770|11656382|FG003|Overall Study|e.g., change in circumstances|3
7394475|NCT01264770|11656383|FG004|Overall Study|e.g., change in circumstances|4
7394476|NCT01264770|11656384|FG005|Overall Study|e.g., change in circumstances|4
7394477|NCT01264770|11656379|FG000|Overall Study|Severe non-compliance to protocol|0
7394478|NCT01264770|11656380|FG001|Overall Study|Severe non-compliance to protocol|0
7394479|NCT01264770|11656381|FG002|Overall Study|Severe non-compliance to protocol|1
7394480|NCT01264770|11656382|FG003|Overall Study|Severe non-compliance to protocol|1
7394481|NCT01264770|11656383|FG004|Overall Study|Severe non-compliance to protocol|0
7394482|NCT01264770|11656384|FG005|Overall Study|Severe non-compliance to protocol|0
7394483|NCT01264770|11656379|FG000|Overall Study|Lack of therapeutic response|1
7394484|NCT01264770|11656380|FG001|Overall Study|Lack of therapeutic response|0
7394485|NCT01264770|11656381|FG002|Overall Study|Lack of therapeutic response|2
7394486|NCT01264770|11656382|FG003|Overall Study|Lack of therapeutic response|1
7394487|NCT01264770|11656383|FG004|Overall Study|Lack of therapeutic response|1
7394488|NCT01264770|11656384|FG005|Overall Study|Lack of therapeutic response|0
7394489|NCT01264770|11656379|FG000|Overall Study|Dev. of study specific discont. criteria|2
7394490|NCT01264770|11656380|FG001|Overall Study|Dev. of study specific discont. criteria|0
7394491|NCT01264770|11656381|FG002|Overall Study|Dev. of study specific discont. criteria|0
7394492|NCT01264770|11656382|FG003|Overall Study|Dev. of study specific discont. criteria|0
7394493|NCT01264770|11656383|FG004|Overall Study|Dev. of study specific discont. criteria|1
7394494|NCT01264770|11656384|FG005|Overall Study|Dev. of study specific discont. criteria|1
7394495|NCT01264770|11656379|FG000|Overall Study|Lost to Follow-up|0
7394496|NCT01264770|11656380|FG001|Overall Study|Lost to Follow-up|0
7394497|NCT01264770|11656381|FG002|Overall Study|Lost to Follow-up|1
7394498|NCT01264770|11656382|FG003|Overall Study|Lost to Follow-up|1
7394499|NCT01264770|11656383|FG004|Overall Study|Lost to Follow-up|0
7394500|NCT01264770|11656384|FG005|Overall Study|Lost to Follow-up|0
7394501|NCT01264770|11656379|FG000|Overall Study|Adverse Event|7
7394502|NCT01264770|11656380|FG001|Overall Study|Adverse Event|7
7394503|NCT01264770|11656381|FG002|Overall Study|Adverse Event|8
7394504|NCT01264770|11656382|FG003|Overall Study|Adverse Event|0
7394505|NCT01264770|11656383|FG004|Overall Study|Adverse Event|2
7394506|NCT01264770|11656384|FG005|Overall Study|Adverse Event|1
7394507|NCT01264887|11656404|FG000|Overall Study|Adverse Event|5
7394508|NCT01264887|11656404|FG000|Overall Study|Death|7
7394509|NCT01264887|11656404|FG000|Overall Study|Lack of Efficacy|5
7394510|NCT01264887|11656404|FG000|Overall Study|Physician Decision|4
7394511|NCT01264887|11656404|FG000|Overall Study|Withdrawal by Subject|6
7394512|NCT01264887|11656404|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
7394513|NCT01264887|11656404|FG000|Overall Study|Other|2
7394514|NCT01264939|11656412|FG000|Overall Study|Adverse Event|1
7394515|NCT01264939|11656413|FG001|Overall Study|Adverse Event|3
7394516|NCT01264939|11656412|FG000|Overall Study|Lost to Follow-up|0
7394517|NCT01264939|11656413|FG001|Overall Study|Lost to Follow-up|3
7394518|NCT01264939|11656412|FG000|Overall Study|Physician Decision|1
7394519|NCT01264939|11656413|FG001|Overall Study|Physician Decision|1
7394520|NCT01264939|11656412|FG000|Overall Study|Patient/Guardian Decision|8
7394521|NCT01264939|11656413|FG001|Overall Study|Patient/Guardian Decision|10
7394522|NCT01264939|11656412|FG000|Overall Study|Disease Progression|8
7394523|NCT01264939|11656413|FG001|Overall Study|Disease Progression|11
7394524|NCT01265056|11656434|FG000|Initial Study Period|Withdrawal by Subject|1
7394525|NCT01265056|11656435|FG001|Initial Study Period|Withdrawal by Subject|1
7394526|NCT01265056|11656434|FG000|Initial Study Period|Withdrawal by Subject|1
7394527|NCT01265056|11656435|FG001|Initial Study Period|Withdrawal by Subject|1
7394528|NCT01265056|11656434|FG000|Follow up|Lost to Follow-up|7
7394529|NCT01265056|11656435|FG001|Follow up|Lost to Follow-up|3
7394530|NCT01265394|11656441|FG000|Overall Study|Subjects withdrawn|37
7394531|NCT01265420|11656446|FG000|Overall Study|Lost to Follow-up|1
7394532|NCT01265498|11656486|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
7394533|NCT01265498|11656487|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
7394534|NCT01265511|11656495|FG000|Overall Study|Lack of Efficacy|2
7394535|NCT01265511|11656496|FG001|Overall Study|Lack of Efficacy|1
7394536|NCT01265511|11656495|FG000|Overall Study|Met stopping rules|0
7394537|NCT01265511|11656496|FG001|Overall Study|Met stopping rules|2
7394538|NCT01265537|11656513|FG000|Overall Study|Adverse Event|2
7394539|NCT01265537|11656514|FG001|Overall Study|Adverse Event|1
7394540|NCT01265537|11656513|FG000|Overall Study|Physician Decision|0
7394541|NCT01265537|11656514|FG001|Overall Study|Physician Decision|1
7394542|NCT01265550|11656524|FG000|Pre Randomization|Withdrawal by Subject|0
7394543|NCT01265550|11656525|FG001|Pre Randomization|Withdrawal by Subject|0
7394544|NCT01265550|11656526|FG002|Pre Randomization|Withdrawal by Subject|0
7394545|NCT01265550|11656527|FG003|Pre Randomization|Withdrawal by Subject|70
7394546|NCT01265550|11656524|FG000|Pre Randomization|Technical Exclusions|0
7394547|NCT01265550|11656525|FG001|Pre Randomization|Technical Exclusions|0
7394548|NCT01265550|11656526|FG002|Pre Randomization|Technical Exclusions|0
7394549|NCT01265550|11656527|FG003|Pre Randomization|Technical Exclusions|54
7394550|NCT01265550|11656524|FG000|Pre Randomization|GERD, PPI-Responsive|0
7394551|NCT01265550|11656525|FG001|Pre Randomization|GERD, PPI-Responsive|0
7394552|NCT01265550|11656526|FG002|Pre Randomization|GERD, PPI-Responsive|0
7394553|NCT01265550|11656527|FG003|Pre Randomization|GERD, PPI-Responsive|42
7394554|NCT01265550|11656524|FG000|Pre Randomization|Non-GERD organic disorders|0
7394555|NCT01265550|11656525|FG001|Pre Randomization|Non-GERD organic disorders|0
7394556|NCT01265550|11656526|FG002|Pre Randomization|Non-GERD organic disorders|0
7394557|NCT01265550|11656527|FG003|Pre Randomization|Non-GERD organic disorders|23
7394558|NCT01265550|11656524|FG000|Pre Randomization|Functional heartburn|0
7394559|NCT01265550|11656525|FG001|Pre Randomization|Functional heartburn|0
7394560|NCT01265550|11656526|FG002|Pre Randomization|Functional heartburn|0
7394561|NCT01265550|11656527|FG003|Pre Randomization|Functional heartburn|99
7394562|NCT01265563|11656546|FG000|Overall Study|Withdrawal by Subject|0
7394563|NCT01265563|11656547|FG001|Overall Study|Withdrawal by Subject|1
7394564|NCT01265563|11656548|FG002|Overall Study|Withdrawal by Subject|1
7394565|NCT01265563|11656549|FG003|Overall Study|Withdrawal by Subject|0
7394566|NCT01265563|11656550|FG004|Overall Study|Withdrawal by Subject|2
7394567|NCT01265615|11656571|FG000|Overall Study|Protocol Violation|2
7394568|NCT01265615|11656572|FG001|Overall Study|Protocol Violation|2
7394569|NCT01265615|11656573|FG002|Overall Study|Protocol Violation|4
7394570|NCT01265615|11656574|FG003|Overall Study|Protocol Violation|3
7394571|NCT01265719|11656595|FG000|Overall Study|Does not meet entrance criteria|0
7394572|NCT01265719|11656596|FG001|Overall Study|Does not meet entrance criteria|3
7394573|NCT01265719|11656595|FG000|Overall Study|Other reasons|2
7394574|NCT01265719|11656596|FG001|Overall Study|Other reasons|0
7471112|NCT01939197|11773785|FG000|Overall Study|Lost to Follow-up|0
7394575|NCT01265719|11656595|FG000|Overall Study|Withdrawal by Subject|8
7394576|NCT01265719|11656596|FG001|Overall Study|Withdrawal by Subject|3
7394577|NCT01265719|11656595|FG000|Overall Study|Lost to Follow-up|2
7394578|NCT01265719|11656596|FG001|Overall Study|Lost to Follow-up|7
7394579|NCT01265719|11656595|FG000|Overall Study|Adverse Event|2
7394580|NCT01265719|11656596|FG001|Overall Study|Adverse Event|0
7394581|NCT01265797|11656604|FG000|Run-in Month|Withdrawal by Subject|0
7394582|NCT01265797|11656605|FG001|Run-in Month|Withdrawal by Subject|4
7394583|NCT01265797|11656604|FG000|Run-in Month|1st seizure during run-in month|0
7394584|NCT01265797|11656605|FG001|Run-in Month|1st seizure during run-in month|1
7394585|NCT01265797|11656604|FG000|Blinded Month|Lack of Efficacy|5
7394586|NCT01265797|11656605|FG001|Blinded Month|Lack of Efficacy|0
7394587|NCT01265797|11656604|FG000|Blinded Month|Lost to Follow-up|1
7394588|NCT01265797|11656605|FG001|Blinded Month|Lost to Follow-up|0
7394589|NCT01265797|11656604|FG000|Blinded Month|Protocol Violation|2
7394590|NCT01265797|11656605|FG001|Blinded Month|Protocol Violation|1
7394591|NCT01265797|11656604|FG000|Blinded Month|Adverse Event|2
7394592|NCT01265797|11656605|FG001|Blinded Month|Adverse Event|0
7394593|NCT01265797|11656604|FG000|Blinded Month|Diary data incomplete|0
7394594|NCT01265797|11656605|FG001|Blinded Month|Diary data incomplete|1
7394595|NCT01265797|11656604|FG000|Open Label Month|Lost to Follow-up|0
7394596|NCT01265797|11656605|FG001|Open Label Month|Lost to Follow-up|1
7471113|NCT01939197|11773786|FG001|Overall Study|Lost to Follow-up|1
7394597|NCT01265823|11656613|FG000|Overall Study|Unsatisfactory Response Efficacy|1
7394598|NCT01265823|11656613|FG000|Overall Study|Failure to Return|4
7471114|NCT01939197|11773787|FG002|Overall Study|Lost to Follow-up|0
7394599|NCT01265823|11656613|FG000|Overall Study|Protocol Violation|1
7394600|NCT01265823|11656613|FG000|Overall Study|Participant Request|1
7394601|NCT01265875|11656621|FG000|Overall Study|Uncooperative/unreliable|1
7394602|NCT01265953|11656628|FG000|Overall Study|Non compliance|5
7394603|NCT01265953|11656629|FG001|Overall Study|Non compliance|3
7394604|NCT01265992|11656648|FG000|Overall Study|Lost to Follow-up|1
7394605|NCT01265992|11656648|FG000|Overall Study|Withdrawal by Subject|1
7394606|NCT01265992|11656648|FG000|Overall Study|Adverse Event|1
7394607|NCT01265992|11656648|FG000|Overall Study|Administrative reasons|2
7394608|NCT01265992|11656648|FG000|Overall Study|Stopped treatment|3
7394609|NCT01265992|11656648|FG000|Overall Study|Did not receive treatment|1
7394610|NCT01266018|11656652|FG000|Overall Study|Physician Decision|1
7394611|NCT01266018|11656653|FG001|Overall Study|Physician Decision|0
7394612|NCT01266018|11656652|FG000|Overall Study|Progressive disease|0
7394613|NCT01266018|11656653|FG001|Overall Study|Progressive disease|1
7394614|NCT01266070|11656659|FG000|Overall Study|Adverse Event|3
7394615|NCT01266070|11656659|FG000|Overall Study|Protocol Violation|1
7394616|NCT01266122|11656665|FG000|Overall Study|Lost to Follow-up|6
7394617|NCT01266122|11656666|FG001|Overall Study|Lost to Follow-up|6
7394618|NCT01266148|11656674|FG000|Overall Study|Adverse Event|2
7394619|NCT01266148|11656675|FG001|Overall Study|Adverse Event|0
7394620|NCT01266148|11656674|FG000|Overall Study|Ongoing rejection|1
7394621|NCT01266148|11656675|FG001|Overall Study|Ongoing rejection|0
7394622|NCT01266148|11656674|FG000|Overall Study|2 2R rejections|1
7394623|NCT01266148|11656675|FG001|Overall Study|2 2R rejections|0
7394624|NCT01266148|11656674|FG000|Overall Study|Death|2
7394625|NCT01266148|11656675|FG001|Overall Study|Death|3
7394626|NCT01266148|11656674|FG000|Overall Study|missing mGFR value + AE|1
7394627|NCT01266148|11656675|FG001|Overall Study|missing mGFR value + AE|0
7394628|NCT01266161|11656683|FG000|Overall Study|Ineligible|1
7394629|NCT01266161|11656684|FG001|Overall Study|Ineligible|0
7394630|NCT01266161|11656683|FG000|Overall Study|Lack of Efficacy|0
7394631|NCT01266161|11656684|FG001|Overall Study|Lack of Efficacy|1
7394632|NCT01266161|11656683|FG000|Overall Study|Vomited within 4 hours of dosing|3
7394633|NCT01266161|11656684|FG001|Overall Study|Vomited within 4 hours of dosing|0
7394634|NCT01266265|11656692|FG000|Overall Study|Death|95
7394635|NCT01266265|11656693|FG001|Overall Study|Death|73
7394636|NCT01266265|11656692|FG000|Overall Study|Lost to Follow-up|23
7394637|NCT01266265|11656693|FG001|Overall Study|Lost to Follow-up|28
7394638|NCT01266265|11656692|FG000|Overall Study|Withdrawal by Subject|13
7394639|NCT01266265|11656693|FG001|Overall Study|Withdrawal by Subject|11
7394640|NCT01266265|11656692|FG000|Overall Study|Respiratory-related adverse event|2
7394641|NCT01266265|11656693|FG001|Overall Study|Respiratory-related adverse event|1
7394642|NCT01266265|11656692|FG000|Overall Study|Transferred care to another provider|22
7394643|NCT01266265|11656693|FG001|Overall Study|Transferred care to another provider|28
7394644|NCT01266265|11656692|FG000|Overall Study|Stopped/changed PAH medication(s)|16
7394645|NCT01266265|11656693|FG001|Overall Study|Stopped/changed PAH medication(s)|9
7394646|NCT01266265|11656692|FG000|Overall Study|Enrolled in another clinical study|15
7394647|NCT01266265|11656693|FG001|Overall Study|Enrolled in another clinical study|26
7394648|NCT01266265|11656692|FG000|Overall Study|Non-compliance|8
7394649|NCT01266265|11656693|FG001|Overall Study|Non-compliance|5
7394650|NCT01266265|11656692|FG000|Overall Study|Lung transplant|6
7394651|NCT01266265|11656693|FG001|Overall Study|Lung transplant|5
7394652|NCT01266265|11656692|FG000|Overall Study|Site closed early|4
7394653|NCT01266265|11656693|FG001|Overall Study|Site closed early|3
7394654|NCT01266265|11656692|FG000|Overall Study|Clinical worsening|1
7394655|NCT01266265|11656693|FG001|Overall Study|Clinical worsening|1
7394656|NCT01266291|11656699|FG000|Overall Study|Adverse Event|1
7394657|NCT01266317|11656703|FG000|Overall Study|Withdrawal by Subject|2
7394658|NCT01266460|11656711|FG000|Overall Study|Adverse Event|3
7394659|NCT01266460|11656711|FG000|Overall Study|Withdrawal by Subject|5
7394660|NCT01266460|11656711|FG000|Overall Study|Disease Progression|18
7394661|NCT01266460|11656711|FG000|Overall Study|Not otherwise specified|8
7394662|NCT01266590|11656715|FG000|Overall Study|Adverse Event|3
7394663|NCT01266590|11656715|FG000|Overall Study|Lost to Follow-up|1
7394664|NCT01266590|11656715|FG000|Overall Study|Withdrawal by Subject|1
7394665|NCT01266590|11656715|FG000|Overall Study|Physician Decision|1
7394666|NCT01266603|11656722|FG000|Overall Study|Adverse Event|1
7394667|NCT01266603|11656722|FG000|Overall Study|Lack of Efficacy|14
7394668|NCT01266603|11656722|FG000|Overall Study|Withdrawal by Subject|1
7394669|NCT01266603|11656722|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
7394670|NCT01266642|11656728|FG000|Overall Study|Protocol Violation|0
7394671|NCT01266642|11656729|FG001|Overall Study|Protocol Violation|1
7394672|NCT01266850|11656740|FG000|Overall Study|Lost to Follow-up|19
7394673|NCT01266850|11656741|FG001|Overall Study|Lost to Follow-up|19
7394674|NCT01266850|11656742|FG002|Overall Study|Lost to Follow-up|13
7394675|NCT01266850|11656743|FG003|Overall Study|Lost to Follow-up|13
7394676|NCT01266850|11656744|FG004|Overall Study|Lost to Follow-up|12
7394677|NCT01266850|11656740|FG000|Overall Study|Withdrawal by Subject|8
7394678|NCT01266850|11656741|FG001|Overall Study|Withdrawal by Subject|9
7394679|NCT01266850|11656742|FG002|Overall Study|Withdrawal by Subject|6
7394680|NCT01266850|11656743|FG003|Overall Study|Withdrawal by Subject|9
7394681|NCT01266850|11656744|FG004|Overall Study|Withdrawal by Subject|12
7394682|NCT01266850|11656740|FG000|Overall Study|Physician Decision|3
7394683|NCT01266850|11656741|FG001|Overall Study|Physician Decision|6
7394684|NCT01266850|11656742|FG002|Overall Study|Physician Decision|4
7394685|NCT01266850|11656743|FG003|Overall Study|Physician Decision|4
7394686|NCT01266850|11656744|FG004|Overall Study|Physician Decision|3
7394687|NCT01266850|11656740|FG000|Overall Study|Protocol Violation|0
7394688|NCT01266850|11656741|FG001|Overall Study|Protocol Violation|1
7394689|NCT01266850|11656742|FG002|Overall Study|Protocol Violation|0
7394690|NCT01266850|11656743|FG003|Overall Study|Protocol Violation|1
7394691|NCT01266850|11656744|FG004|Overall Study|Protocol Violation|2
7394692|NCT01266850|11656740|FG000|Overall Study|Adverse Event|0
7394693|NCT01266850|11656741|FG001|Overall Study|Adverse Event|0
7394694|NCT01266850|11656742|FG002|Overall Study|Adverse Event|0
7394695|NCT01266850|11656743|FG003|Overall Study|Adverse Event|0
7394696|NCT01266850|11656744|FG004|Overall Study|Adverse Event|1
7394697|NCT01266850|11656740|FG000|Overall Study|Site Closure|0
7394698|NCT01266850|11656741|FG001|Overall Study|Site Closure|1
7394699|NCT01266850|11656742|FG002|Overall Study|Site Closure|1
7394700|NCT01266850|11656743|FG003|Overall Study|Site Closure|1
7394701|NCT01266850|11656744|FG004|Overall Study|Site Closure|0
7394702|NCT01266876|11656761|FG000|Overall Study|Adverse Event|0
7394703|NCT01266876|11656762|FG001|Overall Study|Adverse Event|0
7394704|NCT01266876|11656763|FG002|Overall Study|Adverse Event|0
7394705|NCT01266876|11656764|FG003|Overall Study|Adverse Event|1
7394706|NCT01266876|11656765|FG004|Overall Study|Adverse Event|0
7394707|NCT01266902|11656779|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
7394708|NCT01266902|11656780|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
7394709|NCT01266902|11656781|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
7394710|NCT01266902|11656779|FG000|Period 1 (Main Study)|Lost to Follow-up|5
7394711|NCT01266902|11656780|FG001|Period 1 (Main Study)|Lost to Follow-up|12
7394712|NCT01266902|11656781|FG002|Period 1 (Main Study)|Lost to Follow-up|0
7394713|NCT01266902|11656779|FG000|Period 1 (Main Study)|Lack of Efficacy|4
7394714|NCT01266902|11656780|FG001|Period 1 (Main Study)|Lack of Efficacy|2
7394715|NCT01266902|11656781|FG002|Period 1 (Main Study)|Lack of Efficacy|0
7394716|NCT01266902|11656779|FG000|Period 1 (Main Study)|Adverse Event|3
7394717|NCT01266902|11656780|FG001|Period 1 (Main Study)|Adverse Event|11
7394718|NCT01266902|11656781|FG002|Period 1 (Main Study)|Adverse Event|0
7394719|NCT01266902|11656779|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
7394720|NCT01266902|11656780|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
7394721|NCT01266902|11656781|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
7394722|NCT01266902|11656779|FG000|Period 1 (Main Study)|Subject non-compliant|3
7394723|NCT01266902|11656780|FG001|Period 1 (Main Study)|Subject non-compliant|7
7394724|NCT01266902|11656781|FG002|Period 1 (Main Study)|Subject non-compliant|0
7394725|NCT01266902|11656779|FG000|Period 1 (Main Study)|Continued RPV treatment|11
7394726|NCT01266902|11656780|FG001|Period 1 (Main Study)|Continued RPV treatment|34
7394727|NCT01266902|11656781|FG002|Period 1 (Main Study)|Continued RPV treatment|0
7394728|NCT01266902|11656779|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7394729|NCT01266902|11656780|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
7394730|NCT01266902|11656781|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
7394731|NCT01266902|11656779|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7394732|NCT01266902|11656780|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
7394733|NCT01266902|11656781|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
7394734|NCT01266902|11656779|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7394735|NCT01266902|11656780|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
7394736|NCT01266902|11656781|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
7394737|NCT01266967|11656791|FG000|Overall Study|Death|69
7394738|NCT01266967|11656792|FG001|Overall Study|Death|61
7394739|NCT01266967|11656791|FG000|Overall Study|Study Closed/Terminated|15
7394740|NCT01266967|11656792|FG001|Overall Study|Study Closed/Terminated|17
7394741|NCT01266967|11656791|FG000|Overall Study|Lost to Follow-up|2
7394742|NCT01266967|11656792|FG001|Overall Study|Lost to Follow-up|1
7394743|NCT01266967|11656791|FG000|Overall Study|Physician Decision|0
7394744|NCT01266967|11656792|FG001|Overall Study|Physician Decision|1
7394745|NCT01266967|11656791|FG000|Overall Study|Withdrawal by Subject|3
7394746|NCT01266967|11656792|FG001|Overall Study|Withdrawal by Subject|3
7394747|NCT01266993|11656803|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
7394748|NCT01266993|11656804|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
7394749|NCT01266993|11656803|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
7394750|NCT01266993|11656804|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
7394751|NCT01267175|11656844|FG000|Overall Study|Withdrawal by Subject|1
7394752|NCT01267175|11656844|FG000|Overall Study|Lost to Follow-up|1
7394753|NCT01267201|11656848|FG000|First Intervention Period|Withdrawal by Subject|1
7394754|NCT01267201|11656849|FG001|First Intervention Period|Withdrawal by Subject|0
7394755|NCT01267201|11656850|FG002|First Intervention Period|Withdrawal by Subject|0
7394756|NCT01267201|11656851|FG003|First Intervention Period|Withdrawal by Subject|0
7394757|NCT01267201|11656852|FG004|First Intervention Period|Withdrawal by Subject|0
7394758|NCT01267201|11656853|FG005|First Intervention Period|Withdrawal by Subject|0
7394759|NCT01267201|11656848|FG000|Second Intervention Period|Withdrawal by Subject|0
7394760|NCT01267201|11656849|FG001|Second Intervention Period|Withdrawal by Subject|1
7394761|NCT01267201|11656850|FG002|Second Intervention Period|Withdrawal by Subject|0
7394762|NCT01267201|11656851|FG003|Second Intervention Period|Withdrawal by Subject|0
7394763|NCT01267201|11656852|FG004|Second Intervention Period|Withdrawal by Subject|0
7394764|NCT01267201|11656853|FG005|Second Intervention Period|Withdrawal by Subject|0
7394765|NCT01267253|11656886|FG000|Overall Study|Ineligible - required test not done|1
7394766|NCT01267253|11656886|FG000|Overall Study|Inevaluable-never received study treatme|2
7394767|NCT01267266|11656890|FG000|Enrollment Phase|Withdrawal by Subject|2
7394768|NCT01267266|11656891|FG001|Enrollment Phase|Withdrawal by Subject|0
7394769|NCT01267266|11656890|FG000|Lead-in Phase|Lack of Efficacy|20
7394770|NCT01267266|11656891|FG001|Lead-in Phase|Lack of Efficacy|0
7394771|NCT01267266|11656890|FG000|Lead-in Phase|Adverse Event|2
7394772|NCT01267266|11656891|FG001|Lead-in Phase|Adverse Event|0
7394773|NCT01267266|11656890|FG000|Lead-in Phase|Withdrawal by Subject|1
7394774|NCT01267266|11656891|FG001|Lead-in Phase|Withdrawal by Subject|0
7394775|NCT01267994|11656966|FG000|Overall Study|Adverse Event|2
7394776|NCT01268046|11656975|FG000|Overall Study|Withdrawal by Subject|1
7394777|NCT01268046|11656976|FG001|Overall Study|Withdrawal by Subject|0
7394778|NCT01268046|11656977|FG002|Overall Study|Withdrawal by Subject|0
7394779|NCT01268046|11656978|FG003|Overall Study|Withdrawal by Subject|1
7394780|NCT01268046|11656975|FG000|Overall Study|Lost to Follow-up|0
7394781|NCT01268046|11656976|FG001|Overall Study|Lost to Follow-up|0
7394782|NCT01268046|11656977|FG002|Overall Study|Lost to Follow-up|1
7394783|NCT01268046|11656978|FG003|Overall Study|Lost to Follow-up|0
7394784|NCT01268059|11656992|FG000|Overall Study|Lost to Follow-up|0
7394785|NCT01268059|11656993|FG001|Overall Study|Lost to Follow-up|1
7394786|NCT01268059|11656994|FG002|Overall Study|Lost to Follow-up|0
7394787|NCT01268059|11656995|FG003|Overall Study|Lost to Follow-up|0
7394788|NCT01268059|11656992|FG000|Overall Study|Withdrawal by Subject|7
7394789|NCT01268059|11656993|FG001|Overall Study|Withdrawal by Subject|4
7394790|NCT01268059|11656994|FG002|Overall Study|Withdrawal by Subject|0
7394791|NCT01268059|11656995|FG003|Overall Study|Withdrawal by Subject|0
7394792|NCT01268059|11656992|FG000|Overall Study|Death|20
7394793|NCT01268059|11656993|FG001|Overall Study|Death|30
7394794|NCT01268059|11656994|FG002|Overall Study|Death|3
7394795|NCT01268059|11656995|FG003|Overall Study|Death|5
7394796|NCT01268059|11656992|FG000|Overall Study|Progression of disease|1
7394797|NCT01268059|11656993|FG001|Overall Study|Progression of disease|0
7394798|NCT01268059|11656994|FG002|Overall Study|Progression of disease|0
7394799|NCT01268059|11656995|FG003|Overall Study|Progression of disease|0
7394800|NCT01268098|11657010|FG000|Overall Study|Adverse Event|1
7394801|NCT01268098|11657011|FG001|Overall Study|Adverse Event|0
7394802|NCT01268150|11657026|FG000|Treatment Phase|Progression of disease|18
7394803|NCT01268150|11657026|FG000|Treatment Phase|Adverse Event|3
7394804|NCT01268150|11657026|FG000|Treatment Phase|Withdrawal by Subject|3
7394805|NCT01268150|11657026|FG000|Treatment Phase|Other|4
7394806|NCT01268150|11657026|FG000|Extension Phase|Adverse Event|3
7394807|NCT01268150|11657026|FG000|Extension Phase|Disease progression|18
7394808|NCT01268150|11657026|FG000|Extension Phase|Other|6
7394809|NCT01268267|11657036|FG000|Overall Study|Protocol Violation|1
7394810|NCT01268293|11657041|FG000|Overall Study|Disease progression|7
7394811|NCT01268293|11657041|FG000|Overall Study|Adverse Event|1
7394812|NCT01268293|11657041|FG000|Overall Study|Subject choice|1
7394813|NCT01268306|11657045|FG000|Overall Study|Lost to Follow-up|1
7394814|NCT01268488|11657049|FG000|Overall Study|Adverse Event|3
7394815|NCT01268488|11657049|FG000|Overall Study|Physician Decision|2
7394816|NCT01268501|11657054|FG000|Overall Study|Lost to Follow-up|1
7394817|NCT01268501|11657054|FG000|Overall Study|Withdrawal by Subject|3
7394818|NCT01268501|11657054|FG000|Overall Study|Unacceptable Subjective Vision|3
7394819|NCT01268501|11657054|FG000|Overall Study|Handling Difficulties|2
7394820|NCT01268514|11657058|FG000|Overall Study|Adverse Event|20
7394821|NCT01268514|11657058|FG000|Overall Study|Death|8
7394822|NCT01268514|11657058|FG000|Overall Study|Lost to Follow-up|5
7394823|NCT01268514|11657058|FG000|Overall Study|Withdrawal by Subject|3
7394824|NCT01268514|11657058|FG000|Overall Study|Withdrawal by Surgeon|5
7394825|NCT01268566|11657090|FG000|Overall Study|Lost to Follow-up|1
7394826|NCT01268566|11657090|FG000|Overall Study|Withdrawal by Subject|12
7394827|NCT01268566|11657090|FG000|Overall Study|Death|30
7394828|NCT01268683|11657101|FG000|Overall Study|Lost to Follow-up|1
7394829|NCT01268683|11657101|FG000|Overall Study|Death|1
7394830|NCT01268891|11657107|FG000|Overall Study|Adverse Event|3
7394831|NCT01268891|11657108|FG001|Overall Study|Adverse Event|7
7394832|NCT01268891|11657107|FG000|Overall Study|Lack of Efficacy|1
7394833|NCT01268891|11657108|FG001|Overall Study|Lack of Efficacy|0
7394834|NCT01268891|11657107|FG000|Overall Study|Withdrawal of Consent|3
7394835|NCT01268891|11657108|FG001|Overall Study|Withdrawal of Consent|1
7394836|NCT01268891|11657107|FG000|Overall Study|Administrative or other reason(s)|1
7394837|NCT01268891|11657108|FG001|Overall Study|Administrative or other reason(s)|0
7394838|NCT01269125|11657149|FG000|Overall Study|Adverse Event|3
7394839|NCT01269125|11657150|FG001|Overall Study|Adverse Event|5
7394840|NCT01269125|11657151|FG002|Overall Study|Adverse Event|0
7394841|NCT01269125|11657149|FG000|Overall Study|Lost to Follow-up|4
7394842|NCT01269125|11657150|FG001|Overall Study|Lost to Follow-up|0
7394843|NCT01269125|11657151|FG002|Overall Study|Lost to Follow-up|0
7394844|NCT01269346|11657159|FG000|Treatment Phase|Disease progression|3
7394845|NCT01269346|11657159|FG000|Treatment Phase|Adverse Event|3
7394846|NCT01269346|11657159|FG000|Treatment Phase|Withdrawal by Subject|1
7394847|NCT01269346|11657159|FG000|Treatment Phase|Other|2
7394848|NCT01269346|11657159|FG000|Extension Phase|Adverse Event|6
7394849|NCT01269346|11657159|FG000|Extension Phase|Withdrawal by Subject|4
7394850|NCT01269346|11657159|FG000|Extension Phase|Disease progression|22
7394851|NCT01269346|11657159|FG000|Extension Phase|Physician decision or participant choice|9
7394852|NCT01269346|11657159|FG000|Extension Phase|Clinical progression|1
7394853|NCT01269346|11657159|FG000|Extension Phase|Started a prohibited con med|1
7394854|NCT01269385|11657173|FG000|Overall Study|Adverse Event|1
7394855|NCT01269385|11657174|FG001|Overall Study|Adverse Event|1
7394856|NCT01269385|11657175|FG002|Overall Study|Adverse Event|0
7394857|NCT01269385|11657176|FG003|Overall Study|Adverse Event|0
7394858|NCT01269918|11657212|FG000|Overall Study|Did not receive study drug|0
7394859|NCT01269918|11657213|FG001|Overall Study|Did not receive study drug|3
7394860|NCT01270139|11657231|FG000|Overall Study|Adverse Event|8
7394861|NCT01270139|11657232|FG001|Overall Study|Adverse Event|17
7394862|NCT01270139|11657233|FG002|Overall Study|Adverse Event|18
7394863|NCT01270139|11657231|FG000|Overall Study|Lost to Follow-up|10
7394864|NCT01270139|11657232|FG001|Overall Study|Lost to Follow-up|9
7394865|NCT01270139|11657233|FG002|Overall Study|Lost to Follow-up|2
7394866|NCT01270256|11657250|FG000|Overall Study|Withdrawal by Subject|1
7394867|NCT01270256|11657251|FG001|Overall Study|Withdrawal by Subject|0
7394868|NCT01270321|11657260|FG000|Overall Study|Death|3
7394869|NCT01270321|11657261|FG001|Overall Study|Death|1
7394870|NCT01270321|11657262|FG002|Overall Study|Death|4
7394871|NCT01270321|11657260|FG000|Overall Study|Adverse Event|7
7394872|NCT01270321|11657261|FG001|Overall Study|Adverse Event|9
7394873|NCT01270321|11657262|FG002|Overall Study|Adverse Event|5
7394874|NCT01270464|11657273|FG000|Overall Study|Protocol Violation|4
7394875|NCT01270464|11657274|FG001|Overall Study|Protocol Violation|3
7394876|NCT01270464|11657275|FG002|Overall Study|Protocol Violation|2
7394877|NCT01270464|11657273|FG000|Overall Study|Lack of Efficacy|2
7394878|NCT01270464|11657274|FG001|Overall Study|Lack of Efficacy|3
7394879|NCT01270464|11657275|FG002|Overall Study|Lack of Efficacy|1
7394880|NCT01270464|11657273|FG000|Overall Study|Adverse Event|9
7394881|NCT01270464|11657274|FG001|Overall Study|Adverse Event|1
7394882|NCT01270464|11657275|FG002|Overall Study|Adverse Event|7
7394883|NCT01270464|11657273|FG000|Overall Study|Withdrawal by Subject|2
7394884|NCT01270464|11657274|FG001|Overall Study|Withdrawal by Subject|1
7394885|NCT01270464|11657275|FG002|Overall Study|Withdrawal by Subject|4
7394886|NCT01270464|11657273|FG000|Overall Study|Lost to Follow-up|2
7394887|NCT01270464|11657274|FG001|Overall Study|Lost to Follow-up|3
7394888|NCT01270464|11657275|FG002|Overall Study|Lost to Follow-up|1
7394889|NCT01270464|11657273|FG000|Overall Study|Other|1
7394890|NCT01270464|11657274|FG001|Overall Study|Other|1
7394891|NCT01270464|11657275|FG002|Overall Study|Other|3
7465344|NCT03401112|11764563|FG000|Overall Study|Study was Terminated by Sponsor|0
7465345|NCT03401112|11764564|FG001|Overall Study|Study was Terminated by Sponsor|0
7465346|NCT03401112|11764565|FG002|Overall Study|Study was Terminated by Sponsor|0
7465347|NCT03401112|11764566|FG003|Overall Study|Study was Terminated by Sponsor|1
7465348|NCT03401112|11764567|FG004|Overall Study|Study was Terminated by Sponsor|0
7465349|NCT03401112|11764563|FG000|Overall Study|Day 1 Assessment not Done|1
7465350|NCT03401112|11764564|FG001|Overall Study|Day 1 Assessment not Done|0
7465351|NCT03401112|11764565|FG002|Overall Study|Day 1 Assessment not Done|0
7465352|NCT03401112|11764566|FG003|Overall Study|Day 1 Assessment not Done|0
7465353|NCT03401112|11764567|FG004|Overall Study|Day 1 Assessment not Done|0
7465354|NCT03401112|11764563|FG000|Overall Study|Not Dosed|0
7465355|NCT03401112|11764564|FG001|Overall Study|Not Dosed|0
7465356|NCT03401112|11764565|FG002|Overall Study|Not Dosed|1
7465357|NCT03401112|11764566|FG003|Overall Study|Not Dosed|0
7465358|NCT03401112|11764567|FG004|Overall Study|Not Dosed|0
7465359|NCT03401112|11764563|FG000|Overall Study|Missed Clinical Visit|0
7465360|NCT03401112|11764564|FG001|Overall Study|Missed Clinical Visit|0
7465361|NCT03401112|11764565|FG002|Overall Study|Missed Clinical Visit|1
7465362|NCT03401112|11764566|FG003|Overall Study|Missed Clinical Visit|0
7465363|NCT03401112|11764567|FG004|Overall Study|Missed Clinical Visit|0
7465364|NCT03401112|11764563|FG000|Overall Study|Missed Doses|0
7465365|NCT03401112|11764564|FG001|Overall Study|Missed Doses|0
7465366|NCT03401112|11764565|FG002|Overall Study|Missed Doses|1
7465367|NCT03401112|11764566|FG003|Overall Study|Missed Doses|0
7465368|NCT03401112|11764567|FG004|Overall Study|Missed Doses|0
7465369|NCT03041701|11764605|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7465370|NCT03041701|11764606|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
7465371|NCT03041701|11764607|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0
7465372|NCT03041701|11764605|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7465373|NCT03041701|11764606|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
7465374|NCT03041701|11764607|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1
7465375|NCT03000179|11764618|FG000|Overall Study|Lost to Follow-up|2
7465376|NCT02876835|11764624|FG000|Treatment Period (51.1 Month)|Other|1
7465377|NCT02876835|11764625|FG001|Treatment Period (51.1 Month)|Other|0
7465378|NCT02876835|11764624|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6
7465379|NCT02876835|11764625|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13
7465380|NCT02876835|11764624|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32
7465381|NCT02876835|11764625|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23
7394892|NCT01270503|11657283|FG000|Overall Study|Lost to Follow-up|1
7394893|NCT01270620|11657333|FG000|Overall Study|Withdrawal by Subject|1
7394894|NCT01270620|11657334|FG001|Overall Study|Withdrawal by Subject|3
7394895|NCT01270802|11657399|FG000|Overall Study|Withdrawal by Subject|1
7394896|NCT01270802|11657400|FG001|Overall Study|Withdrawal by Subject|0
7394897|NCT01270802|11657399|FG000|Overall Study|Adverse Event|1
7394898|NCT01270802|11657400|FG001|Overall Study|Adverse Event|0
7394899|NCT01270802|11657399|FG000|Overall Study|Lost to Follow-up|0
7394900|NCT01270802|11657400|FG001|Overall Study|Lost to Follow-up|1
7394901|NCT01270828|11657409|FG000|Pregabalin CR SB|Reason Unspecified|0
7394902|NCT01270828|11657410|FG001|Pregabalin CR SB|Reason Unspecified|0
7394903|NCT01270828|11657411|FG002|Pregabalin CR SB|Reason Unspecified|8
7394904|NCT01270828|11657409|FG000|Pregabalin CR SB|Enrolled but not treated|0
7394905|NCT01270828|11657410|FG001|Pregabalin CR SB|Enrolled but not treated|0
7394906|NCT01270828|11657411|FG002|Pregabalin CR SB|Enrolled but not treated|5
7394907|NCT01270828|11657409|FG000|Pregabalin CR SB|Related adverse event|0
7394908|NCT01270828|11657410|FG001|Pregabalin CR SB|Related adverse event|0
7394909|NCT01270828|11657411|FG002|Pregabalin CR SB|Related adverse event|46
7394910|NCT01270828|11657409|FG000|Pregabalin CR SB|Lack of Efficacy|0
7394911|NCT01270828|11657410|FG001|Pregabalin CR SB|Lack of Efficacy|0
7394912|NCT01270828|11657411|FG002|Pregabalin CR SB|Lack of Efficacy|32
7394913|NCT01270828|11657409|FG000|Pregabalin CR SB|Withdrawal by Subject|0
7394914|NCT01270828|11657410|FG001|Pregabalin CR SB|Withdrawal by Subject|0
7394915|NCT01270828|11657411|FG002|Pregabalin CR SB|Withdrawal by Subject|29
7394916|NCT01270828|11657409|FG000|Pregabalin CR SB|Lost to Follow-up|0
7394917|NCT01270828|11657410|FG001|Pregabalin CR SB|Lost to Follow-up|0
7394918|NCT01270828|11657411|FG002|Pregabalin CR SB|Lost to Follow-up|10
7394919|NCT01270828|11657409|FG000|Pregabalin CR SB|Unrelated AE|0
7394920|NCT01270828|11657410|FG001|Pregabalin CR SB|Unrelated AE|0
7394921|NCT01270828|11657411|FG002|Pregabalin CR SB|Unrelated AE|8
7394922|NCT01270828|11657409|FG000|Pregabalin CR SB|Protocol Violation|0
7394923|NCT01270828|11657410|FG001|Pregabalin CR SB|Protocol Violation|0
7394924|NCT01270828|11657411|FG002|Pregabalin CR SB|Protocol Violation|8
7394925|NCT01270828|11657409|FG000|Double Blind Phase|Death|0
7394926|NCT01270828|11657410|FG001|Double Blind Phase|Death|1
7394927|NCT01270828|11657411|FG002|Double Blind Phase|Death|0
7394928|NCT01270828|11657409|FG000|Double Blind Phase|Protocol Violation|0
7394929|NCT01270828|11657410|FG001|Double Blind Phase|Protocol Violation|1
7394930|NCT01270828|11657411|FG002|Double Blind Phase|Protocol Violation|0
7394931|NCT01270828|11657409|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
7394932|NCT01270828|11657410|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
7394933|NCT01270828|11657411|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
7394934|NCT01270828|11657409|FG000|Double Blind Phase|Reason Unspecified|7
7394935|NCT01270828|11657410|FG001|Double Blind Phase|Reason Unspecified|4
7394936|NCT01270828|11657411|FG002|Double Blind Phase|Reason Unspecified|0
7394937|NCT01270828|11657409|FG000|Double Blind Phase|Withdrawal by Subject|6
7394938|NCT01270828|11657410|FG001|Double Blind Phase|Withdrawal by Subject|15
7394939|NCT01270828|11657411|FG002|Double Blind Phase|Withdrawal by Subject|0
7394940|NCT01270828|11657409|FG000|Double Blind Phase|Lost to Follow-up|1
7394941|NCT01270828|11657410|FG001|Double Blind Phase|Lost to Follow-up|2
7394942|NCT01270828|11657411|FG002|Double Blind Phase|Lost to Follow-up|0
7394943|NCT01270828|11657409|FG000|Double Blind Phase|Lack of Efficacy|2
7394944|NCT01270828|11657410|FG001|Double Blind Phase|Lack of Efficacy|11
7394945|NCT01270828|11657411|FG002|Double Blind Phase|Lack of Efficacy|0
7394946|NCT01270828|11657409|FG000|Double Blind Phase|Adverse event not related to study drug|1
7394947|NCT01270828|11657410|FG001|Double Blind Phase|Adverse event not related to study drug|1
7394948|NCT01270828|11657411|FG002|Double Blind Phase|Adverse event not related to study drug|0
7394949|NCT01270828|11657409|FG000|Double Blind Phase|Adverse event related to study drug|5
7394950|NCT01270828|11657410|FG001|Double Blind Phase|Adverse event related to study drug|7
7394951|NCT01270828|11657411|FG002|Double Blind Phase|Adverse event related to study drug|0
7394952|NCT01270841|11657423|FG000|Overall Study|Adverse Event|0
7394953|NCT01270841|11657424|FG001|Overall Study|Adverse Event|1
7394954|NCT01270841|11657425|FG002|Overall Study|Adverse Event|0
7394955|NCT01270841|11657426|FG003|Overall Study|Adverse Event|3
7394956|NCT01270841|11657423|FG000|Overall Study|Withdrawal by Subject|3
7394957|NCT01270841|11657424|FG001|Overall Study|Withdrawal by Subject|2
7394958|NCT01270841|11657425|FG002|Overall Study|Withdrawal by Subject|3
7394959|NCT01270841|11657426|FG003|Overall Study|Withdrawal by Subject|3
7394960|NCT01270841|11657423|FG000|Overall Study|Lost to Follow-up|3
7394961|NCT01270841|11657424|FG001|Overall Study|Lost to Follow-up|1
7394962|NCT01270841|11657425|FG002|Overall Study|Lost to Follow-up|4
7394963|NCT01270841|11657426|FG003|Overall Study|Lost to Follow-up|2
7394964|NCT01270841|11657423|FG000|Overall Study|Physician Decision|0
7394965|NCT01270841|11657424|FG001|Overall Study|Physician Decision|1
7394966|NCT01270841|11657425|FG002|Overall Study|Physician Decision|0
7394967|NCT01270841|11657426|FG003|Overall Study|Physician Decision|0
7394968|NCT01270841|11657423|FG000|Overall Study|Did not qualify|6
7394969|NCT01270841|11657424|FG001|Overall Study|Did not qualify|3
7394970|NCT01270841|11657425|FG002|Overall Study|Did not qualify|4
7394971|NCT01270841|11657426|FG003|Overall Study|Did not qualify|5
7394972|NCT01270841|11657423|FG000|Overall Study|Protocol Violation|1
7394973|NCT01270841|11657424|FG001|Overall Study|Protocol Violation|5
7394974|NCT01270841|11657425|FG002|Overall Study|Protocol Violation|0
7394975|NCT01270841|11657426|FG003|Overall Study|Protocol Violation|0
7394976|NCT01270841|11657423|FG000|Overall Study|Enrolled in error|0
7394977|NCT01270841|11657424|FG001|Overall Study|Enrolled in error|1
7394978|NCT01270841|11657425|FG002|Overall Study|Enrolled in error|0
7394979|NCT01270841|11657426|FG003|Overall Study|Enrolled in error|0
7394980|NCT01270880|11657445|FG000|Overall Study|Never rec'd treatment, but registered.|1
7394981|NCT01270958|11657449|FG000|Overall Study|Lost to Follow-up|2
7394982|NCT01270958|11657449|FG000|Overall Study|Did not meet inclusion criteria for age|2
7394983|NCT01270971|11657455|FG000|Overall Study|Withdrawal by Subject|24
7394984|NCT01270971|11657456|FG001|Overall Study|Withdrawal by Subject|11
7394985|NCT01270971|11657455|FG000|Overall Study|Lost to Follow-up|18
7394986|NCT01270971|11657456|FG001|Overall Study|Lost to Follow-up|5
7394987|NCT01270971|11657455|FG000|Overall Study|Adverse Event|1
7394988|NCT01270971|11657456|FG001|Overall Study|Adverse Event|2
7394989|NCT01270971|11657455|FG000|Overall Study|Non compliance|2
7394990|NCT01270971|11657456|FG001|Overall Study|Non compliance|2
7394991|NCT01270971|11657455|FG000|Overall Study|Non-specific|7
7394992|NCT01270971|11657456|FG001|Overall Study|Non-specific|3
7394993|NCT01271010|11657462|FG000|Overall Study|Reason not specified|11
7394994|NCT01271010|11657462|FG000|Overall Study|Start of new CLL therapy|1
7394995|NCT01271010|11657462|FG000|Overall Study|Protocol Violation|1
7394996|NCT01271010|11657462|FG000|Overall Study|Death|2
7394997|NCT01271010|11657462|FG000|Overall Study|Progression and relapse of disease|1
7394998|NCT01271010|11657462|FG000|Overall Study|Withdrawal by Subject|18
7394999|NCT01271010|11657462|FG000|Overall Study|Disease progression|27
7395000|NCT01271504|11657506|FG000|Overall Study|Death|7
7395001|NCT01271504|11657507|FG001|Overall Study|Death|6
7395002|NCT01271504|11657508|FG002|Overall Study|Death|32
7395003|NCT01271504|11657509|FG003|Overall Study|Death|32
7395004|NCT01271504|11657506|FG000|Overall Study|Lost to Follow-up|0
7395005|NCT01271504|11657507|FG001|Overall Study|Lost to Follow-up|1
7395006|NCT01271504|11657508|FG002|Overall Study|Lost to Follow-up|3
7395007|NCT01271504|11657509|FG003|Overall Study|Lost to Follow-up|1
7395008|NCT01271504|11657506|FG000|Overall Study|Protocol Violation|0
7395009|NCT01271504|11657507|FG001|Overall Study|Protocol Violation|0
7395010|NCT01271504|11657508|FG002|Overall Study|Protocol Violation|0
7395011|NCT01271504|11657509|FG003|Overall Study|Protocol Violation|2
7395012|NCT01271504|11657506|FG000|Overall Study|Administrative Reasons|0
7395013|NCT01271504|11657507|FG001|Overall Study|Administrative Reasons|0
7395014|NCT01271504|11657508|FG002|Overall Study|Administrative Reasons|6
7395015|NCT01271504|11657509|FG003|Overall Study|Administrative Reasons|5
7395016|NCT01271504|11657506|FG000|Overall Study|Withdrawal by Subject|0
7395017|NCT01271504|11657507|FG001|Overall Study|Withdrawal by Subject|0
7395018|NCT01271504|11657508|FG002|Overall Study|Withdrawal by Subject|1
7395019|NCT01271504|11657509|FG003|Overall Study|Withdrawal by Subject|3
7395020|NCT01271504|11657506|FG000|Overall Study|Other|0
7395021|NCT01271504|11657507|FG001|Overall Study|Other|1
7395022|NCT01271504|11657508|FG002|Overall Study|Other|2
7395023|NCT01271504|11657509|FG003|Overall Study|Other|0
7395024|NCT01271712|11657545|FG000|Double Blind Treatment|Death|2
7395025|NCT01271712|11657546|FG001|Double Blind Treatment|Death|0
7395026|NCT01271712|11657545|FG000|Double Blind Treatment|Lack of Efficacy|1
7395027|NCT01271712|11657546|FG001|Double Blind Treatment|Lack of Efficacy|0
7395028|NCT01271712|11657545|FG000|Double Blind Treatment|Adverse Event|9
7395029|NCT01271712|11657546|FG001|Double Blind Treatment|Adverse Event|4
7395030|NCT01271712|11657545|FG000|Double Blind Treatment|Progressive disease|23
7395031|NCT01271712|11657546|FG001|Double Blind Treatment|Progressive disease|3
7395032|NCT01271712|11657545|FG000|Double Blind Treatment|Withdrawal by Subject|4
7395033|NCT01271712|11657546|FG001|Double Blind Treatment|Withdrawal by Subject|1
7395034|NCT01271712|11657545|FG000|Double Blind Treatment|Non compliance with study drug|2
7395035|NCT01271712|11657546|FG001|Double Blind Treatment|Non compliance with study drug|0
7395036|NCT01271712|11657545|FG000|Double Blind Treatment|receive no study drug|1
7395037|NCT01271712|11657546|FG001|Double Blind Treatment|receive no study drug|0
7395038|NCT01271712|11657545|FG000|Open Label Treatment|Death|6
7395039|NCT01271712|11657546|FG001|Open Label Treatment|Death|5
7395040|NCT01271712|11657545|FG000|Open Label Treatment|Withdrawal by Subject|6
7395041|NCT01271712|11657546|FG001|Open Label Treatment|Withdrawal by Subject|11
7395042|NCT01271712|11657545|FG000|Open Label Treatment|Physician Decision|2
7395043|NCT01271712|11657546|FG001|Open Label Treatment|Physician Decision|0
7395044|NCT01271712|11657545|FG000|Open Label Treatment|Adverse Event|14
7395045|NCT01271712|11657546|FG001|Open Label Treatment|Adverse Event|8
7395046|NCT01271712|11657545|FG000|Open Label Treatment|Progressive disease|59
7395047|NCT01271712|11657546|FG001|Open Label Treatment|Progressive disease|32
7395048|NCT01271712|11657545|FG000|Open Label Treatment|transferred to rollover study|1
7395049|NCT01271712|11657546|FG001|Open Label Treatment|transferred to rollover study|0
7395050|NCT01271712|11657545|FG000|Open Label Treatment|Non-compliance with study drug|1
7395051|NCT01271712|11657546|FG001|Open Label Treatment|Non-compliance with study drug|0
7395052|NCT01271712|11657545|FG000|Open Label Treatment|Protocol Violation|0
7395053|NCT01271712|11657546|FG001|Open Label Treatment|Protocol Violation|1
7395054|NCT01271712|11657545|FG000|Open Label Treatment|Switching to other therapy|2
7395055|NCT01271712|11657546|FG001|Open Label Treatment|Switching to other therapy|1
7395056|NCT01271712|11657545|FG000|Safety Follow-up|Death|11
7395057|NCT01271712|11657546|FG001|Safety Follow-up|Death|7
7395058|NCT01271712|11657545|FG000|Safety Follow-up|Withdrawal by Subject|4
7395059|NCT01271712|11657546|FG001|Safety Follow-up|Withdrawal by Subject|2
7395060|NCT01271712|11657545|FG000|Safety Follow-up|Protocol Violation|1
7395061|NCT01271712|11657546|FG001|Safety Follow-up|Protocol Violation|1
7395062|NCT01271712|11657545|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
7395063|NCT01271712|11657546|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
7395064|NCT01271712|11657545|FG000|Safety Follow-up|No follow-up|1
7395065|NCT01271712|11657546|FG001|Safety Follow-up|No follow-up|1
7395066|NCT01271712|11657545|FG000|Safety Follow-up|Progressive disease|1
7395067|NCT01271712|11657546|FG001|Safety Follow-up|Progressive disease|0
7395068|NCT01271712|11657545|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
7395069|NCT01271712|11657546|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
7395070|NCT01271725|11657555|FG000|Part A|Progressive disease according to RECIST|8
7395071|NCT01271725|11657556|FG001|Part A|Progressive disease according to RECIST|0
7395072|NCT01271725|11657555|FG000|Part A|Clinical signs/symptoms of progression|2
7395073|NCT01271725|11657556|FG001|Part A|Clinical signs/symptoms of progression|0
7395074|NCT01271725|11657555|FG000|Part A|Other Adverse Event|8
7395075|NCT01271725|11657556|FG001|Part A|Other Adverse Event|0
7395076|NCT01271725|11657555|FG000|Part A|Lost to Follow-up|1
7395077|NCT01271725|11657556|FG001|Part A|Lost to Follow-up|0
7395078|NCT01271725|11657555|FG000|Part A|Withdrawal by Subject|12
7395079|NCT01271725|11657556|FG001|Part A|Withdrawal by Subject|0
7395080|NCT01271725|11657555|FG000|Part A|Other than specified|3
7395081|NCT01271725|11657556|FG001|Part A|Other than specified|0
7395082|NCT01271725|11657555|FG000|Part A|Protocol Violation|1
7395083|NCT01271725|11657556|FG001|Part A|Protocol Violation|0
7395084|NCT01271725|11657555|FG000|Part B|Other than specified|0
7395085|NCT01271725|11657556|FG001|Part B|Other than specified|2
7395086|NCT01271725|11657555|FG000|Part B|Clinical signs/symptoms of progression|0
7395087|NCT01271725|11657556|FG001|Part B|Clinical signs/symptoms of progression|2
7395088|NCT01271725|11657555|FG000|Part B|Other Adverse Event|0
7395089|NCT01271725|11657556|FG001|Part B|Other Adverse Event|1
7395090|NCT01271725|11657555|FG000|Part B|Protocol Violation|0
7395091|NCT01271725|11657556|FG001|Part B|Protocol Violation|1
7395092|NCT01271725|11657555|FG000|Part B|Withdrawal by Subject|0
7395093|NCT01271725|11657556|FG001|Part B|Withdrawal by Subject|6
7395094|NCT01271803|11657568|FG000|Overall Study|Progressive disease|0
7395095|NCT01271803|11657569|FG001|Overall Study|Progressive disease|0
7395096|NCT01271803|11657570|FG002|Overall Study|Progressive disease|2
7395097|NCT01271803|11657568|FG000|Overall Study|Death|53
7395098|NCT01271803|11657569|FG001|Overall Study|Death|34
7395099|NCT01271803|11657570|FG002|Overall Study|Death|0
7395100|NCT01271803|11657568|FG000|Overall Study|Withdrawal by Subject|1
7395101|NCT01271803|11657569|FG001|Overall Study|Withdrawal by Subject|5
7395102|NCT01271803|11657570|FG002|Overall Study|Withdrawal by Subject|0
7395103|NCT01271803|11657568|FG000|Overall Study|Lost to Follow-up|1
7395104|NCT01271803|11657569|FG001|Overall Study|Lost to Follow-up|0
7395105|NCT01271803|11657570|FG002|Overall Study|Lost to Follow-up|0
7395106|NCT01271933|11657643|FG000|Single-Blind Phase|Lack of Efficacy|37
7395107|NCT01271933|11657644|FG001|Single-Blind Phase|Lack of Efficacy|0
7395108|NCT01271933|11657645|FG002|Single-Blind Phase|Lack of Efficacy|0
7395109|NCT01271933|11657643|FG000|Single-Blind Phase|Lost to Follow-up|10
7395110|NCT01271933|11657644|FG001|Single-Blind Phase|Lost to Follow-up|0
7395111|NCT01271933|11657645|FG002|Single-Blind Phase|Lost to Follow-up|0
7395112|NCT01271933|11657643|FG000|Single-Blind Phase|Withdrawal by Subject|15
7395113|NCT01271933|11657644|FG001|Single-Blind Phase|Withdrawal by Subject|0
7395114|NCT01271933|11657645|FG002|Single-Blind Phase|Withdrawal by Subject|0
7395115|NCT01271933|11657643|FG000|Single-Blind Phase|Protocol Violation|3
7395116|NCT01271933|11657644|FG001|Single-Blind Phase|Protocol Violation|0
7395117|NCT01271933|11657645|FG002|Single-Blind Phase|Protocol Violation|0
7395118|NCT01271933|11657643|FG000|Single-Blind Phase|Adverse Event|52
7395119|NCT01271933|11657644|FG001|Single-Blind Phase|Adverse Event|0
7395120|NCT01271933|11657645|FG002|Single-Blind Phase|Adverse Event|0
7395121|NCT01271933|11657643|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
7395122|NCT01271933|11657644|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
7395123|NCT01271933|11657645|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
7395124|NCT01271933|11657643|FG000|Single-Blind Phase|(Protocol non-compliance)|2
7395125|NCT01271933|11657644|FG001|Single-Blind Phase|(Protocol non-compliance)|0
7395126|NCT01271933|11657645|FG002|Single-Blind Phase|(Protocol non-compliance)|0
7395127|NCT01271933|11657643|FG000|Single-Blind Phase|(Participant request-personal reason)|1
7395128|NCT01271933|11657644|FG001|Single-Blind Phase|(Participant request-personal reason)|0
7395129|NCT01271933|11657645|FG002|Single-Blind Phase|(Participant request-personal reason)|0
7395130|NCT01271933|11657643|FG000|Double-Blind Phase|Randomized but not treated|0
7395131|NCT01271933|11657644|FG001|Double-Blind Phase|Randomized but not treated|0
7395132|NCT01271933|11657645|FG002|Double-Blind Phase|Randomized but not treated|1
7395133|NCT01271933|11657643|FG000|Double-Blind Phase|Lack of Efficacy|0
7395134|NCT01271933|11657644|FG001|Double-Blind Phase|Lack of Efficacy|6
7395135|NCT01271933|11657645|FG002|Double-Blind Phase|Lack of Efficacy|9
7395136|NCT01271933|11657643|FG000|Double-Blind Phase|Lost to Follow-up|0
7395137|NCT01271933|11657644|FG001|Double-Blind Phase|Lost to Follow-up|1
7395138|NCT01271933|11657645|FG002|Double-Blind Phase|Lost to Follow-up|1
7395139|NCT01271933|11657643|FG000|Double-Blind Phase|Withdrawal by Subject|0
7395140|NCT01271933|11657644|FG001|Double-Blind Phase|Withdrawal by Subject|6
7395141|NCT01271933|11657645|FG002|Double-Blind Phase|Withdrawal by Subject|1
7395142|NCT01271933|11657643|FG000|Double-Blind Phase|Adverse Event|0
7395143|NCT01271933|11657644|FG001|Double-Blind Phase|Adverse Event|3
7395144|NCT01271933|11657645|FG002|Double-Blind Phase|Adverse Event|0
7395145|NCT01271933|11657643|FG000|Double-Blind Phase|Participant request-personal reason|0
7395146|NCT01271933|11657644|FG001|Double-Blind Phase|Participant request-personal reason|1
7395147|NCT01271933|11657645|FG002|Double-Blind Phase|Participant request-personal reason|0
7395148|NCT01272011|11657681|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
7395149|NCT01272011|11657682|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
7395150|NCT01272011|11657683|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
7395151|NCT01272180|11657699|FG000|Overall Study|Adverse Event|0
7395152|NCT01272180|11657700|FG001|Overall Study|Adverse Event|0
7395153|NCT01272180|11657701|FG002|Overall Study|Adverse Event|1
7395154|NCT01272180|11657702|FG003|Overall Study|Adverse Event|0
7395155|NCT01272180|11657699|FG000|Overall Study|Withdrawal by Subject|2
7395156|NCT01272180|11657700|FG001|Overall Study|Withdrawal by Subject|6
7395157|NCT01272180|11657701|FG002|Overall Study|Withdrawal by Subject|3
7395158|NCT01272180|11657702|FG003|Overall Study|Withdrawal by Subject|2
7395159|NCT01272180|11657699|FG000|Overall Study|Lost to Follow-up|15
7395160|NCT01272180|11657700|FG001|Overall Study|Lost to Follow-up|14
7395161|NCT01272180|11657701|FG002|Overall Study|Lost to Follow-up|8
7395162|NCT01272180|11657702|FG003|Overall Study|Lost to Follow-up|10
7395163|NCT01272180|11657699|FG000|Overall Study|Inappropriate enrollment|0
7395164|NCT01272180|11657700|FG001|Overall Study|Inappropriate enrollment|0
7395165|NCT01272180|11657701|FG002|Overall Study|Inappropriate enrollment|1
7395166|NCT01272180|11657702|FG003|Overall Study|Inappropriate enrollment|1
7395167|NCT01272180|11657699|FG000|Overall Study|Protocol Violation|0
7395168|NCT01272180|11657700|FG001|Overall Study|Protocol Violation|1
7395169|NCT01272180|11657701|FG002|Overall Study|Protocol Violation|0
7395170|NCT01272180|11657702|FG003|Overall Study|Protocol Violation|1
7395171|NCT01272193|11657718|FG000|Overall Study|Adverse Event|1
7395172|NCT01272193|11657719|FG001|Overall Study|Adverse Event|1
7395173|NCT01272193|11657718|FG000|Overall Study|Lack of Efficacy|0
7395174|NCT01272193|11657719|FG001|Overall Study|Lack of Efficacy|3
7395175|NCT01272193|11657718|FG000|Overall Study|Withdrawal Criteria|1
7395176|NCT01272193|11657719|FG001|Overall Study|Withdrawal Criteria|1
7395177|NCT01272193|11657718|FG000|Overall Study|Unclassified|8
7395178|NCT01272193|11657719|FG001|Overall Study|Unclassified|7
7395179|NCT01272219|11657729|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
7395180|NCT01272219|11657730|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
7395181|NCT01272219|11657731|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
7395182|NCT01272219|11657732|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
7395183|NCT01272219|11657733|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
7395184|NCT01272219|11657734|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
7395185|NCT01272219|11657729|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
7395186|NCT01272219|11657730|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7395187|NCT01272219|11657731|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
7395188|NCT01272219|11657732|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
7395189|NCT01272219|11657733|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
7395190|NCT01272219|11657734|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
7395191|NCT01272219|11657729|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
7395192|NCT01272219|11657730|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
7395193|NCT01272219|11657731|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
7395194|NCT01272219|11657732|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
7395195|NCT01272219|11657733|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
7395196|NCT01272219|11657734|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
7395197|NCT01272219|11657729|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
7395198|NCT01272219|11657730|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7395199|NCT01272219|11657731|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
7395200|NCT01272219|11657732|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
7395201|NCT01272219|11657733|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
7395202|NCT01272219|11657734|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
7395203|NCT01272219|11657729|FG000|Main Period: Week 0 to Week 56|Unclassified|36
7395204|NCT01272219|11657730|FG001|Main Period: Week 0 to Week 56|Unclassified|0
7395205|NCT01272219|11657731|FG002|Main Period: Week 0 to Week 56|Unclassified|0
7395206|NCT01272219|11657732|FG003|Main Period: Week 0 to Week 56|Unclassified|29
7395207|NCT01272219|11657733|FG004|Main Period: Week 0 to Week 56|Unclassified|42
7395208|NCT01272219|11657734|FG005|Main Period: Week 0 to Week 56|Unclassified|34
7395209|NCT01272219|11657729|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7395210|NCT01272219|11657730|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7395211|NCT01272219|11657731|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
7395212|NCT01272219|11657732|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
7395213|NCT01272219|11657733|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7395214|NCT01272219|11657734|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
7395215|NCT01272219|11657729|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7395216|NCT01272219|11657730|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7395217|NCT01272219|11657731|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7395218|NCT01272219|11657732|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
7395219|NCT01272219|11657733|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7395220|NCT01272219|11657734|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
7395221|NCT01272219|11657729|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7395222|NCT01272219|11657730|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
7395223|NCT01272219|11657731|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7395224|NCT01272219|11657732|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
7395225|NCT01272219|11657733|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7395226|NCT01272219|11657734|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
7395227|NCT01272219|11657729|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7395228|NCT01272219|11657730|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
7395229|NCT01272219|11657731|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
7395230|NCT01272219|11657732|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
7395231|NCT01272219|11657733|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7395232|NCT01272219|11657734|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
7395233|NCT01272219|11657729|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7395234|NCT01272219|11657730|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
7395235|NCT01272219|11657731|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7395236|NCT01272219|11657732|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
7395237|NCT01272219|11657733|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7395238|NCT01272219|11657734|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
7395239|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
7395240|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
7395241|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
7395242|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
7395243|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
7395244|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
7395245|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7395246|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7395247|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7395248|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
7395249|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
7395250|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
7395251|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
7395252|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
7395253|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
7395254|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
7395255|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
7395256|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
7395257|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7395258|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7395259|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7395260|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
7395261|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
7395262|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
7395263|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Missing reason|0
7395264|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Missing reason|0
7395265|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Missing reason|0
7395266|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Missing reason|0
7395267|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Missing reason|1
7395268|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Missing reason|0
7395269|NCT01272219|11657729|FG000|Main + Extension Period: Week 0-172|Unclassified|0
7395270|NCT01272219|11657730|FG001|Main + Extension Period: Week 0-172|Unclassified|0
7395271|NCT01272219|11657731|FG002|Main + Extension Period: Week 0-172|Unclassified|0
7395272|NCT01272219|11657732|FG003|Main + Extension Period: Week 0-172|Unclassified|0
7395273|NCT01272219|11657733|FG004|Main + Extension Period: Week 0-172|Unclassified|61
7395274|NCT01272219|11657734|FG005|Main + Extension Period: Week 0-172|Unclassified|51
7395275|NCT01272232|11657750|FG000|Weeks 0-56|Adverse Event|39
7395276|NCT01272232|11657751|FG001|Weeks 0-56|Adverse Event|18
7395277|NCT01272232|11657752|FG002|Weeks 0-56|Adverse Event|7
7395278|NCT01272232|11657750|FG000|Weeks 0-56|Lack of Efficacy|0
7395279|NCT01272232|11657751|FG001|Weeks 0-56|Lack of Efficacy|0
7395280|NCT01272232|11657752|FG002|Weeks 0-56|Lack of Efficacy|3
7395281|NCT01272232|11657750|FG000|Weeks 0-56|Protocol Violation|12
7395282|NCT01272232|11657751|FG001|Weeks 0-56|Protocol Violation|8
7395283|NCT01272232|11657752|FG002|Weeks 0-56|Protocol Violation|13
7395284|NCT01272232|11657750|FG000|Weeks 0-56|Withdrawal criteria|32
7395285|NCT01272232|11657751|FG001|Weeks 0-56|Withdrawal criteria|14
7395286|NCT01272232|11657752|FG002|Weeks 0-56|Withdrawal criteria|37
7395287|NCT01272232|11657750|FG000|Weeks 0-56|Unclassified|16
7395288|NCT01272232|11657751|FG001|Weeks 0-56|Unclassified|7
7395289|NCT01272232|11657752|FG002|Weeks 0-56|Unclassified|12
7395290|NCT01272232|11657750|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7395291|NCT01272232|11657751|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
7395292|NCT01272232|11657752|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
7395293|NCT01272232|11657750|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
7395294|NCT01272232|11657751|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7395295|NCT01272232|11657752|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
7395296|NCT01272232|11657750|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7395297|NCT01272232|11657751|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
7395298|NCT01272232|11657752|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
7395299|NCT01272232|11657750|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
7395300|NCT01272232|11657751|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
7395301|NCT01272232|11657752|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
7395302|NCT01272232|11657750|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7395303|NCT01272232|11657751|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
7395304|NCT01272232|11657752|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
7395305|NCT01272635|11657791|FG000|Overall Study|Lost to Follow-up|31
7395306|NCT01272635|11657792|FG001|Overall Study|Lost to Follow-up|20
7395307|NCT01272635|11657793|FG002|Overall Study|Lost to Follow-up|31
7395308|NCT01272635|11657794|FG003|Overall Study|Lost to Follow-up|23
7395309|NCT01272661|11657805|FG000|Overall Study|lost to followup/case closed/ no birth|126
7395310|NCT01272661|11657806|FG001|Overall Study|lost to followup/case closed/ no birth|209
7395311|NCT01272661|11657807|FG002|Overall Study|lost to followup/case closed/ no birth|72
7395312|NCT01272804|11657821|FG000|Overall Study|Adverse Event|1
7395313|NCT01272804|11657822|FG001|Overall Study|Adverse Event|0
7395314|NCT01272804|11657823|FG002|Overall Study|Adverse Event|0
7395315|NCT01272804|11657824|FG003|Overall Study|Adverse Event|0
7395316|NCT01272804|11657825|FG004|Overall Study|Adverse Event|2
7395317|NCT01272804|11657826|FG005|Overall Study|Adverse Event|1
7395318|NCT01272869|11657851|FG000|Period 2 (14 Days)|Adverse Event|1
7395319|NCT01272869|11657852|FG001|Period 2 (14 Days)|Adverse Event|0
7395320|NCT01272908|11657862|FG000|Initial Treatment Period|Adverse Event|1
7395321|NCT01272908|11657862|FG000|Initial Treatment Period|Lack of Efficacy|5
7395322|NCT01272908|11657862|FG000|Initial Treatment Period|Protocol Violation|1
7395323|NCT01272908|11657862|FG000|Initial Treatment Period|Withdrawal by Subject|1
7395324|NCT01272908|11657862|FG000|Re-Treatment Period|Adverse Event|2
7395325|NCT01272908|11657862|FG000|Re-Treatment Period|Lack of Efficacy|3
7395326|NCT01272908|11657862|FG000|Re-Treatment Period|Withdrawal by Subject|1
7395327|NCT01272921|11657870|FG000|Overall Study|Protocol Violation|2
7395328|NCT01272921|11657871|FG001|Overall Study|Protocol Violation|1
7395329|NCT01272934|11657881|FG000|Overall Study|Adverse Event|0
7395330|NCT01272934|11657882|FG001|Overall Study|Adverse Event|1
7395331|NCT01272934|11657881|FG000|Overall Study|Abnormal Laboratory Value|0
7395332|NCT01272934|11657882|FG001|Overall Study|Abnormal Laboratory Value|1
7395333|NCT01272947|11657891|FG000|Overall Study|Abnormal Laboratory Value|2
7395334|NCT01272947|11657892|FG001|Overall Study|Abnormal Laboratory Value|2
7395335|NCT01273038|11657921|FG000|Second Intervention (14 Days)|Adverse Event|0
7395336|NCT01273038|11657922|FG001|Second Intervention (14 Days)|Adverse Event|1
7395337|NCT01273038|11657921|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7395338|NCT01273038|11657922|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7395339|NCT01273155|11657932|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
7395340|NCT01273155|11657933|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
7395341|NCT01273155|11657934|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
7395342|NCT01273155|11657935|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
7395343|NCT01273155|11657936|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
7395344|NCT01273155|11657937|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
7395345|NCT01273155|11657938|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
7395346|NCT01273155|11657932|FG000|Overall Study|Change in liver function/no longer eval.|0
7395347|NCT01273155|11657933|FG001|Overall Study|Change in liver function/no longer eval.|1
7395348|NCT01273155|11657934|FG002|Overall Study|Change in liver function/no longer eval.|0
7395349|NCT01273155|11657935|FG003|Overall Study|Change in liver function/no longer eval.|0
7395350|NCT01273155|11657936|FG004|Overall Study|Change in liver function/no longer eval.|1
7395351|NCT01273155|11657937|FG005|Overall Study|Change in liver function/no longer eval.|0
7395352|NCT01273155|11657938|FG006|Overall Study|Change in liver function/no longer eval.|0
7395353|NCT01273155|11657932|FG000|Overall Study|Off study prior to C1/due to toxicity|0
7395354|NCT01273155|11657933|FG001|Overall Study|Off study prior to C1/due to toxicity|0
7395355|NCT01273155|11657934|FG002|Overall Study|Off study prior to C1/due to toxicity|2
7395356|NCT01273155|11657935|FG003|Overall Study|Off study prior to C1/due to toxicity|0
7395357|NCT01273155|11657936|FG004|Overall Study|Off study prior to C1/due to toxicity|0
7395358|NCT01273155|11657937|FG005|Overall Study|Off study prior to C1/due to toxicity|0
7395359|NCT01273155|11657938|FG006|Overall Study|Off study prior to C1/due to toxicity|1
7395360|NCT01273155|11657932|FG000|Overall Study|Died during Cycle 1|0
7395361|NCT01273155|11657933|FG001|Overall Study|Died during Cycle 1|0
7395362|NCT01273155|11657934|FG002|Overall Study|Died during Cycle 1|1
7395363|NCT01273155|11657935|FG003|Overall Study|Died during Cycle 1|1
7395364|NCT01273155|11657936|FG004|Overall Study|Died during Cycle 1|0
7395365|NCT01273155|11657937|FG005|Overall Study|Died during Cycle 1|2
7395366|NCT01273155|11657938|FG006|Overall Study|Died during Cycle 1|2
7395367|NCT01273155|11657932|FG000|Overall Study|Withdrew during C1/refused further trmt|0
7395368|NCT01273155|11657933|FG001|Overall Study|Withdrew during C1/refused further trmt|0
7395369|NCT01273155|11657934|FG002|Overall Study|Withdrew during C1/refused further trmt|1
7395370|NCT01273155|11657935|FG003|Overall Study|Withdrew during C1/refused further trmt|0
7395371|NCT01273155|11657936|FG004|Overall Study|Withdrew during C1/refused further trmt|1
7395372|NCT01273155|11657937|FG005|Overall Study|Withdrew during C1/refused further trmt|1
7395373|NCT01273155|11657938|FG006|Overall Study|Withdrew during C1/refused further trmt|0
7395374|NCT01273181|11657965|FG000|Phase I, Dose 1|Study termination|1
7395375|NCT01273181|11657966|FG001|Phase I, Dose 1|Study termination|0
7395376|NCT01273181|11657967|FG002|Phase I, Dose 1|Study termination|0
7395377|NCT01273181|11657968|FG003|Phase I, Dose 1|Study termination|0
7395378|NCT01273181|11657965|FG000|Phase I, Dose 2|Death during treatment|0
7395379|NCT01273181|11657966|FG001|Phase I, Dose 2|Death during treatment|1
7395380|NCT01273181|11657967|FG002|Phase I, Dose 2|Death during treatment|0
7395381|NCT01273181|11657968|FG003|Phase I, Dose 2|Death during treatment|0
7395382|NCT01273181|11657965|FG000|Phase 2, Dose 1|Study termination|0
7395383|NCT01273181|11657966|FG001|Phase 2, Dose 1|Study termination|0
7395384|NCT01273181|11657967|FG002|Phase 2, Dose 1|Study termination|1
7395385|NCT01273181|11657968|FG003|Phase 2, Dose 1|Study termination|0
7395386|NCT01273181|11657965|FG000|Phase 2, Dose 2|Death during treatment|0
7395387|NCT01273181|11657966|FG001|Phase 2, Dose 2|Death during treatment|0
7395388|NCT01273181|11657967|FG002|Phase 2, Dose 2|Death during treatment|0
7395389|NCT01273181|11657968|FG003|Phase 2, Dose 2|Death during treatment|1
7395390|NCT01273519|11657989|FG000|Overall Study|Adverse Event|3
7395391|NCT01273519|11657990|FG001|Overall Study|Adverse Event|0
7395392|NCT01273519|11657991|FG002|Overall Study|Adverse Event|0
7395393|NCT01273519|11657989|FG000|Overall Study|Lost to Follow-up|2
7395394|NCT01273519|11657990|FG001|Overall Study|Lost to Follow-up|1
7395395|NCT01273519|11657991|FG002|Overall Study|Lost to Follow-up|3
7395396|NCT01273519|11657989|FG000|Overall Study|Lack of Efficacy|8
7395397|NCT01273519|11657990|FG001|Overall Study|Lack of Efficacy|3
7395398|NCT01273519|11657991|FG002|Overall Study|Lack of Efficacy|4
7395399|NCT01273519|11657989|FG000|Overall Study|Other|6
7395400|NCT01273519|11657990|FG001|Overall Study|Other|1
7395401|NCT01273519|11657991|FG002|Overall Study|Other|1
7395402|NCT01273597|11658002|FG000|Overall Study|Adverse Event|5
7395403|NCT01273597|11658002|FG000|Overall Study|Underwent Kidney Transplantation|2
7395404|NCT01273597|11658002|FG000|Overall Study|Reason Not Reported|1
7395405|NCT01273623|11658006|FG000|Overall Study|did not meet IVUS criteria|29
7395406|NCT01273805|11658026|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
7395407|NCT01273805|11658027|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
7395408|NCT01273818|11658036|FG000|Overall Study|Physician Decision|13
7395409|NCT01273818|11658037|FG001|Overall Study|Physician Decision|2
7395410|NCT01273818|11658038|FG002|Overall Study|Physician Decision|9
7395411|NCT01273883|11658055|FG000|First Intervention|Adverse Event|2
7395412|NCT01273883|11658056|FG001|First Intervention|Adverse Event|1
7395413|NCT01273883|11658055|FG000|Second Intervention|Lost to Follow-up|1
7395414|NCT01273883|11658056|FG001|Second Intervention|Lost to Follow-up|1
7395415|NCT01273883|11658055|FG000|Second Intervention|Lack of Efficacy|1
7395416|NCT01273883|11658056|FG001|Second Intervention|Lack of Efficacy|0
7395417|NCT01274182|11658069|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7395418|NCT01274182|11658070|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7395419|NCT01274182|11658071|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7395420|NCT01274182|11658069|FG000|Overall Study|Adverse Event|4
7395421|NCT01274182|11658070|FG001|Overall Study|Adverse Event|5
7395422|NCT01274182|11658071|FG002|Overall Study|Adverse Event|3
7395423|NCT01274182|11658069|FG000|Overall Study|Withdrawal by Subject|5
7395424|NCT01274182|11658070|FG001|Overall Study|Withdrawal by Subject|5
7395425|NCT01274182|11658071|FG002|Overall Study|Withdrawal by Subject|3
7395426|NCT01274182|11658069|FG000|Overall Study|Lost to Follow-up|2
7395427|NCT01274182|11658070|FG001|Overall Study|Lost to Follow-up|3
7395428|NCT01274182|11658071|FG002|Overall Study|Lost to Follow-up|1
7395429|NCT01274182|11658069|FG000|Overall Study|Protocol Violation|3
7395430|NCT01274182|11658070|FG001|Overall Study|Protocol Violation|2
7395431|NCT01274182|11658071|FG002|Overall Study|Protocol Violation|0
7395432|NCT01274182|11658069|FG000|Overall Study|Death|1
7395433|NCT01274182|11658070|FG001|Overall Study|Death|0
7395434|NCT01274182|11658071|FG002|Overall Study|Death|1
7395435|NCT01274338|11658089|FG000|Overall Study|Lack of Efficacy|72
7395436|NCT01274338|11658090|FG001|Overall Study|Lack of Efficacy|108
7395437|NCT01274338|11658091|FG002|Overall Study|Lack of Efficacy|116
7395438|NCT01274338|11658092|FG003|Overall Study|Lack of Efficacy|0
7395439|NCT01274338|11658093|FG004|Overall Study|Lack of Efficacy|0
7395440|NCT01274338|11658094|FG005|Overall Study|Lack of Efficacy|0
7395441|NCT01274338|11658089|FG000|Overall Study|Adverse Event|272
7395442|NCT01274338|11658090|FG001|Overall Study|Adverse Event|105
7395443|NCT01274338|11658091|FG002|Overall Study|Adverse Event|180
7395444|NCT01274338|11658092|FG003|Overall Study|Adverse Event|1
7395445|NCT01274338|11658093|FG004|Overall Study|Adverse Event|0
7395446|NCT01274338|11658094|FG005|Overall Study|Adverse Event|0
7395447|NCT01274338|11658089|FG000|Overall Study|Death|8
7395448|NCT01274338|11658090|FG001|Overall Study|Death|1
7395449|NCT01274338|11658091|FG002|Overall Study|Death|0
7395450|NCT01274338|11658092|FG003|Overall Study|Death|0
7395451|NCT01274338|11658093|FG004|Overall Study|Death|0
7395452|NCT01274338|11658094|FG005|Overall Study|Death|0
7395453|NCT01274338|11658089|FG000|Overall Study|Withdrawal by Subject|27
7395454|NCT01274338|11658090|FG001|Overall Study|Withdrawal by Subject|99
7395455|NCT01274338|11658091|FG002|Overall Study|Withdrawal by Subject|17
7395456|NCT01274338|11658092|FG003|Overall Study|Withdrawal by Subject|0
7395457|NCT01274338|11658093|FG004|Overall Study|Withdrawal by Subject|0
7395458|NCT01274338|11658094|FG005|Overall Study|Withdrawal by Subject|0
7395459|NCT01274338|11658089|FG000|Overall Study|Did not start treatment|8
7395460|NCT01274338|11658090|FG001|Overall Study|Did not start treatment|116
7395461|NCT01274338|11658091|FG002|Overall Study|Did not start treatment|7
7395462|NCT01274338|11658092|FG003|Overall Study|Did not start treatment|0
7395463|NCT01274338|11658093|FG004|Overall Study|Did not start treatment|0
7395464|NCT01274338|11658094|FG005|Overall Study|Did not start treatment|0
7395465|NCT01274338|11658089|FG000|Overall Study|Alternative therapy|0
7395466|NCT01274338|11658090|FG001|Overall Study|Alternative therapy|1
7395467|NCT01274338|11658091|FG002|Overall Study|Alternative therapy|0
7395468|NCT01274338|11658092|FG003|Overall Study|Alternative therapy|0
7395469|NCT01274338|11658093|FG004|Overall Study|Alternative therapy|0
7395470|NCT01274338|11658094|FG005|Overall Study|Alternative therapy|0
7395471|NCT01274338|11658089|FG000|Overall Study|Other complicating diseases|0
7395472|NCT01274338|11658090|FG001|Overall Study|Other complicating diseases|3
7395473|NCT01274338|11658091|FG002|Overall Study|Other complicating diseases|1
7395474|NCT01274338|11658092|FG003|Overall Study|Other complicating diseases|0
7395475|NCT01274338|11658093|FG004|Overall Study|Other complicating diseases|0
7395476|NCT01274338|11658094|FG005|Overall Study|Other complicating diseases|0
7395477|NCT01274338|11658089|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
7395478|NCT01274338|11658090|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
7395479|NCT01274338|11658091|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
7395480|NCT01274338|11658092|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
7395481|NCT01274338|11658093|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
7395482|NCT01274338|11658094|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
7395483|NCT01274338|11658089|FG000|Overall Study|Pregnancy|0
7395484|NCT01274338|11658090|FG001|Overall Study|Pregnancy|0
7395485|NCT01274338|11658091|FG002|Overall Study|Pregnancy|1
7395486|NCT01274338|11658092|FG003|Overall Study|Pregnancy|0
7395487|NCT01274338|11658093|FG004|Overall Study|Pregnancy|0
7395488|NCT01274338|11658094|FG005|Overall Study|Pregnancy|0
7395489|NCT01274338|11658089|FG000|Overall Study|Reason not reported|12
7395490|NCT01274338|11658090|FG001|Overall Study|Reason not reported|21
7395491|NCT01274338|11658091|FG002|Overall Study|Reason not reported|3
7395492|NCT01274338|11658092|FG003|Overall Study|Reason not reported|0
7395493|NCT01274338|11658093|FG004|Overall Study|Reason not reported|1
7395494|NCT01274338|11658094|FG005|Overall Study|Reason not reported|0
7395495|NCT01274351|11658107|FG000|Overall Study|Lost to Follow-up|1
7395496|NCT01274351|11658107|FG000|Overall Study|patient not compliant with the protocol|1
7395497|NCT01274351|11658107|FG000|Overall Study|Pregnancy|1
7395498|NCT01274351|11658107|FG000|Overall Study|Death|2
7395499|NCT01274351|11658107|FG000|Overall Study|Withdrawal by Subject|3
7395500|NCT01274351|11658107|FG000|Overall Study|Adverse Event|8
7395501|NCT01274351|11658107|FG000|Overall Study|progression of disease|3
7395502|NCT01274351|11658107|FG000|Overall Study|hospitalization|1
7395503|NCT01274637|11658134|FG000|Overall Study|Withdrawal by Subject|0
7395504|NCT01274637|11658135|FG001|Overall Study|Withdrawal by Subject|1
7395505|NCT01274637|11658134|FG000|Overall Study|Lost to Follow-up|0
7395506|NCT01274637|11658135|FG001|Overall Study|Lost to Follow-up|1
7395507|NCT01274715|11658141|FG000|Overall Study|Lost to Follow-up|1
7395508|NCT01274715|11658141|FG000|Overall Study|After consent, met exclusion criteria.|1
7395509|NCT01274715|11658141|FG000|Overall Study|After consent, met exclusion criteria.|1
7395510|NCT01274715|11658141|FG000|Overall Study|After consent, met exclusion criteria.|1
7395511|NCT01275066|11658161|FG000|Overall Study|Withdrawal by Subject|0
7395512|NCT01275066|11658162|FG001|Overall Study|Withdrawal by Subject|0
7395513|NCT01275066|11658163|FG002|Overall Study|Withdrawal by Subject|1
7395514|NCT01275066|11658161|FG000|Overall Study|Not Diagnosed w/ Disease|1
7395515|NCT01275066|11658162|FG001|Overall Study|Not Diagnosed w/ Disease|0
7395516|NCT01275066|11658163|FG002|Overall Study|Not Diagnosed w/ Disease|0
7395517|NCT01275131|11658179|FG000|Period 1|Withdrawal by Subject|1
7395518|NCT01275131|11658180|FG001|Period 1|Withdrawal by Subject|0
7395519|NCT01275131|11658181|FG002|Period 1|Withdrawal by Subject|3
7395520|NCT01275131|11658182|FG003|Period 1|Withdrawal by Subject|2
7395521|NCT01275131|11658179|FG000|Period 1|Physician Decision|1
7395522|NCT01275131|11658180|FG001|Period 1|Physician Decision|0
7395523|NCT01275131|11658181|FG002|Period 1|Physician Decision|0
7395524|NCT01275131|11658182|FG003|Period 1|Physician Decision|0
7395525|NCT01275131|11658179|FG000|Period 2 (Crossover)|Adverse Event|0
7395526|NCT01275131|11658180|FG001|Period 2 (Crossover)|Adverse Event|1
7395527|NCT01275131|11658181|FG002|Period 2 (Crossover)|Adverse Event|0
7395528|NCT01275131|11658182|FG003|Period 2 (Crossover)|Adverse Event|0
7395529|NCT01275131|11658179|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
7395530|NCT01275131|11658180|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
7395531|NCT01275131|11658181|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
7395532|NCT01275131|11658182|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
7395533|NCT01275144|11658200|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
7395534|NCT01275144|11658201|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
7395535|NCT01275170|11658217|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
7395536|NCT01275170|11658218|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
7395537|NCT01275170|11658219|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
7395538|NCT01275170|11658220|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
7395539|NCT01275170|11658221|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
7395540|NCT01275170|11658222|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
7395541|NCT01275170|11658223|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
7395542|NCT01275170|11658224|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
7395543|NCT01275196|11658259|FG000|Overall Study|Adverse Event|3
7395544|NCT01275196|11658260|FG001|Overall Study|Adverse Event|5
7395545|NCT01275196|11658259|FG000|Overall Study|Withdrawal by Subject|4
7395546|NCT01275196|11658260|FG001|Overall Study|Withdrawal by Subject|5
7395547|NCT01275196|11658259|FG000|Overall Study|Lost to Follow-up|1
7395548|NCT01275196|11658260|FG001|Overall Study|Lost to Follow-up|0
7395549|NCT01275196|11658259|FG000|Overall Study|Disease Progression|6
7395550|NCT01275196|11658260|FG001|Overall Study|Disease Progression|5
7395551|NCT01275196|11658259|FG000|Overall Study|Protocol Violation|1
7395552|NCT01275196|11658260|FG001|Overall Study|Protocol Violation|0
7395553|NCT01275196|11658259|FG000|Overall Study|Suboptimal response/treatment failure|5
7395554|NCT01275196|11658260|FG001|Overall Study|Suboptimal response/treatment failure|6
7395555|NCT01275222|11658274|FG000|Phase l by Treatment|Adverse Event|1
7395556|NCT01275222|11658275|FG001|Phase l by Treatment|Adverse Event|4
7395557|NCT01275222|11658276|FG002|Phase l by Treatment|Adverse Event|2
7395558|NCT01275222|11658277|FG003|Phase l by Treatment|Adverse Event|3
7395559|NCT01275222|11658278|FG004|Phase l by Treatment|Adverse Event|0
7395560|NCT01275222|11658279|FG005|Phase l by Treatment|Adverse Event|0
7395561|NCT01275222|11658274|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
7395562|NCT01275222|11658275|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
7395563|NCT01275222|11658276|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
7395564|NCT01275222|11658277|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
7395565|NCT01275222|11658278|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
7395566|NCT01275222|11658279|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
7395567|NCT01275222|11658274|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
7395568|NCT01275222|11658275|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
7395569|NCT01275222|11658276|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
7395570|NCT01275222|11658277|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
7395571|NCT01275222|11658278|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
7395572|NCT01275222|11658279|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
7395573|NCT01275222|11658274|FG000|Phase l by Treatment|Disease progression|12
7395574|NCT01275222|11658275|FG001|Phase l by Treatment|Disease progression|8
7395575|NCT01275222|11658276|FG002|Phase l by Treatment|Disease progression|2
7395576|NCT01275222|11658277|FG003|Phase l by Treatment|Disease progression|5
7395577|NCT01275222|11658278|FG004|Phase l by Treatment|Disease progression|0
7395578|NCT01275222|11658279|FG005|Phase l by Treatment|Disease progression|0
7395579|NCT01275222|11658274|FG000|Phase l by Treatment|Withdrawal by Subject|0
7395580|NCT01275222|11658275|FG001|Phase l by Treatment|Withdrawal by Subject|0
7395581|NCT01275222|11658276|FG002|Phase l by Treatment|Withdrawal by Subject|0
7395582|NCT01275222|11658277|FG003|Phase l by Treatment|Withdrawal by Subject|1
7395583|NCT01275222|11658278|FG004|Phase l by Treatment|Withdrawal by Subject|0
7395584|NCT01275222|11658279|FG005|Phase l by Treatment|Withdrawal by Subject|0
7395585|NCT01275222|11658274|FG000|Phase l by Treatment|Death|0
7395586|NCT01275222|11658275|FG001|Phase l by Treatment|Death|1
7395587|NCT01275222|11658276|FG002|Phase l by Treatment|Death|0
7395588|NCT01275222|11658277|FG003|Phase l by Treatment|Death|1
7395589|NCT01275222|11658278|FG004|Phase l by Treatment|Death|0
7395590|NCT01275222|11658279|FG005|Phase l by Treatment|Death|0
7395591|NCT01275222|11658274|FG000|Phase ll by Stratum|Adverse Event|0
7395592|NCT01275222|11658275|FG001|Phase ll by Stratum|Adverse Event|0
7395593|NCT01275222|11658276|FG002|Phase ll by Stratum|Adverse Event|0
7395594|NCT01275222|11658277|FG003|Phase ll by Stratum|Adverse Event|0
7395595|NCT01275222|11658278|FG004|Phase ll by Stratum|Adverse Event|2
7395596|NCT01275222|11658279|FG005|Phase ll by Stratum|Adverse Event|10
7395597|NCT01275222|11658274|FG000|Phase ll by Stratum|Abnormal laboratory values|0
7395598|NCT01275222|11658275|FG001|Phase ll by Stratum|Abnormal laboratory values|0
7395599|NCT01275222|11658276|FG002|Phase ll by Stratum|Abnormal laboratory values|0
7395600|NCT01275222|11658277|FG003|Phase ll by Stratum|Abnormal laboratory values|0
7395601|NCT01275222|11658278|FG004|Phase ll by Stratum|Abnormal laboratory values|0
7395602|NCT01275222|11658279|FG005|Phase ll by Stratum|Abnormal laboratory values|1
7395603|NCT01275222|11658274|FG000|Phase ll by Stratum|Disease progression|0
7395604|NCT01275222|11658275|FG001|Phase ll by Stratum|Disease progression|0
7395605|NCT01275222|11658276|FG002|Phase ll by Stratum|Disease progression|0
7395606|NCT01275222|11658277|FG003|Phase ll by Stratum|Disease progression|0
7395607|NCT01275222|11658278|FG004|Phase ll by Stratum|Disease progression|23
7395608|NCT01275222|11658279|FG005|Phase ll by Stratum|Disease progression|31
7395609|NCT01275222|11658274|FG000|Phase ll by Stratum|Withdrawal by Subject|0
7395610|NCT01275222|11658275|FG001|Phase ll by Stratum|Withdrawal by Subject|0
7395611|NCT01275222|11658276|FG002|Phase ll by Stratum|Withdrawal by Subject|0
7395612|NCT01275222|11658277|FG003|Phase ll by Stratum|Withdrawal by Subject|0
7395613|NCT01275222|11658278|FG004|Phase ll by Stratum|Withdrawal by Subject|2
7395614|NCT01275222|11658279|FG005|Phase ll by Stratum|Withdrawal by Subject|3
7395615|NCT01275222|11658274|FG000|Phase ll by Stratum|Death|0
7395616|NCT01275222|11658275|FG001|Phase ll by Stratum|Death|0
7395617|NCT01275222|11658276|FG002|Phase ll by Stratum|Death|0
7395618|NCT01275222|11658277|FG003|Phase ll by Stratum|Death|0
7395619|NCT01275222|11658278|FG004|Phase ll by Stratum|Death|1
7395620|NCT01275222|11658279|FG005|Phase ll by Stratum|Death|1
7395621|NCT01275339|11658308|FG000|Overall Study|Referred for surgery for AS symptoms|1
7395622|NCT01275339|11658309|FG001|Overall Study|Referred for surgery for AS symptoms|0
7395623|NCT01275339|11658310|FG002|Overall Study|Referred for surgery for AS symptoms|0
7395624|NCT01275339|11658311|FG003|Overall Study|Referred for surgery for AS symptoms|0
7395625|NCT01275339|11658308|FG000|Overall Study|Withdrawal by Subject|0
7395626|NCT01275339|11658309|FG001|Overall Study|Withdrawal by Subject|0
7395627|NCT01275339|11658310|FG002|Overall Study|Withdrawal by Subject|1
7395628|NCT01275339|11658311|FG003|Overall Study|Withdrawal by Subject|0
7395629|NCT01275430|11658338|FG000|Overall Study|Adverse Event|1
7395630|NCT01275430|11658338|FG000|Overall Study|No Contrast Injection|6
7395631|NCT01275430|11658338|FG000|Overall Study|Device Malfunction|1
7395632|NCT01275430|11658338|FG000|Overall Study|Inability to achieve maximum p-wave|1
7395633|NCT01275625|11658347|FG000|Overall Study|Death|1
7395634|NCT01275625|11658347|FG000|Overall Study|Lack of Efficacy|2
7395635|NCT01275625|11658347|FG000|Overall Study|Lost to Follow-up|1
7395636|NCT01275625|11658347|FG000|Overall Study|Withdrawal by Subject|3
7395637|NCT01275625|11658347|FG000|Overall Study|Protocol Violation|1
7395638|NCT01275625|11658347|FG000|Overall Study|Adverse Event|4
7395639|NCT01275625|11658347|FG000|Overall Study|Other|1
7395640|NCT01275755|11658357|FG000|Double-blind Treatment Period|Adverse Event|0
7395641|NCT01275755|11658358|FG001|Double-blind Treatment Period|Adverse Event|2
7395642|NCT01275755|11658357|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7395643|NCT01275755|11658358|FG001|Double-blind Treatment Period|Lost to Follow-up|1
7395644|NCT01275755|11658357|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7395645|NCT01275755|11658358|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7395646|NCT01275755|11658357|FG000|Run-out Placebo Period|Lost to Follow-up|1
7395647|NCT01275755|11658358|FG001|Run-out Placebo Period|Lost to Follow-up|0
7395648|NCT01275833|11658366|FG000|Overall Study|Study terminated|1
7395649|NCT01275833|11658367|FG001|Overall Study|Study terminated|1
7395650|NCT01276041|11658373|FG000|Overall Study|Adverse Event|2
7395651|NCT01276041|11658373|FG000|Overall Study|Protocol Violation|1
7395652|NCT01276106|11658381|FG000|Overall Study|Adverse Event|3
7395653|NCT01276106|11658382|FG001|Overall Study|Adverse Event|3
7395654|NCT01276106|11658383|FG002|Overall Study|Adverse Event|11
7395655|NCT01276106|11658384|FG003|Overall Study|Adverse Event|3
7395656|NCT01276106|11658381|FG000|Overall Study|Withdrawal by Subject|6
7395657|NCT01276106|11658382|FG001|Overall Study|Withdrawal by Subject|3
7395658|NCT01276106|11658383|FG002|Overall Study|Withdrawal by Subject|1
7395659|NCT01276106|11658384|FG003|Overall Study|Withdrawal by Subject|6
7395660|NCT01276106|11658381|FG000|Overall Study|Lack of Efficacy|0
7395661|NCT01276106|11658382|FG001|Overall Study|Lack of Efficacy|1
7395662|NCT01276106|11658383|FG002|Overall Study|Lack of Efficacy|0
7395663|NCT01276106|11658384|FG003|Overall Study|Lack of Efficacy|1
7395664|NCT01276106|11658381|FG000|Overall Study|Lost to Follow-up|2
7395665|NCT01276106|11658382|FG001|Overall Study|Lost to Follow-up|1
7395666|NCT01276106|11658383|FG002|Overall Study|Lost to Follow-up|1
7395667|NCT01276106|11658384|FG003|Overall Study|Lost to Follow-up|0
7395668|NCT01276106|11658381|FG000|Overall Study|Physician Decision|0
7395669|NCT01276106|11658382|FG001|Overall Study|Physician Decision|0
7395670|NCT01276106|11658383|FG002|Overall Study|Physician Decision|1
7395671|NCT01276106|11658384|FG003|Overall Study|Physician Decision|1
7395672|NCT01276106|11658381|FG000|Overall Study|Protocol Violation|1
7395673|NCT01276106|11658382|FG001|Overall Study|Protocol Violation|1
7395674|NCT01276106|11658383|FG002|Overall Study|Protocol Violation|0
7395675|NCT01276106|11658384|FG003|Overall Study|Protocol Violation|2
7395676|NCT01276106|11658381|FG000|Overall Study|Insufficient therapeutic effects|0
7395677|NCT01276106|11658382|FG001|Overall Study|Insufficient therapeutic effects|0
7395678|NCT01276106|11658383|FG002|Overall Study|Insufficient therapeutic effects|2
7395679|NCT01276106|11658384|FG003|Overall Study|Insufficient therapeutic effects|0
7395680|NCT01276223|11658428|FG000|Overall Study|Adverse Event|7
7395681|NCT01276223|11658429|FG001|Overall Study|Adverse Event|4
7395682|NCT01276223|11658430|FG002|Overall Study|Adverse Event|1
7395683|NCT01276223|11658428|FG000|Overall Study|Lost to Follow-up|0
7395684|NCT01276223|11658429|FG001|Overall Study|Lost to Follow-up|0
7395685|NCT01276223|11658430|FG002|Overall Study|Lost to Follow-up|1
7395686|NCT01276223|11658428|FG000|Overall Study|Other|0
7395687|NCT01276223|11658429|FG001|Overall Study|Other|0
7395688|NCT01276223|11658430|FG002|Overall Study|Other|1
7395689|NCT01276223|11658428|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
7395690|NCT01276223|11658429|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
7395691|NCT01276223|11658430|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
7395692|NCT01276223|11658428|FG000|Overall Study|Protocol Violation|1
7395693|NCT01276223|11658429|FG001|Overall Study|Protocol Violation|0
7395694|NCT01276223|11658430|FG002|Overall Study|Protocol Violation|0
7395695|NCT01276236|11658437|FG000|Overall Study|Lack of Efficacy|2
7395696|NCT01276236|11658437|FG000|Overall Study|Withdrawal by Subject|4
7395697|NCT01276288|11658441|FG000|Overall Study|Adverse Event|1
7395698|NCT01276288|11658442|FG001|Overall Study|Adverse Event|1
7395699|NCT01276288|11658443|FG002|Overall Study|Adverse Event|0
7395700|NCT01276288|11658444|FG003|Overall Study|Adverse Event|0
7395701|NCT01276288|11658441|FG000|Overall Study|not treated|1
7395702|NCT01276288|11658442|FG001|Overall Study|not treated|0
7395703|NCT01276288|11658443|FG002|Overall Study|not treated|0
7395704|NCT01276288|11658444|FG003|Overall Study|not treated|0
7465382|NCT02876835|11764624|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25
7465383|NCT02876835|11764625|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29
7553073|NCT03004924|11913792|FG000|Overall Study|HSV1 Positive|1
7553074|NCT03004924|11913793|FG001|Overall Study|HSV1 Positive|0
7553075|NCT03004924|11913794|FG002|Overall Study|HSV1 Positive|0
7553076|NCT03005067|11913816|FG000|Overall Study|Withdrawal by Subject|3
7553077|NCT03005067|11913817|FG001|Overall Study|Withdrawal by Subject|2
7553078|NCT03005067|11913816|FG000|Overall Study|Adverse Event|4
7553079|NCT03005067|11913817|FG001|Overall Study|Adverse Event|3
7553080|NCT03005067|11913816|FG000|Overall Study|Other (reason not specified)|3
7553081|NCT03005067|11913817|FG001|Overall Study|Other (reason not specified)|1
7553082|NCT03005067|11913816|FG000|Overall Study|Protocol Violation|0
7468588|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7468589|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
7468590|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
7468591|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7468592|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
7468593|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
7468594|NCT01912339|11769452|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
7468595|NCT01912339|11769453|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
7468596|NCT01912339|11769454|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
7468597|NCT01912456|11769466|FG000|Period 1|Physician Decision|0
7468598|NCT01912456|11769467|FG001|Period 1|Physician Decision|0
7468599|NCT01912456|11769468|FG002|Period 1|Physician Decision|1
7468600|NCT01912456|11769469|FG003|Period 1|Physician Decision|0
7468601|NCT01912456|11769466|FG000|Period 1|non-compliance|1
7468602|NCT01912456|11769467|FG001|Period 1|non-compliance|0
7468603|NCT01912456|11769468|FG002|Period 1|non-compliance|0
7468604|NCT01912456|11769469|FG003|Period 1|non-compliance|1
7468605|NCT01912456|11769466|FG000|Period 1|Adverse Event|1
7468606|NCT01912456|11769467|FG001|Period 1|Adverse Event|0
7468607|NCT01912456|11769468|FG002|Period 1|Adverse Event|0
7468608|NCT01912456|11769469|FG003|Period 1|Adverse Event|1
7468609|NCT01912456|11769466|FG000|Period 1|Withdrawal by Subject|0
7468610|NCT01912456|11769467|FG001|Period 1|Withdrawal by Subject|1
7468611|NCT01912456|11769468|FG002|Period 1|Withdrawal by Subject|1
7468612|NCT01912456|11769469|FG003|Period 1|Withdrawal by Subject|1
7468613|NCT01912456|11769466|FG000|Period 2|Lack of Efficacy|0
7468614|NCT01912456|11769467|FG001|Period 2|Lack of Efficacy|2
7468615|NCT01912456|11769468|FG002|Period 2|Lack of Efficacy|0
7468616|NCT01912456|11769469|FG003|Period 2|Lack of Efficacy|0
7468617|NCT01912456|11769466|FG000|Period 2|Adverse Event|0
7468618|NCT01912456|11769467|FG001|Period 2|Adverse Event|0
7468619|NCT01912456|11769468|FG002|Period 2|Adverse Event|0
7468620|NCT01912456|11769469|FG003|Period 2|Adverse Event|1
7468621|NCT01912599|11769488|FG000|Overall Study|Withdrawal by Subject|0
7468622|NCT01912599|11769489|FG001|Overall Study|Withdrawal by Subject|1
7468623|NCT01912612|11769497|FG000|Overall Study|Adverse Event|4
7468624|NCT01912612|11769498|FG001|Overall Study|Adverse Event|0
7468625|NCT01912612|11769499|FG002|Overall Study|Adverse Event|0
7468626|NCT01912612|11769497|FG000|Overall Study|Withdrew consent|1
7468627|NCT01912612|11769498|FG001|Overall Study|Withdrew consent|0
7468628|NCT01912612|11769499|FG002|Overall Study|Withdrew consent|0
7468629|NCT01912612|11769497|FG000|Overall Study|Study design change|0
7468630|NCT01912612|11769498|FG001|Overall Study|Study design change|0
7468631|NCT01912612|11769499|FG002|Overall Study|Study design change|3
7468711|NCT01913405|11769618|FG000|Overall Study|Adverse Event|1
7468712|NCT01913470|11769637|FG000|Overall Study|Lost to Follow-up|0
7468713|NCT01913470|11769638|FG001|Overall Study|Lost to Follow-up|1
7468714|NCT01913470|11769637|FG000|Overall Study|Physician Decision|0
7468715|NCT01913470|11769638|FG001|Overall Study|Physician Decision|1
7468716|NCT01913470|11769637|FG000|Overall Study|Withdrawal by Subject|0
7468717|NCT01913470|11769638|FG001|Overall Study|Withdrawal by Subject|1
7468718|NCT01913483|11769647|FG000|Overall Study|Withdrawal by Subject|1
7468719|NCT01913483|11769648|FG001|Overall Study|Withdrawal by Subject|2
7468720|NCT01913483|11769647|FG000|Overall Study|Lost to Follow-up|6
7468721|NCT01913483|11769648|FG001|Overall Study|Lost to Follow-up|3
7468722|NCT01913483|11769647|FG000|Overall Study|Death|14
7468723|NCT01913483|11769648|FG001|Overall Study|Death|17
7468724|NCT01913639|11769680|FG000|Overall Study|Not Eligible|3
7468725|NCT01914393|11769700|FG000|Overall Study|Protocol Violation|11
7468726|NCT01914393|11769701|FG001|Overall Study|Protocol Violation|3
7468727|NCT01914393|11769702|FG002|Overall Study|Protocol Violation|19
7395705|NCT01276327|11658493|FG000|Overall Study|Adverse Event|1
7395706|NCT01276327|11658494|FG001|Overall Study|Adverse Event|3
7395707|NCT01276327|11658493|FG000|Overall Study|Withdrawal by Subject|1
7395708|NCT01276327|11658494|FG001|Overall Study|Withdrawal by Subject|0
7395709|NCT01276353|11658502|FG000|Double-blind|Adverse Event|2
7395710|NCT01276353|11658503|FG001|Double-blind|Adverse Event|0
7395711|NCT01276353|11658502|FG000|Double-blind|Withdrawal by Subject|1
7395712|NCT01276353|11658503|FG001|Double-blind|Withdrawal by Subject|0
7395713|NCT01276353|11658502|FG000|Extension|Adverse Event|2
7395714|NCT01276353|11658503|FG001|Extension|Adverse Event|5
7395715|NCT01276353|11658502|FG000|Extension|Withdrawal by Subject|1
7395716|NCT01276353|11658503|FG001|Extension|Withdrawal by Subject|2
7395717|NCT01276353|11658502|FG000|Extension|Withdrawal of study drug 4 days in a row|3
7395718|NCT01276353|11658503|FG001|Extension|Withdrawal of study drug 4 days in a row|1
7395719|NCT01276353|11658502|FG000|Extension|Physician Decision|1
7395720|NCT01276353|11658503|FG001|Extension|Physician Decision|0
7395721|NCT01276353|11658502|FG000|Extension|Prohibited concomitant medications|0
7395722|NCT01276353|11658503|FG001|Extension|Prohibited concomitant medications|1
7395723|NCT01276379|11658515|FG000|Overall Study|Screening failure|40
7395724|NCT01276457|11658523|FG000|Core Study|Adverse Event|6
7395725|NCT01276457|11658524|FG001|Core Study|Adverse Event|3
7395726|NCT01276457|11658523|FG000|Core Study|Lost to Follow-up|1
7395727|NCT01276457|11658524|FG001|Core Study|Lost to Follow-up|2
7395728|NCT01276457|11658523|FG000|Core Study|Administrative problems|1
7395729|NCT01276457|11658524|FG001|Core Study|Administrative problems|1
7395730|NCT01276457|11658523|FG000|Core Study|Death|2
7395731|NCT01276457|11658524|FG001|Core Study|Death|2
7395732|NCT01276457|11658523|FG000|Core Study|Lack of Efficacy|3
7395733|NCT01276457|11658524|FG001|Core Study|Lack of Efficacy|12
7224620|NCT00056316|11433891|FG001|Overall Study|Withdrawal by Subject|2
7224621|NCT00056316|11433890|FG000|Overall Study|Death/NH placement of pt|1
7224622|NCT00056316|11433891|FG001|Overall Study|Death/NH placement of pt|1
7395734|NCT01276457|11658523|FG000|Extension Study|Lost to Follow-up|3
7395735|NCT01276457|11658524|FG001|Extension Study|Lost to Follow-up|0
7395736|NCT01276457|11658523|FG000|Extension Study|Death|0
7395737|NCT01276457|11658524|FG001|Extension Study|Death|1
7395738|NCT01276457|11658523|FG000|Extension Study|Lack of Efficacy|3
7395739|NCT01276457|11658524|FG001|Extension Study|Lack of Efficacy|1
7395740|NCT01276509|11658534|FG000|Overall Study|Adverse Event|9
7395741|NCT01276509|11658535|FG001|Overall Study|Adverse Event|8
7395742|NCT01276509|11658536|FG002|Overall Study|Adverse Event|4
7395743|NCT01276509|11658537|FG003|Overall Study|Adverse Event|3
7395744|NCT01276509|11658534|FG000|Overall Study|Lack of Efficacy|2
7395745|NCT01276509|11658535|FG001|Overall Study|Lack of Efficacy|1
7395746|NCT01276509|11658536|FG002|Overall Study|Lack of Efficacy|1
7395747|NCT01276509|11658537|FG003|Overall Study|Lack of Efficacy|2
7395748|NCT01276509|11658534|FG000|Overall Study|Pregnancy|1
7395749|NCT01276509|11658535|FG001|Overall Study|Pregnancy|0
7395750|NCT01276509|11658536|FG002|Overall Study|Pregnancy|0
7395751|NCT01276509|11658537|FG003|Overall Study|Pregnancy|0
7395752|NCT01276509|11658534|FG000|Overall Study|Withdrawal by Subject|1
7395753|NCT01276509|11658535|FG001|Overall Study|Withdrawal by Subject|2
7395754|NCT01276509|11658536|FG002|Overall Study|Withdrawal by Subject|0
7395755|NCT01276509|11658537|FG003|Overall Study|Withdrawal by Subject|0
7395756|NCT01276509|11658534|FG000|Overall Study|Other|0
7395757|NCT01276509|11658535|FG001|Overall Study|Other|1
7395758|NCT01276509|11658536|FG002|Overall Study|Other|0
7395759|NCT01276509|11658537|FG003|Overall Study|Other|0
7395760|NCT01276639|11658554|FG000|Week 0 to 16|Death|1
7395761|NCT01276639|11658555|FG001|Week 0 to 16|Death|0
7395762|NCT01276639|11658556|FG002|Week 0 to 16|Death|0
7395763|NCT01276639|11658557|FG003|Week 0 to 16|Death|0
7395764|NCT01276639|11658558|FG004|Week 0 to 16|Death|0
7395765|NCT01276639|11658554|FG000|Week 0 to 16|Adverse Event|11
7395766|NCT01276639|11658555|FG001|Week 0 to 16|Adverse Event|8
7395767|NCT01276639|11658556|FG002|Week 0 to 16|Adverse Event|11
7395768|NCT01276639|11658557|FG003|Week 0 to 16|Adverse Event|0
7395769|NCT01276639|11658558|FG004|Week 0 to 16|Adverse Event|0
7395770|NCT01276639|11658554|FG000|Week 0 to 16|Lack of Efficacy|20
7395771|NCT01276639|11658555|FG001|Week 0 to 16|Lack of Efficacy|15
7395772|NCT01276639|11658556|FG002|Week 0 to 16|Lack of Efficacy|25
7395773|NCT01276639|11658557|FG003|Week 0 to 16|Lack of Efficacy|0
7395774|NCT01276639|11658558|FG004|Week 0 to 16|Lack of Efficacy|0
7395775|NCT01276639|11658554|FG000|Week 0 to 16|Lost to Follow-up|3
7395776|NCT01276639|11658555|FG001|Week 0 to 16|Lost to Follow-up|5
7395777|NCT01276639|11658556|FG002|Week 0 to 16|Lost to Follow-up|3
7395778|NCT01276639|11658557|FG003|Week 0 to 16|Lost to Follow-up|0
7395779|NCT01276639|11658558|FG004|Week 0 to 16|Lost to Follow-up|0
7395780|NCT01276639|11658554|FG000|Week 0 to 16|Withdrawal by Subject|8
7395781|NCT01276639|11658555|FG001|Week 0 to 16|Withdrawal by Subject|5
7395782|NCT01276639|11658556|FG002|Week 0 to 16|Withdrawal by Subject|4
7395783|NCT01276639|11658557|FG003|Week 0 to 16|Withdrawal by Subject|0
7395784|NCT01276639|11658558|FG004|Week 0 to 16|Withdrawal by Subject|0
7395785|NCT01276639|11658554|FG000|Week 0 to 16|Other|7
7395786|NCT01276639|11658555|FG001|Week 0 to 16|Other|7
7395787|NCT01276639|11658556|FG002|Week 0 to 16|Other|2
7395788|NCT01276639|11658557|FG003|Week 0 to 16|Other|0
7395789|NCT01276639|11658558|FG004|Week 0 to 16|Other|0
7395790|NCT01276639|11658554|FG000|Week 0 to 16|Randomized, But Not Treated|0
7395791|NCT01276639|11658555|FG001|Week 0 to 16|Randomized, But Not Treated|1
7395792|NCT01276639|11658556|FG002|Week 0 to 16|Randomized, But Not Treated|0
7395793|NCT01276639|11658557|FG003|Week 0 to 16|Randomized, But Not Treated|0
7395794|NCT01276639|11658558|FG004|Week 0 to 16|Randomized, But Not Treated|0
7395795|NCT01276639|11658554|FG000|Week 16 to 52|Death|1
7395796|NCT01276639|11658555|FG001|Week 16 to 52|Death|0
7395797|NCT01276639|11658556|FG002|Week 16 to 52|Death|0
7395798|NCT01276639|11658557|FG003|Week 16 to 52|Death|0
7395799|NCT01276639|11658558|FG004|Week 16 to 52|Death|0
7395800|NCT01276639|11658554|FG000|Week 16 to 52|Adverse Event|10
7395801|NCT01276639|11658555|FG001|Week 16 to 52|Adverse Event|13
7395802|NCT01276639|11658556|FG002|Week 16 to 52|Adverse Event|0
7395803|NCT01276639|11658557|FG003|Week 16 to 52|Adverse Event|1
7395804|NCT01276639|11658558|FG004|Week 16 to 52|Adverse Event|3
7395805|NCT01276639|11658554|FG000|Week 16 to 52|Lack of Efficacy|99
7395806|NCT01276639|11658555|FG001|Week 16 to 52|Lack of Efficacy|71
7395807|NCT01276639|11658556|FG002|Week 16 to 52|Lack of Efficacy|0
7395808|NCT01276639|11658557|FG003|Week 16 to 52|Lack of Efficacy|14
7395809|NCT01276639|11658558|FG004|Week 16 to 52|Lack of Efficacy|13
7395810|NCT01276639|11658554|FG000|Week 16 to 52|Lost to Follow-up|3
7395811|NCT01276639|11658555|FG001|Week 16 to 52|Lost to Follow-up|1
7395812|NCT01276639|11658556|FG002|Week 16 to 52|Lost to Follow-up|0
7395813|NCT01276639|11658557|FG003|Week 16 to 52|Lost to Follow-up|0
7395814|NCT01276639|11658558|FG004|Week 16 to 52|Lost to Follow-up|1
7395815|NCT01276639|11658554|FG000|Week 16 to 52|Withdrawal by Subject|4
7395816|NCT01276639|11658555|FG001|Week 16 to 52|Withdrawal by Subject|4
7395817|NCT01276639|11658556|FG002|Week 16 to 52|Withdrawal by Subject|0
7395818|NCT01276639|11658557|FG003|Week 16 to 52|Withdrawal by Subject|0
7395819|NCT01276639|11658558|FG004|Week 16 to 52|Withdrawal by Subject|1
7395820|NCT01276639|11658554|FG000|Week 16 to 52|Other|10
7395821|NCT01276639|11658555|FG001|Week 16 to 52|Other|12
7395822|NCT01276639|11658556|FG002|Week 16 to 52|Other|0
7395823|NCT01276639|11658557|FG003|Week 16 to 52|Other|1
7395824|NCT01276639|11658558|FG004|Week 16 to 52|Other|3
7395825|NCT01276756|11658593|FG000|Overall Study|Lost to Follow-up|2
7395826|NCT01276756|11658594|FG001|Overall Study|Lost to Follow-up|0
7395827|NCT01276756|11658593|FG000|Overall Study|Adverse Event|3
7395828|NCT01276756|11658594|FG001|Overall Study|Adverse Event|2
7395829|NCT01276821|11658602|FG000|Overall Study|Protocol Violation|0
7395830|NCT01276821|11658603|FG001|Overall Study|Protocol Violation|1
7395831|NCT01276847|11658612|FG000|Overall Study|Withdrawal by Subject|1
7395832|NCT01276847|11658613|FG001|Overall Study|Withdrawal by Subject|0
7395833|NCT01276847|11658614|FG002|Overall Study|Withdrawal by Subject|0
7395834|NCT01277042|11658632|FG000|Overall Study|Adverse Event|4
7395835|NCT01277042|11658633|FG001|Overall Study|Adverse Event|3
7395836|NCT01277042|11658632|FG000|Overall Study|Lost to Follow-up|2
7395837|NCT01277042|11658633|FG001|Overall Study|Lost to Follow-up|2
7395838|NCT01277042|11658632|FG000|Overall Study|Withdrawal by Subject|2
7395839|NCT01277042|11658633|FG001|Overall Study|Withdrawal by Subject|0
7395840|NCT01277302|11658673|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7395841|NCT01277302|11658674|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
7395842|NCT01277302|11658675|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
7395843|NCT01277302|11658673|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
7395844|NCT01277302|11658674|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
7395845|NCT01277302|11658675|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
7395846|NCT01277302|11658673|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7395847|NCT01277302|11658674|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
7395848|NCT01277302|11658675|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
7395849|NCT01277302|11658673|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
7395850|NCT01277302|11658674|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
7395851|NCT01277302|11658675|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
7395852|NCT01277302|11658673|FG000|8-Month Alternate Dose Regimen Period|Death|0
7395853|NCT01277302|11658674|FG001|8-Month Alternate Dose Regimen Period|Death|1
7395854|NCT01277302|11658675|FG002|8-Month Alternate Dose Regimen Period|Death|0
7395855|NCT01277302|11658673|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7395856|NCT01277302|11658674|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
7395857|NCT01277302|11658675|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
7395858|NCT01277302|11658673|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
7395859|NCT01277302|11658674|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
7395860|NCT01277302|11658675|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
7395861|NCT01277302|11658673|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
7395862|NCT01277302|11658674|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
7395863|NCT01277302|11658675|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
7395864|NCT01277302|11658673|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
7395865|NCT01277302|11658674|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
7395866|NCT01277302|11658675|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
7395867|NCT01277510|11658711|FG000|Double-blind Phase|Non-compliance|0
7395868|NCT01277510|11658712|FG001|Double-blind Phase|Non-compliance|1
7395869|NCT01277510|11658711|FG000|Double-blind Phase|Adverse Event|1
7395870|NCT01277510|11658712|FG001|Double-blind Phase|Adverse Event|0
7395871|NCT01277510|11658711|FG000|Double-blind Phase|Withdrawal by Subject|2
7395872|NCT01277510|11658712|FG001|Double-blind Phase|Withdrawal by Subject|0
7395873|NCT01277510|11658711|FG000|Double-blind Phase|Administrative decision|7
7395874|NCT01277510|11658712|FG001|Double-blind Phase|Administrative decision|9
7395875|NCT01277510|11658711|FG000|Double-blind Phase|Death|0
7395876|NCT01277510|11658712|FG001|Double-blind Phase|Death|1
7395877|NCT01277510|11658711|FG000|Double-blind Phase|Protocol-specified criteria|2
7395878|NCT01277510|11658712|FG001|Double-blind Phase|Protocol-specified criteria|6
7395879|NCT01277510|11658711|FG000|Double-blind Phase|Other|1
7395880|NCT01277510|11658712|FG001|Double-blind Phase|Other|1
7395881|NCT01277510|11658711|FG000|Open-label Phase|Administrative decision|4
7395882|NCT01277510|11658712|FG001|Open-label Phase|Administrative decision|3
7395883|NCT01277510|11658711|FG000|Open-label Phase|Protocol-specified criteria|1
7395884|NCT01277510|11658712|FG001|Open-label Phase|Protocol-specified criteria|0
7395885|NCT01277510|11658711|FG000|Open-label Phase|Never received investigational product|2
7395886|NCT01277510|11658712|FG001|Open-label Phase|Never received investigational product|0
7395887|NCT01277523|11658723|FG000|Overall Study|Adverse Event|1
7395888|NCT01277523|11658724|FG001|Overall Study|Adverse Event|0
7395889|NCT01277523|11658725|FG002|Overall Study|Adverse Event|0
7395890|NCT01277523|11658723|FG000|Overall Study|Protocol Violation|2
7395891|NCT01277523|11658724|FG001|Overall Study|Protocol Violation|0
7395892|NCT01277523|11658725|FG002|Overall Study|Protocol Violation|0
7395893|NCT01277523|11658723|FG000|Overall Study|Other Reason not Defined|0
7395894|NCT01277523|11658724|FG001|Overall Study|Other Reason not Defined|1
7395895|NCT01277523|11658725|FG002|Overall Study|Other Reason not Defined|0
7395896|NCT01277549|11658735|FG000|Overall Study|Failed to meet eligibility criteria|13
7395897|NCT01277549|11658736|FG001|Overall Study|Failed to meet eligibility criteria|9
7395898|NCT01277549|11658735|FG000|Overall Study|Withdrawal by Subject|1
7395899|NCT01277549|11658736|FG001|Overall Study|Withdrawal by Subject|3
7395900|NCT01277549|11658735|FG000|Overall Study|Protocol Violation|10
7395901|NCT01277549|11658736|FG001|Overall Study|Protocol Violation|1
7395902|NCT01277549|11658735|FG000|Overall Study|Physician Decision|2
7395903|NCT01277549|11658736|FG001|Overall Study|Physician Decision|1
7395904|NCT01277601|11658749|FG000|Overall Study|Adverse Event|5
7395905|NCT01277601|11658750|FG001|Overall Study|Adverse Event|3
7395906|NCT01277601|11658751|FG002|Overall Study|Adverse Event|0
7395907|NCT01277601|11658752|FG003|Overall Study|Adverse Event|7
7395908|NCT01277601|11658749|FG000|Overall Study|Withdrawal by Subject|18
7395909|NCT01277601|11658750|FG001|Overall Study|Withdrawal by Subject|21
7395910|NCT01277601|11658751|FG002|Overall Study|Withdrawal by Subject|8
7395911|NCT01277601|11658752|FG003|Overall Study|Withdrawal by Subject|17
7395912|NCT01277601|11658749|FG000|Overall Study|Lost to Follow-up|7
7395913|NCT01277601|11658750|FG001|Overall Study|Lost to Follow-up|9
7395914|NCT01277601|11658751|FG002|Overall Study|Lost to Follow-up|4
7395915|NCT01277601|11658752|FG003|Overall Study|Lost to Follow-up|2
7395916|NCT01277601|11658749|FG000|Overall Study|Physician Decision|3
7395917|NCT01277601|11658750|FG001|Overall Study|Physician Decision|5
7395918|NCT01277601|11658751|FG002|Overall Study|Physician Decision|1
7395919|NCT01277601|11658752|FG003|Overall Study|Physician Decision|6
7395920|NCT01277601|11658749|FG000|Overall Study|Pregnancy|2
7395921|NCT01277601|11658750|FG001|Overall Study|Pregnancy|2
7395922|NCT01277601|11658751|FG002|Overall Study|Pregnancy|4
7395923|NCT01277601|11658752|FG003|Overall Study|Pregnancy|1
7395924|NCT01277601|11658749|FG000|Overall Study|Noncompliance with Study Drug|1
7395925|NCT01277601|11658750|FG001|Overall Study|Noncompliance with Study Drug|3
7395926|NCT01277601|11658751|FG002|Overall Study|Noncompliance with Study Drug|2
7395927|NCT01277601|11658752|FG003|Overall Study|Noncompliance with Study Drug|0
7395928|NCT01277601|11658749|FG000|Overall Study|Subject Never Dosed with Study Drug|1
7395929|NCT01277601|11658750|FG001|Overall Study|Subject Never Dosed with Study Drug|2
7395930|NCT01277601|11658751|FG002|Overall Study|Subject Never Dosed with Study Drug|3
7395931|NCT01277601|11658752|FG003|Overall Study|Subject Never Dosed with Study Drug|1
7395932|NCT01277601|11658749|FG000|Overall Study|Protocol Violation|0
7395933|NCT01277601|11658750|FG001|Overall Study|Protocol Violation|2
7395934|NCT01277601|11658751|FG002|Overall Study|Protocol Violation|5
7395935|NCT01277601|11658752|FG003|Overall Study|Protocol Violation|0
7395936|NCT01277601|11658749|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
7395937|NCT01277601|11658750|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
7395938|NCT01277601|11658751|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
7395939|NCT01277601|11658752|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
7395940|NCT01277666|11658782|FG000|Overall Study|Adverse Event|26
7395941|NCT01277666|11658783|FG001|Overall Study|Adverse Event|25
7395942|NCT01277666|11658784|FG002|Overall Study|Adverse Event|20
7395943|NCT01277666|11658782|FG000|Overall Study|Lack of Efficacy|8
7395944|NCT01277666|11658783|FG001|Overall Study|Lack of Efficacy|20
7395945|NCT01277666|11658784|FG002|Overall Study|Lack of Efficacy|12
7395946|NCT01277666|11658782|FG000|Overall Study|Protocol Violation|2
7395947|NCT01277666|11658783|FG001|Overall Study|Protocol Violation|3
7395948|NCT01277666|11658784|FG002|Overall Study|Protocol Violation|2
7395949|NCT01277666|11658782|FG000|Overall Study|Protocol Defined Stopping criteria|1
7395950|NCT01277666|11658783|FG001|Overall Study|Protocol Defined Stopping criteria|2
7395951|NCT01277666|11658784|FG002|Overall Study|Protocol Defined Stopping criteria|6
7395952|NCT01277666|11658782|FG000|Overall Study|Lost to Follow-up|1
7395953|NCT01277666|11658783|FG001|Overall Study|Lost to Follow-up|1
7395954|NCT01277666|11658784|FG002|Overall Study|Lost to Follow-up|2
7395955|NCT01277666|11658782|FG000|Overall Study|Withdrawal by Subject|7
7395956|NCT01277666|11658783|FG001|Overall Study|Withdrawal by Subject|8
7395957|NCT01277666|11658784|FG002|Overall Study|Withdrawal by Subject|6
7395958|NCT01277666|11658782|FG000|Overall Study|Death|0
7395959|NCT01277666|11658783|FG001|Overall Study|Death|0
7395960|NCT01277666|11658784|FG002|Overall Study|Death|1
7395961|NCT01277718|11658792|FG000|Period 2 - Second Intervention|Protocol Violation|0
7395962|NCT01277718|11658793|FG001|Period 2 - Second Intervention|Protocol Violation|1
7395963|NCT01277718|11658792|FG000|Period 2 - Second Intervention|Physician Decision|0
7395964|NCT01277718|11658793|FG001|Period 2 - Second Intervention|Physician Decision|2
7395965|NCT01277744|11658801|FG000|Overall Study|Physician Decision|2
7395966|NCT01277757|11658805|FG000|Overall Study|Disease Progression|1
7395967|NCT01277757|11658805|FG000|Overall Study|Withdrawal by Subject|1
7395968|NCT01277861|11658816|FG000|Overall Study|Physician Decision|2
7395969|NCT01277861|11658817|FG001|Overall Study|Physician Decision|2
7395970|NCT01277887|11658827|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
7395971|NCT01277887|11658828|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
7395972|NCT01277887|11658827|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
7395973|NCT01277887|11658828|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
7395974|NCT01277887|11658827|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
7395975|NCT01277887|11658828|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
7395976|NCT01278030|11658836|FG000|Overall Study|Withdrawal by Subject|8
7395977|NCT01278030|11658837|FG001|Overall Study|Withdrawal by Subject|4
7395978|NCT01278160|11658845|FG000|Overall Study|Adverse Event|1
7395979|NCT01278160|11658846|FG001|Overall Study|Adverse Event|1
7395980|NCT01278160|11658845|FG000|Overall Study|Lost to Follow-up|0
7395981|NCT01278160|11658846|FG001|Overall Study|Lost to Follow-up|1
7395982|NCT01278160|11658845|FG000|Overall Study|Withdrawal by Subject|3
7395983|NCT01278160|11658846|FG001|Overall Study|Withdrawal by Subject|2
7395984|NCT01278160|11658845|FG000|Overall Study|Unclassified|1
7395985|NCT01278160|11658846|FG001|Overall Study|Unclassified|2
7395986|NCT01278173|11658852|FG000|Overall Study|Lack of Efficacy|13
7395987|NCT01278173|11658852|FG000|Overall Study|Adverse Event|8
7395988|NCT01278173|11658852|FG000|Overall Study|Administrative or other reason|4
7395989|NCT01278173|11658852|FG000|Overall Study|Protocol Violation|1
7395990|NCT01278173|11658852|FG000|Overall Study|Withdrawal by Subject|1
7395991|NCT01278342|11658863|FG000|Overall Study|Physician Decision|0
7395992|NCT01278342|11658864|FG001|Overall Study|Physician Decision|1
7395993|NCT01278342|11658865|FG002|Overall Study|Physician Decision|0
7395994|NCT01278342|11658863|FG000|Overall Study|Lost to Follow-up|1
7395995|NCT01278342|11658864|FG001|Overall Study|Lost to Follow-up|0
7395996|NCT01278342|11658865|FG002|Overall Study|Lost to Follow-up|0
7395997|NCT01278342|11658863|FG000|Overall Study|Administrative problems|2
7395998|NCT01278342|11658864|FG001|Overall Study|Administrative problems|0
7395999|NCT01278342|11658865|FG002|Overall Study|Administrative problems|0
7396000|NCT01278342|11658863|FG000|Overall Study|Other|1
7396001|NCT01278342|11658864|FG001|Overall Study|Other|0
7396002|NCT01278342|11658865|FG002|Overall Study|Other|0
7396003|NCT01278394|11658873|FG000|Overall Study|Lost to Follow-up|1
7396004|NCT01278407|11658880|FG000|Confirmatory Phase|Adverse Event|5
7396005|NCT01278407|11658881|FG001|Confirmatory Phase|Adverse Event|10
7396006|NCT01278407|11658882|FG002|Confirmatory Phase|Adverse Event|1
7396007|NCT01278407|11658883|FG003|Confirmatory Phase|Adverse Event|0
7396008|NCT01278407|11658884|FG004|Confirmatory Phase|Adverse Event|0
7396009|NCT01278407|11658880|FG000|Confirmatory Phase|Participant's Choice|3
7396010|NCT01278407|11658881|FG001|Confirmatory Phase|Participant's Choice|5
7396011|NCT01278407|11658882|FG002|Confirmatory Phase|Participant's Choice|3
7396012|NCT01278407|11658883|FG003|Confirmatory Phase|Participant's Choice|0
7396013|NCT01278407|11658884|FG004|Confirmatory Phase|Participant's Choice|0
7396014|NCT01278407|11658880|FG000|Confirmatory Phase|Other|1
7396015|NCT01278407|11658881|FG001|Confirmatory Phase|Other|1
7396016|NCT01278407|11658882|FG002|Confirmatory Phase|Other|2
7396017|NCT01278407|11658883|FG003|Confirmatory Phase|Other|0
7396018|NCT01278407|11658884|FG004|Confirmatory Phase|Other|0
7396019|NCT01278407|11658880|FG000|Extension Phase|Adverse Event|0
7396020|NCT01278407|11658881|FG001|Extension Phase|Adverse Event|0
7396021|NCT01278407|11658882|FG002|Extension Phase|Adverse Event|0
7396022|NCT01278407|11658883|FG003|Extension Phase|Adverse Event|7
7396023|NCT01278407|11658884|FG004|Extension Phase|Adverse Event|16
7396024|NCT01278407|11658880|FG000|Extension Phase|Participant's Choice|0
7396025|NCT01278407|11658881|FG001|Extension Phase|Participant's Choice|0
7396026|NCT01278407|11658882|FG002|Extension Phase|Participant's Choice|0
7396027|NCT01278407|11658883|FG003|Extension Phase|Participant's Choice|4
7396028|NCT01278407|11658884|FG004|Extension Phase|Participant's Choice|11
7396029|NCT01278407|11658880|FG000|Extension Phase|Other|0
7396030|NCT01278407|11658881|FG001|Extension Phase|Other|0
7396031|NCT01278407|11658882|FG002|Extension Phase|Other|0
7396032|NCT01278407|11658883|FG003|Extension Phase|Other|1
7396033|NCT01278407|11658884|FG004|Extension Phase|Other|3
7396034|NCT01278615|11658898|FG000|Overall Study|Withdrawal by Subject|2
7396035|NCT01278745|11658904|FG000|Overall Study|Death|2
7396036|NCT01278745|11658905|FG001|Overall Study|Death|5
7396037|NCT01278745|11658906|FG002|Overall Study|Death|7
7396038|NCT01278745|11658907|FG003|Overall Study|Death|0
7396039|NCT01278745|11658904|FG000|Overall Study|Physician Decision|1
7396040|NCT01278745|11658905|FG001|Overall Study|Physician Decision|0
7396041|NCT01278745|11658906|FG002|Overall Study|Physician Decision|0
7396042|NCT01278745|11658907|FG003|Overall Study|Physician Decision|9
7396043|NCT01278745|11658904|FG000|Overall Study|Withdrawal by Subject|1
7396044|NCT01278745|11658905|FG001|Overall Study|Withdrawal by Subject|1
7396045|NCT01278745|11658906|FG002|Overall Study|Withdrawal by Subject|5
7396046|NCT01278745|11658907|FG003|Overall Study|Withdrawal by Subject|1
7396047|NCT01278745|11658904|FG000|Overall Study|Sponsor Decision|1
7396048|NCT01278745|11658905|FG001|Overall Study|Sponsor Decision|0
7396049|NCT01278745|11658906|FG002|Overall Study|Sponsor Decision|62
7396050|NCT01278745|11658907|FG003|Overall Study|Sponsor Decision|6
7396051|NCT01278745|11658904|FG000|Overall Study|Ineligible|0
7396052|NCT01278745|11658905|FG001|Overall Study|Ineligible|0
7396053|NCT01278745|11658906|FG002|Overall Study|Ineligible|42
7396054|NCT01278745|11658907|FG003|Overall Study|Ineligible|61
7396055|NCT01278745|11658904|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
7396056|NCT01278745|11658905|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
7396057|NCT01278745|11658906|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
7396058|NCT01278745|11658907|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
7396059|NCT01278797|11658915|FG000|Period 1|Adverse Event|0
7396060|NCT01278797|11658916|FG001|Period 1|Adverse Event|1
7396061|NCT01278797|11658915|FG000|Period 1|Protocol Violation|1
7396062|NCT01278797|11658916|FG001|Period 1|Protocol Violation|0
7396063|NCT01278862|11658924|FG000|Overall Study|Lost to Follow-up|1
7396064|NCT01278862|11658925|FG001|Overall Study|Lost to Follow-up|1
7396065|NCT01279044|11658961|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
7396066|NCT01279044|11658962|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
7396067|NCT01279044|11658963|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
7396068|NCT01279044|11658961|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7396069|NCT01279044|11658962|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
7396070|NCT01279044|11658963|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
7396071|NCT01279044|11658961|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
7396072|NCT01279044|11658962|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
7396073|NCT01279044|11658963|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
7396074|NCT01279057|11658972|FG000|Overall Study|Adverse Event|1
7396075|NCT01279057|11658973|FG001|Overall Study|Adverse Event|0
7396076|NCT01279057|11658974|FG002|Overall Study|Adverse Event|1
7396077|NCT01279057|11658972|FG000|Overall Study|Insufficient therapeutic response|0
7396078|NCT01279057|11658973|FG001|Overall Study|Insufficient therapeutic response|0
7396079|NCT01279057|11658974|FG002|Overall Study|Insufficient therapeutic response|1
7396080|NCT01279057|11658972|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7396081|NCT01279057|11658973|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7396082|NCT01279057|11658974|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7396083|NCT01279057|11658972|FG000|Overall Study|Withdrew consent|2
7396084|NCT01279057|11658973|FG001|Overall Study|Withdrew consent|0
7396085|NCT01279057|11658974|FG002|Overall Study|Withdrew consent|1
7396086|NCT01279057|11658972|FG000|Overall Study|Pregnancy|0
7396087|NCT01279057|11658973|FG001|Overall Study|Pregnancy|1
7396088|NCT01279057|11658974|FG002|Overall Study|Pregnancy|0
7396089|NCT01279057|11658972|FG000|Overall Study|Other|3
7396090|NCT01279057|11658973|FG001|Overall Study|Other|3
7396091|NCT01279057|11658974|FG002|Overall Study|Other|0
7396092|NCT01279070|11658984|FG000|Overall Study|Withdrawal by Subject|2
7396093|NCT01279070|11658985|FG001|Overall Study|Withdrawal by Subject|3
7396094|NCT01279070|11658984|FG000|Overall Study|Acute exacerbation|3
7396095|NCT01279070|11658985|FG001|Overall Study|Acute exacerbation|1
7396096|NCT01279200|11659015|FG000|Overall Study|Withdrawal by Subject|1
7396097|NCT01279200|11659016|FG001|Overall Study|Withdrawal by Subject|3
7396098|NCT01279200|11659015|FG000|Overall Study|Patient withdrawal due to high cost|0
7396099|NCT01279200|11659016|FG001|Overall Study|Patient withdrawal due to high cost|1
7396100|NCT01279200|11659015|FG000|Overall Study|Inconvenience of ultrasound visit|0
7396101|NCT01279200|11659016|FG001|Overall Study|Inconvenience of ultrasound visit|1
7396102|NCT01279200|11659015|FG000|Overall Study|ultrasound screening failure|0
7396103|NCT01279200|11659016|FG001|Overall Study|ultrasound screening failure|1
7396104|NCT01279200|11659015|FG000|Overall Study|Lost to Follow-up|0
7396105|NCT01279200|11659016|FG001|Overall Study|Lost to Follow-up|1
7396106|NCT01279200|11659015|FG000|Overall Study|Adverse Event|1
7396107|NCT01279200|11659016|FG001|Overall Study|Adverse Event|0
7396108|NCT01279343|11659041|FG000|Overall Study|Did not receive treatment|2
7396109|NCT01279343|11659042|FG001|Overall Study|Did not receive treatment|6
7396110|NCT01279447|11659050|FG000|Overall Study|Lost to Follow-up|3
7396111|NCT01279447|11659051|FG001|Overall Study|Lost to Follow-up|1
7396112|NCT01279486|11659057|FG000|Overall Study|Lost to Follow-up|1
7396113|NCT01279681|11659072|FG000|Overall Study|Disease Progression|9
7396114|NCT01279681|11659073|FG001|Overall Study|Disease Progression|6
7396115|NCT01279681|11659072|FG000|Overall Study|Withdrawal by Subject|3
7396116|NCT01279681|11659073|FG001|Overall Study|Withdrawal by Subject|4
7396117|NCT01279681|11659072|FG000|Overall Study|Adverse Event|2
7396118|NCT01279681|11659073|FG001|Overall Study|Adverse Event|3
7396119|NCT01279681|11659072|FG000|Overall Study|Death|0
7396120|NCT01279681|11659073|FG001|Overall Study|Death|1
7396121|NCT01279681|11659072|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
7396122|NCT01279681|11659073|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
7396123|NCT01279681|11659072|FG000|Overall Study|Physician Decision|1
7396124|NCT01279681|11659073|FG001|Overall Study|Physician Decision|0
7396125|NCT01279681|11659072|FG000|Overall Study|Other Reason|0
7396126|NCT01279681|11659073|FG001|Overall Study|Other Reason|2
7396127|NCT01279850|11659079|FG000|Overall Study|Protocol Violation|50
7396128|NCT01279850|11659079|FG000|Overall Study|No Drug Administration Information|7
7396129|NCT01279850|11659079|FG000|Overall Study|No Visit After Treatment|34
7396130|NCT01279954|11659085|FG000|Overall Study|Lack of Efficacy|3
7396131|NCT01279954|11659086|FG001|Overall Study|Lack of Efficacy|4
7396132|NCT01280266|11659136|FG000|First Intervention (Week 1-4)|Adverse Event|1
7396133|NCT01280266|11659137|FG001|First Intervention (Week 1-4)|Adverse Event|0
7396134|NCT01280266|11659136|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
7396135|NCT01280266|11659137|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
7396136|NCT01280357|11659147|FG000|Overall Study|Excluded no internal monitoring|14
7396137|NCT01280357|11659147|FG000|Overall Study|IInsufficient data/No data supplied|12
7396138|NCT01280591|11659179|FG000|Overall Study|Withdrawal by Subject|0
7396139|NCT01280591|11659180|FG001|Overall Study|Withdrawal by Subject|0
7396140|NCT01280591|11659181|FG002|Overall Study|Withdrawal by Subject|0
7396141|NCT01280591|11659182|FG003|Overall Study|Withdrawal by Subject|2
7396142|NCT01280591|11659179|FG000|Overall Study|Does not meet exclusion #27 criteria|0
7396143|NCT01280591|11659180|FG001|Overall Study|Does not meet exclusion #27 criteria|0
7396144|NCT01280591|11659181|FG002|Overall Study|Does not meet exclusion #27 criteria|0
7396145|NCT01280591|11659182|FG003|Overall Study|Does not meet exclusion #27 criteria|1
7396146|NCT01280617|11659203|FG000|Overall Study|Adverse Event|0
7396147|NCT01280617|11659204|FG001|Overall Study|Adverse Event|1
7396148|NCT01280656|11659213|FG000|Overall Study|Adverse Event|1
7396149|NCT01280656|11659214|FG001|Overall Study|Adverse Event|14
7396150|NCT01280656|11659215|FG002|Overall Study|Adverse Event|13
7396151|NCT01280656|11659213|FG000|Overall Study|Lack of Efficacy|1
7396152|NCT01280656|11659214|FG001|Overall Study|Lack of Efficacy|22
7396153|NCT01280656|11659215|FG002|Overall Study|Lack of Efficacy|38
7396154|NCT01280656|11659213|FG000|Overall Study|Treatment shortening (RGT)|0
7396155|NCT01280656|11659214|FG001|Overall Study|Treatment shortening (RGT)|4
7396156|NCT01280656|11659215|FG002|Overall Study|Treatment shortening (RGT)|5
7396157|NCT01280656|11659213|FG000|Overall Study|Other|1
7396158|NCT01280656|11659214|FG001|Overall Study|Other|7
7396159|NCT01280656|11659215|FG002|Overall Study|Other|7
7396160|NCT01280721|11659244|FG000|Overall Study|Adverse Event|4
7396161|NCT01280721|11659244|FG000|Overall Study|Physician Decision|3
7396162|NCT01280721|11659244|FG000|Overall Study|Withdrawal by Subject|6
7396163|NCT01280721|11659244|FG000|Overall Study|eGFR under the withdrawal criteria|7
7396164|NCT01280721|11659244|FG000|Overall Study|No tolerability for the lowest dose|2
7396165|NCT01280812|11659262|FG000|Overall Study|Withdrawal by Subject|2
7396166|NCT01280812|11659263|FG001|Overall Study|Withdrawal by Subject|1
7396167|NCT01280812|11659264|FG002|Overall Study|Withdrawal by Subject|0
7396168|NCT01280812|11659262|FG000|Overall Study|Lost to Follow-up|1
7396169|NCT01280812|11659263|FG001|Overall Study|Lost to Follow-up|1
7396170|NCT01280812|11659264|FG002|Overall Study|Lost to Follow-up|1
7396171|NCT01280903|11659275|FG000|Overall Study|Lost to Follow-up|23
7396172|NCT01280903|11659276|FG001|Overall Study|Lost to Follow-up|16
7396173|NCT01280955|11659291|FG000|Overall Study|Death|2
7396174|NCT01280955|11659291|FG000|Overall Study|Withdrawal by Subject|1
7396175|NCT01280968|11659299|FG000|Overall Study|Lost to Follow-up|8
7396176|NCT01280968|11659300|FG001|Overall Study|Lost to Follow-up|2
7396177|NCT01280968|11659299|FG000|Overall Study|Unable to Follow Experimental Protocol|2
7396178|NCT01280968|11659300|FG001|Overall Study|Unable to Follow Experimental Protocol|0
7396179|NCT01280968|11659299|FG000|Overall Study|Commuting Problems|2
7396180|NCT01280968|11659300|FG001|Overall Study|Commuting Problems|0
7396181|NCT01280968|11659299|FG000|Overall Study|Anxiety|2
7396182|NCT01280968|11659300|FG001|Overall Study|Anxiety|0
7396183|NCT01280968|11659299|FG000|Overall Study|Adverse Event|1
7396184|NCT01280968|11659300|FG001|Overall Study|Adverse Event|0
7396185|NCT01280968|11659299|FG000|Overall Study|Scheduling Conflicts|1
7396186|NCT01280968|11659300|FG001|Overall Study|Scheduling Conflicts|1
7396187|NCT01280968|11659299|FG000|Overall Study|Pre-existing Neurological Condition|1
7396188|NCT01280968|11659300|FG001|Overall Study|Pre-existing Neurological Condition|0
7396189|NCT01280968|11659299|FG000|Overall Study|Unable to Smoke in Supine Position|1
7396190|NCT01280968|11659300|FG001|Overall Study|Unable to Smoke in Supine Position|0
7396191|NCT01280981|11659307|FG000|Overall Study|Withdrawal by Subject|11
7396192|NCT01280981|11659307|FG000|Overall Study|Protocol Violation|2
7396193|NCT01280981|11659307|FG000|Overall Study|Lack of Efficacy|13
7396194|NCT01280981|11659307|FG000|Overall Study|Lost to Follow-up|3
7396195|NCT01280981|11659307|FG000|Overall Study|Adverse Event|6
7396196|NCT01280981|11659307|FG000|Overall Study|Irregular or discontinued menses|3
7396197|NCT01280981|11659307|FG000|Overall Study|Failed to return|45
7396198|NCT01280981|11659307|FG000|Overall Study|Non-compliance with protocol|3
7396199|NCT01280981|11659307|FG000|Overall Study|Withdrawal of consent|3
7396200|NCT01280981|11659307|FG000|Overall Study|Elective surgery|2
7396201|NCT01280981|11659307|FG000|Overall Study|Study site closure|1
7396202|NCT01281137|11659322|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
7396203|NCT01281137|11659323|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
7396204|NCT01281137|11659322|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
7396205|NCT01281137|11659323|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
7396206|NCT01281137|11659322|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
7396207|NCT01281137|11659323|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
7396208|NCT01281137|11659322|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
7396209|NCT01281137|11659323|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
7396210|NCT01281137|11659322|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
7396211|NCT01281137|11659323|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
7396212|NCT01281189|11659349|FG000|Overall Study|Adverse Event|7
7396213|NCT01281189|11659350|FG001|Overall Study|Adverse Event|9
7396214|NCT01281189|11659349|FG000|Overall Study|Lost to Follow-up|6
7396215|NCT01281189|11659350|FG001|Overall Study|Lost to Follow-up|4
7396216|NCT01281189|11659349|FG000|Overall Study|Withdrawal by Subject|21
7396217|NCT01281189|11659350|FG001|Overall Study|Withdrawal by Subject|24
7396218|NCT01281189|11659349|FG000|Overall Study|Physician Decision|2
7396219|NCT01281189|11659350|FG001|Overall Study|Physician Decision|3
7396220|NCT01281189|11659349|FG000|Overall Study|Death|103
7396221|NCT01281189|11659350|FG001|Overall Study|Death|91
7396222|NCT01281189|11659349|FG000|Overall Study|Other|8
7396223|NCT01281189|11659350|FG001|Overall Study|Other|12
7396224|NCT01281202|11659358|FG000|Overall Study|Adverse Event|2
7396225|NCT01281202|11659359|FG001|Overall Study|Adverse Event|0
7396226|NCT01281202|11659358|FG000|Overall Study|Withdrawal by Subject|2
7396227|NCT01281202|11659359|FG001|Overall Study|Withdrawal by Subject|2
7396228|NCT01281202|11659358|FG000|Overall Study|Protocol Violation|11
7396229|NCT01281202|11659359|FG001|Overall Study|Protocol Violation|10
7396230|NCT01281202|11659358|FG000|Overall Study|Administrative|2
7396231|NCT01281202|11659359|FG001|Overall Study|Administrative|8
7396232|NCT01281202|11659358|FG000|Overall Study|Lost to Follow-up|11
7396233|NCT01281202|11659359|FG001|Overall Study|Lost to Follow-up|13
7396234|NCT01281202|11659358|FG000|Overall Study|Incarceration|0
7396235|NCT01281202|11659359|FG001|Overall Study|Incarceration|3
7396236|NCT01281306|11659374|FG000|Overall Study|Lack of Efficacy|0
7396237|NCT01281306|11659375|FG001|Overall Study|Lack of Efficacy|1
7396238|NCT01281306|11659376|FG002|Overall Study|Lack of Efficacy|3
7396239|NCT01281306|11659377|FG003|Overall Study|Lack of Efficacy|0
7396240|NCT01281306|11659378|FG004|Overall Study|Lack of Efficacy|2
7396241|NCT01281306|11659379|FG005|Overall Study|Lack of Efficacy|0
7396242|NCT01281306|11659380|FG006|Overall Study|Lack of Efficacy|1
7396243|NCT01281306|11659374|FG000|Overall Study|Withdrawal by Subject|1
7396244|NCT01281306|11659375|FG001|Overall Study|Withdrawal by Subject|0
7396245|NCT01281306|11659376|FG002|Overall Study|Withdrawal by Subject|2
7396246|NCT01281306|11659377|FG003|Overall Study|Withdrawal by Subject|4
7396247|NCT01281306|11659378|FG004|Overall Study|Withdrawal by Subject|1
7396248|NCT01281306|11659379|FG005|Overall Study|Withdrawal by Subject|3
7396249|NCT01281306|11659380|FG006|Overall Study|Withdrawal by Subject|1
7396250|NCT01281306|11659374|FG000|Overall Study|Protocol deviation|0
7396251|NCT01281306|11659375|FG001|Overall Study|Protocol deviation|1
7396252|NCT01281306|11659376|FG002|Overall Study|Protocol deviation|1
7396253|NCT01281306|11659377|FG003|Overall Study|Protocol deviation|1
7396254|NCT01281306|11659378|FG004|Overall Study|Protocol deviation|1
7396255|NCT01281306|11659379|FG005|Overall Study|Protocol deviation|0
7396256|NCT01281306|11659380|FG006|Overall Study|Protocol deviation|0
7396257|NCT01281306|11659374|FG000|Overall Study|Condition no longer requires study drug|1
7396258|NCT01281306|11659375|FG001|Overall Study|Condition no longer requires study drug|0
7396259|NCT01281306|11659376|FG002|Overall Study|Condition no longer requires study drug|0
7396260|NCT01281306|11659377|FG003|Overall Study|Condition no longer requires study drug|0
7396261|NCT01281306|11659378|FG004|Overall Study|Condition no longer requires study drug|0
7396262|NCT01281306|11659379|FG005|Overall Study|Condition no longer requires study drug|1
7396263|NCT01281306|11659380|FG006|Overall Study|Condition no longer requires study drug|1
7396264|NCT01281306|11659374|FG000|Overall Study|Lost to Follow-up|1
7396265|NCT01281306|11659375|FG001|Overall Study|Lost to Follow-up|0
7396266|NCT01281306|11659376|FG002|Overall Study|Lost to Follow-up|0
7396267|NCT01281306|11659377|FG003|Overall Study|Lost to Follow-up|2
7396268|NCT01281306|11659378|FG004|Overall Study|Lost to Follow-up|0
7396269|NCT01281306|11659379|FG005|Overall Study|Lost to Follow-up|0
7396270|NCT01281306|11659380|FG006|Overall Study|Lost to Follow-up|1
7396271|NCT01281306|11659374|FG000|Overall Study|Death|1
7396272|NCT01281306|11659375|FG001|Overall Study|Death|0
7396273|NCT01281306|11659376|FG002|Overall Study|Death|0
7396274|NCT01281306|11659377|FG003|Overall Study|Death|0
7396275|NCT01281306|11659378|FG004|Overall Study|Death|0
7396276|NCT01281306|11659379|FG005|Overall Study|Death|0
7396277|NCT01281306|11659380|FG006|Overall Study|Death|0
7396278|NCT01281306|11659374|FG000|Overall Study|Adverse Event|3
7396279|NCT01281306|11659375|FG001|Overall Study|Adverse Event|2
7396280|NCT01281306|11659376|FG002|Overall Study|Adverse Event|2
7396281|NCT01281306|11659377|FG003|Overall Study|Adverse Event|3
7396282|NCT01281306|11659378|FG004|Overall Study|Adverse Event|5
7396283|NCT01281306|11659379|FG005|Overall Study|Adverse Event|3
7396284|NCT01281306|11659380|FG006|Overall Study|Adverse Event|3
7396285|NCT01281306|11659374|FG000|Overall Study|Randomized in error|1
7396286|NCT01281306|11659375|FG001|Overall Study|Randomized in error|0
7396287|NCT01281306|11659376|FG002|Overall Study|Randomized in error|0
7396288|NCT01281306|11659377|FG003|Overall Study|Randomized in error|1
7396289|NCT01281306|11659378|FG004|Overall Study|Randomized in error|0
7396290|NCT01281306|11659379|FG005|Overall Study|Randomized in error|0
7396291|NCT01281306|11659380|FG006|Overall Study|Randomized in error|0
7396292|NCT01281839|11659418|FG000|Overall Study|Lost to Follow-up|6
7396293|NCT01281839|11659419|FG001|Overall Study|Lost to Follow-up|3
7396294|NCT01281839|11659418|FG000|Overall Study|Withdrawal by Subject|4
7396295|NCT01281839|11659419|FG001|Overall Study|Withdrawal by Subject|10
7396296|NCT01281839|11659418|FG000|Overall Study|Reason not specified|0
7396297|NCT01281839|11659419|FG001|Overall Study|Reason not specified|1
7396298|NCT01281865|11659427|FG000|Overall Study|Adverse Event|1
7396299|NCT01281865|11659428|FG001|Overall Study|Adverse Event|1
7396300|NCT01281865|11659427|FG000|Overall Study|Withdrawal by Subject|1
7396301|NCT01281865|11659428|FG001|Overall Study|Withdrawal by Subject|0
7396302|NCT01281865|11659427|FG000|Overall Study|Lack of Efficacy|1
7396303|NCT01281865|11659428|FG001|Overall Study|Lack of Efficacy|0
7396304|NCT01281917|11659434|FG000|Overall Study|Withdrawal by Subject|1
7396305|NCT01281956|11659438|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
7396306|NCT01281956|11659439|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
7396307|NCT01281969|11659450|FG000|Overall Study|not randomized didn't meet criteria|0
7396308|NCT01281969|11659451|FG001|Overall Study|not randomized didn't meet criteria|0
7396309|NCT01281969|11659452|FG002|Overall Study|not randomized didn't meet criteria|7
7396310|NCT01281969|11659450|FG000|Overall Study|AE during LP prior to IVIG admin|1
7396311|NCT01281969|11659451|FG001|Overall Study|AE during LP prior to IVIG admin|0
7396312|NCT01281969|11659452|FG002|Overall Study|AE during LP prior to IVIG admin|3
7396313|NCT01281969|11659450|FG000|Overall Study|not randomized, child consent not given|0
7396314|NCT01281969|11659451|FG001|Overall Study|not randomized, child consent not given|0
7396315|NCT01281969|11659452|FG002|Overall Study|not randomized, child consent not given|2
7396316|NCT01282164|11659476|FG000|Overall Study|Lack of hypoglycemia during ITT|1
7396317|NCT01282164|11659477|FG001|Overall Study|Lack of hypoglycemia during ITT|0
7396318|NCT01282203|11659491|FG000|Overall Study|Adverse Event|1
7396319|NCT01282229|11659498|FG000|Overall Study|Protocol Violation|2
7396320|NCT01282294|11659525|FG000|Overall Study|Lost to Follow-up|14
7396321|NCT01282294|11659525|FG000|Overall Study|Screening failure|1
7396322|NCT01282294|11659525|FG000|Overall Study|Adverse Event|1
7396323|NCT01282294|11659525|FG000|Overall Study|Patient non-compliance|2
7396324|NCT01282294|11659525|FG000|Overall Study|Physician Decision|1
7396325|NCT01282372|11659529|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
7396326|NCT01282372|11659529|FG000|Overall Study|Lost to Follow-up|23
7396327|NCT01282372|11659529|FG000|Overall Study|Withdrawal by Subject|11
7396328|NCT01282372|11659529|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
7396329|NCT01282372|11659529|FG000|Overall Study|Death|1
7396330|NCT01282372|11659529|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
7396331|NCT01282372|11659529|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
7396332|NCT01282372|11659529|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
7396333|NCT01282372|11659529|FG000|Overall Study|Adverse Event|12
7396334|NCT01282424|11659540|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
7396335|NCT01282424|11659540|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
7396336|NCT01282424|11659540|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
7396337|NCT01282424|11659540|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
7396338|NCT01282424|11659540|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
7396339|NCT01282424|11659540|FG000|Long-term Follow-up Period (5 Years)|Death|40
7396340|NCT01282424|11659540|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
7396341|NCT01282424|11659540|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
7465394|NCT01492361|11764664|FG000|Overall Study|Withdrawal by Subject|281
7465395|NCT01492361|11764665|FG001|Overall Study|Withdrawal by Subject|297
7465396|NCT01492361|11764664|FG000|Overall Study|Physician Decision|12
7465397|NCT01492361|11764665|FG001|Overall Study|Physician Decision|12
7465398|NCT01492361|11764664|FG000|Overall Study|Lost to Follow-up|6
7465399|NCT01492361|11764665|FG001|Overall Study|Lost to Follow-up|13
7465400|NCT01492361|11764664|FG000|Overall Study|Other than specified above|106
7465401|NCT01492361|11764665|FG001|Overall Study|Other than specified above|138
7465402|NCT01296711|11764679|FG000|Overall Study|Adverse Event|3
7465403|NCT01296711|11764680|FG001|Overall Study|Adverse Event|1
7465404|NCT01296711|11764681|FG002|Overall Study|Adverse Event|4
7465405|NCT01296711|11764682|FG003|Overall Study|Adverse Event|3
7465406|NCT01296711|11764683|FG004|Overall Study|Adverse Event|1
7465407|NCT01296711|11764684|FG005|Overall Study|Adverse Event|6
7465408|NCT01296711|11764685|FG006|Overall Study|Adverse Event|11
7465409|NCT01296711|11764686|FG007|Overall Study|Adverse Event|3
7465410|NCT01296711|11764679|FG000|Overall Study|Lack of Efficacy|1
7465411|NCT01296711|11764680|FG001|Overall Study|Lack of Efficacy|4
7465412|NCT01296711|11764681|FG002|Overall Study|Lack of Efficacy|1
7396342|NCT01282463|11659547|FG000|Overall Study|Lost to Follow-up|1
7396343|NCT01282463|11659548|FG001|Overall Study|Lost to Follow-up|0
7396344|NCT01282463|11659549|FG002|Overall Study|Lost to Follow-up|0
7396345|NCT01282463|11659547|FG000|Overall Study|Withdrawal by Subject|6
7396346|NCT01282463|11659548|FG001|Overall Study|Withdrawal by Subject|2
7396347|NCT01282463|11659549|FG002|Overall Study|Withdrawal by Subject|3
7396348|NCT01282463|11659547|FG000|Overall Study|"Never Treated Death"|0
7396349|NCT01282463|11659548|FG001|Overall Study|"Never Treated Death"|1
7396350|NCT01282463|11659549|FG002|Overall Study|"Never Treated Death"|0
7396351|NCT01282463|11659547|FG000|Overall Study|"Never Treated PD"|0
7396352|NCT01282463|11659548|FG001|Overall Study|"Never Treated PD"|1
7396353|NCT01282463|11659549|FG002|Overall Study|"Never Treated PD"|0
7396354|NCT01282463|11659547|FG000|Overall Study|Protocol Violation|0
7396355|NCT01282463|11659548|FG001|Overall Study|Protocol Violation|0
7396356|NCT01282463|11659549|FG002|Overall Study|Protocol Violation|1
7396357|NCT01282463|11659547|FG000|Overall Study|Physician Decision|1
7396358|NCT01282463|11659548|FG001|Overall Study|Physician Decision|0
7396359|NCT01282463|11659549|FG002|Overall Study|Physician Decision|0
7396360|NCT01282476|11659565|FG000|Overall Study|Death|11
7396361|NCT01282801|11659579|FG000|Second Intervention|Emesis During Critical Breakfast|0
7396362|NCT01282801|11659580|FG001|Second Intervention|Emesis During Critical Breakfast|1
7396363|NCT01282814|11659588|FG000|First Intervention|Emesis During Dosing Interval|0
7396364|NCT01282814|11659589|FG001|First Intervention|Emesis During Dosing Interval|3
7396365|NCT01282814|11659588|FG000|Washout of 7 Days|Withdrawal by Subject|2
7396366|NCT01282814|11659589|FG001|Washout of 7 Days|Withdrawal by Subject|0
7396367|NCT01282866|11659595|FG000|Overall Study|Adverse Event|1
7396368|NCT01283009|11659601|FG000|Overall Study|Death|83
7396369|NCT01283009|11659602|FG001|Overall Study|Death|78
7396370|NCT01283009|11659601|FG000|Overall Study|Study ended early|23
7396371|NCT01283009|11659602|FG001|Overall Study|Study ended early|26
7396372|NCT01283009|11659601|FG000|Overall Study|Withdrawal by Subject|10
7396373|NCT01283009|11659602|FG001|Overall Study|Withdrawal by Subject|8
7396374|NCT01283009|11659601|FG000|Overall Study|Physician Decision|1
7396375|NCT01283009|11659602|FG001|Overall Study|Physician Decision|1
7396376|NCT01283009|11659601|FG000|Overall Study|Lost to Follow-up|1
7396377|NCT01283009|11659602|FG001|Overall Study|Lost to Follow-up|0
7396378|NCT01283009|11659601|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
7396379|NCT01283009|11659602|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
7396380|NCT01283035|11659613|FG000|Overall Study|Subject later found ineligible|1
7396381|NCT01283139|11659621|FG000|Overall Study|Lost to Follow-up|5
7396382|NCT01283139|11659622|FG001|Overall Study|Lost to Follow-up|2
7396383|NCT01283139|11659623|FG002|Overall Study|Lost to Follow-up|3
7396384|NCT01283139|11659624|FG003|Overall Study|Lost to Follow-up|1
7396385|NCT01283139|11659621|FG000|Overall Study|Withdrawal by Subject|8
7396386|NCT01283139|11659622|FG001|Overall Study|Withdrawal by Subject|8
7396387|NCT01283139|11659623|FG002|Overall Study|Withdrawal by Subject|6
7396388|NCT01283139|11659624|FG003|Overall Study|Withdrawal by Subject|8
7396389|NCT01283139|11659621|FG000|Overall Study|Death|2
7396390|NCT01283139|11659622|FG001|Overall Study|Death|0
7396391|NCT01283139|11659623|FG002|Overall Study|Death|2
7396392|NCT01283139|11659624|FG003|Overall Study|Death|2
7396393|NCT01283139|11659621|FG000|Overall Study|Lack of Efficacy|1
7396394|NCT01283139|11659622|FG001|Overall Study|Lack of Efficacy|2
7396395|NCT01283139|11659623|FG002|Overall Study|Lack of Efficacy|2
7396396|NCT01283139|11659624|FG003|Overall Study|Lack of Efficacy|1
7396397|NCT01283139|11659621|FG000|Overall Study|Early termination due to AE/SAE|1
7396398|NCT01283139|11659622|FG001|Overall Study|Early termination due to AE/SAE|1
7396399|NCT01283139|11659623|FG002|Overall Study|Early termination due to AE/SAE|0
7396400|NCT01283139|11659624|FG003|Overall Study|Early termination due to AE/SAE|0
7396401|NCT01283139|11659621|FG000|Overall Study|Participant's refusal to continue|0
7396402|NCT01283139|11659622|FG001|Overall Study|Participant's refusal to continue|3
7396403|NCT01283139|11659623|FG002|Overall Study|Participant's refusal to continue|1
7396404|NCT01283139|11659624|FG003|Overall Study|Participant's refusal to continue|1
7396405|NCT01283139|11659621|FG000|Overall Study|Pregnancy|0
7396406|NCT01283139|11659622|FG001|Overall Study|Pregnancy|1
7396407|NCT01283139|11659623|FG002|Overall Study|Pregnancy|1
7396408|NCT01283139|11659624|FG003|Overall Study|Pregnancy|0
7396409|NCT01283139|11659621|FG000|Overall Study|Missed follow-up visit|0
7396410|NCT01283139|11659622|FG001|Overall Study|Missed follow-up visit|1
7396411|NCT01283139|11659623|FG002|Overall Study|Missed follow-up visit|2
7396412|NCT01283139|11659624|FG003|Overall Study|Missed follow-up visit|2
7396413|NCT01283139|11659621|FG000|Overall Study|Participant randomized in error|0
7396414|NCT01283139|11659622|FG001|Overall Study|Participant randomized in error|0
7396415|NCT01283139|11659623|FG002|Overall Study|Participant randomized in error|1
7396416|NCT01283139|11659624|FG003|Overall Study|Participant randomized in error|0
7396417|NCT01283152|11659636|FG000|Overall Study|Discharged prior to 24 hr assessment|1
7396418|NCT01283152|11659637|FG001|Overall Study|Discharged prior to 24 hr assessment|0
7396419|NCT01283152|11659636|FG000|Overall Study|Refused HESA|1
7396420|NCT01283152|11659637|FG001|Overall Study|Refused HESA|0
7396421|NCT01283282|11659643|FG000|First Intervention (6 Weeks)|Physician Decision|0
7396422|NCT01283282|11659644|FG001|First Intervention (6 Weeks)|Physician Decision|1
7396423|NCT01283282|11659643|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
7396424|NCT01283282|11659644|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
7396425|NCT01283282|11659643|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
7396426|NCT01283282|11659644|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
7396427|NCT01283334|11659662|FG000|Overall Study|Withdrawal by Subject|1
7396428|NCT01283334|11659662|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
7396429|NCT01283334|11659662|FG000|Overall Study|Adverse Event|4
7396430|NCT01283334|11659662|FG000|Overall Study|Physician Decision|1
7396431|NCT01283386|11659670|FG000|Overall Study|Death|2
7396432|NCT01283386|11659671|FG001|Overall Study|Death|0
7396433|NCT01283386|11659670|FG000|Overall Study|Withdrawal by Subject|2
7396434|NCT01283386|11659671|FG001|Overall Study|Withdrawal by Subject|1
7396435|NCT01283386|11659670|FG000|Overall Study|Relapse of underlying disease|1
7396436|NCT01283386|11659671|FG001|Overall Study|Relapse of underlying disease|3
7396437|NCT01283386|11659670|FG000|Overall Study|Progression of underlying disease|2
7396438|NCT01283386|11659671|FG001|Overall Study|Progression of underlying disease|7
7396439|NCT01283386|11659670|FG000|Overall Study|Reason not specified|1
7396440|NCT01283386|11659671|FG001|Overall Study|Reason not specified|0
7396441|NCT01283386|11659670|FG000|Overall Study|Protocol Violation|0
7396442|NCT01283386|11659671|FG001|Overall Study|Protocol Violation|1
7396443|NCT01283464|11659679|FG000|Overall Study|Lost to Follow-up|0
7396444|NCT01283464|11659680|FG001|Overall Study|Lost to Follow-up|1
7396445|NCT01283464|11659679|FG000|Overall Study|Withdrawal by Subject|1
7396446|NCT01283464|11659680|FG001|Overall Study|Withdrawal by Subject|0
7396447|NCT01283464|11659679|FG000|Overall Study|Physician Decision|1
7396448|NCT01283464|11659680|FG001|Overall Study|Physician Decision|0
7396449|NCT01283516|11659695|FG000|Overall Study|Adverse Event|0
7396450|NCT01283516|11659696|FG001|Overall Study|Adverse Event|0
7396451|NCT01283516|11659697|FG002|Overall Study|Adverse Event|0
7396452|NCT01283516|11659698|FG003|Overall Study|Adverse Event|0
7396453|NCT01283516|11659699|FG004|Overall Study|Adverse Event|0
7396454|NCT01283516|11659700|FG005|Overall Study|Adverse Event|0
7396455|NCT01283516|11659701|FG006|Overall Study|Adverse Event|2
7396456|NCT01283516|11659702|FG007|Overall Study|Adverse Event|0
7396457|NCT01283516|11659703|FG008|Overall Study|Adverse Event|28
7396458|NCT01283516|11659695|FG000|Overall Study|Death|0
7396459|NCT01283516|11659696|FG001|Overall Study|Death|0
7396460|NCT01283516|11659697|FG002|Overall Study|Death|0
7396461|NCT01283516|11659698|FG003|Overall Study|Death|0
7396462|NCT01283516|11659699|FG004|Overall Study|Death|0
7396463|NCT01283516|11659700|FG005|Overall Study|Death|1
7396464|NCT01283516|11659701|FG006|Overall Study|Death|0
7396465|NCT01283516|11659702|FG007|Overall Study|Death|1
7396466|NCT01283516|11659703|FG008|Overall Study|Death|12
7396467|NCT01283516|11659695|FG000|Overall Study|Disease Progression|2
7396468|NCT01283516|11659696|FG001|Overall Study|Disease Progression|2
7396469|NCT01283516|11659697|FG002|Overall Study|Disease Progression|3
7396470|NCT01283516|11659698|FG003|Overall Study|Disease Progression|3
7396471|NCT01283516|11659699|FG004|Overall Study|Disease Progression|13
7396472|NCT01283516|11659700|FG005|Overall Study|Disease Progression|8
7396473|NCT01283516|11659701|FG006|Overall Study|Disease Progression|6
7396474|NCT01283516|11659702|FG007|Overall Study|Disease Progression|3
7396475|NCT01283516|11659703|FG008|Overall Study|Disease Progression|139
7396476|NCT01283516|11659695|FG000|Overall Study|Withdrawal by Subject|0
7396477|NCT01283516|11659696|FG001|Overall Study|Withdrawal by Subject|0
7396478|NCT01283516|11659697|FG002|Overall Study|Withdrawal by Subject|0
7396479|NCT01283516|11659698|FG003|Overall Study|Withdrawal by Subject|0
7396480|NCT01283516|11659699|FG004|Overall Study|Withdrawal by Subject|1
7396481|NCT01283516|11659700|FG005|Overall Study|Withdrawal by Subject|0
7396482|NCT01283516|11659701|FG006|Overall Study|Withdrawal by Subject|1
7396483|NCT01283516|11659702|FG007|Overall Study|Withdrawal by Subject|0
7396484|NCT01283516|11659703|FG008|Overall Study|Withdrawal by Subject|36
7396485|NCT01283516|11659695|FG000|Overall Study|Administrative problems|0
7396486|NCT01283516|11659696|FG001|Overall Study|Administrative problems|0
7396487|NCT01283516|11659697|FG002|Overall Study|Administrative problems|0
7396488|NCT01283516|11659698|FG003|Overall Study|Administrative problems|0
7396489|NCT01283516|11659699|FG004|Overall Study|Administrative problems|0
7396490|NCT01283516|11659700|FG005|Overall Study|Administrative problems|1
7396491|NCT01283516|11659701|FG006|Overall Study|Administrative problems|1
7396492|NCT01283516|11659702|FG007|Overall Study|Administrative problems|1
7396493|NCT01283516|11659703|FG008|Overall Study|Administrative problems|39
7396494|NCT01283516|11659695|FG000|Overall Study|Lost to Follow-up|0
7396495|NCT01283516|11659696|FG001|Overall Study|Lost to Follow-up|0
7396496|NCT01283516|11659697|FG002|Overall Study|Lost to Follow-up|0
7396497|NCT01283516|11659698|FG003|Overall Study|Lost to Follow-up|0
7396498|NCT01283516|11659699|FG004|Overall Study|Lost to Follow-up|0
7396499|NCT01283516|11659700|FG005|Overall Study|Lost to Follow-up|0
7396500|NCT01283516|11659701|FG006|Overall Study|Lost to Follow-up|0
7396501|NCT01283516|11659702|FG007|Overall Study|Lost to Follow-up|0
7396502|NCT01283516|11659703|FG008|Overall Study|Lost to Follow-up|1
7396503|NCT01283542|11659731|FG000|Main Phase|Acute or progressive vision loss|1
7396504|NCT01283542|11659731|FG000|Main Phase|Uncontrolled diabetes mellitus|1
7396505|NCT01283542|11659731|FG000|Main Phase|abnormal laboratory values|5
7396506|NCT01283542|11659731|FG000|Extension Phase|Physician Decision|1
7396507|NCT01283542|11659731|FG000|Extension Phase|Adverse Event|1
7396508|NCT01283542|11659731|FG000|Extension Phase|Administrative problems|1
7396509|NCT01283581|11659767|FG000|Overall Study|Lost to Follow-up|8
7396510|NCT01283581|11659768|FG001|Overall Study|Lost to Follow-up|6
7396511|NCT01283581|11659769|FG002|Overall Study|Lost to Follow-up|8
7396512|NCT01283581|11659767|FG000|Overall Study|Withdrawal by Subject|2
7396513|NCT01283581|11659768|FG001|Overall Study|Withdrawal by Subject|5
7396514|NCT01283581|11659769|FG002|Overall Study|Withdrawal by Subject|2
7396515|NCT01283581|11659767|FG000|Overall Study|Adverse Event|1
7396516|NCT01283581|11659768|FG001|Overall Study|Adverse Event|1
7396517|NCT01283581|11659769|FG002|Overall Study|Adverse Event|4
7396518|NCT01283581|11659767|FG000|Overall Study|Physician Decision|0
7396519|NCT01283581|11659768|FG001|Overall Study|Physician Decision|1
7396520|NCT01283581|11659769|FG002|Overall Study|Physician Decision|2
7396521|NCT01283581|11659767|FG000|Overall Study|Protocol Violation|0
7396522|NCT01283581|11659768|FG001|Overall Study|Protocol Violation|1
7396523|NCT01283581|11659769|FG002|Overall Study|Protocol Violation|2
7396524|NCT01283581|11659767|FG000|Overall Study|Noncompliance|1
7396525|NCT01283581|11659768|FG001|Overall Study|Noncompliance|0
7396526|NCT01283581|11659769|FG002|Overall Study|Noncompliance|0
7396527|NCT01283581|11659767|FG000|Overall Study|Investigator unblinded|0
7396528|NCT01283581|11659768|FG001|Overall Study|Investigator unblinded|0
7396529|NCT01283581|11659769|FG002|Overall Study|Investigator unblinded|1
7396530|NCT01283581|11659767|FG000|Overall Study|"Early termination"|0
7396531|NCT01283581|11659768|FG001|Overall Study|"Early termination"|0
7396532|NCT01283581|11659769|FG002|Overall Study|"Early termination"|1
7396533|NCT01283971|11659782|FG000|Overall Study|Adverse Event|3
7396534|NCT01283971|11659783|FG001|Overall Study|Adverse Event|5
7396535|NCT01283971|11659782|FG000|Overall Study|Insufficient therapeutic responses|3
7396536|NCT01283971|11659783|FG001|Overall Study|Insufficient therapeutic responses|3
7396537|NCT01283971|11659782|FG000|Overall Study|Protocol Violation|5
7396538|NCT01283971|11659783|FG001|Overall Study|Protocol Violation|1
7396539|NCT01283971|11659782|FG000|Overall Study|Refused treatment|3
7396540|NCT01283971|11659783|FG001|Overall Study|Refused treatment|1
7396541|NCT01283971|11659782|FG000|Overall Study|Failure to return|0
7396542|NCT01283971|11659783|FG001|Overall Study|Failure to return|1
7396543|NCT01283971|11659782|FG000|Overall Study|Administrative reasons|1
7396544|NCT01283971|11659783|FG001|Overall Study|Administrative reasons|1
7396545|NCT01284062|11659793|FG000|Overall Study|Adverse Event|4
7396546|NCT01284062|11659794|FG001|Overall Study|Adverse Event|5
7396547|NCT01284062|11659795|FG002|Overall Study|Adverse Event|0
7396548|NCT01284062|11659796|FG003|Overall Study|Adverse Event|5
7396549|NCT01284062|11659793|FG000|Overall Study|Lack of Efficacy|3
7396550|NCT01284062|11659794|FG001|Overall Study|Lack of Efficacy|2
7396551|NCT01284062|11659795|FG002|Overall Study|Lack of Efficacy|2
7396552|NCT01284062|11659796|FG003|Overall Study|Lack of Efficacy|1
7396553|NCT01284062|11659793|FG000|Overall Study|Medication error without adverse event|0
7396554|NCT01284062|11659794|FG001|Overall Study|Medication error without adverse event|0
7396555|NCT01284062|11659795|FG002|Overall Study|Medication error without adverse event|1
7396556|NCT01284062|11659796|FG003|Overall Study|Medication error without adverse event|0
7396557|NCT01284062|11659793|FG000|Overall Study|Protocol Violation|1
7396558|NCT01284062|11659794|FG001|Overall Study|Protocol Violation|0
7396559|NCT01284062|11659795|FG002|Overall Study|Protocol Violation|0
7396560|NCT01284062|11659796|FG003|Overall Study|Protocol Violation|2
7396561|NCT01284062|11659793|FG000|Overall Study|Withdrawal by Subject|3
7396562|NCT01284062|11659794|FG001|Overall Study|Withdrawal by Subject|1
7396563|NCT01284062|11659795|FG002|Overall Study|Withdrawal by Subject|2
7396564|NCT01284062|11659796|FG003|Overall Study|Withdrawal by Subject|5
7396565|NCT01284062|11659793|FG000|Overall Study|Other|0
7396566|NCT01284062|11659794|FG001|Overall Study|Other|0
7396567|NCT01284062|11659795|FG002|Overall Study|Other|0
7396568|NCT01284062|11659796|FG003|Overall Study|Other|1
7396569|NCT01284062|11659793|FG000|Overall Study|Site Closed|0
7396570|NCT01284062|11659794|FG001|Overall Study|Site Closed|0
7396571|NCT01284062|11659795|FG002|Overall Study|Site Closed|1
7396572|NCT01284062|11659796|FG003|Overall Study|Site Closed|0
7396573|NCT01284114|11659809|FG000|Overall Study|viral infection|1
7396574|NCT01284114|11659809|FG000|Overall Study|From the results of ALLTITUDE study|1
7396575|NCT01284114|11659809|FG000|Overall Study|Symptomatic hypotension|1
7396576|NCT01284114|11659809|FG000|Overall Study|dizziness|1
7396577|NCT01284127|11659814|FG000|Overall Study|Adverse Event|2
7396578|NCT01284127|11659814|FG000|Overall Study|Withdrawal by Subject|4
7396579|NCT01284127|11659814|FG000|Overall Study|Physician Decision|1
7396580|NCT01284140|11659820|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7396581|NCT01284140|11659821|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
7396582|NCT01284140|11659820|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
7396583|NCT01284140|11659821|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
7396584|NCT01284361|11659906|FG000|Overall Study|Withdrawal by Subject|1
7396585|NCT01284361|11659906|FG000|Overall Study|Protocol Violation|5
7396586|NCT01284361|11659906|FG000|Overall Study|Adverse Event|1
7396587|NCT01284361|11659906|FG000|Overall Study|Lost to Follow-up|2
7396588|NCT01284621|11659926|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7396589|NCT01284621|11659927|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7396590|NCT01284621|11659928|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7396591|NCT01284621|11659929|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7553083|NCT03005067|11913817|FG001|Overall Study|Protocol Violation|1
7396592|NCT01284621|11659930|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
7396593|NCT01284621|11659931|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
7396594|NCT01284634|11659945|FG000|Overall Study|Adverse Event|1
7396595|NCT01284634|11659946|FG001|Overall Study|Adverse Event|0
7396596|NCT01284634|11659947|FG002|Overall Study|Adverse Event|2
7396597|NCT01284634|11659948|FG003|Overall Study|Adverse Event|1
7396598|NCT01284959|11659961|FG000|Overall Study|Withdrawal by Subject|1
7396599|NCT01284959|11659962|FG001|Overall Study|Withdrawal by Subject|0
7396600|NCT01284959|11659963|FG002|Overall Study|Withdrawal by Subject|0
7396601|NCT01284959|11659961|FG000|Overall Study|Adverse Event|0
7396602|NCT01284959|11659962|FG001|Overall Study|Adverse Event|0
7396603|NCT01284959|11659963|FG002|Overall Study|Adverse Event|1
7396604|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
7396605|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
7396606|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
7396607|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7396608|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
7396609|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
7396610|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
7396611|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
7396612|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7396613|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
7396614|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
7396615|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7396616|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
7396617|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7396618|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
7396619|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7396620|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
7396621|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
7396622|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7396623|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
7396624|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7396625|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7396626|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
7396627|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7396628|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
7396629|NCT01285310|11659992|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
7396630|NCT01285310|11659993|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
7396631|NCT01285310|11659994|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
7396632|NCT01285310|11659995|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
7396633|NCT01285310|11659996|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
7396634|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7396635|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7396636|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
7396637|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
7396638|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
7396639|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7396640|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
7396641|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
7396642|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
7396643|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
7396644|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7396645|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
7396646|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
7396647|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7396648|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
7396649|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
7396650|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
7396651|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
7396652|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
7396653|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
7396654|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Other|0
7396655|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Other|1
7396656|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Other|0
7396657|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Other|0
7396658|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Other|0
7396659|NCT01285310|11659992|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7396660|NCT01285310|11659993|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7396661|NCT01285310|11659994|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7396662|NCT01285310|11659995|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
7396663|NCT01285310|11659996|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
7396664|NCT01285323|11660036|FG000|Overall Study|Adverse Event|9
7396665|NCT01285323|11660037|FG001|Overall Study|Adverse Event|8
7396666|NCT01285323|11660036|FG000|Overall Study|Lack of Efficacy|4
7396667|NCT01285323|11660037|FG001|Overall Study|Lack of Efficacy|2
7396668|NCT01285323|11660036|FG000|Overall Study|Withdrawal by Subject|15
7396669|NCT01285323|11660037|FG001|Overall Study|Withdrawal by Subject|11
7396670|NCT01285323|11660036|FG000|Overall Study|Protocol Violation|1
7396671|NCT01285323|11660037|FG001|Overall Study|Protocol Violation|2
7396672|NCT01285323|11660036|FG000|Overall Study|Non-compliance with study procedures|2
7396673|NCT01285323|11660037|FG001|Overall Study|Non-compliance with study procedures|3
7396674|NCT01285323|11660036|FG000|Overall Study|Lost to Follow-up|1
7396675|NCT01285323|11660037|FG001|Overall Study|Lost to Follow-up|1
7396676|NCT01285323|11660036|FG000|Overall Study|Other|1
7396677|NCT01285323|11660037|FG001|Overall Study|Other|3
7396678|NCT01285349|11660046|FG000|Overall Study|Lost to Follow-up|27
7396679|NCT01285349|11660047|FG001|Overall Study|Lost to Follow-up|20
7396680|NCT01285349|11660048|FG002|Overall Study|Lost to Follow-up|27
7396681|NCT01285401|11660059|FG000|Overall Study|Prematurely withdrawn from the study|17
7396682|NCT01285401|11660060|FG001|Overall Study|Prematurely withdrawn from the study|29
7396683|NCT01285492|11660080|FG000|Overall Study|Adverse Event|11
7396684|NCT01285492|11660081|FG001|Overall Study|Adverse Event|0
7396685|NCT01285492|11660080|FG000|Overall Study|Protocol Violation|3
7396686|NCT01285492|11660081|FG001|Overall Study|Protocol Violation|0
7396687|NCT01285492|11660080|FG000|Overall Study|Withdrawal by Subject|2
7396688|NCT01285492|11660081|FG001|Overall Study|Withdrawal by Subject|1
7396689|NCT01285492|11660080|FG000|Overall Study|Death|1
7396690|NCT01285492|11660081|FG001|Overall Study|Death|0
7396691|NCT01285518|11660095|FG000|Overall Study|Lost to Follow-up|0
7396692|NCT01285518|11660096|FG001|Overall Study|Lost to Follow-up|0
7396693|NCT01285518|11660097|FG002|Overall Study|Lost to Follow-up|0
7396694|NCT01285518|11660098|FG003|Overall Study|Lost to Follow-up|0
7396695|NCT01285518|11660099|FG004|Overall Study|Lost to Follow-up|0
7396696|NCT01285518|11660100|FG005|Overall Study|Lost to Follow-up|1
7396697|NCT01285518|11660101|FG006|Overall Study|Lost to Follow-up|0
7396698|NCT01285518|11660102|FG007|Overall Study|Lost to Follow-up|0
7396699|NCT01285609|11660123|FG000|Randomized|Progressive Disease|41
7396700|NCT01285609|11660124|FG001|Randomized|Progressive Disease|61
7396701|NCT01285609|11660123|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
7396702|NCT01285609|11660124|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
7396703|NCT01285609|11660123|FG000|Randomized|Study Drug Toxicity|13
7396704|NCT01285609|11660124|FG001|Randomized|Study Drug Toxicity|14
7396705|NCT01285609|11660123|FG000|Randomized|Death|5
7396706|NCT01285609|11660124|FG001|Randomized|Death|7
7396707|NCT01285609|11660123|FG000|Randomized|Withdrawal by Subject|8
7396708|NCT01285609|11660124|FG001|Randomized|Withdrawal by Subject|11
7396709|NCT01285609|11660123|FG000|Randomized|Subject No Longer Met Study Criteria|1
7396710|NCT01285609|11660124|FG001|Randomized|Subject No Longer Met Study Criteria|1
7396711|NCT01285609|11660123|FG000|Randomized|Undisclosed Reasons|1
7396712|NCT01285609|11660124|FG001|Randomized|Undisclosed Reasons|0
7396713|NCT01285609|11660123|FG000|Randomized|Randomized but not Treated|4
7396714|NCT01285609|11660124|FG001|Randomized|Randomized but not Treated|4
7396715|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Progressive Disease|223
7396716|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Progressive Disease|305
7396717|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
7396718|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
7396719|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
7396720|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
7396721|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
7396722|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
7396723|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Death|11
7396724|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Death|3
7396725|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
7396726|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
7396727|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Not Reported|0
7396728|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Not Reported|2
7396729|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
7396730|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
7396731|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
7396732|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
7396733|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
7396734|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
7396735|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
7396736|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
7396737|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Participant refused participation|1
7396738|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Participant refused participation|0
7396739|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
7396740|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
7396741|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Participant hospitalized|1
7396742|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Participant hospitalized|0
7396743|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Investigator's assessment|1
7396744|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Investigator's assessment|0
7396745|NCT01285609|11660123|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
7396746|NCT01285609|11660124|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
7396747|NCT01285609|11660123|FG000|Treated With Blinded Therapy|Worsening of general condition|0
7396748|NCT01285609|11660124|FG001|Treated With Blinded Therapy|Worsening of general condition|1
7396749|NCT01285908|11660179|FG000|Baseline Measurement|unable to insert catheter|1
7396750|NCT01285908|11660180|FG001|Baseline Measurement|unable to insert catheter|0
7396751|NCT01285908|11660181|FG002|Baseline Measurement|unable to insert catheter|0
7396752|NCT01285908|11660179|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
7396753|NCT01285908|11660180|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
7396754|NCT01285908|11660181|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
7396755|NCT01285908|11660179|FG000|Baseline Measurement|unable to tolerate procedure|1
7396756|NCT01285908|11660180|FG001|Baseline Measurement|unable to tolerate procedure|0
7396757|NCT01285908|11660181|FG002|Baseline Measurement|unable to tolerate procedure|0
7396758|NCT01285960|11660211|FG000|Overall Study|Withdrawal by Subject|2
7396759|NCT01285960|11660211|FG000|Overall Study|Lost to Follow-up|2
7396760|NCT01285960|11660211|FG000|Overall Study|2 subjects received less 10 sonications|2
7396761|NCT01286012|11660217|FG000|Overall Study|Adverse Event|3
7396762|NCT01286012|11660218|FG001|Overall Study|Adverse Event|3
7396763|NCT01286012|11660217|FG000|Overall Study|Death|2
7396764|NCT01286012|11660218|FG001|Overall Study|Death|3
7396765|NCT01286012|11660217|FG000|Overall Study|Protocol Violation|1
7396766|NCT01286012|11660218|FG001|Overall Study|Protocol Violation|1
7396767|NCT01286012|11660217|FG000|Overall Study|Withdrawal by Subject|4
7396768|NCT01286012|11660218|FG001|Overall Study|Withdrawal by Subject|4
7396769|NCT01286012|11660217|FG000|Overall Study|Physician Decision|2
7396770|NCT01286012|11660218|FG001|Overall Study|Physician Decision|0
7396771|NCT01286012|11660217|FG000|Overall Study|peritoneal dialysis, randomized in error|1
7396772|NCT01286012|11660218|FG001|Overall Study|peritoneal dialysis, randomized in error|3
7396773|NCT01286077|11660227|FG000|Overall Study|Adverse Event|2
7396774|NCT01286077|11660228|FG001|Overall Study|Adverse Event|0
7396775|NCT01286077|11660227|FG000|Overall Study|Death|1
7396776|NCT01286077|11660228|FG001|Overall Study|Death|0
7396777|NCT01286077|11660227|FG000|Overall Study|Protocol Violation|1
7396778|NCT01286077|11660228|FG001|Overall Study|Protocol Violation|1
7396779|NCT01286077|11660227|FG000|Overall Study|Withdrawal by Subject|0
7396780|NCT01286077|11660228|FG001|Overall Study|Withdrawal by Subject|2
7396781|NCT01286077|11660227|FG000|Overall Study|Intercurrent illness|1
7396782|NCT01286077|11660228|FG001|Overall Study|Intercurrent illness|0
7396783|NCT01286077|11660227|FG000|Overall Study|Non-compliance|1
7396784|NCT01286077|11660228|FG001|Overall Study|Non-compliance|0
7396785|NCT01286077|11660227|FG000|Overall Study|The subject starts with alternative MMY|0
7396786|NCT01286077|11660228|FG001|Overall Study|The subject starts with alternative MMY|3
7396787|NCT01286077|11660227|FG000|Overall Study|Patient's decision to stop treatment|3
7396788|NCT01286077|11660228|FG001|Overall Study|Patient's decision to stop treatment|0
7396789|NCT01286077|11660227|FG000|Overall Study|Progression of disease|0
7396790|NCT01286077|11660228|FG001|Overall Study|Progression of disease|1
7396791|NCT01286077|11660227|FG000|Overall Study|refill medication not received in time|1
7396792|NCT01286077|11660228|FG001|Overall Study|refill medication not received in time|0
7396793|NCT01286129|11660236|FG000|Overall Study|Withdrawal by Subject|4
7396794|NCT01286129|11660237|FG001|Overall Study|Withdrawal by Subject|1
7396795|NCT01286129|11660236|FG000|Overall Study|Could not comply with study requirements|4
7396796|NCT01286129|11660237|FG001|Overall Study|Could not comply with study requirements|4
7396797|NCT01286168|11660245|FG000|Overall Study|Withdrawal by Subject|1
7396798|NCT01286168|11660245|FG000|Overall Study|Surgical Drains Fell Out at Home|2
7396799|NCT01286311|11660256|FG000|Overall Study|Physician did not want outreach sent|14
7396800|NCT01286311|11660257|FG001|Overall Study|Physician did not want outreach sent|0
7396801|NCT01286480|11660324|FG000|Overall Study|Withdrawal by Subject|5
7396802|NCT01286480|11660325|FG001|Overall Study|Withdrawal by Subject|3
7396803|NCT01286558|11660337|FG000|Overall Study|Adverse Event|1
7396804|NCT01286558|11660338|FG001|Overall Study|Adverse Event|1
7396805|NCT01286558|11660337|FG000|Overall Study|Withdrawal by Subject|0
7396806|NCT01286558|11660338|FG001|Overall Study|Withdrawal by Subject|1
7396807|NCT01286740|11660344|FG000|Overall Study|Enrolled but not treated|1
7396808|NCT01286740|11660344|FG000|Overall Study|Protocol Violation|1
7396809|NCT01286753|11660350|FG000|Overall Study|Adverse Event|7
7396810|NCT01286753|11660351|FG001|Overall Study|Adverse Event|6
7396811|NCT01286753|11660350|FG000|Overall Study|Progression|11
7396812|NCT01286753|11660351|FG001|Overall Study|Progression|13
7396813|NCT01286753|11660350|FG000|Overall Study|Refused Treatment|1
7396814|NCT01286753|11660351|FG001|Overall Study|Refused Treatment|0
7396815|NCT01286753|11660350|FG000|Overall Study|Withdrawal of Consent|0
7396816|NCT01286753|11660351|FG001|Overall Study|Withdrawal of Consent|2
7396817|NCT01286753|11660350|FG000|Overall Study|Discontinued to Join Extension Study|6
7396818|NCT01286753|11660351|FG001|Overall Study|Discontinued to Join Extension Study|4
7396819|NCT01286753|11660350|FG000|Overall Study|Participant to Receive Radiotherapy|1
7396820|NCT01286753|11660351|FG001|Overall Study|Participant to Receive Radiotherapy|0
7396821|NCT01286779|11660358|FG000|Overall Study|Withdrawal by Subject|9
7396822|NCT01286779|11660358|FG000|Overall Study|Protocol Violation|5
7396823|NCT01286779|11660358|FG000|Overall Study|Physician Decision|2
7396824|NCT01286779|11660358|FG000|Overall Study|Participant had scheduled surgery|1
7396825|NCT01286779|11660358|FG000|Overall Study|Participant moved to another country|1
7396826|NCT01286779|11660358|FG000|Overall Study|Discontinued by sponsor|1
7396827|NCT01286987|11660404|FG000|Part 1: Dose Escalation|Clinical Progression|1
7396828|NCT01286987|11660405|FG001|Part 1: Dose Escalation|Clinical Progression|1
7396829|NCT01286987|11660406|FG002|Part 1: Dose Escalation|Clinical Progression|0
7396830|NCT01286987|11660407|FG003|Part 1: Dose Escalation|Clinical Progression|1
7396831|NCT01286987|11660408|FG004|Part 1: Dose Escalation|Clinical Progression|1
7396832|NCT01286987|11660409|FG005|Part 1: Dose Escalation|Clinical Progression|1
7396833|NCT01286987|11660410|FG006|Part 1: Dose Escalation|Clinical Progression|0
7396834|NCT01286987|11660411|FG007|Part 1: Dose Escalation|Clinical Progression|2
7396835|NCT01286987|11660412|FG008|Part 1: Dose Escalation|Clinical Progression|1
7396836|NCT01286987|11660413|FG009|Part 1: Dose Escalation|Clinical Progression|0
7396837|NCT01286987|11660414|FG010|Part 1: Dose Escalation|Clinical Progression|0
7396838|NCT01286987|11660415|FG011|Part 1: Dose Escalation|Clinical Progression|0
7396839|NCT01286987|11660416|FG012|Part 1: Dose Escalation|Clinical Progression|0
7396840|NCT01286987|11660417|FG013|Part 1: Dose Escalation|Clinical Progression|0
7396841|NCT01286987|11660418|FG014|Part 1: Dose Escalation|Clinical Progression|0
7396842|NCT01286987|11660404|FG000|Part 1: Dose Escalation|Progressive Disease|2
7396843|NCT01286987|11660405|FG001|Part 1: Dose Escalation|Progressive Disease|2
7396844|NCT01286987|11660406|FG002|Part 1: Dose Escalation|Progressive Disease|3
7396845|NCT01286987|11660407|FG003|Part 1: Dose Escalation|Progressive Disease|2
7396846|NCT01286987|11660408|FG004|Part 1: Dose Escalation|Progressive Disease|1
7396847|NCT01286987|11660409|FG005|Part 1: Dose Escalation|Progressive Disease|5
7396848|NCT01286987|11660410|FG006|Part 1: Dose Escalation|Progressive Disease|5
7396849|NCT01286987|11660411|FG007|Part 1: Dose Escalation|Progressive Disease|3
7396850|NCT01286987|11660412|FG008|Part 1: Dose Escalation|Progressive Disease|5
7396851|NCT01286987|11660413|FG009|Part 1: Dose Escalation|Progressive Disease|0
7396852|NCT01286987|11660414|FG010|Part 1: Dose Escalation|Progressive Disease|0
7396853|NCT01286987|11660415|FG011|Part 1: Dose Escalation|Progressive Disease|0
7396854|NCT01286987|11660416|FG012|Part 1: Dose Escalation|Progressive Disease|0
7396855|NCT01286987|11660417|FG013|Part 1: Dose Escalation|Progressive Disease|0
7396856|NCT01286987|11660418|FG014|Part 1: Dose Escalation|Progressive Disease|0
7396857|NCT01286987|11660404|FG000|Part 1: Dose Escalation|Physician Decision|0
7396858|NCT01286987|11660405|FG001|Part 1: Dose Escalation|Physician Decision|0
7396859|NCT01286987|11660406|FG002|Part 1: Dose Escalation|Physician Decision|0
7396860|NCT01286987|11660407|FG003|Part 1: Dose Escalation|Physician Decision|0
7396861|NCT01286987|11660408|FG004|Part 1: Dose Escalation|Physician Decision|1
7396862|NCT01286987|11660409|FG005|Part 1: Dose Escalation|Physician Decision|0
7396863|NCT01286987|11660410|FG006|Part 1: Dose Escalation|Physician Decision|0
7396864|NCT01286987|11660411|FG007|Part 1: Dose Escalation|Physician Decision|0
7396865|NCT01286987|11660412|FG008|Part 1: Dose Escalation|Physician Decision|0
7396866|NCT01286987|11660413|FG009|Part 1: Dose Escalation|Physician Decision|0
7396867|NCT01286987|11660414|FG010|Part 1: Dose Escalation|Physician Decision|0
7396868|NCT01286987|11660415|FG011|Part 1: Dose Escalation|Physician Decision|0
7396869|NCT01286987|11660416|FG012|Part 1: Dose Escalation|Physician Decision|0
7396870|NCT01286987|11660417|FG013|Part 1: Dose Escalation|Physician Decision|0
7396871|NCT01286987|11660418|FG014|Part 1: Dose Escalation|Physician Decision|0
7396872|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Death|0
7396873|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Death|0
7396874|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Death|0
7396875|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Death|0
7396876|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Death|0
7396877|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Death|0
7396878|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Death|0
7396879|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Death|0
7396880|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Death|0
7396881|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Death|0
7396882|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Death|0
7396883|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Death|0
7396884|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Death|1
7396885|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Death|1
7396886|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Death|0
7396887|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Physician Decision|0
7396888|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Physician Decision|0
7396889|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Physician Decision|0
7396890|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Physician Decision|0
7396891|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Physician Decision|0
7396892|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Physician Decision|0
7396893|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Physician Decision|0
7396894|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Physician Decision|0
7396895|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Physician Decision|0
7396896|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Physician Decision|0
7396897|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Physician Decision|1
7396898|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Physician Decision|1
7396899|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Physician Decision|0
7396900|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Physician Decision|1
7396901|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Physician Decision|0
7396902|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Other|0
7396903|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Other|0
7396904|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Other|0
7396905|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Other|0
7396906|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Other|0
7396907|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Other|0
7396908|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Other|0
7396909|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Other|0
7396910|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Other|0
7396911|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Other|0
7396912|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Other|0
7396913|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Other|0
7396914|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Other|0
7396915|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Other|1
7396916|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Other|0
7396917|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Progressive Disease|0
7396918|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Progressive Disease|0
7396919|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Progressive Disease|0
7396920|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Progressive Disease|0
7396921|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Progressive Disease|0
7396922|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Progressive Disease|0
7396923|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Progressive Disease|0
7396924|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Progressive Disease|0
7396925|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Progressive Disease|0
7396926|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Progressive Disease|11
7396927|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Progressive Disease|6
7396928|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Progressive Disease|7
7396929|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Progressive Disease|11
7396930|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Progressive Disease|19
7396931|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Progressive Disease|2
7396932|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Clinical Progression|0
7396933|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Clinical Progression|0
7396934|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Clinical Progression|0
7396935|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Clinical Progression|0
7396936|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Clinical Progression|0
7396937|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Clinical Progression|0
7396938|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Clinical Progression|0
7396939|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Clinical Progression|0
7396940|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Clinical Progression|0
7396941|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Clinical Progression|0
7396942|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Clinical Progression|2
7396943|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Clinical Progression|2
7396944|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Clinical Progression|0
7396945|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Clinical Progression|2
7396946|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Clinical Progression|0
7396947|NCT01286987|11660404|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
7396948|NCT01286987|11660405|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
7396949|NCT01286987|11660406|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
7396950|NCT01286987|11660407|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
7396951|NCT01286987|11660408|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
7396952|NCT01286987|11660409|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
7396953|NCT01286987|11660410|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
7396954|NCT01286987|11660411|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
7396955|NCT01286987|11660412|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
7396956|NCT01286987|11660413|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
7396957|NCT01286987|11660414|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
7396958|NCT01286987|11660415|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
7396959|NCT01286987|11660416|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
7396960|NCT01286987|11660417|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
7396961|NCT01286987|11660418|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
7396962|NCT01287013|11660462|FG000|Overall Study|Non-evaluable|3
7396963|NCT01287013|11660463|FG001|Overall Study|Non-evaluable|5
7396964|NCT01287013|11660464|FG002|Overall Study|Non-evaluable|21
7396965|NCT01287039|11660474|FG000|Overall Study|Noncompliance with study procedures|0
7396966|NCT01287039|11660475|FG001|Overall Study|Noncompliance with study procedures|1
7396967|NCT01287039|11660474|FG000|Overall Study|Change of location/residence|0
7396968|NCT01287039|11660475|FG001|Overall Study|Change of location/residence|3
7396969|NCT01287039|11660474|FG000|Overall Study|Elective surgery|0
7396970|NCT01287039|11660475|FG001|Overall Study|Elective surgery|1
7396971|NCT01287039|11660474|FG000|Overall Study|Protocol Violation|2
7396972|NCT01287039|11660475|FG001|Overall Study|Protocol Violation|3
7396973|NCT01287039|11660474|FG000|Overall Study|Excluded medication taken|1
7396974|NCT01287039|11660475|FG001|Overall Study|Excluded medication taken|0
7396975|NCT01287039|11660474|FG000|Overall Study|Noncompliance with study medication|0
7396976|NCT01287039|11660475|FG001|Overall Study|Noncompliance with study medication|1
7396977|NCT01287039|11660474|FG000|Overall Study|Problem with travel|0
7396978|NCT01287039|11660475|FG001|Overall Study|Problem with travel|1
7396979|NCT01287039|11660474|FG000|Overall Study|Death|1
7396980|NCT01287039|11660475|FG001|Overall Study|Death|0
7396981|NCT01287039|11660474|FG000|Overall Study|Change of residence|1
7396982|NCT01287039|11660475|FG001|Overall Study|Change of residence|0
7396983|NCT01287039|11660474|FG000|Overall Study|Adverse Event|7
7396984|NCT01287039|11660475|FG001|Overall Study|Adverse Event|4
7396985|NCT01287039|11660474|FG000|Overall Study|Withdrawal by Subject|14
7396986|NCT01287039|11660475|FG001|Overall Study|Withdrawal by Subject|11
7396987|NCT01287039|11660474|FG000|Overall Study|Lost to Follow-up|3
7396988|NCT01287039|11660475|FG001|Overall Study|Lost to Follow-up|2
7396989|NCT01287065|11660481|FG000|Treatment Period 1|Adverse Event|0
7396990|NCT01287065|11660482|FG001|Treatment Period 1|Adverse Event|0
7396991|NCT01287065|11660483|FG002|Treatment Period 1|Adverse Event|0
7396992|NCT01287065|11660484|FG003|Treatment Period 1|Adverse Event|0
7396993|NCT01287065|11660485|FG004|Treatment Period 1|Adverse Event|1
7396994|NCT01287065|11660486|FG005|Treatment Period 1|Adverse Event|0
7396995|NCT01287065|11660481|FG000|Treatment Period 1|Withdrawal by Subject|0
7396996|NCT01287065|11660482|FG001|Treatment Period 1|Withdrawal by Subject|0
7396997|NCT01287065|11660483|FG002|Treatment Period 1|Withdrawal by Subject|0
7396998|NCT01287065|11660484|FG003|Treatment Period 1|Withdrawal by Subject|0
7396999|NCT01287065|11660485|FG004|Treatment Period 1|Withdrawal by Subject|0
7397000|NCT01287065|11660486|FG005|Treatment Period 1|Withdrawal by Subject|1
7397001|NCT01287104|11660507|FG000|Overall Study|Patient developed progressive disease|1
7397002|NCT01287104|11660508|FG001|Overall Study|Patient developed progressive disease|1
7397003|NCT01287104|11660509|FG002|Overall Study|Patient developed progressive disease|3
7397004|NCT01287104|11660510|FG003|Overall Study|Patient developed progressive disease|2
7397005|NCT01287104|11660507|FG000|Overall Study|Donor anaphylaxis|0
7397006|NCT01287104|11660508|FG001|Overall Study|Donor anaphylaxis|1
7397007|NCT01287104|11660509|FG002|Overall Study|Donor anaphylaxis|0
7397008|NCT01287104|11660510|FG003|Overall Study|Donor anaphylaxis|1
7397009|NCT01287104|11660507|FG000|Overall Study|Developed GVHD or complications of BMT|0
7397010|NCT01287104|11660508|FG001|Overall Study|Developed GVHD or complications of BMT|1
7397011|NCT01287104|11660509|FG002|Overall Study|Developed GVHD or complications of BMT|4
7397012|NCT01287104|11660510|FG003|Overall Study|Developed GVHD or complications of BMT|0
7397013|NCT01287104|11660507|FG000|Overall Study|Low donor chimerism|0
7397014|NCT01287104|11660508|FG001|Overall Study|Low donor chimerism|1
7397015|NCT01287104|11660509|FG002|Overall Study|Low donor chimerism|0
7397016|NCT01287104|11660510|FG003|Overall Study|Low donor chimerism|0
7397017|NCT01287104|11660507|FG000|Overall Study|NK cells did not meet release criteria|0
7397018|NCT01287104|11660508|FG001|Overall Study|NK cells did not meet release criteria|1
7397019|NCT01287104|11660509|FG002|Overall Study|NK cells did not meet release criteria|0
7397020|NCT01287104|11660510|FG003|Overall Study|NK cells did not meet release criteria|0
7397021|NCT01287117|11660531|FG000|Overall Study|Adverse Event|2
7397022|NCT01287117|11660532|FG001|Overall Study|Adverse Event|1
7397023|NCT01287117|11660533|FG002|Overall Study|Adverse Event|1
7397024|NCT01287117|11660534|FG003|Overall Study|Adverse Event|1
7397025|NCT01287117|11660531|FG000|Overall Study|Lost to Follow-up|1
7397026|NCT01287117|11660532|FG001|Overall Study|Lost to Follow-up|1
7397027|NCT01287117|11660533|FG002|Overall Study|Lost to Follow-up|0
7397028|NCT01287117|11660534|FG003|Overall Study|Lost to Follow-up|0
7397029|NCT01287117|11660531|FG000|Overall Study|Physician Decision|0
7397030|NCT01287117|11660532|FG001|Overall Study|Physician Decision|1
7397031|NCT01287117|11660533|FG002|Overall Study|Physician Decision|1
7397032|NCT01287117|11660534|FG003|Overall Study|Physician Decision|1
7471115|NCT01939197|11773788|FG003|Overall Study|Lost to Follow-up|1
7471116|NCT01939197|11773789|FG004|Overall Study|Lost to Follow-up|3
7471117|NCT01939197|11773790|FG005|Overall Study|Lost to Follow-up|1
7553084|NCT03005106|11913823|FG000|Overall Study|Lost to Follow-up|16
7397033|NCT01287117|11660531|FG000|Overall Study|Patient/Legal Guardian's Decision|2
7397034|NCT01287117|11660532|FG001|Overall Study|Patient/Legal Guardian's Decision|6
7397035|NCT01287117|11660533|FG002|Overall Study|Patient/Legal Guardian's Decision|8
7397036|NCT01287117|11660534|FG003|Overall Study|Patient/Legal Guardian's Decision|5
7397037|NCT01287117|11660531|FG000|Overall Study|Disease Progression|10
7397038|NCT01287117|11660532|FG001|Overall Study|Disease Progression|5
7397039|NCT01287117|11660533|FG002|Overall Study|Disease Progression|6
7397040|NCT01287117|11660534|FG003|Overall Study|Disease Progression|5
7397041|NCT01287195|11660544|FG000|Overall Study|Withdrawal by Subject|2
7397042|NCT01287221|11660561|FG000|Overall Study|Lack of Perceived Benefit|1
7397043|NCT01287221|11660562|FG001|Overall Study|Lack of Perceived Benefit|1
7397044|NCT01287221|11660561|FG000|Overall Study|Adverse Event|3
7397045|NCT01287221|11660562|FG001|Overall Study|Adverse Event|3
7397046|NCT01287221|11660561|FG000|Overall Study|Withdrawal by Subject|0
7397047|NCT01287221|11660562|FG001|Overall Study|Withdrawal by Subject|1
7397048|NCT01287364|11660570|FG000|Overall Study|Adverse Event|0
7397049|NCT01287364|11660571|FG001|Overall Study|Adverse Event|3
7397050|NCT01287364|11660570|FG000|Overall Study|Protocol Violation|5
7397051|NCT01287364|11660571|FG001|Overall Study|Protocol Violation|5
7397052|NCT01287364|11660570|FG000|Overall Study|Other Reason|4
7397053|NCT01287364|11660571|FG001|Overall Study|Other Reason|2
7397054|NCT01287403|11660603|FG000|1st Intervention (1 Day)|Adverse Event|1
7471118|NCT01939197|11773791|FG006|Overall Study|Lost to Follow-up|2
7397055|NCT01287416|11660619|FG000|Pre-post Training|Withdrawal by Subject|17
7397056|NCT01287416|11660620|FG001|Pre-post Training|Withdrawal by Subject|24
7397057|NCT01287416|11660619|FG000|Pre-post Training|Lost to Follow-up|5
7397058|NCT01287416|11660620|FG001|Pre-post Training|Lost to Follow-up|1
7397059|NCT01287416|11660619|FG000|6 Month Follow-up|Lost to Follow-up|3
7397060|NCT01287416|11660620|FG001|6 Month Follow-up|Lost to Follow-up|2
7397061|NCT01287520|11660635|FG000|Overall Study|Adverse Event|2
7397062|NCT01287520|11660636|FG001|Overall Study|Adverse Event|2
7397063|NCT01287520|11660637|FG002|Overall Study|Adverse Event|2
7397064|NCT01287520|11660638|FG003|Overall Study|Adverse Event|1
7397065|NCT01287520|11660639|FG004|Overall Study|Adverse Event|1
7397066|NCT01287520|11660640|FG005|Overall Study|Adverse Event|2
7397067|NCT01287520|11660641|FG006|Overall Study|Adverse Event|0
7397068|NCT01287520|11660642|FG007|Overall Study|Adverse Event|2
7397069|NCT01287520|11660643|FG008|Overall Study|Adverse Event|0
7397070|NCT01287520|11660635|FG000|Overall Study|Physician Decision|1
7397071|NCT01287520|11660636|FG001|Overall Study|Physician Decision|1
7397072|NCT01287520|11660637|FG002|Overall Study|Physician Decision|2
7397073|NCT01287520|11660638|FG003|Overall Study|Physician Decision|0
7397074|NCT01287520|11660639|FG004|Overall Study|Physician Decision|1
7397075|NCT01287520|11660640|FG005|Overall Study|Physician Decision|1
7397076|NCT01287520|11660641|FG006|Overall Study|Physician Decision|0
7397077|NCT01287520|11660642|FG007|Overall Study|Physician Decision|1
7397078|NCT01287520|11660643|FG008|Overall Study|Physician Decision|0
7397079|NCT01287520|11660635|FG000|Overall Study|Progressive disease|0
7397080|NCT01287520|11660636|FG001|Overall Study|Progressive disease|4
7397081|NCT01287520|11660637|FG002|Overall Study|Progressive disease|1
7397082|NCT01287520|11660638|FG003|Overall Study|Progressive disease|6
7397083|NCT01287520|11660639|FG004|Overall Study|Progressive disease|1
7397084|NCT01287520|11660640|FG005|Overall Study|Progressive disease|0
7397085|NCT01287520|11660641|FG006|Overall Study|Progressive disease|2
7397086|NCT01287520|11660642|FG007|Overall Study|Progressive disease|2
7397087|NCT01287520|11660643|FG008|Overall Study|Progressive disease|4
7397088|NCT01287520|11660635|FG000|Overall Study|Withdrawal by Subject|0
7397089|NCT01287520|11660636|FG001|Overall Study|Withdrawal by Subject|0
7397090|NCT01287520|11660637|FG002|Overall Study|Withdrawal by Subject|0
7397091|NCT01287520|11660638|FG003|Overall Study|Withdrawal by Subject|0
7397092|NCT01287520|11660639|FG004|Overall Study|Withdrawal by Subject|0
7397093|NCT01287520|11660640|FG005|Overall Study|Withdrawal by Subject|1
7397094|NCT01287520|11660641|FG006|Overall Study|Withdrawal by Subject|0
7397095|NCT01287520|11660642|FG007|Overall Study|Withdrawal by Subject|0
7397096|NCT01287520|11660643|FG008|Overall Study|Withdrawal by Subject|1
7397097|NCT01287754|11660694|FG000|Overall Study|Death|2
7397098|NCT01287754|11660695|FG001|Overall Study|Death|12
7397099|NCT01287754|11660694|FG000|Overall Study|Lost to Follow-up|1
7397100|NCT01287754|11660695|FG001|Overall Study|Lost to Follow-up|6
7397101|NCT01287754|11660694|FG000|Overall Study|Protocol Violation|0
7397102|NCT01287754|11660695|FG001|Overall Study|Protocol Violation|3
7397103|NCT01287832|11660703|FG000|Overall Study|Adverse Event|1
7397104|NCT01287832|11660704|FG001|Overall Study|Adverse Event|0
7397105|NCT01287832|11660703|FG000|Overall Study|Death|0
7397106|NCT01287832|11660704|FG001|Overall Study|Death|1
7397107|NCT01287897|11660714|FG000|Overall Study|Adverse Event|5
7397108|NCT01287897|11660715|FG001|Overall Study|Adverse Event|3
7397109|NCT01287897|11660716|FG002|Overall Study|Adverse Event|6
7397110|NCT01287897|11660717|FG003|Overall Study|Adverse Event|4
7397111|NCT01287897|11660714|FG000|Overall Study|Lack of Efficacy|2
7397112|NCT01287897|11660715|FG001|Overall Study|Lack of Efficacy|0
7397113|NCT01287897|11660716|FG002|Overall Study|Lack of Efficacy|0
7397114|NCT01287897|11660717|FG003|Overall Study|Lack of Efficacy|0
7397115|NCT01287897|11660714|FG000|Overall Study|Protocol Violation|1
7397116|NCT01287897|11660715|FG001|Overall Study|Protocol Violation|1
7397117|NCT01287897|11660716|FG002|Overall Study|Protocol Violation|0
7397118|NCT01287897|11660717|FG003|Overall Study|Protocol Violation|1
7397119|NCT01287897|11660714|FG000|Overall Study|Lost to Follow-up|0
7397120|NCT01287897|11660715|FG001|Overall Study|Lost to Follow-up|0
7397121|NCT01287897|11660716|FG002|Overall Study|Lost to Follow-up|2
7397122|NCT01287897|11660717|FG003|Overall Study|Lost to Follow-up|0
7397123|NCT01287897|11660714|FG000|Overall Study|Withdrawal by Subject|1
7397124|NCT01287897|11660715|FG001|Overall Study|Withdrawal by Subject|5
7397125|NCT01287897|11660716|FG002|Overall Study|Withdrawal by Subject|3
7397126|NCT01287897|11660717|FG003|Overall Study|Withdrawal by Subject|2
7397127|NCT01287897|11660714|FG000|Overall Study|Not consented properly|0
7397128|NCT01287897|11660715|FG001|Overall Study|Not consented properly|1
7397129|NCT01287897|11660716|FG002|Overall Study|Not consented properly|0
7397130|NCT01287897|11660717|FG003|Overall Study|Not consented properly|0
7397131|NCT01287897|11660714|FG000|Overall Study|Not meeting entrance criteria|1
7397132|NCT01287897|11660715|FG001|Overall Study|Not meeting entrance criteria|1
7397133|NCT01287897|11660716|FG002|Overall Study|Not meeting entrance criteria|0
7397134|NCT01287897|11660717|FG003|Overall Study|Not meeting entrance criteria|0
7397135|NCT01287897|11660714|FG000|Overall Study|Other|1
7397136|NCT01287897|11660715|FG001|Overall Study|Other|0
7397137|NCT01287897|11660716|FG002|Overall Study|Other|1
7397138|NCT01287897|11660717|FG003|Overall Study|Other|0
7397139|NCT01288053|11660735|FG000|Overall Study|Death|1
7397140|NCT01288079|11660743|FG000|Overall Study|Withdrawal by Subject|2
7397141|NCT01288079|11660744|FG001|Overall Study|Withdrawal by Subject|4
7397142|NCT01288079|11660745|FG002|Overall Study|Withdrawal by Subject|1
7397143|NCT01288079|11660746|FG003|Overall Study|Withdrawal by Subject|0
7397144|NCT01288079|11660743|FG000|Overall Study|Adverse Event|2
7397145|NCT01288079|11660744|FG001|Overall Study|Adverse Event|1
7397146|NCT01288079|11660745|FG002|Overall Study|Adverse Event|2
7397147|NCT01288079|11660746|FG003|Overall Study|Adverse Event|3
7397148|NCT01288079|11660743|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7397149|NCT01288079|11660744|FG001|Overall Study|Severe Non-Compliance to Protocol|3
7397150|NCT01288079|11660745|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7397151|NCT01288079|11660746|FG003|Overall Study|Severe Non-Compliance to Protocol|3
7397152|NCT01288079|11660743|FG000|Overall Study|Condition under Investigation Worsened|0
7397153|NCT01288079|11660744|FG001|Overall Study|Condition under Investigation Worsened|0
7397154|NCT01288079|11660745|FG002|Overall Study|Condition under Investigation Worsened|0
7397155|NCT01288079|11660746|FG003|Overall Study|Condition under Investigation Worsened|1
7397156|NCT01288079|11660743|FG000|Overall Study|Lack of Efficacy|2
7397157|NCT01288079|11660744|FG001|Overall Study|Lack of Efficacy|2
7397158|NCT01288079|11660745|FG002|Overall Study|Lack of Efficacy|0
7397159|NCT01288079|11660746|FG003|Overall Study|Lack of Efficacy|2
7397160|NCT01288079|11660743|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
7397161|NCT01288079|11660744|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7397162|NCT01288079|11660745|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
7397163|NCT01288079|11660746|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
7397164|NCT01288079|11660743|FG000|Overall Study|Lost to Follow-up|1
7397165|NCT01288079|11660744|FG001|Overall Study|Lost to Follow-up|1
7397166|NCT01288079|11660745|FG002|Overall Study|Lost to Follow-up|1
7397167|NCT01288079|11660746|FG003|Overall Study|Lost to Follow-up|0
7397168|NCT01288079|11660743|FG000|Overall Study|Other or Study Termination|11
7397169|NCT01288079|11660744|FG001|Overall Study|Other or Study Termination|15
7397170|NCT01288079|11660745|FG002|Overall Study|Other or Study Termination|14
7397171|NCT01288079|11660746|FG003|Overall Study|Other or Study Termination|8
7397172|NCT01288209|11660758|FG000|Overall Study|Withdrawal by Subject|1
7397173|NCT01288209|11660759|FG001|Overall Study|Withdrawal by Subject|3
7397174|NCT01288209|11660758|FG000|Overall Study|Other|1
7397175|NCT01288209|11660759|FG001|Overall Study|Other|0
7397176|NCT01288287|11660765|FG000|Overall Study|Lost to Follow-up|8
7397177|NCT01288287|11660765|FG000|Overall Study|Withdrawal by Subject|4
7397178|NCT01288287|11660765|FG000|Overall Study|Lack of Efficacy|13
7397179|NCT01288287|11660765|FG000|Overall Study|Other Reason|13
7397180|NCT01288287|11660765|FG000|Overall Study|Unknown Reason|1
7397181|NCT01288287|11660765|FG000|Overall Study|Unknown Status|7
7397182|NCT01288430|11660780|FG000|Part 1|Progressive disease|2
7397183|NCT01288430|11660781|FG001|Part 1|Progressive disease|1
7397184|NCT01288430|11660782|FG002|Part 1|Progressive disease|1
7397185|NCT01288430|11660783|FG003|Part 1|Progressive disease|6
7397186|NCT01288430|11660784|FG004|Part 1|Progressive disease|2
7397187|NCT01288430|11660785|FG005|Part 1|Progressive disease|4
7397188|NCT01288430|11660786|FG006|Part 1|Progressive disease|2
7397189|NCT01288430|11660787|FG007|Part 1|Progressive disease|0
7397190|NCT01288430|11660788|FG008|Part 1|Progressive disease|0
7397191|NCT01288430|11660789|FG009|Part 1|Progressive disease|0
7397192|NCT01288430|11660780|FG000|Part 1|Clinical disease progression|0
7397193|NCT01288430|11660781|FG001|Part 1|Clinical disease progression|0
7397194|NCT01288430|11660782|FG002|Part 1|Clinical disease progression|1
7397195|NCT01288430|11660783|FG003|Part 1|Clinical disease progression|0
7397196|NCT01288430|11660784|FG004|Part 1|Clinical disease progression|0
7397197|NCT01288430|11660785|FG005|Part 1|Clinical disease progression|2
7397198|NCT01288430|11660786|FG006|Part 1|Clinical disease progression|2
7397199|NCT01288430|11660787|FG007|Part 1|Clinical disease progression|0
7397200|NCT01288430|11660788|FG008|Part 1|Clinical disease progression|0
7397201|NCT01288430|11660789|FG009|Part 1|Clinical disease progression|0
7397202|NCT01288430|11660780|FG000|Part 1|Death due to disease progression|0
7397203|NCT01288430|11660781|FG001|Part 1|Death due to disease progression|0
7397204|NCT01288430|11660782|FG002|Part 1|Death due to disease progression|0
7397205|NCT01288430|11660783|FG003|Part 1|Death due to disease progression|0
7397206|NCT01288430|11660784|FG004|Part 1|Death due to disease progression|1
7397207|NCT01288430|11660785|FG005|Part 1|Death due to disease progression|0
7397208|NCT01288430|11660786|FG006|Part 1|Death due to disease progression|0
7397209|NCT01288430|11660787|FG007|Part 1|Death due to disease progression|0
7397210|NCT01288430|11660788|FG008|Part 1|Death due to disease progression|0
7397211|NCT01288430|11660789|FG009|Part 1|Death due to disease progression|0
7397212|NCT01288430|11660780|FG000|Part 1|Adverse Event|0
7397213|NCT01288430|11660781|FG001|Part 1|Adverse Event|0
7397214|NCT01288430|11660782|FG002|Part 1|Adverse Event|3
7397215|NCT01288430|11660783|FG003|Part 1|Adverse Event|1
7397216|NCT01288430|11660784|FG004|Part 1|Adverse Event|0
7397217|NCT01288430|11660785|FG005|Part 1|Adverse Event|0
7397218|NCT01288430|11660786|FG006|Part 1|Adverse Event|2
7397219|NCT01288430|11660787|FG007|Part 1|Adverse Event|0
7397220|NCT01288430|11660788|FG008|Part 1|Adverse Event|0
7397221|NCT01288430|11660789|FG009|Part 1|Adverse Event|0
7397222|NCT01288430|11660780|FG000|Part 1|Other|0
7397223|NCT01288430|11660781|FG001|Part 1|Other|2
7397224|NCT01288430|11660782|FG002|Part 1|Other|0
7397225|NCT01288430|11660783|FG003|Part 1|Other|0
7397226|NCT01288430|11660784|FG004|Part 1|Other|0
7397227|NCT01288430|11660785|FG005|Part 1|Other|0
7397228|NCT01288430|11660786|FG006|Part 1|Other|1
7397229|NCT01288430|11660787|FG007|Part 1|Other|0
7397230|NCT01288430|11660788|FG008|Part 1|Other|0
7397231|NCT01288430|11660789|FG009|Part 1|Other|0
7397232|NCT01288430|11660780|FG000|Part 2|Progressive disease|0
7397233|NCT01288430|11660781|FG001|Part 2|Progressive disease|0
7397234|NCT01288430|11660782|FG002|Part 2|Progressive disease|0
7397235|NCT01288430|11660783|FG003|Part 2|Progressive disease|0
7397236|NCT01288430|11660784|FG004|Part 2|Progressive disease|0
7397237|NCT01288430|11660785|FG005|Part 2|Progressive disease|0
7397238|NCT01288430|11660786|FG006|Part 2|Progressive disease|0
7397239|NCT01288430|11660787|FG007|Part 2|Progressive disease|8
7397240|NCT01288430|11660788|FG008|Part 2|Progressive disease|7
7397241|NCT01288430|11660789|FG009|Part 2|Progressive disease|2
7397242|NCT01288430|11660780|FG000|Part 2|Clinical disease progression|0
7397243|NCT01288430|11660781|FG001|Part 2|Clinical disease progression|0
7397244|NCT01288430|11660782|FG002|Part 2|Clinical disease progression|0
7397245|NCT01288430|11660783|FG003|Part 2|Clinical disease progression|0
7397246|NCT01288430|11660784|FG004|Part 2|Clinical disease progression|0
7397247|NCT01288430|11660785|FG005|Part 2|Clinical disease progression|0
7397248|NCT01288430|11660786|FG006|Part 2|Clinical disease progression|0
7397249|NCT01288430|11660787|FG007|Part 2|Clinical disease progression|2
7397250|NCT01288430|11660788|FG008|Part 2|Clinical disease progression|0
7397251|NCT01288430|11660789|FG009|Part 2|Clinical disease progression|0
7397252|NCT01288430|11660780|FG000|Part 2|Withdrawal by Subject|0
7397253|NCT01288430|11660781|FG001|Part 2|Withdrawal by Subject|0
7397254|NCT01288430|11660782|FG002|Part 2|Withdrawal by Subject|0
7397255|NCT01288430|11660783|FG003|Part 2|Withdrawal by Subject|0
7397256|NCT01288430|11660784|FG004|Part 2|Withdrawal by Subject|0
7397257|NCT01288430|11660785|FG005|Part 2|Withdrawal by Subject|0
7397258|NCT01288430|11660786|FG006|Part 2|Withdrawal by Subject|0
7397259|NCT01288430|11660787|FG007|Part 2|Withdrawal by Subject|1
7397260|NCT01288430|11660788|FG008|Part 2|Withdrawal by Subject|4
7397261|NCT01288430|11660789|FG009|Part 2|Withdrawal by Subject|0
7397262|NCT01288430|11660780|FG000|Part 2|Adverse Event|0
7397263|NCT01288430|11660781|FG001|Part 2|Adverse Event|0
7397264|NCT01288430|11660782|FG002|Part 2|Adverse Event|0
7397265|NCT01288430|11660783|FG003|Part 2|Adverse Event|0
7397266|NCT01288430|11660784|FG004|Part 2|Adverse Event|0
7397267|NCT01288430|11660785|FG005|Part 2|Adverse Event|0
7397268|NCT01288430|11660786|FG006|Part 2|Adverse Event|0
7397269|NCT01288430|11660787|FG007|Part 2|Adverse Event|1
7397270|NCT01288430|11660788|FG008|Part 2|Adverse Event|1
7397271|NCT01288430|11660789|FG009|Part 2|Adverse Event|0
7397272|NCT01288430|11660780|FG000|Part 2|Other|0
7397273|NCT01288430|11660781|FG001|Part 2|Other|0
7397274|NCT01288430|11660782|FG002|Part 2|Other|0
7397275|NCT01288430|11660783|FG003|Part 2|Other|0
7397276|NCT01288430|11660784|FG004|Part 2|Other|0
7397277|NCT01288430|11660785|FG005|Part 2|Other|0
7397278|NCT01288430|11660786|FG006|Part 2|Other|0
7397279|NCT01288430|11660787|FG007|Part 2|Other|0
7397280|NCT01288430|11660788|FG008|Part 2|Other|0
7397281|NCT01288430|11660789|FG009|Part 2|Other|1
7397282|NCT01288443|11660822|FG000|Overall Study|Adverse Event|0
7397283|NCT01288443|11660823|FG001|Overall Study|Adverse Event|0
7397284|NCT01288443|11660824|FG002|Overall Study|Adverse Event|1
7397285|NCT01288443|11660825|FG003|Overall Study|Adverse Event|1
7397286|NCT01288443|11660826|FG004|Overall Study|Adverse Event|3
7397287|NCT01288443|11660827|FG005|Overall Study|Adverse Event|1
7397288|NCT01288443|11660822|FG000|Overall Study|Poor compliance to protocol|0
7397289|NCT01288443|11660823|FG001|Overall Study|Poor compliance to protocol|0
7397290|NCT01288443|11660824|FG002|Overall Study|Poor compliance to protocol|0
7397291|NCT01288443|11660825|FG003|Overall Study|Poor compliance to protocol|0
7397292|NCT01288443|11660826|FG004|Overall Study|Poor compliance to protocol|0
7397293|NCT01288443|11660827|FG005|Overall Study|Poor compliance to protocol|1
7397294|NCT01288443|11660822|FG000|Overall Study|Participant Moved|0
7397295|NCT01288443|11660823|FG001|Overall Study|Participant Moved|0
7397296|NCT01288443|11660824|FG002|Overall Study|Participant Moved|0
7397297|NCT01288443|11660825|FG003|Overall Study|Participant Moved|1
7397298|NCT01288443|11660826|FG004|Overall Study|Participant Moved|2
7397299|NCT01288443|11660827|FG005|Overall Study|Participant Moved|1
7397300|NCT01288443|11660822|FG000|Overall Study|Consent withdrawn by Participant|0
7397301|NCT01288443|11660823|FG001|Overall Study|Consent withdrawn by Participant|0
7397302|NCT01288443|11660824|FG002|Overall Study|Consent withdrawn by Participant|0
7397303|NCT01288443|11660825|FG003|Overall Study|Consent withdrawn by Participant|0
7397304|NCT01288443|11660826|FG004|Overall Study|Consent withdrawn by Participant|0
7397305|NCT01288443|11660827|FG005|Overall Study|Consent withdrawn by Participant|1
7397306|NCT01288443|11660822|FG000|Overall Study|Lost to Follow-up|0
7397307|NCT01288443|11660823|FG001|Overall Study|Lost to Follow-up|1
7397308|NCT01288443|11660824|FG002|Overall Study|Lost to Follow-up|0
7397309|NCT01288443|11660825|FG003|Overall Study|Lost to Follow-up|0
7397310|NCT01288443|11660826|FG004|Overall Study|Lost to Follow-up|0
7397311|NCT01288443|11660827|FG005|Overall Study|Lost to Follow-up|0
7397312|NCT01288443|11660822|FG000|Overall Study|Study drug auto-injector administration|0
7397313|NCT01288443|11660823|FG001|Overall Study|Study drug auto-injector administration|0
7397314|NCT01288443|11660824|FG002|Overall Study|Study drug auto-injector administration|0
7397315|NCT01288443|11660825|FG003|Overall Study|Study drug auto-injector administration|0
7397316|NCT01288443|11660826|FG004|Overall Study|Study drug auto-injector administration|1
7397317|NCT01288443|11660827|FG005|Overall Study|Study drug auto-injector administration|1
7397318|NCT01288443|11660822|FG000|Overall Study|Other than above|0
7397319|NCT01288443|11660823|FG001|Overall Study|Other than above|0
7397320|NCT01288443|11660824|FG002|Overall Study|Other than above|0
7397321|NCT01288443|11660825|FG003|Overall Study|Other than above|2
7397322|NCT01288443|11660826|FG004|Overall Study|Other than above|1
7397323|NCT01288443|11660827|FG005|Overall Study|Other than above|0
7397324|NCT01288469|11660844|FG000|Overall Study|Adverse Event|4
7397325|NCT01288469|11660845|FG001|Overall Study|Adverse Event|1
7397326|NCT01288469|11660846|FG002|Overall Study|Adverse Event|1
7397327|NCT01288469|11660844|FG000|Overall Study|Poor compliance to protocol|0
7397328|NCT01288469|11660845|FG001|Overall Study|Poor compliance to protocol|1
7397329|NCT01288469|11660846|FG002|Overall Study|Poor compliance to protocol|0
7397330|NCT01288469|11660844|FG000|Overall Study|Participant Moved|1
7397331|NCT01288469|11660845|FG001|Overall Study|Participant Moved|0
7397332|NCT01288469|11660846|FG002|Overall Study|Participant Moved|0
7397333|NCT01288469|11660844|FG000|Overall Study|Consent withdrawn by subject|1
7397334|NCT01288469|11660845|FG001|Overall Study|Consent withdrawn by subject|1
7397335|NCT01288469|11660846|FG002|Overall Study|Consent withdrawn by subject|1
7397336|NCT01288469|11660844|FG000|Overall Study|Exclusion criteria finally met|1
7397337|NCT01288469|11660845|FG001|Overall Study|Exclusion criteria finally met|0
7397338|NCT01288469|11660846|FG002|Overall Study|Exclusion criteria finally met|0
7397339|NCT01288612|11660870|FG000|Overall Study|Unable to contact|11
7397340|NCT01288612|11660871|FG001|Overall Study|Unable to contact|16
7397341|NCT01288612|11660872|FG002|Overall Study|Unable to contact|20
7397342|NCT01288612|11660870|FG000|Overall Study|Declined|78
7397343|NCT01288612|11660871|FG001|Overall Study|Declined|63
7397344|NCT01288612|11660872|FG002|Overall Study|Declined|62
7397345|NCT01288612|11660870|FG000|Overall Study|Unable to intubate|0
7397346|NCT01288612|11660871|FG001|Overall Study|Unable to intubate|3
7397347|NCT01288612|11660872|FG002|Overall Study|Unable to intubate|0
7465413|NCT01296711|11764682|FG003|Overall Study|Lack of Efficacy|1
7465414|NCT01296711|11764683|FG004|Overall Study|Lack of Efficacy|1
7465415|NCT01296711|11764684|FG005|Overall Study|Lack of Efficacy|0
7465416|NCT01296711|11764685|FG006|Overall Study|Lack of Efficacy|2
7465417|NCT01296711|11764686|FG007|Overall Study|Lack of Efficacy|3
7465418|NCT01296711|11764679|FG000|Overall Study|Lost to Follow-up|0
7465419|NCT01296711|11764680|FG001|Overall Study|Lost to Follow-up|0
7465420|NCT01296711|11764681|FG002|Overall Study|Lost to Follow-up|1
7465421|NCT01296711|11764682|FG003|Overall Study|Lost to Follow-up|1
7465422|NCT01296711|11764683|FG004|Overall Study|Lost to Follow-up|2
7465423|NCT01296711|11764684|FG005|Overall Study|Lost to Follow-up|0
7465424|NCT01296711|11764685|FG006|Overall Study|Lost to Follow-up|4
7465425|NCT01296711|11764686|FG007|Overall Study|Lost to Follow-up|2
7465426|NCT01296711|11764679|FG000|Overall Study|Protocol Violation|0
7465427|NCT01296711|11764680|FG001|Overall Study|Protocol Violation|0
7465428|NCT01296711|11764681|FG002|Overall Study|Protocol Violation|0
7465429|NCT01296711|11764682|FG003|Overall Study|Protocol Violation|1
7465430|NCT01296711|11764683|FG004|Overall Study|Protocol Violation|1
7465431|NCT01296711|11764684|FG005|Overall Study|Protocol Violation|0
7465432|NCT01296711|11764685|FG006|Overall Study|Protocol Violation|0
7465433|NCT01296711|11764686|FG007|Overall Study|Protocol Violation|0
7465434|NCT01296711|11764679|FG000|Overall Study|Withdrawal by Subject|4
7465435|NCT01296711|11764680|FG001|Overall Study|Withdrawal by Subject|2
7465436|NCT01296711|11764681|FG002|Overall Study|Withdrawal by Subject|2
7465437|NCT01296711|11764682|FG003|Overall Study|Withdrawal by Subject|1
7465438|NCT01296711|11764683|FG004|Overall Study|Withdrawal by Subject|1
7465439|NCT01296711|11764684|FG005|Overall Study|Withdrawal by Subject|1
7465440|NCT01296711|11764685|FG006|Overall Study|Withdrawal by Subject|2
7465441|NCT01296711|11764686|FG007|Overall Study|Withdrawal by Subject|1
7465442|NCT01296711|11764679|FG000|Overall Study|Study termination|8
7465443|NCT01296711|11764680|FG001|Overall Study|Study termination|1
7465444|NCT01296711|11764681|FG002|Overall Study|Study termination|5
7465445|NCT01296711|11764682|FG003|Overall Study|Study termination|4
7465446|NCT01296711|11764683|FG004|Overall Study|Study termination|4
7465447|NCT01296711|11764684|FG005|Overall Study|Study termination|4
7465448|NCT01296711|11764685|FG006|Overall Study|Study termination|8
7465449|NCT01296711|11764686|FG007|Overall Study|Study termination|10
7465450|NCT01296711|11764679|FG000|Overall Study|Continued elevated liver enzymes|0
7465451|NCT01296711|11764680|FG001|Overall Study|Continued elevated liver enzymes|0
7465452|NCT01296711|11764681|FG002|Overall Study|Continued elevated liver enzymes|0
7465453|NCT01296711|11764682|FG003|Overall Study|Continued elevated liver enzymes|1
7465454|NCT01296711|11764683|FG004|Overall Study|Continued elevated liver enzymes|0
7465455|NCT01296711|11764684|FG005|Overall Study|Continued elevated liver enzymes|0
7465456|NCT01296711|11764685|FG006|Overall Study|Continued elevated liver enzymes|0
7465457|NCT01296711|11764686|FG007|Overall Study|Continued elevated liver enzymes|0
7465458|NCT01296711|11764679|FG000|Overall Study|Methotrexate discontinued|0
7465459|NCT01296711|11764680|FG001|Overall Study|Methotrexate discontinued|0
7465460|NCT01296711|11764681|FG002|Overall Study|Methotrexate discontinued|0
7465461|NCT01296711|11764682|FG003|Overall Study|Methotrexate discontinued|1
7465462|NCT01296711|11764683|FG004|Overall Study|Methotrexate discontinued|0
7465463|NCT01296711|11764684|FG005|Overall Study|Methotrexate discontinued|0
7397348|NCT01288729|11660882|FG000|Overall Study|Withdrawal by Subject|1
7397349|NCT01288729|11660883|FG001|Overall Study|Withdrawal by Subject|0
7397376|NCT01288937|11660950|FG000|Overall Study|Adverse Event|1
7397377|NCT01288937|11660951|FG001|Overall Study|Adverse Event|0
7397378|NCT01288976|11660960|FG000|Overall Study|Withdrawal by Subject|58
7397379|NCT01288976|11660961|FG001|Overall Study|Withdrawal by Subject|12
7397380|NCT01288976|11660962|FG002|Overall Study|Withdrawal by Subject|9
7397381|NCT01288976|11660960|FG000|Overall Study|Death|98
7397382|NCT01288976|11660961|FG001|Overall Study|Death|6
7397383|NCT01288976|11660962|FG002|Overall Study|Death|4
7397384|NCT01288976|11660960|FG000|Overall Study|Data unavailable|22
7397385|NCT01288976|11660961|FG001|Overall Study|Data unavailable|9
7397386|NCT01288976|11660962|FG002|Overall Study|Data unavailable|7
7397387|NCT01288989|11660973|FG000|Overall Study|Death|0
7397388|NCT01288989|11660974|FG001|Overall Study|Death|0
7397389|NCT01288989|11660975|FG002|Overall Study|Death|0
7397390|NCT01288989|11660976|FG003|Overall Study|Death|1
7397391|NCT01288989|11660977|FG004|Overall Study|Death|0
7397392|NCT01288989|11660973|FG000|Overall Study|Dose limiting toxicity|1
7397393|NCT01288989|11660974|FG001|Overall Study|Dose limiting toxicity|0
7397394|NCT01288989|11660975|FG002|Overall Study|Dose limiting toxicity|0
7397395|NCT01288989|11660976|FG003|Overall Study|Dose limiting toxicity|0
7397396|NCT01288989|11660977|FG004|Overall Study|Dose limiting toxicity|0
7397397|NCT01288989|11660973|FG000|Overall Study|Adverse Event|0
7397398|NCT01288989|11660974|FG001|Overall Study|Adverse Event|0
7397399|NCT01288989|11660975|FG002|Overall Study|Adverse Event|0
7397400|NCT01288989|11660976|FG003|Overall Study|Adverse Event|0
7397401|NCT01288989|11660977|FG004|Overall Study|Adverse Event|2
7397402|NCT01288989|11660973|FG000|Overall Study|Physician Decision|0
7397403|NCT01288989|11660974|FG001|Overall Study|Physician Decision|0
7397404|NCT01288989|11660975|FG002|Overall Study|Physician Decision|0
7397405|NCT01288989|11660976|FG003|Overall Study|Physician Decision|0
7397406|NCT01288989|11660977|FG004|Overall Study|Physician Decision|1
7397407|NCT01288989|11660973|FG000|Overall Study|Withdrawal by Subject|0
7397408|NCT01288989|11660974|FG001|Overall Study|Withdrawal by Subject|0
7397409|NCT01288989|11660975|FG002|Overall Study|Withdrawal by Subject|0
7397410|NCT01288989|11660976|FG003|Overall Study|Withdrawal by Subject|0
7397411|NCT01288989|11660977|FG004|Overall Study|Withdrawal by Subject|3
7397412|NCT01289015|11660997|FG000|Overall Study|Protocol Violation|12
7397413|NCT01289015|11660998|FG001|Overall Study|Protocol Violation|9
7397414|NCT01289015|11660997|FG000|Overall Study|Adverse Event|3
7397415|NCT01289015|11660998|FG001|Overall Study|Adverse Event|0
7397416|NCT01289015|11660997|FG000|Overall Study|Lost to Follow-up|33
7397417|NCT01289015|11660998|FG001|Overall Study|Lost to Follow-up|17
7397418|NCT01289015|11660997|FG000|Overall Study|Withdrawal by Subject|17
7397419|NCT01289015|11660998|FG001|Overall Study|Withdrawal by Subject|8
7397420|NCT01289015|11660997|FG000|Overall Study|Disease progression|1
7397421|NCT01289015|11660998|FG001|Overall Study|Disease progression|0
7397422|NCT01289015|11660997|FG000|Overall Study|Negative baseline culture and others|33
7397423|NCT01289015|11660998|FG001|Overall Study|Negative baseline culture and others|20
7397424|NCT01289028|11661004|FG000|Overall Study|Progressive Disease|49
7397425|NCT01289028|11661004|FG000|Overall Study|Adverse Event|14
7397426|NCT01289028|11661004|FG000|Overall Study|Withdrawal by Subject|6
7397427|NCT01289028|11661004|FG000|Overall Study|Death|4
7397428|NCT01289028|11661004|FG000|Overall Study|Lack of Efficacy|2
7397429|NCT01289028|11661004|FG000|Overall Study|No longer required|2
7397430|NCT01289028|11661004|FG000|Overall Study|Lost to Follow-up|2
7397431|NCT01289028|11661004|FG000|Overall Study|New Cancer Therapy|2
7397432|NCT01289028|11661004|FG000|Overall Study|Abnormal Lab Value|1
7397433|NCT01289028|11661004|FG000|Overall Study|Missing reason for discon|1
7397434|NCT01289041|11661010|FG000|Overall Study|Adverse Event|24
7397435|NCT01289041|11661010|FG000|Overall Study|Physician Decision|1
7397436|NCT01289041|11661010|FG000|Overall Study|Progressive Disease|41
7397437|NCT01289041|11661010|FG000|Overall Study|Withdrawal by Subject|3
7397438|NCT01289041|11661010|FG000|Overall Study|Death|1
7397439|NCT01289119|11661036|FG000|Overall Study|Adverse Event|2
7397440|NCT01289119|11661037|FG001|Overall Study|Adverse Event|1
7397441|NCT01289119|11661038|FG002|Overall Study|Adverse Event|0
7397442|NCT01289119|11661039|FG003|Overall Study|Adverse Event|2
7397443|NCT01289119|11661040|FG004|Overall Study|Adverse Event|1
7397444|NCT01289119|11661041|FG005|Overall Study|Adverse Event|0
7397445|NCT01289119|11661036|FG000|Overall Study|Major Protocol Deviation|2
7397446|NCT01289119|11661037|FG001|Overall Study|Major Protocol Deviation|1
7397447|NCT01289119|11661038|FG002|Overall Study|Major Protocol Deviation|3
7397448|NCT01289119|11661039|FG003|Overall Study|Major Protocol Deviation|0
7397449|NCT01289119|11661040|FG004|Overall Study|Major Protocol Deviation|2
7397450|NCT01289119|11661041|FG005|Overall Study|Major Protocol Deviation|1
7397451|NCT01289119|11661036|FG000|Overall Study|Lost to Follow-up|0
7397452|NCT01289119|11661037|FG001|Overall Study|Lost to Follow-up|3
7397453|NCT01289119|11661038|FG002|Overall Study|Lost to Follow-up|0
7397454|NCT01289119|11661039|FG003|Overall Study|Lost to Follow-up|0
7397455|NCT01289119|11661040|FG004|Overall Study|Lost to Follow-up|0
7397456|NCT01289119|11661041|FG005|Overall Study|Lost to Follow-up|1
7397457|NCT01289119|11661036|FG000|Overall Study|Withdrawal by Subject|4
7397458|NCT01289119|11661037|FG001|Overall Study|Withdrawal by Subject|2
7397459|NCT01289119|11661038|FG002|Overall Study|Withdrawal by Subject|4
7397460|NCT01289119|11661039|FG003|Overall Study|Withdrawal by Subject|3
7397461|NCT01289119|11661040|FG004|Overall Study|Withdrawal by Subject|1
7397462|NCT01289119|11661041|FG005|Overall Study|Withdrawal by Subject|1
7397463|NCT01289119|11661036|FG000|Overall Study|Pregnancy|0
7397464|NCT01289119|11661037|FG001|Overall Study|Pregnancy|1
7397465|NCT01289119|11661038|FG002|Overall Study|Pregnancy|0
7397466|NCT01289119|11661039|FG003|Overall Study|Pregnancy|0
7397467|NCT01289119|11661040|FG004|Overall Study|Pregnancy|0
7397468|NCT01289119|11661041|FG005|Overall Study|Pregnancy|0
7397469|NCT01289119|11661036|FG000|Overall Study|Lack of Efficacy|0
7397470|NCT01289119|11661037|FG001|Overall Study|Lack of Efficacy|1
7397471|NCT01289119|11661038|FG002|Overall Study|Lack of Efficacy|1
7397472|NCT01289119|11661039|FG003|Overall Study|Lack of Efficacy|1
7397473|NCT01289119|11661040|FG004|Overall Study|Lack of Efficacy|1
7397474|NCT01289119|11661041|FG005|Overall Study|Lack of Efficacy|1
7397475|NCT01289119|11661036|FG000|Overall Study|Other|1
7397476|NCT01289119|11661037|FG001|Overall Study|Other|0
7397477|NCT01289119|11661038|FG002|Overall Study|Other|1
7397478|NCT01289119|11661039|FG003|Overall Study|Other|0
7397479|NCT01289119|11661040|FG004|Overall Study|Other|0
7397480|NCT01289119|11661041|FG005|Overall Study|Other|0
7397481|NCT01289210|11661055|FG000|Overall Study|Adverse Event|1
7397482|NCT01289353|11661080|FG000|Overall Study|Lost to Follow-up|2
7397483|NCT01289418|11661100|FG000|Day 8 Survey|email address invalid|283
7397484|NCT01289418|11661100|FG000|Day 8 Survey|participants did not complete the survey|1935
7397485|NCT01289418|11661100|FG000|Day 29 Survey|email address invalid|283
7397486|NCT01289418|11661100|FG000|Day 29 Survey|participants did not complete the survey|2185
7397487|NCT01289574|11661168|FG000|Overall Study|Lack of Efficacy|4
7397488|NCT01289574|11661169|FG001|Overall Study|Lack of Efficacy|0
7397489|NCT01289574|11661170|FG002|Overall Study|Lack of Efficacy|1
7397490|NCT01289574|11661168|FG000|Overall Study|Lost to Follow-up|2
7397491|NCT01289574|11661169|FG001|Overall Study|Lost to Follow-up|0
7397492|NCT01289574|11661170|FG002|Overall Study|Lost to Follow-up|1
7397493|NCT01289574|11661168|FG000|Overall Study|Withdrawal by Subject|1
7397494|NCT01289574|11661169|FG001|Overall Study|Withdrawal by Subject|1
7397495|NCT01289574|11661170|FG002|Overall Study|Withdrawal by Subject|1
7397496|NCT01289574|11661168|FG000|Overall Study|Adverse Event|0
7397497|NCT01289574|11661169|FG001|Overall Study|Adverse Event|1
7397498|NCT01289574|11661170|FG002|Overall Study|Adverse Event|0
7397499|NCT01289574|11661168|FG000|Overall Study|Subject wanted alternate treatment|0
7397500|NCT01289574|11661169|FG001|Overall Study|Subject wanted alternate treatment|1
7397501|NCT01289574|11661170|FG002|Overall Study|Subject wanted alternate treatment|0
7397502|NCT01289639|11661182|FG000|Overall Study|Lost to Follow-up|1
7397503|NCT01289639|11661183|FG001|Overall Study|Lost to Follow-up|0
7397504|NCT01289639|11661184|FG002|Overall Study|Lost to Follow-up|0
7397505|NCT01289678|11661201|FG000|Overall Study|Physician Decision|6
7397506|NCT01289782|11661207|FG000|Overall Study|Lost to Follow-up|14
7397507|NCT01289782|11661208|FG001|Overall Study|Lost to Follow-up|7
7397508|NCT01289782|11661207|FG000|Overall Study|Protocol Violation|1
7397509|NCT01289782|11661208|FG001|Overall Study|Protocol Violation|1
7397510|NCT01289782|11661207|FG000|Overall Study|Withdrawal by Subject|8
7397511|NCT01289782|11661208|FG001|Overall Study|Withdrawal by Subject|2
7397512|NCT01289782|11661207|FG000|Overall Study|Sponsor's Decision|1
7397513|NCT01289782|11661208|FG001|Overall Study|Sponsor's Decision|0
7397514|NCT01289782|11661207|FG000|Overall Study|Reason not specified|1
7397515|NCT01289782|11661208|FG001|Overall Study|Reason not specified|2
7397516|NCT01289821|11661214|FG000|Treatment Period|Withdrawal by Subject|1
7397517|NCT01289821|11661214|FG000|Treatment Period|Physician Decision|3
7397518|NCT01289821|11661214|FG000|Treatment Period|Adverse Event|4
7397519|NCT01289821|11661214|FG000|Treatment Period|Radiological Progression|43
7397520|NCT01289821|11661214|FG000|Treatment Period|Clinical Progression|2
7397521|NCT01289821|11661214|FG000|Treatment Period|Therapeutic procedure required|1
7397522|NCT01289821|11661214|FG000|Safety Follow-up Period|Withdrawal by Subject|1
7397523|NCT01289821|11661214|FG000|Safety Follow-up Period|Protocol Violation|3
7397524|NCT01289821|11661214|FG000|Safety Follow-up Period|Unspecified reason|1
7397525|NCT01289821|11661214|FG000|Survival Follow-up Period|Protocol Violation|1
7397526|NCT01289821|11661214|FG000|Survival Follow-up Period|Lost to Follow-up|1
7397527|NCT01289821|11661214|FG000|Survival Follow-up Period|Clinical endpoint reached|16
7397528|NCT01289847|11661218|FG000|Overall Study|Patient could not comply with visits|1
7397529|NCT01289990|11661254|FG000|Overall Study|Death|0
7397530|NCT01289990|11661255|FG001|Overall Study|Death|0
7397531|NCT01289990|11661256|FG002|Overall Study|Death|0
7397532|NCT01289990|11661257|FG003|Overall Study|Death|1
7397533|NCT01289990|11661258|FG004|Overall Study|Death|2
7397534|NCT01289990|11661259|FG005|Overall Study|Death|1
7397535|NCT01289990|11661260|FG006|Overall Study|Death|0
7397536|NCT01289990|11661261|FG007|Overall Study|Death|0
7397537|NCT01289990|11661262|FG008|Overall Study|Death|0
7397538|NCT01289990|11661263|FG009|Overall Study|Death|0
7397539|NCT01289990|11661264|FG010|Overall Study|Death|0
7397540|NCT01289990|11661265|FG011|Overall Study|Death|1
7397541|NCT01289990|11661266|FG012|Overall Study|Death|0
7397542|NCT01289990|11661254|FG000|Overall Study|Lost to Follow-up|3
7397543|NCT01289990|11661255|FG001|Overall Study|Lost to Follow-up|2
7397544|NCT01289990|11661256|FG002|Overall Study|Lost to Follow-up|5
7397545|NCT01289990|11661257|FG003|Overall Study|Lost to Follow-up|5
7397546|NCT01289990|11661258|FG004|Overall Study|Lost to Follow-up|3
7397547|NCT01289990|11661259|FG005|Overall Study|Lost to Follow-up|4
7397548|NCT01289990|11661260|FG006|Overall Study|Lost to Follow-up|2
7397549|NCT01289990|11661261|FG007|Overall Study|Lost to Follow-up|2
7397550|NCT01289990|11661262|FG008|Overall Study|Lost to Follow-up|1
7397551|NCT01289990|11661263|FG009|Overall Study|Lost to Follow-up|4
7397552|NCT01289990|11661264|FG010|Overall Study|Lost to Follow-up|2
7397553|NCT01289990|11661265|FG011|Overall Study|Lost to Follow-up|1
7397554|NCT01289990|11661266|FG012|Overall Study|Lost to Follow-up|2
7397555|NCT01289990|11661254|FG000|Overall Study|Withdrawal by Subject|15
7397556|NCT01289990|11661255|FG001|Overall Study|Withdrawal by Subject|14
7397557|NCT01289990|11661256|FG002|Overall Study|Withdrawal by Subject|12
7397558|NCT01289990|11661257|FG003|Overall Study|Withdrawal by Subject|13
7397559|NCT01289990|11661258|FG004|Overall Study|Withdrawal by Subject|8
7397560|NCT01289990|11661259|FG005|Overall Study|Withdrawal by Subject|7
7397561|NCT01289990|11661260|FG006|Overall Study|Withdrawal by Subject|13
7397562|NCT01289990|11661261|FG007|Overall Study|Withdrawal by Subject|9
7397563|NCT01289990|11661262|FG008|Overall Study|Withdrawal by Subject|12
7397564|NCT01289990|11661263|FG009|Overall Study|Withdrawal by Subject|13
7397565|NCT01289990|11661264|FG010|Overall Study|Withdrawal by Subject|11
7397566|NCT01289990|11661265|FG011|Overall Study|Withdrawal by Subject|13
7397567|NCT01289990|11661266|FG012|Overall Study|Withdrawal by Subject|16
7397651|NCT01290315|11661349|FG003|Overall Study|Lost to Follow-up|0
7397568|NCT01289990|11661254|FG000|Overall Study|discontinued in preceding trial|18
7397569|NCT01289990|11661255|FG001|Overall Study|discontinued in preceding trial|20
7397570|NCT01289990|11661256|FG002|Overall Study|discontinued in preceding trial|41
7397571|NCT01289990|11661257|FG003|Overall Study|discontinued in preceding trial|17
7397572|NCT01289990|11661258|FG004|Overall Study|discontinued in preceding trial|11
7397573|NCT01289990|11661259|FG005|Overall Study|discontinued in preceding trial|12
7397574|NCT01289990|11661260|FG006|Overall Study|discontinued in preceding trial|18
7397575|NCT01289990|11661261|FG007|Overall Study|discontinued in preceding trial|8
7397576|NCT01289990|11661262|FG008|Overall Study|discontinued in preceding trial|17
7397577|NCT01289990|11661263|FG009|Overall Study|discontinued in preceding trial|21
7397578|NCT01289990|11661264|FG010|Overall Study|discontinued in preceding trial|17
7397579|NCT01289990|11661265|FG011|Overall Study|discontinued in preceding trial|17
7397580|NCT01289990|11661266|FG012|Overall Study|discontinued in preceding trial|24
7397581|NCT01289990|11661254|FG000|Overall Study|did not continue in extension|41
7397582|NCT01289990|11661255|FG001|Overall Study|did not continue in extension|45
7397583|NCT01289990|11661256|FG002|Overall Study|did not continue in extension|51
7397584|NCT01289990|11661257|FG003|Overall Study|did not continue in extension|51
7397585|NCT01289990|11661258|FG004|Overall Study|did not continue in extension|48
7397586|NCT01289990|11661259|FG005|Overall Study|did not continue in extension|50
7397587|NCT01289990|11661260|FG006|Overall Study|did not continue in extension|54
7397588|NCT01289990|11661261|FG007|Overall Study|did not continue in extension|36
7397589|NCT01289990|11661262|FG008|Overall Study|did not continue in extension|44
7397590|NCT01289990|11661263|FG009|Overall Study|did not continue in extension|48
7397591|NCT01289990|11661264|FG010|Overall Study|did not continue in extension|45
7397592|NCT01289990|11661265|FG011|Overall Study|did not continue in extension|34
7397593|NCT01289990|11661266|FG012|Overall Study|did not continue in extension|56
7397594|NCT01289990|11661254|FG000|Overall Study|Not treated|0
7397595|NCT01289990|11661255|FG001|Overall Study|Not treated|0
7397596|NCT01289990|11661256|FG002|Overall Study|Not treated|0
7397597|NCT01289990|11661257|FG003|Overall Study|Not treated|0
7397598|NCT01289990|11661258|FG004|Overall Study|Not treated|0
7397599|NCT01289990|11661259|FG005|Overall Study|Not treated|0
7397600|NCT01289990|11661260|FG006|Overall Study|Not treated|1
7397601|NCT01289990|11661261|FG007|Overall Study|Not treated|0
7397602|NCT01289990|11661262|FG008|Overall Study|Not treated|1
7397603|NCT01289990|11661263|FG009|Overall Study|Not treated|0
7397604|NCT01289990|11661264|FG010|Overall Study|Not treated|1
7397605|NCT01289990|11661265|FG011|Overall Study|Not treated|2
7397606|NCT01289990|11661266|FG012|Overall Study|Not treated|0
7397607|NCT01290029|11661294|FG000|Overall Study|Other|2
7397608|NCT01290068|11661300|FG000|Overall Study|Adverse Event|1
7397609|NCT01290068|11661301|FG001|Overall Study|Adverse Event|3
7397610|NCT01290068|11661300|FG000|Overall Study|Lost to Follow-up|3
7397611|NCT01290068|11661301|FG001|Overall Study|Lost to Follow-up|0
7397612|NCT01290068|11661300|FG000|Overall Study|Withdrawal by subject prior to implant|0
7397613|NCT01290068|11661301|FG001|Overall Study|Withdrawal by subject prior to implant|2
7397614|NCT01290068|11661300|FG000|Overall Study|Other|3
7397615|NCT01290068|11661301|FG001|Overall Study|Other|1
7397616|NCT01290094|11661307|FG000|Overall Study|Withdrawal by Subject|1
7397617|NCT01290094|11661307|FG000|Overall Study|Lost to Follow-up|5
7397618|NCT01290224|11661311|FG000|Overall Study|Adverse Event|1
7397619|NCT01290224|11661311|FG000|Overall Study|Refused Further Treatment|4
7397620|NCT01290263|11661330|FG000|Overall Study|Adverse Event|0
7397621|NCT01290263|11661331|FG001|Overall Study|Adverse Event|0
7397622|NCT01290263|11661332|FG002|Overall Study|Adverse Event|0
7397623|NCT01290263|11661333|FG003|Overall Study|Adverse Event|1
7397624|NCT01290263|11661334|FG004|Overall Study|Adverse Event|1
7397625|NCT01290263|11661330|FG000|Overall Study|Lack of Efficacy|8
7397626|NCT01290263|11661331|FG001|Overall Study|Lack of Efficacy|2
7397627|NCT01290263|11661332|FG002|Overall Study|Lack of Efficacy|7
7397628|NCT01290263|11661333|FG003|Overall Study|Lack of Efficacy|24
7397629|NCT01290263|11661334|FG004|Overall Study|Lack of Efficacy|33
7397630|NCT01290263|11661330|FG000|Overall Study|Withdrawal by Subject|3
7397631|NCT01290263|11661331|FG001|Overall Study|Withdrawal by Subject|1
7397632|NCT01290263|11661332|FG002|Overall Study|Withdrawal by Subject|0
7397633|NCT01290263|11661333|FG003|Overall Study|Withdrawal by Subject|1
7397634|NCT01290263|11661334|FG004|Overall Study|Withdrawal by Subject|2
7397635|NCT01290263|11661330|FG000|Overall Study|Participant Non-Compliance|0
7397636|NCT01290263|11661331|FG001|Overall Study|Participant Non-Compliance|0
7397637|NCT01290263|11661332|FG002|Overall Study|Participant Non-Compliance|0
7397638|NCT01290263|11661333|FG003|Overall Study|Participant Non-Compliance|1
7397639|NCT01290263|11661334|FG004|Overall Study|Participant Non-Compliance|1
7397640|NCT01290315|11661346|FG000|Overall Study|Adverse Event|0
7397641|NCT01290315|11661347|FG001|Overall Study|Adverse Event|0
7397642|NCT01290315|11661348|FG002|Overall Study|Adverse Event|0
7397643|NCT01290315|11661349|FG003|Overall Study|Adverse Event|3
7397644|NCT01290315|11661346|FG000|Overall Study|Selection criteria/compliance|2
7397645|NCT01290315|11661347|FG001|Overall Study|Selection criteria/compliance|1
7397646|NCT01290315|11661348|FG002|Overall Study|Selection criteria/compliance|0
7397647|NCT01290315|11661349|FG003|Overall Study|Selection criteria/compliance|2
7397648|NCT01290315|11661346|FG000|Overall Study|Lost to Follow-up|0
7397649|NCT01290315|11661347|FG001|Overall Study|Lost to Follow-up|1
7397650|NCT01290315|11661348|FG002|Overall Study|Lost to Follow-up|0
7397652|NCT01290315|11661346|FG000|Overall Study|Withdrawal by Subject|1
7397653|NCT01290315|11661347|FG001|Overall Study|Withdrawal by Subject|1
7397654|NCT01290315|11661348|FG002|Overall Study|Withdrawal by Subject|0
7397655|NCT01290315|11661349|FG003|Overall Study|Withdrawal by Subject|0
7397656|NCT01290341|11661360|FG000|Overall Study|Protocol Violation|7
7397657|NCT01290341|11661361|FG001|Overall Study|Protocol Violation|3
7397658|NCT01290341|11661360|FG000|Overall Study|Adverse Event|1
7397659|NCT01290341|11661361|FG001|Overall Study|Adverse Event|0
7397660|NCT01290341|11661360|FG000|Overall Study|Lost to Follow-up|21
7397661|NCT01290341|11661361|FG001|Overall Study|Lost to Follow-up|10
7397662|NCT01290341|11661360|FG000|Overall Study|Withdrawal by Subject|19
7397663|NCT01290341|11661361|FG001|Overall Study|Withdrawal by Subject|5
7397664|NCT01290341|11661360|FG000|Overall Study|Negative baseline culture and others|44
7397665|NCT01290341|11661361|FG001|Overall Study|Negative baseline culture and others|11
7397666|NCT01290523|11661384|FG000|Overall Study|Death|3
7397667|NCT01290601|11661397|FG000|Overall Study|Adverse Event|0
7397668|NCT01290601|11661398|FG001|Overall Study|Adverse Event|2
7397669|NCT01290601|11661399|FG002|Overall Study|Adverse Event|0
7397670|NCT01290601|11661400|FG003|Overall Study|Adverse Event|0
7397671|NCT01290601|11661397|FG000|Overall Study|Lack of Efficacy|2
7397672|NCT01290601|11661398|FG001|Overall Study|Lack of Efficacy|1
7397673|NCT01290601|11661399|FG002|Overall Study|Lack of Efficacy|0
7397674|NCT01290601|11661400|FG003|Overall Study|Lack of Efficacy|0
7397675|NCT01290601|11661397|FG000|Overall Study|Lost to Follow-up|7
7397676|NCT01290601|11661398|FG001|Overall Study|Lost to Follow-up|2
7397677|NCT01290601|11661399|FG002|Overall Study|Lost to Follow-up|0
7397678|NCT01290601|11661400|FG003|Overall Study|Lost to Follow-up|0
7397679|NCT01290601|11661397|FG000|Overall Study|Other|1
7397680|NCT01290601|11661398|FG001|Overall Study|Other|0
7397681|NCT01290601|11661399|FG002|Overall Study|Other|0
7397682|NCT01290601|11661400|FG003|Overall Study|Other|0
7397683|NCT01290601|11661397|FG000|Overall Study|Protocol Violation|1
7397684|NCT01290601|11661398|FG001|Overall Study|Protocol Violation|0
7397685|NCT01290601|11661399|FG002|Overall Study|Protocol Violation|0
7397686|NCT01290601|11661400|FG003|Overall Study|Protocol Violation|0
7397687|NCT01290666|11661437|FG000|Overall Study|Lost to Follow-up|11
7397688|NCT01290666|11661437|FG000|Overall Study|Withdrawal by Subject|23
7397689|NCT01290666|11661437|FG000|Overall Study|Early Termination of Study|4
7397690|NCT01290679|11661443|FG000|Overall Study|Adverse Event|2
7397691|NCT01290679|11661444|FG001|Overall Study|Adverse Event|0
7397692|NCT01290679|11661443|FG000|Overall Study|Lost to Follow-up|8
7397693|NCT01290679|11661444|FG001|Overall Study|Lost to Follow-up|10
7397694|NCT01290679|11661443|FG000|Overall Study|Protocol Violation|0
7397695|NCT01290679|11661444|FG001|Overall Study|Protocol Violation|1
7397696|NCT01290679|11661443|FG000|Overall Study|Withdrawal by Subject|6
7397697|NCT01290679|11661444|FG001|Overall Study|Withdrawal by Subject|5
7397698|NCT01290679|11661443|FG000|Overall Study|Subject Entered Another Trial|0
7397699|NCT01290679|11661444|FG001|Overall Study|Subject Entered Another Trial|5
7397700|NCT01290731|11661450|FG000|Overall Study|Withdrawal by Subject|1
7397701|NCT01290757|11661456|FG000|Overall Study|Adverse Event|1
7397702|NCT01290757|11661457|FG001|Overall Study|Adverse Event|0
7397703|NCT01290757|11661456|FG000|Overall Study|Protocol Violation|1
7397704|NCT01290757|11661457|FG001|Overall Study|Protocol Violation|1
7397705|NCT01290757|11661456|FG000|Overall Study|Other|0
7397706|NCT01290757|11661457|FG001|Overall Study|Other|1
7397707|NCT01290796|11661463|FG000|Overall Study|Lost to Follow-up|21
7397708|NCT01290796|11661463|FG000|Overall Study|Withdrawal by Subject|4
7397709|NCT01290796|11661463|FG000|Overall Study|Physician Decision|2
7397710|NCT01290796|11661463|FG000|Overall Study|Secondary Surgical Intervention|2
7397711|NCT01290796|11661463|FG000|Overall Study|Withdrawal by Sponsor|1
7397712|NCT01290887|11661479|FG000|Overall Study|Adverse Event|6
7397713|NCT01290887|11661480|FG001|Overall Study|Adverse Event|11
7397714|NCT01290887|11661479|FG000|Overall Study|Lack of Efficacy|4
7397715|NCT01290887|11661480|FG001|Overall Study|Lack of Efficacy|5
7397716|NCT01290887|11661479|FG000|Overall Study|Withdrawal by Subject|26
7397717|NCT01290887|11661480|FG001|Overall Study|Withdrawal by Subject|32
7397718|NCT01290887|11661479|FG000|Overall Study|Protocol Violation|2
7397719|NCT01290887|11661480|FG001|Overall Study|Protocol Violation|1
7397720|NCT01290887|11661479|FG000|Overall Study|Lost to Follow-up|4
7397721|NCT01290887|11661480|FG001|Overall Study|Lost to Follow-up|4
7397722|NCT01290887|11661479|FG000|Overall Study|Non-compliance to study procedures|0
7397723|NCT01290887|11661480|FG001|Overall Study|Non-compliance to study procedures|1
7397724|NCT01290887|11661479|FG000|Overall Study|Non-compliance to study medications|1
7397725|NCT01290887|11661480|FG001|Overall Study|Non-compliance to study medications|0
7397726|NCT01290887|11661479|FG000|Overall Study|Sponsor closure of study|420
7397727|NCT01290887|11661480|FG001|Overall Study|Sponsor closure of study|476
7397728|NCT01290887|11661479|FG000|Overall Study|Other|3
7397729|NCT01290887|11661480|FG001|Overall Study|Other|6
7397730|NCT01291017|11661506|FG000|Overall Study|Lost to Follow-up|2
7397731|NCT01291017|11661506|FG000|Overall Study|Withdrawal by Subject|3
7397732|NCT01291173|11661552|FG000|Overall Study|Adverse Event|0
7397733|NCT01291173|11661553|FG001|Overall Study|Adverse Event|3
7397734|NCT01291173|11661554|FG002|Overall Study|Adverse Event|1
7397735|NCT01291173|11661555|FG003|Overall Study|Adverse Event|3
7397736|NCT01291173|11661552|FG000|Overall Study|Protocol Violation|7
7397737|NCT01291173|11661553|FG001|Overall Study|Protocol Violation|2
7397738|NCT01291173|11661554|FG002|Overall Study|Protocol Violation|2
7397739|NCT01291173|11661555|FG003|Overall Study|Protocol Violation|5
7397740|NCT01291173|11661552|FG000|Overall Study|Withdrawal by Subject|6
7397741|NCT01291173|11661553|FG001|Overall Study|Withdrawal by Subject|4
7397742|NCT01291173|11661554|FG002|Overall Study|Withdrawal by Subject|4
7397743|NCT01291173|11661555|FG003|Overall Study|Withdrawal by Subject|2
7397744|NCT01291173|11661552|FG000|Overall Study|Lost to Follow-up|4
7397745|NCT01291173|11661553|FG001|Overall Study|Lost to Follow-up|6
7397746|NCT01291173|11661554|FG002|Overall Study|Lost to Follow-up|3
7397747|NCT01291173|11661555|FG003|Overall Study|Lost to Follow-up|2
7397748|NCT01291173|11661552|FG000|Overall Study|Unable to meet visit schedule|0
7397749|NCT01291173|11661553|FG001|Overall Study|Unable to meet visit schedule|0
7397750|NCT01291173|11661554|FG002|Overall Study|Unable to meet visit schedule|1
7397751|NCT01291173|11661555|FG003|Overall Study|Unable to meet visit schedule|0
7397752|NCT01291173|11661552|FG000|Overall Study|Lack of compliance|0
7397753|NCT01291173|11661553|FG001|Overall Study|Lack of compliance|0
7397754|NCT01291173|11661554|FG002|Overall Study|Lack of compliance|0
7397755|NCT01291173|11661555|FG003|Overall Study|Lack of compliance|1
7397756|NCT01291173|11661552|FG000|Overall Study|Subject was unblinded|0
7397757|NCT01291173|11661553|FG001|Overall Study|Subject was unblinded|0
7397758|NCT01291173|11661554|FG002|Overall Study|Subject was unblinded|1
7397759|NCT01291173|11661555|FG003|Overall Study|Subject was unblinded|0
7397760|NCT01291173|11661552|FG000|Overall Study|Excluded therapy|0
7397761|NCT01291173|11661553|FG001|Overall Study|Excluded therapy|0
7397762|NCT01291173|11661554|FG002|Overall Study|Excluded therapy|1
7397763|NCT01291173|11661555|FG003|Overall Study|Excluded therapy|0
7397764|NCT01291225|11661567|FG000|Overall Study|Lost to Follow-up|85
7397765|NCT01291225|11661568|FG001|Overall Study|Lost to Follow-up|39
7397766|NCT01291277|11661584|FG000|Overall Study|Death|2
7397767|NCT01291277|11661585|FG001|Overall Study|Death|2
7397768|NCT01291277|11661584|FG000|Overall Study|Lost to Follow-up|3
7397769|NCT01291277|11661585|FG001|Overall Study|Lost to Follow-up|1
7397770|NCT01292057|11661625|FG000|Overall Study|Protocol Violation|1
7397771|NCT01292057|11661626|FG001|Overall Study|Protocol Violation|1
7397772|NCT01292057|11661625|FG000|Overall Study|Lost to Follow-up|1
7397773|NCT01292057|11661626|FG001|Overall Study|Lost to Follow-up|1
7397774|NCT01292187|11661645|FG000|Overall Study|Adverse Event|10
7397775|NCT01292187|11661646|FG001|Overall Study|Adverse Event|5
7397776|NCT01292187|11661645|FG000|Overall Study|Withdrawal by Subject|6
7397777|NCT01292187|11661646|FG001|Overall Study|Withdrawal by Subject|5
7397778|NCT01292187|11661645|FG000|Overall Study|All other reasons|1
7397779|NCT01292187|11661646|FG001|Overall Study|All other reasons|3
7397780|NCT01292226|11661653|FG000|Overall Study|Adverse Event|5
7397781|NCT01292226|11661653|FG000|Overall Study|Death|1
7397782|NCT01292226|11661653|FG000|Overall Study|Graft loss|1
7397783|NCT01292226|11661653|FG000|Overall Study|Protocol Violation|3
7397784|NCT01292226|11661653|FG000|Overall Study|Withdrawal by Subject|1
7397785|NCT01292226|11661653|FG000|Overall Study|Other|2
7397786|NCT01292239|11661659|FG000|Overall Study|Other|1
7397787|NCT01292239|11661660|FG001|Overall Study|Other|1
7397788|NCT01292239|11661659|FG000|Overall Study|Withdrawal by Subject|3
7397789|NCT01292239|11661660|FG001|Overall Study|Withdrawal by Subject|6
7397790|NCT01292473|11661692|FG000|Overall Study|Adverse Event|1
7397791|NCT01292473|11661693|FG001|Overall Study|Adverse Event|0
7397792|NCT01292473|11661694|FG002|Overall Study|Adverse Event|1
7397793|NCT01292473|11661695|FG003|Overall Study|Adverse Event|1
7397794|NCT01292473|11661692|FG000|Overall Study|Lost to Follow-up|1
7397795|NCT01292473|11661693|FG001|Overall Study|Lost to Follow-up|1
7397796|NCT01292473|11661694|FG002|Overall Study|Lost to Follow-up|2
7397797|NCT01292473|11661695|FG003|Overall Study|Lost to Follow-up|2
7397798|NCT01292473|11661692|FG000|Overall Study|Withdrawal by Subject|3
7397799|NCT01292473|11661693|FG001|Overall Study|Withdrawal by Subject|4
7397800|NCT01292473|11661694|FG002|Overall Study|Withdrawal by Subject|3
7397801|NCT01292473|11661695|FG003|Overall Study|Withdrawal by Subject|3
7397802|NCT01292473|11661692|FG000|Overall Study|Physician Decision|0
7397803|NCT01292473|11661693|FG001|Overall Study|Physician Decision|1
7397804|NCT01292473|11661694|FG002|Overall Study|Physician Decision|0
7397805|NCT01292473|11661695|FG003|Overall Study|Physician Decision|0
7397806|NCT01292473|11661692|FG000|Overall Study|Disease Progression|0
7397807|NCT01292473|11661693|FG001|Overall Study|Disease Progression|1
7397808|NCT01292473|11661694|FG002|Overall Study|Disease Progression|3
7397809|NCT01292473|11661695|FG003|Overall Study|Disease Progression|6
7397810|NCT01292486|11661709|FG000|Overall Study|Protocol Violation|2
7397811|NCT01292486|11661709|FG000|Overall Study|Did not meet screening criteria|2
7397812|NCT01292486|11661709|FG000|Overall Study|Adverse Event|1
7397813|NCT01292486|11661709|FG000|Overall Study|Physician Decision|1
7397814|NCT01292603|11661728|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
7397815|NCT01292603|11661729|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
7397816|NCT01292603|11661730|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
7397817|NCT01292603|11661731|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
7397818|NCT01292603|11661732|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
7397819|NCT01292603|11661733|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
7397820|NCT01292603|11661728|FG000|Part 1: Pilot Dose Selection Period|Death|0
7397821|NCT01292603|11661729|FG001|Part 1: Pilot Dose Selection Period|Death|0
7397822|NCT01292603|11661730|FG002|Part 1: Pilot Dose Selection Period|Death|0
7397823|NCT01292603|11661731|FG003|Part 1: Pilot Dose Selection Period|Death|1
7397824|NCT01292603|11661732|FG004|Part 1: Pilot Dose Selection Period|Death|0
7397825|NCT01292603|11661733|FG005|Part 1: Pilot Dose Selection Period|Death|0
7397826|NCT01292603|11661728|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7397827|NCT01292603|11661729|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7397828|NCT01292603|11661730|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7397829|NCT01292603|11661731|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
7397830|NCT01292603|11661732|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7397831|NCT01292603|11661733|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
7397832|NCT01292603|11661728|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7397833|NCT01292603|11661729|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7397834|NCT01292603|11661730|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7397835|NCT01292603|11661731|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
7397836|NCT01292603|11661732|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7397837|NCT01292603|11661733|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
7397838|NCT01292603|11661728|FG000|Part 1: Regular Follow-Up Period|Death|3
7397839|NCT01292603|11661729|FG001|Part 1: Regular Follow-Up Period|Death|1
7397840|NCT01292603|11661730|FG002|Part 1: Regular Follow-Up Period|Death|3
7397841|NCT01292603|11661731|FG003|Part 1: Regular Follow-Up Period|Death|1
7397842|NCT01292603|11661732|FG004|Part 1: Regular Follow-Up Period|Death|0
7397843|NCT01292603|11661733|FG005|Part 1: Regular Follow-Up Period|Death|0
7397844|NCT01292603|11661728|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
7397845|NCT01292603|11661729|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
7397846|NCT01292603|11661730|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
7397847|NCT01292603|11661731|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
7397848|NCT01292603|11661732|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
7397849|NCT01292603|11661733|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
7397850|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Death|0
7397851|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Death|0
7397852|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Death|0
7397853|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Death|0
7397854|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Death|1
7397855|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Death|0
7397856|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
7397857|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
7397858|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
7397859|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
7397860|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
7397861|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
7397862|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7397863|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7397864|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7397865|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
7397866|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7397867|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
7397868|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
7397869|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
7397870|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
7397871|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
7397872|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
7397873|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
7397874|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
7397875|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
7397876|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
7397877|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
7397878|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
7397879|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
7397880|NCT01292603|11661728|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7397881|NCT01292603|11661729|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7397882|NCT01292603|11661730|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7397883|NCT01292603|11661731|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7397884|NCT01292603|11661732|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
7397885|NCT01292603|11661733|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
7397886|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Death|0
7397887|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Death|0
7397888|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Death|0
7397889|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Death|0
7397890|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Death|6
7397891|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Death|3
7397892|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Disease Progression|0
7397893|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Disease Progression|0
7397894|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Disease Progression|0
7397895|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Disease Progression|0
7397896|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Disease Progression|5
7397897|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Disease Progression|5
7397898|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Noncompliance|0
7397899|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Noncompliance|0
7397900|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Noncompliance|0
7397901|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Noncompliance|0
7397902|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Noncompliance|1
7397903|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Noncompliance|0
7397904|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7397905|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7397906|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7397907|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7397908|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
7397909|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
7397910|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
7397911|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
7397912|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
7397913|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
7397914|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
7397915|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
7397916|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Physician Decision|0
7397917|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Physician Decision|0
7397918|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Physician Decision|0
7397919|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Physician Decision|0
7397920|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Physician Decision|2
7397921|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Physician Decision|0
7397922|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
7397923|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
7397924|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
7397925|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
7397926|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
7397927|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
7397928|NCT01292603|11661728|FG000|Part 2: Regular Follow-Up|Adverse Event|0
7397929|NCT01292603|11661729|FG001|Part 2: Regular Follow-Up|Adverse Event|0
7397930|NCT01292603|11661730|FG002|Part 2: Regular Follow-Up|Adverse Event|0
7397931|NCT01292603|11661731|FG003|Part 2: Regular Follow-Up|Adverse Event|0
7397932|NCT01292603|11661732|FG004|Part 2: Regular Follow-Up|Adverse Event|2
7397933|NCT01292603|11661733|FG005|Part 2: Regular Follow-Up|Adverse Event|2
7397934|NCT01292603|11661728|FG000|Overall Survival Status|Death|3
7397935|NCT01292603|11661729|FG001|Overall Survival Status|Death|1
7397936|NCT01292603|11661730|FG002|Overall Survival Status|Death|3
7397937|NCT01292603|11661731|FG003|Overall Survival Status|Death|1
7397938|NCT01292603|11661732|FG004|Overall Survival Status|Death|16
7397939|NCT01292603|11661733|FG005|Overall Survival Status|Death|10
7397940|NCT01292837|11661775|FG000|Overall Study|Adverse Event|1
7397941|NCT01292837|11661775|FG000|Overall Study|Further treatment determined|1
7397942|NCT01292876|11661779|FG000|Overall Study|Physician Decision|4
7397943|NCT01292928|11661785|FG000|Overall Study|Death|8
7397944|NCT01292928|11661785|FG000|Overall Study|Withdrawal by Subject|8
7397945|NCT01292928|11661785|FG000|Overall Study|Lost to Follow-up|6
7397946|NCT01292928|11661785|FG000|Overall Study|Physician Decision|2
7397947|NCT01293006|11661795|FG000|Period 2|Lost to Follow-up|1
7397948|NCT01293006|11661796|FG001|Period 2|Lost to Follow-up|0
7397949|NCT01293006|11661797|FG002|Period 2|Lost to Follow-up|0
7397950|NCT01293006|11661798|FG003|Period 2|Lost to Follow-up|0
7397951|NCT01293032|11661817|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7397952|NCT01293032|11661818|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7397953|NCT01293032|11661819|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
7397954|NCT01293032|11661820|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
7397955|NCT01293032|11661817|FG000|Treatment|Adverse Event|0
7397956|NCT01293032|11661818|FG001|Treatment|Adverse Event|0
7397957|NCT01293032|11661819|FG002|Treatment|Adverse Event|1
7397958|NCT01293032|11661820|FG003|Treatment|Adverse Event|1
7397959|NCT01293032|11661817|FG000|Treatment|Withdrawal by Subject|2
7397960|NCT01293032|11661818|FG001|Treatment|Withdrawal by Subject|4
7397961|NCT01293032|11661819|FG002|Treatment|Withdrawal by Subject|0
7397962|NCT01293032|11661820|FG003|Treatment|Withdrawal by Subject|0
7397963|NCT01293032|11661817|FG000|Treatment|Disease Progression, relapse|0
7397964|NCT01293032|11661818|FG001|Treatment|Disease Progression, relapse|1
7397965|NCT01293032|11661819|FG002|Treatment|Disease Progression, relapse|0
7397966|NCT01293032|11661820|FG003|Treatment|Disease Progression, relapse|0
7397967|NCT01293084|11661827|FG000|Overall Study|Physician Decision|3
7397968|NCT01293084|11661827|FG000|Overall Study|Withdrawal by Subject|2
7397969|NCT01293240|11661833|FG000|Overall Study|Noncompliance|2
7397970|NCT01293539|11661847|FG000|Overall Study|Physician Decision|1
7397971|NCT01293695|11661853|FG000|Overall Study|Withdrawal by Subject|7
7397972|NCT01293695|11661854|FG001|Overall Study|Withdrawal by Subject|1
7397973|NCT01293695|11661853|FG000|Overall Study|Lost to Follow-up|8
7397974|NCT01293695|11661854|FG001|Overall Study|Lost to Follow-up|6
7397975|NCT01293968|11661869|FG000|Overall Study|non-cooperation|3
7397976|NCT01293968|11661870|FG001|Overall Study|non-cooperation|3
7465464|NCT01296711|11764685|FG006|Overall Study|Methotrexate discontinued|0
7465465|NCT01296711|11764686|FG007|Overall Study|Methotrexate discontinued|0
7465466|NCT01296711|11764679|FG000|Overall Study|Investigator discretion|0
7465467|NCT01296711|11764680|FG001|Overall Study|Investigator discretion|0
7465468|NCT01296711|11764681|FG002|Overall Study|Investigator discretion|0
7465469|NCT01296711|11764682|FG003|Overall Study|Investigator discretion|0
7465470|NCT01296711|11764683|FG004|Overall Study|Investigator discretion|0
7465471|NCT01296711|11764684|FG005|Overall Study|Investigator discretion|0
7465472|NCT01296711|11764685|FG006|Overall Study|Investigator discretion|1
7465473|NCT01296711|11764686|FG007|Overall Study|Investigator discretion|0
7465474|NCT01296711|11764679|FG000|Overall Study|Other|0
7465475|NCT01296711|11764680|FG001|Overall Study|Other|0
7465476|NCT01296711|11764681|FG002|Overall Study|Other|0
7465477|NCT01296711|11764682|FG003|Overall Study|Other|0
7465478|NCT01296711|11764683|FG004|Overall Study|Other|0
7465479|NCT01296711|11764684|FG005|Overall Study|Other|0
7465480|NCT01296711|11764685|FG006|Overall Study|Other|1
7465481|NCT01296711|11764686|FG007|Overall Study|Other|0
7465482|NCT01296711|11764679|FG000|Overall Study|Required restricted steroid injections|0
7465483|NCT01296711|11764680|FG001|Overall Study|Required restricted steroid injections|0
7465484|NCT01296711|11764681|FG002|Overall Study|Required restricted steroid injections|0
7465485|NCT01296711|11764682|FG003|Overall Study|Required restricted steroid injections|0
7465486|NCT01296711|11764683|FG004|Overall Study|Required restricted steroid injections|0
7465487|NCT01296711|11764684|FG005|Overall Study|Required restricted steroid injections|0
7465488|NCT01296711|11764685|FG006|Overall Study|Required restricted steroid injections|1
7465489|NCT01296711|11764686|FG007|Overall Study|Required restricted steroid injections|0
7465490|NCT01296711|11764679|FG000|Overall Study|Ongoing missed appointments|0
7465491|NCT01296711|11764680|FG001|Overall Study|Ongoing missed appointments|0
7397977|NCT01294150|11661891|FG000|Overall Study|Physician Decision|2
7397978|NCT01294150|11661892|FG001|Overall Study|Physician Decision|2
7397979|NCT01294358|11661957|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7397980|NCT01294358|11661958|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
7397981|NCT01294358|11661959|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7397982|NCT01294358|11661960|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7397983|NCT01294358|11661961|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
7397984|NCT01294358|11661957|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7397985|NCT01294358|11661958|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7397986|NCT01294358|11661959|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
7397987|NCT01294358|11661960|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7397988|NCT01294358|11661961|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
7397989|NCT01294358|11661957|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7397990|NCT01294358|11661958|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7397991|NCT01294358|11661959|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7397992|NCT01294358|11661960|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
7397993|NCT01294358|11661961|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
7397994|NCT01294358|11661957|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7397995|NCT01294358|11661958|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7397996|NCT01294358|11661959|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7397997|NCT01294358|11661960|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
7397998|NCT01294358|11661961|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
7397999|NCT01294371|11661978|FG000|Overall Study|Adverse Event|1
7398000|NCT01294371|11661978|FG000|Overall Study|Withdrawal by Subject|12
7398001|NCT01294371|11661978|FG000|Overall Study|Lost to Follow-up|6
7398002|NCT01294371|11661978|FG000|Overall Study|Administrative Reason|1
7398003|NCT01294371|11661978|FG000|Overall Study|Other|14
7398004|NCT01294397|11661998|FG000|Overall Study|Withdrawal by Subject|1
7398005|NCT01294397|11661998|FG000|Overall Study|Administrative Decision|1
7398006|NCT01294423|11662007|FG000|Overall Study|Adverse Event|1
7398007|NCT01294423|11662008|FG001|Overall Study|Adverse Event|2
7398008|NCT01294423|11662009|FG002|Overall Study|Adverse Event|3
7398009|NCT01294423|11662007|FG000|Overall Study|Withdrawal by Subject|1
7398010|NCT01294423|11662008|FG001|Overall Study|Withdrawal by Subject|2
7398011|NCT01294423|11662009|FG002|Overall Study|Withdrawal by Subject|2
7398012|NCT01294423|11662007|FG000|Overall Study|subject no longer meets study criteria|2
7398013|NCT01294423|11662008|FG001|Overall Study|subject no longer meets study criteria|5
7398014|NCT01294423|11662009|FG002|Overall Study|subject no longer meets study criteria|2
7398015|NCT01294423|11662007|FG000|Overall Study|poor/non-compliance|1
7398016|NCT01294423|11662008|FG001|Overall Study|poor/non-compliance|0
7398017|NCT01294423|11662009|FG002|Overall Study|poor/non-compliance|1
7398018|NCT01294436|11662019|FG000|Overall Study|Adverse Event|10
7398019|NCT01294436|11662020|FG001|Overall Study|Adverse Event|17
7398020|NCT01294436|11662019|FG000|Overall Study|Withdrawal by Subject|11
7398021|NCT01294436|11662020|FG001|Overall Study|Withdrawal by Subject|28
7398022|NCT01294436|11662019|FG000|Overall Study|subject no longer meets study criteria|5
7398023|NCT01294436|11662020|FG001|Overall Study|subject no longer meets study criteria|20
7398024|NCT01294436|11662019|FG000|Overall Study|poor/non-compliance|2
7398025|NCT01294436|11662020|FG001|Overall Study|poor/non-compliance|5
7398026|NCT01294449|11662028|FG000|Overall Study|Death|11
7398027|NCT01294449|11662029|FG001|Overall Study|Death|12
7398028|NCT01294449|11662028|FG000|Overall Study|Withdrawal by Subject|1
7398029|NCT01294449|11662029|FG001|Overall Study|Withdrawal by Subject|3
7398030|NCT01294462|11662037|FG000|Overall Study|Lost to Follow-up|1
7398031|NCT01294462|11662038|FG001|Overall Study|Lost to Follow-up|0
7398032|NCT01294462|11662037|FG000|Overall Study|Withdrawal by Subject|65
7398033|NCT01294462|11662038|FG001|Overall Study|Withdrawal by Subject|63
7398034|NCT01294514|11662044|FG000|Overall Study|Excluded due to Arrhythmia|1
7398035|NCT01294553|11662052|FG000|Overall Study|Duplicated Participants|1
7398036|NCT01294553|11662052|FG000|Overall Study|Protocol Violation|268
7398037|NCT01294579|11662057|FG000|Overall Study|Disease progression|12
7398038|NCT01294579|11662057|FG000|Overall Study|Adverse Event|11
7398039|NCT01294579|11662057|FG000|Overall Study|Study closed/terminated|3
7398040|NCT01294579|11662057|FG000|Overall Study|Lost to Follow-up|1
7398041|NCT01294579|11662057|FG000|Overall Study|Physician Decision|3
7398042|NCT01294579|11662057|FG000|Overall Study|Withdrawal by Subject|5
7398043|NCT01294592|11662063|FG000|Overall Study|Adverse Event|28
7398044|NCT01294592|11662064|FG001|Overall Study|Adverse Event|13
7398045|NCT01294592|11662063|FG000|Overall Study|Lack of Efficacy|7
7398046|NCT01294592|11662064|FG001|Overall Study|Lack of Efficacy|5
7398047|NCT01294592|11662063|FG000|Overall Study|Protocol Violation|1
7398048|NCT01294592|11662064|FG001|Overall Study|Protocol Violation|7
7398049|NCT01294592|11662063|FG000|Overall Study|Lost to Follow-up|7
7398050|NCT01294592|11662064|FG001|Overall Study|Lost to Follow-up|9
7398051|NCT01294592|11662063|FG000|Overall Study|Physician Decision|6
7398052|NCT01294592|11662064|FG001|Overall Study|Physician Decision|11
7398053|NCT01294592|11662063|FG000|Overall Study|Withdrawal by Subject|28
7398054|NCT01294592|11662064|FG001|Overall Study|Withdrawal by Subject|28
7398055|NCT01294644|11662076|FG000|Overall Study|Adverse Event|2
7398056|NCT01294644|11662077|FG001|Overall Study|Adverse Event|0
7398057|NCT01294644|11662078|FG002|Overall Study|Adverse Event|1
7398058|NCT01294644|11662076|FG000|Overall Study|Withdrawal by Subject|3
7398059|NCT01294644|11662077|FG001|Overall Study|Withdrawal by Subject|7
7398060|NCT01294644|11662078|FG002|Overall Study|Withdrawal by Subject|4
7398061|NCT01294644|11662076|FG000|Overall Study|Lost to Follow-up|3
7398062|NCT01294644|11662077|FG001|Overall Study|Lost to Follow-up|2
7398063|NCT01294644|11662078|FG002|Overall Study|Lost to Follow-up|5
7398064|NCT01294644|11662076|FG000|Overall Study|Miscellaneous Reason|2
7398065|NCT01294644|11662077|FG001|Overall Study|Miscellaneous Reason|1
7398066|NCT01294644|11662078|FG002|Overall Study|Miscellaneous Reason|4
7398067|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Adverse Event|49
7398068|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Adverse Event|52
7398069|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
7398070|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
7398071|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7398072|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
7398073|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Physician Decision|1
7398074|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Physician Decision|0
7398075|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Protocol Violation|5
7398076|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Protocol Violation|5
7398077|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
7398078|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
7398079|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Technical Problems|0
7398080|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Technical Problems|1
7398081|NCT01294683|11662088|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
7398082|NCT01294683|11662089|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
7398083|NCT01294683|11662088|FG000|Post Crossover (Period III)|Adverse Event|6
7398084|NCT01294683|11662089|FG001|Post Crossover (Period III)|Adverse Event|6
7398085|NCT01294683|11662088|FG000|Post Crossover (Period III)|Lost to Follow-up|1
7398086|NCT01294683|11662089|FG001|Post Crossover (Period III)|Lost to Follow-up|3
7398087|NCT01294683|11662088|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
7398088|NCT01294683|11662089|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
7398089|NCT01294683|11662088|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
7398090|NCT01294683|11662089|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
7398091|NCT01294787|11662122|FG000|Period 1|Adverse Event|0
7398092|NCT01294787|11662123|FG001|Period 1|Adverse Event|0
7398093|NCT01294787|11662124|FG002|Period 1|Adverse Event|0
7398094|NCT01294787|11662125|FG003|Period 1|Adverse Event|0
7398095|NCT01294787|11662126|FG004|Period 1|Adverse Event|1
7398096|NCT01294787|11662127|FG005|Period 1|Adverse Event|0
7398097|NCT01294787|11662122|FG000|Period 1|Withdrawal by Subject|0
7398098|NCT01294787|11662123|FG001|Period 1|Withdrawal by Subject|0
7398099|NCT01294787|11662124|FG002|Period 1|Withdrawal by Subject|0
7398100|NCT01294787|11662125|FG003|Period 1|Withdrawal by Subject|1
7398101|NCT01294787|11662126|FG004|Period 1|Withdrawal by Subject|1
7398102|NCT01294787|11662127|FG005|Period 1|Withdrawal by Subject|1
7398103|NCT01294787|11662122|FG000|Period 1|Administrative problem|0
7398104|NCT01294787|11662123|FG001|Period 1|Administrative problem|0
7398105|NCT01294787|11662124|FG002|Period 1|Administrative problem|1
7398106|NCT01294787|11662125|FG003|Period 1|Administrative problem|0
7398107|NCT01294787|11662126|FG004|Period 1|Administrative problem|0
7398108|NCT01294787|11662127|FG005|Period 1|Administrative problem|1
7398109|NCT01294787|11662122|FG000|Period 2|Adverse Event|0
7398110|NCT01294787|11662123|FG001|Period 2|Adverse Event|3
7398111|NCT01294787|11662124|FG002|Period 2|Adverse Event|0
7398112|NCT01294787|11662125|FG003|Period 2|Adverse Event|1
7398113|NCT01294787|11662126|FG004|Period 2|Adverse Event|0
7398114|NCT01294787|11662127|FG005|Period 2|Adverse Event|0
7398115|NCT01294787|11662122|FG000|Period 2|No longer needs study drug|0
7398116|NCT01294787|11662123|FG001|Period 2|No longer needs study drug|0
7398117|NCT01294787|11662124|FG002|Period 2|No longer needs study drug|0
7398118|NCT01294787|11662125|FG003|Period 2|No longer needs study drug|1
7398119|NCT01294787|11662126|FG004|Period 2|No longer needs study drug|0
7398120|NCT01294787|11662127|FG005|Period 2|No longer needs study drug|0
7398121|NCT01294787|11662122|FG000|Period 3|Adverse Event|0
7398122|NCT01294787|11662123|FG001|Period 3|Adverse Event|0
7398123|NCT01294787|11662124|FG002|Period 3|Adverse Event|0
7398124|NCT01294787|11662125|FG003|Period 3|Adverse Event|0
7398125|NCT01294787|11662126|FG004|Period 3|Adverse Event|1
7398126|NCT01294787|11662127|FG005|Period 3|Adverse Event|0
7398127|NCT01294800|11662142|FG000|Overall Study|Adverse Event|7
7398128|NCT01294800|11662143|FG001|Overall Study|Adverse Event|6
7398129|NCT01294800|11662144|FG002|Overall Study|Adverse Event|12
7398130|NCT01294800|11662145|FG003|Overall Study|Adverse Event|5
7398131|NCT01294800|11662142|FG000|Overall Study|Subject Withdrew Consent|2
7398132|NCT01294800|11662143|FG001|Overall Study|Subject Withdrew Consent|2
7398133|NCT01294800|11662144|FG002|Overall Study|Subject Withdrew Consent|2
7398134|NCT01294800|11662145|FG003|Overall Study|Subject Withdrew Consent|11
7398135|NCT01294800|11662142|FG000|Overall Study|Lost to Follow-up|0
7398136|NCT01294800|11662143|FG001|Overall Study|Lost to Follow-up|0
7398137|NCT01294800|11662144|FG002|Overall Study|Lost to Follow-up|1
7398138|NCT01294800|11662145|FG003|Overall Study|Lost to Follow-up|0
7398139|NCT01294800|11662142|FG000|Overall Study|Non-compliance With Protocol|0
7398140|NCT01294800|11662143|FG001|Overall Study|Non-compliance With Protocol|1
7398141|NCT01294800|11662144|FG002|Overall Study|Non-compliance With Protocol|1
7398142|NCT01294800|11662145|FG003|Overall Study|Non-compliance With Protocol|0
7398143|NCT01294800|11662142|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
7398144|NCT01294800|11662143|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7398145|NCT01294800|11662144|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
7398146|NCT01294800|11662145|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
7398147|NCT01294917|11662155|FG000|Overall Study|Relocation|5
7398148|NCT01294917|11662155|FG000|Overall Study|Inconvenience|1
7398149|NCT01295034|11662163|FG000|Overall Study|Lost to Follow-up|5
7398150|NCT01295034|11662164|FG001|Overall Study|Lost to Follow-up|5
7398151|NCT01295281|11662191|FG000|First Intervention (7 Days)|Death|0
7398152|NCT01295281|11662192|FG001|First Intervention (7 Days)|Death|1
7398153|NCT01295320|11662198|FG000|Overall Study|Adverse Event|2
7398154|NCT01295320|11662198|FG000|Overall Study|Lost to Follow-up|4
7398155|NCT01295320|11662198|FG000|Overall Study|Withdrawal by Subject|2
7398156|NCT01295320|11662198|FG000|Overall Study|Subject was bedridden|1
7398157|NCT01295320|11662198|FG000|Overall Study|Unable to travel|1
7398158|NCT01295580|11662208|FG000|Overall Study|Protocol Violation|4
7398159|NCT01295580|11662209|FG001|Overall Study|Protocol Violation|2
7398160|NCT01295580|11662208|FG000|Overall Study|Withdrawal by Subject|1
7398161|NCT01295580|11662209|FG001|Overall Study|Withdrawal by Subject|4
7398162|NCT01295580|11662208|FG000|Overall Study|Adverse Event|2
7398163|NCT01295580|11662209|FG001|Overall Study|Adverse Event|1
7398164|NCT01295580|11662208|FG000|Overall Study|Lost to Follow-up|1
7398165|NCT01295580|11662209|FG001|Overall Study|Lost to Follow-up|0
7398166|NCT01295580|11662208|FG000|Overall Study|Lack of Efficacy|1
7398167|NCT01295580|11662209|FG001|Overall Study|Lack of Efficacy|0
7398168|NCT01295580|11662208|FG000|Overall Study|Other: inconvenience|1
7398169|NCT01295580|11662209|FG001|Overall Study|Other: inconvenience|0
7398170|NCT01295580|11662208|FG000|Overall Study|Other: family objection|0
7398171|NCT01295580|11662209|FG001|Overall Study|Other: family objection|1
7398172|NCT01295671|11662218|FG000|Overall Study|Lost to Follow-up|4
7398173|NCT01295671|11662219|FG001|Overall Study|Lost to Follow-up|6
7398174|NCT01295671|11662220|FG002|Overall Study|Lost to Follow-up|3
7398175|NCT01295671|11662218|FG000|Overall Study|Withdrawal by Subject|3
7398176|NCT01295671|11662219|FG001|Overall Study|Withdrawal by Subject|1
7398177|NCT01295671|11662220|FG002|Overall Study|Withdrawal by Subject|0
7398178|NCT01295814|11662239|FG000|Overall Study|Lack of Efficacy|0
7398179|NCT01295814|11662240|FG001|Overall Study|Lack of Efficacy|2
7398180|NCT01295814|11662239|FG000|Overall Study|Withdrawal by Subject|2
7398181|NCT01295814|11662240|FG001|Overall Study|Withdrawal by Subject|0
7398182|NCT01295827|11662258|FG000|Overall Study|Adverse Event|1
7398183|NCT01295827|11662259|FG001|Overall Study|Adverse Event|2
7398184|NCT01295827|11662260|FG002|Overall Study|Adverse Event|2
7398185|NCT01295827|11662261|FG003|Overall Study|Adverse Event|1
7398186|NCT01295827|11662262|FG004|Overall Study|Adverse Event|1
7398187|NCT01295827|11662263|FG005|Overall Study|Adverse Event|4
7398188|NCT01295827|11662264|FG006|Overall Study|Adverse Event|15
7398189|NCT01295827|11662265|FG007|Overall Study|Adverse Event|49
7398190|NCT01295827|11662266|FG008|Overall Study|Adverse Event|22
7398191|NCT01295827|11662267|FG009|Overall Study|Adverse Event|7
7398192|NCT01295827|11662268|FG010|Overall Study|Adverse Event|50
7398193|NCT01295827|11662269|FG011|Overall Study|Adverse Event|21
7398194|NCT01295827|11662270|FG012|Overall Study|Adverse Event|0
7398195|NCT01295827|11662271|FG013|Overall Study|Adverse Event|0
7398196|NCT01295827|11662272|FG014|Overall Study|Adverse Event|0
7398197|NCT01295827|11662258|FG000|Overall Study|Lost to Follow-up|0
7398198|NCT01295827|11662259|FG001|Overall Study|Lost to Follow-up|0
7398199|NCT01295827|11662260|FG002|Overall Study|Lost to Follow-up|3
7398200|NCT01295827|11662261|FG003|Overall Study|Lost to Follow-up|0
7398201|NCT01295827|11662262|FG004|Overall Study|Lost to Follow-up|1
7398202|NCT01295827|11662263|FG005|Overall Study|Lost to Follow-up|0
7398203|NCT01295827|11662264|FG006|Overall Study|Lost to Follow-up|4
7398204|NCT01295827|11662265|FG007|Overall Study|Lost to Follow-up|8
7398205|NCT01295827|11662266|FG008|Overall Study|Lost to Follow-up|7
7398206|NCT01295827|11662267|FG009|Overall Study|Lost to Follow-up|4
7398207|NCT01295827|11662268|FG010|Overall Study|Lost to Follow-up|7
7398208|NCT01295827|11662269|FG011|Overall Study|Lost to Follow-up|3
7398209|NCT01295827|11662270|FG012|Overall Study|Lost to Follow-up|0
7398210|NCT01295827|11662271|FG013|Overall Study|Lost to Follow-up|0
7398211|NCT01295827|11662272|FG014|Overall Study|Lost to Follow-up|0
7398212|NCT01295827|11662258|FG000|Overall Study|Not Reported|0
7398213|NCT01295827|11662259|FG001|Overall Study|Not Reported|0
7398214|NCT01295827|11662260|FG002|Overall Study|Not Reported|0
7398215|NCT01295827|11662261|FG003|Overall Study|Not Reported|1
7398216|NCT01295827|11662262|FG004|Overall Study|Not Reported|0
7398217|NCT01295827|11662263|FG005|Overall Study|Not Reported|0
7398218|NCT01295827|11662264|FG006|Overall Study|Not Reported|24
7398219|NCT01295827|11662265|FG007|Overall Study|Not Reported|58
7398220|NCT01295827|11662266|FG008|Overall Study|Not Reported|41
7398221|NCT01295827|11662267|FG009|Overall Study|Not Reported|2
7398222|NCT01295827|11662268|FG010|Overall Study|Not Reported|23
7398223|NCT01295827|11662269|FG011|Overall Study|Not Reported|13
7398224|NCT01295827|11662270|FG012|Overall Study|Not Reported|0
7398225|NCT01295827|11662271|FG013|Overall Study|Not Reported|0
7398226|NCT01295827|11662272|FG014|Overall Study|Not Reported|0
7398227|NCT01295827|11662258|FG000|Overall Study|Progressive Disease|2
7398228|NCT01295827|11662259|FG001|Overall Study|Progressive Disease|1
7398229|NCT01295827|11662260|FG002|Overall Study|Progressive Disease|5
7398230|NCT01295827|11662261|FG003|Overall Study|Progressive Disease|2
7398231|NCT01295827|11662262|FG004|Overall Study|Progressive Disease|0
7398232|NCT01295827|11662263|FG005|Overall Study|Progressive Disease|1
7398233|NCT01295827|11662264|FG006|Overall Study|Progressive Disease|87
7398234|NCT01295827|11662265|FG007|Overall Study|Progressive Disease|144
7398235|NCT01295827|11662266|FG008|Overall Study|Progressive Disease|85
7398236|NCT01295827|11662267|FG009|Overall Study|Progressive Disease|40
7398237|NCT01295827|11662268|FG010|Overall Study|Progressive Disease|175
7398238|NCT01295827|11662269|FG011|Overall Study|Progressive Disease|136
7398239|NCT01295827|11662270|FG012|Overall Study|Progressive Disease|0
7398240|NCT01295827|11662271|FG013|Overall Study|Progressive Disease|0
7398241|NCT01295827|11662272|FG014|Overall Study|Progressive Disease|0
7398242|NCT01295827|11662258|FG000|Overall Study|Screen Failure|0
7398243|NCT01295827|11662259|FG001|Overall Study|Screen Failure|0
7398244|NCT01295827|11662260|FG002|Overall Study|Screen Failure|0
7398245|NCT01295827|11662261|FG003|Overall Study|Screen Failure|0
7398246|NCT01295827|11662262|FG004|Overall Study|Screen Failure|0
7398247|NCT01295827|11662263|FG005|Overall Study|Screen Failure|0
7398248|NCT01295827|11662264|FG006|Overall Study|Screen Failure|2
7398249|NCT01295827|11662265|FG007|Overall Study|Screen Failure|2
7398250|NCT01295827|11662266|FG008|Overall Study|Screen Failure|2
7398251|NCT01295827|11662267|FG009|Overall Study|Screen Failure|0
7398252|NCT01295827|11662268|FG010|Overall Study|Screen Failure|1
7398253|NCT01295827|11662269|FG011|Overall Study|Screen Failure|0
7398254|NCT01295827|11662270|FG012|Overall Study|Screen Failure|0
7398255|NCT01295827|11662271|FG013|Overall Study|Screen Failure|0
7398256|NCT01295827|11662272|FG014|Overall Study|Screen Failure|0
7398257|NCT01295827|11662258|FG000|Overall Study|Withdrawal by Subject|1
7398258|NCT01295827|11662259|FG001|Overall Study|Withdrawal by Subject|0
7398259|NCT01295827|11662260|FG002|Overall Study|Withdrawal by Subject|2
7398260|NCT01295827|11662261|FG003|Overall Study|Withdrawal by Subject|0
7398261|NCT01295827|11662262|FG004|Overall Study|Withdrawal by Subject|0
7398262|NCT01295827|11662263|FG005|Overall Study|Withdrawal by Subject|1
7398263|NCT01295827|11662264|FG006|Overall Study|Withdrawal by Subject|13
7398264|NCT01295827|11662265|FG007|Overall Study|Withdrawal by Subject|35
7398265|NCT01295827|11662266|FG008|Overall Study|Withdrawal by Subject|11
7398266|NCT01295827|11662267|FG009|Overall Study|Withdrawal by Subject|2
7398267|NCT01295827|11662268|FG010|Overall Study|Withdrawal by Subject|18
7398268|NCT01295827|11662269|FG011|Overall Study|Withdrawal by Subject|13
7398269|NCT01295827|11662270|FG012|Overall Study|Withdrawal by Subject|0
7398270|NCT01295827|11662271|FG013|Overall Study|Withdrawal by Subject|0
7398271|NCT01295827|11662272|FG014|Overall Study|Withdrawal by Subject|0
7398272|NCT01295827|11662258|FG000|Overall Study|Other|0
7398273|NCT01295827|11662259|FG001|Overall Study|Other|0
7398274|NCT01295827|11662260|FG002|Overall Study|Other|0
7398275|NCT01295827|11662261|FG003|Overall Study|Other|0
7398276|NCT01295827|11662262|FG004|Overall Study|Other|0
7398277|NCT01295827|11662263|FG005|Overall Study|Other|0
7398278|NCT01295827|11662264|FG006|Overall Study|Other|1
7398279|NCT01295827|11662265|FG007|Overall Study|Other|1
7398280|NCT01295827|11662266|FG008|Overall Study|Other|1
7398281|NCT01295827|11662267|FG009|Overall Study|Other|0
7398282|NCT01295827|11662268|FG010|Overall Study|Other|2
7398283|NCT01295827|11662269|FG011|Overall Study|Other|0
7398284|NCT01295827|11662270|FG012|Overall Study|Other|0
7398285|NCT01295827|11662271|FG013|Overall Study|Other|0
7398286|NCT01295827|11662272|FG014|Overall Study|Other|0
7398287|NCT01295905|11662337|FG000|Overall Study|Did not meet inclusion criteria|1
7398288|NCT01295905|11662338|FG001|Overall Study|Did not meet inclusion criteria|0
7398289|NCT01295905|11662337|FG000|Overall Study|Met exclusion criteria|1
7398290|NCT01295905|11662338|FG001|Overall Study|Met exclusion criteria|0
7398291|NCT01296035|11662344|FG000|Overall Study|Withdrawal by Subject|1
7398292|NCT01296152|11662348|FG000|Overall Study|Unwilling to adhere to study requirement|1
7398293|NCT01296347|11662363|FG000|Allocation|Withdrawal by Subject|1
7398294|NCT01296347|11662364|FG001|Allocation|Withdrawal by Subject|2
7398295|NCT01296347|11662363|FG000|Allocation|Lack of Efficacy|1
7398296|NCT01296347|11662364|FG001|Allocation|Lack of Efficacy|2
7398297|NCT01296347|11662363|FG000|Allocation|not received infusion|1
7398298|NCT01296347|11662364|FG001|Allocation|not received infusion|0
7398299|NCT01296347|11662363|FG000|6 Week Follow up|Death|0
7398300|NCT01296347|11662364|FG001|6 Week Follow up|Death|1
7398301|NCT01296347|11662363|FG000|3 Month Follow up|Death|1
7398302|NCT01296347|11662364|FG001|3 Month Follow up|Death|0
7398303|NCT01296347|11662363|FG000|3 Month Follow up|Lost to Follow-up|0
7398304|NCT01296347|11662364|FG001|3 Month Follow up|Lost to Follow-up|1
7398305|NCT01296347|11662363|FG000|6 Month Follow up|Death|2
7398306|NCT01296347|11662364|FG001|6 Month Follow up|Death|1
7398307|NCT01296347|11662363|FG000|6 Month Follow up|Lost to Follow-up|0
7398308|NCT01296347|11662364|FG001|6 Month Follow up|Lost to Follow-up|1
7398309|NCT01296347|11662363|FG000|12 Month Follow up|Lost to Follow-up|3
7398310|NCT01296347|11662364|FG001|12 Month Follow up|Lost to Follow-up|1
7398311|NCT01296347|11662363|FG000|12 Month Follow up|Death|1
7398312|NCT01296347|11662364|FG001|12 Month Follow up|Death|1
7398313|NCT01296347|11662363|FG000|12 Month Follow up|Withdrawal by Subject|0
7398314|NCT01296347|11662364|FG001|12 Month Follow up|Withdrawal by Subject|1
7398315|NCT01296412|11662384|FG000|Overall Study|Adverse Event|8
7398316|NCT01296412|11662385|FG001|Overall Study|Adverse Event|29
7398317|NCT01296412|11662384|FG000|Overall Study|Lack of Efficacy|1
7398318|NCT01296412|11662385|FG001|Overall Study|Lack of Efficacy|0
7398319|NCT01296412|11662384|FG000|Overall Study|Lost to Follow-up|10
7398320|NCT01296412|11662385|FG001|Overall Study|Lost to Follow-up|7
7398321|NCT01296412|11662384|FG000|Overall Study|Non-compliance with study drug|1
7398322|NCT01296412|11662385|FG001|Overall Study|Non-compliance with study drug|2
7398323|NCT01296412|11662384|FG000|Overall Study|Other reason not specified|20
7398324|NCT01296412|11662385|FG001|Overall Study|Other reason not specified|15
7398325|NCT01296412|11662384|FG000|Overall Study|Physician Decision|1
7471119|NCT01939314|11773840|FG000|Overall Study|Withdrawal by Subject|3
7471120|NCT01939314|11773841|FG001|Overall Study|Withdrawal by Subject|1
7471121|NCT01939314|11773840|FG000|Overall Study|Protocol Violation|1
7471122|NCT01939314|11773841|FG001|Overall Study|Protocol Violation|0
7471123|NCT01939314|11773840|FG000|Overall Study|Pregnancy|0
7471124|NCT01939314|11773841|FG001|Overall Study|Pregnancy|1
7471125|NCT01939314|11773840|FG000|Overall Study|Lost to Follow-up|5
7471126|NCT01939314|11773841|FG001|Overall Study|Lost to Follow-up|6
7471127|NCT01939353|11773849|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
7471128|NCT01939353|11773849|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
7471129|NCT01939353|11773849|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
7471130|NCT01939353|11773849|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
7471131|NCT01939353|11773849|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
7471132|NCT01939366|11773858|FG000|Overall Study|Adverse Event|8
7471133|NCT01939366|11773859|FG001|Overall Study|Adverse Event|17
7471134|NCT01939366|11773860|FG002|Overall Study|Adverse Event|30
7398326|NCT01296412|11662385|FG001|Overall Study|Physician Decision|3
7398327|NCT01296412|11662384|FG000|Overall Study|Pregnancy|0
7398328|NCT01296412|11662385|FG001|Overall Study|Pregnancy|1
7398329|NCT01296412|11662384|FG000|Overall Study|Withdrawal by Subject|10
7398330|NCT01296412|11662385|FG001|Overall Study|Withdrawal by Subject|13
7398331|NCT01296568|11662400|FG000|Continued Access Phase|Lost to Follow-up|1
7398332|NCT01296568|11662400|FG000|Continued Access Phase|Withdrawal by Subject|1
7398333|NCT01296568|11662400|FG000|Continued Access Phase|Disease Progression|1
7398334|NCT01296672|11662417|FG000|Overall Study|Lost to Follow-up|73
7398335|NCT01296672|11662418|FG001|Overall Study|Lost to Follow-up|18
7398336|NCT01296698|11662428|FG000|Overall Study|Adverse Event|1
7398337|NCT01296698|11662429|FG001|Overall Study|Adverse Event|0
7398338|NCT01296698|11662428|FG000|Overall Study|Death|1
7398339|NCT01296698|11662429|FG001|Overall Study|Death|0
7398340|NCT01296698|11662428|FG000|Overall Study|Lost to Follow-up|19
7398341|NCT01296698|11662429|FG001|Overall Study|Lost to Follow-up|1
7398342|NCT01296698|11662428|FG000|Overall Study|Withdrawal by Subject|12
7398343|NCT01296698|11662429|FG001|Overall Study|Withdrawal by Subject|0
7398344|NCT01296698|11662428|FG000|Overall Study|Difficulty Contacting Subject|2
7398345|NCT01296698|11662429|FG001|Overall Study|Difficulty Contacting Subject|0
7398346|NCT01296698|11662428|FG000|Overall Study|Study Terminated by Sponsor|209
7398347|NCT01296698|11662429|FG001|Overall Study|Study Terminated by Sponsor|12
7398348|NCT01296932|11662477|FG000|Overall Study|Dose limiting toxicity|0
7398349|NCT01296932|11662478|FG001|Overall Study|Dose limiting toxicity|0
7398350|NCT01296932|11662479|FG002|Overall Study|Dose limiting toxicity|0
7398351|NCT01296932|11662480|FG003|Overall Study|Dose limiting toxicity|0
7398352|NCT01296932|11662481|FG004|Overall Study|Dose limiting toxicity|0
7398353|NCT01296932|11662482|FG005|Overall Study|Dose limiting toxicity|0
7398354|NCT01296932|11662483|FG006|Overall Study|Dose limiting toxicity|1
7398355|NCT01296932|11662484|FG007|Overall Study|Dose limiting toxicity|0
7398356|NCT01296932|11662485|FG008|Overall Study|Dose limiting toxicity|1
7398357|NCT01296932|11662477|FG000|Overall Study|Progressive disease|2
7398358|NCT01296932|11662478|FG001|Overall Study|Progressive disease|0
7398359|NCT01296932|11662479|FG002|Overall Study|Progressive disease|1
7398360|NCT01296932|11662480|FG003|Overall Study|Progressive disease|1
7398361|NCT01296932|11662481|FG004|Overall Study|Progressive disease|2
7398362|NCT01296932|11662482|FG005|Overall Study|Progressive disease|3
7398363|NCT01296932|11662483|FG006|Overall Study|Progressive disease|1
7398364|NCT01296932|11662484|FG007|Overall Study|Progressive disease|0
7398365|NCT01296932|11662485|FG008|Overall Study|Progressive disease|0
7398366|NCT01296932|11662477|FG000|Overall Study|Withdrawal by Subject|0
7398367|NCT01296932|11662478|FG001|Overall Study|Withdrawal by Subject|0
7398368|NCT01296932|11662479|FG002|Overall Study|Withdrawal by Subject|1
7398369|NCT01296932|11662480|FG003|Overall Study|Withdrawal by Subject|1
7398370|NCT01296932|11662481|FG004|Overall Study|Withdrawal by Subject|0
7398371|NCT01296932|11662482|FG005|Overall Study|Withdrawal by Subject|0
7398372|NCT01296932|11662483|FG006|Overall Study|Withdrawal by Subject|3
7398373|NCT01296932|11662484|FG007|Overall Study|Withdrawal by Subject|0
7398374|NCT01296932|11662485|FG008|Overall Study|Withdrawal by Subject|0
7398375|NCT01296932|11662477|FG000|Overall Study|Adverse Event|1
7398376|NCT01296932|11662478|FG001|Overall Study|Adverse Event|1
7398377|NCT01296932|11662479|FG002|Overall Study|Adverse Event|1
7398378|NCT01296932|11662480|FG003|Overall Study|Adverse Event|2
7398379|NCT01296932|11662481|FG004|Overall Study|Adverse Event|1
7398380|NCT01296932|11662482|FG005|Overall Study|Adverse Event|0
7398381|NCT01296932|11662483|FG006|Overall Study|Adverse Event|0
7398382|NCT01296932|11662484|FG007|Overall Study|Adverse Event|0
7398383|NCT01296932|11662485|FG008|Overall Study|Adverse Event|1
7398384|NCT01296932|11662477|FG000|Overall Study|Investigator decision|0
7398385|NCT01296932|11662478|FG001|Overall Study|Investigator decision|1
7398386|NCT01296932|11662479|FG002|Overall Study|Investigator decision|0
7398387|NCT01296932|11662480|FG003|Overall Study|Investigator decision|1
7398388|NCT01296932|11662481|FG004|Overall Study|Investigator decision|0
7398389|NCT01296932|11662482|FG005|Overall Study|Investigator decision|0
7398390|NCT01296932|11662483|FG006|Overall Study|Investigator decision|1
7398391|NCT01296932|11662484|FG007|Overall Study|Investigator decision|0
7398392|NCT01296932|11662485|FG008|Overall Study|Investigator decision|1
7398393|NCT01296932|11662477|FG000|Overall Study|No clinical benefit anymore|0
7398394|NCT01296932|11662478|FG001|Overall Study|No clinical benefit anymore|1
7398395|NCT01296932|11662479|FG002|Overall Study|No clinical benefit anymore|0
7398396|NCT01296932|11662480|FG003|Overall Study|No clinical benefit anymore|0
7398397|NCT01296932|11662481|FG004|Overall Study|No clinical benefit anymore|0
7398398|NCT01296932|11662482|FG005|Overall Study|No clinical benefit anymore|0
7398399|NCT01296932|11662483|FG006|Overall Study|No clinical benefit anymore|0
7398400|NCT01296932|11662484|FG007|Overall Study|No clinical benefit anymore|0
7398401|NCT01296932|11662485|FG008|Overall Study|No clinical benefit anymore|0
7398402|NCT01296932|11662477|FG000|Overall Study|Physician Decision|0
7398403|NCT01296932|11662478|FG001|Overall Study|Physician Decision|0
7398404|NCT01296932|11662479|FG002|Overall Study|Physician Decision|1
7398405|NCT01296932|11662480|FG003|Overall Study|Physician Decision|0
7398406|NCT01296932|11662481|FG004|Overall Study|Physician Decision|0
7398407|NCT01296932|11662482|FG005|Overall Study|Physician Decision|0
7398408|NCT01296932|11662483|FG006|Overall Study|Physician Decision|0
7398409|NCT01296932|11662484|FG007|Overall Study|Physician Decision|0
7398410|NCT01296932|11662485|FG008|Overall Study|Physician Decision|0
7398411|NCT01296932|11662477|FG000|Overall Study|IV problems, administration not possible|0
7398412|NCT01296932|11662478|FG001|Overall Study|IV problems, administration not possible|0
7398413|NCT01296932|11662479|FG002|Overall Study|IV problems, administration not possible|1
7398414|NCT01296932|11662480|FG003|Overall Study|IV problems, administration not possible|0
7398415|NCT01296932|11662481|FG004|Overall Study|IV problems, administration not possible|0
7398416|NCT01296932|11662482|FG005|Overall Study|IV problems, administration not possible|0
7398417|NCT01296932|11662483|FG006|Overall Study|IV problems, administration not possible|0
7398418|NCT01296932|11662484|FG007|Overall Study|IV problems, administration not possible|0
7398419|NCT01296932|11662485|FG008|Overall Study|IV problems, administration not possible|0
7398420|NCT01296932|11662477|FG000|Overall Study|per protocol|0
7398421|NCT01296932|11662478|FG001|Overall Study|per protocol|0
7398422|NCT01296932|11662479|FG002|Overall Study|per protocol|1
7398423|NCT01296932|11662480|FG003|Overall Study|per protocol|1
7398424|NCT01296932|11662481|FG004|Overall Study|per protocol|0
7398425|NCT01296932|11662482|FG005|Overall Study|per protocol|0
7398426|NCT01296932|11662483|FG006|Overall Study|per protocol|0
7398427|NCT01296932|11662484|FG007|Overall Study|per protocol|0
7398428|NCT01296932|11662485|FG008|Overall Study|per protocol|0
7398429|NCT01296932|11662477|FG000|Overall Study|Low benefit and too many side effects|0
7398430|NCT01296932|11662478|FG001|Overall Study|Low benefit and too many side effects|0
7398431|NCT01296932|11662479|FG002|Overall Study|Low benefit and too many side effects|0
7398432|NCT01296932|11662480|FG003|Overall Study|Low benefit and too many side effects|0
7398433|NCT01296932|11662481|FG004|Overall Study|Low benefit and too many side effects|0
7398434|NCT01296932|11662482|FG005|Overall Study|Low benefit and too many side effects|0
7398435|NCT01296932|11662483|FG006|Overall Study|Low benefit and too many side effects|0
7398436|NCT01296932|11662484|FG007|Overall Study|Low benefit and too many side effects|1
7398437|NCT01296932|11662485|FG008|Overall Study|Low benefit and too many side effects|0
7398438|NCT01296932|11662477|FG000|Overall Study|No adequate treatment response|0
7398439|NCT01296932|11662478|FG001|Overall Study|No adequate treatment response|0
7398440|NCT01296932|11662479|FG002|Overall Study|No adequate treatment response|0
7398441|NCT01296932|11662480|FG003|Overall Study|No adequate treatment response|0
7398442|NCT01296932|11662481|FG004|Overall Study|No adequate treatment response|0
7398443|NCT01296932|11662482|FG005|Overall Study|No adequate treatment response|0
7398444|NCT01296932|11662483|FG006|Overall Study|No adequate treatment response|0
7398445|NCT01296932|11662484|FG007|Overall Study|No adequate treatment response|1
7398446|NCT01296932|11662485|FG008|Overall Study|No adequate treatment response|0
7398447|NCT01296932|11662477|FG000|Overall Study|Dosage already reduced, AE still present|0
7398448|NCT01296932|11662478|FG001|Overall Study|Dosage already reduced, AE still present|0
7398449|NCT01296932|11662479|FG002|Overall Study|Dosage already reduced, AE still present|0
7398450|NCT01296932|11662480|FG003|Overall Study|Dosage already reduced, AE still present|0
7398451|NCT01296932|11662481|FG004|Overall Study|Dosage already reduced, AE still present|0
7398452|NCT01296932|11662482|FG005|Overall Study|Dosage already reduced, AE still present|0
7398453|NCT01296932|11662483|FG006|Overall Study|Dosage already reduced, AE still present|0
7398454|NCT01296932|11662484|FG007|Overall Study|Dosage already reduced, AE still present|0
7398455|NCT01296932|11662485|FG008|Overall Study|Dosage already reduced, AE still present|1
7398456|NCT01297062|11662512|FG000|Overall Study|Adverse Event|2
7398457|NCT01297062|11662513|FG001|Overall Study|Adverse Event|0
7398458|NCT01297062|11662514|FG002|Overall Study|Adverse Event|1
7398459|NCT01297062|11662515|FG003|Overall Study|Adverse Event|0
7398460|NCT01297062|11662516|FG004|Overall Study|Adverse Event|0
7398461|NCT01297062|11662517|FG005|Overall Study|Adverse Event|0
7398462|NCT01297062|11662518|FG006|Overall Study|Adverse Event|0
7398463|NCT01297062|11662512|FG000|Overall Study|Physician Decision|1
7398464|NCT01297062|11662513|FG001|Overall Study|Physician Decision|0
7398465|NCT01297062|11662514|FG002|Overall Study|Physician Decision|1
7398466|NCT01297062|11662515|FG003|Overall Study|Physician Decision|0
7398467|NCT01297062|11662516|FG004|Overall Study|Physician Decision|0
7398468|NCT01297062|11662517|FG005|Overall Study|Physician Decision|0
7398469|NCT01297062|11662518|FG006|Overall Study|Physician Decision|6
7398470|NCT01297062|11662512|FG000|Overall Study|Protocol Violation|0
7398471|NCT01297062|11662513|FG001|Overall Study|Protocol Violation|0
7398472|NCT01297062|11662514|FG002|Overall Study|Protocol Violation|0
7398473|NCT01297062|11662515|FG003|Overall Study|Protocol Violation|0
7398474|NCT01297062|11662516|FG004|Overall Study|Protocol Violation|1
7398475|NCT01297062|11662517|FG005|Overall Study|Protocol Violation|0
7398476|NCT01297062|11662518|FG006|Overall Study|Protocol Violation|0
7398477|NCT01297062|11662512|FG000|Overall Study|Subject Decision|1
7398478|NCT01297062|11662513|FG001|Overall Study|Subject Decision|1
7398479|NCT01297062|11662514|FG002|Overall Study|Subject Decision|0
7398480|NCT01297062|11662515|FG003|Overall Study|Subject Decision|1
7398481|NCT01297062|11662516|FG004|Overall Study|Subject Decision|1
7398482|NCT01297062|11662517|FG005|Overall Study|Subject Decision|1
7398483|NCT01297062|11662518|FG006|Overall Study|Subject Decision|2
7398484|NCT01297244|11662528|FG000|Overall Study|Progressive disease|22
7398485|NCT01297244|11662529|FG001|Overall Study|Progressive disease|3
7398486|NCT01297244|11662528|FG000|Overall Study|Adverse Event|9
7398487|NCT01297244|11662529|FG001|Overall Study|Adverse Event|1
7398488|NCT01297244|11662528|FG000|Overall Study|Death|1
7398489|NCT01297244|11662529|FG001|Overall Study|Death|1
7398490|NCT01297244|11662528|FG000|Overall Study|Clinical progression|1
7398491|NCT01297244|11662529|FG001|Overall Study|Clinical progression|1
7398492|NCT01297244|11662528|FG000|Overall Study|Withdrawal by Subject|2
7398493|NCT01297244|11662529|FG001|Overall Study|Withdrawal by Subject|0
7398494|NCT01297270|11662544|FG000|Overall Study|Adverse Event|19
7398495|NCT01297270|11662545|FG001|Overall Study|Adverse Event|32
7398496|NCT01297270|11662546|FG002|Overall Study|Adverse Event|5
7398497|NCT01297270|11662544|FG000|Overall Study|Lack of Efficacy|15
7398498|NCT01297270|11662545|FG001|Overall Study|Lack of Efficacy|17
7398499|NCT01297270|11662546|FG002|Overall Study|Lack of Efficacy|15
7398500|NCT01297270|11662544|FG000|Overall Study|Lost to Follow-up|1
7398501|NCT01297270|11662545|FG001|Overall Study|Lost to Follow-up|2
7398502|NCT01297270|11662546|FG002|Overall Study|Lost to Follow-up|1
7398503|NCT01297270|11662544|FG000|Overall Study|Protocol Violation|0
7398504|NCT01297270|11662545|FG001|Overall Study|Protocol Violation|2
7398505|NCT01297270|11662546|FG002|Overall Study|Protocol Violation|0
7398506|NCT01297270|11662544|FG000|Overall Study|Withdrawal by Subject|7
7398507|NCT01297270|11662545|FG001|Overall Study|Withdrawal by Subject|15
7398508|NCT01297270|11662546|FG002|Overall Study|Withdrawal by Subject|7
7398509|NCT01297270|11662544|FG000|Overall Study|Other reason not defined above|3
7398510|NCT01297270|11662545|FG001|Overall Study|Other reason not defined above|3
7398511|NCT01297270|11662546|FG002|Overall Study|Other reason not defined above|1
7398512|NCT01297270|11662544|FG000|Overall Study|Not treated|0
7398513|NCT01297270|11662545|FG001|Overall Study|Not treated|1
7398514|NCT01297270|11662546|FG002|Overall Study|Not treated|0
7398515|NCT01297309|11662558|FG000|Overall Study|Eligibility failure|2
7398516|NCT01297309|11662558|FG000|Overall Study|Screen failure|2
7398517|NCT01297309|11662558|FG000|Overall Study|Withdrawal by Subject|5
7398518|NCT01297309|11662558|FG000|Overall Study|Adverse Event|1
7398519|NCT01297309|11662558|FG000|Overall Study|Investigator Decision|2
7398520|NCT01297309|11662558|FG000|Overall Study|Death|1
7398521|NCT01297309|11662558|FG000|Overall Study|Participant not entering extensionperiod|1
7398522|NCT01297322|11662564|FG000|Overall Study|Lost to Follow-up|1
7398523|NCT01297322|11662565|FG001|Overall Study|Lost to Follow-up|0
7398524|NCT01297322|11662564|FG000|Overall Study|Withdrawal by Subject|0
7398525|NCT01297322|11662565|FG001|Overall Study|Withdrawal by Subject|1
7398526|NCT01297322|11662564|FG000|Overall Study|Protocol Violation|0
7398527|NCT01297322|11662565|FG001|Overall Study|Protocol Violation|3
7398528|NCT01297465|11662590|FG000|Overall Study|Lack of Ovarian Response|1
7398529|NCT01297465|11662591|FG001|Overall Study|Lack of Ovarian Response|1
7398530|NCT01297465|11662590|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
7398531|NCT01297465|11662591|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
7398532|NCT01297465|11662590|FG000|Overall Study|No Oocytes Retrieved|1
7398533|NCT01297465|11662591|FG001|Overall Study|No Oocytes Retrieved|1
7398534|NCT01297465|11662590|FG000|Overall Study|Poor oocyte quality|0
7398535|NCT01297465|11662591|FG001|Overall Study|Poor oocyte quality|1
7398536|NCT01297465|11662590|FG000|Overall Study|No Fertilization|6
7398537|NCT01297465|11662591|FG001|Overall Study|No Fertilization|4
7398538|NCT01297465|11662590|FG000|Overall Study|All Embryos Discarded|0
7398539|NCT01297465|11662591|FG001|Overall Study|All Embryos Discarded|1
7398540|NCT01297465|11662590|FG000|Overall Study|Intention to Freeze all Embryos|0
7398541|NCT01297465|11662591|FG001|Overall Study|Intention to Freeze all Embryos|1
7398542|NCT01297491|11662599|FG000|Overall Study|Adverse Event|11
7398543|NCT01297491|11662600|FG001|Overall Study|Adverse Event|6
7398544|NCT01297491|11662599|FG000|Overall Study|Physician Decision|3
7398545|NCT01297491|11662600|FG001|Overall Study|Physician Decision|2
7398546|NCT01297491|11662599|FG000|Overall Study|Progressive disease|11
7398547|NCT01297491|11662600|FG001|Overall Study|Progressive disease|20
7398548|NCT01297491|11662599|FG000|Overall Study|Patient/Guardian decision|3
7398549|NCT01297491|11662600|FG001|Overall Study|Patient/Guardian decision|4
7398550|NCT01297491|11662599|FG000|Overall Study|Death|2
7398551|NCT01297491|11662600|FG001|Overall Study|Death|1
7398552|NCT01297504|11662606|FG000|Overall Study|Invalid Consent|1
7398553|NCT01297504|11662606|FG000|Overall Study|Received Palivizumab in Previous Season|1
7398554|NCT01297504|11662606|FG000|Overall Study|No Study Visits|4
7398555|NCT01297504|11662606|FG000|Overall Study|Death|3
7398556|NCT01297504|11662606|FG000|Overall Study|Lost to Follow-up|43
7398557|NCT01297504|11662606|FG000|Overall Study|Withdrawal by Subject|9
7398558|NCT01297504|11662606|FG000|Overall Study|Site Closure|3
7398559|NCT01297504|11662606|FG000|Overall Study|Protocol Violation|3
7398560|NCT01297517|11662617|FG000|Overall Study|Adverse Event|21
7398561|NCT01297517|11662618|FG001|Overall Study|Adverse Event|7
7398562|NCT01297517|11662619|FG002|Overall Study|Adverse Event|16
7398563|NCT01297517|11662617|FG000|Overall Study|Lost to Follow-up|1
7398564|NCT01297517|11662618|FG001|Overall Study|Lost to Follow-up|0
7398565|NCT01297517|11662619|FG002|Overall Study|Lost to Follow-up|1
7398566|NCT01297517|11662617|FG000|Overall Study|Patient Decision Unrelated to AE|2
7398567|NCT01297517|11662618|FG001|Overall Study|Patient Decision Unrelated to AE|3
7398568|NCT01297517|11662619|FG002|Overall Study|Patient Decision Unrelated to AE|7
7398569|NCT01297517|11662617|FG000|Overall Study|Noncompliance|1
7398570|NCT01297517|11662618|FG001|Overall Study|Noncompliance|0
7398571|NCT01297517|11662619|FG002|Overall Study|Noncompliance|0
7398572|NCT01297517|11662617|FG000|Overall Study|Protocol Violation|1
7398573|NCT01297517|11662618|FG001|Overall Study|Protocol Violation|1
7398574|NCT01297517|11662619|FG002|Overall Study|Protocol Violation|1
7398575|NCT01297517|11662617|FG000|Overall Study|Inadequate Control of IOP|1
7398576|NCT01297517|11662618|FG001|Overall Study|Inadequate Control of IOP|1
7398577|NCT01297517|11662619|FG002|Overall Study|Inadequate Control of IOP|2
7398578|NCT01297920|11662637|FG000|Overall Study|Adverse Event|42
7398579|NCT01297920|11662638|FG001|Overall Study|Adverse Event|10
7398580|NCT01297920|11662639|FG002|Overall Study|Adverse Event|38
7398581|NCT01297920|11662637|FG000|Overall Study|Patient Decision Unrelated to AE|6
7398582|NCT01297920|11662638|FG001|Overall Study|Patient Decision Unrelated to AE|5
7398583|NCT01297920|11662639|FG002|Overall Study|Patient Decision Unrelated to AE|2
7398584|NCT01297920|11662637|FG000|Overall Study|Noncompliance|1
7398585|NCT01297920|11662638|FG001|Overall Study|Noncompliance|0
7398586|NCT01297920|11662639|FG002|Overall Study|Noncompliance|0
7398587|NCT01297920|11662637|FG000|Overall Study|Protocol Violation|1
7398588|NCT01297920|11662638|FG001|Overall Study|Protocol Violation|3
7398589|NCT01297920|11662639|FG002|Overall Study|Protocol Violation|0
7398590|NCT01297920|11662637|FG000|Overall Study|Inadequate Control of IOP|7
7398591|NCT01297920|11662638|FG001|Overall Study|Inadequate Control of IOP|9
7398592|NCT01297920|11662639|FG002|Overall Study|Inadequate Control of IOP|17
7398593|NCT01297920|11662637|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
7398594|NCT01297920|11662638|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
7398595|NCT01297920|11662639|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
7398596|NCT01297959|11662649|FG000|Overall Study|Adverse Event|0
7398597|NCT01297959|11662650|FG001|Overall Study|Adverse Event|1
7398598|NCT01297959|11662649|FG000|Overall Study|Protocol Violation|2
7398599|NCT01297959|11662650|FG001|Overall Study|Protocol Violation|1
7398600|NCT01297959|11662649|FG000|Overall Study|Withdrawal by Subject|5
7398601|NCT01297959|11662650|FG001|Overall Study|Withdrawal by Subject|4
7398602|NCT01297959|11662649|FG000|Overall Study|Physician Decision|0
7398603|NCT01297959|11662650|FG001|Overall Study|Physician Decision|1
7398604|NCT01297959|11662649|FG000|Overall Study|Unrelated medical illness / complication|0
7398605|NCT01297959|11662650|FG001|Overall Study|Unrelated medical illness / complication|2
7398606|NCT01297959|11662649|FG000|Overall Study|Other|13
7398607|NCT01297959|11662650|FG001|Overall Study|Other|7
7398608|NCT01298141|11662696|FG000|Overall Study|Adverse Event|3
7398609|NCT01298141|11662696|FG000|Overall Study|Refusal of Required Study Procedures|1
7398610|NCT01298141|11662696|FG000|Overall Study|Withdrawal by Subject|6
7398611|NCT01298141|11662696|FG000|Overall Study|Termination of Study by the Investigator|5
7398612|NCT01298141|11662696|FG000|Overall Study|Other|5
7398613|NCT01298141|11662696|FG000|Overall Study|Lost to Follow-up|1
7398614|NCT01298141|11662696|FG000|Overall Study|Death|6
7398615|NCT01298141|11662696|FG000|Overall Study|Not treated|4
7398616|NCT01298193|11662709|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
7398617|NCT01298193|11662709|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
7398618|NCT01298193|11662709|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
7398619|NCT01298193|11662709|FG000|Efficacy Phase (Second Cycle)|Death|1
7398620|NCT01298323|11662727|FG000|Overall Study|Adverse Event|2
7398621|NCT01298323|11662728|FG001|Overall Study|Adverse Event|4
7398622|NCT01298323|11662727|FG000|Overall Study|Death|11
7398623|NCT01298323|11662728|FG001|Overall Study|Death|16
7398624|NCT01298323|11662727|FG000|Overall Study|Lost to Follow-up|1
7398625|NCT01298323|11662728|FG001|Overall Study|Lost to Follow-up|0
7398626|NCT01298323|11662727|FG000|Overall Study|Withdrawal by Subject|6
7398627|NCT01298323|11662728|FG001|Overall Study|Withdrawal by Subject|3
7398628|NCT01298323|11662727|FG000|Overall Study|Protocol Violation|1
7398629|NCT01298323|11662728|FG001|Overall Study|Protocol Violation|0
7398630|NCT01298323|11662727|FG000|Overall Study|Other|10
7398631|NCT01298323|11662728|FG001|Overall Study|Other|9
7398632|NCT01298323|11662727|FG000|Overall Study|Ongoing|55
7398633|NCT01298323|11662728|FG001|Overall Study|Ongoing|55
7398634|NCT01298323|11662727|FG000|Overall Study|Eligibility criteria not fulfilled|0
7398635|NCT01298323|11662728|FG001|Overall Study|Eligibility criteria not fulfilled|1
7398636|NCT01298362|11662736|FG000|Overall Study|Did not provide 12month BMD measurements|38
7398637|NCT01298362|11662737|FG001|Overall Study|Did not provide 12month BMD measurements|43
7398638|NCT01298492|11662745|FG000|Overall Study|Death|2
7398639|NCT01298492|11662745|FG000|Overall Study|Insufficient Clinical Response|22
7398640|NCT01298492|11662745|FG000|Overall Study|Lost to Follow-up|12
7398641|NCT01298492|11662745|FG000|Overall Study|Withdrawal by Subject|47
7398642|NCT01298492|11662745|FG000|Overall Study|Other (Unspecified)|7
7398643|NCT01298492|11662745|FG000|Overall Study|Withdrawn Due to Pregnancy|1
7398644|NCT01298492|11662745|FG000|Overall Study|Protocol Violation|2
7398645|NCT01298492|11662745|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
7398646|NCT01298492|11662745|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
7398647|NCT01298518|11662752|FG000|Overall Study|Withdrawal by Subject|0
7398648|NCT01298518|11662753|FG001|Overall Study|Withdrawal by Subject|0
7398649|NCT01298518|11662754|FG002|Overall Study|Withdrawal by Subject|1
7398650|NCT01298531|11662764|FG000|Overall Study|Lack of Efficacy|0
7398651|NCT01298531|11662765|FG001|Overall Study|Lack of Efficacy|1
7398652|NCT01298531|11662764|FG000|Overall Study|Lost to Follow-up|2
7398653|NCT01298531|11662765|FG001|Overall Study|Lost to Follow-up|0
7398654|NCT01298531|11662764|FG000|Overall Study|Protocol Violation|1
7398655|NCT01298531|11662765|FG001|Overall Study|Protocol Violation|1
7398656|NCT01298531|11662764|FG000|Overall Study|Adverse Event|4
7398657|NCT01298531|11662765|FG001|Overall Study|Adverse Event|3
7398658|NCT01298531|11662764|FG000|Overall Study|Does not meet entrance criteria|0
7398659|NCT01298531|11662765|FG001|Overall Study|Does not meet entrance criteria|1
7398660|NCT01298531|11662764|FG000|Overall Study|Other|2
7398661|NCT01298531|11662765|FG001|Overall Study|Other|1
7398662|NCT01298570|11662780|FG000|Overall Study|Disease progression, relapse during acti|64
7398663|NCT01298570|11662781|FG001|Overall Study|Disease progression, relapse during acti|40
7398664|NCT01298570|11662780|FG000|Overall Study|Adverse Event|20
7398665|NCT01298570|11662781|FG001|Overall Study|Adverse Event|2
7398666|NCT01298570|11662780|FG000|Overall Study|Withdrawal by Subject|21
7398667|NCT01298570|11662781|FG001|Overall Study|Withdrawal by Subject|6
7398668|NCT01298570|11662780|FG000|Overall Study|Treatment delay > 4 weeks|4
7398669|NCT01298570|11662781|FG001|Overall Study|Treatment delay > 4 weeks|5
7398670|NCT01298570|11662780|FG000|Overall Study|Physician Decision|4
7398671|NCT01298570|11662781|FG001|Overall Study|Physician Decision|2
7398672|NCT01298570|11662780|FG000|Overall Study|Other complicating disease|2
7398673|NCT01298570|11662781|FG001|Overall Study|Other complicating disease|1
7398674|NCT01298570|11662780|FG000|Overall Study|Surgery|2
7398675|NCT01298570|11662781|FG001|Overall Study|Surgery|1
7398676|NCT01298570|11662780|FG000|Overall Study|Symptomatic progression/deterioration|3
7398677|NCT01298570|11662781|FG001|Overall Study|Symptomatic progression/deterioration|2
7398678|NCT01298570|11662780|FG000|Overall Study|Death|0
7398679|NCT01298570|11662781|FG001|Overall Study|Death|1
7398680|NCT01298570|11662780|FG000|Overall Study|Ineligibility|0
7398681|NCT01298570|11662781|FG001|Overall Study|Ineligibility|1
7398682|NCT01298596|11662789|FG000|Overall Study|Withdrawal by Subject|1
7398683|NCT01298596|11662790|FG001|Overall Study|Withdrawal by Subject|1
7398684|NCT01298596|11662789|FG000|Overall Study|Death|5
7398685|NCT01298596|11662790|FG001|Overall Study|Death|3
7398686|NCT01298596|11662789|FG000|Overall Study|Lost to Follow-up|6
7398687|NCT01298596|11662790|FG001|Overall Study|Lost to Follow-up|14
7398688|NCT01298596|11662789|FG000|Overall Study|Referred for further management|16
7398689|NCT01298596|11662790|FG001|Overall Study|Referred for further management|15
7398690|NCT01298648|11662796|FG000|Overall Study|Withdrawal by Subject|2
7398691|NCT01298648|11662796|FG000|Overall Study|Lost to Follow-up|21
7398692|NCT01298661|11662803|FG000|Overall Study|Withdrawal by Subject|2
7398693|NCT01298661|11662804|FG001|Overall Study|Withdrawal by Subject|0
7398694|NCT01298661|11662805|FG002|Overall Study|Withdrawal by Subject|2
7398695|NCT01298700|11662816|FG000|Overall Study|Adverse Event|50
7398696|NCT01298700|11662817|FG001|Overall Study|Adverse Event|51
7398697|NCT01298700|11662816|FG000|Overall Study|Lack of Efficacy|9
7398698|NCT01298700|11662817|FG001|Overall Study|Lack of Efficacy|14
7398699|NCT01298700|11662816|FG000|Overall Study|Lost to Follow-up|5
7398700|NCT01298700|11662817|FG001|Overall Study|Lost to Follow-up|2
7398701|NCT01298700|11662816|FG000|Overall Study|Withdrawal by Subject|12
7398702|NCT01298700|11662817|FG001|Overall Study|Withdrawal by Subject|9
7398703|NCT01298700|11662816|FG000|Overall Study|Protocol Violation|6
7398704|NCT01298700|11662817|FG001|Overall Study|Protocol Violation|4
7398705|NCT01298700|11662816|FG000|Overall Study|Other Miscellaneous Reasons|16
7398706|NCT01298700|11662817|FG001|Overall Study|Other Miscellaneous Reasons|15
7398707|NCT01298700|11662816|FG000|Overall Study|Did not Receive Study Drug|3
7398708|NCT01298700|11662817|FG001|Overall Study|Did not Receive Study Drug|5
7398709|NCT01298765|11662832|FG000|Titration Period|Adverse Event|26
7398710|NCT01298765|11662832|FG000|Titration Period|Death|1
7398711|NCT01298765|11662832|FG000|Titration Period|Lack of Efficacy|21
7398712|NCT01298765|11662832|FG000|Titration Period|Lost to Follow-up|9
7398713|NCT01298765|11662832|FG000|Titration Period|Physician Decision|1
7398714|NCT01298765|11662832|FG000|Titration Period|Withdrawal by Subject|10
7398715|NCT01298765|11662832|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
7398716|NCT01298765|11662832|FG000|Long-Term Treatment Period|Adverse Event|19
7398717|NCT01298765|11662832|FG000|Long-Term Treatment Period|Lack of Efficacy|6
7398718|NCT01298765|11662832|FG000|Long-Term Treatment Period|Lost to Follow-up|8
7398719|NCT01298765|11662832|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
7398720|NCT01298765|11662832|FG000|Long-Term Treatment Period|Physician Decision|1
7398721|NCT01298765|11662832|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
7398722|NCT01298778|11662838|FG000|Overall Study|Lost to Follow-up|2
7398723|NCT01298778|11662839|FG001|Overall Study|Lost to Follow-up|3
7398724|NCT01298778|11662838|FG000|Overall Study|Incorrect use of VAS|1
7398725|NCT01298778|11662839|FG001|Overall Study|Incorrect use of VAS|0
7398726|NCT01298778|11662838|FG000|Overall Study|Withdrawal by Subject|0
7398727|NCT01298778|11662839|FG001|Overall Study|Withdrawal by Subject|1
7398728|NCT01298778|11662838|FG000|Overall Study|Protocol Violation|0
7398729|NCT01298778|11662839|FG001|Overall Study|Protocol Violation|1
7398730|NCT01298778|11662838|FG000|Overall Study|not meet inclusion/exclusion criteria|0
7398731|NCT01298778|11662839|FG001|Overall Study|not meet inclusion/exclusion criteria|1
7398732|NCT01298999|11662849|FG000|Overall Study|Physician Decision|0
7398733|NCT01298999|11662850|FG001|Overall Study|Physician Decision|1
7398734|NCT01298999|11662849|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
7398735|NCT01298999|11662850|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
7398736|NCT01299025|11662858|FG000|Overall Study|Withdrawal by Subject|2
7398737|NCT01299025|11662859|FG001|Overall Study|Withdrawal by Subject|1
7398738|NCT01299025|11662858|FG000|Overall Study|Lost to Follow-up|1
7398739|NCT01299025|11662859|FG001|Overall Study|Lost to Follow-up|0
7398740|NCT01299038|11662867|FG000|Overall Study|Withdrawal by Subject|1
7398741|NCT01299038|11662868|FG001|Overall Study|Withdrawal by Subject|0
7398742|NCT01299116|11662898|FG000|Overall Study|Lost to Follow-up|65
7398743|NCT01299116|11662899|FG001|Overall Study|Lost to Follow-up|9
7398744|NCT01299116|11662900|FG002|Overall Study|Lost to Follow-up|11
7398745|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
7398746|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7398747|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7398748|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
7398749|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Adverse Event|140
7398750|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Adverse Event|0
7398751|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Adverse Event|0
7398752|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Adverse Event|0
7398753|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
7398754|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
7398755|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
7398756|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
7398757|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Protocol Violation|36
7398758|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Protocol Violation|0
7398759|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Protocol Violation|0
7398760|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Protocol Violation|0
7398761|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
7398762|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
7398763|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
7398764|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
7398765|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
7398766|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
7398767|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
7398768|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
7398769|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
7398770|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
7398771|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
7398772|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
7398773|NCT01299272|11662911|FG000|Acute Open-label (OL) Period|Physician Decision|5
7398774|NCT01299272|11662912|FG001|Acute Open-label (OL) Period|Physician Decision|0
7398775|NCT01299272|11662913|FG002|Acute Open-label (OL) Period|Physician Decision|0
7398776|NCT01299272|11662914|FG003|Acute Open-label (OL) Period|Physician Decision|0
7398777|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7398778|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
7398779|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7398780|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
7398781|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
7398782|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
7398783|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
7398784|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
7398785|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
7398786|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
7398787|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
7398788|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
7398789|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7398790|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
7398791|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7398792|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
7398793|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
7398794|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
7398795|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
7398796|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
7398797|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7398798|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
7398799|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7398800|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
7398801|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7398802|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
7398803|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7398804|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
7398805|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7398806|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
7398807|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7398808|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
7398809|NCT01299272|11662911|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
7398810|NCT01299272|11662912|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
7398811|NCT01299272|11662913|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
7398812|NCT01299272|11662914|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
7398813|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7398814|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
7398815|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
7398816|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
7398817|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7398818|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
7398819|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
7398820|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
7398821|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
7398822|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
7398823|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
7398824|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
7398825|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
7398826|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
7398827|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
7398828|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
7398829|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7398830|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
7398831|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7398832|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
7398833|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7398834|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
7398835|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
7398836|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
7398837|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
7398838|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
7398839|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
7398840|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
7398841|NCT01299272|11662911|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
7398842|NCT01299272|11662912|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
7398843|NCT01299272|11662913|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
7398844|NCT01299272|11662914|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
7465492|NCT01296711|11764681|FG002|Overall Study|Ongoing missed appointments|0
7465493|NCT01296711|11764682|FG003|Overall Study|Ongoing missed appointments|0
7465494|NCT01296711|11764683|FG004|Overall Study|Ongoing missed appointments|0
7465495|NCT01296711|11764684|FG005|Overall Study|Ongoing missed appointments|0
7465496|NCT01296711|11764685|FG006|Overall Study|Ongoing missed appointments|1
7465497|NCT01296711|11764686|FG007|Overall Study|Ongoing missed appointments|0
7465498|NCT01296711|11764679|FG000|Overall Study|Failure to comply with visits|0
7465499|NCT01296711|11764680|FG001|Overall Study|Failure to comply with visits|0
7465500|NCT01296711|11764681|FG002|Overall Study|Failure to comply with visits|0
7398845|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
7398846|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
7398847|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
7398848|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
7398849|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
7398850|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
7398851|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
7398852|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
7398853|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
7398854|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
7398855|NCT01299376|11662936|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7398856|NCT01299376|11662937|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
7398857|NCT01299376|11662936|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
7398858|NCT01299376|11662937|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
7398859|NCT01299376|11662936|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
7398860|NCT01299376|11662937|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
7398861|NCT01299376|11662936|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
7398862|NCT01299376|11662937|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
7398863|NCT01299376|11662936|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
7398864|NCT01299376|11662937|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
7398865|NCT01299376|11662936|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
7398866|NCT01299376|11662937|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
7398867|NCT01299389|11662949|FG000|Double-blind|Adverse Event|45
7398868|NCT01299389|11662950|FG001|Double-blind|Adverse Event|27
7398869|NCT01299389|11662951|FG002|Double-blind|Adverse Event|0
7398870|NCT01299389|11662952|FG003|Double-blind|Adverse Event|0
7398871|NCT01299389|11662949|FG000|Double-blind|Lack of Efficacy|45
7398872|NCT01299389|11662950|FG001|Double-blind|Lack of Efficacy|21
7398873|NCT01299389|11662951|FG002|Double-blind|Lack of Efficacy|0
7398874|NCT01299389|11662952|FG003|Double-blind|Lack of Efficacy|0
7398875|NCT01299389|11662949|FG000|Double-blind|Lost to Follow-up|2
7398876|NCT01299389|11662950|FG001|Double-blind|Lost to Follow-up|1
7398877|NCT01299389|11662951|FG002|Double-blind|Lost to Follow-up|0
7398878|NCT01299389|11662952|FG003|Double-blind|Lost to Follow-up|0
7398879|NCT01299389|11662949|FG000|Double-blind|Withdrawal by Subject|16
7398880|NCT01299389|11662950|FG001|Double-blind|Withdrawal by Subject|13
7398881|NCT01299389|11662951|FG002|Double-blind|Withdrawal by Subject|0
7398882|NCT01299389|11662952|FG003|Double-blind|Withdrawal by Subject|0
7398883|NCT01299389|11662949|FG000|Double-blind|Other|1
7398884|NCT01299389|11662950|FG001|Double-blind|Other|1
7398885|NCT01299389|11662951|FG002|Double-blind|Other|0
7398886|NCT01299389|11662952|FG003|Double-blind|Other|0
7398887|NCT01299389|11662949|FG000|Double-blind|"fail to meet study population criteria"|0
7398888|NCT01299389|11662950|FG001|Double-blind|"fail to meet study population criteria"|1
7398889|NCT01299389|11662951|FG002|Double-blind|"fail to meet study population criteria"|0
7398890|NCT01299389|11662952|FG003|Double-blind|"fail to meet study population criteria"|0
7398891|NCT01299389|11662949|FG000|Post-observational|Other|0
7398892|NCT01299389|11662950|FG001|Post-observational|Other|0
7398893|NCT01299389|11662951|FG002|Post-observational|Other|12
7398894|NCT01299389|11662952|FG003|Post-observational|Other|6
7398895|NCT01299480|11663009|FG000|Overall Study|No longer willing to participate|19
7398896|NCT01299480|11663010|FG001|Overall Study|No longer willing to participate|17
7398897|NCT01299480|11663011|FG002|Overall Study|No longer willing to participate|14
7398898|NCT01299480|11663012|FG003|Overall Study|No longer willing to participate|13
7398899|NCT01299480|11663013|FG004|Overall Study|No longer willing to participate|10
7398900|NCT01299480|11663009|FG000|Overall Study|Protocol Violation|7
7398901|NCT01299480|11663010|FG001|Overall Study|Protocol Violation|5
7398902|NCT01299480|11663011|FG002|Overall Study|Protocol Violation|8
7398903|NCT01299480|11663012|FG003|Overall Study|Protocol Violation|1
7398904|NCT01299480|11663013|FG004|Overall Study|Protocol Violation|1
7398905|NCT01299480|11663009|FG000|Overall Study|Withdrawal by Subject|3
7398906|NCT01299480|11663010|FG001|Overall Study|Withdrawal by Subject|4
7398907|NCT01299480|11663011|FG002|Overall Study|Withdrawal by Subject|7
7398908|NCT01299480|11663012|FG003|Overall Study|Withdrawal by Subject|3
7398909|NCT01299480|11663013|FG004|Overall Study|Withdrawal by Subject|4
7398910|NCT01299480|11663009|FG000|Overall Study|Adverse Event|6
7398911|NCT01299480|11663010|FG001|Overall Study|Adverse Event|4
7398912|NCT01299480|11663011|FG002|Overall Study|Adverse Event|5
7398913|NCT01299480|11663012|FG003|Overall Study|Adverse Event|4
7398914|NCT01299480|11663013|FG004|Overall Study|Adverse Event|0
7398915|NCT01299480|11663009|FG000|Overall Study|Withdrawal due to pregnancy|0
7398916|NCT01299480|11663010|FG001|Overall Study|Withdrawal due to pregnancy|1
7398917|NCT01299480|11663011|FG002|Overall Study|Withdrawal due to pregnancy|1
7398918|NCT01299480|11663012|FG003|Overall Study|Withdrawal due to pregnancy|0
7398919|NCT01299480|11663013|FG004|Overall Study|Withdrawal due to pregnancy|0
7398920|NCT01299480|11663009|FG000|Overall Study|Physician Decision|1
7398921|NCT01299480|11663010|FG001|Overall Study|Physician Decision|1
7398922|NCT01299480|11663011|FG002|Overall Study|Physician Decision|0
7398923|NCT01299480|11663012|FG003|Overall Study|Physician Decision|2
7398924|NCT01299480|11663013|FG004|Overall Study|Physician Decision|0
7398925|NCT01299480|11663009|FG000|Overall Study|Lost to Follow-up|3
7398926|NCT01299480|11663010|FG001|Overall Study|Lost to Follow-up|1
7398927|NCT01299480|11663011|FG002|Overall Study|Lost to Follow-up|2
7398928|NCT01299480|11663012|FG003|Overall Study|Lost to Follow-up|1
7398929|NCT01299480|11663013|FG004|Overall Study|Lost to Follow-up|2
7398930|NCT01299480|11663009|FG000|Overall Study|Other|3
7398931|NCT01299480|11663010|FG001|Overall Study|Other|2
7398932|NCT01299480|11663011|FG002|Overall Study|Other|3
7398933|NCT01299480|11663012|FG003|Overall Study|Other|0
7398934|NCT01299480|11663013|FG004|Overall Study|Other|3
7398935|NCT01299480|11663009|FG000|Overall Study|Started, but not vaccinated|0
7398936|NCT01299480|11663010|FG001|Overall Study|Started, but not vaccinated|0
7398937|NCT01299480|11663011|FG002|Overall Study|Started, but not vaccinated|1
7398938|NCT01299480|11663012|FG003|Overall Study|Started, but not vaccinated|1
7398939|NCT01299480|11663013|FG004|Overall Study|Started, but not vaccinated|0
7398940|NCT01299571|11663026|FG000|Overall Study|Protocol Violation|107
7398941|NCT01299584|11663031|FG000|Overall Study|Protocol Violation|9
7398942|NCT01299727|11663055|FG000|Overall Study|Withdrawal by Subject|1
7398943|NCT01299727|11663056|FG001|Overall Study|Withdrawal by Subject|0
7398944|NCT01299727|11663057|FG002|Overall Study|Withdrawal by Subject|0
7398945|NCT01299727|11663055|FG000|Overall Study|Adverse Event|0
7398946|NCT01299727|11663056|FG001|Overall Study|Adverse Event|0
7398947|NCT01299727|11663057|FG002|Overall Study|Adverse Event|1
7398948|NCT01299727|11663055|FG000|Overall Study|Completed the Treatment Period|3
7398949|NCT01299727|11663056|FG001|Overall Study|Completed the Treatment Period|4
7398950|NCT01299727|11663057|FG002|Overall Study|Completed the Treatment Period|3
7398951|NCT01299766|11663067|FG000|Overall Study|Death|5
7398952|NCT01299766|11663068|FG001|Overall Study|Death|4
7398953|NCT01299766|11663067|FG000|Overall Study|Withdrawal by Subject|29
7398954|NCT01299766|11663068|FG001|Overall Study|Withdrawal by Subject|19
7398955|NCT01299805|11663076|FG000|Overall Study|Adverse Event|2
7398956|NCT01299805|11663077|FG001|Overall Study|Adverse Event|0
7398957|NCT01299896|11663085|FG000|Overall Study|Withdrawal by Subject|1
7398958|NCT01299896|11663086|FG001|Overall Study|Withdrawal by Subject|7
7398959|NCT01299896|11663085|FG000|Overall Study|Lost to Follow-up|0
7398960|NCT01299896|11663086|FG001|Overall Study|Lost to Follow-up|11
7398961|NCT01299909|11663095|FG000|Overall Study|Lost to Follow-up|22
7398962|NCT01299909|11663096|FG001|Overall Study|Lost to Follow-up|18
7398963|NCT01299909|11663097|FG002|Overall Study|Lost to Follow-up|17
7398964|NCT01299961|11663104|FG000|Overall Study|Adverse Event|3
7398965|NCT01299961|11663104|FG000|Overall Study|Lack of Efficacy|2
7398966|NCT01299961|11663104|FG000|Overall Study|Lost to Follow-up|1
7398967|NCT01300052|11663110|FG000|Overall Study|Adverse Event|3
7398968|NCT01300052|11663111|FG001|Overall Study|Adverse Event|0
7398969|NCT01300052|11663110|FG000|Overall Study|Withdrawal by Subject|2
7398970|NCT01300052|11663111|FG001|Overall Study|Withdrawal by Subject|2
7398971|NCT01300052|11663110|FG000|Overall Study|Protocol Violation|1
7398972|NCT01300052|11663111|FG001|Overall Study|Protocol Violation|1
7398973|NCT01300234|11663128|FG000|Overall Study|Adverse Event|1
7398974|NCT01300234|11663129|FG001|Overall Study|Adverse Event|1
7398975|NCT01300234|11663128|FG000|Overall Study|Protocol Violation|2
7398976|NCT01300234|11663129|FG001|Overall Study|Protocol Violation|3
7398977|NCT01300234|11663128|FG000|Overall Study|Withdrawal by Subject|5
7398978|NCT01300234|11663129|FG001|Overall Study|Withdrawal by Subject|9
7398979|NCT01300234|11663128|FG000|Overall Study|Lost to Follow-up|14
7398980|NCT01300234|11663129|FG001|Overall Study|Lost to Follow-up|12
7398981|NCT01300234|11663128|FG000|Overall Study|Pregnancy|2
7398982|NCT01300234|11663129|FG001|Overall Study|Pregnancy|1
7398983|NCT01300234|11663128|FG000|Overall Study|Participant reached stopping critera|2
7398984|NCT01300234|11663129|FG001|Overall Study|Participant reached stopping critera|0
7398985|NCT01300234|11663128|FG000|Overall Study|Participant stopped medication|1
7398986|NCT01300234|11663129|FG001|Overall Study|Participant stopped medication|1
7398987|NCT01300234|11663128|FG000|Overall Study|Participant refused return to hospital|1
7398988|NCT01300234|11663129|FG001|Overall Study|Participant refused return to hospital|0
7398989|NCT01300247|11663148|FG000|Overall Study|Death|1
7398990|NCT01300247|11663149|FG001|Overall Study|Death|1
7398991|NCT01300247|11663148|FG000|Overall Study|Lost to Follow-up|2
7398992|NCT01300247|11663149|FG001|Overall Study|Lost to Follow-up|0
7398993|NCT01300247|11663148|FG000|Overall Study|Withdrawal by Subject|1
7398994|NCT01300247|11663149|FG001|Overall Study|Withdrawal by Subject|0
7398995|NCT01300247|11663148|FG000|Overall Study|Non-Compliance|0
7398996|NCT01300247|11663149|FG001|Overall Study|Non-Compliance|1
7398997|NCT01300260|11663157|FG000|Period 1 of Study: First Intervention|Adverse Event|0
7398998|NCT01300260|11663158|FG001|Period 1 of Study: First Intervention|Adverse Event|1
7398999|NCT01300260|11663157|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
7399000|NCT01300260|11663158|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
7399001|NCT01300260|11663157|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
7399002|NCT01300260|11663158|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
7399003|NCT01300286|11663175|FG000|Overall Study|did not get dosed|1
7399004|NCT01300338|11663182|FG000|Overall Study|Lost to Follow-up|5
7399005|NCT01300338|11663183|FG001|Overall Study|Lost to Follow-up|0
7399006|NCT01300351|11663191|FG000|Overall Study|Did not receive treatment|2
7399007|NCT01300351|11663192|FG001|Overall Study|Did not receive treatment|0
7399008|NCT01300351|11663191|FG000|Overall Study|Ongoing treatment at data cut-off|27
7399009|NCT01300351|11663192|FG001|Overall Study|Ongoing treatment at data cut-off|23
7399010|NCT01300351|11663191|FG000|Overall Study|Lost to Follow-up|0
7399011|NCT01300351|11663192|FG001|Overall Study|Lost to Follow-up|1
7399012|NCT01300351|11663191|FG000|Overall Study|Adverse Event|0
7399013|NCT01300351|11663192|FG001|Overall Study|Adverse Event|4
7399014|NCT01300351|11663191|FG000|Overall Study|Withdrawal by Subject|7
7399015|NCT01300351|11663192|FG001|Overall Study|Withdrawal by Subject|10
7399016|NCT01300455|11663200|FG000|Washout|Withdrawal by Subject|1
7399017|NCT01300455|11663201|FG001|Washout|Withdrawal by Subject|0
7399018|NCT01300546|11663209|FG000|Overall Study|Withdrawal by Subject|1
7399019|NCT01300546|11663210|FG001|Overall Study|Withdrawal by Subject|0
7399020|NCT01300546|11663209|FG000|Overall Study|Lost to Follow-up|0
7399021|NCT01300546|11663210|FG001|Overall Study|Lost to Follow-up|2
7399022|NCT01300546|11663209|FG000|Overall Study|Lack of Efficacy|0
7399023|NCT01300546|11663210|FG001|Overall Study|Lack of Efficacy|3
7399024|NCT01300546|11663209|FG000|Overall Study|Adverse Event|0
7399025|NCT01300546|11663210|FG001|Overall Study|Adverse Event|1
7399026|NCT01300572|11663225|FG000|Overall Study|HAMA + post dosimetry|1
7399027|NCT01300650|11663235|FG000|Overall Study|Adverse Event|1
7399028|NCT01300728|11663242|FG000|Overall Study|Withdrawal by Subject|1
7399029|NCT01300728|11663243|FG001|Overall Study|Withdrawal by Subject|1
7399030|NCT01300728|11663242|FG000|Overall Study|Physician Decision|1
7399031|NCT01300728|11663243|FG001|Overall Study|Physician Decision|0
7399032|NCT01300741|11663249|FG000|Overall Study|Lens deposits|1
7399033|NCT01300741|11663249|FG000|Overall Study|Lost to Follow-up|1
7399034|NCT01300741|11663249|FG000|Overall Study|Discomfort|1
7399035|NCT01300767|11663255|FG000|Overall Study|Discomfort|2
7399036|NCT01300767|11663255|FG000|Overall Study|Biomicroscopy|1
7399037|NCT01300767|11663255|FG000|Overall Study|Unacceptable fit|1
7399038|NCT01300819|11663263|FG000|Overall Study|Adverse Event|9
7399039|NCT01300819|11663264|FG001|Overall Study|Adverse Event|27
7399040|NCT01300819|11663263|FG000|Overall Study|Lack of Efficacy|2
7399041|NCT01300819|11663264|FG001|Overall Study|Lack of Efficacy|1
7399042|NCT01300819|11663263|FG000|Overall Study|Withdrawal by Subject|10
7399043|NCT01300819|11663264|FG001|Overall Study|Withdrawal by Subject|12
7399044|NCT01300819|11663263|FG000|Overall Study|Patient was 1 month late for Visit 10|0
7399045|NCT01300819|11663264|FG001|Overall Study|Patient was 1 month late for Visit 10|1
7399046|NCT01300819|11663263|FG000|Overall Study|Refusal to down titrate study drug|0
7399047|NCT01300819|11663264|FG001|Overall Study|Refusal to down titrate study drug|1
7399048|NCT01300819|11663263|FG000|Overall Study|Administrative reason|0
7399049|NCT01300819|11663264|FG001|Overall Study|Administrative reason|1
7399050|NCT01300819|11663263|FG000|Overall Study|Safety follow up not done by mistake|0
7399051|NCT01300819|11663264|FG001|Overall Study|Safety follow up not done by mistake|1
7399052|NCT01300819|11663263|FG000|Overall Study|Follow up call was not done|1
7399053|NCT01300819|11663264|FG001|Overall Study|Follow up call was not done|0
7399054|NCT01300923|11663270|FG000|Overall Study|Physician Decision|0
7399055|NCT01300923|11663271|FG001|Overall Study|Physician Decision|2
7399056|NCT01301001|11663289|FG000|First Intervention|Lost to Follow-up|4
7399057|NCT01301001|11663290|FG001|First Intervention|Lost to Follow-up|4
7399058|NCT01301001|11663289|FG000|First Intervention|Withdrawal by Subject|1
7399059|NCT01301001|11663290|FG001|First Intervention|Withdrawal by Subject|4
7399060|NCT01301001|11663289|FG000|First Intervention|Adverse Event|5
7399061|NCT01301001|11663290|FG001|First Intervention|Adverse Event|0
7399062|NCT01301001|11663289|FG000|First Intervention|Protocol Violation|0
7399063|NCT01301001|11663290|FG001|First Intervention|Protocol Violation|1
7399064|NCT01301001|11663289|FG000|Second Intervention|Adverse Event|2
7399065|NCT01301001|11663290|FG001|Second Intervention|Adverse Event|0
7399066|NCT01301001|11663289|FG000|Second Intervention|Withdrawal by Subject|2
7399067|NCT01301001|11663290|FG001|Second Intervention|Withdrawal by Subject|0
7399068|NCT01301027|11663299|FG000|Overall Study|Physician Decision|2
7399069|NCT01301027|11663300|FG001|Overall Study|Physician Decision|0
7399070|NCT01301027|11663299|FG000|Overall Study|Withdrawal by Subject|2
7399071|NCT01301027|11663300|FG001|Overall Study|Withdrawal by Subject|3
7399072|NCT01301027|11663299|FG000|Overall Study|Adverse Event|0
7399073|NCT01301027|11663300|FG001|Overall Study|Adverse Event|2
7399074|NCT01301027|11663299|FG000|Overall Study|Fracture|1
7399075|NCT01301027|11663300|FG001|Overall Study|Fracture|3
7399076|NCT01301027|11663299|FG000|Overall Study|Transplant|0
7399077|NCT01301027|11663300|FG001|Overall Study|Transplant|2
7399078|NCT01301027|11663299|FG000|Overall Study|Volume Overload|3
7399079|NCT01301027|11663300|FG001|Overall Study|Volume Overload|0
7399080|NCT01301066|11663308|FG000|Overall Study|Lost to Follow-up|5
7399081|NCT01301066|11663309|FG001|Overall Study|Lost to Follow-up|11
7399082|NCT01301066|11663308|FG000|Overall Study|Protocol Violation|8
7399083|NCT01301066|11663309|FG001|Overall Study|Protocol Violation|7
7399084|NCT01301066|11663308|FG000|Overall Study|Withdrawal by Subject|4
7399085|NCT01301066|11663309|FG001|Overall Study|Withdrawal by Subject|9
7399086|NCT01301066|11663308|FG000|Overall Study|Adverse Event|6
7399087|NCT01301066|11663309|FG001|Overall Study|Adverse Event|6
7399088|NCT01301066|11663308|FG000|Overall Study|Sponsor Decision|2
7399089|NCT01301066|11663309|FG001|Overall Study|Sponsor Decision|1
7399090|NCT01301066|11663308|FG000|Overall Study|Physician Decision|0
7399091|NCT01301066|11663309|FG001|Overall Study|Physician Decision|1
7399092|NCT01301066|11663308|FG000|Overall Study|Other|2
7399093|NCT01301066|11663309|FG001|Overall Study|Other|0
7399094|NCT01301079|11663317|FG000|Overall Study|Lost to Follow-up|2
7399095|NCT01301079|11663318|FG001|Overall Study|Lost to Follow-up|2
7399096|NCT01301092|11663331|FG000|Overall Study|Lost to Follow-up|0
7399097|NCT01301092|11663332|FG001|Overall Study|Lost to Follow-up|0
7399098|NCT01301092|11663333|FG002|Overall Study|Lost to Follow-up|1
7399099|NCT01301274|11663357|FG000|Overall Study|Physician Decision|2
7399100|NCT01301274|11663358|FG001|Overall Study|Physician Decision|1
7399101|NCT01301391|11663369|FG000|Overall Study|Death|13
7399102|NCT01301391|11663369|FG000|Overall Study|Lost to Follow-up|3
7399103|NCT01301391|11663369|FG000|Overall Study|Physician Decision|2
7399104|NCT01301391|11663369|FG000|Overall Study|Sponsor's decision|8
7399105|NCT01301456|11663385|FG000|Stage 1|Withdrawal by Subject|0
7399106|NCT01301456|11663386|FG001|Stage 1|Withdrawal by Subject|0
7399107|NCT01301456|11663387|FG002|Stage 1|Withdrawal by Subject|1
7399108|NCT01301456|11663388|FG003|Stage 1|Withdrawal by Subject|0
7399109|NCT01301456|11663389|FG004|Stage 1|Withdrawal by Subject|1
7399110|NCT01301456|11663390|FG005|Stage 1|Withdrawal by Subject|0
7399111|NCT01301456|11663391|FG006|Stage 1|Withdrawal by Subject|0
7399112|NCT01301456|11663392|FG007|Stage 1|Withdrawal by Subject|0
7399113|NCT01301456|11663393|FG008|Stage 1|Withdrawal by Subject|0
7399114|NCT01301456|11663394|FG009|Stage 1|Withdrawal by Subject|0
7399115|NCT01301456|11663395|FG010|Stage 1|Withdrawal by Subject|0
7399116|NCT01301456|11663396|FG011|Stage 1|Withdrawal by Subject|0
7399117|NCT01301456|11663385|FG000|Stage 1|Randomized but not treated|0
7399118|NCT01301456|11663386|FG001|Stage 1|Randomized but not treated|0
7399119|NCT01301456|11663387|FG002|Stage 1|Randomized but not treated|0
7399120|NCT01301456|11663388|FG003|Stage 1|Randomized but not treated|0
7399121|NCT01301456|11663389|FG004|Stage 1|Randomized but not treated|0
7399122|NCT01301456|11663390|FG005|Stage 1|Randomized but not treated|0
7399123|NCT01301456|11663391|FG006|Stage 1|Randomized but not treated|1
7399124|NCT01301456|11663392|FG007|Stage 1|Randomized but not treated|0
7399125|NCT01301456|11663393|FG008|Stage 1|Randomized but not treated|0
7399126|NCT01301456|11663394|FG009|Stage 1|Randomized but not treated|0
7399127|NCT01301456|11663395|FG010|Stage 1|Randomized but not treated|0
7399128|NCT01301456|11663396|FG011|Stage 1|Randomized but not treated|0
7399129|NCT01301456|11663385|FG000|Stage 2|Adverse Event|0
7399130|NCT01301456|11663386|FG001|Stage 2|Adverse Event|0
7399131|NCT01301456|11663387|FG002|Stage 2|Adverse Event|0
7399132|NCT01301456|11663388|FG003|Stage 2|Adverse Event|0
7399133|NCT01301456|11663389|FG004|Stage 2|Adverse Event|0
7399134|NCT01301456|11663390|FG005|Stage 2|Adverse Event|0
7399135|NCT01301456|11663391|FG006|Stage 2|Adverse Event|0
7399136|NCT01301456|11663392|FG007|Stage 2|Adverse Event|0
7399137|NCT01301456|11663393|FG008|Stage 2|Adverse Event|0
7399138|NCT01301456|11663394|FG009|Stage 2|Adverse Event|0
7399139|NCT01301456|11663395|FG010|Stage 2|Adverse Event|1
7399140|NCT01301456|11663396|FG011|Stage 2|Adverse Event|0
7399141|NCT01301508|11663442|FG000|Overall Study|Withdrawal by Subject|1
7399142|NCT01301508|11663443|FG001|Overall Study|Withdrawal by Subject|2
7399143|NCT01301508|11663442|FG000|Overall Study|Lost to Follow-up|0
7399144|NCT01301508|11663443|FG001|Overall Study|Lost to Follow-up|1
7399145|NCT01301625|11663449|FG000|Overall Study|Death|5
7399146|NCT01301625|11663449|FG000|Overall Study|Not Due|21
7399147|NCT01301625|11663449|FG000|Overall Study|Expected|8
7399148|NCT01301625|11663449|FG000|Overall Study|Lost to Follow-up|1
7399149|NCT01301729|11663453|FG000|Overall Study|Withdrawal by Subject|2
7399150|NCT01301729|11663453|FG000|Overall Study|Participant did not Return for Treatment|1
7399151|NCT01301729|11663453|FG000|Overall Study|Violated Selection Criteria|1
7399152|NCT01301833|11663470|FG000|Overall Study|Adverse Event|7
7399153|NCT01301833|11663471|FG001|Overall Study|Adverse Event|5
7399154|NCT01301833|11663472|FG002|Overall Study|Adverse Event|5
7399155|NCT01301833|11663473|FG003|Overall Study|Adverse Event|5
7399156|NCT01301833|11663470|FG000|Overall Study|Lack of Efficacy|1
7399157|NCT01301833|11663471|FG001|Overall Study|Lack of Efficacy|1
7399158|NCT01301833|11663472|FG002|Overall Study|Lack of Efficacy|0
7399159|NCT01301833|11663473|FG003|Overall Study|Lack of Efficacy|0
7399160|NCT01301833|11663470|FG000|Overall Study|Physician Decision|3
7399161|NCT01301833|11663471|FG001|Overall Study|Physician Decision|1
7399162|NCT01301833|11663472|FG002|Overall Study|Physician Decision|1
7399163|NCT01301833|11663473|FG003|Overall Study|Physician Decision|0
7399164|NCT01301833|11663470|FG000|Overall Study|Withdrawal by Subject|3
7399165|NCT01301833|11663471|FG001|Overall Study|Withdrawal by Subject|1
7399166|NCT01301833|11663472|FG002|Overall Study|Withdrawal by Subject|1
7399167|NCT01301833|11663473|FG003|Overall Study|Withdrawal by Subject|2
7399168|NCT01301833|11663470|FG000|Overall Study|Personal matter|1
7399169|NCT01301833|11663471|FG001|Overall Study|Personal matter|0
7399170|NCT01301833|11663472|FG002|Overall Study|Personal matter|0
7399171|NCT01301833|11663473|FG003|Overall Study|Personal matter|0
7399172|NCT01301950|11663485|FG000|Overall Study|Surgery was cancelled by patient|0
7399173|NCT01301950|11663486|FG001|Overall Study|Surgery was cancelled by patient|1
7399174|NCT01302041|11663492|FG000|Overall Study|Death|5
7399175|NCT01302041|11663492|FG000|Overall Study|Withdrawal by Subject|4
7399176|NCT01302041|11663492|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
7399177|NCT01302041|11663492|FG000|Overall Study|Other-Miscellaneous Reason|2
7399178|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
7399179|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7399180|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
7399181|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
7399182|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7399183|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
7399184|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
7399185|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7399186|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
7399187|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
7399188|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7399189|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
7399190|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
7399191|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7399192|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
7399193|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
7399194|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7399195|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
7399196|NCT01302054|11663497|FG000|Tolterodine Open-Label Run-In Phase|Other|7
7399197|NCT01302054|11663498|FG001|Tolterodine Open-Label Run-In Phase|Other|0
7399198|NCT01302054|11663499|FG002|Tolterodine Open-Label Run-In Phase|Other|0
7399199|NCT01302054|11663497|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
7399200|NCT01302054|11663498|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7399201|NCT01302054|11663499|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
7399202|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
7399203|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
7399204|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
7399205|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
7399206|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
7399207|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7399208|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
7399209|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
7399210|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
7399211|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7399212|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Protocol Violation|3
7399213|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Protocol Violation|6
7399214|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Adverse Event|0
7399215|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Adverse Event|10
7399216|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Adverse Event|10
7399217|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7399218|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
7399219|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
7399220|NCT01302054|11663497|FG000|Double-Blind Treatment Phase|Other|0
7399221|NCT01302054|11663498|FG001|Double-Blind Treatment Phase|Other|4
7399222|NCT01302054|11663499|FG002|Double-Blind Treatment Phase|Other|9
7399223|NCT01302067|11663511|FG000|Overall Study|Death|0
7399224|NCT01302067|11663512|FG001|Overall Study|Death|0
7399225|NCT01302067|11663513|FG002|Overall Study|Death|1
7399226|NCT01302067|11663511|FG000|Overall Study|Physician Decision|9
7399227|NCT01302067|11663512|FG001|Overall Study|Physician Decision|5
7399228|NCT01302067|11663513|FG002|Overall Study|Physician Decision|14
7399229|NCT01302067|11663511|FG000|Overall Study|Lack of Efficacy|8
7399230|NCT01302067|11663512|FG001|Overall Study|Lack of Efficacy|4
7399231|NCT01302067|11663513|FG002|Overall Study|Lack of Efficacy|2
7399232|NCT01302067|11663511|FG000|Overall Study|Lost to Follow-up|9
7399233|NCT01302067|11663512|FG001|Overall Study|Lost to Follow-up|4
7399234|NCT01302067|11663513|FG002|Overall Study|Lost to Follow-up|15
7399235|NCT01302067|11663511|FG000|Overall Study|Withdrawal by Subject|13
7399236|NCT01302067|11663512|FG001|Overall Study|Withdrawal by Subject|6
7399237|NCT01302067|11663513|FG002|Overall Study|Withdrawal by Subject|10
7399238|NCT01302067|11663511|FG000|Overall Study|Other|1
7399239|NCT01302067|11663512|FG001|Overall Study|Other|1
7399240|NCT01302067|11663513|FG002|Overall Study|Other|3
7399241|NCT01302067|11663511|FG000|Overall Study|Protocol Violation|11
7399242|NCT01302067|11663512|FG001|Overall Study|Protocol Violation|0
7399243|NCT01302067|11663513|FG002|Overall Study|Protocol Violation|8
7399244|NCT01302067|11663511|FG000|Overall Study|Adverse Event|27
7399245|NCT01302067|11663512|FG001|Overall Study|Adverse Event|14
7399246|NCT01302067|11663513|FG002|Overall Study|Adverse Event|45
7399247|NCT01302080|11663524|FG000|Overall Study|Withdrew Consent|92
7399248|NCT01302080|11663525|FG001|Overall Study|Withdrew Consent|39
7399249|NCT01302080|11663524|FG000|Overall Study|Patient/Family Moved|28
7399250|NCT01302080|11663525|FG001|Overall Study|Patient/Family Moved|3
7399251|NCT01302080|11663524|FG000|Overall Study|Lost to Follow-up|192
7399252|NCT01302080|11663525|FG001|Overall Study|Lost to Follow-up|93
7399253|NCT01302080|11663524|FG000|Overall Study|Death|1
7399254|NCT01302080|11663525|FG001|Overall Study|Death|0
7399255|NCT01302080|11663524|FG000|Overall Study|Other|52
7399256|NCT01302080|11663525|FG001|Overall Study|Other|8
7399257|NCT01302080|11663524|FG000|Overall Study|Reason Missing For Discontinuation|1
7399258|NCT01302080|11663525|FG001|Overall Study|Reason Missing For Discontinuation|0
7399259|NCT01302119|11663557|FG000|Overall Study|Withdrawal by Subject|30
7399260|NCT01302119|11663558|FG001|Overall Study|Withdrawal by Subject|20
7399261|NCT01302119|11663557|FG000|Overall Study|Lost to Follow-up|10
7399262|NCT01302119|11663558|FG001|Overall Study|Lost to Follow-up|4
7399263|NCT01302119|11663557|FG000|Overall Study|Adverse Event|2
7399264|NCT01302119|11663558|FG001|Overall Study|Adverse Event|1
7399265|NCT01302119|11663557|FG000|Overall Study|Non-compliance|4
7399266|NCT01302119|11663558|FG001|Overall Study|Non-compliance|2
7399267|NCT01302119|11663557|FG000|Overall Study|Non-specific|4
7399268|NCT01302119|11663558|FG001|Overall Study|Non-specific|1
7399269|NCT01302366|11663564|FG000|Overall Study|patient choice or noncompliance|5
7399270|NCT01302392|11663585|FG000|Overall Study|Lost to Follow-up|1
7399271|NCT01302392|11663586|FG001|Overall Study|Lost to Follow-up|0
7399272|NCT01302392|11663585|FG000|Overall Study|Withdrawal by Subject|6
7399273|NCT01302392|11663586|FG001|Overall Study|Withdrawal by Subject|1
7399274|NCT01302418|11663592|FG000|Overall Study|Protocol Violation|9
7399275|NCT01302418|11663592|FG000|Overall Study|Non-evaluable|9
7399276|NCT01302548|11663613|FG000|Overall Study|Lost to Follow-up|2
7399277|NCT01302548|11663614|FG001|Overall Study|Lost to Follow-up|1
7399278|NCT01302691|11663622|FG000|Overall Study|Adverse Event|2
7399279|NCT01302691|11663623|FG001|Overall Study|Adverse Event|0
7399280|NCT01302691|11663622|FG000|Overall Study|Death|0
7399281|NCT01302691|11663623|FG001|Overall Study|Death|1
7399282|NCT01302691|11663622|FG000|Overall Study|Lost to Follow-up|1
7399283|NCT01302691|11663623|FG001|Overall Study|Lost to Follow-up|0
7399284|NCT01302691|11663622|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
7399285|NCT01302691|11663623|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
7399286|NCT01302691|11663622|FG000|Overall Study|Physician Decision|0
7399287|NCT01302691|11663623|FG001|Overall Study|Physician Decision|1
7399288|NCT01302691|11663622|FG000|Overall Study|Protocol Violation|1
7399289|NCT01302691|11663623|FG001|Overall Study|Protocol Violation|0
7399290|NCT01302899|11663667|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
7399291|NCT01302899|11663668|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
7399292|NCT01302899|11663667|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
7399293|NCT01302899|11663668|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
7399294|NCT01302938|11663680|FG000|Overall Study|Withdrawal by Subject|1
7399295|NCT01302938|11663681|FG001|Overall Study|Withdrawal by Subject|0
7399296|NCT01302938|11663680|FG000|Overall Study|Adverse Event|1
7399297|NCT01302938|11663681|FG001|Overall Study|Adverse Event|0
7399298|NCT01302964|11663690|FG000|Overall Study|Adverse Event|1
7399299|NCT01302964|11663691|FG001|Overall Study|Adverse Event|0
7399300|NCT01303159|11663706|FG000|Overall Study|Death|16
7399301|NCT01303159|11663706|FG000|Overall Study|Study Termination|7
7399302|NCT01303172|11663712|FG000|Overall Study|Physician Decision|9
7399303|NCT01303172|11663713|FG001|Overall Study|Physician Decision|6
7399304|NCT01303172|11663712|FG000|Overall Study|Adverse Event|5
7399305|NCT01303172|11663713|FG001|Overall Study|Adverse Event|2
7399306|NCT01303172|11663712|FG000|Overall Study|Withdrawal by Subject|4
7399307|NCT01303172|11663713|FG001|Overall Study|Withdrawal by Subject|2
7399308|NCT01303172|11663712|FG000|Overall Study|Death|20
7399309|NCT01303172|11663713|FG001|Overall Study|Death|7
7399310|NCT01303172|11663712|FG000|Overall Study|Lack of Efficacy|25
7399311|NCT01303172|11663713|FG001|Overall Study|Lack of Efficacy|17
7399312|NCT01303380|11663737|FG000|Overall Study|Lack of compliance to study procedures|1
7399313|NCT01303419|11663750|FG000|Overall Study|Discontinuation of study|60
7399314|NCT01303419|11663750|FG000|Overall Study|Did not complete both imaging methods|5
7471135|NCT01939366|11773861|FG003|Overall Study|Adverse Event|8
7471136|NCT01939366|11773862|FG004|Overall Study|Adverse Event|5
7471137|NCT01939366|11773858|FG000|Overall Study|Lack of Efficacy|2
7471138|NCT01939366|11773859|FG001|Overall Study|Lack of Efficacy|1
7471139|NCT01939366|11773860|FG002|Overall Study|Lack of Efficacy|1
7471140|NCT01939366|11773861|FG003|Overall Study|Lack of Efficacy|1
7471141|NCT01939366|11773862|FG004|Overall Study|Lack of Efficacy|3
7471142|NCT01939366|11773858|FG000|Overall Study|Lost to Follow-up|1
7471143|NCT01939366|11773859|FG001|Overall Study|Lost to Follow-up|1
7471144|NCT01939366|11773860|FG002|Overall Study|Lost to Follow-up|0
7471145|NCT01939366|11773861|FG003|Overall Study|Lost to Follow-up|0
7471146|NCT01939366|11773862|FG004|Overall Study|Lost to Follow-up|0
7471147|NCT01939366|11773858|FG000|Overall Study|Withdrawal by Subject|1
7471148|NCT01939366|11773859|FG001|Overall Study|Withdrawal by Subject|0
7471149|NCT01939366|11773860|FG002|Overall Study|Withdrawal by Subject|2
7471150|NCT01939366|11773861|FG003|Overall Study|Withdrawal by Subject|2
7399315|NCT01303419|11663750|FG000|Overall Study|Did not meet all I/E after screening|31
7399316|NCT01303445|11663754|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
7399317|NCT01303445|11663755|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
7399318|NCT01303445|11663754|FG000|Second Intervention (7 Days)|Adverse Event|0
7399319|NCT01303445|11663755|FG001|Second Intervention (7 Days)|Adverse Event|2
7399320|NCT01303445|11663754|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
7471151|NCT01939366|11773862|FG004|Overall Study|Withdrawal by Subject|3
7471152|NCT01939366|11773858|FG000|Overall Study|Inclusion criteria not met|0
7471153|NCT01939366|11773859|FG001|Overall Study|Inclusion criteria not met|1
7471154|NCT01939366|11773860|FG002|Overall Study|Inclusion criteria not met|1
7399321|NCT01303445|11663755|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
7399322|NCT01303445|11663754|FG000|Washout (14 Days)|Protocol Violation|1
7399323|NCT01303445|11663755|FG001|Washout (14 Days)|Protocol Violation|0
7399324|NCT01303445|11663754|FG000|Washout (14 Days)|Lost to Follow-up|0
7399325|NCT01303445|11663755|FG001|Washout (14 Days)|Lost to Follow-up|2
7399326|NCT01303445|11663754|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
7399327|NCT01303445|11663755|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
7399328|NCT01303445|11663754|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
7399329|NCT01303445|11663755|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
7399330|NCT01303510|11663767|FG000|Overall Study|Lost to Follow-up|1
7399331|NCT01303510|11663768|FG001|Overall Study|Lost to Follow-up|0
7399332|NCT01303627|11663776|FG000|Overall Study|the failure while performing URS|0
7399333|NCT01303627|11663777|FG001|Overall Study|the failure while performing URS|1
7399334|NCT01303861|11663814|FG000|Overall Study|Lost to Follow-up|34
7399335|NCT01303861|11663815|FG001|Overall Study|Lost to Follow-up|14
7399336|NCT01303861|11663816|FG002|Overall Study|Lost to Follow-up|27
7399337|NCT01303861|11663817|FG003|Overall Study|Lost to Follow-up|31
7399338|NCT01303861|11663814|FG000|Overall Study|Lack of Efficacy|3
7399339|NCT01303861|11663815|FG001|Overall Study|Lack of Efficacy|2
7399340|NCT01303861|11663816|FG002|Overall Study|Lack of Efficacy|1
7399341|NCT01303861|11663817|FG003|Overall Study|Lack of Efficacy|0
7399342|NCT01303861|11663814|FG000|Overall Study|Withdrawal by Subject|16
7399343|NCT01303861|11663815|FG001|Overall Study|Withdrawal by Subject|8
7399344|NCT01303861|11663816|FG002|Overall Study|Withdrawal by Subject|8
7399345|NCT01303861|11663817|FG003|Overall Study|Withdrawal by Subject|23
7399346|NCT01303861|11663814|FG000|Overall Study|Adverse Event|4
7399347|NCT01303861|11663815|FG001|Overall Study|Adverse Event|1
7399348|NCT01303861|11663816|FG002|Overall Study|Adverse Event|0
7399349|NCT01303861|11663817|FG003|Overall Study|Adverse Event|5
7399350|NCT01303861|11663814|FG000|Overall Study|Pregnancy|1
7399351|NCT01303861|11663815|FG001|Overall Study|Pregnancy|0
7399352|NCT01303861|11663816|FG002|Overall Study|Pregnancy|0
7399353|NCT01303861|11663817|FG003|Overall Study|Pregnancy|0
7399354|NCT01303965|11663841|FG000|Overall Study|Adverse Event|1
7399355|NCT01303965|11663842|FG001|Overall Study|Adverse Event|1
7399356|NCT01303965|11663841|FG000|Overall Study|Death|0
7399357|NCT01303965|11663842|FG001|Overall Study|Death|3
7399358|NCT01303965|11663841|FG000|Overall Study|Withdrawal by Subject|1
7399359|NCT01303965|11663842|FG001|Overall Study|Withdrawal by Subject|0
7399360|NCT01303965|11663841|FG000|Overall Study|Disease Progression|1
7399361|NCT01303965|11663842|FG001|Overall Study|Disease Progression|6
7399362|NCT01304147|11663860|FG000|Second Intervention (7days)|Withdrawal by Subject|1
7399363|NCT01304147|11663861|FG001|Second Intervention (7days)|Withdrawal by Subject|1
7399364|NCT01304329|11663915|FG000|Third Intervention (3 Days)|Adverse Event|0
7399365|NCT01304329|11663916|FG001|Third Intervention (3 Days)|Adverse Event|1
7399366|NCT01304329|11663917|FG002|Third Intervention (3 Days)|Adverse Event|0
7399367|NCT01304329|11663918|FG003|Third Intervention (3 Days)|Adverse Event|0
7399368|NCT01304329|11663919|FG004|Third Intervention (3 Days)|Adverse Event|0
7399369|NCT01304329|11663920|FG005|Third Intervention (3 Days)|Adverse Event|0
7399370|NCT01304498|11663934|FG000|Overall Study|Adverse Event|1
7399371|NCT01304498|11663935|FG001|Overall Study|Adverse Event|1
7399372|NCT01304498|11663934|FG000|Overall Study|Withdrawal by Subject|2
7399373|NCT01304498|11663935|FG001|Overall Study|Withdrawal by Subject|3
7399374|NCT01304498|11663934|FG000|Overall Study|Protocol Violation|1
7399375|NCT01304498|11663935|FG001|Overall Study|Protocol Violation|0
7399376|NCT01304498|11663934|FG000|Overall Study|Lost to Follow-up|2
7399377|NCT01304498|11663935|FG001|Overall Study|Lost to Follow-up|1
7399378|NCT01304693|11663960|FG000|Overall Study|Adverse Event|0
7399379|NCT01304693|11663961|FG001|Overall Study|Adverse Event|0
7399380|NCT01304693|11663962|FG002|Overall Study|Adverse Event|0
7399381|NCT01304693|11663963|FG003|Overall Study|Adverse Event|0
7399382|NCT01304693|11663964|FG004|Overall Study|Adverse Event|1
7399383|NCT01304693|11663960|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
7399384|NCT01304693|11663961|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
7399385|NCT01304693|11663962|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
7399386|NCT01304693|11663963|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
7399387|NCT01304693|11663964|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
7399388|NCT01304706|11663976|FG000|Overall Study|Adverse Event|2
7399389|NCT01304706|11663976|FG000|Overall Study|Lack of Efficacy|1
7399390|NCT01304706|11663976|FG000|Overall Study|Death|3
7399391|NCT01304706|11663976|FG000|Overall Study|Withdrawal by Subject|3
7399392|NCT01304706|11663976|FG000|Overall Study|Lost to Follow-up|7
7399393|NCT01304706|11663976|FG000|Overall Study|Discontinued due to failed drug admin.|1
7399394|NCT01304940|11663982|FG000|Overall Study|not meet symptom severity requirement|3
7399395|NCT01304940|11663983|FG001|Overall Study|not meet symptom severity requirement|0
7399396|NCT01305044|11663997|FG000|Overall Study|Withdrawal by Subject|3
7399397|NCT01305044|11663998|FG001|Overall Study|Withdrawal by Subject|6
7399398|NCT01305200|11664007|FG000|Overall Study|Physician Decision|4
7399399|NCT01305200|11664008|FG001|Overall Study|Physician Decision|6
7399400|NCT01305200|11664009|FG002|Overall Study|Physician Decision|1
7399401|NCT01305200|11664007|FG000|Overall Study|Withdrawal by Subject|24
7399402|NCT01305200|11664008|FG001|Overall Study|Withdrawal by Subject|21
7399403|NCT01305200|11664009|FG002|Overall Study|Withdrawal by Subject|1
7399404|NCT01305200|11664007|FG000|Overall Study|Ineligible|1
7399405|NCT01305200|11664008|FG001|Overall Study|Ineligible|2
7399406|NCT01305200|11664009|FG002|Overall Study|Ineligible|1
7399407|NCT01305200|11664007|FG000|Overall Study|Death|0
7399408|NCT01305200|11664008|FG001|Overall Study|Death|2
7399409|NCT01305200|11664009|FG002|Overall Study|Death|0
7399410|NCT01305239|11664027|FG000|Overall Study|Adverse Event|22
7399411|NCT01305239|11664027|FG000|Overall Study|Exemestane taken prior to inclusion only|1
7465501|NCT01296711|11764682|FG003|Overall Study|Failure to comply with visits|0
7465502|NCT01296711|11764683|FG004|Overall Study|Failure to comply with visits|0
7465503|NCT01296711|11764684|FG005|Overall Study|Failure to comply with visits|0
7465504|NCT01296711|11764685|FG006|Overall Study|Failure to comply with visits|0
7465505|NCT01296711|11764686|FG007|Overall Study|Failure to comply with visits|1
7465506|NCT01296711|11764679|FG000|Overall Study|Patient decision due to transport|0
7465507|NCT01296711|11764680|FG001|Overall Study|Patient decision due to transport|0
7465508|NCT01296711|11764681|FG002|Overall Study|Patient decision due to transport|0
7465509|NCT01296711|11764682|FG003|Overall Study|Patient decision due to transport|0
7465510|NCT01296711|11764683|FG004|Overall Study|Patient decision due to transport|0
7465511|NCT01296711|11764684|FG005|Overall Study|Patient decision due to transport|0
7465512|NCT01296711|11764685|FG006|Overall Study|Patient decision due to transport|0
7465513|NCT01296711|11764686|FG007|Overall Study|Patient decision due to transport|1
7465514|NCT00084656|11764707|FG000|Overall Study|Other reasons|0
7465515|NCT00084656|11764708|FG001|Overall Study|Other reasons|12
7465516|NCT00084656|11764709|FG002|Overall Study|Other reasons|11
7465517|NCT00084656|11764707|FG000|Overall Study|Withdrawal by Subject|15
7465518|NCT00084656|11764708|FG001|Overall Study|Withdrawal by Subject|4
7465519|NCT00084656|11764709|FG002|Overall Study|Withdrawal by Subject|4
7465520|NCT00084656|11764707|FG000|Overall Study|Disease relapse|0
7465521|NCT00084656|11764708|FG001|Overall Study|Disease relapse|9
7465522|NCT00084656|11764709|FG002|Overall Study|Disease relapse|10
7465523|NCT00084656|11764707|FG000|Overall Study|Disease progression|9
7465524|NCT00084656|11764708|FG001|Overall Study|Disease progression|0
7465525|NCT00084656|11764709|FG002|Overall Study|Disease progression|0
7465526|NCT00084656|11764707|FG000|Overall Study|Lost to Follow-up|1
7465527|NCT00084656|11764708|FG001|Overall Study|Lost to Follow-up|0
7465528|NCT00084656|11764709|FG002|Overall Study|Lost to Follow-up|1
7465529|NCT01879852|11764748|FG000|Overall Study|Withdrawal by Subject|2
7465530|NCT01879852|11764749|FG001|Overall Study|Withdrawal by Subject|0
7465531|NCT01880086|11764785|FG000|Overall Study|Lost to Follow-up|1
7465532|NCT01880086|11764786|FG001|Overall Study|Lost to Follow-up|1
7465533|NCT01880424|11764820|FG000|Overall Study|Adverse Event|7
7465534|NCT01880424|11764821|FG001|Overall Study|Adverse Event|6
7465535|NCT01880424|11764820|FG000|Overall Study|Lack of Efficacy|1
7465536|NCT01880424|11764821|FG001|Overall Study|Lack of Efficacy|4
7465537|NCT01880424|11764820|FG000|Overall Study|Lost to Follow-up|3
7465538|NCT01880424|11764821|FG001|Overall Study|Lost to Follow-up|2
7465539|NCT01880424|11764820|FG000|Overall Study|Protocol Violation|11
7465540|NCT01880424|11764821|FG001|Overall Study|Protocol Violation|13
7465541|NCT01880424|11764820|FG000|Overall Study|Withdrawal by Subject|10
7465542|NCT01880424|11764821|FG001|Overall Study|Withdrawal by Subject|30
7465543|NCT01880424|11764820|FG000|Overall Study|Other|1
7465544|NCT01880424|11764821|FG001|Overall Study|Other|0
7465545|NCT01880437|11764830|FG000|Overall Study|Death|12
7465546|NCT01880437|11764831|FG001|Overall Study|Death|4
7465547|NCT01880437|11764832|FG002|Overall Study|Death|17
7465548|NCT01880437|11764830|FG000|Overall Study|Study terminated by Sponsor|3
7465549|NCT01880437|11764831|FG001|Overall Study|Study terminated by Sponsor|0
7465550|NCT01880437|11764832|FG002|Overall Study|Study terminated by Sponsor|2
7465551|NCT01880515|11764844|FG000|Overall Study|Lost to Follow-up|3
7465552|NCT01880515|11764845|FG001|Overall Study|Lost to Follow-up|2
7465553|NCT01880515|11764844|FG000|Overall Study|Disease Progression|5
7465554|NCT01880515|11764845|FG001|Overall Study|Disease Progression|7
7465555|NCT01880528|11764854|FG000|Overall Study|Other|1
7465556|NCT01880528|11764855|FG001|Overall Study|Other|1
7465557|NCT01880554|11764861|FG000|Overall Study|Protocol Violation|14
7465558|NCT01880554|11764861|FG000|Overall Study|Simon's design requirements|2
7465559|NCT01880593|11764868|FG000|Overall Study|Adverse Event|1
7465560|NCT01880593|11764869|FG001|Overall Study|Adverse Event|0
7465561|NCT01880593|11764868|FG000|Overall Study|Lack of Efficacy|1
7465562|NCT01880593|11764869|FG001|Overall Study|Lack of Efficacy|5
7465563|NCT01880593|11764868|FG000|Overall Study|Withdrawal by Subject|6
7465564|NCT01880593|11764869|FG001|Overall Study|Withdrawal by Subject|1
7465565|NCT01880736|11764897|FG000|Overall Study|Adverse Event|0
7465566|NCT01880736|11764898|FG001|Overall Study|Adverse Event|0
7465567|NCT01880736|11764899|FG002|Overall Study|Adverse Event|0
7465568|NCT01880736|11764900|FG003|Overall Study|Adverse Event|1
7465569|NCT01880736|11764897|FG000|Overall Study|Withdrawal Criteria|1
7465570|NCT01880736|11764898|FG001|Overall Study|Withdrawal Criteria|2
7465571|NCT01880736|11764899|FG002|Overall Study|Withdrawal Criteria|1
7465572|NCT01880736|11764900|FG003|Overall Study|Withdrawal Criteria|5
7465573|NCT01881009|11764921|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
7465574|NCT01881009|11764922|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
7465575|NCT01881126|11764953|FG000|Overall Study|Non-compliance|1
7465576|NCT01881126|11764954|FG001|Overall Study|Non-compliance|1
7399412|NCT01305408|11664064|FG000|Overall Study|Adverse Event|10
7399413|NCT01305408|11664065|FG001|Overall Study|Adverse Event|7
7399414|NCT01305408|11664064|FG000|Overall Study|Lack of Efficacy|3
7399415|NCT01305408|11664065|FG001|Overall Study|Lack of Efficacy|4
7399416|NCT01305408|11664064|FG000|Overall Study|Withdrawal by Subject|9
7399417|NCT01305408|11664065|FG001|Overall Study|Withdrawal by Subject|9
7399418|NCT01305408|11664064|FG000|Overall Study|Protocol Violation|4
7399419|NCT01305408|11664065|FG001|Overall Study|Protocol Violation|6
7399420|NCT01305408|11664064|FG000|Overall Study|Lost to Follow-up|5
7399421|NCT01305408|11664065|FG001|Overall Study|Lost to Follow-up|3
7399422|NCT01305408|11664064|FG000|Overall Study|Noncompliance with study medication|0
7399423|NCT01305408|11664065|FG001|Overall Study|Noncompliance with study medication|1
7399424|NCT01305408|11664064|FG000|Overall Study|Noncompliance with study procedures|0
7399425|NCT01305408|11664065|FG001|Overall Study|Noncompliance with study procedures|1
7399426|NCT01305408|11664064|FG000|Overall Study|Other|1
7399427|NCT01305408|11664065|FG001|Overall Study|Other|0
7399428|NCT01305564|11664075|FG000|Overall Study|Death|21
7399429|NCT01305564|11664075|FG000|Overall Study|Lost to Follow-up|12
7399430|NCT01305564|11664075|FG000|Overall Study|Withdrawal by Subject|1
7399431|NCT01305564|11664075|FG000|Overall Study|Physician Decision|3
7399432|NCT01305577|11664093|FG000|Overall Study|Adverse Event|2
7399433|NCT01305577|11664094|FG001|Overall Study|Adverse Event|2
7399434|NCT01305577|11664095|FG002|Overall Study|Adverse Event|1
7399435|NCT01305577|11664093|FG000|Overall Study|Withdrawal by Subject|7
7399436|NCT01305577|11664094|FG001|Overall Study|Withdrawal by Subject|5
7399437|NCT01305577|11664095|FG002|Overall Study|Withdrawal by Subject|6
7399438|NCT01305577|11664093|FG000|Overall Study|Lost to Follow-up|4
7399439|NCT01305577|11664094|FG001|Overall Study|Lost to Follow-up|3
7399440|NCT01305577|11664095|FG002|Overall Study|Lost to Follow-up|2
7399441|NCT01305577|11664093|FG000|Overall Study|Protocol Deviation|0
7399442|NCT01305577|11664094|FG001|Overall Study|Protocol Deviation|1
7399443|NCT01305577|11664095|FG002|Overall Study|Protocol Deviation|1
7399444|NCT01305941|11664126|FG000|Overall Study|Adverse Event|6
7399445|NCT01305941|11664126|FG000|Overall Study|Clinical decline|2
7399446|NCT01305941|11664126|FG000|Overall Study|Withdrawal by Subject|1
7399447|NCT01305941|11664126|FG000|Overall Study|Death|1
7399448|NCT01306032|11664136|FG000|First Intervention|Adverse Event|1
7399449|NCT01306032|11664137|FG001|First Intervention|Adverse Event|0
7399450|NCT01306032|11664138|FG002|First Intervention|Adverse Event|1
7399451|NCT01306032|11664139|FG003|First Intervention|Adverse Event|0
7399452|NCT01306032|11664140|FG004|First Intervention|Adverse Event|0
7399453|NCT01306032|11664141|FG005|First Intervention|Adverse Event|1
7399454|NCT01306032|11664136|FG000|First Intervention|Withdrawal by Subject|0
7399455|NCT01306032|11664137|FG001|First Intervention|Withdrawal by Subject|2
7399456|NCT01306032|11664138|FG002|First Intervention|Withdrawal by Subject|0
7399457|NCT01306032|11664139|FG003|First Intervention|Withdrawal by Subject|1
7399458|NCT01306032|11664140|FG004|First Intervention|Withdrawal by Subject|0
7399459|NCT01306032|11664141|FG005|First Intervention|Withdrawal by Subject|0
7399460|NCT01306032|11664136|FG000|First Intervention|Death|0
7399461|NCT01306032|11664137|FG001|First Intervention|Death|0
7399462|NCT01306032|11664138|FG002|First Intervention|Death|1
7399463|NCT01306032|11664139|FG003|First Intervention|Death|0
7399464|NCT01306032|11664140|FG004|First Intervention|Death|0
7399465|NCT01306032|11664141|FG005|First Intervention|Death|0
7399466|NCT01306032|11664136|FG000|First Intervention|Ineligible|0
7399467|NCT01306032|11664137|FG001|First Intervention|Ineligible|0
7399468|NCT01306032|11664138|FG002|First Intervention|Ineligible|0
7399469|NCT01306032|11664139|FG003|First Intervention|Ineligible|0
7399470|NCT01306032|11664140|FG004|First Intervention|Ineligible|0
7399471|NCT01306032|11664141|FG005|First Intervention|Ineligible|1
7399472|NCT01306032|11664136|FG000|First Intervention|Progressive disease|0
7399473|NCT01306032|11664137|FG001|First Intervention|Progressive disease|0
7399474|NCT01306032|11664138|FG002|First Intervention|Progressive disease|0
7399475|NCT01306032|11664139|FG003|First Intervention|Progressive disease|0
7399476|NCT01306032|11664140|FG004|First Intervention|Progressive disease|2
7399477|NCT01306032|11664141|FG005|First Intervention|Progressive disease|0
7399478|NCT01306032|11664136|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
7399479|NCT01306032|11664137|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
7399480|NCT01306032|11664138|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
7399481|NCT01306032|11664139|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
7399482|NCT01306032|11664140|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
7399483|NCT01306032|11664141|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
7399484|NCT01306032|11664136|FG000|Disease Progression/Crossover|other/symptomatic progression|0
7399485|NCT01306032|11664137|FG001|Disease Progression/Crossover|other/symptomatic progression|2
7399486|NCT01306032|11664138|FG002|Disease Progression/Crossover|other/symptomatic progression|0
7399487|NCT01306032|11664139|FG003|Disease Progression/Crossover|other/symptomatic progression|2
7399488|NCT01306032|11664140|FG004|Disease Progression/Crossover|other/symptomatic progression|0
7399489|NCT01306032|11664141|FG005|Disease Progression/Crossover|other/symptomatic progression|0
7399490|NCT01306058|11664167|FG000|Overall Study|Death|1
7399491|NCT01306058|11664167|FG000|Overall Study|Enrolled but did not get treatment|1
7399492|NCT01306162|11664175|FG000|Period 1|Adverse Event|0
7399493|NCT01306162|11664176|FG001|Period 1|Adverse Event|0
7399494|NCT01306162|11664177|FG002|Period 1|Adverse Event|0
7399495|NCT01306162|11664178|FG003|Period 1|Adverse Event|1
7399496|NCT01306162|11664175|FG000|Washout 1|Non-compliance to protocol|0
7399497|NCT01306162|11664176|FG001|Washout 1|Non-compliance to protocol|1
7399498|NCT01306162|11664177|FG002|Washout 1|Non-compliance to protocol|0
7399499|NCT01306162|11664178|FG003|Washout 1|Non-compliance to protocol|0
7399500|NCT01306201|11664197|FG000|Overall Study|Arrhythmia|4
7399501|NCT01306201|11664197|FG000|Overall Study|Files could not be processed|3
7399502|NCT01306201|11664197|FG000|Overall Study|Files unreadable|3
7399503|NCT01306214|11664208|FG000|Overall Study|Death|0
7399504|NCT01306214|11664209|FG001|Overall Study|Death|0
7399505|NCT01306214|11664210|FG002|Overall Study|Death|1
7399506|NCT01306214|11664208|FG000|Overall Study|Lost to Follow-up|3
7399507|NCT01306214|11664209|FG001|Overall Study|Lost to Follow-up|5
7399508|NCT01306214|11664210|FG002|Overall Study|Lost to Follow-up|4
7399509|NCT01306214|11664208|FG000|Overall Study|Withdrawal by Subject|24
7399510|NCT01306214|11664209|FG001|Overall Study|Withdrawal by Subject|22
7399511|NCT01306214|11664210|FG002|Overall Study|Withdrawal by Subject|16
7399512|NCT01306214|11664208|FG000|Overall Study|Not treated|1
7399513|NCT01306214|11664209|FG001|Overall Study|Not treated|1
7399514|NCT01306214|11664210|FG002|Overall Study|Not treated|1
7399515|NCT01306253|11664220|FG000|Overall Study|Lost to Follow-up|1
7399516|NCT01306253|11664221|FG001|Overall Study|Lost to Follow-up|1
7399517|NCT01306305|11664242|FG000|Overall Study|Lost to Follow-up|1
7399518|NCT01306305|11664243|FG001|Overall Study|Lost to Follow-up|0
7399519|NCT01306305|11664242|FG000|Overall Study|Withdrew consent|1
7399520|NCT01306305|11664243|FG001|Overall Study|Withdrew consent|0
7553085|NCT03005106|11913823|FG000|Overall Study|Adverse Event|1
7553086|NCT03005106|11913823|FG000|Overall Study|Physician Decision|1
7553087|NCT03005106|11913823|FG000|Overall Study|Death|2
7553088|NCT03005288|11913829|FG000|Overall Study|Withdrawal by Subject|7
7553089|NCT03005288|11913830|FG001|Overall Study|Withdrawal by Subject|5
7553090|NCT03005288|11913829|FG000|Overall Study|Lost to Follow-up|0
7553091|NCT03005288|11913830|FG001|Overall Study|Lost to Follow-up|1
7553092|NCT03005288|11913829|FG000|Overall Study|Adverse Event|5
7553093|NCT03005288|11913830|FG001|Overall Study|Adverse Event|0
7553094|NCT03005288|11913829|FG000|Overall Study|Protocol deviation|0
7553095|NCT03005288|11913830|FG001|Overall Study|Protocol deviation|1
7553096|NCT03005288|11913829|FG000|Overall Study|Physician Decision|0
7553097|NCT03005288|11913830|FG001|Overall Study|Physician Decision|1
7553098|NCT03006341|11913840|FG000|Overall Study|Not linked in the EMR|25069
7553099|NCT03006341|11913841|FG001|Overall Study|Not linked in the EMR|67505
7553100|NCT03006341|11913842|FG002|Overall Study|Not linked in the EMR|30993
7553101|NCT03006341|11913843|FG003|Overall Study|Not linked in the EMR|10685
7553102|NCT03006393|11913853|FG000|Overall Study|Withdrawal by Subject|1
7399539|NCT01306617|11664261|FG000|Overall Study|Adverse Event|1
7399540|NCT01306617|11664262|FG001|Overall Study|Adverse Event|0
7399541|NCT01306617|11664263|FG002|Overall Study|Adverse Event|0
7399542|NCT01306617|11664261|FG000|Overall Study|Virologic Failure|0
7399543|NCT01306617|11664262|FG001|Overall Study|Virologic Failure|0
7399544|NCT01306617|11664263|FG002|Overall Study|Virologic Failure|5
7399545|NCT01306617|11664261|FG000|Overall Study|Non-compliance|0
7399546|NCT01306617|11664262|FG001|Overall Study|Non-compliance|1
7399547|NCT01306617|11664263|FG002|Overall Study|Non-compliance|0
7399548|NCT01306643|11664271|FG000|Overall Study|Adverse Event|5
7399549|NCT01306643|11664271|FG000|Overall Study|Disease Progression|7
7399550|NCT01306643|11664271|FG000|Overall Study|Other: Change in Eligibility Status|1
7399551|NCT01306656|11664277|FG000|Overall Study|Lost to Follow-up|1
7399552|NCT01306656|11664278|FG001|Overall Study|Lost to Follow-up|0
7399553|NCT01306877|11664288|FG000|Overall Study|Lost to Follow-up|3
7399554|NCT01306877|11664289|FG001|Overall Study|Lost to Follow-up|3
7399555|NCT01306877|11664288|FG000|Overall Study|Physician Decision|0
7399556|NCT01306877|11664289|FG001|Overall Study|Physician Decision|1
7399557|NCT01306890|11664295|FG000|Overall Study|Adverse Event|2
7399558|NCT01306890|11664295|FG000|Overall Study|Death|1223
7399559|NCT01306890|11664295|FG000|Overall Study|Lost to Follow-up|58
7399560|NCT01306890|11664295|FG000|Overall Study|Withdrawal by Subject|88
7399561|NCT01306890|11664295|FG000|Overall Study|Unspecified reasons|104
7399562|NCT01306890|11664295|FG000|Overall Study|Study Termination|3
7399563|NCT01306890|11664295|FG000|Overall Study|No discontinuation documentation|41
7399564|NCT01306942|11664302|FG000|Phase I|Adverse Event|2
7399565|NCT01306942|11664303|FG001|Phase I|Adverse Event|2
7399566|NCT01306942|11664304|FG002|Phase I|Adverse Event|0
7399567|NCT01306942|11664305|FG003|Phase I|Adverse Event|0
7399568|NCT01306942|11664302|FG000|Phase I|Physician Decision|3
7399569|NCT01306942|11664303|FG001|Phase I|Physician Decision|1
7399570|NCT01306942|11664304|FG002|Phase I|Physician Decision|0
7399571|NCT01306942|11664305|FG003|Phase I|Physician Decision|0
7399572|NCT01306942|11664302|FG000|Phase II|Adverse Event|0
7399573|NCT01306942|11664303|FG001|Phase II|Adverse Event|0
7399574|NCT01306942|11664304|FG002|Phase II|Adverse Event|0
7399575|NCT01306942|11664305|FG003|Phase II|Adverse Event|6
7399576|NCT01306942|11664302|FG000|Phase II|Physician Decision|2
7399577|NCT01306942|11664303|FG001|Phase II|Physician Decision|0
7399578|NCT01306942|11664304|FG002|Phase II|Physician Decision|0
7399579|NCT01306942|11664305|FG003|Phase II|Physician Decision|5
7399580|NCT01306942|11664302|FG000|Phase II|Withdrawal by Subject|0
7399581|NCT01306942|11664303|FG001|Phase II|Withdrawal by Subject|0
7399582|NCT01306942|11664304|FG002|Phase II|Withdrawal by Subject|0
7399583|NCT01306942|11664305|FG003|Phase II|Withdrawal by Subject|2
7399584|NCT01306942|11664302|FG000|Phase II|Death|0
7399585|NCT01306942|11664303|FG001|Phase II|Death|0
7399586|NCT01306942|11664304|FG002|Phase II|Death|0
7399587|NCT01306942|11664305|FG003|Phase II|Death|1
7399588|NCT01306942|11664302|FG000|Phase II|Not finished treatment|0
7399589|NCT01306942|11664303|FG001|Phase II|Not finished treatment|0
7399590|NCT01306942|11664304|FG002|Phase II|Not finished treatment|0
7399591|NCT01306942|11664305|FG003|Phase II|Not finished treatment|1
7399592|NCT01306942|11664302|FG000|Phase II|Protocol Violation|0
7399593|NCT01306942|11664303|FG001|Phase II|Protocol Violation|0
7399594|NCT01306942|11664304|FG002|Phase II|Protocol Violation|0
7399595|NCT01306942|11664305|FG003|Phase II|Protocol Violation|1
7399596|NCT01306968|11664321|FG000|Overall Study|Lost to Follow-up|1
7399597|NCT01306968|11664322|FG001|Overall Study|Lost to Follow-up|1
7399598|NCT01306968|11664323|FG002|Overall Study|Lost to Follow-up|0
7399599|NCT01306968|11664324|FG003|Overall Study|Lost to Follow-up|0
7399600|NCT01306968|11664321|FG000|Overall Study|Physician Decision|0
7399601|NCT01306968|11664322|FG001|Overall Study|Physician Decision|1
7399602|NCT01306968|11664323|FG002|Overall Study|Physician Decision|0
7399603|NCT01306968|11664324|FG003|Overall Study|Physician Decision|0
7399604|NCT01306968|11664321|FG000|Overall Study|Relocated and left active duty|0
7399605|NCT01306968|11664322|FG001|Overall Study|Relocated and left active duty|1
7399606|NCT01306968|11664323|FG002|Overall Study|Relocated and left active duty|1
7399607|NCT01306968|11664324|FG003|Overall Study|Relocated and left active duty|1
7399608|NCT01306968|11664321|FG000|Overall Study|Withdrew - time commitment|0
7399609|NCT01306968|11664322|FG001|Overall Study|Withdrew - time commitment|0
7399610|NCT01306968|11664323|FG002|Overall Study|Withdrew - time commitment|0
7399611|NCT01306968|11664324|FG003|Overall Study|Withdrew - time commitment|2
7399612|NCT01306968|11664321|FG000|Overall Study|Withdrew over privacy concerns|0
7399613|NCT01306968|11664322|FG001|Overall Study|Withdrew over privacy concerns|0
7399614|NCT01306968|11664323|FG002|Overall Study|Withdrew over privacy concerns|0
7399615|NCT01306968|11664324|FG003|Overall Study|Withdrew over privacy concerns|1
7399616|NCT01307020|11664355|FG000|Overall Study|Lost to Follow-up|0
7399617|NCT01307020|11664356|FG001|Overall Study|Lost to Follow-up|0
7399618|NCT01307020|11664357|FG002|Overall Study|Lost to Follow-up|1
7399619|NCT01307020|11664358|FG003|Overall Study|Lost to Follow-up|1
7399620|NCT01307020|11664359|FG004|Overall Study|Lost to Follow-up|0
7399621|NCT01307020|11664360|FG005|Overall Study|Lost to Follow-up|0
7399622|NCT01307020|11664361|FG006|Overall Study|Lost to Follow-up|1
7399623|NCT01307020|11664362|FG007|Overall Study|Lost to Follow-up|0
7399624|NCT01307020|11664363|FG008|Overall Study|Lost to Follow-up|0
7399625|NCT01307020|11664364|FG009|Overall Study|Lost to Follow-up|0
7399626|NCT01307020|11664355|FG000|Overall Study|Electronic data capture failure|0
7399627|NCT01307020|11664356|FG001|Overall Study|Electronic data capture failure|1
7399628|NCT01307020|11664357|FG002|Overall Study|Electronic data capture failure|0
7399629|NCT01307020|11664358|FG003|Overall Study|Electronic data capture failure|0
7399630|NCT01307020|11664359|FG004|Overall Study|Electronic data capture failure|0
7399631|NCT01307020|11664360|FG005|Overall Study|Electronic data capture failure|0
7399632|NCT01307020|11664361|FG006|Overall Study|Electronic data capture failure|0
7399633|NCT01307020|11664362|FG007|Overall Study|Electronic data capture failure|0
7399634|NCT01307020|11664363|FG008|Overall Study|Electronic data capture failure|0
7399635|NCT01307020|11664364|FG009|Overall Study|Electronic data capture failure|0
7399636|NCT01307111|11664402|FG000|IUD Insertion|Lost to Follow-up|2
7399637|NCT01307111|11664403|FG001|IUD Insertion|Lost to Follow-up|0
7399638|NCT01307111|11664402|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
7399639|NCT01307111|11664403|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
7399640|NCT01307267|11664432|FG000|Overall Study|Death|4
7399641|NCT01307267|11664433|FG001|Overall Study|Death|3
7399642|NCT01307267|11664434|FG002|Overall Study|Death|5
7399643|NCT01307267|11664435|FG003|Overall Study|Death|3
7399644|NCT01307267|11664436|FG004|Overall Study|Death|1
7399645|NCT01307267|11664437|FG005|Overall Study|Death|26
7399646|NCT01307267|11664438|FG006|Overall Study|Death|2
7399647|NCT01307267|11664439|FG007|Overall Study|Death|2
7399648|NCT01307267|11664440|FG008|Overall Study|Death|21
7399649|NCT01307267|11664441|FG009|Overall Study|Death|2
7399650|NCT01307267|11664442|FG010|Overall Study|Death|3
7399651|NCT01307267|11664443|FG011|Overall Study|Death|9
7399652|NCT01307267|11664444|FG012|Overall Study|Death|0
7399653|NCT01307267|11664445|FG013|Overall Study|Death|0
7399654|NCT01307267|11664446|FG014|Overall Study|Death|0
7399655|NCT01307267|11664447|FG015|Overall Study|Death|0
7399656|NCT01307267|11664448|FG016|Overall Study|Death|1
7399657|NCT01307267|11664449|FG017|Overall Study|Death|1
7399658|NCT01307267|11664450|FG018|Overall Study|Death|2
7399659|NCT01307267|11664451|FG019|Overall Study|Death|8
7399660|NCT01307267|11664452|FG020|Overall Study|Death|1
7399661|NCT01307267|11664453|FG021|Overall Study|Death|2
7399662|NCT01307267|11664454|FG022|Overall Study|Death|2
7399663|NCT01307267|11664432|FG000|Overall Study|Lost to Follow-up|0
7399664|NCT01307267|11664433|FG001|Overall Study|Lost to Follow-up|0
7399665|NCT01307267|11664434|FG002|Overall Study|Lost to Follow-up|0
7399666|NCT01307267|11664435|FG003|Overall Study|Lost to Follow-up|0
7399667|NCT01307267|11664436|FG004|Overall Study|Lost to Follow-up|0
7399668|NCT01307267|11664437|FG005|Overall Study|Lost to Follow-up|7
7399669|NCT01307267|11664438|FG006|Overall Study|Lost to Follow-up|0
7399670|NCT01307267|11664439|FG007|Overall Study|Lost to Follow-up|0
7399671|NCT01307267|11664440|FG008|Overall Study|Lost to Follow-up|1
7399672|NCT01307267|11664441|FG009|Overall Study|Lost to Follow-up|2
7399673|NCT01307267|11664442|FG010|Overall Study|Lost to Follow-up|1
7399674|NCT01307267|11664443|FG011|Overall Study|Lost to Follow-up|0
7399675|NCT01307267|11664444|FG012|Overall Study|Lost to Follow-up|0
7399676|NCT01307267|11664445|FG013|Overall Study|Lost to Follow-up|0
7399677|NCT01307267|11664446|FG014|Overall Study|Lost to Follow-up|0
7399678|NCT01307267|11664447|FG015|Overall Study|Lost to Follow-up|0
7399679|NCT01307267|11664448|FG016|Overall Study|Lost to Follow-up|0
7399680|NCT01307267|11664449|FG017|Overall Study|Lost to Follow-up|0
7399681|NCT01307267|11664450|FG018|Overall Study|Lost to Follow-up|0
7399682|NCT01307267|11664451|FG019|Overall Study|Lost to Follow-up|2
7399683|NCT01307267|11664452|FG020|Overall Study|Lost to Follow-up|0
7399684|NCT01307267|11664453|FG021|Overall Study|Lost to Follow-up|0
7399685|NCT01307267|11664454|FG022|Overall Study|Lost to Follow-up|0
7399686|NCT01307267|11664432|FG000|Overall Study|Withdrawal by Subject|0
7399687|NCT01307267|11664433|FG001|Overall Study|Withdrawal by Subject|0
7399688|NCT01307267|11664434|FG002|Overall Study|Withdrawal by Subject|0
7399689|NCT01307267|11664435|FG003|Overall Study|Withdrawal by Subject|0
7399690|NCT01307267|11664436|FG004|Overall Study|Withdrawal by Subject|0
7399691|NCT01307267|11664437|FG005|Overall Study|Withdrawal by Subject|1
7399692|NCT01307267|11664438|FG006|Overall Study|Withdrawal by Subject|0
7399693|NCT01307267|11664439|FG007|Overall Study|Withdrawal by Subject|1
7399694|NCT01307267|11664440|FG008|Overall Study|Withdrawal by Subject|5
7399695|NCT01307267|11664441|FG009|Overall Study|Withdrawal by Subject|1
7399696|NCT01307267|11664442|FG010|Overall Study|Withdrawal by Subject|1
7399697|NCT01307267|11664443|FG011|Overall Study|Withdrawal by Subject|1
7399698|NCT01307267|11664444|FG012|Overall Study|Withdrawal by Subject|0
7399699|NCT01307267|11664445|FG013|Overall Study|Withdrawal by Subject|0
7399700|NCT01307267|11664446|FG014|Overall Study|Withdrawal by Subject|0
7399701|NCT01307267|11664447|FG015|Overall Study|Withdrawal by Subject|0
7399702|NCT01307267|11664448|FG016|Overall Study|Withdrawal by Subject|0
7399703|NCT01307267|11664449|FG017|Overall Study|Withdrawal by Subject|0
7399704|NCT01307267|11664450|FG018|Overall Study|Withdrawal by Subject|0
7399705|NCT01307267|11664451|FG019|Overall Study|Withdrawal by Subject|3
7399706|NCT01307267|11664452|FG020|Overall Study|Withdrawal by Subject|0
7399707|NCT01307267|11664453|FG021|Overall Study|Withdrawal by Subject|0
7399708|NCT01307267|11664454|FG022|Overall Study|Withdrawal by Subject|0
7399709|NCT01307267|11664432|FG000|Overall Study|Other|0
7399710|NCT01307267|11664433|FG001|Overall Study|Other|0
7399711|NCT01307267|11664434|FG002|Overall Study|Other|0
7399712|NCT01307267|11664435|FG003|Overall Study|Other|0
7399713|NCT01307267|11664436|FG004|Overall Study|Other|0
7399714|NCT01307267|11664437|FG005|Overall Study|Other|7
7399715|NCT01307267|11664438|FG006|Overall Study|Other|0
7399716|NCT01307267|11664439|FG007|Overall Study|Other|1
7399717|NCT01307267|11664440|FG008|Overall Study|Other|3
7399718|NCT01307267|11664441|FG009|Overall Study|Other|0
7399719|NCT01307267|11664442|FG010|Overall Study|Other|1
7399720|NCT01307267|11664443|FG011|Overall Study|Other|1
7399721|NCT01307267|11664444|FG012|Overall Study|Other|1
7399722|NCT01307267|11664445|FG013|Overall Study|Other|0
7399723|NCT01307267|11664446|FG014|Overall Study|Other|2
7399724|NCT01307267|11664447|FG015|Overall Study|Other|1
7399725|NCT01307267|11664448|FG016|Overall Study|Other|0
7399726|NCT01307267|11664449|FG017|Overall Study|Other|0
7399727|NCT01307267|11664450|FG018|Overall Study|Other|0
7399728|NCT01307267|11664451|FG019|Overall Study|Other|19
7399729|NCT01307267|11664452|FG020|Overall Study|Other|2
7399730|NCT01307267|11664453|FG021|Overall Study|Other|3
7399731|NCT01307267|11664454|FG022|Overall Study|Other|2
7399732|NCT01307319|11664516|FG000|Overall Study|Adverse Event|2
7399733|NCT01307319|11664517|FG001|Overall Study|Adverse Event|2
7399734|NCT01307319|11664518|FG002|Overall Study|Adverse Event|1
7399735|NCT01307319|11664516|FG000|Overall Study|Lost to Follow-up|1
7399736|NCT01307319|11664517|FG001|Overall Study|Lost to Follow-up|0
7399737|NCT01307319|11664518|FG002|Overall Study|Lost to Follow-up|1
7399738|NCT01307319|11664516|FG000|Overall Study|Protocol Violation|1
7399739|NCT01307319|11664517|FG001|Overall Study|Protocol Violation|1
7399740|NCT01307319|11664518|FG002|Overall Study|Protocol Violation|0
7399741|NCT01307319|11664516|FG000|Overall Study|Withdrawal by Subject|0
7399742|NCT01307319|11664517|FG001|Overall Study|Withdrawal by Subject|1
7399743|NCT01307319|11664518|FG002|Overall Study|Withdrawal by Subject|2
7399744|NCT01307319|11664516|FG000|Overall Study|Other|0
7399745|NCT01307319|11664517|FG001|Overall Study|Other|4
7399746|NCT01307319|11664518|FG002|Overall Study|Other|3
7399747|NCT01307449|11664534|FG000|Overall Study|Adverse Event|1
7399748|NCT01307449|11664535|FG001|Overall Study|Adverse Event|0
7399749|NCT01307449|11664536|FG002|Overall Study|Adverse Event|0
7399750|NCT01307449|11664537|FG003|Overall Study|Adverse Event|0
7399751|NCT01307501|11664551|FG000|Overall Study|Treatment Failure|1
7399752|NCT01307501|11664551|FG000|Overall Study|Death|20
7399753|NCT01307501|11664551|FG000|Overall Study|Lost to Follow-up|1
7399754|NCT01307501|11664551|FG000|Overall Study|Starting Hospice|1
7399755|NCT01307579|11664557|FG000|Overall Study|Death|3
7399756|NCT01307579|11664558|FG001|Overall Study|Death|6
7399757|NCT01307579|11664557|FG000|Overall Study|Physician Decision|26
7399758|NCT01307579|11664558|FG001|Overall Study|Physician Decision|29
7399759|NCT01307579|11664557|FG000|Overall Study|Withdrawal by Subject|7
7399760|NCT01307579|11664558|FG001|Overall Study|Withdrawal by Subject|3
7399761|NCT01307579|11664557|FG000|Overall Study|Institutional diagnosis of IFD|21
7399762|NCT01307579|11664558|FG001|Overall Study|Institutional diagnosis of IFD|36
7399763|NCT01307579|11664557|FG000|Overall Study|Begin conditioning for HSCT|42
7399764|NCT01307579|11664558|FG001|Overall Study|Begin conditioning for HSCT|44
7399765|NCT01307579|11664557|FG000|Overall Study|Refractory or relapsed AML|38
7399766|NCT01307579|11664558|FG001|Overall Study|Refractory or relapsed AML|23
7399767|NCT01307579|11664557|FG000|Overall Study|Ineligible|3
7399768|NCT01307579|11664558|FG001|Overall Study|Ineligible|4
7399769|NCT01307891|11664594|FG000|Overall Study|Progressive Disease|3
7399770|NCT01307891|11664595|FG001|Overall Study|Progressive Disease|1
7399771|NCT01308008|11664611|FG000|4 Weeks|Illness, disinterest, time|9
7399772|NCT01308008|11664612|FG001|4 Weeks|Illness, disinterest, time|2
7399773|NCT01308424|11664646|FG000|Baseline Eligibility|Screen Failures|71
7399774|NCT01308424|11664647|FG001|Baseline Eligibility|Screen Failures|0
7399775|NCT01308424|11664648|FG002|Baseline Eligibility|Screen Failures|0
7399776|NCT01308424|11664646|FG000|Randomization|Adverse Event|0
7399777|NCT01308424|11664647|FG001|Randomization|Adverse Event|1
7399778|NCT01308424|11664648|FG002|Randomization|Adverse Event|1
7399779|NCT01308424|11664646|FG000|Randomization|Lost to Follow-up|0
7399780|NCT01308424|11664647|FG001|Randomization|Lost to Follow-up|1
7399781|NCT01308424|11664648|FG002|Randomization|Lost to Follow-up|0
7399782|NCT01308424|11664646|FG000|Randomization|Physician Decision|0
7399783|NCT01308424|11664647|FG001|Randomization|Physician Decision|1
7399784|NCT01308424|11664648|FG002|Randomization|Physician Decision|1
7399785|NCT01308463|11664659|FG000|Overall Study|Study Discontinued|23
7399786|NCT01308463|11664659|FG000|Overall Study|Death|4
7399787|NCT01308463|11664659|FG000|Overall Study|Revision|2
7399788|NCT01308476|11664665|FG000|Overall Study|Lost to Follow-up|2
7399789|NCT01308476|11664666|FG001|Overall Study|Lost to Follow-up|2
7399790|NCT01308476|11664665|FG000|Overall Study|Other|1
7399791|NCT01308476|11664666|FG001|Overall Study|Other|0
7399792|NCT01308567|11664675|FG000|Overall Study|Lost to Follow-up|2
7399793|NCT01308567|11664676|FG001|Overall Study|Lost to Follow-up|4
7399794|NCT01308567|11664677|FG002|Overall Study|Lost to Follow-up|4
7399795|NCT01308580|11664687|FG000|Overall Study|Lost to Follow-up|12
7399796|NCT01308580|11664688|FG001|Overall Study|Lost to Follow-up|7
7399797|NCT01308736|11664708|FG000|Overall Study|Did not attend a single session|6
7399798|NCT01308736|11664709|FG001|Overall Study|Did not attend a single session|5
7399799|NCT01308749|11664717|FG000|Period 1: Double Blind Treatment|Adverse Event|1
7399800|NCT01308749|11664718|FG001|Period 1: Double Blind Treatment|Adverse Event|0
7399801|NCT01308749|11664717|FG000|Period 2: Open Label Treatment|Adverse Event|0
7399802|NCT01308749|11664718|FG001|Period 2: Open Label Treatment|Adverse Event|1
7399803|NCT01308749|11664717|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
7399804|NCT01308749|11664718|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
7399805|NCT01308762|11664741|FG000|Overall Study|Protocol Violation|0
7399806|NCT01308762|11664742|FG001|Overall Study|Protocol Violation|1
7399807|NCT01308762|11664743|FG002|Overall Study|Protocol Violation|0
7399808|NCT01308788|11664756|FG000|2-year Treatment|medication change by treating physician|4
7399809|NCT01308788|11664757|FG001|2-year Treatment|medication change by treating physician|11
7399813|NCT01309100|11664784|FG000|Overall Study|Protocol Violation|1
7399814|NCT01309100|11664784|FG000|Overall Study|Positive Slit lamp finding|1
7399815|NCT01309165|11664793|FG000|Overall Study|Lost to Follow-up|4
7399816|NCT01309165|11664794|FG001|Overall Study|Lost to Follow-up|3
7399817|NCT01309165|11664793|FG000|Overall Study|Return to work|1
7399818|NCT01309165|11664794|FG001|Overall Study|Return to work|2
7399819|NCT01309165|11664793|FG000|Overall Study|Left country|0
7399820|NCT01309165|11664794|FG001|Overall Study|Left country|1
7399821|NCT01309165|11664793|FG000|Overall Study|No transportation|0
7399822|NCT01309165|11664794|FG001|Overall Study|No transportation|1
7399823|NCT01309165|11664793|FG000|Overall Study|Admitted to hospital for second stroke|1
7399824|NCT01309165|11664794|FG001|Overall Study|Admitted to hospital for second stroke|0
7399825|NCT01309204|11664803|FG000|Overall Study|Adverse Event|48
7399826|NCT01309204|11664804|FG001|Overall Study|Adverse Event|58
7399827|NCT01309204|11664803|FG000|Overall Study|Lost to Follow-up|2
7399828|NCT01309204|11664804|FG001|Overall Study|Lost to Follow-up|2
7399829|NCT01309204|11664803|FG000|Overall Study|Subject's decision unrelated to an AE|9
7399830|NCT01309204|11664804|FG001|Overall Study|Subject's decision unrelated to an AE|10
7399831|NCT01309204|11664803|FG000|Overall Study|Inadequate control of IOP|4
7399832|NCT01309204|11664804|FG001|Overall Study|Inadequate control of IOP|4
7399833|NCT01309204|11664803|FG000|Overall Study|Other|4
7399834|NCT01309204|11664804|FG001|Overall Study|Other|1
7399835|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
7399836|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
7399837|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Adverse Event|12
7399838|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Adverse Event|43
7399839|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Death|0
7399840|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Death|1
7399841|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Pregnancy|2
7399842|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Pregnancy|0
7399843|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
7399844|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
7399845|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
7399846|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
7399847|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
7399848|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
7399849|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
7399850|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
7399851|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
7399852|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
7399853|NCT01309243|11664812|FG000|Randomized Phase Through Week 96|Protocol Violation|1
7399854|NCT01309243|11664813|FG001|Randomized Phase Through Week 96|Protocol Violation|1
7399855|NCT01309243|11664812|FG000|Extension Phase|Lost to Follow-up|6
7399856|NCT01309243|11664813|FG001|Extension Phase|Lost to Follow-up|0
7399857|NCT01309269|11664819|FG000|Overall Study|Adverse Event|56
7399858|NCT01309269|11664819|FG000|Overall Study|Withdrawal by Subject|25
7399859|NCT01309269|11664819|FG000|Overall Study|Lack of Acceptance|15
7399860|NCT01309269|11664819|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
7399861|NCT01309269|11664819|FG000|Overall Study|Kidney Transplant|25
7399862|NCT01309269|11664819|FG000|Overall Study|Administrative Problems|141
7399863|NCT01309269|11664819|FG000|Overall Study|Other|256
7399864|NCT01309269|11664819|FG000|Overall Study|Other|1
7399865|NCT01309269|11664819|FG000|Overall Study|Study Completion Data Not Recorded|95
7399866|NCT01309269|11664819|FG000|Overall Study|Enrolled but not Treated|107
7399867|NCT01309282|11664823|FG000|Overall Study|Lost to Follow-up|1
7399868|NCT01309308|11664829|FG000|Overall Study|Lost to Follow-up|6
7399869|NCT01309308|11664830|FG001|Overall Study|Lost to Follow-up|4
7399870|NCT01309386|11664851|FG000|Overall Study|Other|2
7399871|NCT01309386|11664852|FG001|Overall Study|Other|0
7399872|NCT01309386|11664851|FG000|Overall Study|Withdrawal by Subject|2
7399873|NCT01309386|11664852|FG001|Overall Study|Withdrawal by Subject|0
7399874|NCT01309386|11664851|FG000|Overall Study|Progressive disease|9
7399875|NCT01309386|11664852|FG001|Overall Study|Progressive disease|11
7399876|NCT01309386|11664851|FG000|Overall Study|Physician Decision|1
7399877|NCT01309386|11664852|FG001|Overall Study|Physician Decision|1
7399878|NCT01309386|11664851|FG000|Overall Study|Lack of Efficacy|3
7399879|NCT01309386|11664852|FG001|Overall Study|Lack of Efficacy|1
7399880|NCT01309386|11664851|FG000|Overall Study|Adverse Event|5
7399881|NCT01309386|11664852|FG001|Overall Study|Adverse Event|8
7399882|NCT01309659|11664880|FG000|Overall Study|Protocol Violation|0
7399883|NCT01309659|11664881|FG001|Overall Study|Protocol Violation|1
7399884|NCT01309737|11664890|FG000|Week 0 to 16|Death|1
7399885|NCT01309737|11664891|FG001|Week 0 to 16|Death|0
7399886|NCT01309737|11664892|FG002|Week 0 to 16|Death|1
7399887|NCT01309737|11664893|FG003|Week 0 to 16|Death|0
7399888|NCT01309737|11664894|FG004|Week 0 to 16|Death|0
7399889|NCT01309737|11664890|FG000|Week 0 to 16|Adverse Event|11
7399890|NCT01309737|11664891|FG001|Week 0 to 16|Adverse Event|10
7399891|NCT01309737|11664892|FG002|Week 0 to 16|Adverse Event|5
7399892|NCT01309737|11664893|FG003|Week 0 to 16|Adverse Event|0
7399893|NCT01309737|11664894|FG004|Week 0 to 16|Adverse Event|0
7399894|NCT01309737|11664890|FG000|Week 0 to 16|Lack of Efficacy|15
7399895|NCT01309737|11664891|FG001|Week 0 to 16|Lack of Efficacy|2
7399896|NCT01309737|11664892|FG002|Week 0 to 16|Lack of Efficacy|24
7399897|NCT01309737|11664893|FG003|Week 0 to 16|Lack of Efficacy|0
7399898|NCT01309737|11664894|FG004|Week 0 to 16|Lack of Efficacy|0
7399899|NCT01309737|11664890|FG000|Week 0 to 16|Lost to Follow-up|7
7399900|NCT01309737|11664891|FG001|Week 0 to 16|Lost to Follow-up|8
7399901|NCT01309737|11664892|FG002|Week 0 to 16|Lost to Follow-up|3
7399902|NCT01309737|11664893|FG003|Week 0 to 16|Lost to Follow-up|0
7399903|NCT01309737|11664894|FG004|Week 0 to 16|Lost to Follow-up|0
7399904|NCT01309737|11664890|FG000|Week 0 to 16|Withdrawal by Subject|7
7399905|NCT01309737|11664891|FG001|Week 0 to 16|Withdrawal by Subject|6
7399906|NCT01309737|11664892|FG002|Week 0 to 16|Withdrawal by Subject|7
7399907|NCT01309737|11664893|FG003|Week 0 to 16|Withdrawal by Subject|0
7399908|NCT01309737|11664894|FG004|Week 0 to 16|Withdrawal by Subject|0
7399909|NCT01309737|11664890|FG000|Week 0 to 16|Other|10
7399910|NCT01309737|11664891|FG001|Week 0 to 16|Other|14
7399911|NCT01309737|11664892|FG002|Week 0 to 16|Other|4
7399912|NCT01309737|11664893|FG003|Week 0 to 16|Other|0
7399913|NCT01309737|11664894|FG004|Week 0 to 16|Other|0
7399914|NCT01309737|11664890|FG000|Week 0 to 16|Randomized, but not treated|1
7399915|NCT01309737|11664891|FG001|Week 0 to 16|Randomized, but not treated|0
7399916|NCT01309737|11664892|FG002|Week 0 to 16|Randomized, but not treated|0
7399917|NCT01309737|11664893|FG003|Week 0 to 16|Randomized, but not treated|0
7399918|NCT01309737|11664894|FG004|Week 0 to 16|Randomized, but not treated|0
7399919|NCT01309737|11664890|FG000|Week 16 to 52|Death|0
7399920|NCT01309737|11664891|FG001|Week 16 to 52|Death|0
7399921|NCT01309737|11664892|FG002|Week 16 to 52|Death|0
7399922|NCT01309737|11664893|FG003|Week 16 to 52|Death|0
7399923|NCT01309737|11664894|FG004|Week 16 to 52|Death|1
7399924|NCT01309737|11664890|FG000|Week 16 to 52|Adverse Event|7
7399925|NCT01309737|11664891|FG001|Week 16 to 52|Adverse Event|7
7399926|NCT01309737|11664892|FG002|Week 16 to 52|Adverse Event|0
7399927|NCT01309737|11664893|FG003|Week 16 to 52|Adverse Event|6
7399928|NCT01309737|11664894|FG004|Week 16 to 52|Adverse Event|5
7399929|NCT01309737|11664890|FG000|Week 16 to 52|Lack of Efficacy|107
7399930|NCT01309737|11664891|FG001|Week 16 to 52|Lack of Efficacy|76
7399931|NCT01309737|11664892|FG002|Week 16 to 52|Lack of Efficacy|0
7399932|NCT01309737|11664893|FG003|Week 16 to 52|Lack of Efficacy|25
7399933|NCT01309737|11664894|FG004|Week 16 to 52|Lack of Efficacy|21
7399934|NCT01309737|11664890|FG000|Week 16 to 52|Lost to Follow-up|4
7399935|NCT01309737|11664891|FG001|Week 16 to 52|Lost to Follow-up|2
7399936|NCT01309737|11664892|FG002|Week 16 to 52|Lost to Follow-up|0
7399937|NCT01309737|11664893|FG003|Week 16 to 52|Lost to Follow-up|1
7399938|NCT01309737|11664894|FG004|Week 16 to 52|Lost to Follow-up|4
7399939|NCT01309737|11664890|FG000|Week 16 to 52|Withdrawal by Subject|5
7399940|NCT01309737|11664891|FG001|Week 16 to 52|Withdrawal by Subject|6
7399941|NCT01309737|11664892|FG002|Week 16 to 52|Withdrawal by Subject|0
7399942|NCT01309737|11664893|FG003|Week 16 to 52|Withdrawal by Subject|0
7399943|NCT01309737|11664894|FG004|Week 16 to 52|Withdrawal by Subject|2
7399944|NCT01309737|11664890|FG000|Week 16 to 52|Other|10
7399945|NCT01309737|11664891|FG001|Week 16 to 52|Other|12
7399946|NCT01309737|11664892|FG002|Week 16 to 52|Other|0
7399947|NCT01309737|11664893|FG003|Week 16 to 52|Other|2
7399948|NCT01309737|11664894|FG004|Week 16 to 52|Other|0
7399949|NCT01309828|11664928|FG000|Overall Study|Adverse Event|10
7399950|NCT01309828|11664929|FG001|Overall Study|Adverse Event|11
7399951|NCT01309828|11664928|FG000|Overall Study|Voluntary Withdrawal|5
7399952|NCT01309828|11664929|FG001|Overall Study|Voluntary Withdrawal|4
7399953|NCT01309828|11664928|FG000|Overall Study|Major Protocol Deviation|0
7399954|NCT01309828|11664929|FG001|Overall Study|Major Protocol Deviation|1
7399955|NCT01309828|11664928|FG000|Overall Study|Other|1
7399956|NCT01309828|11664929|FG001|Overall Study|Other|0
7399957|NCT01309841|11664938|FG000|Overall Study|Other|0
7399958|NCT01309841|11664939|FG001|Overall Study|Other|1
7399959|NCT01309841|11664940|FG002|Overall Study|Other|1
7399960|NCT01309841|11664938|FG000|Overall Study|Lost to Follow-up|7
7399961|NCT01309841|11664939|FG001|Overall Study|Lost to Follow-up|6
7399962|NCT01309841|11664940|FG002|Overall Study|Lost to Follow-up|4
7399963|NCT01309841|11664938|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
7399964|NCT01309841|11664939|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7399965|NCT01309841|11664940|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
7399966|NCT01309841|11664938|FG000|Overall Study|Lack of Efficacy|0
7399967|NCT01309841|11664939|FG001|Overall Study|Lack of Efficacy|0
7399968|NCT01309841|11664940|FG002|Overall Study|Lack of Efficacy|2
7399969|NCT01309841|11664938|FG000|Overall Study|Adverse Event|9
7399970|NCT01309841|11664939|FG001|Overall Study|Adverse Event|22
7399971|NCT01309841|11664940|FG002|Overall Study|Adverse Event|11
7399972|NCT01309841|11664938|FG000|Overall Study|Death|1
7399973|NCT01309841|11664939|FG001|Overall Study|Death|0
7399974|NCT01309841|11664940|FG002|Overall Study|Death|0
7399975|NCT01309841|11664938|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7399976|NCT01309841|11664939|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7399977|NCT01309841|11664940|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
7399978|NCT01309841|11664938|FG000|Overall Study|Withdrawal by Subject|17
7399979|NCT01309841|11664939|FG001|Overall Study|Withdrawal by Subject|6
7399980|NCT01309841|11664940|FG002|Overall Study|Withdrawal by Subject|13
7399981|NCT01309841|11664938|FG000|Overall Study|Did Not Receive Treatment|2
7399982|NCT01309841|11664939|FG001|Overall Study|Did Not Receive Treatment|0
7399983|NCT01309841|11664940|FG002|Overall Study|Did Not Receive Treatment|1
7399984|NCT01309841|11664938|FG000|Overall Study|Severe non-compliance with protocol|0
7399985|NCT01309841|11664939|FG001|Overall Study|Severe non-compliance with protocol|5
7399986|NCT01309841|11664940|FG002|Overall Study|Severe non-compliance with protocol|2
7399987|NCT01309893|11664962|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
7399988|NCT01309893|11664963|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
7399989|NCT01309893|11664962|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
7399990|NCT01309893|11664963|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
7399991|NCT01309919|11664978|FG000|Overall Study|Did not receive a postpartum IUD|17
7399992|NCT01309919|11664979|FG001|Overall Study|Did not receive a postpartum IUD|48
7399993|NCT01309997|11664987|FG000|Overall Study|Adverse Event|1
7399994|NCT01309997|11664988|FG001|Overall Study|Adverse Event|0
7399995|NCT01309997|11664987|FG000|Overall Study|Death|1
7399996|NCT01309997|11664988|FG001|Overall Study|Death|3
7399997|NCT01309997|11664987|FG000|Overall Study|Lack of Efficacy|2
7399998|NCT01309997|11664988|FG001|Overall Study|Lack of Efficacy|2
7399999|NCT01309997|11664987|FG000|Overall Study|Withdrawal by Subject|1
7400000|NCT01309997|11664988|FG001|Overall Study|Withdrawal by Subject|1
7400001|NCT01310036|11665005|FG000|Overall Study|Administrative/other|10
7400002|NCT01310036|11665005|FG000|Overall Study|Withdrew Consent|11
7400003|NCT01310036|11665005|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
7400004|NCT01310036|11665005|FG000|Overall Study|Progression of Disease|164
7400005|NCT01310036|11665005|FG000|Overall Study|Death|1
7400006|NCT01310036|11665005|FG000|Overall Study|Adverse event or intercurrent illness|12
7400007|NCT01310075|11665011|FG000|Overall Study|Lost to Follow-up|1
7400008|NCT01310075|11665012|FG001|Overall Study|Lost to Follow-up|0
7400009|NCT01310075|11665011|FG000|Overall Study|Physician Decision|10
7400010|NCT01310075|11665012|FG001|Overall Study|Physician Decision|7
7400011|NCT01310075|11665011|FG000|Overall Study|Protocol Violation|2
7400012|NCT01310075|11665012|FG001|Overall Study|Protocol Violation|2
7400013|NCT01310075|11665011|FG000|Overall Study|Withdrawal by Subject|1
7400014|NCT01310075|11665012|FG001|Overall Study|Withdrawal by Subject|1
7400015|NCT01310127|11665020|FG000|Overall Study|Protocol Violation|1
7400016|NCT01310127|11665021|FG001|Overall Study|Protocol Violation|1
7400017|NCT01310127|11665020|FG000|Overall Study|advanced psc cataract outlier|1
7400018|NCT01310127|11665021|FG001|Overall Study|advanced psc cataract outlier|0
7400019|NCT01310413|11665062|FG000|Day 0 to Day 385|Withdrawal by Subject|5
7400020|NCT01310413|11665063|FG001|Day 0 to Day 385|Withdrawal by Subject|2
7400021|NCT01310413|11665064|FG002|Day 0 to Day 385|Withdrawal by Subject|0
7400022|NCT01310413|11665065|FG003|Day 0 to Day 385|Withdrawal by Subject|2
7400023|NCT01310413|11665066|FG004|Day 0 to Day 385|Withdrawal by Subject|1
7400024|NCT01310413|11665067|FG005|Day 0 to Day 385|Withdrawal by Subject|1
7400025|NCT01310413|11665068|FG006|Day 0 to Day 385|Withdrawal by Subject|0
7400026|NCT01310413|11665062|FG000|Day 0 to Day 385|Lost to Follow-up|18
7400027|NCT01310413|11665063|FG001|Day 0 to Day 385|Lost to Follow-up|3
7400028|NCT01310413|11665064|FG002|Day 0 to Day 385|Lost to Follow-up|3
7400029|NCT01310413|11665065|FG003|Day 0 to Day 385|Lost to Follow-up|5
7400030|NCT01310413|11665066|FG004|Day 0 to Day 385|Lost to Follow-up|1
7400031|NCT01310413|11665067|FG005|Day 0 to Day 385|Lost to Follow-up|2
7400032|NCT01310413|11665068|FG006|Day 0 to Day 385|Lost to Follow-up|0
7400033|NCT01310413|11665062|FG000|Day 0 to Day 385|Migrated/moved from study area|3
7400034|NCT01310413|11665063|FG001|Day 0 to Day 385|Migrated/moved from study area|3
7400035|NCT01310413|11665064|FG002|Day 0 to Day 385|Migrated/moved from study area|1
7400036|NCT01310413|11665065|FG003|Day 0 to Day 385|Migrated/moved from study area|1
7400037|NCT01310413|11665066|FG004|Day 0 to Day 385|Migrated/moved from study area|1
7400038|NCT01310413|11665067|FG005|Day 0 to Day 385|Migrated/moved from study area|0
7400039|NCT01310413|11665068|FG006|Day 0 to Day 385|Migrated/moved from study area|0
7400040|NCT01310413|11665062|FG000|Day 0 to Day 385|Other|1
7400041|NCT01310413|11665063|FG001|Day 0 to Day 385|Other|0
7400042|NCT01310413|11665064|FG002|Day 0 to Day 385|Other|3
7400043|NCT01310413|11665065|FG003|Day 0 to Day 385|Other|0
7400044|NCT01310413|11665066|FG004|Day 0 to Day 385|Other|0
7400045|NCT01310413|11665067|FG005|Day 0 to Day 385|Other|0
7400046|NCT01310413|11665068|FG006|Day 0 to Day 385|Other|0
7400047|NCT01310413|11665062|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
7400048|NCT01310413|11665063|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
7400049|NCT01310413|11665064|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
7400050|NCT01310413|11665065|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
7400051|NCT01310413|11665066|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
7400052|NCT01310413|11665067|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
7400053|NCT01310413|11665068|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
7400054|NCT01310413|11665062|FG000|From Day U0 to Day U385|Lost to Follow-up|0
7400055|NCT01310413|11665063|FG001|From Day U0 to Day U385|Lost to Follow-up|0
7400056|NCT01310413|11665064|FG002|From Day U0 to Day U385|Lost to Follow-up|0
7400057|NCT01310413|11665065|FG003|From Day U0 to Day U385|Lost to Follow-up|0
7400058|NCT01310413|11665066|FG004|From Day U0 to Day U385|Lost to Follow-up|0
7400059|NCT01310413|11665067|FG005|From Day U0 to Day U385|Lost to Follow-up|0
7400060|NCT01310413|11665068|FG006|From Day U0 to Day U385|Lost to Follow-up|2
7400061|NCT01310699|11665108|FG000|Overall Study|Patients did not complete tandem.|4
7400062|NCT01310699|11665109|FG001|Overall Study|Patients did not complete tandem.|6
7400063|NCT01310777|11665120|FG000|Overall Study|Adverse Event|23
7400064|NCT01310777|11665121|FG001|Overall Study|Adverse Event|1
7400065|NCT01310777|11665122|FG002|Overall Study|Adverse Event|15
7400066|NCT01310777|11665120|FG000|Overall Study|Lost to Follow-up|0
7400067|NCT01310777|11665121|FG001|Overall Study|Lost to Follow-up|4
7400068|NCT01310777|11665122|FG002|Overall Study|Lost to Follow-up|1
7400069|NCT01310777|11665120|FG000|Overall Study|Patient's Decision Unrelated to AE|1
7400070|NCT01310777|11665121|FG001|Overall Study|Patient's Decision Unrelated to AE|1
7400071|NCT01310777|11665122|FG002|Overall Study|Patient's Decision Unrelated to AE|2
7400072|NCT01310777|11665120|FG000|Overall Study|Inadequate Control of IOP|5
7400073|NCT01310777|11665121|FG001|Overall Study|Inadequate Control of IOP|7
7400074|NCT01310777|11665122|FG002|Overall Study|Inadequate Control of IOP|10
7400075|NCT01310777|11665120|FG000|Overall Study|Other|4
7400076|NCT01310777|11665121|FG001|Overall Study|Other|1
7400077|NCT01310777|11665122|FG002|Overall Study|Other|2
7400078|NCT01310868|11665139|FG000|Overall Study|Do not have histologically confirmed GBM|13
7400079|NCT01311024|11665145|FG000|Overall Study|Protocol Violation|35
7400080|NCT01311024|11665146|FG001|Overall Study|Protocol Violation|22
7400081|NCT01311505|11665172|FG000|First Intervention Period|Protocol Violation|0
7400082|NCT01311505|11665173|FG001|First Intervention Period|Protocol Violation|1
7400083|NCT01311557|11665184|FG000|Overall Study|Serious adverse event|0
7400084|NCT01311557|11665185|FG001|Overall Study|Serious adverse event|1
7400085|NCT01311557|11665184|FG000|Overall Study|Protocol Violation|4
7400086|NCT01311557|11665185|FG001|Overall Study|Protocol Violation|2
7400087|NCT01311557|11665184|FG000|Overall Study|Lost to Follow-up|0
7400088|NCT01311557|11665185|FG001|Overall Study|Lost to Follow-up|1
7400089|NCT01311557|11665184|FG000|Overall Study|Withdrawal by Subject|1
7400090|NCT01311557|11665185|FG001|Overall Study|Withdrawal by Subject|2
7465577|NCT01881126|11764953|FG000|Overall Study|Adverse Event|0
7400091|NCT01311648|11665194|FG000|Main Study|Protocol Violation|0
7400092|NCT01311648|11665195|FG001|Main Study|Protocol Violation|1
7400093|NCT01311648|11665194|FG000|Main Study|Adverse Event|0
7400094|NCT01311648|11665195|FG001|Main Study|Adverse Event|1
7400095|NCT01311648|11665194|FG000|Main Study|Inhibitor management|0
7400096|NCT01311648|11665195|FG001|Main Study|Inhibitor management|17
7400097|NCT01311648|11665194|FG000|Main Study|Withdrawal by Subject|0
7400098|NCT01311648|11665195|FG001|Main Study|Withdrawal by Subject|2
7400099|NCT01311648|11665194|FG000|Extension Study|Physician Decision|0
7400100|NCT01311648|11665195|FG001|Extension Study|Physician Decision|1
7400101|NCT01311648|11665194|FG000|Extension Study|ITI therapy with marketed product|0
7400102|NCT01311648|11665195|FG001|Extension Study|ITI therapy with marketed product|1
7400103|NCT01311648|11665194|FG000|Extension Study|Incorrect visit planning|0
7400104|NCT01311648|11665195|FG001|Extension Study|Incorrect visit planning|1
7400105|NCT01311648|11665194|FG000|Extension Study|Family's decision|0
7400106|NCT01311648|11665195|FG001|Extension Study|Family's decision|1
7400107|NCT01311648|11665194|FG000|Extension Study|Failure of ITI therapy|0
7400108|NCT01311648|11665195|FG001|Extension Study|Failure of ITI therapy|3
7400109|NCT01311648|11665194|FG000|Extension Study|Long travel|0
7400110|NCT01311648|11665195|FG001|Extension Study|Long travel|1
7400111|NCT01311648|11665194|FG000|Extension Study|Diagnosed with von Willebrand disease|1
7400112|NCT01311648|11665195|FG001|Extension Study|Diagnosed with von Willebrand disease|0
7400113|NCT01311648|11665194|FG000|Extension Study|Withdrawal by Subject|0
7400114|NCT01311648|11665195|FG001|Extension Study|Withdrawal by Subject|1
7400115|NCT01311648|11665194|FG000|Extension Study|Inhibitor management|0
7400116|NCT01311648|11665195|FG001|Extension Study|Inhibitor management|2
7400117|NCT01311661|11665208|FG000|Overall Study|Adverse Event|2
7400118|NCT01311661|11665208|FG000|Overall Study|Protocol Violation|3
7400119|NCT01311661|11665208|FG000|Overall Study|Withdrawal by Subject|2
7400120|NCT01312129|11665262|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
7400121|NCT01312129|11665263|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
7400122|NCT01312467|11665317|FG000|Overall Study|Adverse Event|4
7400123|NCT01312467|11665317|FG000|Overall Study|Lost to Follow-up|1
7400124|NCT01312467|11665317|FG000|Overall Study|Withdrawal by Subject|2
7400125|NCT01312467|11665317|FG000|Overall Study|Deported to country of origin|1
7400126|NCT01312467|11665317|FG000|Overall Study|Another medical condition|1
7400127|NCT01312467|11665317|FG000|Overall Study|Ineligible|4
7400128|NCT01312779|11665349|FG000|Overall Study|Withdrawal by Subject|2
7400129|NCT01312779|11665349|FG000|Overall Study|Death|3
7400130|NCT01312779|11665349|FG000|Overall Study|Not Implanted with Device|27
7400131|NCT01312909|11665389|FG000|Overall Study|Randomized but not treated|1
7400132|NCT01312909|11665390|FG001|Overall Study|Randomized but not treated|3
7400133|NCT01312909|11665391|FG002|Overall Study|Randomized but not treated|1
7400134|NCT01312909|11665389|FG000|Overall Study|Adverse Event|1
7400135|NCT01312909|11665390|FG001|Overall Study|Adverse Event|0
7400136|NCT01312909|11665391|FG002|Overall Study|Adverse Event|3
7400137|NCT01312909|11665389|FG000|Overall Study|Protocol Violation|2
7400138|NCT01312909|11665390|FG001|Overall Study|Protocol Violation|0
7400139|NCT01312909|11665391|FG002|Overall Study|Protocol Violation|2
7400140|NCT01312909|11665389|FG000|Overall Study|Other|9
7400141|NCT01312909|11665390|FG001|Overall Study|Other|6
7400142|NCT01312909|11665391|FG002|Overall Study|Other|11
7400143|NCT01312909|11665389|FG000|Overall Study|Withdrawal by Subject|8
7400144|NCT01312909|11665390|FG001|Overall Study|Withdrawal by Subject|10
7400145|NCT01312909|11665391|FG002|Overall Study|Withdrawal by Subject|7
7400146|NCT01312909|11665389|FG000|Overall Study|Lost to Follow-up|21
7400147|NCT01312909|11665390|FG001|Overall Study|Lost to Follow-up|17
7400148|NCT01312909|11665391|FG002|Overall Study|Lost to Follow-up|20
7400149|NCT01312909|11665389|FG000|Overall Study|Insufficient clinical response|0
7400150|NCT01312909|11665390|FG001|Overall Study|Insufficient clinical response|0
7400151|NCT01312909|11665391|FG002|Overall Study|Insufficient clinical response|1
7400152|NCT01312909|11665389|FG000|Overall Study|Entrance criteria not met|0
7400153|NCT01312909|11665390|FG001|Overall Study|Entrance criteria not met|0
7400154|NCT01312909|11665391|FG002|Overall Study|Entrance criteria not met|2
7400155|NCT01312961|11665408|FG000|Overall Study|Adverse Event|3
7400156|NCT01312961|11665409|FG001|Overall Study|Adverse Event|3
7400157|NCT01312961|11665408|FG000|Overall Study|Lack of Efficacy|11
7400158|NCT01312961|11665409|FG001|Overall Study|Lack of Efficacy|1
7400159|NCT01312961|11665408|FG000|Overall Study|Poor compliance to protocol|1
7400160|NCT01312961|11665409|FG001|Overall Study|Poor compliance to protocol|0
7400161|NCT01312961|11665408|FG000|Overall Study|Other than specified above|2
7400162|NCT01312961|11665409|FG001|Overall Study|Other than specified above|3
7400163|NCT01313039|11665416|FG000|Overall Study|Physician Decision|1
7400164|NCT01313039|11665416|FG000|Overall Study|Adverse Event|1
7400165|NCT01313078|11665420|FG000|Overall Study|Death|1
7400166|NCT01313078|11665420|FG000|Overall Study|Discontinued study drug|1
7400167|NCT01313078|11665420|FG000|Overall Study|Withdrawal by Subject|1
7400168|NCT01313117|11665424|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7400169|NCT01313117|11665424|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
7400170|NCT01313182|11665431|FG000|Overall Study|Protocol Violation|66
7400171|NCT01313182|11665432|FG001|Overall Study|Protocol Violation|92
7400172|NCT01313208|11665440|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
7400173|NCT01313208|11665441|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
7400174|NCT01313208|11665440|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
7400175|NCT01313208|11665441|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
7400176|NCT01313208|11665440|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
7400177|NCT01313208|11665441|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
7400178|NCT01313208|11665440|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
7400179|NCT01313208|11665441|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
7400180|NCT01313208|11665440|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
7400181|NCT01313208|11665441|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
7400182|NCT01313208|11665440|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
7400183|NCT01313208|11665441|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
7400184|NCT01313208|11665440|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
7400185|NCT01313208|11665441|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
7400186|NCT01313208|11665440|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
7400187|NCT01313208|11665441|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
7400188|NCT01313208|11665440|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
7400189|NCT01313208|11665441|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
7400190|NCT01313221|11665452|FG000|Overall Study|Protocol Violation|0
7400191|NCT01313221|11665453|FG001|Overall Study|Protocol Violation|1
7400192|NCT01313221|11665454|FG002|Overall Study|Protocol Violation|1
7400193|NCT01313221|11665452|FG000|Overall Study|Non-compliance|3
7400194|NCT01313221|11665453|FG001|Overall Study|Non-compliance|0
7400195|NCT01313221|11665454|FG002|Overall Study|Non-compliance|2
7400196|NCT01313221|11665452|FG000|Overall Study|Withdrawal by Subject|2
7400197|NCT01313221|11665453|FG001|Overall Study|Withdrawal by Subject|3
7400198|NCT01313221|11665454|FG002|Overall Study|Withdrawal by Subject|5
7400199|NCT01313221|11665452|FG000|Overall Study|Requirement for alternative therapy|0
7400200|NCT01313221|11665453|FG001|Overall Study|Requirement for alternative therapy|1
7400201|NCT01313221|11665454|FG002|Overall Study|Requirement for alternative therapy|1
7400202|NCT01313221|11665452|FG000|Overall Study|Lost to Follow-up|6
7400203|NCT01313221|11665453|FG001|Overall Study|Lost to Follow-up|3
7400204|NCT01313221|11665454|FG002|Overall Study|Lost to Follow-up|1
7400205|NCT01313221|11665452|FG000|Overall Study|Other|1
7400206|NCT01313221|11665453|FG001|Overall Study|Other|0
7400207|NCT01313221|11665454|FG002|Overall Study|Other|0
7400208|NCT01313221|11665452|FG000|Overall Study|Adverse Event|0
7400209|NCT01313221|11665453|FG001|Overall Study|Adverse Event|0
7400210|NCT01313221|11665454|FG002|Overall Study|Adverse Event|7
7400211|NCT01313221|11665452|FG000|Overall Study|Disease progression|0
7400212|NCT01313221|11665453|FG001|Overall Study|Disease progression|0
7400213|NCT01313221|11665454|FG002|Overall Study|Disease progression|2
7400214|NCT01313221|11665452|FG000|Overall Study|Physician Decision|0
7400215|NCT01313221|11665453|FG001|Overall Study|Physician Decision|0
7400216|NCT01313221|11665454|FG002|Overall Study|Physician Decision|2
7400217|NCT01313221|11665452|FG000|Overall Study|Pregnancy|0
7400218|NCT01313221|11665453|FG001|Overall Study|Pregnancy|0
7400219|NCT01313221|11665454|FG002|Overall Study|Pregnancy|2
7400220|NCT01313286|11665462|FG000|Period 1|Withdrawal by Subject|2
7400221|NCT01313286|11665463|FG001|Period 1|Withdrawal by Subject|0
7400247|NCT01313559|11665512|FG000|Overall Study|Withdrawal by Subject|1
7400248|NCT01313559|11665513|FG001|Overall Study|Withdrawal by Subject|2
7400249|NCT01313559|11665512|FG000|Overall Study|Disease progression|1
7400250|NCT01313559|11665513|FG001|Overall Study|Disease progression|0
7400251|NCT01313559|11665512|FG000|Overall Study|Rising PSA|2
7400252|NCT01313559|11665513|FG001|Overall Study|Rising PSA|0
7400253|NCT01313624|11665521|FG000|Double-Blind Phase|Adverse Event|27
7400254|NCT01313624|11665522|FG001|Double-Blind Phase|Adverse Event|4
7400255|NCT01313624|11665521|FG000|Double-Blind Phase|Withdrawal by Subject|9
7400256|NCT01313624|11665522|FG001|Double-Blind Phase|Withdrawal by Subject|4
7400257|NCT01313624|11665521|FG000|Double-Blind Phase|Lost to Follow-up|0
7400258|NCT01313624|11665522|FG001|Double-Blind Phase|Lost to Follow-up|2
7400259|NCT01313624|11665521|FG000|Double-Blind Phase|Physician Decision|1
7400260|NCT01313624|11665522|FG001|Double-Blind Phase|Physician Decision|0
7400261|NCT01313624|11665521|FG000|Double-Blind Phase|Lack of Efficacy|1
7400262|NCT01313624|11665522|FG001|Double-Blind Phase|Lack of Efficacy|0
7400263|NCT01313624|11665521|FG000|Open-Label Phase|Adverse Event|1
7400264|NCT01313624|11665522|FG001|Open-Label Phase|Adverse Event|10
7400265|NCT01313624|11665521|FG000|Open-Label Phase|Withdrawal by Subject|2
7400266|NCT01313624|11665522|FG001|Open-Label Phase|Withdrawal by Subject|2
7400267|NCT01313624|11665521|FG000|Open-Label Phase|Lost to Follow-up|1
7400268|NCT01313624|11665522|FG001|Open-Label Phase|Lost to Follow-up|1
7400269|NCT01313637|11665534|FG000|Overall Study|Adverse Event|17
7400270|NCT01313637|11665535|FG001|Overall Study|Adverse Event|24
7400271|NCT01313637|11665536|FG002|Overall Study|Adverse Event|25
7400272|NCT01313637|11665537|FG003|Overall Study|Adverse Event|18
7400273|NCT01313637|11665534|FG000|Overall Study|Lack of Efficacy|44
7400274|NCT01313637|11665535|FG001|Overall Study|Lack of Efficacy|38
7400275|NCT01313637|11665536|FG002|Overall Study|Lack of Efficacy|37
7400276|NCT01313637|11665537|FG003|Overall Study|Lack of Efficacy|24
7400277|NCT01313637|11665534|FG000|Overall Study|Protocol Violation|4
7400278|NCT01313637|11665535|FG001|Overall Study|Protocol Violation|3
7400279|NCT01313637|11665536|FG002|Overall Study|Protocol Violation|11
7400280|NCT01313637|11665537|FG003|Overall Study|Protocol Violation|5
7400281|NCT01313637|11665534|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
7400282|NCT01313637|11665535|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
7400283|NCT01313637|11665536|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
7400284|NCT01313637|11665537|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
7400285|NCT01313637|11665534|FG000|Overall Study|Lost to Follow-up|0
7400286|NCT01313637|11665535|FG001|Overall Study|Lost to Follow-up|2
7400287|NCT01313637|11665536|FG002|Overall Study|Lost to Follow-up|1
7400288|NCT01313637|11665537|FG003|Overall Study|Lost to Follow-up|3
7400289|NCT01313637|11665534|FG000|Overall Study|Withdrawal by Subject|11
7400290|NCT01313637|11665535|FG001|Overall Study|Withdrawal by Subject|13
7400291|NCT01313637|11665536|FG002|Overall Study|Withdrawal by Subject|18
7400292|NCT01313637|11665537|FG003|Overall Study|Withdrawal by Subject|15
7400293|NCT01313650|11665551|FG000|Overall Study|Adverse Event|9
7400294|NCT01313650|11665552|FG001|Overall Study|Adverse Event|34
7400295|NCT01313650|11665553|FG002|Overall Study|Adverse Event|24
7400296|NCT01313650|11665554|FG003|Overall Study|Adverse Event|23
7400297|NCT01313650|11665551|FG000|Overall Study|Lack of Efficacy|37
7400298|NCT01313650|11665552|FG001|Overall Study|Lack of Efficacy|20
7400299|NCT01313650|11665553|FG002|Overall Study|Lack of Efficacy|32
7400300|NCT01313650|11665554|FG003|Overall Study|Lack of Efficacy|20
7400301|NCT01313650|11665551|FG000|Overall Study|Lost to Follow-up|1
7400302|NCT01313650|11665552|FG001|Overall Study|Lost to Follow-up|0
7400303|NCT01313650|11665553|FG002|Overall Study|Lost to Follow-up|3
7400304|NCT01313650|11665554|FG003|Overall Study|Lost to Follow-up|2
7400305|NCT01313650|11665551|FG000|Overall Study|Withdrawal by Subject|16
7400306|NCT01313650|11665552|FG001|Overall Study|Withdrawal by Subject|20
7400307|NCT01313650|11665553|FG002|Overall Study|Withdrawal by Subject|15
7400308|NCT01313650|11665554|FG003|Overall Study|Withdrawal by Subject|15
7400309|NCT01313650|11665551|FG000|Overall Study|Protocol Violation|4
7400310|NCT01313650|11665552|FG001|Overall Study|Protocol Violation|7
7400311|NCT01313650|11665553|FG002|Overall Study|Protocol Violation|5
7400312|NCT01313650|11665554|FG003|Overall Study|Protocol Violation|6
7400313|NCT01313650|11665551|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
7400314|NCT01313650|11665552|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
7400315|NCT01313650|11665553|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
7400316|NCT01313650|11665554|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
7400317|NCT01313663|11665566|FG000|Overall Study|Study Closed/Terminated|2
7400318|NCT01313663|11665567|FG001|Overall Study|Study Closed/Terminated|4
7400319|NCT01313663|11665566|FG000|Overall Study|Lost to Follow-up|0
7400320|NCT01313663|11665567|FG001|Overall Study|Lost to Follow-up|1
7400321|NCT01313663|11665566|FG000|Overall Study|Physician Decision|0
7400322|NCT01313663|11665567|FG001|Overall Study|Physician Decision|2
7400323|NCT01313663|11665566|FG000|Overall Study|Withdrawal by Subject|2
7400324|NCT01313663|11665567|FG001|Overall Study|Withdrawal by Subject|1
7400325|NCT01313676|11665577|FG000|Overall Study|Adverse Event|395
7400326|NCT01313676|11665578|FG001|Overall Study|Adverse Event|365
7400327|NCT01313676|11665579|FG002|Overall Study|Adverse Event|372
7400328|NCT01313676|11665580|FG003|Overall Study|Adverse Event|333
7400329|NCT01313676|11665577|FG000|Overall Study|Lack of Efficacy|98
7400330|NCT01313676|11665578|FG001|Overall Study|Lack of Efficacy|90
7400331|NCT01313676|11665579|FG002|Overall Study|Lack of Efficacy|65
7400332|NCT01313676|11665580|FG003|Overall Study|Lack of Efficacy|46
7400333|NCT01313676|11665577|FG000|Overall Study|Protocol Violation|37
7400334|NCT01313676|11665578|FG001|Overall Study|Protocol Violation|44
7400335|NCT01313676|11665579|FG002|Overall Study|Protocol Violation|46
7400336|NCT01313676|11665580|FG003|Overall Study|Protocol Violation|44
7400337|NCT01313676|11665577|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
7471155|NCT01939366|11773861|FG003|Overall Study|Inclusion criteria not met|0
7471156|NCT01939366|11773862|FG004|Overall Study|Inclusion criteria not met|1
7400338|NCT01313676|11665578|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
7400339|NCT01313676|11665579|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
7400340|NCT01313676|11665580|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
7400341|NCT01313676|11665577|FG000|Overall Study|Study Closed/terminated|7
7400342|NCT01313676|11665578|FG001|Overall Study|Study Closed/terminated|6
7400343|NCT01313676|11665579|FG002|Overall Study|Study Closed/terminated|9
7400344|NCT01313676|11665580|FG003|Overall Study|Study Closed/terminated|9
7400345|NCT01313676|11665577|FG000|Overall Study|Lost to Follow-up|0
7400346|NCT01313676|11665578|FG001|Overall Study|Lost to Follow-up|0
7400347|NCT01313676|11665579|FG002|Overall Study|Lost to Follow-up|1
7400348|NCT01313676|11665580|FG003|Overall Study|Lost to Follow-up|0
7400349|NCT01313676|11665577|FG000|Overall Study|Physician Decision|53
7400350|NCT01313676|11665578|FG001|Overall Study|Physician Decision|64
7400351|NCT01313676|11665579|FG002|Overall Study|Physician Decision|62
7400352|NCT01313676|11665580|FG003|Overall Study|Physician Decision|48
7400353|NCT01313676|11665577|FG000|Overall Study|Decision by Participant or Proxy|643
7400354|NCT01313676|11665578|FG001|Overall Study|Decision by Participant or Proxy|527
7400355|NCT01313676|11665579|FG002|Overall Study|Decision by Participant or Proxy|515
7400356|NCT01313676|11665580|FG003|Overall Study|Decision by Participant or Proxy|492
7400357|NCT01313676|11665577|FG000|Overall Study|Sponsor Terminated Study Treatment|1
7400358|NCT01313676|11665578|FG001|Overall Study|Sponsor Terminated Study Treatment|1
7400359|NCT01313676|11665579|FG002|Overall Study|Sponsor Terminated Study Treatment|0
7400360|NCT01313676|11665580|FG003|Overall Study|Sponsor Terminated Study Treatment|1
7400361|NCT01313676|11665577|FG000|Overall Study|Investigator Site Closed|12
7400362|NCT01313676|11665578|FG001|Overall Study|Investigator Site Closed|11
7400363|NCT01313676|11665579|FG002|Overall Study|Investigator Site Closed|15
7400364|NCT01313676|11665580|FG003|Overall Study|Investigator Site Closed|10
7400365|NCT01313676|11665577|FG000|Overall Study|Missing|1
7400366|NCT01313676|11665578|FG001|Overall Study|Missing|1
7400367|NCT01313676|11665579|FG002|Overall Study|Missing|1
7400368|NCT01313676|11665580|FG003|Overall Study|Missing|0
7400369|NCT01313728|11665591|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
7400370|NCT01313767|11665598|FG000|Overall Study|Adverse Event|1
7400371|NCT01313767|11665599|FG001|Overall Study|Adverse Event|0
7400372|NCT01313767|11665598|FG000|Overall Study|Lost to Follow-up|1
7400373|NCT01313767|11665599|FG001|Overall Study|Lost to Follow-up|0
7400374|NCT01313767|11665598|FG000|Overall Study|Withdrawal by Subject|2
7400375|NCT01313767|11665599|FG001|Overall Study|Withdrawal by Subject|1
7400376|NCT01313767|11665598|FG000|Overall Study|Protocol Violation|3
7400377|NCT01313767|11665599|FG001|Overall Study|Protocol Violation|1
7400378|NCT01313780|11665607|FG000|Overall Study|Lack of Efficacy|4
7400379|NCT01313780|11665608|FG001|Overall Study|Lack of Efficacy|2
7400380|NCT01313780|11665607|FG000|Overall Study|Adverse Event|6
7400381|NCT01313780|11665608|FG001|Overall Study|Adverse Event|11
7400382|NCT01313780|11665607|FG000|Overall Study|Withdrawal by Subject|2
7400383|NCT01313780|11665608|FG001|Overall Study|Withdrawal by Subject|8
7400384|NCT01313780|11665607|FG000|Overall Study|Protocol Violation|10
7400385|NCT01313780|11665608|FG001|Overall Study|Protocol Violation|4
7400386|NCT01313780|11665607|FG000|Overall Study|missing data|3
7400387|NCT01313780|11665608|FG001|Overall Study|missing data|3
7400388|NCT01313858|11665617|FG000|Overall Study|Premature Treatment Termination|251
7400389|NCT01313858|11665618|FG001|Overall Study|Premature Treatment Termination|219
7400390|NCT01313858|11665619|FG002|Overall Study|Premature Treatment Termination|191
7400391|NCT01313858|11665617|FG000|Overall Study|Lost to Follow-up|35
7400392|NCT01313858|11665618|FG001|Overall Study|Lost to Follow-up|51
7400393|NCT01313858|11665619|FG002|Overall Study|Lost to Follow-up|47
7400394|NCT01313884|11665625|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
7400395|NCT01314105|11665680|FG000|Overall Study|Progressive Disease|6
7400396|NCT01314105|11665681|FG001|Overall Study|Progressive Disease|10
7400397|NCT01314105|11665680|FG000|Overall Study|Refused to continue taking medication|0
7400398|NCT01314105|11665681|FG001|Overall Study|Refused to continue taking medication|1
7400399|NCT01314105|11665680|FG000|Overall Study|Other Adverse Event|1
7400400|NCT01314105|11665681|FG001|Overall Study|Other Adverse Event|1
7400401|NCT01314261|11665693|FG000|Overall Study|Adverse Event|1
7400402|NCT01314261|11665694|FG001|Overall Study|Adverse Event|0
7400403|NCT01314261|11665695|FG002|Overall Study|Adverse Event|0
7400404|NCT01314261|11665696|FG003|Overall Study|Adverse Event|0
7400405|NCT01314261|11665693|FG000|Overall Study|Withdrawal by Subject|0
7400406|NCT01314261|11665694|FG001|Overall Study|Withdrawal by Subject|3
7400407|NCT01314261|11665695|FG002|Overall Study|Withdrawal by Subject|1
7400408|NCT01314261|11665696|FG003|Overall Study|Withdrawal by Subject|0
7400409|NCT01314261|11665693|FG000|Overall Study|Lost to Follow-up|1
7400410|NCT01314261|11665694|FG001|Overall Study|Lost to Follow-up|0
7400411|NCT01314261|11665695|FG002|Overall Study|Lost to Follow-up|2
7400412|NCT01314261|11665696|FG003|Overall Study|Lost to Follow-up|2
7400413|NCT01314261|11665693|FG000|Overall Study|Virologic Failure|0
7400414|NCT01314261|11665694|FG001|Overall Study|Virologic Failure|1
7400415|NCT01314261|11665695|FG002|Overall Study|Virologic Failure|0
7400416|NCT01314261|11665696|FG003|Overall Study|Virologic Failure|1
7400417|NCT01314443|11665725|FG000|Overall Study|Withdrawal by Subject|2
7400418|NCT01314443|11665726|FG001|Overall Study|Withdrawal by Subject|1
7400419|NCT01314443|11665727|FG002|Overall Study|Withdrawal by Subject|1
7400420|NCT01314443|11665728|FG003|Overall Study|Withdrawal by Subject|1
7400421|NCT01314443|11665725|FG000|Overall Study|Protocol Violation|2
7400422|NCT01314443|11665726|FG001|Overall Study|Protocol Violation|2
7400423|NCT01314443|11665727|FG002|Overall Study|Protocol Violation|1
7400424|NCT01314443|11665728|FG003|Overall Study|Protocol Violation|1
7400425|NCT01314703|11665738|FG000|Overall Study|screen failure and closed enrollment|8
7400426|NCT01314716|11665745|FG000|Double-Blind Phase|Randomized but not treated|1
7400427|NCT01314716|11665746|FG001|Double-Blind Phase|Randomized but not treated|1
7400428|NCT01314716|11665745|FG000|Double-Blind Phase|Adverse Event|10
7400429|NCT01314716|11665746|FG001|Double-Blind Phase|Adverse Event|4
7400430|NCT01314716|11665745|FG000|Double-Blind Phase|Withdrawal by Subject|5
7400431|NCT01314716|11665746|FG001|Double-Blind Phase|Withdrawal by Subject|6
7400432|NCT01314716|11665745|FG000|Double-Blind Phase|Lost to Follow-up|0
7400433|NCT01314716|11665746|FG001|Double-Blind Phase|Lost to Follow-up|1
7400434|NCT01314716|11665745|FG000|Double-Blind Phase|Sponsor request|1
7400435|NCT01314716|11665746|FG001|Double-Blind Phase|Sponsor request|2
7400436|NCT01314716|11665745|FG000|Double-Blind Phase|Physician Decision|0
7400437|NCT01314716|11665746|FG001|Double-Blind Phase|Physician Decision|1
7400438|NCT01314716|11665745|FG000|Open-Label Phase|Adverse Event|4
7400439|NCT01314716|11665746|FG001|Open-Label Phase|Adverse Event|6
7400440|NCT01314716|11665745|FG000|Open-Label Phase|Withdrawal by Subject|1
7400441|NCT01314716|11665746|FG001|Open-Label Phase|Withdrawal by Subject|2
7400442|NCT01314716|11665745|FG000|Open-Label Phase|Physician Decision|5
7400443|NCT01314716|11665746|FG001|Open-Label Phase|Physician Decision|4
7400444|NCT01314872|11665776|FG000|Treatment Period 1|Protocol Violation|2
7400445|NCT01314872|11665777|FG001|Treatment Period 1|Protocol Violation|1
7400446|NCT01314872|11665778|FG002|Treatment Period 1|Protocol Violation|1
7400447|NCT01314872|11665779|FG003|Treatment Period 1|Protocol Violation|0
7400448|NCT01314872|11665780|FG004|Treatment Period 1|Protocol Violation|1
7400449|NCT01314872|11665781|FG005|Treatment Period 1|Protocol Violation|0
7400450|NCT01314872|11665782|FG006|Treatment Period 1|Protocol Violation|0
7400451|NCT01314872|11665783|FG007|Treatment Period 1|Protocol Violation|0
7400452|NCT01314872|11665784|FG008|Treatment Period 1|Protocol Violation|0
7400453|NCT01314872|11665785|FG009|Treatment Period 1|Protocol Violation|1
7400454|NCT01314872|11665786|FG010|Treatment Period 1|Protocol Violation|1
7400455|NCT01314872|11665787|FG011|Treatment Period 1|Protocol Violation|0
7400456|NCT01314872|11665788|FG012|Treatment Period 1|Protocol Violation|0
7400457|NCT01314872|11665789|FG013|Treatment Period 1|Protocol Violation|0
7400458|NCT01314872|11665790|FG014|Treatment Period 1|Protocol Violation|0
7400459|NCT01314872|11665776|FG000|Treatment Period 1|Physician Decision|0
7400460|NCT01314872|11665777|FG001|Treatment Period 1|Physician Decision|1
7400461|NCT01314872|11665778|FG002|Treatment Period 1|Physician Decision|0
7400462|NCT01314872|11665779|FG003|Treatment Period 1|Physician Decision|1
7400463|NCT01314872|11665780|FG004|Treatment Period 1|Physician Decision|0
7400464|NCT01314872|11665781|FG005|Treatment Period 1|Physician Decision|0
7400465|NCT01314872|11665782|FG006|Treatment Period 1|Physician Decision|0
7400466|NCT01314872|11665783|FG007|Treatment Period 1|Physician Decision|0
7400467|NCT01314872|11665784|FG008|Treatment Period 1|Physician Decision|0
7400468|NCT01314872|11665785|FG009|Treatment Period 1|Physician Decision|1
7400469|NCT01314872|11665786|FG010|Treatment Period 1|Physician Decision|0
7400470|NCT01314872|11665787|FG011|Treatment Period 1|Physician Decision|0
7400471|NCT01314872|11665788|FG012|Treatment Period 1|Physician Decision|0
7400472|NCT01314872|11665789|FG013|Treatment Period 1|Physician Decision|0
7400473|NCT01314872|11665790|FG014|Treatment Period 1|Physician Decision|0
7400474|NCT01314872|11665776|FG000|Treatment Period 1|Lack of Efficacy|1
7400475|NCT01314872|11665777|FG001|Treatment Period 1|Lack of Efficacy|0
7400476|NCT01314872|11665778|FG002|Treatment Period 1|Lack of Efficacy|0
7400477|NCT01314872|11665779|FG003|Treatment Period 1|Lack of Efficacy|0
7400478|NCT01314872|11665780|FG004|Treatment Period 1|Lack of Efficacy|0
7400479|NCT01314872|11665781|FG005|Treatment Period 1|Lack of Efficacy|1
7400480|NCT01314872|11665782|FG006|Treatment Period 1|Lack of Efficacy|0
7400481|NCT01314872|11665783|FG007|Treatment Period 1|Lack of Efficacy|2
7400482|NCT01314872|11665784|FG008|Treatment Period 1|Lack of Efficacy|0
7400483|NCT01314872|11665785|FG009|Treatment Period 1|Lack of Efficacy|0
7400484|NCT01314872|11665786|FG010|Treatment Period 1|Lack of Efficacy|0
7400485|NCT01314872|11665787|FG011|Treatment Period 1|Lack of Efficacy|0
7400486|NCT01314872|11665788|FG012|Treatment Period 1|Lack of Efficacy|0
7400487|NCT01314872|11665789|FG013|Treatment Period 1|Lack of Efficacy|0
7400488|NCT01314872|11665790|FG014|Treatment Period 1|Lack of Efficacy|0
7400489|NCT01314872|11665776|FG000|Treatment Period 1|Adverse event, non-fatal|4
7400490|NCT01314872|11665777|FG001|Treatment Period 1|Adverse event, non-fatal|2
7400491|NCT01314872|11665778|FG002|Treatment Period 1|Adverse event, non-fatal|3
7400492|NCT01314872|11665779|FG003|Treatment Period 1|Adverse event, non-fatal|2
7400493|NCT01314872|11665780|FG004|Treatment Period 1|Adverse event, non-fatal|2
7400494|NCT01314872|11665781|FG005|Treatment Period 1|Adverse event, non-fatal|4
7400495|NCT01314872|11665782|FG006|Treatment Period 1|Adverse event, non-fatal|4
7400496|NCT01314872|11665783|FG007|Treatment Period 1|Adverse event, non-fatal|2
7400497|NCT01314872|11665784|FG008|Treatment Period 1|Adverse event, non-fatal|3
7400498|NCT01314872|11665785|FG009|Treatment Period 1|Adverse event, non-fatal|0
7400499|NCT01314872|11665786|FG010|Treatment Period 1|Adverse event, non-fatal|1
7400500|NCT01314872|11665787|FG011|Treatment Period 1|Adverse event, non-fatal|0
7400501|NCT01314872|11665788|FG012|Treatment Period 1|Adverse event, non-fatal|0
7400502|NCT01314872|11665789|FG013|Treatment Period 1|Adverse event, non-fatal|0
7400503|NCT01314872|11665790|FG014|Treatment Period 1|Adverse event, non-fatal|0
7400504|NCT01314872|11665776|FG000|Treatment Period 1|Withdrawal by Subject|3
7400505|NCT01314872|11665777|FG001|Treatment Period 1|Withdrawal by Subject|1
7400506|NCT01314872|11665778|FG002|Treatment Period 1|Withdrawal by Subject|0
7400507|NCT01314872|11665779|FG003|Treatment Period 1|Withdrawal by Subject|2
7400508|NCT01314872|11665780|FG004|Treatment Period 1|Withdrawal by Subject|3
7400509|NCT01314872|11665781|FG005|Treatment Period 1|Withdrawal by Subject|1
7400510|NCT01314872|11665782|FG006|Treatment Period 1|Withdrawal by Subject|3
7400511|NCT01314872|11665783|FG007|Treatment Period 1|Withdrawal by Subject|2
7400512|NCT01314872|11665784|FG008|Treatment Period 1|Withdrawal by Subject|2
7400513|NCT01314872|11665785|FG009|Treatment Period 1|Withdrawal by Subject|2
7400514|NCT01314872|11665786|FG010|Treatment Period 1|Withdrawal by Subject|1
7400515|NCT01314872|11665787|FG011|Treatment Period 1|Withdrawal by Subject|0
7400516|NCT01314872|11665788|FG012|Treatment Period 1|Withdrawal by Subject|0
7400517|NCT01314872|11665789|FG013|Treatment Period 1|Withdrawal by Subject|0
7400518|NCT01314872|11665790|FG014|Treatment Period 1|Withdrawal by Subject|0
7400519|NCT01314872|11665776|FG000|Treatment Period 1|Lost to Follow-up|0
7400520|NCT01314872|11665777|FG001|Treatment Period 1|Lost to Follow-up|1
7400521|NCT01314872|11665778|FG002|Treatment Period 1|Lost to Follow-up|2
7400522|NCT01314872|11665779|FG003|Treatment Period 1|Lost to Follow-up|2
7400523|NCT01314872|11665780|FG004|Treatment Period 1|Lost to Follow-up|1
7400524|NCT01314872|11665781|FG005|Treatment Period 1|Lost to Follow-up|1
7400525|NCT01314872|11665782|FG006|Treatment Period 1|Lost to Follow-up|1
7400526|NCT01314872|11665783|FG007|Treatment Period 1|Lost to Follow-up|1
7400527|NCT01314872|11665784|FG008|Treatment Period 1|Lost to Follow-up|1
7400528|NCT01314872|11665785|FG009|Treatment Period 1|Lost to Follow-up|0
7400529|NCT01314872|11665786|FG010|Treatment Period 1|Lost to Follow-up|0
7400530|NCT01314872|11665787|FG011|Treatment Period 1|Lost to Follow-up|0
7400531|NCT01314872|11665788|FG012|Treatment Period 1|Lost to Follow-up|0
7400532|NCT01314872|11665789|FG013|Treatment Period 1|Lost to Follow-up|0
7400533|NCT01314872|11665790|FG014|Treatment Period 1|Lost to Follow-up|0
7400534|NCT01314872|11665776|FG000|Period 2|Protocol Violation|0
7400535|NCT01314872|11665777|FG001|Period 2|Protocol Violation|0
7400536|NCT01314872|11665778|FG002|Period 2|Protocol Violation|0
7400537|NCT01314872|11665779|FG003|Period 2|Protocol Violation|0
7400538|NCT01314872|11665780|FG004|Period 2|Protocol Violation|0
7400539|NCT01314872|11665781|FG005|Period 2|Protocol Violation|0
7400540|NCT01314872|11665782|FG006|Period 2|Protocol Violation|0
7400541|NCT01314872|11665783|FG007|Period 2|Protocol Violation|0
7400542|NCT01314872|11665784|FG008|Period 2|Protocol Violation|0
7400543|NCT01314872|11665785|FG009|Period 2|Protocol Violation|0
7400544|NCT01314872|11665786|FG010|Period 2|Protocol Violation|0
7400545|NCT01314872|11665787|FG011|Period 2|Protocol Violation|3
7400546|NCT01314872|11665788|FG012|Period 2|Protocol Violation|3
7400547|NCT01314872|11665789|FG013|Period 2|Protocol Violation|2
7400548|NCT01314872|11665790|FG014|Period 2|Protocol Violation|0
7400549|NCT01314872|11665776|FG000|Period 2|Non-compliance with study drug|0
7400550|NCT01314872|11665777|FG001|Period 2|Non-compliance with study drug|0
7400551|NCT01314872|11665778|FG002|Period 2|Non-compliance with study drug|0
7400552|NCT01314872|11665779|FG003|Period 2|Non-compliance with study drug|0
7400553|NCT01314872|11665780|FG004|Period 2|Non-compliance with study drug|0
7400554|NCT01314872|11665781|FG005|Period 2|Non-compliance with study drug|0
7400555|NCT01314872|11665782|FG006|Period 2|Non-compliance with study drug|0
7400556|NCT01314872|11665783|FG007|Period 2|Non-compliance with study drug|0
7400557|NCT01314872|11665784|FG008|Period 2|Non-compliance with study drug|0
7400558|NCT01314872|11665785|FG009|Period 2|Non-compliance with study drug|0
7400559|NCT01314872|11665786|FG010|Period 2|Non-compliance with study drug|0
7400560|NCT01314872|11665787|FG011|Period 2|Non-compliance with study drug|3
7400561|NCT01314872|11665788|FG012|Period 2|Non-compliance with study drug|3
7400562|NCT01314872|11665789|FG013|Period 2|Non-compliance with study drug|1
7400563|NCT01314872|11665790|FG014|Period 2|Non-compliance with study drug|2
7400564|NCT01314872|11665776|FG000|Period 2|Lack of Efficacy|0
7400565|NCT01314872|11665777|FG001|Period 2|Lack of Efficacy|0
7400566|NCT01314872|11665778|FG002|Period 2|Lack of Efficacy|0
7400567|NCT01314872|11665779|FG003|Period 2|Lack of Efficacy|0
7400568|NCT01314872|11665780|FG004|Period 2|Lack of Efficacy|0
7400569|NCT01314872|11665781|FG005|Period 2|Lack of Efficacy|0
7400570|NCT01314872|11665782|FG006|Period 2|Lack of Efficacy|0
7400571|NCT01314872|11665783|FG007|Period 2|Lack of Efficacy|0
7400572|NCT01314872|11665784|FG008|Period 2|Lack of Efficacy|0
7400573|NCT01314872|11665785|FG009|Period 2|Lack of Efficacy|0
7400574|NCT01314872|11665786|FG010|Period 2|Lack of Efficacy|0
7400575|NCT01314872|11665787|FG011|Period 2|Lack of Efficacy|7
7400576|NCT01314872|11665788|FG012|Period 2|Lack of Efficacy|12
7400577|NCT01314872|11665789|FG013|Period 2|Lack of Efficacy|9
7400578|NCT01314872|11665790|FG014|Period 2|Lack of Efficacy|2
7400579|NCT01314872|11665776|FG000|Period 2|Pregnancy|0
7400580|NCT01314872|11665777|FG001|Period 2|Pregnancy|0
7400581|NCT01314872|11665778|FG002|Period 2|Pregnancy|0
7400582|NCT01314872|11665779|FG003|Period 2|Pregnancy|0
7400583|NCT01314872|11665780|FG004|Period 2|Pregnancy|0
7400584|NCT01314872|11665781|FG005|Period 2|Pregnancy|0
7400585|NCT01314872|11665782|FG006|Period 2|Pregnancy|0
7400586|NCT01314872|11665783|FG007|Period 2|Pregnancy|0
7400587|NCT01314872|11665784|FG008|Period 2|Pregnancy|0
7400588|NCT01314872|11665785|FG009|Period 2|Pregnancy|0
7400589|NCT01314872|11665786|FG010|Period 2|Pregnancy|0
7400590|NCT01314872|11665787|FG011|Period 2|Pregnancy|0
7400591|NCT01314872|11665788|FG012|Period 2|Pregnancy|0
7400592|NCT01314872|11665789|FG013|Period 2|Pregnancy|0
7400593|NCT01314872|11665790|FG014|Period 2|Pregnancy|1
7400594|NCT01314872|11665776|FG000|Period 2|Study terminated by Sponsor|0
7400595|NCT01314872|11665777|FG001|Period 2|Study terminated by Sponsor|0
7400596|NCT01314872|11665778|FG002|Period 2|Study terminated by Sponsor|0
7400597|NCT01314872|11665779|FG003|Period 2|Study terminated by Sponsor|0
7400598|NCT01314872|11665780|FG004|Period 2|Study terminated by Sponsor|0
7400599|NCT01314872|11665781|FG005|Period 2|Study terminated by Sponsor|0
7400600|NCT01314872|11665782|FG006|Period 2|Study terminated by Sponsor|0
7400601|NCT01314872|11665783|FG007|Period 2|Study terminated by Sponsor|0
7400602|NCT01314872|11665784|FG008|Period 2|Study terminated by Sponsor|0
7400603|NCT01314872|11665785|FG009|Period 2|Study terminated by Sponsor|0
7400604|NCT01314872|11665786|FG010|Period 2|Study terminated by Sponsor|0
7400605|NCT01314872|11665787|FG011|Period 2|Study terminated by Sponsor|2
7400606|NCT01314872|11665788|FG012|Period 2|Study terminated by Sponsor|2
7400607|NCT01314872|11665789|FG013|Period 2|Study terminated by Sponsor|3
7400608|NCT01314872|11665790|FG014|Period 2|Study terminated by Sponsor|0
7400609|NCT01314872|11665776|FG000|Period 2|Adverse event, non-fatal|0
7400610|NCT01314872|11665777|FG001|Period 2|Adverse event, non-fatal|0
7400611|NCT01314872|11665778|FG002|Period 2|Adverse event, non-fatal|0
7400612|NCT01314872|11665779|FG003|Period 2|Adverse event, non-fatal|0
7400613|NCT01314872|11665780|FG004|Period 2|Adverse event, non-fatal|0
7400614|NCT01314872|11665781|FG005|Period 2|Adverse event, non-fatal|0
7400615|NCT01314872|11665782|FG006|Period 2|Adverse event, non-fatal|0
7400616|NCT01314872|11665783|FG007|Period 2|Adverse event, non-fatal|0
7400617|NCT01314872|11665784|FG008|Period 2|Adverse event, non-fatal|0
7400618|NCT01314872|11665785|FG009|Period 2|Adverse event, non-fatal|0
7400619|NCT01314872|11665786|FG010|Period 2|Adverse event, non-fatal|0
7400620|NCT01314872|11665787|FG011|Period 2|Adverse event, non-fatal|13
7400621|NCT01314872|11665788|FG012|Period 2|Adverse event, non-fatal|16
7400622|NCT01314872|11665789|FG013|Period 2|Adverse event, non-fatal|24
7400623|NCT01314872|11665790|FG014|Period 2|Adverse event, non-fatal|9
7400624|NCT01314872|11665776|FG000|Period 2|Withdrawal by Subject|0
7400625|NCT01314872|11665777|FG001|Period 2|Withdrawal by Subject|0
7400626|NCT01314872|11665778|FG002|Period 2|Withdrawal by Subject|0
7400627|NCT01314872|11665779|FG003|Period 2|Withdrawal by Subject|0
7400628|NCT01314872|11665780|FG004|Period 2|Withdrawal by Subject|0
7400629|NCT01314872|11665781|FG005|Period 2|Withdrawal by Subject|0
7400630|NCT01314872|11665782|FG006|Period 2|Withdrawal by Subject|0
7400631|NCT01314872|11665783|FG007|Period 2|Withdrawal by Subject|0
7400632|NCT01314872|11665784|FG008|Period 2|Withdrawal by Subject|0
7400633|NCT01314872|11665785|FG009|Period 2|Withdrawal by Subject|0
7400634|NCT01314872|11665786|FG010|Period 2|Withdrawal by Subject|0
7400635|NCT01314872|11665787|FG011|Period 2|Withdrawal by Subject|14
7400636|NCT01314872|11665788|FG012|Period 2|Withdrawal by Subject|17
7400637|NCT01314872|11665789|FG013|Period 2|Withdrawal by Subject|12
7400638|NCT01314872|11665790|FG014|Period 2|Withdrawal by Subject|4
7400639|NCT01314872|11665776|FG000|Period 2|Lost to Follow-up|0
7400640|NCT01314872|11665777|FG001|Period 2|Lost to Follow-up|0
7400641|NCT01314872|11665778|FG002|Period 2|Lost to Follow-up|0
7400642|NCT01314872|11665779|FG003|Period 2|Lost to Follow-up|0
7400643|NCT01314872|11665780|FG004|Period 2|Lost to Follow-up|0
7400644|NCT01314872|11665781|FG005|Period 2|Lost to Follow-up|0
7400645|NCT01314872|11665782|FG006|Period 2|Lost to Follow-up|0
7400646|NCT01314872|11665783|FG007|Period 2|Lost to Follow-up|0
7400647|NCT01314872|11665784|FG008|Period 2|Lost to Follow-up|0
7400648|NCT01314872|11665785|FG009|Period 2|Lost to Follow-up|0
7400649|NCT01314872|11665786|FG010|Period 2|Lost to Follow-up|0
7400650|NCT01314872|11665787|FG011|Period 2|Lost to Follow-up|6
7400651|NCT01314872|11665788|FG012|Period 2|Lost to Follow-up|7
7400652|NCT01314872|11665789|FG013|Period 2|Lost to Follow-up|2
7400653|NCT01314872|11665790|FG014|Period 2|Lost to Follow-up|6
7400654|NCT01314911|11665824|FG000|Overall Study|Lost to Follow-up|3
7400655|NCT01314911|11665825|FG001|Overall Study|Lost to Follow-up|2
7400656|NCT01314911|11665824|FG000|Overall Study|Withdrawal by Subject|1
7400657|NCT01314911|11665825|FG001|Overall Study|Withdrawal by Subject|3
7400658|NCT01314911|11665824|FG000|Overall Study|Received Non-randomized Study Drug|0
7400659|NCT01314911|11665825|FG001|Overall Study|Received Non-randomized Study Drug|1
7400660|NCT01314911|11665824|FG000|Overall Study|Never Started Treatment|1
7400661|NCT01314911|11665825|FG001|Overall Study|Never Started Treatment|0
7400662|NCT01315028|11665846|FG000|Overall Study|Lost to Follow-up|1
7400663|NCT01315028|11665847|FG001|Overall Study|Lost to Follow-up|0
7400664|NCT01315028|11665846|FG000|Overall Study|Death|0
7400665|NCT01315028|11665847|FG001|Overall Study|Death|1
7400666|NCT01315132|11665853|FG000|Overall Study|not treated due to disease progression|1
7400667|NCT01315236|11665877|FG000|Double-blind Phase|Death|1
7400668|NCT01315236|11665878|FG001|Double-blind Phase|Death|0
7400669|NCT01315236|11665877|FG000|Double-blind Phase|Adverse Event|1
7400670|NCT01315236|11665878|FG001|Double-blind Phase|Adverse Event|0
7400671|NCT01315236|11665877|FG000|Double-blind Phase|Withdrawal of Consent|1
7400672|NCT01315236|11665878|FG001|Double-blind Phase|Withdrawal of Consent|0
7400673|NCT01315236|11665877|FG000|Double-blind Phase|Lost to Follow-up|1
7400674|NCT01315236|11665878|FG001|Double-blind Phase|Lost to Follow-up|0
7400675|NCT01315236|11665877|FG000|Open-label Phase|Death|1
7400676|NCT01315236|11665878|FG001|Open-label Phase|Death|0
7400677|NCT01315236|11665877|FG000|Open-label Phase|Adverse Event|0
7400678|NCT01315236|11665878|FG001|Open-label Phase|Adverse Event|1
7400679|NCT01315236|11665877|FG000|Open-label Phase|Other|0
7400680|NCT01315236|11665878|FG001|Open-label Phase|Other|1
7400681|NCT01315236|11665877|FG000|12-Month Follow-up Period|Death|0
7400682|NCT01315236|11665878|FG001|12-Month Follow-up Period|Death|1
7400683|NCT01315236|11665877|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
7400684|NCT01315236|11665878|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
7400685|NCT01315249|11665888|FG000|Overall Study|Adverse Event|22
7400686|NCT01315249|11665889|FG001|Overall Study|Adverse Event|26
7400687|NCT01315249|11665888|FG000|Overall Study|Withdrawal by Subject|11
7400688|NCT01315249|11665889|FG001|Overall Study|Withdrawal by Subject|10
7400689|NCT01315249|11665888|FG000|Overall Study|Protocol Violation|8
7400690|NCT01315249|11665889|FG001|Overall Study|Protocol Violation|5
7400691|NCT01315249|11665888|FG000|Overall Study|Abnormal test results|1
7400692|NCT01315249|11665889|FG001|Overall Study|Abnormal test results|2
7400693|NCT01315249|11665888|FG000|Overall Study|Administrative problems|1
7400694|NCT01315249|11665889|FG001|Overall Study|Administrative problems|0
7400695|NCT01315249|11665888|FG000|Overall Study|inability to use device|1
7400696|NCT01315249|11665889|FG001|Overall Study|inability to use device|0
7400697|NCT01315249|11665888|FG000|Overall Study|Lack of Efficacy|0
7400698|NCT01315249|11665889|FG001|Overall Study|Lack of Efficacy|1
7400699|NCT01315249|11665888|FG000|Overall Study|Lost to Follow-up|0
7400700|NCT01315249|11665889|FG001|Overall Study|Lost to Follow-up|2
7400701|NCT01315249|11665888|FG000|Overall Study|Death|0
7400702|NCT01315249|11665889|FG001|Overall Study|Death|1
7400703|NCT01315678|11665917|FG000|Overall Study|Withdrawal by Subject|7
7400704|NCT01315678|11665918|FG001|Overall Study|Withdrawal by Subject|3
7400705|NCT01315678|11665917|FG000|Overall Study|Adverse Event|3
7471157|NCT01939366|11773858|FG000|Overall Study|Other|0
7471158|NCT01939366|11773859|FG001|Overall Study|Other|0
7471159|NCT01939366|11773860|FG002|Overall Study|Other|2
7471160|NCT01939366|11773861|FG003|Overall Study|Other|2
7471161|NCT01939366|11773862|FG004|Overall Study|Other|1
7471162|NCT01939366|11773858|FG000|Overall Study|Protocol Violation|0
7471163|NCT01939366|11773859|FG001|Overall Study|Protocol Violation|0
7471164|NCT01939366|11773860|FG002|Overall Study|Protocol Violation|0
7471165|NCT01939366|11773861|FG003|Overall Study|Protocol Violation|1
7471166|NCT01939366|11773862|FG004|Overall Study|Protocol Violation|0
7471167|NCT01939366|11773858|FG000|Overall Study|Sponsor decision|0
7471168|NCT01939366|11773859|FG001|Overall Study|Sponsor decision|0
7471169|NCT01939366|11773860|FG002|Overall Study|Sponsor decision|0
7471170|NCT01939366|11773861|FG003|Overall Study|Sponsor decision|0
7471171|NCT01939366|11773862|FG004|Overall Study|Sponsor decision|2
7471172|NCT01939366|11773858|FG000|Overall Study|GCP non-compliance at site|2
7471173|NCT01939366|11773859|FG001|Overall Study|GCP non-compliance at site|3
7471174|NCT01939366|11773860|FG002|Overall Study|GCP non-compliance at site|2
7471175|NCT01939366|11773861|FG003|Overall Study|GCP non-compliance at site|3
7471176|NCT01939366|11773862|FG004|Overall Study|GCP non-compliance at site|3
7471177|NCT01939496|11773886|FG000|Overall Study|Adverse Event|2
7471178|NCT01939496|11773887|FG001|Overall Study|Adverse Event|0
7471179|NCT01939496|11773888|FG002|Overall Study|Adverse Event|0
7471180|NCT01939496|11773886|FG000|Overall Study|Lost to Follow-up|1
7471181|NCT01939496|11773887|FG001|Overall Study|Lost to Follow-up|1
7471182|NCT01939496|11773888|FG002|Overall Study|Lost to Follow-up|0
7471183|NCT01939496|11773886|FG000|Overall Study|Physician Decision|1
7471184|NCT01939496|11773887|FG001|Overall Study|Physician Decision|0
7471185|NCT01939496|11773888|FG002|Overall Study|Physician Decision|0
7471186|NCT01939496|11773886|FG000|Overall Study|Protocol Violation|3
7471187|NCT01939496|11773887|FG001|Overall Study|Protocol Violation|0
7471188|NCT01939496|11773888|FG002|Overall Study|Protocol Violation|0
7471189|NCT01939496|11773886|FG000|Overall Study|Withdrawal by Subject|0
7471190|NCT01939496|11773887|FG001|Overall Study|Withdrawal by Subject|1
7471191|NCT01939496|11773888|FG002|Overall Study|Withdrawal by Subject|1
7471192|NCT01939496|11773886|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
7471193|NCT01939496|11773887|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
7471194|NCT01939496|11773888|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
7471195|NCT01939496|11773886|FG000|Overall Study|Other|2
7471196|NCT01939496|11773887|FG001|Overall Study|Other|0
7471197|NCT01939496|11773888|FG002|Overall Study|Other|1
7471198|NCT01939548|11773899|FG000|Overall Study|Non compliance|0
7471199|NCT01939548|11773900|FG001|Overall Study|Non compliance|2
7400706|NCT01315678|11665918|FG001|Overall Study|Adverse Event|1
7400707|NCT01315678|11665917|FG000|Overall Study|Lost to Follow-up|1
7400708|NCT01315678|11665918|FG001|Overall Study|Lost to Follow-up|0
7400709|NCT01315678|11665917|FG000|Overall Study|similar reason to those listed above|3
7400710|NCT01315678|11665918|FG001|Overall Study|similar reason to those listed above|2
7400711|NCT01315847|11665928|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
7400712|NCT01315847|11665929|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
7471200|NCT01939548|11773901|FG002|Overall Study|Non compliance|0
7471201|NCT01939548|11773899|FG000|Overall Study|Study Terminated by Sponsor|17
7471202|NCT01939548|11773900|FG001|Overall Study|Study Terminated by Sponsor|19
7400713|NCT01315847|11665928|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
7400714|NCT01315847|11665929|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
7400715|NCT01316055|11665947|FG000|Overall Study|Lost to Follow-up|1
7400716|NCT01316055|11665948|FG001|Overall Study|Lost to Follow-up|0
7400717|NCT01316055|11665949|FG002|Overall Study|Lost to Follow-up|0
7400718|NCT01316224|11665969|FG000|Overall Study|Protocol Violation|3
7400719|NCT01316224|11665969|FG000|Overall Study|Adverse Event|3
7400720|NCT01316224|11665969|FG000|Overall Study|Lack of Efficacy|1
7400721|NCT01316224|11665969|FG000|Overall Study|Withdrawal by Subject|1
7400722|NCT01316224|11665969|FG000|Overall Study|Adverse Event With Treatment Failure|1
7400723|NCT01316224|11665969|FG000|Overall Study|Other|1
7400724|NCT01316276|11665984|FG000|Overall Study|Death|1
7400725|NCT01316276|11665984|FG000|Overall Study|Adverse Event|19
7400726|NCT01316276|11665984|FG000|Overall Study|Withdrawal of consent|24
7400727|NCT01316276|11665984|FG000|Overall Study|Lost to Follow-up|1
7400728|NCT01316276|11665984|FG000|Overall Study|Other|22
7400729|NCT01316380|11666036|FG000|Overall Study|Adverse Event|0
7400730|NCT01316380|11666037|FG001|Overall Study|Adverse Event|2
7400731|NCT01316380|11666038|FG002|Overall Study|Adverse Event|1
7400732|NCT01316380|11666036|FG000|Overall Study|Protocol Violation|0
7400733|NCT01316380|11666037|FG001|Overall Study|Protocol Violation|0
7400734|NCT01316380|11666038|FG002|Overall Study|Protocol Violation|1
7400735|NCT01316380|11666036|FG000|Overall Study|Withdrawal by Subject|1
7400736|NCT01316380|11666037|FG001|Overall Study|Withdrawal by Subject|2
7400737|NCT01316380|11666038|FG002|Overall Study|Withdrawal by Subject|0
7400738|NCT01316380|11666036|FG000|Overall Study|Other|0
7400739|NCT01316380|11666037|FG001|Overall Study|Other|1
7400740|NCT01316380|11666038|FG002|Overall Study|Other|1
7400741|NCT01316380|11666036|FG000|Overall Study|Not treated|1
7400742|NCT01316380|11666037|FG001|Overall Study|Not treated|0
7400743|NCT01316380|11666038|FG002|Overall Study|Not treated|0
7400744|NCT01316419|11666046|FG000|Overall Study|Not treated|103
7400745|NCT01316419|11666046|FG000|Overall Study|Violated inclusion/exclusion criterion|143
7400746|NCT01316419|11666046|FG000|Overall Study|Lost to Follow-up|19
7400747|NCT01316575|11666061|FG000|Overall Study|Withdrawal by Subject|2
7400748|NCT01316575|11666062|FG001|Overall Study|Withdrawal by Subject|0
7400749|NCT01316575|11666061|FG000|Overall Study|Required alternate treatment|0
7400750|NCT01316575|11666062|FG001|Overall Study|Required alternate treatment|1
7400751|NCT01316614|11666068|FG000|Overall Study|No solid lesion and FNA not indicated|25
7400752|NCT01316614|11666068|FG000|Overall Study|Cytology slides not available for review|4
7400753|NCT01316614|11666068|FG000|Overall Study|Cystic lesion|5
7400754|NCT01316614|11666068|FG000|Overall Study|Inadequate number of passes|2
7400755|NCT01316614|11666068|FG000|Overall Study|Medically unstable|1
7400756|NCT01316692|11666073|FG000|Overall Study|Adverse Event|5
7400757|NCT01316692|11666073|FG000|Overall Study|Disease Progression|7
7400758|NCT01316887|11666091|FG000|Overall Study|Adverse Event|13
7400759|NCT01316887|11666092|FG001|Overall Study|Adverse Event|21
7400760|NCT01316887|11666093|FG002|Overall Study|Adverse Event|17
7400761|NCT01316887|11666091|FG000|Overall Study|Lack of Efficacy|9
7400762|NCT01316887|11666092|FG001|Overall Study|Lack of Efficacy|3
7400763|NCT01316887|11666093|FG002|Overall Study|Lack of Efficacy|1
7400764|NCT01316887|11666091|FG000|Overall Study|Protocol Violation|2
7400765|NCT01316887|11666092|FG001|Overall Study|Protocol Violation|6
7400766|NCT01316887|11666093|FG002|Overall Study|Protocol Violation|6
7400767|NCT01316887|11666091|FG000|Overall Study|Protocol-defined Stopping Criteria|8
7400768|NCT01316887|11666092|FG001|Overall Study|Protocol-defined Stopping Criteria|37
7400769|NCT01316887|11666093|FG002|Overall Study|Protocol-defined Stopping Criteria|36
7400770|NCT01316887|11666091|FG000|Overall Study|Study Closed/Terminated|2
7400771|NCT01316887|11666092|FG001|Overall Study|Study Closed/Terminated|4
7400772|NCT01316887|11666093|FG002|Overall Study|Study Closed/Terminated|3
7400773|NCT01316887|11666091|FG000|Overall Study|Lost to Follow-up|1
7400774|NCT01316887|11666092|FG001|Overall Study|Lost to Follow-up|7
7400775|NCT01316887|11666093|FG002|Overall Study|Lost to Follow-up|5
7400776|NCT01316887|11666091|FG000|Overall Study|Withdrawal by Subject|8
7400777|NCT01316887|11666092|FG001|Overall Study|Withdrawal by Subject|16
7400778|NCT01316887|11666093|FG002|Overall Study|Withdrawal by Subject|15
7400779|NCT01316900|11666106|FG000|Overall Study|Adverse Event|10
7400780|NCT01316900|11666107|FG001|Overall Study|Adverse Event|10
7400781|NCT01316900|11666108|FG002|Overall Study|Adverse Event|15
7400782|NCT01316900|11666109|FG003|Overall Study|Adverse Event|9
7400783|NCT01316900|11666106|FG000|Overall Study|Lack of Efficacy|17
7400784|NCT01316900|11666107|FG001|Overall Study|Lack of Efficacy|9
7400785|NCT01316900|11666108|FG002|Overall Study|Lack of Efficacy|5
7400786|NCT01316900|11666109|FG003|Overall Study|Lack of Efficacy|7
7400787|NCT01316900|11666106|FG000|Overall Study|Protocol Violation|7
7400788|NCT01316900|11666107|FG001|Overall Study|Protocol Violation|1
7400789|NCT01316900|11666108|FG002|Overall Study|Protocol Violation|4
7400790|NCT01316900|11666109|FG003|Overall Study|Protocol Violation|0
7400791|NCT01316900|11666106|FG000|Overall Study|Protocol-defined Stopping Criteria|2
7400792|NCT01316900|11666107|FG001|Overall Study|Protocol-defined Stopping Criteria|3
7400793|NCT01316900|11666108|FG002|Overall Study|Protocol-defined Stopping Criteria|10
7400794|NCT01316900|11666109|FG003|Overall Study|Protocol-defined Stopping Criteria|5
7400795|NCT01316900|11666106|FG000|Overall Study|Lost to Follow-up|1
7400796|NCT01316900|11666107|FG001|Overall Study|Lost to Follow-up|0
7400797|NCT01316900|11666108|FG002|Overall Study|Lost to Follow-up|1
7400798|NCT01316900|11666109|FG003|Overall Study|Lost to Follow-up|1
7400799|NCT01316900|11666106|FG000|Overall Study|Withdrawal by Subject|7
7400800|NCT01316900|11666107|FG001|Overall Study|Withdrawal by Subject|8
7400801|NCT01316900|11666108|FG002|Overall Study|Withdrawal by Subject|6
7400802|NCT01316900|11666109|FG003|Overall Study|Withdrawal by Subject|9
7400803|NCT01316913|11666123|FG000|Overall Study|Adverse Event|17
7400804|NCT01316913|11666124|FG001|Overall Study|Adverse Event|20
7400805|NCT01316913|11666125|FG002|Overall Study|Adverse Event|15
7400806|NCT01316913|11666126|FG003|Overall Study|Adverse Event|11
7400807|NCT01316913|11666123|FG000|Overall Study|Lack of Efficacy|22
7400808|NCT01316913|11666124|FG001|Overall Study|Lack of Efficacy|12
7400809|NCT01316913|11666125|FG002|Overall Study|Lack of Efficacy|9
7400810|NCT01316913|11666126|FG003|Overall Study|Lack of Efficacy|13
7400811|NCT01316913|11666123|FG000|Overall Study|Protocol Violation|1
7400812|NCT01316913|11666124|FG001|Overall Study|Protocol Violation|4
7400813|NCT01316913|11666125|FG002|Overall Study|Protocol Violation|4
7400814|NCT01316913|11666126|FG003|Overall Study|Protocol Violation|1
7400815|NCT01316913|11666123|FG000|Overall Study|Protocol-defined Stopping Criteria|7
7400816|NCT01316913|11666124|FG001|Overall Study|Protocol-defined Stopping Criteria|8
7400817|NCT01316913|11666125|FG002|Overall Study|Protocol-defined Stopping Criteria|11
7400818|NCT01316913|11666126|FG003|Overall Study|Protocol-defined Stopping Criteria|6
7400819|NCT01316913|11666123|FG000|Overall Study|Lost to Follow-up|0
7400820|NCT01316913|11666124|FG001|Overall Study|Lost to Follow-up|1
7400821|NCT01316913|11666125|FG002|Overall Study|Lost to Follow-up|0
7400822|NCT01316913|11666126|FG003|Overall Study|Lost to Follow-up|2
7400823|NCT01316913|11666123|FG000|Overall Study|Withdrawal by Subject|10
7400824|NCT01316913|11666124|FG001|Overall Study|Withdrawal by Subject|9
7400825|NCT01316913|11666125|FG002|Overall Study|Withdrawal by Subject|10
7400826|NCT01316913|11666126|FG003|Overall Study|Withdrawal by Subject|6
7400827|NCT01316939|11666148|FG000|Overall Study|Study closed/terminated|26
7400828|NCT01316939|11666149|FG001|Overall Study|Study closed/terminated|25
7400829|NCT01316939|11666150|FG002|Overall Study|Study closed/terminated|23
7400830|NCT01316939|11666148|FG000|Overall Study|Lack of Efficacy|24
7400831|NCT01316939|11666149|FG001|Overall Study|Lack of Efficacy|25
7400832|NCT01316939|11666150|FG002|Overall Study|Lack of Efficacy|25
7400833|NCT01316939|11666148|FG000|Overall Study|Adverse Event|9
7400834|NCT01316939|11666149|FG001|Overall Study|Adverse Event|12
7400835|NCT01316939|11666150|FG002|Overall Study|Adverse Event|11
7400836|NCT01316939|11666148|FG000|Overall Study|Withdrawal by Subject|1
7400837|NCT01316939|11666149|FG001|Overall Study|Withdrawal by Subject|3
7400838|NCT01316939|11666150|FG002|Overall Study|Withdrawal by Subject|6
7400839|NCT01316939|11666148|FG000|Overall Study|Physician Decision|2
7400840|NCT01316939|11666149|FG001|Overall Study|Physician Decision|2
7400841|NCT01316939|11666150|FG002|Overall Study|Physician Decision|1
7400842|NCT01316939|11666148|FG000|Overall Study|Lost to Follow-up|0
7400843|NCT01316939|11666149|FG001|Overall Study|Lost to Follow-up|0
7400844|NCT01316939|11666150|FG002|Overall Study|Lost to Follow-up|2
7400845|NCT01316939|11666148|FG000|Overall Study|Met Liver chemistry stopping criteria|1
7400846|NCT01316939|11666149|FG001|Overall Study|Met Liver chemistry stopping criteria|0
7400847|NCT01316939|11666150|FG002|Overall Study|Met Liver chemistry stopping criteria|1
7400848|NCT01316939|11666148|FG000|Overall Study|Protocol Violation|0
7400849|NCT01316939|11666149|FG001|Overall Study|Protocol Violation|1
7400850|NCT01316939|11666150|FG002|Overall Study|Protocol Violation|0
7400851|NCT01317004|11666160|FG000|Overall Study|Withdrawal by Subject|1
7400852|NCT01317004|11666161|FG001|Overall Study|Withdrawal by Subject|4
7400853|NCT01317004|11666160|FG000|Overall Study|Protocol Violation|0
7400854|NCT01317004|11666161|FG001|Overall Study|Protocol Violation|2
7400855|NCT01317004|11666160|FG000|Overall Study|Adverse Event|3
7400856|NCT01317004|11666161|FG001|Overall Study|Adverse Event|3
7400857|NCT01317199|11666189|FG000|Dose-escalation Phase 1|Physician Decision|5
7400858|NCT01317199|11666190|FG001|Dose-escalation Phase 1|Physician Decision|0
7400859|NCT01317199|11666191|FG002|Dose-escalation Phase 1|Physician Decision|0
7400860|NCT01317199|11666192|FG003|Dose-escalation Phase 1|Physician Decision|0
7400861|NCT01317199|11666189|FG000|Dose-escalation Phase 1|Disease progression|1
7400862|NCT01317199|11666190|FG001|Dose-escalation Phase 1|Disease progression|0
7400863|NCT01317199|11666191|FG002|Dose-escalation Phase 1|Disease progression|0
7400864|NCT01317199|11666192|FG003|Dose-escalation Phase 1|Disease progression|0
7400865|NCT01317199|11666189|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
7400866|NCT01317199|11666190|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7400867|NCT01317199|11666191|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7400868|NCT01317199|11666192|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
7400869|NCT01317199|11666189|FG000|Randomized Phase 2|Disease progression|0
7400870|NCT01317199|11666190|FG001|Randomized Phase 2|Disease progression|3
7400871|NCT01317199|11666191|FG002|Randomized Phase 2|Disease progression|7
7400872|NCT01317199|11666192|FG003|Randomized Phase 2|Disease progression|5
7400873|NCT01317199|11666189|FG000|Randomized Phase 2|Withdrawal by Subject|0
7400874|NCT01317199|11666190|FG001|Randomized Phase 2|Withdrawal by Subject|3
7400875|NCT01317199|11666191|FG002|Randomized Phase 2|Withdrawal by Subject|5
7400876|NCT01317199|11666192|FG003|Randomized Phase 2|Withdrawal by Subject|4
7400877|NCT01317199|11666189|FG000|Randomized Phase 2|Adverse Event|0
7400878|NCT01317199|11666190|FG001|Randomized Phase 2|Adverse Event|0
7400879|NCT01317199|11666191|FG002|Randomized Phase 2|Adverse Event|0
7400880|NCT01317199|11666192|FG003|Randomized Phase 2|Adverse Event|1
7400881|NCT01317199|11666189|FG000|Randomized Phase 2|Comorbidities|0
7400882|NCT01317199|11666190|FG001|Randomized Phase 2|Comorbidities|2
7400883|NCT01317199|11666191|FG002|Randomized Phase 2|Comorbidities|2
7400884|NCT01317199|11666192|FG003|Randomized Phase 2|Comorbidities|2
7400885|NCT01317199|11666189|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
7400886|NCT01317199|11666190|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7400887|NCT01317199|11666191|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
7400888|NCT01317199|11666192|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
7400889|NCT01317199|11666189|FG000|Randomized Phase 2|Disenrolled before treatment|0
7400890|NCT01317199|11666190|FG001|Randomized Phase 2|Disenrolled before treatment|1
7400891|NCT01317199|11666191|FG002|Randomized Phase 2|Disenrolled before treatment|1
7400892|NCT01317199|11666192|FG003|Randomized Phase 2|Disenrolled before treatment|2
7400893|NCT01317199|11666189|FG000|Randomized Phase 2|Patient stopped taking study drug|0
7400894|NCT01317199|11666190|FG001|Randomized Phase 2|Patient stopped taking study drug|0
7400895|NCT01317199|11666191|FG002|Randomized Phase 2|Patient stopped taking study drug|0
7400896|NCT01317199|11666192|FG003|Randomized Phase 2|Patient stopped taking study drug|1
7400897|NCT01317199|11666189|FG000|Randomized Phase 2|Patient transferred to other facility|0
7400898|NCT01317199|11666190|FG001|Randomized Phase 2|Patient transferred to other facility|0
7400899|NCT01317199|11666191|FG002|Randomized Phase 2|Patient transferred to other facility|1
7400900|NCT01317199|11666192|FG003|Randomized Phase 2|Patient transferred to other facility|0
7400901|NCT01317277|11666211|FG000|Overall Study|Lost to Follow-up|3
7400902|NCT01317277|11666212|FG001|Overall Study|Lost to Follow-up|1
7400903|NCT01317277|11666211|FG000|Overall Study|Lost MEMS|1
7400904|NCT01317277|11666212|FG001|Overall Study|Lost MEMS|1
7400905|NCT01317277|11666211|FG000|Overall Study|Unable to comply with intervention|1
7400906|NCT01317277|11666212|FG001|Overall Study|Unable to comply with intervention|0
7400907|NCT01317277|11666211|FG000|Overall Study|Withdrawal by Subject|1
7400908|NCT01317277|11666212|FG001|Overall Study|Withdrawal by Subject|0
7400909|NCT01317277|11666211|FG000|Overall Study|Adverse Event|1
7317574|NCT00723528|11546563|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
7317575|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
7317576|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
7317577|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
7317578|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
7317579|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
7317580|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
7317581|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
7317582|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7317583|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7317584|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7317585|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7387513|NCT01214837|11646073|FG000|Overall Study|Death|0
7387514|NCT01214837|11646074|FG001|Overall Study|Death|0
7387515|NCT01214837|11646075|FG002|Overall Study|Death|1
7387516|NCT01214837|11646073|FG000|Overall Study|Adverse Event|1
7387517|NCT01214837|11646074|FG001|Overall Study|Adverse Event|2
7387518|NCT01214837|11646075|FG002|Overall Study|Adverse Event|1
7387519|NCT01214837|11646073|FG000|Overall Study|Withdrawal by Subject|27
7387520|NCT01214837|11646074|FG001|Overall Study|Withdrawal by Subject|36
7387521|NCT01214837|11646075|FG002|Overall Study|Withdrawal by Subject|28
7387522|NCT01214837|11646073|FG000|Overall Study|Lost to Follow-up|20
7387523|NCT01214837|11646074|FG001|Overall Study|Lost to Follow-up|15
7387524|NCT01214837|11646075|FG002|Overall Study|Lost to Follow-up|21
7387525|NCT01214837|11646073|FG000|Overall Study|Inappropriate Enrolment|0
7387526|NCT01214837|11646074|FG001|Overall Study|Inappropriate Enrolment|1
7400910|NCT01317277|11666212|FG001|Overall Study|Adverse Event|0
7400911|NCT01317472|11666220|FG000|Overall Study|Withdrawal by Subject|1
7400912|NCT01317472|11666221|FG001|Overall Study|Withdrawal by Subject|0
7400913|NCT01317472|11666220|FG000|Overall Study|Unrelated hospitalization|1
7400914|NCT01317472|11666221|FG001|Overall Study|Unrelated hospitalization|0
7400915|NCT01317550|11666231|FG000|Overall Study|Withdrawal by Subject|1
7400916|NCT01317550|11666232|FG001|Overall Study|Withdrawal by Subject|0
7400917|NCT01317550|11666233|FG002|Overall Study|Withdrawal by Subject|0
7400918|NCT01317550|11666234|FG003|Overall Study|Withdrawal by Subject|0
7400919|NCT01317550|11666231|FG000|Overall Study|Lack of compliance study med|1
7400920|NCT01317550|11666232|FG001|Overall Study|Lack of compliance study med|0
7400921|NCT01317550|11666233|FG002|Overall Study|Lack of compliance study med|0
7400922|NCT01317550|11666234|FG003|Overall Study|Lack of compliance study med|0
7465578|NCT01881126|11764954|FG001|Overall Study|Adverse Event|1
7465579|NCT01881230|11764963|FG000|Overall Study|Death|2
7465580|NCT01881230|11764964|FG001|Overall Study|Death|0
7465581|NCT01881230|11764965|FG002|Overall Study|Death|1
7465582|NCT01881230|11764963|FG000|Overall Study|Adverse Event|9
7465583|NCT01881230|11764964|FG001|Overall Study|Adverse Event|13
7465584|NCT01881230|11764965|FG002|Overall Study|Adverse Event|12
7465585|NCT01881230|11764963|FG000|Overall Study|Progressive Disease|31
7465586|NCT01881230|11764964|FG001|Overall Study|Progressive Disease|35
7465587|NCT01881230|11764965|FG002|Overall Study|Progressive Disease|36
7465588|NCT01881230|11764963|FG000|Overall Study|Symptomatic Deterioration|3
7465589|NCT01881230|11764964|FG001|Overall Study|Symptomatic Deterioration|3
7465590|NCT01881230|11764965|FG002|Overall Study|Symptomatic Deterioration|1
7465591|NCT01881230|11764963|FG000|Overall Study|Withdrawal by Subject|6
7465592|NCT01881230|11764964|FG001|Overall Study|Withdrawal by Subject|4
7465593|NCT01881230|11764965|FG002|Overall Study|Withdrawal by Subject|6
7465594|NCT01881230|11764963|FG000|Overall Study|Physician Decision|4
7465595|NCT01881230|11764964|FG001|Overall Study|Physician Decision|3
7465596|NCT01881230|11764965|FG002|Overall Study|Physician Decision|6
7465597|NCT01881230|11764963|FG000|Overall Study|Non-Compliance with Study Drug|1
7465598|NCT01881230|11764964|FG001|Overall Study|Non-Compliance with Study Drug|2
7465599|NCT01881230|11764965|FG002|Overall Study|Non-Compliance with Study Drug|0
7465600|NCT01881230|11764963|FG000|Overall Study|Given Commercially Available Drug|0
7465601|NCT01881230|11764964|FG001|Overall Study|Given Commercially Available Drug|0
7465602|NCT01881230|11764965|FG002|Overall Study|Given Commercially Available Drug|2
7465603|NCT01881230|11764963|FG000|Overall Study|Protocol Violation|1
7465604|NCT01881230|11764964|FG001|Overall Study|Protocol Violation|1
7465605|NCT01881230|11764965|FG002|Overall Study|Protocol Violation|0
7465606|NCT01881230|11764963|FG000|Overall Study|Miscellaneous|3
7465607|NCT01881230|11764964|FG001|Overall Study|Miscellaneous|3
7465608|NCT01881230|11764965|FG002|Overall Study|Miscellaneous|0
7465609|NCT01881230|11764963|FG000|Overall Study|Untreated: Other|0
7465610|NCT01881230|11764964|FG001|Overall Study|Untreated: Other|0
7465611|NCT01881230|11764965|FG002|Overall Study|Untreated: Other|1
7465612|NCT01881230|11764963|FG000|Overall Study|Untreated: Death|0
7465613|NCT01881230|11764964|FG001|Overall Study|Untreated: Death|0
7465614|NCT01881230|11764965|FG002|Overall Study|Untreated: Death|1
7465615|NCT01881230|11764963|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
7465616|NCT01881230|11764964|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
7465617|NCT01881230|11764965|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
7465618|NCT01881620|11764999|FG000|Overall Study|Protocol Violation|4
7465619|NCT01881737|11765003|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7465620|NCT01881737|11765003|FG000|Overall Study|Withdrawal by Subject|1
7465621|NCT01881737|11765003|FG000|Overall Study|Worsening of baseline behavior|1
7465622|NCT01881750|11765011|FG000|Overall Study|Changes in concomitant therapies|2
7465623|NCT01881750|11765012|FG001|Overall Study|Changes in concomitant therapies|3
7465624|NCT01881750|11765011|FG000|Overall Study|Lost to Follow-up|0
7465625|NCT01881750|11765012|FG001|Overall Study|Lost to Follow-up|1
7465626|NCT01881776|11765023|FG000|Overall Study|Lost to Follow-up|1
7465627|NCT01881776|11765024|FG001|Overall Study|Lost to Follow-up|2
7465628|NCT01881776|11765025|FG002|Overall Study|Lost to Follow-up|1
7465629|NCT01881776|11765023|FG000|Overall Study|Protocol Violation|0
7465630|NCT01881776|11765024|FG001|Overall Study|Protocol Violation|2
7465631|NCT01881776|11765025|FG002|Overall Study|Protocol Violation|1
7465632|NCT01881789|11765039|FG000|Overall Study|Withdrawal by Subject|0
7465633|NCT01881789|11765040|FG001|Overall Study|Withdrawal by Subject|2
7465634|NCT01881789|11765041|FG002|Overall Study|Withdrawal by Subject|1
7465635|NCT01881789|11765042|FG003|Overall Study|Withdrawal by Subject|0
7465636|NCT01881789|11765043|FG004|Overall Study|Withdrawal by Subject|1
7465637|NCT01881789|11765044|FG005|Overall Study|Withdrawal by Subject|1
7465638|NCT01881789|11765039|FG000|Overall Study|Study Terminated by Sponsor|0
7465639|NCT01881789|11765040|FG001|Overall Study|Study Terminated by Sponsor|0
7465640|NCT01881789|11765041|FG002|Overall Study|Study Terminated by Sponsor|0
7465641|NCT01881789|11765042|FG003|Overall Study|Study Terminated by Sponsor|0
7465642|NCT01881789|11765043|FG004|Overall Study|Study Terminated by Sponsor|0
7465643|NCT01881789|11765044|FG005|Overall Study|Study Terminated by Sponsor|1
7465644|NCT01881789|11765039|FG000|Overall Study|Other|3
7465645|NCT01881789|11765040|FG001|Overall Study|Other|5
7465646|NCT01881789|11765041|FG002|Overall Study|Other|2
7465647|NCT01881789|11765042|FG003|Overall Study|Other|3
7400923|NCT01317615|11666244|FG000|Overall Study|Disease progression|25
7400924|NCT01317615|11666244|FG000|Overall Study|New cancer therapy|5
7400925|NCT01317615|11666244|FG000|Overall Study|Death|6
7400926|NCT01317615|11666244|FG000|Overall Study|Withdrawal by Subject|5
7400927|NCT01317615|11666244|FG000|Overall Study|Abnormal laboratory value(s)|1
7400928|NCT01317615|11666244|FG000|Overall Study|Adverse Event|7
7400929|NCT01317641|11666257|FG000|Overall Study|Not treated|0
7400930|NCT01317641|11666258|FG001|Overall Study|Not treated|0
7400931|NCT01317641|11666259|FG002|Overall Study|Not treated|0
7400932|NCT01317641|11666260|FG003|Overall Study|Not treated|0
7400933|NCT01317641|11666261|FG004|Overall Study|Not treated|0
7400934|NCT01317641|11666262|FG005|Overall Study|Not treated|0
7400935|NCT01317641|11666263|FG006|Overall Study|Not treated|0
7400936|NCT01317641|11666264|FG007|Overall Study|Not treated|1
7400937|NCT01317641|11666265|FG008|Overall Study|Not treated|1
7400938|NCT01317641|11666257|FG000|Overall Study|Adverse Event|0
7400939|NCT01317641|11666258|FG001|Overall Study|Adverse Event|1
7400940|NCT01317641|11666259|FG002|Overall Study|Adverse Event|0
7400941|NCT01317641|11666260|FG003|Overall Study|Adverse Event|1
7400942|NCT01317641|11666261|FG004|Overall Study|Adverse Event|0
7400943|NCT01317641|11666262|FG005|Overall Study|Adverse Event|0
7400944|NCT01317641|11666263|FG006|Overall Study|Adverse Event|2
7400945|NCT01317641|11666264|FG007|Overall Study|Adverse Event|1
7400946|NCT01317641|11666265|FG008|Overall Study|Adverse Event|0
7400947|NCT01317641|11666257|FG000|Overall Study|Protocol Violation|1
7400948|NCT01317641|11666258|FG001|Overall Study|Protocol Violation|0
7400949|NCT01317641|11666259|FG002|Overall Study|Protocol Violation|0
7400950|NCT01317641|11666260|FG003|Overall Study|Protocol Violation|0
7400951|NCT01317641|11666261|FG004|Overall Study|Protocol Violation|0
7400952|NCT01317641|11666262|FG005|Overall Study|Protocol Violation|0
7400953|NCT01317641|11666263|FG006|Overall Study|Protocol Violation|0
7400954|NCT01317641|11666264|FG007|Overall Study|Protocol Violation|0
7400955|NCT01317641|11666265|FG008|Overall Study|Protocol Violation|0
7400956|NCT01317641|11666257|FG000|Overall Study|Disease progression|0
7400957|NCT01317641|11666258|FG001|Overall Study|Disease progression|0
7400958|NCT01317641|11666259|FG002|Overall Study|Disease progression|0
7400959|NCT01317641|11666260|FG003|Overall Study|Disease progression|0
7400960|NCT01317641|11666261|FG004|Overall Study|Disease progression|0
7400961|NCT01317641|11666262|FG005|Overall Study|Disease progression|0
7400962|NCT01317641|11666263|FG006|Overall Study|Disease progression|0
7400963|NCT01317641|11666264|FG007|Overall Study|Disease progression|3
7400964|NCT01317641|11666265|FG008|Overall Study|Disease progression|4
7400965|NCT01317641|11666257|FG000|Overall Study|Withdrawal by Subject|0
7400966|NCT01317641|11666258|FG001|Overall Study|Withdrawal by Subject|0
7400967|NCT01317641|11666259|FG002|Overall Study|Withdrawal by Subject|0
7400968|NCT01317641|11666260|FG003|Overall Study|Withdrawal by Subject|0
7400969|NCT01317641|11666261|FG004|Overall Study|Withdrawal by Subject|0
7400970|NCT01317641|11666262|FG005|Overall Study|Withdrawal by Subject|0
7400971|NCT01317641|11666263|FG006|Overall Study|Withdrawal by Subject|1
7400972|NCT01317641|11666264|FG007|Overall Study|Withdrawal by Subject|0
7400973|NCT01317641|11666265|FG008|Overall Study|Withdrawal by Subject|0
7400974|NCT01317797|11666317|FG000|Overall Study|Other|0
7400975|NCT01317797|11666318|FG001|Overall Study|Other|1
7400976|NCT01317797|11666319|FG002|Overall Study|Other|0
7400977|NCT01317797|11666317|FG000|Overall Study|Withdrawal of Patient|0
7400978|NCT01317797|11666318|FG001|Overall Study|Withdrawal of Patient|0
7400979|NCT01317797|11666319|FG002|Overall Study|Withdrawal of Patient|1
7400980|NCT01317940|11666342|FG000|Overall Study|Death|1
7400981|NCT01317940|11666343|FG001|Overall Study|Death|0
7400982|NCT01317940|11666344|FG002|Overall Study|Death|1
7400983|NCT01317940|11666345|FG003|Overall Study|Death|0
7400984|NCT01317940|11666346|FG004|Overall Study|Death|0
7400985|NCT01317940|11666347|FG005|Overall Study|Death|0
7400986|NCT01317940|11666342|FG000|Overall Study|Lost to Follow-up|0
7400987|NCT01317940|11666343|FG001|Overall Study|Lost to Follow-up|0
7400988|NCT01317940|11666344|FG002|Overall Study|Lost to Follow-up|1
7400989|NCT01317940|11666345|FG003|Overall Study|Lost to Follow-up|1
7400990|NCT01317940|11666346|FG004|Overall Study|Lost to Follow-up|1
7400991|NCT01317940|11666347|FG005|Overall Study|Lost to Follow-up|0
7400992|NCT01317940|11666342|FG000|Overall Study|Change in therapy plan|0
7400993|NCT01317940|11666343|FG001|Overall Study|Change in therapy plan|0
7400994|NCT01317940|11666344|FG002|Overall Study|Change in therapy plan|3
7400995|NCT01317940|11666345|FG003|Overall Study|Change in therapy plan|0
7400996|NCT01317940|11666346|FG004|Overall Study|Change in therapy plan|0
7400997|NCT01317940|11666347|FG005|Overall Study|Change in therapy plan|0
7400998|NCT01318070|11666374|FG000|Overall Study|Adverse Event|1
7400999|NCT01318070|11666375|FG001|Overall Study|Adverse Event|1
7401000|NCT01318070|11666376|FG002|Overall Study|Adverse Event|5
7401001|NCT01318070|11666374|FG000|Overall Study|Withdrawal by Subject|0
7401002|NCT01318070|11666375|FG001|Overall Study|Withdrawal by Subject|1
7401003|NCT01318070|11666376|FG002|Overall Study|Withdrawal by Subject|1
7401004|NCT01318070|11666374|FG000|Overall Study|Lack of Efficacy|0
7401005|NCT01318070|11666375|FG001|Overall Study|Lack of Efficacy|0
7401006|NCT01318070|11666376|FG002|Overall Study|Lack of Efficacy|1
7401007|NCT01318070|11666374|FG000|Overall Study|Principal Investigator Discretion|1
7401008|NCT01318070|11666375|FG001|Overall Study|Principal Investigator Discretion|0
7401009|NCT01318070|11666376|FG002|Overall Study|Principal Investigator Discretion|0
7401010|NCT01318083|11666387|FG000|Overall Study|Adverse Event|4
7401011|NCT01318083|11666388|FG001|Overall Study|Adverse Event|1
7401012|NCT01318083|11666389|FG002|Overall Study|Adverse Event|2
7401013|NCT01318083|11666387|FG000|Overall Study|Withdrawal by Subject|1
7401014|NCT01318083|11666388|FG001|Overall Study|Withdrawal by Subject|0
7401015|NCT01318083|11666389|FG002|Overall Study|Withdrawal by Subject|2
7401016|NCT01318083|11666387|FG000|Overall Study|Lack of Efficacy|0
7401017|NCT01318083|11666388|FG001|Overall Study|Lack of Efficacy|0
7401018|NCT01318083|11666389|FG002|Overall Study|Lack of Efficacy|1
7401019|NCT01318083|11666387|FG000|Overall Study|Treatment Complications|1
7401020|NCT01318083|11666388|FG001|Overall Study|Treatment Complications|0
7401021|NCT01318083|11666389|FG002|Overall Study|Treatment Complications|0
7401022|NCT01318083|11666387|FG000|Overall Study|Lack of Study Medication Compliance|0
7401023|NCT01318083|11666388|FG001|Overall Study|Lack of Study Medication Compliance|1
7401024|NCT01318083|11666389|FG002|Overall Study|Lack of Study Medication Compliance|0
7401025|NCT01318109|11666400|FG000|Overall Study|Adverse Event|0
7401026|NCT01318109|11666401|FG001|Overall Study|Adverse Event|2
7401027|NCT01318109|11666402|FG002|Overall Study|Adverse Event|0
7401028|NCT01318109|11666400|FG000|Overall Study|Withdrawal by Subject|1
7401029|NCT01318109|11666401|FG001|Overall Study|Withdrawal by Subject|0
7401030|NCT01318109|11666402|FG002|Overall Study|Withdrawal by Subject|0
7401031|NCT01318109|11666400|FG000|Overall Study|Schedule Conflict|0
7401032|NCT01318109|11666401|FG001|Overall Study|Schedule Conflict|1
7401033|NCT01318109|11666402|FG002|Overall Study|Schedule Conflict|0
7401034|NCT01318122|11666412|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
7401035|NCT01318122|11666413|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7401036|NCT01318122|11666414|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
7401037|NCT01318122|11666415|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
7401038|NCT01318122|11666412|FG000|Enrolled - Long-Term Extension Study|Other|1
7401039|NCT01318122|11666413|FG001|Enrolled - Long-Term Extension Study|Other|0
7401040|NCT01318122|11666414|FG002|Enrolled - Long-Term Extension Study|Other|0
7401041|NCT01318122|11666415|FG003|Enrolled - Long-Term Extension Study|Other|0
7401042|NCT01318122|11666412|FG000|Entered - Long-Term Extension Study|Adverse Event|6
7401043|NCT01318122|11666413|FG001|Entered - Long-Term Extension Study|Adverse Event|6
7401044|NCT01318122|11666414|FG002|Entered - Long-Term Extension Study|Adverse Event|2
7401045|NCT01318122|11666415|FG003|Entered - Long-Term Extension Study|Adverse Event|4
7401046|NCT01318122|11666412|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
7401047|NCT01318122|11666413|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
7401048|NCT01318122|11666414|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
7401049|NCT01318122|11666415|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
7401050|NCT01318122|11666412|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7401051|NCT01318122|11666413|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
7401052|NCT01318122|11666414|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7401053|NCT01318122|11666415|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7401054|NCT01318122|11666412|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
7401055|NCT01318122|11666413|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
7401056|NCT01318122|11666414|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
7401057|NCT01318122|11666415|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
7401058|NCT01318135|11666425|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
7401059|NCT01318135|11666426|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
7401060|NCT01318135|11666427|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
7401061|NCT01318135|11666428|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
7401062|NCT01318135|11666429|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
7401063|NCT01318135|11666430|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
7401064|NCT01318135|11666431|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
7401065|NCT01318135|11666432|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
7401066|NCT01318135|11666425|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
7401067|NCT01318135|11666426|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401068|NCT01318135|11666427|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401069|NCT01318135|11666428|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401070|NCT01318135|11666429|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401071|NCT01318135|11666430|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401072|NCT01318135|11666431|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401073|NCT01318135|11666432|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
7401074|NCT01318135|11666425|FG000|Entered - Long-Term Extension Study|Adverse Event|9
7401075|NCT01318135|11666426|FG001|Entered - Long-Term Extension Study|Adverse Event|3
7401076|NCT01318135|11666427|FG002|Entered - Long-Term Extension Study|Adverse Event|4
7401077|NCT01318135|11666428|FG003|Entered - Long-Term Extension Study|Adverse Event|3
7401078|NCT01318135|11666429|FG004|Entered - Long-Term Extension Study|Adverse Event|4
7401079|NCT01318135|11666430|FG005|Entered - Long-Term Extension Study|Adverse Event|2
7401080|NCT01318135|11666431|FG006|Entered - Long-Term Extension Study|Adverse Event|0
7401081|NCT01318135|11666432|FG007|Entered - Long-Term Extension Study|Adverse Event|0
7401082|NCT01318135|11666425|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
7401083|NCT01318135|11666426|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
7401084|NCT01318135|11666427|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
7401085|NCT01318135|11666428|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
7401086|NCT01318135|11666429|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
7401087|NCT01318135|11666430|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
7401088|NCT01318135|11666431|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
7401089|NCT01318135|11666432|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
7401090|NCT01318135|11666425|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7401091|NCT01318135|11666426|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7401092|NCT01318135|11666427|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7401093|NCT01318135|11666428|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7401094|NCT01318135|11666429|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
7401095|NCT01318135|11666430|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7401096|NCT01318135|11666431|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
7401097|NCT01318135|11666432|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
7401098|NCT01318135|11666425|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
7401099|NCT01318135|11666426|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
7401100|NCT01318135|11666427|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
7401101|NCT01318135|11666428|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
7401102|NCT01318135|11666429|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
7401103|NCT01318135|11666430|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
7401104|NCT01318135|11666431|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
7401105|NCT01318135|11666432|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
7401106|NCT01318135|11666425|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401107|NCT01318135|11666426|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401108|NCT01318135|11666427|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401109|NCT01318135|11666428|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401110|NCT01318135|11666429|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401111|NCT01318135|11666430|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401112|NCT01318135|11666431|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
7401113|NCT01318135|11666432|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
7401114|NCT01318382|11666469|FG000|Overall Study|Physician Decision|2
7401115|NCT01318382|11666469|FG000|Overall Study|Device Malfunction|10
7401116|NCT01318382|11666469|FG000|Overall Study|Protocol Violation|1
7401117|NCT01318499|11666481|FG000|Overall Study|Adverse Event|16
7401118|NCT01318499|11666482|FG001|Overall Study|Adverse Event|11
7401119|NCT01318499|11666483|FG002|Overall Study|Adverse Event|6
7401120|NCT01318499|11666481|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
7401121|NCT01318499|11666482|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
7401122|NCT01318499|11666483|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
7401123|NCT01318499|11666481|FG000|Overall Study|Noncompliance|2
7401124|NCT01318499|11666482|FG001|Overall Study|Noncompliance|3
7401125|NCT01318499|11666483|FG002|Overall Study|Noncompliance|0
7401126|NCT01318499|11666481|FG000|Overall Study|Treatment Failure|19
7401127|NCT01318499|11666482|FG001|Overall Study|Treatment Failure|19
7401128|NCT01318499|11666483|FG002|Overall Study|Treatment Failure|101
7401129|NCT01318499|11666481|FG000|Overall Study|Protocol Violation|2
7401130|NCT01318499|11666482|FG001|Overall Study|Protocol Violation|4
7401131|NCT01318499|11666483|FG002|Overall Study|Protocol Violation|2
7401132|NCT01318499|11666481|FG000|Overall Study|Patient Did Not Use Study Medication|18
7401133|NCT01318499|11666482|FG001|Overall Study|Patient Did Not Use Study Medication|28
7401134|NCT01318499|11666483|FG002|Overall Study|Patient Did Not Use Study Medication|14
7401135|NCT01318499|11666481|FG000|Overall Study|Other|7
7401136|NCT01318499|11666482|FG001|Overall Study|Other|10
7401137|NCT01318499|11666483|FG002|Overall Study|Other|22
7401138|NCT01318512|11666493|FG000|Maintenance Period (6 Months)|Death|2
7401139|NCT01318512|11666493|FG000|Maintenance Period (6 Months)|Protocol Violation|9
7401140|NCT01318811|11666543|FG000|Overall Study|Physician Decision|1
7401141|NCT01318811|11666544|FG001|Overall Study|Physician Decision|1
7401142|NCT01318811|11666543|FG000|Overall Study|CRRT stopped for head CT|0
7401143|NCT01318811|11666544|FG001|Overall Study|CRRT stopped for head CT|1
7401144|NCT01318811|11666543|FG000|Overall Study|Death|0
7401145|NCT01318811|11666544|FG001|Overall Study|Death|1
7401146|NCT01318811|11666543|FG000|Overall Study|CRRT stopped for head MRI|0
7401147|NCT01318811|11666544|FG001|Overall Study|CRRT stopped for head MRI|1
7401148|NCT01318876|11666550|FG000|Day 8 Survey|email address invalid|96
7401149|NCT01318876|11666550|FG000|Day 8 Survey|survey not completed-don't know why|1724
7401150|NCT01318876|11666550|FG000|Day 29 Survey|survey not completed-don't know why|1825
7401151|NCT01318902|11666558|FG000|Overall Study|Symptomatic Deterioration|0
7401152|NCT01318902|11666559|FG001|Overall Study|Symptomatic Deterioration|1
7401153|NCT01318902|11666560|FG002|Overall Study|Symptomatic Deterioration|1
7401154|NCT01318902|11666561|FG003|Overall Study|Symptomatic Deterioration|2
7401155|NCT01318902|11666558|FG000|Overall Study|Withdrawal by Patient|0
7401156|NCT01318902|11666559|FG001|Overall Study|Withdrawal by Patient|1
7401157|NCT01318902|11666560|FG002|Overall Study|Withdrawal by Patient|0
7401158|NCT01318902|11666561|FG003|Overall Study|Withdrawal by Patient|3
7401159|NCT01318902|11666558|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7401160|NCT01318902|11666559|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7401161|NCT01318902|11666560|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7401162|NCT01318902|11666561|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
7401163|NCT01318902|11666558|FG000|Overall Study|Adverse Event|0
7401164|NCT01318902|11666559|FG001|Overall Study|Adverse Event|1
7401165|NCT01318902|11666560|FG002|Overall Study|Adverse Event|0
7401166|NCT01318902|11666561|FG003|Overall Study|Adverse Event|0
7401167|NCT01318902|11666558|FG000|Overall Study|Terminated by Sponsor|0
7401168|NCT01318902|11666559|FG001|Overall Study|Terminated by Sponsor|0
7401169|NCT01318902|11666560|FG002|Overall Study|Terminated by Sponsor|1
7401170|NCT01318902|11666561|FG003|Overall Study|Terminated by Sponsor|0
7401171|NCT01318915|11666573|FG000|Overall Study|Lost to Follow-up|1
7401172|NCT01319383|11666601|FG000|Overall Study|No ex vivo or in vivo response|4
7401173|NCT01319383|11666602|FG001|Overall Study|No ex vivo or in vivo response|0
7401174|NCT01319383|11666601|FG000|Overall Study|Physician Decision|3
7401175|NCT01319383|11666602|FG001|Overall Study|Physician Decision|0
7401176|NCT01319383|11666601|FG000|Overall Study|Lack of Efficacy|5
7401177|NCT01319383|11666602|FG001|Overall Study|Lack of Efficacy|9
7401178|NCT01319383|11666601|FG000|Overall Study|No in vivo response to interval doses|0
7401179|NCT01319383|11666602|FG001|Overall Study|No in vivo response to interval doses|1
7401180|NCT01319422|11666625|FG000|Overall Study|Withdrawal by Subject|1
7401181|NCT01319422|11666626|FG001|Overall Study|Withdrawal by Subject|0
7401182|NCT01319721|11666663|FG000|Overall Study|Lost to Follow-up|1
7401183|NCT01319721|11666664|FG001|Overall Study|Lost to Follow-up|6
7401184|NCT01319877|11666715|FG000|Overall Study|Lost to Follow-up|100
7401185|NCT01319877|11666716|FG001|Overall Study|Lost to Follow-up|37
7401186|NCT01319877|11666715|FG000|Overall Study|Physician Decision|2
7401187|NCT01319877|11666716|FG001|Overall Study|Physician Decision|0
7401188|NCT01319877|11666715|FG000|Overall Study|Disease Progression|2
7401189|NCT01319877|11666716|FG001|Overall Study|Disease Progression|2
7401190|NCT01319877|11666715|FG000|Overall Study|Withdrawal by Subject|0
7401191|NCT01319877|11666716|FG001|Overall Study|Withdrawal by Subject|1
7401192|NCT01319877|11666715|FG000|Overall Study|Reason Not Specified|4
7401193|NCT01319877|11666716|FG001|Overall Study|Reason Not Specified|5
7401194|NCT01319929|11666723|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
7401195|NCT01319929|11666724|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
7401196|NCT01319929|11666723|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7401197|NCT01319929|11666724|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
7401198|NCT01319929|11666723|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
7401199|NCT01319929|11666724|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
7401200|NCT01319929|11666723|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
7401201|NCT01319929|11666724|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
7401202|NCT01319929|11666723|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
7401203|NCT01319929|11666724|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
7401204|NCT01319994|11666733|FG000|Overall Study|Protocol Violation|7
7401205|NCT01319994|11666734|FG001|Overall Study|Protocol Violation|6
7401206|NCT01320033|11666743|FG000|Overall Study|Lack of Efficacy|0
7401207|NCT01320033|11666744|FG001|Overall Study|Lack of Efficacy|0
7401208|NCT01320033|11666745|FG002|Overall Study|Lack of Efficacy|1
7401209|NCT01320033|11666743|FG000|Overall Study|Adverse Event|9
7401210|NCT01320033|11666744|FG001|Overall Study|Adverse Event|7
7401211|NCT01320033|11666745|FG002|Overall Study|Adverse Event|8
7401212|NCT01320033|11666743|FG000|Overall Study|Withdrawal by Subject|22
7401213|NCT01320033|11666744|FG001|Overall Study|Withdrawal by Subject|23
7401214|NCT01320033|11666745|FG002|Overall Study|Withdrawal by Subject|23
7401215|NCT01320033|11666743|FG000|Overall Study|Protocol Violation|3
7401216|NCT01320033|11666744|FG001|Overall Study|Protocol Violation|5
7401217|NCT01320033|11666745|FG002|Overall Study|Protocol Violation|3
7401218|NCT01320033|11666743|FG000|Overall Study|Lost to Follow-up|22
7401219|NCT01320033|11666744|FG001|Overall Study|Lost to Follow-up|26
7401220|NCT01320033|11666745|FG002|Overall Study|Lost to Follow-up|17
7401221|NCT01320033|11666743|FG000|Overall Study|Other|2
7401222|NCT01320033|11666744|FG001|Overall Study|Other|3
7401223|NCT01320033|11666745|FG002|Overall Study|Other|1
7401224|NCT01320085|11666756|FG000|Overall Study|Treatment Ongoing|0
7401225|NCT01320085|11666757|FG001|Overall Study|Treatment Ongoing|13
7401226|NCT01320085|11666758|FG002|Overall Study|Treatment Ongoing|2
7401227|NCT01320085|11666756|FG000|Overall Study|Disease Progression|26
7401228|NCT01320085|11666757|FG001|Overall Study|Disease Progression|86
7401229|NCT01320085|11666758|FG002|Overall Study|Disease Progression|16
7401230|NCT01320085|11666756|FG000|Overall Study|Adverse Event|12
7401231|NCT01320085|11666757|FG001|Overall Study|Adverse Event|14
7401232|NCT01320085|11666758|FG002|Overall Study|Adverse Event|5
7401233|NCT01320085|11666756|FG000|Overall Study|Withdrawal by Subject|2
7401234|NCT01320085|11666757|FG001|Overall Study|Withdrawal by Subject|4
7401235|NCT01320085|11666758|FG002|Overall Study|Withdrawal by Subject|1
7401236|NCT01320085|11666756|FG000|Overall Study|Protocol Deviation|1
7401237|NCT01320085|11666757|FG001|Overall Study|Protocol Deviation|0
7401238|NCT01320085|11666758|FG002|Overall Study|Protocol Deviation|1
7401239|NCT01320150|11666777|FG000|Overall Study|Protocol Violation|15
7401240|NCT01320150|11666777|FG000|Overall Study|Withdrawal by Subject|5
7401241|NCT01320150|11666777|FG000|Overall Study|Death|2
7401242|NCT01320150|11666777|FG000|Overall Study|Lost to Follow-up|44
7401243|NCT01320202|11666783|FG000|Overall Study|Adverse Event|5
7401244|NCT01320202|11666784|FG001|Overall Study|Adverse Event|5
7401245|NCT01320202|11666783|FG000|Overall Study|Death|5
7401246|NCT01320202|11666784|FG001|Overall Study|Death|3
7401247|NCT01320202|11666783|FG000|Overall Study|Lost to Follow-up|1
7401248|NCT01320202|11666784|FG001|Overall Study|Lost to Follow-up|0
7401249|NCT01320202|11666783|FG000|Overall Study|Physician Decision|3
7401250|NCT01320202|11666784|FG001|Overall Study|Physician Decision|1
7401251|NCT01320202|11666783|FG000|Overall Study|Protocol Violation|2
7401252|NCT01320202|11666784|FG001|Overall Study|Protocol Violation|1
7401253|NCT01320202|11666783|FG000|Overall Study|Withdrawal by Subject|10
7401254|NCT01320202|11666784|FG001|Overall Study|Withdrawal by Subject|3
7401255|NCT01320202|11666783|FG000|Overall Study|non-protocol change to ESA or IV iron|17
7401256|NCT01320202|11666784|FG001|Overall Study|non-protocol change to ESA or IV iron|20
7401257|NCT01320202|11666783|FG000|Overall Study|kidney transplant|1
7401258|NCT01320202|11666784|FG001|Overall Study|kidney transplant|2
7401259|NCT01320202|11666783|FG000|Overall Study|blood transfusion|1
7401260|NCT01320202|11666784|FG001|Overall Study|blood transfusion|7
7401261|NCT01320202|11666783|FG000|Overall Study|moved/changed dialysis|5
7401262|NCT01320202|11666784|FG001|Overall Study|moved/changed dialysis|2
7401263|NCT01320202|11666783|FG000|Overall Study|sponsor request|2
7401264|NCT01320202|11666784|FG001|Overall Study|sponsor request|0
7401265|NCT01320202|11666783|FG000|Overall Study|ineligible|3
7401266|NCT01320202|11666784|FG001|Overall Study|ineligible|0
7401267|NCT01320202|11666783|FG000|Overall Study|regained renal function|1
7401268|NCT01320202|11666784|FG001|Overall Study|regained renal function|0
7401269|NCT01320293|11666793|FG000|Overall Study|Lack of Efficacy|1
7401270|NCT01320293|11666793|FG000|Overall Study|Adverse Event|1
7401271|NCT01320722|11666819|FG000|Overall Study|Did not Receive Intervention|3
7401272|NCT01320722|11666820|FG001|Overall Study|Did not Receive Intervention|2
7401273|NCT01320722|11666821|FG002|Overall Study|Did not Receive Intervention|1
7401274|NCT01320722|11666822|FG003|Overall Study|Did not Receive Intervention|1
7401275|NCT01320722|11666823|FG004|Overall Study|Did not Receive Intervention|2
7401276|NCT01320722|11666819|FG000|Overall Study|Lost to Follow-up|0
7401277|NCT01320722|11666820|FG001|Overall Study|Lost to Follow-up|1
7401278|NCT01320722|11666821|FG002|Overall Study|Lost to Follow-up|0
7401279|NCT01320722|11666822|FG003|Overall Study|Lost to Follow-up|1
7401280|NCT01320722|11666823|FG004|Overall Study|Lost to Follow-up|3
7401281|NCT01320722|11666819|FG000|Overall Study|Not Available for the 8 Week Visit|0
7401282|NCT01320722|11666820|FG001|Overall Study|Not Available for the 8 Week Visit|3
7401283|NCT01320722|11666821|FG002|Overall Study|Not Available for the 8 Week Visit|0
7401284|NCT01320722|11666822|FG003|Overall Study|Not Available for the 8 Week Visit|0
7401285|NCT01320722|11666823|FG004|Overall Study|Not Available for the 8 Week Visit|0
7401286|NCT01320722|11666819|FG000|Overall Study|Participant Developed a Rash|0
7401287|NCT01320722|11666820|FG001|Overall Study|Participant Developed a Rash|0
7401288|NCT01320722|11666821|FG002|Overall Study|Participant Developed a Rash|2
7401289|NCT01320722|11666822|FG003|Overall Study|Participant Developed a Rash|1
7401290|NCT01320722|11666823|FG004|Overall Study|Participant Developed a Rash|1
7401291|NCT01320722|11666819|FG000|Overall Study|Non-compliant with Medication|0
7401292|NCT01320722|11666820|FG001|Overall Study|Non-compliant with Medication|0
7401293|NCT01320722|11666821|FG002|Overall Study|Non-compliant with Medication|1
7401294|NCT01320722|11666822|FG003|Overall Study|Non-compliant with Medication|0
7401295|NCT01320722|11666823|FG004|Overall Study|Non-compliant with Medication|0
7401296|NCT01320722|11666819|FG000|Overall Study|Adverse Event|0
7401297|NCT01320722|11666820|FG001|Overall Study|Adverse Event|0
7401298|NCT01320722|11666821|FG002|Overall Study|Adverse Event|3
7401299|NCT01320722|11666822|FG003|Overall Study|Adverse Event|6
7401300|NCT01320722|11666823|FG004|Overall Study|Adverse Event|0
7401301|NCT01320722|11666819|FG000|Overall Study|Not Compliant with Study Procedures|0
7401302|NCT01320722|11666820|FG001|Overall Study|Not Compliant with Study Procedures|0
7401303|NCT01320722|11666821|FG002|Overall Study|Not Compliant with Study Procedures|0
7401304|NCT01320722|11666822|FG003|Overall Study|Not Compliant with Study Procedures|4
7401305|NCT01320722|11666823|FG004|Overall Study|Not Compliant with Study Procedures|0
7401306|NCT01320722|11666819|FG000|Overall Study|Pregnancy|0
7401307|NCT01320722|11666820|FG001|Overall Study|Pregnancy|0
7401308|NCT01320722|11666821|FG002|Overall Study|Pregnancy|0
7401309|NCT01320722|11666822|FG003|Overall Study|Pregnancy|1
7401310|NCT01320722|11666823|FG004|Overall Study|Pregnancy|0
7401311|NCT01320722|11666819|FG000|Overall Study|Started an Exclusionary Medication|0
7401312|NCT01320722|11666820|FG001|Overall Study|Started an Exclusionary Medication|0
7401313|NCT01320722|11666821|FG002|Overall Study|Started an Exclusionary Medication|0
7401314|NCT01320722|11666822|FG003|Overall Study|Started an Exclusionary Medication|0
7401315|NCT01320722|11666823|FG004|Overall Study|Started an Exclusionary Medication|1
7401316|NCT01320722|11666819|FG000|Overall Study|Withdrew due to Health Condition|0
7401317|NCT01320722|11666820|FG001|Overall Study|Withdrew due to Health Condition|0
7401318|NCT01320722|11666821|FG002|Overall Study|Withdrew due to Health Condition|0
7401319|NCT01320722|11666822|FG003|Overall Study|Withdrew due to Health Condition|0
7401320|NCT01320722|11666823|FG004|Overall Study|Withdrew due to Health Condition|1
7401321|NCT01320735|11666838|FG000|Overall Study|Adverse Event|3
7401322|NCT01320735|11666838|FG000|Overall Study|Withdrawal by Subject|3
7401323|NCT01320735|11666838|FG000|Overall Study|Lost to Follow-up|13
7401324|NCT01320735|11666838|FG000|Overall Study|Administrative Reason|6
7401325|NCT01320735|11666838|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
7401326|NCT01320735|11666838|FG000|Overall Study|Protocol Violation|1
7401327|NCT01320735|11666838|FG000|Overall Study|Other|1
7401328|NCT01320735|11666838|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
7401329|NCT01320735|11666838|FG000|Overall Study|Investigator Unable to be Contacted|17
7401330|NCT01320943|11666859|FG000|Overall Study|Lost to Follow-up|1
7401331|NCT01320943|11666860|FG001|Overall Study|Lost to Follow-up|0
7401332|NCT01320943|11666859|FG000|Overall Study|Physician Decision|0
7401333|NCT01320943|11666860|FG001|Overall Study|Physician Decision|1
7401334|NCT01320943|11666859|FG000|Overall Study|Randomized but not Treated|0
7401335|NCT01320943|11666860|FG001|Overall Study|Randomized but not Treated|1
7401338|NCT01321606|11666923|FG000|Overall Study|Lost to Follow-up|0
7401339|NCT01321606|11666924|FG001|Overall Study|Lost to Follow-up|0
7401340|NCT01321606|11666925|FG002|Overall Study|Lost to Follow-up|0
7401341|NCT01321606|11666926|FG003|Overall Study|Lost to Follow-up|1
7401342|NCT01321710|11666939|FG000|Overall Study|Lost to Follow-up|4
7401343|NCT01321710|11666940|FG001|Overall Study|Lost to Follow-up|5
7401344|NCT01321710|11666941|FG002|Overall Study|Lost to Follow-up|0
7401345|NCT01321723|11666954|FG000|Overall Study|Adverse Event|3
7401346|NCT01321723|11666955|FG001|Overall Study|Adverse Event|5
7401347|NCT01321723|11666956|FG002|Overall Study|Adverse Event|2
7401348|NCT01321723|11666954|FG000|Overall Study|Withdrawal by Subject|2
7401349|NCT01321723|11666955|FG001|Overall Study|Withdrawal by Subject|0
7401350|NCT01321723|11666956|FG002|Overall Study|Withdrawal by Subject|2
7401351|NCT01321749|11666966|FG000|Overall Study|Lost to Follow-up|4
7401352|NCT01321749|11666967|FG001|Overall Study|Lost to Follow-up|11
7401353|NCT01321749|11666966|FG000|Overall Study|Protocol Violation|4
7401354|NCT01321749|11666967|FG001|Overall Study|Protocol Violation|7
7401355|NCT01321749|11666966|FG000|Overall Study|Withdrawal by Subject|5
7401356|NCT01321749|11666967|FG001|Overall Study|Withdrawal by Subject|4
7401357|NCT01321879|11666973|FG000|Overall Study|Lack of Efficacy|5
7401358|NCT01321879|11666973|FG000|Overall Study|Adverse Event|5
7401359|NCT01321879|11666973|FG000|Overall Study|Death|3
7401360|NCT01321879|11666973|FG000|Overall Study|Withdrawal by Subject|1
7401361|NCT01322009|11666979|FG000|Overall Study|Death|0
7401362|NCT01322009|11666980|FG001|Overall Study|Death|1
7401363|NCT01322009|11666979|FG000|Overall Study|Adverse Event|0
7401364|NCT01322009|11666980|FG001|Overall Study|Adverse Event|1
7401365|NCT01322009|11666979|FG000|Overall Study|ng tube discontinued|0
7401366|NCT01322009|11666980|FG001|Overall Study|ng tube discontinued|1
7401367|NCT01322347|11667006|FG000|Overall Study|Adverse Event|7
7401368|NCT01322347|11667007|FG001|Overall Study|Adverse Event|2
7401369|NCT01322347|11667006|FG000|Overall Study|Death|5
7401370|NCT01322347|11667007|FG001|Overall Study|Death|3
7401371|NCT01322347|11667006|FG000|Overall Study|Physician Decision|2
7401372|NCT01322347|11667007|FG001|Overall Study|Physician Decision|1
7401373|NCT01322347|11667006|FG000|Overall Study|Protocol Violation|5
7401374|NCT01322347|11667007|FG001|Overall Study|Protocol Violation|2
7401375|NCT01322347|11667006|FG000|Overall Study|Withdrawal by Subject|1
7401376|NCT01322347|11667007|FG001|Overall Study|Withdrawal by Subject|4
7401377|NCT01322347|11667006|FG000|Overall Study|non-protocol change to ESA or IV iron|14
7401378|NCT01322347|11667007|FG001|Overall Study|non-protocol change to ESA or IV iron|6
7401379|NCT01322347|11667006|FG000|Overall Study|blood transfusion|5
7401380|NCT01322347|11667007|FG001|Overall Study|blood transfusion|5
7401381|NCT01322347|11667006|FG000|Overall Study|sponsor decision|1
7401382|NCT01322347|11667007|FG001|Overall Study|sponsor decision|3
7401383|NCT01322347|11667006|FG000|Overall Study|ineligible|6
7401384|NCT01322347|11667007|FG001|Overall Study|ineligible|3
7401385|NCT01322347|11667006|FG000|Overall Study|kidney transplant|3
7401386|NCT01322347|11667007|FG001|Overall Study|kidney transplant|1
7401387|NCT01322347|11667006|FG000|Overall Study|study drug withheld > 12 wks|0
7401388|NCT01322347|11667007|FG001|Overall Study|study drug withheld > 12 wks|1
7401389|NCT01322347|11667006|FG000|Overall Study|moved/changed dialysis|2
7401390|NCT01322347|11667007|FG001|Overall Study|moved/changed dialysis|4
7401391|NCT01322386|11667021|FG000|Overall Study|Protocol Violation|0
7401392|NCT01322386|11667022|FG001|Overall Study|Protocol Violation|1
7401393|NCT01322386|11667021|FG000|Overall Study|Physician Decision|0
7401394|NCT01322386|11667022|FG001|Overall Study|Physician Decision|1
7401395|NCT01322490|11667033|FG000|Treatment Period|Adverse Event|12
7401396|NCT01322490|11667034|FG001|Treatment Period|Adverse Event|18
7401397|NCT01322490|11667035|FG002|Treatment Period|Adverse Event|15
7401398|NCT01322490|11667033|FG000|Treatment Period|Death|5
7401399|NCT01322490|11667034|FG001|Treatment Period|Death|7
7401400|NCT01322490|11667035|FG002|Treatment Period|Death|3
7401401|NCT01322490|11667033|FG000|Treatment Period|Lack of Efficacy|89
7401402|NCT01322490|11667034|FG001|Treatment Period|Lack of Efficacy|100
7401403|NCT01322490|11667035|FG002|Treatment Period|Lack of Efficacy|112
7401404|NCT01322490|11667033|FG000|Treatment Period|Physician Decision|0
7401405|NCT01322490|11667034|FG001|Treatment Period|Physician Decision|2
7401406|NCT01322490|11667035|FG002|Treatment Period|Physician Decision|1
7401407|NCT01322490|11667033|FG000|Treatment Period|Protocol Violation|7
7401408|NCT01322490|11667034|FG001|Treatment Period|Protocol Violation|5
7401409|NCT01322490|11667035|FG002|Treatment Period|Protocol Violation|4
7401410|NCT01322490|11667033|FG000|Treatment Period|Withdrawal by Subject|14
7401411|NCT01322490|11667034|FG001|Treatment Period|Withdrawal by Subject|16
7401412|NCT01322490|11667035|FG002|Treatment Period|Withdrawal by Subject|11
7401413|NCT01322490|11667033|FG000|Treatment Period|Non-compliance with study drug|0
7401414|NCT01322490|11667034|FG001|Treatment Period|Non-compliance with study drug|0
7401415|NCT01322490|11667035|FG002|Treatment Period|Non-compliance with study drug|1
7401416|NCT01322490|11667033|FG000|Treatment Period|Other per report|2
7401417|NCT01322490|11667034|FG001|Treatment Period|Other per report|2
7401418|NCT01322490|11667035|FG002|Treatment Period|Other per report|1
7401419|NCT01322490|11667033|FG000|Treatment Period|Randomized but Not Treated|3
7401420|NCT01322490|11667034|FG001|Treatment Period|Randomized but Not Treated|3
7401421|NCT01322490|11667035|FG002|Treatment Period|Randomized but Not Treated|5
7401422|NCT01322490|11667033|FG000|Long Term Follow-up Period|Death|235
7401423|NCT01322490|11667034|FG001|Long Term Follow-up Period|Death|239
7401424|NCT01322490|11667035|FG002|Long Term Follow-up Period|Death|236
7401425|NCT01322490|11667033|FG000|Long Term Follow-up Period|Lost to Follow-up|2
7401426|NCT01322490|11667034|FG001|Long Term Follow-up Period|Lost to Follow-up|2
7401427|NCT01322490|11667035|FG002|Long Term Follow-up Period|Lost to Follow-up|3
7401428|NCT01322490|11667033|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
7401429|NCT01322490|11667034|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
7401430|NCT01322490|11667035|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
7401431|NCT01322490|11667033|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
7401432|NCT01322490|11667034|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
7401433|NCT01322490|11667035|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
7401434|NCT01322490|11667033|FG000|Long Term Follow-up Period|Other per report|3
7401435|NCT01322490|11667034|FG001|Long Term Follow-up Period|Other per report|2
7401436|NCT01322490|11667035|FG002|Long Term Follow-up Period|Other per report|2
7401437|NCT01322490|11667033|FG000|Long Term Follow-up Period|Unknown/Missing|0
7401438|NCT01322490|11667034|FG001|Long Term Follow-up Period|Unknown/Missing|1
7401439|NCT01322490|11667035|FG002|Long Term Follow-up Period|Unknown/Missing|1
7401440|NCT01323192|11667151|FG000|Overall Study|Adverse Event|6
7401441|NCT01323192|11667152|FG001|Overall Study|Adverse Event|1
7401442|NCT01323192|11667151|FG000|Overall Study|Withdrawal by Subject|3
7401443|NCT01323192|11667152|FG001|Overall Study|Withdrawal by Subject|1
7401444|NCT01323192|11667151|FG000|Overall Study|Noncompliance with study medication|0
7401445|NCT01323192|11667152|FG001|Overall Study|Noncompliance with study medication|3
7401446|NCT01323192|11667151|FG000|Overall Study|Nonmedical reasons|0
7401447|NCT01323192|11667152|FG001|Overall Study|Nonmedical reasons|1
7401448|NCT01323270|11667160|FG000|Overall Study|Withdrawal by Subject|19
7401449|NCT01323270|11667161|FG001|Overall Study|Withdrawal by Subject|10
7401450|NCT01323270|11667160|FG000|Overall Study|Protocol Violation|9
7401451|NCT01323270|11667161|FG001|Overall Study|Protocol Violation|7
7401452|NCT01323270|11667160|FG000|Overall Study|Lost to Follow-up|4
7401453|NCT01323270|11667161|FG001|Overall Study|Lost to Follow-up|6
7401454|NCT01323270|11667160|FG000|Overall Study|Adverse Event|8
7401455|NCT01323270|11667161|FG001|Overall Study|Adverse Event|0
7401456|NCT01323270|11667160|FG000|Overall Study|Other|0
7401457|NCT01323270|11667161|FG001|Overall Study|Other|3
7401458|NCT01323270|11667160|FG000|Overall Study|Physician Decision|0
7401459|NCT01323270|11667161|FG001|Overall Study|Physician Decision|2
7401460|NCT01323270|11667160|FG000|Overall Study|Not eligible|1
7401461|NCT01323270|11667161|FG001|Overall Study|Not eligible|1
7401462|NCT01323270|11667160|FG000|Overall Study|Death|1
7401463|NCT01323270|11667161|FG001|Overall Study|Death|0
7401464|NCT01323270|11667160|FG000|Overall Study|Randomized, but not vaccinated|1
7401465|NCT01323270|11667161|FG001|Overall Study|Randomized, but not vaccinated|0
7401466|NCT01323387|11667168|FG000|Overall Study|Withdrawal by Subject|41
7401467|NCT01323387|11667168|FG000|Overall Study|Radiographic Data Unavailable|1
7401468|NCT01323387|11667168|FG000|Overall Study|Revision|14
7401469|NCT01323387|11667168|FG000|Overall Study|Protocol Violation|12
7401470|NCT01323387|11667168|FG000|Overall Study|Randomized but Never Treated|16
7401471|NCT01323478|11667174|FG000|Overall Study|Adverse Event|7
7401472|NCT01323478|11667174|FG000|Overall Study|Lack of Efficacy|4
7401473|NCT01323478|11667174|FG000|Overall Study|Non-compliance With Study Product|3
7401474|NCT01323478|11667174|FG000|Overall Study|Protocol Violation|1
7401475|NCT01323478|11667174|FG000|Overall Study|Withdrawal of Consent|1
7401476|NCT01323478|11667174|FG000|Overall Study|Administrative or Other Reasons|8
7401477|NCT01323530|11667189|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7401478|NCT01323530|11667190|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7401479|NCT01323530|11667191|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7401480|NCT01323530|11667192|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7401481|NCT01323530|11667193|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7401482|NCT01323530|11667194|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
7401483|NCT01323530|11667195|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
7401484|NCT01323530|11667189|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7401485|NCT01323530|11667190|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7401486|NCT01323530|11667191|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
7401487|NCT01323530|11667192|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7401488|NCT01323530|11667193|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
7401489|NCT01323530|11667194|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7401490|NCT01323530|11667195|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
7401491|NCT01323530|11667189|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7401492|NCT01323530|11667190|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7401493|NCT01323530|11667191|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7401494|NCT01323530|11667192|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7401495|NCT01323530|11667193|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7401496|NCT01323530|11667194|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
7401497|NCT01323530|11667195|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
7401498|NCT01323530|11667189|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401499|NCT01323530|11667190|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401500|NCT01323530|11667191|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401501|NCT01323530|11667192|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401502|NCT01323530|11667193|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401503|NCT01323530|11667194|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
7401504|NCT01323530|11667195|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
7401505|NCT01323530|11667189|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401506|NCT01323530|11667190|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401507|NCT01323530|11667191|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401508|NCT01323530|11667192|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401509|NCT01323530|11667193|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401510|NCT01323530|11667194|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
7401511|NCT01323530|11667195|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
7401512|NCT01323530|11667189|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401513|NCT01323530|11667190|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401514|NCT01323530|11667191|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401515|NCT01323530|11667192|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401516|NCT01323530|11667193|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401517|NCT01323530|11667194|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
7401518|NCT01323530|11667195|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
7401519|NCT01323530|11667189|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401520|NCT01323530|11667190|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401521|NCT01323530|11667191|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401522|NCT01323530|11667192|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401523|NCT01323530|11667193|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401524|NCT01323530|11667194|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
7401525|NCT01323530|11667195|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
7401526|NCT01323530|11667189|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401527|NCT01323530|11667190|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401528|NCT01323530|11667191|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401529|NCT01323530|11667192|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401530|NCT01323530|11667193|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401531|NCT01323530|11667194|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
7401532|NCT01323530|11667195|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
7401533|NCT01323582|11667214|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7401534|NCT01323582|11667215|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
7401535|NCT01323582|11667214|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
7401536|NCT01323582|11667215|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
7401537|NCT01323582|11667214|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
7401538|NCT01323582|11667215|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
7401539|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
7401540|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7401541|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
7401542|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Physician Decision|7
7401543|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Physician Decision|0
7401544|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Physician Decision|0
7401545|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
7401546|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7401547|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
7401548|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
7401549|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
7401550|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
7401551|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
7401552|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
7401553|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
7401554|NCT01323621|11667236|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
7401555|NCT01323621|11667237|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7401556|NCT01323621|11667238|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
7401557|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
7401558|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
7401559|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
7401560|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
7401561|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
7401562|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
7401563|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
7401564|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
7401565|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
7401566|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7401567|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
7401568|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
7401569|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
7401719|NCT01323790|11667306|FG001|Overall Study|Adverse Event|24
7401570|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
7401571|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
7401572|NCT01323621|11667236|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
7401573|NCT01323621|11667237|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
7401574|NCT01323621|11667238|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
7401575|NCT01323634|11667246|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
7401576|NCT01323634|11667247|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7401577|NCT01323634|11667248|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
7401578|NCT01323634|11667246|FG000|2-week Run-in Period|Continuation Criteria not Met|73
7401579|NCT01323634|11667247|FG001|2-week Run-in Period|Continuation Criteria not Met|0
7401580|NCT01323634|11667248|FG002|2-week Run-in Period|Continuation Criteria not Met|0
7401581|NCT01323634|11667246|FG000|2-week Run-in Period|Withdrawal by Subject|7
7401582|NCT01323634|11667247|FG001|2-week Run-in Period|Withdrawal by Subject|0
7401583|NCT01323634|11667248|FG002|2-week Run-in Period|Withdrawal by Subject|0
7401584|NCT01323634|11667246|FG000|2-week Run-in Period|Physician Decision|5
7401585|NCT01323634|11667247|FG001|2-week Run-in Period|Physician Decision|0
7401586|NCT01323634|11667248|FG002|2-week Run-in Period|Physician Decision|0
7401587|NCT01323634|11667246|FG000|2-week Run-in Period|Protocol Violation|1
7401588|NCT01323634|11667247|FG001|2-week Run-in Period|Protocol Violation|0
7401589|NCT01323634|11667248|FG002|2-week Run-in Period|Protocol Violation|0
7401590|NCT01323634|11667246|FG000|2-week Run-in Period|Adverse Event|1
7401591|NCT01323634|11667247|FG001|2-week Run-in Period|Adverse Event|0
7401592|NCT01323634|11667248|FG002|2-week Run-in Period|Adverse Event|0
7401593|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
7401594|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
7401595|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
7401596|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7401597|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7401598|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7401599|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
7401600|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
7401601|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
7401602|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7401603|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7401604|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7401605|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
7401606|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
7401607|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
7401608|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7401609|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
7401610|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
7401611|NCT01323634|11667246|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
7401612|NCT01323634|11667247|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7401613|NCT01323634|11667248|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
7401614|NCT01323647|11667256|FG000|Overall Study|Migrated/moved from study area|2
7401615|NCT01323647|11667257|FG001|Overall Study|Migrated/moved from study area|0
7401616|NCT01323647|11667256|FG000|Overall Study|Withdrawal by Subject|5
7401617|NCT01323647|11667257|FG001|Overall Study|Withdrawal by Subject|0
7401618|NCT01323647|11667256|FG000|Overall Study|Lost to Follow-up|2
7401619|NCT01323647|11667257|FG001|Overall Study|Lost to Follow-up|0
7401620|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
7401621|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
7401622|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
7401623|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
7401624|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
7401625|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
7401626|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7401627|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7401628|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7401629|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
7401630|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7401631|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
7401632|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7401633|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7401634|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7401635|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7401636|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7401637|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7401638|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7401639|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7401640|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7401641|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7401720|NCT01323790|11667307|FG002|Overall Study|Adverse Event|12
7401642|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
7401643|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7401644|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7401645|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7401646|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7401647|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7401648|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7401649|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7401650|NCT01323660|11667263|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
7401651|NCT01323660|11667264|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7401652|NCT01323660|11667265|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7401653|NCT01323660|11667266|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7401654|NCT01323660|11667267|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
7401655|NCT01323660|11667268|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7401656|NCT01323660|11667263|FG000|Washout Period (14 Days)|Adverse Event|0
7401657|NCT01323660|11667264|FG001|Washout Period (14 Days)|Adverse Event|0
7401658|NCT01323660|11667265|FG002|Washout Period (14 Days)|Adverse Event|0
7401659|NCT01323660|11667266|FG003|Washout Period (14 Days)|Adverse Event|0
7401660|NCT01323660|11667267|FG004|Washout Period (14 Days)|Adverse Event|1
7401661|NCT01323660|11667268|FG005|Washout Period (14 Days)|Adverse Event|0
7401662|NCT01323660|11667263|FG000|Washout Period (14 Days)|Lack of Efficacy|0
7401663|NCT01323660|11667264|FG001|Washout Period (14 Days)|Lack of Efficacy|0
7401664|NCT01323660|11667265|FG002|Washout Period (14 Days)|Lack of Efficacy|1
7401665|NCT01323660|11667266|FG003|Washout Period (14 Days)|Lack of Efficacy|3
7401666|NCT01323660|11667267|FG004|Washout Period (14 Days)|Lack of Efficacy|2
7401667|NCT01323660|11667268|FG005|Washout Period (14 Days)|Lack of Efficacy|2
7401668|NCT01323660|11667263|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
7401669|NCT01323660|11667264|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
7401670|NCT01323660|11667265|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
7401671|NCT01323660|11667266|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
7401672|NCT01323660|11667267|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
7401673|NCT01323660|11667268|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
7401674|NCT01323660|11667263|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
7401675|NCT01323660|11667264|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7401676|NCT01323660|11667265|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7401677|NCT01323660|11667266|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7401678|NCT01323660|11667267|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7401679|NCT01323660|11667268|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7401680|NCT01323660|11667263|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7401681|NCT01323660|11667264|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7401682|NCT01323660|11667265|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7401683|NCT01323660|11667266|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7401684|NCT01323660|11667267|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
7401685|NCT01323660|11667268|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
7401686|NCT01323660|11667263|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7401687|NCT01323660|11667264|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7401688|NCT01323660|11667265|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7401689|NCT01323660|11667266|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7401690|NCT01323660|11667267|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7401691|NCT01323660|11667268|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7401692|NCT01323660|11667263|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7401693|NCT01323660|11667264|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7401694|NCT01323660|11667265|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7401695|NCT01323660|11667266|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7401696|NCT01323660|11667267|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7401697|NCT01323660|11667268|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7401698|NCT01323673|11667284|FG000|Overall Study|Adverse Event|0
7401699|NCT01323673|11667285|FG001|Overall Study|Adverse Event|1
7401700|NCT01323673|11667284|FG000|Overall Study|Lost to Follow-up|0
7401701|NCT01323673|11667285|FG001|Overall Study|Lost to Follow-up|1
7401702|NCT01323673|11667284|FG000|Overall Study|Protocol Violation|1
7401703|NCT01323673|11667285|FG001|Overall Study|Protocol Violation|0
7401704|NCT01323673|11667284|FG000|Overall Study|Withdrawal by Subject|2
7401705|NCT01323673|11667285|FG001|Overall Study|Withdrawal by Subject|3
7401706|NCT01323790|11667305|FG000|Overall Study|Other|3
7401707|NCT01323790|11667306|FG001|Overall Study|Other|2
7401708|NCT01323790|11667307|FG002|Overall Study|Other|1
7401709|NCT01323790|11667305|FG000|Overall Study|Lost to Follow-up|11
7401710|NCT01323790|11667306|FG001|Overall Study|Lost to Follow-up|9
7401711|NCT01323790|11667307|FG002|Overall Study|Lost to Follow-up|9
7401712|NCT01323790|11667305|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7401713|NCT01323790|11667306|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
7401714|NCT01323790|11667307|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
7401715|NCT01323790|11667305|FG000|Overall Study|Lack of Efficacy|3
7401716|NCT01323790|11667306|FG001|Overall Study|Lack of Efficacy|0
7401717|NCT01323790|11667307|FG002|Overall Study|Lack of Efficacy|3
7401718|NCT01323790|11667305|FG000|Overall Study|Adverse Event|11
7401721|NCT01323790|11667305|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7401722|NCT01323790|11667306|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7401723|NCT01323790|11667307|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
7401724|NCT01323790|11667305|FG000|Overall Study|Withdrawal by Subject|23
7401725|NCT01323790|11667306|FG001|Overall Study|Withdrawal by Subject|20
7401726|NCT01323790|11667307|FG002|Overall Study|Withdrawal by Subject|13
7401727|NCT01323790|11667305|FG000|Overall Study|Did Not Receive Treatment|2
7401728|NCT01323790|11667306|FG001|Overall Study|Did Not Receive Treatment|0
7401729|NCT01323790|11667307|FG002|Overall Study|Did Not Receive Treatment|1
7401730|NCT01323790|11667305|FG000|Overall Study|Severe non-compliance with protocol|2
7401731|NCT01323790|11667306|FG001|Overall Study|Severe non-compliance with protocol|2
7401732|NCT01323790|11667307|FG002|Overall Study|Severe non-compliance with protocol|2
7401733|NCT01323920|11667336|FG000|Overall Study|Death|5
7401734|NCT01323920|11667336|FG000|Overall Study|Withdrawal by Subject|1
7465648|NCT01881789|11765043|FG004|Overall Study|Other|1
7465649|NCT01881789|11765044|FG005|Overall Study|Other|1
7465650|NCT01882088|11765083|FG000|Overall Study|Intolerance of esophageal manometry|1
7465651|NCT01882088|11765083|FG000|Overall Study|no possibility to place the catheter|1
7465652|NCT01882088|11765083|FG000|Overall Study|Protocol Violation|1
7465653|NCT01882088|11765083|FG000|Overall Study|inadequate pH-impedance tracings|2
7465654|NCT01882257|11765090|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
7465655|NCT01882257|11765091|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
7465656|NCT01882257|11765092|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
7465657|NCT01882257|11765090|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
7465658|NCT01882257|11765091|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
7465659|NCT01882257|11765092|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
7465660|NCT01882439|11765107|FG000|Overall Study|Adverse event related to study drug|3
7465661|NCT01882439|11765108|FG001|Overall Study|Adverse event related to study drug|8
7465662|NCT01882439|11765109|FG002|Overall Study|Adverse event related to study drug|1
7465663|NCT01882439|11765110|FG003|Overall Study|Adverse event related to study drug|2
7465664|NCT01882439|11765107|FG000|Overall Study|Pregnancy|0
7465665|NCT01882439|11765108|FG001|Overall Study|Pregnancy|1
7465666|NCT01882439|11765109|FG002|Overall Study|Pregnancy|0
7465667|NCT01882439|11765110|FG003|Overall Study|Pregnancy|0
7465668|NCT01882439|11765107|FG000|Overall Study|Protocol Violation|2
7465669|NCT01882439|11765108|FG001|Overall Study|Protocol Violation|2
7465670|NCT01882439|11765109|FG002|Overall Study|Protocol Violation|0
7465671|NCT01882439|11765110|FG003|Overall Study|Protocol Violation|1
7465672|NCT01882439|11765107|FG000|Overall Study|No longer willing to participate|1
7465673|NCT01882439|11765108|FG001|Overall Study|No longer willing to participate|4
7465674|NCT01882439|11765109|FG002|Overall Study|No longer willing to participate|2
7465675|NCT01882439|11765110|FG003|Overall Study|No longer willing to participate|3
7465676|NCT01882439|11765107|FG000|Overall Study|Medication error with no associated AE|0
7465677|NCT01882439|11765108|FG001|Overall Study|Medication error with no associated AE|0
7465678|NCT01882439|11765109|FG002|Overall Study|Medication error with no associated AE|2
7465679|NCT01882439|11765110|FG003|Overall Study|Medication error with no associated AE|0
7465680|NCT01882439|11765107|FG000|Overall Study|Insufficient clinical response|1
7465681|NCT01882439|11765108|FG001|Overall Study|Insufficient clinical response|4
7465682|NCT01882439|11765109|FG002|Overall Study|Insufficient clinical response|4
7465683|NCT01882439|11765110|FG003|Overall Study|Insufficient clinical response|2
7465684|NCT01882439|11765107|FG000|Overall Study|Adverse event unrelated to study drug|2
7465685|NCT01882439|11765108|FG001|Overall Study|Adverse event unrelated to study drug|2
7465686|NCT01882439|11765109|FG002|Overall Study|Adverse event unrelated to study drug|1
7465687|NCT01882439|11765110|FG003|Overall Study|Adverse event unrelated to study drug|1
7465688|NCT01882465|11765125|FG000|Period 1|Lens Discomfort|0
7465689|NCT01882465|11765126|FG001|Period 1|Lens Discomfort|0
7465690|NCT01882465|11765127|FG002|Period 1|Lens Discomfort|0
7465691|NCT01882465|11765128|FG003|Period 1|Lens Discomfort|1
7465692|NCT01882465|11765129|FG004|Period 1|Lens Discomfort|0
7465693|NCT01882465|11765130|FG005|Period 1|Lens Discomfort|0
7465694|NCT01882465|11765131|FG006|Period 1|Lens Discomfort|0
7465695|NCT01882465|11765125|FG000|Period 1|Withdrawal by Subject|0
7465696|NCT01882465|11765126|FG001|Period 1|Withdrawal by Subject|0
7465697|NCT01882465|11765127|FG002|Period 1|Withdrawal by Subject|0
7401735|NCT01323946|11667343|FG000|Overall Study|Lost to Follow-up|0
7401736|NCT01323946|11667344|FG001|Overall Study|Lost to Follow-up|1
7401737|NCT01323946|11667345|FG002|Overall Study|Lost to Follow-up|0
7401738|NCT01323946|11667343|FG000|Overall Study|Parents refused the last blood draw|1
7401739|NCT01323946|11667344|FG001|Overall Study|Parents refused the last blood draw|0
7401740|NCT01323946|11667345|FG002|Overall Study|Parents refused the last blood draw|0
7401741|NCT01323946|11667343|FG000|Overall Study|Withdrawal by Subject|2
7401742|NCT01323946|11667344|FG001|Overall Study|Withdrawal by Subject|2
7401743|NCT01323946|11667345|FG002|Overall Study|Withdrawal by Subject|0
7401744|NCT01323972|11667372|FG000|Overall Study|Withdrawal by Subject|1
7401745|NCT01323972|11667373|FG001|Overall Study|Withdrawal by Subject|0
7401746|NCT01323972|11667374|FG002|Overall Study|Withdrawal by Subject|1
7401747|NCT01323972|11667375|FG003|Overall Study|Withdrawal by Subject|0
7401748|NCT01323972|11667372|FG000|Overall Study|Migrated/moved from study area|1
7401749|NCT01323972|11667373|FG001|Overall Study|Migrated/moved from study area|2
7401750|NCT01323972|11667374|FG002|Overall Study|Migrated/moved from study area|0
7401751|NCT01323972|11667375|FG003|Overall Study|Migrated/moved from study area|0
7401752|NCT01323972|11667372|FG000|Overall Study|Lost to Follow-up|0
7401753|NCT01323972|11667373|FG001|Overall Study|Lost to Follow-up|1
7401754|NCT01323972|11667374|FG002|Overall Study|Lost to Follow-up|1
7401755|NCT01323972|11667375|FG003|Overall Study|Lost to Follow-up|1
7401756|NCT01324024|11667408|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
7401757|NCT01324024|11667409|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7401758|NCT01324102|11667421|FG000|Overall Study|illness|1
7401759|NCT01324102|11667422|FG001|Overall Study|illness|6
7401760|NCT01324141|11667444|FG000|Overall Study|Declined to participate before treatment started|1
7401761|NCT01324141|11667444|FG000|Overall Study|Disease progression on study|1
7401762|NCT01324232|11667462|FG000|Overall Study|Protocol Violation|0
7401763|NCT01324232|11667463|FG001|Overall Study|Protocol Violation|0
7401764|NCT01324232|11667464|FG002|Overall Study|Protocol Violation|0
7401765|NCT01324232|11667465|FG003|Overall Study|Protocol Violation|2
7401766|NCT01324232|11667462|FG000|Overall Study|Missing|0
7401767|NCT01324232|11667463|FG001|Overall Study|Missing|0
7401768|NCT01324232|11667464|FG002|Overall Study|Missing|1
7401769|NCT01324232|11667465|FG003|Overall Study|Missing|0
7401770|NCT01324232|11667462|FG000|Overall Study|Participant's Personal Reason/Decision|0
7401771|NCT01324232|11667463|FG001|Overall Study|Participant's Personal Reason/Decision|1
7401772|NCT01324232|11667464|FG002|Overall Study|Participant's Personal Reason/Decision|0
7401773|NCT01324232|11667465|FG003|Overall Study|Participant's Personal Reason/Decision|0
7401774|NCT01324232|11667462|FG000|Overall Study|Lack of Efficacy|2
7401775|NCT01324232|11667463|FG001|Overall Study|Lack of Efficacy|1
7401776|NCT01324232|11667464|FG002|Overall Study|Lack of Efficacy|2
7401777|NCT01324232|11667465|FG003|Overall Study|Lack of Efficacy|2
7401778|NCT01324232|11667462|FG000|Overall Study|Participant Refused Medication|0
7401779|NCT01324232|11667463|FG001|Overall Study|Participant Refused Medication|1
7401780|NCT01324232|11667464|FG002|Overall Study|Participant Refused Medication|0
7401781|NCT01324232|11667465|FG003|Overall Study|Participant Refused Medication|0
7401782|NCT01324232|11667462|FG000|Overall Study|Intercurrent illness|0
7401783|NCT01324232|11667463|FG001|Overall Study|Intercurrent illness|0
7401784|NCT01324232|11667464|FG002|Overall Study|Intercurrent illness|0
7401785|NCT01324232|11667465|FG003|Overall Study|Intercurrent illness|1
7401786|NCT01324232|11667462|FG000|Overall Study|Adverse Event|2
7401787|NCT01324232|11667463|FG001|Overall Study|Adverse Event|5
7401788|NCT01324232|11667464|FG002|Overall Study|Adverse Event|6
7401789|NCT01324232|11667465|FG003|Overall Study|Adverse Event|6
7401790|NCT01324232|11667462|FG000|Overall Study|Withdrawal by Subject|0
7401791|NCT01324232|11667463|FG001|Overall Study|Withdrawal by Subject|3
7401792|NCT01324232|11667464|FG002|Overall Study|Withdrawal by Subject|4
7401793|NCT01324232|11667465|FG003|Overall Study|Withdrawal by Subject|0
7401794|NCT01324232|11667462|FG000|Overall Study|Lost to Follow-up|1
7401795|NCT01324232|11667463|FG001|Overall Study|Lost to Follow-up|0
7401796|NCT01324232|11667464|FG002|Overall Study|Lost to Follow-up|0
7401797|NCT01324232|11667465|FG003|Overall Study|Lost to Follow-up|0
7401798|NCT01324271|11667480|FG000|Overall Study|Lost to Follow-up|3
7401799|NCT01324271|11667481|FG001|Overall Study|Lost to Follow-up|0
7401800|NCT01324271|11667480|FG000|Overall Study|Physician Decision|1
7401801|NCT01324271|11667481|FG001|Overall Study|Physician Decision|0
7401802|NCT01324310|11667487|FG000|Overall Study|Adverse Event|1
7401803|NCT01324310|11667487|FG000|Overall Study|Disease Progression|1
7401804|NCT01324323|11667493|FG000|Overall Study|Withdrawal by Subject|1
7401805|NCT01324349|11667507|FG000|Overall Study|Death|1
7401806|NCT01324349|11667508|FG001|Overall Study|Death|1
7401807|NCT01324349|11667507|FG000|Overall Study|Withdrawal by Subject|0
7401808|NCT01324349|11667508|FG001|Overall Study|Withdrawal by Subject|1
7401809|NCT01324388|11667517|FG000|Part 1 of Study|Adverse Event|2
7401810|NCT01324388|11667518|FG001|Part 1 of Study|Adverse Event|0
7401811|NCT01324388|11667519|FG002|Part 1 of Study|Adverse Event|0
7401812|NCT01324388|11667520|FG003|Part 1 of Study|Adverse Event|0
7401813|NCT01324388|11667517|FG000|Part 1 of Study|Protocol Violation|1
7401814|NCT01324388|11667518|FG001|Part 1 of Study|Protocol Violation|2
7401815|NCT01324388|11667519|FG002|Part 1 of Study|Protocol Violation|0
7401816|NCT01324388|11667520|FG003|Part 1 of Study|Protocol Violation|0
7401817|NCT01324388|11667517|FG000|Part 1 of Study|Physician Decision|1
7401818|NCT01324388|11667518|FG001|Part 1 of Study|Physician Decision|0
7401819|NCT01324388|11667519|FG002|Part 1 of Study|Physician Decision|0
7401820|NCT01324388|11667520|FG003|Part 1 of Study|Physician Decision|0
7401821|NCT01324388|11667517|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
7401822|NCT01324388|11667518|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
7401823|NCT01324388|11667519|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
7401824|NCT01324388|11667520|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
7401825|NCT01324388|11667517|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7401826|NCT01324388|11667518|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7401827|NCT01324388|11667519|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
7401828|NCT01324388|11667520|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
7401829|NCT01324401|11667534|FG000|Overall Study|Withdrawn before any treatment|0
7401830|NCT01324401|11667535|FG001|Overall Study|Withdrawn before any treatment|3
7401831|NCT01324401|11667534|FG000|Overall Study|Adverse Event|1
7401832|NCT01324401|11667535|FG001|Overall Study|Adverse Event|3
7401833|NCT01324440|11667543|FG000|Overall Study|Subject moved|0
7401834|NCT01324440|11667544|FG001|Overall Study|Subject moved|1
7401835|NCT01324570|11667574|FG000|Overall Study|Adverse Event|4
7401836|NCT01324570|11667575|FG001|Overall Study|Adverse Event|7
7401837|NCT01324570|11667574|FG000|Overall Study|Withdrawal by Subject|0
7401838|NCT01324570|11667575|FG001|Overall Study|Withdrawal by Subject|3
7401839|NCT01324570|11667574|FG000|Overall Study|Lack of Efficacy|0
7401840|NCT01324570|11667575|FG001|Overall Study|Lack of Efficacy|1
7401841|NCT01324570|11667574|FG000|Overall Study|Confirmed or suspected diversion|0
7401842|NCT01324570|11667575|FG001|Overall Study|Confirmed or suspected diversion|1
7401843|NCT01324570|11667574|FG000|Overall Study|Administrative|0
7401844|NCT01324570|11667575|FG001|Overall Study|Administrative|2
7401845|NCT01324622|11667585|FG000|Overall Study|Lost to Follow-up|7
7401846|NCT01324622|11667586|FG001|Overall Study|Lost to Follow-up|7
7401847|NCT01324622|11667585|FG000|Overall Study|Death|1
7401848|NCT01324622|11667586|FG001|Overall Study|Death|0
7401849|NCT01324622|11667585|FG000|Overall Study|Lack of Efficacy|1
7401850|NCT01324622|11667586|FG001|Overall Study|Lack of Efficacy|0
7401851|NCT01324830|11667638|FG000|Overall Study|Progressive Disease|3
7401852|NCT01324830|11667639|FG001|Overall Study|Progressive Disease|2
7401853|NCT01324830|11667640|FG002|Overall Study|Progressive Disease|3
7401854|NCT01324830|11667641|FG003|Overall Study|Progressive Disease|3
7401855|NCT01324830|11667642|FG004|Overall Study|Progressive Disease|6
7401856|NCT01324830|11667643|FG005|Overall Study|Progressive Disease|6
7401857|NCT01324830|11667644|FG006|Overall Study|Progressive Disease|3
7401858|NCT01324830|11667645|FG007|Overall Study|Progressive Disease|3
7401859|NCT01324830|11667646|FG008|Overall Study|Progressive Disease|3
7401860|NCT01324830|11667647|FG009|Overall Study|Progressive Disease|6
7401861|NCT01324830|11667648|FG010|Overall Study|Progressive Disease|2
7401862|NCT01324830|11667649|FG011|Overall Study|Progressive Disease|1
7401863|NCT01324830|11667650|FG012|Overall Study|Progressive Disease|1
7401864|NCT01324830|11667651|FG013|Overall Study|Progressive Disease|1
7401865|NCT01324830|11667652|FG014|Overall Study|Progressive Disease|1
7401866|NCT01324830|11667653|FG015|Overall Study|Progressive Disease|3
7401867|NCT01324830|11667654|FG016|Overall Study|Progressive Disease|2
7401868|NCT01324830|11667655|FG017|Overall Study|Progressive Disease|3
7401869|NCT01324830|11667656|FG018|Overall Study|Progressive Disease|4
7401870|NCT01324830|11667638|FG000|Overall Study|Dose limiting toxicity|0
7401871|NCT01324830|11667639|FG001|Overall Study|Dose limiting toxicity|0
7401872|NCT01324830|11667640|FG002|Overall Study|Dose limiting toxicity|0
7401873|NCT01324830|11667641|FG003|Overall Study|Dose limiting toxicity|0
7401874|NCT01324830|11667642|FG004|Overall Study|Dose limiting toxicity|1
7401875|NCT01324830|11667643|FG005|Overall Study|Dose limiting toxicity|0
7401876|NCT01324830|11667644|FG006|Overall Study|Dose limiting toxicity|0
7401877|NCT01324830|11667645|FG007|Overall Study|Dose limiting toxicity|0
7401878|NCT01324830|11667646|FG008|Overall Study|Dose limiting toxicity|0
7401879|NCT01324830|11667647|FG009|Overall Study|Dose limiting toxicity|0
7401880|NCT01324830|11667648|FG010|Overall Study|Dose limiting toxicity|0
7401881|NCT01324830|11667649|FG011|Overall Study|Dose limiting toxicity|0
7401882|NCT01324830|11667650|FG012|Overall Study|Dose limiting toxicity|0
7401883|NCT01324830|11667651|FG013|Overall Study|Dose limiting toxicity|0
7401884|NCT01324830|11667652|FG014|Overall Study|Dose limiting toxicity|0
7401885|NCT01324830|11667653|FG015|Overall Study|Dose limiting toxicity|0
7401886|NCT01324830|11667654|FG016|Overall Study|Dose limiting toxicity|1
7401887|NCT01324830|11667655|FG017|Overall Study|Dose limiting toxicity|1
7401888|NCT01324830|11667656|FG018|Overall Study|Dose limiting toxicity|1
7401889|NCT01324830|11667638|FG000|Overall Study|Reason not mentioned above|0
7401890|NCT01324830|11667639|FG001|Overall Study|Reason not mentioned above|0
7401891|NCT01324830|11667640|FG002|Overall Study|Reason not mentioned above|0
7401892|NCT01324830|11667641|FG003|Overall Study|Reason not mentioned above|0
7401893|NCT01324830|11667642|FG004|Overall Study|Reason not mentioned above|0
7401894|NCT01324830|11667643|FG005|Overall Study|Reason not mentioned above|0
7401895|NCT01324830|11667644|FG006|Overall Study|Reason not mentioned above|0
7401896|NCT01324830|11667645|FG007|Overall Study|Reason not mentioned above|0
7401897|NCT01324830|11667646|FG008|Overall Study|Reason not mentioned above|0
7401898|NCT01324830|11667647|FG009|Overall Study|Reason not mentioned above|0
7401899|NCT01324830|11667648|FG010|Overall Study|Reason not mentioned above|0
7401900|NCT01324830|11667649|FG011|Overall Study|Reason not mentioned above|0
7401901|NCT01324830|11667650|FG012|Overall Study|Reason not mentioned above|0
7401902|NCT01324830|11667651|FG013|Overall Study|Reason not mentioned above|0
7401903|NCT01324830|11667652|FG014|Overall Study|Reason not mentioned above|0
7401904|NCT01324830|11667653|FG015|Overall Study|Reason not mentioned above|0
7401905|NCT01324830|11667654|FG016|Overall Study|Reason not mentioned above|0
7401906|NCT01324830|11667655|FG017|Overall Study|Reason not mentioned above|1
7401907|NCT01324830|11667656|FG018|Overall Study|Reason not mentioned above|0
7401908|NCT01324830|11667638|FG000|Overall Study|Adverse Event, serious fatal|0
7401909|NCT01324830|11667639|FG001|Overall Study|Adverse Event, serious fatal|1
7401910|NCT01324830|11667640|FG002|Overall Study|Adverse Event, serious fatal|0
7401911|NCT01324830|11667641|FG003|Overall Study|Adverse Event, serious fatal|0
7401912|NCT01324830|11667642|FG004|Overall Study|Adverse Event, serious fatal|0
7401913|NCT01324830|11667643|FG005|Overall Study|Adverse Event, serious fatal|0
7402157|NCT01326702|11667957|FG002|Overall Study|Not Treated|0
7401914|NCT01324830|11667644|FG006|Overall Study|Adverse Event, serious fatal|0
7401915|NCT01324830|11667645|FG007|Overall Study|Adverse Event, serious fatal|0
7401916|NCT01324830|11667646|FG008|Overall Study|Adverse Event, serious fatal|0
7401917|NCT01324830|11667647|FG009|Overall Study|Adverse Event, serious fatal|0
7401918|NCT01324830|11667648|FG010|Overall Study|Adverse Event, serious fatal|0
7401919|NCT01324830|11667649|FG011|Overall Study|Adverse Event, serious fatal|0
7401920|NCT01324830|11667650|FG012|Overall Study|Adverse Event, serious fatal|0
7401921|NCT01324830|11667651|FG013|Overall Study|Adverse Event, serious fatal|0
7401922|NCT01324830|11667652|FG014|Overall Study|Adverse Event, serious fatal|0
7401923|NCT01324830|11667653|FG015|Overall Study|Adverse Event, serious fatal|0
7401924|NCT01324830|11667654|FG016|Overall Study|Adverse Event, serious fatal|0
7401925|NCT01324830|11667655|FG017|Overall Study|Adverse Event, serious fatal|0
7401926|NCT01324830|11667656|FG018|Overall Study|Adverse Event, serious fatal|0
7401927|NCT01324830|11667638|FG000|Overall Study|Adverse Event, non-fatal|0
7401928|NCT01324830|11667639|FG001|Overall Study|Adverse Event, non-fatal|0
7401929|NCT01324830|11667640|FG002|Overall Study|Adverse Event, non-fatal|0
7401930|NCT01324830|11667641|FG003|Overall Study|Adverse Event, non-fatal|0
7401931|NCT01324830|11667642|FG004|Overall Study|Adverse Event, non-fatal|0
7401932|NCT01324830|11667643|FG005|Overall Study|Adverse Event, non-fatal|0
7401933|NCT01324830|11667644|FG006|Overall Study|Adverse Event, non-fatal|0
7401934|NCT01324830|11667645|FG007|Overall Study|Adverse Event, non-fatal|0
7401935|NCT01324830|11667646|FG008|Overall Study|Adverse Event, non-fatal|2
7401936|NCT01324830|11667647|FG009|Overall Study|Adverse Event, non-fatal|0
7401937|NCT01324830|11667648|FG010|Overall Study|Adverse Event, non-fatal|1
7401938|NCT01324830|11667649|FG011|Overall Study|Adverse Event, non-fatal|0
7401939|NCT01324830|11667650|FG012|Overall Study|Adverse Event, non-fatal|0
7401940|NCT01324830|11667651|FG013|Overall Study|Adverse Event, non-fatal|0
7401941|NCT01324830|11667652|FG014|Overall Study|Adverse Event, non-fatal|0
7401942|NCT01324830|11667653|FG015|Overall Study|Adverse Event, non-fatal|0
7401943|NCT01324830|11667654|FG016|Overall Study|Adverse Event, non-fatal|0
7401944|NCT01324830|11667655|FG017|Overall Study|Adverse Event, non-fatal|1
7401945|NCT01324830|11667656|FG018|Overall Study|Adverse Event, non-fatal|0
7401946|NCT01324830|11667638|FG000|Overall Study|Withdrawal by Subject|0
7401947|NCT01324830|11667639|FG001|Overall Study|Withdrawal by Subject|0
7401948|NCT01324830|11667640|FG002|Overall Study|Withdrawal by Subject|0
7401949|NCT01324830|11667641|FG003|Overall Study|Withdrawal by Subject|0
7401950|NCT01324830|11667642|FG004|Overall Study|Withdrawal by Subject|0
7401951|NCT01324830|11667643|FG005|Overall Study|Withdrawal by Subject|1
7401952|NCT01324830|11667644|FG006|Overall Study|Withdrawal by Subject|0
7401953|NCT01324830|11667645|FG007|Overall Study|Withdrawal by Subject|0
7401954|NCT01324830|11667646|FG008|Overall Study|Withdrawal by Subject|0
7401955|NCT01324830|11667647|FG009|Overall Study|Withdrawal by Subject|0
7401956|NCT01324830|11667648|FG010|Overall Study|Withdrawal by Subject|1
7401957|NCT01324830|11667649|FG011|Overall Study|Withdrawal by Subject|0
7401958|NCT01324830|11667650|FG012|Overall Study|Withdrawal by Subject|0
7401959|NCT01324830|11667651|FG013|Overall Study|Withdrawal by Subject|0
7401960|NCT01324830|11667652|FG014|Overall Study|Withdrawal by Subject|0
7401961|NCT01324830|11667653|FG015|Overall Study|Withdrawal by Subject|0
7401962|NCT01324830|11667654|FG016|Overall Study|Withdrawal by Subject|0
7401963|NCT01324830|11667655|FG017|Overall Study|Withdrawal by Subject|0
7401964|NCT01324830|11667656|FG018|Overall Study|Withdrawal by Subject|1
7401965|NCT01324947|11667713|FG000|Overall Study|Adverse Event|7
7401966|NCT01324947|11667713|FG000|Overall Study|Death|10
7401967|NCT01324947|11667713|FG000|Overall Study|Other|3
7401968|NCT01324947|11667713|FG000|Overall Study|Progressive Disease|50
7401969|NCT01324947|11667713|FG000|Overall Study|Withdrawal by Subject|3
7401970|NCT01324947|11667713|FG000|Overall Study|1 discontinued before starting drug|1
7401971|NCT01324999|11667719|FG000|Overall Study|Adverse Event|3
7401972|NCT01324999|11667719|FG000|Overall Study|Withdrawal by Subject|2
7401973|NCT01325207|11667738|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7401974|NCT01325207|11667739|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7401975|NCT01325207|11667740|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7401976|NCT01325207|11667741|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7401977|NCT01325207|11667742|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
7401978|NCT01325207|11667743|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
7401979|NCT01325207|11667738|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7401980|NCT01325207|11667739|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
7401981|NCT01325207|11667740|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7401982|NCT01325207|11667741|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
7401983|NCT01325207|11667742|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
7401984|NCT01325207|11667743|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
7401985|NCT01325207|11667738|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7401986|NCT01325207|11667739|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7401987|NCT01325207|11667740|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7401988|NCT01325207|11667741|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
7401989|NCT01325207|11667742|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
7401990|NCT01325207|11667743|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
7401991|NCT01325207|11667738|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7401992|NCT01325207|11667739|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
7401993|NCT01325207|11667740|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7401994|NCT01325207|11667741|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7401995|NCT01325207|11667742|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7401996|NCT01325207|11667743|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
7401997|NCT01325207|11667738|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7401998|NCT01325207|11667739|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7401999|NCT01325207|11667740|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7402000|NCT01325207|11667741|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7402001|NCT01325207|11667742|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
7402002|NCT01325207|11667743|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
7402003|NCT01325207|11667738|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7402004|NCT01325207|11667739|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7402005|NCT01325207|11667740|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7402006|NCT01325207|11667741|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7402007|NCT01325207|11667742|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
7402008|NCT01325207|11667743|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
7402009|NCT01325207|11667738|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7402010|NCT01325207|11667739|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7402011|NCT01325207|11667740|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7402012|NCT01325207|11667741|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7402013|NCT01325207|11667742|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
7402014|NCT01325207|11667743|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
7402015|NCT01325337|11667772|FG000|Overall Study|Adverse Event|0
7402016|NCT01325337|11667773|FG001|Overall Study|Adverse Event|2
7402017|NCT01325337|11667774|FG002|Overall Study|Adverse Event|2
7402018|NCT01325337|11667775|FG003|Overall Study|Adverse Event|1
7402019|NCT01325337|11667776|FG004|Overall Study|Adverse Event|2
7402020|NCT01325337|11667772|FG000|Overall Study|Lost to Follow-up|2
7402021|NCT01325337|11667773|FG001|Overall Study|Lost to Follow-up|2
7402022|NCT01325337|11667774|FG002|Overall Study|Lost to Follow-up|2
7402023|NCT01325337|11667775|FG003|Overall Study|Lost to Follow-up|1
7402024|NCT01325337|11667776|FG004|Overall Study|Lost to Follow-up|2
7402025|NCT01325337|11667772|FG000|Overall Study|Personal Reasons|2
7402026|NCT01325337|11667773|FG001|Overall Study|Personal Reasons|5
7402027|NCT01325337|11667774|FG002|Overall Study|Personal Reasons|4
7402028|NCT01325337|11667775|FG003|Overall Study|Personal Reasons|8
7402029|NCT01325337|11667776|FG004|Overall Study|Personal Reasons|3
7402030|NCT01325337|11667772|FG000|Overall Study|Withdrawal by Subject|1
7402031|NCT01325337|11667773|FG001|Overall Study|Withdrawal by Subject|0
7402032|NCT01325337|11667774|FG002|Overall Study|Withdrawal by Subject|1
7402033|NCT01325337|11667775|FG003|Overall Study|Withdrawal by Subject|0
7402034|NCT01325337|11667776|FG004|Overall Study|Withdrawal by Subject|1
7402035|NCT01325350|11667793|FG000|Overall Study|Adverse Event|3
7402036|NCT01325350|11667794|FG001|Overall Study|Adverse Event|3
7402037|NCT01325350|11667795|FG002|Overall Study|Adverse Event|3
7402038|NCT01325350|11667796|FG003|Overall Study|Adverse Event|1
7402039|NCT01325350|11667797|FG004|Overall Study|Adverse Event|2
7402040|NCT01325350|11667793|FG000|Overall Study|Pregnancy|0
7402041|NCT01325350|11667794|FG001|Overall Study|Pregnancy|0
7402042|NCT01325350|11667795|FG002|Overall Study|Pregnancy|1
7402043|NCT01325350|11667796|FG003|Overall Study|Pregnancy|0
7402044|NCT01325350|11667797|FG004|Overall Study|Pregnancy|1
7402045|NCT01325350|11667793|FG000|Overall Study|Lost to Follow-up|1
7402046|NCT01325350|11667794|FG001|Overall Study|Lost to Follow-up|0
7402047|NCT01325350|11667795|FG002|Overall Study|Lost to Follow-up|5
7402048|NCT01325350|11667796|FG003|Overall Study|Lost to Follow-up|1
7402049|NCT01325350|11667797|FG004|Overall Study|Lost to Follow-up|5
7402050|NCT01325350|11667793|FG000|Overall Study|Personal Reasons|2
7402051|NCT01325350|11667794|FG001|Overall Study|Personal Reasons|1
7402052|NCT01325350|11667795|FG002|Overall Study|Personal Reasons|6
7402053|NCT01325350|11667796|FG003|Overall Study|Personal Reasons|5
7402054|NCT01325350|11667797|FG004|Overall Study|Personal Reasons|3
7402055|NCT01325350|11667793|FG000|Overall Study|Protocol Violation|0
7402056|NCT01325350|11667794|FG001|Overall Study|Protocol Violation|0
7402057|NCT01325350|11667795|FG002|Overall Study|Protocol Violation|0
7402058|NCT01325350|11667796|FG003|Overall Study|Protocol Violation|1
7402059|NCT01325350|11667797|FG004|Overall Study|Protocol Violation|0
7402060|NCT01325350|11667793|FG000|Overall Study|Withdrawal by Subject|0
7402061|NCT01325350|11667794|FG001|Overall Study|Withdrawal by Subject|0
7402062|NCT01325350|11667795|FG002|Overall Study|Withdrawal by Subject|1
7402063|NCT01325350|11667796|FG003|Overall Study|Withdrawal by Subject|1
7402064|NCT01325350|11667797|FG004|Overall Study|Withdrawal by Subject|0
7402065|NCT01325350|11667793|FG000|Overall Study|Did Not Receive Treatment|0
7402066|NCT01325350|11667794|FG001|Overall Study|Did Not Receive Treatment|1
7402067|NCT01325350|11667795|FG002|Overall Study|Did Not Receive Treatment|1
7402068|NCT01325350|11667796|FG003|Overall Study|Did Not Receive Treatment|0
7402069|NCT01325350|11667797|FG004|Overall Study|Did Not Receive Treatment|1
7402158|NCT01326702|11667958|FG003|Overall Study|Not Treated|1
7402070|NCT01325428|11667809|FG000|Part A|Progressive disease according to RECIST|9
7402071|NCT01325428|11667809|FG000|Part A|Clinical signs, symptoms of progression|2
7402072|NCT01325428|11667809|FG000|Part A|Other adverse event|1
7402073|NCT01325428|11667809|FG000|Part A|Refused continue taking trial medication|2
7402074|NCT01325428|11667809|FG000|Part A|Other reason not defined above|2
7402075|NCT01325428|11667809|FG000|Part B|Refused continue taking trial medication|2
7402076|NCT01325428|11667809|FG000|Part B|Other reason not defined above|1
7402077|NCT01325493|11667820|FG000|Overall Study|Protocol Violation|0
7402078|NCT01325493|11667821|FG001|Overall Study|Protocol Violation|1
7402079|NCT01325493|11667820|FG000|Overall Study|loss of neuromonitoring signals|0
7402080|NCT01325493|11667821|FG001|Overall Study|loss of neuromonitoring signals|2
7402081|NCT01325493|11667820|FG000|Overall Study|Allergy|1
7402082|NCT01325493|11667821|FG001|Overall Study|Allergy|0
7402083|NCT01325532|11667829|FG000|Overall Study|Withdrawal by Subject|2
7402084|NCT01325532|11667830|FG001|Overall Study|Withdrawal by Subject|0
7402085|NCT01325584|11667836|FG000|Overall Study|Death|1
7402086|NCT01325623|11667840|FG000|Overall Study|Withdrawal by Subject|3
7402087|NCT01325701|11667879|FG000|Overall Study|Adverse Event|12
7402088|NCT01325701|11667880|FG001|Overall Study|Adverse Event|0
7402089|NCT01325701|11667879|FG000|Overall Study|Protocol Violation|1
7402090|NCT01325701|11667880|FG001|Overall Study|Protocol Violation|0
7402091|NCT01325701|11667879|FG000|Overall Study|Physician Decision|2
7402092|NCT01325701|11667880|FG001|Overall Study|Physician Decision|2
7402093|NCT01325701|11667879|FG000|Overall Study|Withdrawal by Subject|2
7402094|NCT01325701|11667880|FG001|Overall Study|Withdrawal by Subject|1
7402095|NCT01325701|11667879|FG000|Overall Study|Rollerover Extension Study|4
7402096|NCT01325701|11667880|FG001|Overall Study|Rollerover Extension Study|0
7402097|NCT01326026|11667917|FG000|Overall Study|Adverse Event|4
7402098|NCT01326026|11667918|FG001|Overall Study|Adverse Event|3
7402099|NCT01326026|11667917|FG000|Overall Study|Withdrawal Criteria|5
7402100|NCT01326026|11667918|FG001|Overall Study|Withdrawal Criteria|7
7402101|NCT01326026|11667917|FG000|Overall Study|Other|3
7402102|NCT01326026|11667918|FG001|Overall Study|Other|3
7402103|NCT01326481|11667924|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
7402104|NCT01326533|11667932|FG000|Overall Study|Lost to Follow-up|2
7402105|NCT01326533|11667933|FG001|Overall Study|Lost to Follow-up|0
7402106|NCT01326533|11667932|FG000|Overall Study|Withdrawal by Subject|1
7402107|NCT01326533|11667933|FG001|Overall Study|Withdrawal by Subject|0
7402108|NCT01326533|11667932|FG000|Overall Study|Adverse Event|1
7402109|NCT01326533|11667933|FG001|Overall Study|Adverse Event|0
7402110|NCT01326546|11667941|FG000|Overall Study|Lost to Follow-up|8
7402111|NCT01326546|11667942|FG001|Overall Study|Lost to Follow-up|7
7402112|NCT01326546|11667941|FG000|Overall Study|Protocol Violation|3
7402113|NCT01326546|11667942|FG001|Overall Study|Protocol Violation|4
7402114|NCT01326546|11667941|FG000|Overall Study|Pregnancy|0
7402115|NCT01326546|11667942|FG001|Overall Study|Pregnancy|1
7402116|NCT01326546|11667941|FG000|Overall Study|Adverse Event|1
7402117|NCT01326546|11667942|FG001|Overall Study|Adverse Event|0
7402118|NCT01326546|11667941|FG000|Overall Study|Withdrawal by Subject|5
7402119|NCT01326546|11667942|FG001|Overall Study|Withdrawal by Subject|1
7402120|NCT01326702|11667955|FG000|Overall Study|Other|1
7402121|NCT01326702|11667956|FG001|Overall Study|Other|0
7402122|NCT01326702|11667957|FG002|Overall Study|Other|0
7402123|NCT01326702|11667958|FG003|Overall Study|Other|0
7402124|NCT01326702|11667959|FG004|Overall Study|Other|0
7402125|NCT01326702|11667960|FG005|Overall Study|Other|1
7402126|NCT01326702|11667961|FG006|Overall Study|Other|0
7402127|NCT01326702|11667955|FG000|Overall Study|progressive disease|1
7402128|NCT01326702|11667956|FG001|Overall Study|progressive disease|1
7402129|NCT01326702|11667957|FG002|Overall Study|progressive disease|3
7402130|NCT01326702|11667958|FG003|Overall Study|progressive disease|1
7402131|NCT01326702|11667959|FG004|Overall Study|progressive disease|3
7402132|NCT01326702|11667960|FG005|Overall Study|progressive disease|2
7402133|NCT01326702|11667961|FG006|Overall Study|progressive disease|3
7402134|NCT01326702|11667955|FG000|Overall Study|Death|0
7402135|NCT01326702|11667956|FG001|Overall Study|Death|1
7402136|NCT01326702|11667957|FG002|Overall Study|Death|0
7402137|NCT01326702|11667958|FG003|Overall Study|Death|0
7402138|NCT01326702|11667959|FG004|Overall Study|Death|0
7402139|NCT01326702|11667960|FG005|Overall Study|Death|0
7402140|NCT01326702|11667961|FG006|Overall Study|Death|0
7402141|NCT01326702|11667955|FG000|Overall Study|Adverse Event|0
7402142|NCT01326702|11667956|FG001|Overall Study|Adverse Event|0
7402143|NCT01326702|11667957|FG002|Overall Study|Adverse Event|1
7402144|NCT01326702|11667958|FG003|Overall Study|Adverse Event|1
7402145|NCT01326702|11667959|FG004|Overall Study|Adverse Event|0
7402146|NCT01326702|11667960|FG005|Overall Study|Adverse Event|3
7402147|NCT01326702|11667961|FG006|Overall Study|Adverse Event|1
7402148|NCT01326702|11667955|FG000|Overall Study|Withdrawal by Subject|0
7402149|NCT01326702|11667956|FG001|Overall Study|Withdrawal by Subject|0
7402150|NCT01326702|11667957|FG002|Overall Study|Withdrawal by Subject|1
7402151|NCT01326702|11667958|FG003|Overall Study|Withdrawal by Subject|0
7402152|NCT01326702|11667959|FG004|Overall Study|Withdrawal by Subject|1
7402153|NCT01326702|11667960|FG005|Overall Study|Withdrawal by Subject|1
7402154|NCT01326702|11667961|FG006|Overall Study|Withdrawal by Subject|3
7402155|NCT01326702|11667955|FG000|Overall Study|Not Treated|0
7402156|NCT01326702|11667956|FG001|Overall Study|Not Treated|0
7402159|NCT01326702|11667959|FG004|Overall Study|Not Treated|0
7402160|NCT01326702|11667960|FG005|Overall Study|Not Treated|1
7402161|NCT01326702|11667961|FG006|Overall Study|Not Treated|0
7402162|NCT01326728|11667982|FG000|Overall Study|Death|13
7402163|NCT01326728|11667983|FG001|Overall Study|Death|0
7402164|NCT01326728|11667982|FG000|Overall Study|Early closure of study|34
7402165|NCT01326728|11667983|FG001|Overall Study|Early closure of study|9
7402166|NCT01326910|11668007|FG000|Overall Study|Withdrawal by Subject|3
7402167|NCT01326910|11668008|FG001|Overall Study|Withdrawal by Subject|2
7402168|NCT01326910|11668007|FG000|Overall Study|Protocol Violation|1
7402169|NCT01326910|11668008|FG001|Overall Study|Protocol Violation|1
7402170|NCT01326962|11668014|FG000|Overall Study|Adverse Event|1
7402171|NCT01326962|11668014|FG000|Overall Study|Withdrawal by Subject|1
7402172|NCT01326962|11668014|FG000|Overall Study|Lost to Follow-up|3
7402173|NCT01326962|11668014|FG000|Overall Study|Other|2
7402174|NCT01327053|11668020|FG000|Overall Study|Adverse Event|23
7402175|NCT01327053|11668021|FG001|Overall Study|Adverse Event|57
7402176|NCT01327053|11668020|FG000|Overall Study|Patient/guardian decision|11
7402177|NCT01327053|11668021|FG001|Overall Study|Patient/guardian decision|35
7402178|NCT01327053|11668020|FG000|Overall Study|Physician Decision|10
7402179|NCT01327053|11668021|FG001|Overall Study|Physician Decision|14
7402180|NCT01327053|11668020|FG000|Overall Study|Death|1
7402181|NCT01327053|11668021|FG001|Overall Study|Death|5
7402182|NCT01327053|11668020|FG000|Overall Study|Lost to Follow-up|2
7402183|NCT01327053|11668021|FG001|Overall Study|Lost to Follow-up|4
7402184|NCT01327053|11668020|FG000|Overall Study|Non-compliance with study treatment|0
7402185|NCT01327053|11668021|FG001|Overall Study|Non-compliance with study treatment|5
7402186|NCT01327053|11668020|FG000|Overall Study|Study terminated by Sponsor|1
7402187|NCT01327053|11668021|FG001|Overall Study|Study terminated by Sponsor|3
7402188|NCT01327053|11668020|FG000|Overall Study|Progressive disease|31
7402189|NCT01327053|11668021|FG001|Overall Study|Progressive disease|26
7402190|NCT01327053|11668020|FG000|Overall Study|Protocol Violation|0
7402191|NCT01327053|11668021|FG001|Overall Study|Protocol Violation|1
7402192|NCT01327053|11668020|FG000|Overall Study|Untreated|0
7402193|NCT01327053|11668021|FG001|Overall Study|Untreated|1
7402194|NCT01327300|11668050|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
7402195|NCT01327300|11668051|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
7402196|NCT01327339|11668084|FG000|Overall Study|Protocol Violation|8
7402197|NCT01327482|11668088|FG000|Overall Study|Adverse Event|1
7402198|NCT01327495|11668098|FG000|Overall Study|Adverse Event|2
7402199|NCT01327495|11668099|FG001|Overall Study|Adverse Event|1
7402200|NCT01327495|11668100|FG002|Overall Study|Adverse Event|1
7402201|NCT01327495|11668101|FG003|Overall Study|Adverse Event|0
7402202|NCT01327495|11668102|FG004|Overall Study|Adverse Event|0
7402203|NCT01327495|11668103|FG005|Overall Study|Adverse Event|2
7402204|NCT01327495|11668098|FG000|Overall Study|Withdrawal by Subject|0
7402205|NCT01327495|11668099|FG001|Overall Study|Withdrawal by Subject|1
7402206|NCT01327495|11668100|FG002|Overall Study|Withdrawal by Subject|1
7402207|NCT01327495|11668101|FG003|Overall Study|Withdrawal by Subject|0
7402208|NCT01327495|11668102|FG004|Overall Study|Withdrawal by Subject|1
7402209|NCT01327495|11668103|FG005|Overall Study|Withdrawal by Subject|0
7402210|NCT01327495|11668098|FG000|Overall Study|Physician Decision|0
7402211|NCT01327495|11668099|FG001|Overall Study|Physician Decision|0
7402212|NCT01327495|11668100|FG002|Overall Study|Physician Decision|0
7402213|NCT01327495|11668101|FG003|Overall Study|Physician Decision|0
7402214|NCT01327495|11668102|FG004|Overall Study|Physician Decision|2
7402215|NCT01327495|11668103|FG005|Overall Study|Physician Decision|0
7402216|NCT01327547|11668134|FG000|Overall Study|Adverse Event|4
7402217|NCT01327547|11668135|FG001|Overall Study|Adverse Event|1
7402218|NCT01327547|11668134|FG000|Overall Study|Death|1
7402219|NCT01327547|11668135|FG001|Overall Study|Death|2
7402220|NCT01327547|11668134|FG000|Overall Study|Lost to Follow-up|6
7402221|NCT01327547|11668135|FG001|Overall Study|Lost to Follow-up|6
7402222|NCT01327547|11668134|FG000|Overall Study|Non-Compliance With Study Treatment|0
7402223|NCT01327547|11668135|FG001|Overall Study|Non-Compliance With Study Treatment|2
7402224|NCT01327547|11668134|FG000|Overall Study|Withdrawal by Subject|3
7402225|NCT01327547|11668135|FG001|Overall Study|Withdrawal by Subject|7
7402226|NCT01327547|11668134|FG000|Overall Study|Does Not Meet Entrance Criteria|2
7402227|NCT01327547|11668135|FG001|Overall Study|Does Not Meet Entrance Criteria|2
7402228|NCT01327547|11668134|FG000|Overall Study|Protocol Violation|1
7402229|NCT01327547|11668135|FG001|Overall Study|Protocol Violation|0
7402230|NCT01327547|11668134|FG000|Overall Study|Non-compliance due to alcohol intake|0
7402231|NCT01327547|11668135|FG001|Overall Study|Non-compliance due to alcohol intake|1
7402232|NCT01327547|11668134|FG000|Overall Study|Required prohibited medication|2
7402233|NCT01327547|11668135|FG001|Overall Study|Required prohibited medication|0
7402234|NCT01327547|11668134|FG000|Overall Study|Non-compliance with study procedures|1
7402235|NCT01327547|11668135|FG001|Overall Study|Non-compliance with study procedures|0
7402236|NCT01327547|11668134|FG000|Overall Study|By investigator in subject's interest|0
7402237|NCT01327547|11668135|FG001|Overall Study|By investigator in subject's interest|1
7402238|NCT01327573|11668152|FG000|Overall Study|Physician Decision|3
7402239|NCT01327573|11668153|FG001|Overall Study|Physician Decision|1
7402240|NCT01327599|11668160|FG000|Overall Study|Adverse Event|1
7402241|NCT01327599|11668160|FG000|Overall Study|Could Not Attend Visit|1
7402242|NCT01327599|11668160|FG000|Overall Study|Withdrawal of Consent|1
7402243|NCT01327612|11668171|FG000|Overall Study|Withdrawal by Subject|0
7402244|NCT01327612|11668172|FG001|Overall Study|Withdrawal by Subject|0
7402245|NCT01327612|11668173|FG002|Overall Study|Withdrawal by Subject|0
7402246|NCT01327612|11668174|FG003|Overall Study|Withdrawal by Subject|0
7402247|NCT01327612|11668175|FG004|Overall Study|Withdrawal by Subject|0
7402248|NCT01327612|11668176|FG005|Overall Study|Withdrawal by Subject|1
7402249|NCT01327612|11668177|FG006|Overall Study|Withdrawal by Subject|0
7402250|NCT01327612|11668171|FG000|Overall Study|Disease Progression|1
7402251|NCT01327612|11668172|FG001|Overall Study|Disease Progression|1
7402252|NCT01327612|11668173|FG002|Overall Study|Disease Progression|1
7402253|NCT01327612|11668174|FG003|Overall Study|Disease Progression|0
7402254|NCT01327612|11668175|FG004|Overall Study|Disease Progression|1
7402255|NCT01327612|11668176|FG005|Overall Study|Disease Progression|2
7402256|NCT01327612|11668177|FG006|Overall Study|Disease Progression|2
7402257|NCT01327612|11668171|FG000|Overall Study|Administrative Decision|0
7402258|NCT01327612|11668172|FG001|Overall Study|Administrative Decision|0
7402259|NCT01327612|11668173|FG002|Overall Study|Administrative Decision|0
7402260|NCT01327612|11668174|FG003|Overall Study|Administrative Decision|1
7402261|NCT01327612|11668175|FG004|Overall Study|Administrative Decision|0
7402262|NCT01327612|11668176|FG005|Overall Study|Administrative Decision|0
7402263|NCT01327612|11668177|FG006|Overall Study|Administrative Decision|0
7402264|NCT01327612|11668171|FG000|Overall Study|Death|0
7402265|NCT01327612|11668172|FG001|Overall Study|Death|0
7402266|NCT01327612|11668173|FG002|Overall Study|Death|0
7402267|NCT01327612|11668174|FG003|Overall Study|Death|0
7402268|NCT01327612|11668175|FG004|Overall Study|Death|1
7402269|NCT01327612|11668176|FG005|Overall Study|Death|0
7402270|NCT01327612|11668177|FG006|Overall Study|Death|0
7402307|NCT01327703|11668261|FG000|Second Treatment Period|Adverse Event|1
7402308|NCT01327703|11668262|FG001|Second Treatment Period|Adverse Event|1
7402309|NCT01327703|11668261|FG000|Second Treatment Period|Protocol Violation|0
7402310|NCT01327703|11668262|FG001|Second Treatment Period|Protocol Violation|1
7402339|NCT01327885|11668315|FG000|Overall Study|Disease progression-according to RECIST|173
7402340|NCT01327885|11668316|FG001|Overall Study|Disease progression-according to RECIST|165
7402341|NCT01327885|11668315|FG000|Overall Study|Clinical progression|24
7402342|NCT01327885|11668316|FG001|Overall Study|Clinical progression|27
7402343|NCT01327885|11668315|FG000|Overall Study|Adverse Event|14
7402344|NCT01327885|11668316|FG001|Overall Study|Adverse Event|10
7402345|NCT01327885|11668315|FG000|Overall Study|Subject choice|5
7402346|NCT01327885|11668316|FG001|Overall Study|Subject choice|10
7402347|NCT01327885|11668315|FG000|Overall Study|Other|8
7402348|NCT01327885|11668316|FG001|Overall Study|Other|6
7402349|NCT01327885|11668315|FG000|Overall Study|Withdrawal of consent from study|3
7402350|NCT01327885|11668316|FG001|Overall Study|Withdrawal of consent from study|4
7402351|NCT01327885|11668315|FG000|Overall Study|Not treated|1
7402352|NCT01327885|11668316|FG001|Overall Study|Not treated|1
7402353|NCT01327885|11668315|FG000|Overall Study|Administrative decision|0
7402354|NCT01327885|11668316|FG001|Overall Study|Administrative decision|1
7402355|NCT01328002|11668344|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
7402356|NCT01328002|11668345|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
7402357|NCT01328002|11668344|FG000|Open-Label Period|Adverse Event|8
7402358|NCT01328002|11668345|FG001|Open-Label Period|Adverse Event|0
7402359|NCT01328002|11668344|FG000|Open-Label Period|Lack of Efficacy|3
7402360|NCT01328002|11668345|FG001|Open-Label Period|Lack of Efficacy|0
7402361|NCT01328002|11668344|FG000|Open-Label Period|Protocol Violation|2
7402362|NCT01328002|11668345|FG001|Open-Label Period|Protocol Violation|0
7402363|NCT01328002|11668344|FG000|Open-Label Period|Withdrawal by Subject|9
7402364|NCT01328002|11668345|FG001|Open-Label Period|Withdrawal by Subject|0
7402365|NCT01328002|11668344|FG000|Open-Label Period|Lost to Follow-up|6
7402366|NCT01328002|11668345|FG001|Open-Label Period|Lost to Follow-up|0
7402367|NCT01328002|11668344|FG000|Open-Label Period|Other Reason|2
7402368|NCT01328002|11668345|FG001|Open-Label Period|Other Reason|0
7402369|NCT01328002|11668344|FG000|Double-Blind Period|Adverse Event|1
7402370|NCT01328002|11668345|FG001|Double-Blind Period|Adverse Event|0
7402371|NCT01328002|11668344|FG000|Double-Blind Period|Lack of Efficacy|1
7402372|NCT01328002|11668345|FG001|Double-Blind Period|Lack of Efficacy|0
7402373|NCT01328041|11668352|FG000|Overall Study|Adverse Event|7
7402374|NCT01328041|11668352|FG000|Overall Study|Lack of Efficacy|27
7402375|NCT01328041|11668352|FG000|Overall Study|Protocol Violation|7
7402376|NCT01328041|11668352|FG000|Overall Study|Lost to Follow-up|7
7402377|NCT01328041|11668352|FG000|Overall Study|Physician Decision|2
7402378|NCT01328041|11668352|FG000|Overall Study|Withdrawal by Subject|7
7402379|NCT01328054|11668356|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
7402380|NCT01328054|11668357|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
7402381|NCT01328054|11668356|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
7402382|NCT01328054|11668357|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
7402383|NCT01328054|11668356|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
7402384|NCT01328054|11668357|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
7402385|NCT01328080|11668369|FG000|Overall Study|Lost to Follow-up|5
7402386|NCT01328249|11668388|FG000|Overall Study|Adverse Event|3
7402387|NCT01328249|11668389|FG001|Overall Study|Adverse Event|0
7402388|NCT01328249|11668388|FG000|Overall Study|Disease progression|1
7402389|NCT01328249|11668389|FG001|Overall Study|Disease progression|0
7402390|NCT01328249|11668388|FG000|Overall Study|Withdrawal by Subject|1
7402391|NCT01328249|11668389|FG001|Overall Study|Withdrawal by Subject|1
7402392|NCT01328249|11668388|FG000|Overall Study|Moved before end of treatment visit|1
7402393|NCT01328249|11668389|FG001|Overall Study|Moved before end of treatment visit|0
7402394|NCT01328249|11668388|FG000|Overall Study|Subject choice|1
7402395|NCT01328249|11668389|FG001|Overall Study|Subject choice|1
7402396|NCT01328249|11668388|FG000|Overall Study|Protocol Violation|0
7402397|NCT01328249|11668389|FG001|Overall Study|Protocol Violation|1
7402398|NCT01328366|11668397|FG000|Overall Study|Death|1
7402399|NCT01328366|11668397|FG000|Overall Study|Withdrawal by Subject|2
7402400|NCT01328366|11668397|FG000|Overall Study|Lost to Follow-up|7
7402401|NCT01328431|11668425|FG000|Baseline|Protocol Violation|0
7402402|NCT01328431|11668426|FG001|Baseline|Protocol Violation|2
7402403|NCT01328431|11668425|FG000|1 Month (1M)|Lost to Follow-up|55
7402404|NCT01328431|11668426|FG001|1 Month (1M)|Lost to Follow-up|58
7402405|NCT01328431|11668425|FG000|3 Month (3M)|Death|2
7402406|NCT01328431|11668426|FG001|3 Month (3M)|Death|2
7402407|NCT01328431|11668425|FG000|3 Month (3M)|Lost to Follow-up|75
7402408|NCT01328431|11668426|FG001|3 Month (3M)|Lost to Follow-up|70
7402409|NCT01328431|11668425|FG000|12 Month (12M)|Death|2
7402410|NCT01328431|11668426|FG001|12 Month (12M)|Death|6
7402411|NCT01328431|11668425|FG000|12 Month (12M)|Lost to Follow-up|82
7402412|NCT01328431|11668426|FG001|12 Month (12M)|Lost to Follow-up|91
7402413|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
7402414|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
7402415|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
7402416|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
7402417|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
7402418|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
7402419|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7402420|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7402421|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7402422|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
7402423|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
7402424|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
7402425|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7402426|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7402427|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7402428|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7402429|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
7402430|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
7402744|NCT01331681|11668947|FG002|Overall Study|Lack of Efficacy|0
7402431|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7402432|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
7402433|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7402434|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7402435|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
7402436|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
7402437|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
7402438|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7402439|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7402440|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7402441|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7402442|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7402443|NCT01328444|11668432|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7402444|NCT01328444|11668433|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7402445|NCT01328444|11668434|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7402446|NCT01328444|11668435|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
7402447|NCT01328444|11668436|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7402448|NCT01328444|11668437|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7402449|NCT01328444|11668432|FG000|Washout Period (14 Days)|Adverse Event|1
7402450|NCT01328444|11668433|FG001|Washout Period (14 Days)|Adverse Event|1
7402451|NCT01328444|11668434|FG002|Washout Period (14 Days)|Adverse Event|0
7402452|NCT01328444|11668435|FG003|Washout Period (14 Days)|Adverse Event|1
7402453|NCT01328444|11668436|FG004|Washout Period (14 Days)|Adverse Event|1
7402454|NCT01328444|11668437|FG005|Washout Period (14 Days)|Adverse Event|2
7402455|NCT01328444|11668432|FG000|Washout Period (14 Days)|Lack of Efficacy|0
7402456|NCT01328444|11668433|FG001|Washout Period (14 Days)|Lack of Efficacy|0
7402457|NCT01328444|11668434|FG002|Washout Period (14 Days)|Lack of Efficacy|0
7402458|NCT01328444|11668435|FG003|Washout Period (14 Days)|Lack of Efficacy|0
7402459|NCT01328444|11668436|FG004|Washout Period (14 Days)|Lack of Efficacy|0
7402460|NCT01328444|11668437|FG005|Washout Period (14 Days)|Lack of Efficacy|1
7402461|NCT01328444|11668432|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
7402462|NCT01328444|11668433|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
7402463|NCT01328444|11668434|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
7402464|NCT01328444|11668435|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
7402465|NCT01328444|11668436|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
7402466|NCT01328444|11668437|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
7402467|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
7402468|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
7402469|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
7402470|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
7402471|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
7402472|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
7402473|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
7402474|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7402475|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7402476|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
7402477|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
7402478|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
7402479|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7402480|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7402481|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7402482|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7402483|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
7402484|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
7402485|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7465698|NCT01882465|11765128|FG003|Period 1|Withdrawal by Subject|0
7402486|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7402487|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7402488|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7402489|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
7402490|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
7402491|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7402492|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
7402493|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7402494|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7402495|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
7402496|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7402497|NCT01328444|11668432|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7402498|NCT01328444|11668433|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7402499|NCT01328444|11668434|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7402500|NCT01328444|11668435|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7402501|NCT01328444|11668436|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7402502|NCT01328444|11668437|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7402503|NCT01328496|11668453|FG000|Overall Study|Significant Change in Health Status|1
7402504|NCT01328496|11668454|FG001|Overall Study|Significant Change in Health Status|0
7402505|NCT01328535|11668463|FG000|Overall Study|Ineligible|1
7402506|NCT01328548|11668471|FG000|Overall Study|Death|3
7402507|NCT01328548|11668472|FG001|Overall Study|Death|0
7402508|NCT01328548|11668471|FG000|Overall Study|Protocol Violation|1
7402509|NCT01328548|11668472|FG001|Overall Study|Protocol Violation|0
7402510|NCT01328574|11668478|FG000|Overall Study|Refused further treatment|1
7402511|NCT01328717|11668487|FG000|Overall Study|Adverse Event|1
7402512|NCT01328756|11668500|FG000|Overall Study|Protocol Violation|4
7402513|NCT01328756|11668500|FG000|Overall Study|Adverse Event|39
7402514|NCT01328756|11668500|FG000|Overall Study|Lack of Efficacy|5
7402515|NCT01328756|11668500|FG000|Overall Study|Withdrawal by Subject|41
7402516|NCT01328756|11668500|FG000|Overall Study|Lost to Follow-up|5
7402517|NCT01328756|11668500|FG000|Overall Study|Other|29
7402518|NCT01328951|11668534|FG000|Overall Study|Disease Progression|17
7402519|NCT01328951|11668535|FG001|Overall Study|Disease Progression|14
7402520|NCT01328951|11668534|FG000|Overall Study|Adverse Event|2
7402521|NCT01328951|11668535|FG001|Overall Study|Adverse Event|0
7402522|NCT01328951|11668534|FG000|Overall Study|Death|243
7402523|NCT01328951|11668535|FG001|Overall Study|Death|258
7402524|NCT01328951|11668534|FG000|Overall Study|Lost to Follow-up|6
7402525|NCT01328951|11668535|FG001|Overall Study|Lost to Follow-up|7
7402526|NCT01328951|11668534|FG000|Overall Study|Withdrawal by Subject|6
7402527|NCT01328951|11668535|FG001|Overall Study|Withdrawal by Subject|6
7402528|NCT01328951|11668534|FG000|Overall Study|Study Closed by the Sponsor|36
7402529|NCT01328951|11668535|FG001|Overall Study|Study Closed by the Sponsor|31
7402530|NCT01328951|11668534|FG000|Overall Study|Other|11
7402531|NCT01328951|11668535|FG001|Overall Study|Other|6
7402532|NCT01329029|11668560|FG000|Overall Study|Withdrawal by Subject|117
7402533|NCT01329029|11668561|FG001|Overall Study|Withdrawal by Subject|87
7402534|NCT01329029|11668560|FG000|Overall Study|Adverse Event|82
7402535|NCT01329029|11668561|FG001|Overall Study|Adverse Event|29
7402536|NCT01329029|11668560|FG000|Overall Study|Death|16
7402537|NCT01329029|11668561|FG001|Overall Study|Death|19
7402538|NCT01329029|11668560|FG000|Overall Study|Other|14
7402539|NCT01329029|11668561|FG001|Overall Study|Other|20
7402540|NCT01329029|11668560|FG000|Overall Study|COPD Exacerbation|11
7402541|NCT01329029|11668561|FG001|Overall Study|COPD Exacerbation|18
7402542|NCT01329029|11668560|FG000|Overall Study|Physician Decision|16
7402543|NCT01329029|11668561|FG001|Overall Study|Physician Decision|13
7402544|NCT01329029|11668560|FG000|Overall Study|Lost to Follow-up|8
7402545|NCT01329029|11668561|FG001|Overall Study|Lost to Follow-up|5
7402546|NCT01329029|11668560|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
7402547|NCT01329029|11668561|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
7402548|NCT01329263|11668592|FG000|Overall Study|Lost to Follow-up|4
7402549|NCT01329263|11668593|FG001|Overall Study|Lost to Follow-up|21
7402550|NCT01329263|11668592|FG000|Overall Study|Withdrawal by Subject|1
7402551|NCT01329263|11668593|FG001|Overall Study|Withdrawal by Subject|2
7402552|NCT01329328|11668604|FG000|Overall Study|Withdrawal by Subject|2
7402553|NCT01329328|11668605|FG001|Overall Study|Withdrawal by Subject|4
7402554|NCT01329328|11668606|FG002|Overall Study|Withdrawal by Subject|3
7402555|NCT01329419|11668618|FG000|Overall Study|Protocol Violation|235
7402556|NCT01329562|11668625|FG000|Overall Study|Protocol Violation|5
7402557|NCT01329562|11668626|FG001|Overall Study|Protocol Violation|3
7402558|NCT01329562|11668625|FG000|Overall Study|Lost to Follow-up|1
7402559|NCT01329562|11668626|FG001|Overall Study|Lost to Follow-up|1
7402560|NCT01329562|11668625|FG000|Overall Study|Subject withdrew due to personal issues.|3
7465699|NCT01882465|11765129|FG004|Period 1|Withdrawal by Subject|0
7402561|NCT01329562|11668626|FG001|Overall Study|Subject withdrew due to personal issues.|2
7402562|NCT01329562|11668625|FG000|Overall Study|Physician Decision|0
7402563|NCT01329562|11668626|FG001|Overall Study|Physician Decision|1
7402564|NCT01329900|11668647|FG000|Overall Study|Elevated creatinine/renal function|1
7402565|NCT01329939|11668655|FG000|Overall Study|Lost to Follow-up|3
7402566|NCT01329939|11668656|FG001|Overall Study|Lost to Follow-up|0
7402567|NCT01329939|11668657|FG002|Overall Study|Lost to Follow-up|1
7402568|NCT01329939|11668658|FG003|Overall Study|Lost to Follow-up|2
7402569|NCT01329939|11668655|FG000|Overall Study|Withdrawal by Subject|0
7402570|NCT01329939|11668656|FG001|Overall Study|Withdrawal by Subject|1
7402571|NCT01329939|11668657|FG002|Overall Study|Withdrawal by Subject|0
7402572|NCT01329939|11668658|FG003|Overall Study|Withdrawal by Subject|0
7402573|NCT01329939|11668655|FG000|Overall Study|Adverse Event|0
7402574|NCT01329939|11668656|FG001|Overall Study|Adverse Event|0
7402575|NCT01329939|11668657|FG002|Overall Study|Adverse Event|0
7402576|NCT01329939|11668658|FG003|Overall Study|Adverse Event|3
7402577|NCT01329978|11668671|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
7402578|NCT01329978|11668672|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
7402579|NCT01329978|11668673|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7402580|NCT01329978|11668674|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7402581|NCT01329978|11668675|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
7402582|NCT01329978|11668671|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7402583|NCT01329978|11668672|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
7402584|NCT01329978|11668673|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
7402585|NCT01329978|11668674|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7402586|NCT01329978|11668675|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
7402587|NCT01329978|11668671|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7402588|NCT01329978|11668672|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
7402589|NCT01329978|11668673|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
7402590|NCT01329978|11668674|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7402591|NCT01329978|11668675|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
7402592|NCT01329978|11668671|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7402593|NCT01329978|11668672|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
7402594|NCT01329978|11668673|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7402595|NCT01329978|11668674|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7402596|NCT01329978|11668675|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
7402597|NCT01329978|11668671|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7402598|NCT01329978|11668672|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
7402599|NCT01329978|11668673|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7402600|NCT01329978|11668674|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7402601|NCT01329978|11668675|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
7402602|NCT01329978|11668671|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
7402603|NCT01329978|11668672|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
7402604|NCT01329978|11668673|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
7402605|NCT01329978|11668674|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
7402606|NCT01329978|11668675|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
7402607|NCT01329978|11668671|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
7402608|NCT01329978|11668672|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
7402609|NCT01329978|11668673|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
7402610|NCT01329978|11668674|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
7402611|NCT01329978|11668675|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
7402612|NCT01330017|11668692|FG000|Overall Study|Adverse Event|0
7402613|NCT01330017|11668693|FG001|Overall Study|Adverse Event|1
7402614|NCT01330017|11668694|FG002|Overall Study|Adverse Event|1
7402615|NCT01330017|11668695|FG003|Overall Study|Adverse Event|4
7402616|NCT01330017|11668696|FG004|Overall Study|Adverse Event|0
7402617|NCT01330017|11668692|FG000|Overall Study|Withdrawal by Subject|0
7402618|NCT01330017|11668693|FG001|Overall Study|Withdrawal by Subject|0
7402619|NCT01330017|11668694|FG002|Overall Study|Withdrawal by Subject|1
7402620|NCT01330017|11668695|FG003|Overall Study|Withdrawal by Subject|0
7402621|NCT01330017|11668696|FG004|Overall Study|Withdrawal by Subject|1
7402622|NCT01330017|11668692|FG000|Overall Study|Lost to Follow-up|0
7402623|NCT01330017|11668693|FG001|Overall Study|Lost to Follow-up|0
7402624|NCT01330017|11668694|FG002|Overall Study|Lost to Follow-up|1
7402625|NCT01330017|11668695|FG003|Overall Study|Lost to Follow-up|0
7402626|NCT01330017|11668696|FG004|Overall Study|Lost to Follow-up|0
7402627|NCT01330017|11668692|FG000|Overall Study|Protocol Violation|0
7402628|NCT01330017|11668693|FG001|Overall Study|Protocol Violation|0
7402629|NCT01330017|11668694|FG002|Overall Study|Protocol Violation|0
7402630|NCT01330017|11668695|FG003|Overall Study|Protocol Violation|1
7402631|NCT01330017|11668696|FG004|Overall Study|Protocol Violation|0
7402632|NCT01330017|11668692|FG000|Overall Study|Unknown Reason|5
7402633|NCT01330017|11668693|FG001|Overall Study|Unknown Reason|3
7402634|NCT01330017|11668694|FG002|Overall Study|Unknown Reason|5
7402635|NCT01330017|11668695|FG003|Overall Study|Unknown Reason|7
7402636|NCT01330017|11668696|FG004|Overall Study|Unknown Reason|2
7402637|NCT01330030|11668710|FG000|Overall Study|Lost to Follow-up|16
7402638|NCT01330030|11668711|FG001|Overall Study|Lost to Follow-up|17
7402639|NCT01330108|11668726|FG000|Overall Study|Withdrawal by Subject|4
7402640|NCT01330303|11668743|FG000|Period 1|Adverse Event|1
7402641|NCT01330303|11668744|FG001|Period 1|Adverse Event|0
7402642|NCT01330303|11668743|FG000|Period 1|Protocol Violation|0
7402643|NCT01330303|11668744|FG001|Period 1|Protocol Violation|1
7402644|NCT01330303|11668743|FG000|Period 1|Withdrawal by Subject|0
7402645|NCT01330303|11668744|FG001|Period 1|Withdrawal by Subject|1
7402646|NCT01330316|11668753|FG000|Overall Study|Adverse Event|2
7402647|NCT01330316|11668754|FG001|Overall Study|Adverse Event|2
7402648|NCT01330316|11668753|FG000|Overall Study|Lack of Efficacy|0
7402649|NCT01330316|11668754|FG001|Overall Study|Lack of Efficacy|10
7402650|NCT01330316|11668753|FG000|Overall Study|Lost to Follow-up|0
7402651|NCT01330316|11668754|FG001|Overall Study|Lost to Follow-up|1
7402652|NCT01330316|11668753|FG000|Overall Study|Withdrawal by Subject|0
7402653|NCT01330316|11668754|FG001|Overall Study|Withdrawal by Subject|1
7402654|NCT01330316|11668753|FG000|Overall Study|other than above|0
7402655|NCT01330316|11668754|FG001|Overall Study|other than above|1
7402656|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
7402657|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
7402658|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
7402659|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
7402660|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
7402661|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
7402662|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7402663|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7402664|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
7402665|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
7402666|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7402667|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
7402668|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
7402669|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7402670|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
7402671|NCT01330381|11668771|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7402672|NCT01330381|11668772|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7402673|NCT01330381|11668773|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7402674|NCT01330381|11668771|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
7402675|NCT01330381|11668772|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
7402676|NCT01330381|11668773|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
7402677|NCT01330381|11668771|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
7402678|NCT01330381|11668772|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7402679|NCT01330381|11668773|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
7402680|NCT01330381|11668771|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7402681|NCT01330381|11668772|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
7402682|NCT01330381|11668773|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
7402683|NCT01330381|11668771|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7402684|NCT01330381|11668772|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
7402685|NCT01330381|11668773|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
7402686|NCT01330433|11668797|FG000|Overall Study|Death|1
7402687|NCT01330433|11668798|FG001|Overall Study|Death|3
7402688|NCT01330433|11668797|FG000|Overall Study|Lost to Follow-up|1
7402689|NCT01330433|11668798|FG001|Overall Study|Lost to Follow-up|0
7402690|NCT01330459|11668806|FG000|Overall Study|Physician Decision|0
7402691|NCT01330459|11668807|FG001|Overall Study|Physician Decision|2
7402692|NCT01330628|11668817|FG000|Overall Study|Death|2
7402693|NCT01330628|11668818|FG001|Overall Study|Death|3
7402694|NCT01330628|11668817|FG000|Overall Study|Lost to Follow-up|5
7402695|NCT01330628|11668818|FG001|Overall Study|Lost to Follow-up|6
7402696|NCT01330628|11668817|FG000|Overall Study|Adverse Event|44
7402697|NCT01330628|11668818|FG001|Overall Study|Adverse Event|25
7402698|NCT01330628|11668817|FG000|Overall Study|Withdrawn|18
7402699|NCT01330628|11668818|FG001|Overall Study|Withdrawn|6
7402700|NCT01330628|11668817|FG000|Overall Study|Didn't receive study treatment|1
7402701|NCT01330628|11668818|FG001|Overall Study|Didn't receive study treatment|0
7402702|NCT01330914|11668824|FG000|Overall Study|Withdrawal by Subject|4
7402703|NCT01330914|11668824|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
7402704|NCT01331005|11668860|FG000|Overall Study|Lost to Follow-up|2
7402705|NCT01331005|11668861|FG001|Overall Study|Lost to Follow-up|1
7402706|NCT01331005|11668860|FG000|Overall Study|Withdrawal by Subject|2
7402707|NCT01331005|11668861|FG001|Overall Study|Withdrawal by Subject|3
7402708|NCT01331109|11668876|FG000|Overall Study|Adverse Event|6
7402709|NCT01331109|11668876|FG000|Overall Study|Lack of Efficacy|2
7402710|NCT01331109|11668876|FG000|Overall Study|Protocol Violation|3
7402711|NCT01331109|11668876|FG000|Overall Study|Withdrawal by Subject|7
7402712|NCT01331109|11668876|FG000|Overall Study|Lost to Follow-up|1
7402713|NCT01331109|11668876|FG000|Overall Study|Study Terminated by Sponsor|38
7402714|NCT01331161|11668882|FG000|Overall Study|Physician Decision|1
7402715|NCT01331161|11668883|FG001|Overall Study|Physician Decision|0
7402716|NCT01331161|11668882|FG000|Overall Study|Lost to Follow-up|0
7402717|NCT01331161|11668883|FG001|Overall Study|Lost to Follow-up|1
7402718|NCT01331161|11668882|FG000|Overall Study|Pregnancy|0
7402719|NCT01331161|11668883|FG001|Overall Study|Pregnancy|1
7402720|NCT01331239|11668902|FG000|Part II: Core Study|Adverse Event|0
7402721|NCT01331239|11668903|FG001|Part II: Core Study|Adverse Event|3
7402722|NCT01331239|11668904|FG002|Part II: Core Study|Adverse Event|0
7402723|NCT01331239|11668902|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
7402724|NCT01331239|11668903|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
7402725|NCT01331239|11668904|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
7402726|NCT01331239|11668902|FG000|Part II: Core Study|Withdrawal by Subject|0
7402727|NCT01331239|11668903|FG001|Part II: Core Study|Withdrawal by Subject|2
7402728|NCT01331239|11668904|FG002|Part II: Core Study|Withdrawal by Subject|0
7402729|NCT01331239|11668902|FG000|Part II: Core Study|Administrative problems|0
7402730|NCT01331239|11668903|FG001|Part II: Core Study|Administrative problems|1
7402731|NCT01331239|11668904|FG002|Part II: Core Study|Administrative problems|0
7402732|NCT01331291|11668922|FG000|Overall Study|Lack of Efficacy|2
7402733|NCT01331291|11668923|FG001|Overall Study|Lack of Efficacy|8
7402734|NCT01331291|11668922|FG000|Overall Study|Death|0
7402735|NCT01331291|11668923|FG001|Overall Study|Death|1
7402736|NCT01331681|11668945|FG000|Overall Study|Adverse Event|10
7402737|NCT01331681|11668946|FG001|Overall Study|Adverse Event|13
7402738|NCT01331681|11668947|FG002|Overall Study|Adverse Event|10
7402739|NCT01331681|11668945|FG000|Overall Study|Death|6
7402740|NCT01331681|11668946|FG001|Overall Study|Death|6
7402741|NCT01331681|11668947|FG002|Overall Study|Death|2
7402742|NCT01331681|11668945|FG000|Overall Study|Lack of Efficacy|0
7402743|NCT01331681|11668946|FG001|Overall Study|Lack of Efficacy|1
7402745|NCT01331681|11668945|FG000|Overall Study|Withdrawal by Subject|12
7402746|NCT01331681|11668946|FG001|Overall Study|Withdrawal by Subject|8
7402747|NCT01331681|11668947|FG002|Overall Study|Withdrawal by Subject|15
7402748|NCT01331681|11668945|FG000|Overall Study|Protocol Violation|1
7402749|NCT01331681|11668946|FG001|Overall Study|Protocol Violation|1
7402750|NCT01331681|11668947|FG002|Overall Study|Protocol Violation|0
7402751|NCT01331681|11668945|FG000|Overall Study|Lost to Follow-up|2
7402752|NCT01331681|11668946|FG001|Overall Study|Lost to Follow-up|4
7402753|NCT01331681|11668947|FG002|Overall Study|Lost to Follow-up|1
7402754|NCT01331681|11668945|FG000|Overall Study|Physician Decision|2
7402755|NCT01331681|11668946|FG001|Overall Study|Physician Decision|0
7402756|NCT01331681|11668947|FG002|Overall Study|Physician Decision|4
7402757|NCT01331681|11668945|FG000|Overall Study|Therapeutic procedure required|1
7402758|NCT01331681|11668946|FG001|Overall Study|Therapeutic procedure required|0
7402759|NCT01331681|11668947|FG002|Overall Study|Therapeutic procedure required|0
7402760|NCT01331681|11668945|FG000|Overall Study|Sponsor decision|1
7402761|NCT01331681|11668946|FG001|Overall Study|Sponsor decision|1
7402762|NCT01331681|11668947|FG002|Overall Study|Sponsor decision|0
7402763|NCT01331681|11668945|FG000|Overall Study|Switching to other therapy|0
7402764|NCT01331681|11668946|FG001|Overall Study|Switching to other therapy|0
7402765|NCT01331681|11668947|FG002|Overall Study|Switching to other therapy|1
7402766|NCT01331681|11668945|FG000|Overall Study|Not Received Study Treatment|0
7402767|NCT01331681|11668946|FG001|Overall Study|Not Received Study Treatment|0
7402768|NCT01331681|11668947|FG002|Overall Study|Not Received Study Treatment|2
7402769|NCT01331824|11668980|FG000|Overall Study|Adverse Event|2
7402770|NCT01331824|11668980|FG000|Overall Study|Death|1
7402771|NCT01331824|11668980|FG000|Overall Study|Disease Progression|9
7402772|NCT01331824|11668980|FG000|Overall Study|Withdrawal by Subject|1
7402773|NCT01331837|11668986|FG000|Overall Study|Death|30
7402774|NCT01331837|11668987|FG001|Overall Study|Death|34
7402775|NCT01331837|11668986|FG000|Overall Study|Lost to Follow-up|3
7402776|NCT01331837|11668987|FG001|Overall Study|Lost to Follow-up|1
7402777|NCT01331837|11668986|FG000|Overall Study|Info not recorded|10
7402778|NCT01331837|11668987|FG001|Overall Study|Info not recorded|16
7402779|NCT01331837|11668986|FG000|Overall Study|Withdrawal by Subject|13
7402780|NCT01331837|11668987|FG001|Overall Study|Withdrawal by Subject|16
7402781|NCT01332019|11668995|FG000|Overall Study|Was Not Dosed|1
7402782|NCT01332019|11668996|FG001|Overall Study|Was Not Dosed|0
7402783|NCT01332019|11668995|FG000|Overall Study|Other|16
7402784|NCT01332019|11668996|FG001|Overall Study|Other|18
7402785|NCT01332019|11668995|FG000|Overall Study|Death|2
7402786|NCT01332019|11668996|FG001|Overall Study|Death|1
7402787|NCT01332019|11668995|FG000|Overall Study|Physician Decision|4
7402788|NCT01332019|11668996|FG001|Overall Study|Physician Decision|3
7402789|NCT01332019|11668995|FG000|Overall Study|Withdrawal by Subject|73
7402790|NCT01332019|11668996|FG001|Overall Study|Withdrawal by Subject|71
7402791|NCT01332019|11668995|FG000|Overall Study|Lost to Follow-up|4
7402792|NCT01332019|11668996|FG001|Overall Study|Lost to Follow-up|7
7402793|NCT01332019|11668995|FG000|Overall Study|Adverse Event|13
7402794|NCT01332019|11668996|FG001|Overall Study|Adverse Event|22
7402795|NCT01332149|11669018|FG000|Overall Study|Adverse Event|11
7402796|NCT01332149|11669019|FG001|Overall Study|Adverse Event|9
7402797|NCT01332149|11669018|FG000|Overall Study|Other unspecified|5
7402798|NCT01332149|11669019|FG001|Overall Study|Other unspecified|7
7402799|NCT01332149|11669018|FG000|Overall Study|Protocol Violation|1
7402800|NCT01332149|11669019|FG001|Overall Study|Protocol Violation|3
7402801|NCT01332149|11669018|FG000|Overall Study|Withdrawal by Subject|4
7402802|NCT01332149|11669019|FG001|Overall Study|Withdrawal by Subject|5
7402803|NCT01332149|11669018|FG000|Overall Study|Lost to Follow-up|1
7402804|NCT01332149|11669019|FG001|Overall Study|Lost to Follow-up|1
7402805|NCT01332149|11669018|FG000|Overall Study|Insufficient clinical response|4
7402806|NCT01332149|11669019|FG001|Overall Study|Insufficient clinical response|7
7402807|NCT01332149|11669018|FG000|Overall Study|Did not meet entrance criteria|3
7402808|NCT01332149|11669019|FG001|Overall Study|Did not meet entrance criteria|4
7402809|NCT01332149|11669018|FG000|Overall Study|Randomized but not treated|1
7402810|NCT01332149|11669019|FG001|Overall Study|Randomized but not treated|2
7402811|NCT01332227|11669044|FG000|Overall Study|Adverse Event|4
7402812|NCT01332227|11669045|FG001|Overall Study|Adverse Event|1
7402813|NCT01332227|11669044|FG000|Overall Study|Withdrawal by Subject|5
7402814|NCT01332227|11669045|FG001|Overall Study|Withdrawal by Subject|1
7402815|NCT01332227|11669044|FG000|Overall Study|Lost to Follow-up|2
7402816|NCT01332227|11669045|FG001|Overall Study|Lost to Follow-up|0
7402817|NCT01332227|11669044|FG000|Overall Study|Lack of Efficacy|3
7402818|NCT01332227|11669045|FG001|Overall Study|Lack of Efficacy|1
7402819|NCT01332227|11669044|FG000|Overall Study|Poor compliance/noncompliance|1
7402820|NCT01332227|11669045|FG001|Overall Study|Poor compliance/noncompliance|1
7402821|NCT01332227|11669044|FG000|Overall Study|Patient moved from area|1
7402822|NCT01332227|11669045|FG001|Overall Study|Patient moved from area|0
7402823|NCT01332227|11669044|FG000|Overall Study|Patient began prohibited medication|0
7402824|NCT01332227|11669045|FG001|Overall Study|Patient began prohibited medication|1
7402825|NCT01332292|11669060|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7402826|NCT01332292|11669061|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7402827|NCT01332292|11669060|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
7402828|NCT01332292|11669061|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
7402829|NCT01332292|11669060|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
7402830|NCT01332292|11669061|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
7402831|NCT01332305|11669074|FG000|Overall Study|Adverse Event|1
7402832|NCT01332305|11669075|FG001|Overall Study|Adverse Event|4
7402833|NCT01332305|11669076|FG002|Overall Study|Adverse Event|6
7402834|NCT01332305|11669077|FG003|Overall Study|Adverse Event|3
7402835|NCT01332305|11669078|FG004|Overall Study|Adverse Event|5
7402836|NCT01332305|11669074|FG000|Overall Study|Withdrawal by Subject|6
7402837|NCT01332305|11669075|FG001|Overall Study|Withdrawal by Subject|5
7402838|NCT01332305|11669076|FG002|Overall Study|Withdrawal by Subject|4
7402839|NCT01332305|11669077|FG003|Overall Study|Withdrawal by Subject|1
7402840|NCT01332305|11669078|FG004|Overall Study|Withdrawal by Subject|0
7402841|NCT01332305|11669074|FG000|Overall Study|Lost to Follow-up|0
7402842|NCT01332305|11669075|FG001|Overall Study|Lost to Follow-up|2
7402843|NCT01332305|11669076|FG002|Overall Study|Lost to Follow-up|3
7402844|NCT01332305|11669077|FG003|Overall Study|Lost to Follow-up|2
7402845|NCT01332305|11669078|FG004|Overall Study|Lost to Follow-up|3
7402846|NCT01332305|11669074|FG000|Overall Study|Protocol Violation|1
7402847|NCT01332305|11669075|FG001|Overall Study|Protocol Violation|2
7402848|NCT01332305|11669076|FG002|Overall Study|Protocol Violation|1
7402849|NCT01332305|11669077|FG003|Overall Study|Protocol Violation|0
7402850|NCT01332305|11669078|FG004|Overall Study|Protocol Violation|3
7402851|NCT01332305|11669074|FG000|Overall Study|Withdrawal by Sponsor|1
7402852|NCT01332305|11669075|FG001|Overall Study|Withdrawal by Sponsor|0
7402853|NCT01332305|11669076|FG002|Overall Study|Withdrawal by Sponsor|0
7402854|NCT01332305|11669077|FG003|Overall Study|Withdrawal by Sponsor|1
7402855|NCT01332305|11669078|FG004|Overall Study|Withdrawal by Sponsor|1
7402856|NCT01332305|11669074|FG000|Overall Study|Treatment Failure|1
7402857|NCT01332305|11669075|FG001|Overall Study|Treatment Failure|1
7402858|NCT01332305|11669076|FG002|Overall Study|Treatment Failure|0
7402859|NCT01332305|11669077|FG003|Overall Study|Treatment Failure|0
7402860|NCT01332305|11669078|FG004|Overall Study|Treatment Failure|0
7402861|NCT01332305|11669074|FG000|Overall Study|Physician Decision|0
7402862|NCT01332305|11669075|FG001|Overall Study|Physician Decision|0
7402863|NCT01332305|11669076|FG002|Overall Study|Physician Decision|0
7402864|NCT01332305|11669077|FG003|Overall Study|Physician Decision|1
7402865|NCT01332305|11669078|FG004|Overall Study|Physician Decision|0
7402866|NCT01332318|11669094|FG000|Overall Study|Adverse Event|0
7402867|NCT01332318|11669095|FG001|Overall Study|Adverse Event|3
7402868|NCT01332318|11669096|FG002|Overall Study|Adverse Event|0
7402869|NCT01332318|11669097|FG003|Overall Study|Adverse Event|0
7402870|NCT01332318|11669094|FG000|Overall Study|Withdrawal by Subject|1
7402871|NCT01332318|11669095|FG001|Overall Study|Withdrawal by Subject|1
7402872|NCT01332318|11669096|FG002|Overall Study|Withdrawal by Subject|0
7402873|NCT01332318|11669097|FG003|Overall Study|Withdrawal by Subject|1
7402874|NCT01332318|11669094|FG000|Overall Study|Protocol Violation|1
7402875|NCT01332318|11669095|FG001|Overall Study|Protocol Violation|0
7402876|NCT01332318|11669096|FG002|Overall Study|Protocol Violation|1
7402877|NCT01332318|11669097|FG003|Overall Study|Protocol Violation|1
7402878|NCT01332331|11669110|FG000|Overall Study|Lost to Follow-up|0
7402879|NCT01332331|11669111|FG001|Overall Study|Lost to Follow-up|1
7402880|NCT01332331|11669110|FG000|Overall Study|Adverse Event|1
7402881|NCT01332331|11669111|FG001|Overall Study|Adverse Event|1
7402882|NCT01332331|11669110|FG000|Overall Study|Physician Decision|1
7402883|NCT01332331|11669111|FG001|Overall Study|Physician Decision|0
7402884|NCT01332630|11669183|FG000|Overall Study|Withdrawal by Subject|3
7402885|NCT01332851|11669193|FG000|Overall Study|Withdrawal by Subject|4
7402886|NCT01332851|11669194|FG001|Overall Study|Withdrawal by Subject|2
7402887|NCT01332851|11669193|FG000|Overall Study|Lost to Follow-up|7
7402888|NCT01332851|11669194|FG001|Overall Study|Lost to Follow-up|11
7402889|NCT01332994|11669211|FG000|Overall Study|Adverse Event|34
7402890|NCT01332994|11669211|FG000|Overall Study|Death|1
7402891|NCT01332994|11669211|FG000|Overall Study|Lack of Efficacy|1
7402892|NCT01332994|11669211|FG000|Overall Study|Lost to Follow-up|4
7402893|NCT01332994|11669211|FG000|Overall Study|Protocol Violation|6
7402894|NCT01332994|11669211|FG000|Overall Study|Withdrawal by Subject|15
7402895|NCT01332994|11669211|FG000|Overall Study|Administrative Problem|2
7402896|NCT01332994|11669211|FG000|Overall Study|Other|8
7402897|NCT01333033|11669217|FG000|Overall Study|Ineligible|0
7402898|NCT01333033|11669218|FG001|Overall Study|Ineligible|0
7402899|NCT01333033|11669219|FG002|Overall Study|Ineligible|0
7402900|NCT01333033|11669220|FG003|Overall Study|Ineligible|0
7402901|NCT01333033|11669221|FG004|Overall Study|Ineligible|6
7402902|NCT01333033|11669222|FG005|Overall Study|Ineligible|8
7402903|NCT01333033|11669217|FG000|Overall Study|Withdrawal by Subject|0
7402904|NCT01333033|11669218|FG001|Overall Study|Withdrawal by Subject|0
7402905|NCT01333033|11669219|FG002|Overall Study|Withdrawal by Subject|0
7402906|NCT01333033|11669220|FG003|Overall Study|Withdrawal by Subject|0
7402907|NCT01333033|11669221|FG004|Overall Study|Withdrawal by Subject|4
7402908|NCT01333033|11669222|FG005|Overall Study|Withdrawal by Subject|2
7402909|NCT01333033|11669217|FG000|Overall Study|PET inevaluable|0
7402910|NCT01333033|11669218|FG001|Overall Study|PET inevaluable|0
7402911|NCT01333033|11669219|FG002|Overall Study|PET inevaluable|0
7402912|NCT01333033|11669220|FG003|Overall Study|PET inevaluable|0
7402913|NCT01333033|11669221|FG004|Overall Study|PET inevaluable|2
7402914|NCT01333033|11669222|FG005|Overall Study|PET inevaluable|4
7402915|NCT01333033|11669217|FG000|Overall Study|Adverse Event|0
7402916|NCT01333033|11669218|FG001|Overall Study|Adverse Event|0
7402917|NCT01333033|11669219|FG002|Overall Study|Adverse Event|0
7402918|NCT01333033|11669220|FG003|Overall Study|Adverse Event|0
7402919|NCT01333033|11669221|FG004|Overall Study|Adverse Event|2
7402920|NCT01333033|11669222|FG005|Overall Study|Adverse Event|1
7402921|NCT01333033|11669217|FG000|Overall Study|Progression|0
7402922|NCT01333033|11669218|FG001|Overall Study|Progression|0
7402923|NCT01333033|11669219|FG002|Overall Study|Progression|0
7402924|NCT01333033|11669220|FG003|Overall Study|Progression|0
7402925|NCT01333033|11669221|FG004|Overall Study|Progression|0
7402926|NCT01333033|11669222|FG005|Overall Study|Progression|1
7402927|NCT01333033|11669217|FG000|Overall Study|MD Decision|0
7402928|NCT01333033|11669218|FG001|Overall Study|MD Decision|0
7402929|NCT01333033|11669219|FG002|Overall Study|MD Decision|0
7402930|NCT01333033|11669220|FG003|Overall Study|MD Decision|0
7402931|NCT01333033|11669221|FG004|Overall Study|MD Decision|0
7402932|NCT01333033|11669222|FG005|Overall Study|MD Decision|2
7402933|NCT01333059|11669242|FG000|Overall Study|Physician Decision|3
7402934|NCT01333059|11669243|FG001|Overall Study|Physician Decision|3
7402935|NCT01333059|11669242|FG000|Overall Study|Protocol Violation|3
7402936|NCT01333059|11669243|FG001|Overall Study|Protocol Violation|0
7402937|NCT01333072|11669253|FG000|Overall Study|Lost to Follow-up|3
7402938|NCT01333072|11669254|FG001|Overall Study|Lost to Follow-up|0
7402939|NCT01333072|11669253|FG000|Overall Study|Adverse Event|2
7402940|NCT01333072|11669254|FG001|Overall Study|Adverse Event|4
7402941|NCT01333072|11669253|FG000|Overall Study|Physician Decision|1
7402942|NCT01333072|11669254|FG001|Overall Study|Physician Decision|0
7402943|NCT01333111|11669269|FG000|Overall Study|patient undergoing major surgery|0
7402944|NCT01333111|11669270|FG001|Overall Study|patient undergoing major surgery|2
7402945|NCT01333111|11669271|FG002|Overall Study|patient undergoing major surgery|0
7402946|NCT01333111|11669269|FG000|Overall Study|personal reasons|0
7402947|NCT01333111|11669270|FG001|Overall Study|personal reasons|0
7402948|NCT01333111|11669271|FG002|Overall Study|personal reasons|1
7402949|NCT01333111|11669269|FG000|Overall Study|unclassified|1
7402950|NCT01333111|11669270|FG001|Overall Study|unclassified|0
7402951|NCT01333111|11669271|FG002|Overall Study|unclassified|0
7402952|NCT01333111|11669269|FG000|Overall Study|withdrawal criteria|0
7402953|NCT01333111|11669270|FG001|Overall Study|withdrawal criteria|1
7402954|NCT01333111|11669271|FG002|Overall Study|withdrawal criteria|0
7402955|NCT01333111|11669269|FG000|Overall Study|Non-compliance|1
7402956|NCT01333111|11669270|FG001|Overall Study|Non-compliance|0
7402957|NCT01333111|11669271|FG002|Overall Study|Non-compliance|0
7402958|NCT01333111|11669269|FG000|Overall Study|Ineffective therapy|0
7402959|NCT01333111|11669270|FG001|Overall Study|Ineffective therapy|0
7402960|NCT01333111|11669271|FG002|Overall Study|Ineffective therapy|1
7402961|NCT01333189|11669281|FG000|Overall Study|Time constraints|1
7402962|NCT01333189|11669282|FG001|Overall Study|Time constraints|0
7402963|NCT01333189|11669281|FG000|Overall Study|Adverse Event|1
7402964|NCT01333189|11669282|FG001|Overall Study|Adverse Event|0
7402965|NCT01333189|11669281|FG000|Overall Study|Transportation difficulties|0
7402966|NCT01333189|11669282|FG001|Overall Study|Transportation difficulties|1
7402967|NCT01333189|11669281|FG000|Overall Study|Moved from region|0
7402968|NCT01333189|11669282|FG001|Overall Study|Moved from region|1
7465700|NCT01882465|11765130|FG005|Period 1|Withdrawal by Subject|0
7465701|NCT01882465|11765131|FG006|Period 1|Withdrawal by Subject|1
7465702|NCT01882465|11765125|FG000|Period 2|Protocol Violation|0
7402974|NCT01333475|11669320|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
7402975|NCT01333475|11669321|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
7402976|NCT01333475|11669320|FG000|Overall Study|Toxicity|1
7402977|NCT01333475|11669321|FG001|Overall Study|Toxicity|3
7402978|NCT01333501|11669344|FG000|Overall Study|Adverse Event|3
7402979|NCT01333501|11669345|FG001|Overall Study|Adverse Event|1
7402980|NCT01333501|11669344|FG000|Overall Study|Abnormal laboratory value|2
7402981|NCT01333501|11669345|FG001|Overall Study|Abnormal laboratory value|1
7402982|NCT01333501|11669344|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7402983|NCT01333501|11669345|FG001|Overall Study|Unsatisfactory therapeutic effect|7
7402984|NCT01333501|11669344|FG000|Overall Study|Withdrawn consent|3
7402985|NCT01333501|11669345|FG001|Overall Study|Withdrawn consent|12
7402986|NCT01333722|11669371|FG000|Overall Study|Lack of Efficacy|0
7402987|NCT01333722|11669372|FG001|Overall Study|Lack of Efficacy|2
7402988|NCT01333722|11669371|FG000|Overall Study|Withdrawal by Subject|0
7402989|NCT01333722|11669372|FG001|Overall Study|Withdrawal by Subject|1
7402990|NCT01333865|11669384|FG000|Overall Study|Adverse Event|2
7402991|NCT01333956|11669392|FG000|Overall Study|Lost to Follow-up|1
7402992|NCT01333956|11669393|FG001|Overall Study|Lost to Follow-up|2
7402993|NCT01333956|11669394|FG002|Overall Study|Lost to Follow-up|0
7402994|NCT01333956|11669395|FG003|Overall Study|Lost to Follow-up|1
7402995|NCT01333956|11669392|FG000|Overall Study|Unable to complete study procedure|1
7402996|NCT01333956|11669393|FG001|Overall Study|Unable to complete study procedure|0
7402997|NCT01333956|11669394|FG002|Overall Study|Unable to complete study procedure|0
7402998|NCT01333956|11669395|FG003|Overall Study|Unable to complete study procedure|1
7402999|NCT01333956|11669392|FG000|Overall Study|Withdrawal by Subject|0
7403000|NCT01333956|11669393|FG001|Overall Study|Withdrawal by Subject|2
7403001|NCT01333956|11669394|FG002|Overall Study|Withdrawal by Subject|1
7403002|NCT01333956|11669395|FG003|Overall Study|Withdrawal by Subject|0
7403003|NCT01334125|11669412|FG000|Overall Study|Lost to Follow-up|3
7403004|NCT01334125|11669413|FG001|Overall Study|Lost to Follow-up|3
7403005|NCT01334515|11669440|FG000|Overall Study|Adverse Event|1
7403006|NCT01334515|11669441|FG001|Overall Study|Adverse Event|6
7403007|NCT01334515|11669440|FG000|Overall Study|Death|1
7403008|NCT01334515|11669441|FG001|Overall Study|Death|0
7403009|NCT01334515|11669440|FG000|Overall Study|Lack of Efficacy|8
7403010|NCT01334515|11669441|FG001|Overall Study|Lack of Efficacy|21
7403011|NCT01334515|11669440|FG000|Overall Study|Physician Decision|1
7403012|NCT01334515|11669441|FG001|Overall Study|Physician Decision|1
7403013|NCT01334515|11669440|FG000|Overall Study|Withdrawal by Subject|1
7403014|NCT01334515|11669441|FG001|Overall Study|Withdrawal by Subject|1
7403015|NCT01334554|11669449|FG000|Overall Study|Adverse Event|4
7403016|NCT01334554|11669450|FG001|Overall Study|Adverse Event|2
7403017|NCT01334710|11669458|FG000|Overall Study|Trial was terminated|3
7403018|NCT01334866|11669492|FG000|Overall Study|Withdrawal by Subject|10
7403019|NCT01334866|11669492|FG000|Overall Study|Lost to Follow-up|3
7403020|NCT01334866|11669492|FG000|Overall Study|Physician Decision|3
7403021|NCT01334866|11669492|FG000|Overall Study|medically necessary prior to procedure|2
7403022|NCT01334866|11669492|FG000|Overall Study|medically necessary post-procedure|1
7403023|NCT01334918|11669500|FG000|Overall Study|Did not receive study drug|6
7403024|NCT01334918|11669501|FG001|Overall Study|Did not receive study drug|0
7403025|NCT01334918|11669500|FG000|Overall Study|Adverse Event|2
7403026|NCT01334918|11669501|FG001|Overall Study|Adverse Event|0
7403027|NCT01334918|11669500|FG000|Overall Study|Withdrawal by Subject|0
7403028|NCT01334918|11669501|FG001|Overall Study|Withdrawal by Subject|1
7403029|NCT01335009|11669534|FG000|Overall Study|Too ill to travel to study sites|1
7403030|NCT01335009|11669535|FG001|Overall Study|Too ill to travel to study sites|0
7403031|NCT01335009|11669534|FG000|Overall Study|Death|28
7403032|NCT01335009|11669535|FG001|Overall Study|Death|32
7403033|NCT01335009|11669534|FG000|Overall Study|Withdrawal by Subject|1
7403034|NCT01335009|11669535|FG001|Overall Study|Withdrawal by Subject|1
7403035|NCT01335009|11669534|FG000|Overall Study|Lost to Follow-up|1
7403036|NCT01335009|11669535|FG001|Overall Study|Lost to Follow-up|0
7403037|NCT01335464|11669597|FG000|Overall Study|Adverse Event|15
7403038|NCT01335464|11669598|FG001|Overall Study|Adverse Event|25
7403039|NCT01335464|11669597|FG000|Overall Study|Non compliant with protocol|2
7403040|NCT01335464|11669598|FG001|Overall Study|Non compliant with protocol|0
7403041|NCT01335464|11669597|FG000|Overall Study|Consent withdrawn, not due to AE|12
7403042|NCT01335464|11669598|FG001|Overall Study|Consent withdrawn, not due to AE|23
7403043|NCT01335464|11669597|FG000|Overall Study|Not treated|2
7403044|NCT01335464|11669598|FG001|Overall Study|Not treated|0
7403045|NCT01335464|11669597|FG000|Overall Study|Reason other than those stated above|1
7403046|NCT01335464|11669598|FG001|Overall Study|Reason other than those stated above|1
7403047|NCT01335477|11669606|FG000|Overall Study|Adverse Event|30
7403048|NCT01335477|11669607|FG001|Overall Study|Adverse Event|42
7403049|NCT01335477|11669606|FG000|Overall Study|Non compliant with protocol|0
7403050|NCT01335477|11669607|FG001|Overall Study|Non compliant with protocol|2
7403051|NCT01335477|11669606|FG000|Overall Study|Lost to Follow-up|1
7403052|NCT01335477|11669607|FG001|Overall Study|Lost to Follow-up|2
7403053|NCT01335477|11669606|FG000|Overall Study|Consent withdrawn, not due to AE|7
7403054|NCT01335477|11669607|FG001|Overall Study|Consent withdrawn, not due to AE|9
7403055|NCT01335477|11669606|FG000|Overall Study|Not treated|1
7403056|NCT01335477|11669607|FG001|Overall Study|Not treated|2
7403057|NCT01335477|11669606|FG000|Overall Study|Reason other than those stated above|2
7403058|NCT01335477|11669607|FG001|Overall Study|Reason other than those stated above|2
7403059|NCT01335698|11669631|FG000|Treatment Stage 1|Lack of Efficacy|3
7403060|NCT01335698|11669632|FG001|Treatment Stage 1|Lack of Efficacy|1
7403061|NCT01335698|11669633|FG002|Treatment Stage 1|Lack of Efficacy|3
7403062|NCT01335698|11669634|FG003|Treatment Stage 1|Lack of Efficacy|3
7403063|NCT01335698|11669635|FG004|Treatment Stage 1|Lack of Efficacy|1
7403064|NCT01335698|11669631|FG000|Treatment Stage 1|Adverse Event|1
7403065|NCT01335698|11669632|FG001|Treatment Stage 1|Adverse Event|2
7403066|NCT01335698|11669633|FG002|Treatment Stage 1|Adverse Event|2
7403067|NCT01335698|11669634|FG003|Treatment Stage 1|Adverse Event|1
7403068|NCT01335698|11669635|FG004|Treatment Stage 1|Adverse Event|1
7403069|NCT01335698|11669631|FG000|Treatment Stage 1|Withdrawal by Subject|1
7403070|NCT01335698|11669632|FG001|Treatment Stage 1|Withdrawal by Subject|2
7403071|NCT01335698|11669633|FG002|Treatment Stage 1|Withdrawal by Subject|0
7403072|NCT01335698|11669634|FG003|Treatment Stage 1|Withdrawal by Subject|1
7403073|NCT01335698|11669635|FG004|Treatment Stage 1|Withdrawal by Subject|0
7403074|NCT01335698|11669631|FG000|Treatment Stage 1|Lost to Follow-up|1
7403075|NCT01335698|11669632|FG001|Treatment Stage 1|Lost to Follow-up|1
7403076|NCT01335698|11669633|FG002|Treatment Stage 1|Lost to Follow-up|0
7403077|NCT01335698|11669634|FG003|Treatment Stage 1|Lost to Follow-up|0
7403078|NCT01335698|11669635|FG004|Treatment Stage 1|Lost to Follow-up|0
7403079|NCT01335698|11669631|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
7403080|NCT01335698|11669632|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
7403081|NCT01335698|11669633|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
7403082|NCT01335698|11669634|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
7403083|NCT01335698|11669635|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
7403084|NCT01335698|11669631|FG000|Treatment Stage 1|No longer meets study criteria|1
7403085|NCT01335698|11669632|FG001|Treatment Stage 1|No longer meets study criteria|1
7403086|NCT01335698|11669633|FG002|Treatment Stage 1|No longer meets study criteria|0
7403087|NCT01335698|11669634|FG003|Treatment Stage 1|No longer meets study criteria|1
7403088|NCT01335698|11669635|FG004|Treatment Stage 1|No longer meets study criteria|0
7403089|NCT01335698|11669631|FG000|Treatment Stage 1|Other|1
7403090|NCT01335698|11669632|FG001|Treatment Stage 1|Other|0
7403091|NCT01335698|11669633|FG002|Treatment Stage 1|Other|0
7403092|NCT01335698|11669634|FG003|Treatment Stage 1|Other|1
7403093|NCT01335698|11669635|FG004|Treatment Stage 1|Other|0
7403094|NCT01335698|11669631|FG000|Treatment Stage 2|Lack of Efficacy|2
7403095|NCT01335698|11669632|FG001|Treatment Stage 2|Lack of Efficacy|1
7403096|NCT01335698|11669633|FG002|Treatment Stage 2|Lack of Efficacy|3
7403097|NCT01335698|11669634|FG003|Treatment Stage 2|Lack of Efficacy|1
7403098|NCT01335698|11669635|FG004|Treatment Stage 2|Lack of Efficacy|0
7403099|NCT01335698|11669631|FG000|Treatment Stage 2|Adverse Event|2
7403100|NCT01335698|11669632|FG001|Treatment Stage 2|Adverse Event|0
7403101|NCT01335698|11669633|FG002|Treatment Stage 2|Adverse Event|0
7403102|NCT01335698|11669634|FG003|Treatment Stage 2|Adverse Event|3
7403103|NCT01335698|11669635|FG004|Treatment Stage 2|Adverse Event|0
7403104|NCT01335698|11669631|FG000|Treatment Stage 2|Withdrawal by Subject|3
7403105|NCT01335698|11669632|FG001|Treatment Stage 2|Withdrawal by Subject|1
7403106|NCT01335698|11669633|FG002|Treatment Stage 2|Withdrawal by Subject|1
7403107|NCT01335698|11669634|FG003|Treatment Stage 2|Withdrawal by Subject|0
7403108|NCT01335698|11669635|FG004|Treatment Stage 2|Withdrawal by Subject|0
7403109|NCT01335698|11669631|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
7403110|NCT01335698|11669632|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
7403111|NCT01335698|11669633|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
7403112|NCT01335698|11669634|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
7403113|NCT01335698|11669635|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
7403114|NCT01335698|11669631|FG000|Treatment Stage 2|Lost to Follow-up|1
7403115|NCT01335698|11669632|FG001|Treatment Stage 2|Lost to Follow-up|0
7403116|NCT01335698|11669633|FG002|Treatment Stage 2|Lost to Follow-up|0
7403117|NCT01335698|11669634|FG003|Treatment Stage 2|Lost to Follow-up|0
7403118|NCT01335698|11669635|FG004|Treatment Stage 2|Lost to Follow-up|0
7403119|NCT01335698|11669631|FG000|Treatment Stage 2|Capsules received at state hospital|1
7403120|NCT01335698|11669632|FG001|Treatment Stage 2|Capsules received at state hospital|0
7403121|NCT01335698|11669633|FG002|Treatment Stage 2|Capsules received at state hospital|0
7403122|NCT01335698|11669634|FG003|Treatment Stage 2|Capsules received at state hospital|0
7403123|NCT01335698|11669635|FG004|Treatment Stage 2|Capsules received at state hospital|0
7403124|NCT01335698|11669631|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
7403125|NCT01335698|11669632|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
7403126|NCT01335698|11669633|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
7403127|NCT01335698|11669634|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
7403128|NCT01335698|11669635|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
7403129|NCT01335698|11669631|FG000|Treatment Stage 2|Switched to another formulation|1
7403130|NCT01335698|11669632|FG001|Treatment Stage 2|Switched to another formulation|1
7403131|NCT01335698|11669633|FG002|Treatment Stage 2|Switched to another formulation|0
7403132|NCT01335698|11669634|FG003|Treatment Stage 2|Switched to another formulation|0
7403133|NCT01335698|11669635|FG004|Treatment Stage 2|Switched to another formulation|0
7403134|NCT01335971|11669707|FG000|Overall Study|Withdrawal by Subject|1
7403135|NCT01335971|11669708|FG001|Overall Study|Withdrawal by Subject|0
7403136|NCT01335971|11669709|FG002|Overall Study|Withdrawal by Subject|0
7403137|NCT01335971|11669707|FG000|Overall Study|Did not complete bronchoscopy|1
7403138|NCT01335971|11669708|FG001|Overall Study|Did not complete bronchoscopy|1
7403139|NCT01335971|11669709|FG002|Overall Study|Did not complete bronchoscopy|1
7403140|NCT01336023|11669720|FG000|Week 0 to Week 26|Adverse Event|8
7403141|NCT01336023|11669721|FG001|Week 0 to Week 26|Adverse Event|10
7403142|NCT01336023|11669722|FG002|Week 0 to Week 26|Adverse Event|24
7403143|NCT01336023|11669720|FG000|Week 0 to Week 26|Lack of Efficacy|0
7403144|NCT01336023|11669721|FG001|Week 0 to Week 26|Lack of Efficacy|1
7403145|NCT01336023|11669722|FG002|Week 0 to Week 26|Lack of Efficacy|0
7403146|NCT01336023|11669720|FG000|Week 0 to Week 26|Protocol Violation|1
7403147|NCT01336023|11669721|FG001|Week 0 to Week 26|Protocol Violation|2
7403148|NCT01336023|11669722|FG002|Week 0 to Week 26|Protocol Violation|0
7403149|NCT01336023|11669720|FG000|Week 0 to Week 26|Withdrawal Criteria|34
7403150|NCT01336023|11669721|FG001|Week 0 to Week 26|Withdrawal Criteria|69
7403151|NCT01336023|11669722|FG002|Week 0 to Week 26|Withdrawal Criteria|40
7403152|NCT01336023|11669720|FG000|Week 0 to Week 26|Unclassified|5
7403153|NCT01336023|11669721|FG001|Week 0 to Week 26|Unclassified|16
7403154|NCT01336023|11669722|FG002|Week 0 to Week 26|Unclassified|9
7403155|NCT01336023|11669720|FG000|Week 27 to 52|Adverse Event|1
7403156|NCT01336023|11669721|FG001|Week 27 to 52|Adverse Event|5
7403157|NCT01336023|11669722|FG002|Week 27 to 52|Adverse Event|2
7403158|NCT01336023|11669720|FG000|Week 27 to 52|Protocol Violation|0
7403159|NCT01336023|11669721|FG001|Week 27 to 52|Protocol Violation|2
7403160|NCT01336023|11669722|FG002|Week 27 to 52|Protocol Violation|1
7403161|NCT01336023|11669720|FG000|Week 27 to 52|Withdrawal Criteria|14
7403162|NCT01336023|11669721|FG001|Week 27 to 52|Withdrawal Criteria|19
7403163|NCT01336023|11669722|FG002|Week 27 to 52|Withdrawal Criteria|16
7403164|NCT01336023|11669720|FG000|Week 27 to 52|Unclassified|13
7403165|NCT01336023|11669721|FG001|Week 27 to 52|Unclassified|18
7403166|NCT01336023|11669722|FG002|Week 27 to 52|Unclassified|9
7403167|NCT01336205|11669741|FG000|Overall Study|Other|22
7403168|NCT01336205|11669742|FG001|Overall Study|Other|9
7403169|NCT01336205|11669741|FG000|Overall Study|Lost to Follow-up|40
7403170|NCT01336205|11669742|FG001|Overall Study|Lost to Follow-up|20
7403171|NCT01336205|11669741|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
7403172|NCT01336205|11669742|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
7403173|NCT01336205|11669741|FG000|Overall Study|Lack of Efficacy|4
7403174|NCT01336205|11669742|FG001|Overall Study|Lack of Efficacy|0
7403175|NCT01336205|11669741|FG000|Overall Study|Severe noncompliance with protocol|9
7403176|NCT01336205|11669742|FG001|Overall Study|Severe noncompliance with protocol|2
7403177|NCT01336205|11669741|FG000|Overall Study|Adverse Event|56
7403178|NCT01336205|11669742|FG001|Overall Study|Adverse Event|6
7403179|NCT01336205|11669741|FG000|Overall Study|Death|1
7403180|NCT01336205|11669742|FG001|Overall Study|Death|1
7403181|NCT01336205|11669741|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
7403182|NCT01336205|11669742|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
7403183|NCT01336205|11669741|FG000|Overall Study|Withdrawal by Subject|72
7403184|NCT01336205|11669742|FG001|Overall Study|Withdrawal by Subject|38
7403185|NCT01336205|11669741|FG000|Overall Study|Did not receive treatment|4
7403186|NCT01336205|11669742|FG001|Overall Study|Did not receive treatment|0
7403187|NCT01336569|11669768|FG000|Overall Study|Lost to Follow-up|4
7403188|NCT01336608|11669775|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
7403189|NCT01336608|11669776|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7403190|NCT01336608|11669777|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7403191|NCT01336608|11669778|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7403192|NCT01336608|11669775|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
7403193|NCT01336608|11669776|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7403194|NCT01336608|11669777|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7403195|NCT01336608|11669778|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7403196|NCT01336608|11669775|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
7403197|NCT01336608|11669776|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7403198|NCT01336608|11669777|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7403199|NCT01336608|11669778|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7403200|NCT01336608|11669775|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
7403201|NCT01336608|11669776|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7403202|NCT01336608|11669777|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7403203|NCT01336608|11669778|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7403204|NCT01336608|11669775|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
7403205|NCT01336608|11669776|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7403206|NCT01336608|11669777|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7403207|NCT01336608|11669778|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7403208|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7403209|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
7403210|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
7403211|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
7403212|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7403213|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7403214|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7403215|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7403216|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7403217|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7403218|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7403219|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
7403220|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7403221|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
7403222|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
7403223|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
7403224|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7403225|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7403226|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
7403227|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
7403228|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7403229|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7403230|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7403231|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7403232|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7403233|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
7403234|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7403235|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
7403236|NCT01336608|11669775|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7403237|NCT01336608|11669776|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7403238|NCT01336608|11669777|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
7403239|NCT01336608|11669778|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
7403240|NCT01336647|11669789|FG000|Overall Study|Lost to Follow-up|4
7403241|NCT01336647|11669790|FG001|Overall Study|Lost to Follow-up|1
7403242|NCT01336647|11669791|FG002|Overall Study|Lost to Follow-up|3
7403243|NCT01336712|11669801|FG000|Overall Study|Death|2
7403244|NCT01336712|11669801|FG000|Overall Study|Lack of Efficacy|1
7403245|NCT01336738|11669810|FG000|Overall Study|Adverse Event|0
7403246|NCT01336738|11669811|FG001|Overall Study|Adverse Event|3
7403247|NCT01336738|11669812|FG002|Overall Study|Adverse Event|2
7403248|NCT01336738|11669813|FG003|Overall Study|Adverse Event|1
7403249|NCT01336738|11669814|FG004|Overall Study|Adverse Event|3
7403250|NCT01336738|11669810|FG000|Overall Study|Lost to Follow-up|2
7403251|NCT01336738|11669811|FG001|Overall Study|Lost to Follow-up|1
7403252|NCT01336738|11669812|FG002|Overall Study|Lost to Follow-up|2
7403253|NCT01336738|11669813|FG003|Overall Study|Lost to Follow-up|2
7403254|NCT01336738|11669814|FG004|Overall Study|Lost to Follow-up|2
7403255|NCT01336738|11669810|FG000|Overall Study|Did not meet entrance criteria|0
7403256|NCT01336738|11669811|FG001|Overall Study|Did not meet entrance criteria|1
7403257|NCT01336738|11669812|FG002|Overall Study|Did not meet entrance criteria|0
7403258|NCT01336738|11669813|FG003|Overall Study|Did not meet entrance criteria|0
7403259|NCT01336738|11669814|FG004|Overall Study|Did not meet entrance criteria|0
7403260|NCT01336738|11669810|FG000|Overall Study|Protocol Violation|0
7403261|NCT01336738|11669811|FG001|Overall Study|Protocol Violation|1
7403262|NCT01336738|11669812|FG002|Overall Study|Protocol Violation|0
7403263|NCT01336738|11669813|FG003|Overall Study|Protocol Violation|0
7403264|NCT01336738|11669814|FG004|Overall Study|Protocol Violation|0
7403265|NCT01336738|11669810|FG000|Overall Study|Withdrawal by Subject|2
7403266|NCT01336738|11669811|FG001|Overall Study|Withdrawal by Subject|0
7403267|NCT01336738|11669812|FG002|Overall Study|Withdrawal by Subject|2
7403268|NCT01336738|11669813|FG003|Overall Study|Withdrawal by Subject|1
7403269|NCT01336738|11669814|FG004|Overall Study|Withdrawal by Subject|1
7403270|NCT01336738|11669810|FG000|Overall Study|Other|3
7403271|NCT01336738|11669811|FG001|Overall Study|Other|3
7403272|NCT01336738|11669812|FG002|Overall Study|Other|2
7403273|NCT01336738|11669813|FG003|Overall Study|Other|3
7403274|NCT01336738|11669814|FG004|Overall Study|Other|4
7403275|NCT01336764|11669828|FG000|Overall Study|Withdrawal by Subject|5
7403276|NCT01336764|11669829|FG001|Overall Study|Withdrawal by Subject|5
7403277|NCT01336894|11669849|FG000|Follow-up|Study terminated prematurely|2
7403278|NCT01336894|11669850|FG001|Follow-up|Study terminated prematurely|7
7403279|NCT01336972|11669880|FG000|Overall Study|Adverse Event|1
7403280|NCT01336972|11669881|FG001|Overall Study|Adverse Event|1
7403281|NCT01336972|11669882|FG002|Overall Study|Adverse Event|0
7403282|NCT01337050|11669894|FG000|Overall Study|Death|0
7403283|NCT01337050|11669895|FG001|Overall Study|Death|0
7403284|NCT01337050|11669896|FG002|Overall Study|Death|4
7403285|NCT01337050|11669894|FG000|Overall Study|Other|4
7403286|NCT01337050|11669895|FG001|Overall Study|Other|6
7403287|NCT01337050|11669896|FG002|Overall Study|Other|8
7403288|NCT01337050|11669894|FG000|Overall Study|Participants refused further follow-up|0
7403289|NCT01337050|11669895|FG001|Overall Study|Participants refused further follow-up|7
7403290|NCT01337050|11669896|FG002|Overall Study|Participants refused further follow-up|7
7403291|NCT01337089|11669909|FG000|Overall Study|Adverse Event|237
7403292|NCT01337089|11669909|FG000|Overall Study|Withdrawal by Subject|129
7403293|NCT01337089|11669909|FG000|Overall Study|Withdrawal by Investigator|33
7403294|NCT01337089|11669909|FG000|Overall Study|Met Withdrawal Criteria|3
7403295|NCT01337089|11669909|FG000|Overall Study|Lost to Follow-up|2
7403296|NCT01337115|11669915|FG000|Overall Study|Protocol Violation|2
7403297|NCT01337115|11669916|FG001|Overall Study|Protocol Violation|0
7403298|NCT01337167|11669926|FG000|Infant Series|Adverse Event|1
7403299|NCT01337167|11669927|FG001|Infant Series|Adverse Event|1
7403300|NCT01337167|11669926|FG000|Infant Series|Death|1
7403301|NCT01337167|11669927|FG001|Infant Series|Death|1
7403302|NCT01337167|11669926|FG000|Infant Series|Lost to Follow-up|13
7403303|NCT01337167|11669927|FG001|Infant Series|Lost to Follow-up|7
7403304|NCT01337167|11669926|FG000|Infant Series|Non-compliance with study drug|2
7403305|NCT01337167|11669927|FG001|Infant Series|Non-compliance with study drug|1
7403306|NCT01337167|11669926|FG000|Infant Series|Physician Decision|3
7403307|NCT01337167|11669927|FG001|Infant Series|Physician Decision|1
7403308|NCT01337167|11669926|FG000|Infant Series|Protocol Violation|22
7403309|NCT01337167|11669927|FG001|Infant Series|Protocol Violation|9
7403310|NCT01337167|11669926|FG000|Infant Series|Withdrawal by Subject|15
7403311|NCT01337167|11669927|FG001|Infant Series|Withdrawal by Subject|4
7403312|NCT01337167|11669926|FG000|Infant Series|Randomized but not vaccinated|5
7403313|NCT01337167|11669927|FG001|Infant Series|Randomized but not vaccinated|3
7403314|NCT01337167|11669926|FG000|Interim Period|Lost to Follow-up|51
7403315|NCT01337167|11669927|FG001|Interim Period|Lost to Follow-up|23
7403316|NCT01337167|11669926|FG000|Interim Period|Non-compliance with study drug|1
7403317|NCT01337167|11669927|FG001|Interim Period|Non-compliance with study drug|0
7403318|NCT01337167|11669926|FG000|Interim Period|Physician Decision|6
7403319|NCT01337167|11669927|FG001|Interim Period|Physician Decision|3
7403320|NCT01337167|11669926|FG000|Interim Period|Protocol Violation|5
7403321|NCT01337167|11669927|FG001|Interim Period|Protocol Violation|3
7403322|NCT01337167|11669926|FG000|Interim Period|Withdrawal by Subject|18
7403323|NCT01337167|11669927|FG001|Interim Period|Withdrawal by Subject|10
7403324|NCT01337167|11669926|FG000|Interim Period|Other protocol criterion not met|0
7403325|NCT01337167|11669927|FG001|Interim Period|Other protocol criterion not met|1
7403326|NCT01337167|11669926|FG000|Toddler Vaccinations|Lost to Follow-up|11
7403327|NCT01337167|11669927|FG001|Toddler Vaccinations|Lost to Follow-up|12
7403328|NCT01337167|11669926|FG000|Toddler Vaccinations|Protocol Violation|0
7403329|NCT01337167|11669927|FG001|Toddler Vaccinations|Protocol Violation|1
7403330|NCT01337167|11669926|FG000|Toddler Vaccinations|Withdrawal by Subject|3
7403331|NCT01337167|11669927|FG001|Toddler Vaccinations|Withdrawal by Subject|0
7403332|NCT01337297|11669935|FG000|Overall Study|They entered to single anodal tDCS|4
7403333|NCT01337297|11669936|FG001|Overall Study|They entered to single anodal tDCS|3
7403334|NCT01337297|11669935|FG000|Overall Study|Lost to Follow-up|1
7403335|NCT01337297|11669936|FG001|Overall Study|Lost to Follow-up|3
7403336|NCT01337596|11669960|FG000|Overall Study|Withdrawal by Subject|0
7403337|NCT01337596|11669961|FG001|Overall Study|Withdrawal by Subject|0
7403338|NCT01337596|11669962|FG002|Overall Study|Withdrawal by Subject|0
7403339|NCT01337596|11669963|FG003|Overall Study|Withdrawal by Subject|0
7403340|NCT01337596|11669964|FG004|Overall Study|Withdrawal by Subject|2
7403341|NCT01337596|11669965|FG005|Overall Study|Withdrawal by Subject|0
7403342|NCT01337596|11669966|FG006|Overall Study|Withdrawal by Subject|0
7403343|NCT01337596|11669967|FG007|Overall Study|Withdrawal by Subject|0
7403344|NCT01337596|11669968|FG008|Overall Study|Withdrawal by Subject|0
7403345|NCT01337635|11669993|FG000|Overall Study|Lost to Follow-up|0
7403346|NCT01337635|11669994|FG001|Overall Study|Lost to Follow-up|1
7403347|NCT01337674|11670002|FG000|Treatment Period 1|Adverse Event|0
7403348|NCT01337674|11670003|FG001|Treatment Period 1|Adverse Event|1
7403349|NCT01337674|11670004|FG002|Treatment Period 1|Adverse Event|0
7403350|NCT01337674|11670005|FG003|Treatment Period 1|Adverse Event|0
7403351|NCT01337674|11670002|FG000|Treatment Period 1|Discontinued due to blood draws|0
7403352|NCT01337674|11670003|FG001|Treatment Period 1|Discontinued due to blood draws|0
7403353|NCT01337674|11670004|FG002|Treatment Period 1|Discontinued due to blood draws|0
7403354|NCT01337674|11670005|FG003|Treatment Period 1|Discontinued due to blood draws|1
7403355|NCT01337674|11670002|FG000|Treatment Period 2|Withdrawal by Subject|0
7403356|NCT01337674|11670003|FG001|Treatment Period 2|Withdrawal by Subject|0
7403357|NCT01337674|11670004|FG002|Treatment Period 2|Withdrawal by Subject|1
7403358|NCT01337674|11670005|FG003|Treatment Period 2|Withdrawal by Subject|0
7403359|NCT01337960|11670048|FG000|Overall Study|Lost to Follow-up|1
7403360|NCT01337960|11670049|FG001|Overall Study|Lost to Follow-up|0
7403361|NCT01337960|11670050|FG002|Overall Study|Lost to Follow-up|0
7403362|NCT01337960|11670048|FG000|Overall Study|Withdrawal by Subject|1
7403363|NCT01337960|11670049|FG001|Overall Study|Withdrawal by Subject|0
7403364|NCT01337960|11670050|FG002|Overall Study|Withdrawal by Subject|0
7403365|NCT01337973|11670061|FG000|Overall Study|Lost to Follow-up|2
7403366|NCT01337973|11670062|FG001|Overall Study|Lost to Follow-up|4
7403367|NCT01337973|11670063|FG002|Overall Study|Lost to Follow-up|3
7403368|NCT01337973|11670061|FG000|Overall Study|Death|1
7403369|NCT01337973|11670062|FG001|Overall Study|Death|2
7403370|NCT01337973|11670063|FG002|Overall Study|Death|1
7403371|NCT01337973|11670061|FG000|Overall Study|Withdrawal by Subject|10
7403372|NCT01337973|11670062|FG001|Overall Study|Withdrawal by Subject|8
7403373|NCT01337973|11670063|FG002|Overall Study|Withdrawal by Subject|4
7403374|NCT01337973|11670061|FG000|Overall Study|missing data on primary outcome|3
7403375|NCT01337973|11670062|FG001|Overall Study|missing data on primary outcome|1
7403376|NCT01337973|11670063|FG002|Overall Study|missing data on primary outcome|3
7403377|NCT01337986|11670073|FG000|Overall Study|Adverse Event|2
7403378|NCT01337986|11670074|FG001|Overall Study|Adverse Event|2
7403379|NCT01337986|11670073|FG000|Overall Study|Lost to Follow-up|1
7403380|NCT01337986|11670074|FG001|Overall Study|Lost to Follow-up|0
7403381|NCT01337986|11670073|FG000|Overall Study|Protocol Violation|0
7403382|NCT01337986|11670074|FG001|Overall Study|Protocol Violation|3
7403383|NCT01338012|11670096|FG000|Overall Study|Death|4
7403384|NCT01338012|11670096|FG000|Overall Study|Study terminated|4
7403385|NCT01338025|11670102|FG000|Overall Study|Unexpected closure of study|10
7403386|NCT01338025|11670103|FG001|Overall Study|Unexpected closure of study|9
7403387|NCT01338025|11670102|FG000|Overall Study|Withdrawal by Subject|0
7403388|NCT01338025|11670103|FG001|Overall Study|Withdrawal by Subject|2
7403389|NCT01338025|11670102|FG000|Overall Study|Found ineligible after starting|1
7403390|NCT01338025|11670103|FG001|Overall Study|Found ineligible after starting|0
7403391|NCT01338298|11670111|FG000|Overall Study|Withdrawal by Subject|1
7403392|NCT01338298|11670112|FG001|Overall Study|Withdrawal by Subject|1
7403393|NCT01338298|11670111|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
7403394|NCT01338298|11670112|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
7403395|NCT01338298|11670111|FG000|Overall Study|Administrative error|0
7403396|NCT01338298|11670112|FG001|Overall Study|Administrative error|1
7403397|NCT01338298|11670111|FG000|Overall Study|Positive symptom worsening|1
7403398|NCT01338298|11670112|FG001|Overall Study|Positive symptom worsening|0
7403399|NCT01338298|11670111|FG000|Overall Study|Depressive symptoms and nausea|1
7403400|NCT01338298|11670112|FG001|Overall Study|Depressive symptoms and nausea|0
7403401|NCT01338298|11670111|FG000|Overall Study|Non-adherence|1
7403402|NCT01338298|11670112|FG001|Overall Study|Non-adherence|0
7403403|NCT01338415|11670120|FG000|Core + Extension|Adverse Event|8
7403404|NCT01338415|11670121|FG001|Core + Extension|Adverse Event|6
7403405|NCT01338415|11670122|FG002|Core + Extension|Adverse Event|0
7403406|NCT01338415|11670120|FG000|Core + Extension|Withdrawal by Subject|1
7403407|NCT01338415|11670121|FG001|Core + Extension|Withdrawal by Subject|1
7403408|NCT01338415|11670122|FG002|Core + Extension|Withdrawal by Subject|0
7403409|NCT01338415|11670120|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
7403410|NCT01338415|11670121|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
7403411|NCT01338415|11670122|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
7403412|NCT01338415|11670120|FG000|Core + Extension|Other (administrative reason)|1
7403413|NCT01338415|11670121|FG001|Core + Extension|Other (administrative reason)|0
7403414|NCT01338415|11670122|FG002|Core + Extension|Other (administrative reason)|0
7403415|NCT01338415|11670120|FG000|Exceptional Use Treatment Period|Administrative decision|0
7403416|NCT01338415|11670121|FG001|Exceptional Use Treatment Period|Administrative decision|0
7403417|NCT01338415|11670122|FG002|Exceptional Use Treatment Period|Administrative decision|1
7403418|NCT01338415|11670120|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7403419|NCT01338415|11670121|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
7403420|NCT01338415|11670122|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
7403421|NCT01338415|11670120|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
7403422|NCT01338415|11670121|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
7403423|NCT01338415|11670122|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
7403424|NCT01338415|11670120|FG000|Exceptional Use Treatment Period|Death|0
7403425|NCT01338415|11670121|FG001|Exceptional Use Treatment Period|Death|0
7403426|NCT01338415|11670122|FG002|Exceptional Use Treatment Period|Death|1
7403427|NCT01338493|11670130|FG000|Enrolled|Withdrawal by Subject|1
7403428|NCT01338493|11670130|FG000|Enrolled|Patient not implanted|4
7403429|NCT01338493|11670130|FG000|Discharge|Death|1
7403430|NCT01338493|11670130|FG000|Discharge|Missed visit|1
7403431|NCT01338493|11670130|FG000|6 Months Follow up|Lost to Follow-up|11
7403432|NCT01338493|11670130|FG000|6 Months Follow up|Missed visit|8
7403433|NCT01338493|11670130|FG000|12 Months Follow up|Lost to Follow-up|9
7403434|NCT01338610|11670150|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
7403435|NCT01338610|11670151|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
7403436|NCT01338610|11670152|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
7403437|NCT01338610|11670150|FG000|Overall Study|Protocol Violation|1
7403438|NCT01338610|11670151|FG001|Overall Study|Protocol Violation|0
7403439|NCT01338610|11670152|FG002|Overall Study|Protocol Violation|1
7403440|NCT01338610|11670150|FG000|Overall Study|Adverse Event|3
7403441|NCT01338610|11670151|FG001|Overall Study|Adverse Event|0
7403442|NCT01338610|11670152|FG002|Overall Study|Adverse Event|0
7403443|NCT01338792|11670168|FG000|Overall Study|Adverse Event|2
7403444|NCT01338792|11670168|FG000|Overall Study|Death|1
7403445|NCT01338792|11670168|FG000|Overall Study|Withdrawal by Subject|1
7403446|NCT01338818|11670172|FG000|Overall Study|Adverse Event|8
7403447|NCT01338818|11670172|FG000|Overall Study|Lack of Efficacy|5
7403448|NCT01338818|11670172|FG000|Overall Study|no longer require study drug|1
7403449|NCT01338818|11670172|FG000|Overall Study|Withdrawal by Subject|11
7403450|NCT01338818|11670172|FG000|Overall Study|Lost to Follow-up|4
7403451|NCT01338818|11670172|FG000|Overall Study|Administrative problems|3
7403452|NCT01338818|11670172|FG000|Overall Study|Protocol Deviation|4
7403453|NCT01338870|11670186|FG000|Overall Study|Lost to Follow-up|0
7403454|NCT01338870|11670187|FG001|Overall Study|Lost to Follow-up|0
7403455|NCT01338870|11670188|FG002|Overall Study|Lost to Follow-up|1
7403456|NCT01338870|11670189|FG003|Overall Study|Lost to Follow-up|0
7403457|NCT01338870|11670190|FG004|Overall Study|Lost to Follow-up|1
7403458|NCT01338870|11670191|FG005|Overall Study|Lost to Follow-up|0
7403459|NCT01338870|11670186|FG000|Overall Study|Withdrawal by Subject|2
7403460|NCT01338870|11670187|FG001|Overall Study|Withdrawal by Subject|3
7403461|NCT01338870|11670188|FG002|Overall Study|Withdrawal by Subject|4
7403462|NCT01338870|11670189|FG003|Overall Study|Withdrawal by Subject|0
7403463|NCT01338870|11670190|FG004|Overall Study|Withdrawal by Subject|0
7403464|NCT01338870|11670191|FG005|Overall Study|Withdrawal by Subject|2
7403465|NCT01338870|11670186|FG000|Overall Study|Other|3
7403466|NCT01338870|11670187|FG001|Overall Study|Other|3
7403467|NCT01338870|11670188|FG002|Overall Study|Other|3
7403468|NCT01338870|11670189|FG003|Overall Study|Other|2
7403469|NCT01338870|11670190|FG004|Overall Study|Other|0
7403470|NCT01338870|11670191|FG005|Overall Study|Other|2
7403471|NCT01338870|11670186|FG000|Overall Study|Protocol Violation|0
7403472|NCT01338870|11670187|FG001|Overall Study|Protocol Violation|2
7403473|NCT01338870|11670188|FG002|Overall Study|Protocol Violation|2
7403474|NCT01338870|11670189|FG003|Overall Study|Protocol Violation|2
7403475|NCT01338870|11670190|FG004|Overall Study|Protocol Violation|1
7403476|NCT01338870|11670191|FG005|Overall Study|Protocol Violation|1
7403477|NCT01338870|11670186|FG000|Overall Study|Adverse Event|4
7403478|NCT01338870|11670187|FG001|Overall Study|Adverse Event|4
7403479|NCT01338870|11670188|FG002|Overall Study|Adverse Event|1
7403480|NCT01338870|11670189|FG003|Overall Study|Adverse Event|5
7403481|NCT01338870|11670190|FG004|Overall Study|Adverse Event|4
7403482|NCT01338870|11670191|FG005|Overall Study|Adverse Event|1
7403483|NCT01338987|11670210|FG000|Overall Study|enrolled on new protocol|0
7403484|NCT01338987|11670211|FG001|Overall Study|enrolled on new protocol|0
7403485|NCT01338987|11670212|FG002|Overall Study|enrolled on new protocol|1
7471203|NCT01939548|11773901|FG002|Overall Study|Study Terminated by Sponsor|12
7403486|NCT01338987|11670213|FG003|Overall Study|enrolled on new protocol|0
7403487|NCT01338987|11670214|FG004|Overall Study|enrolled on new protocol|0
7403488|NCT01338987|11670210|FG000|Overall Study|Disease progression on study|2
7403489|NCT01338987|11670211|FG001|Overall Study|Disease progression on study|1
7403490|NCT01338987|11670212|FG002|Overall Study|Disease progression on study|1
7403491|NCT01338987|11670213|FG003|Overall Study|Disease progression on study|0
7403492|NCT01338987|11670214|FG004|Overall Study|Disease progression on study|0
7403493|NCT01339000|11670230|FG000|Overall Study|study closed due to lack of drug supply|1
7403494|NCT01339000|11670231|FG001|Overall Study|study closed due to lack of drug supply|0
7403495|NCT01339052|11670246|FG000|Overall Study|Disease progression|13
7403496|NCT01339052|11670247|FG001|Overall Study|Disease progression|46
7403497|NCT01339052|11670246|FG000|Overall Study|Adverse Event|1
7403498|NCT01339052|11670247|FG001|Overall Study|Adverse Event|1
7403499|NCT01339052|11670246|FG000|Overall Study|Withdrawal by Subject|0
7403500|NCT01339052|11670247|FG001|Overall Study|Withdrawal by Subject|3
7403501|NCT01339052|11670246|FG000|Overall Study|Physician Decision|1
7403502|NCT01339052|11670247|FG001|Overall Study|Physician Decision|0
7403503|NCT01339273|11670285|FG000|Overall Study|Lost to Follow-up|8
7403504|NCT01339273|11670286|FG001|Overall Study|Lost to Follow-up|8
7403505|NCT01339390|11670303|FG000|Overall Study|Death|32
7403506|NCT01339390|11670304|FG001|Overall Study|Death|29
7403507|NCT01339390|11670303|FG000|Overall Study|Lost to Follow-up|125
7403508|NCT01339390|11670304|FG001|Overall Study|Lost to Follow-up|127
7403509|NCT01339429|11670323|FG000|Overall Study|Withdrawal by Subject|1
7403510|NCT01339429|11670323|FG000|Overall Study|Physician Decision|3
7403511|NCT01339559|11670327|FG000|Overall Study|Adverse Event|92
7403512|NCT01339559|11670327|FG000|Overall Study|Death|5
7403513|NCT01339559|11670327|FG000|Overall Study|Lack of Efficacy|164
7403514|NCT01339559|11670327|FG000|Overall Study|Lost to Follow-up|22
7403515|NCT01339559|11670327|FG000|Overall Study|Subject choice|89
7403516|NCT01339559|11670327|FG000|Overall Study|Protocol Violation|15
7403517|NCT01339559|11670327|FG000|Overall Study|Study closure at site|1
7403518|NCT01339559|11670327|FG000|Overall Study|Incarcerated|2
7403519|NCT01339559|11670327|FG000|Overall Study|Epilepsy surgery|1
7403520|NCT01339559|11670327|FG000|Overall Study|Pregnancy planned|2
7403521|NCT01339559|11670327|FG000|Overall Study|Left the country|1
7403522|NCT01339559|11670327|FG000|Overall Study|Investigator decision|2
7403523|NCT01339559|11670327|FG000|Overall Study|Patient didn't wish to continue|1
7403524|NCT01339559|11670327|FG000|Overall Study|PI decision|1
7403525|NCT01339832|11670332|FG000|Overall Study|Lost to Follow-up|3
7403526|NCT01339832|11670332|FG000|Overall Study|Death|11
7465703|NCT01882465|11765126|FG001|Period 2|Protocol Violation|0
7465704|NCT01882465|11765127|FG002|Period 2|Protocol Violation|0
7465705|NCT01882465|11765128|FG003|Period 2|Protocol Violation|0
7465706|NCT01882465|11765129|FG004|Period 2|Protocol Violation|1
7465707|NCT01882465|11765130|FG005|Period 2|Protocol Violation|0
7403527|NCT01339897|11670351|FG000|Overall Study|Adverse Event|1
7403528|NCT01339897|11670352|FG001|Overall Study|Adverse Event|0
7403529|NCT01339897|11670353|FG002|Overall Study|Adverse Event|0
7403530|NCT01339897|11670354|FG003|Overall Study|Adverse Event|1
7403531|NCT01339910|11670368|FG000|Overall Study|Withdrawal by Subject|1
7403532|NCT01339910|11670369|FG001|Overall Study|Withdrawal by Subject|0
7403533|NCT01339910|11670368|FG000|Overall Study|Physician Decision|1
7403534|NCT01339910|11670369|FG001|Overall Study|Physician Decision|0
7403535|NCT01339910|11670368|FG000|Overall Study|Disease relapse|1
7403536|NCT01339910|11670369|FG001|Overall Study|Disease relapse|4
7403537|NCT01339923|11670382|FG000|Overall Study|Adverse Event|1
7403538|NCT01339923|11670383|FG001|Overall Study|Adverse Event|1
7403539|NCT01339923|11670384|FG002|Overall Study|Adverse Event|1
7403540|NCT01339923|11670385|FG003|Overall Study|Adverse Event|0
7403541|NCT01339923|11670386|FG004|Overall Study|Adverse Event|0
7403542|NCT01339923|11670387|FG005|Overall Study|Adverse Event|0
7403543|NCT01339923|11670388|FG006|Overall Study|Adverse Event|1
7403544|NCT01339923|11670382|FG000|Overall Study|Inappropriate Enrollment|1
7403545|NCT01339923|11670383|FG001|Overall Study|Inappropriate Enrollment|0
7403546|NCT01339923|11670384|FG002|Overall Study|Inappropriate Enrollment|0
7403547|NCT01339923|11670385|FG003|Overall Study|Inappropriate Enrollment|0
7403548|NCT01339923|11670386|FG004|Overall Study|Inappropriate Enrollment|0
7403549|NCT01339923|11670387|FG005|Overall Study|Inappropriate Enrollment|1
7403550|NCT01339923|11670388|FG006|Overall Study|Inappropriate Enrollment|0
7403551|NCT01339923|11670382|FG000|Overall Study|Lost to Follow-up|4
7403552|NCT01339923|11670383|FG001|Overall Study|Lost to Follow-up|4
7403553|NCT01339923|11670384|FG002|Overall Study|Lost to Follow-up|0
7403554|NCT01339923|11670385|FG003|Overall Study|Lost to Follow-up|3
7403555|NCT01339923|11670386|FG004|Overall Study|Lost to Follow-up|1
7403556|NCT01339923|11670387|FG005|Overall Study|Lost to Follow-up|1
7403557|NCT01339923|11670388|FG006|Overall Study|Lost to Follow-up|5
7403558|NCT01339923|11670382|FG000|Overall Study|Protocol Violation|0
7403559|NCT01339923|11670383|FG001|Overall Study|Protocol Violation|0
7403560|NCT01339923|11670384|FG002|Overall Study|Protocol Violation|0
7403561|NCT01339923|11670385|FG003|Overall Study|Protocol Violation|0
7403562|NCT01339923|11670386|FG004|Overall Study|Protocol Violation|0
7403563|NCT01339923|11670387|FG005|Overall Study|Protocol Violation|3
7403564|NCT01339923|11670388|FG006|Overall Study|Protocol Violation|1
7403565|NCT01339923|11670382|FG000|Overall Study|Unable to Classify|1
7403566|NCT01339923|11670383|FG001|Overall Study|Unable to Classify|0
7403567|NCT01339923|11670384|FG002|Overall Study|Unable to Classify|1
7403568|NCT01339923|11670385|FG003|Overall Study|Unable to Classify|0
7403569|NCT01339923|11670386|FG004|Overall Study|Unable to Classify|0
7403570|NCT01339923|11670387|FG005|Overall Study|Unable to Classify|1
7403571|NCT01339923|11670388|FG006|Overall Study|Unable to Classify|5
7403572|NCT01339923|11670382|FG000|Overall Study|Withdrawal by Subject|7
7403573|NCT01339923|11670383|FG001|Overall Study|Withdrawal by Subject|11
7403574|NCT01339923|11670384|FG002|Overall Study|Withdrawal by Subject|6
7403575|NCT01339923|11670385|FG003|Overall Study|Withdrawal by Subject|1
7403576|NCT01339923|11670386|FG004|Overall Study|Withdrawal by Subject|4
7403577|NCT01339923|11670387|FG005|Overall Study|Withdrawal by Subject|3
7403578|NCT01339923|11670388|FG006|Overall Study|Withdrawal by Subject|2
7403579|NCT01340014|11670423|FG000|Period 1, First 7 Days|Adverse Event|1
7403580|NCT01340014|11670424|FG001|Period 1, First 7 Days|Adverse Event|0
7403581|NCT01340014|11670423|FG000|Period 1, First 7 Days|Personal Reasons|1
7403582|NCT01340014|11670424|FG001|Period 1, First 7 Days|Personal Reasons|0
7403583|NCT01340014|11670423|FG000|Period 2, Second 7 Days|Adverse Event|0
7403584|NCT01340014|11670424|FG001|Period 2, Second 7 Days|Adverse Event|1
7403585|NCT01340027|11670442|FG000|Overall Study|Randomized but Never Received Study Drug|0
7403586|NCT01340027|11670443|FG001|Overall Study|Randomized but Never Received Study Drug|0
7403587|NCT01340027|11670444|FG002|Overall Study|Randomized but Never Received Study Drug|1
7403588|NCT01340027|11670445|FG003|Overall Study|Randomized but Never Received Study Drug|0
7403589|NCT01340027|11670446|FG004|Overall Study|Randomized but Never Received Study Drug|0
7403590|NCT01340027|11670447|FG005|Overall Study|Randomized but Never Received Study Drug|0
7403591|NCT01340027|11670448|FG006|Overall Study|Randomized but Never Received Study Drug|0
7403592|NCT01340027|11670449|FG007|Overall Study|Randomized but Never Received Study Drug|0
7403593|NCT01340027|11670450|FG008|Overall Study|Randomized but Never Received Study Drug|0
7403594|NCT01340027|11670451|FG009|Overall Study|Randomized but Never Received Study Drug|0
7403595|NCT01340027|11670452|FG010|Overall Study|Randomized but Never Received Study Drug|0
7403596|NCT01340027|11670453|FG011|Overall Study|Randomized but Never Received Study Drug|0
7403597|NCT01340027|11670442|FG000|Overall Study|Adverse Event|0
7403598|NCT01340027|11670443|FG001|Overall Study|Adverse Event|1
7403599|NCT01340027|11670444|FG002|Overall Study|Adverse Event|2
7403600|NCT01340027|11670445|FG003|Overall Study|Adverse Event|0
7403601|NCT01340027|11670446|FG004|Overall Study|Adverse Event|1
7403602|NCT01340027|11670447|FG005|Overall Study|Adverse Event|2
7403603|NCT01340027|11670448|FG006|Overall Study|Adverse Event|2
7403604|NCT01340027|11670449|FG007|Overall Study|Adverse Event|1
7403605|NCT01340027|11670450|FG008|Overall Study|Adverse Event|4
7403606|NCT01340027|11670451|FG009|Overall Study|Adverse Event|1
7403607|NCT01340027|11670452|FG010|Overall Study|Adverse Event|1
7403608|NCT01340027|11670453|FG011|Overall Study|Adverse Event|3
7403609|NCT01340027|11670442|FG000|Overall Study|Lack of Efficacy|0
7403610|NCT01340027|11670443|FG001|Overall Study|Lack of Efficacy|0
7403611|NCT01340027|11670444|FG002|Overall Study|Lack of Efficacy|0
7403612|NCT01340027|11670445|FG003|Overall Study|Lack of Efficacy|0
7403613|NCT01340027|11670446|FG004|Overall Study|Lack of Efficacy|0
7403614|NCT01340027|11670447|FG005|Overall Study|Lack of Efficacy|0
7403615|NCT01340027|11670448|FG006|Overall Study|Lack of Efficacy|1
7403616|NCT01340027|11670449|FG007|Overall Study|Lack of Efficacy|1
7403617|NCT01340027|11670450|FG008|Overall Study|Lack of Efficacy|1
7403618|NCT01340027|11670451|FG009|Overall Study|Lack of Efficacy|0
7403619|NCT01340027|11670452|FG010|Overall Study|Lack of Efficacy|0
7403620|NCT01340027|11670453|FG011|Overall Study|Lack of Efficacy|0
7403621|NCT01340027|11670442|FG000|Overall Study|Lost to Follow-up|0
7403622|NCT01340027|11670443|FG001|Overall Study|Lost to Follow-up|1
7403623|NCT01340027|11670444|FG002|Overall Study|Lost to Follow-up|0
7403624|NCT01340027|11670445|FG003|Overall Study|Lost to Follow-up|0
7403625|NCT01340027|11670446|FG004|Overall Study|Lost to Follow-up|0
7403626|NCT01340027|11670447|FG005|Overall Study|Lost to Follow-up|0
7403627|NCT01340027|11670448|FG006|Overall Study|Lost to Follow-up|1
7403628|NCT01340027|11670449|FG007|Overall Study|Lost to Follow-up|0
7403629|NCT01340027|11670450|FG008|Overall Study|Lost to Follow-up|0
7403630|NCT01340027|11670451|FG009|Overall Study|Lost to Follow-up|1
7403631|NCT01340027|11670452|FG010|Overall Study|Lost to Follow-up|0
7403632|NCT01340027|11670453|FG011|Overall Study|Lost to Follow-up|0
7403633|NCT01340027|11670442|FG000|Overall Study|Protocol Violation|1
7403634|NCT01340027|11670443|FG001|Overall Study|Protocol Violation|2
7403635|NCT01340027|11670444|FG002|Overall Study|Protocol Violation|0
7403636|NCT01340027|11670445|FG003|Overall Study|Protocol Violation|0
7403637|NCT01340027|11670446|FG004|Overall Study|Protocol Violation|6
7403638|NCT01340027|11670447|FG005|Overall Study|Protocol Violation|0
7403639|NCT01340027|11670448|FG006|Overall Study|Protocol Violation|0
7403640|NCT01340027|11670449|FG007|Overall Study|Protocol Violation|1
7403641|NCT01340027|11670450|FG008|Overall Study|Protocol Violation|2
7403642|NCT01340027|11670451|FG009|Overall Study|Protocol Violation|2
7403643|NCT01340027|11670452|FG010|Overall Study|Protocol Violation|0
7403644|NCT01340027|11670453|FG011|Overall Study|Protocol Violation|0
7403645|NCT01340027|11670442|FG000|Overall Study|Withdrawal by Subject|4
7403646|NCT01340027|11670443|FG001|Overall Study|Withdrawal by Subject|3
7403647|NCT01340027|11670444|FG002|Overall Study|Withdrawal by Subject|1
7403648|NCT01340027|11670445|FG003|Overall Study|Withdrawal by Subject|3
7403649|NCT01340027|11670446|FG004|Overall Study|Withdrawal by Subject|3
7403650|NCT01340027|11670447|FG005|Overall Study|Withdrawal by Subject|2
7403651|NCT01340027|11670448|FG006|Overall Study|Withdrawal by Subject|3
7403652|NCT01340027|11670449|FG007|Overall Study|Withdrawal by Subject|4
7403653|NCT01340027|11670450|FG008|Overall Study|Withdrawal by Subject|1
7403654|NCT01340027|11670451|FG009|Overall Study|Withdrawal by Subject|2
7403655|NCT01340027|11670452|FG010|Overall Study|Withdrawal by Subject|0
7403656|NCT01340027|11670453|FG011|Overall Study|Withdrawal by Subject|1
7403657|NCT01340027|11670442|FG000|Overall Study|Miscellaneous|0
7403658|NCT01340027|11670443|FG001|Overall Study|Miscellaneous|0
7403659|NCT01340027|11670444|FG002|Overall Study|Miscellaneous|0
7403660|NCT01340027|11670445|FG003|Overall Study|Miscellaneous|1
7403661|NCT01340027|11670446|FG004|Overall Study|Miscellaneous|0
7403662|NCT01340027|11670447|FG005|Overall Study|Miscellaneous|0
7403663|NCT01340027|11670448|FG006|Overall Study|Miscellaneous|0
7403664|NCT01340027|11670449|FG007|Overall Study|Miscellaneous|0
7403665|NCT01340027|11670450|FG008|Overall Study|Miscellaneous|0
7403666|NCT01340027|11670451|FG009|Overall Study|Miscellaneous|0
7403667|NCT01340027|11670452|FG010|Overall Study|Miscellaneous|1
7403668|NCT01340027|11670453|FG011|Overall Study|Miscellaneous|0
7403669|NCT01340066|11670498|FG000|Placebo Run in Period|Screen Failures|27
7403670|NCT01340066|11670499|FG001|Placebo Run in Period|Screen Failures|0
7403671|NCT01340066|11670500|FG002|Placebo Run in Period|Screen Failures|0
7403672|NCT01340066|11670498|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
7403673|NCT01340066|11670499|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
7403674|NCT01340066|11670500|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
7403675|NCT01340066|11670498|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
7403676|NCT01340066|11670499|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
7403677|NCT01340066|11670500|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
7403678|NCT01340066|11670498|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
7403679|NCT01340066|11670499|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
7403680|NCT01340066|11670500|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
7403681|NCT01340196|11670516|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
7403682|NCT01340209|11670528|FG000|Overall Study|Adverse Event|1
7403683|NCT01340209|11670529|FG001|Overall Study|Adverse Event|1
7403684|NCT01340209|11670530|FG002|Overall Study|Adverse Event|2
7403685|NCT01340209|11670528|FG000|Overall Study|Protocol Violation|1
7403686|NCT01340209|11670529|FG001|Overall Study|Protocol Violation|2
7403687|NCT01340209|11670530|FG002|Overall Study|Protocol Violation|1
7403688|NCT01340209|11670528|FG000|Overall Study|Withdrawal by Subject|0
7403689|NCT01340209|11670529|FG001|Overall Study|Withdrawal by Subject|0
7403690|NCT01340209|11670530|FG002|Overall Study|Withdrawal by Subject|1
7403691|NCT01340209|11670528|FG000|Overall Study|Other reason not defined above|3
7403692|NCT01340209|11670529|FG001|Overall Study|Other reason not defined above|5
7403693|NCT01340209|11670530|FG002|Overall Study|Other reason not defined above|4
7403694|NCT01340300|11670542|FG000|Overall Study|Lost to Follow-up|3
7403695|NCT01340300|11670543|FG001|Overall Study|Lost to Follow-up|0
7403696|NCT01340300|11670544|FG002|Overall Study|Lost to Follow-up|5
7403697|NCT01340300|11670545|FG003|Overall Study|Lost to Follow-up|10
7403698|NCT01340300|11670542|FG000|Overall Study|Withdrawal by Subject|5
7403699|NCT01340300|11670543|FG001|Overall Study|Withdrawal by Subject|6
7403700|NCT01340300|11670544|FG002|Overall Study|Withdrawal by Subject|6
7403701|NCT01340300|11670545|FG003|Overall Study|Withdrawal by Subject|3
7403702|NCT01340300|11670542|FG000|Overall Study|Adverse Event|1
7403703|NCT01340300|11670543|FG001|Overall Study|Adverse Event|0
7403704|NCT01340300|11670544|FG002|Overall Study|Adverse Event|4
7403705|NCT01340300|11670545|FG003|Overall Study|Adverse Event|0
7403706|NCT01340300|11670542|FG000|Overall Study|Physician Decision|0
7403707|NCT01340300|11670543|FG001|Overall Study|Physician Decision|1
7403708|NCT01340300|11670544|FG002|Overall Study|Physician Decision|0
7403709|NCT01340300|11670545|FG003|Overall Study|Physician Decision|0
7403710|NCT01340300|11670542|FG000|Overall Study|Unrelated sickness|0
7403711|NCT01340300|11670543|FG001|Overall Study|Unrelated sickness|2
7403712|NCT01340300|11670544|FG002|Overall Study|Unrelated sickness|0
7403713|NCT01340300|11670545|FG003|Overall Study|Unrelated sickness|1
7403714|NCT01340482|11670558|FG000|Overall Study|Adverse Event|2
7403715|NCT01340482|11670559|FG001|Overall Study|Adverse Event|0
7403716|NCT01340482|11670560|FG002|Overall Study|Adverse Event|0
7403717|NCT01340495|11670570|FG000|Overall Study|Withdrawal by Subject|1
7403718|NCT01340625|11670590|FG000|First Intervention|Adverse Event|1
7403719|NCT01340625|11670591|FG001|First Intervention|Adverse Event|0
7403720|NCT01340625|11670590|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
7403721|NCT01340625|11670591|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
7403722|NCT01340651|11670597|FG000|Overall Study|Adverse Event|3
7403723|NCT01340651|11670597|FG000|Overall Study|Consent Withdrawn|2
7403724|NCT01340651|11670597|FG000|Overall Study|Commercial Supply per Sponsor|12
7403725|NCT01340664|11670606|FG000|Overall Study|Adverse Event|0
7403726|NCT01340664|11670607|FG001|Overall Study|Adverse Event|1
7403727|NCT01340664|11670608|FG002|Overall Study|Adverse Event|7
7403728|NCT01340664|11670606|FG000|Overall Study|Lost to Follow-up|2
7403729|NCT01340664|11670607|FG001|Overall Study|Lost to Follow-up|0
7403730|NCT01340664|11670608|FG002|Overall Study|Lost to Follow-up|2
7403731|NCT01340664|11670606|FG000|Overall Study|Withdrawal by Subject|2
7403732|NCT01340664|11670607|FG001|Overall Study|Withdrawal by Subject|4
7403733|NCT01340664|11670608|FG002|Overall Study|Withdrawal by Subject|0
7403734|NCT01340664|11670606|FG000|Overall Study|Glycemic withdrawal criteria|2
7403735|NCT01340664|11670607|FG001|Overall Study|Glycemic withdrawal criteria|0
7403736|NCT01340664|11670608|FG002|Overall Study|Glycemic withdrawal criteria|0
7403737|NCT01340664|11670606|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
7403738|NCT01340664|11670607|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
7403739|NCT01340664|11670608|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
7403740|NCT01340664|11670606|FG000|Overall Study|Other|1
7403741|NCT01340664|11670607|FG001|Overall Study|Other|2
7403742|NCT01340664|11670608|FG002|Overall Study|Other|2
7403743|NCT01340768|11670618|FG000|Overall Study|Lost to Follow-up|10
7403744|NCT01340768|11670619|FG001|Overall Study|Lost to Follow-up|4
7403745|NCT01340768|11670618|FG000|Overall Study|Withdrawal by Subject|5
7403746|NCT01340768|11670619|FG001|Overall Study|Withdrawal by Subject|1
7403747|NCT01340768|11670618|FG000|Overall Study|Other|2
7403748|NCT01340768|11670619|FG001|Overall Study|Other|0
7403749|NCT01340794|11670627|FG000|Overall Study|Withdrawal by Subject|0
7403750|NCT01340794|11670628|FG001|Overall Study|Withdrawal by Subject|1
7403751|NCT01340872|11670638|FG000|Double-blind Phase|Adverse Event|6
7403752|NCT01340872|11670639|FG001|Double-blind Phase|Adverse Event|4
7403753|NCT01340872|11670640|FG002|Double-blind Phase|Adverse Event|0
7403754|NCT01340872|11670641|FG003|Double-blind Phase|Adverse Event|0
7403755|NCT01340872|11670638|FG000|Double-blind Phase|Withdrawal by Subject|3
7403756|NCT01340872|11670639|FG001|Double-blind Phase|Withdrawal by Subject|5
7403757|NCT01340872|11670640|FG002|Double-blind Phase|Withdrawal by Subject|0
7403758|NCT01340872|11670641|FG003|Double-blind Phase|Withdrawal by Subject|0
7403759|NCT01340872|11670638|FG000|Double-blind Phase|Lost to Follow-up|0
7403760|NCT01340872|11670639|FG001|Double-blind Phase|Lost to Follow-up|1
7403761|NCT01340872|11670640|FG002|Double-blind Phase|Lost to Follow-up|0
7403762|NCT01340872|11670641|FG003|Double-blind Phase|Lost to Follow-up|0
7403763|NCT01340872|11670638|FG000|Double-blind Phase|Protocol Violation|0
7403764|NCT01340872|11670639|FG001|Double-blind Phase|Protocol Violation|1
7403765|NCT01340872|11670640|FG002|Double-blind Phase|Protocol Violation|0
7403766|NCT01340872|11670641|FG003|Double-blind Phase|Protocol Violation|0
7403767|NCT01340872|11670638|FG000|Open-label Phase|Physician Decision|0
7403768|NCT01340872|11670639|FG001|Open-label Phase|Physician Decision|0
7403769|NCT01340872|11670640|FG002|Open-label Phase|Physician Decision|2
7403770|NCT01340872|11670641|FG003|Open-label Phase|Physician Decision|1
7403771|NCT01340872|11670638|FG000|Open-label Phase|Pregnancy|0
7403772|NCT01340872|11670639|FG001|Open-label Phase|Pregnancy|0
7403773|NCT01340872|11670640|FG002|Open-label Phase|Pregnancy|1
7403774|NCT01340872|11670641|FG003|Open-label Phase|Pregnancy|0
7403775|NCT01340872|11670638|FG000|Open-label Phase|Adverse Event|0
7403776|NCT01340872|11670639|FG001|Open-label Phase|Adverse Event|0
7403777|NCT01340872|11670640|FG002|Open-label Phase|Adverse Event|8
7403778|NCT01340872|11670641|FG003|Open-label Phase|Adverse Event|4
7403779|NCT01340872|11670638|FG000|Open-label Phase|Withdrawal by Subject|0
7403780|NCT01340872|11670639|FG001|Open-label Phase|Withdrawal by Subject|0
7403781|NCT01340872|11670640|FG002|Open-label Phase|Withdrawal by Subject|1
7403782|NCT01340872|11670641|FG003|Open-label Phase|Withdrawal by Subject|6
7403783|NCT01340872|11670638|FG000|Open-label Phase|Worsening of IBD|0
7403784|NCT01340872|11670639|FG001|Open-label Phase|Worsening of IBD|0
7403785|NCT01340872|11670640|FG002|Open-label Phase|Worsening of IBD|1
7403786|NCT01340872|11670641|FG003|Open-label Phase|Worsening of IBD|0
7403787|NCT01340898|11670656|FG000|Primary Phase|Serious Adverse Events|0
7403788|NCT01340898|11670657|FG001|Primary Phase|Serious Adverse Events|0
7403789|NCT01340898|11670658|FG002|Primary Phase|Serious Adverse Events|1
7403790|NCT01340898|11670656|FG000|Primary Phase|Withdrawal by Subject|8
7403791|NCT01340898|11670657|FG001|Primary Phase|Withdrawal by Subject|7
7403792|NCT01340898|11670658|FG002|Primary Phase|Withdrawal by Subject|5
7403793|NCT01340898|11670656|FG000|Primary Phase|Migrated/moved from study area|4
7403794|NCT01340898|11670657|FG001|Primary Phase|Migrated/moved from study area|1
7403795|NCT01340898|11670658|FG002|Primary Phase|Migrated/moved from study area|0
7403796|NCT01340898|11670656|FG000|Primary Phase|Lost to Follow-up|4
7403797|NCT01340898|11670657|FG001|Primary Phase|Lost to Follow-up|1
7403798|NCT01340898|11670658|FG002|Primary Phase|Lost to Follow-up|0
7403799|NCT01340898|11670656|FG000|Booster Phase|Withdrawal by Subject|3
7403800|NCT01340898|11670657|FG001|Booster Phase|Withdrawal by Subject|0
7403801|NCT01340898|11670658|FG002|Booster Phase|Withdrawal by Subject|4
7403802|NCT01340898|11670656|FG000|Booster Phase|Migrated/moved from study area|3
7403803|NCT01340898|11670657|FG001|Booster Phase|Migrated/moved from study area|0
7403804|NCT01340898|11670658|FG002|Booster Phase|Migrated/moved from study area|0
7403805|NCT01340898|11670656|FG000|Booster Phase|Lost to Follow-up|4
7403806|NCT01340898|11670657|FG001|Booster Phase|Lost to Follow-up|2
7403807|NCT01340898|11670658|FG002|Booster Phase|Lost to Follow-up|3
7403808|NCT01340937|11670672|FG000|Period 1: Infant Series|Other protocol criterion not met|0
7403809|NCT01340937|11670673|FG001|Period 1: Infant Series|Other protocol criterion not met|1
7403810|NCT01340937|11670674|FG002|Period 1: Infant Series|Other protocol criterion not met|1
7403811|NCT01340937|11670675|FG003|Period 1: Infant Series|Other protocol criterion not met|0
7403812|NCT01340937|11670672|FG000|Period 1: Infant Series|Adverse Event|0
7403813|NCT01340937|11670673|FG001|Period 1: Infant Series|Adverse Event|1
7403814|NCT01340937|11670674|FG002|Period 1: Infant Series|Adverse Event|4
7403815|NCT01340937|11670675|FG003|Period 1: Infant Series|Adverse Event|0
7403816|NCT01340937|11670672|FG000|Period 1: Infant Series|Death|2
7403817|NCT01340937|11670673|FG001|Period 1: Infant Series|Death|0
7403818|NCT01340937|11670674|FG002|Period 1: Infant Series|Death|2
7403819|NCT01340937|11670675|FG003|Period 1: Infant Series|Death|0
7403820|NCT01340937|11670672|FG000|Period 1: Infant Series|Lost to Follow-up|20
7403821|NCT01340937|11670673|FG001|Period 1: Infant Series|Lost to Follow-up|14
7403822|NCT01340937|11670674|FG002|Period 1: Infant Series|Lost to Follow-up|12
7403823|NCT01340937|11670675|FG003|Period 1: Infant Series|Lost to Follow-up|13
7403824|NCT01340937|11670672|FG000|Period 1: Infant Series|Physician Decision|2
7403825|NCT01340937|11670673|FG001|Period 1: Infant Series|Physician Decision|3
7403826|NCT01340937|11670674|FG002|Period 1: Infant Series|Physician Decision|1
7403827|NCT01340937|11670675|FG003|Period 1: Infant Series|Physician Decision|0
7403828|NCT01340937|11670672|FG000|Period 1: Infant Series|Protocol Violation|1
7403829|NCT01340937|11670673|FG001|Period 1: Infant Series|Protocol Violation|4
7403830|NCT01340937|11670674|FG002|Period 1: Infant Series|Protocol Violation|4
7403831|NCT01340937|11670675|FG003|Period 1: Infant Series|Protocol Violation|3
7403832|NCT01340937|11670672|FG000|Period 1: Infant Series|Withdrawal by Subject|33
7403833|NCT01340937|11670673|FG001|Period 1: Infant Series|Withdrawal by Subject|32
7403834|NCT01340937|11670674|FG002|Period 1: Infant Series|Withdrawal by Subject|30
7403835|NCT01340937|11670675|FG003|Period 1: Infant Series|Withdrawal by Subject|15
7403836|NCT01340937|11670672|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
7403837|NCT01340937|11670673|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
7403838|NCT01340937|11670674|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
7403839|NCT01340937|11670675|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
7403840|NCT01340937|11670672|FG000|Period 2: Interim Period|Withdrawal by Subject|28
7403841|NCT01340937|11670673|FG001|Period 2: Interim Period|Withdrawal by Subject|23
7403842|NCT01340937|11670674|FG002|Period 2: Interim Period|Withdrawal by Subject|17
7403843|NCT01340937|11670675|FG003|Period 2: Interim Period|Withdrawal by Subject|12
7403844|NCT01340937|11670672|FG000|Period 2: Interim Period|Adverse Event|1
7403845|NCT01340937|11670673|FG001|Period 2: Interim Period|Adverse Event|0
7403846|NCT01340937|11670674|FG002|Period 2: Interim Period|Adverse Event|1
7403847|NCT01340937|11670675|FG003|Period 2: Interim Period|Adverse Event|0
7403848|NCT01340937|11670672|FG000|Period 2: Interim Period|Lost to Follow-up|29
7403849|NCT01340937|11670673|FG001|Period 2: Interim Period|Lost to Follow-up|48
7403850|NCT01340937|11670674|FG002|Period 2: Interim Period|Lost to Follow-up|53
7403851|NCT01340937|11670675|FG003|Period 2: Interim Period|Lost to Follow-up|23
7403852|NCT01340937|11670672|FG000|Period 2: Interim Period|Physician Decision|0
7403853|NCT01340937|11670673|FG001|Period 2: Interim Period|Physician Decision|1
7403854|NCT01340937|11670674|FG002|Period 2: Interim Period|Physician Decision|1
7403855|NCT01340937|11670675|FG003|Period 2: Interim Period|Physician Decision|0
7403856|NCT01340937|11670672|FG000|Period 2: Interim Period|Protocol Violation|5
7403857|NCT01340937|11670673|FG001|Period 2: Interim Period|Protocol Violation|3
7403858|NCT01340937|11670674|FG002|Period 2: Interim Period|Protocol Violation|6
7403859|NCT01340937|11670675|FG003|Period 2: Interim Period|Protocol Violation|3
7403860|NCT01340937|11670672|FG000|Period 2: Interim Period|Technical problems|4
7403861|NCT01340937|11670673|FG001|Period 2: Interim Period|Technical problems|4
7403862|NCT01340937|11670674|FG002|Period 2: Interim Period|Technical problems|6
7403863|NCT01340937|11670675|FG003|Period 2: Interim Period|Technical problems|3
7403864|NCT01340937|11670672|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7403865|NCT01340937|11670673|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
7403866|NCT01340937|11670674|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7403867|NCT01340937|11670675|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
7403868|NCT01340937|11670672|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
7403869|NCT01340937|11670673|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
7403870|NCT01340937|11670674|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
7403871|NCT01340937|11670675|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
7403872|NCT01340937|11670672|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
7403873|NCT01340937|11670673|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
7403874|NCT01340937|11670674|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
7403875|NCT01340937|11670675|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
7403876|NCT01340937|11670672|FG000|Period 3: Toddler Vaccinations|Technical problem|1
7403877|NCT01340937|11670673|FG001|Period 3: Toddler Vaccinations|Technical problem|1
7403878|NCT01340937|11670674|FG002|Period 3: Toddler Vaccinations|Technical problem|1
7403879|NCT01340937|11670675|FG003|Period 3: Toddler Vaccinations|Technical problem|0
7403880|NCT01340976|11670697|FG000|Overall Study|Physician Decision|2
7403881|NCT01340976|11670698|FG001|Overall Study|Physician Decision|0
7403882|NCT01340976|11670699|FG002|Overall Study|Physician Decision|1
7403883|NCT01340976|11670700|FG003|Overall Study|Physician Decision|1
7403884|NCT01340976|11670701|FG004|Overall Study|Physician Decision|1
7403885|NCT01340976|11670702|FG005|Overall Study|Physician Decision|0
7403886|NCT01340976|11670697|FG000|Overall Study|Death|0
7403887|NCT01340976|11670698|FG001|Overall Study|Death|1
7403888|NCT01340976|11670699|FG002|Overall Study|Death|0
7403889|NCT01340976|11670700|FG003|Overall Study|Death|0
7403890|NCT01340976|11670701|FG004|Overall Study|Death|0
7403891|NCT01340976|11670702|FG005|Overall Study|Death|0
7403892|NCT01340976|11670697|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
7403893|NCT01340976|11670698|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7403894|NCT01340976|11670699|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7403895|NCT01340976|11670700|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7403896|NCT01340976|11670701|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7403897|NCT01340976|11670702|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
7403898|NCT01340976|11670697|FG000|Overall Study|Withdrawal by Subject|0
7403899|NCT01340976|11670698|FG001|Overall Study|Withdrawal by Subject|0
7403900|NCT01340976|11670699|FG002|Overall Study|Withdrawal by Subject|0
7403901|NCT01340976|11670700|FG003|Overall Study|Withdrawal by Subject|1
7403902|NCT01340976|11670701|FG004|Overall Study|Withdrawal by Subject|1
7403903|NCT01340976|11670702|FG005|Overall Study|Withdrawal by Subject|0
7403904|NCT01340976|11670697|FG000|Overall Study|Other anemia treatment|1
7403905|NCT01340976|11670698|FG001|Overall Study|Other anemia treatment|0
7403906|NCT01340976|11670699|FG002|Overall Study|Other anemia treatment|2
7403907|NCT01340976|11670700|FG003|Overall Study|Other anemia treatment|1
7403908|NCT01340976|11670701|FG004|Overall Study|Other anemia treatment|0
7403909|NCT01340976|11670702|FG005|Overall Study|Other anemia treatment|1
7403910|NCT01340976|11670697|FG000|Overall Study|Adverse Event|0
7403911|NCT01340976|11670698|FG001|Overall Study|Adverse Event|1
7403912|NCT01340976|11670699|FG002|Overall Study|Adverse Event|0
7403913|NCT01340976|11670700|FG003|Overall Study|Adverse Event|0
7403914|NCT01340976|11670701|FG004|Overall Study|Adverse Event|0
7403915|NCT01340976|11670702|FG005|Overall Study|Adverse Event|0
7403916|NCT01341457|11670743|FG000|Overall Study|Adverse Event|2
7403917|NCT01341457|11670744|FG001|Overall Study|Adverse Event|0
7403918|NCT01341470|11670757|FG000|Overall Study|Sponsor decision|0
7403919|NCT01341470|11670758|FG001|Overall Study|Sponsor decision|0
7403920|NCT01341470|11670759|FG002|Overall Study|Sponsor decision|1
7403921|NCT01341470|11670760|FG003|Overall Study|Sponsor decision|1
7403922|NCT01341470|11670761|FG004|Overall Study|Sponsor decision|0
7403923|NCT01341470|11670762|FG005|Overall Study|Sponsor decision|1
7403924|NCT01341639|11670780|FG000|Infant Series|Protocol Violation|1
7403925|NCT01341639|11670781|FG001|Infant Series|Protocol Violation|0
7403926|NCT01341639|11670780|FG000|Infant Series|Not Vaccinated|0
7403927|NCT01341639|11670781|FG001|Infant Series|Not Vaccinated|1
7403928|NCT01341639|11670780|FG000|Infant Series|Adverse Event|0
7403929|NCT01341639|11670781|FG001|Infant Series|Adverse Event|5
7403930|NCT01341639|11670780|FG000|Infant Series|Withdrawal by Subject|11
7403931|NCT01341639|11670781|FG001|Infant Series|Withdrawal by Subject|8
7403932|NCT01341639|11670780|FG000|Infant Series|Lost to Follow-up|0
7403933|NCT01341639|11670781|FG001|Infant Series|Lost to Follow-up|2
7403934|NCT01341639|11670780|FG000|Infant Series|Site 0048 Participants|17
7403935|NCT01341639|11670781|FG001|Infant Series|Site 0048 Participants|16
7403936|NCT01341639|11670780|FG000|Interim Period|Withdrawal by Subject|6
7403937|NCT01341639|11670781|FG001|Interim Period|Withdrawal by Subject|7
7403938|NCT01341639|11670780|FG000|Interim Period|Lost to Follow-up|2
7403939|NCT01341639|11670781|FG001|Interim Period|Lost to Follow-up|0
7403940|NCT01341639|11670780|FG000|Interim Period|Physician Decision|0
7403941|NCT01341639|11670781|FG001|Interim Period|Physician Decision|1
7403942|NCT01341639|11670780|FG000|Interim Period|Protocol Violation|0
7403943|NCT01341639|11670781|FG001|Interim Period|Protocol Violation|1
7403944|NCT01341639|11670780|FG000|Post-Treatment|Withdrawal by Subject|0
7403945|NCT01341639|11670781|FG001|Post-Treatment|Withdrawal by Subject|1
7403946|NCT01341639|11670780|FG000|Post-Treatment|Adverse Event|0
7403947|NCT01341639|11670781|FG001|Post-Treatment|Adverse Event|2
7403948|NCT01341652|11670789|FG000|Overall Study|Incorrect Random Assignment|0
7403949|NCT01341652|11670790|FG001|Overall Study|Incorrect Random Assignment|1
7403950|NCT01341652|11670789|FG000|Overall Study|ineligible; presence metastatic disease|0
7403951|NCT01341652|11670790|FG001|Overall Study|ineligible; presence metastatic disease|1
7403952|NCT01341782|11670809|FG000|Overall Study|Adverse Event|1
7403953|NCT01341782|11670810|FG001|Overall Study|Adverse Event|1
7403954|NCT01341782|11670809|FG000|Overall Study|Withdrawal by Subject|6
7403955|NCT01341782|11670810|FG001|Overall Study|Withdrawal by Subject|5
7403956|NCT01341782|11670809|FG000|Overall Study|Missed 3 consecutive doses|0
7403957|NCT01341782|11670810|FG001|Overall Study|Missed 3 consecutive doses|4
7403958|NCT01341782|11670809|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
7403959|NCT01341782|11670810|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
7403960|NCT01341782|11670809|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7403961|NCT01341782|11670810|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
7403962|NCT01341782|11670809|FG000|Overall Study|Other|5
7403963|NCT01341782|11670810|FG001|Overall Study|Other|0
7403964|NCT01341990|11670831|FG000|Overall Study|Adverse Event|0
7403965|NCT01341990|11670832|FG001|Overall Study|Adverse Event|1
7403966|NCT01341990|11670831|FG000|Overall Study|Torn Study Lens|1
7403967|NCT01341990|11670832|FG001|Overall Study|Torn Study Lens|0
7403968|NCT01341990|11670831|FG000|Overall Study|Withdrawal by Subject|2
7403969|NCT01341990|11670832|FG001|Overall Study|Withdrawal by Subject|0
7403970|NCT01342081|11670850|FG000|Overall Study|Did not receive allocated intervention|0
7403971|NCT01342081|11670851|FG001|Overall Study|Did not receive allocated intervention|0
7403972|NCT01342081|11670852|FG002|Overall Study|Did not receive allocated intervention|1
7403973|NCT01342081|11670850|FG000|Overall Study|Adverse Event|1
7403974|NCT01342081|11670851|FG001|Overall Study|Adverse Event|0
7403975|NCT01342081|11670852|FG002|Overall Study|Adverse Event|0
7403976|NCT01342081|11670850|FG000|Overall Study|Physician Decision|0
7403977|NCT01342081|11670851|FG001|Overall Study|Physician Decision|1
7403978|NCT01342081|11670852|FG002|Overall Study|Physician Decision|0
7403979|NCT01342081|11670850|FG000|Overall Study|Withdrawal by Subject|1
7403980|NCT01342081|11670851|FG001|Overall Study|Withdrawal by Subject|1
7403981|NCT01342081|11670852|FG002|Overall Study|Withdrawal by Subject|0
7403982|NCT01342094|11670862|FG000|Overall Study|Adverse Event|5
7403983|NCT01342094|11670863|FG001|Overall Study|Adverse Event|0
7403984|NCT01342094|11670862|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
7403985|NCT01342094|11670863|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7403986|NCT01342094|11670862|FG000|Overall Study|Withdrawal by Subject|0
7403987|NCT01342094|11670863|FG001|Overall Study|Withdrawal by Subject|2
7403988|NCT01342211|11670888|FG000|Overall Study|Lost to Follow-up|0
7403989|NCT01342211|11670889|FG001|Overall Study|Lost to Follow-up|0
7403990|NCT01342211|11670890|FG002|Overall Study|Lost to Follow-up|0
7403991|NCT01342211|11670891|FG003|Overall Study|Lost to Follow-up|1
7403992|NCT01342211|11670892|FG004|Overall Study|Lost to Follow-up|0
7403993|NCT01342211|11670888|FG000|Overall Study|Adverse Event|0
7403994|NCT01342211|11670889|FG001|Overall Study|Adverse Event|0
7403995|NCT01342211|11670890|FG002|Overall Study|Adverse Event|0
7403996|NCT01342211|11670891|FG003|Overall Study|Adverse Event|0
7403997|NCT01342211|11670892|FG004|Overall Study|Adverse Event|1
7403998|NCT01342211|11670888|FG000|Overall Study|Withdrawal by Subject|0
7403999|NCT01342211|11670889|FG001|Overall Study|Withdrawal by Subject|0
7404000|NCT01342211|11670890|FG002|Overall Study|Withdrawal by Subject|0
7404001|NCT01342211|11670891|FG003|Overall Study|Withdrawal by Subject|1
7404002|NCT01342211|11670892|FG004|Overall Study|Withdrawal by Subject|0
7404003|NCT01342211|11670888|FG000|Overall Study|Randomized, but not Treated|0
7404004|NCT01342211|11670889|FG001|Overall Study|Randomized, but not Treated|2
7404005|NCT01342211|11670890|FG002|Overall Study|Randomized, but not Treated|0
7404006|NCT01342211|11670891|FG003|Overall Study|Randomized, but not Treated|0
7404007|NCT01342211|11670892|FG004|Overall Study|Randomized, but not Treated|1
7404008|NCT01342341|11670910|FG000|Overall Study|Lost to Follow-up|4
7404009|NCT01342341|11670911|FG001|Overall Study|Lost to Follow-up|4
7404010|NCT01342367|11670919|FG000|Overall Study|Death|1
7404011|NCT01342367|11670920|FG001|Overall Study|Death|0
7404012|NCT01342367|11670919|FG000|Overall Study|Withdrawal by Subject|1
7404013|NCT01342367|11670920|FG001|Overall Study|Withdrawal by Subject|2
7404014|NCT01342445|11670928|FG000|Overall Study|Experienced side effects|0
7404015|NCT01342445|11670929|FG001|Overall Study|Experienced side effects|2
7404016|NCT01342484|11670974|FG000|Overall Study|Other Reasons|1
7404017|NCT01342484|11670975|FG001|Overall Study|Other Reasons|0
7404018|NCT01342484|11670976|FG002|Overall Study|Other Reasons|0
7404019|NCT01342484|11670974|FG000|Overall Study|Protocol Violation|0
7404020|NCT01342484|11670975|FG001|Overall Study|Protocol Violation|0
7404021|NCT01342484|11670976|FG002|Overall Study|Protocol Violation|1
7404022|NCT01342484|11670974|FG000|Overall Study|Withdrawal by Subject|1
7404023|NCT01342484|11670975|FG001|Overall Study|Withdrawal by Subject|0
7404024|NCT01342484|11670976|FG002|Overall Study|Withdrawal by Subject|0
7404025|NCT01342510|11670988|FG000|Overall Study|Protocol Violation|12
7404026|NCT01342510|11670989|FG001|Overall Study|Protocol Violation|6
7404027|NCT01342510|11670990|FG002|Overall Study|Protocol Violation|13
7404028|NCT01342510|11670991|FG003|Overall Study|Protocol Violation|11
7404029|NCT01342640|11671090|FG000|Overall Study|Adverse Event|3
7404030|NCT01342640|11671090|FG000|Overall Study|Protocol Violation|16
7404031|NCT01342640|11671090|FG000|Overall Study|Lost to Follow-up|21
7404032|NCT01342640|11671090|FG000|Overall Study|Other|1
7404033|NCT01342796|11671113|FG000|Overall Study|Withdrawal by Subject|2
7404034|NCT01342796|11671114|FG001|Overall Study|Withdrawal by Subject|0
7404035|NCT01342796|11671113|FG000|Overall Study|Lost to Follow-up|0
7404036|NCT01342796|11671114|FG001|Overall Study|Lost to Follow-up|3
7404037|NCT01342796|11671113|FG000|Overall Study|Inappropriate enrollment|1
7404038|NCT01342796|11671114|FG001|Overall Study|Inappropriate enrollment|0
7404039|NCT01342887|11671120|FG000|Overall Study|Death|2
7404040|NCT01342913|11671126|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
7404041|NCT01342913|11671127|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7404042|NCT01342913|11671128|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7404043|NCT01342913|11671126|FG000|2-week Run-in Period|Physician Decision|6
7404044|NCT01342913|11671127|FG001|2-week Run-in Period|Physician Decision|0
7404045|NCT01342913|11671128|FG002|2-week Run-in Period|Physician Decision|0
7404046|NCT01342913|11671126|FG000|2-week Run-in Period|Withdrawal by Subject|7
7404047|NCT01342913|11671127|FG001|2-week Run-in Period|Withdrawal by Subject|0
7404048|NCT01342913|11671128|FG002|2-week Run-in Period|Withdrawal by Subject|0
7404049|NCT01342913|11671126|FG000|2-week Run-in Period|Adverse Event|2
7404050|NCT01342913|11671127|FG001|2-week Run-in Period|Adverse Event|0
7404051|NCT01342913|11671128|FG002|2-week Run-in Period|Adverse Event|0
7404052|NCT01342913|11671126|FG000|2-week Run-in Period|Protocol Violation|5
7404053|NCT01342913|11671127|FG001|2-week Run-in Period|Protocol Violation|0
7404054|NCT01342913|11671128|FG002|2-week Run-in Period|Protocol Violation|0
7404055|NCT01342913|11671126|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
7404056|NCT01342913|11671127|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7404057|NCT01342913|11671128|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7404058|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Adverse Event|0
7404059|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Adverse Event|3
7404060|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Adverse Event|6
7404061|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7404062|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
7404063|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
7404064|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Protocol Violation|0
7404065|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Protocol Violation|6
7404066|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Protocol Violation|9
7404067|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7404068|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7404069|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
7404070|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Physician Decision|0
7404071|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Physician Decision|2
7404072|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Physician Decision|0
7404073|NCT01342913|11671126|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7404074|NCT01342913|11671127|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
7404075|NCT01342913|11671128|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
7404076|NCT01342926|11671138|FG000|Overall Study|Adverse Event|5
7404077|NCT01342926|11671139|FG001|Overall Study|Adverse Event|8
7404078|NCT01342926|11671140|FG002|Overall Study|Adverse Event|10
7404079|NCT01342926|11671141|FG003|Overall Study|Adverse Event|7
7404080|NCT01342926|11671138|FG000|Overall Study|Lost to Follow-up|0
7404081|NCT01342926|11671139|FG001|Overall Study|Lost to Follow-up|1
7404082|NCT01342926|11671140|FG002|Overall Study|Lost to Follow-up|1
7404083|NCT01342926|11671141|FG003|Overall Study|Lost to Follow-up|0
7404084|NCT01342926|11671138|FG000|Overall Study|Investigator Discretion|2
7404085|NCT01342926|11671139|FG001|Overall Study|Investigator Discretion|2
7404086|NCT01342926|11671140|FG002|Overall Study|Investigator Discretion|0
7404087|NCT01342926|11671141|FG003|Overall Study|Investigator Discretion|0
7404088|NCT01342926|11671138|FG000|Overall Study|Withdrawal by Subject|2
7404089|NCT01342926|11671139|FG001|Overall Study|Withdrawal by Subject|4
7404090|NCT01342926|11671140|FG002|Overall Study|Withdrawal by Subject|3
7404091|NCT01342926|11671141|FG003|Overall Study|Withdrawal by Subject|5
7404092|NCT01342965|11671153|FG000|Overall Study|Death|58
7404093|NCT01342965|11671154|FG001|Overall Study|Death|57
7404094|NCT01342965|11671153|FG000|Overall Study|Lost to Follow-up|5
7404095|NCT01342965|11671154|FG001|Overall Study|Lost to Follow-up|3
7404096|NCT01342965|11671153|FG000|Overall Study|Other Reasons- Unspecified|44
7404097|NCT01342965|11671154|FG001|Overall Study|Other Reasons- Unspecified|38
7404098|NCT01342965|11671153|FG000|Overall Study|Withdrawal by Subject|2
7404099|NCT01342965|11671154|FG001|Overall Study|Withdrawal by Subject|9
7404100|NCT01343043|11671177|FG000|Overall Study|Disease progression before treatment|1
7404101|NCT01343043|11671178|FG001|Overall Study|Disease progression before treatment|0
7404102|NCT01343043|11671179|FG002|Overall Study|Disease progression before treatment|0
7404103|NCT01343043|11671180|FG003|Overall Study|Disease progression before treatment|0
7404104|NCT01343043|11671177|FG000|Overall Study|Withdrawal by Subject|1
7404105|NCT01343043|11671178|FG001|Overall Study|Withdrawal by Subject|0
7404106|NCT01343043|11671179|FG002|Overall Study|Withdrawal by Subject|0
7404107|NCT01343043|11671180|FG003|Overall Study|Withdrawal by Subject|0
7404108|NCT01343043|11671177|FG000|Overall Study|Death|1
7404109|NCT01343043|11671178|FG001|Overall Study|Death|1
7404110|NCT01343043|11671179|FG002|Overall Study|Death|0
7404111|NCT01343043|11671180|FG003|Overall Study|Death|1
7404112|NCT01343056|11671197|FG000|Overall Study|Lost to Follow-up|7
7404113|NCT01343056|11671198|FG001|Overall Study|Lost to Follow-up|5
7404114|NCT01343056|11671199|FG002|Overall Study|Lost to Follow-up|3
7404115|NCT01343056|11671200|FG003|Overall Study|Lost to Follow-up|9
7404116|NCT01343082|11671214|FG000|The run-in Period|Not meeting criteria|3
7404117|NCT01343082|11671215|FG001|The run-in Period|Not meeting criteria|4
7404118|NCT01343082|11671216|FG002|The run-in Period|Not meeting criteria|5
7404119|NCT01343082|11671214|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
7404120|NCT01343082|11671215|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
7404121|NCT01343082|11671216|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
7404122|NCT01343082|11671214|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
7404123|NCT01343082|11671215|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
7404124|NCT01343082|11671216|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
7404125|NCT01343082|11671214|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
7404126|NCT01343082|11671215|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
7404127|NCT01343082|11671216|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
7404128|NCT01343082|11671214|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
7404129|NCT01343082|11671215|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
7404130|NCT01343082|11671216|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
7404131|NCT01343277|11671254|FG000|Overall Study|Other|3
7404132|NCT01343277|11671255|FG001|Overall Study|Other|3
7404133|NCT01343277|11671254|FG000|Overall Study|Withdrawal by Subject|18
7404134|NCT01343277|11671255|FG001|Overall Study|Withdrawal by Subject|13
7404135|NCT01343277|11671254|FG000|Overall Study|Physician Decision|1
7404136|NCT01343277|11671255|FG001|Overall Study|Physician Decision|2
7404137|NCT01343277|11671254|FG000|Overall Study|Death|10
7404138|NCT01343277|11671255|FG001|Overall Study|Death|1
7404139|NCT01343277|11671254|FG000|Overall Study|Adverse Event|67
7404140|NCT01343277|11671255|FG001|Overall Study|Adverse Event|13
7404141|NCT01343277|11671254|FG000|Overall Study|Disease progression|270
7404142|NCT01343277|11671255|FG001|Overall Study|Disease progression|138
7404143|NCT01343277|11671254|FG000|Overall Study|Randomized not treated|6
7404144|NCT01343277|11671255|FG001|Overall Study|Randomized not treated|21
7404145|NCT01343277|11671254|FG000|Overall Study|Treatment ongoing|8
7317586|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7317587|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
7317588|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
7317589|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Other|0
7317590|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Other|0
7317591|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Other|0
7317592|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Other|0
7317593|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Other|1
7317594|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Other|4
7317595|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Other|0
7317596|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Adverse Event|0
7317597|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Adverse Event|0
7317598|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Adverse Event|0
7317599|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Adverse Event|0
7317600|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Adverse Event|1
7317601|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Adverse Event|0
7317602|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Adverse Event|1
7317603|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7317604|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7317605|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7317606|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7317607|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7404146|NCT01343277|11671255|FG001|Overall Study|Treatment ongoing|2
7404147|NCT01343277|11671254|FG000|Overall Study|Subsequent anticancer therapy|1
7404148|NCT01343277|11671255|FG001|Overall Study|Subsequent anticancer therapy|0
7404149|NCT01343368|11671263|FG000|Overall Study|Death|1
7404150|NCT01343368|11671264|FG001|Overall Study|Death|0
7404151|NCT01343368|11671263|FG000|Overall Study|Lost to Follow-up|1
7404152|NCT01343368|11671264|FG001|Overall Study|Lost to Follow-up|0
7404153|NCT01343407|11671270|FG000|Second Treatment Period (Part 2)|Adverse Event|0
7404154|NCT01343407|11671271|FG001|Second Treatment Period (Part 2)|Adverse Event|0
7404155|NCT01343407|11671272|FG002|Second Treatment Period (Part 2)|Adverse Event|1
7404156|NCT01343407|11671273|FG003|Second Treatment Period (Part 2)|Adverse Event|0
7404157|NCT01343407|11671274|FG004|Second Treatment Period (Part 2)|Adverse Event|0
7404158|NCT01343407|11671275|FG005|Second Treatment Period (Part 2)|Adverse Event|0
7404159|NCT01343407|11671270|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
7404160|NCT01343407|11671271|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
7404161|NCT01343407|11671272|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
7404162|NCT01343407|11671273|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
7404163|NCT01343407|11671274|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
7404164|NCT01343407|11671275|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
7404165|NCT01343693|11671301|FG000|Overall Study|Lost to Follow-up|9
7404166|NCT01343823|11671309|FG000|Overall Study|Study Terminated|1
7404167|NCT01343823|11671310|FG001|Overall Study|Study Terminated|0
7404168|NCT01343823|11671311|FG002|Overall Study|Study Terminated|0
7404169|NCT01343823|11671312|FG003|Overall Study|Study Terminated|1
7404170|NCT01343823|11671309|FG000|Overall Study|Withdrawal by Subject|1
7404171|NCT01343823|11671310|FG001|Overall Study|Withdrawal by Subject|0
7404172|NCT01343823|11671311|FG002|Overall Study|Withdrawal by Subject|0
7404173|NCT01343823|11671312|FG003|Overall Study|Withdrawal by Subject|0
7404174|NCT01343888|11671325|FG000|Overall Study|Adverse Event|12
7404175|NCT01343888|11671326|FG001|Overall Study|Adverse Event|22
7404176|NCT01343888|11671327|FG002|Overall Study|Adverse Event|5
7404177|NCT01343888|11671325|FG000|Overall Study|Lack of Efficacy|9
7404178|NCT01343888|11671326|FG001|Overall Study|Lack of Efficacy|9
7404179|NCT01343888|11671327|FG002|Overall Study|Lack of Efficacy|13
7404180|NCT01343888|11671325|FG000|Overall Study|Lost to Follow-up|0
7404181|NCT01343888|11671326|FG001|Overall Study|Lost to Follow-up|2
7404182|NCT01343888|11671327|FG002|Overall Study|Lost to Follow-up|1
7404183|NCT01343888|11671325|FG000|Overall Study|Protocol Violation|0
7404184|NCT01343888|11671326|FG001|Overall Study|Protocol Violation|2
7404185|NCT01343888|11671327|FG002|Overall Study|Protocol Violation|0
7404186|NCT01343888|11671325|FG000|Overall Study|Withdrawal by Subject|4
7404187|NCT01343888|11671326|FG001|Overall Study|Withdrawal by Subject|4
7404188|NCT01343888|11671327|FG002|Overall Study|Withdrawal by Subject|2
7404189|NCT01343888|11671325|FG000|Overall Study|other than stated above|0
7404190|NCT01343888|11671326|FG001|Overall Study|other than stated above|0
7404191|NCT01343888|11671327|FG002|Overall Study|other than stated above|1
7404192|NCT01343901|11671335|FG000|Overall Study|Death|85
7404193|NCT01343901|11671335|FG000|Overall Study|Physician Decision|4
7404194|NCT01343901|11671335|FG000|Overall Study|Lost to Follow-up|12
7404195|NCT01343901|11671335|FG000|Overall Study|Management by another medical team|11
7404196|NCT01343901|11671335|FG000|Overall Study|Participant decision|1
7404197|NCT01344057|11671339|FG000|Overall Study|Premature Withdrawal|1
7404198|NCT01344161|11671345|FG000|Overall Study|Lost to Follow-up|4
7404199|NCT01344161|11671346|FG001|Overall Study|Lost to Follow-up|1
7404200|NCT01344161|11671345|FG000|Overall Study|Pregnancy|0
7404201|NCT01344161|11671346|FG001|Overall Study|Pregnancy|1
7404202|NCT01344161|11671345|FG000|Overall Study|Protocol Violation|1
7404203|NCT01344161|11671346|FG001|Overall Study|Protocol Violation|1
7404204|NCT01344226|11671352|FG000|Overall Study|Protocol Violation|2
7404205|NCT01344226|11671352|FG000|Overall Study|Withdrawal by Subject|3
7404206|NCT01344226|11671352|FG000|Overall Study|Lack of Efficacy|3
7404207|NCT01344356|11671358|FG000|Overall Study|Physician Decision|0
7404208|NCT01344356|11671359|FG001|Overall Study|Physician Decision|3
7404209|NCT01344356|11671358|FG000|Overall Study|Lost to Follow-up|0
7404210|NCT01344356|11671359|FG001|Overall Study|Lost to Follow-up|6
7404211|NCT01344369|11671369|FG000|Washout of 28 Days|Withdrawal by Subject|1
7404212|NCT01344369|11671370|FG001|Washout of 28 Days|Withdrawal by Subject|0
7404213|NCT01344369|11671369|FG000|Washout of 28 Days|Physician Decision|0
7404214|NCT01344369|11671370|FG001|Washout of 28 Days|Physician Decision|1
7404215|NCT01344369|11671369|FG000|Second Intervention|Emesis within 2 x Tmax|0
7404216|NCT01344369|11671370|FG001|Second Intervention|Emesis within 2 x Tmax|1
7404217|NCT01344447|11671376|FG000|Overall Study|Adverse Event|1
7404218|NCT01344447|11671376|FG000|Overall Study|Protocol Violation|1
7404219|NCT01344447|11671376|FG000|Overall Study|Withdrawal by Subject|1
7404220|NCT01344447|11671376|FG000|Overall Study|The contrast was not seen|1
7404221|NCT01344447|11671376|FG000|Overall Study|Physician Decision|1
7404222|NCT01344447|11671376|FG000|Overall Study|MRA unsuccessful|1
7404223|NCT01344447|11671376|FG000|Overall Study|Bolus tracking failed|1
7404224|NCT01344447|11671376|FG000|Overall Study|Error of power injector|1
7404225|NCT01344460|11671384|FG000|Overall Study|Withdrawal by Subject|1
7404226|NCT01344460|11671384|FG000|Overall Study|Lost to Follow-up|2
7404227|NCT01344538|11671394|FG000|Overall Study|Adverse Event|1
7404228|NCT01344538|11671395|FG001|Overall Study|Adverse Event|1
7404229|NCT01344538|11671394|FG000|Overall Study|Lost to Follow-up|1
7404230|NCT01344538|11671395|FG001|Overall Study|Lost to Follow-up|0
7404231|NCT01344629|11671412|FG000|Crossover Period 2|Withdrawal by Subject|0
7404232|NCT01344629|11671413|FG001|Crossover Period 2|Withdrawal by Subject|1
7404233|NCT01344759|11671421|FG000|Overall Study|Patients failed to reach sedation level|0
7404234|NCT01344759|11671422|FG001|Overall Study|Patients failed to reach sedation level|2
7404235|NCT01344824|11671434|FG000|Overall Study|Adverse Event|15
7404236|NCT01344824|11671434|FG000|Overall Study|Withdrawal by Subject|6
7404237|NCT01344824|11671434|FG000|Overall Study|Other complicating disease|1
7404238|NCT01344824|11671434|FG000|Overall Study|Progression|15
7404239|NCT01344876|11671439|FG000|Overall Study|Adverse Event|0
7404240|NCT01344876|11671440|FG001|Overall Study|Adverse Event|0
7404241|NCT01344876|11671441|FG002|Overall Study|Adverse Event|0
7404242|NCT01344876|11671442|FG003|Overall Study|Adverse Event|0
7404243|NCT01344876|11671443|FG004|Overall Study|Adverse Event|1
7404244|NCT01344876|11671439|FG000|Overall Study|Withdrawal by Subject|0
7404245|NCT01344876|11671440|FG001|Overall Study|Withdrawal by Subject|0
7404246|NCT01344876|11671441|FG002|Overall Study|Withdrawal by Subject|1
7404247|NCT01344876|11671442|FG003|Overall Study|Withdrawal by Subject|0
7404248|NCT01344876|11671443|FG004|Overall Study|Withdrawal by Subject|0
7404249|NCT01344876|11671439|FG000|Overall Study|Definite progression of primary disease|1
7404250|NCT01344876|11671440|FG001|Overall Study|Definite progression of primary disease|0
7404251|NCT01344876|11671441|FG002|Overall Study|Definite progression of primary disease|0
7404252|NCT01344876|11671442|FG003|Overall Study|Definite progression of primary disease|3
7404253|NCT01344876|11671443|FG004|Overall Study|Definite progression of primary disease|0
7404254|NCT01345019|11671458|FG000|Blinded Treatment Phase|Death|147
7404255|NCT01345019|11671459|FG001|Blinded Treatment Phase|Death|137
7404256|NCT01345019|11671458|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
7404257|NCT01345019|11671459|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
7404258|NCT01345019|11671458|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
7404259|NCT01345019|11671459|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
7404260|NCT01345019|11671458|FG000|Blinded Treatment Phase|Disease Progression|12
7404261|NCT01345019|11671459|FG001|Blinded Treatment Phase|Disease Progression|10
7404262|NCT01345019|11671458|FG000|Blinded Treatment Phase|Adverse Event|6
7404263|NCT01345019|11671459|FG001|Blinded Treatment Phase|Adverse Event|13
7404264|NCT01345019|11671458|FG000|Blinded Treatment Phase|Administrative Decision|10
7404265|NCT01345019|11671459|FG001|Blinded Treatment Phase|Administrative Decision|8
7404266|NCT01345019|11671458|FG000|Blinded Treatment Phase|Noncompliance|5
7404267|NCT01345019|11671459|FG001|Blinded Treatment Phase|Noncompliance|3
7404268|NCT01345019|11671458|FG000|Blinded Treatment Phase|Ineligibility Determined|1
7404269|NCT01345019|11671459|FG001|Blinded Treatment Phase|Ineligibility Determined|6
7404270|NCT01345019|11671458|FG000|Blinded Treatment Phase|Protocol Deviation|5
7404271|NCT01345019|11671459|FG001|Blinded Treatment Phase|Protocol Deviation|0
7404272|NCT01345019|11671458|FG000|Blinded Treatment Phase|Other, Not Specified|2
7404273|NCT01345019|11671459|FG001|Blinded Treatment Phase|Other, Not Specified|3
7404274|NCT01345019|11671458|FG000|Blinded Treatment Phase|Lost to Follow-up|6
7404275|NCT01345019|11671459|FG001|Blinded Treatment Phase|Lost to Follow-up|3
7404276|NCT01345019|11671458|FG000|Open Label Treatment Phase|Death|49
7404277|NCT01345019|11671459|FG001|Open Label Treatment Phase|Death|48
7404278|NCT01345019|11671458|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
7404279|NCT01345019|11671459|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
7404280|NCT01345019|11671458|FG000|Open Label Treatment Phase|Adverse Event|30
7404281|NCT01345019|11671459|FG001|Open Label Treatment Phase|Adverse Event|51
7404282|NCT01345019|11671458|FG000|Open Label Treatment Phase|Administrative Decision|30
7404283|NCT01345019|11671459|FG001|Open Label Treatment Phase|Administrative Decision|15
7404284|NCT01345019|11671458|FG000|Open Label Treatment Phase|Disease Progression|17
7404285|NCT01345019|11671459|FG001|Open Label Treatment Phase|Disease Progression|18
7404286|NCT01345019|11671458|FG000|Open Label Treatment Phase|Noncompliance|5
7404287|NCT01345019|11671459|FG001|Open Label Treatment Phase|Noncompliance|4
7404288|NCT01345019|11671458|FG000|Open Label Treatment Phase|Lost to Follow-up|1
7404289|NCT01345019|11671459|FG001|Open Label Treatment Phase|Lost to Follow-up|2
7404290|NCT01345019|11671458|FG000|Open Label Treatment Phase|Pregnancy|1
7404291|NCT01345019|11671459|FG001|Open Label Treatment Phase|Pregnancy|0
7404292|NCT01345019|11671458|FG000|Open Label Treatment Phase|Other, Not Specified|9
7404293|NCT01345019|11671459|FG001|Open Label Treatment Phase|Other, Not Specified|7
7404294|NCT01345019|11671458|FG000|Open Label Treatment Phase|Protocol Violation|0
7404295|NCT01345019|11671459|FG001|Open Label Treatment Phase|Protocol Violation|1
7404296|NCT01345058|11671469|FG000|Overall Study|Withdrawal by Subject|1
7404297|NCT01345058|11671470|FG001|Overall Study|Withdrawal by Subject|0
7404298|NCT01345058|11671469|FG000|Overall Study|Participant Reported Increase in Events|1
7404299|NCT01345058|11671470|FG001|Overall Study|Participant Reported Increase in Events|0
7404300|NCT01345058|11671469|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
7404301|NCT01345058|11671470|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
7404302|NCT01345058|11671469|FG000|Overall Study|Participant Stopped Taking Study Drug|1
7404303|NCT01345058|11671470|FG001|Overall Study|Participant Stopped Taking Study Drug|0
7404304|NCT01345058|11671469|FG000|Overall Study|Participant No-Show at Multiple Visits|1
7404305|NCT01345058|11671470|FG001|Overall Study|Participant No-Show at Multiple Visits|0
7404306|NCT01345123|11671479|FG000|Overall Study|participants no longer with health plan|79
7404307|NCT01345123|11671480|FG001|Overall Study|participants no longer with health plan|85
7404308|NCT01345123|11671481|FG002|Overall Study|participants no longer with health plan|88
7404309|NCT01345162|11671492|FG000|Overall Study|Protocol Violation|2
7404310|NCT01345162|11671493|FG001|Overall Study|Protocol Violation|4
7404311|NCT01345188|11671499|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
7404312|NCT01345188|11671499|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
7404313|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
7404314|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
7404315|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
7404316|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
7404317|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
7404318|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
7404319|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
7404320|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
7404321|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
7404322|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
7404323|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
7404324|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
7404325|NCT01345253|11671508|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
7404326|NCT01345253|11671509|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
7404327|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
7404328|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
7404329|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
7404330|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
7404331|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
7404332|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
7404333|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
7404334|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
7404335|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
7404336|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
7404337|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
7404338|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
7404339|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
7404340|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
7404341|NCT01345253|11671508|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7404342|NCT01345253|11671509|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
7404343|NCT01345292|11671520|FG000|Overall Study|Withdrawal by Subject|2
7404344|NCT01345292|11671521|FG001|Overall Study|Withdrawal by Subject|0
7404345|NCT01345292|11671522|FG002|Overall Study|Withdrawal by Subject|1
7404346|NCT01345318|11671530|FG000|Overall Study|Adverse Event|16
7404347|NCT01345318|11671530|FG000|Overall Study|Lack of Efficacy|17
7404348|NCT01345318|11671530|FG000|Overall Study|Lost to Follow-up|2
7404349|NCT01345318|11671530|FG000|Overall Study|Protocol Violation|1
7404350|NCT01345318|11671530|FG000|Overall Study|Withdrawal by Subject|41
7404351|NCT01345318|11671530|FG000|Overall Study|Other|3
7404352|NCT01345591|11671539|FG000|Overall Study|Lost to Follow-up|1
7404353|NCT01345630|11671550|FG000|Overall Study|Adverse Event|22
7404354|NCT01345630|11671551|FG001|Overall Study|Adverse Event|23
7404355|NCT01345630|11671550|FG000|Overall Study|Lost to Follow-up|17
7404356|NCT01345630|11671551|FG001|Overall Study|Lost to Follow-up|16
7404357|NCT01345630|11671550|FG000|Overall Study|Protocol Violation|4
7404358|NCT01345630|11671551|FG001|Overall Study|Protocol Violation|1
7404359|NCT01345630|11671550|FG000|Overall Study|Medication error without associated AE|0
7404360|NCT01345630|11671551|FG001|Overall Study|Medication error without associated AE|1
7404361|NCT01345630|11671550|FG000|Overall Study|Study terminated by sponsor|254
7404362|NCT01345630|11671551|FG001|Overall Study|Study terminated by sponsor|285
7404363|NCT01345630|11671550|FG000|Overall Study|Other reasons|6
7404364|NCT01345630|11671551|FG001|Overall Study|Other reasons|8
7404365|NCT01345630|11671550|FG000|Overall Study|Withdrawn due to pregnancy|1
7404366|NCT01345630|11671551|FG001|Overall Study|Withdrawn due to pregnancy|2
7404367|NCT01345630|11671550|FG000|Overall Study|No longer willing to participate|9
7404368|NCT01345630|11671551|FG001|Overall Study|No longer willing to participate|12
7404369|NCT01345630|11671550|FG000|Overall Study|Insufficient clinical response|48
7404370|NCT01345630|11671551|FG001|Overall Study|Insufficient clinical response|11
7465708|NCT01882465|11765131|FG006|Period 2|Protocol Violation|0
7468632|NCT01912729|11769518|FG000|Overall Study|Withdrawal by Subject|0
7468633|NCT01912729|11769519|FG001|Overall Study|Withdrawal by Subject|1
7468634|NCT01912768|11769527|FG000|Overall Study|Adverse Event|2
7468635|NCT01912768|11769528|FG001|Overall Study|Adverse Event|0
7468636|NCT01912768|11769527|FG000|Overall Study|Lost to Follow-up|2
7468637|NCT01912768|11769528|FG001|Overall Study|Lost to Follow-up|1
7404371|NCT01345669|11671563|FG000|Overall Study|Primary tumour recurrence|53
7404372|NCT01345669|11671564|FG001|Overall Study|Primary tumour recurrence|32
7404373|NCT01345669|11671563|FG000|Overall Study|Second primary tumour|4
7404374|NCT01345669|11671564|FG001|Overall Study|Second primary tumour|3
7404375|NCT01345669|11671563|FG000|Overall Study|Adverse Event|63
7404376|NCT01345669|11671564|FG001|Overall Study|Adverse Event|9
7404377|NCT01345669|11671563|FG000|Overall Study|Protocol Violation|3
7404378|NCT01345669|11671564|FG001|Overall Study|Protocol Violation|1
7404379|NCT01345669|11671563|FG000|Overall Study|Lost to Follow-up|1
7404380|NCT01345669|11671564|FG001|Overall Study|Lost to Follow-up|1
7404381|NCT01345669|11671563|FG000|Overall Study|Withdrawal by Subject|52
7404382|NCT01345669|11671564|FG001|Overall Study|Withdrawal by Subject|13
7404383|NCT01345669|11671563|FG000|Overall Study|Other Reasons|111
7404384|NCT01345669|11671564|FG001|Overall Study|Other Reasons|60
7404385|NCT01345682|11671572|FG000|Overall Study|Progressive disease per RECIST|226
7404386|NCT01345682|11671573|FG001|Overall Study|Progressive disease per RECIST|93
7404387|NCT01345682|11671572|FG000|Overall Study|Worsening of underlying cancer disease|23
7404388|NCT01345682|11671573|FG001|Overall Study|Worsening of underlying cancer disease|12
7404389|NCT01345682|11671572|FG000|Overall Study|Adverse Event|51
7404390|NCT01345682|11671573|FG001|Overall Study|Adverse Event|41
7404391|NCT01345682|11671572|FG000|Overall Study|Non-compliance with protocol|0
7404392|NCT01345682|11671573|FG001|Overall Study|Non-compliance with protocol|1
7404393|NCT01345682|11671572|FG000|Overall Study|Lost to Follow-up|0
7404394|NCT01345682|11671573|FG001|Overall Study|Lost to Follow-up|1
7404395|NCT01345682|11671572|FG000|Overall Study|Refused to continue trial medication|16
7404396|NCT01345682|11671573|FG001|Overall Study|Refused to continue trial medication|9
7404397|NCT01345682|11671572|FG000|Overall Study|Not treated|2
7404398|NCT01345682|11671573|FG001|Overall Study|Not treated|1
7404399|NCT01345682|11671572|FG000|Overall Study|Reason other than those specified above|4
7404400|NCT01345682|11671573|FG001|Overall Study|Reason other than those specified above|3
7404401|NCT01345929|11671598|FG000|Overall Study|Withdrawal by Subject|9
7404402|NCT01345929|11671599|FG001|Overall Study|Withdrawal by Subject|8
7404403|NCT01345929|11671598|FG000|Overall Study|Lost to Follow-up|9
7404404|NCT01345929|11671599|FG001|Overall Study|Lost to Follow-up|9
7404405|NCT01345929|11671598|FG000|Overall Study|Adverse Event|0
7404406|NCT01345929|11671599|FG001|Overall Study|Adverse Event|1
7404407|NCT01345929|11671598|FG000|Overall Study|Didn't meet eligibility criteria|2
7404408|NCT01345929|11671599|FG001|Overall Study|Didn't meet eligibility criteria|0
7404409|NCT01345929|11671598|FG000|Overall Study|40,000 CFU/ML|1
7404410|NCT01345929|11671599|FG001|Overall Study|40,000 CFU/ML|0
7404411|NCT01345929|11671598|FG000|Overall Study|Patient withdrawal|0
7404412|NCT01345929|11671599|FG001|Overall Study|Patient withdrawal|1
7404413|NCT01346059|11671607|FG000|Overall Study|Withdrawal by Subject|1
7404414|NCT01346059|11671608|FG001|Overall Study|Withdrawal by Subject|0
7404415|NCT01346176|11671630|FG000|Recruited|Protocol Violation|1
7404416|NCT01346176|11671631|FG001|Recruited|Protocol Violation|0
7404417|NCT01346176|11671632|FG002|Recruited|Protocol Violation|0
7404418|NCT01346176|11671630|FG000|Completed Advance Directive|Death|3
7404419|NCT01346176|11671631|FG001|Completed Advance Directive|Death|2
7404420|NCT01346176|11671632|FG002|Completed Advance Directive|Death|2
7404421|NCT01346176|11671630|FG000|Completed Advance Directive|Became Ineligible|3
7404422|NCT01346176|11671631|FG001|Completed Advance Directive|Became Ineligible|0
7404423|NCT01346176|11671632|FG002|Completed Advance Directive|Became Ineligible|1
7404424|NCT01346176|11671630|FG000|Completed Advance Directive|Other reason did not complete AD|7
7404425|NCT01346176|11671631|FG001|Completed Advance Directive|Other reason did not complete AD|12
7404426|NCT01346176|11671632|FG002|Completed Advance Directive|Other reason did not complete AD|7
7404427|NCT01346176|11671630|FG000|Completed Satisfaction Survey|Death|3
7404428|NCT01346176|11671631|FG001|Completed Satisfaction Survey|Death|0
7404429|NCT01346176|11671632|FG002|Completed Satisfaction Survey|Death|2
7404430|NCT01346176|11671630|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
7404431|NCT01346176|11671631|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
7404432|NCT01346176|11671632|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
7404433|NCT01346189|11671644|FG000|Overall Study|Withdrawal by Subject|7
7404434|NCT01346189|11671645|FG001|Overall Study|Withdrawal by Subject|5
7404435|NCT01346189|11671646|FG002|Overall Study|Withdrawal by Subject|3
7404436|NCT01346189|11671647|FG003|Overall Study|Withdrawal by Subject|5
7404437|NCT01346189|11671644|FG000|Overall Study|Physician Decision|4
7404438|NCT01346189|11671645|FG001|Overall Study|Physician Decision|0
7404439|NCT01346189|11671646|FG002|Overall Study|Physician Decision|0
7404440|NCT01346189|11671647|FG003|Overall Study|Physician Decision|0
7404441|NCT01346189|11671644|FG000|Overall Study|Moved|3
7404442|NCT01346189|11671645|FG001|Overall Study|Moved|0
7404443|NCT01346189|11671646|FG002|Overall Study|Moved|4
7404444|NCT01346189|11671647|FG003|Overall Study|Moved|0
7404445|NCT01346189|11671644|FG000|Overall Study|Other|2
7404446|NCT01346189|11671645|FG001|Overall Study|Other|4
7404447|NCT01346189|11671646|FG002|Overall Study|Other|7
7404448|NCT01346189|11671647|FG003|Overall Study|Other|3
7404449|NCT01346189|11671644|FG000|Overall Study|Death|0
7404450|NCT01346189|11671645|FG001|Overall Study|Death|3
7404451|NCT01346189|11671646|FG002|Overall Study|Death|0
7404452|NCT01346189|11671647|FG003|Overall Study|Death|0
7404453|NCT01346189|11671644|FG000|Overall Study|Non-health system primary care physician|0
7404454|NCT01346189|11671645|FG001|Overall Study|Non-health system primary care physician|5
7404455|NCT01346189|11671646|FG002|Overall Study|Non-health system primary care physician|0
7404456|NCT01346189|11671647|FG003|Overall Study|Non-health system primary care physician|0
7404457|NCT01346189|11671644|FG000|Overall Study|Travel|0
7404458|NCT01346189|11671645|FG001|Overall Study|Travel|0
7404459|NCT01346189|11671646|FG002|Overall Study|Travel|0
7404460|NCT01346189|11671647|FG003|Overall Study|Travel|3
7404461|NCT01346293|11671668|FG000|Overall Study|Protocol Violation|30
7404462|NCT01346293|11671669|FG001|Overall Study|Protocol Violation|9
7404463|NCT01346293|11671668|FG000|Overall Study|Lost to Follow-up|21
7404464|NCT01346293|11671669|FG001|Overall Study|Lost to Follow-up|8
7404465|NCT01346293|11671668|FG000|Overall Study|Withdrawal by Subject|15
7404466|NCT01346293|11671669|FG001|Overall Study|Withdrawal by Subject|4
7404467|NCT01346293|11671668|FG000|Overall Study|Other|1
7404468|NCT01346293|11671669|FG001|Overall Study|Other|0
7404469|NCT01346371|11671679|FG000|Overall Study|Lost to Follow-up|2
7404470|NCT01346371|11671680|FG001|Overall Study|Lost to Follow-up|0
7404471|NCT01346410|11671695|FG000|Overall Study|Death|1
7404472|NCT01346475|11671701|FG000|First Intervention|Lost to Follow-up|4
7404473|NCT01346475|11671702|FG001|First Intervention|Lost to Follow-up|3
7404474|NCT01346501|11671714|FG000|Overall Study|Initiated Other Biological Agents|3
7404475|NCT01346501|11671715|FG001|Overall Study|Initiated Other Biological Agents|1
7404476|NCT01346501|11671714|FG000|Overall Study|Other|8
7404477|NCT01346501|11671715|FG001|Overall Study|Other|12
7404478|NCT01346514|11671725|FG000|Overall Study|Lost to Follow-up|19
7404479|NCT01346514|11671726|FG001|Overall Study|Lost to Follow-up|30
7404480|NCT01346514|11671725|FG000|Overall Study|Withdrawal by Subject|7
7404481|NCT01346514|11671726|FG001|Overall Study|Withdrawal by Subject|3
7404482|NCT01346514|11671725|FG000|Overall Study|Death|3
7404483|NCT01346514|11671726|FG001|Overall Study|Death|4
7404484|NCT01346540|11671736|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
7404485|NCT01346540|11671737|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
7404486|NCT01346540|11671736|FG000|Overall Study|Adverse Event|0
7404487|NCT01346540|11671737|FG001|Overall Study|Adverse Event|4
7404488|NCT01346592|11671747|FG000|Overall Study|Lost to Follow-up|62
7404489|NCT01346592|11671748|FG001|Overall Study|Lost to Follow-up|29
7404490|NCT01346592|11671749|FG002|Overall Study|Lost to Follow-up|29
7404491|NCT01346592|11671747|FG000|Overall Study|Protocol Violation|2
7404492|NCT01346592|11671748|FG001|Overall Study|Protocol Violation|1
7404493|NCT01346592|11671749|FG002|Overall Study|Protocol Violation|0
7404494|NCT01346592|11671747|FG000|Overall Study|Death|1
7404495|NCT01346592|11671748|FG001|Overall Study|Death|3
7404496|NCT01346592|11671749|FG002|Overall Study|Death|4
7404497|NCT01346592|11671747|FG000|Overall Study|Adverse Event|0
7404498|NCT01346592|11671748|FG001|Overall Study|Adverse Event|1
7404499|NCT01346592|11671749|FG002|Overall Study|Adverse Event|0
7404500|NCT01346592|11671747|FG000|Overall Study|Withdrawal by Subject|77
7404501|NCT01346592|11671748|FG001|Overall Study|Withdrawal by Subject|51
7404502|NCT01346592|11671749|FG002|Overall Study|Withdrawal by Subject|38
7404503|NCT01346592|11671747|FG000|Overall Study|Inappropriate enrollment|3
7404504|NCT01346592|11671748|FG001|Overall Study|Inappropriate enrollment|1
7404505|NCT01346592|11671749|FG002|Overall Study|Inappropriate enrollment|1
7404506|NCT01346592|11671747|FG000|Overall Study|Administrative reason|1
7404507|NCT01346592|11671748|FG001|Overall Study|Administrative reason|0
7404508|NCT01346592|11671749|FG002|Overall Study|Administrative reason|0
7404509|NCT01346592|11671747|FG000|Overall Study|Unable to Classify|7
7404510|NCT01346592|11671748|FG001|Overall Study|Unable to Classify|3
7404511|NCT01346592|11671749|FG002|Overall Study|Unable to Classify|6
7404512|NCT01346696|11671778|FG000|Overall Study|Death|1
7404513|NCT01346774|11671784|FG000|Overall Study|Did not take a single dose|6
7404514|NCT01346774|11671785|FG001|Overall Study|Did not take a single dose|4
7404515|NCT01346774|11671784|FG000|Overall Study|Lost to Follow-up|3
7404516|NCT01346774|11671785|FG001|Overall Study|Lost to Follow-up|4
7404517|NCT01346774|11671784|FG000|Overall Study|Withdrawal by Subject|1
7404518|NCT01346774|11671785|FG001|Overall Study|Withdrawal by Subject|4
7404519|NCT01346774|11671784|FG000|Overall Study|Protocol Violation|2
7404520|NCT01346774|11671785|FG001|Overall Study|Protocol Violation|3
7404521|NCT01346774|11671784|FG000|Overall Study|Adverse Event|1
7404522|NCT01346774|11671785|FG001|Overall Study|Adverse Event|2
7404523|NCT01346969|11671813|FG000|Overall Study|Withdrawal by Subject|0
7404524|NCT01346969|11671814|FG001|Overall Study|Withdrawal by Subject|0
7404525|NCT01346969|11671815|FG002|Overall Study|Withdrawal by Subject|1
7404526|NCT01346969|11671816|FG003|Overall Study|Withdrawal by Subject|0
7404527|NCT01346969|11671813|FG000|Overall Study|Lost to Follow-up|1
7404528|NCT01346969|11671814|FG001|Overall Study|Lost to Follow-up|0
7404529|NCT01346969|11671815|FG002|Overall Study|Lost to Follow-up|2
7404530|NCT01346969|11671816|FG003|Overall Study|Lost to Follow-up|0
7404531|NCT01346969|11671813|FG000|Overall Study|Physician Decision|0
7404532|NCT01346969|11671814|FG001|Overall Study|Physician Decision|0
7404533|NCT01346969|11671815|FG002|Overall Study|Physician Decision|0
7404534|NCT01346969|11671816|FG003|Overall Study|Physician Decision|1
7404535|NCT01346969|11671813|FG000|Overall Study|Randomized but not treated|1
7404536|NCT01346969|11671814|FG001|Overall Study|Randomized but not treated|0
7404537|NCT01346969|11671815|FG002|Overall Study|Randomized but not treated|0
7404538|NCT01346969|11671816|FG003|Overall Study|Randomized but not treated|0
7404539|NCT01347073|11671853|FG000|Overall Study|Adverse Event|1
7404540|NCT01347073|11671853|FG000|Overall Study|Liver Transplant|1
7404541|NCT01347086|11671873|FG000|Overall Study|failed screening visit|0
7404542|NCT01347086|11671874|FG001|Overall Study|failed screening visit|0
7404543|NCT01347086|11671875|FG002|Overall Study|failed screening visit|1
7404544|NCT01347086|11671876|FG003|Overall Study|failed screening visit|0
7404545|NCT01347086|11671877|FG004|Overall Study|failed screening visit|0
7404546|NCT01347086|11671878|FG005|Overall Study|failed screening visit|0
7404547|NCT01347086|11671879|FG006|Overall Study|failed screening visit|1
7404548|NCT01347086|11671880|FG007|Overall Study|failed screening visit|1
7404549|NCT01347086|11671881|FG008|Overall Study|failed screening visit|0
7404550|NCT01347086|11671882|FG009|Overall Study|failed screening visit|1
7404551|NCT01347112|11671916|FG000|Overall Study|Withdrawal by Subject|1
7404552|NCT01347112|11671917|FG001|Overall Study|Withdrawal by Subject|7
7404553|NCT01347112|11671916|FG000|Overall Study|Lost to Follow-up|3
7404554|NCT01347112|11671917|FG001|Overall Study|Lost to Follow-up|5
7404555|NCT01347307|11671933|FG000|Overall Study|Death|0
7404556|NCT01347307|11671934|FG001|Overall Study|Death|4
7404557|NCT01347307|11671933|FG000|Overall Study|Physician Decision|0
7404558|NCT01347307|11671934|FG001|Overall Study|Physician Decision|1
7404559|NCT01347554|11671960|FG000|Overall Study|Lack of Efficacy|7
7404560|NCT01347554|11671961|FG001|Overall Study|Lack of Efficacy|11
7404561|NCT01347580|11671969|FG000|Overall Study|Withdrawal by Subject|13
7404562|NCT01347580|11671970|FG001|Overall Study|Withdrawal by Subject|23
7404563|NCT01347580|11671969|FG000|Overall Study|Death|30
7404564|NCT01347580|11671970|FG001|Overall Study|Death|19
7404565|NCT01347580|11671969|FG000|Overall Study|Protocol Violation|10
7404566|NCT01347580|11671970|FG001|Overall Study|Protocol Violation|7
7404567|NCT01347580|11671969|FG000|Overall Study|Lost to Follow-up|3
7404568|NCT01347580|11671970|FG001|Overall Study|Lost to Follow-up|1
7404569|NCT01347580|11671969|FG000|Overall Study|Had other reason|9
7404570|NCT01347580|11671970|FG001|Overall Study|Had other reason|6
7404571|NCT01347710|11671976|FG000|Overall Study|Withdrawal by Subject|2
7404572|NCT01347710|11671976|FG000|Overall Study|Adverse Event|4
7404573|NCT01347710|11671976|FG000|Overall Study|Angio or SPECT not completed|18
7404574|NCT01347710|11671976|FG000|Overall Study|issue with vitals prior to dosing|1
7404575|NCT01347710|11671976|FG000|Overall Study|Lost to Follow-up|1
7404576|NCT01347710|11671976|FG000|Overall Study|Physician Decision|2
7404577|NCT01347710|11671976|FG000|Overall Study|Other|3
7404578|NCT01347762|11671988|FG000|Overall Study|Lost to Follow-up|0
7404579|NCT01347762|11671989|FG001|Overall Study|Lost to Follow-up|1
7404580|NCT01347762|11671990|FG002|Overall Study|Lost to Follow-up|6
7404581|NCT01347762|11671991|FG003|Overall Study|Lost to Follow-up|5
7404582|NCT01347762|11671988|FG000|Overall Study|Withdrawal by Subject|4
7404583|NCT01347762|11671989|FG001|Overall Study|Withdrawal by Subject|1
7404584|NCT01347762|11671990|FG002|Overall Study|Withdrawal by Subject|3
7404585|NCT01347762|11671991|FG003|Overall Study|Withdrawal by Subject|3
7404586|NCT01347866|11672028|FG000|Overall Study|Death|0
7404587|NCT01347866|11672029|FG001|Overall Study|Death|0
7404588|NCT01347866|11672030|FG002|Overall Study|Death|0
7404589|NCT01347866|11672031|FG003|Overall Study|Death|1
7404590|NCT01347866|11672032|FG004|Overall Study|Death|2
7404591|NCT01347866|11672033|FG005|Overall Study|Death|2
7404592|NCT01347866|11672034|FG006|Overall Study|Death|1
7404593|NCT01347866|11672035|FG007|Overall Study|Death|0
7404594|NCT01347866|11672036|FG008|Overall Study|Death|4
7404595|NCT01347866|11672037|FG009|Overall Study|Death|1
7404596|NCT01347866|11672038|FG010|Overall Study|Death|3
7404597|NCT01347866|11672039|FG011|Overall Study|Death|1
7404598|NCT01347866|11672040|FG012|Overall Study|Death|2
7404599|NCT01347866|11672041|FG013|Overall Study|Death|0
7404600|NCT01347866|11672042|FG014|Overall Study|Death|0
7404601|NCT01347866|11672043|FG015|Overall Study|Death|1
7404602|NCT01347866|11672044|FG016|Overall Study|Death|0
7404603|NCT01347866|11672028|FG000|Overall Study|Lost to Follow-up|0
7404604|NCT01347866|11672029|FG001|Overall Study|Lost to Follow-up|0
7404605|NCT01347866|11672030|FG002|Overall Study|Lost to Follow-up|0
7404606|NCT01347866|11672031|FG003|Overall Study|Lost to Follow-up|0
7404607|NCT01347866|11672032|FG004|Overall Study|Lost to Follow-up|0
7404608|NCT01347866|11672033|FG005|Overall Study|Lost to Follow-up|0
7404609|NCT01347866|11672034|FG006|Overall Study|Lost to Follow-up|0
7404610|NCT01347866|11672035|FG007|Overall Study|Lost to Follow-up|1
7404611|NCT01347866|11672036|FG008|Overall Study|Lost to Follow-up|1
7404612|NCT01347866|11672037|FG009|Overall Study|Lost to Follow-up|0
7404613|NCT01347866|11672038|FG010|Overall Study|Lost to Follow-up|0
7404614|NCT01347866|11672039|FG011|Overall Study|Lost to Follow-up|0
7404615|NCT01347866|11672040|FG012|Overall Study|Lost to Follow-up|0
7404616|NCT01347866|11672041|FG013|Overall Study|Lost to Follow-up|0
7404617|NCT01347866|11672042|FG014|Overall Study|Lost to Follow-up|0
7404618|NCT01347866|11672043|FG015|Overall Study|Lost to Follow-up|0
7404619|NCT01347866|11672044|FG016|Overall Study|Lost to Follow-up|0
7404620|NCT01347866|11672028|FG000|Overall Study|Other|3
7404621|NCT01347866|11672029|FG001|Overall Study|Other|1
7404622|NCT01347866|11672030|FG002|Overall Study|Other|1
7404623|NCT01347866|11672031|FG003|Overall Study|Other|4
7404624|NCT01347866|11672032|FG004|Overall Study|Other|5
7404625|NCT01347866|11672033|FG005|Overall Study|Other|0
7404626|NCT01347866|11672034|FG006|Overall Study|Other|5
7404627|NCT01347866|11672035|FG007|Overall Study|Other|3
7404628|NCT01347866|11672036|FG008|Overall Study|Other|22
7404629|NCT01347866|11672037|FG009|Overall Study|Other|5
7404630|NCT01347866|11672038|FG010|Overall Study|Other|0
7404631|NCT01347866|11672039|FG011|Overall Study|Other|3
7404632|NCT01347866|11672040|FG012|Overall Study|Other|4
7404633|NCT01347866|11672041|FG013|Overall Study|Other|4
7404634|NCT01347866|11672042|FG014|Overall Study|Other|2
7404635|NCT01347866|11672043|FG015|Overall Study|Other|3
7404636|NCT01347866|11672044|FG016|Overall Study|Other|0
7404637|NCT01347866|11672028|FG000|Overall Study|Subject refused further follow-up|2
7404638|NCT01347866|11672029|FG001|Overall Study|Subject refused further follow-up|0
7404639|NCT01347866|11672030|FG002|Overall Study|Subject refused further follow-up|0
7404640|NCT01347866|11672031|FG003|Overall Study|Subject refused further follow-up|2
7404641|NCT01347866|11672032|FG004|Overall Study|Subject refused further follow-up|0
7404642|NCT01347866|11672033|FG005|Overall Study|Subject refused further follow-up|1
7404643|NCT01347866|11672034|FG006|Overall Study|Subject refused further follow-up|0
7404644|NCT01347866|11672035|FG007|Overall Study|Subject refused further follow-up|0
7404645|NCT01347866|11672036|FG008|Overall Study|Subject refused further follow-up|4
7404646|NCT01347866|11672037|FG009|Overall Study|Subject refused further follow-up|1
7404647|NCT01347866|11672038|FG010|Overall Study|Subject refused further follow-up|0
7404648|NCT01347866|11672039|FG011|Overall Study|Subject refused further follow-up|0
7404649|NCT01347866|11672040|FG012|Overall Study|Subject refused further follow-up|1
7404650|NCT01347866|11672041|FG013|Overall Study|Subject refused further follow-up|3
7404651|NCT01347866|11672042|FG014|Overall Study|Subject refused further follow-up|1
7404652|NCT01347866|11672043|FG015|Overall Study|Subject refused further follow-up|0
7404653|NCT01347866|11672044|FG016|Overall Study|Subject refused further follow-up|2
7404654|NCT01347879|11672117|FG000|Overall Study|Adverse Event|0
7404655|NCT01347879|11672118|FG001|Overall Study|Adverse Event|12
7404656|NCT01347879|11672117|FG000|Overall Study|Lost to Follow-up|2
7404657|NCT01347879|11672118|FG001|Overall Study|Lost to Follow-up|0
7404658|NCT01347879|11672117|FG000|Overall Study|Withdrawal by Subject|3
7404659|NCT01347879|11672118|FG001|Overall Study|Withdrawal by Subject|2
7404660|NCT01347879|11672117|FG000|Overall Study|Other|2
7404661|NCT01347879|11672118|FG001|Overall Study|Other|3
7404662|NCT01347931|11672124|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
7404663|NCT01348087|11672130|FG000|Overall Study|Unsatisfactory therapeutic effect|35
7404664|NCT01348087|11672130|FG000|Overall Study|Administrative problems|79
7404665|NCT01348087|11672130|FG000|Overall Study|protocol deviation|1
7404666|NCT01348087|11672130|FG000|Overall Study|Lost to Follow-up|1
7404667|NCT01348087|11672130|FG000|Overall Study|Subject withdrew consent|7
7404668|NCT01348087|11672130|FG000|Overall Study|Adverse Event|25
7404669|NCT01348100|11672151|FG000|Overall Study|Subject Withdrew Consent|0
7404670|NCT01348100|11672152|FG001|Overall Study|Subject Withdrew Consent|0
7404671|NCT01348100|11672153|FG002|Overall Study|Subject Withdrew Consent|2
7404672|NCT01348100|11672154|FG003|Overall Study|Subject Withdrew Consent|0
7404673|NCT01348100|11672155|FG004|Overall Study|Subject Withdrew Consent|1
7404674|NCT01348100|11672156|FG005|Overall Study|Subject Withdrew Consent|0
7404675|NCT01348100|11672157|FG006|Overall Study|Subject Withdrew Consent|1
7404676|NCT01348100|11672151|FG000|Overall Study|Protocol Deviation|0
7404677|NCT01348100|11672152|FG001|Overall Study|Protocol Deviation|0
7404678|NCT01348100|11672153|FG002|Overall Study|Protocol Deviation|0
7404679|NCT01348100|11672154|FG003|Overall Study|Protocol Deviation|1
7404680|NCT01348100|11672155|FG004|Overall Study|Protocol Deviation|0
7404681|NCT01348100|11672156|FG005|Overall Study|Protocol Deviation|0
7404682|NCT01348100|11672157|FG006|Overall Study|Protocol Deviation|0
7404683|NCT01348100|11672151|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
7404684|NCT01348100|11672152|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7404685|NCT01348100|11672153|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
7404686|NCT01348100|11672154|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
7404687|NCT01348100|11672155|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
7404688|NCT01348100|11672156|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
7404689|NCT01348100|11672157|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
7404690|NCT01348100|11672151|FG000|Overall Study|Lost to Follow-up|0
7404691|NCT01348100|11672152|FG001|Overall Study|Lost to Follow-up|0
7404692|NCT01348100|11672153|FG002|Overall Study|Lost to Follow-up|0
7404693|NCT01348100|11672154|FG003|Overall Study|Lost to Follow-up|0
7404694|NCT01348100|11672155|FG004|Overall Study|Lost to Follow-up|0
7404695|NCT01348100|11672156|FG005|Overall Study|Lost to Follow-up|0
7404696|NCT01348100|11672157|FG006|Overall Study|Lost to Follow-up|1
7404697|NCT01348100|11672151|FG000|Overall Study|Administrative Problems|0
7404698|NCT01348100|11672152|FG001|Overall Study|Administrative Problems|0
7404699|NCT01348100|11672153|FG002|Overall Study|Administrative Problems|0
7404700|NCT01348100|11672154|FG003|Overall Study|Administrative Problems|0
7404701|NCT01348100|11672155|FG004|Overall Study|Administrative Problems|0
7404702|NCT01348100|11672156|FG005|Overall Study|Administrative Problems|1
7404703|NCT01348100|11672157|FG006|Overall Study|Administrative Problems|1
7404704|NCT01348139|11672178|FG000|Period 1|Adverse Event|1
7404705|NCT01348139|11672179|FG001|Period 1|Adverse Event|0
7404706|NCT01348139|11672180|FG002|Period 1|Adverse Event|0
7404707|NCT01348139|11672181|FG003|Period 1|Adverse Event|0
7404708|NCT01348139|11672182|FG004|Period 1|Adverse Event|0
7404709|NCT01348139|11672183|FG005|Period 1|Adverse Event|0
7404710|NCT01348165|11672204|FG000|Overall Study|Adverse Event|0
7404711|NCT01348165|11672205|FG001|Overall Study|Adverse Event|0
7404712|NCT01348165|11672206|FG002|Overall Study|Adverse Event|0
7404713|NCT01348165|11672207|FG003|Overall Study|Adverse Event|0
7404714|NCT01348165|11672208|FG004|Overall Study|Adverse Event|0
7404715|NCT01348165|11672209|FG005|Overall Study|Adverse Event|0
7404716|NCT01348165|11672210|FG006|Overall Study|Adverse Event|1
7404717|NCT01348347|11672233|FG000|Overall Study|Withdrawal by Subject|1
7404718|NCT01348347|11672234|FG001|Overall Study|Withdrawal by Subject|1
7404719|NCT01348347|11672235|FG002|Overall Study|Withdrawal by Subject|1
7404720|NCT01348347|11672233|FG000|Overall Study|Progressive disease|2
7404721|NCT01348347|11672234|FG001|Overall Study|Progressive disease|5
7404722|NCT01348347|11672235|FG002|Overall Study|Progressive disease|5
7404723|NCT01348425|11672246|FG000|Overall Study|Imaging was not taken.|1
7404724|NCT01348425|11672247|FG001|Overall Study|Imaging was not taken.|1
7404725|NCT01348490|11672252|FG000|Overall Study|Death|1
7404726|NCT01348490|11672252|FG000|Overall Study|Adverse Event|3
7404727|NCT01348490|11672252|FG000|Overall Study|Consent withdrawn|7
7404728|NCT01348490|11672252|FG000|Overall Study|Disease progression|3
7404729|NCT01348490|11672252|FG000|Overall Study|Lost to Follow-up|1
7404730|NCT01348490|11672252|FG000|Overall Study|Termination of clinical trial by sponsor|1
7404731|NCT01348490|11672252|FG000|Overall Study|Other Unspecified|8
7404732|NCT01348542|11672275|FG000|Overall Study|Withdrawal by Subject|3
7404733|NCT01348542|11672276|FG001|Overall Study|Withdrawal by Subject|0
7404734|NCT01348698|11672295|FG000|Overall Study|Does not meet lesion size criteria|1
7404735|NCT01348698|11672295|FG000|Overall Study|Death|3
7404736|NCT01348698|11672295|FG000|Overall Study|PI decision to close study|68
7404737|NCT01348763|11672299|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
7404738|NCT01348763|11672299|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
7404739|NCT01348776|11672303|FG000|Overall Study|Lost to Follow-up|3
7404740|NCT01348789|11672316|FG000|Overall Study|Protocol Violation|2
7404741|NCT01348789|11672316|FG000|Overall Study|Withdrawal by Subject|2
7404742|NCT01348828|11672327|FG000|Overall Study|Death|20
7404743|NCT01348828|11672327|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
7404744|NCT01348828|11672327|FG000|Overall Study|Conversion|2
7404745|NCT01348828|11672327|FG000|Overall Study|missed visit|1
7404746|NCT01348854|11672333|FG000|Overall Study|Lost to Follow-up|2
7404747|NCT01348854|11672334|FG001|Overall Study|Lost to Follow-up|1
7404748|NCT01348854|11672333|FG000|Overall Study|Withdrawal by Subject|1
7404749|NCT01348854|11672334|FG001|Overall Study|Withdrawal by Subject|0
7404750|NCT01349036|11672342|FG000|Overall Study|Disease progression|13
7404751|NCT01349036|11672343|FG001|Overall Study|Disease progression|22
7404752|NCT01349036|11672342|FG000|Overall Study|Other|1
7404753|NCT01349036|11672343|FG001|Overall Study|Other|0
7404754|NCT01349036|11672342|FG000|Overall Study|Withdrawal by Subject|0
7404755|NCT01349036|11672343|FG001|Overall Study|Withdrawal by Subject|2
7404756|NCT01349049|11672362|FG000|Overall Study|Disease progression|3
7404757|NCT01349049|11672363|FG001|Overall Study|Disease progression|5
7404758|NCT01349049|11672364|FG002|Overall Study|Disease progression|3
7404759|NCT01349049|11672365|FG003|Overall Study|Disease progression|2
7404760|NCT01349049|11672366|FG004|Overall Study|Disease progression|2
7404761|NCT01349049|11672367|FG005|Overall Study|Disease progression|2
7404762|NCT01349049|11672368|FG006|Overall Study|Disease progression|3
7404763|NCT01349049|11672369|FG007|Overall Study|Disease progression|2
7404764|NCT01349049|11672370|FG008|Overall Study|Disease progression|33
7404765|NCT01349049|11672362|FG000|Overall Study|Adverse Event|0
7404766|NCT01349049|11672363|FG001|Overall Study|Adverse Event|1
7404767|NCT01349049|11672364|FG002|Overall Study|Adverse Event|0
7404768|NCT01349049|11672365|FG003|Overall Study|Adverse Event|0
7404769|NCT01349049|11672366|FG004|Overall Study|Adverse Event|0
7404770|NCT01349049|11672367|FG005|Overall Study|Adverse Event|3
7404771|NCT01349049|11672368|FG006|Overall Study|Adverse Event|1
7404772|NCT01349049|11672369|FG007|Overall Study|Adverse Event|0
7404773|NCT01349049|11672370|FG008|Overall Study|Adverse Event|4
7404774|NCT01349049|11672362|FG000|Overall Study|Physician Decision|0
7404775|NCT01349049|11672363|FG001|Overall Study|Physician Decision|1
7404776|NCT01349049|11672364|FG002|Overall Study|Physician Decision|0
7404777|NCT01349049|11672365|FG003|Overall Study|Physician Decision|0
7404778|NCT01349049|11672366|FG004|Overall Study|Physician Decision|0
7404779|NCT01349049|11672367|FG005|Overall Study|Physician Decision|0
7404780|NCT01349049|11672368|FG006|Overall Study|Physician Decision|0
7404781|NCT01349049|11672369|FG007|Overall Study|Physician Decision|0
7404782|NCT01349049|11672370|FG008|Overall Study|Physician Decision|2
7404783|NCT01349049|11672362|FG000|Overall Study|Protocol Violation|0
7404784|NCT01349049|11672363|FG001|Overall Study|Protocol Violation|0
7404785|NCT01349049|11672364|FG002|Overall Study|Protocol Violation|0
7404786|NCT01349049|11672365|FG003|Overall Study|Protocol Violation|0
7404787|NCT01349049|11672366|FG004|Overall Study|Protocol Violation|0
7404788|NCT01349049|11672367|FG005|Overall Study|Protocol Violation|0
7404789|NCT01349049|11672368|FG006|Overall Study|Protocol Violation|0
7404790|NCT01349049|11672369|FG007|Overall Study|Protocol Violation|0
7404791|NCT01349049|11672370|FG008|Overall Study|Protocol Violation|1
7404792|NCT01349049|11672362|FG000|Overall Study|Hematopoietic stem cell transplant|0
7404793|NCT01349049|11672363|FG001|Overall Study|Hematopoietic stem cell transplant|0
7404794|NCT01349049|11672364|FG002|Overall Study|Hematopoietic stem cell transplant|0
7404795|NCT01349049|11672365|FG003|Overall Study|Hematopoietic stem cell transplant|0
7404796|NCT01349049|11672366|FG004|Overall Study|Hematopoietic stem cell transplant|1
7404797|NCT01349049|11672367|FG005|Overall Study|Hematopoietic stem cell transplant|0
7404798|NCT01349049|11672368|FG006|Overall Study|Hematopoietic stem cell transplant|1
7404799|NCT01349049|11672369|FG007|Overall Study|Hematopoietic stem cell transplant|1
7404800|NCT01349049|11672370|FG008|Overall Study|Hematopoietic stem cell transplant|0
7404801|NCT01349049|11672362|FG000|Overall Study|Other|0
7404802|NCT01349049|11672363|FG001|Overall Study|Other|0
7404803|NCT01349049|11672364|FG002|Overall Study|Other|0
7404804|NCT01349049|11672365|FG003|Overall Study|Other|0
7404805|NCT01349049|11672366|FG004|Overall Study|Other|0
7404806|NCT01349049|11672367|FG005|Overall Study|Other|1
7404807|NCT01349049|11672368|FG006|Overall Study|Other|0
7404808|NCT01349049|11672369|FG007|Overall Study|Other|0
7404809|NCT01349049|11672370|FG008|Overall Study|Other|4
7404810|NCT01349049|11672362|FG000|Overall Study|Death|0
7404811|NCT01349049|11672363|FG001|Overall Study|Death|0
7404812|NCT01349049|11672364|FG002|Overall Study|Death|0
7404813|NCT01349049|11672365|FG003|Overall Study|Death|0
7404814|NCT01349049|11672366|FG004|Overall Study|Death|0
7404815|NCT01349049|11672367|FG005|Overall Study|Death|0
7404816|NCT01349049|11672368|FG006|Overall Study|Death|0
7404817|NCT01349049|11672369|FG007|Overall Study|Death|1
7404818|NCT01349049|11672370|FG008|Overall Study|Death|5
7404819|NCT01349049|11672362|FG000|Overall Study|Non-compliance|0
7404820|NCT01349049|11672363|FG001|Overall Study|Non-compliance|0
7404821|NCT01349049|11672364|FG002|Overall Study|Non-compliance|0
7404822|NCT01349049|11672365|FG003|Overall Study|Non-compliance|1
7404823|NCT01349049|11672366|FG004|Overall Study|Non-compliance|0
7404824|NCT01349049|11672367|FG005|Overall Study|Non-compliance|0
7404825|NCT01349049|11672368|FG006|Overall Study|Non-compliance|0
7404826|NCT01349049|11672369|FG007|Overall Study|Non-compliance|0
7404827|NCT01349049|11672370|FG008|Overall Study|Non-compliance|0
7404828|NCT01349049|11672362|FG000|Overall Study|Withdrawal by Subject|0
7404829|NCT01349049|11672363|FG001|Overall Study|Withdrawal by Subject|0
7404830|NCT01349049|11672364|FG002|Overall Study|Withdrawal by Subject|0
7404831|NCT01349049|11672365|FG003|Overall Study|Withdrawal by Subject|0
7404832|NCT01349049|11672366|FG004|Overall Study|Withdrawal by Subject|0
7404833|NCT01349049|11672367|FG005|Overall Study|Withdrawal by Subject|0
7404834|NCT01349049|11672368|FG006|Overall Study|Withdrawal by Subject|0
7404835|NCT01349049|11672369|FG007|Overall Study|Withdrawal by Subject|0
7404836|NCT01349049|11672370|FG008|Overall Study|Withdrawal by Subject|6
7404837|NCT01349192|11672419|FG000|Overall Study|Protocol Violation|0
7404838|NCT01349192|11672420|FG001|Overall Study|Protocol Violation|1
7404839|NCT01349192|11672419|FG000|Overall Study|Withdrawal by Subject|0
7404840|NCT01349192|11672420|FG001|Overall Study|Withdrawal by Subject|2
7404841|NCT01349192|11672419|FG000|Overall Study|Lost to Follow-up|1
7404842|NCT01349192|11672420|FG001|Overall Study|Lost to Follow-up|3
7404843|NCT01349192|11672419|FG000|Overall Study|Failure to adhere to Protocol|2
7404844|NCT01349192|11672420|FG001|Overall Study|Failure to adhere to Protocol|0
7404845|NCT01349465|11672434|FG000|Overall Study|Adverse Event|1
7404846|NCT01349465|11672435|FG001|Overall Study|Adverse Event|0
7404847|NCT01349465|11672434|FG000|Overall Study|Death|3
7404848|NCT01349465|11672435|FG001|Overall Study|Death|0
7404849|NCT01349465|11672434|FG000|Overall Study|Lost to Follow-up|10
7404850|NCT01349465|11672435|FG001|Overall Study|Lost to Follow-up|1
7404851|NCT01349465|11672434|FG000|Overall Study|Withdrawal by Subject|4
7404852|NCT01349465|11672435|FG001|Overall Study|Withdrawal by Subject|2
7404853|NCT01349465|11672434|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
7404854|NCT01349465|11672435|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
7404855|NCT01349569|11672452|FG000|Overall Study|Lack of Efficacy|4
7404856|NCT01349660|11672462|FG000|Overall Study|Still Receiving Study Treatment|0
7404857|NCT01349660|11672463|FG001|Overall Study|Still Receiving Study Treatment|0
7404858|NCT01349660|11672464|FG002|Overall Study|Still Receiving Study Treatment|1
7404859|NCT01349660|11672462|FG000|Overall Study|Disease Progression|2
7404860|NCT01349660|11672463|FG001|Overall Study|Disease Progression|4
7404861|NCT01349660|11672464|FG002|Overall Study|Disease Progression|50
7404862|NCT01349660|11672462|FG000|Overall Study|Adverse Event|1
7404863|NCT01349660|11672463|FG001|Overall Study|Adverse Event|1
7404864|NCT01349660|11672464|FG002|Overall Study|Adverse Event|12
7404865|NCT01349660|11672462|FG000|Overall Study|Withdrawal by Subject|2
7404866|NCT01349660|11672463|FG001|Overall Study|Withdrawal by Subject|0
7404867|NCT01349660|11672464|FG002|Overall Study|Withdrawal by Subject|9
7404868|NCT01349660|11672462|FG000|Overall Study|Death|1
7404869|NCT01349660|11672463|FG001|Overall Study|Death|1
7404870|NCT01349660|11672464|FG002|Overall Study|Death|0
7404871|NCT01349660|11672462|FG000|Overall Study|Non-Permitted Interventions|0
7404872|NCT01349660|11672463|FG001|Overall Study|Non-Permitted Interventions|0
7404873|NCT01349660|11672464|FG002|Overall Study|Non-Permitted Interventions|2
7404874|NCT01349660|11672462|FG000|Overall Study|Study Compliance|0
7404875|NCT01349660|11672463|FG001|Overall Study|Study Compliance|0
7404876|NCT01349660|11672464|FG002|Overall Study|Study Compliance|1
7404877|NCT01349660|11672462|FG000|Overall Study|Declining Performance Status|0
7404878|NCT01349660|11672463|FG001|Overall Study|Declining Performance Status|0
7404879|NCT01349660|11672464|FG002|Overall Study|Declining Performance Status|1
7404880|NCT01349673|11672479|FG000|Overall Study|Progression Of Disease Past 40 cm|1
7404881|NCT01349673|11672479|FG000|Overall Study|No Longer Qualified For Study|1
7404882|NCT01349673|11672479|FG000|Overall Study|Site Closure|10
7404883|NCT01349673|11672479|FG000|Overall Study|Withdrawal by Subject|21
7404884|NCT01349673|11672479|FG000|Overall Study|Lost to Follow-up|6
7404885|NCT01349673|11672479|FG000|Overall Study|Adverse Event|17
7404886|NCT01349673|11672479|FG000|Overall Study|Study Terminated By Sponsor|50
7404887|NCT01349673|11672479|FG000|Overall Study|Lack of Efficacy|8
7404888|NCT01349790|11672483|FG000|Overall Study|Investigator Judgement|3
7404889|NCT01349790|11672483|FG000|Overall Study|Death|2
7404890|NCT01349790|11672483|FG000|Overall Study|Withdrawal by Patient|2
7404891|NCT01349790|11672483|FG000|Overall Study|Adverse Event|1
7404892|NCT01349790|11672483|FG000|Overall Study|Lost to Follow-up|1
7404893|NCT01349803|11672491|FG000|Overall Study|Adverse Event|0
7404894|NCT01349803|11672492|FG001|Overall Study|Adverse Event|0
7404895|NCT01349803|11672493|FG002|Overall Study|Adverse Event|0
7404896|NCT01349803|11672494|FG003|Overall Study|Adverse Event|2
7404897|NCT01349803|11672491|FG000|Overall Study|Withdrawal by Subject|1
7404898|NCT01349803|11672492|FG001|Overall Study|Withdrawal by Subject|0
7404899|NCT01349803|11672493|FG002|Overall Study|Withdrawal by Subject|0
7404900|NCT01349803|11672494|FG003|Overall Study|Withdrawal by Subject|0
7404901|NCT01349803|11672491|FG000|Overall Study|Protocol-specified criteria|0
7404902|NCT01349803|11672492|FG001|Overall Study|Protocol-specified criteria|1
7404903|NCT01349803|11672493|FG002|Overall Study|Protocol-specified criteria|3
7404904|NCT01349803|11672494|FG003|Overall Study|Protocol-specified criteria|0
7404905|NCT01349816|11672512|FG000|Overall Study|Withdrawal by Subject|4
7404906|NCT01349816|11672512|FG000|Overall Study|Physician Decision|1
7404907|NCT01349816|11672512|FG000|Overall Study|Adverse Event|14
7404908|NCT01349816|11672512|FG000|Overall Study|Lost to Follow-up|2
7404909|NCT01349816|11672512|FG000|Overall Study|Protocol Violation|1
7404910|NCT01349816|11672512|FG000|Overall Study|Protocol-specified criteria|8
7404911|NCT01349829|11672528|FG000|Overall Study|Lost to Follow-up|4
7404912|NCT01349829|11672529|FG001|Overall Study|Lost to Follow-up|8
7404913|NCT01349829|11672528|FG000|Overall Study|Consent withdrawal|3
7404914|NCT01349829|11672529|FG001|Overall Study|Consent withdrawal|8
7404915|NCT01349829|11672528|FG000|Overall Study|Migrated/moved|2
7404916|NCT01349829|11672529|FG001|Overall Study|Migrated/moved|7
7404917|NCT01350102|11672560|FG000|Overall Study|Adverse Event|0
7404918|NCT01350102|11672561|FG001|Overall Study|Adverse Event|0
7404919|NCT01350102|11672562|FG002|Overall Study|Adverse Event|1
7404920|NCT01350102|11672563|FG003|Overall Study|Adverse Event|0
7404921|NCT01350115|11672575|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
7404922|NCT01350115|11672576|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
7404923|NCT01350115|11672575|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
7404924|NCT01350115|11672576|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
7404925|NCT01350115|11672575|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
7404926|NCT01350115|11672576|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
7404927|NCT01350128|11672584|FG000|Overall Study|Withdrawal by Subject|3
7404928|NCT01350128|11672584|FG000|Overall Study|Protocol discontinuation criteria|8
7404929|NCT01350128|11672584|FG000|Overall Study|Physician Decision|1
7404930|NCT01350128|11672584|FG000|Overall Study|Lost to Follow-up|2
7404931|NCT01350141|11672601|FG000|Overall Study|Lost to Follow-up|1
7404932|NCT01350141|11672602|FG001|Overall Study|Lost to Follow-up|0
7404933|NCT01350141|11672603|FG002|Overall Study|Lost to Follow-up|1
7404934|NCT01350141|11672601|FG000|Overall Study|Withdrawal by Subject|1
7404935|NCT01350141|11672602|FG001|Overall Study|Withdrawal by Subject|0
7404936|NCT01350141|11672603|FG002|Overall Study|Withdrawal by Subject|0
7404937|NCT01350141|11672601|FG000|Overall Study|Randomized but not treated|1
7404938|NCT01350141|11672602|FG001|Overall Study|Randomized but not treated|0
7404939|NCT01350141|11672603|FG002|Overall Study|Randomized but not treated|0
7404940|NCT01350271|11672620|FG000|Overall Study|Lost to Follow-up|21
7404941|NCT01350271|11672621|FG001|Overall Study|Lost to Follow-up|17
7404942|NCT01350271|11672622|FG002|Overall Study|Lost to Follow-up|26
7404943|NCT01350336|11672633|FG000|Overall Study|Lost to Follow-up|31
7404944|NCT01350336|11672633|FG000|Overall Study|Withdrawal by Subject|14
7404945|NCT01350336|11672633|FG000|Overall Study|Physician Decision|8
7404946|NCT01350336|11672633|FG000|Overall Study|Death|4
7404947|NCT01350414|11672699|FG000|Overall Study|Lost to Follow-up|13
7404948|NCT01350414|11672699|FG000|Overall Study|Withdrawal by Subject|4
7404949|NCT01350414|11672699|FG000|Overall Study|Physician Decision|2
7404950|NCT01350492|11672731|FG000|Intervention|Lost to Follow-up|2
7404951|NCT01350492|11672732|FG001|Intervention|Lost to Follow-up|5
7404952|NCT01350492|11672731|FG000|Intervention|Withdrawal by Subject|3
7404953|NCT01350492|11672732|FG001|Intervention|Withdrawal by Subject|1
7404954|NCT01350492|11672731|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
7404955|NCT01350492|11672732|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
7404956|NCT01350492|11672731|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
7404957|NCT01350492|11672732|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
7404958|NCT01350505|11672738|FG000|Overall Study|Lost to Follow-up|4
7404959|NCT01350544|11672744|FG000|Overall Study|Administrative Withdrawal|0
7404960|NCT01350544|11672745|FG001|Overall Study|Administrative Withdrawal|1
7404961|NCT01350544|11672744|FG000|Overall Study|Death|1
7404962|NCT01350544|11672745|FG001|Overall Study|Death|2
7404963|NCT01350544|11672744|FG000|Overall Study|Moved out of LA County|2
7404964|NCT01350544|11672745|FG001|Overall Study|Moved out of LA County|2
7404965|NCT01350544|11672744|FG000|Overall Study|Medical Issues|1
7404966|NCT01350544|11672745|FG001|Overall Study|Medical Issues|1
7404967|NCT01350544|11672744|FG000|Overall Study|Withdrawal by Subject|0
7404968|NCT01350544|11672745|FG001|Overall Study|Withdrawal by Subject|1
7404969|NCT01350544|11672744|FG000|Overall Study|Incarceration|1
7404970|NCT01350544|11672745|FG001|Overall Study|Incarceration|0
7404971|NCT01350544|11672744|FG000|Overall Study|Lost to Follow-up|18
7404972|NCT01350544|11672745|FG001|Overall Study|Lost to Follow-up|15
7404973|NCT01350804|11672755|FG000|Core Study|Withdrawal by Subject|11
7404974|NCT01350804|11672756|FG001|Core Study|Withdrawal by Subject|17
7404975|NCT01350804|11672757|FG002|Core Study|Withdrawal by Subject|16
7404976|NCT01350804|11672758|FG003|Core Study|Withdrawal by Subject|7
7404977|NCT01350804|11672755|FG000|Core Study|Study terminated by Sponsor|0
7404978|NCT01350804|11672756|FG001|Core Study|Study terminated by Sponsor|0
7404979|NCT01350804|11672757|FG002|Core Study|Study terminated by Sponsor|0
7404980|NCT01350804|11672758|FG003|Core Study|Study terminated by Sponsor|2
7404981|NCT01350804|11672755|FG000|Core Study|Protocol deviation|1
7404982|NCT01350804|11672756|FG001|Core Study|Protocol deviation|0
7404983|NCT01350804|11672757|FG002|Core Study|Protocol deviation|1
7404984|NCT01350804|11672758|FG003|Core Study|Protocol deviation|0
7404985|NCT01350804|11672755|FG000|Core Study|Physician Decision|1
7404986|NCT01350804|11672756|FG001|Core Study|Physician Decision|0
7404987|NCT01350804|11672757|FG002|Core Study|Physician Decision|1
7404988|NCT01350804|11672758|FG003|Core Study|Physician Decision|3
7404989|NCT01350804|11672755|FG000|Core Study|Lost to Follow-up|3
7404990|NCT01350804|11672756|FG001|Core Study|Lost to Follow-up|0
7404991|NCT01350804|11672757|FG002|Core Study|Lost to Follow-up|2
7404992|NCT01350804|11672758|FG003|Core Study|Lost to Follow-up|1
7404993|NCT01350804|11672755|FG000|Core Study|Lack of Efficacy|16
7404994|NCT01350804|11672756|FG001|Core Study|Lack of Efficacy|19
7404995|NCT01350804|11672757|FG002|Core Study|Lack of Efficacy|18
7404996|NCT01350804|11672758|FG003|Core Study|Lack of Efficacy|5
7404997|NCT01350804|11672755|FG000|Core Study|Death|1
7404998|NCT01350804|11672756|FG001|Core Study|Death|1
7404999|NCT01350804|11672757|FG002|Core Study|Death|1
7405000|NCT01350804|11672758|FG003|Core Study|Death|0
7405001|NCT01350804|11672755|FG000|Core Study|Adverse Event|8
7405002|NCT01350804|11672756|FG001|Core Study|Adverse Event|10
7405003|NCT01350804|11672757|FG002|Core Study|Adverse Event|8
7405004|NCT01350804|11672758|FG003|Core Study|Adverse Event|8
7405005|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
7405006|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
7405007|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
7405008|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
7405009|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7405010|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
7405011|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
7405012|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
7405013|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
7405014|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
7405015|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
7405016|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
7405017|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7405018|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
7405019|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7405020|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
7405021|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7405022|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
7405023|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
7405024|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
7405025|NCT01350804|11672755|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
7405026|NCT01350804|11672756|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
7405027|NCT01350804|11672757|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
7405028|NCT01350804|11672758|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
7405029|NCT01350973|11672785|FG000|Overall Study|Adverse Event|4
7405030|NCT01350973|11672786|FG001|Overall Study|Adverse Event|7
7405031|NCT01350973|11672787|FG002|Overall Study|Adverse Event|7
7405032|NCT01350973|11672785|FG000|Overall Study|Voluntary Withdrawal|2
7405033|NCT01350973|11672786|FG001|Overall Study|Voluntary Withdrawal|1
7405034|NCT01350973|11672787|FG002|Overall Study|Voluntary Withdrawal|1
7405035|NCT01350999|11672798|FG000|Overall Study|Adverse Event|4
7405036|NCT01350999|11672799|FG001|Overall Study|Adverse Event|9
7405037|NCT01350999|11672800|FG002|Overall Study|Adverse Event|10
7405038|NCT01350999|11672798|FG000|Overall Study|Voluntary withdrawal|3
7405039|NCT01350999|11672799|FG001|Overall Study|Voluntary withdrawal|4
7405040|NCT01350999|11672800|FG002|Overall Study|Voluntary withdrawal|6
7405041|NCT01350999|11672798|FG000|Overall Study|Difficulty Making it to Study Visit|1
7405042|NCT01350999|11672799|FG001|Overall Study|Difficulty Making it to Study Visit|1
7405043|NCT01350999|11672800|FG002|Overall Study|Difficulty Making it to Study Visit|5
7405044|NCT01351025|11672810|FG000|Week 0 - 20|Lost to Follow-up|2
7405045|NCT01351025|11672811|FG001|Week 0 - 20|Lost to Follow-up|1
7405046|NCT01351025|11672810|FG000|Week 0 - 20|Withdrawal by Subject|1
7405047|NCT01351025|11672811|FG001|Week 0 - 20|Withdrawal by Subject|0
7405048|NCT01351025|11672810|FG000|Week 24 - 44|Lost to Follow-up|0
7405049|NCT01351025|11672811|FG001|Week 24 - 44|Lost to Follow-up|2
7405050|NCT01351025|11672810|FG000|Week 24 - 44|Site closed|0
7405051|NCT01351025|11672811|FG001|Week 24 - 44|Site closed|1
7405052|NCT01351025|11672810|FG000|Week 24 - 44|unable to get to clinic|1
7405053|NCT01351025|11672811|FG001|Week 24 - 44|unable to get to clinic|1
7465709|NCT01882647|11765151|FG000|Overall Study|Lost to Follow-up|2
7465710|NCT01882647|11765152|FG001|Overall Study|Lost to Follow-up|2
7465711|NCT01882647|11765151|FG000|Overall Study|Withdrawal by Subject|0
7465712|NCT01882647|11765152|FG001|Overall Study|Withdrawal by Subject|4
7465713|NCT01882803|11765171|FG000|Overall Study|Disease Progression|53
7465714|NCT01882803|11765171|FG000|Overall Study|Adverse Event|22
7465715|NCT01882803|11765171|FG000|Overall Study|Death|7
7465716|NCT01882803|11765171|FG000|Overall Study|Physician Decision|7
7465717|NCT01882803|11765171|FG000|Overall Study|Protocol Violation|1
7465718|NCT01882803|11765171|FG000|Overall Study|Withdrawal by Subject|4
7465719|NCT01882829|11765176|FG000|Overall Study|Adverse Event|4
7465720|NCT01882829|11765176|FG000|Overall Study|Protocol Violation|1
7465721|NCT01882829|11765176|FG000|Overall Study|Withdrawal by Subject|1
7465722|NCT01882907|11765186|FG000|Overall Study|Adverse Event|3
7465723|NCT01882907|11765187|FG001|Overall Study|Adverse Event|1
7465724|NCT01882907|11765186|FG000|Overall Study|Lack of Efficacy|0
7465725|NCT01882907|11765187|FG001|Overall Study|Lack of Efficacy|3
7465726|NCT01882907|11765186|FG000|Overall Study|Lost to Follow-up|1
7465727|NCT01882907|11765187|FG001|Overall Study|Lost to Follow-up|4
7465728|NCT01882907|11765186|FG000|Overall Study|Protocol Violation|10
7465729|NCT01882907|11765187|FG001|Overall Study|Protocol Violation|14
7465730|NCT01882907|11765186|FG000|Overall Study|Withdrawal by Subject|0
7465731|NCT01882907|11765187|FG001|Overall Study|Withdrawal by Subject|6
7465732|NCT01882985|11765195|FG000|Overall Study|Lost to Follow-up|1
7465733|NCT01882985|11765195|FG000|Overall Study|Withdrawal by Subject|1
7465734|NCT01883362|11765205|FG000|Treatment|Adverse Event|1
7465735|NCT01883362|11765206|FG001|Treatment|Adverse Event|8
7465736|NCT01883362|11765205|FG000|Treatment|Withdrawal by Subject|6
7465737|NCT01883362|11765206|FG001|Treatment|Withdrawal by Subject|2
7465738|NCT01883362|11765205|FG000|Treatment|Administrative problems|4
7465739|NCT01883362|11765206|FG001|Treatment|Administrative problems|1
7465740|NCT01883362|11765205|FG000|Treatment|Relapse|4
7465741|NCT01883362|11765206|FG001|Treatment|Relapse|2
7465742|NCT01883362|11765205|FG000|Treatment|Randomized, not treated|1
7465743|NCT01883362|11765206|FG001|Treatment|Randomized, not treated|1
7465744|NCT01883362|11765205|FG000|Post Treatment Follow-up|Protocol Violation|0
7465745|NCT01883362|11765206|FG001|Post Treatment Follow-up|Protocol Violation|1
7465746|NCT01883362|11765205|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
7465747|NCT01883362|11765206|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
7465748|NCT01883362|11765205|FG000|Post Treatment Follow-up|Lost to Follow-up|1
7465749|NCT01883362|11765206|FG001|Post Treatment Follow-up|Lost to Follow-up|4
7465750|NCT01883362|11765205|FG000|Post Treatment Follow-up|Administrative problems|2
7465751|NCT01883362|11765206|FG001|Post Treatment Follow-up|Administrative problems|0
7465752|NCT01883362|11765205|FG000|Post Treatment Follow-up|Death|8
7465753|NCT01883362|11765206|FG001|Post Treatment Follow-up|Death|4
7465754|NCT01883362|11765205|FG000|Post Treatment Follow-up|Relapse|1
7465755|NCT01883362|11765206|FG001|Post Treatment Follow-up|Relapse|2
7465756|NCT01883453|11765237|FG000|Overall Study|No episode of common cold|25
7465757|NCT01883453|11765238|FG001|Overall Study|No episode of common cold|23
7465758|NCT01883492|11765246|FG000|Overall Study|Lost to Follow-up|3
7465759|NCT01883492|11765247|FG001|Overall Study|Lost to Follow-up|4
7465760|NCT01883492|11765246|FG000|Overall Study|Surgery on contra-lateral hip|0
7465761|NCT01883492|11765247|FG001|Overall Study|Surgery on contra-lateral hip|1
7465762|NCT01883492|11765246|FG000|Overall Study|Poor X-ray quality|7
7465763|NCT01883492|11765247|FG001|Overall Study|Poor X-ray quality|4
7465764|NCT01883492|11765246|FG000|Overall Study|Withdrawal by Subject|1
7465765|NCT01883492|11765247|FG001|Overall Study|Withdrawal by Subject|0
7465766|NCT01883492|11765246|FG000|Overall Study|inappropriate implant used|1
7465767|NCT01883492|11765247|FG001|Overall Study|inappropriate implant used|1
7465768|NCT01883492|11765246|FG000|Overall Study|bone anatomy did not meet study criteria|1
7465769|NCT01883492|11765247|FG001|Overall Study|bone anatomy did not meet study criteria|1
7465770|NCT01883635|11765255|FG000|Overall Study|Withdrawal by Subject|4
7465771|NCT01883635|11765256|FG001|Overall Study|Withdrawal by Subject|0
7465772|NCT01883895|11765273|FG000|Overall Study|Lost to Follow-up|2
7465773|NCT01884025|11765292|FG000|Overall Study|Lost to Follow-up|3
7465774|NCT01884025|11765293|FG001|Overall Study|Lost to Follow-up|4
7465775|NCT01884311|11765308|FG000|Overall Study|Withdrawal by Subject|3
7465776|NCT01884311|11765308|FG000|Overall Study|withdrew consent due to AEs|1
7465777|NCT01884311|11765308|FG000|Overall Study|Precautionary measure|1
7465778|NCT01884337|11765317|FG000|Treatment|Adverse Event|2
7465779|NCT01884337|11765318|FG001|Treatment|Adverse Event|2
7465780|NCT01884337|11765317|FG000|Treatment|Subj. request to discont. treatment|2
7465781|NCT01884337|11765318|FG001|Treatment|Subj. request to discont. treatment|0
7465782|NCT01884337|11765317|FG000|Follow-up Period|Lost to Follow-up|1
7465783|NCT01884337|11765318|FG001|Follow-up Period|Lost to Follow-up|1
7468638|NCT01912768|11769527|FG000|Overall Study|Withdrawal by Subject|5
7405054|NCT01351350|11672864|FG000|Overall Study|Disease Progression|5
7405055|NCT01351350|11672865|FG001|Overall Study|Disease Progression|13
7405056|NCT01351350|11672866|FG002|Overall Study|Disease Progression|6
7405057|NCT01351350|11672867|FG003|Overall Study|Disease Progression|8
7405058|NCT01351350|11672868|FG004|Overall Study|Disease Progression|5
7405059|NCT01351350|11672864|FG000|Overall Study|Adverse Event|1
7405060|NCT01351350|11672865|FG001|Overall Study|Adverse Event|10
7405061|NCT01351350|11672866|FG002|Overall Study|Adverse Event|1
7405062|NCT01351350|11672867|FG003|Overall Study|Adverse Event|2
7405063|NCT01351350|11672868|FG004|Overall Study|Adverse Event|0
7405064|NCT01351350|11672864|FG000|Overall Study|Participant Decision|2
7405065|NCT01351350|11672865|FG001|Overall Study|Participant Decision|6
7405066|NCT01351350|11672866|FG002|Overall Study|Participant Decision|3
7405067|NCT01351350|11672867|FG003|Overall Study|Participant Decision|3
7405068|NCT01351350|11672868|FG004|Overall Study|Participant Decision|2
7405069|NCT01351350|11672864|FG000|Overall Study|Enrolled but not Treated|0
7405070|NCT01351350|11672865|FG001|Overall Study|Enrolled but not Treated|0
7405071|NCT01351350|11672866|FG002|Overall Study|Enrolled but not Treated|1
7405072|NCT01351350|11672867|FG003|Overall Study|Enrolled but not Treated|0
7405073|NCT01351350|11672868|FG004|Overall Study|Enrolled but not Treated|0
7405074|NCT01351415|11672904|FG000|Overall Study|Withdrawal by Subject|15
7405075|NCT01351415|11672905|FG001|Overall Study|Withdrawal by Subject|17
7405076|NCT01351415|11672904|FG000|Overall Study|Trial termination by the Sponsor|28
7405077|NCT01351415|11672905|FG001|Overall Study|Trial termination by the Sponsor|19
7405078|NCT01351415|11672904|FG000|Overall Study|Lost to Follow-up|5
7405079|NCT01351415|11672905|FG001|Overall Study|Lost to Follow-up|7
7405080|NCT01351415|11672904|FG000|Overall Study|Death|190
7405081|NCT01351415|11672905|FG001|Overall Study|Death|187
7405082|NCT01351415|11672904|FG000|Overall Study|Physician Decision|2
7405083|NCT01351415|11672905|FG001|Overall Study|Physician Decision|3
7405084|NCT01351415|11672904|FG000|Overall Study|Reason unknown|0
7405085|NCT01351415|11672905|FG001|Overall Study|Reason unknown|2
7405086|NCT01351415|11672904|FG000|Overall Study|Never Started|5
7405087|NCT01351415|11672905|FG001|Overall Study|Never Started|5
7405088|NCT01351623|11672923|FG000|Overall Study|Protocol Violation|2
7405089|NCT01351623|11672923|FG000|Overall Study|Adverse Event|4
7405090|NCT01351623|11672923|FG000|Overall Study|Withdrawal by Subject|1
7405091|NCT01351623|11672923|FG000|Overall Study|Death|2
7405092|NCT01352117|11672987|FG000|Overall Study|Death|15
7405093|NCT01352117|11672988|FG001|Overall Study|Death|16
7405094|NCT01352117|11672987|FG000|Overall Study|Withdrawal by Subject|1
7405095|NCT01352117|11672988|FG001|Overall Study|Withdrawal by Subject|0
7405096|NCT01352117|11672987|FG000|Overall Study|Lost to Follow-up|2
7405097|NCT01352117|11672988|FG001|Overall Study|Lost to Follow-up|7
7405098|NCT01352117|11672987|FG000|Overall Study|Non-adherent to study requirements|1
7405099|NCT01352117|11672988|FG001|Overall Study|Non-adherent to study requirements|1
7405100|NCT01352117|11672987|FG000|Overall Study|Did not initiate study treatment|1
7405101|NCT01352117|11672988|FG001|Overall Study|Did not initiate study treatment|0
7405102|NCT01352117|11672987|FG000|Overall Study|Ineligible (no KS diagnosis)|1
7405103|NCT01352117|11672988|FG001|Overall Study|Ineligible (no KS diagnosis)|0
7405104|NCT01352221|11673010|FG000|Double-blind Phase|Adverse Event|6
7405105|NCT01352221|11673011|FG001|Double-blind Phase|Adverse Event|4
7405106|NCT01352221|11673012|FG002|Double-blind Phase|Adverse Event|0
7405107|NCT01352221|11673013|FG003|Double-blind Phase|Adverse Event|0
7405108|NCT01352221|11673010|FG000|Double-blind Phase|Withdrawal by Subject|3
7405109|NCT01352221|11673011|FG001|Double-blind Phase|Withdrawal by Subject|5
7405110|NCT01352221|11673012|FG002|Double-blind Phase|Withdrawal by Subject|0
7405111|NCT01352221|11673013|FG003|Double-blind Phase|Withdrawal by Subject|0
7405112|NCT01352221|11673010|FG000|Double-blind Phase|Lost to Follow-up|0
7405113|NCT01352221|11673011|FG001|Double-blind Phase|Lost to Follow-up|1
7405114|NCT01352221|11673012|FG002|Double-blind Phase|Lost to Follow-up|0
7405115|NCT01352221|11673013|FG003|Double-blind Phase|Lost to Follow-up|0
7405116|NCT01352221|11673010|FG000|Double-blind Phase|Protocol Violation|0
7405117|NCT01352221|11673011|FG001|Double-blind Phase|Protocol Violation|1
7405118|NCT01352221|11673012|FG002|Double-blind Phase|Protocol Violation|0
7405119|NCT01352221|11673013|FG003|Double-blind Phase|Protocol Violation|0
7405120|NCT01352221|11673010|FG000|Open-label Phase|Physician Decision|0
7405121|NCT01352221|11673011|FG001|Open-label Phase|Physician Decision|0
7405122|NCT01352221|11673012|FG002|Open-label Phase|Physician Decision|2
7405123|NCT01352221|11673013|FG003|Open-label Phase|Physician Decision|1
7405124|NCT01352221|11673010|FG000|Open-label Phase|Pregnancy|0
7405125|NCT01352221|11673011|FG001|Open-label Phase|Pregnancy|0
7405126|NCT01352221|11673012|FG002|Open-label Phase|Pregnancy|1
7405127|NCT01352221|11673013|FG003|Open-label Phase|Pregnancy|0
7405128|NCT01352221|11673010|FG000|Open-label Phase|Adverse Event|0
7405129|NCT01352221|11673011|FG001|Open-label Phase|Adverse Event|0
7405130|NCT01352221|11673012|FG002|Open-label Phase|Adverse Event|8
7405131|NCT01352221|11673013|FG003|Open-label Phase|Adverse Event|4
7405132|NCT01352221|11673010|FG000|Open-label Phase|Withdrawal by Subject|0
7405133|NCT01352221|11673011|FG001|Open-label Phase|Withdrawal by Subject|0
7405134|NCT01352221|11673012|FG002|Open-label Phase|Withdrawal by Subject|1
7405135|NCT01352221|11673013|FG003|Open-label Phase|Withdrawal by Subject|6
7405136|NCT01352221|11673010|FG000|Open-label Phase|Worsening of IBD|0
7405137|NCT01352221|11673011|FG001|Open-label Phase|Worsening of IBD|0
7405138|NCT01352221|11673012|FG002|Open-label Phase|Worsening of IBD|1
7405139|NCT01352221|11673013|FG003|Open-label Phase|Worsening of IBD|0
7405140|NCT01352507|11673045|FG000|Treatment Period 1|Adverse Event|3
7405141|NCT01352507|11673046|FG001|Treatment Period 1|Adverse Event|0
7405142|NCT01352507|11673045|FG000|Treatment Period 1|Lost to Follow-up|3
7405143|NCT01352507|11673046|FG001|Treatment Period 1|Lost to Follow-up|4
7405144|NCT01352507|11673045|FG000|Treatment Period 1|Withdrawal by Subject|7
7405145|NCT01352507|11673046|FG001|Treatment Period 1|Withdrawal by Subject|5
7405146|NCT01352507|11673045|FG000|Treatment Period 1|Physician Decision|1
7405147|NCT01352507|11673046|FG001|Treatment Period 1|Physician Decision|0
7405148|NCT01352507|11673045|FG000|Washout Period|Withdrawal by Subject|0
7405149|NCT01352507|11673046|FG001|Washout Period|Withdrawal by Subject|1
7405150|NCT01352507|11673045|FG000|Treatment Period 2|Entry Criteria Not Met|1
7405151|NCT01352507|11673046|FG001|Treatment Period 2|Entry Criteria Not Met|0
7405152|NCT01352507|11673045|FG000|Treatment Period 2|Withdrawal by Subject|4
7405153|NCT01352507|11673046|FG001|Treatment Period 2|Withdrawal by Subject|3
7405154|NCT01352507|11673045|FG000|Treatment Period 2|Lack of Efficacy|1
7405155|NCT01352507|11673046|FG001|Treatment Period 2|Lack of Efficacy|0
7405156|NCT01352585|11673064|FG000|Overall Study|Adverse Event|2
7405157|NCT01352585|11673065|FG001|Overall Study|Adverse Event|1
7405158|NCT01352585|11673064|FG000|Overall Study|Lost to Follow-up|1
7405159|NCT01352585|11673065|FG001|Overall Study|Lost to Follow-up|0
7405160|NCT01352585|11673064|FG000|Overall Study|Other|5
7405161|NCT01352585|11673065|FG001|Overall Study|Other|2
7405162|NCT01352715|11673095|FG000|Overall Study|Death|3
7405163|NCT01352715|11673096|FG001|Overall Study|Death|3
7405164|NCT01352715|11673095|FG000|Overall Study|Lost to Follow-up|5
7405165|NCT01352715|11673096|FG001|Overall Study|Lost to Follow-up|7
7405166|NCT01352715|11673095|FG000|Overall Study|Withdrawal by Subject|4
7405167|NCT01352715|11673096|FG001|Overall Study|Withdrawal by Subject|8
7405168|NCT01352715|11673095|FG000|Overall Study|site closure|16
7405169|NCT01352715|11673096|FG001|Overall Study|site closure|15
7405170|NCT01352715|11673095|FG000|Overall Study|no final visit in closeout period|15
7405171|NCT01352715|11673096|FG001|Overall Study|no final visit in closeout period|12
7405172|NCT01352715|11673095|FG000|Overall Study|major ineligibility|2
7405173|NCT01352715|11673096|FG001|Overall Study|major ineligibility|1
7405174|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
7405175|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
7405176|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
7405177|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
7405178|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
7405179|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
7405180|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
7405181|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
7405182|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
7405183|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
7405184|NCT01352741|11673102|FG000|Open-label Tapentadol Titration Period|Other|4
7405185|NCT01352741|11673103|FG001|Open-label Tapentadol Titration Period|Other|0
7405186|NCT01352741|11673102|FG000|Double-blind Comparative Period|Protocol Violation|2
7405187|NCT01352741|11673103|FG001|Double-blind Comparative Period|Protocol Violation|0
7405188|NCT01352741|11673102|FG000|Double-blind Comparative Period|Lack of Efficacy|0
7405189|NCT01352741|11673103|FG001|Double-blind Comparative Period|Lack of Efficacy|3
7405190|NCT01352741|11673102|FG000|Double-blind Comparative Period|Adverse Event|16
7405191|NCT01352741|11673103|FG001|Double-blind Comparative Period|Adverse Event|17
7405192|NCT01352741|11673102|FG000|Double-blind Comparative Period|Lost to Follow-up|1
7405193|NCT01352741|11673103|FG001|Double-blind Comparative Period|Lost to Follow-up|0
7405194|NCT01352741|11673102|FG000|Double-blind Comparative Period|Death|0
7405195|NCT01352741|11673103|FG001|Double-blind Comparative Period|Death|1
7405196|NCT01352741|11673102|FG000|Double-blind Comparative Period|Withdrawal of consent|8
7405197|NCT01352741|11673103|FG001|Double-blind Comparative Period|Withdrawal of consent|3
7405198|NCT01352741|11673102|FG000|Double-blind Comparative Period|Other|1
7405199|NCT01352741|11673103|FG001|Double-blind Comparative Period|Other|2
7405200|NCT01352741|11673102|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
7405201|NCT01352741|11673103|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
7405202|NCT01352741|11673102|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
7405203|NCT01352741|11673103|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
7405204|NCT01352741|11673102|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
7405205|NCT01352741|11673103|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
7405206|NCT01352741|11673102|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
7405207|NCT01352741|11673103|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
7405208|NCT01352793|11673125|FG000|Overall Study|Lost to Follow-up|289
7405209|NCT01352793|11673126|FG001|Overall Study|Lost to Follow-up|125
7405210|NCT01352793|11673125|FG000|Overall Study|Withdrawal by Subject|120
7405211|NCT01352793|11673126|FG001|Overall Study|Withdrawal by Subject|55
7405212|NCT01352793|11673125|FG000|Overall Study|Protocol Violation|44
7405213|NCT01352793|11673126|FG001|Overall Study|Protocol Violation|23
7405214|NCT01352793|11673125|FG000|Overall Study|Adverse Event|44
7405215|NCT01352793|11673126|FG001|Overall Study|Adverse Event|10
7405216|NCT01352793|11673125|FG000|Overall Study|Physician Decision|1
7405217|NCT01352793|11673126|FG001|Overall Study|Physician Decision|0
7405218|NCT01352793|11673125|FG000|Overall Study|Pregnancy|26
7405219|NCT01352793|11673126|FG001|Overall Study|Pregnancy|8
7405220|NCT01352793|11673125|FG000|Overall Study|Other|25
7405221|NCT01352793|11673126|FG001|Overall Study|Other|7
7405222|NCT01352793|11673125|FG000|Overall Study|Medication error|2
7405223|NCT01352793|11673126|FG001|Overall Study|Medication error|2
7405224|NCT01352793|11673125|FG000|Overall Study|Death|1
7405225|NCT01352793|11673126|FG001|Overall Study|Death|0
7405226|NCT01352793|11673125|FG000|Overall Study|Randomized but not vaccinated|8
7405227|NCT01352793|11673126|FG001|Overall Study|Randomized but not vaccinated|0
7405228|NCT01352793|11673125|FG000|Overall Study|No longer meets eligibility criteria|25
7405229|NCT01352793|11673126|FG001|Overall Study|No longer meets eligibility criteria|15
7405230|NCT01352845|11673134|FG000|Overall Study|Lost to Follow-up|313
7405231|NCT01352845|11673135|FG001|Overall Study|Lost to Follow-up|92
7405232|NCT01352845|11673134|FG000|Overall Study|No Longer Willing to Participate|205
7405233|NCT01352845|11673135|FG001|Overall Study|No Longer Willing to Participate|58
7405234|NCT01352845|11673134|FG000|Overall Study|Withdrawal by Subject|48
7405235|NCT01352845|11673135|FG001|Overall Study|Withdrawal by Subject|16
7405236|NCT01352845|11673134|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
7405237|NCT01352845|11673135|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
7405238|NCT01352845|11673134|FG000|Overall Study|Pregnancy|27
7405239|NCT01352845|11673135|FG001|Overall Study|Pregnancy|7
7405240|NCT01352845|11673134|FG000|Overall Study|Adverse Event|22
7405241|NCT01352845|11673135|FG001|Overall Study|Adverse Event|6
7405242|NCT01352845|11673134|FG000|Overall Study|Other|17
7405243|NCT01352845|11673135|FG001|Overall Study|Other|7
7405244|NCT01352845|11673134|FG000|Overall Study|Protocol Violation|12
7405245|NCT01352845|11673135|FG001|Overall Study|Protocol Violation|6
7405246|NCT01352845|11673134|FG000|Overall Study|Death|3
7405247|NCT01352845|11673135|FG001|Overall Study|Death|0
7405248|NCT01353222|11673174|FG000|Overall Study|Death|30
7405249|NCT01353222|11673175|FG001|Overall Study|Death|30
7405250|NCT01353222|11673174|FG000|Overall Study|Withdrawal by Subject|8
7405251|NCT01353222|11673175|FG001|Overall Study|Withdrawal by Subject|5
7405252|NCT01353222|11673174|FG000|Overall Study|Study Terminated|31
7405253|NCT01353222|11673175|FG001|Overall Study|Study Terminated|37
7405254|NCT01353222|11673174|FG000|Overall Study|Site closed research department|1
7405255|NCT01353222|11673175|FG001|Overall Study|Site closed research department|0
7405256|NCT01353274|11673181|FG000|Overall Study|No case report form (CRF) collected|28
7405257|NCT01353508|11673198|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
7405258|NCT01353508|11673199|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
7405259|NCT01353508|11673200|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
7405260|NCT01353508|11673201|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
7405261|NCT01353508|11673198|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
7405262|NCT01353508|11673199|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7405263|NCT01353508|11673200|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7405264|NCT01353508|11673201|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
7405265|NCT01353586|11673213|FG000|Overall Study|Procedure terminated prior to ablation|3
7405266|NCT01353586|11673214|FG001|Overall Study|Procedure terminated prior to ablation|0
7405267|NCT01353586|11673213|FG000|Overall Study|Never had insertion of study catheter|4
7405268|NCT01353586|11673214|FG001|Overall Study|Never had insertion of study catheter|1
7405269|NCT01353586|11673213|FG000|Overall Study|Neurological exam not done|0
7405270|NCT01353586|11673214|FG001|Overall Study|Neurological exam not done|1
7405271|NCT01353664|11673223|FG000|Overall Study|Other|3
7405272|NCT01353664|11673223|FG000|Overall Study|Disease Progression|16
7405273|NCT01353703|11673229|FG000|Overall Study|Migrated/moved from study area|1
7405274|NCT01353703|11673230|FG001|Overall Study|Migrated/moved from study area|0
7405275|NCT01353859|11673238|FG000|Overall Study|Adverse Event|3
7405276|NCT01353859|11673238|FG000|Overall Study|Lack of Efficacy|1
7405277|NCT01353898|11673248|FG000|Overall Study|Study site terminated|0
7405278|NCT01353898|11673249|FG001|Overall Study|Study site terminated|0
7405279|NCT01353898|11673250|FG002|Overall Study|Study site terminated|0
7405280|NCT01353898|11673251|FG003|Overall Study|Study site terminated|0
7405281|NCT01353898|11673252|FG004|Overall Study|Study site terminated|0
7405282|NCT01353898|11673253|FG005|Overall Study|Study site terminated|1
7405283|NCT01353911|11673275|FG000|Overall Study|Lost to Follow-up|2
7405284|NCT01353911|11673276|FG001|Overall Study|Lost to Follow-up|6
7405285|NCT01353911|11673277|FG002|Overall Study|Lost to Follow-up|4
7405286|NCT01353911|11673278|FG003|Overall Study|Lost to Follow-up|0
7405287|NCT01353911|11673279|FG004|Overall Study|Lost to Follow-up|4
7405288|NCT01353911|11673280|FG005|Overall Study|Lost to Follow-up|4
7405289|NCT01353911|11673281|FG006|Overall Study|Lost to Follow-up|3
7405290|NCT01353911|11673282|FG007|Overall Study|Lost to Follow-up|6
7405291|NCT01353911|11673275|FG000|Overall Study|Withdrawal by Subject|2
7405292|NCT01353911|11673276|FG001|Overall Study|Withdrawal by Subject|3
7405293|NCT01353911|11673277|FG002|Overall Study|Withdrawal by Subject|4
7405294|NCT01353911|11673278|FG003|Overall Study|Withdrawal by Subject|2
7405295|NCT01353911|11673279|FG004|Overall Study|Withdrawal by Subject|2
7405296|NCT01353911|11673280|FG005|Overall Study|Withdrawal by Subject|3
7405297|NCT01353911|11673281|FG006|Overall Study|Withdrawal by Subject|3
7405298|NCT01353911|11673282|FG007|Overall Study|Withdrawal by Subject|9
7405299|NCT01353911|11673275|FG000|Overall Study|Status Not Recorded|4
7405300|NCT01353911|11673276|FG001|Overall Study|Status Not Recorded|0
7405301|NCT01353911|11673277|FG002|Overall Study|Status Not Recorded|1
7405302|NCT01353911|11673278|FG003|Overall Study|Status Not Recorded|0
7405303|NCT01353911|11673279|FG004|Overall Study|Status Not Recorded|0
7405304|NCT01353911|11673280|FG005|Overall Study|Status Not Recorded|0
7405305|NCT01353911|11673281|FG006|Overall Study|Status Not Recorded|0
7405306|NCT01353911|11673282|FG007|Overall Study|Status Not Recorded|0
7405307|NCT01353963|11673300|FG000|Overall Study|Adverse Event|2
7405308|NCT01354028|11673322|FG000|Overall Study|Physician Decision|0
7405309|NCT01354028|11673323|FG001|Overall Study|Physician Decision|2
7405310|NCT01354028|11673322|FG000|Overall Study|Discharged before study start|2
7405311|NCT01354028|11673323|FG001|Overall Study|Discharged before study start|2
7405312|NCT01354028|11673322|FG000|Overall Study|No quiet alert state|0
7405313|NCT01354028|11673323|FG001|Overall Study|No quiet alert state|1
7405314|NCT01354106|11673335|FG000|Overall Study|Withdrawal by Subject|2
7405315|NCT01354132|11673343|FG000|Randomization|Physician Decision|1
7405316|NCT01354132|11673344|FG001|Randomization|Physician Decision|0
7405317|NCT01354132|11673343|FG000|Randomization|Withdrawal by Subject|0
7405318|NCT01354132|11673344|FG001|Randomization|Withdrawal by Subject|1
7405319|NCT01354132|11673343|FG000|Double Blind (Visits 1-7)|Adverse Event|1
7405320|NCT01354132|11673344|FG001|Double Blind (Visits 1-7)|Adverse Event|0
7405321|NCT01354132|11673343|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
7405322|NCT01354132|11673344|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
7405323|NCT01354132|11673343|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
7405324|NCT01354132|11673344|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
7405325|NCT01354223|11673371|FG000|Overall Study|Withdrawal by Subject|3
7405326|NCT01354223|11673372|FG001|Overall Study|Withdrawal by Subject|1
7405327|NCT01354314|11673382|FG000|Overall Study|Lost to Follow-up|1
7405328|NCT01354314|11673383|FG001|Overall Study|Lost to Follow-up|0
7405329|NCT01354314|11673384|FG002|Overall Study|Lost to Follow-up|1
7405330|NCT01354314|11673385|FG003|Overall Study|Lost to Follow-up|1
7405331|NCT01354314|11673382|FG000|Overall Study|Withdrawal by Subject|0
7405332|NCT01354314|11673383|FG001|Overall Study|Withdrawal by Subject|0
7405333|NCT01354314|11673384|FG002|Overall Study|Withdrawal by Subject|1
7405334|NCT01354314|11673385|FG003|Overall Study|Withdrawal by Subject|0
7405335|NCT01354314|11673382|FG000|Overall Study|Adverse Event|0
7405336|NCT01354314|11673383|FG001|Overall Study|Adverse Event|0
7405337|NCT01354314|11673384|FG002|Overall Study|Adverse Event|0
7405338|NCT01354314|11673385|FG003|Overall Study|Adverse Event|1
7405339|NCT01354314|11673382|FG000|Overall Study|Protocol Violation|1
7405340|NCT01354314|11673383|FG001|Overall Study|Protocol Violation|1
7405341|NCT01354314|11673384|FG002|Overall Study|Protocol Violation|0
7405342|NCT01354314|11673385|FG003|Overall Study|Protocol Violation|0
7405343|NCT01354314|11673382|FG000|Overall Study|Less than 90% Adherence|4
7405344|NCT01354314|11673383|FG001|Overall Study|Less than 90% Adherence|2
7405345|NCT01354314|11673384|FG002|Overall Study|Less than 90% Adherence|6
7405346|NCT01354314|11673385|FG003|Overall Study|Less than 90% Adherence|4
7405371|NCT01354496|11673442|FG000|Period 1|Adverse Event|0
7405372|NCT01354496|11673443|FG001|Period 1|Adverse Event|0
7405373|NCT01354496|11673444|FG002|Period 1|Adverse Event|1
7405374|NCT01354496|11673445|FG003|Period 1|Adverse Event|0
7405375|NCT01354496|11673446|FG004|Period 1|Adverse Event|0
7405376|NCT01354496|11673447|FG005|Period 1|Adverse Event|0
7405377|NCT01354496|11673442|FG000|Period 1|Physician Decision|0
7405378|NCT01354496|11673443|FG001|Period 1|Physician Decision|0
7405379|NCT01354496|11673444|FG002|Period 1|Physician Decision|1
7405380|NCT01354496|11673445|FG003|Period 1|Physician Decision|0
7405381|NCT01354496|11673446|FG004|Period 1|Physician Decision|0
7405382|NCT01354496|11673447|FG005|Period 1|Physician Decision|0
7405383|NCT01354496|11673442|FG000|Period 2|Adverse Event|0
7405384|NCT01354496|11673443|FG001|Period 2|Adverse Event|0
7405385|NCT01354496|11673444|FG002|Period 2|Adverse Event|0
7405386|NCT01354496|11673445|FG003|Period 2|Adverse Event|1
7405387|NCT01354496|11673446|FG004|Period 2|Adverse Event|0
7405388|NCT01354496|11673447|FG005|Period 2|Adverse Event|0
7405389|NCT01354496|11673442|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
7405390|NCT01354496|11673443|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
7405391|NCT01354496|11673444|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
7405392|NCT01354496|11673445|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
7405393|NCT01354496|11673446|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
7405394|NCT01354496|11673447|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
7405395|NCT01354899|11673491|FG000|Overall Study|discharge from the hospital|2
7405396|NCT01354899|11673491|FG000|Overall Study|Protocol Violation|1
7405397|NCT01354938|11673495|FG000|Overall Study|Lost to Follow-up|1
7405398|NCT01354964|11673501|FG000|Overall Study|Lost to Follow-up|2
7405399|NCT01354964|11673502|FG001|Overall Study|Lost to Follow-up|0
7405400|NCT01354964|11673501|FG000|Overall Study|IV access issues|1
7405401|NCT01354964|11673502|FG001|Overall Study|IV access issues|1
7405402|NCT01354964|11673501|FG000|Overall Study|Physician Decision|1
7405403|NCT01354964|11673502|FG001|Overall Study|Physician Decision|0
7405404|NCT01355068|11673514|FG000|First Intervention Period|Adverse Event|0
7405405|NCT01355068|11673515|FG001|First Intervention Period|Adverse Event|1
7405406|NCT01355068|11673514|FG000|First Intervention Period|Withdrawal by Subject|0
7405407|NCT01355068|11673515|FG001|First Intervention Period|Withdrawal by Subject|1
7405408|NCT01355081|11673524|FG000|Overall Study|Pretreatment Event or Adverse Event|3
7405409|NCT01355081|11673525|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7405410|NCT01355081|11673526|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7405411|NCT01355081|11673524|FG000|Overall Study|Major Protocol Deviation|0
7405412|NCT01355081|11673525|FG001|Overall Study|Major Protocol Deviation|1
7405413|NCT01355081|11673526|FG002|Overall Study|Major Protocol Deviation|0
7405414|NCT01355081|11673524|FG000|Overall Study|Lost to Follow-up|0
7405415|NCT01355081|11673525|FG001|Overall Study|Lost to Follow-up|0
7405416|NCT01355081|11673526|FG002|Overall Study|Lost to Follow-up|1
7405417|NCT01355081|11673524|FG000|Overall Study|Withdrawal of Consent|2
7405418|NCT01355081|11673525|FG001|Overall Study|Withdrawal of Consent|3
7405419|NCT01355081|11673526|FG002|Overall Study|Withdrawal of Consent|3
7405420|NCT01355081|11673524|FG000|Overall Study|Lack of Efficacy|2
7405421|NCT01355081|11673525|FG001|Overall Study|Lack of Efficacy|1
7405422|NCT01355081|11673526|FG002|Overall Study|Lack of Efficacy|1
7405423|NCT01355081|11673524|FG000|Overall Study|Non Compliance with Study Medication|0
7405424|NCT01355081|11673525|FG001|Overall Study|Non Compliance with Study Medication|1
7405425|NCT01355081|11673526|FG002|Overall Study|Non Compliance with Study Medication|0
7405426|NCT01355159|11673536|FG000|Overall Study|Withdrew consent|39
7405427|NCT01355159|11673537|FG001|Overall Study|Withdrew consent|47
7405428|NCT01355159|11673536|FG000|Overall Study|No primary outcome data|17
7405429|NCT01355159|11673537|FG001|Overall Study|No primary outcome data|11
7405430|NCT01355159|11673536|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
7405431|NCT01355159|11673537|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
7405432|NCT01355159|11673536|FG000|Overall Study|Early intrauterine fetal death|6
7405433|NCT01355159|11673537|FG001|Overall Study|Early intrauterine fetal death|6
7405434|NCT01355289|11673572|FG000|Core Study|Adverse Event, Non-Fatal|1
7405435|NCT01355289|11673573|FG001|Core Study|Adverse Event, Non-Fatal|0
7405436|NCT01355289|11673574|FG002|Core Study|Adverse Event, Non-Fatal|0
7405437|NCT01355289|11673575|FG003|Core Study|Adverse Event, Non-Fatal|0
7405438|NCT01355289|11673576|FG004|Core Study|Adverse Event, Non-Fatal|0
7405439|NCT01355289|11673572|FG000|Core Study|Inadequate Therapeutic Effect|0
7405440|NCT01355289|11673573|FG001|Core Study|Inadequate Therapeutic Effect|0
7405441|NCT01355289|11673574|FG002|Core Study|Inadequate Therapeutic Effect|0
7405442|NCT01355289|11673575|FG003|Core Study|Inadequate Therapeutic Effect|1
7405443|NCT01355289|11673576|FG004|Core Study|Inadequate Therapeutic Effect|0
7405444|NCT01355289|11673572|FG000|Core Study|Other|0
7405445|NCT01355289|11673573|FG001|Core Study|Other|0
7405446|NCT01355289|11673574|FG002|Core Study|Other|0
7405447|NCT01355289|11673575|FG003|Core Study|Other|1
7405448|NCT01355289|11673576|FG004|Core Study|Other|0
7405449|NCT01355289|11673572|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
7405450|NCT01355289|11673573|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
7405451|NCT01355289|11673574|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
7405452|NCT01355289|11673575|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
7405453|NCT01355289|11673576|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
7405454|NCT01355289|11673572|FG000|Open Label Extension|Lost to Follow-up|0
7405455|NCT01355289|11673573|FG001|Open Label Extension|Lost to Follow-up|0
7405456|NCT01355289|11673574|FG002|Open Label Extension|Lost to Follow-up|0
7405457|NCT01355289|11673575|FG003|Open Label Extension|Lost to Follow-up|0
7405458|NCT01355289|11673576|FG004|Open Label Extension|Lost to Follow-up|1
7405459|NCT01355289|11673572|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
7405460|NCT01355289|11673573|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
7405461|NCT01355289|11673574|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
7405462|NCT01355289|11673575|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
7405463|NCT01355289|11673576|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
7405464|NCT01355289|11673572|FG000|Open Label Extension|Other|0
7405465|NCT01355289|11673573|FG001|Open Label Extension|Other|0
7405466|NCT01355289|11673574|FG002|Open Label Extension|Other|0
7405467|NCT01355289|11673575|FG003|Open Label Extension|Other|0
7405468|NCT01355289|11673576|FG004|Open Label Extension|Other|3
7405469|NCT01355302|11673589|FG000|Phase 1b|Death|4
7405470|NCT01355302|11673590|FG001|Phase 1b|Death|0
7405471|NCT01355302|11673591|FG002|Phase 1b|Death|0
7405472|NCT01355302|11673589|FG000|Phase 1b|Study terminated by sponsor|2
7405473|NCT01355302|11673590|FG001|Phase 1b|Study terminated by sponsor|0
7405474|NCT01355302|11673591|FG002|Phase 1b|Study terminated by sponsor|0
7405475|NCT01355497|11673632|FG000|Overall Study|Death|19
7405476|NCT01355497|11673633|FG001|Overall Study|Death|18
7405477|NCT01355497|11673632|FG000|Overall Study|Lost to Follow-up|3
7405478|NCT01355497|11673633|FG001|Overall Study|Lost to Follow-up|0
7405479|NCT01355497|11673632|FG000|Overall Study|Protocol Violation|0
7405480|NCT01355497|11673633|FG001|Overall Study|Protocol Violation|1
7405481|NCT01355497|11673632|FG000|Overall Study|other-not provided|9
7405482|NCT01355497|11673633|FG001|Overall Study|other-not provided|4
7405483|NCT01355497|11673632|FG000|Overall Study|Withdrawal by Subject|12
7405484|NCT01355497|11673633|FG001|Overall Study|Withdrawal by Subject|20
7405485|NCT01355497|11673632|FG000|Overall Study|noncompliance|1
7405486|NCT01355497|11673633|FG001|Overall Study|noncompliance|2
7405487|NCT01355497|11673632|FG000|Overall Study|progressive disease|11
7405488|NCT01355497|11673633|FG001|Overall Study|progressive disease|8
7405489|NCT01355497|11673632|FG000|Overall Study|Adverse Event|11
7405490|NCT01355497|11673633|FG001|Overall Study|Adverse Event|10
7405491|NCT01355523|11673641|FG000|Overall Study|Withdrawal by Subject|1
7405492|NCT01355523|11673642|FG001|Overall Study|Withdrawal by Subject|4
7405493|NCT01355523|11673641|FG000|Overall Study|Lost to Follow-up|0
7405494|NCT01355523|11673642|FG001|Overall Study|Lost to Follow-up|2
7405495|NCT01355523|11673641|FG000|Overall Study|Protocol Violation|0
7405496|NCT01355523|11673642|FG001|Overall Study|Protocol Violation|2
7405497|NCT01355523|11673641|FG000|Overall Study|Adverse Event|0
7405498|NCT01355523|11673642|FG001|Overall Study|Adverse Event|2
7405499|NCT01355575|11673648|FG000|Overall Study|Withdrawal by Subject|2
7405500|NCT01355627|11673675|FG000|Overall Study|Request By the Patient to Discontinue|5
7405501|NCT01355627|11673676|FG001|Overall Study|Request By the Patient to Discontinue|7
7405502|NCT01355627|11673675|FG000|Overall Study|Lost to Follow-up|8
7405503|NCT01355627|11673676|FG001|Overall Study|Lost to Follow-up|7
7405504|NCT01355627|11673675|FG000|Overall Study|Fatal Adverse Event|19
7405505|NCT01355627|11673676|FG001|Overall Study|Fatal Adverse Event|23
7405506|NCT01355627|11673675|FG000|Overall Study|Other|1
7405507|NCT01355627|11673676|FG001|Overall Study|Other|1
7405508|NCT01356407|11673720|FG000|Overall Study|Lost to Follow-up|2
7405509|NCT01356407|11673721|FG001|Overall Study|Lost to Follow-up|0
7405510|NCT01356407|11673720|FG000|Overall Study|Patient Withdrew Consent|2
7405511|NCT01356407|11673721|FG001|Overall Study|Patient Withdrew Consent|1
7405512|NCT01356407|11673720|FG000|Overall Study|Could not afford IMP administration|0
7405513|NCT01356407|11673721|FG001|Overall Study|Could not afford IMP administration|1
7405514|NCT01356407|11673720|FG000|Overall Study|Not complete Endoscopy|2
7405515|NCT01356407|11673721|FG001|Overall Study|Not complete Endoscopy|2
7405516|NCT01356589|11673758|FG000|Overall Study|Enrolled, but not treated|3
7405517|NCT01356589|11673758|FG000|Overall Study|Dose data not recorded|2
7405518|NCT01356602|11673765|FG000|Overall Study|Protocol Deviation|0
7405519|NCT01356602|11673766|FG001|Overall Study|Protocol Deviation|1
7405520|NCT01356602|11673767|FG002|Overall Study|Protocol Deviation|1
7405521|NCT01356602|11673765|FG000|Overall Study|Administrative Problems|1
7405522|NCT01356602|11673766|FG001|Overall Study|Administrative Problems|4
7405523|NCT01356602|11673767|FG002|Overall Study|Administrative Problems|5
7405524|NCT01356602|11673765|FG000|Overall Study|Lost to Follow-up|4
7405525|NCT01356602|11673766|FG001|Overall Study|Lost to Follow-up|5
7405526|NCT01356602|11673767|FG002|Overall Study|Lost to Follow-up|6
7405527|NCT01356602|11673765|FG000|Overall Study|Withdrawal by Subject|4
7405528|NCT01356602|11673766|FG001|Overall Study|Withdrawal by Subject|3
7405529|NCT01356602|11673767|FG002|Overall Study|Withdrawal by Subject|7
7405530|NCT01356602|11673765|FG000|Overall Study|Lack of Efficacy|0
7405531|NCT01356602|11673766|FG001|Overall Study|Lack of Efficacy|1
7405532|NCT01356602|11673767|FG002|Overall Study|Lack of Efficacy|4
7405533|NCT01356602|11673765|FG000|Overall Study|Adverse Event|0
7405534|NCT01356602|11673766|FG001|Overall Study|Adverse Event|1
7405535|NCT01356602|11673767|FG002|Overall Study|Adverse Event|1
7405536|NCT01356940|11673781|FG000|First Intervention (28 Days)|Adverse Event|1
7405537|NCT01356940|11673782|FG001|First Intervention (28 Days)|Adverse Event|0
7405538|NCT01356940|11673781|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
7405539|NCT01356940|11673782|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
7405540|NCT01356966|11673792|FG000|Overall Study|Withdrawal by Subject|1
7405541|NCT01356966|11673793|FG001|Overall Study|Withdrawal by Subject|2
7405542|NCT01356966|11673792|FG000|Overall Study|Physician Decision|1
7405543|NCT01356966|11673793|FG001|Overall Study|Physician Decision|0
7405544|NCT01357161|11673819|FG000|Part 1 (Open Label Run-in)|Death|5
7405545|NCT01357161|11673820|FG001|Part 1 (Open Label Run-in)|Death|0
7405546|NCT01357161|11673821|FG002|Part 1 (Open Label Run-in)|Death|0
7405547|NCT01357161|11673819|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
7405548|NCT01357161|11673820|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7405549|NCT01357161|11673821|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
7405550|NCT01357161|11673819|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
7405551|NCT01357161|11673820|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
7405552|NCT01357161|11673821|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
7405553|NCT01357161|11673819|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
7405554|NCT01357161|11673820|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7405555|NCT01357161|11673821|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
7405556|NCT01357161|11673819|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
7405557|NCT01357161|11673820|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7405558|NCT01357161|11673821|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
7405559|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Death|0
7405560|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Death|22
7405561|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Death|19
7405562|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
7405563|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
7405564|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
7405565|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
7405566|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
7405567|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
7405568|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
7405569|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
7405570|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
7405571|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
7405572|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
7405573|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
7405574|NCT01357161|11673819|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
7405575|NCT01357161|11673820|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
7405576|NCT01357161|11673821|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
7405577|NCT01357239|11673833|FG000|Stratum: All Patients|Adverse Event|0
7405578|NCT01357239|11673834|FG001|Stratum: All Patients|Adverse Event|0
7405579|NCT01357239|11673835|FG002|Stratum: All Patients|Adverse Event|1
7405580|NCT01357239|11673836|FG003|Stratum: All Patients|Adverse Event|1
7405581|NCT01357239|11673833|FG000|Stratum: All Patients|Subject withdrew consent|0
7405582|NCT01357239|11673834|FG001|Stratum: All Patients|Subject withdrew consent|0
7405583|NCT01357239|11673835|FG002|Stratum: All Patients|Subject withdrew consent|1
7405584|NCT01357239|11673836|FG003|Stratum: All Patients|Subject withdrew consent|1
7405585|NCT01357239|11673833|FG000|Stratum I: Fully-Methylated|Adverse Event|0
7405586|NCT01357239|11673834|FG001|Stratum I: Fully-Methylated|Adverse Event|0
7405587|NCT01357239|11673835|FG002|Stratum I: Fully-Methylated|Adverse Event|1
7405588|NCT01357239|11673836|FG003|Stratum I: Fully-Methylated|Adverse Event|0
7405589|NCT01357239|11673833|FG000|Stratum II: Partially-Methylated|Adverse Event|0
7405590|NCT01357239|11673834|FG001|Stratum II: Partially-Methylated|Adverse Event|0
7405591|NCT01357239|11673835|FG002|Stratum II: Partially-Methylated|Adverse Event|0
7405592|NCT01357239|11673836|FG003|Stratum II: Partially-Methylated|Adverse Event|1
7405593|NCT01357239|11673833|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
7405594|NCT01357239|11673834|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
7405595|NCT01357239|11673835|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
7405596|NCT01357239|11673836|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
7405597|NCT01357551|11673883|FG000|Overall Study|Withdrawal by Subject|6
7405598|NCT01357551|11673884|FG001|Overall Study|Withdrawal by Subject|4
7405599|NCT01357551|11673883|FG000|Overall Study|Death|0
7405600|NCT01357551|11673884|FG001|Overall Study|Death|1
7405601|NCT01357551|11673883|FG000|Overall Study|Lost to Follow-up|16
7405602|NCT01357551|11673884|FG001|Overall Study|Lost to Follow-up|6
7405603|NCT01357577|11673906|FG000|Overall Study|Lost to Follow-up|20
7405604|NCT01357577|11673907|FG001|Overall Study|Lost to Follow-up|16
7405605|NCT01357577|11673906|FG000|Overall Study|Withdrawal by Subject|16
7405606|NCT01357577|11673907|FG001|Overall Study|Withdrawal by Subject|8
7405607|NCT01357577|11673906|FG000|Overall Study|look at data in database?|1
7405608|NCT01357577|11673907|FG001|Overall Study|look at data in database?|2
7405609|NCT01357616|11673916|FG000|Overall Study|Adverse Event|1
7405610|NCT01357616|11673917|FG001|Overall Study|Adverse Event|1
7405611|NCT01357616|11673916|FG000|Overall Study|Lost to Follow-up|4
7405612|NCT01357616|11673917|FG001|Overall Study|Lost to Follow-up|3
7405613|NCT01357616|11673916|FG000|Overall Study|Protocol Violation|0
7405614|NCT01357616|11673917|FG001|Overall Study|Protocol Violation|2
7405615|NCT01357616|11673916|FG000|Overall Study|Inadequate Control of IOP|1
7405616|NCT01357616|11673917|FG001|Overall Study|Inadequate Control of IOP|2
7405617|NCT01357616|11673916|FG000|Overall Study|Decision Unrelated to Adverse Event|3
7405618|NCT01357616|11673917|FG001|Overall Study|Decision Unrelated to Adverse Event|1
7405619|NCT01357616|11673916|FG000|Overall Study|Withdrawal by Subject|1
7405620|NCT01357616|11673917|FG001|Overall Study|Withdrawal by Subject|0
7405621|NCT01357655|11673925|FG000|Overall Study|Administrative Reason by Sponsor|45
7405622|NCT01357655|11673926|FG001|Overall Study|Administrative Reason by Sponsor|0
7405623|NCT01357655|11673925|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
7405624|NCT01357655|11673926|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
7405625|NCT01357655|11673925|FG000|Overall Study|Disease Progression|1
7405626|NCT01357655|11673926|FG001|Overall Study|Disease Progression|0
7405627|NCT01357655|11673925|FG000|Overall Study|Lost to Follow-up|2
7405628|NCT01357655|11673926|FG001|Overall Study|Lost to Follow-up|0
7405629|NCT01357655|11673925|FG000|Overall Study|Maximum Clinical Benefit|2
7405630|NCT01357655|11673926|FG001|Overall Study|Maximum Clinical Benefit|0
7405631|NCT01357655|11673925|FG000|Overall Study|Reason Unspecified|1
7405632|NCT01357655|11673926|FG001|Overall Study|Reason Unspecified|0
7405633|NCT01357655|11673925|FG000|Overall Study|Study Drug Toxicity|11
7405634|NCT01357655|11673926|FG001|Overall Study|Study Drug Toxicity|0
7405635|NCT01357655|11673925|FG000|Overall Study|Subject Withdrew Consent|1
7405636|NCT01357655|11673926|FG001|Overall Study|Subject Withdrew Consent|0
7405637|NCT01357850|11673944|FG000|Overall Study|Lost to Follow-up|1
7405638|NCT01357850|11673945|FG001|Overall Study|Lost to Follow-up|0
7405639|NCT01357850|11673946|FG002|Overall Study|Lost to Follow-up|0
7405640|NCT01357850|11673947|FG003|Overall Study|Lost to Follow-up|0
7405641|NCT01357889|11673960|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
7405642|NCT01357889|11673961|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
7405643|NCT01357889|11673960|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7405644|NCT01357889|11673961|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
7405645|NCT01357889|11673960|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
7405646|NCT01357889|11673961|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
7405647|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7405648|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
7405649|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
7405650|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
7405651|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
7405652|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
7405653|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
7405654|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
7405655|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
7405656|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
7405657|NCT01357889|11673960|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7317608|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
7405658|NCT01357889|11673961|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
7405659|NCT01357889|11673960|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
7405660|NCT01357889|11673961|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
7405661|NCT01357889|11673960|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
7405662|NCT01357889|11673961|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
7317609|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
7317610|NCT00723528|11546557|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317611|NCT00723528|11546558|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317612|NCT00723528|11546559|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317613|NCT00723528|11546560|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317614|NCT00723528|11546561|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317615|NCT00723528|11546562|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
7317616|NCT00723528|11546563|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
7317617|NCT00723554|11546579|FG000|Overall Study|Adverse Event|12
7317618|NCT00723554|11546579|FG000|Overall Study|Investigator's judgement|5
7317619|NCT00723554|11546579|FG000|Overall Study|Inhaled medication other than iloprost|4
7317620|NCT00723554|11546579|FG000|Overall Study|Withdrawal of consent|3
7317621|NCT00723554|11546579|FG000|Overall Study|Other|3
7317622|NCT00723554|11546579|FG000|Overall Study|Lost to Follow-up|1
7317623|NCT00723554|11546579|FG000|Overall Study|Non-compliance|1
7317624|NCT00723606|11546591|FG000|Overall Study|Adverse Event|2
7317625|NCT00723606|11546592|FG001|Overall Study|Adverse Event|5
7317626|NCT00723606|11546591|FG000|Overall Study|Other|2
7317627|NCT00723606|11546592|FG001|Overall Study|Other|0
7317628|NCT00723606|11546591|FG000|Overall Study|Withdrawal by Subject|0
7317629|NCT00723606|11546592|FG001|Overall Study|Withdrawal by Subject|2
7384589|NCT01195636|11641815|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
7384590|NCT01195636|11641814|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
7384591|NCT01195636|11641815|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
7384592|NCT01195636|11641814|FG000|Washout Period (2 Weeks)|Adverse Event|1
7384593|NCT01195636|11641815|FG001|Washout Period (2 Weeks)|Adverse Event|1
7384594|NCT01195636|11641814|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
7384595|NCT01195636|11641815|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
7384596|NCT01195636|11641814|FG000|Second Intervention (3 Weeks)|Adverse Event|1
7384597|NCT01195636|11641815|FG001|Second Intervention (3 Weeks)|Adverse Event|1
7384598|NCT01195636|11641814|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7384599|NCT01195636|11641815|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7384600|NCT01195662|11641824|FG000|Double Blind Treatment Period|Adverse Event|4
7405663|NCT01357889|11673960|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
7405664|NCT01357889|11673961|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
7405665|NCT01357889|11673960|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
7405666|NCT01357889|11673961|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
7405667|NCT01357915|11673971|FG000|Overall Study|Lost to Follow-up|3
7405668|NCT01357915|11673972|FG001|Overall Study|Lost to Follow-up|0
7465784|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
7465785|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
7465786|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
7465787|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
7465788|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
7465789|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
7465790|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7465791|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
7465792|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
7465793|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
7465794|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
7465795|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
7465796|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
7465797|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
7465798|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
7465799|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7465800|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
7465801|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
7465802|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
7465803|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
7465804|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
7465805|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
7465806|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7465807|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
7465808|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7465809|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
7465810|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
7465811|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7465812|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
7465813|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
7465814|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7465815|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
7465816|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
7465817|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
7465818|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
7465819|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
7465820|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
7465821|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7465822|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
7465823|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7465824|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
7465825|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
7465826|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
7465827|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
7465828|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
7465829|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
7465830|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
7465831|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
7465832|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
7465833|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
7465834|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
7465835|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
7465836|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7465837|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
7465838|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
7465839|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7465840|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
7465841|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
7465842|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
7468639|NCT01912768|11769528|FG001|Overall Study|Withdrawal by Subject|3
7405677|NCT01358175|11673998|FG000|Overall Study|Death|1
7405678|NCT01358175|11673999|FG001|Overall Study|Death|0
7405679|NCT01358175|11674000|FG002|Overall Study|Death|1
7405680|NCT01358175|11673998|FG000|Overall Study|Withdrawal by Subject|9
7405681|NCT01358175|11673999|FG001|Overall Study|Withdrawal by Subject|5
7405682|NCT01358175|11674000|FG002|Overall Study|Withdrawal by Subject|10
7405683|NCT01358175|11673998|FG000|Overall Study|Technical issues|0
7405684|NCT01358175|11673999|FG001|Overall Study|Technical issues|1
7405685|NCT01358175|11674000|FG002|Overall Study|Technical issues|0
7405686|NCT01358175|11673998|FG000|Overall Study|Pregnancy|0
7405687|NCT01358175|11673999|FG001|Overall Study|Pregnancy|1
7405688|NCT01358175|11674000|FG002|Overall Study|Pregnancy|0
7405689|NCT01358175|11673998|FG000|Overall Study|Physician Decision|1
7405690|NCT01358175|11673999|FG001|Overall Study|Physician Decision|0
7405691|NCT01358175|11674000|FG002|Overall Study|Physician Decision|0
7405692|NCT01358175|11673998|FG000|Overall Study|Non Compliance with Study Treatment|0
7405693|NCT01358175|11673999|FG001|Overall Study|Non Compliance with Study Treatment|1
7405694|NCT01358175|11674000|FG002|Overall Study|Non Compliance with Study Treatment|1
7405695|NCT01358175|11673998|FG000|Overall Study|Lost to Follow-up|1
7405696|NCT01358175|11673999|FG001|Overall Study|Lost to Follow-up|1
7405697|NCT01358175|11674000|FG002|Overall Study|Lost to Follow-up|3
7405698|NCT01358175|11673998|FG000|Overall Study|Lack of Efficacy|3
7405699|NCT01358175|11673999|FG001|Overall Study|Lack of Efficacy|8
7405700|NCT01358175|11674000|FG002|Overall Study|Lack of Efficacy|6
7405701|NCT01358175|11673998|FG000|Overall Study|Adverse Event|6
7405702|NCT01358175|11673999|FG001|Overall Study|Adverse Event|11
7405703|NCT01358175|11674000|FG002|Overall Study|Adverse Event|11
7405704|NCT01358331|11674032|FG000|Overall Study|Lost to Follow-up|0
7405705|NCT01358331|11674033|FG001|Overall Study|Lost to Follow-up|0
7405706|NCT01358331|11674034|FG002|Overall Study|Lost to Follow-up|0
7405707|NCT01358331|11674035|FG003|Overall Study|Lost to Follow-up|1
7405708|NCT01358331|11674036|FG004|Overall Study|Lost to Follow-up|0
7405709|NCT01358331|11674037|FG005|Overall Study|Lost to Follow-up|0
7405710|NCT01358331|11674032|FG000|Overall Study|Withdrawal by Subject|0
7405711|NCT01358331|11674033|FG001|Overall Study|Withdrawal by Subject|0
7405712|NCT01358331|11674034|FG002|Overall Study|Withdrawal by Subject|0
7405713|NCT01358331|11674035|FG003|Overall Study|Withdrawal by Subject|1
7405714|NCT01358331|11674036|FG004|Overall Study|Withdrawal by Subject|1
7405715|NCT01358331|11674037|FG005|Overall Study|Withdrawal by Subject|1
7405716|NCT01358331|11674032|FG000|Overall Study|Adverse Events|1
7405717|NCT01358331|11674033|FG001|Overall Study|Adverse Events|1
7405718|NCT01358331|11674034|FG002|Overall Study|Adverse Events|1
7405719|NCT01358331|11674035|FG003|Overall Study|Adverse Events|0
7405720|NCT01358331|11674036|FG004|Overall Study|Adverse Events|1
7405721|NCT01358331|11674037|FG005|Overall Study|Adverse Events|5
7405722|NCT01358331|11674032|FG000|Overall Study|Symptomatic Deterioration|0
7405723|NCT01358331|11674033|FG001|Overall Study|Symptomatic Deterioration|0
7405724|NCT01358331|11674034|FG002|Overall Study|Symptomatic Deterioration|0
7405725|NCT01358331|11674035|FG003|Overall Study|Symptomatic Deterioration|0
7405726|NCT01358331|11674036|FG004|Overall Study|Symptomatic Deterioration|1
7405727|NCT01358331|11674037|FG005|Overall Study|Symptomatic Deterioration|0
7405728|NCT01358331|11674032|FG000|Overall Study|Participants did not wish to continue|0
7405729|NCT01358331|11674033|FG001|Overall Study|Participants did not wish to continue|0
7405730|NCT01358331|11674034|FG002|Overall Study|Participants did not wish to continue|0
7405731|NCT01358331|11674035|FG003|Overall Study|Participants did not wish to continue|0
7405732|NCT01358331|11674036|FG004|Overall Study|Participants did not wish to continue|1
7405733|NCT01358331|11674037|FG005|Overall Study|Participants did not wish to continue|0
7405734|NCT01358331|11674032|FG000|Overall Study|Progress of disease under investigation|1
7405735|NCT01358331|11674033|FG001|Overall Study|Progress of disease under investigation|2
7405736|NCT01358331|11674034|FG002|Overall Study|Progress of disease under investigation|3
7405737|NCT01358331|11674035|FG003|Overall Study|Progress of disease under investigation|1
7405738|NCT01358331|11674036|FG004|Overall Study|Progress of disease under investigation|3
7405739|NCT01358331|11674037|FG005|Overall Study|Progress of disease under investigation|0
7405740|NCT01358357|11674053|FG000|Open Label Phase|Adverse Event|0
7405741|NCT01358357|11674054|FG001|Open Label Phase|Adverse Event|0
7405742|NCT01358357|11674055|FG002|Open Label Phase|Adverse Event|59
7405743|NCT01358357|11674053|FG000|Open Label Phase|Lack of Efficacy|0
7405744|NCT01358357|11674054|FG001|Open Label Phase|Lack of Efficacy|0
7405745|NCT01358357|11674055|FG002|Open Label Phase|Lack of Efficacy|107
7405746|NCT01358357|11674053|FG000|Open Label Phase|Lost to Follow-up|0
7405747|NCT01358357|11674054|FG001|Open Label Phase|Lost to Follow-up|0
7405748|NCT01358357|11674055|FG002|Open Label Phase|Lost to Follow-up|76
7405749|NCT01358357|11674053|FG000|Open Label Phase|Protocol Violation|0
7405750|NCT01358357|11674054|FG001|Open Label Phase|Protocol Violation|0
7405751|NCT01358357|11674055|FG002|Open Label Phase|Protocol Violation|45
7405752|NCT01358357|11674053|FG000|Open Label Phase|Withdrawal by Subject|0
7405753|NCT01358357|11674054|FG001|Open Label Phase|Withdrawal by Subject|0
7405754|NCT01358357|11674055|FG002|Open Label Phase|Withdrawal by Subject|112
7405755|NCT01358357|11674053|FG000|Open Label Phase|Did not meet criteria for DB phase|0
7405756|NCT01358357|11674054|FG001|Open Label Phase|Did not meet criteria for DB phase|0
7405757|NCT01358357|11674055|FG002|Open Label Phase|Did not meet criteria for DB phase|16
7405758|NCT01358357|11674053|FG000|Open Label Phase|Terminated at study completion|0
7405759|NCT01358357|11674054|FG001|Open Label Phase|Terminated at study completion|0
7405760|NCT01358357|11674055|FG002|Open Label Phase|Terminated at study completion|5
7405761|NCT01358357|11674053|FG000|Open Label Phase|Mood episode|0
7405762|NCT01358357|11674054|FG001|Open Label Phase|Mood episode|0
7405763|NCT01358357|11674055|FG002|Open Label Phase|Mood episode|42
7405764|NCT01358357|11674053|FG000|Double-Blind Phase|Adverse Event|8
7405765|NCT01358357|11674054|FG001|Double-Blind Phase|Adverse Event|5
7405766|NCT01358357|11674055|FG002|Double-Blind Phase|Adverse Event|0
7405767|NCT01358357|11674053|FG000|Double-Blind Phase|Lost to Follow-up|5
7405768|NCT01358357|11674054|FG001|Double-Blind Phase|Lost to Follow-up|7
7405769|NCT01358357|11674055|FG002|Double-Blind Phase|Lost to Follow-up|0
7405770|NCT01358357|11674053|FG000|Double-Blind Phase|Protocol Violation|1
7405771|NCT01358357|11674054|FG001|Double-Blind Phase|Protocol Violation|11
7405772|NCT01358357|11674055|FG002|Double-Blind Phase|Protocol Violation|0
7405773|NCT01358357|11674053|FG000|Double-Blind Phase|Protocol Violation|16
7405774|NCT01358357|11674054|FG001|Double-Blind Phase|Protocol Violation|12
7405775|NCT01358357|11674055|FG002|Double-Blind Phase|Protocol Violation|0
7405776|NCT01358357|11674053|FG000|Double-Blind Phase|Terminated at study completion|2
7405777|NCT01358357|11674054|FG001|Double-Blind Phase|Terminated at study completion|0
7405778|NCT01358357|11674055|FG002|Double-Blind Phase|Terminated at study completion|0
7405779|NCT01358357|11674053|FG000|Double-Blind Phase|Recurrence of mood event|48
7405780|NCT01358357|11674054|FG001|Double-Blind Phase|Recurrence of mood event|64
7405781|NCT01358357|11674055|FG002|Double-Blind Phase|Recurrence of mood event|0
7405782|NCT01358357|11674053|FG000|Double-Blind Phase|Administrative|0
7405783|NCT01358357|11674054|FG001|Double-Blind Phase|Administrative|1
7405784|NCT01358357|11674055|FG002|Double-Blind Phase|Administrative|0
7405785|NCT01358526|11674064|FG000|Open-label Titration Period|Adverse Event|95
7405786|NCT01358526|11674065|FG001|Open-label Titration Period|Adverse Event|0
7405787|NCT01358526|11674066|FG002|Open-label Titration Period|Adverse Event|0
7405788|NCT01358526|11674064|FG000|Open-label Titration Period|Withdrawal by Subject|65
7405789|NCT01358526|11674065|FG001|Open-label Titration Period|Withdrawal by Subject|0
7405790|NCT01358526|11674066|FG002|Open-label Titration Period|Withdrawal by Subject|0
7405791|NCT01358526|11674064|FG000|Open-label Titration Period|Lost to Follow-up|25
7405792|NCT01358526|11674065|FG001|Open-label Titration Period|Lost to Follow-up|0
7405793|NCT01358526|11674066|FG002|Open-label Titration Period|Lost to Follow-up|0
7405794|NCT01358526|11674064|FG000|Open-label Titration Period|Lack of Efficacy|107
7405795|NCT01358526|11674065|FG001|Open-label Titration Period|Lack of Efficacy|0
7405796|NCT01358526|11674066|FG002|Open-label Titration Period|Lack of Efficacy|0
7405797|NCT01358526|11674064|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
7405798|NCT01358526|11674065|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
7405799|NCT01358526|11674066|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
7405800|NCT01358526|11674064|FG000|Open-label Titration Period|Administrative|8
7405801|NCT01358526|11674065|FG001|Open-label Titration Period|Administrative|0
7405802|NCT01358526|11674066|FG002|Open-label Titration Period|Administrative|0
7405803|NCT01358526|11674064|FG000|Open-label Titration Period|Did not qualify|178
7405804|NCT01358526|11674065|FG001|Open-label Titration Period|Did not qualify|0
7405805|NCT01358526|11674066|FG002|Open-label Titration Period|Did not qualify|0
7405806|NCT01358526|11674064|FG000|Double-blind Phase|Adverse Event|0
7405807|NCT01358526|11674065|FG001|Double-blind Phase|Adverse Event|24
7405808|NCT01358526|11674066|FG002|Double-blind Phase|Adverse Event|23
7405809|NCT01358526|11674064|FG000|Double-blind Phase|Withdrawal by Subject|0
7405810|NCT01358526|11674065|FG001|Double-blind Phase|Withdrawal by Subject|10
7405811|NCT01358526|11674066|FG002|Double-blind Phase|Withdrawal by Subject|8
7405812|NCT01358526|11674064|FG000|Double-blind Phase|Lost to Follow-up|0
7405813|NCT01358526|11674065|FG001|Double-blind Phase|Lost to Follow-up|4
7405814|NCT01358526|11674066|FG002|Double-blind Phase|Lost to Follow-up|1
7405815|NCT01358526|11674064|FG000|Double-blind Phase|Lack of Efficacy|0
7405816|NCT01358526|11674065|FG001|Double-blind Phase|Lack of Efficacy|31
7405817|NCT01358526|11674066|FG002|Double-blind Phase|Lack of Efficacy|73
7405818|NCT01358526|11674064|FG000|Double-blind Phase|Confirmed or suspected diversion|0
7405819|NCT01358526|11674065|FG001|Double-blind Phase|Confirmed or suspected diversion|5
7405820|NCT01358526|11674066|FG002|Double-blind Phase|Confirmed or suspected diversion|6
7405821|NCT01358526|11674064|FG000|Double-blind Phase|Administrative|0
7405822|NCT01358526|11674065|FG001|Double-blind Phase|Administrative|6
7405823|NCT01358526|11674066|FG002|Double-blind Phase|Administrative|10
7405824|NCT01358578|11674077|FG000|Induction Period|Adverse Event|2
7405825|NCT01358578|11674078|FG001|Induction Period|Adverse Event|4
7405826|NCT01358578|11674079|FG002|Induction Period|Adverse Event|2
7405827|NCT01358578|11674080|FG003|Induction Period|Adverse Event|6
7405828|NCT01358578|11674081|FG004|Induction Period|Adverse Event|0
7405829|NCT01358578|11674082|FG005|Induction Period|Adverse Event|0
7405830|NCT01358578|11674077|FG000|Induction Period|Lack of Efficacy|0
7405831|NCT01358578|11674078|FG001|Induction Period|Lack of Efficacy|0
7405832|NCT01358578|11674079|FG002|Induction Period|Lack of Efficacy|9
7405833|NCT01358578|11674080|FG003|Induction Period|Lack of Efficacy|1
7405834|NCT01358578|11674081|FG004|Induction Period|Lack of Efficacy|0
7405835|NCT01358578|11674082|FG005|Induction Period|Lack of Efficacy|0
7405836|NCT01358578|11674077|FG000|Induction Period|Lost to Follow-up|0
7405837|NCT01358578|11674078|FG001|Induction Period|Lost to Follow-up|0
7405838|NCT01358578|11674079|FG002|Induction Period|Lost to Follow-up|1
7405839|NCT01358578|11674080|FG003|Induction Period|Lost to Follow-up|4
7405840|NCT01358578|11674081|FG004|Induction Period|Lost to Follow-up|0
7405841|NCT01358578|11674082|FG005|Induction Period|Lost to Follow-up|0
7405842|NCT01358578|11674077|FG000|Induction Period|Physician Decision|2
7405843|NCT01358578|11674078|FG001|Induction Period|Physician Decision|1
7405844|NCT01358578|11674079|FG002|Induction Period|Physician Decision|2
7405845|NCT01358578|11674080|FG003|Induction Period|Physician Decision|0
7405846|NCT01358578|11674081|FG004|Induction Period|Physician Decision|0
7405847|NCT01358578|11674082|FG005|Induction Period|Physician Decision|0
7405848|NCT01358578|11674077|FG000|Induction Period|Protocol Deviation|3
7405849|NCT01358578|11674078|FG001|Induction Period|Protocol Deviation|5
7405850|NCT01358578|11674079|FG002|Induction Period|Protocol Deviation|0
7405851|NCT01358578|11674080|FG003|Induction Period|Protocol Deviation|3
7405852|NCT01358578|11674081|FG004|Induction Period|Protocol Deviation|0
7405853|NCT01358578|11674082|FG005|Induction Period|Protocol Deviation|0
7405854|NCT01358578|11674077|FG000|Induction Period|technical problems|0
7405855|NCT01358578|11674078|FG001|Induction Period|technical problems|0
7405856|NCT01358578|11674079|FG002|Induction Period|technical problems|1
7405857|NCT01358578|11674080|FG003|Induction Period|technical problems|1
7405858|NCT01358578|11674081|FG004|Induction Period|technical problems|0
7405859|NCT01358578|11674082|FG005|Induction Period|technical problems|0
7405860|NCT01358578|11674077|FG000|Induction Period|Withdrawal by Subject|5
7405861|NCT01358578|11674078|FG001|Induction Period|Withdrawal by Subject|5
7405862|NCT01358578|11674079|FG002|Induction Period|Withdrawal by Subject|10
7405863|NCT01358578|11674080|FG003|Induction Period|Withdrawal by Subject|6
7405864|NCT01358578|11674081|FG004|Induction Period|Withdrawal by Subject|0
7405865|NCT01358578|11674082|FG005|Induction Period|Withdrawal by Subject|0
7405866|NCT01358578|11674077|FG000|Maintenance Period|Adverse Event|2
7405867|NCT01358578|11674078|FG001|Maintenance Period|Adverse Event|7
7405868|NCT01358578|11674079|FG002|Maintenance Period|Adverse Event|0
7405869|NCT01358578|11674080|FG003|Maintenance Period|Adverse Event|6
7405870|NCT01358578|11674081|FG004|Maintenance Period|Adverse Event|4
7405871|NCT01358578|11674082|FG005|Maintenance Period|Adverse Event|3
7405872|NCT01358578|11674077|FG000|Maintenance Period|Lack of Efficacy|10
7405873|NCT01358578|11674078|FG001|Maintenance Period|Lack of Efficacy|2
7405874|NCT01358578|11674079|FG002|Maintenance Period|Lack of Efficacy|0
7405875|NCT01358578|11674080|FG003|Maintenance Period|Lack of Efficacy|11
7405876|NCT01358578|11674081|FG004|Maintenance Period|Lack of Efficacy|3
7405877|NCT01358578|11674082|FG005|Maintenance Period|Lack of Efficacy|0
7405878|NCT01358578|11674077|FG000|Maintenance Period|Lost to Follow-up|4
7405879|NCT01358578|11674078|FG001|Maintenance Period|Lost to Follow-up|0
7405880|NCT01358578|11674079|FG002|Maintenance Period|Lost to Follow-up|0
7405881|NCT01358578|11674080|FG003|Maintenance Period|Lost to Follow-up|5
7405882|NCT01358578|11674081|FG004|Maintenance Period|Lost to Follow-up|1
7405883|NCT01358578|11674082|FG005|Maintenance Period|Lost to Follow-up|1
7405884|NCT01358578|11674077|FG000|Maintenance Period|Non-compliance with study treatment|3
7405885|NCT01358578|11674078|FG001|Maintenance Period|Non-compliance with study treatment|1
7405886|NCT01358578|11674079|FG002|Maintenance Period|Non-compliance with study treatment|0
7405887|NCT01358578|11674080|FG003|Maintenance Period|Non-compliance with study treatment|2
7405888|NCT01358578|11674081|FG004|Maintenance Period|Non-compliance with study treatment|1
7405889|NCT01358578|11674082|FG005|Maintenance Period|Non-compliance with study treatment|2
7405890|NCT01358578|11674077|FG000|Maintenance Period|Physician Decision|0
7405891|NCT01358578|11674078|FG001|Maintenance Period|Physician Decision|1
7405892|NCT01358578|11674079|FG002|Maintenance Period|Physician Decision|0
7405893|NCT01358578|11674080|FG003|Maintenance Period|Physician Decision|1
7405894|NCT01358578|11674081|FG004|Maintenance Period|Physician Decision|0
7405895|NCT01358578|11674082|FG005|Maintenance Period|Physician Decision|0
7405896|NCT01358578|11674077|FG000|Maintenance Period|Pregnancy|1
7405897|NCT01358578|11674078|FG001|Maintenance Period|Pregnancy|0
7405898|NCT01358578|11674079|FG002|Maintenance Period|Pregnancy|0
7405899|NCT01358578|11674080|FG003|Maintenance Period|Pregnancy|0
7405900|NCT01358578|11674081|FG004|Maintenance Period|Pregnancy|0
7405901|NCT01358578|11674082|FG005|Maintenance Period|Pregnancy|0
7405902|NCT01358578|11674077|FG000|Maintenance Period|Protocol deviation|7
7405903|NCT01358578|11674078|FG001|Maintenance Period|Protocol deviation|4
7405904|NCT01358578|11674079|FG002|Maintenance Period|Protocol deviation|0
7405905|NCT01358578|11674080|FG003|Maintenance Period|Protocol deviation|2
7405906|NCT01358578|11674081|FG004|Maintenance Period|Protocol deviation|2
7405907|NCT01358578|11674082|FG005|Maintenance Period|Protocol deviation|2
7405908|NCT01358578|11674077|FG000|Maintenance Period|Withdrawal by Subject|12
7405909|NCT01358578|11674078|FG001|Maintenance Period|Withdrawal by Subject|7
7405910|NCT01358578|11674079|FG002|Maintenance Period|Withdrawal by Subject|2
7405911|NCT01358578|11674080|FG003|Maintenance Period|Withdrawal by Subject|15
7405912|NCT01358578|11674081|FG004|Maintenance Period|Withdrawal by Subject|6
7405913|NCT01358578|11674082|FG005|Maintenance Period|Withdrawal by Subject|3
7405914|NCT01358578|11674077|FG000|Follow-up Period|Adverse Event|1
7405915|NCT01358578|11674078|FG001|Follow-up Period|Adverse Event|1
7405916|NCT01358578|11674079|FG002|Follow-up Period|Adverse Event|0
7405917|NCT01358578|11674080|FG003|Follow-up Period|Adverse Event|0
7405918|NCT01358578|11674081|FG004|Follow-up Period|Adverse Event|0
7405919|NCT01358578|11674082|FG005|Follow-up Period|Adverse Event|0
7405920|NCT01358578|11674077|FG000|Follow-up Period|Lack of Efficacy|3
7405921|NCT01358578|11674078|FG001|Follow-up Period|Lack of Efficacy|0
7405922|NCT01358578|11674079|FG002|Follow-up Period|Lack of Efficacy|4
7405923|NCT01358578|11674080|FG003|Follow-up Period|Lack of Efficacy|1
7405924|NCT01358578|11674081|FG004|Follow-up Period|Lack of Efficacy|0
7405925|NCT01358578|11674082|FG005|Follow-up Period|Lack of Efficacy|0
7405926|NCT01358578|11674077|FG000|Follow-up Period|Lost to Follow-up|0
7405927|NCT01358578|11674078|FG001|Follow-up Period|Lost to Follow-up|1
7405928|NCT01358578|11674079|FG002|Follow-up Period|Lost to Follow-up|0
7405929|NCT01358578|11674080|FG003|Follow-up Period|Lost to Follow-up|4
7405930|NCT01358578|11674081|FG004|Follow-up Period|Lost to Follow-up|0
7405931|NCT01358578|11674082|FG005|Follow-up Period|Lost to Follow-up|0
7405932|NCT01358578|11674077|FG000|Follow-up Period|non- compliance with study treatment|1
7405933|NCT01358578|11674078|FG001|Follow-up Period|non- compliance with study treatment|0
7405934|NCT01358578|11674079|FG002|Follow-up Period|non- compliance with study treatment|0
7405935|NCT01358578|11674080|FG003|Follow-up Period|non- compliance with study treatment|0
7405936|NCT01358578|11674081|FG004|Follow-up Period|non- compliance with study treatment|0
7405937|NCT01358578|11674082|FG005|Follow-up Period|non- compliance with study treatment|0
7405938|NCT01358578|11674077|FG000|Follow-up Period|Pregnancy|1
7405939|NCT01358578|11674078|FG001|Follow-up Period|Pregnancy|0
7405940|NCT01358578|11674079|FG002|Follow-up Period|Pregnancy|0
7405941|NCT01358578|11674080|FG003|Follow-up Period|Pregnancy|0
7405942|NCT01358578|11674081|FG004|Follow-up Period|Pregnancy|0
7405943|NCT01358578|11674082|FG005|Follow-up Period|Pregnancy|0
7405944|NCT01358578|11674077|FG000|Follow-up Period|Withdrawal by Subject|3
7405945|NCT01358578|11674078|FG001|Follow-up Period|Withdrawal by Subject|3
7405946|NCT01358578|11674079|FG002|Follow-up Period|Withdrawal by Subject|1
7405947|NCT01358578|11674080|FG003|Follow-up Period|Withdrawal by Subject|12
7405948|NCT01358578|11674081|FG004|Follow-up Period|Withdrawal by Subject|0
7405949|NCT01358578|11674082|FG005|Follow-up Period|Withdrawal by Subject|0
7405950|NCT01358578|11674077|FG000|Follow-up Period|Physician Decision|1
7405951|NCT01358578|11674078|FG001|Follow-up Period|Physician Decision|1
7405952|NCT01358578|11674079|FG002|Follow-up Period|Physician Decision|0
7405953|NCT01358578|11674080|FG003|Follow-up Period|Physician Decision|2
7405954|NCT01358578|11674081|FG004|Follow-up Period|Physician Decision|0
7405955|NCT01358578|11674082|FG005|Follow-up Period|Physician Decision|0
7405956|NCT01358708|11674112|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
7405957|NCT01358708|11674113|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7405958|NCT01358708|11674112|FG000|Double-Blind Treatment Phase|Protocol Violation|1
7405959|NCT01358708|11674113|FG001|Double-Blind Treatment Phase|Protocol Violation|0
7405960|NCT01358721|11674127|FG000|Overall Study|Withdrawal by Subject|0
7405961|NCT01358721|11674128|FG001|Overall Study|Withdrawal by Subject|0
7405962|NCT01358721|11674129|FG002|Overall Study|Withdrawal by Subject|0
7405963|NCT01358721|11674130|FG003|Overall Study|Withdrawal by Subject|1
7405964|NCT01358721|11674127|FG000|Overall Study|Death|0
7405965|NCT01358721|11674128|FG001|Overall Study|Death|2
7405966|NCT01358721|11674129|FG002|Overall Study|Death|0
7405967|NCT01358721|11674130|FG003|Overall Study|Death|0
7405968|NCT01358721|11674127|FG000|Overall Study|Study Drug Toxicity|1
7405969|NCT01358721|11674128|FG001|Overall Study|Study Drug Toxicity|3
7405970|NCT01358721|11674129|FG002|Overall Study|Study Drug Toxicity|4
7405971|NCT01358721|11674130|FG003|Overall Study|Study Drug Toxicity|5
7405972|NCT01358721|11674127|FG000|Overall Study|SUBJ request to discontinue study TRT|0
7406057|NCT01358864|11674183|FG000|Overall Study|Withdrawal by Subject|3
7405973|NCT01358721|11674128|FG001|Overall Study|SUBJ request to discontinue study TRT|0
7405974|NCT01358721|11674129|FG002|Overall Study|SUBJ request to discontinue study TRT|0
7405975|NCT01358721|11674130|FG003|Overall Study|SUBJ request to discontinue study TRT|1
7405976|NCT01358721|11674127|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7405977|NCT01358721|11674128|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7405978|NCT01358721|11674129|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7405979|NCT01358721|11674130|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
7405980|NCT01358721|11674127|FG000|Overall Study|Adverse Event related to study drug|1
7405981|NCT01358721|11674128|FG001|Overall Study|Adverse Event related to study drug|0
7405982|NCT01358721|11674129|FG002|Overall Study|Adverse Event related to study drug|0
7405983|NCT01358721|11674130|FG003|Overall Study|Adverse Event related to study drug|1
7405984|NCT01358721|11674127|FG000|Overall Study|Disease Progression|19
7405985|NCT01358721|11674128|FG001|Overall Study|Disease Progression|15
7405986|NCT01358721|11674129|FG002|Overall Study|Disease Progression|17
7405987|NCT01358721|11674130|FG003|Overall Study|Disease Progression|15
7405988|NCT01358721|11674127|FG000|Overall Study|Out of State/Unmet Criteria|0
7405989|NCT01358721|11674128|FG001|Overall Study|Out of State/Unmet Criteria|0
7405990|NCT01358721|11674129|FG002|Overall Study|Out of State/Unmet Criteria|1
7405991|NCT01358721|11674130|FG003|Overall Study|Out of State/Unmet Criteria|0
7405992|NCT01358734|11674143|FG000|Overall Study|Adverse Event|4
7405993|NCT01358734|11674144|FG001|Overall Study|Adverse Event|7
7405994|NCT01358734|11674145|FG002|Overall Study|Adverse Event|3
7405995|NCT01358734|11674143|FG000|Overall Study|Lack of Efficacy|0
7405996|NCT01358734|11674144|FG001|Overall Study|Lack of Efficacy|1
7405997|NCT01358734|11674145|FG002|Overall Study|Lack of Efficacy|3
7405998|NCT01358734|11674143|FG000|Overall Study|Withdrawal by Subject|1
7405999|NCT01358734|11674144|FG001|Overall Study|Withdrawal by Subject|6
7406000|NCT01358734|11674145|FG002|Overall Study|Withdrawal by Subject|3
7406001|NCT01358734|11674143|FG000|Overall Study|Death|3
7406002|NCT01358734|11674144|FG001|Overall Study|Death|7
7406003|NCT01358734|11674145|FG002|Overall Study|Death|2
7406004|NCT01358734|11674143|FG000|Overall Study|Progressive Disease|5
7406005|NCT01358734|11674144|FG001|Overall Study|Progressive Disease|13
7406006|NCT01358734|11674145|FG002|Overall Study|Progressive Disease|16
7406007|NCT01358734|11674143|FG000|Overall Study|Non-compliance with study drug|0
7406008|NCT01358734|11674144|FG001|Overall Study|Non-compliance with study drug|0
7406009|NCT01358734|11674145|FG002|Overall Study|Non-compliance with study drug|1
7406010|NCT01358734|11674143|FG000|Overall Study|Other|2
7406011|NCT01358734|11674144|FG001|Overall Study|Other|5
7406012|NCT01358734|11674145|FG002|Overall Study|Other|4
7406013|NCT01358734|11674143|FG000|Overall Study|Protocol Violation|0
7406014|NCT01358734|11674144|FG001|Overall Study|Protocol Violation|0
7406015|NCT01358734|11674145|FG002|Overall Study|Protocol Violation|2
7406016|NCT01358760|11674156|FG000|Overall Study|Adverse Event|3
7406017|NCT01358760|11674157|FG001|Overall Study|Adverse Event|4
7406018|NCT01358760|11674158|FG002|Overall Study|Adverse Event|3
7406019|NCT01358760|11674156|FG000|Overall Study|Lost to Follow-up|1
7406020|NCT01358760|11674157|FG001|Overall Study|Lost to Follow-up|1
7406021|NCT01358760|11674158|FG002|Overall Study|Lost to Follow-up|3
7406022|NCT01358760|11674156|FG000|Overall Study|Withdrawal by Subject|5
7406023|NCT01358760|11674157|FG001|Overall Study|Withdrawal by Subject|3
7406024|NCT01358760|11674158|FG002|Overall Study|Withdrawal by Subject|2
7406025|NCT01358760|11674156|FG000|Overall Study|Physician Decision|1
7406026|NCT01358760|11674157|FG001|Overall Study|Physician Decision|0
7406027|NCT01358760|11674158|FG002|Overall Study|Physician Decision|1
7406028|NCT01358760|11674156|FG000|Overall Study|Entry criteria not met/Non-compliance|12
7406029|NCT01358760|11674157|FG001|Overall Study|Entry criteria not met/Non-compliance|12
7406030|NCT01358760|11674158|FG002|Overall Study|Entry criteria not met/Non-compliance|16
7406031|NCT01358825|11674168|FG000|Overall Study|Blood sample not drawn|0
7406032|NCT01358825|11674169|FG001|Overall Study|Blood sample not drawn|1
7406033|NCT01358864|11674183|FG000|Overall Study|Adverse Event|0
7406034|NCT01358864|11674184|FG001|Overall Study|Adverse Event|6
7406035|NCT01358864|11674185|FG002|Overall Study|Adverse Event|9
7406036|NCT01358864|11674186|FG003|Overall Study|Adverse Event|0
7406037|NCT01358864|11674187|FG004|Overall Study|Adverse Event|4
7406038|NCT01358864|11674188|FG005|Overall Study|Adverse Event|8
7406039|NCT01358864|11674189|FG006|Overall Study|Adverse Event|12
7406040|NCT01358864|11674190|FG007|Overall Study|Adverse Event|7
7406041|NCT01358864|11674183|FG000|Overall Study|Lack of Efficacy|26
7406042|NCT01358864|11674184|FG001|Overall Study|Lack of Efficacy|3
7406043|NCT01358864|11674185|FG002|Overall Study|Lack of Efficacy|4
7406044|NCT01358864|11674186|FG003|Overall Study|Lack of Efficacy|19
7406045|NCT01358864|11674187|FG004|Overall Study|Lack of Efficacy|7
7406046|NCT01358864|11674188|FG005|Overall Study|Lack of Efficacy|4
7406047|NCT01358864|11674189|FG006|Overall Study|Lack of Efficacy|49
7406048|NCT01358864|11674190|FG007|Overall Study|Lack of Efficacy|44
7406049|NCT01358864|11674183|FG000|Overall Study|Lost to Follow-up|0
7406050|NCT01358864|11674184|FG001|Overall Study|Lost to Follow-up|0
7406051|NCT01358864|11674185|FG002|Overall Study|Lost to Follow-up|1
7406052|NCT01358864|11674186|FG003|Overall Study|Lost to Follow-up|0
7406053|NCT01358864|11674187|FG004|Overall Study|Lost to Follow-up|0
7406054|NCT01358864|11674188|FG005|Overall Study|Lost to Follow-up|0
7406055|NCT01358864|11674189|FG006|Overall Study|Lost to Follow-up|0
7406056|NCT01358864|11674190|FG007|Overall Study|Lost to Follow-up|1
7406058|NCT01358864|11674184|FG001|Overall Study|Withdrawal by Subject|4
7406059|NCT01358864|11674185|FG002|Overall Study|Withdrawal by Subject|2
7406060|NCT01358864|11674186|FG003|Overall Study|Withdrawal by Subject|0
7406061|NCT01358864|11674187|FG004|Overall Study|Withdrawal by Subject|0
7406062|NCT01358864|11674188|FG005|Overall Study|Withdrawal by Subject|1
7406063|NCT01358864|11674189|FG006|Overall Study|Withdrawal by Subject|1
7406064|NCT01358864|11674190|FG007|Overall Study|Withdrawal by Subject|3
7406065|NCT01358864|11674183|FG000|Overall Study|Other reason not defined above|2
7406066|NCT01358864|11674184|FG001|Overall Study|Other reason not defined above|0
7406067|NCT01358864|11674185|FG002|Overall Study|Other reason not defined above|0
7406068|NCT01358864|11674186|FG003|Overall Study|Other reason not defined above|0
7406069|NCT01358864|11674187|FG004|Overall Study|Other reason not defined above|0
7406070|NCT01358864|11674188|FG005|Overall Study|Other reason not defined above|0
7406071|NCT01358864|11674189|FG006|Overall Study|Other reason not defined above|2
7406072|NCT01358864|11674190|FG007|Overall Study|Other reason not defined above|0
7406073|NCT01358864|11674183|FG000|Overall Study|Not treated|0
7406074|NCT01358864|11674184|FG001|Overall Study|Not treated|0
7406075|NCT01358864|11674185|FG002|Overall Study|Not treated|0
7406076|NCT01358864|11674186|FG003|Overall Study|Not treated|0
7406077|NCT01358864|11674187|FG004|Overall Study|Not treated|0
7406078|NCT01358864|11674188|FG005|Overall Study|Not treated|0
7406079|NCT01358864|11674189|FG006|Overall Study|Not treated|1
7406080|NCT01358864|11674190|FG007|Overall Study|Not treated|0
7406081|NCT01358968|11674210|FG000|Period 2|Adverse Event|0
7406082|NCT01358968|11674211|FG001|Period 2|Adverse Event|1
7406083|NCT01358968|11674212|FG002|Period 2|Adverse Event|0
7406084|NCT01358968|11674213|FG003|Period 2|Adverse Event|0
7406085|NCT01358968|11674210|FG000|Continued Access Phase|Progression of Disease|0
7406086|NCT01358968|11674211|FG001|Continued Access Phase|Progression of Disease|0
7406087|NCT01358968|11674212|FG002|Continued Access Phase|Progression of Disease|8
7406088|NCT01358968|11674213|FG003|Continued Access Phase|Progression of Disease|4
7406089|NCT01358968|11674210|FG000|Continued Access Phase|Protocol Violation|0
7406090|NCT01358968|11674211|FG001|Continued Access Phase|Protocol Violation|0
7406091|NCT01358968|11674212|FG002|Continued Access Phase|Protocol Violation|0
7406092|NCT01358968|11674213|FG003|Continued Access Phase|Protocol Violation|2
7406093|NCT01358968|11674210|FG000|Continued Access Phase|Withdrawal by Subject|0
7406094|NCT01358968|11674211|FG001|Continued Access Phase|Withdrawal by Subject|0
7406095|NCT01358968|11674212|FG002|Continued Access Phase|Withdrawal by Subject|3
7406096|NCT01358968|11674213|FG003|Continued Access Phase|Withdrawal by Subject|0
7406097|NCT01358968|11674210|FG000|Continued Access Phase|Death|0
7406098|NCT01358968|11674211|FG001|Continued Access Phase|Death|0
7406099|NCT01358968|11674212|FG002|Continued Access Phase|Death|1
7406100|NCT01358968|11674213|FG003|Continued Access Phase|Death|1
7406101|NCT01358981|11674230|FG000|Period 1|Withdrawal by Subject|0
7406102|NCT01358981|11674231|FG001|Period 1|Withdrawal by Subject|0
7406103|NCT01358981|11674232|FG002|Period 1|Withdrawal by Subject|0
7406104|NCT01358981|11674233|FG003|Period 1|Withdrawal by Subject|1
7406105|NCT01358981|11674234|FG004|Period 1|Withdrawal by Subject|0
7406106|NCT01358981|11674235|FG005|Period 1|Withdrawal by Subject|0
7406107|NCT01358981|11674236|FG006|Period 1|Withdrawal by Subject|0
7406108|NCT01359046|11674268|FG000|Overall Study|Did not receive allocated intervention|6
7406109|NCT01359046|11674269|FG001|Overall Study|Did not receive allocated intervention|6
7406110|NCT01359046|11674268|FG000|Overall Study|Physician Decision|1
7406111|NCT01359046|11674269|FG001|Overall Study|Physician Decision|11
7406112|NCT01359150|11674283|FG000|Overall Study|Lack of Efficacy|1
7406113|NCT01359150|11674284|FG001|Overall Study|Lack of Efficacy|1
7406114|NCT01359150|11674283|FG000|Overall Study|Withdrawal by Subject|1
7406115|NCT01359150|11674284|FG001|Overall Study|Withdrawal by Subject|1
7406116|NCT01359150|11674283|FG000|Overall Study|Adverse Event|4
7406117|NCT01359150|11674284|FG001|Overall Study|Adverse Event|3
7406118|NCT01359150|11674283|FG000|Overall Study|Other|1
7406119|NCT01359150|11674284|FG001|Overall Study|Other|0
7406120|NCT01359449|11674310|FG000|Overall Study|Lost to Follow-up|1
7406121|NCT01359449|11674311|FG001|Overall Study|Lost to Follow-up|0
7406122|NCT01359449|11674310|FG000|Overall Study|Protocol Violation|0
7406123|NCT01359449|11674311|FG001|Overall Study|Protocol Violation|2
7406124|NCT01359449|11674310|FG000|Overall Study|Withdrawal by Subject|3
7406125|NCT01359449|11674311|FG001|Overall Study|Withdrawal by Subject|2
7406154|NCT01359644|11674345|FG000|Treatment Period|Lack of Efficacy|0
7406155|NCT01359644|11674346|FG001|Treatment Period|Lack of Efficacy|1
7406156|NCT01359644|11674347|FG002|Treatment Period|Lack of Efficacy|0
7406157|NCT01359644|11674348|FG003|Treatment Period|Lack of Efficacy|0
7406158|NCT01359644|11674349|FG004|Treatment Period|Lack of Efficacy|0
7406159|NCT01359644|11674350|FG005|Treatment Period|Lack of Efficacy|0
7406160|NCT01359644|11674351|FG006|Treatment Period|Lack of Efficacy|0
7406161|NCT01359644|11674352|FG007|Treatment Period|Lack of Efficacy|0
7406162|NCT01359644|11674353|FG008|Treatment Period|Lack of Efficacy|0
7406163|NCT01359644|11674354|FG009|Treatment Period|Lack of Efficacy|0
7406164|NCT01359644|11674345|FG000|Treatment Period|Adverse Event|0
7406165|NCT01359644|11674346|FG001|Treatment Period|Adverse Event|0
7406166|NCT01359644|11674347|FG002|Treatment Period|Adverse Event|1
7406167|NCT01359644|11674348|FG003|Treatment Period|Adverse Event|0
7406168|NCT01359644|11674349|FG004|Treatment Period|Adverse Event|0
7406169|NCT01359644|11674350|FG005|Treatment Period|Adverse Event|1
7406170|NCT01359644|11674351|FG006|Treatment Period|Adverse Event|0
7406171|NCT01359644|11674352|FG007|Treatment Period|Adverse Event|0
7406172|NCT01359644|11674353|FG008|Treatment Period|Adverse Event|0
7406173|NCT01359644|11674354|FG009|Treatment Period|Adverse Event|0
7406174|NCT01359644|11674345|FG000|Treatment Period|Lost to Follow-up|0
7406175|NCT01359644|11674346|FG001|Treatment Period|Lost to Follow-up|0
7406176|NCT01359644|11674347|FG002|Treatment Period|Lost to Follow-up|0
7406177|NCT01359644|11674348|FG003|Treatment Period|Lost to Follow-up|0
7406178|NCT01359644|11674349|FG004|Treatment Period|Lost to Follow-up|0
7406179|NCT01359644|11674350|FG005|Treatment Period|Lost to Follow-up|1
7406180|NCT01359644|11674351|FG006|Treatment Period|Lost to Follow-up|0
7406181|NCT01359644|11674352|FG007|Treatment Period|Lost to Follow-up|0
7406182|NCT01359644|11674353|FG008|Treatment Period|Lost to Follow-up|0
7406183|NCT01359644|11674354|FG009|Treatment Period|Lost to Follow-up|0
7406184|NCT01359644|11674345|FG000|Follow-up Period|Withdrawal by Subject|0
7406185|NCT01359644|11674346|FG001|Follow-up Period|Withdrawal by Subject|0
7406186|NCT01359644|11674347|FG002|Follow-up Period|Withdrawal by Subject|0
7406187|NCT01359644|11674348|FG003|Follow-up Period|Withdrawal by Subject|0
7406188|NCT01359644|11674349|FG004|Follow-up Period|Withdrawal by Subject|0
7406189|NCT01359644|11674350|FG005|Follow-up Period|Withdrawal by Subject|1
7406190|NCT01359644|11674351|FG006|Follow-up Period|Withdrawal by Subject|0
7406191|NCT01359644|11674352|FG007|Follow-up Period|Withdrawal by Subject|0
7406192|NCT01359644|11674353|FG008|Follow-up Period|Withdrawal by Subject|0
7406193|NCT01359644|11674354|FG009|Follow-up Period|Withdrawal by Subject|0
7406194|NCT01359644|11674345|FG000|Follow-up Period|Lost to Follow-up|0
7406195|NCT01359644|11674346|FG001|Follow-up Period|Lost to Follow-up|0
7406196|NCT01359644|11674347|FG002|Follow-up Period|Lost to Follow-up|0
7406197|NCT01359644|11674348|FG003|Follow-up Period|Lost to Follow-up|0
7406198|NCT01359644|11674349|FG004|Follow-up Period|Lost to Follow-up|0
7406199|NCT01359644|11674350|FG005|Follow-up Period|Lost to Follow-up|0
7406200|NCT01359644|11674351|FG006|Follow-up Period|Lost to Follow-up|1
7406201|NCT01359644|11674352|FG007|Follow-up Period|Lost to Follow-up|2
7406202|NCT01359644|11674353|FG008|Follow-up Period|Lost to Follow-up|0
7406203|NCT01359644|11674354|FG009|Follow-up Period|Lost to Follow-up|0
7406204|NCT01359904|11674413|FG000|Overall Study|Withdrawal by Subject|1
7406205|NCT01359904|11674414|FG001|Overall Study|Withdrawal by Subject|0
7406206|NCT01359943|11674423|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
7406207|NCT01359943|11674424|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7406208|NCT01359943|11674425|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
7406209|NCT01359943|11674423|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
7406210|NCT01359943|11674424|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
7406211|NCT01359943|11674425|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
7406212|NCT01359943|11674423|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7406213|NCT01359943|11674424|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
7406214|NCT01359943|11674425|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
7406215|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
7406216|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7406217|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
7406218|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
7406219|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
7406220|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
7406221|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7406222|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
7406223|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
7406224|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7406225|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7406226|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
7406227|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7406228|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
7406229|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
7406230|NCT01359943|11674423|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
7406231|NCT01359943|11674424|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
7406232|NCT01359943|11674425|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
7406233|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
7406234|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
7406235|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
7406236|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
7406237|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
7406238|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
7406239|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7406240|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
7406241|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
7406242|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7406243|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7406244|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
7406245|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7406246|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
7406247|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
7406248|NCT01359943|11674423|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
7406249|NCT01359943|11674424|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
7406250|NCT01359943|11674425|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
7406251|NCT01359956|11674439|FG000|Overall Study|Death|61
7406252|NCT01359956|11674440|FG001|Overall Study|Death|64
7406253|NCT01359956|11674441|FG002|Overall Study|Death|67
7406254|NCT01359956|11674442|FG003|Overall Study|Death|58
7406255|NCT01360021|11674455|FG000|Overall Study|Eligibility criteria + other|2
7406256|NCT01360021|11674456|FG001|Overall Study|Eligibility criteria + other|1
7406257|NCT01360021|11674457|FG002|Overall Study|Eligibility criteria + other|1
7406258|NCT01360021|11674455|FG000|Overall Study|Protocol Violation|0
7406259|NCT01360021|11674456|FG001|Overall Study|Protocol Violation|0
7406260|NCT01360021|11674457|FG002|Overall Study|Protocol Violation|1
7406261|NCT01360021|11674455|FG000|Overall Study|Withdrawal by Subject|4
7406262|NCT01360021|11674456|FG001|Overall Study|Withdrawal by Subject|0
7406263|NCT01360021|11674457|FG002|Overall Study|Withdrawal by Subject|2
7406264|NCT01360021|11674455|FG000|Overall Study|Adverse Event|2
7406265|NCT01360021|11674456|FG001|Overall Study|Adverse Event|3
7406266|NCT01360021|11674457|FG002|Overall Study|Adverse Event|3
7406267|NCT01360398|11674474|FG000|Overall Study|Withdrawal by Subject|14
7406268|NCT01360398|11674474|FG000|Overall Study|Other|7
7406269|NCT01360398|11674474|FG000|Overall Study|Migrated/moved from study area|1
7406270|NCT01360554|11674490|FG000|Overall Study|Death|359
7406271|NCT01360554|11674491|FG001|Overall Study|Death|371
7406272|NCT01360554|11674490|FG000|Overall Study|Lost to Follow-up|4
7406273|NCT01360554|11674491|FG001|Overall Study|Lost to Follow-up|4
7406274|NCT01360554|11674490|FG000|Overall Study|Withdrawal by Subject|23
7406275|NCT01360554|11674491|FG001|Overall Study|Withdrawal by Subject|24
7406276|NCT01360554|11674490|FG000|Overall Study|Study terminated by sponsor|49
7406277|NCT01360554|11674491|FG001|Overall Study|Study terminated by sponsor|37
7406278|NCT01360554|11674490|FG000|Overall Study|Other, not specified|1
7406279|NCT01360554|11674491|FG001|Overall Study|Other, not specified|0
7406280|NCT01360554|11674490|FG000|Overall Study|Randomized but not treated.|3
7406281|NCT01360554|11674491|FG001|Overall Study|Randomized but not treated.|3
7406282|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
7406283|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
7406284|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
7406285|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
7406286|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
7406287|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Adverse Event|60
7406288|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Adverse Event|0
7406289|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Adverse Event|0
7406290|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Adverse Event|0
7406291|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Adverse Event|0
7406292|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
7406293|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7406294|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7406295|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7406296|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
7406297|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Physician Decision|10
7406298|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Physician Decision|0
7406299|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Physician Decision|0
7406300|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Physician Decision|0
7406301|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Physician Decision|0
7406302|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
7406303|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
7406304|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
7406305|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
7406306|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
7406307|NCT01360632|11674500|FG000|Phase A (8 Weeks)|Protocol Deviation|39
7406308|NCT01360632|11674501|FG001|Phase A (8 Weeks)|Protocol Deviation|0
7406309|NCT01360632|11674502|FG002|Phase A (8 Weeks)|Protocol Deviation|0
7406310|NCT01360632|11674503|FG003|Phase A (8 Weeks)|Protocol Deviation|0
7406311|NCT01360632|11674504|FG004|Phase A (8 Weeks)|Protocol Deviation|0
7406312|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
7406313|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
7406314|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
7406315|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
7406316|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
7406317|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Adverse Event|0
7406318|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Adverse Event|3
7406319|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Adverse Event|9
7406320|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Adverse Event|3
7406321|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Adverse Event|0
7406322|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7406323|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7406324|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7406325|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
7406326|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7406327|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Physician Decision|0
7406328|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Physician Decision|0
7406329|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Physician Decision|0
7406330|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Physician Decision|1
7406331|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Physician Decision|0
7406332|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
7406333|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
7406334|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
7406335|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
7406336|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
7406337|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Protocol Deviation|0
7406338|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Protocol Deviation|1
7406339|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Protocol Deviation|4
7406340|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Protocol Deviation|1
7406341|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Protocol Deviation|0
7406342|NCT01360632|11674500|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
7406343|NCT01360632|11674501|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
7406344|NCT01360632|11674502|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
7406345|NCT01360632|11674503|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
7406346|NCT01360632|11674504|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
7406347|NCT01360632|11674500|FG000|Phase A+|Lost to Follow-up|0
7406348|NCT01360632|11674501|FG001|Phase A+|Lost to Follow-up|0
7406349|NCT01360632|11674502|FG002|Phase A+|Lost to Follow-up|0
7406350|NCT01360632|11674503|FG003|Phase A+|Lost to Follow-up|0
7406351|NCT01360632|11674504|FG004|Phase A+|Lost to Follow-up|2
7406352|NCT01360632|11674500|FG000|Phase A+|Adverse Event|0
7406353|NCT01360632|11674501|FG001|Phase A+|Adverse Event|0
7406354|NCT01360632|11674502|FG002|Phase A+|Adverse Event|0
7406355|NCT01360632|11674503|FG003|Phase A+|Adverse Event|0
7406356|NCT01360632|11674504|FG004|Phase A+|Adverse Event|2
7406357|NCT01360632|11674500|FG000|Phase A+|Met Withdrawal Criteria|0
7406358|NCT01360632|11674501|FG001|Phase A+|Met Withdrawal Criteria|0
7406359|NCT01360632|11674502|FG002|Phase A+|Met Withdrawal Criteria|0
7406360|NCT01360632|11674503|FG003|Phase A+|Met Withdrawal Criteria|0
7406361|NCT01360632|11674504|FG004|Phase A+|Met Withdrawal Criteria|7
7406362|NCT01360632|11674500|FG000|Phase A+|Physician Decision|0
7406363|NCT01360632|11674501|FG001|Phase A+|Physician Decision|0
7406364|NCT01360632|11674502|FG002|Phase A+|Physician Decision|0
7406365|NCT01360632|11674503|FG003|Phase A+|Physician Decision|0
7406366|NCT01360632|11674504|FG004|Phase A+|Physician Decision|3
7406367|NCT01360632|11674500|FG000|Phase A+|Withdrawal by Subject|0
7406368|NCT01360632|11674501|FG001|Phase A+|Withdrawal by Subject|0
7406369|NCT01360632|11674502|FG002|Phase A+|Withdrawal by Subject|0
7406370|NCT01360632|11674503|FG003|Phase A+|Withdrawal by Subject|0
7406371|NCT01360632|11674504|FG004|Phase A+|Withdrawal by Subject|8
7406372|NCT01360632|11674500|FG000|Phase A+|Protocol Deviation|0
7406373|NCT01360632|11674501|FG001|Phase A+|Protocol Deviation|0
7406374|NCT01360632|11674502|FG002|Phase A+|Protocol Deviation|0
7406375|NCT01360632|11674503|FG003|Phase A+|Protocol Deviation|0
7406376|NCT01360632|11674504|FG004|Phase A+|Protocol Deviation|3
7406377|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
7406378|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7406379|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7406380|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
7406381|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
7406382|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7406383|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7406384|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
7406385|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
7406386|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7406387|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7406388|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
7406389|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
7406390|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7406391|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7406392|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
7406393|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
7406394|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7406395|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7406396|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
7406397|NCT01360645|11674514|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
7406398|NCT01360645|11674515|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7406399|NCT01360645|11674516|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7406400|NCT01360645|11674517|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
7406401|NCT01360645|11674514|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
7406402|NCT01360645|11674515|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
7406403|NCT01360645|11674516|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
7406404|NCT01360645|11674517|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
7406405|NCT01360645|11674514|FG000|Phase B (6 Weeks)|Adverse Event|0
7406406|NCT01360645|11674515|FG001|Phase B (6 Weeks)|Adverse Event|6
7406407|NCT01360645|11674516|FG002|Phase B (6 Weeks)|Adverse Event|0
7406408|NCT01360645|11674517|FG003|Phase B (6 Weeks)|Adverse Event|0
7406409|NCT01360645|11674514|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7406410|NCT01360645|11674515|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
7406411|NCT01360645|11674516|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
7406412|NCT01360645|11674517|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
7406413|NCT01360645|11674514|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
7406414|NCT01360645|11674515|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
7406415|NCT01360645|11674516|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
7406416|NCT01360645|11674517|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
7406417|NCT01360645|11674514|FG000|Phase B (6 Weeks)|Protocol Deviation|0
7406418|NCT01360645|11674515|FG001|Phase B (6 Weeks)|Protocol Deviation|1
7406419|NCT01360645|11674516|FG002|Phase B (6 Weeks)|Protocol Deviation|3
7406420|NCT01360645|11674517|FG003|Phase B (6 Weeks)|Protocol Deviation|0
7406421|NCT01360645|11674514|FG000|Phase A+|Lost to Follow-up|0
7406422|NCT01360645|11674515|FG001|Phase A+|Lost to Follow-up|0
7406423|NCT01360645|11674516|FG002|Phase A+|Lost to Follow-up|0
7406424|NCT01360645|11674517|FG003|Phase A+|Lost to Follow-up|7
7406425|NCT01360645|11674514|FG000|Phase A+|Adverse Event|0
7406426|NCT01360645|11674515|FG001|Phase A+|Adverse Event|0
7406427|NCT01360645|11674516|FG002|Phase A+|Adverse Event|0
7406428|NCT01360645|11674517|FG003|Phase A+|Adverse Event|2
7406429|NCT01360645|11674514|FG000|Phase A+|Met Withdrawal Criteria|0
7406430|NCT01360645|11674515|FG001|Phase A+|Met Withdrawal Criteria|0
7406431|NCT01360645|11674516|FG002|Phase A+|Met Withdrawal Criteria|0
7406432|NCT01360645|11674517|FG003|Phase A+|Met Withdrawal Criteria|4
7406433|NCT01360645|11674514|FG000|Phase A+|Physician Decision|0
7406434|NCT01360645|11674515|FG001|Phase A+|Physician Decision|0
7406435|NCT01360645|11674516|FG002|Phase A+|Physician Decision|0
7406436|NCT01360645|11674517|FG003|Phase A+|Physician Decision|2
7406437|NCT01360645|11674514|FG000|Phase A+|Withdrawal by Subject|0
7406438|NCT01360645|11674515|FG001|Phase A+|Withdrawal by Subject|0
7406439|NCT01360645|11674516|FG002|Phase A+|Withdrawal by Subject|0
7406440|NCT01360645|11674517|FG003|Phase A+|Withdrawal by Subject|5
7406441|NCT01360645|11674514|FG000|Phase A+|Protocol Deviation|0
7406442|NCT01360645|11674515|FG001|Phase A+|Protocol Deviation|0
7406443|NCT01360645|11674516|FG002|Phase A+|Protocol Deviation|0
7406444|NCT01360645|11674517|FG003|Phase A+|Protocol Deviation|4
7406445|NCT01360762|11674523|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
7406446|NCT01360762|11674523|FG000|Main Study Period (12-month Treatment)|Death|5
7406447|NCT01360762|11674523|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
7406448|NCT01360762|11674523|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
7406449|NCT01360762|11674523|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
7406450|NCT01360762|11674523|FG000|Whole Study Period|Lost to Follow-up|10
7406451|NCT01360762|11674523|FG000|Whole Study Period|Death|7
7406452|NCT01360762|11674523|FG000|Whole Study Period|Patient relapsed|18
7406453|NCT01360762|11674523|FG000|Whole Study Period|Discontinuation of study drug for safety|1
7406454|NCT01360840|11674530|FG000|Overall Study|Ongoing at data cut-off|10
7406455|NCT01360840|11674531|FG001|Overall Study|Ongoing at data cut-off|10
7406456|NCT01360840|11674532|FG002|Overall Study|Ongoing at data cut-off|9
7406457|NCT01360866|11674546|FG000|Overall Study|Lost to Follow-up|11
7406458|NCT01360866|11674547|FG001|Overall Study|Lost to Follow-up|28
7406459|NCT01360866|11674548|FG002|Overall Study|Lost to Follow-up|41
7406460|NCT01360866|11674549|FG003|Overall Study|Lost to Follow-up|0
7406461|NCT01360866|11674546|FG000|Overall Study|Adverse Event|56
7406462|NCT01360866|11674547|FG001|Overall Study|Adverse Event|61
7406463|NCT01360866|11674548|FG002|Overall Study|Adverse Event|134
7406464|NCT01360866|11674549|FG003|Overall Study|Adverse Event|6
7406465|NCT01360866|11674546|FG000|Overall Study|Paticipant met withdrawal criteria|11
7406466|NCT01360866|11674547|FG001|Overall Study|Paticipant met withdrawal criteria|28
7406467|NCT01360866|11674548|FG002|Overall Study|Paticipant met withdrawal criteria|54
7406468|NCT01360866|11674549|FG003|Overall Study|Paticipant met withdrawal criteria|0
7406469|NCT01360866|11674546|FG000|Overall Study|Withdrawn by Investigator|9
7406470|NCT01360866|11674547|FG001|Overall Study|Withdrawn by Investigator|8
7406471|NCT01360866|11674548|FG002|Overall Study|Withdrawn by Investigator|31
7406472|NCT01360866|11674549|FG003|Overall Study|Withdrawn by Investigator|2
7406473|NCT01360866|11674546|FG000|Overall Study|Withdrawal by participant|79
7406474|NCT01360866|11674547|FG001|Overall Study|Withdrawal by participant|89
7406475|NCT01360866|11674548|FG002|Overall Study|Withdrawal by participant|168
7406476|NCT01360866|11674549|FG003|Overall Study|Withdrawal by participant|8
7406477|NCT01360866|11674546|FG000|Overall Study|Protocol Deviation|25
7406478|NCT01360866|11674547|FG001|Overall Study|Protocol Deviation|33
7406479|NCT01360866|11674548|FG002|Overall Study|Protocol Deviation|61
7406480|NCT01360866|11674549|FG003|Overall Study|Protocol Deviation|2
7406481|NCT01360866|11674546|FG000|Overall Study|Lack of Efficacy|30
7406482|NCT01360866|11674547|FG001|Overall Study|Lack of Efficacy|40
7406483|NCT01360866|11674548|FG002|Overall Study|Lack of Efficacy|30
7406484|NCT01360866|11674549|FG003|Overall Study|Lack of Efficacy|4
7406485|NCT01360996|11674562|FG000|Overall Study|Withdrawal by Subject|4
7406486|NCT01360996|11674563|FG001|Overall Study|Withdrawal by Subject|3
7406487|NCT01360996|11674564|FG002|Overall Study|Withdrawal by Subject|2
7406488|NCT01360996|11674562|FG000|Overall Study|Noncompliant|2
7406489|NCT01360996|11674563|FG001|Overall Study|Noncompliant|0
7406490|NCT01360996|11674564|FG002|Overall Study|Noncompliant|0
7406491|NCT01361009|11674571|FG000|Overall Study|Protocol Violation|116
7406492|NCT01361126|11674599|FG000|Overall Study|Sponsor decision|0
7406493|NCT01361126|11674600|FG001|Overall Study|Sponsor decision|2
7406494|NCT01361178|11674609|FG000|Overall Study|Death|13
7406495|NCT01361178|11674610|FG001|Overall Study|Death|0
7406496|NCT01361308|11674624|FG000|Overall Study|Withdrawal by Subject|9
7406497|NCT01361308|11674625|FG001|Overall Study|Withdrawal by Subject|13
7406498|NCT01361308|11674624|FG000|Overall Study|Physician Decision|3
7406499|NCT01361308|11674625|FG001|Overall Study|Physician Decision|3
7406500|NCT01361308|11674624|FG000|Overall Study|Lack of Efficacy|2
7406501|NCT01361308|11674625|FG001|Overall Study|Lack of Efficacy|0
7406502|NCT01361308|11674624|FG000|Overall Study|Protocol Violation|1
7406503|NCT01361308|11674625|FG001|Overall Study|Protocol Violation|0
7406504|NCT01361308|11674624|FG000|Overall Study|Lost to Follow-up|5
7406505|NCT01361308|11674625|FG001|Overall Study|Lost to Follow-up|4
7406506|NCT01361308|11674624|FG000|Overall Study|Adverse Event|8
7406507|NCT01361308|11674625|FG001|Overall Study|Adverse Event|4
7406508|NCT01361308|11674624|FG000|Overall Study|Eligibility Criteria Not Met|2
7406509|NCT01361308|11674625|FG001|Overall Study|Eligibility Criteria Not Met|3
7406510|NCT01361308|11674624|FG000|Overall Study|Failed C-SSRS|5
7406511|NCT01361308|11674625|FG001|Overall Study|Failed C-SSRS|2
7406512|NCT01361308|11674624|FG000|Overall Study|Other|0
7406513|NCT01361308|11674625|FG001|Overall Study|Other|1
7406514|NCT01361464|11674631|FG000|Overall Study|Death|1
7406515|NCT01361464|11674631|FG000|Overall Study|Withdrawal by Subject|2
7406516|NCT01361568|11674641|FG000|Overall Study|Adverse Event|0
7406517|NCT01361568|11674642|FG001|Overall Study|Adverse Event|0
7406518|NCT01361568|11674643|FG002|Overall Study|Adverse Event|0
7406519|NCT01361568|11674644|FG003|Overall Study|Adverse Event|0
7406520|NCT01361568|11674645|FG004|Overall Study|Adverse Event|1
7406521|NCT01361568|11674646|FG005|Overall Study|Adverse Event|0
7406522|NCT01361568|11674641|FG000|Overall Study|Physician Decision|0
7406523|NCT01361568|11674642|FG001|Overall Study|Physician Decision|0
7406524|NCT01361568|11674643|FG002|Overall Study|Physician Decision|0
7406525|NCT01361568|11674644|FG003|Overall Study|Physician Decision|0
7406526|NCT01361568|11674645|FG004|Overall Study|Physician Decision|0
7406527|NCT01361568|11674646|FG005|Overall Study|Physician Decision|1
7406528|NCT01361568|11674641|FG000|Overall Study|Withdrawal by Subject|2
7406529|NCT01361568|11674642|FG001|Overall Study|Withdrawal by Subject|1
7406530|NCT01361568|11674643|FG002|Overall Study|Withdrawal by Subject|0
7406531|NCT01361568|11674644|FG003|Overall Study|Withdrawal by Subject|0
7406532|NCT01361568|11674645|FG004|Overall Study|Withdrawal by Subject|0
7406533|NCT01361568|11674646|FG005|Overall Study|Withdrawal by Subject|1
7406534|NCT01361594|11674663|FG000|Overall Study|Withdrawal by Subject|1
7406535|NCT01361594|11674664|FG001|Overall Study|Withdrawal by Subject|2
7406536|NCT01361607|11674672|FG000|Overall Study|Adverse Event|38
7406537|NCT01361607|11674673|FG001|Overall Study|Adverse Event|29
7406538|NCT01361607|11674672|FG000|Overall Study|Withdrawal by Subject|19
7406539|NCT01361607|11674673|FG001|Overall Study|Withdrawal by Subject|8
7406540|NCT01361607|11674672|FG000|Overall Study|Withdrawal by Investigator|5
7406541|NCT01361607|11674673|FG001|Overall Study|Withdrawal by Investigator|3
7406542|NCT01361607|11674672|FG000|Overall Study|Lost to Follow-up|1
7406543|NCT01361607|11674673|FG001|Overall Study|Lost to Follow-up|0
7406544|NCT01361607|11674672|FG000|Overall Study|Met Withdrawal Criteria|1
7406545|NCT01361607|11674673|FG001|Overall Study|Met Withdrawal Criteria|1
7406546|NCT01361711|11674695|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
7406547|NCT01361711|11674695|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
7406548|NCT01361711|11674695|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
7406549|NCT01361711|11674695|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
7406550|NCT01361711|11674695|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
7406551|NCT01361711|11674695|FG000|Completed Week 18 of Treatment|Complete Remission|2
7406552|NCT01361711|11674695|FG000|Completed Week 18 of Treatment|Other|9
7406553|NCT01361711|11674695|FG000|10 Year Follow-up|Still in follow-up|22
7406554|NCT01361711|11674695|FG000|10 Year Follow-up|Death|7
7406555|NCT01361711|11674695|FG000|10 Year Follow-up|Developed new cancer|1
7406556|NCT01361711|11674695|FG000|10 Year Follow-up|Lost to Follow-up|2
7406557|NCT01361711|11674695|FG000|10 Year Follow-up|New treatment started|6
7406558|NCT01361711|11674695|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
7406559|NCT01361711|11674695|FG000|10 Year Follow-up|Progressive Disease|1
7406560|NCT01361919|11674713|FG000|Overall Study|technical issues|10
7406561|NCT01361919|11674714|FG001|Overall Study|technical issues|12
7406562|NCT01361919|11674715|FG002|Overall Study|technical issues|10
7406563|NCT01362049|11674727|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
7406564|NCT01362049|11674728|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
7406565|NCT01362049|11674729|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
7406566|NCT01362049|11674730|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
7406567|NCT01362049|11674727|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
7406568|NCT01362049|11674728|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7406569|NCT01362049|11674729|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
7406570|NCT01362049|11674730|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
7406571|NCT01362062|11674746|FG000|Overall Study|Adverse Event|1
7406572|NCT01362062|11674747|FG001|Overall Study|Adverse Event|0
7406573|NCT01362062|11674746|FG000|Overall Study|Lost to Follow-up|11
7406574|NCT01362062|11674747|FG001|Overall Study|Lost to Follow-up|0
7406575|NCT01362062|11674746|FG000|Overall Study|Withdrawal by Subject|2
7406576|NCT01362062|11674747|FG001|Overall Study|Withdrawal by Subject|0
7406577|NCT01362062|11674746|FG000|Overall Study|Non-compliant participant|2
7406578|NCT01362062|11674747|FG001|Overall Study|Non-compliant participant|0
7406579|NCT01362062|11674746|FG000|Overall Study|Detected with Spondylo-arthritis|1
7406580|NCT01362062|11674747|FG001|Overall Study|Detected with Spondylo-arthritis|0
7406581|NCT01362062|11674746|FG000|Overall Study|Had significant improvement|9
7406582|NCT01362062|11674747|FG001|Overall Study|Had significant improvement|0
7406583|NCT01362140|11674763|FG000|Overall Study|Noncompliance|1
7406584|NCT01362140|11674764|FG001|Overall Study|Noncompliance|0
7406585|NCT01362140|11674763|FG000|Overall Study|Adverse Event|2
7406586|NCT01362140|11674764|FG001|Overall Study|Adverse Event|2
7406587|NCT01362140|11674763|FG000|Overall Study|Withdrawal by Subject|3
7406588|NCT01362140|11674764|FG001|Overall Study|Withdrawal by Subject|3
7406589|NCT01362140|11674763|FG000|Overall Study|Administrative Decision|0
7406590|NCT01362140|11674764|FG001|Overall Study|Administrative Decision|1
7406591|NCT01362140|11674763|FG000|Overall Study|Death|2
7406592|NCT01362140|11674764|FG001|Overall Study|Death|1
7406593|NCT01362140|11674763|FG000|Overall Study|Other|1
7406594|NCT01362140|11674764|FG001|Overall Study|Other|1
7406595|NCT01362140|11674763|FG000|Overall Study|Protocol-specified Criteria|1
7406596|NCT01362140|11674764|FG001|Overall Study|Protocol-specified Criteria|2
7406597|NCT01362140|11674763|FG000|Overall Study|Discontinued Without Receiving Treatment|0
7406598|NCT01362140|11674764|FG001|Overall Study|Discontinued Without Receiving Treatment|1
7406599|NCT01362244|11674785|FG000|Overall Study|Adverse Event|3
7406600|NCT01362244|11674786|FG001|Overall Study|Adverse Event|5
7406601|NCT01362244|11674785|FG000|Overall Study|Lack of Efficacy|5
7406602|NCT01362244|11674786|FG001|Overall Study|Lack of Efficacy|11
7406603|NCT01362244|11674785|FG000|Overall Study|Lost to Follow-up|0
7406604|NCT01362244|11674786|FG001|Overall Study|Lost to Follow-up|2
7406605|NCT01362244|11674785|FG000|Overall Study|Protocol Violation|5
7406606|NCT01362244|11674786|FG001|Overall Study|Protocol Violation|1
7406607|NCT01362244|11674785|FG000|Overall Study|Withdrawal by Subject|2
7406608|NCT01362244|11674786|FG001|Overall Study|Withdrawal by Subject|1
7406609|NCT01362244|11674785|FG000|Overall Study|Did not Meet Continuation Criteria|17
7406610|NCT01362244|11674786|FG001|Overall Study|Did not Meet Continuation Criteria|11
7406611|NCT01362244|11674785|FG000|Overall Study|Protocol Defined Stopping Criteria|0
7406612|NCT01362244|11674786|FG001|Overall Study|Protocol Defined Stopping Criteria|1
7406613|NCT01362270|11674794|FG000|Overall Study|Withdrawal by Subject|1
7406614|NCT01362270|11674795|FG001|Overall Study|Withdrawal by Subject|0
7406615|NCT01362270|11674794|FG000|Overall Study|Met exclusion criteria after 1st session|0
7406616|NCT01362270|11674795|FG001|Overall Study|Met exclusion criteria after 1st session|1
7406617|NCT01362270|11674794|FG000|Overall Study|Met excl. criteria before 1st session|1
7406618|NCT01362270|11674795|FG001|Overall Study|Met excl. criteria before 1st session|1
7406619|NCT01362296|11674803|FG000|Randomized Phase (RP)|PD including Death due to PD|56
7406620|NCT01362296|11674804|FG001|Randomized Phase (RP)|PD including Death due to PD|28
7406621|NCT01362296|11674805|FG002|Randomized Phase (RP)|PD including Death due to PD|0
7406622|NCT01362296|11674806|FG003|Randomized Phase (RP)|PD including Death due to PD|0
7406623|NCT01362296|11674803|FG000|Randomized Phase (RP)|Physician Decision|1
7406624|NCT01362296|11674804|FG001|Randomized Phase (RP)|Physician Decision|9
7406625|NCT01362296|11674805|FG002|Randomized Phase (RP)|Physician Decision|0
7406626|NCT01362296|11674806|FG003|Randomized Phase (RP)|Physician Decision|0
7406627|NCT01362296|11674803|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
7406628|NCT01362296|11674804|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
7406629|NCT01362296|11674805|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
7406630|NCT01362296|11674806|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
7406631|NCT01362296|11674803|FG000|Randomized Phase (RP)|Adverse Event|20
7406632|NCT01362296|11674804|FG001|Randomized Phase (RP)|Adverse Event|4
7406633|NCT01362296|11674805|FG002|Randomized Phase (RP)|Adverse Event|0
7406634|NCT01362296|11674806|FG003|Randomized Phase (RP)|Adverse Event|0
7406635|NCT01362296|11674803|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
7406636|NCT01362296|11674804|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
7406637|NCT01362296|11674805|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
7406638|NCT01362296|11674806|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
7406639|NCT01362296|11674803|FG000|Crossover Phase|PD including Death due to PD|0
7406640|NCT01362296|11674804|FG001|Crossover Phase|PD including Death due to PD|0
7406641|NCT01362296|11674805|FG002|Crossover Phase|PD including Death due to PD|16
7406642|NCT01362296|11674806|FG003|Crossover Phase|PD including Death due to PD|1
7406643|NCT01362296|11674803|FG000|Crossover Phase|Withdrawal by Subject|0
7406644|NCT01362296|11674804|FG001|Crossover Phase|Withdrawal by Subject|0
7406645|NCT01362296|11674805|FG002|Crossover Phase|Withdrawal by Subject|2
7406646|NCT01362296|11674806|FG003|Crossover Phase|Withdrawal by Subject|1
7406647|NCT01362296|11674803|FG000|Crossover Phase|Adverse Event|0
7406648|NCT01362296|11674804|FG001|Crossover Phase|Adverse Event|0
7406649|NCT01362296|11674805|FG002|Crossover Phase|Adverse Event|4
7406650|NCT01362296|11674806|FG003|Crossover Phase|Adverse Event|0
7406651|NCT01362296|11674803|FG000|Crossover Phase|Study Closed/Terminated|0
7406652|NCT01362296|11674804|FG001|Crossover Phase|Study Closed/Terminated|0
7406653|NCT01362296|11674805|FG002|Crossover Phase|Study Closed/Terminated|1
7406654|NCT01362296|11674806|FG003|Crossover Phase|Study Closed/Terminated|0
7406655|NCT01362322|11674818|FG000|Overall Study|Withdrawal by Subject|3
7406656|NCT01362322|11674819|FG001|Overall Study|Withdrawal by Subject|1
7406657|NCT01362322|11674818|FG000|Overall Study|Lost to Follow-up|2
7406658|NCT01362322|11674819|FG001|Overall Study|Lost to Follow-up|6
7406659|NCT01362348|11674825|FG000|Overall Study|Protocol-defined stopping criteria|9
7406660|NCT01362348|11674825|FG000|Overall Study|Study closed/terminated|5
7406661|NCT01362439|11674829|FG000|Overall Study|Adverse Event|1
7406662|NCT01362439|11674829|FG000|Overall Study|Lack of Efficacy|3
7406663|NCT01362439|11674829|FG000|Overall Study|Lost to Follow-up|2
7406664|NCT01362439|11674829|FG000|Overall Study|Study medication non-compliant|1
7406665|NCT01362439|11674829|FG000|Overall Study|Participant who withdrew consent|8
7406666|NCT01362491|11674837|FG000|Overall Study|Ineligible|1
7406667|NCT01362491|11674838|FG001|Overall Study|Ineligible|0
7406668|NCT01362491|11674839|FG002|Overall Study|Ineligible|0
7406669|NCT01362517|11674848|FG000|Overall Study|Protocol Violation|1
7406670|NCT01362517|11674848|FG000|Overall Study|Lost to Follow-up|1
7406671|NCT01362530|11674857|FG000|Base Study (Cycle 1)|Adverse Event|2
7406672|NCT01362530|11674858|FG001|Base Study (Cycle 1)|Adverse Event|0
7406673|NCT01362530|11674857|FG000|Base Study (Cycle 1)|Physician Decision|0
7406674|NCT01362530|11674858|FG001|Base Study (Cycle 1)|Physician Decision|1
7406675|NCT01362530|11674857|FG000|Base Study (Cycle 1)|Protocol Violation|2
7406676|NCT01362530|11674858|FG001|Base Study (Cycle 1)|Protocol Violation|0
7406677|NCT01362530|11674857|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
7406678|NCT01362530|11674858|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
7406679|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
7406680|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
7406681|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
7406682|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
7406683|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
7406684|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
7406685|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
7406686|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
7406687|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
7406688|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
7406689|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
7406690|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
7406691|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
7406692|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
7406693|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
7406694|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
7406695|NCT01362530|11674857|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
7406696|NCT01362530|11674858|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
7406697|NCT01362608|11674867|FG000|Overall Study|Protocol Violation|0
7406698|NCT01362608|11674868|FG001|Overall Study|Protocol Violation|1
7406699|NCT01362608|11674867|FG000|Overall Study|Lost to Follow-up|3
7406700|NCT01362608|11674868|FG001|Overall Study|Lost to Follow-up|1
7406701|NCT01362608|11674867|FG000|Overall Study|Withdrawal by Subject|1
7406702|NCT01362608|11674868|FG001|Overall Study|Withdrawal by Subject|2
7406703|NCT01362608|11674867|FG000|Overall Study|Lack of Efficacy|0
7406704|NCT01362608|11674868|FG001|Overall Study|Lack of Efficacy|2
7406705|NCT01362608|11674867|FG000|Overall Study|Adverse Event|0
7406706|NCT01362608|11674868|FG001|Overall Study|Adverse Event|2
7406707|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
7406708|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406709|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406710|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406711|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406712|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406713|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
7406714|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Adverse Event|0
7406715|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Adverse Event|1
7406716|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Adverse Event|0
7406717|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Adverse Event|1
7406718|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Adverse Event|0
7406719|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Adverse Event|2
7406720|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Adverse Event|0
7406721|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Physician Decision|0
7406722|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Physician Decision|0
7406723|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Physician Decision|0
7406724|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Physician Decision|1
7406725|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Physician Decision|0
7406726|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Physician Decision|0
7406727|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Physician Decision|0
7406728|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Developed antibodies|7
7406729|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Developed antibodies|2
7406730|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Developed antibodies|3
7406731|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Developed antibodies|8
7406732|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Developed antibodies|0
7406733|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Developed antibodies|0
7406734|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Developed antibodies|0
7406735|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Refused further treatment|0
7406736|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Refused further treatment|1
7406737|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Refused further treatment|0
7406738|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Refused further treatment|0
7406739|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Refused further treatment|0
7406740|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Refused further treatment|0
7406741|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Refused further treatment|0
7406742|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Progressive disease|1
7406743|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Progressive disease|2
7406744|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Progressive disease|2
7406745|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Progressive disease|3
7406746|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Progressive disease|0
7406747|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Progressive disease|2
7406748|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Progressive disease|0
7406749|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
7406750|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406751|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406752|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406753|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406754|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406755|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
7406756|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406757|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
7406758|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406759|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406760|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406761|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406762|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
7406763|NCT01362790|11674893|FG000|Pilot Phase & Phase 2|Death on study|0
7406764|NCT01362790|11674894|FG001|Pilot Phase & Phase 2|Death on study|0
7406765|NCT01362790|11674895|FG002|Pilot Phase & Phase 2|Death on study|0
7406766|NCT01362790|11674896|FG003|Pilot Phase & Phase 2|Death on study|1
7406767|NCT01362790|11674897|FG004|Pilot Phase & Phase 2|Death on study|0
7406768|NCT01362790|11674898|FG005|Pilot Phase & Phase 2|Death on study|0
7406769|NCT01362790|11674899|FG006|Pilot Phase & Phase 2|Death on study|0
7406770|NCT01362790|11674893|FG000|Dose De-escalation of Regimen A|Adverse Event|0
7406771|NCT01362790|11674894|FG001|Dose De-escalation of Regimen A|Adverse Event|0
7406772|NCT01362790|11674895|FG002|Dose De-escalation of Regimen A|Adverse Event|0
7406773|NCT01362790|11674896|FG003|Dose De-escalation of Regimen A|Adverse Event|0
7406774|NCT01362790|11674897|FG004|Dose De-escalation of Regimen A|Adverse Event|1
7406775|NCT01362790|11674898|FG005|Dose De-escalation of Regimen A|Adverse Event|0
7406776|NCT01362790|11674899|FG006|Dose De-escalation of Regimen A|Adverse Event|0
7406777|NCT01362790|11674893|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406778|NCT01362790|11674894|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406779|NCT01362790|11674895|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406780|NCT01362790|11674896|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406781|NCT01362790|11674897|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
7406782|NCT01362790|11674898|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406783|NCT01362790|11674899|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
7406784|NCT01362790|11674893|FG000|Dose De-escalation of Regimen A|Progressive disease|0
7406785|NCT01362790|11674894|FG001|Dose De-escalation of Regimen A|Progressive disease|0
7406786|NCT01362790|11674895|FG002|Dose De-escalation of Regimen A|Progressive disease|0
7406787|NCT01362790|11674896|FG003|Dose De-escalation of Regimen A|Progressive disease|0
7406788|NCT01362790|11674897|FG004|Dose De-escalation of Regimen A|Progressive disease|2
7406789|NCT01362790|11674898|FG005|Dose De-escalation of Regimen A|Progressive disease|0
7406790|NCT01362790|11674899|FG006|Dose De-escalation of Regimen A|Progressive disease|0
7406791|NCT01363011|11674951|FG000|Main Study|Adverse Event|2
7406792|NCT01363011|11674952|FG001|Main Study|Adverse Event|3
7406793|NCT01363011|11674951|FG000|Main Study|Investigator's Discretion|1
7406794|NCT01363011|11674952|FG001|Main Study|Investigator's Discretion|1
7406795|NCT01363011|11674951|FG000|Main Study|Withdrew Consent|1
7406796|NCT01363011|11674952|FG001|Main Study|Withdrew Consent|4
7406797|NCT01363011|11674951|FG000|Main Study|Protocol Violation|0
7406798|NCT01363011|11674952|FG001|Main Study|Protocol Violation|1
7406799|NCT01363011|11674951|FG000|Extension Phase|Adverse Event|1
7406800|NCT01363011|11674952|FG001|Extension Phase|Adverse Event|1
7406801|NCT01363011|11674951|FG000|Extension Phase|Lack of Efficacy|0
7406802|NCT01363011|11674952|FG001|Extension Phase|Lack of Efficacy|1
7406803|NCT01363011|11674951|FG000|Extension Phase|Investigator's Discretion|2
7406804|NCT01363011|11674952|FG001|Extension Phase|Investigator's Discretion|2
7406805|NCT01363011|11674951|FG000|Extension Phase|Withdrew Consent|0
7406806|NCT01363011|11674952|FG001|Extension Phase|Withdrew Consent|1
7406807|NCT01363011|11674951|FG000|Extension Phase|Lost to Follow-up|0
7406808|NCT01363011|11674952|FG001|Extension Phase|Lost to Follow-up|2
7406809|NCT01363011|11674951|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
7406810|NCT01363011|11674952|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
7406811|NCT01363076|11674966|FG000|Overall Study|Withdrawal by Subject|0
7406812|NCT01363076|11674967|FG001|Overall Study|Withdrawal by Subject|1
7406813|NCT01363297|11674991|FG000|Overall Study|Other|0
7406814|NCT01363297|11674992|FG001|Overall Study|Other|0
7406815|NCT01363297|11674993|FG002|Overall Study|Other|0
7406816|NCT01363297|11674994|FG003|Overall Study|Other|0
7406817|NCT01363297|11674995|FG004|Overall Study|Other|1
7406818|NCT01363297|11674991|FG000|Overall Study|Death|3
7406819|NCT01363297|11674992|FG001|Overall Study|Death|6
7406820|NCT01363297|11674993|FG002|Overall Study|Death|6
7406821|NCT01363297|11674994|FG003|Overall Study|Death|10
7406822|NCT01363297|11674995|FG004|Overall Study|Death|30
7406823|NCT01363349|11675014|FG000|Overall Study|Adverse Event|6
7406824|NCT01363349|11675015|FG001|Overall Study|Adverse Event|7
7406825|NCT01363349|11675014|FG000|Overall Study|Lack of Efficacy|3
7406826|NCT01363349|11675015|FG001|Overall Study|Lack of Efficacy|10
7406827|NCT01363349|11675014|FG000|Overall Study|Non compliance/Protocol deviations|2
7406828|NCT01363349|11675015|FG001|Overall Study|Non compliance/Protocol deviations|2
7406829|NCT01363349|11675014|FG000|Overall Study|Withdrawal by Subject|14
7406830|NCT01363349|11675015|FG001|Overall Study|Withdrawal by Subject|6
7406831|NCT01363349|11675014|FG000|Overall Study|Lost to Follow-up|5
7406832|NCT01363349|11675015|FG001|Overall Study|Lost to Follow-up|6
7406833|NCT01363349|11675014|FG000|Overall Study|Not reported|36
7406834|NCT01363349|11675015|FG001|Overall Study|Not reported|37
7406835|NCT01363349|11675014|FG000|Overall Study|missing|1
7406836|NCT01363349|11675015|FG001|Overall Study|missing|2
7406837|NCT01363440|11675037|FG000|Overall Study|Adverse Event|5
7406838|NCT01363440|11675038|FG001|Overall Study|Adverse Event|4
7406839|NCT01363440|11675039|FG002|Overall Study|Adverse Event|4
7406840|NCT01363440|11675037|FG000|Overall Study|Death|3
7406841|NCT01363440|11675038|FG001|Overall Study|Death|7
7406842|NCT01363440|11675039|FG002|Overall Study|Death|5
7406843|NCT01363440|11675037|FG000|Overall Study|Withdrawal by Subject|9
7406844|NCT01363440|11675038|FG001|Overall Study|Withdrawal by Subject|11
7406845|NCT01363440|11675039|FG002|Overall Study|Withdrawal by Subject|11
7406846|NCT01363440|11675037|FG000|Overall Study|Lost to Follow-up|2
7406847|NCT01363440|11675038|FG001|Overall Study|Lost to Follow-up|4
7406848|NCT01363440|11675039|FG002|Overall Study|Lost to Follow-up|5
7406849|NCT01363440|11675037|FG000|Overall Study|Other|4
7406850|NCT01363440|11675038|FG001|Overall Study|Other|5
7406851|NCT01363440|11675039|FG002|Overall Study|Other|2
7406852|NCT01363661|11675067|FG000|Overall Study|Adverse Event|9
7406853|NCT01363661|11675068|FG001|Overall Study|Adverse Event|2
7406854|NCT01363661|11675067|FG000|Overall Study|Withdrawal by Subject|1
7406855|NCT01363661|11675068|FG001|Overall Study|Withdrawal by Subject|1
7406856|NCT01363661|11675067|FG000|Overall Study|Protocol Violation|1
7406857|NCT01363661|11675068|FG001|Overall Study|Protocol Violation|0
7406858|NCT01363661|11675067|FG000|Overall Study|Lost to Follow-up|3
7406859|NCT01363661|11675068|FG001|Overall Study|Lost to Follow-up|1
7406860|NCT01363700|11675077|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7406861|NCT01363700|11675078|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
7406862|NCT01363700|11675079|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7406863|NCT01363700|11675080|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7406864|NCT01363700|11675081|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
7406865|NCT01363713|11675092|FG000|Overall Study|Adverse Event|1
7406866|NCT01363713|11675092|FG000|Overall Study|Protocol Violation|3
7406867|NCT01363713|11675092|FG000|Overall Study|Withdrawal by Subject|2
7406868|NCT01363765|11675098|FG000|Overall Study|non-diagnostic|2621
7406869|NCT01363765|11675099|FG001|Overall Study|non-diagnostic|1124
7406870|NCT01363765|11675098|FG000|Overall Study|duplicate records|736
7406871|NCT01363765|11675099|FG001|Overall Study|duplicate records|3177
7406872|NCT01363765|11675098|FG000|Overall Study|non-resident|156
7406873|NCT01363765|11675099|FG001|Overall Study|non-resident|76
7406874|NCT01363765|11675098|FG000|Overall Study|age not recorded (used for cross-linkage|117
7406875|NCT01363765|11675099|FG001|Overall Study|age not recorded (used for cross-linkage|354
7406876|NCT01363765|11675098|FG000|Overall Study|smear during intervention|2170
7406877|NCT01363765|11675099|FG001|Overall Study|smear during intervention|0
7406878|NCT01363908|11675114|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
7406879|NCT01363908|11675115|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
7406880|NCT01363908|11675114|FG000|Chronic Dosing (CD) Phase|Patient decision|0
7406881|NCT01363908|11675115|FG001|Chronic Dosing (CD) Phase|Patient decision|1
7406882|NCT01363908|11675114|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
7406883|NCT01363908|11675115|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
7406884|NCT01363908|11675114|FG000|Chronic Dosing (CD) Phase|Early study termination|9
7406885|NCT01363908|11675115|FG001|Chronic Dosing (CD) Phase|Early study termination|3
7406886|NCT01363986|11675121|FG000|Overall Study|Disease progression|1
7465843|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
7465844|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
7465845|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7465846|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
7465847|NCT01884350|11765326|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
7465848|NCT01884350|11765327|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7465849|NCT01884350|11765328|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
7465850|NCT01884545|11765359|FG000|Overall Study|Lost to Follow-up|6
7465851|NCT01884545|11765360|FG001|Overall Study|Lost to Follow-up|4
7465852|NCT01884545|11765361|FG002|Overall Study|Lost to Follow-up|9
7465853|NCT01884545|11765362|FG003|Overall Study|Lost to Follow-up|4
7465854|NCT01884545|11765359|FG000|Overall Study|Patient withdrawn|7
7465855|NCT01884545|11765360|FG001|Overall Study|Patient withdrawn|12
7465856|NCT01884545|11765361|FG002|Overall Study|Patient withdrawn|5
7465857|NCT01884545|11765362|FG003|Overall Study|Patient withdrawn|5
7465858|NCT01884545|11765359|FG000|Overall Study|Non-adherence|0
7465859|NCT01884545|11765360|FG001|Overall Study|Non-adherence|2
7465860|NCT01884545|11765361|FG002|Overall Study|Non-adherence|0
7465861|NCT01884545|11765362|FG003|Overall Study|Non-adherence|0
7465862|NCT01884571|11765372|FG000|Overall Study|Adverse Event|1
7465863|NCT01884571|11765372|FG000|Overall Study|Death|2
7465864|NCT01884571|11765372|FG000|Overall Study|Withdrawal by Subject|2
7465865|NCT01884571|11765372|FG000|Overall Study|Disease progression|3
7465866|NCT01884597|11765379|FG000|Overall Study|Adverse Event|0
7465867|NCT01884597|11765380|FG001|Overall Study|Adverse Event|0
7465868|NCT01884597|11765381|FG002|Overall Study|Adverse Event|1
7465869|NCT01884597|11765379|FG000|Overall Study|Lack of Efficacy|1
7465870|NCT01884597|11765380|FG001|Overall Study|Lack of Efficacy|0
7465871|NCT01884597|11765381|FG002|Overall Study|Lack of Efficacy|0
7465872|NCT01884597|11765379|FG000|Overall Study|Death|0
7465873|NCT01884597|11765380|FG001|Overall Study|Death|1
7465874|NCT01884597|11765381|FG002|Overall Study|Death|0
7465875|NCT01884675|11765397|FG000|Overall Study|Study closed/terminated|3
7465876|NCT01884675|11765398|FG001|Overall Study|Study closed/terminated|2
7465877|NCT01884688|11765406|FG000|Overall Study|Screen Failure|2
7465878|NCT01885000|11765421|FG000|Overall Study|Adverse Event|1
7465879|NCT01885000|11765422|FG001|Overall Study|Adverse Event|0
7465880|NCT01885000|11765421|FG000|Overall Study|Withdrawal by Subject|1
7465881|NCT01885000|11765422|FG001|Overall Study|Withdrawal by Subject|1
7465882|NCT01885000|11765421|FG000|Overall Study|Protocol Violation|0
7465883|NCT01885000|11765422|FG001|Overall Study|Protocol Violation|1
7465884|NCT01885104|11765430|FG000|Overall Study|Withdrawal of Consent|1
7465885|NCT01885104|11765431|FG001|Overall Study|Withdrawal of Consent|0
7465886|NCT01885104|11765430|FG000|Overall Study|Lost to Follow-up|0
7465887|NCT01885104|11765431|FG001|Overall Study|Lost to Follow-up|1
7465888|NCT01885104|11765430|FG000|Overall Study|Physician Decision|1
7465889|NCT01885104|11765431|FG001|Overall Study|Physician Decision|0
7465890|NCT01885182|11765448|FG000|Overall Study|Adverse Event|11
7465891|NCT01885182|11765449|FG001|Overall Study|Adverse Event|13
7465892|NCT01885182|11765448|FG000|Overall Study|Withdrawal by Subject|13
7465893|NCT01885182|11765449|FG001|Overall Study|Withdrawal by Subject|6
7465894|NCT01885182|11765448|FG000|Overall Study|Lost to Follow-up|2
7465895|NCT01885182|11765449|FG001|Overall Study|Lost to Follow-up|2
7465896|NCT01885182|11765448|FG000|Overall Study|Lack of Efficacy|8
7465897|NCT01885182|11765449|FG001|Overall Study|Lack of Efficacy|1
7465898|NCT01885195|11765457|FG000|Overall Study|Adverse Event|29
7465899|NCT01885195|11765457|FG000|Overall Study|Death|1
7465900|NCT01885195|11765457|FG000|Overall Study|Disease Progression|67
7465901|NCT01885195|11765457|FG000|Overall Study|Protocol Deviation|2
7465902|NCT01885195|11765457|FG000|Overall Study|Physician Decision|3
7465903|NCT01885195|11765457|FG000|Overall Study|Patient/guardian decision|8
7465904|NCT01885208|11765463|FG000|Overall Study|Unclassified|32
7465905|NCT01885208|11765464|FG001|Overall Study|Unclassified|38
7465906|NCT01885559|11765472|FG000|Overall Study|Lost to Follow-up|15
7465907|NCT01885559|11765473|FG001|Overall Study|Lost to Follow-up|16
7465908|NCT01885559|11765472|FG000|Overall Study|Less than full participation|9
7465909|NCT01885559|11765473|FG001|Overall Study|Less than full participation|19
7465910|NCT01885559|11765472|FG000|Overall Study|Protocol Violation|0
7465911|NCT01885559|11765473|FG001|Overall Study|Protocol Violation|1
7465912|NCT01885936|11765516|FG000|Overall Study|Withdrawal by Subject|1
7465913|NCT01885936|11765517|FG001|Overall Study|Withdrawal by Subject|0
7465914|NCT01886105|11765523|FG000|Overall Study|Lack of Efficacy|3
7465915|NCT01886287|11765532|FG000|Overall Study|Radiographic disease progression|1
7465916|NCT01886287|11765532|FG000|Overall Study|Clinical progression due to disease|1
7465917|NCT01886300|11765536|FG000|Overall Study|Trial terminated by sponsor|16
7406887|NCT01364233|11675152|FG000|Overall Study|Lost to Follow-up|1
7406888|NCT01364298|11675167|FG000|Overall Study|Adverse Event|3
7406889|NCT01364298|11675168|FG001|Overall Study|Adverse Event|4
7406890|NCT01364298|11675167|FG000|Overall Study|Lack of adherence to treatment|1
7406891|NCT01364298|11675168|FG001|Overall Study|Lack of adherence to treatment|3
7406892|NCT01364298|11675167|FG000|Overall Study|Lack of Efficacy|1
7406893|NCT01364298|11675168|FG001|Overall Study|Lack of Efficacy|0
7406894|NCT01364298|11675167|FG000|Overall Study|Lost to Follow-up|5
7406895|NCT01364298|11675168|FG001|Overall Study|Lost to Follow-up|10
7406896|NCT01364298|11675167|FG000|Overall Study|Withdrawal by Subject|3
7406897|NCT01364298|11675168|FG001|Overall Study|Withdrawal by Subject|3
7406898|NCT01364298|11675167|FG000|Overall Study|Other|1
7406899|NCT01364298|11675168|FG001|Overall Study|Other|3
7406900|NCT01364389|11675177|FG000|Overall Study|Withdrawal by Subject|0
7406901|NCT01364389|11675178|FG001|Overall Study|Withdrawal by Subject|1
7406902|NCT01364389|11675179|FG002|Overall Study|Withdrawal by Subject|0
7406903|NCT01364389|11675177|FG000|Overall Study|Protocol deviation|0
7406904|NCT01364389|11675178|FG001|Overall Study|Protocol deviation|0
7406905|NCT01364389|11675179|FG002|Overall Study|Protocol deviation|1
7406906|NCT01364389|11675177|FG000|Overall Study|Administrative problems|1
7406907|NCT01364389|11675178|FG001|Overall Study|Administrative problems|0
7406908|NCT01364389|11675179|FG002|Overall Study|Administrative problems|0
7406909|NCT01364389|11675177|FG000|Overall Study|Adverse Event|1
7406910|NCT01364389|11675178|FG001|Overall Study|Adverse Event|0
7406911|NCT01364389|11675179|FG002|Overall Study|Adverse Event|0
7406912|NCT01364428|11675189|FG000|Overall Study|Adverse Event|1
7406913|NCT01364428|11675190|FG001|Overall Study|Adverse Event|2
7406914|NCT01364428|11675189|FG000|Overall Study|Protocol Violation|2
7406915|NCT01364428|11675190|FG001|Overall Study|Protocol Violation|0
7406916|NCT01364428|11675189|FG000|Overall Study|Withdrawal Criteria|14
7406917|NCT01364428|11675190|FG001|Overall Study|Withdrawal Criteria|10
7406918|NCT01364428|11675189|FG000|Overall Study|Other|3
7406919|NCT01364428|11675190|FG001|Overall Study|Other|3
7406920|NCT01364467|11675198|FG000|Overall Study|Lost to Follow-up|1
7406921|NCT01364467|11675199|FG001|Overall Study|Lost to Follow-up|2
7406922|NCT01364649|11675249|FG000|Overall Study|Pretreatment Event or Adverse Event|20
7406923|NCT01364649|11675250|FG001|Overall Study|Pretreatment Event or Adverse Event|14
7406924|NCT01364649|11675249|FG000|Overall Study|Lack of Efficacy|6
7406925|NCT01364649|11675250|FG001|Overall Study|Lack of Efficacy|0
7406926|NCT01364649|11675249|FG000|Overall Study|Non-compliance with Investigational Drug|1
7406927|NCT01364649|11675250|FG001|Overall Study|Non-compliance with Investigational Drug|0
7406928|NCT01364649|11675249|FG000|Overall Study|Protocol Deviations|4
7406929|NCT01364649|11675250|FG001|Overall Study|Protocol Deviations|8
7406930|NCT01364649|11675249|FG000|Overall Study|Withdrawal of Consent|9
7406931|NCT01364649|11675250|FG001|Overall Study|Withdrawal of Consent|7
7406932|NCT01364649|11675249|FG000|Overall Study|Lost to Follow-up|12
7406933|NCT01364649|11675250|FG001|Overall Study|Lost to Follow-up|13
7406934|NCT01364649|11675249|FG000|Overall Study|Other|4
7406935|NCT01364649|11675250|FG001|Overall Study|Other|1
7406936|NCT01364727|11675256|FG000|Overall Study|Not Eligible|2
7406937|NCT01364870|11675270|FG000|Overall Study|Withdrawal by Subject|13
7406938|NCT01364870|11675271|FG001|Overall Study|Withdrawal by Subject|24
7406939|NCT01364870|11675272|FG002|Overall Study|Withdrawal by Subject|10
7406940|NCT01364870|11675270|FG000|Overall Study|Adverse Event|8
7406941|NCT01364870|11675271|FG001|Overall Study|Adverse Event|6
7406942|NCT01364870|11675272|FG002|Overall Study|Adverse Event|4
7406943|NCT01364870|11675270|FG000|Overall Study|Protocol Violation|1
7406944|NCT01364870|11675271|FG001|Overall Study|Protocol Violation|0
7406945|NCT01364870|11675272|FG002|Overall Study|Protocol Violation|0
7406946|NCT01364922|11675287|FG000|Open-label (OL) Period|Adverse Event|7
7406947|NCT01364922|11675288|FG001|Open-label (OL) Period|Adverse Event|0
7406948|NCT01364922|11675289|FG002|Open-label (OL) Period|Adverse Event|0
7406949|NCT01364922|11675287|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
7406950|NCT01364922|11675288|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7406951|NCT01364922|11675289|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
7406952|NCT01364922|11675287|FG000|Open-label (OL) Period|Withdrawal by Subject|4
7406953|NCT01364922|11675288|FG001|Open-label (OL) Period|Withdrawal by Subject|0
7406954|NCT01364922|11675289|FG002|Open-label (OL) Period|Withdrawal by Subject|0
7406955|NCT01364922|11675287|FG000|Open-label (OL) Period|Lack of Efficacy|3
7406956|NCT01364922|11675288|FG001|Open-label (OL) Period|Lack of Efficacy|0
7406957|NCT01364922|11675289|FG002|Open-label (OL) Period|Lack of Efficacy|0
7406958|NCT01364922|11675287|FG000|Open-label (OL) Period|Lost to Follow-up|1
7406959|NCT01364922|11675288|FG001|Open-label (OL) Period|Lost to Follow-up|0
7406960|NCT01364922|11675289|FG002|Open-label (OL) Period|Lost to Follow-up|0
7406961|NCT01364922|11675287|FG000|Open-label (OL) Period|Other, Unspecified|1
7406962|NCT01364922|11675288|FG001|Open-label (OL) Period|Other, Unspecified|0
7406963|NCT01364922|11675289|FG002|Open-label (OL) Period|Other, Unspecified|0
7406964|NCT01364922|11675287|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
7406965|NCT01364922|11675288|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
7406966|NCT01364922|11675289|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
7406967|NCT01364922|11675287|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
7406968|NCT01364922|11675288|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
7406969|NCT01364922|11675289|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
7406970|NCT01364922|11675287|FG000|Double-Blind (DB) Period|Adverse Event|0
7406971|NCT01364922|11675288|FG001|Double-Blind (DB) Period|Adverse Event|0
7406972|NCT01364922|11675289|FG002|Double-Blind (DB) Period|Adverse Event|1
7406973|NCT01364922|11675287|FG000|Double-Blind (DB) Period|Other, Unspecified|0
7406974|NCT01364922|11675288|FG001|Double-Blind (DB) Period|Other, Unspecified|1
7406975|NCT01364922|11675289|FG002|Double-Blind (DB) Period|Other, Unspecified|0
7406976|NCT01365039|11675298|FG000|Overall Study|Study related symptoms and complaints|1
7406977|NCT01365039|11675299|FG001|Overall Study|Study related symptoms and complaints|0
7406978|NCT01365052|11675308|FG000|Overall Study|Adverse Event|4
7406979|NCT01365052|11675309|FG001|Overall Study|Adverse Event|4
7406980|NCT01365091|11675319|FG000|Period 1|Adverse Event|1
7406981|NCT01365091|11675320|FG001|Period 1|Adverse Event|0
7406982|NCT01365091|11675321|FG002|Period 1|Adverse Event|2
7406983|NCT01365091|11675322|FG003|Period 1|Adverse Event|3
7406984|NCT01365091|11675319|FG000|Period 1|Positive test result for drugs of abuse|1
7406985|NCT01365091|11675320|FG001|Period 1|Positive test result for drugs of abuse|0
7406986|NCT01365091|11675321|FG002|Period 1|Positive test result for drugs of abuse|0
7406987|NCT01365091|11675322|FG003|Period 1|Positive test result for drugs of abuse|0
7406988|NCT01365091|11675319|FG000|Period 1|No longer met study criteria|0
7406989|NCT01365091|11675320|FG001|Period 1|No longer met study criteria|1
7406990|NCT01365091|11675321|FG002|Period 1|No longer met study criteria|0
7406991|NCT01365091|11675322|FG003|Period 1|No longer met study criteria|0
7406992|NCT01365091|11675319|FG000|Period 1|Withdrawal by Subject|0
7406993|NCT01365091|11675320|FG001|Period 1|Withdrawal by Subject|1
7406994|NCT01365091|11675321|FG002|Period 1|Withdrawal by Subject|0
7406995|NCT01365091|11675322|FG003|Period 1|Withdrawal by Subject|0
7406996|NCT01365091|11675319|FG000|Period 1|Personal reasons|0
7406997|NCT01365091|11675320|FG001|Period 1|Personal reasons|0
7406998|NCT01365091|11675321|FG002|Period 1|Personal reasons|1
7406999|NCT01365091|11675322|FG003|Period 1|Personal reasons|0
7407000|NCT01365091|11675319|FG000|Period 2|Withdrawal by Subject|1
7407001|NCT01365091|11675320|FG001|Period 2|Withdrawal by Subject|0
7407002|NCT01365091|11675321|FG002|Period 2|Withdrawal by Subject|0
7407003|NCT01365091|11675322|FG003|Period 2|Withdrawal by Subject|0
7407004|NCT01365091|11675319|FG000|Period 2|Adverse Event|0
7407005|NCT01365091|11675320|FG001|Period 2|Adverse Event|0
7407006|NCT01365091|11675321|FG002|Period 2|Adverse Event|1
7407007|NCT01365091|11675322|FG003|Period 2|Adverse Event|0
7407008|NCT01365130|11675346|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
7407009|NCT01365273|11675352|FG000|Overall Study|Lost to Follow-up|1
7407010|NCT01365273|11675353|FG001|Overall Study|Lost to Follow-up|0
7407011|NCT01365273|11675352|FG000|Overall Study|Protocol Violation|0
7407012|NCT01365273|11675353|FG001|Overall Study|Protocol Violation|1
7407013|NCT01365273|11675352|FG000|Overall Study|Physician Decision|1
7407014|NCT01365273|11675353|FG001|Overall Study|Physician Decision|0
7407015|NCT01365455|11675362|FG000|Induction Period|Adverse Event|5
7407016|NCT01365455|11675363|FG001|Induction Period|Adverse Event|3
7407017|NCT01365455|11675364|FG002|Induction Period|Adverse Event|4
7407018|NCT01365455|11675365|FG003|Induction Period|Adverse Event|0
7407019|NCT01365455|11675366|FG004|Induction Period|Adverse Event|0
7407020|NCT01365455|11675362|FG000|Induction Period|Lack of Efficacy|1
7407021|NCT01365455|11675363|FG001|Induction Period|Lack of Efficacy|1
7407022|NCT01365455|11675364|FG002|Induction Period|Lack of Efficacy|0
7407023|NCT01365455|11675365|FG003|Induction Period|Lack of Efficacy|0
7407024|NCT01365455|11675366|FG004|Induction Period|Lack of Efficacy|0
7407025|NCT01365455|11675362|FG000|Induction Period|Pregnancy|0
7407026|NCT01365455|11675363|FG001|Induction Period|Pregnancy|1
7407027|NCT01365455|11675364|FG002|Induction Period|Pregnancy|0
7407028|NCT01365455|11675365|FG003|Induction Period|Pregnancy|0
7407029|NCT01365455|11675366|FG004|Induction Period|Pregnancy|0
7407030|NCT01365455|11675362|FG000|Induction Period|Protocol deviation|0
7407031|NCT01365455|11675363|FG001|Induction Period|Protocol deviation|1
7407032|NCT01365455|11675364|FG002|Induction Period|Protocol deviation|1
7407033|NCT01365455|11675365|FG003|Induction Period|Protocol deviation|0
7407034|NCT01365455|11675366|FG004|Induction Period|Protocol deviation|0
7407035|NCT01365455|11675362|FG000|Induction Period|Subject/guardian decision|9
7407036|NCT01365455|11675363|FG001|Induction Period|Subject/guardian decision|1
7407037|NCT01365455|11675364|FG002|Induction Period|Subject/guardian decision|8
7407038|NCT01365455|11675365|FG003|Induction Period|Subject/guardian decision|0
7407039|NCT01365455|11675366|FG004|Induction Period|Subject/guardian decision|0
7407040|NCT01365455|11675362|FG000|Induction Period|Lost to Follow-up|0
7407041|NCT01365455|11675363|FG001|Induction Period|Lost to Follow-up|0
7407042|NCT01365455|11675364|FG002|Induction Period|Lost to Follow-up|3
7407043|NCT01365455|11675365|FG003|Induction Period|Lost to Follow-up|0
7407044|NCT01365455|11675366|FG004|Induction Period|Lost to Follow-up|0
7407045|NCT01365455|11675362|FG000|Maintenance Period|Adverse Event|12
7407046|NCT01365455|11675363|FG001|Maintenance Period|Adverse Event|5
7407047|NCT01365455|11675364|FG002|Maintenance Period|Adverse Event|1
7407048|NCT01365455|11675365|FG003|Maintenance Period|Adverse Event|2
7407049|NCT01365455|11675366|FG004|Maintenance Period|Adverse Event|4
7407050|NCT01365455|11675362|FG000|Maintenance Period|Lack of Efficacy|10
7407051|NCT01365455|11675363|FG001|Maintenance Period|Lack of Efficacy|2
7407052|NCT01365455|11675364|FG002|Maintenance Period|Lack of Efficacy|0
7407053|NCT01365455|11675365|FG003|Maintenance Period|Lack of Efficacy|2
7407054|NCT01365455|11675366|FG004|Maintenance Period|Lack of Efficacy|2
7407055|NCT01365455|11675362|FG000|Maintenance Period|Lost to Follow-up|2
7407056|NCT01365455|11675363|FG001|Maintenance Period|Lost to Follow-up|4
7407057|NCT01365455|11675364|FG002|Maintenance Period|Lost to Follow-up|0
7407058|NCT01365455|11675365|FG003|Maintenance Period|Lost to Follow-up|0
7407059|NCT01365455|11675366|FG004|Maintenance Period|Lost to Follow-up|3
7407060|NCT01365455|11675362|FG000|Maintenance Period|Non-compliance with study treatment|0
7407061|NCT01365455|11675363|FG001|Maintenance Period|Non-compliance with study treatment|0
7407062|NCT01365455|11675364|FG002|Maintenance Period|Non-compliance with study treatment|0
7407063|NCT01365455|11675365|FG003|Maintenance Period|Non-compliance with study treatment|1
7407064|NCT01365455|11675366|FG004|Maintenance Period|Non-compliance with study treatment|0
7407065|NCT01365455|11675362|FG000|Maintenance Period|Physician Decision|0
7407066|NCT01365455|11675363|FG001|Maintenance Period|Physician Decision|1
7407067|NCT01365455|11675364|FG002|Maintenance Period|Physician Decision|0
7407068|NCT01365455|11675365|FG003|Maintenance Period|Physician Decision|0
7407069|NCT01365455|11675366|FG004|Maintenance Period|Physician Decision|1
7407070|NCT01365455|11675362|FG000|Maintenance Period|Pregnancy|0
7407071|NCT01365455|11675363|FG001|Maintenance Period|Pregnancy|4
7407072|NCT01365455|11675364|FG002|Maintenance Period|Pregnancy|0
7407073|NCT01365455|11675365|FG003|Maintenance Period|Pregnancy|0
7407074|NCT01365455|11675366|FG004|Maintenance Period|Pregnancy|2
7407075|NCT01365455|11675362|FG000|Maintenance Period|Protocol deviation|1
7407076|NCT01365455|11675363|FG001|Maintenance Period|Protocol deviation|1
7407077|NCT01365455|11675364|FG002|Maintenance Period|Protocol deviation|0
7407078|NCT01365455|11675365|FG003|Maintenance Period|Protocol deviation|0
7407079|NCT01365455|11675366|FG004|Maintenance Period|Protocol deviation|0
7407080|NCT01365455|11675362|FG000|Maintenance Period|Subject/guardian decision|4
7407081|NCT01365455|11675363|FG001|Maintenance Period|Subject/guardian decision|6
7407082|NCT01365455|11675364|FG002|Maintenance Period|Subject/guardian decision|2
7407083|NCT01365455|11675365|FG003|Maintenance Period|Subject/guardian decision|4
7407084|NCT01365455|11675366|FG004|Maintenance Period|Subject/guardian decision|1
7407085|NCT01365468|11675386|FG000|Overall Study|Physician Decision|1
7407086|NCT01365468|11675387|FG001|Overall Study|Physician Decision|0
7407087|NCT01365468|11675386|FG000|Overall Study|Disease progression|1
7407088|NCT01365468|11675387|FG001|Overall Study|Disease progression|0
7407089|NCT01365468|11675386|FG000|Overall Study|Lost to Follow-up|2
7407090|NCT01365468|11675387|FG001|Overall Study|Lost to Follow-up|0
7407091|NCT01365481|11675398|FG000|Overall Study|Adverse Event|6
7407092|NCT01365481|11675399|FG001|Overall Study|Adverse Event|9
7407093|NCT01365481|11675400|FG002|Overall Study|Adverse Event|0
7407094|NCT01365481|11675401|FG003|Overall Study|Adverse Event|2
7407095|NCT01365481|11675398|FG000|Overall Study|Withdrawal by Subject|0
7407096|NCT01365481|11675399|FG001|Overall Study|Withdrawal by Subject|2
7407097|NCT01365481|11675400|FG002|Overall Study|Withdrawal by Subject|1
7407098|NCT01365481|11675401|FG003|Overall Study|Withdrawal by Subject|1
7407099|NCT01365481|11675398|FG000|Overall Study|Lost to Follow-up|1
7407100|NCT01365481|11675399|FG001|Overall Study|Lost to Follow-up|1
7407101|NCT01365481|11675400|FG002|Overall Study|Lost to Follow-up|2
7407102|NCT01365481|11675401|FG003|Overall Study|Lost to Follow-up|3
7407103|NCT01365481|11675398|FG000|Overall Study|Abnormal laboratory value(s)|0
7407104|NCT01365481|11675399|FG001|Overall Study|Abnormal laboratory value(s)|1
7407105|NCT01365481|11675400|FG002|Overall Study|Abnormal laboratory value(s)|0
7407106|NCT01365481|11675401|FG003|Overall Study|Abnormal laboratory value(s)|0
7407107|NCT01365481|11675398|FG000|Overall Study|Administrative problems|0
7407108|NCT01365481|11675399|FG001|Overall Study|Administrative problems|1
7407109|NCT01365481|11675400|FG002|Overall Study|Administrative problems|0
7407110|NCT01365481|11675401|FG003|Overall Study|Administrative problems|0
7407111|NCT01365481|11675398|FG000|Overall Study|Protocol deviation|0
7407112|NCT01365481|11675399|FG001|Overall Study|Protocol deviation|1
7407113|NCT01365481|11675400|FG002|Overall Study|Protocol deviation|0
7407114|NCT01365481|11675401|FG003|Overall Study|Protocol deviation|1
7407115|NCT01365481|11675398|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7407116|NCT01365481|11675399|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7407117|NCT01365481|11675400|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7407118|NCT01365481|11675401|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7407119|NCT01365494|11675413|FG000|Overall Study|Adverse Event|1
7407120|NCT01365494|11675414|FG001|Overall Study|Adverse Event|0
7407121|NCT01365494|11675413|FG000|Overall Study|Withdrawal by Subject|0
7407122|NCT01365494|11675414|FG001|Overall Study|Withdrawal by Subject|1
7407123|NCT01365494|11675413|FG000|Overall Study|Lost to Follow-up|1
7407124|NCT01365494|11675414|FG001|Overall Study|Lost to Follow-up|2
7407125|NCT01365507|11675423|FG000|Overall Study|Withdrawal Criteria|8
7407126|NCT01365507|11675424|FG001|Overall Study|Withdrawal Criteria|5
7407127|NCT01365507|11675423|FG000|Overall Study|Unclassified|1
7407128|NCT01365507|11675424|FG001|Overall Study|Unclassified|4
7407129|NCT01365546|11675430|FG000|Overall Study|Withdrawal by Subject|1
7407130|NCT01365546|11675430|FG000|Overall Study|Screen failure|9
7407131|NCT01365546|11675430|FG000|Overall Study|Study termination|1
7407132|NCT01365910|11675498|FG000|Overall Study|Withdrawal by Subject|7
7407133|NCT01365910|11675498|FG000|Overall Study|disease progression|18
7407134|NCT01365910|11675498|FG000|Overall Study|Adverse Event|3
7407135|NCT01365910|11675498|FG000|Overall Study|other complicating disease|1
7407136|NCT01365910|11675498|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
7407137|NCT01366209|11675513|FG000|Overall Study|Adverse Event|6
7407138|NCT01366209|11675514|FG001|Overall Study|Adverse Event|7
7407139|NCT01366209|11675513|FG000|Overall Study|Withdrawal by Subject|4
7407140|NCT01366209|11675514|FG001|Overall Study|Withdrawal by Subject|4
7407141|NCT01366209|11675513|FG000|Overall Study|Death|12
7407142|NCT01366209|11675514|FG001|Overall Study|Death|19
7407143|NCT01366209|11675513|FG000|Overall Study|Lung transplantation|6
7407144|NCT01366209|11675514|FG001|Overall Study|Lung transplantation|1
7407145|NCT01366209|11675513|FG000|Overall Study|Lost to Follow-up|2
7407146|NCT01366209|11675514|FG001|Overall Study|Lost to Follow-up|1
7407147|NCT01366209|11675513|FG000|Overall Study|Physician Decision|1
7407148|NCT01366209|11675514|FG001|Overall Study|Physician Decision|0
7407149|NCT01366209|11675513|FG000|Overall Study|Sponsors decision|0
7407150|NCT01366209|11675514|FG001|Overall Study|Sponsors decision|1
7407151|NCT01366209|11675513|FG000|Overall Study|Withdrew consent|4
7407152|NCT01366209|11675514|FG001|Overall Study|Withdrew consent|3
7407153|NCT01366443|11675525|FG000|Overall Study|Lost to Follow-up|2
7407154|NCT01366443|11675525|FG000|Overall Study|Under 18 yo|1
7407155|NCT01366521|11675551|FG000|Overall Study|Adverse Event|1
7407156|NCT01366521|11675552|FG001|Overall Study|Adverse Event|0
7407157|NCT01366521|11675553|FG002|Overall Study|Adverse Event|0
7407158|NCT01366521|11675554|FG003|Overall Study|Adverse Event|0
7407159|NCT01366521|11675551|FG000|Overall Study|Protocol Violation|0
7407160|NCT01366521|11675552|FG001|Overall Study|Protocol Violation|0
7407161|NCT01366521|11675553|FG002|Overall Study|Protocol Violation|1
7407162|NCT01366521|11675554|FG003|Overall Study|Protocol Violation|0
7407163|NCT01366521|11675551|FG000|Overall Study|Physician Decision|0
7407164|NCT01366521|11675552|FG001|Overall Study|Physician Decision|0
7407165|NCT01366521|11675553|FG002|Overall Study|Physician Decision|1
7407166|NCT01366521|11675554|FG003|Overall Study|Physician Decision|0
7407167|NCT01366521|11675551|FG000|Overall Study|Withdrawal by Subject|0
7407168|NCT01366521|11675552|FG001|Overall Study|Withdrawal by Subject|1
7407169|NCT01366521|11675553|FG002|Overall Study|Withdrawal by Subject|0
7407170|NCT01366521|11675554|FG003|Overall Study|Withdrawal by Subject|0
7407171|NCT01366534|11675569|FG000|Overall Study|Lost to Follow-up|1
7407172|NCT01366534|11675570|FG001|Overall Study|Lost to Follow-up|0
7407173|NCT01366534|11675571|FG002|Overall Study|Lost to Follow-up|0
7407174|NCT01366534|11675569|FG000|Overall Study|Migrated|1
7407175|NCT01366534|11675570|FG001|Overall Study|Migrated|1
7407176|NCT01366534|11675571|FG002|Overall Study|Migrated|0
7407177|NCT01366534|11675569|FG000|Overall Study|Declined challenged|0
7407178|NCT01366534|11675570|FG001|Overall Study|Declined challenged|1
7407179|NCT01366534|11675571|FG002|Overall Study|Declined challenged|0
7407180|NCT01366638|11675582|FG000|Overall Study|Withdrawal by Subject|0
7407181|NCT01366638|11675583|FG001|Overall Study|Withdrawal by Subject|0
7407182|NCT01366638|11675584|FG002|Overall Study|Withdrawal by Subject|6
7407183|NCT01366638|11675582|FG000|Overall Study|Other|1
7407184|NCT01366638|11675583|FG001|Overall Study|Other|0
7407185|NCT01366638|11675584|FG002|Overall Study|Other|0
7407186|NCT01366846|11675596|FG000|Overall Study|Withdrawal by Subject|2
7407187|NCT01366846|11675597|FG001|Overall Study|Withdrawal by Subject|0
7407188|NCT01366846|11675598|FG002|Overall Study|Withdrawal by Subject|0
7407189|NCT01366846|11675599|FG003|Overall Study|Withdrawal by Subject|0
7407190|NCT01366846|11675596|FG000|Overall Study|Communication Difficulties|1
7407191|NCT01366846|11675597|FG001|Overall Study|Communication Difficulties|4
7407192|NCT01366846|11675598|FG002|Overall Study|Communication Difficulties|0
7407193|NCT01366846|11675599|FG003|Overall Study|Communication Difficulties|1
7407194|NCT01366846|11675596|FG000|Overall Study|Scheduling Conflicts|0
7407195|NCT01366846|11675597|FG001|Overall Study|Scheduling Conflicts|0
7407196|NCT01366846|11675598|FG002|Overall Study|Scheduling Conflicts|1
7407197|NCT01366846|11675599|FG003|Overall Study|Scheduling Conflicts|0
7407198|NCT01367119|11675642|FG000|Overall Study|Adverse Event|1
7407199|NCT01367119|11675643|FG001|Overall Study|Adverse Event|0
7407200|NCT01367119|11675642|FG000|Overall Study|Withdrawal by Subject|1
7407201|NCT01367119|11675643|FG001|Overall Study|Withdrawal by Subject|1
7407202|NCT01367158|11675660|FG000|Overall Study|Withdrew consent|0
7407203|NCT01367158|11675661|FG001|Overall Study|Withdrew consent|2
7407204|NCT01367158|11675662|FG002|Overall Study|Withdrew consent|1
7407205|NCT01367158|11675663|FG003|Overall Study|Withdrew consent|0
7407206|NCT01367158|11675664|FG004|Overall Study|Withdrew consent|2
7407207|NCT01367158|11675665|FG005|Overall Study|Withdrew consent|0
7407208|NCT01367158|11675666|FG006|Overall Study|Withdrew consent|0
7407209|NCT01367158|11675667|FG007|Overall Study|Withdrew consent|1
7407210|NCT01367158|11675668|FG008|Overall Study|Withdrew consent|0
7407211|NCT01367158|11675669|FG009|Overall Study|Withdrew consent|0
7407212|NCT01367158|11675670|FG010|Overall Study|Withdrew consent|0
7407213|NCT01367158|11675660|FG000|Overall Study|Lost to Follow-up|0
7407214|NCT01367158|11675661|FG001|Overall Study|Lost to Follow-up|0
7407215|NCT01367158|11675662|FG002|Overall Study|Lost to Follow-up|0
7407216|NCT01367158|11675663|FG003|Overall Study|Lost to Follow-up|1
7407217|NCT01367158|11675664|FG004|Overall Study|Lost to Follow-up|0
7407218|NCT01367158|11675665|FG005|Overall Study|Lost to Follow-up|2
7407219|NCT01367158|11675666|FG006|Overall Study|Lost to Follow-up|0
7407220|NCT01367158|11675667|FG007|Overall Study|Lost to Follow-up|1
7407221|NCT01367158|11675668|FG008|Overall Study|Lost to Follow-up|0
7407222|NCT01367158|11675669|FG009|Overall Study|Lost to Follow-up|0
7407223|NCT01367158|11675670|FG010|Overall Study|Lost to Follow-up|1
7407224|NCT01367158|11675660|FG000|Overall Study|Protocol Violation|0
7407225|NCT01367158|11675661|FG001|Overall Study|Protocol Violation|1
7407226|NCT01367158|11675662|FG002|Overall Study|Protocol Violation|0
7407227|NCT01367158|11675663|FG003|Overall Study|Protocol Violation|0
7407228|NCT01367158|11675664|FG004|Overall Study|Protocol Violation|0
7407229|NCT01367158|11675665|FG005|Overall Study|Protocol Violation|0
7407230|NCT01367158|11675666|FG006|Overall Study|Protocol Violation|0
7407231|NCT01367158|11675667|FG007|Overall Study|Protocol Violation|0
7407232|NCT01367158|11675668|FG008|Overall Study|Protocol Violation|0
7407233|NCT01367158|11675669|FG009|Overall Study|Protocol Violation|0
7407234|NCT01367158|11675670|FG010|Overall Study|Protocol Violation|0
7407235|NCT01367236|11675707|FG000|Overall Study|Withdrawal by Subject|3
7407236|NCT01367236|11675708|FG001|Overall Study|Withdrawal by Subject|1
7407237|NCT01367249|11675716|FG000|Overall Study|Withdrawal by Subject|6
7407238|NCT01367249|11675717|FG001|Overall Study|Withdrawal by Subject|6
7407239|NCT01367249|11675716|FG000|Overall Study|Other|3
7407240|NCT01367249|11675717|FG001|Overall Study|Other|10
7407241|NCT01367275|11675727|FG000|Overall Study|Ineligible|1
7407242|NCT01367275|11675727|FG000|Overall Study|Disease Progression|2
7407243|NCT01367457|11675763|FG000|Overall Study|Death|2
7407244|NCT01367457|11675764|FG001|Overall Study|Death|0
7407245|NCT01367457|11675765|FG002|Overall Study|Death|0
7407246|NCT01367457|11675763|FG000|Overall Study|Investigator's decision|2
7407247|NCT01367457|11675764|FG001|Overall Study|Investigator's decision|0
7407248|NCT01367457|11675765|FG002|Overall Study|Investigator's decision|0
7407249|NCT01367457|11675763|FG000|Overall Study|Clinical decline (CD)|2
7407250|NCT01367457|11675764|FG001|Overall Study|Clinical decline (CD)|0
7407251|NCT01367457|11675765|FG002|Overall Study|Clinical decline (CD)|0
7407252|NCT01367457|11675763|FG000|Overall Study|Progression and death|8
7407253|NCT01367457|11675764|FG001|Overall Study|Progression and death|0
7407254|NCT01367457|11675765|FG002|Overall Study|Progression and death|0
7407255|NCT01367457|11675763|FG000|Overall Study|Toxicity|16
7407256|NCT01367457|11675764|FG001|Overall Study|Toxicity|0
7407257|NCT01367457|11675765|FG002|Overall Study|Toxicity|0
7407258|NCT01367457|11675763|FG000|Overall Study|Progression|137
7407259|NCT01367457|11675764|FG001|Overall Study|Progression|0
7407260|NCT01367457|11675765|FG002|Overall Study|Progression|0
7407261|NCT01367457|11675763|FG000|Overall Study|Patient asks for rest + slow progression|1
7407262|NCT01367457|11675764|FG001|Overall Study|Patient asks for rest + slow progression|0
7407263|NCT01367457|11675765|FG002|Overall Study|Patient asks for rest + slow progression|0
7407264|NCT01367457|11675763|FG000|Overall Study|Investigator's opinion, stable disease|1
7407265|NCT01367457|11675764|FG001|Overall Study|Investigator's opinion, stable disease|0
7407266|NCT01367457|11675765|FG002|Overall Study|Investigator's opinion, stable disease|0
7407267|NCT01367457|11675763|FG000|Overall Study|Bleeding from cavernous haemangioma|1
7407268|NCT01367457|11675764|FG001|Overall Study|Bleeding from cavernous haemangioma|0
7407269|NCT01367457|11675765|FG002|Overall Study|Bleeding from cavernous haemangioma|0
7407270|NCT01367457|11675763|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
7407271|NCT01367457|11675764|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7407272|NCT01367457|11675765|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
7407273|NCT01367457|11675763|FG000|Overall Study|low grade toxicities + stable disease|1
7407274|NCT01367457|11675764|FG001|Overall Study|low grade toxicities + stable disease|0
7407275|NCT01367457|11675765|FG002|Overall Study|low grade toxicities + stable disease|0
7407276|NCT01367457|11675763|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
7407277|NCT01367457|11675764|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
7407278|NCT01367457|11675765|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
7407279|NCT01367457|11675763|FG000|Overall Study|Withdrawal by Subject|1
7407280|NCT01367457|11675764|FG001|Overall Study|Withdrawal by Subject|0
7407281|NCT01367457|11675765|FG002|Overall Study|Withdrawal by Subject|0
7407282|NCT01367457|11675763|FG000|Overall Study|CD, associated leukaemia|1
7407283|NCT01367457|11675764|FG001|Overall Study|CD, associated leukaemia|0
7407284|NCT01367457|11675765|FG002|Overall Study|CD, associated leukaemia|0
7407285|NCT01367457|11675763|FG000|Overall Study|Uncontrolled pain|1
7407286|NCT01367457|11675764|FG001|Overall Study|Uncontrolled pain|0
7407287|NCT01367457|11675765|FG002|Overall Study|Uncontrolled pain|0
7407288|NCT01367457|11675763|FG000|Overall Study|Overall status worsens to grade 4|1
7407289|NCT01367457|11675764|FG001|Overall Study|Overall status worsens to grade 4|0
7407290|NCT01367457|11675765|FG002|Overall Study|Overall status worsens to grade 4|0
7407291|NCT01367457|11675763|FG000|Overall Study|Stabilisation + frequent infections|1
7407292|NCT01367457|11675764|FG001|Overall Study|Stabilisation + frequent infections|0
7407293|NCT01367457|11675765|FG002|Overall Study|Stabilisation + frequent infections|0
7407294|NCT01367457|11675763|FG000|Overall Study|No clinical benefit|1
7407295|NCT01367457|11675764|FG001|Overall Study|No clinical benefit|0
7407296|NCT01367457|11675765|FG002|Overall Study|No clinical benefit|0
7407297|NCT01367457|11675763|FG000|Overall Study|Intestinal obstruction with necrosis|1
7407298|NCT01367457|11675764|FG001|Overall Study|Intestinal obstruction with necrosis|0
7407299|NCT01367457|11675765|FG002|Overall Study|Intestinal obstruction with necrosis|0
7407300|NCT01367457|11675763|FG000|Overall Study|Overall decline|1
7407301|NCT01367457|11675764|FG001|Overall Study|Overall decline|0
7407302|NCT01367457|11675765|FG002|Overall Study|Overall decline|0
7407303|NCT01367457|11675763|FG000|Overall Study|Rejection of treatment|1
7407304|NCT01367457|11675764|FG001|Overall Study|Rejection of treatment|0
7407305|NCT01367457|11675765|FG002|Overall Study|Rejection of treatment|0
7407306|NCT01367457|11675763|FG000|Overall Study|Lost to Follow-up|1
7407307|NCT01367457|11675764|FG001|Overall Study|Lost to Follow-up|0
7407308|NCT01367457|11675765|FG002|Overall Study|Lost to Follow-up|0
7407309|NCT01367457|11675763|FG000|Overall Study|Death from septic shock|1
7407310|NCT01367457|11675764|FG001|Overall Study|Death from septic shock|0
7407311|NCT01367457|11675765|FG002|Overall Study|Death from septic shock|0
7407312|NCT01367457|11675763|FG000|Overall Study|CD, Suspected disease progression (DP)|1
7407313|NCT01367457|11675764|FG001|Overall Study|CD, Suspected disease progression (DP)|0
7407314|NCT01367457|11675765|FG002|Overall Study|CD, Suspected disease progression (DP)|0
7407315|NCT01367457|11675763|FG000|Overall Study|Patient's Wish|1
7407316|NCT01367457|11675764|FG001|Overall Study|Patient's Wish|0
7407317|NCT01367457|11675765|FG002|Overall Study|Patient's Wish|0
7407318|NCT01367457|11675763|FG000|Overall Study|Palliative. Overall decline|1
7407319|NCT01367457|11675764|FG001|Overall Study|Palliative. Overall decline|0
7407320|NCT01367457|11675765|FG002|Overall Study|Palliative. Overall decline|0
7407321|NCT01367457|11675763|FG000|Overall Study|Suspected DP/suspected active infection|1
7407322|NCT01367457|11675764|FG001|Overall Study|Suspected DP/suspected active infection|0
7407323|NCT01367457|11675765|FG002|Overall Study|Suspected DP/suspected active infection|0
7407324|NCT01367665|11675775|FG000|Overall Study|Death|102
7407325|NCT01367665|11675776|FG001|Overall Study|Death|19
7407326|NCT01367665|11675775|FG000|Overall Study|Lost to Follow-up|222
7407327|NCT01367665|11675776|FG001|Overall Study|Lost to Follow-up|22
7407328|NCT01367665|11675775|FG000|Overall Study|Not Done|118
7407329|NCT01367665|11675776|FG001|Overall Study|Not Done|14
7407330|NCT01367704|11675785|FG000|Overall Study|Lost to Follow-up|47
7407331|NCT01367704|11675786|FG001|Overall Study|Lost to Follow-up|161
7407332|NCT01367834|11675794|FG000|Overall Study|Withdrawal by Subject|2
7407333|NCT01367834|11675795|FG001|Overall Study|Withdrawal by Subject|2
7407334|NCT01367834|11675794|FG000|Overall Study|Study was ended.|0
7407335|NCT01367834|11675795|FG001|Overall Study|Study was ended.|1
7407336|NCT01367847|11675803|FG000|Overall Study|Withdrawal by Subject|2
7407337|NCT01367847|11675804|FG001|Overall Study|Withdrawal by Subject|2
7407338|NCT01367886|11675820|FG000|Overall Study|Lost to Follow-up|4
7407339|NCT01367886|11675820|FG000|Overall Study|Lack of Efficacy|2
7407340|NCT01367886|11675820|FG000|Overall Study|Death|1
7407341|NCT01368042|11675825|FG000|Overall Study|Death|14
7407342|NCT01368042|11675825|FG000|Overall Study|Protocol Violation|11
7407343|NCT01368042|11675825|FG000|Overall Study|Lost to Follow-up|4
7407344|NCT01368042|11675825|FG000|Overall Study|Transplanted|1
7407345|NCT01368081|11675842|FG000|Overall Study|Adverse Event|4
7407346|NCT01368081|11675843|FG001|Overall Study|Adverse Event|4
7407347|NCT01368081|11675844|FG002|Overall Study|Adverse Event|3
7407348|NCT01368081|11675845|FG003|Overall Study|Adverse Event|2
7407349|NCT01368081|11675846|FG004|Overall Study|Adverse Event|2
7407350|NCT01368081|11675847|FG005|Overall Study|Adverse Event|5
7407351|NCT01368081|11675848|FG006|Overall Study|Adverse Event|6
7407352|NCT01368081|11675849|FG007|Overall Study|Adverse Event|2
7407353|NCT01368081|11675850|FG008|Overall Study|Adverse Event|3
7407354|NCT01368081|11675851|FG009|Overall Study|Adverse Event|5
7407355|NCT01368081|11675852|FG010|Overall Study|Adverse Event|6
7407356|NCT01368081|11675853|FG011|Overall Study|Adverse Event|1
7407357|NCT01368081|11675854|FG012|Overall Study|Adverse Event|3
7407358|NCT01368081|11675842|FG000|Overall Study|Lack of Efficacy|0
7407359|NCT01368081|11675843|FG001|Overall Study|Lack of Efficacy|1
7407360|NCT01368081|11675844|FG002|Overall Study|Lack of Efficacy|0
7407361|NCT01368081|11675845|FG003|Overall Study|Lack of Efficacy|1
7407362|NCT01368081|11675846|FG004|Overall Study|Lack of Efficacy|0
7407363|NCT01368081|11675847|FG005|Overall Study|Lack of Efficacy|0
7407364|NCT01368081|11675848|FG006|Overall Study|Lack of Efficacy|0
7407365|NCT01368081|11675849|FG007|Overall Study|Lack of Efficacy|2
7407366|NCT01368081|11675850|FG008|Overall Study|Lack of Efficacy|0
7407367|NCT01368081|11675851|FG009|Overall Study|Lack of Efficacy|0
7407368|NCT01368081|11675852|FG010|Overall Study|Lack of Efficacy|0
7407369|NCT01368081|11675853|FG011|Overall Study|Lack of Efficacy|0
7407370|NCT01368081|11675854|FG012|Overall Study|Lack of Efficacy|0
7407371|NCT01368081|11675842|FG000|Overall Study|Protocol Violation|0
7407372|NCT01368081|11675843|FG001|Overall Study|Protocol Violation|0
7407373|NCT01368081|11675844|FG002|Overall Study|Protocol Violation|0
7407374|NCT01368081|11675845|FG003|Overall Study|Protocol Violation|0
7407375|NCT01368081|11675846|FG004|Overall Study|Protocol Violation|0
7407376|NCT01368081|11675847|FG005|Overall Study|Protocol Violation|1
7407377|NCT01368081|11675848|FG006|Overall Study|Protocol Violation|0
7407378|NCT01368081|11675849|FG007|Overall Study|Protocol Violation|1
7407379|NCT01368081|11675850|FG008|Overall Study|Protocol Violation|0
7407380|NCT01368081|11675851|FG009|Overall Study|Protocol Violation|0
7407381|NCT01368081|11675852|FG010|Overall Study|Protocol Violation|0
7407382|NCT01368081|11675853|FG011|Overall Study|Protocol Violation|0
7407383|NCT01368081|11675854|FG012|Overall Study|Protocol Violation|0
7407384|NCT01368081|11675842|FG000|Overall Study|Lost to Follow-up|0
7407385|NCT01368081|11675843|FG001|Overall Study|Lost to Follow-up|0
7407386|NCT01368081|11675844|FG002|Overall Study|Lost to Follow-up|0
7407387|NCT01368081|11675845|FG003|Overall Study|Lost to Follow-up|0
7407388|NCT01368081|11675846|FG004|Overall Study|Lost to Follow-up|0
7407389|NCT01368081|11675847|FG005|Overall Study|Lost to Follow-up|0
7407390|NCT01368081|11675848|FG006|Overall Study|Lost to Follow-up|0
7407391|NCT01368081|11675849|FG007|Overall Study|Lost to Follow-up|0
7407392|NCT01368081|11675850|FG008|Overall Study|Lost to Follow-up|0
7407393|NCT01368081|11675851|FG009|Overall Study|Lost to Follow-up|0
7407394|NCT01368081|11675852|FG010|Overall Study|Lost to Follow-up|0
7407395|NCT01368081|11675853|FG011|Overall Study|Lost to Follow-up|0
7407396|NCT01368081|11675854|FG012|Overall Study|Lost to Follow-up|1
7407397|NCT01368081|11675842|FG000|Overall Study|Withdrawal by Subject|4
7407398|NCT01368081|11675843|FG001|Overall Study|Withdrawal by Subject|4
7407399|NCT01368081|11675844|FG002|Overall Study|Withdrawal by Subject|1
7407400|NCT01368081|11675845|FG003|Overall Study|Withdrawal by Subject|1
7407401|NCT01368081|11675846|FG004|Overall Study|Withdrawal by Subject|0
7407402|NCT01368081|11675847|FG005|Overall Study|Withdrawal by Subject|3
7407403|NCT01368081|11675848|FG006|Overall Study|Withdrawal by Subject|4
7407404|NCT01368081|11675849|FG007|Overall Study|Withdrawal by Subject|2
7407405|NCT01368081|11675850|FG008|Overall Study|Withdrawal by Subject|5
7407406|NCT01368081|11675851|FG009|Overall Study|Withdrawal by Subject|4
7407407|NCT01368081|11675852|FG010|Overall Study|Withdrawal by Subject|3
7407408|NCT01368081|11675853|FG011|Overall Study|Withdrawal by Subject|2
7407409|NCT01368081|11675854|FG012|Overall Study|Withdrawal by Subject|0
7407410|NCT01368081|11675842|FG000|Overall Study|Other reason not defined above|2
7407411|NCT01368081|11675843|FG001|Overall Study|Other reason not defined above|0
7407412|NCT01368081|11675844|FG002|Overall Study|Other reason not defined above|0
7407413|NCT01368081|11675845|FG003|Overall Study|Other reason not defined above|1
7407414|NCT01368081|11675846|FG004|Overall Study|Other reason not defined above|0
7407415|NCT01368081|11675847|FG005|Overall Study|Other reason not defined above|1
7407416|NCT01368081|11675848|FG006|Overall Study|Other reason not defined above|2
7407417|NCT01368081|11675849|FG007|Overall Study|Other reason not defined above|0
7407418|NCT01368081|11675850|FG008|Overall Study|Other reason not defined above|0
7407419|NCT01368081|11675851|FG009|Overall Study|Other reason not defined above|1
7407420|NCT01368081|11675852|FG010|Overall Study|Other reason not defined above|0
7407421|NCT01368081|11675853|FG011|Overall Study|Other reason not defined above|0
7407422|NCT01368081|11675854|FG012|Overall Study|Other reason not defined above|3
7407423|NCT01368211|11675884|FG000|Second Platelets Transfusion|No need for additional transfusion|1
7407424|NCT01368211|11675885|FG001|Second Platelets Transfusion|No need for additional transfusion|2
7407425|NCT01368276|11675906|FG000|Overall Study|Death|1
7407426|NCT01368276|11675907|FG001|Overall Study|Death|10
7407427|NCT01368406|11675915|FG000|Overall Study|Lost to Follow-up|8
7407428|NCT01368406|11675916|FG001|Overall Study|Lost to Follow-up|4
7407429|NCT01368406|11675915|FG000|Overall Study|Withdrawal by Subject|8
7407430|NCT01368406|11675916|FG001|Overall Study|Withdrawal by Subject|4
7407431|NCT01368406|11675915|FG000|Overall Study|relapse of the disease|3
7407432|NCT01368406|11675916|FG001|Overall Study|relapse of the disease|2
7407433|NCT01368406|11675915|FG000|Overall Study|started working|2
7407434|NCT01368406|11675916|FG001|Overall Study|started working|3
7407435|NCT01368432|11675924|FG000|Overall Study|Lost to Follow-up|0
7407436|NCT01368432|11675925|FG001|Overall Study|Lost to Follow-up|1
7407437|NCT01368536|11675948|FG000|Overall Study|Adverse Event|5
7407438|NCT01368536|11675949|FG001|Overall Study|Adverse Event|6
7407439|NCT01368536|11675950|FG002|Overall Study|Adverse Event|8
7407440|NCT01368536|11675948|FG000|Overall Study|Abnormal laboratory value(s)|0
7407441|NCT01368536|11675949|FG001|Overall Study|Abnormal laboratory value(s)|1
7407442|NCT01368536|11675950|FG002|Overall Study|Abnormal laboratory value(s)|2
7407443|NCT01368536|11675948|FG000|Overall Study|Abnormal test procedure result(s)|0
7407444|NCT01368536|11675949|FG001|Overall Study|Abnormal test procedure result(s)|0
7407445|NCT01368536|11675950|FG002|Overall Study|Abnormal test procedure result(s)|1
7407446|NCT01368536|11675948|FG000|Overall Study|Unsatisfactory therapeutic effect|7
7407447|NCT01368536|11675949|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7407448|NCT01368536|11675950|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7407449|NCT01368536|11675948|FG000|Overall Study|No longer required study medication|0
7407450|NCT01368536|11675949|FG001|Overall Study|No longer required study medication|0
7407451|NCT01368536|11675950|FG002|Overall Study|No longer required study medication|1
7407452|NCT01368536|11675948|FG000|Overall Study|Withdrawal by Subject|2
7407453|NCT01368536|11675949|FG001|Overall Study|Withdrawal by Subject|5
7407454|NCT01368536|11675950|FG002|Overall Study|Withdrawal by Subject|4
7407455|NCT01368536|11675948|FG000|Overall Study|Lost to Follow-up|3
7407456|NCT01368536|11675949|FG001|Overall Study|Lost to Follow-up|3
7407457|NCT01368536|11675950|FG002|Overall Study|Lost to Follow-up|5
7407458|NCT01368536|11675948|FG000|Overall Study|Administrative problems|34
7407459|NCT01368536|11675949|FG001|Overall Study|Administrative problems|39
7407460|NCT01368536|11675950|FG002|Overall Study|Administrative problems|35
7407461|NCT01368536|11675948|FG000|Overall Study|Protocol deviation|0
7407462|NCT01368536|11675949|FG001|Overall Study|Protocol deviation|3
7407463|NCT01368536|11675950|FG002|Overall Study|Protocol deviation|1
7407464|NCT01368562|11675959|FG000|Overall Study|Adverse Event|1
7407465|NCT01368562|11675959|FG000|Overall Study|Disease progression|1
7407466|NCT01368562|11675959|FG000|Overall Study|Lost to Follow-up|1
7407467|NCT01368562|11675959|FG000|Overall Study|Death|6
7407468|NCT01368562|11675959|FG000|Overall Study|Unresponsive to treatment|5
7407469|NCT01368562|11675959|FG000|Overall Study|Other|3
7407470|NCT01368562|11675959|FG000|Overall Study|Other than specified|2
7407471|NCT01368614|11675963|FG000|Screening Period|Screen Failure|58
7407472|NCT01368614|11675964|FG001|Screening Period|Screen Failure|0
7407473|NCT01368614|11675965|FG002|Screening Period|Screen Failure|0
7407474|NCT01368614|11675966|FG003|Screening Period|Screen Failure|0
7407475|NCT01368614|11675963|FG000|Study Period|Withdrawal by Subject|0
7407476|NCT01368614|11675964|FG001|Study Period|Withdrawal by Subject|1
7407477|NCT01368614|11675965|FG002|Study Period|Withdrawal by Subject|1
7407478|NCT01368614|11675966|FG003|Study Period|Withdrawal by Subject|3
7407479|NCT01368614|11675963|FG000|Study Period|Lost to Follow-up|0
7407480|NCT01368614|11675964|FG001|Study Period|Lost to Follow-up|0
7407481|NCT01368614|11675965|FG002|Study Period|Lost to Follow-up|1
7407482|NCT01368614|11675966|FG003|Study Period|Lost to Follow-up|0
7407483|NCT01368835|11676001|FG000|Overall Study|Inclusion criteria/photography quality|22
7407484|NCT01368835|11676001|FG000|Overall Study|Lost to Follow-up|11
7407485|NCT01368900|11676053|FG000|Overall Study|Lost to Follow-up|7
7407486|NCT01368965|11676059|FG000|Overall Study|Lost to Follow-up|12
7407487|NCT01369069|11676071|FG000|Overall Study|Lost to Follow-up|8
7407488|NCT01369069|11676072|FG001|Overall Study|Lost to Follow-up|9
7407489|NCT01369069|11676071|FG000|Overall Study|Withdrawal by Subject|9
7407490|NCT01369069|11676072|FG001|Overall Study|Withdrawal by Subject|7
7407491|NCT01369225|11676089|FG000|Overall Study|Withdrawal by Subject|1
7407492|NCT01369225|11676090|FG001|Overall Study|Withdrawal by Subject|0
7407493|NCT01369225|11676091|FG002|Overall Study|Withdrawal by Subject|2
7407494|NCT01369225|11676092|FG003|Overall Study|Withdrawal by Subject|1
7407495|NCT01369225|11676093|FG004|Overall Study|Withdrawal by Subject|0
7407496|NCT01369225|11676094|FG005|Overall Study|Withdrawal by Subject|0
7407497|NCT01369225|11676089|FG000|Overall Study|Does Not Meet Entrance Criteria|0
7407498|NCT01369225|11676090|FG001|Overall Study|Does Not Meet Entrance Criteria|0
7407499|NCT01369225|11676091|FG002|Overall Study|Does Not Meet Entrance Criteria|1
7407500|NCT01369225|11676092|FG003|Overall Study|Does Not Meet Entrance Criteria|0
7407501|NCT01369225|11676093|FG004|Overall Study|Does Not Meet Entrance Criteria|0
7407502|NCT01369225|11676094|FG005|Overall Study|Does Not Meet Entrance Criteria|0
7407503|NCT01369225|11676089|FG000|Overall Study|Other|1
7407504|NCT01369225|11676090|FG001|Overall Study|Other|0
7407505|NCT01369225|11676091|FG002|Overall Study|Other|0
7407506|NCT01369225|11676092|FG003|Overall Study|Other|0
7407507|NCT01369225|11676093|FG004|Overall Study|Other|1
7407508|NCT01369225|11676094|FG005|Overall Study|Other|0
7407509|NCT01369225|11676089|FG000|Overall Study|Adverse Event|0
7407510|NCT01369225|11676090|FG001|Overall Study|Adverse Event|0
7407511|NCT01369225|11676091|FG002|Overall Study|Adverse Event|0
7407512|NCT01369225|11676092|FG003|Overall Study|Adverse Event|1
7407513|NCT01369225|11676093|FG004|Overall Study|Adverse Event|1
7407514|NCT01369225|11676094|FG005|Overall Study|Adverse Event|0
7407515|NCT01369329|11676111|FG000|Overall Study|Withdrawal by Subject|8
7407516|NCT01369329|11676112|FG001|Overall Study|Withdrawal by Subject|6
7407517|NCT01369329|11676113|FG002|Overall Study|Withdrawal by Subject|10
7407518|NCT01369329|11676111|FG000|Overall Study|Lost to Follow-up|2
7407519|NCT01369329|11676112|FG001|Overall Study|Lost to Follow-up|2
7407520|NCT01369329|11676113|FG002|Overall Study|Lost to Follow-up|2
7407521|NCT01369329|11676111|FG000|Overall Study|Other|2
7407522|NCT01369329|11676112|FG001|Overall Study|Other|3
7407523|NCT01369329|11676113|FG002|Overall Study|Other|2
7407524|NCT01369342|11676124|FG000|Overall Study|Withdrawal by Subject|7
7407525|NCT01369342|11676125|FG001|Overall Study|Withdrawal by Subject|7
7407526|NCT01369342|11676126|FG002|Overall Study|Withdrawal by Subject|2
7407527|NCT01369342|11676124|FG000|Overall Study|Lost to Follow-up|5
7407528|NCT01369342|11676125|FG001|Overall Study|Lost to Follow-up|2
7407529|NCT01369342|11676126|FG002|Overall Study|Lost to Follow-up|1
7407530|NCT01369342|11676124|FG000|Overall Study|Not Treated|1
7407531|NCT01369342|11676125|FG001|Overall Study|Not Treated|0
7407532|NCT01369342|11676126|FG002|Overall Study|Not Treated|0
7407533|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
7407534|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
7407535|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
7407536|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
7407537|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
7407538|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
7407539|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7407540|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7407541|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
7407542|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7407543|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
7407544|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7407545|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
7407546|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
7407547|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
7407548|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7407549|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7407550|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
7407551|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407552|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7407553|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
7407554|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407555|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407556|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
7407557|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407558|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407559|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
7407560|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7407561|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7407562|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
7407563|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
7407564|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
7407565|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
7407566|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7407567|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7407568|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
7407569|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7407570|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
7407571|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
7407572|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
7407573|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
7407574|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
7407575|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7407576|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7407577|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
7407578|NCT01369355|11676140|FG000|Week 0 - Week 44 (Maintenance)|Other|0
7407579|NCT01369355|11676141|FG001|Week 0 - Week 44 (Maintenance)|Other|0
7407580|NCT01369355|11676142|FG002|Week 0 - Week 44 (Maintenance)|Other|1
7407581|NCT01369355|11676143|FG003|Week 0 - Week 44 (Maintenance)|Other|0
7407582|NCT01369355|11676144|FG004|Week 0 - Week 44 (Maintenance)|Other|1
7407583|NCT01369355|11676145|FG005|Week 0 - Week 44 (Maintenance)|Other|0
7407584|NCT01369355|11676146|FG006|Week 0 - Week 44 (Maintenance)|Other|0
7407585|NCT01369355|11676147|FG007|Week 0 - Week 44 (Maintenance)|Other|0
7407586|NCT01369355|11676148|FG008|Week 0 - Week 44 (Maintenance)|Other|0
7407587|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
7407588|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
7407589|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
7407590|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
7407591|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
7407592|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
7407593|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
7407594|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
7407595|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
7407596|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Death|0
7407597|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Death|0
7407598|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Death|0
7407599|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Death|0
7407600|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Death|0
7407601|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Death|0
7407602|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Death|0
7407603|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Death|1
7407604|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Death|3
7407605|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407606|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407607|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407608|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407609|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407610|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
7407611|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
7407612|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
7407613|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
7407614|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
7407615|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
7407616|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
7407617|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
7407618|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
7407619|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
7407620|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
7407621|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
7407622|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
7407623|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
7407624|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
7407625|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
7407626|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
7407627|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
7407628|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
7407629|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
7407630|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
7407631|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
7407632|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407633|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407634|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407635|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407636|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407637|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
7407638|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
7407639|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
7407640|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
7407641|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407642|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407643|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407644|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407645|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407646|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
7407647|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
7407648|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
7407649|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
7407650|NCT01369355|11676140|FG000|Long-term Extension (Week 44-272)|Other|0
7407651|NCT01369355|11676141|FG001|Long-term Extension (Week 44-272)|Other|0
7407652|NCT01369355|11676142|FG002|Long-term Extension (Week 44-272)|Other|0
7407653|NCT01369355|11676143|FG003|Long-term Extension (Week 44-272)|Other|0
7407654|NCT01369355|11676144|FG004|Long-term Extension (Week 44-272)|Other|0
7407655|NCT01369355|11676145|FG005|Long-term Extension (Week 44-272)|Other|0
7407656|NCT01369355|11676146|FG006|Long-term Extension (Week 44-272)|Other|110
7407657|NCT01369355|11676147|FG007|Long-term Extension (Week 44-272)|Other|9
7407658|NCT01369355|11676148|FG008|Long-term Extension (Week 44-272)|Other|17
7407659|NCT01369433|11676167|FG000|Overall Study|Adverse Event|31
7407660|NCT01369433|11676168|FG001|Overall Study|Adverse Event|1
7407661|NCT01369433|11676167|FG000|Overall Study|Required significant surgical procedure|1
7407662|NCT01369433|11676168|FG001|Overall Study|Required significant surgical procedure|0
7407663|NCT01369433|11676167|FG000|Overall Study|Non-compliance|1
7407664|NCT01369433|11676168|FG001|Overall Study|Non-compliance|0
7407665|NCT01369433|11676167|FG000|Overall Study|Withdrawal by Subject|5
7407666|NCT01369433|11676168|FG001|Overall Study|Withdrawal by Subject|2
7407667|NCT01369433|11676167|FG000|Overall Study|Study terminated by Sponsor|67
7407668|NCT01369433|11676168|FG001|Overall Study|Study terminated by Sponsor|0
7407669|NCT01369433|11676167|FG000|Overall Study|Lost to Follow-up|1
7407670|NCT01369433|11676168|FG001|Overall Study|Lost to Follow-up|0
7407671|NCT01369433|11676167|FG000|Overall Study|Death|5
7407672|NCT01369433|11676168|FG001|Overall Study|Death|0
7407673|NCT01369433|11676167|FG000|Overall Study|Investigator discretion|6
7407674|NCT01369433|11676168|FG001|Overall Study|Investigator discretion|1
7407675|NCT01369433|11676167|FG000|Overall Study|Progressive Disease|92
7407676|NCT01369433|11676168|FG001|Overall Study|Progressive Disease|12
7407677|NCT01369485|11676176|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
7407678|NCT01369485|11676177|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
7407679|NCT01369485|11676176|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
7407680|NCT01369485|11676177|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
7407681|NCT01369485|11676176|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
7407682|NCT01369485|11676177|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
7407683|NCT01369485|11676176|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
7407684|NCT01369485|11676177|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
7407685|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
7407686|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
7407687|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
7407688|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
7407689|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
7407690|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
7407691|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
7407692|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
7407693|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
7407694|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
7407695|NCT01369485|11676176|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
7407696|NCT01369485|11676177|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
7407697|NCT01369498|11676195|FG000|Overall Study|Lack of Efficacy|9
7407698|NCT01369498|11676196|FG001|Overall Study|Lack of Efficacy|9
7407699|NCT01369498|11676197|FG002|Overall Study|Lack of Efficacy|1
7407700|NCT01369498|11676198|FG003|Overall Study|Lack of Efficacy|3
7407701|NCT01369498|11676195|FG000|Overall Study|Adverse Event|1
7407702|NCT01369498|11676196|FG001|Overall Study|Adverse Event|2
7407703|NCT01369498|11676197|FG002|Overall Study|Adverse Event|0
7407704|NCT01369498|11676198|FG003|Overall Study|Adverse Event|1
7407705|NCT01369498|11676195|FG000|Overall Study|Withdrawal of Consent|0
7407706|NCT01369498|11676196|FG001|Overall Study|Withdrawal of Consent|1
7407707|NCT01369498|11676197|FG002|Overall Study|Withdrawal of Consent|1
7407708|NCT01369498|11676198|FG003|Overall Study|Withdrawal of Consent|1
7407709|NCT01369498|11676195|FG000|Overall Study|Death|0
7407710|NCT01369498|11676196|FG001|Overall Study|Death|0
7407711|NCT01369498|11676197|FG002|Overall Study|Death|1
7407712|NCT01369498|11676198|FG003|Overall Study|Death|0
7407713|NCT01369498|11676195|FG000|Overall Study|Investigator's Discretion|1
7407714|NCT01369498|11676196|FG001|Overall Study|Investigator's Discretion|0
7407715|NCT01369498|11676197|FG002|Overall Study|Investigator's Discretion|1
7407716|NCT01369498|11676198|FG003|Overall Study|Investigator's Discretion|3
7407717|NCT01369498|11676195|FG000|Overall Study|Unknown Reason|1
7407718|NCT01369498|11676196|FG001|Overall Study|Unknown Reason|0
7407719|NCT01369498|11676197|FG002|Overall Study|Unknown Reason|11
7407720|NCT01369498|11676198|FG003|Overall Study|Unknown Reason|6
7407721|NCT01369498|11676195|FG000|Overall Study|Disease Progression|0
7407722|NCT01369498|11676196|FG001|Overall Study|Disease Progression|0
7407723|NCT01369498|11676197|FG002|Overall Study|Disease Progression|0
7407724|NCT01369498|11676198|FG003|Overall Study|Disease Progression|1
7407725|NCT01369511|11676213|FG000|Overall Study|Adverse Event|1
7407726|NCT01369511|11676214|FG001|Overall Study|Adverse Event|1
7407727|NCT01369511|11676215|FG002|Overall Study|Adverse Event|5
7407728|NCT01369511|11676216|FG003|Overall Study|Adverse Event|0
7407729|NCT01369511|11676213|FG000|Overall Study|Entry criteria not met|2
7407730|NCT01369511|11676214|FG001|Overall Study|Entry criteria not met|0
7407731|NCT01369511|11676215|FG002|Overall Study|Entry criteria not met|0
7407732|NCT01369511|11676216|FG003|Overall Study|Entry criteria not met|1
7407733|NCT01369511|11676213|FG000|Overall Study|Lost to Follow-up|0
7407734|NCT01369511|11676214|FG001|Overall Study|Lost to Follow-up|1
7407735|NCT01369511|11676215|FG002|Overall Study|Lost to Follow-up|1
7407736|NCT01369511|11676216|FG003|Overall Study|Lost to Follow-up|2
7407737|NCT01369511|11676213|FG000|Overall Study|Protocol Violation|0
7407738|NCT01369511|11676214|FG001|Overall Study|Protocol Violation|1
7407739|NCT01369511|11676215|FG002|Overall Study|Protocol Violation|0
7407740|NCT01369511|11676216|FG003|Overall Study|Protocol Violation|2
7407741|NCT01369511|11676213|FG000|Overall Study|Physician Decision|3
7407742|NCT01369511|11676214|FG001|Overall Study|Physician Decision|4
7407743|NCT01369511|11676215|FG002|Overall Study|Physician Decision|0
7407744|NCT01369511|11676216|FG003|Overall Study|Physician Decision|0
7407745|NCT01369511|11676213|FG000|Overall Study|Sponsor decision|2
7407746|NCT01369511|11676214|FG001|Overall Study|Sponsor decision|0
7407747|NCT01369511|11676215|FG002|Overall Study|Sponsor decision|1
7407748|NCT01369511|11676216|FG003|Overall Study|Sponsor decision|0
7407749|NCT01369511|11676213|FG000|Overall Study|Withdrawal by Subject|5
7407750|NCT01369511|11676214|FG001|Overall Study|Withdrawal by Subject|6
7407751|NCT01369511|11676215|FG002|Overall Study|Withdrawal by Subject|4
7407752|NCT01369511|11676216|FG003|Overall Study|Withdrawal by Subject|6
7407753|NCT01369615|11676228|FG000|Overall Study|Withdrawal by Subject|0
7407754|NCT01369615|11676229|FG001|Overall Study|Withdrawal by Subject|1
7407755|NCT01369615|11676228|FG000|Overall Study|Lost to Follow-up|0
7407756|NCT01369615|11676229|FG001|Overall Study|Lost to Follow-up|1
7407757|NCT01369680|11676239|FG000|Overall Study|Lost to Follow-up|0
7407758|NCT01369680|11676240|FG001|Overall Study|Lost to Follow-up|0
7407759|NCT01369680|11676241|FG002|Overall Study|Lost to Follow-up|1
7407760|NCT01369680|11676242|FG003|Overall Study|Lost to Follow-up|2
7407761|NCT01369784|11676301|FG000|Overall Study|Protocol Violation|12
7407762|NCT01369849|11676308|FG000|Overall Study|Ineligible prior to treatment|0
7407763|NCT01369849|11676309|FG001|Overall Study|Ineligible prior to treatment|0
7407764|NCT01369849|11676310|FG002|Overall Study|Ineligible prior to treatment|1
7407765|NCT01369849|11676308|FG000|Overall Study|Ineligible after receiving treatment|0
7407766|NCT01369849|11676309|FG001|Overall Study|Ineligible after receiving treatment|1
7407767|NCT01369849|11676310|FG002|Overall Study|Ineligible after receiving treatment|0
7407768|NCT01370005|11676345|FG000|Overall Study|Not treated|1
7407769|NCT01370005|11676346|FG001|Overall Study|Not treated|0
7407770|NCT01370005|11676347|FG002|Overall Study|Not treated|0
7407771|NCT01370005|11676345|FG000|Overall Study|Adverse Event|5
7407772|NCT01370005|11676346|FG001|Overall Study|Adverse Event|5
7407773|NCT01370005|11676347|FG002|Overall Study|Adverse Event|6
7407774|NCT01370005|11676345|FG000|Overall Study|Lack of Efficacy|1
7407775|NCT01370005|11676346|FG001|Overall Study|Lack of Efficacy|0
7407776|NCT01370005|11676347|FG002|Overall Study|Lack of Efficacy|0
7407777|NCT01370005|11676345|FG000|Overall Study|Non compliant with protocol|0
7407778|NCT01370005|11676346|FG001|Overall Study|Non compliant with protocol|1
7407779|NCT01370005|11676347|FG002|Overall Study|Non compliant with protocol|2
7407780|NCT01370005|11676345|FG000|Overall Study|Lost to Follow-up|1
7407781|NCT01370005|11676346|FG001|Overall Study|Lost to Follow-up|1
7407782|NCT01370005|11676347|FG002|Overall Study|Lost to Follow-up|1
7407783|NCT01370005|11676345|FG000|Overall Study|Patient refusal to continue,not due toAE|5
7407784|NCT01370005|11676346|FG001|Overall Study|Patient refusal to continue,not due toAE|4
7407785|NCT01370005|11676347|FG002|Overall Study|Patient refusal to continue,not due toAE|0
7407786|NCT01370005|11676345|FG000|Overall Study|Other reason not defined above|3
7407787|NCT01370005|11676346|FG001|Overall Study|Other reason not defined above|0
7407788|NCT01370005|11676347|FG002|Overall Study|Other reason not defined above|2
7407789|NCT01370018|11676355|FG000|Overall Study|Did not meet criteria for analysis|1
7465918|NCT01886313|11765542|FG000|Overall Study|Adverse Event|1
7465919|NCT01886313|11765543|FG001|Overall Study|Adverse Event|1
7465920|NCT01886378|11765549|FG000|Overall Study|Adverse Event|1
7465921|NCT01886378|11765549|FG000|Overall Study|Withdrawal by Subject|4
7465922|NCT01886690|11765555|FG000|Overall Study|Protocol Violation|0
7465923|NCT01886690|11765556|FG001|Overall Study|Protocol Violation|1
7465924|NCT01886690|11765555|FG000|Overall Study|Personal Reasons|0
7465925|NCT01886690|11765556|FG001|Overall Study|Personal Reasons|1
7465926|NCT01886716|11765566|FG000|Week 1|Lost to Follow-up|0
7465927|NCT01886716|11765567|FG001|Week 1|Lost to Follow-up|0
7465928|NCT01886716|11765568|FG002|Week 1|Lost to Follow-up|2
7465929|NCT01886716|11765569|FG003|Week 1|Lost to Follow-up|2
7465930|NCT01886716|11765566|FG000|Week 2|Lost to Follow-up|3
7465931|NCT01886716|11765567|FG001|Week 2|Lost to Follow-up|2
7465932|NCT01886716|11765568|FG002|Week 2|Lost to Follow-up|1
7465933|NCT01886716|11765569|FG003|Week 2|Lost to Follow-up|3
7465934|NCT01886716|11765566|FG000|Week 3|Lost to Follow-up|1
7465935|NCT01886716|11765567|FG001|Week 3|Lost to Follow-up|1
7465936|NCT01886716|11765568|FG002|Week 3|Lost to Follow-up|0
7465937|NCT01886716|11765569|FG003|Week 3|Lost to Follow-up|1
7465938|NCT01886781|11765581|FG000|Overall Study|Protocol Violation|5
7465939|NCT01886781|11765582|FG001|Overall Study|Protocol Violation|0
7465940|NCT01886781|11765581|FG000|Overall Study|Adverse Event|1
7465941|NCT01886781|11765582|FG001|Overall Study|Adverse Event|0
7465942|NCT01886781|11765581|FG000|Overall Study|Lost to Follow-up|5
7465943|NCT01886781|11765582|FG001|Overall Study|Lost to Follow-up|0
7465944|NCT01886781|11765581|FG000|Overall Study|Withdrawal by Subject|2
7465945|NCT01886781|11765582|FG001|Overall Study|Withdrawal by Subject|1
7465946|NCT01886781|11765581|FG000|Overall Study|Worsening of symptoms|1
7465947|NCT01886781|11765582|FG001|Overall Study|Worsening of symptoms|1
7465948|NCT01886833|11765604|FG000|Overall Study|IgA not available from both periods|204
7465949|NCT01887210|11765635|FG000|Overall Study|Withdrawal by Subject|1
7465950|NCT01887210|11765636|FG001|Overall Study|Withdrawal by Subject|3
7465951|NCT01887210|11765635|FG000|Overall Study|Lost to Follow-up|0
7465952|NCT01887210|11765636|FG001|Overall Study|Lost to Follow-up|1
7465953|NCT01887353|11765658|FG000|Overall Study|Study stopped early|4
7465954|NCT01887353|11765659|FG001|Overall Study|Study stopped early|3
7465955|NCT01887418|11765668|FG000|Overall Study|Travelling difficulties|0
7465956|NCT01887418|11765669|FG001|Overall Study|Travelling difficulties|0
7465957|NCT01887418|11765670|FG002|Overall Study|Travelling difficulties|1
7465958|NCT01887600|11765702|FG000|Overall Study|Death|39
7465959|NCT01887600|11765703|FG001|Overall Study|Death|16
7465960|NCT01887600|11765702|FG000|Overall Study|Lack of Efficacy|3
7465961|NCT01887600|11765703|FG001|Overall Study|Lack of Efficacy|26
7465962|NCT01887600|11765702|FG000|Overall Study|Lost to Follow-up|5
7465963|NCT01887600|11765703|FG001|Overall Study|Lost to Follow-up|1
7465964|NCT01887600|11765702|FG000|Overall Study|Physician Decision|7
7465965|NCT01887600|11765703|FG001|Overall Study|Physician Decision|8
7465966|NCT01887600|11765702|FG000|Overall Study|Protocol Deviation|3
7465967|NCT01887600|11765703|FG001|Overall Study|Protocol Deviation|0
7465968|NCT01887600|11765702|FG000|Overall Study|Withdrawal by Subject|58
7465969|NCT01887600|11765703|FG001|Overall Study|Withdrawal by Subject|52
7465970|NCT01887600|11765702|FG000|Overall Study|Adverse Event|21
7465971|NCT01887600|11765703|FG001|Overall Study|Adverse Event|9
7465972|NCT01887600|11765702|FG000|Overall Study|Non-compliance with study drug|3
7465973|NCT01887600|11765703|FG001|Overall Study|Non-compliance with study drug|0
7465974|NCT01887600|11765702|FG000|Overall Study|Miscellaneous|6
7465975|NCT01887600|11765703|FG001|Overall Study|Miscellaneous|2
7465976|NCT01887600|11765702|FG000|Overall Study|Progressive Disease|1
7465977|NCT01887600|11765703|FG001|Overall Study|Progressive Disease|0
7465978|NCT01887678|11765712|FG000|Overall Study|Adverse Event|4
7465979|NCT01887678|11765713|FG001|Overall Study|Adverse Event|6
7465980|NCT01887678|11765712|FG000|Overall Study|Exceeded rescue medication dosage|4
7465981|NCT01887678|11765713|FG001|Overall Study|Exceeded rescue medication dosage|5
7465982|NCT01887678|11765712|FG000|Overall Study|Withdrawal of consent|3
7465983|NCT01887678|11765713|FG001|Overall Study|Withdrawal of consent|4
7465984|NCT01887678|11765712|FG000|Overall Study|Lost to Follow-up|4
7465985|NCT01887678|11765713|FG001|Overall Study|Lost to Follow-up|2
7465986|NCT01887678|11765712|FG000|Overall Study|Deterioration of clinical condition|0
7465987|NCT01887678|11765713|FG001|Overall Study|Deterioration of clinical condition|4
7465988|NCT01887678|11765712|FG000|Overall Study|Lack of Efficacy|1
7465989|NCT01887678|11765713|FG001|Overall Study|Lack of Efficacy|2
7465990|NCT01887678|11765712|FG000|Overall Study|Non-compliance|0
7465991|NCT01887678|11765713|FG001|Overall Study|Non-compliance|3
7465992|NCT01887678|11765712|FG000|Overall Study|Specified|1
7465993|NCT01887678|11765713|FG001|Overall Study|Specified|2
7465994|NCT01887717|11765721|FG000|Overall Study|Withdrawal by Subject|1
7465995|NCT01887717|11765722|FG001|Overall Study|Withdrawal by Subject|7
7465996|NCT01887717|11765721|FG000|Overall Study|Physician Decision|0
7465997|NCT01887717|11765722|FG001|Overall Study|Physician Decision|2
7465998|NCT01887717|11765721|FG000|Overall Study|Administrative reasons|5
7407790|NCT01370083|11676361|FG000|Overall Study|Lost to Follow-up|2
7407791|NCT01370083|11676362|FG001|Overall Study|Lost to Follow-up|0
7407792|NCT01370083|11676361|FG000|Overall Study|Adverse Event|0
7407793|NCT01370083|11676362|FG001|Overall Study|Adverse Event|1
7407794|NCT01370213|11676388|FG000|Overall Study|Early Death|1
7407795|NCT01370213|11676389|FG001|Overall Study|Early Death|0
7407796|NCT01370213|11676390|FG002|Overall Study|Early Death|0
7407797|NCT01370213|11676388|FG000|Overall Study|Not evaluable|0
7407798|NCT01370213|11676389|FG001|Overall Study|Not evaluable|2
7407799|NCT01370213|11676390|FG002|Overall Study|Not evaluable|0
7407800|NCT01370265|11676397|FG000|First Intervention|Adverse Event|1
7407801|NCT01370265|11676398|FG001|First Intervention|Adverse Event|1
7407802|NCT01370317|11676407|FG000|Overall Study|Participant withdrew consent|1
7407803|NCT01370317|11676408|FG001|Overall Study|Participant withdrew consent|0
7407804|NCT01370317|11676407|FG000|Overall Study|Protocol deviation|0
7407805|NCT01370317|11676408|FG001|Overall Study|Protocol deviation|1
7407806|NCT01370356|11676416|FG000|Overall Study|Death|1
7407807|NCT01370356|11676417|FG001|Overall Study|Death|0
7407808|NCT01370356|11676416|FG000|Overall Study|Lack of Efficacy|6
7407809|NCT01370356|11676417|FG001|Overall Study|Lack of Efficacy|28
7407810|NCT01370356|11676416|FG000|Overall Study|Lost to Follow-up|76
7407811|NCT01370356|11676417|FG001|Overall Study|Lost to Follow-up|81
7407812|NCT01370356|11676416|FG000|Overall Study|Withdrawal by Subject|54
7407813|NCT01370356|11676417|FG001|Overall Study|Withdrawal by Subject|59
7407814|NCT01370356|11676416|FG000|Overall Study|Reason not specified|39
7407815|NCT01370356|11676417|FG001|Overall Study|Reason not specified|43
7407816|NCT01370356|11676416|FG000|Overall Study|Protocol Violation|3
7407817|NCT01370356|11676417|FG001|Overall Study|Protocol Violation|3
7407818|NCT01370356|11676416|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
7407819|NCT01370356|11676417|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
7407820|NCT01370356|11676416|FG000|Overall Study|AE Not Related to Study Drug|1
7407821|NCT01370356|11676417|FG001|Overall Study|AE Not Related to Study Drug|4
7407822|NCT01370408|11676436|FG000|Overall Study|treatment failure|9
7407823|NCT01370499|11676452|FG000|Overall Study|Adverse Event|38
7407824|NCT01370499|11676453|FG001|Overall Study|Adverse Event|12
7407825|NCT01370499|11676452|FG000|Overall Study|Lack of Efficacy|4
7407826|NCT01370499|11676453|FG001|Overall Study|Lack of Efficacy|2
7407827|NCT01370499|11676452|FG000|Overall Study|Lost to Follow-up|2
7407828|NCT01370499|11676453|FG001|Overall Study|Lost to Follow-up|1
7407829|NCT01370499|11676452|FG000|Overall Study|Physician Decision|3
7407830|NCT01370499|11676453|FG001|Overall Study|Physician Decision|3
7407831|NCT01370499|11676452|FG000|Overall Study|Protocol Violation|5
7407832|NCT01370499|11676453|FG001|Overall Study|Protocol Violation|4
7407833|NCT01370499|11676452|FG000|Overall Study|Withdrawal by Subject|18
7407834|NCT01370499|11676453|FG001|Overall Study|Withdrawal by Subject|7
7407835|NCT01370499|11676452|FG000|Overall Study|Sponsor Decision|41
7407836|NCT01370499|11676453|FG001|Overall Study|Sponsor Decision|15
7407837|NCT01370525|11676463|FG000|Overall Study|Voluntary Discontinuation by Subject|2
7407838|NCT01370525|11676464|FG001|Overall Study|Voluntary Discontinuation by Subject|3
7407839|NCT01370525|11676463|FG000|Overall Study|Eligibility criteria not fulfilled|2
7407840|NCT01370525|11676464|FG001|Overall Study|Eligibility criteria not fulfilled|0
7407841|NCT01370525|11676463|FG000|Overall Study|Adverse Event|0
7407842|NCT01370525|11676464|FG001|Overall Study|Adverse Event|1
7407843|NCT01370525|11676463|FG000|Overall Study|Protocol Violation|2
7407844|NCT01370525|11676464|FG001|Overall Study|Protocol Violation|1
7407845|NCT01370525|11676463|FG000|Overall Study|Lost to follow up|2
7407846|NCT01370525|11676464|FG001|Overall Study|Lost to follow up|6
7407847|NCT01370538|11676472|FG000|Overall Study|Voluntary Discontinuation by Subject|3
7407848|NCT01370538|11676473|FG001|Overall Study|Voluntary Discontinuation by Subject|2
7407849|NCT01370538|11676472|FG000|Overall Study|Eligibility criteria not fulfilled|0
7407850|NCT01370538|11676473|FG001|Overall Study|Eligibility criteria not fulfilled|1
7407851|NCT01370538|11676472|FG000|Overall Study|Adverse Event|1
7407852|NCT01370538|11676473|FG001|Overall Study|Adverse Event|0
7407853|NCT01370538|11676472|FG000|Overall Study|Protocol Violation|8
7407854|NCT01370538|11676473|FG001|Overall Study|Protocol Violation|5
7407855|NCT01370538|11676472|FG000|Overall Study|Development of study specific withdrawal|1
7407856|NCT01370538|11676473|FG001|Overall Study|Development of study specific withdrawal|1
7407857|NCT01370538|11676472|FG000|Overall Study|Lost to follow up|6
7407858|NCT01370538|11676473|FG001|Overall Study|Lost to follow up|10
7407859|NCT01370616|11676485|FG000|Overall Study|Adverse Event|11
7407860|NCT01370616|11676486|FG001|Overall Study|Adverse Event|16
7407861|NCT01370616|11676485|FG000|Overall Study|Death|1
7407862|NCT01370616|11676486|FG001|Overall Study|Death|0
7407863|NCT01370616|11676485|FG000|Overall Study|Lack of Efficacy|6
7407864|NCT01370616|11676486|FG001|Overall Study|Lack of Efficacy|2
7407865|NCT01370616|11676485|FG000|Overall Study|Lost to Follow-up|0
7407866|NCT01370616|11676486|FG001|Overall Study|Lost to Follow-up|3
7407867|NCT01370616|11676485|FG000|Overall Study|Physician Decision|6
7407868|NCT01370616|11676486|FG001|Overall Study|Physician Decision|6
7407869|NCT01370616|11676485|FG000|Overall Study|Progressive Disease|0
7407870|NCT01370616|11676486|FG001|Overall Study|Progressive Disease|1
7407871|NCT01370616|11676485|FG000|Overall Study|Recovery|1
7407872|NCT01370616|11676486|FG001|Overall Study|Recovery|0
7407873|NCT01370616|11676485|FG000|Overall Study|Technical Problems|3
7407874|NCT01370616|11676486|FG001|Overall Study|Technical Problems|5
7407875|NCT01370616|11676485|FG000|Overall Study|Withdrawal by Subject|34
7407876|NCT01370616|11676486|FG001|Overall Study|Withdrawal by Subject|34
7407877|NCT01370642|11676499|FG000|Overall Study|Adverse Event|2
7407878|NCT01370642|11676500|FG001|Overall Study|Adverse Event|1
7407879|NCT01370642|11676501|FG002|Overall Study|Adverse Event|1
7407880|NCT01370642|11676499|FG000|Overall Study|Detectable HCV RNA|0
7407881|NCT01370642|11676500|FG001|Overall Study|Detectable HCV RNA|0
7407882|NCT01370642|11676501|FG002|Overall Study|Detectable HCV RNA|22
7407883|NCT01370642|11676499|FG000|Overall Study|Lost to Follow-up|0
7407884|NCT01370642|11676500|FG001|Overall Study|Lost to Follow-up|0
7407885|NCT01370642|11676501|FG002|Overall Study|Lost to Follow-up|1
7407886|NCT01370642|11676499|FG000|Overall Study|Physician Decision|4
7407887|NCT01370642|11676500|FG001|Overall Study|Physician Decision|1
7407888|NCT01370642|11676501|FG002|Overall Study|Physician Decision|2
7407889|NCT01370642|11676499|FG000|Overall Study|Withdrawal by Subject|2
7407890|NCT01370642|11676500|FG001|Overall Study|Withdrawal by Subject|4
7407891|NCT01370642|11676501|FG002|Overall Study|Withdrawal by Subject|3
7407892|NCT01370655|11676521|FG000|Period 1|Adverse Event|2
7407893|NCT01370655|11676522|FG001|Period 1|Adverse Event|0
7407894|NCT01370655|11676523|FG002|Period 1|Adverse Event|0
7407895|NCT01370655|11676524|FG003|Period 1|Adverse Event|0
7407896|NCT01370655|11676525|FG004|Period 1|Adverse Event|0
7407897|NCT01370655|11676526|FG005|Period 1|Adverse Event|0
7407898|NCT01370655|11676527|FG006|Period 1|Adverse Event|1
7407899|NCT01370655|11676528|FG007|Period 1|Adverse Event|0
7407900|NCT01370655|11676529|FG008|Period 1|Adverse Event|0
7407901|NCT01370655|11676530|FG009|Period 1|Adverse Event|0
7407902|NCT01370655|11676531|FG010|Period 1|Adverse Event|0
7407903|NCT01370655|11676532|FG011|Period 1|Adverse Event|0
7407904|NCT01370655|11676521|FG000|Period 2|Adverse Event|0
7407905|NCT01370655|11676522|FG001|Period 2|Adverse Event|0
7407906|NCT01370655|11676523|FG002|Period 2|Adverse Event|1
7407907|NCT01370655|11676524|FG003|Period 2|Adverse Event|0
7407908|NCT01370655|11676525|FG004|Period 2|Adverse Event|1
7407909|NCT01370655|11676526|FG005|Period 2|Adverse Event|0
7407910|NCT01370655|11676527|FG006|Period 2|Adverse Event|0
7407911|NCT01370655|11676528|FG007|Period 2|Adverse Event|1
7407912|NCT01370655|11676529|FG008|Period 2|Adverse Event|0
7407913|NCT01370655|11676530|FG009|Period 2|Adverse Event|0
7407914|NCT01370655|11676531|FG010|Period 2|Adverse Event|0
7407915|NCT01370655|11676532|FG011|Period 2|Adverse Event|0
7407916|NCT01370655|11676521|FG000|Period 2|met protocol specified stopping criteria|0
7407917|NCT01370655|11676522|FG001|Period 2|met protocol specified stopping criteria|0
7407918|NCT01370655|11676523|FG002|Period 2|met protocol specified stopping criteria|1
7407919|NCT01370655|11676524|FG003|Period 2|met protocol specified stopping criteria|0
7407920|NCT01370655|11676525|FG004|Period 2|met protocol specified stopping criteria|0
7407921|NCT01370655|11676526|FG005|Period 2|met protocol specified stopping criteria|0
7407922|NCT01370655|11676527|FG006|Period 2|met protocol specified stopping criteria|1
7407923|NCT01370655|11676528|FG007|Period 2|met protocol specified stopping criteria|0
7407924|NCT01370655|11676529|FG008|Period 2|met protocol specified stopping criteria|1
7407925|NCT01370655|11676530|FG009|Period 2|met protocol specified stopping criteria|0
7407926|NCT01370655|11676531|FG010|Period 2|met protocol specified stopping criteria|1
7407927|NCT01370655|11676532|FG011|Period 2|met protocol specified stopping criteria|0
7407928|NCT01370655|11676521|FG000|Period 2|Withdrawal by Subject|0
7407929|NCT01370655|11676522|FG001|Period 2|Withdrawal by Subject|0
7407930|NCT01370655|11676523|FG002|Period 2|Withdrawal by Subject|0
7407931|NCT01370655|11676524|FG003|Period 2|Withdrawal by Subject|0
7407932|NCT01370655|11676525|FG004|Period 2|Withdrawal by Subject|0
7407933|NCT01370655|11676526|FG005|Period 2|Withdrawal by Subject|0
7407934|NCT01370655|11676527|FG006|Period 2|Withdrawal by Subject|0
7407935|NCT01370655|11676528|FG007|Period 2|Withdrawal by Subject|0
7407936|NCT01370655|11676529|FG008|Period 2|Withdrawal by Subject|1
7407937|NCT01370655|11676530|FG009|Period 2|Withdrawal by Subject|0
7407938|NCT01370655|11676531|FG010|Period 2|Withdrawal by Subject|0
7407939|NCT01370655|11676532|FG011|Period 2|Withdrawal by Subject|0
7407940|NCT01370694|11676542|FG000|Overall Study|Switched to rituximab|4
7407941|NCT01370694|11676542|FG000|Overall Study|Progressive disease|2
7407942|NCT01370733|11676548|FG000|Overall Study|Withdrawal by Subject|8
7407943|NCT01370733|11676549|FG001|Overall Study|Withdrawal by Subject|8
7407944|NCT01370733|11676548|FG000|Overall Study|Lost to Follow-up|3
7407945|NCT01370733|11676549|FG001|Overall Study|Lost to Follow-up|0
7407946|NCT01370733|11676548|FG000|Overall Study|Adverse Event|2
7407947|NCT01370733|11676549|FG001|Overall Study|Adverse Event|4
7407948|NCT01370733|11676548|FG000|Overall Study|Lack of Efficacy|3
7407949|NCT01370733|11676549|FG001|Overall Study|Lack of Efficacy|5
7407950|NCT01370733|11676548|FG000|Overall Study|Physician Decision|0
7407951|NCT01370733|11676549|FG001|Overall Study|Physician Decision|2
7407952|NCT01370733|11676548|FG000|Overall Study|Protocol Violation|1
7407953|NCT01370733|11676549|FG001|Overall Study|Protocol Violation|3
7407954|NCT01370863|11676570|FG000|Overall Study|Adverse Event|1
7407955|NCT01370863|11676571|FG001|Overall Study|Adverse Event|1
7407956|NCT01370863|11676570|FG000|Overall Study|Did not want second pH/MII monitoring|1
7407957|NCT01370863|11676571|FG001|Overall Study|Did not want second pH/MII monitoring|1
7407958|NCT01370863|11676570|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
7407959|NCT01370863|11676571|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7407960|NCT01371006|11676579|FG000|Overall Study|Adverse Event|1
7407961|NCT01371006|11676580|FG001|Overall Study|Adverse Event|0
7407962|NCT01371539|11676626|FG000|Period One: One Week|Lost to Follow-up|0
7407963|NCT01371539|11676627|FG001|Period One: One Week|Lost to Follow-up|1
7407964|NCT01371539|11676626|FG000|Period Two: One Week|Lost to Follow-up|0
7407965|NCT01371539|11676627|FG001|Period Two: One Week|Lost to Follow-up|1
7407966|NCT01371539|11676626|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
7407967|NCT01371539|11676627|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
7407968|NCT01371539|11676626|FG000|Period Two: One Week|Time/job conflict|0
7407969|NCT01371539|11676627|FG001|Period Two: One Week|Time/job conflict|1
7407970|NCT01371552|11676633|FG000|Part 1, First 3 Days|Inconvenience|0
7407971|NCT01371552|11676634|FG001|Part 1, First 3 Days|Inconvenience|0
7407972|NCT01371552|11676635|FG002|Part 1, First 3 Days|Inconvenience|1
7407973|NCT01371552|11676636|FG003|Part 1, First 3 Days|Inconvenience|0
7407974|NCT01371552|11676637|FG004|Part 1, First 3 Days|Inconvenience|0
7407975|NCT01371552|11676638|FG005|Part 1, First 3 Days|Inconvenience|0
7407976|NCT01371565|11676647|FG000|Overall Study|Withdrawal by Subject|1
7407977|NCT01371565|11676647|FG000|Overall Study|Death|1
7407978|NCT01371565|11676647|FG000|Overall Study|Resection of neuroendocrine tumor|1
7407979|NCT01371643|11676653|FG000|Overall Study|Withdrawal by Subject|3
7407980|NCT01371643|11676654|FG001|Overall Study|Withdrawal by Subject|0
7407981|NCT01371656|11676662|FG000|Overall Study|Death|7
7407982|NCT01371656|11676663|FG001|Overall Study|Death|4
7407983|NCT01371656|11676662|FG000|Overall Study|Physician Decision|46
7407984|NCT01371656|11676663|FG001|Overall Study|Physician Decision|7
7407985|NCT01371656|11676662|FG000|Overall Study|Withdrawal by Subject|7
7407986|NCT01371656|11676663|FG001|Overall Study|Withdrawal by Subject|0
7407987|NCT01371656|11676662|FG000|Overall Study|Ineligible|4
7407988|NCT01371656|11676663|FG001|Overall Study|Ineligible|3
7407989|NCT01371708|11676672|FG000|Overall Study|Insufficient clinical response|3
7407990|NCT01371708|11676673|FG001|Overall Study|Insufficient clinical response|2
7407991|NCT01371708|11676674|FG002|Overall Study|Insufficient clinical response|0
7407992|NCT01371708|11676672|FG000|Overall Study|Lost to Follow-up|5
7407993|NCT01371708|11676673|FG001|Overall Study|Lost to Follow-up|9
7407994|NCT01371708|11676674|FG002|Overall Study|Lost to Follow-up|7
7407995|NCT01371708|11676672|FG000|Overall Study|Protocol Violation|2
7407996|NCT01371708|11676673|FG001|Overall Study|Protocol Violation|1
7407997|NCT01371708|11676674|FG002|Overall Study|Protocol Violation|2
7407998|NCT01371708|11676672|FG000|Overall Study|No longer willing to participate|7
7407999|NCT01371708|11676673|FG001|Overall Study|No longer willing to participate|7
7408000|NCT01371708|11676674|FG002|Overall Study|No longer willing to participate|13
7408001|NCT01371708|11676672|FG000|Overall Study|Medication error/not related to AE|0
7408002|NCT01371708|11676673|FG001|Overall Study|Medication error/not related to AE|1
7408003|NCT01371708|11676674|FG002|Overall Study|Medication error/not related to AE|0
7408004|NCT01371708|11676672|FG000|Overall Study|Other|3
7408005|NCT01371708|11676673|FG001|Overall Study|Other|2
7408006|NCT01371708|11676674|FG002|Overall Study|Other|4
7408007|NCT01371708|11676672|FG000|Overall Study|Adverse Event|5
7408008|NCT01371708|11676673|FG001|Overall Study|Adverse Event|8
7408009|NCT01371708|11676674|FG002|Overall Study|Adverse Event|12
7408010|NCT01371708|11676672|FG000|Overall Study|Started but did not receive treatment|1
7408011|NCT01371708|11676673|FG001|Overall Study|Started but did not receive treatment|0
7408012|NCT01371708|11676674|FG002|Overall Study|Started but did not receive treatment|1
7408013|NCT01371721|11676687|FG000|Overall Study|Adverse Event|5
7408014|NCT01371721|11676688|FG001|Overall Study|Adverse Event|4
7408015|NCT01371721|11676689|FG002|Overall Study|Adverse Event|5
7408016|NCT01371721|11676687|FG000|Overall Study|Protocol Violation|6
7408017|NCT01371721|11676688|FG001|Overall Study|Protocol Violation|4
7408018|NCT01371721|11676689|FG002|Overall Study|Protocol Violation|5
7408019|NCT01371721|11676687|FG000|Overall Study|Lost to Follow-up|8
7408020|NCT01371721|11676688|FG001|Overall Study|Lost to Follow-up|2
7408021|NCT01371721|11676689|FG002|Overall Study|Lost to Follow-up|6
7408022|NCT01371721|11676687|FG000|Overall Study|Withdrawal by Subject|5
7408023|NCT01371721|11676688|FG001|Overall Study|Withdrawal by Subject|7
7408024|NCT01371721|11676689|FG002|Overall Study|Withdrawal by Subject|11
7408025|NCT01371721|11676687|FG000|Overall Study|Other|2
7408026|NCT01371721|11676688|FG001|Overall Study|Other|3
7408027|NCT01371721|11676689|FG002|Overall Study|Other|0
7408028|NCT01371721|11676687|FG000|Overall Study|Lack of Efficacy|2
7408029|NCT01371721|11676688|FG001|Overall Study|Lack of Efficacy|4
7408030|NCT01371721|11676689|FG002|Overall Study|Lack of Efficacy|3
7408031|NCT01371721|11676687|FG000|Overall Study|Randomized but not treated|1
7408032|NCT01371721|11676688|FG001|Overall Study|Randomized but not treated|0
7408033|NCT01371721|11676689|FG002|Overall Study|Randomized but not treated|0
7408034|NCT01371734|11676702|FG000|Overall Study|Other|2
7408035|NCT01371734|11676703|FG001|Overall Study|Other|1
7408036|NCT01371734|11676704|FG002|Overall Study|Other|2
7408037|NCT01371734|11676702|FG000|Overall Study|Withdrawal by Subject|3
7408038|NCT01371734|11676703|FG001|Overall Study|Withdrawal by Subject|4
7408039|NCT01371734|11676704|FG002|Overall Study|Withdrawal by Subject|9
7408040|NCT01371734|11676702|FG000|Overall Study|Lost to Follow-up|5
7408041|NCT01371734|11676703|FG001|Overall Study|Lost to Follow-up|3
7408042|NCT01371734|11676704|FG002|Overall Study|Lost to Follow-up|1
7408043|NCT01371734|11676702|FG000|Overall Study|Protocol Violation|3
7408044|NCT01371734|11676703|FG001|Overall Study|Protocol Violation|1
7408045|NCT01371734|11676704|FG002|Overall Study|Protocol Violation|2
7408046|NCT01371734|11676702|FG000|Overall Study|Adverse Event|8
7408047|NCT01371734|11676703|FG001|Overall Study|Adverse Event|8
7408048|NCT01371734|11676704|FG002|Overall Study|Adverse Event|3
7408049|NCT01371734|11676702|FG000|Overall Study|Lack of Efficacy|2
7408050|NCT01371734|11676703|FG001|Overall Study|Lack of Efficacy|2
7408051|NCT01371734|11676704|FG002|Overall Study|Lack of Efficacy|0
7408052|NCT01371747|11676718|FG000|Overall Study|Adverse Event|4
7408053|NCT01371747|11676719|FG001|Overall Study|Adverse Event|2
7408054|NCT01371747|11676720|FG002|Overall Study|Adverse Event|7
7408055|NCT01371747|11676721|FG003|Overall Study|Adverse Event|2
7408056|NCT01371747|11676722|FG004|Overall Study|Adverse Event|2
7408057|NCT01371747|11676723|FG005|Overall Study|Adverse Event|2
7408058|NCT01371747|11676718|FG000|Overall Study|Death|1
7408059|NCT01371747|11676719|FG001|Overall Study|Death|0
7408060|NCT01371747|11676720|FG002|Overall Study|Death|4
7408061|NCT01371747|11676721|FG003|Overall Study|Death|1
7408062|NCT01371747|11676722|FG004|Overall Study|Death|2
7408063|NCT01371747|11676723|FG005|Overall Study|Death|0
7408064|NCT01371747|11676718|FG000|Overall Study|Abnormal Renal Function|0
7408065|NCT01371747|11676719|FG001|Overall Study|Abnormal Renal Function|2
7408066|NCT01371747|11676720|FG002|Overall Study|Abnormal Renal Function|0
7408067|NCT01371747|11676721|FG003|Overall Study|Abnormal Renal Function|1
7408068|NCT01371747|11676722|FG004|Overall Study|Abnormal Renal Function|0
7408069|NCT01371747|11676723|FG005|Overall Study|Abnormal Renal Function|1
7408070|NCT01371747|11676718|FG000|Overall Study|High Serum Potassium Results|1
7408071|NCT01371747|11676719|FG001|Overall Study|High Serum Potassium Results|1
7408072|NCT01371747|11676720|FG002|Overall Study|High Serum Potassium Results|1
7408073|NCT01371747|11676721|FG003|Overall Study|High Serum Potassium Results|2
7408074|NCT01371747|11676722|FG004|Overall Study|High Serum Potassium Results|0
7408075|NCT01371747|11676723|FG005|Overall Study|High Serum Potassium Results|2
7408076|NCT01371747|11676718|FG000|Overall Study|Low Serum Potassium Results|1
7408077|NCT01371747|11676719|FG001|Overall Study|Low Serum Potassium Results|1
7408078|NCT01371747|11676720|FG002|Overall Study|Low Serum Potassium Results|1
7408079|NCT01371747|11676721|FG003|Overall Study|Low Serum Potassium Results|1
7408080|NCT01371747|11676722|FG004|Overall Study|Low Serum Potassium Results|0
7408081|NCT01371747|11676723|FG005|Overall Study|Low Serum Potassium Results|3
7408082|NCT01371747|11676718|FG000|Overall Study|Protocol Violation|0
7408083|NCT01371747|11676719|FG001|Overall Study|Protocol Violation|0
7408084|NCT01371747|11676720|FG002|Overall Study|Protocol Violation|1
7408085|NCT01371747|11676721|FG003|Overall Study|Protocol Violation|0
7408086|NCT01371747|11676722|FG004|Overall Study|Protocol Violation|0
7408087|NCT01371747|11676723|FG005|Overall Study|Protocol Violation|0
7408088|NCT01371747|11676718|FG000|Overall Study|Non-Compliance|3
7408089|NCT01371747|11676719|FG001|Overall Study|Non-Compliance|4
7408090|NCT01371747|11676720|FG002|Overall Study|Non-Compliance|3
7408091|NCT01371747|11676721|FG003|Overall Study|Non-Compliance|0
7408092|NCT01371747|11676722|FG004|Overall Study|Non-Compliance|0
7408093|NCT01371747|11676723|FG005|Overall Study|Non-Compliance|1
7408094|NCT01371747|11676718|FG000|Overall Study|Physician Decision|0
7408095|NCT01371747|11676719|FG001|Overall Study|Physician Decision|0
7408096|NCT01371747|11676720|FG002|Overall Study|Physician Decision|0
7408097|NCT01371747|11676721|FG003|Overall Study|Physician Decision|0
7408098|NCT01371747|11676722|FG004|Overall Study|Physician Decision|1
7408099|NCT01371747|11676723|FG005|Overall Study|Physician Decision|0
7408100|NCT01371747|11676718|FG000|Overall Study|Withdrawal by Subject|6
7408101|NCT01371747|11676719|FG001|Overall Study|Withdrawal by Subject|12
7408102|NCT01371747|11676720|FG002|Overall Study|Withdrawal by Subject|5
7408103|NCT01371747|11676721|FG003|Overall Study|Withdrawal by Subject|2
7408104|NCT01371747|11676722|FG004|Overall Study|Withdrawal by Subject|2
7408105|NCT01371747|11676723|FG005|Overall Study|Withdrawal by Subject|4
7408106|NCT01371747|11676718|FG000|Overall Study|Other Reasons|2
7408107|NCT01371747|11676719|FG001|Overall Study|Other Reasons|1
7408108|NCT01371747|11676720|FG002|Overall Study|Other Reasons|2
7408109|NCT01371747|11676721|FG003|Overall Study|Other Reasons|0
7408110|NCT01371747|11676722|FG004|Overall Study|Other Reasons|0
7408111|NCT01371747|11676723|FG005|Overall Study|Other Reasons|1
7408112|NCT01371825|11676747|FG000|Overall Study|Death|4
7408113|NCT01371838|11676753|FG000|Overall Study|Withdrawal by Subject|27
7408114|NCT01371838|11676754|FG001|Overall Study|Withdrawal by Subject|33
7408115|NCT01371838|11676753|FG000|Overall Study|Lost to Follow-up|10
7408116|NCT01371838|11676754|FG001|Overall Study|Lost to Follow-up|20
7408117|NCT01371838|11676753|FG000|Overall Study|Death|3
7408118|NCT01371838|11676754|FG001|Overall Study|Death|4
7408119|NCT01371838|11676753|FG000|Overall Study|Protocol Violation|3
7408120|NCT01371838|11676754|FG001|Overall Study|Protocol Violation|0
7408121|NCT01371838|11676753|FG000|Overall Study|Investigator Decision|3
7408122|NCT01371838|11676754|FG001|Overall Study|Investigator Decision|8
7408123|NCT01371838|11676753|FG000|Overall Study|Last follow-up visit not conducted|2
7408124|NCT01371838|11676754|FG001|Overall Study|Last follow-up visit not conducted|0
7408125|NCT01371838|11676753|FG000|Overall Study|Lack of therapeutic response|0
7408126|NCT01371838|11676754|FG001|Overall Study|Lack of therapeutic response|1
7408127|NCT01371838|11676753|FG000|Overall Study|Surgery|1
7408128|NCT01371838|11676754|FG001|Overall Study|Surgery|0
7408129|NCT01371851|11676762|FG000|Overall Study|Lost to Follow-up|5
7408130|NCT01371851|11676763|FG001|Overall Study|Lost to Follow-up|8
7408131|NCT01371851|11676762|FG000|Overall Study|was arrested and put in jail|0
7408132|NCT01371851|11676763|FG001|Overall Study|was arrested and put in jail|1
7408133|NCT01371851|11676762|FG000|Overall Study|non study related adverse event|1
7408134|NCT01371851|11676763|FG001|Overall Study|non study related adverse event|0
7408135|NCT01371851|11676762|FG000|Overall Study|Blood Pressure outside study parameters|2
7408136|NCT01371851|11676763|FG001|Overall Study|Blood Pressure outside study parameters|0
7408137|NCT01371877|11676771|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
7408138|NCT01371877|11676772|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
7408139|NCT01371994|11676780|FG000|Overall Study|Adverse Event|3
7408140|NCT01371994|11676781|FG001|Overall Study|Adverse Event|6
7408141|NCT01371994|11676780|FG000|Overall Study|Lack of Efficacy|3
7408142|NCT01371994|11676781|FG001|Overall Study|Lack of Efficacy|0
7408143|NCT01371994|11676780|FG000|Overall Study|Withdrawal by Subject|13
7408144|NCT01371994|11676781|FG001|Overall Study|Withdrawal by Subject|7
7408145|NCT01371994|11676780|FG000|Overall Study|Lost to Follow-up|1
7408146|NCT01371994|11676781|FG001|Overall Study|Lost to Follow-up|1
7408147|NCT01371994|11676780|FG000|Overall Study|Protocol Violation|24
7408148|NCT01371994|11676781|FG001|Overall Study|Protocol Violation|17
7408149|NCT01371994|11676780|FG000|Overall Study|Randomized but Never Received Study Drug|6
7408150|NCT01371994|11676781|FG001|Overall Study|Randomized but Never Received Study Drug|6
7408151|NCT01371994|11676780|FG000|Overall Study|Physician Decision|1
7408152|NCT01371994|11676781|FG001|Overall Study|Physician Decision|1
7408153|NCT01371994|11676780|FG000|Overall Study|Miscellaneous Reasons|6
7408154|NCT01371994|11676781|FG001|Overall Study|Miscellaneous Reasons|4
7408155|NCT01372085|11676797|FG000|Washout Period 2|Physician Decision|0
7408156|NCT01372085|11676798|FG001|Washout Period 2|Physician Decision|0
7408157|NCT01372085|11676799|FG002|Washout Period 2|Physician Decision|0
7408158|NCT01372085|11676800|FG003|Washout Period 2|Physician Decision|0
7408159|NCT01372085|11676801|FG004|Washout Period 2|Physician Decision|1
7408160|NCT01372085|11676802|FG005|Washout Period 2|Physician Decision|0
7408161|NCT01372085|11676803|FG006|Washout Period 2|Physician Decision|0
7408162|NCT01372085|11676804|FG007|Washout Period 2|Physician Decision|0
7408163|NCT01372085|11676805|FG008|Washout Period 2|Physician Decision|0
7408164|NCT01372085|11676806|FG009|Washout Period 2|Physician Decision|0
7408165|NCT01372085|11676797|FG000|Washout Period 3|Withdrawal by Subject|0
7408166|NCT01372085|11676798|FG001|Washout Period 3|Withdrawal by Subject|0
7408167|NCT01372085|11676799|FG002|Washout Period 3|Withdrawal by Subject|0
7408168|NCT01372085|11676800|FG003|Washout Period 3|Withdrawal by Subject|0
7408169|NCT01372085|11676801|FG004|Washout Period 3|Withdrawal by Subject|0
7408170|NCT01372085|11676802|FG005|Washout Period 3|Withdrawal by Subject|2
7408171|NCT01372085|11676803|FG006|Washout Period 3|Withdrawal by Subject|0
7408172|NCT01372085|11676804|FG007|Washout Period 3|Withdrawal by Subject|0
7408173|NCT01372085|11676805|FG008|Washout Period 3|Withdrawal by Subject|0
7408174|NCT01372085|11676806|FG009|Washout Period 3|Withdrawal by Subject|0
7408175|NCT01372150|11676833|FG000|Overall Study|Lack of Efficacy|3
7408176|NCT01372150|11676834|FG001|Overall Study|Lack of Efficacy|0
7408177|NCT01372150|11676835|FG002|Overall Study|Lack of Efficacy|1
7408178|NCT01372150|11676833|FG000|Overall Study|Lost to Follow-up|4
7408179|NCT01372150|11676834|FG001|Overall Study|Lost to Follow-up|5
7408180|NCT01372150|11676835|FG002|Overall Study|Lost to Follow-up|6
7408181|NCT01372150|11676833|FG000|Overall Study|Protocol Violation|1
7408182|NCT01372150|11676834|FG001|Overall Study|Protocol Violation|0
7408183|NCT01372150|11676835|FG002|Overall Study|Protocol Violation|3
7408184|NCT01372150|11676833|FG000|Overall Study|Withdrawal by Subject|2
7408185|NCT01372150|11676834|FG001|Overall Study|Withdrawal by Subject|7
7408186|NCT01372150|11676835|FG002|Overall Study|Withdrawal by Subject|2
7408187|NCT01372150|11676833|FG000|Overall Study|Other|1
7408188|NCT01372150|11676834|FG001|Overall Study|Other|0
7408189|NCT01372150|11676835|FG002|Overall Study|Other|2
7408190|NCT01372150|11676833|FG000|Overall Study|Adverse Event|2
7408191|NCT01372150|11676834|FG001|Overall Study|Adverse Event|1
7408192|NCT01372150|11676835|FG002|Overall Study|Adverse Event|2
7408193|NCT01372150|11676833|FG000|Overall Study|Randomized but not treated|0
7408194|NCT01372150|11676834|FG001|Overall Study|Randomized but not treated|1
7408195|NCT01372150|11676835|FG002|Overall Study|Randomized but not treated|0
7408196|NCT01372384|11676861|FG000|Overall Study|Progression of disease|3
7408197|NCT01372410|11676865|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7408198|NCT01372410|11676866|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7408199|NCT01372410|11676867|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7408200|NCT01372410|11676868|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7408201|NCT01372410|11676869|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
7408202|NCT01372410|11676870|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7408203|NCT01372410|11676871|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7408204|NCT01372410|11676872|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
7408205|NCT01372410|11676865|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
7408206|NCT01372410|11676866|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
7408207|NCT01372410|11676867|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
7408208|NCT01372410|11676868|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
7408209|NCT01372410|11676869|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
7408210|NCT01372410|11676870|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
7408211|NCT01372410|11676871|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
7408212|NCT01372410|11676872|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
7408213|NCT01372410|11676865|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408214|NCT01372410|11676866|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408215|NCT01372410|11676867|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408216|NCT01372410|11676868|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408217|NCT01372410|11676869|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7408218|NCT01372410|11676870|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408219|NCT01372410|11676871|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408220|NCT01372410|11676872|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7408221|NCT01372410|11676865|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408222|NCT01372410|11676866|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408223|NCT01372410|11676867|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408224|NCT01372410|11676868|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408225|NCT01372410|11676869|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408226|NCT01372410|11676870|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408227|NCT01372410|11676871|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
7408228|NCT01372410|11676872|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
7408229|NCT01372410|11676865|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7408230|NCT01372410|11676866|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408231|NCT01372410|11676867|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408232|NCT01372410|11676868|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408233|NCT01372410|11676869|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408234|NCT01372410|11676870|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408235|NCT01372410|11676871|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
7408236|NCT01372410|11676872|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
7408237|NCT01372410|11676865|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
7408238|NCT01372410|11676866|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
7408239|NCT01372410|11676867|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
7408240|NCT01372410|11676868|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
7408241|NCT01372410|11676869|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
7408242|NCT01372410|11676870|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
7408243|NCT01372410|11676871|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
7408244|NCT01372410|11676872|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
7408245|NCT01372410|11676865|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7408246|NCT01372410|11676866|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7408247|NCT01372410|11676867|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7408248|NCT01372410|11676868|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7408249|NCT01372410|11676869|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7408250|NCT01372410|11676870|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
7408251|NCT01372410|11676871|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7408252|NCT01372410|11676872|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
7408253|NCT01372410|11676865|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408254|NCT01372410|11676866|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408255|NCT01372410|11676867|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408256|NCT01372410|11676868|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408257|NCT01372410|11676869|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408258|NCT01372410|11676870|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408259|NCT01372410|11676871|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
7408260|NCT01372410|11676872|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
7408261|NCT01372410|11676865|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
7408262|NCT01372410|11676866|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
7408263|NCT01372410|11676867|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
7408264|NCT01372410|11676868|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
7408265|NCT01372410|11676869|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
7408266|NCT01372410|11676870|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
7408267|NCT01372410|11676871|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
7408268|NCT01372410|11676872|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
7408269|NCT01372410|11676865|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408270|NCT01372410|11676866|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408271|NCT01372410|11676867|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408272|NCT01372410|11676868|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408273|NCT01372410|11676869|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408274|NCT01372410|11676870|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
7408275|NCT01372410|11676871|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408276|NCT01372410|11676872|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
7408277|NCT01372501|11676901|FG000|Overall Study|Adverse Event|4
7408278|NCT01372501|11676901|FG000|Overall Study|Device migration|1
7408279|NCT01372605|11676908|FG000|Overall Study|Death|1
7408280|NCT01372605|11676909|FG001|Overall Study|Death|2
7408281|NCT01372605|11676908|FG000|Overall Study|Lost to Follow-up|2
7408282|NCT01372605|11676909|FG001|Overall Study|Lost to Follow-up|1
7408283|NCT01372605|11676908|FG000|Overall Study|Withdrawal by Subject|4
7408284|NCT01372605|11676909|FG001|Overall Study|Withdrawal by Subject|7
7408285|NCT01372605|11676908|FG000|Overall Study|Moved|3
7408286|NCT01372605|11676909|FG001|Overall Study|Moved|0
7408287|NCT01372605|11676908|FG000|Overall Study|Changed medical home|2
7408288|NCT01372605|11676909|FG001|Overall Study|Changed medical home|0
7408289|NCT01372748|11676917|FG000|Overall Study|Lost to Follow-up|16
7408290|NCT01372748|11676918|FG001|Overall Study|Lost to Follow-up|34
7408291|NCT01372748|11676917|FG000|Overall Study|Withdrawal by Subject|7
7408292|NCT01372748|11676918|FG001|Overall Study|Withdrawal by Subject|5
7408295|NCT01372878|11676939|FG000|Overall Study|Withdrawal by Subject|63
7408296|NCT01372878|11676939|FG000|Overall Study|Protocol Violation|17
7408297|NCT01372878|11676939|FG000|Overall Study|incomplete study procedure|104
7408298|NCT01372995|11676946|FG000|Overall Study|Spouse withdrew participant from study|0
7408299|NCT01372995|11676947|FG001|Overall Study|Spouse withdrew participant from study|1
7408300|NCT01372995|11676948|FG002|Overall Study|Spouse withdrew participant from study|0
7408301|NCT01372995|11676946|FG000|Overall Study|Physician Decision|0
7408302|NCT01372995|11676947|FG001|Overall Study|Physician Decision|0
7408303|NCT01372995|11676948|FG002|Overall Study|Physician Decision|1
7408304|NCT01373164|11676961|FG000|Overall Study|Lost to Follow-up|0
7408305|NCT01373164|11676962|FG001|Overall Study|Lost to Follow-up|0
7408306|NCT01373164|11676963|FG002|Overall Study|Lost to Follow-up|1
7408307|NCT01373164|11676964|FG003|Overall Study|Lost to Follow-up|2
7408308|NCT01373164|11676965|FG004|Overall Study|Lost to Follow-up|0
7408309|NCT01373164|11676961|FG000|Overall Study|Withdrawal by Subject|0
7408310|NCT01373164|11676962|FG001|Overall Study|Withdrawal by Subject|1
7408311|NCT01373164|11676963|FG002|Overall Study|Withdrawal by Subject|0
7408312|NCT01373164|11676964|FG003|Overall Study|Withdrawal by Subject|10
7408313|NCT01373164|11676965|FG004|Overall Study|Withdrawal by Subject|2
7408314|NCT01373229|11676980|FG000|Overall Study|Death|3
7408315|NCT01373229|11676980|FG000|Overall Study|Physician Decision|3
7408316|NCT01373294|11676992|FG000|Overall Study|Adverse Event|1
7408317|NCT01373294|11676993|FG001|Overall Study|Adverse Event|0
7408318|NCT01373346|11676999|FG000|Overall Study|Death|1
7408319|NCT01373918|11677047|FG000|Overall Study|Physician Decision|0
7408320|NCT01373918|11677048|FG001|Overall Study|Physician Decision|1
7408321|NCT01373931|11677056|FG000|Lead-in Period|Adverse Event|2
7408322|NCT01373931|11677057|FG001|Lead-in Period|Adverse Event|0
7408323|NCT01373931|11677056|FG000|Period 1|Adverse Event|2
7408324|NCT01373931|11677057|FG001|Period 1|Adverse Event|0
7408325|NCT01373931|11677056|FG000|Period 1|Withdrawal by Subject|0
7408326|NCT01373931|11677057|FG001|Period 1|Withdrawal by Subject|2
7408327|NCT01374087|11677066|FG000|Overall Study|Adverse Event|1
7408328|NCT01374087|11677067|FG001|Overall Study|Adverse Event|0
7408329|NCT01374087|11677066|FG000|Overall Study|Disease progression|2
7408330|NCT01374087|11677067|FG001|Overall Study|Disease progression|2
7408331|NCT01374087|11677066|FG000|Overall Study|Study discontinued|13
7408332|NCT01374087|11677067|FG001|Overall Study|Study discontinued|13
7408333|NCT01374178|11677073|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
7408334|NCT01374178|11677074|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
7408335|NCT01374178|11677073|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
7408336|NCT01374178|11677074|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
7408337|NCT01374217|11677080|FG000|Overall Study|Lack of Efficacy|13
7408338|NCT01374269|11677086|FG000|Overall Study|Withdrawal by Subject|4
7408339|NCT01374269|11677087|FG001|Overall Study|Withdrawal by Subject|0
7408340|NCT01374269|11677086|FG000|Overall Study|Lost to Follow-up|1
7408341|NCT01374269|11677087|FG001|Overall Study|Lost to Follow-up|3
7408342|NCT01374269|11677086|FG000|Overall Study|closed research|1
7408343|NCT01374269|11677087|FG001|Overall Study|closed research|2
7408344|NCT01374425|11677095|FG000|Overall Study|Radiographic Disease Progression|86
7408345|NCT01374425|11677096|FG001|Overall Study|Radiographic Disease Progression|81
7408346|NCT01374425|11677095|FG000|Overall Study|Clinical Disease Progression|9
7408347|NCT01374425|11677096|FG001|Overall Study|Clinical Disease Progression|6
7408348|NCT01374425|11677095|FG000|Overall Study|Adverse Event|29
7408349|NCT01374425|11677096|FG001|Overall Study|Adverse Event|18
7408350|NCT01374425|11677095|FG000|Overall Study|Death (Progression of Disease)|1
7408351|NCT01374425|11677096|FG001|Overall Study|Death (Progression of Disease)|0
7408352|NCT01374425|11677095|FG000|Overall Study|Death (Adverse Event)|2
7408353|NCT01374425|11677096|FG001|Overall Study|Death (Adverse Event)|4
7408354|NCT01374425|11677095|FG000|Overall Study|Withdrawal by Subject|6
7408355|NCT01374425|11677096|FG001|Overall Study|Withdrawal by Subject|7
7408356|NCT01374425|11677095|FG000|Overall Study|Refused Treatment|10
7408357|NCT01374425|11677096|FG001|Overall Study|Refused Treatment|24
7408358|NCT01374425|11677095|FG000|Overall Study|Protocol Violation|2
7408359|NCT01374425|11677096|FG001|Overall Study|Protocol Violation|3
7408360|NCT01374425|11677095|FG000|Overall Study|Sponsor Decision|0
7408361|NCT01374425|11677096|FG001|Overall Study|Sponsor Decision|1
7408362|NCT01374425|11677095|FG000|Overall Study|Lost to Follow-up|2
7408363|NCT01374425|11677096|FG001|Overall Study|Lost to Follow-up|1
7408364|NCT01374425|11677095|FG000|Overall Study|Other|41
7408365|NCT01374425|11677096|FG001|Overall Study|Other|43
7408366|NCT01374451|11677134|FG000|Overall Study|Administrative problems|1
7408367|NCT01374451|11677135|FG001|Overall Study|Administrative problems|0
7408368|NCT01374568|11677147|FG000|Overall Study|Lab unable to analyze BTM|0
7408369|NCT01374568|11677148|FG001|Overall Study|Lab unable to analyze BTM|2
7408370|NCT01374906|11677162|FG000|Overall Study|Abnormal laboratory value(s)|0
7408371|NCT01374906|11677163|FG001|Overall Study|Abnormal laboratory value(s)|3
7408372|NCT01374906|11677162|FG000|Overall Study|Administrative problems|2
7408373|NCT01374906|11677163|FG001|Overall Study|Administrative problems|2
7408374|NCT01374906|11677162|FG000|Overall Study|Adverse Event|10
7408375|NCT01374906|11677163|FG001|Overall Study|Adverse Event|11
7408376|NCT01374906|11677162|FG000|Overall Study|Death|0
7408377|NCT01374906|11677163|FG001|Overall Study|Death|2
7408378|NCT01374906|11677162|FG000|Overall Study|Protocol Violation|2
7408379|NCT01374906|11677163|FG001|Overall Study|Protocol Violation|2
7408380|NCT01374906|11677162|FG000|Overall Study|Withdrawal by Subject|15
7408381|NCT01374906|11677163|FG001|Overall Study|Withdrawal by Subject|9
7408382|NCT01374906|11677162|FG000|Overall Study|Unsatisfactory therapeutic effect|11
7408383|NCT01374906|11677163|FG001|Overall Study|Unsatisfactory therapeutic effect|19
7408384|NCT01374919|11677173|FG000|Overall Study|Withdrawal by Subject|2
7408385|NCT01374971|11677177|FG000|Overall Study|Withdrawal by Subject|1
7408386|NCT01375010|11677183|FG000|Overall Study|Lost to Follow-up|8
7408387|NCT01375010|11677184|FG001|Overall Study|Lost to Follow-up|2
7408388|NCT01375010|11677183|FG000|Overall Study|Withdrawal by Subject|4
7408389|NCT01375010|11677184|FG001|Overall Study|Withdrawal by Subject|2
7408390|NCT01375049|11677190|FG000|Overall Study|Adverse Event|2
7408391|NCT01375049|11677190|FG000|Overall Study|Lost to Follow-up|1
7408392|NCT01375049|11677190|FG000|Overall Study|Withdrawal by Subject|2
7408393|NCT01375049|11677190|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
7408394|NCT01375075|11677204|FG000|Overall Study|Adverse Event|0
7408395|NCT01375075|11677205|FG001|Overall Study|Adverse Event|0
7408396|NCT01375075|11677206|FG002|Overall Study|Adverse Event|3
7408397|NCT01375075|11677207|FG003|Overall Study|Adverse Event|1
7408398|NCT01375075|11677208|FG004|Overall Study|Adverse Event|0
7408399|NCT01375075|11677209|FG005|Overall Study|Adverse Event|1
7408400|NCT01375075|11677204|FG000|Overall Study|Entry Criterion Not Met|1
7408401|NCT01375075|11677205|FG001|Overall Study|Entry Criterion Not Met|0
7408402|NCT01375075|11677206|FG002|Overall Study|Entry Criterion Not Met|0
7408403|NCT01375075|11677207|FG003|Overall Study|Entry Criterion Not Met|0
7408404|NCT01375075|11677208|FG004|Overall Study|Entry Criterion Not Met|0
7408405|NCT01375075|11677209|FG005|Overall Study|Entry Criterion Not Met|1
7408406|NCT01375075|11677204|FG000|Overall Study|Withdrawal by Subject|0
7408407|NCT01375075|11677205|FG001|Overall Study|Withdrawal by Subject|1
7408408|NCT01375075|11677206|FG002|Overall Study|Withdrawal by Subject|0
7408409|NCT01375075|11677207|FG003|Overall Study|Withdrawal by Subject|0
7408410|NCT01375075|11677208|FG004|Overall Study|Withdrawal by Subject|0
7408411|NCT01375075|11677209|FG005|Overall Study|Withdrawal by Subject|1
7408412|NCT01375205|11677258|FG000|Overall Study|Lost to Follow-up|15
7408413|NCT01375205|11677259|FG001|Overall Study|Lost to Follow-up|12
7408414|NCT01375205|11677258|FG000|Overall Study|Withdrawal by Subject|6
7408415|NCT01375205|11677259|FG001|Overall Study|Withdrawal by Subject|1
7408416|NCT01375374|11677265|FG000|Overall Study|Adverse Event|1
7408417|NCT01375608|11677285|FG000|Overall Study|Withdrawal by Subject|2
7408418|NCT01375673|11677301|FG000|Overall Study|Withdrawal by Subject|0
7408419|NCT01375673|11677302|FG001|Overall Study|Withdrawal by Subject|1
7408420|NCT01375751|11677311|FG000|Overall Study|Other|0
7408421|NCT01375751|11677312|FG001|Overall Study|Other|1
7408422|NCT01375751|11677313|FG002|Overall Study|Other|0
7408423|NCT01375764|11677326|FG000|Overall Study|Lost to Follow-up|0
7408424|NCT01375764|11677327|FG001|Overall Study|Lost to Follow-up|1
7408425|NCT01375764|11677328|FG002|Overall Study|Lost to Follow-up|0
7408426|NCT01375764|11677329|FG003|Overall Study|Lost to Follow-up|0
7408427|NCT01375764|11677330|FG004|Overall Study|Lost to Follow-up|0
7408428|NCT01375764|11677326|FG000|Overall Study|Withdrawal by Subject|2
7408429|NCT01375764|11677327|FG001|Overall Study|Withdrawal by Subject|0
7408430|NCT01375764|11677328|FG002|Overall Study|Withdrawal by Subject|0
7408431|NCT01375764|11677329|FG003|Overall Study|Withdrawal by Subject|0
7408432|NCT01375764|11677330|FG004|Overall Study|Withdrawal by Subject|1
7408433|NCT01375764|11677326|FG000|Overall Study|Other|0
7408434|NCT01375764|11677327|FG001|Overall Study|Other|0
7408435|NCT01375764|11677328|FG002|Overall Study|Other|0
7408436|NCT01375764|11677329|FG003|Overall Study|Other|1
7408437|NCT01375764|11677330|FG004|Overall Study|Other|0
7408438|NCT01375777|11677351|FG000|Overall Study|Withdrawal by Subject|0
7408439|NCT01375777|11677352|FG001|Overall Study|Withdrawal by Subject|2
7408440|NCT01375777|11677353|FG002|Overall Study|Withdrawal by Subject|1
7408441|NCT01375777|11677354|FG003|Overall Study|Withdrawal by Subject|0
7408442|NCT01375777|11677355|FG004|Overall Study|Withdrawal by Subject|1
7408443|NCT01375777|11677356|FG005|Overall Study|Withdrawal by Subject|1
7408444|NCT01375777|11677357|FG006|Overall Study|Withdrawal by Subject|1
7408445|NCT01375777|11677358|FG007|Overall Study|Withdrawal by Subject|2
7408446|NCT01375777|11677359|FG008|Overall Study|Withdrawal by Subject|1
7408447|NCT01375777|11677351|FG000|Overall Study|Lost to Follow-up|1
7408448|NCT01375777|11677352|FG001|Overall Study|Lost to Follow-up|0
7408449|NCT01375777|11677353|FG002|Overall Study|Lost to Follow-up|0
7408450|NCT01375777|11677354|FG003|Overall Study|Lost to Follow-up|0
7408451|NCT01375777|11677355|FG004|Overall Study|Lost to Follow-up|0
7408452|NCT01375777|11677356|FG005|Overall Study|Lost to Follow-up|0
7408453|NCT01375777|11677357|FG006|Overall Study|Lost to Follow-up|1
7408454|NCT01375777|11677358|FG007|Overall Study|Lost to Follow-up|0
7408455|NCT01375777|11677359|FG008|Overall Study|Lost to Follow-up|0
7408456|NCT01375777|11677351|FG000|Overall Study|Other|1
7408457|NCT01375777|11677352|FG001|Overall Study|Other|1
7408458|NCT01375777|11677353|FG002|Overall Study|Other|0
7408459|NCT01375777|11677354|FG003|Overall Study|Other|0
7408460|NCT01375777|11677355|FG004|Overall Study|Other|0
7408461|NCT01375777|11677356|FG005|Overall Study|Other|0
7408462|NCT01375777|11677357|FG006|Overall Study|Other|0
7408463|NCT01375777|11677358|FG007|Overall Study|Other|0
7408464|NCT01375777|11677359|FG008|Overall Study|Other|1
7408465|NCT01376037|11677390|FG000|Overall Study|Lost to Follow-up|0
7408466|NCT01376037|11677391|FG001|Overall Study|Lost to Follow-up|2
7408467|NCT01376089|11677408|FG000|Overall Study|Patient received no contrast media|3
7408468|NCT01376089|11677409|FG001|Overall Study|Patient received no contrast media|4
7408469|NCT01376167|11677422|FG000|Overall Study|Lost to Follow-up|2
7408470|NCT01376167|11677423|FG001|Overall Study|Lost to Follow-up|4
7408471|NCT01376167|11677424|FG002|Overall Study|Lost to Follow-up|2
7408472|NCT01376167|11677422|FG000|Overall Study|Physician Decision|1
7408473|NCT01376167|11677423|FG001|Overall Study|Physician Decision|1
7408474|NCT01376167|11677424|FG002|Overall Study|Physician Decision|0
7408475|NCT01376167|11677422|FG000|Overall Study|Withdrawal by Subject|1
7408476|NCT01376167|11677423|FG001|Overall Study|Withdrawal by Subject|5
7408477|NCT01376167|11677424|FG002|Overall Study|Withdrawal by Subject|4
7408478|NCT01376245|11677439|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
7408479|NCT01376245|11677440|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7408480|NCT01376245|11677441|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7408481|NCT01376245|11677442|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7408482|NCT01376245|11677443|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
7408483|NCT01376245|11677439|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
7408484|NCT01376245|11677440|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7408485|NCT01376245|11677441|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7408486|NCT01376245|11677442|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7408487|NCT01376245|11677443|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
7408488|NCT01376245|11677439|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
7408489|NCT01376245|11677440|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7408490|NCT01376245|11677441|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7408491|NCT01376245|11677442|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7408492|NCT01376245|11677443|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
7408493|NCT01376245|11677439|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
7408494|NCT01376245|11677440|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7408495|NCT01376245|11677441|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7408496|NCT01376245|11677442|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7408497|NCT01376245|11677443|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
7408498|NCT01376245|11677439|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
7408499|NCT01376245|11677440|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7408500|NCT01376245|11677441|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7408501|NCT01376245|11677442|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7408502|NCT01376245|11677443|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
7408503|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7408504|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
7408505|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
7408506|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
7408507|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
7408508|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
7408509|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7408510|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
7408511|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
7408512|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
7408513|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7408514|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
7408515|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
7408516|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7408517|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
7408518|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7408519|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
7408520|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
7408521|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
7408566|NCT01376908|11677527|FG000|Overall Study|Protocol Violation|1
7408522|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7408523|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7408524|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7408525|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7408526|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7408527|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7408528|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7408529|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
7408530|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7408531|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
7408532|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
7408533|NCT01376245|11677439|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7408534|NCT01376245|11677440|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7408535|NCT01376245|11677441|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7408536|NCT01376245|11677442|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
7408537|NCT01376245|11677443|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7408538|NCT01376310|11677464|FG000|Overall Study|Study closed/terminated|1
7408539|NCT01376310|11677465|FG001|Overall Study|Study closed/terminated|2
7408540|NCT01376310|11677464|FG000|Overall Study|Withdrawal by Subject|8
7408541|NCT01376310|11677465|FG001|Overall Study|Withdrawal by Subject|2
7408542|NCT01376310|11677464|FG000|Overall Study|Physician Decision|26
7408543|NCT01376310|11677465|FG001|Overall Study|Physician Decision|7
7408544|NCT01376310|11677464|FG000|Overall Study|Lost to Follow-up|1
7408545|NCT01376310|11677465|FG001|Overall Study|Lost to Follow-up|0
7408546|NCT01376349|11677474|FG000|Raondomized Treatment|Withdrawal by Subject|10
7408547|NCT01376349|11677475|FG001|Raondomized Treatment|Withdrawal by Subject|16
7408548|NCT01376349|11677476|FG002|Raondomized Treatment|Withdrawal by Subject|13
7408549|NCT01376349|11677474|FG000|Raondomized Treatment|Adverse Event|13
7408550|NCT01376349|11677475|FG001|Raondomized Treatment|Adverse Event|17
7408551|NCT01376349|11677476|FG002|Raondomized Treatment|Adverse Event|14
7408552|NCT01376349|11677474|FG000|Raondomized Treatment|Unkown|1
7408553|NCT01376349|11677475|FG001|Raondomized Treatment|Unkown|2
7408554|NCT01376349|11677476|FG002|Raondomized Treatment|Unkown|1
7408555|NCT01376349|11677474|FG000|Raondomized Treatment|Alternative Treatment|0
7408556|NCT01376349|11677475|FG001|Raondomized Treatment|Alternative Treatment|0
7408557|NCT01376349|11677476|FG002|Raondomized Treatment|Alternative Treatment|1
7465999|NCT01887717|11765722|FG001|Overall Study|Administrative reasons|2
7466000|NCT01888003|11765750|FG000|Overall Study|Study Terminated|5
7466001|NCT01888003|11765751|FG001|Overall Study|Study Terminated|6
7466002|NCT01888003|11765752|FG002|Overall Study|Study Terminated|40
7466003|NCT01888367|11765763|FG000|Overall Study|Physician Decision|3
7466004|NCT01888367|11765764|FG001|Overall Study|Physician Decision|4
7466005|NCT01888367|11765765|FG002|Overall Study|Physician Decision|2
7466006|NCT01888367|11765763|FG000|Overall Study|Death|2
7466007|NCT01888367|11765764|FG001|Overall Study|Death|0
7466008|NCT01888367|11765765|FG002|Overall Study|Death|1
7466009|NCT01888367|11765763|FG000|Overall Study|Withdrawal by Subject|1
7466010|NCT01888367|11765764|FG001|Overall Study|Withdrawal by Subject|0
7466011|NCT01888367|11765765|FG002|Overall Study|Withdrawal by Subject|1
7466012|NCT01888367|11765763|FG000|Overall Study|Lost to Follow-up|1
7466013|NCT01888367|11765764|FG001|Overall Study|Lost to Follow-up|1
7466014|NCT01888367|11765765|FG002|Overall Study|Lost to Follow-up|0
7466015|NCT01888367|11765763|FG000|Overall Study|Protocol Violation|0
7466016|NCT01888367|11765764|FG001|Overall Study|Protocol Violation|0
7466017|NCT01888367|11765765|FG002|Overall Study|Protocol Violation|1
7466018|NCT01888367|11765763|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
7466019|NCT01888367|11765764|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7466020|NCT01888367|11765765|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
7466021|NCT01888432|11765775|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
7466022|NCT01888432|11765776|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
7466023|NCT01888432|11765775|FG000|12-month Analysis (FAS)|Physician Decision|1
7466024|NCT01888432|11765776|FG001|12-month Analysis (FAS)|Physician Decision|1
7466025|NCT01888432|11765775|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
7466026|NCT01888432|11765776|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
7466027|NCT01888432|11765775|FG000|12-month Analysis (FAS)|Death|4
7466028|NCT01888432|11765776|FG001|12-month Analysis (FAS)|Death|3
7466029|NCT01888432|11765775|FG000|24-month Analysis (FAS)|Graft loss|0
7466030|NCT01888432|11765776|FG001|24-month Analysis (FAS)|Graft loss|1
7466031|NCT01888432|11765775|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
7466032|NCT01888432|11765776|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
7466033|NCT01888432|11765775|FG000|24-month Analysis (FAS)|Physician Decision|2
7408558|NCT01376388|11677489|FG000|Overall Study|Adverse Event|13
7408559|NCT01376388|11677489|FG000|Overall Study|Lack of Efficacy|2
7408560|NCT01376388|11677489|FG000|Overall Study|Withdrawal by Subject|3
7408561|NCT01376700|11677514|FG000|Overall Study|Sponsor terminated study early|8
7408562|NCT01376700|11677514|FG000|Overall Study|Low or high titer inhibitor|8
7408563|NCT01376804|11677521|FG000|Treatment Period|Withdrawal by Subject|1
7408564|NCT01376804|11677521|FG000|Treatment Period|Adverse Event|6
7408565|NCT01376804|11677521|FG000|Treatment Period|Patient did not receive study drug|1
7408567|NCT01376908|11677528|FG001|Overall Study|Protocol Violation|1
7408568|NCT01376908|11677527|FG000|Overall Study|Withdrawal by Subject|1
7408569|NCT01376908|11677528|FG001|Overall Study|Withdrawal by Subject|2
7408570|NCT01377012|11677544|FG000|Core Study|Study terminated by Sponsor|47
7408571|NCT01377012|11677545|FG001|Core Study|Study terminated by Sponsor|54
7408572|NCT01377012|11677546|FG002|Core Study|Study terminated by Sponsor|46
7408573|NCT01377012|11677544|FG000|Core Study|Technical problems|1
7408574|NCT01377012|11677545|FG001|Core Study|Technical problems|0
7408575|NCT01377012|11677546|FG002|Core Study|Technical problems|0
7408576|NCT01377012|11677544|FG000|Core Study|Withdrawal by Subject|15
7408577|NCT01377012|11677545|FG001|Core Study|Withdrawal by Subject|23
7408578|NCT01377012|11677546|FG002|Core Study|Withdrawal by Subject|18
7408579|NCT01377012|11677544|FG000|Core Study|Protocol Violation|7
7408580|NCT01377012|11677545|FG001|Core Study|Protocol Violation|3
7408581|NCT01377012|11677546|FG002|Core Study|Protocol Violation|2
7408582|NCT01377012|11677544|FG000|Core Study|Pregnancy|0
7408583|NCT01377012|11677545|FG001|Core Study|Pregnancy|0
7408584|NCT01377012|11677546|FG002|Core Study|Pregnancy|1
7408585|NCT01377012|11677544|FG000|Core Study|Physician Decision|5
7408586|NCT01377012|11677545|FG001|Core Study|Physician Decision|4
7408587|NCT01377012|11677546|FG002|Core Study|Physician Decision|10
7408588|NCT01377012|11677544|FG000|Core Study|Non-Compliant with study treatment|0
7408589|NCT01377012|11677545|FG001|Core Study|Non-Compliant with study treatment|0
7408590|NCT01377012|11677546|FG002|Core Study|Non-Compliant with study treatment|1
7408591|NCT01377012|11677544|FG000|Core Study|No Longer require treatment|0
7408592|NCT01377012|11677545|FG001|Core Study|No Longer require treatment|0
7408593|NCT01377012|11677546|FG002|Core Study|No Longer require treatment|1
7408594|NCT01377012|11677544|FG000|Core Study|Lost to Follow-up|7
7408595|NCT01377012|11677545|FG001|Core Study|Lost to Follow-up|5
7408596|NCT01377012|11677546|FG002|Core Study|Lost to Follow-up|4
7408597|NCT01377012|11677544|FG000|Core Study|Lack of Efficacy|41
7408598|NCT01377012|11677545|FG001|Core Study|Lack of Efficacy|28
7408599|NCT01377012|11677546|FG002|Core Study|Lack of Efficacy|37
7408600|NCT01377012|11677544|FG000|Core Study|Death|1
7408601|NCT01377012|11677545|FG001|Core Study|Death|1
7408602|NCT01377012|11677546|FG002|Core Study|Death|1
7408603|NCT01377012|11677544|FG000|Core Study|Adverse Event|10
7408604|NCT01377012|11677545|FG001|Core Study|Adverse Event|14
7408605|NCT01377012|11677546|FG002|Core Study|Adverse Event|13
7408606|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
7408607|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
7408608|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
7408609|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
7408610|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
7408611|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
7408612|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
7408613|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
7408614|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
7408615|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Physician Decision|1
7408616|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Physician Decision|0
7408617|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Physician Decision|0
7408618|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
7408619|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
7408620|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
7408621|NCT01377012|11677544|FG000|Extension Study, Weeks 104-260|Adverse Event|0
7408622|NCT01377012|11677545|FG001|Extension Study, Weeks 104-260|Adverse Event|2
7408623|NCT01377012|11677546|FG002|Extension Study, Weeks 104-260|Adverse Event|1
7408624|NCT01377194|11677557|FG000|Overall Study|Adverse Event|3
7408625|NCT01377194|11677558|FG001|Overall Study|Adverse Event|12
7408626|NCT01377194|11677559|FG002|Overall Study|Adverse Event|19
7408627|NCT01377194|11677557|FG000|Overall Study|Lack of Efficacy|3
7408628|NCT01377194|11677558|FG001|Overall Study|Lack of Efficacy|3
7408629|NCT01377194|11677559|FG002|Overall Study|Lack of Efficacy|3
7408630|NCT01377194|11677557|FG000|Overall Study|Protocol Violation|4
7408631|NCT01377194|11677558|FG001|Overall Study|Protocol Violation|10
7408632|NCT01377194|11677559|FG002|Overall Study|Protocol Violation|6
7408633|NCT01377194|11677557|FG000|Overall Study|Withdrawal by Subject|8
7408634|NCT01377194|11677558|FG001|Overall Study|Withdrawal by Subject|10
7408635|NCT01377194|11677559|FG002|Overall Study|Withdrawal by Subject|7
7408636|NCT01377194|11677557|FG000|Overall Study|Lost to Follow-up|14
7408637|NCT01377194|11677558|FG001|Overall Study|Lost to Follow-up|8
7408638|NCT01377194|11677559|FG002|Overall Study|Lost to Follow-up|11
7408639|NCT01377233|11677575|FG000|Open-label|Adverse Event|1
7408640|NCT01377233|11677576|FG001|Open-label|Adverse Event|0
7408641|NCT01377233|11677577|FG002|Open-label|Adverse Event|0
7408642|NCT01377233|11677578|FG003|Open-label|Adverse Event|0
7408643|NCT01377233|11677579|FG004|Open-label|Adverse Event|0
7408644|NCT01377233|11677575|FG000|Open-label|Withdrawal by Subject|3
7408645|NCT01377233|11677576|FG001|Open-label|Withdrawal by Subject|0
7408646|NCT01377233|11677577|FG002|Open-label|Withdrawal by Subject|0
7408647|NCT01377233|11677578|FG003|Open-label|Withdrawal by Subject|0
7408648|NCT01377233|11677579|FG004|Open-label|Withdrawal by Subject|0
7408649|NCT01377233|11677575|FG000|Double-blind|Adverse Event|0
7408650|NCT01377233|11677576|FG001|Double-blind|Adverse Event|1
7408651|NCT01377233|11677577|FG002|Double-blind|Adverse Event|2
7408652|NCT01377233|11677578|FG003|Double-blind|Adverse Event|2
7408653|NCT01377233|11677579|FG004|Double-blind|Adverse Event|0
7408654|NCT01377233|11677575|FG000|Double-blind|Protocol Violation|0
7408655|NCT01377233|11677576|FG001|Double-blind|Protocol Violation|0
7408656|NCT01377233|11677577|FG002|Double-blind|Protocol Violation|0
7408657|NCT01377233|11677578|FG003|Double-blind|Protocol Violation|0
7408658|NCT01377233|11677579|FG004|Double-blind|Protocol Violation|1
7408659|NCT01377233|11677575|FG000|Double-blind|Withdrawal by Subject|0
7408660|NCT01377233|11677576|FG001|Double-blind|Withdrawal by Subject|0
7408661|NCT01377233|11677577|FG002|Double-blind|Withdrawal by Subject|0
7408662|NCT01377233|11677578|FG003|Double-blind|Withdrawal by Subject|1
7408663|NCT01377233|11677579|FG004|Double-blind|Withdrawal by Subject|0
7408664|NCT01377233|11677575|FG000|Double-blind|Administrative or other|0
7408665|NCT01377233|11677576|FG001|Double-blind|Administrative or other|0
7408666|NCT01377233|11677577|FG002|Double-blind|Administrative or other|0
7408667|NCT01377233|11677578|FG003|Double-blind|Administrative or other|1
7408668|NCT01377233|11677579|FG004|Double-blind|Administrative or other|1
7408669|NCT01377389|11677595|FG000|Overall Study|Withdrawal by Subject|1
7408670|NCT01377389|11677595|FG000|Overall Study|Screen failure|2
7408671|NCT01377480|11677618|FG000|Overall Study|Protocol Violation|0
7408672|NCT01377480|11677619|FG001|Overall Study|Protocol Violation|0
7408673|NCT01377480|11677620|FG002|Overall Study|Protocol Violation|0
7408674|NCT01377480|11677621|FG003|Overall Study|Protocol Violation|4
7408675|NCT01377480|11677618|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
7408676|NCT01377480|11677619|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
7408677|NCT01377480|11677620|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
7408678|NCT01377480|11677621|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
7408679|NCT01377480|11677618|FG000|Overall Study|Withdrawal by Subject|0
7408680|NCT01377480|11677619|FG001|Overall Study|Withdrawal by Subject|0
7408681|NCT01377480|11677620|FG002|Overall Study|Withdrawal by Subject|1
7408682|NCT01377480|11677621|FG003|Overall Study|Withdrawal by Subject|0
7408683|NCT01377480|11677618|FG000|Overall Study|Serious adverse event|0
7408684|NCT01377480|11677619|FG001|Overall Study|Serious adverse event|0
7408685|NCT01377480|11677620|FG002|Overall Study|Serious adverse event|1
7408686|NCT01377480|11677621|FG003|Overall Study|Serious adverse event|1
7408687|NCT01377480|11677618|FG000|Overall Study|Other|0
7408688|NCT01377480|11677619|FG001|Overall Study|Other|0
7408689|NCT01377480|11677620|FG002|Overall Study|Other|7
7408690|NCT01377480|11677621|FG003|Overall Study|Other|6
7408691|NCT01377844|11677676|FG000|Overall Study|Withdrawal by Subject|25
7408692|NCT01377844|11677677|FG001|Overall Study|Withdrawal by Subject|28
7408693|NCT01377844|11677676|FG000|Overall Study|Protocol Violation|2
7408694|NCT01377844|11677677|FG001|Overall Study|Protocol Violation|3
7408695|NCT01377844|11677676|FG000|Overall Study|Adverse Event|3
7408696|NCT01377844|11677677|FG001|Overall Study|Adverse Event|0
7408697|NCT01377844|11677676|FG000|Overall Study|Physician Decision|6
7408698|NCT01377844|11677677|FG001|Overall Study|Physician Decision|3
7408699|NCT01377844|11677676|FG000|Overall Study|Study terminated by Sponsor|0
7408700|NCT01377844|11677677|FG001|Overall Study|Study terminated by Sponsor|1
7408701|NCT01377922|11677686|FG000|Overall Study|rescue tx after part 2, entered part 4|1
7408702|NCT01377922|11677687|FG001|Overall Study|rescue tx after part 2, entered part 4|0
7408703|NCT01377987|11677693|FG000|Washout (7 Days)|Withdrawal by Subject|1
7408704|NCT01377987|11677694|FG001|Washout (7 Days)|Withdrawal by Subject|1
7408705|NCT01378104|11677706|FG000|Overall Study|Adverse Event|8
7408706|NCT01378104|11677707|FG001|Overall Study|Adverse Event|8
7408707|NCT01378104|11677706|FG000|Overall Study|Lack of Efficacy|7
7408708|NCT01378104|11677707|FG001|Overall Study|Lack of Efficacy|5
7408709|NCT01378104|11677706|FG000|Overall Study|Withdrawal by Subject|12
7408710|NCT01378104|11677707|FG001|Overall Study|Withdrawal by Subject|13
7408711|NCT01378117|11677718|FG000|Overall Study|withdrawal|2
7408712|NCT01378117|11677719|FG001|Overall Study|withdrawal|1
7408713|NCT01378117|11677720|FG002|Overall Study|withdrawal|2
7408714|NCT01378117|11677718|FG000|Overall Study|discharged before med given|2
7408715|NCT01378117|11677719|FG001|Overall Study|discharged before med given|0
7408716|NCT01378117|11677720|FG002|Overall Study|discharged before med given|1
7408717|NCT01378195|11677735|FG000|Overall Study|Lost to Follow-up|29
7408718|NCT01378195|11677736|FG001|Overall Study|Lost to Follow-up|18
7408719|NCT01378325|11677796|FG000|Overall Study|Protocol Violation|0
7408720|NCT01378325|11677797|FG001|Overall Study|Protocol Violation|1
7408721|NCT01378429|11677827|FG000|Overall Study|Noncompliance with study drug|1
7408722|NCT01378429|11677828|FG001|Overall Study|Noncompliance with study drug|0
7408723|NCT01378858|11677846|FG000|Overall Study|Withdrawal by Subject|4
7408724|NCT01378858|11677847|FG001|Overall Study|Withdrawal by Subject|4
7408725|NCT01378962|11677853|FG000|Overall Study|Death|14
7408726|NCT01378962|11677853|FG000|Overall Study|Lost to Follow-up|1
7408727|NCT01378962|11677853|FG000|Overall Study|Other|2
7408728|NCT01378975|11677859|FG000|Overall Study|Death|77
7408729|NCT01378975|11677860|FG001|Overall Study|Death|46
7408730|NCT01378975|11677859|FG000|Overall Study|Investigator Request|1
7408731|NCT01378975|11677860|FG001|Overall Study|Investigator Request|0
7408732|NCT01378975|11677859|FG000|Overall Study|Lost to Follow-up|4
7408733|NCT01378975|11677860|FG001|Overall Study|Lost to Follow-up|1
7408734|NCT01378975|11677859|FG000|Overall Study|Withdrew Consent|4
7408735|NCT01378975|11677860|FG001|Overall Study|Withdrew Consent|3
7408736|NCT01379508|11677895|FG000|Treatment to Week 104|Adverse Event|2
7408737|NCT01379508|11677896|FG001|Treatment to Week 104|Adverse Event|0
7408738|NCT01379508|11677897|FG002|Treatment to Week 104|Adverse Event|5
7408739|NCT01379508|11677898|FG003|Treatment to Week 104|Adverse Event|0
7408740|NCT01379508|11677895|FG000|Treatment to Week 104|Abnormal lab value|1
7408741|NCT01379508|11677896|FG001|Treatment to Week 104|Abnormal lab value|0
7408742|NCT01379508|11677897|FG002|Treatment to Week 104|Abnormal lab value|0
7408743|NCT01379508|11677898|FG003|Treatment to Week 104|Abnormal lab value|0
7408744|NCT01379508|11677895|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
7408745|NCT01379508|11677896|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
7408746|NCT01379508|11677897|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
7408747|NCT01379508|11677898|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
7408748|NCT01379508|11677895|FG000|Treatment to Week 104|Withdrawal by Subject|6
7408749|NCT01379508|11677896|FG001|Treatment to Week 104|Withdrawal by Subject|1
7408750|NCT01379508|11677897|FG002|Treatment to Week 104|Withdrawal by Subject|4
7408751|NCT01379508|11677898|FG003|Treatment to Week 104|Withdrawal by Subject|0
7408752|NCT01379508|11677895|FG000|Treatment to Week 104|Lost to Follow-up|5
7408753|NCT01379508|11677896|FG001|Treatment to Week 104|Lost to Follow-up|0
7408754|NCT01379508|11677897|FG002|Treatment to Week 104|Lost to Follow-up|3
7408755|NCT01379508|11677898|FG003|Treatment to Week 104|Lost to Follow-up|0
7408756|NCT01379508|11677895|FG000|Treatment to Week 104|Administrative problems|3
7408757|NCT01379508|11677896|FG001|Treatment to Week 104|Administrative problems|1
7408758|NCT01379508|11677897|FG002|Treatment to Week 104|Administrative problems|0
7408759|NCT01379508|11677898|FG003|Treatment to Week 104|Administrative problems|0
7408760|NCT01379508|11677895|FG000|Treatment to Week 104|Protocol Violation|1
7408761|NCT01379508|11677896|FG001|Treatment to Week 104|Protocol Violation|1
7408762|NCT01379508|11677897|FG002|Treatment to Week 104|Protocol Violation|1
7408763|NCT01379508|11677898|FG003|Treatment to Week 104|Protocol Violation|0
7408764|NCT01379508|11677895|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
7408765|NCT01379508|11677896|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
7408766|NCT01379508|11677897|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
7408767|NCT01379508|11677898|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
7408768|NCT01379508|11677895|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
7408769|NCT01379508|11677896|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
7408770|NCT01379508|11677897|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
7408771|NCT01379508|11677898|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
7408772|NCT01379508|11677895|FG000|Extension Period Weeks 109-156|Administrative problems|3
7408773|NCT01379508|11677896|FG001|Extension Period Weeks 109-156|Administrative problems|0
7408774|NCT01379508|11677897|FG002|Extension Period Weeks 109-156|Administrative problems|1
7408775|NCT01379508|11677898|FG003|Extension Period Weeks 109-156|Administrative problems|0
7408776|NCT01379508|11677895|FG000|Extension Period Weeks 109-156|Protocol Violation|2
7408777|NCT01379508|11677896|FG001|Extension Period Weeks 109-156|Protocol Violation|1
7408778|NCT01379508|11677897|FG002|Extension Period Weeks 109-156|Protocol Violation|0
7408779|NCT01379508|11677898|FG003|Extension Period Weeks 109-156|Protocol Violation|0
7408780|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Adverse Event|3
7408781|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Adverse Event|0
7408782|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
7408783|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
7408784|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Disease Progression|23
7408785|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Disease Progression|22
7408786|NCT01379521|11677914|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
7408787|NCT01379521|11677915|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
7408788|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Protocol Deviation|0
7408789|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Protocol Deviation|2
7408790|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
7408791|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
7408792|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Administrative Problems|1
7408793|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Administrative Problems|0
7408794|NCT01379521|11677914|FG000|Overall Study -Treatment Period|Death|2
7408795|NCT01379521|11677915|FG001|Overall Study -Treatment Period|Death|1
7408796|NCT01379521|11677914|FG000|Post-Treatment Evaluations|Disease Progression|22
7408797|NCT01379521|11677915|FG001|Post-Treatment Evaluations|Disease Progression|20
7408798|NCT01379521|11677914|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
7408799|NCT01379521|11677915|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
7408800|NCT01379521|11677914|FG000|Post-Treatment Evaluations|Death|1
7408801|NCT01379521|11677915|FG001|Post-Treatment Evaluations|Death|0
7408802|NCT01379534|11677923|FG000|Treatment Phase|Withdrawal by Subject|2
7408803|NCT01379534|11677924|FG001|Treatment Phase|Withdrawal by Subject|2
7408804|NCT01379534|11677923|FG000|Treatment Phase|Progressive disease|13
7408805|NCT01379534|11677924|FG001|Treatment Phase|Progressive disease|22
7408806|NCT01379534|11677923|FG000|Treatment Phase|Adverse Event|7
7408807|NCT01379534|11677924|FG001|Treatment Phase|Adverse Event|7
7408808|NCT01379534|11677923|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
7408809|NCT01379534|11677924|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
7408886|NCT01379937|11678001|FG000|Overall Study|Lost to Follow-up|1
7408810|NCT01379534|11677923|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
7408811|NCT01379534|11677924|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
7408812|NCT01379534|11677923|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
7408813|NCT01379534|11677924|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
7408814|NCT01379534|11677923|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
7408815|NCT01379534|11677924|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
7408816|NCT01379573|11677930|FG000|Overall Study|Lost to Follow-up|1
7408817|NCT01379573|11677930|FG000|Overall Study|Screen Failure|10
7408818|NCT01379703|11677961|FG000|Study Start Through 9 Months|Lost to Follow-up|2
7408819|NCT01379703|11677962|FG001|Study Start Through 9 Months|Lost to Follow-up|61
7408820|NCT01379703|11677963|FG002|Study Start Through 9 Months|Lost to Follow-up|104
7408821|NCT01379703|11677961|FG000|Study Start Through 9 Months|Adverse Event|0
7408822|NCT01379703|11677962|FG001|Study Start Through 9 Months|Adverse Event|14
7408823|NCT01379703|11677963|FG002|Study Start Through 9 Months|Adverse Event|10
7408824|NCT01379703|11677961|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
7408825|NCT01379703|11677962|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
7408826|NCT01379703|11677963|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
7408827|NCT01379703|11677961|FG000|Study Start Through 9 Months|Treatment Failure|0
7408828|NCT01379703|11677962|FG001|Study Start Through 9 Months|Treatment Failure|2
7408829|NCT01379703|11677963|FG002|Study Start Through 9 Months|Treatment Failure|2
7408830|NCT01379703|11677961|FG000|Study Start Through 9 Months|Patient Noncompliance|0
7408831|NCT01379703|11677962|FG001|Study Start Through 9 Months|Patient Noncompliance|0
7408832|NCT01379703|11677963|FG002|Study Start Through 9 Months|Patient Noncompliance|1
7408833|NCT01379703|11677961|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7408834|NCT01379703|11677962|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
7408835|NCT01379703|11677963|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
7408836|NCT01379703|11677961|FG000|Study Start Through 9 Months|Medication not available|0
7408837|NCT01379703|11677962|FG001|Study Start Through 9 Months|Medication not available|2
7408838|NCT01379703|11677963|FG002|Study Start Through 9 Months|Medication not available|1
7408839|NCT01379703|11677961|FG000|Study Start Through 9 Months|Poor general condition|0
7408840|NCT01379703|11677962|FG001|Study Start Through 9 Months|Poor general condition|1
7408841|NCT01379703|11677963|FG002|Study Start Through 9 Months|Poor general condition|0
7408842|NCT01379703|11677961|FG000|Study Start Through 9 Months|Increased triglycerides|0
7408843|NCT01379703|11677962|FG001|Study Start Through 9 Months|Increased triglycerides|1
7408844|NCT01379703|11677963|FG002|Study Start Through 9 Months|Increased triglycerides|0
7408845|NCT01379703|11677961|FG000|Study Start Through 9 Months|Reason unknown|2
7408846|NCT01379703|11677962|FG001|Study Start Through 9 Months|Reason unknown|31
7408847|NCT01379703|11677963|FG002|Study Start Through 9 Months|Reason unknown|24
7408848|NCT01379703|11677961|FG000|9 Months Through 18 Months|Lost to Follow-up|0
7408849|NCT01379703|11677962|FG001|9 Months Through 18 Months|Lost to Follow-up|178
7408850|NCT01379703|11677963|FG002|9 Months Through 18 Months|Lost to Follow-up|0
7408851|NCT01379703|11677961|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
7408852|NCT01379703|11677962|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
7408853|NCT01379703|11677963|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
7408854|NCT01379703|11677961|FG000|9 Months Through 18 Months|Adverse Event|0
7408855|NCT01379703|11677962|FG001|9 Months Through 18 Months|Adverse Event|6
7408856|NCT01379703|11677963|FG002|9 Months Through 18 Months|Adverse Event|0
7408857|NCT01379703|11677961|FG000|9 Months Through 18 Months|Treatment failure|0
7408858|NCT01379703|11677962|FG001|9 Months Through 18 Months|Treatment failure|5
7408859|NCT01379703|11677963|FG002|9 Months Through 18 Months|Treatment failure|0
7408860|NCT01379703|11677961|FG000|9 Months Through 18 Months|Patient Noncompliance|0
7408861|NCT01379703|11677962|FG001|9 Months Through 18 Months|Patient Noncompliance|4
7408862|NCT01379703|11677963|FG002|9 Months Through 18 Months|Patient Noncompliance|0
7408863|NCT01379703|11677961|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7408864|NCT01379703|11677962|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
7408865|NCT01379703|11677963|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
7408866|NCT01379703|11677961|FG000|9 Months Through 18 Months|Fatigue|0
7408867|NCT01379703|11677962|FG001|9 Months Through 18 Months|Fatigue|1
7408868|NCT01379703|11677963|FG002|9 Months Through 18 Months|Fatigue|0
7408869|NCT01379703|11677961|FG000|9 Months Through 18 Months|Reason Unknown|0
7408870|NCT01379703|11677962|FG001|9 Months Through 18 Months|Reason Unknown|23
7408871|NCT01379703|11677963|FG002|9 Months Through 18 Months|Reason Unknown|0
7408872|NCT01379768|11677975|FG000|Overall Study|Adverse Event|1
7408873|NCT01379768|11677976|FG001|Overall Study|Adverse Event|1
7408874|NCT01379768|11677977|FG002|Overall Study|Adverse Event|0
7408875|NCT01379768|11677975|FG000|Overall Study|Lost to Follow-up|2
7408876|NCT01379768|11677976|FG001|Overall Study|Lost to Follow-up|0
7408877|NCT01379768|11677977|FG002|Overall Study|Lost to Follow-up|0
7408878|NCT01379937|11678001|FG000|Overall Study|Protocol Violation|0
7408879|NCT01379937|11678002|FG001|Overall Study|Protocol Violation|0
7408880|NCT01379937|11678003|FG002|Overall Study|Protocol Violation|0
7408881|NCT01379937|11678004|FG003|Overall Study|Protocol Violation|1
7408882|NCT01379937|11678001|FG000|Overall Study|Consent withdrawal|0
7408883|NCT01379937|11678002|FG001|Overall Study|Consent withdrawal|1
7408884|NCT01379937|11678003|FG002|Overall Study|Consent withdrawal|0
7408885|NCT01379937|11678004|FG003|Overall Study|Consent withdrawal|0
7408887|NCT01379937|11678002|FG001|Overall Study|Lost to Follow-up|2
7408888|NCT01379937|11678003|FG002|Overall Study|Lost to Follow-up|2
7408889|NCT01379937|11678004|FG003|Overall Study|Lost to Follow-up|0
7408890|NCT01380080|11678025|FG000|Overall Study|Death|36
7408891|NCT01380080|11678026|FG001|Overall Study|Death|44
7408892|NCT01380080|11678025|FG000|Overall Study|Site is closing|28
7408893|NCT01380080|11678026|FG001|Overall Study|Site is closing|31
7408894|NCT01380080|11678025|FG000|Overall Study|Not able to get to clinic|7
7408895|NCT01380080|11678026|FG001|Overall Study|Not able to get to clinic|1
7408896|NCT01380080|11678025|FG000|Overall Study|Not willing to adhere to requirements|6
7408897|NCT01380080|11678026|FG001|Overall Study|Not willing to adhere to requirements|2
7408898|NCT01380080|11678025|FG000|Overall Study|Withdrawal by Subject|5
7408899|NCT01380080|11678026|FG001|Overall Study|Withdrawal by Subject|2
7408900|NCT01380080|11678025|FG000|Overall Study|Lost to Follow-up|3
7408901|NCT01380080|11678026|FG001|Overall Study|Lost to Follow-up|3
7408902|NCT01380093|11678032|FG000|Naloxone Challenge Phase|Screen failures|21
7408903|NCT01380093|11678033|FG001|Naloxone Challenge Phase|Screen failures|0
7408904|NCT01380093|11678034|FG002|Naloxone Challenge Phase|Screen failures|0
7408905|NCT01380093|11678035|FG003|Naloxone Challenge Phase|Screen failures|0
7408906|NCT01380093|11678036|FG004|Naloxone Challenge Phase|Screen failures|0
7408907|NCT01380093|11678037|FG005|Naloxone Challenge Phase|Screen failures|0
7408908|NCT01380093|11678038|FG006|Naloxone Challenge Phase|Screen failures|0
7408909|NCT01380093|11678039|FG007|Naloxone Challenge Phase|Screen failures|0
7408910|NCT01380093|11678040|FG008|Naloxone Challenge Phase|Screen failures|0
7408911|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408912|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
7408913|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408914|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408915|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408916|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408917|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408918|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408919|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
7408920|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
7408921|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
7408922|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
7408923|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
7408924|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
7408925|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
7408926|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
7408927|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
7408928|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
7408929|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408930|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
7408931|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408932|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408933|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408934|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408935|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408936|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408937|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
7408938|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408939|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
7408940|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
7408941|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408942|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408943|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408944|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408945|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408946|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
7408947|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408948|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7408949|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
7408950|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408951|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408952|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408953|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408954|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408955|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
7408956|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
7408957|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
7408958|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
7408959|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
7408960|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
7408961|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
7408962|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
7408963|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
7408964|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
7408965|NCT01380093|11678032|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408966|NCT01380093|11678033|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408967|NCT01380093|11678034|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
7408968|NCT01380093|11678035|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408969|NCT01380093|11678036|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408970|NCT01380093|11678037|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408971|NCT01380093|11678038|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408972|NCT01380093|11678039|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408973|NCT01380093|11678040|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
7408974|NCT01380093|11678032|FG000|Treatment Phase: Second Intervention|Other|0
7408975|NCT01380093|11678033|FG001|Treatment Phase: Second Intervention|Other|0
7408976|NCT01380093|11678034|FG002|Treatment Phase: Second Intervention|Other|0
7408977|NCT01380093|11678035|FG003|Treatment Phase: Second Intervention|Other|1
7408978|NCT01380093|11678036|FG004|Treatment Phase: Second Intervention|Other|0
7408979|NCT01380093|11678037|FG005|Treatment Phase: Second Intervention|Other|0
7408980|NCT01380093|11678038|FG006|Treatment Phase: Second Intervention|Other|0
7408981|NCT01380093|11678039|FG007|Treatment Phase: Second Intervention|Other|0
7408982|NCT01380093|11678040|FG008|Treatment Phase: Second Intervention|Other|0
7408983|NCT01380093|11678032|FG000|Treatment Phase: Third Intervention|Non-compliance|0
7408984|NCT01380093|11678033|FG001|Treatment Phase: Third Intervention|Non-compliance|0
7408985|NCT01380093|11678034|FG002|Treatment Phase: Third Intervention|Non-compliance|0
7408986|NCT01380093|11678035|FG003|Treatment Phase: Third Intervention|Non-compliance|0
7408987|NCT01380093|11678036|FG004|Treatment Phase: Third Intervention|Non-compliance|0
7408988|NCT01380093|11678037|FG005|Treatment Phase: Third Intervention|Non-compliance|0
7408989|NCT01380093|11678038|FG006|Treatment Phase: Third Intervention|Non-compliance|0
7408990|NCT01380093|11678039|FG007|Treatment Phase: Third Intervention|Non-compliance|0
7408991|NCT01380093|11678040|FG008|Treatment Phase: Third Intervention|Non-compliance|1
7408992|NCT01380093|11678032|FG000|Treatment Phase: Third Intervention|Other|0
7408993|NCT01380093|11678033|FG001|Treatment Phase: Third Intervention|Other|0
7408994|NCT01380093|11678034|FG002|Treatment Phase: Third Intervention|Other|0
7408995|NCT01380093|11678035|FG003|Treatment Phase: Third Intervention|Other|0
7408996|NCT01380093|11678036|FG004|Treatment Phase: Third Intervention|Other|0
7408997|NCT01380093|11678037|FG005|Treatment Phase: Third Intervention|Other|0
7408998|NCT01380093|11678038|FG006|Treatment Phase: Third Intervention|Other|0
7408999|NCT01380093|11678039|FG007|Treatment Phase: Third Intervention|Other|0
7409000|NCT01380093|11678040|FG008|Treatment Phase: Third Intervention|Other|1
7409001|NCT01380145|11678063|FG000|Overall Study|Progressive disease|4
7409002|NCT01380184|11678069|FG000|Part 1 (19 Days)|Adverse Event|1
7409003|NCT01380184|11678069|FG000|Part 2|Adverse Event|5
7409004|NCT01380184|11678069|FG000|Part 2|Disease Progression|8
7409005|NCT01380184|11678069|FG000|Part 2|Lost to Follow-up|1
7409006|NCT01380327|11678085|FG000|Overall Study|Lost to Follow-up|0
7409007|NCT01380327|11678086|FG001|Overall Study|Lost to Follow-up|1
7409008|NCT01380327|11678087|FG002|Overall Study|Lost to Follow-up|1
7409009|NCT01380327|11678085|FG000|Overall Study|Protocol Violation|3
7409010|NCT01380327|11678086|FG001|Overall Study|Protocol Violation|2
7409011|NCT01380327|11678087|FG002|Overall Study|Protocol Violation|3
7409012|NCT01380327|11678085|FG000|Overall Study|Withdrawal by Subject|0
7409013|NCT01380327|11678086|FG001|Overall Study|Withdrawal by Subject|0
7409014|NCT01380327|11678087|FG002|Overall Study|Withdrawal by Subject|1
7409015|NCT01380327|11678085|FG000|Overall Study|Housing situation precluded ability to k|0
7409016|NCT01380327|11678086|FG001|Overall Study|Housing situation precluded ability to k|0
7409017|NCT01380327|11678087|FG002|Overall Study|Housing situation precluded ability to k|1
7409018|NCT01380327|11678085|FG000|Overall Study|Questionable onset of epilepsy|0
7409019|NCT01380327|11678086|FG001|Overall Study|Questionable onset of epilepsy|0
7409020|NCT01380327|11678087|FG002|Overall Study|Questionable onset of epilepsy|1
7409021|NCT01380379|11678100|FG000|Overall Study|Pregnancy|1
7409022|NCT01380535|11678106|FG000|Overall Study|Adverse Event|3
7409023|NCT01380535|11678107|FG001|Overall Study|Adverse Event|3
7409024|NCT01380535|11678106|FG000|Overall Study|Death|3
7409025|NCT01380535|11678107|FG001|Overall Study|Death|0
7409026|NCT01380535|11678106|FG000|Overall Study|Study site closed|0
7409027|NCT01380535|11678107|FG001|Overall Study|Study site closed|5
7409028|NCT01380535|11678106|FG000|Overall Study|Withdrawal by Subject|1
7409029|NCT01380535|11678107|FG001|Overall Study|Withdrawal by Subject|2
7409030|NCT01380535|11678106|FG000|Overall Study|Protocol Violation|0
7409031|NCT01380535|11678107|FG001|Overall Study|Protocol Violation|2
7409032|NCT01380535|11678106|FG000|Overall Study|Lack of Efficacy|0
7409033|NCT01380535|11678107|FG001|Overall Study|Lack of Efficacy|3
7409034|NCT01380691|11678122|FG000|Washout (7 Days)|Protocol Violation|0
7409035|NCT01380691|11678123|FG001|Washout (7 Days)|Protocol Violation|0
7409036|NCT01380691|11678124|FG002|Washout (7 Days)|Protocol Violation|0
7409037|NCT01380691|11678125|FG003|Washout (7 Days)|Protocol Violation|1
7409038|NCT01380691|11678122|FG000|Washout (7 Days)|Withdrawal by Subject|0
7409039|NCT01380691|11678123|FG001|Washout (7 Days)|Withdrawal by Subject|0
7409040|NCT01380691|11678124|FG002|Washout (7 Days)|Withdrawal by Subject|1
7409041|NCT01380691|11678125|FG003|Washout (7 Days)|Withdrawal by Subject|0
7409042|NCT01380730|11678144|FG000|Overall Study|Death|0
7409043|NCT01380730|11678145|FG001|Overall Study|Death|0
7409044|NCT01380730|11678146|FG002|Overall Study|Death|0
7409045|NCT01380730|11678147|FG003|Overall Study|Death|0
7409046|NCT01380730|11678148|FG004|Overall Study|Death|1
7409047|NCT01380730|11678149|FG005|Overall Study|Death|0
7409048|NCT01380730|11678150|FG006|Overall Study|Death|0
7409049|NCT01380730|11678151|FG007|Overall Study|Death|0
7409050|NCT01380769|11678188|FG000|Overall Study|Withdrawal by Subject|7
7409051|NCT01380769|11678189|FG001|Overall Study|Withdrawal by Subject|11
7409052|NCT01380769|11678188|FG000|Overall Study|Physician Decision|1
7409053|NCT01380769|11678189|FG001|Overall Study|Physician Decision|1
7409054|NCT01380769|11678188|FG000|Overall Study|Adverse Event|1
7409055|NCT01380769|11678189|FG001|Overall Study|Adverse Event|1
7409056|NCT01380769|11678188|FG000|Overall Study|Protocol Violation|0
7409057|NCT01380769|11678189|FG001|Overall Study|Protocol Violation|1
7409058|NCT01380782|11678197|FG000|Overall Study|Adverse Event|0
7409059|NCT01380782|11678198|FG001|Overall Study|Adverse Event|1
7409060|NCT01380782|11678199|FG002|Overall Study|Adverse Event|0
7409061|NCT01380782|11678200|FG003|Overall Study|Adverse Event|0
7409062|NCT01380782|11678197|FG000|Overall Study|Death|1
7409063|NCT01380782|11678198|FG001|Overall Study|Death|0
7409064|NCT01380782|11678199|FG002|Overall Study|Death|0
7409065|NCT01380782|11678200|FG003|Overall Study|Death|0
7409066|NCT01380782|11678197|FG000|Overall Study|Lack of Efficacy|10
7409067|NCT01380782|11678198|FG001|Overall Study|Lack of Efficacy|9
7409068|NCT01380782|11678199|FG002|Overall Study|Lack of Efficacy|10
7409069|NCT01380782|11678200|FG003|Overall Study|Lack of Efficacy|3
7409070|NCT01380782|11678197|FG000|Overall Study|Physician Decision|1
7409071|NCT01380782|11678198|FG001|Overall Study|Physician Decision|0
7409072|NCT01380782|11678199|FG002|Overall Study|Physician Decision|0
7409073|NCT01380782|11678200|FG003|Overall Study|Physician Decision|0
7409074|NCT01380782|11678197|FG000|Overall Study|Withdrawal by Subject|0
7409075|NCT01380782|11678198|FG001|Overall Study|Withdrawal by Subject|0
7409076|NCT01380782|11678199|FG002|Overall Study|Withdrawal by Subject|1
7409077|NCT01380782|11678200|FG003|Overall Study|Withdrawal by Subject|1
7409078|NCT01380834|11678214|FG000|Overall Study|Physician Decision|1
7409079|NCT01380834|11678215|FG001|Overall Study|Physician Decision|0
7409080|NCT01380990|11678236|FG000|Overall Study|Treatment Failure|1
7409081|NCT01380990|11678237|FG001|Overall Study|Treatment Failure|0
7409082|NCT01380990|11678236|FG000|Overall Study|Death|0
7409083|NCT01380990|11678237|FG001|Overall Study|Death|1
7409084|NCT01381016|11678249|FG000|Overall Study|Lost to Follow-up|1
7409085|NCT01381016|11678250|FG001|Overall Study|Lost to Follow-up|1
7409086|NCT01381016|11678249|FG000|Overall Study|Screen Failure|2
7409087|NCT01381016|11678250|FG001|Overall Study|Screen Failure|2
7409088|NCT01381016|11678249|FG000|Overall Study|Withdrawal by Subject|0
7409089|NCT01381016|11678250|FG001|Overall Study|Withdrawal by Subject|1
7409090|NCT01381016|11678249|FG000|Overall Study|Physician Decision|0
7409091|NCT01381016|11678250|FG001|Overall Study|Physician Decision|2
7409092|NCT01381068|11678260|FG000|Overall Study|Death|1
7409093|NCT01381068|11678261|FG001|Overall Study|Death|0
7409094|NCT01381549|11678301|FG000|Overall Study|Ineligible: No organisms isolated|0
7409095|NCT01381549|11678302|FG001|Overall Study|Ineligible: No organisms isolated|0
7409096|NCT01381549|11678303|FG002|Overall Study|Ineligible: No organisms isolated|1
7409097|NCT01381562|11678315|FG000|Overall Study|Adverse Event|0
7409098|NCT01381562|11678316|FG001|Overall Study|Adverse Event|1
7409099|NCT01381562|11678317|FG002|Overall Study|Adverse Event|0
7409100|NCT01381575|11678328|FG000|Overall Study|Serious Adverse Event|1
7409101|NCT01381575|11678329|FG001|Overall Study|Serious Adverse Event|0
7409102|NCT01381575|11678330|FG002|Overall Study|Serious Adverse Event|0
7409103|NCT01381575|11678328|FG000|Overall Study|Non-Serious Adverse Event|0
7409104|NCT01381575|11678329|FG001|Overall Study|Non-Serious Adverse Event|0
7409105|NCT01381575|11678330|FG002|Overall Study|Non-Serious Adverse Event|1
7409106|NCT01381575|11678328|FG000|Overall Study|Protocol Violation|0
7409107|NCT01381575|11678329|FG001|Overall Study|Protocol Violation|1
7409108|NCT01381575|11678330|FG002|Overall Study|Protocol Violation|1
7409109|NCT01381575|11678328|FG000|Overall Study|Withdrawal by Subject|15
7409110|NCT01381575|11678329|FG001|Overall Study|Withdrawal by Subject|9
7409111|NCT01381575|11678330|FG002|Overall Study|Withdrawal by Subject|7
7409112|NCT01381575|11678328|FG000|Overall Study|Migrated/moved from study area|2
7409113|NCT01381575|11678329|FG001|Overall Study|Migrated/moved from study area|12
7409114|NCT01381575|11678330|FG002|Overall Study|Migrated/moved from study area|2
7409115|NCT01381575|11678328|FG000|Overall Study|Lost to Follow-up|8
7409116|NCT01381575|11678329|FG001|Overall Study|Lost to Follow-up|17
7409117|NCT01381575|11678330|FG002|Overall Study|Lost to Follow-up|9
7409118|NCT01381692|11678341|FG000|Overall Study|Adverse Event|1
7409119|NCT01381692|11678342|FG001|Overall Study|Adverse Event|0
7409120|NCT01381692|11678343|FG002|Overall Study|Adverse Event|0
7409121|NCT01381692|11678344|FG003|Overall Study|Adverse Event|0
7409122|NCT01381692|11678345|FG004|Overall Study|Adverse Event|0
7409123|NCT01381692|11678346|FG005|Overall Study|Adverse Event|0
7409124|NCT01381718|11678356|FG000|Overall Study|Withdrawal by Subject|2
7409125|NCT01381718|11678357|FG001|Overall Study|Withdrawal by Subject|5
7409126|NCT01381718|11678356|FG000|Overall Study|Lost to Follow-up|3
7409127|NCT01381718|11678357|FG001|Overall Study|Lost to Follow-up|5
7409128|NCT01381718|11678356|FG000|Overall Study|Toxicity, side effects or complications related to study|0
7409129|NCT01381718|11678357|FG001|Overall Study|Toxicity, side effects or complications related to study|3
7409130|NCT01381874|11678370|FG000|Overall Study|Lost to Follow-up|1
7409131|NCT01381874|11678371|FG001|Overall Study|Lost to Follow-up|1
7409132|NCT01381874|11678372|FG002|Overall Study|Lost to Follow-up|0
7409133|NCT01381874|11678370|FG000|Overall Study|Withdrawal by Subject|9
7409134|NCT01381874|11678371|FG001|Overall Study|Withdrawal by Subject|10
7409135|NCT01381874|11678372|FG002|Overall Study|Withdrawal by Subject|9
7409136|NCT01381874|11678370|FG000|Overall Study|Other|67
7409137|NCT01381874|11678371|FG001|Overall Study|Other|52
7409138|NCT01381874|11678372|FG002|Overall Study|Other|67
7409139|NCT01381900|11678383|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
7409140|NCT01381900|11678384|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
7409141|NCT01381900|11678385|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
7409142|NCT01381900|11678383|FG000|Overall Study|Adverse Event|4
7409143|NCT01381900|11678384|FG001|Overall Study|Adverse Event|6
7409144|NCT01381900|11678385|FG002|Overall Study|Adverse Event|7
7409145|NCT01381900|11678383|FG000|Overall Study|Noncompliance with study drug|0
7409146|NCT01381900|11678384|FG001|Overall Study|Noncompliance with study drug|0
7409147|NCT01381900|11678385|FG002|Overall Study|Noncompliance with study drug|1
7409148|NCT01381900|11678383|FG000|Overall Study|Physician Decision|0
7409149|NCT01381900|11678384|FG001|Overall Study|Physician Decision|1
7409150|NCT01381900|11678385|FG002|Overall Study|Physician Decision|1
7409151|NCT01381900|11678383|FG000|Overall Study|Protocol Violation|0
7409152|NCT01381900|11678384|FG001|Overall Study|Protocol Violation|1
7409153|NCT01381900|11678385|FG002|Overall Study|Protocol Violation|1
7409154|NCT01381900|11678383|FG000|Overall Study|Withdrawal by Subject|0
7409155|NCT01381900|11678384|FG001|Overall Study|Withdrawal by Subject|0
7409156|NCT01381900|11678385|FG002|Overall Study|Withdrawal by Subject|1
7409157|NCT01381900|11678383|FG000|Overall Study|Early withdraw|3
7409158|NCT01381900|11678384|FG001|Overall Study|Early withdraw|1
7409159|NCT01381900|11678385|FG002|Overall Study|Early withdraw|1
7409160|NCT01381926|11678395|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
7409161|NCT01381926|11678396|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
7409162|NCT01381926|11678395|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
7409163|NCT01381926|11678396|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
7409164|NCT01382212|11678432|FG000|Overall Study|Kidney transplant|1
7409165|NCT01382212|11678432|FG000|Overall Study|Withdrew consent|1
7409166|NCT01382225|11678438|FG000|Overall Study|Adverse Event|3
7409167|NCT01382225|11678439|FG001|Overall Study|Adverse Event|2
7409168|NCT01382225|11678438|FG000|Overall Study|Protocol Violation|2
7409169|NCT01382225|11678439|FG001|Overall Study|Protocol Violation|1
7409170|NCT01382225|11678438|FG000|Overall Study|Subject Withdrew Consent|5
7409171|NCT01382225|11678439|FG001|Overall Study|Subject Withdrew Consent|2
7409172|NCT01382225|11678438|FG000|Overall Study|Other|4
7409173|NCT01382225|11678439|FG001|Overall Study|Other|2
7409174|NCT01382251|11678447|FG000|Overall Study|Surgeries cancelled or delayed|16
7409175|NCT01382251|11678448|FG001|Overall Study|Surgeries cancelled or delayed|16
7409176|NCT01382251|11678447|FG000|Overall Study|Lost to Follow-up|4
7409177|NCT01382251|11678448|FG001|Overall Study|Lost to Follow-up|4
7409178|NCT01382251|11678447|FG000|Overall Study|Contacted after study closed|1
7409179|NCT01382251|11678448|FG001|Overall Study|Contacted after study closed|1
7409180|NCT01382446|11678464|FG000|Overall Study|Withdrawal by Subject|0
7409181|NCT01382446|11678465|FG001|Overall Study|Withdrawal by Subject|1
7409182|NCT01382446|11678464|FG000|Overall Study|Removal from Mechanical Ventilation|3
7409183|NCT01382446|11678465|FG001|Overall Study|Removal from Mechanical Ventilation|3
7409184|NCT01382602|11678473|FG000|Overall Study|Protocol Violation|0
7409185|NCT01382602|11678474|FG001|Overall Study|Protocol Violation|3
7409186|NCT01382602|11678473|FG000|Overall Study|Withdrawal by Subject|0
7409187|NCT01382602|11678474|FG001|Overall Study|Withdrawal by Subject|1
7409188|NCT01382940|11678506|FG000|Overall Study|Adverse Event|19
7409189|NCT01382940|11678506|FG000|Overall Study|Lost to Follow-up|4
7409190|NCT01382940|11678506|FG000|Overall Study|Physician Decision|7
7409191|NCT01382940|11678506|FG000|Overall Study|Withdrawal by Subject|23
7409192|NCT01382940|11678506|FG000|Overall Study|Protocol Violation|20
7409193|NCT01383018|11678519|FG000|Overall Study|Adverse Event|14
7409194|NCT01383018|11678519|FG000|Overall Study|Death|10
7409195|NCT01383018|11678519|FG000|Overall Study|Lost to Follow-up|5
7409196|NCT01383018|11678519|FG000|Overall Study|Physician Decision|5
7409197|NCT01383018|11678519|FG000|Overall Study|Withdrawal by Subject|9
7409198|NCT01383018|11678519|FG000|Overall Study|Subject not implanted|76
7409199|NCT01383018|11678519|FG000|Overall Study|Missed Visit|247
7409200|NCT01383018|11678519|FG000|Overall Study|Site closed early-not compliance related|7
7409201|NCT01383018|11678519|FG000|Overall Study|Patient moved away from site|1
7409202|NCT01383018|11678519|FG000|Overall Study|Subject Incarcerated|1
7409203|NCT01383096|11678536|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7409204|NCT01383096|11678537|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7409205|NCT01383096|11678538|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7409206|NCT01383096|11678536|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7409207|NCT01383096|11678537|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7409208|NCT01383096|11678538|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7409209|NCT01383096|11678536|FG000|Third Intervention (8 Days)|Elevated AST|0
7409210|NCT01383096|11678537|FG001|Third Intervention (8 Days)|Elevated AST|1
7409211|NCT01383096|11678538|FG002|Third Intervention (8 Days)|Elevated AST|0
7409212|NCT01383096|11678536|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
7409213|NCT01383096|11678537|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
7409214|NCT01383096|11678538|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
7409215|NCT01383096|11678536|FG000|Third Intervention (8 Days)|Adverse Event|1
7409216|NCT01383096|11678537|FG001|Third Intervention (8 Days)|Adverse Event|0
7409217|NCT01383096|11678538|FG002|Third Intervention (8 Days)|Adverse Event|0
7409218|NCT01383096|11678536|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
7409219|NCT01383096|11678537|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
7409220|NCT01383096|11678538|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
7409221|NCT01383096|11678536|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
7409222|NCT01383096|11678537|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7409223|NCT01383096|11678538|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
7409224|NCT01383096|11678536|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
7409225|NCT01383096|11678537|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7409226|NCT01383096|11678538|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
7409227|NCT01383096|11678536|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
7409228|NCT01383096|11678537|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7409229|NCT01383096|11678538|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
7409230|NCT01383096|11678536|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
7409231|NCT01383096|11678537|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7409232|NCT01383096|11678538|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
7409233|NCT01383096|11678536|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
7409234|NCT01383096|11678537|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7409235|NCT01383096|11678538|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
7409236|NCT01383161|11678577|FG000|Overall Study|Adverse Event|5
7409237|NCT01383161|11678578|FG001|Overall Study|Adverse Event|1
7409238|NCT01383161|11678577|FG000|Overall Study|Withdrawal by Subject|0
7409239|NCT01383161|11678578|FG001|Overall Study|Withdrawal by Subject|2
7409240|NCT01383161|11678577|FG000|Overall Study|Lack of Efficacy|0
7409241|NCT01383161|11678578|FG001|Overall Study|Lack of Efficacy|1
7409242|NCT01383174|11678586|FG000|3 Month Assessment|Death|0
7409243|NCT01383174|11678587|FG001|3 Month Assessment|Death|1
7409244|NCT01383174|11678586|FG000|3 Month Assessment|Lost to Follow-up|2
7409245|NCT01383174|11678587|FG001|3 Month Assessment|Lost to Follow-up|0
7409246|NCT01383174|11678586|FG000|3 Month Assessment|Refused to complete|4
7409247|NCT01383174|11678587|FG001|3 Month Assessment|Refused to complete|0
7409248|NCT01383174|11678586|FG000|6 Month Assessment|Lost to Follow-up|1
7409249|NCT01383174|11678587|FG001|6 Month Assessment|Lost to Follow-up|1
7409250|NCT01383174|11678586|FG000|6 Month Assessment|Refused to complete|4
7409251|NCT01383174|11678587|FG001|6 Month Assessment|Refused to complete|0
7466034|NCT01888432|11765776|FG001|24-month Analysis (FAS)|Physician Decision|4
7466035|NCT01888432|11765775|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
7409252|NCT01383317|11678613|FG000|Overall Study|Lost to Follow-up|2
7409253|NCT01383317|11678614|FG001|Overall Study|Lost to Follow-up|1
7409254|NCT01383317|11678613|FG000|Overall Study|Death|1
7409255|NCT01383317|11678614|FG001|Overall Study|Death|0
7409256|NCT01383317|11678613|FG000|Overall Study|Adverse Event|0
7409257|NCT01383317|11678614|FG001|Overall Study|Adverse Event|1
7409258|NCT01383356|11678620|FG000|Period 1|Adverse Event|5
7409259|NCT01383356|11678621|FG001|Period 1|Adverse Event|3
7409260|NCT01383356|11678620|FG000|Period 1|Non-compliance|3
7409261|NCT01383356|11678621|FG001|Period 1|Non-compliance|0
7409262|NCT01383356|11678620|FG000|Period 1|Out of Range Mid-study-Test|0
7409263|NCT01383356|11678621|FG001|Period 1|Out of Range Mid-study-Test|1
7409264|NCT01383356|11678620|FG000|Period 1|Personal|0
7409265|NCT01383356|11678621|FG001|Period 1|Personal|2
7409266|NCT01383486|11678635|FG000|Overall Study|Lost to Follow-up|10
7409267|NCT01383486|11678635|FG000|Overall Study|Incomplete information for analysis|2
7409268|NCT01383486|11678635|FG000|Overall Study|Did not take any product|6
7409269|NCT01383499|11678640|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
7409270|NCT01383499|11678641|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
7409271|NCT01383499|11678642|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
7409272|NCT01383499|11678643|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
7409273|NCT01383707|11678669|FG000|Overall Study|Consent withdrawal|6
7409274|NCT01383707|11678669|FG000|Overall Study|Death|19
7409275|NCT01383707|11678669|FG000|Overall Study|Other|8
7409276|NCT01383707|11678669|FG000|Overall Study|Sponsor's decision|2
7409277|NCT01383707|11678669|FG000|Overall Study|Adverse Event|14
7409278|NCT01383707|11678669|FG000|Overall Study|Progressive disease|23
7409279|NCT01383928|11678689|FG000|Overall Study|Initiation of ASCT|2
7409280|NCT01383928|11678690|FG001|Overall Study|Initiation of ASCT|1
7409281|NCT01383928|11678691|FG002|Overall Study|Initiation of ASCT|18
7409282|NCT01383928|11678689|FG000|Overall Study|Adverse Event|1
7409283|NCT01383928|11678690|FG001|Overall Study|Adverse Event|2
7409284|NCT01383928|11678691|FG002|Overall Study|Adverse Event|8
7409285|NCT01383928|11678689|FG000|Overall Study|Other|1
7409286|NCT01383928|11678690|FG001|Overall Study|Other|3
7409287|NCT01383928|11678691|FG002|Overall Study|Other|4
7409288|NCT01383928|11678689|FG000|Overall Study|Progressive Disease|1
7409289|NCT01383928|11678690|FG001|Overall Study|Progressive Disease|1
7409290|NCT01383928|11678691|FG002|Overall Study|Progressive Disease|5
7409291|NCT01383928|11678689|FG000|Overall Study|Withdrawal by Subject|0
7409292|NCT01383928|11678690|FG001|Overall Study|Withdrawal by Subject|0
7409293|NCT01383928|11678691|FG002|Overall Study|Withdrawal by Subject|4
7409294|NCT01383928|11678689|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
7409295|NCT01383928|11678690|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7409296|NCT01383928|11678691|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7409297|NCT01383954|11678701|FG000|Overall Study|Lack of Efficacy|2
7409298|NCT01383954|11678701|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
7409299|NCT01383954|11678701|FG000|Overall Study|Adverse Event|1
7409300|NCT01383954|11678701|FG000|Overall Study|Reason Not Specified|9
7409301|NCT01383993|11678708|FG000|Overall Study|Adverse Event|1
7409302|NCT01383993|11678709|FG001|Overall Study|Adverse Event|1
7409303|NCT01383993|11678710|FG002|Overall Study|Adverse Event|0
7409304|NCT01383993|11678708|FG000|Overall Study|Withdrawal by Subject|0
7409305|NCT01383993|11678709|FG001|Overall Study|Withdrawal by Subject|0
7409306|NCT01383993|11678710|FG002|Overall Study|Withdrawal by Subject|1
7409307|NCT01383993|11678708|FG000|Overall Study|Marketed voriconazole in post-therapy|2
7409308|NCT01383993|11678709|FG001|Overall Study|Marketed voriconazole in post-therapy|0
7409309|NCT01383993|11678710|FG002|Overall Study|Marketed voriconazole in post-therapy|0
7409310|NCT01384019|11678721|FG000|Overall Study|Withdrawal by Subject|3
7409311|NCT01384019|11678722|FG001|Overall Study|Withdrawal by Subject|0
7409312|NCT01384019|11678721|FG000|Overall Study|Death|1
7409313|NCT01384019|11678722|FG001|Overall Study|Death|0
7409314|NCT01384019|11678721|FG000|Overall Study|MRI refusal|6
7409315|NCT01384019|11678722|FG001|Overall Study|MRI refusal|6
7409316|NCT01384292|11678731|FG000|Part B|Severe non-compliance to protocol|1
7409317|NCT01384292|11678732|FG001|Part B|Severe non-compliance to protocol|0
7409318|NCT01384292|11678733|FG002|Part B|Severe non-compliance to protocol|0
7409319|NCT01384734|11678770|FG000|Overall Study|Adverse Event|0
7409320|NCT01384734|11678771|FG001|Overall Study|Adverse Event|3
7409321|NCT01384734|11678772|FG002|Overall Study|Adverse Event|0
7409322|NCT01384734|11678773|FG003|Overall Study|Adverse Event|2
7409323|NCT01384734|11678774|FG004|Overall Study|Adverse Event|7
7409324|NCT01384734|11678770|FG000|Overall Study|Death|1
7409325|NCT01384734|11678771|FG001|Overall Study|Death|0
7409326|NCT01384734|11678772|FG002|Overall Study|Death|1
7409327|NCT01384734|11678773|FG003|Overall Study|Death|0
7409328|NCT01384734|11678774|FG004|Overall Study|Death|0
7409329|NCT01384734|11678770|FG000|Overall Study|Continuation criteria not met|0
7409330|NCT01384734|11678771|FG001|Overall Study|Continuation criteria not met|0
7409331|NCT01384734|11678772|FG002|Overall Study|Continuation criteria not met|1
7409332|NCT01384734|11678773|FG003|Overall Study|Continuation criteria not met|1
7409333|NCT01384734|11678774|FG004|Overall Study|Continuation criteria not met|0
7409334|NCT01384734|11678770|FG000|Overall Study|Lack of Efficacy|3
7409335|NCT01384734|11678771|FG001|Overall Study|Lack of Efficacy|7
7409336|NCT01384734|11678772|FG002|Overall Study|Lack of Efficacy|4
7409337|NCT01384734|11678773|FG003|Overall Study|Lack of Efficacy|4
7409338|NCT01384734|11678774|FG004|Overall Study|Lack of Efficacy|2
7409339|NCT01384734|11678770|FG000|Overall Study|Lost to Follow-up|5
7409340|NCT01384734|11678771|FG001|Overall Study|Lost to Follow-up|3
7409341|NCT01384734|11678772|FG002|Overall Study|Lost to Follow-up|3
7409342|NCT01384734|11678773|FG003|Overall Study|Lost to Follow-up|8
7409343|NCT01384734|11678774|FG004|Overall Study|Lost to Follow-up|5
7409344|NCT01384734|11678770|FG000|Overall Study|Non-compliance with study drug|1
7409345|NCT01384734|11678771|FG001|Overall Study|Non-compliance with study drug|2
7409346|NCT01384734|11678772|FG002|Overall Study|Non-compliance with study drug|6
7409347|NCT01384734|11678773|FG003|Overall Study|Non-compliance with study drug|0
7409348|NCT01384734|11678774|FG004|Overall Study|Non-compliance with study drug|2
7409349|NCT01384734|11678770|FG000|Overall Study|Pregnancy|0
7409350|NCT01384734|11678771|FG001|Overall Study|Pregnancy|1
7409351|NCT01384734|11678772|FG002|Overall Study|Pregnancy|0
7409352|NCT01384734|11678773|FG003|Overall Study|Pregnancy|0
7409353|NCT01384734|11678774|FG004|Overall Study|Pregnancy|1
7409354|NCT01384734|11678770|FG000|Overall Study|Sponsor terminated|0
7409355|NCT01384734|11678771|FG001|Overall Study|Sponsor terminated|0
7409356|NCT01384734|11678772|FG002|Overall Study|Sponsor terminated|0
7409357|NCT01384734|11678773|FG003|Overall Study|Sponsor terminated|0
7409358|NCT01384734|11678774|FG004|Overall Study|Sponsor terminated|1
7317630|NCT00723697|11546606|FG000|Overall Study|Physician questionnaires not received|2
7317631|NCT00723697|11546606|FG000|Overall Study|Missing Informed Consent Form|10
7317632|NCT00723697|11546606|FG000|Overall Study|Other exclusion criteria applied|6
7317633|NCT00723710|11546613|FG000|Overall Study|Disease progression|48
7409359|NCT01384734|11678770|FG000|Overall Study|Withdrawal by Subject|5
7409360|NCT01384734|11678771|FG001|Overall Study|Withdrawal by Subject|5
7409361|NCT01384734|11678772|FG002|Overall Study|Withdrawal by Subject|6
7409362|NCT01384734|11678773|FG003|Overall Study|Withdrawal by Subject|7
7409363|NCT01384734|11678774|FG004|Overall Study|Withdrawal by Subject|9
7409364|NCT01384734|11678770|FG000|Overall Study|Investigator relocating|0
7409365|NCT01384734|11678771|FG001|Overall Study|Investigator relocating|2
7409366|NCT01384734|11678772|FG002|Overall Study|Investigator relocating|0
7409367|NCT01384734|11678773|FG003|Overall Study|Investigator relocating|3
7409368|NCT01384734|11678774|FG004|Overall Study|Investigator relocating|1
7409369|NCT01384734|11678770|FG000|Overall Study|Unable to come back for visit|1
7409370|NCT01384734|11678771|FG001|Overall Study|Unable to come back for visit|0
7409371|NCT01384734|11678772|FG002|Overall Study|Unable to come back for visit|1
7409372|NCT01384734|11678773|FG003|Overall Study|Unable to come back for visit|1
7409373|NCT01384734|11678774|FG004|Overall Study|Unable to come back for visit|0
7409374|NCT01384734|11678770|FG000|Overall Study|Prison|0
7409375|NCT01384734|11678771|FG001|Overall Study|Prison|0
7409376|NCT01384734|11678772|FG002|Overall Study|Prison|1
7409377|NCT01384734|11678773|FG003|Overall Study|Prison|0
7409378|NCT01384734|11678774|FG004|Overall Study|Prison|0
7409379|NCT01384734|11678770|FG000|Overall Study|As per Exclusion criteria|0
7409380|NCT01384734|11678771|FG001|Overall Study|As per Exclusion criteria|1
7409381|NCT01384734|11678772|FG002|Overall Study|As per Exclusion criteria|0
7409382|NCT01384734|11678773|FG003|Overall Study|As per Exclusion criteria|0
7409383|NCT01384734|11678774|FG004|Overall Study|As per Exclusion criteria|0
7409384|NCT01384734|11678770|FG000|Overall Study|Missed End of treatment visit|0
7409385|NCT01384734|11678771|FG001|Overall Study|Missed End of treatment visit|0
7409386|NCT01384734|11678772|FG002|Overall Study|Missed End of treatment visit|0
7409387|NCT01384734|11678773|FG003|Overall Study|Missed End of treatment visit|1
7409388|NCT01384734|11678774|FG004|Overall Study|Missed End of treatment visit|0
7409389|NCT01384734|11678770|FG000|Overall Study|Adhesion problem|0
7409390|NCT01384734|11678771|FG001|Overall Study|Adhesion problem|0
7409391|NCT01384734|11678772|FG002|Overall Study|Adhesion problem|0
7409392|NCT01384734|11678773|FG003|Overall Study|Adhesion problem|1
7409393|NCT01384734|11678774|FG004|Overall Study|Adhesion problem|0
7409394|NCT01384734|11678770|FG000|Overall Study|Early termination|0
7409395|NCT01384734|11678771|FG001|Overall Study|Early termination|0
7409396|NCT01384734|11678772|FG002|Overall Study|Early termination|0
7409397|NCT01384734|11678773|FG003|Overall Study|Early termination|0
7409398|NCT01384734|11678774|FG004|Overall Study|Early termination|1
7409399|NCT01384734|11678770|FG000|Overall Study|Physician Decision|1
7409400|NCT01384734|11678771|FG001|Overall Study|Physician Decision|0
7409401|NCT01384734|11678772|FG002|Overall Study|Physician Decision|0
7409402|NCT01384734|11678773|FG003|Overall Study|Physician Decision|0
7409403|NCT01384734|11678774|FG004|Overall Study|Physician Decision|0
7409404|NCT01384760|11678785|FG000|Overall Study|Lost to Follow-up|0
7409405|NCT01384760|11678786|FG001|Overall Study|Lost to Follow-up|6
7409406|NCT01384760|11678785|FG000|Overall Study|Protocol Violation|16
7409407|NCT01384760|11678786|FG001|Overall Study|Protocol Violation|0
7409408|NCT01384877|11678794|FG000|Treatment 2|Lost to Follow-up|2
7317634|NCT00723710|11546613|FG000|Overall Study|Adverse Event|88
7317635|NCT00723710|11546613|FG000|Overall Study|Withdrawal by Subject|36
7317636|NCT00723710|11546613|FG000|Overall Study|Physician Decision|2
7317637|NCT00723801|11546629|FG000|Overall Study|Lost to Follow-up|1
7317638|NCT00723801|11546630|FG001|Overall Study|Lost to Follow-up|2
7317639|NCT00723801|11546629|FG000|Overall Study|Protocol Violation|2
7317640|NCT00723801|11546630|FG001|Overall Study|Protocol Violation|1
7317641|NCT00723840|11546640|FG000|Overall Study|Lost to Follow-up|2
7317642|NCT00723840|11546640|FG000|Overall Study|Failure to return|18
7409409|NCT01384877|11678795|FG001|Treatment 2|Lost to Follow-up|2
7409410|NCT01385098|11678801|FG000|Overall Study|Adverse Event|10
7409411|NCT01385098|11678801|FG000|Overall Study|Lost to Follow-up|4
7409412|NCT01385202|11678844|FG000|Overall Study|Lost to Follow-up|6
7409413|NCT01385202|11678844|FG000|Overall Study|Not Eligible|11
7409414|NCT01385202|11678844|FG000|Overall Study|Withdrawn|1
7409415|NCT01385371|11678860|FG000|Overall Study|Adverse Event|54
7409416|NCT01385371|11678861|FG001|Overall Study|Adverse Event|19
7409417|NCT01385371|11678860|FG000|Overall Study|Lost to Follow-up|16
7409418|NCT01385371|11678861|FG001|Overall Study|Lost to Follow-up|16
7409419|NCT01385371|11678860|FG000|Overall Study|Withdrawal by Subject|52
7409420|NCT01385371|11678861|FG001|Overall Study|Withdrawal by Subject|39
7409421|NCT01385371|11678860|FG000|Overall Study|Protocol Violation|25
7409422|NCT01385371|11678861|FG001|Overall Study|Protocol Violation|21
7409423|NCT01385371|11678860|FG000|Overall Study|Administrative|2
7409424|NCT01385371|11678861|FG001|Overall Study|Administrative|2
7409425|NCT01385566|11678873|FG000|Overall Study|Lost to Follow-up|1
7409426|NCT01385566|11678874|FG001|Overall Study|Lost to Follow-up|0
7409427|NCT01385566|11678875|FG002|Overall Study|Lost to Follow-up|0
7409428|NCT01385566|11678876|FG003|Overall Study|Lost to Follow-up|0
7409429|NCT01385566|11678877|FG004|Overall Study|Lost to Follow-up|0
7409430|NCT01385566|11678878|FG005|Overall Study|Lost to Follow-up|0
7409431|NCT01385566|11678873|FG000|Overall Study|Withdrawal by Subject|0
7409432|NCT01385566|11678874|FG001|Overall Study|Withdrawal by Subject|0
7409433|NCT01385566|11678875|FG002|Overall Study|Withdrawal by Subject|0
7409434|NCT01385566|11678876|FG003|Overall Study|Withdrawal by Subject|1
7409435|NCT01385566|11678877|FG004|Overall Study|Withdrawal by Subject|0
7409436|NCT01385566|11678878|FG005|Overall Study|Withdrawal by Subject|0
7409437|NCT01385748|11678923|FG000|Overall Study|Withdrawal by Subject|7
7409438|NCT01385748|11678924|FG001|Overall Study|Withdrawal by Subject|4
7409439|NCT01385748|11678925|FG002|Overall Study|Withdrawal by Subject|5
7409440|NCT01385748|11678923|FG000|Overall Study|Noncompliance|3
7409441|NCT01385748|11678924|FG001|Overall Study|Noncompliance|1
7409442|NCT01385748|11678925|FG002|Overall Study|Noncompliance|6
7409443|NCT01385748|11678923|FG000|Overall Study|Other|1
7409444|NCT01385748|11678924|FG001|Overall Study|Other|7
7409445|NCT01385748|11678925|FG002|Overall Study|Other|1
7409446|NCT01385748|11678923|FG000|Overall Study|Adverse Event|4
7409447|NCT01385748|11678924|FG001|Overall Study|Adverse Event|2
7409448|NCT01385748|11678925|FG002|Overall Study|Adverse Event|1
7409449|NCT01385995|11678939|FG000|Period 1, 2 Months|Physician Decision|1
7409450|NCT01385995|11678940|FG001|Period 1, 2 Months|Physician Decision|0
7409451|NCT01386008|11678948|FG000|Overall Study|exited w/o incident /study discontinued|17
7409452|NCT01386008|11678948|FG000|Overall Study|Adverse Event|3
7409453|NCT01386554|11678959|FG000|Overall Study|Lost to Follow-up|0
7409454|NCT01386554|11678960|FG001|Overall Study|Lost to Follow-up|0
7409455|NCT01386554|11678961|FG002|Overall Study|Lost to Follow-up|1
7409456|NCT01386554|11678959|FG000|Overall Study|Adverse Event|2
7409457|NCT01386554|11678960|FG001|Overall Study|Adverse Event|5
7409458|NCT01386554|11678961|FG002|Overall Study|Adverse Event|2
7409459|NCT01386554|11678959|FG000|Overall Study|Progressive disease|1
7409460|NCT01386554|11678960|FG001|Overall Study|Progressive disease|2
7409461|NCT01386554|11678961|FG002|Overall Study|Progressive disease|2
7409462|NCT01386554|11678959|FG000|Overall Study|Administration of live vaccines|0
7409463|NCT01386554|11678960|FG001|Overall Study|Administration of live vaccines|1
7409464|NCT01386554|11678961|FG002|Overall Study|Administration of live vaccines|0
7409465|NCT01386554|11678959|FG000|Overall Study|Investigator discretion|0
7409466|NCT01386554|11678960|FG001|Overall Study|Investigator discretion|0
7409467|NCT01386554|11678961|FG002|Overall Study|Investigator discretion|1
7409468|NCT01386554|11678959|FG000|Overall Study|Reason not collected|0
7409469|NCT01386554|11678960|FG001|Overall Study|Reason not collected|1
7409470|NCT01386554|11678961|FG002|Overall Study|Reason not collected|0
7409471|NCT01386606|11678975|FG000|Overall Study|Adverse Event|0
7409472|NCT01386606|11678976|FG001|Overall Study|Adverse Event|1
7409473|NCT01386606|11678977|FG002|Overall Study|Adverse Event|0
7409474|NCT01386606|11678978|FG003|Overall Study|Adverse Event|0
7409475|NCT01386606|11678975|FG000|Overall Study|Withdrawal by Subject|0
7409476|NCT01386606|11678976|FG001|Overall Study|Withdrawal by Subject|1
7409477|NCT01386606|11678977|FG002|Overall Study|Withdrawal by Subject|1
7409478|NCT01386606|11678978|FG003|Overall Study|Withdrawal by Subject|0
7409479|NCT01386606|11678975|FG000|Overall Study|Protocol Violation|1
7409480|NCT01386606|11678976|FG001|Overall Study|Protocol Violation|0
7409481|NCT01386606|11678977|FG002|Overall Study|Protocol Violation|1
7409482|NCT01386606|11678978|FG003|Overall Study|Protocol Violation|1
7409483|NCT01386606|11678975|FG000|Overall Study|Lost to Follow-up|2
7409484|NCT01386606|11678976|FG001|Overall Study|Lost to Follow-up|0
7409485|NCT01386606|11678977|FG002|Overall Study|Lost to Follow-up|0
7409486|NCT01386606|11678978|FG003|Overall Study|Lost to Follow-up|0
7409487|NCT01386606|11678975|FG000|Overall Study|Subject incarcerated|0
7409488|NCT01386606|11678976|FG001|Overall Study|Subject incarcerated|1
7409489|NCT01386606|11678977|FG002|Overall Study|Subject incarcerated|0
7409490|NCT01386606|11678978|FG003|Overall Study|Subject incarcerated|0
7409491|NCT01386606|11678975|FG000|Overall Study|Unable to draw PK|1
7409492|NCT01386606|11678976|FG001|Overall Study|Unable to draw PK|0
7409493|NCT01386606|11678977|FG002|Overall Study|Unable to draw PK|0
7409494|NCT01386606|11678978|FG003|Overall Study|Unable to draw PK|0
7409495|NCT01386606|11678975|FG000|Overall Study|T levels too high|0
7409496|NCT01386606|11678976|FG001|Overall Study|T levels too high|1
7409497|NCT01386606|11678977|FG002|Overall Study|T levels too high|1
7409498|NCT01386606|11678978|FG003|Overall Study|T levels too high|0
7409499|NCT01386645|11679004|FG000|Overall Study|Physician Decision|0
7409500|NCT01386645|11679005|FG001|Overall Study|Physician Decision|0
7409501|NCT01386645|11679006|FG002|Overall Study|Physician Decision|1
7409502|NCT01386645|11679004|FG000|Overall Study|Withdrawal by Subject|0
7409503|NCT01386645|11679005|FG001|Overall Study|Withdrawal by Subject|1
7409504|NCT01386645|11679006|FG002|Overall Study|Withdrawal by Subject|1
7409505|NCT01386788|11679014|FG000|Overall Study|Lost to Follow-up|2
7409506|NCT01386944|11679018|FG000|Overall Study|Adverse Event|26
7409507|NCT01386944|11679018|FG000|Overall Study|Lack of Efficacy|14
7409508|NCT01386944|11679018|FG000|Overall Study|Lost to Follow-up|8
7409509|NCT01386944|11679018|FG000|Overall Study|Unspecified reason|8
7409510|NCT01386970|11679024|FG000|Overall Study|Withdrawal by Subject|0
7409511|NCT01386970|11679025|FG001|Overall Study|Withdrawal by Subject|1
7409512|NCT01386970|11679024|FG000|Overall Study|Adverse Event|4
7409513|NCT01386970|11679025|FG001|Overall Study|Adverse Event|1
7409514|NCT01387022|11679044|FG000|Overall Study|Death|1
7409515|NCT01387022|11679045|FG001|Overall Study|Death|1
7409516|NCT01387022|11679044|FG000|Overall Study|Lost to Follow-up|0
7409517|NCT01387022|11679045|FG001|Overall Study|Lost to Follow-up|3
7409518|NCT01387074|11679051|FG000|Overall Study|Lost to Follow-up|7
7409519|NCT01387074|11679051|FG000|Overall Study|Lack of Efficacy|1
7409520|NCT01387230|11679077|FG000|Overall Study|Adverse Event|0
7409521|NCT01387230|11679078|FG001|Overall Study|Adverse Event|1
7409522|NCT01387230|11679079|FG002|Overall Study|Adverse Event|3
7409523|NCT01387230|11679077|FG000|Overall Study|Lack of Efficacy|8
7409524|NCT01387230|11679078|FG001|Overall Study|Lack of Efficacy|5
7409525|NCT01387230|11679079|FG002|Overall Study|Lack of Efficacy|4
7409526|NCT01387230|11679077|FG000|Overall Study|Protocol-defined Stopping Criteria|6
7409527|NCT01387230|11679078|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7409528|NCT01387230|11679079|FG002|Overall Study|Protocol-defined Stopping Criteria|5
7409529|NCT01387230|11679077|FG000|Overall Study|Lost to Follow-up|0
7409530|NCT01387230|11679078|FG001|Overall Study|Lost to Follow-up|0
7409531|NCT01387230|11679079|FG002|Overall Study|Lost to Follow-up|1
7409532|NCT01387230|11679077|FG000|Overall Study|Withdrawal by Subject|4
7409533|NCT01387230|11679078|FG001|Overall Study|Withdrawal by Subject|1
7409534|NCT01387230|11679079|FG002|Overall Study|Withdrawal by Subject|0
7409535|NCT01387269|11679089|FG000|Overall Study|Death|38
7409536|NCT01387269|11679090|FG001|Overall Study|Death|20
7409537|NCT01387269|11679089|FG000|Overall Study|Other|8
7409538|NCT01387269|11679090|FG001|Overall Study|Other|7
7409539|NCT01387269|11679089|FG000|Overall Study|Unrelated AE|12
7409540|NCT01387269|11679090|FG001|Overall Study|Unrelated AE|3
7409541|NCT01387269|11679089|FG000|Overall Study|Withdrawal by patient|32
7409542|NCT01387269|11679090|FG001|Overall Study|Withdrawal by patient|10
7409543|NCT01387269|11679089|FG000|Overall Study|Study drug-related AE|1
7409544|NCT01387269|11679090|FG001|Overall Study|Study drug-related AE|0
7409545|NCT01387269|11679089|FG000|Overall Study|Lost to Follow-up|1
7409546|NCT01387269|11679090|FG001|Overall Study|Lost to Follow-up|0
7409547|NCT01387282|11679098|FG000|Overall Study|Death|47
7409548|NCT01387282|11679099|FG001|Overall Study|Death|16
7409549|NCT01387282|11679098|FG000|Overall Study|Other|5
7409550|NCT01387282|11679099|FG001|Overall Study|Other|1
7409551|NCT01387282|11679098|FG000|Overall Study|Unrelated AE|6
7409552|NCT01387282|11679099|FG001|Overall Study|Unrelated AE|4
7409553|NCT01387282|11679098|FG000|Overall Study|Withdrawal by patient|33
7409554|NCT01387282|11679099|FG001|Overall Study|Withdrawal by patient|23
7409555|NCT01387282|11679098|FG000|Overall Study|Study drug-related AE|2
7409556|NCT01387282|11679099|FG001|Overall Study|Study drug-related AE|2
7409557|NCT01387282|11679098|FG000|Overall Study|Lost to Follow-up|4
7409558|NCT01387282|11679099|FG001|Overall Study|Lost to Follow-up|1
7409559|NCT01387347|11679107|FG000|Overall Study|Lost to Follow-up|2
7409560|NCT01387347|11679108|FG001|Overall Study|Lost to Follow-up|1
7409561|NCT01387516|11679131|FG000|Overall Study|Lost to Follow-up|4
7409562|NCT01387516|11679132|FG001|Overall Study|Lost to Follow-up|4
7409563|NCT01387516|11679133|FG002|Overall Study|Lost to Follow-up|2
7409564|NCT01387516|11679134|FG003|Overall Study|Lost to Follow-up|3
7409565|NCT01387516|11679131|FG000|Overall Study|Withdrawal by Subject|1
7409566|NCT01387516|11679132|FG001|Overall Study|Withdrawal by Subject|1
7409567|NCT01387516|11679133|FG002|Overall Study|Withdrawal by Subject|2
7409568|NCT01387516|11679134|FG003|Overall Study|Withdrawal by Subject|0
7409569|NCT01387516|11679131|FG000|Overall Study|Death|0
7409570|NCT01387516|11679132|FG001|Overall Study|Death|0
7409571|NCT01387516|11679133|FG002|Overall Study|Death|0
7409572|NCT01387516|11679134|FG003|Overall Study|Death|1
7409573|NCT01387542|11679144|FG000|Overall Study|Adverse Event|3
7409574|NCT01387542|11679144|FG000|Overall Study|Withdrawal by Subject|1
7409575|NCT01387542|11679144|FG000|Overall Study|Changed diagnosis|1
7409576|NCT01387542|11679144|FG000|Overall Study|Insufficient response|1
7409577|NCT01387542|11679144|FG000|Overall Study|Non-compliant|1
7409578|NCT01387542|11679144|FG000|Overall Study|Lost to Follow-up|1
7409579|NCT01387594|11679163|FG000|Overall Study|Withdrawal by Subject|0
7409580|NCT01387594|11679164|FG001|Overall Study|Withdrawal by Subject|2
7409581|NCT01387594|11679163|FG000|Overall Study|Lost to Follow-up|0
7409582|NCT01387594|11679164|FG001|Overall Study|Lost to Follow-up|1
7409583|NCT01387607|11679175|FG000|Overall Study|Adverse Event|23
7409584|NCT01387607|11679176|FG001|Overall Study|Adverse Event|11
7409585|NCT01387607|11679175|FG000|Overall Study|Lack of Efficacy|8
7409586|NCT01387607|11679176|FG001|Overall Study|Lack of Efficacy|6
7409587|NCT01387607|11679175|FG000|Overall Study|Lost to Follow-up|2
7409588|NCT01387607|11679176|FG001|Overall Study|Lost to Follow-up|1
7409589|NCT01387607|11679175|FG000|Overall Study|No longer meets eligibility criteria|0
7409590|NCT01387607|11679176|FG001|Overall Study|No longer meets eligibility criteria|1
7409591|NCT01387607|11679175|FG000|Overall Study|Protocol Violation|1
7409592|NCT01387607|11679176|FG001|Overall Study|Protocol Violation|5
7409593|NCT01387607|11679175|FG000|Overall Study|Withdrawal by Subject|13
7409594|NCT01387607|11679176|FG001|Overall Study|Withdrawal by Subject|14
7409595|NCT01387607|11679175|FG000|Overall Study|Other|1
7409596|NCT01387607|11679176|FG001|Overall Study|Other|1
7409597|NCT01387607|11679175|FG000|Overall Study|Randomized, not treated|3
7409598|NCT01387607|11679176|FG001|Overall Study|Randomized, not treated|6
7409599|NCT01387737|11679210|FG000|Overall Study|Adverse Event|20
7409600|NCT01387737|11679211|FG001|Overall Study|Adverse Event|30
7409601|NCT01387737|11679210|FG000|Overall Study|Lack of Efficacy|1
7409602|NCT01387737|11679211|FG001|Overall Study|Lack of Efficacy|0
7409603|NCT01387737|11679210|FG000|Overall Study|Physician Decision|3
7409604|NCT01387737|11679211|FG001|Overall Study|Physician Decision|10
7409605|NCT01387737|11679210|FG000|Overall Study|Withdrawal by Subject|27
7409606|NCT01387737|11679211|FG001|Overall Study|Withdrawal by Subject|31
7409607|NCT01387737|11679210|FG000|Overall Study|Clearly not eligible for the study|1
7409608|NCT01387737|11679211|FG001|Overall Study|Clearly not eligible for the study|3
7409609|NCT01387789|11679217|FG000|Overall Study|Adverse Event|5
7409610|NCT01387789|11679217|FG000|Overall Study|Lack of Efficacy|2
7409611|NCT01387789|11679217|FG000|Overall Study|Lost to Follow-up|1
7409612|NCT01387932|11679232|FG000|Randomized and Treated|Physician Decision|3
7409613|NCT01387932|11679233|FG001|Randomized and Treated|Physician Decision|2
7409614|NCT01387932|11679232|FG000|Randomized and Treated|Withdrawal by Subject|4
7409615|NCT01387932|11679233|FG001|Randomized and Treated|Withdrawal by Subject|2
7409616|NCT01387932|11679232|FG000|Survival Follow-up|Liver Transplant|24
7409617|NCT01387932|11679233|FG001|Survival Follow-up|Liver Transplant|28
7409618|NCT01387932|11679232|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
7409619|NCT01387932|11679233|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
7409620|NCT01387932|11679232|FG000|Survival Follow-up|Withdrawal by Subject|2
7409621|NCT01387932|11679233|FG001|Survival Follow-up|Withdrawal by Subject|4
7409622|NCT01387932|11679232|FG000|Survival Follow-up|Lost to Follow-up|6
7409623|NCT01387932|11679233|FG001|Survival Follow-up|Lost to Follow-up|5
7409624|NCT01388166|11679241|FG000|Overall Study|Adverse Event|16
7409625|NCT01388166|11679241|FG000|Overall Study|Lost to Follow-up|30
7409626|NCT01388166|11679241|FG000|Overall Study|Others than specified above|13
7409627|NCT01388335|11679245|FG000|Period 1|Progressive Disease|1
7409628|NCT01388335|11679245|FG000|Period 2|Progressive Disease|2
7409629|NCT01388335|11679245|FG000|Period 2|Sponsor Decision|1
7409630|NCT01388335|11679245|FG000|Safety Extension|Progressive Disease|7
7409631|NCT01388361|11679260|FG000|Overall Study|Adverse Event|0
7409632|NCT01388361|11679261|FG001|Overall Study|Adverse Event|5
7409633|NCT01388361|11679262|FG002|Overall Study|Adverse Event|1
7409634|NCT01388361|11679260|FG000|Overall Study|Protocol Violation|0
7409635|NCT01388361|11679261|FG001|Overall Study|Protocol Violation|0
7409636|NCT01388361|11679262|FG002|Overall Study|Protocol Violation|2
7409637|NCT01388361|11679260|FG000|Overall Study|Withdrawal criteria|12
7409638|NCT01388361|11679261|FG001|Overall Study|Withdrawal criteria|7
7409639|NCT01388361|11679262|FG002|Overall Study|Withdrawal criteria|10
7409640|NCT01388361|11679260|FG000|Overall Study|Unclassified|0
7409641|NCT01388361|11679261|FG001|Overall Study|Unclassified|0
7409642|NCT01388361|11679262|FG002|Overall Study|Unclassified|1
7409643|NCT01388478|11679270|FG000|Overall Study|Adverse Event|4
7409644|NCT01388478|11679270|FG000|Overall Study|Withdrawal by Subject|1
7409645|NCT01388530|11679274|FG000|Overall Study|Lost to Follow-up|5
7409646|NCT01388543|11679280|FG000|Day 14|Adverse Event|1
7409647|NCT01388543|11679281|FG001|Day 14|Adverse Event|4
7409648|NCT01388647|11679289|FG000|Overall Study|Adverse Event|1
7409649|NCT01388647|11679290|FG001|Overall Study|Adverse Event|2
7409650|NCT01388790|11679301|FG000|Overall Study|Ongoing at data cut-off date|8
7409651|NCT01388816|11679309|FG000|Overall Study|Adverse Event|0
7409652|NCT01388816|11679310|FG001|Overall Study|Adverse Event|2
7409653|NCT01388816|11679311|FG002|Overall Study|Adverse Event|0
7409654|NCT01388816|11679312|FG003|Overall Study|Adverse Event|0
7409655|NCT01388816|11679309|FG000|Overall Study|Lost to Follow-up|0
7409656|NCT01388816|11679310|FG001|Overall Study|Lost to Follow-up|1
7409657|NCT01388816|11679311|FG002|Overall Study|Lost to Follow-up|0
7409658|NCT01388816|11679312|FG003|Overall Study|Lost to Follow-up|0
7409659|NCT01388816|11679309|FG000|Overall Study|Withdrawal by Subject|2
7409660|NCT01388816|11679310|FG001|Overall Study|Withdrawal by Subject|1
7409661|NCT01388816|11679311|FG002|Overall Study|Withdrawal by Subject|1
7409662|NCT01388816|11679312|FG003|Overall Study|Withdrawal by Subject|0
7409663|NCT01388816|11679309|FG000|Overall Study|Protocol Violation|0
7409664|NCT01388816|11679310|FG001|Overall Study|Protocol Violation|0
7409665|NCT01388816|11679311|FG002|Overall Study|Protocol Violation|2
7409666|NCT01388816|11679312|FG003|Overall Study|Protocol Violation|0
7409667|NCT01388907|11679327|FG000|Overall Study|Adverse Event|2
7409668|NCT01388907|11679328|FG001|Overall Study|Adverse Event|0
7409669|NCT01388985|11679347|FG000|Overall Study|Death|0
7409670|NCT01388985|11679348|FG001|Overall Study|Death|1
7409671|NCT01388985|11679347|FG000|Overall Study|Lost to Follow-up|30
7409672|NCT01388985|11679348|FG001|Overall Study|Lost to Follow-up|30
7409673|NCT01388985|11679347|FG000|Overall Study|Withdrawal by Subject|13
7409674|NCT01388985|11679348|FG001|Overall Study|Withdrawal by Subject|4
7409675|NCT01388985|11679347|FG000|Overall Study|Subject unavailable|1
7409676|NCT01388985|11679348|FG001|Overall Study|Subject unavailable|1
7409677|NCT01388985|11679347|FG000|Overall Study|Other (no reason)|0
7409678|NCT01388985|11679348|FG001|Overall Study|Other (no reason)|1
7409679|NCT01388985|11679347|FG000|Overall Study|Error of nurse|5
7409680|NCT01388985|11679348|FG001|Overall Study|Error of nurse|1
7409681|NCT01389102|11679364|FG000|Overall Study|Adverse Event|1
7409682|NCT01389102|11679365|FG001|Overall Study|Adverse Event|3
7409683|NCT01389102|11679366|FG002|Overall Study|Adverse Event|2
7409684|NCT01389102|11679367|FG003|Overall Study|Adverse Event|2
7409685|NCT01389102|11679368|FG004|Overall Study|Adverse Event|2
7409686|NCT01389102|11679369|FG005|Overall Study|Adverse Event|2
7409687|NCT01389102|11679364|FG000|Overall Study|Hurricane Katrina|4
7409688|NCT01389102|11679365|FG001|Overall Study|Hurricane Katrina|2
7409689|NCT01389102|11679366|FG002|Overall Study|Hurricane Katrina|3
7409690|NCT01389102|11679367|FG003|Overall Study|Hurricane Katrina|0
7409691|NCT01389102|11679368|FG004|Overall Study|Hurricane Katrina|3
7409692|NCT01389102|11679369|FG005|Overall Study|Hurricane Katrina|1
7409693|NCT01389102|11679364|FG000|Overall Study|Lost to Follow-up|4
7409694|NCT01389102|11679365|FG001|Overall Study|Lost to Follow-up|1
7409695|NCT01389102|11679366|FG002|Overall Study|Lost to Follow-up|1
7409696|NCT01389102|11679367|FG003|Overall Study|Lost to Follow-up|2
7409697|NCT01389102|11679368|FG004|Overall Study|Lost to Follow-up|4
7409698|NCT01389102|11679369|FG005|Overall Study|Lost to Follow-up|1
7409699|NCT01389102|11679364|FG000|Overall Study|Protocol Violation|0
7409700|NCT01389102|11679365|FG001|Overall Study|Protocol Violation|0
7409701|NCT01389102|11679366|FG002|Overall Study|Protocol Violation|3
7409702|NCT01389102|11679367|FG003|Overall Study|Protocol Violation|0
7409703|NCT01389102|11679368|FG004|Overall Study|Protocol Violation|1
7409704|NCT01389102|11679369|FG005|Overall Study|Protocol Violation|1
7409705|NCT01389102|11679364|FG000|Overall Study|Withdrawal by Subject|7
7409706|NCT01389102|11679365|FG001|Overall Study|Withdrawal by Subject|4
7409707|NCT01389102|11679366|FG002|Overall Study|Withdrawal by Subject|9
7409708|NCT01389102|11679367|FG003|Overall Study|Withdrawal by Subject|2
7409709|NCT01389102|11679368|FG004|Overall Study|Withdrawal by Subject|3
7409710|NCT01389102|11679369|FG005|Overall Study|Withdrawal by Subject|3
7409711|NCT01389102|11679364|FG000|Overall Study|Subject Traveling Out of Country|0
7409712|NCT01389102|11679365|FG001|Overall Study|Subject Traveling Out of Country|0
7409713|NCT01389102|11679366|FG002|Overall Study|Subject Traveling Out of Country|0
7409714|NCT01389102|11679367|FG003|Overall Study|Subject Traveling Out of Country|1
7409715|NCT01389102|11679368|FG004|Overall Study|Subject Traveling Out of Country|0
7409716|NCT01389102|11679369|FG005|Overall Study|Subject Traveling Out of Country|0
7409717|NCT01389102|11679364|FG000|Overall Study|Subject Moved|2
7409718|NCT01389102|11679365|FG001|Overall Study|Subject Moved|0
7409719|NCT01389102|11679366|FG002|Overall Study|Subject Moved|1
7409720|NCT01389102|11679367|FG003|Overall Study|Subject Moved|0
7409721|NCT01389102|11679368|FG004|Overall Study|Subject Moved|0
7409722|NCT01389102|11679369|FG005|Overall Study|Subject Moved|0
7409723|NCT01389102|11679364|FG000|Overall Study|Unavailable due to husband's illness|0
7409724|NCT01389102|11679365|FG001|Overall Study|Unavailable due to husband's illness|1
7409725|NCT01389102|11679366|FG002|Overall Study|Unavailable due to husband's illness|0
7409726|NCT01389102|11679367|FG003|Overall Study|Unavailable due to husband's illness|0
7409727|NCT01389102|11679368|FG004|Overall Study|Unavailable due to husband's illness|0
7409728|NCT01389102|11679369|FG005|Overall Study|Unavailable due to husband's illness|0
7409729|NCT01389102|11679364|FG000|Overall Study|Investigator Judgement|0
7409730|NCT01389102|11679365|FG001|Overall Study|Investigator Judgement|1
7409731|NCT01389102|11679366|FG002|Overall Study|Investigator Judgement|0
7409732|NCT01389102|11679367|FG003|Overall Study|Investigator Judgement|0
7409733|NCT01389102|11679368|FG004|Overall Study|Investigator Judgement|0
7409734|NCT01389102|11679369|FG005|Overall Study|Investigator Judgement|0
7409735|NCT01389128|11679391|FG000|Overall Study|Fetal distress|1
7409736|NCT01389128|11679392|FG001|Overall Study|Fetal distress|0
7409737|NCT01389128|11679391|FG000|Overall Study|Cervix dilation stop|1
7409738|NCT01389128|11679392|FG001|Overall Study|Cervix dilation stop|2
7409739|NCT01389128|11679391|FG000|Overall Study|Rapid labor evolution|3
7409740|NCT01389128|11679392|FG001|Overall Study|Rapid labor evolution|2
7409741|NCT01389128|11679391|FG000|Overall Study|Intolerance to procedure|0
7409742|NCT01389128|11679392|FG001|Overall Study|Intolerance to procedure|2
7409743|NCT01389232|11679402|FG000|Overall Study|Had scaffold removed|15
7409744|NCT01389232|11679402|FG000|Overall Study|Personal reasons|2
7409745|NCT01389232|11679402|FG000|Overall Study|Adverse Event|1
7409746|NCT01389232|11679402|FG000|Overall Study|Death|1
7409747|NCT01389245|11679416|FG000|Overall Study|Protocol Violation|10
7409748|NCT01389245|11679416|FG000|Overall Study|Lost to Follow-up|3
7409749|NCT01389245|11679416|FG000|Overall Study|Withdrawal by Subject|2
7409750|NCT01389258|11679420|FG000|Overall Study|Lost to Follow-up|5
7409751|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
7409752|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
7409753|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
7409754|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
7409755|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
7409756|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
7409757|NCT01389323|11679437|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
7409758|NCT01389323|11679437|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
7409759|NCT01389323|11679437|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
7409760|NCT01389323|11679437|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
7409761|NCT01389323|11679437|FG000|Follow-up Period (up to 48 Weeks)|Other|3
7409762|NCT01389596|11679451|FG000|Overall Study|Protocol Violation|3
7409763|NCT01389596|11679452|FG001|Overall Study|Protocol Violation|4
7409764|NCT01389596|11679453|FG002|Overall Study|Protocol Violation|3
7409765|NCT01389596|11679451|FG000|Overall Study|Withdrawal by Subject|1
7409766|NCT01389596|11679452|FG001|Overall Study|Withdrawal by Subject|2
7409767|NCT01389596|11679453|FG002|Overall Study|Withdrawal by Subject|2
7409768|NCT01389596|11679451|FG000|Overall Study|Insufficient Clinical Response|3
7409769|NCT01389596|11679452|FG001|Overall Study|Insufficient Clinical Response|4
7409770|NCT01389596|11679453|FG002|Overall Study|Insufficient Clinical Response|5
7409771|NCT01389596|11679451|FG000|Overall Study|Adverse Event|1
7409772|NCT01389596|11679452|FG001|Overall Study|Adverse Event|4
7409773|NCT01389596|11679453|FG002|Overall Study|Adverse Event|0
7409774|NCT01389596|11679451|FG000|Overall Study|Death|0
7409775|NCT01389596|11679452|FG001|Overall Study|Death|1
7409776|NCT01389596|11679453|FG002|Overall Study|Death|0
7409777|NCT01389596|11679451|FG000|Overall Study|Other Unspecified|2
7409778|NCT01389596|11679452|FG001|Overall Study|Other Unspecified|1
7409779|NCT01389596|11679453|FG002|Overall Study|Other Unspecified|0
7409780|NCT01389752|11679461|FG000|Study Period 1|Sponsor decision|0
7409781|NCT01389752|11679462|FG001|Study Period 1|Sponsor decision|2
7409782|NCT01389752|11679461|FG000|Study Period 2|Sponsor decision|1
7409783|NCT01389752|11679462|FG001|Study Period 2|Sponsor decision|0
7409784|NCT01389882|11679487|FG000|Overall Study|Respiratory rate > 80/min during study|1
7409785|NCT01389882|11679488|FG001|Overall Study|Respiratory rate > 80/min during study|3
7409786|NCT01389882|11679487|FG000|Overall Study|Withdrawal by Subject|0
7409787|NCT01389882|11679488|FG001|Overall Study|Withdrawal by Subject|1
7409788|NCT01389973|11679494|FG000|Overall Study|Lost to Follow-up|1
7409789|NCT01389973|11679494|FG000|Overall Study|Trial Stopped by Sponsor|9
7409790|NCT01389973|11679494|FG000|Overall Study|Other|10
7409791|NCT01390038|11679498|FG000|Overall Study|Death|1
7409792|NCT01390038|11679498|FG000|Overall Study|Lost to Follow-up|1
7409793|NCT01390038|11679498|FG000|Overall Study|Withdrawal by Subject|4
7409794|NCT01390038|11679498|FG000|Overall Study|Simpliciti System Removal|2
7409795|NCT01390220|11679520|FG000|Test Dose Phase|Adverse Event|17
7409796|NCT01390220|11679521|FG001|Test Dose Phase|Adverse Event|0
7409797|NCT01390220|11679522|FG002|Test Dose Phase|Adverse Event|0
7409798|NCT01390220|11679520|FG000|Test Dose Phase|Withdrawal by Subject|8
7409799|NCT01390220|11679521|FG001|Test Dose Phase|Withdrawal by Subject|0
7409800|NCT01390220|11679522|FG002|Test Dose Phase|Withdrawal by Subject|0
7409801|NCT01390220|11679520|FG000|Test Dose Phase|Lost to Follow-up|2
7409802|NCT01390220|11679521|FG001|Test Dose Phase|Lost to Follow-up|0
7409803|NCT01390220|11679522|FG002|Test Dose Phase|Lost to Follow-up|0
7409804|NCT01390220|11679520|FG000|Test Dose Phase|Protocol Violation|8
7409805|NCT01390220|11679521|FG001|Test Dose Phase|Protocol Violation|0
7409806|NCT01390220|11679522|FG002|Test Dose Phase|Protocol Violation|0
7409807|NCT01390220|11679520|FG000|Test Dose Phase|No treated seizure cluster episode|37
7409808|NCT01390220|11679521|FG001|Test Dose Phase|No treated seizure cluster episode|0
7409809|NCT01390220|11679522|FG002|Test Dose Phase|No treated seizure cluster episode|0
7409810|NCT01390220|11679520|FG000|Test Dose Phase|Study/Site closure|6
7409811|NCT01390220|11679521|FG001|Test Dose Phase|Study/Site closure|0
7409812|NCT01390220|11679522|FG002|Test Dose Phase|Study/Site closure|0
7409813|NCT01390220|11679520|FG000|Test Dose Phase|Caregiver no longer available|5
7409814|NCT01390220|11679521|FG001|Test Dose Phase|Caregiver no longer available|0
7409815|NCT01390220|11679522|FG002|Test Dose Phase|Caregiver no longer available|0
7409816|NCT01390220|11679520|FG000|Test Dose Phase|Noncompliance|2
7409817|NCT01390220|11679521|FG001|Test Dose Phase|Noncompliance|0
7409818|NCT01390220|11679522|FG002|Test Dose Phase|Noncompliance|0
7409819|NCT01390220|11679520|FG000|Test Dose Phase|Logistical|6
7409820|NCT01390220|11679521|FG001|Test Dose Phase|Logistical|0
7409821|NCT01390220|11679522|FG002|Test Dose Phase|Logistical|0
7409822|NCT01390220|11679520|FG000|Comparative Phase|Withdrawal by Subject|0
7409823|NCT01390220|11679521|FG001|Comparative Phase|Withdrawal by Subject|1
7409824|NCT01390220|11679522|FG002|Comparative Phase|Withdrawal by Subject|0
7409825|NCT01390272|11679561|FG000|Overall Study|Death|3
7409826|NCT01390272|11679562|FG001|Overall Study|Death|2
7409827|NCT01390272|11679561|FG000|Overall Study|Withdrawal by Subject|9
7409828|NCT01390272|11679562|FG001|Overall Study|Withdrawal by Subject|5
7409829|NCT01390272|11679561|FG000|Overall Study|Patient moved, no longer eligible|5
7409830|NCT01390272|11679562|FG001|Overall Study|Patient moved, no longer eligible|8
7409831|NCT01390298|11679568|FG000|Overall Study|Death|1
7409832|NCT01390298|11679568|FG000|Overall Study|long term ICU admission|1
7409833|NCT01390298|11679568|FG000|Overall Study|Withdrawal by Subject|14
7409834|NCT01390298|11679568|FG000|Overall Study|Lost to Follow-up|7
7409835|NCT01390298|11679568|FG000|Overall Study|Surgery cancelled|1
7409836|NCT01390389|11679574|FG000|Overall Study|Withdrawal by Subject|2
7409837|NCT01390389|11679575|FG001|Overall Study|Withdrawal by Subject|0
7409838|NCT01390389|11679574|FG000|Overall Study|Screen Fail|2
7409839|NCT01390389|11679575|FG001|Overall Study|Screen Fail|1
7466036|NCT01888432|11765776|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
7466037|NCT01888432|11765775|FG000|24-month Analysis (FAS)|Death|8
7466038|NCT01888432|11765776|FG001|24-month Analysis (FAS)|Death|4
7466039|NCT01888432|11765775|FG000|36-month Analysis (Extension)|Death|1
7466040|NCT01888432|11765776|FG001|36-month Analysis (Extension)|Death|0
7466041|NCT01888497|11765792|FG000|Washout Period 1|Withdrawal by Subject|0
7466042|NCT01888497|11765793|FG001|Washout Period 1|Withdrawal by Subject|0
7466043|NCT01888497|11765794|FG002|Washout Period 1|Withdrawal by Subject|1
7466044|NCT01888497|11765795|FG003|Washout Period 1|Withdrawal by Subject|1
7466045|NCT01888497|11765792|FG000|Washout Period 2|Adverse Event|0
7466046|NCT01888497|11765793|FG001|Washout Period 2|Adverse Event|0
7466047|NCT01888497|11765794|FG002|Washout Period 2|Adverse Event|0
7466048|NCT01888497|11765795|FG003|Washout Period 2|Adverse Event|1
7466049|NCT01888497|11765792|FG000|Washout Period 2|Withdrawal by Subject|0
7466050|NCT01888497|11765793|FG001|Washout Period 2|Withdrawal by Subject|0
7466051|NCT01888497|11765794|FG002|Washout Period 2|Withdrawal by Subject|0
7466052|NCT01888497|11765795|FG003|Washout Period 2|Withdrawal by Subject|1
7466053|NCT01888640|11765808|FG000|Overall Study|Lost to Follow-up|1
7466054|NCT01888640|11765809|FG001|Overall Study|Lost to Follow-up|2
7466055|NCT01888640|11765810|FG002|Overall Study|Lost to Follow-up|0
7466056|NCT01888640|11765808|FG000|Overall Study|Withdrawal by Subject|15
7466057|NCT01888640|11765809|FG001|Overall Study|Withdrawal by Subject|11
7466058|NCT01888640|11765810|FG002|Overall Study|Withdrawal by Subject|4
7466059|NCT01888640|11765808|FG000|Overall Study|Minimum dose not met|10
7466060|NCT01888640|11765809|FG001|Overall Study|Minimum dose not met|16
7466061|NCT01888640|11765810|FG002|Overall Study|Minimum dose not met|0
7466062|NCT01888640|11765808|FG000|Overall Study|Given wrong unit (placebo)|1
7466063|NCT01888640|11765809|FG001|Overall Study|Given wrong unit (placebo)|0
7466064|NCT01888640|11765810|FG002|Overall Study|Given wrong unit (placebo)|0
7466065|NCT01888640|11765808|FG000|Overall Study|Excluded for prior TENS|0
7466066|NCT01888640|11765809|FG001|Overall Study|Excluded for prior TENS|1
7466067|NCT01888640|11765810|FG002|Overall Study|Excluded for prior TENS|0
7466068|NCT01888640|11765808|FG000|Overall Study|Researcher Termination of Participant|0
7466069|NCT01888640|11765809|FG001|Overall Study|Researcher Termination of Participant|1
7466070|NCT01888640|11765810|FG002|Overall Study|Researcher Termination of Participant|1
7466071|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7466072|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7466073|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7466074|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
7466075|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7466076|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7466077|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
7466078|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Other|1
7466079|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Other|0
7466080|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Other|1
7466081|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Other|1
7466082|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Other|3
7466083|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Other|3
7466084|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Other|0
7466085|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466086|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466087|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466088|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466089|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466090|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
7466091|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
7466092|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
7466093|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
7466094|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
7466095|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7466096|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
7466097|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
7466098|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
7409840|NCT01390402|11679585|FG000|Overall Study|Death|1
7409841|NCT01390402|11679585|FG000|Overall Study|Disease Progression|4
7409842|NCT01390428|11679595|FG000|Overall Study|Elective Surgery|0
7409843|NCT01390428|11679596|FG001|Overall Study|Elective Surgery|0
7409844|NCT01390428|11679597|FG002|Overall Study|Elective Surgery|0
7409845|NCT01390428|11679598|FG003|Overall Study|Elective Surgery|0
7409846|NCT01390428|11679599|FG004|Overall Study|Elective Surgery|1
7409847|NCT01390428|11679600|FG005|Overall Study|Elective Surgery|0
7409848|NCT01390428|11679595|FG000|Overall Study|Withdrawal by Subject|0
7409849|NCT01390428|11679596|FG001|Overall Study|Withdrawal by Subject|0
7409850|NCT01390428|11679597|FG002|Overall Study|Withdrawal by Subject|1
7409851|NCT01390428|11679598|FG003|Overall Study|Withdrawal by Subject|0
7409852|NCT01390428|11679599|FG004|Overall Study|Withdrawal by Subject|0
7409853|NCT01390428|11679600|FG005|Overall Study|Withdrawal by Subject|0
7409854|NCT01390441|11679619|FG000|Treatment Period|Protocol Violation|0
7409855|NCT01390441|11679620|FG001|Treatment Period|Protocol Violation|1
7409856|NCT01390441|11679621|FG002|Treatment Period|Protocol Violation|0
7409857|NCT01390441|11679622|FG003|Treatment Period|Protocol Violation|0
7409858|NCT01390441|11679623|FG004|Treatment Period|Protocol Violation|0
7409859|NCT01390441|11679619|FG000|Treatment Period|Physician Decision|0
7409860|NCT01390441|11679620|FG001|Treatment Period|Physician Decision|0
7409861|NCT01390441|11679621|FG002|Treatment Period|Physician Decision|0
7409862|NCT01390441|11679622|FG003|Treatment Period|Physician Decision|1
7409863|NCT01390441|11679623|FG004|Treatment Period|Physician Decision|0
7409864|NCT01390441|11679619|FG000|Treatment Period|Lack of Efficacy|0
7409865|NCT01390441|11679620|FG001|Treatment Period|Lack of Efficacy|0
7409866|NCT01390441|11679621|FG002|Treatment Period|Lack of Efficacy|0
7409867|NCT01390441|11679622|FG003|Treatment Period|Lack of Efficacy|0
7409868|NCT01390441|11679623|FG004|Treatment Period|Lack of Efficacy|1
7409869|NCT01390441|11679619|FG000|Treatment Period|Unknown due to early stopping of study|0
7409870|NCT01390441|11679620|FG001|Treatment Period|Unknown due to early stopping of study|0
7409871|NCT01390441|11679621|FG002|Treatment Period|Unknown due to early stopping of study|8
7409872|NCT01390441|11679622|FG003|Treatment Period|Unknown due to early stopping of study|11
7409873|NCT01390441|11679623|FG004|Treatment Period|Unknown due to early stopping of study|7
7409874|NCT01390441|11679619|FG000|Treatment Period|Adverse Event|0
7409875|NCT01390441|11679620|FG001|Treatment Period|Adverse Event|0
7409876|NCT01390441|11679621|FG002|Treatment Period|Adverse Event|1
7409877|NCT01390441|11679622|FG003|Treatment Period|Adverse Event|1
7409878|NCT01390441|11679623|FG004|Treatment Period|Adverse Event|2
7409879|NCT01390441|11679619|FG000|Treatment Period|Withdrawal by Subject|0
7409880|NCT01390441|11679620|FG001|Treatment Period|Withdrawal by Subject|0
7409881|NCT01390441|11679621|FG002|Treatment Period|Withdrawal by Subject|1
7409882|NCT01390441|11679622|FG003|Treatment Period|Withdrawal by Subject|0
7409883|NCT01390441|11679623|FG004|Treatment Period|Withdrawal by Subject|1
7409884|NCT01390441|11679619|FG000|Treatment Period|Lost to Follow-up|1
7409885|NCT01390441|11679620|FG001|Treatment Period|Lost to Follow-up|0
7409886|NCT01390441|11679621|FG002|Treatment Period|Lost to Follow-up|0
7409887|NCT01390441|11679622|FG003|Treatment Period|Lost to Follow-up|0
7409888|NCT01390441|11679623|FG004|Treatment Period|Lost to Follow-up|0
7409889|NCT01390441|11679619|FG000|Extension Period|Protocol Violation|3
7409890|NCT01390441|11679620|FG001|Extension Period|Protocol Violation|1
7409891|NCT01390441|11679621|FG002|Extension Period|Protocol Violation|0
7409892|NCT01390441|11679622|FG003|Extension Period|Protocol Violation|1
7409893|NCT01390441|11679623|FG004|Extension Period|Protocol Violation|0
7409894|NCT01390584|11679663|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7409895|NCT01390584|11679664|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
7409896|NCT01390584|11679665|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
7409897|NCT01390649|11679674|FG000|Overall Study|Physician Decision|1
7409898|NCT01390779|11679678|FG000|Overall Study|Physician Decision|1
7409899|NCT01390844|11679815|FG000|Treatment Phase|Adverse Event|12
7409900|NCT01390844|11679816|FG001|Treatment Phase|Adverse Event|2
7409901|NCT01390844|11679817|FG002|Treatment Phase|Adverse Event|3
7409902|NCT01390844|11679818|FG003|Treatment Phase|Adverse Event|2
7409903|NCT01390844|11679815|FG000|Treatment Phase|Treatment Failure|23
7409904|NCT01390844|11679816|FG001|Treatment Phase|Treatment Failure|25
7409905|NCT01390844|11679817|FG002|Treatment Phase|Treatment Failure|10
7409906|NCT01390844|11679818|FG003|Treatment Phase|Treatment Failure|13
7409907|NCT01390844|11679815|FG000|Treatment Phase|Non-Medical Reasons|5
7409908|NCT01390844|11679816|FG001|Treatment Phase|Non-Medical Reasons|1
7409909|NCT01390844|11679817|FG002|Treatment Phase|Non-Medical Reasons|8
7409910|NCT01390844|11679818|FG003|Treatment Phase|Non-Medical Reasons|1
7409911|NCT01390844|11679815|FG000|Treatment Phase|Non-GCP Compliant|0
7409912|NCT01390844|11679816|FG001|Treatment Phase|Non-GCP Compliant|0
7409913|NCT01390844|11679817|FG002|Treatment Phase|Non-GCP Compliant|10
7409914|NCT01390844|11679818|FG003|Treatment Phase|Non-GCP Compliant|3
7409915|NCT01390844|11679815|FG000|Follow-Up Phase|Non-Medical Reasons|1
7409916|NCT01390844|11679816|FG001|Follow-Up Phase|Non-Medical Reasons|1
7409917|NCT01390844|11679817|FG002|Follow-Up Phase|Non-Medical Reasons|1
7409918|NCT01390844|11679818|FG003|Follow-Up Phase|Non-Medical Reasons|0
7409919|NCT01390857|11679828|FG000|Overall Study|Protocol Violation|2
7409920|NCT01390857|11679828|FG000|Overall Study|Lost to Follow-up|1
7409921|NCT01390857|11679828|FG000|Overall Study|No Visit after the First Visit|7
7409922|NCT01390948|11679868|FG000|Overall Study|End of Study|1
7409923|NCT01390948|11679869|FG001|Overall Study|End of Study|0
7409924|NCT01390948|11679870|FG002|Overall Study|End of Study|0
7409925|NCT01390948|11679868|FG000|Overall Study|Withdrew consent|2
7409926|NCT01390948|11679869|FG001|Overall Study|Withdrew consent|2
7409927|NCT01390948|11679870|FG002|Overall Study|Withdrew consent|0
7409928|NCT01390948|11679868|FG000|Overall Study|Progressive Disease|2
7409929|NCT01390948|11679869|FG001|Overall Study|Progressive Disease|5
7409930|NCT01390948|11679870|FG002|Overall Study|Progressive Disease|0
7409931|NCT01390948|11679868|FG000|Overall Study|Death during follow-up|10
7409932|NCT01390948|11679869|FG001|Overall Study|Death during follow-up|11
7409933|NCT01390948|11679870|FG002|Overall Study|Death during follow-up|1
7409934|NCT01391000|11679879|FG000|Overall Study|Lost to Follow-up|2
7409935|NCT01391000|11679880|FG001|Overall Study|Lost to Follow-up|0
7409936|NCT01391130|11679897|FG000|Overall Study|Withdrawal by Subject|3
7409937|NCT01391130|11679898|FG001|Overall Study|Withdrawal by Subject|2
7409938|NCT01391130|11679897|FG000|Overall Study|Physician Decision|2
7409939|NCT01391130|11679898|FG001|Overall Study|Physician Decision|3
7409940|NCT01391130|11679897|FG000|Overall Study|Did not Receive Drug|1
7409941|NCT01391130|11679898|FG001|Overall Study|Did not Receive Drug|1
7409942|NCT01391507|11679975|FG000|Overall Study|Death|0
7409943|NCT01391507|11679976|FG001|Overall Study|Death|0
7409944|NCT01391507|11679977|FG002|Overall Study|Death|0
7409945|NCT01391507|11679978|FG003|Overall Study|Death|1
7409946|NCT01391507|11679975|FG000|Overall Study|Adverse Event|1
7409947|NCT01391507|11679976|FG001|Overall Study|Adverse Event|1
7409948|NCT01391507|11679977|FG002|Overall Study|Adverse Event|2
7409949|NCT01391507|11679978|FG003|Overall Study|Adverse Event|2
7409950|NCT01391507|11679975|FG000|Overall Study|Withdrawal by Subject|1
7409951|NCT01391507|11679976|FG001|Overall Study|Withdrawal by Subject|2
7409952|NCT01391507|11679977|FG002|Overall Study|Withdrawal by Subject|1
7409953|NCT01391507|11679978|FG003|Overall Study|Withdrawal by Subject|1
7409954|NCT01391507|11679975|FG000|Overall Study|Lack of Efficacy|0
7409955|NCT01391507|11679976|FG001|Overall Study|Lack of Efficacy|0
7409956|NCT01391507|11679977|FG002|Overall Study|Lack of Efficacy|0
7409957|NCT01391507|11679978|FG003|Overall Study|Lack of Efficacy|1
7409958|NCT01391507|11679975|FG000|Overall Study|Protocol Violation|2
7409959|NCT01391507|11679976|FG001|Overall Study|Protocol Violation|1
7409960|NCT01391507|11679977|FG002|Overall Study|Protocol Violation|1
7409961|NCT01391507|11679978|FG003|Overall Study|Protocol Violation|2
7409962|NCT01391546|11679990|FG000|Overall Study|History of Herpes Zoster (HZ)|1
7409963|NCT01391546|11679991|FG001|Overall Study|History of Herpes Zoster (HZ)|0
7409964|NCT01391663|11680013|FG000|Overall Study|Withdrawal by Subject|0
7409965|NCT01391663|11680014|FG001|Overall Study|Withdrawal by Subject|0
7409966|NCT01391663|11680015|FG002|Overall Study|Withdrawal by Subject|1
7409967|NCT01391663|11680016|FG003|Overall Study|Withdrawal by Subject|0
7409968|NCT01391793|11680028|FG000|Overall Study|Ineligible|3
7409969|NCT01391793|11680029|FG001|Overall Study|Ineligible|0
7409970|NCT01391793|11680028|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
7409971|NCT01391793|11680029|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
7409972|NCT01391793|11680028|FG000|Overall Study|No DMSA|73
7409973|NCT01391793|11680029|FG001|Overall Study|No DMSA|57
7409974|NCT01391819|11680035|FG000|Overall Study|Withdrawal by Subject|56
7409975|NCT01391819|11680035|FG000|Overall Study|Migrated/moved from study area|82
7409976|NCT01391819|11680035|FG000|Overall Study|Lost to Follow-up|252
7409977|NCT01391819|11680035|FG000|Overall Study|Death|3
7409978|NCT01391819|11680035|FG000|Overall Study|Other|9
7409979|NCT01391832|11680044|FG000|Overall Study|Withdrawal by Subject|21
7409980|NCT01391832|11680045|FG001|Overall Study|Withdrawal by Subject|22
7409981|NCT01391832|11680044|FG000|Overall Study|Lost to Follow-up|0
7409982|NCT01391832|11680045|FG001|Overall Study|Lost to Follow-up|1
7409983|NCT01392183|11680071|FG000|First Drug Administration|Adverse Event|3
7409984|NCT01392183|11680072|FG001|First Drug Administration|Adverse Event|2
7409985|NCT01392183|11680071|FG000|First Drug Administration|Death|1
7409986|NCT01392183|11680072|FG001|First Drug Administration|Death|0
7409987|NCT01392183|11680071|FG000|First Drug Administration|Withdrawal by Subject|10
7409988|NCT01392183|11680072|FG001|First Drug Administration|Withdrawal by Subject|17
7409989|NCT01392300|11680082|FG000|Main Period (MP)|Predefined discontinuation criteria|2
7409990|NCT01392300|11680083|FG001|Main Period (MP)|Predefined discontinuation criteria|3
7409991|NCT01392300|11680084|FG002|Main Period (MP)|Predefined discontinuation criteria|0
7409992|NCT01392300|11680082|FG000|Main Period (MP)|Withdrawal by Subject|5
7409993|NCT01392300|11680083|FG001|Main Period (MP)|Withdrawal by Subject|1
7409994|NCT01392300|11680084|FG002|Main Period (MP)|Withdrawal by Subject|0
7409995|NCT01392300|11680082|FG000|Main Period (MP)|Lost to Follow-up|3
7409996|NCT01392300|11680083|FG001|Main Period (MP)|Lost to Follow-up|3
7409997|NCT01392300|11680084|FG002|Main Period (MP)|Lost to Follow-up|0
7409998|NCT01392300|11680082|FG000|Main Period (MP)|Non-compliance|1
7409999|NCT01392300|11680083|FG001|Main Period (MP)|Non-compliance|0
7410000|NCT01392300|11680084|FG002|Main Period (MP)|Non-compliance|0
7410001|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
7410002|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
7410003|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
7410004|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7410005|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
7410006|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
7410007|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
7410008|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
7410009|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
7410010|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Death|0
7410011|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Death|0
7410012|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Death|4
7410013|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
7410014|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
7410015|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
7410016|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7410017|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
7410018|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
7410019|NCT01392300|11680082|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7410020|NCT01392300|11680083|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
7410021|NCT01392300|11680084|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
7410022|NCT01392326|11680094|FG000|Overall Study|Death|2
7410023|NCT01392326|11680095|FG001|Overall Study|Death|0
7410024|NCT01392326|11680096|FG002|Overall Study|Death|0
7410025|NCT01392326|11680094|FG000|Overall Study|Withdrawal by Subject|12
7410026|NCT01392326|11680095|FG001|Overall Study|Withdrawal by Subject|11
7410027|NCT01392326|11680096|FG002|Overall Study|Withdrawal by Subject|15
7410028|NCT01392326|11680094|FG000|Overall Study|Protocol Violation|2
7410029|NCT01392326|11680095|FG001|Overall Study|Protocol Violation|0
7410030|NCT01392326|11680096|FG002|Overall Study|Protocol Violation|0
7410031|NCT01392326|11680094|FG000|Overall Study|Pregnancy|0
7410032|NCT01392326|11680095|FG001|Overall Study|Pregnancy|0
7410033|NCT01392326|11680096|FG002|Overall Study|Pregnancy|1
7410034|NCT01392326|11680094|FG000|Overall Study|Physician Decision|7
7410035|NCT01392326|11680095|FG001|Overall Study|Physician Decision|5
7410036|NCT01392326|11680096|FG002|Overall Study|Physician Decision|2
7410037|NCT01392326|11680094|FG000|Overall Study|Lost to Follow-up|1
7410038|NCT01392326|11680095|FG001|Overall Study|Lost to Follow-up|3
7410039|NCT01392326|11680096|FG002|Overall Study|Lost to Follow-up|4
7410040|NCT01392326|11680094|FG000|Overall Study|Lack of Efficacy|14
7410041|NCT01392326|11680095|FG001|Overall Study|Lack of Efficacy|10
7410042|NCT01392326|11680096|FG002|Overall Study|Lack of Efficacy|15
7410043|NCT01392326|11680094|FG000|Overall Study|Adverse Event|9
7410044|NCT01392326|11680095|FG001|Overall Study|Adverse Event|6
7410045|NCT01392326|11680096|FG002|Overall Study|Adverse Event|11
7410046|NCT01392378|11680109|FG000|Infant Series|Adverse Event|0
7410047|NCT01392378|11680110|FG001|Infant Series|Adverse Event|0
7410048|NCT01392378|11680111|FG002|Infant Series|Adverse Event|0
7410049|NCT01392378|11680112|FG003|Infant Series|Adverse Event|1
7410050|NCT01392378|11680113|FG004|Infant Series|Adverse Event|0
7410051|NCT01392378|11680109|FG000|Infant Series|Lost to Follow-up|0
7410052|NCT01392378|11680110|FG001|Infant Series|Lost to Follow-up|0
7410053|NCT01392378|11680111|FG002|Infant Series|Lost to Follow-up|0
7410054|NCT01392378|11680112|FG003|Infant Series|Lost to Follow-up|1
7410055|NCT01392378|11680113|FG004|Infant Series|Lost to Follow-up|0
7410056|NCT01392378|11680109|FG000|Infant Series|Protocol Violation|0
7410057|NCT01392378|11680110|FG001|Infant Series|Protocol Violation|1
7553103|NCT03006393|11913854|FG001|Overall Study|Withdrawal by Subject|1
7410058|NCT01392378|11680111|FG002|Infant Series|Protocol Violation|0
7410059|NCT01392378|11680112|FG003|Infant Series|Protocol Violation|0
7410060|NCT01392378|11680113|FG004|Infant Series|Protocol Violation|0
7410061|NCT01392378|11680109|FG000|Infant Series|Withdrawal by Parent|4
7410062|NCT01392378|11680110|FG001|Infant Series|Withdrawal by Parent|1
7410063|NCT01392378|11680111|FG002|Infant Series|Withdrawal by Parent|0
7410064|NCT01392378|11680112|FG003|Infant Series|Withdrawal by Parent|0
7410065|NCT01392378|11680113|FG004|Infant Series|Withdrawal by Parent|0
7410066|NCT01392378|11680109|FG000|After Infant Series|Lost to Follow-up|0
7410067|NCT01392378|11680110|FG001|After Infant Series|Lost to Follow-up|0
7410068|NCT01392378|11680111|FG002|After Infant Series|Lost to Follow-up|1
7410069|NCT01392378|11680112|FG003|After Infant Series|Lost to Follow-up|0
7410070|NCT01392378|11680113|FG004|After Infant Series|Lost to Follow-up|0
7410071|NCT01392378|11680109|FG000|After Infant Series|Withdrawal by Parent|0
7410072|NCT01392378|11680110|FG001|After Infant Series|Withdrawal by Parent|1
7410073|NCT01392378|11680111|FG002|After Infant Series|Withdrawal by Parent|1
7410074|NCT01392378|11680112|FG003|After Infant Series|Withdrawal by Parent|0
7410075|NCT01392378|11680113|FG004|After Infant Series|Withdrawal by Parent|1
7410076|NCT01392378|11680109|FG000|Toddler Dose|Lost to Follow-up|0
7410077|NCT01392378|11680110|FG001|Toddler Dose|Lost to Follow-up|0
7410078|NCT01392378|11680111|FG002|Toddler Dose|Lost to Follow-up|0
7410079|NCT01392378|11680112|FG003|Toddler Dose|Lost to Follow-up|1
7410080|NCT01392378|11680113|FG004|Toddler Dose|Lost to Follow-up|0
7410081|NCT01392378|11680109|FG000|Toddler Dose|Withdrawal by Parent|0
7410082|NCT01392378|11680110|FG001|Toddler Dose|Withdrawal by Parent|1
7410083|NCT01392378|11680111|FG002|Toddler Dose|Withdrawal by Parent|0
7410084|NCT01392378|11680112|FG003|Toddler Dose|Withdrawal by Parent|1
7410085|NCT01392378|11680113|FG004|Toddler Dose|Withdrawal by Parent|1
7410086|NCT01392443|11680135|FG000|Overall Study|Disease progression|30
7410087|NCT01392443|11680135|FG000|Overall Study|Adverse Event|24
7410088|NCT01392443|11680135|FG000|Overall Study|Death|7
7410089|NCT01392443|11680135|FG000|Overall Study|Withdrawal by Subject|5
7410090|NCT01392443|11680135|FG000|Overall Study|Lost to Follow-up|1
7410091|NCT01392443|11680135|FG000|Overall Study|Protocol Violation|1
7410092|NCT01392469|11680139|FG000|Overall Study|Adverse Event|2
7410093|NCT01392469|11680139|FG000|Overall Study|Withdrawal by Subject|1
7410094|NCT01392469|11680139|FG000|Overall Study|Protocol Violation|1
7410095|NCT01392495|11680154|FG000|Overall Study|Death|3
7410096|NCT01392495|11680154|FG000|Overall Study|Administrative problems|8
7410097|NCT01392495|11680154|FG000|Overall Study|Withdrawal by Subject|2
7410098|NCT01392495|11680154|FG000|Overall Study|Adverse Event|3
7410099|NCT01392547|11680160|FG000|Overall Study|Adverse Event|2
7410100|NCT01392547|11680160|FG000|Overall Study|Non-compliance|2
7410101|NCT01392547|11680160|FG000|Overall Study|Withdrawal criteria|3
7410102|NCT01392547|11680160|FG000|Overall Study|Unclassified|1
7410103|NCT01392560|11680166|FG000|Overall Study|Adverse Event|2
7410104|NCT01392560|11680166|FG000|Overall Study|not entered|8
7410105|NCT01392560|11680166|FG000|Overall Study|discontinued during placebo run-in|2
7410106|NCT01392573|11680174|FG000|Overall Study|Adverse Event|1
7410107|NCT01392573|11680175|FG001|Overall Study|Adverse Event|3
7410108|NCT01392573|11680174|FG000|Overall Study|Lack of Efficacy|1
7410109|NCT01392573|11680175|FG001|Overall Study|Lack of Efficacy|2
7410110|NCT01392573|11680174|FG000|Overall Study|Protocol Violation|0
7410111|NCT01392573|11680175|FG001|Overall Study|Protocol Violation|2
7410112|NCT01392573|11680174|FG000|Overall Study|Withdrawal Criteria|13
7410113|NCT01392573|11680175|FG001|Overall Study|Withdrawal Criteria|15
7410114|NCT01392573|11680174|FG000|Overall Study|Site closure|8
7410115|NCT01392573|11680175|FG001|Overall Study|Site closure|7
7410116|NCT01392573|11680174|FG000|Overall Study|Unclassified|9
7410117|NCT01392573|11680175|FG001|Overall Study|Unclassified|6
7410118|NCT01392677|11680192|FG000|Overall Study|Adverse Event|3
7410119|NCT01392677|11680193|FG001|Overall Study|Adverse Event|1
7410120|NCT01392677|11680192|FG000|Overall Study|Withdrawal by Subject|0
7410121|NCT01392677|11680193|FG001|Overall Study|Withdrawal by Subject|2
7410122|NCT01392677|11680192|FG000|Overall Study|Incorrect enrollment|2
7410123|NCT01392677|11680193|FG001|Overall Study|Incorrect enrollment|3
7410124|NCT01392677|11680192|FG000|Overall Study|Other reason|3
7410125|NCT01392677|11680193|FG001|Overall Study|Other reason|2
7410126|NCT01392742|11680211|FG000|Overall Study|Premature study termination|42
7410127|NCT01392742|11680211|FG000|Overall Study|Failure to return|35
7410128|NCT01392742|11680211|FG000|Overall Study|No treatment/no cooperation/withdrew|12
7410129|NCT01392742|11680211|FG000|Overall Study|Lost to Follow-up|34
7410130|NCT01392742|11680211|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
7410131|NCT01392742|11680211|FG000|Overall Study|ITR and Protocol deviation|1
7410132|NCT01392742|11680211|FG000|Overall Study|Adverse event/intercurrent illness|17
7410133|NCT01392742|11680211|FG000|Overall Study|Protocol Violation|14
7410134|NCT01392742|11680211|FG000|Overall Study|Other|3
7410135|NCT01392742|11680211|FG000|Overall Study|Missing information|13
7410136|NCT01392963|11680225|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
7410137|NCT01392963|11680226|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
7410138|NCT01392963|11680225|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
7410139|NCT01392963|11680226|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
7410140|NCT01392963|11680225|FG000|Week 24 Follow-up|Lost to Follow-up|2
7410141|NCT01392963|11680226|FG001|Week 24 Follow-up|Lost to Follow-up|0
7410142|NCT01393106|11680239|FG000|Overall Study|Adverse Event|3
7410143|NCT01393106|11680239|FG000|Overall Study|Withdrawal by Subject|1
7410144|NCT01393106|11680239|FG000|Overall Study|Lack of Efficacy|1
7410145|NCT01393158|11680256|FG000|Overall Study|Adverse Event|1
7410146|NCT01393158|11680257|FG001|Overall Study|Adverse Event|0
7410147|NCT01393301|11680271|FG000|Overall Study|Lost to Follow-up|5
7410148|NCT01393301|11680272|FG001|Overall Study|Lost to Follow-up|3
7410149|NCT01393301|11680271|FG000|Overall Study|Withdrawal by Subject|2
7410150|NCT01393301|11680272|FG001|Overall Study|Withdrawal by Subject|0
7410151|NCT01393301|11680271|FG000|Overall Study|Completed <7 sessions (intervention)|2
7410152|NCT01393301|11680272|FG001|Overall Study|Completed <7 sessions (intervention)|0
7410153|NCT01393405|11680287|FG000|Induction Period (week1-16)|Lack of Efficacy|70
7410154|NCT01393405|11680288|FG001|Induction Period (week1-16)|Lack of Efficacy|0
7410155|NCT01393405|11680289|FG002|Induction Period (week1-16)|Lack of Efficacy|0
7410156|NCT01393405|11680287|FG000|Induction Period (week1-16)|Adverse Event|16
7410157|NCT01393405|11680288|FG001|Induction Period (week1-16)|Adverse Event|0
7410158|NCT01393405|11680289|FG002|Induction Period (week1-16)|Adverse Event|0
7410159|NCT01393405|11680287|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
7410160|NCT01393405|11680288|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
7410161|NCT01393405|11680289|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
7410162|NCT01393405|11680287|FG000|Maintenance Period Week|Lack of Efficacy|0
7410163|NCT01393405|11680288|FG001|Maintenance Period Week|Lack of Efficacy|22
7410164|NCT01393405|11680289|FG002|Maintenance Period Week|Lack of Efficacy|22
7410165|NCT01393405|11680287|FG000|Maintenance Period Week|Adverse Event|0
7410166|NCT01393405|11680288|FG001|Maintenance Period Week|Adverse Event|5
7410167|NCT01393405|11680289|FG002|Maintenance Period Week|Adverse Event|2
7410168|NCT01393405|11680287|FG000|Maintenance Period Week|Withdrawal by Subject|0
7410169|NCT01393405|11680288|FG001|Maintenance Period Week|Withdrawal by Subject|1
7410170|NCT01393405|11680289|FG002|Maintenance Period Week|Withdrawal by Subject|0
7410171|NCT01393405|11680287|FG000|Maintenance Period Week|Lost to Follow-up|0
7410172|NCT01393405|11680288|FG001|Maintenance Period Week|Lost to Follow-up|1
7410173|NCT01393405|11680289|FG002|Maintenance Period Week|Lost to Follow-up|0
7410174|NCT01393444|11680299|FG000|Overall Study|Withdrawal by Subject|1
7410175|NCT01393444|11680299|FG000|Overall Study|Determined ineligible during screening.|2
7410176|NCT01393600|11680320|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7410177|NCT01393600|11680321|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
7410178|NCT01393600|11680322|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7410179|NCT01393600|11680323|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
7410180|NCT01393600|11680320|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7410181|NCT01393600|11680321|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7410182|NCT01393600|11680322|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
7410183|NCT01393600|11680323|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
7410184|NCT01393600|11680320|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7410185|NCT01393600|11680321|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7410186|NCT01393600|11680322|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
7410187|NCT01393600|11680323|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
7410188|NCT01393600|11680320|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7410189|NCT01393600|11680321|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7410190|NCT01393600|11680322|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
7410191|NCT01393600|11680323|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
7410192|NCT01393600|11680320|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7410193|NCT01393600|11680321|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7410194|NCT01393600|11680322|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
7410195|NCT01393600|11680323|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
7410196|NCT01393600|11680320|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7410197|NCT01393600|11680321|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7410198|NCT01393600|11680322|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
7410199|NCT01393600|11680323|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
7410200|NCT01393600|11680320|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7410201|NCT01393600|11680321|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7410202|NCT01393600|11680322|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
7410203|NCT01393600|11680323|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
7410204|NCT01393613|11680339|FG000|Overall Study|Adverse Event|11
7410205|NCT01393613|11680340|FG001|Overall Study|Adverse Event|11
7410206|NCT01393613|11680341|FG002|Overall Study|Adverse Event|13
7410207|NCT01393613|11680342|FG003|Overall Study|Adverse Event|22
7410208|NCT01393613|11680339|FG000|Overall Study|Participant Met Withdrawal Criteria|0
7410209|NCT01393613|11680340|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7410210|NCT01393613|11680341|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7410211|NCT01393613|11680342|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7410212|NCT01393613|11680339|FG000|Overall Study|Physician Decision|2
7410213|NCT01393613|11680340|FG001|Overall Study|Physician Decision|0
7410214|NCT01393613|11680341|FG002|Overall Study|Physician Decision|0
7410215|NCT01393613|11680342|FG003|Overall Study|Physician Decision|1
7410216|NCT01393613|11680339|FG000|Overall Study|Withdrawal by Subject|15
7410217|NCT01393613|11680340|FG001|Overall Study|Withdrawal by Subject|25
7410218|NCT01393613|11680341|FG002|Overall Study|Withdrawal by Subject|23
7410219|NCT01393613|11680342|FG003|Overall Study|Withdrawal by Subject|21
7410220|NCT01393613|11680339|FG000|Overall Study|Protocol Deviation|2
7410221|NCT01393613|11680340|FG001|Overall Study|Protocol Deviation|1
7410222|NCT01393613|11680341|FG002|Overall Study|Protocol Deviation|0
7410223|NCT01393613|11680342|FG003|Overall Study|Protocol Deviation|0
7410224|NCT01393613|11680339|FG000|Overall Study|Lack of Efficacy|9
7410225|NCT01393613|11680340|FG001|Overall Study|Lack of Efficacy|20
7410226|NCT01393613|11680341|FG002|Overall Study|Lack of Efficacy|16
7410227|NCT01393613|11680342|FG003|Overall Study|Lack of Efficacy|21
7410228|NCT01393626|11680358|FG000|Overall Study|Adverse Event|2
7410229|NCT01393626|11680359|FG001|Overall Study|Adverse Event|1
7410230|NCT01393626|11680360|FG002|Overall Study|Adverse Event|5
7410231|NCT01393626|11680361|FG003|Overall Study|Adverse Event|0
7410232|NCT01393626|11680358|FG000|Overall Study|Did not meet entrance criteria|1
7410233|NCT01393626|11680359|FG001|Overall Study|Did not meet entrance criteria|0
7410234|NCT01393626|11680360|FG002|Overall Study|Did not meet entrance criteria|0
7410235|NCT01393626|11680361|FG003|Overall Study|Did not meet entrance criteria|0
7410236|NCT01393626|11680358|FG000|Overall Study|Lack of Efficacy|6
7410237|NCT01393626|11680359|FG001|Overall Study|Lack of Efficacy|6
7410238|NCT01393626|11680360|FG002|Overall Study|Lack of Efficacy|4
7410239|NCT01393626|11680361|FG003|Overall Study|Lack of Efficacy|1
7410240|NCT01393626|11680358|FG000|Overall Study|Lost to Follow-up|1
7410241|NCT01393626|11680359|FG001|Overall Study|Lost to Follow-up|1
7410242|NCT01393626|11680360|FG002|Overall Study|Lost to Follow-up|1
7410243|NCT01393626|11680361|FG003|Overall Study|Lost to Follow-up|0
7410244|NCT01393626|11680358|FG000|Overall Study|Withdrawal by Subject|6
7410245|NCT01393626|11680359|FG001|Overall Study|Withdrawal by Subject|4
7410246|NCT01393626|11680360|FG002|Overall Study|Withdrawal by Subject|0
7410247|NCT01393626|11680361|FG003|Overall Study|Withdrawal by Subject|0
7410248|NCT01393626|11680358|FG000|Overall Study|Other|1
7410249|NCT01393626|11680359|FG001|Overall Study|Other|0
7410250|NCT01393626|11680360|FG002|Overall Study|Other|0
7410251|NCT01393626|11680361|FG003|Overall Study|Other|0
7410252|NCT01393626|11680358|FG000|Overall Study|Protocol Violation|1
7410253|NCT01393626|11680359|FG001|Overall Study|Protocol Violation|0
7410254|NCT01393626|11680360|FG002|Overall Study|Protocol Violation|2
7410255|NCT01393626|11680361|FG003|Overall Study|Protocol Violation|0
7410256|NCT01393730|11680398|FG000|Overall Study|Withdrawal by Subject|3
7410257|NCT01393730|11680398|FG000|Overall Study|Other|2
7410258|NCT01393730|11680398|FG000|Overall Study|Adverse Event|1
7410259|NCT01393743|11680404|FG000|Core Study|Adverse Event|5
7410260|NCT01393743|11680405|FG001|Core Study|Adverse Event|9
7410261|NCT01393743|11680406|FG002|Core Study|Adverse Event|0
7410262|NCT01393743|11680404|FG000|Core Study|Lost to Follow-up|1
7410263|NCT01393743|11680405|FG001|Core Study|Lost to Follow-up|1
7410264|NCT01393743|11680406|FG002|Core Study|Lost to Follow-up|0
7410265|NCT01393743|11680404|FG000|Core Study|Participant's Choice|2
7410266|NCT01393743|11680405|FG001|Core Study|Participant's Choice|3
7410267|NCT01393743|11680406|FG002|Core Study|Participant's Choice|0
7410268|NCT01393743|11680404|FG000|Core Study|Inadequate therapeutic effect|2
7410269|NCT01393743|11680405|FG001|Core Study|Inadequate therapeutic effect|0
7410270|NCT01393743|11680406|FG002|Core Study|Inadequate therapeutic effect|0
7410271|NCT01393743|11680404|FG000|Extension Phase|Adverse Event|0
7410272|NCT01393743|11680405|FG001|Extension Phase|Adverse Event|0
7410273|NCT01393743|11680406|FG002|Extension Phase|Adverse Event|12
7410274|NCT01393743|11680404|FG000|Extension Phase|Lost to Follow-up|0
7410275|NCT01393743|11680405|FG001|Extension Phase|Lost to Follow-up|0
7410276|NCT01393743|11680406|FG002|Extension Phase|Lost to Follow-up|2
7410277|NCT01393743|11680404|FG000|Extension Phase|Participant choice|0
7410278|NCT01393743|11680405|FG001|Extension Phase|Participant choice|0
7410279|NCT01393743|11680406|FG002|Extension Phase|Participant choice|16
7410280|NCT01393743|11680404|FG000|Extension Phase|Inadequate therapeutic effect|0
7410281|NCT01393743|11680405|FG001|Extension Phase|Inadequate therapeutic effect|0
7410282|NCT01393743|11680406|FG002|Extension Phase|Inadequate therapeutic effect|7
7410283|NCT01393743|11680404|FG000|Extension Phase|Withdrawal by Subject|0
7410284|NCT01393743|11680405|FG001|Extension Phase|Withdrawal by Subject|0
7410285|NCT01393743|11680406|FG002|Extension Phase|Withdrawal by Subject|8
7410286|NCT01393743|11680404|FG000|Extension Phase|Pregnancy|0
7410287|NCT01393743|11680405|FG001|Extension Phase|Pregnancy|0
7410288|NCT01393743|11680406|FG002|Extension Phase|Pregnancy|1
7410289|NCT01393743|11680404|FG000|Extension Phase|Other|0
7410290|NCT01393743|11680405|FG001|Extension Phase|Other|0
7410291|NCT01393743|11680406|FG002|Extension Phase|Other|14
7410292|NCT01393821|11680419|FG000|Overall Study|Cancel|1
7410293|NCT01393821|11680420|FG001|Overall Study|Cancel|1
7410294|NCT01393821|11680419|FG000|Overall Study|not evaluable for primary endpoint|4
7410295|NCT01393821|11680420|FG001|Overall Study|not evaluable for primary endpoint|2
7410296|NCT01393899|11680429|FG000|Overall Study|Study terminated by sponsor|1
7410297|NCT01393899|11680430|FG001|Overall Study|Study terminated by sponsor|0
7410298|NCT01393899|11680431|FG002|Overall Study|Study terminated by sponsor|1
7410299|NCT01393899|11680429|FG000|Overall Study|Other|1
7410300|NCT01393899|11680430|FG001|Overall Study|Other|0
7410301|NCT01393899|11680431|FG002|Overall Study|Other|0
7410302|NCT01393899|11680429|FG000|Overall Study|Withdrawal by Subject|2
7410303|NCT01393899|11680430|FG001|Overall Study|Withdrawal by Subject|2
7410304|NCT01393899|11680431|FG002|Overall Study|Withdrawal by Subject|1
7410305|NCT01393899|11680429|FG000|Overall Study|Lost to Follow-up|0
7410306|NCT01393899|11680430|FG001|Overall Study|Lost to Follow-up|0
7410307|NCT01393899|11680431|FG002|Overall Study|Lost to Follow-up|1
7410308|NCT01393899|11680429|FG000|Overall Study|Does not meet entrance criteria|1
7410309|NCT01393899|11680430|FG001|Overall Study|Does not meet entrance criteria|0
7410310|NCT01393899|11680431|FG002|Overall Study|Does not meet entrance criteria|1
7410311|NCT01393899|11680429|FG000|Overall Study|Lack of Efficacy|26
7410312|NCT01393899|11680430|FG001|Overall Study|Lack of Efficacy|21
7410313|NCT01393899|11680431|FG002|Overall Study|Lack of Efficacy|16
7410314|NCT01393899|11680429|FG000|Overall Study|Adverse Event|1
7410315|NCT01393899|11680430|FG001|Overall Study|Adverse Event|5
7410316|NCT01393899|11680431|FG002|Overall Study|Adverse Event|3
7410317|NCT01393964|11680444|FG000|Overall Study|Disease Progression|4
7410318|NCT01393964|11680445|FG001|Overall Study|Disease Progression|3
7410319|NCT01393964|11680446|FG002|Overall Study|Disease Progression|5
7410320|NCT01393964|11680444|FG000|Overall Study|Study drug toxicity|1
7410321|NCT01393964|11680445|FG001|Overall Study|Study drug toxicity|0
7410322|NCT01393964|11680446|FG002|Overall Study|Study drug toxicity|0
7410323|NCT01393964|11680444|FG000|Overall Study|Withdrawal by Subject|0
7410324|NCT01393964|11680445|FG001|Overall Study|Withdrawal by Subject|0
7410325|NCT01393964|11680446|FG002|Overall Study|Withdrawal by Subject|1
7410326|NCT01393964|11680444|FG000|Overall Study|Adverse event unrelated to study drug|0
7410327|NCT01393964|11680445|FG001|Overall Study|Adverse event unrelated to study drug|3
7410328|NCT01393964|11680446|FG002|Overall Study|Adverse event unrelated to study drug|0
7410329|NCT01393964|11680444|FG000|Overall Study|Subject request stop study treatment|0
7410330|NCT01393964|11680445|FG001|Overall Study|Subject request stop study treatment|1
7410331|NCT01393964|11680446|FG002|Overall Study|Subject request stop study treatment|0
7410332|NCT01393964|11680444|FG000|Overall Study|Subject decided to move to transplant|1
7410333|NCT01393964|11680445|FG001|Overall Study|Subject decided to move to transplant|0
7410334|NCT01393964|11680446|FG002|Overall Study|Subject decided to move to transplant|0
7410335|NCT01393964|11680444|FG000|Overall Study|Subject switched to commercial supply|1
7410336|NCT01393964|11680445|FG001|Overall Study|Subject switched to commercial supply|0
7410337|NCT01393964|11680446|FG002|Overall Study|Subject switched to commercial supply|2
7410338|NCT01393964|11680444|FG000|Overall Study|Subject plateaued in terms of effect|1
7410339|NCT01393964|11680445|FG001|Overall Study|Subject plateaued in terms of effect|0
7410340|NCT01393964|11680446|FG002|Overall Study|Subject plateaued in terms of effect|0
7410341|NCT01393964|11680444|FG000|Overall Study|Investigator removed subject from study|0
7410342|NCT01393964|11680445|FG001|Overall Study|Investigator removed subject from study|1
7410343|NCT01393964|11680446|FG002|Overall Study|Investigator removed subject from study|0
7410344|NCT01393964|11680444|FG000|Overall Study|Subject converted to roll-over study|0
7410345|NCT01393964|11680445|FG001|Overall Study|Subject converted to roll-over study|1
7410346|NCT01393964|11680446|FG002|Overall Study|Subject converted to roll-over study|0
7410347|NCT01393964|11680444|FG000|Overall Study|Subject to receive non-protocol therapy|0
7410348|NCT01393964|11680445|FG001|Overall Study|Subject to receive non-protocol therapy|0
7410349|NCT01393964|11680446|FG002|Overall Study|Subject to receive non-protocol therapy|1
7410350|NCT01393990|11680478|FG000|Overall Study|Adverse Event|0
7410351|NCT01393990|11680479|FG001|Overall Study|Adverse Event|0
7410352|NCT01393990|11680480|FG002|Overall Study|Adverse Event|0
7410353|NCT01393990|11680481|FG003|Overall Study|Adverse Event|0
7410354|NCT01393990|11680482|FG004|Overall Study|Adverse Event|0
7410355|NCT01393990|11680483|FG005|Overall Study|Adverse Event|0
7410356|NCT01393990|11680484|FG006|Overall Study|Adverse Event|0
7410357|NCT01393990|11680485|FG007|Overall Study|Adverse Event|0
7410358|NCT01393990|11680486|FG008|Overall Study|Adverse Event|0
7410359|NCT01393990|11680487|FG009|Overall Study|Adverse Event|0
7410360|NCT01393990|11680488|FG010|Overall Study|Adverse Event|0
7410361|NCT01393990|11680489|FG011|Overall Study|Adverse Event|0
7410362|NCT01393990|11680490|FG012|Overall Study|Adverse Event|0
7410363|NCT01393990|11680491|FG013|Overall Study|Adverse Event|0
7410364|NCT01393990|11680492|FG014|Overall Study|Adverse Event|1
7410365|NCT01393990|11680493|FG015|Overall Study|Adverse Event|1
7410366|NCT01393990|11680494|FG016|Overall Study|Adverse Event|0
7410367|NCT01393990|11680495|FG017|Overall Study|Adverse Event|0
7410368|NCT01393990|11680478|FG000|Overall Study|Progressive Disease|1
7410369|NCT01393990|11680479|FG001|Overall Study|Progressive Disease|0
7410370|NCT01393990|11680480|FG002|Overall Study|Progressive Disease|0
7410371|NCT01393990|11680481|FG003|Overall Study|Progressive Disease|1
7410372|NCT01393990|11680482|FG004|Overall Study|Progressive Disease|1
7410373|NCT01393990|11680483|FG005|Overall Study|Progressive Disease|1
7410374|NCT01393990|11680484|FG006|Overall Study|Progressive Disease|1
7410375|NCT01393990|11680485|FG007|Overall Study|Progressive Disease|1
7410376|NCT01393990|11680486|FG008|Overall Study|Progressive Disease|3
7410377|NCT01393990|11680487|FG009|Overall Study|Progressive Disease|1
7410378|NCT01393990|11680488|FG010|Overall Study|Progressive Disease|0
7410379|NCT01393990|11680489|FG011|Overall Study|Progressive Disease|0
7410380|NCT01393990|11680490|FG012|Overall Study|Progressive Disease|0
7410381|NCT01393990|11680491|FG013|Overall Study|Progressive Disease|1
7410382|NCT01393990|11680492|FG014|Overall Study|Progressive Disease|6
7410383|NCT01393990|11680493|FG015|Overall Study|Progressive Disease|1
7410384|NCT01393990|11680494|FG016|Overall Study|Progressive Disease|0
7410385|NCT01393990|11680495|FG017|Overall Study|Progressive Disease|0
7410386|NCT01393990|11680478|FG000|Overall Study|Death|0
7410387|NCT01393990|11680479|FG001|Overall Study|Death|0
7410388|NCT01393990|11680480|FG002|Overall Study|Death|0
7410389|NCT01393990|11680481|FG003|Overall Study|Death|0
7410390|NCT01393990|11680482|FG004|Overall Study|Death|1
7410391|NCT01393990|11680483|FG005|Overall Study|Death|0
7410392|NCT01393990|11680484|FG006|Overall Study|Death|0
7410393|NCT01393990|11680485|FG007|Overall Study|Death|0
7410394|NCT01393990|11680486|FG008|Overall Study|Death|0
7410395|NCT01393990|11680487|FG009|Overall Study|Death|0
7410396|NCT01393990|11680488|FG010|Overall Study|Death|0
7410397|NCT01393990|11680489|FG011|Overall Study|Death|0
7410398|NCT01393990|11680490|FG012|Overall Study|Death|0
7410399|NCT01393990|11680491|FG013|Overall Study|Death|1
7410400|NCT01393990|11680492|FG014|Overall Study|Death|1
7410401|NCT01393990|11680493|FG015|Overall Study|Death|0
7410402|NCT01393990|11680494|FG016|Overall Study|Death|0
7410403|NCT01393990|11680495|FG017|Overall Study|Death|0
7410404|NCT01393990|11680478|FG000|Overall Study|Withdrawal by Subject|0
7410405|NCT01393990|11680479|FG001|Overall Study|Withdrawal by Subject|0
7410406|NCT01393990|11680480|FG002|Overall Study|Withdrawal by Subject|0
7410407|NCT01393990|11680481|FG003|Overall Study|Withdrawal by Subject|0
7410408|NCT01393990|11680482|FG004|Overall Study|Withdrawal by Subject|0
7410409|NCT01393990|11680483|FG005|Overall Study|Withdrawal by Subject|0
7410410|NCT01393990|11680484|FG006|Overall Study|Withdrawal by Subject|0
7410411|NCT01393990|11680485|FG007|Overall Study|Withdrawal by Subject|0
7410412|NCT01393990|11680486|FG008|Overall Study|Withdrawal by Subject|0
7410413|NCT01393990|11680487|FG009|Overall Study|Withdrawal by Subject|0
7410414|NCT01393990|11680488|FG010|Overall Study|Withdrawal by Subject|0
7410415|NCT01393990|11680489|FG011|Overall Study|Withdrawal by Subject|0
7410416|NCT01393990|11680490|FG012|Overall Study|Withdrawal by Subject|0
7410417|NCT01393990|11680491|FG013|Overall Study|Withdrawal by Subject|0
7410418|NCT01393990|11680492|FG014|Overall Study|Withdrawal by Subject|1
7410419|NCT01393990|11680493|FG015|Overall Study|Withdrawal by Subject|1
7410420|NCT01393990|11680494|FG016|Overall Study|Withdrawal by Subject|0
7410421|NCT01393990|11680495|FG017|Overall Study|Withdrawal by Subject|0
7410422|NCT01394185|11680603|FG000|Overall Study|Withdrawal by Subject|2
7410423|NCT01394185|11680604|FG001|Overall Study|Withdrawal by Subject|0
7410424|NCT01394185|11680605|FG002|Overall Study|Withdrawal by Subject|0
7410425|NCT01394185|11680606|FG003|Overall Study|Withdrawal by Subject|0
7410426|NCT01394185|11680607|FG004|Overall Study|Withdrawal by Subject|1
7410427|NCT01394185|11680608|FG005|Overall Study|Withdrawal by Subject|0
7410428|NCT01394185|11680603|FG000|Overall Study|Change in protocol|3
7410429|NCT01394185|11680604|FG001|Overall Study|Change in protocol|0
7410430|NCT01394185|11680605|FG002|Overall Study|Change in protocol|0
7410431|NCT01394185|11680606|FG003|Overall Study|Change in protocol|0
7410432|NCT01394185|11680607|FG004|Overall Study|Change in protocol|3
7410433|NCT01394185|11680608|FG005|Overall Study|Change in protocol|0
7410434|NCT01394185|11680603|FG000|Overall Study|Protocol Violation|1
7410435|NCT01394185|11680604|FG001|Overall Study|Protocol Violation|0
7410436|NCT01394185|11680605|FG002|Overall Study|Protocol Violation|0
7410437|NCT01394185|11680606|FG003|Overall Study|Protocol Violation|1
7410438|NCT01394185|11680607|FG004|Overall Study|Protocol Violation|0
7410439|NCT01394185|11680608|FG005|Overall Study|Protocol Violation|1
7410440|NCT01394250|11680618|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
7410441|NCT01394250|11680619|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
7410442|NCT01394250|11680618|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
7410443|NCT01394250|11680619|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
7410444|NCT01394276|11680625|FG000|Overall Study|Related Adverse event (AEs)|15
7410445|NCT01394276|11680625|FG000|Overall Study|Not related AEs|9
7410446|NCT01394276|11680625|FG000|Overall Study|Remission of disease|2
7410447|NCT01394276|11680625|FG000|Overall Study|Insufficient therapeutic effect|17
7410448|NCT01394276|11680625|FG000|Overall Study|Insufficient compliance|9
7410449|NCT01394276|11680625|FG000|Overall Study|Lost to Follow-up|5
7410450|NCT01394276|11680625|FG000|Overall Study|Participant moved to another site|1
7410451|NCT01394276|11680625|FG000|Overall Study|Pregnancy|1
7410452|NCT01394276|11680625|FG000|Overall Study|unavailability of drug at the Hospital|2
7410453|NCT01394276|11680625|FG000|Overall Study|Symptoms of concurrent diseases|1
7410454|NCT01394523|11680641|FG000|Overall Study|Unable to place block|1
7410455|NCT01394523|11680642|FG001|Overall Study|Unable to place block|0
7410456|NCT01394523|11680643|FG002|Overall Study|Unable to place block|0
7410457|NCT01394627|11680660|FG000|First Intervention (1 Day)|poor intravenous access|0
7410458|NCT01394627|11680661|FG001|First Intervention (1 Day)|poor intravenous access|1
7410459|NCT01394627|11680660|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
7410460|NCT01394627|11680661|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
7410461|NCT01394718|11680688|FG000|Overall Study|Met protocol-specific stopping criteria|2
7410462|NCT01394718|11680689|FG001|Overall Study|Met protocol-specific stopping criteria|1
7410463|NCT01394939|11680699|FG000|Overall Study|Adverse Event|1
7410464|NCT01394939|11680700|FG001|Overall Study|Adverse Event|3
7410465|NCT01394939|11680701|FG002|Overall Study|Adverse Event|0
7410466|NCT01394939|11680702|FG003|Overall Study|Adverse Event|2
7410467|NCT01394939|11680699|FG000|Overall Study|Death|0
7410468|NCT01394939|11680700|FG001|Overall Study|Death|2
7410469|NCT01394939|11680701|FG002|Overall Study|Death|0
7410470|NCT01394939|11680702|FG003|Overall Study|Death|0
7410471|NCT01394939|11680699|FG000|Overall Study|Physician Decision|0
7410472|NCT01394939|11680700|FG001|Overall Study|Physician Decision|1
7410473|NCT01394939|11680701|FG002|Overall Study|Physician Decision|0
7410474|NCT01394939|11680702|FG003|Overall Study|Physician Decision|0
7410475|NCT01394939|11680699|FG000|Overall Study|Withdrawal by Subject|0
7410476|NCT01394939|11680700|FG001|Overall Study|Withdrawal by Subject|2
7410477|NCT01394939|11680701|FG002|Overall Study|Withdrawal by Subject|0
7410478|NCT01394939|11680702|FG003|Overall Study|Withdrawal by Subject|2
7410479|NCT01394939|11680699|FG000|Overall Study|Others|0
7410480|NCT01394939|11680700|FG001|Overall Study|Others|2
7410481|NCT01394939|11680701|FG002|Overall Study|Others|0
7410482|NCT01394939|11680702|FG003|Overall Study|Others|3
7410483|NCT01394952|11680714|FG000|Overall Study|Lost to Follow-up|0
7410484|NCT01394952|11680715|FG001|Overall Study|Lost to Follow-up|5
7410485|NCT01394952|11680714|FG000|Overall Study|Withdrawal by Subject|10
7410486|NCT01394952|11680715|FG001|Overall Study|Withdrawal by Subject|5
7410487|NCT01394952|11680714|FG000|Overall Study|Physician Decision|2
7410488|NCT01394952|11680715|FG001|Overall Study|Physician Decision|0
7410489|NCT01394952|11680714|FG000|Overall Study|Sponsor Decision|5
7410490|NCT01394952|11680715|FG001|Overall Study|Sponsor Decision|7
7410491|NCT01394978|11680724|FG000|Overall Study|Withdrawal by Subject|2
7410492|NCT01394978|11680725|FG001|Overall Study|Withdrawal by Subject|4
7410493|NCT01394978|11680724|FG000|Overall Study|Lost to Follow-up|13
7410494|NCT01394978|11680725|FG001|Overall Study|Lost to Follow-up|20
7410495|NCT01394978|11680724|FG000|Overall Study|Death|6
7410496|NCT01394978|11680725|FG001|Overall Study|Death|7
7410497|NCT01394991|11680734|FG000|Overall Study|Adverse Event|0
7410498|NCT01394991|11680735|FG001|Overall Study|Adverse Event|4
7410499|NCT01394991|11680734|FG000|Overall Study|Lack of Efficacy|5
7410500|NCT01394991|11680735|FG001|Overall Study|Lack of Efficacy|7
7410501|NCT01394991|11680734|FG000|Overall Study|Lost to Follow-up|6
7410502|NCT01394991|11680735|FG001|Overall Study|Lost to Follow-up|8
7410503|NCT01394991|11680734|FG000|Overall Study|Physician Decision|1
7410504|NCT01394991|11680735|FG001|Overall Study|Physician Decision|3
7410505|NCT01394991|11680734|FG000|Overall Study|Protocol Violation|1
7410506|NCT01394991|11680735|FG001|Overall Study|Protocol Violation|1
7410507|NCT01394991|11680734|FG000|Overall Study|Withdrawal by Subject|20
7410508|NCT01394991|11680735|FG001|Overall Study|Withdrawal by Subject|17
7410509|NCT01394991|11680734|FG000|Overall Study|Chemotherapy Termination|10
7410510|NCT01394991|11680735|FG001|Overall Study|Chemotherapy Termination|15
7410511|NCT01394991|11680734|FG000|Overall Study|Disease Progression|7
7410512|NCT01394991|11680735|FG001|Overall Study|Disease Progression|7
7410513|NCT01394991|11680734|FG000|Overall Study|Prematurely Termination of Trial|9
7410514|NCT01394991|11680735|FG001|Overall Study|Prematurely Termination of Trial|10
7410515|NCT01395017|11680743|FG000|Overall Study|Lost to Follow-up|1
7410516|NCT01395017|11680744|FG001|Overall Study|Lost to Follow-up|0
7410517|NCT01395017|11680743|FG000|Overall Study|Adverse Event|26
7410518|NCT01395017|11680744|FG001|Overall Study|Adverse Event|12
7410519|NCT01395017|11680743|FG000|Overall Study|Physician Decision|11
7410520|NCT01395017|11680744|FG001|Overall Study|Physician Decision|15
7410521|NCT01395017|11680743|FG000|Overall Study|Withdrawal by Subject|14
7410522|NCT01395017|11680744|FG001|Overall Study|Withdrawal by Subject|8
7410523|NCT01395017|11680743|FG000|Overall Study|Protocol deviation|1
7410524|NCT01395017|11680744|FG001|Overall Study|Protocol deviation|2
7410525|NCT01395017|11680743|FG000|Overall Study|Death|4
7410526|NCT01395017|11680744|FG001|Overall Study|Death|3
7410527|NCT01395017|11680743|FG000|Overall Study|Disease progression|42
7410528|NCT01395017|11680744|FG001|Overall Study|Disease progression|58
7410529|NCT01395017|11680743|FG000|Overall Study|Sponsor discontinued study|1
7410530|NCT01395017|11680744|FG001|Overall Study|Sponsor discontinued study|4
7410531|NCT01395030|11680751|FG000|Overall Study|Did not complete FCH PET/CT|7
7410532|NCT01395316|11680773|FG000|Overall Study|Lost to Follow-up|2
7410533|NCT01395316|11680773|FG000|Overall Study|poor MRI quality|1
7410534|NCT01395368|11680793|FG000|Overall Study|Physician Decision|14
7410535|NCT01395368|11680793|FG000|Overall Study|Withdrawal by Subject|2
7410536|NCT01395394|11680800|FG000|Baseline Study Visit|Protocol Violation|1
7410537|NCT01395394|11680801|FG001|Baseline Study Visit|Protocol Violation|0
7410538|NCT01395394|11680802|FG002|Baseline Study Visit|Protocol Violation|0
7410539|NCT01395524|11680813|FG000|Overall Study|Non-compliance with study schedule|1
7410540|NCT01395524|11680814|FG001|Overall Study|Non-compliance with study schedule|0
7410541|NCT01395524|11680815|FG002|Overall Study|Non-compliance with study schedule|1
7410542|NCT01395524|11680813|FG000|Overall Study|Lost to Follow-up|3
7410543|NCT01395524|11680814|FG001|Overall Study|Lost to Follow-up|1
7410544|NCT01395524|11680815|FG002|Overall Study|Lost to Follow-up|1
7410545|NCT01395524|11680813|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
7410546|NCT01395524|11680814|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
7410547|NCT01395524|11680815|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
7410548|NCT01395524|11680813|FG000|Overall Study|Severe noncompliance with protocol|1
7410549|NCT01395524|11680814|FG001|Overall Study|Severe noncompliance with protocol|0
7410550|NCT01395524|11680815|FG002|Overall Study|Severe noncompliance with protocol|0
7410551|NCT01395524|11680813|FG000|Overall Study|Adverse Event|4
7410552|NCT01395524|11680814|FG001|Overall Study|Adverse Event|4
7410553|NCT01395524|11680815|FG002|Overall Study|Adverse Event|3
7410554|NCT01395524|11680813|FG000|Overall Study|Death|1
7410555|NCT01395524|11680814|FG001|Overall Study|Death|0
7410556|NCT01395524|11680815|FG002|Overall Study|Death|0
7410557|NCT01395524|11680813|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7410558|NCT01395524|11680814|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
7410559|NCT01395524|11680815|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
7410560|NCT01395524|11680813|FG000|Overall Study|Withdrawal by Subject|4
7410561|NCT01395524|11680814|FG001|Overall Study|Withdrawal by Subject|8
7410562|NCT01395524|11680815|FG002|Overall Study|Withdrawal by Subject|8
7410563|NCT01395524|11680813|FG000|Overall Study|Did not receive treatment|1
7410564|NCT01395524|11680814|FG001|Overall Study|Did not receive treatment|1
7410565|NCT01395524|11680815|FG002|Overall Study|Did not receive treatment|3
7410566|NCT01395524|11680813|FG000|Overall Study|Subject had spinal surgery|0
7410567|NCT01395524|11680814|FG001|Overall Study|Subject had spinal surgery|0
7410568|NCT01395524|11680815|FG002|Overall Study|Subject had spinal surgery|1
7410569|NCT01395758|11680829|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7410570|NCT01395758|11680830|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7410571|NCT01395758|11680831|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7410572|NCT01395784|11680838|FG000|Overall Study|Lost to Follow-up|7
7410573|NCT01395784|11680838|FG000|Overall Study|Withdrawal by Subject|3
7410574|NCT01395784|11680838|FG000|Overall Study|Physician Decision|5
7410575|NCT01395810|11680877|FG000|Overall Study|Adverse Event|0
7410576|NCT01395810|11680878|FG001|Overall Study|Adverse Event|1
7410577|NCT01395810|11680879|FG002|Overall Study|Adverse Event|0
7410578|NCT01395810|11680880|FG003|Overall Study|Adverse Event|0
7410579|NCT01395810|11680877|FG000|Overall Study|Lack of Efficacy|0
7410580|NCT01395810|11680878|FG001|Overall Study|Lack of Efficacy|1
7410581|NCT01395810|11680879|FG002|Overall Study|Lack of Efficacy|0
7410582|NCT01395810|11680880|FG003|Overall Study|Lack of Efficacy|0
7410583|NCT01395810|11680877|FG000|Overall Study|Withdrawal criteria|0
7410584|NCT01395810|11680878|FG001|Overall Study|Withdrawal criteria|2
7410585|NCT01395810|11680879|FG002|Overall Study|Withdrawal criteria|0
7410586|NCT01395810|11680880|FG003|Overall Study|Withdrawal criteria|0
7410587|NCT01395810|11680877|FG000|Overall Study|Unclassified|2
7410588|NCT01395810|11680878|FG001|Overall Study|Unclassified|0
7410589|NCT01395810|11680879|FG002|Overall Study|Unclassified|0
7410590|NCT01395810|11680880|FG003|Overall Study|Unclassified|0
7410591|NCT01395823|11680893|FG000|Overall Study|Death|4
7410592|NCT01395823|11680894|FG001|Overall Study|Death|4
7410593|NCT01395823|11680893|FG000|Overall Study|Physician Decision|3
7410594|NCT01395823|11680894|FG001|Overall Study|Physician Decision|1
7410595|NCT01395823|11680893|FG000|Overall Study|Lost to Follow-up|1
7410596|NCT01395823|11680894|FG001|Overall Study|Lost to Follow-up|0
7410597|NCT01395823|11680893|FG000|Overall Study|Transplant|1
7410598|NCT01395823|11680894|FG001|Overall Study|Transplant|0
7410599|NCT01395823|11680893|FG000|Overall Study|GI symptoms|1
7410600|NCT01395823|11680894|FG001|Overall Study|GI symptoms|0
7410601|NCT01395823|11680893|FG000|Overall Study|Withdrawal by Subject|5
7410602|NCT01395823|11680894|FG001|Overall Study|Withdrawal by Subject|4
7466099|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466100|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466101|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466102|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466103|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
7466104|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466105|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466106|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466107|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
7466108|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466109|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466110|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466111|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466112|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
7466113|NCT01888874|11765828|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7466114|NCT01888874|11765829|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7466115|NCT01888874|11765830|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7466116|NCT01888874|11765831|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7466117|NCT01888874|11765832|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7466118|NCT01888874|11765833|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
7466119|NCT01888874|11765834|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
7466120|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7466121|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7466122|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7466123|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466124|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
7466125|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466126|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466127|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7466128|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7466129|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7466130|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7471204|NCT01939548|11773899|FG000|Overall Study|Insufficient Clinical Response|1
7466131|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
7466132|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7466133|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
7466134|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7466135|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7466136|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
7466137|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7466138|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7466139|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
7466140|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
7466141|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466142|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466143|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
7466144|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466145|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466146|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466147|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
7466148|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
7410603|NCT01395888|11680902|FG000|2-week Run-in Period|Adverse Event|2
7410604|NCT01395888|11680903|FG001|2-week Run-in Period|Adverse Event|0
7410605|NCT01395888|11680904|FG002|2-week Run-in Period|Adverse Event|0
7410606|NCT01395888|11680902|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
7410607|NCT01395888|11680903|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7410608|NCT01395888|11680904|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7410609|NCT01395888|11680902|FG000|2-week Run-in Period|Lost to Follow-up|1
7410610|NCT01395888|11680903|FG001|2-week Run-in Period|Lost to Follow-up|0
7410611|NCT01395888|11680904|FG002|2-week Run-in Period|Lost to Follow-up|0
7410612|NCT01395888|11680902|FG000|2-week Run-in Period|Protocol Violation|2
7410613|NCT01395888|11680903|FG001|2-week Run-in Period|Protocol Violation|0
7410614|NCT01395888|11680904|FG002|2-week Run-in Period|Protocol Violation|0
7410615|NCT01395888|11680902|FG000|2-week Run-in Period|Withdrawal by Subject|4
7410616|NCT01395888|11680903|FG001|2-week Run-in Period|Withdrawal by Subject|0
7410617|NCT01395888|11680904|FG002|2-week Run-in Period|Withdrawal by Subject|0
7410618|NCT01395888|11680902|FG000|Treatment Period (TP)|Adverse Event|0
7410619|NCT01395888|11680903|FG001|Treatment Period (TP)|Adverse Event|7
7410620|NCT01395888|11680904|FG002|Treatment Period (TP)|Adverse Event|6
7410621|NCT01395888|11680902|FG000|Treatment Period (TP)|Lack of Efficacy|0
7410622|NCT01395888|11680903|FG001|Treatment Period (TP)|Lack of Efficacy|4
7410623|NCT01395888|11680904|FG002|Treatment Period (TP)|Lack of Efficacy|3
7410624|NCT01395888|11680902|FG000|Treatment Period (TP)|Protocol Violation|0
7410625|NCT01395888|11680903|FG001|Treatment Period (TP)|Protocol Violation|1
7410626|NCT01395888|11680904|FG002|Treatment Period (TP)|Protocol Violation|5
7410627|NCT01395888|11680902|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7410628|NCT01395888|11680903|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
7410629|NCT01395888|11680904|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
7410630|NCT01395888|11680902|FG000|Treatment Period (TP)|Withdrawal by Subject|0
7410631|NCT01395888|11680903|FG001|Treatment Period (TP)|Withdrawal by Subject|2
7410632|NCT01395888|11680904|FG002|Treatment Period (TP)|Withdrawal by Subject|3
7410633|NCT01395901|11680912|FG000|Overall Study|Lost to Follow-up|4
7410634|NCT01395901|11680913|FG001|Overall Study|Lost to Follow-up|0
7410635|NCT01395901|11680912|FG000|Overall Study|Randomized but not received study drug|5
7410636|NCT01395901|11680913|FG001|Overall Study|Randomized but not received study drug|4
7410637|NCT01395901|11680912|FG000|Overall Study|Adverse Event|0
7410638|NCT01395901|11680913|FG001|Overall Study|Adverse Event|1
7410639|NCT01395901|11680912|FG000|Overall Study|Withdrawal of consent|1
7410640|NCT01395901|11680913|FG001|Overall Study|Withdrawal of consent|0
7410641|NCT01395914|11680921|FG000|Overall Study|Unrelated to study drug AE|6
7410642|NCT01395914|11680922|FG001|Overall Study|Unrelated to study drug AE|1
7410643|NCT01395914|11680921|FG000|Overall Study|Death|23
7410644|NCT01395914|11680922|FG001|Overall Study|Death|17
7410645|NCT01395914|11680921|FG000|Overall Study|Other|9
7410646|NCT01395914|11680922|FG001|Overall Study|Other|3
7410647|NCT01395914|11680921|FG000|Overall Study|Withdrawal by patient|27
7410648|NCT01395914|11680922|FG001|Overall Study|Withdrawal by patient|14
7410649|NCT01395914|11680921|FG000|Overall Study|Study drug-related AE|1
7410650|NCT01395914|11680922|FG001|Overall Study|Study drug-related AE|0
7410651|NCT01395914|11680921|FG000|Overall Study|Lost to Follow-up|6
7410652|NCT01395914|11680922|FG001|Overall Study|Lost to Follow-up|2
7410653|NCT01396005|11680943|FG000|Overall Study|Withdrawal by Subject|0
7410654|NCT01396005|11680944|FG001|Overall Study|Withdrawal by Subject|1
7410655|NCT01396005|11680943|FG000|Overall Study|Non-compliance with protocol|0
7410656|NCT01396005|11680944|FG001|Overall Study|Non-compliance with protocol|1
7410657|NCT01396057|11680963|FG000|Overall Study|Adverse Event|2
7410658|NCT01396057|11680964|FG001|Overall Study|Adverse Event|6
7410659|NCT01396057|11680963|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7410660|NCT01396057|11680964|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7410661|NCT01396057|11680963|FG000|Overall Study|Protocol deviation|4
7410662|NCT01396057|11680964|FG001|Overall Study|Protocol deviation|4
7410663|NCT01396057|11680963|FG000|Overall Study|Consent withdrawn|3
7410664|NCT01396057|11680964|FG001|Overall Study|Consent withdrawn|2
7410665|NCT01396070|11680970|FG000|Overall Study|Withdrawal by Subject|2
7410666|NCT01396070|11680970|FG000|Overall Study|Death|2
7410667|NCT01396070|11680970|FG000|Overall Study|Adverse Event|8
7410668|NCT01396070|11680970|FG000|Overall Study|Physician Decision|3
7410669|NCT01396070|11680970|FG000|Overall Study|Lack of Efficacy|4
7410670|NCT01396083|11680977|FG000|Overall Study|Adverse Event|2
7410671|NCT01396083|11680978|FG001|Overall Study|Adverse Event|28
7410672|NCT01396083|11680977|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7410673|NCT01396083|11680978|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7410674|NCT01396083|11680977|FG000|Overall Study|Consent withdrawn|4
7410675|NCT01396083|11680978|FG001|Overall Study|Consent withdrawn|5
7410676|NCT01396083|11680977|FG000|Overall Study|Protocol deviation(s)|0
7410677|NCT01396083|11680978|FG001|Overall Study|Protocol deviation(s)|1
7410678|NCT01396083|11680977|FG000|Overall Study|Abnormal laboratory value(s)|1
7410679|NCT01396083|11680978|FG001|Overall Study|Abnormal laboratory value(s)|0
7410680|NCT01396083|11680977|FG000|Overall Study|Administrative problems|1
7410681|NCT01396083|11680978|FG001|Overall Study|Administrative problems|0
7410682|NCT01396083|11680977|FG000|Overall Study|Lost to Follow-up|1
7410683|NCT01396083|11680978|FG001|Overall Study|Lost to Follow-up|0
7410684|NCT01396148|11680984|FG000|Overall Study|Patient Decision|1
7410685|NCT01396161|11680997|FG000|Overall Study|Withdrawal by Subject|0
7410686|NCT01396161|11680998|FG001|Overall Study|Withdrawal by Subject|0
7410687|NCT01396161|11680999|FG002|Overall Study|Withdrawal by Subject|0
7410688|NCT01396161|11681000|FG003|Overall Study|Withdrawal by Subject|0
7410689|NCT01396161|11681001|FG004|Overall Study|Withdrawal by Subject|1
7410690|NCT01396161|11681002|FG005|Overall Study|Withdrawal by Subject|0
7410691|NCT01396161|11681003|FG006|Overall Study|Withdrawal by Subject|0
7410692|NCT01396161|11680997|FG000|Overall Study|Other|0
7410693|NCT01396161|11680998|FG001|Overall Study|Other|0
7410694|NCT01396161|11680999|FG002|Overall Study|Other|0
7410695|NCT01396161|11681000|FG003|Overall Study|Other|0
7410696|NCT01396161|11681001|FG004|Overall Study|Other|0
7410697|NCT01396161|11681002|FG005|Overall Study|Other|0
7410698|NCT01396161|11681003|FG006|Overall Study|Other|1
7410699|NCT01396187|11681029|FG000|Overall Study|Adverse Event|0
7410700|NCT01396187|11681030|FG001|Overall Study|Adverse Event|1
7410701|NCT01396187|11681031|FG002|Overall Study|Adverse Event|0
7410702|NCT01396187|11681032|FG003|Overall Study|Adverse Event|0
7410703|NCT01396187|11681033|FG004|Overall Study|Adverse Event|0
7410704|NCT01396187|11681029|FG000|Overall Study|Withdrawal by Subject|0
7410705|NCT01396187|11681030|FG001|Overall Study|Withdrawal by Subject|1
7410706|NCT01396187|11681031|FG002|Overall Study|Withdrawal by Subject|1
7410707|NCT01396187|11681032|FG003|Overall Study|Withdrawal by Subject|0
7410708|NCT01396187|11681033|FG004|Overall Study|Withdrawal by Subject|0
7410709|NCT01396187|11681029|FG000|Overall Study|Other|1
7410710|NCT01396187|11681030|FG001|Overall Study|Other|1
7410711|NCT01396187|11681031|FG002|Overall Study|Other|0
7410712|NCT01396187|11681032|FG003|Overall Study|Other|0
7410713|NCT01396187|11681033|FG004|Overall Study|Other|1
7410714|NCT01396265|11681081|FG000|Rifa+Afatinib|Withdrawal by Subject|1
7410715|NCT01396317|11681089|FG000|Overall Study|Adverse Event|1
7410716|NCT01396317|11681090|FG001|Overall Study|Adverse Event|0
7410717|NCT01396395|11681105|FG000|Overall Study|Withdrawal by Subject|10
7410718|NCT01396395|11681106|FG001|Overall Study|Withdrawal by Subject|12
7410719|NCT01396395|11681105|FG000|Overall Study|Protocol Violation|3
7410720|NCT01396395|11681106|FG001|Overall Study|Protocol Violation|1
7410721|NCT01396395|11681105|FG000|Overall Study|Adverse Event|10
7410722|NCT01396395|11681106|FG001|Overall Study|Adverse Event|2
7410723|NCT01396395|11681105|FG000|Overall Study|Lost to Follow-up|17
7410724|NCT01396395|11681106|FG001|Overall Study|Lost to Follow-up|11
7410725|NCT01396395|11681105|FG000|Overall Study|Other|0
7410726|NCT01396395|11681106|FG001|Overall Study|Other|1
7410727|NCT01396421|11681118|FG000|Overall Study|Lost to Follow-up|0
7410728|NCT01396421|11681119|FG001|Overall Study|Lost to Follow-up|0
7410729|NCT01396421|11681120|FG002|Overall Study|Lost to Follow-up|0
7410730|NCT01396421|11681121|FG003|Overall Study|Lost to Follow-up|1
7410731|NCT01396421|11681118|FG000|Overall Study|Adverse Event|17
7410732|NCT01396421|11681119|FG001|Overall Study|Adverse Event|15
7410733|NCT01396421|11681120|FG002|Overall Study|Adverse Event|12
7410734|NCT01396421|11681121|FG003|Overall Study|Adverse Event|32
7410735|NCT01396421|11681118|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7410736|NCT01396421|11681119|FG001|Overall Study|Participant Met Withdrawal Criteria|0
7410737|NCT01396421|11681120|FG002|Overall Study|Participant Met Withdrawal Criteria|1
7410738|NCT01396421|11681121|FG003|Overall Study|Participant Met Withdrawal Criteria|0
7410739|NCT01396421|11681118|FG000|Overall Study|Physician Decision|1
7410740|NCT01396421|11681119|FG001|Overall Study|Physician Decision|1
7410741|NCT01396421|11681120|FG002|Overall Study|Physician Decision|0
7410742|NCT01396421|11681121|FG003|Overall Study|Physician Decision|3
7410743|NCT01396421|11681118|FG000|Overall Study|Withdrawal by Subject|31
7410744|NCT01396421|11681119|FG001|Overall Study|Withdrawal by Subject|24
7410745|NCT01396421|11681120|FG002|Overall Study|Withdrawal by Subject|13
7410746|NCT01396421|11681121|FG003|Overall Study|Withdrawal by Subject|21
7410747|NCT01396421|11681118|FG000|Overall Study|Protocol Deviation|2
7410748|NCT01396421|11681119|FG001|Overall Study|Protocol Deviation|1
7410749|NCT01396421|11681120|FG002|Overall Study|Protocol Deviation|1
7410750|NCT01396421|11681121|FG003|Overall Study|Protocol Deviation|0
7410751|NCT01396421|11681118|FG000|Overall Study|Lack of Efficacy|7
7410752|NCT01396421|11681119|FG001|Overall Study|Lack of Efficacy|17
7410753|NCT01396421|11681120|FG002|Overall Study|Lack of Efficacy|7
7410754|NCT01396421|11681121|FG003|Overall Study|Lack of Efficacy|18
7410755|NCT01396434|11681148|FG000|Overall Study|Lost to Follow-up|1
7410756|NCT01396434|11681149|FG001|Overall Study|Lost to Follow-up|0
7410757|NCT01396434|11681150|FG002|Overall Study|Lost to Follow-up|0
7410758|NCT01396434|11681148|FG000|Overall Study|Other|10
7410759|NCT01396434|11681149|FG001|Overall Study|Other|0
7410760|NCT01396434|11681150|FG002|Overall Study|Other|0
7410761|NCT01396447|11681162|FG000|Overall Study|Did Not Receive Treatment|3
7410762|NCT01396447|11681163|FG001|Overall Study|Did Not Receive Treatment|2
7410763|NCT01396447|11681164|FG002|Overall Study|Did Not Receive Treatment|1
7410764|NCT01396447|11681165|FG003|Overall Study|Did Not Receive Treatment|0
7410765|NCT01396447|11681162|FG000|Overall Study|Adverse Event|15
7410766|NCT01396447|11681163|FG001|Overall Study|Adverse Event|12
7410767|NCT01396447|11681164|FG002|Overall Study|Adverse Event|12
7410768|NCT01396447|11681165|FG003|Overall Study|Adverse Event|17
7410769|NCT01396447|11681162|FG000|Overall Study|Insufficient Therapeutic Response|5
7410770|NCT01396447|11681163|FG001|Overall Study|Insufficient Therapeutic Response|5
7410771|NCT01396447|11681164|FG002|Overall Study|Insufficient Therapeutic Response|2
7410772|NCT01396447|11681165|FG003|Overall Study|Insufficient Therapeutic Response|4
7410773|NCT01396447|11681162|FG000|Overall Study|Protocol Violation|5
7410774|NCT01396447|11681163|FG001|Overall Study|Protocol Violation|2
7410775|NCT01396447|11681164|FG002|Overall Study|Protocol Violation|3
7410776|NCT01396447|11681165|FG003|Overall Study|Protocol Violation|7
7410777|NCT01396447|11681162|FG000|Overall Study|Withdrawal of Consent|11
7410778|NCT01396447|11681163|FG001|Overall Study|Withdrawal of Consent|9
7410779|NCT01396447|11681164|FG002|Overall Study|Withdrawal of Consent|4
7410780|NCT01396447|11681165|FG003|Overall Study|Withdrawal of Consent|15
7410781|NCT01396447|11681162|FG000|Overall Study|Lost to Follow-up|4
7410782|NCT01396447|11681163|FG001|Overall Study|Lost to Follow-up|8
7410783|NCT01396447|11681164|FG002|Overall Study|Lost to Follow-up|7
7410784|NCT01396447|11681165|FG003|Overall Study|Lost to Follow-up|9
7410785|NCT01396447|11681162|FG000|Overall Study|Other Miscellaneous Reasons|0
7410786|NCT01396447|11681163|FG001|Overall Study|Other Miscellaneous Reasons|2
7410787|NCT01396447|11681164|FG002|Overall Study|Other Miscellaneous Reasons|1
7410788|NCT01396447|11681165|FG003|Overall Study|Other Miscellaneous Reasons|0
7410789|NCT01396512|11681190|FG000|Overall Study|Withdrawal by Subject|0
7410790|NCT01396512|11681191|FG001|Overall Study|Withdrawal by Subject|1
7410791|NCT01396525|11681197|FG000|Overall Study|Withdrawal by Subject|8
7410792|NCT01396525|11681197|FG000|Overall Study|Death|14
7410793|NCT01396525|11681197|FG000|Overall Study|Lost to Follow-up|4
7410794|NCT01397084|11681221|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7410795|NCT01397084|11681221|FG000|Overall Study|Protocol Violation|2
7410796|NCT01397084|11681221|FG000|Overall Study|Adverse Event|2
7410797|NCT01397084|11681221|FG000|Overall Study|Withdrawal by Subject|1
7410798|NCT01397084|11681221|FG000|Overall Study|Lost to Follow-up|1
7410799|NCT01397084|11681221|FG000|Overall Study|Used other proton pump inhibitor|1
7410800|NCT01397253|11681227|FG000|Overall Study|Reviewed by only 1 pharmacist|126
7410801|NCT01397253|11681228|FG001|Overall Study|Reviewed by only 1 pharmacist|149
7410802|NCT01397409|11681244|FG000|Stage 2|Adverse Event|0
7410803|NCT01397409|11681245|FG001|Stage 2|Adverse Event|0
7410804|NCT01397409|11681246|FG002|Stage 2|Adverse Event|0
7410805|NCT01397409|11681247|FG003|Stage 2|Adverse Event|0
7410806|NCT01397409|11681248|FG004|Stage 2|Adverse Event|6
7410807|NCT01397409|11681249|FG005|Stage 2|Adverse Event|3
7410808|NCT01397409|11681250|FG006|Stage 2|Adverse Event|0
7410809|NCT01397409|11681251|FG007|Stage 2|Adverse Event|0
7410810|NCT01397409|11681252|FG008|Stage 2|Adverse Event|0
7410811|NCT01397409|11681253|FG009|Stage 2|Adverse Event|0
7410812|NCT01397409|11681244|FG000|Stage 2|Personal Reasons|0
7410813|NCT01397409|11681245|FG001|Stage 2|Personal Reasons|0
7410814|NCT01397409|11681246|FG002|Stage 2|Personal Reasons|0
7410815|NCT01397409|11681247|FG003|Stage 2|Personal Reasons|0
7410816|NCT01397409|11681248|FG004|Stage 2|Personal Reasons|1
7410817|NCT01397409|11681249|FG005|Stage 2|Personal Reasons|0
7410818|NCT01397409|11681250|FG006|Stage 2|Personal Reasons|0
7410819|NCT01397409|11681251|FG007|Stage 2|Personal Reasons|0
7410820|NCT01397409|11681252|FG008|Stage 2|Personal Reasons|0
7410821|NCT01397409|11681253|FG009|Stage 2|Personal Reasons|0
7410822|NCT01397409|11681244|FG000|Stage 2|Other Miscellaneous Reasons|0
7410823|NCT01397409|11681245|FG001|Stage 2|Other Miscellaneous Reasons|0
7410824|NCT01397409|11681246|FG002|Stage 2|Other Miscellaneous Reasons|0
7410825|NCT01397409|11681247|FG003|Stage 2|Other Miscellaneous Reasons|0
7410826|NCT01397409|11681248|FG004|Stage 2|Other Miscellaneous Reasons|1
7410827|NCT01397409|11681249|FG005|Stage 2|Other Miscellaneous Reasons|1
7410828|NCT01397409|11681250|FG006|Stage 2|Other Miscellaneous Reasons|0
7410829|NCT01397409|11681251|FG007|Stage 2|Other Miscellaneous Reasons|0
7410830|NCT01397409|11681252|FG008|Stage 2|Other Miscellaneous Reasons|0
7410831|NCT01397409|11681253|FG009|Stage 2|Other Miscellaneous Reasons|0
7410832|NCT01397409|11681244|FG000|Stage 3|Adverse Event|0
7410833|NCT01397409|11681245|FG001|Stage 3|Adverse Event|0
7410834|NCT01397409|11681246|FG002|Stage 3|Adverse Event|0
7410835|NCT01397409|11681247|FG003|Stage 3|Adverse Event|0
7410836|NCT01397409|11681248|FG004|Stage 3|Adverse Event|0
7410837|NCT01397409|11681249|FG005|Stage 3|Adverse Event|0
7410838|NCT01397409|11681250|FG006|Stage 3|Adverse Event|0
7410839|NCT01397409|11681251|FG007|Stage 3|Adverse Event|1
7410840|NCT01397409|11681252|FG008|Stage 3|Adverse Event|0
7410841|NCT01397409|11681253|FG009|Stage 3|Adverse Event|0
7410842|NCT01397409|11681244|FG000|Stage 3|Other Miscellaneous Reasons|0
7410843|NCT01397409|11681245|FG001|Stage 3|Other Miscellaneous Reasons|0
7410844|NCT01397409|11681246|FG002|Stage 3|Other Miscellaneous Reasons|0
7410845|NCT01397409|11681247|FG003|Stage 3|Other Miscellaneous Reasons|0
7410846|NCT01397409|11681248|FG004|Stage 3|Other Miscellaneous Reasons|0
7410847|NCT01397409|11681249|FG005|Stage 3|Other Miscellaneous Reasons|0
7410848|NCT01397409|11681250|FG006|Stage 3|Other Miscellaneous Reasons|0
7410849|NCT01397409|11681251|FG007|Stage 3|Other Miscellaneous Reasons|1
7410850|NCT01397409|11681252|FG008|Stage 3|Other Miscellaneous Reasons|0
7410851|NCT01397409|11681253|FG009|Stage 3|Other Miscellaneous Reasons|0
7410852|NCT01397422|11681280|FG000|Overall Study|Adverse Event|0
7410853|NCT01397422|11681281|FG001|Overall Study|Adverse Event|3
7410854|NCT01397422|11681282|FG002|Overall Study|Adverse Event|3
7410855|NCT01397422|11681283|FG003|Overall Study|Adverse Event|8
7410856|NCT01397422|11681280|FG000|Overall Study|Withdrawal by Subject|1
7410857|NCT01397422|11681281|FG001|Overall Study|Withdrawal by Subject|0
7410858|NCT01397422|11681282|FG002|Overall Study|Withdrawal by Subject|0
7410859|NCT01397422|11681283|FG003|Overall Study|Withdrawal by Subject|0
7410860|NCT01397422|11681280|FG000|Overall Study|Increased bradykinesia related to PD|1
7410861|NCT01397422|11681281|FG001|Overall Study|Increased bradykinesia related to PD|0
7410862|NCT01397422|11681282|FG002|Overall Study|Increased bradykinesia related to PD|0
7410863|NCT01397422|11681283|FG003|Overall Study|Increased bradykinesia related to PD|0
7410864|NCT01397448|11681298|FG000|Overall Study|Adverse Event|4
7410865|NCT01397448|11681299|FG001|Overall Study|Adverse Event|4
7410866|NCT01397448|11681300|FG002|Overall Study|Adverse Event|6
7410867|NCT01397448|11681298|FG000|Overall Study|Withdrawal by Subject|4
7410868|NCT01397448|11681299|FG001|Overall Study|Withdrawal by Subject|4
7410869|NCT01397448|11681300|FG002|Overall Study|Withdrawal by Subject|3
7410870|NCT01397448|11681298|FG000|Overall Study|Lack of Efficacy|2
7410871|NCT01397448|11681299|FG001|Overall Study|Lack of Efficacy|0
7410872|NCT01397448|11681300|FG002|Overall Study|Lack of Efficacy|5
7410873|NCT01397448|11681298|FG000|Overall Study|Other|8
7410874|NCT01397448|11681299|FG001|Overall Study|Other|7
7553104|NCT03006393|11913853|FG000|Overall Study|Pregnancy|0
7410875|NCT01397448|11681300|FG002|Overall Study|Other|4
7410876|NCT01397461|11681311|FG000|Overall Study|Withdrawal by Subject|2
7410877|NCT01397461|11681312|FG001|Overall Study|Withdrawal by Subject|1
7410878|NCT01397461|11681313|FG002|Overall Study|Withdrawal by Subject|0
7410879|NCT01397461|11681311|FG000|Overall Study|Lost to Follow-up|0
7410880|NCT01397461|11681312|FG001|Overall Study|Lost to Follow-up|2
7410881|NCT01397461|11681313|FG002|Overall Study|Lost to Follow-up|1
7410882|NCT01397461|11681311|FG000|Overall Study|Lack of Efficacy|0
7410883|NCT01397461|11681312|FG001|Overall Study|Lack of Efficacy|3
7410884|NCT01397461|11681313|FG002|Overall Study|Lack of Efficacy|0
7410885|NCT01397461|11681311|FG000|Overall Study|Not treated|0
7410886|NCT01397461|11681312|FG001|Overall Study|Not treated|0
7410887|NCT01397461|11681313|FG002|Overall Study|Not treated|1
7410888|NCT01397747|11681353|FG000|Overall Study|Multitarget DNA test excluded|689
7410889|NCT01397747|11681353|FG000|Overall Study|Colonoscopy excluded|304
7410890|NCT01397747|11681353|FG000|Overall Study|FIT excluded|34
7410891|NCT01397786|11681361|FG000|Phase A|Lost to Follow-up|0
7410892|NCT01397786|11681362|FG001|Phase A|Lost to Follow-up|0
7410893|NCT01397786|11681363|FG002|Phase A|Lost to Follow-up|6
7410894|NCT01397786|11681361|FG000|Phase A|Adverse Event|0
7410895|NCT01397786|11681362|FG001|Phase A|Adverse Event|0
7410896|NCT01397786|11681363|FG002|Phase A|Adverse Event|8
7410897|NCT01397786|11681361|FG000|Phase A|Subject Met Withdrawal Criteria|0
7410898|NCT01397786|11681362|FG001|Phase A|Subject Met Withdrawal Criteria|0
7410899|NCT01397786|11681363|FG002|Phase A|Subject Met Withdrawal Criteria|7
7410900|NCT01397786|11681361|FG000|Phase A|Physician Decision|0
7410901|NCT01397786|11681362|FG001|Phase A|Physician Decision|0
7410902|NCT01397786|11681363|FG002|Phase A|Physician Decision|1
7410903|NCT01397786|11681361|FG000|Phase A|Withdrawal by Subject|0
7410904|NCT01397786|11681362|FG001|Phase A|Withdrawal by Subject|0
7410905|NCT01397786|11681363|FG002|Phase A|Withdrawal by Subject|5
7410906|NCT01397786|11681361|FG000|Phase A|Lack of Efficacy|0
7410907|NCT01397786|11681362|FG001|Phase A|Lack of Efficacy|0
7410908|NCT01397786|11681363|FG002|Phase A|Lack of Efficacy|1
7410909|NCT01397786|11681361|FG000|Phase B|Lost to Follow-up|22
7410910|NCT01397786|11681362|FG001|Phase B|Lost to Follow-up|12
7410911|NCT01397786|11681363|FG002|Phase B|Lost to Follow-up|22
7410912|NCT01397786|11681361|FG000|Phase B|Adverse Event|109
7410913|NCT01397786|11681362|FG001|Phase B|Adverse Event|23
7410914|NCT01397786|11681363|FG002|Phase B|Adverse Event|27
7410915|NCT01397786|11681361|FG000|Phase B|Subject Met Withdrawal Criteria|38
7410916|NCT01397786|11681362|FG001|Phase B|Subject Met Withdrawal Criteria|5
7410917|NCT01397786|11681363|FG002|Phase B|Subject Met Withdrawal Criteria|38
7410918|NCT01397786|11681361|FG000|Phase B|Physician Decision|9
7410919|NCT01397786|11681362|FG001|Phase B|Physician Decision|1
7410920|NCT01397786|11681363|FG002|Phase B|Physician Decision|3
7410921|NCT01397786|11681361|FG000|Phase B|Withdrawal by Subject|102
7410922|NCT01397786|11681362|FG001|Phase B|Withdrawal by Subject|45
7410923|NCT01397786|11681363|FG002|Phase B|Withdrawal by Subject|30
7410924|NCT01397786|11681361|FG000|Phase B|Protocol Deviation|1
7410925|NCT01397786|11681362|FG001|Phase B|Protocol Deviation|2
7410926|NCT01397786|11681363|FG002|Phase B|Protocol Deviation|4
7410927|NCT01397786|11681361|FG000|Phase B|Lack of Efficacy|22
7410928|NCT01397786|11681362|FG001|Phase B|Lack of Efficacy|7
7410929|NCT01397786|11681363|FG002|Phase B|Lack of Efficacy|14
7410930|NCT01397825|11681379|FG000|Overall Study|Progressive Disease|10
7410931|NCT01397825|11681380|FG001|Overall Study|Progressive Disease|3
7410932|NCT01397825|11681381|FG002|Overall Study|Progressive Disease|11
7410933|NCT01397825|11681382|FG003|Overall Study|Progressive Disease|1
7410934|NCT01397825|11681383|FG004|Overall Study|Progressive Disease|0
7410935|NCT01397825|11681379|FG000|Overall Study|Symptomatic Deterioration|2
7410936|NCT01397825|11681380|FG001|Overall Study|Symptomatic Deterioration|0
7410937|NCT01397825|11681381|FG002|Overall Study|Symptomatic Deterioration|4
7410938|NCT01397825|11681382|FG003|Overall Study|Symptomatic Deterioration|0
7410939|NCT01397825|11681383|FG004|Overall Study|Symptomatic Deterioration|0
7410940|NCT01397825|11681379|FG000|Overall Study|Adverse Event|0
7410941|NCT01397825|11681380|FG001|Overall Study|Adverse Event|1
7410942|NCT01397825|11681381|FG002|Overall Study|Adverse Event|5
7410943|NCT01397825|11681382|FG003|Overall Study|Adverse Event|1
7410944|NCT01397825|11681383|FG004|Overall Study|Adverse Event|0
7410945|NCT01397825|11681379|FG000|Overall Study|Withdrawal by Subject|1
7410946|NCT01397825|11681380|FG001|Overall Study|Withdrawal by Subject|0
7410947|NCT01397825|11681381|FG002|Overall Study|Withdrawal by Subject|5
7410948|NCT01397825|11681382|FG003|Overall Study|Withdrawal by Subject|1
7410949|NCT01397825|11681383|FG004|Overall Study|Withdrawal by Subject|0
7410950|NCT01397890|11681408|FG000|Overall Study|Withdrawal by Subject|7
7410951|NCT01397890|11681409|FG001|Overall Study|Withdrawal by Subject|11
7410952|NCT01397890|11681408|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
7410953|NCT01397890|11681409|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
7410954|NCT01397890|11681408|FG000|Overall Study|Death|2
7410955|NCT01397890|11681409|FG001|Overall Study|Death|3
7410956|NCT01397890|11681408|FG000|Overall Study|Lost to Follow-up|1
7410957|NCT01397890|11681409|FG001|Overall Study|Lost to Follow-up|4
7410958|NCT01397890|11681408|FG000|Overall Study|Condition under Investigation Worsened|1
7410959|NCT01397890|11681409|FG001|Overall Study|Condition under Investigation Worsened|3
7410960|NCT01397890|11681408|FG000|Overall Study|Adverse Event|1
7410961|NCT01397890|11681409|FG001|Overall Study|Adverse Event|2
7410962|NCT01397890|11681408|FG000|Overall Study|Severe Non-Compliance to Protocol|2
7410963|NCT01397890|11681409|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7410964|NCT01397890|11681408|FG000|Overall Study|Others|2
7410965|NCT01397890|11681409|FG001|Overall Study|Others|1
7410966|NCT01398176|11681430|FG000|Overall Study|Lost to Follow-up|1
7410967|NCT01398176|11681431|FG001|Overall Study|Lost to Follow-up|3
7410968|NCT01398176|11681430|FG000|Overall Study|Physician Decision|2
7410969|NCT01398176|11681431|FG001|Overall Study|Physician Decision|3
7410970|NCT01398358|11681449|FG000|Overall Study|Lost to Follow-up|11
7410971|NCT01398358|11681450|FG001|Overall Study|Lost to Follow-up|21
7410972|NCT01398358|11681451|FG002|Overall Study|Lost to Follow-up|18
7410973|NCT01398358|11681449|FG000|Overall Study|Withdrawal by Subject|3
7410974|NCT01398358|11681450|FG001|Overall Study|Withdrawal by Subject|2
7410975|NCT01398358|11681451|FG002|Overall Study|Withdrawal by Subject|2
7410976|NCT01398358|11681449|FG000|Overall Study|no longer eligible|1
7410977|NCT01398358|11681450|FG001|Overall Study|no longer eligible|0
7410978|NCT01398358|11681451|FG002|Overall Study|no longer eligible|1
7410979|NCT01398410|11681461|FG000|Overall Study|Adverse Event|12
7410980|NCT01398410|11681462|FG001|Overall Study|Adverse Event|16
7410981|NCT01398410|11681461|FG000|Overall Study|Participants Choice|8
7410982|NCT01398410|11681462|FG001|Overall Study|Participants Choice|11
7410983|NCT01398410|11681461|FG000|Overall Study|Inadequate Therapeutic Effect|2
7410984|NCT01398410|11681462|FG001|Overall Study|Inadequate Therapeutic Effect|0
7410985|NCT01398410|11681461|FG000|Overall Study|Other|36
7410986|NCT01398410|11681462|FG001|Overall Study|Other|29
7410987|NCT01398514|11681483|FG000|Overall Study|Adverse Event|1
7410988|NCT01398514|11681484|FG001|Overall Study|Adverse Event|0
7410989|NCT01398514|11681483|FG000|Overall Study|Non-compliance with study procedures|2
7410990|NCT01398514|11681484|FG001|Overall Study|Non-compliance with study procedures|0
7410991|NCT01398514|11681483|FG000|Overall Study|Physiologic non-responsiveness|1
7410992|NCT01398514|11681484|FG001|Overall Study|Physiologic non-responsiveness|3
7410993|NCT01398514|11681483|FG000|Overall Study|Failure to show a conditioned response|4
7410994|NCT01398514|11681484|FG001|Overall Study|Failure to show a conditioned response|3
7410995|NCT01398787|11681496|FG000|Overall Study|Adverse Event|1
7410996|NCT01398956|11681515|FG000|Overall Study|Withdrawal by Subject|4
7410997|NCT01398956|11681515|FG000|Overall Study|AE, non-serious non-fatal|4
7410998|NCT01398956|11681515|FG000|Overall Study|Withdrawal Criteria No.3|1
7410999|NCT01398956|11681515|FG000|Overall Study|Subject moved a long distance|1
7411000|NCT01399047|11681544|FG000|Overall Study|Withdrawal by Subject|0
7411001|NCT01399047|11681545|FG001|Overall Study|Withdrawal by Subject|1
7411002|NCT01399099|11681553|FG000|Overall Study|Lost to Follow-up|11
7411003|NCT01399099|11681553|FG000|Overall Study|Physician Decision|1
7411004|NCT01399099|11681553|FG000|Overall Study|Protocol Violation|1
7411005|NCT01399099|11681553|FG000|Overall Study|Skin Irritation|13
7411006|NCT01399099|11681553|FG000|Overall Study|Infection|1
7411007|NCT01399099|11681553|FG000|Overall Study|Miscellaneous|4
7411008|NCT01399125|11681560|FG000|Overall Study|Adverse Event|32
7411009|NCT01399125|11681561|FG001|Overall Study|Adverse Event|30
7411010|NCT01399125|11681560|FG000|Overall Study|Abnormal Lab values|0
7411011|NCT01399125|11681561|FG001|Overall Study|Abnormal Lab values|1
7411012|NCT01399125|11681560|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
7411013|NCT01399125|11681561|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
7411014|NCT01399125|11681560|FG000|Overall Study|Withdrawal by Subject|5
7411015|NCT01399125|11681561|FG001|Overall Study|Withdrawal by Subject|8
7411016|NCT01399125|11681560|FG000|Overall Study|Lost to Follow-up|2
7411017|NCT01399125|11681561|FG001|Overall Study|Lost to Follow-up|3
7411018|NCT01399125|11681560|FG000|Overall Study|Administrative Problems|7
7411019|NCT01399125|11681561|FG001|Overall Study|Administrative Problems|11
7411020|NCT01399125|11681560|FG000|Overall Study|Death|0
7411021|NCT01399125|11681561|FG001|Overall Study|Death|1
7411022|NCT01399125|11681560|FG000|Overall Study|Protocol Deviation|5
7411023|NCT01399125|11681561|FG001|Overall Study|Protocol Deviation|2
7411024|NCT01399190|11681567|FG000|Overall Study|Not Eligible for Final Analysis|5
7411025|NCT01399190|11681567|FG000|Overall Study|Adverse Event|8
7411026|NCT01399190|11681567|FG000|Overall Study|Participant's Request|5
7411027|NCT01399190|11681567|FG000|Overall Study|Physician Decision|2
7411028|NCT01399593|11681588|FG000|Overall Study|Physician Decision|1
7411029|NCT01399593|11681589|FG001|Overall Study|Physician Decision|0
7411030|NCT01399593|11681588|FG000|Overall Study|Adverse Event|1
7411031|NCT01399593|11681589|FG001|Overall Study|Adverse Event|0
7411032|NCT01399593|11681588|FG000|Overall Study|Death|1
7411033|NCT01399593|11681589|FG001|Overall Study|Death|1
7411034|NCT01399593|11681588|FG000|Overall Study|Transplantectomy|0
7411035|NCT01399593|11681589|FG001|Overall Study|Transplantectomy|1
7411036|NCT01399619|11681597|FG000|Overall Study|Adverse Event|10
7411037|NCT01399619|11681598|FG001|Overall Study|Adverse Event|0
7411038|NCT01399619|11681599|FG002|Overall Study|Adverse Event|4
7411039|NCT01399619|11681600|FG003|Overall Study|Adverse Event|10
7411040|NCT01399619|11681597|FG000|Overall Study|Lack of Efficacy|9
7411041|NCT01399619|11681598|FG001|Overall Study|Lack of Efficacy|0
7411042|NCT01399619|11681599|FG002|Overall Study|Lack of Efficacy|5
7411043|NCT01399619|11681600|FG003|Overall Study|Lack of Efficacy|0
7411044|NCT01399619|11681597|FG000|Overall Study|Withdrawal by Subject|6
7411045|NCT01399619|11681598|FG001|Overall Study|Withdrawal by Subject|0
7411046|NCT01399619|11681599|FG002|Overall Study|Withdrawal by Subject|3
7411047|NCT01399619|11681600|FG003|Overall Study|Withdrawal by Subject|4
7411048|NCT01399619|11681597|FG000|Overall Study|Protocol Violation|0
7411049|NCT01399619|11681598|FG001|Overall Study|Protocol Violation|0
7411050|NCT01399619|11681599|FG002|Overall Study|Protocol Violation|0
7411051|NCT01399619|11681600|FG003|Overall Study|Protocol Violation|1
7411052|NCT01399619|11681597|FG000|Overall Study|Not treated|0
7411053|NCT01399619|11681598|FG001|Overall Study|Not treated|0
7411054|NCT01399619|11681599|FG002|Overall Study|Not treated|0
7411055|NCT01399619|11681600|FG003|Overall Study|Not treated|2
7411056|NCT01399697|11681618|FG000|Overall Study|Adverse Event|13
7411057|NCT01399697|11681619|FG001|Overall Study|Adverse Event|3
7411058|NCT01399697|11681620|FG002|Overall Study|Adverse Event|1
7411059|NCT01399697|11681618|FG000|Overall Study|Lost to Follow-up|2
7411060|NCT01399697|11681619|FG001|Overall Study|Lost to Follow-up|0
7411061|NCT01399697|11681620|FG002|Overall Study|Lost to Follow-up|0
7411062|NCT01399697|11681618|FG000|Overall Study|Withdrawal by Subject|8
7411063|NCT01399697|11681619|FG001|Overall Study|Withdrawal by Subject|0
7411064|NCT01399697|11681620|FG002|Overall Study|Withdrawal by Subject|0
7411065|NCT01399697|11681618|FG000|Overall Study|Investigator Decisión|1
7411066|NCT01399697|11681619|FG001|Overall Study|Investigator Decisión|0
7411067|NCT01399697|11681620|FG002|Overall Study|Investigator Decisión|2
7411068|NCT01399697|11681618|FG000|Overall Study|Lack of Efficacy|9
7411069|NCT01399697|11681619|FG001|Overall Study|Lack of Efficacy|0
7411070|NCT01399697|11681620|FG002|Overall Study|Lack of Efficacy|1
7411071|NCT01399697|11681618|FG000|Overall Study|Protocol Violation|2
7411072|NCT01399697|11681619|FG001|Overall Study|Protocol Violation|0
7411073|NCT01399697|11681620|FG002|Overall Study|Protocol Violation|0
7411074|NCT01399697|11681618|FG000|Overall Study|Non-Compliant|1
7411075|NCT01399697|11681619|FG001|Overall Study|Non-Compliant|0
7411076|NCT01399697|11681620|FG002|Overall Study|Non-Compliant|0
7411077|NCT01399697|11681618|FG000|Overall Study|Inclusion Error|2
7411078|NCT01399697|11681619|FG001|Overall Study|Inclusion Error|0
7411079|NCT01399697|11681620|FG002|Overall Study|Inclusion Error|0
7411080|NCT01399697|11681618|FG000|Overall Study|Positive result for hepatitis B|1
7411081|NCT01399697|11681619|FG001|Overall Study|Positive result for hepatitis B|0
7411082|NCT01399697|11681620|FG002|Overall Study|Positive result for hepatitis B|0
7411083|NCT01399697|11681618|FG000|Overall Study|Clinical RA remission|1
7411084|NCT01399697|11681619|FG001|Overall Study|Clinical RA remission|0
7411085|NCT01399697|11681620|FG002|Overall Study|Clinical RA remission|0
7411086|NCT01399697|11681618|FG000|Overall Study|Sponsor Decision|1
7411087|NCT01399697|11681619|FG001|Overall Study|Sponsor Decision|0
7411088|NCT01399697|11681620|FG002|Overall Study|Sponsor Decision|0
7411089|NCT01399723|11681633|FG000|Overall Study|Lost to Follow-up|0
7411090|NCT01399723|11681634|FG001|Overall Study|Lost to Follow-up|1
7411091|NCT01399736|11681643|FG000|Overall Study|Withdrawal by Subject|4
7411092|NCT01399736|11681644|FG001|Overall Study|Withdrawal by Subject|2
7411093|NCT01399736|11681643|FG000|Overall Study|Lost to Follow-up|0
7411094|NCT01399736|11681644|FG001|Overall Study|Lost to Follow-up|2
7411095|NCT01399788|11681658|FG000|First Intervention Period|Adverse Event|1
7411096|NCT01399788|11681659|FG001|First Intervention Period|Adverse Event|0
7411097|NCT01399905|11681685|FG000|Overall Study|Withdrawal by Subject|1
7411098|NCT01399905|11681686|FG001|Overall Study|Withdrawal by Subject|1
7411099|NCT01400113|11681699|FG000|Overall Study|Withdrawal by Subject|1
7411100|NCT01400113|11681700|FG001|Overall Study|Withdrawal by Subject|1
7411101|NCT01400139|11681706|FG000|HYD Core Study|Adverse Event|210
7411102|NCT01400139|11681706|FG000|HYD Core Study|Lack of Efficacy|59
7411103|NCT01400139|11681706|FG000|HYD Core Study|Withdrawal by Subject|114
7411104|NCT01400139|11681706|FG000|HYD Core Study|Lost to Follow-up|39
7411105|NCT01400139|11681706|FG000|HYD Core Study|Confirmed or suspected diversion|20
7411106|NCT01400139|11681706|FG000|HYD Core Study|Administrative|56
7411107|NCT01400139|11681706|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
7411108|NCT01400139|11681706|FG000|HYD Extension Period|Adverse Event|8
7411109|NCT01400139|11681706|FG000|HYD Extension Period|Withdrawal by Subject|5
7411110|NCT01400139|11681706|FG000|HYD Extension Period|Administrative|10
7411111|NCT01400243|11681714|FG000|Overall Study|Protocol Violation|8
7411112|NCT01400243|11681715|FG001|Overall Study|Protocol Violation|11
7411113|NCT01400412|11681725|FG000|Overall Study|Lost to Follow-up|4
7411114|NCT01400412|11681726|FG001|Overall Study|Lost to Follow-up|7
7411115|NCT01400412|11681725|FG000|Overall Study|Withdrawal by Subject|3
7411116|NCT01400412|11681726|FG001|Overall Study|Withdrawal by Subject|4
7411117|NCT01400412|11681725|FG000|Overall Study|Unable to complete|3
7411118|NCT01400412|11681726|FG001|Overall Study|Unable to complete|3
7411119|NCT01400412|11681725|FG000|Overall Study|Never started study treatment|0
7411120|NCT01400412|11681726|FG001|Overall Study|Never started study treatment|3
7411121|NCT01400425|11681734|FG000|Overall Study|Withdrawal by Subject|10
7411122|NCT01400451|11681743|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
7411123|NCT01400451|11681744|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
7411124|NCT01400451|11681745|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
7411125|NCT01400451|11681743|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
7411126|NCT01400451|11681744|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
7411127|NCT01400451|11681745|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
7411128|NCT01400451|11681743|FG000|Combination Treatment (or Intended)|Adverse Event|1
7411129|NCT01400451|11681744|FG001|Combination Treatment (or Intended)|Adverse Event|0
7411130|NCT01400451|11681745|FG002|Combination Treatment (or Intended)|Adverse Event|0
7411131|NCT01400451|11681743|FG000|Combination Treatment (or Intended)|Disease Progression|3
7411132|NCT01400451|11681744|FG001|Combination Treatment (or Intended)|Disease Progression|1
7411133|NCT01400451|11681745|FG002|Combination Treatment (or Intended)|Disease Progression|1
7411134|NCT01400451|11681743|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7411135|NCT01400451|11681744|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
7411136|NCT01400451|11681745|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
7411137|NCT01400503|11681767|FG000|Overall Study|Withdrawal by Subject|1
7411138|NCT01400503|11681767|FG000|Overall Study|Study Terminated by Sponsor|58
7411139|NCT01400503|11681767|FG000|Overall Study|Other|1
7411140|NCT01400516|11681773|FG000|Primary Trial|Withdrawal by Subject|0
7411141|NCT01400516|11681774|FG001|Primary Trial|Withdrawal by Subject|2
7411142|NCT01400698|11681784|FG000|Overall Study|Lost to Follow-up|2
7411143|NCT01400698|11681785|FG001|Overall Study|Lost to Follow-up|5
7411144|NCT01400698|11681786|FG002|Overall Study|Lost to Follow-up|2
7411145|NCT01400698|11681787|FG003|Overall Study|Lost to Follow-up|1
7411146|NCT01400698|11681788|FG004|Overall Study|Lost to Follow-up|4
7411147|NCT01400698|11681789|FG005|Overall Study|Lost to Follow-up|3
7411148|NCT01400698|11681784|FG000|Overall Study|Withdrawal by Subject|8
7411149|NCT01400698|11681785|FG001|Overall Study|Withdrawal by Subject|2
7411150|NCT01400698|11681786|FG002|Overall Study|Withdrawal by Subject|0
7411151|NCT01400698|11681787|FG003|Overall Study|Withdrawal by Subject|4
7411152|NCT01400698|11681788|FG004|Overall Study|Withdrawal by Subject|1
7411153|NCT01400698|11681789|FG005|Overall Study|Withdrawal by Subject|3
7411154|NCT01400698|11681784|FG000|Overall Study|Protocol Violation|0
7411155|NCT01400698|11681785|FG001|Overall Study|Protocol Violation|1
7411156|NCT01400698|11681786|FG002|Overall Study|Protocol Violation|0
7411157|NCT01400698|11681787|FG003|Overall Study|Protocol Violation|0
7411158|NCT01400698|11681788|FG004|Overall Study|Protocol Violation|1
7411159|NCT01400698|11681789|FG005|Overall Study|Protocol Violation|0
7411160|NCT01400698|11681784|FG000|Overall Study|Non-compliance|0
7411161|NCT01400698|11681785|FG001|Overall Study|Non-compliance|1
7411162|NCT01400698|11681786|FG002|Overall Study|Non-compliance|0
7411163|NCT01400698|11681787|FG003|Overall Study|Non-compliance|1
7411164|NCT01400698|11681788|FG004|Overall Study|Non-compliance|0
7411165|NCT01400698|11681789|FG005|Overall Study|Non-compliance|0
7411166|NCT01400698|11681784|FG000|Overall Study|Adverse Event|1
7411167|NCT01400698|11681785|FG001|Overall Study|Adverse Event|0
7411168|NCT01400698|11681786|FG002|Overall Study|Adverse Event|0
7411169|NCT01400698|11681787|FG003|Overall Study|Adverse Event|0
7411170|NCT01400698|11681788|FG004|Overall Study|Adverse Event|0
7411171|NCT01400698|11681789|FG005|Overall Study|Adverse Event|0
7411172|NCT01400698|11681784|FG000|Overall Study|Other|4
7411173|NCT01400698|11681785|FG001|Overall Study|Other|2
7411174|NCT01400698|11681786|FG002|Overall Study|Other|0
7411175|NCT01400698|11681787|FG003|Overall Study|Other|2
7411176|NCT01400698|11681788|FG004|Overall Study|Other|1
7411177|NCT01400698|11681789|FG005|Overall Study|Other|0
7411178|NCT01400815|11681801|FG000|Overall Study|Adverse Event|3
7411179|NCT01400815|11681802|FG001|Overall Study|Adverse Event|0
7411180|NCT01400815|11681801|FG000|Overall Study|Death|0
7411181|NCT01400815|11681802|FG001|Overall Study|Death|1
7411182|NCT01400815|11681801|FG000|Overall Study|Lost to Follow-up|18
7411183|NCT01400815|11681802|FG001|Overall Study|Lost to Follow-up|11
7411184|NCT01400815|11681801|FG000|Overall Study|Protocol Violation|0
7411185|NCT01400815|11681802|FG001|Overall Study|Protocol Violation|1
7411186|NCT01400815|11681801|FG000|Overall Study|Physician Decision|1
7411187|NCT01400815|11681802|FG001|Overall Study|Physician Decision|0
7411188|NCT01400815|11681801|FG000|Overall Study|Withdrawal by Subject|15
7411189|NCT01400815|11681802|FG001|Overall Study|Withdrawal by Subject|8
7411190|NCT01400815|11681801|FG000|Overall Study|Subject in jail|1
7411191|NCT01400815|11681802|FG001|Overall Study|Subject in jail|0
7411192|NCT01400841|11681808|FG000|Initial Study Phase (6 Months)|Death|1
7411193|NCT01400841|11681808|FG000|Extended Study Phase (2 Years)|Adverse Event|2
7411194|NCT01400893|11681818|FG000|Overall Study|Death|27
7411195|NCT01400893|11681819|FG001|Overall Study|Death|21
7411196|NCT01400893|11681818|FG000|Overall Study|Lost to Follow-up|0
7411197|NCT01400893|11681819|FG001|Overall Study|Lost to Follow-up|6
7411198|NCT01400919|11681840|FG000|Overall Study|Withdrawal by Subject|4
7411199|NCT01400919|11681840|FG000|Overall Study|Lost to Follow-up|2
7411200|NCT01400919|11681840|FG000|Overall Study|Missed visit|2
7411201|NCT01400932|11681846|FG000|Overall Study|Adverse Event|10
7411202|NCT01400932|11681847|FG001|Overall Study|Adverse Event|5
7411203|NCT01400932|11681846|FG000|Overall Study|Lack of Efficacy|0
7411204|NCT01400932|11681847|FG001|Overall Study|Lack of Efficacy|3
7411205|NCT01400932|11681846|FG000|Overall Study|Withdrawal by Subject|2
7411206|NCT01400932|11681847|FG001|Overall Study|Withdrawal by Subject|6
7411207|NCT01400932|11681846|FG000|Overall Study|Lost to Follow-up|1
7411208|NCT01400932|11681847|FG001|Overall Study|Lost to Follow-up|0
7411209|NCT01400932|11681846|FG000|Overall Study|Protocol Deviation|0
7411210|NCT01400932|11681847|FG001|Overall Study|Protocol Deviation|1
7411211|NCT01400932|11681846|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7411212|NCT01400932|11681847|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
7411213|NCT01400958|11681855|FG000|Overall Study|Physician Decision|0
7411214|NCT01400958|11681856|FG001|Overall Study|Physician Decision|1
7411215|NCT01400958|11681855|FG000|Overall Study|Withdrawal by Subject|0
7411216|NCT01400958|11681856|FG001|Overall Study|Withdrawal by Subject|1
7411217|NCT01400958|11681855|FG000|Overall Study|Adverse Event|1
7411218|NCT01400958|11681856|FG001|Overall Study|Adverse Event|0
7411219|NCT01400971|11681862|FG000|Overall Study|Death|82
7411220|NCT01400971|11681862|FG000|Overall Study|Lost to Follow-up|196
7411221|NCT01400971|11681862|FG000|Overall Study|Lost to follow up + Subject Decision|2
7411222|NCT01400971|11681862|FG000|Overall Study|Physician Decision|57
7411223|NCT01400971|11681862|FG000|Overall Study|Withdrawal by Subject|158
7411224|NCT01400971|11681862|FG000|Overall Study|Other|422
7411225|NCT01401010|11681868|FG000|Overall Study|Could not interpret assay results|1
7411226|NCT01401010|11681869|FG001|Overall Study|Could not interpret assay results|0
7411227|NCT01401062|11681888|FG000|Overall Study|Death|9
7411228|NCT01401062|11681889|FG001|Overall Study|Death|7
7411229|NCT01401062|11681888|FG000|Overall Study|Physician Decision|1
7411230|NCT01401062|11681889|FG001|Overall Study|Physician Decision|0
7411231|NCT01401062|11681888|FG000|Overall Study|Withdrawal by Subject|1
7411232|NCT01401062|11681889|FG001|Overall Study|Withdrawal by Subject|1
7411233|NCT01401153|11681906|FG000|First Test Day|Learning disabilities; illness|1
7411234|NCT01401153|11681907|FG001|First Test Day|Learning disabilities; illness|10
7411235|NCT01401153|11681906|FG000|Second Test Day|illness|0
7411236|NCT01401153|11681907|FG001|Second Test Day|illness|5
7411237|NCT01401283|11681955|FG000|Overall Study|surgery cancelled|5
7411238|NCT01401283|11681956|FG001|Overall Study|surgery cancelled|8
7411239|NCT01401283|11681955|FG000|Overall Study|preoperative arrhythmia|5
7411240|NCT01401283|11681956|FG001|Overall Study|preoperative arrhythmia|0
7411241|NCT01401283|11681955|FG000|Overall Study|no central venous access|0
7411242|NCT01401283|11681956|FG001|Overall Study|no central venous access|1
7411243|NCT01401283|11681955|FG000|Overall Study|suspicion of malignant hyperthermia|0
7411244|NCT01401283|11681956|FG001|Overall Study|suspicion of malignant hyperthermia|1
7411245|NCT01401322|11681962|FG000|Overall Study|Withdrawal by Subject|1
7411246|NCT01401322|11681962|FG000|Overall Study|Physician Decision|1
7411247|NCT01401361|11681966|FG000|Overall Study|Withdrawal by Subject|16
7411248|NCT01401361|11681966|FG000|Overall Study|Lack of Efficacy|6
7411249|NCT01401361|11681966|FG000|Overall Study|Physician Decision|1
7411250|NCT01401361|11681966|FG000|Overall Study|Lost to Follow-up|3
7411251|NCT01401361|11681966|FG000|Overall Study|Subject/family decision post procedure|2
7411252|NCT01401452|11681970|FG000|Overall Study|Adverse reaction|9
7411253|NCT01401452|11681970|FG000|Overall Study|Lost to Follow-up|12
7411254|NCT01401452|11681970|FG000|Overall Study|Lack of Efficacy|30
7411255|NCT01401452|11681970|FG000|Overall Study|Participant developed breast cancer|1
7411256|NCT01401452|11681970|FG000|Overall Study|Tx stopped due to financial reasons|1
7411257|NCT01401452|11681970|FG000|Overall Study|Tx stopped by psychiatrist|1
7411258|NCT01401452|11681970|FG000|Overall Study|No more visits within the 36 wk followup|4
7411259|NCT01401452|11681970|FG000|Overall Study|Subject did not come to follow up visits|2
7411260|NCT01401452|11681970|FG000|Overall Study|Subject didn't return for routine visits|1
7411261|NCT01401452|11681970|FG000|Overall Study|Subject moved to another city|1
7411262|NCT01401452|11681970|FG000|Overall Study|Subject's wife wants to get pregnant|1
7411263|NCT01401452|11681970|FG000|Overall Study|Psoriatic arthritis|1
7411264|NCT01401452|11681970|FG000|Overall Study|Participant stopped Tx|2
7411265|NCT01401452|11681970|FG000|Overall Study|Discontinuation for personal reasons|1
7411266|NCT01401452|11681970|FG000|Overall Study|Treatment failure|1
7411267|NCT01401452|11681970|FG000|Overall Study|Unsatisfactory output|1
7411268|NCT01401452|11681970|FG000|Overall Study|Subject withdrew because of Tx success|1
7411269|NCT01401452|11681970|FG000|Overall Study|Subject chose to discontinue treatment|1
7411270|NCT01401452|11681970|FG000|Overall Study|Participant withdrew consent|1
7411271|NCT01401465|11681976|FG000|Treatment Period 1|Adverse Event|4
7411272|NCT01401465|11681977|FG001|Treatment Period 1|Adverse Event|1
7411273|NCT01401465|11681976|FG000|Treatment Period 1|Pregnancy|0
7411274|NCT01401465|11681977|FG001|Treatment Period 1|Pregnancy|1
7411275|NCT01401465|11681976|FG000|Treatment Period 1|Protocol Violation|5
7411276|NCT01401465|11681977|FG001|Treatment Period 1|Protocol Violation|0
7411277|NCT01401465|11681976|FG000|Treatment Period 1|Withdrawal by Subject|1
7411278|NCT01401465|11681977|FG001|Treatment Period 1|Withdrawal by Subject|4
7411279|NCT01401465|11681976|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
7411280|NCT01401465|11681977|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
7411281|NCT01401465|11681976|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
7411282|NCT01401465|11681977|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
7411283|NCT01401465|11681976|FG000|Treatment Period 1|Scheduling Difficulties|1
7411284|NCT01401465|11681977|FG001|Treatment Period 1|Scheduling Difficulties|1
7411285|NCT01401465|11681976|FG000|Treatment Period 2|Lost to Follow-up|0
7411286|NCT01401465|11681977|FG001|Treatment Period 2|Lost to Follow-up|1
7411287|NCT01401465|11681976|FG000|Treatment Period 2|Withdrawal by Subject|0
7411288|NCT01401465|11681977|FG001|Treatment Period 2|Withdrawal by Subject|1
7466149|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
7466150|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7466151|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
7466152|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
7466153|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
7466154|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
7466155|NCT01888874|11765828|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7466156|NCT01888874|11765829|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7466157|NCT01888874|11765830|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7466158|NCT01888874|11765831|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7466159|NCT01888874|11765832|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7466160|NCT01888874|11765833|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
7466161|NCT01888874|11765834|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
7466162|NCT01888900|11765853|FG000|Overall Study|failed treatment|0
7466163|NCT01888900|11765854|FG001|Overall Study|failed treatment|2
7466164|NCT01888965|11765866|FG000|Overall Study|Adverse Event|5
7466165|NCT01888965|11765866|FG000|Overall Study|Lack of Efficacy|4
7466166|NCT01889069|11765872|FG000|Overall Study|Death|18
7466167|NCT01889069|11765872|FG000|Overall Study|Progression of Disease|14
7466168|NCT01889069|11765872|FG000|Overall Study|Lost to Follow-up|6
7466169|NCT01889069|11765872|FG000|Overall Study|Other|4
7466170|NCT01889069|11765872|FG000|Overall Study|Consent Withdrawal|3
7466171|NCT01889251|11765884|FG000|Overall Study|Adverse Event|1
7466172|NCT01889251|11765885|FG001|Overall Study|Adverse Event|0
7466173|NCT01889602|11765907|FG000|First Intervention|Adverse Event|1
7466174|NCT01889602|11765908|FG001|First Intervention|Adverse Event|1
7466175|NCT01889602|11765909|FG002|First Intervention|Adverse Event|1
7466176|NCT01889602|11765907|FG000|First Intervention|Protocol Violation|0
7466177|NCT01889602|11765908|FG001|First Intervention|Protocol Violation|1
7466178|NCT01889602|11765909|FG002|First Intervention|Protocol Violation|1
7466179|NCT01889602|11765907|FG000|First Intervention|Study ending|0
7466180|NCT01889602|11765908|FG001|First Intervention|Study ending|1
7466181|NCT01889602|11765909|FG002|First Intervention|Study ending|0
7466182|NCT01889602|11765907|FG000|Second Intervention|Adverse Event|0
7466183|NCT01889602|11765908|FG001|Second Intervention|Adverse Event|0
7466184|NCT01889602|11765909|FG002|Second Intervention|Adverse Event|1
7466185|NCT01889602|11765907|FG000|Second Intervention|Study ending|1
7466186|NCT01889602|11765908|FG001|Second Intervention|Study ending|0
7466187|NCT01889602|11765909|FG002|Second Intervention|Study ending|0
7466188|NCT01889602|11765907|FG000|Second Intervention|Withdrawal by Subject|0
7466189|NCT01889602|11765908|FG001|Second Intervention|Withdrawal by Subject|0
7466190|NCT01889602|11765909|FG002|Second Intervention|Withdrawal by Subject|1
7466191|NCT01889602|11765907|FG000|Third Intervention|Protocol Violation|1
7466192|NCT01889602|11765908|FG001|Third Intervention|Protocol Violation|0
7466193|NCT01889602|11765909|FG002|Third Intervention|Protocol Violation|0
7466194|NCT01889602|11765907|FG000|Third Intervention|Withdrawal by Subject|2
7466195|NCT01889602|11765908|FG001|Third Intervention|Withdrawal by Subject|2
7466196|NCT01889602|11765909|FG002|Third Intervention|Withdrawal by Subject|0
7466197|NCT01889862|11765949|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
7466198|NCT01889862|11765950|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
7466199|NCT01889862|11765951|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
7466200|NCT01889862|11765952|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
7466201|NCT01889862|11765953|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
7466202|NCT01889862|11765949|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
7466203|NCT01889862|11765950|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7466204|NCT01889862|11765951|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7466205|NCT01889862|11765952|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7466206|NCT01889862|11765953|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
7466207|NCT01889862|11765949|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
7466208|NCT01889862|11765950|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7466209|NCT01889862|11765951|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7466210|NCT01889862|11765952|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7466211|NCT01889862|11765953|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
7466212|NCT01889862|11765949|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
7466213|NCT01889862|11765950|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
7466214|NCT01889862|11765951|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
7411289|NCT01401478|11681986|FG000|Overall Study|Study drug not available|6
7411290|NCT01401478|11681986|FG000|Overall Study|Adverse Event|5
7411291|NCT01401478|11681986|FG000|Overall Study|Hyperphosphatemia|5
7411292|NCT01401478|11681986|FG000|Overall Study|Lost to Follow-up|5
7411293|NCT01401478|11681986|FG000|Overall Study|Kidney transplantation|3
7411294|NCT01401478|11681986|FG000|Overall Study|Withdrawal by Subject|3
7411295|NCT01401478|11681986|FG000|Overall Study|Blood samples not available|1
7411296|NCT01401478|11681986|FG000|Overall Study|Hyperphosphatemia and adverse event|1
7411297|NCT01401478|11681986|FG000|Overall Study|Low intact parathyroid hormone|1
7411298|NCT01401478|11681986|FG000|Overall Study|Serious adverse event|1
7411299|NCT01401530|11682006|FG000|Overall Study|Disease Progression|1
7411300|NCT01401530|11682007|FG001|Overall Study|Disease Progression|2
7411301|NCT01401530|11682008|FG002|Overall Study|Disease Progression|1
7411302|NCT01401530|11682006|FG000|Overall Study|Adverse Event|1
7411303|NCT01401530|11682007|FG001|Overall Study|Adverse Event|1
7411304|NCT01401530|11682008|FG002|Overall Study|Adverse Event|1
7411305|NCT01401530|11682006|FG000|Overall Study|Participant Choice|1
7411306|NCT01401530|11682007|FG001|Overall Study|Participant Choice|2
7411307|NCT01401530|11682008|FG002|Overall Study|Participant Choice|1
7411308|NCT01401530|11682006|FG000|Overall Study|Physician Decision|0
7411309|NCT01401530|11682007|FG001|Overall Study|Physician Decision|1
7411310|NCT01401530|11682008|FG002|Overall Study|Physician Decision|0
7411311|NCT01401647|11682060|FG000|Overall Study|Withdrawal by Subject|1
7411312|NCT01401647|11682061|FG001|Overall Study|Withdrawal by Subject|5
7411313|NCT01401647|11682062|FG002|Overall Study|Withdrawal by Subject|2
7411314|NCT01401647|11682060|FG000|Overall Study|Lost to Follow-up|3
7411315|NCT01401647|11682061|FG001|Overall Study|Lost to Follow-up|3
7411316|NCT01401647|11682062|FG002|Overall Study|Lost to Follow-up|1
7411317|NCT01401842|11682076|FG000|Overall Study|Withdrawal by Subject|3
7411318|NCT01401842|11682077|FG001|Overall Study|Withdrawal by Subject|2
7411319|NCT01401842|11682076|FG000|Overall Study|academic reason|4
7411320|NCT01401842|11682077|FG001|Overall Study|academic reason|1
7411321|NCT01401842|11682076|FG000|Overall Study|changed companies|20
7411322|NCT01401842|11682077|FG001|Overall Study|changed companies|34
7411323|NCT01401842|11682076|FG000|Overall Study|discharged from US Army|3
7411324|NCT01401842|11682077|FG001|Overall Study|discharged from US Army|4
7411325|NCT01401842|11682076|FG000|Overall Study|invalid follow-up strength data|1
7411326|NCT01401842|11682077|FG001|Overall Study|invalid follow-up strength data|4
7411327|NCT01401842|11682076|FG000|Overall Study|on profile|9
7411328|NCT01401842|11682077|FG001|Overall Study|on profile|5
7411329|NCT01401842|11682076|FG000|Overall Study|other/unknown|28
7411330|NCT01401842|11682077|FG001|Overall Study|other/unknown|17
7411331|NCT01401959|11682097|FG000|Enrolled|Withdrawal by Subject|1
7411332|NCT01401959|11682098|FG001|Enrolled|Withdrawal by Subject|0
7411333|NCT01401959|11682099|FG002|Enrolled|Withdrawal by Subject|0
7411334|NCT01401959|11682097|FG000|Treated|Disease Progression|2
7411335|NCT01401959|11682098|FG001|Treated|Disease Progression|2
7411336|NCT01401959|11682099|FG002|Treated|Disease Progression|1
7411337|NCT01401959|11682097|FG000|Treated|Adverse Event|4
7411338|NCT01401959|11682098|FG001|Treated|Adverse Event|3
7411339|NCT01401959|11682099|FG002|Treated|Adverse Event|2
7411340|NCT01401959|11682097|FG000|Treated|Withdrawal by Subject|1
7411341|NCT01401959|11682098|FG001|Treated|Withdrawal by Subject|2
7411342|NCT01401959|11682099|FG002|Treated|Withdrawal by Subject|2
7411343|NCT01401959|11682097|FG000|Treated|Protocol Violation|0
7411344|NCT01401959|11682098|FG001|Treated|Protocol Violation|1
7411345|NCT01401959|11682099|FG002|Treated|Protocol Violation|0
7411346|NCT01402011|11682112|FG000|Delayed Treatment Period|Withdrawal by Subject|1
7411347|NCT01402011|11682113|FG001|Delayed Treatment Period|Withdrawal by Subject|0
7411348|NCT01402011|11682114|FG002|Delayed Treatment Period|Withdrawal by Subject|0
7411349|NCT01402011|11682112|FG000|Active Treatment Period|Withdrawal by Subject|1
7411350|NCT01402011|11682113|FG001|Active Treatment Period|Withdrawal by Subject|3
7411351|NCT01402011|11682114|FG002|Active Treatment Period|Withdrawal by Subject|0
7411352|NCT01402011|11682112|FG000|Nine Month Follow-up|Withdrawal by Subject|0
7411353|NCT01402011|11682113|FG001|Nine Month Follow-up|Withdrawal by Subject|1
7411354|NCT01402011|11682114|FG002|Nine Month Follow-up|Withdrawal by Subject|0
7411355|NCT01402063|11682136|FG000|Overall Study|Withdrawal by Subject|3
7411356|NCT01402063|11682137|FG001|Overall Study|Withdrawal by Subject|3
7411357|NCT01402102|11682145|FG000|Overall Study|Protocol Violation|1
7411358|NCT01402102|11682146|FG001|Overall Study|Protocol Violation|0
7411359|NCT01402102|11682145|FG000|Overall Study|Insufficiency of compliance|1
7411360|NCT01402102|11682146|FG001|Overall Study|Insufficiency of compliance|1
7411361|NCT01402102|11682145|FG000|Overall Study|Withdrawal by Subject|0
7411362|NCT01402102|11682146|FG001|Overall Study|Withdrawal by Subject|2
7411363|NCT01402284|11682182|FG000|Overall Study|Withdrawal consent|2
7411364|NCT01402284|11682182|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
7411365|NCT01402284|11682182|FG000|Overall Study|Physician Decision|1
7411366|NCT01402284|11682182|FG000|Overall Study|Disease progression on study|10
7411367|NCT01402492|11682223|FG000|Overall Study|Withdrawal by Subject|17
7411368|NCT01402492|11682224|FG001|Overall Study|Withdrawal by Subject|11
7411369|NCT01402492|11682225|FG002|Overall Study|Withdrawal by Subject|11
7411370|NCT01402492|11682223|FG000|Overall Study|Adverse Event|2
7411371|NCT01402492|11682224|FG001|Overall Study|Adverse Event|3
7411372|NCT01402492|11682225|FG002|Overall Study|Adverse Event|4
7411373|NCT01402492|11682223|FG000|Overall Study|Physician Decision|0
7411374|NCT01402492|11682224|FG001|Overall Study|Physician Decision|3
7411375|NCT01402492|11682225|FG002|Overall Study|Physician Decision|0
7411376|NCT01402492|11682223|FG000|Overall Study|Incarcerated (N=3)|2
7411377|NCT01402492|11682224|FG001|Overall Study|Incarcerated (N=3)|0
7411378|NCT01402492|11682225|FG002|Overall Study|Incarcerated (N=3)|1
7411379|NCT01402544|11682233|FG000|Overall Study|Withdrawal by Subject|6
7411380|NCT01402570|11682237|FG000|Overall Study|Adverse Event|1
7411381|NCT01402700|11682242|FG000|Overall Study|Death|3
7411382|NCT01402700|11682242|FG000|Overall Study|Withdrawal by Subject|3
7411383|NCT01402700|11682242|FG000|Overall Study|Missed Visit|1
7411384|NCT01402817|11682246|FG000|Overall Study|Withdrawal by Subject|3
7411385|NCT01402817|11682246|FG000|Overall Study|Study Suspended by FDA|8
7411386|NCT01402869|11682254|FG000|Overall Study|Required Tooth Extraction|0
7411387|NCT01402869|11682255|FG001|Overall Study|Required Tooth Extraction|0
7411388|NCT01402869|11682256|FG002|Overall Study|Required Tooth Extraction|1
7411389|NCT01402947|11682266|FG000|First Intervention|Adverse Event|0
7411390|NCT01402947|11682267|FG001|First Intervention|Adverse Event|1
7411391|NCT01402986|11682277|FG000|Overall Study|Withdrawal by Subject|7
7411392|NCT01402986|11682278|FG001|Overall Study|Withdrawal by Subject|10
7411393|NCT01402986|11682279|FG002|Overall Study|Withdrawal by Subject|7
7411394|NCT01402986|11682280|FG003|Overall Study|Withdrawal by Subject|13
7411395|NCT01402986|11682277|FG000|Overall Study|Death|0
7411396|NCT01402986|11682278|FG001|Overall Study|Death|0
7411397|NCT01402986|11682279|FG002|Overall Study|Death|0
7411398|NCT01402986|11682280|FG003|Overall Study|Death|2
7411399|NCT01402986|11682277|FG000|Overall Study|Lost to Follow-up|0
7411400|NCT01402986|11682278|FG001|Overall Study|Lost to Follow-up|0
7411401|NCT01402986|11682279|FG002|Overall Study|Lost to Follow-up|0
7411402|NCT01402986|11682280|FG003|Overall Study|Lost to Follow-up|1
7411403|NCT01402986|11682277|FG000|Overall Study|Other|2
7411404|NCT01402986|11682278|FG001|Overall Study|Other|5
7411405|NCT01402986|11682279|FG002|Overall Study|Other|1
7411406|NCT01402986|11682280|FG003|Overall Study|Other|6
7411407|NCT01403051|11682292|FG000|Overall Study|Protocol Violation|2
7411408|NCT01403051|11682293|FG001|Overall Study|Protocol Violation|0
7411409|NCT01403051|11682292|FG000|Overall Study|Death|1
7411410|NCT01403051|11682293|FG001|Overall Study|Death|0
7411411|NCT01403051|11682292|FG000|Overall Study|Withdrawal by Subject|2
7411412|NCT01403051|11682293|FG001|Overall Study|Withdrawal by Subject|1
7411413|NCT01403051|11682292|FG000|Overall Study|Lost to Follow-up|5
7411414|NCT01403051|11682293|FG001|Overall Study|Lost to Follow-up|5
7411415|NCT01403064|11682304|FG000|Overall Study|Death|0
7411416|NCT01403064|11682305|FG001|Overall Study|Death|0
7411417|NCT01403064|11682306|FG002|Overall Study|Death|1
7411418|NCT01403064|11682307|FG003|Overall Study|Death|1
7411419|NCT01403064|11682304|FG000|Overall Study|Withdrawal by Subject|0
7411420|NCT01403064|11682305|FG001|Overall Study|Withdrawal by Subject|0
7411421|NCT01403064|11682306|FG002|Overall Study|Withdrawal by Subject|1
7411422|NCT01403064|11682307|FG003|Overall Study|Withdrawal by Subject|1
7411423|NCT01403064|11682304|FG000|Overall Study|Other|1
7411424|NCT01403064|11682305|FG001|Overall Study|Other|0
7411425|NCT01403064|11682306|FG002|Overall Study|Other|2
7411426|NCT01403064|11682307|FG003|Overall Study|Other|1
7411427|NCT01403116|11682328|FG000|Overall Study|Adverse Event|7
7411428|NCT01403116|11682329|FG001|Overall Study|Adverse Event|4
7411429|NCT01403116|11682328|FG000|Overall Study|Lost to Follow-up|7
7411430|NCT01403116|11682329|FG001|Overall Study|Lost to Follow-up|5
7411431|NCT01403116|11682328|FG000|Overall Study|Withdrawal by Subject|12
7411432|NCT01403116|11682329|FG001|Overall Study|Withdrawal by Subject|15
7411433|NCT01403116|11682328|FG000|Overall Study|Non-compliance of study drug|3
7411434|NCT01403116|11682329|FG001|Overall Study|Non-compliance of study drug|0
7411435|NCT01403116|11682328|FG000|Overall Study|Protocol Violation|0
7411436|NCT01403116|11682329|FG001|Overall Study|Protocol Violation|1
7411437|NCT01403116|11682328|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
7411438|NCT01403116|11682329|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
7411439|NCT01403116|11682328|FG000|Overall Study|Hct >54%|2
7411440|NCT01403116|11682329|FG001|Overall Study|Hct >54%|0
7411441|NCT01403116|11682328|FG000|Overall Study|unable to keep appointments|0
7411442|NCT01403116|11682329|FG001|Overall Study|unable to keep appointments|2
7411443|NCT01403610|11682369|FG000|Overall Study|Withdrawal by Subject|2
7411444|NCT01403610|11682370|FG001|Overall Study|Withdrawal by Subject|0
7411445|NCT01403610|11682371|FG002|Overall Study|Withdrawal by Subject|0
7411446|NCT01403610|11682372|FG003|Overall Study|Withdrawal by Subject|0
7411447|NCT01403610|11682369|FG000|Overall Study|Didn't recover from surgery sufficiently|0
7411448|NCT01403610|11682370|FG001|Overall Study|Didn't recover from surgery sufficiently|3
7411449|NCT01403610|11682371|FG002|Overall Study|Didn't recover from surgery sufficiently|0
7411450|NCT01403610|11682372|FG003|Overall Study|Didn't recover from surgery sufficiently|0
7411451|NCT01403805|11682384|FG000|Overall Study|Withdrawal by Subject|0
7411452|NCT01403805|11682385|FG001|Overall Study|Withdrawal by Subject|4
7411453|NCT01403805|11682384|FG000|Overall Study|Lost to Follow-up|0
7411454|NCT01403805|11682385|FG001|Overall Study|Lost to Follow-up|2
7411455|NCT01403805|11682384|FG000|Overall Study|Death|0
7411456|NCT01403805|11682385|FG001|Overall Study|Death|1
7411457|NCT01403987|11682398|FG000|Overall Study|Residents forgot their secret PIN|18
7411458|NCT01403987|11682399|FG001|Overall Study|Residents forgot their secret PIN|17
7411459|NCT01403987|11682400|FG002|Overall Study|Residents forgot their secret PIN|18
7411460|NCT01404208|11682464|FG000|Overall Study|Discontinued|3
7411461|NCT01404208|11682465|FG001|Overall Study|Discontinued|0
7411462|NCT01404234|11682471|FG000|Overall Study|Withdrawal by Subject|2
7411463|NCT01404325|11682486|FG000|Overall Study|Lost to Follow-up|1
7411464|NCT01404325|11682487|FG001|Overall Study|Lost to Follow-up|0
7411465|NCT01404325|11682486|FG000|Overall Study|Death|2
7411466|NCT01404325|11682487|FG001|Overall Study|Death|0
7411467|NCT01404325|11682486|FG000|Overall Study|Graft loss/Retransplantation|1
7411468|NCT01404325|11682487|FG001|Overall Study|Graft loss/Retransplantation|0
7411469|NCT01404325|11682486|FG000|Overall Study|non-specified reason|0
7411470|NCT01404325|11682487|FG001|Overall Study|non-specified reason|2
7411471|NCT01404949|11682563|FG000|Overall Study|Not Treated|1
7411472|NCT01404988|11682570|FG000|Overall Study|Death|2
7411473|NCT01404988|11682571|FG001|Overall Study|Death|0
7411474|NCT01404988|11682572|FG002|Overall Study|Death|2
7411475|NCT01404988|11682570|FG000|Overall Study|Adverse Event|1
7411476|NCT01404988|11682571|FG001|Overall Study|Adverse Event|0
7411477|NCT01404988|11682572|FG002|Overall Study|Adverse Event|0
7411478|NCT01404988|11682570|FG000|Overall Study|Withdrawal by Subject|2
7411479|NCT01404988|11682571|FG001|Overall Study|Withdrawal by Subject|2
7411480|NCT01404988|11682572|FG002|Overall Study|Withdrawal by Subject|0
7411481|NCT01404988|11682570|FG000|Overall Study|Lost to Follow-up|1
7411482|NCT01404988|11682571|FG001|Overall Study|Lost to Follow-up|2
7411483|NCT01404988|11682572|FG002|Overall Study|Lost to Follow-up|1
7411484|NCT01405027|11682585|FG000|Overall Study|Withdrawn consent|3
7411485|NCT01405027|11682586|FG001|Overall Study|Withdrawn consent|0
7411486|NCT01405027|11682585|FG000|Overall Study|Lost to Follow-up|16
7411487|NCT01405027|11682586|FG001|Overall Study|Lost to Follow-up|24
7411488|NCT01405027|11682585|FG000|Overall Study|Investigator judgement|0
7411489|NCT01405027|11682586|FG001|Overall Study|Investigator judgement|2
7411490|NCT01405027|11682585|FG000|Overall Study|Death|1
7411491|NCT01405027|11682586|FG001|Overall Study|Death|0
7411492|NCT01405027|11682585|FG000|Overall Study|Other or Unknown|12
7411493|NCT01405027|11682586|FG001|Overall Study|Other or Unknown|25
7411494|NCT01405053|11682596|FG000|Overall Study|Adverse Event|3
7411495|NCT01405053|11682597|FG001|Overall Study|Adverse Event|0
7411496|NCT01405053|11682596|FG000|Overall Study|Lost to Follow-up|0
7411497|NCT01405053|11682597|FG001|Overall Study|Lost to Follow-up|1
7411498|NCT01405053|11682596|FG000|Overall Study|Participant choice|2
7411499|NCT01405053|11682597|FG001|Overall Study|Participant choice|1
7411500|NCT01405053|11682596|FG000|Overall Study|Inadequate therapeutic effect|2
7411501|NCT01405053|11682597|FG001|Overall Study|Inadequate therapeutic effect|1
7411502|NCT01405053|11682596|FG000|Overall Study|Withdrawal by Subject|3
7411503|NCT01405053|11682597|FG001|Overall Study|Withdrawal by Subject|4
7411504|NCT01405053|11682596|FG000|Overall Study|Other|0
7411505|NCT01405053|11682597|FG001|Overall Study|Other|1
7411506|NCT01405196|11682607|FG000|Overall Study|Study Terminated by Sponsor|0
7411507|NCT01405196|11682608|FG001|Overall Study|Study Terminated by Sponsor|0
7411508|NCT01405196|11682609|FG002|Overall Study|Study Terminated by Sponsor|9
7411509|NCT01405196|11682610|FG003|Overall Study|Study Terminated by Sponsor|0
7411510|NCT01405196|11682607|FG000|Overall Study|Other|2
7411511|NCT01405196|11682608|FG001|Overall Study|Other|2
7411512|NCT01405196|11682609|FG002|Overall Study|Other|5
7411513|NCT01405196|11682610|FG003|Overall Study|Other|0
7411514|NCT01405196|11682607|FG000|Overall Study|Withdrawal by Subject|4
7411515|NCT01405196|11682608|FG001|Overall Study|Withdrawal by Subject|6
7411516|NCT01405196|11682609|FG002|Overall Study|Withdrawal by Subject|3
7411517|NCT01405196|11682610|FG003|Overall Study|Withdrawal by Subject|6
7411518|NCT01405196|11682607|FG000|Overall Study|Adverse Event|2
7411519|NCT01405196|11682608|FG001|Overall Study|Adverse Event|2
7411520|NCT01405196|11682609|FG002|Overall Study|Adverse Event|0
7411521|NCT01405196|11682610|FG003|Overall Study|Adverse Event|2
7411522|NCT01405196|11682607|FG000|Overall Study|Death|1
7411523|NCT01405196|11682608|FG001|Overall Study|Death|0
7411524|NCT01405196|11682609|FG002|Overall Study|Death|3
7411525|NCT01405196|11682610|FG003|Overall Study|Death|0
7411526|NCT01405196|11682607|FG000|Overall Study|Lost to Follow-up|2
7411527|NCT01405196|11682608|FG001|Overall Study|Lost to Follow-up|2
7411528|NCT01405196|11682609|FG002|Overall Study|Lost to Follow-up|3
7411529|NCT01405196|11682610|FG003|Overall Study|Lost to Follow-up|1
7411530|NCT01405456|11682631|FG000|Overall Study|Lost to Follow-up|2
7411531|NCT01405456|11682632|FG001|Overall Study|Lost to Follow-up|1
7411532|NCT01405456|11682631|FG000|Overall Study|Physician Decision|1
7411533|NCT01405456|11682632|FG001|Overall Study|Physician Decision|0
7411534|NCT01405508|11682647|FG000|Overall Study|AE, non-serious non-fatal|1
7411535|NCT01405508|11682648|FG001|Overall Study|AE, non-serious non-fatal|1
7411536|NCT01405508|11682649|FG002|Overall Study|AE, non-serious non-fatal|0
7411537|NCT01405508|11682650|FG003|Overall Study|AE, non-serious non-fatal|0
7411538|NCT01405560|11682660|FG000|Overall Study|Physician Decision|1
7411539|NCT01405742|11682664|FG000|Overall Study|Lost to Follow-up|1
7411540|NCT01405742|11682665|FG001|Overall Study|Lost to Follow-up|0
7411541|NCT01405768|11682673|FG000|Overall Study|Didn't complete questionnaire correctly|4
7411542|NCT01405768|11682674|FG001|Overall Study|Didn't complete questionnaire correctly|0
7411543|NCT01405820|11682692|FG000|Randomized Treatment Period|Adverse Event|3
7411544|NCT01405820|11682693|FG001|Randomized Treatment Period|Adverse Event|3
7411545|NCT01405820|11682694|FG002|Randomized Treatment Period|Adverse Event|3
7411546|NCT01405820|11682695|FG003|Randomized Treatment Period|Adverse Event|0
7411547|NCT01405820|11682696|FG004|Randomized Treatment Period|Adverse Event|2
7411548|NCT01405820|11682697|FG005|Randomized Treatment Period|Adverse Event|1
7411549|NCT01405820|11682692|FG000|Randomized Treatment Period|Withdrawal by Subject|6
7411550|NCT01405820|11682693|FG001|Randomized Treatment Period|Withdrawal by Subject|2
7411551|NCT01405820|11682694|FG002|Randomized Treatment Period|Withdrawal by Subject|2
7411552|NCT01405820|11682695|FG003|Randomized Treatment Period|Withdrawal by Subject|2
7411553|NCT01405820|11682696|FG004|Randomized Treatment Period|Withdrawal by Subject|0
7411554|NCT01405820|11682697|FG005|Randomized Treatment Period|Withdrawal by Subject|0
7411555|NCT01405820|11682692|FG000|Randomized Treatment Period|Other|2
7411556|NCT01405820|11682693|FG001|Randomized Treatment Period|Other|2
7411557|NCT01405820|11682694|FG002|Randomized Treatment Period|Other|1
7411558|NCT01405820|11682695|FG003|Randomized Treatment Period|Other|1
7411559|NCT01405820|11682696|FG004|Randomized Treatment Period|Other|0
7411560|NCT01405820|11682697|FG005|Randomized Treatment Period|Other|0
7411561|NCT01405820|11682692|FG000|Randomized Treatment Period|Physician Decision|0
7411562|NCT01405820|11682693|FG001|Randomized Treatment Period|Physician Decision|2
7411563|NCT01405820|11682694|FG002|Randomized Treatment Period|Physician Decision|1
7411564|NCT01405820|11682695|FG003|Randomized Treatment Period|Physician Decision|0
7411565|NCT01405820|11682696|FG004|Randomized Treatment Period|Physician Decision|0
7411566|NCT01405820|11682697|FG005|Randomized Treatment Period|Physician Decision|0
7411567|NCT01405820|11682692|FG000|Randomized Treatment Period|Rescue|0
7411568|NCT01405820|11682693|FG001|Randomized Treatment Period|Rescue|1
7411569|NCT01405820|11682694|FG002|Randomized Treatment Period|Rescue|13
7411570|NCT01405820|11682695|FG003|Randomized Treatment Period|Rescue|10
7411571|NCT01405820|11682696|FG004|Randomized Treatment Period|Rescue|8
7411572|NCT01405820|11682697|FG005|Randomized Treatment Period|Rescue|8
7411573|NCT01405820|11682692|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
7411574|NCT01405820|11682693|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
7411575|NCT01405820|11682694|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
7411576|NCT01405820|11682695|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
7411577|NCT01405820|11682696|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
7411578|NCT01405820|11682697|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
7411579|NCT01405820|11682692|FG000|Randomized Treatment Period|Treatment Arm Closed|0
7411580|NCT01405820|11682693|FG001|Randomized Treatment Period|Treatment Arm Closed|0
7411581|NCT01405820|11682694|FG002|Randomized Treatment Period|Treatment Arm Closed|20
7411582|NCT01405820|11682695|FG003|Randomized Treatment Period|Treatment Arm Closed|36
7411583|NCT01405820|11682696|FG004|Randomized Treatment Period|Treatment Arm Closed|33
7411584|NCT01405820|11682697|FG005|Randomized Treatment Period|Treatment Arm Closed|28
7411585|NCT01405820|11682692|FG000|Randomized Treatment Period|Death|0
7411586|NCT01405820|11682693|FG001|Randomized Treatment Period|Death|0
7411587|NCT01405820|11682694|FG002|Randomized Treatment Period|Death|0
7411588|NCT01405820|11682695|FG003|Randomized Treatment Period|Death|1
7411589|NCT01405820|11682696|FG004|Randomized Treatment Period|Death|0
7411590|NCT01405820|11682697|FG005|Randomized Treatment Period|Death|0
7411591|NCT01405820|11682692|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
7411592|NCT01405820|11682693|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
7411593|NCT01405820|11682694|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
7411594|NCT01405820|11682695|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
7411595|NCT01405820|11682696|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
7411596|NCT01405820|11682697|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
7411597|NCT01405820|11682692|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
7411598|NCT01405820|11682693|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
7411599|NCT01405820|11682694|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
7411600|NCT01405820|11682695|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
7411601|NCT01405820|11682696|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7411602|NCT01405820|11682697|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
7411603|NCT01405820|11682692|FG000|Open-Label Treatment Period|Other|1
7411604|NCT01405820|11682693|FG001|Open-Label Treatment Period|Other|1
7411605|NCT01405820|11682694|FG002|Open-Label Treatment Period|Other|1
7411606|NCT01405820|11682695|FG003|Open-Label Treatment Period|Other|1
7411607|NCT01405820|11682696|FG004|Open-Label Treatment Period|Other|1
7411608|NCT01405820|11682697|FG005|Open-Label Treatment Period|Other|1
7411609|NCT01405820|11682692|FG000|Open-Label Treatment Period|Physician Decision|0
7411610|NCT01405820|11682693|FG001|Open-Label Treatment Period|Physician Decision|0
7411611|NCT01405820|11682694|FG002|Open-Label Treatment Period|Physician Decision|1
7411612|NCT01405820|11682695|FG003|Open-Label Treatment Period|Physician Decision|2
7411613|NCT01405820|11682696|FG004|Open-Label Treatment Period|Physician Decision|1
7411614|NCT01405820|11682697|FG005|Open-Label Treatment Period|Physician Decision|0
7411615|NCT01405820|11682692|FG000|Open-Label Treatment Period|Adverse Event|0
7411616|NCT01405820|11682693|FG001|Open-Label Treatment Period|Adverse Event|0
7411617|NCT01405820|11682694|FG002|Open-Label Treatment Period|Adverse Event|0
7411618|NCT01405820|11682695|FG003|Open-Label Treatment Period|Adverse Event|1
7411619|NCT01405820|11682696|FG004|Open-Label Treatment Period|Adverse Event|0
7411620|NCT01405820|11682697|FG005|Open-Label Treatment Period|Adverse Event|0
7411621|NCT01405898|11682719|FG000|Overall Study|Withdrawal by Subject|2
7411622|NCT01405898|11682720|FG001|Overall Study|Withdrawal by Subject|2
7411623|NCT01405911|11682729|FG000|Overall Study|Pre-treatment lab AE|0
7411624|NCT01405911|11682730|FG001|Overall Study|Pre-treatment lab AE|1
7411625|NCT01405911|11682731|FG002|Overall Study|Pre-treatment lab AE|0
7411626|NCT01405911|11682729|FG000|Overall Study|Lost to Follow-up|0
7411627|NCT01405911|11682730|FG001|Overall Study|Lost to Follow-up|1
7411628|NCT01405911|11682731|FG002|Overall Study|Lost to Follow-up|0
7411629|NCT01405911|11682729|FG000|Overall Study|Protocol Violation|1
7411630|NCT01405911|11682730|FG001|Overall Study|Protocol Violation|0
7411631|NCT01405911|11682731|FG002|Overall Study|Protocol Violation|0
7411632|NCT01405911|11682729|FG000|Overall Study|Withdrawal by Subject|3
7411633|NCT01405911|11682730|FG001|Overall Study|Withdrawal by Subject|1
7411634|NCT01405911|11682731|FG002|Overall Study|Withdrawal by Subject|1
7411635|NCT01405924|11682739|FG000|Overall Study|Protocol Violation|8
7411636|NCT01405924|11682739|FG000|Overall Study|Missing/Incomplete Data|2
7411637|NCT01405950|11682756|FG000|Overall Study|Withdrawal by Subject|1
7411638|NCT01405950|11682757|FG001|Overall Study|Withdrawal by Subject|0
7411639|NCT01405950|11682758|FG002|Overall Study|Withdrawal by Subject|0
7411640|NCT01405950|11682759|FG003|Overall Study|Withdrawal by Subject|0
7411641|NCT01406015|11682769|FG000|Overall Study|Withdrawal by Subject|3
7411642|NCT01406015|11682770|FG001|Overall Study|Withdrawal by Subject|3
7411643|NCT01406574|11682806|FG000|Overall Study|Adverse Event|0
7411644|NCT01406574|11682807|FG001|Overall Study|Adverse Event|0
7411645|NCT01406574|11682808|FG002|Overall Study|Adverse Event|1
7411646|NCT01406574|11682809|FG003|Overall Study|Adverse Event|3
7411647|NCT01406574|11682806|FG000|Overall Study|Physician Decision|0
7411648|NCT01406574|11682807|FG001|Overall Study|Physician Decision|0
7411649|NCT01406574|11682808|FG002|Overall Study|Physician Decision|0
7411650|NCT01406574|11682809|FG003|Overall Study|Physician Decision|1
7411651|NCT01406574|11682806|FG000|Overall Study|Withdrawal by Subject|0
7411652|NCT01406574|11682807|FG001|Overall Study|Withdrawal by Subject|1
7411653|NCT01406574|11682808|FG002|Overall Study|Withdrawal by Subject|0
7411654|NCT01406574|11682809|FG003|Overall Study|Withdrawal by Subject|0
7411655|NCT01406574|11682806|FG000|Overall Study|Definite progression of primary disease|1
7411656|NCT01406574|11682807|FG001|Overall Study|Definite progression of primary disease|0
7411657|NCT01406574|11682808|FG002|Overall Study|Definite progression of primary disease|0
7411658|NCT01406574|11682809|FG003|Overall Study|Definite progression of primary disease|0
7411659|NCT01406652|11682822|FG000|Overall Study|Lost-to-follow-up|3
7411660|NCT01406652|11682823|FG001|Overall Study|Lost-to-follow-up|4
7411661|NCT01406652|11682822|FG000|Overall Study|Withdrawal by Subject|2
7411662|NCT01406652|11682823|FG001|Overall Study|Withdrawal by Subject|2
7411663|NCT01406652|11682822|FG000|Overall Study|Insufficient follow-up|5
7411664|NCT01406652|11682823|FG001|Overall Study|Insufficient follow-up|4
7411665|NCT01406652|11682822|FG000|Overall Study|Infection not sure|10
7411666|NCT01406652|11682823|FG001|Overall Study|Infection not sure|10
7411667|NCT01406717|11682833|FG000|Overall Study|Subject non-compliance|4
7411668|NCT01406717|11682834|FG001|Overall Study|Subject non-compliance|3
7411669|NCT01406717|11682833|FG000|Overall Study|Protocol Violation|5
7411670|NCT01406717|11682834|FG001|Overall Study|Protocol Violation|1
7411671|NCT01406717|11682833|FG000|Overall Study|Lost to Follow-up|14
7411672|NCT01406717|11682834|FG001|Overall Study|Lost to Follow-up|8
7411673|NCT01406717|11682833|FG000|Overall Study|Withdrawal by Subject|19
7411674|NCT01406717|11682834|FG001|Overall Study|Withdrawal by Subject|15
7411675|NCT01406717|11682833|FG000|Overall Study|Adverse Event|1
7411676|NCT01406717|11682834|FG001|Overall Study|Adverse Event|2
7411677|NCT01406717|11682833|FG000|Overall Study|Lack of Efficacy|0
7411678|NCT01406717|11682834|FG001|Overall Study|Lack of Efficacy|1
7411679|NCT01406717|11682833|FG000|Overall Study|Non-completion of visit activity|0
7411680|NCT01406717|11682834|FG001|Overall Study|Non-completion of visit activity|1
7411681|NCT01406795|11682850|FG000|Overall Study|Withdrawal by Subject|1
7411682|NCT01406873|11682856|FG000|Overall Study|Withdrawal by Subject|1
7411683|NCT01406873|11682857|FG001|Overall Study|Withdrawal by Subject|1
7411684|NCT01406938|11682875|FG000|Induction Period|Subject/guardian decision|6
7411685|NCT01406938|11682876|FG001|Induction Period|Subject/guardian decision|8
7411686|NCT01406938|11682877|FG002|Induction Period|Subject/guardian decision|0
7411687|NCT01406938|11682878|FG003|Induction Period|Subject/guardian decision|0
7411688|NCT01406938|11682879|FG004|Induction Period|Subject/guardian decision|0
7411689|NCT01406938|11682880|FG005|Induction Period|Subject/guardian decision|0
7411690|NCT01406938|11682875|FG000|Induction Period|Protocol deviation|1
7411691|NCT01406938|11682876|FG001|Induction Period|Protocol deviation|0
7411692|NCT01406938|11682877|FG002|Induction Period|Protocol deviation|0
7411693|NCT01406938|11682878|FG003|Induction Period|Protocol deviation|0
7411694|NCT01406938|11682879|FG004|Induction Period|Protocol deviation|0
7411695|NCT01406938|11682880|FG005|Induction Period|Protocol deviation|0
7411696|NCT01406938|11682875|FG000|Induction Period|Adverse Event|8
7411697|NCT01406938|11682876|FG001|Induction Period|Adverse Event|9
7411698|NCT01406938|11682877|FG002|Induction Period|Adverse Event|0
7411699|NCT01406938|11682878|FG003|Induction Period|Adverse Event|0
7411700|NCT01406938|11682879|FG004|Induction Period|Adverse Event|0
7411701|NCT01406938|11682880|FG005|Induction Period|Adverse Event|0
7411702|NCT01406938|11682875|FG000|Induction Period|Lack of Efficacy|1
7411703|NCT01406938|11682876|FG001|Induction Period|Lack of Efficacy|0
7411704|NCT01406938|11682877|FG002|Induction Period|Lack of Efficacy|0
7411705|NCT01406938|11682878|FG003|Induction Period|Lack of Efficacy|0
7411706|NCT01406938|11682879|FG004|Induction Period|Lack of Efficacy|0
7411707|NCT01406938|11682880|FG005|Induction Period|Lack of Efficacy|0
7411708|NCT01406938|11682875|FG000|Induction Period|Lost to Follow-up|2
7411709|NCT01406938|11682876|FG001|Induction Period|Lost to Follow-up|3
7411710|NCT01406938|11682877|FG002|Induction Period|Lost to Follow-up|0
7411711|NCT01406938|11682878|FG003|Induction Period|Lost to Follow-up|0
7411712|NCT01406938|11682879|FG004|Induction Period|Lost to Follow-up|0
7411713|NCT01406938|11682880|FG005|Induction Period|Lost to Follow-up|0
7411714|NCT01406938|11682875|FG000|Maintenance Period|Adverse Event|0
7411715|NCT01406938|11682876|FG001|Maintenance Period|Adverse Event|0
7411716|NCT01406938|11682877|FG002|Maintenance Period|Adverse Event|2
7411717|NCT01406938|11682878|FG003|Maintenance Period|Adverse Event|8
7411718|NCT01406938|11682879|FG004|Maintenance Period|Adverse Event|4
7411719|NCT01406938|11682880|FG005|Maintenance Period|Adverse Event|2
7411720|NCT01406938|11682875|FG000|Maintenance Period|Death|0
7411721|NCT01406938|11682876|FG001|Maintenance Period|Death|0
7411722|NCT01406938|11682877|FG002|Maintenance Period|Death|0
7411723|NCT01406938|11682878|FG003|Maintenance Period|Death|0
7411724|NCT01406938|11682879|FG004|Maintenance Period|Death|1
7411725|NCT01406938|11682880|FG005|Maintenance Period|Death|0
7411726|NCT01406938|11682875|FG000|Maintenance Period|Subject/guardian decision|0
7411727|NCT01406938|11682876|FG001|Maintenance Period|Subject/guardian decision|0
7411728|NCT01406938|11682877|FG002|Maintenance Period|Subject/guardian decision|11
7411729|NCT01406938|11682878|FG003|Maintenance Period|Subject/guardian decision|7
7411730|NCT01406938|11682879|FG004|Maintenance Period|Subject/guardian decision|10
7411731|NCT01406938|11682880|FG005|Maintenance Period|Subject/guardian decision|7
7411732|NCT01406938|11682875|FG000|Maintenance Period|Protocol Violation|0
7411733|NCT01406938|11682876|FG001|Maintenance Period|Protocol Violation|0
7411734|NCT01406938|11682877|FG002|Maintenance Period|Protocol Violation|2
7411735|NCT01406938|11682878|FG003|Maintenance Period|Protocol Violation|2
7411736|NCT01406938|11682879|FG004|Maintenance Period|Protocol Violation|2
7411737|NCT01406938|11682880|FG005|Maintenance Period|Protocol Violation|2
7411738|NCT01406938|11682875|FG000|Maintenance Period|Pregnancy|0
7411739|NCT01406938|11682876|FG001|Maintenance Period|Pregnancy|0
7411740|NCT01406938|11682877|FG002|Maintenance Period|Pregnancy|0
7411741|NCT01406938|11682878|FG003|Maintenance Period|Pregnancy|0
7411742|NCT01406938|11682879|FG004|Maintenance Period|Pregnancy|1
7411743|NCT01406938|11682880|FG005|Maintenance Period|Pregnancy|0
7411744|NCT01406938|11682875|FG000|Maintenance Period|Lost to Follow-up|0
7411745|NCT01406938|11682876|FG001|Maintenance Period|Lost to Follow-up|0
7411746|NCT01406938|11682877|FG002|Maintenance Period|Lost to Follow-up|0
7411747|NCT01406938|11682878|FG003|Maintenance Period|Lost to Follow-up|0
7411748|NCT01406938|11682879|FG004|Maintenance Period|Lost to Follow-up|4
7411749|NCT01406938|11682880|FG005|Maintenance Period|Lost to Follow-up|0
7411750|NCT01406938|11682875|FG000|Maintenance Period|Lack of Efficacy|0
7411751|NCT01406938|11682876|FG001|Maintenance Period|Lack of Efficacy|0
7411752|NCT01406938|11682877|FG002|Maintenance Period|Lack of Efficacy|2
7411753|NCT01406938|11682878|FG003|Maintenance Period|Lack of Efficacy|1
7411754|NCT01406938|11682879|FG004|Maintenance Period|Lack of Efficacy|3
7411755|NCT01406938|11682880|FG005|Maintenance Period|Lack of Efficacy|5
7411756|NCT01406938|11682875|FG000|Follow up|Lack of Efficacy|3
7411757|NCT01406938|11682876|FG001|Follow up|Lack of Efficacy|2
7411758|NCT01406938|11682877|FG002|Follow up|Lack of Efficacy|1
7411759|NCT01406938|11682878|FG003|Follow up|Lack of Efficacy|0
7411760|NCT01406938|11682879|FG004|Follow up|Lack of Efficacy|0
7411761|NCT01406938|11682880|FG005|Follow up|Lack of Efficacy|0
7411762|NCT01406938|11682875|FG000|Follow up|Patient/guardian decision|4
7411763|NCT01406938|11682876|FG001|Follow up|Patient/guardian decision|2
7411764|NCT01406938|11682877|FG002|Follow up|Patient/guardian decision|4
7411765|NCT01406938|11682878|FG003|Follow up|Patient/guardian decision|2
7411766|NCT01406938|11682879|FG004|Follow up|Patient/guardian decision|4
7411767|NCT01406938|11682880|FG005|Follow up|Patient/guardian decision|1
7411768|NCT01406938|11682875|FG000|Follow up|Protocol Violation|0
7411769|NCT01406938|11682876|FG001|Follow up|Protocol Violation|0
7411770|NCT01406938|11682877|FG002|Follow up|Protocol Violation|1
7411771|NCT01406938|11682878|FG003|Follow up|Protocol Violation|0
7411772|NCT01406938|11682879|FG004|Follow up|Protocol Violation|0
7411773|NCT01406938|11682880|FG005|Follow up|Protocol Violation|0
7411774|NCT01406938|11682875|FG000|Follow up|Physician Decision|0
7411775|NCT01406938|11682876|FG001|Follow up|Physician Decision|0
7411776|NCT01406938|11682877|FG002|Follow up|Physician Decision|2
7411777|NCT01406938|11682878|FG003|Follow up|Physician Decision|0
7411778|NCT01406938|11682879|FG004|Follow up|Physician Decision|3
7411779|NCT01406938|11682880|FG005|Follow up|Physician Decision|1
7411780|NCT01406938|11682875|FG000|Follow up|Lost to Follow-up|1
7411781|NCT01406938|11682876|FG001|Follow up|Lost to Follow-up|1
7411782|NCT01406938|11682877|FG002|Follow up|Lost to Follow-up|0
7411783|NCT01406938|11682878|FG003|Follow up|Lost to Follow-up|1
7411784|NCT01406938|11682879|FG004|Follow up|Lost to Follow-up|2
7411785|NCT01406938|11682880|FG005|Follow up|Lost to Follow-up|1
7411786|NCT01407276|11682944|FG000|Overall Study|Withdrawal by Subject|0
7411787|NCT01407276|11682945|FG001|Overall Study|Withdrawal by Subject|0
7411788|NCT01407276|11682946|FG002|Overall Study|Withdrawal by Subject|0
7411789|NCT01407276|11682947|FG003|Overall Study|Withdrawal by Subject|0
7411790|NCT01407276|11682948|FG004|Overall Study|Withdrawal by Subject|0
7411791|NCT01407276|11682949|FG005|Overall Study|Withdrawal by Subject|0
7411792|NCT01407276|11682950|FG006|Overall Study|Withdrawal by Subject|0
7411793|NCT01407276|11682951|FG007|Overall Study|Withdrawal by Subject|1
7411794|NCT01407354|11682976|FG000|First Intervention|Withdrawal by Subject|0
7411795|NCT01407354|11682977|FG001|First Intervention|Withdrawal by Subject|2
7411796|NCT01407354|11682976|FG000|First Intervention|Adverse Event|1
7411797|NCT01407354|11682977|FG001|First Intervention|Adverse Event|0
7411798|NCT01407354|11682976|FG000|First Intervention|Physician Decision|1
7411799|NCT01407354|11682977|FG001|First Intervention|Physician Decision|0
7411800|NCT01407367|11682986|FG000|Overall Study|Death|24
7411801|NCT01407367|11682987|FG001|Overall Study|Death|32
7411802|NCT01407367|11682986|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
7411803|NCT01407367|11682987|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
7411804|NCT01407367|11682986|FG000|Overall Study|Withdrawal by Subject|4
7411805|NCT01407367|11682987|FG001|Overall Study|Withdrawal by Subject|15
7411806|NCT01407367|11682986|FG000|Overall Study|Lost to Follow-up|0
7411807|NCT01407367|11682987|FG001|Overall Study|Lost to Follow-up|2
7411808|NCT01407926|11683011|FG000|Overall Study|Lost to Follow-up|55
7411809|NCT01408030|11683029|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
7411810|NCT01408030|11683030|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
7411811|NCT01408030|11683031|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
7411812|NCT01408030|11683032|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
7411813|NCT01408030|11683029|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
7411814|NCT01408030|11683030|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
7411815|NCT01408030|11683031|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
7411816|NCT01408030|11683032|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
7411817|NCT01408030|11683029|FG000|Treatment Phase (on Drug)|Protocol Violation|0
7411818|NCT01408030|11683030|FG001|Treatment Phase (on Drug)|Protocol Violation|1
7411819|NCT01408030|11683031|FG002|Treatment Phase (on Drug)|Protocol Violation|0
7411820|NCT01408030|11683032|FG003|Treatment Phase (on Drug)|Protocol Violation|0
7411821|NCT01408030|11683029|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
7411822|NCT01408030|11683030|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
7411823|NCT01408030|11683031|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
7411824|NCT01408030|11683032|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
7411825|NCT01408030|11683029|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
7411826|NCT01408030|11683030|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
7411827|NCT01408030|11683031|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
7411828|NCT01408030|11683032|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
7411829|NCT01408030|11683029|FG000|Observation Phase (Off Drug)|Physician Decision|0
7411830|NCT01408030|11683030|FG001|Observation Phase (Off Drug)|Physician Decision|1
7411831|NCT01408030|11683031|FG002|Observation Phase (Off Drug)|Physician Decision|2
7411832|NCT01408030|11683032|FG003|Observation Phase (Off Drug)|Physician Decision|0
7411833|NCT01408030|11683029|FG000|Observation Phase (Off Drug)|Other|1
7411834|NCT01408030|11683030|FG001|Observation Phase (Off Drug)|Other|1
7411835|NCT01408030|11683031|FG002|Observation Phase (Off Drug)|Other|1
7411836|NCT01408030|11683032|FG003|Observation Phase (Off Drug)|Other|1
7411837|NCT01408043|11683042|FG000|Overall Study|unable to collect cells|1
7411838|NCT01408147|11683048|FG000|Overall Study|Withdrawal by Subject|0
7411839|NCT01408147|11683049|FG001|Overall Study|Withdrawal by Subject|1
7411840|NCT01408277|11683057|FG000|Overall Study|Adverse Event|3
7411841|NCT01408277|11683058|FG001|Overall Study|Adverse Event|4
7411842|NCT01408277|11683057|FG000|Overall Study|Lost to Follow-up|1
7411843|NCT01408277|11683058|FG001|Overall Study|Lost to Follow-up|0
7411844|NCT01408277|11683057|FG000|Overall Study|Withdrawal by Subject|2
7411845|NCT01408277|11683058|FG001|Overall Study|Withdrawal by Subject|0
7411846|NCT01408277|11683057|FG000|Overall Study|Protocol Violation|2
7411847|NCT01408277|11683058|FG001|Overall Study|Protocol Violation|0
7411848|NCT01408303|11683067|FG000|Overall Study|Adverse Event|3
7411849|NCT01408303|11683068|FG001|Overall Study|Adverse Event|7
7411850|NCT01408303|11683069|FG002|Overall Study|Adverse Event|2
7411851|NCT01408303|11683067|FG000|Overall Study|Lost to Follow-up|0
7411852|NCT01408303|11683068|FG001|Overall Study|Lost to Follow-up|1
7411853|NCT01408303|11683069|FG002|Overall Study|Lost to Follow-up|2
7411854|NCT01408303|11683067|FG000|Overall Study|Withdrawal by Subject|2
7411855|NCT01408303|11683068|FG001|Overall Study|Withdrawal by Subject|3
7411856|NCT01408303|11683069|FG002|Overall Study|Withdrawal by Subject|1
7411857|NCT01408303|11683067|FG000|Overall Study|Protocol Violation|0
7411858|NCT01408303|11683068|FG001|Overall Study|Protocol Violation|1
7411859|NCT01408303|11683069|FG002|Overall Study|Protocol Violation|0
7411860|NCT01408303|11683067|FG000|Overall Study|Noncompliance|1
7411861|NCT01408303|11683068|FG001|Overall Study|Noncompliance|0
7411862|NCT01408303|11683069|FG002|Overall Study|Noncompliance|1
7411863|NCT01408459|11683088|FG000|Overall Study|Withdrawal by Subject|1
7411864|NCT01408459|11683089|FG001|Overall Study|Withdrawal by Subject|1
7466215|NCT01889862|11765952|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
7466216|NCT01889862|11765953|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
7466217|NCT01889862|11765949|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
7466218|NCT01889862|11765950|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
7466219|NCT01889862|11765951|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
7466220|NCT01889862|11765952|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
7466221|NCT01889862|11765953|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
7466222|NCT01889862|11765949|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
7466223|NCT01889862|11765950|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
7466224|NCT01889862|11765951|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
7466225|NCT01889862|11765952|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
7466226|NCT01889862|11765953|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
7466227|NCT01889862|11765949|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7466228|NCT01889862|11765950|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7466229|NCT01889862|11765951|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7466230|NCT01889862|11765952|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
7466231|NCT01889862|11765953|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
7466232|NCT01889862|11765949|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7466233|NCT01889862|11765950|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7466234|NCT01889862|11765951|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7466235|NCT01889862|11765952|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
7466236|NCT01889862|11765953|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
7466237|NCT01889862|11765949|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
7466238|NCT01889862|11765950|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
7466239|NCT01889862|11765951|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
7466240|NCT01889862|11765952|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
7466241|NCT01889862|11765953|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
7466242|NCT01889862|11765949|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7466243|NCT01889862|11765950|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7466244|NCT01889862|11765951|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7466245|NCT01889862|11765952|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
7466246|NCT01889862|11765953|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
7466247|NCT01890109|11766001|FG000|Overall Study|Withdrawal by Subject|0
7466248|NCT01890109|11766002|FG001|Overall Study|Withdrawal by Subject|3
7466249|NCT01890109|11766001|FG000|Overall Study|Lost to Follow-up|1
7466250|NCT01890109|11766002|FG001|Overall Study|Lost to Follow-up|2
7466251|NCT01890122|11766013|FG000|Overall Study|Adverse Event|1
7466252|NCT01890122|11766014|FG001|Overall Study|Adverse Event|1
7466253|NCT01890122|11766015|FG002|Overall Study|Adverse Event|1
7466254|NCT01890122|11766016|FG003|Overall Study|Adverse Event|2
7466255|NCT01890122|11766013|FG000|Overall Study|Major Protocol Deviation|3
7466256|NCT01890122|11766014|FG001|Overall Study|Major Protocol Deviation|1
7466257|NCT01890122|11766015|FG002|Overall Study|Major Protocol Deviation|0
7466258|NCT01890122|11766016|FG003|Overall Study|Major Protocol Deviation|1
7466259|NCT01890122|11766013|FG000|Overall Study|Lost to Follow-up|0
7466260|NCT01890122|11766014|FG001|Overall Study|Lost to Follow-up|1
7466261|NCT01890122|11766015|FG002|Overall Study|Lost to Follow-up|2
7466262|NCT01890122|11766016|FG003|Overall Study|Lost to Follow-up|2
7466263|NCT01890122|11766013|FG000|Overall Study|Voluntary Withdrawal|8
7466264|NCT01890122|11766014|FG001|Overall Study|Voluntary Withdrawal|8
7466265|NCT01890122|11766015|FG002|Overall Study|Voluntary Withdrawal|2
7466266|NCT01890122|11766016|FG003|Overall Study|Voluntary Withdrawal|11
7466267|NCT01890122|11766013|FG000|Overall Study|Lack of Efficacy|14
7466268|NCT01890122|11766014|FG001|Overall Study|Lack of Efficacy|24
7466269|NCT01890122|11766015|FG002|Overall Study|Lack of Efficacy|7
7466270|NCT01890122|11766016|FG003|Overall Study|Lack of Efficacy|41
7466271|NCT01890122|11766013|FG000|Overall Study|Reason not Specified|0
7466272|NCT01890122|11766014|FG001|Overall Study|Reason not Specified|1
7466273|NCT01890122|11766015|FG002|Overall Study|Reason not Specified|1
7466274|NCT01890122|11766016|FG003|Overall Study|Reason not Specified|2
7466275|NCT01890122|11766013|FG000|Overall Study|Randomized but not Treated|1
7466276|NCT01890122|11766014|FG001|Overall Study|Randomized but not Treated|1
7466277|NCT01890122|11766015|FG002|Overall Study|Randomized but not Treated|0
7466278|NCT01890122|11766016|FG003|Overall Study|Randomized but not Treated|0
7466279|NCT01890148|11766026|FG000|Overall Study|Adverse Event|1
7466280|NCT01890265|11766045|FG000|Overall Study|Other (Unspecified reason)|0
7466281|NCT01890265|11766046|FG001|Overall Study|Other (Unspecified reason)|1
7466282|NCT01890265|11766047|FG002|Overall Study|Other (Unspecified reason)|0
7466283|NCT01890265|11766048|FG003|Overall Study|Other (Unspecified reason)|0
7466284|NCT01890265|11766049|FG004|Overall Study|Other (Unspecified reason)|0
7466285|NCT01890265|11766050|FG005|Overall Study|Other (Unspecified reason)|0
7466286|NCT01890265|11766045|FG000|Overall Study|Progressive disease|6
7466287|NCT01890265|11766046|FG001|Overall Study|Progressive disease|6
7466288|NCT01890265|11766047|FG002|Overall Study|Progressive disease|0
7466289|NCT01890265|11766048|FG003|Overall Study|Progressive disease|0
7466290|NCT01890265|11766049|FG004|Overall Study|Progressive disease|0
7411865|NCT01408485|11683096|FG000|Overall Study|Withdrawal by Subject|21
7411866|NCT01408537|11683100|FG000|Overall Study|Withdrawal by Subject|2
7411867|NCT01408537|11683100|FG000|Overall Study|Protocol Violation|3
7411868|NCT01408537|11683100|FG000|Overall Study|Lost to Follow-up|3
7411869|NCT01408563|11683115|FG000|Overall Study|Ineligible after consent/ registration|2
7411870|NCT01408576|11683122|FG000|Overall Study|Lack of Efficacy|17
7411871|NCT01408576|11683123|FG001|Overall Study|Lack of Efficacy|30
7411872|NCT01408576|11683124|FG002|Overall Study|Lack of Efficacy|48
7411873|NCT01408576|11683122|FG000|Overall Study|Protocol Violation|1
7411874|NCT01408576|11683123|FG001|Overall Study|Protocol Violation|2
7411875|NCT01408576|11683124|FG002|Overall Study|Protocol Violation|2
7411876|NCT01408576|11683122|FG000|Overall Study|Lost to Follow-up|10
7411877|NCT01408576|11683123|FG001|Overall Study|Lost to Follow-up|9
7411878|NCT01408576|11683124|FG002|Overall Study|Lost to Follow-up|17
7411879|NCT01408576|11683122|FG000|Overall Study|Withdrawal by Subject|34
7411880|NCT01408576|11683123|FG001|Overall Study|Withdrawal by Subject|60
7411881|NCT01408576|11683124|FG002|Overall Study|Withdrawal by Subject|66
7411882|NCT01408576|11683122|FG000|Overall Study|Sponsor terminated study|89
7411883|NCT01408576|11683123|FG001|Overall Study|Sponsor terminated study|333
7411884|NCT01408576|11683124|FG002|Overall Study|Sponsor terminated study|330
7411885|NCT01408576|11683122|FG000|Overall Study|AE, serious fatal|4
7411886|NCT01408576|11683123|FG001|Overall Study|AE, serious fatal|4
7411887|NCT01408576|11683124|FG002|Overall Study|AE, serious fatal|1
7411888|NCT01408576|11683122|FG000|Overall Study|SAE, non-fatal|11
7411889|NCT01408576|11683123|FG001|Overall Study|SAE, non-fatal|23
7411890|NCT01408576|11683124|FG002|Overall Study|SAE, non-fatal|14
7411891|NCT01408576|11683122|FG000|Overall Study|AE, non-serious non-fatal|12
7411892|NCT01408576|11683123|FG001|Overall Study|AE, non-serious non-fatal|19
7411893|NCT01408576|11683124|FG002|Overall Study|AE, non-serious non-fatal|11
7411894|NCT01408576|11683122|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7411895|NCT01408576|11683123|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7411896|NCT01408576|11683124|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7411897|NCT01408576|11683122|FG000|Overall Study|AE, unknown type|0
7411898|NCT01408576|11683123|FG001|Overall Study|AE, unknown type|1
7411899|NCT01408576|11683124|FG002|Overall Study|AE, unknown type|0
7411900|NCT01408576|11683122|FG000|Overall Study|Other|10
7411901|NCT01408576|11683123|FG001|Overall Study|Other|16
7411902|NCT01408576|11683124|FG002|Overall Study|Other|18
7411903|NCT01408628|11683144|FG000|Consented|Withdrawal by Subject|12
7411904|NCT01408628|11683144|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
7411905|NCT01408628|11683144|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
7411906|NCT01408628|11683144|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
7411907|NCT01408706|11683151|FG000|Overall Study|Physician Decision|1
7411908|NCT01408706|11683152|FG001|Overall Study|Physician Decision|0
7411909|NCT01408732|11683209|FG000|Overall Study|Withdrawal by Subject|2
7411910|NCT01408732|11683210|FG001|Overall Study|Withdrawal by Subject|2
7411911|NCT01408888|11683221|FG000|First Intervention|Adverse Event|0
7411912|NCT01408888|11683222|FG001|First Intervention|Adverse Event|1
7411913|NCT01408888|11683221|FG000|First Intervention|Withdrawal by Subject|0
7411914|NCT01408888|11683222|FG001|First Intervention|Withdrawal by Subject|2
7411915|NCT01408888|11683221|FG000|Second Intervention|Withdrawal by Subject|1
7411916|NCT01408888|11683222|FG001|Second Intervention|Withdrawal by Subject|0
7411917|NCT01408888|11683221|FG000|Second Intervention|Adverse Event|1
7411918|NCT01408888|11683222|FG001|Second Intervention|Adverse Event|0
7411919|NCT01408901|11683242|FG000|6-Week Follow-Up|Lost to Follow-up|2
7411920|NCT01408901|11683243|FG001|6-Week Follow-Up|Lost to Follow-up|1
7411921|NCT01408901|11683244|FG002|6-Week Follow-Up|Lost to Follow-up|3
7411922|NCT01408901|11683245|FG003|6-Week Follow-Up|Lost to Follow-up|2
7411923|NCT01408901|11683242|FG000|6-Week Follow-Up|Death|1
7411924|NCT01408901|11683243|FG001|6-Week Follow-Up|Death|0
7411925|NCT01408901|11683244|FG002|6-Week Follow-Up|Death|0
7411926|NCT01408901|11683245|FG003|6-Week Follow-Up|Death|0
7411927|NCT01408901|11683242|FG000|6-Week Follow-Up|Cancelled visit|0
7411928|NCT01408901|11683243|FG001|6-Week Follow-Up|Cancelled visit|1
7411929|NCT01408901|11683244|FG002|6-Week Follow-Up|Cancelled visit|0
7411930|NCT01408901|11683245|FG003|6-Week Follow-Up|Cancelled visit|2
7411931|NCT01408901|11683242|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7411932|NCT01408901|11683243|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7411933|NCT01408901|11683244|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
7411934|NCT01408901|11683245|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
7411935|NCT01408901|11683242|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
7411936|NCT01408901|11683243|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
7411937|NCT01408901|11683244|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
7411938|NCT01408901|11683245|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
7411939|NCT01408901|11683242|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7411940|NCT01408901|11683243|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
7411941|NCT01408901|11683244|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
7411942|NCT01408901|11683245|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
7411943|NCT01408901|11683242|FG000|26-Week Follow-Up|Lost to Follow-up|1
7411944|NCT01408901|11683243|FG001|26-Week Follow-Up|Lost to Follow-up|1
7411945|NCT01408901|11683244|FG002|26-Week Follow-Up|Lost to Follow-up|0
7411946|NCT01408901|11683245|FG003|26-Week Follow-Up|Lost to Follow-up|1
7411947|NCT01408901|11683242|FG000|26-Week Follow-Up|Death|0
7411948|NCT01408901|11683243|FG001|26-Week Follow-Up|Death|1
7411949|NCT01408901|11683244|FG002|26-Week Follow-Up|Death|0
7411950|NCT01408901|11683245|FG003|26-Week Follow-Up|Death|0
7411951|NCT01408914|11683260|FG000|Overall Study|Could not complete tx in protocol period|5
7411952|NCT01408914|11683261|FG001|Overall Study|Could not complete tx in protocol period|5
7411953|NCT01408914|11683262|FG002|Overall Study|Could not complete tx in protocol period|6
7411954|NCT01408914|11683260|FG000|Overall Study|Lost to Follow-up|4
7411955|NCT01408914|11683261|FG001|Overall Study|Lost to Follow-up|1
7411956|NCT01408914|11683262|FG002|Overall Study|Lost to Follow-up|2
7411957|NCT01408914|11683260|FG000|Overall Study|Physician Decision|1
7411958|NCT01408914|11683261|FG001|Overall Study|Physician Decision|1
7411959|NCT01408914|11683262|FG002|Overall Study|Physician Decision|0
7411960|NCT01408914|11683260|FG000|Overall Study|Withdrawal by Subject|1
7411961|NCT01408914|11683261|FG001|Overall Study|Withdrawal by Subject|0
7411962|NCT01408914|11683262|FG002|Overall Study|Withdrawal by Subject|1
7411963|NCT01408914|11683260|FG000|Overall Study|Moved out of study jurisdiction|1
7411964|NCT01408914|11683261|FG001|Overall Study|Moved out of study jurisdiction|1
7411965|NCT01408914|11683262|FG002|Overall Study|Moved out of study jurisdiction|0
7411966|NCT01408914|11683260|FG000|Overall Study|Late exclusion|0
7411967|NCT01408914|11683261|FG001|Overall Study|Late exclusion|3
7411968|NCT01408914|11683262|FG002|Overall Study|Late exclusion|3
7411969|NCT01408914|11683260|FG000|Overall Study|Change in local TB/HIV norms|0
7411970|NCT01408914|11683261|FG001|Overall Study|Change in local TB/HIV norms|1
7411971|NCT01408914|11683262|FG002|Overall Study|Change in local TB/HIV norms|1
7411972|NCT01409382|11683315|FG000|Overall Study|Lost to Follow-up|1
7411973|NCT01409382|11683316|FG001|Overall Study|Lost to Follow-up|1
7411974|NCT01409382|11683315|FG000|Overall Study|Protocol Violation|0
7411975|NCT01409382|11683316|FG001|Overall Study|Protocol Violation|3
7411976|NCT01409382|11683315|FG000|Overall Study|Multiple pregnancy|2
7411977|NCT01409382|11683316|FG001|Overall Study|Multiple pregnancy|4
7411978|NCT01409382|11683315|FG000|Overall Study|Still pregnant when study ended|13
7411979|NCT01409382|11683316|FG001|Overall Study|Still pregnant when study ended|2
7411980|NCT01409382|11683315|FG000|Overall Study|Did not manage to get pregnant|64
7411981|NCT01409382|11683316|FG001|Overall Study|Did not manage to get pregnant|70
7411982|NCT01409382|11683315|FG000|Overall Study|Had a 2nd trimester loss after accident|1
7411983|NCT01409382|11683316|FG001|Overall Study|Had a 2nd trimester loss after accident|0
7411984|NCT01409434|11683326|FG000|Overall Study|Protocol Violation|4
7411985|NCT01409564|11683332|FG000|Overall Study|low medication compliance|4
7411986|NCT01409564|11683333|FG001|Overall Study|low medication compliance|3
7411987|NCT01409564|11683332|FG000|Overall Study|brain abnormalities found in T1 MR|1
7411988|NCT01409564|11683333|FG001|Overall Study|brain abnormalities found in T1 MR|2
7411989|NCT01409707|11683346|FG000|Overall Study|Withdrawal by Subject|5
7411990|NCT01409707|11683347|FG001|Overall Study|Withdrawal by Subject|17
7411991|NCT01409707|11683348|FG002|Overall Study|Withdrawal by Subject|16
7411992|NCT01409811|11683355|FG000|Overall Study|Insurance denial|1
7411993|NCT01409837|11683361|FG000|Overall Study|Withdrawal by Subject|2
7411994|NCT01409837|11683362|FG001|Overall Study|Withdrawal by Subject|1
7411995|NCT01409837|11683361|FG000|Overall Study|Lost to Follow-up|1
7411996|NCT01409837|11683362|FG001|Overall Study|Lost to Follow-up|0
7411997|NCT01409837|11683361|FG000|Overall Study|Physician Decision|0
7411998|NCT01409837|11683362|FG001|Overall Study|Physician Decision|1
7411999|NCT01409915|11683372|FG000|Overall Study|Adverse Event|0
7412000|NCT01409915|11683373|FG001|Overall Study|Adverse Event|2
7412001|NCT01409915|11683372|FG000|Overall Study|Withdrawal by Subject|0
7412002|NCT01409915|11683373|FG001|Overall Study|Withdrawal by Subject|1
7412003|NCT01409915|11683372|FG000|Overall Study|Protocol Violation|1
7412004|NCT01409915|11683373|FG001|Overall Study|Protocol Violation|0
7412005|NCT01409928|11683379|FG000|Overall Study|Physician Decision|12
7412006|NCT01409993|11683385|FG000|Overall Study|Adverse Event|4
7412007|NCT01409993|11683386|FG001|Overall Study|Adverse Event|4
7412008|NCT01409993|11683387|FG002|Overall Study|Adverse Event|3
7412009|NCT01409993|11683388|FG003|Overall Study|Adverse Event|1
7412010|NCT01409993|11683385|FG000|Overall Study|Withdrawal by Subject|0
7412011|NCT01409993|11683386|FG001|Overall Study|Withdrawal by Subject|0
7412012|NCT01409993|11683387|FG002|Overall Study|Withdrawal by Subject|0
7412013|NCT01409993|11683388|FG003|Overall Study|Withdrawal by Subject|4
7412014|NCT01409993|11683385|FG000|Overall Study|Lost to Follow-up|0
7412015|NCT01409993|11683386|FG001|Overall Study|Lost to Follow-up|1
7412016|NCT01409993|11683387|FG002|Overall Study|Lost to Follow-up|0
7412017|NCT01409993|11683388|FG003|Overall Study|Lost to Follow-up|0
7412018|NCT01410110|11683433|FG000|Overall Study|Withdrawal by Subject|4
7412019|NCT01410110|11683434|FG001|Overall Study|Withdrawal by Subject|2
7412020|NCT01410227|11683440|FG000|Overall Study|Adverse Event|1
7412021|NCT01410227|11683441|FG001|Overall Study|Adverse Event|0
7412022|NCT01410227|11683442|FG002|Overall Study|Adverse Event|0
7412023|NCT01410227|11683443|FG003|Overall Study|Adverse Event|0
7412024|NCT01410227|11683440|FG000|Overall Study|Withdrawal by Subject|3
7412025|NCT01410227|11683441|FG001|Overall Study|Withdrawal by Subject|0
7412026|NCT01410227|11683442|FG002|Overall Study|Withdrawal by Subject|1
7412027|NCT01410227|11683443|FG003|Overall Study|Withdrawal by Subject|0
7412028|NCT01410227|11683440|FG000|Overall Study|Pregnancy|0
7412029|NCT01410227|11683441|FG001|Overall Study|Pregnancy|0
7412030|NCT01410227|11683442|FG002|Overall Study|Pregnancy|0
7412031|NCT01410227|11683443|FG003|Overall Study|Pregnancy|1
7412032|NCT01410227|11683440|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
7412033|NCT01410227|11683441|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
7412034|NCT01410227|11683442|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
7412035|NCT01410227|11683443|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
7412036|NCT01410240|11683456|FG000|Overall Study|Physician Decision|0
7412037|NCT01410240|11683457|FG001|Overall Study|Physician Decision|0
7412038|NCT01410240|11683458|FG002|Overall Study|Physician Decision|1
7412039|NCT01410240|11683456|FG000|Overall Study|Missed week 6 assessments|1
7412040|NCT01410240|11683457|FG001|Overall Study|Missed week 6 assessments|1
7412041|NCT01410240|11683458|FG002|Overall Study|Missed week 6 assessments|1
7412042|NCT01410357|11683475|FG000|Overall Study|Death|2
7412043|NCT01410357|11683476|FG001|Overall Study|Death|1
7412044|NCT01410357|11683475|FG000|Overall Study|Withdrawal by Subject|1
7412045|NCT01410357|11683476|FG001|Overall Study|Withdrawal by Subject|2
7412046|NCT01410357|11683475|FG000|Overall Study|Lost to Follow-up|23
7412047|NCT01410357|11683476|FG001|Overall Study|Lost to Follow-up|21
7412048|NCT01410448|11683495|FG000|Overall Study|No conversion to everolimus|0
7412049|NCT01410448|11683496|FG001|Overall Study|No conversion to everolimus|24
7412050|NCT01410448|11683495|FG000|Overall Study|Graft loss|4
7412051|NCT01410448|11683496|FG001|Overall Study|Graft loss|1
7412052|NCT01410448|11683495|FG000|Overall Study|Administrative issues|2
7412053|NCT01410448|11683496|FG001|Overall Study|Administrative issues|1
7412054|NCT01410448|11683495|FG000|Overall Study|Lost to Follow-up|1
7412055|NCT01410448|11683496|FG001|Overall Study|Lost to Follow-up|0
7412056|NCT01410448|11683495|FG000|Overall Study|Withdrawal by Subject|3
7412057|NCT01410448|11683496|FG001|Overall Study|Withdrawal by Subject|2
7412058|NCT01410448|11683495|FG000|Overall Study|Protocol Violation|0
7412059|NCT01410448|11683496|FG001|Overall Study|Protocol Violation|4
7412060|NCT01410448|11683495|FG000|Overall Study|Death|2
7412061|NCT01410448|11683496|FG001|Overall Study|Death|3
7412062|NCT01410474|11683504|FG000|Overall Study|Withdrawal by Subject|0
7412063|NCT01410474|11683505|FG001|Overall Study|Withdrawal by Subject|1
7412064|NCT01410604|11683534|FG000|Overall Study|Adverse Event|2
7412065|NCT01410604|11683535|FG001|Overall Study|Adverse Event|1
7412066|NCT01410604|11683534|FG000|Overall Study|Lost to Follow-up|1
7412067|NCT01410604|11683535|FG001|Overall Study|Lost to Follow-up|0
7412068|NCT01410604|11683534|FG000|Overall Study|Physician Decision|0
7412069|NCT01410604|11683535|FG001|Overall Study|Physician Decision|1
7412070|NCT01411085|11683558|FG000|Overall Study|Physician Decision|1
7412071|NCT01411085|11683558|FG000|Overall Study|Protocol Violation|1
7412072|NCT01411085|11683558|FG000|Overall Study|Adverse Event|1
7412073|NCT01411215|11683579|FG000|Overall Study|Adverse Event|1
7412074|NCT01411215|11683580|FG001|Overall Study|Adverse Event|2
7412075|NCT01411215|11683579|FG000|Overall Study|Lack of Efficacy|2
7412076|NCT01411215|11683580|FG001|Overall Study|Lack of Efficacy|4
7412077|NCT01411215|11683579|FG000|Overall Study|Lost to Follow-up|12
7412078|NCT01411215|11683580|FG001|Overall Study|Lost to Follow-up|18
7412079|NCT01411215|11683579|FG000|Overall Study|Did not meet entrance criteria|0
7412080|NCT01411215|11683580|FG001|Overall Study|Did not meet entrance criteria|1
7412081|NCT01411215|11683579|FG000|Overall Study|Study terminated by sponsor|2
7412082|NCT01411215|11683580|FG001|Overall Study|Study terminated by sponsor|15
7412083|NCT01411215|11683579|FG000|Overall Study|Protocol Violation|3
7412084|NCT01411215|11683580|FG001|Overall Study|Protocol Violation|5
7412085|NCT01411215|11683579|FG000|Overall Study|Withdrawal by Subject|34
7412086|NCT01411215|11683580|FG001|Overall Study|Withdrawal by Subject|21
7412087|NCT01411215|11683579|FG000|Overall Study|Other|12
7412088|NCT01411215|11683580|FG001|Overall Study|Other|17
7412089|NCT01411215|11683579|FG000|Overall Study|Screen failure|0
7412090|NCT01411215|11683580|FG001|Overall Study|Screen failure|1
7412091|NCT01411228|11683589|FG000|Overall Study|Lost to Follow-up|0
7412092|NCT01411228|11683590|FG001|Overall Study|Lost to Follow-up|0
7412093|NCT01411228|11683591|FG002|Overall Study|Lost to Follow-up|1
7412094|NCT01411228|11683589|FG000|Overall Study|Withdrawal by Subject|1
7412095|NCT01411228|11683590|FG001|Overall Study|Withdrawal by Subject|0
7412096|NCT01411228|11683591|FG002|Overall Study|Withdrawal by Subject|0
7412097|NCT01411319|11683599|FG000|Overall Study|Lost to Follow-up|1
7412098|NCT01411774|11683652|FG000|Overall Study|Withdrawal by Subject|0
7412099|NCT01411774|11683653|FG001|Overall Study|Withdrawal by Subject|3
7412100|NCT01411839|11683661|FG000|Overall Study|Lost to Follow-up|4
7412101|NCT01411839|11683662|FG001|Overall Study|Lost to Follow-up|3
7412102|NCT01411852|11683670|FG000|Prehospital Intervention Phase|No qualifying SBP|5
7412103|NCT01411852|11683671|FG001|Prehospital Intervention Phase|No qualifying SBP|4
7412104|NCT01411852|11683670|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7412105|NCT01411852|11683671|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
7412106|NCT01411852|11683670|FG000|Prehospital Intervention Phase|Found to be under age|0
7412107|NCT01411852|11683671|FG001|Prehospital Intervention Phase|Found to be under age|1
7412108|NCT01411852|11683670|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
7412109|NCT01411852|11683671|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
7412110|NCT01411852|11683670|FG000|Hospital Intervention Phase|Severe head injury|5
7412111|NCT01411852|11683671|FG001|Hospital Intervention Phase|Severe head injury|4
7412112|NCT01411852|11683670|FG000|Hospital Intervention Phase|No qualifying SBP|5
7412113|NCT01411852|11683671|FG001|Hospital Intervention Phase|No qualifying SBP|1
7412114|NCT01411852|11683670|FG000|Hospital Intervention Phase|Miscommunication error|1
7412115|NCT01411852|11683671|FG001|Hospital Intervention Phase|Miscommunication error|2
7412116|NCT01411852|11683670|FG000|Hospital Intervention Phase|CPR administered|3
7412117|NCT01411852|11683671|FG001|Hospital Intervention Phase|CPR administered|1
7412118|NCT01411852|11683670|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
7412119|NCT01411852|11683671|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
7412120|NCT01411852|11683670|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
7412121|NCT01411852|11683671|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
7412122|NCT01411852|11683670|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
7412123|NCT01411852|11683671|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
7412124|NCT01411852|11683670|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
7412125|NCT01411852|11683671|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
7412126|NCT01411852|11683670|FG000|Hospital Intervention Phase|Other ineligible|2
7412127|NCT01411852|11683671|FG001|Hospital Intervention Phase|Other ineligible|2
7412128|NCT01411852|11683670|FG000|Hospital Intervention Phase|Spinal cord injury|2
7412129|NCT01411852|11683671|FG001|Hospital Intervention Phase|Spinal cord injury|0
7412130|NCT01411852|11683670|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
7412131|NCT01411852|11683671|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
7412132|NCT01411852|11683670|FG000|Hospital Intervention Phase|Vascular access failed|1
7412133|NCT01411852|11683671|FG001|Hospital Intervention Phase|Vascular access failed|0
7412134|NCT01411891|11683681|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
7412135|NCT01411891|11683682|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
7412136|NCT01411917|11683690|FG000|Overall Study|Patient did not undergo scheduled surger|0
7412137|NCT01411917|11683691|FG001|Overall Study|Patient did not undergo scheduled surger|1
7412138|NCT01411995|11683699|FG000|Overall Study|Failed IUD insertion|0
7412139|NCT01411995|11683700|FG001|Overall Study|Failed IUD insertion|1
7412140|NCT01412021|11683706|FG000|Overall Study|Case Report Forms Not Retrieved|7
7412141|NCT01412021|11683706|FG000|Overall Study|Treatment Prior to Approval|3
7412142|NCT01412021|11683706|FG000|Overall Study|Transferred to Other Hospital|9
7412143|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
7412144|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
7412145|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
7412146|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
7412147|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7412148|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
7412149|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
7412150|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
7412151|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
7412152|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
7412153|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7412154|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
7412155|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
7412156|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7412157|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
7412158|NCT01412060|11683710|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
7412159|NCT01412060|11683711|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7412160|NCT01412060|11683712|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
7412161|NCT01412060|11683710|FG000|Period Between RIP and SP|Adverse Event|4
7412162|NCT01412060|11683711|FG001|Period Between RIP and SP|Adverse Event|0
7412163|NCT01412060|11683712|FG002|Period Between RIP and SP|Adverse Event|0
7412164|NCT01412060|11683710|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
7412165|NCT01412060|11683711|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
7412166|NCT01412060|11683712|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
7412167|NCT01412060|11683710|FG000|Period Between RIP and SP|Protocol Violation|2
7412168|NCT01412060|11683711|FG001|Period Between RIP and SP|Protocol Violation|0
7412169|NCT01412060|11683712|FG002|Period Between RIP and SP|Protocol Violation|0
7412170|NCT01412060|11683710|FG000|Period Between RIP and SP|Withdrawal of Consent|1
7412171|NCT01412060|11683711|FG001|Period Between RIP and SP|Withdrawal of Consent|0
7412172|NCT01412060|11683712|FG002|Period Between RIP and SP|Withdrawal of Consent|0
7412173|NCT01412060|11683710|FG000|Period Between RIP and SP|Lost to Follow-up|5
7412174|NCT01412060|11683711|FG001|Period Between RIP and SP|Lost to Follow-up|0
7412175|NCT01412060|11683712|FG002|Period Between RIP and SP|Lost to Follow-up|0
7412176|NCT01412060|11683710|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
7412177|NCT01412060|11683711|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
7412178|NCT01412060|11683712|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
7412179|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
7412180|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
7412181|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
7412182|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
7412183|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7412184|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
7412185|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
7412186|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
7412187|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
7412188|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
7412189|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7412190|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
7412191|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
7412192|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7412193|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
7412194|NCT01412060|11683710|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
7412195|NCT01412060|11683711|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7412196|NCT01412060|11683712|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
7412197|NCT01412060|11683710|FG000|Period Between SP and DBP|Protocol Violation|2
7412198|NCT01412060|11683711|FG001|Period Between SP and DBP|Protocol Violation|0
7412199|NCT01412060|11683712|FG002|Period Between SP and DBP|Protocol Violation|0
7412200|NCT01412060|11683710|FG000|Period Between SP and DBP|Withdrawal of Consent|2
7412201|NCT01412060|11683711|FG001|Period Between SP and DBP|Withdrawal of Consent|0
7412202|NCT01412060|11683712|FG002|Period Between SP and DBP|Withdrawal of Consent|0
7412203|NCT01412060|11683710|FG000|Period Between SP and DBP|Lost to Follow-up|1
7412204|NCT01412060|11683711|FG001|Period Between SP and DBP|Lost to Follow-up|0
7412205|NCT01412060|11683712|FG002|Period Between SP and DBP|Lost to Follow-up|0
7412206|NCT01412060|11683710|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
7412207|NCT01412060|11683711|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7412208|NCT01412060|11683712|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
7412209|NCT01412060|11683710|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
7412210|NCT01412060|11683711|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
7412211|NCT01412060|11683712|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
7412212|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
7412213|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
7412214|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
7412215|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
7412216|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
7412217|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
7412218|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
7412219|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
7412220|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
7412221|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
7412222|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
7412223|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
7412224|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
7412225|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
7412226|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
7412227|NCT01412060|11683710|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
7412228|NCT01412060|11683711|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
7412229|NCT01412060|11683712|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
7412230|NCT01412151|11683726|FG000|Week 0 - 306 - Treatment Period|Death|1
7412231|NCT01412151|11683726|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
7412232|NCT01412151|11683726|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
7412233|NCT01412151|11683726|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
7412234|NCT01412229|11683736|FG000|Overall Study|Physician Decision|1
7412235|NCT01412424|11683767|FG000|Core Treatment Period|Treatment Failure|24
7412236|NCT01412424|11683767|FG000|Core Treatment Period|Adverse Event|21
7412237|NCT01412424|11683767|FG000|Core Treatment Period|Patient Request|5
7412238|NCT01412424|11683767|FG000|Core Treatment Period|Lost to Follow-up|2
7412239|NCT01412424|11683767|FG000|Core Treatment Period|Sponsor Request|1
7412240|NCT01412424|11683767|FG000|Extension Treatment Period|Adverse Event|2
7412241|NCT01412424|11683767|FG000|Extension Treatment Period|Treatment Failure|2
7412242|NCT01412424|11683767|FG000|Extension Treatment Period|Patient Request|2
7412243|NCT01412801|11683808|FG000|Overall Study|Death|0
7412244|NCT01412801|11683809|FG001|Overall Study|Death|1
7412245|NCT01412801|11683810|FG002|Overall Study|Death|0
7412246|NCT01412801|11683811|FG003|Overall Study|Death|4
7412247|NCT01412801|11683812|FG004|Overall Study|Death|2
7412248|NCT01412801|11683813|FG005|Overall Study|Death|2
7412249|NCT01412801|11683808|FG000|Overall Study|Lost to Follow-up|1
7412250|NCT01412801|11683809|FG001|Overall Study|Lost to Follow-up|2
7412251|NCT01412801|11683810|FG002|Overall Study|Lost to Follow-up|4
7412252|NCT01412801|11683811|FG003|Overall Study|Lost to Follow-up|0
7412253|NCT01412801|11683812|FG004|Overall Study|Lost to Follow-up|1
7412254|NCT01412801|11683813|FG005|Overall Study|Lost to Follow-up|1
7412255|NCT01412801|11683808|FG000|Overall Study|Withdrawal by Subject|3
7412256|NCT01412801|11683809|FG001|Overall Study|Withdrawal by Subject|2
7412257|NCT01412801|11683810|FG002|Overall Study|Withdrawal by Subject|1
7412258|NCT01412801|11683811|FG003|Overall Study|Withdrawal by Subject|0
7412259|NCT01412801|11683812|FG004|Overall Study|Withdrawal by Subject|0
7412260|NCT01412801|11683813|FG005|Overall Study|Withdrawal by Subject|0
7412261|NCT01412801|11683808|FG000|Overall Study|Relocated to another area|0
7412262|NCT01412801|11683809|FG001|Overall Study|Relocated to another area|0
7412263|NCT01412801|11683810|FG002|Overall Study|Relocated to another area|2
7412264|NCT01412801|11683811|FG003|Overall Study|Relocated to another area|0
7412265|NCT01412801|11683812|FG004|Overall Study|Relocated to another area|0
7412266|NCT01412801|11683813|FG005|Overall Study|Relocated to another area|0
7412267|NCT01412879|11683847|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
7412268|NCT01412879|11683848|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
7412269|NCT01412879|11683849|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
7412270|NCT01412879|11683847|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
7412271|NCT01412879|11683848|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
7412272|NCT01412879|11683849|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
7412273|NCT01412879|11683847|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
7412274|NCT01412879|11683848|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
7412275|NCT01412879|11683849|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
7412276|NCT01412879|11683847|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
7412277|NCT01412879|11683848|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
7412278|NCT01412879|11683849|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
7412279|NCT01412879|11683847|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
7412280|NCT01412879|11683848|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
7412281|NCT01412879|11683849|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
7412282|NCT01412944|11683871|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7412283|NCT01412944|11683872|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7412284|NCT01412944|11683873|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
7412285|NCT01412944|11683874|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7412286|NCT01412944|11683875|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7412287|NCT01412944|11683876|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
7412288|NCT01412944|11683871|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7412289|NCT01412944|11683872|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7412290|NCT01412944|11683873|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7412291|NCT01412944|11683874|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7412292|NCT01412944|11683875|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
7412293|NCT01412944|11683876|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
7412294|NCT01412944|11683871|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7412295|NCT01412944|11683872|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7412296|NCT01412944|11683873|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7412297|NCT01412944|11683874|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7412298|NCT01412944|11683875|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
7412299|NCT01412944|11683876|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
7412300|NCT01412944|11683871|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
7412301|NCT01412944|11683872|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
7412302|NCT01412944|11683873|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
7412303|NCT01412944|11683874|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
7412304|NCT01412944|11683875|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
7412305|NCT01412944|11683876|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
7412306|NCT01412944|11683871|FG000|IV: Per CAIN457A2307|Protocol deviation|0
7412307|NCT01412944|11683872|FG001|IV: Per CAIN457A2307|Protocol deviation|1
7412308|NCT01412944|11683873|FG002|IV: Per CAIN457A2307|Protocol deviation|0
7412309|NCT01412944|11683874|FG003|IV: Per CAIN457A2307|Protocol deviation|0
7412310|NCT01412944|11683875|FG004|IV: Per CAIN457A2307|Protocol deviation|0
7412311|NCT01412944|11683876|FG005|IV: Per CAIN457A2307|Protocol deviation|0
7412312|NCT01412944|11683871|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
7412313|NCT01412944|11683872|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
7412314|NCT01412944|11683873|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
7412315|NCT01412944|11683874|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
7412316|NCT01412944|11683875|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
7412317|NCT01412944|11683876|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
7412318|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
7412319|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
7412320|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
7412321|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
7412322|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
7412323|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7412324|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Adverse Event|0
7412325|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Adverse Event|0
7412326|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Adverse Event|0
7412327|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Adverse Event|0
7412328|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Adverse Event|1
7412329|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Adverse Event|0
7412330|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Protocol deviation|0
7412331|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Protocol deviation|0
7412332|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Protocol deviation|0
7412333|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Protocol deviation|0
7412334|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Protocol deviation|0
7412335|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Protocol deviation|1
7412336|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7412337|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
7412338|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7412339|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7412340|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7412341|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
7412342|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7412343|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
7412344|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7412345|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7412346|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
7412347|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7412348|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
7412349|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
7412350|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
7412351|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
7412352|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
7412353|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
7412354|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Protocol deviation|0
7412355|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Protocol deviation|1
7412356|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Protocol deviation|0
7412357|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Protocol deviation|0
7412358|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Protocol deviation|0
7412359|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Protocol deviation|0
7412360|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
7412361|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
7412362|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
7412363|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
7412364|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
7412365|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
7412366|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
7412367|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
7412368|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
7412369|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
7412370|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
7412371|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
7412372|NCT01412944|11683871|FG000|Entire: IV + Maintenance|Adverse Event|0
7412373|NCT01412944|11683872|FG001|Entire: IV + Maintenance|Adverse Event|1
7412374|NCT01412944|11683873|FG002|Entire: IV + Maintenance|Adverse Event|0
7412375|NCT01412944|11683874|FG003|Entire: IV + Maintenance|Adverse Event|0
7412376|NCT01412944|11683875|FG004|Entire: IV + Maintenance|Adverse Event|0
7412377|NCT01412944|11683876|FG005|Entire: IV + Maintenance|Adverse Event|0
7412378|NCT01412957|11683894|FG000|Overall Study|Withdrawal by Subject|6
7412379|NCT01412957|11683895|FG001|Overall Study|Withdrawal by Subject|22
7412380|NCT01412957|11683894|FG000|Overall Study|Lost to Follow-up|7
7412381|NCT01412957|11683895|FG001|Overall Study|Lost to Follow-up|2
7412382|NCT01412957|11683894|FG000|Overall Study|Death|136
7412383|NCT01412957|11683895|FG001|Overall Study|Death|133
7412384|NCT01412983|11683901|FG000|1st Period|Ineligible|0
7412385|NCT01412983|11683902|FG001|1st Period|Ineligible|1
7412386|NCT01412983|11683901|FG000|1st Period|Positive slit lamp finding|0
7412387|NCT01412983|11683902|FG001|1st Period|Positive slit lamp finding|1
7412388|NCT01412983|11683901|FG000|1st Period|Unacceptable lens movement|0
7412389|NCT01412983|11683902|FG001|1st Period|Unacceptable lens movement|1
7412390|NCT01412983|11683901|FG000|1st Period|Inability to maintain wear|0
7412391|NCT01412983|11683902|FG001|1st Period|Inability to maintain wear|1
7412392|NCT01413178|11683920|FG000|Overall Study|Toxicity|1
7412393|NCT01413178|11683921|FG001|Overall Study|Toxicity|0
7412394|NCT01413178|11683920|FG000|Overall Study|Ineligible|0
7412395|NCT01413178|11683921|FG001|Overall Study|Ineligible|2
7412396|NCT01413191|11683927|FG000|Overall Study|Lost to Follow-up|5
7412397|NCT01413191|11683927|FG000|Overall Study|Disease Progression|5
7412398|NCT01413191|11683927|FG000|Overall Study|Death|1
7412399|NCT01413204|11683934|FG000|Overall Study|Adverse Event|1
7412400|NCT01413204|11683935|FG001|Overall Study|Adverse Event|2
7412401|NCT01413204|11683936|FG002|Overall Study|Adverse Event|2
7412402|NCT01413204|11683934|FG000|Overall Study|Physician Decision|3
7412403|NCT01413204|11683935|FG001|Overall Study|Physician Decision|0
7412404|NCT01413204|11683936|FG002|Overall Study|Physician Decision|2
7412405|NCT01413204|11683934|FG000|Overall Study|Withdrawal by Subject|1
7412406|NCT01413204|11683935|FG001|Overall Study|Withdrawal by Subject|4
7412407|NCT01413204|11683936|FG002|Overall Study|Withdrawal by Subject|4
7412408|NCT01413204|11683934|FG000|Overall Study|Clearly not eligible for the study|0
7412409|NCT01413204|11683935|FG001|Overall Study|Clearly not eligible for the study|0
7412410|NCT01413204|11683936|FG002|Overall Study|Clearly not eligible for the study|1
7412411|NCT01413204|11683934|FG000|Overall Study|Fasting plasma glucose level increased|1
7412412|NCT01413204|11683935|FG001|Overall Study|Fasting plasma glucose level increased|0
7412413|NCT01413204|11683936|FG002|Overall Study|Fasting plasma glucose level increased|10
7412414|NCT01413360|11683944|FG000|Overall Study|Lost to Follow-up|2
7412415|NCT01413360|11683944|FG000|Overall Study|Adverse Event|1
7412416|NCT01413503|11683948|FG000|Overall Study|Lost to Follow-up|1
7412417|NCT01413542|11683963|FG000|Overall Study|Physician Decision|1
7412418|NCT01413542|11683964|FG001|Overall Study|Physician Decision|0
7412419|NCT01413542|11683965|FG002|Overall Study|Physician Decision|3
7412420|NCT01413542|11683966|FG003|Overall Study|Physician Decision|0
7412421|NCT01413542|11683963|FG000|Overall Study|Adverse Event|0
7412422|NCT01413542|11683964|FG001|Overall Study|Adverse Event|0
7412423|NCT01413542|11683965|FG002|Overall Study|Adverse Event|0
7412424|NCT01413542|11683966|FG003|Overall Study|Adverse Event|1
7412425|NCT01413958|11683998|FG000|Overall Study|Lost to Follow-up|0
7412426|NCT01413958|11683999|FG001|Overall Study|Lost to Follow-up|1
7412427|NCT01414075|11684042|FG000|Overall Study|Adverse Event|1
7412428|NCT01414075|11684043|FG001|Overall Study|Adverse Event|0
7412429|NCT01414075|11684044|FG002|Overall Study|Adverse Event|1
7412430|NCT01414075|11684045|FG003|Overall Study|Adverse Event|0
7412431|NCT01414075|11684042|FG000|Overall Study|Death|1
7412432|NCT01414075|11684043|FG001|Overall Study|Death|0
7412433|NCT01414075|11684044|FG002|Overall Study|Death|0
7412434|NCT01414075|11684045|FG003|Overall Study|Death|1
7412435|NCT01414075|11684042|FG000|Overall Study|Withdrawal by Subject|0
7412436|NCT01414075|11684043|FG001|Overall Study|Withdrawal by Subject|0
7412437|NCT01414075|11684044|FG002|Overall Study|Withdrawal by Subject|0
7412438|NCT01414075|11684045|FG003|Overall Study|Withdrawal by Subject|1
7412439|NCT01414075|11684042|FG000|Overall Study|Other than specified|1
7412440|NCT01414075|11684043|FG001|Overall Study|Other than specified|0
7412441|NCT01414075|11684044|FG002|Overall Study|Other than specified|1
7412442|NCT01414075|11684045|FG003|Overall Study|Other than specified|0
7412443|NCT01414114|11684055|FG000|Overall Study|Adverse Event|2
7412444|NCT01414114|11684055|FG000|Overall Study|Withdrawal by Subject|1
7412445|NCT01414114|11684055|FG000|Overall Study|Other|2
7412446|NCT01414205|11684080|FG000|Overall Study|Death|5
7412447|NCT01414205|11684081|FG001|Overall Study|Death|1
7412448|NCT01414205|11684080|FG000|Overall Study|Lost to Follow-up|1
7412449|NCT01414205|11684081|FG001|Overall Study|Lost to Follow-up|4
7412450|NCT01414205|11684080|FG000|Overall Study|Physician Decision|0
7412451|NCT01414205|11684081|FG001|Overall Study|Physician Decision|1
7412452|NCT01414205|11684080|FG000|Overall Study|Randomized but not Treated|1
7412453|NCT01414205|11684081|FG001|Overall Study|Randomized but not Treated|1
7412454|NCT01414257|11684096|FG000|Overall Study|No Visit After First Day of Treatment|12
7412455|NCT01414257|11684096|FG000|Overall Study|Protocol Violation|10
7412456|NCT01414738|11684136|FG000|Overall Study|Death|26
7412457|NCT01414738|11684136|FG000|Overall Study|Refused testing|5
7412458|NCT01414738|11684136|FG000|Overall Study|Lost to Follow-up|2
7412459|NCT01414738|11684136|FG000|Overall Study|Refused, disease progression|8
7412460|NCT01414738|11684136|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
7412461|NCT01414855|11684140|FG000|Overall Study|Death|17
7412462|NCT01414855|11684140|FG000|Overall Study|Lost to Follow-up|5
7412463|NCT01414855|11684140|FG000|Overall Study|Withdrawal by Subject|7
7466291|NCT01890265|11766050|FG005|Overall Study|Progressive disease|0
7466292|NCT01890265|11766045|FG000|Overall Study|Adverse Event|2
7466293|NCT01890265|11766046|FG001|Overall Study|Adverse Event|1
7466294|NCT01890265|11766047|FG002|Overall Study|Adverse Event|0
7466295|NCT01890265|11766048|FG003|Overall Study|Adverse Event|0
7466296|NCT01890265|11766049|FG004|Overall Study|Adverse Event|0
7466297|NCT01890265|11766050|FG005|Overall Study|Adverse Event|0
7466298|NCT01890265|11766045|FG000|Overall Study|Death|2
7466299|NCT01890265|11766046|FG001|Overall Study|Death|3
7466300|NCT01890265|11766047|FG002|Overall Study|Death|1
7466301|NCT01890265|11766048|FG003|Overall Study|Death|0
7466302|NCT01890265|11766049|FG004|Overall Study|Death|0
7466303|NCT01890265|11766050|FG005|Overall Study|Death|0
7466304|NCT01890265|11766045|FG000|Overall Study|Withdrawal by Subject|0
7466305|NCT01890265|11766046|FG001|Overall Study|Withdrawal by Subject|2
7466306|NCT01890265|11766047|FG002|Overall Study|Withdrawal by Subject|3
7466307|NCT01890265|11766048|FG003|Overall Study|Withdrawal by Subject|0
7466308|NCT01890265|11766049|FG004|Overall Study|Withdrawal by Subject|2
7466309|NCT01890265|11766050|FG005|Overall Study|Withdrawal by Subject|0
7466310|NCT01890421|11766073|FG000|Overall Study|Adverse Event|1
7466311|NCT01890421|11766073|FG000|Overall Study|Other reason|10
7466312|NCT01890434|11766077|FG000|Overall Study|Adverse Event|8
7466313|NCT01890434|11766077|FG000|Overall Study|PCI at external hospital|1
7466314|NCT01890434|11766077|FG000|Overall Study|Assessment discrepancy|1
7466315|NCT01890434|11766077|FG000|Overall Study|CRC didn't contact participant for FU|1
7466316|NCT01890434|11766077|FG000|Overall Study|Could not get whole set of images|1
7466317|NCT01890434|11766077|FG000|Overall Study|Decline to return for GSPECT|1
7466318|NCT01890434|11766077|FG000|Overall Study|GSPECT at rest was not done|1
7466319|NCT01890434|11766077|FG000|Overall Study|Participant didn't complete MRI|1
7412464|NCT01415349|11684148|FG000|Treatment Period 1|Adverse Event|0
7412465|NCT01415349|11684149|FG001|Treatment Period 1|Adverse Event|1
7412466|NCT01415349|11684148|FG000|Treatment Period 1|Withdrawal by Subject|0
7412467|NCT01415349|11684149|FG001|Treatment Period 1|Withdrawal by Subject|1
7412468|NCT01415401|11684155|FG000|Overall Study|Adverse Event|5
7412469|NCT01415401|11684155|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
7412470|NCT01415401|11684155|FG000|Overall Study|Terminated by Sponsor|1
7412480|NCT01415518|11684196|FG000|Overall Study|Withdrawal by Subject|2
7412481|NCT01415518|11684197|FG001|Overall Study|Withdrawal by Subject|12
7412482|NCT01415518|11684196|FG000|Overall Study|Protocol Violation|6
7412483|NCT01415518|11684197|FG001|Overall Study|Protocol Violation|8
7412484|NCT01415518|11684196|FG000|Overall Study|Lost to Follow-up|3
7412485|NCT01415518|11684197|FG001|Overall Study|Lost to Follow-up|5
7412486|NCT01415518|11684196|FG000|Overall Study|Adverse Event|3
7412487|NCT01415518|11684197|FG001|Overall Study|Adverse Event|4
7412488|NCT01415518|11684196|FG000|Overall Study|Death|1
7412489|NCT01415518|11684197|FG001|Overall Study|Death|1
7412490|NCT01415518|11684196|FG000|Overall Study|Condition under Investigation Worsened|1
7412491|NCT01415518|11684197|FG001|Overall Study|Condition under Investigation Worsened|1
7412492|NCT01415531|11684205|FG000|Overall Study|Adverse Event|7
7412493|NCT01415531|11684206|FG001|Overall Study|Adverse Event|10
7412494|NCT01415531|11684205|FG000|Overall Study|Lack of Efficacy|3
7412495|NCT01415531|11684206|FG001|Overall Study|Lack of Efficacy|2
7412496|NCT01415531|11684205|FG000|Overall Study|Protocol Violation|0
7412497|NCT01415531|11684206|FG001|Overall Study|Protocol Violation|1
7412498|NCT01415531|11684205|FG000|Overall Study|Withdrawal by Subject|5
7412499|NCT01415531|11684206|FG001|Overall Study|Withdrawal by Subject|4
7412500|NCT01415531|11684205|FG000|Overall Study|Lost to Follow-up|6
7412501|NCT01415531|11684206|FG001|Overall Study|Lost to Follow-up|14
7412502|NCT01415531|11684205|FG000|Overall Study|Lack of Compliance|1
7412503|NCT01415531|11684206|FG001|Overall Study|Lack of Compliance|4
7412504|NCT01415531|11684205|FG000|Overall Study|Other Reasons|3
7412505|NCT01415531|11684206|FG001|Overall Study|Other Reasons|2
7412506|NCT01415908|11684223|FG000|Overall Study|Withdrawal by Subject|1
7412507|NCT01415908|11684224|FG001|Overall Study|Withdrawal by Subject|0
7412508|NCT01415921|11684232|FG000|Overall Study|Adverse Event|0
7412509|NCT01415921|11684233|FG001|Overall Study|Adverse Event|1
7412510|NCT01415921|11684232|FG000|Overall Study|Physician Decision|1
7412511|NCT01415921|11684233|FG001|Overall Study|Physician Decision|1
7412512|NCT01415921|11684232|FG000|Overall Study|Withdrawal by Subject|0
7412513|NCT01415921|11684233|FG001|Overall Study|Withdrawal by Subject|1
7412514|NCT01415921|11684232|FG000|Overall Study|Other|2
7412515|NCT01415921|11684233|FG001|Overall Study|Other|0
7412516|NCT01416142|11684270|FG000|PureVision2 HD|Inability to maintain lens wear|0
7412517|NCT01416142|11684271|FG001|PureVision2 HD|Inability to maintain lens wear|0
7412518|NCT01416142|11684272|FG002|PureVision2 HD|Inability to maintain lens wear|1
7412519|NCT01416155|11684280|FG000|Overall Study|Adverse Event|8
7412520|NCT01416155|11684280|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
7412521|NCT01416155|11684280|FG000|Overall Study|Withdrawal by Subject|33
7412522|NCT01416155|11684280|FG000|Overall Study|Investigator decision|8
7412523|NCT01416155|11684280|FG000|Overall Study|Other|7
7412524|NCT01416181|11684286|FG000|Part 1|Other|10
7412525|NCT01416181|11684287|FG001|Part 1|Other|24
7412526|NCT01416181|11684286|FG000|Part 1|Death|0
7412527|NCT01416181|11684287|FG001|Part 1|Death|1
7412528|NCT01416181|11684286|FG000|Part 1|Investigator Decision|7
7412529|NCT01416181|11684287|FG001|Part 1|Investigator Decision|6
7412530|NCT01416181|11684286|FG000|Part 1|Withdrawal by Subject|74
7412531|NCT01416181|11684287|FG001|Part 1|Withdrawal by Subject|48
7412532|NCT01416181|11684286|FG000|Part 1|Lack of Efficacy|16
7412533|NCT01416181|11684287|FG001|Part 1|Lack of Efficacy|8
7412534|NCT01416181|11684286|FG000|Part 1|Lost to Follow-up|1
7412535|NCT01416181|11684287|FG001|Part 1|Lost to Follow-up|1
7412536|NCT01416181|11684286|FG000|Part 1|Adverse Event|15
7412537|NCT01416181|11684287|FG001|Part 1|Adverse Event|18
7412538|NCT01416181|11684286|FG000|Part 1|Ongoing in Follow-Up|14
7412539|NCT01416181|11684287|FG001|Part 1|Ongoing in Follow-Up|8
7412540|NCT01416181|11684286|FG000|Part 2|Adverse Event|11
7412541|NCT01416181|11684287|FG001|Part 2|Adverse Event|4
7412542|NCT01416181|11684286|FG000|Part 2|Other|234
7412543|NCT01416181|11684287|FG001|Part 2|Other|267
7412544|NCT01416181|11684286|FG000|Part 2|Investigator Decision|6
7412545|NCT01416181|11684287|FG001|Part 2|Investigator Decision|7
7412546|NCT01416181|11684286|FG000|Part 2|Withdrawal by Subject|14
7412547|NCT01416181|11684287|FG001|Part 2|Withdrawal by Subject|5
7412548|NCT01416181|11684286|FG000|Part 2|Lack of Efficacy|4
7412549|NCT01416181|11684287|FG001|Part 2|Lack of Efficacy|1
7412550|NCT01416181|11684286|FG000|Part 2|Lost to Follow-up|2
7412551|NCT01416181|11684287|FG001|Part 2|Lost to Follow-up|2
7412552|NCT01416389|11684310|FG000|Overall Study|Lost to Follow-up|1
7412553|NCT01416389|11684311|FG001|Overall Study|Lost to Follow-up|0
7412554|NCT01416389|11684310|FG000|Overall Study|Started New Therapy|2
7412555|NCT01416389|11684311|FG001|Overall Study|Started New Therapy|0
7412556|NCT01416441|11684319|FG000|Overall Study|Lost to Follow-up|5
7412557|NCT01416441|11684319|FG000|Overall Study|Adverse Event|6
7412558|NCT01416441|11684319|FG000|Overall Study|Sponsor Discontinued Trial Site|43
7412559|NCT01416441|11684319|FG000|Overall Study|Subject Met Withdrawal Criteria|10
7412560|NCT01416441|11684319|FG000|Overall Study|Investigator Withdrew Subject|2
7412561|NCT01416441|11684319|FG000|Overall Study|Subject Withdrew Consent|12
7412562|NCT01416441|11684319|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
7412563|NCT01416571|11684323|FG000|Overall Study|Lost to Follow-up|2
7412564|NCT01416610|11684346|FG000|Overall Study|Adverse Event|4
7412565|NCT01416610|11684346|FG000|Overall Study|Adverse Event -Patient decision|3
7412566|NCT01416610|11684346|FG000|Overall Study|Lack of Efficacy|4
7412567|NCT01416610|11684346|FG000|Overall Study|No reason given|5
7412568|NCT01416610|11684346|FG000|Overall Study|Withdrawal by Subject|13
7412569|NCT01416610|11684346|FG000|Overall Study|Lost to Follow-up|7
7412570|NCT01416610|11684346|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
7412571|NCT01416805|11684356|FG000|Overall Study|Lost to Follow-up|4
7412572|NCT01416805|11684357|FG001|Overall Study|Lost to Follow-up|4
7412573|NCT01417000|11684369|FG000|Overall Study|Death|59
7412574|NCT01417000|11684370|FG001|Overall Study|Death|28
7412575|NCT01417000|11684369|FG000|Overall Study|Lost to Follow-up|1
7412576|NCT01417000|11684370|FG001|Overall Study|Lost to Follow-up|0
7412577|NCT01417000|11684369|FG000|Overall Study|Study Terminated by Sponsor|1
7412578|NCT01417000|11684370|FG001|Overall Study|Study Terminated by Sponsor|1
7412579|NCT01417078|11684385|FG000|Overall Study|Withdrawal by Subject|1
7412580|NCT01417104|11684393|FG000|Overall Study|Withdrawal by Subject|5
7412581|NCT01417104|11684394|FG001|Overall Study|Withdrawal by Subject|1
7412582|NCT01417104|11684393|FG000|Overall Study|Failure to make contact|0
7412583|NCT01417104|11684394|FG001|Overall Study|Failure to make contact|1
7412584|NCT01417104|11684393|FG000|Overall Study|Adverse Event|1
7412585|NCT01417104|11684394|FG001|Overall Study|Adverse Event|0
7412586|NCT01417156|11684400|FG000|Overall Study|Adverse Event|12
7412587|NCT01417156|11684400|FG000|Overall Study|Protocol Violation|2
7412588|NCT01417195|11684406|FG000|Overall Study|Stimulation failure|1
7412589|NCT01417195|11684407|FG001|Overall Study|Stimulation failure|0
7412590|NCT01417195|11684406|FG000|Overall Study|No embryos for transfer|0
7412591|NCT01417195|11684407|FG001|Overall Study|No embryos for transfer|1
7412592|NCT01417195|11684406|FG000|Overall Study|No transfer due to risk of OHSS|1
7412593|NCT01417195|11684407|FG001|Overall Study|No transfer due to risk of OHSS|0
7412594|NCT01417195|11684406|FG000|Overall Study|No transfer due to elevated progesterone|1
7412595|NCT01417195|11684407|FG001|Overall Study|No transfer due to elevated progesterone|0
7412597|NCT01417481|11684453|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
7412598|NCT01417481|11684454|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
7412599|NCT01418209|11684494|FG000|Overall Study|Withdrawal by Subject|1
7412600|NCT01418209|11684495|FG001|Overall Study|Withdrawal by Subject|0
7412601|NCT01418209|11684496|FG002|Overall Study|Withdrawal by Subject|1
7412602|NCT01418209|11684494|FG000|Overall Study|Did not provide hot flash diary data|1
7412603|NCT01418209|11684495|FG001|Overall Study|Did not provide hot flash diary data|3
7412604|NCT01418209|11684496|FG002|Overall Study|Did not provide hot flash diary data|3
7412605|NCT01418339|11684506|FG000|Overall Study|Adverse Event|5
7412606|NCT01418339|11684507|FG001|Overall Study|Adverse Event|2
7412607|NCT01418339|11684506|FG000|Overall Study|Subject Withdrew Consent|1
7412608|NCT01418339|11684507|FG001|Overall Study|Subject Withdrew Consent|2
7412609|NCT01418339|11684506|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7412610|NCT01418339|11684507|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
7412611|NCT01418352|11684517|FG000|Overall Study|Lost to Follow-up|2
7412612|NCT01418352|11684518|FG001|Overall Study|Lost to Follow-up|0
7412613|NCT01418352|11684519|FG002|Overall Study|Lost to Follow-up|0
7412614|NCT01418352|11684520|FG003|Overall Study|Lost to Follow-up|0
7412615|NCT01418352|11684517|FG000|Overall Study|Adverse Event|0
7412616|NCT01418352|11684518|FG001|Overall Study|Adverse Event|1
7412617|NCT01418352|11684519|FG002|Overall Study|Adverse Event|0
7412618|NCT01418352|11684520|FG003|Overall Study|Adverse Event|0
7412619|NCT01418352|11684517|FG000|Overall Study|Sponsor Discontinued Trial Site|0
7412620|NCT01418352|11684518|FG001|Overall Study|Sponsor Discontinued Trial Site|2
7412621|NCT01418352|11684519|FG002|Overall Study|Sponsor Discontinued Trial Site|2
7412622|NCT01418352|11684520|FG003|Overall Study|Sponsor Discontinued Trial Site|2
7412623|NCT01418352|11684517|FG000|Overall Study|Subject Withdrew Consent|0
7412624|NCT01418352|11684518|FG001|Overall Study|Subject Withdrew Consent|1
7412625|NCT01418352|11684519|FG002|Overall Study|Subject Withdrew Consent|2
7412626|NCT01418352|11684520|FG003|Overall Study|Subject Withdrew Consent|1
7412627|NCT01418352|11684517|FG000|Overall Study|Protocol Deviation|0
7412628|NCT01418352|11684518|FG001|Overall Study|Protocol Deviation|0
7412629|NCT01418352|11684519|FG002|Overall Study|Protocol Deviation|1
7412630|NCT01418352|11684520|FG003|Overall Study|Protocol Deviation|0
7412631|NCT01418352|11684517|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
7412632|NCT01418352|11684518|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7412633|NCT01418352|11684519|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7412634|NCT01418352|11684520|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
7412635|NCT01418365|11684532|FG000|First Intervention|Withdrawal by Subject|0
7412636|NCT01418365|11684533|FG001|First Intervention|Withdrawal by Subject|1
7412637|NCT01418365|11684532|FG000|First Intervention|Non-compliance|1
7412638|NCT01418365|11684533|FG001|First Intervention|Non-compliance|0
7412639|NCT01418365|11684532|FG000|Second Intervention|Withdrawal by Subject|0
7412640|NCT01418365|11684533|FG001|Second Intervention|Withdrawal by Subject|1
7412641|NCT01418378|11684541|FG000|Overall Study|Death|1
7412642|NCT01418378|11684542|FG001|Overall Study|Death|2
7412643|NCT01418378|11684541|FG000|Overall Study|Physician Decision|0
7412644|NCT01418378|11684542|FG001|Overall Study|Physician Decision|1
7412645|NCT01418378|11684541|FG000|Overall Study|ligament imbalance|0
7412646|NCT01418378|11684542|FG001|Overall Study|ligament imbalance|1
7412647|NCT01418378|11684541|FG000|Overall Study|developed chronic myopathy|0
7412648|NCT01418378|11684542|FG001|Overall Study|developed chronic myopathy|1
7412649|NCT01418937|11684564|FG000|Overall Study|Lost to Follow-up|5
7412650|NCT01418937|11684564|FG000|Overall Study|Protocol Violation|1
7412651|NCT01418937|11684564|FG000|Overall Study|Pregnancy|1
7412652|NCT01418937|11684564|FG000|Overall Study|Withdrawal by Subject|1
7412653|NCT01419015|11684568|FG000|Overall Study|Death|2
7412654|NCT01419184|11684582|FG000|Overall Study|Site data not available|3
7412655|NCT01419184|11684583|FG001|Overall Study|Site data not available|2
7412656|NCT01419184|11684582|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
7412657|NCT01419184|11684583|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
7412658|NCT01419184|11684582|FG000|Overall Study|No IRLOS-randomized, not treated|2
7412659|NCT01419184|11684583|FG001|Overall Study|No IRLOS-randomized, not treated|4
7412660|NCT01419184|11684582|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
7412661|NCT01419184|11684583|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
7412662|NCT01419184|11684582|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
7412663|NCT01419184|11684583|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
7412664|NCT01419184|11684582|FG000|Overall Study|Participant randomized, not treated|1
7412665|NCT01419184|11684583|FG001|Overall Study|Participant randomized, not treated|0
7412666|NCT01419197|11684591|FG000|Overall Study|Death|247
7412667|NCT01419197|11684592|FG001|Overall Study|Death|122
7412668|NCT01419197|11684591|FG000|Overall Study|Physician Decision|4
7412669|NCT01419197|11684592|FG001|Overall Study|Physician Decision|4
7412670|NCT01419197|11684591|FG000|Overall Study|Non-compliance|3
7412671|NCT01419197|11684592|FG001|Overall Study|Non-compliance|1
7412672|NCT01419197|11684591|FG000|Overall Study|Withdrawal by Subject|33
7412673|NCT01419197|11684592|FG001|Overall Study|Withdrawal by Subject|32
7412674|NCT01419197|11684591|FG000|Overall Study|Study Completed by Sponsor|103
7412675|NCT01419197|11684592|FG001|Overall Study|Study Completed by Sponsor|34
7412676|NCT01419197|11684591|FG000|Overall Study|Reason Not Specified|0
7412677|NCT01419197|11684592|FG001|Overall Study|Reason Not Specified|1
7412678|NCT01419197|11684591|FG000|Overall Study|Lost to Follow-up|14
7412679|NCT01419197|11684592|FG001|Overall Study|Lost to Follow-up|4
7412680|NCT01419236|11684601|FG000|Overall Study|Adverse Event|1
7412681|NCT01419236|11684602|FG001|Overall Study|Adverse Event|0
7412682|NCT01419236|11684601|FG000|Overall Study|Lack of Efficacy|0
7412683|NCT01419236|11684602|FG001|Overall Study|Lack of Efficacy|1
7412684|NCT01419236|11684601|FG000|Overall Study|Lost to Follow-up|1
7412685|NCT01419236|11684602|FG001|Overall Study|Lost to Follow-up|0
7412686|NCT01419236|11684601|FG000|Overall Study|Physician Decision|1
7412687|NCT01419236|11684602|FG001|Overall Study|Physician Decision|0
7412688|NCT01419236|11684601|FG000|Overall Study|Withdrawal by Subject|1
7412689|NCT01419236|11684602|FG001|Overall Study|Withdrawal by Subject|4
7412690|NCT01419236|11684601|FG000|Overall Study|Entry Criteria Not Met|1
7412691|NCT01419236|11684602|FG001|Overall Study|Entry Criteria Not Met|0
7412692|NCT01419314|11684624|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
7412693|NCT01419314|11684625|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
7412694|NCT01419314|11684624|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
7412695|NCT01419314|11684625|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
7412696|NCT01419314|11684624|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
7412697|NCT01419314|11684625|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
7412698|NCT01419535|11684637|FG000|Overall Study|could not maintain iv line|1
7412699|NCT01419535|11684638|FG001|Overall Study|could not maintain iv line|1
7412700|NCT01419535|11684637|FG000|Overall Study|Withdrawal by Subject|0
7412701|NCT01419535|11684638|FG001|Overall Study|Withdrawal by Subject|1
7412702|NCT01419626|11684647|FG000|Overall Study|Protocol Violation|3
7412703|NCT01419626|11684648|FG001|Overall Study|Protocol Violation|2
7412704|NCT01419626|11684649|FG002|Overall Study|Protocol Violation|2
7412705|NCT01419626|11684647|FG000|Overall Study|Withdrawal by Subject|1
7412706|NCT01419626|11684648|FG001|Overall Study|Withdrawal by Subject|0
7412707|NCT01419626|11684649|FG002|Overall Study|Withdrawal by Subject|0
7412708|NCT01419626|11684647|FG000|Overall Study|Lost to Follow-up|0
7412709|NCT01419626|11684648|FG001|Overall Study|Lost to Follow-up|1
7412710|NCT01419626|11684649|FG002|Overall Study|Lost to Follow-up|1
7412711|NCT01419665|11684663|FG000|Combination Treatment|Adverse Event|7
7412712|NCT01419665|11684664|FG001|Combination Treatment|Adverse Event|10
7412713|NCT01419665|11684663|FG000|Combination Treatment|Physician Decision|5
7412714|NCT01419665|11684664|FG001|Combination Treatment|Physician Decision|8
7412715|NCT01419665|11684663|FG000|Combination Treatment|Protocol Violation|6
7412716|NCT01419665|11684664|FG001|Combination Treatment|Protocol Violation|2
7412717|NCT01419665|11684663|FG000|Combination Treatment|disease progression|10
7412718|NCT01419665|11684664|FG001|Combination Treatment|disease progression|9
7412719|NCT01419665|11684663|FG000|Combination Treatment|Death|5
7412720|NCT01419665|11684664|FG001|Combination Treatment|Death|7
7412721|NCT01419665|11684663|FG000|Combination Treatment|administrative problems|0
7412722|NCT01419665|11684664|FG001|Combination Treatment|administrative problems|1
7412723|NCT01419665|11684663|FG000|Combination Treatment|Withdrawal by Subject|5
7412724|NCT01419665|11684664|FG001|Combination Treatment|Withdrawal by Subject|4
7412725|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
7412726|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
7412727|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
7412728|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
7412729|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7412730|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
7412731|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
7412732|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
7412733|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
7412734|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
7412735|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|disease progression|53
7412736|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|disease progression|37
7412737|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Death|1
7412738|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Death|2
7412739|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
7412740|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
7412741|NCT01419665|11684663|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
7412742|NCT01419665|11684664|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
7412743|NCT01419665|11684663|FG000|Open Label Phase|Death|1
7412744|NCT01419665|11684664|FG001|Open Label Phase|Death|0
7412745|NCT01419665|11684663|FG000|Open Label Phase|disease progression|0
7412746|NCT01419665|11684664|FG001|Open Label Phase|disease progression|1
7412747|NCT01419717|11684672|FG000|Overall Study|Protocol-specified Criteria|62
7412748|NCT01419717|11684672|FG000|Overall Study|Adverse Event|19
7412749|NCT01419717|11684672|FG000|Overall Study|Death|17
7412750|NCT01419717|11684672|FG000|Overall Study|Withdrawal by Subject|10
7412751|NCT01419717|11684672|FG000|Overall Study|Disease Progression|9
7412752|NCT01419717|11684672|FG000|Overall Study|Other|4
7412753|NCT01419717|11684672|FG000|Overall Study|Lost to Follow-up|2
7412754|NCT01419717|11684672|FG000|Overall Study|Administrative Decision|1
7412755|NCT01419717|11684672|FG000|Overall Study|Noncompliance|1
7412756|NCT01419769|11684676|FG000|Overall Study|Did not receive the AXIOS stent|3
7412757|NCT01419769|11684676|FG000|Overall Study|Not evaluable due to pigtail stents|1
7412758|NCT01420068|11684711|FG000|Overall Study|Administrative problems|1
7412759|NCT01420068|11684712|FG001|Overall Study|Administrative problems|3
7412760|NCT01420068|11684711|FG000|Overall Study|Withdrawal by Subject|1
7412761|NCT01420068|11684712|FG001|Overall Study|Withdrawal by Subject|2
7412762|NCT01420081|11684727|FG000|Overall Study|Death|1
7412763|NCT01420081|11684728|FG001|Overall Study|Death|0
7412764|NCT01420081|11684729|FG002|Overall Study|Death|8
7412765|NCT01420081|11684730|FG003|Overall Study|Death|0
7412766|NCT01420081|11684731|FG004|Overall Study|Death|7
7412767|NCT01420081|11684732|FG005|Overall Study|Death|12
7412768|NCT01420081|11684733|FG006|Overall Study|Death|0
7412769|NCT01420081|11684734|FG007|Overall Study|Death|1
7412770|NCT01420081|11684735|FG008|Overall Study|Death|1
7412771|NCT01420081|11684727|FG000|Overall Study|Lost to Follow-up|0
7412772|NCT01420081|11684728|FG001|Overall Study|Lost to Follow-up|0
7412773|NCT01420081|11684729|FG002|Overall Study|Lost to Follow-up|0
7412774|NCT01420081|11684730|FG003|Overall Study|Lost to Follow-up|0
7412775|NCT01420081|11684731|FG004|Overall Study|Lost to Follow-up|1
7412776|NCT01420081|11684732|FG005|Overall Study|Lost to Follow-up|1
7412777|NCT01420081|11684733|FG006|Overall Study|Lost to Follow-up|0
7412778|NCT01420081|11684734|FG007|Overall Study|Lost to Follow-up|0
7412779|NCT01420081|11684735|FG008|Overall Study|Lost to Follow-up|0
7412780|NCT01420081|11684727|FG000|Overall Study|Study Terminated by Sponsor|2
7412781|NCT01420081|11684728|FG001|Overall Study|Study Terminated by Sponsor|1
7412782|NCT01420081|11684729|FG002|Overall Study|Study Terminated by Sponsor|1
7412783|NCT01420081|11684730|FG003|Overall Study|Study Terminated by Sponsor|3
7412784|NCT01420081|11684731|FG004|Overall Study|Study Terminated by Sponsor|11
7412785|NCT01420081|11684732|FG005|Overall Study|Study Terminated by Sponsor|7
7412786|NCT01420081|11684733|FG006|Overall Study|Study Terminated by Sponsor|3
7412787|NCT01420081|11684734|FG007|Overall Study|Study Terminated by Sponsor|2
7412788|NCT01420081|11684735|FG008|Overall Study|Study Terminated by Sponsor|2
7412789|NCT01420081|11684727|FG000|Overall Study|Subject Refused Futher Follow-up|0
7412790|NCT01420081|11684728|FG001|Overall Study|Subject Refused Futher Follow-up|0
7412791|NCT01420081|11684729|FG002|Overall Study|Subject Refused Futher Follow-up|1
7412792|NCT01420081|11684730|FG003|Overall Study|Subject Refused Futher Follow-up|0
7412793|NCT01420081|11684731|FG004|Overall Study|Subject Refused Futher Follow-up|1
7412794|NCT01420081|11684732|FG005|Overall Study|Subject Refused Futher Follow-up|0
7412795|NCT01420081|11684733|FG006|Overall Study|Subject Refused Futher Follow-up|0
7412796|NCT01420081|11684734|FG007|Overall Study|Subject Refused Futher Follow-up|0
7412797|NCT01420081|11684735|FG008|Overall Study|Subject Refused Futher Follow-up|0
7412798|NCT01420081|11684727|FG000|Overall Study|Other Reasons|0
7412799|NCT01420081|11684728|FG001|Overall Study|Other Reasons|0
7412800|NCT01420081|11684729|FG002|Overall Study|Other Reasons|1
7412801|NCT01420081|11684730|FG003|Overall Study|Other Reasons|0
7412802|NCT01420081|11684731|FG004|Overall Study|Other Reasons|0
7412803|NCT01420081|11684732|FG005|Overall Study|Other Reasons|0
7412804|NCT01420081|11684733|FG006|Overall Study|Other Reasons|0
7412805|NCT01420081|11684734|FG007|Overall Study|Other Reasons|0
7412806|NCT01420081|11684735|FG008|Overall Study|Other Reasons|0
7412807|NCT01420536|11684766|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
7412808|NCT01420536|11684767|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
7412809|NCT01420549|11684777|FG000|Overall Study|Adverse Event|1
7412810|NCT01420549|11684778|FG001|Overall Study|Adverse Event|1
7412811|NCT01420549|11684777|FG000|Overall Study|Lost to Follow-up|2
7412812|NCT01420549|11684778|FG001|Overall Study|Lost to Follow-up|2
7412813|NCT01420549|11684777|FG000|Overall Study|Protocol Violation|0
7412814|NCT01420549|11684778|FG001|Overall Study|Protocol Violation|1
7412815|NCT01420549|11684777|FG000|Overall Study|Non-adherence to medication|4
7412816|NCT01420549|11684778|FG001|Overall Study|Non-adherence to medication|1
7412817|NCT01420627|11684784|FG000|EZN-2279 Treatment Period|Adverse Event|1
7412818|NCT01420679|11684811|FG000|Overall Study|Disease Progression|3
7412819|NCT01420679|11684812|FG001|Overall Study|Disease Progression|2
7412820|NCT01420679|11684811|FG000|Overall Study|Adverse Event|4
7412821|NCT01420679|11684812|FG001|Overall Study|Adverse Event|0
7412822|NCT01420679|11684811|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
7412823|NCT01420679|11684812|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
7412824|NCT01420679|11684811|FG000|Overall Study|Patient Decision|1
7412825|NCT01420679|11684812|FG001|Overall Study|Patient Decision|0
7412826|NCT01420679|11684811|FG000|Overall Study|Investigator Decision|1
7412827|NCT01420679|11684812|FG001|Overall Study|Investigator Decision|2
7412828|NCT01420679|11684811|FG000|Overall Study|Sponsor Decision|3
7412829|NCT01420679|11684812|FG001|Overall Study|Sponsor Decision|3
7412830|NCT01420679|11684811|FG000|Overall Study|Other|1
7412831|NCT01420679|11684812|FG001|Overall Study|Other|0
7412832|NCT01421017|11684834|FG000|Overall Study|Withdrawal by Subject|2
7412833|NCT01421017|11684835|FG001|Overall Study|Withdrawal by Subject|0
7412834|NCT01421017|11684836|FG002|Overall Study|Withdrawal by Subject|0
7412835|NCT01421017|11684834|FG000|Overall Study|POD|0
7412836|NCT01421017|11684835|FG001|Overall Study|POD|6
7412837|NCT01421017|11684836|FG002|Overall Study|POD|3
7412838|NCT01421134|11684846|FG000|Overall Study|Adverse Event|3
7412839|NCT01421134|11684847|FG001|Overall Study|Adverse Event|5
7412840|NCT01421134|11684846|FG000|Overall Study|Lack of Efficacy|2
7412841|NCT01421134|11684847|FG001|Overall Study|Lack of Efficacy|4
7412842|NCT01421134|11684846|FG000|Overall Study|Protocol Violation|0
7412843|NCT01421134|11684847|FG001|Overall Study|Protocol Violation|3
7412844|NCT01421134|11684846|FG000|Overall Study|Withdrawal by Subject|1
7412845|NCT01421134|11684847|FG001|Overall Study|Withdrawal by Subject|1
7412846|NCT01421134|11684846|FG000|Overall Study|Administrative|0
7412847|NCT01421134|11684847|FG001|Overall Study|Administrative|1
7412848|NCT01421134|11684846|FG000|Overall Study|Lost to Follow-up|1
7412849|NCT01421134|11684847|FG001|Overall Study|Lost to Follow-up|1
7412850|NCT01421147|11684855|FG000|Treatment Period|Adverse Event|2
7412851|NCT01421147|11684856|FG001|Treatment Period|Adverse Event|3
7412852|NCT01421147|11684855|FG000|Treatment Period|Lost to Follow-up|2
7412853|NCT01421147|11684856|FG001|Treatment Period|Lost to Follow-up|1
7412854|NCT01421147|11684855|FG000|Treatment Period|Physician Decision|2
7412855|NCT01421147|11684856|FG001|Treatment Period|Physician Decision|2
7412856|NCT01421147|11684855|FG000|Treatment Period|Withdrawal by Subject|10
7412857|NCT01421147|11684856|FG001|Treatment Period|Withdrawal by Subject|5
7412858|NCT01421147|11684855|FG000|Extension Period|Adverse Event|0
7412859|NCT01421147|11684856|FG001|Extension Period|Adverse Event|2
7412860|NCT01421147|11684855|FG000|Extension Period|Death|0
7412861|NCT01421147|11684856|FG001|Extension Period|Death|1
7412862|NCT01421147|11684855|FG000|Extension Period|Lost to Follow-up|2
7412863|NCT01421147|11684856|FG001|Extension Period|Lost to Follow-up|5
7412864|NCT01421147|11684855|FG000|Extension Period|Physician Decision|1
7412865|NCT01421147|11684856|FG001|Extension Period|Physician Decision|0
7412866|NCT01421147|11684855|FG000|Extension Period|Withdrawal by Subject|5
7412867|NCT01421147|11684856|FG001|Extension Period|Withdrawal by Subject|3
7412868|NCT01421225|11684891|FG000|Overall Study|Withdrawal by Subject|0
7412869|NCT01421225|11684892|FG001|Overall Study|Withdrawal by Subject|1
7412870|NCT01421277|11684901|FG000|Overall Study|Lack of qualifying event|0
7412871|NCT01421277|11684902|FG001|Overall Study|Lack of qualifying event|61
7412872|NCT01421277|11684901|FG000|Overall Study|Incomplete baseline data|0
7412873|NCT01421277|11684902|FG001|Overall Study|Incomplete baseline data|31
7412874|NCT01421303|11684908|FG000|Overall Study|Lost to Follow-up|13
7412875|NCT01421303|11684908|FG000|Overall Study|Non compliance with study procedure|1
7412876|NCT01421303|11684908|FG000|Overall Study|Other|7
7412877|NCT01421303|11684908|FG000|Overall Study|Withdrawal by Subject|1
7412878|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
7412879|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
7412880|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
7412881|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
7412882|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
7412883|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
7412884|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
7412885|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
7412886|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
7412887|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Death|0
7412888|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Death|0
7412889|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Death|3
7412890|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
7412891|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
7412892|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
7412893|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
7412894|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
7412895|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
7412896|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
7412897|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
7412898|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
7412899|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7412900|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
7412901|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
7412902|NCT01421342|11684915|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
7412903|NCT01421342|11684916|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
7412904|NCT01421342|11684917|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
7412905|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
7412906|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
7412907|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
7412908|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
7412909|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
7412910|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
7412911|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
7412912|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
7412913|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
7412914|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
7412915|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
7412916|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
7412917|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
7412918|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7412919|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
7412920|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7412921|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
7412922|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
7412923|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
7412924|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
7412925|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
7412926|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
7412927|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7412928|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
7412929|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7412930|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
7412931|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
7412932|NCT01421342|11684915|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7412933|NCT01421342|11684916|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
7412934|NCT01421342|11684917|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
7412935|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7412936|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
7412937|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
7412938|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
7412939|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
7412940|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
7412941|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
7412942|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
7412943|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
7412944|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
7412945|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
7412946|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
7412947|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
7412948|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
7412949|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
7412950|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
7412951|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
7412952|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
7412953|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
7412954|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
7412955|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
7412956|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7412957|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7412958|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
7412959|NCT01421342|11684915|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
7412960|NCT01421342|11684916|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
7412961|NCT01421342|11684917|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
7412962|NCT01421459|11684931|FG000|Overall Study|Adverse Event|6
7412963|NCT01421459|11684932|FG001|Overall Study|Adverse Event|10
7412964|NCT01421459|11684931|FG000|Overall Study|Death|1
7412965|NCT01421459|11684932|FG001|Overall Study|Death|1
7412966|NCT01421459|11684931|FG000|Overall Study|Lack of Efficacy|1
7412967|NCT01421459|11684932|FG001|Overall Study|Lack of Efficacy|2
7412968|NCT01421459|11684931|FG000|Overall Study|Lost to Follow-up|8
7412969|NCT01421459|11684932|FG001|Overall Study|Lost to Follow-up|9
7412970|NCT01421459|11684931|FG000|Overall Study|Physician Decision|9
7412971|NCT01421459|11684932|FG001|Overall Study|Physician Decision|9
7412972|NCT01421459|11684931|FG000|Overall Study|Protocol Violation|8
7412973|NCT01421459|11684932|FG001|Overall Study|Protocol Violation|5
7412974|NCT01421459|11684931|FG000|Overall Study|Withdrawal by Subject|12
7412975|NCT01421459|11684932|FG001|Overall Study|Withdrawal by Subject|16
7412976|NCT01421511|11684966|FG000|Overall Study|Lost to Follow-up|11
7412977|NCT01421511|11684967|FG001|Overall Study|Lost to Follow-up|14
7412978|NCT01421511|11684966|FG000|Overall Study|Randomized but didn't receive study drug|1
7412979|NCT01421511|11684967|FG001|Overall Study|Randomized but didn't receive study drug|7
7412980|NCT01421511|11684966|FG000|Overall Study|Physician Decision|0
7412981|NCT01421511|11684967|FG001|Overall Study|Physician Decision|1
7412982|NCT01421511|11684966|FG000|Overall Study|Withdrawal by Subject|6
7412983|NCT01421511|11684967|FG001|Overall Study|Withdrawal by Subject|5
7412984|NCT01421511|11684966|FG000|Overall Study|Death|1
7412985|NCT01421511|11684967|FG001|Overall Study|Death|1
7412986|NCT01421641|11684981|FG000|Overall Study|Protocol Violation|2
7412987|NCT01421641|11684982|FG001|Overall Study|Protocol Violation|2
7412988|NCT01421667|11685001|FG000|Overall Study|Withdrawal by Subject|0
7412989|NCT01421667|11685002|FG001|Overall Study|Withdrawal by Subject|1
7412990|NCT01421667|11685003|FG002|Overall Study|Withdrawal by Subject|2
7412991|NCT01421667|11685004|FG003|Overall Study|Withdrawal by Subject|1
7412992|NCT01421667|11685001|FG000|Overall Study|Lost to Follow-up|0
7412993|NCT01421667|11685002|FG001|Overall Study|Lost to Follow-up|1
7412994|NCT01421667|11685003|FG002|Overall Study|Lost to Follow-up|0
7412995|NCT01421667|11685004|FG003|Overall Study|Lost to Follow-up|0
7412996|NCT01421719|11685022|FG000|Overall Study|Withdrawal by Subject|4
7412997|NCT01422187|11685066|FG000|Overall Study|Personal reason|1
7412998|NCT01422187|11685067|FG001|Overall Study|Personal reason|0
7412999|NCT01422187|11685068|FG002|Overall Study|Personal reason|0
7413000|NCT01422187|11685066|FG000|Overall Study|Lost to Follow-up|0
7413001|NCT01422187|11685067|FG001|Overall Study|Lost to Follow-up|1
7413002|NCT01422187|11685068|FG002|Overall Study|Lost to Follow-up|0
7413003|NCT01422213|11685090|FG000|Overall Study|Adverse Event|8
7413004|NCT01422213|11685091|FG001|Overall Study|Adverse Event|7
7413005|NCT01422213|11685092|FG002|Overall Study|Adverse Event|11
7413006|NCT01422213|11685090|FG000|Overall Study|Lack of Efficacy|10
7413007|NCT01422213|11685091|FG001|Overall Study|Lack of Efficacy|2
7413008|NCT01422213|11685092|FG002|Overall Study|Lack of Efficacy|2
7413009|NCT01422213|11685090|FG000|Overall Study|Non-compliance with study drug|0
7413010|NCT01422213|11685091|FG001|Overall Study|Non-compliance with study drug|1
7413011|NCT01422213|11685092|FG002|Overall Study|Non-compliance with study drug|0
7413012|NCT01422213|11685090|FG000|Overall Study|Protocol Violation|0
7413013|NCT01422213|11685091|FG001|Overall Study|Protocol Violation|2
7413014|NCT01422213|11685092|FG002|Overall Study|Protocol Violation|4
7413015|NCT01422213|11685090|FG000|Overall Study|Withdrawal of Consent|7
7413016|NCT01422213|11685091|FG001|Overall Study|Withdrawal of Consent|3
7413017|NCT01422213|11685092|FG002|Overall Study|Withdrawal of Consent|5
7413018|NCT01422213|11685090|FG000|Overall Study|Lost to Follow-up|3
7471205|NCT01939548|11773900|FG001|Overall Study|Insufficient Clinical Response|0
7471206|NCT01939548|11773901|FG002|Overall Study|Insufficient Clinical Response|0
7413019|NCT01422213|11685091|FG001|Overall Study|Lost to Follow-up|3
7413020|NCT01422213|11685092|FG002|Overall Study|Lost to Follow-up|5
7413021|NCT01422213|11685090|FG000|Overall Study|Administrative or Other Reason(s)|5
7413022|NCT01422213|11685091|FG001|Overall Study|Administrative or Other Reason(s)|4
7413023|NCT01422213|11685092|FG002|Overall Study|Administrative or Other Reason(s)|2
7466320|NCT01890434|11766077|FG000|Overall Study|Uncontactable by phone|1
7466321|NCT01890434|11766077|FG000|Overall Study|Moved out of position|1
7466322|NCT01890434|11766077|FG000|Overall Study|Unable to contact|1
7466323|NCT01890434|11766077|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
7466324|NCT01890473|11766083|FG000|Overall Study|Lost to Follow-up|1
7466325|NCT01890473|11766084|FG001|Overall Study|Lost to Follow-up|0
7466326|NCT01890473|11766083|FG000|Overall Study|Poor/non-compliance|1
7466327|NCT01890473|11766084|FG001|Overall Study|Poor/non-compliance|0
7466328|NCT01890512|11766092|FG000|Overall Study|Physician Decision|1
7466329|NCT01890512|11766092|FG000|Overall Study|Withdrawal by Subject|1
7466330|NCT01890512|11766092|FG000|Overall Study|Protocol Violation|1
7466331|NCT01890707|11766111|FG000|Overall Study|Lost to Follow-up|1
7466332|NCT01890707|11766112|FG001|Overall Study|Lost to Follow-up|1
7466333|NCT01890746|11766120|FG000|Overall Study|Death|39
7466334|NCT01890746|11766121|FG001|Overall Study|Death|30
7466335|NCT01890746|11766120|FG000|Overall Study|Adverse Event|1
7466336|NCT01890746|11766121|FG001|Overall Study|Adverse Event|0
7466337|NCT01890746|11766120|FG000|Overall Study|Lost to Follow-up|4
7466338|NCT01890746|11766121|FG001|Overall Study|Lost to Follow-up|1
7466339|NCT01890746|11766120|FG000|Overall Study|Physician Decision|3
7466340|NCT01890746|11766121|FG001|Overall Study|Physician Decision|2
7466341|NCT01890746|11766120|FG000|Overall Study|Withdrawal by Subject|5
7466342|NCT01890746|11766121|FG001|Overall Study|Withdrawal by Subject|8
7466343|NCT01890785|11766133|FG000|Third Intervention|Withdrawal by Subject|0
7466344|NCT01890785|11766134|FG001|Third Intervention|Withdrawal by Subject|1
7466345|NCT01890785|11766135|FG002|Third Intervention|Withdrawal by Subject|0
7466346|NCT01890785|11766136|FG003|Third Intervention|Withdrawal by Subject|0
7466347|NCT01890785|11766137|FG004|Third Intervention|Withdrawal by Subject|0
7466348|NCT01890785|11766138|FG005|Third Intervention|Withdrawal by Subject|0
7468640|NCT01912768|11769527|FG000|Overall Study|Randomized in error|1
7468641|NCT01912768|11769528|FG001|Overall Study|Randomized in error|0
7468642|NCT01912781|11769537|FG000|Overall Study|Withdrawal by Subject|2
7468643|NCT01912781|11769538|FG001|Overall Study|Withdrawal by Subject|0
7468644|NCT01912807|11769547|FG000|Overall Study|Did not meet elegibility criteria|6
7468645|NCT01912807|11769548|FG001|Overall Study|Did not meet elegibility criteria|4
7468646|NCT01912807|11769547|FG000|Overall Study|Lost to Follow-up|36
7468647|NCT01912807|11769548|FG001|Overall Study|Lost to Follow-up|37
7468648|NCT01912872|11769558|FG000|Overall Study|Lost to Follow-up|2
7468649|NCT01912872|11769559|FG001|Overall Study|Lost to Follow-up|3
7468650|NCT01912872|11769560|FG002|Overall Study|Lost to Follow-up|5
7468651|NCT01912872|11769561|FG003|Overall Study|Lost to Follow-up|5
7468652|NCT01912872|11769558|FG000|Overall Study|Other unspecified|3
7468653|NCT01912872|11769559|FG001|Overall Study|Other unspecified|1
7468654|NCT01912872|11769560|FG002|Overall Study|Other unspecified|3
7468655|NCT01912872|11769561|FG003|Overall Study|Other unspecified|0
7468656|NCT01912872|11769558|FG000|Overall Study|Informed consent withdrawn|0
7468657|NCT01912872|11769559|FG001|Overall Study|Informed consent withdrawn|0
7468658|NCT01912872|11769560|FG002|Overall Study|Informed consent withdrawn|1
7468659|NCT01912872|11769561|FG003|Overall Study|Informed consent withdrawn|1
7468660|NCT01912872|11769558|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
7468661|NCT01912872|11769559|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
7468662|NCT01912872|11769560|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
7468663|NCT01912872|11769561|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
7468664|NCT01912872|11769558|FG000|Overall Study|Protocol Violation|0
7468665|NCT01912872|11769559|FG001|Overall Study|Protocol Violation|0
7468666|NCT01912872|11769560|FG002|Overall Study|Protocol Violation|1
7468667|NCT01912872|11769561|FG003|Overall Study|Protocol Violation|0
7471207|NCT01939548|11773899|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7471208|NCT01939548|11773900|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7471209|NCT01939548|11773901|FG002|Overall Study|Did Not Meet Entrance Criteria|0
7471210|NCT01939548|11773899|FG000|Overall Study|Withdrawal by Subject|4
7471211|NCT01939548|11773900|FG001|Overall Study|Withdrawal by Subject|4
7471212|NCT01939548|11773901|FG002|Overall Study|Withdrawal by Subject|1
7471213|NCT01939548|11773899|FG000|Overall Study|Protocol Violation|7
7471214|NCT01939548|11773900|FG001|Overall Study|Protocol Violation|6
7471215|NCT01939548|11773901|FG002|Overall Study|Protocol Violation|5
7471216|NCT01939548|11773899|FG000|Overall Study|Lost to Follow-up|5
7471217|NCT01939548|11773900|FG001|Overall Study|Lost to Follow-up|5
7471218|NCT01939548|11773901|FG002|Overall Study|Lost to Follow-up|3
7471219|NCT01939548|11773899|FG000|Overall Study|Adverse Event|2
7471220|NCT01939548|11773900|FG001|Overall Study|Adverse Event|9
7471221|NCT01939548|11773901|FG002|Overall Study|Adverse Event|7
7471222|NCT01939548|11773899|FG000|Overall Study|Death|0
7471223|NCT01939548|11773900|FG001|Overall Study|Death|0
7471224|NCT01939548|11773901|FG002|Overall Study|Death|1
7471225|NCT01939548|11773899|FG000|Overall Study|Participant dropped|0
7471226|NCT01939548|11773900|FG001|Overall Study|Participant dropped|0
7471227|NCT01939548|11773901|FG002|Overall Study|Participant dropped|1
7471228|NCT01939548|11773899|FG000|Overall Study|Participant unwilling to continue|0
7471229|NCT01939548|11773900|FG001|Overall Study|Participant unwilling to continue|1
7471230|NCT01939548|11773901|FG002|Overall Study|Participant unwilling to continue|0
7471231|NCT01939548|11773899|FG000|Overall Study|Participant withdrew consent|0
7471232|NCT01939548|11773900|FG001|Overall Study|Participant withdrew consent|2
7471233|NCT01939548|11773901|FG002|Overall Study|Participant withdrew consent|0
7471234|NCT01939548|11773899|FG000|Overall Study|Did not complete follow-up|0
7471235|NCT01939548|11773900|FG001|Overall Study|Did not complete follow-up|1
7471236|NCT01939548|11773901|FG002|Overall Study|Did not complete follow-up|0
7471237|NCT01939899|11773914|FG000|Lead-in Dose Finding Phase|Death|0
7471238|NCT01939899|11773915|FG001|Lead-in Dose Finding Phase|Death|3
7471239|NCT01939899|11773916|FG002|Lead-in Dose Finding Phase|Death|1
7471240|NCT01939899|11773917|FG003|Lead-in Dose Finding Phase|Death|0
7471241|NCT01939899|11773918|FG004|Lead-in Dose Finding Phase|Death|0
7471242|NCT01939899|11773914|FG000|Lead-in Dose Finding Phase|Disease Progression|2
7471243|NCT01939899|11773915|FG001|Lead-in Dose Finding Phase|Disease Progression|4
7471244|NCT01939899|11773916|FG002|Lead-in Dose Finding Phase|Disease Progression|3
7471245|NCT01939899|11773917|FG003|Lead-in Dose Finding Phase|Disease Progression|0
7471246|NCT01939899|11773918|FG004|Lead-in Dose Finding Phase|Disease Progression|0
7471247|NCT01939899|11773914|FG000|Lead-in Dose Finding Phase|Other|0
7471248|NCT01939899|11773915|FG001|Lead-in Dose Finding Phase|Other|0
7471249|NCT01939899|11773916|FG002|Lead-in Dose Finding Phase|Other|1
7471250|NCT01939899|11773917|FG003|Lead-in Dose Finding Phase|Other|0
7471251|NCT01939899|11773918|FG004|Lead-in Dose Finding Phase|Other|0
7471252|NCT01939899|11773914|FG000|Phase 2|Withdrawal by Subject|0
7471253|NCT01939899|11773915|FG001|Phase 2|Withdrawal by Subject|0
7471254|NCT01939899|11773916|FG002|Phase 2|Withdrawal by Subject|0
7471255|NCT01939899|11773917|FG003|Phase 2|Withdrawal by Subject|2
7471256|NCT01939899|11773918|FG004|Phase 2|Withdrawal by Subject|0
7471257|NCT01939899|11773914|FG000|Phase 2|Disease Progression|0
7471258|NCT01939899|11773915|FG001|Phase 2|Disease Progression|0
7471259|NCT01939899|11773916|FG002|Phase 2|Disease Progression|0
7471260|NCT01939899|11773917|FG003|Phase 2|Disease Progression|9
7471261|NCT01939899|11773918|FG004|Phase 2|Disease Progression|1
7471262|NCT01939977|11773944|FG000|Overall Study|Adverse Event|4
7471263|NCT01939977|11773945|FG001|Overall Study|Adverse Event|3
7471264|NCT01939977|11773944|FG000|Overall Study|Lack of Efficacy|3
7471265|NCT01939977|11773945|FG001|Overall Study|Lack of Efficacy|0
7471266|NCT01939977|11773944|FG000|Overall Study|Physician Decision|1
7471267|NCT01939977|11773945|FG001|Overall Study|Physician Decision|1
7471268|NCT01939977|11773944|FG000|Overall Study|Withdrawal by Subject|0
7471269|NCT01939977|11773945|FG001|Overall Study|Withdrawal by Subject|2
7471270|NCT01939977|11773944|FG000|Overall Study|Did not meet inclusion criteria|1
7471271|NCT01939977|11773945|FG001|Overall Study|Did not meet inclusion criteria|0
7471272|NCT01939977|11773944|FG000|Overall Study|Did not receive study medication|0
7471273|NCT01939977|11773945|FG001|Overall Study|Did not receive study medication|1
7471274|NCT01940120|11773951|FG000|Overall Study|Death|40
7471275|NCT01940120|11773951|FG000|Overall Study|Withdrawal by Subject|8
7471276|NCT01940354|11773984|FG000|Overall Study|Withdrawal by Subject|4
7471277|NCT01940354|11773985|FG001|Overall Study|Withdrawal by Subject|2
7471278|NCT01940484|11773991|FG000|Overall Study|Withdrawal by Subject|3
7471279|NCT01940484|11773991|FG000|Overall Study|Underwent transplantation|4
7471280|NCT01940484|11773991|FG000|Overall Study|Death|2
7471281|NCT01940484|11773991|FG000|Overall Study|Adverse Event|1
7471282|NCT01940497|11773997|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
7471283|NCT01940497|11773998|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
7471284|NCT01940497|11773997|FG000|Overall Study|Recurrence of Disease Postsurgery|1
7471285|NCT01940497|11773998|FG001|Overall Study|Recurrence of Disease Postsurgery|3
7471286|NCT01940497|11773997|FG000|Overall Study|Violation of Entry Criteria|1
7471287|NCT01940497|11773998|FG001|Overall Study|Violation of Entry Criteria|1
7471288|NCT01940497|11773997|FG000|Overall Study|Refused Treatment|1
7471289|NCT01940497|11773998|FG001|Overall Study|Refused Treatment|3
7471290|NCT01940497|11773997|FG000|Overall Study|Withdrew Consent|6
7471291|NCT01940497|11773998|FG001|Overall Study|Withdrew Consent|2
7471292|NCT01940497|11773997|FG000|Overall Study|Administrative/Other|1
7471293|NCT01940497|11773998|FG001|Overall Study|Administrative/Other|1
7471294|NCT01940705|11774037|FG000|Overall Study|Lost to Follow-up|1
7471295|NCT01940705|11774038|FG001|Overall Study|Lost to Follow-up|3
7471296|NCT01940705|11774039|FG002|Overall Study|Lost to Follow-up|2
7471297|NCT01940705|11774040|FG003|Overall Study|Lost to Follow-up|2
7471298|NCT01940705|11774037|FG000|Overall Study|Withdrawal by Subject|2
7471299|NCT01940705|11774038|FG001|Overall Study|Withdrawal by Subject|2
7471300|NCT01940705|11774039|FG002|Overall Study|Withdrawal by Subject|3
7471301|NCT01940705|11774040|FG003|Overall Study|Withdrawal by Subject|2
7471302|NCT01940705|11774037|FG000|Overall Study|Intervention not given|0
7471303|NCT01940705|11774038|FG001|Overall Study|Intervention not given|3
7471304|NCT01940705|11774039|FG002|Overall Study|Intervention not given|3
7471305|NCT01940705|11774040|FG003|Overall Study|Intervention not given|0
7471306|NCT01940705|11774037|FG000|Overall Study|Withdrawal by team - hearing aid change|1
7471307|NCT01940705|11774038|FG001|Overall Study|Withdrawal by team - hearing aid change|0
7471308|NCT01940705|11774039|FG002|Overall Study|Withdrawal by team - hearing aid change|0
7471309|NCT01940705|11774040|FG003|Overall Study|Withdrawal by team - hearing aid change|0
7471310|NCT01940887|11774055|FG000|Year 1|Protocol Violation|0
7471311|NCT01940887|11774056|FG001|Year 1|Protocol Violation|1
7471312|NCT01940887|11774055|FG000|Year 1|Physician Decision|7
7471313|NCT01940887|11774056|FG001|Year 1|Physician Decision|3
7471314|NCT01940887|11774055|FG000|Year 1|Death|5
7471315|NCT01940887|11774056|FG001|Year 1|Death|3
7471316|NCT01940887|11774055|FG000|Year 1|Adverse Event|7
7471317|NCT01940887|11774056|FG001|Year 1|Adverse Event|6
7471318|NCT01940887|11774055|FG000|Year 1|Withdrawal by Subject|18
7471319|NCT01940887|11774056|FG001|Year 1|Withdrawal by Subject|9
7471320|NCT01940887|11774055|FG000|Year 1|Lost to Follow-up|2
7471321|NCT01940887|11774056|FG001|Year 1|Lost to Follow-up|1
7471322|NCT01940887|11774055|FG000|Year 2|Physician Decision|8
7471323|NCT01940887|11774056|FG001|Year 2|Physician Decision|1
7471324|NCT01940887|11774055|FG000|Year 2|Death|0
7471325|NCT01940887|11774056|FG001|Year 2|Death|2
7471326|NCT01940887|11774055|FG000|Year 2|Sponsor Decision, early termination|192
7471327|NCT01940887|11774056|FG001|Year 2|Sponsor Decision, early termination|203
7471328|NCT01940887|11774055|FG000|Year 2|Adverse Event|8
7471329|NCT01940887|11774056|FG001|Year 2|Adverse Event|2
7471330|NCT01940887|11774055|FG000|Year 2|Withdrawal by Subject|8
7471331|NCT01940887|11774056|FG001|Year 2|Withdrawal by Subject|8
7471332|NCT01940887|11774055|FG000|Year 2|Lost to Follow-up|1
7471333|NCT01940887|11774056|FG001|Year 2|Lost to Follow-up|6
7471334|NCT01940900|11774064|FG000|Overall Study|Physician Decision|4
7471335|NCT01940900|11774065|FG001|Overall Study|Physician Decision|0
7471336|NCT01940900|11774064|FG000|Overall Study|Adverse Event|10
7471337|NCT01940900|11774065|FG001|Overall Study|Adverse Event|15
7471338|NCT01940900|11774064|FG000|Overall Study|Withdrawal by Subject|11
7471339|NCT01940900|11774065|FG001|Overall Study|Withdrawal by Subject|15
7471340|NCT01940900|11774064|FG000|Overall Study|Lost to Follow-up|1
7471341|NCT01940900|11774065|FG001|Overall Study|Lost to Follow-up|0
7471342|NCT01940900|11774064|FG000|Overall Study|Sponsor Decision|1
7471343|NCT01940900|11774065|FG001|Overall Study|Sponsor Decision|0
7471344|NCT01940900|11774064|FG000|Overall Study|subject non-compliance|1
7471345|NCT01940900|11774065|FG001|Overall Study|subject non-compliance|1
7471346|NCT01940900|11774064|FG000|Overall Study|other|1
7471347|NCT01940900|11774065|FG001|Overall Study|other|0
7471348|NCT01940939|11774073|FG000|Overall Study|Withdrawal by Subject|2
7471349|NCT01940939|11774074|FG001|Overall Study|Withdrawal by Subject|8
7471350|NCT01941030|11774082|FG000|Overall Study|Death|3
7471351|NCT01941030|11774083|FG001|Overall Study|Death|2
7471352|NCT01941030|11774082|FG000|Overall Study|Lost to Follow-up|6
7471353|NCT01941030|11774083|FG001|Overall Study|Lost to Follow-up|5
7471354|NCT01941030|11774082|FG000|Overall Study|Withdrawal by Subject|4
7471355|NCT01941030|11774083|FG001|Overall Study|Withdrawal by Subject|6
7471356|NCT01941095|11774089|FG000|Overall Study|Insufficient therapeutic response|13
7471357|NCT01941095|11774089|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
7471358|NCT01941095|11774089|FG000|Overall Study|Adverse Event|11
7471359|NCT01941095|11774089|FG000|Overall Study|Physician Decision|3
7471360|NCT01941095|11774089|FG000|Overall Study|Withdrawal by Subject|17
7471361|NCT01941095|11774089|FG000|Overall Study|Lost to Follow-up|10
7471362|NCT01941186|11774096|FG000|Follow-up|Lost to Follow-up|1
7471363|NCT01941186|11774097|FG001|Follow-up|Lost to Follow-up|0
7471364|NCT01941498|11774142|FG000|Overall Study|Relocated out of state|1
7471365|NCT01941537|11774163|FG000|Overall Study|Lack of Efficacy|1
7471366|NCT01941537|11774164|FG001|Overall Study|Lack of Efficacy|2
7471367|NCT01941537|11774163|FG000|Overall Study|Lost to Follow-up|1
7471368|NCT01941537|11774164|FG001|Overall Study|Lost to Follow-up|0
7471369|NCT01941537|11774163|FG000|Overall Study|Pregnancy|1
7471370|NCT01941537|11774164|FG001|Overall Study|Pregnancy|0
7471371|NCT01941537|11774163|FG000|Overall Study|Adverse Event|1
7471372|NCT01941537|11774164|FG001|Overall Study|Adverse Event|0
7471373|NCT01941537|11774163|FG000|Overall Study|Withdrawal by Subject|0
7471374|NCT01941537|11774164|FG001|Overall Study|Withdrawal by Subject|1
7471375|NCT01941940|11774209|FG000|Overall Study|Adverse Event|11
7471376|NCT01941940|11774209|FG000|Overall Study|Lost to Follow-up|2
7471377|NCT01941940|11774209|FG000|Overall Study|Physician Decision|2
7471378|NCT01941940|11774209|FG000|Overall Study|Withdrawal by Subject|15
7471379|NCT01941940|11774209|FG000|Overall Study|Death|1
7471380|NCT01941940|11774209|FG000|Overall Study|Other|1
7471381|NCT01941940|11774209|FG000|Overall Study|Other|1
7471382|NCT01942148|11774213|FG000|Overall Study|Adverse Event|4
7471383|NCT01942148|11774213|FG000|Overall Study|Lack of Efficacy|2
7471384|NCT01942148|11774213|FG000|Overall Study|Physician Decision|11
7471385|NCT01942148|11774213|FG000|Overall Study|Protocol Violation|1
7471386|NCT01942148|11774213|FG000|Overall Study|Withdrawal by Subject|8
7471387|NCT01942148|11774213|FG000|Overall Study|Use of the prohibition medicine|1
7471388|NCT01942161|11774220|FG000|Overall Study|Adverse Event|1
7471389|NCT01942161|11774221|FG001|Overall Study|Adverse Event|2
7471390|NCT01942161|11774222|FG002|Overall Study|Adverse Event|5
7471391|NCT01942161|11774220|FG000|Overall Study|Physician Decision|3
7471392|NCT01942161|11774221|FG001|Overall Study|Physician Decision|1
7471393|NCT01942161|11774222|FG002|Overall Study|Physician Decision|0
7471394|NCT01942161|11774220|FG000|Overall Study|Protocol Violation|1
7471395|NCT01942161|11774221|FG001|Overall Study|Protocol Violation|0
7471396|NCT01942161|11774222|FG002|Overall Study|Protocol Violation|0
7471397|NCT01942161|11774220|FG000|Overall Study|Withdrawal by Subject|3
7471398|NCT01942161|11774221|FG001|Overall Study|Withdrawal by Subject|3
7471399|NCT01942161|11774222|FG002|Overall Study|Withdrawal by Subject|1
7471400|NCT01942486|11774230|FG000|Overall Study|Lost to Follow-up|27
7533853|NCT02689206|11880194|FG000|Overall Study|Withdrawal by Subject|1
7533854|NCT02689206|11880195|FG001|Overall Study|Withdrawal by Subject|0
7533855|NCT02689206|11880196|FG002|Overall Study|Withdrawal by Subject|1
7533856|NCT02689206|11880197|FG003|Overall Study|Withdrawal by Subject|0
7533857|NCT02689206|11880198|FG004|Overall Study|Withdrawal by Subject|0
7533858|NCT02689219|11880216|FG000|Overall Study|Death|1
7533859|NCT02689219|11880217|FG001|Overall Study|Death|1
7533860|NCT02689219|11880216|FG000|Overall Study|Disease Progression|10
7533861|NCT02689219|11880217|FG001|Overall Study|Disease Progression|6
7533862|NCT02689492|11880223|FG000|Overall Study|Lost to Follow-up|61
7533863|NCT02689492|11880223|FG000|Overall Study|Withdrawal by Subject|11
7533864|NCT02689492|11880223|FG000|Overall Study|Death|9
7533865|NCT02689492|11880223|FG000|Overall Study|Physician Decision|2
7533866|NCT02689492|11880223|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
7533867|NCT02689492|11880223|FG000|Overall Study|Withdrawal/ Physician's Decision|1
7533868|NCT02689492|11880223|FG000|Overall Study|Other than listed|1
7533869|NCT02689804|11880232|FG000|Overall Study|Withdrawal by Subject|2
7533870|NCT02689804|11880233|FG001|Overall Study|Withdrawal by Subject|0
7533871|NCT02690194|11880293|FG000|Overall Study|Withdrawal by Subject|1
7533872|NCT02690194|11880294|FG001|Overall Study|Withdrawal by Subject|4
7533873|NCT02690194|11880295|FG002|Overall Study|Withdrawal by Subject|0
7533874|NCT02690207|11880303|FG000|Overall Study|Lost to Follow-up|48
7533875|NCT02690207|11880303|FG000|Overall Study|Withdrawal by Subject|46
7533876|NCT02690207|11880303|FG000|Overall Study|Protocol Violation|2
7533877|NCT02690207|11880303|FG000|Overall Study|Serious adverse event|110
7533878|NCT02690207|11880303|FG000|Overall Study|Non-serious Adverse Event|18
7533879|NCT02690207|11880303|FG000|Overall Study|Migrated/moved from study area|5
7533880|NCT02690207|11880303|FG000|Overall Study|Suspected HZ Episode|1
7533881|NCT02690207|11880303|FG000|Overall Study|Other reasons for withdrawal|23
7533882|NCT02690649|11880313|FG000|Overall Study|Withdrawal by Subject|1
7533883|NCT02690649|11880314|FG001|Overall Study|Withdrawal by Subject|1
7533884|NCT02690649|11880313|FG000|Overall Study|Protocol Violation|0
7533885|NCT02690649|11880314|FG001|Overall Study|Protocol Violation|3
7533886|NCT02690701|11880324|FG000|Treatment Period 1|Adverse Event|2
7533887|NCT02690701|11880325|FG001|Treatment Period 1|Adverse Event|2
7533888|NCT02690701|11880324|FG000|Treatment Period 1|Withdrawal by Subject|0
7533889|NCT02690701|11880325|FG001|Treatment Period 1|Withdrawal by Subject|1
7533890|NCT02690701|11880324|FG000|Treatment Period 2|Adverse Event|2
7533891|NCT02690701|11880325|FG001|Treatment Period 2|Adverse Event|0
7533892|NCT02690701|11880324|FG000|Treatment Period 2|Lack of Efficacy|1
7533893|NCT02690701|11880325|FG001|Treatment Period 2|Lack of Efficacy|0
7533894|NCT02690701|11880324|FG000|Treatment Period 2|Lost to Follow-up|0
7533895|NCT02690701|11880325|FG001|Treatment Period 2|Lost to Follow-up|2
7533896|NCT02690701|11880324|FG000|Treatment Period 2|Withdrawal by Subject|0
7533897|NCT02690701|11880325|FG001|Treatment Period 2|Withdrawal by Subject|2
7533898|NCT02690701|11880324|FG000|Treatment Period 2|Protocol Violation|0
7533899|NCT02690701|11880325|FG001|Treatment Period 2|Protocol Violation|1
7533900|NCT02690714|11880332|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
7533901|NCT02690714|11880332|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
7533902|NCT02690727|11880340|FG000|Overall Study|Adverse Event|2
7533903|NCT02690727|11880341|FG001|Overall Study|Adverse Event|2
7537688|NCT02759185|11886791|FG003|Stage 2|Withdrawal by Subject|0
7537689|NCT02759185|11886792|FG004|Stage 2|Withdrawal by Subject|1
7537690|NCT02759185|11886793|FG005|Stage 2|Withdrawal by Subject|1
7537691|NCT02759185|11886794|FG006|Stage 2|Withdrawal by Subject|1
7537692|NCT02629159|11886819|FG000|Overall Study|Adverse Event|17
7537693|NCT02629159|11886820|FG001|Overall Study|Adverse Event|20
7537694|NCT02629159|11886821|FG002|Overall Study|Adverse Event|22
7537695|NCT02629159|11886819|FG000|Overall Study|Withdrawal by Subject|22
7537696|NCT02629159|11886820|FG001|Overall Study|Withdrawal by Subject|11
7537697|NCT02629159|11886821|FG002|Overall Study|Withdrawal by Subject|15
7537698|NCT02629159|11886819|FG000|Overall Study|Lost to Follow-up|7
7537699|NCT02629159|11886820|FG001|Overall Study|Lost to Follow-up|4
7537700|NCT02629159|11886821|FG002|Overall Study|Lost to Follow-up|5
7537701|NCT02629159|11886819|FG000|Overall Study|Lack of Efficacy|4
7537702|NCT02629159|11886820|FG001|Overall Study|Lack of Efficacy|0
7537703|NCT02629159|11886821|FG002|Overall Study|Lack of Efficacy|1
7537704|NCT02629159|11886819|FG000|Overall Study|Other|6
7537705|NCT02629159|11886820|FG001|Overall Study|Other|4
7537706|NCT02629159|11886821|FG002|Overall Study|Other|8
7537711|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
7537712|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
7537713|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Death|1
7537714|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Death|0
7537715|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Adverse Event|1
7537716|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Adverse Event|0
7537717|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
7471401|NCT01942590|11774236|FG000|Overall Study|Withdrawal by Subject|0
7471402|NCT01942590|11774237|FG001|Overall Study|Withdrawal by Subject|1
7471403|NCT01942590|11774236|FG000|Overall Study|Adverse Event|1
7471404|NCT01942590|11774237|FG001|Overall Study|Adverse Event|0
7471405|NCT01942733|11774292|FG000|Overall Study|Lost to Follow-up|1
7471406|NCT01942733|11774292|FG000|Overall Study|Non-compliance with IMP|1
7471407|NCT01942733|11774292|FG000|Overall Study|Administrative|1
7471408|NCT01942785|11774296|FG000|Overall Study|Adverse Event|2
7471409|NCT01942785|11774296|FG000|Overall Study|Withdrawal by Subject|1
7471410|NCT01942785|11774296|FG000|Overall Study|Protocol Violation|1
7471411|NCT01942993|11774302|FG000|Overall Study|Lost to Follow-up|1
7471412|NCT01942993|11774302|FG000|Overall Study|Physician Decision|1
7471413|NCT01943292|11774334|FG000|Overall Study|Withdrawal by Subject|1
7471414|NCT01943292|11774335|FG001|Overall Study|Withdrawal by Subject|0
7471415|NCT01943292|11774336|FG002|Overall Study|Withdrawal by Subject|0
7471416|NCT01943435|11774353|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
7471417|NCT01943435|11774354|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
7471418|NCT01943435|11774355|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
7471419|NCT01943435|11774353|FG000|Intervention Period|Withdrawal by Subject|3
7471420|NCT01943435|11774354|FG001|Intervention Period|Withdrawal by Subject|3
7471421|NCT01943435|11774355|FG002|Intervention Period|Withdrawal by Subject|4
7471422|NCT01943435|11774353|FG000|2 Month Follow up|Lost to Follow-up|2
7471423|NCT01943435|11774354|FG001|2 Month Follow up|Lost to Follow-up|3
7471424|NCT01943435|11774355|FG002|2 Month Follow up|Lost to Follow-up|0
7471425|NCT01943435|11774353|FG000|6 Month Follow up|Lost to Follow-up|12
7471426|NCT01943435|11774354|FG001|6 Month Follow up|Lost to Follow-up|7
7471427|NCT01943435|11774355|FG002|6 Month Follow up|Lost to Follow-up|15
7471428|NCT01943539|11774389|FG000|Overall Study|Non-compliance with at-home intervention|4
7471429|NCT01943539|11774390|FG001|Overall Study|Non-compliance with at-home intervention|0
7471430|NCT01943552|11774399|FG000|Overall Study|Adverse Event|3
7471431|NCT01943552|11774400|FG001|Overall Study|Adverse Event|2
7471432|NCT01943552|11774399|FG000|Overall Study|Withdrawal by Subject|6
7471433|NCT01943552|11774400|FG001|Overall Study|Withdrawal by Subject|6
7471434|NCT01943552|11774399|FG000|Overall Study|Other Reasons|16
7471435|NCT01943552|11774400|FG001|Overall Study|Other Reasons|17
7471436|NCT01943591|11774421|FG000|Overall Study|Lost to Follow-up|3
7471437|NCT01943591|11774422|FG001|Overall Study|Lost to Follow-up|4
7471438|NCT01943591|11774421|FG000|Overall Study|Death|2
7471439|NCT01943591|11774422|FG001|Overall Study|Death|7
7471440|NCT01943799|11774432|FG000|Overall Study|Lost to Follow-up|0
7471441|NCT01943799|11774433|FG001|Overall Study|Lost to Follow-up|1
7471442|NCT01943799|11774434|FG002|Overall Study|Lost to Follow-up|1
7471443|NCT01943799|11774435|FG003|Overall Study|Lost to Follow-up|0
7471444|NCT01943799|11774432|FG000|Overall Study|Protocol Violation|1
7471445|NCT01943799|11774433|FG001|Overall Study|Protocol Violation|0
7471446|NCT01943799|11774434|FG002|Overall Study|Protocol Violation|0
7471447|NCT01943799|11774435|FG003|Overall Study|Protocol Violation|0
7317643|NCT00723840|11546640|FG000|Overall Study|Withdrawal by Subject|55
7317644|NCT00723840|11546640|FG000|Overall Study|Serious Adverse Events|3
7471448|NCT01943799|11774432|FG000|Overall Study|Withdrawal by Subject|4
7471449|NCT01943799|11774433|FG001|Overall Study|Withdrawal by Subject|2
7471450|NCT01943799|11774434|FG002|Overall Study|Withdrawal by Subject|1
7471451|NCT01943799|11774435|FG003|Overall Study|Withdrawal by Subject|0
7471452|NCT01943851|11774463|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471453|NCT01943851|11774464|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471454|NCT01943851|11774465|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471455|NCT01943851|11774466|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7471456|NCT01943851|11774467|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471457|NCT01943851|11774468|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471458|NCT01943851|11774469|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7471459|NCT01943851|11774470|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7471460|NCT01943851|11774471|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
7471461|NCT01943851|11774472|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471462|NCT01943851|11774473|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471463|NCT01943851|11774474|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471464|NCT01943851|11774475|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471465|NCT01943851|11774476|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471466|NCT01943851|11774477|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471467|NCT01943851|11774478|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471468|NCT01943851|11774479|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471469|NCT01943851|11774480|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
7471470|NCT01943851|11774463|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471471|NCT01943851|11774464|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471472|NCT01943851|11774465|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471473|NCT01943851|11774466|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471550|NCT01944046|11774536|FG000|Randomized to DB|Adverse Event|5
7471474|NCT01943851|11774467|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7471475|NCT01943851|11774468|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471476|NCT01943851|11774469|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471477|NCT01943851|11774470|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
7471478|NCT01943851|11774471|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471479|NCT01943851|11774472|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471480|NCT01943851|11774473|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471481|NCT01943851|11774474|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471482|NCT01943851|11774475|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471483|NCT01943851|11774476|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471484|NCT01943851|11774477|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471485|NCT01943851|11774478|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471486|NCT01943851|11774479|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471487|NCT01943851|11774480|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
7471488|NCT01943851|11774463|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471489|NCT01943851|11774464|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471490|NCT01943851|11774465|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471491|NCT01943851|11774466|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471492|NCT01943851|11774467|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471493|NCT01943851|11774468|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471494|NCT01943851|11774469|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471495|NCT01943851|11774470|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471496|NCT01943851|11774471|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471497|NCT01943851|11774472|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471498|NCT01943851|11774473|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471499|NCT01943851|11774474|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471500|NCT01943851|11774475|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471501|NCT01943851|11774476|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
7471502|NCT01943851|11774477|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471503|NCT01943851|11774478|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471504|NCT01943851|11774479|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471505|NCT01943851|11774480|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
7471506|NCT01943851|11774463|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471507|NCT01943851|11774464|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471508|NCT01943851|11774465|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471509|NCT01943851|11774466|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471510|NCT01943851|11774467|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471511|NCT01943851|11774468|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471512|NCT01943851|11774469|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471513|NCT01943851|11774470|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471514|NCT01943851|11774471|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471515|NCT01943851|11774472|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471516|NCT01943851|11774473|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471517|NCT01943851|11774474|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471518|NCT01943851|11774475|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471519|NCT01943851|11774476|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471520|NCT01943851|11774477|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471521|NCT01943851|11774478|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
7471522|NCT01943851|11774479|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471523|NCT01943851|11774480|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
7471524|NCT01943851|11774463|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471525|NCT01943851|11774464|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471526|NCT01943851|11774465|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471527|NCT01943851|11774466|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471528|NCT01943851|11774467|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471529|NCT01943851|11774468|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471530|NCT01943851|11774469|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471531|NCT01943851|11774470|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471532|NCT01943851|11774471|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471533|NCT01943851|11774472|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471534|NCT01943851|11774473|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471535|NCT01943851|11774474|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471536|NCT01943851|11774475|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471537|NCT01943851|11774476|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471538|NCT01943851|11774477|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
7471539|NCT01943851|11774478|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
7471540|NCT01943851|11774479|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
7471541|NCT01943851|11774480|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
7471542|NCT01943916|11774525|FG000|Overall Study|Technically invalid images|10
7471543|NCT01943916|11774525|FG000|Overall Study|Enrollment Failure|23
7471544|NCT01943916|11774525|FG000|Overall Study|Pilot Phase exclusion|100
7471545|NCT01943916|11774525|FG000|Overall Study|Quality Assurance Reader Fail|130
7471546|NCT01943916|11774525|FG000|Overall Study|Technical Failure|39
7471547|NCT01943916|11774525|FG000|Overall Study|Protocol Deviation No Biopsy|25
7471548|NCT01943916|11774525|FG000|Overall Study|No Truth Panel Review|38
7471549|NCT01943916|11774525|FG000|Overall Study|Protocol Deviation|1
7471551|NCT01944046|11774537|FG001|Randomized to DB|Adverse Event|2
7471552|NCT01944046|11774536|FG000|Randomized to DB|Clinical Worsening|3
7471553|NCT01944046|11774537|FG001|Randomized to DB|Clinical Worsening|2
7471554|NCT01944046|11774536|FG000|Randomized to DB|Lost to Follow-up|3
7471555|NCT01944046|11774537|FG001|Randomized to DB|Lost to Follow-up|3
7471556|NCT01944046|11774536|FG000|Randomized to DB|Withdrawal by Subject|2
7471557|NCT01944046|11774537|FG001|Randomized to DB|Withdrawal by Subject|4
7471558|NCT01944046|11774536|FG000|Randomized to DB|Physician Decision|1
7471559|NCT01944046|11774537|FG001|Randomized to DB|Physician Decision|2
7471560|NCT01944046|11774536|FG000|Randomized to DB|Did not have baseline ABC-SW|2
7471561|NCT01944046|11774537|FG001|Randomized to DB|Did not have baseline ABC-SW|0
7471562|NCT01944046|11774536|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
7471563|NCT01944046|11774537|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
7471564|NCT01944046|11774536|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
7471565|NCT01944046|11774537|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
7471566|NCT01944046|11774536|FG000|Open Label Eligible and Consented|Adverse Event|6
7471567|NCT01944046|11774537|FG001|Open Label Eligible and Consented|Adverse Event|1
7471568|NCT01944046|11774536|FG000|Open Label Eligible and Consented|Clinical Worsening|4
7471569|NCT01944046|11774537|FG001|Open Label Eligible and Consented|Clinical Worsening|2
7471570|NCT01944046|11774536|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
7471571|NCT01944046|11774537|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
7471572|NCT01944098|11774549|FG000|Overall Study|Physician Decision|1
7471573|NCT01944098|11774550|FG001|Overall Study|Physician Decision|0
7471574|NCT01944462|11774601|FG000|PPPP Educational Program|Lost to Follow-up|60
7471575|NCT01944631|11774608|FG000|Overall Study|Adverse Event|1
7471576|NCT01944631|11774609|FG001|Overall Study|Adverse Event|0
7471577|NCT01944631|11774608|FG000|Overall Study|Lost to Follow-up|3
7471578|NCT01944631|11774609|FG001|Overall Study|Lost to Follow-up|1
7471579|NCT01944631|11774608|FG000|Overall Study|Withdrawal by Subject|0
7471580|NCT01944631|11774609|FG001|Overall Study|Withdrawal by Subject|1
7471581|NCT01944670|11774624|FG000|Overall Study|Lost to Follow-up|2
7471582|NCT01944722|11774630|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
7471583|NCT01944722|11774630|FG000|Overall Study|Specimen Shipping Issues|34
7471584|NCT01944722|11774630|FG000|Overall Study|Improper Storage/Transport|5
7471585|NCT01944722|11774630|FG000|Overall Study|Insufficient Volume for Test|1
7471586|NCT01944722|11774630|FG000|Overall Study|Missing Specimens|3
7471587|NCT01944722|11774630|FG000|Overall Study|Specimens Mislabeled|2
7471588|NCT01944722|11774630|FG000|Overall Study|Withdrawal by Subject|8
7471589|NCT01944722|11774630|FG000|Overall Study|NILM Subjects <30 years old|8106
7471590|NCT01944722|11774630|FG000|Overall Study|Unsatisfactory Cytology Result|63
7471591|NCT01944722|11774630|FG000|Overall Study|>ASCUS Cytology|1122
7471592|NCT01944774|11774642|FG000|Overall Study|Withdrawal by Subject|2
7471593|NCT01944774|11774643|FG001|Overall Study|Withdrawal by Subject|3
7471594|NCT01944774|11774644|FG002|Overall Study|Withdrawal by Subject|3
7471595|NCT01944774|11774642|FG000|Overall Study|Adverse Event|3
7471596|NCT01944774|11774643|FG001|Overall Study|Adverse Event|2
7471597|NCT01944774|11774644|FG002|Overall Study|Adverse Event|3
7471598|NCT01944774|11774642|FG000|Overall Study|Lack of Efficacy|1
7471599|NCT01944774|11774643|FG001|Overall Study|Lack of Efficacy|2
7471600|NCT01944774|11774644|FG002|Overall Study|Lack of Efficacy|2
7471601|NCT01944774|11774642|FG000|Overall Study|Lost to Follow-up|0
7471602|NCT01944774|11774643|FG001|Overall Study|Lost to Follow-up|1
7471603|NCT01944774|11774644|FG002|Overall Study|Lost to Follow-up|0
7471604|NCT01944839|11774657|FG000|Overall Study|Physician Decision|2
7471605|NCT01944839|11774658|FG001|Overall Study|Physician Decision|2
7471606|NCT01944839|11774657|FG000|Overall Study|Protocol Violation|0
7471607|NCT01944839|11774658|FG001|Overall Study|Protocol Violation|1
7471608|NCT01944839|11774657|FG000|Overall Study|Adverse Event|10
7471609|NCT01944839|11774658|FG001|Overall Study|Adverse Event|5
7471610|NCT01944839|11774657|FG000|Overall Study|Withdrawal by Subject|9
7471611|NCT01944839|11774658|FG001|Overall Study|Withdrawal by Subject|17
7471612|NCT01944839|11774657|FG000|Overall Study|Lost to Follow-up|1
7471613|NCT01944839|11774658|FG001|Overall Study|Lost to Follow-up|0
7471614|NCT01944839|11774657|FG000|Overall Study|Subject non-compliance|0
7471615|NCT01944839|11774658|FG001|Overall Study|Subject non-compliance|3
7471616|NCT01944969|11774684|FG000|Overall Study|Adverse Event|1
7471617|NCT01944969|11774684|FG000|Overall Study|Lack of Efficacy|1
7471618|NCT01944969|11774684|FG000|Overall Study|Non-compliance with IMP|1
7471619|NCT01944969|11774684|FG000|Overall Study|Administrative or other reasons|23
7471620|NCT01945034|11774693|FG000|Overall Study|Medication Error|0
7471621|NCT01945034|11774694|FG001|Overall Study|Medication Error|1
7471622|NCT01945034|11774695|FG002|Overall Study|Medication Error|0
7471623|NCT01945034|11774693|FG000|Overall Study|Withdrawal by Subject|0
7471624|NCT01945034|11774694|FG001|Overall Study|Withdrawal by Subject|3
7471625|NCT01945034|11774695|FG002|Overall Study|Withdrawal by Subject|1
7471626|NCT01945034|11774693|FG000|Overall Study|Other|0
7471627|NCT01945034|11774694|FG001|Overall Study|Other|1
7471628|NCT01945034|11774695|FG002|Overall Study|Other|3
7471629|NCT01945034|11774693|FG000|Overall Study|Lost to Follow-up|0
7471630|NCT01945034|11774694|FG001|Overall Study|Lost to Follow-up|0
7471631|NCT01945034|11774695|FG002|Overall Study|Lost to Follow-up|2
7471632|NCT01945034|11774693|FG000|Overall Study|Protocol Violation|1
7471633|NCT01945034|11774694|FG001|Overall Study|Protocol Violation|0
7471634|NCT01945034|11774695|FG002|Overall Study|Protocol Violation|1
7471635|NCT01945086|11774706|FG000|Overall Study|Withdrawal by Subject|1
7471636|NCT01945086|11774707|FG001|Overall Study|Withdrawal by Subject|0
7471637|NCT01945086|11774708|FG002|Overall Study|Withdrawal by Subject|1
7471638|NCT01945086|11774706|FG000|Overall Study|Adverse Event|0
7471639|NCT01945086|11774707|FG001|Overall Study|Adverse Event|0
7471640|NCT01945086|11774708|FG002|Overall Study|Adverse Event|1
7471641|NCT01945216|11774734|FG000|Overall Study|Case report forms (CRF) uncollected|52
7471642|NCT01945216|11774734|FG000|Overall Study|Protocol Violation|42
7471643|NCT01945216|11774734|FG000|Overall Study|CRF not assured by investigators|5
7471644|NCT01945242|11774744|FG000|Overall Study|Physician Decision|3
7471645|NCT01945242|11774745|FG001|Overall Study|Physician Decision|3
7471646|NCT01945281|11774754|FG000|Overall Study|Adverse Event|1
7471647|NCT01945281|11774755|FG001|Overall Study|Adverse Event|0
7471648|NCT01945281|11774754|FG000|Overall Study|Death|3
7471649|NCT01945281|11774755|FG001|Overall Study|Death|3
7471650|NCT01945281|11774754|FG000|Overall Study|Physician Decision|1
7471651|NCT01945281|11774755|FG001|Overall Study|Physician Decision|1
7471652|NCT01945281|11774754|FG000|Overall Study|Technical Problems|1
7471653|NCT01945281|11774755|FG001|Overall Study|Technical Problems|0
7471654|NCT01945489|11774778|FG000|Cycle 1|Adverse Event|2
7471655|NCT01945489|11774779|FG001|Cycle 1|Adverse Event|0
7471656|NCT01945489|11774778|FG000|Cycle 1|Lost to Follow-up|4
7471657|NCT01945489|11774779|FG001|Cycle 1|Lost to Follow-up|0
7471658|NCT01945489|11774778|FG000|Cycle 1|Personal Reasons|4
7471659|NCT01945489|11774779|FG001|Cycle 1|Personal Reasons|2
7471660|NCT01945489|11774778|FG000|Cycle 1|Protocol Violation|0
7471661|NCT01945489|11774779|FG001|Cycle 1|Protocol Violation|1
7471662|NCT01945489|11774778|FG000|Cycle 1|Other Miscellaneous Reasons|3
7471663|NCT01945489|11774779|FG001|Cycle 1|Other Miscellaneous Reasons|1
7471664|NCT01945489|11774778|FG000|Cycle 2|Adverse Event|1
7471665|NCT01945489|11774779|FG001|Cycle 2|Adverse Event|0
7471666|NCT01945489|11774778|FG000|Cycle 2|Lost to Follow-up|0
7471667|NCT01945489|11774779|FG001|Cycle 2|Lost to Follow-up|1
7471668|NCT01945580|11774788|FG000|Overall Study|Withdrawal by Subject|13
7471669|NCT01945580|11774789|FG001|Overall Study|Withdrawal by Subject|35
7471670|NCT01945580|11774788|FG000|Overall Study|Physician Decision|3
7471671|NCT01945580|11774789|FG001|Overall Study|Physician Decision|2
7471672|NCT01945580|11774788|FG000|Overall Study|Lost to Follow-up|26
7471673|NCT01945580|11774789|FG001|Overall Study|Lost to Follow-up|39
7471674|NCT01945580|11774788|FG000|Overall Study|Death|7
7471675|NCT01945580|11774789|FG001|Overall Study|Death|2
7471676|NCT01945580|11774788|FG000|Overall Study|Patient moved out of state|0
7471677|NCT01945580|11774789|FG001|Overall Study|Patient moved out of state|1
7471678|NCT01945580|11774788|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
7471679|NCT01945580|11774789|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
7471680|NCT01945580|11774788|FG000|Overall Study|Family illness - unable to return|0
7471681|NCT01945580|11774789|FG001|Overall Study|Family illness - unable to return|1
7471682|NCT01945580|11774788|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
7471683|NCT01945580|11774789|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
7471684|NCT01945580|11774788|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
7471685|NCT01945580|11774789|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
7471686|NCT01945580|11774788|FG000|Overall Study|Noncompliance with 36 month visit|1
7471687|NCT01945580|11774789|FG001|Overall Study|Noncompliance with 36 month visit|0
7471688|NCT01945580|11774788|FG000|Overall Study|The patient moved.|1
7471689|NCT01945580|11774789|FG001|Overall Study|The patient moved.|0
7471690|NCT01945580|11774788|FG000|Overall Study|No data available|0
7471691|NCT01945580|11774789|FG001|Overall Study|No data available|2
7471692|NCT01945593|11774803|FG000|Overall Study|Adverse Event|0
7471693|NCT01945593|11774804|FG001|Overall Study|Adverse Event|0
7471694|NCT01945593|11774805|FG002|Overall Study|Adverse Event|0
7471695|NCT01945593|11774806|FG003|Overall Study|Adverse Event|5
7471696|NCT01945593|11774803|FG000|Overall Study|Physician Decision|0
7471697|NCT01945593|11774804|FG001|Overall Study|Physician Decision|0
7471698|NCT01945593|11774805|FG002|Overall Study|Physician Decision|1
7471699|NCT01945593|11774806|FG003|Overall Study|Physician Decision|1
7471700|NCT01945593|11774803|FG000|Overall Study|Withdrawal by Subject|0
7471701|NCT01945593|11774804|FG001|Overall Study|Withdrawal by Subject|2
7471702|NCT01945593|11774805|FG002|Overall Study|Withdrawal by Subject|0
7471703|NCT01945593|11774806|FG003|Overall Study|Withdrawal by Subject|4
7471704|NCT01945593|11774803|FG000|Overall Study|Protocol Violation|0
7471705|NCT01945593|11774804|FG001|Overall Study|Protocol Violation|2
7471706|NCT01945593|11774805|FG002|Overall Study|Protocol Violation|1
7471707|NCT01945593|11774806|FG003|Overall Study|Protocol Violation|3
7471708|NCT01945593|11774803|FG000|Overall Study|Death|0
7471709|NCT01945593|11774804|FG001|Overall Study|Death|0
7471710|NCT01945593|11774805|FG002|Overall Study|Death|1
7471711|NCT01945593|11774806|FG003|Overall Study|Death|0
7471712|NCT01945593|11774803|FG000|Overall Study|Other: Terminated|0
7471713|NCT01945593|11774804|FG001|Overall Study|Other: Terminated|0
7471714|NCT01945593|11774805|FG002|Overall Study|Other: Terminated|0
7471715|NCT01945593|11774806|FG003|Overall Study|Other: Terminated|1
7471716|NCT01945593|11774803|FG000|Overall Study|Other: Surgical Procedure|0
7471717|NCT01945593|11774804|FG001|Overall Study|Other: Surgical Procedure|2
7471718|NCT01945593|11774805|FG002|Overall Study|Other: Surgical Procedure|0
7471719|NCT01945593|11774806|FG003|Overall Study|Other: Surgical Procedure|6
7471720|NCT01945593|11774803|FG000|Overall Study|Other: Screen Failure|0
7471721|NCT01945593|11774804|FG001|Overall Study|Other: Screen Failure|2
7471722|NCT01945593|11774805|FG002|Overall Study|Other: Screen Failure|0
7471723|NCT01945593|11774806|FG003|Overall Study|Other: Screen Failure|0
7471724|NCT01945710|11774828|FG000|Overall Study|Progressive Disease|5
7471725|NCT01945710|11774829|FG001|Overall Study|Progressive Disease|4
7471726|NCT01945710|11774830|FG002|Overall Study|Progressive Disease|3
7471727|NCT01945710|11774831|FG003|Overall Study|Progressive Disease|2
7471728|NCT01945710|11774832|FG004|Overall Study|Progressive Disease|7
7471729|NCT01945710|11774833|FG005|Overall Study|Progressive Disease|3
7471730|NCT01945710|11774834|FG006|Overall Study|Progressive Disease|19
7471731|NCT01945710|11774828|FG000|Overall Study|Adverse Event|0
7471732|NCT01945710|11774829|FG001|Overall Study|Adverse Event|1
7471733|NCT01945710|11774830|FG002|Overall Study|Adverse Event|0
7471734|NCT01945710|11774831|FG003|Overall Study|Adverse Event|0
7471735|NCT01945710|11774832|FG004|Overall Study|Adverse Event|0
7471736|NCT01945710|11774833|FG005|Overall Study|Adverse Event|0
7471737|NCT01945710|11774834|FG006|Overall Study|Adverse Event|0
7471738|NCT01945710|11774828|FG000|Overall Study|Other|2
7471739|NCT01945710|11774829|FG001|Overall Study|Other|0
7471740|NCT01945710|11774830|FG002|Overall Study|Other|3
7471741|NCT01945710|11774831|FG003|Overall Study|Other|1
7471742|NCT01945710|11774832|FG004|Overall Study|Other|1
7471743|NCT01945710|11774833|FG005|Overall Study|Other|0
7471744|NCT01945710|11774834|FG006|Overall Study|Other|4
7471745|NCT01945710|11774828|FG000|Overall Study|Withdrawal by Subject|0
7471746|NCT01945710|11774829|FG001|Overall Study|Withdrawal by Subject|1
7471747|NCT01945710|11774830|FG002|Overall Study|Withdrawal by Subject|1
7471748|NCT01945710|11774831|FG003|Overall Study|Withdrawal by Subject|0
7471749|NCT01945710|11774832|FG004|Overall Study|Withdrawal by Subject|1
7471750|NCT01945710|11774833|FG005|Overall Study|Withdrawal by Subject|0
7471751|NCT01945710|11774834|FG006|Overall Study|Withdrawal by Subject|0
7471752|NCT01945866|11774854|FG000|Overall Study|Eyes did not complete or were dropped|2
7471753|NCT01945866|11774855|FG001|Overall Study|Eyes did not complete or were dropped|0
7471754|NCT01945944|11774864|FG000|Overall Study|Adverse Event|0
7471755|NCT01945944|11774865|FG001|Overall Study|Adverse Event|2
7471756|NCT01945944|11774864|FG000|Overall Study|Physician Decision|1
7471757|NCT01945944|11774865|FG001|Overall Study|Physician Decision|0
7471758|NCT01945944|11774864|FG000|Overall Study|Withdrawal by Subject|0
7471759|NCT01945944|11774865|FG001|Overall Study|Withdrawal by Subject|1
7471760|NCT01945996|11774890|FG000|Overall Study|Lost to Follow-up|3
7471761|NCT01945996|11774891|FG001|Overall Study|Lost to Follow-up|5
7471762|NCT01946152|11774912|FG000|Overall Study|Adverse Event|1
7471763|NCT01946152|11774913|FG001|Overall Study|Adverse Event|0
7471764|NCT01946152|11774914|FG002|Overall Study|Adverse Event|0
7471765|NCT01946152|11774915|FG003|Overall Study|Adverse Event|0
7471766|NCT01946152|11774912|FG000|Overall Study|Withdrawal by Subject|0
7471767|NCT01946152|11774913|FG001|Overall Study|Withdrawal by Subject|2
7471768|NCT01946152|11774914|FG002|Overall Study|Withdrawal by Subject|0
7471769|NCT01946152|11774915|FG003|Overall Study|Withdrawal by Subject|0
7471770|NCT01946152|11774912|FG000|Overall Study|Progression|0
7471771|NCT01946152|11774913|FG001|Overall Study|Progression|1
7471772|NCT01946152|11774914|FG002|Overall Study|Progression|4
7471773|NCT01946152|11774915|FG003|Overall Study|Progression|7
7471774|NCT01946152|11774912|FG000|Overall Study|Physician Decision|0
7471775|NCT01946152|11774913|FG001|Overall Study|Physician Decision|0
7471776|NCT01946152|11774914|FG002|Overall Study|Physician Decision|1
7471777|NCT01946152|11774915|FG003|Overall Study|Physician Decision|0
7471778|NCT01946152|11774912|FG000|Overall Study|Second malignancy|0
7471779|NCT01946152|11774913|FG001|Overall Study|Second malignancy|0
7471780|NCT01946152|11774914|FG002|Overall Study|Second malignancy|1
7471781|NCT01946152|11774915|FG003|Overall Study|Second malignancy|0
7471782|NCT01946152|11774912|FG000|Overall Study|Adverse Event|0
7471783|NCT01946152|11774913|FG001|Overall Study|Adverse Event|0
7471784|NCT01946152|11774914|FG002|Overall Study|Adverse Event|0
7471785|NCT01946152|11774915|FG003|Overall Study|Adverse Event|1
7471786|NCT01946165|11774929|FG000|Overall Study|Physician Decision|2
7471787|NCT01946165|11774930|FG001|Overall Study|Physician Decision|0
7471788|NCT01946165|11774929|FG000|Overall Study|Withdrawal by Subject|0
7471789|NCT01946165|11774930|FG001|Overall Study|Withdrawal by Subject|2
7471790|NCT01946178|11774937|FG000|Overall Study|Pregnancy|1
7471791|NCT01946178|11774937|FG000|Overall Study|Lost to Follow-up|1
7471792|NCT01946191|11774947|FG000|Allocation|Did not complete orientation|1
7471793|NCT01946191|11774948|FG001|Allocation|Did not complete orientation|1
7471794|NCT01946191|11774947|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
7471795|NCT01946191|11774948|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
7471796|NCT01946191|11774947|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
7471797|NCT01946191|11774948|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
7471798|NCT01946191|11774947|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
7471799|NCT01946191|11774948|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
7471800|NCT01946282|11774964|FG000|Year 1|Did not return FIT kit|4186
7471801|NCT01946282|11774965|FG001|Year 1|Did not return FIT kit|608
7471802|NCT01946282|11774966|FG002|Year 1|Did not return FIT kit|654
7471803|NCT01946282|11774964|FG000|Year 2|Did not return FIT kit|803
7471804|NCT01946282|11774965|FG001|Year 2|Did not return FIT kit|131
7471805|NCT01946282|11774966|FG002|Year 2|Did not return FIT kit|115
7471806|NCT01946282|11774964|FG000|Year 3|Did not return FIT kit|288
7471807|NCT01946282|11774965|FG001|Year 3|Did not return FIT kit|43
7471808|NCT01946282|11774966|FG002|Year 3|Did not return FIT kit|30
7471809|NCT01946412|11774976|FG000|Overall Study|Adverse Event|1
7471810|NCT01946412|11774976|FG000|Overall Study|Non-Compliance|1
7471811|NCT01946412|11774976|FG000|Overall Study|Continued with commercial Kalydeco|2
7471812|NCT01946412|11774976|FG000|Overall Study|Difficulty in swallowing|1
7471813|NCT01946425|11774984|FG000|Overall Study|Protocol Violation|1
7471814|NCT01946425|11774985|FG001|Overall Study|Protocol Violation|0
7471815|NCT01946425|11774984|FG000|Overall Study|Withdrawal by Subject|1
7471816|NCT01946425|11774985|FG001|Overall Study|Withdrawal by Subject|0
7471817|NCT01946438|11774996|FG000|Overall Study|Adverse Event|0
7471818|NCT01946438|11774997|FG001|Overall Study|Adverse Event|0
7471819|NCT01946438|11774998|FG002|Overall Study|Adverse Event|0
7471820|NCT01946438|11774999|FG003|Overall Study|Adverse Event|1
7471821|NCT01946438|11774996|FG000|Overall Study|Serious Adverse event|1
7471822|NCT01946438|11774997|FG001|Overall Study|Serious Adverse event|0
7471823|NCT01946438|11774998|FG002|Overall Study|Serious Adverse event|0
7471824|NCT01946438|11774999|FG003|Overall Study|Serious Adverse event|0
7471825|NCT01946438|11774996|FG000|Overall Study|Protocol Violation|0
7471826|NCT01946438|11774997|FG001|Overall Study|Protocol Violation|0
7471827|NCT01946438|11774998|FG002|Overall Study|Protocol Violation|1
7471828|NCT01946438|11774999|FG003|Overall Study|Protocol Violation|0
7471829|NCT01946438|11774996|FG000|Overall Study|Withdrawal by Subject|1
7471830|NCT01946438|11774997|FG001|Overall Study|Withdrawal by Subject|0
7471831|NCT01946438|11774998|FG002|Overall Study|Withdrawal by Subject|0
7471832|NCT01946438|11774999|FG003|Overall Study|Withdrawal by Subject|0
7471839|NCT01946802|11775027|FG000|Overall Study|Death|1
7471840|NCT01946802|11775027|FG000|Overall Study|Withdrawal by Subject|2
7471841|NCT01946802|11775027|FG000|Overall Study|Combined septic shock|1
7471842|NCT01946802|11775027|FG000|Overall Study|Protocol Violation|1
7471843|NCT01946880|11775033|FG000|Overall Study|Lost to Follow-up|1
7471844|NCT01946880|11775034|FG001|Overall Study|Lost to Follow-up|0
7471845|NCT01946880|11775033|FG000|Overall Study|Physician Decision|1
7471846|NCT01946880|11775034|FG001|Overall Study|Physician Decision|1
7471847|NCT01946880|11775033|FG000|Overall Study|Withdrawal by Subject|3
7471848|NCT01946880|11775034|FG001|Overall Study|Withdrawal by Subject|2
7471849|NCT01946880|11775033|FG000|Overall Study|Met Primary Endpoint|1
7471850|NCT01946880|11775034|FG001|Overall Study|Met Primary Endpoint|0
7471851|NCT01946880|11775033|FG000|Overall Study|Personal and Family Issues|1
7471852|NCT01946880|11775034|FG001|Overall Study|Personal and Family Issues|0
7471853|NCT01947127|11775042|FG000|Overall Study|Protocol Violation|18
7471854|NCT01947127|11775043|FG001|Overall Study|Protocol Violation|38
7471855|NCT01947127|11775042|FG000|Overall Study|Withdrawal by Subject|1
7471856|NCT01947127|11775043|FG001|Overall Study|Withdrawal by Subject|1
7471857|NCT01947127|11775042|FG000|Overall Study|Data loss|4
7471858|NCT01947127|11775043|FG001|Overall Study|Data loss|4
7471859|NCT01947283|11775063|FG000|Overall Study|Death|1
7471860|NCT01947283|11775064|FG001|Overall Study|Death|1
7471861|NCT01947283|11775065|FG002|Overall Study|Death|1
7471862|NCT01947283|11775066|FG003|Overall Study|Death|0
7471863|NCT01947283|11775067|FG004|Overall Study|Death|0
7471864|NCT01947283|11775068|FG005|Overall Study|Death|0
7471865|NCT01947283|11775069|FG006|Overall Study|Death|0
7471866|NCT01947283|11775063|FG000|Overall Study|Lost to Follow-up|4
7471867|NCT01947283|11775064|FG001|Overall Study|Lost to Follow-up|6
7471868|NCT01947283|11775065|FG002|Overall Study|Lost to Follow-up|5
7471869|NCT01947283|11775066|FG003|Overall Study|Lost to Follow-up|5
7471870|NCT01947283|11775067|FG004|Overall Study|Lost to Follow-up|0
7471871|NCT01947283|11775068|FG005|Overall Study|Lost to Follow-up|2
7471872|NCT01947283|11775069|FG006|Overall Study|Lost to Follow-up|5
7471873|NCT01947283|11775063|FG000|Overall Study|Withdrawal by Subject|10
7471874|NCT01947283|11775064|FG001|Overall Study|Withdrawal by Subject|8
7471875|NCT01947283|11775065|FG002|Overall Study|Withdrawal by Subject|4
7471876|NCT01947283|11775066|FG003|Overall Study|Withdrawal by Subject|1
7471877|NCT01947283|11775067|FG004|Overall Study|Withdrawal by Subject|0
7471878|NCT01947283|11775068|FG005|Overall Study|Withdrawal by Subject|0
7471879|NCT01947283|11775069|FG006|Overall Study|Withdrawal by Subject|2
7471880|NCT01947283|11775063|FG000|Overall Study|No Clinical Recording|12
7471881|NCT01947283|11775064|FG001|Overall Study|No Clinical Recording|6
7471882|NCT01947283|11775065|FG002|Overall Study|No Clinical Recording|8
7471883|NCT01947283|11775066|FG003|Overall Study|No Clinical Recording|10
7471884|NCT01947283|11775067|FG004|Overall Study|No Clinical Recording|0
7471885|NCT01947283|11775068|FG005|Overall Study|No Clinical Recording|0
7471886|NCT01947283|11775069|FG006|Overall Study|No Clinical Recording|0
7471887|NCT01947283|11775063|FG000|Overall Study|Non-coding Clinical Recording language|0
7533904|NCT02690974|11880367|FG000|Overall Study|Adverse Event|16
7471888|NCT01947283|11775064|FG001|Overall Study|Non-coding Clinical Recording language|0
7471889|NCT01947283|11775065|FG002|Overall Study|Non-coding Clinical Recording language|0
7471890|NCT01947283|11775066|FG003|Overall Study|Non-coding Clinical Recording language|1
7471891|NCT01947283|11775067|FG004|Overall Study|Non-coding Clinical Recording language|0
7471892|NCT01947283|11775068|FG005|Overall Study|Non-coding Clinical Recording language|0
7471893|NCT01947283|11775069|FG006|Overall Study|Non-coding Clinical Recording language|0
7471894|NCT01947283|11775063|FG000|Overall Study|Missing Follow-up Assessment|2
7471895|NCT01947283|11775064|FG001|Overall Study|Missing Follow-up Assessment|2
7471896|NCT01947283|11775065|FG002|Overall Study|Missing Follow-up Assessment|3
7471897|NCT01947283|11775066|FG003|Overall Study|Missing Follow-up Assessment|0
7471898|NCT01947283|11775067|FG004|Overall Study|Missing Follow-up Assessment|0
7471899|NCT01947283|11775068|FG005|Overall Study|Missing Follow-up Assessment|2
7471900|NCT01947283|11775069|FG006|Overall Study|Missing Follow-up Assessment|0
7471901|NCT01947283|11775063|FG000|Overall Study|No patients were enrolled in study|0
7471902|NCT01947283|11775064|FG001|Overall Study|No patients were enrolled in study|0
7413024|NCT01422239|11685111|FG000|Overall Study|Lost to Follow-up|4
7413025|NCT01422239|11685112|FG001|Overall Study|Lost to Follow-up|3
7413026|NCT01422304|11685120|FG000|Overall Study|Adverse Event|0
7413027|NCT01422304|11685121|FG001|Overall Study|Adverse Event|1
7413028|NCT01422304|11685120|FG000|Overall Study|Lost to Follow-up|14
7413029|NCT01422304|11685121|FG001|Overall Study|Lost to Follow-up|20
7413030|NCT01422304|11685120|FG000|Overall Study|Never Entered Follow-up|2
7413031|NCT01422304|11685121|FG001|Overall Study|Never Entered Follow-up|1
7413032|NCT01422304|11685120|FG000|Overall Study|Protocol Violation|1
7413033|NCT01422304|11685121|FG001|Overall Study|Protocol Violation|0
7471903|NCT01947283|11775065|FG002|Overall Study|No patients were enrolled in study|0
7471904|NCT01947283|11775066|FG003|Overall Study|No patients were enrolled in study|0
7471905|NCT01947283|11775067|FG004|Overall Study|No patients were enrolled in study|0
7471906|NCT01947283|11775068|FG005|Overall Study|No patients were enrolled in study|3
7471907|NCT01947283|11775069|FG006|Overall Study|No patients were enrolled in study|1
7471908|NCT01947491|11775099|FG000|Overall Study|Lost to Follow-up|5
7471909|NCT01947491|11775100|FG001|Overall Study|Lost to Follow-up|3
7471910|NCT01947491|11775101|FG002|Overall Study|Lost to Follow-up|1
7471911|NCT01947491|11775102|FG003|Overall Study|Lost to Follow-up|2
7471912|NCT01947491|11775099|FG000|Overall Study|Lack of Efficacy|1
7471913|NCT01947491|11775100|FG001|Overall Study|Lack of Efficacy|0
7471914|NCT01947491|11775101|FG002|Overall Study|Lack of Efficacy|0
7471915|NCT01947491|11775102|FG003|Overall Study|Lack of Efficacy|1
7471916|NCT01947491|11775099|FG000|Overall Study|Protocol Violation|1
7471917|NCT01947491|11775100|FG001|Overall Study|Protocol Violation|0
7471918|NCT01947491|11775101|FG002|Overall Study|Protocol Violation|0
7471919|NCT01947491|11775102|FG003|Overall Study|Protocol Violation|0
7471920|NCT01947491|11775099|FG000|Overall Study|Withdrawal by Subject|1
7471921|NCT01947491|11775100|FG001|Overall Study|Withdrawal by Subject|1
7471922|NCT01947491|11775101|FG002|Overall Study|Withdrawal by Subject|1
7471923|NCT01947491|11775102|FG003|Overall Study|Withdrawal by Subject|0
7471924|NCT01947491|11775099|FG000|Overall Study|Worsening of condition|0
7471925|NCT01947491|11775100|FG001|Overall Study|Worsening of condition|1
7471926|NCT01947491|11775101|FG002|Overall Study|Worsening of condition|0
7471927|NCT01947491|11775102|FG003|Overall Study|Worsening of condition|0
7471928|NCT01947491|11775099|FG000|Overall Study|Adverse Event|0
7471929|NCT01947491|11775100|FG001|Overall Study|Adverse Event|1
7471930|NCT01947491|11775101|FG002|Overall Study|Adverse Event|0
7471931|NCT01947491|11775102|FG003|Overall Study|Adverse Event|2
7471932|NCT01947517|11775114|FG000|Overall Study|Withdrawal by Subject|1
7471933|NCT01947517|11775115|FG001|Overall Study|Withdrawal by Subject|1
7471934|NCT01947582|11775121|FG000|Overall Study|Withdrawal by Subject|1
7471935|NCT01947855|11775141|FG000|Overall Study|Withdrawal by Subject|1
7471936|NCT01947855|11775142|FG001|Overall Study|Withdrawal by Subject|0
7471937|NCT01947855|11775143|FG002|Overall Study|Withdrawal by Subject|0
7471938|NCT01947894|11775154|FG000|Overall Study|Other|3
7471939|NCT01947894|11775155|FG001|Overall Study|Other|4
7471940|NCT01947894|11775156|FG002|Overall Study|Other|3
7471941|NCT01947894|11775154|FG000|Overall Study|Withdrawal by Subject|12
7471942|NCT01947894|11775155|FG001|Overall Study|Withdrawal by Subject|4
7471943|NCT01947894|11775156|FG002|Overall Study|Withdrawal by Subject|1
7471944|NCT01947894|11775154|FG000|Overall Study|Death|12
7471945|NCT01947894|11775155|FG001|Overall Study|Death|1
7471946|NCT01947894|11775156|FG002|Overall Study|Death|0
7471947|NCT01947894|11775154|FG000|Overall Study|Physician Decision|2
7471948|NCT01947894|11775155|FG001|Overall Study|Physician Decision|0
7471949|NCT01947894|11775156|FG002|Overall Study|Physician Decision|0
7471950|NCT01947894|11775154|FG000|Overall Study|Adverse Event|5
7471951|NCT01947894|11775155|FG001|Overall Study|Adverse Event|1
7471952|NCT01947894|11775156|FG002|Overall Study|Adverse Event|0
7471953|NCT01947894|11775154|FG000|Overall Study|Switched to other growth hormone brand|53
7471954|NCT01947894|11775155|FG001|Overall Study|Switched to other growth hormone brand|8
7471955|NCT01947894|11775156|FG002|Overall Study|Switched to other growth hormone brand|23
7413034|NCT01422304|11685120|FG000|Overall Study|Withdrawal by Subject|4
7471956|NCT01948050|11775196|FG000|Overall Study|Withdrawal by Subject|0
7471957|NCT01948050|11775197|FG001|Overall Study|Withdrawal by Subject|1
7471958|NCT01948063|11775205|FG000|Overall Study|Boston MCI halted research protocol|0
7471959|NCT01948063|11775206|FG001|Overall Study|Boston MCI halted research protocol|1
7471960|NCT01948063|11775205|FG000|Overall Study|Discovered an enrollment in other study|0
7471961|NCT01948063|11775206|FG001|Overall Study|Discovered an enrollment in other study|1
7471962|NCT01948063|11775205|FG000|Overall Study|Blood samples were accidentally thawed|1
7471963|NCT01948063|11775206|FG001|Overall Study|Blood samples were accidentally thawed|0
7471964|NCT01948076|11775214|FG000|Overall Study|Withdrawal by Subject|0
7471965|NCT01948076|11775215|FG001|Overall Study|Withdrawal by Subject|1
7471966|NCT01948193|11775227|FG000|Overall Study|Serious event|2
7471967|NCT01948193|11775227|FG000|Overall Study|Lost to Follow-up|7
7471968|NCT01948258|11775232|FG000|Overall Study|Pregnancy|41
7471969|NCT01948258|11775232|FG000|Overall Study|Did not complete by cut-off date|35
7471970|NCT01948258|11775232|FG000|Overall Study|Lost to Follow-up|27
7471971|NCT01948258|11775232|FG000|Overall Study|Withdrawal by SPD|8
7471972|NCT01948258|11775232|FG000|Overall Study|Withdrawal by Subject|6
7471973|NCT01948258|11775232|FG000|Overall Study|Health Care Professional|43
7471974|NCT01948258|11775232|FG000|Overall Study|Removed from statistical analysis|2
7471975|NCT01948427|11775272|FG000|Overall Study|Serious Adverse Event|3
7471976|NCT01948427|11775273|FG001|Overall Study|Serious Adverse Event|0
7471977|NCT01948427|11775274|FG002|Overall Study|Serious Adverse Event|0
7471978|NCT01948427|11775275|FG003|Overall Study|Serious Adverse Event|0
7471979|NCT01948427|11775276|FG004|Overall Study|Serious Adverse Event|1
7471980|NCT01948427|11775272|FG000|Overall Study|Investigator Request|0
7471981|NCT01948427|11775273|FG001|Overall Study|Investigator Request|8
7471982|NCT01948427|11775274|FG002|Overall Study|Investigator Request|0
7471983|NCT01948427|11775275|FG003|Overall Study|Investigator Request|0
7471984|NCT01948427|11775276|FG004|Overall Study|Investigator Request|6
7471985|NCT01948427|11775272|FG000|Overall Study|Lost to Follow-up|1
7471986|NCT01948427|11775273|FG001|Overall Study|Lost to Follow-up|0
7471987|NCT01948427|11775274|FG002|Overall Study|Lost to Follow-up|0
7471988|NCT01948427|11775275|FG003|Overall Study|Lost to Follow-up|0
7471989|NCT01948427|11775276|FG004|Overall Study|Lost to Follow-up|4
7471990|NCT01948427|11775272|FG000|Overall Study|Withdrawal by Subject|2
7471991|NCT01948427|11775273|FG001|Overall Study|Withdrawal by Subject|0
7471992|NCT01948427|11775274|FG002|Overall Study|Withdrawal by Subject|0
7471993|NCT01948427|11775275|FG003|Overall Study|Withdrawal by Subject|0
7471994|NCT01948427|11775276|FG004|Overall Study|Withdrawal by Subject|1
7471995|NCT01948427|11775272|FG000|Overall Study|Other, Not Specified|1
7471996|NCT01948427|11775273|FG001|Overall Study|Other, Not Specified|9
7471997|NCT01948427|11775274|FG002|Overall Study|Other, Not Specified|0
7471998|NCT01948427|11775275|FG003|Overall Study|Other, Not Specified|0
7471999|NCT01948427|11775276|FG004|Overall Study|Other, Not Specified|2
7472000|NCT01948791|11775301|FG000|Overall Study|Adverse Event|12
7472001|NCT01948791|11775301|FG000|Overall Study|Lack of Efficacy|3
7472002|NCT01948791|11775301|FG000|Overall Study|Protocol Violation|2
7472003|NCT01948791|11775301|FG000|Overall Study|Withdrawal by Subject|5
7472004|NCT01948791|11775301|FG000|Overall Study|Lost to Follow-up|6
7472005|NCT01948791|11775301|FG000|Overall Study|Management issues|1
7472006|NCT01948791|11775301|FG000|Overall Study|Others|7
7472007|NCT01948791|11775301|FG000|Overall Study|Screening failure|35
7472008|NCT01948830|11775307|FG000|Overall Study|Physician Decision|1
7472009|NCT01948830|11775308|FG001|Overall Study|Physician Decision|3
7472010|NCT01948830|11775307|FG000|Overall Study|Protocol deviation|1
7472011|NCT01948830|11775308|FG001|Overall Study|Protocol deviation|2
7472012|NCT01948830|11775307|FG000|Overall Study|Lost to Follow-up|5
7472013|NCT01948830|11775308|FG001|Overall Study|Lost to Follow-up|4
7472014|NCT01948830|11775307|FG000|Overall Study|Withdrawal by Subject|14
7472015|NCT01948830|11775308|FG001|Overall Study|Withdrawal by Subject|17
7472016|NCT01948830|11775307|FG000|Overall Study|Adverse Event|9
7472017|NCT01948830|11775308|FG001|Overall Study|Adverse Event|2
7472018|NCT01948830|11775307|FG000|Overall Study|Death|3
7472019|NCT01948830|11775308|FG001|Overall Study|Death|4
7472020|NCT01948908|11775317|FG000|Overall Study|Protocol Violation|1
7472021|NCT01948908|11775318|FG001|Overall Study|Protocol Violation|0
7472022|NCT01948908|11775319|FG002|Overall Study|Protocol Violation|2
7472023|NCT01949051|11775357|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
7472024|NCT01949051|11775358|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
7472025|NCT01949051|11775359|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
7472026|NCT01949051|11775360|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
7472027|NCT01949051|11775361|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
7472028|NCT01949051|11775362|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
7472029|NCT01949051|11775357|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
7472030|NCT01949051|11775358|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7472031|NCT01949051|11775359|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7472032|NCT01949051|11775360|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7472033|NCT01949051|11775361|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7472034|NCT01949051|11775362|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
7472035|NCT01949051|11775357|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
7472036|NCT01949051|11775358|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
7472037|NCT01949051|11775359|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
7472038|NCT01949051|11775360|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
7472039|NCT01949051|11775361|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
7472040|NCT01949051|11775362|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
7472041|NCT01949051|11775357|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7472042|NCT01949051|11775358|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
7472043|NCT01949051|11775359|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7472044|NCT01949051|11775360|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7472045|NCT01949051|11775361|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7472046|NCT01949051|11775362|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7472047|NCT01949051|11775357|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7472048|NCT01949051|11775358|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7472049|NCT01949051|11775359|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
7472050|NCT01949051|11775360|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7472051|NCT01949051|11775361|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7472052|NCT01949051|11775362|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7533905|NCT02690974|11880367|FG000|Overall Study|Death|9
7533906|NCT02690974|11880367|FG000|Overall Study|Subject/guardian decision|4
7533907|NCT02690974|11880367|FG000|Overall Study|Lost to Follow-up|3
7533908|NCT02690974|11880367|FG000|Overall Study|Withdrawal of Informed Consent|3
7533909|NCT02690974|11880367|FG000|Overall Study|Physician Decision|2
7533910|NCT02690974|11880367|FG000|Overall Study|Non-compliance with study treatment|1
7533911|NCT02690974|11880367|FG000|Overall Study|Protocol-defined stopping criteria|1
7533912|NCT02690974|11880367|FG000|Overall Study|Protocol Deviation|1
7533913|NCT02691247|11880383|FG000|Overall Study|Withdrawal by Subject|1
7533914|NCT02691247|11880384|FG001|Overall Study|Withdrawal by Subject|2
7533915|NCT02691247|11880385|FG002|Overall Study|Withdrawal by Subject|2
7533916|NCT02691247|11880383|FG000|Overall Study|Lost to Follow-up|2
7533917|NCT02691247|11880384|FG001|Overall Study|Lost to Follow-up|0
7533918|NCT02691247|11880385|FG002|Overall Study|Lost to Follow-up|1
7533919|NCT02691455|11880425|FG000|Overall Study|Withdrawal by Subject|1
7533920|NCT02691455|11880426|FG001|Overall Study|Withdrawal by Subject|2
7533921|NCT02691455|11880425|FG000|Overall Study|Lost to Follow-up|15
7533922|NCT02691455|11880426|FG001|Overall Study|Lost to Follow-up|15
7533923|NCT02691468|11880434|FG000|Overall Study|Bronchial blocker use|2
7533924|NCT02691468|11880435|FG001|Overall Study|Bronchial blocker use|1
7533925|NCT02691468|11880434|FG000|Overall Study|Lost to Follow-up|2
7533926|NCT02691468|11880435|FG001|Overall Study|Lost to Follow-up|1
7533927|NCT02691468|11880434|FG000|Overall Study|Failure to advance FOB|2
7533928|NCT02691468|11880435|FG001|Overall Study|Failure to advance FOB|0
7533929|NCT02691494|11880444|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7533930|NCT02691494|11880445|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7533931|NCT02691494|11880446|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7533932|NCT02691494|11880444|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7533933|NCT02691494|11880445|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7533934|NCT02691494|11880446|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7533935|NCT02691494|11880444|FG000|Post-Treatment Follow-Up Period|Other|2
7533936|NCT02691494|11880445|FG001|Post-Treatment Follow-Up Period|Other|1
7533937|NCT02691494|11880446|FG002|Post-Treatment Follow-Up Period|Other|1
7533938|NCT02691494|11880444|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7533939|NCT02691494|11880445|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
7533940|NCT02691494|11880446|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
7533941|NCT02691494|11880444|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7533942|NCT02691494|11880445|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
7533943|NCT02691494|11880446|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7533944|NCT02691507|11880456|FG000|Overall Study|Missed Visit 3|0
7533945|NCT02691507|11880457|FG001|Overall Study|Missed Visit 3|1
7533946|NCT02691572|11880465|FG000|Overall Study|Withdrawal by Subject|1
7533947|NCT02691572|11880466|FG001|Overall Study|Withdrawal by Subject|0
7533948|NCT02691572|11880465|FG000|Overall Study|Protocol Violation|0
7533949|NCT02691572|11880466|FG001|Overall Study|Protocol Violation|1
7533950|NCT02691702|11880483|FG000|Overall Study|Adverse Event|1
7533951|NCT02691702|11880484|FG001|Overall Study|Adverse Event|0
7533952|NCT02691702|11880485|FG002|Overall Study|Adverse Event|0
7533953|NCT02691702|11880486|FG003|Overall Study|Adverse Event|0
7533954|NCT02691702|11880487|FG004|Overall Study|Adverse Event|0
7533955|NCT02691702|11880488|FG005|Overall Study|Adverse Event|0
7533956|NCT02691702|11880489|FG006|Overall Study|Adverse Event|0
7533957|NCT02691702|11880490|FG007|Overall Study|Adverse Event|0
7533958|NCT02691702|11880491|FG008|Overall Study|Adverse Event|1
7533959|NCT02691702|11880492|FG009|Overall Study|Adverse Event|0
7533960|NCT02691702|11880493|FG010|Overall Study|Adverse Event|1
7533961|NCT02691702|11880483|FG000|Overall Study|Lost to Follow-up|0
7533962|NCT02691702|11880484|FG001|Overall Study|Lost to Follow-up|0
7533963|NCT02691702|11880485|FG002|Overall Study|Lost to Follow-up|1
7533964|NCT02691702|11880486|FG003|Overall Study|Lost to Follow-up|0
7533965|NCT02691702|11880487|FG004|Overall Study|Lost to Follow-up|0
7533966|NCT02691702|11880488|FG005|Overall Study|Lost to Follow-up|2
7533967|NCT02691702|11880489|FG006|Overall Study|Lost to Follow-up|0
7533968|NCT02691702|11880490|FG007|Overall Study|Lost to Follow-up|0
7533969|NCT02691702|11880491|FG008|Overall Study|Lost to Follow-up|0
7533970|NCT02691702|11880492|FG009|Overall Study|Lost to Follow-up|0
7533971|NCT02691702|11880493|FG010|Overall Study|Lost to Follow-up|1
7533972|NCT02691702|11880483|FG000|Overall Study|Withdrawal by Subject|1
7472053|NCT01949090|11775375|FG000|Overall Study|Serious Adverse Event|0
7472054|NCT01949090|11775376|FG001|Overall Study|Serious Adverse Event|1
7472055|NCT01949090|11775377|FG002|Overall Study|Serious Adverse Event|2
7472056|NCT01949090|11775378|FG003|Overall Study|Serious Adverse Event|0
7472057|NCT01949090|11775379|FG004|Overall Study|Serious Adverse Event|1
7472058|NCT01949090|11775375|FG000|Overall Study|Withdrawal by Subject|2
7472059|NCT01949090|11775376|FG001|Overall Study|Withdrawal by Subject|0
7472060|NCT01949090|11775377|FG002|Overall Study|Withdrawal by Subject|0
7472061|NCT01949090|11775378|FG003|Overall Study|Withdrawal by Subject|0
7472062|NCT01949090|11775379|FG004|Overall Study|Withdrawal by Subject|1
7472063|NCT01949090|11775375|FG000|Overall Study|Protocol non-compliance|0
7472064|NCT01949090|11775376|FG001|Overall Study|Protocol non-compliance|0
7472065|NCT01949090|11775377|FG002|Overall Study|Protocol non-compliance|0
7472066|NCT01949090|11775378|FG003|Overall Study|Protocol non-compliance|0
7472067|NCT01949090|11775379|FG004|Overall Study|Protocol non-compliance|1
7472068|NCT01949090|11775375|FG000|Overall Study|Lost to Follow-up|2
7472069|NCT01949090|11775376|FG001|Overall Study|Lost to Follow-up|1
7472070|NCT01949090|11775377|FG002|Overall Study|Lost to Follow-up|0
7472071|NCT01949090|11775378|FG003|Overall Study|Lost to Follow-up|1
7472072|NCT01949090|11775379|FG004|Overall Study|Lost to Follow-up|1
7472073|NCT01949116|11775394|FG000|Overall Study|Death|2
7472074|NCT01949116|11775395|FG001|Overall Study|Death|0
7472075|NCT01949116|11775394|FG000|Overall Study|Lost to Follow-up|1
7472076|NCT01949116|11775395|FG001|Overall Study|Lost to Follow-up|3
7472077|NCT01949116|11775394|FG000|Overall Study|Withdrawal by Subject|5
7472078|NCT01949116|11775395|FG001|Overall Study|Withdrawal by Subject|3
7472079|NCT01949142|11775407|FG000|Overall Study|Withdrawal of consent|1
7472080|NCT01949142|11775408|FG001|Overall Study|Withdrawal of consent|0
7472081|NCT01949142|11775407|FG000|Overall Study|Lost to Follow-up|1
7472082|NCT01949142|11775408|FG001|Overall Study|Lost to Follow-up|1
7472083|NCT01949142|11775407|FG000|Overall Study|Parent changed their mind|1
7472084|NCT01949142|11775408|FG001|Overall Study|Parent changed their mind|0
7472085|NCT01949155|11775417|FG000|Overall Study|Lost to Follow-up|1
7472086|NCT01949155|11775418|FG001|Overall Study|Lost to Follow-up|0
7472087|NCT01949155|11775417|FG000|Overall Study|Protocol Violation|1
7472088|NCT01949155|11775418|FG001|Overall Study|Protocol Violation|0
7472089|NCT01949480|11775440|FG000|Overall Study|Physician Decision|5
7472090|NCT01949480|11775441|FG001|Overall Study|Physician Decision|8
7472091|NCT01949532|11775449|FG000|Overall Study|On-study at the Data Cut-off Date|3
7472092|NCT01949532|11775450|FG001|Overall Study|On-study at the Data Cut-off Date|3
7472101|NCT01949870|11775490|FG000|Overall Study|Lack of Efficacy|2
7472102|NCT01949870|11775490|FG000|Overall Study|Adverse Event|1
7472103|NCT01949870|11775490|FG000|Overall Study|Study termination|1
7472104|NCT01949870|11775490|FG000|Overall Study|Eligibility requirements not fulfilled|2
7472105|NCT01950013|11775497|FG000|Overall Study|Withdrawal by Subject|0
7472106|NCT01950013|11775498|FG001|Overall Study|Withdrawal by Subject|2
7472107|NCT01950013|11775499|FG002|Overall Study|Withdrawal by Subject|0
7472108|NCT01950169|11775528|FG000|Overall Study|Withdrawal by Subject|2
7472109|NCT01950169|11775529|FG001|Overall Study|Withdrawal by Subject|8
7472110|NCT01950169|11775530|FG002|Overall Study|Withdrawal by Subject|1
7472111|NCT01950169|11775528|FG000|Overall Study|Death|1
7472112|NCT01950169|11775529|FG001|Overall Study|Death|0
7472113|NCT01950169|11775530|FG002|Overall Study|Death|0
7472114|NCT01950273|11775550|FG000|Overall Study|Protocol Violation|1
7472115|NCT01950273|11775551|FG001|Overall Study|Protocol Violation|0
7472116|NCT01950273|11775550|FG000|Overall Study|Withdrawal by Subject|2
7472117|NCT01950273|11775551|FG001|Overall Study|Withdrawal by Subject|0
7472118|NCT01950273|11775550|FG000|Overall Study|Other not defined above|1
7472119|NCT01950273|11775551|FG001|Overall Study|Other not defined above|0
7472120|NCT01950364|11775572|FG000|Overall Study|Adverse Event|3
7472121|NCT01950364|11775573|FG001|Overall Study|Adverse Event|0
7472122|NCT01950364|11775572|FG000|Overall Study|Stem Cell Transplant|2
7472123|NCT01950364|11775573|FG001|Overall Study|Stem Cell Transplant|6
7472124|NCT01950364|11775572|FG000|Overall Study|Disease Progression|5
7472125|NCT01950364|11775573|FG001|Overall Study|Disease Progression|2
7472126|NCT01950364|11775572|FG000|Overall Study|Withdrawal by Subject|0
7472127|NCT01950364|11775573|FG001|Overall Study|Withdrawal by Subject|1
7472128|NCT01950364|11775572|FG000|Overall Study|Protocol Violation|0
7472129|NCT01950364|11775573|FG001|Overall Study|Protocol Violation|1
7472130|NCT01950741|11775583|FG000|Overall Study|Lost to Follow-up|1
7472131|NCT01950741|11775583|FG000|Overall Study|Death|1
7472132|NCT01950741|11775583|FG000|Overall Study|Withdrawal by Subject|1
7472133|NCT01950819|11775594|FG000|Overall Study|Graft Loss|35
7472134|NCT01950819|11775595|FG001|Overall Study|Graft Loss|30
7472135|NCT01950819|11775594|FG000|Overall Study|Death|29
7472136|NCT01950819|11775595|FG001|Overall Study|Death|34
7472137|NCT01950819|11775594|FG000|Overall Study|Subject / Gardian decision|54
7472138|NCT01950819|11775595|FG001|Overall Study|Subject / Gardian decision|51
7472139|NCT01950819|11775594|FG000|Overall Study|technical problems|2
7472140|NCT01950819|11775595|FG001|Overall Study|technical problems|0
7472141|NCT01950819|11775594|FG000|Overall Study|Pregnancy|0
7472142|NCT01950819|11775595|FG001|Overall Study|Pregnancy|2
7472143|NCT01950819|11775594|FG000|Overall Study|Lost to Follow-up|9
7472144|NCT01950819|11775595|FG001|Overall Study|Lost to Follow-up|17
7472145|NCT01951092|11775607|FG000|Overall Study|Lost to Follow-up|10
7472146|NCT01951092|11775607|FG000|Overall Study|Incarceration|1
7472147|NCT01951092|11775607|FG000|Overall Study|Transfer of Care|1
7472148|NCT01951105|11775614|FG000|Overall Study|Adverse Event|0
7472149|NCT01951105|11775615|FG001|Overall Study|Adverse Event|5
7472150|NCT01951105|11775616|FG002|Overall Study|Adverse Event|0
7472151|NCT01951105|11775614|FG000|Overall Study|Lost to Follow-up|0
7472152|NCT01951105|11775615|FG001|Overall Study|Lost to Follow-up|1
7472153|NCT01951105|11775616|FG002|Overall Study|Lost to Follow-up|0
7472154|NCT01951105|11775614|FG000|Overall Study|Protocol Violation|1
7472155|NCT01951105|11775615|FG001|Overall Study|Protocol Violation|1
7472156|NCT01951105|11775616|FG002|Overall Study|Protocol Violation|1
7472157|NCT01951105|11775614|FG000|Overall Study|Withdrawal by Subject|0
7472158|NCT01951105|11775615|FG001|Overall Study|Withdrawal by Subject|3
7472159|NCT01951105|11775616|FG002|Overall Study|Withdrawal by Subject|1
7472160|NCT01951157|11775642|FG000|Overall Study|Progressive Disease|12
7472161|NCT01951157|11775643|FG001|Overall Study|Progressive Disease|13
7472162|NCT01951157|11775644|FG002|Overall Study|Progressive Disease|10
7472163|NCT01951157|11775642|FG000|Overall Study|Treatment-unrelated AE|1
7472164|NCT01951157|11775643|FG001|Overall Study|Treatment-unrelated AE|0
7472165|NCT01951157|11775644|FG002|Overall Study|Treatment-unrelated AE|3
7472166|NCT01951157|11775642|FG000|Overall Study|Study Termination|0
7472167|NCT01951157|11775643|FG001|Overall Study|Study Termination|0
7472168|NCT01951157|11775644|FG002|Overall Study|Study Termination|1
7472169|NCT01951157|11775642|FG000|Overall Study|Physician Decision|5
7472170|NCT01951157|11775643|FG001|Overall Study|Physician Decision|3
7472171|NCT01951157|11775644|FG002|Overall Study|Physician Decision|2
7472172|NCT01951157|11775642|FG000|Overall Study|Non-treatmentrelated death|2
7472173|NCT01951157|11775643|FG001|Overall Study|Non-treatmentrelated death|2
7472174|NCT01951157|11775644|FG002|Overall Study|Non-treatmentrelated death|2
7472175|NCT01951157|11775642|FG000|Overall Study|No treated|0
7472176|NCT01951157|11775643|FG001|Overall Study|No treated|1
7472177|NCT01951157|11775644|FG002|Overall Study|No treated|0
7472178|NCT01951157|11775642|FG000|Overall Study|Treatment-related AE|2
7472179|NCT01951157|11775643|FG001|Overall Study|Treatment-related AE|0
7472180|NCT01951157|11775644|FG002|Overall Study|Treatment-related AE|4
7472181|NCT01951157|11775642|FG000|Overall Study|Consent withdrawn by subject|0
7472182|NCT01951157|11775643|FG001|Overall Study|Consent withdrawn by subject|1
7472183|NCT01951157|11775644|FG002|Overall Study|Consent withdrawn by subject|3
7472184|NCT01951157|11775642|FG000|Overall Study|Treatment-related death|0
7472185|NCT01951157|11775643|FG001|Overall Study|Treatment-related death|2
7472186|NCT01951157|11775644|FG002|Overall Study|Treatment-related death|0
7472187|NCT01951170|11775653|FG000|Overall Study|Investigator decision|1
7472188|NCT01951261|11775659|FG000|Overall Study|Death|1
7472189|NCT01951261|11775660|FG001|Overall Study|Death|0
7472190|NCT01951261|11775659|FG000|Overall Study|Lost to Follow-up|4
7472191|NCT01951261|11775660|FG001|Overall Study|Lost to Follow-up|3
7472192|NCT01951261|11775659|FG000|Overall Study|Protocol Violation|4
7472193|NCT01951261|11775660|FG001|Overall Study|Protocol Violation|3
7472197|NCT01951573|11775708|FG000|Washout Period|Adverse Event|0
7472198|NCT01951573|11775709|FG001|Washout Period|Adverse Event|1
7472199|NCT01951586|11775717|FG000|Overall Study|Death|61
7472200|NCT01951586|11775718|FG001|Overall Study|Death|120
7472201|NCT01951586|11775717|FG000|Overall Study|Withdrawal by Subject|8
7472202|NCT01951586|11775718|FG001|Overall Study|Withdrawal by Subject|17
7472203|NCT01951586|11775717|FG000|Overall Study|Lost to Follow-up|0
7472204|NCT01951586|11775718|FG001|Overall Study|Lost to Follow-up|1
7472205|NCT01951586|11775717|FG000|Overall Study|Sponsor Decision|9
7472206|NCT01951586|11775718|FG001|Overall Study|Sponsor Decision|10
7472207|NCT01951625|11775730|FG000|Treatment Period|Protocol Violation|2
7472208|NCT01951625|11775731|FG001|Treatment Period|Protocol Violation|0
7472209|NCT01951625|11775732|FG002|Treatment Period|Protocol Violation|1
7472210|NCT01951625|11775733|FG003|Treatment Period|Protocol Violation|3
7472211|NCT01951625|11775734|FG004|Treatment Period|Protocol Violation|2
7472212|NCT01951625|11775730|FG000|Treatment Period|Physician Decision|0
7472213|NCT01951625|11775731|FG001|Treatment Period|Physician Decision|0
7472214|NCT01951625|11775732|FG002|Treatment Period|Physician Decision|0
7472215|NCT01951625|11775733|FG003|Treatment Period|Physician Decision|0
7472216|NCT01951625|11775734|FG004|Treatment Period|Physician Decision|1
7472217|NCT01951625|11775730|FG000|Treatment Period|Protocol driven decision point|0
7472218|NCT01951625|11775731|FG001|Treatment Period|Protocol driven decision point|5
7472219|NCT01951625|11775732|FG002|Treatment Period|Protocol driven decision point|0
7472220|NCT01951625|11775733|FG003|Treatment Period|Protocol driven decision point|2
7472221|NCT01951625|11775734|FG004|Treatment Period|Protocol driven decision point|1
7472222|NCT01951625|11775730|FG000|Treatment Period|Non compliance with study drug|1
7472223|NCT01951625|11775731|FG001|Treatment Period|Non compliance with study drug|2
7472224|NCT01951625|11775732|FG002|Treatment Period|Non compliance with study drug|2
7472225|NCT01951625|11775733|FG003|Treatment Period|Non compliance with study drug|0
7472226|NCT01951625|11775734|FG004|Treatment Period|Non compliance with study drug|0
7472227|NCT01951625|11775730|FG000|Treatment Period|Death|3
7472228|NCT01951625|11775731|FG001|Treatment Period|Death|2
7472229|NCT01951625|11775732|FG002|Treatment Period|Death|2
7472230|NCT01951625|11775733|FG003|Treatment Period|Death|1
7472231|NCT01951625|11775734|FG004|Treatment Period|Death|2
7472232|NCT01951625|11775730|FG000|Treatment Period|Adverse Event|7
7472233|NCT01951625|11775731|FG001|Treatment Period|Adverse Event|10
7472234|NCT01951625|11775732|FG002|Treatment Period|Adverse Event|9
7472235|NCT01951625|11775733|FG003|Treatment Period|Adverse Event|8
7472236|NCT01951625|11775734|FG004|Treatment Period|Adverse Event|8
7472237|NCT01951625|11775730|FG000|Treatment Period|Withdrawal by Subject|5
7472238|NCT01951625|11775731|FG001|Treatment Period|Withdrawal by Subject|2
7472239|NCT01951625|11775732|FG002|Treatment Period|Withdrawal by Subject|1
7472240|NCT01951625|11775733|FG003|Treatment Period|Withdrawal by Subject|7
7472241|NCT01951625|11775734|FG004|Treatment Period|Withdrawal by Subject|3
7472242|NCT01951625|11775730|FG000|Treatment Period|Lost to Follow-up|1
7472243|NCT01951625|11775731|FG001|Treatment Period|Lost to Follow-up|0
7472244|NCT01951625|11775732|FG002|Treatment Period|Lost to Follow-up|0
7472245|NCT01951625|11775733|FG003|Treatment Period|Lost to Follow-up|1
7472246|NCT01951625|11775734|FG004|Treatment Period|Lost to Follow-up|0
7472247|NCT01951625|11775730|FG000|Follow Up Period|Non-compliance with study drug|1
7472248|NCT01951625|11775731|FG001|Follow Up Period|Non-compliance with study drug|0
7472249|NCT01951625|11775732|FG002|Follow Up Period|Non-compliance with study drug|0
7472250|NCT01951625|11775733|FG003|Follow Up Period|Non-compliance with study drug|0
7472251|NCT01951625|11775734|FG004|Follow Up Period|Non-compliance with study drug|0
7472252|NCT01951625|11775730|FG000|Follow Up Period|Death|1
7472253|NCT01951625|11775731|FG001|Follow Up Period|Death|3
7472254|NCT01951625|11775732|FG002|Follow Up Period|Death|2
7472255|NCT01951625|11775733|FG003|Follow Up Period|Death|2
7472256|NCT01951625|11775734|FG004|Follow Up Period|Death|1
7472257|NCT01951625|11775730|FG000|Follow Up Period|Logistical difficulties|1
7472258|NCT01951625|11775731|FG001|Follow Up Period|Logistical difficulties|2
7472259|NCT01951625|11775732|FG002|Follow Up Period|Logistical difficulties|0
7472260|NCT01951625|11775733|FG003|Follow Up Period|Logistical difficulties|0
7472261|NCT01951625|11775734|FG004|Follow Up Period|Logistical difficulties|0
7472262|NCT01951625|11775730|FG000|Follow Up Period|Adverse Event|0
7224623|NCT00056407|11433899|FG000|Overall Study|Adverse Event|282
7224624|NCT00056407|11433900|FG001|Overall Study|Adverse Event|364
7224625|NCT00056407|11433899|FG000|Overall Study|Withdrawal by Subject|377
7224626|NCT00056407|11433900|FG001|Overall Study|Withdrawal by Subject|361
7224627|NCT00056407|11433899|FG000|Overall Study|Lost to Follow-up|123
7472263|NCT01951625|11775731|FG001|Follow Up Period|Adverse Event|3
7472264|NCT01951625|11775732|FG002|Follow Up Period|Adverse Event|2
7472265|NCT01951625|11775733|FG003|Follow Up Period|Adverse Event|3
7472266|NCT01951625|11775734|FG004|Follow Up Period|Adverse Event|5
7472267|NCT01951625|11775730|FG000|Follow Up Period|Withdrawal by Subject|4
7472268|NCT01951625|11775731|FG001|Follow Up Period|Withdrawal by Subject|1
7472269|NCT01951625|11775732|FG002|Follow Up Period|Withdrawal by Subject|0
7472270|NCT01951625|11775733|FG003|Follow Up Period|Withdrawal by Subject|5
7472271|NCT01951625|11775734|FG004|Follow Up Period|Withdrawal by Subject|3
7472272|NCT01951625|11775730|FG000|Follow Up Period|Lost to Follow-up|1
7472273|NCT01951625|11775731|FG001|Follow Up Period|Lost to Follow-up|0
7472274|NCT01951625|11775732|FG002|Follow Up Period|Lost to Follow-up|0
7472275|NCT01951625|11775733|FG003|Follow Up Period|Lost to Follow-up|1
7472276|NCT01951625|11775734|FG004|Follow Up Period|Lost to Follow-up|1
7472277|NCT01951638|11775752|FG000|Treatment Period|Protocol Violation|0
7472278|NCT01951638|11775753|FG001|Treatment Period|Protocol Violation|0
7472279|NCT01951638|11775754|FG002|Treatment Period|Protocol Violation|0
7472280|NCT01951638|11775755|FG003|Treatment Period|Protocol Violation|2
7224628|NCT00056407|11433900|FG001|Overall Study|Lost to Follow-up|113
7472281|NCT01951638|11775756|FG004|Treatment Period|Protocol Violation|0
7472282|NCT01951638|11775752|FG000|Treatment Period|Protocol-driven decision point|1
7472283|NCT01951638|11775753|FG001|Treatment Period|Protocol-driven decision point|3
7472284|NCT01951638|11775754|FG002|Treatment Period|Protocol-driven decision point|0
7472285|NCT01951638|11775755|FG003|Treatment Period|Protocol-driven decision point|0
7472286|NCT01951638|11775756|FG004|Treatment Period|Protocol-driven decision point|0
7472287|NCT01951638|11775752|FG000|Treatment Period|Logistical difficulties|0
7472288|NCT01951638|11775753|FG001|Treatment Period|Logistical difficulties|1
7472289|NCT01951638|11775754|FG002|Treatment Period|Logistical difficulties|1
7472290|NCT01951638|11775755|FG003|Treatment Period|Logistical difficulties|0
7472291|NCT01951638|11775756|FG004|Treatment Period|Logistical difficulties|0
7472292|NCT01951638|11775752|FG000|Treatment Period|Withdrawal by Subject|9
7472293|NCT01951638|11775753|FG001|Treatment Period|Withdrawal by Subject|6
7472294|NCT01951638|11775754|FG002|Treatment Period|Withdrawal by Subject|4
7472295|NCT01951638|11775755|FG003|Treatment Period|Withdrawal by Subject|5
7472296|NCT01951638|11775756|FG004|Treatment Period|Withdrawal by Subject|4
7472297|NCT01951638|11775752|FG000|Treatment Period|Death|0
7472298|NCT01951638|11775753|FG001|Treatment Period|Death|0
7472299|NCT01951638|11775754|FG002|Treatment Period|Death|0
7472300|NCT01951638|11775755|FG003|Treatment Period|Death|3
7472301|NCT01951638|11775756|FG004|Treatment Period|Death|1
7472302|NCT01951638|11775752|FG000|Treatment Period|Adverse Event|3
7472303|NCT01951638|11775753|FG001|Treatment Period|Adverse Event|4
7472304|NCT01951638|11775754|FG002|Treatment Period|Adverse Event|8
7472305|NCT01951638|11775755|FG003|Treatment Period|Adverse Event|6
7472306|NCT01951638|11775756|FG004|Treatment Period|Adverse Event|5
7472307|NCT01951638|11775752|FG000|Follow-up Period|Protocol Violation|0
7472308|NCT01951638|11775753|FG001|Follow-up Period|Protocol Violation|0
7472309|NCT01951638|11775754|FG002|Follow-up Period|Protocol Violation|0
7472310|NCT01951638|11775755|FG003|Follow-up Period|Protocol Violation|1
7472311|NCT01951638|11775756|FG004|Follow-up Period|Protocol Violation|0
7472312|NCT01951638|11775752|FG000|Follow-up Period|Logistical difficulties|0
7472313|NCT01951638|11775753|FG001|Follow-up Period|Logistical difficulties|2
7472314|NCT01951638|11775754|FG002|Follow-up Period|Logistical difficulties|0
7472315|NCT01951638|11775755|FG003|Follow-up Period|Logistical difficulties|0
7472316|NCT01951638|11775756|FG004|Follow-up Period|Logistical difficulties|1
7472317|NCT01951638|11775752|FG000|Follow-up Period|Withdrawal by Subject|1
7472318|NCT01951638|11775753|FG001|Follow-up Period|Withdrawal by Subject|5
7472319|NCT01951638|11775754|FG002|Follow-up Period|Withdrawal by Subject|2
7472320|NCT01951638|11775755|FG003|Follow-up Period|Withdrawal by Subject|1
7472321|NCT01951638|11775756|FG004|Follow-up Period|Withdrawal by Subject|2
7472322|NCT01951638|11775752|FG000|Follow-up Period|Lost to Follow-up|0
7472323|NCT01951638|11775753|FG001|Follow-up Period|Lost to Follow-up|1
7472324|NCT01951638|11775754|FG002|Follow-up Period|Lost to Follow-up|0
7472325|NCT01951638|11775755|FG003|Follow-up Period|Lost to Follow-up|1
7472326|NCT01951638|11775756|FG004|Follow-up Period|Lost to Follow-up|0
7472327|NCT01951638|11775752|FG000|Follow-up Period|Death|1
7472328|NCT01951638|11775753|FG001|Follow-up Period|Death|0
7472329|NCT01951638|11775754|FG002|Follow-up Period|Death|1
7472330|NCT01951638|11775755|FG003|Follow-up Period|Death|4
7472331|NCT01951638|11775756|FG004|Follow-up Period|Death|1
7472332|NCT01951638|11775752|FG000|Follow-up Period|Adverse Event|0
7472333|NCT01951638|11775753|FG001|Follow-up Period|Adverse Event|1
7472334|NCT01951638|11775754|FG002|Follow-up Period|Adverse Event|2
7472335|NCT01951638|11775755|FG003|Follow-up Period|Adverse Event|1
7472336|NCT01951638|11775756|FG004|Follow-up Period|Adverse Event|1
7472337|NCT01951703|11775779|FG000|First Intervention|Withdrawal by Subject|1
7472338|NCT01951703|11775780|FG001|First Intervention|Withdrawal by Subject|0
7472339|NCT01951703|11775779|FG000|First Intervention|Subject was not compliant|1
7472340|NCT01951703|11775780|FG001|First Intervention|Subject was not compliant|1
7472341|NCT01951703|11775779|FG000|First Intervention|Physician Decision|1
7472342|NCT01951703|11775780|FG001|First Intervention|Physician Decision|0
7472343|NCT01951703|11775779|FG000|Second Intervention|Protocol Violation|0
7472344|NCT01951703|11775780|FG001|Second Intervention|Protocol Violation|1
7472345|NCT01951703|11775779|FG000|Second Intervention|Unsatisfactory Lens fitting|0
7472346|NCT01951703|11775780|FG001|Second Intervention|Unsatisfactory Lens fitting|1
7472347|NCT01952015|11775827|FG000|Induction|Protocol Violation|1
7472348|NCT01952015|11775827|FG000|Maintenance|Adverse Event|2
7472349|NCT01952015|11775827|FG000|Treatment Period 3|Physician Decision|9
7472350|NCT01952041|11775845|FG000|Overall Study|Lost to Follow-up|9
7472351|NCT01952041|11775846|FG001|Overall Study|Lost to Follow-up|16
7472352|NCT01952041|11775845|FG000|Overall Study|Withdrawal by Subject|7
7472353|NCT01952041|11775846|FG001|Overall Study|Withdrawal by Subject|5
7472354|NCT01952041|11775845|FG000|Overall Study|Death|1
7472355|NCT01952041|11775846|FG001|Overall Study|Death|0
7472356|NCT01952054|11775852|FG000|Overall Study|Physician Decision|1
7472357|NCT01952080|11775860|FG000|Overall Study|Withdrawal by Subject|0
7472358|NCT01952080|11775861|FG001|Overall Study|Withdrawal by Subject|0
7472359|NCT01952080|11775862|FG002|Overall Study|Withdrawal by Subject|0
7472360|NCT01952080|11775863|FG003|Overall Study|Withdrawal by Subject|1
7472361|NCT01952080|11775860|FG000|Overall Study|Protocol Non-compliance|0
7472362|NCT01952080|11775861|FG001|Overall Study|Protocol Non-compliance|1
7472363|NCT01952080|11775862|FG002|Overall Study|Protocol Non-compliance|0
7472364|NCT01952080|11775863|FG003|Overall Study|Protocol Non-compliance|0
7472365|NCT01952145|11775875|FG000|Overall Study|Protocol Violation|2
7472366|NCT01952145|11775876|FG001|Overall Study|Protocol Violation|1
7472367|NCT01952145|11775875|FG000|Overall Study|Death|0
7472368|NCT01952145|11775876|FG001|Overall Study|Death|1
7472369|NCT01952145|11775875|FG000|Overall Study|Adverse Event|9
7472370|NCT01952145|11775876|FG001|Overall Study|Adverse Event|0
7472371|NCT01952145|11775875|FG000|Overall Study|Withdrawal Criteria|16
7472372|NCT01952145|11775876|FG001|Overall Study|Withdrawal Criteria|11
7472373|NCT01952145|11775875|FG000|Overall Study|Unclassified|1
7472374|NCT01952145|11775876|FG001|Overall Study|Unclassified|1
7472375|NCT01952366|11775888|FG000|Overall Study|Death|22
7472376|NCT01952366|11775888|FG000|Overall Study|Withdrawal by Subject|9
7472377|NCT01952665|11775942|FG000|Overall Study|Physician Decision|3
7472378|NCT01952665|11775943|FG001|Overall Study|Physician Decision|2
7472379|NCT01952665|11775942|FG000|Overall Study|Lost to Follow-up|1
7472380|NCT01952665|11775943|FG001|Overall Study|Lost to Follow-up|2
7472381|NCT01952665|11775942|FG000|Overall Study|Adverse Event|2
7472382|NCT01952665|11775943|FG001|Overall Study|Adverse Event|1
7472383|NCT01952665|11775942|FG000|Overall Study|Protocol Violation|0
7472384|NCT01952665|11775943|FG001|Overall Study|Protocol Violation|1
7472385|NCT01952691|11775971|FG000|Overall Study|Lost to Follow-up|2
7472386|NCT01952834|11775975|FG000|Overall Study|Adverse Event|1
7472387|NCT01953003|11775982|FG000|Overall Study|Not treated|0
7472388|NCT01953003|11775983|FG001|Overall Study|Not treated|1
7472389|NCT01953003|11775982|FG000|Overall Study|Progressive disease|35
7472390|NCT01953003|11775983|FG001|Overall Study|Progressive disease|45
7472391|NCT01953003|11775982|FG000|Overall Study|Related Adverse events|7
7472392|NCT01953003|11775983|FG001|Overall Study|Related Adverse events|2
7472393|NCT01953003|11775982|FG000|Overall Study|Non-related adverse events|0
7472394|NCT01953003|11775983|FG001|Overall Study|Non-related adverse events|2
7472395|NCT01953003|11775982|FG000|Overall Study|Protocol Violation|0
7472396|NCT01953003|11775983|FG001|Overall Study|Protocol Violation|1
7472397|NCT01953003|11775982|FG000|Overall Study|Withdrawal by Subject|14
7472398|NCT01953003|11775983|FG001|Overall Study|Withdrawal by Subject|4
7472399|NCT01953224|11776006|FG000|Overall Study|Lost to Follow-up|1
7472400|NCT01953224|11776007|FG001|Overall Study|Lost to Follow-up|1
7472401|NCT01953224|11776006|FG000|Overall Study|Withdrawal by Subject|1
7472402|NCT01953224|11776007|FG001|Overall Study|Withdrawal by Subject|2
7472403|NCT01953328|11776030|FG000|Overall Study|Withdrawal by Subject|0
7472404|NCT01953328|11776031|FG001|Overall Study|Withdrawal by Subject|0
7472405|NCT01953328|11776032|FG002|Overall Study|Withdrawal by Subject|0
7472406|NCT01953328|11776033|FG003|Overall Study|Withdrawal by Subject|0
7472407|NCT01953328|11776034|FG004|Overall Study|Withdrawal by Subject|1
7472408|NCT01953328|11776035|FG005|Overall Study|Withdrawal by Subject|0
7472409|NCT01953328|11776036|FG006|Overall Study|Withdrawal by Subject|0
7472410|NCT01953328|11776037|FG007|Overall Study|Withdrawal by Subject|0
7472411|NCT01953328|11776030|FG000|Overall Study|Lost to Follow-up|0
7472412|NCT01953328|11776031|FG001|Overall Study|Lost to Follow-up|0
7472413|NCT01953328|11776032|FG002|Overall Study|Lost to Follow-up|0
7472414|NCT01953328|11776033|FG003|Overall Study|Lost to Follow-up|0
7472415|NCT01953328|11776034|FG004|Overall Study|Lost to Follow-up|1
7472416|NCT01953328|11776035|FG005|Overall Study|Lost to Follow-up|0
7472417|NCT01953328|11776036|FG006|Overall Study|Lost to Follow-up|0
7472418|NCT01953328|11776037|FG007|Overall Study|Lost to Follow-up|0
7472419|NCT01953354|11776057|FG000|Overall Study|Withdrawal by Subject|0
7472420|NCT01953354|11776058|FG001|Overall Study|Withdrawal by Subject|1
7472421|NCT01953354|11776057|FG000|Overall Study|Decision of Sponsor|0
7472422|NCT01953354|11776058|FG001|Overall Study|Decision of Sponsor|1
7472423|NCT01953354|11776057|FG000|Overall Study|Disease Exacerbation|1
7472424|NCT01953354|11776058|FG001|Overall Study|Disease Exacerbation|0
7472425|NCT01953601|11776089|FG000|Part 1 (Base Study)|Adverse Event|24
7472426|NCT01953601|11776090|FG001|Part 1 (Base Study)|Adverse Event|37
7472427|NCT01953601|11776091|FG002|Part 1 (Base Study)|Adverse Event|15
7472428|NCT01953601|11776089|FG000|Part 1 (Base Study)|Death|2
7472429|NCT01953601|11776090|FG001|Part 1 (Base Study)|Death|0
7472430|NCT01953601|11776091|FG002|Part 1 (Base Study)|Death|3
7472431|NCT01953601|11776089|FG000|Part 1 (Base Study)|Lack of Efficacy|3
7472432|NCT01953601|11776090|FG001|Part 1 (Base Study)|Lack of Efficacy|1
7472433|NCT01953601|11776091|FG002|Part 1 (Base Study)|Lack of Efficacy|4
7472434|NCT01953601|11776089|FG000|Part 1 (Base Study)|Lost to Follow-up|1
7472435|NCT01953601|11776090|FG001|Part 1 (Base Study)|Lost to Follow-up|3
7472436|NCT01953601|11776091|FG002|Part 1 (Base Study)|Lost to Follow-up|6
7472437|NCT01953601|11776089|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
7472438|NCT01953601|11776090|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
7472439|NCT01953601|11776091|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
7472440|NCT01953601|11776089|FG000|Part 1 (Base Study)|Physician Decision|3
7472441|NCT01953601|11776090|FG001|Part 1 (Base Study)|Physician Decision|7
7472442|NCT01953601|11776091|FG002|Part 1 (Base Study)|Physician Decision|4
7472443|NCT01953601|11776089|FG000|Part 1 (Base Study)|Screen failure|1
7472444|NCT01953601|11776090|FG001|Part 1 (Base Study)|Screen failure|0
7472445|NCT01953601|11776091|FG002|Part 1 (Base Study)|Screen failure|1
7472446|NCT01953601|11776089|FG000|Part 1 (Base Study)|Site discontinued study participation|2
7472447|NCT01953601|11776090|FG001|Part 1 (Base Study)|Site discontinued study participation|0
7472448|NCT01953601|11776091|FG002|Part 1 (Base Study)|Site discontinued study participation|0
7472449|NCT01953601|11776089|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
7472450|NCT01953601|11776090|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
7472451|NCT01953601|11776091|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
7472452|NCT01953601|11776089|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
7472453|NCT01953601|11776090|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
7472454|NCT01953601|11776091|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
7472455|NCT01953601|11776089|FG000|Part 1 (Base Study)|Subject moved|2
7472456|NCT01953601|11776090|FG001|Part 1 (Base Study)|Subject moved|2
7472457|NCT01953601|11776091|FG002|Part 1 (Base Study)|Subject moved|1
7472458|NCT01953601|11776089|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
7472459|NCT01953601|11776090|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
7472460|NCT01953601|11776091|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
7472461|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Adverse Event|1
7472462|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Adverse Event|1
7472463|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Adverse Event|10
7472464|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Death|0
7472465|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Death|3
7472466|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Death|0
7472467|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
7472468|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
7472469|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
7472470|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
7472471|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
7472472|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
7472473|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Physician Decision|2
7472474|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Physician Decision|0
7472475|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Physician Decision|2
7472476|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
7472477|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
7472478|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
7472479|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
7472480|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
7472481|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
7472482|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
7472483|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
7472484|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
7472485|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Subject moved|0
7472486|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Subject moved|0
7472487|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Subject moved|1
7472488|NCT01953601|11776089|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
7472489|NCT01953601|11776090|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
7472490|NCT01953601|11776091|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
7472491|NCT01953692|11776111|FG000|Overall Study|Adverse Event|5
7472492|NCT01953692|11776112|FG001|Overall Study|Adverse Event|2
7472493|NCT01953692|11776113|FG002|Overall Study|Adverse Event|4
7472494|NCT01953692|11776114|FG003|Overall Study|Adverse Event|2
7472495|NCT01953692|11776115|FG004|Overall Study|Adverse Event|1
7472496|NCT01953692|11776116|FG005|Overall Study|Adverse Event|2
7472497|NCT01953692|11776117|FG006|Overall Study|Adverse Event|0
7472498|NCT01953692|11776118|FG007|Overall Study|Adverse Event|0
7472499|NCT01953692|11776119|FG008|Overall Study|Adverse Event|0
7472500|NCT01953692|11776111|FG000|Overall Study|Clinical Progression|0
7472501|NCT01953692|11776112|FG001|Overall Study|Clinical Progression|15
7472502|NCT01953692|11776113|FG002|Overall Study|Clinical Progression|7
7472503|NCT01953692|11776114|FG003|Overall Study|Clinical Progression|5
7472504|NCT01953692|11776115|FG004|Overall Study|Clinical Progression|0
7472505|NCT01953692|11776116|FG005|Overall Study|Clinical Progression|7
7472506|NCT01953692|11776117|FG006|Overall Study|Clinical Progression|20
7472507|NCT01953692|11776118|FG007|Overall Study|Clinical Progression|3
7472508|NCT01953692|11776119|FG008|Overall Study|Clinical Progression|3
7472509|NCT01953692|11776111|FG000|Overall Study|Death|5
7472510|NCT01953692|11776112|FG001|Overall Study|Death|0
7472511|NCT01953692|11776113|FG002|Overall Study|Death|2
7472512|NCT01953692|11776114|FG003|Overall Study|Death|2
7472513|NCT01953692|11776115|FG004|Overall Study|Death|1
7472514|NCT01953692|11776116|FG005|Overall Study|Death|3
7472515|NCT01953692|11776117|FG006|Overall Study|Death|6
7472516|NCT01953692|11776118|FG007|Overall Study|Death|2
7472517|NCT01953692|11776119|FG008|Overall Study|Death|1
7472518|NCT01953692|11776111|FG000|Overall Study|Excluded Medication|1
7472519|NCT01953692|11776112|FG001|Overall Study|Excluded Medication|0
7472520|NCT01953692|11776113|FG002|Overall Study|Excluded Medication|0
7472521|NCT01953692|11776114|FG003|Overall Study|Excluded Medication|0
7472522|NCT01953692|11776115|FG004|Overall Study|Excluded Medication|0
7472523|NCT01953692|11776116|FG005|Overall Study|Excluded Medication|0
7472524|NCT01953692|11776117|FG006|Overall Study|Excluded Medication|0
7472525|NCT01953692|11776118|FG007|Overall Study|Excluded Medication|0
7472526|NCT01953692|11776119|FG008|Overall Study|Excluded Medication|0
7472527|NCT01953692|11776111|FG000|Overall Study|Lost to Follow-up|1
7472528|NCT01953692|11776112|FG001|Overall Study|Lost to Follow-up|0
7472529|NCT01953692|11776113|FG002|Overall Study|Lost to Follow-up|3
7472530|NCT01953692|11776114|FG003|Overall Study|Lost to Follow-up|1
7472531|NCT01953692|11776115|FG004|Overall Study|Lost to Follow-up|0
7472532|NCT01953692|11776116|FG005|Overall Study|Lost to Follow-up|1
7472533|NCT01953692|11776117|FG006|Overall Study|Lost to Follow-up|0
7472534|NCT01953692|11776118|FG007|Overall Study|Lost to Follow-up|0
7472535|NCT01953692|11776119|FG008|Overall Study|Lost to Follow-up|0
7472536|NCT01953692|11776111|FG000|Overall Study|Physician Decision|11
7472537|NCT01953692|11776112|FG001|Overall Study|Physician Decision|4
7472538|NCT01953692|11776113|FG002|Overall Study|Physician Decision|2
7472539|NCT01953692|11776114|FG003|Overall Study|Physician Decision|2
7472540|NCT01953692|11776115|FG004|Overall Study|Physician Decision|1
7472541|NCT01953692|11776116|FG005|Overall Study|Physician Decision|2
7472542|NCT01953692|11776117|FG006|Overall Study|Physician Decision|4
7472543|NCT01953692|11776118|FG007|Overall Study|Physician Decision|1
7472544|NCT01953692|11776119|FG008|Overall Study|Physician Decision|0
7472545|NCT01953692|11776111|FG000|Overall Study|Protocol Violation|0
7472546|NCT01953692|11776112|FG001|Overall Study|Protocol Violation|2
7472547|NCT01953692|11776113|FG002|Overall Study|Protocol Violation|1
7472548|NCT01953692|11776114|FG003|Overall Study|Protocol Violation|0
7472549|NCT01953692|11776115|FG004|Overall Study|Protocol Violation|0
7472550|NCT01953692|11776116|FG005|Overall Study|Protocol Violation|0
7472551|NCT01953692|11776117|FG006|Overall Study|Protocol Violation|0
7472552|NCT01953692|11776118|FG007|Overall Study|Protocol Violation|1
7472553|NCT01953692|11776119|FG008|Overall Study|Protocol Violation|0
7472554|NCT01953692|11776111|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472555|NCT01953692|11776112|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472556|NCT01953692|11776113|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472557|NCT01953692|11776114|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472558|NCT01953692|11776115|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472559|NCT01953692|11776116|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472560|NCT01953692|11776117|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472561|NCT01953692|11776118|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
7472562|NCT01953692|11776119|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
7472563|NCT01953692|11776111|FG000|Overall Study|Withdrawal by Subject|4
7472564|NCT01953692|11776112|FG001|Overall Study|Withdrawal by Subject|2
7472565|NCT01953692|11776113|FG002|Overall Study|Withdrawal by Subject|1
7472566|NCT01953692|11776114|FG003|Overall Study|Withdrawal by Subject|2
7472567|NCT01953692|11776115|FG004|Overall Study|Withdrawal by Subject|0
7472568|NCT01953692|11776116|FG005|Overall Study|Withdrawal by Subject|3
7472569|NCT01953692|11776117|FG006|Overall Study|Withdrawal by Subject|2
7472570|NCT01953692|11776118|FG007|Overall Study|Withdrawal by Subject|1
7472571|NCT01953692|11776119|FG008|Overall Study|Withdrawal by Subject|1
7472572|NCT01953783|11776149|FG000|Overall Study|Progressive disease|2
7472573|NCT01953913|11776163|FG000|Overall Study|Disease Progression|349
7472574|NCT01953913|11776163|FG000|Overall Study|Worsening of underlying cancer|22
7472575|NCT01953913|11776163|FG000|Overall Study|Adverse Event|20
7472576|NCT01953913|11776163|FG000|Overall Study|Protocol Violation|6
7472577|NCT01953913|11776163|FG000|Overall Study|Lost to Follow-up|4
7472578|NCT01953913|11776163|FG000|Overall Study|Withdrawal by Subject|32
7472579|NCT01953913|11776163|FG000|Overall Study|Other than listed|108
7472580|NCT01953913|11776163|FG000|Overall Study|Not Treated|1
7472581|NCT01954017|11776170|FG000|Overall Study|Adverse Event|0
7472582|NCT01954017|11776171|FG001|Overall Study|Adverse Event|0
7472583|NCT01954017|11776172|FG002|Overall Study|Adverse Event|1
7472584|NCT01954017|11776170|FG000|Overall Study|Death|2
7472585|NCT01954017|11776171|FG001|Overall Study|Death|1
7472586|NCT01954017|11776172|FG002|Overall Study|Death|1
7472587|NCT01954017|11776170|FG000|Overall Study|Withdrawal by Subject|0
7472588|NCT01954017|11776171|FG001|Overall Study|Withdrawal by Subject|1
7472589|NCT01954017|11776172|FG002|Overall Study|Withdrawal by Subject|0
7472590|NCT01954017|11776170|FG000|Overall Study|Protocol Violation|0
7472591|NCT01954017|11776171|FG001|Overall Study|Protocol Violation|3
7472592|NCT01954017|11776172|FG002|Overall Study|Protocol Violation|2
7472593|NCT01954017|11776170|FG000|Overall Study|Necrotizing enterocolitis|1
7472594|NCT01954017|11776171|FG001|Overall Study|Necrotizing enterocolitis|0
7472595|NCT01954017|11776172|FG002|Overall Study|Necrotizing enterocolitis|1
7472596|NCT01954017|11776170|FG000|Overall Study|Enteral intake stopped >7 days|0
7472597|NCT01954017|11776171|FG001|Overall Study|Enteral intake stopped >7 days|1
7472598|NCT01954017|11776172|FG002|Overall Study|Enteral intake stopped >7 days|1
7472599|NCT01954017|11776170|FG000|Overall Study|All other reasons|2
7472600|NCT01954017|11776171|FG001|Overall Study|All other reasons|2
7472601|NCT01954017|11776172|FG002|Overall Study|All other reasons|7
7472602|NCT01954056|11776208|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
7472603|NCT01954056|11776209|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
7472604|NCT01954082|11776217|FG000|Overall Study|Study Suspension|42
7472605|NCT01954082|11776218|FG001|Overall Study|Study Suspension|36
7472606|NCT01954082|11776217|FG000|Overall Study|Adverse Event|10
7472607|NCT01954082|11776218|FG001|Overall Study|Adverse Event|4
7472608|NCT01954082|11776217|FG000|Overall Study|Intolerance|0
7472609|NCT01954082|11776218|FG001|Overall Study|Intolerance|1
7472610|NCT01954082|11776217|FG000|Overall Study|Non-compliance|6
7472611|NCT01954082|11776218|FG001|Overall Study|Non-compliance|4
7472612|NCT01954082|11776217|FG000|Overall Study|Physician Decision|2
7472613|NCT01954082|11776218|FG001|Overall Study|Physician Decision|0
7472614|NCT01954082|11776217|FG000|Overall Study|Parent Decision|1
7472615|NCT01954082|11776218|FG001|Overall Study|Parent Decision|0
7472616|NCT01954082|11776217|FG000|Overall Study|Withdrawal by Subject|0
7472617|NCT01954082|11776218|FG001|Overall Study|Withdrawal by Subject|1
7472618|NCT01954082|11776217|FG000|Overall Study|Discontinued Early Prior to Transfer|3
7472619|NCT01954082|11776218|FG001|Overall Study|Discontinued Early Prior to Transfer|2
7472620|NCT01954082|11776217|FG000|Overall Study|Redirection of Care|0
7472621|NCT01954082|11776218|FG001|Overall Study|Redirection of Care|2
7472622|NCT01954082|11776217|FG000|Overall Study|Miscalculation of Final Dose Day|0
7472623|NCT01954082|11776218|FG001|Overall Study|Miscalculation of Final Dose Day|3
7472624|NCT01954082|11776217|FG000|Overall Study|Comfort Care|0
7472625|NCT01954082|11776218|FG001|Overall Study|Comfort Care|1
7472626|NCT01954082|11776217|FG000|Overall Study|Infant Moved|0
7472627|NCT01954082|11776218|FG001|Overall Study|Infant Moved|1
7472628|NCT01954082|11776217|FG000|Overall Study|Randomized not Treated|4
7472629|NCT01954082|11776218|FG001|Overall Study|Randomized not Treated|2
7472630|NCT01954121|11776226|FG000|Overall Study|Lack of Efficacy|94
7472631|NCT01954121|11776227|FG001|Overall Study|Lack of Efficacy|41
7472632|NCT01954121|11776226|FG000|Overall Study|Protocol Violation|0
7472633|NCT01954121|11776227|FG001|Overall Study|Protocol Violation|2
7472634|NCT01954121|11776226|FG000|Overall Study|Lost to Follow-up|5
7472635|NCT01954121|11776227|FG001|Overall Study|Lost to Follow-up|6
7472636|NCT01954121|11776226|FG000|Overall Study|Withdrawal by Subject|18
7472637|NCT01954121|11776227|FG001|Overall Study|Withdrawal by Subject|12
7472638|NCT01954121|11776226|FG000|Overall Study|Pregnancy|1
7472639|NCT01954121|11776227|FG001|Overall Study|Pregnancy|1
7472640|NCT01954121|11776226|FG000|Overall Study|AE, serious fatal|1
7472641|NCT01954121|11776227|FG001|Overall Study|AE, serious fatal|0
7472642|NCT01954121|11776226|FG000|Overall Study|AE, non-serious non-fatal|5
7472643|NCT01954121|11776227|FG001|Overall Study|AE, non-serious non-fatal|22
7472644|NCT01954121|11776226|FG000|Overall Study|SAE, non-fatal|1
7472645|NCT01954121|11776227|FG001|Overall Study|SAE, non-fatal|4
7472646|NCT01954121|11776226|FG000|Overall Study|Non-compliant with study procedures|1
7472647|NCT01954121|11776227|FG001|Overall Study|Non-compliant with study procedures|0
7472648|NCT01954121|11776226|FG000|Overall Study|Non-compliant patient|1
7472649|NCT01954121|11776227|FG001|Overall Study|Non-compliant patient|1
7472650|NCT01954121|11776226|FG000|Overall Study|Subject did not follow instructions|0
7472651|NCT01954121|11776227|FG001|Overall Study|Subject did not follow instructions|2
7472652|NCT01954251|11776235|FG000|Overall Study|Adverse Event|5
7472653|NCT01954251|11776236|FG001|Overall Study|Adverse Event|7
7472654|NCT01954251|11776235|FG000|Overall Study|Lost to Follow-up|6
7472655|NCT01954251|11776236|FG001|Overall Study|Lost to Follow-up|6
7472656|NCT01954251|11776235|FG000|Overall Study|Withdrawal by Subject|2
7472657|NCT01954251|11776236|FG001|Overall Study|Withdrawal by Subject|6
7472658|NCT01954342|11776264|FG000|Overall Study|Missing data from 13-16week study visit|0
7472659|NCT01954342|11776265|FG001|Overall Study|Missing data from 13-16week study visit|0
7472660|NCT01954342|11776266|FG002|Overall Study|Missing data from 13-16week study visit|0
7472661|NCT01954342|11776267|FG003|Overall Study|Missing data from 13-16week study visit|1
7472662|NCT01954342|11776264|FG000|Overall Study|Miscarriage|0
7472663|NCT01954342|11776265|FG001|Overall Study|Miscarriage|0
7472664|NCT01954342|11776266|FG002|Overall Study|Miscarriage|0
7472665|NCT01954342|11776267|FG003|Overall Study|Miscarriage|3
7472666|NCT01954342|11776264|FG000|Overall Study|Lost to Follow-up|0
7472667|NCT01954342|11776265|FG001|Overall Study|Lost to Follow-up|0
7472668|NCT01954342|11776266|FG002|Overall Study|Lost to Follow-up|0
7472669|NCT01954342|11776267|FG003|Overall Study|Lost to Follow-up|5
7472670|NCT01954342|11776264|FG000|Overall Study|Preterm delivery|0
7472671|NCT01954342|11776265|FG001|Overall Study|Preterm delivery|0
7472672|NCT01954342|11776266|FG002|Overall Study|Preterm delivery|0
7472673|NCT01954342|11776267|FG003|Overall Study|Preterm delivery|3
7472674|NCT01954342|11776264|FG000|Overall Study|Pre-eclampsia|0
7472675|NCT01954342|11776265|FG001|Overall Study|Pre-eclampsia|0
7472676|NCT01954342|11776266|FG002|Overall Study|Pre-eclampsia|0
7472677|NCT01954342|11776267|FG003|Overall Study|Pre-eclampsia|4
7472678|NCT01954342|11776264|FG000|Overall Study|Unreliable Data|0
7472679|NCT01954342|11776265|FG001|Overall Study|Unreliable Data|0
7472680|NCT01954342|11776266|FG002|Overall Study|Unreliable Data|0
7472681|NCT01954342|11776267|FG003|Overall Study|Unreliable Data|2
7472682|NCT01954394|11776279|FG000|Overall Study|Enrolled but not treated|1
7472683|NCT01954394|11776280|FG001|Overall Study|Enrolled but not treated|0
7472684|NCT01954394|11776279|FG000|Overall Study|Adverse Event|10
7472685|NCT01954394|11776280|FG001|Overall Study|Adverse Event|23
7472686|NCT01954394|11776279|FG000|Overall Study|Poor compliance to protocol|7
7472687|NCT01954394|11776280|FG001|Overall Study|Poor compliance to protocol|7
7472688|NCT01954394|11776279|FG000|Overall Study|Participant Moved|0
7472689|NCT01954394|11776280|FG001|Overall Study|Participant Moved|4
7472690|NCT01954394|11776279|FG000|Overall Study|Related to Study Drug administration|2
7472691|NCT01954394|11776280|FG001|Overall Study|Related to Study Drug administration|2
7472692|NCT01954394|11776279|FG000|Overall Study|Other than specified above|10
7472693|NCT01954394|11776280|FG001|Overall Study|Other than specified above|21
7472694|NCT01954745|11776301|FG000|Overall Study|Radiological Progression|11
7472695|NCT01954745|11776301|FG000|Overall Study|Clinical Progression|5
7472696|NCT01954745|11776301|FG000|Overall Study|Adverse Event|2
7472697|NCT01954745|11776301|FG000|Overall Study|Death|1
7472698|NCT01954771|11776308|FG000|Overall Study|Missing HbA1c of end-point|1
7472699|NCT01954771|11776309|FG001|Overall Study|Missing HbA1c of end-point|1
7472700|NCT01954771|11776310|FG002|Overall Study|Missing HbA1c of end-point|0
7472701|NCT01954771|11776308|FG000|Overall Study|Missing CGMS of end-point|1
7472702|NCT01954771|11776309|FG001|Overall Study|Missing CGMS of end-point|1
7472703|NCT01954771|11776310|FG002|Overall Study|Missing CGMS of end-point|0
7472704|NCT01954771|11776308|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
7472705|NCT01954771|11776309|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
7472706|NCT01954771|11776310|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
7472707|NCT01954927|11776323|FG000|Overall Study|Withdrawal by Subject|3
7472708|NCT01954927|11776324|FG001|Overall Study|Withdrawal by Subject|1
7472709|NCT01955005|11776332|FG000|Overall Study|Withdrawal by Subject|3
7472710|NCT01955005|11776333|FG001|Overall Study|Withdrawal by Subject|5
7472711|NCT01955044|11776342|FG000|Overall Study|Death|1
7472712|NCT01955044|11776343|FG001|Overall Study|Death|1
7472713|NCT01955044|11776344|FG002|Overall Study|Death|0
7472714|NCT01955083|11776354|FG000|Overall Study|Lost to Follow-up|1
7472715|NCT01955083|11776355|FG001|Overall Study|Lost to Follow-up|1
7472716|NCT01955122|11776387|FG000|Overall Study|Physician Decision|5
7472717|NCT01955122|11776388|FG001|Overall Study|Physician Decision|5
7472718|NCT01955161|11776403|FG000|Overall Study|Withdrawal before treatment|2
7472719|NCT01955161|11776404|FG001|Overall Study|Withdrawal before treatment|0
7472720|NCT01955161|11776405|FG002|Overall Study|Withdrawal before treatment|1
7472721|NCT01955161|11776403|FG000|Overall Study|Adverse Event|10
7472722|NCT01955161|11776404|FG001|Overall Study|Adverse Event|14
7472723|NCT01955161|11776405|FG002|Overall Study|Adverse Event|15
7472724|NCT01955161|11776403|FG000|Overall Study|Death|1
7472725|NCT01955161|11776404|FG001|Overall Study|Death|1
7472726|NCT01955161|11776405|FG002|Overall Study|Death|3
7472727|NCT01955161|11776403|FG000|Overall Study|Withdrawal by Subject|9
7472728|NCT01955161|11776404|FG001|Overall Study|Withdrawal by Subject|8
7472729|NCT01955161|11776405|FG002|Overall Study|Withdrawal by Subject|12
7472730|NCT01955161|11776403|FG000|Overall Study|Protocol Violation|2
7472731|NCT01955161|11776404|FG001|Overall Study|Protocol Violation|0
7472732|NCT01955161|11776405|FG002|Overall Study|Protocol Violation|0
7472733|NCT01955161|11776403|FG000|Overall Study|Other reason: physician decision|0
7472734|NCT01955161|11776404|FG001|Overall Study|Other reason: physician decision|1
7472735|NCT01955161|11776405|FG002|Overall Study|Other reason: physician decision|1
7472736|NCT01955161|11776403|FG000|Overall Study|Other reason: disallowed medication|1
7472737|NCT01955161|11776404|FG001|Overall Study|Other reason: disallowed medication|0
7472738|NCT01955161|11776405|FG002|Overall Study|Other reason: disallowed medication|1
7472739|NCT01955161|11776403|FG000|Overall Study|Other reason: caregiver unavailable|1
7472740|NCT01955161|11776404|FG001|Overall Study|Other reason: caregiver unavailable|0
7472741|NCT01955161|11776405|FG002|Overall Study|Other reason: caregiver unavailable|0
7472742|NCT01955161|11776403|FG000|Overall Study|Other reason: moved to nursing home|0
7472743|NCT01955161|11776404|FG001|Overall Study|Other reason: moved to nursing home|1
7472744|NCT01955161|11776405|FG002|Overall Study|Other reason: moved to nursing home|0
7472745|NCT01955161|11776403|FG000|Overall Study|Other reason: insufficient compliance|0
7472746|NCT01955161|11776404|FG001|Overall Study|Other reason: insufficient compliance|0
7472747|NCT01955161|11776405|FG002|Overall Study|Other reason: insufficient compliance|1
7472748|NCT01955161|11776403|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
7472749|NCT01955161|11776404|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
7472750|NCT01955161|11776405|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
7472751|NCT01955161|11776403|FG000|Overall Study|Other reason: patient's will|0
7472752|NCT01955161|11776404|FG001|Overall Study|Other reason: patient's will|0
7472753|NCT01955161|11776405|FG002|Overall Study|Other reason: patient's will|1
7472754|NCT01955707|11776497|FG000|Overall Study|Adverse Event|1
7472755|NCT01955707|11776498|FG001|Overall Study|Adverse Event|2
7472756|NCT01955707|11776497|FG000|Overall Study|Lost to Follow-up|2
7472757|NCT01955707|11776498|FG001|Overall Study|Lost to Follow-up|1
7472758|NCT01955707|11776497|FG000|Overall Study|Withdrawal by Subject|0
7472759|NCT01955707|11776498|FG001|Overall Study|Withdrawal by Subject|3
7472760|NCT01955707|11776497|FG000|Overall Study|Death|13
7472761|NCT01955707|11776498|FG001|Overall Study|Death|14
7472762|NCT01955707|11776497|FG000|Overall Study|Other|4
7472763|NCT01955707|11776498|FG001|Overall Study|Other|2
7533973|NCT02691702|11880484|FG001|Overall Study|Withdrawal by Subject|1
7533974|NCT02691702|11880485|FG002|Overall Study|Withdrawal by Subject|0
7533975|NCT02691702|11880486|FG003|Overall Study|Withdrawal by Subject|0
7533976|NCT02691702|11880487|FG004|Overall Study|Withdrawal by Subject|0
7533977|NCT02691702|11880488|FG005|Overall Study|Withdrawal by Subject|1
7533978|NCT02691702|11880489|FG006|Overall Study|Withdrawal by Subject|2
7533979|NCT02691702|11880490|FG007|Overall Study|Withdrawal by Subject|0
7533980|NCT02691702|11880491|FG008|Overall Study|Withdrawal by Subject|0
7533981|NCT02691702|11880492|FG009|Overall Study|Withdrawal by Subject|0
7533982|NCT02691702|11880493|FG010|Overall Study|Withdrawal by Subject|0
7533983|NCT02691702|11880483|FG000|Overall Study|Other|0
7533984|NCT02691702|11880484|FG001|Overall Study|Other|0
7533985|NCT02691702|11880485|FG002|Overall Study|Other|0
7533986|NCT02691702|11880486|FG003|Overall Study|Other|0
7533987|NCT02691702|11880487|FG004|Overall Study|Other|0
7533988|NCT02691702|11880488|FG005|Overall Study|Other|0
7533989|NCT02691702|11880489|FG006|Overall Study|Other|1
7533990|NCT02691702|11880490|FG007|Overall Study|Other|0
7533991|NCT02691702|11880491|FG008|Overall Study|Other|1
7533992|NCT02691702|11880492|FG009|Overall Study|Other|0
7533993|NCT02691702|11880493|FG010|Overall Study|Other|0
7533994|NCT02691702|11880483|FG000|Overall Study|Protocol Violation|0
7533995|NCT02691702|11880484|FG001|Overall Study|Protocol Violation|0
7533996|NCT02691702|11880485|FG002|Overall Study|Protocol Violation|0
7533997|NCT02691702|11880486|FG003|Overall Study|Protocol Violation|0
7533998|NCT02691702|11880487|FG004|Overall Study|Protocol Violation|0
7533999|NCT02691702|11880488|FG005|Overall Study|Protocol Violation|0
7534000|NCT02691702|11880489|FG006|Overall Study|Protocol Violation|0
7534001|NCT02691702|11880490|FG007|Overall Study|Protocol Violation|0
7534002|NCT02691702|11880491|FG008|Overall Study|Protocol Violation|0
7534003|NCT02691702|11880492|FG009|Overall Study|Protocol Violation|2
7534004|NCT02691702|11880493|FG010|Overall Study|Protocol Violation|0
7534005|NCT02691741|11880527|FG000|Overall Study|Adverse Event|0
7534006|NCT02691741|11880528|FG001|Overall Study|Adverse Event|2
7534007|NCT02691741|11880527|FG000|Overall Study|Lost to Follow-up|1
7534008|NCT02691741|11880528|FG001|Overall Study|Lost to Follow-up|0
7534009|NCT02691741|11880527|FG000|Overall Study|Physician Decision|0
7534010|NCT02691741|11880528|FG001|Overall Study|Physician Decision|1
7534011|NCT02691741|11880527|FG000|Overall Study|Withdrawal by Subject|0
7534012|NCT02691741|11880528|FG001|Overall Study|Withdrawal by Subject|4
7534013|NCT02691936|11880541|FG000|Overall Study|Withdrawal by Subject|2
7534014|NCT02691936|11880542|FG001|Overall Study|Withdrawal by Subject|5
7534015|NCT02692040|11880570|FG000|Overall Study|Protocol Violation|0
7534016|NCT02692040|11880571|FG001|Overall Study|Protocol Violation|0
7534017|NCT02692040|11880572|FG002|Overall Study|Protocol Violation|0
7534018|NCT02692040|11880573|FG003|Overall Study|Protocol Violation|0
7534019|NCT02692040|11880574|FG004|Overall Study|Protocol Violation|0
7534020|NCT02692040|11880575|FG005|Overall Study|Protocol Violation|0
7534021|NCT02692040|11880576|FG006|Overall Study|Protocol Violation|0
7534022|NCT02692040|11880577|FG007|Overall Study|Protocol Violation|0
7534023|NCT02692040|11880578|FG008|Overall Study|Protocol Violation|0
7534024|NCT02692040|11880579|FG009|Overall Study|Protocol Violation|0
7534025|NCT02692040|11880580|FG010|Overall Study|Protocol Violation|0
7534026|NCT02692040|11880581|FG011|Overall Study|Protocol Violation|0
7534027|NCT02692040|11880582|FG012|Overall Study|Protocol Violation|1
7534028|NCT02692040|11880583|FG013|Overall Study|Protocol Violation|0
7534029|NCT02692040|11880584|FG014|Overall Study|Protocol Violation|0
7534030|NCT02692040|11880585|FG015|Overall Study|Protocol Violation|0
7534031|NCT02692040|11880586|FG016|Overall Study|Protocol Violation|0
7534032|NCT02692040|11880570|FG000|Overall Study|Adverse Event|0
7534033|NCT02692040|11880571|FG001|Overall Study|Adverse Event|0
7534034|NCT02692040|11880572|FG002|Overall Study|Adverse Event|0
7534035|NCT02692040|11880573|FG003|Overall Study|Adverse Event|0
7534036|NCT02692040|11880574|FG004|Overall Study|Adverse Event|0
7534037|NCT02692040|11880575|FG005|Overall Study|Adverse Event|0
7534038|NCT02692040|11880576|FG006|Overall Study|Adverse Event|0
7534039|NCT02692040|11880577|FG007|Overall Study|Adverse Event|0
7534040|NCT02692040|11880578|FG008|Overall Study|Adverse Event|0
7472764|NCT01955733|11776558|FG000|Period 1|Lost to Follow-up|1
7472765|NCT01955733|11776559|FG001|Period 1|Lost to Follow-up|0
7472766|NCT01955733|11776560|FG002|Period 1|Lost to Follow-up|0
7472767|NCT01955733|11776558|FG000|Period 2|Adverse Event|1
7472768|NCT01955733|11776559|FG001|Period 2|Adverse Event|0
7472769|NCT01955733|11776560|FG002|Period 2|Adverse Event|0
7472770|NCT01955733|11776558|FG000|Period 2|Physician Decision|0
7472771|NCT01955733|11776559|FG001|Period 2|Physician Decision|0
7472772|NCT01955733|11776560|FG002|Period 2|Physician Decision|1
7472773|NCT01955733|11776558|FG000|Period 2|Withdrawal by Subject|1
7472774|NCT01955733|11776559|FG001|Period 2|Withdrawal by Subject|3
7472775|NCT01955733|11776560|FG002|Period 2|Withdrawal by Subject|2
7472776|NCT01955733|11776558|FG000|Period 2|Study terminated by sponsor|8
7472777|NCT01955733|11776559|FG001|Period 2|Study terminated by sponsor|14
7472778|NCT01955733|11776560|FG002|Period 2|Study terminated by sponsor|16
7472779|NCT01955733|11776558|FG000|Period 2|Lost to Follow-up|2
7472780|NCT01955733|11776559|FG001|Period 2|Lost to Follow-up|0
7472781|NCT01955733|11776560|FG002|Period 2|Lost to Follow-up|0
7472782|NCT01955733|11776558|FG000|Period 2|Other not defined above|0
7472783|NCT01955733|11776559|FG001|Period 2|Other not defined above|2
7472784|NCT01955733|11776560|FG002|Period 2|Other not defined above|2
7472785|NCT01956123|11776604|FG000|COS Cycle 2|Protocol Violation|8
7472786|NCT01956123|11776605|FG001|COS Cycle 2|Protocol Violation|3
7472787|NCT01956123|11776606|FG002|COS Cycle 2|Protocol Violation|0
7472788|NCT01956123|11776607|FG003|COS Cycle 2|Protocol Violation|0
7472789|NCT01956123|11776604|FG000|COS Cycle 2|Adverse Event|3
7472790|NCT01956123|11776605|FG001|COS Cycle 2|Adverse Event|4
7472791|NCT01956123|11776606|FG002|COS Cycle 2|Adverse Event|0
7472792|NCT01956123|11776607|FG003|COS Cycle 2|Adverse Event|0
7472793|NCT01956123|11776604|FG000|COS Cycle 2|Personal Reasons|2
7472794|NCT01956123|11776605|FG001|COS Cycle 2|Personal Reasons|0
7472795|NCT01956123|11776606|FG002|COS Cycle 2|Personal Reasons|0
7472796|NCT01956123|11776607|FG003|COS Cycle 2|Personal Reasons|0
7472797|NCT01956123|11776604|FG000|COS Cycle 2|Withdrawal by Subject|1
7472798|NCT01956123|11776605|FG001|COS Cycle 2|Withdrawal by Subject|0
7472799|NCT01956123|11776606|FG002|COS Cycle 2|Withdrawal by Subject|0
7472800|NCT01956123|11776607|FG003|COS Cycle 2|Withdrawal by Subject|0
7472801|NCT01956123|11776604|FG000|COS Cycle 3|Protocol Violation|0
7472802|NCT01956123|11776605|FG001|COS Cycle 3|Protocol Violation|0
7472803|NCT01956123|11776606|FG002|COS Cycle 3|Protocol Violation|2
7472804|NCT01956123|11776607|FG003|COS Cycle 3|Protocol Violation|1
7472805|NCT01956123|11776604|FG000|COS Cycle 3|Adverse Event|0
7472806|NCT01956123|11776605|FG001|COS Cycle 3|Adverse Event|0
7472807|NCT01956123|11776606|FG002|COS Cycle 3|Adverse Event|3
7472808|NCT01956123|11776607|FG003|COS Cycle 3|Adverse Event|0
7472809|NCT01956123|11776604|FG000|COS Cycle 3|Personal Reasons|0
7472810|NCT01956123|11776605|FG001|COS Cycle 3|Personal Reasons|0
7472811|NCT01956123|11776606|FG002|COS Cycle 3|Personal Reasons|1
7472812|NCT01956123|11776607|FG003|COS Cycle 3|Personal Reasons|0
7472813|NCT01956123|11776604|FG000|COS Cycle 3|Withdrawal by Subject|0
7472814|NCT01956123|11776605|FG001|COS Cycle 3|Withdrawal by Subject|0
7472815|NCT01956123|11776606|FG002|COS Cycle 3|Withdrawal by Subject|0
7472816|NCT01956123|11776607|FG003|COS Cycle 3|Withdrawal by Subject|1
7472817|NCT01956240|11776620|FG000|Overall Study|Lost to Follow-up|6
7472818|NCT01956240|11776621|FG001|Overall Study|Lost to Follow-up|20
7472819|NCT01956240|11776620|FG000|Overall Study|Adverse Event|17
7472820|NCT01956240|11776621|FG001|Overall Study|Adverse Event|4
7472821|NCT01956773|11776646|FG000|Overall Study|Lost to Follow-up|628
7472822|NCT01956773|11776647|FG001|Overall Study|Lost to Follow-up|1
7472823|NCT01957111|11776660|FG000|Overall Study|Withdrawal by Subject|1
7472824|NCT01957111|11776661|FG001|Overall Study|Withdrawal by Subject|1
7472825|NCT01957137|11776667|FG000|Randomized Portion|Adverse Event|1
7472826|NCT01957137|11776667|FG000|Randomized Portion|Withdrawal by Subject|1
7472827|NCT01957150|11776681|FG000|Overall Study|Adverse Event|23
7472828|NCT01957150|11776682|FG001|Overall Study|Adverse Event|20
7472829|NCT01957150|11776681|FG000|Overall Study|Withdrawal by Subject|13
7472830|NCT01957150|11776682|FG001|Overall Study|Withdrawal by Subject|17
7472831|NCT01957150|11776681|FG000|Overall Study|Physician Decision|3
7472832|NCT01957150|11776682|FG001|Overall Study|Physician Decision|6
7472833|NCT01957150|11776681|FG000|Overall Study|Lost to Follow-up|4
7472834|NCT01957150|11776682|FG001|Overall Study|Lost to Follow-up|4
7472835|NCT01957150|11776681|FG000|Overall Study|Protocol Violation|1
7472836|NCT01957150|11776682|FG001|Overall Study|Protocol Violation|0
7472837|NCT01957150|11776681|FG000|Overall Study|Lack of Efficacy|11
7472838|NCT01957150|11776682|FG001|Overall Study|Lack of Efficacy|11
7472839|NCT01957163|11776691|FG000|Overall Study|Adverse Event|5
7472840|NCT01957163|11776692|FG001|Overall Study|Adverse Event|2
7472841|NCT01957163|11776693|FG002|Overall Study|Adverse Event|4
7472842|NCT01957163|11776691|FG000|Overall Study|Lack of Efficacy|5
7472843|NCT01957163|11776692|FG001|Overall Study|Lack of Efficacy|4
7472844|NCT01957163|11776693|FG002|Overall Study|Lack of Efficacy|9
7472845|NCT01957163|11776691|FG000|Overall Study|Protocol Violation|1
7472846|NCT01957163|11776692|FG001|Overall Study|Protocol Violation|2
7472847|NCT01957163|11776693|FG002|Overall Study|Protocol Violation|0
7472848|NCT01957163|11776691|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
7472849|NCT01957163|11776692|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
7472850|NCT01957163|11776693|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
7472851|NCT01957163|11776691|FG000|Overall Study|Lost to Follow-up|0
7472852|NCT01957163|11776692|FG001|Overall Study|Lost to Follow-up|1
7472853|NCT01957163|11776693|FG002|Overall Study|Lost to Follow-up|0
7472854|NCT01957163|11776691|FG000|Overall Study|Withdrawal by Subject|4
7472855|NCT01957163|11776692|FG001|Overall Study|Withdrawal by Subject|2
7472856|NCT01957163|11776693|FG002|Overall Study|Withdrawal by Subject|4
7472857|NCT01957202|11776701|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472858|NCT01957202|11776702|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7472859|NCT01957202|11776703|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472860|NCT01957202|11776704|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472861|NCT01957202|11776705|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472862|NCT01957202|11776706|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472863|NCT01957202|11776707|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472864|NCT01957202|11776708|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472865|NCT01957202|11776709|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472866|NCT01957202|11776710|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472867|NCT01957202|11776711|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472868|NCT01957202|11776712|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472869|NCT01957202|11776713|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472870|NCT01957202|11776714|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472871|NCT01957202|11776715|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472872|NCT01957202|11776716|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472873|NCT01957202|11776717|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7472874|NCT01957202|11776718|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7472875|NCT01957202|11776701|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
7472876|NCT01957202|11776702|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
7472877|NCT01957202|11776703|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
7472878|NCT01957202|11776704|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
7472879|NCT01957202|11776705|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
7472880|NCT01957202|11776706|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
7472881|NCT01957202|11776707|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
7472882|NCT01957202|11776708|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
7472883|NCT01957202|11776709|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
7472884|NCT01957202|11776710|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
7472885|NCT01957202|11776711|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
7472886|NCT01957202|11776712|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
7472887|NCT01957202|11776713|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
7472888|NCT01957202|11776714|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
7472889|NCT01957202|11776715|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
7472890|NCT01957202|11776716|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
7472891|NCT01957202|11776717|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
7472892|NCT01957202|11776718|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
7472893|NCT01957215|11776730|FG000|Overall Study|Adverse Event|2
7472894|NCT01957215|11776731|FG001|Overall Study|Adverse Event|2
7472895|NCT01957215|11776730|FG000|Overall Study|Lost to Follow-up|3
7472896|NCT01957215|11776731|FG001|Overall Study|Lost to Follow-up|3
7472897|NCT01957215|11776730|FG000|Overall Study|Protocol Violation|1
7472898|NCT01957215|11776731|FG001|Overall Study|Protocol Violation|2
7472899|NCT01957215|11776730|FG000|Overall Study|Withdrawal by Subject|7
7472900|NCT01957215|11776731|FG001|Overall Study|Withdrawal by Subject|5
7472901|NCT01957397|11776754|FG000|Test Period 1|sudden leakage/small bag|1
7472902|NCT01957397|11776755|FG001|Test Period 1|sudden leakage/small bag|1
7472903|NCT01957397|11776754|FG000|Test Period 1|Withdrawal by Subject|1
7472904|NCT01957397|11776755|FG001|Test Period 1|Withdrawal by Subject|0
7472905|NCT01957397|11776754|FG000|Test Period 2|Adverse Event|0
7472906|NCT01957397|11776755|FG001|Test Period 2|Adverse Event|1
7472907|NCT01957397|11776754|FG000|Test Period 3|Adverse Event|1
7472908|NCT01957397|11776755|FG001|Test Period 3|Adverse Event|2
7472909|NCT01957397|11776754|FG000|Test Period 3|the adhesive did not work|1
7472910|NCT01957397|11776755|FG001|Test Period 3|the adhesive did not work|0
7472911|NCT01957462|11776769|FG000|Test Period 1|Withdrawal by Subject|1
7472912|NCT01957462|11776770|FG001|Test Period 1|Withdrawal by Subject|0
7472913|NCT01957462|11776769|FG000|Test Period 1|Adverse Event|1
7472914|NCT01957462|11776770|FG001|Test Period 1|Adverse Event|0
7472915|NCT01957475|11776776|FG000|Test Period 1|Withdrawal by Subject|1
7472916|NCT01957475|11776777|FG001|Test Period 1|Withdrawal by Subject|0
7472917|NCT01957475|11776776|FG000|Test Period 1|Other|1
7472918|NCT01957475|11776777|FG001|Test Period 1|Other|0
7472919|NCT01957475|11776776|FG000|Test Period 1|Lack of Efficacy|0
7472920|NCT01957475|11776777|FG001|Test Period 1|Lack of Efficacy|1
7472921|NCT01957475|11776776|FG000|Test Period 2|Adverse Event|1
7472922|NCT01957475|11776777|FG001|Test Period 2|Adverse Event|0
7472923|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
7472924|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7472925|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7472926|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
7472927|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7472928|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
7472929|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
7472930|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
7472931|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
7472932|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
7472933|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
7472934|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
7472935|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
7472936|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
7472937|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
7472938|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
7472939|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
7472940|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
7472941|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7472942|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7472943|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
7472944|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7472945|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
7472946|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
7472947|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7472948|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7472949|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7472950|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7472951|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
7472952|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
7472953|NCT01957488|11776783|FG000|Test Period 1 (2 Weeks)|screen failure|0
7472954|NCT01957488|11776784|FG001|Test Period 1 (2 Weeks)|screen failure|0
7472955|NCT01957488|11776785|FG002|Test Period 1 (2 Weeks)|screen failure|0
7472956|NCT01957488|11776786|FG003|Test Period 1 (2 Weeks)|screen failure|0
7472957|NCT01957488|11776787|FG004|Test Period 1 (2 Weeks)|screen failure|0
7472958|NCT01957488|11776788|FG005|Test Period 1 (2 Weeks)|screen failure|1
7472959|NCT01957488|11776783|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
7472960|NCT01957488|11776784|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
7472961|NCT01957488|11776785|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
7472962|NCT01957488|11776786|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
7472963|NCT01957488|11776787|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
7472964|NCT01957488|11776788|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
7472965|NCT01957488|11776783|FG000|Test Period 2 (2 Weeks)|Other|1
7472966|NCT01957488|11776784|FG001|Test Period 2 (2 Weeks)|Other|0
7472967|NCT01957488|11776785|FG002|Test Period 2 (2 Weeks)|Other|0
7472968|NCT01957488|11776786|FG003|Test Period 2 (2 Weeks)|Other|0
7472969|NCT01957488|11776787|FG004|Test Period 2 (2 Weeks)|Other|0
7472970|NCT01957488|11776788|FG005|Test Period 2 (2 Weeks)|Other|0
7472971|NCT01957488|11776783|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7472972|NCT01957488|11776784|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
7472973|NCT01957488|11776785|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7472974|NCT01957488|11776786|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7472975|NCT01957488|11776787|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7472976|NCT01957488|11776788|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
7472977|NCT01957488|11776783|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
7472978|NCT01957488|11776784|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
7472979|NCT01957488|11776785|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
7472980|NCT01957488|11776786|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
7472981|NCT01957488|11776787|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
7472982|NCT01957488|11776788|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
7472983|NCT01957488|11776783|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7472984|NCT01957488|11776784|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7472985|NCT01957488|11776785|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7472986|NCT01957488|11776786|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7472987|NCT01957488|11776787|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
7472988|NCT01957488|11776788|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
7472989|NCT01957488|11776783|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
7472990|NCT01957488|11776784|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7472991|NCT01957488|11776785|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7472992|NCT01957488|11776786|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7472993|NCT01957488|11776787|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7472994|NCT01957488|11776788|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
7472995|NCT01957488|11776783|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7472996|NCT01957488|11776784|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
7472997|NCT01957488|11776785|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7472998|NCT01957488|11776786|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7472999|NCT01957488|11776787|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7473000|NCT01957488|11776788|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
7473001|NCT01957553|11776796|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
7473002|NCT01957553|11776797|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
7473003|NCT01957553|11776796|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
7473004|NCT01957553|11776797|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
7473005|NCT01957553|11776796|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
7473006|NCT01957553|11776797|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
7473007|NCT01957553|11776796|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
7473008|NCT01957553|11776797|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
7473009|NCT01957553|11776796|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
7473010|NCT01957553|11776797|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
7473011|NCT01957553|11776796|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
7473012|NCT01957553|11776797|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
7473013|NCT01957553|11776796|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
7473014|NCT01957553|11776797|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
7473015|NCT01957553|11776796|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
7473016|NCT01957553|11776797|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
7473017|NCT01957553|11776796|FG000|Test Period 2 (21 +- 1 Days)|Other|1
7473018|NCT01957553|11776797|FG001|Test Period 2 (21 +- 1 Days)|Other|0
7473019|NCT01957579|11776807|FG000|Overall Study|Withdrawal of concent|0
7473020|NCT01957579|11776808|FG001|Overall Study|Withdrawal of concent|1
7473021|NCT01957579|11776809|FG002|Overall Study|Withdrawal of concent|0
7473022|NCT01957579|11776810|FG003|Overall Study|Withdrawal of concent|0
7473023|NCT01957579|11776807|FG000|Overall Study|Death|0
7473024|NCT01957579|11776808|FG001|Overall Study|Death|0
7473025|NCT01957579|11776809|FG002|Overall Study|Death|2
7473026|NCT01957579|11776810|FG003|Overall Study|Death|0
7473027|NCT01957644|11776842|FG000|Overall Study|Adverse Event|4
7473028|NCT01957644|11776843|FG001|Overall Study|Adverse Event|2
7473029|NCT01957644|11776844|FG002|Overall Study|Adverse Event|0
7473030|NCT01957644|11776845|FG003|Overall Study|Adverse Event|0
7473031|NCT01957644|11776846|FG004|Overall Study|Adverse Event|1
7473032|NCT01957644|11776842|FG000|Overall Study|Progressive disease / relapse|0
7473033|NCT01957644|11776843|FG001|Overall Study|Progressive disease / relapse|1
7473034|NCT01957644|11776844|FG002|Overall Study|Progressive disease / relapse|0
7473035|NCT01957644|11776845|FG003|Overall Study|Progressive disease / relapse|1
7473036|NCT01957644|11776846|FG004|Overall Study|Progressive disease / relapse|0
7473037|NCT01957644|11776842|FG000|Overall Study|Other reason|1
7473038|NCT01957644|11776843|FG001|Overall Study|Other reason|2
7473039|NCT01957644|11776844|FG002|Overall Study|Other reason|1
7473040|NCT01957644|11776845|FG003|Overall Study|Other reason|1
7473041|NCT01957644|11776846|FG004|Overall Study|Other reason|0
7473042|NCT01957644|11776842|FG000|Overall Study|Withdrawal by Subject|1
7473043|NCT01957644|11776843|FG001|Overall Study|Withdrawal by Subject|0
7473044|NCT01957644|11776844|FG002|Overall Study|Withdrawal by Subject|0
7473045|NCT01957644|11776845|FG003|Overall Study|Withdrawal by Subject|0
7473046|NCT01957644|11776846|FG004|Overall Study|Withdrawal by Subject|0
7473047|NCT01957644|11776842|FG000|Overall Study|Protocol Violation|0
7473048|NCT01957644|11776843|FG001|Overall Study|Protocol Violation|1
7473049|NCT01957644|11776844|FG002|Overall Study|Protocol Violation|0
7473050|NCT01957644|11776845|FG003|Overall Study|Protocol Violation|0
7473051|NCT01957644|11776846|FG004|Overall Study|Protocol Violation|0
7473052|NCT01957709|11776864|FG000|Overall Study|Patient refused to complete post-tx bx|1
7473053|NCT01957787|11776872|FG000|Overall Study|Death|18
7473054|NCT01957787|11776872|FG000|Overall Study|Lost to Follow-up|3
7473055|NCT01957787|11776872|FG000|Overall Study|Withdrawal by Subject|3
7473056|NCT01957787|11776872|FG000|Overall Study|Entered Hospice or Similar Program|2
7473057|NCT01957787|11776872|FG000|Overall Study|Index Tumor(s) Resected|2
7473058|NCT01957787|11776872|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
7473059|NCT01957787|11776872|FG000|Overall Study|Local therapy, not cryoablation|6
7473060|NCT01957865|11776879|FG000|Overall Study|Found HIV negative|0
7473061|NCT01957865|11776880|FG001|Overall Study|Found HIV negative|0
7473062|NCT01957865|11776881|FG002|Overall Study|Found HIV negative|1
7473063|NCT01957865|11776879|FG000|Overall Study|Lost to Follow-up|0
7473064|NCT01957865|11776880|FG001|Overall Study|Lost to Follow-up|2
7473065|NCT01957865|11776881|FG002|Overall Study|Lost to Follow-up|2
7473066|NCT01958008|11776906|FG000|Overall Study|Worsening of disease under study|0
7473067|NCT01958008|11776907|FG001|Overall Study|Worsening of disease under study|0
7473068|NCT01958008|11776908|FG002|Overall Study|Worsening of disease under study|1
7473069|NCT01958008|11776909|FG003|Overall Study|Worsening of disease under study|0
7473070|NCT01958008|11776906|FG000|Overall Study|Other adverse event|1
7473071|NCT01958008|11776907|FG001|Overall Study|Other adverse event|0
7473072|NCT01958008|11776908|FG002|Overall Study|Other adverse event|0
7473073|NCT01958008|11776909|FG003|Overall Study|Other adverse event|0
7473074|NCT01958060|11776928|FG000|Overall Study|Not treated|2
7473075|NCT01958060|11776929|FG001|Overall Study|Not treated|0
7473076|NCT01958060|11776930|FG002|Overall Study|Not treated|0
7473077|NCT01958060|11776931|FG003|Overall Study|Not treated|0
7473078|NCT01958060|11776932|FG004|Overall Study|Not treated|1
7473079|NCT01958060|11776933|FG005|Overall Study|Not treated|0
7473080|NCT01958125|11776980|FG000|Overall Study|Missing diary data|2
7473081|NCT01958125|11776981|FG001|Overall Study|Missing diary data|6
7473082|NCT01958125|11776980|FG000|Overall Study|No headache attacks|0
7473083|NCT01958125|11776981|FG001|Overall Study|No headache attacks|2
7473084|NCT01958164|11776989|FG000|Overall Study|Adverse Event|0
7473085|NCT01958164|11776990|FG001|Overall Study|Adverse Event|2
7473086|NCT01958164|11776989|FG000|Overall Study|Lost to Follow-up|2
7473087|NCT01958164|11776990|FG001|Overall Study|Lost to Follow-up|3
7473088|NCT01958281|11776999|FG000|Overall Study|Lack of Efficacy|5
7473089|NCT01958281|11777000|FG001|Overall Study|Lack of Efficacy|2
7473090|NCT01958281|11777001|FG002|Overall Study|Lack of Efficacy|0
7473091|NCT01958281|11776999|FG000|Overall Study|Adverse Event|0
7473092|NCT01958281|11777000|FG001|Overall Study|Adverse Event|2
7473093|NCT01958281|11777001|FG002|Overall Study|Adverse Event|0
7473094|NCT01958281|11776999|FG000|Overall Study|Withdrew Consent|1
7473095|NCT01958281|11777000|FG001|Overall Study|Withdrew Consent|0
7473096|NCT01958281|11777001|FG002|Overall Study|Withdrew Consent|0
7473097|NCT01958294|11777010|FG000|Overall Study|Clinical Circumstances|2
7473098|NCT01958437|11777036|FG000|Overall Study|Incidental MRI findings|0
7473099|NCT01958437|11777037|FG001|Overall Study|Incidental MRI findings|0
7473100|NCT01958437|11777038|FG002|Overall Study|Incidental MRI findings|1
7473101|NCT01958437|11777039|FG003|Overall Study|Incidental MRI findings|1
7473102|NCT01958476|11777058|FG000|Overall Study|Parent requested exclusion from analysis|1
7473103|NCT01958476|11777059|FG001|Overall Study|Parent requested exclusion from analysis|0
7473104|NCT01958489|11777065|FG000|Period 2|Adverse Event|0
7473105|NCT01958489|11777066|FG001|Period 2|Adverse Event|1
7473106|NCT01958619|11777090|FG000|Overall Study|Protocol Violation|2
7473107|NCT01958619|11777091|FG001|Overall Study|Protocol Violation|0
7473108|NCT01958619|11777092|FG002|Overall Study|Protocol Violation|1
7473109|NCT01958619|11777093|FG003|Overall Study|Protocol Violation|0
7473110|NCT01958671|11777121|FG000|Overall Study|Adverse Event|1
7473111|NCT01958671|11777122|FG001|Overall Study|Adverse Event|1
7473112|NCT01958671|11777123|FG002|Overall Study|Adverse Event|5
7473113|NCT01958671|11777121|FG000|Overall Study|Death|1
7473114|NCT01958671|11777122|FG001|Overall Study|Death|0
7473115|NCT01958671|11777123|FG002|Overall Study|Death|0
7473116|NCT01958671|11777121|FG000|Overall Study|Excluded medication|0
7473117|NCT01958671|11777122|FG001|Overall Study|Excluded medication|0
7473118|NCT01958671|11777123|FG002|Overall Study|Excluded medication|1
7473119|NCT01958671|11777121|FG000|Overall Study|Hyperglycemia|0
7473120|NCT01958671|11777122|FG001|Overall Study|Hyperglycemia|0
7224629|NCT00056407|11433899|FG000|Overall Study|Protocol Violation|104
7224630|NCT00056407|11433900|FG001|Overall Study|Protocol Violation|95
7413035|NCT01422304|11685121|FG001|Overall Study|Withdrawal by Subject|2
7413036|NCT01422304|11685120|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7413037|NCT01422304|11685121|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
7413038|NCT01422304|11685120|FG000|Overall Study|Not Treated|3
7413039|NCT01422304|11685121|FG001|Overall Study|Not Treated|11
7413040|NCT01422382|11685136|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
7413041|NCT01422408|11685140|FG000|Overall Study|Adverse Event|1
7413042|NCT01422408|11685140|FG000|Overall Study|Withdrawal by Subject|3
7413043|NCT01422538|11685160|FG000|Overall Study|Lost to Follow-up|0
7413044|NCT01422538|11685161|FG001|Overall Study|Lost to Follow-up|1
7413045|NCT01422538|11685162|FG002|Overall Study|Lost to Follow-up|1
7413046|NCT01422538|11685160|FG000|Overall Study|Missed visit|0
7413047|NCT01422538|11685161|FG001|Overall Study|Missed visit|1
7413048|NCT01422538|11685162|FG002|Overall Study|Missed visit|1
7473121|NCT01958671|11777123|FG002|Overall Study|Hyperglycemia|2
7224631|NCT00056407|11433899|FG000|Overall Study|Diagnosed with Prostate Cancer|202
7473122|NCT01958671|11777121|FG000|Overall Study|Lost to Follow-up|7
7473123|NCT01958671|11777122|FG001|Overall Study|Lost to Follow-up|11
7473124|NCT01958671|11777123|FG002|Overall Study|Lost to Follow-up|7
7473125|NCT01958671|11777121|FG000|Overall Study|Non-compliance with study drug|1
7473126|NCT01958671|11777122|FG001|Overall Study|Non-compliance with study drug|1
7473127|NCT01958671|11777123|FG002|Overall Study|Non-compliance with study drug|1
7473128|NCT01958671|11777121|FG000|Overall Study|Pregnancy|0
7473129|NCT01958671|11777122|FG001|Overall Study|Pregnancy|0
7473130|NCT01958671|11777123|FG002|Overall Study|Pregnancy|1
7473131|NCT01958671|11777121|FG000|Overall Study|Protocol Violation|0
7473132|NCT01958671|11777122|FG001|Overall Study|Protocol Violation|1
7473133|NCT01958671|11777123|FG002|Overall Study|Protocol Violation|0
7473134|NCT01958671|11777121|FG000|Overall Study|Study site terminated by sponsor|1
7473135|NCT01958671|11777122|FG001|Overall Study|Study site terminated by sponsor|0
7473136|NCT01958671|11777123|FG002|Overall Study|Study site terminated by sponsor|1
7473137|NCT01958671|11777121|FG000|Overall Study|Participant moved|0
7473138|NCT01958671|11777122|FG001|Overall Study|Participant moved|0
7473139|NCT01958671|11777123|FG002|Overall Study|Participant moved|1
7473140|NCT01958671|11777121|FG000|Overall Study|Withdrawal by Subject|8
7473141|NCT01958671|11777122|FG001|Overall Study|Withdrawal by Subject|10
7473142|NCT01958671|11777123|FG002|Overall Study|Withdrawal by Subject|13
7473143|NCT01958827|11777139|FG000|Overall Study|Adverse Event|3
7473144|NCT01958827|11777139|FG000|Overall Study|Lack of Efficacy|6
7473145|NCT01958827|11777139|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
7473146|NCT01958918|11777145|FG000|Overall Study|Death|1
7473147|NCT01958918|11777146|FG001|Overall Study|Death|3
7473148|NCT01958918|11777145|FG000|Overall Study|Lost to Follow-up|4
7473149|NCT01958918|11777146|FG001|Overall Study|Lost to Follow-up|7
7473150|NCT01958918|11777145|FG000|Overall Study|Withdrawal by Subject|13
7473151|NCT01958918|11777146|FG001|Overall Study|Withdrawal by Subject|8
7473152|NCT01958918|11777145|FG000|Overall Study|Lack of Efficacy|13
7473153|NCT01958918|11777146|FG001|Overall Study|Lack of Efficacy|10
7473154|NCT01958918|11777145|FG000|Overall Study|Adverse Event|12
7473155|NCT01958918|11777146|FG001|Overall Study|Adverse Event|12
7473156|NCT01958918|11777145|FG000|Overall Study|administrative problems|0
7473157|NCT01958918|11777146|FG001|Overall Study|administrative problems|2
7473158|NCT01959035|11777152|FG000|Overall Study|Adverse Event|5
7473159|NCT01959035|11777152|FG000|Overall Study|Withdrawal by Subject|4
7473160|NCT01959035|11777152|FG000|Overall Study|Lost to Follow-up|1
7473161|NCT01959035|11777152|FG000|Overall Study|Other (no primary reason given)|1
7473162|NCT01959165|11777170|FG000|Overall Study|Adverse Event|0
7473163|NCT01959165|11777171|FG001|Overall Study|Adverse Event|0
7473164|NCT01959165|11777172|FG002|Overall Study|Adverse Event|0
7473165|NCT01959165|11777173|FG003|Overall Study|Adverse Event|1
7473166|NCT01959165|11777170|FG000|Overall Study|Lack of Efficacy|1
7473167|NCT01959165|11777171|FG001|Overall Study|Lack of Efficacy|0
7473168|NCT01959165|11777172|FG002|Overall Study|Lack of Efficacy|0
7473169|NCT01959165|11777173|FG003|Overall Study|Lack of Efficacy|0
7473170|NCT01959165|11777170|FG000|Overall Study|overdose|0
7473171|NCT01959165|11777171|FG001|Overall Study|overdose|0
7473172|NCT01959165|11777172|FG002|Overall Study|overdose|0
7473173|NCT01959165|11777173|FG003|Overall Study|overdose|1
7473174|NCT01959165|11777170|FG000|Overall Study|Welfare recipient|0
7473175|NCT01959165|11777171|FG001|Overall Study|Welfare recipient|1
7473176|NCT01959165|11777172|FG002|Overall Study|Welfare recipient|0
7473177|NCT01959165|11777173|FG003|Overall Study|Welfare recipient|0
7473178|NCT01959230|11777192|FG000|Overall Study|Failure to follow study procedures|0
7473179|NCT01959230|11777193|FG001|Overall Study|Failure to follow study procedures|1
7473180|NCT01959230|11777192|FG000|Overall Study|Administrative reasons|2
7473181|NCT01959230|11777193|FG001|Overall Study|Administrative reasons|0
7473182|NCT01959230|11777192|FG000|Overall Study|Withdrawal by Subject|2
7473183|NCT01959230|11777193|FG001|Overall Study|Withdrawal by Subject|0
7473184|NCT01959243|11777201|FG000|Overall Study|Investigator Decision|3
7473185|NCT01959243|11777202|FG001|Overall Study|Investigator Decision|0
7473186|NCT01959243|11777201|FG000|Overall Study|Adverse Event|5
7473187|NCT01959243|11777202|FG001|Overall Study|Adverse Event|2
7473188|NCT01959243|11777201|FG000|Overall Study|Administrative reasons|2
7473189|NCT01959243|11777202|FG001|Overall Study|Administrative reasons|1
7473190|NCT01959243|11777201|FG000|Overall Study|Lost to Follow-up|3
7473191|NCT01959243|11777202|FG001|Overall Study|Lost to Follow-up|1
7473192|NCT01959334|11777210|FG000|Second Dose|Adverse Event|1
7473193|NCT01959334|11777211|FG001|Second Dose|Adverse Event|0
7473194|NCT01959334|11777210|FG000|Third Dose|Adverse Event|0
7473195|NCT01959334|11777211|FG001|Third Dose|Adverse Event|1
7473196|NCT01959347|11777219|FG000|Overall Study|Protocol Violation|9
7473197|NCT01959347|11777220|FG001|Overall Study|Protocol Violation|7
7473198|NCT01959412|11777226|FG000|Overall Study|Protocol deviation|1
7473199|NCT01959412|11777227|FG001|Overall Study|Protocol deviation|1
7473200|NCT01959412|11777228|FG002|Overall Study|Protocol deviation|0
7473201|NCT01959412|11777229|FG003|Overall Study|Protocol deviation|1
7473202|NCT01959412|11777230|FG004|Overall Study|Protocol deviation|3
7473203|NCT01959412|11777231|FG005|Overall Study|Protocol deviation|0
7473204|NCT01959412|11777226|FG000|Overall Study|Adverse Event|0
7473205|NCT01959412|11777227|FG001|Overall Study|Adverse Event|0
7473206|NCT01959412|11777228|FG002|Overall Study|Adverse Event|0
7473207|NCT01959412|11777229|FG003|Overall Study|Adverse Event|1
7473208|NCT01959412|11777230|FG004|Overall Study|Adverse Event|0
7473209|NCT01959412|11777231|FG005|Overall Study|Adverse Event|0
7473210|NCT01959425|11777247|FG000|Overall Study|Withdrawal by Subject|5
7473211|NCT01959425|11777248|FG001|Overall Study|Withdrawal by Subject|4
7473212|NCT01959425|11777247|FG000|Overall Study|Lost to Follow-up|1
7473213|NCT01959425|11777248|FG001|Overall Study|Lost to Follow-up|0
7473214|NCT01959425|11777247|FG000|Overall Study|Discontinued Subjects|6
7473215|NCT01959425|11777248|FG001|Overall Study|Discontinued Subjects|4
7473216|NCT01959503|11777269|FG000|Overall Study|Death|2
7473217|NCT01959503|11777270|FG001|Overall Study|Death|1
7473218|NCT01959503|11777269|FG000|Overall Study|Randomized but not treated|1
7473219|NCT01959503|11777270|FG001|Overall Study|Randomized but not treated|1
7473220|NCT01959516|11777276|FG000|Epoch 1|Adverse Event|4
7473221|NCT01959516|11777277|FG001|Epoch 1|Adverse Event|1
7473222|NCT01959516|11777276|FG000|Epoch 1|unsatisfactory therapeutic effect|1
7473223|NCT01959516|11777277|FG001|Epoch 1|unsatisfactory therapeutic effect|0
7473224|NCT01959516|11777276|FG000|Epoch 1|Subject withdrew consent|3
7473225|NCT01959516|11777277|FG001|Epoch 1|Subject withdrew consent|2
7473226|NCT01959516|11777276|FG000|Epoch 1|Administrative problems|1
7473227|NCT01959516|11777277|FG001|Epoch 1|Administrative problems|0
7473228|NCT01959516|11777276|FG000|Epoch 1|Use of prohibited treatment|1
7473229|NCT01959516|11777277|FG001|Epoch 1|Use of prohibited treatment|0
7473230|NCT01959516|11777276|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
7473231|NCT01959516|11777277|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
7473232|NCT01959516|11777276|FG000|Epoch 1|Protocol deviation|0
7473233|NCT01959516|11777277|FG001|Epoch 1|Protocol deviation|1
7473234|NCT01959516|11777276|FG000|Epoch 2|unsatisfactory therapeutic effect|1
7473235|NCT01959516|11777277|FG001|Epoch 2|unsatisfactory therapeutic effect|0
7473236|NCT01959516|11777276|FG000|Epoch 2|Subject withdrew consent|1
7473237|NCT01959516|11777277|FG001|Epoch 2|Subject withdrew consent|0
7473238|NCT01959516|11777276|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
7473239|NCT01959516|11777277|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
7473240|NCT01959529|11777285|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
7473241|NCT01959529|11777286|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
7473242|NCT01959529|11777285|FG000|Overall Study|Lost to Follow-up|4
7473243|NCT01959529|11777286|FG001|Overall Study|Lost to Follow-up|1
7473244|NCT01959529|11777285|FG000|Overall Study|Other|70
7473245|NCT01959529|11777286|FG001|Overall Study|Other|68
7473246|NCT01959529|11777285|FG000|Overall Study|Hypoglycaemia|1
7473247|NCT01959529|11777286|FG001|Overall Study|Hypoglycaemia|1
7473248|NCT01959529|11777285|FG000|Overall Study|Lack of glycaemic control|1
7473249|NCT01959529|11777286|FG001|Overall Study|Lack of glycaemic control|1
7473250|NCT01959581|11777297|FG000|Overall Study|Lost to Follow-up|5
7473251|NCT01959607|11777303|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7473252|NCT01959607|11777304|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7473253|NCT01959607|11777305|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7473254|NCT01959607|11777306|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7473255|NCT01959672|11777315|FG000|Overall Study|Death|1
7473270|NCT01959841|11777359|FG000|Overall Study|Adverse Event|1
7473271|NCT01959841|11777360|FG001|Overall Study|Adverse Event|3
7473272|NCT01959841|11777361|FG002|Overall Study|Adverse Event|2
7473273|NCT01959841|11777359|FG000|Overall Study|Lack of Efficacy|5
7473274|NCT01959841|11777360|FG001|Overall Study|Lack of Efficacy|0
7473275|NCT01959841|11777361|FG002|Overall Study|Lack of Efficacy|0
7473276|NCT01959841|11777359|FG000|Overall Study|Lost to Follow-up|1
7473277|NCT01959841|11777360|FG001|Overall Study|Lost to Follow-up|1
7473278|NCT01959841|11777361|FG002|Overall Study|Lost to Follow-up|0
7473279|NCT01959841|11777359|FG000|Overall Study|Physician Decision|0
7473280|NCT01959841|11777360|FG001|Overall Study|Physician Decision|2
7473281|NCT01959841|11777361|FG002|Overall Study|Physician Decision|3
7473282|NCT01959841|11777359|FG000|Overall Study|Protocol Violation|16
7473283|NCT01959841|11777360|FG001|Overall Study|Protocol Violation|23
7473284|NCT01959841|11777361|FG002|Overall Study|Protocol Violation|16
7473285|NCT01959841|11777359|FG000|Overall Study|Withdrawal by Subject|7
7473286|NCT01959841|11777360|FG001|Overall Study|Withdrawal by Subject|7
7473287|NCT01959841|11777361|FG002|Overall Study|Withdrawal by Subject|5
7473288|NCT01959841|11777359|FG000|Overall Study|Clinical laboratory value|2
7473289|NCT01959841|11777360|FG001|Overall Study|Clinical laboratory value|6
7473290|NCT01959841|11777361|FG002|Overall Study|Clinical laboratory value|6
7473291|NCT01959841|11777359|FG000|Overall Study|Platelet count below on day1 or 4|11
7473292|NCT01959841|11777360|FG001|Overall Study|Platelet count below on day1 or 4|15
7473293|NCT01959841|11777361|FG002|Overall Study|Platelet count below on day1 or 4|11
7473294|NCT01959880|11777373|FG000|Overall Study|Withdrawal by Subject|11
7473295|NCT01959880|11777374|FG001|Overall Study|Withdrawal by Subject|13
7473296|NCT01959880|11777375|FG002|Overall Study|Withdrawal by Subject|8
7473297|NCT01959880|11777376|FG003|Overall Study|Withdrawal by Subject|7
7473298|NCT01959880|11777373|FG000|Overall Study|Death|1
7473299|NCT01959880|11777374|FG001|Overall Study|Death|10
7473300|NCT01959880|11777375|FG002|Overall Study|Death|1
7473301|NCT01959880|11777376|FG003|Overall Study|Death|2
7473302|NCT01959880|11777373|FG000|Overall Study|Lost to Follow-up|95
7473303|NCT01959880|11777374|FG001|Overall Study|Lost to Follow-up|18
7473304|NCT01959880|11777375|FG002|Overall Study|Lost to Follow-up|15
7473305|NCT01959880|11777376|FG003|Overall Study|Lost to Follow-up|8
7473306|NCT01959880|11777373|FG000|Overall Study|Explantation w/o study device reimplant.|22
7473307|NCT01959880|11777374|FG001|Overall Study|Explantation w/o study device reimplant.|17
7473308|NCT01959880|11777375|FG002|Overall Study|Explantation w/o study device reimplant.|5
7473309|NCT01959880|11777376|FG003|Overall Study|Explantation w/o study device reimplant.|12
7473310|NCT01959880|11777373|FG000|Overall Study|Study completed early-FDA approved|1003
7473311|NCT01959880|11777374|FG001|Overall Study|Study completed early-FDA approved|311
7473312|NCT01959880|11777375|FG002|Overall Study|Study completed early-FDA approved|179
7473313|NCT01959880|11777376|FG003|Overall Study|Study completed early-FDA approved|152
7473314|NCT01959919|11777386|FG000|Overall Study|Did not meet the eligibility criteria|2
7473315|NCT01959932|11777393|FG000|Overall Study|Withdrawal by Subject|1
7473316|NCT01959932|11777394|FG001|Overall Study|Withdrawal by Subject|0
7473317|NCT01959932|11777395|FG002|Overall Study|Withdrawal by Subject|0
7473318|NCT01960114|11777438|FG000|Overall Study|Adverse Event|1
7473319|NCT01960114|11777439|FG001|Overall Study|Adverse Event|0
7473320|NCT01960114|11777438|FG000|Overall Study|Could not swallow study medication|0
7473321|NCT01960114|11777439|FG001|Overall Study|Could not swallow study medication|1
7473322|NCT01960140|11777445|FG000|Period 2 (Days 3-18)|Adverse Event|2
7473323|NCT01960257|11777453|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
7473324|NCT01960257|11777454|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7473325|NCT01960257|11777455|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
7473326|NCT01960257|11777453|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
7473327|NCT01960257|11777454|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7473328|NCT01960257|11777455|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
7473329|NCT01960257|11777453|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
7473330|NCT01960257|11777454|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
7473331|NCT01960257|11777455|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
7473332|NCT01960296|11777467|FG000|Overall Study|Postponed surgery|1
7473333|NCT01960296|11777468|FG001|Overall Study|Postponed surgery|0
7473334|NCT01960296|11777467|FG000|Overall Study|Received different procedure|1
7473335|NCT01960296|11777468|FG001|Overall Study|Received different procedure|3
7473336|NCT01960348|11777476|FG000|Overall Study|Adverse event, not serious|2
7473337|NCT01960348|11777477|FG001|Overall Study|Adverse event, not serious|2
7473338|NCT01960348|11777476|FG000|Overall Study|Adverse event, serious fatal|6
7473339|NCT01960348|11777477|FG001|Overall Study|Adverse event, serious fatal|5
7473340|NCT01960348|11777476|FG000|Overall Study|Adverse event, serious non-fatal|0
7473341|NCT01960348|11777477|FG001|Overall Study|Adverse event, serious non-fatal|3
7473342|NCT01960348|11777476|FG000|Overall Study|Withdrawal by Subject|1
7473343|NCT01960348|11777477|FG001|Overall Study|Withdrawal by Subject|11
7473344|NCT01960348|11777476|FG000|Overall Study|Physician Decision|0
7473345|NCT01960348|11777477|FG001|Overall Study|Physician Decision|1
7473346|NCT01960348|11777476|FG000|Overall Study|Protocol Violation|1
7473347|NCT01960348|11777477|FG001|Overall Study|Protocol Violation|0
7473348|NCT01960413|11777498|FG000|Overall Study|Withdrawal by Subject|1
7473349|NCT01960413|11777499|FG001|Overall Study|Withdrawal by Subject|1
7473350|NCT01960413|11777498|FG000|Overall Study|Physician Decision|1
7473351|NCT01960413|11777499|FG001|Overall Study|Physician Decision|0
7473352|NCT01960413|11777498|FG000|Overall Study|Lost to Follow-up|2
7473353|NCT01960413|11777499|FG001|Overall Study|Lost to Follow-up|0
7473354|NCT01960725|11777516|FG000|Overall Study|Lost to Follow-up|4
7473355|NCT01960725|11777517|FG001|Overall Study|Lost to Follow-up|3
7473356|NCT01960725|11777516|FG000|Overall Study|Withdrawal by Subject|1
7473357|NCT01960725|11777517|FG001|Overall Study|Withdrawal by Subject|0
7473358|NCT01960725|11777516|FG000|Overall Study|unable to obtain blood sample|1
7473359|NCT01960725|11777517|FG001|Overall Study|unable to obtain blood sample|2
7473360|NCT01960790|11777523|FG000|Overall Study|Survey forms could not be recovered|3
7473361|NCT01960790|11777523|FG000|Overall Study|Treat with Humira outside survey period|3
7473362|NCT01960790|11777523|FG000|Overall Study|Transferred to another hospital|4
7473363|NCT01960790|11777523|FG000|Overall Study|Unevaluable for safety|1
7473364|NCT01960816|11777527|FG000|Overall Study|Lost to Follow-up|1
7473365|NCT01960842|11777531|FG000|Overall Study|Adverse Event|1
7473366|NCT01960842|11777531|FG000|Overall Study|Withdrawal by Subject|2
7473367|NCT01960855|11777540|FG000|Overall Study|Subject noncompliant|1
7473368|NCT01960855|11777541|FG001|Overall Study|Subject noncompliant|0
7473369|NCT01960855|11777542|FG002|Overall Study|Subject noncompliant|0
7473370|NCT01960855|11777543|FG003|Overall Study|Subject noncompliant|0
7473371|NCT01960855|11777544|FG004|Overall Study|Subject noncompliant|0
7473372|NCT01960855|11777540|FG000|Overall Study|Adverse Event|2
7473373|NCT01960855|11777541|FG001|Overall Study|Adverse Event|0
7473374|NCT01960855|11777542|FG002|Overall Study|Adverse Event|6
7473375|NCT01960855|11777543|FG003|Overall Study|Adverse Event|2
7473376|NCT01960855|11777544|FG004|Overall Study|Adverse Event|2
7473377|NCT01960855|11777540|FG000|Overall Study|Lack of Efficacy|1
7473378|NCT01960855|11777541|FG001|Overall Study|Lack of Efficacy|1
7473379|NCT01960855|11777542|FG002|Overall Study|Lack of Efficacy|0
7473380|NCT01960855|11777543|FG003|Overall Study|Lack of Efficacy|0
7473381|NCT01960855|11777544|FG004|Overall Study|Lack of Efficacy|0
7473382|NCT01960855|11777540|FG000|Overall Study|Other|2
7473383|NCT01960855|11777541|FG001|Overall Study|Other|1
7473384|NCT01960855|11777542|FG002|Overall Study|Other|1
7473385|NCT01960855|11777543|FG003|Overall Study|Other|1
7473386|NCT01960855|11777544|FG004|Overall Study|Other|0
7473387|NCT01960855|11777540|FG000|Overall Study|Consent withdrawn by subject|3
7473388|NCT01960855|11777541|FG001|Overall Study|Consent withdrawn by subject|1
7473389|NCT01960855|11777542|FG002|Overall Study|Consent withdrawn by subject|2
7473390|NCT01960855|11777543|FG003|Overall Study|Consent withdrawn by subject|1
7473391|NCT01960855|11777544|FG004|Overall Study|Consent withdrawn by subject|1
7473392|NCT01960855|11777540|FG000|Overall Study|Lost to Follow-up|2
7473393|NCT01960855|11777541|FG001|Overall Study|Lost to Follow-up|1
7473394|NCT01960855|11777542|FG002|Overall Study|Lost to Follow-up|0
7473395|NCT01960855|11777543|FG003|Overall Study|Lost to Follow-up|0
7473396|NCT01960855|11777544|FG004|Overall Study|Lost to Follow-up|2
7473397|NCT01960907|11777558|FG000|Overall Study|Death|4
7473398|NCT01960907|11777559|FG001|Overall Study|Death|3
7473399|NCT01960907|11777558|FG000|Overall Study|Withdrawal by Subject|32
7473400|NCT01960907|11777559|FG001|Overall Study|Withdrawal by Subject|42
7473401|NCT01960998|11777570|FG000|Overall Study|Lost to Follow-up|3
7473402|NCT01960998|11777571|FG001|Overall Study|Lost to Follow-up|7
7473403|NCT01960998|11777570|FG000|Overall Study|Death|0
7473404|NCT01960998|11777571|FG001|Overall Study|Death|1
7473405|NCT01960998|11777570|FG000|Overall Study|Withdrawal by Subject|8
7473406|NCT01960998|11777571|FG001|Overall Study|Withdrawal by Subject|2
7473407|NCT01960998|11777570|FG000|Overall Study|lost computer access|0
7473408|NCT01960998|11777571|FG001|Overall Study|lost computer access|1
7473409|NCT01961115|11777586|FG000|Overall Study|Disease Progression|1
7473410|NCT01961115|11777587|FG001|Overall Study|Disease Progression|0
7473411|NCT01961115|11777588|FG002|Overall Study|Disease Progression|3
7473412|NCT01961115|11777586|FG000|Overall Study|Adverse Event|1
7473413|NCT01961115|11777587|FG001|Overall Study|Adverse Event|0
7473414|NCT01961115|11777588|FG002|Overall Study|Adverse Event|1
7534041|NCT02692040|11880579|FG009|Overall Study|Adverse Event|0
7534042|NCT02692040|11880580|FG010|Overall Study|Adverse Event|0
7534043|NCT02692040|11880581|FG011|Overall Study|Adverse Event|0
7534044|NCT02692040|11880582|FG012|Overall Study|Adverse Event|0
7534045|NCT02692040|11880583|FG013|Overall Study|Adverse Event|3
7534046|NCT02692040|11880584|FG014|Overall Study|Adverse Event|1
7534047|NCT02692040|11880585|FG015|Overall Study|Adverse Event|1
7534048|NCT02692040|11880586|FG016|Overall Study|Adverse Event|0
7534049|NCT02692235|11880671|FG000|Overall Study|Withdrawal by Subject|2
7534050|NCT02692235|11880672|FG001|Overall Study|Withdrawal by Subject|1
7534051|NCT02692235|11880671|FG000|Overall Study|Adverse Event|1
7534052|NCT02692235|11880672|FG001|Overall Study|Adverse Event|2
7534053|NCT02692417|11880689|FG000|Overall Study|Withdrawal by Subject|5
7534054|NCT02692417|11880690|FG001|Overall Study|Withdrawal by Subject|1
7534055|NCT02692417|11880689|FG000|Overall Study|Adverse Event|1
7534056|NCT02692417|11880690|FG001|Overall Study|Adverse Event|0
7534057|NCT02692482|11880698|FG000|Overall Study|Death|2
7534058|NCT02692482|11880699|FG001|Overall Study|Death|2
7534059|NCT02692482|11880698|FG000|Overall Study|Withdrawal by Subject|1
7534060|NCT02692482|11880699|FG001|Overall Study|Withdrawal by Subject|2
7534061|NCT02692560|11880721|FG000|Overall Study|Withdrawal by Subject|0
7534062|NCT02692560|11880722|FG001|Overall Study|Withdrawal by Subject|6
7534063|NCT02692586|11880728|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
7534064|NCT02692586|11880728|FG000|Overall Study|Received adjunctive thrombolytics|2
7534065|NCT02692703|11880732|FG000|Overall Study|Lost to Follow-up|1
7534066|NCT02692703|11880732|FG000|Overall Study|Other|1
7534071|NCT02693106|11880759|FG000|Overall Study|No time|3
7534072|NCT02693119|11880771|FG000|Open-Label Period|Withdrawal by Subject|0
7534073|NCT02693119|11880772|FG001|Open-Label Period|Withdrawal by Subject|1
7534074|NCT02693418|11880833|FG000|Overall Study|Lost to Follow-up|1
7534075|NCT02693418|11880834|FG001|Overall Study|Lost to Follow-up|2
7534076|NCT02693418|11880835|FG002|Overall Study|Lost to Follow-up|0
7534077|NCT02693418|11880836|FG003|Overall Study|Lost to Follow-up|0
7534078|NCT02693418|11880837|FG004|Overall Study|Lost to Follow-up|0
7534079|NCT02693418|11880833|FG000|Overall Study|Menses during study period|0
7534080|NCT02693418|11880834|FG001|Overall Study|Menses during study period|0
7534081|NCT02693418|11880835|FG002|Overall Study|Menses during study period|2
7534082|NCT02693418|11880836|FG003|Overall Study|Menses during study period|0
7534083|NCT02693418|11880837|FG004|Overall Study|Menses during study period|0
7534084|NCT02693834|11880866|FG000|Baseline Measurement|Withdrawal by Subject|1
7534085|NCT02693834|11880867|FG001|Baseline Measurement|Withdrawal by Subject|0
7534086|NCT02693834|11880866|FG000|Baseline Measurement|Adverse Event|1
7534087|NCT02693834|11880867|FG001|Baseline Measurement|Adverse Event|0
7534088|NCT02693834|11880866|FG000|Week 2 Practice|Adverse Event|0
7534089|NCT02693834|11880867|FG001|Week 2 Practice|Adverse Event|1
7534090|NCT02694328|11880896|FG000|Overall Study|Adverse Event|27
7534091|NCT02694328|11880897|FG001|Overall Study|Adverse Event|33
7534092|NCT02694328|11880896|FG000|Overall Study|Withdrawal by Subject|27
7534093|NCT02694328|11880897|FG001|Overall Study|Withdrawal by Subject|23
7534094|NCT02694328|11880896|FG000|Overall Study|Lost to Follow-up|26
7534095|NCT02694328|11880897|FG001|Overall Study|Lost to Follow-up|22
7534096|NCT02694328|11880896|FG000|Overall Study|Noncompliant with study drug|11
7534097|NCT02694328|11880897|FG001|Overall Study|Noncompliant with study drug|8
7534098|NCT02694328|11880896|FG000|Overall Study|Incarceration|1
7534099|NCT02694328|11880897|FG001|Overall Study|Incarceration|1
7534100|NCT02694328|11880896|FG000|Overall Study|Lack of Efficacy|1
7534101|NCT02694328|11880897|FG001|Overall Study|Lack of Efficacy|2
7534102|NCT02694328|11880896|FG000|Overall Study|Pregnancy|1
7534103|NCT02694328|11880897|FG001|Overall Study|Pregnancy|1
7534104|NCT02694328|11880896|FG000|Overall Study|Protocol Violation|6
7534105|NCT02694328|11880897|FG001|Overall Study|Protocol Violation|5
7534106|NCT02694328|11880896|FG000|Overall Study|Abnormal Laboratory Value|0
7534107|NCT02694328|11880897|FG001|Overall Study|Abnormal Laboratory Value|3
7534108|NCT02694523|11880909|FG000|Part A|Adverse Event|7
7534109|NCT02694523|11880910|FG001|Part A|Adverse Event|3
7534110|NCT02694523|11880911|FG002|Part A|Adverse Event|0
7534111|NCT02694523|11880912|FG003|Part A|Adverse Event|0
7534112|NCT02694523|11880913|FG004|Part A|Adverse Event|0
7534113|NCT02694523|11880914|FG005|Part A|Adverse Event|0
7534114|NCT02694523|11880915|FG006|Part A|Adverse Event|0
7534115|NCT02694523|11880909|FG000|Part A|Protocol Violation|1
7534116|NCT02694523|11880910|FG001|Part A|Protocol Violation|0
7534117|NCT02694523|11880911|FG002|Part A|Protocol Violation|0
7534118|NCT02694523|11880912|FG003|Part A|Protocol Violation|0
7534119|NCT02694523|11880913|FG004|Part A|Protocol Violation|0
7473415|NCT01961297|11777606|FG000|Overall Study|unconfirmed diagnosis of SD|2
7473416|NCT01961297|11777607|FG001|Overall Study|unconfirmed diagnosis of SD|1
7473417|NCT01961323|11777613|FG000|Overall Study|Withdrawal by Subject|7
7473418|NCT01961323|11777613|FG000|Overall Study|Lost to Follow-up|8
7473419|NCT01961323|11777613|FG000|Overall Study|screen failure|34
7473420|NCT01961349|11777620|FG000|Overall Study|Withdrawal by Subject|1
7473421|NCT01961349|11777621|FG001|Overall Study|Withdrawal by Subject|4
7473422|NCT01961349|11777622|FG002|Overall Study|Withdrawal by Subject|0
7473423|NCT01961349|11777620|FG000|Overall Study|Adverse Event|0
7473424|NCT01961349|11777621|FG001|Overall Study|Adverse Event|0
7473425|NCT01961349|11777622|FG002|Overall Study|Adverse Event|1
7473426|NCT01961349|11777620|FG000|Overall Study|registration error, personal reason etc|2
7473427|NCT01961349|11777621|FG001|Overall Study|registration error, personal reason etc|2
7473428|NCT01961349|11777622|FG002|Overall Study|registration error, personal reason etc|1
7473429|NCT01961544|11777634|FG000|Overall Study|Protocol Violation|1
7473430|NCT01961544|11777634|FG000|Overall Study|Withdrawal by Subject|7
7473431|NCT01961544|11777634|FG000|Overall Study|Adverse Event|1
7473432|NCT01961544|11777634|FG000|Overall Study|Physician Decision|2
7473433|NCT01961544|11777634|FG000|Overall Study|Poor Tolerance|1
7473434|NCT01961544|11777634|FG000|Overall Study|Aggravation of Steral Pain|1
7473435|NCT01961609|11777640|FG000|Initiation|Missing|3
7473436|NCT01961609|11777641|FG001|Initiation|Missing|2
7473437|NCT01961609|11777642|FG002|Initiation|Missing|0
7473438|NCT01961609|11777643|FG003|Initiation|Missing|0
7473439|NCT01961609|11777640|FG000|Initiation|Protocol deviation|1
7473440|NCT01961609|11777641|FG001|Initiation|Protocol deviation|0
7473441|NCT01961609|11777642|FG002|Initiation|Protocol deviation|0
7473442|NCT01961609|11777643|FG003|Initiation|Protocol deviation|0
7473443|NCT01961609|11777640|FG000|Initiation|Death|0
7473444|NCT01961609|11777641|FG001|Initiation|Death|1
7473445|NCT01961609|11777642|FG002|Initiation|Death|0
7473446|NCT01961609|11777643|FG003|Initiation|Death|0
7473447|NCT01961609|11777640|FG000|Initiation|Administrative problems|1
7473448|NCT01961609|11777641|FG001|Initiation|Administrative problems|0
7473449|NCT01961609|11777642|FG002|Initiation|Administrative problems|0
7473450|NCT01961609|11777643|FG003|Initiation|Administrative problems|0
7473451|NCT01961609|11777640|FG000|Initiation|Withdrawal by Subject|1
7473452|NCT01961609|11777641|FG001|Initiation|Withdrawal by Subject|2
7473453|NCT01961609|11777642|FG002|Initiation|Withdrawal by Subject|0
7473454|NCT01961609|11777643|FG003|Initiation|Withdrawal by Subject|0
7473455|NCT01961609|11777640|FG000|Initiation|Lack of Efficacy|2
7473456|NCT01961609|11777641|FG001|Initiation|Lack of Efficacy|1
7473457|NCT01961609|11777642|FG002|Initiation|Lack of Efficacy|0
7473458|NCT01961609|11777643|FG003|Initiation|Lack of Efficacy|0
7473459|NCT01961609|11777640|FG000|Initiation|Abnormal lab values|0
7473460|NCT01961609|11777641|FG001|Initiation|Abnormal lab values|1
7473461|NCT01961609|11777642|FG002|Initiation|Abnormal lab values|0
7473462|NCT01961609|11777643|FG003|Initiation|Abnormal lab values|0
7473463|NCT01961609|11777640|FG000|Initiation|Adverse Event|3
7473464|NCT01961609|11777641|FG001|Initiation|Adverse Event|5
7473465|NCT01961609|11777642|FG002|Initiation|Adverse Event|0
7473466|NCT01961609|11777643|FG003|Initiation|Adverse Event|0
7473467|NCT01961609|11777640|FG000|Initiation|Randomized but not treated|1
7473468|NCT01961609|11777641|FG001|Initiation|Randomized but not treated|1
7473469|NCT01961609|11777642|FG002|Initiation|Randomized but not treated|0
7473470|NCT01961609|11777643|FG003|Initiation|Randomized but not treated|0
7473471|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
7473472|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7473473|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
7473474|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
7473475|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
7473476|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7473477|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
7473478|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
7473479|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7473480|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7473481|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
7473482|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
7473483|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
7473484|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
7473485|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
7473486|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
7473487|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7473488|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
7473489|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
7473490|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
7473491|NCT01961609|11777640|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7473492|NCT01961609|11777641|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7473493|NCT01961609|11777642|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
7473494|NCT01961609|11777643|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
7473495|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
7473496|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
7473497|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
7473498|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
7473499|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7473500|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7473501|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
7473502|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
7473503|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
7473504|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7473505|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7473506|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
7473507|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7473508|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
7473509|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7473510|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
7473511|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7473512|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
7473513|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
7473514|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
7473515|NCT01961609|11777640|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
7473516|NCT01961609|11777641|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7473517|NCT01961609|11777642|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
7473518|NCT01961609|11777643|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
7473519|NCT01961687|11777660|FG000|Overall Study|Lost to Follow-up|19
7473520|NCT01961687|11777660|FG000|Overall Study|Re-operation|17
7473521|NCT01961687|11777660|FG000|Overall Study|Death|7
7473522|NCT01961687|11777660|FG000|Overall Study|Withdrawal by Subject|6
7473523|NCT01961687|11777660|FG000|Overall Study|Adverse Event|6
7473524|NCT01961687|11777660|FG000|Overall Study|Moved to area without study site|2
7473525|NCT01961687|11777660|FG000|Overall Study|Sponsor decision|2
7473526|NCT01961687|11777660|FG000|Overall Study|Physician Decision|1
7473527|NCT01961687|11777660|FG000|Overall Study|Unable to meet follow-up requirements|1
7473528|NCT01961882|11777666|FG000|Overall Study|Adverse Event|3
7473529|NCT01961882|11777667|FG001|Overall Study|Adverse Event|2
7473530|NCT01961882|11777666|FG000|Overall Study|Physician Decision|1
7473531|NCT01961882|11777667|FG001|Overall Study|Physician Decision|0
7473532|NCT01961882|11777666|FG000|Overall Study|Withdrawal by Subject|4
7473533|NCT01961882|11777667|FG001|Overall Study|Withdrawal by Subject|1
7473534|NCT01961882|11777666|FG000|Overall Study|Relapse of AML|39
7473535|NCT01961882|11777667|FG001|Overall Study|Relapse of AML|37
7473536|NCT01961882|11777666|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
7473537|NCT01961882|11777667|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
7473538|NCT01961882|11777666|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
7473539|NCT01961882|11777667|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
7473540|NCT01962103|11777697|FG000|Phase 1|Adverse Event|4
7473541|NCT01962103|11777698|FG001|Phase 1|Adverse Event|0
7473542|NCT01962103|11777699|FG002|Phase 1|Adverse Event|2
7473543|NCT01962103|11777700|FG003|Phase 1|Adverse Event|1
7473544|NCT01962103|11777701|FG004|Phase 1|Adverse Event|2
7473545|NCT01962103|11777702|FG005|Phase 1|Adverse Event|2
7473546|NCT01962103|11777703|FG006|Phase 1|Adverse Event|0
7473547|NCT01962103|11777704|FG007|Phase 1|Adverse Event|0
7473548|NCT01962103|11777705|FG008|Phase 1|Adverse Event|0
7473549|NCT01962103|11777697|FG000|Phase 1|Progressive Disease|8
7473550|NCT01962103|11777698|FG001|Phase 1|Progressive Disease|6
7473551|NCT01962103|11777699|FG002|Phase 1|Progressive Disease|8
7473552|NCT01962103|11777700|FG003|Phase 1|Progressive Disease|4
7473553|NCT01962103|11777701|FG004|Phase 1|Progressive Disease|5
7473554|NCT01962103|11777702|FG005|Phase 1|Progressive Disease|4
7473555|NCT01962103|11777703|FG006|Phase 1|Progressive Disease|0
7473556|NCT01962103|11777704|FG007|Phase 1|Progressive Disease|0
7473557|NCT01962103|11777705|FG008|Phase 1|Progressive Disease|0
7473558|NCT01962103|11777697|FG000|Phase 1|Withdrawal by Subject|0
7473559|NCT01962103|11777698|FG001|Phase 1|Withdrawal by Subject|0
7473560|NCT01962103|11777699|FG002|Phase 1|Withdrawal by Subject|0
7473561|NCT01962103|11777700|FG003|Phase 1|Withdrawal by Subject|2
7473562|NCT01962103|11777701|FG004|Phase 1|Withdrawal by Subject|0
7473563|NCT01962103|11777702|FG005|Phase 1|Withdrawal by Subject|0
7473564|NCT01962103|11777703|FG006|Phase 1|Withdrawal by Subject|0
7473565|NCT01962103|11777704|FG007|Phase 1|Withdrawal by Subject|0
7473566|NCT01962103|11777705|FG008|Phase 1|Withdrawal by Subject|0
7473567|NCT01962103|11777697|FG000|Phase 1|Withdrawal by Parent/Guardian|0
7473568|NCT01962103|11777698|FG001|Phase 1|Withdrawal by Parent/Guardian|0
7473569|NCT01962103|11777699|FG002|Phase 1|Withdrawal by Parent/Guardian|2
7473570|NCT01962103|11777700|FG003|Phase 1|Withdrawal by Parent/Guardian|1
7473571|NCT01962103|11777701|FG004|Phase 1|Withdrawal by Parent/Guardian|0
7473572|NCT01962103|11777702|FG005|Phase 1|Withdrawal by Parent/Guardian|0
7473573|NCT01962103|11777703|FG006|Phase 1|Withdrawal by Parent/Guardian|0
7473574|NCT01962103|11777704|FG007|Phase 1|Withdrawal by Parent/Guardian|0
7473575|NCT01962103|11777705|FG008|Phase 1|Withdrawal by Parent/Guardian|0
7473576|NCT01962103|11777697|FG000|Phase 1|Physician Decision|0
7473577|NCT01962103|11777698|FG001|Phase 1|Physician Decision|0
7473578|NCT01962103|11777699|FG002|Phase 1|Physician Decision|0
7473579|NCT01962103|11777700|FG003|Phase 1|Physician Decision|1
7473580|NCT01962103|11777701|FG004|Phase 1|Physician Decision|0
7473581|NCT01962103|11777702|FG005|Phase 1|Physician Decision|0
7473582|NCT01962103|11777703|FG006|Phase 1|Physician Decision|0
7473583|NCT01962103|11777704|FG007|Phase 1|Physician Decision|0
7473584|NCT01962103|11777705|FG008|Phase 1|Physician Decision|0
7473585|NCT01962103|11777697|FG000|Phase 1|Symptomatic Deterioration|3
7473586|NCT01962103|11777698|FG001|Phase 1|Symptomatic Deterioration|2
7473587|NCT01962103|11777699|FG002|Phase 1|Symptomatic Deterioration|2
7473588|NCT01962103|11777700|FG003|Phase 1|Symptomatic Deterioration|2
7473589|NCT01962103|11777701|FG004|Phase 1|Symptomatic Deterioration|1
7473590|NCT01962103|11777702|FG005|Phase 1|Symptomatic Deterioration|1
7473591|NCT01962103|11777703|FG006|Phase 1|Symptomatic Deterioration|0
7473592|NCT01962103|11777704|FG007|Phase 1|Symptomatic Deterioration|0
7473593|NCT01962103|11777705|FG008|Phase 1|Symptomatic Deterioration|0
7473594|NCT01962103|11777697|FG000|Phase 1|Miscellaneous|1
7473595|NCT01962103|11777698|FG001|Phase 1|Miscellaneous|0
7473596|NCT01962103|11777699|FG002|Phase 1|Miscellaneous|0
7473597|NCT01962103|11777700|FG003|Phase 1|Miscellaneous|0
7473598|NCT01962103|11777701|FG004|Phase 1|Miscellaneous|0
7473599|NCT01962103|11777702|FG005|Phase 1|Miscellaneous|0
7473600|NCT01962103|11777703|FG006|Phase 1|Miscellaneous|0
7473601|NCT01962103|11777704|FG007|Phase 1|Miscellaneous|0
7473602|NCT01962103|11777705|FG008|Phase 1|Miscellaneous|0
7473603|NCT01962103|11777697|FG000|Phase 2|Adverse Event|0
7473604|NCT01962103|11777698|FG001|Phase 2|Adverse Event|0
7473605|NCT01962103|11777699|FG002|Phase 2|Adverse Event|0
7473606|NCT01962103|11777700|FG003|Phase 2|Adverse Event|0
7473607|NCT01962103|11777701|FG004|Phase 2|Adverse Event|0
7473608|NCT01962103|11777702|FG005|Phase 2|Adverse Event|0
7473609|NCT01962103|11777703|FG006|Phase 2|Adverse Event|1
7473610|NCT01962103|11777704|FG007|Phase 2|Adverse Event|0
7473611|NCT01962103|11777705|FG008|Phase 2|Adverse Event|3
7473612|NCT01962103|11777697|FG000|Phase 2|Progressive Disease|0
7473613|NCT01962103|11777698|FG001|Phase 2|Progressive Disease|0
7473614|NCT01962103|11777699|FG002|Phase 2|Progressive Disease|0
7473615|NCT01962103|11777700|FG003|Phase 2|Progressive Disease|0
7473616|NCT01962103|11777701|FG004|Phase 2|Progressive Disease|0
7473617|NCT01962103|11777702|FG005|Phase 2|Progressive Disease|0
7473618|NCT01962103|11777703|FG006|Phase 2|Progressive Disease|11
7473619|NCT01962103|11777704|FG007|Phase 2|Progressive Disease|12
7473620|NCT01962103|11777705|FG008|Phase 2|Progressive Disease|11
7473621|NCT01962103|11777697|FG000|Phase 2|Symptomatic Deterioration|0
7473622|NCT01962103|11777698|FG001|Phase 2|Symptomatic Deterioration|0
7473623|NCT01962103|11777699|FG002|Phase 2|Symptomatic Deterioration|0
7473624|NCT01962103|11777700|FG003|Phase 2|Symptomatic Deterioration|0
7473625|NCT01962103|11777701|FG004|Phase 2|Symptomatic Deterioration|0
7473626|NCT01962103|11777702|FG005|Phase 2|Symptomatic Deterioration|0
7473627|NCT01962103|11777703|FG006|Phase 2|Symptomatic Deterioration|2
7473628|NCT01962103|11777704|FG007|Phase 2|Symptomatic Deterioration|2
7473629|NCT01962103|11777705|FG008|Phase 2|Symptomatic Deterioration|0
7473630|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
7473631|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
7473632|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
7473633|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
7473634|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
7473635|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
7473636|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
7473637|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
7473638|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
7473639|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
7473640|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
7473641|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
7473642|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7473643|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
7473644|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
7473645|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
7473646|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Adverse Event|0
7473647|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Adverse Event|0
7473648|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Adverse Event|1
7473649|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Adverse Event|0
7473650|NCT01962207|11777729|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
7473651|NCT01962207|11777730|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
7473652|NCT01962207|11777731|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
7473653|NCT01962207|11777732|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
7473654|NCT01962298|11777751|FG000|Overall Study|Protocol Violation|1
7473655|NCT01962298|11777752|FG001|Overall Study|Protocol Violation|0
7473656|NCT01962298|11777753|FG002|Overall Study|Protocol Violation|1
7473657|NCT01962298|11777754|FG003|Overall Study|Protocol Violation|1
7473658|NCT01962298|11777755|FG004|Overall Study|Protocol Violation|0
7473659|NCT01962298|11777751|FG000|Overall Study|Data quality insufficient|2
7473660|NCT01962298|11777752|FG001|Overall Study|Data quality insufficient|0
7473661|NCT01962298|11777753|FG002|Overall Study|Data quality insufficient|3
7473662|NCT01962298|11777754|FG003|Overall Study|Data quality insufficient|1
7473663|NCT01962298|11777755|FG004|Overall Study|Data quality insufficient|4
7473664|NCT01962298|11777751|FG000|Overall Study|Insufficient data|0
7473665|NCT01962298|11777752|FG001|Overall Study|Insufficient data|2
7473666|NCT01962298|11777753|FG002|Overall Study|Insufficient data|1
7473667|NCT01962298|11777754|FG003|Overall Study|Insufficient data|0
7473668|NCT01962298|11777755|FG004|Overall Study|Insufficient data|1
7473669|NCT01962298|11777751|FG000|Overall Study|Incorrect data recorded|0
7473670|NCT01962298|11777752|FG001|Overall Study|Incorrect data recorded|1
7473671|NCT01962298|11777753|FG002|Overall Study|Incorrect data recorded|0
7473672|NCT01962298|11777754|FG003|Overall Study|Incorrect data recorded|0
7473673|NCT01962298|11777755|FG004|Overall Study|Incorrect data recorded|0
7473674|NCT01962298|11777751|FG000|Overall Study|Physician Decision|0
7473675|NCT01962298|11777752|FG001|Overall Study|Physician Decision|1
7473676|NCT01962298|11777753|FG002|Overall Study|Physician Decision|0
7473677|NCT01962298|11777754|FG003|Overall Study|Physician Decision|0
7473678|NCT01962298|11777755|FG004|Overall Study|Physician Decision|1
7473679|NCT01962441|11777779|FG000|Randomized Period|Randomized but Never Treated|4
7473680|NCT01962441|11777780|FG001|Randomized Period|Randomized but Never Treated|2
7473681|NCT01962441|11777781|FG002|Randomized Period|Randomized but Never Treated|3
7473682|NCT01962441|11777779|FG000|Randomized Period|Lost to Follow-up|2
7473683|NCT01962441|11777780|FG001|Randomized Period|Lost to Follow-up|4
7473684|NCT01962441|11777781|FG002|Randomized Period|Lost to Follow-up|4
7473685|NCT01962441|11777779|FG000|Randomized Period|Withdrew Consent|3
7473686|NCT01962441|11777780|FG001|Randomized Period|Withdrew Consent|3
7473687|NCT01962441|11777781|FG002|Randomized Period|Withdrew Consent|2
7473688|NCT01962441|11777779|FG000|Randomized Period|Adverse Event|1
7473689|NCT01962441|11777780|FG001|Randomized Period|Adverse Event|1
7473690|NCT01962441|11777781|FG002|Randomized Period|Adverse Event|0
7473691|NCT01962441|11777779|FG000|Randomized Period|Death|0
7473692|NCT01962441|11777780|FG001|Randomized Period|Death|0
7473693|NCT01962441|11777781|FG002|Randomized Period|Death|2
7473694|NCT01962441|11777779|FG000|Randomized Period|Protocol Violation|0
7473695|NCT01962441|11777780|FG001|Randomized Period|Protocol Violation|1
7473696|NCT01962441|11777781|FG002|Randomized Period|Protocol Violation|0
7473697|NCT01962441|11777779|FG000|Retreatment Substudy|Lack of Efficacy|1
7473698|NCT01962441|11777780|FG001|Retreatment Substudy|Lack of Efficacy|0
7473699|NCT01962441|11777781|FG002|Retreatment Substudy|Lack of Efficacy|0
7473700|NCT01962441|11777779|FG000|Retreatment Substudy|Lost to Follow-up|1
7473701|NCT01962441|11777780|FG001|Retreatment Substudy|Lost to Follow-up|0
7473702|NCT01962441|11777781|FG002|Retreatment Substudy|Lost to Follow-up|0
7473703|NCT01962493|11777792|FG000|Overall Study|Adverse Event|1
7473704|NCT01962493|11777793|FG001|Overall Study|Adverse Event|2
7473705|NCT01962493|11777792|FG000|Overall Study|Protocol Violation|0
7473706|NCT01962493|11777793|FG001|Overall Study|Protocol Violation|1
7473707|NCT01962493|11777792|FG000|Overall Study|Withdrawal by Subject|4
7473708|NCT01962493|11777793|FG001|Overall Study|Withdrawal by Subject|2
7473709|NCT01962896|11777835|FG000|Overall Study|Lack of Efficacy|4
7473710|NCT01962922|11777842|FG000|PK Portion Day 7|Withdrawal by Subject|3
7473711|NCT01962922|11777843|FG001|PK Portion Day 7|Withdrawal by Subject|0
7473712|NCT01962922|11777842|FG000|PK Portion Day 7|non-compliance|1
7473713|NCT01962922|11777843|FG001|PK Portion Day 7|non-compliance|0
7473714|NCT01962922|11777842|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
7473715|NCT01962922|11777843|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
7473716|NCT01962922|11777842|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
7473717|NCT01962922|11777843|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
7473718|NCT01962987|11777865|FG000|Overall Study|Adverse Event|4
7473719|NCT01962987|11777866|FG001|Overall Study|Adverse Event|4
7473720|NCT01962987|11777867|FG002|Overall Study|Adverse Event|0
7473721|NCT01962987|11777865|FG000|Overall Study|Lost to Follow-up|0
7473722|NCT01962987|11777866|FG001|Overall Study|Lost to Follow-up|0
7473723|NCT01962987|11777867|FG002|Overall Study|Lost to Follow-up|1
7473724|NCT01962987|11777865|FG000|Overall Study|Non compliance with dosing requirements|4
7473725|NCT01962987|11777866|FG001|Overall Study|Non compliance with dosing requirements|2
7473726|NCT01962987|11777867|FG002|Overall Study|Non compliance with dosing requirements|0
7473727|NCT01962987|11777865|FG000|Overall Study|Miscellaneous|1
7473728|NCT01962987|11777866|FG001|Overall Study|Miscellaneous|9
7473729|NCT01962987|11777867|FG002|Overall Study|Miscellaneous|2
7473730|NCT01962987|11777865|FG000|Overall Study|Restricted medication|5
7473731|NCT01962987|11777866|FG001|Overall Study|Restricted medication|1
7473732|NCT01962987|11777867|FG002|Overall Study|Restricted medication|1
7473733|NCT01962987|11777865|FG000|Overall Study|Serious Adverse Event|1
7473734|NCT01962987|11777866|FG001|Overall Study|Serious Adverse Event|0
7473735|NCT01962987|11777867|FG002|Overall Study|Serious Adverse Event|0
7473736|NCT01962987|11777865|FG000|Overall Study|Withdrawal by Subject|11
7473737|NCT01962987|11777866|FG001|Overall Study|Withdrawal by Subject|10
7473738|NCT01962987|11777867|FG002|Overall Study|Withdrawal by Subject|6
7473739|NCT01962987|11777865|FG000|Overall Study|Randomized in Error|4
7473740|NCT01962987|11777866|FG001|Overall Study|Randomized in Error|2
7473741|NCT01962987|11777867|FG002|Overall Study|Randomized in Error|2
7473742|NCT01963117|11777901|FG000|Overall Study|Death|1
7473743|NCT01963260|11777955|FG000|Overall Study|Withdrawal by Subject|2
7473744|NCT01963260|11777956|FG001|Overall Study|Withdrawal by Subject|0
7473745|NCT01963260|11777957|FG002|Overall Study|Withdrawal by Subject|0
7473746|NCT01963260|11777958|FG003|Overall Study|Withdrawal by Subject|1
7473747|NCT01963260|11777959|FG004|Overall Study|Withdrawal by Subject|2
7473748|NCT01963260|11777960|FG005|Overall Study|Withdrawal by Subject|0
7473749|NCT01963260|11777961|FG006|Overall Study|Withdrawal by Subject|0
7473750|NCT01963260|11777962|FG007|Overall Study|Withdrawal by Subject|0
7473751|NCT01963260|11777963|FG008|Overall Study|Withdrawal by Subject|0
7473752|NCT01963260|11777964|FG009|Overall Study|Withdrawal by Subject|0
7473753|NCT01963403|11777995|FG000|Overall Study|Lost to Follow-up|2
7473754|NCT01963403|11777996|FG001|Overall Study|Lost to Follow-up|3
7473755|NCT01963403|11777995|FG000|Overall Study|Implant removal|0
7473756|NCT01963403|11777996|FG001|Overall Study|Implant removal|1
7473757|NCT01963611|11778013|FG000|Overall Study|Adverse Event|1
7473758|NCT01963611|11778014|FG001|Overall Study|Adverse Event|1
7473759|NCT01963611|11778015|FG002|Overall Study|Adverse Event|3
7473760|NCT01963611|11778016|FG003|Overall Study|Adverse Event|4
7473761|NCT01963611|11778017|FG004|Overall Study|Adverse Event|3
7473762|NCT01963611|11778013|FG000|Overall Study|Protocol Violation|0
7473763|NCT01963611|11778014|FG001|Overall Study|Protocol Violation|0
7473764|NCT01963611|11778015|FG002|Overall Study|Protocol Violation|0
7473765|NCT01963611|11778016|FG003|Overall Study|Protocol Violation|1
7473766|NCT01963611|11778017|FG004|Overall Study|Protocol Violation|0
7473767|NCT01963611|11778013|FG000|Overall Study|Lack of Efficacy|0
7473768|NCT01963611|11778014|FG001|Overall Study|Lack of Efficacy|0
7473769|NCT01963611|11778015|FG002|Overall Study|Lack of Efficacy|0
7473770|NCT01963611|11778016|FG003|Overall Study|Lack of Efficacy|1
7473771|NCT01963611|11778017|FG004|Overall Study|Lack of Efficacy|0
7473772|NCT01963611|11778013|FG000|Overall Study|Withdrawal by Subject|3
7473773|NCT01963611|11778014|FG001|Overall Study|Withdrawal by Subject|2
7473774|NCT01963611|11778015|FG002|Overall Study|Withdrawal by Subject|1
7473775|NCT01963611|11778016|FG003|Overall Study|Withdrawal by Subject|1
7473776|NCT01963611|11778017|FG004|Overall Study|Withdrawal by Subject|3
7473777|NCT01963611|11778013|FG000|Overall Study|Other|47
7473778|NCT01963611|11778014|FG001|Overall Study|Other|46
7473779|NCT01963611|11778015|FG002|Overall Study|Other|48
7473780|NCT01963611|11778016|FG003|Overall Study|Other|45
7473781|NCT01963611|11778017|FG004|Overall Study|Other|45
7473782|NCT01963676|11778032|FG000|Overall Study|Withdrawal by Subject|1
7473783|NCT01963676|11778033|FG001|Overall Study|Withdrawal by Subject|0
7473784|NCT01963767|11778041|FG000|Overall Study|Withdrawal by Subject|4
7473785|NCT01963767|11778042|FG001|Overall Study|Withdrawal by Subject|2
7473786|NCT01963767|11778041|FG000|Overall Study|Adverse Event|2
7473787|NCT01963767|11778042|FG001|Overall Study|Adverse Event|0
7473788|NCT01964105|11778100|FG000|Overall Study|Lost to Follow-up|2
7473789|NCT01964105|11778101|FG001|Overall Study|Lost to Follow-up|13
7473790|NCT01964105|11778102|FG002|Overall Study|Lost to Follow-up|0
7473791|NCT01964222|11778112|FG000|Overall Study|Lost to Follow-up|7
7473792|NCT01964222|11778113|FG001|Overall Study|Lost to Follow-up|5
7473793|NCT01964222|11778112|FG000|Overall Study|Withdrawal by Subject|6
7473794|NCT01964222|11778113|FG001|Overall Study|Withdrawal by Subject|6
7473795|NCT01964222|11778112|FG000|Overall Study|Screening Failure|2
7473796|NCT01964222|11778113|FG001|Overall Study|Screening Failure|0
7473797|NCT01964300|11778121|FG000|Overall Study|Ineligible after enrollment|0
7473798|NCT01964300|11778122|FG001|Overall Study|Ineligible after enrollment|1
7473799|NCT01964300|11778121|FG000|Overall Study|Adverse Event|1
7473800|NCT01964300|11778122|FG001|Overall Study|Adverse Event|1
7473801|NCT01964300|11778121|FG000|Overall Study|Lack of Efficacy|3
7473802|NCT01964300|11778122|FG001|Overall Study|Lack of Efficacy|5
7473803|NCT01964300|11778121|FG000|Overall Study|Withdrawal by Subject|0
7473804|NCT01964300|11778122|FG001|Overall Study|Withdrawal by Subject|1
7473805|NCT01964300|11778121|FG000|Overall Study|To receive alternative therapy|1
7473806|NCT01964300|11778122|FG001|Overall Study|To receive alternative therapy|2
7473807|NCT01964300|11778121|FG000|Overall Study|Enlargement of cyst requiring drainage|1
7473808|NCT01964300|11778122|FG001|Overall Study|Enlargement of cyst requiring drainage|0
7473809|NCT01964300|11778121|FG000|Overall Study|Weight criteria not met|0
7473810|NCT01964300|11778122|FG001|Overall Study|Weight criteria not met|1
7473811|NCT01964326|11778128|FG000|Overall Study|Adverse Event|48
7473812|NCT01964326|11778128|FG000|Overall Study|Death|2
7473813|NCT01964326|11778128|FG000|Overall Study|Protocol Violation|4
7473814|NCT01964326|11778128|FG000|Overall Study|Lost to Follow-up|88
7473815|NCT01964326|11778128|FG000|Overall Study|Withdrawal by Subject|87
7473816|NCT01964326|11778128|FG000|Overall Study|Pregnancy|1
7473817|NCT01964326|11778128|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
7473818|NCT01964326|11778128|FG000|Overall Study|Physician Decision|55
7473819|NCT01964326|11778128|FG000|Overall Study|Investigator Discretion|1
7473820|NCT01964326|11778128|FG000|Overall Study|Other|9
7473821|NCT01964326|11778128|FG000|Overall Study|Did not meet eligibility criteria|1
7473822|NCT01964352|11778136|FG000|Overall Study|Adverse Event|13
7473823|NCT01964352|11778137|FG001|Overall Study|Adverse Event|3
7473824|NCT01964352|11778138|FG002|Overall Study|Adverse Event|4
7473825|NCT01964352|11778139|FG003|Overall Study|Adverse Event|3
7473826|NCT01964352|11778136|FG000|Overall Study|Lack of Efficacy|6
7473827|NCT01964352|11778137|FG001|Overall Study|Lack of Efficacy|0
7473828|NCT01964352|11778138|FG002|Overall Study|Lack of Efficacy|0
7473829|NCT01964352|11778139|FG003|Overall Study|Lack of Efficacy|0
7473830|NCT01964352|11778136|FG000|Overall Study|Protocol Violation|2
7473831|NCT01964352|11778137|FG001|Overall Study|Protocol Violation|4
7473832|NCT01964352|11778138|FG002|Overall Study|Protocol Violation|0
7473833|NCT01964352|11778139|FG003|Overall Study|Protocol Violation|2
7473834|NCT01964352|11778136|FG000|Overall Study|Lost to Follow-up|1
7473835|NCT01964352|11778137|FG001|Overall Study|Lost to Follow-up|0
7473836|NCT01964352|11778138|FG002|Overall Study|Lost to Follow-up|0
7473837|NCT01964352|11778139|FG003|Overall Study|Lost to Follow-up|1
7473838|NCT01964352|11778136|FG000|Overall Study|Withdrawal by Subject|4
7473839|NCT01964352|11778137|FG001|Overall Study|Withdrawal by Subject|2
7473840|NCT01964352|11778138|FG002|Overall Study|Withdrawal by Subject|1
7473841|NCT01964352|11778139|FG003|Overall Study|Withdrawal by Subject|0
7473842|NCT01964352|11778136|FG000|Overall Study|Other than stated above|0
7473843|NCT01964352|11778137|FG001|Overall Study|Other than stated above|2
7473844|NCT01964352|11778138|FG002|Overall Study|Other than stated above|1
7473845|NCT01964352|11778139|FG003|Overall Study|Other than stated above|2
7473846|NCT01964378|11778151|FG000|Overall Study|Disc. due to death before first dosing|0
7473847|NCT01964378|11778152|FG001|Overall Study|Disc. due to death before first dosing|1
7473848|NCT01964378|11778151|FG000|Overall Study|Disc. due to AE before first dosing|1
7473849|NCT01964378|11778152|FG001|Overall Study|Disc. due to AE before first dosing|0
7473850|NCT01964378|11778151|FG000|Overall Study|Death|3
7473851|NCT01964378|11778152|FG001|Overall Study|Death|2
7473852|NCT01964378|11778151|FG000|Overall Study|Adverse Event|12
7473853|NCT01964378|11778152|FG001|Overall Study|Adverse Event|5
7473854|NCT01964378|11778151|FG000|Overall Study|Lack of Efficacy|0
7473855|NCT01964378|11778152|FG001|Overall Study|Lack of Efficacy|1
7473856|NCT01964378|11778151|FG000|Overall Study|Protocol Violation|0
7473857|NCT01964378|11778152|FG001|Overall Study|Protocol Violation|1
7473858|NCT01964378|11778151|FG000|Overall Study|Lost to Follow-up|0
7473859|NCT01964378|11778152|FG001|Overall Study|Lost to Follow-up|1
7473860|NCT01964378|11778151|FG000|Overall Study|Withdrawal by Subject|7
7473861|NCT01964378|11778152|FG001|Overall Study|Withdrawal by Subject|5
7473862|NCT01964378|11778151|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7473863|NCT01964378|11778152|FG001|Overall Study|Inclusion/exclusion criteria not met|3
7473864|NCT01964378|11778151|FG000|Overall Study|Other|1
7473865|NCT01964378|11778152|FG001|Overall Study|Other|2
7473882|NCT01964521|11778167|FG000|Overall Study|Lost to Follow-up|4
7473883|NCT01964547|11778174|FG000|Overall Study|Adverse Event|8
7473884|NCT01964547|11778175|FG001|Overall Study|Adverse Event|2
7473885|NCT01964547|11778174|FG000|Overall Study|Withdrawal by Subject|4
7473886|NCT01964547|11778175|FG001|Overall Study|Withdrawal by Subject|7
7473887|NCT01964547|11778174|FG000|Overall Study|Lost to Follow-up|0
7473888|NCT01964547|11778175|FG001|Overall Study|Lost to Follow-up|1
7473889|NCT01964547|11778174|FG000|Overall Study|Withdrawal by Investigator|0
7473890|NCT01964547|11778175|FG001|Overall Study|Withdrawal by Investigator|1
7473891|NCT01964716|11778183|FG000|Overall Study|Withdrawal by Subject|2
7473892|NCT01964716|11778184|FG001|Overall Study|Withdrawal by Subject|3
7473893|NCT01964716|11778183|FG000|Overall Study|Lost to Follow-up|1
7473894|NCT01964716|11778184|FG001|Overall Study|Lost to Follow-up|2
7473895|NCT01964716|11778183|FG000|Overall Study|No longer met eligibility criteria|1
7473896|NCT01964716|11778184|FG001|Overall Study|No longer met eligibility criteria|1
7473897|NCT01964716|11778183|FG000|Overall Study|Death|1
7473898|NCT01964716|11778184|FG001|Overall Study|Death|0
7473899|NCT01964755|11778198|FG000|Overall Study|Death|2
7473900|NCT01964898|11778204|FG000|Overall Study|ineligible post-randomization|1
7473901|NCT01964898|11778205|FG001|Overall Study|ineligible post-randomization|1
7473902|NCT01964898|11778204|FG000|Overall Study|did not receive the allocated interventi|2
7473903|NCT01964898|11778205|FG001|Overall Study|did not receive the allocated interventi|1
7473904|NCT01964898|11778204|FG000|Overall Study|Lost to Follow-up|3
7473905|NCT01964898|11778205|FG001|Overall Study|Lost to Follow-up|5
7473906|NCT01964898|11778204|FG000|Overall Study|Withdrawal by Subject|1
7473907|NCT01964898|11778205|FG001|Overall Study|Withdrawal by Subject|0
7473908|NCT01964924|11778211|FG000|Trametinib Monotherapy|Progression|19
7473909|NCT01964924|11778212|FG001|Trametinib Monotherapy|Progression|0
7473910|NCT01964950|11778223|FG000|Overall Study|Protocol Violation|25
7473911|NCT01964963|11778230|FG000|Overall Study|Case Report Forms Uncollected|888
7473912|NCT01964963|11778230|FG000|Overall Study|Protocol Deviation|50
7473913|NCT01964963|11778230|FG000|Overall Study|Data Reliability was not Assured|5
7473914|NCT01964976|11778236|FG000|Overall Study|Protocol Violation|31
7473915|NCT01965158|11778260|FG000|Overall Study|Adverse Event|14
7473916|NCT01965158|11778261|FG001|Overall Study|Adverse Event|5
7473917|NCT01965158|11778260|FG000|Overall Study|Withdrawal by Subject|16
7473918|NCT01965158|11778261|FG001|Overall Study|Withdrawal by Subject|24
7473919|NCT01965158|11778260|FG000|Overall Study|Lost to Follow-up|7
7473920|NCT01965158|11778261|FG001|Overall Study|Lost to Follow-up|5
7473921|NCT01965158|11778260|FG000|Overall Study|Protocol Violation|1
7473922|NCT01965158|11778261|FG001|Overall Study|Protocol Violation|1
7473923|NCT01965158|11778260|FG000|Overall Study|Other - Miscellaneous|3
7473924|NCT01965158|11778261|FG001|Overall Study|Other - Miscellaneous|0
7473925|NCT01965262|11778267|FG000|Second Intervention (7 Days)|Discontinued|0
7473926|NCT01965262|11778268|FG001|Second Intervention (7 Days)|Discontinued|1
7473927|NCT01965262|11778267|FG000|Second Intervention (7 Days)|Poor lens fit|0
7473928|NCT01965262|11778268|FG001|Second Intervention (7 Days)|Poor lens fit|9
7473929|NCT01965262|11778267|FG000|Second Intervention (7 Days)|Poor visual acuity|1
7473930|NCT01965262|11778268|FG001|Second Intervention (7 Days)|Poor visual acuity|0
7473931|NCT01965327|11778295|FG000|Overall Study|Physician Decision|2
7473932|NCT01965431|11778308|FG000|Overall Study|Adverse Event|0
7473933|NCT01965431|11778309|FG001|Overall Study|Adverse Event|1
7473934|NCT01965431|11778310|FG002|Overall Study|Adverse Event|0
7317645|NCT00723840|11546640|FG000|Overall Study|Other Medical Event|2
7317646|NCT00723840|11546640|FG000|Overall Study|Unspecified reason|2
7473935|NCT01965431|11778311|FG003|Overall Study|Adverse Event|0
7473936|NCT01965431|11778312|FG004|Overall Study|Adverse Event|0
7473937|NCT01965431|11778313|FG005|Overall Study|Adverse Event|0
7473938|NCT01965431|11778308|FG000|Overall Study|Other than stated above|6
7473939|NCT01965431|11778309|FG001|Overall Study|Other than stated above|5
7473940|NCT01965431|11778310|FG002|Overall Study|Other than stated above|6
7473941|NCT01965431|11778311|FG003|Overall Study|Other than stated above|6
7473942|NCT01965431|11778312|FG004|Overall Study|Other than stated above|6
7473943|NCT01965431|11778313|FG005|Overall Study|Other than stated above|6
7473944|NCT01965535|11778325|FG000|Overall Study|Lack of Efficacy|2
7473945|NCT01965535|11778326|FG001|Overall Study|Lack of Efficacy|1
7473946|NCT01965600|11778339|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7473947|NCT01965600|11778340|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
7473948|NCT01965600|11778341|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
7473949|NCT01965600|11778342|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7473950|NCT01965600|11778339|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7473951|NCT01965600|11778340|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
7473952|NCT01965600|11778341|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7473953|NCT01965600|11778342|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7473954|NCT01965600|11778339|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
7473955|NCT01965600|11778340|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7473956|NCT01965600|11778341|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7473957|NCT01965600|11778342|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7473958|NCT01965600|11778339|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
7473959|NCT01965600|11778340|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
7473960|NCT01965600|11778341|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
7473961|NCT01965600|11778342|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
7473962|NCT01965600|11778339|FG000|Second Intervention|Study terminated by Sponsor|0
7473963|NCT01965600|11778340|FG001|Second Intervention|Study terminated by Sponsor|0
7534120|NCT02694523|11880914|FG005|Part A|Protocol Violation|0
7473964|NCT01965600|11778341|FG002|Second Intervention|Study terminated by Sponsor|2
7473965|NCT01965600|11778342|FG003|Second Intervention|Study terminated by Sponsor|2
7473966|NCT01965652|11778352|FG000|Overall Study|Adverse Event|40
7473967|NCT01965652|11778353|FG001|Overall Study|Adverse Event|37
7473968|NCT01965652|11778352|FG000|Overall Study|Withdrawal by Subject|62
7473969|NCT01965652|11778353|FG001|Overall Study|Withdrawal by Subject|69
7473970|NCT01965652|11778352|FG000|Overall Study|Lost to Follow-up|53
7473971|NCT01965652|11778353|FG001|Overall Study|Lost to Follow-up|40
7473972|NCT01965652|11778352|FG000|Overall Study|Protocol Violation|34
7473973|NCT01965652|11778353|FG001|Overall Study|Protocol Violation|38
7473974|NCT01965652|11778352|FG000|Overall Study|Death|3
7473975|NCT01965652|11778353|FG001|Overall Study|Death|4
7473976|NCT01965652|11778352|FG000|Overall Study|Other - Miscellaneous|18
7473977|NCT01965652|11778353|FG001|Overall Study|Other - Miscellaneous|21
7473978|NCT01965652|11778352|FG000|Overall Study|Pregnancy|0
7473979|NCT01965652|11778353|FG001|Overall Study|Pregnancy|1
7473980|NCT01965834|11778376|FG000|Overall Study|Lack of Efficacy|4
7473981|NCT01965860|11778383|FG000|Overall Study|Pregnancy|1
7473982|NCT01965860|11778384|FG001|Overall Study|Pregnancy|0
7473983|NCT01965860|11778385|FG002|Overall Study|Pregnancy|1
7473984|NCT01965860|11778383|FG000|Overall Study|Logistics|1
7473985|NCT01965860|11778384|FG001|Overall Study|Logistics|0
7473986|NCT01965860|11778385|FG002|Overall Study|Logistics|0
7473987|NCT01965938|11778400|FG000|Overall Study|Withdrawal by Subject|1
7473988|NCT01965938|11778401|FG001|Overall Study|Withdrawal by Subject|0
7473989|NCT01966003|11778411|FG000|Overall Study|Death|43
7473990|NCT01966003|11778412|FG001|Overall Study|Death|36
7473991|NCT01966003|11778411|FG000|Overall Study|Protocol Violation|6
7473992|NCT01966003|11778412|FG001|Overall Study|Protocol Violation|4
7473993|NCT01966003|11778411|FG000|Overall Study|Lost to Follow-up|4
7473994|NCT01966003|11778412|FG001|Overall Study|Lost to Follow-up|3
7473995|NCT01966003|11778411|FG000|Overall Study|Physician Decision|12
7473996|NCT01966003|11778412|FG001|Overall Study|Physician Decision|13
7473997|NCT01966003|11778411|FG000|Overall Study|Withdrawal by Subject|29
7473998|NCT01966003|11778412|FG001|Overall Study|Withdrawal by Subject|19
7473999|NCT01966003|11778411|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
7474000|NCT01966003|11778412|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
7474001|NCT01966003|11778411|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
7474002|NCT01966003|11778412|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
7474003|NCT01966003|11778411|FG000|Overall Study|Other|1
7474004|NCT01966003|11778412|FG001|Overall Study|Other|1
7474005|NCT01966042|11778418|FG000|Overall Study|Death|2
7474006|NCT01966068|11778424|FG000|Overall Study|Withdrawal by Subject|57
7474007|NCT01966068|11778424|FG000|Overall Study|Lost to Follow-up|81
7474008|NCT01966107|11778431|FG000|Overall Study|excluded from FAS|21
7474009|NCT01966107|11778432|FG001|Overall Study|excluded from FAS|20
7474010|NCT01966107|11778431|FG000|Overall Study|discontinued treatment|345
7474011|NCT01966107|11778432|FG001|Overall Study|discontinued treatment|372
7474012|NCT01966107|11778431|FG000|Overall Study|due to study closure|164
7474013|NCT01966107|11778432|FG001|Overall Study|due to study closure|186
7474014|NCT01966107|11778431|FG000|Overall Study|withdrew from the study|272
7474015|NCT01966107|11778432|FG001|Overall Study|withdrew from the study|303
7474016|NCT01966120|11778440|FG000|Overall Study|Withdrawal by Subject|0
7474017|NCT01966120|11778441|FG001|Overall Study|Withdrawal by Subject|5
7474018|NCT01966120|11778440|FG000|Overall Study|Lost to Follow-up|1
7474019|NCT01966120|11778441|FG001|Overall Study|Lost to Follow-up|1
7474020|NCT01966432|11778488|FG000|Overall Study|Lost to Follow-up|3
7474021|NCT01966432|11778489|FG001|Overall Study|Lost to Follow-up|2
7474022|NCT01966432|11778490|FG002|Overall Study|Lost to Follow-up|5
7474023|NCT01966432|11778488|FG000|Overall Study|Withdrawal by Subject|1
7474024|NCT01966432|11778489|FG001|Overall Study|Withdrawal by Subject|3
7474025|NCT01966432|11778490|FG002|Overall Study|Withdrawal by Subject|0
7474026|NCT01966432|11778488|FG000|Overall Study|Subject Incarcerated|0
7474027|NCT01966432|11778489|FG001|Overall Study|Subject Incarcerated|0
7474028|NCT01966432|11778490|FG002|Overall Study|Subject Incarcerated|1
7474029|NCT01966432|11778488|FG000|Overall Study|SBIRT program ended|1
7474030|NCT01966432|11778489|FG001|Overall Study|SBIRT program ended|8
7474031|NCT01966432|11778490|FG002|Overall Study|SBIRT program ended|20
7474032|NCT01966445|11778506|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7474033|NCT01966445|11778507|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7474034|NCT01966445|11778508|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7474035|NCT01966445|11778509|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
7474036|NCT01966445|11778510|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7474037|NCT01966445|11778511|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
7474038|NCT01966445|11778512|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
7474039|NCT01966445|11778506|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7474040|NCT01966445|11778507|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7474041|NCT01966445|11778508|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7474042|NCT01966445|11778509|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7474043|NCT01966445|11778510|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
7474044|NCT01966445|11778511|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7474045|NCT01966445|11778512|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
7474046|NCT01966445|11778506|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7474047|NCT01966445|11778507|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7474048|NCT01966445|11778508|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
7474049|NCT01966445|11778509|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7474050|NCT01966445|11778510|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
7474051|NCT01966445|11778511|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7474052|NCT01966445|11778512|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
7474053|NCT01966445|11778506|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474054|NCT01966445|11778507|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474055|NCT01966445|11778508|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474056|NCT01966445|11778509|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474057|NCT01966445|11778510|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474058|NCT01966445|11778511|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
7474059|NCT01966445|11778512|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
7474060|NCT01966445|11778506|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474061|NCT01966445|11778507|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474062|NCT01966445|11778508|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474063|NCT01966445|11778509|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474064|NCT01966445|11778510|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474065|NCT01966445|11778511|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
7474066|NCT01966445|11778512|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
7474067|NCT01967069|11778631|FG000|Overall Study|Adverse Event|2
7474068|NCT01967069|11778632|FG001|Overall Study|Adverse Event|2
7474069|NCT01967069|11778631|FG000|Overall Study|Lost to Follow-up|5
7474070|NCT01967069|11778632|FG001|Overall Study|Lost to Follow-up|2
7474071|NCT01967069|11778631|FG000|Overall Study|Withdrawal by Subject|1
7474072|NCT01967069|11778632|FG001|Overall Study|Withdrawal by Subject|3
7474073|NCT01967069|11778631|FG000|Overall Study|Lack of Efficacy|0
7474074|NCT01967069|11778632|FG001|Overall Study|Lack of Efficacy|1
7474075|NCT01967134|11778654|FG000|Overall Study|Lost to Follow-up|0
7474076|NCT01967134|11778655|FG001|Overall Study|Lost to Follow-up|1
7474077|NCT01967134|11778656|FG002|Overall Study|Lost to Follow-up|0
7474078|NCT01967147|11778666|FG000|Overall Study|Adverse Event|5
7474079|NCT01967147|11778667|FG001|Overall Study|Adverse Event|2
7474080|NCT01967147|11778666|FG000|Overall Study|Lack of Efficacy|1
7474081|NCT01967147|11778667|FG001|Overall Study|Lack of Efficacy|4
7474082|NCT01967147|11778666|FG000|Overall Study|Lost to Follow-up|1
7474083|NCT01967147|11778667|FG001|Overall Study|Lost to Follow-up|2
7474084|NCT01967147|11778666|FG000|Overall Study|Withdrawal by Subject|2
7474085|NCT01967147|11778667|FG001|Overall Study|Withdrawal by Subject|4
7474086|NCT01967147|11778666|FG000|Overall Study|Non-compliance with Study Drug|0
7474087|NCT01967147|11778667|FG001|Overall Study|Non-compliance with Study Drug|3
7474088|NCT01967147|11778666|FG000|Overall Study|Other|4
7474089|NCT01967147|11778667|FG001|Overall Study|Other|5
7474090|NCT01967173|11778682|FG000|Overall Study|Lost to Follow-up|5
7474091|NCT01967173|11778683|FG001|Overall Study|Lost to Follow-up|3
7474092|NCT01967173|11778684|FG002|Overall Study|Lost to Follow-up|2
7474093|NCT01967173|11778685|FG003|Overall Study|Lost to Follow-up|4
7474094|NCT01967173|11778686|FG004|Overall Study|Lost to Follow-up|8
7474095|NCT01967173|11778687|FG005|Overall Study|Lost to Follow-up|12
7474096|NCT01967173|11778688|FG006|Overall Study|Lost to Follow-up|6
7474097|NCT01967173|11778689|FG007|Overall Study|Lost to Follow-up|8
7474098|NCT01967173|11778682|FG000|Overall Study|Physician Decision|2
7474099|NCT01967173|11778683|FG001|Overall Study|Physician Decision|0
7474100|NCT01967173|11778684|FG002|Overall Study|Physician Decision|2
7474101|NCT01967173|11778685|FG003|Overall Study|Physician Decision|1
7474102|NCT01967173|11778686|FG004|Overall Study|Physician Decision|1
7474103|NCT01967173|11778687|FG005|Overall Study|Physician Decision|1
7474104|NCT01967173|11778688|FG006|Overall Study|Physician Decision|1
7474105|NCT01967173|11778689|FG007|Overall Study|Physician Decision|0
7474106|NCT01967173|11778682|FG000|Overall Study|Lack of Efficacy|2
7474107|NCT01967173|11778683|FG001|Overall Study|Lack of Efficacy|0
7474108|NCT01967173|11778684|FG002|Overall Study|Lack of Efficacy|2
7474109|NCT01967173|11778685|FG003|Overall Study|Lack of Efficacy|2
7474110|NCT01967173|11778686|FG004|Overall Study|Lack of Efficacy|0
7474111|NCT01967173|11778687|FG005|Overall Study|Lack of Efficacy|1
7474112|NCT01967173|11778688|FG006|Overall Study|Lack of Efficacy|0
7474113|NCT01967173|11778689|FG007|Overall Study|Lack of Efficacy|2
7474114|NCT01967173|11778682|FG000|Overall Study|Pregnancy|0
7474115|NCT01967173|11778683|FG001|Overall Study|Pregnancy|0
7474116|NCT01967173|11778684|FG002|Overall Study|Pregnancy|0
7474117|NCT01967173|11778685|FG003|Overall Study|Pregnancy|0
7474118|NCT01967173|11778686|FG004|Overall Study|Pregnancy|0
7474119|NCT01967173|11778687|FG005|Overall Study|Pregnancy|0
7474120|NCT01967173|11778688|FG006|Overall Study|Pregnancy|1
7474121|NCT01967173|11778689|FG007|Overall Study|Pregnancy|1
7474122|NCT01967173|11778682|FG000|Overall Study|Adverse Event|0
7474123|NCT01967173|11778683|FG001|Overall Study|Adverse Event|0
7474124|NCT01967173|11778684|FG002|Overall Study|Adverse Event|0
7474125|NCT01967173|11778685|FG003|Overall Study|Adverse Event|0
7474126|NCT01967173|11778686|FG004|Overall Study|Adverse Event|0
7474127|NCT01967173|11778687|FG005|Overall Study|Adverse Event|0
7474128|NCT01967173|11778688|FG006|Overall Study|Adverse Event|0
7474129|NCT01967173|11778689|FG007|Overall Study|Adverse Event|1
7474130|NCT01967173|11778682|FG000|Overall Study|Withdrawal by Subject|15
7474131|NCT01967173|11778683|FG001|Overall Study|Withdrawal by Subject|14
7474132|NCT01967173|11778684|FG002|Overall Study|Withdrawal by Subject|10
7474133|NCT01967173|11778685|FG003|Overall Study|Withdrawal by Subject|7
7474134|NCT01967173|11778686|FG004|Overall Study|Withdrawal by Subject|8
7474135|NCT01967173|11778687|FG005|Overall Study|Withdrawal by Subject|9
7474136|NCT01967173|11778688|FG006|Overall Study|Withdrawal by Subject|10
7474137|NCT01967173|11778689|FG007|Overall Study|Withdrawal by Subject|12
7474138|NCT01967225|11778705|FG000|Overall Study|Adverse Event|3
7474139|NCT01967225|11778706|FG001|Overall Study|Adverse Event|1
7474140|NCT01967225|11778705|FG000|Overall Study|Withdrawal by Subject|2
7474141|NCT01967225|11778706|FG001|Overall Study|Withdrawal by Subject|1
7474142|NCT01967225|11778705|FG000|Overall Study|Lack of Efficacy|1
7474143|NCT01967225|11778706|FG001|Overall Study|Lack of Efficacy|1
7474144|NCT01967225|11778705|FG000|Overall Study|Switching to other therapy|2
7474145|NCT01967225|11778706|FG001|Overall Study|Switching to other therapy|0
7474146|NCT01967225|11778705|FG000|Overall Study|Protocol driven decision point|1
7474147|NCT01967225|11778706|FG001|Overall Study|Protocol driven decision point|0
7474148|NCT01967225|11778705|FG000|Overall Study|Logistical difficulties|1
7474149|NCT01967225|11778706|FG001|Overall Study|Logistical difficulties|0
7474150|NCT01967225|11778705|FG000|Overall Study|Protocol Violation|2
7474151|NCT01967225|11778706|FG001|Overall Study|Protocol Violation|0
7534121|NCT02694523|11880915|FG006|Part A|Protocol Violation|0
7534122|NCT02694523|11880909|FG000|Part A|Lost to Follow-up|1
7534123|NCT02694523|11880910|FG001|Part A|Lost to Follow-up|2
7534124|NCT02694523|11880911|FG002|Part A|Lost to Follow-up|0
7534125|NCT02694523|11880912|FG003|Part A|Lost to Follow-up|0
7534126|NCT02694523|11880913|FG004|Part A|Lost to Follow-up|0
7534127|NCT02694523|11880914|FG005|Part A|Lost to Follow-up|0
7534128|NCT02694523|11880915|FG006|Part A|Lost to Follow-up|0
7534129|NCT02694523|11880909|FG000|Part A|Withdrawal by Subject|3
7534130|NCT02694523|11880910|FG001|Part A|Withdrawal by Subject|1
7534131|NCT02694523|11880911|FG002|Part A|Withdrawal by Subject|0
7534132|NCT02694523|11880912|FG003|Part A|Withdrawal by Subject|0
7534133|NCT02694523|11880913|FG004|Part A|Withdrawal by Subject|0
7534134|NCT02694523|11880914|FG005|Part A|Withdrawal by Subject|0
7534135|NCT02694523|11880915|FG006|Part A|Withdrawal by Subject|0
7534136|NCT02694523|11880909|FG000|Part A|Other|1
7534137|NCT02694523|11880910|FG001|Part A|Other|1
7534138|NCT02694523|11880911|FG002|Part A|Other|0
7534139|NCT02694523|11880912|FG003|Part A|Other|0
7534140|NCT02694523|11880913|FG004|Part A|Other|0
7534141|NCT02694523|11880914|FG005|Part A|Other|0
7534142|NCT02694523|11880915|FG006|Part A|Other|0
7534143|NCT02694523|11880909|FG000|Part B|Adverse Event|0
7534144|NCT02694523|11880910|FG001|Part B|Adverse Event|0
7534145|NCT02694523|11880911|FG002|Part B|Adverse Event|7
7534146|NCT02694523|11880912|FG003|Part B|Adverse Event|1
7534147|NCT02694523|11880913|FG004|Part B|Adverse Event|1
7534148|NCT02694523|11880914|FG005|Part B|Adverse Event|2
7534149|NCT02694523|11880915|FG006|Part B|Adverse Event|0
7534150|NCT02694523|11880909|FG000|Part B|Protocol Violation|0
7534151|NCT02694523|11880910|FG001|Part B|Protocol Violation|0
7534152|NCT02694523|11880911|FG002|Part B|Protocol Violation|1
7534153|NCT02694523|11880912|FG003|Part B|Protocol Violation|0
7534154|NCT02694523|11880913|FG004|Part B|Protocol Violation|0
7534155|NCT02694523|11880914|FG005|Part B|Protocol Violation|0
7534156|NCT02694523|11880915|FG006|Part B|Protocol Violation|0
7534157|NCT02694523|11880909|FG000|Part B|Lost to Follow-up|0
7534158|NCT02694523|11880910|FG001|Part B|Lost to Follow-up|0
7534159|NCT02694523|11880911|FG002|Part B|Lost to Follow-up|2
7534160|NCT02694523|11880912|FG003|Part B|Lost to Follow-up|3
7534161|NCT02694523|11880913|FG004|Part B|Lost to Follow-up|2
7534162|NCT02694523|11880914|FG005|Part B|Lost to Follow-up|0
7534163|NCT02694523|11880915|FG006|Part B|Lost to Follow-up|1
7534164|NCT02694523|11880909|FG000|Part B|Withdrawal by Subject|0
7534165|NCT02694523|11880910|FG001|Part B|Withdrawal by Subject|0
7534166|NCT02694523|11880911|FG002|Part B|Withdrawal by Subject|9
7534167|NCT02694523|11880912|FG003|Part B|Withdrawal by Subject|0
7534168|NCT02694523|11880913|FG004|Part B|Withdrawal by Subject|1
7534169|NCT02694523|11880914|FG005|Part B|Withdrawal by Subject|3
7534170|NCT02694523|11880915|FG006|Part B|Withdrawal by Subject|0
7534171|NCT02694523|11880909|FG000|Part B|Other|0
7534172|NCT02694523|11880910|FG001|Part B|Other|0
7534173|NCT02694523|11880911|FG002|Part B|Other|1
7534174|NCT02694523|11880912|FG003|Part B|Other|0
7534175|NCT02694523|11880913|FG004|Part B|Other|0
7534176|NCT02694523|11880914|FG005|Part B|Other|0
7534177|NCT02694523|11880915|FG006|Part B|Other|1
7534178|NCT02694536|11880927|FG000|Overall Study|Progressive Disease|40
7534179|NCT02694536|11880927|FG000|Overall Study|Lost to Follow-up|1
7534180|NCT02694536|11880927|FG000|Overall Study|Study Drug-Related Adverse Event|1
7534181|NCT02694536|11880927|FG000|Overall Study|Withdrawal by Subject|8
7534182|NCT02694536|11880927|FG000|Overall Study|Death|8
7534183|NCT02694536|11880927|FG000|Overall Study|Other|22
7534184|NCT02694549|11880931|FG000|Overall Study|screen failures|2
7534185|NCT02694562|11880935|FG000|Overall Study|Death|8
7534186|NCT02694562|11880935|FG000|Overall Study|Protocol Violation|4
7534187|NCT02694562|11880935|FG000|Overall Study|Lost to Follow-up|3
7474152|NCT01967277|11778716|FG000|Overall Study|Lost to Follow-up|1
7474153|NCT01967277|11778717|FG001|Overall Study|Lost to Follow-up|2
7474154|NCT01967277|11778716|FG000|Overall Study|Unrelated illness|0
7474155|NCT01967277|11778717|FG001|Overall Study|Unrelated illness|1
7474156|NCT01967537|11778751|FG000|Overall Study|Withdrawal by Subject|52
7474157|NCT01967537|11778751|FG000|Overall Study|Refuse treatment|2
7474158|NCT01967537|11778751|FG000|Overall Study|Lost to Follow-up|6
7474159|NCT01967550|11778757|FG000|Overall Study|Withdrawal by Subject|1
7474160|NCT01967550|11778758|FG001|Overall Study|Withdrawal by Subject|0
7474161|NCT01967550|11778757|FG000|Overall Study|Adverse Event|2
7474162|NCT01967550|11778758|FG001|Overall Study|Adverse Event|0
7474163|NCT01967550|11778757|FG000|Overall Study|Protocol Violation|2
7474164|NCT01967550|11778758|FG001|Overall Study|Protocol Violation|1
7474165|NCT01967550|11778757|FG000|Overall Study|Non Compliance|0
7474166|NCT01967550|11778758|FG001|Overall Study|Non Compliance|1
7474167|NCT01967576|11778764|FG000|Overall Study|Withdrawal by Subject|3
7474168|NCT01967576|11778764|FG000|Overall Study|Progressed/Removed from treatment|1
7474169|NCT01967576|11778764|FG000|Overall Study|Study closing at site|1
7474170|NCT01967576|11778764|FG000|Overall Study|Adverse Event|1
7474171|NCT01967576|11778764|FG000|Overall Study|Refused further treatment|1
7474172|NCT01967628|11778770|FG000|Overall Study|Withdrawal by Subject|2
7474173|NCT01967628|11778771|FG001|Overall Study|Withdrawal by Subject|0
7474174|NCT01967628|11778770|FG000|Overall Study|Unable to complete bronchoscopy|4
7474175|NCT01967628|11778771|FG001|Overall Study|Unable to complete bronchoscopy|6
7474176|NCT01967628|11778770|FG000|Overall Study|Lost to Follow-up|1
7474177|NCT01967628|11778771|FG001|Overall Study|Lost to Follow-up|0
7474178|NCT01967628|11778770|FG000|Overall Study|Low protein concentration in sample|20
7474179|NCT01967628|11778771|FG001|Overall Study|Low protein concentration in sample|25
7474180|NCT01967706|11778784|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7474181|NCT01967706|11778785|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7474182|NCT01967706|11778786|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7474183|NCT01967706|11778787|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7474184|NCT01967719|11778798|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
7474185|NCT01967719|11778799|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
7474186|NCT01967719|11778800|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7474187|NCT01967719|11778801|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7474188|NCT01967719|11778798|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
7474189|NCT01967719|11778799|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
7474190|NCT01967719|11778800|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
7474191|NCT01967719|11778801|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
7474192|NCT01967732|11778813|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7474193|NCT01967732|11778814|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
7474194|NCT01967732|11778815|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7474195|NCT01967732|11778816|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7474196|NCT01967732|11778813|FG000|First Intervention (Day 1)|Poor venous access|0
7474197|NCT01967732|11778814|FG001|First Intervention (Day 1)|Poor venous access|1
7474198|NCT01967732|11778815|FG002|First Intervention (Day 1)|Poor venous access|0
7474199|NCT01967732|11778816|FG003|First Intervention (Day 1)|Poor venous access|0
7474200|NCT01967888|11778839|FG000|Overall Study|Lost to Follow-up|6
7474201|NCT01967888|11778840|FG001|Overall Study|Lost to Follow-up|4
7474202|NCT01967888|11778839|FG000|Overall Study|Withdrawal by Subject|1
7474203|NCT01967888|11778840|FG001|Overall Study|Withdrawal by Subject|1
7474204|NCT01967888|11778839|FG000|Overall Study|Did Not Have Transplant|1
7474205|NCT01967888|11778840|FG001|Overall Study|Did Not Have Transplant|0
7474206|NCT01967888|11778839|FG000|Overall Study|Research visit not done, data recorded|1
7474207|NCT01967888|11778840|FG001|Overall Study|Research visit not done, data recorded|0
7474208|NCT01967888|11778839|FG000|Overall Study|Subject excluded after randomization|1
7474209|NCT01967888|11778840|FG001|Overall Study|Subject excluded after randomization|0
7474210|NCT01967888|11778839|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
7474211|NCT01967888|11778840|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
7474212|NCT01967888|11778839|FG000|Overall Study|Subject Unable To Comply With Final Day|0
7474213|NCT01967888|11778840|FG001|Overall Study|Subject Unable To Comply With Final Day|1
7474214|NCT01967940|11778849|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
7474215|NCT01967940|11778850|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
7474216|NCT01967940|11778851|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
7474217|NCT01967940|11778852|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
7474218|NCT01967940|11778849|FG000|Part 2|Adverse Event|0
7474219|NCT01967940|11778850|FG001|Part 2|Adverse Event|0
7474220|NCT01967940|11778851|FG002|Part 2|Adverse Event|0
7474221|NCT01967940|11778852|FG003|Part 2|Adverse Event|1
7474222|NCT01967940|11778849|FG000|Part 2|Unknown Reason|0
7474223|NCT01967940|11778850|FG001|Part 2|Unknown Reason|0
7474224|NCT01967940|11778851|FG002|Part 2|Unknown Reason|0
7474225|NCT01967940|11778852|FG003|Part 2|Unknown Reason|1
7474226|NCT01968031|11778865|FG000|Overall Study|Adverse Event|13
7474227|NCT01968031|11778866|FG001|Overall Study|Adverse Event|10
7474228|NCT01968031|11778867|FG002|Overall Study|Adverse Event|22
7474229|NCT01968031|11778865|FG000|Overall Study|Withdrawal by Subject|3
7474230|NCT01968031|11778866|FG001|Overall Study|Withdrawal by Subject|7
7474231|NCT01968031|11778867|FG002|Overall Study|Withdrawal by Subject|3
7474232|NCT01968031|11778865|FG000|Overall Study|Did not meet entry criteria|1
7474233|NCT01968031|11778866|FG001|Overall Study|Did not meet entry criteria|1
7474234|NCT01968031|11778867|FG002|Overall Study|Did not meet entry criteria|1
7474235|NCT01968031|11778865|FG000|Overall Study|Noncompliance|0
7474236|NCT01968031|11778866|FG001|Overall Study|Noncompliance|0
7474237|NCT01968031|11778867|FG002|Overall Study|Noncompliance|2
7474238|NCT01968031|11778865|FG000|Overall Study|Failed inclusion criteria|0
7474239|NCT01968031|11778866|FG001|Overall Study|Failed inclusion criteria|2
7474240|NCT01968031|11778867|FG002|Overall Study|Failed inclusion criteria|0
7474241|NCT01968031|11778865|FG000|Overall Study|Death|0
7474242|NCT01968031|11778866|FG001|Overall Study|Death|0
7474243|NCT01968031|11778867|FG002|Overall Study|Death|1
7474244|NCT01968031|11778865|FG000|Overall Study|Prohibited concomitant medication|1
7474245|NCT01968031|11778866|FG001|Overall Study|Prohibited concomitant medication|0
7474246|NCT01968031|11778867|FG002|Overall Study|Prohibited concomitant medication|0
7474247|NCT01968070|11778899|FG000|Period 1|Withdrawal by Subject|0
7474248|NCT01968070|11778900|FG001|Period 1|Withdrawal by Subject|1
7474249|NCT01968070|11778901|FG002|Period 1|Withdrawal by Subject|0
7474250|NCT01968070|11778902|FG003|Period 1|Withdrawal by Subject|0
7474251|NCT01968070|11778903|FG004|Period 1|Withdrawal by Subject|0
7474252|NCT01968070|11778904|FG005|Period 1|Withdrawal by Subject|0
7474253|NCT01968070|11778905|FG006|Period 1|Withdrawal by Subject|1
7474254|NCT01968070|11778906|FG007|Period 1|Withdrawal by Subject|0
7474255|NCT01968070|11778907|FG008|Period 1|Withdrawal by Subject|0
7474256|NCT01968070|11778908|FG009|Period 1|Withdrawal by Subject|0
7474257|NCT01968070|11778909|FG010|Period 1|Withdrawal by Subject|0
7474258|NCT01968070|11778910|FG011|Period 1|Withdrawal by Subject|0
7474259|NCT01968070|11778911|FG012|Period 1|Withdrawal by Subject|0
7474260|NCT01968070|11778912|FG013|Period 1|Withdrawal by Subject|0
7474261|NCT01968070|11778913|FG014|Period 1|Withdrawal by Subject|0
7474262|NCT01968070|11778914|FG015|Period 1|Withdrawal by Subject|1
7474263|NCT01968070|11778915|FG016|Period 1|Withdrawal by Subject|0
7474264|NCT01968070|11778916|FG017|Period 1|Withdrawal by Subject|0
7474265|NCT01968070|11778899|FG000|Period 1|Protocol Violation|0
7474266|NCT01968070|11778900|FG001|Period 1|Protocol Violation|0
7474267|NCT01968070|11778901|FG002|Period 1|Protocol Violation|0
7474268|NCT01968070|11778902|FG003|Period 1|Protocol Violation|1
7474269|NCT01968070|11778903|FG004|Period 1|Protocol Violation|1
7474270|NCT01968070|11778904|FG005|Period 1|Protocol Violation|0
7474271|NCT01968070|11778905|FG006|Period 1|Protocol Violation|0
7474272|NCT01968070|11778906|FG007|Period 1|Protocol Violation|0
7474273|NCT01968070|11778907|FG008|Period 1|Protocol Violation|0
7474274|NCT01968070|11778908|FG009|Period 1|Protocol Violation|0
7474275|NCT01968070|11778909|FG010|Period 1|Protocol Violation|0
7474276|NCT01968070|11778910|FG011|Period 1|Protocol Violation|0
7474277|NCT01968070|11778911|FG012|Period 1|Protocol Violation|0
7474278|NCT01968070|11778912|FG013|Period 1|Protocol Violation|0
7474279|NCT01968070|11778913|FG014|Period 1|Protocol Violation|0
7474280|NCT01968070|11778914|FG015|Period 1|Protocol Violation|0
7474281|NCT01968070|11778915|FG016|Period 1|Protocol Violation|0
7474282|NCT01968070|11778916|FG017|Period 1|Protocol Violation|0
7474283|NCT01968070|11778899|FG000|Period 1|Lost to Follow-up|0
7474284|NCT01968070|11778900|FG001|Period 1|Lost to Follow-up|0
7474285|NCT01968070|11778901|FG002|Period 1|Lost to Follow-up|0
7474286|NCT01968070|11778902|FG003|Period 1|Lost to Follow-up|1
7474287|NCT01968070|11778903|FG004|Period 1|Lost to Follow-up|0
7474288|NCT01968070|11778904|FG005|Period 1|Lost to Follow-up|0
7474289|NCT01968070|11778905|FG006|Period 1|Lost to Follow-up|0
7474290|NCT01968070|11778906|FG007|Period 1|Lost to Follow-up|0
7474291|NCT01968070|11778907|FG008|Period 1|Lost to Follow-up|0
7474292|NCT01968070|11778908|FG009|Period 1|Lost to Follow-up|0
7474293|NCT01968070|11778909|FG010|Period 1|Lost to Follow-up|0
7474294|NCT01968070|11778910|FG011|Period 1|Lost to Follow-up|0
7474295|NCT01968070|11778911|FG012|Period 1|Lost to Follow-up|0
7474296|NCT01968070|11778912|FG013|Period 1|Lost to Follow-up|0
7474297|NCT01968070|11778913|FG014|Period 1|Lost to Follow-up|0
7474298|NCT01968070|11778914|FG015|Period 1|Lost to Follow-up|0
7474299|NCT01968070|11778915|FG016|Period 1|Lost to Follow-up|0
7474300|NCT01968070|11778916|FG017|Period 1|Lost to Follow-up|0
7474301|NCT01968070|11778899|FG000|Period 1|Adverse Event|0
7474302|NCT01968070|11778900|FG001|Period 1|Adverse Event|0
7474303|NCT01968070|11778901|FG002|Period 1|Adverse Event|0
7474304|NCT01968070|11778902|FG003|Period 1|Adverse Event|0
7474305|NCT01968070|11778903|FG004|Period 1|Adverse Event|0
7474306|NCT01968070|11778904|FG005|Period 1|Adverse Event|0
7474307|NCT01968070|11778905|FG006|Period 1|Adverse Event|1
7474308|NCT01968070|11778906|FG007|Period 1|Adverse Event|0
7474309|NCT01968070|11778907|FG008|Period 1|Adverse Event|0
7474310|NCT01968070|11778908|FG009|Period 1|Adverse Event|0
7474311|NCT01968070|11778909|FG010|Period 1|Adverse Event|0
7474312|NCT01968070|11778910|FG011|Period 1|Adverse Event|0
7474313|NCT01968070|11778911|FG012|Period 1|Adverse Event|0
7474314|NCT01968070|11778912|FG013|Period 1|Adverse Event|0
7474315|NCT01968070|11778913|FG014|Period 1|Adverse Event|0
7474316|NCT01968070|11778914|FG015|Period 1|Adverse Event|0
7474317|NCT01968070|11778915|FG016|Period 1|Adverse Event|0
7474318|NCT01968070|11778916|FG017|Period 1|Adverse Event|0
7474319|NCT01968070|11778899|FG000|Period 1|Physician Decision|0
7474320|NCT01968070|11778900|FG001|Period 1|Physician Decision|0
7474321|NCT01968070|11778901|FG002|Period 1|Physician Decision|0
7474322|NCT01968070|11778902|FG003|Period 1|Physician Decision|0
7474323|NCT01968070|11778903|FG004|Period 1|Physician Decision|0
7474324|NCT01968070|11778904|FG005|Period 1|Physician Decision|0
7474325|NCT01968070|11778905|FG006|Period 1|Physician Decision|0
7474326|NCT01968070|11778906|FG007|Period 1|Physician Decision|0
7474327|NCT01968070|11778907|FG008|Period 1|Physician Decision|0
7474328|NCT01968070|11778908|FG009|Period 1|Physician Decision|0
7474329|NCT01968070|11778909|FG010|Period 1|Physician Decision|0
7474330|NCT01968070|11778910|FG011|Period 1|Physician Decision|1
7474331|NCT01968070|11778911|FG012|Period 1|Physician Decision|0
7474332|NCT01968070|11778912|FG013|Period 1|Physician Decision|0
7474333|NCT01968070|11778913|FG014|Period 1|Physician Decision|0
7474334|NCT01968070|11778914|FG015|Period 1|Physician Decision|0
7474335|NCT01968070|11778915|FG016|Period 1|Physician Decision|0
7474336|NCT01968070|11778916|FG017|Period 1|Physician Decision|0
7474337|NCT01968070|11778899|FG000|Period 2|Withdrawal by Subject|0
7474338|NCT01968070|11778900|FG001|Period 2|Withdrawal by Subject|0
7474339|NCT01968070|11778901|FG002|Period 2|Withdrawal by Subject|0
7474340|NCT01968070|11778902|FG003|Period 2|Withdrawal by Subject|0
7474341|NCT01968070|11778903|FG004|Period 2|Withdrawal by Subject|1
7474342|NCT01968070|11778904|FG005|Period 2|Withdrawal by Subject|0
7474343|NCT01968070|11778905|FG006|Period 2|Withdrawal by Subject|0
7474344|NCT01968070|11778906|FG007|Period 2|Withdrawal by Subject|0
7474345|NCT01968070|11778907|FG008|Period 2|Withdrawal by Subject|0
7474346|NCT01968070|11778908|FG009|Period 2|Withdrawal by Subject|0
7474347|NCT01968070|11778909|FG010|Period 2|Withdrawal by Subject|0
7474348|NCT01968070|11778910|FG011|Period 2|Withdrawal by Subject|0
7474349|NCT01968070|11778911|FG012|Period 2|Withdrawal by Subject|0
7474350|NCT01968070|11778912|FG013|Period 2|Withdrawal by Subject|0
7474351|NCT01968070|11778913|FG014|Period 2|Withdrawal by Subject|0
7474352|NCT01968070|11778914|FG015|Period 2|Withdrawal by Subject|0
7474353|NCT01968070|11778915|FG016|Period 2|Withdrawal by Subject|0
7474354|NCT01968070|11778916|FG017|Period 2|Withdrawal by Subject|0
7474355|NCT01968434|11779037|FG000|Overall Study|Lost to Follow-up|3
7474356|NCT01968434|11779038|FG001|Overall Study|Lost to Follow-up|6
7474357|NCT01968551|11779056|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7474441|NCT01968967|11779149|FG004|Treatment Period|Death|0
7474358|NCT01968551|11779057|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7474359|NCT01968551|11779058|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
7474360|NCT01968551|11779056|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7474361|NCT01968551|11779057|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
7474362|NCT01968551|11779058|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
7474363|NCT01968551|11779056|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
7474364|NCT01968551|11779057|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
7474365|NCT01968551|11779058|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
7474366|NCT01968551|11779056|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7474367|NCT01968551|11779057|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7474368|NCT01968551|11779058|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
7474369|NCT01968551|11779056|FG000|Extension Phase|Adverse Event|0
7474370|NCT01968551|11779057|FG001|Extension Phase|Adverse Event|0
7474371|NCT01968551|11779058|FG002|Extension Phase|Adverse Event|2
7474372|NCT01968551|11779056|FG000|Extension Phase|Death|0
7474373|NCT01968551|11779057|FG001|Extension Phase|Death|1
7474374|NCT01968551|11779058|FG002|Extension Phase|Death|0
7474375|NCT01968551|11779056|FG000|Extension Phase|Withdrew Consent|0
7474376|NCT01968551|11779057|FG001|Extension Phase|Withdrew Consent|0
7474377|NCT01968551|11779058|FG002|Extension Phase|Withdrew Consent|1
7474378|NCT01968551|11779056|FG000|Extension Phase|Lost to Follow-up|1
7474379|NCT01968551|11779057|FG001|Extension Phase|Lost to Follow-up|0
7474380|NCT01968551|11779058|FG002|Extension Phase|Lost to Follow-up|1
7474381|NCT01968694|11779072|FG000|Washout (1 Month)|Lost to Follow-up|0
7474382|NCT01968694|11779073|FG001|Washout (1 Month)|Lost to Follow-up|1
7474383|NCT01968707|11779089|FG000|Overall Study|Did not meet treatment day baseline|49
7474384|NCT01968707|11779090|FG001|Overall Study|Did not meet treatment day baseline|12
7474385|NCT01968707|11779091|FG002|Overall Study|Did not meet treatment day baseline|41
7474386|NCT01968707|11779092|FG003|Overall Study|Did not meet treatment day baseline|44
7474387|NCT01968707|11779093|FG004|Overall Study|Did not meet treatment day baseline|36
7474388|NCT01968707|11779094|FG005|Overall Study|Did not meet treatment day baseline|11
7474389|NCT01968707|11779095|FG006|Overall Study|Did not meet treatment day baseline|34
7474390|NCT01968707|11779096|FG007|Overall Study|Did not meet treatment day baseline|35
7474391|NCT01968811|11779129|FG000|Overall Study|Protocol Violation|4
7474392|NCT01968811|11779129|FG000|Overall Study|post op.ref. of subject to other hospita|1
7474393|NCT01968954|11779135|FG000|Overall Study|Adverse Event|6
7474394|NCT01968954|11779136|FG001|Overall Study|Adverse Event|3
7474395|NCT01968954|11779135|FG000|Overall Study|Death|1
7474396|NCT01968954|11779136|FG001|Overall Study|Death|2
7474397|NCT01968954|11779135|FG000|Overall Study|Lost to Follow-up|6
7474398|NCT01968954|11779136|FG001|Overall Study|Lost to Follow-up|4
7474399|NCT01968954|11779135|FG000|Overall Study|Withdrawal by Subject|20
7474400|NCT01968954|11779136|FG001|Overall Study|Withdrawal by Subject|23
7474401|NCT01968954|11779135|FG000|Overall Study|Other|7
7474402|NCT01968954|11779136|FG001|Overall Study|Other|8
7474403|NCT01968954|11779135|FG000|Overall Study|Protocol Violation|0
7474404|NCT01968954|11779136|FG001|Overall Study|Protocol Violation|1
7474405|NCT01968954|11779135|FG000|Overall Study|Did not met inclusion criteria|0
7474406|NCT01968954|11779136|FG001|Overall Study|Did not met inclusion criteria|2
7474407|NCT01968967|11779145|FG000|Treatment Period|Other|22
7474408|NCT01968967|11779146|FG001|Treatment Period|Other|22
7474409|NCT01968967|11779147|FG002|Treatment Period|Other|0
7474410|NCT01968967|11779148|FG003|Treatment Period|Other|0
7474411|NCT01968967|11779149|FG004|Treatment Period|Other|0
7474412|NCT01968967|11779145|FG000|Treatment Period|Withdrawal by Subject|71
7474413|NCT01968967|11779146|FG001|Treatment Period|Withdrawal by Subject|61
7474414|NCT01968967|11779147|FG002|Treatment Period|Withdrawal by Subject|0
7474415|NCT01968967|11779148|FG003|Treatment Period|Withdrawal by Subject|0
7474416|NCT01968967|11779149|FG004|Treatment Period|Withdrawal by Subject|0
7474417|NCT01968967|11779145|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
7474418|NCT01968967|11779146|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
7474419|NCT01968967|11779147|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7474420|NCT01968967|11779148|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7474421|NCT01968967|11779149|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7474422|NCT01968967|11779145|FG000|Treatment Period|Lost to Follow-up|26
7474423|NCT01968967|11779146|FG001|Treatment Period|Lost to Follow-up|31
7474424|NCT01968967|11779147|FG002|Treatment Period|Lost to Follow-up|0
7474425|NCT01968967|11779148|FG003|Treatment Period|Lost to Follow-up|0
7474426|NCT01968967|11779149|FG004|Treatment Period|Lost to Follow-up|0
7474427|NCT01968967|11779145|FG000|Treatment Period|Protocol Violation|1
7474428|NCT01968967|11779146|FG001|Treatment Period|Protocol Violation|2
7474429|NCT01968967|11779147|FG002|Treatment Period|Protocol Violation|0
7474430|NCT01968967|11779148|FG003|Treatment Period|Protocol Violation|0
7474431|NCT01968967|11779149|FG004|Treatment Period|Protocol Violation|0
7474432|NCT01968967|11779145|FG000|Treatment Period|Adverse Event|9
7474433|NCT01968967|11779146|FG001|Treatment Period|Adverse Event|8
7474434|NCT01968967|11779147|FG002|Treatment Period|Adverse Event|0
7474435|NCT01968967|11779148|FG003|Treatment Period|Adverse Event|0
7474436|NCT01968967|11779149|FG004|Treatment Period|Adverse Event|0
7474437|NCT01968967|11779145|FG000|Treatment Period|Death|9
7474438|NCT01968967|11779146|FG001|Treatment Period|Death|2
7474439|NCT01968967|11779147|FG002|Treatment Period|Death|0
7474440|NCT01968967|11779148|FG003|Treatment Period|Death|0
7474442|NCT01968967|11779145|FG000|Treatment Period|Randomized Not Treated|6
7474443|NCT01968967|11779146|FG001|Treatment Period|Randomized Not Treated|5
7474444|NCT01968967|11779147|FG002|Treatment Period|Randomized Not Treated|0
7474445|NCT01968967|11779148|FG003|Treatment Period|Randomized Not Treated|0
7474446|NCT01968967|11779149|FG004|Treatment Period|Randomized Not Treated|0
7474447|NCT01968967|11779145|FG000|Extension Period|Withdrew Consent|0
7474448|NCT01968967|11779146|FG001|Extension Period|Withdrew Consent|0
7474449|NCT01968967|11779147|FG002|Extension Period|Withdrew Consent|2
7474450|NCT01968967|11779148|FG003|Extension Period|Withdrew Consent|0
7474451|NCT01968967|11779149|FG004|Extension Period|Withdrew Consent|5
7474452|NCT01968980|11779165|FG000|Overall Study|Death|0
7474453|NCT01968980|11779166|FG001|Overall Study|Death|1
7474454|NCT01968980|11779165|FG000|Overall Study|Adverse Event|1
7474455|NCT01968980|11779166|FG001|Overall Study|Adverse Event|3
7474456|NCT01968980|11779165|FG000|Overall Study|Does not meet entry criteria|1
7474457|NCT01968980|11779166|FG001|Overall Study|Does not meet entry criteria|3
7474458|NCT01968980|11779165|FG000|Overall Study|Withdrawal by Subject|13
7474459|NCT01968980|11779166|FG001|Overall Study|Withdrawal by Subject|5
7474460|NCT01968980|11779165|FG000|Overall Study|Other unspecified|1
7474461|NCT01968980|11779166|FG001|Overall Study|Other unspecified|2
7474462|NCT01969058|11779175|FG000|Overall Study|Withdrawal by Subject|2
7474463|NCT01969058|11779176|FG001|Overall Study|Withdrawal by Subject|0
7474464|NCT01969058|11779175|FG000|Overall Study|Adverse Event|1
7474465|NCT01969058|11779176|FG001|Overall Study|Adverse Event|0
7474466|NCT01969084|11779184|FG000|Overall Study|Adverse Event|0
7474467|NCT01969084|11779185|FG001|Overall Study|Adverse Event|1
7474468|NCT01969500|11779242|FG000|Overall Study|Death|0
7474469|NCT01969500|11779243|FG001|Overall Study|Death|1
7474470|NCT01969500|11779242|FG000|Overall Study|extended hospitalization|1
7474471|NCT01969500|11779243|FG001|Overall Study|extended hospitalization|1
7474472|NCT01969721|11779262|FG000|Overall Study|Adverse Event|3
7474473|NCT01969721|11779263|FG001|Overall Study|Adverse Event|8
7474474|NCT01969721|11779264|FG002|Overall Study|Adverse Event|3
7474475|NCT01969721|11779265|FG003|Overall Study|Adverse Event|2
7474476|NCT01969721|11779262|FG000|Overall Study|Lack of Efficacy|0
7474477|NCT01969721|11779263|FG001|Overall Study|Lack of Efficacy|0
7474478|NCT01969721|11779264|FG002|Overall Study|Lack of Efficacy|1
7474479|NCT01969721|11779265|FG003|Overall Study|Lack of Efficacy|0
7474480|NCT01969721|11779262|FG000|Overall Study|Non compliant with protocol|1
7474481|NCT01969721|11779263|FG001|Overall Study|Non compliant with protocol|1
7474482|NCT01969721|11779264|FG002|Overall Study|Non compliant with protocol|0
7474483|NCT01969721|11779265|FG003|Overall Study|Non compliant with protocol|2
7474484|NCT01969721|11779262|FG000|Overall Study|Other not defined above|0
7474485|NCT01969721|11779263|FG001|Overall Study|Other not defined above|2
7474486|NCT01969721|11779264|FG002|Overall Study|Other not defined above|0
7474487|NCT01969721|11779265|FG003|Overall Study|Other not defined above|0
7474488|NCT01969721|11779262|FG000|Overall Study|Discontinued during washout periods.|0
7474489|NCT01969721|11779263|FG001|Overall Study|Discontinued during washout periods.|1
7474490|NCT01969721|11779264|FG002|Overall Study|Discontinued during washout periods.|1
7474491|NCT01969721|11779265|FG003|Overall Study|Discontinued during washout periods.|2
7474492|NCT01969799|11779294|FG000|Overall Study|Adverse Event|0
7474493|NCT01969799|11779295|FG001|Overall Study|Adverse Event|1
7474494|NCT01969799|11779294|FG000|Overall Study|Death|16
7474495|NCT01969799|11779295|FG001|Overall Study|Death|11
7474496|NCT01969799|11779294|FG000|Overall Study|Lost to Follow-up|0
7474497|NCT01969799|11779295|FG001|Overall Study|Lost to Follow-up|2
7474498|NCT01969799|11779294|FG000|Overall Study|Physician Decision|1
7474499|NCT01969799|11779295|FG001|Overall Study|Physician Decision|0
7474500|NCT01969851|11779304|FG000|Overall Study|Adverse Event|0
7474501|NCT01969851|11779305|FG001|Overall Study|Adverse Event|0
7474502|NCT01969851|11779306|FG002|Overall Study|Adverse Event|3
7474503|NCT01969851|11779304|FG000|Overall Study|Lack of Efficacy|0
7474504|NCT01969851|11779305|FG001|Overall Study|Lack of Efficacy|3
7474505|NCT01969851|11779306|FG002|Overall Study|Lack of Efficacy|1
7474506|NCT01969851|11779304|FG000|Overall Study|Withdrawal by Subject|1
7474507|NCT01969851|11779305|FG001|Overall Study|Withdrawal by Subject|0
7474508|NCT01969851|11779306|FG002|Overall Study|Withdrawal by Subject|1
7474509|NCT01969851|11779304|FG000|Overall Study|No effective dose in Titration period|0
7474510|NCT01969851|11779305|FG001|Overall Study|No effective dose in Titration period|0
7474511|NCT01969851|11779306|FG002|Overall Study|No effective dose in Titration period|1
7413049|NCT01422720|11685171|FG000|Overall Study|Adverse Event|16
7413050|NCT01422720|11685171|FG000|Overall Study|Lack of Efficacy|1
7413051|NCT01422720|11685171|FG000|Overall Study|Withdrawal by Subject|4
7413052|NCT01422720|11685171|FG000|Overall Study|Ineligibility|1
7474512|NCT01969851|11779304|FG000|Overall Study|Sponsor decision|0
7474513|NCT01969851|11779305|FG001|Overall Study|Sponsor decision|0
7474514|NCT01969851|11779306|FG002|Overall Study|Sponsor decision|1
7474515|NCT01970007|11779318|FG000|Overall Study|Death|5
7474516|NCT01970007|11779318|FG000|Overall Study|Withdrawal by Subject|23
7474517|NCT01970007|11779318|FG000|Overall Study|Lost to Follow-up|24
7474518|NCT01970007|11779318|FG000|Overall Study|"Other endpoint"|3
7474519|NCT01970241|11779333|FG000|Overall Study|Withdrawal by Subject|2
7474520|NCT01970241|11779334|FG001|Overall Study|Withdrawal by Subject|0
7474521|NCT01970241|11779333|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
7474522|NCT01970241|11779334|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
7474523|NCT01970371|11779345|FG000|Overall Study|Death|8
7474524|NCT01970371|11779346|FG001|Overall Study|Death|13
7474525|NCT01970371|11779347|FG002|Overall Study|Death|12
7474526|NCT01970371|11779345|FG000|Overall Study|Lost to Follow-up|0
7474527|NCT01970371|11779346|FG001|Overall Study|Lost to Follow-up|0
7474528|NCT01970371|11779347|FG002|Overall Study|Lost to Follow-up|1
7413053|NCT01422824|11685179|FG000|Overall Study|Case record form not evaluated|1
7413054|NCT01422824|11685179|FG000|Overall Study|Lost to Follow-up|37
7474529|NCT01970397|11779359|FG000|Overall Study|Adverse Event|0
7474530|NCT01970397|11779360|FG001|Overall Study|Adverse Event|1
7474531|NCT01970397|11779359|FG000|Overall Study|Lost to Follow-up|0
7474532|NCT01970397|11779360|FG001|Overall Study|Lost to Follow-up|1
7474533|NCT01970397|11779359|FG000|Overall Study|Personal Reasons|1
7474534|NCT01970397|11779360|FG001|Overall Study|Personal Reasons|2
7474535|NCT01970397|11779359|FG000|Overall Study|Protocol Violation|1
7474536|NCT01970397|11779360|FG001|Overall Study|Protocol Violation|1
7474537|NCT01970475|11779368|FG000|Overall Study|Withdrawal by Subject|11
7474538|NCT01970475|11779369|FG001|Overall Study|Withdrawal by Subject|6
7474539|NCT01970475|11779368|FG000|Overall Study|Adverse Event|7
7474540|NCT01970475|11779369|FG001|Overall Study|Adverse Event|3
7474541|NCT01970475|11779368|FG000|Overall Study|Lost to Follow-up|2
7474542|NCT01970475|11779369|FG001|Overall Study|Lost to Follow-up|2
7474543|NCT01970475|11779368|FG000|Overall Study|Protocol Violation|1
7474544|NCT01970475|11779369|FG001|Overall Study|Protocol Violation|0
7474545|NCT01970488|11779377|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
7474546|NCT01970488|11779378|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
7474547|NCT01970488|11779379|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
7474548|NCT01970488|11779380|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
7474549|NCT01970488|11779381|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
7474550|NCT01970488|11779377|FG000|Part 1: Through Week 16|Protocol Violation|1
7474551|NCT01970488|11779378|FG001|Part 1: Through Week 16|Protocol Violation|2
7413055|NCT01422850|11685183|FG000|Overall Study|Physician Decision|3
7413056|NCT01422876|11685199|FG000|Week 24|Lost to Follow-up|1
7413057|NCT01422876|11685200|FG001|Week 24|Lost to Follow-up|1
7413058|NCT01422876|11685201|FG002|Week 24|Lost to Follow-up|2
7474552|NCT01970488|11779379|FG002|Part 1: Through Week 16|Protocol Violation|0
7474553|NCT01970488|11779380|FG003|Part 1: Through Week 16|Protocol Violation|0
7474554|NCT01970488|11779381|FG004|Part 1: Through Week 16|Protocol Violation|0
7474555|NCT01970488|11779377|FG000|Part 1: Through Week 16|Adverse Event|6
7474556|NCT01970488|11779378|FG001|Part 1: Through Week 16|Adverse Event|5
7474557|NCT01970488|11779379|FG002|Part 1: Through Week 16|Adverse Event|0
7474558|NCT01970488|11779380|FG003|Part 1: Through Week 16|Adverse Event|0
7474559|NCT01970488|11779381|FG004|Part 1: Through Week 16|Adverse Event|0
7474560|NCT01970488|11779377|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
7474561|NCT01970488|11779378|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
7474562|NCT01970488|11779379|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
7474563|NCT01970488|11779380|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
7474564|NCT01970488|11779381|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
7474565|NCT01970488|11779377|FG000|Part 1: Through Week 16|Lost to Follow-up|0
7474566|NCT01970488|11779378|FG001|Part 1: Through Week 16|Lost to Follow-up|2
7474567|NCT01970488|11779379|FG002|Part 1: Through Week 16|Lost to Follow-up|0
7474568|NCT01970488|11779380|FG003|Part 1: Through Week 16|Lost to Follow-up|0
7474569|NCT01970488|11779381|FG004|Part 1: Through Week 16|Lost to Follow-up|0
7474570|NCT01970488|11779377|FG000|Part 2: Post Week 16|Physician Decision|0
7474571|NCT01970488|11779378|FG001|Part 2: Post Week 16|Physician Decision|0
7474572|NCT01970488|11779379|FG002|Part 2: Post Week 16|Physician Decision|0
7474573|NCT01970488|11779380|FG003|Part 2: Post Week 16|Physician Decision|0
7474574|NCT01970488|11779381|FG004|Part 2: Post Week 16|Physician Decision|1
7474575|NCT01970488|11779377|FG000|Part 2: Post Week 16|Non-compliance|0
7474576|NCT01970488|11779378|FG001|Part 2: Post Week 16|Non-compliance|0
7474577|NCT01970488|11779379|FG002|Part 2: Post Week 16|Non-compliance|1
7474578|NCT01970488|11779380|FG003|Part 2: Post Week 16|Non-compliance|0
7474579|NCT01970488|11779381|FG004|Part 2: Post Week 16|Non-compliance|0
7474580|NCT01970488|11779377|FG000|Part 2: Post Week 16|Lack of Efficacy|0
7474581|NCT01970488|11779378|FG001|Part 2: Post Week 16|Lack of Efficacy|0
7474582|NCT01970488|11779379|FG002|Part 2: Post Week 16|Lack of Efficacy|2
7474583|NCT01970488|11779380|FG003|Part 2: Post Week 16|Lack of Efficacy|3
7474584|NCT01970488|11779381|FG004|Part 2: Post Week 16|Lack of Efficacy|1
7474585|NCT01970488|11779377|FG000|Part 2: Post Week 16|Adverse Event|0
7474586|NCT01970488|11779378|FG001|Part 2: Post Week 16|Adverse Event|0
7474587|NCT01970488|11779379|FG002|Part 2: Post Week 16|Adverse Event|5
7474588|NCT01970488|11779380|FG003|Part 2: Post Week 16|Adverse Event|1
7474589|NCT01970488|11779381|FG004|Part 2: Post Week 16|Adverse Event|1
7474590|NCT01970488|11779377|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
7474591|NCT01970488|11779378|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
7474592|NCT01970488|11779379|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
7474593|NCT01970488|11779380|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
7474594|NCT01970488|11779381|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
7474595|NCT01970488|11779377|FG000|Part 2: Post Week 16|Lost to Follow-up|0
7474596|NCT01970488|11779378|FG001|Part 2: Post Week 16|Lost to Follow-up|0
7474597|NCT01970488|11779379|FG002|Part 2: Post Week 16|Lost to Follow-up|1
7474598|NCT01970488|11779380|FG003|Part 2: Post Week 16|Lost to Follow-up|1
7474599|NCT01970488|11779381|FG004|Part 2: Post Week 16|Lost to Follow-up|2
7474600|NCT01970527|11779398|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
7474601|NCT01970527|11779399|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
7474602|NCT01970527|11779398|FG000|Treatment|Disease progression|0
7474603|NCT01970527|11779399|FG001|Treatment|Disease progression|1
7474604|NCT01970527|11779398|FG000|Treatment|Participant did not tolerate Ipilimumab|0
7474605|NCT01970527|11779399|FG001|Treatment|Participant did not tolerate Ipilimumab|1
7474606|NCT01970527|11779398|FG000|Treatment|Death|0
7474607|NCT01970527|11779399|FG001|Treatment|Death|1
7474608|NCT01970527|11779398|FG000|Follow-up Clinic Visit|Disease progression|1
7474609|NCT01970527|11779399|FG001|Follow-up Clinic Visit|Disease progression|1
7474610|NCT01970527|11779398|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
7474611|NCT01970527|11779399|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
7474612|NCT01970527|11779398|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
7474613|NCT01970527|11779399|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
7474614|NCT01970540|11779411|FG000|Overall Study|Non-treatment-related AE|0
7474615|NCT01970540|11779412|FG001|Overall Study|Non-treatment-related AE|0
7474616|NCT01970540|11779413|FG002|Overall Study|Non-treatment-related AE|1
7474617|NCT01970540|11779411|FG000|Overall Study|Progressive disease|55
7474618|NCT01970540|11779412|FG001|Overall Study|Progressive disease|23
7474619|NCT01970540|11779413|FG002|Overall Study|Progressive disease|10
7474620|NCT01970540|11779411|FG000|Overall Study|Treatment delay over protocol|0
7474621|NCT01970540|11779412|FG001|Overall Study|Treatment delay over protocol|0
7474622|NCT01970540|11779413|FG002|Overall Study|Treatment delay over protocol|1
7474623|NCT01970540|11779411|FG000|Overall Study|Physician Decision|7
7474624|NCT01970540|11779412|FG001|Overall Study|Physician Decision|2
7474625|NCT01970540|11779413|FG002|Overall Study|Physician Decision|0
7474626|NCT01970540|11779411|FG000|Overall Study|Clinical progression|0
7474627|NCT01970540|11779412|FG001|Overall Study|Clinical progression|1
7474628|NCT01970540|11779413|FG002|Overall Study|Clinical progression|1
7474629|NCT01970540|11779411|FG000|Overall Study|End of study|2
7474630|NCT01970540|11779412|FG001|Overall Study|End of study|0
7474631|NCT01970540|11779413|FG002|Overall Study|End of study|2
7474632|NCT01970540|11779411|FG000|Overall Study|Adverse Event|0
7474633|NCT01970540|11779412|FG001|Overall Study|Adverse Event|2
7474634|NCT01970540|11779413|FG002|Overall Study|Adverse Event|1
7474635|NCT01970540|11779411|FG000|Overall Study|Treatment-related AE|4
7474636|NCT01970540|11779412|FG001|Overall Study|Treatment-related AE|0
7474637|NCT01970540|11779413|FG002|Overall Study|Treatment-related AE|2
7474638|NCT01970540|11779411|FG000|Overall Study|Withdrawal by Subject|4
7474639|NCT01970540|11779412|FG001|Overall Study|Withdrawal by Subject|0
7474640|NCT01970540|11779413|FG002|Overall Study|Withdrawal by Subject|1
7474641|NCT01970540|11779411|FG000|Overall Study|Clinical deterioration|1
7474642|NCT01970540|11779412|FG001|Overall Study|Clinical deterioration|0
7474643|NCT01970540|11779413|FG002|Overall Study|Clinical deterioration|0
7474644|NCT01970592|11779432|FG000|Overall Study|Withdrawal by Subject|4
7474645|NCT01970592|11779432|FG000|Overall Study|Physician Decision|1
7474646|NCT01970592|11779432|FG000|Overall Study|Adverse Event|1
7474647|NCT01970878|11779444|FG000|Overall Study|Withdrawal by Subject|11
7474648|NCT01970878|11779445|FG001|Overall Study|Withdrawal by Subject|10
7474649|NCT01970878|11779446|FG002|Overall Study|Withdrawal by Subject|14
7474650|NCT01970878|11779447|FG003|Overall Study|Withdrawal by Subject|7
7474651|NCT01970878|11779444|FG000|Overall Study|Lost to Follow-up|1
7474652|NCT01970878|11779445|FG001|Overall Study|Lost to Follow-up|3
7474653|NCT01970878|11779446|FG002|Overall Study|Lost to Follow-up|2
7474654|NCT01970878|11779447|FG003|Overall Study|Lost to Follow-up|4
7474655|NCT01970878|11779444|FG000|Overall Study|Administrative Reasons|1
7474656|NCT01970878|11779445|FG001|Overall Study|Administrative Reasons|0
7474657|NCT01970878|11779446|FG002|Overall Study|Administrative Reasons|0
7474658|NCT01970878|11779447|FG003|Overall Study|Administrative Reasons|4
7474659|NCT01970878|11779444|FG000|Overall Study|Lack of Efficacy|2
7474660|NCT01970878|11779445|FG001|Overall Study|Lack of Efficacy|1
7474661|NCT01970878|11779446|FG002|Overall Study|Lack of Efficacy|2
7474662|NCT01970878|11779447|FG003|Overall Study|Lack of Efficacy|0
7474663|NCT01970878|11779444|FG000|Overall Study|Adverse Event|12
7474664|NCT01970878|11779445|FG001|Overall Study|Adverse Event|7
7474665|NCT01970878|11779446|FG002|Overall Study|Adverse Event|4
7474666|NCT01970878|11779447|FG003|Overall Study|Adverse Event|3
7474667|NCT01970878|11779444|FG000|Overall Study|Protocol Specified Criteria|10
7474668|NCT01970878|11779445|FG001|Overall Study|Protocol Specified Criteria|4
7474669|NCT01970878|11779446|FG002|Overall Study|Protocol Specified Criteria|3
7474670|NCT01970878|11779447|FG003|Overall Study|Protocol Specified Criteria|6
7474671|NCT01970878|11779444|FG000|Overall Study|Physician Decision|0
7474672|NCT01970878|11779445|FG001|Overall Study|Physician Decision|1
7474673|NCT01970878|11779446|FG002|Overall Study|Physician Decision|1
7474674|NCT01970878|11779447|FG003|Overall Study|Physician Decision|0
7474675|NCT01970878|11779444|FG000|Overall Study|No Completion Status|0
7474676|NCT01970878|11779445|FG001|Overall Study|No Completion Status|1
7474677|NCT01970878|11779446|FG002|Overall Study|No Completion Status|0
7474678|NCT01970878|11779447|FG003|Overall Study|No Completion Status|0
7474679|NCT01970982|11779467|FG000|Overall Study|Withdrawal by Subject|0
7474680|NCT01970982|11779468|FG001|Overall Study|Withdrawal by Subject|0
7474681|NCT01970982|11779469|FG002|Overall Study|Withdrawal by Subject|2
7474682|NCT01970995|11779481|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7474683|NCT01970995|11779482|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7474684|NCT01970995|11779483|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7474685|NCT01970995|11779481|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
7474686|NCT01970995|11779482|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
7474687|NCT01970995|11779483|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
7474688|NCT01971203|11779498|FG000|Overall Study|Protocol Violation|3
7474689|NCT01971203|11779499|FG001|Overall Study|Protocol Violation|2
7474690|NCT01971203|11779498|FG000|Overall Study|Withdrawal by Subject|5
7474691|NCT01971203|11779499|FG001|Overall Study|Withdrawal by Subject|6
7474692|NCT01971203|11779498|FG000|Overall Study|Adverse Event|1
7474693|NCT01971203|11779499|FG001|Overall Study|Adverse Event|0
7474694|NCT01971346|11779514|FG000|Overall Study|Protocol Violation|3
7474695|NCT01971346|11779514|FG000|Overall Study|Lost to Follow-up|2
7474696|NCT01971346|11779514|FG000|Overall Study|Withdrawal by Subject|2
7474697|NCT01971346|11779514|FG000|Overall Study|Physician Decision|1
7474698|NCT01971476|11779545|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
7474699|NCT01971476|11779546|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
7474700|NCT01971476|11779547|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
7474701|NCT01971476|11779545|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
7474702|NCT01971476|11779546|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
7474703|NCT01971476|11779547|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
7474704|NCT01971476|11779545|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
7474705|NCT01971476|11779546|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
7474706|NCT01971476|11779547|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
7474707|NCT01971554|11779568|FG000|Overall Study|Lost to Follow-up|1
7474708|NCT01971554|11779569|FG001|Overall Study|Lost to Follow-up|0
7474709|NCT01971554|11779570|FG002|Overall Study|Lost to Follow-up|0
7474710|NCT01971554|11779571|FG003|Overall Study|Lost to Follow-up|0
7474711|NCT01971567|11779583|FG000|Overall Study|Withdrawal by Subject|3
7474712|NCT01971567|11779584|FG001|Overall Study|Withdrawal by Subject|2
7474713|NCT01971567|11779583|FG000|Overall Study|Lost to Follow-up|1
7474714|NCT01971567|11779584|FG001|Overall Study|Lost to Follow-up|0
7474715|NCT01971645|11779609|FG000|Overall Study|Adverse Event|1
7474716|NCT01971645|11779610|FG001|Overall Study|Adverse Event|0
7474717|NCT01971645|11779611|FG002|Overall Study|Adverse Event|0
7474718|NCT01971645|11779609|FG000|Overall Study|Lost to Follow-up|1
7474719|NCT01971645|11779610|FG001|Overall Study|Lost to Follow-up|0
7474720|NCT01971645|11779611|FG002|Overall Study|Lost to Follow-up|1
7474721|NCT01971645|11779609|FG000|Overall Study|Protocol Violation|0
7474722|NCT01971645|11779610|FG001|Overall Study|Protocol Violation|0
7474723|NCT01971645|11779611|FG002|Overall Study|Protocol Violation|1
7474724|NCT01971723|11779621|FG000|Overall Study|Withdrawal by Subject|1
7474725|NCT01971723|11779622|FG001|Overall Study|Withdrawal by Subject|1
7474726|NCT01971723|11779621|FG000|Overall Study|Protocol Violation|1
7474727|NCT01971723|11779622|FG001|Overall Study|Protocol Violation|2
7474728|NCT01972074|11779644|FG000|Overall Study|Adverse Event|4
7474729|NCT01972074|11779645|FG001|Overall Study|Adverse Event|1
7474730|NCT01972074|11779646|FG002|Overall Study|Adverse Event|0
7474731|NCT01972074|11779644|FG000|Overall Study|Lack of Efficacy|1
7474732|NCT01972074|11779645|FG001|Overall Study|Lack of Efficacy|1
7474733|NCT01972074|11779646|FG002|Overall Study|Lack of Efficacy|0
7474734|NCT01972074|11779644|FG000|Overall Study|Lost to Follow-up|0
7474735|NCT01972074|11779645|FG001|Overall Study|Lost to Follow-up|1
7474736|NCT01972074|11779646|FG002|Overall Study|Lost to Follow-up|1
7474737|NCT01972074|11779644|FG000|Overall Study|Withdrawal by Subject|1
7474738|NCT01972074|11779645|FG001|Overall Study|Withdrawal by Subject|1
7474739|NCT01972074|11779646|FG002|Overall Study|Withdrawal by Subject|1
7474740|NCT01972074|11779644|FG000|Overall Study|Scanner Unavailable|0
7474741|NCT01972074|11779645|FG001|Overall Study|Scanner Unavailable|0
7474742|NCT01972074|11779646|FG002|Overall Study|Scanner Unavailable|1
7474743|NCT01972152|11779653|FG000|First Treatment Visit|Lost to Follow-up|0
7474744|NCT01972152|11779654|FG001|First Treatment Visit|Lost to Follow-up|1
7474745|NCT01972152|11779655|FG002|First Treatment Visit|Lost to Follow-up|0
7474746|NCT01972152|11779656|FG003|First Treatment Visit|Lost to Follow-up|0
7474747|NCT01972152|11779657|FG004|First Treatment Visit|Lost to Follow-up|0
7474748|NCT01972152|11779658|FG005|First Treatment Visit|Lost to Follow-up|0
7474749|NCT01972152|11779653|FG000|Second Treatment Visit|Protocol Violation|0
7474750|NCT01972152|11779654|FG001|Second Treatment Visit|Protocol Violation|1
7474751|NCT01972152|11779655|FG002|Second Treatment Visit|Protocol Violation|0
7474752|NCT01972152|11779656|FG003|Second Treatment Visit|Protocol Violation|0
7474753|NCT01972152|11779657|FG004|Second Treatment Visit|Protocol Violation|0
7474754|NCT01972152|11779658|FG005|Second Treatment Visit|Protocol Violation|0
7474761|NCT01972438|11779695|FG000|Baseline-Month 3 Crossover Period|Death|1
7474762|NCT01972438|11779696|FG001|Baseline-Month 3 Crossover Period|Death|0
7474763|NCT01972438|11779695|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
7474764|NCT01972438|11779696|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
7474765|NCT01972438|11779695|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
7474766|NCT01972438|11779696|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
7474767|NCT01972438|11779695|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
7474768|NCT01972438|11779696|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
7474769|NCT01972438|11779695|FG000|Months 3-6 Crossover Period|Early Study Closure|0
7474770|NCT01972438|11779696|FG001|Months 3-6 Crossover Period|Early Study Closure|1
7474771|NCT01972438|11779695|FG000|Months 6-12 Study Period|Death|1
7474772|NCT01972438|11779696|FG001|Months 6-12 Study Period|Death|0
7474773|NCT01972438|11779695|FG000|Months 6-12 Study Period|Early Study Closure|2
7474774|NCT01972438|11779696|FG001|Months 6-12 Study Period|Early Study Closure|2
7474775|NCT01972438|11779695|FG000|Post Month 12 Study Period|Early Study Closure|3
7474776|NCT01972438|11779696|FG001|Post Month 12 Study Period|Early Study Closure|4
7474777|NCT01972464|11779706|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
7474778|NCT01972464|11779707|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
7474779|NCT01972464|11779706|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
7474780|NCT01972464|11779707|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
7474781|NCT01972464|11779706|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
7474782|NCT01972464|11779707|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
7474783|NCT01972464|11779706|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7474784|NCT01972464|11779707|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
7474785|NCT01972529|11779727|FG000|Overall Study|Adverse Event|0
7474786|NCT01972529|11779728|FG001|Overall Study|Adverse Event|1
7474787|NCT01972529|11779729|FG002|Overall Study|Adverse Event|0
7474788|NCT01972529|11779730|FG003|Overall Study|Adverse Event|0
7474789|NCT01972529|11779727|FG000|Overall Study|Lost to Follow-up|1
7474790|NCT01972529|11779728|FG001|Overall Study|Lost to Follow-up|0
7474791|NCT01972529|11779729|FG002|Overall Study|Lost to Follow-up|0
7474792|NCT01972529|11779730|FG003|Overall Study|Lost to Follow-up|0
7474793|NCT01972529|11779727|FG000|Overall Study|Participant Choice|0
7474794|NCT01972529|11779728|FG001|Overall Study|Participant Choice|1
7474795|NCT01972529|11779729|FG002|Overall Study|Participant Choice|0
7474796|NCT01972529|11779730|FG003|Overall Study|Participant Choice|0
7474797|NCT01972529|11779727|FG000|Overall Study|Withdrawl of Consent|1
7474798|NCT01972529|11779728|FG001|Overall Study|Withdrawl of Consent|2
7474799|NCT01972529|11779729|FG002|Overall Study|Withdrawl of Consent|0
7474800|NCT01972529|11779730|FG003|Overall Study|Withdrawl of Consent|1
7474801|NCT01972529|11779727|FG000|Overall Study|Other|0
7474802|NCT01972529|11779728|FG001|Overall Study|Other|0
7474803|NCT01972529|11779729|FG002|Overall Study|Other|0
7474804|NCT01972529|11779730|FG003|Overall Study|Other|2
7474805|NCT01972529|11779727|FG000|Overall Study|Not treated|0
7474806|NCT01972529|11779728|FG001|Overall Study|Not treated|1
7474807|NCT01972529|11779729|FG002|Overall Study|Not treated|2
7474808|NCT01972529|11779730|FG003|Overall Study|Not treated|1
7474809|NCT01972568|11779744|FG000|Overall Study|Other events|3
7474810|NCT01972568|11779745|FG001|Overall Study|Other events|0
7474811|NCT01972568|11779746|FG002|Overall Study|Other events|0
7474812|NCT01972568|11779744|FG000|Overall Study|Lack of Efficacy|0
7474813|NCT01972568|11779745|FG001|Overall Study|Lack of Efficacy|1
7474814|NCT01972568|11779746|FG002|Overall Study|Lack of Efficacy|2
7474815|NCT01972568|11779744|FG000|Overall Study|Protocol Violation|1
7474816|NCT01972568|11779745|FG001|Overall Study|Protocol Violation|2
7474817|NCT01972568|11779746|FG002|Overall Study|Protocol Violation|2
7474818|NCT01972568|11779744|FG000|Overall Study|Withdrawal by Subject|6
7474819|NCT01972568|11779745|FG001|Overall Study|Withdrawal by Subject|3
7474820|NCT01972568|11779746|FG002|Overall Study|Withdrawal by Subject|7
7474821|NCT01972568|11779744|FG000|Overall Study|Lost to Follow-up|1
7474822|NCT01972568|11779745|FG001|Overall Study|Lost to Follow-up|0
7474823|NCT01972568|11779746|FG002|Overall Study|Lost to Follow-up|0
7474824|NCT01972568|11779744|FG000|Overall Study|Adverse Event|5
7474825|NCT01972568|11779745|FG001|Overall Study|Adverse Event|6
7474826|NCT01972568|11779746|FG002|Overall Study|Adverse Event|5
7474827|NCT01972659|11779756|FG000|Overall Study|Protocol Violation|2
7474828|NCT01972659|11779757|FG001|Overall Study|Protocol Violation|2
7474829|NCT01972659|11779756|FG000|Overall Study|problems realted to acceleromyograph|2
7474830|NCT01972659|11779757|FG001|Overall Study|problems realted to acceleromyograph|1
7474831|NCT01972724|11779766|FG000|Double-Blind|Rescue Criteria Met|1
7474832|NCT01972724|11779767|FG001|Double-Blind|Rescue Criteria Met|0
7474833|NCT01972724|11779768|FG002|Double-Blind|Rescue Criteria Met|0
7474834|NCT01972724|11779766|FG000|Double-Blind|Adverse Event|1
7474835|NCT01972724|11779767|FG001|Double-Blind|Adverse Event|0
7474836|NCT01972724|11779768|FG002|Double-Blind|Adverse Event|0
7474837|NCT01972724|11779766|FG000|Double-Blind|Withdrawal of Consent|2
7474838|NCT01972724|11779767|FG001|Double-Blind|Withdrawal of Consent|1
7474839|NCT01972724|11779768|FG002|Double-Blind|Withdrawal of Consent|0
7474840|NCT01972724|11779766|FG000|Double-Blind|Significant Protocol Deviation|5
7474841|NCT01972724|11779767|FG001|Double-Blind|Significant Protocol Deviation|8
7474842|NCT01972724|11779768|FG002|Double-Blind|Significant Protocol Deviation|0
7474843|NCT01972724|11779766|FG000|Open-Label|Withdrew Consent|0
7474844|NCT01972724|11779767|FG001|Open-Label|Withdrew Consent|0
7474845|NCT01972724|11779768|FG002|Open-Label|Withdrew Consent|3
7474846|NCT01972724|11779766|FG000|Open-Label|Significant Protocol Deviation|0
7474847|NCT01972724|11779767|FG001|Open-Label|Significant Protocol Deviation|0
7474848|NCT01972724|11779768|FG002|Open-Label|Significant Protocol Deviation|2
7474849|NCT01972776|11779782|FG000|Part 1|Withdrawal by Subject|0
7474850|NCT01972776|11779783|FG001|Part 1|Withdrawal by Subject|0
7474851|NCT01972776|11779784|FG002|Part 1|Withdrawal by Subject|1
7474852|NCT01972776|11779785|FG003|Part 1|Withdrawal by Subject|0
7474853|NCT01972776|11779786|FG004|Part 1|Withdrawal by Subject|0
7474854|NCT01972776|11779787|FG005|Part 1|Withdrawal by Subject|0
7474855|NCT01972776|11779782|FG000|Part 1|Adverse Event|0
7474856|NCT01972776|11779783|FG001|Part 1|Adverse Event|0
7474857|NCT01972776|11779784|FG002|Part 1|Adverse Event|1
7474858|NCT01972776|11779785|FG003|Part 1|Adverse Event|1
7474859|NCT01972776|11779786|FG004|Part 1|Adverse Event|0
7474860|NCT01972776|11779787|FG005|Part 1|Adverse Event|0
7474861|NCT01972776|11779782|FG000|Part 2|Adverse Event|0
7474862|NCT01972776|11779783|FG001|Part 2|Adverse Event|0
7474863|NCT01972776|11779784|FG002|Part 2|Adverse Event|0
7474864|NCT01972776|11779785|FG003|Part 2|Adverse Event|0
7474865|NCT01972776|11779786|FG004|Part 2|Adverse Event|3
7474866|NCT01972776|11779787|FG005|Part 2|Adverse Event|0
7474867|NCT01972776|11779782|FG000|Part 2|Administrative problems|0
7474868|NCT01972776|11779783|FG001|Part 2|Administrative problems|0
7474869|NCT01972776|11779784|FG002|Part 2|Administrative problems|0
7474870|NCT01972776|11779785|FG003|Part 2|Administrative problems|0
7474871|NCT01972776|11779786|FG004|Part 2|Administrative problems|10
7474872|NCT01972776|11779787|FG005|Part 2|Administrative problems|7
7474873|NCT01972789|11779803|FG000|Overall Study|Adverse Event|11
7474874|NCT01972789|11779804|FG001|Overall Study|Adverse Event|4
7474875|NCT01972789|11779803|FG000|Overall Study|Subject withdrew consent|14
7474876|NCT01972789|11779804|FG001|Overall Study|Subject withdrew consent|12
7474877|NCT01972789|11779803|FG000|Overall Study|Lost to Follow-up|4
7474878|NCT01972789|11779804|FG001|Overall Study|Lost to Follow-up|7
7474879|NCT01972789|11779803|FG000|Overall Study|Death|7
7474880|NCT01972789|11779804|FG001|Overall Study|Death|5
7474881|NCT01972789|11779803|FG000|Overall Study|Protocol deviation|1
7474882|NCT01972789|11779804|FG001|Overall Study|Protocol deviation|0
7474883|NCT01972789|11779803|FG000|Overall Study|Physician Decision|3
7474884|NCT01972789|11779804|FG001|Overall Study|Physician Decision|2
7474885|NCT01972841|11779816|FG000|Overall Study|Randomized but Never Received Treatment|2
7474886|NCT01972841|11779817|FG001|Overall Study|Randomized but Never Received Treatment|5
7474887|NCT01972841|11779818|FG002|Overall Study|Randomized but Never Received Treatment|4
7474888|NCT01972841|11779819|FG003|Overall Study|Randomized but Never Received Treatment|2
7474889|NCT01972841|11779820|FG004|Overall Study|Randomized but Never Received Treatment|6
7474890|NCT01972841|11779821|FG005|Overall Study|Randomized but Never Received Treatment|13
7474891|NCT01972841|11779816|FG000|Overall Study|Adverse Event|13
7474892|NCT01972841|11779817|FG001|Overall Study|Adverse Event|8
7474893|NCT01972841|11779818|FG002|Overall Study|Adverse Event|12
7474894|NCT01972841|11779819|FG003|Overall Study|Adverse Event|9
7474895|NCT01972841|11779820|FG004|Overall Study|Adverse Event|21
7474896|NCT01972841|11779821|FG005|Overall Study|Adverse Event|26
7474897|NCT01972841|11779816|FG000|Overall Study|Lack of Efficacy|1
7474898|NCT01972841|11779817|FG001|Overall Study|Lack of Efficacy|0
7474899|NCT01972841|11779818|FG002|Overall Study|Lack of Efficacy|0
7474900|NCT01972841|11779819|FG003|Overall Study|Lack of Efficacy|2
7474901|NCT01972841|11779820|FG004|Overall Study|Lack of Efficacy|4
7474902|NCT01972841|11779821|FG005|Overall Study|Lack of Efficacy|1
7474903|NCT01972841|11779816|FG000|Overall Study|Lost to Follow-up|4
7474904|NCT01972841|11779817|FG001|Overall Study|Lost to Follow-up|2
7474905|NCT01972841|11779818|FG002|Overall Study|Lost to Follow-up|4
7474906|NCT01972841|11779819|FG003|Overall Study|Lost to Follow-up|2
7474907|NCT01972841|11779820|FG004|Overall Study|Lost to Follow-up|9
7474908|NCT01972841|11779821|FG005|Overall Study|Lost to Follow-up|3
7474909|NCT01972841|11779816|FG000|Overall Study|Protocol Violation|2
7474910|NCT01972841|11779817|FG001|Overall Study|Protocol Violation|2
7474911|NCT01972841|11779818|FG002|Overall Study|Protocol Violation|3
7474912|NCT01972841|11779819|FG003|Overall Study|Protocol Violation|5
7474913|NCT01972841|11779820|FG004|Overall Study|Protocol Violation|9
7474914|NCT01972841|11779821|FG005|Overall Study|Protocol Violation|4
7474915|NCT01972841|11779816|FG000|Overall Study|Withdrawal by participants|21
7474916|NCT01972841|11779817|FG001|Overall Study|Withdrawal by participants|27
7474917|NCT01972841|11779818|FG002|Overall Study|Withdrawal by participants|23
7474918|NCT01972841|11779819|FG003|Overall Study|Withdrawal by participants|16
7474919|NCT01972841|11779820|FG004|Overall Study|Withdrawal by participants|33
7474920|NCT01972841|11779821|FG005|Overall Study|Withdrawal by participants|34
7474921|NCT01972841|11779816|FG000|Overall Study|Miscellaneous|0
7474922|NCT01972841|11779817|FG001|Overall Study|Miscellaneous|0
7474923|NCT01972841|11779818|FG002|Overall Study|Miscellaneous|4
7474924|NCT01972841|11779819|FG003|Overall Study|Miscellaneous|1
7474925|NCT01972841|11779820|FG004|Overall Study|Miscellaneous|0
7474926|NCT01972841|11779821|FG005|Overall Study|Miscellaneous|4
7474927|NCT01972841|11779816|FG000|Overall Study|Did not have end of treatment page|0
7474928|NCT01972841|11779817|FG001|Overall Study|Did not have end of treatment page|0
7474929|NCT01972841|11779818|FG002|Overall Study|Did not have end of treatment page|0
7474930|NCT01972841|11779819|FG003|Overall Study|Did not have end of treatment page|0
7474931|NCT01972841|11779820|FG004|Overall Study|Did not have end of treatment page|1
7474932|NCT01972841|11779821|FG005|Overall Study|Did not have end of treatment page|0
7474933|NCT01973218|11779856|FG000|Overall Study|Adverse Event|1
7474934|NCT01973218|11779857|FG001|Overall Study|Adverse Event|0
7474935|NCT01973218|11779856|FG000|Overall Study|Withdrawal by Subject|1
7474936|NCT01973218|11779857|FG001|Overall Study|Withdrawal by Subject|0
7474937|NCT01973231|11779867|FG000|Overall Study|Protocol Violation|1
7474938|NCT01973231|11779868|FG001|Overall Study|Protocol Violation|1
7474939|NCT01973231|11779867|FG000|Overall Study|Lost to Follow-up|1
7474940|NCT01973231|11779868|FG001|Overall Study|Lost to Follow-up|1
7474941|NCT01973231|11779867|FG000|Overall Study|unclassified|2
7474942|NCT01973231|11779868|FG001|Overall Study|unclassified|1
7474943|NCT01973231|11779867|FG000|Overall Study|Withdrawal by Subject|7
7474944|NCT01973231|11779868|FG001|Overall Study|Withdrawal by Subject|9
7474945|NCT01973283|11779874|FG000|Overall Study|Lost to Follow-up|4
7534188|NCT02694562|11880935|FG000|Overall Study|Screen Failure|2
7534189|NCT02694562|11880935|FG000|Overall Study|Physician Decision|1
7534190|NCT02694718|11880943|FG000|Overall Study|Death|1
7534191|NCT02694718|11880943|FG000|Overall Study|Withdrawal by Subject|1
7534192|NCT02694744|11880949|FG000|Overall Study|Adverse Event|2
7534193|NCT02694744|11880950|FG001|Overall Study|Adverse Event|1
7534194|NCT02694744|11880949|FG000|Overall Study|Withdrawal by Subject|2
7534195|NCT02694744|11880950|FG001|Overall Study|Withdrawal by Subject|1
7534196|NCT02694744|11880949|FG000|Overall Study|Physician Decision|1
7534197|NCT02694744|11880950|FG001|Overall Study|Physician Decision|2
7534198|NCT02694744|11880949|FG000|Overall Study|Lost to Follow-up|1
7534199|NCT02694744|11880950|FG001|Overall Study|Lost to Follow-up|0
7534200|NCT02694744|11880949|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
7534201|NCT02694744|11880950|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
7534202|NCT02694978|11880969|FG000|Overall Study|Adverse Event|10
7534203|NCT02694978|11880970|FG001|Overall Study|Adverse Event|9
7534204|NCT02694978|11880969|FG000|Overall Study|Withdrawal by Subject|22
7534205|NCT02694978|11880970|FG001|Overall Study|Withdrawal by Subject|19
7534206|NCT02694978|11880969|FG000|Overall Study|Lost to Follow-up|14
7534207|NCT02694978|11880970|FG001|Overall Study|Lost to Follow-up|17
7534208|NCT02694978|11880969|FG000|Overall Study|Death|4
7474946|NCT01973387|11779916|FG000|Overall Study|Adverse Event|14
7474947|NCT01973387|11779917|FG001|Overall Study|Adverse Event|4
7474948|NCT01973387|11779916|FG000|Overall Study|Withdrawal by Subject|7
7474949|NCT01973387|11779917|FG001|Overall Study|Withdrawal by Subject|4
7474950|NCT01973387|11779916|FG000|Overall Study|Study terminated by sponsor|63
7474951|NCT01973387|11779917|FG001|Overall Study|Study terminated by sponsor|0
7474952|NCT01973387|11779916|FG000|Overall Study|Progressive disease or relapse|16
7474953|NCT01973387|11779917|FG001|Overall Study|Progressive disease or relapse|5
7474954|NCT01973387|11779916|FG000|Overall Study|Death|4
7474955|NCT01973387|11779917|FG001|Overall Study|Death|3
7474956|NCT01973387|11779916|FG000|Overall Study|Randomized, not treated|2
7474957|NCT01973387|11779917|FG001|Overall Study|Randomized, not treated|2
7474958|NCT01973439|11779933|FG000|Overall Study|Lost samples from one PK Day|2
7474959|NCT01973439|11779933|FG000|Overall Study|Vomiting after commencing once daily|1
7474960|NCT01973439|11779933|FG000|Overall Study|PK curve incomplete|2
7474961|NCT01973491|11779937|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
7474962|NCT01973491|11779937|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
7474963|NCT01973491|11779937|FG000|Treatment Period (16 Weeks)|Adverse Event|1
7474964|NCT01973569|11779944|FG000|Overall Study|Adverse Event|9
7474965|NCT01973569|11779945|FG001|Overall Study|Adverse Event|2
7474966|NCT01973569|11779946|FG002|Overall Study|Adverse Event|4
7474967|NCT01973569|11779944|FG000|Overall Study|Protocol Violation|2
7474968|NCT01973569|11779945|FG001|Overall Study|Protocol Violation|1
7474969|NCT01973569|11779946|FG002|Overall Study|Protocol Violation|3
7474970|NCT01973569|11779944|FG000|Overall Study|Withdrawal by Subject|7
7474971|NCT01973569|11779945|FG001|Overall Study|Withdrawal by Subject|5
7474972|NCT01973569|11779946|FG002|Overall Study|Withdrawal by Subject|2
7474973|NCT01973569|11779944|FG000|Overall Study|Invasive dental treatment|3
7474974|NCT01973569|11779945|FG001|Overall Study|Invasive dental treatment|5
7474975|NCT01973569|11779946|FG002|Overall Study|Invasive dental treatment|6
7474976|NCT01973569|11779944|FG000|Overall Study|Prohibited concomitant d|1
7474977|NCT01973569|11779945|FG001|Overall Study|Prohibited concomitant d|5
7474978|NCT01973569|11779946|FG002|Overall Study|Prohibited concomitant d|0
7474979|NCT01973569|11779944|FG000|Overall Study|Disease progression|0
7474980|NCT01973569|11779945|FG001|Overall Study|Disease progression|3
7474981|NCT01973569|11779946|FG002|Overall Study|Disease progression|0
7474982|NCT01973569|11779944|FG000|Overall Study|Other|1
7474983|NCT01973569|11779945|FG001|Overall Study|Other|1
7474984|NCT01973569|11779946|FG002|Overall Study|Other|0
7474985|NCT01973569|11779944|FG000|Overall Study|Did not receive study drug|6
7474986|NCT01973569|11779945|FG001|Overall Study|Did not receive study drug|3
7474987|NCT01973569|11779946|FG002|Overall Study|Did not receive study drug|3
7474988|NCT01973595|11779958|FG000|Washout|Withdrawal by Subject|1
7474989|NCT01973595|11779959|FG001|Washout|Withdrawal by Subject|0
7474990|NCT01973595|11779960|FG002|Washout|Withdrawal by Subject|1
7474991|NCT01973595|11779961|FG003|Washout|Withdrawal by Subject|0
7474992|NCT01973998|11780008|FG000|Overall Study|Death|2
7474993|NCT01973998|11780009|FG001|Overall Study|Death|2
7474994|NCT01974141|11780043|FG000|Overall Study|Other Reasons|28
7474995|NCT01974141|11780044|FG001|Overall Study|Other Reasons|18
7474996|NCT01974141|11780043|FG000|Overall Study|Protocol Violation|2
7474997|NCT01974141|11780044|FG001|Overall Study|Protocol Violation|6
7474998|NCT01974141|11780043|FG000|Overall Study|Personal Reasons|21
7474999|NCT01974141|11780044|FG001|Overall Study|Personal Reasons|20
7475000|NCT01974141|11780043|FG000|Overall Study|Lost to Follow-up|38
7475001|NCT01974141|11780044|FG001|Overall Study|Lost to Follow-up|29
7475002|NCT01974141|11780043|FG000|Overall Study|Pregnancy|3
7475003|NCT01974141|11780044|FG001|Overall Study|Pregnancy|3
7475004|NCT01974141|11780043|FG000|Overall Study|Lack of Efficacy|0
7475005|NCT01974141|11780044|FG001|Overall Study|Lack of Efficacy|1
7475006|NCT01974141|11780043|FG000|Overall Study|Adverse Event|4
7475007|NCT01974141|11780044|FG001|Overall Study|Adverse Event|5
7475008|NCT01974323|11780061|FG000|Overall Study|Other Reasons|25
7475009|NCT01974323|11780062|FG001|Overall Study|Other Reasons|28
7475010|NCT01974323|11780061|FG000|Overall Study|Protocol Violation|2
7475011|NCT01974323|11780062|FG001|Overall Study|Protocol Violation|2
7475012|NCT01974323|11780061|FG000|Overall Study|Personal Reasons|15
7475013|NCT01974323|11780062|FG001|Overall Study|Personal Reasons|19
7475014|NCT01974323|11780061|FG000|Overall Study|Lost to Follow-up|45
7475015|NCT01974323|11780062|FG001|Overall Study|Lost to Follow-up|40
7475016|NCT01974323|11780061|FG000|Overall Study|Pregnancy|2
7475017|NCT01974323|11780062|FG001|Overall Study|Pregnancy|1
7475018|NCT01974323|11780061|FG000|Overall Study|Lack of Efficacy|1
7475019|NCT01974323|11780062|FG001|Overall Study|Lack of Efficacy|1
7475020|NCT01974323|11780061|FG000|Overall Study|Adverse Event|2
7475021|NCT01974323|11780062|FG001|Overall Study|Adverse Event|2
7475022|NCT01974752|11780208|FG000|Overall Study|Death|33
7475023|NCT01974752|11780209|FG001|Overall Study|Death|11
7475024|NCT01974752|11780208|FG000|Overall Study|Lost to Follow-up|2
7475025|NCT01974752|11780209|FG001|Overall Study|Lost to Follow-up|0
7475026|NCT01974752|11780208|FG000|Overall Study|Withdrawal by Subject|2
7475027|NCT01974752|11780209|FG001|Overall Study|Withdrawal by Subject|3
7475028|NCT01974752|11780208|FG000|Overall Study|Other Eligibility Criteria|0
7475029|NCT01974752|11780209|FG001|Overall Study|Other Eligibility Criteria|1
7475030|NCT01974817|11780215|FG000|Overall Study|Death|4
7475031|NCT01974817|11780215|FG000|Overall Study|Lost to Follow-up|2
7475032|NCT01974817|11780215|FG000|Overall Study|Protocol Violation|2
7475033|NCT01974895|11780221|FG000|Overall Study|Protocol Violation|1
7475034|NCT01974895|11780222|FG001|Overall Study|Protocol Violation|0
7475035|NCT01974895|11780221|FG000|Overall Study|Lost to Follow-up|4
7475036|NCT01974895|11780222|FG001|Overall Study|Lost to Follow-up|6
7475037|NCT01974895|11780221|FG000|Overall Study|Withdrawal by Subject|0
7475038|NCT01974895|11780222|FG001|Overall Study|Withdrawal by Subject|1
7475039|NCT01974895|11780221|FG000|Overall Study|Other (Missed Visit)|1
7475040|NCT01974895|11780222|FG001|Overall Study|Other (Missed Visit)|0
7475041|NCT01974895|11780221|FG000|Overall Study|Other (Reason unknown)|9
7475042|NCT01974895|11780222|FG001|Overall Study|Other (Reason unknown)|8
7475043|NCT01975220|11780241|FG000|Test Period 1|Not treated|0
7475044|NCT01975220|11780242|FG001|Test Period 1|Not treated|1
7475045|NCT01975220|11780243|FG002|Test Period 1|Not treated|0
7475046|NCT01975220|11780244|FG003|Test Period 1|Not treated|0
7475047|NCT01975220|11780245|FG004|Test Period 1|Not treated|0
7475048|NCT01975220|11780246|FG005|Test Period 1|Not treated|0
7475049|NCT01975246|11780263|FG000|Overall Study|Adverse Event|2
7475050|NCT01975246|11780264|FG001|Overall Study|Adverse Event|1
7475051|NCT01975246|11780263|FG000|Overall Study|Lack of Efficacy|1
7475052|NCT01975246|11780264|FG001|Overall Study|Lack of Efficacy|0
7475053|NCT01975246|11780263|FG000|Overall Study|Protocol Violation|1
7475054|NCT01975246|11780264|FG001|Overall Study|Protocol Violation|0
7475055|NCT01975246|11780263|FG000|Overall Study|Other than stated|0
7475056|NCT01975246|11780264|FG001|Overall Study|Other than stated|1
7475057|NCT01975285|11780272|FG000|Overall Study|Failed Block and follow up|2
7475058|NCT01975285|11780273|FG001|Overall Study|Failed Block and follow up|2
7475059|NCT01975376|11780281|FG000|Overall Study|Adverse Event|5
7475060|NCT01975376|11780282|FG001|Overall Study|Adverse Event|5
7475061|NCT01975376|11780281|FG000|Overall Study|Death|65
7475062|NCT01975376|11780282|FG001|Overall Study|Death|72
7475063|NCT01975376|11780281|FG000|Overall Study|Lost to Follow-up|70
7475064|NCT01975376|11780282|FG001|Overall Study|Lost to Follow-up|66
7475065|NCT01975376|11780281|FG000|Overall Study|Withdrew consent|68
7475066|NCT01975376|11780282|FG001|Overall Study|Withdrew consent|62
7475067|NCT01975376|11780281|FG000|Overall Study|Other|2
7475068|NCT01975376|11780282|FG001|Overall Study|Other|4
7475069|NCT01975376|11780281|FG000|Overall Study|Randomized, Not Treated|16
7475070|NCT01975376|11780282|FG001|Overall Study|Randomized, Not Treated|8
7475071|NCT01975389|11780290|FG000|Overall Study|Adverse Event|10
7475072|NCT01975389|11780291|FG001|Overall Study|Adverse Event|6
7475073|NCT01975389|11780290|FG000|Overall Study|Death|61
7475074|NCT01975389|11780291|FG001|Overall Study|Death|54
7475075|NCT01975389|11780290|FG000|Overall Study|Lost to Follow-up|81
7475076|NCT01975389|11780291|FG001|Overall Study|Lost to Follow-up|86
7475077|NCT01975389|11780290|FG000|Overall Study|Withdrawal by Subject|90
7475078|NCT01975389|11780291|FG001|Overall Study|Withdrawal by Subject|76
7475079|NCT01975389|11780290|FG000|Overall Study|Other|6
7475080|NCT01975389|11780291|FG001|Overall Study|Other|9
7475081|NCT01975389|11780290|FG000|Overall Study|Randomized, not treated|4
7475082|NCT01975389|11780291|FG001|Overall Study|Randomized, not treated|5
7475083|NCT01975428|11780299|FG000|Overall Study|Lost to Follow-up|17
7475084|NCT01975428|11780300|FG001|Overall Study|Lost to Follow-up|4
7475085|NCT01975428|11780299|FG000|Overall Study|Withdrawal by Subject|3
7475086|NCT01975428|11780300|FG001|Overall Study|Withdrawal by Subject|10
7475087|NCT01975675|11780327|FG000|Overall Study|Death|0
7475088|NCT01975675|11780328|FG001|Overall Study|Death|1
7475089|NCT01975675|11780329|FG002|Overall Study|Death|0
7475090|NCT01975675|11780330|FG003|Overall Study|Death|0
7475091|NCT01975701|11780340|FG000|Overall Study|Lost to Follow-up|1
7475092|NCT01975701|11780340|FG000|Overall Study|Death|23
7475093|NCT01975701|11780340|FG000|Overall Study|Physician Decision|1
7475094|NCT01975831|11780353|FG000|Overall Study|Adverse Event|1
7475095|NCT01975831|11780354|FG001|Overall Study|Adverse Event|2
7475096|NCT01975831|11780355|FG002|Overall Study|Adverse Event|2
7475097|NCT01975831|11780356|FG003|Overall Study|Adverse Event|0
7475098|NCT01975831|11780357|FG004|Overall Study|Adverse Event|1
7475099|NCT01975831|11780358|FG005|Overall Study|Adverse Event|1
7475100|NCT01975831|11780359|FG006|Overall Study|Adverse Event|3
7475101|NCT01975831|11780360|FG007|Overall Study|Adverse Event|4
7475102|NCT01975831|11780361|FG008|Overall Study|Adverse Event|1
7475103|NCT01975831|11780353|FG000|Overall Study|Death|1
7475104|NCT01975831|11780354|FG001|Overall Study|Death|1
7475105|NCT01975831|11780355|FG002|Overall Study|Death|0
7475106|NCT01975831|11780356|FG003|Overall Study|Death|0
7475107|NCT01975831|11780357|FG004|Overall Study|Death|1
7475108|NCT01975831|11780358|FG005|Overall Study|Death|0
7475109|NCT01975831|11780359|FG006|Overall Study|Death|1
7475110|NCT01975831|11780360|FG007|Overall Study|Death|0
7475111|NCT01975831|11780361|FG008|Overall Study|Death|0
7475112|NCT01975831|11780353|FG000|Overall Study|Progressive Disease|1
7475113|NCT01975831|11780354|FG001|Overall Study|Progressive Disease|3
7475114|NCT01975831|11780355|FG002|Overall Study|Progressive Disease|2
7475115|NCT01975831|11780356|FG003|Overall Study|Progressive Disease|4
7475116|NCT01975831|11780357|FG004|Overall Study|Progressive Disease|13
7475117|NCT01975831|11780358|FG005|Overall Study|Progressive Disease|9
7475118|NCT01975831|11780359|FG006|Overall Study|Progressive Disease|10
7475119|NCT01975831|11780360|FG007|Overall Study|Progressive Disease|8
7475120|NCT01975831|11780361|FG008|Overall Study|Progressive Disease|10
7475121|NCT01975831|11780353|FG000|Overall Study|Withdrawal by Subject|0
7475122|NCT01975831|11780354|FG001|Overall Study|Withdrawal by Subject|3
7475123|NCT01975831|11780355|FG002|Overall Study|Withdrawal by Subject|0
7475124|NCT01975831|11780356|FG003|Overall Study|Withdrawal by Subject|0
7475125|NCT01975831|11780357|FG004|Overall Study|Withdrawal by Subject|3
7475126|NCT01975831|11780358|FG005|Overall Study|Withdrawal by Subject|1
7475127|NCT01975831|11780359|FG006|Overall Study|Withdrawal by Subject|1
7475128|NCT01975831|11780360|FG007|Overall Study|Withdrawal by Subject|0
7475129|NCT01975831|11780361|FG008|Overall Study|Withdrawal by Subject|0
7475130|NCT01975831|11780353|FG000|Overall Study|Physician Decision|0
7475131|NCT01975831|11780354|FG001|Overall Study|Physician Decision|0
7475132|NCT01975831|11780355|FG002|Overall Study|Physician Decision|0
7475133|NCT01975831|11780356|FG003|Overall Study|Physician Decision|0
7475134|NCT01975831|11780357|FG004|Overall Study|Physician Decision|0
7475135|NCT01975831|11780358|FG005|Overall Study|Physician Decision|1
7475136|NCT01975831|11780359|FG006|Overall Study|Physician Decision|0
7475137|NCT01975831|11780360|FG007|Overall Study|Physician Decision|1
7475138|NCT01975831|11780361|FG008|Overall Study|Physician Decision|0
7475139|NCT01975831|11780353|FG000|Overall Study|Initiation of Subsequent Therapy|0
7475140|NCT01975831|11780354|FG001|Overall Study|Initiation of Subsequent Therapy|0
7475141|NCT01975831|11780355|FG002|Overall Study|Initiation of Subsequent Therapy|0
7475142|NCT01975831|11780356|FG003|Overall Study|Initiation of Subsequent Therapy|0
7475143|NCT01975831|11780357|FG004|Overall Study|Initiation of Subsequent Therapy|0
7475144|NCT01975831|11780358|FG005|Overall Study|Initiation of Subsequent Therapy|1
7475145|NCT01975831|11780359|FG006|Overall Study|Initiation of Subsequent Therapy|0
7475146|NCT01975831|11780360|FG007|Overall Study|Initiation of Subsequent Therapy|2
7475147|NCT01975831|11780361|FG008|Overall Study|Initiation of Subsequent Therapy|0
7475148|NCT01975831|11780353|FG000|Overall Study|Entered Hospice|0
7475149|NCT01975831|11780354|FG001|Overall Study|Entered Hospice|0
7475150|NCT01975831|11780355|FG002|Overall Study|Entered Hospice|0
7475151|NCT01975831|11780356|FG003|Overall Study|Entered Hospice|0
7475152|NCT01975831|11780357|FG004|Overall Study|Entered Hospice|0
7475153|NCT01975831|11780358|FG005|Overall Study|Entered Hospice|1
7475154|NCT01975831|11780359|FG006|Overall Study|Entered Hospice|0
7475155|NCT01975831|11780360|FG007|Overall Study|Entered Hospice|0
7475156|NCT01975831|11780361|FG008|Overall Study|Entered Hospice|0
7475157|NCT01975831|11780353|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
7475158|NCT01975831|11780354|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
7475159|NCT01975831|11780355|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
7475160|NCT01975831|11780356|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
7475161|NCT01975831|11780357|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
7475162|NCT01975831|11780358|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
7475163|NCT01975831|11780359|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
7475164|NCT01975831|11780360|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
7475165|NCT01975831|11780361|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
7475166|NCT01975948|11780412|FG000|Overall Study|Withdrawal by Subject|17
7475167|NCT01975948|11780413|FG001|Overall Study|Withdrawal by Subject|21
7475168|NCT01975948|11780414|FG002|Overall Study|Withdrawal by Subject|7
7475169|NCT01975948|11780415|FG003|Overall Study|Withdrawal by Subject|6
7475170|NCT01976104|11780433|FG000|Overall Study|Adverse Event|0
7475171|NCT01976104|11780434|FG001|Overall Study|Adverse Event|0
7475172|NCT01976104|11780435|FG002|Overall Study|Adverse Event|1
7475173|NCT01976104|11780436|FG003|Overall Study|Adverse Event|0
7475174|NCT01976104|11780433|FG000|Overall Study|Lost to Follow-up|3
7475175|NCT01976104|11780434|FG001|Overall Study|Lost to Follow-up|0
7475176|NCT01976104|11780435|FG002|Overall Study|Lost to Follow-up|1
7475177|NCT01976104|11780436|FG003|Overall Study|Lost to Follow-up|1
7475178|NCT01976104|11780433|FG000|Overall Study|Subject Choice|0
7475179|NCT01976104|11780434|FG001|Overall Study|Subject Choice|1
7475180|NCT01976104|11780435|FG002|Overall Study|Subject Choice|0
7475181|NCT01976104|11780436|FG003|Overall Study|Subject Choice|1
7475182|NCT01976104|11780433|FG000|Overall Study|Withdrawal by Subject|3
7475183|NCT01976104|11780434|FG001|Overall Study|Withdrawal by Subject|0
7475184|NCT01976104|11780435|FG002|Overall Study|Withdrawal by Subject|0
7475185|NCT01976104|11780436|FG003|Overall Study|Withdrawal by Subject|1
7475186|NCT01976104|11780433|FG000|Overall Study|Other|0
7475187|NCT01976104|11780434|FG001|Overall Study|Other|1
7475188|NCT01976104|11780435|FG002|Overall Study|Other|0
7475189|NCT01976104|11780436|FG003|Overall Study|Other|0
7475190|NCT01976299|11780449|FG000|Overall Study|Withdrawal by Subject|3
7475191|NCT01976299|11780450|FG001|Overall Study|Withdrawal by Subject|1
7475192|NCT01976299|11780449|FG000|Overall Study|Death|4
7475193|NCT01976299|11780450|FG001|Overall Study|Death|2
7475194|NCT01976299|11780449|FG000|Overall Study|Lost to Follow-up|7
7475195|NCT01976299|11780450|FG001|Overall Study|Lost to Follow-up|1
7475196|NCT01976299|11780449|FG000|Overall Study|See clarification above in comments|9
7475197|NCT01976299|11780450|FG001|Overall Study|See clarification above in comments|2
7475198|NCT01976312|11780458|FG000|Overall Study|Pregnancy|0
7475199|NCT01976312|11780459|FG001|Overall Study|Pregnancy|1
7475200|NCT01976312|11780458|FG000|Overall Study|Lost to Follow-up|2
7475201|NCT01976312|11780459|FG001|Overall Study|Lost to Follow-up|0
7475202|NCT01976312|11780458|FG000|Overall Study|Withdrawal by Subject|7
7475203|NCT01976312|11780459|FG001|Overall Study|Withdrawal by Subject|2
7475204|NCT01976312|11780458|FG000|Overall Study|Adverse Event|6
7475205|NCT01976312|11780459|FG001|Overall Study|Adverse Event|6
7475206|NCT01976312|11780458|FG000|Overall Study|Protocol Violation|2
7475207|NCT01976312|11780459|FG001|Overall Study|Protocol Violation|0
7475208|NCT01976338|11780468|FG000|Overall Study|Physician Decision|0
7475209|NCT01976338|11780469|FG001|Overall Study|Physician Decision|1
7475210|NCT01976338|11780468|FG000|Overall Study|Lost to Follow-up|3
7475211|NCT01976338|11780469|FG001|Overall Study|Lost to Follow-up|0
7475212|NCT01976338|11780468|FG000|Overall Study|Withdrawal by Subject|5
7475213|NCT01976338|11780469|FG001|Overall Study|Withdrawal by Subject|2
7475214|NCT01976338|11780468|FG000|Overall Study|Adverse Event|5
7475215|NCT01976338|11780469|FG001|Overall Study|Adverse Event|1
7475216|NCT01976364|11780476|FG000|Main Study (36 Months)|Adverse Event|63
7475217|NCT01976364|11780477|FG001|Main Study (36 Months)|Adverse Event|0
7475218|NCT01976364|11780478|FG002|Main Study (36 Months)|Adverse Event|0
7475219|NCT01976364|11780476|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
7475220|NCT01976364|11780477|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
7475221|NCT01976364|11780478|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
7475222|NCT01976364|11780476|FG000|Main Study (36 Months)|Other|13
7475223|NCT01976364|11780477|FG001|Main Study (36 Months)|Other|0
7475224|NCT01976364|11780478|FG002|Main Study (36 Months)|Other|0
7475225|NCT01976364|11780476|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
7475226|NCT01976364|11780477|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
7475227|NCT01976364|11780478|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
7475228|NCT01976364|11780476|FG000|Main Study (36 Months)|Medication error|1
7475229|NCT01976364|11780477|FG001|Main Study (36 Months)|Medication error|0
7475230|NCT01976364|11780478|FG002|Main Study (36 Months)|Medication error|0
7475231|NCT01976364|11780476|FG000|Main Study (36 Months)|Lost to Follow-up|10
7475232|NCT01976364|11780477|FG001|Main Study (36 Months)|Lost to Follow-up|0
7475233|NCT01976364|11780478|FG002|Main Study (36 Months)|Lost to Follow-up|0
7475234|NCT01976364|11780476|FG000|Main Study (36 Months)|Lack of Efficacy|40
7475235|NCT01976364|11780477|FG001|Main Study (36 Months)|Lack of Efficacy|0
7475236|NCT01976364|11780478|FG002|Main Study (36 Months)|Lack of Efficacy|0
7475237|NCT01976364|11780476|FG000|Main Study (36 Months)|Protocol Violation|13
7475238|NCT01976364|11780477|FG001|Main Study (36 Months)|Protocol Violation|0
7475239|NCT01976364|11780478|FG002|Main Study (36 Months)|Protocol Violation|0
7475240|NCT01976364|11780476|FG000|Main Study (36 Months)|Withdrawal by Subject|69
7475241|NCT01976364|11780477|FG001|Main Study (36 Months)|Withdrawal by Subject|0
7475242|NCT01976364|11780478|FG002|Main Study (36 Months)|Withdrawal by Subject|0
7475243|NCT01976364|11780476|FG000|Main Study (36 Months)|Death|5
7475244|NCT01976364|11780477|FG001|Main Study (36 Months)|Death|0
7475245|NCT01976364|11780478|FG002|Main Study (36 Months)|Death|0
7475246|NCT01976364|11780476|FG000|Sub-study (12 Months)|Lost to Follow-up|0
7475247|NCT01976364|11780477|FG001|Sub-study (12 Months)|Lost to Follow-up|1
7475248|NCT01976364|11780478|FG002|Sub-study (12 Months)|Lost to Follow-up|0
7475249|NCT01976364|11780476|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
7475250|NCT01976364|11780477|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
7475251|NCT01976364|11780478|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
7475252|NCT01976364|11780476|FG000|Sub-study (12 Months)|Protocol Violation|0
7475253|NCT01976364|11780477|FG001|Sub-study (12 Months)|Protocol Violation|1
7475254|NCT01976364|11780478|FG002|Sub-study (12 Months)|Protocol Violation|1
7475255|NCT01976364|11780476|FG000|Sub-study (12 Months)|Adverse Event|0
7475256|NCT01976364|11780477|FG001|Sub-study (12 Months)|Adverse Event|4
7475257|NCT01976364|11780478|FG002|Sub-study (12 Months)|Adverse Event|3
7475258|NCT01976507|11780514|FG000|Overall Study|Adverse Event|6
7475259|NCT01976507|11780514|FG000|Overall Study|ablation not done, drug not given|1
7475260|NCT01976624|11780529|FG000|Overall Study|Participants contraindicated|2
7475261|NCT01976624|11780529|FG000|Overall Study|Participants age less than 19 years|12
7475262|NCT01976663|11780537|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
7475263|NCT01976663|11780537|FG000|Overall Study|Personal Reasons|6
7475264|NCT01976663|11780537|FG000|Overall Study|Withdrawal by Subject|4
7475265|NCT01976663|11780537|FG000|Overall Study|Screen Failure|3
7475266|NCT01976663|11780537|FG000|Overall Study|Adverse Event|2
7475267|NCT01976663|11780537|FG000|Overall Study|Lost to Follow-up|3
7475268|NCT01976728|11780549|FG000|Overall Study|Subject missed multiple doses of IMP|1
7475269|NCT01976728|11780550|FG001|Overall Study|Subject missed multiple doses of IMP|0
7475270|NCT01976728|11780551|FG002|Overall Study|Subject missed multiple doses of IMP|0
7475271|NCT01976728|11780552|FG003|Overall Study|Subject missed multiple doses of IMP|0
7475272|NCT01976741|11780588|FG000|Overall Study|Withdrawal by Subject|1
7475273|NCT01976741|11780589|FG001|Overall Study|Withdrawal by Subject|0
7475274|NCT01976741|11780590|FG002|Overall Study|Withdrawal by Subject|1
7475275|NCT01976741|11780591|FG003|Overall Study|Withdrawal by Subject|1
7475276|NCT01976741|11780592|FG004|Overall Study|Withdrawal by Subject|0
7475277|NCT01976741|11780593|FG005|Overall Study|Withdrawal by Subject|0
7475278|NCT01976741|11780594|FG006|Overall Study|Withdrawal by Subject|1
7475279|NCT01976741|11780595|FG007|Overall Study|Withdrawal by Subject|4
7475280|NCT01976741|11780596|FG008|Overall Study|Withdrawal by Subject|0
7475281|NCT01976741|11780597|FG009|Overall Study|Withdrawal by Subject|0
7475282|NCT01976741|11780588|FG000|Overall Study|Adverse Event|0
7475283|NCT01976741|11780589|FG001|Overall Study|Adverse Event|0
7475284|NCT01976741|11780590|FG002|Overall Study|Adverse Event|2
7475285|NCT01976741|11780591|FG003|Overall Study|Adverse Event|0
7475286|NCT01976741|11780592|FG004|Overall Study|Adverse Event|0
7475287|NCT01976741|11780593|FG005|Overall Study|Adverse Event|0
7475288|NCT01976741|11780594|FG006|Overall Study|Adverse Event|3
7475289|NCT01976741|11780595|FG007|Overall Study|Adverse Event|8
7475290|NCT01976741|11780596|FG008|Overall Study|Adverse Event|1
7475291|NCT01976741|11780597|FG009|Overall Study|Adverse Event|4
7475292|NCT01976806|11780633|FG000|Overall Study|Lost to Follow-up|1
7475293|NCT01976806|11780634|FG001|Overall Study|Lost to Follow-up|4
7475294|NCT01976806|11780633|FG000|Overall Study|Adverse Event|1
7475295|NCT01976806|11780634|FG001|Overall Study|Adverse Event|1
7475296|NCT01976806|11780633|FG000|Overall Study|Withdrawal by Subject|1
7475297|NCT01976806|11780634|FG001|Overall Study|Withdrawal by Subject|1
7475298|NCT01976845|11780652|FG000|Overall Study|Physician Decision|8
7475299|NCT01976845|11780653|FG001|Overall Study|Physician Decision|8
7475300|NCT01976845|11780654|FG002|Overall Study|Physician Decision|3
7475301|NCT01977040|11780686|FG000|Overall Study|Vasa previa not confirmed|2
7475302|NCT01977092|11780696|FG000|Overall Study|Death|3
7475303|NCT01977092|11780697|FG001|Overall Study|Death|4
7475304|NCT01977092|11780696|FG000|Overall Study|Lost to Follow-up|23
7475305|NCT01977092|11780697|FG001|Overall Study|Lost to Follow-up|14
7475306|NCT01977092|11780696|FG000|Overall Study|Withdrawal by Subject|2
7475307|NCT01977092|11780697|FG001|Overall Study|Withdrawal by Subject|1
7475308|NCT01977092|11780696|FG000|Overall Study|In prison|3
7475309|NCT01977092|11780697|FG001|Overall Study|In prison|11
7475310|NCT01977222|11780703|FG000|Overall Study|Withdrawal by Subject|1
7475311|NCT01977352|11780709|FG000|Overall Study|Lost to Follow-up|1
7475312|NCT01977352|11780710|FG001|Overall Study|Lost to Follow-up|2
7475313|NCT01977456|11780716|FG000|Overall Study|Death|5
7475314|NCT01977482|11780726|FG000|Overall Study|Adverse Event|0
7475315|NCT01977482|11780727|FG001|Overall Study|Adverse Event|1
7475316|NCT01977482|11780728|FG002|Overall Study|Adverse Event|1
7475317|NCT01977482|11780729|FG003|Overall Study|Adverse Event|0
7475318|NCT01977482|11780730|FG004|Overall Study|Adverse Event|2
7475319|NCT01977482|11780731|FG005|Overall Study|Adverse Event|0
7475320|NCT01977482|11780726|FG000|Overall Study|Lost to Follow-up|1
7475321|NCT01977482|11780727|FG001|Overall Study|Lost to Follow-up|0
7475322|NCT01977482|11780728|FG002|Overall Study|Lost to Follow-up|0
7475323|NCT01977482|11780729|FG003|Overall Study|Lost to Follow-up|0
7475324|NCT01977482|11780730|FG004|Overall Study|Lost to Follow-up|0
7475325|NCT01977482|11780731|FG005|Overall Study|Lost to Follow-up|0
7475326|NCT01977482|11780726|FG000|Overall Study|Physician Decision|0
7475327|NCT01977482|11780727|FG001|Overall Study|Physician Decision|1
7475328|NCT01977482|11780728|FG002|Overall Study|Physician Decision|0
7475329|NCT01977482|11780729|FG003|Overall Study|Physician Decision|0
7475330|NCT01977482|11780730|FG004|Overall Study|Physician Decision|0
7475331|NCT01977482|11780731|FG005|Overall Study|Physician Decision|0
7475332|NCT01977482|11780726|FG000|Overall Study|Protocol Violation|0
7475333|NCT01977482|11780727|FG001|Overall Study|Protocol Violation|0
7475334|NCT01977482|11780728|FG002|Overall Study|Protocol Violation|1
7475335|NCT01977482|11780729|FG003|Overall Study|Protocol Violation|0
7475336|NCT01977482|11780730|FG004|Overall Study|Protocol Violation|0
7475337|NCT01977482|11780731|FG005|Overall Study|Protocol Violation|0
7475338|NCT01977482|11780726|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
7475339|NCT01977482|11780727|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
7475340|NCT01977482|11780728|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
7475341|NCT01977482|11780729|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
7475342|NCT01977482|11780730|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
7475343|NCT01977482|11780731|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
7475344|NCT01977482|11780726|FG000|Overall Study|Withdrawal by Subject|2
7475345|NCT01977482|11780727|FG001|Overall Study|Withdrawal by Subject|4
7475346|NCT01977482|11780728|FG002|Overall Study|Withdrawal by Subject|1
7475347|NCT01977482|11780729|FG003|Overall Study|Withdrawal by Subject|3
7475348|NCT01977482|11780730|FG004|Overall Study|Withdrawal by Subject|1
7475349|NCT01977482|11780731|FG005|Overall Study|Withdrawal by Subject|5
7475350|NCT01977573|11780763|FG000|Overall Study|Adverse Event|7
7475351|NCT01977573|11780764|FG001|Overall Study|Adverse Event|0
7475352|NCT01977573|11780765|FG002|Overall Study|Adverse Event|2
7475353|NCT01977573|11780766|FG003|Overall Study|Adverse Event|1
7475354|NCT01977573|11780763|FG000|Overall Study|Lost to Follow-up|1
7475355|NCT01977573|11780764|FG001|Overall Study|Lost to Follow-up|0
7475356|NCT01977573|11780765|FG002|Overall Study|Lost to Follow-up|0
7475357|NCT01977573|11780766|FG003|Overall Study|Lost to Follow-up|1
7475358|NCT01977573|11780763|FG000|Overall Study|Physician Decision|1
7475359|NCT01977573|11780764|FG001|Overall Study|Physician Decision|0
7475360|NCT01977573|11780765|FG002|Overall Study|Physician Decision|0
7475361|NCT01977573|11780766|FG003|Overall Study|Physician Decision|0
7475362|NCT01977573|11780763|FG000|Overall Study|Protocol Violation|3
7475363|NCT01977573|11780764|FG001|Overall Study|Protocol Violation|1
7475364|NCT01977573|11780765|FG002|Overall Study|Protocol Violation|0
7475365|NCT01977573|11780766|FG003|Overall Study|Protocol Violation|0
7475366|NCT01977573|11780763|FG000|Overall Study|Reached Defined Stopping Criteria|2
7475367|NCT01977573|11780764|FG001|Overall Study|Reached Defined Stopping Criteria|1
7475368|NCT01977573|11780765|FG002|Overall Study|Reached Defined Stopping Criteria|1
7475369|NCT01977573|11780766|FG003|Overall Study|Reached Defined Stopping Criteria|0
7475370|NCT01977573|11780763|FG000|Overall Study|Withdrawal by Subject|6
7475371|NCT01977573|11780764|FG001|Overall Study|Withdrawal by Subject|1
7475372|NCT01977573|11780765|FG002|Overall Study|Withdrawal by Subject|1
7475373|NCT01977573|11780766|FG003|Overall Study|Withdrawal by Subject|1
7475374|NCT01977612|11780788|FG000|Overall Study|Lost to Follow-up|1
7475375|NCT01977612|11780789|FG001|Overall Study|Lost to Follow-up|1
7475376|NCT01977625|11780795|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
7475377|NCT01977625|11780796|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
7475378|NCT01977625|11780795|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7475379|NCT01977625|11780796|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7475380|NCT01977651|11780804|FG000|4 Month Treatment Period|Adverse Event|34
7475381|NCT01977651|11780804|FG000|4 Month Treatment Period|Death|3
7475382|NCT01977651|11780804|FG000|4 Month Treatment Period|Progressive Disease|43
7475383|NCT01977651|11780804|FG000|4 Month Treatment Period|Withdrawal by Subject|17
7475384|NCT01977651|11780804|FG000|4 Month Treatment Period|Physician Decision|4
7475385|NCT01977651|11780804|FG000|1 Year Extension Period|Adverse Event|14
7475386|NCT01977651|11780804|FG000|1 Year Extension Period|Death|10
7475387|NCT01977651|11780804|FG000|1 Year Extension Period|Lost to Follow-up|2
7475388|NCT01977651|11780804|FG000|1 Year Extension Period|Progressive Disease|86
7475389|NCT01977651|11780804|FG000|1 Year Extension Period|Withdrawal by Subject|11
7475390|NCT01977651|11780804|FG000|1 Year Extension Period|Physician Decision|6
7475391|NCT01977651|11780804|FG000|1 Year Extension Period|Miscellaneous|1
7475392|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Adverse Event|5
7475393|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Death|13
7475394|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Progressive Disease|60
7475395|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
7475396|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Physician Decision|4
7475397|NCT01977651|11780804|FG000|Post 1 Year Extension Period|Miscellaneous|49
7475398|NCT01977677|11780811|FG000|Overall Study|Unrelated Adverse Event|0
7475399|NCT01977677|11780812|FG001|Overall Study|Unrelated Adverse Event|0
7475400|NCT01977677|11780813|FG002|Overall Study|Unrelated Adverse Event|1
7475401|NCT01977690|11780823|FG000|Overall Study|Withdrawal by Subject|0
7475402|NCT01977690|11780824|FG001|Overall Study|Withdrawal by Subject|4
7475403|NCT01977794|11780841|FG000|Overall Study|Adverse Event|2
7475404|NCT01977794|11780842|FG001|Overall Study|Adverse Event|2
7475405|NCT01977794|11780841|FG000|Overall Study|Lost to Follow-up|2
7475406|NCT01977794|11780842|FG001|Overall Study|Lost to Follow-up|1
7475407|NCT01977794|11780841|FG000|Overall Study|Protocol Violation|1
7475408|NCT01977794|11780842|FG001|Overall Study|Protocol Violation|0
7475409|NCT01977794|11780841|FG000|Overall Study|Death|1
7475410|NCT01977794|11780842|FG001|Overall Study|Death|1
7475411|NCT01977794|11780841|FG000|Overall Study|Withdrew consent|2
7475412|NCT01977794|11780842|FG001|Overall Study|Withdrew consent|1
7475413|NCT01977794|11780841|FG000|Overall Study|Other|0
7475414|NCT01977794|11780842|FG001|Overall Study|Other|1
7475415|NCT01977820|11780850|FG000|Overall Study|Sponsor terminated the study|1
7475416|NCT01977820|11780851|FG001|Overall Study|Sponsor terminated the study|1
7475417|NCT01977846|11780859|FG000|Total Study - Prospective|Death|0
7475418|NCT01977846|11780860|FG001|Total Study - Prospective|Death|1
7475419|NCT01977846|11780859|FG000|Total Study - Prospective|Lost to Follow-up|0
7475420|NCT01977846|11780860|FG001|Total Study - Prospective|Lost to Follow-up|8
7475421|NCT01977846|11780859|FG000|Total Study - Prospective|Withdrawal by Subject|0
7475422|NCT01977846|11780860|FG001|Total Study - Prospective|Withdrawal by Subject|13
7475423|NCT01977846|11780859|FG000|Total Study - Prospective|Not available at time of visit|0
7475424|NCT01977846|11780860|FG001|Total Study - Prospective|Not available at time of visit|5
7475425|NCT01977846|11780859|FG000|Total Study - Prospective|No show|0
7475426|NCT01977846|11780860|FG001|Total Study - Prospective|No show|1
7475427|NCT01977846|11780859|FG000|Total Study - Prospective|Protocol Violation|0
7475428|NCT01977846|11780860|FG001|Total Study - Prospective|Protocol Violation|1
7475429|NCT01977898|11780869|FG000|Overall Study|Non functioning catheter|1
7475430|NCT01977898|11780870|FG001|Overall Study|Non functioning catheter|1
7475431|NCT01977937|11780878|FG000|Overall Study|Withdrawal by Subject|2
7475432|NCT01977937|11780879|FG001|Overall Study|Withdrawal by Subject|1
7475433|NCT01977937|11780878|FG000|Overall Study|Adverse Event|1
7475434|NCT01977937|11780879|FG001|Overall Study|Adverse Event|0
7475435|NCT01977937|11780878|FG000|Overall Study|Physician Decision|0
7475436|NCT01977937|11780879|FG001|Overall Study|Physician Decision|1
7475437|NCT01978093|11780887|FG000|Overall Study|Death|1
7475438|NCT01978093|11780888|FG001|Overall Study|Death|0
7475439|NCT01978093|11780887|FG000|Overall Study|Adverse Event|0
7475440|NCT01978093|11780888|FG001|Overall Study|Adverse Event|5
7475441|NCT01978093|11780887|FG000|Overall Study|Protocol Violation|8
7475442|NCT01978093|11780888|FG001|Overall Study|Protocol Violation|2
7475443|NCT01978093|11780887|FG000|Overall Study|Withdrawal by Subject|29
7475444|NCT01978093|11780888|FG001|Overall Study|Withdrawal by Subject|25
7475445|NCT01978093|11780887|FG000|Overall Study|Lost to Follow-up|11
7475446|NCT01978093|11780888|FG001|Overall Study|Lost to Follow-up|15
7475447|NCT01978093|11780887|FG000|Overall Study|Migrated/moved from study area|11
7475448|NCT01978093|11780888|FG001|Overall Study|Migrated/moved from study area|13
7475449|NCT01978093|11780887|FG000|Overall Study|Loss of kaiser coverage|4
7475450|NCT01978093|11780888|FG001|Overall Study|Loss of kaiser coverage|10
7475451|NCT01978093|11780887|FG000|Overall Study|Lost kaiser health plan unable to contac|1
7475452|NCT01978093|11780888|FG001|Overall Study|Lost kaiser health plan unable to contac|0
7475453|NCT01978093|11780887|FG000|Overall Study|Mother lost custody of child|0
7475454|NCT01978093|11780888|FG001|Overall Study|Mother lost custody of child|1
7475455|NCT01978093|11780887|FG000|Overall Study|Child was in care of grandmother|0
7475456|NCT01978093|11780888|FG001|Overall Study|Child was in care of grandmother|1
7475457|NCT01978093|11780887|FG000|Overall Study|N/A for vaccine administration|0
7475458|NCT01978093|11780888|FG001|Overall Study|N/A for vaccine administration|1
7475459|NCT01978119|11780897|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
7475460|NCT01978119|11780898|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
7475461|NCT01978119|11780897|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
7475462|NCT01978119|11780898|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7475463|NCT01978119|11780897|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7475464|NCT01978119|11780898|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
7475465|NCT01978145|11780904|FG000|Treatment Period 1|Adverse Event|1
7475466|NCT01978145|11780905|FG001|Treatment Period 1|Adverse Event|9
7475467|NCT01978145|11780904|FG000|Treatment Period 1|Physician Decision|1
7475468|NCT01978145|11780905|FG001|Treatment Period 1|Physician Decision|0
7475469|NCT01978145|11780904|FG000|Treatment Period 1|Withdrawal by Subject|5
7475470|NCT01978145|11780905|FG001|Treatment Period 1|Withdrawal by Subject|4
7475471|NCT01978145|11780904|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
7475472|NCT01978145|11780905|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
7475473|NCT01978145|11780904|FG000|Washout Period 1|Adverse Event|0
7475474|NCT01978145|11780905|FG001|Washout Period 1|Adverse Event|1
7475475|NCT01978145|11780904|FG000|Washout Period 1|Withdrawal by Subject|1
7475476|NCT01978145|11780905|FG001|Washout Period 1|Withdrawal by Subject|1
7475477|NCT01978145|11780904|FG000|Washout Period 1|Par. reached defined stopping criteria|0
7475478|NCT01978145|11780905|FG001|Washout Period 1|Par. reached defined stopping criteria|1
7475479|NCT01978145|11780904|FG000|Treatment Period 2|Adverse Event|3
7475480|NCT01978145|11780905|FG001|Treatment Period 2|Adverse Event|3
7475481|NCT01978145|11780904|FG000|Treatment Period 2|Protocol Violation|0
7475482|NCT01978145|11780905|FG001|Treatment Period 2|Protocol Violation|1
7475483|NCT01978145|11780904|FG000|Treatment Period 2|Lost to Follow-up|1
7475484|NCT01978145|11780905|FG001|Treatment Period 2|Lost to Follow-up|1
7475485|NCT01978145|11780904|FG000|Treatment Period 2|Withdrawal by Subject|7
7475486|NCT01978145|11780905|FG001|Treatment Period 2|Withdrawal by Subject|4
7475487|NCT01978145|11780904|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
7475488|NCT01978145|11780905|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
7475489|NCT01978184|11780913|FG000|Overall Study|Progressive disease|5
7475490|NCT01978184|11780914|FG001|Overall Study|Progressive disease|5
7475491|NCT01978184|11780913|FG000|Overall Study|Other than PDA|2
7475492|NCT01978184|11780914|FG001|Overall Study|Other than PDA|2
7475493|NCT01978184|11780913|FG000|Overall Study|Physician Decision|0
7475494|NCT01978184|11780914|FG001|Overall Study|Physician Decision|3
7475495|NCT01978184|11780913|FG000|Overall Study|Noncompliance|1
7475496|NCT01978184|11780914|FG001|Overall Study|Noncompliance|2
7475497|NCT01978184|11780913|FG000|Overall Study|Death|1
7475498|NCT01978184|11780914|FG001|Overall Study|Death|0
7475499|NCT01978184|11780913|FG000|Overall Study|Withdrew- toxicities or physical decline|4
7475500|NCT01978184|11780914|FG001|Overall Study|Withdrew- toxicities or physical decline|8
7475501|NCT01978236|11780920|FG000|Overall Study|Discontinued due to study close|2
7475502|NCT01978262|11780924|FG000|Overall Study|Withdrawal by Subject|9
7475503|NCT01978262|11780924|FG000|Overall Study|Lost to Follow-up|2
7475504|NCT01978912|11780992|FG000|Overall Study|Adverse Event|0
7475505|NCT01978912|11780993|FG001|Overall Study|Adverse Event|1
7475506|NCT01978912|11780994|FG002|Overall Study|Adverse Event|0
7475507|NCT01978912|11780995|FG003|Overall Study|Adverse Event|0
7475508|NCT01978912|11780992|FG000|Overall Study|Lost to Follow-up|1
7475509|NCT01978912|11780993|FG001|Overall Study|Lost to Follow-up|1
7475510|NCT01978912|11780994|FG002|Overall Study|Lost to Follow-up|0
7475511|NCT01978912|11780995|FG003|Overall Study|Lost to Follow-up|1
7475512|NCT01978912|11780992|FG000|Overall Study|Withdrawal by Subject|1
7475513|NCT01978912|11780993|FG001|Overall Study|Withdrawal by Subject|0
7475514|NCT01978912|11780994|FG002|Overall Study|Withdrawal by Subject|2
7475515|NCT01978912|11780995|FG003|Overall Study|Withdrawal by Subject|2
7475516|NCT01978912|11780992|FG000|Overall Study|Lumbar Surgery|1
7475517|NCT01978912|11780993|FG001|Overall Study|Lumbar Surgery|0
7475518|NCT01978912|11780994|FG002|Overall Study|Lumbar Surgery|1
7475519|NCT01978912|11780995|FG003|Overall Study|Lumbar Surgery|0
7475520|NCT01978912|11780992|FG000|Overall Study|Intradiscal Steroid Injection|0
7475521|NCT01978912|11780993|FG001|Overall Study|Intradiscal Steroid Injection|1
7475522|NCT01978912|11780994|FG002|Overall Study|Intradiscal Steroid Injection|0
7475523|NCT01978912|11780995|FG003|Overall Study|Intradiscal Steroid Injection|0
7475524|NCT01979016|11781007|FG000|Overall Study|Withdrawal by Subject|2
7475525|NCT01979016|11781008|FG001|Overall Study|Withdrawal by Subject|0
7475526|NCT01979016|11781007|FG000|Overall Study|Adverse Event|0
7475527|NCT01979016|11781008|FG001|Overall Study|Adverse Event|1
7475528|NCT01979185|11781048|FG000|Period 2|Other|0
7475529|NCT01979185|11781049|FG001|Period 2|Other|1
7475530|NCT01979523|11781084|FG000|Overall Study|Withdrawal by Subject|1
7475531|NCT01979523|11781085|FG001|Overall Study|Withdrawal by Subject|0
7475532|NCT01979614|11781094|FG000|Overall Study|Adverse Event|1
7475533|NCT01979614|11781095|FG001|Overall Study|Adverse Event|1
7475534|NCT01979835|11781101|FG000|Primary Outcome SA Measurment|failed insertion|18
7475535|NCT01979835|11781101|FG000|Follow-up|Lost to Follow-up|32
7475536|NCT01979952|11781107|FG000|Overall Study|Adverse Event|4
7475537|NCT01979952|11781108|FG001|Overall Study|Adverse Event|5
7475538|NCT01979952|11781107|FG000|Overall Study|Protocol Violation|1
7475539|NCT01979952|11781108|FG001|Overall Study|Protocol Violation|0
7475540|NCT01979952|11781107|FG000|Overall Study|Withdrawal by Subject|2
7475541|NCT01979952|11781108|FG001|Overall Study|Withdrawal by Subject|1
7475542|NCT01979952|11781107|FG000|Overall Study|Other than specified above|1
7475543|NCT01979952|11781108|FG001|Overall Study|Other than specified above|0
7534209|NCT02694978|11880970|FG001|Overall Study|Death|1
7534210|NCT02694978|11880969|FG000|Overall Study|Other-Decision of Participant|6
7534211|NCT02694978|11880970|FG001|Overall Study|Other-Decision of Participant|1
7534212|NCT02694978|11880969|FG000|Overall Study|Other-Investigator's decision|1
7534213|NCT02694978|11880970|FG001|Overall Study|Other-Investigator's decision|0
7534214|NCT02694978|11880969|FG000|Overall Study|Other-Unable to be reached|0
7534215|NCT02694978|11880970|FG001|Overall Study|Other-Unable to be reached|1
7534216|NCT02694978|11880969|FG000|Overall Study|Other-Protocol noncompliant|2
7534217|NCT02694978|11880970|FG001|Overall Study|Other-Protocol noncompliant|1
7534218|NCT02694978|11880969|FG000|Overall Study|Other-Personal reasons|3
7534219|NCT02694978|11880970|FG001|Overall Study|Other-Personal reasons|3
7534220|NCT02694978|11880969|FG000|Overall Study|Other-Withdrew prior to dosing|9
7534221|NCT02694978|11880970|FG001|Overall Study|Other-Withdrew prior to dosing|8
7534222|NCT02695329|11880982|FG000|Overall Study|Adverse Event|1
7534223|NCT02695329|11880983|FG001|Overall Study|Adverse Event|0
7534224|NCT02695329|11880982|FG000|Overall Study|Poor X-ray quality for measurement|4
7534225|NCT02695329|11880983|FG001|Overall Study|Poor X-ray quality for measurement|5
7534226|NCT02695420|11880993|FG000|Overall Study|Death|0
7534227|NCT02695420|11880994|FG001|Overall Study|Death|1
7534228|NCT02695420|11880995|FG002|Overall Study|Death|0
7534229|NCT02695420|11880996|FG003|Overall Study|Death|0
7534230|NCT02695524|11881015|FG000|Overall Study|Lost to Follow-up|3
7534231|NCT02695524|11881016|FG001|Overall Study|Lost to Follow-up|2
7534232|NCT02695524|11881015|FG000|Overall Study|Death|0
7534233|NCT02695524|11881016|FG001|Overall Study|Death|1
7534234|NCT02695537|11881022|FG000|Overall Study|Adverse Event|3
7534235|NCT02695537|11881022|FG000|Overall Study|Lack of Efficacy|28
7534236|NCT02695537|11881022|FG000|Overall Study|Withdrawal by Subject|4
7534237|NCT02695537|11881022|FG000|Overall Study|Protocol Violation|3
7534238|NCT02695628|11881026|FG000|Overall Study|Withdrawal by Subject|1
7534239|NCT02695719|11881032|FG000|Overall Study|Pretreatment Event/Adverse Event|2
7534240|NCT02695719|11881033|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7534241|NCT02695719|11881032|FG000|Overall Study|Significant Protocol Deviation|0
7534242|NCT02695719|11881033|FG001|Overall Study|Significant Protocol Deviation|1
7534243|NCT02695719|11881032|FG000|Overall Study|Voluntary Withdrawal|1
7534244|NCT02695719|11881033|FG001|Overall Study|Voluntary Withdrawal|0
7534245|NCT02696317|11881075|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
7534246|NCT02696317|11881076|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
7534247|NCT02696317|11881075|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
7534248|NCT02696317|11881076|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
7534249|NCT02696434|11881086|FG000|Overall Study|Adverse Event|3
7534250|NCT02696434|11881087|FG001|Overall Study|Adverse Event|1
7534251|NCT02696434|11881086|FG000|Overall Study|Lost to Follow-up|5
7534252|NCT02696434|11881087|FG001|Overall Study|Lost to Follow-up|4
7534253|NCT02696434|11881086|FG000|Overall Study|Withdrawal by Subject|14
7534254|NCT02696434|11881087|FG001|Overall Study|Withdrawal by Subject|12
7534255|NCT02696434|11881086|FG000|Overall Study|Physician Decision|0
7534256|NCT02696434|11881087|FG001|Overall Study|Physician Decision|1
7534257|NCT02696785|11881097|FG000|Blinded Treatment Period|Adverse Event|0
7534258|NCT02696785|11881098|FG001|Blinded Treatment Period|Adverse Event|1
7534259|NCT02696785|11881099|FG002|Blinded Treatment Period|Adverse Event|3
7534260|NCT02696785|11881100|FG003|Blinded Treatment Period|Adverse Event|0
7534261|NCT02696785|11881097|FG000|Blinded Treatment Period|Withdrawal by Subject|0
7534262|NCT02696785|11881098|FG001|Blinded Treatment Period|Withdrawal by Subject|1
7534263|NCT02696785|11881099|FG002|Blinded Treatment Period|Withdrawal by Subject|1
7534264|NCT02696785|11881100|FG003|Blinded Treatment Period|Withdrawal by Subject|2
7534265|NCT02696785|11881097|FG000|Blinded Treatment Period|Lack of Efficacy|0
7534266|NCT02696785|11881098|FG001|Blinded Treatment Period|Lack of Efficacy|0
7534267|NCT02696785|11881099|FG002|Blinded Treatment Period|Lack of Efficacy|0
7534268|NCT02696785|11881100|FG003|Blinded Treatment Period|Lack of Efficacy|1
7534269|NCT02696785|11881097|FG000|Blinded Treatment Period|Screen Failure|1
7534270|NCT02696785|11881098|FG001|Blinded Treatment Period|Screen Failure|0
7534271|NCT02696785|11881099|FG002|Blinded Treatment Period|Screen Failure|0
7534272|NCT02696785|11881100|FG003|Blinded Treatment Period|Screen Failure|0
7534273|NCT02696785|11881097|FG000|Washout Period|Withdrawal by Subject|0
7534274|NCT02696785|11881098|FG001|Washout Period|Withdrawal by Subject|1
7534275|NCT02696785|11881099|FG002|Washout Period|Withdrawal by Subject|0
7534276|NCT02696785|11881100|FG003|Washout Period|Withdrawal by Subject|0
7534277|NCT02696785|11881097|FG000|Washout Period|Lack of Efficacy|0
7475544|NCT01980056|11781117|FG000|Overall Study|Death|1
7475545|NCT01980056|11781118|FG001|Overall Study|Death|1
7475546|NCT01980056|11781119|FG002|Overall Study|Death|0
7475547|NCT01980095|11781133|FG000|Overall Study|Lost to Follow-up|6
7475548|NCT01980095|11781134|FG001|Overall Study|Lost to Follow-up|7
7475549|NCT01980095|11781133|FG000|Overall Study|Withdrawal by Subject|2
7475550|NCT01980095|11781134|FG001|Overall Study|Withdrawal by Subject|3
7475551|NCT01980095|11781133|FG000|Overall Study|Poor compliance|5
7475552|NCT01980095|11781134|FG001|Overall Study|Poor compliance|0
7475553|NCT01980095|11781133|FG000|Overall Study|Safety issue|0
7475554|NCT01980095|11781134|FG001|Overall Study|Safety issue|1
7475555|NCT01980095|11781133|FG000|Overall Study|Study drug discontinued|1
7475556|NCT01980095|11781134|FG001|Overall Study|Study drug discontinued|0
7475557|NCT01980095|11781133|FG000|Overall Study|Randomized by mistake|1
7475558|NCT01980095|11781134|FG001|Overall Study|Randomized by mistake|0
7475559|NCT01980628|11781173|FG000|Overall Study|Adverse Event|12
7475560|NCT01980628|11781173|FG000|Overall Study|Physician Decision|5
7475561|NCT01980628|11781173|FG000|Overall Study|Withdrawal by Subject|4
7475562|NCT01980628|11781173|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
7475563|NCT01980706|11781190|FG000|Overall Study|Withdrawal by Subject|9
7475564|NCT01980706|11781191|FG001|Overall Study|Withdrawal by Subject|6
7475565|NCT01980706|11781192|FG002|Overall Study|Withdrawal by Subject|2
7475566|NCT01980706|11781190|FG000|Overall Study|Adverse Event|1
7475567|NCT01980706|11781191|FG001|Overall Study|Adverse Event|2
7475568|NCT01980706|11781192|FG002|Overall Study|Adverse Event|5
7475569|NCT01980706|11781190|FG000|Overall Study|Lost to Follow-up|3
7475570|NCT01980706|11781191|FG001|Overall Study|Lost to Follow-up|4
7475571|NCT01980706|11781192|FG002|Overall Study|Lost to Follow-up|3
7475572|NCT01980706|11781190|FG000|Overall Study|miscellaneous|4
7475573|NCT01980706|11781191|FG001|Overall Study|miscellaneous|5
7475574|NCT01980706|11781192|FG002|Overall Study|miscellaneous|3
7475575|NCT01980888|11781211|FG000|Overall Study|Study Terminated by Sponsor|116
7475576|NCT01980888|11781212|FG001|Overall Study|Study Terminated by Sponsor|122
7475577|NCT01980888|11781211|FG000|Overall Study|Withdrew Consent|17
7475578|NCT01980888|11781212|FG001|Overall Study|Withdrew Consent|6
7475579|NCT01980888|11781211|FG000|Overall Study|Investigator's Discretion|8
7475580|NCT01980888|11781212|FG001|Overall Study|Investigator's Discretion|3
7475581|NCT01980888|11781211|FG000|Overall Study|Non-Compliance with Study Drug|3
7475582|NCT01980888|11781212|FG001|Overall Study|Non-Compliance with Study Drug|2
7475583|NCT01980992|11781225|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
7475584|NCT01980992|11781226|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
7475585|NCT01980992|11781225|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7475586|NCT01980992|11781226|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
7475587|NCT01980992|11781225|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
7475588|NCT01980992|11781226|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
7475589|NCT01980992|11781225|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
7475590|NCT01980992|11781226|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
7475591|NCT01980992|11781225|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
7475592|NCT01980992|11781226|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
7475762|NCT01984242|11781676|FG002|Overall Study|Study terminated by Sponsor|34
7475593|NCT01980992|11781225|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
7475594|NCT01980992|11781226|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
7475595|NCT01981109|11781248|FG000|Overall Study|Death|36
7475596|NCT01981109|11781248|FG000|Overall Study|Withdrawal by Subject|40
7475597|NCT01981109|11781248|FG000|Overall Study|Lost to Follow-up|9
7475598|NCT01981109|11781248|FG000|Overall Study|No Discontinuation Documentation|37
7475599|NCT01981109|11781248|FG000|Overall Study|Study Termination|100
7475600|NCT01981109|11781248|FG000|Overall Study|No data available|2
7475601|NCT01981122|11781255|FG000|Overall Study|Withdrawal by Subject|0
7475602|NCT01981122|11781256|FG001|Overall Study|Withdrawal by Subject|2
7475603|NCT01981122|11781255|FG000|Overall Study|Protocol Violation|0
7475604|NCT01981122|11781256|FG001|Overall Study|Protocol Violation|1
7475605|NCT01981122|11781255|FG000|Overall Study|Lost to Follow-up|0
7475606|NCT01981122|11781256|FG001|Overall Study|Lost to Follow-up|1
7475607|NCT01981122|11781255|FG000|Overall Study|Investigator Or Dendreon Discretion|0
7475608|NCT01981122|11781256|FG001|Overall Study|Investigator Or Dendreon Discretion|1
7475609|NCT01981122|11781255|FG000|Overall Study|Death|14
7475610|NCT01981122|11781256|FG001|Overall Study|Death|15
7475611|NCT01981187|11781262|FG000|Overall Study|Participant/guardian decision|2
7475612|NCT01981187|11781262|FG000|Overall Study|Physician Decision|1
7475613|NCT01981187|11781262|FG000|Overall Study|Disease progression|2
7475614|NCT01981187|11781262|FG000|Overall Study|Adverse Event|7
7475615|NCT01981356|11781268|FG000|Overall Study|Lost to Follow-up|4
7475616|NCT01981356|11781269|FG001|Overall Study|Lost to Follow-up|1
7475617|NCT01981356|11781268|FG000|Overall Study|Withdrawal by Subject|1
7475618|NCT01981356|11781269|FG001|Overall Study|Withdrawal by Subject|1
7475619|NCT01981356|11781268|FG000|Overall Study|Protocol Violation|2
7475620|NCT01981356|11781269|FG001|Overall Study|Protocol Violation|0
7475621|NCT01981473|11781279|FG000|Overall Study|Incorrect diagnosis of RA|0
7475622|NCT01981473|11781280|FG001|Overall Study|Incorrect diagnosis of RA|0
7475623|NCT01981473|11781281|FG002|Overall Study|Incorrect diagnosis of RA|1
7475624|NCT01981473|11781279|FG000|Overall Study|Received treatment for < 6 months|0
7475625|NCT01981473|11781280|FG001|Overall Study|Received treatment for < 6 months|0
7475626|NCT01981473|11781281|FG002|Overall Study|Received treatment for < 6 months|1
7475627|NCT01981473|11781279|FG000|Overall Study|Received treatment for >24 months|2
7475628|NCT01981473|11781280|FG001|Overall Study|Received treatment for >24 months|0
7475629|NCT01981473|11781281|FG002|Overall Study|Received treatment for >24 months|6
7475630|NCT01981616|11781309|FG000|Overall Study|Adverse Event|0
7475631|NCT01981616|11781310|FG001|Overall Study|Adverse Event|1
7475632|NCT01981616|11781309|FG000|Overall Study|Protocol Violation|1
7475633|NCT01981616|11781310|FG001|Overall Study|Protocol Violation|0
7475634|NCT01981954|11781343|FG000|Titration Period|Protocol Deviation|1
7475635|NCT01981954|11781343|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
7475636|NCT01982292|11781379|FG000|Overall Study|Adverse Event|2
7475637|NCT01982292|11781380|FG001|Overall Study|Adverse Event|0
7475638|NCT01982292|11781379|FG000|Overall Study|Death|1
7475639|NCT01982292|11781380|FG001|Overall Study|Death|0
7475640|NCT01982292|11781379|FG000|Overall Study|Lost to Follow-up|2
7475641|NCT01982292|11781380|FG001|Overall Study|Lost to Follow-up|0
7475642|NCT01982292|11781379|FG000|Overall Study|Non-Compliance With Study Treatment|1
7475643|NCT01982292|11781380|FG001|Overall Study|Non-Compliance With Study Treatment|0
7475644|NCT01982292|11781379|FG000|Overall Study|Protocol Deviation|1
7475645|NCT01982292|11781380|FG001|Overall Study|Protocol Deviation|0
7475646|NCT01982292|11781379|FG000|Overall Study|Patient/Guardian Decision|3
7475647|NCT01982292|11781380|FG001|Overall Study|Patient/Guardian Decision|1
7475648|NCT01982292|11781379|FG000|Overall Study|Technical Problems|2
7475649|NCT01982292|11781380|FG001|Overall Study|Technical Problems|0
7475650|NCT01982331|11781388|FG000|Received Vaccination 2|Adverse Event|1
7475651|NCT01982331|11781389|FG001|Received Vaccination 2|Adverse Event|2
7475652|NCT01982331|11781388|FG000|Received Vaccination 2|Withdrawal by Subject|0
7475653|NCT01982331|11781389|FG001|Received Vaccination 2|Withdrawal by Subject|1
7475654|NCT01982331|11781388|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
7475655|NCT01982331|11781389|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
7475656|NCT01982435|11781397|FG000|Overall Study|Adverse Event|1
7475657|NCT01982435|11781398|FG001|Overall Study|Adverse Event|0
7475658|NCT01982682|11781412|FG000|Overall Study|Physician Decision|1
7475659|NCT01982773|11781428|FG000|Overall Study|Withdrawal by Subject|1
7475660|NCT01982773|11781429|FG001|Overall Study|Withdrawal by Subject|3
7475661|NCT01982773|11781428|FG000|Overall Study|Lost to Follow-up|7
7475662|NCT01982773|11781429|FG001|Overall Study|Lost to Follow-up|1
7475663|NCT01982812|11781446|FG000|Overall Study|Death|1
7475664|NCT01982812|11781447|FG001|Overall Study|Death|5
7475665|NCT01982812|11781446|FG000|Overall Study|Adverse Event|0
7475666|NCT01982812|11781447|FG001|Overall Study|Adverse Event|5
7475667|NCT01982942|11781455|FG000|Overall Study|Adverse Event|10
7475668|NCT01982942|11781456|FG001|Overall Study|Adverse Event|5
7475669|NCT01982942|11781455|FG000|Overall Study|Lost to Follow-up|4
7475670|NCT01982942|11781456|FG001|Overall Study|Lost to Follow-up|3
7475671|NCT01982942|11781455|FG000|Overall Study|Multiple sclerosis progression|3
7475672|NCT01982942|11781456|FG001|Overall Study|Multiple sclerosis progression|2
7475673|NCT01982942|11781455|FG000|Overall Study|Wanted to try therapy not permitted|1
7475674|NCT01982942|11781456|FG001|Overall Study|Wanted to try therapy not permitted|0
7475675|NCT01982942|11781455|FG000|Overall Study|Subject declined future visits|0
7475676|NCT01982942|11781456|FG001|Overall Study|Subject declined future visits|1
7475677|NCT01982942|11781455|FG000|Overall Study|Left geographical area|2
7475678|NCT01982942|11781456|FG001|Overall Study|Left geographical area|0
7475679|NCT01982942|11781455|FG000|Overall Study|Too many pills|1
7475680|NCT01982942|11781456|FG001|Overall Study|Too many pills|0
7475681|NCT01982942|11781455|FG000|Overall Study|MS Relapse|0
7475682|NCT01982942|11781456|FG001|Overall Study|MS Relapse|1
7475683|NCT01982942|11781455|FG000|Overall Study|Chose to join a stem cell trial|0
7475684|NCT01982942|11781456|FG001|Overall Study|Chose to join a stem cell trial|1
7475685|NCT01982942|11781455|FG000|Overall Study|Subject bedridden, rapidly declining|0
7475686|NCT01982942|11781456|FG001|Overall Study|Subject bedridden, rapidly declining|1
7475697|NCT01983111|11781512|FG000|Overall Study|Withdrawal by Subject|8
7475698|NCT01983111|11781513|FG001|Overall Study|Withdrawal by Subject|6
7475699|NCT01983111|11781512|FG000|Overall Study|Adverse Event|4
7475700|NCT01983111|11781513|FG001|Overall Study|Adverse Event|0
7475701|NCT01983111|11781512|FG000|Overall Study|Protocol Violation|0
7475702|NCT01983111|11781513|FG001|Overall Study|Protocol Violation|1
7475703|NCT01983254|11781532|FG000|Overall Study|Death|6
7475704|NCT01983254|11781533|FG001|Overall Study|Death|6
7475705|NCT01983254|11781532|FG000|Overall Study|Lost to Follow-up|17
7475706|NCT01983254|11781533|FG001|Overall Study|Lost to Follow-up|16
7475707|NCT01983254|11781532|FG000|Overall Study|too ill|11
7475708|NCT01983254|11781533|FG001|Overall Study|too ill|8
7475709|NCT01983293|11781541|FG000|Overall Study|Withdrawal by Subject|29
7475710|NCT01983293|11781542|FG001|Overall Study|Withdrawal by Subject|15
7475711|NCT01983293|11781541|FG000|Overall Study|Missing 12-month visit|3
7475712|NCT01983293|11781542|FG001|Overall Study|Missing 12-month visit|3
7475713|NCT01983293|11781541|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
7475714|NCT01983293|11781542|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
7475715|NCT01983683|11781568|FG000|Overall Study|Withdrawal by Subject|14
7475716|NCT01983683|11781569|FG001|Overall Study|Withdrawal by Subject|18
7475717|NCT01983683|11781568|FG000|Overall Study|Death|11
7475718|NCT01983683|11781569|FG001|Overall Study|Death|15
7475719|NCT01983683|11781568|FG000|Overall Study|Physician Decision|8
7475720|NCT01983683|11781569|FG001|Overall Study|Physician Decision|9
7475721|NCT01983683|11781568|FG000|Overall Study|Lost to Follow-up|4
7475722|NCT01983683|11781569|FG001|Overall Study|Lost to Follow-up|8
7475723|NCT01983683|11781568|FG000|Overall Study|Sponsor Decision|1
7475724|NCT01983683|11781569|FG001|Overall Study|Sponsor Decision|1
7475725|NCT01983930|11781622|FG000|Overall Study|Withdrawal by Subject|9
7475726|NCT01983930|11781623|FG001|Overall Study|Withdrawal by Subject|8
7475727|NCT01983930|11781622|FG000|Overall Study|Adverse Event|0
7475728|NCT01983930|11781623|FG001|Overall Study|Adverse Event|1
7475729|NCT01983969|11781633|FG000|Overall Study|Disease Progression|0
7475730|NCT01983969|11781634|FG001|Overall Study|Disease Progression|1
7475731|NCT01983969|11781635|FG002|Overall Study|Disease Progression|0
7475732|NCT01984164|11781649|FG000|Overall Study|Withdrawal by Subject|4
7475733|NCT01984164|11781650|FG001|Overall Study|Withdrawal by Subject|3
7475734|NCT01984164|11781649|FG000|Overall Study|Adverse Event|5
7475735|NCT01984164|11781650|FG001|Overall Study|Adverse Event|19
7475736|NCT01984164|11781649|FG000|Overall Study|Lost to Follow-up|1
7475737|NCT01984164|11781650|FG001|Overall Study|Lost to Follow-up|3
7475738|NCT01984229|11781658|FG000|Safety Follow-up Period|Adverse Event|1
7475739|NCT01984229|11781659|FG001|Safety Follow-up Period|Adverse Event|1
7475740|NCT01984229|11781658|FG000|Safety Follow-up Period|Lost to Follow-up|1
7475741|NCT01984229|11781659|FG001|Safety Follow-up Period|Lost to Follow-up|0
7475742|NCT01984242|11781674|FG000|Overall Study|Death|52
7475743|NCT01984242|11781675|FG001|Overall Study|Death|50
7475744|NCT01984242|11781676|FG002|Overall Study|Death|52
7475745|NCT01984242|11781674|FG000|Overall Study|Withdrawal by Subject|5
7475746|NCT01984242|11781675|FG001|Overall Study|Withdrawal by Subject|3
7475747|NCT01984242|11781676|FG002|Overall Study|Withdrawal by Subject|10
7475748|NCT01984242|11781674|FG000|Overall Study|Physician Decision|0
7475749|NCT01984242|11781675|FG001|Overall Study|Physician Decision|0
7475750|NCT01984242|11781676|FG002|Overall Study|Physician Decision|1
7475751|NCT01984242|11781674|FG000|Overall Study|Lost to Follow-up|4
7475752|NCT01984242|11781675|FG001|Overall Study|Lost to Follow-up|0
7475753|NCT01984242|11781676|FG002|Overall Study|Lost to Follow-up|3
7475754|NCT01984242|11781674|FG000|Overall Study|Sponsor Decision|1
7475755|NCT01984242|11781675|FG001|Overall Study|Sponsor Decision|0
7475756|NCT01984242|11781676|FG002|Overall Study|Sponsor Decision|0
7475757|NCT01984242|11781674|FG000|Overall Study|Non-Compliance|1
7475758|NCT01984242|11781675|FG001|Overall Study|Non-Compliance|0
7475759|NCT01984242|11781676|FG002|Overall Study|Non-Compliance|0
7475760|NCT01984242|11781674|FG000|Overall Study|Study terminated by Sponsor|38
7475761|NCT01984242|11781675|FG001|Overall Study|Study terminated by Sponsor|50
7475763|NCT01984242|11781674|FG000|Overall Study|Disease Progression|0
7475764|NCT01984242|11781675|FG001|Overall Study|Disease Progression|0
7475765|NCT01984242|11781676|FG002|Overall Study|Disease Progression|1
7475766|NCT01984294|11781695|FG000|Overall Study|Randomized but Never Treated|0
7475767|NCT01984294|11781696|FG001|Overall Study|Randomized but Never Treated|0
7475768|NCT01984294|11781697|FG002|Overall Study|Randomized but Never Treated|1
7475769|NCT01984294|11781695|FG000|Overall Study|Lack of Efficacy|4
7475770|NCT01984294|11781696|FG001|Overall Study|Lack of Efficacy|2
7475771|NCT01984294|11781697|FG002|Overall Study|Lack of Efficacy|6
7475772|NCT01984294|11781695|FG000|Overall Study|Adverse Event|0
7475773|NCT01984294|11781696|FG001|Overall Study|Adverse Event|1
7475774|NCT01984294|11781697|FG002|Overall Study|Adverse Event|0
7475775|NCT01984424|11781722|FG000|Overall Study|Withdrawal by Subject|3
7475776|NCT01984424|11781723|FG001|Overall Study|Withdrawal by Subject|5
7475777|NCT01984424|11781722|FG000|Overall Study|Sponsor Decision|0
7475778|NCT01984424|11781723|FG001|Overall Study|Sponsor Decision|1
7475779|NCT01984424|11781722|FG000|Overall Study|Lost to Follow-up|0
7475780|NCT01984424|11781723|FG001|Overall Study|Lost to Follow-up|1
7475781|NCT01984684|11781735|FG000|Overall Study|Lost to Follow-up|25
7475782|NCT01984684|11781736|FG001|Overall Study|Lost to Follow-up|24
7475783|NCT01984684|11781735|FG000|Overall Study|Adverse Event|8
7475784|NCT01984684|11781736|FG001|Overall Study|Adverse Event|12
7475785|NCT01984684|11781735|FG000|Overall Study|Withdrawal by Subject|9
7475786|NCT01984684|11781736|FG001|Overall Study|Withdrawal by Subject|9
7475787|NCT01984684|11781735|FG000|Overall Study|Lack of Efficacy|3
7475788|NCT01984684|11781736|FG001|Overall Study|Lack of Efficacy|6
7475789|NCT01984684|11781735|FG000|Overall Study|Physician Decision|4
7475790|NCT01984684|11781736|FG001|Overall Study|Physician Decision|2
7475791|NCT01984684|11781735|FG000|Overall Study|Protocol Violation|4
7475792|NCT01984684|11781736|FG001|Overall Study|Protocol Violation|2
7475793|NCT01984684|11781735|FG000|Overall Study|Death|0
7475794|NCT01984684|11781736|FG001|Overall Study|Death|1
7475795|NCT01984684|11781735|FG000|Overall Study|Noncompliance with study drug|2
7475796|NCT01984684|11781736|FG001|Overall Study|Noncompliance with study drug|1
7475797|NCT01984684|11781735|FG000|Overall Study|Subject incarcerated|1
7475798|NCT01984684|11781736|FG001|Overall Study|Subject incarcerated|0
7475799|NCT01984684|11781735|FG000|Overall Study|Study drug not available at site|1
7475800|NCT01984684|11781736|FG001|Overall Study|Study drug not available at site|1
7475801|NCT01984684|11781735|FG000|Overall Study|Subject had inadequate IV access|0
7475802|NCT01984684|11781736|FG001|Overall Study|Subject had inadequate IV access|1
7475803|NCT01984697|11781747|FG000|Overall Study|Adverse Event|0
7475804|NCT01984697|11781748|FG001|Overall Study|Adverse Event|0
7475805|NCT01984697|11781749|FG002|Overall Study|Adverse Event|2
7475806|NCT01984697|11781750|FG003|Overall Study|Adverse Event|0
7475807|NCT01984697|11781751|FG004|Overall Study|Adverse Event|0
7475808|NCT01984697|11781747|FG000|Overall Study|Lost to Follow-up|14
7475809|NCT01984697|11781748|FG001|Overall Study|Lost to Follow-up|5
7475810|NCT01984697|11781749|FG002|Overall Study|Lost to Follow-up|10
7475811|NCT01984697|11781750|FG003|Overall Study|Lost to Follow-up|6
7475812|NCT01984697|11781751|FG004|Overall Study|Lost to Follow-up|21
7475813|NCT01984697|11781747|FG000|Overall Study|Physician Decision|3
7475814|NCT01984697|11781748|FG001|Overall Study|Physician Decision|0
7475815|NCT01984697|11781749|FG002|Overall Study|Physician Decision|0
7475816|NCT01984697|11781750|FG003|Overall Study|Physician Decision|1
7475817|NCT01984697|11781751|FG004|Overall Study|Physician Decision|0
7475818|NCT01984697|11781747|FG000|Overall Study|Protocol Violation|8
7475819|NCT01984697|11781748|FG001|Overall Study|Protocol Violation|5
7475820|NCT01984697|11781749|FG002|Overall Study|Protocol Violation|3
7475821|NCT01984697|11781750|FG003|Overall Study|Protocol Violation|2
7475822|NCT01984697|11781751|FG004|Overall Study|Protocol Violation|0
7475823|NCT01984697|11781747|FG000|Overall Study|Withdrawal by Subject|15
7475824|NCT01984697|11781748|FG001|Overall Study|Withdrawal by Subject|21
7475825|NCT01984697|11781749|FG002|Overall Study|Withdrawal by Subject|13
7475826|NCT01984697|11781750|FG003|Overall Study|Withdrawal by Subject|11
7475827|NCT01984697|11781751|FG004|Overall Study|Withdrawal by Subject|13
7475828|NCT01984697|11781747|FG000|Overall Study|Missed last follow-up visit|1
7475829|NCT01984697|11781748|FG001|Overall Study|Missed last follow-up visit|0
7475830|NCT01984697|11781749|FG002|Overall Study|Missed last follow-up visit|0
7475831|NCT01984697|11781750|FG003|Overall Study|Missed last follow-up visit|0
7475832|NCT01984697|11781751|FG004|Overall Study|Missed last follow-up visit|0
7475833|NCT01984697|11781747|FG000|Overall Study|Death|0
7475834|NCT01984697|11781748|FG001|Overall Study|Death|0
7475835|NCT01984697|11781749|FG002|Overall Study|Death|0
7475836|NCT01984697|11781750|FG003|Overall Study|Death|1
7475837|NCT01984697|11781751|FG004|Overall Study|Death|0
7475838|NCT01984697|11781747|FG000|Overall Study|Pregnancy|2
7475839|NCT01984697|11781748|FG001|Overall Study|Pregnancy|0
7475840|NCT01984697|11781749|FG002|Overall Study|Pregnancy|1
7475841|NCT01984697|11781750|FG003|Overall Study|Pregnancy|0
7475842|NCT01984697|11781751|FG004|Overall Study|Pregnancy|1
7475843|NCT01984892|11781763|FG000|Overall Study|Progressive disease|7
7475844|NCT01985126|11781769|FG000|Overall Study|Death|15
7475845|NCT01985126|11781770|FG001|Overall Study|Death|69
7475846|NCT01985126|11781769|FG000|Overall Study|Lost to Follow-up|0
7475847|NCT01985126|11781770|FG001|Overall Study|Lost to Follow-up|8
7475848|NCT01985126|11781769|FG000|Overall Study|Study Terminated By Sponsor|1
7475849|NCT01985126|11781770|FG001|Overall Study|Study Terminated By Sponsor|22
7475850|NCT01985126|11781769|FG000|Overall Study|Withdrawal by Subject|2
7475851|NCT01985126|11781770|FG001|Overall Study|Withdrawal by Subject|7
7475852|NCT01985321|11781778|FG000|Overall Study|Protocol Violation|4
7475853|NCT01985321|11781779|FG001|Overall Study|Protocol Violation|3
7475854|NCT01985321|11781778|FG000|Overall Study|Withdrawal by Subject|1
7475855|NCT01985321|11781779|FG001|Overall Study|Withdrawal by Subject|0
7475856|NCT01985321|11781778|FG000|Overall Study|Lost to Follow-up|5
7475857|NCT01985321|11781779|FG001|Overall Study|Lost to Follow-up|2
7475858|NCT01985321|11781778|FG000|Overall Study|Subject treated wrong type of sore|1
7475859|NCT01985321|11781779|FG001|Overall Study|Subject treated wrong type of sore|0
7475860|NCT01985334|11781793|FG000|Overall Study|Administrative problems|1
7475861|NCT01985334|11781794|FG001|Overall Study|Administrative problems|1
7475862|NCT01985334|11781795|FG002|Overall Study|Administrative problems|0
7475863|NCT01985334|11781796|FG003|Overall Study|Administrative problems|2
7475864|NCT01985334|11781797|FG004|Overall Study|Administrative problems|0
7475865|NCT01985334|11781798|FG005|Overall Study|Administrative problems|1
7475866|NCT01985334|11781799|FG006|Overall Study|Administrative problems|1
7475867|NCT01985334|11781800|FG007|Overall Study|Administrative problems|3
7475868|NCT01985334|11781793|FG000|Overall Study|Death|1
7475869|NCT01985334|11781794|FG001|Overall Study|Death|0
7475870|NCT01985334|11781795|FG002|Overall Study|Death|0
7475871|NCT01985334|11781796|FG003|Overall Study|Death|3
7475872|NCT01985334|11781797|FG004|Overall Study|Death|0
7475873|NCT01985334|11781798|FG005|Overall Study|Death|0
7475874|NCT01985334|11781799|FG006|Overall Study|Death|1
7475875|NCT01985334|11781800|FG007|Overall Study|Death|2
7475876|NCT01985334|11781793|FG000|Overall Study|Worsening of disease|0
7475877|NCT01985334|11781794|FG001|Overall Study|Worsening of disease|0
7475878|NCT01985334|11781795|FG002|Overall Study|Worsening of disease|0
7475879|NCT01985334|11781796|FG003|Overall Study|Worsening of disease|1
7475880|NCT01985334|11781797|FG004|Overall Study|Worsening of disease|0
7475881|NCT01985334|11781798|FG005|Overall Study|Worsening of disease|3
7475882|NCT01985334|11781799|FG006|Overall Study|Worsening of disease|0
7475883|NCT01985334|11781800|FG007|Overall Study|Worsening of disease|1
7475884|NCT01985334|11781793|FG000|Overall Study|Other|2
7475885|NCT01985334|11781794|FG001|Overall Study|Other|9
7475886|NCT01985334|11781795|FG002|Overall Study|Other|7
7475887|NCT01985334|11781796|FG003|Overall Study|Other|17
7475888|NCT01985334|11781797|FG004|Overall Study|Other|4
7475889|NCT01985334|11781798|FG005|Overall Study|Other|8
7475890|NCT01985334|11781799|FG006|Overall Study|Other|4
7475891|NCT01985334|11781800|FG007|Overall Study|Other|7
7475892|NCT01985334|11781793|FG000|Overall Study|Protocol deviation|6
7475893|NCT01985334|11781794|FG001|Overall Study|Protocol deviation|31
7475894|NCT01985334|11781795|FG002|Overall Study|Protocol deviation|25
7475895|NCT01985334|11781796|FG003|Overall Study|Protocol deviation|84
7475896|NCT01985334|11781797|FG004|Overall Study|Protocol deviation|17
7475897|NCT01985334|11781798|FG005|Overall Study|Protocol deviation|47
7475898|NCT01985334|11781799|FG006|Overall Study|Protocol deviation|15
7475899|NCT01985334|11781800|FG007|Overall Study|Protocol deviation|42
7475900|NCT01985334|11781793|FG000|Overall Study|Moderate / severe COPD exacerbation|5
7475901|NCT01985334|11781794|FG001|Overall Study|Moderate / severe COPD exacerbation|14
7475902|NCT01985334|11781795|FG002|Overall Study|Moderate / severe COPD exacerbation|12
7475903|NCT01985334|11781796|FG003|Overall Study|Moderate / severe COPD exacerbation|40
7475904|NCT01985334|11781797|FG004|Overall Study|Moderate / severe COPD exacerbation|6
7475905|NCT01985334|11781798|FG005|Overall Study|Moderate / severe COPD exacerbation|40
7475906|NCT01985334|11781799|FG006|Overall Study|Moderate / severe COPD exacerbation|8
7475907|NCT01985334|11781800|FG007|Overall Study|Moderate / severe COPD exacerbation|19
7475908|NCT01985334|11781793|FG000|Overall Study|Subject withdrawal of consent|3
7475909|NCT01985334|11781794|FG001|Overall Study|Subject withdrawal of consent|6
7475910|NCT01985334|11781795|FG002|Overall Study|Subject withdrawal of consent|2
7475911|NCT01985334|11781796|FG003|Overall Study|Subject withdrawal of consent|28
7475912|NCT01985334|11781797|FG004|Overall Study|Subject withdrawal of consent|4
7475913|NCT01985334|11781798|FG005|Overall Study|Subject withdrawal of consent|19
7475914|NCT01985334|11781799|FG006|Overall Study|Subject withdrawal of consent|0
7475915|NCT01985334|11781800|FG007|Overall Study|Subject withdrawal of consent|20
7475916|NCT01985334|11781793|FG000|Overall Study|Adverse Event|0
7475917|NCT01985334|11781794|FG001|Overall Study|Adverse Event|8
7475918|NCT01985334|11781795|FG002|Overall Study|Adverse Event|2
7475919|NCT01985334|11781796|FG003|Overall Study|Adverse Event|26
7475920|NCT01985334|11781797|FG004|Overall Study|Adverse Event|3
7475921|NCT01985334|11781798|FG005|Overall Study|Adverse Event|18
7475922|NCT01985334|11781799|FG006|Overall Study|Adverse Event|3
7475923|NCT01985334|11781800|FG007|Overall Study|Adverse Event|15
7475924|NCT01985334|11781793|FG000|Overall Study|Other|4
7475925|NCT01985334|11781794|FG001|Overall Study|Other|2
7475926|NCT01985334|11781795|FG002|Overall Study|Other|3
7475927|NCT01985334|11781796|FG003|Overall Study|Other|10
7475928|NCT01985334|11781797|FG004|Overall Study|Other|1
7475929|NCT01985334|11781798|FG005|Overall Study|Other|6
7475930|NCT01985334|11781799|FG006|Overall Study|Other|2
7475931|NCT01985334|11781800|FG007|Overall Study|Other|2
7475932|NCT01985334|11781793|FG000|Overall Study|Medication non-compliance|0
7475933|NCT01985334|11781794|FG001|Overall Study|Medication non-compliance|4
7475934|NCT01985334|11781795|FG002|Overall Study|Medication non-compliance|1
7475935|NCT01985334|11781796|FG003|Overall Study|Medication non-compliance|6
7475936|NCT01985334|11781797|FG004|Overall Study|Medication non-compliance|2
7475937|NCT01985334|11781798|FG005|Overall Study|Medication non-compliance|3
7475938|NCT01985334|11781799|FG006|Overall Study|Medication non-compliance|1
7475939|NCT01985334|11781800|FG007|Overall Study|Medication non-compliance|3
7475940|NCT01985334|11781793|FG000|Overall Study|Use of prohibited treatment|1
7475941|NCT01985334|11781794|FG001|Overall Study|Use of prohibited treatment|4
7475942|NCT01985334|11781795|FG002|Overall Study|Use of prohibited treatment|1
7475943|NCT01985334|11781796|FG003|Overall Study|Use of prohibited treatment|2
7475944|NCT01985334|11781797|FG004|Overall Study|Use of prohibited treatment|1
7475945|NCT01985334|11781798|FG005|Overall Study|Use of prohibited treatment|6
7475946|NCT01985334|11781799|FG006|Overall Study|Use of prohibited treatment|2
7475947|NCT01985334|11781800|FG007|Overall Study|Use of prohibited treatment|0
7475948|NCT01985334|11781793|FG000|Overall Study|Investigator decision|0
7475949|NCT01985334|11781794|FG001|Overall Study|Investigator decision|3
7475950|NCT01985334|11781795|FG002|Overall Study|Investigator decision|0
7475951|NCT01985334|11781796|FG003|Overall Study|Investigator decision|7
7475952|NCT01985334|11781797|FG004|Overall Study|Investigator decision|1
7475953|NCT01985334|11781798|FG005|Overall Study|Investigator decision|1
7475954|NCT01985334|11781799|FG006|Overall Study|Investigator decision|0
7475955|NCT01985334|11781800|FG007|Overall Study|Investigator decision|4
7475956|NCT01985334|11781793|FG000|Overall Study|Lost to Follow-up|0
7475957|NCT01985334|11781794|FG001|Overall Study|Lost to Follow-up|2
7475958|NCT01985334|11781795|FG002|Overall Study|Lost to Follow-up|0
7475959|NCT01985334|11781796|FG003|Overall Study|Lost to Follow-up|3
7475960|NCT01985334|11781797|FG004|Overall Study|Lost to Follow-up|1
7475961|NCT01985334|11781798|FG005|Overall Study|Lost to Follow-up|4
7475962|NCT01985334|11781799|FG006|Overall Study|Lost to Follow-up|0
7475963|NCT01985334|11781800|FG007|Overall Study|Lost to Follow-up|3
7475964|NCT01985360|11781834|FG000|Overall Study|Withdrawal by Subject|4
7475965|NCT01985360|11781835|FG001|Overall Study|Withdrawal by Subject|0
7475966|NCT01985360|11781834|FG000|Overall Study|Lost to Follow-up|5
7475967|NCT01985360|11781835|FG001|Overall Study|Lost to Follow-up|3
7475968|NCT01986010|11781923|FG000|Overall Study|Adverse Event|0
7475969|NCT01986010|11781924|FG001|Overall Study|Adverse Event|1
7475970|NCT01986010|11781925|FG002|Overall Study|Adverse Event|0
7475971|NCT01986010|11781926|FG003|Overall Study|Adverse Event|0
7475972|NCT01986010|11781927|FG004|Overall Study|Adverse Event|0
7475973|NCT01986010|11781928|FG005|Overall Study|Adverse Event|0
7475974|NCT01986010|11781929|FG006|Overall Study|Adverse Event|0
7475975|NCT01986010|11781930|FG007|Overall Study|Adverse Event|0
7475976|NCT01986010|11781931|FG008|Overall Study|Adverse Event|0
7475977|NCT01986010|11781932|FG009|Overall Study|Adverse Event|0
7475978|NCT01986010|11781933|FG010|Overall Study|Adverse Event|0
7475979|NCT01986010|11781934|FG011|Overall Study|Adverse Event|0
7475980|NCT01986010|11781935|FG012|Overall Study|Adverse Event|0
7475981|NCT01986010|11781936|FG013|Overall Study|Adverse Event|0
7475982|NCT01986010|11781937|FG014|Overall Study|Adverse Event|0
7475983|NCT01986010|11781938|FG015|Overall Study|Adverse Event|1
7475984|NCT01986010|11781939|FG016|Overall Study|Adverse Event|0
7475985|NCT01986010|11781923|FG000|Overall Study|Lost to Follow-up|2
7475986|NCT01986010|11781924|FG001|Overall Study|Lost to Follow-up|1
7475987|NCT01986010|11781925|FG002|Overall Study|Lost to Follow-up|2
7475988|NCT01986010|11781926|FG003|Overall Study|Lost to Follow-up|2
7475989|NCT01986010|11781927|FG004|Overall Study|Lost to Follow-up|2
7475990|NCT01986010|11781928|FG005|Overall Study|Lost to Follow-up|2
7475991|NCT01986010|11781929|FG006|Overall Study|Lost to Follow-up|0
7475992|NCT01986010|11781930|FG007|Overall Study|Lost to Follow-up|0
7475993|NCT01986010|11781931|FG008|Overall Study|Lost to Follow-up|4
7475994|NCT01986010|11781932|FG009|Overall Study|Lost to Follow-up|2
7475995|NCT01986010|11781933|FG010|Overall Study|Lost to Follow-up|0
7475996|NCT01986010|11781934|FG011|Overall Study|Lost to Follow-up|1
7475997|NCT01986010|11781935|FG012|Overall Study|Lost to Follow-up|1
7475998|NCT01986010|11781936|FG013|Overall Study|Lost to Follow-up|1
7475999|NCT01986010|11781937|FG014|Overall Study|Lost to Follow-up|2
7476000|NCT01986010|11781938|FG015|Overall Study|Lost to Follow-up|0
7476001|NCT01986010|11781939|FG016|Overall Study|Lost to Follow-up|0
7476002|NCT01986010|11781923|FG000|Overall Study|Physician Decision|0
7476003|NCT01986010|11781924|FG001|Overall Study|Physician Decision|0
7476004|NCT01986010|11781925|FG002|Overall Study|Physician Decision|0
7476005|NCT01986010|11781926|FG003|Overall Study|Physician Decision|0
7476006|NCT01986010|11781927|FG004|Overall Study|Physician Decision|0
7476007|NCT01986010|11781928|FG005|Overall Study|Physician Decision|0
7476008|NCT01986010|11781929|FG006|Overall Study|Physician Decision|0
7476009|NCT01986010|11781930|FG007|Overall Study|Physician Decision|0
7476010|NCT01986010|11781931|FG008|Overall Study|Physician Decision|0
7476011|NCT01986010|11781932|FG009|Overall Study|Physician Decision|0
7476012|NCT01986010|11781933|FG010|Overall Study|Physician Decision|0
7476013|NCT01986010|11781934|FG011|Overall Study|Physician Decision|0
7476014|NCT01986010|11781935|FG012|Overall Study|Physician Decision|0
7476015|NCT01986010|11781936|FG013|Overall Study|Physician Decision|0
7476016|NCT01986010|11781937|FG014|Overall Study|Physician Decision|1
7476017|NCT01986010|11781938|FG015|Overall Study|Physician Decision|0
7476018|NCT01986010|11781939|FG016|Overall Study|Physician Decision|0
7476019|NCT01986010|11781923|FG000|Overall Study|Withdrawal by Subject|2
7476020|NCT01986010|11781924|FG001|Overall Study|Withdrawal by Subject|2
7476021|NCT01986010|11781925|FG002|Overall Study|Withdrawal by Subject|3
7476022|NCT01986010|11781926|FG003|Overall Study|Withdrawal by Subject|0
7476023|NCT01986010|11781927|FG004|Overall Study|Withdrawal by Subject|2
7476024|NCT01986010|11781928|FG005|Overall Study|Withdrawal by Subject|4
7476025|NCT01986010|11781929|FG006|Overall Study|Withdrawal by Subject|0
7476026|NCT01986010|11781930|FG007|Overall Study|Withdrawal by Subject|0
7476027|NCT01986010|11781931|FG008|Overall Study|Withdrawal by Subject|0
7476028|NCT01986010|11781932|FG009|Overall Study|Withdrawal by Subject|0
7476029|NCT01986010|11781933|FG010|Overall Study|Withdrawal by Subject|0
7476030|NCT01986010|11781934|FG011|Overall Study|Withdrawal by Subject|2
7476031|NCT01986010|11781935|FG012|Overall Study|Withdrawal by Subject|0
7476032|NCT01986010|11781936|FG013|Overall Study|Withdrawal by Subject|1
7476033|NCT01986010|11781937|FG014|Overall Study|Withdrawal by Subject|2
7476034|NCT01986010|11781938|FG015|Overall Study|Withdrawal by Subject|0
7476035|NCT01986010|11781939|FG016|Overall Study|Withdrawal by Subject|0
7476036|NCT01986010|11781923|FG000|Overall Study|Status Not Recorded|2
7476037|NCT01986010|11781924|FG001|Overall Study|Status Not Recorded|4
7476038|NCT01986010|11781925|FG002|Overall Study|Status Not Recorded|2
7476039|NCT01986010|11781926|FG003|Overall Study|Status Not Recorded|0
7476040|NCT01986010|11781927|FG004|Overall Study|Status Not Recorded|1
7476041|NCT01986010|11781928|FG005|Overall Study|Status Not Recorded|2
7476042|NCT01986010|11781929|FG006|Overall Study|Status Not Recorded|0
7476043|NCT01986010|11781930|FG007|Overall Study|Status Not Recorded|0
7476044|NCT01986010|11781931|FG008|Overall Study|Status Not Recorded|2
7476045|NCT01986010|11781932|FG009|Overall Study|Status Not Recorded|1
7476046|NCT01986010|11781933|FG010|Overall Study|Status Not Recorded|7
7476047|NCT01986010|11781934|FG011|Overall Study|Status Not Recorded|7
7476048|NCT01986010|11781935|FG012|Overall Study|Status Not Recorded|9
7476049|NCT01986010|11781936|FG013|Overall Study|Status Not Recorded|9
7476050|NCT01986010|11781937|FG014|Overall Study|Status Not Recorded|5
7476051|NCT01986010|11781938|FG015|Overall Study|Status Not Recorded|10
7476052|NCT01986010|11781939|FG016|Overall Study|Status Not Recorded|4
7476053|NCT01986062|11781987|FG000|Overall Study|Lost to Follow-up|1
7476054|NCT01986062|11781988|FG001|Overall Study|Lost to Follow-up|0
7476055|NCT01986062|11781987|FG000|Overall Study|Withdrawal by Subject|0
7476056|NCT01986062|11781988|FG001|Overall Study|Withdrawal by Subject|1
7476057|NCT01986140|11781996|FG000|Overall Study|Withdrawal by Subject|31
7476058|NCT01986140|11781997|FG001|Overall Study|Withdrawal by Subject|25
7476059|NCT01986140|11781996|FG000|Overall Study|alternative treatment|1
7476060|NCT01986140|11781997|FG001|Overall Study|alternative treatment|1
7476061|NCT01986140|11781996|FG000|Overall Study|found not eligible|3
7476062|NCT01986140|11781997|FG001|Overall Study|found not eligible|0
7476063|NCT01986140|11781996|FG000|Overall Study|Adverse Event|0
7476064|NCT01986140|11781997|FG001|Overall Study|Adverse Event|1
7476065|NCT01986140|11781996|FG000|Overall Study|progression disease|0
7476066|NCT01986140|11781997|FG001|Overall Study|progression disease|1
7476067|NCT01986231|11782003|FG000|Overall Study|Adverse Event|1
7476068|NCT01986348|11782011|FG000|Overall Study|Death|8
7476069|NCT01986348|11782012|FG001|Overall Study|Death|22
7476070|NCT01986348|11782013|FG002|Overall Study|Death|10
7476071|NCT01986348|11782014|FG003|Overall Study|Death|21
7476072|NCT01986348|11782011|FG000|Overall Study|Lost to Follow-up|0
7476073|NCT01986348|11782012|FG001|Overall Study|Lost to Follow-up|0
7476074|NCT01986348|11782013|FG002|Overall Study|Lost to Follow-up|0
7476075|NCT01986348|11782014|FG003|Overall Study|Lost to Follow-up|2
7476076|NCT01986348|11782011|FG000|Overall Study|Physician Decision|0
7476077|NCT01986348|11782012|FG001|Overall Study|Physician Decision|0
7476078|NCT01986348|11782013|FG002|Overall Study|Physician Decision|0
7476079|NCT01986348|11782014|FG003|Overall Study|Physician Decision|1
7476080|NCT01986348|11782011|FG000|Overall Study|Progressive Disease|0
7476081|NCT01986348|11782012|FG001|Overall Study|Progressive Disease|0
7476082|NCT01986348|11782013|FG002|Overall Study|Progressive Disease|2
7476083|NCT01986348|11782014|FG003|Overall Study|Progressive Disease|0
7476084|NCT01986348|11782011|FG000|Overall Study|Withdrawal by Participant|0
7476085|NCT01986348|11782012|FG001|Overall Study|Withdrawal by Participant|1
7476086|NCT01986348|11782013|FG002|Overall Study|Withdrawal by Participant|2
7476087|NCT01986348|11782014|FG003|Overall Study|Withdrawal by Participant|1
7476088|NCT01986348|11782011|FG000|Overall Study|Study Terminated by Sponsor|0
7476089|NCT01986348|11782012|FG001|Overall Study|Study Terminated by Sponsor|0
7476090|NCT01986348|11782013|FG002|Overall Study|Study Terminated by Sponsor|0
7476091|NCT01986348|11782014|FG003|Overall Study|Study Terminated by Sponsor|3
7476092|NCT01986348|11782011|FG000|Overall Study|Other-unspecified|0
7476093|NCT01986348|11782012|FG001|Overall Study|Other-unspecified|1
7476094|NCT01986348|11782013|FG002|Overall Study|Other-unspecified|0
7476095|NCT01986348|11782014|FG003|Overall Study|Other-unspecified|2
7476096|NCT01986647|11782040|FG000|Overall Study|Lost to Follow-up|4
7476097|NCT01986647|11782041|FG001|Overall Study|Lost to Follow-up|1
7476098|NCT01986647|11782042|FG002|Overall Study|Lost to Follow-up|4
7476099|NCT01986647|11782043|FG003|Overall Study|Lost to Follow-up|4
7476100|NCT01986647|11782040|FG000|Overall Study|Withdrawal by Subject|1
7476101|NCT01986647|11782041|FG001|Overall Study|Withdrawal by Subject|3
7476102|NCT01986647|11782042|FG002|Overall Study|Withdrawal by Subject|2
7476103|NCT01986647|11782043|FG003|Overall Study|Withdrawal by Subject|3
7476104|NCT01986647|11782040|FG000|Overall Study|Health|5
7476105|NCT01986647|11782041|FG001|Overall Study|Health|3
7476106|NCT01986647|11782042|FG002|Overall Study|Health|6
7476107|NCT01986647|11782043|FG003|Overall Study|Health|4
7476108|NCT01986829|11782079|FG000|Overall Study|Death|1
7476109|NCT01986855|11782089|FG000|Overall Study|Adverse Event|1
7476110|NCT01986855|11782090|FG001|Overall Study|Adverse Event|0
7476111|NCT01986855|11782091|FG002|Overall Study|Adverse Event|0
7476112|NCT01986855|11782089|FG000|Overall Study|Death|3
7476113|NCT01986855|11782090|FG001|Overall Study|Death|4
7476114|NCT01986855|11782091|FG002|Overall Study|Death|4
7476115|NCT01986855|11782089|FG000|Overall Study|Lost to Follow-up|2
7476116|NCT01986855|11782090|FG001|Overall Study|Lost to Follow-up|1
7476117|NCT01986855|11782091|FG002|Overall Study|Lost to Follow-up|0
7476118|NCT01986855|11782089|FG000|Overall Study|Screen Failure|0
7476119|NCT01986855|11782090|FG001|Overall Study|Screen Failure|1
7476120|NCT01986855|11782091|FG002|Overall Study|Screen Failure|0
7476121|NCT01986855|11782089|FG000|Overall Study|Participant Moved|0
7476122|NCT01986855|11782090|FG001|Overall Study|Participant Moved|0
7476123|NCT01986855|11782091|FG002|Overall Study|Participant Moved|2
7476124|NCT01986855|11782089|FG000|Overall Study|Withdrawal by Subject|7
7476125|NCT01986855|11782090|FG001|Overall Study|Withdrawal by Subject|8
7476126|NCT01986855|11782091|FG002|Overall Study|Withdrawal by Subject|5
7476148|NCT01986907|11782135|FG000|Overall Study|Adverse Event|11
7476149|NCT01986907|11782135|FG000|Overall Study|Unsatisfactory therapeutic effect|24
7476150|NCT01986907|11782135|FG000|Overall Study|Protocol Violation|4
7476151|NCT01986907|11782135|FG000|Overall Study|Withdrawal by Subject|76
7476152|NCT01986907|11782135|FG000|Overall Study|Lost to Follow-up|38
7476153|NCT01986907|11782135|FG000|Overall Study|Death|9
7476154|NCT01986920|11782142|FG000|A- 101 25%|Withdrawal by Subject|1
7476155|NCT01986920|11782143|FG001|A- 101 25%|Withdrawal by Subject|0
7476156|NCT01986920|11782144|FG002|A- 101 25%|Withdrawal by Subject|0
7476157|NCT01986920|11782145|FG003|A- 101 25%|Withdrawal by Subject|0
7476158|NCT01986920|11782142|FG000|A-101 32.5%|Withdrawal by Subject|0
7476159|NCT01986920|11782143|FG001|A-101 32.5%|Withdrawal by Subject|1
7476160|NCT01986920|11782144|FG002|A-101 32.5%|Withdrawal by Subject|0
7476161|NCT01986920|11782145|FG003|A-101 32.5%|Withdrawal by Subject|0
7476162|NCT01986920|11782142|FG000|A-101 40%|Withdrawal by Subject|0
7476163|NCT01986920|11782143|FG001|A-101 40%|Withdrawal by Subject|0
7476164|NCT01986920|11782144|FG002|A-101 40%|Withdrawal by Subject|1
7476165|NCT01986920|11782145|FG003|A-101 40%|Withdrawal by Subject|0
7476166|NCT01986920|11782142|FG000|Placebo|Withdrawal by Subject|0
7476167|NCT01986920|11782143|FG001|Placebo|Withdrawal by Subject|0
7476168|NCT01986920|11782144|FG002|Placebo|Withdrawal by Subject|0
7476169|NCT01986920|11782145|FG003|Placebo|Withdrawal by Subject|1
7476170|NCT01986985|11782164|FG000|Overall Study|Withdrawal by Subject|4
7476171|NCT01986985|11782164|FG000|Overall Study|Scan not completed due to malfunction|3
7476172|NCT01987102|11782179|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7476173|NCT01987102|11782180|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
7476174|NCT01987102|11782179|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
7476175|NCT01987102|11782180|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
7476176|NCT01987102|11782179|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
7476177|NCT01987102|11782180|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
7476178|NCT01987102|11782179|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
7476179|NCT01987102|11782180|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
7476180|NCT01987102|11782179|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
7476181|NCT01987102|11782180|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
7476182|NCT01987102|11782179|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
7476183|NCT01987102|11782180|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
7476184|NCT01987232|11782211|FG000|Overall Study|Ongoing in Study|0
7476185|NCT01987232|11782212|FG001|Overall Study|Ongoing in Study|0
7476186|NCT01987232|11782213|FG002|Overall Study|Ongoing in Study|0
7476187|NCT01987232|11782214|FG003|Overall Study|Ongoing in Study|1
7476188|NCT01987232|11782215|FG004|Overall Study|Ongoing in Study|0
7476189|NCT01987427|11782291|FG000|Overall Study|Adverse Event|4
7476190|NCT01987427|11782292|FG001|Overall Study|Adverse Event|2
7476191|NCT01987427|11782293|FG002|Overall Study|Adverse Event|8
7476192|NCT01987427|11782291|FG000|Overall Study|Lost to Follow-up|6
7476193|NCT01987427|11782292|FG001|Overall Study|Lost to Follow-up|6
7476194|NCT01987427|11782293|FG002|Overall Study|Lost to Follow-up|9
7476195|NCT01987427|11782291|FG000|Overall Study|Withdrawal by Subject|2
7476196|NCT01987427|11782292|FG001|Overall Study|Withdrawal by Subject|1
7476197|NCT01987427|11782293|FG002|Overall Study|Withdrawal by Subject|3
7476198|NCT01987427|11782291|FG000|Overall Study|Lack of Efficacy|1
7476199|NCT01987427|11782292|FG001|Overall Study|Lack of Efficacy|0
7476200|NCT01987427|11782293|FG002|Overall Study|Lack of Efficacy|0
7476201|NCT01987427|11782291|FG000|Overall Study|Other|1
7476202|NCT01987427|11782292|FG001|Overall Study|Other|1
7476203|NCT01987427|11782293|FG002|Overall Study|Other|0
7534278|NCT02696785|11881098|FG001|Washout Period|Lack of Efficacy|1
7534279|NCT02696785|11881099|FG002|Washout Period|Lack of Efficacy|0
7534280|NCT02696785|11881100|FG003|Washout Period|Lack of Efficacy|0
7534281|NCT02696785|11881097|FG000|Extended Treatment Period|Adverse Event|2
7534282|NCT02696785|11881098|FG001|Extended Treatment Period|Adverse Event|3
7534283|NCT02696785|11881099|FG002|Extended Treatment Period|Adverse Event|2
7534284|NCT02696785|11881100|FG003|Extended Treatment Period|Adverse Event|1
7534285|NCT02696785|11881097|FG000|Extended Treatment Period|Lack of Efficacy|0
7534286|NCT02696785|11881098|FG001|Extended Treatment Period|Lack of Efficacy|1
7534287|NCT02696785|11881099|FG002|Extended Treatment Period|Lack of Efficacy|0
7534288|NCT02696785|11881100|FG003|Extended Treatment Period|Lack of Efficacy|0
7534289|NCT02696785|11881097|FG000|Extended Treatment Period|Withdrawal by Subject|1
7534290|NCT02696785|11881098|FG001|Extended Treatment Period|Withdrawal by Subject|2
7534291|NCT02696785|11881099|FG002|Extended Treatment Period|Withdrawal by Subject|3
7534292|NCT02696785|11881100|FG003|Extended Treatment Period|Withdrawal by Subject|5
7534293|NCT02696785|11881097|FG000|Follow-up Period|Adverse Event|0
7534294|NCT02696785|11881098|FG001|Follow-up Period|Adverse Event|0
7534295|NCT02696785|11881099|FG002|Follow-up Period|Adverse Event|8
7534296|NCT02696785|11881100|FG003|Follow-up Period|Adverse Event|2
7476204|NCT01987453|11782304|FG000|Overall Study|Death|0
7476205|NCT01987453|11782305|FG001|Overall Study|Death|0
7476206|NCT01987453|11782306|FG002|Overall Study|Death|1
7476207|NCT01987453|11782304|FG000|Overall Study|Lack of Efficacy|1
7476208|NCT01987453|11782305|FG001|Overall Study|Lack of Efficacy|12
7476209|NCT01987453|11782306|FG002|Overall Study|Lack of Efficacy|0
7476210|NCT01987479|11782318|FG000|Overall Study|Protocol Violation|1
7476211|NCT01987479|11782318|FG000|Overall Study|Physician Decision|2
7476212|NCT01987479|11782318|FG000|Overall Study|Participant/legal guardian decision|1
7476213|NCT01987479|11782318|FG000|Overall Study|Other|5
7476214|NCT01987479|11782318|FG000|Overall Study|Lost to Follow-up|1
7476215|NCT01987479|11782318|FG000|Overall Study|Adverse Event|7
7476216|NCT01987505|11782324|FG000|Overall Study|Other|9
7476217|NCT01987505|11782324|FG000|Overall Study|Withdrawal by Subject|2
7476218|NCT01987505|11782324|FG000|Overall Study|Other Reason|2
7476219|NCT01987505|11782324|FG000|Overall Study|Lost to Follow-up|15
7476220|NCT01987505|11782324|FG000|Overall Study|Investigator Decision|2
7476221|NCT01987505|11782324|FG000|Overall Study|Death|4
7476222|NCT01987557|11782333|FG000|Overall Study|Protocol Violation|1
7476223|NCT01987557|11782334|FG001|Overall Study|Protocol Violation|0
7476224|NCT01987557|11782335|FG002|Overall Study|Protocol Violation|1
7476225|NCT01987557|11782333|FG000|Overall Study|Withdrawal by Subject|2
7476226|NCT01987557|11782334|FG001|Overall Study|Withdrawal by Subject|1
7476227|NCT01987557|11782335|FG002|Overall Study|Withdrawal by Subject|2
7476228|NCT01987557|11782333|FG000|Overall Study|Adverse Event|0
7476229|NCT01987557|11782334|FG001|Overall Study|Adverse Event|2
7476230|NCT01987557|11782335|FG002|Overall Study|Adverse Event|0
7476231|NCT01987596|11782354|FG000|Overall Study|Physician Decision|1
7476232|NCT01987596|11782355|FG001|Overall Study|Physician Decision|0
7476233|NCT01987596|11782354|FG000|Overall Study|Progressive Disease; missing all period|0
7476234|NCT01987596|11782355|FG001|Overall Study|Progressive Disease; missing all period|1
7476235|NCT01987609|11782367|FG000|Overall Study|Adverse Event|1
7476236|NCT01987765|11782385|FG000|Overall Study|Protocol Violation|65
7476237|NCT01987765|11782385|FG000|Overall Study|Lost to Follow-up|37
7476238|NCT01987817|11782391|FG000|Overall Study|Adverse Event|4
7476239|NCT01987817|11782392|FG001|Overall Study|Adverse Event|0
7476240|NCT01987817|11782391|FG000|Overall Study|Withdrawal by Subject|1
7476241|NCT01987817|11782392|FG001|Overall Study|Withdrawal by Subject|1
7476242|NCT01987817|11782391|FG000|Overall Study|Physician Decision|1
7476243|NCT01987817|11782392|FG001|Overall Study|Physician Decision|0
7476244|NCT01987830|11782399|FG000|Overall Study|Never received baseline scan|1
7476245|NCT01987895|11782405|FG000|Overall Study|Withdrawal by Subject|12
7476246|NCT01987895|11782406|FG001|Overall Study|Withdrawal by Subject|7
7476247|NCT01987895|11782405|FG000|Overall Study|Physician Decision|8
7476248|NCT01987895|11782406|FG001|Overall Study|Physician Decision|10
7476249|NCT01987895|11782405|FG000|Overall Study|Death|7
7476250|NCT01987895|11782406|FG001|Overall Study|Death|7
7476251|NCT01987895|11782405|FG000|Overall Study|Lost to Follow-up|3
7476252|NCT01987895|11782406|FG001|Overall Study|Lost to Follow-up|5
7476253|NCT01987895|11782405|FG000|Overall Study|randomized before giving IC|0
7476254|NCT01987895|11782406|FG001|Overall Study|randomized before giving IC|1
7476255|NCT01987908|11782412|FG000|Placebo Lead-in Period|Adverse Event|2
7476256|NCT01987908|11782413|FG001|Placebo Lead-in Period|Adverse Event|0
7476257|NCT01987908|11782414|FG002|Placebo Lead-in Period|Adverse Event|0
7476258|NCT01987908|11782412|FG000|Placebo Lead-in Period|Physician Decision|2
7476259|NCT01987908|11782413|FG001|Placebo Lead-in Period|Physician Decision|0
7476260|NCT01987908|11782414|FG002|Placebo Lead-in Period|Physician Decision|0
7476261|NCT01987908|11782412|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
7476262|NCT01987908|11782413|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
7476263|NCT01987908|11782414|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
7476264|NCT01987908|11782412|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
7476265|NCT01987908|11782413|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7476266|NCT01987908|11782414|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
7476267|NCT01987908|11782412|FG000|Treatment Period|Adverse Event|0
7476268|NCT01987908|11782413|FG001|Treatment Period|Adverse Event|1
7476269|NCT01987908|11782414|FG002|Treatment Period|Adverse Event|1
7476270|NCT01987908|11782412|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7476271|NCT01987908|11782413|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
7476272|NCT01987908|11782414|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
7476273|NCT01987908|11782412|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
7476274|NCT01987908|11782413|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
7476275|NCT01987908|11782414|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
7476276|NCT01987960|11782440|FG000|Period 1|Adverse Event|24
7476277|NCT01987960|11782441|FG001|Period 1|Adverse Event|0
7476278|NCT01987960|11782442|FG002|Period 1|Adverse Event|0
7476279|NCT01987960|11782443|FG003|Period 1|Adverse Event|0
7476280|NCT01987960|11782440|FG000|Period 1|Lack of Efficacy|4
7476281|NCT01987960|11782441|FG001|Period 1|Lack of Efficacy|0
7476282|NCT01987960|11782442|FG002|Period 1|Lack of Efficacy|0
7476283|NCT01987960|11782443|FG003|Period 1|Lack of Efficacy|0
7476284|NCT01987960|11782440|FG000|Period 1|Non-compliance with IMP|6
7476285|NCT01987960|11782441|FG001|Period 1|Non-compliance with IMP|0
7476286|NCT01987960|11782442|FG002|Period 1|Non-compliance with IMP|0
7476287|NCT01987960|11782443|FG003|Period 1|Non-compliance with IMP|0
7476288|NCT01987960|11782440|FG000|Period 1|Protocol Violation|12
7476289|NCT01987960|11782441|FG001|Period 1|Protocol Violation|0
7476290|NCT01987960|11782442|FG002|Period 1|Protocol Violation|0
7476291|NCT01987960|11782443|FG003|Period 1|Protocol Violation|0
7476292|NCT01987960|11782440|FG000|Period 1|Withdrawal by Subject|21
7476293|NCT01987960|11782441|FG001|Period 1|Withdrawal by Subject|0
7476294|NCT01987960|11782442|FG002|Period 1|Withdrawal by Subject|0
7476295|NCT01987960|11782443|FG003|Period 1|Withdrawal by Subject|0
7476296|NCT01987960|11782440|FG000|Period 1|Lost to Follow-up|40
7476297|NCT01987960|11782441|FG001|Period 1|Lost to Follow-up|0
7476298|NCT01987960|11782442|FG002|Period 1|Lost to Follow-up|0
7476299|NCT01987960|11782443|FG003|Period 1|Lost to Follow-up|0
7476300|NCT01987960|11782440|FG000|Period 1|administrative or other reason|75
7476301|NCT01987960|11782441|FG001|Period 1|administrative or other reason|0
7476302|NCT01987960|11782442|FG002|Period 1|administrative or other reason|0
7476303|NCT01987960|11782443|FG003|Period 1|administrative or other reason|0
7476304|NCT01987960|11782440|FG000|Period 1|Withdrawal of consent before treatment|4
7476305|NCT01987960|11782441|FG001|Period 1|Withdrawal of consent before treatment|0
7476306|NCT01987960|11782442|FG002|Period 1|Withdrawal of consent before treatment|0
7476307|NCT01987960|11782443|FG003|Period 1|Withdrawal of consent before treatment|0
7476308|NCT01987960|11782440|FG000|Period 2|Adverse Event|0
7476309|NCT01987960|11782441|FG001|Period 2|Adverse Event|0
7476310|NCT01987960|11782442|FG002|Period 2|Adverse Event|1
7476311|NCT01987960|11782443|FG003|Period 2|Adverse Event|0
7476312|NCT01987960|11782440|FG000|Period 2|Withdrawal by Subject|0
7476313|NCT01987960|11782441|FG001|Period 2|Withdrawal by Subject|0
7476314|NCT01987960|11782442|FG002|Period 2|Withdrawal by Subject|1
7476315|NCT01987960|11782443|FG003|Period 2|Withdrawal by Subject|0
7476316|NCT01987960|11782440|FG000|Period 2|Administrative or other reason|0
7476317|NCT01987960|11782441|FG001|Period 2|Administrative or other reason|5
7476318|NCT01987960|11782442|FG002|Period 2|Administrative or other reason|7
7476319|NCT01987960|11782443|FG003|Period 2|Administrative or other reason|0
7476320|NCT01987960|11782440|FG000|Period 3|Adverse Event|0
7476321|NCT01987960|11782441|FG001|Period 3|Adverse Event|0
7476322|NCT01987960|11782442|FG002|Period 3|Adverse Event|0
7476323|NCT01987960|11782443|FG003|Period 3|Adverse Event|7
7476324|NCT01987960|11782440|FG000|Period 3|Non-compliance with IMP|0
7476325|NCT01987960|11782441|FG001|Period 3|Non-compliance with IMP|0
7476326|NCT01987960|11782442|FG002|Period 3|Non-compliance with IMP|0
7476327|NCT01987960|11782443|FG003|Period 3|Non-compliance with IMP|1
7476328|NCT01987960|11782440|FG000|Period 3|Protocol Violation|0
7476329|NCT01987960|11782441|FG001|Period 3|Protocol Violation|0
7476330|NCT01987960|11782442|FG002|Period 3|Protocol Violation|0
7476331|NCT01987960|11782443|FG003|Period 3|Protocol Violation|6
7476332|NCT01987960|11782440|FG000|Period 3|Withdrawal by Subject|0
7476333|NCT01987960|11782441|FG001|Period 3|Withdrawal by Subject|0
7476334|NCT01987960|11782442|FG002|Period 3|Withdrawal by Subject|0
7476335|NCT01987960|11782443|FG003|Period 3|Withdrawal by Subject|9
7476336|NCT01987960|11782440|FG000|Period 3|Lost to Follow-up|0
7476337|NCT01987960|11782441|FG001|Period 3|Lost to Follow-up|0
7476338|NCT01987960|11782442|FG002|Period 3|Lost to Follow-up|0
7476339|NCT01987960|11782443|FG003|Period 3|Lost to Follow-up|5
7476340|NCT01987960|11782440|FG000|Period 3|Administrative or other reason|0
7476341|NCT01987960|11782441|FG001|Period 3|Administrative or other reason|0
7476342|NCT01987960|11782442|FG002|Period 3|Administrative or other reason|0
7476343|NCT01987960|11782443|FG003|Period 3|Administrative or other reason|43
7476344|NCT01987986|11782457|FG000|Overall Study|Lost to Follow-up|1
7476345|NCT01987986|11782458|FG001|Overall Study|Lost to Follow-up|0
7476346|NCT01987986|11782459|FG002|Overall Study|Lost to Follow-up|0
7476347|NCT01987986|11782460|FG003|Overall Study|Lost to Follow-up|0
7476348|NCT01987986|11782457|FG000|Overall Study|Adverse Event|1
7476349|NCT01987986|11782458|FG001|Overall Study|Adverse Event|0
7476350|NCT01987986|11782459|FG002|Overall Study|Adverse Event|2
7476351|NCT01987986|11782460|FG003|Overall Study|Adverse Event|0
7476352|NCT01988012|11782470|FG000|Overall Study|Adverse Event|5
7476353|NCT01988012|11782470|FG000|Overall Study|Insufficient Therapeutic Response|3
7476354|NCT01988012|11782470|FG000|Overall Study|Patient Withdrawal of Consent|4
7476355|NCT01988012|11782470|FG000|Overall Study|Lost to Follow-up|1
7476356|NCT01988012|11782470|FG000|Overall Study|Physician Decision|1
7476357|NCT01988012|11782470|FG000|Overall Study|Protocol Violation|1
7476358|NCT01988090|11782476|FG000|Start Treament After Randomization|Withdrawal by Subject|2
7476359|NCT01988090|11782477|FG001|Start Treament After Randomization|Withdrawal by Subject|3
7476360|NCT01988090|11782476|FG000|Start Treament After Randomization|Protocol Violation|0
7476361|NCT01988090|11782477|FG001|Start Treament After Randomization|Protocol Violation|1
7476362|NCT01988090|11782476|FG000|Complete Study After Start|Withdrawal by Subject|2
7476363|NCT01988090|11782477|FG001|Complete Study After Start|Withdrawal by Subject|0
7476364|NCT01988090|11782476|FG000|Complete Study After Start|Protocol Violation|1
7476365|NCT01988090|11782477|FG001|Complete Study After Start|Protocol Violation|1
7476366|NCT01988103|11782486|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
7476367|NCT01988103|11782487|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
7476368|NCT01988103|11782488|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
7476369|NCT01988103|11782489|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7476370|NCT01988103|11782490|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
7476371|NCT01988103|11782486|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
7476372|NCT01988103|11782487|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7476373|NCT01988103|11782488|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
7476374|NCT01988103|11782489|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7476375|NCT01988103|11782490|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
7476376|NCT01988103|11782486|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
7476377|NCT01988103|11782487|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
7476378|NCT01988103|11782488|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
7476379|NCT01988103|11782489|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7476380|NCT01988103|11782490|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
7476381|NCT01988103|11782486|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
7476382|NCT01988103|11782487|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
7476383|NCT01988103|11782488|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7476384|NCT01988103|11782489|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
7476385|NCT01988103|11782490|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
7476386|NCT01988103|11782486|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7476387|NCT01988103|11782487|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
7476388|NCT01988103|11782488|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
7476389|NCT01988103|11782489|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7476390|NCT01988103|11782490|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
7476391|NCT01988103|11782486|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7476392|NCT01988103|11782487|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
7476393|NCT01988103|11782488|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
7476394|NCT01988103|11782489|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
7476395|NCT01988103|11782490|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
7476396|NCT01988103|11782486|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7476397|NCT01988103|11782487|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
7476398|NCT01988103|11782488|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7476399|NCT01988103|11782489|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
7476400|NCT01988103|11782490|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
7476401|NCT01988402|11782537|FG000|Overall Study|Adverse Event|1
7476402|NCT01988402|11782538|FG001|Overall Study|Adverse Event|2
7476403|NCT01988402|11782537|FG000|Overall Study|Withdrawal by Subject|1
7476404|NCT01988402|11782538|FG001|Overall Study|Withdrawal by Subject|0
7476405|NCT01988662|11782552|FG000|Overall Study|Subject/guardian decision|1
7476406|NCT01988662|11782553|FG001|Overall Study|Subject/guardian decision|1
7476407|NCT01988662|11782552|FG000|Overall Study|Adverse Event|3
7476408|NCT01988662|11782553|FG001|Overall Study|Adverse Event|1
7476409|NCT01988779|11782562|FG000|Overall Study|Withdrawal by Subject|2
7476410|NCT01988779|11782563|FG001|Overall Study|Withdrawal by Subject|2
7476411|NCT01988779|11782562|FG000|Overall Study|Protocol Violation|1
7476412|NCT01988779|11782563|FG001|Overall Study|Protocol Violation|0
7476413|NCT01989156|11782601|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
7476414|NCT01989156|11782602|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7476415|NCT01989156|11782603|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
7476416|NCT01989156|11782601|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
7476417|NCT01989156|11782602|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
7476418|NCT01989156|11782603|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
7476419|NCT01989156|11782601|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
7476420|NCT01989156|11782602|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
7476421|NCT01989156|11782603|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
7476422|NCT01989156|11782601|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
7476423|NCT01989156|11782602|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
7476424|NCT01989156|11782603|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
7476425|NCT01989156|11782601|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
7476426|NCT01989156|11782602|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
7476427|NCT01989156|11782603|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
7476428|NCT01989156|11782601|FG000|End of Study (Population at Day 90)|Physician Decision|1
7476429|NCT01989156|11782602|FG001|End of Study (Population at Day 90)|Physician Decision|0
7476430|NCT01989156|11782603|FG002|End of Study (Population at Day 90)|Physician Decision|1
7476431|NCT01989156|11782601|FG000|End of Study (Population at Day 90)|Moved out of state|1
7476432|NCT01989156|11782602|FG001|End of Study (Population at Day 90)|Moved out of state|0
7476433|NCT01989156|11782603|FG002|End of Study (Population at Day 90)|Moved out of state|0
7476434|NCT01989156|11782601|FG000|End of Study (Population at Day 90)|Employment Conflict|0
7476435|NCT01989156|11782602|FG001|End of Study (Population at Day 90)|Employment Conflict|1
7476436|NCT01989156|11782603|FG002|End of Study (Population at Day 90)|Employment Conflict|0
7476437|NCT01989169|11782613|FG000|Period 2|Adverse Event|0
7476438|NCT01989169|11782614|FG001|Period 2|Adverse Event|1
7476439|NCT01989208|11782629|FG000|200 mg (7 Days)|Protocol Violation|0
7476440|NCT01989208|11782630|FG001|200 mg (7 Days)|Protocol Violation|1
7476441|NCT01989455|11782657|FG000|Overall Study|Adverse Event|0
7476442|NCT01989455|11782658|FG001|Overall Study|Adverse Event|1
7476443|NCT01989455|11782659|FG002|Overall Study|Adverse Event|0
7476444|NCT01989455|11782660|FG003|Overall Study|Adverse Event|0
7476445|NCT01989455|11782661|FG004|Overall Study|Adverse Event|0
7476446|NCT01989455|11782657|FG000|Overall Study|Withdrawal by Subject|0
7476447|NCT01989455|11782658|FG001|Overall Study|Withdrawal by Subject|1
7476448|NCT01989455|11782659|FG002|Overall Study|Withdrawal by Subject|0
7476449|NCT01989455|11782660|FG003|Overall Study|Withdrawal by Subject|0
7476450|NCT01989455|11782661|FG004|Overall Study|Withdrawal by Subject|0
7476451|NCT01989455|11782657|FG000|Overall Study|Technical problems with infusion|0
7476452|NCT01989455|11782658|FG001|Overall Study|Technical problems with infusion|0
7476453|NCT01989455|11782659|FG002|Overall Study|Technical problems with infusion|1
7476454|NCT01989455|11782660|FG003|Overall Study|Technical problems with infusion|0
7476455|NCT01989455|11782661|FG004|Overall Study|Technical problems with infusion|1
7476456|NCT01989468|11782680|FG000|Overall Study|Adverse Event|10
7476457|NCT01989468|11782681|FG001|Overall Study|Adverse Event|15
7476458|NCT01989468|11782682|FG002|Overall Study|Adverse Event|4
7476459|NCT01989468|11782683|FG003|Overall Study|Adverse Event|5
7476460|NCT01989468|11782684|FG004|Overall Study|Adverse Event|4
7476461|NCT01989468|11782680|FG000|Overall Study|Lack of Efficacy|11
7476462|NCT01989468|11782681|FG001|Overall Study|Lack of Efficacy|11
7476463|NCT01989468|11782682|FG002|Overall Study|Lack of Efficacy|7
7476464|NCT01989468|11782683|FG003|Overall Study|Lack of Efficacy|4
7476465|NCT01989468|11782684|FG004|Overall Study|Lack of Efficacy|2
7476466|NCT01989468|11782680|FG000|Overall Study|Lost to Follow-up|5
7476467|NCT01989468|11782681|FG001|Overall Study|Lost to Follow-up|2
7476468|NCT01989468|11782682|FG002|Overall Study|Lost to Follow-up|0
7476469|NCT01989468|11782683|FG003|Overall Study|Lost to Follow-up|1
7476470|NCT01989468|11782684|FG004|Overall Study|Lost to Follow-up|1
7476471|NCT01989468|11782680|FG000|Overall Study|Physician Decision|4
7476472|NCT01989468|11782681|FG001|Overall Study|Physician Decision|1
7476473|NCT01989468|11782682|FG002|Overall Study|Physician Decision|0
7476474|NCT01989468|11782683|FG003|Overall Study|Physician Decision|1
7476475|NCT01989468|11782684|FG004|Overall Study|Physician Decision|0
7476476|NCT01989468|11782680|FG000|Overall Study|Pregnancy|0
7476477|NCT01989468|11782681|FG001|Overall Study|Pregnancy|1
7476478|NCT01989468|11782682|FG002|Overall Study|Pregnancy|0
7476479|NCT01989468|11782683|FG003|Overall Study|Pregnancy|0
7476480|NCT01989468|11782684|FG004|Overall Study|Pregnancy|0
7476481|NCT01989468|11782680|FG000|Overall Study|Technical Problems|3
7476482|NCT01989468|11782681|FG001|Overall Study|Technical Problems|1
7476483|NCT01989468|11782682|FG002|Overall Study|Technical Problems|3
7476484|NCT01989468|11782683|FG003|Overall Study|Technical Problems|1
7476485|NCT01989468|11782684|FG004|Overall Study|Technical Problems|0
7476486|NCT01989468|11782680|FG000|Overall Study|Subject Guardian Decision|11
7476487|NCT01989468|11782681|FG001|Overall Study|Subject Guardian Decision|6
7476488|NCT01989468|11782682|FG002|Overall Study|Subject Guardian Decision|4
7476489|NCT01989468|11782683|FG003|Overall Study|Subject Guardian Decision|4
7476490|NCT01989468|11782684|FG004|Overall Study|Subject Guardian Decision|1
7476491|NCT01989468|11782680|FG000|Overall Study|Death|3
7476492|NCT01989468|11782681|FG001|Overall Study|Death|0
7476493|NCT01989468|11782682|FG002|Overall Study|Death|1
7476494|NCT01989468|11782683|FG003|Overall Study|Death|0
7476495|NCT01989468|11782684|FG004|Overall Study|Death|0
7476496|NCT01989546|11782697|FG000|Overall Study|Clinical Progression|1
7476497|NCT01989546|11782697|FG000|Overall Study|Disease progression on study|8
7476498|NCT01989572|11782707|FG000|Overall Study|Lack of Efficacy|35
7476499|NCT01989572|11782708|FG001|Overall Study|Lack of Efficacy|48
7476500|NCT01989572|11782709|FG002|Overall Study|Lack of Efficacy|48
7476501|NCT01989572|11782710|FG003|Overall Study|Lack of Efficacy|43
7476502|NCT01989572|11782711|FG004|Overall Study|Lack of Efficacy|71
7476503|NCT01989572|11782712|FG005|Overall Study|Lack of Efficacy|79
7476504|NCT01989572|11782707|FG000|Overall Study|Adverse Event|2
7476505|NCT01989572|11782708|FG001|Overall Study|Adverse Event|1
7476506|NCT01989572|11782709|FG002|Overall Study|Adverse Event|3
7476507|NCT01989572|11782710|FG003|Overall Study|Adverse Event|0
7476508|NCT01989572|11782711|FG004|Overall Study|Adverse Event|3
7476509|NCT01989572|11782712|FG005|Overall Study|Adverse Event|0
7476510|NCT01989572|11782707|FG000|Overall Study|Death|0
7476511|NCT01989572|11782708|FG001|Overall Study|Death|0
7476512|NCT01989572|11782709|FG002|Overall Study|Death|0
7476513|NCT01989572|11782710|FG003|Overall Study|Death|0
7476514|NCT01989572|11782711|FG004|Overall Study|Death|1
7476515|NCT01989572|11782712|FG005|Overall Study|Death|0
7476516|NCT01989572|11782707|FG000|Overall Study|Withdrawal by Subject|4
7476517|NCT01989572|11782708|FG001|Overall Study|Withdrawal by Subject|1
7476518|NCT01989572|11782709|FG002|Overall Study|Withdrawal by Subject|5
7476519|NCT01989572|11782710|FG003|Overall Study|Withdrawal by Subject|1
7476520|NCT01989572|11782711|FG004|Overall Study|Withdrawal by Subject|12
7476521|NCT01989572|11782712|FG005|Overall Study|Withdrawal by Subject|4
7476522|NCT01989572|11782707|FG000|Overall Study|complicating disease|1
7476523|NCT01989572|11782708|FG001|Overall Study|complicating disease|1
7476524|NCT01989572|11782709|FG002|Overall Study|complicating disease|2
7476525|NCT01989572|11782710|FG003|Overall Study|complicating disease|0
7476526|NCT01989572|11782711|FG004|Overall Study|complicating disease|1
7476527|NCT01989572|11782712|FG005|Overall Study|complicating disease|0
7476528|NCT01989572|11782707|FG000|Overall Study|error|2
7476529|NCT01989572|11782708|FG001|Overall Study|error|1
7476530|NCT01989572|11782709|FG002|Overall Study|error|1
7476531|NCT01989572|11782710|FG003|Overall Study|error|1
7476532|NCT01989572|11782711|FG004|Overall Study|error|1
7476533|NCT01989572|11782712|FG005|Overall Study|error|1
7476534|NCT01989572|11782707|FG000|Overall Study|maximum dose reached|0
7476535|NCT01989572|11782708|FG001|Overall Study|maximum dose reached|1
7476536|NCT01989572|11782709|FG002|Overall Study|maximum dose reached|0
7476537|NCT01989572|11782710|FG003|Overall Study|maximum dose reached|0
7476538|NCT01989572|11782711|FG004|Overall Study|maximum dose reached|1
7476539|NCT01989572|11782712|FG005|Overall Study|maximum dose reached|0
7476540|NCT01989572|11782707|FG000|Overall Study|unknown/not specify|3
7476541|NCT01989572|11782708|FG001|Overall Study|unknown/not specify|4
7476542|NCT01989572|11782709|FG002|Overall Study|unknown/not specify|1
7476543|NCT01989572|11782710|FG003|Overall Study|unknown/not specify|3
7476544|NCT01989572|11782711|FG004|Overall Study|unknown/not specify|3
7476545|NCT01989572|11782712|FG005|Overall Study|unknown/not specify|5
7476546|NCT01989572|11782707|FG000|Overall Study|not start protocol therapy|5
7476547|NCT01989572|11782708|FG001|Overall Study|not start protocol therapy|1
7476548|NCT01989572|11782709|FG002|Overall Study|not start protocol therapy|2
7476549|NCT01989572|11782710|FG003|Overall Study|not start protocol therapy|3
7476550|NCT01989572|11782711|FG004|Overall Study|not start protocol therapy|4
7476551|NCT01989572|11782712|FG005|Overall Study|not start protocol therapy|18
7476552|NCT01989572|11782707|FG000|Overall Study|alternative therapy|3
7476553|NCT01989572|11782708|FG001|Overall Study|alternative therapy|0
7476554|NCT01989572|11782709|FG002|Overall Study|alternative therapy|0
7476555|NCT01989572|11782710|FG003|Overall Study|alternative therapy|0
7476556|NCT01989572|11782711|FG004|Overall Study|alternative therapy|1
7476557|NCT01989572|11782712|FG005|Overall Study|alternative therapy|3
7476558|NCT01989689|11782732|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
7476559|NCT01989689|11782733|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
7476560|NCT01989689|11782732|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
7476561|NCT01989689|11782733|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
7476562|NCT01989754|11782743|FG000|Overall Study|Withdrawal by Subject|10
7476563|NCT01989754|11782744|FG001|Overall Study|Withdrawal by Subject|14
7476564|NCT01989754|11782743|FG000|Overall Study|Lost to Follow-up|28
7476565|NCT01989754|11782744|FG001|Overall Study|Lost to Follow-up|20
7476566|NCT01989754|11782743|FG000|Overall Study|Closed Site|1
7476567|NCT01989754|11782744|FG001|Overall Study|Closed Site|1
7476568|NCT01990261|11782772|FG000|Overall Study|Death Before Treatment Start|2
7476569|NCT01990261|11782772|FG000|Overall Study|Death due to Disease Progression (PD)|10
7476570|NCT01990261|11782772|FG000|Overall Study|Death From other Causes|1
7476571|NCT01990261|11782772|FG000|Overall Study|Disease Progression (PD)|8
7476572|NCT01990261|11782772|FG000|Overall Study|PD Before Treatment Start|1
7476573|NCT01990261|11782772|FG000|Overall Study|Dossier not Approved|1
7476574|NCT01990261|11782772|FG000|Overall Study|Lost to Follow-up|2
7476575|NCT01990300|11782776|FG000|Overall Study|Case Report Forms Uncollected|89
7476576|NCT01990300|11782776|FG000|Overall Study|Protocol Deviation|53
7476577|NCT01990313|11782780|FG000|Overall Study|Lost to Follow-up|1
7476578|NCT01990339|11782784|FG000|Overall Study|Data Not Available|49
7476579|NCT01990339|11782784|FG000|Overall Study|Voluntary Withdrawal|1402
7476580|NCT01990339|11782784|FG000|Overall Study|Lost to Follow-up|861
7476581|NCT01990495|11782790|FG000|Overall Study|Physician Decision|5
7476582|NCT01990495|11782791|FG001|Overall Study|Physician Decision|4
7476583|NCT01990534|11782799|FG000|Overall Study|Death|22
7476584|NCT01990534|11782799|FG000|Overall Study|Progressive disease|3
7476585|NCT01990534|11782799|FG000|Overall Study|Protocol Violation|1
7476586|NCT01990534|11782799|FG000|Overall Study|Withdrawal of Informed Consent|2
7476587|NCT01990534|11782799|FG000|Overall Study|Symptomatic Deterioration|1
7476588|NCT01990534|11782799|FG000|Overall Study|Withdrawal by Subject|3
7476589|NCT01990534|11782799|FG000|Overall Study|Reason not Specified|2
7476590|NCT01990534|11782799|FG000|Overall Study|Lost to Follow-up|1
7476591|NCT01990560|11782803|FG000|Overall Study|Withdrawal by Subject|1
7476592|NCT01990573|11782810|FG000|Overall Study|Physician Decision|0
7476593|NCT01990573|11782811|FG001|Overall Study|Physician Decision|0
7476594|NCT01990573|11782812|FG002|Overall Study|Physician Decision|1
7476595|NCT01990612|11782822|FG000|Overall Study|Lost to Follow-up|2
7476596|NCT01990612|11782823|FG001|Overall Study|Lost to Follow-up|1
7476597|NCT01990612|11782822|FG000|Overall Study|Withdrawal by Subject|5
7476598|NCT01990612|11782823|FG001|Overall Study|Withdrawal by Subject|2
7476599|NCT01990664|11782831|FG000|Overall Study|Lost to Follow-up|2
7476600|NCT01990664|11782832|FG001|Overall Study|Lost to Follow-up|6
7476601|NCT01990664|11782831|FG000|Overall Study|Withdrawal by Subject|2
7476602|NCT01990664|11782832|FG001|Overall Study|Withdrawal by Subject|3
7476603|NCT01990664|11782831|FG000|Overall Study|Protocol Violation|1
7476604|NCT01990664|11782832|FG001|Overall Study|Protocol Violation|0
7476605|NCT01990664|11782831|FG000|Overall Study|Lens Discomfort|1
7476606|NCT01990664|11782832|FG001|Overall Study|Lens Discomfort|1
7476607|NCT01990664|11782831|FG000|Overall Study|Lens Handling Difficulties|1
7476608|NCT01990664|11782832|FG001|Overall Study|Lens Handling Difficulties|0
7476609|NCT01990664|11782831|FG000|Overall Study|Unsatisfactory Visual Response|0
7476610|NCT01990664|11782832|FG001|Overall Study|Unsatisfactory Visual Response|1
7476611|NCT01990742|11782858|FG000|Overall Study|Withdrawal by facility|407
7476612|NCT01990742|11782859|FG001|Overall Study|Withdrawal by facility|1083
7476613|NCT01990742|11782858|FG000|Overall Study|Facility closed|0
7476614|NCT01990742|11782859|FG001|Overall Study|Facility closed|270
7476615|NCT01990768|11782868|FG000|Intervention Started|Found to be ineligible|14
7476616|NCT01990768|11782869|FG001|Intervention Started|Found to be ineligible|13
7476617|NCT01990768|11782870|FG002|Intervention Started|Found to be ineligible|11
7476618|NCT01990768|11782868|FG000|Intervention Started|Study drug issue or kit malfunction|9
7476619|NCT01990768|11782869|FG001|Intervention Started|Study drug issue or kit malfunction|6
7476620|NCT01990768|11782870|FG002|Intervention Started|Study drug issue or kit malfunction|7
7476621|NCT01990768|11782868|FG000|Intervention Started|Patient became ineligible due to vitals|5
7476622|NCT01990768|11782869|FG001|Intervention Started|Patient became ineligible due to vitals|5
7476623|NCT01990768|11782870|FG002|Intervention Started|Patient became ineligible due to vitals|2
7476624|NCT01990768|11782868|FG000|Intervention Started|Not enough time for EMS to enroll|4
7476625|NCT01990768|11782869|FG001|Intervention Started|Not enough time for EMS to enroll|3
7476626|NCT01990768|11782870|FG002|Intervention Started|Not enough time for EMS to enroll|0
7476627|NCT01990768|11782868|FG000|Intervention Started|Patient care priority|1
7476628|NCT01990768|11782869|FG001|Intervention Started|Patient care priority|2
7476629|NCT01990768|11782870|FG002|Intervention Started|Patient care priority|3
7476630|NCT01990768|11782868|FG000|Intervention Started|IV lost|2
7476631|NCT01990768|11782869|FG001|Intervention Started|IV lost|2
7476632|NCT01990768|11782870|FG002|Intervention Started|IV lost|2
7476633|NCT01990768|11782868|FG000|Intervention Started|Required CPR|1
7476634|NCT01990768|11782869|FG001|Intervention Started|Required CPR|1
7476635|NCT01990768|11782870|FG002|Intervention Started|Required CPR|0
7476636|NCT01990768|11782868|FG000|Intervention Started|Seizure or hx of seizure|0
7476637|NCT01990768|11782869|FG001|Intervention Started|Seizure or hx of seizure|0
7476638|NCT01990768|11782870|FG002|Intervention Started|Seizure or hx of seizure|2
7476639|NCT01990768|11782868|FG000|Intervention Started|Discovered to be pregnant|0
7476640|NCT01990768|11782869|FG001|Intervention Started|Discovered to be pregnant|1
7476641|NCT01990768|11782870|FG002|Intervention Started|Discovered to be pregnant|0
7476642|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
7476643|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
7476644|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
7476645|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7476646|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
7476647|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
7476648|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Required CPR|2
7476649|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Required CPR|6
7476650|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Required CPR|0
7476651|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Other safety concern|2
7476652|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Other safety concern|1
7476653|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Other safety concern|1
7476654|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Death|3
7476655|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Death|1
7476656|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Death|1
7476657|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Discharged|2
7476658|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Discharged|1
7476659|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Discharged|0
7476660|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
7476661|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7476662|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
7476663|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
7476664|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
7476665|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
7476666|NCT01990768|11782868|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
7476667|NCT01990768|11782869|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
7476668|NCT01990768|11782870|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
7476669|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Discharged|19
7476670|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Discharged|18
7476671|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Discharged|13
7476672|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
7476673|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
7476674|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
7476675|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
7476676|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
7476677|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
7476678|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
7476679|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
7476680|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
7476681|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
7476682|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
7476683|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
7476684|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
7476685|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
7476686|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
7476687|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7476688|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
7476689|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
7476690|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Required CPR|3
7476691|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Required CPR|7
7476692|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Required CPR|1
7476693|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
7476694|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
7476695|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
7476696|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
7476697|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
7476698|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
7476699|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
7476700|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
7476701|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
7476702|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7476703|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
7476704|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
7476705|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
7476706|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
7476707|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
7476708|NCT01990768|11782868|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
7476709|NCT01990768|11782869|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
7476710|NCT01990768|11782870|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
7476711|NCT01990768|11782868|FG000|6-Month Follow-up|Withdrawal by Subject|25
7476712|NCT01990768|11782869|FG001|6-Month Follow-up|Withdrawal by Subject|25
7476713|NCT01990768|11782870|FG002|6-Month Follow-up|Withdrawal by Subject|26
7476714|NCT01990768|11782868|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
7476715|NCT01990768|11782869|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
7476716|NCT01990768|11782870|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
7476717|NCT01990768|11782868|FG000|6-Month Follow-up|No contact information|5
7476718|NCT01990768|11782869|FG001|6-Month Follow-up|No contact information|6
7476719|NCT01990768|11782870|FG002|6-Month Follow-up|No contact information|5
7476720|NCT01990768|11782868|FG000|6-Month Follow-up|Homeless|4
7476721|NCT01990768|11782869|FG001|6-Month Follow-up|Homeless|3
7476722|NCT01990768|11782870|FG002|6-Month Follow-up|Homeless|6
7476723|NCT01990768|11782868|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
7476724|NCT01990768|11782869|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
7476725|NCT01990768|11782870|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
7476726|NCT01990768|11782868|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
7476727|NCT01990768|11782869|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
7476728|NCT01990768|11782870|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
7476729|NCT01990768|11782868|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
7476730|NCT01990768|11782869|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
7476731|NCT01990768|11782870|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
7476732|NCT01990859|11782975|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
7476733|NCT01990859|11782975|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
7476734|NCT01990950|11782984|FG000|Overall Study|Death|3
7476735|NCT01990950|11782984|FG000|Overall Study|Lost to Follow-up|2
7476736|NCT01990950|11782984|FG000|Overall Study|Withdrawal by Subject|6
7476737|NCT01991197|11782990|FG000|Overall Study|Lost to Follow-up|1
7476738|NCT01991197|11782991|FG001|Overall Study|Lost to Follow-up|1
7476739|NCT01991197|11782990|FG000|Overall Study|Physician Decision|0
7476740|NCT01991197|11782991|FG001|Overall Study|Physician Decision|2
7476741|NCT01991197|11782990|FG000|Overall Study|Withdrawal by Subject|2
7476742|NCT01991197|11782991|FG001|Overall Study|Withdrawal by Subject|0
7476743|NCT01991314|11783004|FG000|Overall Study|Adverse Event|5
7476744|NCT01991314|11783005|FG001|Overall Study|Adverse Event|1
7476745|NCT01991314|11783004|FG000|Overall Study|Lost to Follow-up|6
7476746|NCT01991314|11783005|FG001|Overall Study|Lost to Follow-up|10
7476747|NCT01991470|11783011|FG000|Enlite 1 Period|Withdrawal by Subject|18
7476748|NCT01991470|11783011|FG000|Enlite 1 Period|Adverse Event|1
7476749|NCT01991470|11783011|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
7476750|NCT01991470|11783011|FG000|Enlite 3 Period|Lost to Follow-up|1
7476751|NCT01991470|11783011|FG000|Enlite 3 Period|Physician Decision|2
7476752|NCT01991470|11783011|FG000|Enlite 3 Period|Physician Decision|8
7476753|NCT01991470|11783011|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
7476754|NCT01991483|11783027|FG000|Dose Level 600 mg|Withdrawal by Subject|0
7476755|NCT01991483|11783028|FG001|Dose Level 600 mg|Withdrawal by Subject|0
7476756|NCT01991483|11783029|FG002|Dose Level 600 mg|Withdrawal by Subject|1
7476757|NCT01991483|11783030|FG003|Dose Level 600 mg|Withdrawal by Subject|0
7476758|NCT01991483|11783027|FG000|Dose Level 600 mg|Physician Decision|0
7476759|NCT01991483|11783028|FG001|Dose Level 600 mg|Physician Decision|0
7476760|NCT01991483|11783029|FG002|Dose Level 600 mg|Physician Decision|1
7476761|NCT01991483|11783030|FG003|Dose Level 600 mg|Physician Decision|0
7476762|NCT01991483|11783027|FG000|Dose Level 1000 mg|Protocol Violation|0
7476763|NCT01991483|11783028|FG001|Dose Level 1000 mg|Protocol Violation|0
7476764|NCT01991483|11783029|FG002|Dose Level 1000 mg|Protocol Violation|0
7476765|NCT01991483|11783030|FG003|Dose Level 1000 mg|Protocol Violation|1
7476766|NCT01991743|11783060|FG000|Overall Study|external cephalic version not performed|0
7476767|NCT01991743|11783061|FG001|Overall Study|external cephalic version not performed|0
7476768|NCT01991743|11783062|FG002|Overall Study|external cephalic version not performed|1
7476769|NCT01991743|11783063|FG003|Overall Study|external cephalic version not performed|0
7476770|NCT01991795|11783075|FG000|Overall Study|Lost to Follow-up|6
7476771|NCT01991795|11783076|FG001|Overall Study|Lost to Follow-up|4
7476772|NCT01991795|11783075|FG000|Overall Study|Withdrawal by Subject|117
7476773|NCT01991795|11783076|FG001|Overall Study|Withdrawal by Subject|94
7476774|NCT01991795|11783075|FG000|Overall Study|Site prematurely closed by sponsor|26
7476775|NCT01991795|11783076|FG001|Overall Study|Site prematurely closed by sponsor|25
7476778|NCT01992094|11783135|FG000|Overall Study|ADMINISTRATIVE REASON|6
7476779|NCT01992094|11783136|FG001|Overall Study|ADMINISTRATIVE REASON|7
7476780|NCT01992094|11783137|FG002|Overall Study|ADMINISTRATIVE REASON|1
7476781|NCT01992094|11783135|FG000|Overall Study|Adverse Event|1
7476782|NCT01992094|11783136|FG001|Overall Study|Adverse Event|0
7476783|NCT01992094|11783137|FG002|Overall Study|Adverse Event|0
7476784|NCT01992094|11783135|FG000|Overall Study|Death|5
7476785|NCT01992094|11783136|FG001|Overall Study|Death|5
7476786|NCT01992094|11783137|FG002|Overall Study|Death|2
7476787|NCT01992094|11783135|FG000|Overall Study|Lost to Follow-up|26
7476788|NCT01992094|11783136|FG001|Overall Study|Lost to Follow-up|9
7476789|NCT01992094|11783137|FG002|Overall Study|Lost to Follow-up|13
7476790|NCT01992094|11783135|FG000|Overall Study|OTHER|4
7476791|NCT01992094|11783136|FG001|Overall Study|OTHER|0
7476792|NCT01992094|11783137|FG002|Overall Study|OTHER|0
7476793|NCT01992094|11783135|FG000|Overall Study|Protocol Violation|1
7476794|NCT01992094|11783136|FG001|Overall Study|Protocol Violation|0
7476795|NCT01992094|11783137|FG002|Overall Study|Protocol Violation|1
7476796|NCT01992094|11783135|FG000|Overall Study|Withdrawal by Subject|7
7476797|NCT01992094|11783136|FG001|Overall Study|Withdrawal by Subject|3
7476798|NCT01992094|11783137|FG002|Overall Study|Withdrawal by Subject|4
7476799|NCT01992107|11783164|FG000|Overall Study|Administrative reasons|2
7476800|NCT01992107|11783165|FG001|Overall Study|Administrative reasons|0
7476801|NCT01992107|11783166|FG002|Overall Study|Administrative reasons|0
7476802|NCT01992107|11783164|FG000|Overall Study|Adverse Event|0
7476803|NCT01992107|11783165|FG001|Overall Study|Adverse Event|1
7476804|NCT01992107|11783166|FG002|Overall Study|Adverse Event|0
7476805|NCT01992107|11783164|FG000|Overall Study|Lost to Follow-up|46
7476806|NCT01992107|11783165|FG001|Overall Study|Lost to Follow-up|22
7476807|NCT01992107|11783166|FG002|Overall Study|Lost to Follow-up|26
7476808|NCT01992107|11783164|FG000|Overall Study|noncompliance and were unavailable|7
7476809|NCT01992107|11783165|FG001|Overall Study|noncompliance and were unavailable|3
7476810|NCT01992107|11783166|FG002|Overall Study|noncompliance and were unavailable|2
7476811|NCT01992107|11783164|FG000|Overall Study|Withdrawal by Subject|13
7476812|NCT01992107|11783165|FG001|Overall Study|Withdrawal by Subject|7
7476813|NCT01992107|11783166|FG002|Overall Study|Withdrawal by Subject|8
7476814|NCT01992159|11783195|FG000|Overall Study|Withdrawal by Subject|4
7476815|NCT01992159|11783196|FG001|Overall Study|Withdrawal by Subject|7
7476816|NCT01992159|11783197|FG002|Overall Study|Withdrawal by Subject|0
7476817|NCT01992159|11783198|FG003|Overall Study|Withdrawal by Subject|3
7476818|NCT01992159|11783195|FG000|Overall Study|Adverse Event|0
7476819|NCT01992159|11783196|FG001|Overall Study|Adverse Event|1
7476820|NCT01992159|11783197|FG002|Overall Study|Adverse Event|0
7476821|NCT01992159|11783198|FG003|Overall Study|Adverse Event|1
7476822|NCT01992159|11783195|FG000|Overall Study|Death|0
7476823|NCT01992159|11783196|FG001|Overall Study|Death|0
7476824|NCT01992159|11783197|FG002|Overall Study|Death|1
7476825|NCT01992159|11783198|FG003|Overall Study|Death|0
7476826|NCT01992536|11783263|FG000|Overall Study|Administrative Reason|0
7476827|NCT01992536|11783264|FG001|Overall Study|Administrative Reason|0
7476828|NCT01992536|11783265|FG002|Overall Study|Administrative Reason|0
7476829|NCT01992536|11783266|FG003|Overall Study|Administrative Reason|0
7476830|NCT01992536|11783267|FG004|Overall Study|Administrative Reason|0
7476831|NCT01992536|11783268|FG005|Overall Study|Administrative Reason|0
7476832|NCT01992536|11783269|FG006|Overall Study|Administrative Reason|7
7476833|NCT01992536|11783270|FG007|Overall Study|Administrative Reason|0
7476834|NCT01992536|11783271|FG008|Overall Study|Administrative Reason|0
7476835|NCT01992536|11783272|FG009|Overall Study|Administrative Reason|0
7476836|NCT01992536|11783263|FG000|Overall Study|Lost to Follow-up|4
7476837|NCT01992536|11783264|FG001|Overall Study|Lost to Follow-up|2
7476838|NCT01992536|11783265|FG002|Overall Study|Lost to Follow-up|1
7476839|NCT01992536|11783266|FG003|Overall Study|Lost to Follow-up|0
7476840|NCT01992536|11783267|FG004|Overall Study|Lost to Follow-up|0
7476841|NCT01992536|11783268|FG005|Overall Study|Lost to Follow-up|1
7476842|NCT01992536|11783269|FG006|Overall Study|Lost to Follow-up|0
7476843|NCT01992536|11783270|FG007|Overall Study|Lost to Follow-up|0
7476844|NCT01992536|11783271|FG008|Overall Study|Lost to Follow-up|1
7476845|NCT01992536|11783272|FG009|Overall Study|Lost to Follow-up|1
7476846|NCT01992536|11783263|FG000|Overall Study|Withdrawal by Subject|0
7476847|NCT01992536|11783264|FG001|Overall Study|Withdrawal by Subject|1
7476848|NCT01992536|11783265|FG002|Overall Study|Withdrawal by Subject|0
7476849|NCT01992536|11783266|FG003|Overall Study|Withdrawal by Subject|2
7476850|NCT01992536|11783267|FG004|Overall Study|Withdrawal by Subject|0
7476851|NCT01992536|11783268|FG005|Overall Study|Withdrawal by Subject|0
7476852|NCT01992536|11783269|FG006|Overall Study|Withdrawal by Subject|0
7476853|NCT01992536|11783270|FG007|Overall Study|Withdrawal by Subject|0
7476854|NCT01992536|11783271|FG008|Overall Study|Withdrawal by Subject|0
7476855|NCT01992536|11783272|FG009|Overall Study|Withdrawal by Subject|0
7476856|NCT01992549|11783314|FG000|Overall Study|Lost to Follow-up|2
7476857|NCT01992549|11783314|FG000|Overall Study|Serious Adverse Event|1
7476858|NCT01992549|11783314|FG000|Overall Study|Product Switch to Extend Half Life|1
7476859|NCT01992757|11783324|FG000|Overall Study|2 patients excluded due to FFP given.|2
7476860|NCT01993017|11783344|FG000|Overall Study|Death|23
7476861|NCT01993017|11783345|FG001|Overall Study|Death|26
7476862|NCT01993017|11783346|FG002|Overall Study|Death|18
7476863|NCT01993017|11783344|FG000|Overall Study|Could not be contacted|43
7476864|NCT01993017|11783345|FG001|Overall Study|Could not be contacted|42
7476865|NCT01993017|11783346|FG002|Overall Study|Could not be contacted|38
7476866|NCT01993017|11783344|FG000|Overall Study|Dropped out|19
7476867|NCT01993017|11783345|FG001|Overall Study|Dropped out|6
7476868|NCT01993017|11783346|FG002|Overall Study|Dropped out|11
7476869|NCT01993017|11783344|FG000|Overall Study|Other reasons|17
7476870|NCT01993017|11783345|FG001|Overall Study|Other reasons|11
7476871|NCT01993017|11783346|FG002|Overall Study|Other reasons|7
7476872|NCT01993017|11783344|FG000|Overall Study|Ineligible after randomization|4
7476873|NCT01993017|11783345|FG001|Overall Study|Ineligible after randomization|5
7476874|NCT01993017|11783346|FG002|Overall Study|Ineligible after randomization|5
7476875|NCT01993030|11783357|FG000|Overall Study|Adverse Event|0
7476876|NCT01993030|11783358|FG001|Overall Study|Adverse Event|4
7476877|NCT01993186|11783387|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
7476878|NCT01993186|11783388|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7476879|NCT01993186|11783387|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
7476880|NCT01993186|11783388|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
7476881|NCT01993186|11783387|FG000|Open-Label Extension Period|Other, Not Specified|0
7476882|NCT01993186|11783388|FG001|Open-Label Extension Period|Other, Not Specified|1
7476883|NCT01993186|11783387|FG000|Open-Label Extension Period|Adverse Event|1
7476884|NCT01993186|11783388|FG001|Open-Label Extension Period|Adverse Event|0
7476885|NCT01993186|11783387|FG000|Open-Label Extension Period|Principal Investigator Decision|1
7476886|NCT01993186|11783388|FG001|Open-Label Extension Period|Principal Investigator Decision|0
7476887|NCT01993186|11783387|FG000|Open-Label Extension Period|Withdrawal by Subject|4
7476888|NCT01993186|11783388|FG001|Open-Label Extension Period|Withdrawal by Subject|5
7476889|NCT01993186|11783387|FG000|Open-Label Extension Period|Subject Non-Compliance|1
7476890|NCT01993186|11783388|FG001|Open-Label Extension Period|Subject Non-Compliance|0
7476891|NCT01993329|11783405|FG000|Period 2|Adverse Event|0
7476892|NCT01993329|11783406|FG001|Period 2|Adverse Event|0
7476893|NCT01993329|11783407|FG002|Period 2|Adverse Event|0
7476894|NCT01993329|11783408|FG003|Period 2|Adverse Event|0
7476895|NCT01993329|11783409|FG004|Period 2|Adverse Event|0
7476896|NCT01993329|11783410|FG005|Period 2|Adverse Event|1
7476897|NCT01993329|11783405|FG000|Wash-out|Personal reasons|0
7476898|NCT01993329|11783406|FG001|Wash-out|Personal reasons|1
7476899|NCT01993329|11783407|FG002|Wash-out|Personal reasons|0
7476900|NCT01993329|11783408|FG003|Wash-out|Personal reasons|0
7476901|NCT01993329|11783409|FG004|Wash-out|Personal reasons|0
7476902|NCT01993329|11783410|FG005|Wash-out|Personal reasons|0
7476903|NCT01993615|11783424|FG000|Overall Study|Death|1
7476904|NCT01993615|11783425|FG001|Overall Study|Death|0
7476905|NCT01993667|11783433|FG000|Overall Study|Insufficient data to analyze|16
7476906|NCT01993667|11783434|FG001|Overall Study|Insufficient data to analyze|16
7476907|NCT01993667|11783433|FG000|Overall Study|Insufficient altitude reached|3
7476908|NCT01993667|11783434|FG001|Overall Study|Insufficient altitude reached|1
7476909|NCT01993667|11783433|FG000|Overall Study|Lost to Follow-up|2
7476910|NCT01993667|11783434|FG001|Overall Study|Lost to Follow-up|2
7476911|NCT01993823|11783442|FG000|Overall Study|Requested by the patient|6
7476912|NCT01993823|11783443|FG001|Overall Study|Requested by the patient|11
7476913|NCT01993823|11783442|FG000|Overall Study|Protocol Violation|0
7476914|NCT01993823|11783443|FG001|Overall Study|Protocol Violation|1
7476915|NCT01993823|11783442|FG000|Overall Study|Lost to Follow-up|1
7476916|NCT01993823|11783443|FG001|Overall Study|Lost to Follow-up|4
7476917|NCT01993836|11783452|FG000|Overall Study|Surgery Cancelled|3
7476918|NCT01993836|11783453|FG001|Overall Study|Surgery Cancelled|0
7476919|NCT01993836|11783454|FG002|Overall Study|Surgery Cancelled|0
7476920|NCT01993836|11783452|FG000|Overall Study|Physician Decision|2
7476921|NCT01993836|11783453|FG001|Overall Study|Physician Decision|1
7476922|NCT01993836|11783454|FG002|Overall Study|Physician Decision|0
7476923|NCT01993836|11783452|FG000|Overall Study|Death|0
7476924|NCT01993836|11783453|FG001|Overall Study|Death|2
7476925|NCT01993836|11783454|FG002|Overall Study|Death|0
7476926|NCT01993836|11783452|FG000|Overall Study|Withdrawal by Subject|12
7476927|NCT01993836|11783453|FG001|Overall Study|Withdrawal by Subject|10
7476928|NCT01993836|11783454|FG002|Overall Study|Withdrawal by Subject|5
7476929|NCT01993888|11783485|FG000|Overall Study|Death|1
7476930|NCT01993888|11783486|FG001|Overall Study|Death|1
7476931|NCT01993888|11783485|FG000|Overall Study|Lost to Follow-up|1
7476932|NCT01993888|11783486|FG001|Overall Study|Lost to Follow-up|1
7476933|NCT01993888|11783485|FG000|Overall Study|Withdrawal by Subject|0
7476934|NCT01993888|11783486|FG001|Overall Study|Withdrawal by Subject|1
7534297|NCT02696785|11881097|FG000|Follow-up Period|Lost to Follow-up|0
7534298|NCT02696785|11881098|FG001|Follow-up Period|Lost to Follow-up|0
7534299|NCT02696785|11881099|FG002|Follow-up Period|Lost to Follow-up|0
7534300|NCT02696785|11881100|FG003|Follow-up Period|Lost to Follow-up|1
7534301|NCT02696785|11881097|FG000|Follow-up Period|Lack of Efficacy|0
7534302|NCT02696785|11881098|FG001|Follow-up Period|Lack of Efficacy|0
7534303|NCT02696785|11881099|FG002|Follow-up Period|Lack of Efficacy|0
7534304|NCT02696785|11881100|FG003|Follow-up Period|Lack of Efficacy|1
7534305|NCT02696785|11881097|FG000|Follow-up Period|Withdrawal by Subject|1
7534306|NCT02696785|11881098|FG001|Follow-up Period|Withdrawal by Subject|0
7534307|NCT02696785|11881099|FG002|Follow-up Period|Withdrawal by Subject|5
7534308|NCT02696785|11881100|FG003|Follow-up Period|Withdrawal by Subject|4
7534309|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Adverse Event|2
7534310|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Adverse Event|9
7534311|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Adverse Event|2
7534312|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Death|0
7534313|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Death|0
7534314|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Death|1
7534315|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
7534316|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
7534317|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
7534318|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
7534319|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
7534320|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
7534321|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Physician Decision|0
7534322|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Physician Decision|1
7534323|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Physician Decision|0
7534324|NCT02696798|11881131|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
7534325|NCT02696798|11881132|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
7534326|NCT02696798|11881133|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
7534327|NCT02696798|11881131|FG000|Extended Treatment Period|Adverse Event|1
7534328|NCT02696798|11881132|FG001|Extended Treatment Period|Adverse Event|4
7534329|NCT02696798|11881133|FG002|Extended Treatment Period|Adverse Event|5
7534330|NCT02696798|11881131|FG000|Extended Treatment Period|Lack of Efficacy|7
7534331|NCT02696798|11881132|FG001|Extended Treatment Period|Lack of Efficacy|2
7534332|NCT02696798|11881133|FG002|Extended Treatment Period|Lack of Efficacy|2
7534333|NCT02696798|11881131|FG000|Extended Treatment Period|Lost to Follow-up|1
7534334|NCT02696798|11881132|FG001|Extended Treatment Period|Lost to Follow-up|0
7534335|NCT02696798|11881133|FG002|Extended Treatment Period|Lost to Follow-up|0
7534336|NCT02696798|11881131|FG000|Extended Treatment Period|Physician Decision|0
7534337|NCT02696798|11881132|FG001|Extended Treatment Period|Physician Decision|1
7534338|NCT02696798|11881133|FG002|Extended Treatment Period|Physician Decision|0
7534339|NCT02696798|11881131|FG000|Extended Treatment Period|Withdrawal by Subject|3
7534340|NCT02696798|11881132|FG001|Extended Treatment Period|Withdrawal by Subject|2
7534341|NCT02696798|11881133|FG002|Extended Treatment Period|Withdrawal by Subject|3
7534342|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|Adverse Event|2
7534343|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|Adverse Event|12
7534344|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|Adverse Event|6
7534345|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
7534346|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
7534347|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
7534348|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
7534349|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
7534350|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
7534351|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
7534352|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
7534353|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
7534354|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|Physician Decision|0
7534355|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|Physician Decision|2
7534356|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|Physician Decision|0
7534357|NCT02696798|11881131|FG000|Post-treatment Follow-up Period|No progressive improvement|0
7534358|NCT02696798|11881132|FG001|Post-treatment Follow-up Period|No progressive improvement|1
7534359|NCT02696798|11881133|FG002|Post-treatment Follow-up Period|No progressive improvement|0
7534360|NCT02696850|11881157|FG000|Overall Study|Withdrawal by Subject|3
7534361|NCT02696850|11881158|FG001|Overall Study|Withdrawal by Subject|3
7534362|NCT02696850|11881157|FG000|Overall Study|Lost to Follow-up|8
7534363|NCT02696850|11881158|FG001|Overall Study|Lost to Follow-up|5
7534364|NCT02696902|11881167|FG000|Overall Study|Lost to Follow-up|0
7534365|NCT02696902|11881168|FG001|Overall Study|Lost to Follow-up|1
7534366|NCT02696902|11881169|FG002|Overall Study|Lost to Follow-up|1
7534367|NCT02696902|11881167|FG000|Overall Study|Withdrawal by Subject|0
7476935|NCT01993927|11783492|FG000|Overall Study|Case Report Forms Uncollected|18
7476936|NCT01993927|11783492|FG000|Overall Study|Protocol Violation|11
7476937|NCT01993940|11783498|FG000|Overall Study|Adverse Event|16
7476938|NCT01993940|11783499|FG001|Overall Study|Adverse Event|11
7476939|NCT01993940|11783498|FG000|Overall Study|Withdrawal by Subject|15
7476940|NCT01993940|11783499|FG001|Overall Study|Withdrawal by Subject|19
7476941|NCT01993940|11783498|FG000|Overall Study|Lost to Follow-up|2
7476942|NCT01993940|11783499|FG001|Overall Study|Lost to Follow-up|5
7476943|NCT01993940|11783498|FG000|Overall Study|Protocol Violation|5
7476944|NCT01993940|11783499|FG001|Overall Study|Protocol Violation|8
7476945|NCT01993940|11783498|FG000|Overall Study|Death|1
7476946|NCT01993940|11783499|FG001|Overall Study|Death|0
7476947|NCT01993940|11783498|FG000|Overall Study|Other - Miscellaneous|1
7476948|NCT01993940|11783499|FG001|Overall Study|Other - Miscellaneous|1
7476949|NCT01994226|11783523|FG000|Overall Study|Protocol Violation|13
7476950|NCT01994226|11783524|FG001|Overall Study|Protocol Violation|10
7476951|NCT01994226|11783523|FG000|Overall Study|Early Cessation of treatment|6
7476952|NCT01994226|11783524|FG001|Overall Study|Early Cessation of treatment|11
7476953|NCT01994291|11783533|FG000|Overall Study|Adverse Event|4
7476954|NCT01994291|11783534|FG001|Overall Study|Adverse Event|1
7476955|NCT01994291|11783535|FG002|Overall Study|Adverse Event|3
7476956|NCT01994291|11783533|FG000|Overall Study|Lost to Follow-up|1
7476957|NCT01994291|11783534|FG001|Overall Study|Lost to Follow-up|1
7476958|NCT01994291|11783535|FG002|Overall Study|Lost to Follow-up|0
7476959|NCT01994291|11783533|FG000|Overall Study|Does not meet entrance criteria|1
7476960|NCT01994291|11783534|FG001|Overall Study|Does not meet entrance criteria|0
7476961|NCT01994291|11783535|FG002|Overall Study|Does not meet entrance criteria|0
7476962|NCT01994291|11783533|FG000|Overall Study|Medication error without associated AE|1
7476963|NCT01994291|11783534|FG001|Overall Study|Medication error without associated AE|0
7476964|NCT01994291|11783535|FG002|Overall Study|Medication error without associated AE|1
7476965|NCT01994291|11783533|FG000|Overall Study|Protocol Violation|1
7476966|NCT01994291|11783534|FG001|Overall Study|Protocol Violation|0
7476967|NCT01994291|11783535|FG002|Overall Study|Protocol Violation|0
7476968|NCT01994291|11783533|FG000|Overall Study|Withdrawal by Subject|6
7476969|NCT01994291|11783534|FG001|Overall Study|Withdrawal by Subject|3
7476970|NCT01994291|11783535|FG002|Overall Study|Withdrawal by Subject|5
7476971|NCT01994291|11783533|FG000|Overall Study|Other|1
7476972|NCT01994291|11783534|FG001|Overall Study|Other|2
7476973|NCT01994291|11783535|FG002|Overall Study|Other|0
7476974|NCT01994395|11783546|FG000|Overall Study|Withdrawal by Subject|1
7476975|NCT01994395|11783547|FG001|Overall Study|Withdrawal by Subject|2
7476976|NCT01994590|11783568|FG000|Overall Study|Adverse Event|1
7476977|NCT01994590|11783568|FG000|Overall Study|Trial Terminated|1
7476978|NCT01994629|11783574|FG000|Overall Study|Withdrawal by Subject|1
7476979|NCT01994629|11783575|FG001|Overall Study|Withdrawal by Subject|0
7476980|NCT01994629|11783574|FG000|Overall Study|Lost to Follow-up|0
7476981|NCT01994629|11783575|FG001|Overall Study|Lost to Follow-up|3
7476982|NCT01994720|11783583|FG000|Overall Study|Withdrawal by Subject|46
7476983|NCT01994720|11783584|FG001|Overall Study|Withdrawal by Subject|56
7476984|NCT01994837|11783614|FG000|Overall Study|Progressive disease per protocol|23
7476985|NCT01994837|11783614|FG000|Overall Study|Adv event related to progressive disease|3
7476986|NCT01994837|11783614|FG000|Overall Study|Fatal progressive disease|2
7476987|NCT01994837|11783614|FG000|Overall Study|Adverse event not related to progression|1
7476988|NCT01994837|11783614|FG000|Overall Study|Chose palliative care|1
7476989|NCT01994837|11783614|FG000|Overall Study|Proceeded to transplant|1
7476990|NCT01994837|11783614|FG000|Overall Study|Removed from study due to no response|1
7476991|NCT01994850|11783618|FG000|Overall Study|Physician Decision|1
7476992|NCT01994850|11783618|FG000|Overall Study|Withdrawal by Subject|1
7476993|NCT01994863|11783622|FG000|Period 1|Adverse Event|4
7476994|NCT01994863|11783623|FG001|Period 1|Adverse Event|0
7476995|NCT01994863|11783622|FG000|Period 1|Withdrawal by Subject|1
7476996|NCT01994863|11783623|FG001|Period 1|Withdrawal by Subject|0
7476997|NCT01994863|11783622|FG000|Period 1|Trial stopped by sponsor|1
7476998|NCT01994863|11783623|FG001|Period 1|Trial stopped by sponsor|3
7476999|NCT01994863|11783622|FG000|Period 1|Lack of Efficacy|1
7477000|NCT01994863|11783623|FG001|Period 1|Lack of Efficacy|0
7477001|NCT01994863|11783622|FG000|Period 2|Adverse Event|0
7477002|NCT01994863|11783623|FG001|Period 2|Adverse Event|1
7477003|NCT01994863|11783622|FG000|Period 2|Lack of Efficacy|0
7477004|NCT01994863|11783623|FG001|Period 2|Lack of Efficacy|2
7477005|NCT01994863|11783622|FG000|Period 2|Withdrawal by Subject|1
7477006|NCT01994863|11783623|FG001|Period 2|Withdrawal by Subject|1
7477007|NCT01994876|11783629|FG000|Test Period 1|Withdrawal by Subject|0
7477008|NCT01994876|11783630|FG001|Test Period 1|Withdrawal by Subject|1
7477009|NCT01994876|11783629|FG000|Test Period 1|Adverse Event|0
7477010|NCT01994876|11783630|FG001|Test Period 1|Adverse Event|1
7477011|NCT01994876|11783629|FG000|Test Period 2|Adverse Event|1
7477012|NCT01994876|11783630|FG001|Test Period 2|Adverse Event|0
7477013|NCT01994876|11783629|FG000|Test Period 2|Protocol Violation|0
7477014|NCT01994876|11783630|FG001|Test Period 2|Protocol Violation|1
7477015|NCT01994889|11783641|FG000|Overall Study|Adverse Event|5
7477016|NCT01994889|11783642|FG001|Overall Study|Adverse Event|12
7477017|NCT01994889|11783643|FG002|Overall Study|Adverse Event|11
7477018|NCT01994889|11783641|FG000|Overall Study|Cardiac Device Implantation|0
7477019|NCT01994889|11783642|FG001|Overall Study|Cardiac Device Implantation|2
7477020|NCT01994889|11783643|FG002|Overall Study|Cardiac Device Implantation|0
7477021|NCT01994889|11783641|FG000|Overall Study|Organ Transplantation|1
7477022|NCT01994889|11783642|FG001|Overall Study|Organ Transplantation|5
7477023|NCT01994889|11783643|FG002|Overall Study|Organ Transplantation|5
7477024|NCT01994889|11783641|FG000|Overall Study|No longer willing to participate|8
7477025|NCT01994889|11783642|FG001|Overall Study|No longer willing to participate|17
7477026|NCT01994889|11783643|FG002|Overall Study|No longer willing to participate|37
7477027|NCT01994889|11783641|FG000|Overall Study|Lost to Follow-up|0
7477028|NCT01994889|11783642|FG001|Overall Study|Lost to Follow-up|1
7477029|NCT01994889|11783643|FG002|Overall Study|Lost to Follow-up|0
7477030|NCT01994889|11783641|FG000|Overall Study|Protocol Violation|0
7477031|NCT01994889|11783642|FG001|Overall Study|Protocol Violation|1
7477032|NCT01994889|11783643|FG002|Overall Study|Protocol Violation|1
7477033|NCT01994889|11783641|FG000|Overall Study|Death|14
7477034|NCT01994889|11783642|FG001|Overall Study|Death|25
7477035|NCT01994889|11783643|FG002|Overall Study|Death|38
7477036|NCT01994902|11783650|FG000|Test Period 1|Withdrawal by Subject|3
7477037|NCT01994902|11783651|FG001|Test Period 1|Withdrawal by Subject|0
7477038|NCT01994902|11783650|FG000|Test Period 1|device deficiency with adverse event|0
7477039|NCT01994902|11783651|FG001|Test Period 1|device deficiency with adverse event|1
7477040|NCT01994902|11783650|FG000|Test Period 1|Adverse Event|2
7477041|NCT01994902|11783651|FG001|Test Period 1|Adverse Event|1
7477042|NCT01994902|11783650|FG000|Test Period 1|Lack of Efficacy|0
7477043|NCT01994902|11783651|FG001|Test Period 1|Lack of Efficacy|1
7477044|NCT01994902|11783650|FG000|Test Period 1|bag too small|1
7477045|NCT01994902|11783651|FG001|Test Period 1|bag too small|0
7477046|NCT01994902|11783650|FG000|Test Period 2|Withdrawal by Subject|0
7477047|NCT01994902|11783651|FG001|Test Period 2|Withdrawal by Subject|2
7477048|NCT01994902|11783650|FG000|Test Period 2|Lack of Efficacy|0
7477049|NCT01994902|11783651|FG001|Test Period 2|Lack of Efficacy|1
7477050|NCT01994902|11783650|FG000|Test Period 2|Other|0
7477051|NCT01994902|11783651|FG001|Test Period 2|Other|3
7477052|NCT01994954|11783659|FG000|Overall Study|Death|1
7477053|NCT01994954|11783660|FG001|Overall Study|Death|0
7477054|NCT01994954|11783659|FG000|Overall Study|Withdrawal by Subject|9
7477055|NCT01994954|11783660|FG001|Overall Study|Withdrawal by Subject|14
7477056|NCT01994954|11783659|FG000|Overall Study|Physician Decision|2
7477057|NCT01994954|11783660|FG001|Overall Study|Physician Decision|2
7477058|NCT01994954|11783659|FG000|Overall Study|Lost to Follow-up|8
7477059|NCT01994954|11783660|FG001|Overall Study|Lost to Follow-up|10
7477060|NCT01994954|11783659|FG000|Overall Study|6 Month Follow-up Not Complete|5
7477061|NCT01994954|11783660|FG001|Overall Study|6 Month Follow-up Not Complete|4
7477062|NCT01995071|11783714|FG000|Overall Study|Adverse Event|0
7477063|NCT01995071|11783715|FG001|Overall Study|Adverse Event|0
7477064|NCT01995071|11783716|FG002|Overall Study|Adverse Event|0
7477065|NCT01995071|11783717|FG003|Overall Study|Adverse Event|0
7477066|NCT01995071|11783718|FG004|Overall Study|Adverse Event|0
7477067|NCT01995071|11783719|FG005|Overall Study|Adverse Event|0
7477068|NCT01995071|11783720|FG006|Overall Study|Adverse Event|1
7477069|NCT01995071|11783721|FG007|Overall Study|Adverse Event|0
7477070|NCT01995071|11783722|FG008|Overall Study|Adverse Event|0
7477071|NCT01995071|11783723|FG009|Overall Study|Adverse Event|0
7477072|NCT01995071|11783724|FG010|Overall Study|Adverse Event|0
7477073|NCT01995071|11783725|FG011|Overall Study|Adverse Event|0
7477074|NCT01995071|11783714|FG000|Overall Study|Moved|0
7477075|NCT01995071|11783715|FG001|Overall Study|Moved|0
7477076|NCT01995071|11783716|FG002|Overall Study|Moved|1
7477077|NCT01995071|11783717|FG003|Overall Study|Moved|0
7477078|NCT01995071|11783718|FG004|Overall Study|Moved|1
7477079|NCT01995071|11783719|FG005|Overall Study|Moved|0
7477080|NCT01995071|11783720|FG006|Overall Study|Moved|0
7477081|NCT01995071|11783721|FG007|Overall Study|Moved|0
7477082|NCT01995071|11783722|FG008|Overall Study|Moved|0
7477083|NCT01995071|11783723|FG009|Overall Study|Moved|0
7477084|NCT01995071|11783724|FG010|Overall Study|Moved|1
7477085|NCT01995071|11783725|FG011|Overall Study|Moved|0
7477086|NCT01995071|11783714|FG000|Overall Study|Lost to Follow-up|1
7477087|NCT01995071|11783715|FG001|Overall Study|Lost to Follow-up|0
7477088|NCT01995071|11783716|FG002|Overall Study|Lost to Follow-up|0
7477089|NCT01995071|11783717|FG003|Overall Study|Lost to Follow-up|0
7477090|NCT01995071|11783718|FG004|Overall Study|Lost to Follow-up|0
7477091|NCT01995071|11783719|FG005|Overall Study|Lost to Follow-up|0
7477092|NCT01995071|11783720|FG006|Overall Study|Lost to Follow-up|0
7477093|NCT01995071|11783721|FG007|Overall Study|Lost to Follow-up|1
7477094|NCT01995071|11783722|FG008|Overall Study|Lost to Follow-up|1
7477095|NCT01995071|11783723|FG009|Overall Study|Lost to Follow-up|0
7477096|NCT01995071|11783724|FG010|Overall Study|Lost to Follow-up|0
7477097|NCT01995071|11783725|FG011|Overall Study|Lost to Follow-up|0
7477098|NCT01995071|11783714|FG000|Overall Study|Incarcerated|0
7477099|NCT01995071|11783715|FG001|Overall Study|Incarcerated|0
7477100|NCT01995071|11783716|FG002|Overall Study|Incarcerated|0
7477101|NCT01995071|11783717|FG003|Overall Study|Incarcerated|0
7477102|NCT01995071|11783718|FG004|Overall Study|Incarcerated|0
7477103|NCT01995071|11783719|FG005|Overall Study|Incarcerated|0
7477104|NCT01995071|11783720|FG006|Overall Study|Incarcerated|0
7477105|NCT01995071|11783721|FG007|Overall Study|Incarcerated|1
7477106|NCT01995071|11783722|FG008|Overall Study|Incarcerated|0
7477107|NCT01995071|11783723|FG009|Overall Study|Incarcerated|0
7477108|NCT01995071|11783724|FG010|Overall Study|Incarcerated|0
7477109|NCT01995071|11783725|FG011|Overall Study|Incarcerated|0
7477110|NCT01995136|11783766|FG000|Overall Study|Change in residence|1
7477111|NCT01995201|11783772|FG000|From Baseline Until Week 24|Adverse Event|4
7477112|NCT01995201|11783773|FG001|From Baseline Until Week 24|Adverse Event|15
7477113|NCT01995201|11783774|FG002|From Baseline Until Week 24|Adverse Event|0
7477114|NCT01995201|11783775|FG003|From Baseline Until Week 24|Adverse Event|0
7477115|NCT01995201|11783776|FG004|From Baseline Until Week 24|Adverse Event|0
7477116|NCT01995201|11783777|FG005|From Baseline Until Week 24|Adverse Event|0
7477117|NCT01995201|11783778|FG006|From Baseline Until Week 24|Adverse Event|0
7477118|NCT01995201|11783772|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477119|NCT01995201|11783773|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
7477120|NCT01995201|11783774|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477121|NCT01995201|11783775|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477122|NCT01995201|11783776|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477123|NCT01995201|11783777|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477124|NCT01995201|11783778|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
7477125|NCT01995201|11783772|FG000|From Baseline Until Week 24|Death|0
7477126|NCT01995201|11783773|FG001|From Baseline Until Week 24|Death|1
7477127|NCT01995201|11783774|FG002|From Baseline Until Week 24|Death|0
7477128|NCT01995201|11783775|FG003|From Baseline Until Week 24|Death|0
7477129|NCT01995201|11783776|FG004|From Baseline Until Week 24|Death|0
7477130|NCT01995201|11783777|FG005|From Baseline Until Week 24|Death|0
7477131|NCT01995201|11783778|FG006|From Baseline Until Week 24|Death|0
7477132|NCT01995201|11783772|FG000|From Baseline Until Week 24|Lack of Efficacy|2
7477133|NCT01995201|11783773|FG001|From Baseline Until Week 24|Lack of Efficacy|5
7477134|NCT01995201|11783774|FG002|From Baseline Until Week 24|Lack of Efficacy|0
7477135|NCT01995201|11783775|FG003|From Baseline Until Week 24|Lack of Efficacy|0
7477136|NCT01995201|11783776|FG004|From Baseline Until Week 24|Lack of Efficacy|0
7477137|NCT01995201|11783777|FG005|From Baseline Until Week 24|Lack of Efficacy|0
7477138|NCT01995201|11783778|FG006|From Baseline Until Week 24|Lack of Efficacy|0
7477139|NCT01995201|11783772|FG000|From Baseline Until Week 24|Lost to Follow-up|2
7477140|NCT01995201|11783773|FG001|From Baseline Until Week 24|Lost to Follow-up|3
7477141|NCT01995201|11783774|FG002|From Baseline Until Week 24|Lost to Follow-up|0
7477142|NCT01995201|11783775|FG003|From Baseline Until Week 24|Lost to Follow-up|0
7477143|NCT01995201|11783776|FG004|From Baseline Until Week 24|Lost to Follow-up|0
7477144|NCT01995201|11783777|FG005|From Baseline Until Week 24|Lost to Follow-up|0
7477145|NCT01995201|11783778|FG006|From Baseline Until Week 24|Lost to Follow-up|0
7477146|NCT01995201|11783772|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
7477147|NCT01995201|11783773|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
7477148|NCT01995201|11783774|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
7477149|NCT01995201|11783775|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
7477150|NCT01995201|11783776|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
7477151|NCT01995201|11783777|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
7477152|NCT01995201|11783778|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
7477153|NCT01995201|11783772|FG000|From Baseline Until Week 24|Physician Decision|0
7477154|NCT01995201|11783773|FG001|From Baseline Until Week 24|Physician Decision|2
7477155|NCT01995201|11783774|FG002|From Baseline Until Week 24|Physician Decision|0
7477156|NCT01995201|11783775|FG003|From Baseline Until Week 24|Physician Decision|0
7477157|NCT01995201|11783776|FG004|From Baseline Until Week 24|Physician Decision|0
7477158|NCT01995201|11783777|FG005|From Baseline Until Week 24|Physician Decision|0
7477159|NCT01995201|11783778|FG006|From Baseline Until Week 24|Physician Decision|0
7477160|NCT01995201|11783772|FG000|From Baseline Until Week 24|Protocol Violation|0
7477161|NCT01995201|11783773|FG001|From Baseline Until Week 24|Protocol Violation|9
7477162|NCT01995201|11783774|FG002|From Baseline Until Week 24|Protocol Violation|0
7477163|NCT01995201|11783775|FG003|From Baseline Until Week 24|Protocol Violation|0
7477164|NCT01995201|11783776|FG004|From Baseline Until Week 24|Protocol Violation|0
7477165|NCT01995201|11783777|FG005|From Baseline Until Week 24|Protocol Violation|0
7477166|NCT01995201|11783778|FG006|From Baseline Until Week 24|Protocol Violation|0
7477167|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Adverse Event|0
7477168|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Adverse Event|0
7477169|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Adverse Event|2
7477170|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Adverse Event|1
7477171|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Adverse Event|1
7477172|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Adverse Event|3
7477173|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Adverse Event|1
7477174|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Death|0
7477175|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Death|0
7477176|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Death|0
7477177|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Death|0
7477178|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Death|0
7477179|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Death|2
7477180|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Death|0
7477181|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
7477182|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
7477183|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
7477184|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
7477185|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
7477186|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
7477187|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
7477188|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
7477189|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
7477190|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
7477191|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
7477192|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
7477193|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
7477194|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
7477195|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
7477196|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
7477197|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
7477198|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
7477199|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
7477200|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
7477201|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
7477202|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Physician Decision|0
7477203|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Physician Decision|0
7477204|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Physician Decision|0
7477205|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Physician Decision|0
7477206|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Physician Decision|1
7477207|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Physician Decision|0
7477208|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Physician Decision|0
7477209|NCT01995201|11783772|FG000|From Week 24 Until Week 48|Protocol Violation|0
7477210|NCT01995201|11783773|FG001|From Week 24 Until Week 48|Protocol Violation|0
7477211|NCT01995201|11783774|FG002|From Week 24 Until Week 48|Protocol Violation|1
7477212|NCT01995201|11783775|FG003|From Week 24 Until Week 48|Protocol Violation|0
7477213|NCT01995201|11783776|FG004|From Week 24 Until Week 48|Protocol Violation|2
7477214|NCT01995201|11783777|FG005|From Week 24 Until Week 48|Protocol Violation|0
7477215|NCT01995201|11783778|FG006|From Week 24 Until Week 48|Protocol Violation|0
7477216|NCT01995266|11783799|FG000|Overall Study|Death|1
7477217|NCT01995266|11783799|FG000|Overall Study|Lack of Efficacy|6
7477218|NCT01995266|11783799|FG000|Overall Study|Adverse Event|2
7477219|NCT01995357|11783803|FG000|Period 5|Lack of Efficacy|1
7477220|NCT01995357|11783804|FG001|Period 5|Lack of Efficacy|0
7477221|NCT01995357|11783805|FG002|Period 5|Lack of Efficacy|0
7477222|NCT01995357|11783806|FG003|Period 5|Lack of Efficacy|0
7477223|NCT01995357|11783807|FG004|Period 5|Lack of Efficacy|0
7477224|NCT01995357|11783808|FG005|Period 5|Lack of Efficacy|0
7477225|NCT01995357|11783803|FG000|Period 5|Adverse Event|1
7477226|NCT01995357|11783804|FG001|Period 5|Adverse Event|0
7477227|NCT01995357|11783805|FG002|Period 5|Adverse Event|1
7477228|NCT01995357|11783806|FG003|Period 5|Adverse Event|0
7477229|NCT01995357|11783807|FG004|Period 5|Adverse Event|0
7477230|NCT01995357|11783808|FG005|Period 5|Adverse Event|0
7477231|NCT01995461|11783824|FG000|Overall Study|Death|1
7477232|NCT01995461|11783824|FG000|Overall Study|Lost to Follow-up|2
7477233|NCT01995461|11783824|FG000|Overall Study|Withdrawal by Subject|2
7477234|NCT01995513|11783837|FG000|Open Label Treatment Period|Other|9
7477235|NCT01995513|11783838|FG001|Open Label Treatment Period|Other|0
7477236|NCT01995513|11783839|FG002|Open Label Treatment Period|Other|0
7477237|NCT01995513|11783837|FG000|Open Label Treatment Period|Withdrawal by Subject|14
7477238|NCT01995513|11783838|FG001|Open Label Treatment Period|Withdrawal by Subject|0
7477239|NCT01995513|11783839|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7477240|NCT01995513|11783837|FG000|Open Label Treatment Period|Protocol Violation|1
7477241|NCT01995513|11783838|FG001|Open Label Treatment Period|Protocol Violation|0
7477242|NCT01995513|11783839|FG002|Open Label Treatment Period|Protocol Violation|0
7477243|NCT01995513|11783837|FG000|Open Label Treatment Period|Disease Progression|64
7477244|NCT01995513|11783838|FG001|Open Label Treatment Period|Disease Progression|0
7477245|NCT01995513|11783839|FG002|Open Label Treatment Period|Disease Progression|0
7477246|NCT01995513|11783837|FG000|Open Label Treatment Period|No PSA response at week 13|43
7477247|NCT01995513|11783838|FG001|Open Label Treatment Period|No PSA response at week 13|0
7477248|NCT01995513|11783839|FG002|Open Label Treatment Period|No PSA response at week 13|0
7477249|NCT01995513|11783837|FG000|Open Label Treatment Period|Adverse Event|35
7477250|NCT01995513|11783838|FG001|Open Label Treatment Period|Adverse Event|0
7477251|NCT01995513|11783839|FG002|Open Label Treatment Period|Adverse Event|0
7477252|NCT01995513|11783837|FG000|Open Label Treatment Period|Death|8
7477253|NCT01995513|11783838|FG001|Open Label Treatment Period|Death|0
7477254|NCT01995513|11783839|FG002|Open Label Treatment Period|Death|0
7477255|NCT01995513|11783837|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
7477256|NCT01995513|11783838|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7477257|NCT01995513|11783839|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7477258|NCT01995513|11783837|FG000|Double Blind Treatment Period|Adverse Event|0
7477259|NCT01995513|11783838|FG001|Double Blind Treatment Period|Adverse Event|12
7477260|NCT01995513|11783839|FG002|Double Blind Treatment Period|Adverse Event|5
7477261|NCT01995513|11783837|FG000|Double Blind Treatment Period|Other|0
7477262|NCT01995513|11783838|FG001|Double Blind Treatment Period|Other|1
7477263|NCT01995513|11783839|FG002|Double Blind Treatment Period|Other|2
7477264|NCT01995513|11783837|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7477265|NCT01995513|11783838|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
7477266|NCT01995513|11783839|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
7477267|NCT01995513|11783837|FG000|Double Blind Treatment Period|Death|0
7477268|NCT01995513|11783838|FG001|Double Blind Treatment Period|Death|0
7477269|NCT01995513|11783839|FG002|Double Blind Treatment Period|Death|1
7477270|NCT01995513|11783837|FG000|Double Blind Treatment Period|Disease Progression|0
7477271|NCT01995513|11783838|FG001|Double Blind Treatment Period|Disease Progression|82
7477272|NCT01995513|11783839|FG002|Double Blind Treatment Period|Disease Progression|93
7477273|NCT01995513|11783837|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
7477274|NCT01995513|11783838|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
7477275|NCT01995513|11783839|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
7477276|NCT01995526|11783849|FG000|Overall Study|Physician Decision|1
7477277|NCT01995539|11783853|FG000|Overall Study|Screening Failure|1
7477278|NCT01995539|11783853|FG000|Overall Study|Withdrawal by Investigator|15
7477279|NCT01995539|11783853|FG000|Overall Study|Withdrawal by Subject|11
7477280|NCT01995539|11783853|FG000|Overall Study|Lost to Follow-up|5
7477281|NCT01995539|11783853|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
7477282|NCT01995552|11783857|FG000|Overall Study|Protocol Violation|1
7477283|NCT01995552|11783857|FG000|Overall Study|Lack of Efficacy|15
7477284|NCT01995552|11783857|FG000|Overall Study|Death|1
7477285|NCT01995825|11783865|FG000|Overall Study|Withdrawal by Subject|1
7477286|NCT01995825|11783866|FG001|Overall Study|Withdrawal by Subject|0
7477287|NCT01995838|11783879|FG000|Overall Study|Lost to Follow-up|0
7477288|NCT01995838|11783880|FG001|Overall Study|Lost to Follow-up|1
7477289|NCT01995838|11783881|FG002|Overall Study|Lost to Follow-up|0
7477290|NCT01995838|11783882|FG003|Overall Study|Lost to Follow-up|0
7477291|NCT01995838|11783883|FG004|Overall Study|Lost to Follow-up|0
7477292|NCT01995838|11783884|FG005|Overall Study|Lost to Follow-up|0
7477293|NCT01995838|11783885|FG006|Overall Study|Lost to Follow-up|1
7477294|NCT01995838|11783879|FG000|Overall Study|Participant choice|2
7477295|NCT01995838|11783880|FG001|Overall Study|Participant choice|0
7477296|NCT01995838|11783881|FG002|Overall Study|Participant choice|0
7477297|NCT01995838|11783882|FG003|Overall Study|Participant choice|0
7477298|NCT01995838|11783883|FG004|Overall Study|Participant choice|0
7477299|NCT01995838|11783884|FG005|Overall Study|Participant choice|1
7477300|NCT01995838|11783885|FG006|Overall Study|Participant choice|1
7477301|NCT01995838|11783879|FG000|Overall Study|Adverse Event|0
7477302|NCT01995838|11783880|FG001|Overall Study|Adverse Event|0
7477303|NCT01995838|11783881|FG002|Overall Study|Adverse Event|0
7477304|NCT01995838|11783882|FG003|Overall Study|Adverse Event|0
7477305|NCT01995838|11783883|FG004|Overall Study|Adverse Event|0
7477306|NCT01995838|11783884|FG005|Overall Study|Adverse Event|0
7477307|NCT01995838|11783885|FG006|Overall Study|Adverse Event|1
7477308|NCT01995838|11783879|FG000|Overall Study|Withdrawal by Subject|0
7477309|NCT01995838|11783880|FG001|Overall Study|Withdrawal by Subject|0
7477310|NCT01995838|11783881|FG002|Overall Study|Withdrawal by Subject|0
7477311|NCT01995838|11783882|FG003|Overall Study|Withdrawal by Subject|0
7477312|NCT01995838|11783883|FG004|Overall Study|Withdrawal by Subject|1
7477313|NCT01995838|11783884|FG005|Overall Study|Withdrawal by Subject|0
7477314|NCT01995838|11783885|FG006|Overall Study|Withdrawal by Subject|0
7477315|NCT01995838|11783879|FG000|Overall Study|Other|3
7477316|NCT01995838|11783880|FG001|Overall Study|Other|1
7477317|NCT01995838|11783881|FG002|Overall Study|Other|0
7477318|NCT01995838|11783882|FG003|Overall Study|Other|2
7477319|NCT01995838|11783883|FG004|Overall Study|Other|1
7477320|NCT01995838|11783884|FG005|Overall Study|Other|1
7477321|NCT01995838|11783885|FG006|Overall Study|Other|2
7477322|NCT01996033|11783902|FG000|Overall Study|Death|1
7477323|NCT01996033|11783902|FG000|Overall Study|Physician Decision|1
7477324|NCT01996033|11783902|FG000|Overall Study|Withdrawal by Subject|4
7477325|NCT01996033|11783902|FG000|Overall Study|Lost to Follow-up|3
7477326|NCT01996241|11783908|FG000|Overall Study|Lost to Follow-up|252
7477327|NCT01996241|11783909|FG001|Overall Study|Lost to Follow-up|235
7477328|NCT01996254|11783919|FG000|Overall Study|Change in Eligibility|0
7477329|NCT01996254|11783920|FG001|Overall Study|Change in Eligibility|2
7477330|NCT01996254|11783921|FG002|Overall Study|Change in Eligibility|0
7477331|NCT01996254|11783919|FG000|Overall Study|Withdrawal by Subject|0
7477332|NCT01996254|11783920|FG001|Overall Study|Withdrawal by Subject|3
7477333|NCT01996254|11783921|FG002|Overall Study|Withdrawal by Subject|4
7477334|NCT01996254|11783919|FG000|Overall Study|Lost to Follow-up|1
7477335|NCT01996254|11783920|FG001|Overall Study|Lost to Follow-up|0
7477336|NCT01996254|11783921|FG002|Overall Study|Lost to Follow-up|4
7477337|NCT01996319|11783933|FG000|Overall Study|Protocol Violation|1
7477338|NCT01996319|11783934|FG001|Overall Study|Protocol Violation|0
7477339|NCT01996319|11783933|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
7477340|NCT01996319|11783934|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
7477341|NCT01996319|11783933|FG000|Overall Study|Adverse Event|2
7477342|NCT01996319|11783934|FG001|Overall Study|Adverse Event|2
7477343|NCT01996332|11783940|FG000|Overall Study|Adverse Event|117
7477344|NCT01996332|11783940|FG000|Overall Study|Lack of Efficacy|1245
7477345|NCT01996332|11783940|FG000|Overall Study|Death|264
7477346|NCT01996332|11783940|FG000|Overall Study|Protocol Violation|9
7477347|NCT01996332|11783940|FG000|Overall Study|Withdrawal by Subject|71
7477348|NCT01996332|11783940|FG000|Overall Study|Other|20
7477349|NCT01996332|11783940|FG000|Overall Study|Clinical Deterioration|28
7477350|NCT01996332|11783940|FG000|Overall Study|Physician Decision|17
7477351|NCT01996332|11783940|FG000|Overall Study|Lost to Follow-up|34
7477352|NCT01996592|11783944|FG000|Overall Study|no response to text/no diary entry|32
7477353|NCT01996592|11783944|FG000|Overall Study|change in surgical date|4
7477354|NCT01996592|11783944|FG000|Overall Study|Withdrawal by Subject|5
7477355|NCT01996592|11783944|FG000|Overall Study|change in mode of delivery|4
7477356|NCT01996709|11783980|FG000|Overall Study|Withdrawal by Subject|1
7477357|NCT01996709|11783981|FG001|Overall Study|Withdrawal by Subject|0
7477358|NCT01996709|11783980|FG000|Overall Study|Lost to Follow-up|3
7477359|NCT01996709|11783981|FG001|Overall Study|Lost to Follow-up|0
7477360|NCT01996709|11783980|FG000|Overall Study|Subject Non-Compliant|1
7477361|NCT01996709|11783981|FG001|Overall Study|Subject Non-Compliant|0
7477362|NCT01996709|11783980|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7477363|NCT01996709|11783981|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
7477364|NCT01996748|11783993|FG000|Overall Study|Personal reason|1
7477365|NCT01996748|11783994|FG001|Overall Study|Personal reason|0
7477366|NCT01996748|11783993|FG000|Overall Study|Physician Decision|2
7477367|NCT01996748|11783994|FG001|Overall Study|Physician Decision|0
7477368|NCT01996748|11783993|FG000|Overall Study|Adverse Event|1
7477369|NCT01996748|11783994|FG001|Overall Study|Adverse Event|4
7477370|NCT01996748|11783993|FG000|Overall Study|Withdrawal by Subject|0
7477371|NCT01996748|11783994|FG001|Overall Study|Withdrawal by Subject|1
7477372|NCT01996748|11783993|FG000|Overall Study|Lost to Follow-up|4
7477373|NCT01996748|11783994|FG001|Overall Study|Lost to Follow-up|1
7477374|NCT01996826|11784013|FG000|Overall Study|Lost to Follow-up|6
7477375|NCT01996826|11784014|FG001|Overall Study|Lost to Follow-up|2
7477376|NCT01996826|11784013|FG000|Overall Study|Physician Decision|1
7477377|NCT01996826|11784014|FG001|Overall Study|Physician Decision|1
7477378|NCT01996904|11784035|FG000|Overall Study|Lost to Follow-up|38
7477379|NCT01996904|11784036|FG001|Overall Study|Lost to Follow-up|27
7477380|NCT01997281|11784078|FG000|Overall Study|Withdrawal by Subject|1
7477381|NCT01997281|11784079|FG001|Overall Study|Withdrawal by Subject|0
7477382|NCT01997333|11784087|FG000|Randomization and Treatment|Disease Progression|70
7477383|NCT01997333|11784088|FG001|Randomization and Treatment|Disease Progression|159
7477384|NCT01997333|11784087|FG000|Randomization and Treatment|Adverse Event|10
7477385|NCT01997333|11784088|FG001|Randomization and Treatment|Adverse Event|32
7477386|NCT01997333|11784087|FG000|Randomization and Treatment|Physician Decision|0
7477387|NCT01997333|11784088|FG001|Randomization and Treatment|Physician Decision|4
7477388|NCT01997333|11784087|FG000|Randomization and Treatment|Withdrawal by Subject|6
7477389|NCT01997333|11784088|FG001|Randomization and Treatment|Withdrawal by Subject|3
7477390|NCT01997333|11784087|FG000|Randomization and Treatment|Did not receive treatment|17
7477391|NCT01997333|11784088|FG001|Randomization and Treatment|Did not receive treatment|5
7477392|NCT01997333|11784087|FG000|Survival Follow up|Withdrawal by Subject|15
7477393|NCT01997333|11784088|FG001|Survival Follow up|Withdrawal by Subject|6
7477394|NCT01997333|11784087|FG000|Survival Follow up|Lost to Follow-up|0
7477395|NCT01997333|11784088|FG001|Survival Follow up|Lost to Follow-up|6
7477396|NCT01997333|11784087|FG000|Survival Follow up|Various|1
7477397|NCT01997333|11784088|FG001|Survival Follow up|Various|2
7477398|NCT01997892|11784152|FG000|Overall Study|Physician Decision|2
7477399|NCT01997892|11784152|FG000|Overall Study|Lost to Follow-up|6
7477400|NCT01997892|11784152|FG000|Overall Study|Death|14
7477401|NCT01997892|11784152|FG000|Overall Study|Renal transplant|8
7477402|NCT01997892|11784152|FG000|Overall Study|Other|3
7477403|NCT01997892|11784152|FG000|Overall Study|Study completion data not recorded|35
7477404|NCT01998243|11784167|FG000|Overall Study|Pregnancy|0
7477405|NCT01998243|11784168|FG001|Overall Study|Pregnancy|1
7477406|NCT01998243|11784167|FG000|Overall Study|Protocol Violation|5
7477407|NCT01998243|11784168|FG001|Overall Study|Protocol Violation|2
7477408|NCT01998243|11784167|FG000|Overall Study|Withdrawal by Subject|3
7477409|NCT01998243|11784168|FG001|Overall Study|Withdrawal by Subject|4
7477410|NCT01998399|11784191|FG000|Overall Study|Lost to Follow-up|1
7477411|NCT01998399|11784192|FG001|Overall Study|Lost to Follow-up|3
7477412|NCT01998399|11784191|FG000|Overall Study|Death|4
7477413|NCT01998399|11784192|FG001|Overall Study|Death|2
7477414|NCT01998399|11784191|FG000|Overall Study|Study stopped before dosing completed|3
7477415|NCT01998399|11784192|FG001|Overall Study|Study stopped before dosing completed|3
7477416|NCT01998399|11784191|FG000|Overall Study|Withdrawal by Subject|0
7477417|NCT01998399|11784192|FG001|Overall Study|Withdrawal by Subject|1
7477418|NCT01998477|11784213|FG000|Overall Study|Lost to Follow-up|4
7477419|NCT01998477|11784214|FG001|Overall Study|Lost to Follow-up|5
7477420|NCT01998477|11784213|FG000|Overall Study|Withdrawal by Subject|6
7477421|NCT01998477|11784214|FG001|Overall Study|Withdrawal by Subject|0
7477422|NCT01998581|11784247|FG000|Overall Study|Refused repeat treatment|20
7477423|NCT01998581|11784248|FG001|Overall Study|Refused repeat treatment|4
7477424|NCT01998581|11784247|FG000|Overall Study|Protocol Violation|1
7477425|NCT01998581|11784248|FG001|Overall Study|Protocol Violation|0
7477426|NCT01998581|11784247|FG000|Overall Study|Withdrawal by Subject|8
7477427|NCT01998581|11784248|FG001|Overall Study|Withdrawal by Subject|1
7477428|NCT01998581|11784247|FG000|Overall Study|Lost to Follow-up|12
7477429|NCT01998581|11784248|FG001|Overall Study|Lost to Follow-up|4
7477430|NCT01998581|11784247|FG000|Overall Study|Adverse Event|1
7477431|NCT01998581|11784248|FG001|Overall Study|Adverse Event|1
7477432|NCT01998581|11784247|FG000|Overall Study|Other reasons|3
7477433|NCT01998581|11784248|FG001|Overall Study|Other reasons|2
7477434|NCT01998581|11784247|FG000|Overall Study|Randomized but withdrew before treatment|1
7477435|NCT01998581|11784248|FG001|Overall Study|Randomized but withdrew before treatment|0
7477436|NCT01998633|11784257|FG000|Overall Study|Death|1
7477437|NCT01998737|11784267|FG000|Overall Study|Corrupted database|23
7477438|NCT01998737|11784268|FG001|Overall Study|Corrupted database|0
7477439|NCT01998880|11784276|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
7477440|NCT01998880|11784277|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
7477441|NCT01998880|11784276|FG000|Overall Study|Disease Progression|1
7477442|NCT01998880|11784277|FG001|Overall Study|Disease Progression|8
7477443|NCT01998880|11784276|FG000|Overall Study|Withdrew Consent|2
7477444|NCT01998880|11784277|FG001|Overall Study|Withdrew Consent|1
7477445|NCT01998880|11784276|FG000|Overall Study|Death|3
7477446|NCT01998880|11784277|FG001|Overall Study|Death|6
7477447|NCT01998880|11784276|FG000|Overall Study|Insufficient Therapeutic Response|1
7477448|NCT01998880|11784277|FG001|Overall Study|Insufficient Therapeutic Response|5
7477449|NCT01998880|11784276|FG000|Overall Study|Administrative/Other|1
7477450|NCT01998880|11784277|FG001|Overall Study|Administrative/Other|1
7477451|NCT01998880|11784276|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
7477452|NCT01998880|11784277|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7477453|NCT01998880|11784276|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7477454|NCT01998880|11784277|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7477455|NCT01998880|11784276|FG000|Overall Study|Did Not Receive Treatment|3
7477456|NCT01998880|11784277|FG001|Overall Study|Did Not Receive Treatment|2
7477457|NCT01998893|11784283|FG000|Overall Study|Adverse Event|2
7477458|NCT01998893|11784283|FG000|Overall Study|Death|1
7477459|NCT01998893|11784283|FG000|Overall Study|Lost to Follow-up|8
7477460|NCT01998893|11784283|FG000|Overall Study|Physician Decision|2
7477461|NCT01998893|11784283|FG000|Overall Study|Protocol Violation|2
7477462|NCT01998893|11784283|FG000|Overall Study|Withdrawal by Subject|1
7477463|NCT01998893|11784283|FG000|Overall Study|Transformation to high-grade lymphoma|1
7477464|NCT01998906|11784290|FG000|Overall Study|Participants ongoing in follow-up|77
7477465|NCT01998906|11784291|FG001|Overall Study|Participants ongoing in follow-up|60
7477466|NCT01998906|11784292|FG002|Overall Study|Participants ongoing in follow-up|58
7477467|NCT01998906|11784290|FG000|Overall Study|Death|21
7477468|NCT01998906|11784291|FG001|Overall Study|Death|30
7477469|NCT01998906|11784292|FG002|Overall Study|Death|17
7477470|NCT01998906|11784290|FG000|Overall Study|Lack of Efficacy|10
7477471|NCT01998906|11784291|FG001|Overall Study|Lack of Efficacy|9
7477472|NCT01998906|11784292|FG002|Overall Study|Lack of Efficacy|8
7477473|NCT01998906|11784290|FG000|Overall Study|Failure to return|0
7477474|NCT01998906|11784291|FG001|Overall Study|Failure to return|2
7477475|NCT01998906|11784292|FG002|Overall Study|Failure to return|4
7477476|NCT01998906|11784290|FG000|Overall Study|Violation of Selection Criteria|0
7477477|NCT01998906|11784291|FG001|Overall Study|Violation of Selection Criteria|0
7477478|NCT01998906|11784292|FG002|Overall Study|Violation of Selection Criteria|1
7477479|NCT01998906|11784290|FG000|Overall Study|Withdrawal by Subject|1
7477480|NCT01998906|11784291|FG001|Overall Study|Withdrawal by Subject|4
7477481|NCT01998906|11784292|FG002|Overall Study|Withdrawal by Subject|3
7477482|NCT01998906|11784290|FG000|Overall Study|Administrative/Other|2
7477483|NCT01998906|11784291|FG001|Overall Study|Administrative/Other|1
7477484|NCT01998906|11784292|FG002|Overall Study|Administrative/Other|3
7477485|NCT01998906|11784290|FG000|Overall Study|Other|3
7477486|NCT01998906|11784291|FG001|Overall Study|Other|8
7477487|NCT01998906|11784292|FG002|Overall Study|Other|4
7477488|NCT01998919|11784305|FG000|Overall Study|Death|2
7477489|NCT01998919|11784306|FG001|Overall Study|Death|2
7477490|NCT01998919|11784305|FG000|Overall Study|Adverse Event|0
7477491|NCT01998919|11784306|FG001|Overall Study|Adverse Event|5
7477492|NCT01998919|11784305|FG000|Overall Study|Disease progression|31
7477493|NCT01998919|11784306|FG001|Overall Study|Disease progression|22
7477494|NCT01998919|11784305|FG000|Overall Study|Withdrawal by Subject|2
7477495|NCT01998919|11784306|FG001|Overall Study|Withdrawal by Subject|4
7477496|NCT01998919|11784305|FG000|Overall Study|Lost to Follow-up|2
7477497|NCT01998919|11784306|FG001|Overall Study|Lost to Follow-up|0
7477498|NCT01998919|11784305|FG000|Overall Study|Other|5
7477499|NCT01998919|11784306|FG001|Overall Study|Other|2
7477500|NCT01998958|11784319|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477501|NCT01998958|11784320|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
7477502|NCT01998958|11784321|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477503|NCT01998958|11784322|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477504|NCT01998958|11784323|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477505|NCT01998958|11784324|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477506|NCT01998958|11784325|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477507|NCT01998958|11784326|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477508|NCT01998958|11784327|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477509|NCT01998958|11784328|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477510|NCT01998958|11784329|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477511|NCT01998958|11784330|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477512|NCT01998958|11784331|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477513|NCT01998958|11784332|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477514|NCT01998958|11784333|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477515|NCT01998958|11784334|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477516|NCT01998958|11784335|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477517|NCT01998958|11784336|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477518|NCT01998958|11784337|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477519|NCT01998958|11784338|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477520|NCT01998958|11784339|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477521|NCT01998958|11784340|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477522|NCT01998958|11784341|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477523|NCT01998958|11784342|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477524|NCT01998958|11784343|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477525|NCT01998958|11784344|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477526|NCT01998958|11784345|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477527|NCT01998958|11784346|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477528|NCT01998958|11784347|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477529|NCT01998958|11784348|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477530|NCT01998958|11784349|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477531|NCT01998958|11784350|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
7477532|NCT01998958|11784319|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
7477533|NCT01998958|11784320|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
7477534|NCT01998958|11784321|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
7477535|NCT01998958|11784322|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
7477536|NCT01998958|11784323|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
7477537|NCT01998958|11784324|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
7477538|NCT01998958|11784325|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
7477539|NCT01998958|11784326|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
7477540|NCT01998958|11784327|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
7477541|NCT01998958|11784328|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
7477542|NCT01998958|11784329|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
7477543|NCT01998958|11784330|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
7477544|NCT01998958|11784331|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
7477545|NCT01998958|11784332|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
7477546|NCT01998958|11784333|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
7477547|NCT01998958|11784334|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
7477548|NCT01998958|11784335|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
7477549|NCT01998958|11784336|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
7477550|NCT01998958|11784337|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
7477551|NCT01998958|11784338|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
7477552|NCT01998958|11784339|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
7477553|NCT01998958|11784340|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
7477554|NCT01998958|11784341|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
7477555|NCT01998958|11784342|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
7477556|NCT01998958|11784343|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
7477557|NCT01998958|11784344|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
7477558|NCT01998958|11784345|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
7477559|NCT01998958|11784346|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
7477560|NCT01998958|11784347|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
7477561|NCT01998958|11784348|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
7477562|NCT01998958|11784349|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
7477563|NCT01998958|11784350|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
7477564|NCT01998958|11784319|FG000|Period 1 (Panel A and B)|Adverse Event|0
7477565|NCT01998958|11784320|FG001|Period 1 (Panel A and B)|Adverse Event|1
7477566|NCT01998958|11784321|FG002|Period 1 (Panel A and B)|Adverse Event|0
7477567|NCT01998958|11784322|FG003|Period 1 (Panel A and B)|Adverse Event|0
7477568|NCT01998958|11784323|FG004|Period 1 (Panel A and B)|Adverse Event|0
7477569|NCT01998958|11784324|FG005|Period 1 (Panel A and B)|Adverse Event|0
7477570|NCT01998958|11784325|FG006|Period 1 (Panel A and B)|Adverse Event|0
7477571|NCT01998958|11784326|FG007|Period 1 (Panel A and B)|Adverse Event|0
7477572|NCT01998958|11784327|FG008|Period 1 (Panel A and B)|Adverse Event|0
7477573|NCT01998958|11784328|FG009|Period 1 (Panel A and B)|Adverse Event|0
7477574|NCT01998958|11784329|FG010|Period 1 (Panel A and B)|Adverse Event|0
7477575|NCT01998958|11784330|FG011|Period 1 (Panel A and B)|Adverse Event|0
7477576|NCT01998958|11784331|FG012|Period 1 (Panel A and B)|Adverse Event|0
7477577|NCT01998958|11784332|FG013|Period 1 (Panel A and B)|Adverse Event|0
7477578|NCT01998958|11784333|FG014|Period 1 (Panel A and B)|Adverse Event|0
7477579|NCT01998958|11784334|FG015|Period 1 (Panel A and B)|Adverse Event|0
7477580|NCT01998958|11784335|FG016|Period 1 (Panel A and B)|Adverse Event|0
7477581|NCT01998958|11784336|FG017|Period 1 (Panel A and B)|Adverse Event|0
7477582|NCT01998958|11784337|FG018|Period 1 (Panel A and B)|Adverse Event|0
7477583|NCT01998958|11784338|FG019|Period 1 (Panel A and B)|Adverse Event|0
7477584|NCT01998958|11784339|FG020|Period 1 (Panel A and B)|Adverse Event|0
7477585|NCT01998958|11784340|FG021|Period 1 (Panel A and B)|Adverse Event|0
7477586|NCT01998958|11784341|FG022|Period 1 (Panel A and B)|Adverse Event|0
7477587|NCT01998958|11784342|FG023|Period 1 (Panel A and B)|Adverse Event|0
7477588|NCT01998958|11784343|FG024|Period 1 (Panel A and B)|Adverse Event|0
7477589|NCT01998958|11784344|FG025|Period 1 (Panel A and B)|Adverse Event|0
7477590|NCT01998958|11784345|FG026|Period 1 (Panel A and B)|Adverse Event|0
7477591|NCT01998958|11784346|FG027|Period 1 (Panel A and B)|Adverse Event|0
7477592|NCT01998958|11784347|FG028|Period 1 (Panel A and B)|Adverse Event|0
7477593|NCT01998958|11784348|FG029|Period 1 (Panel A and B)|Adverse Event|0
7477594|NCT01998958|11784349|FG030|Period 1 (Panel A and B)|Adverse Event|0
7477595|NCT01998958|11784350|FG031|Period 1 (Panel A and B)|Adverse Event|0
7477596|NCT01998958|11784319|FG000|Period 1 (Panel A and B)|Other|1
7477597|NCT01998958|11784320|FG001|Period 1 (Panel A and B)|Other|0
7477598|NCT01998958|11784321|FG002|Period 1 (Panel A and B)|Other|0
7477599|NCT01998958|11784322|FG003|Period 1 (Panel A and B)|Other|0
7477600|NCT01998958|11784323|FG004|Period 1 (Panel A and B)|Other|0
7477601|NCT01998958|11784324|FG005|Period 1 (Panel A and B)|Other|0
7477602|NCT01998958|11784325|FG006|Period 1 (Panel A and B)|Other|0
7477603|NCT01998958|11784326|FG007|Period 1 (Panel A and B)|Other|0
7477604|NCT01998958|11784327|FG008|Period 1 (Panel A and B)|Other|0
7477605|NCT01998958|11784328|FG009|Period 1 (Panel A and B)|Other|0
7477606|NCT01998958|11784329|FG010|Period 1 (Panel A and B)|Other|0
7477607|NCT01998958|11784330|FG011|Period 1 (Panel A and B)|Other|0
7477608|NCT01998958|11784331|FG012|Period 1 (Panel A and B)|Other|0
7477609|NCT01998958|11784332|FG013|Period 1 (Panel A and B)|Other|0
7477610|NCT01998958|11784333|FG014|Period 1 (Panel A and B)|Other|0
7477611|NCT01998958|11784334|FG015|Period 1 (Panel A and B)|Other|0
7477612|NCT01998958|11784335|FG016|Period 1 (Panel A and B)|Other|0
7477613|NCT01998958|11784336|FG017|Period 1 (Panel A and B)|Other|0
7477614|NCT01998958|11784337|FG018|Period 1 (Panel A and B)|Other|0
7477615|NCT01998958|11784338|FG019|Period 1 (Panel A and B)|Other|0
7477616|NCT01998958|11784339|FG020|Period 1 (Panel A and B)|Other|0
7477617|NCT01998958|11784340|FG021|Period 1 (Panel A and B)|Other|0
7477618|NCT01998958|11784341|FG022|Period 1 (Panel A and B)|Other|0
7477619|NCT01998958|11784342|FG023|Period 1 (Panel A and B)|Other|0
7477620|NCT01998958|11784343|FG024|Period 1 (Panel A and B)|Other|0
7477621|NCT01998958|11784344|FG025|Period 1 (Panel A and B)|Other|0
7477622|NCT01998958|11784345|FG026|Period 1 (Panel A and B)|Other|0
7477623|NCT01998958|11784346|FG027|Period 1 (Panel A and B)|Other|0
7477624|NCT01998958|11784347|FG028|Period 1 (Panel A and B)|Other|0
7477625|NCT01998958|11784348|FG029|Period 1 (Panel A and B)|Other|0
7477626|NCT01998958|11784349|FG030|Period 1 (Panel A and B)|Other|0
7477627|NCT01998958|11784350|FG031|Period 1 (Panel A and B)|Other|0
7477628|NCT01998958|11784319|FG000|Period 2 (Panel A and B)|Adverse Event|0
7477629|NCT01998958|11784320|FG001|Period 2 (Panel A and B)|Adverse Event|0
7477630|NCT01998958|11784321|FG002|Period 2 (Panel A and B)|Adverse Event|0
7477631|NCT01998958|11784322|FG003|Period 2 (Panel A and B)|Adverse Event|0
7477632|NCT01998958|11784323|FG004|Period 2 (Panel A and B)|Adverse Event|0
7477633|NCT01998958|11784324|FG005|Period 2 (Panel A and B)|Adverse Event|0
7477634|NCT01998958|11784325|FG006|Period 2 (Panel A and B)|Adverse Event|0
7477635|NCT01998958|11784326|FG007|Period 2 (Panel A and B)|Adverse Event|0
7477636|NCT01998958|11784327|FG008|Period 2 (Panel A and B)|Adverse Event|0
7477637|NCT01998958|11784328|FG009|Period 2 (Panel A and B)|Adverse Event|0
7477638|NCT01998958|11784329|FG010|Period 2 (Panel A and B)|Adverse Event|1
7477639|NCT01998958|11784330|FG011|Period 2 (Panel A and B)|Adverse Event|0
7477640|NCT01998958|11784331|FG012|Period 2 (Panel A and B)|Adverse Event|0
7477641|NCT01998958|11784332|FG013|Period 2 (Panel A and B)|Adverse Event|0
7477642|NCT01998958|11784333|FG014|Period 2 (Panel A and B)|Adverse Event|1
7477643|NCT01998958|11784334|FG015|Period 2 (Panel A and B)|Adverse Event|0
7477644|NCT01998958|11784335|FG016|Period 2 (Panel A and B)|Adverse Event|0
7477645|NCT01998958|11784336|FG017|Period 2 (Panel A and B)|Adverse Event|0
7477646|NCT01998958|11784337|FG018|Period 2 (Panel A and B)|Adverse Event|0
7477647|NCT01998958|11784338|FG019|Period 2 (Panel A and B)|Adverse Event|0
7477648|NCT01998958|11784339|FG020|Period 2 (Panel A and B)|Adverse Event|0
7477649|NCT01998958|11784340|FG021|Period 2 (Panel A and B)|Adverse Event|0
7477650|NCT01998958|11784341|FG022|Period 2 (Panel A and B)|Adverse Event|0
7477651|NCT01998958|11784342|FG023|Period 2 (Panel A and B)|Adverse Event|0
7477652|NCT01998958|11784343|FG024|Period 2 (Panel A and B)|Adverse Event|0
7477653|NCT01998958|11784344|FG025|Period 2 (Panel A and B)|Adverse Event|0
7477654|NCT01998958|11784345|FG026|Period 2 (Panel A and B)|Adverse Event|0
7477655|NCT01998958|11784346|FG027|Period 2 (Panel A and B)|Adverse Event|0
7477656|NCT01998958|11784347|FG028|Period 2 (Panel A and B)|Adverse Event|0
7477657|NCT01998958|11784348|FG029|Period 2 (Panel A and B)|Adverse Event|0
7477658|NCT01998958|11784349|FG030|Period 2 (Panel A and B)|Adverse Event|0
7477659|NCT01998958|11784350|FG031|Period 2 (Panel A and B)|Adverse Event|0
7477660|NCT01998958|11784319|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477661|NCT01998958|11784320|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477662|NCT01998958|11784321|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477663|NCT01998958|11784322|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477664|NCT01998958|11784323|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477665|NCT01998958|11784324|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477666|NCT01998958|11784325|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477667|NCT01998958|11784326|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477668|NCT01998958|11784327|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477669|NCT01998958|11784328|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477670|NCT01998958|11784329|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477671|NCT01998958|11784330|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477672|NCT01998958|11784331|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477673|NCT01998958|11784332|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477674|NCT01998958|11784333|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
7477675|NCT01998958|11784334|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477676|NCT01998958|11784335|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477677|NCT01998958|11784336|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477678|NCT01998958|11784337|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
7477679|NCT01998958|11784338|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477680|NCT01998958|11784339|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477681|NCT01998958|11784340|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477682|NCT01998958|11784341|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477683|NCT01998958|11784342|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477684|NCT01998958|11784343|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477685|NCT01998958|11784344|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477686|NCT01998958|11784345|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477687|NCT01998958|11784346|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477688|NCT01998958|11784347|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477689|NCT01998958|11784348|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477690|NCT01998958|11784349|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477691|NCT01998958|11784350|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
7477692|NCT01998958|11784319|FG000|Open Label Phase (Optional)|Adverse Event|0
7477693|NCT01998958|11784320|FG001|Open Label Phase (Optional)|Adverse Event|0
7477694|NCT01998958|11784321|FG002|Open Label Phase (Optional)|Adverse Event|0
7477695|NCT01998958|11784322|FG003|Open Label Phase (Optional)|Adverse Event|0
7477696|NCT01998958|11784323|FG004|Open Label Phase (Optional)|Adverse Event|0
7477697|NCT01998958|11784324|FG005|Open Label Phase (Optional)|Adverse Event|0
7477698|NCT01998958|11784325|FG006|Open Label Phase (Optional)|Adverse Event|0
7477699|NCT01998958|11784326|FG007|Open Label Phase (Optional)|Adverse Event|0
7477700|NCT01998958|11784327|FG008|Open Label Phase (Optional)|Adverse Event|0
7477701|NCT01998958|11784328|FG009|Open Label Phase (Optional)|Adverse Event|0
7477702|NCT01998958|11784329|FG010|Open Label Phase (Optional)|Adverse Event|0
7477703|NCT01998958|11784330|FG011|Open Label Phase (Optional)|Adverse Event|0
7477704|NCT01998958|11784331|FG012|Open Label Phase (Optional)|Adverse Event|0
7477705|NCT01998958|11784332|FG013|Open Label Phase (Optional)|Adverse Event|0
7477706|NCT01998958|11784333|FG014|Open Label Phase (Optional)|Adverse Event|0
7477707|NCT01998958|11784334|FG015|Open Label Phase (Optional)|Adverse Event|0
7477708|NCT01998958|11784335|FG016|Open Label Phase (Optional)|Adverse Event|0
7477709|NCT01998958|11784336|FG017|Open Label Phase (Optional)|Adverse Event|0
7477710|NCT01998958|11784337|FG018|Open Label Phase (Optional)|Adverse Event|0
7477711|NCT01998958|11784338|FG019|Open Label Phase (Optional)|Adverse Event|0
7477712|NCT01998958|11784339|FG020|Open Label Phase (Optional)|Adverse Event|0
7477713|NCT01998958|11784340|FG021|Open Label Phase (Optional)|Adverse Event|0
7477714|NCT01998958|11784341|FG022|Open Label Phase (Optional)|Adverse Event|0
7477715|NCT01998958|11784342|FG023|Open Label Phase (Optional)|Adverse Event|1
7477716|NCT01998958|11784343|FG024|Open Label Phase (Optional)|Adverse Event|0
7477717|NCT01998958|11784344|FG025|Open Label Phase (Optional)|Adverse Event|0
7477718|NCT01998958|11784345|FG026|Open Label Phase (Optional)|Adverse Event|0
7477719|NCT01998958|11784346|FG027|Open Label Phase (Optional)|Adverse Event|0
7477720|NCT01998958|11784347|FG028|Open Label Phase (Optional)|Adverse Event|0
7477721|NCT01998958|11784348|FG029|Open Label Phase (Optional)|Adverse Event|0
7477722|NCT01998958|11784349|FG030|Open Label Phase (Optional)|Adverse Event|0
7477723|NCT01998958|11784350|FG031|Open Label Phase (Optional)|Adverse Event|0
7477724|NCT01998958|11784319|FG000|Open Label Phase (Optional)|Other|0
7477725|NCT01998958|11784320|FG001|Open Label Phase (Optional)|Other|0
7477726|NCT01998958|11784321|FG002|Open Label Phase (Optional)|Other|0
7477727|NCT01998958|11784322|FG003|Open Label Phase (Optional)|Other|0
7477728|NCT01998958|11784323|FG004|Open Label Phase (Optional)|Other|0
7477729|NCT01998958|11784324|FG005|Open Label Phase (Optional)|Other|0
7477730|NCT01998958|11784325|FG006|Open Label Phase (Optional)|Other|0
7477731|NCT01998958|11784326|FG007|Open Label Phase (Optional)|Other|0
7477732|NCT01998958|11784327|FG008|Open Label Phase (Optional)|Other|0
7477733|NCT01998958|11784328|FG009|Open Label Phase (Optional)|Other|0
7477734|NCT01998958|11784329|FG010|Open Label Phase (Optional)|Other|0
7477735|NCT01998958|11784330|FG011|Open Label Phase (Optional)|Other|0
7477736|NCT01998958|11784331|FG012|Open Label Phase (Optional)|Other|0
7477737|NCT01998958|11784332|FG013|Open Label Phase (Optional)|Other|0
7477738|NCT01998958|11784333|FG014|Open Label Phase (Optional)|Other|0
7477739|NCT01998958|11784334|FG015|Open Label Phase (Optional)|Other|0
7477740|NCT01998958|11784335|FG016|Open Label Phase (Optional)|Other|0
7477741|NCT01998958|11784336|FG017|Open Label Phase (Optional)|Other|0
7477742|NCT01998958|11784337|FG018|Open Label Phase (Optional)|Other|0
7477743|NCT01998958|11784338|FG019|Open Label Phase (Optional)|Other|0
7477744|NCT01998958|11784339|FG020|Open Label Phase (Optional)|Other|0
7477745|NCT01998958|11784340|FG021|Open Label Phase (Optional)|Other|0
7477746|NCT01998958|11784341|FG022|Open Label Phase (Optional)|Other|5
7477747|NCT01998958|11784342|FG023|Open Label Phase (Optional)|Other|1
7477748|NCT01998958|11784343|FG024|Open Label Phase (Optional)|Other|0
7477749|NCT01998958|11784344|FG025|Open Label Phase (Optional)|Other|0
7477750|NCT01998958|11784345|FG026|Open Label Phase (Optional)|Other|0
7477751|NCT01998958|11784346|FG027|Open Label Phase (Optional)|Other|0
7477752|NCT01998958|11784347|FG028|Open Label Phase (Optional)|Other|0
7477753|NCT01998958|11784348|FG029|Open Label Phase (Optional)|Other|0
7477754|NCT01998958|11784349|FG030|Open Label Phase (Optional)|Other|0
7477755|NCT01998958|11784350|FG031|Open Label Phase (Optional)|Other|0
7477756|NCT01998958|11784319|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
7477757|NCT01998958|11784320|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
7477758|NCT01998958|11784321|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
7477759|NCT01998958|11784322|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
7477760|NCT01998958|11784323|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
7477761|NCT01998958|11784324|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
7477762|NCT01998958|11784325|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
7477763|NCT01998958|11784326|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
7477764|NCT01998958|11784327|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
7477765|NCT01998958|11784328|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
7477766|NCT01998958|11784329|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
7477767|NCT01998958|11784330|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
7477768|NCT01998958|11784331|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
7477769|NCT01998958|11784332|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
7477770|NCT01998958|11784333|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
7477771|NCT01998958|11784334|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
7477772|NCT01998958|11784335|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
7477773|NCT01998958|11784336|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
7477774|NCT01998958|11784337|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
7477775|NCT01998958|11784338|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
7477776|NCT01998958|11784339|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
7477777|NCT01998958|11784340|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
7477778|NCT01998958|11784341|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
7477779|NCT01998958|11784342|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
7477780|NCT01998958|11784343|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
7477781|NCT01998958|11784344|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
7477782|NCT01998958|11784345|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
7477783|NCT01998958|11784346|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
7477784|NCT01998958|11784347|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
7477785|NCT01998958|11784348|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
7477786|NCT01998958|11784349|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
7477787|NCT01998958|11784350|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
7477788|NCT01998958|11784319|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
7477789|NCT01998958|11784320|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
7477790|NCT01998958|11784321|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
7477791|NCT01998958|11784322|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
7477792|NCT01998958|11784323|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
7477793|NCT01998958|11784324|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
7477794|NCT01998958|11784325|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
7477795|NCT01998958|11784326|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
7477796|NCT01998958|11784327|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
7477797|NCT01998958|11784328|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
7477798|NCT01998958|11784329|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
7477799|NCT01998958|11784330|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
7477800|NCT01998958|11784331|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
7477801|NCT01998958|11784332|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
7477802|NCT01998958|11784333|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
7477803|NCT01998958|11784334|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
7477804|NCT01998958|11784335|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
7477805|NCT01998958|11784336|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
7477806|NCT01998958|11784337|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
7477807|NCT01998958|11784338|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
7477808|NCT01998958|11784339|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
7477809|NCT01998958|11784340|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
7477810|NCT01998958|11784341|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
7477811|NCT01998958|11784342|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
7477812|NCT01998958|11784343|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
7477813|NCT01998958|11784344|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
7477814|NCT01998958|11784345|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
7477815|NCT01998958|11784346|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
7477816|NCT01998958|11784347|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
7477817|NCT01998958|11784348|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
7477818|NCT01998958|11784349|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
7477819|NCT01998958|11784350|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
7477820|NCT01998958|11784319|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
7477821|NCT01998958|11784320|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
7477822|NCT01998958|11784321|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
7477823|NCT01998958|11784322|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
7477824|NCT01998958|11784323|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
7477825|NCT01998958|11784324|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
7477826|NCT01998958|11784325|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
7477827|NCT01998958|11784326|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
7477828|NCT01998958|11784327|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
7477829|NCT01998958|11784328|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
7477830|NCT01998958|11784329|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
7477831|NCT01998958|11784330|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
7477832|NCT01998958|11784331|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
7477833|NCT01998958|11784332|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
7477834|NCT01998958|11784333|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
7477835|NCT01998958|11784334|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
7477836|NCT01998958|11784335|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
7477837|NCT01998958|11784336|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
7477838|NCT01998958|11784337|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
7477839|NCT01998958|11784338|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
7477840|NCT01998958|11784339|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
7477841|NCT01998958|11784340|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
7477842|NCT01998958|11784341|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
7477843|NCT01998958|11784342|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
7477844|NCT01998958|11784343|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
7477845|NCT01998958|11784344|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
7477846|NCT01998958|11784345|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
7477847|NCT01998958|11784346|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
7477848|NCT01998958|11784347|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
7477849|NCT01998958|11784348|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
7477850|NCT01998958|11784349|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
7477851|NCT01998958|11784350|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
7477852|NCT01998984|11784404|FG000|Overall Study|Adverse Event|0
7477853|NCT01998984|11784405|FG001|Overall Study|Adverse Event|0
7477854|NCT01998984|11784406|FG002|Overall Study|Adverse Event|0
7477855|NCT01998984|11784407|FG003|Overall Study|Adverse Event|1
7477856|NCT01998984|11784404|FG000|Overall Study|Lost to Follow-up|0
7477857|NCT01998984|11784405|FG001|Overall Study|Lost to Follow-up|1
7477858|NCT01998984|11784406|FG002|Overall Study|Lost to Follow-up|0
7477859|NCT01998984|11784407|FG003|Overall Study|Lost to Follow-up|1
7477860|NCT01998984|11784404|FG000|Overall Study|Withdrawal by Subject|0
7477861|NCT01998984|11784405|FG001|Overall Study|Withdrawal by Subject|0
7477862|NCT01998984|11784406|FG002|Overall Study|Withdrawal by Subject|1
7477863|NCT01998984|11784407|FG003|Overall Study|Withdrawal by Subject|0
7477864|NCT01998984|11784404|FG000|Overall Study|Other|0
7477865|NCT01998984|11784405|FG001|Overall Study|Other|0
7477866|NCT01998984|11784406|FG002|Overall Study|Other|0
7477867|NCT01998984|11784407|FG003|Overall Study|Other|1
7477868|NCT01999114|11784422|FG000|Overall Study|Adverse Event|8
7477869|NCT01999114|11784423|FG001|Overall Study|Adverse Event|7
7477870|NCT01999114|11784424|FG002|Overall Study|Adverse Event|2
7477871|NCT01999114|11784425|FG003|Overall Study|Adverse Event|2
7477872|NCT01999114|11784426|FG004|Overall Study|Adverse Event|1
7477873|NCT01999114|11784422|FG000|Overall Study|Withdrawal by Subject|0
7477874|NCT01999114|11784423|FG001|Overall Study|Withdrawal by Subject|0
7477875|NCT01999114|11784424|FG002|Overall Study|Withdrawal by Subject|1
7477876|NCT01999114|11784425|FG003|Overall Study|Withdrawal by Subject|0
7477877|NCT01999114|11784426|FG004|Overall Study|Withdrawal by Subject|1
7477878|NCT01999114|11784422|FG000|Overall Study|Lost to Follow-up|0
7477879|NCT01999114|11784423|FG001|Overall Study|Lost to Follow-up|0
7477880|NCT01999114|11784424|FG002|Overall Study|Lost to Follow-up|1
7477881|NCT01999114|11784425|FG003|Overall Study|Lost to Follow-up|0
7477882|NCT01999114|11784426|FG004|Overall Study|Lost to Follow-up|0
7477883|NCT01999114|11784422|FG000|Overall Study|Administrative|0
7477884|NCT01999114|11784423|FG001|Overall Study|Administrative|0
7477885|NCT01999114|11784424|FG002|Overall Study|Administrative|1
7477886|NCT01999114|11784425|FG003|Overall Study|Administrative|1
7477887|NCT01999114|11784426|FG004|Overall Study|Administrative|2
7477888|NCT01999218|11784472|FG000|Overall Study|Hyperglycemia|18
7477889|NCT01999218|11784473|FG001|Overall Study|Hyperglycemia|17
7477890|NCT01999218|11784474|FG002|Overall Study|Hyperglycemia|17
7477891|NCT01999218|11784472|FG000|Overall Study|Lack of Efficacy|1
7477892|NCT01999218|11784473|FG001|Overall Study|Lack of Efficacy|0
7477893|NCT01999218|11784474|FG002|Overall Study|Lack of Efficacy|1
7477894|NCT01999218|11784472|FG000|Overall Study|Lost to Follow-up|22
7477895|NCT01999218|11784473|FG001|Overall Study|Lost to Follow-up|17
7477896|NCT01999218|11784474|FG002|Overall Study|Lost to Follow-up|18
7477897|NCT01999218|11784472|FG000|Overall Study|Non-Compliance With Study Drug|6
7477898|NCT01999218|11784473|FG001|Overall Study|Non-Compliance With Study Drug|4
7477899|NCT01999218|11784474|FG002|Overall Study|Non-Compliance With Study Drug|1
7477900|NCT01999218|11784472|FG000|Overall Study|Physician Decision|1
7477901|NCT01999218|11784473|FG001|Overall Study|Physician Decision|4
7477902|NCT01999218|11784474|FG002|Overall Study|Physician Decision|6
7477903|NCT01999218|11784472|FG000|Overall Study|Protocol Violation|4
7477904|NCT01999218|11784473|FG001|Overall Study|Protocol Violation|5
7477905|NCT01999218|11784474|FG002|Overall Study|Protocol Violation|4
7477906|NCT01999218|11784472|FG000|Overall Study|Screen failure|0
7477907|NCT01999218|11784473|FG001|Overall Study|Screen failure|1
7477908|NCT01999218|11784474|FG002|Overall Study|Screen failure|0
7477909|NCT01999218|11784472|FG000|Overall Study|Study Terminated By Sponsor|7
7477910|NCT01999218|11784473|FG001|Overall Study|Study Terminated By Sponsor|5
7477911|NCT01999218|11784474|FG002|Overall Study|Study Terminated By Sponsor|12
7477912|NCT01999218|11784472|FG000|Overall Study|Participant moves|2
7477913|NCT01999218|11784473|FG001|Overall Study|Participant moves|5
7477914|NCT01999218|11784474|FG002|Overall Study|Participant moves|3
7477915|NCT01999218|11784472|FG000|Overall Study|Withdrawal by Subject|28
7477916|NCT01999218|11784473|FG001|Overall Study|Withdrawal by Subject|29
7477917|NCT01999218|11784474|FG002|Overall Study|Withdrawal by Subject|34
7477918|NCT01999218|11784472|FG000|Overall Study|Creatinine/eGFR|0
7477919|NCT01999218|11784473|FG001|Overall Study|Creatinine/eGFR|0
7477920|NCT01999218|11784474|FG002|Overall Study|Creatinine/eGFR|1
7477921|NCT01999218|11784472|FG000|Overall Study|Death|7
7477922|NCT01999218|11784473|FG001|Overall Study|Death|1
7477923|NCT01999218|11784474|FG002|Overall Study|Death|2
7477924|NCT01999218|11784472|FG000|Overall Study|Excluded Medication|1
7477925|NCT01999218|11784473|FG001|Overall Study|Excluded Medication|1
7477926|NCT01999218|11784474|FG002|Overall Study|Excluded Medication|2
7477927|NCT01999218|11784472|FG000|Overall Study|Adverse Event|9
7477928|NCT01999218|11784473|FG001|Overall Study|Adverse Event|7
7477929|NCT01999218|11784474|FG002|Overall Study|Adverse Event|7
7477930|NCT01999218|11784472|FG000|Overall Study|Treated but excluded at 1 trial site|3
7477931|NCT01999218|11784473|FG001|Overall Study|Treated but excluded at 1 trial site|5
7477932|NCT01999218|11784474|FG002|Overall Study|Treated but excluded at 1 trial site|2
7477933|NCT01999322|11784503|FG000|Overall Study|Adverse Event|1
7477934|NCT01999322|11784504|FG001|Overall Study|Adverse Event|0
7477935|NCT01999335|11784515|FG000|Overall Study|Discontinued before receiving treatment|0
7477936|NCT01999335|11784516|FG001|Overall Study|Discontinued before receiving treatment|0
7477937|NCT01999335|11784517|FG002|Overall Study|Discontinued before receiving treatment|0
7477938|NCT01999335|11784518|FG003|Overall Study|Discontinued before receiving treatment|0
7477939|NCT01999335|11784519|FG004|Overall Study|Discontinued before receiving treatment|2
7477940|NCT01999465|11784555|FG000|Overall Study|Lost to Follow-up|0
7477941|NCT01999465|11784556|FG001|Overall Study|Lost to Follow-up|2
7477942|NCT01999465|11784555|FG000|Overall Study|Protocol Violation|0
7477943|NCT01999465|11784556|FG001|Overall Study|Protocol Violation|1
7477944|NCT01999868|11784587|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7477945|NCT01999868|11784588|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
7477946|NCT01999868|11784589|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
7477947|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7477948|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
7477949|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
7477950|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
7477951|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
7477952|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
7477953|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7477954|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
7477955|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
7477956|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7477957|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
7477958|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
7477959|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
7477960|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
7477961|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
7477962|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
7477963|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
7477964|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
7477965|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
7477966|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7477967|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
7477968|NCT01999868|11784587|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
7477969|NCT01999868|11784588|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7477970|NCT01999868|11784589|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
7477971|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7477972|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
7477973|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
7477974|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7477975|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
7477976|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
7477977|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
7477978|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
7477979|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
7477980|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
7477981|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
7477982|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
7477983|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7477984|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
7477985|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
7477986|NCT01999868|11784587|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
7477987|NCT01999868|11784588|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
7477988|NCT01999868|11784589|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
7477989|NCT01999894|11784597|FG000|Overall Study|Adverse Event|9
7477990|NCT01999894|11784597|FG000|Overall Study|Lack of Efficacy|5
7477991|NCT01999894|11784597|FG000|Overall Study|Protocol Violation|1
7477992|NCT01999894|11784597|FG000|Overall Study|Withdrawal by Subject|7
7477993|NCT01999894|11784597|FG000|Overall Study|Lost to Follow-up|10
7477994|NCT01999894|11784597|FG000|Overall Study|Other Reason|3
7477995|NCT01999894|11784597|FG000|Overall Study|Inclusion/exclusion criteria not met|1
7477996|NCT01999946|11784614|FG000|Overall Study|Participant not released from jail|2
7477997|NCT01999946|11784615|FG001|Overall Study|Participant not released from jail|2
7477998|NCT01999946|11784616|FG002|Overall Study|Participant not released from jail|0
7477999|NCT01999946|11784614|FG000|Overall Study|Not included in primary outcome analysis|0
7478000|NCT01999946|11784615|FG001|Overall Study|Not included in primary outcome analysis|0
7478001|NCT01999946|11784616|FG002|Overall Study|Not included in primary outcome analysis|79
7478002|NCT01999972|11784629|FG000|Dose Escalation Part|Participant refused further follow-up|1
7478003|NCT01999972|11784630|FG001|Dose Escalation Part|Participant refused further follow-up|0
7478004|NCT01999972|11784631|FG002|Dose Escalation Part|Participant refused further follow-up|1
7478005|NCT01999972|11784632|FG003|Dose Escalation Part|Participant refused further follow-up|1
7478006|NCT01999972|11784633|FG004|Dose Escalation Part|Participant refused further follow-up|0
7478007|NCT01999972|11784634|FG005|Dose Escalation Part|Participant refused further follow-up|0
7478008|NCT01999972|11784629|FG000|Dose Escalation Part|Death|0
7478009|NCT01999972|11784630|FG001|Dose Escalation Part|Death|1
7478010|NCT01999972|11784631|FG002|Dose Escalation Part|Death|0
7478011|NCT01999972|11784632|FG003|Dose Escalation Part|Death|0
7478012|NCT01999972|11784633|FG004|Dose Escalation Part|Death|0
7478013|NCT01999972|11784634|FG005|Dose Escalation Part|Death|0
7478014|NCT01999972|11784629|FG000|Dose Escalation Part|Enrolled but not treated|0
7478015|NCT01999972|11784630|FG001|Dose Escalation Part|Enrolled but not treated|0
7478016|NCT01999972|11784631|FG002|Dose Escalation Part|Enrolled but not treated|1
7478017|NCT01999972|11784632|FG003|Dose Escalation Part|Enrolled but not treated|1
7478018|NCT01999972|11784633|FG004|Dose Escalation Part|Enrolled but not treated|0
7478019|NCT01999972|11784634|FG005|Dose Escalation Part|Enrolled but not treated|0
7478020|NCT01999972|11784629|FG000|Dose Escalation Part|Disease progression|3
7478021|NCT01999972|11784630|FG001|Dose Escalation Part|Disease progression|2
7478022|NCT01999972|11784631|FG002|Dose Escalation Part|Disease progression|3
7478023|NCT01999972|11784632|FG003|Dose Escalation Part|Disease progression|6
7478024|NCT01999972|11784633|FG004|Dose Escalation Part|Disease progression|0
7478025|NCT01999972|11784634|FG005|Dose Escalation Part|Disease progression|0
7478026|NCT01999972|11784629|FG000|Dose Escalation Part|Adverse Event|0
7478027|NCT01999972|11784630|FG001|Dose Escalation Part|Adverse Event|0
7478028|NCT01999972|11784631|FG002|Dose Escalation Part|Adverse Event|0
7478029|NCT01999972|11784632|FG003|Dose Escalation Part|Adverse Event|2
7478030|NCT01999972|11784633|FG004|Dose Escalation Part|Adverse Event|0
7478031|NCT01999972|11784634|FG005|Dose Escalation Part|Adverse Event|0
7478032|NCT01999972|11784629|FG000|Dose Escalation Part|Global deterioration of health status|1
7478033|NCT01999972|11784630|FG001|Dose Escalation Part|Global deterioration of health status|0
7478034|NCT01999972|11784631|FG002|Dose Escalation Part|Global deterioration of health status|0
7478035|NCT01999972|11784632|FG003|Dose Escalation Part|Global deterioration of health status|1
7478036|NCT01999972|11784633|FG004|Dose Escalation Part|Global deterioration of health status|0
7478037|NCT01999972|11784634|FG005|Dose Escalation Part|Global deterioration of health status|0
7478038|NCT01999972|11784629|FG000|Dose Expansion Part|Death|0
7478039|NCT01999972|11784630|FG001|Dose Expansion Part|Death|0
7478040|NCT01999972|11784631|FG002|Dose Expansion Part|Death|0
7478041|NCT01999972|11784632|FG003|Dose Expansion Part|Death|0
7478042|NCT01999972|11784633|FG004|Dose Expansion Part|Death|2
7478043|NCT01999972|11784634|FG005|Dose Expansion Part|Death|1
7478044|NCT01999972|11784629|FG000|Dose Expansion Part|Disease progression|0
7478045|NCT01999972|11784630|FG001|Dose Expansion Part|Disease progression|0
7478046|NCT01999972|11784631|FG002|Dose Expansion Part|Disease progression|0
7478047|NCT01999972|11784632|FG003|Dose Expansion Part|Disease progression|0
7478048|NCT01999972|11784633|FG004|Dose Expansion Part|Disease progression|9
7478049|NCT01999972|11784634|FG005|Dose Expansion Part|Disease progression|3
7478050|NCT01999972|11784629|FG000|Dose Expansion Part|Sponsor decision|0
7478051|NCT01999972|11784630|FG001|Dose Expansion Part|Sponsor decision|0
7478052|NCT01999972|11784631|FG002|Dose Expansion Part|Sponsor decision|0
7478053|NCT01999972|11784632|FG003|Dose Expansion Part|Sponsor decision|0
7478054|NCT01999972|11784633|FG004|Dose Expansion Part|Sponsor decision|1
7478055|NCT01999972|11784634|FG005|Dose Expansion Part|Sponsor decision|0
7478056|NCT01999972|11784629|FG000|Dose Expansion Part|Adverse Event|0
7478057|NCT01999972|11784630|FG001|Dose Expansion Part|Adverse Event|0
7478058|NCT01999972|11784631|FG002|Dose Expansion Part|Adverse Event|0
7478059|NCT01999972|11784632|FG003|Dose Expansion Part|Adverse Event|0
7478060|NCT01999972|11784633|FG004|Dose Expansion Part|Adverse Event|4
7478061|NCT01999972|11784634|FG005|Dose Expansion Part|Adverse Event|2
7478062|NCT01999972|11784629|FG000|Dose Expansion Part|Participant's non-compliance|0
7478063|NCT01999972|11784630|FG001|Dose Expansion Part|Participant's non-compliance|0
7478064|NCT01999972|11784631|FG002|Dose Expansion Part|Participant's non-compliance|0
7478065|NCT01999972|11784632|FG003|Dose Expansion Part|Participant's non-compliance|0
7478066|NCT01999972|11784633|FG004|Dose Expansion Part|Participant's non-compliance|0
7478067|NCT01999972|11784634|FG005|Dose Expansion Part|Participant's non-compliance|1
7478068|NCT01999972|11784629|FG000|Dose Expansion Part|Participant refused further follow-up|0
7478069|NCT01999972|11784630|FG001|Dose Expansion Part|Participant refused further follow-up|0
7478070|NCT01999972|11784631|FG002|Dose Expansion Part|Participant refused further follow-up|0
7478071|NCT01999972|11784632|FG003|Dose Expansion Part|Participant refused further follow-up|0
7478072|NCT01999972|11784633|FG004|Dose Expansion Part|Participant refused further follow-up|4
7478073|NCT01999972|11784634|FG005|Dose Expansion Part|Participant refused further follow-up|0
7478074|NCT01999972|11784629|FG000|Dose Expansion Part|Changed to standard of care|0
7478075|NCT01999972|11784630|FG001|Dose Expansion Part|Changed to standard of care|0
7478076|NCT01999972|11784631|FG002|Dose Expansion Part|Changed to standard of care|0
7478077|NCT01999972|11784632|FG003|Dose Expansion Part|Changed to standard of care|0
7478078|NCT01999972|11784633|FG004|Dose Expansion Part|Changed to standard of care|1
7478079|NCT01999972|11784634|FG005|Dose Expansion Part|Changed to standard of care|0
7478080|NCT02000440|11784671|FG000|Overall Study|Adverse Event|3
7478081|NCT02000440|11784671|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
7534368|NCT02696902|11881168|FG001|Overall Study|Withdrawal by Subject|0
7534369|NCT02696902|11881169|FG002|Overall Study|Withdrawal by Subject|1
7534370|NCT02696902|11881167|FG000|Overall Study|Death|19
7534371|NCT02696902|11881168|FG001|Overall Study|Death|3
7534372|NCT02696902|11881169|FG002|Overall Study|Death|24
7534373|NCT02696902|11881167|FG000|Overall Study|Participant not fit post-randomization|0
7534374|NCT02696902|11881168|FG001|Overall Study|Participant not fit post-randomization|0
7534375|NCT02696902|11881169|FG002|Overall Study|Participant not fit post-randomization|1
7534376|NCT02696902|11881167|FG000|Overall Study|Participant not eligible (negative PCR)|0
7534377|NCT02696902|11881168|FG001|Overall Study|Participant not eligible (negative PCR)|0
7534378|NCT02696902|11881169|FG002|Overall Study|Participant not eligible (negative PCR)|1
7534379|NCT02696902|11881167|FG000|Overall Study|Principal investigator's decision|1
7534380|NCT02696902|11881168|FG001|Overall Study|Principal investigator's decision|0
7534381|NCT02696902|11881169|FG002|Overall Study|Principal investigator's decision|0
7534382|NCT02696902|11881167|FG000|Overall Study|Sponsor's decision|1
7534383|NCT02696902|11881168|FG001|Overall Study|Sponsor's decision|0
7534384|NCT02696902|11881169|FG002|Overall Study|Sponsor's decision|0
7534385|NCT02696902|11881167|FG000|Overall Study|Transferred to other hospital|1
7534386|NCT02696902|11881168|FG001|Overall Study|Transferred to other hospital|0
7534387|NCT02696902|11881169|FG002|Overall Study|Transferred to other hospital|0
7534388|NCT02697435|11881248|FG000|Overall Study|Withdrawal by Subject|1
7534389|NCT02697435|11881249|FG001|Overall Study|Withdrawal by Subject|0
7534390|NCT02697435|11881248|FG000|Overall Study|Physician Decision|0
7534391|NCT02697435|11881249|FG001|Overall Study|Physician Decision|4
7534392|NCT02697591|11881266|FG000|Overall Study|Lost to Follow-up|0
7534393|NCT02697591|11881267|FG001|Overall Study|Lost to Follow-up|0
7534394|NCT02697591|11881268|FG002|Overall Study|Lost to Follow-up|0
7534395|NCT02697591|11881269|FG003|Overall Study|Lost to Follow-up|0
7534396|NCT02697591|11881270|FG004|Overall Study|Lost to Follow-up|0
7534397|NCT02697591|11881271|FG005|Overall Study|Lost to Follow-up|1
7534398|NCT02697591|11881272|FG006|Overall Study|Lost to Follow-up|1
7534399|NCT02697591|11881273|FG007|Overall Study|Lost to Follow-up|0
7534400|NCT02697591|11881274|FG008|Overall Study|Lost to Follow-up|0
7478082|NCT02000531|11784677|FG000|Overall Study|Lost to Follow-up|1
7478083|NCT02000531|11784678|FG001|Overall Study|Lost to Follow-up|0
7478084|NCT02000531|11784677|FG000|Overall Study|Discontinued due to data cut-off|3
7478085|NCT02000531|11784678|FG001|Overall Study|Discontinued due to data cut-off|8
7478086|NCT02000752|11784695|FG000|Overall Study|Dystocic delivery|19
7478087|NCT02000752|11784696|FG001|Overall Study|Dystocic delivery|8
7478088|NCT02000752|11784695|FG000|Overall Study|Shift Changes|12
7478089|NCT02000752|11784696|FG001|Overall Study|Shift Changes|5
7478090|NCT02000817|11784706|FG000|Overall Study|Withdrawal by Subject|2
7478091|NCT02000817|11784707|FG001|Overall Study|Withdrawal by Subject|0
7478092|NCT02000817|11784708|FG002|Overall Study|Withdrawal by Subject|0
7478093|NCT02000817|11784709|FG003|Overall Study|Withdrawal by Subject|0
7478094|NCT02000817|11784706|FG000|Overall Study|Adverse Event|0
7478095|NCT02000817|11784707|FG001|Overall Study|Adverse Event|1
7478096|NCT02000817|11784708|FG002|Overall Study|Adverse Event|0
7478097|NCT02000817|11784709|FG003|Overall Study|Adverse Event|0
7478098|NCT02000817|11784706|FG000|Overall Study|Lost to Follow-up|0
7478099|NCT02000817|11784707|FG001|Overall Study|Lost to Follow-up|0
7478100|NCT02000817|11784708|FG002|Overall Study|Lost to Follow-up|1
7478101|NCT02000817|11784709|FG003|Overall Study|Lost to Follow-up|0
7478102|NCT02000921|11784734|FG000|Overall Study|Withdrawal by Subject|3
7478103|NCT02000921|11784735|FG001|Overall Study|Withdrawal by Subject|10
7478104|NCT02000921|11784736|FG002|Overall Study|Withdrawal by Subject|5
7478105|NCT02000921|11784734|FG000|Overall Study|Lost to Follow-up|2
7478106|NCT02000921|11784735|FG001|Overall Study|Lost to Follow-up|4
7478107|NCT02000921|11784736|FG002|Overall Study|Lost to Follow-up|5
7478108|NCT02000921|11784734|FG000|Overall Study|Physician Decision|0
7478109|NCT02000921|11784735|FG001|Overall Study|Physician Decision|2
7478110|NCT02000921|11784736|FG002|Overall Study|Physician Decision|0
7478111|NCT02001051|11784763|FG000|Overall Study|Deemed not eligible following enrollment|0
7478112|NCT02001051|11784764|FG001|Overall Study|Deemed not eligible following enrollment|1
7478113|NCT02001064|11784772|FG000|Overall Study|Withdrawal by Subject|2
7478114|NCT02001064|11784773|FG001|Overall Study|Withdrawal by Subject|1
7478115|NCT02001181|11784781|FG000|Overall Study|Adverse Event|0
7478116|NCT02001181|11784782|FG001|Overall Study|Adverse Event|2
7478117|NCT02001181|11784781|FG000|Overall Study|Lost to Follow-up|1
7478118|NCT02001181|11784782|FG001|Overall Study|Lost to Follow-up|0
7478119|NCT02001181|11784781|FG000|Overall Study|Withdrawal by Subject|0
7478120|NCT02001181|11784782|FG001|Overall Study|Withdrawal by Subject|1
7478121|NCT02001194|11784792|FG000|Intervention Period (13 Weeks)|No longer interested|1
7478122|NCT02001194|11784793|FG001|Intervention Period (13 Weeks)|No longer interested|0
7478123|NCT02001194|11784794|FG002|Intervention Period (13 Weeks)|No longer interested|2
7478124|NCT02001194|11784795|FG003|Intervention Period (13 Weeks)|No longer interested|2
7478125|NCT02001194|11784792|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
7478126|NCT02001194|11784793|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
7478127|NCT02001194|11784794|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
7478128|NCT02001194|11784795|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
7478129|NCT02001558|11784807|FG000|Overall Study|Lost to Follow-up|8
7478130|NCT02001558|11784808|FG001|Overall Study|Lost to Follow-up|14
7478131|NCT02001688|11784817|FG000|Overall Study|Withdrawal by Subject|0
7478132|NCT02001688|11784818|FG001|Overall Study|Withdrawal by Subject|0
7478133|NCT02001688|11784819|FG002|Overall Study|Withdrawal by Subject|1
7478134|NCT02001688|11784817|FG000|Overall Study|Adverse Event|0
7478135|NCT02001688|11784818|FG001|Overall Study|Adverse Event|1
7478136|NCT02001688|11784819|FG002|Overall Study|Adverse Event|0
7478137|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Adverse Event|9
7478138|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Death|1
7478139|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
7478140|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Physician Decision|1
7478141|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
7478142|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
7478143|NCT02001987|11784837|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
7478144|NCT02001987|11784837|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
7478145|NCT02001987|11784837|FG000|LTE Period (52 Weeks)|Physician Decision|2
7478146|NCT02001987|11784837|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
7478147|NCT02001987|11784837|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
7478148|NCT02001987|11784837|FG000|LTE Period (52 Weeks)|Other|3
7478149|NCT02002091|11784848|FG000|Screening|Lost to Follow-up|10
7478150|NCT02002091|11784849|FG001|Screening|Lost to Follow-up|12
7478151|NCT02002091|11784848|FG000|Screening|Death|3
7478152|NCT02002091|11784849|FG001|Screening|Death|2
7478159|NCT02002221|11784904|FG000|Overall Study|Adverse Event|2
7478160|NCT02002221|11784905|FG001|Overall Study|Adverse Event|1
7478161|NCT02002221|11784904|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7478162|NCT02002221|11784905|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7478163|NCT02002221|11784904|FG000|Overall Study|Patient withdrew consent|0
7478164|NCT02002221|11784905|FG001|Overall Study|Patient withdrew consent|1
7478165|NCT02002533|11784928|FG000|Overall Study|Withdrawal by Subject|6
7478166|NCT02002533|11784929|FG001|Overall Study|Withdrawal by Subject|13
7478167|NCT02002533|11784928|FG000|Overall Study|Protocol Violation|0
7478168|NCT02002533|11784929|FG001|Overall Study|Protocol Violation|1
7478169|NCT02002533|11784928|FG000|Overall Study|Adverse Event|0
7478170|NCT02002533|11784929|FG001|Overall Study|Adverse Event|3
7478171|NCT02002533|11784928|FG000|Overall Study|Lost to Follow-up|0
7478172|NCT02002533|11784929|FG001|Overall Study|Lost to Follow-up|1
7478173|NCT02002689|11784946|FG000|Overall Study|Disease Progression|7
7478174|NCT02002689|11784946|FG000|Overall Study|Adverse Event|3
7478175|NCT02002884|11784990|FG000|Main Period (MP)|Other|0
7478176|NCT02002884|11784991|FG001|Main Period (MP)|Other|3
7478177|NCT02002884|11784992|FG002|Main Period (MP)|Other|3
7478178|NCT02002884|11784993|FG003|Main Period (MP)|Other|0
7478179|NCT02002884|11784990|FG000|Main Period (MP)|Adverse Event|0
7478180|NCT02002884|11784991|FG001|Main Period (MP)|Adverse Event|1
7478181|NCT02002884|11784992|FG002|Main Period (MP)|Adverse Event|1
7478182|NCT02002884|11784993|FG003|Main Period (MP)|Adverse Event|0
7478183|NCT02002884|11784990|FG000|Main Period (MP)|Withdrawal by Subject|6
7478184|NCT02002884|11784991|FG001|Main Period (MP)|Withdrawal by Subject|2
7478185|NCT02002884|11784992|FG002|Main Period (MP)|Withdrawal by Subject|2
7478186|NCT02002884|11784993|FG003|Main Period (MP)|Withdrawal by Subject|0
7478187|NCT02002884|11784990|FG000|Main Period (MP)|Lost to Follow-up|0
7478188|NCT02002884|11784991|FG001|Main Period (MP)|Lost to Follow-up|0
7478189|NCT02002884|11784992|FG002|Main Period (MP)|Lost to Follow-up|2
7478190|NCT02002884|11784993|FG003|Main Period (MP)|Lost to Follow-up|0
7478191|NCT02002884|11784990|FG000|Open-Label Extension Period (OLEX)|Other|0
7478192|NCT02002884|11784991|FG001|Open-Label Extension Period (OLEX)|Other|0
7478193|NCT02002884|11784992|FG002|Open-Label Extension Period (OLEX)|Other|0
7478194|NCT02002884|11784993|FG003|Open-Label Extension Period (OLEX)|Other|24
7478195|NCT02002884|11784990|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
7478196|NCT02002884|11784991|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
7478197|NCT02002884|11784992|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
7478198|NCT02002884|11784993|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
7478199|NCT02002884|11784990|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
7478200|NCT02002884|11784991|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
7478201|NCT02002884|11784992|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
7478202|NCT02002884|11784993|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
7478203|NCT02002884|11784990|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7478204|NCT02002884|11784991|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7478205|NCT02002884|11784992|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
7478206|NCT02002884|11784993|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
7478207|NCT02002884|11784990|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7478208|NCT02002884|11784991|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7478209|NCT02002884|11784992|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
7478210|NCT02002884|11784993|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
7478211|NCT02002975|11785007|FG000|Overall Study|Case Report Forms Uncollected|135
7478212|NCT02002975|11785007|FG000|Overall Study|Protocol Deviation|437
7478213|NCT02003014|11785011|FG000|Overall Study|Case report forms uncollected|9
7478214|NCT02003014|11785011|FG000|Overall Study|Treatment started after contract period|1
7478215|NCT02003014|11785011|FG000|Overall Study|Patient did not visit the study site|5
7478216|NCT02003014|11785011|FG000|Overall Study|Investigator's transfer|4
7478217|NCT02003183|11785026|FG000|Overall Study|Lost to Follow-up|0
7478218|NCT02003183|11785027|FG001|Overall Study|Lost to Follow-up|2
7478219|NCT02003365|11785040|FG000|Overall Study|Lost to Follow-up|0
7478220|NCT02003365|11785041|FG001|Overall Study|Lost to Follow-up|0
7478221|NCT02003365|11785042|FG002|Overall Study|Lost to Follow-up|1
7478222|NCT02003391|11785052|FG000|Overall Study|Withdrawal by Subject|2
7478223|NCT02003391|11785053|FG001|Overall Study|Withdrawal by Subject|1
7478224|NCT02003391|11785052|FG000|Overall Study|Protocol Violation|0
7478225|NCT02003391|11785053|FG001|Overall Study|Protocol Violation|1
7478226|NCT02003391|11785052|FG000|Overall Study|Adverse Event|1
7478227|NCT02003391|11785053|FG001|Overall Study|Adverse Event|0
7478228|NCT02003534|11785074|FG000|Overall Study|Lost to Follow-up|47
7478229|NCT02003573|11785081|FG000|Overall Study|Progressive disease|2
7478230|NCT02003573|11785082|FG001|Overall Study|Progressive disease|0
7478231|NCT02003573|11785083|FG002|Overall Study|Progressive disease|1
7478232|NCT02003573|11785081|FG000|Overall Study|Other Adverse event|0
7478233|NCT02003573|11785082|FG001|Overall Study|Other Adverse event|1
7478234|NCT02003573|11785083|FG002|Overall Study|Other Adverse event|1
7478235|NCT02003573|11785081|FG000|Overall Study|Refuse to take trial medication|0
7478236|NCT02003573|11785082|FG001|Overall Study|Refuse to take trial medication|1
7478237|NCT02003573|11785083|FG002|Overall Study|Refuse to take trial medication|1
7478238|NCT02003573|11785081|FG000|Overall Study|Other than specified|1
7478239|NCT02003573|11785082|FG001|Overall Study|Other than specified|2
7478240|NCT02003573|11785083|FG002|Overall Study|Other than specified|3
7478241|NCT02003638|11785104|FG000|Overall Study|Withdrawal by Subject|1
7478242|NCT02003638|11785105|FG001|Overall Study|Withdrawal by Subject|0
7478243|NCT02003898|11785111|FG000|Overall Study|Death|3
7478244|NCT02003898|11785111|FG000|Overall Study|Lost to Follow-up|12
7478245|NCT02003898|11785111|FG000|Overall Study|Withdrawal by Subject|52
7478246|NCT02003963|11785126|FG000|Overall Study|Lost to Follow-up|2
7478247|NCT02003963|11785127|FG001|Overall Study|Lost to Follow-up|1
7478248|NCT02004093|11785137|FG000|Overall Study|Death|2
7478249|NCT02004093|11785138|FG001|Overall Study|Death|1
7478250|NCT02004093|11785137|FG000|Overall Study|Lack of Efficacy|66
7478251|NCT02004093|11785138|FG001|Overall Study|Lack of Efficacy|62
7478252|NCT02004093|11785137|FG000|Overall Study|Protocol Violation|0
7478253|NCT02004093|11785138|FG001|Overall Study|Protocol Violation|1
7478254|NCT02004093|11785137|FG000|Overall Study|Lost to Follow-up|0
7478255|NCT02004093|11785138|FG001|Overall Study|Lost to Follow-up|1
7478256|NCT02004093|11785137|FG000|Overall Study|Withdrawal by Subject|3
7478257|NCT02004093|11785138|FG001|Overall Study|Withdrawal by Subject|7
7478258|NCT02004093|11785137|FG000|Overall Study|Other|3
7478259|NCT02004093|11785138|FG001|Overall Study|Other|1
7478260|NCT02004236|11785160|FG000|Overall Study|Lack of Efficacy|0
7478261|NCT02004236|11785161|FG001|Overall Study|Lack of Efficacy|0
7478262|NCT02004236|11785162|FG002|Overall Study|Lack of Efficacy|16
7478263|NCT02004262|11785177|FG000|Overall Study|Death|67
7478264|NCT02004262|11785178|FG001|Overall Study|Death|64
7478265|NCT02004262|11785179|FG002|Overall Study|Death|66
7478266|NCT02004262|11785180|FG003|Overall Study|Death|28
7478267|NCT02004262|11785181|FG004|Overall Study|Death|29
7478268|NCT02004262|11785182|FG005|Overall Study|Death|22
7478269|NCT02004262|11785177|FG000|Overall Study|Withdrawal by Subject|1
7478270|NCT02004262|11785178|FG001|Overall Study|Withdrawal by Subject|0
7478271|NCT02004262|11785179|FG002|Overall Study|Withdrawal by Subject|4
7478272|NCT02004262|11785180|FG003|Overall Study|Withdrawal by Subject|0
7478273|NCT02004262|11785181|FG004|Overall Study|Withdrawal by Subject|1
7478274|NCT02004262|11785182|FG005|Overall Study|Withdrawal by Subject|3
7478275|NCT02004262|11785177|FG000|Overall Study|Lost to Follow-up|1
7478276|NCT02004262|11785178|FG001|Overall Study|Lost to Follow-up|1
7478277|NCT02004262|11785179|FG002|Overall Study|Lost to Follow-up|0
7478278|NCT02004262|11785180|FG003|Overall Study|Lost to Follow-up|0
7478279|NCT02004262|11785181|FG004|Overall Study|Lost to Follow-up|0
7478280|NCT02004262|11785182|FG005|Overall Study|Lost to Follow-up|0
7478281|NCT02004262|11785177|FG000|Overall Study|Study Terminated by Sponsor|4
7478282|NCT02004262|11785178|FG001|Overall Study|Study Terminated by Sponsor|3
7478283|NCT02004262|11785179|FG002|Overall Study|Study Terminated by Sponsor|2
7478284|NCT02004262|11785180|FG003|Overall Study|Study Terminated by Sponsor|1
7478285|NCT02004262|11785181|FG004|Overall Study|Study Terminated by Sponsor|1
7478286|NCT02004262|11785182|FG005|Overall Study|Study Terminated by Sponsor|5
7478287|NCT02004353|11785205|FG000|Overall Study|Voluntary participation|1334
7478288|NCT02004847|11785242|FG000|Overall Study|Protocol Violation|1
7478289|NCT02004847|11785243|FG001|Overall Study|Protocol Violation|1
7478290|NCT02004873|11785258|FG000|Overall Study|Implant unsuccessful|6
7478291|NCT02004873|11785258|FG000|Overall Study|Awaiting 6-month visit|390
7478292|NCT02004873|11785258|FG000|Overall Study|Missed 6-month visit|4
7478293|NCT02004873|11785258|FG000|Overall Study|Death|23
7478294|NCT02004873|11785258|FG000|Overall Study|Withdrawal by Subject|1
7478295|NCT02004886|11785269|FG000|Overall Study|Adverse Event|0
7478296|NCT02004886|11785270|FG001|Overall Study|Adverse Event|1
7478297|NCT02004886|11785271|FG002|Overall Study|Adverse Event|0
7478298|NCT02004886|11785272|FG003|Overall Study|Adverse Event|0
7478299|NCT02004886|11785269|FG000|Overall Study|Unable to attend future visits|1
7478300|NCT02004886|11785270|FG001|Overall Study|Unable to attend future visits|0
7478301|NCT02004886|11785271|FG002|Overall Study|Unable to attend future visits|0
7478302|NCT02004886|11785272|FG003|Overall Study|Unable to attend future visits|0
7478303|NCT02005029|11785301|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
7478304|NCT02005029|11785302|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
7478305|NCT02005211|11785333|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478306|NCT02005211|11785334|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478307|NCT02005211|11785335|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478308|NCT02005211|11785336|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478309|NCT02005211|11785337|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
7478310|NCT02005211|11785338|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478311|NCT02005211|11785339|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
7478312|NCT02005250|11785364|FG000|Overall Study|Lost to Follow-up|15
7478313|NCT02005250|11785365|FG001|Overall Study|Lost to Follow-up|5
7478314|NCT02005276|11785375|FG000|Overall Study|No longer interested|5
7478315|NCT02005276|11785376|FG001|Overall Study|No longer interested|2
7478316|NCT02005276|11785377|FG002|Overall Study|No longer interested|3
7224632|NCT00056407|11433900|FG001|Overall Study|Diagnosed with Prostate Cancer|166
7224633|NCT00056407|11433899|FG000|Overall Study|"Listed as Other on Case Report Form"|98
7224634|NCT00056407|11433900|FG001|Overall Study|"Listed as Other on Case Report Form"|60
7224635|NCT00056407|11433899|FG000|Overall Study|Missing|25
7224636|NCT00056407|11433900|FG001|Overall Study|Missing|34
7224637|NCT00056862|11433940|FG000|Overall Study|Protocol Violation|1
7224638|NCT00056862|11433941|FG001|Overall Study|Protocol Violation|0
7224639|NCT00057330|11433949|FG000|Overall Study|Adverse Event|9
7478317|NCT02005276|11785378|FG003|Overall Study|No longer interested|3
7478318|NCT02005484|11785403|FG000|Overall Study|Death|1
7478319|NCT02005484|11785403|FG000|Overall Study|Disease progression|1
7478320|NCT02005484|11785403|FG000|Overall Study|Changed to a Different Study|1
7478321|NCT02005484|11785403|FG000|Overall Study|Sponsor decision|1
7478322|NCT02005562|11785426|FG000|Overall Study|Death|2
7478323|NCT02005562|11785427|FG001|Overall Study|Death|2
7478324|NCT02005562|11785426|FG000|Overall Study|Graft loss|7
7478325|NCT02005562|11785427|FG001|Overall Study|Graft loss|6
7478326|NCT02005562|11785426|FG000|Overall Study|Withdrawal by Subject|2
7478327|NCT02005562|11785427|FG001|Overall Study|Withdrawal by Subject|2
7478328|NCT02005562|11785426|FG000|Overall Study|No transplant|1
7478329|NCT02005562|11785427|FG001|Overall Study|No transplant|4
7478330|NCT02005562|11785426|FG000|Overall Study|Physician Decision|0
7478331|NCT02005562|11785427|FG001|Overall Study|Physician Decision|1
7478332|NCT02005627|11785444|FG000|Overall Study|Lost to Follow-up|1
7478333|NCT02005627|11785445|FG001|Overall Study|Lost to Follow-up|2
7478334|NCT02005627|11785444|FG000|Overall Study|Withdrawal by Subject|1
7478335|NCT02005627|11785445|FG001|Overall Study|Withdrawal by Subject|2
7478336|NCT02005692|11785465|FG000|Overall Study|Protocol Violation|1
7478337|NCT02005692|11785465|FG000|Overall Study|Withdrawal by Subject|1
7478338|NCT02005692|11785465|FG000|Overall Study|Discharged earlier than anticipated|5
7478339|NCT02005887|11785472|FG000|Overall Study|Protocol Violation|0
7478340|NCT02005887|11785473|FG001|Overall Study|Protocol Violation|2
7478341|NCT02006121|11785494|FG000|Double Blind Phase|Adverse Event|6
7478342|NCT02006121|11785495|FG001|Double Blind Phase|Adverse Event|0
7478343|NCT02006121|11785494|FG000|Double Blind Phase|Lack of Efficacy|1
7478344|NCT02006121|11785495|FG001|Double Blind Phase|Lack of Efficacy|16
7478345|NCT02006121|11785494|FG000|Double Blind Phase|Withdrawal by Subject|3
7478346|NCT02006121|11785495|FG001|Double Blind Phase|Withdrawal by Subject|4
7478347|NCT02006121|11785494|FG000|Double Blind Phase|Non-compliance with study drug|1
7478348|NCT02006121|11785495|FG001|Double Blind Phase|Non-compliance with study drug|3
7478349|NCT02006121|11785494|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
7478350|NCT02006121|11785495|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
7478351|NCT02006121|11785494|FG000|Double Blind Phase|Inconvenience of infusion system|0
7478352|NCT02006121|11785495|FG001|Double Blind Phase|Inconvenience of infusion system|1
7478353|NCT02006121|11785494|FG000|Open Label Phase|Adverse Event|15
7478354|NCT02006121|11785495|FG001|Open Label Phase|Adverse Event|0
7478355|NCT02006121|11785494|FG000|Open Label Phase|Lack of Efficacy|2
7478356|NCT02006121|11785495|FG001|Open Label Phase|Lack of Efficacy|0
7478357|NCT02006121|11785494|FG000|Open Label Phase|Protocol Violation|2
7478358|NCT02006121|11785495|FG001|Open Label Phase|Protocol Violation|0
7478359|NCT02006121|11785494|FG000|Open Label Phase|Withdrawal by Subject|3
7478360|NCT02006121|11785495|FG001|Open Label Phase|Withdrawal by Subject|0
7478361|NCT02006121|11785494|FG000|Open Label Phase|Non-compliance with study drug|3
7478362|NCT02006121|11785495|FG001|Open Label Phase|Non-compliance with study drug|0
7478363|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Protocol Violation|1
7478364|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Protocol Violation|1
7478365|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Protocol Violation|1
7478366|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Protocol Violation|1
7478367|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Protocol Violation|0
7478368|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
7478369|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
7478370|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
7478371|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
7478372|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
7478373|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Noncompliance|2
7478374|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Noncompliance|1
7478375|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Noncompliance|1
7478376|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Noncompliance|0
7478377|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Noncompliance|0
7478378|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Other|1
7478379|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Other|5
7478380|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Other|0
7478381|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Other|2
7478382|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Other|3
7478383|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Adverse Event|5
7478384|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Adverse Event|6
7478385|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Adverse Event|11
7478386|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Adverse Event|11
7478387|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Adverse Event|14
7478388|NCT02006472|11785552|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
7478389|NCT02006472|11785553|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
7478390|NCT02006472|11785554|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
7478391|NCT02006472|11785555|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
7478392|NCT02006472|11785556|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
7478393|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
7478394|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
7478395|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
7478396|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
7478397|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
7478398|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Noncompliance|1
7478399|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Noncompliance|0
7478400|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Noncompliance|0
7478401|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Noncompliance|0
7478402|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Noncompliance|0
7478403|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Adverse Event|1
7478404|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Adverse Event|4
7478405|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Adverse Event|5
7478406|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Adverse Event|1
7478407|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Adverse Event|1
7478408|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Other|0
7478409|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Other|1
7478410|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Other|0
7478411|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Other|1
7478412|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Other|0
7478413|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Not treated|0
7478414|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Not treated|0
7478415|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Not treated|2
7478416|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Not treated|0
7478417|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Not treated|0
7478418|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
7478419|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
7478420|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
7478421|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
7478422|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
7478423|NCT02006472|11785552|FG000|Period 2 (Through Week 52)|Sponsor decision|0
7478424|NCT02006472|11785553|FG001|Period 2 (Through Week 52)|Sponsor decision|0
7478425|NCT02006472|11785554|FG002|Period 2 (Through Week 52)|Sponsor decision|1
7478426|NCT02006472|11785555|FG003|Period 2 (Through Week 52)|Sponsor decision|0
7478427|NCT02006472|11785556|FG004|Period 2 (Through Week 52)|Sponsor decision|0
7478428|NCT02006576|11785576|FG000|Overall Study|Withdrawal by Subject|4
7478429|NCT02006576|11785577|FG001|Overall Study|Withdrawal by Subject|6
7478430|NCT02006576|11785578|FG002|Overall Study|Withdrawal by Subject|2
7478431|NCT02006576|11785576|FG000|Overall Study|Death|0
7478432|NCT02006576|11785577|FG001|Overall Study|Death|0
7478433|NCT02006576|11785578|FG002|Overall Study|Death|1
7478434|NCT02006576|11785576|FG000|Overall Study|Lost to Follow-up|1
7478435|NCT02006576|11785577|FG001|Overall Study|Lost to Follow-up|0
7478436|NCT02006576|11785578|FG002|Overall Study|Lost to Follow-up|1
7478437|NCT02006576|11785576|FG000|Overall Study|Screen Failure, too sick, other|13
7478438|NCT02006576|11785577|FG001|Overall Study|Screen Failure, too sick, other|1
7478439|NCT02006576|11785578|FG002|Overall Study|Screen Failure, too sick, other|13
7478444|NCT02006641|11785598|FG000|Overall Study|Withdrawal before treatment|2
7478445|NCT02006641|11785599|FG001|Overall Study|Withdrawal before treatment|5
7478446|NCT02006641|11785600|FG002|Overall Study|Withdrawal before treatment|3
7478447|NCT02006641|11785598|FG000|Overall Study|Adverse Event|15
7478448|NCT02006641|11785599|FG001|Overall Study|Adverse Event|11
7478449|NCT02006641|11785600|FG002|Overall Study|Adverse Event|15
7478450|NCT02006641|11785598|FG000|Overall Study|Protocol Violation|0
7478451|NCT02006641|11785599|FG001|Overall Study|Protocol Violation|2
7478452|NCT02006641|11785600|FG002|Overall Study|Protocol Violation|2
7478453|NCT02006641|11785598|FG000|Overall Study|Lost to Follow-up|0
7478454|NCT02006641|11785599|FG001|Overall Study|Lost to Follow-up|1
7478455|NCT02006641|11785600|FG002|Overall Study|Lost to Follow-up|0
7478456|NCT02006641|11785598|FG000|Overall Study|Withdrawal by Subject|7
7478457|NCT02006641|11785599|FG001|Overall Study|Withdrawal by Subject|12
7478458|NCT02006641|11785600|FG002|Overall Study|Withdrawal by Subject|11
7478459|NCT02006641|11785598|FG000|Overall Study|Other reason: patient didn't show up|1
7478460|NCT02006641|11785599|FG001|Overall Study|Other reason: patient didn't show up|0
7478461|NCT02006641|11785600|FG002|Overall Study|Other reason: patient didn't show up|0
7478462|NCT02006641|11785598|FG000|Overall Study|Other reason:patient didn't want to come|0
7478463|NCT02006641|11785599|FG001|Overall Study|Other reason:patient didn't want to come|0
7478464|NCT02006641|11785600|FG002|Overall Study|Other reason:patient didn't want to come|1
7478465|NCT02006641|11785598|FG000|Overall Study|Other reason: patient has moved|1
7478466|NCT02006641|11785599|FG001|Overall Study|Other reason: patient has moved|0
7478467|NCT02006641|11785600|FG002|Overall Study|Other reason: patient has moved|1
7478468|NCT02006641|11785598|FG000|Overall Study|Other reason: caregiver in hospital|0
7478469|NCT02006641|11785599|FG001|Overall Study|Other reason: caregiver in hospital|1
7478470|NCT02006641|11785600|FG002|Overall Study|Other reason: caregiver in hospital|0
7478471|NCT02006641|11785598|FG000|Overall Study|Other reason: patient's wife has died|0
7478472|NCT02006641|11785599|FG001|Overall Study|Other reason: patient's wife has died|0
7478473|NCT02006641|11785600|FG002|Overall Study|Other reason: patient's wife has died|1
7478474|NCT02006641|11785598|FG000|Overall Study|Other reason: hospitalisation|0
7478475|NCT02006641|11785599|FG001|Overall Study|Other reason: hospitalisation|1
7478476|NCT02006641|11785600|FG002|Overall Study|Other reason: hospitalisation|0
7478477|NCT02006641|11785598|FG000|Overall Study|Other reason: caregiver impossibility|0
7534401|NCT02697591|11881275|FG009|Overall Study|Lost to Follow-up|1
7478478|NCT02006641|11785599|FG001|Overall Study|Other reason: caregiver impossibility|0
7478479|NCT02006641|11785600|FG002|Overall Study|Other reason: caregiver impossibility|1
7478480|NCT02006641|11785598|FG000|Overall Study|Other reason: protocol non-compliance|0
7478481|NCT02006641|11785599|FG001|Overall Study|Other reason: protocol non-compliance|0
7478482|NCT02006641|11785600|FG002|Overall Study|Other reason: protocol non-compliance|1
7478483|NCT02006654|11785610|FG000|Overall Study|Withdrawal before treatment|4
7478484|NCT02006654|11785611|FG001|Overall Study|Withdrawal before treatment|2
7478485|NCT02006654|11785610|FG000|Overall Study|Adverse Event|16
7478486|NCT02006654|11785611|FG001|Overall Study|Adverse Event|17
7478487|NCT02006654|11785610|FG000|Overall Study|Death|1
7478488|NCT02006654|11785611|FG001|Overall Study|Death|0
7478489|NCT02006654|11785610|FG000|Overall Study|Withdrawal by Subject|14
7478490|NCT02006654|11785611|FG001|Overall Study|Withdrawal by Subject|12
7478491|NCT02006654|11785610|FG000|Overall Study|Protocol Violation|5
7478492|NCT02006654|11785611|FG001|Overall Study|Protocol Violation|8
7478493|NCT02006654|11785610|FG000|Overall Study|Lost to Follow-up|1
7478494|NCT02006654|11785611|FG001|Overall Study|Lost to Follow-up|0
7478495|NCT02006654|11785610|FG000|Overall Study|patient's will|2
7478496|NCT02006654|11785611|FG001|Overall Study|patient's will|1
7478497|NCT02006654|11785610|FG000|Overall Study|insufficient compliance|1
7478498|NCT02006654|11785611|FG001|Overall Study|insufficient compliance|0
7478499|NCT02006654|11785610|FG000|Overall Study|worsening cognitive condition|0
7478500|NCT02006654|11785611|FG001|Overall Study|worsening cognitive condition|1
7478501|NCT02006654|11785610|FG000|Overall Study|faecal incontinence|0
7478502|NCT02006654|11785611|FG001|Overall Study|faecal incontinence|1
7478503|NCT02006654|11785610|FG000|Overall Study|mood disorder|0
7478504|NCT02006654|11785611|FG001|Overall Study|mood disorder|1
7478505|NCT02006654|11785610|FG000|Overall Study|disallowed medication|1
7478506|NCT02006654|11785611|FG001|Overall Study|disallowed medication|0
7478507|NCT02006654|11785610|FG000|Overall Study|moving out of state|0
7478508|NCT02006654|11785611|FG001|Overall Study|moving out of state|1
7478509|NCT02006667|11785618|FG000|Overall Study|Adverse Event|3
7478510|NCT02006667|11785618|FG000|Overall Study|Death|2
7478511|NCT02006667|11785618|FG000|Overall Study|Withdrawal by Subject|1
7478512|NCT02006693|11785624|FG000|Overall Study|No Reason Specified|6
7478513|NCT02006693|11785625|FG001|Overall Study|No Reason Specified|8
7478514|NCT02006693|11785624|FG000|Overall Study|Another Glaucoma-related Surgery|12
7478515|NCT02006693|11785625|FG001|Overall Study|Another Glaucoma-related Surgery|1
7478516|NCT02006693|11785624|FG000|Overall Study|XEN Implant Explantation|0
7478517|NCT02006693|11785625|FG001|Overall Study|XEN Implant Explantation|1
7478518|NCT02006693|11785624|FG000|Overall Study|Death|2
7478519|NCT02006693|11785625|FG001|Overall Study|Death|2
7478520|NCT02006693|11785624|FG000|Overall Study|Lost to Follow-up|4
7478521|NCT02006693|11785625|FG001|Overall Study|Lost to Follow-up|1
7478522|NCT02006693|11785624|FG000|Overall Study|Patient Decision|4
7478523|NCT02006693|11785625|FG001|Overall Study|Patient Decision|0
7478524|NCT02006706|11785631|FG000|Overall Study|Lost to Follow-up|1
7478525|NCT02006719|11785637|FG000|Overall Study|Withdrawal by Subject|10
7478526|NCT02006719|11785638|FG001|Overall Study|Withdrawal by Subject|2
7478527|NCT02006719|11785637|FG000|Overall Study|Lost to Follow-up|5
7478528|NCT02006719|11785638|FG001|Overall Study|Lost to Follow-up|1
7478529|NCT02006719|11785637|FG000|Overall Study|Protocol Violation|2
7478530|NCT02006719|11785638|FG001|Overall Study|Protocol Violation|0
7478531|NCT02006719|11785637|FG000|Overall Study|Adverse Event|1
7478532|NCT02006719|11785638|FG001|Overall Study|Adverse Event|1
7478533|NCT02006719|11785637|FG000|Overall Study|Other/Unknown|0
7478534|NCT02006719|11785638|FG001|Overall Study|Other/Unknown|1
7478535|NCT02006732|11785648|FG000|Overall Study|Adverse Event|10
7478536|NCT02006732|11785649|FG001|Overall Study|Adverse Event|7
7478537|NCT02006732|11785650|FG002|Overall Study|Adverse Event|4
7478538|NCT02006732|11785651|FG003|Overall Study|Adverse Event|2
7478539|NCT02006732|11785648|FG000|Overall Study|Lack of Efficacy|6
7478540|NCT02006732|11785649|FG001|Overall Study|Lack of Efficacy|3
7478541|NCT02006732|11785650|FG002|Overall Study|Lack of Efficacy|1
7478542|NCT02006732|11785651|FG003|Overall Study|Lack of Efficacy|1
7478543|NCT02006732|11785648|FG000|Overall Study|Protocol Violation|1
7478544|NCT02006732|11785649|FG001|Overall Study|Protocol Violation|1
7478545|NCT02006732|11785650|FG002|Overall Study|Protocol Violation|0
7478546|NCT02006732|11785651|FG003|Overall Study|Protocol Violation|0
7478547|NCT02006732|11785648|FG000|Overall Study|Lost to Follow-up|0
7478548|NCT02006732|11785649|FG001|Overall Study|Lost to Follow-up|1
7478549|NCT02006732|11785650|FG002|Overall Study|Lost to Follow-up|0
7478550|NCT02006732|11785651|FG003|Overall Study|Lost to Follow-up|0
7478551|NCT02006732|11785648|FG000|Overall Study|Withdrawal by Subject|3
7478552|NCT02006732|11785649|FG001|Overall Study|Withdrawal by Subject|0
7478553|NCT02006732|11785650|FG002|Overall Study|Withdrawal by Subject|4
7478554|NCT02006732|11785651|FG003|Overall Study|Withdrawal by Subject|1
7478555|NCT02006758|11785661|FG000|Overall Study|Protocol Violation|1
7478556|NCT02006758|11785661|FG000|Overall Study|Death|1
7478557|NCT02006758|11785661|FG000|Overall Study|Lost to Follow-up|4
7478558|NCT02006758|11785661|FG000|Overall Study|Withdrawal by Subject|4
7478559|NCT02006758|11785661|FG000|Overall Study|Procedurally excluded|1
7478560|NCT02006758|11785661|FG000|Overall Study|Other|2
7478561|NCT02006979|11785696|FG000|Overall Study|Withdrawal by Subject|1
7478562|NCT02006979|11785697|FG001|Overall Study|Withdrawal by Subject|1
7478563|NCT02006979|11785696|FG000|Overall Study|Protocol Violation|0
7478564|NCT02006979|11785697|FG001|Overall Study|Protocol Violation|1
7478565|NCT02007070|11785703|FG000|Overall Study|Adverse Event|4
7478566|NCT02007070|11785703|FG000|Overall Study|Clinical Progression|4
7478567|NCT02007070|11785703|FG000|Overall Study|Death|1
7478568|NCT02007070|11785703|FG000|Overall Study|Protocol Violation|2
7478569|NCT02007070|11785703|FG000|Overall Study|Physician Decision|1
7478570|NCT02007070|11785703|FG000|Overall Study|Progressive Disease|21
7478571|NCT02007096|11785709|FG000|Overall Study|medication not available|2
7478572|NCT02007096|11785710|FG001|Overall Study|medication not available|0
7478573|NCT02007096|11785709|FG000|Overall Study|did not inject saline|0
7478574|NCT02007096|11785710|FG001|Overall Study|did not inject saline|3
7478575|NCT02007096|11785709|FG000|Overall Study|did not follow postoperative protocol|8
7478576|NCT02007096|11785710|FG001|Overall Study|did not follow postoperative protocol|11
7478577|NCT02007096|11785709|FG000|Overall Study|converted to open surgery|1
7478578|NCT02007096|11785710|FG001|Overall Study|converted to open surgery|1
7478579|NCT02007096|11785709|FG000|Overall Study|no mesh placed|0
7478580|NCT02007096|11785710|FG001|Overall Study|no mesh placed|1
7478581|NCT02007109|11785716|FG000|Overall Study|Diary not returned or excluded|102
7478582|NCT02007109|11785716|FG000|Overall Study|Excluded - Age<7yo|9
7534402|NCT02697591|11881266|FG000|Overall Study|Withdrawal by Subject|1
7534403|NCT02697591|11881267|FG001|Overall Study|Withdrawal by Subject|1
7534404|NCT02697591|11881268|FG002|Overall Study|Withdrawal by Subject|2
7534405|NCT02697591|11881269|FG003|Overall Study|Withdrawal by Subject|1
7534406|NCT02697591|11881270|FG004|Overall Study|Withdrawal by Subject|7
7534407|NCT02697591|11881271|FG005|Overall Study|Withdrawal by Subject|6
7534408|NCT02697591|11881272|FG006|Overall Study|Withdrawal by Subject|9
7534409|NCT02697591|11881273|FG007|Overall Study|Withdrawal by Subject|1
7534410|NCT02697591|11881274|FG008|Overall Study|Withdrawal by Subject|6
7534411|NCT02697591|11881275|FG009|Overall Study|Withdrawal by Subject|10
7534412|NCT02697591|11881266|FG000|Overall Study|Physician Decision|1
7534413|NCT02697591|11881267|FG001|Overall Study|Physician Decision|0
7534414|NCT02697591|11881268|FG002|Overall Study|Physician Decision|0
7534415|NCT02697591|11881269|FG003|Overall Study|Physician Decision|0
7534416|NCT02697591|11881270|FG004|Overall Study|Physician Decision|1
7534417|NCT02697591|11881271|FG005|Overall Study|Physician Decision|2
7534418|NCT02697591|11881272|FG006|Overall Study|Physician Decision|0
7534419|NCT02697591|11881273|FG007|Overall Study|Physician Decision|0
7534420|NCT02697591|11881274|FG008|Overall Study|Physician Decision|1
7534421|NCT02697591|11881275|FG009|Overall Study|Physician Decision|1
7534422|NCT02697591|11881266|FG000|Overall Study|Death|2
7534423|NCT02697591|11881267|FG001|Overall Study|Death|3
7534424|NCT02697591|11881268|FG002|Overall Study|Death|1
7534425|NCT02697591|11881269|FG003|Overall Study|Death|1
7534426|NCT02697591|11881270|FG004|Overall Study|Death|4
7534427|NCT02697591|11881271|FG005|Overall Study|Death|5
7534428|NCT02697591|11881272|FG006|Overall Study|Death|3
7534429|NCT02697591|11881273|FG007|Overall Study|Death|1
7534430|NCT02697591|11881274|FG008|Overall Study|Death|1
7534431|NCT02697591|11881275|FG009|Overall Study|Death|5
7534432|NCT02697591|11881266|FG000|Overall Study|Reason not Specified|0
7534433|NCT02697591|11881267|FG001|Overall Study|Reason not Specified|0
7534434|NCT02697591|11881268|FG002|Overall Study|Reason not Specified|0
7534435|NCT02697591|11881269|FG003|Overall Study|Reason not Specified|1
7534436|NCT02697591|11881270|FG004|Overall Study|Reason not Specified|1
7534437|NCT02697591|11881271|FG005|Overall Study|Reason not Specified|2
7534438|NCT02697591|11881272|FG006|Overall Study|Reason not Specified|3
7534439|NCT02697591|11881273|FG007|Overall Study|Reason not Specified|1
7534440|NCT02697591|11881274|FG008|Overall Study|Reason not Specified|1
7534441|NCT02697591|11881275|FG009|Overall Study|Reason not Specified|3
7534442|NCT02697617|11881298|FG000|Overall Study|Withdrawal by Subject|0
7534443|NCT02697617|11881299|FG001|Overall Study|Withdrawal by Subject|2
7534444|NCT02697617|11881298|FG000|Overall Study|Pregnancy|1
7534445|NCT02697617|11881299|FG001|Overall Study|Pregnancy|0
7534446|NCT02697734|11881311|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
7534447|NCT02697734|11881312|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
7534448|NCT02697734|11881311|FG000|Core Phase - up to Week 48|Adverse Event|1
7534449|NCT02697734|11881312|FG001|Core Phase - up to Week 48|Adverse Event|2
7534450|NCT02697734|11881311|FG000|Core Phase - up to Week 48|Physician Decision|1
7534451|NCT02697734|11881312|FG001|Core Phase - up to Week 48|Physician Decision|0
7534452|NCT02697734|11881311|FG000|Optional Extension Phase|Adverse Event|5
7534453|NCT02697734|11881312|FG001|Optional Extension Phase|Adverse Event|1
7534454|NCT02697734|11881311|FG000|Optional Extension Phase|Physician Decision|0
7534455|NCT02697734|11881312|FG001|Optional Extension Phase|Physician Decision|1
7534456|NCT02697773|11881329|FG000|Overall Study|Adverse Event|2
7534457|NCT02697773|11881330|FG001|Overall Study|Adverse Event|1
7534458|NCT02697773|11881331|FG002|Overall Study|Adverse Event|2
7534459|NCT02697773|11881329|FG000|Overall Study|Death|0
7534460|NCT02697773|11881330|FG001|Overall Study|Death|0
7534461|NCT02697773|11881331|FG002|Overall Study|Death|2
7534462|NCT02697773|11881329|FG000|Overall Study|Lack of Efficacy|4
7534463|NCT02697773|11881330|FG001|Overall Study|Lack of Efficacy|6
7534464|NCT02697773|11881331|FG002|Overall Study|Lack of Efficacy|6
7534465|NCT02697773|11881329|FG000|Overall Study|Lost to Follow-up|5
7534466|NCT02697773|11881330|FG001|Overall Study|Lost to Follow-up|5
7478583|NCT02007252|11785729|FG000|Overall Study|Administrative problems|3
7478584|NCT02007252|11785730|FG001|Overall Study|Administrative problems|7
7478585|NCT02007252|11785729|FG000|Overall Study|Abnormal laboratory value(s)|1
7478586|NCT02007252|11785730|FG001|Overall Study|Abnormal laboratory value(s)|0
7478587|NCT02007252|11785729|FG000|Overall Study|Adverse Event|7
7478588|NCT02007252|11785730|FG001|Overall Study|Adverse Event|4
7478589|NCT02007278|11785738|FG000|Overall Study|Failure to comply with an eligibility|0
7478590|NCT02007278|11785739|FG001|Overall Study|Failure to comply with an eligibility|1
7478591|NCT02007278|11785738|FG000|Overall Study|Ingestion of drugs not allowed in study|0
7478592|NCT02007278|11785739|FG001|Overall Study|Ingestion of drugs not allowed in study|1
7478593|NCT02007278|11785738|FG000|Overall Study|Incorrect medication administration|1
7478594|NCT02007278|11785739|FG001|Overall Study|Incorrect medication administration|0
7478595|NCT02007278|11785738|FG000|Overall Study|Mis-randomization|1
7478596|NCT02007278|11785739|FG001|Overall Study|Mis-randomization|1
7478597|NCT02007434|11785773|FG000|Overall Study|Lost to Follow-up|0
7478598|NCT02007434|11785774|FG001|Overall Study|Lost to Follow-up|1
7478599|NCT02007434|11785775|FG002|Overall Study|Lost to Follow-up|0
7478600|NCT02007434|11785776|FG003|Overall Study|Lost to Follow-up|0
7478601|NCT02007434|11785777|FG004|Overall Study|Lost to Follow-up|0
7478602|NCT02007434|11785778|FG005|Overall Study|Lost to Follow-up|0
7478603|NCT02007434|11785779|FG006|Overall Study|Lost to Follow-up|0
7478604|NCT02007434|11785780|FG007|Overall Study|Lost to Follow-up|0
7478605|NCT02007434|11785773|FG000|Overall Study|Non-compliance|1
7478606|NCT02007434|11785774|FG001|Overall Study|Non-compliance|0
7478607|NCT02007434|11785775|FG002|Overall Study|Non-compliance|1
7478608|NCT02007434|11785776|FG003|Overall Study|Non-compliance|0
7478609|NCT02007434|11785777|FG004|Overall Study|Non-compliance|0
7478610|NCT02007434|11785778|FG005|Overall Study|Non-compliance|0
7478611|NCT02007434|11785779|FG006|Overall Study|Non-compliance|0
7478612|NCT02007434|11785780|FG007|Overall Study|Non-compliance|0
7478613|NCT02007577|11785801|FG000|Overall Study|Adverse Event|1
7478614|NCT02007577|11785802|FG001|Overall Study|Adverse Event|0
7478615|NCT02007577|11785801|FG000|Overall Study|Withdrawal by Subject|0
7478616|NCT02007577|11785802|FG001|Overall Study|Withdrawal by Subject|1
7478617|NCT02007720|11785810|FG000|Overall Study|Withdrawal by Subject|9
7478618|NCT02007720|11785811|FG001|Overall Study|Withdrawal by Subject|11
7478619|NCT02007720|11785810|FG000|Overall Study|study terminated by sponsor|58
7478620|NCT02007720|11785811|FG001|Overall Study|study terminated by sponsor|54
7478621|NCT02007720|11785810|FG000|Overall Study|technical problem|4
7478622|NCT02007720|11785811|FG001|Overall Study|technical problem|2
7478623|NCT02007720|11785810|FG000|Overall Study|patient followd less than 165 days|11
7478624|NCT02007720|11785811|FG001|Overall Study|patient followd less than 165 days|5
7478625|NCT02007954|11785822|FG000|Overall Study|Received liver transplant|3
7478626|NCT02007954|11785822|FG000|Overall Study|Switch in treatment modality|2
7478627|NCT02007954|11785822|FG000|Overall Study|Disease progression and unrelated AE|1
7478628|NCT02007954|11785822|FG000|Overall Study|Death|1
7478629|NCT02008227|11785841|FG000|Overall Study|Lost to Follow-up|7
7478630|NCT02008227|11785842|FG001|Overall Study|Lost to Follow-up|9
7478631|NCT02008227|11785841|FG000|Overall Study|Death|494
7478632|NCT02008227|11785842|FG001|Overall Study|Death|485
7478633|NCT02008227|11785841|FG000|Overall Study|Withdrawal by Subject|67
7478634|NCT02008227|11785842|FG001|Overall Study|Withdrawal by Subject|36
7478635|NCT02008227|11785841|FG000|Overall Study|Study Terminated By Sponsor|44
7478636|NCT02008227|11785842|FG001|Overall Study|Study Terminated By Sponsor|83
7478637|NCT02008318|11785851|FG000|Overall Study|Adverse Event|4
7478638|NCT02008318|11785852|FG001|Overall Study|Adverse Event|0
7478639|NCT02008318|11785851|FG000|Overall Study|Physician Decision|2
7478640|NCT02008318|11785852|FG001|Overall Study|Physician Decision|0
7478641|NCT02008318|11785851|FG000|Overall Study|Progressive Disease|2
7478642|NCT02008318|11785852|FG001|Overall Study|Progressive Disease|0
7478643|NCT02008318|11785851|FG000|Overall Study|Protocol Violation|1
7478644|NCT02008318|11785852|FG001|Overall Study|Protocol Violation|1
7478645|NCT02008318|11785851|FG000|Overall Study|Withdrawal by Subject|3
7478646|NCT02008318|11785852|FG001|Overall Study|Withdrawal by Subject|0
7478647|NCT02008526|11785864|FG000|Overall Study|Death|0
7478648|NCT02008526|11785865|FG001|Overall Study|Death|2
7478649|NCT02008526|11785866|FG002|Overall Study|Death|1
7478650|NCT02008526|11785864|FG000|Overall Study|Withdrawal by Subject|3
7478651|NCT02008526|11785865|FG001|Overall Study|Withdrawal by Subject|3
7478652|NCT02008526|11785866|FG002|Overall Study|Withdrawal by Subject|2
7478653|NCT02008526|11785864|FG000|Overall Study|Lost to Follow-up|5
7478654|NCT02008526|11785865|FG001|Overall Study|Lost to Follow-up|9
7478655|NCT02008526|11785866|FG002|Overall Study|Lost to Follow-up|6
7478656|NCT02008565|11785878|FG000|Overall Study|Protocol Violation|1
7478657|NCT02008565|11785879|FG001|Overall Study|Protocol Violation|1
7478658|NCT02008565|11785880|FG002|Overall Study|Protocol Violation|2
7478659|NCT02008565|11785881|FG003|Overall Study|Protocol Violation|0
7478660|NCT02008773|11785915|FG000|Overall Study|Adverse Event|3
7478661|NCT02008773|11785916|FG001|Overall Study|Adverse Event|3
7478662|NCT02008773|11785917|FG002|Overall Study|Adverse Event|1
7478663|NCT02008773|11785918|FG003|Overall Study|Adverse Event|2
7478664|NCT02008773|11785915|FG000|Overall Study|Medication Non-compliance|2
7478665|NCT02008773|11785916|FG001|Overall Study|Medication Non-compliance|1
7478666|NCT02008773|11785917|FG002|Overall Study|Medication Non-compliance|3
7478667|NCT02008773|11785918|FG003|Overall Study|Medication Non-compliance|2
7478668|NCT02008773|11785915|FG000|Overall Study|Withdrawal by Subject|8
7478669|NCT02008773|11785916|FG001|Overall Study|Withdrawal by Subject|4
7478670|NCT02008773|11785917|FG002|Overall Study|Withdrawal by Subject|7
7478671|NCT02008773|11785918|FG003|Overall Study|Withdrawal by Subject|6
7478672|NCT02008773|11785915|FG000|Overall Study|Lost to Follow-up|0
7478673|NCT02008773|11785916|FG001|Overall Study|Lost to Follow-up|1
7478674|NCT02008773|11785917|FG002|Overall Study|Lost to Follow-up|3
7478675|NCT02008773|11785918|FG003|Overall Study|Lost to Follow-up|2
7478676|NCT02008877|11785926|FG000|Overall Study|Inevaluable|0
7478677|NCT02008877|11785927|FG001|Overall Study|Inevaluable|1
7478678|NCT02008877|11785928|FG002|Overall Study|Inevaluable|0
7478679|NCT02008890|11785940|FG000|Period 1|Withdrawal by Subject|7
7478680|NCT02008890|11785941|FG001|Period 1|Withdrawal by Subject|7
7478681|NCT02008890|11785942|FG002|Period 1|Withdrawal by Subject|5
7478682|NCT02008890|11785943|FG003|Period 1|Withdrawal by Subject|0
7478683|NCT02008890|11785944|FG004|Period 1|Withdrawal by Subject|0
7478684|NCT02008890|11785940|FG000|Period 1|Pregnancy|1
7478685|NCT02008890|11785941|FG001|Period 1|Pregnancy|0
7478686|NCT02008890|11785942|FG002|Period 1|Pregnancy|0
7478687|NCT02008890|11785943|FG003|Period 1|Pregnancy|0
7478688|NCT02008890|11785944|FG004|Period 1|Pregnancy|0
7478689|NCT02008890|11785940|FG000|Period 1|Physician Decision|1
7478690|NCT02008890|11785941|FG001|Period 1|Physician Decision|0
7478691|NCT02008890|11785942|FG002|Period 1|Physician Decision|1
7478692|NCT02008890|11785943|FG003|Period 1|Physician Decision|0
7478693|NCT02008890|11785944|FG004|Period 1|Physician Decision|0
7478694|NCT02008890|11785940|FG000|Period 1|Adverse Event|6
7478695|NCT02008890|11785941|FG001|Period 1|Adverse Event|8
7478696|NCT02008890|11785942|FG002|Period 1|Adverse Event|6
7478697|NCT02008890|11785943|FG003|Period 1|Adverse Event|0
7478698|NCT02008890|11785944|FG004|Period 1|Adverse Event|0
7478699|NCT02008890|11785940|FG000|Period 2|Adverse Event|12
7478700|NCT02008890|11785941|FG001|Period 2|Adverse Event|7
7478701|NCT02008890|11785942|FG002|Period 2|Adverse Event|0
7478702|NCT02008890|11785943|FG003|Period 2|Adverse Event|5
7478703|NCT02008890|11785944|FG004|Period 2|Adverse Event|5
7478704|NCT02008890|11785940|FG000|Period 2|Withdrawal by Subject|11
7478705|NCT02008890|11785941|FG001|Period 2|Withdrawal by Subject|8
7478706|NCT02008890|11785942|FG002|Period 2|Withdrawal by Subject|0
7478707|NCT02008890|11785943|FG003|Period 2|Withdrawal by Subject|7
7478708|NCT02008890|11785944|FG004|Period 2|Withdrawal by Subject|2
7478709|NCT02008890|11785940|FG000|Period 2|Physician Decision|4
7478710|NCT02008890|11785941|FG001|Period 2|Physician Decision|0
7478711|NCT02008890|11785942|FG002|Period 2|Physician Decision|0
7478712|NCT02008890|11785943|FG003|Period 2|Physician Decision|2
7478713|NCT02008890|11785944|FG004|Period 2|Physician Decision|1
7478714|NCT02008890|11785940|FG000|Period 2|Lost to Follow-up|0
7478715|NCT02008890|11785941|FG001|Period 2|Lost to Follow-up|0
7478716|NCT02008890|11785942|FG002|Period 2|Lost to Follow-up|1
7478717|NCT02008890|11785943|FG003|Period 2|Lost to Follow-up|0
7478718|NCT02008890|11785944|FG004|Period 2|Lost to Follow-up|0
7478719|NCT02008890|11785940|FG000|Extension Period|Withdrawal by Subject|3
7478720|NCT02008890|11785941|FG001|Extension Period|Withdrawal by Subject|2
7478721|NCT02008890|11785942|FG002|Extension Period|Withdrawal by Subject|0
7478722|NCT02008890|11785943|FG003|Extension Period|Withdrawal by Subject|4
7478723|NCT02008890|11785944|FG004|Extension Period|Withdrawal by Subject|2
7478724|NCT02008890|11785940|FG000|Extension Period|Lost to Follow-up|1
7478725|NCT02008890|11785941|FG001|Extension Period|Lost to Follow-up|0
7478726|NCT02008890|11785942|FG002|Extension Period|Lost to Follow-up|0
7478727|NCT02008890|11785943|FG003|Extension Period|Lost to Follow-up|0
7478728|NCT02008890|11785944|FG004|Extension Period|Lost to Follow-up|0
7478729|NCT02008890|11785940|FG000|Extension Period|Adverse Event|1
7478730|NCT02008890|11785941|FG001|Extension Period|Adverse Event|3
7478731|NCT02008890|11785942|FG002|Extension Period|Adverse Event|0
7478732|NCT02008890|11785943|FG003|Extension Period|Adverse Event|0
7478733|NCT02008890|11785944|FG004|Extension Period|Adverse Event|2
7478734|NCT02008916|11785962|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
7478735|NCT02008916|11785963|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
7478736|NCT02008916|11785964|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
7478737|NCT02008916|11785962|FG000|Week 16 - 156|Adverse Event|4
7478738|NCT02008916|11785963|FG001|Week 16 - 156|Adverse Event|2
7478739|NCT02008916|11785964|FG002|Week 16 - 156|Adverse Event|3
7478740|NCT02008916|11785962|FG000|Week 16 - 156|Withdrawal by Subject|7
7478741|NCT02008916|11785963|FG001|Week 16 - 156|Withdrawal by Subject|3
7478742|NCT02008916|11785964|FG002|Week 16 - 156|Withdrawal by Subject|5
7478743|NCT02008916|11785962|FG000|Week 16 - 156|No longer requires treatment|0
7478744|NCT02008916|11785963|FG001|Week 16 - 156|No longer requires treatment|1
7478745|NCT02008916|11785964|FG002|Week 16 - 156|No longer requires treatment|0
7478746|NCT02008916|11785962|FG000|Week 16 - 156|Lost to Follow-up|5
7478747|NCT02008916|11785963|FG001|Week 16 - 156|Lost to Follow-up|0
7478748|NCT02008916|11785964|FG002|Week 16 - 156|Lost to Follow-up|0
7478749|NCT02008916|11785962|FG000|Week 16 - 156|Lack of Efficacy|3
7478750|NCT02008916|11785963|FG001|Week 16 - 156|Lack of Efficacy|5
7478751|NCT02008916|11785964|FG002|Week 16 - 156|Lack of Efficacy|2
7478752|NCT02008916|11785962|FG000|Week 16 - 156|Pregnancy|0
7478753|NCT02008916|11785963|FG001|Week 16 - 156|Pregnancy|1
7478754|NCT02008916|11785964|FG002|Week 16 - 156|Pregnancy|0
7478755|NCT02008916|11785962|FG000|Week 16 - 156|Physician Decision|0
7478756|NCT02008916|11785963|FG001|Week 16 - 156|Physician Decision|1
7478757|NCT02008916|11785964|FG002|Week 16 - 156|Physician Decision|0
7478758|NCT02009046|11785982|FG000|Overall Study|Lost to Follow-up|256
7478759|NCT02009046|11785983|FG001|Overall Study|Lost to Follow-up|206
7478760|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
7478761|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7478762|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
7478763|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
7478764|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7478765|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
7478766|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Adverse Event|22
7478767|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Adverse Event|0
7478768|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Adverse Event|0
7478769|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
7478770|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
7478771|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
7478772|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
7478773|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
7478774|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
7478775|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Pregnancy|1
7478776|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Pregnancy|0
7478777|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Pregnancy|0
7478778|NCT02009163|11785997|FG000|Open-label Period (Non-randomized)|Other|13
7478779|NCT02009163|11785998|FG001|Open-label Period (Non-randomized)|Other|0
7478780|NCT02009163|11785999|FG002|Open-label Period (Non-randomized)|Other|0
7478781|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
7478782|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
7478783|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
7478784|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
7478785|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
7478786|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
7478787|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Adverse Event|0
7478788|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Adverse Event|0
7478789|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Adverse Event|6
7478790|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
7478791|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
7478792|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
7478793|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Protocol Violation|0
7478794|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Protocol Violation|1
7478795|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Protocol Violation|2
7478796|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Pregnancy|0
7478797|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Pregnancy|0
7478798|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Pregnancy|2
7478799|NCT02009163|11785997|FG000|Randomized-withdrawal Period|Other|0
7478800|NCT02009163|11785998|FG001|Randomized-withdrawal Period|Other|9
7478801|NCT02009163|11785999|FG002|Randomized-withdrawal Period|Other|5
7478802|NCT02009332|11786015|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7478803|NCT02009332|11786016|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
7478804|NCT02009332|11786017|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7478805|NCT02009332|11786018|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7478806|NCT02009332|11786019|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7478807|NCT02009332|11786020|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
7478808|NCT02009332|11786015|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7478809|NCT02009332|11786016|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7478810|NCT02009332|11786017|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7478811|NCT02009332|11786018|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7478812|NCT02009332|11786019|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
7478813|NCT02009332|11786020|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
7478814|NCT02009332|11786015|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7478815|NCT02009332|11786016|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7478816|NCT02009332|11786017|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7478817|NCT02009332|11786018|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7478818|NCT02009332|11786019|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
7478819|NCT02009332|11786020|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
7478820|NCT02009397|11786034|FG000|Overall Study|Protocol Violation|6
7478821|NCT02009397|11786034|FG000|Overall Study|Death|8
7478822|NCT02009397|11786034|FG000|Overall Study|Lost to Follow-up|6
7478823|NCT02009696|11786047|FG000|Overall Study|Withdrawal by Subject|2
7478824|NCT02009722|11786053|FG000|Overall Study|Protocol Violation|1
7478825|NCT02009722|11786054|FG001|Overall Study|Protocol Violation|2
7478826|NCT02009722|11786053|FG000|Overall Study|Did not receive intervention|0
7478827|NCT02009722|11786054|FG001|Overall Study|Did not receive intervention|1
7478828|NCT02009865|11786062|FG000|Overall Study|Adverse Event|0
7478829|NCT02009865|11786063|FG001|Overall Study|Adverse Event|2
7478830|NCT02009865|11786062|FG000|Overall Study|Protocol Violation|0
7478831|NCT02009865|11786063|FG001|Overall Study|Protocol Violation|2
7478832|NCT02009865|11786062|FG000|Overall Study|Withdrawal by Subject|1
7478833|NCT02009865|11786063|FG001|Overall Study|Withdrawal by Subject|1
7478834|NCT02009878|11786072|FG000|Overall Study|Participant Met Withdrawal Criteria|0
7478835|NCT02009878|11786073|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7478836|NCT02009878|11786074|FG002|Overall Study|Participant Met Withdrawal Criteria|0
7478837|NCT02009930|11786082|FG000|Overall Study|withdrawn|5
7478838|NCT02010255|11786150|FG000|Overall Study|Death|0
7478839|NCT02010255|11786151|FG001|Overall Study|Death|1
7478840|NCT02010255|11786152|FG002|Overall Study|Death|4
7478841|NCT02010255|11786153|FG003|Overall Study|Death|4
7478842|NCT02010255|11786154|FG004|Overall Study|Death|2
7478843|NCT02010255|11786155|FG005|Overall Study|Death|0
7478844|NCT02010255|11786156|FG006|Overall Study|Death|1
7478845|NCT02010255|11786157|FG007|Overall Study|Death|1
7478846|NCT02010255|11786158|FG008|Overall Study|Death|1
7478847|NCT02010255|11786159|FG009|Overall Study|Death|0
7478848|NCT02010255|11786160|FG010|Overall Study|Death|1
7478849|NCT02010255|11786161|FG011|Overall Study|Death|1
7478850|NCT02010255|11786162|FG012|Overall Study|Death|0
7478851|NCT02010255|11786163|FG013|Overall Study|Death|0
7478852|NCT02010255|11786150|FG000|Overall Study|Lack of Efficacy|4
7478853|NCT02010255|11786151|FG001|Overall Study|Lack of Efficacy|1
7478854|NCT02010255|11786152|FG002|Overall Study|Lack of Efficacy|2
7478855|NCT02010255|11786153|FG003|Overall Study|Lack of Efficacy|1
7478856|NCT02010255|11786154|FG004|Overall Study|Lack of Efficacy|1
7478857|NCT02010255|11786155|FG005|Overall Study|Lack of Efficacy|0
7478858|NCT02010255|11786156|FG006|Overall Study|Lack of Efficacy|0
7478859|NCT02010255|11786157|FG007|Overall Study|Lack of Efficacy|0
7478860|NCT02010255|11786158|FG008|Overall Study|Lack of Efficacy|0
7478861|NCT02010255|11786159|FG009|Overall Study|Lack of Efficacy|0
7478862|NCT02010255|11786160|FG010|Overall Study|Lack of Efficacy|1
7478863|NCT02010255|11786161|FG011|Overall Study|Lack of Efficacy|0
7478864|NCT02010255|11786162|FG012|Overall Study|Lack of Efficacy|0
7478865|NCT02010255|11786163|FG013|Overall Study|Lack of Efficacy|0
7478866|NCT02010255|11786150|FG000|Overall Study|Withdrew Consent|1
7478867|NCT02010255|11786151|FG001|Overall Study|Withdrew Consent|0
7478868|NCT02010255|11786152|FG002|Overall Study|Withdrew Consent|0
7478869|NCT02010255|11786153|FG003|Overall Study|Withdrew Consent|1
7478870|NCT02010255|11786154|FG004|Overall Study|Withdrew Consent|0
7478871|NCT02010255|11786155|FG005|Overall Study|Withdrew Consent|0
7478872|NCT02010255|11786156|FG006|Overall Study|Withdrew Consent|0
7478873|NCT02010255|11786157|FG007|Overall Study|Withdrew Consent|0
7478874|NCT02010255|11786158|FG008|Overall Study|Withdrew Consent|0
7478875|NCT02010255|11786159|FG009|Overall Study|Withdrew Consent|0
7478876|NCT02010255|11786160|FG010|Overall Study|Withdrew Consent|0
7478877|NCT02010255|11786161|FG011|Overall Study|Withdrew Consent|0
7478878|NCT02010255|11786162|FG012|Overall Study|Withdrew Consent|0
7478879|NCT02010255|11786163|FG013|Overall Study|Withdrew Consent|0
7478880|NCT02010255|11786150|FG000|Overall Study|Adverse Event|1
7478881|NCT02010255|11786151|FG001|Overall Study|Adverse Event|0
7478882|NCT02010255|11786152|FG002|Overall Study|Adverse Event|0
7478883|NCT02010255|11786153|FG003|Overall Study|Adverse Event|0
7478884|NCT02010255|11786154|FG004|Overall Study|Adverse Event|0
7478885|NCT02010255|11786155|FG005|Overall Study|Adverse Event|0
7478886|NCT02010255|11786156|FG006|Overall Study|Adverse Event|0
7478887|NCT02010255|11786157|FG007|Overall Study|Adverse Event|0
7478888|NCT02010255|11786158|FG008|Overall Study|Adverse Event|0
7478889|NCT02010255|11786159|FG009|Overall Study|Adverse Event|0
7478890|NCT02010255|11786160|FG010|Overall Study|Adverse Event|0
7478891|NCT02010255|11786161|FG011|Overall Study|Adverse Event|0
7478892|NCT02010255|11786162|FG012|Overall Study|Adverse Event|0
7478893|NCT02010255|11786163|FG013|Overall Study|Adverse Event|0
7478894|NCT02010255|11786150|FG000|Overall Study|Lost to Follow-up|0
7478895|NCT02010255|11786151|FG001|Overall Study|Lost to Follow-up|0
7478896|NCT02010255|11786152|FG002|Overall Study|Lost to Follow-up|1
7478897|NCT02010255|11786153|FG003|Overall Study|Lost to Follow-up|0
7478898|NCT02010255|11786154|FG004|Overall Study|Lost to Follow-up|1
7478899|NCT02010255|11786155|FG005|Overall Study|Lost to Follow-up|0
7478900|NCT02010255|11786156|FG006|Overall Study|Lost to Follow-up|0
7478901|NCT02010255|11786157|FG007|Overall Study|Lost to Follow-up|0
7478902|NCT02010255|11786158|FG008|Overall Study|Lost to Follow-up|0
7478903|NCT02010255|11786159|FG009|Overall Study|Lost to Follow-up|0
7478904|NCT02010255|11786160|FG010|Overall Study|Lost to Follow-up|0
7478905|NCT02010255|11786161|FG011|Overall Study|Lost to Follow-up|0
7478906|NCT02010255|11786162|FG012|Overall Study|Lost to Follow-up|0
7478907|NCT02010255|11786163|FG013|Overall Study|Lost to Follow-up|0
7478908|NCT02010255|11786150|FG000|Overall Study|Randomized but Not Treated|0
7478909|NCT02010255|11786151|FG001|Overall Study|Randomized but Not Treated|0
7478910|NCT02010255|11786152|FG002|Overall Study|Randomized but Not Treated|0
7478911|NCT02010255|11786153|FG003|Overall Study|Randomized but Not Treated|0
7478912|NCT02010255|11786154|FG004|Overall Study|Randomized but Not Treated|0
7478913|NCT02010255|11786155|FG005|Overall Study|Randomized but Not Treated|0
7478914|NCT02010255|11786156|FG006|Overall Study|Randomized but Not Treated|0
7478915|NCT02010255|11786157|FG007|Overall Study|Randomized but Not Treated|0
7478916|NCT02010255|11786158|FG008|Overall Study|Randomized but Not Treated|0
7478917|NCT02010255|11786159|FG009|Overall Study|Randomized but Not Treated|0
7478918|NCT02010255|11786160|FG010|Overall Study|Randomized but Not Treated|0
7478919|NCT02010255|11786161|FG011|Overall Study|Randomized but Not Treated|0
7478920|NCT02010255|11786162|FG012|Overall Study|Randomized but Not Treated|0
7478921|NCT02010255|11786163|FG013|Overall Study|Randomized but Not Treated|1
7478922|NCT02010567|11786232|FG000|Overall Study|Adverse Event|0
7478923|NCT02010567|11786233|FG001|Overall Study|Adverse Event|0
7478924|NCT02010567|11786234|FG002|Overall Study|Adverse Event|1
7478925|NCT02010567|11786235|FG003|Overall Study|Adverse Event|0
7478926|NCT02010567|11786236|FG004|Overall Study|Adverse Event|1
7478927|NCT02010632|11786246|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
7478928|NCT02010632|11786247|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
7478929|NCT02010684|11786259|FG000|Overall Study|Lost to Follow-up|8
7478930|NCT02010684|11786260|FG001|Overall Study|Lost to Follow-up|18
7478931|NCT02010684|11786259|FG000|Overall Study|Withdrawal by Subject|4
7478932|NCT02010684|11786260|FG001|Overall Study|Withdrawal by Subject|5
7478933|NCT02010775|11786284|FG000|Overall Study|Adverse Event|0
7478934|NCT02010775|11786285|FG001|Overall Study|Adverse Event|0
7478935|NCT02010775|11786286|FG002|Overall Study|Adverse Event|0
7478936|NCT02010775|11786287|FG003|Overall Study|Adverse Event|0
7478937|NCT02010775|11786288|FG004|Overall Study|Adverse Event|1
7478938|NCT02010775|11786284|FG000|Overall Study|Pregnancy|0
7478939|NCT02010775|11786285|FG001|Overall Study|Pregnancy|0
7478940|NCT02010775|11786286|FG002|Overall Study|Pregnancy|2
7478941|NCT02010775|11786287|FG003|Overall Study|Pregnancy|0
7478942|NCT02010775|11786288|FG004|Overall Study|Pregnancy|0
7478943|NCT02010775|11786284|FG000|Overall Study|Lost to Follow-up|2
7478944|NCT02010775|11786285|FG001|Overall Study|Lost to Follow-up|0
7478945|NCT02010775|11786286|FG002|Overall Study|Lost to Follow-up|0
7478946|NCT02010775|11786287|FG003|Overall Study|Lost to Follow-up|1
7478947|NCT02010775|11786288|FG004|Overall Study|Lost to Follow-up|1
7478948|NCT02010775|11786284|FG000|Overall Study|Personal Reasons|3
7478949|NCT02010775|11786285|FG001|Overall Study|Personal Reasons|3
7478950|NCT02010775|11786286|FG002|Overall Study|Personal Reasons|1
7478951|NCT02010775|11786287|FG003|Overall Study|Personal Reasons|2
7478952|NCT02010775|11786288|FG004|Overall Study|Personal Reasons|4
7478953|NCT02011113|11786313|FG000|Overall Study|Adverse Event|4
7478954|NCT02011113|11786313|FG000|Overall Study|Disease Progression (DP)|16
7478955|NCT02011113|11786313|FG000|Overall Study|Death|1
7478956|NCT02011113|11786313|FG000|Overall Study|Insufficient effect of Pomalidomide|1
7478957|NCT02011113|11786313|FG000|Overall Study|Investigator's judgement- DP|3
7478958|NCT02011113|11786313|FG000|Overall Study|Study terminated by sponsor|11
7478959|NCT02011386|11786318|FG000|Overall Study|Non-compliance|2
7478960|NCT02011386|11786318|FG000|Overall Study|Lack of Efficacy|3
7478961|NCT02011893|11786374|FG000|Enrollment to Randomization|Adverse Event|2
7478962|NCT02011893|11786375|FG001|Enrollment to Randomization|Adverse Event|0
7478963|NCT02011893|11786376|FG002|Enrollment to Randomization|Adverse Event|0
7478964|NCT02011893|11786374|FG000|Enrollment to Randomization|Physician Decision|10
7478965|NCT02011893|11786375|FG001|Enrollment to Randomization|Physician Decision|0
7478966|NCT02011893|11786376|FG002|Enrollment to Randomization|Physician Decision|0
7478967|NCT02011893|11786374|FG000|Enrollment to Randomization|Withdrawal by Subject|21
7478968|NCT02011893|11786375|FG001|Enrollment to Randomization|Withdrawal by Subject|0
7478969|NCT02011893|11786376|FG002|Enrollment to Randomization|Withdrawal by Subject|0
7478970|NCT02011893|11786374|FG000|Enrollment to Randomization|Screening Failure|29
7478971|NCT02011893|11786375|FG001|Enrollment to Randomization|Screening Failure|0
7478972|NCT02011893|11786376|FG002|Enrollment to Randomization|Screening Failure|0
7478973|NCT02011893|11786374|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
7478974|NCT02011893|11786375|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7478975|NCT02011893|11786376|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
7478976|NCT02011893|11786374|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
7478977|NCT02011893|11786375|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
7478978|NCT02011893|11786376|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
7478979|NCT02011893|11786374|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7478980|NCT02011893|11786375|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
7478981|NCT02011893|11786376|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
7478982|NCT02011893|11786374|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7478983|NCT02011893|11786375|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
7478984|NCT02011893|11786376|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
7478985|NCT02011893|11786374|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7478986|NCT02011893|11786375|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
7478987|NCT02011893|11786376|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
7478988|NCT02011945|11786384|FG000|Overall Study|Participant requested to Discontinue|0
7478989|NCT02011945|11786385|FG001|Overall Study|Participant requested to Discontinue|1
7478990|NCT02011945|11786386|FG002|Overall Study|Participant requested to Discontinue|1
7478991|NCT02011945|11786384|FG000|Overall Study|Adverse Event unrelated to Drug|0
7478992|NCT02011945|11786385|FG001|Overall Study|Adverse Event unrelated to Drug|2
7478993|NCT02011945|11786386|FG002|Overall Study|Adverse Event unrelated to Drug|1
7478994|NCT02011945|11786384|FG000|Overall Study|Study Drug Toxicity|0
7478995|NCT02011945|11786385|FG001|Overall Study|Study Drug Toxicity|0
7478996|NCT02011945|11786386|FG002|Overall Study|Study Drug Toxicity|1
7478997|NCT02011945|11786384|FG000|Overall Study|Treatment Failure|0
7478998|NCT02011945|11786385|FG001|Overall Study|Treatment Failure|7
7478999|NCT02011945|11786386|FG002|Overall Study|Treatment Failure|6
7479000|NCT02011945|11786384|FG000|Overall Study|No Longer Meets Study Criteria|1
7479001|NCT02011945|11786385|FG001|Overall Study|No Longer Meets Study Criteria|0
7479002|NCT02011945|11786386|FG002|Overall Study|No Longer Meets Study Criteria|0
7479003|NCT02011945|11786384|FG000|Overall Study|Proceeded to stem cell transplant|0
7224640|NCT00057330|11433950|FG001|Overall Study|Adverse Event|12
7224641|NCT00057330|11433949|FG000|Overall Study|Death|1
7479004|NCT02011945|11786385|FG001|Overall Study|Proceeded to stem cell transplant|0
7479005|NCT02011945|11786386|FG002|Overall Study|Proceeded to stem cell transplant|1
7479006|NCT02011945|11786384|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
7479007|NCT02011945|11786385|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
7479008|NCT02011945|11786386|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
7479009|NCT02012218|11786408|FG000|Overall Study|Withdrawal by Subject|1
7479010|NCT02012218|11786409|FG001|Overall Study|Withdrawal by Subject|0
7479011|NCT02012218|11786410|FG002|Overall Study|Withdrawal by Subject|1
7479012|NCT02012218|11786411|FG003|Overall Study|Withdrawal by Subject|1
7479013|NCT02012218|11786412|FG004|Overall Study|Withdrawal by Subject|1
7479014|NCT02012218|11786408|FG000|Overall Study|Adverse Event|1
7479015|NCT02012218|11786409|FG001|Overall Study|Adverse Event|0
7479016|NCT02012218|11786410|FG002|Overall Study|Adverse Event|0
7479017|NCT02012218|11786411|FG003|Overall Study|Adverse Event|1
7479018|NCT02012218|11786412|FG004|Overall Study|Adverse Event|0
7479019|NCT02012218|11786408|FG000|Overall Study|Lost to Follow-up|0
7479020|NCT02012218|11786409|FG001|Overall Study|Lost to Follow-up|1
7479021|NCT02012218|11786410|FG002|Overall Study|Lost to Follow-up|1
7479022|NCT02012218|11786411|FG003|Overall Study|Lost to Follow-up|0
7479023|NCT02012218|11786412|FG004|Overall Study|Lost to Follow-up|0
7479024|NCT02012218|11786408|FG000|Overall Study|Protocol Specified|1
7479025|NCT02012218|11786409|FG001|Overall Study|Protocol Specified|0
7479026|NCT02012218|11786410|FG002|Overall Study|Protocol Specified|0
7479027|NCT02012218|11786411|FG003|Overall Study|Protocol Specified|0
7479028|NCT02012218|11786412|FG004|Overall Study|Protocol Specified|0
7479029|NCT02012218|11786408|FG000|Overall Study|Protocol Deviation|1
7479030|NCT02012218|11786409|FG001|Overall Study|Protocol Deviation|0
7479031|NCT02012218|11786410|FG002|Overall Study|Protocol Deviation|0
7479032|NCT02012218|11786411|FG003|Overall Study|Protocol Deviation|0
7479033|NCT02012218|11786412|FG004|Overall Study|Protocol Deviation|0
7479034|NCT02012452|11786453|FG000|Overall Study|Lost to Follow-up|2
7479035|NCT02012452|11786454|FG001|Overall Study|Lost to Follow-up|1
7479036|NCT02012452|11786453|FG000|Overall Study|Withdrawal by Subject|4
7479037|NCT02012452|11786454|FG001|Overall Study|Withdrawal by Subject|0
7479038|NCT02012491|11786462|FG000|Overall Study|Lost to Follow-up|1
7479039|NCT02012491|11786463|FG001|Overall Study|Lost to Follow-up|0
7479040|NCT02012491|11786462|FG000|Overall Study|Protocol Violation|0
7479041|NCT02012491|11786463|FG001|Overall Study|Protocol Violation|1
7479042|NCT02012491|11786462|FG000|Overall Study|Withdrawal by Subject|1
7479043|NCT02012491|11786463|FG001|Overall Study|Withdrawal by Subject|0
7479044|NCT02012686|11786492|FG000|Overall Study|muscle contraction|0
7479045|NCT02012686|11786493|FG001|Overall Study|muscle contraction|1
7479046|NCT02012686|11786492|FG000|Overall Study|electrocardiography monitoring noise|0
7479047|NCT02012686|11786493|FG001|Overall Study|electrocardiography monitoring noise|1
7479048|NCT02012959|11786499|FG000|Treatment Phase A|Adverse Event|2
7479049|NCT02012959|11786500|FG001|Treatment Phase A|Adverse Event|0
7479050|NCT02012959|11786501|FG002|Treatment Phase A|Adverse Event|0
7479051|NCT02012959|11786502|FG003|Treatment Phase A|Adverse Event|0
7479052|NCT02012959|11786503|FG004|Treatment Phase A|Adverse Event|0
7479053|NCT02013037|11786513|FG000|Overall Study|Death|6
7479054|NCT02013037|11786513|FG000|Overall Study|Withdrawal by Subject|1
7479055|NCT02013037|11786513|FG000|Overall Study|Awaiting Transplantation|7
7479056|NCT02013037|11786513|FG000|Overall Study|Transplanted without DSA|2
7479057|NCT02013206|11786546|FG000|Overall Study|Progressive disease (PD)|14
7479058|NCT02013206|11786547|FG001|Overall Study|Progressive disease (PD)|17
7479059|NCT02013206|11786546|FG000|Overall Study|Symptomatic deterioration|3
7479060|NCT02013206|11786547|FG001|Overall Study|Symptomatic deterioration|1
7479061|NCT02013206|11786546|FG000|Overall Study|Adverse Event|1
7479062|NCT02013206|11786547|FG001|Overall Study|Adverse Event|0
7479063|NCT02013206|11786546|FG000|Overall Study|Patient refusal|2
7479064|NCT02013206|11786547|FG001|Overall Study|Patient refusal|0
7479065|NCT02013206|11786546|FG000|Overall Study|Patient non-compliance|1
7479066|NCT02013206|11786547|FG001|Overall Study|Patient non-compliance|0
7479067|NCT02013206|11786546|FG000|Overall Study|Death|1
7479068|NCT02013206|11786547|FG001|Overall Study|Death|2
7479069|NCT02013206|11786546|FG000|Overall Study|Other reasons off treatment|5
7479070|NCT02013206|11786547|FG001|Overall Study|Other reasons off treatment|2
7479071|NCT02013375|11786570|FG000|Overall Study|Did not engraft|1
7479072|NCT02013375|11786570|FG000|Overall Study|Did not engraft|1
7479073|NCT02013388|11786583|FG000|Overall Study|work emergency|1
7479074|NCT02013388|11786584|FG001|Overall Study|work emergency|0
7479075|NCT02013388|11786585|FG002|Overall Study|work emergency|0
7479076|NCT02013388|11786586|FG003|Overall Study|work emergency|0
7479077|NCT02013388|11786587|FG004|Overall Study|work emergency|1
7479078|NCT02013388|11786588|FG005|Overall Study|work emergency|0
7479079|NCT02013388|11786589|FG006|Overall Study|work emergency|0
7479080|NCT02013388|11786590|FG007|Overall Study|work emergency|0
7479081|NCT02013531|11786612|FG000|Overall Study|Lost to Follow-up|3
7479082|NCT02013531|11786612|FG000|Overall Study|Met Withdrawal Criteria|1
7479083|NCT02013531|11786612|FG000|Overall Study|Withdrawal by Subject|1
7479084|NCT02013544|11786618|FG000|Overall Study|Adverse Event|5
7479085|NCT02013544|11786619|FG001|Overall Study|Adverse Event|5
7479086|NCT02013544|11786618|FG000|Overall Study|Lost to Follow-up|2
7479087|NCT02013544|11786619|FG001|Overall Study|Lost to Follow-up|3
7479088|NCT02013544|11786618|FG000|Overall Study|Withdrawal by Subject|2
7479089|NCT02013544|11786619|FG001|Overall Study|Withdrawal by Subject|8
7479090|NCT02013544|11786618|FG000|Overall Study|Physician Decision|0
7479091|NCT02013544|11786619|FG001|Overall Study|Physician Decision|1
7479092|NCT02013544|11786618|FG000|Overall Study|Entry criteria not met/non-compliance|2
7479093|NCT02013544|11786619|FG001|Overall Study|Entry criteria not met/non-compliance|3
7479094|NCT02013609|11786625|FG000|Overall Study|Withdrawal by Subject|9
7479095|NCT02013609|11786625|FG000|Overall Study|Lost to Follow-up|3
7479096|NCT02013609|11786625|FG000|Overall Study|Adverse Event|3
7479097|NCT02013609|11786625|FG000|Overall Study|Met Withdrawal Criteria|3
7479098|NCT02013622|11786629|FG000|Overall Study|Lost to Follow-up|10
7479099|NCT02013622|11786629|FG000|Overall Study|Adverse Event|3
7479100|NCT02013622|11786629|FG000|Overall Study|Met Withdrawal Criteria|3
7479101|NCT02013622|11786629|FG000|Overall Study|Withdrawal by Subject|6
7479102|NCT02013622|11786629|FG000|Overall Study|Protocol Deviation|1
7479103|NCT02013622|11786629|FG000|Overall Study|Lack of Efficacy|1
7479104|NCT02013674|11786635|FG000|Overall Study|Death|0
7479105|NCT02013674|11786636|FG001|Overall Study|Death|1
7479106|NCT02013674|11786635|FG000|Overall Study|Lost to Follow-up|1
7479107|NCT02013674|11786636|FG001|Overall Study|Lost to Follow-up|0
7479108|NCT02013687|11786646|FG000|Overall Study|Lost to Follow-up|0
7479109|NCT02013687|11786647|FG001|Overall Study|Lost to Follow-up|0
7479110|NCT02013687|11786648|FG002|Overall Study|Lost to Follow-up|1
7479111|NCT02013687|11786649|FG003|Overall Study|Lost to Follow-up|0
7479112|NCT02013687|11786646|FG000|Overall Study|Protocol Violation|0
7479113|NCT02013687|11786647|FG001|Overall Study|Protocol Violation|0
7479114|NCT02013687|11786648|FG002|Overall Study|Protocol Violation|0
7479115|NCT02013687|11786649|FG003|Overall Study|Protocol Violation|1
7479116|NCT02013687|11786646|FG000|Overall Study|Withdrawal by Subject|0
7479117|NCT02013687|11786647|FG001|Overall Study|Withdrawal by Subject|0
7479118|NCT02013687|11786648|FG002|Overall Study|Withdrawal by Subject|0
7479119|NCT02013687|11786649|FG003|Overall Study|Withdrawal by Subject|1
7479120|NCT02013687|11786646|FG000|Overall Study|Missed visits due to patient travel|0
7479121|NCT02013687|11786647|FG001|Overall Study|Missed visits due to patient travel|0
7479122|NCT02013687|11786648|FG002|Overall Study|Missed visits due to patient travel|1
7479123|NCT02013687|11786649|FG003|Overall Study|Missed visits due to patient travel|0
7479124|NCT02013765|11786663|FG000|Overall Study|Trial was terminated by sponsor|1
7479125|NCT02013778|11786667|FG000|Overall Study|Death|4
7479126|NCT02013778|11786667|FG000|Overall Study|Withdrawal by Subject|1
7479127|NCT02013778|11786667|FG000|Overall Study|Physician Decision|1
7479128|NCT02013778|11786667|FG000|Overall Study|Adverse Event|1
7479129|NCT02013791|11786680|FG000|Period 1|Lost to Follow-up|0
7479130|NCT02013791|11786681|FG001|Period 1|Lost to Follow-up|0
7479131|NCT02013791|11786682|FG002|Period 1|Lost to Follow-up|0
7479132|NCT02013791|11786683|FG003|Period 1|Lost to Follow-up|1
7479133|NCT02013791|11786684|FG004|Period 1|Lost to Follow-up|0
7479134|NCT02013791|11786685|FG005|Period 1|Lost to Follow-up|0
7479135|NCT02013791|11786686|FG006|Period 1|Lost to Follow-up|1
7479136|NCT02013791|11786687|FG007|Period 1|Lost to Follow-up|1
7479137|NCT02013791|11786688|FG008|Period 1|Lost to Follow-up|0
7479138|NCT02013791|11786680|FG000|Period 1|Other Miscellaneous Reasons|0
7479139|NCT02013791|11786681|FG001|Period 1|Other Miscellaneous Reasons|2
7479140|NCT02013791|11786682|FG002|Period 1|Other Miscellaneous Reasons|0
7479141|NCT02013791|11786683|FG003|Period 1|Other Miscellaneous Reasons|0
7479142|NCT02013791|11786684|FG004|Period 1|Other Miscellaneous Reasons|0
7479143|NCT02013791|11786685|FG005|Period 1|Other Miscellaneous Reasons|0
7479144|NCT02013791|11786686|FG006|Period 1|Other Miscellaneous Reasons|0
7479145|NCT02013791|11786687|FG007|Period 1|Other Miscellaneous Reasons|0
7479146|NCT02013791|11786688|FG008|Period 1|Other Miscellaneous Reasons|0
7479147|NCT02013817|11786709|FG000|Overall Study|Adverse Event|12
7479148|NCT02013817|11786709|FG000|Overall Study|Withdrawal by Subject|4
7479149|NCT02013817|11786709|FG000|Overall Study|Death|2
7479150|NCT02013817|11786709|FG000|Overall Study|Other|9
7479151|NCT02013830|11786713|FG000|Overall Study|Adverse Event|3
7479152|NCT02013830|11786713|FG000|Overall Study|Death|1
7479153|NCT02013830|11786713|FG000|Overall Study|Insufficient therapeutic response|25
7479154|NCT02013830|11786713|FG000|Overall Study|Refused treatment|1
7479155|NCT02014116|11786734|FG000|Overall Study|Progressive Disease|3
7479156|NCT02014116|11786735|FG001|Overall Study|Progressive Disease|4
7479157|NCT02014116|11786736|FG002|Overall Study|Progressive Disease|2
7479158|NCT02014116|11786737|FG003|Overall Study|Progressive Disease|6
7479159|NCT02014116|11786738|FG004|Overall Study|Progressive Disease|1
7479160|NCT02014116|11786739|FG005|Overall Study|Progressive Disease|13
7479161|NCT02014116|11786740|FG006|Overall Study|Progressive Disease|1
7479162|NCT02014116|11786741|FG007|Overall Study|Progressive Disease|3
7479163|NCT02014116|11786742|FG008|Overall Study|Progressive Disease|7
7479164|NCT02014116|11786734|FG000|Overall Study|Adverse Event|0
7479165|NCT02014116|11786735|FG001|Overall Study|Adverse Event|0
7479166|NCT02014116|11786736|FG002|Overall Study|Adverse Event|0
7479167|NCT02014116|11786737|FG003|Overall Study|Adverse Event|0
7479168|NCT02014116|11786738|FG004|Overall Study|Adverse Event|1
7479169|NCT02014116|11786739|FG005|Overall Study|Adverse Event|0
7479170|NCT02014116|11786740|FG006|Overall Study|Adverse Event|0
7479171|NCT02014116|11786741|FG007|Overall Study|Adverse Event|1
7479172|NCT02014116|11786742|FG008|Overall Study|Adverse Event|0
7479173|NCT02014116|11786734|FG000|Overall Study|Lost to Follow-up|0
7479174|NCT02014116|11786735|FG001|Overall Study|Lost to Follow-up|0
7479175|NCT02014116|11786736|FG002|Overall Study|Lost to Follow-up|0
7479176|NCT02014116|11786737|FG003|Overall Study|Lost to Follow-up|0
7479177|NCT02014116|11786738|FG004|Overall Study|Lost to Follow-up|0
7479178|NCT02014116|11786739|FG005|Overall Study|Lost to Follow-up|1
7479179|NCT02014116|11786740|FG006|Overall Study|Lost to Follow-up|0
7479180|NCT02014116|11786741|FG007|Overall Study|Lost to Follow-up|0
7479181|NCT02014116|11786742|FG008|Overall Study|Lost to Follow-up|1
7479182|NCT02014116|11786734|FG000|Overall Study|Death|0
7479183|NCT02014116|11786735|FG001|Overall Study|Death|0
7479184|NCT02014116|11786736|FG002|Overall Study|Death|0
7479185|NCT02014116|11786737|FG003|Overall Study|Death|0
7479186|NCT02014116|11786738|FG004|Overall Study|Death|0
7479187|NCT02014116|11786739|FG005|Overall Study|Death|0
7479188|NCT02014116|11786740|FG006|Overall Study|Death|0
7479189|NCT02014116|11786741|FG007|Overall Study|Death|1
7479190|NCT02014116|11786742|FG008|Overall Study|Death|1
7479191|NCT02014116|11786734|FG000|Overall Study|Withdrawal by Subject|0
7479192|NCT02014116|11786735|FG001|Overall Study|Withdrawal by Subject|0
7479193|NCT02014116|11786736|FG002|Overall Study|Withdrawal by Subject|1
7479194|NCT02014116|11786737|FG003|Overall Study|Withdrawal by Subject|1
7479195|NCT02014116|11786738|FG004|Overall Study|Withdrawal by Subject|0
7479196|NCT02014116|11786739|FG005|Overall Study|Withdrawal by Subject|1
7479197|NCT02014116|11786740|FG006|Overall Study|Withdrawal by Subject|0
7479198|NCT02014116|11786741|FG007|Overall Study|Withdrawal by Subject|0
7479199|NCT02014116|11786742|FG008|Overall Study|Withdrawal by Subject|0
7479200|NCT02014116|11786734|FG000|Overall Study|Withdrawal Caregiver Decision|0
7479201|NCT02014116|11786735|FG001|Overall Study|Withdrawal Caregiver Decision|0
7479202|NCT02014116|11786736|FG002|Overall Study|Withdrawal Caregiver Decision|0
7479203|NCT02014116|11786737|FG003|Overall Study|Withdrawal Caregiver Decision|0
7479204|NCT02014116|11786738|FG004|Overall Study|Withdrawal Caregiver Decision|0
7479205|NCT02014116|11786739|FG005|Overall Study|Withdrawal Caregiver Decision|1
7479206|NCT02014116|11786740|FG006|Overall Study|Withdrawal Caregiver Decision|0
7479207|NCT02014116|11786741|FG007|Overall Study|Withdrawal Caregiver Decision|0
7479208|NCT02014116|11786742|FG008|Overall Study|Withdrawal Caregiver Decision|0
7479209|NCT02014116|11786734|FG000|Overall Study|Physician Decision|0
7479210|NCT02014116|11786735|FG001|Overall Study|Physician Decision|0
7479211|NCT02014116|11786736|FG002|Overall Study|Physician Decision|0
7479212|NCT02014116|11786737|FG003|Overall Study|Physician Decision|0
7479213|NCT02014116|11786738|FG004|Overall Study|Physician Decision|0
7479214|NCT02014116|11786739|FG005|Overall Study|Physician Decision|0
7479215|NCT02014116|11786740|FG006|Overall Study|Physician Decision|0
7479216|NCT02014116|11786741|FG007|Overall Study|Physician Decision|0
7479217|NCT02014116|11786742|FG008|Overall Study|Physician Decision|1
7479218|NCT02014272|11786778|FG000|Intervention Period 1|Withdrawal by Subject|1
7479219|NCT02014272|11786779|FG001|Intervention Period 1|Withdrawal by Subject|0
7479220|NCT02014272|11786778|FG000|Intervention Period 1|Adverse Event|0
7479221|NCT02014272|11786779|FG001|Intervention Period 1|Adverse Event|1
7479222|NCT02014376|11786801|FG000|Overall Study|Adverse Event|1
7479223|NCT02014376|11786802|FG001|Overall Study|Adverse Event|1
7479224|NCT02014376|11786803|FG002|Overall Study|Adverse Event|0
7479225|NCT02014376|11786801|FG000|Overall Study|Lost to Follow-up|2
7479226|NCT02014376|11786802|FG001|Overall Study|Lost to Follow-up|0
7479227|NCT02014376|11786803|FG002|Overall Study|Lost to Follow-up|0
7479228|NCT02014402|11786815|FG000|Overall Study|Adverse Event|1
7479229|NCT02014402|11786816|FG001|Overall Study|Adverse Event|0
7479230|NCT02014402|11786817|FG002|Overall Study|Adverse Event|0
7479231|NCT02014402|11786818|FG003|Overall Study|Adverse Event|0
7479232|NCT02014402|11786815|FG000|Overall Study|Withdrawal by Subject|1
7479233|NCT02014402|11786816|FG001|Overall Study|Withdrawal by Subject|2
7479234|NCT02014402|11786817|FG002|Overall Study|Withdrawal by Subject|2
7479235|NCT02014402|11786818|FG003|Overall Study|Withdrawal by Subject|1
7479236|NCT02014402|11786815|FG000|Overall Study|Subject did not have transportation|0
7479237|NCT02014402|11786816|FG001|Overall Study|Subject did not have transportation|1
7479238|NCT02014402|11786817|FG002|Overall Study|Subject did not have transportation|0
7479239|NCT02014402|11786818|FG003|Overall Study|Subject did not have transportation|0
7479240|NCT02014402|11786815|FG000|Overall Study|Lost to Follow-up|0
7479241|NCT02014402|11786816|FG001|Overall Study|Lost to Follow-up|0
7479242|NCT02014402|11786817|FG002|Overall Study|Lost to Follow-up|1
7479243|NCT02014402|11786818|FG003|Overall Study|Lost to Follow-up|2
7479244|NCT02014441|11786835|FG000|Overall Study|Withdrawal by Subject|12
7479245|NCT02014467|11786843|FG000|Overall Study|Adverse Event|4
7479246|NCT02014467|11786844|FG001|Overall Study|Adverse Event|0
7479247|NCT02014467|11786843|FG000|Overall Study|Protocol Violation|3
7479248|NCT02014467|11786844|FG001|Overall Study|Protocol Violation|0
7479249|NCT02014467|11786843|FG000|Overall Study|Physician Decision|2
7479250|NCT02014467|11786844|FG001|Overall Study|Physician Decision|3
7479251|NCT02014467|11786843|FG000|Overall Study|Withdrawal by Subject|16
7479252|NCT02014467|11786844|FG001|Overall Study|Withdrawal by Subject|4
7479253|NCT02014480|11786850|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7479254|NCT02014480|11786851|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7479255|NCT02014480|11786852|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
7479256|NCT02014480|11786853|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7479257|NCT02014480|11786854|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7479258|NCT02014480|11786855|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
7479259|NCT02014480|11786850|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7479260|NCT02014480|11786851|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7479261|NCT02014480|11786852|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7479262|NCT02014480|11786853|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7479263|NCT02014480|11786854|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7479264|NCT02014480|11786855|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7479265|NCT02014480|11786850|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7479266|NCT02014480|11786851|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7479267|NCT02014480|11786852|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7479268|NCT02014480|11786853|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7479269|NCT02014480|11786854|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7479270|NCT02014480|11786855|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7479271|NCT02014480|11786850|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
7479272|NCT02014480|11786851|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
7479273|NCT02014480|11786852|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
7479274|NCT02014480|11786853|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
7479275|NCT02014480|11786854|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
7479276|NCT02014480|11786855|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7479277|NCT02014480|11786850|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7479278|NCT02014480|11786851|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7479279|NCT02014480|11786852|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7479280|NCT02014480|11786853|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7479281|NCT02014480|11786854|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7479282|NCT02014480|11786855|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7479283|NCT02014480|11786850|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
7479284|NCT02014480|11786851|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
7479285|NCT02014480|11786852|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
7479286|NCT02014480|11786853|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
7479287|NCT02014480|11786854|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
7479288|NCT02014480|11786855|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
7479289|NCT02014480|11786850|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7479290|NCT02014480|11786851|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7479291|NCT02014480|11786852|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7479292|NCT02014480|11786853|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7479293|NCT02014480|11786854|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7479294|NCT02014480|11786855|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
7479295|NCT02014584|11786877|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
7479296|NCT02014584|11786878|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
7479297|NCT02014584|11786879|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
7479298|NCT02014584|11786880|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
7479299|NCT02014584|11786881|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
7479300|NCT02014584|11786882|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
7479301|NCT02014584|11786877|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
7479302|NCT02014584|11786878|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
7479303|NCT02014584|11786879|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7479304|NCT02014584|11786880|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7479305|NCT02014584|11786881|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7479306|NCT02014584|11786882|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
7479307|NCT02014584|11786877|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7479308|NCT02014584|11786878|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7479309|NCT02014584|11786879|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
7479310|NCT02014584|11786880|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7479311|NCT02014584|11786881|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7479312|NCT02014584|11786882|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
7479313|NCT02014584|11786877|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7479314|NCT02014584|11786878|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7479315|NCT02014584|11786879|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
7479316|NCT02014584|11786880|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
7479317|NCT02014584|11786881|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7479318|NCT02014584|11786882|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
7479319|NCT02014584|11786877|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7479320|NCT02014584|11786878|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7479321|NCT02014584|11786879|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7479322|NCT02014584|11786880|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7479323|NCT02014584|11786881|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
7479324|NCT02014584|11786882|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
7479325|NCT02014597|11786896|FG000|Overall Study|Unable to record log contrast sensitivity|2
7479326|NCT02014597|11786897|FG001|Overall Study|Unable to record log contrast sensitivity|1
7479327|NCT02014740|11786905|FG000|Overall Study|Lost to Follow-up|4
7479328|NCT02014740|11786906|FG001|Overall Study|Lost to Follow-up|4
7479329|NCT02014740|11786905|FG000|Overall Study|Withdrawal by Subject|2
7479330|NCT02014740|11786906|FG001|Overall Study|Withdrawal by Subject|1
7479331|NCT02015039|11786914|FG000|Overall Study|Not eligible|0
7479332|NCT02015039|11786915|FG001|Overall Study|Not eligible|1
7479333|NCT02015065|11786924|FG000|Overall Study|Death on study|1
7479334|NCT02015065|11786925|FG001|Overall Study|Death on study|2
7479335|NCT02015065|11786926|FG002|Overall Study|Death on study|1
7479336|NCT02015104|11786936|FG000|Overall Study|Withdrew consent after first dose drug|1
7479337|NCT02015104|11786937|FG001|Overall Study|Withdrew consent after first dose drug|0
7479338|NCT02015104|11786936|FG000|Overall Study|Withdrew consent prior to treatment|0
7479339|NCT02015104|11786937|FG001|Overall Study|Withdrew consent prior to treatment|1
7479340|NCT02015195|11786953|FG000|Overall Study|Adverse Event|0
7479341|NCT02015195|11786954|FG001|Overall Study|Adverse Event|0
7479342|NCT02015195|11786955|FG002|Overall Study|Adverse Event|0
7479343|NCT02015195|11786956|FG003|Overall Study|Adverse Event|1
7479344|NCT02015195|11786957|FG004|Overall Study|Adverse Event|0
7479345|NCT02015195|11786958|FG005|Overall Study|Adverse Event|0
7479346|NCT02015195|11786959|FG006|Overall Study|Adverse Event|0
7479347|NCT02015221|11786976|FG000|Overall Study|Withdrawal by Subject|8
7479348|NCT02015221|11786977|FG001|Overall Study|Withdrawal by Subject|6
7479349|NCT02015221|11786976|FG000|Overall Study|Lost to Follow-up|1
7479350|NCT02015221|11786977|FG001|Overall Study|Lost to Follow-up|0
7534467|NCT02697773|11881331|FG002|Overall Study|Lost to Follow-up|7
7534468|NCT02697773|11881329|FG000|Overall Study|Other|15
7534469|NCT02697773|11881330|FG001|Overall Study|Other|11
7534470|NCT02697773|11881331|FG002|Overall Study|Other|10
7534471|NCT02697773|11881329|FG000|Overall Study|Protocol Violation|1
7534472|NCT02697773|11881330|FG001|Overall Study|Protocol Violation|1
7534473|NCT02697773|11881331|FG002|Overall Study|Protocol Violation|0
7534474|NCT02697773|11881329|FG000|Overall Study|Withdrawal by Subject|10
7534475|NCT02697773|11881330|FG001|Overall Study|Withdrawal by Subject|13
7534476|NCT02697773|11881331|FG002|Overall Study|Withdrawal by Subject|13
7534477|NCT02697773|11881329|FG000|Overall Study|Randomized but not treated|1
7534478|NCT02697773|11881330|FG001|Overall Study|Randomized but not treated|1
7534479|NCT02697773|11881331|FG002|Overall Study|Randomized but not treated|0
7534480|NCT02697916|11881350|FG000|Overall Study|Death|357
7534481|NCT02697916|11881351|FG001|Overall Study|Death|315
7534482|NCT02697916|11881350|FG000|Overall Study|Withdrawal by Subject|221
7534483|NCT02697916|11881351|FG001|Overall Study|Withdrawal by Subject|393
7534484|NCT02698176|11881364|FG000|Overall Study|Progressive disease|4
7534485|NCT02698176|11881365|FG001|Overall Study|Progressive disease|3
7534486|NCT02698176|11881366|FG002|Overall Study|Progressive disease|1
7534487|NCT02698176|11881367|FG003|Overall Study|Progressive disease|0
7534488|NCT02698176|11881364|FG000|Overall Study|Adverse Event|2
7534489|NCT02698176|11881365|FG001|Overall Study|Adverse Event|0
7534490|NCT02698176|11881366|FG002|Overall Study|Adverse Event|0
7534491|NCT02698176|11881367|FG003|Overall Study|Adverse Event|0
7534492|NCT02698176|11881364|FG000|Overall Study|Clinical progression|3
7534493|NCT02698176|11881365|FG001|Overall Study|Clinical progression|0
7534494|NCT02698176|11881366|FG002|Overall Study|Clinical progression|0
7534495|NCT02698176|11881367|FG003|Overall Study|Clinical progression|0
7534500|NCT02698241|11881398|FG000|Overall Study|Inclusion/exclusion criteria not met|4
7534501|NCT02698241|11881398|FG000|Overall Study|Screening not met|7
7534502|NCT02698241|11881398|FG000|Overall Study|Withdrawal by Subject|7
7534503|NCT02698241|11881398|FG000|Overall Study|Physician Decision|2
7534504|NCT02698241|11881398|FG000|Overall Study|Subject underwent system modification|2
7534505|NCT02698241|11881398|FG000|Overall Study|Lost to Follow-up|3
7534506|NCT02698241|11881398|FG000|Overall Study|Subject on inodrip not safe to continue|6
7534507|NCT02698241|11881398|FG000|Overall Study|geographic and licensing issue|1
7534508|NCT02698241|11881398|FG000|Overall Study|Death|2
7534509|NCT02698371|11881402|FG000|All Participants Flow|Lost to Follow-up|3
7534510|NCT02698371|11881402|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
7534511|NCT02698371|11881402|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
7534512|NCT02698371|11881402|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
7534513|NCT02698371|11881402|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
7534514|NCT02698371|11881402|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
7534515|NCT02698371|11881402|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
7534516|NCT02698410|11881418|FG000|Overall Study|Adverse Event|2
7479351|NCT02015390|11786996|FG000|Overall Study|Lost to Follow-up|1
7479352|NCT02015390|11786997|FG001|Overall Study|Lost to Follow-up|0
7479353|NCT02015390|11786996|FG000|Overall Study|Adverse Event|0
7479354|NCT02015390|11786997|FG001|Overall Study|Adverse Event|3
7479355|NCT02015390|11786996|FG000|Overall Study|Physician Decision|0
7479356|NCT02015390|11786997|FG001|Overall Study|Physician Decision|1
7479357|NCT02015481|11787011|FG000|Overall Study|Death|1
7479358|NCT02015520|11787020|FG000|Overall Study|Lack of Efficacy|1
7479359|NCT02015520|11787021|FG001|Overall Study|Lack of Efficacy|0
7479360|NCT02015520|11787022|FG002|Overall Study|Lack of Efficacy|3
7479361|NCT02015520|11787023|FG003|Overall Study|Lack of Efficacy|2
7479362|NCT02015520|11787020|FG000|Overall Study|Adverse Event|0
7479363|NCT02015520|11787021|FG001|Overall Study|Adverse Event|0
7479364|NCT02015520|11787022|FG002|Overall Study|Adverse Event|0
7479365|NCT02015520|11787023|FG003|Overall Study|Adverse Event|1
7479366|NCT02015520|11787020|FG000|Overall Study|Withdrawal by Subject|2
7479367|NCT02015520|11787021|FG001|Overall Study|Withdrawal by Subject|2
7479368|NCT02015520|11787022|FG002|Overall Study|Withdrawal by Subject|1
7479369|NCT02015520|11787023|FG003|Overall Study|Withdrawal by Subject|0
7479370|NCT02015520|11787020|FG000|Overall Study|Death|1
7479371|NCT02015520|11787021|FG001|Overall Study|Death|0
7479372|NCT02015520|11787022|FG002|Overall Study|Death|0
7479373|NCT02015520|11787023|FG003|Overall Study|Death|0
7479374|NCT02015520|11787020|FG000|Overall Study|Lost to Follow-up|0
7479375|NCT02015520|11787021|FG001|Overall Study|Lost to Follow-up|0
7479376|NCT02015520|11787022|FG002|Overall Study|Lost to Follow-up|1
7479377|NCT02015520|11787023|FG003|Overall Study|Lost to Follow-up|0
7479378|NCT02015520|11787020|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
7479379|NCT02015520|11787021|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
7479380|NCT02015520|11787022|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
7479381|NCT02015520|11787023|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
7479382|NCT02015520|11787020|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
7479383|NCT02015520|11787021|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
7479384|NCT02015520|11787022|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
7479385|NCT02015520|11787023|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
7479386|NCT02015546|11787036|FG000|Overall Study|Withdrawal by Subject|1
7479387|NCT02015546|11787037|FG001|Overall Study|Withdrawal by Subject|1
7479388|NCT02015546|11787038|FG002|Overall Study|Withdrawal by Subject|1
7479389|NCT02015546|11787036|FG000|Overall Study|Screem Failure|2
7479390|NCT02015546|11787037|FG001|Overall Study|Screem Failure|1
7479391|NCT02015546|11787038|FG002|Overall Study|Screem Failure|3
7479392|NCT02015637|11787048|FG000|Overall Study|Lost to Follow-up|3
7479393|NCT02015637|11787049|FG001|Overall Study|Lost to Follow-up|5
7479394|NCT02015637|11787048|FG000|Overall Study|Adverse Event|3
7479395|NCT02015637|11787049|FG001|Overall Study|Adverse Event|0
7479396|NCT02015637|11787048|FG000|Overall Study|Did not take study drug|2
7479397|NCT02015637|11787049|FG001|Overall Study|Did not take study drug|0
7479398|NCT02015676|11787058|FG000|Overall Study|Adverse Event|2
7479399|NCT02015676|11787059|FG001|Overall Study|Adverse Event|18
7479400|NCT02015676|11787060|FG002|Overall Study|Adverse Event|0
7479401|NCT02015676|11787058|FG000|Overall Study|Lack of Efficacy|2
7479402|NCT02015676|11787059|FG001|Overall Study|Lack of Efficacy|4
7479403|NCT02015676|11787060|FG002|Overall Study|Lack of Efficacy|0
7479404|NCT02015676|11787058|FG000|Overall Study|Protocol Violation|1
7479405|NCT02015676|11787059|FG001|Overall Study|Protocol Violation|0
7479406|NCT02015676|11787060|FG002|Overall Study|Protocol Violation|0
7479407|NCT02015676|11787058|FG000|Overall Study|Withdrawal by Subject|1
7479408|NCT02015676|11787059|FG001|Overall Study|Withdrawal by Subject|7
7479409|NCT02015676|11787060|FG002|Overall Study|Withdrawal by Subject|1
7479410|NCT02015676|11787058|FG000|Overall Study|Administrative reasons|0
7479411|NCT02015676|11787059|FG001|Overall Study|Administrative reasons|3
7479412|NCT02015676|11787060|FG002|Overall Study|Administrative reasons|1
7479413|NCT02015676|11787058|FG000|Overall Study|Death|0
7479414|NCT02015676|11787059|FG001|Overall Study|Death|1
7479415|NCT02015676|11787060|FG002|Overall Study|Death|0
7479416|NCT02015676|11787058|FG000|Overall Study|Disease progression|3
7479417|NCT02015676|11787059|FG001|Overall Study|Disease progression|1
7479418|NCT02015676|11787060|FG002|Overall Study|Disease progression|1
7479419|NCT02015754|11787064|FG000|Overall Study|Disease progression|5
7479420|NCT02015754|11787064|FG000|Overall Study|Change in treatment modality|5
7479421|NCT02015754|11787064|FG000|Overall Study|Lost to Follow-up|1
7479422|NCT02015793|11787070|FG000|Overall Study|Adverse Event|3
7479423|NCT02015793|11787071|FG001|Overall Study|Adverse Event|3
7479424|NCT02015793|11787070|FG000|Overall Study|Withdrawal by Subject|1
7479425|NCT02015793|11787071|FG001|Overall Study|Withdrawal by Subject|1
7479426|NCT02015819|11787087|FG000|Overall Study|Rickham catheter was misaligned|0
7479427|NCT02015819|11787088|FG001|Overall Study|Rickham catheter was misaligned|0
7479428|NCT02015819|11787089|FG002|Overall Study|Rickham catheter was misaligned|0
7479429|NCT02015819|11787090|FG003|Overall Study|Rickham catheter was misaligned|1
7479430|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Protocol Violation|2
7479431|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Protocol Violation|8
7479432|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Protocol Violation|0
7479433|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Protocol Violation|0
7479434|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Protocol Violation|0
7479435|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Protocol Violation|0
7479436|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Physician Decision|0
7479437|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Physician Decision|2
7479438|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Physician Decision|0
7479439|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Physician Decision|0
7479440|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Physician Decision|0
7479441|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Physician Decision|0
7479442|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
7479443|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
7479444|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
7479445|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
7479446|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
7479447|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
7479448|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Pregnancy|0
7479449|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Pregnancy|1
7479450|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Pregnancy|0
7479451|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Pregnancy|0
7479452|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Pregnancy|0
7479453|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Pregnancy|0
7479454|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Adverse Event|3
7479455|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Adverse Event|5
7479456|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Adverse Event|0
7479457|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Adverse Event|0
7479458|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Adverse Event|0
7479459|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Adverse Event|0
7479460|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
7479461|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
7479462|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
7479463|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
7479464|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
7479465|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
7479466|NCT02016105|11787106|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
7479467|NCT02016105|11787107|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
7479468|NCT02016105|11787108|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
7479469|NCT02016105|11787109|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
7479470|NCT02016105|11787110|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
7479471|NCT02016105|11787111|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
7479472|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
7479473|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
7479474|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
7479475|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
7479476|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
7479477|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
7479478|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
7479479|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
7479480|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
7479481|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
7479482|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
7479483|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
7479484|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Pregnancy|0
7479485|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Pregnancy|0
7479486|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Pregnancy|0
7479487|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Pregnancy|0
7479488|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Pregnancy|0
7479489|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Pregnancy|1
7479490|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Death|0
7479491|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Death|0
7479492|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Death|0
7479493|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Death|0
7479494|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Death|0
7479495|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Death|1
7479496|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Adverse Event|0
7479497|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Adverse Event|0
7479498|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Adverse Event|0
7479499|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Adverse Event|4
7479500|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Adverse Event|0
7479501|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Adverse Event|1
7479502|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
7479503|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
7479504|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
7479505|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
7479506|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
7479507|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
7479508|NCT02016105|11787106|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
7479509|NCT02016105|11787107|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
7479510|NCT02016105|11787108|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
7479511|NCT02016105|11787109|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
7479512|NCT02016105|11787110|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
7479513|NCT02016105|11787111|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
7479514|NCT02016105|11787106|FG000|EXTENSION PERIOD|New therapy for study indication|0
7479515|NCT02016105|11787107|FG001|EXTENSION PERIOD|New therapy for study indication|0
7479516|NCT02016105|11787108|FG002|EXTENSION PERIOD|New therapy for study indication|0
7479517|NCT02016105|11787109|FG003|EXTENSION PERIOD|New therapy for study indication|0
7479518|NCT02016105|11787110|FG004|EXTENSION PERIOD|New therapy for study indication|1
7479519|NCT02016105|11787111|FG005|EXTENSION PERIOD|New therapy for study indication|1
7479520|NCT02016105|11787106|FG000|EXTENSION PERIOD|Lack of Efficacy|0
7479521|NCT02016105|11787107|FG001|EXTENSION PERIOD|Lack of Efficacy|0
7479522|NCT02016105|11787108|FG002|EXTENSION PERIOD|Lack of Efficacy|1
7479523|NCT02016105|11787109|FG003|EXTENSION PERIOD|Lack of Efficacy|3
7479524|NCT02016105|11787110|FG004|EXTENSION PERIOD|Lack of Efficacy|1
7479525|NCT02016105|11787111|FG005|EXTENSION PERIOD|Lack of Efficacy|1
7479526|NCT02016105|11787106|FG000|EXTENSION PERIOD|Adverse Event|0
7479527|NCT02016105|11787107|FG001|EXTENSION PERIOD|Adverse Event|0
7479528|NCT02016105|11787108|FG002|EXTENSION PERIOD|Adverse Event|2
7479529|NCT02016105|11787109|FG003|EXTENSION PERIOD|Adverse Event|0
7479530|NCT02016105|11787110|FG004|EXTENSION PERIOD|Adverse Event|1
7479531|NCT02016105|11787111|FG005|EXTENSION PERIOD|Adverse Event|0
7479532|NCT02016105|11787106|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
7479533|NCT02016105|11787107|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
7479534|NCT02016105|11787108|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
7479535|NCT02016105|11787109|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
7479536|NCT02016105|11787110|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
7479537|NCT02016105|11787111|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
7479538|NCT02016105|11787106|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
7479539|NCT02016105|11787107|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
7479540|NCT02016105|11787108|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
7479541|NCT02016105|11787109|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
7479542|NCT02016105|11787110|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
7479543|NCT02016105|11787111|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
7479544|NCT02016105|11787106|FG000|EXTENSION PERIOD|Lost to Follow-up|0
7479545|NCT02016105|11787107|FG001|EXTENSION PERIOD|Lost to Follow-up|0
7479546|NCT02016105|11787108|FG002|EXTENSION PERIOD|Lost to Follow-up|0
7479547|NCT02016105|11787109|FG003|EXTENSION PERIOD|Lost to Follow-up|0
7479548|NCT02016105|11787110|FG004|EXTENSION PERIOD|Lost to Follow-up|0
7479549|NCT02016105|11787111|FG005|EXTENSION PERIOD|Lost to Follow-up|2
7479550|NCT02016170|11787128|FG000|Overall Study|Adverse Event|1
7479551|NCT02016170|11787129|FG001|Overall Study|Adverse Event|1
7479552|NCT02016170|11787130|FG002|Overall Study|Adverse Event|0
7479553|NCT02016170|11787128|FG000|Overall Study|Protocol Violation|1
7479554|NCT02016170|11787129|FG001|Overall Study|Protocol Violation|0
7479555|NCT02016170|11787130|FG002|Overall Study|Protocol Violation|0
7479556|NCT02016183|11787137|FG000|Overall Study|Case Report Forms Uncollected|13
7479557|NCT02016183|11787137|FG000|Overall Study|Protocol Violation|52
7479558|NCT02016300|11787156|FG000|Overall Study|Lost to Follow-up|0
7479559|NCT02016300|11787157|FG001|Overall Study|Lost to Follow-up|3
7479560|NCT02016482|11787165|FG000|Period A|Adverse Event|3
7479561|NCT02016482|11787166|FG001|Period A|Adverse Event|5
7479562|NCT02016482|11787165|FG000|Period A|Withdrawal by Subject|3
7479563|NCT02016482|11787166|FG001|Period A|Withdrawal by Subject|4
7479564|NCT02016482|11787165|FG000|Period A|Lost to Follow-up|3
7479565|NCT02016482|11787166|FG001|Period A|Lost to Follow-up|3
7479566|NCT02016482|11787165|FG000|Period A|Lack of Efficacy|2
7479567|NCT02016482|11787166|FG001|Period A|Lack of Efficacy|1
7479568|NCT02016482|11787165|FG000|Period A|Other|3
7479569|NCT02016482|11787166|FG001|Period A|Other|0
7479570|NCT02016482|11787165|FG000|Period A|Protocol Violation|0
7479571|NCT02016482|11787166|FG001|Period A|Protocol Violation|1
7479572|NCT02016482|11787165|FG000|Period A|Required Alternative/Prohibited Therapy|0
7479573|NCT02016482|11787166|FG001|Period A|Required Alternative/Prohibited Therapy|1
7479574|NCT02016482|11787165|FG000|Period B|Withdrawal by Subject|1
7479575|NCT02016482|11787166|FG001|Period B|Withdrawal by Subject|1
7479576|NCT02016482|11787165|FG000|Period B|Lost to Follow-up|2
7479577|NCT02016482|11787166|FG001|Period B|Lost to Follow-up|0
7479578|NCT02016482|11787165|FG000|Period B|Lack of Efficacy|6
7479579|NCT02016482|11787166|FG001|Period B|Lack of Efficacy|4
7479580|NCT02016482|11787165|FG000|Period B|Other|4
7479581|NCT02016482|11787166|FG001|Period B|Other|0
7479582|NCT02016482|11787165|FG000|Period B|Required Alternative/Prohibited Therapy|0
7479583|NCT02016482|11787166|FG001|Period B|Required Alternative/Prohibited Therapy|2
7479584|NCT02016625|11787226|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
7479585|NCT02016625|11787227|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
7479586|NCT02016625|11787226|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
7479587|NCT02016625|11787227|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
7479588|NCT02016625|11787226|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
7479589|NCT02016625|11787227|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
7479590|NCT02016690|11787243|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
7479591|NCT02016690|11787243|FG000|Overall Study|Excluded from SAS: Duplication|2
7479592|NCT02016690|11787243|FG000|Overall Study|Excluded from SAS: Early treatment|2
7479593|NCT02016690|11787243|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
7479594|NCT02016690|11787243|FG000|Overall Study|Did not meet inclusion criteria|13
7479595|NCT02016690|11787243|FG000|Overall Study|Hospitalized for RSV at study start|3
7479596|NCT02016716|11787250|FG000|Overall Study|Withdrawal by Subject|5
7479597|NCT02016716|11787251|FG001|Overall Study|Withdrawal by Subject|5
7479598|NCT02016716|11787252|FG002|Overall Study|Withdrawal by Subject|5
7479599|NCT02016716|11787250|FG000|Overall Study|Protocol-specified Criteria|0
7479600|NCT02016716|11787251|FG001|Overall Study|Protocol-specified Criteria|1
7479601|NCT02016716|11787252|FG002|Overall Study|Protocol-specified Criteria|0
7479602|NCT02016716|11787250|FG000|Overall Study|Lost to Follow-up|1
7479603|NCT02016716|11787251|FG001|Overall Study|Lost to Follow-up|2
7479604|NCT02016716|11787252|FG002|Overall Study|Lost to Follow-up|1
7479605|NCT02016755|11787261|FG000|Overall Study|Major amputation of index limb|2
7479606|NCT02016755|11787261|FG000|Overall Study|Adverse Event|2
7479607|NCT02016755|11787261|FG000|Overall Study|Physician Decision|1
7479608|NCT02016755|11787261|FG000|Overall Study|Death|2
7479609|NCT02016898|11787288|FG000|Overall Study|Death|1
7479610|NCT02016898|11787289|FG001|Overall Study|Death|1
7479611|NCT02016898|11787288|FG000|Overall Study|Lost to Follow-up|4
7479612|NCT02016898|11787289|FG001|Overall Study|Lost to Follow-up|4
7479613|NCT02017015|11787300|FG000|Overall Study|Adverse Event|9
7479614|NCT02017015|11787300|FG000|Overall Study|Withdrawal by Subject|21
7479615|NCT02017015|11787300|FG000|Overall Study|Death|4
7479616|NCT02017015|11787300|FG000|Overall Study|Progressive Disease|31
7479617|NCT02017015|11787300|FG000|Overall Study|Non-compliance with study drug|2
7479618|NCT02017015|11787300|FG000|Overall Study|Physician Decision|2
7479619|NCT02017171|11787318|FG000|Overall Study|Death|10
7479620|NCT02017171|11787319|FG001|Overall Study|Death|4
7413059|NCT01422876|11685202|FG003|Week 24|Lost to Follow-up|4
7413060|NCT01422876|11685203|FG004|Week 24|Lost to Follow-up|2
7413061|NCT01422876|11685204|FG005|Week 24|Lost to Follow-up|0
7413062|NCT01422876|11685205|FG006|Week 24|Lost to Follow-up|1
7413063|NCT01422876|11685206|FG007|Week 24|Lost to Follow-up|3
7413064|NCT01422876|11685207|FG008|Week 24|Lost to Follow-up|3
7413065|NCT01422876|11685208|FG009|Week 24|Lost to Follow-up|4
7413066|NCT01422876|11685199|FG000|Week 24|Consent withdrawn|5
7413067|NCT01422876|11685200|FG001|Week 24|Consent withdrawn|1
7413068|NCT01422876|11685201|FG002|Week 24|Consent withdrawn|3
7413069|NCT01422876|11685202|FG003|Week 24|Consent withdrawn|4
7413070|NCT01422876|11685203|FG004|Week 24|Consent withdrawn|5
7413071|NCT01422876|11685204|FG005|Week 24|Consent withdrawn|6
7479621|NCT02017171|11787318|FG000|Overall Study|Withdrawal by Subject|23
7479622|NCT02017171|11787319|FG001|Overall Study|Withdrawal by Subject|17
7479623|NCT02017171|11787318|FG000|Overall Study|Lost to Follow-up|21
7479624|NCT02017171|11787319|FG001|Overall Study|Lost to Follow-up|20
7479625|NCT02017171|11787318|FG000|Overall Study|ESKD|6
7479626|NCT02017171|11787319|FG001|Overall Study|ESKD|2
7479627|NCT02017171|11787318|FG000|Overall Study|Miscellaneous|2
7479628|NCT02017171|11787319|FG001|Overall Study|Miscellaneous|3
7479629|NCT02017223|11787342|FG000|Overall Study|Algorithm problems|2
7479630|NCT02017444|11787361|FG000|Overall Study|Physician Decision|1
7479631|NCT02017444|11787362|FG001|Overall Study|Physician Decision|0
7479632|NCT02017444|11787361|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
7479633|NCT02017444|11787362|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
7479634|NCT02017535|11787372|FG000|Overall Study|Withdrawal by Subject|1
7479635|NCT02017535|11787373|FG001|Overall Study|Withdrawal by Subject|0
7479636|NCT02017535|11787374|FG002|Overall Study|Withdrawal by Subject|0
7479637|NCT02017535|11787375|FG003|Overall Study|Withdrawal by Subject|0
7479638|NCT02017860|11787394|FG000|Overall Study|Adverse Event|1
7479639|NCT02017860|11787394|FG000|Overall Study|Withdrawal by Subject|1
7479640|NCT02017899|11787404|FG000|Overall Study|Withdrawal by Subject|0
7479641|NCT02017899|11787405|FG001|Overall Study|Withdrawal by Subject|0
7479642|NCT02017899|11787406|FG002|Overall Study|Withdrawal by Subject|0
7479643|NCT02017899|11787407|FG003|Overall Study|Withdrawal by Subject|1
7479644|NCT02017899|11787408|FG004|Overall Study|Withdrawal by Subject|1
7479645|NCT02017899|11787409|FG005|Overall Study|Withdrawal by Subject|0
7479646|NCT02018042|11787423|FG000|Overall Study|Withdrawal by Subject|1
7479647|NCT02018458|11787442|FG000|Overall Study|Death|4
7479648|NCT02018562|11787448|FG000|Overall Study|Withdrawal by Subject|2
7479649|NCT02018562|11787449|FG001|Overall Study|Withdrawal by Subject|0
7479650|NCT02018562|11787448|FG000|Overall Study|Discharged prior to study completion|1
7479651|NCT02018562|11787449|FG001|Overall Study|Discharged prior to study completion|0
7479652|NCT02018822|11787492|FG000|Overall Study|filling replaced by crown|0
7479653|NCT02018822|11787493|FG001|Overall Study|filling replaced by crown|1
7479654|NCT02018822|11787494|FG002|Overall Study|filling replaced by crown|0
7479655|NCT02018822|11787492|FG000|Overall Study|Physician Decision|0
7479656|NCT02018822|11787493|FG001|Overall Study|Physician Decision|1
7479657|NCT02018822|11787494|FG002|Overall Study|Physician Decision|1
7479658|NCT02018822|11787492|FG000|Overall Study|Lost to Follow-up|6
7479659|NCT02018822|11787493|FG001|Overall Study|Lost to Follow-up|6
7479660|NCT02018822|11787494|FG002|Overall Study|Lost to Follow-up|5
7479661|NCT02018887|11787513|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
7479662|NCT02018887|11787514|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479663|NCT02018887|11787515|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479664|NCT02018887|11787516|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7413072|NCT01422876|11685205|FG006|Week 24|Consent withdrawn|5
7413073|NCT01422876|11685206|FG007|Week 24|Consent withdrawn|4
7479665|NCT02018887|11787517|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479666|NCT02018887|11787518|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479667|NCT02018887|11787519|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479668|NCT02018887|11787520|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479669|NCT02018887|11787521|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479670|NCT02018887|11787522|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479671|NCT02018887|11787523|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
7479672|NCT02018887|11787513|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479673|NCT02018887|11787514|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479674|NCT02018887|11787515|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479675|NCT02018887|11787516|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479676|NCT02018887|11787517|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
7479677|NCT02018887|11787518|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479678|NCT02018887|11787519|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
7479679|NCT02018887|11787520|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
7479680|NCT02018887|11787521|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479681|NCT02018887|11787522|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479682|NCT02018887|11787523|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
7479683|NCT02018887|11787513|FG000|Part C: Cohort 8 Overall|Adverse Event|0
7479684|NCT02018887|11787514|FG001|Part C: Cohort 8 Overall|Adverse Event|0
7479685|NCT02018887|11787515|FG002|Part C: Cohort 8 Overall|Adverse Event|0
7479686|NCT02018887|11787516|FG003|Part C: Cohort 8 Overall|Adverse Event|0
7479687|NCT02018887|11787517|FG004|Part C: Cohort 8 Overall|Adverse Event|0
7479688|NCT02018887|11787518|FG005|Part C: Cohort 8 Overall|Adverse Event|0
7479689|NCT02018887|11787519|FG006|Part C: Cohort 8 Overall|Adverse Event|0
7479690|NCT02018887|11787520|FG007|Part C: Cohort 8 Overall|Adverse Event|0
7479691|NCT02018887|11787521|FG008|Part C: Cohort 8 Overall|Adverse Event|1
7479692|NCT02018887|11787522|FG009|Part C: Cohort 8 Overall|Adverse Event|3
7479693|NCT02018887|11787523|FG010|Part C: Cohort 8 Overall|Adverse Event|0
7479694|NCT02018887|11787513|FG000|Part C: Cohort 8 Overall|Physician Decision|0
7479695|NCT02018887|11787514|FG001|Part C: Cohort 8 Overall|Physician Decision|0
7479696|NCT02018887|11787515|FG002|Part C: Cohort 8 Overall|Physician Decision|0
7479697|NCT02018887|11787516|FG003|Part C: Cohort 8 Overall|Physician Decision|0
7479698|NCT02018887|11787517|FG004|Part C: Cohort 8 Overall|Physician Decision|0
7479699|NCT02018887|11787518|FG005|Part C: Cohort 8 Overall|Physician Decision|0
7479700|NCT02018887|11787519|FG006|Part C: Cohort 8 Overall|Physician Decision|0
7479701|NCT02018887|11787520|FG007|Part C: Cohort 8 Overall|Physician Decision|0
7479702|NCT02018887|11787521|FG008|Part C: Cohort 8 Overall|Physician Decision|2
7479703|NCT02018887|11787522|FG009|Part C: Cohort 8 Overall|Physician Decision|0
7479704|NCT02018887|11787523|FG010|Part C: Cohort 8 Overall|Physician Decision|1
7479705|NCT02019108|11787595|FG000|Overall Study|Lost to Follow-up|5
7479706|NCT02019108|11787596|FG001|Overall Study|Lost to Follow-up|7
7479707|NCT02019264|11787604|FG000|Overall Study|Not treated|6
7479708|NCT02019264|11787605|FG001|Overall Study|Not treated|4
7479709|NCT02019264|11787604|FG000|Overall Study|Lost to Follow-up|50
7479710|NCT02019264|11787605|FG001|Overall Study|Lost to Follow-up|47
7479711|NCT02019264|11787604|FG000|Overall Study|Withdrawal by Subject|142
7479712|NCT02019264|11787605|FG001|Overall Study|Withdrawal by Subject|117
7479713|NCT02019264|11787604|FG000|Overall Study|Administrative reason|36
7479714|NCT02019264|11787605|FG001|Overall Study|Administrative reason|28
7479715|NCT02019264|11787604|FG000|Overall Study|Missing|14
7479716|NCT02019264|11787605|FG001|Overall Study|Missing|11
7479717|NCT02019277|11787611|FG000|Overall Study|Withdrawal by Subject|3
7479718|NCT02019277|11787611|FG000|Overall Study|Death|7
7479719|NCT02019277|11787611|FG000|Overall Study|Did no Cooperate|1
7479720|NCT02019277|11787611|FG000|Overall Study|Adverse Event|1
7479721|NCT02019420|11787617|FG000|Overall Study|Did not receive study drug|2
7479722|NCT02019420|11787618|FG001|Overall Study|Did not receive study drug|2
7479723|NCT02019420|11787617|FG000|Overall Study|Withdrawal by Subject|1
7479724|NCT02019420|11787618|FG001|Overall Study|Withdrawal by Subject|3
7479725|NCT02019420|11787617|FG000|Overall Study|At request of sponsor or investigator|0
7479726|NCT02019420|11787618|FG001|Overall Study|At request of sponsor or investigator|1
7479727|NCT02019420|11787617|FG000|Overall Study|Death|104
7479728|NCT02019420|11787618|FG001|Overall Study|Death|99
7479729|NCT02019420|11787617|FG000|Overall Study|Transferred to other care facility|1
7479730|NCT02019420|11787618|FG001|Overall Study|Transferred to other care facility|1
7479731|NCT02019472|11787627|FG000|Overall Study|Adverse Event|14
7479732|NCT02019472|11787628|FG001|Overall Study|Adverse Event|23
7479733|NCT02019472|11787629|FG002|Overall Study|Adverse Event|17
7479734|NCT02019472|11787627|FG000|Overall Study|Death|0
7479735|NCT02019472|11787628|FG001|Overall Study|Death|1
7479736|NCT02019472|11787629|FG002|Overall Study|Death|1
7479737|NCT02019472|11787627|FG000|Overall Study|Lack of Efficacy|7
7479738|NCT02019472|11787628|FG001|Overall Study|Lack of Efficacy|4
7479739|NCT02019472|11787629|FG002|Overall Study|Lack of Efficacy|4
7479740|NCT02019472|11787627|FG000|Overall Study|Lost to Follow-up|0
7479741|NCT02019472|11787628|FG001|Overall Study|Lost to Follow-up|2
7479742|NCT02019472|11787629|FG002|Overall Study|Lost to Follow-up|1
7479743|NCT02019472|11787627|FG000|Overall Study|Physician Decision|1
7479744|NCT02019472|11787628|FG001|Overall Study|Physician Decision|2
7479745|NCT02019472|11787629|FG002|Overall Study|Physician Decision|0
7479746|NCT02019472|11787627|FG000|Overall Study|Pregnancy|1
7479747|NCT02019472|11787628|FG001|Overall Study|Pregnancy|2
7479748|NCT02019472|11787629|FG002|Overall Study|Pregnancy|2
7479749|NCT02019472|11787627|FG000|Overall Study|Withdrawal by Subject|11
7479750|NCT02019472|11787628|FG001|Overall Study|Withdrawal by Subject|10
7479751|NCT02019472|11787629|FG002|Overall Study|Withdrawal by Subject|11
7479752|NCT02019472|11787627|FG000|Overall Study|Other|3
7479753|NCT02019472|11787628|FG001|Overall Study|Other|8
7479754|NCT02019472|11787629|FG002|Overall Study|Other|6
7479755|NCT02019550|11787643|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7479756|NCT02019550|11787644|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
7479757|NCT02019602|11787665|FG000|Screening Period|Ineligibility|4
7479758|NCT02019602|11787666|FG001|Screening Period|Ineligibility|0
7479759|NCT02019602|11787665|FG000|Screening Period|Adverse Event|1
7479760|NCT02019602|11787666|FG001|Screening Period|Adverse Event|0
7479761|NCT02019667|11787673|FG000|First Intervention (6 Months)|Adverse Event|0
7479762|NCT02019667|11787674|FG001|First Intervention (6 Months)|Adverse Event|1
7479763|NCT02019667|11787673|FG000|2nd Intervention (6 Months)|Adverse Event|0
7479764|NCT02019667|11787674|FG001|2nd Intervention (6 Months)|Adverse Event|1
7479765|NCT02019667|11787673|FG000|2nd Intervention (6 Months)|Physician Decision|0
7479766|NCT02019667|11787674|FG001|2nd Intervention (6 Months)|Physician Decision|1
7479767|NCT02019719|11787687|FG000|Overall Study|Adverse Event|1
7479768|NCT02019719|11787688|FG001|Overall Study|Adverse Event|0
7479769|NCT02019719|11787689|FG002|Overall Study|Adverse Event|0
7479770|NCT02019719|11787690|FG003|Overall Study|Adverse Event|1
7479771|NCT02019719|11787691|FG004|Overall Study|Adverse Event|1
7479772|NCT02019719|11787687|FG000|Overall Study|Protocol Violation|1
7479773|NCT02019719|11787688|FG001|Overall Study|Protocol Violation|1
7479774|NCT02019719|11787689|FG002|Overall Study|Protocol Violation|0
7479775|NCT02019719|11787690|FG003|Overall Study|Protocol Violation|0
7479776|NCT02019719|11787691|FG004|Overall Study|Protocol Violation|0
7479777|NCT02019719|11787687|FG000|Overall Study|Protocol defined stopping criteria|2
7479778|NCT02019719|11787688|FG001|Overall Study|Protocol defined stopping criteria|0
7479779|NCT02019719|11787689|FG002|Overall Study|Protocol defined stopping criteria|0
7479780|NCT02019719|11787690|FG003|Overall Study|Protocol defined stopping criteria|1
7479781|NCT02019719|11787691|FG004|Overall Study|Protocol defined stopping criteria|1
7479782|NCT02019719|11787687|FG000|Overall Study|Physician Decision|2
7479783|NCT02019719|11787688|FG001|Overall Study|Physician Decision|0
7479784|NCT02019719|11787689|FG002|Overall Study|Physician Decision|0
7479785|NCT02019719|11787690|FG003|Overall Study|Physician Decision|0
7479786|NCT02019719|11787691|FG004|Overall Study|Physician Decision|0
7479787|NCT02019927|11787738|FG000|Overall Study|Lost to Follow-up|2
7479788|NCT02019927|11787739|FG001|Overall Study|Lost to Follow-up|4
7479789|NCT02019927|11787740|FG002|Overall Study|Lost to Follow-up|1
7479790|NCT02019927|11787741|FG003|Overall Study|Lost to Follow-up|2
7479791|NCT02019927|11787742|FG004|Overall Study|Lost to Follow-up|3
7479792|NCT02019927|11787743|FG005|Overall Study|Lost to Follow-up|1
7479793|NCT02019979|11787765|FG000|Overall Study|study terminated|14
7479794|NCT02020031|11787780|FG000|Overall Study|Physician Decision|1
7479795|NCT02020031|11787781|FG001|Overall Study|Physician Decision|1
7479796|NCT02020512|11787836|FG000|Overall Study|Adverse Event|1
7479797|NCT02020512|11787836|FG000|Overall Study|Lost to Follow-up|3
7479798|NCT02020512|11787836|FG000|Overall Study|Protocol Violation|4
7479799|NCT02020577|11787842|FG000|Overall Study|Progressive disease|3
7479800|NCT02020577|11787843|FG001|Overall Study|Progressive disease|38
7479801|NCT02020577|11787842|FG000|Overall Study|Other AE or clinical progression|0
7479802|NCT02020577|11787843|FG001|Overall Study|Other AE or clinical progression|15
7479803|NCT02020577|11787842|FG000|Overall Study|Withdrawal by Subject|0
7479804|NCT02020577|11787843|FG001|Overall Study|Withdrawal by Subject|1
7479805|NCT02020577|11787842|FG000|Overall Study|Other than stated above|0
7479806|NCT02020577|11787843|FG001|Overall Study|Other than stated above|1
7479807|NCT02020616|11787862|FG000|Overall Study|Adverse Event|0
7479808|NCT02020616|11787863|FG001|Overall Study|Adverse Event|0
7479809|NCT02020616|11787864|FG002|Overall Study|Adverse Event|0
7479810|NCT02020616|11787865|FG003|Overall Study|Adverse Event|0
7479811|NCT02020616|11787866|FG004|Overall Study|Adverse Event|0
7479812|NCT02020616|11787867|FG005|Overall Study|Adverse Event|1
7479813|NCT02020616|11787868|FG006|Overall Study|Adverse Event|1
7479814|NCT02020616|11787862|FG000|Overall Study|Physician Decision|0
7479815|NCT02020616|11787863|FG001|Overall Study|Physician Decision|0
7479816|NCT02020616|11787864|FG002|Overall Study|Physician Decision|0
7479817|NCT02020616|11787865|FG003|Overall Study|Physician Decision|0
7479818|NCT02020616|11787866|FG004|Overall Study|Physician Decision|0
7479819|NCT02020616|11787867|FG005|Overall Study|Physician Decision|1
7479820|NCT02020616|11787868|FG006|Overall Study|Physician Decision|2
7479821|NCT02020616|11787862|FG000|Overall Study|Withdrawal by Subject|0
7479822|NCT02020616|11787863|FG001|Overall Study|Withdrawal by Subject|0
7479823|NCT02020616|11787864|FG002|Overall Study|Withdrawal by Subject|1
7479824|NCT02020616|11787865|FG003|Overall Study|Withdrawal by Subject|0
7479825|NCT02020616|11787866|FG004|Overall Study|Withdrawal by Subject|0
7479826|NCT02020616|11787867|FG005|Overall Study|Withdrawal by Subject|1
7479827|NCT02020616|11787868|FG006|Overall Study|Withdrawal by Subject|1
7479828|NCT02020616|11787862|FG000|Overall Study|Lost to Follow-up|0
7479829|NCT02020616|11787863|FG001|Overall Study|Lost to Follow-up|1
7479830|NCT02020616|11787864|FG002|Overall Study|Lost to Follow-up|0
7479831|NCT02020616|11787865|FG003|Overall Study|Lost to Follow-up|1
7479832|NCT02020616|11787866|FG004|Overall Study|Lost to Follow-up|1
7479833|NCT02020616|11787867|FG005|Overall Study|Lost to Follow-up|1
7479834|NCT02020616|11787868|FG006|Overall Study|Lost to Follow-up|0
7479835|NCT02020616|11787862|FG000|Overall Study|Early Termination Criteria Met|0
7479836|NCT02020616|11787863|FG001|Overall Study|Early Termination Criteria Met|0
7479837|NCT02020616|11787864|FG002|Overall Study|Early Termination Criteria Met|1
7479838|NCT02020616|11787865|FG003|Overall Study|Early Termination Criteria Met|0
7479839|NCT02020616|11787866|FG004|Overall Study|Early Termination Criteria Met|0
7479840|NCT02020616|11787867|FG005|Overall Study|Early Termination Criteria Met|1
7479841|NCT02020616|11787868|FG006|Overall Study|Early Termination Criteria Met|0
7479842|NCT02020616|11787862|FG000|Overall Study|Randomized in Error|0
7479843|NCT02020616|11787863|FG001|Overall Study|Randomized in Error|0
7479844|NCT02020616|11787864|FG002|Overall Study|Randomized in Error|0
7479845|NCT02020616|11787865|FG003|Overall Study|Randomized in Error|1
7479846|NCT02020616|11787866|FG004|Overall Study|Randomized in Error|0
7479847|NCT02020616|11787867|FG005|Overall Study|Randomized in Error|0
7479848|NCT02020616|11787868|FG006|Overall Study|Randomized in Error|0
7479849|NCT02020616|11787862|FG000|Overall Study|Lack of Efficacy|0
7479850|NCT02020616|11787863|FG001|Overall Study|Lack of Efficacy|0
7479851|NCT02020616|11787864|FG002|Overall Study|Lack of Efficacy|0
7479852|NCT02020616|11787865|FG003|Overall Study|Lack of Efficacy|0
7479853|NCT02020616|11787866|FG004|Overall Study|Lack of Efficacy|1
7479854|NCT02020616|11787867|FG005|Overall Study|Lack of Efficacy|0
7479855|NCT02020616|11787868|FG006|Overall Study|Lack of Efficacy|0
7479856|NCT02020863|11787907|FG000|Overall Study|Discovery of Metastatic disease|4
7479857|NCT02020863|11787907|FG000|Overall Study|Team chose not to place an a line|1
7479858|NCT02020889|11787913|FG000|Overall Study|Adverse Event|0
7479859|NCT02020889|11787914|FG001|Overall Study|Adverse Event|1
7479860|NCT02020889|11787913|FG000|Overall Study|Lack of Efficacy|1
7479861|NCT02020889|11787914|FG001|Overall Study|Lack of Efficacy|0
7479862|NCT02020889|11787913|FG000|Overall Study|Lost to Follow-up|1
7479863|NCT02020889|11787914|FG001|Overall Study|Lost to Follow-up|0
7479864|NCT02020889|11787913|FG000|Overall Study|Physician Decision|2
7479865|NCT02020889|11787914|FG001|Overall Study|Physician Decision|0
7479866|NCT02020889|11787913|FG000|Overall Study|Withdrawal by Subject|3
7479867|NCT02020889|11787914|FG001|Overall Study|Withdrawal by Subject|2
7479868|NCT02020941|11787920|FG000|Overall Study|Adverse Event|1
7479869|NCT02020941|11787920|FG000|Overall Study|Physician Decision|2
7479870|NCT02020941|11787920|FG000|Overall Study|Withdrawal by Subject|1
7479871|NCT02020941|11787920|FG000|Overall Study|Disease Progression|4
7479872|NCT02020967|11787926|FG000|Overall Study|Withdrawal by Subject|51
7479873|NCT02021292|11787934|FG000|Overall Study|Physician Decision|0
7479874|NCT02021292|11787935|FG001|Overall Study|Physician Decision|1
7479875|NCT02021292|11787934|FG000|Overall Study|Lost to Follow-up|0
7479876|NCT02021292|11787935|FG001|Overall Study|Lost to Follow-up|1
7479877|NCT02021292|11787934|FG000|Overall Study|Death|0
7479878|NCT02021292|11787935|FG001|Overall Study|Death|1
7479879|NCT02021318|11787945|FG000|Overall Study|Adverse Event|2
7479880|NCT02021318|11787946|FG001|Overall Study|Adverse Event|1
7479881|NCT02021318|11787945|FG000|Overall Study|Death|33
7479882|NCT02021318|11787946|FG001|Overall Study|Death|34
7479883|NCT02021318|11787945|FG000|Overall Study|Lost to Follow-up|3
7479884|NCT02021318|11787946|FG001|Overall Study|Lost to Follow-up|3
7479885|NCT02021318|11787945|FG000|Overall Study|Progressive Disease|0
7479886|NCT02021318|11787946|FG001|Overall Study|Progressive Disease|1
7479887|NCT02021318|11787945|FG000|Overall Study|Withdrawal by Subject|30
7479888|NCT02021318|11787946|FG001|Overall Study|Withdrawal by Subject|18
7479889|NCT02021318|11787945|FG000|Overall Study|Physician Decision|3
7479890|NCT02021318|11787946|FG001|Overall Study|Physician Decision|3
7479891|NCT02021318|11787945|FG000|Overall Study|Miscellaneous|2
7479892|NCT02021318|11787946|FG001|Overall Study|Miscellaneous|3
7479893|NCT02021331|11787955|FG000|Overall Study|Adverse Event|0
7479894|NCT02021331|11787956|FG001|Overall Study|Adverse Event|2
7479895|NCT02021565|11787970|FG000|Baseline Through Intervention|Death|0
7479896|NCT02021565|11787971|FG001|Baseline Through Intervention|Death|1
7479897|NCT02021565|11787970|FG000|Baseline Through Intervention|Withdrawal by Subject|8
7479898|NCT02021565|11787971|FG001|Baseline Through Intervention|Withdrawal by Subject|8
7479899|NCT02021565|11787970|FG000|Baseline Through Intervention|Protocol Violation|0
7479900|NCT02021565|11787971|FG001|Baseline Through Intervention|Protocol Violation|7
7479901|NCT02021565|11787970|FG000|Baseline Through Intervention|Lost to Follow-up|4
7479902|NCT02021565|11787971|FG001|Baseline Through Intervention|Lost to Follow-up|2
7479903|NCT02021565|11787970|FG000|3-month Follow-up|Death|3
7479904|NCT02021565|11787971|FG001|3-month Follow-up|Death|0
7479905|NCT02021565|11787970|FG000|3-month Follow-up|Withdrawal by Subject|4
7479906|NCT02021565|11787971|FG001|3-month Follow-up|Withdrawal by Subject|0
7479907|NCT02021565|11787970|FG000|3-month Follow-up|Protocol Violation|3
7479908|NCT02021565|11787971|FG001|3-month Follow-up|Protocol Violation|2
7479909|NCT02021643|11787985|FG000|Overall Study|Enrolled but Never Treated|1
7479910|NCT02021643|11787986|FG001|Overall Study|Enrolled but Never Treated|0
7479911|NCT02021643|11787987|FG002|Overall Study|Enrolled but Never Treated|0
7479912|NCT02021643|11787988|FG003|Overall Study|Enrolled but Never Treated|0
7479913|NCT02021643|11787985|FG000|Overall Study|Adverse Event|0
7479914|NCT02021643|11787986|FG001|Overall Study|Adverse Event|1
7479915|NCT02021643|11787987|FG002|Overall Study|Adverse Event|0
7479916|NCT02021643|11787988|FG003|Overall Study|Adverse Event|0
7479917|NCT02021643|11787985|FG000|Overall Study|Death|0
7479918|NCT02021643|11787986|FG001|Overall Study|Death|1
7479919|NCT02021643|11787987|FG002|Overall Study|Death|0
7479920|NCT02021643|11787988|FG003|Overall Study|Death|0
7479921|NCT02021643|11787985|FG000|Overall Study|Investigator's Discretion|1
7479922|NCT02021643|11787986|FG001|Overall Study|Investigator's Discretion|0
7479923|NCT02021643|11787987|FG002|Overall Study|Investigator's Discretion|0
7479924|NCT02021643|11787988|FG003|Overall Study|Investigator's Discretion|0
7479925|NCT02021643|11787985|FG000|Overall Study|Lack of Efficacy|7
7479926|NCT02021643|11787986|FG001|Overall Study|Lack of Efficacy|6
7479927|NCT02021643|11787987|FG002|Overall Study|Lack of Efficacy|0
7479928|NCT02021643|11787988|FG003|Overall Study|Lack of Efficacy|12
7479929|NCT02021643|11787985|FG000|Overall Study|Lost to Follow-up|0
7479930|NCT02021643|11787986|FG001|Overall Study|Lost to Follow-up|1
7479931|NCT02021643|11787987|FG002|Overall Study|Lost to Follow-up|0
7479932|NCT02021643|11787988|FG003|Overall Study|Lost to Follow-up|0
7479933|NCT02021643|11787985|FG000|Overall Study|Withdrew Consent|0
7479934|NCT02021643|11787986|FG001|Overall Study|Withdrew Consent|1
7479935|NCT02021643|11787987|FG002|Overall Study|Withdrew Consent|0
7479936|NCT02021643|11787988|FG003|Overall Study|Withdrew Consent|0
7479937|NCT02021656|11788004|FG000|Overall Study|Adverse Event|1
7479938|NCT02021656|11788004|FG000|Overall Study|Lack of Efficacy|2
7479939|NCT02021656|11788004|FG000|Overall Study|Lost to Follow-up|1
7479940|NCT02021656|11788004|FG000|Overall Study|Withdrew Consent|2
7479941|NCT02022007|11788047|FG000|Overall Study|Withdrawal by Subject|1
7479942|NCT02022007|11788048|FG001|Overall Study|Withdrawal by Subject|1
7479943|NCT02022007|11788049|FG002|Overall Study|Withdrawal by Subject|1
7479944|NCT02022007|11788047|FG000|Overall Study|Noncompliant|0
7479945|NCT02022007|11788048|FG001|Overall Study|Noncompliant|0
7479946|NCT02022007|11788049|FG002|Overall Study|Noncompliant|1
7479947|NCT02022657|11788076|FG000|Overall Study|Withdrawal by Subject|2
7479948|NCT02022657|11788077|FG001|Overall Study|Withdrawal by Subject|0
7479949|NCT02022657|11788078|FG002|Overall Study|Withdrawal by Subject|1
7479950|NCT02022657|11788079|FG003|Overall Study|Withdrawal by Subject|0
7479951|NCT02022657|11788080|FG004|Overall Study|Withdrawal by Subject|0
7479952|NCT02022657|11788081|FG005|Overall Study|Withdrawal by Subject|0
7479953|NCT02022657|11788076|FG000|Overall Study|Physician Decision|0
7479954|NCT02022657|11788077|FG001|Overall Study|Physician Decision|0
7479955|NCT02022657|11788078|FG002|Overall Study|Physician Decision|0
7479956|NCT02022657|11788079|FG003|Overall Study|Physician Decision|0
7479957|NCT02022657|11788080|FG004|Overall Study|Physician Decision|0
7479958|NCT02022657|11788081|FG005|Overall Study|Physician Decision|1
7479959|NCT02022670|11788090|FG000|Overall Study|Adverse Event|1
7479960|NCT02022670|11788091|FG001|Overall Study|Adverse Event|0
7479961|NCT02022670|11788092|FG002|Overall Study|Adverse Event|1
7479962|NCT02022748|11788113|FG000|Overall Study|Adverse Event|1
7479963|NCT02022748|11788114|FG001|Overall Study|Adverse Event|1
7479964|NCT02022748|11788115|FG002|Overall Study|Adverse Event|0
7479965|NCT02022748|11788113|FG000|Overall Study|Withdrawal by Subject|0
7479966|NCT02022748|11788114|FG001|Overall Study|Withdrawal by Subject|1
7479967|NCT02022748|11788115|FG002|Overall Study|Withdrawal by Subject|0
7534517|NCT02698410|11881418|FG000|Overall Study|Withdrawal by Subject|1
7534518|NCT02698410|11881418|FG000|Overall Study|Other|1
7534519|NCT02698423|11881424|FG000|Overall Study|Lost to Follow-up|19
7534520|NCT02698423|11881425|FG001|Overall Study|Lost to Follow-up|24
7534521|NCT02698436|11881435|FG000|Overall Study|Adverse Event|1
7534522|NCT02698436|11881436|FG001|Overall Study|Adverse Event|0
7534523|NCT02698436|11881435|FG000|Overall Study|Withdrawal by Subject|3
7534524|NCT02698436|11881436|FG001|Overall Study|Withdrawal by Subject|3
7534525|NCT02698436|11881435|FG000|Overall Study|Lost to Follow-up|2
7534526|NCT02698436|11881436|FG001|Overall Study|Lost to Follow-up|4
7534527|NCT02698436|11881435|FG000|Overall Study|Non-compliance with study regimen|1
7534528|NCT02698436|11881436|FG001|Overall Study|Non-compliance with study regimen|0
7534529|NCT02698475|11881442|FG000|Main Study Period|Lack of Efficacy|1
7534530|NCT02698475|11881442|FG000|Main Study Period|Protocol Violation|2
7534531|NCT02698475|11881442|FG000|Long-Term Extension Period|Lost to Follow-up|1
7534532|NCT02698475|11881442|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
7534533|NCT02698475|11881442|FG000|Long-Term Extension Period|Withdrawal by Subject|3
7534534|NCT02698475|11881442|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
7534535|NCT02698475|11881442|FG000|Long-Term Extension Period|Other|1
7534536|NCT02698787|11881466|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
7534537|NCT02698787|11881467|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
7534538|NCT02699099|11881484|FG000|Overall Study|Adverse Event|1
7534539|NCT02699099|11881485|FG001|Overall Study|Adverse Event|0
7534540|NCT02699099|11881486|FG002|Overall Study|Adverse Event|2
7534541|NCT02699099|11881484|FG000|Overall Study|Lost to Follow-up|0
7534542|NCT02699099|11881485|FG001|Overall Study|Lost to Follow-up|1
7534543|NCT02699099|11881486|FG002|Overall Study|Lost to Follow-up|0
7534544|NCT02699099|11881484|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
7534545|NCT02699099|11881485|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7534546|NCT02699099|11881486|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
7534547|NCT02699125|11881496|FG000|Placebo|Lost to Follow-up|2
7534548|NCT02699125|11881497|FG001|Placebo|Lost to Follow-up|0
7534549|NCT02699125|11881496|FG000|Placebo|Protocol Violation|1
7534550|NCT02699125|11881497|FG001|Placebo|Protocol Violation|0
7534551|NCT02699125|11881496|FG000|Placebo|Withdrawal by Subject|0
7534552|NCT02699125|11881497|FG001|Placebo|Withdrawal by Subject|4
7534553|NCT02699125|11881496|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
7479968|NCT02023099|11788130|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
7479969|NCT02023099|11788131|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
7479970|NCT02023099|11788132|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
7479971|NCT02023099|11788130|FG000|Overall Study|Withdrawn Consent|3
7479972|NCT02023099|11788131|FG001|Overall Study|Withdrawn Consent|0
7479973|NCT02023099|11788132|FG002|Overall Study|Withdrawn Consent|1
7479974|NCT02023099|11788130|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
7479975|NCT02023099|11788131|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
7479976|NCT02023099|11788132|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
7479977|NCT02023112|11788142|FG000|Overall Study|Withdrawal by Subject|2
7479978|NCT02023112|11788143|FG001|Overall Study|Withdrawal by Subject|1
7479979|NCT02023151|11788167|FG000|Overall Study|Lost to Follow-up|4
7479980|NCT02023242|11788173|FG000|Overall Study|Lost to Follow-up|3
7479981|NCT02023242|11788174|FG001|Overall Study|Lost to Follow-up|1
7479982|NCT02023242|11788173|FG000|Overall Study|Death|0
7479983|NCT02023242|11788174|FG001|Overall Study|Death|1
7479984|NCT02023268|11788182|FG000|Overall Study|Lack of Efficacy|0
7479985|NCT02023268|11788183|FG001|Overall Study|Lack of Efficacy|1
7479986|NCT02023268|11788182|FG000|Overall Study|Adverse Event|0
7479987|NCT02023268|11788183|FG001|Overall Study|Adverse Event|2
7479988|NCT02023268|11788182|FG000|Overall Study|Withdrawal by Subject|0
7479989|NCT02023268|11788183|FG001|Overall Study|Withdrawal by Subject|1
7479990|NCT02023697|11788211|FG000|Treatment Period|Radiological progression|13
7479991|NCT02023697|11788212|FG001|Treatment Period|Radiological progression|17
7479992|NCT02023697|11788213|FG002|Treatment Period|Radiological progression|26
7479993|NCT02023697|11788211|FG000|Treatment Period|Never Treated|5
7479994|NCT02023697|11788212|FG001|Treatment Period|Never Treated|6
7479995|NCT02023697|11788213|FG002|Treatment Period|Never Treated|10
7479996|NCT02023697|11788211|FG000|Treatment Period|Adverse Event|13
7479997|NCT02023697|11788212|FG001|Treatment Period|Adverse Event|25
7479998|NCT02023697|11788213|FG002|Treatment Period|Adverse Event|23
7479999|NCT02023697|11788211|FG000|Treatment Period|Logistical difficulties|1
7480000|NCT02023697|11788212|FG001|Treatment Period|Logistical difficulties|1
7480001|NCT02023697|11788213|FG002|Treatment Period|Logistical difficulties|1
7480002|NCT02023697|11788211|FG000|Treatment Period|Clinical progression|10
7480003|NCT02023697|11788212|FG001|Treatment Period|Clinical progression|8
7480004|NCT02023697|11788213|FG002|Treatment Period|Clinical progression|28
7480005|NCT02023697|11788211|FG000|Treatment Period|Withdrawal by Subject|4
7480006|NCT02023697|11788212|FG001|Treatment Period|Withdrawal by Subject|5
7480007|NCT02023697|11788213|FG002|Treatment Period|Withdrawal by Subject|13
7480008|NCT02023697|11788211|FG000|Treatment Period|Safety outcome reached|0
7480009|NCT02023697|11788212|FG001|Treatment Period|Safety outcome reached|1
7480010|NCT02023697|11788213|FG002|Treatment Period|Safety outcome reached|0
7480011|NCT02023697|11788211|FG000|Treatment Period|Physician Decision|0
7480012|NCT02023697|11788212|FG001|Treatment Period|Physician Decision|0
7480013|NCT02023697|11788213|FG002|Treatment Period|Physician Decision|1
7480014|NCT02023697|11788211|FG000|Active Follow-up Period|Withdrawal by Subject|5
7480015|NCT02023697|11788212|FG001|Active Follow-up Period|Withdrawal by Subject|13
7480016|NCT02023697|11788213|FG002|Active Follow-up Period|Withdrawal by Subject|7
7480017|NCT02023697|11788211|FG000|Active Follow-up Period|Lost to Follow-up|1
7480018|NCT02023697|11788212|FG001|Active Follow-up Period|Lost to Follow-up|1
7480019|NCT02023697|11788213|FG002|Active Follow-up Period|Lost to Follow-up|1
7480020|NCT02023697|11788211|FG000|Active Follow-up Period|Deterioration of general condition|1
7480021|NCT02023697|11788212|FG001|Active Follow-up Period|Deterioration of general condition|1
7480022|NCT02023697|11788213|FG002|Active Follow-up Period|Deterioration of general condition|1
7480023|NCT02023697|11788211|FG000|Active Follow-up Period|Other unspecified|2
7480024|NCT02023697|11788212|FG001|Active Follow-up Period|Other unspecified|0
7480025|NCT02023697|11788213|FG002|Active Follow-up Period|Other unspecified|1
7480026|NCT02023697|11788211|FG000|Active Follow-up Period|Clinical progression|0
7480027|NCT02023697|11788212|FG001|Active Follow-up Period|Clinical progression|2
7480028|NCT02023697|11788213|FG002|Active Follow-up Period|Clinical progression|1
7480029|NCT02023697|11788211|FG000|Active Follow-up Period|Radiological progression|0
7480030|NCT02023697|11788212|FG001|Active Follow-up Period|Radiological progression|0
7480031|NCT02023697|11788213|FG002|Active Follow-up Period|Radiological progression|1
7480032|NCT02023697|11788211|FG000|Active Follow-up Period|Death|83
7480033|NCT02023697|11788212|FG001|Active Follow-up Period|Death|82
7480034|NCT02023697|11788213|FG002|Active Follow-up Period|Death|87
7480035|NCT02023697|11788211|FG000|Long-term Follow-up Period|Death|9
7480036|NCT02023697|11788212|FG001|Long-term Follow-up Period|Death|6
7480037|NCT02023697|11788213|FG002|Long-term Follow-up Period|Death|4
7480038|NCT02023697|11788211|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
7480039|NCT02023697|11788212|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
7480040|NCT02023697|11788213|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
7480041|NCT02023697|11788211|FG000|Long-term Follow-up Period|Lost to Follow-up|1
7480042|NCT02023697|11788212|FG001|Long-term Follow-up Period|Lost to Follow-up|0
7480043|NCT02023697|11788213|FG002|Long-term Follow-up Period|Lost to Follow-up|1
7480044|NCT02023697|11788211|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
7480045|NCT02023697|11788212|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
7480046|NCT02023697|11788213|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
7480047|NCT02023697|11788211|FG000|Long-term Follow-up Period|Technical problems|0
7480048|NCT02023697|11788212|FG001|Long-term Follow-up Period|Technical problems|0
7480049|NCT02023697|11788213|FG002|Long-term Follow-up Period|Technical problems|1
7480050|NCT02023697|11788211|FG000|Long-term Follow-up Period|Other unspecified|6
7480051|NCT02023697|11788212|FG001|Long-term Follow-up Period|Other unspecified|3
7480052|NCT02023697|11788213|FG002|Long-term Follow-up Period|Other unspecified|5
7480053|NCT02023866|11788232|FG000|Overall Study|Non-compliance|2
7480054|NCT02023866|11788232|FG000|Overall Study|Adverse Event|3
7480055|NCT02023866|11788232|FG000|Overall Study|Withdrawal by Subject|1
7480056|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7480057|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
7480058|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
7480059|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
7480060|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
7480061|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
7480062|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7480063|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
7480064|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
7480065|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7480066|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
7480067|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
7480068|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
7480069|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7480070|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
7480071|NCT02023879|11788239|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7480072|NCT02023879|11788240|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
7480073|NCT02023879|11788241|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
7480074|NCT02023879|11788239|FG000|Extension Open Label Treatment|Adverse Event|1
7480075|NCT02023879|11788240|FG001|Extension Open Label Treatment|Adverse Event|7
7480076|NCT02023879|11788241|FG002|Extension Open Label Treatment|Adverse Event|3
7480077|NCT02023879|11788239|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
7480078|NCT02023879|11788240|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
7480079|NCT02023879|11788241|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
7480080|NCT02023879|11788239|FG000|Extension Open Label Treatment|Participant moved|1
7480081|NCT02023879|11788240|FG001|Extension Open Label Treatment|Participant moved|2
7480082|NCT02023879|11788241|FG002|Extension Open Label Treatment|Participant moved|0
7480083|NCT02023879|11788239|FG000|Extension Open Label Treatment|Other than specified above|2
7480084|NCT02023879|11788240|FG001|Extension Open Label Treatment|Other than specified above|7
7480085|NCT02023879|11788241|FG002|Extension Open Label Treatment|Other than specified above|2
7480086|NCT02024698|11788339|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
7480087|NCT02024698|11788340|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
7480088|NCT02024750|11788366|FG000|Overall Study|Withdrawal by Subject|2
7480089|NCT02024750|11788367|FG001|Overall Study|Withdrawal by Subject|1
7480090|NCT02024867|11788375|FG000|Overall Study|Protocol Violation|3
7480091|NCT02024867|11788376|FG001|Overall Study|Protocol Violation|3
7480092|NCT02024867|11788375|FG000|Overall Study|Lost to Follow-up|6
7480093|NCT02024867|11788376|FG001|Overall Study|Lost to Follow-up|4
7480094|NCT02024932|11788388|FG000|Overall Study|Adverse Event|2
7480095|NCT02024932|11788389|FG001|Overall Study|Adverse Event|3
7480096|NCT02024932|11788390|FG002|Overall Study|Adverse Event|0
7480097|NCT02024932|11788391|FG003|Overall Study|Adverse Event|0
7480098|NCT02024932|11788392|FG004|Overall Study|Adverse Event|2
7480099|NCT02024932|11788393|FG005|Overall Study|Adverse Event|0
7480100|NCT02024932|11788388|FG000|Overall Study|Abnormal laboratory value|0
7480101|NCT02024932|11788389|FG001|Overall Study|Abnormal laboratory value|0
7480102|NCT02024932|11788390|FG002|Overall Study|Abnormal laboratory value|0
7480103|NCT02024932|11788391|FG003|Overall Study|Abnormal laboratory value|2
7480104|NCT02024932|11788392|FG004|Overall Study|Abnormal laboratory value|0
7480105|NCT02024932|11788393|FG005|Overall Study|Abnormal laboratory value|0
7480106|NCT02024971|11788413|FG000|Overall Study|Data Not Available|30
7480107|NCT02024971|11788413|FG000|Overall Study|Lost to Follow-up|6
7480108|NCT02025179|11788435|FG000|Overall Study|Lost to Follow-up|0
7480109|NCT02025179|11788436|FG001|Overall Study|Lost to Follow-up|0
7480110|NCT02025179|11788437|FG002|Overall Study|Lost to Follow-up|1
7480111|NCT02025205|11788447|FG000|Overall Study|Withdrawal by Subject|1
7480112|NCT02025205|11788448|FG001|Overall Study|Withdrawal by Subject|1
7480113|NCT02025205|11788447|FG000|Overall Study|Protocol Violation|2
7480114|NCT02025205|11788448|FG001|Overall Study|Protocol Violation|1
7480115|NCT02025205|11788447|FG000|Overall Study|Death|0
7480116|NCT02025205|11788448|FG001|Overall Study|Death|1
7480117|NCT02025530|11788476|FG000|Overall Study|No longer met elligibility criteria|5
7480118|NCT02025530|11788477|FG001|Overall Study|No longer met elligibility criteria|1
7480119|NCT02025621|11788485|FG000|Overall Study|Withdrawal by Subject|1
7480120|NCT02025621|11788486|FG001|Overall Study|Withdrawal by Subject|0
7480121|NCT02025621|11788485|FG000|Overall Study|Death|0
7480122|NCT02025621|11788486|FG001|Overall Study|Death|1
7480123|NCT02025621|11788485|FG000|Overall Study|No longer eligible|10
7480124|NCT02025621|11788486|FG001|Overall Study|No longer eligible|15
7480125|NCT02025621|11788485|FG000|Overall Study|Surgery initiated before infusion|3
7480126|NCT02025621|11788486|FG001|Overall Study|Surgery initiated before infusion|3
7480127|NCT02025725|11788507|FG000|Overall Study|Adverse Event|5
7480128|NCT02025725|11788508|FG001|Overall Study|Adverse Event|0
7480129|NCT02025725|11788507|FG000|Overall Study|Lost to Follow-up|2
7480130|NCT02025725|11788508|FG001|Overall Study|Lost to Follow-up|0
7480131|NCT02025725|11788507|FG000|Overall Study|Protocol Violation|1
7480132|NCT02025725|11788508|FG001|Overall Study|Protocol Violation|1
7480133|NCT02025725|11788507|FG000|Overall Study|Withdrawal by Subject|3
7480134|NCT02025725|11788508|FG001|Overall Study|Withdrawal by Subject|2
7480135|NCT02025725|11788507|FG000|Overall Study|Post-dose QTcB > 270 msec|0
7480136|NCT02025725|11788508|FG001|Overall Study|Post-dose QTcB > 270 msec|1
7480137|NCT02025751|11788518|FG000|Overall Study|Lost to Follow-up|1
7480138|NCT02025751|11788519|FG001|Overall Study|Lost to Follow-up|0
7480139|NCT02025751|11788518|FG000|Overall Study|Adverse Event|0
7480140|NCT02025751|11788519|FG001|Overall Study|Adverse Event|1
7480141|NCT02025751|11788518|FG000|Overall Study|Physician Decision|0
7480142|NCT02025751|11788519|FG001|Overall Study|Physician Decision|1
7480143|NCT02025751|11788518|FG000|Overall Study|Withdrawal by Subject|0
7480144|NCT02025751|11788519|FG001|Overall Study|Withdrawal by Subject|1
7480145|NCT02025907|11788537|FG000|Overall Study|Lack of Efficacy|1
7480146|NCT02025907|11788538|FG001|Overall Study|Lack of Efficacy|0
7480147|NCT02025907|11788537|FG000|Overall Study|Withdrawal by Subject|15
7480148|NCT02025907|11788538|FG001|Overall Study|Withdrawal by Subject|8
7480149|NCT02025907|11788537|FG000|Overall Study|Protocol Violation|2
7480150|NCT02025907|11788538|FG001|Overall Study|Protocol Violation|0
7480151|NCT02025907|11788537|FG000|Overall Study|Physician Decision|2
7480152|NCT02025907|11788538|FG001|Overall Study|Physician Decision|0
7480153|NCT02025907|11788537|FG000|Overall Study|Lost to Follow-up|2
7480154|NCT02025907|11788538|FG001|Overall Study|Lost to Follow-up|2
7480155|NCT02025907|11788537|FG000|Overall Study|Adverse Event|3
7480156|NCT02025907|11788538|FG001|Overall Study|Adverse Event|1
7480157|NCT02025907|11788537|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
7480158|NCT02025907|11788538|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
7480159|NCT02025985|11788549|FG000|Overall Study|Consent withdrawn|0
7480160|NCT02025985|11788550|FG001|Overall Study|Consent withdrawn|0
7480161|NCT02025985|11788551|FG002|Overall Study|Consent withdrawn|1
7480162|NCT02025985|11788552|FG003|Overall Study|Consent withdrawn|0
7480163|NCT02025985|11788553|FG004|Overall Study|Consent withdrawn|0
7480164|NCT02025985|11788549|FG000|Overall Study|Termination of study by Sponsor|4
7480165|NCT02025985|11788550|FG001|Overall Study|Termination of study by Sponsor|3
7480166|NCT02025985|11788551|FG002|Overall Study|Termination of study by Sponsor|1
7480167|NCT02025985|11788552|FG003|Overall Study|Termination of study by Sponsor|1
7480168|NCT02025985|11788553|FG004|Overall Study|Termination of study by Sponsor|3
7480169|NCT02025985|11788549|FG000|Overall Study|Death|21
7480170|NCT02025985|11788550|FG001|Overall Study|Death|20
7480171|NCT02025985|11788551|FG002|Overall Study|Death|23
7480172|NCT02025985|11788552|FG003|Overall Study|Death|20
7480173|NCT02025985|11788553|FG004|Overall Study|Death|17
7480174|NCT02026011|11788569|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
7480175|NCT02026011|11788570|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
7480176|NCT02026011|11788569|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
7480177|NCT02026011|11788570|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
7480178|NCT02026011|11788569|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
7480179|NCT02026011|11788570|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
7480180|NCT02026011|11788569|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
7480181|NCT02026011|11788570|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
7480182|NCT02026063|11788581|FG000|Overall Study|Physician Decision|0
7480183|NCT02026063|11788582|FG001|Overall Study|Physician Decision|10
7480184|NCT02026063|11788581|FG000|Overall Study|Noncompliance with Study Drug|1
7480185|NCT02026063|11788582|FG001|Overall Study|Noncompliance with Study Drug|1
7480186|NCT02026063|11788581|FG000|Overall Study|Withdrawal of Consent|1
7480187|NCT02026063|11788582|FG001|Overall Study|Withdrawal of Consent|6
7480188|NCT02026063|11788581|FG000|Overall Study|Adverse Event|5
7480189|NCT02026063|11788582|FG001|Overall Study|Adverse Event|20
7480190|NCT02026063|11788581|FG000|Overall Study|Lack of Efficacy|0
7480191|NCT02026063|11788582|FG001|Overall Study|Lack of Efficacy|4
7480192|NCT02026063|11788581|FG000|Overall Study|Lost to Follow-up|0
7480193|NCT02026063|11788582|FG001|Overall Study|Lost to Follow-up|1
7480194|NCT02026063|11788581|FG000|Overall Study|Reason not Specified|2
7480195|NCT02026063|11788582|FG001|Overall Study|Reason not Specified|7
7480196|NCT02026141|11788591|FG000|Overall Study|Protocol Violation|0
7480197|NCT02026141|11788592|FG001|Overall Study|Protocol Violation|1
7480198|NCT02026258|11788618|FG000|Randomized|Did not start treatment|2
7480199|NCT02026258|11788619|FG001|Randomized|Did not start treatment|1
7480200|NCT02026258|11788618|FG000|Randomized|Change in treatment plan|1
7480201|NCT02026258|11788619|FG001|Randomized|Change in treatment plan|0
7480202|NCT02026258|11788618|FG000|Randomized|Presence of periodontal disease|1
7480203|NCT02026258|11788619|FG001|Randomized|Presence of periodontal disease|1
7480204|NCT02026258|11788618|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
7480205|NCT02026258|11788619|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
7480206|NCT02026258|11788618|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
7480207|NCT02026258|11788619|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
7480208|NCT02027025|11788660|FG000|Overall Study|Adverse Event|0
7480209|NCT02027025|11788661|FG001|Overall Study|Adverse Event|1
7480210|NCT02027025|11788662|FG002|Overall Study|Adverse Event|1
7480211|NCT02027025|11788660|FG000|Overall Study|Protocol Violation|1
7480212|NCT02027025|11788661|FG001|Overall Study|Protocol Violation|0
7480213|NCT02027025|11788662|FG002|Overall Study|Protocol Violation|0
7480214|NCT02027025|11788660|FG000|Overall Study|Lost to Follow-up|0
7480215|NCT02027025|11788661|FG001|Overall Study|Lost to Follow-up|2
7480216|NCT02027025|11788662|FG002|Overall Study|Lost to Follow-up|0
7480217|NCT02027025|11788660|FG000|Overall Study|Withdrawal by Subject|0
7480218|NCT02027025|11788661|FG001|Overall Study|Withdrawal by Subject|1
7480219|NCT02027025|11788662|FG002|Overall Study|Withdrawal by Subject|0
7480220|NCT02027025|11788660|FG000|Overall Study|Sponsor's decision|0
7480221|NCT02027025|11788661|FG001|Overall Study|Sponsor's decision|1
7480222|NCT02027025|11788662|FG002|Overall Study|Sponsor's decision|0
7480223|NCT02027311|11788683|FG000|Overall Study|Protocol Violation|3
7480224|NCT02027311|11788684|FG001|Overall Study|Protocol Violation|2
7480225|NCT02027376|11788692|FG000|Overall Study|Death|1
7480226|NCT02027376|11788693|FG001|Overall Study|Death|0
7480227|NCT02027376|11788694|FG002|Overall Study|Death|0
7480228|NCT02027402|11788706|FG000|Overall Study|Withdrawal by Subject|4
7480229|NCT02027402|11788707|FG001|Overall Study|Withdrawal by Subject|1
7480230|NCT02027428|11788717|FG000|Induction|Never treated|7
7480231|NCT02027428|11788718|FG001|Induction|Never treated|0
7480232|NCT02027428|11788719|FG002|Induction|Never treated|0
7480233|NCT02027428|11788717|FG000|Induction|Progressive disease|77
7480234|NCT02027428|11788718|FG001|Induction|Progressive disease|0
7480235|NCT02027428|11788719|FG002|Induction|Progressive disease|0
7480236|NCT02027428|11788717|FG000|Induction|Adverse Event|51
7480237|NCT02027428|11788718|FG001|Induction|Adverse Event|0
7480238|NCT02027428|11788719|FG002|Induction|Adverse Event|0
7480239|NCT02027428|11788717|FG000|Induction|Withdrawal by Subject|22
7480240|NCT02027428|11788718|FG001|Induction|Withdrawal by Subject|0
7480241|NCT02027428|11788719|FG002|Induction|Withdrawal by Subject|0
7480242|NCT02027428|11788717|FG000|Induction|Death|21
7480243|NCT02027428|11788718|FG001|Induction|Death|0
7480244|NCT02027428|11788719|FG002|Induction|Death|0
7480245|NCT02027428|11788717|FG000|Induction|Symptomatic deterioration|16
7480246|NCT02027428|11788718|FG001|Induction|Symptomatic deterioration|0
7480247|NCT02027428|11788719|FG002|Induction|Symptomatic deterioration|0
7480248|NCT02027428|11788717|FG000|Induction|Study terminated by sponsor|12
7480249|NCT02027428|11788718|FG001|Induction|Study terminated by sponsor|0
7480250|NCT02027428|11788719|FG002|Induction|Study terminated by sponsor|0
7480251|NCT02027428|11788717|FG000|Induction|Protocol Violation|1
7480252|NCT02027428|11788718|FG001|Induction|Protocol Violation|0
7480253|NCT02027428|11788719|FG002|Induction|Protocol Violation|0
7480254|NCT02027428|11788717|FG000|Induction|Miscellaneous|14
7480255|NCT02027428|11788718|FG001|Induction|Miscellaneous|0
7480256|NCT02027428|11788719|FG002|Induction|Miscellaneous|0
7480257|NCT02027428|11788717|FG000|Induction|Induction Treatment Ongoing|4
7480258|NCT02027428|11788718|FG001|Induction|Induction Treatment Ongoing|0
7480259|NCT02027428|11788719|FG002|Induction|Induction Treatment Ongoing|0
7480260|NCT02027428|11788717|FG000|Maintenance|Death|0
7480261|NCT02027428|11788718|FG001|Maintenance|Death|3
7480262|NCT02027428|11788719|FG002|Maintenance|Death|2
7480263|NCT02027428|11788717|FG000|Maintenance|Adverse Event|0
7480264|NCT02027428|11788718|FG001|Maintenance|Adverse Event|21
7480265|NCT02027428|11788719|FG002|Maintenance|Adverse Event|1
7480266|NCT02027428|11788717|FG000|Maintenance|Progressive disease|0
7480267|NCT02027428|11788718|FG001|Maintenance|Progressive disease|84
7480268|NCT02027428|11788719|FG002|Maintenance|Progressive disease|47
7480269|NCT02027428|11788717|FG000|Maintenance|Symptomatic deterioration|0
7480270|NCT02027428|11788718|FG001|Maintenance|Symptomatic deterioration|4
7480271|NCT02027428|11788719|FG002|Maintenance|Symptomatic deterioration|1
7480272|NCT02027428|11788717|FG000|Maintenance|Withdrawal by Subject|0
7480273|NCT02027428|11788718|FG001|Maintenance|Withdrawal by Subject|6
7480274|NCT02027428|11788719|FG002|Maintenance|Withdrawal by Subject|5
7480275|NCT02027428|11788717|FG000|Maintenance|Protocol Violation|0
7480276|NCT02027428|11788718|FG001|Maintenance|Protocol Violation|0
7480277|NCT02027428|11788719|FG002|Maintenance|Protocol Violation|1
7480278|NCT02027428|11788717|FG000|Maintenance|Other|0
7480279|NCT02027428|11788718|FG001|Maintenance|Other|6
7480280|NCT02027428|11788719|FG002|Maintenance|Other|3
7480281|NCT02027428|11788717|FG000|Survival Follow-up|Death|0
7480282|NCT02027428|11788718|FG001|Survival Follow-up|Death|78
7480283|NCT02027428|11788719|FG002|Survival Follow-up|Death|45
7480284|NCT02027428|11788717|FG000|Survival Follow-up|Lost to Follow-up|0
7480285|NCT02027428|11788718|FG001|Survival Follow-up|Lost to Follow-up|1
7480286|NCT02027428|11788719|FG002|Survival Follow-up|Lost to Follow-up|1
7480287|NCT02027545|11788744|FG000|Overall Study|Failed to sign HIPAA|0
7480288|NCT02027545|11788745|FG001|Overall Study|Failed to sign HIPAA|2
7480289|NCT02027545|11788744|FG000|Overall Study|Failed to attend study visit|2
7480290|NCT02027545|11788745|FG001|Overall Study|Failed to attend study visit|0
7480291|NCT02027558|11788753|FG000|Overall Study|Death|0
7480292|NCT02027558|11788754|FG001|Overall Study|Death|1
7480293|NCT02027558|11788753|FG000|Overall Study|Withdrawal by Subject|2
7480294|NCT02027558|11788754|FG001|Overall Study|Withdrawal by Subject|0
7480295|NCT02027558|11788753|FG000|Overall Study|Lost to Follow-up|4
7480296|NCT02027558|11788754|FG001|Overall Study|Lost to Follow-up|1
7480297|NCT02027558|11788753|FG000|Overall Study|Refused assessment|3
7480298|NCT02027558|11788754|FG001|Overall Study|Refused assessment|0
7480299|NCT02027623|11788764|FG000|Overall Study|Lost to Follow-up|3
7480300|NCT02027623|11788765|FG001|Overall Study|Lost to Follow-up|3
7480301|NCT02027623|11788764|FG000|Overall Study|Withdrawal by Subject|6
7480302|NCT02027623|11788765|FG001|Overall Study|Withdrawal by Subject|9
7480303|NCT02027701|11788772|FG000|Overall Study|Adverse Event|3
7480304|NCT02027701|11788772|FG000|Overall Study|Lack of Efficacy|8
7480305|NCT02027701|11788772|FG000|Overall Study|Physician Decision|2
7480306|NCT02027701|11788772|FG000|Overall Study|Withdrawal by Subject|3
7480307|NCT02027844|11788781|FG000|Overall Study|Withdrawal by Subject|3
7480308|NCT02027844|11788782|FG001|Overall Study|Withdrawal by Subject|2
7480309|NCT02027844|11788783|FG002|Overall Study|Withdrawal by Subject|1
7480310|NCT02027844|11788781|FG000|Overall Study|Lost to Follow-up|0
7480311|NCT02027844|11788782|FG001|Overall Study|Lost to Follow-up|2
7480312|NCT02027844|11788783|FG002|Overall Study|Lost to Follow-up|1
7480313|NCT02027844|11788781|FG000|Overall Study|Protocol Violation|0
7480314|NCT02027844|11788782|FG001|Overall Study|Protocol Violation|2
7480315|NCT02027844|11788783|FG002|Overall Study|Protocol Violation|0
7480316|NCT02027844|11788781|FG000|Overall Study|Incomlete data|2
7480317|NCT02027844|11788782|FG001|Overall Study|Incomlete data|0
7480318|NCT02027844|11788783|FG002|Overall Study|Incomlete data|0
7480319|NCT02028065|11788807|FG000|Randomization Through Start Treatment|Not treated|1
7480320|NCT02028065|11788808|FG001|Randomization Through Start Treatment|Not treated|3
7480321|NCT02028065|11788809|FG002|Randomization Through Start Treatment|Not treated|3
7480322|NCT02028065|11788807|FG000|Treatment Through Study Completion|Lost to Follow-up|2
7480323|NCT02028065|11788808|FG001|Treatment Through Study Completion|Lost to Follow-up|4
7480324|NCT02028065|11788809|FG002|Treatment Through Study Completion|Lost to Follow-up|6
7480325|NCT02028065|11788807|FG000|Treatment Through Study Completion|Physician Decision|1
7480326|NCT02028065|11788808|FG001|Treatment Through Study Completion|Physician Decision|0
7480327|NCT02028065|11788809|FG002|Treatment Through Study Completion|Physician Decision|0
7480328|NCT02028065|11788807|FG000|Treatment Through Study Completion|Protocol Violation|1
7480329|NCT02028065|11788808|FG001|Treatment Through Study Completion|Protocol Violation|4
7480330|NCT02028065|11788809|FG002|Treatment Through Study Completion|Protocol Violation|0
7480331|NCT02028065|11788807|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
7480332|NCT02028065|11788808|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
7480333|NCT02028065|11788809|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
7480334|NCT02028065|11788807|FG000|Treatment Through Study Completion|Adverse Event|3
7480335|NCT02028065|11788808|FG001|Treatment Through Study Completion|Adverse Event|3
7480336|NCT02028065|11788809|FG002|Treatment Through Study Completion|Adverse Event|5
7480337|NCT02028169|11788817|FG000|Overall Study|Lost to Follow-up|21
7480338|NCT02028169|11788817|FG000|Overall Study|Lack of Efficacy|2
7480339|NCT02028169|11788817|FG000|Overall Study|Withdrawal by Subject|2
7480340|NCT02028169|11788817|FG000|Overall Study|Adverse Event|1
7480341|NCT02028169|11788817|FG000|Overall Study|Cessation of Drug|1
7480342|NCT02028169|11788817|FG000|Overall Study|Concomitant Medication Usage|1
7480343|NCT02028182|11788821|FG000|Overall Study|Protocol Violation|2
7480344|NCT02028715|11788908|FG000|Overall Study|Adverse Event|2
7480345|NCT02028715|11788909|FG001|Overall Study|Adverse Event|2
7480346|NCT02028715|11788908|FG000|Overall Study|Physician Decision|1
7480347|NCT02028715|11788909|FG001|Overall Study|Physician Decision|0
7480348|NCT02028715|11788908|FG000|Overall Study|Did not complete satisfaction surveys|2
7480349|NCT02028715|11788909|FG001|Overall Study|Did not complete satisfaction surveys|2
7480350|NCT02028767|11788924|FG000|Treatment Period 2|Non compliant with protocol|1
7480351|NCT02028767|11788925|FG001|Treatment Period 2|Non compliant with protocol|0
7480352|NCT02028767|11788924|FG000|Treatment Period 2|Reason other than those specified above|1
7480353|NCT02028767|11788925|FG001|Treatment Period 2|Reason other than those specified above|0
7480354|NCT02028871|11789000|FG000|Overall Study|Positive urine drug screen|1
7480355|NCT02028871|11789001|FG001|Overall Study|Positive urine drug screen|1
7480356|NCT02028871|11789000|FG000|Overall Study|Withdrawal by Subject|1
7480357|NCT02028871|11789001|FG001|Overall Study|Withdrawal by Subject|2
7480358|NCT02028871|11789000|FG000|Overall Study|IV placement difficulty|1
7480359|NCT02028871|11789001|FG001|Overall Study|IV placement difficulty|0
7480360|NCT02028871|11789000|FG000|Overall Study|Current Illness|1
7480361|NCT02028871|11789001|FG001|Overall Study|Current Illness|0
7480362|NCT02029235|11789030|FG000|Overall Study|Non-compliance with study meds or diary|4
7480363|NCT02029235|11789031|FG001|Overall Study|Non-compliance with study meds or diary|1
7480364|NCT02029274|11789041|FG000|Overall Study|Adverse Event|1
7480365|NCT02029274|11789042|FG001|Overall Study|Adverse Event|0
7480366|NCT02029274|11789043|FG002|Overall Study|Adverse Event|2
7480367|NCT02029274|11789044|FG003|Overall Study|Adverse Event|2
7480368|NCT02029417|11789058|FG000|Overall Study|Death|1
7480369|NCT02029417|11789058|FG000|Overall Study|Adverse Event|1
7480370|NCT02029521|11789077|FG000|Overall Study|Protocol Violation|1
7480371|NCT02029521|11789078|FG001|Overall Study|Protocol Violation|0
7480372|NCT02029521|11789077|FG000|Overall Study|Withdrawal by Subject|1
7480373|NCT02029521|11789078|FG001|Overall Study|Withdrawal by Subject|1
7480374|NCT02029638|11789090|FG000|Overall Study|Death|0
7480375|NCT02029638|11789091|FG001|Overall Study|Death|0
7480376|NCT02029638|11789092|FG002|Overall Study|Death|1
7480377|NCT02029638|11789090|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
7480378|NCT02029638|11789091|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
7480379|NCT02029638|11789092|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
7480380|NCT02029976|11789137|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
7480381|NCT02029976|11789138|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
7480382|NCT02029976|11789137|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
7480383|NCT02029976|11789138|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
7480384|NCT02029976|11789137|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7480385|NCT02029976|11789138|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
7480386|NCT02029976|11789137|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
7480387|NCT02029976|11789138|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
7480388|NCT02029989|11789146|FG000|Overall Study|Withdrawal by Subject|1
7480389|NCT02029989|11789147|FG001|Overall Study|Withdrawal by Subject|0
7480390|NCT02029989|11789146|FG000|Overall Study|Withdrawal: Fear of needles|1
7480391|NCT02029989|11789147|FG001|Overall Study|Withdrawal: Fear of needles|0
7480392|NCT02029989|11789146|FG000|Overall Study|Change of location|2
7480393|NCT02029989|11789147|FG001|Overall Study|Change of location|3
7480394|NCT02029989|11789146|FG000|Overall Study|Physician Decision|2
7480395|NCT02029989|11789147|FG001|Overall Study|Physician Decision|0
7480396|NCT02029989|11789146|FG000|Overall Study|Lost to Follow-up|9
7480397|NCT02029989|11789147|FG001|Overall Study|Lost to Follow-up|7
7480398|NCT02029989|11789146|FG000|Overall Study|Death|0
7480399|NCT02029989|11789147|FG001|Overall Study|Death|1
7480400|NCT02029989|11789146|FG000|Overall Study|Protocol Violation|1
7480401|NCT02029989|11789147|FG001|Overall Study|Protocol Violation|0
7480402|NCT02030002|11789153|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
7480403|NCT02030002|11789153|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
7480404|NCT02030002|11789153|FG000|Follow-up|Lost to Follow-up|2
7480405|NCT02030041|11789162|FG000|Overall Study|Withdrawal by Subject|2
7480406|NCT02030041|11789163|FG001|Overall Study|Withdrawal by Subject|2
7480407|NCT02030041|11789164|FG002|Overall Study|Withdrawal by Subject|1
7480408|NCT02030119|11789193|FG000|Overall Study|Withdrawal by Subject|3
7480409|NCT02030119|11789194|FG001|Overall Study|Withdrawal by Subject|1
7480410|NCT02030119|11789195|FG002|Overall Study|Withdrawal by Subject|5
7480411|NCT02030119|11789196|FG003|Overall Study|Withdrawal by Subject|3
7480412|NCT02030119|11789193|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
7480413|NCT02030119|11789194|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
7480414|NCT02030119|11789195|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
7480415|NCT02030119|11789196|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
7480416|NCT02030405|11789219|FG000|Overall Study|Withdrawal by Subject|1
7480417|NCT02030405|11789219|FG000|Overall Study|Lost to Follow-up|1
7480418|NCT02030535|11789224|FG000|Washout Period 1 (21 Days)|Adverse Event|1
7480419|NCT02030600|11789244|FG000|Treatment Period 1|Adverse Event|5
7480420|NCT02030600|11789245|FG001|Treatment Period 1|Adverse Event|7
7480421|NCT02030600|11789244|FG000|Treatment Period 1|Lack of Efficacy|0
7480422|NCT02030600|11789245|FG001|Treatment Period 1|Lack of Efficacy|1
7480423|NCT02030600|11789244|FG000|Treatment Period 1|Lost to Follow-up|11
7480424|NCT02030600|11789245|FG001|Treatment Period 1|Lost to Follow-up|3
7480425|NCT02030600|11789244|FG000|Treatment Period 1|Protocol Violation|22
7480426|NCT02030600|11789245|FG001|Treatment Period 1|Protocol Violation|17
7480427|NCT02030600|11789244|FG000|Treatment Period 1|Withdrawal by Subject|13
7480428|NCT02030600|11789245|FG001|Treatment Period 1|Withdrawal by Subject|17
7480429|NCT02030600|11789244|FG000|Treatment Period 1|Casebook Unsigned|1
7480430|NCT02030600|11789245|FG001|Treatment Period 1|Casebook Unsigned|0
7480431|NCT02030600|11789244|FG000|Treatment Period 1|Unclassified|1
7480432|NCT02030600|11789245|FG001|Treatment Period 1|Unclassified|0
7480433|NCT02030600|11789244|FG000|Treatment Period 2|Adverse Event|4
7480434|NCT02030600|11789245|FG001|Treatment Period 2|Adverse Event|4
7480435|NCT02030600|11789244|FG000|Treatment Period 2|Lack of Efficacy|2
7480436|NCT02030600|11789245|FG001|Treatment Period 2|Lack of Efficacy|1
7480437|NCT02030600|11789244|FG000|Treatment Period 2|Lost to Follow-up|4
7480438|NCT02030600|11789245|FG001|Treatment Period 2|Lost to Follow-up|2
7480439|NCT02030600|11789244|FG000|Treatment Period 2|Protocol Violation|1
7480440|NCT02030600|11789245|FG001|Treatment Period 2|Protocol Violation|2
7480441|NCT02030600|11789244|FG000|Treatment Period 2|Withdrawal by Subject|13
7480442|NCT02030600|11789245|FG001|Treatment Period 2|Withdrawal by Subject|9
7480443|NCT02030600|11789244|FG000|Treatment Period 2|Unclassified|1
7480444|NCT02030600|11789245|FG001|Treatment Period 2|Unclassified|0
7480445|NCT02030821|11789257|FG000|Overall Study|Physician Decision|2
7480446|NCT02030821|11789258|FG001|Overall Study|Physician Decision|2
7480447|NCT02030821|11789259|FG002|Overall Study|Physician Decision|5
7480448|NCT02030821|11789260|FG003|Overall Study|Physician Decision|2
7480449|NCT02030834|11789273|FG000|Overall Study|Death|4
7480450|NCT02030834|11789274|FG001|Overall Study|Death|0
7480451|NCT02030834|11789275|FG002|Overall Study|Death|0
7480452|NCT02030834|11789273|FG000|Overall Study|Manufacturing failure|2
7480453|NCT02030834|11789274|FG001|Overall Study|Manufacturing failure|0
7480454|NCT02030834|11789275|FG002|Overall Study|Manufacturing failure|1
7480455|NCT02030834|11789273|FG000|Overall Study|Disease progression|2
7480456|NCT02030834|11789274|FG001|Overall Study|Disease progression|0
7480457|NCT02030834|11789275|FG002|Overall Study|Disease progression|2
7480458|NCT02030834|11789273|FG000|Overall Study|Lost to Follow-up|1
7480459|NCT02030834|11789274|FG001|Overall Study|Lost to Follow-up|0
7480460|NCT02030834|11789275|FG002|Overall Study|Lost to Follow-up|0
7480461|NCT02030834|11789273|FG000|Overall Study|Withdrawal by Subject|1
7480462|NCT02030834|11789274|FG001|Overall Study|Withdrawal by Subject|0
7480463|NCT02030834|11789275|FG002|Overall Study|Withdrawal by Subject|0
7480464|NCT02030834|11789273|FG000|Overall Study|Lack of funding|1
7480465|NCT02030834|11789274|FG001|Overall Study|Lack of funding|0
7480466|NCT02030834|11789275|FG002|Overall Study|Lack of funding|0
7534554|NCT02699125|11881497|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7534555|NCT02699450|11881510|FG000|Overall Study|Death|2
7534556|NCT02699450|11881511|FG001|Overall Study|Death|1
7534557|NCT02699450|11881512|FG002|Overall Study|Death|2
7534558|NCT02699450|11881510|FG000|Overall Study|Met Criteria for Study Exit|0
7534559|NCT02699450|11881511|FG001|Overall Study|Met Criteria for Study Exit|0
7534560|NCT02699450|11881512|FG002|Overall Study|Met Criteria for Study Exit|1
7534561|NCT02699450|11881510|FG000|Overall Study|Protocol Violation|4
7534562|NCT02699450|11881511|FG001|Overall Study|Protocol Violation|3
7534563|NCT02699450|11881512|FG002|Overall Study|Protocol Violation|5
7534564|NCT02699450|11881510|FG000|Overall Study|Lost to Follow-up|3
7534565|NCT02699450|11881511|FG001|Overall Study|Lost to Follow-up|0
7534566|NCT02699450|11881512|FG002|Overall Study|Lost to Follow-up|5
7534567|NCT02699450|11881510|FG000|Overall Study|Physician Decision|2
7534568|NCT02699450|11881511|FG001|Overall Study|Physician Decision|0
7534569|NCT02699450|11881512|FG002|Overall Study|Physician Decision|0
7534570|NCT02699450|11881510|FG000|Overall Study|Withdrawal by Subject|3
7534571|NCT02699450|11881511|FG001|Overall Study|Withdrawal by Subject|1
7534572|NCT02699450|11881512|FG002|Overall Study|Withdrawal by Subject|2
7534573|NCT02699450|11881510|FG000|Overall Study|Adverse Event|1
7534574|NCT02699450|11881511|FG001|Overall Study|Adverse Event|0
7534575|NCT02699450|11881512|FG002|Overall Study|Adverse Event|0
7534576|NCT02699463|11881523|FG000|Overall Study|Lost to Follow-up|11
7534577|NCT02699463|11881524|FG001|Overall Study|Lost to Follow-up|8
7534578|NCT02699463|11881523|FG000|Overall Study|Withdrawal by Subject|4
7534579|NCT02699463|11881524|FG001|Overall Study|Withdrawal by Subject|1
7534580|NCT02699593|11881530|FG000|Period 1|Unsatisfactory Visual Response|0
7534581|NCT02699593|11881531|FG001|Period 1|Unsatisfactory Visual Response|1
7534582|NCT02699593|11881530|FG000|Period 1|Torn Contact Len|4
7534583|NCT02699593|11881531|FG001|Period 1|Torn Contact Len|3
7534584|NCT02699593|11881530|FG000|Period 1|Protocol Violation|0
7534585|NCT02699593|11881531|FG001|Period 1|Protocol Violation|1
7534586|NCT02699593|11881530|FG000|Period 1|Withdrawal by Subject|0
7534587|NCT02699593|11881531|FG001|Period 1|Withdrawal by Subject|1
7534588|NCT02699593|11881530|FG000|Period 1|Adverse Event|1
7534589|NCT02699593|11881531|FG001|Period 1|Adverse Event|1
7534590|NCT02699593|11881530|FG000|Period 2|Adverse Event|1
7534591|NCT02699593|11881531|FG001|Period 2|Adverse Event|1
7534592|NCT02699593|11881530|FG000|Period 2|Lost Contact Lens|0
7534593|NCT02699593|11881531|FG001|Period 2|Lost Contact Lens|1
7534594|NCT02699593|11881530|FG000|Period 2|Torn Contact Lens|1
7534595|NCT02699593|11881531|FG001|Period 2|Torn Contact Lens|0
7537718|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
7537719|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Physician Decision|2
7537720|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Physician Decision|1
7537721|NCT02586025|11886838|FG000|Neoadjuvant Treatment|Progressive Disease|2
7537722|NCT02586025|11886839|FG001|Neoadjuvant Treatment|Progressive Disease|3
7537723|NCT02586025|11886838|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
7537724|NCT02586025|11886839|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
7537725|NCT02586025|11886838|FG000|Adjuvant Treatment|Withdrawal by Subject|5
7537726|NCT02586025|11886839|FG001|Adjuvant Treatment|Withdrawal by Subject|3
7537727|NCT02586025|11886838|FG000|Adjuvant Treatment|Physician Decision|0
7537728|NCT02586025|11886839|FG001|Adjuvant Treatment|Physician Decision|1
7537729|NCT02586025|11886838|FG000|Adjuvant Treatment|Recurrent Disease|1
7537730|NCT02586025|11886839|FG001|Adjuvant Treatment|Recurrent Disease|4
7537731|NCT02586025|11886838|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
7537732|NCT02586025|11886839|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
7480467|NCT02030847|11789283|FG000|Overall Study|Death|10
7480468|NCT02030847|11789283|FG000|Overall Study|Disease Progression|15
7480469|NCT02030847|11789283|FG000|Overall Study|New Cancer Therapy|8
7480470|NCT02030847|11789283|FG000|Overall Study|Physician Decision|3
7480471|NCT02030847|11789283|FG000|Overall Study|Withdrawal by Subject|1
7480472|NCT02031146|11789301|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
7480473|NCT02031146|11789302|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
7480474|NCT02031146|11789303|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
7480475|NCT02031146|11789304|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
7480476|NCT02031146|11789305|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
7480477|NCT02031146|11789306|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
7480478|NCT02031146|11789307|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
7480479|NCT02031237|11789319|FG000|Overall Study|Death|1
7480480|NCT02031237|11789320|FG001|Overall Study|Death|5
7480481|NCT02031237|11789321|FG002|Overall Study|Death|0
7480482|NCT02031237|11789319|FG000|Overall Study|Physician Decision|0
7480483|NCT02031237|11789320|FG001|Overall Study|Physician Decision|1
7480484|NCT02031237|11789321|FG002|Overall Study|Physician Decision|0
7480485|NCT02031237|11789319|FG000|Overall Study|Withdrawal by Subject|2
7480486|NCT02031237|11789320|FG001|Overall Study|Withdrawal by Subject|2
7480487|NCT02031237|11789321|FG002|Overall Study|Withdrawal by Subject|0
7480488|NCT02031237|11789319|FG000|Overall Study|Protocol Violation|2
7480489|NCT02031237|11789320|FG001|Overall Study|Protocol Violation|6
7480490|NCT02031237|11789321|FG002|Overall Study|Protocol Violation|0
7480491|NCT02031237|11789319|FG000|Overall Study|Alternate Treatment Given|0
7480492|NCT02031237|11789320|FG001|Overall Study|Alternate Treatment Given|0
7480493|NCT02031237|11789321|FG002|Overall Study|Alternate Treatment Given|3
7480494|NCT02031276|11789331|FG000|Period 1 Double-blind IV|Adverse Event|6
7480495|NCT02031276|11789332|FG001|Period 1 Double-blind IV|Adverse Event|5
7480496|NCT02031276|11789333|FG002|Period 1 Double-blind IV|Adverse Event|1
7480497|NCT02031276|11789331|FG000|Period 1 Double-blind IV|Other|0
7480498|NCT02031276|11789332|FG001|Period 1 Double-blind IV|Other|1
7480499|NCT02031276|11789333|FG002|Period 1 Double-blind IV|Other|0
7480500|NCT02031276|11789331|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
7480501|NCT02031276|11789332|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
7480502|NCT02031276|11789333|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
7480503|NCT02031276|11789331|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
7480504|NCT02031276|11789332|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7480505|NCT02031276|11789333|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
7480506|NCT02031276|11789331|FG000|Period 2 Open-label Risankizumab IV|Other|0
7480507|NCT02031276|11789332|FG001|Period 2 Open-label Risankizumab IV|Other|2
7480508|NCT02031276|11789333|FG002|Period 2 Open-label Risankizumab IV|Other|1
7480509|NCT02031276|11789331|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
7480510|NCT02031276|11789332|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
7480511|NCT02031276|11789333|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
7480512|NCT02031276|11789331|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
7480513|NCT02031276|11789332|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7480514|NCT02031276|11789333|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
7480515|NCT02031276|11789331|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7480516|NCT02031276|11789332|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7480517|NCT02031276|11789333|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
7480518|NCT02031276|11789331|FG000|Period 3 Open-label Risankizumab SC|Other|0
7480519|NCT02031276|11789332|FG001|Period 3 Open-label Risankizumab SC|Other|0
7480520|NCT02031276|11789333|FG002|Period 3 Open-label Risankizumab SC|Other|1
7480521|NCT02031302|11789347|FG000|Overall Study|Death|115
7480522|NCT02031302|11789348|FG001|Overall Study|Death|0
7480523|NCT02031302|11789347|FG000|Overall Study|Not treated with study valve system|18
7480524|NCT02031302|11789348|FG001|Overall Study|Not treated with study valve system|0
7480525|NCT02031302|11789347|FG000|Overall Study|Missed Follow Up|27
7480526|NCT02031302|11789348|FG001|Overall Study|Missed Follow Up|0
7480527|NCT02031302|11789347|FG000|Overall Study|Lost to Follow-up|4
7480528|NCT02031302|11789348|FG001|Overall Study|Lost to Follow-up|0
7480529|NCT02031432|11789355|FG000|Overall Study|Protocol Violation|1
7480530|NCT02031432|11789355|FG000|Overall Study|Lack of Efficacy|5
7480531|NCT02031432|11789355|FG000|Overall Study|Cancer Progression|2
7480532|NCT02031432|11789355|FG000|Overall Study|Withdrawn as forbidden meds required|1
7480533|NCT02031432|11789355|FG000|Overall Study|Adverse Event|8
7480534|NCT02031432|11789355|FG000|Overall Study|Withdrawal by Subject|5
7480535|NCT02031432|11789355|FG000|Overall Study|Lost to Follow-up|1
7480536|NCT02031432|11789355|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
7480537|NCT02031432|11789355|FG000|Overall Study|Death|10
7480538|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Death|89
7480539|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Death|193
7480540|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Death|198
7480541|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
7480542|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
7480543|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
7480544|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
7480545|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7480546|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
7480547|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
7480548|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
7480549|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
7480550|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
7480551|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
7480552|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
7480553|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
7480554|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
7480555|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
7480556|NCT02031458|11789362|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
7480557|NCT02031458|11789363|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
7480558|NCT02031458|11789364|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
7480559|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Death|36
7480560|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Death|87
7480561|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Death|100
7480562|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Protocol Violation|7
7480563|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Protocol Violation|4
7480564|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Protocol Violation|0
7480565|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Physician Decision|0
7480566|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Physician Decision|1
7480567|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Physician Decision|0
7480568|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Unknown Reason|0
7480569|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Unknown Reason|1
7480570|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Unknown Reason|2
7480571|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
7480572|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
7480573|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
7480574|NCT02031458|11789362|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
7480575|NCT02031458|11789363|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
7480576|NCT02031458|11789364|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
7480577|NCT02031458|11789362|FG000|Baseline to May 8, 2015|On Treatment|43
7480578|NCT02031458|11789363|FG001|Baseline to May 8, 2015|On Treatment|81
7480579|NCT02031458|11789364|FG002|Baseline to May 8, 2015|On Treatment|73
7480580|NCT02031458|11789362|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
7480581|NCT02031458|11789363|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
7480582|NCT02031458|11789364|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
7480583|NCT02031471|11789374|FG000|24 Week Treatment Period|Adverse Event|6
7480584|NCT02031471|11789374|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
7480585|NCT02031471|11789374|FG000|24 Week Treatment Period|Protocol Violation|1
7480586|NCT02031471|11789374|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
7480587|NCT02031471|11789374|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
7480588|NCT02031471|11789374|FG000|Long Term Extension (LTE) Period|Adverse Event|1
7480589|NCT02031471|11789374|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
7480590|NCT02031536|11789380|FG000|Overall Study|ineligible|1
7480591|NCT02031536|11789381|FG001|Overall Study|ineligible|0
7480592|NCT02031640|11789405|FG000|Screening Period|Adverse Event|1
7480593|NCT02031640|11789406|FG001|Screening Period|Adverse Event|0
7480594|NCT02031640|11789407|FG002|Screening Period|Adverse Event|0
7480595|NCT02031640|11789408|FG003|Screening Period|Adverse Event|0
7480596|NCT02031640|11789409|FG004|Screening Period|Adverse Event|0
7480597|NCT02031640|11789410|FG005|Screening Period|Adverse Event|0
7480598|NCT02031640|11789405|FG000|Screening Period|Withdrawal by Subject|29
7480599|NCT02031640|11789406|FG001|Screening Period|Withdrawal by Subject|0
7480600|NCT02031640|11789407|FG002|Screening Period|Withdrawal by Subject|0
7480601|NCT02031640|11789408|FG003|Screening Period|Withdrawal by Subject|0
7480602|NCT02031640|11789409|FG004|Screening Period|Withdrawal by Subject|0
7480603|NCT02031640|11789410|FG005|Screening Period|Withdrawal by Subject|0
7480604|NCT02031640|11789405|FG000|Screening Period|Inclusion criteria not met|312
7480605|NCT02031640|11789406|FG001|Screening Period|Inclusion criteria not met|0
7480606|NCT02031640|11789407|FG002|Screening Period|Inclusion criteria not met|0
7480607|NCT02031640|11789408|FG003|Screening Period|Inclusion criteria not met|0
7480608|NCT02031640|11789409|FG004|Screening Period|Inclusion criteria not met|0
7480609|NCT02031640|11789410|FG005|Screening Period|Inclusion criteria not met|0
7480610|NCT02031640|11789405|FG000|Screening Period|Exclusion criteria met|30
7480611|NCT02031640|11789406|FG001|Screening Period|Exclusion criteria met|0
7480612|NCT02031640|11789407|FG002|Screening Period|Exclusion criteria met|0
7480613|NCT02031640|11789408|FG003|Screening Period|Exclusion criteria met|0
7480614|NCT02031640|11789409|FG004|Screening Period|Exclusion criteria met|0
7480615|NCT02031640|11789410|FG005|Screening Period|Exclusion criteria met|0
7480616|NCT02031640|11789405|FG000|Screening Period|Lost to Follow-up|14
7480617|NCT02031640|11789406|FG001|Screening Period|Lost to Follow-up|0
7480618|NCT02031640|11789407|FG002|Screening Period|Lost to Follow-up|0
7480619|NCT02031640|11789408|FG003|Screening Period|Lost to Follow-up|0
7480620|NCT02031640|11789409|FG004|Screening Period|Lost to Follow-up|0
7480621|NCT02031640|11789410|FG005|Screening Period|Lost to Follow-up|0
7480622|NCT02031640|11789405|FG000|Screening Period|Enrollment closed|26
7480623|NCT02031640|11789406|FG001|Screening Period|Enrollment closed|0
7480624|NCT02031640|11789407|FG002|Screening Period|Enrollment closed|0
7480625|NCT02031640|11789408|FG003|Screening Period|Enrollment closed|0
7480626|NCT02031640|11789409|FG004|Screening Period|Enrollment closed|0
7480627|NCT02031640|11789410|FG005|Screening Period|Enrollment closed|0
7480628|NCT02031640|11789405|FG000|Run-In Period|Adverse Event|4
7480629|NCT02031640|11789406|FG001|Run-In Period|Adverse Event|0
7480630|NCT02031640|11789407|FG002|Run-In Period|Adverse Event|0
7480631|NCT02031640|11789408|FG003|Run-In Period|Adverse Event|0
7480632|NCT02031640|11789409|FG004|Run-In Period|Adverse Event|0
7480633|NCT02031640|11789410|FG005|Run-In Period|Adverse Event|0
7480634|NCT02031640|11789405|FG000|Run-In Period|Withdrawal by Subject|17
7480635|NCT02031640|11789406|FG001|Run-In Period|Withdrawal by Subject|0
7480636|NCT02031640|11789407|FG002|Run-In Period|Withdrawal by Subject|0
7480637|NCT02031640|11789408|FG003|Run-In Period|Withdrawal by Subject|0
7480638|NCT02031640|11789409|FG004|Run-In Period|Withdrawal by Subject|0
7480639|NCT02031640|11789410|FG005|Run-In Period|Withdrawal by Subject|0
7480640|NCT02031640|11789405|FG000|Run-In Period|Inclusion criteria not met|38
7480641|NCT02031640|11789406|FG001|Run-In Period|Inclusion criteria not met|0
7480642|NCT02031640|11789407|FG002|Run-In Period|Inclusion criteria not met|0
7480643|NCT02031640|11789408|FG003|Run-In Period|Inclusion criteria not met|0
7480644|NCT02031640|11789409|FG004|Run-In Period|Inclusion criteria not met|0
7480645|NCT02031640|11789410|FG005|Run-In Period|Inclusion criteria not met|0
7480646|NCT02031640|11789405|FG000|Run-In Period|Exclusion criteria met|8
7480647|NCT02031640|11789406|FG001|Run-In Period|Exclusion criteria met|0
7480648|NCT02031640|11789407|FG002|Run-In Period|Exclusion criteria met|0
7480649|NCT02031640|11789408|FG003|Run-In Period|Exclusion criteria met|0
7480650|NCT02031640|11789409|FG004|Run-In Period|Exclusion criteria met|0
7480651|NCT02031640|11789410|FG005|Run-In Period|Exclusion criteria met|0
7480652|NCT02031640|11789405|FG000|Run-In Period|Randomization criteria not met|85
7480653|NCT02031640|11789406|FG001|Run-In Period|Randomization criteria not met|0
7480654|NCT02031640|11789407|FG002|Run-In Period|Randomization criteria not met|0
7480655|NCT02031640|11789408|FG003|Run-In Period|Randomization criteria not met|0
7480656|NCT02031640|11789409|FG004|Run-In Period|Randomization criteria not met|0
7480657|NCT02031640|11789410|FG005|Run-In Period|Randomization criteria not met|0
7480658|NCT02031640|11789405|FG000|Run-In Period|Various administrative reasons|17
7480659|NCT02031640|11789406|FG001|Run-In Period|Various administrative reasons|0
7480660|NCT02031640|11789407|FG002|Run-In Period|Various administrative reasons|0
7480661|NCT02031640|11789408|FG003|Run-In Period|Various administrative reasons|0
7480662|NCT02031640|11789409|FG004|Run-In Period|Various administrative reasons|0
7480663|NCT02031640|11789410|FG005|Run-In Period|Various administrative reasons|0
7480664|NCT02031640|11789405|FG000|Double-blind Treatment Period|Protocol deviation|0
7480665|NCT02031640|11789406|FG001|Double-blind Treatment Period|Protocol deviation|2
7480666|NCT02031640|11789407|FG002|Double-blind Treatment Period|Protocol deviation|0
7480667|NCT02031640|11789408|FG003|Double-blind Treatment Period|Protocol deviation|1
7480668|NCT02031640|11789409|FG004|Double-blind Treatment Period|Protocol deviation|3
7480669|NCT02031640|11789410|FG005|Double-blind Treatment Period|Protocol deviation|1
7480670|NCT02031640|11789405|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7480671|NCT02031640|11789406|FG001|Double-blind Treatment Period|Lack of Efficacy|14
7480672|NCT02031640|11789407|FG002|Double-blind Treatment Period|Lack of Efficacy|3
7480673|NCT02031640|11789408|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7480674|NCT02031640|11789409|FG004|Double-blind Treatment Period|Lack of Efficacy|5
7480675|NCT02031640|11789410|FG005|Double-blind Treatment Period|Lack of Efficacy|1
7480676|NCT02031640|11789405|FG000|Double-blind Treatment Period|Non-compliance|0
7480677|NCT02031640|11789406|FG001|Double-blind Treatment Period|Non-compliance|1
7480678|NCT02031640|11789407|FG002|Double-blind Treatment Period|Non-compliance|0
7480679|NCT02031640|11789408|FG003|Double-blind Treatment Period|Non-compliance|1
7480680|NCT02031640|11789409|FG004|Double-blind Treatment Period|Non-compliance|1
7480681|NCT02031640|11789410|FG005|Double-blind Treatment Period|Non-compliance|0
7480682|NCT02031640|11789405|FG000|Double-blind Treatment Period|Adverse Event|0
7480683|NCT02031640|11789406|FG001|Double-blind Treatment Period|Adverse Event|0
7480684|NCT02031640|11789407|FG002|Double-blind Treatment Period|Adverse Event|0
7480685|NCT02031640|11789408|FG003|Double-blind Treatment Period|Adverse Event|2
7480686|NCT02031640|11789409|FG004|Double-blind Treatment Period|Adverse Event|0
7480687|NCT02031640|11789410|FG005|Double-blind Treatment Period|Adverse Event|0
7480688|NCT02031640|11789405|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7480689|NCT02031640|11789406|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7480690|NCT02031640|11789407|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
7480691|NCT02031640|11789408|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
7480692|NCT02031640|11789409|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
7480693|NCT02031640|11789410|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
7480694|NCT02031640|11789405|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7480695|NCT02031640|11789406|FG001|Double-blind Treatment Period|Lost to Follow-up|3
7480696|NCT02031640|11789407|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7480697|NCT02031640|11789408|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7480698|NCT02031640|11789409|FG004|Double-blind Treatment Period|Lost to Follow-up|1
7480699|NCT02031640|11789410|FG005|Double-blind Treatment Period|Lost to Follow-up|0
7480700|NCT02031679|11789431|FG000|Overall Study|Protocol Violation|0
7480701|NCT02031679|11789432|FG001|Overall Study|Protocol Violation|1
7480702|NCT02031679|11789431|FG000|Overall Study|Lack of Efficacy|0
7480703|NCT02031679|11789432|FG001|Overall Study|Lack of Efficacy|1
7480704|NCT02032173|11789445|FG000|Overall Study|Discontinuation due to sponsor decision|31
7480705|NCT02032238|11789468|FG000|Overall Study|Lost to Follow-up|2
7480706|NCT02032238|11789469|FG001|Overall Study|Lost to Follow-up|0
7480707|NCT02032407|11789475|FG000|Overall Study|Lost to Follow-up|2
7480708|NCT02032407|11789475|FG000|Overall Study|Pregnancy|1
7480709|NCT02032407|11789475|FG000|Overall Study|Other Miscellaneous Reasons|2
7480710|NCT02032706|11789521|FG000|Overall Study|Did not qualify|5
7480711|NCT02032706|11789521|FG000|Overall Study|Protocol Violation|1
7480712|NCT02032875|11789536|FG000|Treatment Period|Adverse Event|1
7480713|NCT02032875|11789537|FG001|Treatment Period|Adverse Event|0
7480714|NCT02032875|11789536|FG000|Treatment Period|Liver transplant, No extension needed|0
7480715|NCT02032875|11789537|FG001|Treatment Period|Liver transplant, No extension needed|1
7480716|NCT02032875|11789536|FG000|Treatment Period|Liver transplant, Treatment extension|0
7480717|NCT02032875|11789537|FG001|Treatment Period|Liver transplant, Treatment extension|3
7480718|NCT02032875|11789536|FG000|Follow-up Period|Death|0
7480719|NCT02032875|11789537|FG001|Follow-up Period|Death|1
7480720|NCT02032875|11789536|FG000|Follow-up Period|Virologic Relapse|3
7480721|NCT02032875|11789537|FG001|Follow-up Period|Virologic Relapse|10
7480722|NCT02032888|11789547|FG000|Treatment Period|Poor compliance/noncompliance|1
7480723|NCT02032888|11789548|FG001|Treatment Period|Poor compliance/noncompliance|1
7480724|NCT02032888|11789549|FG002|Treatment Period|Poor compliance/noncompliance|0
7480725|NCT02032888|11789547|FG000|Treatment Period|Other|1
7480726|NCT02032888|11789548|FG001|Treatment Period|Other|1
7480727|NCT02032888|11789549|FG002|Treatment Period|Other|0
7480728|NCT02032888|11789547|FG000|Follow-up Period|Lost to Follow-up|1
7480729|NCT02032888|11789548|FG001|Follow-up Period|Lost to Follow-up|1
7480730|NCT02032888|11789549|FG002|Follow-up Period|Lost to Follow-up|0
7480731|NCT02032888|11789547|FG000|Follow-up Period|Death|1
7480732|NCT02032888|11789548|FG001|Follow-up Period|Death|1
7480733|NCT02032888|11789549|FG002|Follow-up Period|Death|0
7480734|NCT02032888|11789547|FG000|Follow-up Period|Other|1
7480735|NCT02032888|11789548|FG001|Follow-up Period|Other|0
7480736|NCT02032888|11789549|FG002|Follow-up Period|Other|0
7480737|NCT02032901|11789568|FG000|Treatment Period (12 Weeks)|Pregnancy|1
7480738|NCT02032901|11789569|FG001|Treatment Period (12 Weeks)|Pregnancy|0
7480739|NCT02032901|11789568|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
7480740|NCT02032901|11789569|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
7480741|NCT02033369|11789633|FG000|Overall Study|Physician Decision|1
7480742|NCT02033369|11789634|FG001|Overall Study|Physician Decision|2
7480743|NCT02033369|11789633|FG000|Overall Study|Not a good demographic match|0
7480744|NCT02033369|11789634|FG001|Overall Study|Not a good demographic match|2
7480745|NCT02033369|11789633|FG000|Overall Study|Withdrawal by Subject|1
7480746|NCT02033369|11789634|FG001|Overall Study|Withdrawal by Subject|1
7480747|NCT02033369|11789633|FG000|Overall Study|Lost to Follow-up|1
7480748|NCT02033369|11789634|FG001|Overall Study|Lost to Follow-up|0
7480749|NCT02033369|11789633|FG000|Overall Study|Protocol Violation|2
7480750|NCT02033369|11789634|FG001|Overall Study|Protocol Violation|0
7480751|NCT02033759|11789672|FG000|Overall Study|Withdrawal by Subject|2
7480752|NCT02033759|11789673|FG001|Overall Study|Withdrawal by Subject|1
7480753|NCT02033759|11789672|FG000|Overall Study|Protocol Violation|1
7480754|NCT02033759|11789673|FG001|Overall Study|Protocol Violation|1
7480755|NCT02033850|11789681|FG000|Overall Study|Death|1
7480756|NCT02033850|11789682|FG001|Overall Study|Death|0
7480757|NCT02033850|11789681|FG000|Overall Study|unrelated medical reason|1
7480758|NCT02033850|11789682|FG001|Overall Study|unrelated medical reason|1
7480759|NCT02033889|11789700|FG000|Overall Study|Adverse Event|3
7480760|NCT02033889|11789701|FG001|Overall Study|Adverse Event|1
7480761|NCT02033889|11789702|FG002|Overall Study|Adverse Event|3
7480762|NCT02033889|11789700|FG000|Overall Study|Death|3
7480763|NCT02033889|11789701|FG001|Overall Study|Death|1
7480764|NCT02033889|11789702|FG002|Overall Study|Death|2
7480765|NCT02033889|11789700|FG000|Overall Study|Excluded Medication|1
7480766|NCT02033889|11789701|FG001|Overall Study|Excluded Medication|1
7480767|NCT02033889|11789702|FG002|Overall Study|Excluded Medication|0
7480768|NCT02033889|11789700|FG000|Overall Study|Lost to Follow-up|8
7480769|NCT02033889|11789701|FG001|Overall Study|Lost to Follow-up|5
7480770|NCT02033889|11789702|FG002|Overall Study|Lost to Follow-up|6
7480771|NCT02033889|11789700|FG000|Overall Study|Non-Compliance With Study Drug|1
7480772|NCT02033889|11789701|FG001|Overall Study|Non-Compliance With Study Drug|0
7480773|NCT02033889|11789702|FG002|Overall Study|Non-Compliance With Study Drug|0
7480774|NCT02033889|11789700|FG000|Overall Study|Physician Decision|0
7480775|NCT02033889|11789701|FG001|Overall Study|Physician Decision|1
7480776|NCT02033889|11789702|FG002|Overall Study|Physician Decision|1
7480777|NCT02033889|11789700|FG000|Overall Study|Participant moved|0
7480778|NCT02033889|11789701|FG001|Overall Study|Participant moved|1
7480779|NCT02033889|11789702|FG002|Overall Study|Participant moved|0
7480780|NCT02033889|11789700|FG000|Overall Study|Withdrawal by Subject|18
7480781|NCT02033889|11789701|FG001|Overall Study|Withdrawal by Subject|10
7480782|NCT02033889|11789702|FG002|Overall Study|Withdrawal by Subject|13
7480783|NCT02034006|11789721|FG000|Overall Study|Withdrawal by Subject|7
7480784|NCT02034006|11789721|FG000|Overall Study|Lost to Follow-up|5
7480785|NCT02034006|11789721|FG000|Overall Study|Death|1
7480786|NCT02034006|11789721|FG000|Overall Study|Pregnancy|1
7480787|NCT02034058|11789737|FG000|Overall Study|Death|3
7480788|NCT02034162|11789743|FG000|Double-blind|Lost to Follow-up|3
7480789|NCT02034162|11789744|FG001|Double-blind|Lost to Follow-up|0
7480790|NCT02034162|11789745|FG002|Double-blind|Lost to Follow-up|0
7480791|NCT02034162|11789743|FG000|Double-blind|Physician Decision|1
7480792|NCT02034162|11789744|FG001|Double-blind|Physician Decision|0
7480793|NCT02034162|11789745|FG002|Double-blind|Physician Decision|0
7480794|NCT02034162|11789743|FG000|Double-blind|Protocol Violation|0
7480795|NCT02034162|11789744|FG001|Double-blind|Protocol Violation|1
7480796|NCT02034162|11789745|FG002|Double-blind|Protocol Violation|0
7480797|NCT02034162|11789743|FG000|Double-blind|Withdrawal by Subject|5
7480798|NCT02034162|11789744|FG001|Double-blind|Withdrawal by Subject|7
7480799|NCT02034162|11789745|FG002|Double-blind|Withdrawal by Subject|0
7480800|NCT02034409|11789762|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
7480801|NCT02034409|11789763|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
7480802|NCT02034409|11789762|FG000|Sham-Controlled Treatment Period|Adverse Event|1
7480803|NCT02034409|11789763|FG001|Sham-Controlled Treatment Period|Adverse Event|1
7480804|NCT02034409|11789762|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
7480805|NCT02034409|11789763|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
7480806|NCT02034409|11789762|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7480807|NCT02034409|11789763|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
7480808|NCT02034409|11789762|FG000|Sham-Controlled Treatment Period|Physician Decision|1
7480809|NCT02034409|11789763|FG001|Sham-Controlled Treatment Period|Physician Decision|3
7480810|NCT02034409|11789762|FG000|Sham-Controlled Treatment Period|misrandomized|2
7480811|NCT02034409|11789763|FG001|Sham-Controlled Treatment Period|misrandomized|2
7480812|NCT02034435|11789771|FG000|Overall Study|Withdrawal by Subject|1
7480813|NCT02034435|11789772|FG001|Overall Study|Withdrawal by Subject|0
7480814|NCT02034435|11789773|FG002|Overall Study|Withdrawal by Subject|0
7480815|NCT02034435|11789774|FG003|Overall Study|Withdrawal by Subject|0
7480816|NCT02034435|11789771|FG000|Overall Study|Illness|0
7480817|NCT02034435|11789772|FG001|Overall Study|Illness|2
7480818|NCT02034435|11789773|FG002|Overall Study|Illness|0
7480819|NCT02034435|11789774|FG003|Overall Study|Illness|0
7480820|NCT02034435|11789771|FG000|Overall Study|Inadequate IV access|1
7480821|NCT02034435|11789772|FG001|Overall Study|Inadequate IV access|0
7480822|NCT02034435|11789773|FG002|Overall Study|Inadequate IV access|0
7480823|NCT02034435|11789774|FG003|Overall Study|Inadequate IV access|1
7480824|NCT02034474|11789786|FG000|Overall Study|Adverse Event|3
7480825|NCT02034474|11789787|FG001|Overall Study|Adverse Event|2
7480826|NCT02034474|11789786|FG000|Overall Study|Withdrawal by Subject|1
7480827|NCT02034474|11789787|FG001|Overall Study|Withdrawal by Subject|2
7480828|NCT02034513|11789797|FG000|Overall Study|Adverse Event|11
7480829|NCT02034513|11789798|FG001|Overall Study|Adverse Event|10
7480830|NCT02034513|11789797|FG000|Overall Study|Lack of Efficacy|0
7480831|NCT02034513|11789798|FG001|Overall Study|Lack of Efficacy|1
7480832|NCT02034513|11789797|FG000|Overall Study|Lost to Follow-up|6
7480833|NCT02034513|11789798|FG001|Overall Study|Lost to Follow-up|7
7480834|NCT02034513|11789797|FG000|Overall Study|Pregnancy|0
7480835|NCT02034513|11789798|FG001|Overall Study|Pregnancy|3
7480836|NCT02034513|11789797|FG000|Overall Study|Protocol Violation|7
7480837|NCT02034513|11789798|FG001|Overall Study|Protocol Violation|10
7480838|NCT02034513|11789797|FG000|Overall Study|Withdrawal by Subject|25
7480839|NCT02034513|11789798|FG001|Overall Study|Withdrawal by Subject|25
7480840|NCT02034513|11789797|FG000|Overall Study|Unclassified|0
7480841|NCT02034513|11789798|FG001|Overall Study|Unclassified|1
7480842|NCT02034552|11789809|FG000|Overall Study|Never treated|3
7480843|NCT02034552|11789810|FG001|Overall Study|Never treated|2
7480844|NCT02034552|11789811|FG002|Overall Study|Never treated|0
7480845|NCT02034552|11789809|FG000|Overall Study|Radiological progression|3
7480846|NCT02034552|11789810|FG001|Overall Study|Radiological progression|5
7480847|NCT02034552|11789811|FG002|Overall Study|Radiological progression|4
7480848|NCT02034552|11789809|FG000|Overall Study|AE not assoc. with disease progression|1
7480849|NCT02034552|11789810|FG001|Overall Study|AE not assoc. with disease progression|4
7480850|NCT02034552|11789811|FG002|Overall Study|AE not assoc. with disease progression|2
7480851|NCT02034552|11789809|FG000|Overall Study|AE associated with disease progression|0
7480852|NCT02034552|11789810|FG001|Overall Study|AE associated with disease progression|1
7480853|NCT02034552|11789811|FG002|Overall Study|AE associated with disease progression|0
7480854|NCT02034552|11789809|FG000|Overall Study|Withdrawal by Subject|2
7480855|NCT02034552|11789810|FG001|Overall Study|Withdrawal by Subject|1
7480856|NCT02034552|11789811|FG002|Overall Study|Withdrawal by Subject|1
7480857|NCT02034552|11789809|FG000|Overall Study|Non-compliance with study drug|0
7480858|NCT02034552|11789810|FG001|Overall Study|Non-compliance with study drug|0
7480859|NCT02034552|11789811|FG002|Overall Study|Non-compliance with study drug|1
7480860|NCT02034552|11789809|FG000|Overall Study|Clinical progression|5
7480861|NCT02034552|11789810|FG001|Overall Study|Clinical progression|7
7480862|NCT02034552|11789811|FG002|Overall Study|Clinical progression|9
7480863|NCT02034565|11789819|FG000|Overall Study|Adverse Event|1
7480864|NCT02034565|11789820|FG001|Overall Study|Adverse Event|0
7480865|NCT02034591|11789842|FG000|Overall Study|Withdrawal by Subject|0
7480866|NCT02034591|11789843|FG001|Overall Study|Withdrawal by Subject|0
7480867|NCT02034591|11789844|FG002|Overall Study|Withdrawal by Subject|0
7480868|NCT02034591|11789845|FG003|Overall Study|Withdrawal by Subject|0
7480869|NCT02034591|11789846|FG004|Overall Study|Withdrawal by Subject|1
7480870|NCT02034591|11789847|FG005|Overall Study|Withdrawal by Subject|0
7480871|NCT02034708|11789858|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
7480872|NCT02034708|11789859|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
7480873|NCT02034708|11789858|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
7480874|NCT02034708|11789859|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
7480875|NCT02034708|11789858|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7480876|NCT02034708|11789859|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
7480877|NCT02034708|11789858|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
7480878|NCT02034708|11789859|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
7480879|NCT02034799|11789872|FG000|Overall Study|Withdrawal by Subject|0
7480880|NCT02034799|11789873|FG001|Overall Study|Withdrawal by Subject|2
7480881|NCT02034799|11789872|FG000|Overall Study|Lost to Follow-up|0
7480882|NCT02034799|11789873|FG001|Overall Study|Lost to Follow-up|1
7480883|NCT02034799|11789872|FG000|Overall Study|Death|2
7480884|NCT02034799|11789873|FG001|Overall Study|Death|1
7480885|NCT02034877|11789881|FG000|Overall Study|Lost to Follow-up|0
7480886|NCT02034877|11789882|FG001|Overall Study|Lost to Follow-up|3
7480887|NCT02034877|11789881|FG000|Overall Study|No Longer Willing to Participate|0
7480888|NCT02034877|11789882|FG001|Overall Study|No Longer Willing to Participate|3
7480889|NCT02034916|11789890|FG000|Overall Study|Death|39
7480890|NCT02034916|11789891|FG001|Overall Study|Death|28
7480891|NCT02034916|11789890|FG000|Overall Study|Withdrawal by Subject|2
7480892|NCT02034916|11789891|FG001|Overall Study|Withdrawal by Subject|1
7480893|NCT02034916|11789890|FG000|Overall Study|Lost to Follow-up|4
7480894|NCT02034916|11789891|FG001|Overall Study|Lost to Follow-up|1
7480895|NCT02034916|11789890|FG000|Overall Study|Study terminated by sponsor|4
7480896|NCT02034916|11789891|FG001|Overall Study|Study terminated by sponsor|5
7480897|NCT02035202|11789901|FG000|Overall Study|Lost to Follow-up|8
7480898|NCT02035202|11789902|FG001|Overall Study|Lost to Follow-up|16
7480899|NCT02035202|11789903|FG002|Overall Study|Lost to Follow-up|2
7480900|NCT02035267|11789915|FG000|Overall Study|Withdrawal consent-subject convenience|0
7480901|NCT02035267|11789916|FG001|Overall Study|Withdrawal consent-subject convenience|0
7480902|NCT02035267|11789917|FG002|Overall Study|Withdrawal consent-subject convenience|1
7480903|NCT02035267|11789918|FG003|Overall Study|Withdrawal consent-subject convenience|0
7480904|NCT02035267|11789915|FG000|Overall Study|Adverse Event|0
7480905|NCT02035267|11789916|FG001|Overall Study|Adverse Event|0
7480906|NCT02035267|11789917|FG002|Overall Study|Adverse Event|1
7480907|NCT02035267|11789918|FG003|Overall Study|Adverse Event|0
7480908|NCT02035267|11789915|FG000|Overall Study|Lost to Follow-up|0
7480909|NCT02035267|11789916|FG001|Overall Study|Lost to Follow-up|0
7480910|NCT02035267|11789917|FG002|Overall Study|Lost to Follow-up|0
7480911|NCT02035267|11789918|FG003|Overall Study|Lost to Follow-up|1
7480912|NCT02035267|11789915|FG000|Overall Study|Other unspecified|0
7480913|NCT02035267|11789916|FG001|Overall Study|Other unspecified|1
7480914|NCT02035267|11789917|FG002|Overall Study|Other unspecified|0
7480915|NCT02035267|11789918|FG003|Overall Study|Other unspecified|0
7480916|NCT02035332|11789930|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
7480917|NCT02035475|11789939|FG000|Overall Study|Withdrawal by Subject|4
7480918|NCT02035475|11789939|FG000|Overall Study|Physician Decision|1
7480919|NCT02035475|11789939|FG000|Overall Study|Equipment Error|1
7480920|NCT02035553|11789947|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
7480921|NCT02035553|11789948|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
7480922|NCT02035553|11789947|FG000|Overall Study|Adverse Event|10
7480923|NCT02035553|11789948|FG001|Overall Study|Adverse Event|6
7480924|NCT02035553|11789947|FG000|Overall Study|Physician Decision|3
7480925|NCT02035553|11789948|FG001|Overall Study|Physician Decision|2
7480926|NCT02035553|11789947|FG000|Overall Study|Lack of Efficacy|1
7480927|NCT02035553|11789948|FG001|Overall Study|Lack of Efficacy|1
7480928|NCT02035553|11789947|FG000|Overall Study|Withdrawal by Subject|4
7480929|NCT02035553|11789948|FG001|Overall Study|Withdrawal by Subject|7
7480930|NCT02035553|11789947|FG000|Overall Study|Non-compliance with Study Drug|0
7480931|NCT02035553|11789948|FG001|Overall Study|Non-compliance with Study Drug|1
7480932|NCT02035553|11789947|FG000|Overall Study|Lost to Follow-up|0
7480933|NCT02035553|11789948|FG001|Overall Study|Lost to Follow-up|1
7480934|NCT02035553|11789947|FG000|Overall Study|Other Reason|0
7480935|NCT02035553|11789948|FG001|Overall Study|Other Reason|4
7480936|NCT02035696|11789958|FG000|Overall Study|Lost to Follow-up|0
7480937|NCT02035696|11789959|FG001|Overall Study|Lost to Follow-up|3
7480938|NCT02035696|11789960|FG002|Overall Study|Lost to Follow-up|1
7480939|NCT02035696|11789961|FG003|Overall Study|Lost to Follow-up|2
7480940|NCT02035696|11789958|FG000|Overall Study|Withdrawal by Subject|3
7480941|NCT02035696|11789959|FG001|Overall Study|Withdrawal by Subject|0
7480942|NCT02035696|11789960|FG002|Overall Study|Withdrawal by Subject|2
7480943|NCT02035696|11789961|FG003|Overall Study|Withdrawal by Subject|1
7480944|NCT02035748|11789975|FG000|Overall Study|Adverse Event|5
7480945|NCT02035748|11789975|FG000|Overall Study|Death|3
7480946|NCT02035748|11789975|FG000|Overall Study|Lost to Follow-up|2
7480947|NCT02035748|11789975|FG000|Overall Study|Physician Decision|3
7480948|NCT02035748|11789975|FG000|Overall Study|Withdrawal by Subject|6
7480949|NCT02035748|11789975|FG000|Overall Study|Progressive Disease|1
7480950|NCT02036294|11789982|FG000|Overall Study|Death|7
7480951|NCT02036294|11789983|FG001|Overall Study|Death|8
7480952|NCT02036294|11789982|FG000|Overall Study|Withdrawal by Subject|2
7480953|NCT02036294|11789983|FG001|Overall Study|Withdrawal by Subject|3
7480954|NCT02036502|11790013|FG000|Part 1:Dose Determination/Escalation|Death|3
7480955|NCT02036502|11790014|FG001|Part 1:Dose Determination/Escalation|Death|2
7480956|NCT02036502|11790015|FG002|Part 1:Dose Determination/Escalation|Death|0
7480957|NCT02036502|11790016|FG003|Part 1:Dose Determination/Escalation|Death|0
7480958|NCT02036502|11790017|FG004|Part 1:Dose Determination/Escalation|Death|0
7480959|NCT02036502|11790018|FG005|Part 1:Dose Determination/Escalation|Death|0
7480960|NCT02036502|11790019|FG006|Part 1:Dose Determination/Escalation|Death|0
7480961|NCT02036502|11790020|FG007|Part 1:Dose Determination/Escalation|Death|0
7480962|NCT02036502|11790013|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
7480963|NCT02036502|11790014|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480964|NCT02036502|11790015|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480965|NCT02036502|11790016|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480966|NCT02036502|11790017|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480967|NCT02036502|11790018|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480968|NCT02036502|11790019|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480969|NCT02036502|11790020|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
7480970|NCT02036502|11790013|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
7480971|NCT02036502|11790014|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
7480972|NCT02036502|11790015|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
7480973|NCT02036502|11790016|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
7480974|NCT02036502|11790017|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
7480975|NCT02036502|11790018|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
7480976|NCT02036502|11790019|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
7480977|NCT02036502|11790020|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
7480978|NCT02036502|11790013|FG000|Part 1:Dose Determination/Escalation|Not treated|0
7480979|NCT02036502|11790014|FG001|Part 1:Dose Determination/Escalation|Not treated|1
7480980|NCT02036502|11790015|FG002|Part 1:Dose Determination/Escalation|Not treated|0
7480981|NCT02036502|11790016|FG003|Part 1:Dose Determination/Escalation|Not treated|0
7480982|NCT02036502|11790017|FG004|Part 1:Dose Determination/Escalation|Not treated|0
7480983|NCT02036502|11790018|FG005|Part 1:Dose Determination/Escalation|Not treated|0
7480984|NCT02036502|11790019|FG006|Part 1:Dose Determination/Escalation|Not treated|0
7480985|NCT02036502|11790020|FG007|Part 1:Dose Determination/Escalation|Not treated|0
7480986|NCT02036502|11790013|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7480987|NCT02036502|11790014|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7480988|NCT02036502|11790015|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
7480989|NCT02036502|11790016|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7480990|NCT02036502|11790017|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
7480991|NCT02036502|11790018|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7480992|NCT02036502|11790019|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7480993|NCT02036502|11790020|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
7480994|NCT02036502|11790013|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
7480995|NCT02036502|11790014|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
7480996|NCT02036502|11790015|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
7480997|NCT02036502|11790016|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
7480998|NCT02036502|11790017|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
7480999|NCT02036502|11790018|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
7481000|NCT02036502|11790019|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
7481001|NCT02036502|11790020|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
7481002|NCT02036502|11790013|FG000|Part 2:Dose Confirmation|Death|0
7481003|NCT02036502|11790014|FG001|Part 2:Dose Confirmation|Death|0
7481004|NCT02036502|11790015|FG002|Part 2:Dose Confirmation|Death|1
7481005|NCT02036502|11790016|FG003|Part 2:Dose Confirmation|Death|0
7481006|NCT02036502|11790017|FG004|Part 2:Dose Confirmation|Death|0
7481007|NCT02036502|11790018|FG005|Part 2:Dose Confirmation|Death|0
7481008|NCT02036502|11790019|FG006|Part 2:Dose Confirmation|Death|0
7481009|NCT02036502|11790020|FG007|Part 2:Dose Confirmation|Death|0
7481010|NCT02036502|11790013|FG000|Part 2:Dose Confirmation|Not treated|0
7481011|NCT02036502|11790014|FG001|Part 2:Dose Confirmation|Not treated|0
7481012|NCT02036502|11790015|FG002|Part 2:Dose Confirmation|Not treated|0
7481013|NCT02036502|11790016|FG003|Part 2:Dose Confirmation|Not treated|1
7481014|NCT02036502|11790017|FG004|Part 2:Dose Confirmation|Not treated|0
7481015|NCT02036502|11790018|FG005|Part 2:Dose Confirmation|Not treated|0
7481016|NCT02036502|11790019|FG006|Part 2:Dose Confirmation|Not treated|0
7481017|NCT02036502|11790020|FG007|Part 2:Dose Confirmation|Not treated|0
7481018|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Adverse Event|0
7481019|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Adverse Event|0
7481020|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Adverse Event|0
7481021|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Adverse Event|0
7481022|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Adverse Event|0
7481023|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Adverse Event|4
7481024|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Adverse Event|0
7481025|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Adverse Event|2
7481026|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Death|0
7481027|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Death|0
7481028|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Death|0
7481029|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Death|0
7481030|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Death|0
7481031|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Death|24
7481032|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Death|0
7481033|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Death|3
7481034|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
7481035|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
7481036|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
7481037|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
7481038|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
7481039|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
7481040|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
7481041|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
7481042|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Physician Decision|0
7481043|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Physician Decision|0
7481044|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Physician Decision|0
7481045|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Physician Decision|0
7481046|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Physician Decision|0
7481047|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Physician Decision|1
7481048|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Physician Decision|0
7481049|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Physician Decision|0
7481050|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Progressive Disease|0
7481051|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Progressive Disease|0
7481052|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Progressive Disease|0
7481053|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Progressive Disease|0
7481054|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Progressive Disease|0
7481055|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Progressive Disease|1
7481056|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Progressive Disease|0
7481057|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Progressive Disease|0
7481058|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481059|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481060|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481061|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481062|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481063|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
7481064|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
7481065|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
7481066|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
7481067|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
7481068|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
7481069|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
7481070|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
7481071|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
7481072|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
7481073|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
7481074|NCT02036502|11790013|FG000|Part 3:Dose Expansion|Not Treated|0
7481075|NCT02036502|11790014|FG001|Part 3:Dose Expansion|Not Treated|0
7481076|NCT02036502|11790015|FG002|Part 3:Dose Expansion|Not Treated|0
7481077|NCT02036502|11790016|FG003|Part 3:Dose Expansion|Not Treated|0
7481078|NCT02036502|11790017|FG004|Part 3:Dose Expansion|Not Treated|0
7481079|NCT02036502|11790018|FG005|Part 3:Dose Expansion|Not Treated|2
7481080|NCT02036502|11790019|FG006|Part 3:Dose Expansion|Not Treated|0
7481081|NCT02036502|11790020|FG007|Part 3:Dose Expansion|Not Treated|0
7481082|NCT02036515|11790043|FG000|Overall Study|Adverse Event|1
7481083|NCT02036515|11790044|FG001|Overall Study|Adverse Event|1
7481084|NCT02036515|11790045|FG002|Overall Study|Adverse Event|2
7481085|NCT02036515|11790043|FG000|Overall Study|Lost to Follow-up|0
7481086|NCT02036515|11790044|FG001|Overall Study|Lost to Follow-up|2
7481087|NCT02036515|11790045|FG002|Overall Study|Lost to Follow-up|0
7481088|NCT02036515|11790043|FG000|Overall Study|Non-compliance with study drug|0
7481089|NCT02036515|11790044|FG001|Overall Study|Non-compliance with study drug|0
7481090|NCT02036515|11790045|FG002|Overall Study|Non-compliance with study drug|2
7481091|NCT02036515|11790043|FG000|Overall Study|Screen failure|0
7481092|NCT02036515|11790044|FG001|Overall Study|Screen failure|2
7481093|NCT02036515|11790045|FG002|Overall Study|Screen failure|0
7481094|NCT02036515|11790043|FG000|Overall Study|Withdrawal by Subject|4
7481095|NCT02036515|11790044|FG001|Overall Study|Withdrawal by Subject|7
7481096|NCT02036515|11790045|FG002|Overall Study|Withdrawal by Subject|9
7481097|NCT02036515|11790043|FG000|Overall Study|Hyperglycemia|0
7481098|NCT02036515|11790044|FG001|Overall Study|Hyperglycemia|0
7481099|NCT02036515|11790045|FG002|Overall Study|Hyperglycemia|1
7481100|NCT02036580|11790060|FG000|Overall Study|Withdrawal by Subject|0
7481101|NCT02036580|11790061|FG001|Overall Study|Withdrawal by Subject|1
7481102|NCT02036580|11790062|FG002|Overall Study|Withdrawal by Subject|0
7481103|NCT02036580|11790060|FG000|Overall Study|Adverse Event|1
7481104|NCT02036580|11790061|FG001|Overall Study|Adverse Event|0
7481105|NCT02036580|11790062|FG002|Overall Study|Adverse Event|0
7481106|NCT02036645|11790082|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481107|NCT02036645|11790083|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481108|NCT02036645|11790084|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481109|NCT02036645|11790085|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481110|NCT02036645|11790086|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481111|NCT02036645|11790087|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481112|NCT02036645|11790088|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
7481113|NCT02036645|11790089|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481114|NCT02036645|11790090|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481115|NCT02036645|11790091|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481116|NCT02036645|11790092|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481117|NCT02036645|11790093|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
7481118|NCT02036645|11790082|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481119|NCT02036645|11790083|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481120|NCT02036645|11790084|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481121|NCT02036645|11790085|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
7481122|NCT02036645|11790086|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481123|NCT02036645|11790087|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481124|NCT02036645|11790088|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481125|NCT02036645|11790089|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481126|NCT02036645|11790090|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481127|NCT02036645|11790091|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481128|NCT02036645|11790092|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481129|NCT02036645|11790093|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
7481130|NCT02036775|11790131|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7481131|NCT02036775|11790132|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7481132|NCT02036775|11790133|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7481133|NCT02036775|11790134|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7481134|NCT02036775|11790135|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
7481135|NCT02036775|11790136|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
7481136|NCT02036853|11790150|FG000|Overall Study|Adverse Event|0
7481137|NCT02036853|11790151|FG001|Overall Study|Adverse Event|2
7481138|NCT02036853|11790150|FG000|Overall Study|Lack of Efficacy|0
7481139|NCT02036853|11790151|FG001|Overall Study|Lack of Efficacy|2
7481140|NCT02036853|11790150|FG000|Overall Study|Physician Decision|0
7481141|NCT02036853|11790151|FG001|Overall Study|Physician Decision|1
7481142|NCT02036853|11790150|FG000|Overall Study|Withdrawal by Subject|0
7481143|NCT02036853|11790151|FG001|Overall Study|Withdrawal by Subject|1
7481144|NCT02037165|11790173|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7481145|NCT02037165|11790174|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7481146|NCT02037165|11790175|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7481147|NCT02037165|11790176|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
7481148|NCT02037165|11790177|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
7481149|NCT02037256|11790218|FG000|Overall Study|Protocol Violation|0
7481150|NCT02037256|11790219|FG001|Overall Study|Protocol Violation|1
7481151|NCT02037256|11790218|FG000|Overall Study|Withdrawn prior to Velcade|0
7481152|NCT02037256|11790219|FG001|Overall Study|Withdrawn prior to Velcade|2
7481153|NCT02037295|11790231|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7481154|NCT02037295|11790232|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7481155|NCT02037295|11790233|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
7481156|NCT02037295|11790234|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
7481157|NCT02037477|11790269|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7481158|NCT02037477|11790270|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7481159|NCT02037477|11790271|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
7481160|NCT02037477|11790272|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
7481161|NCT02037568|11790293|FG000|Overall Study|Withdrawal by Subject|17
7481162|NCT02037568|11790294|FG001|Overall Study|Withdrawal by Subject|24
7481163|NCT02037568|11790293|FG000|Overall Study|Lost to Follow-up|16
7481164|NCT02037568|11790294|FG001|Overall Study|Lost to Follow-up|13
7481165|NCT02037568|11790293|FG000|Overall Study|Screen Failure|3
7481166|NCT02037568|11790294|FG001|Overall Study|Screen Failure|1
7481167|NCT02037568|11790293|FG000|Overall Study|Patient did not receive transplant|0
7481168|NCT02037568|11790294|FG001|Overall Study|Patient did not receive transplant|1
7481169|NCT02037984|11790338|FG000|Overall Study|Lack of Efficacy|0
7481170|NCT02037984|11790339|FG001|Overall Study|Lack of Efficacy|0
7481171|NCT02037984|11790340|FG002|Overall Study|Lack of Efficacy|3
7481172|NCT02037984|11790341|FG003|Overall Study|Lack of Efficacy|10
7481173|NCT02037984|11790342|FG004|Overall Study|Lack of Efficacy|2
7481174|NCT02037984|11790343|FG005|Overall Study|Lack of Efficacy|2
7481175|NCT02037984|11790344|FG006|Overall Study|Lack of Efficacy|4
7481176|NCT02037984|11790345|FG007|Overall Study|Lack of Efficacy|3
7481177|NCT02037984|11790338|FG000|Overall Study|Lost to Follow-up|1
7481178|NCT02037984|11790339|FG001|Overall Study|Lost to Follow-up|0
7481179|NCT02037984|11790340|FG002|Overall Study|Lost to Follow-up|3
7481180|NCT02037984|11790341|FG003|Overall Study|Lost to Follow-up|5
7481181|NCT02037984|11790342|FG004|Overall Study|Lost to Follow-up|2
7481182|NCT02037984|11790343|FG005|Overall Study|Lost to Follow-up|2
7481183|NCT02037984|11790344|FG006|Overall Study|Lost to Follow-up|2
7481184|NCT02037984|11790345|FG007|Overall Study|Lost to Follow-up|4
7481185|NCT02037984|11790338|FG000|Overall Study|Physician Decision|0
7481186|NCT02037984|11790339|FG001|Overall Study|Physician Decision|0
7481187|NCT02037984|11790340|FG002|Overall Study|Physician Decision|0
7481188|NCT02037984|11790341|FG003|Overall Study|Physician Decision|0
7481189|NCT02037984|11790342|FG004|Overall Study|Physician Decision|0
7481190|NCT02037984|11790343|FG005|Overall Study|Physician Decision|0
7481191|NCT02037984|11790344|FG006|Overall Study|Physician Decision|1
7481192|NCT02037984|11790345|FG007|Overall Study|Physician Decision|0
7481193|NCT02037984|11790338|FG000|Overall Study|Protocol Violation|0
7481194|NCT02037984|11790339|FG001|Overall Study|Protocol Violation|0
7481195|NCT02037984|11790340|FG002|Overall Study|Protocol Violation|0
7481196|NCT02037984|11790341|FG003|Overall Study|Protocol Violation|0
7481197|NCT02037984|11790342|FG004|Overall Study|Protocol Violation|0
7481198|NCT02037984|11790343|FG005|Overall Study|Protocol Violation|1
7481199|NCT02037984|11790344|FG006|Overall Study|Protocol Violation|2
7481200|NCT02037984|11790345|FG007|Overall Study|Protocol Violation|0
7481201|NCT02037984|11790338|FG000|Overall Study|Technical Problems|0
7481202|NCT02037984|11790339|FG001|Overall Study|Technical Problems|0
7481203|NCT02037984|11790340|FG002|Overall Study|Technical Problems|3
7481204|NCT02037984|11790341|FG003|Overall Study|Technical Problems|3
7481205|NCT02037984|11790342|FG004|Overall Study|Technical Problems|2
7481206|NCT02037984|11790343|FG005|Overall Study|Technical Problems|3
7481207|NCT02037984|11790344|FG006|Overall Study|Technical Problems|4
7481208|NCT02037984|11790345|FG007|Overall Study|Technical Problems|2
7481209|NCT02037984|11790338|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7481210|NCT02037984|11790339|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7481211|NCT02037984|11790340|FG002|Overall Study|Withdrawal by Parent/Guardian|3
7481212|NCT02037984|11790341|FG003|Overall Study|Withdrawal by Parent/Guardian|2
7481213|NCT02037984|11790342|FG004|Overall Study|Withdrawal by Parent/Guardian|5
7481214|NCT02037984|11790343|FG005|Overall Study|Withdrawal by Parent/Guardian|1
7481215|NCT02037984|11790344|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7481216|NCT02037984|11790345|FG007|Overall Study|Withdrawal by Parent/Guardian|2
7481217|NCT02037984|11790338|FG000|Overall Study|Withdrawal by Subject|0
7481218|NCT02037984|11790339|FG001|Overall Study|Withdrawal by Subject|0
7481219|NCT02037984|11790340|FG002|Overall Study|Withdrawal by Subject|0
7481220|NCT02037984|11790341|FG003|Overall Study|Withdrawal by Subject|1
7481221|NCT02037984|11790342|FG004|Overall Study|Withdrawal by Subject|1
7481222|NCT02037984|11790343|FG005|Overall Study|Withdrawal by Subject|3
7481223|NCT02037984|11790344|FG006|Overall Study|Withdrawal by Subject|0
7481224|NCT02037984|11790345|FG007|Overall Study|Withdrawal by Subject|1
7481225|NCT02038010|11790373|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7481226|NCT02038010|11790374|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
7481227|NCT02038010|11790375|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7481228|NCT02038010|11790376|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
7481229|NCT02038010|11790373|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
7481230|NCT02038010|11790374|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7481231|NCT02038010|11790375|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7481232|NCT02038010|11790376|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
7481233|NCT02038010|11790373|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7481234|NCT02038010|11790374|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
7481235|NCT02038010|11790375|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7481236|NCT02038010|11790376|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
7481237|NCT02038010|11790373|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7481238|NCT02038010|11790374|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
7481239|NCT02038010|11790375|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7481240|NCT02038010|11790376|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
7481241|NCT02038010|11790373|FG000|Follow Up|Death|4
7481242|NCT02038010|11790374|FG001|Follow Up|Death|3
7481243|NCT02038010|11790375|FG002|Follow Up|Death|0
7481244|NCT02038010|11790376|FG003|Follow Up|Death|0
7481245|NCT02038010|11790373|FG000|Follow Up|Other|3
7481246|NCT02038010|11790374|FG001|Follow Up|Other|0
7481247|NCT02038010|11790375|FG002|Follow Up|Other|0
7481248|NCT02038010|11790376|FG003|Follow Up|Other|0
7481249|NCT02038036|11790392|FG000|Core Study|Adverse Event|7
7481250|NCT02038036|11790393|FG001|Core Study|Adverse Event|7
7481251|NCT02038036|11790392|FG000|Core Study|Death|1
7481252|NCT02038036|11790393|FG001|Core Study|Death|1
7481253|NCT02038036|11790392|FG000|Core Study|Disease progression|2
7481254|NCT02038036|11790393|FG001|Core Study|Disease progression|2
7481255|NCT02038036|11790392|FG000|Core Study|Lost to Follow-up|0
7481256|NCT02038036|11790393|FG001|Core Study|Lost to Follow-up|1
7481257|NCT02038036|11790392|FG000|Core Study|Physician Decision|2
7481258|NCT02038036|11790393|FG001|Core Study|Physician Decision|1
7481259|NCT02038036|11790392|FG000|Core Study|Subject/guardian decision|0
7481260|NCT02038036|11790393|FG001|Core Study|Subject/guardian decision|1
7481261|NCT02038036|11790392|FG000|Core Study|Withdrawal by Subject|3
7481262|NCT02038036|11790393|FG001|Core Study|Withdrawal by Subject|1
7481263|NCT02038036|11790392|FG000|Crossover Period|Withdrawal by Subject|0
7481264|NCT02038036|11790393|FG001|Crossover Period|Withdrawal by Subject|3
7481265|NCT02038036|11790392|FG000|Crossover Period|Adverse Event|0
7481266|NCT02038036|11790393|FG001|Crossover Period|Adverse Event|9
7481267|NCT02038036|11790392|FG000|Crossover Period|Death|0
7481268|NCT02038036|11790393|FG001|Crossover Period|Death|2
7481269|NCT02038036|11790392|FG000|Crossover Period|Disease progression|0
7481270|NCT02038036|11790393|FG001|Crossover Period|Disease progression|3
7481271|NCT02038036|11790392|FG000|Crossover Period|Lost to Follow-up|0
7481272|NCT02038036|11790393|FG001|Crossover Period|Lost to Follow-up|1
7481273|NCT02038036|11790392|FG000|Crossover Period|Physician Decision|0
7481274|NCT02038036|11790393|FG001|Crossover Period|Physician Decision|2
7481275|NCT02038049|11790404|FG000|Overall Study|Lost to Follow-up|1
7481276|NCT02038049|11790405|FG001|Overall Study|Lost to Follow-up|0
7481277|NCT02038075|11790417|FG000|Overall Study|Withdrawal by Subject|3
7481278|NCT02038075|11790418|FG001|Overall Study|Withdrawal by Subject|0
7534596|NCT02699684|11881544|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7534597|NCT02699684|11881545|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
7534598|NCT02699749|11881566|FG000|Overall Study|Other|0
7534599|NCT02699749|11881567|FG001|Overall Study|Other|0
7534600|NCT02699749|11881568|FG002|Overall Study|Other|2
7534601|NCT02699749|11881569|FG003|Overall Study|Other|0
7534602|NCT02699749|11881570|FG004|Overall Study|Other|0
7534603|NCT02699749|11881571|FG005|Overall Study|Other|1
7534604|NCT02699749|11881572|FG006|Overall Study|Other|1
7534605|NCT02699749|11881573|FG007|Overall Study|Other|0
7534606|NCT02699749|11881574|FG008|Overall Study|Other|0
7534607|NCT02699749|11881575|FG009|Overall Study|Other|0
7534608|NCT02699749|11881576|FG010|Overall Study|Other|1
7534609|NCT02699749|11881577|FG011|Overall Study|Other|0
7534610|NCT02699749|11881578|FG012|Overall Study|Other|0
7534611|NCT02699749|11881579|FG013|Overall Study|Other|0
7534612|NCT02699749|11881566|FG000|Overall Study|Progressive Disease|3
7534613|NCT02699749|11881567|FG001|Overall Study|Progressive Disease|3
7534614|NCT02699749|11881568|FG002|Overall Study|Progressive Disease|14
7534615|NCT02699749|11881569|FG003|Overall Study|Progressive Disease|3
7534616|NCT02699749|11881570|FG004|Overall Study|Progressive Disease|3
7534617|NCT02699749|11881571|FG005|Overall Study|Progressive Disease|7
7534618|NCT02699749|11881572|FG006|Overall Study|Progressive Disease|5
7534619|NCT02699749|11881573|FG007|Overall Study|Progressive Disease|5
7534620|NCT02699749|11881574|FG008|Overall Study|Progressive Disease|6
7534621|NCT02699749|11881575|FG009|Overall Study|Progressive Disease|6
7534622|NCT02699749|11881576|FG010|Overall Study|Progressive Disease|5
7534623|NCT02699749|11881577|FG011|Overall Study|Progressive Disease|4
7534624|NCT02699749|11881578|FG012|Overall Study|Progressive Disease|3
7534625|NCT02699749|11881579|FG013|Overall Study|Progressive Disease|5
7534626|NCT02699749|11881566|FG000|Overall Study|Death|0
7534627|NCT02699749|11881567|FG001|Overall Study|Death|0
7534628|NCT02699749|11881568|FG002|Overall Study|Death|0
7534629|NCT02699749|11881569|FG003|Overall Study|Death|0
7534630|NCT02699749|11881570|FG004|Overall Study|Death|0
7534631|NCT02699749|11881571|FG005|Overall Study|Death|0
7534632|NCT02699749|11881572|FG006|Overall Study|Death|0
7534633|NCT02699749|11881573|FG007|Overall Study|Death|0
7534634|NCT02699749|11881574|FG008|Overall Study|Death|0
7534635|NCT02699749|11881575|FG009|Overall Study|Death|0
7534636|NCT02699749|11881576|FG010|Overall Study|Death|0
7534637|NCT02699749|11881577|FG011|Overall Study|Death|0
7534638|NCT02699749|11881578|FG012|Overall Study|Death|0
7534639|NCT02699749|11881579|FG013|Overall Study|Death|1
7534640|NCT02699749|11881566|FG000|Overall Study|Lost to Follow-up|0
7534641|NCT02699749|11881567|FG001|Overall Study|Lost to Follow-up|0
7534642|NCT02699749|11881568|FG002|Overall Study|Lost to Follow-up|0
7534643|NCT02699749|11881569|FG003|Overall Study|Lost to Follow-up|0
7534644|NCT02699749|11881570|FG004|Overall Study|Lost to Follow-up|0
7534645|NCT02699749|11881571|FG005|Overall Study|Lost to Follow-up|1
7534646|NCT02699749|11881572|FG006|Overall Study|Lost to Follow-up|0
7534647|NCT02699749|11881573|FG007|Overall Study|Lost to Follow-up|1
7534648|NCT02699749|11881574|FG008|Overall Study|Lost to Follow-up|0
7534649|NCT02699749|11881575|FG009|Overall Study|Lost to Follow-up|0
7534650|NCT02699749|11881576|FG010|Overall Study|Lost to Follow-up|0
7534651|NCT02699749|11881577|FG011|Overall Study|Lost to Follow-up|0
7534652|NCT02699749|11881578|FG012|Overall Study|Lost to Follow-up|0
7534653|NCT02699749|11881579|FG013|Overall Study|Lost to Follow-up|0
7534654|NCT02699866|11881609|FG000|Overall Study|Withdrawal by Subject|3
7534655|NCT02699866|11881609|FG000|Overall Study|Physician Decision|2
7534656|NCT02699866|11881609|FG000|Overall Study|Adverse Event|3
7534657|NCT02699892|11881613|FG000|Overall Study|Other|36
7534658|NCT02699983|11881624|FG000|Overall Study|Withdrawal by Subject|1
7534659|NCT02699983|11881625|FG001|Overall Study|Withdrawal by Subject|0
7534660|NCT02699996|11881637|FG000|Overall Study|Withdrawal by Subject|5
7534661|NCT02699996|11881638|FG001|Overall Study|Withdrawal by Subject|2
7534662|NCT02700412|11881659|FG000|Overall Study|Adverse Event|6
7534663|NCT02700412|11881659|FG000|Overall Study|Death|1
7534664|NCT02700412|11881659|FG000|Overall Study|Lack of Efficacy|19
7534665|NCT02700412|11881659|FG000|Overall Study|Protocol Violation|5
7534666|NCT02700412|11881659|FG000|Overall Study|Withdrawal by Subject|2
7534667|NCT02700815|11881676|FG000|Overall Study|Adverse Event|0
7481279|NCT02038543|11790444|FG000|Overall Study|Screen Failure|0
7481280|NCT02038543|11790445|FG001|Overall Study|Screen Failure|0
7481281|NCT02038543|11790446|FG002|Overall Study|Screen Failure|0
7481282|NCT02038543|11790447|FG003|Overall Study|Screen Failure|1
7481283|NCT02038543|11790444|FG000|Overall Study|Withdrawal by Subject|0
7481284|NCT02038543|11790445|FG001|Overall Study|Withdrawal by Subject|0
7481285|NCT02038543|11790446|FG002|Overall Study|Withdrawal by Subject|0
7481286|NCT02038543|11790447|FG003|Overall Study|Withdrawal by Subject|1
7481287|NCT02038647|11790464|FG000|Overall Study|Progressive Disease|50
7481288|NCT02038647|11790465|FG001|Overall Study|Progressive Disease|59
7481289|NCT02038647|11790464|FG000|Overall Study|Adverse Event|18
7481290|NCT02038647|11790465|FG001|Overall Study|Adverse Event|10
7481291|NCT02038647|11790464|FG000|Overall Study|Symptomatic Deterioration|7
7481292|NCT02038647|11790465|FG001|Overall Study|Symptomatic Deterioration|7
7481293|NCT02038647|11790464|FG000|Overall Study|Withdrawal by Subject|5
7481294|NCT02038647|11790465|FG001|Overall Study|Withdrawal by Subject|2
7481295|NCT02038647|11790464|FG000|Overall Study|Not Reported|0
7481296|NCT02038647|11790465|FG001|Overall Study|Not Reported|1
7481297|NCT02038647|11790464|FG000|Overall Study|Ongoing at Datacut|9
7481298|NCT02038647|11790465|FG001|Overall Study|Ongoing at Datacut|10
7481299|NCT02038764|11790476|FG000|Overall Study|Adverse Event|0
7481300|NCT02038764|11790477|FG001|Overall Study|Adverse Event|0
7481301|NCT02038764|11790478|FG002|Overall Study|Adverse Event|1
7481302|NCT02038764|11790479|FG003|Overall Study|Adverse Event|0
7481303|NCT02038764|11790480|FG004|Overall Study|Adverse Event|0
7481304|NCT02038764|11790476|FG000|Overall Study|Lost to Follow-up|0
7481305|NCT02038764|11790477|FG001|Overall Study|Lost to Follow-up|1
7481306|NCT02038764|11790478|FG002|Overall Study|Lost to Follow-up|0
7481307|NCT02038764|11790479|FG003|Overall Study|Lost to Follow-up|0
7481308|NCT02038764|11790480|FG004|Overall Study|Lost to Follow-up|0
7481309|NCT02038764|11790476|FG000|Overall Study|Withdrawal by Subject|0
7481310|NCT02038764|11790477|FG001|Overall Study|Withdrawal by Subject|0
7481311|NCT02038764|11790478|FG002|Overall Study|Withdrawal by Subject|0
7481312|NCT02038764|11790479|FG003|Overall Study|Withdrawal by Subject|0
7481313|NCT02038764|11790480|FG004|Overall Study|Withdrawal by Subject|1
7481314|NCT02038764|11790476|FG000|Overall Study|Other|1
7481315|NCT02038764|11790477|FG001|Overall Study|Other|0
7481316|NCT02038764|11790478|FG002|Overall Study|Other|1
7481317|NCT02038764|11790479|FG003|Overall Study|Other|0
7481318|NCT02038764|11790480|FG004|Overall Study|Other|0
7481319|NCT02038790|11790496|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
7481320|NCT02038790|11790497|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
7481321|NCT02038829|11790504|FG000|Washout Period 1|Death|0
7481322|NCT02038829|11790505|FG001|Washout Period 1|Death|0
7481323|NCT02038829|11790506|FG002|Washout Period 1|Death|0
7481324|NCT02038829|11790507|FG003|Washout Period 1|Death|0
7481325|NCT02038829|11790508|FG004|Washout Period 1|Death|1
7481326|NCT02038829|11790509|FG005|Washout Period 1|Death|0
7481327|NCT02038829|11790510|FG006|Washout Period 1|Death|0
7481328|NCT02038829|11790511|FG007|Washout Period 1|Death|0
7481329|NCT02038829|11790512|FG008|Washout Period 1|Death|0
7481330|NCT02038829|11790513|FG009|Washout Period 1|Death|0
7481331|NCT02038829|11790514|FG010|Washout Period 1|Death|0
7481332|NCT02038829|11790515|FG011|Washout Period 1|Death|0
7481333|NCT02038829|11790504|FG000|Treatment Period 2|Adverse Event|0
7481334|NCT02038829|11790505|FG001|Treatment Period 2|Adverse Event|0
7481335|NCT02038829|11790506|FG002|Treatment Period 2|Adverse Event|0
7481336|NCT02038829|11790507|FG003|Treatment Period 2|Adverse Event|0
7481337|NCT02038829|11790508|FG004|Treatment Period 2|Adverse Event|0
7481338|NCT02038829|11790509|FG005|Treatment Period 2|Adverse Event|0
7481339|NCT02038829|11790510|FG006|Treatment Period 2|Adverse Event|0
7481340|NCT02038829|11790511|FG007|Treatment Period 2|Adverse Event|0
7481341|NCT02038829|11790512|FG008|Treatment Period 2|Adverse Event|0
7481342|NCT02038829|11790513|FG009|Treatment Period 2|Adverse Event|0
7481343|NCT02038829|11790514|FG010|Treatment Period 2|Adverse Event|1
7481344|NCT02038829|11790515|FG011|Treatment Period 2|Adverse Event|0
7481345|NCT02038829|11790504|FG000|Treatment Period 2|Withdrawal by Subject|1
7481346|NCT02038829|11790505|FG001|Treatment Period 2|Withdrawal by Subject|0
7481347|NCT02038829|11790506|FG002|Treatment Period 2|Withdrawal by Subject|0
7481348|NCT02038829|11790507|FG003|Treatment Period 2|Withdrawal by Subject|0
7481349|NCT02038829|11790508|FG004|Treatment Period 2|Withdrawal by Subject|0
7481350|NCT02038829|11790509|FG005|Treatment Period 2|Withdrawal by Subject|0
7481351|NCT02038829|11790510|FG006|Treatment Period 2|Withdrawal by Subject|0
7481352|NCT02038829|11790511|FG007|Treatment Period 2|Withdrawal by Subject|0
7481353|NCT02038829|11790512|FG008|Treatment Period 2|Withdrawal by Subject|0
7481354|NCT02038829|11790513|FG009|Treatment Period 2|Withdrawal by Subject|0
7481355|NCT02038829|11790514|FG010|Treatment Period 2|Withdrawal by Subject|0
7481356|NCT02038829|11790515|FG011|Treatment Period 2|Withdrawal by Subject|0
7481357|NCT02038829|11790504|FG000|Washout Period 2|Adverse Event|0
7481358|NCT02038829|11790505|FG001|Washout Period 2|Adverse Event|0
7481359|NCT02038829|11790506|FG002|Washout Period 2|Adverse Event|0
7481360|NCT02038829|11790507|FG003|Washout Period 2|Adverse Event|0
7481361|NCT02038829|11790508|FG004|Washout Period 2|Adverse Event|0
7481362|NCT02038829|11790509|FG005|Washout Period 2|Adverse Event|0
7481363|NCT02038829|11790510|FG006|Washout Period 2|Adverse Event|0
7481364|NCT02038829|11790511|FG007|Washout Period 2|Adverse Event|0
7481365|NCT02038829|11790512|FG008|Washout Period 2|Adverse Event|1
7481366|NCT02038829|11790513|FG009|Washout Period 2|Adverse Event|0
7481367|NCT02038829|11790514|FG010|Washout Period 2|Adverse Event|0
7481368|NCT02038829|11790515|FG011|Washout Period 2|Adverse Event|0
7481369|NCT02038829|11790504|FG000|Washout Period 2|Withdrawal by Subject|0
7481370|NCT02038829|11790505|FG001|Washout Period 2|Withdrawal by Subject|0
7481371|NCT02038829|11790506|FG002|Washout Period 2|Withdrawal by Subject|0
7481372|NCT02038829|11790507|FG003|Washout Period 2|Withdrawal by Subject|0
7481373|NCT02038829|11790508|FG004|Washout Period 2|Withdrawal by Subject|0
7481374|NCT02038829|11790509|FG005|Washout Period 2|Withdrawal by Subject|1
7481375|NCT02038829|11790510|FG006|Washout Period 2|Withdrawal by Subject|0
7481376|NCT02038829|11790511|FG007|Washout Period 2|Withdrawal by Subject|0
7481377|NCT02038829|11790512|FG008|Washout Period 2|Withdrawal by Subject|0
7481378|NCT02038829|11790513|FG009|Washout Period 2|Withdrawal by Subject|0
7481379|NCT02038829|11790514|FG010|Washout Period 2|Withdrawal by Subject|0
7481380|NCT02038829|11790515|FG011|Washout Period 2|Withdrawal by Subject|0
7481381|NCT02038829|11790504|FG000|Treatment Period 4|Adverse Event|0
7481382|NCT02038829|11790505|FG001|Treatment Period 4|Adverse Event|1
7481383|NCT02038829|11790506|FG002|Treatment Period 4|Adverse Event|0
7481384|NCT02038829|11790507|FG003|Treatment Period 4|Adverse Event|0
7481385|NCT02038829|11790508|FG004|Treatment Period 4|Adverse Event|0
7481386|NCT02038829|11790509|FG005|Treatment Period 4|Adverse Event|0
7481387|NCT02038829|11790510|FG006|Treatment Period 4|Adverse Event|0
7481388|NCT02038829|11790511|FG007|Treatment Period 4|Adverse Event|0
7481389|NCT02038829|11790512|FG008|Treatment Period 4|Adverse Event|0
7481390|NCT02038829|11790513|FG009|Treatment Period 4|Adverse Event|0
7481391|NCT02038829|11790514|FG010|Treatment Period 4|Adverse Event|0
7481392|NCT02038829|11790515|FG011|Treatment Period 4|Adverse Event|0
7481393|NCT02038829|11790504|FG000|Washout Period 4|Adverse Event|0
7481394|NCT02038829|11790505|FG001|Washout Period 4|Adverse Event|0
7481395|NCT02038829|11790506|FG002|Washout Period 4|Adverse Event|0
7481396|NCT02038829|11790507|FG003|Washout Period 4|Adverse Event|0
7481397|NCT02038829|11790508|FG004|Washout Period 4|Adverse Event|0
7481398|NCT02038829|11790509|FG005|Washout Period 4|Adverse Event|0
7481399|NCT02038829|11790510|FG006|Washout Period 4|Adverse Event|1
7481400|NCT02038829|11790511|FG007|Washout Period 4|Adverse Event|0
7481401|NCT02038829|11790512|FG008|Washout Period 4|Adverse Event|0
7481402|NCT02038829|11790513|FG009|Washout Period 4|Adverse Event|0
7481403|NCT02038829|11790514|FG010|Washout Period 4|Adverse Event|0
7481404|NCT02038829|11790515|FG011|Washout Period 4|Adverse Event|0
7481405|NCT02038829|11790504|FG000|Treatment Period 6|Adverse Event|0
7481406|NCT02038829|11790505|FG001|Treatment Period 6|Adverse Event|0
7481407|NCT02038829|11790506|FG002|Treatment Period 6|Adverse Event|1
7481408|NCT02038829|11790507|FG003|Treatment Period 6|Adverse Event|0
7481409|NCT02038829|11790508|FG004|Treatment Period 6|Adverse Event|0
7481410|NCT02038829|11790509|FG005|Treatment Period 6|Adverse Event|0
7481411|NCT02038829|11790510|FG006|Treatment Period 6|Adverse Event|0
7481412|NCT02038829|11790511|FG007|Treatment Period 6|Adverse Event|0
7481413|NCT02038829|11790512|FG008|Treatment Period 6|Adverse Event|0
7481414|NCT02038829|11790513|FG009|Treatment Period 6|Adverse Event|0
7481415|NCT02038829|11790514|FG010|Treatment Period 6|Adverse Event|0
7481416|NCT02038829|11790515|FG011|Treatment Period 6|Adverse Event|0
7481417|NCT02038881|11790533|FG000|Overall Study|Withdrawal by Subject|0
7481418|NCT02038881|11790534|FG001|Overall Study|Withdrawal by Subject|0
7481419|NCT02038881|11790535|FG002|Overall Study|Withdrawal by Subject|1
7481420|NCT02038881|11790533|FG000|Overall Study|Lost to Follow-up|2
7481421|NCT02038881|11790534|FG001|Overall Study|Lost to Follow-up|0
7481422|NCT02038881|11790535|FG002|Overall Study|Lost to Follow-up|0
7481423|NCT02038881|11790533|FG000|Overall Study|incarcerated|1
7481424|NCT02038881|11790534|FG001|Overall Study|incarcerated|0
7481425|NCT02038881|11790535|FG002|Overall Study|incarcerated|0
7481426|NCT02038907|11790576|FG000|Overall Study|Protocol Violation|0
7481427|NCT02038907|11790577|FG001|Overall Study|Protocol Violation|0
7481428|NCT02038907|11790578|FG002|Overall Study|Protocol Violation|0
7481429|NCT02038907|11790579|FG003|Overall Study|Protocol Violation|0
7481430|NCT02038907|11790580|FG004|Overall Study|Protocol Violation|0
7481431|NCT02038907|11790581|FG005|Overall Study|Protocol Violation|0
7481432|NCT02038907|11790582|FG006|Overall Study|Protocol Violation|0
7481433|NCT02038907|11790583|FG007|Overall Study|Protocol Violation|0
7481434|NCT02038907|11790584|FG008|Overall Study|Protocol Violation|0
7481435|NCT02038907|11790585|FG009|Overall Study|Protocol Violation|0
7481436|NCT02038907|11790586|FG010|Overall Study|Protocol Violation|1
7481437|NCT02038907|11790587|FG011|Overall Study|Protocol Violation|0
7481438|NCT02038907|11790588|FG012|Overall Study|Protocol Violation|0
7481439|NCT02038907|11790589|FG013|Overall Study|Protocol Violation|0
7481440|NCT02038907|11790576|FG000|Overall Study|Withdrawal by Subject|0
7481441|NCT02038907|11790577|FG001|Overall Study|Withdrawal by Subject|0
7481442|NCT02038907|11790578|FG002|Overall Study|Withdrawal by Subject|0
7481443|NCT02038907|11790579|FG003|Overall Study|Withdrawal by Subject|0
7481444|NCT02038907|11790580|FG004|Overall Study|Withdrawal by Subject|0
7481445|NCT02038907|11790581|FG005|Overall Study|Withdrawal by Subject|0
7481446|NCT02038907|11790582|FG006|Overall Study|Withdrawal by Subject|0
7481447|NCT02038907|11790583|FG007|Overall Study|Withdrawal by Subject|0
7481448|NCT02038907|11790584|FG008|Overall Study|Withdrawal by Subject|0
7481449|NCT02038907|11790585|FG009|Overall Study|Withdrawal by Subject|0
7481450|NCT02038907|11790586|FG010|Overall Study|Withdrawal by Subject|1
7481451|NCT02038907|11790587|FG011|Overall Study|Withdrawal by Subject|0
7481452|NCT02038907|11790588|FG012|Overall Study|Withdrawal by Subject|0
7481453|NCT02038907|11790589|FG013|Overall Study|Withdrawal by Subject|0
7481454|NCT02038920|11790623|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
7481455|NCT02038920|11790624|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
7481456|NCT02038920|11790625|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7481457|NCT02038920|11790626|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7481458|NCT02038920|11790627|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7481459|NCT02038920|11790628|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
7481460|NCT02038920|11790623|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
7481461|NCT02038920|11790624|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7481462|NCT02038920|11790625|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7481463|NCT02038920|11790626|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7481464|NCT02038920|11790627|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7481465|NCT02038920|11790628|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
7481466|NCT02038920|11790623|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7481467|NCT02038920|11790624|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
7481468|NCT02038920|11790625|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7481469|NCT02038920|11790626|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7481470|NCT02038920|11790627|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7481471|NCT02038920|11790628|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
7481472|NCT02038920|11790623|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7481546|NCT02039219|11790672|FG000|Follow up|Adverse Event|0
7481473|NCT02038920|11790624|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7481474|NCT02038920|11790625|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7481475|NCT02038920|11790626|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
7481476|NCT02038920|11790627|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
7481477|NCT02038920|11790628|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
7481478|NCT02038920|11790623|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7481479|NCT02038920|11790624|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7481480|NCT02038920|11790625|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
7481481|NCT02038920|11790626|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7481482|NCT02038920|11790627|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7481483|NCT02038920|11790628|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
7481484|NCT02038920|11790623|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7481485|NCT02038920|11790624|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7481486|NCT02038920|11790625|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
7481487|NCT02038920|11790626|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
7481488|NCT02038920|11790627|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
7481489|NCT02038920|11790628|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
7481490|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7481491|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7481492|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7481493|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7481494|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
7481495|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
7481496|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7481497|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7481498|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7481499|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7481500|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
7481501|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
7481502|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7481503|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7481504|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7481505|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7481506|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
7481507|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
7481508|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7481509|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7481510|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7481511|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7481512|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
7481513|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
7481514|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7481515|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7481516|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7481517|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7481518|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
7481519|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
7481520|NCT02038920|11790623|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7481521|NCT02038920|11790624|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7481522|NCT02038920|11790625|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7481523|NCT02038920|11790626|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7481524|NCT02038920|11790627|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
7481525|NCT02038920|11790628|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
7481526|NCT02038933|11790647|FG000|Overall Study|Disease progression|104
7481527|NCT02038933|11790647|FG000|Overall Study|Study drug toxicity|6
7481528|NCT02038933|11790647|FG000|Overall Study|Adverse event unrelated to study drug|6
7481529|NCT02038933|11790647|FG000|Overall Study|Participant request to discontinue treatment|2
7481530|NCT02038933|11790647|FG000|Overall Study|Lost to Follow-up|1
7481531|NCT02038933|11790647|FG000|Overall Study|Other reasons|2
7481532|NCT02038959|11790654|FG000|Overall Study|Withdrawal by Subject|6
7481533|NCT02038959|11790655|FG001|Overall Study|Withdrawal by Subject|8
7481534|NCT02039219|11790672|FG000|Treatment|Withdrawal by Subject|1
7481535|NCT02039219|11790673|FG001|Treatment|Withdrawal by Subject|0
7481536|NCT02039219|11790672|FG000|Treatment|Adverse Event|0
7481537|NCT02039219|11790673|FG001|Treatment|Adverse Event|1
7481538|NCT02039219|11790672|FG000|Treatment|Physician Decision|1
7481539|NCT02039219|11790673|FG001|Treatment|Physician Decision|0
7481540|NCT02039219|11790672|FG000|Treatment|Lost to Follow-up|0
7481541|NCT02039219|11790673|FG001|Treatment|Lost to Follow-up|1
7481542|NCT02039219|11790672|FG000|Treatment|Protocol Violation|1
7481543|NCT02039219|11790673|FG001|Treatment|Protocol Violation|0
7481544|NCT02039219|11790672|FG000|Treatment|Death|1
7481545|NCT02039219|11790673|FG001|Treatment|Death|0
7481547|NCT02039219|11790673|FG001|Follow up|Adverse Event|1
7481548|NCT02039375|11790679|FG000|Overall Study|Lost to Follow-up|2
7481549|NCT02039414|11790685|FG000|Overall Study|Delivered|1
7481550|NCT02039414|11790686|FG001|Overall Study|Delivered|1
7481551|NCT02039414|11790685|FG000|Overall Study|Lost to Follow-up|2
7481552|NCT02039414|11790686|FG001|Overall Study|Lost to Follow-up|0
7481553|NCT02039414|11790685|FG000|Overall Study|Protocol Violation|3
7481554|NCT02039414|11790686|FG001|Overall Study|Protocol Violation|1
7481555|NCT02039427|11790696|FG000|Overall Study|Duration of surgery > 3h|1
7481556|NCT02039427|11790697|FG001|Overall Study|Duration of surgery > 3h|1
7481557|NCT02039427|11790698|FG002|Overall Study|Duration of surgery > 3h|0
7481558|NCT02039427|11790699|FG003|Overall Study|Duration of surgery > 3h|0
7481559|NCT02039427|11790696|FG000|Overall Study|Withdrawal on concent|0
7481560|NCT02039427|11790697|FG001|Overall Study|Withdrawal on concent|0
7481561|NCT02039427|11790698|FG002|Overall Study|Withdrawal on concent|0
7481562|NCT02039427|11790699|FG003|Overall Study|Withdrawal on concent|1
7481563|NCT02039427|11790696|FG000|Overall Study|Cancellation of surgery|0
7481564|NCT02039427|11790697|FG001|Overall Study|Cancellation of surgery|0
7481565|NCT02039427|11790698|FG002|Overall Study|Cancellation of surgery|1
7481566|NCT02039427|11790699|FG003|Overall Study|Cancellation of surgery|0
7481567|NCT02039427|11790696|FG000|Overall Study|Loss of follow - up|1
7481568|NCT02039427|11790697|FG001|Overall Study|Loss of follow - up|0
7481569|NCT02039427|11790698|FG002|Overall Study|Loss of follow - up|2
7481570|NCT02039427|11790699|FG003|Overall Study|Loss of follow - up|4
7481571|NCT02039427|11790696|FG000|Overall Study|Steroid Use|1
7481572|NCT02039427|11790697|FG001|Overall Study|Steroid Use|0
7481573|NCT02039427|11790698|FG002|Overall Study|Steroid Use|0
7481574|NCT02039427|11790699|FG003|Overall Study|Steroid Use|0
7481575|NCT02039505|11790716|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
7481576|NCT02039505|11790717|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
7481577|NCT02039505|11790718|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
7481578|NCT02039505|11790719|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7481579|NCT02039505|11790720|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7481580|NCT02039505|11790721|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7481581|NCT02039505|11790722|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
7481582|NCT02039505|11790716|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7481583|NCT02039505|11790717|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
7481584|NCT02039505|11790718|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
7481585|NCT02039505|11790719|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7481586|NCT02039505|11790720|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7481587|NCT02039505|11790721|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7481588|NCT02039505|11790722|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
7481589|NCT02039505|11790716|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
7481590|NCT02039505|11790717|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481591|NCT02039505|11790718|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481592|NCT02039505|11790719|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481593|NCT02039505|11790720|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481594|NCT02039505|11790721|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481595|NCT02039505|11790722|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
7481596|NCT02039505|11790716|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7481597|NCT02039505|11790717|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7481598|NCT02039505|11790718|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7481599|NCT02039505|11790719|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
7481600|NCT02039505|11790720|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
7481601|NCT02039505|11790721|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
7481602|NCT02039505|11790722|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
7481603|NCT02039505|11790716|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7481604|NCT02039505|11790717|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7481605|NCT02039505|11790718|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7481606|NCT02039505|11790719|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
7481607|NCT02039505|11790720|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7481608|NCT02039505|11790721|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
7481609|NCT02039505|11790722|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
7481610|NCT02039505|11790716|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7481611|NCT02039505|11790717|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7481612|NCT02039505|11790718|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7481613|NCT02039505|11790719|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
7481614|NCT02039505|11790720|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
7481615|NCT02039505|11790721|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
7481616|NCT02039505|11790722|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
7481617|NCT02039505|11790716|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481618|NCT02039505|11790717|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481619|NCT02039505|11790718|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481620|NCT02039505|11790719|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
7481621|NCT02039505|11790720|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481622|NCT02039505|11790721|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481623|NCT02039505|11790722|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
7481624|NCT02039505|11790716|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481625|NCT02039505|11790717|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481626|NCT02039505|11790718|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481627|NCT02039505|11790719|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481628|NCT02039505|11790720|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481629|NCT02039505|11790721|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
7481630|NCT02039505|11790722|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
7481631|NCT02039505|11790716|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481632|NCT02039505|11790717|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481633|NCT02039505|11790718|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481634|NCT02039505|11790719|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481635|NCT02039505|11790720|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481636|NCT02039505|11790721|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
7481637|NCT02039505|11790722|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
7481638|NCT02039505|11790716|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481639|NCT02039505|11790717|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481640|NCT02039505|11790718|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481641|NCT02039505|11790719|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481642|NCT02039505|11790720|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481643|NCT02039505|11790721|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
7481644|NCT02039505|11790722|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
7481645|NCT02039505|11790716|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481646|NCT02039505|11790717|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481647|NCT02039505|11790718|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481648|NCT02039505|11790719|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481649|NCT02039505|11790720|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481650|NCT02039505|11790721|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
7481651|NCT02039505|11790722|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
7481652|NCT02039674|11790756|FG000|Overall Study|Adverse Event|0
7481653|NCT02039674|11790757|FG001|Overall Study|Adverse Event|0
7481654|NCT02039674|11790758|FG002|Overall Study|Adverse Event|1
7481655|NCT02039674|11790759|FG003|Overall Study|Adverse Event|1
7481656|NCT02039674|11790760|FG004|Overall Study|Adverse Event|0
7481657|NCT02039674|11790761|FG005|Overall Study|Adverse Event|0
7481658|NCT02039674|11790762|FG006|Overall Study|Adverse Event|0
7481659|NCT02039674|11790763|FG007|Overall Study|Adverse Event|0
7481660|NCT02039674|11790764|FG008|Overall Study|Adverse Event|2
7481661|NCT02039674|11790765|FG009|Overall Study|Adverse Event|0
7481662|NCT02039674|11790766|FG010|Overall Study|Adverse Event|0
7481663|NCT02039674|11790767|FG011|Overall Study|Adverse Event|2
7481664|NCT02039674|11790768|FG012|Overall Study|Adverse Event|2
7481665|NCT02039674|11790769|FG013|Overall Study|Adverse Event|1
7481666|NCT02039674|11790756|FG000|Overall Study|Death|0
7481667|NCT02039674|11790757|FG001|Overall Study|Death|0
7481668|NCT02039674|11790758|FG002|Overall Study|Death|1
7481669|NCT02039674|11790759|FG003|Overall Study|Death|2
7481670|NCT02039674|11790760|FG004|Overall Study|Death|0
7481671|NCT02039674|11790761|FG005|Overall Study|Death|0
7481672|NCT02039674|11790762|FG006|Overall Study|Death|0
7481673|NCT02039674|11790763|FG007|Overall Study|Death|0
7481674|NCT02039674|11790764|FG008|Overall Study|Death|0
7481675|NCT02039674|11790765|FG009|Overall Study|Death|0
7481676|NCT02039674|11790766|FG010|Overall Study|Death|1
7481677|NCT02039674|11790767|FG011|Overall Study|Death|1
7481678|NCT02039674|11790768|FG012|Overall Study|Death|0
7481679|NCT02039674|11790769|FG013|Overall Study|Death|8
7481680|NCT02039674|11790756|FG000|Overall Study|Excluded Medication|1
7481681|NCT02039674|11790757|FG001|Overall Study|Excluded Medication|1
7481682|NCT02039674|11790758|FG002|Overall Study|Excluded Medication|0
7481683|NCT02039674|11790759|FG003|Overall Study|Excluded Medication|1
7481684|NCT02039674|11790760|FG004|Overall Study|Excluded Medication|0
7481685|NCT02039674|11790761|FG005|Overall Study|Excluded Medication|1
7481686|NCT02039674|11790762|FG006|Overall Study|Excluded Medication|0
7481687|NCT02039674|11790763|FG007|Overall Study|Excluded Medication|0
7481688|NCT02039674|11790764|FG008|Overall Study|Excluded Medication|2
7481689|NCT02039674|11790765|FG009|Overall Study|Excluded Medication|2
7481690|NCT02039674|11790766|FG010|Overall Study|Excluded Medication|4
7481691|NCT02039674|11790767|FG011|Overall Study|Excluded Medication|2
7481692|NCT02039674|11790768|FG012|Overall Study|Excluded Medication|4
7481693|NCT02039674|11790769|FG013|Overall Study|Excluded Medication|3
7481694|NCT02039674|11790756|FG000|Overall Study|Lost to Follow-up|0
7481695|NCT02039674|11790757|FG001|Overall Study|Lost to Follow-up|0
7481696|NCT02039674|11790758|FG002|Overall Study|Lost to Follow-up|0
7481697|NCT02039674|11790759|FG003|Overall Study|Lost to Follow-up|0
7481698|NCT02039674|11790760|FG004|Overall Study|Lost to Follow-up|0
7481699|NCT02039674|11790761|FG005|Overall Study|Lost to Follow-up|0
7481700|NCT02039674|11790762|FG006|Overall Study|Lost to Follow-up|0
7481701|NCT02039674|11790763|FG007|Overall Study|Lost to Follow-up|0
7481702|NCT02039674|11790764|FG008|Overall Study|Lost to Follow-up|0
7481703|NCT02039674|11790765|FG009|Overall Study|Lost to Follow-up|0
7481704|NCT02039674|11790766|FG010|Overall Study|Lost to Follow-up|0
7481705|NCT02039674|11790767|FG011|Overall Study|Lost to Follow-up|0
7481706|NCT02039674|11790768|FG012|Overall Study|Lost to Follow-up|1
7481707|NCT02039674|11790769|FG013|Overall Study|Lost to Follow-up|0
7481708|NCT02039674|11790756|FG000|Overall Study|Physician Decision|0
7481709|NCT02039674|11790757|FG001|Overall Study|Physician Decision|0
7481710|NCT02039674|11790758|FG002|Overall Study|Physician Decision|0
7481711|NCT02039674|11790759|FG003|Overall Study|Physician Decision|0
7481712|NCT02039674|11790760|FG004|Overall Study|Physician Decision|0
7481713|NCT02039674|11790761|FG005|Overall Study|Physician Decision|0
7481714|NCT02039674|11790762|FG006|Overall Study|Physician Decision|0
7481715|NCT02039674|11790763|FG007|Overall Study|Physician Decision|0
7481716|NCT02039674|11790764|FG008|Overall Study|Physician Decision|0
7481717|NCT02039674|11790765|FG009|Overall Study|Physician Decision|0
7481718|NCT02039674|11790766|FG010|Overall Study|Physician Decision|0
7481719|NCT02039674|11790767|FG011|Overall Study|Physician Decision|1
7481720|NCT02039674|11790768|FG012|Overall Study|Physician Decision|0
7481721|NCT02039674|11790769|FG013|Overall Study|Physician Decision|0
7481722|NCT02039674|11790756|FG000|Overall Study|Progressive Disease|6
7481723|NCT02039674|11790757|FG001|Overall Study|Progressive Disease|7
7481724|NCT02039674|11790758|FG002|Overall Study|Progressive Disease|6
7481725|NCT02039674|11790759|FG003|Overall Study|Progressive Disease|7
7481726|NCT02039674|11790760|FG004|Overall Study|Progressive Disease|8
7481727|NCT02039674|11790761|FG005|Overall Study|Progressive Disease|10
7481728|NCT02039674|11790762|FG006|Overall Study|Progressive Disease|1
7481729|NCT02039674|11790763|FG007|Overall Study|Progressive Disease|3
7481730|NCT02039674|11790764|FG008|Overall Study|Progressive Disease|7
7481731|NCT02039674|11790765|FG009|Overall Study|Progressive Disease|2
7481732|NCT02039674|11790766|FG010|Overall Study|Progressive Disease|0
7481733|NCT02039674|11790767|FG011|Overall Study|Progressive Disease|17
7481734|NCT02039674|11790768|FG012|Overall Study|Progressive Disease|18
7481735|NCT02039674|11790769|FG013|Overall Study|Progressive Disease|16
7481736|NCT02039674|11790756|FG000|Overall Study|Withdrawal by Subject|0
7481737|NCT02039674|11790757|FG001|Overall Study|Withdrawal by Subject|2
7481738|NCT02039674|11790758|FG002|Overall Study|Withdrawal by Subject|1
7481739|NCT02039674|11790759|FG003|Overall Study|Withdrawal by Subject|0
7481740|NCT02039674|11790760|FG004|Overall Study|Withdrawal by Subject|1
7481741|NCT02039674|11790761|FG005|Overall Study|Withdrawal by Subject|0
7481742|NCT02039674|11790762|FG006|Overall Study|Withdrawal by Subject|0
7481743|NCT02039674|11790763|FG007|Overall Study|Withdrawal by Subject|0
7481744|NCT02039674|11790764|FG008|Overall Study|Withdrawal by Subject|0
7481745|NCT02039674|11790765|FG009|Overall Study|Withdrawal by Subject|2
7481746|NCT02039674|11790766|FG010|Overall Study|Withdrawal by Subject|1
7481747|NCT02039674|11790767|FG011|Overall Study|Withdrawal by Subject|3
7481748|NCT02039674|11790768|FG012|Overall Study|Withdrawal by Subject|5
7481749|NCT02039674|11790769|FG013|Overall Study|Withdrawal by Subject|2
7481750|NCT02039674|11790756|FG000|Overall Study|Ongoing in Study|5
7481751|NCT02039674|11790757|FG001|Overall Study|Ongoing in Study|2
7481752|NCT02039674|11790758|FG002|Overall Study|Ongoing in Study|3
7481753|NCT02039674|11790759|FG003|Overall Study|Ongoing in Study|2
7481754|NCT02039674|11790760|FG004|Overall Study|Ongoing in Study|3
7481755|NCT02039674|11790761|FG005|Overall Study|Ongoing in Study|1
7481756|NCT02039674|11790762|FG006|Overall Study|Ongoing in Study|2
7481757|NCT02039674|11790763|FG007|Overall Study|Ongoing in Study|0
7481758|NCT02039674|11790764|FG008|Overall Study|Ongoing in Study|1
7481759|NCT02039674|11790765|FG009|Overall Study|Ongoing in Study|6
7481760|NCT02039674|11790766|FG010|Overall Study|Ongoing in Study|1
7481761|NCT02039674|11790767|FG011|Overall Study|Ongoing in Study|34
7481762|NCT02039674|11790768|FG012|Overall Study|Ongoing in Study|33
7481763|NCT02039674|11790769|FG013|Overall Study|Ongoing in Study|3
7481764|NCT02039687|11790806|FG000|Overall Study|Adverse Event|0
7481765|NCT02039687|11790807|FG001|Overall Study|Adverse Event|0
7481766|NCT02039687|11790808|FG002|Overall Study|Adverse Event|1
7481767|NCT02039687|11790809|FG003|Overall Study|Adverse Event|0
7481768|NCT02039687|11790806|FG000|Overall Study|Withdrawal by Subject|0
7481769|NCT02039687|11790807|FG001|Overall Study|Withdrawal by Subject|1
7481770|NCT02039687|11790808|FG002|Overall Study|Withdrawal by Subject|0
7481771|NCT02039687|11790809|FG003|Overall Study|Withdrawal by Subject|0
7481772|NCT02039687|11790806|FG000|Overall Study|treatment assignment could not be confir|0
7481773|NCT02039687|11790807|FG001|Overall Study|treatment assignment could not be confir|0
7481774|NCT02039687|11790808|FG002|Overall Study|treatment assignment could not be confir|2
7481775|NCT02039687|11790809|FG003|Overall Study|treatment assignment could not be confir|0
7481776|NCT02039778|11790828|FG000|Overall Study|Death|2
7481777|NCT02039778|11790828|FG000|Overall Study|Withdrawal by Subject|1
7481778|NCT02039778|11790828|FG000|Overall Study|Never started the protocol treatment|1
7481779|NCT02039856|11790842|FG000|Overall Study|Death|5
7481780|NCT02039856|11790843|FG001|Overall Study|Death|3
7481781|NCT02039856|11790842|FG000|Overall Study|Partial survey completion|61
7481782|NCT02039856|11790843|FG001|Overall Study|Partial survey completion|26
7481783|NCT02039856|11790842|FG000|Overall Study|Lost to Follow-up|388
7481784|NCT02039856|11790843|FG001|Overall Study|Lost to Follow-up|206
7481785|NCT02039856|11790842|FG000|Overall Study|Withdrawal by Subject|1573
7481786|NCT02039856|11790843|FG001|Overall Study|Withdrawal by Subject|618
7481787|NCT02039908|11790851|FG000|Phase 1-Summer|Withdrawal by Subject|7
7481788|NCT02039908|11790852|FG001|Phase 1-Summer|Withdrawal by Subject|6
7481789|NCT02039908|11790853|FG002|Phase 1-Summer|Withdrawal by Subject|0
7481790|NCT02039908|11790854|FG003|Phase 1-Summer|Withdrawal by Subject|0
7481791|NCT02039908|11790851|FG000|Phase 1-Summer|Protocol Violation|6
7481792|NCT02039908|11790852|FG001|Phase 1-Summer|Protocol Violation|0
7481793|NCT02039908|11790853|FG002|Phase 1-Summer|Protocol Violation|0
7481794|NCT02039908|11790854|FG003|Phase 1-Summer|Protocol Violation|0
7481795|NCT02039908|11790851|FG000|Phase 2-School Year|Lost to Follow-up|0
7481796|NCT02039908|11790852|FG001|Phase 2-School Year|Lost to Follow-up|0
7481797|NCT02039908|11790853|FG002|Phase 2-School Year|Lost to Follow-up|1
7481798|NCT02039908|11790854|FG003|Phase 2-School Year|Lost to Follow-up|3
7481799|NCT02039908|11790851|FG000|Phase 2-School Year|Protocol Violation|0
7481800|NCT02039908|11790852|FG001|Phase 2-School Year|Protocol Violation|0
7481801|NCT02039908|11790853|FG002|Phase 2-School Year|Protocol Violation|3
7481802|NCT02039908|11790854|FG003|Phase 2-School Year|Protocol Violation|0
7481803|NCT02039908|11790851|FG000|Phase 2-School Year|Withdrawal by Subject|0
7481804|NCT02039908|11790852|FG001|Phase 2-School Year|Withdrawal by Subject|0
7481805|NCT02039908|11790853|FG002|Phase 2-School Year|Withdrawal by Subject|8
7481806|NCT02039908|11790854|FG003|Phase 2-School Year|Withdrawal by Subject|5
7481807|NCT02040090|11790899|FG000|Overall Study|Adverse Event|2
7481808|NCT02040090|11790900|FG001|Overall Study|Adverse Event|0
7481809|NCT02040090|11790899|FG000|Overall Study|Physician Decision|1
7481810|NCT02040090|11790900|FG001|Overall Study|Physician Decision|0
7481811|NCT02040090|11790899|FG000|Overall Study|Withdrawal by Subject|0
7481812|NCT02040090|11790900|FG001|Overall Study|Withdrawal by Subject|1
7481813|NCT02040090|11790899|FG000|Overall Study|Lost to Follow-up|0
7481814|NCT02040090|11790900|FG001|Overall Study|Lost to Follow-up|1
7481815|NCT02040259|11790914|FG000|Overall Study|Death|280
7481816|NCT02040259|11790914|FG000|Overall Study|Lost to Follow-up|76
7481817|NCT02040259|11790914|FG000|Overall Study|Assessment not completed|3
7481818|NCT02040259|11790914|FG000|Overall Study|Withdrawal by Subject|4
7481819|NCT02040428|11790937|FG000|Overall Study|Death|4
7481820|NCT02040428|11790938|FG001|Overall Study|Death|3
7481821|NCT02040428|11790937|FG000|Overall Study|Withdrawal by Subject|1
7481822|NCT02040428|11790938|FG001|Overall Study|Withdrawal by Subject|1
7481823|NCT02040532|11790944|FG000|Overall Study|Lost to Follow-up|1
7481824|NCT02040532|11790944|FG000|Overall Study|Physician Decision|4
7481825|NCT02040532|11790944|FG000|Overall Study|Adverse Event|4
7481826|NCT02040532|11790944|FG000|Overall Study|Withdrawal by Subject|3
7481827|NCT02040766|11790966|FG000|Overall Study|Adverse Event|1
7481828|NCT02040766|11790967|FG001|Overall Study|Adverse Event|1
7481829|NCT02040766|11790968|FG002|Overall Study|Adverse Event|1
7481830|NCT02040766|11790969|FG003|Overall Study|Adverse Event|0
7481831|NCT02040766|11790970|FG004|Overall Study|Adverse Event|2
7481832|NCT02040766|11790966|FG000|Overall Study|Withdrawal by Subject|4
7481833|NCT02040766|11790967|FG001|Overall Study|Withdrawal by Subject|3
7481834|NCT02040766|11790968|FG002|Overall Study|Withdrawal by Subject|2
7481835|NCT02040766|11790969|FG003|Overall Study|Withdrawal by Subject|3
7481836|NCT02040766|11790970|FG004|Overall Study|Withdrawal by Subject|2
7481837|NCT02040766|11790966|FG000|Overall Study|Non-compliance|0
7481838|NCT02040766|11790967|FG001|Overall Study|Non-compliance|1
7481839|NCT02040766|11790968|FG002|Overall Study|Non-compliance|0
7481840|NCT02040766|11790969|FG003|Overall Study|Non-compliance|0
7481841|NCT02040766|11790970|FG004|Overall Study|Non-compliance|0
7481842|NCT02040766|11790966|FG000|Overall Study|Protocol Violation|2
7481843|NCT02040766|11790967|FG001|Overall Study|Protocol Violation|1
7481844|NCT02040766|11790968|FG002|Overall Study|Protocol Violation|2
7481845|NCT02040766|11790969|FG003|Overall Study|Protocol Violation|3
7481846|NCT02040766|11790970|FG004|Overall Study|Protocol Violation|0
7481847|NCT02040766|11790966|FG000|Overall Study|Lost to Follow-up|4
7481848|NCT02040766|11790967|FG001|Overall Study|Lost to Follow-up|1
7481849|NCT02040766|11790968|FG002|Overall Study|Lost to Follow-up|3
7481850|NCT02040766|11790969|FG003|Overall Study|Lost to Follow-up|1
7481851|NCT02040766|11790970|FG004|Overall Study|Lost to Follow-up|4
7481852|NCT02040766|11790966|FG000|Overall Study|Not reported|1
7481853|NCT02040766|11790967|FG001|Overall Study|Not reported|0
7481854|NCT02040766|11790968|FG002|Overall Study|Not reported|0
7481855|NCT02040766|11790969|FG003|Overall Study|Not reported|0
7481856|NCT02040766|11790970|FG004|Overall Study|Not reported|0
7481857|NCT02040766|11790966|FG000|Overall Study|Lack of Efficacy|6
7481858|NCT02040766|11790967|FG001|Overall Study|Lack of Efficacy|3
7481859|NCT02040766|11790968|FG002|Overall Study|Lack of Efficacy|4
7481860|NCT02040766|11790969|FG003|Overall Study|Lack of Efficacy|6
7481861|NCT02040766|11790970|FG004|Overall Study|Lack of Efficacy|5
7481862|NCT02040779|11790986|FG000|Overall Study|Adverse Event|1
7481863|NCT02040779|11790987|FG001|Overall Study|Adverse Event|0
7481864|NCT02040779|11790988|FG002|Overall Study|Adverse Event|0
7481865|NCT02040779|11790986|FG000|Overall Study|Withdrawal by Subject|4
7481866|NCT02040779|11790987|FG001|Overall Study|Withdrawal by Subject|1
7481867|NCT02040779|11790988|FG002|Overall Study|Withdrawal by Subject|3
7481868|NCT02040779|11790986|FG000|Overall Study|Non-compliance|0
7481869|NCT02040779|11790987|FG001|Overall Study|Non-compliance|1
7481870|NCT02040779|11790988|FG002|Overall Study|Non-compliance|0
7481871|NCT02040779|11790986|FG000|Overall Study|Protocol Violation|2
7481872|NCT02040779|11790987|FG001|Overall Study|Protocol Violation|1
7481873|NCT02040779|11790988|FG002|Overall Study|Protocol Violation|0
7481874|NCT02040779|11790986|FG000|Overall Study|Lost to Follow-up|1
7481875|NCT02040779|11790987|FG001|Overall Study|Lost to Follow-up|2
7481876|NCT02040779|11790988|FG002|Overall Study|Lost to Follow-up|1
7481877|NCT02040779|11790986|FG000|Overall Study|Lack of Efficacy|4
7481878|NCT02040779|11790987|FG001|Overall Study|Lack of Efficacy|2
7481879|NCT02040779|11790988|FG002|Overall Study|Lack of Efficacy|0
7481880|NCT02040805|11790998|FG000|Overall Study|Lost to Follow-up|14
7481881|NCT02040805|11790999|FG001|Overall Study|Lost to Follow-up|9
7481882|NCT02040805|11790998|FG000|Overall Study|Withdrawal by Subject|28
7481883|NCT02040805|11790999|FG001|Overall Study|Withdrawal by Subject|41
7481884|NCT02040844|11791008|FG000|Overall Study|Adverse Event|0
7481885|NCT02040844|11791009|FG001|Overall Study|Adverse Event|0
7481886|NCT02040844|11791010|FG002|Overall Study|Adverse Event|1
7481887|NCT02040844|11791008|FG000|Overall Study|Withdrawal by Subject|16
7481888|NCT02040844|11791009|FG001|Overall Study|Withdrawal by Subject|22
7481889|NCT02040844|11791010|FG002|Overall Study|Withdrawal by Subject|25
7481890|NCT02040844|11791008|FG000|Overall Study|Lost to Follow-up|12
7481891|NCT02040844|11791009|FG001|Overall Study|Lost to Follow-up|9
7481892|NCT02040844|11791010|FG002|Overall Study|Lost to Follow-up|13
7481893|NCT02040844|11791008|FG000|Overall Study|Missing|13
7481894|NCT02040844|11791009|FG001|Overall Study|Missing|3
7481895|NCT02040844|11791010|FG002|Overall Study|Missing|2
7481896|NCT02040844|11791008|FG000|Overall Study|Non-specified|8
7481897|NCT02040844|11791009|FG001|Overall Study|Non-specified|2
7481898|NCT02040844|11791010|FG002|Overall Study|Non-specified|5
7481899|NCT02040844|11791008|FG000|Overall Study|Concomitant medication|1
7481900|NCT02040844|11791009|FG001|Overall Study|Concomitant medication|3
7481901|NCT02040844|11791010|FG002|Overall Study|Concomitant medication|1
7481902|NCT02040870|11791018|FG000|Overall Study|Completed treatment phase|6
7481903|NCT02040870|11791018|FG000|Overall Study|Adverse Event|7
7481904|NCT02040870|11791018|FG000|Overall Study|Progressive disease|58
7481905|NCT02040870|11791018|FG000|Overall Study|Physician Decision|6
7481906|NCT02040870|11791018|FG000|Overall Study|Subject/guardian decision|10
7481907|NCT02040870|11791018|FG000|Overall Study|Lost to Follow-up|3
7481908|NCT02040870|11791018|FG000|Overall Study|Death|13
7481909|NCT02041091|11791024|FG000|Treatment|Adverse Event|3
7481910|NCT02041091|11791025|FG001|Treatment|Adverse Event|3
7481911|NCT02041091|11791024|FG000|Treatment|Withdrawal by Subject|2
7481912|NCT02041091|11791025|FG001|Treatment|Withdrawal by Subject|4
7481913|NCT02041091|11791024|FG000|Treatment|Physician Decision|1
7481914|NCT02041091|11791025|FG001|Treatment|Physician Decision|0
7481915|NCT02041091|11791024|FG000|Treatment|Sponsor Decision|15
7481916|NCT02041091|11791025|FG001|Treatment|Sponsor Decision|16
7481917|NCT02041091|11791024|FG000|Treatment|Lost to Follow-up|1
7481918|NCT02041091|11791025|FG001|Treatment|Lost to Follow-up|0
7481919|NCT02041091|11791024|FG000|Optional Safety Extension Period|Adverse Event|4
7481920|NCT02041091|11791025|FG001|Optional Safety Extension Period|Adverse Event|2
7481921|NCT02041091|11791024|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
7481922|NCT02041091|11791025|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
7481923|NCT02041091|11791024|FG000|Optional Safety Extension Period|Protocol Violation|2
7481924|NCT02041091|11791025|FG001|Optional Safety Extension Period|Protocol Violation|0
7481925|NCT02041091|11791024|FG000|Optional Safety Extension Period|Physician Decision|2
7481926|NCT02041091|11791025|FG001|Optional Safety Extension Period|Physician Decision|1
7481927|NCT02041091|11791024|FG000|Optional Safety Extension Period|Sponsor Decision|70
7481928|NCT02041091|11791025|FG001|Optional Safety Extension Period|Sponsor Decision|74
7481929|NCT02041091|11791024|FG000|Optional Safety Extension Period|Lost to Follow-up|2
7481930|NCT02041091|11791025|FG001|Optional Safety Extension Period|Lost to Follow-up|3
7481931|NCT02041104|11791039|FG000|Overall Study|Lost to Follow-up|1
7481932|NCT02041104|11791040|FG001|Overall Study|Lost to Follow-up|4
7481933|NCT02041104|11791039|FG000|Overall Study|discomfort during OGTT|0
7481934|NCT02041104|11791040|FG001|Overall Study|discomfort during OGTT|3
7481935|NCT02041286|11791073|FG000|Overall Study|Adverse Event|1
7481936|NCT02041299|11791081|FG000|Overall Study|Adverse Event|9
7481937|NCT02041299|11791082|FG001|Overall Study|Adverse Event|3
7481938|NCT02041299|11791081|FG000|Overall Study|Lost to Follow-up|4
7481939|NCT02041299|11791082|FG001|Overall Study|Lost to Follow-up|1
7481940|NCT02041299|11791081|FG000|Overall Study|Physician Decision|1
7481941|NCT02041299|11791082|FG001|Overall Study|Physician Decision|1
7481942|NCT02041299|11791081|FG000|Overall Study|Withdrawal by Subject|13
7481943|NCT02041299|11791082|FG001|Overall Study|Withdrawal by Subject|7
7481944|NCT02041299|11791081|FG000|Overall Study|Protocol Violation|11
7481945|NCT02041299|11791082|FG001|Overall Study|Protocol Violation|4
7481946|NCT02041299|11791081|FG000|Overall Study|Termination of the study|7
7481947|NCT02041299|11791082|FG001|Overall Study|Termination of the study|3
7481948|NCT02041299|11791081|FG000|Overall Study|Required bone marrow transplant|0
7481949|NCT02041299|11791082|FG001|Overall Study|Required bone marrow transplant|1
7481950|NCT02041299|11791081|FG000|Overall Study|Patient stopped dosing on unknown date|1
7481951|NCT02041299|11791082|FG001|Overall Study|Patient stopped dosing on unknown date|0
7481952|NCT02041429|11791113|FG000|Overall Study|Progressive Disease|2
7481953|NCT02041429|11791114|FG001|Overall Study|Progressive Disease|2
7481954|NCT02041429|11791115|FG002|Overall Study|Progressive Disease|3
7481955|NCT02041429|11791116|FG003|Overall Study|Progressive Disease|2
7481956|NCT02041429|11791113|FG000|Overall Study|Toxicity|0
7481957|NCT02041429|11791114|FG001|Overall Study|Toxicity|1
7481958|NCT02041429|11791115|FG002|Overall Study|Toxicity|4
7481959|NCT02041429|11791116|FG003|Overall Study|Toxicity|2
7481960|NCT02041429|11791113|FG000|Overall Study|Withdrawal by Subject|0
7481961|NCT02041429|11791114|FG001|Overall Study|Withdrawal by Subject|1
7481962|NCT02041429|11791115|FG002|Overall Study|Withdrawal by Subject|0
7481963|NCT02041429|11791116|FG003|Overall Study|Withdrawal by Subject|0
7481964|NCT02041429|11791113|FG000|Overall Study|On Maintenance Therapy|1
7481965|NCT02041429|11791114|FG001|Overall Study|On Maintenance Therapy|0
7481966|NCT02041429|11791115|FG002|Overall Study|On Maintenance Therapy|0
7481967|NCT02041429|11791116|FG003|Overall Study|On Maintenance Therapy|2
7481968|NCT02041494|11791133|FG000|Overall Study|Death|1
7481969|NCT02041494|11791134|FG001|Overall Study|Death|3
7481970|NCT02041494|11791133|FG000|Overall Study|Lost to Follow-up|2
7481971|NCT02041494|11791134|FG001|Overall Study|Lost to Follow-up|6
7481972|NCT02041494|11791133|FG000|Overall Study|study terminated|16
7481973|NCT02041494|11791134|FG001|Overall Study|study terminated|11
7481974|NCT02041520|11791143|FG000|Overall Study|Adverse Event|2
7481975|NCT02041520|11791144|FG001|Overall Study|Adverse Event|1
7481976|NCT02041520|11791143|FG000|Overall Study|Withdrawal by Subject|3
7481977|NCT02041520|11791144|FG001|Overall Study|Withdrawal by Subject|4
7481978|NCT02041520|11791143|FG000|Overall Study|Protocol Violation|1
7481979|NCT02041520|11791144|FG001|Overall Study|Protocol Violation|0
7481980|NCT02041520|11791143|FG000|Overall Study|Lost to Follow-up|0
7481981|NCT02041520|11791144|FG001|Overall Study|Lost to Follow-up|1
7481982|NCT02041520|11791143|FG000|Overall Study|Hypothiroidism identified during follow-|0
7481983|NCT02041520|11791144|FG001|Overall Study|Hypothiroidism identified during follow-|1
7481984|NCT02041702|11791154|FG000|Overall Study|Lost to Follow-up|1
7481985|NCT02041702|11791155|FG001|Overall Study|Lost to Follow-up|6
7481986|NCT02041702|11791154|FG000|Overall Study|Death|4
7481987|NCT02041702|11791155|FG001|Overall Study|Death|0
7481988|NCT02041702|11791154|FG000|Overall Study|Withdrawal by Subject|4
7481989|NCT02041702|11791155|FG001|Overall Study|Withdrawal by Subject|3
7481990|NCT02041702|11791154|FG000|Overall Study|Patient not confirmed as MRI compatible|1
7481991|NCT02041702|11791155|FG001|Overall Study|Patient not confirmed as MRI compatible|0
7481992|NCT02041702|11791154|FG000|Overall Study|Cardiac Resynchronization Therapy|1
7481993|NCT02041702|11791155|FG001|Overall Study|Cardiac Resynchronization Therapy|0
7481994|NCT02041923|11791163|FG000|Overall Study|Lost to Follow-up|26
7481995|NCT02041923|11791164|FG001|Overall Study|Lost to Follow-up|30
7481996|NCT02041962|11791174|FG000|Overall Study|Lost Aetna Coverage|43
7481997|NCT02041962|11791175|FG001|Overall Study|Lost Aetna Coverage|40
7481998|NCT02041962|11791174|FG000|Overall Study|Death|1
7481999|NCT02041962|11791175|FG001|Overall Study|Death|1
7482000|NCT02041962|11791174|FG000|Overall Study|Lost to Follow-up|37
7482001|NCT02041962|11791175|FG001|Overall Study|Lost to Follow-up|32
7482002|NCT02041962|11791174|FG000|Overall Study|Withdrawal by Subject|0
7482003|NCT02041962|11791175|FG001|Overall Study|Withdrawal by Subject|11
7482004|NCT02042014|11791181|FG000|Overall Study|Adverse Event|1
7482005|NCT02042014|11791181|FG000|Overall Study|Physician Decision|7
7482006|NCT02042183|11791202|FG000|Overall Study|Physician Decision|7
7482007|NCT02042183|11791203|FG001|Overall Study|Physician Decision|2
7482008|NCT02042183|11791202|FG000|Overall Study|Lack of Efficacy|4
7482009|NCT02042183|11791203|FG001|Overall Study|Lack of Efficacy|3
7482010|NCT02042183|11791202|FG000|Overall Study|Non-compliance with Study Drug|2
7482011|NCT02042183|11791203|FG001|Overall Study|Non-compliance with Study Drug|3
7482012|NCT02042183|11791202|FG000|Overall Study|Adverse Event|17
7482013|NCT02042183|11791203|FG001|Overall Study|Adverse Event|6
7482014|NCT02042183|11791202|FG000|Overall Study|Other|3
7482015|NCT02042183|11791203|FG001|Overall Study|Other|3
7482016|NCT02042183|11791202|FG000|Overall Study|Withdrawal by Subject|21
7482017|NCT02042183|11791203|FG001|Overall Study|Withdrawal by Subject|16
7482018|NCT02042183|11791202|FG000|Overall Study|Site Terminated by Sponsor|2
7482019|NCT02042183|11791203|FG001|Overall Study|Site Terminated by Sponsor|1
7482020|NCT02042183|11791202|FG000|Overall Study|Lost to Follow-up|9
7482021|NCT02042183|11791203|FG001|Overall Study|Lost to Follow-up|2
7482022|NCT02042404|11791215|FG000|Overall Study|Death|1
7482023|NCT02042404|11791216|FG001|Overall Study|Death|0
7482024|NCT02042404|11791215|FG000|Overall Study|Unrelated Adverse Event|3
7482025|NCT02042404|11791216|FG001|Overall Study|Unrelated Adverse Event|0
7482026|NCT02042404|11791215|FG000|Overall Study|Inability to meet time requirements|1
7482027|NCT02042404|11791216|FG001|Overall Study|Inability to meet time requirements|0
7482028|NCT02042443|11791225|FG000|Overall Study|Adverse Event|2
7482029|NCT02042443|11791226|FG001|Overall Study|Adverse Event|1
7482030|NCT02042443|11791225|FG000|Overall Study|Withdrawal by Subject|0
7482031|NCT02042443|11791226|FG001|Overall Study|Withdrawal by Subject|1
7482032|NCT02042443|11791225|FG000|Overall Study|Progression|21
7482033|NCT02042443|11791226|FG001|Overall Study|Progression|17
7482034|NCT02042443|11791225|FG000|Overall Study|not protocol specified|1
7482035|NCT02042443|11791226|FG001|Overall Study|not protocol specified|1
7482036|NCT02042443|11791225|FG000|Overall Study|Not eligible/not analyzable|3
7482037|NCT02042443|11791226|FG001|Overall Study|Not eligible/not analyzable|6
7482038|NCT02043015|11791255|FG000|Overall Study|Lost to Follow-up|4
7482039|NCT02043015|11791255|FG000|Overall Study|Withdrawal by Subject|4
7482040|NCT02043015|11791255|FG000|Overall Study|Removed once target enrollment reached|15
7482041|NCT02043015|11791255|FG000|Overall Study|Participant moved away from study city|4
7482042|NCT02043015|11791255|FG000|Overall Study|Incarceration|1
7482043|NCT02043132|11791263|FG000|Overall Study|Lost to Follow-up|1
7482044|NCT02043132|11791264|FG001|Overall Study|Lost to Follow-up|1
7482045|NCT02043132|11791263|FG000|Overall Study|screen failures|4
7482046|NCT02043132|11791264|FG001|Overall Study|screen failures|8
7482047|NCT02043301|11791292|FG000|Overall Study|Discontinued|0
7482048|NCT02043301|11791293|FG001|Overall Study|Discontinued|1
7482049|NCT02043301|11791294|FG002|Overall Study|Discontinued|0
7482050|NCT02043366|11791308|FG000|Overall Study|Lost to Follow-up|2
7482051|NCT02043366|11791309|FG001|Overall Study|Lost to Follow-up|2
7482052|NCT02043366|11791310|FG002|Overall Study|Lost to Follow-up|2
7482053|NCT02043366|11791311|FG003|Overall Study|Lost to Follow-up|2
7482054|NCT02043366|11791312|FG004|Overall Study|Lost to Follow-up|2
7482055|NCT02043366|11791313|FG005|Overall Study|Lost to Follow-up|2
7482056|NCT02043509|11791340|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
7482057|NCT02043509|11791341|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
7482058|NCT02043509|11791340|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
7482059|NCT02043509|11791341|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
7482060|NCT02043509|11791340|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
7482061|NCT02043509|11791341|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
7482062|NCT02043509|11791340|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
7482063|NCT02043509|11791341|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
7482064|NCT02043548|11791349|FG000|Overall Study|Lack of Efficacy|1
7482065|NCT02043548|11791350|FG001|Overall Study|Lack of Efficacy|0
7482066|NCT02043548|11791349|FG000|Overall Study|Adverse Event|0
7482067|NCT02043548|11791350|FG001|Overall Study|Adverse Event|1
7482068|NCT02043782|11791379|FG000|Period 1|Adverse Event|0
7482069|NCT02043782|11791380|FG001|Period 1|Adverse Event|0
7482070|NCT02043782|11791381|FG002|Period 1|Adverse Event|1
7482071|NCT02043782|11791382|FG003|Period 1|Adverse Event|0
7482072|NCT02043782|11791383|FG004|Period 1|Adverse Event|0
7482073|NCT02043782|11791384|FG005|Period 1|Adverse Event|0
7482074|NCT02043899|11791401|FG000|Overall Study|Adverse Event|3
7482075|NCT02043899|11791401|FG000|Overall Study|Physician Decision|1
7482076|NCT02043899|11791401|FG000|Overall Study|Withdrawal by Subject|2
7482077|NCT02043899|11791401|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
7482078|NCT02043899|11791401|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
7482079|NCT02043899|11791401|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
7482080|NCT02043899|11791401|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
7482081|NCT02043899|11791401|FG000|Overall Study|Treatment delayed|1
7482082|NCT02043938|11791405|FG000|Overall Study|Withdrawal by Subject|7
7482083|NCT02043938|11791405|FG000|Overall Study|Unable to place EEG sensors on patient|1
7482084|NCT02043938|11791405|FG000|Overall Study|No show by subject|1
7482085|NCT02043938|11791405|FG000|Overall Study|Investigator decision|1
7482086|NCT02044094|11791412|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
7482087|NCT02044094|11791412|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
7482088|NCT02044094|11791412|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
7482089|NCT02044094|11791412|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
7482090|NCT02044094|11791412|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
7482091|NCT02044094|11791412|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
7482092|NCT02044094|11791412|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
7482093|NCT02044094|11791412|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
7482094|NCT02044159|11791429|FG000|Overall Study|Consent declined (deferred consent)|2
7482095|NCT02044159|11791430|FG001|Overall Study|Consent declined (deferred consent)|4
7482096|NCT02044159|11791429|FG000|Overall Study|No longer eligible, drug not given|1
7482097|NCT02044159|11791430|FG001|Overall Study|No longer eligible, drug not given|0
7482098|NCT02044159|11791429|FG000|Overall Study|Nurse declined to give study drug|1
7482099|NCT02044159|11791430|FG001|Overall Study|Nurse declined to give study drug|0
7482100|NCT02044458|11791488|FG000|Overall Study|Protocol Violation|3
7482101|NCT02044458|11791489|FG001|Overall Study|Protocol Violation|8
7482102|NCT02044510|11791497|FG000|Overall Study|Adverse Event|1
7482103|NCT02044510|11791498|FG001|Overall Study|Adverse Event|2
7482104|NCT02044874|11791536|FG000|Overall Study|Adverse Event|5
7482105|NCT02044874|11791537|FG001|Overall Study|Adverse Event|6
7482106|NCT02044874|11791538|FG002|Overall Study|Adverse Event|6
7482107|NCT02044874|11791536|FG000|Overall Study|Withdrawal by Subject|8
7482108|NCT02044874|11791537|FG001|Overall Study|Withdrawal by Subject|16
7482109|NCT02044874|11791538|FG002|Overall Study|Withdrawal by Subject|23
7482110|NCT02044874|11791536|FG000|Overall Study|Physician Decision|0
7482111|NCT02044874|11791537|FG001|Overall Study|Physician Decision|2
7482112|NCT02044874|11791538|FG002|Overall Study|Physician Decision|1
7482113|NCT02044874|11791536|FG000|Overall Study|Lost to Follow-up|10
7482114|NCT02044874|11791537|FG001|Overall Study|Lost to Follow-up|27
7482115|NCT02044874|11791538|FG002|Overall Study|Lost to Follow-up|21
7482116|NCT02044874|11791536|FG000|Overall Study|Sponsor Decision|0
7482117|NCT02044874|11791537|FG001|Overall Study|Sponsor Decision|1
7482118|NCT02044874|11791538|FG002|Overall Study|Sponsor Decision|1
7482119|NCT02044874|11791536|FG000|Overall Study|Other|7
7482120|NCT02044874|11791537|FG001|Overall Study|Other|3
7482121|NCT02044874|11791538|FG002|Overall Study|Other|8
7482122|NCT02045095|11791557|FG000|Overall Study|Other|0
7482123|NCT02045095|11791558|FG001|Overall Study|Other|0
7482124|NCT02045095|11791559|FG002|Overall Study|Other|1
7482125|NCT02045095|11791560|FG003|Overall Study|Other|0
7482126|NCT02045095|11791561|FG004|Overall Study|Other|0
7482127|NCT02045095|11791562|FG005|Overall Study|Other|2
7482128|NCT02045095|11791563|FG006|Overall Study|Other|0
7482129|NCT02045095|11791557|FG000|Overall Study|Progressive Disease|3
7482130|NCT02045095|11791558|FG001|Overall Study|Progressive Disease|3
7482131|NCT02045095|11791559|FG002|Overall Study|Progressive Disease|2
7482132|NCT02045095|11791560|FG003|Overall Study|Progressive Disease|4
7482133|NCT02045095|11791561|FG004|Overall Study|Progressive Disease|2
7482134|NCT02045095|11791562|FG005|Overall Study|Progressive Disease|4
7482135|NCT02045095|11791563|FG006|Overall Study|Progressive Disease|1
7482136|NCT02045095|11791557|FG000|Overall Study|Withdrawal by Subject|0
7482137|NCT02045095|11791558|FG001|Overall Study|Withdrawal by Subject|0
7482138|NCT02045095|11791559|FG002|Overall Study|Withdrawal by Subject|0
7482139|NCT02045095|11791560|FG003|Overall Study|Withdrawal by Subject|0
7482140|NCT02045095|11791561|FG004|Overall Study|Withdrawal by Subject|3
7482141|NCT02045095|11791562|FG005|Overall Study|Withdrawal by Subject|0
7482142|NCT02045095|11791563|FG006|Overall Study|Withdrawal by Subject|0
7482143|NCT02045095|11791557|FG000|Overall Study|Adverse Event|0
7482144|NCT02045095|11791558|FG001|Overall Study|Adverse Event|1
7482145|NCT02045095|11791559|FG002|Overall Study|Adverse Event|1
7482146|NCT02045095|11791560|FG003|Overall Study|Adverse Event|0
7482147|NCT02045095|11791561|FG004|Overall Study|Adverse Event|0
7482148|NCT02045095|11791562|FG005|Overall Study|Adverse Event|2
7482149|NCT02045095|11791563|FG006|Overall Study|Adverse Event|0
7482150|NCT02045212|11791598|FG000|Overall Study|Adverse Event|0
7482151|NCT02045212|11791599|FG001|Overall Study|Adverse Event|1
7482152|NCT02045212|11791598|FG000|Overall Study|Withdrawal by Subject|1
7482153|NCT02045212|11791599|FG001|Overall Study|Withdrawal by Subject|0
7482154|NCT02045212|11791598|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
7482155|NCT02045212|11791599|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
7482156|NCT02045433|11791639|FG000|Overall Study|Withdrawal by Subject|1
7482157|NCT02045732|11791654|FG000|Overall Study|At the discretion of the investigator|1
7482158|NCT02045732|11791655|FG001|Overall Study|At the discretion of the investigator|1
7482159|NCT02045836|11791663|FG000|Overall Study|Adverse Event|4
7482160|NCT02045836|11791664|FG001|Overall Study|Adverse Event|4
7482161|NCT02045836|11791663|FG000|Overall Study|Withdrawal by Subject|1
7482162|NCT02045836|11791664|FG001|Overall Study|Withdrawal by Subject|1
7482163|NCT02045836|11791663|FG000|Overall Study|Lost to Follow-up|4
7482164|NCT02045836|11791664|FG001|Overall Study|Lost to Follow-up|7
7482165|NCT02045836|11791663|FG000|Overall Study|Migrated from study area|0
7482166|NCT02045836|11791664|FG001|Overall Study|Migrated from study area|2
7534668|NCT02700815|11881677|FG001|Overall Study|Adverse Event|6
7534669|NCT02700815|11881678|FG002|Overall Study|Adverse Event|2
7534670|NCT02700815|11881679|FG003|Overall Study|Adverse Event|3
7534671|NCT02700815|11881676|FG000|Overall Study|Lack of Efficacy|0
7534672|NCT02700815|11881677|FG001|Overall Study|Lack of Efficacy|0
7534673|NCT02700815|11881678|FG002|Overall Study|Lack of Efficacy|1
7534674|NCT02700815|11881679|FG003|Overall Study|Lack of Efficacy|2
7534675|NCT02700815|11881676|FG000|Overall Study|Lost to Follow-up|1
7534676|NCT02700815|11881677|FG001|Overall Study|Lost to Follow-up|0
7534677|NCT02700815|11881678|FG002|Overall Study|Lost to Follow-up|0
7482167|NCT02045862|11791674|FG000|Overall Study|Death|0
7482168|NCT02045862|11791675|FG001|Overall Study|Death|0
7482169|NCT02045862|11791676|FG002|Overall Study|Death|1
7482170|NCT02045862|11791674|FG000|Overall Study|Miscellaneous|5
7482171|NCT02045862|11791675|FG001|Overall Study|Miscellaneous|0
7482172|NCT02045862|11791676|FG002|Overall Study|Miscellaneous|8
7482173|NCT02045862|11791674|FG000|Overall Study|Withdrawal by Patient|18
7482174|NCT02045862|11791675|FG001|Overall Study|Withdrawal by Patient|27
7482175|NCT02045862|11791676|FG002|Overall Study|Withdrawal by Patient|57
7482176|NCT02045862|11791674|FG000|Overall Study|Protocol Violation|0
7482177|NCT02045862|11791675|FG001|Overall Study|Protocol Violation|0
7482178|NCT02045862|11791676|FG002|Overall Study|Protocol Violation|6
7482179|NCT02045862|11791674|FG000|Overall Study|Lack of Efficacy|8
7482180|NCT02045862|11791675|FG001|Overall Study|Lack of Efficacy|4
7482181|NCT02045862|11791676|FG002|Overall Study|Lack of Efficacy|13
7482182|NCT02045862|11791674|FG000|Overall Study|Randomized but not Received Study Drug|0
7482183|NCT02045862|11791675|FG001|Overall Study|Randomized but not Received Study Drug|2
7482184|NCT02045862|11791676|FG002|Overall Study|Randomized but not Received Study Drug|8
7482185|NCT02045862|11791674|FG000|Overall Study|Adverse Event|7
7482186|NCT02045862|11791675|FG001|Overall Study|Adverse Event|5
7482187|NCT02045862|11791676|FG002|Overall Study|Adverse Event|27
7482188|NCT02045862|11791674|FG000|Overall Study|Lost to Follow-up|1
7482189|NCT02045862|11791675|FG001|Overall Study|Lost to Follow-up|2
7482190|NCT02045862|11791676|FG002|Overall Study|Lost to Follow-up|6
7482191|NCT02045875|11791686|FG000|Overall Study|Lost to Follow-up|3
7482192|NCT02045875|11791687|FG001|Overall Study|Lost to Follow-up|0
7482193|NCT02045875|11791686|FG000|Overall Study|Withdrawal by Subject|4
7224642|NCT00057330|11433950|FG001|Overall Study|Death|0
7224643|NCT00057330|11433949|FG000|Overall Study|Protocol Violation|1
7224644|NCT00057330|11433950|FG001|Overall Study|Protocol Violation|1
7224645|NCT00057330|11433949|FG000|Overall Study|Withdrawal by Subject|115
7482194|NCT02045875|11791687|FG001|Overall Study|Withdrawal by Subject|3
7482195|NCT02045979|11791696|FG000|Overall Study|Informed Consent Withdrawn|2
7482196|NCT02045979|11791697|FG001|Overall Study|Informed Consent Withdrawn|0
7482197|NCT02045979|11791698|FG002|Overall Study|Informed Consent Withdrawn|1
7482198|NCT02045979|11791696|FG000|Overall Study|not specified above|0
7482199|NCT02045979|11791697|FG001|Overall Study|not specified above|1
7482200|NCT02045979|11791698|FG002|Overall Study|not specified above|0
7482201|NCT02046070|11791722|FG000|Overall Study|Progressive Disease|18
7482202|NCT02046070|11791723|FG001|Overall Study|Progressive Disease|11
7482203|NCT02046070|11791724|FG002|Overall Study|Progressive Disease|40
7482204|NCT02046070|11791722|FG000|Overall Study|Adverse Event|8
7482205|NCT02046070|11791723|FG001|Overall Study|Adverse Event|10
7482206|NCT02046070|11791724|FG002|Overall Study|Adverse Event|17
7482207|NCT02046070|11791722|FG000|Overall Study|Withdrawal by Subject|1
7482208|NCT02046070|11791723|FG001|Overall Study|Withdrawal by Subject|2
7482209|NCT02046070|11791724|FG002|Overall Study|Withdrawal by Subject|6
7482210|NCT02046070|11791722|FG000|Overall Study|Study Terminated by Sponsor|1
7482211|NCT02046070|11791723|FG001|Overall Study|Study Terminated by Sponsor|1
7482212|NCT02046070|11791724|FG002|Overall Study|Study Terminated by Sponsor|1
7482213|NCT02046070|11791722|FG000|Overall Study|Reason not Specified|4
7482214|NCT02046070|11791723|FG001|Overall Study|Reason not Specified|4
7482215|NCT02046070|11791724|FG002|Overall Study|Reason not Specified|6
7482216|NCT02046122|11791732|FG000|Overall Study|Physician Decision|8
7482217|NCT02046122|11791732|FG000|Overall Study|Withdrawal by Subject|1
7482218|NCT02046148|11791747|FG000|Overall Study|Lost to Follow-up|1
7482219|NCT02046148|11791748|FG001|Overall Study|Lost to Follow-up|1
7482220|NCT02046148|11791747|FG000|Overall Study|Withdrawal by Subject|0
7482221|NCT02046148|11791748|FG001|Overall Study|Withdrawal by Subject|2
7482222|NCT02046174|11791754|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
7482223|NCT02046174|11791755|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
7482224|NCT02046369|11791883|FG000|Overall Study|Adverse Event|3
7482225|NCT02046369|11791884|FG001|Overall Study|Adverse Event|3
7482226|NCT02046369|11791883|FG000|Overall Study|Lack of Efficacy|3
7482227|NCT02046369|11791884|FG001|Overall Study|Lack of Efficacy|3
7482228|NCT02046369|11791883|FG000|Overall Study|Lost to Follow-up|3
7482229|NCT02046369|11791884|FG001|Overall Study|Lost to Follow-up|3
7482230|NCT02046369|11791883|FG000|Overall Study|Protocol Violation|1
7482231|NCT02046369|11791884|FG001|Overall Study|Protocol Violation|2
7482232|NCT02046369|11791883|FG000|Overall Study|Withdrawal by Subject|3
7482233|NCT02046369|11791884|FG001|Overall Study|Withdrawal by Subject|6
7482234|NCT02046369|11791883|FG000|Overall Study|never received study drug|0
7482235|NCT02046369|11791884|FG001|Overall Study|never received study drug|1
7482236|NCT02046369|11791883|FG000|Overall Study|non compliance|1
7482237|NCT02046369|11791884|FG001|Overall Study|non compliance|0
7482238|NCT02046564|11791910|FG000|Overall Study|Adverse Event|6
7482239|NCT02046564|11791911|FG001|Overall Study|Adverse Event|3
7482240|NCT02046564|11791910|FG000|Overall Study|Physician Decision|0
7482241|NCT02046564|11791911|FG001|Overall Study|Physician Decision|1
7482242|NCT02046564|11791910|FG000|Overall Study|Protocol Violation|3
7482243|NCT02046564|11791911|FG001|Overall Study|Protocol Violation|1
7482244|NCT02046564|11791910|FG000|Overall Study|Withdrawal by Subject|4
7482245|NCT02046564|11791911|FG001|Overall Study|Withdrawal by Subject|10
7482246|NCT02046564|11791910|FG000|Overall Study|Subject met withdrawal criteria|2
7482247|NCT02046564|11791911|FG001|Overall Study|Subject met withdrawal criteria|5
7482248|NCT02046603|11791919|FG000|Overall Study|Other|11
7482249|NCT02046603|11791920|FG001|Overall Study|Other|66
7482250|NCT02046603|11791919|FG000|Overall Study|Protocol Violation|0
7482251|NCT02046603|11791920|FG001|Overall Study|Protocol Violation|1
7482252|NCT02046603|11791919|FG000|Overall Study|Participant/legal guardian decision|1
7482253|NCT02046603|11791920|FG001|Overall Study|Participant/legal guardian decision|3
7482254|NCT02046603|11791919|FG000|Overall Study|Physician Decision|2
7482255|NCT02046603|11791920|FG001|Overall Study|Physician Decision|1
7482256|NCT02046603|11791919|FG000|Overall Study|Lost to Follow-up|1
7482257|NCT02046603|11791920|FG001|Overall Study|Lost to Follow-up|2
7482258|NCT02046603|11791919|FG000|Overall Study|Death|0
7482259|NCT02046603|11791920|FG001|Overall Study|Death|1
7482260|NCT02046603|11791919|FG000|Overall Study|Adverse Event|0
7482261|NCT02046603|11791920|FG001|Overall Study|Adverse Event|1
7482262|NCT02046616|11791927|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
7482263|NCT02046616|11791927|FG000|24-Week Treatment Period|Any Other Adverse Event|13
7482264|NCT02046616|11791927|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
7482265|NCT02046616|11791927|FG000|24-Week Treatment Period|Physician Decision|3
7482266|NCT02046616|11791927|FG000|24-Week Treatment Period|Other|1
7482267|NCT02046616|11791927|FG000|8-Week FU Period|Lost to Follow-up|1
7482268|NCT02046993|11791976|FG000|Overall Study|Withdrawal by Subject|2
7482269|NCT02046993|11791977|FG001|Overall Study|Withdrawal by Subject|10
7482270|NCT02046993|11791976|FG000|Overall Study|Lost to Follow-up|1
7482271|NCT02046993|11791977|FG001|Overall Study|Lost to Follow-up|1
7482272|NCT02047045|11791998|FG000|Baseline|Withdrawal by Subject|3
7482273|NCT02047045|11791999|FG001|Baseline|Withdrawal by Subject|2
7482274|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|Adverse Event|3
7482275|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|Adverse Event|1
7482352|NCT02047227|11792031|FG000|Overall Study|Other|10
7482276|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
7482277|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
7482278|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
7482279|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
7482280|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
7482281|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
7482282|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|no reason was given|1
7482283|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|no reason was given|0
7482284|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
7482285|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
7482286|NCT02047045|11791998|FG000|Treatment Period (8 Weeks )|for safety considerations|0
7482287|NCT02047045|11791999|FG001|Treatment Period (8 Weeks )|for safety considerations|1
7482288|NCT02047045|11791998|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7482289|NCT02047045|11791999|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7482290|NCT02047110|11792009|FG000|DB Treatment Period up to Week 24|Adverse Event|1
7482291|NCT02047110|11792010|FG001|DB Treatment Period up to Week 24|Adverse Event|0
7482292|NCT02047110|11792011|FG002|DB Treatment Period up to Week 24|Adverse Event|0
7482293|NCT02047110|11792012|FG003|DB Treatment Period up to Week 24|Adverse Event|0
7482294|NCT02047110|11792009|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
7482295|NCT02047110|11792010|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
7482296|NCT02047110|11792011|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
7482297|NCT02047110|11792012|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
7482298|NCT02047110|11792009|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
7482299|NCT02047110|11792010|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
7482300|NCT02047110|11792011|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
7482301|NCT02047110|11792012|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
7482302|NCT02047110|11792009|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7482303|NCT02047110|11792010|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7482304|NCT02047110|11792011|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
7482305|NCT02047110|11792012|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
7482306|NCT02047110|11792009|FG000|DB Treatment Period up to Week 24|Other than specified|1
7482307|NCT02047110|11792010|FG001|DB Treatment Period up to Week 24|Other than specified|2
7482308|NCT02047110|11792011|FG002|DB Treatment Period up to Week 24|Other than specified|3
7482309|NCT02047110|11792012|FG003|DB Treatment Period up to Week 24|Other than specified|1
7482310|NCT02047110|11792009|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7482311|NCT02047110|11792010|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
7482312|NCT02047110|11792011|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7482313|NCT02047110|11792012|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
7482314|NCT02047110|11792009|FG000|DB (Week 12 up to Week 24)|Other than specified|0
7482315|NCT02047110|11792010|FG001|DB (Week 12 up to Week 24)|Other than specified|1
7482316|NCT02047110|11792011|FG002|DB (Week 12 up to Week 24)|Other than specified|1
7482317|NCT02047110|11792012|FG003|DB (Week 12 up to Week 24)|Other than specified|0
7482318|NCT02047110|11792009|FG000|Escape Treatment Period|Withdrawal by Subject|1
7482319|NCT02047110|11792010|FG001|Escape Treatment Period|Withdrawal by Subject|2
7482320|NCT02047110|11792011|FG002|Escape Treatment Period|Withdrawal by Subject|1
7482321|NCT02047110|11792012|FG003|Escape Treatment Period|Withdrawal by Subject|1
7482322|NCT02047110|11792009|FG000|Escape Treatment Period|Adverse Event|1
7482323|NCT02047110|11792010|FG001|Escape Treatment Period|Adverse Event|2
7482324|NCT02047110|11792011|FG002|Escape Treatment Period|Adverse Event|2
7482325|NCT02047110|11792012|FG003|Escape Treatment Period|Adverse Event|0
7482326|NCT02047110|11792009|FG000|Escape Treatment Period|Other than specified|1
7482327|NCT02047110|11792010|FG001|Escape Treatment Period|Other than specified|2
7482328|NCT02047110|11792011|FG002|Escape Treatment Period|Other than specified|0
7482329|NCT02047110|11792012|FG003|Escape Treatment Period|Other than specified|1
7482330|NCT02047110|11792009|FG000|OLE Treatment Period|Other than specified|0
7482331|NCT02047110|11792010|FG001|OLE Treatment Period|Other than specified|0
7482332|NCT02047110|11792011|FG002|OLE Treatment Period|Other than specified|1
7482333|NCT02047110|11792012|FG003|OLE Treatment Period|Other than specified|0
7482334|NCT02047227|11792031|FG000|Overall Study|Adverse Event|2
7482335|NCT02047227|11792032|FG001|Overall Study|Adverse Event|4
7482336|NCT02047227|11792031|FG000|Overall Study|Lost to Follow-up|0
7482337|NCT02047227|11792032|FG001|Overall Study|Lost to Follow-up|3
7482338|NCT02047227|11792031|FG000|Overall Study|Protocol Violation|1
7482339|NCT02047227|11792032|FG001|Overall Study|Protocol Violation|0
7482340|NCT02047227|11792031|FG000|Overall Study|Spontaneous pregnancy|1
7482341|NCT02047227|11792032|FG001|Overall Study|Spontaneous pregnancy|0
7482342|NCT02047227|11792031|FG000|Overall Study|Lack of ovarian response to stimulation|35
7482343|NCT02047227|11792032|FG001|Overall Study|Lack of ovarian response to stimulation|32
7482344|NCT02047227|11792031|FG000|Overall Study|No oocytes retrieved|21
7482345|NCT02047227|11792032|FG001|Overall Study|No oocytes retrieved|20
7482346|NCT02047227|11792031|FG000|Overall Study|No fertilization|61
7482347|NCT02047227|11792032|FG001|Overall Study|No fertilization|51
7482348|NCT02047227|11792031|FG000|Overall Study|Intention to freeze all embryos|1
7482349|NCT02047227|11792032|FG001|Overall Study|Intention to freeze all embryos|0
7482350|NCT02047227|11792031|FG000|Overall Study|All embryos discarded|12
7482351|NCT02047227|11792032|FG001|Overall Study|All embryos discarded|11
7482353|NCT02047227|11792032|FG001|Overall Study|Other|9
7482354|NCT02047253|11792038|FG000|Overall Study|Lost to Follow-up|8
7482355|NCT02047318|11792046|FG000|Core Study Period|Did not consent to 52-week follow- up|8
7482356|NCT02047318|11792046|FG000|Core Study Period|Adverse Event|1
7482357|NCT02047318|11792046|FG000|Core Study Period|Withdrawal by caregiver|3
7482358|NCT02047318|11792046|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
7482359|NCT02047604|11792086|FG000|Overall Study|Withdrawal by Subject|0
7482360|NCT02047604|11792087|FG001|Overall Study|Withdrawal by Subject|0
7482361|NCT02047604|11792088|FG002|Overall Study|Withdrawal by Subject|0
7482362|NCT02047604|11792089|FG003|Overall Study|Withdrawal by Subject|0
7482363|NCT02047604|11792090|FG004|Overall Study|Withdrawal by Subject|1
7482364|NCT02047604|11792091|FG005|Overall Study|Withdrawal by Subject|1
7482365|NCT02047734|11792115|FG000|Overall Study|Adverse Event|18
7482366|NCT02047734|11792116|FG001|Overall Study|Adverse Event|13
7482367|NCT02047734|11792117|FG002|Overall Study|Adverse Event|13
7482368|NCT02047734|11792115|FG000|Overall Study|Lack of Efficacy|4
7482369|NCT02047734|11792116|FG001|Overall Study|Lack of Efficacy|5
7482370|NCT02047734|11792117|FG002|Overall Study|Lack of Efficacy|1
7482371|NCT02047734|11792115|FG000|Overall Study|Protocol Violation|3
7482372|NCT02047734|11792116|FG001|Overall Study|Protocol Violation|1
7482373|NCT02047734|11792117|FG002|Overall Study|Protocol Violation|1
7482374|NCT02047734|11792115|FG000|Overall Study|Lost to Follow-up|1
7482375|NCT02047734|11792116|FG001|Overall Study|Lost to Follow-up|4
7482376|NCT02047734|11792117|FG002|Overall Study|Lost to Follow-up|0
7482377|NCT02047734|11792115|FG000|Overall Study|Death|0
7482378|NCT02047734|11792116|FG001|Overall Study|Death|1
7482379|NCT02047734|11792117|FG002|Overall Study|Death|0
7482380|NCT02047734|11792115|FG000|Overall Study|Withdrawal by Subject|30
7482381|NCT02047734|11792116|FG001|Overall Study|Withdrawal by Subject|31
7482382|NCT02047734|11792117|FG002|Overall Study|Withdrawal by Subject|19
7482383|NCT02047734|11792115|FG000|Overall Study|Physician Decision|7
7482384|NCT02047734|11792116|FG001|Overall Study|Physician Decision|6
7482385|NCT02047734|11792117|FG002|Overall Study|Physician Decision|5
7482386|NCT02047734|11792115|FG000|Overall Study|Miscellaneous|2
7482387|NCT02047734|11792116|FG001|Overall Study|Miscellaneous|4
7482388|NCT02047734|11792117|FG002|Overall Study|Miscellaneous|6
7482389|NCT02047734|11792115|FG000|Overall Study|Did Not Receive Study Drug|2
7482390|NCT02047734|11792116|FG001|Overall Study|Did Not Receive Study Drug|4
7482391|NCT02047734|11792117|FG002|Overall Study|Did Not Receive Study Drug|1
7482392|NCT02047903|11792125|FG000|Overall Study|Adverse Event|14
7482393|NCT02047903|11792125|FG000|Overall Study|Serious adverse event|10
7482394|NCT02047903|11792125|FG000|Overall Study|Withdrawal by Subject|16
7482395|NCT02047903|11792125|FG000|Overall Study|Lost to Follow-up|4
7482396|NCT02047903|11792125|FG000|Overall Study|Reason not listed|6
7482397|NCT02047903|11792125|FG000|Overall Study|Not Treated|9
7482398|NCT02048072|11792138|FG000|Overall Study|Adverse Event|3
7482399|NCT02048072|11792138|FG000|Overall Study|Lost to Follow-up|1
7482400|NCT02048241|11792144|FG000|Overall Study|Withdrawal by Subject|0
7482401|NCT02048241|11792145|FG001|Overall Study|Withdrawal by Subject|1
7482402|NCT02048826|11792162|FG000|Overall Study|Withdrawal by Subject|1
7482403|NCT02048826|11792163|FG001|Overall Study|Withdrawal by Subject|0
7482404|NCT02049437|11792216|FG000|Period 1|Adverse Event|1
7482405|NCT02049437|11792217|FG001|Period 1|Adverse Event|1
7482406|NCT02049437|11792216|FG000|Period 1|Adverse Event|1
7482407|NCT02049437|11792217|FG001|Period 1|Adverse Event|0
7482408|NCT02049450|11792223|FG000|Overall Study|Adverse Event|2
7482409|NCT02049450|11792223|FG000|Overall Study|Withdrawal by Subject|1
7482410|NCT02049450|11792223|FG000|Overall Study|Patients/guardian decision|1
7482411|NCT02049814|11792254|FG000|Overall Study|Reason not Specified|4
7482412|NCT02049814|11792255|FG001|Overall Study|Reason not Specified|3
7482413|NCT02049814|11792254|FG000|Overall Study|Pregnancy|1
7482414|NCT02049814|11792255|FG001|Overall Study|Pregnancy|0
7482415|NCT02049814|11792254|FG000|Overall Study|Lost to Follow-up|2
7482416|NCT02049814|11792255|FG001|Overall Study|Lost to Follow-up|3
7482417|NCT02049814|11792254|FG000|Overall Study|Serious Protocol Violation|5
7482418|NCT02049814|11792255|FG001|Overall Study|Serious Protocol Violation|7
7482419|NCT02049814|11792254|FG000|Overall Study|Study Termination|0
7482420|NCT02049814|11792255|FG001|Overall Study|Study Termination|1
7482421|NCT02049814|11792254|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
7482422|NCT02049814|11792255|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
7482423|NCT02049814|11792254|FG000|Overall Study|Voluntary withdrawal|9
7482424|NCT02049814|11792255|FG001|Overall Study|Voluntary withdrawal|8
7482425|NCT02049866|11792261|FG000|Overall Study|Withdrawal by Subject|1
7482426|NCT02049944|11792278|FG000|Overall Study|Protocol Violation|2
7482427|NCT02049957|11792291|FG000|Overall Study|Progressive Disease|5
7482428|NCT02049957|11792292|FG001|Overall Study|Progressive Disease|4
7482429|NCT02049957|11792293|FG002|Overall Study|Progressive Disease|2
7482430|NCT02049957|11792294|FG003|Overall Study|Progressive Disease|2
7482431|NCT02049957|11792295|FG004|Overall Study|Progressive Disease|6
7482432|NCT02049957|11792296|FG005|Overall Study|Progressive Disease|35
7482433|NCT02049957|11792297|FG006|Overall Study|Progressive Disease|7
7482434|NCT02049957|11792298|FG007|Overall Study|Progressive Disease|26
7482435|NCT02049957|11792299|FG008|Overall Study|Progressive Disease|6
7482436|NCT02049957|11792291|FG000|Overall Study|Adverse Event|1
7482437|NCT02049957|11792292|FG001|Overall Study|Adverse Event|1
7482438|NCT02049957|11792293|FG002|Overall Study|Adverse Event|1
7482439|NCT02049957|11792294|FG003|Overall Study|Adverse Event|0
7482440|NCT02049957|11792295|FG004|Overall Study|Adverse Event|0
7482441|NCT02049957|11792296|FG005|Overall Study|Adverse Event|5
7482442|NCT02049957|11792297|FG006|Overall Study|Adverse Event|0
7482443|NCT02049957|11792298|FG007|Overall Study|Adverse Event|6
7482444|NCT02049957|11792299|FG008|Overall Study|Adverse Event|1
7482445|NCT02049957|11792291|FG000|Overall Study|Study Terminated by Sponsor|0
7482446|NCT02049957|11792292|FG001|Overall Study|Study Terminated by Sponsor|1
7482447|NCT02049957|11792293|FG002|Overall Study|Study Terminated by Sponsor|0
7482448|NCT02049957|11792294|FG003|Overall Study|Study Terminated by Sponsor|0
7482449|NCT02049957|11792295|FG004|Overall Study|Study Terminated by Sponsor|0
7482450|NCT02049957|11792296|FG005|Overall Study|Study Terminated by Sponsor|0
7482451|NCT02049957|11792297|FG006|Overall Study|Study Terminated by Sponsor|1
7482452|NCT02049957|11792298|FG007|Overall Study|Study Terminated by Sponsor|0
7482453|NCT02049957|11792299|FG008|Overall Study|Study Terminated by Sponsor|0
7482454|NCT02049957|11792291|FG000|Overall Study|Withdrawal by Subject|0
7482455|NCT02049957|11792292|FG001|Overall Study|Withdrawal by Subject|0
7482456|NCT02049957|11792293|FG002|Overall Study|Withdrawal by Subject|0
7482457|NCT02049957|11792294|FG003|Overall Study|Withdrawal by Subject|1
7482458|NCT02049957|11792295|FG004|Overall Study|Withdrawal by Subject|0
7482459|NCT02049957|11792296|FG005|Overall Study|Withdrawal by Subject|2
7482460|NCT02049957|11792297|FG006|Overall Study|Withdrawal by Subject|0
7482461|NCT02049957|11792298|FG007|Overall Study|Withdrawal by Subject|3
7482462|NCT02049957|11792299|FG008|Overall Study|Withdrawal by Subject|1
7482463|NCT02049957|11792291|FG000|Overall Study|Physician Decision|0
7482464|NCT02049957|11792292|FG001|Overall Study|Physician Decision|0
7482465|NCT02049957|11792293|FG002|Overall Study|Physician Decision|0
7482466|NCT02049957|11792294|FG003|Overall Study|Physician Decision|0
7482467|NCT02049957|11792295|FG004|Overall Study|Physician Decision|0
7482468|NCT02049957|11792296|FG005|Overall Study|Physician Decision|1
7482469|NCT02049957|11792297|FG006|Overall Study|Physician Decision|0
7482470|NCT02049957|11792298|FG007|Overall Study|Physician Decision|0
7482471|NCT02049957|11792299|FG008|Overall Study|Physician Decision|0
7482472|NCT02050048|11792321|FG000|Overall Study|Lost to Follow-up|0
7482473|NCT02050048|11792322|FG001|Overall Study|Lost to Follow-up|1
7482474|NCT02050048|11792321|FG000|Overall Study|Death|1
7482475|NCT02050048|11792322|FG001|Overall Study|Death|0
7482476|NCT02050048|11792321|FG000|Overall Study|Ineligible after ERCP|4
7482477|NCT02050048|11792322|FG001|Overall Study|Ineligible after ERCP|1
7482478|NCT02050321|11792328|FG000|Overall Study|Withdrawal by Subject|1
7482479|NCT02050321|11792328|FG000|Overall Study|Adverse Event|1
7482480|NCT02050373|11792344|FG000|Overall Study|Adverse Event|4
7482481|NCT02050373|11792345|FG001|Overall Study|Adverse Event|7
7482482|NCT02050373|11792344|FG000|Overall Study|Death|3
7482483|NCT02050373|11792345|FG001|Overall Study|Death|3
7482484|NCT02051296|11792364|FG000|Overall Study|Lost to Follow-up|1
7482485|NCT02051296|11792365|FG001|Overall Study|Lost to Follow-up|2
7482486|NCT02051296|11792364|FG000|Overall Study|withdraw prior to treatment|7
7482487|NCT02051296|11792365|FG001|Overall Study|withdraw prior to treatment|7
7482488|NCT02051764|11792421|FG000|Overall Study|Study terminated by sponsor|0
7482489|NCT02051764|11792422|FG001|Overall Study|Study terminated by sponsor|7
7482490|NCT02052011|11792455|FG000|Overall Study|Lost to Follow-up|3
7482491|NCT02052011|11792456|FG001|Overall Study|Lost to Follow-up|0
7482492|NCT02052011|11792455|FG000|Overall Study|Withdrawal by Subject|1
7482493|NCT02052011|11792456|FG001|Overall Study|Withdrawal by Subject|2
7482494|NCT02052310|11792473|FG000|Overall Study|Death|64
7482495|NCT02052310|11792474|FG001|Overall Study|Death|54
7482496|NCT02052310|11792473|FG000|Overall Study|Withdrawal by Subject|37
7482497|NCT02052310|11792474|FG001|Overall Study|Withdrawal by Subject|49
7482498|NCT02052310|11792473|FG000|Overall Study|Other than specified|32
7482499|NCT02052310|11792474|FG001|Overall Study|Other than specified|29
7482500|NCT02052310|11792473|FG000|Overall Study|Adverse Event|29
7482501|NCT02052310|11792474|FG001|Overall Study|Adverse Event|22
7482502|NCT02052310|11792473|FG000|Overall Study|Kidney Transplant|23
7482503|NCT02052310|11792474|FG001|Overall Study|Kidney Transplant|29
7482504|NCT02052310|11792473|FG000|Overall Study|Physician Decision|14
7482505|NCT02052310|11792474|FG001|Overall Study|Physician Decision|7
7482506|NCT02052310|11792473|FG000|Overall Study|Lack of Efficacy|6
7482507|NCT02052310|11792474|FG001|Overall Study|Lack of Efficacy|1
7482508|NCT02052310|11792473|FG000|Overall Study|Site Terminated by Sponsor|5
7482509|NCT02052310|11792474|FG001|Overall Study|Site Terminated by Sponsor|13
7482510|NCT02052310|11792473|FG000|Overall Study|Lost to Follow-up|4
7482511|NCT02052310|11792474|FG001|Overall Study|Lost to Follow-up|2
7482512|NCT02052310|11792473|FG000|Overall Study|Protocol Violation|1
7482513|NCT02052310|11792474|FG001|Overall Study|Protocol Violation|6
7482514|NCT02052414|11792480|FG000|Overall Study|Adverse Event|12
7482515|NCT02052414|11792480|FG000|Overall Study|Lack of Efficacy|2
7482516|NCT02052414|11792480|FG000|Overall Study|Withdrawal by Subject|3
7482517|NCT02052440|11792487|FG000|Overall Study|Withdrawal by Subject|0
7482518|NCT02052440|11792488|FG001|Overall Study|Withdrawal by Subject|1
7482519|NCT02052466|11792494|FG000|Overall Study|Withdrawal by Subject|1
7482520|NCT02052466|11792494|FG000|Overall Study|Acromial fracture|1
7482521|NCT02052596|11792516|FG000|Active Phase|Adverse Event|3
7482522|NCT02052596|11792517|FG001|Active Phase|Adverse Event|2
7482523|NCT02052596|11792516|FG000|Active Phase|Lost to Follow-up|8
7482524|NCT02052596|11792517|FG001|Active Phase|Lost to Follow-up|11
7482525|NCT02052596|11792516|FG000|Active Phase|Protocol Violation|1
7482526|NCT02052596|11792517|FG001|Active Phase|Protocol Violation|2
7482527|NCT02052596|11792516|FG000|Active Phase|Withdrawal by Subject|3
7482528|NCT02052596|11792517|FG001|Active Phase|Withdrawal by Subject|4
7482529|NCT02052596|11792516|FG000|Active Phase|Enrolled in error|1
7482530|NCT02052596|11792517|FG001|Active Phase|Enrolled in error|0
7482531|NCT02052596|11792516|FG000|Active Phase|Lost due to Crohn's disease|0
7482532|NCT02052596|11792517|FG001|Active Phase|Lost due to Crohn's disease|1
7482533|NCT02052596|11792516|FG000|Safety Phase|Adverse Event|6
7482534|NCT02052596|11792517|FG001|Safety Phase|Adverse Event|3
7482535|NCT02052596|11792516|FG000|Safety Phase|Lost to Follow-up|11
7482536|NCT02052596|11792517|FG001|Safety Phase|Lost to Follow-up|18
7482537|NCT02052596|11792516|FG000|Safety Phase|Protocol Violation|1
7482538|NCT02052596|11792517|FG001|Safety Phase|Protocol Violation|2
7482539|NCT02052596|11792516|FG000|Safety Phase|Withdrawal by Subject|8
7482540|NCT02052596|11792517|FG001|Safety Phase|Withdrawal by Subject|11
7482541|NCT02052596|11792516|FG000|Safety Phase|Enrolled in error|1
7482542|NCT02052596|11792517|FG001|Safety Phase|Enrolled in error|0
7482543|NCT02052596|11792516|FG000|Safety Phase|Lost due to Crohn's disease|0
7482544|NCT02052596|11792517|FG001|Safety Phase|Lost due to Crohn's disease|1
7482545|NCT02052960|11792564|FG000|Overall Study|Adverse Event|19
7482546|NCT02052960|11792565|FG001|Overall Study|Adverse Event|17
7482547|NCT02052960|11792564|FG000|Overall Study|Protocol Violation|4
7482548|NCT02052960|11792565|FG001|Overall Study|Protocol Violation|3
7482549|NCT02052960|11792564|FG000|Overall Study|Withdrawal by Subject|6
7482550|NCT02052960|11792565|FG001|Overall Study|Withdrawal by Subject|11
7482551|NCT02052960|11792564|FG000|Overall Study|Other|25
7482552|NCT02052960|11792565|FG001|Overall Study|Other|15
7482553|NCT02053168|11792578|FG000|Overall Study|Withdrawal by Subject|1
7482554|NCT02053168|11792578|FG000|Overall Study|Physician Decision|1
7482555|NCT02053168|11792578|FG000|Overall Study|Lost to Follow-up|1
7482556|NCT02053493|11792605|FG000|Overall Study|Withdrawal by Subject|1
7482557|NCT02053493|11792606|FG001|Overall Study|Withdrawal by Subject|1
7482558|NCT02053610|11792614|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
7482559|NCT02053610|11792615|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
7482560|NCT02053610|11792614|FG000|Overall Study|Withdrew Consent|2
7482561|NCT02053610|11792615|FG001|Overall Study|Withdrew Consent|9
7482562|NCT02053610|11792614|FG000|Overall Study|Death|5
7482563|NCT02053610|11792615|FG001|Overall Study|Death|5
7482564|NCT02053610|11792614|FG000|Overall Study|Administrative/Other|1
7482565|NCT02053610|11792615|FG001|Overall Study|Administrative/Other|1
7482566|NCT02053610|11792614|FG000|Overall Study|Disease Progression|2
7482567|NCT02053610|11792615|FG001|Overall Study|Disease Progression|3
7482568|NCT02053610|11792614|FG000|Overall Study|Refused treatment/Did not cooperate|1
7482569|NCT02053610|11792615|FG001|Overall Study|Refused treatment/Did not cooperate|3
7482570|NCT02053610|11792614|FG000|Overall Study|Did not Receive Treatment|4
7482571|NCT02053610|11792615|FG001|Overall Study|Did not Receive Treatment|2
7482572|NCT02053610|11792614|FG000|Overall Study|Insufficient Therapeutic Response|1
7482573|NCT02053610|11792615|FG001|Overall Study|Insufficient Therapeutic Response|1
7482574|NCT02053610|11792614|FG000|Overall Study|Violation of Selection Criteria|1
7482575|NCT02053610|11792615|FG001|Overall Study|Violation of Selection Criteria|0
7482576|NCT02053753|11792623|FG000|Overall Study|Withdrawal by Subject|2
7482577|NCT02053753|11792624|FG001|Overall Study|Withdrawal by Subject|4
7482578|NCT02053753|11792623|FG000|Overall Study|Decision by Sponsor|1
7482579|NCT02053753|11792624|FG001|Overall Study|Decision by Sponsor|1
7482580|NCT02053753|11792623|FG000|Overall Study|Lost to Follow-up|4
7482581|NCT02053753|11792624|FG001|Overall Study|Lost to Follow-up|3
7482582|NCT02054130|11792634|FG000|Overall Study|Withdrawal by Subject|4
7482583|NCT02054130|11792635|FG001|Overall Study|Withdrawal by Subject|4
7482584|NCT02054130|11792636|FG002|Overall Study|Withdrawal by Subject|7
7482585|NCT02054130|11792637|FG003|Overall Study|Withdrawal by Subject|10
7482586|NCT02054130|11792634|FG000|Overall Study|Death|0
7482587|NCT02054130|11792635|FG001|Overall Study|Death|1
7482588|NCT02054130|11792636|FG002|Overall Study|Death|0
7482589|NCT02054130|11792637|FG003|Overall Study|Death|0
7482590|NCT02054130|11792634|FG000|Overall Study|Lost to Follow-up|0
7482591|NCT02054130|11792635|FG001|Overall Study|Lost to Follow-up|0
7482592|NCT02054130|11792636|FG002|Overall Study|Lost to Follow-up|1
7482593|NCT02054130|11792637|FG003|Overall Study|Lost to Follow-up|2
7482594|NCT02054130|11792634|FG000|Overall Study|Missed dose|4
7482595|NCT02054130|11792635|FG001|Overall Study|Missed dose|6
7482596|NCT02054130|11792636|FG002|Overall Study|Missed dose|7
7482597|NCT02054130|11792637|FG003|Overall Study|Missed dose|10
7482598|NCT02054325|11792661|FG000|Overall Study|Lost to Follow-up|8
7482599|NCT02054325|11792662|FG001|Overall Study|Lost to Follow-up|5
7482600|NCT02054481|11792681|FG000|Overall Study|Adverse Event|1
7482601|NCT02054481|11792682|FG001|Overall Study|Adverse Event|1
7482602|NCT02054481|11792683|FG002|Overall Study|Adverse Event|0
7482603|NCT02054481|11792684|FG003|Overall Study|Adverse Event|1
7482604|NCT02054481|11792681|FG000|Overall Study|Lost to Follow-up|1
7482605|NCT02054481|11792682|FG001|Overall Study|Lost to Follow-up|0
7482606|NCT02054481|11792683|FG002|Overall Study|Lost to Follow-up|0
7482607|NCT02054481|11792684|FG003|Overall Study|Lost to Follow-up|0
7482608|NCT02054481|11792681|FG000|Overall Study|Other reason|2
7482609|NCT02054481|11792682|FG001|Overall Study|Other reason|1
7482610|NCT02054481|11792683|FG002|Overall Study|Other reason|2
7482611|NCT02054481|11792684|FG003|Overall Study|Other reason|0
7482612|NCT02054520|11792701|FG000|Overall Study|Adverse Event|1
7482613|NCT02054520|11792702|FG001|Overall Study|Adverse Event|4
7482614|NCT02054520|11792703|FG002|Overall Study|Adverse Event|2
7482615|NCT02054520|11792704|FG003|Overall Study|Adverse Event|1
7482616|NCT02054520|11792705|FG004|Overall Study|Adverse Event|1
7482617|NCT02054520|11792706|FG005|Overall Study|Adverse Event|0
7482618|NCT02054520|11792701|FG000|Overall Study|Lack of Efficacy|7
7482619|NCT02054520|11792702|FG001|Overall Study|Lack of Efficacy|0
7482620|NCT02054520|11792703|FG002|Overall Study|Lack of Efficacy|2
7482621|NCT02054520|11792704|FG003|Overall Study|Lack of Efficacy|1
7482622|NCT02054520|11792705|FG004|Overall Study|Lack of Efficacy|3
7482623|NCT02054520|11792706|FG005|Overall Study|Lack of Efficacy|2
7482624|NCT02054520|11792701|FG000|Overall Study|Withdrawal by Subject|1
7482625|NCT02054520|11792702|FG001|Overall Study|Withdrawal by Subject|0
7482626|NCT02054520|11792703|FG002|Overall Study|Withdrawal by Subject|0
7482627|NCT02054520|11792704|FG003|Overall Study|Withdrawal by Subject|2
7482628|NCT02054520|11792705|FG004|Overall Study|Withdrawal by Subject|1
7482629|NCT02054520|11792706|FG005|Overall Study|Withdrawal by Subject|0
7482630|NCT02054520|11792701|FG000|Overall Study|Physician Decision|0
7482631|NCT02054520|11792702|FG001|Overall Study|Physician Decision|1
7482632|NCT02054520|11792703|FG002|Overall Study|Physician Decision|0
7482633|NCT02054520|11792704|FG003|Overall Study|Physician Decision|1
7482634|NCT02054520|11792705|FG004|Overall Study|Physician Decision|0
7482635|NCT02054520|11792706|FG005|Overall Study|Physician Decision|1
7482636|NCT02054520|11792701|FG000|Overall Study|Study terminated by Sponsor|0
7482637|NCT02054520|11792702|FG001|Overall Study|Study terminated by Sponsor|0
7482638|NCT02054520|11792703|FG002|Overall Study|Study terminated by Sponsor|2
7482639|NCT02054520|11792704|FG003|Overall Study|Study terminated by Sponsor|1
7482640|NCT02054520|11792705|FG004|Overall Study|Study terminated by Sponsor|0
7482641|NCT02054520|11792706|FG005|Overall Study|Study terminated by Sponsor|0
7482642|NCT02054702|11792726|FG000|Overall Study|Lost to Follow-up|3
7482643|NCT02054702|11792727|FG001|Overall Study|Lost to Follow-up|5
7482644|NCT02054702|11792726|FG000|Overall Study|Adverse Event|3
7482645|NCT02054702|11792727|FG001|Overall Study|Adverse Event|1
7482646|NCT02054702|11792726|FG000|Overall Study|Met Withdrawal Criteria|4
7482647|NCT02054702|11792727|FG001|Overall Study|Met Withdrawal Criteria|1
7482648|NCT02054702|11792726|FG000|Overall Study|Physician Decision|0
7482649|NCT02054702|11792727|FG001|Overall Study|Physician Decision|1
7482650|NCT02054702|11792726|FG000|Overall Study|Withdrawal by Subject|14
7482651|NCT02054702|11792727|FG001|Overall Study|Withdrawal by Subject|4
7534678|NCT02700815|11881679|FG003|Overall Study|Lost to Follow-up|1
7534679|NCT02700815|11881676|FG000|Overall Study|Refusal to continue medication|0
7534680|NCT02700815|11881677|FG001|Overall Study|Refusal to continue medication|1
7534681|NCT02700815|11881678|FG002|Overall Study|Refusal to continue medication|0
7534682|NCT02700815|11881679|FG003|Overall Study|Refusal to continue medication|1
7534683|NCT02700815|11881676|FG000|Overall Study|Withdrawal by Subject|0
7534684|NCT02700815|11881677|FG001|Overall Study|Withdrawal by Subject|0
7534685|NCT02700815|11881678|FG002|Overall Study|Withdrawal by Subject|1
7534686|NCT02700815|11881679|FG003|Overall Study|Withdrawal by Subject|0
7482652|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Refused|1
7482653|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Refused|3
7482654|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Medical|0
7482655|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Medical|1
7482656|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
7482657|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
7482658|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Disliked Procedure|0
7482659|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Disliked Procedure|1
7482660|NCT02054715|11792735|FG000|Baseline/Follow-up 1|No Reason|0
7482661|NCT02054715|11792736|FG001|Baseline/Follow-up 1|No Reason|1
7482662|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Overwhelmed|2
7482663|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Overwhelmed|0
7482664|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Ineligible|3
7482665|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Ineligible|0
7482666|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Hospitalization|1
7482667|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Hospitalization|0
7482668|NCT02054715|11792735|FG000|Baseline/Follow-up 1|Changed Mind|1
7482669|NCT02054715|11792736|FG001|Baseline/Follow-up 1|Changed Mind|0
7482670|NCT02054715|11792735|FG000|Follow-up 2|Lost to Followup|3
7482671|NCT02054715|11792736|FG001|Follow-up 2|Lost to Followup|1
7482672|NCT02054715|11792735|FG000|Follow-up 2|Refused|3
7482673|NCT02054715|11792736|FG001|Follow-up 2|Refused|2
7482674|NCT02054715|11792735|FG000|Follow-up 2|Followup Not Completed|3
7482675|NCT02054715|11792736|FG001|Follow-up 2|Followup Not Completed|4
7482676|NCT02054715|11792735|FG000|Follow-up 2|Ineligible|4
7482677|NCT02054715|11792736|FG001|Follow-up 2|Ineligible|5
7482678|NCT02054715|11792735|FG000|Follow-up 2|Death|3
7482679|NCT02054715|11792736|FG001|Follow-up 2|Death|3
7482680|NCT02054715|11792735|FG000|Follow-up 2|Hospitalization|0
7482681|NCT02054715|11792736|FG001|Follow-up 2|Hospitalization|2
7482682|NCT02054715|11792735|FG000|Follow-up 2|Changed MD/Facility|0
7482683|NCT02054715|11792736|FG001|Follow-up 2|Changed MD/Facility|1
7482684|NCT02054715|11792735|FG000|Follow-up 2|Changed Mind|0
7482685|NCT02054715|11792736|FG001|Follow-up 2|Changed Mind|1
7482686|NCT02054715|11792735|FG000|Follow-up 2|No Reason|2
7482687|NCT02054715|11792736|FG001|Follow-up 2|No Reason|0
7482688|NCT02054715|11792735|FG000|Follow-up 2|Treatment Change or Delay|1
7482689|NCT02054715|11792736|FG001|Follow-up 2|Treatment Change or Delay|0
7482690|NCT02054897|11792767|FG000|Overall Study|Withdrawal by Subject|2
7482691|NCT02054897|11792768|FG001|Overall Study|Withdrawal by Subject|0
7482692|NCT02054897|11792769|FG002|Overall Study|Withdrawal by Subject|2
7482693|NCT02054897|11792767|FG000|Overall Study|Missing follow-up information|3
7482694|NCT02054897|11792768|FG001|Overall Study|Missing follow-up information|5
7482695|NCT02054897|11792769|FG002|Overall Study|Missing follow-up information|3
7482696|NCT02054897|11792767|FG000|Overall Study|Lost to Follow-up|4
7482697|NCT02054897|11792768|FG001|Overall Study|Lost to Follow-up|2
7482698|NCT02054897|11792769|FG002|Overall Study|Lost to Follow-up|7
7482699|NCT02054897|11792767|FG000|Overall Study|Randomized but not exposed|1
7482700|NCT02054897|11792768|FG001|Overall Study|Randomized but not exposed|0
7482701|NCT02054897|11792769|FG002|Overall Study|Randomized but not exposed|0
7482702|NCT02055118|11792780|FG000|Overall Study|Withdrawal by Subject|0
7482703|NCT02055118|11792781|FG001|Overall Study|Withdrawal by Subject|2
7482704|NCT02055118|11792782|FG002|Overall Study|Withdrawal by Subject|0
7482705|NCT02055157|11792795|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7482706|NCT02055157|11792796|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
7482707|NCT02055157|11792797|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7482708|NCT02055157|11792798|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
7482709|NCT02055157|11792795|FG000|Initial 6 Months|Adverse Event|0
7482710|NCT02055157|11792796|FG001|Initial 6 Months|Adverse Event|0
7482711|NCT02055157|11792797|FG002|Initial 6 Months|Adverse Event|0
7482712|NCT02055157|11792798|FG003|Initial 6 Months|Adverse Event|1
7482713|NCT02055157|11792795|FG000|Initial 6 Months|Consent withdrawn by subject|1
7482714|NCT02055157|11792796|FG001|Initial 6 Months|Consent withdrawn by subject|0
7482715|NCT02055157|11792797|FG002|Initial 6 Months|Consent withdrawn by subject|0
7482716|NCT02055157|11792798|FG003|Initial 6 Months|Consent withdrawn by subject|0
7482717|NCT02055157|11792795|FG000|18-month Extension|Investigator decision|0
7482718|NCT02055157|11792796|FG001|18-month Extension|Investigator decision|1
7482719|NCT02055157|11792797|FG002|18-month Extension|Investigator decision|0
7482720|NCT02055157|11792798|FG003|18-month Extension|Investigator decision|0
7482721|NCT02055157|11792795|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
7482722|NCT02055157|11792796|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
7482723|NCT02055157|11792797|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
7482724|NCT02055157|11792798|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
7482725|NCT02055352|11792821|FG000|Overall Study|Adverse Event|0
7482726|NCT02055352|11792822|FG001|Overall Study|Adverse Event|1
7482727|NCT02055352|11792821|FG000|Overall Study|Non-eligible|0
7482728|NCT02055352|11792822|FG001|Overall Study|Non-eligible|1
7482729|NCT02055352|11792821|FG000|Overall Study|Poor compliance|1
7482730|NCT02055352|11792822|FG001|Overall Study|Poor compliance|1
7482731|NCT02055352|11792821|FG000|Overall Study|Death|1
7482732|NCT02055352|11792822|FG001|Overall Study|Death|2
7482733|NCT02055352|11792821|FG000|Overall Study|Patient decision|1
7482734|NCT02055352|11792822|FG001|Overall Study|Patient decision|1
7482735|NCT02055352|11792821|FG000|Overall Study|Use of prohibited treatment|0
7482736|NCT02055352|11792822|FG001|Overall Study|Use of prohibited treatment|3
7482737|NCT02055352|11792821|FG000|Overall Study|AE, study drug would be detrimental|1
7482738|NCT02055352|11792822|FG001|Overall Study|AE, study drug would be detrimental|3
7482739|NCT02055352|11792821|FG000|Overall Study|Withdrawal of informed consent|1
7482740|NCT02055352|11792822|FG001|Overall Study|Withdrawal of informed consent|0
7482741|NCT02055352|11792821|FG000|Overall Study|Reason unknown|1
7482742|NCT02055352|11792822|FG001|Overall Study|Reason unknown|5
7482743|NCT02055365|11792828|FG000|Overall Study|Prematurely Withdrawn|1
7482744|NCT02055820|11792893|FG000|Phase I: Dose-Finding|Death|1
7482745|NCT02055820|11792894|FG001|Phase I: Dose-Finding|Death|0
7482746|NCT02055820|11792895|FG002|Phase I: Dose-Finding|Death|1
7482747|NCT02055820|11792896|FG003|Phase I: Dose-Finding|Death|2
7482748|NCT02055820|11792897|FG004|Phase I: Dose-Finding|Death|0
7482749|NCT02055820|11792898|FG005|Phase I: Dose-Finding|Death|1
7482750|NCT02055820|11792899|FG006|Phase I: Dose-Finding|Death|1
7482751|NCT02055820|11792900|FG007|Phase I: Dose-Finding|Death|0
7482752|NCT02055820|11792901|FG008|Phase I: Dose-Finding|Death|0
7482753|NCT02055820|11792902|FG009|Phase I: Dose-Finding|Death|0
7482754|NCT02055820|11792893|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
7482755|NCT02055820|11792894|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
7482756|NCT02055820|11792895|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
7482757|NCT02055820|11792896|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
7482758|NCT02055820|11792897|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
7482759|NCT02055820|11792898|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
7482760|NCT02055820|11792899|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
7482761|NCT02055820|11792900|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
7482762|NCT02055820|11792901|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
7482763|NCT02055820|11792902|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
7482764|NCT02055820|11792893|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
7482765|NCT02055820|11792894|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
7482766|NCT02055820|11792895|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
7482767|NCT02055820|11792896|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
7482768|NCT02055820|11792897|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
7482769|NCT02055820|11792898|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
7482770|NCT02055820|11792899|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
7482771|NCT02055820|11792900|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
7482772|NCT02055820|11792901|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
7482773|NCT02055820|11792902|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
7482774|NCT02055820|11792893|FG000|Phase II: Expansion|Death|0
7482775|NCT02055820|11792894|FG001|Phase II: Expansion|Death|0
7482776|NCT02055820|11792895|FG002|Phase II: Expansion|Death|0
7482777|NCT02055820|11792896|FG003|Phase II: Expansion|Death|0
7482778|NCT02055820|11792897|FG004|Phase II: Expansion|Death|33
7482779|NCT02055820|11792898|FG005|Phase II: Expansion|Death|0
7482780|NCT02055820|11792899|FG006|Phase II: Expansion|Death|0
7482781|NCT02055820|11792900|FG007|Phase II: Expansion|Death|0
7482782|NCT02055820|11792901|FG008|Phase II: Expansion|Death|0
7482783|NCT02055820|11792902|FG009|Phase II: Expansion|Death|0
7482784|NCT02055820|11792893|FG000|Phase II: Expansion|Lost to Follow-up|0
7482785|NCT02055820|11792894|FG001|Phase II: Expansion|Lost to Follow-up|0
7482786|NCT02055820|11792895|FG002|Phase II: Expansion|Lost to Follow-up|0
7482787|NCT02055820|11792896|FG003|Phase II: Expansion|Lost to Follow-up|0
7482788|NCT02055820|11792897|FG004|Phase II: Expansion|Lost to Follow-up|4
7482789|NCT02055820|11792898|FG005|Phase II: Expansion|Lost to Follow-up|0
7482790|NCT02055820|11792899|FG006|Phase II: Expansion|Lost to Follow-up|0
7482791|NCT02055820|11792900|FG007|Phase II: Expansion|Lost to Follow-up|0
7482792|NCT02055820|11792901|FG008|Phase II: Expansion|Lost to Follow-up|0
7482793|NCT02055820|11792902|FG009|Phase II: Expansion|Lost to Follow-up|0
7482794|NCT02055820|11792893|FG000|Phase II: Expansion|Withdrawal by Subject|0
7482795|NCT02055820|11792894|FG001|Phase II: Expansion|Withdrawal by Subject|0
7482796|NCT02055820|11792895|FG002|Phase II: Expansion|Withdrawal by Subject|0
7482797|NCT02055820|11792896|FG003|Phase II: Expansion|Withdrawal by Subject|0
7482798|NCT02055820|11792897|FG004|Phase II: Expansion|Withdrawal by Subject|12
7482799|NCT02055820|11792898|FG005|Phase II: Expansion|Withdrawal by Subject|0
7482800|NCT02055820|11792899|FG006|Phase II: Expansion|Withdrawal by Subject|0
7482801|NCT02055820|11792900|FG007|Phase II: Expansion|Withdrawal by Subject|0
7482802|NCT02055820|11792901|FG008|Phase II: Expansion|Withdrawal by Subject|0
7482803|NCT02055820|11792902|FG009|Phase II: Expansion|Withdrawal by Subject|0
7482804|NCT02055898|11792946|FG000|First Intervention (5 Days)|Physician Decision|2
7482805|NCT02055898|11792947|FG001|First Intervention (5 Days)|Physician Decision|0
7482806|NCT02055898|11792946|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
7482807|NCT02055898|11792947|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
7482808|NCT02055976|11792962|FG000|Overall Study|Other|0
7482809|NCT02055976|11792963|FG001|Overall Study|Other|0
7482810|NCT02055976|11792964|FG002|Overall Study|Other|1
7482811|NCT02055976|11792965|FG003|Overall Study|Other|0
7482812|NCT02055976|11792966|FG004|Overall Study|Other|0
7482813|NCT02055976|11792967|FG005|Overall Study|Other|0
7482814|NCT02055976|11792968|FG006|Overall Study|Other|0
7482815|NCT02055976|11792969|FG007|Overall Study|Other|0
7482816|NCT02055976|11792970|FG008|Overall Study|Other|0
7482817|NCT02055976|11792962|FG000|Overall Study|Adverse Event|0
7482818|NCT02055976|11792963|FG001|Overall Study|Adverse Event|0
7482819|NCT02055976|11792964|FG002|Overall Study|Adverse Event|0
7482820|NCT02055976|11792965|FG003|Overall Study|Adverse Event|0
7482821|NCT02055976|11792966|FG004|Overall Study|Adverse Event|0
7482822|NCT02055976|11792967|FG005|Overall Study|Adverse Event|1
7482823|NCT02055976|11792968|FG006|Overall Study|Adverse Event|1
7482824|NCT02055976|11792969|FG007|Overall Study|Adverse Event|0
7482825|NCT02055976|11792970|FG008|Overall Study|Adverse Event|0
7482826|NCT02055976|11792962|FG000|Overall Study|Does not meet entrance criteria|0
7482827|NCT02055976|11792963|FG001|Overall Study|Does not meet entrance criteria|0
7482828|NCT02055976|11792964|FG002|Overall Study|Does not meet entrance criteria|0
7482829|NCT02055976|11792965|FG003|Overall Study|Does not meet entrance criteria|0
7482830|NCT02055976|11792966|FG004|Overall Study|Does not meet entrance criteria|0
7482831|NCT02055976|11792967|FG005|Overall Study|Does not meet entrance criteria|0
7482832|NCT02055976|11792968|FG006|Overall Study|Does not meet entrance criteria|1
7482833|NCT02055976|11792969|FG007|Overall Study|Does not meet entrance criteria|0
7482834|NCT02055976|11792970|FG008|Overall Study|Does not meet entrance criteria|0
7482835|NCT02055976|11792962|FG000|Overall Study|Lost to Follow-up|0
7482836|NCT02055976|11792963|FG001|Overall Study|Lost to Follow-up|0
7482837|NCT02055976|11792964|FG002|Overall Study|Lost to Follow-up|0
7482838|NCT02055976|11792965|FG003|Overall Study|Lost to Follow-up|1
7482839|NCT02055976|11792966|FG004|Overall Study|Lost to Follow-up|0
7482840|NCT02055976|11792967|FG005|Overall Study|Lost to Follow-up|0
7482841|NCT02055976|11792968|FG006|Overall Study|Lost to Follow-up|0
7482842|NCT02055976|11792969|FG007|Overall Study|Lost to Follow-up|0
7482843|NCT02055976|11792970|FG008|Overall Study|Lost to Follow-up|0
7482844|NCT02056288|11793008|FG000|In-Hospital Data|Surgery cancelled|1
7482845|NCT02056288|11793009|FG001|In-Hospital Data|Surgery cancelled|0
7482846|NCT02056288|11793008|FG000|In-Hospital Data|Protocol Violation|3
7482847|NCT02056288|11793009|FG001|In-Hospital Data|Protocol Violation|0
7482848|NCT02056288|11793008|FG000|In-Hospital Data|Physician Decision|1
7482849|NCT02056288|11793009|FG001|In-Hospital Data|Physician Decision|0
7482850|NCT02056288|11793008|FG000|48-Hour Post-Discharge Data|Did not return diary|14
7482851|NCT02056288|11793009|FG001|48-Hour Post-Discharge Data|Did not return diary|20
7482852|NCT02056301|11793017|FG000|Overall Study|Protocol Violation|1
7482853|NCT02056301|11793018|FG001|Overall Study|Protocol Violation|2
7482854|NCT02056301|11793017|FG000|Overall Study|Surgical complications req. 2nd surgery|1
7482855|NCT02056301|11793018|FG001|Overall Study|Surgical complications req. 2nd surgery|0
7482856|NCT02056301|11793017|FG000|Overall Study|Withdrawal by Subject|0
7482857|NCT02056301|11793018|FG001|Overall Study|Withdrawal by Subject|1
7482858|NCT02056301|11793017|FG000|Overall Study|Issues with epidural|0
7482859|NCT02056301|11793018|FG001|Overall Study|Issues with epidural|3
7482860|NCT02056340|11793026|FG000|Overall Study|Lost to Follow-up|5
7482861|NCT02056340|11793027|FG001|Overall Study|Lost to Follow-up|5
7482862|NCT02056340|11793026|FG000|Overall Study|Withdrawal by Subject|2
7482863|NCT02056340|11793027|FG001|Overall Study|Withdrawal by Subject|6
7482864|NCT02056392|11793039|FG000|Overall Study|Lost to Follow-up|0
7482865|NCT02056392|11793040|FG001|Overall Study|Lost to Follow-up|1
7482866|NCT02056392|11793041|FG002|Overall Study|Lost to Follow-up|2
7482867|NCT02056392|11793042|FG003|Overall Study|Lost to Follow-up|0
7482868|NCT02056392|11793043|FG004|Overall Study|Lost to Follow-up|0
7482869|NCT02056392|11793044|FG005|Overall Study|Lost to Follow-up|0
7482870|NCT02056392|11793039|FG000|Overall Study|Protocol Violation|1
7482871|NCT02056392|11793040|FG001|Overall Study|Protocol Violation|0
7482872|NCT02056392|11793041|FG002|Overall Study|Protocol Violation|1
7482873|NCT02056392|11793042|FG003|Overall Study|Protocol Violation|0
7482874|NCT02056392|11793043|FG004|Overall Study|Protocol Violation|0
7482875|NCT02056392|11793044|FG005|Overall Study|Protocol Violation|0
7482876|NCT02056392|11793039|FG000|Overall Study|Withdrawal by Subject|1
7482877|NCT02056392|11793040|FG001|Overall Study|Withdrawal by Subject|0
7482878|NCT02056392|11793041|FG002|Overall Study|Withdrawal by Subject|0
7482879|NCT02056392|11793042|FG003|Overall Study|Withdrawal by Subject|0
7482880|NCT02056392|11793043|FG004|Overall Study|Withdrawal by Subject|1
7482881|NCT02056392|11793044|FG005|Overall Study|Withdrawal by Subject|0
7482882|NCT02056626|11793067|FG000|Overall Study|patient did not follow directions|3
7482883|NCT02056626|11793068|FG001|Overall Study|patient did not follow directions|1
7482884|NCT02056626|11793069|FG002|Overall Study|patient did not follow directions|0
7482885|NCT02056626|11793070|FG003|Overall Study|patient did not follow directions|0
7482886|NCT02056652|11793093|FG000|Overall Study|Withdrawal by Subject|1
7482887|NCT02056652|11793094|FG001|Overall Study|Withdrawal by Subject|0
7482888|NCT02056652|11793093|FG000|Overall Study|Lost to Follow-up|0
7482889|NCT02056652|11793094|FG001|Overall Study|Lost to Follow-up|3
7482890|NCT02056834|11793100|FG000|Overall Study|Lost to Follow-up|7
7482891|NCT02057068|11793116|FG000|Overall Study|Withdrawal by Subject|2
7482892|NCT02057068|11793117|FG001|Overall Study|Withdrawal by Subject|2
7482893|NCT02057068|11793116|FG000|Overall Study|Caregiver (CG) Health|0
7482894|NCT02057068|11793117|FG001|Overall Study|Caregiver (CG) Health|2
7482895|NCT02057068|11793116|FG000|Overall Study|Carepartner (CP) Health|4
7482896|NCT02057068|11793117|FG001|Overall Study|Carepartner (CP) Health|2
7482897|NCT02057068|11793116|FG000|Overall Study|Lost to Follow-up|2
7482898|NCT02057068|11793117|FG001|Overall Study|Lost to Follow-up|2
7482899|NCT02057198|11793137|FG000|Overall Study|Death|0
7482900|NCT02057198|11793138|FG001|Overall Study|Death|0
7482901|NCT02057198|11793139|FG002|Overall Study|Death|1
7482902|NCT02057198|11793137|FG000|Overall Study|Discharged early; lost to followup|0
7482903|NCT02057198|11793138|FG001|Overall Study|Discharged early; lost to followup|1
7482904|NCT02057198|11793139|FG002|Overall Study|Discharged early; lost to followup|0
7482905|NCT02057250|11793151|FG000|AID Assessment Phase|Adverse Event|3
7482906|NCT02057250|11793152|FG001|AID Assessment Phase|Adverse Event|2
7482907|NCT02057250|11793153|FG002|AID Assessment Phase|Adverse Event|6
7482908|NCT02057250|11793154|FG003|AID Assessment Phase|Adverse Event|1
7482909|NCT02057250|11793155|FG004|AID Assessment Phase|Adverse Event|0
7482910|NCT02057250|11793151|FG000|AID Assessment Phase|Other than specified above|1
7482911|NCT02057250|11793152|FG001|AID Assessment Phase|Other than specified above|1
7482912|NCT02057250|11793153|FG002|AID Assessment Phase|Other than specified above|1
7482913|NCT02057250|11793154|FG003|AID Assessment Phase|Other than specified above|1
7482914|NCT02057250|11793155|FG004|AID Assessment Phase|Other than specified above|0
7482915|NCT02057250|11793151|FG000|Extension Phase|Adverse Event|0
7482916|NCT02057250|11793152|FG001|Extension Phase|Adverse Event|0
7482917|NCT02057250|11793153|FG002|Extension Phase|Adverse Event|0
7482918|NCT02057250|11793154|FG003|Extension Phase|Adverse Event|0
7482919|NCT02057250|11793155|FG004|Extension Phase|Adverse Event|15
7482920|NCT02057250|11793151|FG000|Extension Phase|Lack of Efficacy|0
7482921|NCT02057250|11793152|FG001|Extension Phase|Lack of Efficacy|0
7482922|NCT02057250|11793153|FG002|Extension Phase|Lack of Efficacy|0
7482923|NCT02057250|11793154|FG003|Extension Phase|Lack of Efficacy|0
7482924|NCT02057250|11793155|FG004|Extension Phase|Lack of Efficacy|10
7482925|NCT02057250|11793151|FG000|Extension Phase|Entered in this period but not treated|0
7482926|NCT02057250|11793152|FG001|Extension Phase|Entered in this period but not treated|0
7482927|NCT02057250|11793153|FG002|Extension Phase|Entered in this period but not treated|0
7482928|NCT02057250|11793154|FG003|Extension Phase|Entered in this period but not treated|0
7482929|NCT02057250|11793155|FG004|Extension Phase|Entered in this period but not treated|4
7482930|NCT02057250|11793151|FG000|Extension Phase|Other than specified above|0
7482931|NCT02057250|11793152|FG001|Extension Phase|Other than specified above|0
7482932|NCT02057250|11793153|FG002|Extension Phase|Other than specified above|0
7482933|NCT02057250|11793154|FG003|Extension Phase|Other than specified above|0
7482934|NCT02057250|11793155|FG004|Extension Phase|Other than specified above|7
7482935|NCT02057393|11793167|FG000|Overall Study|Withdrawal by Subject|1
7482936|NCT02057393|11793167|FG000|Overall Study|Patient did not meet criteria|1
7482937|NCT02057406|11793174|FG000|Overall Study|Physician Decision|0
7482938|NCT02057406|11793175|FG001|Overall Study|Physician Decision|0
7482939|NCT02057406|11793176|FG002|Overall Study|Physician Decision|2
7482940|NCT02057406|11793174|FG000|Overall Study|Withdrawal by Subject|0
7482941|NCT02057406|11793175|FG001|Overall Study|Withdrawal by Subject|2
7482942|NCT02057406|11793176|FG002|Overall Study|Withdrawal by Subject|0
7482943|NCT02057406|11793174|FG000|Overall Study|Lost to Follow-up|0
7482944|NCT02057406|11793175|FG001|Overall Study|Lost to Follow-up|0
7482945|NCT02057406|11793176|FG002|Overall Study|Lost to Follow-up|1
7482946|NCT02057406|11793174|FG000|Overall Study|Death|1
7482947|NCT02057406|11793175|FG001|Overall Study|Death|0
7482948|NCT02057406|11793176|FG002|Overall Study|Death|0
7482949|NCT02057406|11793174|FG000|Overall Study|Protocol Violation|0
7482950|NCT02057406|11793175|FG001|Overall Study|Protocol Violation|1
7482951|NCT02057406|11793176|FG002|Overall Study|Protocol Violation|0
7482952|NCT02057406|11793174|FG000|Overall Study|Patient transportation issues|0
7482953|NCT02057406|11793175|FG001|Overall Study|Patient transportation issues|0
7482954|NCT02057406|11793176|FG002|Overall Study|Patient transportation issues|1
7482955|NCT02057458|11793184|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
7482956|NCT02057458|11793185|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
7482957|NCT02057458|11793186|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
7482958|NCT02057458|11793184|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
7482959|NCT02057458|11793185|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7482960|NCT02057458|11793186|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
7482961|NCT02057458|11793184|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
7482962|NCT02057458|11793185|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7482963|NCT02057458|11793186|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
7482964|NCT02057523|11793216|FG000|Overall Study|Withdrawal by Subject|1
7482965|NCT02057523|11793216|FG000|Overall Study|Lack of Efficacy|1
7482966|NCT02057549|11793222|FG000|Overall Study|Lost to Follow-up|1
7482967|NCT02057549|11793223|FG001|Overall Study|Lost to Follow-up|0
7482968|NCT02057549|11793222|FG000|Overall Study|Physician Decision|1
7482969|NCT02057549|11793223|FG001|Overall Study|Physician Decision|0
7482970|NCT02057549|11793222|FG000|Overall Study|Withdrawal by Subject|1
7482971|NCT02057549|11793223|FG001|Overall Study|Withdrawal by Subject|0
7482972|NCT02057575|11793233|FG000|Overall Study|Adverse Event|0
7482973|NCT02057575|11793234|FG001|Overall Study|Adverse Event|2
7482974|NCT02057575|11793235|FG002|Overall Study|Adverse Event|0
7482975|NCT02057575|11793236|FG003|Overall Study|Adverse Event|1
7482976|NCT02057575|11793233|FG000|Overall Study|Withdrawal by Subject|1
7482977|NCT02057575|11793234|FG001|Overall Study|Withdrawal by Subject|0
7482978|NCT02057575|11793235|FG002|Overall Study|Withdrawal by Subject|0
7482979|NCT02057575|11793236|FG003|Overall Study|Withdrawal by Subject|0
7482980|NCT02057575|11793233|FG000|Overall Study|Dissallowed Concurrent Medication|0
7482981|NCT02057575|11793234|FG001|Overall Study|Dissallowed Concurrent Medication|1
7482982|NCT02057575|11793235|FG002|Overall Study|Dissallowed Concurrent Medication|0
7482983|NCT02057575|11793236|FG003|Overall Study|Dissallowed Concurrent Medication|0
7482984|NCT02057575|11793233|FG000|Overall Study|Protocol Violation|0
7482985|NCT02057575|11793234|FG001|Overall Study|Protocol Violation|1
7482986|NCT02057575|11793235|FG002|Overall Study|Protocol Violation|0
7482987|NCT02057575|11793236|FG003|Overall Study|Protocol Violation|0
7482988|NCT02057666|11793258|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
7482989|NCT02057666|11793259|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
7482990|NCT02057666|11793258|FG000|Double Blind Treatment Period|Poor tolerability|7
7482991|NCT02057666|11793259|FG001|Double Blind Treatment Period|Poor tolerability|2
7482992|NCT02057666|11793258|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
7482993|NCT02057666|11793259|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
7482994|NCT02057666|11793258|FG000|Double Blind Treatment Period|Physician Decision|1
7482995|NCT02057666|11793259|FG001|Double Blind Treatment Period|Physician Decision|0
7482996|NCT02057666|11793258|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
7482997|NCT02057666|11793259|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
7482998|NCT02057666|11793258|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
7482999|NCT02057666|11793259|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
7483000|NCT02057666|11793258|FG000|Double Blind Treatment Period|Sponsor's request|70
7483001|NCT02057666|11793259|FG001|Double Blind Treatment Period|Sponsor's request|34
7483002|NCT02057666|11793258|FG000|Open-Label Treatment Period|Poor tolerability|0
7483003|NCT02057666|11793259|FG001|Open-Label Treatment Period|Poor tolerability|1
7483004|NCT02057666|11793258|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
7483005|NCT02057666|11793259|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
7483006|NCT02057666|11793258|FG000|Open-Label Treatment Period|Sponsor's request|0
7483007|NCT02057666|11793259|FG001|Open-Label Treatment Period|Sponsor's request|4
7483008|NCT02057692|11793269|FG000|Overall Study|Adverse Event|1
7483009|NCT02057692|11793270|FG001|Overall Study|Adverse Event|0
7483010|NCT02057692|11793271|FG002|Overall Study|Adverse Event|0
7483011|NCT02057692|11793272|FG003|Overall Study|Adverse Event|0
7483012|NCT02057692|11793269|FG000|Overall Study|Lost to Follow-up|0
7483013|NCT02057692|11793270|FG001|Overall Study|Lost to Follow-up|0
7483014|NCT02057692|11793271|FG002|Overall Study|Lost to Follow-up|0
7483015|NCT02057692|11793272|FG003|Overall Study|Lost to Follow-up|1
7483016|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
7483017|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
7483018|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
7483019|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
7483020|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
7483021|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
7483022|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
7483023|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
7483024|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7483025|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
7483026|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
7483027|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
7483028|NCT02057718|11793290|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
7483029|NCT02057718|11793291|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
7483030|NCT02057718|11793290|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
7483031|NCT02057718|11793291|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
7483032|NCT02057718|11793290|FG000|Optional Follow-up Treatment Period|Progressive disease|0
7483033|NCT02057718|11793291|FG001|Optional Follow-up Treatment Period|Progressive disease|1
7483034|NCT02057718|11793290|FG000|Optional Follow-up Treatment Period|Adverse Event|1
7483035|NCT02057718|11793291|FG001|Optional Follow-up Treatment Period|Adverse Event|2
7483036|NCT02057718|11793290|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
7483037|NCT02057718|11793291|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
7483038|NCT02057757|11793299|FG000|Overall Study|Withdrawal by Subject|3
7483039|NCT02057757|11793300|FG001|Overall Study|Withdrawal by Subject|5
7483040|NCT02057757|11793299|FG000|Overall Study|Death|2
7483041|NCT02057757|11793300|FG001|Overall Study|Death|0
7483042|NCT02057757|11793299|FG000|Overall Study|Lost to Follow-up|8
7483043|NCT02057757|11793300|FG001|Overall Study|Lost to Follow-up|3
7483044|NCT02057757|11793299|FG000|Overall Study|Non-compliance|1
7483045|NCT02057757|11793300|FG001|Overall Study|Non-compliance|0
7483046|NCT02057835|11793320|FG000|Overall Study|Withdrawal by Subject|0
7483047|NCT02057835|11793321|FG001|Overall Study|Withdrawal by Subject|2
7483048|NCT02057835|11793322|FG002|Overall Study|Withdrawal by Subject|0
7483049|NCT02057835|11793323|FG003|Overall Study|Withdrawal by Subject|0
7483050|NCT02057835|11793324|FG004|Overall Study|Withdrawal by Subject|0
7483051|NCT02057835|11793325|FG005|Overall Study|Withdrawal by Subject|0
7483052|NCT02057835|11793326|FG006|Overall Study|Withdrawal by Subject|0
7483053|NCT02057835|11793327|FG007|Overall Study|Withdrawal by Subject|0
7483054|NCT02057835|11793328|FG008|Overall Study|Withdrawal by Subject|0
7483055|NCT02057835|11793329|FG009|Overall Study|Withdrawal by Subject|0
7483056|NCT02058069|11793375|FG000|Overall Study|Exclusion due to implant size|5
7483057|NCT02058069|11793375|FG000|Overall Study|Withdrawal by Subject|6
7483058|NCT02058095|11793381|FG000|Overall Study|Adverse Event|1
7483059|NCT02058095|11793382|FG001|Overall Study|Adverse Event|0
7483060|NCT02058108|11793390|FG000|Overall Study|Abnormal Laboratory Values|0
7483061|NCT02058108|11793391|FG001|Overall Study|Abnormal Laboratory Values|1
7483062|NCT02058108|11793390|FG000|Overall Study|Unsatisfactory therapeutic effect|37
7483063|NCT02058108|11793391|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7483064|NCT02058108|11793390|FG000|Overall Study|No longer requires study drug|0
7483065|NCT02058108|11793391|FG001|Overall Study|No longer requires study drug|1
7483066|NCT02058108|11793390|FG000|Overall Study|Withdrawal by Subject|1
7483067|NCT02058108|11793391|FG001|Overall Study|Withdrawal by Subject|0
7483068|NCT02058108|11793390|FG000|Overall Study|Administrative problems|3
7483069|NCT02058108|11793391|FG001|Overall Study|Administrative problems|3
7483070|NCT02058108|11793390|FG000|Overall Study|Protocol Violation|0
7483071|NCT02058108|11793391|FG001|Overall Study|Protocol Violation|1
7483072|NCT02058147|11793402|FG000|Overall Study|Randomized but not treated|0
7483073|NCT02058147|11793403|FG001|Overall Study|Randomized but not treated|0
7483074|NCT02058147|11793404|FG002|Overall Study|Randomized but not treated|1
7483075|NCT02058147|11793402|FG000|Overall Study|Adverse Event|12
7483076|NCT02058147|11793403|FG001|Overall Study|Adverse Event|9
7483077|NCT02058147|11793404|FG002|Overall Study|Adverse Event|21
7483078|NCT02058147|11793402|FG000|Overall Study|Lack of Efficacy|1
7483079|NCT02058147|11793403|FG001|Overall Study|Lack of Efficacy|0
7483080|NCT02058147|11793404|FG002|Overall Study|Lack of Efficacy|3
7483081|NCT02058147|11793402|FG000|Overall Study|Poor compliance to protocol|8
7483082|NCT02058147|11793403|FG001|Overall Study|Poor compliance to protocol|9
7483083|NCT02058147|11793404|FG002|Overall Study|Poor compliance to protocol|4
7483084|NCT02058147|11793402|FG000|Overall Study|Other than specified|8
7483085|NCT02058147|11793403|FG001|Overall Study|Other than specified|9
7483086|NCT02058147|11793404|FG002|Overall Study|Other than specified|0
7483087|NCT02058160|11793414|FG000|Overall Study|Randomized but not treated|2
7483088|NCT02058160|11793415|FG001|Overall Study|Randomized but not treated|4
7483089|NCT02058160|11793414|FG000|Overall Study|Poor compliance to protocol|4
7483090|NCT02058160|11793415|FG001|Overall Study|Poor compliance to protocol|1
7483091|NCT02058160|11793414|FG000|Overall Study|Adverse Event|12
7483092|NCT02058160|11793415|FG001|Overall Study|Adverse Event|3
7483093|NCT02058160|11793414|FG000|Overall Study|Lost to Follow-up|1
7483094|NCT02058160|11793415|FG001|Overall Study|Lost to Follow-up|0
7483095|NCT02058160|11793414|FG000|Overall Study|Other than specified above|12
7483096|NCT02058160|11793415|FG001|Overall Study|Other than specified above|6
7483097|NCT02058290|11793432|FG000|Overall Study|Protocol Violation|2
7483098|NCT02058290|11793433|FG001|Overall Study|Protocol Violation|1
7483099|NCT02058290|11793432|FG000|Overall Study|Physician Decision|1
7483100|NCT02058290|11793433|FG001|Overall Study|Physician Decision|0
7483101|NCT02058290|11793432|FG000|Overall Study|Didn't meet intraoperative criteria|8
7483102|NCT02058290|11793433|FG001|Overall Study|Didn't meet intraoperative criteria|7
7483103|NCT02058290|11793432|FG000|Overall Study|Withdrawal by Subject|0
7483104|NCT02058290|11793433|FG001|Overall Study|Withdrawal by Subject|1
7483105|NCT02058368|11793441|FG000|Overall Study|Adverse Event|15
7483106|NCT02058368|11793442|FG001|Overall Study|Adverse Event|20
7483107|NCT02058368|11793441|FG000|Overall Study|Lack of Efficacy|0
7483108|NCT02058368|11793442|FG001|Overall Study|Lack of Efficacy|1
7483109|NCT02058368|11793441|FG000|Overall Study|Protocol Violation|0
7483110|NCT02058368|11793442|FG001|Overall Study|Protocol Violation|4
7483111|NCT02058368|11793441|FG000|Overall Study|Lost to Follow-up|2
7483112|NCT02058368|11793442|FG001|Overall Study|Lost to Follow-up|0
7483113|NCT02058368|11793441|FG000|Overall Study|Physician Decision|2
7483114|NCT02058368|11793442|FG001|Overall Study|Physician Decision|3
7483115|NCT02058368|11793441|FG000|Overall Study|Withdrawal by Subject|22
7483116|NCT02058368|11793442|FG001|Overall Study|Withdrawal by Subject|26
7483117|NCT02058498|11793448|FG000|Overall Study|Withdrawal by Subject|4
7483118|NCT02058563|11793458|FG000|Overall Study|Lost to Follow-up|26
7483119|NCT02058563|11793459|FG001|Overall Study|Lost to Follow-up|22
7483120|NCT02058563|11793458|FG000|Overall Study|Other (vaccinated later as new subject)|1
7483121|NCT02058563|11793459|FG001|Overall Study|Other (vaccinated later as new subject)|0
7483122|NCT02058563|11793458|FG000|Overall Study|Consent Withdrawal|1
7483123|NCT02058563|11793459|FG001|Overall Study|Consent Withdrawal|1
7483124|NCT02058563|11793458|FG000|Overall Study|Other (patient incarcerated)|0
7483125|NCT02058563|11793459|FG001|Overall Study|Other (patient incarcerated)|1
7483126|NCT02058589|11793467|FG000|Overall Study|Serious Adverse Event|1
7483127|NCT02058589|11793468|FG001|Overall Study|Serious Adverse Event|1
7483128|NCT02058589|11793467|FG000|Overall Study|Non-Serious Adverse Event|1
7483129|NCT02058589|11793468|FG001|Overall Study|Non-Serious Adverse Event|0
7483130|NCT02058589|11793467|FG000|Overall Study|Withdrawal by Subject|0
7483131|NCT02058589|11793468|FG001|Overall Study|Withdrawal by Subject|1
7483132|NCT02058628|11793478|FG000|Overall Study|Adverse Event|1
7483133|NCT02058628|11793479|FG001|Overall Study|Adverse Event|0
7483134|NCT02058628|11793478|FG000|Overall Study|Withdrawal by Subject|2
7483135|NCT02058628|11793479|FG001|Overall Study|Withdrawal by Subject|2
7483136|NCT02058628|11793478|FG000|Overall Study|Lost to Follow-up|2
7483137|NCT02058628|11793479|FG001|Overall Study|Lost to Follow-up|4
7483138|NCT02058628|11793478|FG000|Overall Study|Not in time schedule|0
7483139|NCT02058628|11793479|FG001|Overall Study|Not in time schedule|1
7483140|NCT02058628|11793478|FG000|Overall Study|The visit date was not in timeline|0
7483141|NCT02058628|11793479|FG001|Overall Study|The visit date was not in timeline|1
7483142|NCT02058628|11793478|FG000|Overall Study|A lot of time for study for participant|1
7483143|NCT02058628|11793479|FG001|Overall Study|A lot of time for study for participant|0
7483144|NCT02058628|11793478|FG000|Overall Study|Non compliance|1
7483145|NCT02058628|11793479|FG001|Overall Study|Non compliance|0
7483146|NCT02058836|11793490|FG000|Overall Study|Withdrawal by Subject|1
7483147|NCT02058836|11793491|FG001|Overall Study|Withdrawal by Subject|1
7483148|NCT02058849|11793499|FG000|Overall Study|Hospitalization|1
7483149|NCT02058849|11793500|FG001|Overall Study|Hospitalization|1
7483150|NCT02058849|11793499|FG000|Overall Study|Death|1
7483151|NCT02058849|11793500|FG001|Overall Study|Death|0
7483152|NCT02058849|11793499|FG000|Overall Study|Lost to Follow-up|1
7483153|NCT02058849|11793500|FG001|Overall Study|Lost to Follow-up|0
7483154|NCT02058849|11793499|FG000|Overall Study|Withdrawal by Subject|4
7483155|NCT02058849|11793500|FG001|Overall Study|Withdrawal by Subject|0
7483156|NCT02058940|11793506|FG000|Overall Study|Discharged from Critical Care Unit|1
7483157|NCT02058966|11793510|FG000|Open-Label Methamphetamine|Adverse Event|1
7483158|NCT02058966|11793510|FG000|First Intervention|Withdrawal by Subject|1
7483159|NCT02058992|11793522|FG000|Overall Study|Lost to Follow-up|4
7483160|NCT02058992|11793522|FG000|Overall Study|Protocol Violation|92
7483161|NCT02058992|11793522|FG000|Overall Study|CRF Uncollected|20
7483162|NCT02059005|11793528|FG000|Overall Study|Death|1
7483163|NCT02059005|11793529|FG001|Overall Study|Death|3
7483164|NCT02059005|11793528|FG000|Overall Study|Lost to Follow-up|19
7483165|NCT02059005|11793529|FG001|Overall Study|Lost to Follow-up|19
7483166|NCT02059005|11793528|FG000|Overall Study|Incarceration|0
7483167|NCT02059005|11793529|FG001|Overall Study|Incarceration|1
7483168|NCT02059005|11793528|FG000|Overall Study|Inpatient|0
7483169|NCT02059005|11793529|FG001|Overall Study|Inpatient|1
7483170|NCT02059135|11793553|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
7483171|NCT02059135|11793554|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
7483172|NCT02059135|11793553|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
7483173|NCT02059135|11793554|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
7483174|NCT02059135|11793553|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
7483175|NCT02059135|11793554|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
7483176|NCT02059135|11793553|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
7483177|NCT02059135|11793554|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
7483178|NCT02059135|11793553|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
7483179|NCT02059135|11793554|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
7483180|NCT02059135|11793553|FG000|Neonatal Follow-up (Safety Population)|Death|3
7483181|NCT02059135|11793554|FG001|Neonatal Follow-up (Safety Population)|Death|2
7483182|NCT02059135|11793553|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
7483183|NCT02059135|11793554|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
7483184|NCT02059135|11793553|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
7483185|NCT02059135|11793554|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
7483186|NCT02059148|11793562|FG000|Treatment 1|Protocol Violation|0
7483187|NCT02059148|11793563|FG001|Treatment 1|Protocol Violation|0
7483188|NCT02059148|11793564|FG002|Treatment 1|Protocol Violation|0
7483189|NCT02059148|11793565|FG003|Treatment 1|Protocol Violation|0
7483190|NCT02059148|11793566|FG004|Treatment 1|Protocol Violation|0
7483191|NCT02059148|11793567|FG005|Treatment 1|Protocol Violation|1
7483192|NCT02059161|11793580|FG000|Overall Study|Pregnancy|0
7483193|NCT02059161|11793581|FG001|Overall Study|Pregnancy|2
7483194|NCT02059161|11793580|FG000|Overall Study|Adverse Event|2
7483195|NCT02059161|11793581|FG001|Overall Study|Adverse Event|6
7483196|NCT02059161|11793580|FG000|Overall Study|Lost to Follow-up|20
7483197|NCT02059161|11793581|FG001|Overall Study|Lost to Follow-up|12
7483198|NCT02059161|11793580|FG000|Overall Study|Physician Decision|4
7483199|NCT02059161|11793581|FG001|Overall Study|Physician Decision|4
7483200|NCT02059161|11793580|FG000|Overall Study|Protocol Violation|1
7483201|NCT02059161|11793581|FG001|Overall Study|Protocol Violation|1
7483202|NCT02059161|11793580|FG000|Overall Study|Withdrawal by Subject|16
7483203|NCT02059161|11793581|FG001|Overall Study|Withdrawal by Subject|13
7483204|NCT02059161|11793580|FG000|Overall Study|Randomized in error, no study drug|0
7483205|NCT02059161|11793581|FG001|Overall Study|Randomized in error, no study drug|1
7483206|NCT02059161|11793580|FG000|Overall Study|Non-compliance with study drug|6
7483207|NCT02059161|11793581|FG001|Overall Study|Non-compliance with study drug|2
7483208|NCT02059174|11793587|FG000|Period 1|Withdrawal by Subject|0
7483209|NCT02059174|11793588|FG001|Period 1|Withdrawal by Subject|2
7483210|NCT02059174|11793587|FG000|Period 2|Withdrawal by Subject|0
7483211|NCT02059174|11793588|FG001|Period 2|Withdrawal by Subject|2
7483212|NCT02059174|11793587|FG000|Period 2|Protocol Violation|1
7483213|NCT02059174|11793588|FG001|Period 2|Protocol Violation|0
7483214|NCT02059174|11793587|FG000|Period 3|Physician Decision|1
7483215|NCT02059174|11793588|FG001|Period 3|Physician Decision|0
7483216|NCT02059187|11793596|FG000|Overall Study|Adverse Event|0
7483217|NCT02059187|11793597|FG001|Overall Study|Adverse Event|3
7483218|NCT02059187|11793596|FG000|Overall Study|Death|1
7483219|NCT02059187|11793597|FG001|Overall Study|Death|1
7483220|NCT02059187|11793596|FG000|Overall Study|Lost to Follow-up|9
7483221|NCT02059187|11793597|FG001|Overall Study|Lost to Follow-up|8
7483222|NCT02059187|11793596|FG000|Overall Study|Non-compliance with study drug|1
7483223|NCT02059187|11793597|FG001|Overall Study|Non-compliance with study drug|0
7483224|NCT02059187|11793596|FG000|Overall Study|Physician Decision|1
7483225|NCT02059187|11793597|FG001|Overall Study|Physician Decision|2
7483226|NCT02059187|11793596|FG000|Overall Study|Protocol Violation|1
7483227|NCT02059187|11793597|FG001|Overall Study|Protocol Violation|0
7483228|NCT02059187|11793596|FG000|Overall Study|Withdrawal by Subject|12
7483229|NCT02059187|11793597|FG001|Overall Study|Withdrawal by Subject|8
7483230|NCT02059239|11793617|FG000|Overall Study|Progressive Disease after Bendamustine|1
7483231|NCT02059239|11793618|FG001|Overall Study|Progressive Disease after Bendamustine|3
7483232|NCT02059239|11793617|FG000|Overall Study|Physician Decision|1
7483233|NCT02059239|11793618|FG001|Overall Study|Physician Decision|0
7483234|NCT02059278|11793627|FG000|Overall Study|Adverse Event|1
7483235|NCT02059278|11793628|FG001|Overall Study|Adverse Event|1
7483236|NCT02059278|11793627|FG000|Overall Study|Lost to Follow-up|1
7483237|NCT02059278|11793628|FG001|Overall Study|Lost to Follow-up|0
7483238|NCT02059278|11793627|FG000|Overall Study|Withdrawal by Subject|0
7483239|NCT02059278|11793628|FG001|Overall Study|Withdrawal by Subject|3
7483240|NCT02059278|11793627|FG000|Overall Study|Ran out of IP and decided to discontinue|1
7483241|NCT02059278|11793628|FG001|Overall Study|Ran out of IP and decided to discontinue|0
7483242|NCT02059291|11793643|FG000|Epoch 2|Lack of Efficacy|0
7483243|NCT02059291|11793644|FG001|Epoch 2|Lack of Efficacy|0
7483244|NCT02059291|11793645|FG002|Epoch 2|Lack of Efficacy|0
7483245|NCT02059291|11793646|FG003|Epoch 2|Lack of Efficacy|1
7483246|NCT02059291|11793647|FG004|Epoch 2|Lack of Efficacy|0
7483247|NCT02059291|11793648|FG005|Epoch 2|Lack of Efficacy|1
7483248|NCT02059291|11793649|FG006|Epoch 2|Lack of Efficacy|0
7483249|NCT02059291|11793650|FG007|Epoch 2|Lack of Efficacy|0
7483250|NCT02059291|11793651|FG008|Epoch 2|Lack of Efficacy|0
7483251|NCT02059291|11793652|FG009|Epoch 2|Lack of Efficacy|0
7483252|NCT02059291|11793653|FG010|Epoch 2|Lack of Efficacy|0
7483253|NCT02059291|11793654|FG011|Epoch 2|Lack of Efficacy|0
7483254|NCT02059291|11793655|FG012|Epoch 2|Lack of Efficacy|0
7483255|NCT02059291|11793656|FG013|Epoch 2|Lack of Efficacy|0
7483256|NCT02059291|11793657|FG014|Epoch 2|Lack of Efficacy|0
7483257|NCT02059291|11793658|FG015|Epoch 2|Lack of Efficacy|0
7483258|NCT02059291|11793659|FG016|Epoch 2|Lack of Efficacy|0
7483259|NCT02059291|11793660|FG017|Epoch 2|Lack of Efficacy|0
7483260|NCT02059291|11793661|FG018|Epoch 2|Lack of Efficacy|0
7483261|NCT02059291|11793662|FG019|Epoch 2|Lack of Efficacy|0
7483262|NCT02059291|11793663|FG020|Epoch 2|Lack of Efficacy|0
7483263|NCT02059291|11793664|FG021|Epoch 2|Lack of Efficacy|0
7483264|NCT02059291|11793665|FG022|Epoch 2|Lack of Efficacy|0
7483265|NCT02059291|11793666|FG023|Epoch 2|Lack of Efficacy|0
7483266|NCT02059291|11793667|FG024|Epoch 2|Lack of Efficacy|0
7483267|NCT02059291|11793643|FG000|Epoch 2|Adverse Event|0
7483268|NCT02059291|11793644|FG001|Epoch 2|Adverse Event|0
7483269|NCT02059291|11793645|FG002|Epoch 2|Adverse Event|1
7483270|NCT02059291|11793646|FG003|Epoch 2|Adverse Event|1
7483271|NCT02059291|11793647|FG004|Epoch 2|Adverse Event|0
7483272|NCT02059291|11793648|FG005|Epoch 2|Adverse Event|0
7483273|NCT02059291|11793649|FG006|Epoch 2|Adverse Event|0
7483274|NCT02059291|11793650|FG007|Epoch 2|Adverse Event|1
7483275|NCT02059291|11793651|FG008|Epoch 2|Adverse Event|1
7483276|NCT02059291|11793652|FG009|Epoch 2|Adverse Event|0
7483277|NCT02059291|11793653|FG010|Epoch 2|Adverse Event|0
7483278|NCT02059291|11793654|FG011|Epoch 2|Adverse Event|0
7483279|NCT02059291|11793655|FG012|Epoch 2|Adverse Event|0
7483280|NCT02059291|11793656|FG013|Epoch 2|Adverse Event|0
7483281|NCT02059291|11793657|FG014|Epoch 2|Adverse Event|0
7483282|NCT02059291|11793658|FG015|Epoch 2|Adverse Event|0
7483283|NCT02059291|11793659|FG016|Epoch 2|Adverse Event|0
7483284|NCT02059291|11793660|FG017|Epoch 2|Adverse Event|0
7483285|NCT02059291|11793661|FG018|Epoch 2|Adverse Event|0
7483286|NCT02059291|11793662|FG019|Epoch 2|Adverse Event|0
7483287|NCT02059291|11793663|FG020|Epoch 2|Adverse Event|0
7483288|NCT02059291|11793664|FG021|Epoch 2|Adverse Event|0
7483289|NCT02059291|11793665|FG022|Epoch 2|Adverse Event|0
7483290|NCT02059291|11793666|FG023|Epoch 2|Adverse Event|0
7483291|NCT02059291|11793667|FG024|Epoch 2|Adverse Event|0
7483292|NCT02059291|11793643|FG000|Epoch 2|Withdrawal by Subject|0
7483293|NCT02059291|11793644|FG001|Epoch 2|Withdrawal by Subject|1
7483294|NCT02059291|11793645|FG002|Epoch 2|Withdrawal by Subject|0
7483295|NCT02059291|11793646|FG003|Epoch 2|Withdrawal by Subject|0
7483296|NCT02059291|11793647|FG004|Epoch 2|Withdrawal by Subject|0
7483297|NCT02059291|11793648|FG005|Epoch 2|Withdrawal by Subject|1
7483298|NCT02059291|11793649|FG006|Epoch 2|Withdrawal by Subject|0
7483299|NCT02059291|11793650|FG007|Epoch 2|Withdrawal by Subject|0
7483300|NCT02059291|11793651|FG008|Epoch 2|Withdrawal by Subject|1
7483301|NCT02059291|11793652|FG009|Epoch 2|Withdrawal by Subject|0
7483302|NCT02059291|11793653|FG010|Epoch 2|Withdrawal by Subject|0
7483303|NCT02059291|11793654|FG011|Epoch 2|Withdrawal by Subject|0
7483304|NCT02059291|11793655|FG012|Epoch 2|Withdrawal by Subject|0
7483305|NCT02059291|11793656|FG013|Epoch 2|Withdrawal by Subject|0
7483306|NCT02059291|11793657|FG014|Epoch 2|Withdrawal by Subject|0
7483307|NCT02059291|11793658|FG015|Epoch 2|Withdrawal by Subject|0
7483308|NCT02059291|11793659|FG016|Epoch 2|Withdrawal by Subject|0
7483309|NCT02059291|11793660|FG017|Epoch 2|Withdrawal by Subject|0
7483310|NCT02059291|11793661|FG018|Epoch 2|Withdrawal by Subject|0
7483311|NCT02059291|11793662|FG019|Epoch 2|Withdrawal by Subject|0
7483312|NCT02059291|11793663|FG020|Epoch 2|Withdrawal by Subject|0
7483313|NCT02059291|11793664|FG021|Epoch 2|Withdrawal by Subject|0
7483314|NCT02059291|11793665|FG022|Epoch 2|Withdrawal by Subject|0
7483315|NCT02059291|11793666|FG023|Epoch 2|Withdrawal by Subject|0
7483316|NCT02059291|11793667|FG024|Epoch 2|Withdrawal by Subject|0
7483317|NCT02059291|11793643|FG000|Epoch 3|Physician Decision|0
7483318|NCT02059291|11793644|FG001|Epoch 3|Physician Decision|0
7483319|NCT02059291|11793645|FG002|Epoch 3|Physician Decision|0
7483320|NCT02059291|11793646|FG003|Epoch 3|Physician Decision|0
7483321|NCT02059291|11793647|FG004|Epoch 3|Physician Decision|0
7483322|NCT02059291|11793648|FG005|Epoch 3|Physician Decision|0
7483323|NCT02059291|11793649|FG006|Epoch 3|Physician Decision|0
7483324|NCT02059291|11793650|FG007|Epoch 3|Physician Decision|0
7483325|NCT02059291|11793651|FG008|Epoch 3|Physician Decision|0
7483326|NCT02059291|11793652|FG009|Epoch 3|Physician Decision|0
7483327|NCT02059291|11793653|FG010|Epoch 3|Physician Decision|0
7483328|NCT02059291|11793654|FG011|Epoch 3|Physician Decision|0
7483329|NCT02059291|11793655|FG012|Epoch 3|Physician Decision|0
7483330|NCT02059291|11793656|FG013|Epoch 3|Physician Decision|1
7483331|NCT02059291|11793657|FG014|Epoch 3|Physician Decision|0
7483332|NCT02059291|11793658|FG015|Epoch 3|Physician Decision|1
7483333|NCT02059291|11793659|FG016|Epoch 3|Physician Decision|0
7483334|NCT02059291|11793660|FG017|Epoch 3|Physician Decision|0
7483335|NCT02059291|11793661|FG018|Epoch 3|Physician Decision|0
7483336|NCT02059291|11793662|FG019|Epoch 3|Physician Decision|0
7483337|NCT02059291|11793663|FG020|Epoch 3|Physician Decision|0
7483338|NCT02059291|11793664|FG021|Epoch 3|Physician Decision|0
7483339|NCT02059291|11793665|FG022|Epoch 3|Physician Decision|0
7483340|NCT02059291|11793666|FG023|Epoch 3|Physician Decision|0
7483341|NCT02059291|11793667|FG024|Epoch 3|Physician Decision|0
7483342|NCT02059291|11793643|FG000|Epoch 3|Adverse Event|0
7483343|NCT02059291|11793644|FG001|Epoch 3|Adverse Event|0
7483344|NCT02059291|11793645|FG002|Epoch 3|Adverse Event|0
7483345|NCT02059291|11793646|FG003|Epoch 3|Adverse Event|0
7483346|NCT02059291|11793647|FG004|Epoch 3|Adverse Event|0
7483347|NCT02059291|11793648|FG005|Epoch 3|Adverse Event|0
7483348|NCT02059291|11793649|FG006|Epoch 3|Adverse Event|0
7483349|NCT02059291|11793650|FG007|Epoch 3|Adverse Event|0
7483350|NCT02059291|11793651|FG008|Epoch 3|Adverse Event|0
7483351|NCT02059291|11793652|FG009|Epoch 3|Adverse Event|0
7483352|NCT02059291|11793653|FG010|Epoch 3|Adverse Event|0
7483353|NCT02059291|11793654|FG011|Epoch 3|Adverse Event|0
7483354|NCT02059291|11793655|FG012|Epoch 3|Adverse Event|0
7483355|NCT02059291|11793656|FG013|Epoch 3|Adverse Event|0
7483356|NCT02059291|11793657|FG014|Epoch 3|Adverse Event|0
7483357|NCT02059291|11793658|FG015|Epoch 3|Adverse Event|1
7483358|NCT02059291|11793659|FG016|Epoch 3|Adverse Event|0
7483359|NCT02059291|11793660|FG017|Epoch 3|Adverse Event|0
7483360|NCT02059291|11793661|FG018|Epoch 3|Adverse Event|0
7483361|NCT02059291|11793662|FG019|Epoch 3|Adverse Event|0
7483362|NCT02059291|11793663|FG020|Epoch 3|Adverse Event|0
7483363|NCT02059291|11793664|FG021|Epoch 3|Adverse Event|0
7483364|NCT02059291|11793665|FG022|Epoch 3|Adverse Event|0
7483365|NCT02059291|11793666|FG023|Epoch 3|Adverse Event|0
7483366|NCT02059291|11793667|FG024|Epoch 3|Adverse Event|0
7483367|NCT02059291|11793643|FG000|Epoch 3|Lack of Efficacy|0
7483368|NCT02059291|11793644|FG001|Epoch 3|Lack of Efficacy|0
7483369|NCT02059291|11793645|FG002|Epoch 3|Lack of Efficacy|0
7483370|NCT02059291|11793646|FG003|Epoch 3|Lack of Efficacy|0
7483371|NCT02059291|11793647|FG004|Epoch 3|Lack of Efficacy|0
7483372|NCT02059291|11793648|FG005|Epoch 3|Lack of Efficacy|0
7483373|NCT02059291|11793649|FG006|Epoch 3|Lack of Efficacy|0
7483374|NCT02059291|11793650|FG007|Epoch 3|Lack of Efficacy|0
7483375|NCT02059291|11793651|FG008|Epoch 3|Lack of Efficacy|0
7483376|NCT02059291|11793652|FG009|Epoch 3|Lack of Efficacy|0
7483377|NCT02059291|11793653|FG010|Epoch 3|Lack of Efficacy|0
7483378|NCT02059291|11793654|FG011|Epoch 3|Lack of Efficacy|0
7483379|NCT02059291|11793655|FG012|Epoch 3|Lack of Efficacy|0
7483380|NCT02059291|11793656|FG013|Epoch 3|Lack of Efficacy|0
7483381|NCT02059291|11793657|FG014|Epoch 3|Lack of Efficacy|0
7483382|NCT02059291|11793658|FG015|Epoch 3|Lack of Efficacy|3
7483383|NCT02059291|11793659|FG016|Epoch 3|Lack of Efficacy|0
7483384|NCT02059291|11793660|FG017|Epoch 3|Lack of Efficacy|0
7483385|NCT02059291|11793661|FG018|Epoch 3|Lack of Efficacy|0
7483386|NCT02059291|11793662|FG019|Epoch 3|Lack of Efficacy|0
7483387|NCT02059291|11793663|FG020|Epoch 3|Lack of Efficacy|0
7483388|NCT02059291|11793664|FG021|Epoch 3|Lack of Efficacy|0
7483389|NCT02059291|11793665|FG022|Epoch 3|Lack of Efficacy|0
7483390|NCT02059291|11793666|FG023|Epoch 3|Lack of Efficacy|0
7483391|NCT02059291|11793667|FG024|Epoch 3|Lack of Efficacy|0
7483392|NCT02059291|11793643|FG000|Epoch 3|Withdrawal by Subject|0
7483393|NCT02059291|11793644|FG001|Epoch 3|Withdrawal by Subject|0
7483394|NCT02059291|11793645|FG002|Epoch 3|Withdrawal by Subject|0
7483395|NCT02059291|11793646|FG003|Epoch 3|Withdrawal by Subject|0
7483396|NCT02059291|11793647|FG004|Epoch 3|Withdrawal by Subject|0
7483397|NCT02059291|11793648|FG005|Epoch 3|Withdrawal by Subject|0
7483398|NCT02059291|11793649|FG006|Epoch 3|Withdrawal by Subject|0
7483399|NCT02059291|11793650|FG007|Epoch 3|Withdrawal by Subject|0
7483400|NCT02059291|11793651|FG008|Epoch 3|Withdrawal by Subject|0
7483401|NCT02059291|11793652|FG009|Epoch 3|Withdrawal by Subject|0
7483402|NCT02059291|11793653|FG010|Epoch 3|Withdrawal by Subject|0
7483403|NCT02059291|11793654|FG011|Epoch 3|Withdrawal by Subject|0
7483404|NCT02059291|11793655|FG012|Epoch 3|Withdrawal by Subject|0
7483405|NCT02059291|11793656|FG013|Epoch 3|Withdrawal by Subject|0
7483406|NCT02059291|11793657|FG014|Epoch 3|Withdrawal by Subject|0
7483407|NCT02059291|11793658|FG015|Epoch 3|Withdrawal by Subject|1
7483408|NCT02059291|11793659|FG016|Epoch 3|Withdrawal by Subject|0
7483409|NCT02059291|11793660|FG017|Epoch 3|Withdrawal by Subject|0
7483410|NCT02059291|11793661|FG018|Epoch 3|Withdrawal by Subject|0
7483411|NCT02059291|11793662|FG019|Epoch 3|Withdrawal by Subject|0
7483412|NCT02059291|11793663|FG020|Epoch 3|Withdrawal by Subject|0
7483413|NCT02059291|11793664|FG021|Epoch 3|Withdrawal by Subject|0
7483414|NCT02059291|11793665|FG022|Epoch 3|Withdrawal by Subject|0
7483415|NCT02059291|11793666|FG023|Epoch 3|Withdrawal by Subject|0
7483416|NCT02059291|11793667|FG024|Epoch 3|Withdrawal by Subject|0
7483417|NCT02059291|11793643|FG000|Epoch 4|Adverse Event|0
7483418|NCT02059291|11793644|FG001|Epoch 4|Adverse Event|0
7483419|NCT02059291|11793645|FG002|Epoch 4|Adverse Event|0
7483420|NCT02059291|11793646|FG003|Epoch 4|Adverse Event|0
7483421|NCT02059291|11793647|FG004|Epoch 4|Adverse Event|0
7483422|NCT02059291|11793648|FG005|Epoch 4|Adverse Event|0
7483423|NCT02059291|11793649|FG006|Epoch 4|Adverse Event|0
7483424|NCT02059291|11793650|FG007|Epoch 4|Adverse Event|0
7483425|NCT02059291|11793651|FG008|Epoch 4|Adverse Event|0
7483426|NCT02059291|11793652|FG009|Epoch 4|Adverse Event|0
7483427|NCT02059291|11793653|FG010|Epoch 4|Adverse Event|0
7483428|NCT02059291|11793654|FG011|Epoch 4|Adverse Event|0
7483429|NCT02059291|11793655|FG012|Epoch 4|Adverse Event|0
7483430|NCT02059291|11793656|FG013|Epoch 4|Adverse Event|0
7483431|NCT02059291|11793657|FG014|Epoch 4|Adverse Event|0
7483432|NCT02059291|11793658|FG015|Epoch 4|Adverse Event|0
7483433|NCT02059291|11793659|FG016|Epoch 4|Adverse Event|1
7483434|NCT02059291|11793660|FG017|Epoch 4|Adverse Event|0
7483435|NCT02059291|11793661|FG018|Epoch 4|Adverse Event|0
7483436|NCT02059291|11793662|FG019|Epoch 4|Adverse Event|0
7483437|NCT02059291|11793663|FG020|Epoch 4|Adverse Event|0
7483438|NCT02059291|11793664|FG021|Epoch 4|Adverse Event|0
7483439|NCT02059291|11793665|FG022|Epoch 4|Adverse Event|1
7483440|NCT02059291|11793666|FG023|Epoch 4|Adverse Event|0
7483441|NCT02059291|11793667|FG024|Epoch 4|Adverse Event|0
7483442|NCT02059291|11793643|FG000|Epoch 4|Pregnancy|0
7483443|NCT02059291|11793644|FG001|Epoch 4|Pregnancy|0
7483444|NCT02059291|11793645|FG002|Epoch 4|Pregnancy|0
7483445|NCT02059291|11793646|FG003|Epoch 4|Pregnancy|0
7483446|NCT02059291|11793647|FG004|Epoch 4|Pregnancy|0
7483447|NCT02059291|11793648|FG005|Epoch 4|Pregnancy|0
7483448|NCT02059291|11793649|FG006|Epoch 4|Pregnancy|0
7483449|NCT02059291|11793650|FG007|Epoch 4|Pregnancy|0
7483450|NCT02059291|11793651|FG008|Epoch 4|Pregnancy|0
7483451|NCT02059291|11793652|FG009|Epoch 4|Pregnancy|0
7483452|NCT02059291|11793653|FG010|Epoch 4|Pregnancy|0
7483453|NCT02059291|11793654|FG011|Epoch 4|Pregnancy|0
7483454|NCT02059291|11793655|FG012|Epoch 4|Pregnancy|0
7483455|NCT02059291|11793656|FG013|Epoch 4|Pregnancy|0
7483456|NCT02059291|11793657|FG014|Epoch 4|Pregnancy|0
7483457|NCT02059291|11793658|FG015|Epoch 4|Pregnancy|0
7483458|NCT02059291|11793659|FG016|Epoch 4|Pregnancy|1
7483459|NCT02059291|11793660|FG017|Epoch 4|Pregnancy|0
7483460|NCT02059291|11793661|FG018|Epoch 4|Pregnancy|0
7483461|NCT02059291|11793662|FG019|Epoch 4|Pregnancy|0
7483462|NCT02059291|11793663|FG020|Epoch 4|Pregnancy|0
7483463|NCT02059291|11793664|FG021|Epoch 4|Pregnancy|0
7483464|NCT02059291|11793665|FG022|Epoch 4|Pregnancy|0
7483465|NCT02059291|11793666|FG023|Epoch 4|Pregnancy|0
7483466|NCT02059291|11793667|FG024|Epoch 4|Pregnancy|0
7483467|NCT02059291|11793643|FG000|Epoch 4|Withdrawal by Subject|0
7483468|NCT02059291|11793644|FG001|Epoch 4|Withdrawal by Subject|0
7483469|NCT02059291|11793645|FG002|Epoch 4|Withdrawal by Subject|0
7483470|NCT02059291|11793646|FG003|Epoch 4|Withdrawal by Subject|0
7483471|NCT02059291|11793647|FG004|Epoch 4|Withdrawal by Subject|0
7483472|NCT02059291|11793648|FG005|Epoch 4|Withdrawal by Subject|0
7483473|NCT02059291|11793649|FG006|Epoch 4|Withdrawal by Subject|0
7483474|NCT02059291|11793650|FG007|Epoch 4|Withdrawal by Subject|0
7483475|NCT02059291|11793651|FG008|Epoch 4|Withdrawal by Subject|0
7483476|NCT02059291|11793652|FG009|Epoch 4|Withdrawal by Subject|0
7483477|NCT02059291|11793653|FG010|Epoch 4|Withdrawal by Subject|0
7483478|NCT02059291|11793654|FG011|Epoch 4|Withdrawal by Subject|0
7483479|NCT02059291|11793655|FG012|Epoch 4|Withdrawal by Subject|0
7483480|NCT02059291|11793656|FG013|Epoch 4|Withdrawal by Subject|0
7483481|NCT02059291|11793657|FG014|Epoch 4|Withdrawal by Subject|0
7483482|NCT02059291|11793658|FG015|Epoch 4|Withdrawal by Subject|0
7483483|NCT02059291|11793659|FG016|Epoch 4|Withdrawal by Subject|0
7483484|NCT02059291|11793660|FG017|Epoch 4|Withdrawal by Subject|0
7483485|NCT02059291|11793661|FG018|Epoch 4|Withdrawal by Subject|0
7483486|NCT02059291|11793662|FG019|Epoch 4|Withdrawal by Subject|0
7483487|NCT02059291|11793663|FG020|Epoch 4|Withdrawal by Subject|1
7483488|NCT02059291|11793664|FG021|Epoch 4|Withdrawal by Subject|0
7483489|NCT02059291|11793665|FG022|Epoch 4|Withdrawal by Subject|0
7483490|NCT02059291|11793666|FG023|Epoch 4|Withdrawal by Subject|0
7483491|NCT02059291|11793667|FG024|Epoch 4|Withdrawal by Subject|0
7483492|NCT02059291|11793643|FG000|Epoch 4|Lack of Efficacy|0
7483493|NCT02059291|11793644|FG001|Epoch 4|Lack of Efficacy|0
7483494|NCT02059291|11793645|FG002|Epoch 4|Lack of Efficacy|0
7483495|NCT02059291|11793646|FG003|Epoch 4|Lack of Efficacy|0
7483496|NCT02059291|11793647|FG004|Epoch 4|Lack of Efficacy|0
7483497|NCT02059291|11793648|FG005|Epoch 4|Lack of Efficacy|0
7483498|NCT02059291|11793649|FG006|Epoch 4|Lack of Efficacy|0
7483499|NCT02059291|11793650|FG007|Epoch 4|Lack of Efficacy|0
7483500|NCT02059291|11793651|FG008|Epoch 4|Lack of Efficacy|0
7483501|NCT02059291|11793652|FG009|Epoch 4|Lack of Efficacy|0
7483502|NCT02059291|11793653|FG010|Epoch 4|Lack of Efficacy|0
7483503|NCT02059291|11793654|FG011|Epoch 4|Lack of Efficacy|0
7483504|NCT02059291|11793655|FG012|Epoch 4|Lack of Efficacy|0
7483505|NCT02059291|11793656|FG013|Epoch 4|Lack of Efficacy|0
7483506|NCT02059291|11793657|FG014|Epoch 4|Lack of Efficacy|0
7483507|NCT02059291|11793658|FG015|Epoch 4|Lack of Efficacy|0
7483508|NCT02059291|11793659|FG016|Epoch 4|Lack of Efficacy|0
7483509|NCT02059291|11793660|FG017|Epoch 4|Lack of Efficacy|0
7483510|NCT02059291|11793661|FG018|Epoch 4|Lack of Efficacy|0
7483511|NCT02059291|11793662|FG019|Epoch 4|Lack of Efficacy|0
7483512|NCT02059291|11793663|FG020|Epoch 4|Lack of Efficacy|0
7483513|NCT02059291|11793664|FG021|Epoch 4|Lack of Efficacy|0
7483514|NCT02059291|11793665|FG022|Epoch 4|Lack of Efficacy|0
7483515|NCT02059291|11793666|FG023|Epoch 4|Lack of Efficacy|1
7483516|NCT02059291|11793667|FG024|Epoch 4|Lack of Efficacy|0
7483517|NCT02059395|11793697|FG000|Overall Study|Lost to Follow-up|2
7483518|NCT02059395|11793698|FG001|Overall Study|Lost to Follow-up|4
7483519|NCT02059408|11793707|FG000|Overall Study|Did not get tested|0
7483520|NCT02059408|11793708|FG001|Overall Study|Did not get tested|330
7483521|NCT02059408|11793709|FG002|Overall Study|Did not get tested|358
7483522|NCT02059434|11793728|FG000|Washout Between Periods 1 and 2|Physician Decision|0
7483523|NCT02059434|11793729|FG001|Washout Between Periods 1 and 2|Physician Decision|0
7483524|NCT02059434|11793730|FG002|Washout Between Periods 1 and 2|Physician Decision|0
7483525|NCT02059434|11793731|FG003|Washout Between Periods 1 and 2|Physician Decision|0
7483526|NCT02059434|11793732|FG004|Washout Between Periods 1 and 2|Physician Decision|0
7483527|NCT02059434|11793733|FG005|Washout Between Periods 1 and 2|Physician Decision|0
7483528|NCT02059434|11793734|FG006|Washout Between Periods 1 and 2|Physician Decision|0
7483529|NCT02059434|11793735|FG007|Washout Between Periods 1 and 2|Physician Decision|1
7483530|NCT02059434|11793736|FG008|Washout Between Periods 1 and 2|Physician Decision|0
7483531|NCT02059434|11793728|FG000|Washout Between Periods 4 and 5|Adverse Event|0
7483532|NCT02059434|11793729|FG001|Washout Between Periods 4 and 5|Adverse Event|0
7483533|NCT02059434|11793730|FG002|Washout Between Periods 4 and 5|Adverse Event|0
7483534|NCT02059434|11793731|FG003|Washout Between Periods 4 and 5|Adverse Event|0
7483535|NCT02059434|11793732|FG004|Washout Between Periods 4 and 5|Adverse Event|0
7483536|NCT02059434|11793733|FG005|Washout Between Periods 4 and 5|Adverse Event|0
7483537|NCT02059434|11793734|FG006|Washout Between Periods 4 and 5|Adverse Event|0
7483538|NCT02059434|11793735|FG007|Washout Between Periods 4 and 5|Adverse Event|0
7483539|NCT02059434|11793736|FG008|Washout Between Periods 4 and 5|Adverse Event|1
7483540|NCT02059434|11793728|FG000|Washout Between Periods 6 and 7|Physician Decision|0
7483541|NCT02059434|11793729|FG001|Washout Between Periods 6 and 7|Physician Decision|0
7483542|NCT02059434|11793730|FG002|Washout Between Periods 6 and 7|Physician Decision|0
7483543|NCT02059434|11793731|FG003|Washout Between Periods 6 and 7|Physician Decision|0
7483544|NCT02059434|11793732|FG004|Washout Between Periods 6 and 7|Physician Decision|0
7483545|NCT02059434|11793733|FG005|Washout Between Periods 6 and 7|Physician Decision|0
7483546|NCT02059434|11793734|FG006|Washout Between Periods 6 and 7|Physician Decision|0
7483547|NCT02059434|11793735|FG007|Washout Between Periods 6 and 7|Physician Decision|0
7483548|NCT02059434|11793736|FG008|Washout Between Periods 6 and 7|Physician Decision|1
7483549|NCT02059434|11793728|FG000|Washout Between Periods 7 and 8|Adverse Event|0
7483550|NCT02059434|11793729|FG001|Washout Between Periods 7 and 8|Adverse Event|0
7483551|NCT02059434|11793730|FG002|Washout Between Periods 7 and 8|Adverse Event|0
7483552|NCT02059434|11793731|FG003|Washout Between Periods 7 and 8|Adverse Event|0
7483553|NCT02059434|11793732|FG004|Washout Between Periods 7 and 8|Adverse Event|0
7483554|NCT02059434|11793733|FG005|Washout Between Periods 7 and 8|Adverse Event|0
7483555|NCT02059434|11793734|FG006|Washout Between Periods 7 and 8|Adverse Event|0
7483556|NCT02059434|11793735|FG007|Washout Between Periods 7 and 8|Adverse Event|0
7483557|NCT02059434|11793736|FG008|Washout Between Periods 7 and 8|Adverse Event|1
7483558|NCT02059434|11793728|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483559|NCT02059434|11793729|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483560|NCT02059434|11793730|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483561|NCT02059434|11793731|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483562|NCT02059434|11793732|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483563|NCT02059434|11793733|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483564|NCT02059434|11793734|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483565|NCT02059434|11793735|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
7483566|NCT02059434|11793736|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
7483567|NCT02059980|11793817|FG000|Overall Study|Lost to Follow-up|2
7483568|NCT02059980|11793818|FG001|Overall Study|Lost to Follow-up|1
7483569|NCT02060370|11793847|FG000|Overall Study|Physician Decision|1
7483570|NCT02060383|11793856|FG000|Core Phase|Unsatisfactory therapeutic effect|1
7483571|NCT02060383|11793857|FG001|Core Phase|Unsatisfactory therapeutic effect|5
7483572|NCT02060383|11793858|FG002|Core Phase|Unsatisfactory therapeutic effect|0
7483573|NCT02060383|11793859|FG003|Core Phase|Unsatisfactory therapeutic effect|0
7483574|NCT02060383|11793860|FG004|Core Phase|Unsatisfactory therapeutic effect|0
7483575|NCT02060383|11793856|FG000|Core Phase|Adverse Event|2
7483576|NCT02060383|11793857|FG001|Core Phase|Adverse Event|0
7483577|NCT02060383|11793858|FG002|Core Phase|Adverse Event|0
7483578|NCT02060383|11793859|FG003|Core Phase|Adverse Event|2
7483579|NCT02060383|11793860|FG004|Core Phase|Adverse Event|6
7483580|NCT02060383|11793856|FG000|Core Phase|Administrative problems|0
7483581|NCT02060383|11793857|FG001|Core Phase|Administrative problems|1
7483582|NCT02060383|11793858|FG002|Core Phase|Administrative problems|0
7483583|NCT02060383|11793859|FG003|Core Phase|Administrative problems|0
7483584|NCT02060383|11793860|FG004|Core Phase|Administrative problems|0
7483585|NCT02060383|11793856|FG000|Core Phase|Protocol Violation|0
7483586|NCT02060383|11793857|FG001|Core Phase|Protocol Violation|0
7483587|NCT02060383|11793858|FG002|Core Phase|Protocol Violation|0
7483588|NCT02060383|11793859|FG003|Core Phase|Protocol Violation|1
7483589|NCT02060383|11793860|FG004|Core Phase|Protocol Violation|0
7483590|NCT02060383|11793856|FG000|Core Phase|Withdrawal by Subject|0
7483591|NCT02060383|11793857|FG001|Core Phase|Withdrawal by Subject|0
7483592|NCT02060383|11793858|FG002|Core Phase|Withdrawal by Subject|0
7483593|NCT02060383|11793859|FG003|Core Phase|Withdrawal by Subject|4
7483594|NCT02060383|11793860|FG004|Core Phase|Withdrawal by Subject|2
7483595|NCT02060383|11793856|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
7483596|NCT02060383|11793857|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
7483597|NCT02060383|11793858|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7483598|NCT02060383|11793859|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
7483599|NCT02060383|11793860|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
7483600|NCT02060383|11793856|FG000|Extension Phase|Adverse Event|1
7483601|NCT02060383|11793857|FG001|Extension Phase|Adverse Event|1
7483602|NCT02060383|11793858|FG002|Extension Phase|Adverse Event|2
7483603|NCT02060383|11793859|FG003|Extension Phase|Adverse Event|0
7483604|NCT02060383|11793860|FG004|Extension Phase|Adverse Event|1
7483605|NCT02060383|11793856|FG000|Extension Phase|Withdrawal by Subject|0
7483606|NCT02060383|11793857|FG001|Extension Phase|Withdrawal by Subject|1
7483607|NCT02060383|11793858|FG002|Extension Phase|Withdrawal by Subject|0
7483608|NCT02060383|11793859|FG003|Extension Phase|Withdrawal by Subject|0
7483609|NCT02060383|11793860|FG004|Extension Phase|Withdrawal by Subject|2
7483610|NCT02060383|11793856|FG000|Extension Phase|Administrative problems|1
7483611|NCT02060383|11793857|FG001|Extension Phase|Administrative problems|0
7483612|NCT02060383|11793858|FG002|Extension Phase|Administrative problems|0
7483613|NCT02060383|11793859|FG003|Extension Phase|Administrative problems|0
7483614|NCT02060383|11793860|FG004|Extension Phase|Administrative problems|0
7483615|NCT02060383|11793856|FG000|Extension Phase|Death|0
7483616|NCT02060383|11793857|FG001|Extension Phase|Death|0
7483617|NCT02060383|11793858|FG002|Extension Phase|Death|1
7483618|NCT02060383|11793859|FG003|Extension Phase|Death|0
7483619|NCT02060383|11793860|FG004|Extension Phase|Death|1
7483620|NCT02060383|11793856|FG000|Extension Phase|Protocol Violation|0
7483621|NCT02060383|11793857|FG001|Extension Phase|Protocol Violation|0
7483622|NCT02060383|11793858|FG002|Extension Phase|Protocol Violation|0
7483623|NCT02060383|11793859|FG003|Extension Phase|Protocol Violation|0
7483624|NCT02060383|11793860|FG004|Extension Phase|Protocol Violation|1
7483625|NCT02060903|11793913|FG000|Overall Study|Lost to Follow-up|4
7483626|NCT02060903|11793914|FG001|Overall Study|Lost to Follow-up|0
7483627|NCT02060903|11793913|FG000|Overall Study|Withdrawal by Subject|0
7483628|NCT02060903|11793914|FG001|Overall Study|Withdrawal by Subject|7
7483629|NCT02061202|11793922|FG000|Overall Study|Lost to Follow-up|1
7483630|NCT02061202|11793923|FG001|Overall Study|Lost to Follow-up|1
7483631|NCT02061280|11793931|FG000|Overall Study|Protocol Violation|12
7483632|NCT02061280|11793932|FG001|Overall Study|Protocol Violation|8
7483633|NCT02061280|11793931|FG000|Overall Study|moved out of state|0
7483634|NCT02061280|11793932|FG001|Overall Study|moved out of state|1
7483635|NCT02061280|11793931|FG000|Overall Study|Withdrawal by Subject|1
7483636|NCT02061280|11793932|FG001|Overall Study|Withdrawal by Subject|2
7483637|NCT02061280|11793931|FG000|Overall Study|Lost to Follow-up|5
7483638|NCT02061280|11793932|FG001|Overall Study|Lost to Follow-up|1
7483639|NCT02061540|11793991|FG000|Overall Study|Adverse Event|2
7483640|NCT02061540|11793991|FG000|Overall Study|Withdrawal by Subject|2
7483641|NCT02061592|11794002|FG000|Period 1|Withdrawal by Subject|1
7483642|NCT02061592|11794003|FG001|Period 1|Withdrawal by Subject|0
7483643|NCT02061592|11794002|FG000|Period 1|Protocol Violation|1
7483644|NCT02061592|11794003|FG001|Period 1|Protocol Violation|0
7483645|NCT02061592|11794002|FG000|Period 2|Lost to Follow-up|0
7483646|NCT02061592|11794003|FG001|Period 2|Lost to Follow-up|1
7534687|NCT02700919|11881692|FG000|Overall Study|Physician Decision|1
7534688|NCT02700919|11881693|FG001|Overall Study|Physician Decision|0
7534689|NCT02700919|11881694|FG002|Overall Study|Physician Decision|0
7534690|NCT02700919|11881692|FG000|Overall Study|Protocol Violation|1
7534691|NCT02700919|11881693|FG001|Overall Study|Protocol Violation|0
7534692|NCT02700919|11881694|FG002|Overall Study|Protocol Violation|0
7534693|NCT02700919|11881692|FG000|Overall Study|Adverse Event|1
7534694|NCT02700919|11881693|FG001|Overall Study|Adverse Event|3
7534695|NCT02700919|11881694|FG002|Overall Study|Adverse Event|1
7534696|NCT02700919|11881692|FG000|Overall Study|Withdrawal by Subject|5
7534697|NCT02700919|11881693|FG001|Overall Study|Withdrawal by Subject|8
7534698|NCT02700919|11881694|FG002|Overall Study|Withdrawal by Subject|2
7483647|NCT02061813|11794042|FG000|Overall Study|Withdrawal by Subject|1
7483648|NCT02061813|11794042|FG000|Overall Study|Protocol Violation|2
7483649|NCT02062151|11794062|FG000|Overall Study|screen failure|1
7483650|NCT02062385|11794087|FG000|Overall Study|Adverse Event|19
7483651|NCT02062385|11794088|FG001|Overall Study|Adverse Event|13
7483652|NCT02062385|11794089|FG002|Overall Study|Adverse Event|1
7483653|NCT02062385|11794090|FG003|Overall Study|Adverse Event|0
7483654|NCT02062385|11794087|FG000|Overall Study|Protocol Violation|1
7483655|NCT02062385|11794088|FG001|Overall Study|Protocol Violation|0
7483656|NCT02062385|11794089|FG002|Overall Study|Protocol Violation|0
7483657|NCT02062385|11794090|FG003|Overall Study|Protocol Violation|0
7483658|NCT02062385|11794087|FG000|Overall Study|Incomplete EPI by database lock|2
7483659|NCT02062385|11794088|FG001|Overall Study|Incomplete EPI by database lock|0
7483660|NCT02062385|11794089|FG002|Overall Study|Incomplete EPI by database lock|0
7483661|NCT02062385|11794090|FG003|Overall Study|Incomplete EPI by database lock|0
7483662|NCT02062385|11794087|FG000|Overall Study|Moved|10
7483663|NCT02062385|11794088|FG001|Overall Study|Moved|11
7483664|NCT02062385|11794089|FG002|Overall Study|Moved|1
7483665|NCT02062385|11794090|FG003|Overall Study|Moved|0
7483666|NCT02062385|11794087|FG000|Overall Study|Withdrawn by parent/guardian|46
7483667|NCT02062385|11794088|FG001|Overall Study|Withdrawn by parent/guardian|41
7483668|NCT02062385|11794089|FG002|Overall Study|Withdrawn by parent/guardian|9
7483669|NCT02062385|11794090|FG003|Overall Study|Withdrawn by parent/guardian|8
7483670|NCT02062385|11794087|FG000|Overall Study|Death|0
7483671|NCT02062385|11794088|FG001|Overall Study|Death|0
7483672|NCT02062385|11794089|FG002|Overall Study|Death|0
7483673|NCT02062385|11794090|FG003|Overall Study|Death|1
7483674|NCT02062385|11794087|FG000|Overall Study|Lost to Follow-up|0
7483675|NCT02062385|11794088|FG001|Overall Study|Lost to Follow-up|0
7483676|NCT02062385|11794089|FG002|Overall Study|Lost to Follow-up|1
7483677|NCT02062385|11794090|FG003|Overall Study|Lost to Follow-up|0
7483678|NCT02062398|11794098|FG000|Overall Study|Implant removal|1
7483679|NCT02062437|11794102|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
7483680|NCT02062437|11794102|FG000|Overall Study|Patient not available for the 2y visit|18
7483681|NCT02062437|11794102|FG000|Overall Study|Death|2
7483682|NCT02062437|11794102|FG000|Overall Study|Pt. couldn't come due to med. condition|1
7483683|NCT02062450|11794108|FG000|Overall Study|No follow-up visit|124
7483684|NCT02062632|11794176|FG000|Overall Study|No treatment data|1
7483685|NCT02062645|11794180|FG000|Overall Study|Adverse Event|2
7483686|NCT02062645|11794180|FG000|Overall Study|Protocol Violation|8
7483687|NCT02062645|11794180|FG000|Overall Study|Lost to Follow-up|5
7483688|NCT02062658|11794184|FG000|Overall Study|Withdrawal by Subject|1
7483689|NCT02062658|11794184|FG000|Overall Study|Lack of Efficacy|1
7483690|NCT02062879|11794212|FG000|Overall Study|Withdrawal by Subject|4
7483691|NCT02062879|11794213|FG001|Overall Study|Withdrawal by Subject|1
7483692|NCT02063217|11794262|FG000|Overall Study|Withdrawal by Subject|1
7483693|NCT02063217|11794263|FG001|Overall Study|Withdrawal by Subject|0
7483694|NCT02063217|11794264|FG002|Overall Study|Withdrawal by Subject|0
7483695|NCT02063659|11794301|FG000|Double-Blind Treatment Period|Adverse Event|1
7483696|NCT02063659|11794302|FG001|Double-Blind Treatment Period|Adverse Event|2
7483697|NCT02063659|11794303|FG002|Double-Blind Treatment Period|Adverse Event|0
7483698|NCT02063659|11794304|FG003|Double-Blind Treatment Period|Adverse Event|0
7483699|NCT02063659|11794301|FG000|Double-Blind Treatment Period|Physician Decision|1
7483700|NCT02063659|11794302|FG001|Double-Blind Treatment Period|Physician Decision|0
7483701|NCT02063659|11794303|FG002|Double-Blind Treatment Period|Physician Decision|0
7483702|NCT02063659|11794304|FG003|Double-Blind Treatment Period|Physician Decision|0
7483703|NCT02063659|11794301|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
7483704|NCT02063659|11794302|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
7483705|NCT02063659|11794303|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7483706|NCT02063659|11794304|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7483707|NCT02063659|11794301|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7483708|NCT02063659|11794302|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7483709|NCT02063659|11794303|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7483710|NCT02063659|11794304|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
7483711|NCT02063659|11794301|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7483712|NCT02063659|11794302|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7483713|NCT02063659|11794303|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7483714|NCT02063659|11794304|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7483715|NCT02063659|11794301|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7483716|NCT02063659|11794302|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7483717|NCT02063659|11794303|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7483718|NCT02063659|11794304|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
7483719|NCT02063659|11794301|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7483720|NCT02063659|11794302|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7483721|NCT02063659|11794303|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7483722|NCT02063659|11794304|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
7483723|NCT02063659|11794301|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7483724|NCT02063659|11794302|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7483725|NCT02063659|11794303|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7483726|NCT02063659|11794304|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7483727|NCT02063672|11794320|FG000|Overall Study|Ongoing Follow-up|27
7483728|NCT02063672|11794321|FG001|Overall Study|Ongoing Follow-up|14
7483729|NCT02063672|11794320|FG000|Overall Study|Death|5
7483730|NCT02063672|11794321|FG001|Overall Study|Death|3
7483731|NCT02063672|11794320|FG000|Overall Study|Lost to Follow-up|1
7483732|NCT02063672|11794321|FG001|Overall Study|Lost to Follow-up|3
7483733|NCT02063672|11794320|FG000|Overall Study|Withdrawal by Subject|2
7483734|NCT02063672|11794321|FG001|Overall Study|Withdrawal by Subject|2
7483735|NCT02063698|11794329|FG000|Overall Study|did not complete booklet for days 2-8|1
7483736|NCT02063698|11794330|FG001|Overall Study|did not complete booklet for days 2-8|2
7483737|NCT02063737|11794338|FG000|Overall Study|Lost to Follow-up|11
7483738|NCT02063737|11794339|FG001|Overall Study|Lost to Follow-up|4
7483739|NCT02063828|11794348|FG000|Overall Study|Withdrawal by Subject|4
7483740|NCT02063828|11794349|FG001|Overall Study|Withdrawal by Subject|6
7483741|NCT02063828|11794350|FG002|Overall Study|Withdrawal by Subject|3
7483742|NCT02063828|11794348|FG000|Overall Study|Death|0
7483743|NCT02063828|11794349|FG001|Overall Study|Death|0
7483744|NCT02063828|11794350|FG002|Overall Study|Death|1
7483745|NCT02063854|11794365|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7483746|NCT02063854|11794366|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7483747|NCT02063854|11794367|FG002|Overall Study|Pretreatment Event/Adverse Event|13
7483748|NCT02063854|11794368|FG003|Overall Study|Pretreatment Event/Adverse Event|8
7483749|NCT02063854|11794369|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7483750|NCT02063854|11794370|FG005|Overall Study|Pretreatment Event/Adverse Event|18
7483751|NCT02063854|11794371|FG006|Overall Study|Pretreatment Event/Adverse Event|4
7483752|NCT02063854|11794365|FG000|Overall Study|Major Protocol Deviation|0
7483753|NCT02063854|11794366|FG001|Overall Study|Major Protocol Deviation|0
7483754|NCT02063854|11794367|FG002|Overall Study|Major Protocol Deviation|3
7483755|NCT02063854|11794368|FG003|Overall Study|Major Protocol Deviation|0
7483756|NCT02063854|11794369|FG004|Overall Study|Major Protocol Deviation|0
7483757|NCT02063854|11794370|FG005|Overall Study|Major Protocol Deviation|0
7483758|NCT02063854|11794371|FG006|Overall Study|Major Protocol Deviation|0
7483759|NCT02063854|11794365|FG000|Overall Study|Voluntary Withdrawal|2
7483760|NCT02063854|11794366|FG001|Overall Study|Voluntary Withdrawal|0
7483761|NCT02063854|11794367|FG002|Overall Study|Voluntary Withdrawal|8
7483762|NCT02063854|11794368|FG003|Overall Study|Voluntary Withdrawal|1
7483763|NCT02063854|11794369|FG004|Overall Study|Voluntary Withdrawal|3
7483764|NCT02063854|11794370|FG005|Overall Study|Voluntary Withdrawal|6
7483765|NCT02063854|11794371|FG006|Overall Study|Voluntary Withdrawal|1
7483766|NCT02063854|11794365|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
7483767|NCT02063854|11794366|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
7483768|NCT02063854|11794367|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
7483769|NCT02063854|11794368|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
7483770|NCT02063854|11794369|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
7483771|NCT02063854|11794370|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
7483772|NCT02063854|11794371|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
7483773|NCT02063854|11794365|FG000|Overall Study|Reason Not Specified|1
7483774|NCT02063854|11794366|FG001|Overall Study|Reason Not Specified|0
7483775|NCT02063854|11794367|FG002|Overall Study|Reason Not Specified|0
7483776|NCT02063854|11794368|FG003|Overall Study|Reason Not Specified|0
7483777|NCT02063854|11794369|FG004|Overall Study|Reason Not Specified|0
7483778|NCT02063854|11794370|FG005|Overall Study|Reason Not Specified|0
7483779|NCT02063854|11794371|FG006|Overall Study|Reason Not Specified|0
7483780|NCT02063854|11794365|FG000|Overall Study|Did Not Receive Study Drug|0
7483781|NCT02063854|11794366|FG001|Overall Study|Did Not Receive Study Drug|0
7483782|NCT02063854|11794367|FG002|Overall Study|Did Not Receive Study Drug|0
7483783|NCT02063854|11794368|FG003|Overall Study|Did Not Receive Study Drug|0
7483784|NCT02063854|11794369|FG004|Overall Study|Did Not Receive Study Drug|0
7483785|NCT02063854|11794370|FG005|Overall Study|Did Not Receive Study Drug|1
7483786|NCT02063854|11794371|FG006|Overall Study|Did Not Receive Study Drug|0
7483787|NCT02063880|11794400|FG000|Overall Study|Death|21
7483788|NCT02063880|11794401|FG001|Overall Study|Death|18
7483789|NCT02063880|11794400|FG000|Overall Study|Lost to Follow-up|7
7483790|NCT02063880|11794401|FG001|Overall Study|Lost to Follow-up|7
7483791|NCT02063880|11794400|FG000|Overall Study|Ineligible|0
7483792|NCT02063880|11794401|FG001|Overall Study|Ineligible|2
7483793|NCT02063984|11794409|FG000|Overall Study|Lost to Follow-up|6
7483794|NCT02063984|11794410|FG001|Overall Study|Lost to Follow-up|5
7483795|NCT02064166|11794422|FG000|Overall Study|Adverse Event|1
7483796|NCT02064166|11794423|FG001|Overall Study|Adverse Event|0
7483797|NCT02064205|11794451|FG000|Overall Study|Withdrawal by Subject|1
7483798|NCT02064231|11794467|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
7483799|NCT02064231|11794468|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
7483800|NCT02064231|11794469|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
7483801|NCT02064231|11794470|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
7483802|NCT02064231|11794467|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7483803|NCT02064231|11794468|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
7483804|NCT02064231|11794469|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7483805|NCT02064231|11794470|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
7483806|NCT02064231|11794467|FG000|First Test Period (Test A or Test C)|Adverse Event|1
7483807|NCT02064231|11794468|FG001|First Test Period (Test A or Test C)|Adverse Event|0
7483808|NCT02064231|11794469|FG002|First Test Period (Test A or Test C)|Adverse Event|1
7483809|NCT02064231|11794470|FG003|First Test Period (Test A or Test C)|Adverse Event|0
7483810|NCT02064231|11794467|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7483811|NCT02064231|11794468|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
7483812|NCT02064231|11794469|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7483813|NCT02064231|11794470|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
7483814|NCT02064439|11794494|FG000|Overall Study|Adverse Event|51
7483815|NCT02064439|11794495|FG001|Overall Study|Adverse Event|47
7483816|NCT02064439|11794496|FG002|Overall Study|Adverse Event|46
7483817|NCT02064439|11794494|FG000|Overall Study|Death|0
7483818|NCT02064439|11794495|FG001|Overall Study|Death|2
7483819|NCT02064439|11794496|FG002|Overall Study|Death|3
7483820|NCT02064439|11794494|FG000|Overall Study|Withdrawal by Subject|29
7483821|NCT02064439|11794495|FG001|Overall Study|Withdrawal by Subject|18
7483822|NCT02064439|11794496|FG002|Overall Study|Withdrawal by Subject|26
7483823|NCT02064439|11794494|FG000|Overall Study|Protocol Violation|3
7483824|NCT02064439|11794495|FG001|Overall Study|Protocol Violation|5
7483825|NCT02064439|11794496|FG002|Overall Study|Protocol Violation|3
7483826|NCT02064439|11794494|FG000|Overall Study|Lost to Follow-up|1
7483827|NCT02064439|11794495|FG001|Overall Study|Lost to Follow-up|3
7483828|NCT02064439|11794496|FG002|Overall Study|Lost to Follow-up|4
7483829|NCT02064439|11794494|FG000|Overall Study|Non-compliance with study medication|21
7483830|NCT02064439|11794495|FG001|Overall Study|Non-compliance with study medication|19
7483831|NCT02064439|11794496|FG002|Overall Study|Non-compliance with study medication|23
7483832|NCT02064439|11794494|FG000|Overall Study|Physician Decision|0
7483833|NCT02064439|11794495|FG001|Overall Study|Physician Decision|1
7483834|NCT02064439|11794496|FG002|Overall Study|Physician Decision|1
7483835|NCT02064439|11794494|FG000|Overall Study|Logistical difficulties|6
7483836|NCT02064439|11794495|FG001|Overall Study|Logistical difficulties|5
7483837|NCT02064439|11794496|FG002|Overall Study|Logistical difficulties|2
7483838|NCT02064439|11794494|FG000|Overall Study|Efficacy outcome reached|18
7483839|NCT02064439|11794495|FG001|Overall Study|Efficacy outcome reached|16
7483840|NCT02064439|11794496|FG002|Overall Study|Efficacy outcome reached|57
7483841|NCT02064439|11794494|FG000|Overall Study|Safety outcome reached|12
7483842|NCT02064439|11794495|FG001|Overall Study|Safety outcome reached|20
7483843|NCT02064439|11794496|FG002|Overall Study|Safety outcome reached|10
7483844|NCT02064439|11794494|FG000|Overall Study|Other|2
7483845|NCT02064439|11794495|FG001|Overall Study|Other|2
7483846|NCT02064439|11794496|FG002|Overall Study|Other|7
7483847|NCT02064816|11794510|FG000|Overall Study|Adverse Event|3
7483848|NCT02064816|11794511|FG001|Overall Study|Adverse Event|2
7483849|NCT02064816|11794510|FG000|Overall Study|Withdrawal by Subject|2
7483850|NCT02064816|11794511|FG001|Overall Study|Withdrawal by Subject|1
7483851|NCT02064816|11794510|FG000|Overall Study|Lost to Follow-up|2
7483852|NCT02064816|11794511|FG001|Overall Study|Lost to Follow-up|1
7483853|NCT02064816|11794510|FG000|Overall Study|Therapeutic failure|0
7483854|NCT02064816|11794511|FG001|Overall Study|Therapeutic failure|1
7483855|NCT02064816|11794510|FG000|Overall Study|Other|1
7483856|NCT02064816|11794511|FG001|Overall Study|Other|3
7483857|NCT02064868|11794566|FG000|Overall Study|Lost to Follow-up|14
7483858|NCT02064868|11794567|FG001|Overall Study|Lost to Follow-up|8
7483859|NCT02064868|11794566|FG000|Overall Study|Physician Decision|1
7483860|NCT02064868|11794567|FG001|Overall Study|Physician Decision|0
7483861|NCT02064868|11794566|FG000|Overall Study|Withdrawal by Subject|14
7483862|NCT02064868|11794567|FG001|Overall Study|Withdrawal by Subject|3
7483863|NCT02064868|11794566|FG000|Overall Study|Technical Problems or Missing|5
7483864|NCT02064868|11794567|FG001|Overall Study|Technical Problems or Missing|2
7483865|NCT02064894|11794576|FG000|Overall Study|Withdrawal by Subject|43
7483866|NCT02064894|11794577|FG001|Overall Study|Withdrawal by Subject|102
7483867|NCT02064894|11794578|FG002|Overall Study|Withdrawal by Subject|115
7483868|NCT02064920|11794597|FG000|Overall Study|Adverse Event|0
7483869|NCT02064920|11794598|FG001|Overall Study|Adverse Event|4
7483870|NCT02064920|11794597|FG000|Overall Study|Physician Decision|0
7483871|NCT02064920|11794598|FG001|Overall Study|Physician Decision|1
7483872|NCT02064920|11794597|FG000|Overall Study|Technical Problems|0
7483873|NCT02064920|11794598|FG001|Overall Study|Technical Problems|1
7483874|NCT02064920|11794597|FG000|Overall Study|Withdrawal by Subject|1
7483875|NCT02064920|11794598|FG001|Overall Study|Withdrawal by Subject|3
7483876|NCT02065245|11794633|FG000|Infusion 1|Lost to Follow-up|0
7483877|NCT02065245|11794634|FG001|Infusion 1|Lost to Follow-up|0
7483878|NCT02065245|11794635|FG002|Infusion 1|Lost to Follow-up|0
7483879|NCT02065245|11794636|FG003|Infusion 1|Lost to Follow-up|0
7483880|NCT02065245|11794637|FG004|Infusion 1|Lost to Follow-up|0
7483881|NCT02065245|11794638|FG005|Infusion 1|Lost to Follow-up|0
7483882|NCT02065245|11794639|FG006|Infusion 1|Lost to Follow-up|1
7483883|NCT02065245|11794633|FG000|Infusion 1|Death|0
7483884|NCT02065245|11794634|FG001|Infusion 1|Death|0
7483885|NCT02065245|11794635|FG002|Infusion 1|Death|1
7483886|NCT02065245|11794636|FG003|Infusion 1|Death|0
7483887|NCT02065245|11794637|FG004|Infusion 1|Death|1
7483888|NCT02065245|11794638|FG005|Infusion 1|Death|0
7483889|NCT02065245|11794639|FG006|Infusion 1|Death|0
7483890|NCT02065245|11794633|FG000|Infusion 2|Death|0
7483891|NCT02065245|11794634|FG001|Infusion 2|Death|0
7483892|NCT02065245|11794635|FG002|Infusion 2|Death|0
7483893|NCT02065245|11794636|FG003|Infusion 2|Death|0
7483894|NCT02065245|11794637|FG004|Infusion 2|Death|0
7483895|NCT02065245|11794638|FG005|Infusion 2|Death|0
7483896|NCT02065245|11794639|FG006|Infusion 2|Death|1
7483897|NCT02065245|11794633|FG000|Infusion 3|Lost to Follow-up|1
7483898|NCT02065245|11794634|FG001|Infusion 3|Lost to Follow-up|1
7483899|NCT02065245|11794635|FG002|Infusion 3|Lost to Follow-up|0
7483900|NCT02065245|11794636|FG003|Infusion 3|Lost to Follow-up|0
7483901|NCT02065245|11794637|FG004|Infusion 3|Lost to Follow-up|0
7483902|NCT02065245|11794638|FG005|Infusion 3|Lost to Follow-up|0
7483903|NCT02065245|11794639|FG006|Infusion 3|Lost to Follow-up|0
7483904|NCT02065336|11794663|FG000|Extension Phase|Study Terminated by Sponsor|0
7483905|NCT02065336|11794664|FG001|Extension Phase|Study Terminated by Sponsor|0
7483906|NCT02065336|11794665|FG002|Extension Phase|Study Terminated by Sponsor|0
7483907|NCT02065336|11794666|FG003|Extension Phase|Study Terminated by Sponsor|0
7483908|NCT02065336|11794667|FG004|Extension Phase|Study Terminated by Sponsor|0
7483909|NCT02065336|11794668|FG005|Extension Phase|Study Terminated by Sponsor|0
7483910|NCT02065336|11794669|FG006|Extension Phase|Study Terminated by Sponsor|0
7483911|NCT02065336|11794670|FG007|Extension Phase|Study Terminated by Sponsor|0
7483912|NCT02065336|11794671|FG008|Extension Phase|Study Terminated by Sponsor|2
7483913|NCT02065336|11794672|FG009|Extension Phase|Study Terminated by Sponsor|8
7483914|NCT02065518|11794724|FG000|Overall Study|Lost to Follow-up|3
7483915|NCT02065518|11794725|FG001|Overall Study|Lost to Follow-up|4
7483916|NCT02065518|11794726|FG002|Overall Study|Lost to Follow-up|0
7483917|NCT02065518|11794727|FG003|Overall Study|Lost to Follow-up|3
7483918|NCT02065518|11794724|FG000|Overall Study|Withdrawal by Subject|3
7483919|NCT02065518|11794725|FG001|Overall Study|Withdrawal by Subject|4
7483920|NCT02065518|11794726|FG002|Overall Study|Withdrawal by Subject|9
7483921|NCT02065518|11794727|FG003|Overall Study|Withdrawal by Subject|2
7483922|NCT02065557|11794740|FG000|Induction Period|Withdrawal by Subject|2
7483923|NCT02065557|11794741|FG001|Induction Period|Withdrawal by Subject|1
7483924|NCT02065557|11794742|FG002|Induction Period|Withdrawal by Subject|0
7483925|NCT02065557|11794743|FG003|Induction Period|Withdrawal by Subject|0
7483926|NCT02065557|11794744|FG004|Induction Period|Withdrawal by Subject|0
7483927|NCT02065557|11794745|FG005|Induction Period|Withdrawal by Subject|0
7483928|NCT02065557|11794740|FG000|Induction Period|Lack of Efficacy|2
7483929|NCT02065557|11794741|FG001|Induction Period|Lack of Efficacy|1
7483930|NCT02065557|11794742|FG002|Induction Period|Lack of Efficacy|1
7483931|NCT02065557|11794743|FG003|Induction Period|Lack of Efficacy|0
7483932|NCT02065557|11794744|FG004|Induction Period|Lack of Efficacy|0
7483933|NCT02065557|11794745|FG005|Induction Period|Lack of Efficacy|0
7483934|NCT02065557|11794740|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
7483935|NCT02065557|11794741|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
7483936|NCT02065557|11794742|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
7483937|NCT02065557|11794743|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
7483938|NCT02065557|11794744|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
7483939|NCT02065557|11794745|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
7483940|NCT02065557|11794740|FG000|Induction Period|Non-Responder at Week 8|4
7483941|NCT02065557|11794741|FG001|Induction Period|Non-Responder at Week 8|4
7483942|NCT02065557|11794742|FG002|Induction Period|Non-Responder at Week 8|0
7483943|NCT02065557|11794743|FG003|Induction Period|Non-Responder at Week 8|0
7483944|NCT02065557|11794744|FG004|Induction Period|Non-Responder at Week 8|0
7483945|NCT02065557|11794745|FG005|Induction Period|Non-Responder at Week 8|0
7483946|NCT02065557|11794740|FG000|Induction Period|Adverse Event|1
7483947|NCT02065557|11794741|FG001|Induction Period|Adverse Event|1
7483948|NCT02065557|11794742|FG002|Induction Period|Adverse Event|0
7483949|NCT02065557|11794743|FG003|Induction Period|Adverse Event|0
7483950|NCT02065557|11794744|FG004|Induction Period|Adverse Event|0
7483951|NCT02065557|11794745|FG005|Induction Period|Adverse Event|0
7483952|NCT02065557|11794740|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7483953|NCT02065557|11794741|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7483954|NCT02065557|11794742|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7483955|NCT02065557|11794743|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7483956|NCT02065557|11794744|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
7483957|NCT02065557|11794745|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
7483958|NCT02065557|11794740|FG000|Maintenance Period|Withdrawal by Subject|0
7483959|NCT02065557|11794741|FG001|Maintenance Period|Withdrawal by Subject|0
7483960|NCT02065557|11794742|FG002|Maintenance Period|Withdrawal by Subject|0
7483961|NCT02065557|11794743|FG003|Maintenance Period|Withdrawal by Subject|0
7483962|NCT02065557|11794744|FG004|Maintenance Period|Withdrawal by Subject|2
7483963|NCT02065557|11794745|FG005|Maintenance Period|Withdrawal by Subject|1
7483964|NCT02065557|11794740|FG000|Maintenance Period|Lack of Efficacy|0
7483965|NCT02065557|11794741|FG001|Maintenance Period|Lack of Efficacy|0
7483966|NCT02065557|11794742|FG002|Maintenance Period|Lack of Efficacy|0
7483967|NCT02065557|11794743|FG003|Maintenance Period|Lack of Efficacy|0
7483968|NCT02065557|11794744|FG004|Maintenance Period|Lack of Efficacy|5
7483969|NCT02065557|11794745|FG005|Maintenance Period|Lack of Efficacy|2
7483970|NCT02065557|11794740|FG000|Maintenance Period|Subject Non-Compliance|0
7483971|NCT02065557|11794741|FG001|Maintenance Period|Subject Non-Compliance|0
7483972|NCT02065557|11794742|FG002|Maintenance Period|Subject Non-Compliance|0
7483973|NCT02065557|11794743|FG003|Maintenance Period|Subject Non-Compliance|0
7483974|NCT02065557|11794744|FG004|Maintenance Period|Subject Non-Compliance|0
7483975|NCT02065557|11794745|FG005|Maintenance Period|Subject Non-Compliance|1
7483976|NCT02065570|11794772|FG000|Induction Study|Adverse Event|5
7483977|NCT02065570|11794773|FG001|Induction Study|Adverse Event|12
7483978|NCT02065570|11794774|FG002|Induction Study|Adverse Event|0
7483979|NCT02065570|11794775|FG003|Induction Study|Adverse Event|0
7483980|NCT02065570|11794772|FG000|Induction Study|Withdrawal by Subject|2
7483981|NCT02065570|11794773|FG001|Induction Study|Withdrawal by Subject|3
7483982|NCT02065570|11794774|FG002|Induction Study|Withdrawal by Subject|0
7483983|NCT02065570|11794775|FG003|Induction Study|Withdrawal by Subject|0
7483984|NCT02065570|11794772|FG000|Induction Study|Lost to Follow-up|1
7483985|NCT02065570|11794773|FG001|Induction Study|Lost to Follow-up|1
7483986|NCT02065570|11794774|FG002|Induction Study|Lost to Follow-up|0
7483987|NCT02065570|11794775|FG003|Induction Study|Lost to Follow-up|0
7483988|NCT02065570|11794772|FG000|Induction Study|Other, Not Specified|6
7483989|NCT02065570|11794773|FG001|Induction Study|Other, Not Specified|5
7483990|NCT02065570|11794774|FG002|Induction Study|Other, Not Specified|0
7483991|NCT02065570|11794775|FG003|Induction Study|Other, Not Specified|0
7483992|NCT02065570|11794772|FG000|Maintenance Study|Adverse Event|0
7483993|NCT02065570|11794773|FG001|Maintenance Study|Adverse Event|0
7483994|NCT02065570|11794774|FG002|Maintenance Study|Adverse Event|8
7483995|NCT02065570|11794775|FG003|Maintenance Study|Adverse Event|8
7483996|NCT02065570|11794772|FG000|Maintenance Study|Withdrawal by Subject|0
7483997|NCT02065570|11794773|FG001|Maintenance Study|Withdrawal by Subject|0
7483998|NCT02065570|11794774|FG002|Maintenance Study|Withdrawal by Subject|1
7483999|NCT02065570|11794775|FG003|Maintenance Study|Withdrawal by Subject|4
7484000|NCT02065570|11794772|FG000|Maintenance Study|Lost to Follow-up|0
7484001|NCT02065570|11794773|FG001|Maintenance Study|Lost to Follow-up|0
7484002|NCT02065570|11794774|FG002|Maintenance Study|Lost to Follow-up|2
7484003|NCT02065570|11794775|FG003|Maintenance Study|Lost to Follow-up|2
7484004|NCT02065570|11794772|FG000|Maintenance Study|Other, Not Specified|0
7484005|NCT02065570|11794773|FG001|Maintenance Study|Other, Not Specified|0
7484006|NCT02065570|11794774|FG002|Maintenance Study|Other, Not Specified|11
7484007|NCT02065570|11794775|FG003|Maintenance Study|Other, Not Specified|5
7484008|NCT02065622|11794788|FG000|Induction Study|Adverse Event|13
7484009|NCT02065622|11794789|FG001|Induction Study|Adverse Event|19
7484010|NCT02065622|11794790|FG002|Induction Study|Adverse Event|0
7484011|NCT02065622|11794791|FG003|Induction Study|Adverse Event|0
7484012|NCT02065622|11794792|FG004|Induction Study|Adverse Event|0
7484013|NCT02065622|11794788|FG000|Induction Study|Withdrawal by Subject|3
7484014|NCT02065622|11794789|FG001|Induction Study|Withdrawal by Subject|5
7484015|NCT02065622|11794790|FG002|Induction Study|Withdrawal by Subject|0
7484016|NCT02065622|11794791|FG003|Induction Study|Withdrawal by Subject|0
7484017|NCT02065622|11794792|FG004|Induction Study|Withdrawal by Subject|0
7484018|NCT02065622|11794788|FG000|Induction Study|Lost to Follow-up|1
7484019|NCT02065622|11794789|FG001|Induction Study|Lost to Follow-up|0
7484020|NCT02065622|11794790|FG002|Induction Study|Lost to Follow-up|0
7484021|NCT02065622|11794791|FG003|Induction Study|Lost to Follow-up|0
7484022|NCT02065622|11794792|FG004|Induction Study|Lost to Follow-up|0
7484023|NCT02065622|11794788|FG000|Induction Study|Lack of Efficacy|22
7484024|NCT02065622|11794789|FG001|Induction Study|Lack of Efficacy|27
7484025|NCT02065622|11794790|FG002|Induction Study|Lack of Efficacy|0
7484026|NCT02065622|11794791|FG003|Induction Study|Lack of Efficacy|0
7484027|NCT02065622|11794792|FG004|Induction Study|Lack of Efficacy|0
7484028|NCT02065622|11794788|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
7484029|NCT02065622|11794789|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
7484030|NCT02065622|11794790|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
7484031|NCT02065622|11794791|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
7484032|NCT02065622|11794792|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
7484033|NCT02065622|11794788|FG000|Induction Study|Subject Noncompliance|1
7484034|NCT02065622|11794789|FG001|Induction Study|Subject Noncompliance|1
7484035|NCT02065622|11794790|FG002|Induction Study|Subject Noncompliance|0
7484036|NCT02065622|11794791|FG003|Induction Study|Subject Noncompliance|0
7484037|NCT02065622|11794792|FG004|Induction Study|Subject Noncompliance|0
7484038|NCT02065622|11794788|FG000|Induction Study|Other, Not Specified|3
7484039|NCT02065622|11794789|FG001|Induction Study|Other, Not Specified|2
7484040|NCT02065622|11794790|FG002|Induction Study|Other, Not Specified|0
7484041|NCT02065622|11794791|FG003|Induction Study|Other, Not Specified|0
7484042|NCT02065622|11794792|FG004|Induction Study|Other, Not Specified|0
7484043|NCT02065622|11794788|FG000|Maintenance Study|Adverse Event|0
7484044|NCT02065622|11794789|FG001|Maintenance Study|Adverse Event|0
7484045|NCT02065622|11794790|FG002|Maintenance Study|Adverse Event|25
7484046|NCT02065622|11794791|FG003|Maintenance Study|Adverse Event|22
7484047|NCT02065622|11794792|FG004|Maintenance Study|Adverse Event|11
7484048|NCT02065622|11794788|FG000|Maintenance Study|Withdrawal by Subject|0
7484049|NCT02065622|11794789|FG001|Maintenance Study|Withdrawal by Subject|0
7484050|NCT02065622|11794790|FG002|Maintenance Study|Withdrawal by Subject|11
7484051|NCT02065622|11794791|FG003|Maintenance Study|Withdrawal by Subject|5
7484052|NCT02065622|11794792|FG004|Maintenance Study|Withdrawal by Subject|7
7484053|NCT02065622|11794788|FG000|Maintenance Study|Lost to Follow-up|0
7484054|NCT02065622|11794789|FG001|Maintenance Study|Lost to Follow-up|0
7484055|NCT02065622|11794790|FG002|Maintenance Study|Lost to Follow-up|4
7484056|NCT02065622|11794791|FG003|Maintenance Study|Lost to Follow-up|1
7484057|NCT02065622|11794792|FG004|Maintenance Study|Lost to Follow-up|1
7484058|NCT02065622|11794788|FG000|Maintenance Study|Lack of Efficacy|0
7484059|NCT02065622|11794789|FG001|Maintenance Study|Lack of Efficacy|0
7484060|NCT02065622|11794790|FG002|Maintenance Study|Lack of Efficacy|70
7484061|NCT02065622|11794791|FG003|Maintenance Study|Lack of Efficacy|55
7484062|NCT02065622|11794792|FG004|Maintenance Study|Lack of Efficacy|19
7484063|NCT02065622|11794788|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7484064|NCT02065622|11794789|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
7484065|NCT02065622|11794790|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
7484066|NCT02065622|11794791|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
7484067|NCT02065622|11794792|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
7484068|NCT02065622|11794788|FG000|Maintenance Study|Subject Non-Compliance|0
7484069|NCT02065622|11794789|FG001|Maintenance Study|Subject Non-Compliance|0
7484070|NCT02065622|11794790|FG002|Maintenance Study|Subject Non-Compliance|1
7484071|NCT02065622|11794791|FG003|Maintenance Study|Subject Non-Compliance|3
7484072|NCT02065622|11794792|FG004|Maintenance Study|Subject Non-Compliance|2
7484073|NCT02065622|11794788|FG000|Maintenance Study|Other, Not Specified|0
7484074|NCT02065622|11794789|FG001|Maintenance Study|Other, Not Specified|0
7484075|NCT02065622|11794790|FG002|Maintenance Study|Other, Not Specified|6
7484076|NCT02065622|11794791|FG003|Maintenance Study|Other, Not Specified|14
7484077|NCT02065622|11794792|FG004|Maintenance Study|Other, Not Specified|2
7484078|NCT02065622|11794788|FG000|Maintenance Study|Unknown Reason|0
7484079|NCT02065622|11794789|FG001|Maintenance Study|Unknown Reason|0
7484080|NCT02065622|11794790|FG002|Maintenance Study|Unknown Reason|0
7484081|NCT02065622|11794791|FG003|Maintenance Study|Unknown Reason|1
7484082|NCT02065622|11794792|FG004|Maintenance Study|Unknown Reason|0
7484083|NCT02065713|11794818|FG000|Overall Study|Adverse Event|0
7484084|NCT02065713|11794819|FG001|Overall Study|Adverse Event|1
7484085|NCT02065713|11794818|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7484086|NCT02065713|11794819|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7484087|NCT02065791|11794827|FG000|Overall Study|Closed Site|1
7484088|NCT02065791|11794828|FG001|Overall Study|Closed Site|1
7484089|NCT02065791|11794827|FG000|Overall Study|Withdrawal by Subject|11
7484090|NCT02065791|11794828|FG001|Overall Study|Withdrawal by Subject|5
7484091|NCT02065791|11794827|FG000|Overall Study|Lost to Follow-up|13
7484092|NCT02065791|11794828|FG001|Overall Study|Lost to Follow-up|9
7484093|NCT02065895|11794834|FG000|Overall Study|Protocol Violation|1
7484094|NCT02065895|11794835|FG001|Overall Study|Protocol Violation|0
7484095|NCT02065895|11794836|FG002|Overall Study|Protocol Violation|0
7484096|NCT02065895|11794837|FG003|Overall Study|Protocol Violation|1
7484097|NCT02065895|11794838|FG004|Overall Study|Protocol Violation|0
7484098|NCT02065895|11794839|FG005|Overall Study|Protocol Violation|0
7484099|NCT02065895|11794834|FG000|Overall Study|Scheduling conflicts|0
7484100|NCT02065895|11794835|FG001|Overall Study|Scheduling conflicts|1
7484101|NCT02065895|11794836|FG002|Overall Study|Scheduling conflicts|0
7484102|NCT02065895|11794837|FG003|Overall Study|Scheduling conflicts|0
7484103|NCT02065895|11794838|FG004|Overall Study|Scheduling conflicts|0
7484104|NCT02065895|11794839|FG005|Overall Study|Scheduling conflicts|0
7484105|NCT02066051|11794856|FG000|Overall Study|Subject developed active GVHD|1
7484106|NCT02066129|11794862|FG000|Overall Study|Lost to Follow-up|13
7484107|NCT02066129|11794863|FG001|Overall Study|Lost to Follow-up|12
7484108|NCT02066129|11794862|FG000|Overall Study|Withdrawal by Subject|7
7484109|NCT02066129|11794863|FG001|Overall Study|Withdrawal by Subject|10
7484110|NCT02066129|11794862|FG000|Overall Study|Lack of Efficacy|8
7484111|NCT02066129|11794863|FG001|Overall Study|Lack of Efficacy|10
7484112|NCT02066129|11794862|FG000|Overall Study|Physician Decision|1
7484113|NCT02066129|11794863|FG001|Overall Study|Physician Decision|1
7484114|NCT02066233|11794871|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
7484115|NCT02066233|11794872|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
7484116|NCT02066298|11794884|FG000|Overall Study|Lost to Follow-up|3
7484117|NCT02066298|11794885|FG001|Overall Study|Lost to Follow-up|2
7484118|NCT02066298|11794886|FG002|Overall Study|Lost to Follow-up|3
7484119|NCT02066298|11794887|FG003|Overall Study|Lost to Follow-up|2
7484120|NCT02066298|11794888|FG004|Overall Study|Lost to Follow-up|3
7484121|NCT02066298|11794889|FG005|Overall Study|Lost to Follow-up|4
7484122|NCT02066298|11794884|FG000|Overall Study|Withdrawal by Subject|6
7484123|NCT02066298|11794885|FG001|Overall Study|Withdrawal by Subject|6
7484124|NCT02066298|11794886|FG002|Overall Study|Withdrawal by Subject|6
7484125|NCT02066298|11794887|FG003|Overall Study|Withdrawal by Subject|4
7484126|NCT02066298|11794888|FG004|Overall Study|Withdrawal by Subject|5
7484127|NCT02066298|11794889|FG005|Overall Study|Withdrawal by Subject|8
7484128|NCT02066298|11794884|FG000|Overall Study|Physician Decision|0
7484129|NCT02066298|11794885|FG001|Overall Study|Physician Decision|0
7484130|NCT02066298|11794886|FG002|Overall Study|Physician Decision|1
7484131|NCT02066298|11794887|FG003|Overall Study|Physician Decision|0
7484132|NCT02066298|11794888|FG004|Overall Study|Physician Decision|1
7484133|NCT02066298|11794889|FG005|Overall Study|Physician Decision|0
7484134|NCT02066311|11794901|FG000|Overall Study|Adverse Event|4
7484135|NCT02066311|11794901|FG000|Overall Study|Withdrawal by Subject|1
7484136|NCT02066389|11794911|FG000|Overall Study|Adverse Event|1
7484137|NCT02066389|11794912|FG001|Overall Study|Adverse Event|1
7484138|NCT02066389|11794913|FG002|Overall Study|Adverse Event|1
7484139|NCT02066389|11794914|FG003|Overall Study|Adverse Event|1
7484140|NCT02066389|11794915|FG004|Overall Study|Adverse Event|5
7484141|NCT02066389|11794916|FG005|Overall Study|Adverse Event|1
7484142|NCT02066389|11794911|FG000|Overall Study|Withdrawal by Subject|4
7484143|NCT02066389|11794912|FG001|Overall Study|Withdrawal by Subject|0
7484144|NCT02066389|11794913|FG002|Overall Study|Withdrawal by Subject|5
7484145|NCT02066389|11794914|FG003|Overall Study|Withdrawal by Subject|1
7484146|NCT02066389|11794915|FG004|Overall Study|Withdrawal by Subject|1
7484147|NCT02066389|11794916|FG005|Overall Study|Withdrawal by Subject|2
7484148|NCT02066389|11794911|FG000|Overall Study|Lost to Follow-up|0
7484149|NCT02066389|11794912|FG001|Overall Study|Lost to Follow-up|0
7484150|NCT02066389|11794913|FG002|Overall Study|Lost to Follow-up|0
7484151|NCT02066389|11794914|FG003|Overall Study|Lost to Follow-up|1
7484152|NCT02066389|11794915|FG004|Overall Study|Lost to Follow-up|1
7484153|NCT02066389|11794916|FG005|Overall Study|Lost to Follow-up|1
7484154|NCT02066389|11794911|FG000|Overall Study|Randomized in Error|0
7484155|NCT02066389|11794912|FG001|Overall Study|Randomized in Error|0
7484156|NCT02066389|11794913|FG002|Overall Study|Randomized in Error|0
7484157|NCT02066389|11794914|FG003|Overall Study|Randomized in Error|0
7484158|NCT02066389|11794915|FG004|Overall Study|Randomized in Error|0
7484159|NCT02066389|11794916|FG005|Overall Study|Randomized in Error|1
7484160|NCT02066402|11794932|FG000|Overall Study|Adverse Event|1
7484161|NCT02066402|11794933|FG001|Overall Study|Adverse Event|2
7484162|NCT02066402|11794932|FG000|Overall Study|Lost to Follow-up|11
7484163|NCT02066402|11794933|FG001|Overall Study|Lost to Follow-up|8
7484164|NCT02066402|11794932|FG000|Overall Study|Withdrawal by Subject|14
7484165|NCT02066402|11794933|FG001|Overall Study|Withdrawal by Subject|11
7484166|NCT02066402|11794932|FG000|Overall Study|Progressive disease-clinical progression|0
7484167|NCT02066402|11794933|FG001|Overall Study|Progressive disease-clinical progression|1
7484168|NCT02066402|11794932|FG000|Overall Study|Protocol driven decision point|0
7484169|NCT02066402|11794933|FG001|Overall Study|Protocol driven decision point|1
7484170|NCT02066467|11794939|FG000|Overall Study|Did not undergo implant procedure|24
7484171|NCT02066467|11794939|FG000|Overall Study|Attempted to implant withoput success|43
7484172|NCT02066467|11794939|FG000|Overall Study|Consent ineligible|1
7484173|NCT02066467|11794939|FG000|Overall Study|Death|54
7484174|NCT02066467|11794939|FG000|Overall Study|Lost to Follow-up|51
7484175|NCT02066467|11794939|FG000|Overall Study|Adverse Event|20
7484176|NCT02066467|11794939|FG000|Overall Study|Withdrawal by Subject|16
7484177|NCT02066467|11794939|FG000|Overall Study|Physician Decision|2
7484178|NCT02066467|11794939|FG000|Overall Study|Not defined|4
7484179|NCT02066922|11794992|FG000|Overall Study|Adverse Event|1
7484180|NCT02067533|11795038|FG000|Overall Study|Lost to Follow-up|4
7484181|NCT02067533|11795039|FG001|Overall Study|Lost to Follow-up|2
7484182|NCT02067663|11795060|FG000|Overall Study|Lost to Follow-up|13
7484183|NCT02067663|11795061|FG001|Overall Study|Lost to Follow-up|14
7484184|NCT02067676|11795073|FG000|Overall Study|Withdrawal by Subject|1
7484185|NCT02067676|11795074|FG001|Overall Study|Withdrawal by Subject|0
7484186|NCT02067676|11795075|FG002|Overall Study|Withdrawal by Subject|0
7484187|NCT02067676|11795076|FG003|Overall Study|Withdrawal by Subject|0
7484188|NCT02067676|11795077|FG004|Overall Study|Withdrawal by Subject|0
7484189|NCT02067676|11795078|FG005|Overall Study|Withdrawal by Subject|0
7484190|NCT02067728|11795099|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
7484191|NCT02067728|11795100|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
7484192|NCT02067728|11795099|FG000|6 Month Follow up Survey|Lost to Follow-up|48
7484193|NCT02067728|11795100|FG001|6 Month Follow up Survey|Lost to Follow-up|60
7484194|NCT02067728|11795099|FG000|6 Month Measurements|Unable to attend|114
7484195|NCT02067728|11795100|FG001|6 Month Measurements|Unable to attend|97
7484196|NCT02068118|11795126|FG000|18-month Comparative Study Period|Death|90
7484197|NCT02068118|11795127|FG001|18-month Comparative Study Period|Death|97
7484198|NCT02068118|11795126|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
7484199|NCT02068118|11795127|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
7484200|NCT02068118|11795126|FG000|18-month Comparative Study Period|Lost to Follow-up|6
7484201|NCT02068118|11795127|FG001|18-month Comparative Study Period|Lost to Follow-up|7
7484202|NCT02068118|11795126|FG000|18-month Comparative Study Period|Heart transplant|9
7484203|NCT02068118|11795127|FG001|18-month Comparative Study Period|Heart transplant|15
7484204|NCT02068118|11795126|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
7484205|NCT02068118|11795127|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
7484206|NCT02068118|11795126|FG000|18-month Comparative Study Period|Hemiplegia|0
7484207|NCT02068118|11795127|FG001|18-month Comparative Study Period|Hemiplegia|1
7484208|NCT02068118|11795126|FG000|18-month Comparative Study Period|Alzheimer's disease|0
7484209|NCT02068118|11795127|FG001|18-month Comparative Study Period|Alzheimer's disease|1
7484210|NCT02068118|11795126|FG000|18-month Comparative Study Period|Move|0
7484211|NCT02068118|11795127|FG001|18-month Comparative Study Period|Move|1
7484212|NCT02068118|11795126|FG000|18-month Comparative Study Period|Hearing loss|0
7484213|NCT02068118|11795127|FG001|18-month Comparative Study Period|Hearing loss|1
7484214|NCT02068118|11795126|FG000|Extension Period|Death|0
7484215|NCT02068118|11795127|FG001|Extension Period|Death|2
7484216|NCT02068118|11795126|FG000|Extension Period|Withdrawal by Subject|1
7484217|NCT02068118|11795127|FG001|Extension Period|Withdrawal by Subject|0
7484218|NCT02068118|11795126|FG000|Extension Period|Heart transplant|1
7484219|NCT02068118|11795127|FG001|Extension Period|Heart transplant|0
7484220|NCT02068118|11795126|FG000|Extension Period|Wrong device use|0
7484221|NCT02068118|11795127|FG001|Extension Period|Wrong device use|1
7484222|NCT02068222|11795139|FG000|Overall Study|Lost to Follow-up|1
7484223|NCT02068352|11795146|FG000|Overall Study|Lost to Follow-up|0
7484224|NCT02068352|11795147|FG001|Overall Study|Lost to Follow-up|2
7484225|NCT02068352|11795148|FG002|Overall Study|Lost to Follow-up|0
7484226|NCT02068352|11795146|FG000|Overall Study|Adverse Event|4
7484227|NCT02068352|11795147|FG001|Overall Study|Adverse Event|2
7484228|NCT02068352|11795148|FG002|Overall Study|Adverse Event|7
7484229|NCT02068352|11795146|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7484230|NCT02068352|11795147|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
7484231|NCT02068352|11795148|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
7484232|NCT02068352|11795146|FG000|Overall Study|Participant Withdrew Consent to Participate|6
7484233|NCT02068352|11795147|FG001|Overall Study|Participant Withdrew Consent to Participate|3
7484234|NCT02068352|11795148|FG002|Overall Study|Participant Withdrew Consent to Participate|1
7484235|NCT02068352|11795146|FG000|Overall Study|Protocol Deviation|0
7484236|NCT02068352|11795147|FG001|Overall Study|Protocol Deviation|0
7484237|NCT02068352|11795148|FG002|Overall Study|Protocol Deviation|1
7484238|NCT02068443|11795159|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7484239|NCT02068443|11795160|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7484240|NCT02068443|11795161|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7484241|NCT02068443|11795159|FG000|Overall Study|Voluntary Withdrawal|4
7484242|NCT02068443|11795160|FG001|Overall Study|Voluntary Withdrawal|0
7484243|NCT02068443|11795161|FG002|Overall Study|Voluntary Withdrawal|1
7484244|NCT02068443|11795159|FG000|Overall Study|Lack of Efficacy|2
7484245|NCT02068443|11795160|FG001|Overall Study|Lack of Efficacy|1
7484246|NCT02068443|11795161|FG002|Overall Study|Lack of Efficacy|0
7484247|NCT02068443|11795159|FG000|Overall Study|Other Reason Not Specified|1
7484248|NCT02068443|11795160|FG001|Overall Study|Other Reason Not Specified|0
7484249|NCT02068443|11795161|FG002|Overall Study|Other Reason Not Specified|0
7484250|NCT02068495|11795169|FG000|Overall Study|Case Report Forms Uncollected|60
7484251|NCT02068495|11795169|FG000|Overall Study|Protocol Deviation|49
7484252|NCT02068508|11795173|FG000|Overall Study|Case report forms uncollected|27
7484253|NCT02068508|11795173|FG000|Overall Study|Patient did not visit the study site|1
7484254|NCT02068508|11795173|FG000|Overall Study|Protocol Violation|4
7484255|NCT02068599|11795180|FG000|Overall Study|Adverse Event|4
7484256|NCT02068599|11795181|FG001|Overall Study|Adverse Event|1
7484257|NCT02068599|11795182|FG002|Overall Study|Adverse Event|1
7484258|NCT02068599|11795180|FG000|Overall Study|Withdrawal by Subject|2
7484259|NCT02068599|11795181|FG001|Overall Study|Withdrawal by Subject|7
7484260|NCT02068599|11795182|FG002|Overall Study|Withdrawal by Subject|5
7484261|NCT02068599|11795180|FG000|Overall Study|Protocol Violation|4
7484262|NCT02068599|11795181|FG001|Overall Study|Protocol Violation|2
7484263|NCT02068599|11795182|FG002|Overall Study|Protocol Violation|3
7484264|NCT02068599|11795180|FG000|Overall Study|Lost to Follow-up|1
7484265|NCT02068599|11795181|FG001|Overall Study|Lost to Follow-up|0
7484266|NCT02068599|11795182|FG002|Overall Study|Lost to Follow-up|0
7484267|NCT02068599|11795180|FG000|Overall Study|Lack of Efficacy|0
7484268|NCT02068599|11795181|FG001|Overall Study|Lack of Efficacy|0
7484269|NCT02068599|11795182|FG002|Overall Study|Lack of Efficacy|3
7484270|NCT02068599|11795180|FG000|Overall Study|Noncompliance|0
7484271|NCT02068599|11795181|FG001|Overall Study|Noncompliance|0
7484272|NCT02068599|11795182|FG002|Overall Study|Noncompliance|1
7534699|NCT02700919|11881692|FG000|Overall Study|Lost to Follow-up|2
7534700|NCT02700919|11881693|FG001|Overall Study|Lost to Follow-up|0
7534701|NCT02700919|11881694|FG002|Overall Study|Lost to Follow-up|0
7534702|NCT02700919|11881692|FG000|Overall Study|Other|2
7534703|NCT02700919|11881693|FG001|Overall Study|Other|1
7534704|NCT02700919|11881694|FG002|Overall Study|Other|1
7534705|NCT02700984|11881704|FG000|Overall Study|Death|2
7534706|NCT02700984|11881705|FG001|Overall Study|Death|1
7534707|NCT02700984|11881704|FG000|Overall Study|Lost to Follow-up|2
7534708|NCT02700984|11881705|FG001|Overall Study|Lost to Follow-up|1
7534709|NCT02700984|11881704|FG000|Overall Study|Physician Decision|0
7534710|NCT02700984|11881705|FG001|Overall Study|Physician Decision|1
7534711|NCT02700984|11881704|FG000|Overall Study|Withdrawal by Subject|8
7534712|NCT02700984|11881705|FG001|Overall Study|Withdrawal by Subject|9
7534713|NCT02700984|11881704|FG000|Overall Study|Reason not specified|3
7534714|NCT02700984|11881705|FG001|Overall Study|Reason not specified|2
7534715|NCT02700997|11881721|FG000|Overall Study|Did not undergo CT imaging|1
7534716|NCT02700997|11881721|FG000|Overall Study|No CT measurement - pelvic calcification|1
7534717|NCT02701296|11881805|FG000|Overall Study|Incomplete Data|0
7534718|NCT02701296|11881806|FG001|Overall Study|Incomplete Data|2
7534719|NCT02701361|11881815|FG000|Overall Study|Lost to Follow-up|5
7534720|NCT02701361|11881816|FG001|Overall Study|Lost to Follow-up|2
7534721|NCT02701361|11881817|FG002|Overall Study|Lost to Follow-up|1
7534722|NCT02701361|11881815|FG000|Overall Study|Withdrawal by Subject|4
7534723|NCT02701361|11881816|FG001|Overall Study|Withdrawal by Subject|0
7534724|NCT02701361|11881817|FG002|Overall Study|Withdrawal by Subject|0
7534725|NCT02701361|11881815|FG000|Overall Study|timed out in rehab center|0
7534726|NCT02701361|11881816|FG001|Overall Study|timed out in rehab center|1
7484273|NCT02068768|11795249|FG000|Overall Study|Lost to Follow-up|5
7484274|NCT02068768|11795249|FG000|Overall Study|Early Termination by Sponsor|2
7484278|NCT02069015|11795292|FG000|Overall Study|Lost to Follow-up|39
7484279|NCT02069015|11795293|FG001|Overall Study|Lost to Follow-up|32
7484280|NCT02069015|11795292|FG000|Overall Study|Withdrawal by Subject|1
7484281|NCT02069015|11795293|FG001|Overall Study|Withdrawal by Subject|1
7484282|NCT02069093|11795304|FG000|Overall Study|Disease progression|14
7484283|NCT02069093|11795304|FG000|Overall Study|New cancer therapy|1
7484284|NCT02069093|11795304|FG000|Overall Study|Death|1
7484285|NCT02069093|11795304|FG000|Overall Study|Administrative problems|1
7484286|NCT02069093|11795304|FG000|Overall Study|Withdrawal by Subject|2
7484287|NCT02069093|11795304|FG000|Overall Study|Abnormal laboratory values|1
7484288|NCT02069093|11795304|FG000|Overall Study|Adverse Event|10
7484289|NCT02069379|11795342|FG000|Baseline Measurements|Lost to Follow-up|1
7484290|NCT02069379|11795343|FG001|Baseline Measurements|Lost to Follow-up|0
7484291|NCT02069379|11795344|FG002|Baseline Measurements|Lost to Follow-up|0
7484292|NCT02069379|11795345|FG003|Baseline Measurements|Lost to Follow-up|0
7484293|NCT02069379|11795342|FG000|Baseline Measurements|Ineligible based on initial assessments|2
7484294|NCT02069379|11795343|FG001|Baseline Measurements|Ineligible based on initial assessments|0
7484295|NCT02069379|11795344|FG002|Baseline Measurements|Ineligible based on initial assessments|0
7484296|NCT02069379|11795345|FG003|Baseline Measurements|Ineligible based on initial assessments|2
7484297|NCT02069379|11795342|FG000|First Treatment Arm|Lost to Follow-up|0
7484298|NCT02069379|11795343|FG001|First Treatment Arm|Lost to Follow-up|1
7484299|NCT02069379|11795344|FG002|First Treatment Arm|Lost to Follow-up|1
7484300|NCT02069379|11795345|FG003|First Treatment Arm|Lost to Follow-up|0
7484301|NCT02069379|11795342|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
7484302|NCT02069379|11795343|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7484303|NCT02069379|11795344|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
7484304|NCT02069379|11795345|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
7484305|NCT02069379|11795342|FG000|Washout Period (4 Weeks)|Unrelated event|0
7484306|NCT02069379|11795343|FG001|Washout Period (4 Weeks)|Unrelated event|1
7484307|NCT02069379|11795344|FG002|Washout Period (4 Weeks)|Unrelated event|0
7484308|NCT02069379|11795345|FG003|Washout Period (4 Weeks)|Unrelated event|0
7484309|NCT02069379|11795342|FG000|Second Treatment Arm|Lost to Follow-up|0
7484310|NCT02069379|11795343|FG001|Second Treatment Arm|Lost to Follow-up|0
7484311|NCT02069379|11795344|FG002|Second Treatment Arm|Lost to Follow-up|1
7484312|NCT02069379|11795345|FG003|Second Treatment Arm|Lost to Follow-up|0
7484313|NCT02069392|11795357|FG000|Overall Study|Withdrawal by Subject|4
7484314|NCT02069392|11795358|FG001|Overall Study|Withdrawal by Subject|2
7484315|NCT02070380|11795425|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
7484316|NCT02070380|11795426|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
7484317|NCT02070380|11795427|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
7484318|NCT02070380|11795428|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
7484319|NCT02070380|11795425|FG000|Second Injection|Image sets missing or technically inadeq|0
7484320|NCT02070380|11795426|FG001|Second Injection|Image sets missing or technically inadeq|1
7484321|NCT02070380|11795427|FG002|Second Injection|Image sets missing or technically inadeq|0
7484322|NCT02070380|11795428|FG003|Second Injection|Image sets missing or technically inadeq|0
7484323|NCT02070380|11795425|FG000|Second Injection|Protocol Violation|0
7484324|NCT02070380|11795426|FG001|Second Injection|Protocol Violation|1
7484325|NCT02070380|11795427|FG002|Second Injection|Protocol Violation|1
7484326|NCT02070380|11795428|FG003|Second Injection|Protocol Violation|5
7484327|NCT02070484|11795442|FG000|Overall Study|Withdrawal by Subject|1
7484328|NCT02070484|11795443|FG001|Overall Study|Withdrawal by Subject|0
7484329|NCT02070588|11795452|FG000|Overall Study|Withdrawal by Subject|29
7484330|NCT02070588|11795453|FG001|Overall Study|Withdrawal by Subject|1
7484331|NCT02070588|11795454|FG002|Overall Study|Withdrawal by Subject|0
7484332|NCT02070588|11795452|FG000|Overall Study|Writhdrawal due to early termination|9
7484333|NCT02070588|11795453|FG001|Overall Study|Writhdrawal due to early termination|0
7484334|NCT02070588|11795454|FG002|Overall Study|Writhdrawal due to early termination|0
7484335|NCT02070588|11795452|FG000|Overall Study|Adverse Event|1
7484336|NCT02070588|11795453|FG001|Overall Study|Adverse Event|0
7484337|NCT02070588|11795454|FG002|Overall Study|Adverse Event|0
7484338|NCT02070744|11795485|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
7484339|NCT02070744|11795486|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
7484340|NCT02070744|11795487|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
7484341|NCT02070744|11795488|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
7484342|NCT02070744|11795489|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
7484343|NCT02070744|11795485|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7484344|NCT02070744|11795486|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7484345|NCT02070744|11795487|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7484346|NCT02070744|11795488|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
7484347|NCT02070744|11795489|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
7484348|NCT02070744|11795485|FG000|OLE Phase (48 Weeks)|Other|0
7484349|NCT02070744|11795486|FG001|OLE Phase (48 Weeks)|Other|0
7484350|NCT02070744|11795487|FG002|OLE Phase (48 Weeks)|Other|0
7484351|NCT02070744|11795488|FG003|OLE Phase (48 Weeks)|Other|0
7484352|NCT02070744|11795489|FG004|OLE Phase (48 Weeks)|Other|1
7484353|NCT02070757|11795506|FG000|Overall Study|Adverse Event|107
7484354|NCT02070757|11795507|FG001|Overall Study|Adverse Event|99
7484355|NCT02070757|11795506|FG000|Overall Study|Lost to Follow-up|7
7484356|NCT02070757|11795507|FG001|Overall Study|Lost to Follow-up|4
7484357|NCT02070757|11795506|FG000|Overall Study|Protocol Violation|0
7484358|NCT02070757|11795507|FG001|Overall Study|Protocol Violation|4
7484359|NCT02070757|11795506|FG000|Overall Study|Withdrawal by Subject|1
7484360|NCT02070757|11795507|FG001|Overall Study|Withdrawal by Subject|3
7484361|NCT02070757|11795506|FG000|Overall Study|Investigator Decision|0
7484362|NCT02070757|11795507|FG001|Overall Study|Investigator Decision|2
7484363|NCT02070757|11795506|FG000|Overall Study|Discharged from Study Hospital|2
7484364|NCT02070757|11795507|FG001|Overall Study|Discharged from Study Hospital|2
7484365|NCT02070965|11795516|FG000|Overall Study|Lost to Follow-up|0
7484366|NCT02070965|11795517|FG001|Overall Study|Lost to Follow-up|1
7484367|NCT02070965|11795518|FG002|Overall Study|Lost to Follow-up|0
7484368|NCT02070965|11795516|FG000|Overall Study|Withdrawal by Subject|1
7484369|NCT02070965|11795517|FG001|Overall Study|Withdrawal by Subject|1
7484370|NCT02070965|11795518|FG002|Overall Study|Withdrawal by Subject|1
7484371|NCT02070965|11795516|FG000|Overall Study|Subject moved|1
7484372|NCT02070965|11795517|FG001|Overall Study|Subject moved|0
7484373|NCT02070965|11795518|FG002|Overall Study|Subject moved|0
7484374|NCT02070978|11795529|FG000|Overall Study|Adverse Event|6
7484375|NCT02070978|11795530|FG001|Overall Study|Adverse Event|2
7484376|NCT02070978|11795531|FG002|Overall Study|Adverse Event|0
7484377|NCT02070978|11795529|FG000|Overall Study|Lost to Follow-up|1
7484378|NCT02070978|11795530|FG001|Overall Study|Lost to Follow-up|3
7484379|NCT02070978|11795531|FG002|Overall Study|Lost to Follow-up|4
7484380|NCT02070978|11795529|FG000|Overall Study|Withdrawal by Subject|3
7484381|NCT02070978|11795530|FG001|Overall Study|Withdrawal by Subject|5
7484382|NCT02070978|11795531|FG002|Overall Study|Withdrawal by Subject|3
7484383|NCT02070978|11795529|FG000|Overall Study|Protocol Violation|1
7484384|NCT02070978|11795530|FG001|Overall Study|Protocol Violation|0
7484385|NCT02070978|11795531|FG002|Overall Study|Protocol Violation|3
7484386|NCT02070978|11795529|FG000|Overall Study|Lack of Efficacy|0
7484387|NCT02070978|11795530|FG001|Overall Study|Lack of Efficacy|1
7484388|NCT02070978|11795531|FG002|Overall Study|Lack of Efficacy|0
7484389|NCT02070978|11795529|FG000|Overall Study|Death|0
7484390|NCT02070978|11795530|FG001|Overall Study|Death|0
7484391|NCT02070978|11795531|FG002|Overall Study|Death|2
7484392|NCT02070978|11795529|FG000|Overall Study|Un-specified|3
7484393|NCT02070978|11795530|FG001|Overall Study|Un-specified|2
7484394|NCT02070978|11795531|FG002|Overall Study|Un-specified|2
7484395|NCT02070978|11795529|FG000|Overall Study|Terminated by Sponsor|33
7484396|NCT02070978|11795530|FG001|Overall Study|Terminated by Sponsor|40
7484397|NCT02070978|11795531|FG002|Overall Study|Terminated by Sponsor|39
7484398|NCT02070991|11795541|FG000|Overall Study|Death|2
7484399|NCT02070991|11795542|FG001|Overall Study|Death|0
7484400|NCT02070991|11795541|FG000|Overall Study|Withdrawal by Subject|1
7484401|NCT02070991|11795542|FG001|Overall Study|Withdrawal by Subject|0
7484402|NCT02071082|11795550|FG000|Overall Study|Enrolled and Never Treated|1
7484403|NCT02071082|11795551|FG001|Overall Study|Enrolled and Never Treated|1
7484404|NCT02071082|11795550|FG000|Overall Study|Adverse Event|0
7484405|NCT02071082|11795551|FG001|Overall Study|Adverse Event|1
7484406|NCT02071082|11795550|FG000|Overall Study|Withdrew Consent|0
7484407|NCT02071082|11795551|FG001|Overall Study|Withdrew Consent|4
7484408|NCT02071082|11795550|FG000|Overall Study|Lost to Follow-up|1
7484409|NCT02071082|11795551|FG001|Overall Study|Lost to Follow-up|1
7534727|NCT02701361|11881817|FG002|Overall Study|timed out in rehab center|0
7534728|NCT02701361|11881815|FG000|Overall Study|incarceration|0
7534729|NCT02701361|11881816|FG001|Overall Study|incarceration|0
7534730|NCT02701361|11881817|FG002|Overall Study|incarceration|1
7534731|NCT02701413|11881844|FG000|Overall Study|Withdrawal by Subject|7
7534732|NCT02701413|11881845|FG001|Overall Study|Withdrawal by Subject|11
7534733|NCT02701634|11881864|FG000|Overall Study|Adverse Event|2
7534734|NCT02701634|11881865|FG001|Overall Study|Adverse Event|3
7534735|NCT02701634|11881864|FG000|Overall Study|Death|1
7534736|NCT02701634|11881865|FG001|Overall Study|Death|0
7534737|NCT02701634|11881864|FG000|Overall Study|Investigator's Discretion|7
7534738|NCT02701634|11881865|FG001|Overall Study|Investigator's Discretion|4
7534739|NCT02701634|11881864|FG000|Overall Study|Study terminated by Sponsor|15
7534740|NCT02701634|11881865|FG001|Overall Study|Study terminated by Sponsor|17
7534741|NCT02701634|11881864|FG000|Overall Study|Withdrew Consent|6
7534742|NCT02701634|11881865|FG001|Overall Study|Withdrew Consent|7
7534743|NCT02701634|11881864|FG000|Overall Study|Randomized but not treated|1
7534744|NCT02701634|11881865|FG001|Overall Study|Randomized but not treated|0
7534745|NCT02701764|11881893|FG000|Overall Study|Lost to Follow-up|0
7534746|NCT02701764|11881894|FG001|Overall Study|Lost to Follow-up|1
7534747|NCT02701985|11881916|FG000|Overall Study|Withdrawal by Subject|1
7534748|NCT02701985|11881917|FG001|Overall Study|Withdrawal by Subject|1
7534749|NCT02701985|11881916|FG000|Overall Study|Lost to Follow-up|1
7534750|NCT02701985|11881917|FG001|Overall Study|Lost to Follow-up|0
7534751|NCT02701985|11881916|FG000|Overall Study|Death|1
7534752|NCT02701985|11881917|FG001|Overall Study|Death|0
7484410|NCT02071225|11795575|FG000|Overall Study|Withdrawal of Consent|2
7484411|NCT02071225|11795575|FG000|Overall Study|Protocol Deviation|1
7484412|NCT02071225|11795575|FG000|Overall Study|Lost to Follow-up|2
7484413|NCT02071225|11795575|FG000|Overall Study|Death|25
7484414|NCT02071290|11795581|FG000|Overall Study|Death|1
7484415|NCT02071290|11795582|FG001|Overall Study|Death|0
7484416|NCT02071290|11795581|FG000|Overall Study|Withdrawal by Subject|0
7484417|NCT02071290|11795582|FG001|Overall Study|Withdrawal by Subject|1
7484418|NCT02071290|11795581|FG000|Overall Study|Protocol Violation|3
7484419|NCT02071290|11795582|FG001|Overall Study|Protocol Violation|5
7484420|NCT02071290|11795581|FG000|Overall Study|Physician Decision|0
7484421|NCT02071290|11795582|FG001|Overall Study|Physician Decision|1
7484422|NCT02071706|11795597|FG000|Overall Study|Adverse Event|1
7484423|NCT02071706|11795597|FG000|Overall Study|Withdrawal by Subject|2
7484424|NCT02071771|11795601|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
7484425|NCT02071771|11795602|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
7484426|NCT02071771|11795601|FG000|Period 1: First 10 Days|Unavailable lens power|1
7484427|NCT02071771|11795602|FG001|Period 1: First 10 Days|Unavailable lens power|0
7484428|NCT02071849|11795640|FG000|6-month Primary Endpoint|Did not receive device|4
7484429|NCT02071849|11795640|FG000|6-month Primary Endpoint|Adverse Event|1
7484430|NCT02071849|11795640|FG000|2-year Extended Follow-up|Adverse Event|1
7484431|NCT02072096|11795659|FG000|Overall Study|Lack of Efficacy|18
7484432|NCT02072096|11795660|FG001|Overall Study|Lack of Efficacy|29
7484433|NCT02072096|11795659|FG000|Overall Study|Protocol Violation|7
7484434|NCT02072096|11795660|FG001|Overall Study|Protocol Violation|7
7484435|NCT02072096|11795659|FG000|Overall Study|Withdrawal by Subject|5
7484436|NCT02072096|11795660|FG001|Overall Study|Withdrawal by Subject|7
7484437|NCT02072096|11795659|FG000|Overall Study|Adverse Event|5
7484438|NCT02072096|11795660|FG001|Overall Study|Adverse Event|2
7484439|NCT02072096|11795659|FG000|Overall Study|No Reason Provided|4
7484440|NCT02072096|11795660|FG001|Overall Study|No Reason Provided|2
7484441|NCT02072096|11795659|FG000|Overall Study|Death|2
7484442|NCT02072096|11795660|FG001|Overall Study|Death|0
7484443|NCT02072096|11795659|FG000|Overall Study|Physician Decision|0
7484444|NCT02072096|11795660|FG001|Overall Study|Physician Decision|1
7484445|NCT02072096|11795659|FG000|Overall Study|Study Terminated by Sponsor|43
7484446|NCT02072096|11795660|FG001|Overall Study|Study Terminated by Sponsor|30
7484447|NCT02072096|11795659|FG000|Overall Study|Lost to Follow-up|1
7484448|NCT02072096|11795660|FG001|Overall Study|Lost to Follow-up|0
7484449|NCT02072174|11795669|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
7484450|NCT02072174|11795670|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
7484451|NCT02072174|11795669|FG000|Overall Study|Protocol Violation|16
7484452|NCT02072174|11795670|FG001|Overall Study|Protocol Violation|23
7484453|NCT02072174|11795669|FG000|Overall Study|Physician Decision|0
7484454|NCT02072174|11795670|FG001|Overall Study|Physician Decision|1
7484455|NCT02072174|11795669|FG000|Overall Study|Non-compliance with protocol requirement|2
7484456|NCT02072174|11795670|FG001|Overall Study|Non-compliance with protocol requirement|0
7484457|NCT02072226|11795684|FG000|Overall Study|Lost to Follow-up|11
7484458|NCT02072226|11795685|FG001|Overall Study|Lost to Follow-up|7
7484459|NCT02072226|11795684|FG000|Overall Study|Patient Non-compliance|2
7484460|NCT02072226|11795685|FG001|Overall Study|Patient Non-compliance|3
7484461|NCT02072226|11795684|FG000|Overall Study|Death|1
7484462|NCT02072226|11795685|FG001|Overall Study|Death|0
7484463|NCT02072226|11795684|FG000|Overall Study|Patient Withdrawal of Consent|1
7484464|NCT02072226|11795685|FG001|Overall Study|Patient Withdrawal of Consent|0
7484465|NCT02072434|11795698|FG000|Overall Study|Protocol Violation|10
7484466|NCT02072434|11795699|FG001|Overall Study|Protocol Violation|9
7484467|NCT02072434|11795698|FG000|Overall Study|Physician Decision|5
7484468|NCT02072434|11795699|FG001|Overall Study|Physician Decision|10
7484469|NCT02072434|11795698|FG000|Overall Study|Adverse event, serious fatal|1
7484470|NCT02072434|11795699|FG001|Overall Study|Adverse event, serious fatal|6
7484471|NCT02072434|11795698|FG000|Overall Study|Adverse Event|7
7484472|NCT02072434|11795699|FG001|Overall Study|Adverse Event|6
7484473|NCT02072434|11795698|FG000|Overall Study|Withdrawal by Subject|17
7484474|NCT02072434|11795699|FG001|Overall Study|Withdrawal by Subject|29
7484475|NCT02072434|11795698|FG000|Overall Study|Other|14
7484476|NCT02072434|11795699|FG001|Overall Study|Other|29
7484477|NCT02072434|11795698|FG000|Overall Study|Lost to Follow-up|0
7484478|NCT02072434|11795699|FG001|Overall Study|Lost to Follow-up|1
7484479|NCT02072668|11795705|FG000|Second Intervention|Lost to Follow-up|1
7484480|NCT02072668|11795706|FG001|Second Intervention|Lost to Follow-up|0
7484481|NCT02072824|11795717|FG000|Overall Study|Insufficient clinical response|1
7484482|NCT02072824|11795718|FG001|Overall Study|Insufficient clinical response|0
7484483|NCT02072824|11795719|FG002|Overall Study|Insufficient clinical response|1
7484484|NCT02072824|11795717|FG000|Overall Study|No longer willing to participate|1
7484485|NCT02072824|11795718|FG001|Overall Study|No longer willing to participate|0
7484486|NCT02072824|11795719|FG002|Overall Study|No longer willing to participate|1
7553105|NCT03006393|11913854|FG001|Overall Study|Pregnancy|1
7484487|NCT02072824|11795717|FG000|Overall Study|Medication error|0
7484488|NCT02072824|11795718|FG001|Overall Study|Medication error|1
7484489|NCT02072824|11795719|FG002|Overall Study|Medication error|0
7484490|NCT02072824|11795717|FG000|Overall Study|Adverse Event|0
7484491|NCT02072824|11795718|FG001|Overall Study|Adverse Event|0
7484492|NCT02072824|11795719|FG002|Overall Study|Adverse Event|1
7484493|NCT02072941|11795733|FG000|Overall Study|Withdrawal by Subject|29
7484494|NCT02072941|11795734|FG001|Overall Study|Withdrawal by Subject|21
7484495|NCT02072941|11795733|FG000|Overall Study|Lost to Follow-up|4
7484496|NCT02072941|11795734|FG001|Overall Study|Lost to Follow-up|4
7484497|NCT02072941|11795733|FG000|Overall Study|Death|3
7484498|NCT02072941|11795734|FG001|Overall Study|Death|2
7484499|NCT02072941|11795733|FG000|Overall Study|Removed by Study Staff|2
7484500|NCT02072941|11795734|FG001|Overall Study|Removed by Study Staff|2
7484501|NCT02072980|11795740|FG000|Period 2, Second Wear|Adverse Event|0
7484502|NCT02072980|11795741|FG001|Period 2, Second Wear|Adverse Event|1
7484503|NCT02073643|11795807|FG000|Overall Study|Lost to Follow-up|24
7484504|NCT02073656|11795811|FG000|Primary Study|Lost to Follow-up|6
7484505|NCT02073656|11795811|FG000|Primary Study|Death|1
7484506|NCT02073656|11795811|FG000|Primary Study|Withdrew Consent|1
7484507|NCT02073682|11795819|FG000|Overall Study|Low Creatinine Clearance|1
7484508|NCT02073682|11795820|FG001|Overall Study|Low Creatinine Clearance|2
7484509|NCT02073682|11795819|FG000|Overall Study|Death|86
7484510|NCT02073682|11795820|FG001|Overall Study|Death|100
7484511|NCT02073682|11795819|FG000|Overall Study|Cancer Cured|10
7484512|NCT02073682|11795820|FG001|Overall Study|Cancer Cured|15
7484513|NCT02073682|11795819|FG000|Overall Study|ID: Patient Noncompliance|1
7484514|NCT02073682|11795820|FG001|Overall Study|ID: Patient Noncompliance|2
7484515|NCT02073682|11795819|FG000|Overall Study|ID: Palliative Treatment Only|10
7484516|NCT02073682|11795820|FG001|Overall Study|ID: Palliative Treatment Only|7
7484517|NCT02073682|11795819|FG000|Overall Study|Prohibited Concomitant Medication Use|0
7484518|NCT02073682|11795820|FG001|Overall Study|Prohibited Concomitant Medication Use|1
7484519|NCT02073682|11795819|FG000|Overall Study|Platelet Count <50,000/mL|1
7484520|NCT02073682|11795820|FG001|Overall Study|Platelet Count <50,000/mL|2
7484521|NCT02073682|11795819|FG000|Overall Study|Surgery/Medical Procedure|3
7484522|NCT02073682|11795820|FG001|Overall Study|Surgery/Medical Procedure|1
7484523|NCT02073682|11795819|FG000|Overall Study|Withdrawal by Subject|6
7484524|NCT02073682|11795820|FG001|Overall Study|Withdrawal by Subject|8
7484525|NCT02073682|11795819|FG000|Overall Study|Start of New Chemotherapy Regimen|6
7484526|NCT02073682|11795820|FG001|Overall Study|Start of New Chemotherapy Regimen|3
7484527|NCT02073682|11795819|FG000|Overall Study|Cancer Progression|53
7484528|NCT02073682|11795820|FG001|Overall Study|Cancer Progression|33
7484529|NCT02073682|11795819|FG000|Overall Study|Protocol Violation|1
7484530|NCT02073682|11795820|FG001|Overall Study|Protocol Violation|0
7484531|NCT02073682|11795819|FG000|Overall Study|Adverse Event|79
7484532|NCT02073682|11795820|FG001|Overall Study|Adverse Event|62
7484533|NCT02073682|11795819|FG000|Overall Study|No reason provided|11
7484534|NCT02073682|11795820|FG001|Overall Study|No reason provided|9
7484535|NCT02073682|11795819|FG000|Overall Study|PD: Inconvenience of Dosing|21
7484536|NCT02073682|11795820|FG001|Overall Study|PD: Inconvenience of Dosing|78
7484537|NCT02073682|11795819|FG000|Overall Study|Lost to Follow-up|1
7484538|NCT02073682|11795820|FG001|Overall Study|Lost to Follow-up|1
7484539|NCT02073682|11795819|FG000|Overall Study|ID: Benefit/Risk Judgment|32
7484540|NCT02073682|11795820|FG001|Overall Study|ID: Benefit/Risk Judgment|46
7484541|NCT02073929|11795837|FG000|Overall Study|Lost to Follow-up|2
7484542|NCT02073929|11795838|FG001|Overall Study|Lost to Follow-up|1
7484543|NCT02073929|11795837|FG000|Overall Study|Adverse Event|2
7484544|NCT02073929|11795838|FG001|Overall Study|Adverse Event|1
7484545|NCT02073929|11795837|FG000|Overall Study|Withdrawal by Subject|0
7484546|NCT02073929|11795838|FG001|Overall Study|Withdrawal by Subject|1
7484547|NCT02074059|11795850|FG000|Overall Study|Death|0
7484548|NCT02074059|11795851|FG001|Overall Study|Death|0
7484549|NCT02074059|11795852|FG002|Overall Study|Death|0
7484550|NCT02074059|11795853|FG003|Overall Study|Death|0
7484551|NCT02074059|11795854|FG004|Overall Study|Death|1
7484552|NCT02074059|11795855|FG005|Overall Study|Death|1
7484553|NCT02074514|11795904|FG000|Overall Study|Lack of Efficacy|3
7484554|NCT02074514|11795905|FG001|Overall Study|Lack of Efficacy|2
7484555|NCT02074514|11795904|FG000|Overall Study|Lost to Follow-up|0
7484556|NCT02074514|11795905|FG001|Overall Study|Lost to Follow-up|1
7484557|NCT02074514|11795904|FG000|Overall Study|Withdrew Consent|0
7484558|NCT02074514|11795905|FG001|Overall Study|Withdrew Consent|1
7484559|NCT02074553|11795917|FG000|Intervention Period 1|Family Emergency|0
7484560|NCT02074553|11795918|FG001|Intervention Period 1|Family Emergency|0
7484561|NCT02074553|11795919|FG002|Intervention Period 1|Family Emergency|0
7484562|NCT02074553|11795920|FG003|Intervention Period 1|Family Emergency|1
7484563|NCT02074553|11795921|FG004|Intervention Period 1|Family Emergency|0
7484564|NCT02074553|11795922|FG005|Intervention Period 1|Family Emergency|0
7484565|NCT02074553|11795923|FG006|Intervention Period 1|Family Emergency|0
7484566|NCT02074553|11795924|FG007|Intervention Period 1|Family Emergency|0
7484567|NCT02074553|11795917|FG000|Washout Period 1|Adverse Event|1
7484568|NCT02074553|11795918|FG001|Washout Period 1|Adverse Event|0
7484569|NCT02074553|11795919|FG002|Washout Period 1|Adverse Event|0
7484570|NCT02074553|11795920|FG003|Washout Period 1|Adverse Event|0
7484571|NCT02074553|11795921|FG004|Washout Period 1|Adverse Event|0
7484572|NCT02074553|11795922|FG005|Washout Period 1|Adverse Event|0
7484573|NCT02074553|11795923|FG006|Washout Period 1|Adverse Event|0
7484574|NCT02074553|11795924|FG007|Washout Period 1|Adverse Event|0
7484575|NCT02074553|11795917|FG000|Washout Period 1|Physician Decision|0
7484576|NCT02074553|11795918|FG001|Washout Period 1|Physician Decision|0
7484577|NCT02074553|11795919|FG002|Washout Period 1|Physician Decision|0
7484578|NCT02074553|11795920|FG003|Washout Period 1|Physician Decision|1
7484579|NCT02074553|11795921|FG004|Washout Period 1|Physician Decision|0
7484580|NCT02074553|11795922|FG005|Washout Period 1|Physician Decision|0
7484581|NCT02074553|11795923|FG006|Washout Period 1|Physician Decision|0
7484582|NCT02074553|11795924|FG007|Washout Period 1|Physician Decision|0
7484583|NCT02074553|11795917|FG000|Washout Period 1|Other|0
7484584|NCT02074553|11795918|FG001|Washout Period 1|Other|0
7484585|NCT02074553|11795919|FG002|Washout Period 1|Other|0
7484586|NCT02074553|11795920|FG003|Washout Period 1|Other|0
7484587|NCT02074553|11795921|FG004|Washout Period 1|Other|0
7484588|NCT02074553|11795922|FG005|Washout Period 1|Other|1
7484589|NCT02074553|11795923|FG006|Washout Period 1|Other|0
7484590|NCT02074553|11795924|FG007|Washout Period 1|Other|0
7484591|NCT02074553|11795917|FG000|Washout Period 2|Adverse Event|0
7484592|NCT02074553|11795918|FG001|Washout Period 2|Adverse Event|0
7484593|NCT02074553|11795919|FG002|Washout Period 2|Adverse Event|0
7484594|NCT02074553|11795920|FG003|Washout Period 2|Adverse Event|0
7484595|NCT02074553|11795921|FG004|Washout Period 2|Adverse Event|0
7484596|NCT02074553|11795922|FG005|Washout Period 2|Adverse Event|0
7484597|NCT02074553|11795923|FG006|Washout Period 2|Adverse Event|1
7484598|NCT02074553|11795924|FG007|Washout Period 2|Adverse Event|0
7484599|NCT02074553|11795917|FG000|Washout Period 2|Physician Decision|0
7484600|NCT02074553|11795918|FG001|Washout Period 2|Physician Decision|0
7484601|NCT02074553|11795919|FG002|Washout Period 2|Physician Decision|0
7484602|NCT02074553|11795920|FG003|Washout Period 2|Physician Decision|0
7484603|NCT02074553|11795921|FG004|Washout Period 2|Physician Decision|0
7484604|NCT02074553|11795922|FG005|Washout Period 2|Physician Decision|1
7484605|NCT02074553|11795923|FG006|Washout Period 2|Physician Decision|0
7484606|NCT02074553|11795924|FG007|Washout Period 2|Physician Decision|0
7484607|NCT02074553|11795917|FG000|Washout Period 2|Lost to Follow-up|0
7484608|NCT02074553|11795918|FG001|Washout Period 2|Lost to Follow-up|0
7484609|NCT02074553|11795919|FG002|Washout Period 2|Lost to Follow-up|1
7484610|NCT02074553|11795920|FG003|Washout Period 2|Lost to Follow-up|0
7484611|NCT02074553|11795921|FG004|Washout Period 2|Lost to Follow-up|0
7484612|NCT02074553|11795922|FG005|Washout Period 2|Lost to Follow-up|0
7484613|NCT02074553|11795923|FG006|Washout Period 2|Lost to Follow-up|0
7484614|NCT02074553|11795924|FG007|Washout Period 2|Lost to Follow-up|0
7484615|NCT02074553|11795917|FG000|Washout Period 3|Physician Decision|0
7484616|NCT02074553|11795918|FG001|Washout Period 3|Physician Decision|0
7484617|NCT02074553|11795919|FG002|Washout Period 3|Physician Decision|0
7484618|NCT02074553|11795920|FG003|Washout Period 3|Physician Decision|0
7484619|NCT02074553|11795921|FG004|Washout Period 3|Physician Decision|0
7484620|NCT02074553|11795922|FG005|Washout Period 3|Physician Decision|0
7484621|NCT02074553|11795923|FG006|Washout Period 3|Physician Decision|0
7484622|NCT02074553|11795924|FG007|Washout Period 3|Physician Decision|1
7484623|NCT02074982|11795962|FG000|Overall Study|Adverse Event|15
7484624|NCT02074982|11795963|FG001|Overall Study|Adverse Event|7
7484625|NCT02074982|11795962|FG000|Overall Study|Lack of Efficacy|6
7484626|NCT02074982|11795963|FG001|Overall Study|Lack of Efficacy|1
7484627|NCT02074982|11795962|FG000|Overall Study|Lost to Follow-up|9
7484628|NCT02074982|11795963|FG001|Overall Study|Lost to Follow-up|10
7484629|NCT02074982|11795962|FG000|Overall Study|Non-compliance with study treatment|0
7484630|NCT02074982|11795963|FG001|Overall Study|Non-compliance with study treatment|2
7484631|NCT02074982|11795962|FG000|Overall Study|Physician Decision|1
7484632|NCT02074982|11795963|FG001|Overall Study|Physician Decision|1
7484633|NCT02074982|11795962|FG000|Overall Study|Pregnancy|1
7484634|NCT02074982|11795963|FG001|Overall Study|Pregnancy|2
7484635|NCT02074982|11795962|FG000|Overall Study|Protocol deviation|4
7484636|NCT02074982|11795963|FG001|Overall Study|Protocol deviation|3
7484637|NCT02074982|11795962|FG000|Overall Study|Technical problems|0
7484638|NCT02074982|11795963|FG001|Overall Study|Technical problems|2
7484639|NCT02074982|11795962|FG000|Overall Study|Subject/guardian decision|15
7484640|NCT02074982|11795963|FG001|Overall Study|Subject/guardian decision|24
7484641|NCT02074982|11795962|FG000|Overall Study|Death|0
7484642|NCT02074982|11795963|FG001|Overall Study|Death|2
7484643|NCT02075008|11795975|FG000|Overall Study|Technical problems|1
7484644|NCT02075008|11795975|FG000|Overall Study|Pregnancy|1
7484645|NCT02075008|11795975|FG000|Overall Study|Physician Decision|1
7484646|NCT02075008|11795975|FG000|Overall Study|Lost to Follow-up|1
7484647|NCT02075008|11795975|FG000|Overall Study|Lack of Efficacy|1
7484648|NCT02075008|11795975|FG000|Overall Study|Death|1
7484649|NCT02075008|11795975|FG000|Overall Study|Adverse Event|5
7484650|NCT02075008|11795975|FG000|Overall Study|Withdrawal by Subject|6
7484651|NCT02075008|11795975|FG000|Overall Study|Study terminated by Sponsor|159
7484652|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
7484653|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
7484654|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7484655|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
7484656|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
7484657|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
7484658|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
7484659|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
7484660|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
7484661|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
7484662|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Other|1
7484663|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Other|1
7484664|NCT02075047|11795981|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
7484665|NCT02075047|11795982|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
7484666|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
7484667|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
7484668|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7484669|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
7484670|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
7484671|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
7484672|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
7484673|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
7484674|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
7484675|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
7484676|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Other|1
7484677|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Other|2
7484678|NCT02075047|11795981|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
7484679|NCT02075047|11795982|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
7484680|NCT02075073|11795991|FG000|Overall Study|Withdrawal by Subject|0
7484681|NCT02075073|11795992|FG001|Overall Study|Withdrawal by Subject|1
7484682|NCT02075073|11795993|FG002|Overall Study|Withdrawal by Subject|0
7484683|NCT02075203|11796013|FG000|Overall Study|Withdrawal by Subject|1
7484684|NCT02075203|11796014|FG001|Overall Study|Withdrawal by Subject|0
7484685|NCT02075203|11796015|FG002|Overall Study|Withdrawal by Subject|1
7484686|NCT02075203|11796013|FG000|Overall Study|Adverse Event|1
7484687|NCT02075203|11796014|FG001|Overall Study|Adverse Event|0
7484688|NCT02075203|11796015|FG002|Overall Study|Adverse Event|0
7484689|NCT02075203|11796013|FG000|Overall Study|participant refused to use contraception|1
7484690|NCT02075203|11796014|FG001|Overall Study|participant refused to use contraception|0
7484691|NCT02075203|11796015|FG002|Overall Study|participant refused to use contraception|0
7484692|NCT02075255|11796026|FG000|Overall Study|Study specific withdrawal criteria|0
7484693|NCT02075255|11796027|FG001|Overall Study|Study specific withdrawal criteria|1
7484694|NCT02075255|11796028|FG002|Overall Study|Study specific withdrawal criteria|1
7484695|NCT02075255|11796026|FG000|Overall Study|Withdrawal by Subject|4
7484696|NCT02075255|11796027|FG001|Overall Study|Withdrawal by Subject|1
7484697|NCT02075255|11796028|FG002|Overall Study|Withdrawal by Subject|0
7484698|NCT02075255|11796026|FG000|Overall Study|Lost to Follow-up|0
7484699|NCT02075255|11796027|FG001|Overall Study|Lost to Follow-up|0
7484700|NCT02075255|11796028|FG002|Overall Study|Lost to Follow-up|1
7484701|NCT02075255|11796026|FG000|Overall Study|Adverse Event|0
7484702|NCT02075255|11796027|FG001|Overall Study|Adverse Event|0
7484703|NCT02075255|11796028|FG002|Overall Study|Adverse Event|1
7484704|NCT02075255|11796026|FG000|Overall Study|Death|0
7484705|NCT02075255|11796027|FG001|Overall Study|Death|2
7484706|NCT02075255|11796028|FG002|Overall Study|Death|0
7484707|NCT02075463|11796036|FG000|Overall Study|Adverse Event|3
7484708|NCT02075463|11796036|FG000|Overall Study|Par. reached stopping criteria|4
7484709|NCT02075463|11796036|FG000|Overall Study|Withdrawal by Subject|1
7484710|NCT02075476|11796043|FG000|Overall Study|Death|2
7484711|NCT02075476|11796044|FG001|Overall Study|Death|2
7484712|NCT02075476|11796043|FG000|Overall Study|Lost to Follow-up|1
7484713|NCT02075476|11796044|FG001|Overall Study|Lost to Follow-up|3
7484714|NCT02075515|11796053|FG000|Overall Study|Serious Adverse Event|1
7484715|NCT02075515|11796054|FG001|Overall Study|Serious Adverse Event|1
7484716|NCT02075515|11796055|FG002|Overall Study|Serious Adverse Event|1
7484717|NCT02075515|11796053|FG000|Overall Study|Non-Serious Adverse Event|0
7484718|NCT02075515|11796054|FG001|Overall Study|Non-Serious Adverse Event|1
7484719|NCT02075515|11796055|FG002|Overall Study|Non-Serious Adverse Event|0
7484720|NCT02075515|11796053|FG000|Overall Study|Withdrawal by Subject|2
7484721|NCT02075515|11796054|FG001|Overall Study|Withdrawal by Subject|0
7484722|NCT02075515|11796055|FG002|Overall Study|Withdrawal by Subject|1
7484723|NCT02075515|11796053|FG000|Overall Study|Lost to Follow-up|1
7484724|NCT02075515|11796054|FG001|Overall Study|Lost to Follow-up|3
7484725|NCT02075515|11796055|FG002|Overall Study|Lost to Follow-up|6
7484726|NCT02075541|11796066|FG000|Overall Study|Serious Adverse Event|1
7484727|NCT02075541|11796067|FG001|Overall Study|Serious Adverse Event|4
7484728|NCT02075541|11796066|FG000|Overall Study|Protocol Violation|1
7484729|NCT02075541|11796067|FG001|Overall Study|Protocol Violation|0
7484730|NCT02075541|11796066|FG000|Overall Study|Withdrawal by Subject|1
7484731|NCT02075541|11796067|FG001|Overall Study|Withdrawal by Subject|3
7484732|NCT02075541|11796066|FG000|Overall Study|Sponsor study termination|0
7484733|NCT02075541|11796067|FG001|Overall Study|Sponsor study termination|1
7484734|NCT02075541|11796066|FG000|Overall Study|Other- unable to perform study procedure|1
7484735|NCT02075541|11796067|FG001|Overall Study|Other- unable to perform study procedure|0
7484736|NCT02075554|11796073|FG000|Overall Study|Lost to Follow-up|7
7484737|NCT02075554|11796073|FG000|Overall Study|Withdrawal by Subject|5
7484738|NCT02075554|11796073|FG000|Overall Study|Physician Decision|3
7484739|NCT02075606|11796077|FG000|Overall Study|Adverse Event|5
7484740|NCT02075606|11796077|FG000|Overall Study|Withdrawal by Subject|1
7484741|NCT02075606|11796077|FG000|Overall Study|Death|1
7484742|NCT02075606|11796077|FG000|Overall Study|Investigator's decision|1
7484743|NCT02075606|11796077|FG000|Overall Study|Symptom management|1
7484744|NCT02075606|11796077|FG000|Overall Study|Increasing Symptoms|1
7484745|NCT02075632|11796088|FG000|Overall Study|Adverse Event|1
7484746|NCT02075632|11796089|FG001|Overall Study|Adverse Event|1
7484747|NCT02075632|11796088|FG000|Overall Study|Lost to Follow-up|0
7484748|NCT02075632|11796089|FG001|Overall Study|Lost to Follow-up|3
7484749|NCT02075632|11796088|FG000|Overall Study|Withdrawal by Subject|0
7484750|NCT02075632|11796089|FG001|Overall Study|Withdrawal by Subject|1
7484751|NCT02075658|11796097|FG000|Overall Study|Physician Decision|2
7484752|NCT02075658|11796098|FG001|Overall Study|Physician Decision|2
7484753|NCT02076022|11796106|FG000|Overall Study|Withdrawal by Subject|2
7484754|NCT02076022|11796107|FG001|Overall Study|Withdrawal by Subject|0
7484761|NCT02076165|11796168|FG000|Overall Study|Lost to Follow-up|7
7484762|NCT02076165|11796169|FG001|Overall Study|Lost to Follow-up|5
7484763|NCT02076165|11796168|FG000|Overall Study|Refused follow-up assessment|1
7484764|NCT02076165|11796169|FG001|Overall Study|Refused follow-up assessment|1
7484765|NCT02076334|11796192|FG000|Overall Study|Protocol Violation|1
7484766|NCT02076334|11796193|FG001|Overall Study|Protocol Violation|0
7484767|NCT02076334|11796194|FG002|Overall Study|Protocol Violation|0
7484768|NCT02076334|11796195|FG003|Overall Study|Protocol Violation|0
7484769|NCT02076334|11796192|FG000|Overall Study|Lost to Follow-up|0
7484770|NCT02076334|11796193|FG001|Overall Study|Lost to Follow-up|1
7484771|NCT02076334|11796194|FG002|Overall Study|Lost to Follow-up|1
7484772|NCT02076334|11796195|FG003|Overall Study|Lost to Follow-up|0
7484773|NCT02076334|11796192|FG000|Overall Study|muscle soreness|0
7484774|NCT02076334|11796193|FG001|Overall Study|muscle soreness|0
7484775|NCT02076334|11796194|FG002|Overall Study|muscle soreness|0
7484776|NCT02076334|11796195|FG003|Overall Study|muscle soreness|1
7534753|NCT02701985|11881916|FG000|Overall Study|Adverse Event|0
7534754|NCT02701985|11881917|FG001|Overall Study|Adverse Event|5
7534755|NCT02702011|11881928|FG000|Overall Study|Withdrawal by Subject|0
7534756|NCT02702011|11881929|FG001|Overall Study|Withdrawal by Subject|1
7534757|NCT02702011|11881930|FG002|Overall Study|Withdrawal by Subject|0
7534758|NCT02702011|11881931|FG003|Overall Study|Withdrawal by Subject|0
7534759|NCT02702193|11881943|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
7534760|NCT02702193|11881944|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
7534761|NCT02702193|11881943|FG000|4 Month Follow up|Withdrawal by Subject|1
7534762|NCT02702193|11881944|FG001|4 Month Follow up|Withdrawal by Subject|0
7534763|NCT02702193|11881943|FG000|4 Month Follow up|Lost to Follow-up|17
7534764|NCT02702193|11881944|FG001|4 Month Follow up|Lost to Follow-up|18
7534765|NCT02702193|11881943|FG000|8 Month Follow up|Withdrawal by Subject|1
7534766|NCT02702193|11881944|FG001|8 Month Follow up|Withdrawal by Subject|0
7534767|NCT02702193|11881943|FG000|8 Month Follow up|Lost to Follow-up|14
7534768|NCT02702193|11881944|FG001|8 Month Follow up|Lost to Follow-up|18
7534769|NCT02702193|11881943|FG000|12 Month Follow up|Withdrawal by Subject|1
7534770|NCT02702193|11881944|FG001|12 Month Follow up|Withdrawal by Subject|0
7534771|NCT02702193|11881943|FG000|12 Month Follow up|Lost to Follow-up|16
7534772|NCT02702193|11881944|FG001|12 Month Follow up|Lost to Follow-up|18
7534773|NCT02702388|11881952|FG000|Overall Study|Disease Progression|18
7534774|NCT02702388|11881953|FG001|Overall Study|Disease Progression|25
7534775|NCT02702388|11881952|FG000|Overall Study|Withdrawal by Subject|9
7534776|NCT02702388|11881953|FG001|Overall Study|Withdrawal by Subject|7
7534777|NCT02702388|11881952|FG000|Overall Study|Adverse Event|11
7534778|NCT02702388|11881953|FG001|Overall Study|Adverse Event|15
7534779|NCT02702388|11881952|FG000|Overall Study|Other|2
7534780|NCT02702388|11881953|FG001|Overall Study|Other|4
7534781|NCT02702401|11881970|FG000|Overall Study|Death|180
7534782|NCT02702401|11881971|FG001|Overall Study|Death|101
7534783|NCT02702401|11881970|FG000|Overall Study|Withdrawal by Subject|4
7534784|NCT02702401|11881971|FG001|Overall Study|Withdrawal by Subject|0
7534785|NCT02702401|11881970|FG000|Overall Study|Ongoing in study|94
7534786|NCT02702401|11881971|FG001|Overall Study|Ongoing in study|34
7534787|NCT02702518|11881979|FG000|Overall Study|Lost to Follow-up|3
7534788|NCT02702518|11881980|FG001|Overall Study|Lost to Follow-up|4
7534789|NCT02702609|11881988|FG000|Overall Study|Lost to Follow-up|8
7534790|NCT02702609|11881989|FG001|Overall Study|Lost to Follow-up|4
7534791|NCT02702609|11881988|FG000|Overall Study|Physician Decision|1
7534792|NCT02702609|11881989|FG001|Overall Study|Physician Decision|0
7534793|NCT02703259|11882015|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
7534794|NCT02703259|11882016|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
7534795|NCT02703259|11882015|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
7534796|NCT02703259|11882016|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
7534797|NCT02703259|11882015|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7534798|NCT02703259|11882016|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
7534799|NCT02703311|11882022|FG000|Overall Study|Death|5
7484777|NCT02077140|11796296|FG000|Overall Study|Lost to Follow-up|4
7484778|NCT02077140|11796297|FG001|Overall Study|Lost to Follow-up|1
7484779|NCT02077140|11796298|FG002|Overall Study|Lost to Follow-up|2
7484780|NCT02077140|11796299|FG003|Overall Study|Lost to Follow-up|2
7484781|NCT02077140|11796300|FG004|Overall Study|Lost to Follow-up|3
7484782|NCT02077140|11796296|FG000|Overall Study|Withdrawal by Subject|0
7484783|NCT02077140|11796297|FG001|Overall Study|Withdrawal by Subject|1
7484784|NCT02077140|11796298|FG002|Overall Study|Withdrawal by Subject|0
7484785|NCT02077140|11796299|FG003|Overall Study|Withdrawal by Subject|2
7484786|NCT02077140|11796300|FG004|Overall Study|Withdrawal by Subject|2
7484787|NCT02077374|11796317|FG000|Overall Study|Withdrawal by Subject|0
7484788|NCT02077374|11796318|FG001|Overall Study|Withdrawal by Subject|1
7484789|NCT02077374|11796317|FG000|Overall Study|Protocol Violation|0
7484790|NCT02077374|11796318|FG001|Overall Study|Protocol Violation|1
7484791|NCT02077465|11796329|FG000|Overall Study|Withdrew Consent|0
7484792|NCT02077465|11796330|FG001|Overall Study|Withdrew Consent|1
7484793|NCT02077465|11796329|FG000|Overall Study|Lost to Follow-up|1
7484794|NCT02077465|11796330|FG001|Overall Study|Lost to Follow-up|0
7484795|NCT02078102|11796338|FG000|Overall Study|Adverse Event|1
7484796|NCT02078102|11796339|FG001|Overall Study|Adverse Event|0
7484797|NCT02078102|11796338|FG000|Overall Study|Withdrawal by Subject|1
7484798|NCT02078102|11796339|FG001|Overall Study|Withdrawal by Subject|0
7484799|NCT02078102|11796338|FG000|Overall Study|Physician Decision|0
7484800|NCT02078102|11796339|FG001|Overall Study|Physician Decision|1
7484801|NCT02078219|11796365|FG000|Overall Study|Other|2
7484802|NCT02078219|11796366|FG001|Overall Study|Other|2
7484803|NCT02078219|11796367|FG002|Overall Study|Other|3
7484804|NCT02078219|11796368|FG003|Overall Study|Other|0
7484805|NCT02078219|11796369|FG004|Overall Study|Other|1
7484806|NCT02078219|11796365|FG000|Overall Study|Withdrawal by Subject|0
7484807|NCT02078219|11796366|FG001|Overall Study|Withdrawal by Subject|1
7484808|NCT02078219|11796367|FG002|Overall Study|Withdrawal by Subject|0
7484809|NCT02078219|11796368|FG003|Overall Study|Withdrawal by Subject|1
7484810|NCT02078219|11796369|FG004|Overall Study|Withdrawal by Subject|1
7484811|NCT02078219|11796365|FG000|Overall Study|Protocol Violation|0
7484812|NCT02078219|11796366|FG001|Overall Study|Protocol Violation|0
7484813|NCT02078219|11796367|FG002|Overall Study|Protocol Violation|0
7484814|NCT02078219|11796368|FG003|Overall Study|Protocol Violation|1
7484815|NCT02078219|11796369|FG004|Overall Study|Protocol Violation|0
7484816|NCT02078219|11796365|FG000|Overall Study|Death|0
7484817|NCT02078219|11796366|FG001|Overall Study|Death|0
7484818|NCT02078219|11796367|FG002|Overall Study|Death|0
7484819|NCT02078219|11796368|FG003|Overall Study|Death|1
7484820|NCT02078219|11796369|FG004|Overall Study|Death|0
7484821|NCT02078219|11796365|FG000|Overall Study|Adverse Event|1
7484822|NCT02078219|11796366|FG001|Overall Study|Adverse Event|1
7484823|NCT02078219|11796367|FG002|Overall Study|Adverse Event|3
7484824|NCT02078219|11796368|FG003|Overall Study|Adverse Event|1
7484825|NCT02078219|11796369|FG004|Overall Study|Adverse Event|0
7484826|NCT02078713|11796423|FG000|Overall Study|Lost to Follow-up|49
7484827|NCT02078713|11796424|FG001|Overall Study|Lost to Follow-up|55
7484828|NCT02078713|11796425|FG002|Overall Study|Lost to Follow-up|0
7484829|NCT02078713|11796426|FG003|Overall Study|Lost to Follow-up|0
7484830|NCT02078713|11796423|FG000|Overall Study|Pregnant at baseline|3
7484831|NCT02078713|11796424|FG001|Overall Study|Pregnant at baseline|5
7484832|NCT02078713|11796425|FG002|Overall Study|Pregnant at baseline|0
7484833|NCT02078713|11796426|FG003|Overall Study|Pregnant at baseline|0
7484834|NCT02078713|11796423|FG000|Overall Study|Enrolled twice|0
7484835|NCT02078713|11796424|FG001|Overall Study|Enrolled twice|1
7484836|NCT02078713|11796425|FG002|Overall Study|Enrolled twice|0
7484837|NCT02078713|11796426|FG003|Overall Study|Enrolled twice|0
7484838|NCT02078752|11796457|FG000|Overall Study|Death|0
7484839|NCT02078752|11796458|FG001|Overall Study|Death|3
7484840|NCT02078752|11796459|FG002|Overall Study|Death|0
7484841|NCT02078752|11796460|FG003|Overall Study|Death|0
7484842|NCT02078752|11796461|FG004|Overall Study|Death|0
7484843|NCT02078752|11796462|FG005|Overall Study|Death|1
7484844|NCT02078752|11796463|FG006|Overall Study|Death|0
7484845|NCT02078752|11796464|FG007|Overall Study|Death|1
7484846|NCT02078752|11796465|FG008|Overall Study|Death|0
7484847|NCT02078752|11796466|FG009|Overall Study|Death|4
7484848|NCT02078752|11796457|FG000|Overall Study|Lost to Follow-up|1
7484849|NCT02078752|11796458|FG001|Overall Study|Lost to Follow-up|0
7484850|NCT02078752|11796459|FG002|Overall Study|Lost to Follow-up|0
7484851|NCT02078752|11796460|FG003|Overall Study|Lost to Follow-up|1
7484852|NCT02078752|11796461|FG004|Overall Study|Lost to Follow-up|0
7484853|NCT02078752|11796462|FG005|Overall Study|Lost to Follow-up|0
7484854|NCT02078752|11796463|FG006|Overall Study|Lost to Follow-up|0
7484855|NCT02078752|11796464|FG007|Overall Study|Lost to Follow-up|0
7484856|NCT02078752|11796465|FG008|Overall Study|Lost to Follow-up|0
7484857|NCT02078752|11796466|FG009|Overall Study|Lost to Follow-up|0
7484858|NCT02078752|11796457|FG000|Overall Study|Withdrawal by Subject|1
7484859|NCT02078752|11796458|FG001|Overall Study|Withdrawal by Subject|1
7484860|NCT02078752|11796459|FG002|Overall Study|Withdrawal by Subject|1
7484861|NCT02078752|11796460|FG003|Overall Study|Withdrawal by Subject|1
7484862|NCT02078752|11796461|FG004|Overall Study|Withdrawal by Subject|0
7484863|NCT02078752|11796462|FG005|Overall Study|Withdrawal by Subject|3
7484864|NCT02078752|11796463|FG006|Overall Study|Withdrawal by Subject|2
7484865|NCT02078752|11796464|FG007|Overall Study|Withdrawal by Subject|1
7484866|NCT02078752|11796465|FG008|Overall Study|Withdrawal by Subject|0
7484867|NCT02078752|11796466|FG009|Overall Study|Withdrawal by Subject|1
7484868|NCT02078752|11796457|FG000|Overall Study|Other|0
7484869|NCT02078752|11796458|FG001|Overall Study|Other|3
7484870|NCT02078752|11796459|FG002|Overall Study|Other|0
7484871|NCT02078752|11796460|FG003|Overall Study|Other|0
7484872|NCT02078752|11796461|FG004|Overall Study|Other|1
7484873|NCT02078752|11796462|FG005|Overall Study|Other|0
7484874|NCT02078752|11796463|FG006|Overall Study|Other|0
7484875|NCT02078752|11796464|FG007|Overall Study|Other|1
7484876|NCT02078752|11796465|FG008|Overall Study|Other|0
7484877|NCT02078752|11796466|FG009|Overall Study|Other|0
7484878|NCT02078752|11796457|FG000|Overall Study|Study terminated by sponsor|0
7484879|NCT02078752|11796458|FG001|Overall Study|Study terminated by sponsor|0
7484880|NCT02078752|11796459|FG002|Overall Study|Study terminated by sponsor|0
7484881|NCT02078752|11796460|FG003|Overall Study|Study terminated by sponsor|0
7484882|NCT02078752|11796461|FG004|Overall Study|Study terminated by sponsor|0
7484883|NCT02078752|11796462|FG005|Overall Study|Study terminated by sponsor|0
7484884|NCT02078752|11796463|FG006|Overall Study|Study terminated by sponsor|0
7484885|NCT02078752|11796464|FG007|Overall Study|Study terminated by sponsor|0
7484886|NCT02078752|11796465|FG008|Overall Study|Study terminated by sponsor|0
7484887|NCT02078752|11796466|FG009|Overall Study|Study terminated by sponsor|5
7484888|NCT02078817|11796497|FG000|Overall Study|Withdrawal by Subject|1
7484889|NCT02078960|11796508|FG000|Treatment Period|Other|0
7484890|NCT02078960|11796509|FG001|Treatment Period|Other|0
7484891|NCT02078960|11796510|FG002|Treatment Period|Other|1
7484892|NCT02078960|11796508|FG000|Treatment Period|Lack of Efficacy|0
7484893|NCT02078960|11796509|FG001|Treatment Period|Lack of Efficacy|1
7484894|NCT02078960|11796510|FG002|Treatment Period|Lack of Efficacy|0
7484895|NCT02078960|11796508|FG000|Treatment Period|Disease progression - accelerated phase|0
7484896|NCT02078960|11796509|FG001|Treatment Period|Disease progression - accelerated phase|1
7484897|NCT02078960|11796510|FG002|Treatment Period|Disease progression - accelerated phase|0
7484898|NCT02078960|11796508|FG000|Treatment Period|Disease progression - blast phase|1
7484899|NCT02078960|11796509|FG001|Treatment Period|Disease progression - blast phase|0
7484900|NCT02078960|11796510|FG002|Treatment Period|Disease progression - blast phase|0
7484901|NCT02078960|11796508|FG000|Treatment Period|Withdrawal by Subject|0
7484902|NCT02078960|11796509|FG001|Treatment Period|Withdrawal by Subject|1
7484903|NCT02078960|11796510|FG002|Treatment Period|Withdrawal by Subject|1
7484904|NCT02078960|11796508|FG000|Treatment Period|Adverse Event|1
7484905|NCT02078960|11796509|FG001|Treatment Period|Adverse Event|0
7484906|NCT02078960|11796510|FG002|Treatment Period|Adverse Event|0
7484907|NCT02078960|11796508|FG000|Treatment Period|Death|0
7484908|NCT02078960|11796509|FG001|Treatment Period|Death|0
7484909|NCT02078960|11796510|FG002|Treatment Period|Death|1
7484910|NCT02078960|11796508|FG000|Follow-up Period|Death|2
7484911|NCT02078960|11796509|FG001|Follow-up Period|Death|0
7484912|NCT02078960|11796510|FG002|Follow-up Period|Death|0
7484913|NCT02078960|11796508|FG000|Follow-up Period|Lost to Follow-up|0
7484914|NCT02078960|11796509|FG001|Follow-up Period|Lost to Follow-up|1
7484915|NCT02078960|11796510|FG002|Follow-up Period|Lost to Follow-up|0
7484916|NCT02079038|11796532|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
7484917|NCT02079038|11796533|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
7484918|NCT02079038|11796532|FG000|Modified Intent to Treat Population|Death|1
7484919|NCT02079038|11796533|FG001|Modified Intent to Treat Population|Death|0
7484920|NCT02079038|11796532|FG000|Completed 6 Months|Lost to Follow-up|2
7484921|NCT02079038|11796533|FG001|Completed 6 Months|Lost to Follow-up|1
7484922|NCT02079077|11796541|FG000|Overall Study|Lost to Follow-up|5
7484923|NCT02079077|11796542|FG001|Overall Study|Lost to Follow-up|7
7484924|NCT02079077|11796541|FG000|Overall Study|Became STIs Positive|1
7484925|NCT02079077|11796542|FG001|Overall Study|Became STIs Positive|2
7484926|NCT02079246|11796548|FG000|OLEX|Withdrawal before treatment|1
7484927|NCT02079246|11796549|FG001|OLEX|Withdrawal before treatment|0
7484928|NCT02079246|11796548|FG000|OLEX|Death|11
7484929|NCT02079246|11796549|FG001|OLEX|Death|0
7484930|NCT02079246|11796548|FG000|OLEX|Adverse Event|66
7484931|NCT02079246|11796549|FG001|OLEX|Adverse Event|0
7484932|NCT02079246|11796548|FG000|OLEX|Withdrawal by Subject|60
7484933|NCT02079246|11796549|FG001|OLEX|Withdrawal by Subject|0
7484934|NCT02079246|11796548|FG000|OLEX|Lost to Follow-up|6
7484935|NCT02079246|11796549|FG001|OLEX|Lost to Follow-up|0
7484936|NCT02079246|11796548|FG000|OLEX|Protocol Violation|6
7484937|NCT02079246|11796549|FG001|OLEX|Protocol Violation|0
7484938|NCT02079246|11796548|FG000|OLEX|Lack of Efficacy|3
7484939|NCT02079246|11796549|FG001|OLEX|Lack of Efficacy|0
7484940|NCT02079246|11796548|FG000|OLEX|Results of the lead-in studies|58
7484941|NCT02079246|11796549|FG001|OLEX|Results of the lead-in studies|0
7484942|NCT02079246|11796548|FG000|OLEX|Other: Disallowed medication|8
7484943|NCT02079246|11796549|FG001|OLEX|Other: Disallowed medication|0
7484944|NCT02079246|11796548|FG000|OLEX|Other: Insufficient compliance|2
7484945|NCT02079246|11796549|FG001|OLEX|Other: Insufficient compliance|0
7484946|NCT02079246|11796548|FG000|OLEX|Other: Caregiver unavailable|3
7484947|NCT02079246|11796549|FG001|OLEX|Other: Caregiver unavailable|0
7484948|NCT02079246|11796548|FG000|OLEX|Other: Coordinator decision|1
7484949|NCT02079246|11796549|FG001|OLEX|Other: Coordinator decision|0
7484950|NCT02079246|11796548|FG000|OLEX|Other: Worsening of condition|1
7484951|NCT02079246|11796549|FG001|OLEX|Other: Worsening of condition|0
7484952|NCT02079246|11796548|FG000|OLEX|Other: Moved to nursing home|1
7484953|NCT02079246|11796549|FG001|OLEX|Other: Moved to nursing home|0
7484954|NCT02079246|11796548|FG000|OLEX|Other: Withdrawal of caregiver consent|1
7484955|NCT02079246|11796549|FG001|OLEX|Other: Withdrawal of caregiver consent|0
7484956|NCT02079246|11796548|FG000|OLEX-MEM|Adverse Event|0
7484957|NCT02079246|11796549|FG001|OLEX-MEM|Adverse Event|6
7484958|NCT02079246|11796548|FG000|OLEX-MEM|Withdrawal by Subject|0
7484959|NCT02079246|11796549|FG001|OLEX-MEM|Withdrawal by Subject|7
7484960|NCT02079246|11796548|FG000|OLEX-MEM|Protocol Violation|0
7484961|NCT02079246|11796549|FG001|OLEX-MEM|Protocol Violation|2
7484962|NCT02079246|11796548|FG000|OLEX-MEM|Lost to Follow-up|0
7484963|NCT02079246|11796549|FG001|OLEX-MEM|Lost to Follow-up|1
7484964|NCT02079246|11796548|FG000|OLEX-MEM|Other: Moved to nursing home|0
7484965|NCT02079246|11796549|FG001|OLEX-MEM|Other: Moved to nursing home|3
7484966|NCT02079519|11796567|FG000|Overall Study|Disease Progression|9
7484967|NCT02079519|11796567|FG000|Overall Study|Adverse Event|1
7484968|NCT02079532|11796571|FG000|Overall Study|Adverse Event|7
7484969|NCT02079532|11796571|FG000|Overall Study|Additional or changed therapy|2
7484970|NCT02079532|11796571|FG000|Overall Study|Lack of Efficacy|9
7484971|NCT02079532|11796571|FG000|Overall Study|Protocol Violation|3
7484972|NCT02079532|11796571|FG000|Overall Study|Withdrawal by Subject|1
7484973|NCT02079532|11796571|FG000|Overall Study|Administrative problems|1
7484974|NCT02079532|11796571|FG000|Overall Study|Inclusion into ReFIRST|3
7484975|NCT02079532|11796571|FG000|Overall Study|Other|3
7484976|NCT02079610|11796577|FG000|Overall Study|Withdrawal by Subject|1
7484977|NCT02079610|11796578|FG001|Overall Study|Withdrawal by Subject|1
7484978|NCT02079636|11796599|FG000|Overall Study|Death|2
7484979|NCT02079636|11796600|FG001|Overall Study|Death|1
7484980|NCT02079636|11796601|FG002|Overall Study|Death|0
7484981|NCT02079636|11796602|FG003|Overall Study|Death|5
7484982|NCT02079636|11796603|FG004|Overall Study|Death|1
7484983|NCT02079636|11796604|FG005|Overall Study|Death|2
7484984|NCT02079636|11796605|FG006|Overall Study|Death|1
7484985|NCT02079636|11796606|FG007|Overall Study|Death|0
7484986|NCT02079636|11796607|FG008|Overall Study|Death|0
7484987|NCT02079636|11796608|FG009|Overall Study|Death|0
7484988|NCT02079636|11796609|FG010|Overall Study|Death|0
7484989|NCT02079636|11796610|FG011|Overall Study|Death|1
7484990|NCT02079636|11796611|FG012|Overall Study|Death|1
7484991|NCT02079636|11796612|FG013|Overall Study|Death|0
7484992|NCT02079636|11796613|FG014|Overall Study|Death|2
7484993|NCT02079636|11796599|FG000|Overall Study|Adverse Event|1
7484994|NCT02079636|11796600|FG001|Overall Study|Adverse Event|1
7484995|NCT02079636|11796601|FG002|Overall Study|Adverse Event|0
7484996|NCT02079636|11796602|FG003|Overall Study|Adverse Event|1
7484997|NCT02079636|11796603|FG004|Overall Study|Adverse Event|1
7484998|NCT02079636|11796604|FG005|Overall Study|Adverse Event|2
7484999|NCT02079636|11796605|FG006|Overall Study|Adverse Event|0
7485000|NCT02079636|11796606|FG007|Overall Study|Adverse Event|0
7485001|NCT02079636|11796607|FG008|Overall Study|Adverse Event|0
7485002|NCT02079636|11796608|FG009|Overall Study|Adverse Event|0
7485003|NCT02079636|11796609|FG010|Overall Study|Adverse Event|0
7485004|NCT02079636|11796610|FG011|Overall Study|Adverse Event|0
7485005|NCT02079636|11796611|FG012|Overall Study|Adverse Event|0
7485006|NCT02079636|11796612|FG013|Overall Study|Adverse Event|0
7485007|NCT02079636|11796613|FG014|Overall Study|Adverse Event|0
7485008|NCT02079636|11796599|FG000|Overall Study|Progressive disease|0
7485009|NCT02079636|11796600|FG001|Overall Study|Progressive disease|0
7485010|NCT02079636|11796601|FG002|Overall Study|Progressive disease|0
7485011|NCT02079636|11796602|FG003|Overall Study|Progressive disease|2
7485012|NCT02079636|11796603|FG004|Overall Study|Progressive disease|0
7485013|NCT02079636|11796604|FG005|Overall Study|Progressive disease|0
7485014|NCT02079636|11796605|FG006|Overall Study|Progressive disease|0
7485015|NCT02079636|11796606|FG007|Overall Study|Progressive disease|0
7485016|NCT02079636|11796607|FG008|Overall Study|Progressive disease|0
7485017|NCT02079636|11796608|FG009|Overall Study|Progressive disease|0
7485018|NCT02079636|11796609|FG010|Overall Study|Progressive disease|0
7485019|NCT02079636|11796610|FG011|Overall Study|Progressive disease|0
7485020|NCT02079636|11796611|FG012|Overall Study|Progressive disease|1
7485021|NCT02079636|11796612|FG013|Overall Study|Progressive disease|0
7485022|NCT02079636|11796613|FG014|Overall Study|Progressive disease|0
7485023|NCT02079636|11796599|FG000|Overall Study|Withdrawal by Subject|0
7485024|NCT02079636|11796600|FG001|Overall Study|Withdrawal by Subject|0
7485025|NCT02079636|11796601|FG002|Overall Study|Withdrawal by Subject|0
7485026|NCT02079636|11796602|FG003|Overall Study|Withdrawal by Subject|4
7485027|NCT02079636|11796603|FG004|Overall Study|Withdrawal by Subject|0
7485028|NCT02079636|11796604|FG005|Overall Study|Withdrawal by Subject|1
7485029|NCT02079636|11796605|FG006|Overall Study|Withdrawal by Subject|0
7485030|NCT02079636|11796606|FG007|Overall Study|Withdrawal by Subject|0
7485031|NCT02079636|11796607|FG008|Overall Study|Withdrawal by Subject|0
7485032|NCT02079636|11796608|FG009|Overall Study|Withdrawal by Subject|2
7485033|NCT02079636|11796609|FG010|Overall Study|Withdrawal by Subject|1
7485034|NCT02079636|11796610|FG011|Overall Study|Withdrawal by Subject|1
7485035|NCT02079636|11796611|FG012|Overall Study|Withdrawal by Subject|1
7485036|NCT02079636|11796612|FG013|Overall Study|Withdrawal by Subject|0
7485037|NCT02079636|11796613|FG014|Overall Study|Withdrawal by Subject|2
7485038|NCT02079636|11796599|FG000|Overall Study|Physician Decision|0
7485039|NCT02079636|11796600|FG001|Overall Study|Physician Decision|0
7485040|NCT02079636|11796601|FG002|Overall Study|Physician Decision|0
7485041|NCT02079636|11796602|FG003|Overall Study|Physician Decision|0
7485042|NCT02079636|11796603|FG004|Overall Study|Physician Decision|0
7485043|NCT02079636|11796604|FG005|Overall Study|Physician Decision|1
7485044|NCT02079636|11796605|FG006|Overall Study|Physician Decision|0
7485045|NCT02079636|11796606|FG007|Overall Study|Physician Decision|0
7485046|NCT02079636|11796607|FG008|Overall Study|Physician Decision|0
7485047|NCT02079636|11796608|FG009|Overall Study|Physician Decision|1
7485048|NCT02079636|11796609|FG010|Overall Study|Physician Decision|1
7485049|NCT02079636|11796610|FG011|Overall Study|Physician Decision|0
7485050|NCT02079636|11796611|FG012|Overall Study|Physician Decision|0
7485051|NCT02079636|11796612|FG013|Overall Study|Physician Decision|0
7485052|NCT02079636|11796613|FG014|Overall Study|Physician Decision|1
7485053|NCT02079636|11796599|FG000|Overall Study|Lost to Follow-up|0
7485054|NCT02079636|11796600|FG001|Overall Study|Lost to Follow-up|0
7485055|NCT02079636|11796601|FG002|Overall Study|Lost to Follow-up|0
7485056|NCT02079636|11796602|FG003|Overall Study|Lost to Follow-up|0
7485057|NCT02079636|11796603|FG004|Overall Study|Lost to Follow-up|0
7485058|NCT02079636|11796604|FG005|Overall Study|Lost to Follow-up|0
7485059|NCT02079636|11796605|FG006|Overall Study|Lost to Follow-up|0
7485060|NCT02079636|11796606|FG007|Overall Study|Lost to Follow-up|1
7485061|NCT02079636|11796607|FG008|Overall Study|Lost to Follow-up|0
7485062|NCT02079636|11796608|FG009|Overall Study|Lost to Follow-up|0
7485063|NCT02079636|11796609|FG010|Overall Study|Lost to Follow-up|0
7485064|NCT02079636|11796610|FG011|Overall Study|Lost to Follow-up|0
7485065|NCT02079636|11796611|FG012|Overall Study|Lost to Follow-up|0
7485066|NCT02079636|11796612|FG013|Overall Study|Lost to Follow-up|0
7485067|NCT02079636|11796613|FG014|Overall Study|Lost to Follow-up|0
7485068|NCT02079649|11796681|FG000|Overall Study|Lost to Follow-up|0
7485069|NCT02079649|11796682|FG001|Overall Study|Lost to Follow-up|0
7485070|NCT02079649|11796683|FG002|Overall Study|Lost to Follow-up|0
7485071|NCT02079649|11796684|FG003|Overall Study|Lost to Follow-up|1
7485072|NCT02079649|11796681|FG000|Overall Study|Withdrawal by Subject|0
7485073|NCT02079649|11796682|FG001|Overall Study|Withdrawal by Subject|0
7485074|NCT02079649|11796683|FG002|Overall Study|Withdrawal by Subject|0
7485075|NCT02079649|11796684|FG003|Overall Study|Withdrawal by Subject|1
7485076|NCT02079649|11796681|FG000|Overall Study|Randomization error (prior to treatment)|1
7485077|NCT02079649|11796682|FG001|Overall Study|Randomization error (prior to treatment)|0
7485078|NCT02079649|11796683|FG002|Overall Study|Randomization error (prior to treatment)|1
7485079|NCT02079649|11796684|FG003|Overall Study|Randomization error (prior to treatment)|0
7485080|NCT02079805|11796697|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7485081|NCT02079805|11796698|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7485082|NCT02079805|11796697|FG000|Overall Study|Voluntary Withdrawal|0
7485083|NCT02079805|11796698|FG001|Overall Study|Voluntary Withdrawal|1
7485084|NCT02079844|11796707|FG000|Treatment Period 1|Voluntary Withdrawal|0
7485085|NCT02079844|11796708|FG001|Treatment Period 1|Voluntary Withdrawal|0
7485086|NCT02079844|11796709|FG002|Treatment Period 1|Voluntary Withdrawal|2
7485087|NCT02079844|11796707|FG000|Treatment Period 2|Voluntary Withdrawal|0
7485088|NCT02079844|11796708|FG001|Treatment Period 2|Voluntary Withdrawal|1
7485089|NCT02079844|11796709|FG002|Treatment Period 2|Voluntary Withdrawal|0
7485090|NCT02079909|11796723|FG000|Overall Study|Adverse Event|23
7485091|NCT02079909|11796724|FG001|Overall Study|Adverse Event|23
7485092|NCT02079909|11796725|FG002|Overall Study|Adverse Event|7
7485093|NCT02079909|11796723|FG000|Overall Study|Withdrawal by Subject|9
7485094|NCT02079909|11796724|FG001|Overall Study|Withdrawal by Subject|17
7485095|NCT02079909|11796725|FG002|Overall Study|Withdrawal by Subject|4
7485096|NCT02079909|11796723|FG000|Overall Study|Lost to Follow-up|2
7485097|NCT02079909|11796724|FG001|Overall Study|Lost to Follow-up|3
7485098|NCT02079909|11796725|FG002|Overall Study|Lost to Follow-up|1
7485099|NCT02079909|11796723|FG000|Overall Study|Death|2
7485100|NCT02079909|11796724|FG001|Overall Study|Death|2
7485101|NCT02079909|11796725|FG002|Overall Study|Death|0
7485102|NCT02079909|11796723|FG000|Overall Study|Lack of Efficacy|0
7485103|NCT02079909|11796724|FG001|Overall Study|Lack of Efficacy|0
7485104|NCT02079909|11796725|FG002|Overall Study|Lack of Efficacy|1
7485105|NCT02079909|11796723|FG000|Overall Study|Protocol Violation|0
7485106|NCT02079909|11796724|FG001|Overall Study|Protocol Violation|1
7485107|NCT02079909|11796725|FG002|Overall Study|Protocol Violation|1
7485108|NCT02079909|11796723|FG000|Overall Study|Physician Decision|0
7485109|NCT02079909|11796724|FG001|Overall Study|Physician Decision|1
7485110|NCT02079909|11796725|FG002|Overall Study|Physician Decision|1
7485111|NCT02079909|11796723|FG000|Overall Study|Relocation etc.|2
7485112|NCT02079909|11796724|FG001|Overall Study|Relocation etc.|2
7485113|NCT02079909|11796725|FG002|Overall Study|Relocation etc.|3
7485114|NCT02080091|11796743|FG000|Overall Study|Study Terminated|22
7485115|NCT02080091|11796743|FG000|Overall Study|Death|1
7485116|NCT02080091|11796743|FG000|Overall Study|Withdrawal by Subject|1
7485117|NCT02080091|11796743|FG000|Overall Study|Other|1
7485120|NCT02080364|11796777|FG000|Baseline Period|Protocol Violation|2
7485121|NCT02080364|11796778|FG001|Baseline Period|Protocol Violation|1
7485122|NCT02080364|11796779|FG002|Baseline Period|Protocol Violation|0
7485123|NCT02080364|11796780|FG003|Baseline Period|Protocol Violation|0
7485124|NCT02080364|11796777|FG000|Baseline Period|Other|0
7485125|NCT02080364|11796778|FG001|Baseline Period|Other|1
7485126|NCT02080364|11796779|FG002|Baseline Period|Other|1
7485127|NCT02080364|11796780|FG003|Baseline Period|Other|0
7485128|NCT02080364|11796777|FG000|Treatment Period|Adverse Event|10
7485129|NCT02080364|11796778|FG001|Treatment Period|Adverse Event|15
7485130|NCT02080364|11796779|FG002|Treatment Period|Adverse Event|11
7485131|NCT02080364|11796780|FG003|Treatment Period|Adverse Event|14
7485132|NCT02080364|11796777|FG000|Treatment Period|Lost to Follow-up|2
7485133|NCT02080364|11796778|FG001|Treatment Period|Lost to Follow-up|3
7485134|NCT02080364|11796779|FG002|Treatment Period|Lost to Follow-up|5
7485135|NCT02080364|11796780|FG003|Treatment Period|Lost to Follow-up|0
7485136|NCT02080364|11796777|FG000|Treatment Period|Protocol Violation|5
7485137|NCT02080364|11796778|FG001|Treatment Period|Protocol Violation|3
7485138|NCT02080364|11796779|FG002|Treatment Period|Protocol Violation|5
7485139|NCT02080364|11796780|FG003|Treatment Period|Protocol Violation|1
7485140|NCT02080364|11796777|FG000|Treatment Period|Withdrawal by Subject|16
7485141|NCT02080364|11796778|FG001|Treatment Period|Withdrawal by Subject|16
7485142|NCT02080364|11796779|FG002|Treatment Period|Withdrawal by Subject|15
7485143|NCT02080364|11796780|FG003|Treatment Period|Withdrawal by Subject|10
7485144|NCT02080364|11796777|FG000|Treatment Period|Study Terminated by Sponsor|0
7485145|NCT02080364|11796778|FG001|Treatment Period|Study Terminated by Sponsor|0
7485146|NCT02080364|11796779|FG002|Treatment Period|Study Terminated by Sponsor|180
7485147|NCT02080364|11796780|FG003|Treatment Period|Study Terminated by Sponsor|183
7485148|NCT02080364|11796777|FG000|Treatment Period|Other|14
7485149|NCT02080364|11796778|FG001|Treatment Period|Other|12
7485150|NCT02080364|11796779|FG002|Treatment Period|Other|21
7485151|NCT02080364|11796780|FG003|Treatment Period|Other|16
7485164|NCT02080481|11796834|FG000|Overall Study|Never received a block.|1
7485165|NCT02080481|11796835|FG001|Overall Study|Never received a block.|0
7485166|NCT02080832|11796891|FG000|Overall Study|Excluded from analysis by MRI|9
7485167|NCT02080832|11796892|FG001|Overall Study|Excluded from analysis by MRI|10
7485168|NCT02080832|11796893|FG002|Overall Study|Excluded from analysis by MRI|14
7485169|NCT02080832|11796891|FG000|Overall Study|Lost to Follow-up|0
7485170|NCT02080832|11796892|FG001|Overall Study|Lost to Follow-up|2
7485171|NCT02080832|11796893|FG002|Overall Study|Lost to Follow-up|2
7485172|NCT02080871|11796903|FG000|Overall Study|Death|1
7485173|NCT02080871|11796903|FG000|Overall Study|Lost to Follow-up|1
7485174|NCT02081001|11796909|FG000|Overall Study|Adverse Event|0
7485175|NCT02081001|11796910|FG001|Overall Study|Adverse Event|0
7485176|NCT02081001|11796911|FG002|Overall Study|Adverse Event|0
7485177|NCT02081001|11796912|FG003|Overall Study|Adverse Event|0
7485178|NCT02081001|11796913|FG004|Overall Study|Adverse Event|1
7485179|NCT02081001|11796914|FG005|Overall Study|Adverse Event|0
7485180|NCT02081001|11796915|FG006|Overall Study|Adverse Event|0
7485181|NCT02081001|11796916|FG007|Overall Study|Adverse Event|0
7485182|NCT02081001|11796917|FG008|Overall Study|Adverse Event|0
7485183|NCT02081001|11796918|FG009|Overall Study|Adverse Event|0
7485184|NCT02081001|11796919|FG010|Overall Study|Adverse Event|0
7485185|NCT02081001|11796920|FG011|Overall Study|Adverse Event|0
7485186|NCT02081079|11796957|FG000|Overall Study|Lack of Efficacy|3
7485187|NCT02081079|11796958|FG001|Overall Study|Lack of Efficacy|2
7485188|NCT02081079|11796957|FG000|Overall Study|Lost to Follow-up|1
7485189|NCT02081079|11796958|FG001|Overall Study|Lost to Follow-up|0
7485190|NCT02081196|11796968|FG000|Overall Study|Lost to Follow-up|1
7485191|NCT02081417|11796994|FG000|Overall Study|Lost to Follow-up|26
7485192|NCT02081417|11796995|FG001|Overall Study|Lost to Follow-up|23
7485193|NCT02081417|11796994|FG000|Overall Study|Moved Away|1
7485194|NCT02081417|11796995|FG001|Overall Study|Moved Away|2
7485195|NCT02081417|11796994|FG000|Overall Study|Incarcerated|2
7485196|NCT02081417|11796995|FG001|Overall Study|Incarcerated|2
7485197|NCT02081417|11796994|FG000|Overall Study|Death|4
7485198|NCT02081417|11796995|FG001|Overall Study|Death|3
7485199|NCT02081417|11796994|FG000|Overall Study|Withdrawal by Subject|4
7485200|NCT02081417|11796995|FG001|Overall Study|Withdrawal by Subject|0
7485201|NCT02081417|11796994|FG000|Overall Study|Admitted to Residential Treatment|2
7485202|NCT02081417|11796995|FG001|Overall Study|Admitted to Residential Treatment|0
7485203|NCT02081417|11796994|FG000|Overall Study|Did not start treatment|17
7485204|NCT02081417|11796995|FG001|Overall Study|Did not start treatment|21
7485205|NCT02081534|11797026|FG000|Overall Study|Adverse Event|5
7485206|NCT02081534|11797027|FG001|Overall Study|Adverse Event|4
7485207|NCT02081534|11797028|FG002|Overall Study|Adverse Event|3
7485208|NCT02081534|11797029|FG003|Overall Study|Adverse Event|10
7485209|NCT02081534|11797030|FG004|Overall Study|Adverse Event|2
7485210|NCT02081534|11797031|FG005|Overall Study|Adverse Event|8
7485211|NCT02081534|11797032|FG006|Overall Study|Adverse Event|2
7485212|NCT02081534|11797026|FG000|Overall Study|Withdrawal by Subject|0
7485213|NCT02081534|11797027|FG001|Overall Study|Withdrawal by Subject|1
7485214|NCT02081534|11797028|FG002|Overall Study|Withdrawal by Subject|1
7485215|NCT02081534|11797029|FG003|Overall Study|Withdrawal by Subject|1
7485216|NCT02081534|11797030|FG004|Overall Study|Withdrawal by Subject|1
7485217|NCT02081534|11797031|FG005|Overall Study|Withdrawal by Subject|0
7485218|NCT02081534|11797032|FG006|Overall Study|Withdrawal by Subject|1
7485219|NCT02081534|11797026|FG000|Overall Study|Protocol Violation|0
7485220|NCT02081534|11797027|FG001|Overall Study|Protocol Violation|3
7485221|NCT02081534|11797028|FG002|Overall Study|Protocol Violation|0
7485222|NCT02081534|11797029|FG003|Overall Study|Protocol Violation|0
7485223|NCT02081534|11797030|FG004|Overall Study|Protocol Violation|0
7485224|NCT02081534|11797031|FG005|Overall Study|Protocol Violation|0
7485225|NCT02081534|11797032|FG006|Overall Study|Protocol Violation|1
7485226|NCT02081534|11797026|FG000|Overall Study|Lost to Follow-up|0
7485227|NCT02081534|11797027|FG001|Overall Study|Lost to Follow-up|0
7485228|NCT02081534|11797028|FG002|Overall Study|Lost to Follow-up|0
7485229|NCT02081534|11797029|FG003|Overall Study|Lost to Follow-up|2
7485230|NCT02081534|11797030|FG004|Overall Study|Lost to Follow-up|1
7485231|NCT02081534|11797031|FG005|Overall Study|Lost to Follow-up|1
7485232|NCT02081534|11797032|FG006|Overall Study|Lost to Follow-up|0
7485233|NCT02081586|11797056|FG000|Overall Study|Lost to Follow-up|0
7485234|NCT02081586|11797057|FG001|Overall Study|Lost to Follow-up|1
7485235|NCT02081586|11797058|FG002|Overall Study|Lost to Follow-up|0
7485236|NCT02081586|11797059|FG003|Overall Study|Lost to Follow-up|1
7485237|NCT02081586|11797056|FG000|Overall Study|Head injury not related to study|0
7485238|NCT02081586|11797057|FG001|Overall Study|Head injury not related to study|0
7485239|NCT02081586|11797058|FG002|Overall Study|Head injury not related to study|1
7485240|NCT02081586|11797059|FG003|Overall Study|Head injury not related to study|0
7485241|NCT02081599|11797073|FG000|Period 1：Double-blind Period|Adverse Event|3
7485242|NCT02081599|11797074|FG001|Period 1：Double-blind Period|Adverse Event|0
7485243|NCT02081599|11797073|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
7485244|NCT02081599|11797074|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
7485245|NCT02081599|11797073|FG000|Period 1：Double-blind Period|Physician Decision|1
7485246|NCT02081599|11797074|FG001|Period 1：Double-blind Period|Physician Decision|0
7485247|NCT02081599|11797073|FG000|Period 1：Double-blind Period|Protocol Violation|0
7485248|NCT02081599|11797074|FG001|Period 1：Double-blind Period|Protocol Violation|1
7485249|NCT02081599|11797073|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
7485250|NCT02081599|11797074|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
7485251|NCT02081599|11797073|FG000|Period 1：Double-blind Period|stopping criteria|1
7485252|NCT02081599|11797074|FG001|Period 1：Double-blind Period|stopping criteria|0
7485253|NCT02081599|11797073|FG000|Period 2：Open-label Period|Adverse Event|1
7485254|NCT02081599|11797074|FG001|Period 2：Open-label Period|Adverse Event|0
7485255|NCT02081599|11797073|FG000|Period 2：Open-label Period|Lack of Efficacy|2
7485256|NCT02081599|11797074|FG001|Period 2：Open-label Period|Lack of Efficacy|4
7485257|NCT02081599|11797073|FG000|Period 2：Open-label Period|Physician Decision|1
7485258|NCT02081599|11797074|FG001|Period 2：Open-label Period|Physician Decision|0
7485259|NCT02081599|11797073|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
7485260|NCT02081599|11797074|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
7485261|NCT02081677|11797099|FG000|Overall Study|Adverse Event|0
7485262|NCT02081677|11797100|FG001|Overall Study|Adverse Event|0
7485263|NCT02081677|11797101|FG002|Overall Study|Adverse Event|1
7485264|NCT02081677|11797102|FG003|Overall Study|Adverse Event|0
7485265|NCT02081677|11797099|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7485266|NCT02081677|11797100|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7485267|NCT02081677|11797101|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
7485268|NCT02081677|11797102|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7485269|NCT02081677|11797099|FG000|Overall Study|Not comfortable with lens care system|1
7485270|NCT02081677|11797100|FG001|Overall Study|Not comfortable with lens care system|0
7485271|NCT02081677|11797101|FG002|Overall Study|Not comfortable with lens care system|0
7485272|NCT02081677|11797102|FG003|Overall Study|Not comfortable with lens care system|0
7485273|NCT02081677|11797099|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7485274|NCT02081677|11797100|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7485275|NCT02081677|11797101|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7485276|NCT02081677|11797102|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7485277|NCT02081690|11797112|FG000|Overall Study|Death|3
7485278|NCT02081690|11797112|FG000|Overall Study|Physician Decision|3
7485279|NCT02081690|11797112|FG000|Overall Study|Withdrawal by Subject|1
7485280|NCT02081846|11797161|FG000|Overall Study|Withdrawal by Subject|1
7485281|NCT02081846|11797162|FG001|Overall Study|Withdrawal by Subject|0
7485282|NCT02081846|11797161|FG000|Overall Study|invalid consent|1
7485283|NCT02081846|11797162|FG001|Overall Study|invalid consent|0
7485284|NCT02081859|11797170|FG000|Overall Study|No fertilization|2
7485285|NCT02081859|11797171|FG001|Overall Study|No fertilization|2
7485286|NCT02081859|11797170|FG000|Overall Study|No sperm|1
7485287|NCT02081859|11797171|FG001|Overall Study|No sperm|0
7485288|NCT02081859|11797170|FG000|Overall Study|Unanticipated freeze all cycle|2
7485289|NCT02081859|11797171|FG001|Overall Study|Unanticipated freeze all cycle|6
7485290|NCT02081859|11797170|FG000|Overall Study|< 4 embryos|27
7485291|NCT02081859|11797171|FG001|Overall Study|< 4 embryos|23
7485292|NCT02081859|11797170|FG000|Overall Study|Other reasons|2
7485293|NCT02081859|11797171|FG001|Overall Study|Other reasons|0
7485294|NCT02082158|11797213|FG000|Overall Study|Withdrawal by Subject|0
7485295|NCT02082158|11797214|FG001|Overall Study|Withdrawal by Subject|0
7485296|NCT02082158|11797215|FG002|Overall Study|Withdrawal by Subject|0
7485297|NCT02082158|11797216|FG003|Overall Study|Withdrawal by Subject|0
7485298|NCT02082158|11797217|FG004|Overall Study|Withdrawal by Subject|1
7485299|NCT02082158|11797218|FG005|Overall Study|Withdrawal by Subject|0
7485300|NCT02082158|11797213|FG000|Overall Study|Failed Fit-testing|8
7485301|NCT02082158|11797214|FG001|Overall Study|Failed Fit-testing|8
7485302|NCT02082158|11797215|FG002|Overall Study|Failed Fit-testing|14
7485303|NCT02082158|11797216|FG003|Overall Study|Failed Fit-testing|4
7485304|NCT02082158|11797217|FG004|Overall Study|Failed Fit-testing|3
7485305|NCT02082158|11797218|FG005|Overall Study|Failed Fit-testing|7
7485306|NCT02082184|11797240|FG000|Overall Study|Adverse Event|1
7413074|NCT01422876|11685207|FG008|Week 24|Consent withdrawn|3
7413075|NCT01422876|11685208|FG009|Week 24|Consent withdrawn|6
7413076|NCT01422876|11685199|FG000|Week 24|Death|0
7413077|NCT01422876|11685200|FG001|Week 24|Death|1
7413078|NCT01422876|11685201|FG002|Week 24|Death|0
7413079|NCT01422876|11685202|FG003|Week 24|Death|0
7413080|NCT01422876|11685203|FG004|Week 24|Death|0
7413081|NCT01422876|11685204|FG005|Week 24|Death|0
7413082|NCT01422876|11685205|FG006|Week 24|Death|0
7413083|NCT01422876|11685206|FG007|Week 24|Death|0
7413084|NCT01422876|11685207|FG008|Week 24|Death|0
7413085|NCT01422876|11685208|FG009|Week 24|Death|0
7413086|NCT01422876|11685199|FG000|Week 52|Lost to Follow-up|3
7413087|NCT01422876|11685200|FG001|Week 52|Lost to Follow-up|5
7413088|NCT01422876|11685201|FG002|Week 52|Lost to Follow-up|7
7413089|NCT01422876|11685202|FG003|Week 52|Lost to Follow-up|5
7413090|NCT01422876|11685203|FG004|Week 52|Lost to Follow-up|8
7413091|NCT01422876|11685204|FG005|Week 52|Lost to Follow-up|5
7413092|NCT01422876|11685205|FG006|Week 52|Lost to Follow-up|5
7413093|NCT01422876|11685206|FG007|Week 52|Lost to Follow-up|8
7413094|NCT01422876|11685207|FG008|Week 52|Lost to Follow-up|7
7413095|NCT01422876|11685208|FG009|Week 52|Lost to Follow-up|8
7413096|NCT01422876|11685199|FG000|Week 52|Consent withdrawn|9
7413097|NCT01422876|11685200|FG001|Week 52|Consent withdrawn|4
7413098|NCT01422876|11685201|FG002|Week 52|Consent withdrawn|6
7413099|NCT01422876|11685202|FG003|Week 52|Consent withdrawn|12
7413100|NCT01422876|11685203|FG004|Week 52|Consent withdrawn|7
7413101|NCT01422876|11685204|FG005|Week 52|Consent withdrawn|12
7413102|NCT01422876|11685205|FG006|Week 52|Consent withdrawn|10
7413103|NCT01422876|11685206|FG007|Week 52|Consent withdrawn|12
7413104|NCT01422876|11685207|FG008|Week 52|Consent withdrawn|13
7413105|NCT01422876|11685208|FG009|Week 52|Consent withdrawn|9
7413106|NCT01422876|11685199|FG000|Week 52|Death|0
7413107|NCT01422876|11685200|FG001|Week 52|Death|1
7413108|NCT01422876|11685201|FG002|Week 52|Death|0
7413109|NCT01422876|11685202|FG003|Week 52|Death|1
7413110|NCT01422876|11685203|FG004|Week 52|Death|0
7413111|NCT01422876|11685204|FG005|Week 52|Death|0
7413112|NCT01422876|11685205|FG006|Week 52|Death|1
7413113|NCT01422876|11685206|FG007|Week 52|Death|3
7413114|NCT01422876|11685207|FG008|Week 52|Death|1
7413115|NCT01422876|11685208|FG009|Week 52|Death|0
7413116|NCT01422889|11685226|FG000|Overall Study|No Data Entered for Study Stent|9
7413117|NCT01422915|11685230|FG000|Overall Study|Adverse Event|1
7413118|NCT01423084|11685237|FG000|Overall Study|Adverse Event|0
7413119|NCT01423084|11685238|FG001|Overall Study|Adverse Event|1
7413120|NCT01423084|11685237|FG000|Overall Study|Withdrawal by Subject|2
7413121|NCT01423084|11685238|FG001|Overall Study|Withdrawal by Subject|3
7413122|NCT01423253|11685254|FG000|Overall Study|Adverse Event|2
7413123|NCT01423253|11685254|FG000|Overall Study|Lack of Efficacy|2
7413124|NCT01423253|11685254|FG000|Overall Study|Lost to Follow-up|1
7413125|NCT01423253|11685254|FG000|Overall Study|Protocol Violation|2
7413126|NCT01423253|11685254|FG000|Overall Study|Withdrawal by Subject|2
7413127|NCT01423604|11685261|FG000|Safety Run-In|Adverse Event|3
7413128|NCT01423604|11685262|FG001|Safety Run-In|Adverse Event|0
7413129|NCT01423604|11685261|FG000|Safety Run-In|Death|1
7413130|NCT01423604|11685262|FG001|Safety Run-In|Death|0
7413131|NCT01423604|11685261|FG000|Safety Run-In|Physician Decision|1
7413132|NCT01423604|11685262|FG001|Safety Run-In|Physician Decision|0
7413133|NCT01423604|11685261|FG000|Safety Run-In|Disease progression|3
7413134|NCT01423604|11685262|FG001|Safety Run-In|Disease progression|0
7413135|NCT01423604|11685261|FG000|Safety Run-In|Patient decision|1
7413136|NCT01423604|11685262|FG001|Safety Run-In|Patient decision|0
7413137|NCT01423604|11685261|FG000|Randomized|Adverse Event|4
7413138|NCT01423604|11685262|FG001|Randomized|Adverse Event|10
7413139|NCT01423604|11685261|FG000|Randomized|Death|1
7413140|NCT01423604|11685262|FG001|Randomized|Death|0
7413141|NCT01423604|11685261|FG000|Randomized|Physician Decision|16
7413142|NCT01423604|11685262|FG001|Randomized|Physician Decision|13
7413143|NCT01423604|11685261|FG000|Randomized|Other - unspecified|37
7413144|NCT01423604|11685262|FG001|Randomized|Other - unspecified|31
7413145|NCT01423604|11685261|FG000|Randomized|Patient decision|5
7413146|NCT01423604|11685262|FG001|Randomized|Patient decision|9
7485307|NCT02082184|11797241|FG001|Overall Study|Adverse Event|0
7485308|NCT02082184|11797240|FG000|Overall Study|Medical diagnosis|1
7485309|NCT02082184|11797241|FG001|Overall Study|Medical diagnosis|2
7485310|NCT02082184|11797240|FG000|Overall Study|Device associated symptoms|5
7485311|NCT02082184|11797241|FG001|Overall Study|Device associated symptoms|0
7485312|NCT02082184|11797240|FG000|Overall Study|Withdrawal by Subject|3
7485313|NCT02082184|11797241|FG001|Overall Study|Withdrawal by Subject|2
7485314|NCT02082184|11797240|FG000|Overall Study|Protocol Violation|0
7485315|NCT02082184|11797241|FG001|Overall Study|Protocol Violation|6
7485316|NCT02082184|11797240|FG000|Overall Study|Lost to Follow-up|0
7485317|NCT02082184|11797241|FG001|Overall Study|Lost to Follow-up|2
7485318|NCT02082184|11797240|FG000|Overall Study|Subject non-compliance|0
7485319|NCT02082184|11797241|FG001|Overall Study|Subject non-compliance|1
7485320|NCT02082210|11797253|FG000|Overall Study|Death|0
7485321|NCT02082210|11797254|FG001|Overall Study|Death|0
7485322|NCT02082210|11797255|FG002|Overall Study|Death|1
7485323|NCT02082210|11797256|FG003|Overall Study|Death|1
7485324|NCT02082210|11797257|FG004|Overall Study|Death|1
7485325|NCT02082210|11797258|FG005|Overall Study|Death|0
7485326|NCT02082210|11797253|FG000|Overall Study|Withdrawal by Subject|0
7485327|NCT02082210|11797254|FG001|Overall Study|Withdrawal by Subject|0
7485328|NCT02082210|11797255|FG002|Overall Study|Withdrawal by Subject|0
7485329|NCT02082210|11797256|FG003|Overall Study|Withdrawal by Subject|1
7485330|NCT02082210|11797257|FG004|Overall Study|Withdrawal by Subject|2
7485331|NCT02082210|11797258|FG005|Overall Study|Withdrawal by Subject|2
7485332|NCT02082210|11797253|FG000|Overall Study|Clinical Progression|0
7485333|NCT02082210|11797254|FG001|Overall Study|Clinical Progression|0
7485334|NCT02082210|11797255|FG002|Overall Study|Clinical Progression|0
7485335|NCT02082210|11797256|FG003|Overall Study|Clinical Progression|1
7485336|NCT02082210|11797257|FG004|Overall Study|Clinical Progression|0
7485337|NCT02082210|11797258|FG005|Overall Study|Clinical Progression|0
7485338|NCT02082210|11797253|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
7485339|NCT02082210|11797254|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
7485340|NCT02082210|11797255|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
7485341|NCT02082210|11797256|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
7485342|NCT02082210|11797257|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
7485343|NCT02082210|11797258|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
7485344|NCT02082210|11797253|FG000|Overall Study|Physician Decision|0
7485345|NCT02082210|11797254|FG001|Overall Study|Physician Decision|0
7485346|NCT02082210|11797255|FG002|Overall Study|Physician Decision|1
7485347|NCT02082210|11797256|FG003|Overall Study|Physician Decision|1
7485348|NCT02082210|11797257|FG004|Overall Study|Physician Decision|0
7485349|NCT02082210|11797258|FG005|Overall Study|Physician Decision|0
7485350|NCT02082262|11797284|FG000|Overall Study|Withdrawal by Subject|3
7485351|NCT02082262|11797284|FG000|Overall Study|Adverse Event|48
7485352|NCT02082340|11797294|FG000|Overall Study|Lost to Follow-up|1
7485353|NCT02082340|11797295|FG001|Overall Study|Lost to Follow-up|1
7485354|NCT02082483|11797312|FG000|Overall Study|Lost to Follow-up|1
7485355|NCT02082483|11797313|FG001|Overall Study|Lost to Follow-up|1
7485356|NCT02082483|11797312|FG000|Overall Study|Withdrawal by Subject|2
7485357|NCT02082483|11797313|FG001|Overall Study|Withdrawal by Subject|1
7485358|NCT02082483|11797312|FG000|Overall Study|Physician Decision|1
7485359|NCT02082483|11797313|FG001|Overall Study|Physician Decision|1
7485360|NCT02082483|11797312|FG000|Overall Study|Death|2
7485361|NCT02082483|11797313|FG001|Overall Study|Death|3
7485362|NCT02082522|11797322|FG000|Overall Study|Sponsor termination|5
7485363|NCT02082522|11797323|FG001|Overall Study|Sponsor termination|3
7485364|NCT02082522|11797322|FG000|Overall Study|Withdrawal by Subject|2
7485365|NCT02082522|11797323|FG001|Overall Study|Withdrawal by Subject|4
7485366|NCT02082522|11797322|FG000|Overall Study|Death|1
7485367|NCT02082522|11797323|FG001|Overall Study|Death|0
7485368|NCT02082522|11797322|FG000|Overall Study|Lost to Follow-up|1
7485369|NCT02082522|11797323|FG001|Overall Study|Lost to Follow-up|0
7485370|NCT02082522|11797322|FG000|Overall Study|Physician Decision|3
7485371|NCT02082522|11797323|FG001|Overall Study|Physician Decision|1
7485372|NCT02082522|11797322|FG000|Overall Study|Disease progression|2
7485373|NCT02082522|11797323|FG001|Overall Study|Disease progression|2
7485374|NCT02082522|11797322|FG000|Overall Study|Chemotherapy change|1
7485375|NCT02082522|11797323|FG001|Overall Study|Chemotherapy change|3
7485376|NCT02082912|11797366|FG000|Overall Study|Physician Decision|0
7485377|NCT02082912|11797367|FG001|Overall Study|Physician Decision|1
7485378|NCT02082977|11797383|FG000|Part 1 (Up to 3.2 Years)|Death|1
7485379|NCT02082977|11797384|FG001|Part 1 (Up to 3.2 Years)|Death|0
7485380|NCT02082977|11797385|FG002|Part 1 (Up to 3.2 Years)|Death|0
7485381|NCT02082977|11797386|FG003|Part 1 (Up to 3.2 Years)|Death|0
7485382|NCT02082977|11797387|FG004|Part 1 (Up to 3.2 Years)|Death|0
7485383|NCT02082977|11797388|FG005|Part 1 (Up to 3.2 Years)|Death|1
7485384|NCT02082977|11797389|FG006|Part 1 (Up to 3.2 Years)|Death|2
7485385|NCT02082977|11797390|FG007|Part 1 (Up to 3.2 Years)|Death|0
7485386|NCT02082977|11797391|FG008|Part 1 (Up to 3.2 Years)|Death|1
7485387|NCT02082977|11797392|FG009|Part 1 (Up to 3.2 Years)|Death|0
7485388|NCT02082977|11797383|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485389|NCT02082977|11797384|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485390|NCT02082977|11797385|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485391|NCT02082977|11797386|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485392|NCT02082977|11797387|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485393|NCT02082977|11797388|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485394|NCT02082977|11797389|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485395|NCT02082977|11797390|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
7485396|NCT02082977|11797391|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485397|NCT02082977|11797392|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
7485398|NCT02082977|11797383|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485399|NCT02082977|11797384|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485400|NCT02082977|11797385|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485401|NCT02082977|11797386|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485402|NCT02082977|11797387|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485403|NCT02082977|11797388|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
7485404|NCT02082977|11797389|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485405|NCT02082977|11797390|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485406|NCT02082977|11797391|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485407|NCT02082977|11797392|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
7485408|NCT02082977|11797383|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
7485409|NCT02082977|11797384|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
7485410|NCT02082977|11797385|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
7485411|NCT02082977|11797386|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
7485412|NCT02082977|11797387|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
7485413|NCT02082977|11797388|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
7485414|NCT02082977|11797389|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
7485415|NCT02082977|11797390|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
7485416|NCT02082977|11797391|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
7485417|NCT02082977|11797392|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
7485418|NCT02082977|11797383|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485419|NCT02082977|11797384|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485420|NCT02082977|11797385|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485421|NCT02082977|11797386|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485422|NCT02082977|11797387|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485423|NCT02082977|11797388|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485424|NCT02082977|11797389|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485425|NCT02082977|11797390|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
7485426|NCT02082977|11797391|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485427|NCT02082977|11797392|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
7485428|NCT02083185|11797440|FG000|Overall Study|Lost to Follow-up|0
7485429|NCT02083185|11797441|FG001|Overall Study|Lost to Follow-up|3
7485430|NCT02083185|11797442|FG002|Overall Study|Lost to Follow-up|0
7485431|NCT02083185|11797440|FG000|Overall Study|Withdrawal by Subject|9
7485432|NCT02083185|11797441|FG001|Overall Study|Withdrawal by Subject|15
7485433|NCT02083185|11797442|FG002|Overall Study|Withdrawal by Subject|1
7485434|NCT02083185|11797440|FG000|Overall Study|Death|2
7485435|NCT02083185|11797441|FG001|Overall Study|Death|2
7485436|NCT02083185|11797442|FG002|Overall Study|Death|1
7485437|NCT02083185|11797440|FG000|Overall Study|Reason not Specified|9
7485438|NCT02083185|11797441|FG001|Overall Study|Reason not Specified|6
7485439|NCT02083185|11797442|FG002|Overall Study|Reason not Specified|5
7485440|NCT02083185|11797440|FG000|Overall Study|Study Terminated by Sponsor|0
7485441|NCT02083185|11797441|FG001|Overall Study|Study Terminated by Sponsor|1
7485442|NCT02083185|11797442|FG002|Overall Study|Study Terminated by Sponsor|0
7485443|NCT02083185|11797440|FG000|Overall Study|Did not Receive Study Drug|0
7485444|NCT02083185|11797441|FG001|Overall Study|Did not Receive Study Drug|2
7485445|NCT02083185|11797442|FG002|Overall Study|Did not Receive Study Drug|0
7485446|NCT02083380|11797462|FG000|Overall Study|Lack of Efficacy|68
7485447|NCT02083380|11797463|FG001|Overall Study|Lack of Efficacy|79
7485448|NCT02083380|11797464|FG002|Overall Study|Lack of Efficacy|64
7485449|NCT02083380|11797462|FG000|Overall Study|Withdrawal by Subject|9
7485450|NCT02083380|11797463|FG001|Overall Study|Withdrawal by Subject|3
7485451|NCT02083380|11797464|FG002|Overall Study|Withdrawal by Subject|7
7485452|NCT02083380|11797462|FG000|Overall Study|Physician Decision|1
7485453|NCT02083380|11797463|FG001|Overall Study|Physician Decision|6
7485454|NCT02083380|11797464|FG002|Overall Study|Physician Decision|3
7485455|NCT02083380|11797462|FG000|Overall Study|Adverse Event|0
7485456|NCT02083380|11797463|FG001|Overall Study|Adverse Event|0
7485457|NCT02083380|11797464|FG002|Overall Study|Adverse Event|1
7485458|NCT02083380|11797462|FG000|Overall Study|Lost to Follow-up|5
7485459|NCT02083380|11797463|FG001|Overall Study|Lost to Follow-up|3
7485460|NCT02083380|11797464|FG002|Overall Study|Lost to Follow-up|3
7485461|NCT02083380|11797462|FG000|Overall Study|Other|8
7485462|NCT02083380|11797463|FG001|Overall Study|Other|4
7485463|NCT02083380|11797464|FG002|Overall Study|Other|6
7485464|NCT02083653|11797493|FG000|Overall Study|Randomized but not Treated|0
7485465|NCT02083653|11797494|FG001|Overall Study|Randomized but not Treated|2
7485466|NCT02083653|11797495|FG002|Overall Study|Randomized but not Treated|7
7485467|NCT02083653|11797493|FG000|Overall Study|Adverse Event|12
7485468|NCT02083653|11797494|FG001|Overall Study|Adverse Event|5
7485469|NCT02083653|11797495|FG002|Overall Study|Adverse Event|4
7485470|NCT02083653|11797493|FG000|Overall Study|Lost to Follow-up|1
7485471|NCT02083653|11797494|FG001|Overall Study|Lost to Follow-up|0
7485472|NCT02083653|11797495|FG002|Overall Study|Lost to Follow-up|0
7485473|NCT02083653|11797493|FG000|Overall Study|Death|2
7485474|NCT02083653|11797494|FG001|Overall Study|Death|2
7485475|NCT02083653|11797495|FG002|Overall Study|Death|2
7485476|NCT02083653|11797493|FG000|Overall Study|Progressive Disease|65
7485477|NCT02083653|11797494|FG001|Overall Study|Progressive Disease|73
7485478|NCT02083653|11797495|FG002|Overall Study|Progressive Disease|63
7485479|NCT02083653|11797493|FG000|Overall Study|Withdrawal by Subject|2
7485480|NCT02083653|11797494|FG001|Overall Study|Withdrawal by Subject|1
7485481|NCT02083653|11797495|FG002|Overall Study|Withdrawal by Subject|2
7485482|NCT02083653|11797493|FG000|Overall Study|Other Events|0
7485483|NCT02083653|11797494|FG001|Overall Study|Other Events|2
7485484|NCT02083653|11797495|FG002|Overall Study|Other Events|2
7485485|NCT02083653|11797493|FG000|Overall Study|Reason Missing|0
7485486|NCT02083653|11797494|FG001|Overall Study|Reason Missing|0
7485487|NCT02083653|11797495|FG002|Overall Study|Reason Missing|4
7485488|NCT02083783|11797522|FG000|Overall Study|Withdrawal by Subject|1
7485489|NCT02083783|11797523|FG001|Overall Study|Withdrawal by Subject|0
7485490|NCT02083926|11797553|FG000|Overall Study|Withdrawal by Subject|1
7485491|NCT02083926|11797554|FG001|Overall Study|Withdrawal by Subject|0
7485492|NCT02083965|11797563|FG000|Treatment Period|Other|1
7485493|NCT02083965|11797564|FG001|Treatment Period|Other|0
7485494|NCT02084056|11797574|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7485495|NCT02084056|11797575|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7485496|NCT02084056|11797576|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7485497|NCT02084056|11797577|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7485498|NCT02084056|11797574|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7485499|NCT02084056|11797575|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485500|NCT02084056|11797576|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485501|NCT02084056|11797577|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485502|NCT02084082|11797598|FG000|Washout Period 1 (35 Days)|Adverse Event|0
7485503|NCT02084082|11797599|FG001|Washout Period 1 (35 Days)|Adverse Event|0
7485504|NCT02084082|11797600|FG002|Washout Period 1 (35 Days)|Adverse Event|1
7485505|NCT02084082|11797601|FG003|Washout Period 1 (35 Days)|Adverse Event|1
7485506|NCT02084082|11797598|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485507|NCT02084082|11797599|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485508|NCT02084082|11797600|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
7485509|NCT02084082|11797601|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
7485510|NCT02084134|11797613|FG000|Overall Study|Protocol Violation|4
7485511|NCT02084134|11797614|FG001|Overall Study|Protocol Violation|2
7485512|NCT02084134|11797613|FG000|Overall Study|Death|0
7485513|NCT02084134|11797614|FG001|Overall Study|Death|1
7534800|NCT02703311|11882022|FG000|Overall Study|Withdrawal by Subject|3
7534801|NCT02703324|11882026|FG000|Period Two|Withdrawal by Subject|0
7534802|NCT02703324|11882027|FG001|Period Two|Withdrawal by Subject|0
7534803|NCT02703324|11882028|FG002|Period Two|Withdrawal by Subject|1
7534804|NCT02703324|11882029|FG003|Period Two|Withdrawal by Subject|0
7534805|NCT02703324|11882030|FG004|Period Two|Withdrawal by Subject|0
7534806|NCT02703324|11882031|FG005|Period Two|Withdrawal by Subject|0
7534807|NCT02703337|11882040|FG000|Period One (Part A)|Withdrawal by Subject|0
7534808|NCT02703337|11882041|FG001|Period One (Part A)|Withdrawal by Subject|0
7534809|NCT02703337|11882042|FG002|Period One (Part A)|Withdrawal by Subject|0
7534810|NCT02703337|11882043|FG003|Period One (Part A)|Withdrawal by Subject|0
7534811|NCT02703337|11882044|FG004|Period One (Part A)|Withdrawal by Subject|1
7534812|NCT02703337|11882045|FG005|Period One (Part A)|Withdrawal by Subject|0
7534813|NCT02703337|11882046|FG006|Period One (Part A)|Withdrawal by Subject|0
7534814|NCT02703337|11882047|FG007|Period One (Part A)|Withdrawal by Subject|0
7534815|NCT02703454|11882092|FG000|Overall Study|Not treated|1
7534816|NCT02703454|11882093|FG001|Overall Study|Not treated|3
7534817|NCT02703454|11882092|FG000|Overall Study|Withdrawal by Subject|4
7534818|NCT02703454|11882093|FG001|Overall Study|Withdrawal by Subject|3
7534819|NCT02703454|11882092|FG000|Overall Study|Lost to Follow-up|1
7534820|NCT02703454|11882093|FG001|Overall Study|Lost to Follow-up|2
7534821|NCT02703454|11882092|FG000|Overall Study|Study discontinuation|5
7534822|NCT02703454|11882093|FG001|Overall Study|Study discontinuation|8
7534823|NCT02703532|11882120|FG000|Overall Study|Withdrawal by Subject|0
7534824|NCT02703532|11882121|FG001|Overall Study|Withdrawal by Subject|1
7534825|NCT02703532|11882122|FG002|Overall Study|Withdrawal by Subject|0
7534826|NCT02703532|11882123|FG003|Overall Study|Withdrawal by Subject|1
7534827|NCT02703532|11882120|FG000|Overall Study|Lost to Follow-up|2
7534828|NCT02703532|11882121|FG001|Overall Study|Lost to Follow-up|0
7534829|NCT02703532|11882122|FG002|Overall Study|Lost to Follow-up|2
7534830|NCT02703532|11882123|FG003|Overall Study|Lost to Follow-up|0
7534831|NCT02703636|11882133|FG000|Overall Study|Adverse Event|14
7534832|NCT02703636|11882133|FG000|Overall Study|Study stopped by sponsor|1
7534833|NCT02703636|11882133|FG000|Overall Study|Withdrawal by Subject|1
7534834|NCT02704091|11882180|FG000|Overall Study|Adverse Event|4
7485514|NCT02084238|11797624|FG000|Overall Study|Lost to Follow-up|2
7485515|NCT02085135|11797680|FG000|Overall Study|Adverse Event|4
7485516|NCT02085135|11797681|FG001|Overall Study|Adverse Event|7
7485517|NCT02085135|11797680|FG000|Overall Study|Lost to Follow-up|2
7485518|NCT02085135|11797681|FG001|Overall Study|Lost to Follow-up|2
7485519|NCT02085135|11797680|FG000|Overall Study|Withdrawal by Subject|3
7485520|NCT02085135|11797681|FG001|Overall Study|Withdrawal by Subject|0
7485521|NCT02085135|11797680|FG000|Overall Study|Lack of Efficacy|2
7485522|NCT02085135|11797681|FG001|Overall Study|Lack of Efficacy|0
7485523|NCT02085161|11797691|FG000|Overall Study|Not Treated|1
7485524|NCT02085161|11797692|FG001|Overall Study|Not Treated|0
7485525|NCT02085161|11797693|FG002|Overall Study|Not Treated|0
7485526|NCT02085161|11797694|FG003|Overall Study|Not Treated|0
7485527|NCT02085161|11797691|FG000|Overall Study|Adverse Event|8
7485528|NCT02085161|11797692|FG001|Overall Study|Adverse Event|5
7485529|NCT02085161|11797693|FG002|Overall Study|Adverse Event|4
7485530|NCT02085161|11797694|FG003|Overall Study|Adverse Event|5
7485531|NCT02085161|11797691|FG000|Overall Study|Protocol Violation|0
7485532|NCT02085161|11797692|FG001|Overall Study|Protocol Violation|1
7485533|NCT02085161|11797693|FG002|Overall Study|Protocol Violation|0
7485534|NCT02085161|11797694|FG003|Overall Study|Protocol Violation|1
7485535|NCT02085161|11797691|FG000|Overall Study|Withdrawal by Subject|2
7485536|NCT02085161|11797692|FG001|Overall Study|Withdrawal by Subject|4
7485537|NCT02085161|11797693|FG002|Overall Study|Withdrawal by Subject|0
7485538|NCT02085161|11797694|FG003|Overall Study|Withdrawal by Subject|3
7485539|NCT02085161|11797691|FG000|Overall Study|Other Reason|1
7485540|NCT02085161|11797692|FG001|Overall Study|Other Reason|0
7485541|NCT02085161|11797693|FG002|Overall Study|Other Reason|1
7485542|NCT02085161|11797694|FG003|Overall Study|Other Reason|1
7485543|NCT02085252|11797707|FG000|Overall Study|Withdrawal of Consent|1
7485544|NCT02085252|11797708|FG001|Overall Study|Withdrawal of Consent|0
7485545|NCT02085252|11797707|FG000|Overall Study|Adverse Event|0
7485546|NCT02085252|11797708|FG001|Overall Study|Adverse Event|1
7485547|NCT02085252|11797707|FG000|Overall Study|Discontinuation Due to Patient Decision|0
7485548|NCT02085252|11797708|FG001|Overall Study|Discontinuation Due to Patient Decision|1
7485549|NCT02085252|11797707|FG000|Overall Study|Reason Not Specified|0
7485550|NCT02085252|11797708|FG001|Overall Study|Reason Not Specified|1
7485551|NCT02085252|11797707|FG000|Overall Study|Reason Unknown|0
7485552|NCT02085252|11797708|FG001|Overall Study|Reason Unknown|1
7485553|NCT02085460|11797739|FG000|Overall Study|Adverse Event|2
7485554|NCT02085460|11797740|FG001|Overall Study|Adverse Event|2
7485555|NCT02085460|11797741|FG002|Overall Study|Adverse Event|1
7485556|NCT02085460|11797739|FG000|Overall Study|Physician Decision|1
7485557|NCT02085460|11797740|FG001|Overall Study|Physician Decision|1
7485558|NCT02085460|11797741|FG002|Overall Study|Physician Decision|2
7485559|NCT02085460|11797739|FG000|Overall Study|Withdrawal by Subject|11
7485560|NCT02085460|11797740|FG001|Overall Study|Withdrawal by Subject|5
7485561|NCT02085460|11797741|FG002|Overall Study|Withdrawal by Subject|7
7485562|NCT02085785|11797780|FG000|Overall Study|Withdrawal by Subject|2
7485563|NCT02085785|11797781|FG001|Overall Study|Withdrawal by Subject|1
7485564|NCT02085785|11797780|FG000|Overall Study|Lost to Follow-up|0
7485565|NCT02085785|11797781|FG001|Overall Study|Lost to Follow-up|1
7485566|NCT02086110|11797795|FG000|Overall Study|Withdrawal by Subject|1
7485567|NCT02086110|11797796|FG001|Overall Study|Withdrawal by Subject|1
7485568|NCT02086162|11797805|FG000|Overall Study|Withdrawal by Subject|4
7485569|NCT02086162|11797806|FG001|Overall Study|Withdrawal by Subject|4
7485570|NCT02086162|11797805|FG000|Overall Study|moved|1
7485571|NCT02086162|11797806|FG001|Overall Study|moved|1
7485572|NCT02086162|11797805|FG000|Overall Study|Lost to Follow-up|4
7485573|NCT02086162|11797806|FG001|Overall Study|Lost to Follow-up|2
7485574|NCT02086162|11797805|FG000|Overall Study|Death|1
7485575|NCT02086162|11797806|FG001|Overall Study|Death|0
7485576|NCT02086565|11797840|FG000|Overall Study|Lost to Follow-up|9
7485577|NCT02086565|11797841|FG001|Overall Study|Lost to Follow-up|7
7485578|NCT02086565|11797840|FG000|Overall Study|Withdrawal by Subject|2
7485579|NCT02086565|11797841|FG001|Overall Study|Withdrawal by Subject|1
7485580|NCT02086565|11797840|FG000|Overall Study|Death|3
7485581|NCT02086565|11797841|FG001|Overall Study|Death|2
7485582|NCT02086565|11797840|FG000|Overall Study|withdrawn by research team|2
7485583|NCT02086565|11797841|FG001|Overall Study|withdrawn by research team|2
7485584|NCT02086591|11797847|FG000|Overall Study|Adverse Event|1
7485585|NCT02086591|11797847|FG000|Overall Study|Withdrawal by Subject|1
7485586|NCT02086591|11797847|FG000|Overall Study|protocol terminated|3
7485587|NCT02086968|11797885|FG000|Overall Study|Adverse Event|1
7485588|NCT02086968|11797886|FG001|Overall Study|Adverse Event|5
7485589|NCT02086968|11797885|FG000|Overall Study|Lost to Follow-up|2
7485590|NCT02086968|11797886|FG001|Overall Study|Lost to Follow-up|3
7485591|NCT02086968|11797885|FG000|Overall Study|Study drug received outside protocol|0
7485592|NCT02086968|11797886|FG001|Overall Study|Study drug received outside protocol|1
7485593|NCT02086968|11797885|FG000|Overall Study|Physician Decision|4
7485594|NCT02086968|11797886|FG001|Overall Study|Physician Decision|0
7485595|NCT02086968|11797885|FG000|Overall Study|Withdrawal by Subject|1
7485596|NCT02086968|11797886|FG001|Overall Study|Withdrawal by Subject|4
7485597|NCT02087046|11797892|FG000|Overall Study|Adverse Event|4
7485598|NCT02087046|11797892|FG000|Overall Study|Death|1
7485599|NCT02087046|11797892|FG000|Overall Study|Lost to Follow-up|3
7485600|NCT02087046|11797892|FG000|Overall Study|Withdrawal by Subject|2
7485601|NCT02087046|11797892|FG000|Overall Study|Physician Decision|1
7485602|NCT02087059|11797897|FG000|Overall Study|Disease Progression|1
7485603|NCT02087059|11797897|FG000|Overall Study|Adverse Event|5
7485604|NCT02087059|11797897|FG000|Overall Study|Lost to Follow-up|1
7485605|NCT02087085|11797903|FG000|Overall Study|Adverse Event|10
7485606|NCT02087085|11797904|FG001|Overall Study|Adverse Event|14
7485607|NCT02087085|11797903|FG000|Overall Study|Lack of Efficacy|4
7485608|NCT02087085|11797904|FG001|Overall Study|Lack of Efficacy|3
7485609|NCT02087085|11797903|FG000|Overall Study|Lost to Follow-up|6
7485610|NCT02087085|11797904|FG001|Overall Study|Lost to Follow-up|4
7485611|NCT02087085|11797903|FG000|Overall Study|Withdrawal by Subject|9
7485612|NCT02087085|11797904|FG001|Overall Study|Withdrawal by Subject|11
7485613|NCT02087085|11797903|FG000|Overall Study|Protocol Violation|1
7485614|NCT02087085|11797904|FG001|Overall Study|Protocol Violation|0
7485615|NCT02087085|11797903|FG000|Overall Study|Study Terminated by Sponsor|87
7485616|NCT02087085|11797904|FG001|Overall Study|Study Terminated by Sponsor|80
7485617|NCT02087085|11797903|FG000|Overall Study|Other Miscellaneous Reasons|3
7485618|NCT02087085|11797904|FG001|Overall Study|Other Miscellaneous Reasons|4
7485619|NCT02087150|11797913|FG000|Overall Study|Death|0
7485620|NCT02087150|11797914|FG001|Overall Study|Death|1
7485621|NCT02087150|11797915|FG002|Overall Study|Death|0
7485622|NCT02087150|11797913|FG000|Overall Study|Lost to Follow-up|6
7485623|NCT02087150|11797914|FG001|Overall Study|Lost to Follow-up|13
7485624|NCT02087150|11797915|FG002|Overall Study|Lost to Follow-up|7
7485625|NCT02087150|11797913|FG000|Overall Study|Withdrawal by Subject|2
7485626|NCT02087150|11797914|FG001|Overall Study|Withdrawal by Subject|5
7485627|NCT02087150|11797915|FG002|Overall Study|Withdrawal by Subject|3
7485628|NCT02087150|11797913|FG000|Overall Study|Physician Decision|0
7485629|NCT02087150|11797914|FG001|Overall Study|Physician Decision|1
7485630|NCT02087150|11797915|FG002|Overall Study|Physician Decision|0
7485631|NCT02087150|11797913|FG000|Overall Study|Procedure not done|1
7485632|NCT02087150|11797914|FG001|Overall Study|Procedure not done|13
7485633|NCT02087150|11797915|FG002|Overall Study|Procedure not done|0
7485634|NCT02087150|11797913|FG000|Overall Study|F/U not completed w/in study window|0
7485635|NCT02087150|11797914|FG001|Overall Study|F/U not completed w/in study window|0
7485636|NCT02087150|11797915|FG002|Overall Study|F/U not completed w/in study window|1
7485637|NCT02087150|11797913|FG000|Overall Study|Other|1
7485638|NCT02087150|11797914|FG001|Overall Study|Other|0
7485639|NCT02087150|11797915|FG002|Overall Study|Other|0
7485640|NCT02087150|11797913|FG000|Overall Study|Pt moved out of town|0
7485641|NCT02087150|11797914|FG001|Overall Study|Pt moved out of town|1
7485642|NCT02087150|11797915|FG002|Overall Study|Pt moved out of town|0
7485643|NCT02087176|11797928|FG000|Overall Study|Withdrawal by Subject|1
7485644|NCT02087176|11797928|FG000|Overall Study|Death|10
7485645|NCT02087176|11797928|FG000|Overall Study|Censored|19
7485646|NCT02087176|11797928|FG000|Overall Study|Study Terminated by Sponsor|2
7485647|NCT02087241|11797936|FG000|Overall Study|Death|2
7485648|NCT02087241|11797937|FG001|Overall Study|Death|1
7485649|NCT02087241|11797938|FG002|Overall Study|Death|1
7485650|NCT02087241|11797939|FG003|Overall Study|Death|1
7485651|NCT02087241|11797936|FG000|Overall Study|Withdrawal by Subject|1
7485652|NCT02087241|11797937|FG001|Overall Study|Withdrawal by Subject|0
7485653|NCT02087241|11797938|FG002|Overall Study|Withdrawal by Subject|0
7485654|NCT02087241|11797939|FG003|Overall Study|Withdrawal by Subject|1
7485655|NCT02087241|11797936|FG000|Overall Study|Progressive Disease|0
7485656|NCT02087241|11797937|FG001|Overall Study|Progressive Disease|0
7485657|NCT02087241|11797938|FG002|Overall Study|Progressive Disease|0
7485658|NCT02087241|11797939|FG003|Overall Study|Progressive Disease|1
7485659|NCT02087241|11797936|FG000|Overall Study|Study Terminated by Sponsor|0
7485660|NCT02087241|11797937|FG001|Overall Study|Study Terminated by Sponsor|2
7485661|NCT02087241|11797938|FG002|Overall Study|Study Terminated by Sponsor|0
7485662|NCT02087241|11797939|FG003|Overall Study|Study Terminated by Sponsor|4
7485663|NCT02087670|11797992|FG000|Overall Study|Withdrawal by Subject|3
7485664|NCT02087670|11797993|FG001|Overall Study|Withdrawal by Subject|2
7485665|NCT02087774|11798009|FG000|Overall Study|Were absent day of data collection|8
7485666|NCT02087774|11798010|FG001|Overall Study|Were absent day of data collection|20
7485667|NCT02087904|11798020|FG000|Overall Study|Did Not Receive Study Drug|0
7485668|NCT02087904|11798021|FG001|Overall Study|Did Not Receive Study Drug|0
7485669|NCT02087904|11798022|FG002|Overall Study|Did Not Receive Study Drug|2
7485670|NCT02087904|11798023|FG003|Overall Study|Did Not Receive Study Drug|1
7485671|NCT02087904|11798020|FG000|Overall Study|Adverse Event|8
7485672|NCT02087904|11798021|FG001|Overall Study|Adverse Event|4
7485673|NCT02087904|11798022|FG002|Overall Study|Adverse Event|4
7485674|NCT02087904|11798023|FG003|Overall Study|Adverse Event|12
7485675|NCT02087904|11798020|FG000|Overall Study|Lack of Efficacy|3
7485676|NCT02087904|11798021|FG001|Overall Study|Lack of Efficacy|6
7485677|NCT02087904|11798022|FG002|Overall Study|Lack of Efficacy|3
7485678|NCT02087904|11798023|FG003|Overall Study|Lack of Efficacy|2
7485679|NCT02087904|11798020|FG000|Overall Study|Other|6
7485680|NCT02087904|11798021|FG001|Overall Study|Other|2
7485681|NCT02087904|11798022|FG002|Overall Study|Other|4
7485682|NCT02087904|11798023|FG003|Overall Study|Other|4
7485683|NCT02087904|11798020|FG000|Overall Study|Withdrawal by Subject|8
7485684|NCT02087904|11798021|FG001|Overall Study|Withdrawal by Subject|3
7485685|NCT02087904|11798022|FG002|Overall Study|Withdrawal by Subject|7
7485686|NCT02087904|11798023|FG003|Overall Study|Withdrawal by Subject|4
7485687|NCT02087904|11798020|FG000|Overall Study|Lost to Follow-up|0
7485688|NCT02087904|11798021|FG001|Overall Study|Lost to Follow-up|4
7485689|NCT02087904|11798022|FG002|Overall Study|Lost to Follow-up|2
7485690|NCT02087904|11798023|FG003|Overall Study|Lost to Follow-up|2
7485691|NCT02087943|11798036|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
7485692|NCT02087943|11798037|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
7485693|NCT02087943|11798038|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
7485694|NCT02087943|11798039|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7485695|NCT02087943|11798040|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
7485696|NCT02087943|11798036|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
7485697|NCT02087943|11798037|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
7485698|NCT02087943|11798038|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
7485699|NCT02087943|11798039|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7485700|NCT02087943|11798040|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
7485701|NCT02087943|11798036|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
7485702|NCT02087943|11798037|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7485703|NCT02087943|11798038|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
7485704|NCT02087943|11798039|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7485705|NCT02087943|11798040|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
7485706|NCT02087943|11798036|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7485707|NCT02087943|11798037|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7485708|NCT02087943|11798038|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
7485709|NCT02087943|11798039|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7485710|NCT02087943|11798040|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
7485711|NCT02087943|11798036|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7485712|NCT02087943|11798037|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
7485713|NCT02087943|11798038|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7485714|NCT02087943|11798039|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7485715|NCT02087943|11798040|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
7485716|NCT02087943|11798036|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
7485717|NCT02087943|11798037|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
7485718|NCT02087943|11798038|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
7485719|NCT02087943|11798039|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
7485720|NCT02087943|11798040|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
7485721|NCT02087943|11798036|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7485722|NCT02087943|11798037|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
7485723|NCT02087943|11798038|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7485724|NCT02087943|11798039|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
7485725|NCT02087943|11798040|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
7485726|NCT02087943|11798036|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7485727|NCT02087943|11798037|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7485728|NCT02087943|11798038|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
7485729|NCT02087943|11798039|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7485730|NCT02087943|11798040|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
7485731|NCT02087943|11798036|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7485732|NCT02087943|11798037|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7485733|NCT02087943|11798038|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7485734|NCT02087943|11798039|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
7485735|NCT02087943|11798040|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
7485736|NCT02087943|11798036|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
7485737|NCT02087943|11798037|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
7485738|NCT02087943|11798038|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
7485739|NCT02087943|11798039|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
7485826|NCT02088541|11798139|FG001|Overall Study|Study terminated by sponsor|1
7485740|NCT02087943|11798040|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
7485741|NCT02088034|11798070|FG000|Overall Study|Lost to Follow-up|1
7485742|NCT02088034|11798071|FG001|Overall Study|Lost to Follow-up|1
7485743|NCT02088034|11798072|FG002|Overall Study|Lost to Follow-up|0
7485744|NCT02088034|11798070|FG000|Overall Study|Pregnancy|2
7485745|NCT02088034|11798071|FG001|Overall Study|Pregnancy|1
7485746|NCT02088034|11798072|FG002|Overall Study|Pregnancy|2
7485747|NCT02088047|11798082|FG000|Overall Study|Withdrawal by Subject|1
7485748|NCT02088047|11798083|FG001|Overall Study|Withdrawal by Subject|0
7485749|NCT02088073|11798094|FG000|Acute Phase|Withdrawal by Subject|5
7485750|NCT02088073|11798095|FG001|Acute Phase|Withdrawal by Subject|0
7485751|NCT02088073|11798096|FG002|Acute Phase|Withdrawal by Subject|0
7485752|NCT02088073|11798097|FG003|Acute Phase|Withdrawal by Subject|0
7485753|NCT02088073|11798098|FG004|Acute Phase|Withdrawal by Subject|0
7485754|NCT02088073|11798094|FG000|Acute Phase|Hyperkalemia|2
7485755|NCT02088073|11798095|FG001|Acute Phase|Hyperkalemia|0
7485756|NCT02088073|11798096|FG002|Acute Phase|Hyperkalemia|0
7485757|NCT02088073|11798097|FG003|Acute Phase|Hyperkalemia|0
7485758|NCT02088073|11798098|FG004|Acute Phase|Hyperkalemia|0
7485759|NCT02088073|11798094|FG000|Maintanance Phase|Withdrawal by Subject|0
7485760|NCT02088073|11798095|FG001|Maintanance Phase|Withdrawal by Subject|2
7485761|NCT02088073|11798096|FG002|Maintanance Phase|Withdrawal by Subject|0
7485762|NCT02088073|11798097|FG003|Maintanance Phase|Withdrawal by Subject|0
7485763|NCT02088073|11798098|FG004|Maintanance Phase|Withdrawal by Subject|0
7485764|NCT02088073|11798094|FG000|Maintanance Phase|Adverse Event|0
7485765|NCT02088073|11798095|FG001|Maintanance Phase|Adverse Event|0
7485766|NCT02088073|11798096|FG002|Maintanance Phase|Adverse Event|3
7485767|NCT02088073|11798097|FG003|Maintanance Phase|Adverse Event|0
7485768|NCT02088073|11798098|FG004|Maintanance Phase|Adverse Event|1
7485769|NCT02088073|11798094|FG000|Maintanance Phase|Physician Decision|0
7485770|NCT02088073|11798095|FG001|Maintanance Phase|Physician Decision|0
7485771|NCT02088073|11798096|FG002|Maintanance Phase|Physician Decision|0
7485772|NCT02088073|11798097|FG003|Maintanance Phase|Physician Decision|0
7485773|NCT02088073|11798098|FG004|Maintanance Phase|Physician Decision|1
7485774|NCT02088073|11798094|FG000|Maintanance Phase|Sponsor's decision|0
7485775|NCT02088073|11798095|FG001|Maintanance Phase|Sponsor's decision|2
7485776|NCT02088073|11798096|FG002|Maintanance Phase|Sponsor's decision|0
7485777|NCT02088073|11798097|FG003|Maintanance Phase|Sponsor's decision|2
7485778|NCT02088073|11798098|FG004|Maintanance Phase|Sponsor's decision|1
7485779|NCT02088073|11798094|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
7485780|NCT02088073|11798095|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
7485781|NCT02088073|11798096|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
7485782|NCT02088073|11798097|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
7485783|NCT02088073|11798098|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
7485784|NCT02088073|11798094|FG000|Maintanance Phase|Miscellaneous|0
7485785|NCT02088073|11798095|FG001|Maintanance Phase|Miscellaneous|2
7485786|NCT02088073|11798096|FG002|Maintanance Phase|Miscellaneous|1
7485787|NCT02088073|11798097|FG003|Maintanance Phase|Miscellaneous|2
7485788|NCT02088073|11798098|FG004|Maintanance Phase|Miscellaneous|1
7485789|NCT02088073|11798094|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
7485790|NCT02088073|11798095|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
7485791|NCT02088073|11798096|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
7485792|NCT02088073|11798097|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
7485793|NCT02088073|11798098|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
7485794|NCT02088073|11798094|FG000|Maintanance Phase|Subject compliance|0
7485795|NCT02088073|11798095|FG001|Maintanance Phase|Subject compliance|1
7485796|NCT02088073|11798096|FG002|Maintanance Phase|Subject compliance|0
7485797|NCT02088073|11798097|FG003|Maintanance Phase|Subject compliance|0
7485798|NCT02088073|11798098|FG004|Maintanance Phase|Subject compliance|0
7485799|NCT02088177|11798111|FG000|Overall Study|Lost to Follow-up|3
7485800|NCT02088541|11798138|FG000|Overall Study|Adverse Event|3
7485801|NCT02088541|11798139|FG001|Overall Study|Adverse Event|0
7485802|NCT02088541|11798140|FG002|Overall Study|Adverse Event|3
7485803|NCT02088541|11798141|FG003|Overall Study|Adverse Event|3
7485804|NCT02088541|11798142|FG004|Overall Study|Adverse Event|0
7485805|NCT02088541|11798138|FG000|Overall Study|Death|51
7485806|NCT02088541|11798139|FG001|Overall Study|Death|21
7485807|NCT02088541|11798140|FG002|Overall Study|Death|85
7485808|NCT02088541|11798141|FG003|Overall Study|Death|28
7485809|NCT02088541|11798142|FG004|Overall Study|Death|38
7485810|NCT02088541|11798138|FG000|Overall Study|Lost to Follow-up|2
7485811|NCT02088541|11798139|FG001|Overall Study|Lost to Follow-up|0
7485812|NCT02088541|11798140|FG002|Overall Study|Lost to Follow-up|1
7485813|NCT02088541|11798141|FG003|Overall Study|Lost to Follow-up|0
7485814|NCT02088541|11798142|FG004|Overall Study|Lost to Follow-up|0
7485815|NCT02088541|11798138|FG000|Overall Study|Physician Decision|2
7485816|NCT02088541|11798139|FG001|Overall Study|Physician Decision|1
7485817|NCT02088541|11798140|FG002|Overall Study|Physician Decision|2
7485818|NCT02088541|11798141|FG003|Overall Study|Physician Decision|0
7485819|NCT02088541|11798142|FG004|Overall Study|Physician Decision|2
7485820|NCT02088541|11798138|FG000|Overall Study|Disease progression|7
7485821|NCT02088541|11798139|FG001|Overall Study|Disease progression|1
7485822|NCT02088541|11798140|FG002|Overall Study|Disease progression|2
7485823|NCT02088541|11798141|FG003|Overall Study|Disease progression|3
7485824|NCT02088541|11798142|FG004|Overall Study|Disease progression|1
7485825|NCT02088541|11798138|FG000|Overall Study|Study terminated by sponsor|1
7485827|NCT02088541|11798140|FG002|Overall Study|Study terminated by sponsor|12
7485828|NCT02088541|11798141|FG003|Overall Study|Study terminated by sponsor|2
7485829|NCT02088541|11798142|FG004|Overall Study|Study terminated by sponsor|6
7485830|NCT02088541|11798138|FG000|Overall Study|Withdrawal by Subject|3
7485831|NCT02088541|11798139|FG001|Overall Study|Withdrawal by Subject|2
7485832|NCT02088541|11798140|FG002|Overall Study|Withdrawal by Subject|9
7485833|NCT02088541|11798141|FG003|Overall Study|Withdrawal by Subject|7
7485834|NCT02088541|11798142|FG004|Overall Study|Withdrawal by Subject|10
7485835|NCT02088541|11798138|FG000|Overall Study|Other|2
7485836|NCT02088541|11798139|FG001|Overall Study|Other|1
7485837|NCT02088541|11798140|FG002|Overall Study|Other|3
7485838|NCT02088541|11798141|FG003|Overall Study|Other|1
7485839|NCT02088541|11798142|FG004|Overall Study|Other|1
7485840|NCT02088697|11798154|FG000|Period I|Physician Decision|1
7485841|NCT02088697|11798155|FG001|Period I|Physician Decision|4
7485842|NCT02088697|11798154|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
7485843|NCT02088697|11798155|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
7485844|NCT02088905|11798172|FG000|Overall Study|Withdrawal by Subject|5
7485845|NCT02088905|11798173|FG001|Overall Study|Withdrawal by Subject|1
7485846|NCT02089230|11798198|FG000|Overall Study|Death|0
7485847|NCT02089230|11798199|FG001|Overall Study|Death|0
7485848|NCT02089230|11798200|FG002|Overall Study|Death|2
7485849|NCT02089230|11798198|FG000|Overall Study|Seeking Alternative Therapy|0
7485850|NCT02089230|11798199|FG001|Overall Study|Seeking Alternative Therapy|0
7485851|NCT02089230|11798200|FG002|Overall Study|Seeking Alternative Therapy|4
7485852|NCT02089334|11798212|FG000|Overall Study|Withdrawal by Subject|0
7485853|NCT02089334|11798213|FG001|Overall Study|Withdrawal by Subject|0
7485854|NCT02089334|11798214|FG002|Overall Study|Withdrawal by Subject|0
7485855|NCT02089334|11798215|FG003|Overall Study|Withdrawal by Subject|2
7485856|NCT02089334|11798212|FG000|Overall Study|Adverse Event|0
7485857|NCT02089334|11798213|FG001|Overall Study|Adverse Event|0
7485858|NCT02089334|11798214|FG002|Overall Study|Adverse Event|0
7485859|NCT02089334|11798215|FG003|Overall Study|Adverse Event|2
7485860|NCT02089334|11798212|FG000|Overall Study|Progressive disease|0
7485861|NCT02089334|11798213|FG001|Overall Study|Progressive disease|0
7485862|NCT02089334|11798214|FG002|Overall Study|Progressive disease|0
7485863|NCT02089334|11798215|FG003|Overall Study|Progressive disease|2
7485864|NCT02089334|11798212|FG000|Overall Study|Physician Decision|0
7485865|NCT02089334|11798213|FG001|Overall Study|Physician Decision|0
7485866|NCT02089334|11798214|FG002|Overall Study|Physician Decision|1
7485867|NCT02089334|11798215|FG003|Overall Study|Physician Decision|1
7485868|NCT02089347|11798230|FG000|Overall Study|Protocol Violation|1
7485869|NCT02089347|11798231|FG001|Overall Study|Protocol Violation|0
7485870|NCT02089737|11798256|FG000|Overall Study|Survey form not completed|5
7485871|NCT02089737|11798256|FG000|Overall Study|Not treated|1
7485872|NCT02089997|11798261|FG000|Overall Study|Case report forms uncollected|99
7485873|NCT02089997|11798261|FG000|Overall Study|Protocol Violation|147
7485874|NCT02090283|11798282|FG000|Overall Study|Withdrawal by Subject|6
7485875|NCT02090283|11798283|FG001|Overall Study|Withdrawal by Subject|6
7485876|NCT02090283|11798284|FG002|Overall Study|Withdrawal by Subject|6
7485877|NCT02090283|11798282|FG000|Overall Study|Sponsor Terminated Study|6
7485878|NCT02090283|11798283|FG001|Overall Study|Sponsor Terminated Study|6
7485879|NCT02090283|11798284|FG002|Overall Study|Sponsor Terminated Study|1
7485880|NCT02090283|11798282|FG000|Overall Study|Lost to Follow-up|2
7485881|NCT02090283|11798283|FG001|Overall Study|Lost to Follow-up|2
7485882|NCT02090283|11798284|FG002|Overall Study|Lost to Follow-up|3
7485883|NCT02090283|11798282|FG000|Overall Study|Adverse Event|1
7485884|NCT02090283|11798283|FG001|Overall Study|Adverse Event|1
7485885|NCT02090283|11798284|FG002|Overall Study|Adverse Event|0
7485886|NCT02090283|11798282|FG000|Overall Study|Protocol Violation|2
7485887|NCT02090283|11798283|FG001|Overall Study|Protocol Violation|0
7485888|NCT02090283|11798284|FG002|Overall Study|Protocol Violation|0
7485889|NCT02090413|11798328|FG000|Overall Study|Adverse Event|11
7485890|NCT02090413|11798329|FG001|Overall Study|Adverse Event|15
7485891|NCT02090413|11798330|FG002|Overall Study|Adverse Event|20
7485892|NCT02090413|11798328|FG000|Overall Study|Flushing event|2
7485893|NCT02090413|11798329|FG001|Overall Study|Flushing event|0
7485894|NCT02090413|11798330|FG002|Overall Study|Flushing event|1
7485895|NCT02090413|11798328|FG000|Overall Study|Withdrawal by Subject|2
7485896|NCT02090413|11798329|FG001|Overall Study|Withdrawal by Subject|2
7485897|NCT02090413|11798330|FG002|Overall Study|Withdrawal by Subject|2
7485898|NCT02090413|11798328|FG000|Overall Study|Investigator Decision|1
7485899|NCT02090413|11798329|FG001|Overall Study|Investigator Decision|1
7485900|NCT02090413|11798330|FG002|Overall Study|Investigator Decision|0
7485901|NCT02090413|11798328|FG000|Overall Study|Other|2
7485902|NCT02090413|11798329|FG001|Overall Study|Other|1
7485903|NCT02090413|11798330|FG002|Overall Study|Other|0
7485904|NCT02090413|11798328|FG000|Overall Study|Lost to Follow-up|1
7485905|NCT02090413|11798329|FG001|Overall Study|Lost to Follow-up|1
7485906|NCT02090413|11798330|FG002|Overall Study|Lost to Follow-up|0
7485907|NCT02090426|11798341|FG000|Overall Study|Lost to Follow-up|12
7485908|NCT02090426|11798342|FG001|Overall Study|Lost to Follow-up|6
7485909|NCT02090634|11798350|FG000|Overall Study|Lost to Follow-up|0
7485910|NCT02090634|11798351|FG001|Overall Study|Lost to Follow-up|1
7485911|NCT02090634|11798350|FG000|Overall Study|Death|0
7485912|NCT02090634|11798351|FG001|Overall Study|Death|1
7485913|NCT02090634|11798350|FG000|Overall Study|Protocol Violation|3
7485914|NCT02090634|11798351|FG001|Overall Study|Protocol Violation|1
7485915|NCT02090634|11798350|FG000|Overall Study|Adverse Event|2
7485916|NCT02090634|11798351|FG001|Overall Study|Adverse Event|0
7485917|NCT02090725|11798357|FG000|Overall Study|Withdrawal by Subject|1
7485918|NCT02090725|11798357|FG000|Overall Study|participants moved from area|3
7485919|NCT02090764|11798363|FG000|Overall Study|Adverse Event|1
7485920|NCT02090764|11798364|FG001|Overall Study|Adverse Event|3
7485921|NCT02090764|11798363|FG000|Overall Study|Lack of Efficacy|0
7485922|NCT02090764|11798364|FG001|Overall Study|Lack of Efficacy|13
7485923|NCT02090764|11798363|FG000|Overall Study|Withdrawal by Subject|2
7485924|NCT02090764|11798364|FG001|Overall Study|Withdrawal by Subject|1
7485925|NCT02090764|11798363|FG000|Overall Study|Intercurrent illness and other|1
7485926|NCT02090764|11798364|FG001|Overall Study|Intercurrent illness and other|1
7485927|NCT02090764|11798363|FG000|Overall Study|Lost to Follow-up|2
7485928|NCT02090764|11798364|FG001|Overall Study|Lost to Follow-up|2
7485929|NCT02090855|11798374|FG000|Overall Study|no evaluable Standard of Truth results|2
7485930|NCT02090959|11798385|FG000|Overall Study|Withdrawal by Subject|10
7485931|NCT02090959|11798385|FG000|Overall Study|Adverse Event|1
7485932|NCT02090959|11798385|FG000|Overall Study|Investigator decision|2
7485933|NCT02090959|11798385|FG000|Overall Study|Study termination|6
7485934|NCT02090959|11798385|FG000|Overall Study|Enrolled but not treated|1
7485935|NCT02090959|11798385|FG000|Overall Study|Transfer for compassionate use medicine|4
7485936|NCT02090959|11798385|FG000|Overall Study|Move to medical need program|3
7485937|NCT02090959|11798385|FG000|Overall Study|Entered in to other study|34
7485938|NCT02090959|11798385|FG000|Overall Study|Switched to commercial supply|88
7485939|NCT02090959|11798385|FG000|Overall Study|Other than specified|2
7485940|NCT02091089|11798389|FG000|Overall Study|Lost to Follow-up|2
7485941|NCT02091167|11798399|FG000|Overall Study|Lost to Follow-up|0
7485942|NCT02091167|11798400|FG001|Overall Study|Lost to Follow-up|2
7485959|NCT02091284|11798425|FG000|Overall Study|Withdrawal by Subject|2
7485960|NCT02091284|11798426|FG001|Overall Study|Withdrawal by Subject|1
7485961|NCT02091284|11798425|FG000|Overall Study|unreliable data|1
7485962|NCT02091284|11798426|FG001|Overall Study|unreliable data|0
7485963|NCT02091362|11798436|FG000|Period 1|Protocol Violation|1
7485964|NCT02091362|11798437|FG001|Period 1|Protocol Violation|0
7485965|NCT02091362|11798436|FG000|Period 1|Withdrawal by Subject|2
7485966|NCT02091362|11798437|FG001|Period 1|Withdrawal by Subject|3
7485967|NCT02091362|11798436|FG000|Period 1|Lost to Follow-up|0
7485968|NCT02091362|11798437|FG001|Period 1|Lost to Follow-up|1
7485969|NCT02091362|11798436|FG000|Period 1|Adverse Event|2
7485970|NCT02091362|11798437|FG001|Period 1|Adverse Event|0
7485971|NCT02091362|11798436|FG000|Wash-out|Lost to Follow-up|1
7485972|NCT02091362|11798437|FG001|Wash-out|Lost to Follow-up|1
7485973|NCT02091362|11798436|FG000|Wash-out|Withdrawal by Subject|0
7485974|NCT02091362|11798437|FG001|Wash-out|Withdrawal by Subject|2
7485975|NCT02091362|11798436|FG000|Period 2|Adverse Event|1
7485976|NCT02091362|11798437|FG001|Period 2|Adverse Event|0
7485977|NCT02091362|11798436|FG000|Period 2|Lost to Follow-up|0
7485978|NCT02091362|11798437|FG001|Period 2|Lost to Follow-up|1
7485979|NCT02091362|11798436|FG000|Period 2|Withdrawal by Subject|1
7485980|NCT02091362|11798437|FG001|Period 2|Withdrawal by Subject|1
7485989|NCT02091414|11798456|FG000|Overall Study|Withdrawal by Subject|2
7485990|NCT02091414|11798456|FG000|Overall Study|Death|2
7485991|NCT02091440|11798460|FG000|Overall Study|Death|2
7485992|NCT02091726|11798477|FG000|Overall Study|Lost to Follow-up|6
7485993|NCT02091739|11798484|FG000|MP: 16 Weeks|Adverse Event|1
7485994|NCT02091739|11798485|FG001|MP: 16 Weeks|Adverse Event|1
7485995|NCT02091739|11798486|FG002|MP: 16 Weeks|Adverse Event|1
7485996|NCT02091739|11798487|FG003|MP: 16 Weeks|Adverse Event|0
7485997|NCT02091739|11798488|FG004|MP: 16 Weeks|Adverse Event|0
7485998|NCT02091739|11798484|FG000|MP: 16 Weeks|Withdrawal by Subject|3
7485999|NCT02091739|11798485|FG001|MP: 16 Weeks|Withdrawal by Subject|4
7486000|NCT02091739|11798486|FG002|MP: 16 Weeks|Withdrawal by Subject|0
7486001|NCT02091739|11798487|FG003|MP: 16 Weeks|Withdrawal by Subject|0
7486002|NCT02091739|11798488|FG004|MP: 16 Weeks|Withdrawal by Subject|0
7486003|NCT02091739|11798484|FG000|MP: 16 Weeks|Lost to Follow-up|0
7486004|NCT02091739|11798485|FG001|MP: 16 Weeks|Lost to Follow-up|0
7486005|NCT02091739|11798486|FG002|MP: 16 Weeks|Lost to Follow-up|1
7486006|NCT02091739|11798487|FG003|MP: 16 Weeks|Lost to Follow-up|0
7486007|NCT02091739|11798488|FG004|MP: 16 Weeks|Lost to Follow-up|0
7486008|NCT02091739|11798484|FG000|EP: 48 Weeks|Other|0
7486009|NCT02091739|11798485|FG001|EP: 48 Weeks|Other|0
7486010|NCT02091739|11798486|FG002|EP: 48 Weeks|Other|0
7486011|NCT02091739|11798487|FG003|EP: 48 Weeks|Other|1
7486012|NCT02091739|11798488|FG004|EP: 48 Weeks|Other|0
7486013|NCT02091739|11798484|FG000|EP: 48 Weeks|Death|0
7486014|NCT02091739|11798485|FG001|EP: 48 Weeks|Death|0
7486015|NCT02091739|11798486|FG002|EP: 48 Weeks|Death|0
7486016|NCT02091739|11798487|FG003|EP: 48 Weeks|Death|3
7486017|NCT02091739|11798488|FG004|EP: 48 Weeks|Death|2
7486018|NCT02091739|11798484|FG000|EP: 48 Weeks|Adverse Event|0
7486019|NCT02091739|11798485|FG001|EP: 48 Weeks|Adverse Event|0
7486020|NCT02091739|11798486|FG002|EP: 48 Weeks|Adverse Event|0
7486021|NCT02091739|11798487|FG003|EP: 48 Weeks|Adverse Event|2
7486022|NCT02091739|11798488|FG004|EP: 48 Weeks|Adverse Event|6
7486023|NCT02091739|11798484|FG000|EP: 48 Weeks|Withdrawal by Subject|0
7486024|NCT02091739|11798485|FG001|EP: 48 Weeks|Withdrawal by Subject|0
7486025|NCT02091739|11798486|FG002|EP: 48 Weeks|Withdrawal by Subject|0
7486026|NCT02091739|11798487|FG003|EP: 48 Weeks|Withdrawal by Subject|2
7486027|NCT02091739|11798488|FG004|EP: 48 Weeks|Withdrawal by Subject|6
7486028|NCT02091869|11798517|FG000|Overall Study|Withdrawal by Subject|0
7486029|NCT02091869|11798518|FG001|Overall Study|Withdrawal by Subject|3
7486030|NCT02091921|11798528|FG000|Overall Study|Adverse Event|3
7486031|NCT02091986|11798538|FG000|Overall Study|7 rand in error 1 patient decision|2
7486032|NCT02091986|11798539|FG001|Overall Study|7 rand in error 1 patient decision|3
7486033|NCT02091986|11798540|FG002|Overall Study|7 rand in error 1 patient decision|3
7486034|NCT02091986|11798538|FG000|Overall Study|Lost to Follow-up|1
7486035|NCT02091986|11798539|FG001|Overall Study|Lost to Follow-up|0
7486036|NCT02091986|11798540|FG002|Overall Study|Lost to Follow-up|0
7486037|NCT02091986|11798538|FG000|Overall Study|Withdrawal by Subject|4
7486038|NCT02091986|11798539|FG001|Overall Study|Withdrawal by Subject|8
7486039|NCT02091986|11798540|FG002|Overall Study|Withdrawal by Subject|3
7486040|NCT02091986|11798538|FG000|Overall Study|Adverse Event|0
7486041|NCT02091986|11798539|FG001|Overall Study|Adverse Event|0
7486042|NCT02091986|11798540|FG002|Overall Study|Adverse Event|2
7486043|NCT02092025|11798548|FG000|Overall Study|Case Report Forms Uncollected|44
7486044|NCT02092025|11798548|FG000|Overall Study|Protocol Deviation|24
7486045|NCT02092116|11798554|FG000|Overall Study|Withdrawal by Subject|0
7486046|NCT02092116|11798555|FG001|Overall Study|Withdrawal by Subject|3
7486047|NCT02092116|11798554|FG000|Overall Study|Adverse Event|0
7486048|NCT02092116|11798555|FG001|Overall Study|Adverse Event|1
7486049|NCT02092220|11798579|FG000|Period 1|Unrelated Illness|0
7486050|NCT02092220|11798580|FG001|Period 1|Unrelated Illness|2
7486051|NCT02092220|11798579|FG000|Period 2|Severe Hypoglycaemia|1
7486052|NCT02092220|11798580|FG001|Period 2|Severe Hypoglycaemia|0
7486053|NCT02092220|11798579|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
7486054|NCT02092220|11798580|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
7534835|NCT02704091|11882181|FG001|Overall Study|Adverse Event|3
7534836|NCT02704091|11882180|FG000|Overall Study|Protocol Violation|5
7534837|NCT02704091|11882181|FG001|Overall Study|Protocol Violation|3
7534838|NCT02704091|11882180|FG000|Overall Study|Consent withdrawn|4
7534839|NCT02704091|11882181|FG001|Overall Study|Consent withdrawn|4
7534840|NCT02704091|11882180|FG000|Overall Study|Lost to Follow-up|13
7534841|NCT02704091|11882181|FG001|Overall Study|Lost to Follow-up|5
7534842|NCT02704091|11882180|FG000|Overall Study|Other|2
7534843|NCT02704091|11882181|FG001|Overall Study|Other|8
7534844|NCT02704143|11882195|FG000|Overall Study|disease progression|10
7534845|NCT02704689|11882199|FG000|Overall Study|Physician Decision|1
7534846|NCT02704689|11882199|FG000|Overall Study|Study device not implanted|2
7534867|NCT02705586|11882277|FG000|Overall Study|Health Issues|2
7534868|NCT02705586|11882277|FG000|Overall Study|Transportation Difficulties|5
7534869|NCT02705586|11882277|FG000|Overall Study|Vacation/Planned Absence|1
7534870|NCT02705625|11882284|FG000|Overall Study|Protocol Violation|1
7534871|NCT02705625|11882285|FG001|Overall Study|Protocol Violation|0
7534872|NCT02705625|11882286|FG002|Overall Study|Protocol Violation|0
7534873|NCT02705625|11882284|FG000|Overall Study|Adverse Event|6
7534874|NCT02705625|11882285|FG001|Overall Study|Adverse Event|5
7534875|NCT02705625|11882286|FG002|Overall Study|Adverse Event|2
7534876|NCT02705625|11882284|FG000|Overall Study|Death|0
7534877|NCT02705625|11882285|FG001|Overall Study|Death|0
7534878|NCT02705625|11882286|FG002|Overall Study|Death|1
7534879|NCT02705625|11882284|FG000|Overall Study|Withdrawal by Subject|1
7534880|NCT02705625|11882285|FG001|Overall Study|Withdrawal by Subject|4
7534881|NCT02705625|11882286|FG002|Overall Study|Withdrawal by Subject|5
7534882|NCT02705625|11882284|FG000|Overall Study|Lost to Follow-up|0
7534883|NCT02705625|11882285|FG001|Overall Study|Lost to Follow-up|0
7486055|NCT02092285|11798588|FG000|Induction Phase|Adverse Event|7
7486056|NCT02092285|11798588|FG000|Induction Phase|Physician Decision|4
7486057|NCT02092285|11798588|FG000|Induction Phase|Pregnancy|1
7486058|NCT02092285|11798588|FG000|Induction Phase|Relapse/Recurrence|7
7486059|NCT02092285|11798588|FG000|Induction Phase|Withdrawal by Subject|2
7486060|NCT02092285|11798588|FG000|Induction Phase|Lack of Efficacy|14
7486061|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Adverse Event|22
7486062|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
7486063|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
7486064|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Physician Decision|10
7486065|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Pregnancy|1
7486066|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
7486067|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
7486068|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
7486069|NCT02092285|11798588|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
7486070|NCT02092324|11798607|FG000|Overall Study|Adverse Event|1
7486071|NCT02092324|11798607|FG000|Overall Study|Lack of Efficacy|6
7486072|NCT02092324|11798607|FG000|Overall Study|Proceed to Transplant|3
7486073|NCT02092324|11798607|FG000|Overall Study|Physician Decision|7
7486074|NCT02092324|11798607|FG000|Overall Study|Misdiagnosis|2
7486075|NCT02092350|11798616|FG000|Overall Study|Adverse Event|0
7486076|NCT02092350|11798617|FG001|Overall Study|Adverse Event|3
7486077|NCT02092350|11798616|FG000|Overall Study|Death|2
7486078|NCT02092350|11798617|FG001|Overall Study|Death|5
7486079|NCT02092350|11798616|FG000|Overall Study|Lost to Follow-up|3
7486080|NCT02092350|11798617|FG001|Overall Study|Lost to Follow-up|1
7486081|NCT02092350|11798616|FG000|Overall Study|Protocol Violation|1
7486082|NCT02092350|11798617|FG001|Overall Study|Protocol Violation|0
7486083|NCT02092350|11798616|FG000|Overall Study|Physician Decision|1
7486084|NCT02092350|11798617|FG001|Overall Study|Physician Decision|1
7486085|NCT02092350|11798616|FG000|Overall Study|Screen Failure|1
7486086|NCT02092350|11798617|FG001|Overall Study|Screen Failure|0
7486087|NCT02092350|11798616|FG000|Overall Study|Withdrawal by Subject|2
7486088|NCT02092350|11798617|FG001|Overall Study|Withdrawal by Subject|2
7486089|NCT02092389|11798625|FG000|Overall Study|Adverse Event|1
7486090|NCT02092389|11798625|FG000|Overall Study|Other|5
7486091|NCT02092467|11798646|FG000|Overall Study|Death|49
7486092|NCT02092467|11798647|FG001|Overall Study|Death|66
7486093|NCT02092467|11798648|FG002|Overall Study|Death|38
7486094|NCT02092467|11798646|FG000|Overall Study|Lost to Follow-up|38
7486095|NCT02092467|11798647|FG001|Overall Study|Lost to Follow-up|35
7486096|NCT02092467|11798648|FG002|Overall Study|Lost to Follow-up|40
7486097|NCT02092467|11798646|FG000|Overall Study|Global Deterioration of Health Status|1
7486098|NCT02092467|11798647|FG001|Overall Study|Global Deterioration of Health Status|0
7486099|NCT02092467|11798648|FG002|Overall Study|Global Deterioration of Health Status|0
7486100|NCT02092467|11798646|FG000|Overall Study|Other|32
7486101|NCT02092467|11798647|FG001|Overall Study|Other|30
7486102|NCT02092467|11798648|FG002|Overall Study|Other|24
7486103|NCT02092467|11798646|FG000|Overall Study|Withdrawal by Subject|282
7486104|NCT02092467|11798647|FG001|Overall Study|Withdrawal by Subject|327
7486105|NCT02092467|11798648|FG002|Overall Study|Withdrawal by Subject|289
7486106|NCT02092467|11798646|FG000|Overall Study|Randomized but not treated|2
7486107|NCT02092467|11798647|FG001|Overall Study|Randomized but not treated|1
7486108|NCT02092467|11798648|FG002|Overall Study|Randomized but not treated|7
7486109|NCT02092662|11798678|FG000|Overall Study|Lost to Follow-up|13
7486110|NCT02092662|11798679|FG001|Overall Study|Lost to Follow-up|0
7486111|NCT02092909|11798703|FG000|Overall Study|Adverse Event|0
7486112|NCT02092909|11798704|FG001|Overall Study|Adverse Event|0
7486113|NCT02092909|11798705|FG002|Overall Study|Adverse Event|4
7486114|NCT02092909|11798706|FG003|Overall Study|Adverse Event|2
7486115|NCT02092909|11798703|FG000|Overall Study|Lack of Efficacy|0
7486116|NCT02092909|11798704|FG001|Overall Study|Lack of Efficacy|2
7486117|NCT02092909|11798705|FG002|Overall Study|Lack of Efficacy|1
7486118|NCT02092909|11798706|FG003|Overall Study|Lack of Efficacy|0
7486119|NCT02092909|11798703|FG000|Overall Study|Withdrawal by Subject|0
7486120|NCT02092909|11798704|FG001|Overall Study|Withdrawal by Subject|0
7486121|NCT02092909|11798705|FG002|Overall Study|Withdrawal by Subject|2
7486122|NCT02092909|11798706|FG003|Overall Study|Withdrawal by Subject|1
7486123|NCT02092909|11798703|FG000|Overall Study|Study terminated by Sponsor|0
7486124|NCT02092909|11798704|FG001|Overall Study|Study terminated by Sponsor|0
7486125|NCT02092909|11798705|FG002|Overall Study|Study terminated by Sponsor|0
7486126|NCT02092909|11798706|FG003|Overall Study|Study terminated by Sponsor|2
7486127|NCT02092909|11798703|FG000|Overall Study|Miscellaneous|1
7486128|NCT02092909|11798704|FG001|Overall Study|Miscellaneous|1
7486129|NCT02092909|11798705|FG002|Overall Study|Miscellaneous|2
7486130|NCT02092909|11798706|FG003|Overall Study|Miscellaneous|1
7486131|NCT02092961|11798719|FG000|Overall Study|Not reported|1
7486132|NCT02092961|11798720|FG001|Overall Study|Not reported|0
7486133|NCT02092961|11798721|FG002|Overall Study|Not reported|1
7486134|NCT02092961|11798719|FG000|Overall Study|Study stopped|13
7486135|NCT02092961|11798720|FG001|Overall Study|Study stopped|9
7486136|NCT02092961|11798721|FG002|Overall Study|Study stopped|12
7486137|NCT02092961|11798719|FG000|Overall Study|Lack of therapeutic response|2
7486138|NCT02092961|11798720|FG001|Overall Study|Lack of therapeutic response|1
7486139|NCT02092961|11798721|FG002|Overall Study|Lack of therapeutic response|3
7486140|NCT02092961|11798719|FG000|Overall Study|Dev. of study specific discont. criteria|3
7486141|NCT02092961|11798720|FG001|Overall Study|Dev. of study specific discont. criteria|0
7486142|NCT02092961|11798721|FG002|Overall Study|Dev. of study specific discont. criteria|0
7486143|NCT02092961|11798719|FG000|Overall Study|Adverse Event|2
7486144|NCT02092961|11798720|FG001|Overall Study|Adverse Event|4
7486145|NCT02092961|11798721|FG002|Overall Study|Adverse Event|0
7486146|NCT02093026|11798742|FG000|Overall Study|Adverse Event|26
7486147|NCT02093026|11798742|FG000|Overall Study|Death|10
7486148|NCT02093026|11798742|FG000|Overall Study|Other|157
7486149|NCT02093221|11798752|FG000|Overall Study|Adverse Event|1
7486150|NCT02093221|11798753|FG001|Overall Study|Adverse Event|0
7486151|NCT02093221|11798754|FG002|Overall Study|Adverse Event|0
7486152|NCT02093221|11798755|FG003|Overall Study|Adverse Event|0
7486153|NCT02093221|11798756|FG004|Overall Study|Adverse Event|0
7486154|NCT02093221|11798752|FG000|Overall Study|Withdrawal by Subject|1
7486155|NCT02093221|11798753|FG001|Overall Study|Withdrawal by Subject|1
7486156|NCT02093221|11798754|FG002|Overall Study|Withdrawal by Subject|4
7486157|NCT02093221|11798755|FG003|Overall Study|Withdrawal by Subject|1
7486158|NCT02093221|11798756|FG004|Overall Study|Withdrawal by Subject|1
7486159|NCT02093221|11798752|FG000|Overall Study|Lost to Follow-up|2
7486160|NCT02093221|11798753|FG001|Overall Study|Lost to Follow-up|0
7486161|NCT02093221|11798754|FG002|Overall Study|Lost to Follow-up|1
7486162|NCT02093221|11798755|FG003|Overall Study|Lost to Follow-up|1
7486163|NCT02093221|11798756|FG004|Overall Study|Lost to Follow-up|0
7486164|NCT02093221|11798752|FG000|Overall Study|Death|0
7486165|NCT02093221|11798753|FG001|Overall Study|Death|1
7486166|NCT02093221|11798754|FG002|Overall Study|Death|0
7486167|NCT02093221|11798755|FG003|Overall Study|Death|0
7486168|NCT02093221|11798756|FG004|Overall Study|Death|0
7486169|NCT02093221|11798752|FG000|Overall Study|Protocol Violation|0
7486170|NCT02093221|11798753|FG001|Overall Study|Protocol Violation|1
7486171|NCT02093221|11798754|FG002|Overall Study|Protocol Violation|0
7486172|NCT02093221|11798755|FG003|Overall Study|Protocol Violation|0
7486173|NCT02093221|11798756|FG004|Overall Study|Protocol Violation|0
7486174|NCT02093221|11798752|FG000|Overall Study|Study termination|6
7486175|NCT02093221|11798753|FG001|Overall Study|Study termination|5
7486176|NCT02093221|11798754|FG002|Overall Study|Study termination|4
7486177|NCT02093221|11798755|FG003|Overall Study|Study termination|6
7486178|NCT02093221|11798756|FG004|Overall Study|Study termination|7
7486179|NCT02093351|11798784|FG000|Part A|Adverse Event|0
7486180|NCT02093351|11798785|FG001|Part A|Adverse Event|1
7486181|NCT02093351|11798786|FG002|Part A|Adverse Event|1
7486182|NCT02093351|11798787|FG003|Part A|Adverse Event|0
7486183|NCT02093351|11798784|FG000|Part A|Condition under investigation worsened|2
7486184|NCT02093351|11798785|FG001|Part A|Condition under investigation worsened|0
7486185|NCT02093351|11798786|FG002|Part A|Condition under investigation worsened|2
7486186|NCT02093351|11798787|FG003|Part A|Condition under investigation worsened|0
7486187|NCT02093351|11798784|FG000|Part A|Death|0
7486188|NCT02093351|11798785|FG001|Part A|Death|1
7486189|NCT02093351|11798786|FG002|Part A|Death|0
7486190|NCT02093351|11798787|FG003|Part A|Death|0
7486191|NCT02093351|11798784|FG000|Part B|Patient decision|0
7486192|NCT02093351|11798785|FG001|Part B|Patient decision|0
7486193|NCT02093351|11798786|FG002|Part B|Patient decision|0
7486194|NCT02093351|11798787|FG003|Part B|Patient decision|3
7486195|NCT02093351|11798784|FG000|Part B|Disease progression|0
7486196|NCT02093351|11798785|FG001|Part B|Disease progression|0
7486197|NCT02093351|11798786|FG002|Part B|Disease progression|0
7486198|NCT02093351|11798787|FG003|Part B|Disease progression|4
7486199|NCT02093351|11798784|FG000|Part B|Complete response|0
7486200|NCT02093351|11798785|FG001|Part B|Complete response|0
7486201|NCT02093351|11798786|FG002|Part B|Complete response|0
7486202|NCT02093351|11798787|FG003|Part B|Complete response|1
7486203|NCT02093351|11798784|FG000|Part B|Adverse event + disease progression|0
7486204|NCT02093351|11798785|FG001|Part B|Adverse event + disease progression|0
7486205|NCT02093351|11798786|FG002|Part B|Adverse event + disease progression|0
7486206|NCT02093351|11798787|FG003|Part B|Adverse event + disease progression|1
7486207|NCT02093351|11798784|FG000|Part B|Lack of therapeutic response|0
7486208|NCT02093351|11798785|FG001|Part B|Lack of therapeutic response|0
7486209|NCT02093351|11798786|FG002|Part B|Lack of therapeutic response|0
7486210|NCT02093351|11798787|FG003|Part B|Lack of therapeutic response|12
7486211|NCT02093351|11798784|FG000|Part B|Condition under investigation worsened|0
7486212|NCT02093351|11798785|FG001|Part B|Condition under investigation worsened|0
7486213|NCT02093351|11798786|FG002|Part B|Condition under investigation worsened|0
7486214|NCT02093351|11798787|FG003|Part B|Condition under investigation worsened|39
7486215|NCT02093351|11798784|FG000|Part B|Adverse Event|0
7486216|NCT02093351|11798785|FG001|Part B|Adverse Event|0
7486217|NCT02093351|11798786|FG002|Part B|Adverse Event|0
7486218|NCT02093351|11798787|FG003|Part B|Adverse Event|2
7486219|NCT02093351|11798784|FG000|Part B|Death|0
7486220|NCT02093351|11798785|FG001|Part B|Death|0
7486221|NCT02093351|11798786|FG002|Part B|Death|0
7486222|NCT02093351|11798787|FG003|Part B|Death|1
7486223|NCT02093390|11798804|FG000|Overall Study|Withdrawal by Subject|0
7486224|NCT02093390|11798805|FG001|Overall Study|Withdrawal by Subject|1
7486225|NCT02093520|11798814|FG000|Overall Study|Not treated|6
7486226|NCT02093520|11798815|FG001|Overall Study|Not treated|22
7486227|NCT02093663|11798821|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
7486228|NCT02093663|11798822|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7486229|NCT02093663|11798823|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7486230|NCT02093663|11798824|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7486231|NCT02093663|11798825|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
7486232|NCT02093663|11798821|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
7486233|NCT02093663|11798822|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7486234|NCT02093663|11798823|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7486235|NCT02093663|11798824|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7486236|NCT02093663|11798825|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
7486237|NCT02093663|11798821|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
7486238|NCT02093663|11798822|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
7486239|NCT02093663|11798823|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7486240|NCT02093663|11798824|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7486241|NCT02093663|11798825|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
7486242|NCT02093663|11798821|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7486243|NCT02093663|11798822|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7486244|NCT02093663|11798823|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
7486245|NCT02093663|11798824|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7486246|NCT02093663|11798825|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
7486247|NCT02093663|11798821|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7486248|NCT02093663|11798822|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7486249|NCT02093663|11798823|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
7486250|NCT02093663|11798824|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7486251|NCT02093663|11798825|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
7486252|NCT02093663|11798821|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7486253|NCT02093663|11798822|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7486254|NCT02093663|11798823|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
7486255|NCT02093663|11798824|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
7486256|NCT02093663|11798825|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
7486257|NCT02093663|11798821|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7486258|NCT02093663|11798822|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7486259|NCT02093663|11798823|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
7486260|NCT02093663|11798824|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
7486261|NCT02093663|11798825|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
7486262|NCT02093663|11798821|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7486263|NCT02093663|11798822|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7486264|NCT02093663|11798823|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
7486265|NCT02093663|11798824|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7486266|NCT02093663|11798825|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
7486267|NCT02093663|11798821|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7486268|NCT02093663|11798822|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7486269|NCT02093663|11798823|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7486270|NCT02093663|11798824|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
7486271|NCT02093663|11798825|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
7486272|NCT02093897|11798907|FG000|Overall Study|Physician Decision|1
7486273|NCT02093897|11798907|FG000|Overall Study|Planned age group closure - no's reached|17
7486274|NCT02093897|11798907|FG000|Overall Study|Adverse event, non-fatal|1
7486275|NCT02093923|11798923|FG000|Overall Study|Lost to Follow-up|0
7486276|NCT02093923|11798924|FG001|Overall Study|Lost to Follow-up|0
7486277|NCT02093923|11798925|FG002|Overall Study|Lost to Follow-up|0
7486278|NCT02093923|11798926|FG003|Overall Study|Lost to Follow-up|1
7486279|NCT02093923|11798927|FG004|Overall Study|Lost to Follow-up|0
7486280|NCT02093923|11798923|FG000|Overall Study|Screen failure after randomization|0
7486281|NCT02093923|11798924|FG001|Overall Study|Screen failure after randomization|0
7486282|NCT02093923|11798925|FG002|Overall Study|Screen failure after randomization|0
7486283|NCT02093923|11798926|FG003|Overall Study|Screen failure after randomization|1
7486284|NCT02093923|11798927|FG004|Overall Study|Screen failure after randomization|0
7486285|NCT02094300|11798982|FG000|Overall Study|Death|7
7486286|NCT02094300|11798982|FG000|Overall Study|Lost to Follow-up|10
7486287|NCT02094300|11798982|FG000|Overall Study|Still be eligible for follow-up|3
7486288|NCT02094417|11798995|FG000|Overall Study|Adverse Event|0
7486289|NCT02094417|11798996|FG001|Overall Study|Adverse Event|0
7486290|NCT02094417|11798997|FG002|Overall Study|Adverse Event|0
7486291|NCT02094417|11798998|FG003|Overall Study|Adverse Event|1
7486292|NCT02094417|11798995|FG000|Overall Study|Eligibility criteria|0
7486293|NCT02094417|11798996|FG001|Overall Study|Eligibility criteria|1
7486294|NCT02094417|11798997|FG002|Overall Study|Eligibility criteria|0
7486295|NCT02094417|11798998|FG003|Overall Study|Eligibility criteria|0
7486296|NCT02094417|11798995|FG000|Overall Study|No responder|4
7486297|NCT02094417|11798996|FG001|Overall Study|No responder|4
7486298|NCT02094417|11798997|FG002|Overall Study|No responder|4
7486299|NCT02094417|11798998|FG003|Overall Study|No responder|3
7486300|NCT02094417|11798995|FG000|Overall Study|Unable to conduct observations or assess|0
7486301|NCT02094417|11798996|FG001|Overall Study|Unable to conduct observations or assess|1
7486302|NCT02094417|11798997|FG002|Overall Study|Unable to conduct observations or assess|0
7486303|NCT02094417|11798998|FG003|Overall Study|Unable to conduct observations or assess|0
7486304|NCT02094417|11798995|FG000|Overall Study|Withdrawal by Subject|1
7486305|NCT02094417|11798996|FG001|Overall Study|Withdrawal by Subject|2
7486306|NCT02094417|11798997|FG002|Overall Study|Withdrawal by Subject|1
7486307|NCT02094417|11798998|FG003|Overall Study|Withdrawal by Subject|3
7486308|NCT02094573|11799028|FG000|Overall Study|Adverse Event|4
7486309|NCT02094573|11799029|FG001|Overall Study|Adverse Event|14
7486310|NCT02094573|11799028|FG000|Overall Study|Clinical Progressive Disease|9
7486311|NCT02094573|11799029|FG001|Overall Study|Clinical Progressive Disease|13
7486312|NCT02094573|11799028|FG000|Overall Study|Death|11
7486313|NCT02094573|11799029|FG001|Overall Study|Death|3
7486314|NCT02094573|11799028|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
7486315|NCT02094573|11799029|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
7486316|NCT02094573|11799028|FG000|Overall Study|Non-compliance with Study Drug|1
7486317|NCT02094573|11799029|FG001|Overall Study|Non-compliance with Study Drug|1
7486318|NCT02094573|11799028|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
7486319|NCT02094573|11799029|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
7486320|NCT02094573|11799028|FG000|Overall Study|Physician Decision|4
7486321|NCT02094573|11799029|FG001|Overall Study|Physician Decision|4
7486322|NCT02094573|11799028|FG000|Overall Study|Site Terminated by Sponsor|10
7486323|NCT02094573|11799029|FG001|Overall Study|Site Terminated by Sponsor|17
7486324|NCT02094573|11799028|FG000|Overall Study|Withdrawal by Subject|6
7486325|NCT02094573|11799029|FG001|Overall Study|Withdrawal by Subject|8
7486326|NCT02094573|11799028|FG000|Overall Study|Randomized but not Treated|3
7486327|NCT02094573|11799029|FG001|Overall Study|Randomized but not Treated|0
7486328|NCT02094612|11799066|FG000|Overall Study|Lost to Follow-up|47
7486329|NCT02094612|11799067|FG001|Overall Study|Lost to Follow-up|47
7486330|NCT02094612|11799066|FG000|Overall Study|Never started ADHD medication|32
7486331|NCT02094612|11799067|FG001|Overall Study|Never started ADHD medication|23
7486332|NCT02094677|11799084|FG000|Overall Study|Screening|3
7486333|NCT02094677|11799085|FG001|Overall Study|Screening|1
7486334|NCT02094885|11799108|FG000|Overall Study|Death|1
7486335|NCT02094885|11799109|FG001|Overall Study|Death|5
7486336|NCT02094885|11799108|FG000|Overall Study|Withdrawn due to age|1
7486337|NCT02094885|11799109|FG001|Overall Study|Withdrawn due to age|0
7486338|NCT02094898|11799115|FG000|Overall Study|Clinical Worsening|2
7486339|NCT02094898|11799115|FG000|Overall Study|Adverse Event|2
7486340|NCT02094898|11799115|FG000|Overall Study|Lack of Efficacy|1
7486341|NCT02094937|11799121|FG000|8 Weeks in Period 1|Adverse Event|9
7486342|NCT02094937|11799122|FG001|8 Weeks in Period 1|Adverse Event|0
7486343|NCT02094937|11799123|FG002|8 Weeks in Period 1|Adverse Event|0
7486344|NCT02094937|11799124|FG003|8 Weeks in Period 1|Adverse Event|0
7486345|NCT02094937|11799121|FG000|8 Weeks in Period 1|Lack of Efficacy|3
7486346|NCT02094937|11799122|FG001|8 Weeks in Period 1|Lack of Efficacy|0
7486347|NCT02094937|11799123|FG002|8 Weeks in Period 1|Lack of Efficacy|0
7486348|NCT02094937|11799124|FG003|8 Weeks in Period 1|Lack of Efficacy|0
7486349|NCT02094937|11799121|FG000|8 Weeks in Period 1|Protocol Violation|2
7486350|NCT02094937|11799122|FG001|8 Weeks in Period 1|Protocol Violation|0
7486351|NCT02094937|11799123|FG002|8 Weeks in Period 1|Protocol Violation|0
7486352|NCT02094937|11799124|FG003|8 Weeks in Period 1|Protocol Violation|0
7486353|NCT02094937|11799121|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
7486354|NCT02094937|11799122|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
7486355|NCT02094937|11799123|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
7486356|NCT02094937|11799124|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
7486357|NCT02094937|11799121|FG000|8 Weeks in Period 1|Physician Decision|1
7486358|NCT02094937|11799122|FG001|8 Weeks in Period 1|Physician Decision|0
7486359|NCT02094937|11799123|FG002|8 Weeks in Period 1|Physician Decision|0
7486360|NCT02094937|11799124|FG003|8 Weeks in Period 1|Physician Decision|0
7486361|NCT02094937|11799121|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
7486362|NCT02094937|11799122|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
7486363|NCT02094937|11799123|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
7486364|NCT02094937|11799124|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
7486365|NCT02094937|11799121|FG000|12 Weeks in Period 2|Adverse Event|0
7486366|NCT02094937|11799122|FG001|12 Weeks in Period 2|Adverse Event|2
7486367|NCT02094937|11799123|FG002|12 Weeks in Period 2|Adverse Event|4
7486368|NCT02094937|11799124|FG003|12 Weeks in Period 2|Adverse Event|1
7486369|NCT02094937|11799121|FG000|12 Weeks in Period 2|Lack of Efficacy|0
7486370|NCT02094937|11799122|FG001|12 Weeks in Period 2|Lack of Efficacy|1
7486371|NCT02094937|11799123|FG002|12 Weeks in Period 2|Lack of Efficacy|0
7486372|NCT02094937|11799124|FG003|12 Weeks in Period 2|Lack of Efficacy|0
7486373|NCT02094937|11799121|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
7486374|NCT02094937|11799122|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
7486375|NCT02094937|11799123|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
7486376|NCT02094937|11799124|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
7486377|NCT02094937|11799121|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
7486378|NCT02094937|11799122|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
7486379|NCT02094937|11799123|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
7534884|NCT02705625|11882286|FG002|Overall Study|Lost to Follow-up|1
7486380|NCT02094937|11799124|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
7486381|NCT02094937|11799121|FG000|12 Weeks in Period 2|Randomized incorrectly|0
7486382|NCT02094937|11799122|FG001|12 Weeks in Period 2|Randomized incorrectly|1
7486383|NCT02094937|11799123|FG002|12 Weeks in Period 2|Randomized incorrectly|0
7486384|NCT02094937|11799124|FG003|12 Weeks in Period 2|Randomized incorrectly|0
7486385|NCT02095106|11799135|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7486386|NCT02095106|11799136|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7486387|NCT02095145|11799148|FG000|Overall Study|Withdrawal by Subject|1
7486388|NCT02095145|11799149|FG001|Overall Study|Withdrawal by Subject|0
7486389|NCT02095158|11799157|FG000|Overall Study|Adverse Event|14
7486390|NCT02095158|11799157|FG000|Overall Study|Lack of Efficacy|3
7486391|NCT02095158|11799157|FG000|Overall Study|Pregnancy|1
7486392|NCT02095158|11799157|FG000|Overall Study|Lost to Follow-up|20
7486393|NCT02095158|11799157|FG000|Overall Study|Personal Reasons|35
7486394|NCT02095158|11799157|FG000|Overall Study|Protocol Violation|1
7486395|NCT02095158|11799157|FG000|Overall Study|Other Miscellaneous Reasons|1
7486396|NCT02095197|11799163|FG000|Overall Study|Lost to Follow-up|0
7486397|NCT02095197|11799164|FG001|Overall Study|Lost to Follow-up|3
7486398|NCT02095223|11799172|FG000|Overall Study|Withdrawal by Subject|1
7486399|NCT02095223|11799173|FG001|Overall Study|Withdrawal by Subject|0
7486400|NCT02095535|11799193|FG000|Recruitment|Protocol Violation|2
7486401|NCT02095691|11799206|FG000|Overall Study|Physician Decision|1
7486402|NCT02095873|11799224|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
7486403|NCT02095873|11799225|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
7486404|NCT02095873|11799224|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7486405|NCT02095873|11799225|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7486406|NCT02095873|11799224|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
7486407|NCT02095873|11799225|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
7486408|NCT02095951|11799235|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
7486409|NCT02095951|11799236|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
7486410|NCT02096003|11799248|FG000|Overall Study|Protocol Violation|0
7486411|NCT02096003|11799249|FG001|Overall Study|Protocol Violation|2
7486412|NCT02096003|11799248|FG000|Overall Study|additional surgery|2
7486413|NCT02096003|11799249|FG001|Overall Study|additional surgery|1
7486414|NCT02096263|11799285|FG000|Overall Study|Adverse Event|1
7486415|NCT02096263|11799286|FG001|Overall Study|Adverse Event|0
7486416|NCT02096263|11799287|FG002|Overall Study|Adverse Event|1
7486417|NCT02096263|11799285|FG000|Overall Study|Lost to Follow-up|14
7486418|NCT02096263|11799286|FG001|Overall Study|Lost to Follow-up|18
7486419|NCT02096263|11799287|FG002|Overall Study|Lost to Follow-up|15
7486420|NCT02096263|11799285|FG000|Overall Study|Other|7
7486421|NCT02096263|11799286|FG001|Overall Study|Other|9
7486422|NCT02096263|11799287|FG002|Overall Study|Other|6
7486423|NCT02096263|11799285|FG000|Overall Study|Sponsor study termination|0
7486424|NCT02096263|11799286|FG001|Overall Study|Sponsor study termination|0
7486425|NCT02096263|11799287|FG002|Overall Study|Sponsor study termination|1
7486426|NCT02096263|11799285|FG000|Overall Study|Protocol Violation|7
7486427|NCT02096263|11799286|FG001|Overall Study|Protocol Violation|2
7486428|NCT02096263|11799287|FG002|Overall Study|Protocol Violation|8
7486429|NCT02096263|11799285|FG000|Overall Study|Withdrawal by Subject|5
7486430|NCT02096263|11799286|FG001|Overall Study|Withdrawal by Subject|7
7486431|NCT02096263|11799287|FG002|Overall Study|Withdrawal by Subject|8
7486432|NCT02096471|11799308|FG000|Overall Study|Adverse Event|1
7486433|NCT02096471|11799308|FG000|Overall Study|Lack of Efficacy|7
7486434|NCT02096471|11799308|FG000|Overall Study|Withdrawal by Subject|3
7486435|NCT02096471|11799308|FG000|Overall Study|Non-Compliant|2
7486436|NCT02096705|11799333|FG000|Treatment|Adverse Event|6
7486437|NCT02096705|11799334|FG001|Treatment|Adverse Event|3
7486438|NCT02096705|11799333|FG000|Treatment|Subject request to discontinue treatment|1
7486439|NCT02096705|11799334|FG001|Treatment|Subject request to discontinue treatment|1
7486440|NCT02096705|11799333|FG000|Treatment|Withdrawal by Subject|1
7486441|NCT02096705|11799334|FG001|Treatment|Withdrawal by Subject|0
7486442|NCT02096705|11799333|FG000|Treatment|Other|1
7486443|NCT02096705|11799334|FG001|Treatment|Other|1
7486444|NCT02096705|11799333|FG000|Follow-up|Withdrawal by Subject|1
7486445|NCT02096705|11799334|FG001|Follow-up|Withdrawal by Subject|0
7486446|NCT02096705|11799333|FG000|Follow-up|Adverse Event|2
7486447|NCT02096705|11799334|FG001|Follow-up|Adverse Event|2
7486448|NCT02096705|11799333|FG000|Follow-up|Subjects not reporting status|1
7486449|NCT02096705|11799334|FG001|Follow-up|Subjects not reporting status|2
7486450|NCT02096744|11799366|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
7486451|NCT02096744|11799367|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
7486452|NCT02096744|11799366|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
7486453|NCT02096744|11799367|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
7486454|NCT02096744|11799366|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
7486455|NCT02096744|11799367|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
7486456|NCT02096835|11799378|FG000|Overall Study|Withdrawal by Subject|1
7486457|NCT02096835|11799379|FG001|Overall Study|Withdrawal by Subject|0
7486458|NCT02096835|11799380|FG002|Overall Study|Withdrawal by Subject|0
7486459|NCT02096835|11799378|FG000|Overall Study|converted to open procedures|1
7486460|NCT02096835|11799379|FG001|Overall Study|converted to open procedures|0
7486461|NCT02096835|11799380|FG002|Overall Study|converted to open procedures|0
7486462|NCT02096835|11799378|FG000|Overall Study|Lost to Follow-up|1
7486463|NCT02096835|11799379|FG001|Overall Study|Lost to Follow-up|0
7486464|NCT02096835|11799380|FG002|Overall Study|Lost to Follow-up|1
7486465|NCT02096900|11799409|FG000|Overall Study|Did not receive medication|3
7486466|NCT02096900|11799410|FG001|Overall Study|Did not receive medication|1
7486467|NCT02096900|11799409|FG000|Overall Study|Surgery cancelled- medication received|1
7486468|NCT02096900|11799410|FG001|Overall Study|Surgery cancelled- medication received|1
7486469|NCT02096952|11799416|FG000|Overall Study|Adverse Event|1
7486470|NCT02097030|11799422|FG000|First Intervention (3 Days)|Lost to Follow-up|1
7486471|NCT02097030|11799423|FG001|First Intervention (3 Days)|Lost to Follow-up|0
7486472|NCT02097030|11799422|FG000|First Intervention (3 Days)|Visual Acuity|0
7486473|NCT02097030|11799423|FG001|First Intervention (3 Days)|Visual Acuity|1
7486474|NCT02097056|11799433|FG000|Overall Study|Protocol Violation|2
7486475|NCT02097056|11799433|FG000|Overall Study|Withdrawal by Subject|15
7486476|NCT02097056|11799433|FG000|Overall Study|Lost to Follow-up|2
7486477|NCT02097056|11799433|FG000|Overall Study|Adverse Event|37
7486478|NCT02097056|11799433|FG000|Overall Study|Other|2
7486479|NCT02097108|11799437|FG000|Overall Study|Adverse Event|1
7486480|NCT02097108|11799437|FG000|Overall Study|patient was abroad for 6 months|1
7486481|NCT02097238|11799441|FG000|Overall Study|Death|1
7486482|NCT02097238|11799441|FG000|Overall Study|Physician Decision|1
7486483|NCT02097238|11799441|FG000|Overall Study|Progressive Disease|17
7486484|NCT02097277|11799451|FG000|Overall Study|Subject no longer meets study criteria|0
7486485|NCT02097277|11799452|FG001|Overall Study|Subject no longer meets study criteria|1
7486486|NCT02097277|11799453|FG002|Overall Study|Subject no longer meets study criteria|0
7486487|NCT02097277|11799454|FG003|Overall Study|Subject no longer meets study criteria|1
7486488|NCT02097277|11799455|FG004|Overall Study|Subject no longer meets study criteria|0
7486489|NCT02097277|11799451|FG000|Overall Study|Subject request to discontinue treatment|0
7486490|NCT02097277|11799452|FG001|Overall Study|Subject request to discontinue treatment|0
7486491|NCT02097277|11799453|FG002|Overall Study|Subject request to discontinue treatment|0
7486492|NCT02097277|11799454|FG003|Overall Study|Subject request to discontinue treatment|0
7486493|NCT02097277|11799455|FG004|Overall Study|Subject request to discontinue treatment|1
7486494|NCT02097277|11799451|FG000|Overall Study|Lost to Follow-up|0
7486495|NCT02097277|11799452|FG001|Overall Study|Lost to Follow-up|1
7486496|NCT02097277|11799453|FG002|Overall Study|Lost to Follow-up|1
7486497|NCT02097277|11799454|FG003|Overall Study|Lost to Follow-up|0
7486498|NCT02097277|11799455|FG004|Overall Study|Lost to Follow-up|0
7486499|NCT02097277|11799451|FG000|Overall Study|Withdrawal by Subject|2
7486500|NCT02097277|11799452|FG001|Overall Study|Withdrawal by Subject|1
7486501|NCT02097277|11799453|FG002|Overall Study|Withdrawal by Subject|0
7486502|NCT02097277|11799454|FG003|Overall Study|Withdrawal by Subject|1
7486503|NCT02097277|11799455|FG004|Overall Study|Withdrawal by Subject|0
7486504|NCT02097277|11799451|FG000|Overall Study|Adverse Event|0
7486505|NCT02097277|11799452|FG001|Overall Study|Adverse Event|0
7486506|NCT02097277|11799453|FG002|Overall Study|Adverse Event|1
7486507|NCT02097277|11799454|FG003|Overall Study|Adverse Event|2
7486508|NCT02097277|11799455|FG004|Overall Study|Adverse Event|0
7486509|NCT02097290|11799471|FG000|Overall Study|Death|6
7486510|NCT02097290|11799471|FG000|Overall Study|Total Withdrawals|3
7486511|NCT02097290|11799471|FG000|Overall Study|Attempt|8
7486512|NCT02097472|11799487|FG000|Received Vaccination 2|Adverse Event|0
7486513|NCT02097472|11799488|FG001|Received Vaccination 2|Adverse Event|0
7486514|NCT02097472|11799489|FG002|Received Vaccination 2|Adverse Event|0
7486515|NCT02097472|11799490|FG003|Received Vaccination 2|Adverse Event|0
7486516|NCT02097472|11799491|FG004|Received Vaccination 2|Adverse Event|0
7486517|NCT02097472|11799492|FG005|Received Vaccination 2|Adverse Event|0
7486518|NCT02097472|11799493|FG006|Received Vaccination 2|Adverse Event|1
7486519|NCT02097472|11799494|FG007|Received Vaccination 2|Adverse Event|0
7486520|NCT02097719|11799604|FG000|Overall Study|Subject Withdrew Consent|1
7486521|NCT02097719|11799605|FG001|Overall Study|Subject Withdrew Consent|0
7486522|NCT02097719|11799604|FG000|Overall Study|Lost to Follow-up|0
7486523|NCT02097719|11799605|FG001|Overall Study|Lost to Follow-up|1
7486524|NCT02097719|11799604|FG000|Overall Study|Adverse Event|2
7486525|NCT02097719|11799605|FG001|Overall Study|Adverse Event|0
7486526|NCT02097745|11799621|FG000|Overall Study|Adverse Event|25
7486527|NCT02097745|11799621|FG000|Overall Study|Death|16
7486528|NCT02097745|11799621|FG000|Overall Study|Failure to Return|14
7486529|NCT02097745|11799621|FG000|Overall Study|Administrative/Other|27
7486530|NCT02097745|11799621|FG000|Overall Study|Reason Not Specified|96
7486531|NCT02097823|11799630|FG000|Overall Study|Withdrawal by Subject|1
7486532|NCT02097823|11799631|FG001|Overall Study|Withdrawal by Subject|1
7486533|NCT02098109|11799664|FG000|Overall Study|Protocol Violation|3
7486534|NCT02098109|11799665|FG001|Overall Study|Protocol Violation|0
7486535|NCT02098369|11799680|FG000|Overall Study|Withdrawal by Subject|1
7486536|NCT02098369|11799681|FG001|Overall Study|Withdrawal by Subject|5
7486537|NCT02098369|11799682|FG002|Overall Study|Withdrawal by Subject|0
7486538|NCT02098369|11799680|FG000|Overall Study|Lost to Follow-up|5
7486539|NCT02098369|11799681|FG001|Overall Study|Lost to Follow-up|1
7486540|NCT02098369|11799682|FG002|Overall Study|Lost to Follow-up|3
7486541|NCT02098369|11799680|FG000|Overall Study|Death|1
7486542|NCT02098369|11799681|FG001|Overall Study|Death|1
7486543|NCT02098369|11799682|FG002|Overall Study|Death|1
7486544|NCT02098369|11799680|FG000|Overall Study|Other|0
7486545|NCT02098369|11799681|FG001|Overall Study|Other|2
7486546|NCT02098369|11799682|FG002|Overall Study|Other|1
7486547|NCT02098395|11799694|FG000|Overall Study|Protocol Violation|2
7486548|NCT02098395|11799695|FG001|Overall Study|Protocol Violation|2
7486549|NCT02098395|11799696|FG002|Overall Study|Protocol Violation|0
7486550|NCT02098395|11799697|FG003|Overall Study|Protocol Violation|7
7486551|NCT02098395|11799694|FG000|Overall Study|Withdrawal by Subject|10
7486552|NCT02098395|11799695|FG001|Overall Study|Withdrawal by Subject|10
7486553|NCT02098395|11799696|FG002|Overall Study|Withdrawal by Subject|5
7486554|NCT02098395|11799697|FG003|Overall Study|Withdrawal by Subject|13
7486555|NCT02098395|11799694|FG000|Overall Study|Adverse Event|12
7486556|NCT02098395|11799695|FG001|Overall Study|Adverse Event|19
7486557|NCT02098395|11799696|FG002|Overall Study|Adverse Event|34
7486558|NCT02098395|11799697|FG003|Overall Study|Adverse Event|2
7486559|NCT02098395|11799694|FG000|Overall Study|Lost to Follow-up|2
7486560|NCT02098395|11799695|FG001|Overall Study|Lost to Follow-up|1
7486561|NCT02098395|11799696|FG002|Overall Study|Lost to Follow-up|0
7486562|NCT02098395|11799697|FG003|Overall Study|Lost to Follow-up|3
7486563|NCT02098395|11799694|FG000|Overall Study|Unclassified|0
7486564|NCT02098395|11799695|FG001|Overall Study|Unclassified|0
7486565|NCT02098395|11799696|FG002|Overall Study|Unclassified|3
7486566|NCT02098395|11799697|FG003|Overall Study|Unclassified|2
7486567|NCT02098733|11799707|FG000|Overall Study|Data Not Available|5
7486568|NCT02098733|11799707|FG000|Overall Study|Lost to Follow-up|5
7486569|NCT02098746|11799711|FG000|Overall Study|Changes of Investigator|2
7486570|NCT02098746|11799711|FG000|Overall Study|Other Miscellaneous Reasons|1
7486571|NCT02098746|11799711|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
7486572|NCT02098746|11799711|FG000|Overall Study|Data Not Available After Treatment|1
7534885|NCT02705625|11882284|FG000|Overall Study|Non-compliance|0
7534886|NCT02705625|11882285|FG001|Overall Study|Non-compliance|1
7534887|NCT02705625|11882286|FG002|Overall Study|Non-compliance|1
7534888|NCT02705625|11882284|FG000|Overall Study|Overdosing|0
7534889|NCT02705625|11882285|FG001|Overall Study|Overdosing|0
7534890|NCT02705625|11882286|FG002|Overall Study|Overdosing|1
7534891|NCT02705716|11882296|FG000|Overall Study|Adverse Event|0
7534892|NCT02705716|11882297|FG001|Overall Study|Adverse Event|1
7534893|NCT02705716|11882296|FG000|Overall Study|Protocol Violation|3
7534894|NCT02705716|11882297|FG001|Overall Study|Protocol Violation|0
7534895|NCT02705716|11882296|FG000|Overall Study|Withdrawal of Consent|1
7534896|NCT02705716|11882297|FG001|Overall Study|Withdrawal of Consent|1
7534897|NCT02706327|11882330|FG000|Overall Study|Lost to Follow-up|1
7534898|NCT02706327|11882331|FG001|Overall Study|Lost to Follow-up|1
7534899|NCT02706327|11882332|FG002|Overall Study|Lost to Follow-up|2
7534900|NCT02706483|11882340|FG000|Overall Study|Adverse Event|97
7534901|NCT02706483|11882340|FG000|Overall Study|Death|1
7534902|NCT02706483|11882340|FG000|Overall Study|Lack of Efficacy|39
7534903|NCT02706483|11882340|FG000|Overall Study|Lost to Follow-up|101
7534904|NCT02706483|11882340|FG000|Overall Study|Non-compliance with study drug|15
7534905|NCT02706483|11882340|FG000|Overall Study|Physician Decision|6
7534906|NCT02706483|11882340|FG000|Overall Study|Pregnancy|6
7534907|NCT02706483|11882340|FG000|Overall Study|Protocol Violation|18
7534908|NCT02706483|11882340|FG000|Overall Study|Withdrawal by Subject|136
7534909|NCT02706483|11882340|FG000|Overall Study|Non-compliance with visits|6
7534910|NCT02706483|11882340|FG000|Overall Study|Site closure|4
7534911|NCT02706483|11882340|FG000|Overall Study|Subject moved|1
7534912|NCT02706717|11882346|FG000|Overall Study|Withdrawal by Subject|1
7534913|NCT02706717|11882347|FG001|Overall Study|Withdrawal by Subject|8
7534914|NCT02706717|11882346|FG000|Overall Study|Lost to Follow-up|0
7534915|NCT02706717|11882347|FG001|Overall Study|Lost to Follow-up|1
7534916|NCT02706717|11882346|FG000|Overall Study|Physician Decision|0
7534917|NCT02706717|11882347|FG001|Overall Study|Physician Decision|1
7534918|NCT02706717|11882346|FG000|Overall Study|Death|0
7534919|NCT02706717|11882347|FG001|Overall Study|Death|1
7534920|NCT02706834|11882364|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7534921|NCT02706834|11882365|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7534922|NCT02706834|11882366|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7534923|NCT02706834|11882367|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7534924|NCT02706834|11882368|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7534925|NCT02706834|11882369|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7534926|NCT02706834|11882370|FG006|Overall Study|Pretreatment Event/Adverse Event|0
7534927|NCT02706834|11882371|FG007|Overall Study|Pretreatment Event/Adverse Event|0
7534928|NCT02706834|11882372|FG008|Overall Study|Pretreatment Event/Adverse Event|0
7534929|NCT02706834|11882373|FG009|Overall Study|Pretreatment Event/Adverse Event|0
7534930|NCT02706834|11882374|FG010|Overall Study|Pretreatment Event/Adverse Event|1
7534931|NCT02706834|11882364|FG000|Overall Study|Lost to Follow-up|0
7534932|NCT02706834|11882365|FG001|Overall Study|Lost to Follow-up|0
7534933|NCT02706834|11882366|FG002|Overall Study|Lost to Follow-up|1
7534934|NCT02706834|11882367|FG003|Overall Study|Lost to Follow-up|0
7534935|NCT02706834|11882368|FG004|Overall Study|Lost to Follow-up|0
7534936|NCT02706834|11882369|FG005|Overall Study|Lost to Follow-up|0
7534937|NCT02706834|11882370|FG006|Overall Study|Lost to Follow-up|0
7534938|NCT02706834|11882371|FG007|Overall Study|Lost to Follow-up|0
7534939|NCT02706834|11882372|FG008|Overall Study|Lost to Follow-up|0
7534940|NCT02706834|11882373|FG009|Overall Study|Lost to Follow-up|0
7534941|NCT02706834|11882374|FG010|Overall Study|Lost to Follow-up|0
7486573|NCT02099110|11799742|FG000|Overall Study|Protocol Violation|2
7486574|NCT02099110|11799743|FG001|Overall Study|Protocol Violation|1
7486575|NCT02099110|11799744|FG002|Overall Study|Protocol Violation|0
7486576|NCT02099110|11799745|FG003|Overall Study|Protocol Violation|3
7486577|NCT02099110|11799746|FG004|Overall Study|Protocol Violation|1
7486578|NCT02099110|11799742|FG000|Overall Study|Participant moved|1
7486579|NCT02099110|11799743|FG001|Overall Study|Participant moved|1
7486580|NCT02099110|11799744|FG002|Overall Study|Participant moved|1
7486581|NCT02099110|11799745|FG003|Overall Study|Participant moved|0
7486582|NCT02099110|11799746|FG004|Overall Study|Participant moved|2
7486583|NCT02099110|11799742|FG000|Overall Study|Withdrawal by Subject|7
7486584|NCT02099110|11799743|FG001|Overall Study|Withdrawal by Subject|11
7486585|NCT02099110|11799744|FG002|Overall Study|Withdrawal by Subject|13
7486586|NCT02099110|11799745|FG003|Overall Study|Withdrawal by Subject|9
7486587|NCT02099110|11799746|FG004|Overall Study|Withdrawal by Subject|13
7486588|NCT02099110|11799742|FG000|Overall Study|Adverse Event|3
7486589|NCT02099110|11799743|FG001|Overall Study|Adverse Event|5
7486590|NCT02099110|11799744|FG002|Overall Study|Adverse Event|2
7486591|NCT02099110|11799745|FG003|Overall Study|Adverse Event|3
7486592|NCT02099110|11799746|FG004|Overall Study|Adverse Event|2
7486593|NCT02099110|11799742|FG000|Overall Study|Lost to Follow-up|6
7486594|NCT02099110|11799743|FG001|Overall Study|Lost to Follow-up|12
7486595|NCT02099110|11799744|FG002|Overall Study|Lost to Follow-up|11
7486596|NCT02099110|11799745|FG003|Overall Study|Lost to Follow-up|5
7486597|NCT02099110|11799746|FG004|Overall Study|Lost to Follow-up|6
7486598|NCT02099110|11799742|FG000|Overall Study|Death|0
7486599|NCT02099110|11799743|FG001|Overall Study|Death|1
7486600|NCT02099110|11799744|FG002|Overall Study|Death|0
7486601|NCT02099110|11799745|FG003|Overall Study|Death|0
7486602|NCT02099110|11799746|FG004|Overall Study|Death|0
7486603|NCT02099110|11799742|FG000|Overall Study|Screen failure|0
7486604|NCT02099110|11799743|FG001|Overall Study|Screen failure|0
7486605|NCT02099110|11799744|FG002|Overall Study|Screen failure|0
7486606|NCT02099110|11799745|FG003|Overall Study|Screen failure|0
7486607|NCT02099110|11799746|FG004|Overall Study|Screen failure|1
7486608|NCT02099110|11799742|FG000|Overall Study|Non-compliance with study drug|2
7486609|NCT02099110|11799743|FG001|Overall Study|Non-compliance with study drug|0
7486610|NCT02099110|11799744|FG002|Overall Study|Non-compliance with study drug|0
7486611|NCT02099110|11799745|FG003|Overall Study|Non-compliance with study drug|0
7486612|NCT02099110|11799746|FG004|Overall Study|Non-compliance with study drug|1
7486613|NCT02099110|11799742|FG000|Overall Study|Physician Decision|3
7486614|NCT02099110|11799743|FG001|Overall Study|Physician Decision|0
7486615|NCT02099110|11799744|FG002|Overall Study|Physician Decision|1
7486616|NCT02099110|11799745|FG003|Overall Study|Physician Decision|2
7486617|NCT02099110|11799746|FG004|Overall Study|Physician Decision|1
7486618|NCT02099682|11799778|FG000|Overall Study|Data Not Available|51
7486619|NCT02099682|11799778|FG000|Overall Study|Lost to Follow-up|31
7486620|NCT02099682|11799778|FG000|Overall Study|Other|29
7486621|NCT02099708|11799782|FG000|Overall Study|Data Not Available|30
7486622|NCT02099708|11799782|FG000|Overall Study|Lost to Follow-up|141
7486623|NCT02099708|11799782|FG000|Overall Study|Other|29
7486624|NCT02099838|11799832|FG000|Overall Study|Death|1
7486625|NCT02099838|11799833|FG001|Overall Study|Death|0
7486626|NCT02099838|11799832|FG000|Overall Study|Lost to Follow-up|3
7486627|NCT02099838|11799833|FG001|Overall Study|Lost to Follow-up|1
7486628|NCT02099838|11799832|FG000|Overall Study|Withdrawal by Subject|0
7486629|NCT02099838|11799833|FG001|Overall Study|Withdrawal by Subject|1
7486630|NCT02100124|11799859|FG000|Overall Study|Lost to Follow-up|5
7486631|NCT02100124|11799860|FG001|Overall Study|Lost to Follow-up|11
7486632|NCT02100124|11799861|FG002|Overall Study|Lost to Follow-up|3
7486633|NCT02100124|11799859|FG000|Overall Study|Withdrawal by Subject|1
7486634|NCT02100124|11799860|FG001|Overall Study|Withdrawal by Subject|0
7486635|NCT02100124|11799861|FG002|Overall Study|Withdrawal by Subject|0
7486636|NCT02100228|11799875|FG000|Overall Study|Other|19
7486637|NCT02100228|11799876|FG001|Overall Study|Other|19
7486638|NCT02100228|11799875|FG000|Overall Study|Administrative reason|0
7486639|NCT02100228|11799876|FG001|Overall Study|Administrative reason|1
7486640|NCT02100228|11799875|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
7486641|NCT02100228|11799876|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
7486642|NCT02100228|11799875|FG000|Overall Study|Non-compliance|0
7486643|NCT02100228|11799876|FG001|Overall Study|Non-compliance|3
7486644|NCT02100228|11799875|FG000|Overall Study|Lost to Follow-up|0
7486645|NCT02100228|11799876|FG001|Overall Study|Lost to Follow-up|1
7486646|NCT02100228|11799875|FG000|Overall Study|Withdrawal by Subject|27
7486647|NCT02100228|11799876|FG001|Overall Study|Withdrawal by Subject|37
7486648|NCT02100228|11799875|FG000|Overall Study|Adverse Event|16
7486649|NCT02100228|11799876|FG001|Overall Study|Adverse Event|12
7486650|NCT02100228|11799875|FG000|Overall Study|Death|1
7486651|NCT02100228|11799876|FG001|Overall Study|Death|1
7486652|NCT02100319|11799893|FG000|Overall Study|Case Report Forms Uncollected|11
7486653|NCT02100319|11799893|FG000|Overall Study|Protocol Deviation|5
7486654|NCT02100475|11799916|FG000|Overall Study|Unclassified|1
7486655|NCT02100475|11799917|FG001|Overall Study|Unclassified|2
7486656|NCT02100475|11799916|FG000|Overall Study|Withdrawal criteria|1
7486657|NCT02100475|11799917|FG001|Overall Study|Withdrawal criteria|0
7486658|NCT02100514|11799925|FG000|Treatment Period|Adverse Event|0
7486659|NCT02100514|11799926|FG001|Treatment Period|Adverse Event|5
7486660|NCT02100514|11799927|FG002|Treatment Period|Adverse Event|0
7486661|NCT02100514|11799928|FG003|Treatment Period|Adverse Event|0
7486662|NCT02100514|11799929|FG004|Treatment Period|Adverse Event|0
7486663|NCT02100514|11799925|FG000|Treatment Period|Death|2
7486664|NCT02100514|11799926|FG001|Treatment Period|Death|2
7486665|NCT02100514|11799927|FG002|Treatment Period|Death|0
7486666|NCT02100514|11799928|FG003|Treatment Period|Death|0
7486667|NCT02100514|11799929|FG004|Treatment Period|Death|0
7486668|NCT02100514|11799925|FG000|Treatment Period|Lost to Follow-up|5
7486669|NCT02100514|11799926|FG001|Treatment Period|Lost to Follow-up|17
7486670|NCT02100514|11799927|FG002|Treatment Period|Lost to Follow-up|0
7486671|NCT02100514|11799928|FG003|Treatment Period|Lost to Follow-up|0
7486672|NCT02100514|11799929|FG004|Treatment Period|Lost to Follow-up|0
7486673|NCT02100514|11799925|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
7486674|NCT02100514|11799926|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
7486675|NCT02100514|11799927|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
7486676|NCT02100514|11799928|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
7486677|NCT02100514|11799929|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
7486678|NCT02100514|11799925|FG000|Treatment Period|Protocol Violation|1
7486679|NCT02100514|11799926|FG001|Treatment Period|Protocol Violation|1
7486680|NCT02100514|11799927|FG002|Treatment Period|Protocol Violation|0
7486681|NCT02100514|11799928|FG003|Treatment Period|Protocol Violation|0
7486682|NCT02100514|11799929|FG004|Treatment Period|Protocol Violation|0
7486683|NCT02100514|11799925|FG000|Treatment Period|Withdrawal by Subject|12
7486684|NCT02100514|11799926|FG001|Treatment Period|Withdrawal by Subject|37
7486685|NCT02100514|11799927|FG002|Treatment Period|Withdrawal by Subject|0
7486686|NCT02100514|11799928|FG003|Treatment Period|Withdrawal by Subject|0
7486687|NCT02100514|11799929|FG004|Treatment Period|Withdrawal by Subject|0
7486688|NCT02100514|11799925|FG000|Treatment Period|Other|9
7486689|NCT02100514|11799926|FG001|Treatment Period|Other|11
7486690|NCT02100514|11799927|FG002|Treatment Period|Other|0
7486691|NCT02100514|11799928|FG003|Treatment Period|Other|0
7486692|NCT02100514|11799929|FG004|Treatment Period|Other|0
7486693|NCT02100514|11799925|FG000|Extension Period|Withdrew consent|0
7486694|NCT02100514|11799926|FG001|Extension Period|Withdrew consent|0
7486695|NCT02100514|11799927|FG002|Extension Period|Withdrew consent|2
7486696|NCT02100514|11799928|FG003|Extension Period|Withdrew consent|0
7486697|NCT02100514|11799929|FG004|Extension Period|Withdrew consent|0
7486698|NCT02100631|11799955|FG000|Overall Study|Withdrawal by Subject|1
7486699|NCT02100631|11799956|FG001|Overall Study|Withdrawal by Subject|0
7486700|NCT02100631|11799957|FG002|Overall Study|Withdrawal by Subject|0
7486701|NCT02100631|11799955|FG000|Overall Study|Lost to Follow-up|3
7486702|NCT02100631|11799956|FG001|Overall Study|Lost to Follow-up|4
7486703|NCT02100631|11799957|FG002|Overall Study|Lost to Follow-up|0
7486704|NCT02100631|11799955|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
7486705|NCT02100631|11799956|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7486706|NCT02100631|11799957|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
7486707|NCT02100644|11799965|FG000|LTG Escalation Phase|Adverse Event|9
7486708|NCT02100644|11799966|FG001|LTG Escalation Phase|Adverse Event|0
7486709|NCT02100644|11799967|FG002|LTG Escalation Phase|Adverse Event|0
7486710|NCT02100644|11799965|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
7486711|NCT02100644|11799966|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7486712|NCT02100644|11799967|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
7486713|NCT02100644|11799965|FG000|LTG Escalation Phase|Withdrawal by Subject|3
7486714|NCT02100644|11799966|FG001|LTG Escalation Phase|Withdrawal by Subject|0
7486715|NCT02100644|11799967|FG002|LTG Escalation Phase|Withdrawal by Subject|0
7486716|NCT02100657|11799974|FG000|Cohort 1: Dose Level 1|Progressive disease|6
7486717|NCT02100657|11799975|FG001|Cohort 1: Dose Level 1|Progressive disease|0
7486718|NCT02100657|11799976|FG002|Cohort 1: Dose Level 1|Progressive disease|0
7486719|NCT02100657|11799974|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
7486720|NCT02100657|11799975|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7486721|NCT02100657|11799976|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
7486722|NCT02100657|11799974|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
7486723|NCT02100657|11799975|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7486724|NCT02100657|11799976|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
7486725|NCT02100657|11799974|FG000|Cohort 2: Dose Level 2|Progressive disease|0
7486726|NCT02100657|11799975|FG001|Cohort 2: Dose Level 2|Progressive disease|2
7486727|NCT02100657|11799976|FG002|Cohort 2: Dose Level 2|Progressive disease|0
7486728|NCT02100657|11799974|FG000|Cohort 2: Dose Level 2|Physician Decision|0
7486729|NCT02100657|11799975|FG001|Cohort 2: Dose Level 2|Physician Decision|1
7486730|NCT02100657|11799976|FG002|Cohort 2: Dose Level 2|Physician Decision|0
7486731|NCT02100657|11799974|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7486732|NCT02100657|11799975|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
7486733|NCT02100657|11799976|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
7486734|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Progressive disease|0
7486735|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Progressive disease|0
7486736|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Progressive disease|15
7486737|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Death|0
7486738|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Death|0
7486739|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Death|1
7486740|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7486741|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
7486742|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
7486743|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Physician Decision|0
7486744|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Physician Decision|0
7486745|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Physician Decision|1
7486746|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Never were treated|0
7486747|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Never were treated|0
7486748|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Never were treated|3
7486749|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7486750|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
7486751|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
7486752|NCT02100657|11799974|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7486753|NCT02100657|11799975|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
7486754|NCT02100657|11799976|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
7486755|NCT02100670|11799989|FG000|Overall Study|Adverse Event|10
7486756|NCT02100670|11799990|FG001|Overall Study|Adverse Event|3
7486757|NCT02100670|11799991|FG002|Overall Study|Adverse Event|3
7486758|NCT02100670|11799992|FG003|Overall Study|Adverse Event|0
7486759|NCT02100670|11799989|FG000|Overall Study|Lost to Follow-up|1
7486760|NCT02100670|11799990|FG001|Overall Study|Lost to Follow-up|0
7486761|NCT02100670|11799991|FG002|Overall Study|Lost to Follow-up|0
7486762|NCT02100670|11799992|FG003|Overall Study|Lost to Follow-up|0
7486763|NCT02100670|11799989|FG000|Overall Study|Protocol Violation|0
7486764|NCT02100670|11799990|FG001|Overall Study|Protocol Violation|1
7486765|NCT02100670|11799991|FG002|Overall Study|Protocol Violation|0
7486766|NCT02100670|11799992|FG003|Overall Study|Protocol Violation|1
7486767|NCT02100670|11799989|FG000|Overall Study|Withdrawal of Consent|0
7486768|NCT02100670|11799990|FG001|Overall Study|Withdrawal of Consent|1
7486769|NCT02100670|11799991|FG002|Overall Study|Withdrawal of Consent|1
7486770|NCT02100670|11799992|FG003|Overall Study|Withdrawal of Consent|0
7486771|NCT02100670|11799989|FG000|Overall Study|No swelling no pain|1
7486772|NCT02100670|11799990|FG001|Overall Study|No swelling no pain|0
7486773|NCT02100670|11799991|FG002|Overall Study|No swelling no pain|0
7486774|NCT02100670|11799992|FG003|Overall Study|No swelling no pain|0
7486775|NCT02100670|11799989|FG000|Overall Study|Poor Efficacy|0
7486776|NCT02100670|11799990|FG001|Overall Study|Poor Efficacy|1
7486777|NCT02100670|11799991|FG002|Overall Study|Poor Efficacy|0
7486778|NCT02100670|11799992|FG003|Overall Study|Poor Efficacy|0
7486779|NCT02100670|11799989|FG000|Overall Study|Physician Decision|0
7486780|NCT02100670|11799990|FG001|Overall Study|Physician Decision|1
7486781|NCT02100670|11799991|FG002|Overall Study|Physician Decision|0
7486782|NCT02100670|11799992|FG003|Overall Study|Physician Decision|0
7486783|NCT02100670|11799989|FG000|Overall Study|Withdrawal by Subject|1
7486784|NCT02100670|11799990|FG001|Overall Study|Withdrawal by Subject|0
7486785|NCT02100670|11799991|FG002|Overall Study|Withdrawal by Subject|0
7486786|NCT02100670|11799992|FG003|Overall Study|Withdrawal by Subject|0
7486787|NCT02100696|11800015|FG000|Induction Phase|Adverse Event|0
7486788|NCT02100696|11800016|FG001|Induction Phase|Adverse Event|0
7486789|NCT02100696|11800017|FG002|Induction Phase|Adverse Event|1
7486790|NCT02100696|11800018|FG003|Induction Phase|Adverse Event|0
7486791|NCT02100696|11800019|FG004|Induction Phase|Adverse Event|0
7486792|NCT02100696|11800020|FG005|Induction Phase|Adverse Event|0
7486793|NCT02100696|11800015|FG000|Induction Phase|Lost to Follow-up|1
7486794|NCT02100696|11800016|FG001|Induction Phase|Lost to Follow-up|0
7486795|NCT02100696|11800017|FG002|Induction Phase|Lost to Follow-up|1
7486796|NCT02100696|11800018|FG003|Induction Phase|Lost to Follow-up|0
7486797|NCT02100696|11800019|FG004|Induction Phase|Lost to Follow-up|0
7486798|NCT02100696|11800020|FG005|Induction Phase|Lost to Follow-up|0
7486799|NCT02100696|11800015|FG000|Induction Phase|Protocol Violation|0
7486800|NCT02100696|11800016|FG001|Induction Phase|Protocol Violation|1
7486801|NCT02100696|11800017|FG002|Induction Phase|Protocol Violation|1
7486802|NCT02100696|11800018|FG003|Induction Phase|Protocol Violation|0
7486803|NCT02100696|11800019|FG004|Induction Phase|Protocol Violation|0
7486804|NCT02100696|11800020|FG005|Induction Phase|Protocol Violation|0
7486805|NCT02100696|11800015|FG000|Induction Phase|Withdrawal by Subject|8
7486806|NCT02100696|11800016|FG001|Induction Phase|Withdrawal by Subject|2
7486807|NCT02100696|11800017|FG002|Induction Phase|Withdrawal by Subject|13
7486808|NCT02100696|11800018|FG003|Induction Phase|Withdrawal by Subject|0
7486809|NCT02100696|11800019|FG004|Induction Phase|Withdrawal by Subject|0
7486810|NCT02100696|11800020|FG005|Induction Phase|Withdrawal by Subject|0
7486811|NCT02100696|11800015|FG000|Induction Phase|Physician Decision|1
7486812|NCT02100696|11800016|FG001|Induction Phase|Physician Decision|0
7486813|NCT02100696|11800017|FG002|Induction Phase|Physician Decision|2
7486814|NCT02100696|11800018|FG003|Induction Phase|Physician Decision|0
7486815|NCT02100696|11800019|FG004|Induction Phase|Physician Decision|0
7486816|NCT02100696|11800020|FG005|Induction Phase|Physician Decision|0
7486817|NCT02100696|11800015|FG000|Induction Phase|Multiple Reasons|5
7486818|NCT02100696|11800016|FG001|Induction Phase|Multiple Reasons|2
7486819|NCT02100696|11800017|FG002|Induction Phase|Multiple Reasons|8
7486820|NCT02100696|11800018|FG003|Induction Phase|Multiple Reasons|0
7486821|NCT02100696|11800019|FG004|Induction Phase|Multiple Reasons|0
7486822|NCT02100696|11800020|FG005|Induction Phase|Multiple Reasons|0
7486823|NCT02100696|11800015|FG000|Maintenance Phase|Adverse Event|0
7486824|NCT02100696|11800016|FG001|Maintenance Phase|Adverse Event|0
7486825|NCT02100696|11800017|FG002|Maintenance Phase|Adverse Event|0
7486826|NCT02100696|11800018|FG003|Maintenance Phase|Adverse Event|0
7486827|NCT02100696|11800019|FG004|Maintenance Phase|Adverse Event|0
7486828|NCT02100696|11800020|FG005|Maintenance Phase|Adverse Event|2
7486829|NCT02100696|11800015|FG000|Maintenance Phase|Lost to Follow-up|0
7486830|NCT02100696|11800016|FG001|Maintenance Phase|Lost to Follow-up|0
7486831|NCT02100696|11800017|FG002|Maintenance Phase|Lost to Follow-up|0
7486832|NCT02100696|11800018|FG003|Maintenance Phase|Lost to Follow-up|0
7486833|NCT02100696|11800019|FG004|Maintenance Phase|Lost to Follow-up|1
7486834|NCT02100696|11800020|FG005|Maintenance Phase|Lost to Follow-up|0
7486835|NCT02100696|11800015|FG000|Maintenance Phase|Protocol Violation|0
7486836|NCT02100696|11800016|FG001|Maintenance Phase|Protocol Violation|0
7486837|NCT02100696|11800017|FG002|Maintenance Phase|Protocol Violation|0
7486838|NCT02100696|11800018|FG003|Maintenance Phase|Protocol Violation|0
7486839|NCT02100696|11800019|FG004|Maintenance Phase|Protocol Violation|1
7486840|NCT02100696|11800020|FG005|Maintenance Phase|Protocol Violation|0
7486841|NCT02100696|11800015|FG000|Maintenance Phase|Withdrawal by Subject|0
7486842|NCT02100696|11800016|FG001|Maintenance Phase|Withdrawal by Subject|0
7486843|NCT02100696|11800017|FG002|Maintenance Phase|Withdrawal by Subject|0
7486844|NCT02100696|11800018|FG003|Maintenance Phase|Withdrawal by Subject|1
7486845|NCT02100696|11800019|FG004|Maintenance Phase|Withdrawal by Subject|4
7486846|NCT02100696|11800020|FG005|Maintenance Phase|Withdrawal by Subject|2
7486847|NCT02100696|11800015|FG000|Maintenance Phase|Physician Decision|0
7486848|NCT02100696|11800016|FG001|Maintenance Phase|Physician Decision|0
7486849|NCT02100696|11800017|FG002|Maintenance Phase|Physician Decision|0
7486850|NCT02100696|11800018|FG003|Maintenance Phase|Physician Decision|0
7486851|NCT02100696|11800019|FG004|Maintenance Phase|Physician Decision|1
7486852|NCT02100696|11800020|FG005|Maintenance Phase|Physician Decision|0
7486853|NCT02100696|11800015|FG000|Maintenance Phase|Multiple Reasons|0
7486854|NCT02100696|11800016|FG001|Maintenance Phase|Multiple Reasons|0
7486855|NCT02100696|11800017|FG002|Maintenance Phase|Multiple Reasons|0
7486856|NCT02100696|11800018|FG003|Maintenance Phase|Multiple Reasons|0
7486857|NCT02100696|11800019|FG004|Maintenance Phase|Multiple Reasons|2
7486858|NCT02100696|11800020|FG005|Maintenance Phase|Multiple Reasons|1
7486859|NCT02100813|11800098|FG000|Overall Study|Adverse Event|0
7486860|NCT02100813|11800099|FG001|Overall Study|Adverse Event|0
7486861|NCT02100813|11800100|FG002|Overall Study|Adverse Event|0
7486862|NCT02100813|11800101|FG003|Overall Study|Adverse Event|0
7486863|NCT02100813|11800102|FG004|Overall Study|Adverse Event|0
7486864|NCT02100813|11800103|FG005|Overall Study|Adverse Event|0
7486865|NCT02100813|11800104|FG006|Overall Study|Adverse Event|0
7486866|NCT02100813|11800105|FG007|Overall Study|Adverse Event|1
7486867|NCT02100839|11800132|FG000|Multiple Ascending Dose|Adverse Event|2
7486868|NCT02100839|11800133|FG001|Multiple Ascending Dose|Adverse Event|0
7486869|NCT02100839|11800132|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
7486870|NCT02100839|11800133|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
7486871|NCT02100969|11800143|FG000|Overall Study|Did not pass screening phase|1
7486872|NCT02101021|11800157|FG000|Overall Study|Death|4
7486873|NCT02101021|11800158|FG001|Overall Study|Death|3
7486874|NCT02101021|11800159|FG002|Overall Study|Death|6
7486875|NCT02101021|11800160|FG003|Overall Study|Death|0
7486876|NCT02101021|11800161|FG004|Overall Study|Death|3
7486877|NCT02101021|11800157|FG000|Overall Study|Withdrew Consent from study|1
7486878|NCT02101021|11800158|FG001|Overall Study|Withdrew Consent from study|1
7486879|NCT02101021|11800159|FG002|Overall Study|Withdrew Consent from study|0
7486880|NCT02101021|11800160|FG003|Overall Study|Withdrew Consent from study|2
7486881|NCT02101021|11800161|FG004|Overall Study|Withdrew Consent from study|0
7486882|NCT02101021|11800157|FG000|Overall Study|Lost to Follow-up|1
7486883|NCT02101021|11800158|FG001|Overall Study|Lost to Follow-up|0
7486884|NCT02101021|11800159|FG002|Overall Study|Lost to Follow-up|0
7486885|NCT02101021|11800160|FG003|Overall Study|Lost to Follow-up|0
7486886|NCT02101021|11800161|FG004|Overall Study|Lost to Follow-up|0
7486887|NCT02101021|11800157|FG000|Overall Study|Study Terminated by Sponsor|1
7486888|NCT02101021|11800158|FG001|Overall Study|Study Terminated by Sponsor|0
7486889|NCT02101021|11800159|FG002|Overall Study|Study Terminated by Sponsor|1
7486890|NCT02101021|11800160|FG003|Overall Study|Study Terminated by Sponsor|1
7486891|NCT02101021|11800161|FG004|Overall Study|Study Terminated by Sponsor|1
7486892|NCT02101060|11800175|FG000|Overall Study|Adverse Event|1
7486893|NCT02101060|11800176|FG001|Overall Study|Adverse Event|0
7486894|NCT02101060|11800175|FG000|Overall Study|Withdrawal by Subject|1
7486895|NCT02101060|11800176|FG001|Overall Study|Withdrawal by Subject|1
7486896|NCT02101060|11800175|FG000|Overall Study|Lost to Follow-up|3
7486897|NCT02101060|11800176|FG001|Overall Study|Lost to Follow-up|3
7486898|NCT02101112|11800182|FG000|Overall Study|Adverse Event|0
7486899|NCT02101112|11800183|FG001|Overall Study|Adverse Event|0
7486900|NCT02101112|11800184|FG002|Overall Study|Adverse Event|1
7486901|NCT02101112|11800185|FG003|Overall Study|Adverse Event|0
7486902|NCT02101112|11800186|FG004|Overall Study|Adverse Event|0
7486903|NCT02101112|11800187|FG005|Overall Study|Adverse Event|0
7486904|NCT02101112|11800182|FG000|Overall Study|Withdrawal by Subject|0
7486905|NCT02101112|11800183|FG001|Overall Study|Withdrawal by Subject|0
7486906|NCT02101112|11800184|FG002|Overall Study|Withdrawal by Subject|0
7486907|NCT02101112|11800185|FG003|Overall Study|Withdrawal by Subject|0
7486908|NCT02101112|11800186|FG004|Overall Study|Withdrawal by Subject|1
7486909|NCT02101112|11800187|FG005|Overall Study|Withdrawal by Subject|0
7486910|NCT02101281|11800208|FG000|Overall Study|Adverse Event|0
7486911|NCT02101281|11800209|FG001|Overall Study|Adverse Event|1
7486912|NCT02101294|11800221|FG000|Overall Study|Withdrawal by Subject|5
7486913|NCT02101294|11800221|FG000|Overall Study|Lost to Follow-up|6
7486914|NCT02101359|11800230|FG000|Overall Study|Not included|23
7486915|NCT02101359|11800231|FG001|Overall Study|Not included|13
7486916|NCT02101359|11800230|FG000|Overall Study|Withdrawal by Subject|5
7486917|NCT02101359|11800231|FG001|Overall Study|Withdrawal by Subject|4
7486918|NCT02101359|11800230|FG000|Overall Study|Lost to Follow-up|1
7486919|NCT02101359|11800231|FG001|Overall Study|Lost to Follow-up|0
7486920|NCT02101359|11800230|FG000|Overall Study|Protocol Violation|0
7486921|NCT02101359|11800231|FG001|Overall Study|Protocol Violation|2
7486922|NCT02101554|11800279|FG000|Overall Study|Protocol Violation|0
7486923|NCT02101554|11800280|FG001|Overall Study|Protocol Violation|1
7486924|NCT02101554|11800281|FG002|Overall Study|Protocol Violation|0
7486925|NCT02101554|11800279|FG000|Overall Study|Insufficient Clinical Response|0
7486926|NCT02101554|11800280|FG001|Overall Study|Insufficient Clinical Response|2
7486927|NCT02101554|11800281|FG002|Overall Study|Insufficient Clinical Response|0
7486928|NCT02101554|11800279|FG000|Overall Study|Adverse Event|2
7486929|NCT02101554|11800280|FG001|Overall Study|Adverse Event|1
7486930|NCT02101554|11800281|FG002|Overall Study|Adverse Event|1
7486931|NCT02101554|11800279|FG000|Overall Study|Lost to Follow-up|0
7486932|NCT02101554|11800280|FG001|Overall Study|Lost to Follow-up|1
7486933|NCT02101554|11800281|FG002|Overall Study|Lost to Follow-up|0
7486934|NCT02101554|11800279|FG000|Overall Study|Withdrawl by Parents/Guardians|1
7486935|NCT02101554|11800280|FG001|Overall Study|Withdrawl by Parents/Guardians|0
7486936|NCT02101554|11800281|FG002|Overall Study|Withdrawl by Parents/Guardians|0
7486937|NCT02101983|11800295|FG000|Overall Study|Physician Decision|1
7486938|NCT02101983|11800296|FG001|Overall Study|Physician Decision|0
7486939|NCT02102204|11800311|FG000|Overall Study|Withdrawal by Subject|137
7486940|NCT02102204|11800311|FG000|Overall Study|Death|92
7486941|NCT02102204|11800311|FG000|Overall Study|Lost to Follow-up|65
7486942|NCT02102204|11800311|FG000|Overall Study|Sponsor Decision|5
7486943|NCT02102204|11800311|FG000|Overall Study|Ongoing|5
7486944|NCT02102399|11800331|FG000|Overall Study|Withdrawal by Subject|6
7486945|NCT02102399|11800332|FG001|Overall Study|Withdrawal by Subject|4
7486946|NCT02102464|11800345|FG000|Randomized Study|Withdrawal by Subject|0
7486947|NCT02102464|11800346|FG001|Randomized Study|Withdrawal by Subject|1
7486948|NCT02102464|11800347|FG002|Randomized Study|Withdrawal by Subject|0
7486949|NCT02102490|11800356|FG000|Overall Study|Death|6
7486950|NCT02102490|11800356|FG000|Overall Study|Lost to Follow-up|1
7486951|NCT02102724|11800362|FG000|Overall Study|Lost to Follow-up|1
7486952|NCT02102724|11800363|FG001|Overall Study|Lost to Follow-up|0
7486953|NCT02102724|11800362|FG000|Overall Study|surgery for brain aneurysm|1
7486954|NCT02102724|11800363|FG001|Overall Study|surgery for brain aneurysm|1
7486955|NCT02103062|11800404|FG000|Overall Study|Adverse Event|1
7486956|NCT02103062|11800405|FG001|Overall Study|Adverse Event|2
7486957|NCT02103062|11800404|FG000|Overall Study|Progressive Disease|17
7486958|NCT02103062|11800405|FG001|Overall Study|Progressive Disease|20
7486959|NCT02103062|11800404|FG000|Overall Study|Death|0
7486960|NCT02103062|11800405|FG001|Overall Study|Death|1
7486961|NCT02103439|11800474|FG000|Overall Study|Adverse Event|0
7486962|NCT02103439|11800475|FG001|Overall Study|Adverse Event|2
7486963|NCT02103439|11800474|FG000|Overall Study|Withdrawal by Subject|3
7486964|NCT02103439|11800475|FG001|Overall Study|Withdrawal by Subject|1
7486965|NCT02103478|11800492|FG000|Overall Study|Adverse Event|0
7486966|NCT02103478|11800493|FG001|Overall Study|Adverse Event|0
7486967|NCT02103478|11800494|FG002|Overall Study|Adverse Event|1
7486968|NCT02103478|11800495|FG003|Overall Study|Adverse Event|1
7486969|NCT02103478|11800496|FG004|Overall Study|Adverse Event|2
7486970|NCT02103478|11800497|FG005|Overall Study|Adverse Event|1
7486971|NCT02103478|11800498|FG006|Overall Study|Adverse Event|0
7486972|NCT02103478|11800499|FG007|Overall Study|Adverse Event|0
7486973|NCT02103478|11800500|FG008|Overall Study|Adverse Event|0
7486974|NCT02103478|11800492|FG000|Overall Study|Death|2
7486975|NCT02103478|11800493|FG001|Overall Study|Death|2
7486976|NCT02103478|11800494|FG002|Overall Study|Death|1
7486977|NCT02103478|11800495|FG003|Overall Study|Death|1
7486978|NCT02103478|11800496|FG004|Overall Study|Death|5
7486979|NCT02103478|11800497|FG005|Overall Study|Death|15
7486980|NCT02103478|11800498|FG006|Overall Study|Death|14
7486981|NCT02103478|11800499|FG007|Overall Study|Death|10
7486982|NCT02103478|11800500|FG008|Overall Study|Death|11
7486983|NCT02103478|11800492|FG000|Overall Study|Progressive Disease|2
7486984|NCT02103478|11800493|FG001|Overall Study|Progressive Disease|1
7486985|NCT02103478|11800494|FG002|Overall Study|Progressive Disease|2
7486986|NCT02103478|11800495|FG003|Overall Study|Progressive Disease|0
7486987|NCT02103478|11800496|FG004|Overall Study|Progressive Disease|9
7486988|NCT02103478|11800497|FG005|Overall Study|Progressive Disease|1
7486989|NCT02103478|11800498|FG006|Overall Study|Progressive Disease|2
7486990|NCT02103478|11800499|FG007|Overall Study|Progressive Disease|0
7486991|NCT02103478|11800500|FG008|Overall Study|Progressive Disease|1
7486992|NCT02103478|11800492|FG000|Overall Study|Withdrawal by Subject|2
7486993|NCT02103478|11800493|FG001|Overall Study|Withdrawal by Subject|0
7486994|NCT02103478|11800494|FG002|Overall Study|Withdrawal by Subject|0
7486995|NCT02103478|11800495|FG003|Overall Study|Withdrawal by Subject|4
7486996|NCT02103478|11800496|FG004|Overall Study|Withdrawal by Subject|0
7486997|NCT02103478|11800497|FG005|Overall Study|Withdrawal by Subject|0
7486998|NCT02103478|11800498|FG006|Overall Study|Withdrawal by Subject|1
7486999|NCT02103478|11800499|FG007|Overall Study|Withdrawal by Subject|1
7487000|NCT02103478|11800500|FG008|Overall Study|Withdrawal by Subject|0
7487001|NCT02103478|11800492|FG000|Overall Study|Lost to Follow-up|0
7487002|NCT02103478|11800493|FG001|Overall Study|Lost to Follow-up|0
7487003|NCT02103478|11800494|FG002|Overall Study|Lost to Follow-up|0
7487004|NCT02103478|11800495|FG003|Overall Study|Lost to Follow-up|0
7487005|NCT02103478|11800496|FG004|Overall Study|Lost to Follow-up|0
7487006|NCT02103478|11800497|FG005|Overall Study|Lost to Follow-up|0
7487007|NCT02103478|11800498|FG006|Overall Study|Lost to Follow-up|0
7487008|NCT02103478|11800499|FG007|Overall Study|Lost to Follow-up|1
7487009|NCT02103478|11800500|FG008|Overall Study|Lost to Follow-up|0
7487010|NCT02103478|11800492|FG000|Overall Study|Other|1
7487011|NCT02103478|11800493|FG001|Overall Study|Other|3
7487012|NCT02103478|11800494|FG002|Overall Study|Other|2
7487013|NCT02103478|11800495|FG003|Overall Study|Other|0
7487014|NCT02103478|11800496|FG004|Overall Study|Other|3
7487015|NCT02103478|11800497|FG005|Overall Study|Other|8
7487016|NCT02103478|11800498|FG006|Overall Study|Other|8
7487017|NCT02103478|11800499|FG007|Overall Study|Other|4
7487018|NCT02103478|11800500|FG008|Overall Study|Other|2
7487019|NCT02104505|11800591|FG000|First Intervention (14 Days)|Adverse Event|2
7487020|NCT02104505|11800592|FG001|First Intervention (14 Days)|Adverse Event|0
7487021|NCT02104505|11800591|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
7487022|NCT02104505|11800592|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
7487023|NCT02104505|11800591|FG000|First Intervention (14 Days)|Lost to Follow-up|0
7487024|NCT02104505|11800592|FG001|First Intervention (14 Days)|Lost to Follow-up|1
7487025|NCT02104505|11800591|FG000|First Intervention (14 Days)|exclusionary condition|0
7487026|NCT02104505|11800592|FG001|First Intervention (14 Days)|exclusionary condition|1
7487027|NCT02104505|11800591|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
7487028|NCT02104505|11800592|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
7487029|NCT02104505|11800591|FG000|Second Intervention (14 Days)|Adverse Event|2
7487030|NCT02104505|11800592|FG001|Second Intervention (14 Days)|Adverse Event|0
7487031|NCT02104557|11800599|FG000|Overall Study|Adverse Event|24
7487032|NCT02104557|11800599|FG000|Overall Study|Lost to Follow-up|34
7487033|NCT02104557|11800599|FG000|Overall Study|Violated the usage and dosage|14
7487034|NCT02104557|11800599|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
7487035|NCT02104557|11800599|FG000|Overall Study|Administered Sayana prior to the contract|1
7487036|NCT02104557|11800599|FG000|Overall Study|Other|17
7487037|NCT02104557|11800599|FG000|Overall Study|Change to other contraception methods|5
7487038|NCT02104557|11800599|FG000|Overall Study|Discontinuation due to no pain|1
7487039|NCT02104557|11800599|FG000|Overall Study|Withdrawal consent|2
7487040|NCT02104557|11800599|FG000|Overall Study|Refusal of administration due to unknown reasons|69
7487041|NCT02104557|11800599|FG000|Overall Study|Discontinuation of contraception|9
7487042|NCT02104583|11800608|FG000|Overall Study|New ICD or CRT-D implanted|2
7487043|NCT02104583|11800609|FG001|Overall Study|New ICD or CRT-D implanted|0
7487044|NCT02104583|11800610|FG002|Overall Study|New ICD or CRT-D implanted|1
7487045|NCT02104583|11800611|FG003|Overall Study|New ICD or CRT-D implanted|0
7487046|NCT02104583|11800612|FG004|Overall Study|New ICD or CRT-D implanted|0
7487047|NCT02104583|11800608|FG000|Overall Study|Death|2
7487048|NCT02104583|11800609|FG001|Overall Study|Death|1
7487049|NCT02104583|11800610|FG002|Overall Study|Death|3
7487050|NCT02104583|11800611|FG003|Overall Study|Death|3
7487051|NCT02104583|11800612|FG004|Overall Study|Death|5
7487052|NCT02104583|11800608|FG000|Overall Study|Subject required cardiac ablation|6
7487053|NCT02104583|11800609|FG001|Overall Study|Subject required cardiac ablation|4
7487054|NCT02104583|11800610|FG002|Overall Study|Subject required cardiac ablation|4
7487055|NCT02104583|11800611|FG003|Overall Study|Subject required cardiac ablation|5
7487056|NCT02104583|11800612|FG004|Overall Study|Subject required cardiac ablation|4
7487057|NCT02104583|11800608|FG000|Overall Study|Subject required prohibited medication|0
7487141|NCT02104947|11800736|FG001|Overall Study|Protocol Violation|8
7487058|NCT02104583|11800609|FG001|Overall Study|Subject required prohibited medication|1
7487059|NCT02104583|11800610|FG002|Overall Study|Subject required prohibited medication|1
7487060|NCT02104583|11800611|FG003|Overall Study|Subject required prohibited medication|0
7487061|NCT02104583|11800612|FG004|Overall Study|Subject required prohibited medication|1
7487062|NCT02104583|11800608|FG000|Overall Study|Withdrew Consent|3
7487063|NCT02104583|11800609|FG001|Overall Study|Withdrew Consent|2
7487064|NCT02104583|11800610|FG002|Overall Study|Withdrew Consent|0
7487065|NCT02104583|11800611|FG003|Overall Study|Withdrew Consent|2
7487066|NCT02104583|11800612|FG004|Overall Study|Withdrew Consent|1
7487067|NCT02104583|11800608|FG000|Overall Study|Investigator's Discretion|1
7487068|NCT02104583|11800609|FG001|Overall Study|Investigator's Discretion|0
7487069|NCT02104583|11800610|FG002|Overall Study|Investigator's Discretion|0
7487070|NCT02104583|11800611|FG003|Overall Study|Investigator's Discretion|0
7487071|NCT02104583|11800612|FG004|Overall Study|Investigator's Discretion|0
7487072|NCT02104583|11800608|FG000|Overall Study|Protocol Violation|0
7487073|NCT02104583|11800609|FG001|Overall Study|Protocol Violation|0
7487074|NCT02104583|11800610|FG002|Overall Study|Protocol Violation|1
7487075|NCT02104583|11800611|FG003|Overall Study|Protocol Violation|0
7487076|NCT02104583|11800612|FG004|Overall Study|Protocol Violation|0
7487077|NCT02104583|11800608|FG000|Overall Study|Adverse Event|3
7487078|NCT02104583|11800609|FG001|Overall Study|Adverse Event|3
7487079|NCT02104583|11800610|FG002|Overall Study|Adverse Event|6
7487080|NCT02104583|11800611|FG003|Overall Study|Adverse Event|6
7487081|NCT02104583|11800612|FG004|Overall Study|Adverse Event|1
7487082|NCT02104583|11800608|FG000|Overall Study|Lost to Follow-up|1
7487083|NCT02104583|11800609|FG001|Overall Study|Lost to Follow-up|0
7487084|NCT02104583|11800610|FG002|Overall Study|Lost to Follow-up|0
7487085|NCT02104583|11800611|FG003|Overall Study|Lost to Follow-up|0
7487086|NCT02104583|11800612|FG004|Overall Study|Lost to Follow-up|0
7487087|NCT02104583|11800608|FG000|Overall Study|Randomized but Never Treated|0
7487088|NCT02104583|11800609|FG001|Overall Study|Randomized but Never Treated|0
7487089|NCT02104583|11800610|FG002|Overall Study|Randomized but Never Treated|0
7487090|NCT02104583|11800611|FG003|Overall Study|Randomized but Never Treated|1
7487091|NCT02104583|11800612|FG004|Overall Study|Randomized but Never Treated|0
7487092|NCT02104752|11800651|FG000|Overall Study|Withdrawal by Subject|1
7487093|NCT02104752|11800652|FG001|Overall Study|Withdrawal by Subject|0
7487094|NCT02104752|11800651|FG000|Overall Study|Weight gain; unrelated anxiety|0
7487095|NCT02104752|11800652|FG001|Overall Study|Weight gain; unrelated anxiety|2
7487096|NCT02104765|11800665|FG000|Overall Study|Lost to Follow-up|0
7487097|NCT02104765|11800666|FG001|Overall Study|Lost to Follow-up|0
7487098|NCT02104765|11800667|FG002|Overall Study|Lost to Follow-up|1
7487099|NCT02104765|11800668|FG003|Overall Study|Lost to Follow-up|0
7487100|NCT02104765|11800669|FG004|Overall Study|Lost to Follow-up|0
7487101|NCT02104765|11800670|FG005|Overall Study|Lost to Follow-up|0
7487102|NCT02104765|11800671|FG006|Overall Study|Lost to Follow-up|0
7487103|NCT02104765|11800665|FG000|Overall Study|Withdrawal by Subject|0
7487104|NCT02104765|11800666|FG001|Overall Study|Withdrawal by Subject|0
7487105|NCT02104765|11800667|FG002|Overall Study|Withdrawal by Subject|0
7487106|NCT02104765|11800668|FG003|Overall Study|Withdrawal by Subject|1
7487107|NCT02104765|11800669|FG004|Overall Study|Withdrawal by Subject|1
7487108|NCT02104765|11800670|FG005|Overall Study|Withdrawal by Subject|0
7487109|NCT02104765|11800671|FG006|Overall Study|Withdrawal by Subject|1
7487110|NCT02104804|11800695|FG000|Overall Study|Did not take study medication|0
7487111|NCT02104804|11800696|FG001|Overall Study|Did not take study medication|1
7487112|NCT02104804|11800695|FG000|Overall Study|Study specific discontinuation criteria|6
7487113|NCT02104804|11800696|FG001|Overall Study|Study specific discontinuation criteria|1
7487114|NCT02104804|11800695|FG000|Overall Study|Other listed|2
7487115|NCT02104804|11800696|FG001|Overall Study|Other listed|1
7487116|NCT02104804|11800695|FG000|Overall Study|Protocol Violation|0
7487117|NCT02104804|11800696|FG001|Overall Study|Protocol Violation|1
7487118|NCT02104804|11800695|FG000|Overall Study|Adverse Event|4
7487119|NCT02104804|11800696|FG001|Overall Study|Adverse Event|3
7487120|NCT02104804|11800695|FG000|Overall Study|Withdrawal by Subject|4
7487121|NCT02104804|11800696|FG001|Overall Study|Withdrawal by Subject|12
7487122|NCT02104817|11800704|FG000|Overall Study|Death|363
7487123|NCT02104817|11800705|FG001|Overall Study|Death|330
7487124|NCT02104817|11800704|FG000|Overall Study|Lost to Follow-up|3
7487125|NCT02104817|11800705|FG001|Overall Study|Lost to Follow-up|2
7487126|NCT02104817|11800704|FG000|Overall Study|Protocol Violation|0
7487127|NCT02104817|11800705|FG001|Overall Study|Protocol Violation|1
7487128|NCT02104817|11800704|FG000|Overall Study|Study terminated by sponsor|5854
7487129|NCT02104817|11800705|FG001|Overall Study|Study terminated by sponsor|5901
7487130|NCT02104817|11800704|FG000|Overall Study|Withdrawal by Subject|111
7487131|NCT02104817|11800705|FG001|Overall Study|Withdrawal by Subject|78
7487132|NCT02104817|11800704|FG000|Overall Study|Other reasons|128
7487133|NCT02104817|11800705|FG001|Overall Study|Other reasons|135
7487134|NCT02104895|11800726|FG000|Overall Study|Withdrawal by Subject|0
7487135|NCT02104895|11800727|FG001|Overall Study|Withdrawal by Subject|14
7487136|NCT02104947|11800735|FG000|Overall Study|Withdrawal by Subject|10
7487137|NCT02104947|11800736|FG001|Overall Study|Withdrawal by Subject|3
7487138|NCT02104947|11800735|FG000|Overall Study|Lost to Follow-up|4
7487139|NCT02104947|11800736|FG001|Overall Study|Lost to Follow-up|4
7487140|NCT02104947|11800735|FG000|Overall Study|Protocol Violation|6
7487142|NCT02104947|11800735|FG000|Overall Study|Adverse Event|57
7487143|NCT02104947|11800736|FG001|Overall Study|Adverse Event|38
7487144|NCT02104947|11800735|FG000|Overall Study|Other than stated above|2
7487145|NCT02104947|11800736|FG001|Overall Study|Other than stated above|3
7487146|NCT02105012|11800746|FG000|Overall Study|Withdrawal by Subject|11
7487147|NCT02105012|11800746|FG000|Overall Study|Protocol Specified Criteria|9
7487148|NCT02105012|11800746|FG000|Overall Study|Lost to Follow-up|4
7487149|NCT02105012|11800746|FG000|Overall Study|Protocol Violation|4
7487150|NCT02105012|11800746|FG000|Overall Study|Physician Decision|3
7487151|NCT02105012|11800746|FG000|Overall Study|Adverse Event|1
7487152|NCT02105012|11800746|FG000|Overall Study|Lack of Efficacy|1
7487153|NCT02105272|11800773|FG000|Overall Study|Adverse Event|1
7487154|NCT02105272|11800774|FG001|Overall Study|Adverse Event|2
7487155|NCT02105272|11800773|FG000|Overall Study|Physician Decision|0
7487156|NCT02105272|11800774|FG001|Overall Study|Physician Decision|1
7487157|NCT02105272|11800773|FG000|Overall Study|Protocol Violation|2
7487158|NCT02105272|11800774|FG001|Overall Study|Protocol Violation|0
7487159|NCT02105272|11800773|FG000|Overall Study|Withdrawal by Subject|2
7487160|NCT02105272|11800774|FG001|Overall Study|Withdrawal by Subject|0
7487161|NCT02105285|11800783|FG000|Overall Study|Adverse Event|1
7487162|NCT02105285|11800784|FG001|Overall Study|Adverse Event|1
7487163|NCT02105285|11800785|FG002|Overall Study|Adverse Event|0
7487164|NCT02105285|11800783|FG000|Overall Study|Protocol Violation|0
7487165|NCT02105285|11800784|FG001|Overall Study|Protocol Violation|1
7487166|NCT02105285|11800785|FG002|Overall Study|Protocol Violation|0
7487167|NCT02105285|11800783|FG000|Overall Study|Withdrawal by Subject|1
7487168|NCT02105285|11800784|FG001|Overall Study|Withdrawal by Subject|0
7487169|NCT02105285|11800785|FG002|Overall Study|Withdrawal by Subject|0
7487170|NCT02105454|11800816|FG000|Overall Study|Withdrawal by Subject|1
7487171|NCT02105467|11800822|FG000|Period 1|Lost to Follow-up|1
7487172|NCT02105467|11800823|FG001|Period 1|Lost to Follow-up|0
7487173|NCT02105467|11800822|FG000|Period 1|Death|1
7487174|NCT02105467|11800823|FG001|Period 1|Death|0
7487175|NCT02105467|11800822|FG000|Period 2|Lost to Follow-up|1
7487176|NCT02105467|11800823|FG001|Period 2|Lost to Follow-up|0
7487177|NCT02105467|11800822|FG000|Period 2|Death|1
7487178|NCT02105467|11800823|FG001|Period 2|Death|0
7487179|NCT02105467|11800822|FG000|Period 2|Withdrawal by Subject|0
7487180|NCT02105467|11800823|FG001|Period 2|Withdrawal by Subject|2
7487181|NCT02105467|11800822|FG000|Period 3|Lost to Follow-up|0
7487182|NCT02105467|11800823|FG001|Period 3|Lost to Follow-up|1
7487183|NCT02105662|11800839|FG000|Overall Study|Lost to Follow-up|5
7487184|NCT02105662|11800839|FG000|Overall Study|Withdrawal by Subject|1
7487185|NCT02105688|11800845|FG000|Part A: Double-Blind|Adverse Event|1
7487186|NCT02105688|11800846|FG001|Part A: Double-Blind|Adverse Event|0
7487187|NCT02105688|11800845|FG000|Part A: Double-Blind|Death|0
7487188|NCT02105688|11800846|FG001|Part A: Double-Blind|Death|1
7487189|NCT02105688|11800845|FG000|Part A: Double-Blind|Lost to Follow-up|15
7487190|NCT02105688|11800846|FG001|Part A: Double-Blind|Lost to Follow-up|11
7487191|NCT02105688|11800845|FG000|Part A: Double-Blind|Physician Decision|0
7487192|NCT02105688|11800846|FG001|Part A: Double-Blind|Physician Decision|1
7487193|NCT02105688|11800845|FG000|Part A: Double-Blind|Status Unknown|0
7487194|NCT02105688|11800846|FG001|Part A: Double-Blind|Status Unknown|2
7487195|NCT02105688|11800845|FG000|Part A: Double-Blind|Withdrawal by Subject|4
7487196|NCT02105688|11800846|FG001|Part A: Double-Blind|Withdrawal by Subject|2
7487197|NCT02105688|11800845|FG000|Part B: Observational Follow-up|Death|2
7487198|NCT02105688|11800846|FG001|Part B: Observational Follow-up|Death|1
7487199|NCT02105688|11800845|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
7487200|NCT02105688|11800846|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
7487201|NCT02105688|11800845|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
7487202|NCT02105688|11800846|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
7487203|NCT02105688|11800845|FG000|Part B: Observational Follow-up|Physician Decision|3
7487204|NCT02105688|11800846|FG001|Part B: Observational Follow-up|Physician Decision|1
7487205|NCT02105701|11800857|FG000|Overall Study|Lost to Follow-up|1
7487206|NCT02105701|11800858|FG001|Overall Study|Lost to Follow-up|0
7487207|NCT02105701|11800859|FG002|Overall Study|Lost to Follow-up|2
7487208|NCT02105701|11800860|FG003|Overall Study|Lost to Follow-up|1
7487209|NCT02105701|11800857|FG000|Overall Study|Protocol Violation|0
7487210|NCT02105701|11800858|FG001|Overall Study|Protocol Violation|0
7487211|NCT02105701|11800859|FG002|Overall Study|Protocol Violation|1
7487212|NCT02105701|11800860|FG003|Overall Study|Protocol Violation|0
7487213|NCT02105701|11800857|FG000|Overall Study|Withdrawal by Subject|2
7487214|NCT02105701|11800858|FG001|Overall Study|Withdrawal by Subject|1
7487215|NCT02105701|11800859|FG002|Overall Study|Withdrawal by Subject|0
7487216|NCT02105701|11800860|FG003|Overall Study|Withdrawal by Subject|1
7487217|NCT02105701|11800857|FG000|Overall Study|Death|1
7487218|NCT02105701|11800858|FG001|Overall Study|Death|0
7487219|NCT02105701|11800859|FG002|Overall Study|Death|0
7487220|NCT02105701|11800860|FG003|Overall Study|Death|0
7487221|NCT02105948|11800885|FG000|Overall Study|Adverse Event|10
7487222|NCT02105948|11800886|FG001|Overall Study|Adverse Event|7
7487223|NCT02105948|11800887|FG002|Overall Study|Adverse Event|11
7487224|NCT02105948|11800888|FG003|Overall Study|Adverse Event|11
7487225|NCT02105948|11800885|FG000|Overall Study|Lack of Efficacy|0
7487226|NCT02105948|11800886|FG001|Overall Study|Lack of Efficacy|1
7487227|NCT02105948|11800887|FG002|Overall Study|Lack of Efficacy|3
7487228|NCT02105948|11800888|FG003|Overall Study|Lack of Efficacy|2
7487229|NCT02105948|11800885|FG000|Overall Study|Lost to Follow-up|0
7487230|NCT02105948|11800886|FG001|Overall Study|Lost to Follow-up|0
7487231|NCT02105948|11800887|FG002|Overall Study|Lost to Follow-up|2
7487232|NCT02105948|11800888|FG003|Overall Study|Lost to Follow-up|1
7487233|NCT02105948|11800885|FG000|Overall Study|Physician Decision|2
7487234|NCT02105948|11800886|FG001|Overall Study|Physician Decision|2
7487235|NCT02105948|11800887|FG002|Overall Study|Physician Decision|2
7487236|NCT02105948|11800888|FG003|Overall Study|Physician Decision|2
7487237|NCT02105948|11800885|FG000|Overall Study|Withdrawal by Subject|15
7487238|NCT02105948|11800886|FG001|Overall Study|Withdrawal by Subject|10
7487239|NCT02105948|11800887|FG002|Overall Study|Withdrawal by Subject|10
7487240|NCT02105948|11800888|FG003|Overall Study|Withdrawal by Subject|11
7487241|NCT02105961|11800902|FG000|Overall Study|Adverse Event|18
7487242|NCT02105961|11800903|FG001|Overall Study|Adverse Event|7
7487243|NCT02105961|11800904|FG002|Overall Study|Adverse Event|13
7487244|NCT02105961|11800902|FG000|Overall Study|Lack of Efficacy|3
7487245|NCT02105961|11800903|FG001|Overall Study|Lack of Efficacy|0
7487246|NCT02105961|11800904|FG002|Overall Study|Lack of Efficacy|3
7487247|NCT02105961|11800902|FG000|Overall Study|Lost to Follow-up|2
7487248|NCT02105961|11800903|FG001|Overall Study|Lost to Follow-up|0
7487249|NCT02105961|11800904|FG002|Overall Study|Lost to Follow-up|1
7487250|NCT02105961|11800902|FG000|Overall Study|Physician Decision|3
7487251|NCT02105961|11800903|FG001|Overall Study|Physician Decision|3
7487252|NCT02105961|11800904|FG002|Overall Study|Physician Decision|2
7487253|NCT02105961|11800902|FG000|Overall Study|Withdrawal by Subject|15
7487254|NCT02105961|11800903|FG001|Overall Study|Withdrawal by Subject|7
7487255|NCT02105961|11800904|FG002|Overall Study|Withdrawal by Subject|11
7487256|NCT02105974|11800915|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
7487257|NCT02105974|11800916|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
7487258|NCT02105974|11800917|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
7487259|NCT02105974|11800915|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
7487260|NCT02105974|11800916|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7487261|NCT02105974|11800917|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
7487262|NCT02105974|11800915|FG000|2 Week Run-in Period|Adverse Event|6
7487263|NCT02105974|11800916|FG001|2 Week Run-in Period|Adverse Event|0
7487264|NCT02105974|11800917|FG002|2 Week Run-in Period|Adverse Event|0
7487265|NCT02105974|11800915|FG000|2 Week Run-in Period|Study closed/terminated|1
7487266|NCT02105974|11800916|FG001|2 Week Run-in Period|Study closed/terminated|0
7487267|NCT02105974|11800917|FG002|2 Week Run-in Period|Study closed/terminated|0
7487268|NCT02105974|11800915|FG000|2 Week Run-in Period|Lost to Follow-up|2
7487269|NCT02105974|11800916|FG001|2 Week Run-in Period|Lost to Follow-up|0
7487270|NCT02105974|11800917|FG002|2 Week Run-in Period|Lost to Follow-up|0
7487271|NCT02105974|11800915|FG000|2 Week Run-in Period|Withdrew consent|23
7487272|NCT02105974|11800916|FG001|2 Week Run-in Period|Withdrew consent|0
7487273|NCT02105974|11800917|FG002|2 Week Run-in Period|Withdrew consent|0
7487274|NCT02105974|11800915|FG000|2 Week Run-in Period|Investigator discretion|8
7487275|NCT02105974|11800916|FG001|2 Week Run-in Period|Investigator discretion|0
7487276|NCT02105974|11800917|FG002|2 Week Run-in Period|Investigator discretion|0
7487277|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
7487278|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
7487279|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
7487280|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
7487281|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
7487282|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
7487283|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
7487284|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
7487285|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
7487286|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
7487287|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
7487288|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
7487289|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7487290|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
7487291|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
7487292|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
7487293|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
7487294|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
7487295|NCT02105974|11800915|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
7487296|NCT02105974|11800916|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
7487297|NCT02105974|11800917|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
7534942|NCT02706834|11882364|FG000|Overall Study|Voluntary Withdrawal|1
7534943|NCT02706834|11882365|FG001|Overall Study|Voluntary Withdrawal|0
7534944|NCT02706834|11882366|FG002|Overall Study|Voluntary Withdrawal|0
7534945|NCT02706834|11882367|FG003|Overall Study|Voluntary Withdrawal|0
7534946|NCT02706834|11882368|FG004|Overall Study|Voluntary Withdrawal|0
7534947|NCT02706834|11882369|FG005|Overall Study|Voluntary Withdrawal|0
7534948|NCT02706834|11882370|FG006|Overall Study|Voluntary Withdrawal|0
7534949|NCT02706834|11882371|FG007|Overall Study|Voluntary Withdrawal|0
7534950|NCT02706834|11882372|FG008|Overall Study|Voluntary Withdrawal|0
7534951|NCT02706834|11882373|FG009|Overall Study|Voluntary Withdrawal|1
7534952|NCT02706834|11882374|FG010|Overall Study|Voluntary Withdrawal|0
7534953|NCT02706834|11882364|FG000|Overall Study|Other Reason Not Specified|1
7534954|NCT02706834|11882365|FG001|Overall Study|Other Reason Not Specified|0
7534955|NCT02706834|11882366|FG002|Overall Study|Other Reason Not Specified|0
7534956|NCT02706834|11882367|FG003|Overall Study|Other Reason Not Specified|0
7534957|NCT02706834|11882368|FG004|Overall Study|Other Reason Not Specified|1
7534958|NCT02706834|11882369|FG005|Overall Study|Other Reason Not Specified|0
7534959|NCT02706834|11882370|FG006|Overall Study|Other Reason Not Specified|0
7534960|NCT02706834|11882371|FG007|Overall Study|Other Reason Not Specified|0
7534961|NCT02706834|11882372|FG008|Overall Study|Other Reason Not Specified|0
7487298|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
7487299|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
7487300|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
7487301|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
7487302|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
7487303|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
7487304|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
7487305|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
7487306|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
7487307|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
7487308|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
7487309|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
7487310|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
7487311|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
7487312|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487313|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487314|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487315|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487316|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7487317|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
7487318|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7487319|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7487320|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7487321|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
7487322|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
7487323|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
7487324|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
7487325|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
7487326|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
7487327|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
7487328|NCT02105987|11800925|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7487329|NCT02105987|11800926|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
7487330|NCT02105987|11800927|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7487331|NCT02105987|11800928|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7487332|NCT02105987|11800929|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7487333|NCT02105987|11800930|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
7487334|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
7487335|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
7487336|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
7487337|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
7487338|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
7487339|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
7487340|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
7487341|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
7487342|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
7487343|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
7487344|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
7487345|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
7487346|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487347|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487348|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
7487349|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
7487350|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487351|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
7487352|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7487353|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7487354|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
7487355|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
7487356|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7487357|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
7487358|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
7487359|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
7487360|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
7487361|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
7487362|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
7487363|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
7487364|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7487365|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7487366|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7487367|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
7487368|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7487369|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
7487370|NCT02105987|11800925|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
7487371|NCT02105987|11800926|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
7487372|NCT02105987|11800927|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
7487373|NCT02105987|11800928|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
7487374|NCT02105987|11800929|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
7487375|NCT02105987|11800930|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
7487376|NCT02105987|11800925|FG000|Continuation Phase|Protocol Violation|0
7487377|NCT02105987|11800926|FG001|Continuation Phase|Protocol Violation|0
7487378|NCT02105987|11800927|FG002|Continuation Phase|Protocol Violation|0
7487379|NCT02105987|11800928|FG003|Continuation Phase|Protocol Violation|0
7487380|NCT02105987|11800929|FG004|Continuation Phase|Protocol Violation|1
7487381|NCT02105987|11800930|FG005|Continuation Phase|Protocol Violation|0
7487382|NCT02106156|11800952|FG000|Overall Study|Patient Died|19
7487383|NCT02106156|11800953|FG001|Overall Study|Patient Died|0
7487384|NCT02106156|11800954|FG002|Overall Study|Patient Died|0
7487385|NCT02106156|11800952|FG000|Overall Study|Lack of Tolerability|305
7487386|NCT02106156|11800953|FG001|Overall Study|Lack of Tolerability|3
7487387|NCT02106156|11800954|FG002|Overall Study|Lack of Tolerability|0
7487388|NCT02106156|11800952|FG000|Overall Study|Lack of Virological Response|1044
7487389|NCT02106156|11800953|FG001|Overall Study|Lack of Virological Response|8
7487390|NCT02106156|11800954|FG002|Overall Study|Lack of Virological Response|0
7487391|NCT02106156|11800952|FG000|Overall Study|Concomitant Disease|74
7487392|NCT02106156|11800953|FG001|Overall Study|Concomitant Disease|2
7487393|NCT02106156|11800954|FG002|Overall Study|Concomitant Disease|0
7487394|NCT02106156|11800952|FG000|Overall Study|Lack of Compliance|211
7487395|NCT02106156|11800953|FG001|Overall Study|Lack of Compliance|7
7487396|NCT02106156|11800954|FG002|Overall Study|Lack of Compliance|0
7487397|NCT02106156|11800952|FG000|Overall Study|Patients Request|307
7487398|NCT02106156|11800953|FG001|Overall Study|Patients Request|9
7487399|NCT02106156|11800954|FG002|Overall Study|Patients Request|0
7487400|NCT02106156|11800952|FG000|Overall Study|Lost to Follow-up|451
7487401|NCT02106156|11800953|FG001|Overall Study|Lost to Follow-up|8
7487402|NCT02106156|11800954|FG002|Overall Study|Lost to Follow-up|0
7487403|NCT02106156|11800952|FG000|Overall Study|Unplanned Event|82
7487404|NCT02106156|11800953|FG001|Overall Study|Unplanned Event|2
7487405|NCT02106156|11800954|FG002|Overall Study|Unplanned Event|0
7487406|NCT02106156|11800952|FG000|Overall Study|Change of Laboratory Parameter|10
7487407|NCT02106156|11800953|FG001|Overall Study|Change of Laboratory Parameter|0
7487408|NCT02106156|11800954|FG002|Overall Study|Change of Laboratory Parameter|0
7487409|NCT02106156|11800952|FG000|Overall Study|Hospitalization/Surgical Intervention|6
7487410|NCT02106156|11800953|FG001|Overall Study|Hospitalization/Surgical Intervention|0
7487411|NCT02106156|11800954|FG002|Overall Study|Hospitalization/Surgical Intervention|0
7487412|NCT02106156|11800952|FG000|Overall Study|Relocation/Change of Physician|40
7487413|NCT02106156|11800953|FG001|Overall Study|Relocation/Change of Physician|1
7487414|NCT02106156|11800954|FG002|Overall Study|Relocation/Change of Physician|0
7487415|NCT02106325|11800963|FG000|Phase 1|Lost to Follow-up|2
7487416|NCT02106325|11800964|FG001|Phase 1|Lost to Follow-up|2
7487417|NCT02106325|11800963|FG000|Phase 2|Lost to Follow-up|2
7487418|NCT02106325|11800964|FG001|Phase 2|Lost to Follow-up|3
7487419|NCT02106325|11800963|FG000|Phase 3|Lost to Follow-up|2
7487420|NCT02106325|11800964|FG001|Phase 3|Lost to Follow-up|1
7487463|NCT02106390|11800992|FG000|Overall Study|Withdrawal by Subject|15
7487464|NCT02106390|11800993|FG001|Overall Study|Withdrawal by Subject|16
7487465|NCT02106390|11800994|FG002|Overall Study|Withdrawal by Subject|15
7487466|NCT02106390|11800992|FG000|Overall Study|Lost to Follow-up|25
7487467|NCT02106390|11800993|FG001|Overall Study|Lost to Follow-up|20
7487468|NCT02106390|11800994|FG002|Overall Study|Lost to Follow-up|13
7487469|NCT02106390|11800992|FG000|Overall Study|Other: Administrative Reason|8
7487470|NCT02106390|11800993|FG001|Overall Study|Other: Administrative Reason|5
7487471|NCT02106390|11800994|FG002|Overall Study|Other: Administrative Reason|12
7487472|NCT02106390|11800992|FG000|Overall Study|Other: Unspecified|1
7487473|NCT02106390|11800993|FG001|Overall Study|Other: Unspecified|4
7487474|NCT02106390|11800994|FG002|Overall Study|Other: Unspecified|2
7487475|NCT02106390|11800992|FG000|Overall Study|Adverse Event|0
7487476|NCT02106390|11800993|FG001|Overall Study|Adverse Event|2
7487477|NCT02106390|11800994|FG002|Overall Study|Adverse Event|1
7487478|NCT02106390|11800992|FG000|Overall Study|Protocol Violation|0
7487479|NCT02106390|11800993|FG001|Overall Study|Protocol Violation|1
7487480|NCT02106390|11800994|FG002|Overall Study|Protocol Violation|0
7487481|NCT02106403|11801005|FG000|Follow-Up Visit 3|Other Reason|0
7487482|NCT02106403|11801006|FG001|Follow-Up Visit 3|Other Reason|0
7487483|NCT02106403|11801007|FG002|Follow-Up Visit 3|Other Reason|0
7487484|NCT02106403|11801008|FG003|Follow-Up Visit 3|Other Reason|0
7487485|NCT02106403|11801009|FG004|Follow-Up Visit 3|Other Reason|0
7487486|NCT02106403|11801010|FG005|Follow-Up Visit 3|Other Reason|1
7487487|NCT02106442|11801020|FG000|Overall Study|Case Report Forms Uncollected|7
7487488|NCT02106442|11801020|FG000|Overall Study|Protocol Deviation|30
7487489|NCT02106455|11801024|FG000|Overall Study|Case Report Form Uncollected|6
7487490|NCT02106455|11801024|FG000|Overall Study|Protocol Deviation|2
7487491|NCT02106832|11801058|FG000|Overall Study|Adverse Event|1
7487492|NCT02106832|11801059|FG001|Overall Study|Adverse Event|2
7487493|NCT02106832|11801060|FG002|Overall Study|Adverse Event|3
7487494|NCT02106832|11801061|FG003|Overall Study|Adverse Event|0
7487495|NCT02106832|11801058|FG000|Overall Study|Death|4
7487496|NCT02106832|11801059|FG001|Overall Study|Death|4
7487497|NCT02106832|11801060|FG002|Overall Study|Death|1
7487498|NCT02106832|11801061|FG003|Overall Study|Death|4
7487499|NCT02106832|11801058|FG000|Overall Study|Deterioration of general conditions|0
7487500|NCT02106832|11801059|FG001|Overall Study|Deterioration of general conditions|0
7487501|NCT02106832|11801060|FG002|Overall Study|Deterioration of general conditions|1
7487502|NCT02106832|11801061|FG003|Overall Study|Deterioration of general conditions|0
7487503|NCT02106832|11801058|FG000|Overall Study|Lost to Follow-up|0
7487504|NCT02106832|11801059|FG001|Overall Study|Lost to Follow-up|1
7487505|NCT02106832|11801060|FG002|Overall Study|Lost to Follow-up|1
7487506|NCT02106832|11801061|FG003|Overall Study|Lost to Follow-up|3
7487507|NCT02106832|11801058|FG000|Overall Study|Physician Decision|1
7487508|NCT02106832|11801059|FG001|Overall Study|Physician Decision|0
7487509|NCT02106832|11801060|FG002|Overall Study|Physician Decision|0
7487510|NCT02106832|11801061|FG003|Overall Study|Physician Decision|0
7487511|NCT02106832|11801058|FG000|Overall Study|Protocol Violation|0
7487512|NCT02106832|11801059|FG001|Overall Study|Protocol Violation|0
7487513|NCT02106832|11801060|FG002|Overall Study|Protocol Violation|0
7487514|NCT02106832|11801061|FG003|Overall Study|Protocol Violation|1
7487515|NCT02106832|11801058|FG000|Overall Study|Withdrawal by Subject|17
7487516|NCT02106832|11801059|FG001|Overall Study|Withdrawal by Subject|17
7487517|NCT02106832|11801060|FG002|Overall Study|Withdrawal by Subject|10
7487518|NCT02106832|11801061|FG003|Overall Study|Withdrawal by Subject|7
7487519|NCT02106832|11801058|FG000|Overall Study|Technical problems|0
7487520|NCT02106832|11801059|FG001|Overall Study|Technical problems|1
7487521|NCT02106832|11801060|FG002|Overall Study|Technical problems|0
7487522|NCT02106832|11801061|FG003|Overall Study|Technical problems|0
7487523|NCT02106884|11801075|FG000|Overall Study|Change of diagnosis/exclusion|0
7487524|NCT02106884|11801076|FG001|Overall Study|Change of diagnosis/exclusion|1
7487525|NCT02106910|11801087|FG000|Overall Study|Lost to Follow-up|1
7487526|NCT02106910|11801088|FG001|Overall Study|Lost to Follow-up|1
7487527|NCT02106923|11801098|FG000|Overall Study|Protocol Violation|0
7487528|NCT02106923|11801099|FG001|Overall Study|Protocol Violation|0
7487529|NCT02106923|11801100|FG002|Overall Study|Protocol Violation|0
7487530|NCT02106923|11801101|FG003|Overall Study|Protocol Violation|0
7487531|NCT02106923|11801102|FG004|Overall Study|Protocol Violation|0
7487532|NCT02106923|11801103|FG005|Overall Study|Protocol Violation|1
7487533|NCT02106975|11801130|FG000|Overall Study|Death|25
7487534|NCT02106975|11801131|FG001|Overall Study|Death|39
7487535|NCT02107014|11801137|FG000|Overall Study|Withdrew before drug: moving interstate|1
7487536|NCT02107092|11801141|FG000|Overall Study|Miscellaneous|3
7487537|NCT02107092|11801141|FG000|Overall Study|Subject compliance|3
7487538|NCT02107092|11801141|FG000|Overall Study|Hypo-or hyperkalemia|2
7487539|NCT02107092|11801141|FG000|Overall Study|Met ECG withdrawal criteria|3
7487540|NCT02107092|11801141|FG000|Overall Study|Physician Decision|3
7487541|NCT02107092|11801141|FG000|Overall Study|Lost to Follow-up|2
7487542|NCT02107092|11801141|FG000|Overall Study|Withdrawal by Subject|9
7487543|NCT02107092|11801141|FG000|Overall Study|Adverse Event|7
7487544|NCT02107092|11801141|FG000|Overall Study|Expected progression of CKD|12
7487545|NCT02107131|11801147|FG000|Overall Study|Lost to Follow-up|4
7487546|NCT02107131|11801148|FG001|Overall Study|Lost to Follow-up|4
7487547|NCT02107131|11801147|FG000|Overall Study|Physician Decision|1
7487548|NCT02107131|11801148|FG001|Overall Study|Physician Decision|0
7487549|NCT02107131|11801147|FG000|Overall Study|Withdrawal by Subject|2
7487550|NCT02107131|11801148|FG001|Overall Study|Withdrawal by Subject|0
7487551|NCT02107131|11801147|FG000|Overall Study|mental instability|1
7487552|NCT02107131|11801148|FG001|Overall Study|mental instability|0
7487553|NCT02107131|11801147|FG000|Overall Study|Death|0
7487554|NCT02107131|11801148|FG001|Overall Study|Death|1
7487555|NCT02107131|11801147|FG000|Overall Study|Protocol Violation|0
7487556|NCT02107131|11801148|FG001|Overall Study|Protocol Violation|4
7487557|NCT02107196|11801171|FG000|12-week Treatment Period|Adverse Event|6
7487558|NCT02107196|11801172|FG001|12-week Treatment Period|Adverse Event|3
7487559|NCT02107196|11801171|FG000|12-week Treatment Period|Lack of Efficacy|2
7487560|NCT02107196|11801172|FG001|12-week Treatment Period|Lack of Efficacy|1
7487561|NCT02107196|11801171|FG000|12-week Treatment Period|Lost to Follow-up|3
7487562|NCT02107196|11801172|FG001|12-week Treatment Period|Lost to Follow-up|6
7487563|NCT02107196|11801171|FG000|12-week Treatment Period|Physician Decision|0
7487564|NCT02107196|11801172|FG001|12-week Treatment Period|Physician Decision|1
7487565|NCT02107196|11801171|FG000|12-week Treatment Period|Withdrawal by Subject|15
7487566|NCT02107196|11801172|FG001|12-week Treatment Period|Withdrawal by Subject|12
7487567|NCT02107196|11801171|FG000|12-week Treatment Period|Protocol Violation|7
7487568|NCT02107196|11801172|FG001|12-week Treatment Period|Protocol Violation|8
7487569|NCT02107196|11801171|FG000|12-week Treatment Period|Reason Missing|11
7487570|NCT02107196|11801172|FG001|12-week Treatment Period|Reason Missing|8
7487571|NCT02107196|11801171|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
7487572|NCT02107196|11801172|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
7487573|NCT02107196|11801171|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7487574|NCT02107196|11801172|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7487575|NCT02107196|11801171|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
7487576|NCT02107196|11801172|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
7487577|NCT02107196|11801171|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
7487578|NCT02107196|11801172|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
7487579|NCT02107274|11801180|FG000|Treatment vs. Placebo|Adverse Event|3
7487580|NCT02107274|11801181|FG001|Treatment vs. Placebo|Adverse Event|0
7487581|NCT02107274|11801180|FG000|Treatment vs. Placebo|Lost to Follow-up|0
7487582|NCT02107274|11801181|FG001|Treatment vs. Placebo|Lost to Follow-up|2
7487583|NCT02107274|11801180|FG000|Control Phase|Lost to Follow-up|1
7487584|NCT02107274|11801181|FG001|Control Phase|Lost to Follow-up|1
7487585|NCT02107274|11801180|FG000|Control Phase|Death|2
7487586|NCT02107274|11801181|FG001|Control Phase|Death|0
7487587|NCT02107274|11801180|FG000|Control Phase|Adverse Event|0
7487588|NCT02107274|11801181|FG001|Control Phase|Adverse Event|1
7487589|NCT02107313|11801196|FG000|Overall Study|One participant did not do the FED cohor|0
7487590|NCT02107313|11801197|FG001|Overall Study|One participant did not do the FED cohor|1
7487591|NCT02107443|11801214|FG000|Overall Study|Death|42
7487592|NCT02107443|11801215|FG001|Overall Study|Death|30
7487593|NCT02107443|11801214|FG000|Overall Study|Study Protocol Violation|3
7487594|NCT02107443|11801215|FG001|Overall Study|Study Protocol Violation|1
7487595|NCT02107443|11801214|FG000|Overall Study|Registered but Not Eligible|0
7487596|NCT02107443|11801215|FG001|Overall Study|Registered but Not Eligible|1
7487597|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
7487598|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
7487599|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
7487600|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
7487601|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Changed Mind|2
7487602|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Changed Mind|0
7487603|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
7487604|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
7487605|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Too Many Forms|3
7487606|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Too Many Forms|1
7487607|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Too Time Consuming|3
7487608|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Too Time Consuming|6
7487609|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
7487610|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
7487611|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Other Medical|9
7487612|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Other Medical|5
7487613|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Disease Progression|4
7487614|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Disease Progression|2
7487615|NCT02107443|11801214|FG000|Overall Study|Withdrawal: Personal Issues|0
7487616|NCT02107443|11801215|FG001|Overall Study|Withdrawal: Personal Issues|3
7487617|NCT02107482|11801222|FG000|Overall Study|inconveinence|2
7487618|NCT02107482|11801222|FG000|Overall Study|Lost to Follow-up|1
7487619|NCT02107482|11801222|FG000|Overall Study|Lack of Efficacy|1
7487620|NCT02107703|11801235|FG000|Overall Study|Withdrawal by Subject|36
7487621|NCT02107703|11801236|FG001|Overall Study|Withdrawal by Subject|19
7487622|NCT02107703|11801235|FG000|Overall Study|Lost to Follow-up|6
7487623|NCT02107703|11801236|FG001|Overall Study|Lost to Follow-up|4
7487624|NCT02107703|11801235|FG000|Overall Study|On study treatment/follow up|319
7487625|NCT02107703|11801236|FG001|Overall Study|On study treatment/follow up|152
7487626|NCT02107859|11801245|FG000|Overall Study|Withdrawal by Subject|14
7487627|NCT02107859|11801245|FG000|Overall Study|Adverse Event|3
7487628|NCT02107859|11801245|FG000|Overall Study|Study closure|41
7487629|NCT02107859|11801245|FG000|Overall Study|Other than specified|3
7487630|NCT02107898|11801251|FG000|Overall Study|Adverse Event|4
7487631|NCT02107898|11801252|FG001|Overall Study|Adverse Event|7
7487632|NCT02107898|11801251|FG000|Overall Study|Poor compliance to protocol|0
7487633|NCT02107898|11801252|FG001|Overall Study|Poor compliance to protocol|1
7487634|NCT02107898|11801251|FG000|Overall Study|Participant moved|0
7487635|NCT02107898|11801252|FG001|Overall Study|Participant moved|2
7487636|NCT02107898|11801251|FG000|Overall Study|Consent withdrawn by participant|2
7487637|NCT02107898|11801252|FG001|Overall Study|Consent withdrawn by participant|1
7487638|NCT02107898|11801251|FG000|Overall Study|Randomized but not treated|0
7487639|NCT02107898|11801252|FG001|Overall Study|Randomized but not treated|1
7487640|NCT02108262|11801288|FG000|Overall Study|Non-compliance|0
7487641|NCT02108262|11801289|FG001|Overall Study|Non-compliance|2
7487642|NCT02108262|11801290|FG002|Overall Study|Non-compliance|1
7487643|NCT02108262|11801291|FG003|Overall Study|Non-compliance|1
7487644|NCT02108262|11801288|FG000|Overall Study|Randomized by error/screen failure|0
7487645|NCT02108262|11801289|FG001|Overall Study|Randomized by error/screen failure|0
7487646|NCT02108262|11801290|FG002|Overall Study|Randomized by error/screen failure|1
7487647|NCT02108262|11801291|FG003|Overall Study|Randomized by error/screen failure|0
7487648|NCT02108262|11801288|FG000|Overall Study|Distance to center|0
7487649|NCT02108262|11801289|FG001|Overall Study|Distance to center|1
7487650|NCT02108262|11801290|FG002|Overall Study|Distance to center|1
7487651|NCT02108262|11801291|FG003|Overall Study|Distance to center|0
7487652|NCT02108262|11801288|FG000|Overall Study|Adverse Event|0
7487653|NCT02108262|11801289|FG001|Overall Study|Adverse Event|11
7487654|NCT02108262|11801290|FG002|Overall Study|Adverse Event|6
7487655|NCT02108262|11801291|FG003|Overall Study|Adverse Event|12
7487656|NCT02108262|11801288|FG000|Overall Study|Death|0
7487657|NCT02108262|11801289|FG001|Overall Study|Death|2
7487658|NCT02108262|11801290|FG002|Overall Study|Death|2
7487659|NCT02108262|11801291|FG003|Overall Study|Death|1
7487660|NCT02108262|11801288|FG000|Overall Study|Lost to Follow-up|0
7487661|NCT02108262|11801289|FG001|Overall Study|Lost to Follow-up|0
7487662|NCT02108262|11801290|FG002|Overall Study|Lost to Follow-up|1
7487663|NCT02108262|11801291|FG003|Overall Study|Lost to Follow-up|0
7487664|NCT02108262|11801288|FG000|Overall Study|Physician Decision|0
7487665|NCT02108262|11801289|FG001|Overall Study|Physician Decision|0
7487666|NCT02108262|11801290|FG002|Overall Study|Physician Decision|2
7487667|NCT02108262|11801291|FG003|Overall Study|Physician Decision|0
7487668|NCT02108262|11801288|FG000|Overall Study|Withdrawal by Subject|0
7487669|NCT02108262|11801289|FG001|Overall Study|Withdrawal by Subject|7
7487670|NCT02108262|11801290|FG002|Overall Study|Withdrawal by Subject|3
7487671|NCT02108262|11801291|FG003|Overall Study|Withdrawal by Subject|4
7487672|NCT02108262|11801288|FG000|Overall Study|Due to key hepatic values|0
7487673|NCT02108262|11801289|FG001|Overall Study|Due to key hepatic values|1
7487674|NCT02108262|11801290|FG002|Overall Study|Due to key hepatic values|0
7487675|NCT02108262|11801291|FG003|Overall Study|Due to key hepatic values|0
7487676|NCT02108262|11801288|FG000|Overall Study|Unable to contact patient|0
7487677|NCT02108262|11801289|FG001|Overall Study|Unable to contact patient|3
7487678|NCT02108262|11801290|FG002|Overall Study|Unable to contact patient|1
7487679|NCT02108262|11801291|FG003|Overall Study|Unable to contact patient|2
7487680|NCT02108262|11801288|FG000|Overall Study|Patient unable to come to site/attend visit|0
7487681|NCT02108262|11801289|FG001|Overall Study|Patient unable to come to site/attend visit|6
7487682|NCT02108262|11801290|FG002|Overall Study|Patient unable to come to site/attend visit|11
7487683|NCT02108262|11801291|FG003|Overall Study|Patient unable to come to site/attend visit|6
7487684|NCT02108262|11801288|FG000|Overall Study|Patient did not want another infusion|0
7487685|NCT02108262|11801289|FG001|Overall Study|Patient did not want another infusion|3
7487686|NCT02108262|11801290|FG002|Overall Study|Patient did not want another infusion|3
7487687|NCT02108262|11801291|FG003|Overall Study|Patient did not want another infusion|2
7487688|NCT02108262|11801288|FG000|Overall Study|Vacation|0
7487689|NCT02108262|11801289|FG001|Overall Study|Vacation|1
7487690|NCT02108262|11801290|FG002|Overall Study|Vacation|0
7487691|NCT02108262|11801291|FG003|Overall Study|Vacation|0
7487692|NCT02108262|11801288|FG000|Overall Study|Patient decision|0
7487693|NCT02108262|11801289|FG001|Overall Study|Patient decision|7
7487694|NCT02108262|11801290|FG002|Overall Study|Patient decision|9
7487695|NCT02108262|11801291|FG003|Overall Study|Patient decision|14
7487696|NCT02108262|11801288|FG000|Overall Study|Missed IV due to pharmacy error|0
7487697|NCT02108262|11801289|FG001|Overall Study|Missed IV due to pharmacy error|0
7487698|NCT02108262|11801290|FG002|Overall Study|Missed IV due to pharmacy error|1
7487699|NCT02108262|11801291|FG003|Overall Study|Missed IV due to pharmacy error|0
7487700|NCT02108600|11801328|FG000|Overall Study|Withdrawal by Subject|2
7487701|NCT02108600|11801329|FG001|Overall Study|Withdrawal by Subject|0
7487702|NCT02108600|11801328|FG000|Overall Study|Lost to Follow-up|1
7487703|NCT02108600|11801329|FG001|Overall Study|Lost to Follow-up|1
7487704|NCT02108912|11801352|FG000|Overall Study|Lost to Follow-up|1
7487705|NCT02108912|11801353|FG001|Overall Study|Lost to Follow-up|1
7487706|NCT02108912|11801352|FG000|Overall Study|lack of transportation|1
7487707|NCT02108912|11801353|FG001|Overall Study|lack of transportation|0
7487708|NCT02108912|11801352|FG000|Overall Study|high blood pressure|1
7487709|NCT02108912|11801353|FG001|Overall Study|high blood pressure|0
7487710|NCT02108951|11801359|FG000|Overall Study|Lost to Follow-up|1
7487711|NCT02108951|11801359|FG000|Overall Study|Patient's/guardian's decision|1
7487712|NCT02108951|11801359|FG000|Overall Study|Study Terminated by Sponsor|14
7487713|NCT02109029|11801377|FG000|Part B|Adverse Event|0
7487714|NCT02109029|11801378|FG001|Part B|Adverse Event|0
7487715|NCT02109029|11801379|FG002|Part B|Adverse Event|0
7487716|NCT02109029|11801380|FG003|Part B|Adverse Event|0
7487717|NCT02109029|11801381|FG004|Part B|Adverse Event|1
7487718|NCT02109029|11801382|FG005|Part B|Adverse Event|1
7487719|NCT02109042|11801393|FG000|Overall Study|Sponsor Decision|15
7487720|NCT02109107|11801398|FG000|Overall Study|Lost to Follow-up|2
7487721|NCT02109133|11801404|FG000|Overall Study|Lost to Follow-up|1
7487722|NCT02109133|11801405|FG001|Overall Study|Lost to Follow-up|0
7487723|NCT02109432|11801428|FG000|Overall Study|Withdrawal by Subject|1
7487724|NCT02109445|11801432|FG000|Overall Study|Symptomatic deterioration|2
7487725|NCT02109445|11801432|FG000|Overall Study|Adverse Event|1
7487726|NCT02109484|11801448|FG000|Overall Study|Lost to Follow-up|0
7487727|NCT02109484|11801449|FG001|Overall Study|Lost to Follow-up|0
7487728|NCT02109484|11801450|FG002|Overall Study|Lost to Follow-up|0
7487729|NCT02109484|11801451|FG003|Overall Study|Lost to Follow-up|1
7487730|NCT02109484|11801452|FG004|Overall Study|Lost to Follow-up|1
7487731|NCT02109484|11801453|FG005|Overall Study|Lost to Follow-up|0
7487732|NCT02109484|11801454|FG006|Overall Study|Lost to Follow-up|1
7487733|NCT02109484|11801455|FG007|Overall Study|Lost to Follow-up|0
7487734|NCT02109484|11801448|FG000|Overall Study|Withdrawal by Subject|0
7487735|NCT02109484|11801449|FG001|Overall Study|Withdrawal by Subject|0
7487736|NCT02109484|11801450|FG002|Overall Study|Withdrawal by Subject|0
7487737|NCT02109484|11801451|FG003|Overall Study|Withdrawal by Subject|0
7487738|NCT02109484|11801452|FG004|Overall Study|Withdrawal by Subject|1
7487739|NCT02109484|11801453|FG005|Overall Study|Withdrawal by Subject|1
7487740|NCT02109484|11801454|FG006|Overall Study|Withdrawal by Subject|1
7487741|NCT02109484|11801455|FG007|Overall Study|Withdrawal by Subject|0
7487742|NCT02109484|11801448|FG000|Overall Study|Physician Decision|0
7487743|NCT02109484|11801449|FG001|Overall Study|Physician Decision|0
7487744|NCT02109484|11801450|FG002|Overall Study|Physician Decision|0
7487745|NCT02109484|11801451|FG003|Overall Study|Physician Decision|0
7487746|NCT02109484|11801452|FG004|Overall Study|Physician Decision|2
7487747|NCT02109484|11801453|FG005|Overall Study|Physician Decision|0
7487748|NCT02109484|11801454|FG006|Overall Study|Physician Decision|0
7487749|NCT02109484|11801455|FG007|Overall Study|Physician Decision|0
7487750|NCT02109484|11801448|FG000|Overall Study|Death|0
7487751|NCT02109484|11801449|FG001|Overall Study|Death|0
7487752|NCT02109484|11801450|FG002|Overall Study|Death|0
7487753|NCT02109484|11801451|FG003|Overall Study|Death|0
7487754|NCT02109484|11801452|FG004|Overall Study|Death|0
7487755|NCT02109484|11801453|FG005|Overall Study|Death|0
7487756|NCT02109484|11801454|FG006|Overall Study|Death|0
7487757|NCT02109484|11801455|FG007|Overall Study|Death|2
7487758|NCT02109484|11801448|FG000|Overall Study|Moved away from study area|0
7487759|NCT02109484|11801449|FG001|Overall Study|Moved away from study area|0
7487760|NCT02109484|11801450|FG002|Overall Study|Moved away from study area|0
7487761|NCT02109484|11801451|FG003|Overall Study|Moved away from study area|0
7487762|NCT02109484|11801452|FG004|Overall Study|Moved away from study area|0
7487763|NCT02109484|11801453|FG005|Overall Study|Moved away from study area|0
7487764|NCT02109484|11801454|FG006|Overall Study|Moved away from study area|1
7487765|NCT02109484|11801455|FG007|Overall Study|Moved away from study area|1
7487766|NCT02109562|11801497|FG000|Overall Study|Insufficient clinical response|2
7487767|NCT02109562|11801498|FG001|Overall Study|Insufficient clinical response|0
7487768|NCT02109562|11801499|FG002|Overall Study|Insufficient clinical response|4
7487769|NCT02109562|11801497|FG000|Overall Study|Adverse Event|0
7487770|NCT02109562|11801498|FG001|Overall Study|Adverse Event|2
7487771|NCT02109562|11801499|FG002|Overall Study|Adverse Event|3
7487772|NCT02109562|11801497|FG000|Overall Study|Lost to Follow-up|1
7487773|NCT02109562|11801498|FG001|Overall Study|Lost to Follow-up|0
7487774|NCT02109562|11801499|FG002|Overall Study|Lost to Follow-up|1
7487775|NCT02109562|11801497|FG000|Overall Study|Protocol Violation|0
7487776|NCT02109562|11801498|FG001|Overall Study|Protocol Violation|3
7487777|NCT02109562|11801499|FG002|Overall Study|Protocol Violation|1
7487778|NCT02109562|11801497|FG000|Overall Study|Withdrawal by Subject|20
7487779|NCT02109562|11801498|FG001|Overall Study|Withdrawal by Subject|25
7487780|NCT02109562|11801499|FG002|Overall Study|Withdrawal by Subject|21
7487781|NCT02109562|11801497|FG000|Overall Study|Physician Decision|3
7487782|NCT02109562|11801498|FG001|Overall Study|Physician Decision|4
7487783|NCT02109562|11801499|FG002|Overall Study|Physician Decision|5
7487784|NCT02110225|11801561|FG000|Overall Study|Lost to Follow-up|0
7487785|NCT02110225|11801562|FG001|Overall Study|Lost to Follow-up|1
7487786|NCT02110225|11801563|FG002|Overall Study|Lost to Follow-up|0
7487787|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Adverse Event|3
7487788|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Adverse Event|0
7487789|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
7487790|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
7487791|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
7487792|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
7487793|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Physician Decision|0
7487794|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Physician Decision|2
7487795|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Protocol Violation|0
7487796|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Protocol Violation|1
7487797|NCT02110238|11801574|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
7487798|NCT02110238|11801575|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
7487799|NCT02110238|11801574|FG000|14 Week Blinded Extension Phase|Adverse Event|1
7487800|NCT02110238|11801575|FG001|14 Week Blinded Extension Phase|Adverse Event|1
7487801|NCT02110238|11801574|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
7487802|NCT02110238|11801575|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
7487803|NCT02110238|11801574|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
7487804|NCT02110238|11801575|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
7487805|NCT02110238|11801574|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
7487806|NCT02110238|11801575|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
7487807|NCT02110238|11801574|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
7487808|NCT02110238|11801575|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
7487809|NCT02110693|11801613|FG000|Overall Study|Withdrawal by Subject|6
7487810|NCT02110693|11801614|FG001|Overall Study|Withdrawal by Subject|7
7487811|NCT02110693|11801613|FG000|Overall Study|skipped assessment|15
7487812|NCT02110693|11801614|FG001|Overall Study|skipped assessment|18
7487813|NCT02110693|11801613|FG000|Overall Study|technical difficulties|6
7487814|NCT02110693|11801614|FG001|Overall Study|technical difficulties|4
7487815|NCT02110693|11801613|FG000|Overall Study|Other|1
7487816|NCT02110693|11801614|FG001|Overall Study|Other|0
7487817|NCT02110706|11801636|FG000|Overall Study|Adverse Event|2
7487818|NCT02110706|11801637|FG001|Overall Study|Adverse Event|3
7487819|NCT02110706|11801636|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
7487820|NCT02110706|11801637|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
7487821|NCT02110732|11801647|FG000|Overall Study|Physician Decision|5
7487822|NCT02110732|11801648|FG001|Overall Study|Physician Decision|2
7487823|NCT02110732|11801647|FG000|Overall Study|Lost to Follow-up|1
7487824|NCT02110732|11801648|FG001|Overall Study|Lost to Follow-up|1
7487825|NCT02110901|11801677|FG000|Overall Study|Death|6
7487826|NCT02110901|11801678|FG001|Overall Study|Death|3
7487827|NCT02110901|11801677|FG000|Overall Study|Lost to Follow-up|12
7487828|NCT02110901|11801678|FG001|Overall Study|Lost to Follow-up|8
7487829|NCT02110901|11801677|FG000|Overall Study|Withdrawal by Subject|7
7487830|NCT02110901|11801678|FG001|Overall Study|Withdrawal by Subject|3
7487831|NCT02110901|11801677|FG000|Overall Study|received a kidney transplant|5
7487832|NCT02110901|11801678|FG001|Overall Study|received a kidney transplant|0
7487833|NCT02111083|11801687|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
7487834|NCT02111083|11801688|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
7487835|NCT02111096|11801697|FG000|Overall Study|Adverse Event|4
7487836|NCT02111096|11801698|FG001|Overall Study|Adverse Event|1
7487837|NCT02111096|11801699|FG002|Overall Study|Adverse Event|2
7487838|NCT02111096|11801697|FG000|Overall Study|Non-Compliance with Study Drug|1
7487839|NCT02111096|11801698|FG001|Overall Study|Non-Compliance with Study Drug|1
7487840|NCT02111096|11801699|FG002|Overall Study|Non-Compliance with Study Drug|0
7487841|NCT02111096|11801697|FG000|Overall Study|Lost to Follow Up|1
7487842|NCT02111096|11801698|FG001|Overall Study|Lost to Follow Up|1
7487843|NCT02111096|11801699|FG002|Overall Study|Lost to Follow Up|1
7487844|NCT02111096|11801697|FG000|Overall Study|Physician Decision|0
7487845|NCT02111096|11801698|FG001|Overall Study|Physician Decision|1
7487846|NCT02111096|11801699|FG002|Overall Study|Physician Decision|0
7487847|NCT02111096|11801697|FG000|Overall Study|Protocol Violation|1
7487848|NCT02111096|11801698|FG001|Overall Study|Protocol Violation|0
7487849|NCT02111096|11801699|FG002|Overall Study|Protocol Violation|1
7487850|NCT02111096|11801697|FG000|Overall Study|Terminated by Sponsor|53
7487851|NCT02111096|11801698|FG001|Overall Study|Terminated by Sponsor|35
7487852|NCT02111096|11801699|FG002|Overall Study|Terminated by Sponsor|54
7487853|NCT02111096|11801697|FG000|Overall Study|Withdrawal by Subject|4
7487854|NCT02111096|11801698|FG001|Overall Study|Withdrawal by Subject|2
7487855|NCT02111096|11801699|FG002|Overall Study|Withdrawal by Subject|8
7487856|NCT02111174|11801712|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
7487857|NCT02111174|11801713|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
7487858|NCT02111174|11801712|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
7487859|NCT02111174|11801713|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
7487860|NCT02111174|11801712|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
7487861|NCT02111174|11801713|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
7487862|NCT02111174|11801712|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
7487863|NCT02111174|11801713|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
7487864|NCT02111213|11801745|FG000|Overall Study|Withdrawal by Subject|3
7487865|NCT02111213|11801746|FG001|Overall Study|Withdrawal by Subject|2
7487866|NCT02111213|11801745|FG000|Overall Study|Lost to Follow-up|3
7487867|NCT02111213|11801746|FG001|Overall Study|Lost to Follow-up|4
7487868|NCT02111369|11801756|FG000|Overall Study|Lost to Follow-up|2
7487869|NCT02111369|11801756|FG000|Overall Study|Withdrawal by Subject|1
7487870|NCT02111564|11801779|FG000|Overall Study|Death|109
7487871|NCT02111564|11801780|FG001|Overall Study|Death|120
7487872|NCT02111564|11801779|FG000|Overall Study|Lost to Follow-up|2
7487873|NCT02111564|11801780|FG001|Overall Study|Lost to Follow-up|3
7487874|NCT02111564|11801779|FG000|Overall Study|Withdrawal by Subject|20
7487875|NCT02111564|11801780|FG001|Overall Study|Withdrawal by Subject|20
7487876|NCT02111577|11801788|FG000|Overall Study|Protocol Violation|2
7487877|NCT02111577|11801789|FG001|Overall Study|Protocol Violation|0
7487878|NCT02111577|11801788|FG000|Overall Study|Unable to tolerate leukapheresis|1
7487879|NCT02111577|11801789|FG001|Overall Study|Unable to tolerate leukapheresis|0
7487880|NCT02111577|11801788|FG000|Overall Study|Failure to produce study treatment|6
7487881|NCT02111577|11801789|FG001|Overall Study|Failure to produce study treatment|0
7487882|NCT02111577|11801788|FG000|Overall Study|Death|518
7487883|NCT02111577|11801789|FG001|Overall Study|Death|254
7487884|NCT02111577|11801788|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
7487885|NCT02111577|11801789|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
7487886|NCT02111577|11801788|FG000|Overall Study|Adverse Event|1
7487887|NCT02111577|11801789|FG001|Overall Study|Adverse Event|1
7487888|NCT02111577|11801788|FG000|Overall Study|Withdrawal by Subject|51
7487889|NCT02111577|11801789|FG001|Overall Study|Withdrawal by Subject|23
7487890|NCT02111577|11801788|FG000|Overall Study|Disease progression|0
7487891|NCT02111577|11801789|FG001|Overall Study|Disease progression|1
7487892|NCT02111577|11801788|FG000|Overall Study|Lost to Follow-up|19
7487893|NCT02111577|11801789|FG001|Overall Study|Lost to Follow-up|10
7487894|NCT02111603|11801797|FG000|Overall Study|Withdrawal by Subject|1
7487895|NCT02111785|11801823|FG000|Overall Study|Death|0
7487896|NCT02111785|11801824|FG001|Overall Study|Death|1
7487897|NCT02111785|11801825|FG002|Overall Study|Death|0
7487898|NCT02111785|11801826|FG003|Overall Study|Death|0
7487899|NCT02111811|11801860|FG000|Treatment Phase|Lost to Follow-up|22
7487900|NCT02111811|11801861|FG001|Treatment Phase|Lost to Follow-up|18
7487901|NCT02111811|11801860|FG000|Treatment Phase|Death|2
7487902|NCT02111811|11801861|FG001|Treatment Phase|Death|0
7487903|NCT02111811|11801860|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
7487904|NCT02111811|11801861|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
7487905|NCT02111811|11801860|FG000|Follow up Period (Aim 2)|Death|2
7487906|NCT02111811|11801861|FG001|Follow up Period (Aim 2)|Death|0
7487907|NCT02111993|11801880|FG000|Overall Study|Physician Decision|5
7487908|NCT02111993|11801881|FG001|Overall Study|Physician Decision|4
7487909|NCT02112045|11801891|FG000|Overall Study|Withdrawal by Subject|1
7487910|NCT02112045|11801892|FG001|Overall Study|Withdrawal by Subject|0
7487911|NCT02112448|11801909|FG000|Overall Study|lab values precluding use of ketorolac|2
7487912|NCT02112448|11801910|FG001|Overall Study|lab values precluding use of ketorolac|2
7487913|NCT02112448|11801909|FG000|Overall Study|Protocol Violation|1
7487914|NCT02112448|11801910|FG001|Overall Study|Protocol Violation|2
7487915|NCT02112448|11801909|FG000|Overall Study|Physician Decision|4
7487916|NCT02112448|11801910|FG001|Overall Study|Physician Decision|6
7487917|NCT02112448|11801909|FG000|Overall Study|required heparin so could not use ketoro|1
7487918|NCT02112448|11801910|FG001|Overall Study|required heparin so could not use ketoro|0
7487919|NCT02112877|11801933|FG000|Overall Study|Withdrawal by Subject|1
7487920|NCT02112877|11801934|FG001|Overall Study|Withdrawal by Subject|7
7487921|NCT02112877|11801933|FG000|Overall Study|Visit Missed|1
7487922|NCT02112877|11801934|FG001|Overall Study|Visit Missed|6
7487923|NCT02112994|11801942|FG000|Overall Study|Progressive Disease|0
7487924|NCT02112994|11801943|FG001|Overall Study|Progressive Disease|0
7487925|NCT02112994|11801944|FG002|Overall Study|Progressive Disease|1
7487926|NCT02112994|11801942|FG000|Overall Study|Pregnancy|0
7487927|NCT02112994|11801943|FG001|Overall Study|Pregnancy|1
7487928|NCT02112994|11801944|FG002|Overall Study|Pregnancy|1
7487929|NCT02112994|11801942|FG000|Overall Study|Liver Transplant|0
7487930|NCT02112994|11801943|FG001|Overall Study|Liver Transplant|1
7487931|NCT02112994|11801944|FG002|Overall Study|Liver Transplant|0
7487932|NCT02112994|11801942|FG000|Overall Study|Withdrawal by Subject|0
7487933|NCT02112994|11801943|FG001|Overall Study|Withdrawal by Subject|0
7487934|NCT02112994|11801944|FG002|Overall Study|Withdrawal by Subject|1
7487935|NCT02113007|11801956|FG000|Overall Study|Progressive disease|2
7534962|NCT02706834|11882373|FG009|Overall Study|Other Reason Not Specified|0
7534963|NCT02706834|11882374|FG010|Overall Study|Other Reason Not Specified|0
7487936|NCT02113124|11801962|FG000|Overall Study|Unable to retrieve blood sample|1
7487937|NCT02113124|11801963|FG001|Overall Study|Unable to retrieve blood sample|1
7487938|NCT02113189|11801972|FG000|Overall Study|Lost to follow up|2
7487939|NCT02113189|11801973|FG001|Overall Study|Lost to follow up|1
7487940|NCT02113189|11801974|FG002|Overall Study|Lost to follow up|3
7487941|NCT02113436|11802007|FG000|Period 1: 8 Weeks|Adverse Event|1
7487942|NCT02113436|11802008|FG001|Period 1: 8 Weeks|Adverse Event|0
7487943|NCT02113436|11802009|FG002|Period 1: 8 Weeks|Adverse Event|0
7487944|NCT02113436|11802010|FG003|Period 1: 8 Weeks|Adverse Event|0
7487945|NCT02113436|11802007|FG000|Period 1: 8 Weeks|Protocol Violation|1
7487946|NCT02113436|11802008|FG001|Period 1: 8 Weeks|Protocol Violation|0
7487947|NCT02113436|11802009|FG002|Period 1: 8 Weeks|Protocol Violation|0
7487948|NCT02113436|11802010|FG003|Period 1: 8 Weeks|Protocol Violation|0
7487949|NCT02113436|11802007|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
7487950|NCT02113436|11802008|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
7487951|NCT02113436|11802009|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7487952|NCT02113436|11802010|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7487953|NCT02113436|11802007|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
7487954|NCT02113436|11802008|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
7487955|NCT02113436|11802009|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
7487956|NCT02113436|11802010|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
7487957|NCT02113436|11802007|FG000|Period 2: 16 Weeks|Adverse Event|0
7487958|NCT02113436|11802008|FG001|Period 2: 16 Weeks|Adverse Event|0
7487959|NCT02113436|11802009|FG002|Period 2: 16 Weeks|Adverse Event|4
7487960|NCT02113436|11802010|FG003|Period 2: 16 Weeks|Adverse Event|5
7487961|NCT02113436|11802007|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7487962|NCT02113436|11802008|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7487963|NCT02113436|11802009|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
7487964|NCT02113436|11802010|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
7487965|NCT02113436|11802007|FG000|Period 2: 16 Weeks|Physician Decision|0
7487966|NCT02113436|11802008|FG001|Period 2: 16 Weeks|Physician Decision|0
7487967|NCT02113436|11802009|FG002|Period 2: 16 Weeks|Physician Decision|2
7487968|NCT02113436|11802010|FG003|Period 2: 16 Weeks|Physician Decision|0
7487969|NCT02113436|11802007|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
7487970|NCT02113436|11802008|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
7487971|NCT02113436|11802009|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
7487972|NCT02113436|11802010|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
7487973|NCT02113449|11802019|FG000|Overall Study|Adverse Event|4
7487974|NCT02113579|11802029|FG000|Overall Study|Adverse Event|1
7487975|NCT02113579|11802030|FG001|Overall Study|Adverse Event|0
7487976|NCT02113579|11802029|FG000|Overall Study|Withdrawal by Subject|3
7487977|NCT02113579|11802030|FG001|Overall Study|Withdrawal by Subject|2
7487978|NCT02113579|11802029|FG000|Overall Study|Lost to Follow-up|6
7487979|NCT02113579|11802030|FG001|Overall Study|Lost to Follow-up|2
7487980|NCT02113956|11802038|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
7487981|NCT02113956|11802039|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
7487982|NCT02113956|11802038|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
7487983|NCT02113956|11802039|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
7487984|NCT02113956|11802038|FG000|3 Month Post-intervention|Lost to Follow-up|4
7487985|NCT02113956|11802039|FG001|3 Month Post-intervention|Lost to Follow-up|2
7487986|NCT02114151|11802045|FG000|Overall Study|Death|1
7487987|NCT02114151|11802045|FG000|Overall Study|Lost to Follow-up|1
7487988|NCT02114151|11802045|FG000|Overall Study|Withdrawal by Subject|5
7487989|NCT02114177|11802060|FG000|Overall Study|Lost to Follow-up|1
7487990|NCT02114177|11802061|FG001|Overall Study|Lost to Follow-up|2
7487991|NCT02114177|11802060|FG000|Overall Study|Withdrawal by Subject|6
7487992|NCT02114177|11802061|FG001|Overall Study|Withdrawal by Subject|1
7487993|NCT02114177|11802060|FG000|Overall Study|Other|2
7487994|NCT02114177|11802061|FG001|Overall Study|Other|1
7487995|NCT02114203|11802070|FG000|Overall Study|Adverse Event|0
7487996|NCT02114203|11802071|FG001|Overall Study|Adverse Event|1
7487997|NCT02114203|11802072|FG002|Overall Study|Adverse Event|0
7487998|NCT02114203|11802070|FG000|Overall Study|Withdrawal by Subject|0
7487999|NCT02114203|11802071|FG001|Overall Study|Withdrawal by Subject|1
7488000|NCT02114203|11802072|FG002|Overall Study|Withdrawal by Subject|0
7488001|NCT02114268|11802102|FG000|Overall Study|Lost to Follow-up|4
7488002|NCT02114268|11802103|FG001|Overall Study|Lost to Follow-up|1
7488003|NCT02114268|11802104|FG002|Overall Study|Lost to Follow-up|1
7488004|NCT02114268|11802105|FG003|Overall Study|Lost to Follow-up|0
7488005|NCT02114268|11802106|FG004|Overall Study|Lost to Follow-up|0
7488006|NCT02114268|11802107|FG005|Overall Study|Lost to Follow-up|2
7488007|NCT02114268|11802102|FG000|Overall Study|Withdrawal by Subject|1
7488008|NCT02114268|11802103|FG001|Overall Study|Withdrawal by Subject|0
7488009|NCT02114268|11802104|FG002|Overall Study|Withdrawal by Subject|0
7488010|NCT02114268|11802105|FG003|Overall Study|Withdrawal by Subject|0
7488011|NCT02114268|11802106|FG004|Overall Study|Withdrawal by Subject|0
7488012|NCT02114268|11802107|FG005|Overall Study|Withdrawal by Subject|1
7488013|NCT02114268|11802102|FG000|Overall Study|Withdrawn by site due to noncompliance|1
7488014|NCT02114268|11802103|FG001|Overall Study|Withdrawn by site due to noncompliance|0
7488015|NCT02114268|11802104|FG002|Overall Study|Withdrawn by site due to noncompliance|0
7488016|NCT02114268|11802105|FG003|Overall Study|Withdrawn by site due to noncompliance|0
7488017|NCT02114268|11802106|FG004|Overall Study|Withdrawn by site due to noncompliance|0
7488018|NCT02114268|11802107|FG005|Overall Study|Withdrawn by site due to noncompliance|0
7488019|NCT02114385|11802139|FG000|Overall Study|Withdrawal by Subject|3
7488020|NCT02114385|11802140|FG001|Overall Study|Withdrawal by Subject|2
7488021|NCT02114385|11802139|FG000|Overall Study|Lost to Follow-up|0
7488022|NCT02114385|11802140|FG001|Overall Study|Lost to Follow-up|6
7488023|NCT02114515|11802148|FG000|Overall Study|Lost to Follow-up|52
7488024|NCT02114515|11802149|FG001|Overall Study|Lost to Follow-up|55
7488025|NCT02114515|11802148|FG000|Overall Study|Death|12
7488026|NCT02114515|11802149|FG001|Overall Study|Death|12
7488027|NCT02114515|11802148|FG000|Overall Study|Withdrawal by Subject|4
7488028|NCT02114515|11802149|FG001|Overall Study|Withdrawal by Subject|22
7488029|NCT02114515|11802148|FG000|Overall Study|Other|65
7488030|NCT02114515|11802149|FG001|Overall Study|Other|61
7488031|NCT02114606|11802155|FG000|Overall Study|Unable to swallow Cytosponge|6
7488032|NCT02114684|11802161|FG000|Overall Study|Death|6
7488033|NCT02114684|11802162|FG001|Overall Study|Death|4
7488034|NCT02114684|11802161|FG000|Overall Study|Lost to Follow-up|1
7488035|NCT02114684|11802162|FG001|Overall Study|Lost to Follow-up|2
7488036|NCT02114684|11802161|FG000|Overall Study|Withdrawal by Subject|1
7488037|NCT02114684|11802162|FG001|Overall Study|Withdrawal by Subject|2
7488038|NCT02114684|11802161|FG000|Overall Study|Relocation|3
7488039|NCT02114684|11802162|FG001|Overall Study|Relocation|1
7488040|NCT02114684|11802161|FG000|Overall Study|Rifampicin resistant on culture|0
7488041|NCT02114684|11802162|FG001|Overall Study|Rifampicin resistant on culture|1
7488042|NCT02114684|11802161|FG000|Overall Study|Patient Incarcerated|1
7488043|NCT02114684|11802162|FG001|Overall Study|Patient Incarcerated|0
7488044|NCT02114879|11802174|FG000|Overall Study|Withdrawal by Subject|9
7488045|NCT02114879|11802175|FG001|Overall Study|Withdrawal by Subject|5
7488046|NCT02114879|11802174|FG000|Overall Study|Death|6
7488047|NCT02114879|11802175|FG001|Overall Study|Death|11
7488048|NCT02114879|11802174|FG000|Overall Study|Lost to Follow-up|4
7488049|NCT02114879|11802175|FG001|Overall Study|Lost to Follow-up|6
7488050|NCT02114879|11802174|FG000|Overall Study|Physician Decision|0
7488051|NCT02114879|11802175|FG001|Overall Study|Physician Decision|2
7488052|NCT02114892|11802183|FG000|Overall Study|Lost to Follow-up|1
7488053|NCT02114892|11802184|FG001|Overall Study|Lost to Follow-up|2
7488054|NCT02114931|11802192|FG000|Overall Study|Withdrawal by Subject|15
7488055|NCT02114931|11802193|FG001|Overall Study|Withdrawal by Subject|18
7488056|NCT02114931|11802192|FG000|Overall Study|Adverse Event|4
7488057|NCT02114931|11802193|FG001|Overall Study|Adverse Event|6
7488058|NCT02114931|11802192|FG000|Overall Study|Lost to Follow-up|3
7488059|NCT02114931|11802193|FG001|Overall Study|Lost to Follow-up|3
7488060|NCT02114931|11802192|FG000|Overall Study|Physician Decision|1
7488061|NCT02114931|11802193|FG001|Overall Study|Physician Decision|2
7488062|NCT02114931|11802192|FG000|Overall Study|Other|2
7488063|NCT02114931|11802193|FG001|Overall Study|Other|1
7488064|NCT02115113|11802208|FG000|Participants in Run-in Period|Death|0
7488065|NCT02115113|11802209|FG001|Participants in Run-in Period|Death|0
7488066|NCT02115113|11802210|FG002|Participants in Run-in Period|Death|1
7488067|NCT02115113|11802208|FG000|Participants in Run-in Period|Administrative problems|0
7488068|NCT02115113|11802209|FG001|Participants in Run-in Period|Administrative problems|0
7488069|NCT02115113|11802210|FG002|Participants in Run-in Period|Administrative problems|1
7488070|NCT02115113|11802208|FG000|Participants in Run-in Period|Lost to Follow-up|0
7488071|NCT02115113|11802209|FG001|Participants in Run-in Period|Lost to Follow-up|0
7488072|NCT02115113|11802210|FG002|Participants in Run-in Period|Lost to Follow-up|5
7488073|NCT02115113|11802208|FG000|Participants in Run-in Period|Withdrawal by Subject|0
7488074|NCT02115113|11802209|FG001|Participants in Run-in Period|Withdrawal by Subject|0
7488075|NCT02115113|11802210|FG002|Participants in Run-in Period|Withdrawal by Subject|3
7488076|NCT02115113|11802208|FG000|Participants Randomized|Lost to Follow-up|1
7488077|NCT02115113|11802209|FG001|Participants Randomized|Lost to Follow-up|0
7488078|NCT02115113|11802210|FG002|Participants Randomized|Lost to Follow-up|0
7488079|NCT02115113|11802208|FG000|Participants Randomized|Death|1
7488080|NCT02115113|11802209|FG001|Participants Randomized|Death|0
7488081|NCT02115113|11802210|FG002|Participants Randomized|Death|0
7488082|NCT02115139|11802219|FG000|Overall Study|Protocol Violation|1
7488083|NCT02115139|11802219|FG000|Overall Study|treatment discontinuation|6
7488084|NCT02115256|11802225|FG000|Overall Study|Withdrawal by Subject|0
7488085|NCT02115256|11802226|FG001|Overall Study|Withdrawal by Subject|1
7488086|NCT02115269|11802232|FG000|Overall Study|Lost to Follow-up|43
7488087|NCT02115269|11802232|FG000|Overall Study|Did not complete patient diary|3
7488088|NCT02115269|11802232|FG000|Overall Study|Moved to another city|7
7488089|NCT02115269|11802232|FG000|Overall Study|Withdrawal by Subject|2
7488090|NCT02115269|11802232|FG000|Overall Study|Didn't take study drug|2
7488091|NCT02115282|11802249|FG000|Overall Study|Disease progression during treatment|216
7488092|NCT02115282|11802250|FG001|Overall Study|Disease progression during treatment|229
7488093|NCT02115282|11802249|FG000|Overall Study|Adverse Event|49
7488094|NCT02115282|11802250|FG001|Overall Study|Adverse Event|23
7488095|NCT02115282|11802249|FG000|Overall Study|Death|1
7488096|NCT02115282|11802250|FG001|Overall Study|Death|3
7488097|NCT02115282|11802249|FG000|Overall Study|Alternative therapy|1
7488098|NCT02115282|11802250|FG001|Overall Study|Alternative therapy|1
7488099|NCT02115282|11802249|FG000|Overall Study|Complicating disease|0
7488100|NCT02115282|11802250|FG001|Overall Study|Complicating disease|3
7488101|NCT02115282|11802249|FG000|Overall Study|Withdrawal by Subject|12
7488102|NCT02115282|11802250|FG001|Overall Study|Withdrawal by Subject|10
7488103|NCT02115282|11802249|FG000|Overall Study|Symptomatic progression/deterioration|7
7488104|NCT02115282|11802250|FG001|Overall Study|Symptomatic progression/deterioration|18
7488105|NCT02115282|11802249|FG000|Overall Study|Non-compliance|5
7488106|NCT02115282|11802250|FG001|Overall Study|Non-compliance|1
7488107|NCT02115282|11802249|FG000|Overall Study|Protocol Violation|2
7488108|NCT02115282|11802250|FG001|Overall Study|Protocol Violation|2
7488109|NCT02115282|11802249|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
7488110|NCT02115282|11802250|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
7488111|NCT02115282|11802249|FG000|Overall Study|Not start protocol therapy|9
7488112|NCT02115282|11802250|FG001|Overall Study|Not start protocol therapy|10
7488113|NCT02115308|11802260|FG000|Overall Study|Safety Screening|2
7488114|NCT02115308|11802261|FG001|Overall Study|Safety Screening|2
7488115|NCT02115321|11802273|FG000|Overall Study|Death|1
7488116|NCT02115321|11802274|FG001|Overall Study|Death|0
7488117|NCT02115386|11802310|FG000|Overall Study|Protocol Violation|1
7488118|NCT02115386|11802310|FG000|Overall Study|Administrative - trial was terminated|6
7488119|NCT02115607|11802327|FG000|Overall Study|Withdrawal by Subject|1
7488120|NCT02115815|11802370|FG000|Overall Study|Withdrawal by Subject|2
7488121|NCT02115815|11802371|FG001|Overall Study|Withdrawal by Subject|0
7488122|NCT02115815|11802372|FG002|Overall Study|Withdrawal by Subject|0
7488123|NCT02115815|11802373|FG003|Overall Study|Withdrawal by Subject|0
7488124|NCT02115815|11802374|FG004|Overall Study|Withdrawal by Subject|0
7488125|NCT02115815|11802375|FG005|Overall Study|Withdrawal by Subject|0
7488126|NCT02115815|11802376|FG006|Overall Study|Withdrawal by Subject|0
7488127|NCT02115815|11802370|FG000|Overall Study|Not enough drug to dose participant|0
7488128|NCT02115815|11802371|FG001|Overall Study|Not enough drug to dose participant|0
7488129|NCT02115815|11802372|FG002|Overall Study|Not enough drug to dose participant|0
7488130|NCT02115815|11802373|FG003|Overall Study|Not enough drug to dose participant|0
7488131|NCT02115815|11802374|FG004|Overall Study|Not enough drug to dose participant|0
7488132|NCT02115815|11802375|FG005|Overall Study|Not enough drug to dose participant|1
7488133|NCT02115815|11802376|FG006|Overall Study|Not enough drug to dose participant|0
7488134|NCT02115815|11802370|FG000|Overall Study|Missed appointment, randomized in error|0
7488135|NCT02115815|11802371|FG001|Overall Study|Missed appointment, randomized in error|0
7488136|NCT02115815|11802372|FG002|Overall Study|Missed appointment, randomized in error|0
7488137|NCT02115815|11802373|FG003|Overall Study|Missed appointment, randomized in error|0
7488138|NCT02115815|11802374|FG004|Overall Study|Missed appointment, randomized in error|0
7488139|NCT02115815|11802375|FG005|Overall Study|Missed appointment, randomized in error|1
7488140|NCT02115815|11802376|FG006|Overall Study|Missed appointment, randomized in error|0
7488141|NCT02116205|11802409|FG000|Overall Study|Withdrawal by Subject|2
7488142|NCT02116205|11802410|FG001|Overall Study|Withdrawal by Subject|4
7488143|NCT02116205|11802411|FG002|Overall Study|Withdrawal by Subject|1
7488144|NCT02116205|11802412|FG003|Overall Study|Withdrawal by Subject|3
7488145|NCT02116205|11802409|FG000|Overall Study|Lost to Follow-up|0
7488146|NCT02116205|11802410|FG001|Overall Study|Lost to Follow-up|2
7488147|NCT02116205|11802411|FG002|Overall Study|Lost to Follow-up|1
7488148|NCT02116205|11802412|FG003|Overall Study|Lost to Follow-up|2
7488149|NCT02116205|11802409|FG000|Overall Study|Physician Decision|0
7488150|NCT02116205|11802410|FG001|Overall Study|Physician Decision|1
7488151|NCT02116205|11802411|FG002|Overall Study|Physician Decision|1
7488152|NCT02116205|11802412|FG003|Overall Study|Physician Decision|1
7488153|NCT02116205|11802409|FG000|Overall Study|Exclusion criteria|0
7488154|NCT02116205|11802410|FG001|Overall Study|Exclusion criteria|0
7488155|NCT02116205|11802411|FG002|Overall Study|Exclusion criteria|1
7488156|NCT02116205|11802412|FG003|Overall Study|Exclusion criteria|0
7488157|NCT02116309|11802424|FG000|Overall Study|Lost to Follow-up|0
7488158|NCT02116309|11802425|FG001|Overall Study|Lost to Follow-up|1
7488159|NCT02116361|11802439|FG000|Overall Study|Pregnancy|0
7488160|NCT02116361|11802440|FG001|Overall Study|Pregnancy|0
7488161|NCT02116361|11802441|FG002|Overall Study|Pregnancy|0
7488162|NCT02116361|11802442|FG003|Overall Study|Pregnancy|1
7488163|NCT02116361|11802439|FG000|Overall Study|Protocol Violation|1
7488164|NCT02116361|11802440|FG001|Overall Study|Protocol Violation|0
7488165|NCT02116361|11802441|FG002|Overall Study|Protocol Violation|0
7488166|NCT02116361|11802442|FG003|Overall Study|Protocol Violation|2
7488167|NCT02116361|11802439|FG000|Overall Study|Physician Decision|2
7488168|NCT02116361|11802440|FG001|Overall Study|Physician Decision|3
7488169|NCT02116361|11802441|FG002|Overall Study|Physician Decision|0
7488170|NCT02116361|11802442|FG003|Overall Study|Physician Decision|0
7488171|NCT02116361|11802439|FG000|Overall Study|Adverse Event|1
7488172|NCT02116361|11802440|FG001|Overall Study|Adverse Event|0
7488173|NCT02116361|11802441|FG002|Overall Study|Adverse Event|0
7488174|NCT02116361|11802442|FG003|Overall Study|Adverse Event|3
7488175|NCT02116361|11802439|FG000|Overall Study|Other Reasons|3
7488176|NCT02116361|11802440|FG001|Overall Study|Other Reasons|3
7488177|NCT02116361|11802441|FG002|Overall Study|Other Reasons|3
7488178|NCT02116361|11802442|FG003|Overall Study|Other Reasons|3
7488179|NCT02116361|11802439|FG000|Overall Study|Lack of Efficacy|5
7488180|NCT02116361|11802440|FG001|Overall Study|Lack of Efficacy|7
7488181|NCT02116361|11802441|FG002|Overall Study|Lack of Efficacy|4
7488182|NCT02116361|11802442|FG003|Overall Study|Lack of Efficacy|3
7488183|NCT02116361|11802439|FG000|Overall Study|Lost to Follow-up|4
7488184|NCT02116361|11802440|FG001|Overall Study|Lost to Follow-up|5
7488185|NCT02116361|11802441|FG002|Overall Study|Lost to Follow-up|7
7488186|NCT02116361|11802442|FG003|Overall Study|Lost to Follow-up|5
7488187|NCT02116361|11802439|FG000|Overall Study|Personal Reasons|6
7488188|NCT02116361|11802440|FG001|Overall Study|Personal Reasons|6
7488189|NCT02116361|11802441|FG002|Overall Study|Personal Reasons|4
7488190|NCT02116361|11802442|FG003|Overall Study|Personal Reasons|9
7488191|NCT02116361|11802439|FG000|Overall Study|Investigator Decision - Relapse|9
7488192|NCT02116361|11802440|FG001|Overall Study|Investigator Decision - Relapse|7
7488193|NCT02116361|11802441|FG002|Overall Study|Investigator Decision - Relapse|8
7488194|NCT02116361|11802442|FG003|Overall Study|Investigator Decision - Relapse|5
7488195|NCT02116530|11802454|FG000|Overall Study|Withdrawal by Subject|1
7488196|NCT02116530|11802455|FG001|Overall Study|Withdrawal by Subject|2
7488197|NCT02116530|11802454|FG000|Overall Study|Adverse Event|4
7488198|NCT02116530|11802455|FG001|Overall Study|Adverse Event|0
7488199|NCT02116530|11802454|FG000|Overall Study|Physician Decision|1
7488200|NCT02116530|11802455|FG001|Overall Study|Physician Decision|0
7488201|NCT02116530|11802454|FG000|Overall Study|Lost to Follow-up|1
7488202|NCT02116530|11802455|FG001|Overall Study|Lost to Follow-up|0
7488203|NCT02116530|11802454|FG000|Overall Study|Other Medical Problems|2
7488204|NCT02116530|11802455|FG001|Overall Study|Other Medical Problems|2
7488205|NCT02116582|11802461|FG000|Overall Study|Enrolled but Never Received Study Drug|1
7488206|NCT02116582|11802461|FG000|Overall Study|Adverse Event|22
7488207|NCT02116582|11802461|FG000|Overall Study|Death|9
7488208|NCT02116582|11802461|FG000|Overall Study|Progressive Disease|148
7488209|NCT02116582|11802461|FG000|Overall Study|Protocol Violation|3
7488210|NCT02116582|11802461|FG000|Overall Study|Withdrawal by Subject|8
7488211|NCT02116582|11802461|FG000|Overall Study|Other: Miscellaneous|11
7488212|NCT02116582|11802461|FG000|Overall Study|Lost to Follow-up|1
7488213|NCT02116582|11802461|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
7488214|NCT02116608|11802468|FG000|Overall Study|Lost to Follow-up|0
7488215|NCT02116608|11802469|FG001|Overall Study|Lost to Follow-up|0
7488216|NCT02116608|11802470|FG002|Overall Study|Lost to Follow-up|1
7488217|NCT02116608|11802468|FG000|Overall Study|Physician Decision|0
7488218|NCT02116608|11802469|FG001|Overall Study|Physician Decision|1
7488219|NCT02116608|11802470|FG002|Overall Study|Physician Decision|0
7488220|NCT02116608|11802468|FG000|Overall Study|Death|0
7488221|NCT02116608|11802469|FG001|Overall Study|Death|1
7488222|NCT02116608|11802470|FG002|Overall Study|Death|0
7488223|NCT02116621|11802480|FG000|Baseline|Withdrawal by Subject|0
7488224|NCT02116621|11802481|FG001|Baseline|Withdrawal by Subject|4
7488225|NCT02116621|11802480|FG000|Three Month Follow-up|Death|1
7488226|NCT02116621|11802481|FG001|Three Month Follow-up|Death|1
7488227|NCT02116621|11802480|FG000|Three Month Follow-up|Withdrawal by Subject|4
7488228|NCT02116621|11802481|FG001|Three Month Follow-up|Withdrawal by Subject|1
7488229|NCT02116621|11802480|FG000|Three Month Follow-up|Lost to Follow-up|0
7488230|NCT02116621|11802481|FG001|Three Month Follow-up|Lost to Follow-up|1
7488231|NCT02116621|11802480|FG000|Three Month Follow-up|Did not complete follow-up survey|14
7488232|NCT02116621|11802481|FG001|Three Month Follow-up|Did not complete follow-up survey|4
7488233|NCT02116621|11802480|FG000|Six Month Follow-up|Withdrawal by Subject|1
7488234|NCT02116621|11802481|FG001|Six Month Follow-up|Withdrawal by Subject|1
7488235|NCT02116621|11802480|FG000|Six Month Follow-up|Lost to Follow-up|2
7488236|NCT02116621|11802481|FG001|Six Month Follow-up|Lost to Follow-up|1
7488237|NCT02116621|11802480|FG000|Six Month Follow-up|Did not complete follow-up survey|1
7488238|NCT02116621|11802481|FG001|Six Month Follow-up|Did not complete follow-up survey|1
7488239|NCT02116621|11802480|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
7488240|NCT02116621|11802481|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
7488241|NCT02116621|11802480|FG000|Twelve Month Follow-up|Lost to Follow-up|0
7488242|NCT02116621|11802481|FG001|Twelve Month Follow-up|Lost to Follow-up|1
7488243|NCT02116621|11802480|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
7488244|NCT02116621|11802481|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
7488245|NCT02116621|11802480|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
7488246|NCT02116621|11802481|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
7488247|NCT02116660|11802489|FG000|Overall Study|Deteriorating renal function|0
7488248|NCT02116660|11802490|FG001|Overall Study|Deteriorating renal function|1
7488249|NCT02116660|11802489|FG000|Overall Study|Adverse Event|1
7488250|NCT02116660|11802490|FG001|Overall Study|Adverse Event|1
7488251|NCT02116660|11802489|FG000|Overall Study|Withdrawal by Subject|0
7488252|NCT02116660|11802490|FG001|Overall Study|Withdrawal by Subject|2
7488253|NCT02116660|11802489|FG000|Overall Study|Organization reason|1
7488254|NCT02116660|11802490|FG001|Overall Study|Organization reason|0
7488255|NCT02116777|11802505|FG000|Overall Study|Adverse Event|0
7488256|NCT02116777|11802506|FG001|Overall Study|Adverse Event|0
7488257|NCT02116777|11802507|FG002|Overall Study|Adverse Event|0
7488258|NCT02116777|11802508|FG003|Overall Study|Adverse Event|0
7488259|NCT02116777|11802509|FG004|Overall Study|Adverse Event|2
7488260|NCT02116777|11802510|FG005|Overall Study|Adverse Event|2
7488261|NCT02116777|11802511|FG006|Overall Study|Adverse Event|0
7488262|NCT02116777|11802505|FG000|Overall Study|Death|0
7488263|NCT02116777|11802506|FG001|Overall Study|Death|0
7488264|NCT02116777|11802507|FG002|Overall Study|Death|0
7488265|NCT02116777|11802508|FG003|Overall Study|Death|1
7488266|NCT02116777|11802509|FG004|Overall Study|Death|0
7488267|NCT02116777|11802510|FG005|Overall Study|Death|0
7488268|NCT02116777|11802511|FG006|Overall Study|Death|0
7488269|NCT02116777|11802505|FG000|Overall Study|Lack of Efficacy|3
7488270|NCT02116777|11802506|FG001|Overall Study|Lack of Efficacy|3
7488271|NCT02116777|11802507|FG002|Overall Study|Lack of Efficacy|3
7488272|NCT02116777|11802508|FG003|Overall Study|Lack of Efficacy|8
7488273|NCT02116777|11802509|FG004|Overall Study|Lack of Efficacy|4
7488274|NCT02116777|11802510|FG005|Overall Study|Lack of Efficacy|1
7488275|NCT02116777|11802511|FG006|Overall Study|Lack of Efficacy|9
7488276|NCT02116777|11802505|FG000|Overall Study|Physician Decision|0
7488277|NCT02116777|11802506|FG001|Overall Study|Physician Decision|0
7488278|NCT02116777|11802507|FG002|Overall Study|Physician Decision|0
7488279|NCT02116777|11802508|FG003|Overall Study|Physician Decision|2
7488280|NCT02116777|11802509|FG004|Overall Study|Physician Decision|0
7488281|NCT02116777|11802510|FG005|Overall Study|Physician Decision|0
7488282|NCT02116777|11802511|FG006|Overall Study|Physician Decision|0
7488283|NCT02116777|11802505|FG000|Overall Study|Protocol Violation|0
7488284|NCT02116777|11802506|FG001|Overall Study|Protocol Violation|0
7488285|NCT02116777|11802507|FG002|Overall Study|Protocol Violation|0
7488286|NCT02116777|11802508|FG003|Overall Study|Protocol Violation|1
7488287|NCT02116777|11802509|FG004|Overall Study|Protocol Violation|0
7488288|NCT02116777|11802510|FG005|Overall Study|Protocol Violation|0
7488289|NCT02116777|11802511|FG006|Overall Study|Protocol Violation|0
7488290|NCT02116777|11802505|FG000|Overall Study|Withdrawal by Subject|0
7488291|NCT02116777|11802506|FG001|Overall Study|Withdrawal by Subject|0
7488292|NCT02116777|11802507|FG002|Overall Study|Withdrawal by Subject|0
7488293|NCT02116777|11802508|FG003|Overall Study|Withdrawal by Subject|1
7488294|NCT02116777|11802509|FG004|Overall Study|Withdrawal by Subject|0
7488295|NCT02116777|11802510|FG005|Overall Study|Withdrawal by Subject|0
7488296|NCT02116777|11802511|FG006|Overall Study|Withdrawal by Subject|0
7488297|NCT02116803|11802532|FG000|Overall Study|Adverse Event|2
7488298|NCT02116803|11802533|FG001|Overall Study|Adverse Event|1
7488299|NCT02116803|11802532|FG000|Overall Study|Physician Decision|1
7488300|NCT02116803|11802533|FG001|Overall Study|Physician Decision|0
7488301|NCT02116803|11802532|FG000|Overall Study|Progressive disease|4
7488302|NCT02116803|11802533|FG001|Overall Study|Progressive disease|0
7488303|NCT02116803|11802532|FG000|Overall Study|Study terminated by sponsor|2
7488304|NCT02116803|11802533|FG001|Overall Study|Study terminated by sponsor|1
7488305|NCT02116803|11802532|FG000|Overall Study|Death|1
7488306|NCT02116803|11802533|FG001|Overall Study|Death|0
7488307|NCT02116972|11802542|FG000|Overall Study|Adverse Event|4
7488308|NCT02116972|11802543|FG001|Overall Study|Adverse Event|4
7488309|NCT02116972|11802544|FG002|Overall Study|Adverse Event|1
7488310|NCT02116972|11802542|FG000|Overall Study|Withdrawal by Subject|1
7488311|NCT02116972|11802543|FG001|Overall Study|Withdrawal by Subject|1
7488312|NCT02116972|11802544|FG002|Overall Study|Withdrawal by Subject|5
7488313|NCT02116972|11802542|FG000|Overall Study|Protocol Violation|1
7488314|NCT02116972|11802543|FG001|Overall Study|Protocol Violation|0
7488315|NCT02116972|11802544|FG002|Overall Study|Protocol Violation|1
7488316|NCT02116972|11802542|FG000|Overall Study|Lost to Follow-up|4
7488317|NCT02116972|11802543|FG001|Overall Study|Lost to Follow-up|3
7488318|NCT02116972|11802544|FG002|Overall Study|Lost to Follow-up|1
7488319|NCT02116972|11802542|FG000|Overall Study|Lack of Efficacy|6
7488320|NCT02116972|11802543|FG001|Overall Study|Lack of Efficacy|6
7488321|NCT02116972|11802544|FG002|Overall Study|Lack of Efficacy|5
7488322|NCT02116972|11802542|FG000|Overall Study|scheduling conflicts and relocation|3
7488323|NCT02116972|11802543|FG001|Overall Study|scheduling conflicts and relocation|3
7488324|NCT02116972|11802544|FG002|Overall Study|scheduling conflicts and relocation|6
7488325|NCT02117024|11802556|FG000|Overall Study|Progressive Disease|26
7488326|NCT02117024|11802557|FG001|Overall Study|Progressive Disease|9
7488327|NCT02117024|11802556|FG000|Overall Study|Significant Clinical Progression|7
7488328|NCT02117024|11802557|FG001|Overall Study|Significant Clinical Progression|4
7488329|NCT02117024|11802556|FG000|Overall Study|Death|5
7488330|NCT02117024|11802557|FG001|Overall Study|Death|0
7488331|NCT02117024|11802556|FG000|Overall Study|Withdrawal by Subject|3
7488332|NCT02117024|11802557|FG001|Overall Study|Withdrawal by Subject|1
7488333|NCT02117024|11802556|FG000|Overall Study|Protocol Violation|1
7488334|NCT02117024|11802557|FG001|Overall Study|Protocol Violation|0
7488335|NCT02117024|11802556|FG000|Overall Study|Adverse Event|1
7488336|NCT02117024|11802557|FG001|Overall Study|Adverse Event|2
7488337|NCT02117024|11802556|FG000|Overall Study|Randomized in Error|1
7488338|NCT02117024|11802557|FG001|Overall Study|Randomized in Error|0
7488339|NCT02117024|11802556|FG000|Overall Study|Patient returned to primary oncologist|0
7488340|NCT02117024|11802557|FG001|Overall Study|Patient returned to primary oncologist|1
7488341|NCT02117024|11802556|FG000|Overall Study|Patient took treatment break|0
7488342|NCT02117024|11802557|FG001|Overall Study|Patient took treatment break|1
7488343|NCT02117024|11802556|FG000|Overall Study|Physician Decision|0
7488344|NCT02117024|11802557|FG001|Overall Study|Physician Decision|2
7488345|NCT02117349|11802588|FG000|Overall Study|Withdrawal by Subject|1
7488346|NCT02117349|11802589|FG001|Overall Study|Withdrawal by Subject|0
7488347|NCT02117349|11802588|FG000|Overall Study|Lost to Follow-up|1
7488348|NCT02117349|11802589|FG001|Overall Study|Lost to Follow-up|1
7488349|NCT02117349|11802588|FG000|Overall Study|Death|1
7488350|NCT02117349|11802589|FG001|Overall Study|Death|0
7488351|NCT02117414|11802597|FG000|Overall Study|Death|5
7488352|NCT02117414|11802598|FG001|Overall Study|Death|2
7488353|NCT02117414|11802597|FG000|Overall Study|Withdrawal by Subject|10
7488354|NCT02117414|11802598|FG001|Overall Study|Withdrawal by Subject|4
7488355|NCT02117427|11802609|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
7488356|NCT02117427|11802610|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
7488357|NCT02117427|11802611|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
7488358|NCT02117427|11802609|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
7488359|NCT02117427|11802610|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
7488360|NCT02117427|11802611|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
7488361|NCT02117427|11802609|FG000|Overall Study|Physician Decision|0
7488362|NCT02117427|11802610|FG001|Overall Study|Physician Decision|2
7488363|NCT02117427|11802611|FG002|Overall Study|Physician Decision|0
7488364|NCT02117427|11802609|FG000|Overall Study|No longer meets inclusion criteria|0
7488365|NCT02117427|11802610|FG001|Overall Study|No longer meets inclusion criteria|1
7488366|NCT02117427|11802611|FG002|Overall Study|No longer meets inclusion criteria|0
7488367|NCT02117427|11802609|FG000|Overall Study|Death|0
7488368|NCT02117427|11802610|FG001|Overall Study|Death|1
7488369|NCT02117427|11802611|FG002|Overall Study|Death|0
7488370|NCT02117479|11802619|FG000|Overall Study|Death|13
7488371|NCT02117479|11802620|FG001|Overall Study|Death|8
7488372|NCT02117479|11802619|FG000|Overall Study|Adverse Event|8
7488373|NCT02117479|11802620|FG001|Overall Study|Adverse Event|16
7488374|NCT02117479|11802619|FG000|Overall Study|Subject decision|8
7488375|NCT02117479|11802620|FG001|Overall Study|Subject decision|9
7488376|NCT02117479|11802619|FG000|Overall Study|Disease progression|104
7488377|NCT02117479|11802620|FG001|Overall Study|Disease progression|108
7488378|NCT02117479|11802619|FG000|Overall Study|Noncompliance with study treatment|1
7488379|NCT02117479|11802620|FG001|Overall Study|Noncompliance with study treatment|0
7488380|NCT02117479|11802619|FG000|Overall Study|Study terminated by the sponsor|4
7488381|NCT02117479|11802620|FG001|Overall Study|Study terminated by the sponsor|6
7488382|NCT02117479|11802619|FG000|Overall Study|Physician Decision|7
7488383|NCT02117479|11802620|FG001|Overall Study|Physician Decision|2
7488384|NCT02117479|11802619|FG000|Overall Study|Other unspecified|11
7488385|NCT02117479|11802620|FG001|Overall Study|Other unspecified|7
7488386|NCT02117544|11802626|FG000|Period 1|Lost to follow-up (prior to treatment)|2
7488387|NCT02117544|11802627|FG001|Period 1|Lost to follow-up (prior to treatment)|0
7488388|NCT02117570|11802637|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
7488389|NCT02117570|11802638|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
7488390|NCT02117570|11802639|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
7488391|NCT02117570|11802637|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7488392|NCT02117570|11802638|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7488393|NCT02117570|11802639|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
7488394|NCT02117570|11802637|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7488395|NCT02117570|11802638|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7488396|NCT02117570|11802639|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
7488397|NCT02117570|11802637|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
7488398|NCT02117570|11802638|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
7488399|NCT02117570|11802639|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
7488400|NCT02117570|11802637|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7488401|NCT02117570|11802638|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7488402|NCT02117570|11802639|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
7488403|NCT02117570|11802637|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
7488404|NCT02117570|11802638|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7488405|NCT02117570|11802639|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7488406|NCT02117570|11802637|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7488407|NCT02117570|11802638|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
7488408|NCT02117570|11802639|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7488409|NCT02117648|11802650|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
7488410|NCT02117648|11802650|FG000|Abemaciclib Alone Period 1|Adverse Event|1
7488411|NCT02117648|11802650|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
7488412|NCT02117648|11802650|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
7488413|NCT02117648|11802650|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
7488414|NCT02117648|11802650|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
7488415|NCT02117648|11802650|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
7488416|NCT02117648|11802650|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
7488417|NCT02117648|11802650|FG000|Abemaciclib Safety-Extension Phase|Death|3
7488418|NCT02117648|11802650|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
7488419|NCT02117648|11802650|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
7488420|NCT02117687|11802660|FG000|Overall Study|Lost to Follow-up|0
7488421|NCT02117687|11802661|FG001|Overall Study|Lost to Follow-up|1
7488422|NCT02117687|11802660|FG000|Overall Study|Adverse Event|0
7488423|NCT02117687|11802661|FG001|Overall Study|Adverse Event|2
7488424|NCT02117687|11802660|FG000|Overall Study|Other Reasons|1
7488425|NCT02117687|11802661|FG001|Overall Study|Other Reasons|1
7488426|NCT02117713|11802667|FG000|Week 48|Adverse Event|4
7488427|NCT02117713|11802667|FG000|Week 48|Withdrawal by caregiver|2
7488428|NCT02117713|11802667|FG000|Week 48|Did not consent to Protocol Amendment 4|2
7488429|NCT02117713|11802667|FG000|Long Term Follow-up Treatment|Adverse Event|3
7488430|NCT02117713|11802667|FG000|Long Term Follow-up Treatment|Progressive Disease|2
7488431|NCT02117713|11802667|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
7488432|NCT02118012|11802701|FG000|Overall Study|Adverse Event|0
7488433|NCT02118012|11802702|FG001|Overall Study|Adverse Event|1
7488434|NCT02118012|11802701|FG000|Overall Study|Physician Decision|0
7488435|NCT02118012|11802702|FG001|Overall Study|Physician Decision|1
7488436|NCT02118337|11802717|FG000|Overall Study|Other|1
7488437|NCT02118337|11802718|FG001|Overall Study|Other|0
7488438|NCT02118337|11802719|FG002|Overall Study|Other|0
7488439|NCT02118337|11802720|FG003|Overall Study|Other|0
7488440|NCT02118337|11802721|FG004|Overall Study|Other|2
7488441|NCT02118337|11802722|FG005|Overall Study|Other|3
7488442|NCT02118337|11802723|FG006|Overall Study|Other|1
7488443|NCT02118337|11802724|FG007|Overall Study|Other|28
7488444|NCT02118337|11802725|FG008|Overall Study|Other|15
7488445|NCT02118337|11802717|FG000|Overall Study|Lost to Follow-up|0
7488446|NCT02118337|11802718|FG001|Overall Study|Lost to Follow-up|0
7488447|NCT02118337|11802719|FG002|Overall Study|Lost to Follow-up|0
7488448|NCT02118337|11802720|FG003|Overall Study|Lost to Follow-up|0
7488449|NCT02118337|11802721|FG004|Overall Study|Lost to Follow-up|0
7488450|NCT02118337|11802722|FG005|Overall Study|Lost to Follow-up|0
7488451|NCT02118337|11802723|FG006|Overall Study|Lost to Follow-up|0
7488452|NCT02118337|11802724|FG007|Overall Study|Lost to Follow-up|1
7488453|NCT02118337|11802725|FG008|Overall Study|Lost to Follow-up|0
7488454|NCT02118337|11802717|FG000|Overall Study|Withdrawal by Subject|1
7488455|NCT02118337|11802718|FG001|Overall Study|Withdrawal by Subject|3
7488456|NCT02118337|11802719|FG002|Overall Study|Withdrawal by Subject|2
7488457|NCT02118337|11802720|FG003|Overall Study|Withdrawal by Subject|1
7488458|NCT02118337|11802721|FG004|Overall Study|Withdrawal by Subject|2
7488459|NCT02118337|11802722|FG005|Overall Study|Withdrawal by Subject|2
7488460|NCT02118337|11802723|FG006|Overall Study|Withdrawal by Subject|1
7488461|NCT02118337|11802724|FG007|Overall Study|Withdrawal by Subject|4
7488462|NCT02118337|11802725|FG008|Overall Study|Withdrawal by Subject|2
7488463|NCT02118337|11802717|FG000|Overall Study|Death|2
7488464|NCT02118337|11802718|FG001|Overall Study|Death|2
7488465|NCT02118337|11802719|FG002|Overall Study|Death|1
7488466|NCT02118337|11802720|FG003|Overall Study|Death|2
7488467|NCT02118337|11802721|FG004|Overall Study|Death|5
7488468|NCT02118337|11802722|FG005|Overall Study|Death|1
7488469|NCT02118337|11802723|FG006|Overall Study|Death|2
7488470|NCT02118337|11802724|FG007|Overall Study|Death|9
7488471|NCT02118337|11802725|FG008|Overall Study|Death|4
7488472|NCT02118428|11802751|FG000|Overall Study|Physician Decision|0
7488473|NCT02118428|11802752|FG001|Overall Study|Physician Decision|1
7488474|NCT02118428|11802753|FG002|Overall Study|Physician Decision|0
7488475|NCT02118428|11802751|FG000|Overall Study|Withdrawal by Subject|2
7488476|NCT02118428|11802752|FG001|Overall Study|Withdrawal by Subject|2
7488477|NCT02118428|11802753|FG002|Overall Study|Withdrawal by Subject|0
7488478|NCT02118428|11802751|FG000|Overall Study|Death|7
7488479|NCT02118428|11802752|FG001|Overall Study|Death|5
7488480|NCT02118428|11802753|FG002|Overall Study|Death|0
7488481|NCT02118428|11802751|FG000|Overall Study|Lost to Follow-up|3
7488482|NCT02118428|11802752|FG001|Overall Study|Lost to Follow-up|1
7488483|NCT02118428|11802753|FG002|Overall Study|Lost to Follow-up|0
7488484|NCT02118428|11802751|FG000|Overall Study|Screen Failure or Became Inelegible|1
7488485|NCT02118428|11802752|FG001|Overall Study|Screen Failure or Became Inelegible|0
7488486|NCT02118428|11802753|FG002|Overall Study|Screen Failure or Became Inelegible|1
7488487|NCT02118597|11802769|FG000|Overall Study|Sponsor terminated the study|14
7488488|NCT02118597|11802769|FG000|Overall Study|Serious Adverse Event|1
7488489|NCT02118597|11802769|FG000|Overall Study|Investigator's decision|1
7488490|NCT02118714|11802773|FG000|Overall Study|Lost to Follow-up|2
7488491|NCT02118714|11802773|FG000|Overall Study|Protocol Violation|1
7488492|NCT02118766|11802779|FG000|Overall Study|Adverse Event|7
7488493|NCT02118766|11802780|FG001|Overall Study|Adverse Event|2
7488494|NCT02118766|11802779|FG000|Overall Study|Withdrawal by Subject|3
7488495|NCT02118766|11802780|FG001|Overall Study|Withdrawal by Subject|6
7488496|NCT02118766|11802779|FG000|Overall Study|Lost to Follow-up|5
7488497|NCT02118766|11802780|FG001|Overall Study|Lost to Follow-up|4
7488498|NCT02118766|11802779|FG000|Overall Study|Withdrawal by parent/guardian|12
7488499|NCT02118766|11802780|FG001|Overall Study|Withdrawal by parent/guardian|18
7488500|NCT02118766|11802779|FG000|Overall Study|Other|3
7488501|NCT02118766|11802780|FG001|Overall Study|Other|1
7488502|NCT02118792|11802788|FG000|Overall Study|Withdrawal by Subject|6
7488503|NCT02118792|11802789|FG001|Overall Study|Withdrawal by Subject|3
7488504|NCT02118792|11802788|FG000|Overall Study|Lost to Follow-up|4
7488505|NCT02118792|11802789|FG001|Overall Study|Lost to Follow-up|4
7488506|NCT02118792|11802788|FG000|Overall Study|Adverse Event|5
7488507|NCT02118792|11802789|FG001|Overall Study|Adverse Event|4
7488508|NCT02118792|11802788|FG000|Overall Study|Withdrawal by parent/guardian|14
7488509|NCT02118792|11802789|FG001|Overall Study|Withdrawal by parent/guardian|20
7488510|NCT02118792|11802788|FG000|Overall Study|Other|1
7488511|NCT02118792|11802789|FG001|Overall Study|Other|6
7488512|NCT02118792|11802788|FG000|Overall Study|Randomised but not treated|1
7488513|NCT02118792|11802789|FG001|Overall Study|Randomised but not treated|0
7488514|NCT02118896|11802820|FG000|Overall Study|Death|4
7488515|NCT02118896|11802821|FG001|Overall Study|Death|0
7488516|NCT02118896|11802822|FG002|Overall Study|Death|4
7488517|NCT02118896|11802823|FG003|Overall Study|Death|6
7488518|NCT02118896|11802824|FG004|Overall Study|Death|3
7488519|NCT02118896|11802825|FG005|Overall Study|Death|1
7488520|NCT02118896|11802826|FG006|Overall Study|Death|0
7488521|NCT02118896|11802827|FG007|Overall Study|Death|0
7488522|NCT02118896|11802828|FG008|Overall Study|Death|0
7488523|NCT02118896|11802829|FG009|Overall Study|Death|0
7488524|NCT02118896|11802820|FG000|Overall Study|Adverse Event|5
7488525|NCT02118896|11802821|FG001|Overall Study|Adverse Event|4
7488526|NCT02118896|11802822|FG002|Overall Study|Adverse Event|4
7488527|NCT02118896|11802823|FG003|Overall Study|Adverse Event|5
7488528|NCT02118896|11802824|FG004|Overall Study|Adverse Event|5
7488529|NCT02118896|11802825|FG005|Overall Study|Adverse Event|9
7488530|NCT02118896|11802826|FG006|Overall Study|Adverse Event|1
7488531|NCT02118896|11802827|FG007|Overall Study|Adverse Event|1
7488532|NCT02118896|11802828|FG008|Overall Study|Adverse Event|4
7488533|NCT02118896|11802829|FG009|Overall Study|Adverse Event|0
7488534|NCT02118896|11802820|FG000|Overall Study|Consent withdrawn|2
7488535|NCT02118896|11802821|FG001|Overall Study|Consent withdrawn|0
7488536|NCT02118896|11802822|FG002|Overall Study|Consent withdrawn|3
7488537|NCT02118896|11802823|FG003|Overall Study|Consent withdrawn|4
7488538|NCT02118896|11802824|FG004|Overall Study|Consent withdrawn|1
7488539|NCT02118896|11802825|FG005|Overall Study|Consent withdrawn|4
7488540|NCT02118896|11802826|FG006|Overall Study|Consent withdrawn|0
7488541|NCT02118896|11802827|FG007|Overall Study|Consent withdrawn|0
7488542|NCT02118896|11802828|FG008|Overall Study|Consent withdrawn|0
7488543|NCT02118896|11802829|FG009|Overall Study|Consent withdrawn|0
7488544|NCT02118896|11802820|FG000|Overall Study|Non-compliance|2
7488545|NCT02118896|11802821|FG001|Overall Study|Non-compliance|1
7488546|NCT02118896|11802822|FG002|Overall Study|Non-compliance|1
7488547|NCT02118896|11802823|FG003|Overall Study|Non-compliance|5
7488548|NCT02118896|11802824|FG004|Overall Study|Non-compliance|0
7488549|NCT02118896|11802825|FG005|Overall Study|Non-compliance|1
7488550|NCT02118896|11802826|FG006|Overall Study|Non-compliance|0
7488551|NCT02118896|11802827|FG007|Overall Study|Non-compliance|1
7488552|NCT02118896|11802828|FG008|Overall Study|Non-compliance|0
7488553|NCT02118896|11802829|FG009|Overall Study|Non-compliance|0
7488554|NCT02118896|11802820|FG000|Overall Study|Pregnancy|1
7488555|NCT02118896|11802821|FG001|Overall Study|Pregnancy|1
7488556|NCT02118896|11802822|FG002|Overall Study|Pregnancy|0
7488557|NCT02118896|11802823|FG003|Overall Study|Pregnancy|0
7488558|NCT02118896|11802824|FG004|Overall Study|Pregnancy|1
7488559|NCT02118896|11802825|FG005|Overall Study|Pregnancy|3
7488560|NCT02118896|11802826|FG006|Overall Study|Pregnancy|1
7488561|NCT02118896|11802827|FG007|Overall Study|Pregnancy|0
7488562|NCT02118896|11802828|FG008|Overall Study|Pregnancy|0
7488563|NCT02118896|11802829|FG009|Overall Study|Pregnancy|0
7488564|NCT02118896|11802820|FG000|Overall Study|Lost to Follow-up|1
7488565|NCT02118896|11802821|FG001|Overall Study|Lost to Follow-up|2
7488566|NCT02118896|11802822|FG002|Overall Study|Lost to Follow-up|1
7488567|NCT02118896|11802823|FG003|Overall Study|Lost to Follow-up|0
7488568|NCT02118896|11802824|FG004|Overall Study|Lost to Follow-up|2
7488569|NCT02118896|11802825|FG005|Overall Study|Lost to Follow-up|1
7488570|NCT02118896|11802826|FG006|Overall Study|Lost to Follow-up|0
7488571|NCT02118896|11802827|FG007|Overall Study|Lost to Follow-up|0
7488572|NCT02118896|11802828|FG008|Overall Study|Lost to Follow-up|0
7488573|NCT02118896|11802829|FG009|Overall Study|Lost to Follow-up|0
7488574|NCT02118896|11802820|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
7488575|NCT02118896|11802821|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
7488576|NCT02118896|11802822|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
7488577|NCT02118896|11802823|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
7488578|NCT02118896|11802824|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
7488579|NCT02118896|11802825|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
7488580|NCT02118896|11802826|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
7488581|NCT02118896|11802827|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
7488582|NCT02118896|11802828|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
7488583|NCT02118896|11802829|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
7488584|NCT02118896|11802820|FG000|Overall Study|Prohibited medication|0
7488585|NCT02118896|11802821|FG001|Overall Study|Prohibited medication|0
7488586|NCT02118896|11802822|FG002|Overall Study|Prohibited medication|0
7488587|NCT02118896|11802823|FG003|Overall Study|Prohibited medication|0
7488588|NCT02118896|11802824|FG004|Overall Study|Prohibited medication|1
7488589|NCT02118896|11802825|FG005|Overall Study|Prohibited medication|3
7488590|NCT02118896|11802826|FG006|Overall Study|Prohibited medication|0
7488591|NCT02118896|11802827|FG007|Overall Study|Prohibited medication|0
7488592|NCT02118896|11802828|FG008|Overall Study|Prohibited medication|0
7488593|NCT02118896|11802829|FG009|Overall Study|Prohibited medication|0
7488594|NCT02118896|11802820|FG000|Overall Study|Miscellaneous|1
7488595|NCT02118896|11802821|FG001|Overall Study|Miscellaneous|2
7488596|NCT02118896|11802822|FG002|Overall Study|Miscellaneous|0
7488597|NCT02118896|11802823|FG003|Overall Study|Miscellaneous|2
7488598|NCT02118896|11802824|FG004|Overall Study|Miscellaneous|0
7488599|NCT02118896|11802825|FG005|Overall Study|Miscellaneous|4
7488600|NCT02118896|11802826|FG006|Overall Study|Miscellaneous|0
7488601|NCT02118896|11802827|FG007|Overall Study|Miscellaneous|0
7488602|NCT02118896|11802828|FG008|Overall Study|Miscellaneous|0
7488603|NCT02118896|11802829|FG009|Overall Study|Miscellaneous|0
7488604|NCT02118961|11802854|FG000|Overall Study|Withdrawal by Subject|1
7488605|NCT02118961|11802855|FG001|Overall Study|Withdrawal by Subject|0
7488606|NCT02119026|11802863|FG000|1st-line Treatment|Adverse Event|9
7488607|NCT02119026|11802864|FG001|1st-line Treatment|Adverse Event|14
7488608|NCT02119026|11802863|FG000|1st-line Treatment|Physician Decision|3
7488609|NCT02119026|11802864|FG001|1st-line Treatment|Physician Decision|8
7488610|NCT02119026|11802863|FG000|1st-line Treatment|Withdrawal by Subject|4
7488611|NCT02119026|11802864|FG001|1st-line Treatment|Withdrawal by Subject|10
7488612|NCT02119026|11802863|FG000|1st-line Treatment|Patient condition or compliance|6
7488613|NCT02119026|11802864|FG001|1st-line Treatment|Patient condition or compliance|4
7488614|NCT02119026|11802863|FG000|1st-line Treatment|Surgery of metastases|2
7488615|NCT02119026|11802864|FG001|1st-line Treatment|Surgery of metastases|1
7488616|NCT02119026|11802863|FG000|1st-line Treatment|Death|2
7488617|NCT02119026|11802864|FG001|1st-line Treatment|Death|1
7488618|NCT02119026|11802863|FG000|2nd-line Treatment|Lost to Follow-up|2
7488619|NCT02119026|11802864|FG001|2nd-line Treatment|Lost to Follow-up|0
7488620|NCT02119026|11802863|FG000|2nd-line Treatment|Withdrawal by Subject|3
7488621|NCT02119026|11802864|FG001|2nd-line Treatment|Withdrawal by Subject|1
7488622|NCT02119026|11802863|FG000|2nd-line Treatment|Adverse Event|4
7488623|NCT02119026|11802864|FG001|2nd-line Treatment|Adverse Event|1
7488624|NCT02119104|11802870|FG000|Overall Study|Protocol Violation|16
7488625|NCT02119156|11802877|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7488626|NCT02119156|11802878|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
7488627|NCT02119156|11802879|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
7488628|NCT02119156|11802877|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
7488629|NCT02119156|11802878|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7488630|NCT02119156|11802879|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
7488631|NCT02119156|11802877|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
7488632|NCT02119156|11802878|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
7488633|NCT02119156|11802879|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
7488634|NCT02119156|11802877|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
7488635|NCT02119156|11802878|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7488636|NCT02119156|11802879|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
7488637|NCT02119156|11802877|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
7488638|NCT02119156|11802878|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
7488639|NCT02119156|11802879|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
7488640|NCT02119260|11802901|FG000|Overall Study|Adverse Event|1
7488641|NCT02119260|11802902|FG001|Overall Study|Adverse Event|0
7488642|NCT02119260|11802903|FG002|Overall Study|Adverse Event|0
7488643|NCT02119260|11802904|FG003|Overall Study|Adverse Event|0
7488644|NCT02119260|11802905|FG004|Overall Study|Adverse Event|0
7488645|NCT02119260|11802906|FG005|Overall Study|Adverse Event|0
7488646|NCT02119260|11802907|FG006|Overall Study|Adverse Event|0
7488647|NCT02119260|11802901|FG000|Overall Study|Withdrew consent|0
7488648|NCT02119260|11802902|FG001|Overall Study|Withdrew consent|1
7488649|NCT02119260|11802903|FG002|Overall Study|Withdrew consent|1
7488650|NCT02119260|11802904|FG003|Overall Study|Withdrew consent|0
7488651|NCT02119260|11802905|FG004|Overall Study|Withdrew consent|0
7488652|NCT02119260|11802906|FG005|Overall Study|Withdrew consent|0
7488653|NCT02119260|11802907|FG006|Overall Study|Withdrew consent|0
7488654|NCT02119286|11802935|FG000|Overall Study|Adverse Event|9
7488655|NCT02119286|11802936|FG001|Overall Study|Adverse Event|7
7488656|NCT02119286|11802937|FG002|Overall Study|Adverse Event|2
7488657|NCT02119286|11802935|FG000|Overall Study|Lack of Efficacy|11
7488658|NCT02119286|11802936|FG001|Overall Study|Lack of Efficacy|3
7488659|NCT02119286|11802937|FG002|Overall Study|Lack of Efficacy|4
7488660|NCT02119286|11802935|FG000|Overall Study|Lost to Follow-up|2
7488661|NCT02119286|11802936|FG001|Overall Study|Lost to Follow-up|0
7488662|NCT02119286|11802937|FG002|Overall Study|Lost to Follow-up|1
7488663|NCT02119286|11802935|FG000|Overall Study|Withdrawal by Subject|4
7488664|NCT02119286|11802936|FG001|Overall Study|Withdrawal by Subject|1
7488665|NCT02119286|11802937|FG002|Overall Study|Withdrawal by Subject|0
7488666|NCT02119299|11802945|FG000|Overall Study|Withdrawal by Subject|7
7488667|NCT02119299|11802945|FG000|Overall Study|Lack of Efficacy|1
7488668|NCT02119299|11802945|FG000|Overall Study|Pregnancy|1
7488669|NCT02119325|11802949|FG000|Washout Period 1|Adverse Event|0
7488670|NCT02119325|11802950|FG001|Washout Period 1|Adverse Event|1
7488671|NCT02119650|11802973|FG000|Overall Study|Adverse Event|3
7488672|NCT02119650|11802974|FG001|Overall Study|Adverse Event|4
7488673|NCT02119650|11802973|FG000|Overall Study|Subject decision|2
7488674|NCT02119650|11802974|FG001|Overall Study|Subject decision|3
7488675|NCT02119650|11802973|FG000|Overall Study|Disease progression|11
7488676|NCT02119650|11802974|FG001|Overall Study|Disease progression|14
7488677|NCT02119650|11802973|FG000|Overall Study|Death|5
7488678|NCT02119650|11802974|FG001|Overall Study|Death|1
7488679|NCT02119650|11802973|FG000|Overall Study|Noncompliance with study treatment|1
7488680|NCT02119650|11802974|FG001|Overall Study|Noncompliance with study treatment|1
7488681|NCT02119650|11802973|FG000|Overall Study|Study terminated by the sponsor|1
7488682|NCT02119650|11802974|FG001|Overall Study|Study terminated by the sponsor|0
7488683|NCT02119650|11802973|FG000|Overall Study|Physician Decision|0
7488684|NCT02119650|11802974|FG001|Overall Study|Physician Decision|2
7488685|NCT02119650|11802973|FG000|Overall Study|Multiple reasons for termination|2
7488686|NCT02119650|11802974|FG001|Overall Study|Multiple reasons for termination|1
7488687|NCT02119663|11802982|FG000|Overall Study|Disease progression|26
7488688|NCT02119663|11802983|FG001|Overall Study|Disease progression|27
7488689|NCT02119663|11802982|FG000|Overall Study|Adverse Event|5
7488690|NCT02119663|11802983|FG001|Overall Study|Adverse Event|5
7488691|NCT02119663|11802982|FG000|Overall Study|Death|3
7488692|NCT02119663|11802983|FG001|Overall Study|Death|2
7488693|NCT02119663|11802982|FG000|Overall Study|Physician Decision|1
7488694|NCT02119663|11802983|FG001|Overall Study|Physician Decision|2
7488695|NCT02119663|11802982|FG000|Overall Study|Other unspecified|2
7488696|NCT02119663|11802983|FG001|Overall Study|Other unspecified|0
7488697|NCT02119663|11802982|FG000|Overall Study|Subject decision|0
7488698|NCT02119663|11802983|FG001|Overall Study|Subject decision|1
7488699|NCT02119663|11802982|FG000|Overall Study|Study Terminated by the Sponsor|3
7488700|NCT02119663|11802983|FG001|Overall Study|Study Terminated by the Sponsor|4
7488701|NCT02119676|11802993|FG000|Overall Study|Adverse Event|9
7488702|NCT02119676|11802994|FG001|Overall Study|Adverse Event|17
7488703|NCT02119676|11802995|FG002|Overall Study|Adverse Event|10
7488704|NCT02119676|11802996|FG003|Overall Study|Adverse Event|10
7488705|NCT02119676|11802993|FG000|Overall Study|Disease progression|53
7488706|NCT02119676|11802994|FG001|Overall Study|Disease progression|55
7488707|NCT02119676|11802995|FG002|Overall Study|Disease progression|68
7488708|NCT02119676|11802996|FG003|Overall Study|Disease progression|73
7488709|NCT02119676|11802993|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
7488710|NCT02119676|11802994|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
7488711|NCT02119676|11802995|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
7488712|NCT02119676|11802996|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
7488713|NCT02119676|11802993|FG000|Overall Study|Physician Decision|4
7488714|NCT02119676|11802994|FG001|Overall Study|Physician Decision|2
7488715|NCT02119676|11802995|FG002|Overall Study|Physician Decision|3
7488716|NCT02119676|11802996|FG003|Overall Study|Physician Decision|2
7488717|NCT02119676|11802993|FG000|Overall Study|Death|9
7488718|NCT02119676|11802994|FG001|Overall Study|Death|3
7488719|NCT02119676|11802995|FG002|Overall Study|Death|2
7488720|NCT02119676|11802996|FG003|Overall Study|Death|1
7488721|NCT02119676|11802993|FG000|Overall Study|Noncompliance|0
7488722|NCT02119676|11802994|FG001|Overall Study|Noncompliance|1
7488723|NCT02119676|11802995|FG002|Overall Study|Noncompliance|0
7488724|NCT02119676|11802996|FG003|Overall Study|Noncompliance|0
7488725|NCT02119676|11802993|FG000|Overall Study|Lost to Follow-up|0
7488726|NCT02119676|11802994|FG001|Overall Study|Lost to Follow-up|0
7488727|NCT02119676|11802995|FG002|Overall Study|Lost to Follow-up|1
7488728|NCT02119676|11802996|FG003|Overall Study|Lost to Follow-up|0
7488729|NCT02119676|11802993|FG000|Overall Study|Protocol deviation|0
7488730|NCT02119676|11802994|FG001|Overall Study|Protocol deviation|0
7488731|NCT02119676|11802995|FG002|Overall Study|Protocol deviation|1
7488732|NCT02119676|11802996|FG003|Overall Study|Protocol deviation|0
7488733|NCT02119676|11802993|FG000|Overall Study|Other, unspecified|2
7488734|NCT02119676|11802994|FG001|Overall Study|Other, unspecified|1
7488735|NCT02119676|11802995|FG002|Overall Study|Other, unspecified|3
7488736|NCT02119676|11802996|FG003|Overall Study|Other, unspecified|4
7488737|NCT02119676|11802993|FG000|Overall Study|Did not receive study med|2
7488738|NCT02119676|11802994|FG001|Overall Study|Did not receive study med|2
7488739|NCT02119676|11802995|FG002|Overall Study|Did not receive study med|4
7488740|NCT02119676|11802996|FG003|Overall Study|Did not receive study med|5
7488741|NCT02119819|11803012|FG000|Overall Study|Adverse Event|3
7488742|NCT02119819|11803013|FG001|Overall Study|Adverse Event|1
7488743|NCT02119819|11803014|FG002|Overall Study|Adverse Event|2
7488744|NCT02119819|11803015|FG003|Overall Study|Adverse Event|3
7488745|NCT02119819|11803016|FG004|Overall Study|Adverse Event|0
7488746|NCT02119819|11803017|FG005|Overall Study|Adverse Event|1
7488747|NCT02119819|11803012|FG000|Overall Study|Lack of Efficacy|0
7488748|NCT02119819|11803013|FG001|Overall Study|Lack of Efficacy|0
7488749|NCT02119819|11803014|FG002|Overall Study|Lack of Efficacy|0
7488750|NCT02119819|11803015|FG003|Overall Study|Lack of Efficacy|0
7488751|NCT02119819|11803016|FG004|Overall Study|Lack of Efficacy|0
7488752|NCT02119819|11803017|FG005|Overall Study|Lack of Efficacy|1
7488753|NCT02119819|11803012|FG000|Overall Study|Lost to Follow-up|0
7488754|NCT02119819|11803013|FG001|Overall Study|Lost to Follow-up|0
7488755|NCT02119819|11803014|FG002|Overall Study|Lost to Follow-up|1
7488756|NCT02119819|11803015|FG003|Overall Study|Lost to Follow-up|2
7488757|NCT02119819|11803016|FG004|Overall Study|Lost to Follow-up|1
7488758|NCT02119819|11803017|FG005|Overall Study|Lost to Follow-up|2
7488759|NCT02119819|11803012|FG000|Overall Study|Physician Decision|1
7488760|NCT02119819|11803013|FG001|Overall Study|Physician Decision|1
7488761|NCT02119819|11803014|FG002|Overall Study|Physician Decision|0
7488762|NCT02119819|11803015|FG003|Overall Study|Physician Decision|0
7488763|NCT02119819|11803016|FG004|Overall Study|Physician Decision|0
7488764|NCT02119819|11803017|FG005|Overall Study|Physician Decision|1
7488765|NCT02119819|11803012|FG000|Overall Study|Withdrawal by Subject|5
7488766|NCT02119819|11803013|FG001|Overall Study|Withdrawal by Subject|3
7488767|NCT02119819|11803014|FG002|Overall Study|Withdrawal by Subject|0
7488768|NCT02119819|11803015|FG003|Overall Study|Withdrawal by Subject|0
7488769|NCT02119819|11803016|FG004|Overall Study|Withdrawal by Subject|6
7488770|NCT02119819|11803017|FG005|Overall Study|Withdrawal by Subject|10
7488771|NCT02119819|11803012|FG000|Overall Study|Jury Duty|0
7488772|NCT02119819|11803013|FG001|Overall Study|Jury Duty|0
7488773|NCT02119819|11803014|FG002|Overall Study|Jury Duty|1
7488774|NCT02119819|11803015|FG003|Overall Study|Jury Duty|0
7488775|NCT02119819|11803016|FG004|Overall Study|Jury Duty|0
7488776|NCT02119819|11803017|FG005|Overall Study|Jury Duty|0
7488777|NCT02119819|11803012|FG000|Overall Study|Protocol Violation|0
7488778|NCT02119819|11803013|FG001|Overall Study|Protocol Violation|0
7488779|NCT02119819|11803014|FG002|Overall Study|Protocol Violation|0
7488780|NCT02119819|11803015|FG003|Overall Study|Protocol Violation|1
7488781|NCT02119819|11803016|FG004|Overall Study|Protocol Violation|0
7488782|NCT02119819|11803017|FG005|Overall Study|Protocol Violation|0
7488783|NCT02119819|11803012|FG000|Overall Study|Left the city to get a job|0
7488784|NCT02119819|11803013|FG001|Overall Study|Left the city to get a job|0
7488785|NCT02119819|11803014|FG002|Overall Study|Left the city to get a job|0
7488786|NCT02119819|11803015|FG003|Overall Study|Left the city to get a job|1
7488787|NCT02119819|11803016|FG004|Overall Study|Left the city to get a job|0
7488788|NCT02119819|11803017|FG005|Overall Study|Left the city to get a job|0
7488789|NCT02119936|11803040|FG000|Overall Study|Lost to Follow-up|10
7488790|NCT02120027|11803055|FG000|Overall Study|Adverse Event|4
7488791|NCT02120027|11803056|FG001|Overall Study|Adverse Event|5
7488792|NCT02120027|11803055|FG000|Overall Study|Lack of Efficacy|3
7488793|NCT02120027|11803056|FG001|Overall Study|Lack of Efficacy|5
7488794|NCT02120027|11803055|FG000|Overall Study|Lost to Follow-up|5
7488795|NCT02120027|11803056|FG001|Overall Study|Lost to Follow-up|13
7488796|NCT02120027|11803055|FG000|Overall Study|Other|4
7488797|NCT02120027|11803056|FG001|Overall Study|Other|0
7488798|NCT02120027|11803055|FG000|Overall Study|Physician Decision|4
7488799|NCT02120027|11803056|FG001|Overall Study|Physician Decision|3
7488800|NCT02120027|11803055|FG000|Overall Study|Protocol Violation|18
7488801|NCT02120027|11803056|FG001|Overall Study|Protocol Violation|21
7488802|NCT02120027|11803055|FG000|Overall Study|Study terminated by Sponsor|45
7488803|NCT02120027|11803056|FG001|Overall Study|Study terminated by Sponsor|47
7488804|NCT02120027|11803055|FG000|Overall Study|Withdrawal by Subject|33
7488805|NCT02120027|11803056|FG001|Overall Study|Withdrawal by Subject|25
7488806|NCT02120157|11803062|FG000|Overall Study|Death|8
7488807|NCT02120300|11803085|FG000|Overall Study|Enrolled but Never Treated|2
7488808|NCT02120300|11803086|FG001|Overall Study|Enrolled but Never Treated|0
7488809|NCT02120300|11803087|FG002|Overall Study|Enrolled but Never Treated|0
7488810|NCT02120300|11803088|FG003|Overall Study|Enrolled but Never Treated|0
7488811|NCT02120300|11803085|FG000|Overall Study|Lack of Efficacy|0
7488812|NCT02120300|11803086|FG001|Overall Study|Lack of Efficacy|0
7488813|NCT02120300|11803087|FG002|Overall Study|Lack of Efficacy|0
7488814|NCT02120300|11803088|FG003|Overall Study|Lack of Efficacy|1
7488815|NCT02120300|11803085|FG000|Overall Study|Lost to Follow-up|1
7488816|NCT02120300|11803086|FG001|Overall Study|Lost to Follow-up|0
7488817|NCT02120300|11803087|FG002|Overall Study|Lost to Follow-up|0
7488818|NCT02120300|11803088|FG003|Overall Study|Lost to Follow-up|0
7534992|NCT02706886|11882447|FG000|Part A: SAD Period|Withdrawal by Subject|0
7534993|NCT02706886|11882448|FG001|Part A: SAD Period|Withdrawal by Subject|0
7534994|NCT02706886|11882449|FG002|Part A: SAD Period|Withdrawal by Subject|0
7534995|NCT02706886|11882450|FG003|Part A: SAD Period|Withdrawal by Subject|2
7534996|NCT02706886|11882451|FG004|Part A: SAD Period|Withdrawal by Subject|0
7534997|NCT02706886|11882452|FG005|Part A: SAD Period|Withdrawal by Subject|0
7534998|NCT02706886|11882453|FG006|Part A: SAD Period|Withdrawal by Subject|0
7534999|NCT02706886|11882454|FG007|Part A: SAD Period|Withdrawal by Subject|0
7535000|NCT02706886|11882455|FG008|Part A: SAD Period|Withdrawal by Subject|0
7535001|NCT02706899|11882500|FG000|Overall Study|Withdrawal by Subject|1
7535002|NCT02706899|11882501|FG001|Overall Study|Withdrawal by Subject|0
7535003|NCT02706899|11882500|FG000|Overall Study|Death|8
7535004|NCT02706899|11882501|FG001|Overall Study|Death|0
7535005|NCT02706899|11882500|FG000|Overall Study|Study Termination by Sponsor|4
7535006|NCT02706899|11882501|FG001|Overall Study|Study Termination by Sponsor|6
7535007|NCT02706938|11882554|FG000|First Period, 6 Weeks|Adverse Event|8
7535008|NCT02706938|11882555|FG001|First Period, 6 Weeks|Adverse Event|0
7535009|NCT02706938|11882554|FG000|First Period, 6 Weeks|Lost to Follow-up|2
7535010|NCT02706938|11882555|FG001|First Period, 6 Weeks|Lost to Follow-up|2
7535011|NCT02706938|11882554|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
7488819|NCT02120417|11803102|FG000|Overall Study|Death|5
7488820|NCT02120417|11803103|FG001|Overall Study|Death|1
7488821|NCT02120417|11803102|FG000|Overall Study|Adverse Event|3
7488822|NCT02120417|11803103|FG001|Overall Study|Adverse Event|9
7488823|NCT02120417|11803102|FG000|Overall Study|Participant decision|4
7488824|NCT02120417|11803103|FG001|Overall Study|Participant decision|4
7488825|NCT02120417|11803102|FG000|Overall Study|Disease progression|41
7488826|NCT02120417|11803103|FG001|Overall Study|Disease progression|45
7488827|NCT02120417|11803102|FG000|Overall Study|Noncompliance with study treatment|0
7488828|NCT02120417|11803103|FG001|Overall Study|Noncompliance with study treatment|2
7488829|NCT02120417|11803102|FG000|Overall Study|Physician Decision|2
7488830|NCT02120417|11803103|FG001|Overall Study|Physician Decision|3
7488831|NCT02120417|11803102|FG000|Overall Study|Other unspecified|5
7488832|NCT02120417|11803103|FG001|Overall Study|Other unspecified|4
7488833|NCT02120456|11803122|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
7488834|NCT02120456|11803123|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
7488835|NCT02120456|11803124|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
7488836|NCT02120456|11803125|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
7488837|NCT02120456|11803126|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
7488838|NCT02120456|11803127|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
7488839|NCT02120456|11803128|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
7488840|NCT02120456|11803129|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
7488841|NCT02120456|11803130|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
7488842|NCT02120456|11803122|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
7488843|NCT02120456|11803123|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
7488844|NCT02120456|11803124|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
7488845|NCT02120456|11803125|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
7488846|NCT02120456|11803126|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
7488847|NCT02120456|11803127|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
7488848|NCT02120456|11803128|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
7488849|NCT02120456|11803129|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
7488850|NCT02120456|11803130|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
7488851|NCT02120456|11803122|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488852|NCT02120456|11803123|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488853|NCT02120456|11803124|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488854|NCT02120456|11803125|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488855|NCT02120456|11803126|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488856|NCT02120456|11803127|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488857|NCT02120456|11803128|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488858|NCT02120456|11803129|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
7488859|NCT02120456|11803130|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
7488860|NCT02120625|11803150|FG000|Overall Study|Physician Decision|2
7488861|NCT02120664|11803159|FG000|Overall Study|Withdrawal by Subject|0
7488862|NCT02120664|11803160|FG001|Overall Study|Withdrawal by Subject|0
7488863|NCT02120664|11803161|FG002|Overall Study|Withdrawal by Subject|0
7488864|NCT02120664|11803162|FG003|Overall Study|Withdrawal by Subject|1
7488865|NCT02120664|11803163|FG004|Overall Study|Withdrawal by Subject|0
7488866|NCT02120781|11803187|FG000|Overall Study|Physician Decision|2
7488867|NCT02120781|11803188|FG001|Overall Study|Physician Decision|0
7488868|NCT02120781|11803187|FG000|Overall Study|Completion not documented|2
7488869|NCT02120781|11803188|FG001|Overall Study|Completion not documented|1
7488870|NCT02120794|11803194|FG000|Overall Study|Withdrawal by Subject|43
7488871|NCT02120794|11803194|FG000|Overall Study|Adverse Event|10
7488872|NCT02120794|11803194|FG000|Overall Study|Physician Decision|4
7488873|NCT02120794|11803194|FG000|Overall Study|Due to insurance coverage|1
7488874|NCT02120833|11803200|FG000|Overall Study|Adverse Event|1
7488875|NCT02120833|11803201|FG001|Overall Study|Adverse Event|0
7488876|NCT02120833|11803200|FG000|Overall Study|Withdrawal by Subject|2
7488877|NCT02120833|11803201|FG001|Overall Study|Withdrawal by Subject|0
7488878|NCT02120833|11803200|FG000|Overall Study|Lost to Follow-up|1
7488879|NCT02120833|11803201|FG001|Overall Study|Lost to Follow-up|1
7488880|NCT02120898|11803210|FG000|Overall Study|Withdrawal by Subject|4
7488881|NCT02120898|11803211|FG001|Overall Study|Withdrawal by Subject|2
7488882|NCT02120898|11803212|FG002|Overall Study|Withdrawal by Subject|2
7488883|NCT02120898|11803210|FG000|Overall Study|Non-compliance with study drug|3
7488884|NCT02120898|11803211|FG001|Overall Study|Non-compliance with study drug|0
7488885|NCT02120898|11803212|FG002|Overall Study|Non-compliance with study drug|0
7488886|NCT02120898|11803210|FG000|Overall Study|Adverse Event|1
7488887|NCT02120898|11803211|FG001|Overall Study|Adverse Event|2
7488888|NCT02120898|11803212|FG002|Overall Study|Adverse Event|1
7488889|NCT02120898|11803210|FG000|Overall Study|Protocol Violation|1
7488890|NCT02120898|11803211|FG001|Overall Study|Protocol Violation|2
7488891|NCT02120898|11803212|FG002|Overall Study|Protocol Violation|0
7488892|NCT02120898|11803210|FG000|Overall Study|Lost to Follow-up|0
7488893|NCT02120898|11803211|FG001|Overall Study|Lost to Follow-up|0
7488894|NCT02120898|11803212|FG002|Overall Study|Lost to Follow-up|1
7488895|NCT02120924|11803223|FG000|Overall Study|Lack of Efficacy|1
7488896|NCT02120924|11803224|FG001|Overall Study|Lack of Efficacy|2
7488897|NCT02120924|11803225|FG002|Overall Study|Lack of Efficacy|3
7488898|NCT02120924|11803223|FG000|Overall Study|Adverse Event|0
7488899|NCT02120924|11803224|FG001|Overall Study|Adverse Event|1
7488900|NCT02120924|11803225|FG002|Overall Study|Adverse Event|3
7488901|NCT02120924|11803223|FG000|Overall Study|Withdrawal by Subject|16
7488902|NCT02120924|11803224|FG001|Overall Study|Withdrawal by Subject|20
7488903|NCT02120924|11803225|FG002|Overall Study|Withdrawal by Subject|8
7488904|NCT02120924|11803223|FG000|Overall Study|Lost to Follow-up|14
7488905|NCT02120924|11803224|FG001|Overall Study|Lost to Follow-up|14
7488906|NCT02120924|11803225|FG002|Overall Study|Lost to Follow-up|11
7488907|NCT02120924|11803223|FG000|Overall Study|Pregnancy|2
7488908|NCT02120924|11803224|FG001|Overall Study|Pregnancy|0
7488909|NCT02120924|11803225|FG002|Overall Study|Pregnancy|0
7488910|NCT02120924|11803223|FG000|Overall Study|Protocol Violation|3
7488911|NCT02120924|11803224|FG001|Overall Study|Protocol Violation|7
7488912|NCT02120924|11803225|FG002|Overall Study|Protocol Violation|2
7488913|NCT02120924|11803223|FG000|Overall Study|Physician Decision|0
7488914|NCT02120924|11803224|FG001|Overall Study|Physician Decision|1
7488915|NCT02120924|11803225|FG002|Overall Study|Physician Decision|1
7488916|NCT02120924|11803223|FG000|Overall Study|Death|1
7488917|NCT02120924|11803224|FG001|Overall Study|Death|0
7488918|NCT02120924|11803225|FG002|Overall Study|Death|0
7488919|NCT02120924|11803223|FG000|Overall Study|Compliance with IP|5
7488920|NCT02120924|11803224|FG001|Overall Study|Compliance with IP|1
7488921|NCT02120924|11803225|FG002|Overall Study|Compliance with IP|1
7488922|NCT02120950|11803236|FG000|Overall Study|Adverse Event|5
7488923|NCT02120950|11803237|FG001|Overall Study|Adverse Event|4
7488924|NCT02120950|11803238|FG002|Overall Study|Adverse Event|3
7488925|NCT02120950|11803236|FG000|Overall Study|Death|3
7488926|NCT02120950|11803237|FG001|Overall Study|Death|0
7488927|NCT02120950|11803238|FG002|Overall Study|Death|1
7488928|NCT02120950|11803236|FG000|Overall Study|Withdrawal by Subject|6
7488929|NCT02120950|11803237|FG001|Overall Study|Withdrawal by Subject|3
7488930|NCT02120950|11803238|FG002|Overall Study|Withdrawal by Subject|2
7488931|NCT02120950|11803236|FG000|Overall Study|Protocol Violation|1
7488932|NCT02120950|11803237|FG001|Overall Study|Protocol Violation|1
7488933|NCT02120950|11803238|FG002|Overall Study|Protocol Violation|7
7488934|NCT02120950|11803236|FG000|Overall Study|Other reasons|5
7488935|NCT02120950|11803237|FG001|Overall Study|Other reasons|4
7488936|NCT02120950|11803238|FG002|Overall Study|Other reasons|1
7488937|NCT02120950|11803236|FG000|Overall Study|Lost to Follow-up|0
7488938|NCT02120950|11803237|FG001|Overall Study|Lost to Follow-up|2
7488939|NCT02120950|11803238|FG002|Overall Study|Lost to Follow-up|1
7488940|NCT02121002|11803248|FG000|Overall Study|Physician Decision|2
7488941|NCT02121002|11803249|FG001|Overall Study|Physician Decision|0
7488942|NCT02121002|11803250|FG002|Overall Study|Physician Decision|0
7488943|NCT02121002|11803248|FG000|Overall Study|Withdrawal by Subject|3
7488944|NCT02121002|11803249|FG001|Overall Study|Withdrawal by Subject|1
7488945|NCT02121002|11803250|FG002|Overall Study|Withdrawal by Subject|4
7488946|NCT02121002|11803248|FG000|Overall Study|Protocol Violation|1
7488947|NCT02121002|11803249|FG001|Overall Study|Protocol Violation|2
7488948|NCT02121002|11803250|FG002|Overall Study|Protocol Violation|4
7488949|NCT02121002|11803248|FG000|Overall Study|Concomitant therapy|0
7488950|NCT02121002|11803249|FG001|Overall Study|Concomitant therapy|1
7488951|NCT02121002|11803250|FG002|Overall Study|Concomitant therapy|1
7488952|NCT02121002|11803248|FG000|Overall Study|Others|1
7488953|NCT02121002|11803249|FG001|Overall Study|Others|0
7488954|NCT02121002|11803250|FG002|Overall Study|Others|1
7488955|NCT02121210|11803274|FG000|Overall Study|Adverse Event|5
7488956|NCT02121210|11803275|FG001|Overall Study|Adverse Event|7
7488957|NCT02121210|11803274|FG000|Overall Study|Lack of Efficacy|2
7488958|NCT02121210|11803275|FG001|Overall Study|Lack of Efficacy|0
7488959|NCT02121210|11803274|FG000|Overall Study|Other than specified above|0
7488960|NCT02121210|11803275|FG001|Overall Study|Other than specified above|2
7488961|NCT02121262|11803283|FG000|Overall Study|Adverse Event|6
7488962|NCT02121262|11803284|FG001|Overall Study|Adverse Event|3
7488963|NCT02121262|11803283|FG000|Overall Study|Lack of Efficacy|3
7488964|NCT02121262|11803284|FG001|Overall Study|Lack of Efficacy|0
7488965|NCT02121262|11803283|FG000|Overall Study|Personal Reasons|19
7488966|NCT02121262|11803284|FG001|Overall Study|Personal Reasons|5
7488967|NCT02121262|11803283|FG000|Overall Study|Protocol Violation|1
7488968|NCT02121262|11803284|FG001|Overall Study|Protocol Violation|1
7488969|NCT02121262|11803283|FG000|Overall Study|Participant Dropped-out|0
7488970|NCT02121262|11803284|FG001|Overall Study|Participant Dropped-out|1
7488971|NCT02121262|11803283|FG000|Overall Study|Participant was Deemed Unsuitable|1
7488972|NCT02121262|11803284|FG001|Overall Study|Participant was Deemed Unsuitable|0
7488973|NCT02121262|11803283|FG000|Overall Study|Consent Withdrawn|1
7488974|NCT02121262|11803284|FG001|Overall Study|Consent Withdrawn|0
7488975|NCT02121301|11803293|FG000|Overall Study|Protocol Violation|1
7488976|NCT02121301|11803294|FG001|Overall Study|Protocol Violation|4
7488977|NCT02121301|11803295|FG002|Overall Study|Protocol Violation|1
7488978|NCT02121392|11803305|FG000|Prior to Intervention|Protocol Violation|40
7488979|NCT02121392|11803306|FG001|Prior to Intervention|Protocol Violation|35
7488980|NCT02121392|11803305|FG000|Prior to Intervention|Withdrawal by Subject|8
7488981|NCT02121392|11803306|FG001|Prior to Intervention|Withdrawal by Subject|6
7488982|NCT02121392|11803305|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
7488983|NCT02121392|11803306|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
7488984|NCT02121392|11803305|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
7488985|NCT02121392|11803306|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
7488986|NCT02121509|11803331|FG000|Washout Period (35 Days)|Adverse Event|1
7488987|NCT02121509|11803332|FG001|Washout Period (35 Days)|Adverse Event|1
7488988|NCT02121509|11803333|FG002|Washout Period (35 Days)|Adverse Event|0
7488989|NCT02121509|11803334|FG003|Washout Period (35 Days)|Adverse Event|0
7488990|NCT02121509|11803331|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
7488991|NCT02121509|11803332|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
7488992|NCT02121509|11803333|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
7488993|NCT02121509|11803334|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
7488994|NCT02121509|11803331|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
7488995|NCT02121509|11803332|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
7488996|NCT02121509|11803333|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
7488997|NCT02121509|11803334|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
7488998|NCT02121522|11803344|FG000|Overall Study|Adverse Event|1
7488999|NCT02121535|11803350|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
7489000|NCT02121535|11803351|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
7489001|NCT02121535|11803350|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
7489002|NCT02121535|11803351|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
7489003|NCT02121756|11803360|FG000|Overall Study|Adverse Event|3
7489004|NCT02121756|11803361|FG001|Overall Study|Adverse Event|0
7489005|NCT02121756|11803360|FG000|Overall Study|Protocol Violation|1
7489006|NCT02121756|11803361|FG001|Overall Study|Protocol Violation|1
7489007|NCT02121756|11803360|FG000|Overall Study|Physician Decision|2
7489008|NCT02121756|11803361|FG001|Overall Study|Physician Decision|1
7489009|NCT02121795|11803372|FG000|Double-Blind Phase|Randomized but Never Treated|1
7489010|NCT02121795|11803373|FG001|Double-Blind Phase|Randomized but Never Treated|4
7489011|NCT02121795|11803372|FG000|Double-Blind Phase|Withdrawal by Subject|19
7489012|NCT02121795|11803373|FG001|Double-Blind Phase|Withdrawal by Subject|16
7489013|NCT02121795|11803372|FG000|Double-Blind Phase|Lost to Follow-up|7
7489014|NCT02121795|11803373|FG001|Double-Blind Phase|Lost to Follow-up|4
7489015|NCT02121795|11803372|FG000|Double-Blind Phase|Physician Decision|2
7489016|NCT02121795|11803373|FG001|Double-Blind Phase|Physician Decision|5
7489017|NCT02121795|11803372|FG000|Double-Blind Phase|Adverse Event|5
7489018|NCT02121795|11803373|FG001|Double-Blind Phase|Adverse Event|0
7489019|NCT02121795|11803372|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7489020|NCT02121795|11803373|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7489021|NCT02121795|11803372|FG000|Double-Blind Phase|Protocol Violation|0
7489022|NCT02121795|11803373|FG001|Double-Blind Phase|Protocol Violation|3
7489023|NCT02121795|11803372|FG000|Double-Blind Phase|Death|1
7489024|NCT02121795|11803373|FG001|Double-Blind Phase|Death|1
7489025|NCT02121795|11803372|FG000|Open-Label Phase|Physician Decision|8
7489026|NCT02121795|11803373|FG001|Open-Label Phase|Physician Decision|8
7489027|NCT02121795|11803372|FG000|Open-Label Phase|Withdrawal by Subject|3
7489028|NCT02121795|11803373|FG001|Open-Label Phase|Withdrawal by Subject|2
7489029|NCT02121795|11803372|FG000|Open-Label Phase|Lost to Follow-up|1
7489030|NCT02121795|11803373|FG001|Open-Label Phase|Lost to Follow-up|0
7489031|NCT02121808|11803381|FG000|Overall Study|Technical problem|3
7489032|NCT02121834|11803397|FG000|Overall Study|Protocol Violation|0
7489033|NCT02121834|11803398|FG001|Overall Study|Protocol Violation|1
7489034|NCT02121834|11803399|FG002|Overall Study|Protocol Violation|0
7489035|NCT02121834|11803400|FG003|Overall Study|Protocol Violation|0
7489036|NCT02121834|11803401|FG004|Overall Study|Protocol Violation|0
7489037|NCT02121834|11803402|FG005|Overall Study|Protocol Violation|0
7489038|NCT02121834|11803403|FG006|Overall Study|Protocol Violation|0
7489039|NCT02121834|11803397|FG000|Overall Study|Withdrawal by Subject|0
7489040|NCT02121834|11803398|FG001|Overall Study|Withdrawal by Subject|1
7489041|NCT02121834|11803399|FG002|Overall Study|Withdrawal by Subject|1
7489042|NCT02121834|11803400|FG003|Overall Study|Withdrawal by Subject|0
7489043|NCT02121834|11803401|FG004|Overall Study|Withdrawal by Subject|0
7489044|NCT02121834|11803402|FG005|Overall Study|Withdrawal by Subject|0
7489045|NCT02121834|11803403|FG006|Overall Study|Withdrawal by Subject|0
7489046|NCT02121834|11803397|FG000|Overall Study|Lost to Follow-up|0
7489047|NCT02121834|11803398|FG001|Overall Study|Lost to Follow-up|0
7489048|NCT02121834|11803399|FG002|Overall Study|Lost to Follow-up|1
7489049|NCT02121834|11803400|FG003|Overall Study|Lost to Follow-up|0
7489050|NCT02121834|11803401|FG004|Overall Study|Lost to Follow-up|0
7489051|NCT02121834|11803402|FG005|Overall Study|Lost to Follow-up|0
7489052|NCT02121834|11803403|FG006|Overall Study|Lost to Follow-up|0
7489053|NCT02121847|11803429|FG000|Overall Study|Administrative Reasons|1
7489054|NCT02121847|11803429|FG000|Overall Study|Adverse Event|2
7489055|NCT02122146|11803464|FG000|Part 1: Dose Escalation|Death|0
7489056|NCT02122146|11803465|FG001|Part 1: Dose Escalation|Death|1
7489057|NCT02122146|11803466|FG002|Part 1: Dose Escalation|Death|1
7489058|NCT02122146|11803467|FG003|Part 1: Dose Escalation|Death|0
7489059|NCT02122146|11803468|FG004|Part 1: Dose Escalation|Death|0
7489060|NCT02122146|11803469|FG005|Part 1: Dose Escalation|Death|0
7489061|NCT02122146|11803470|FG006|Part 1: Dose Escalation|Death|0
7489062|NCT02122146|11803471|FG007|Part 1: Dose Escalation|Death|0
7489063|NCT02122146|11803464|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
7489064|NCT02122146|11803465|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7489065|NCT02122146|11803466|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
7489066|NCT02122146|11803467|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7489067|NCT02122146|11803468|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
7489068|NCT02122146|11803469|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
7489069|NCT02122146|11803470|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
7489070|NCT02122146|11803471|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
7489071|NCT02122146|11803464|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
7489072|NCT02122146|11803465|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
7489073|NCT02122146|11803466|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
7489074|NCT02122146|11803467|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
7489075|NCT02122146|11803468|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
7489076|NCT02122146|11803469|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
7489077|NCT02122146|11803470|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
7489078|NCT02122146|11803471|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
7489079|NCT02122146|11803464|FG000|Part 1: Dose Escalation|Other|1
7489080|NCT02122146|11803465|FG001|Part 1: Dose Escalation|Other|0
7489081|NCT02122146|11803466|FG002|Part 1: Dose Escalation|Other|0
7489082|NCT02122146|11803467|FG003|Part 1: Dose Escalation|Other|0
7489083|NCT02122146|11803468|FG004|Part 1: Dose Escalation|Other|0
7489084|NCT02122146|11803469|FG005|Part 1: Dose Escalation|Other|1
7489085|NCT02122146|11803470|FG006|Part 1: Dose Escalation|Other|1
7489086|NCT02122146|11803471|FG007|Part 1: Dose Escalation|Other|2
7489087|NCT02122380|11803501|FG000|First Intervention (30 Days)|Adverse Event|1
7489088|NCT02122380|11803502|FG001|First Intervention (30 Days)|Adverse Event|0
7489089|NCT02122380|11803501|FG000|First Intervention (30 Days)|Physician Decision|0
7489090|NCT02122380|11803502|FG001|First Intervention (30 Days)|Physician Decision|1
7489091|NCT02122380|11803501|FG000|Washout (8 Weeks)|Lost to Follow-up|1
7489092|NCT02122380|11803502|FG001|Washout (8 Weeks)|Lost to Follow-up|0
7489093|NCT02122380|11803501|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
7489094|NCT02122380|11803502|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
7489095|NCT02122380|11803501|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
7489096|NCT02122380|11803502|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
7489097|NCT02122770|11803539|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
7489098|NCT02122770|11803540|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
7489099|NCT02122770|11803541|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
7489100|NCT02122770|11803542|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
7489101|NCT02122770|11803543|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
7489102|NCT02122770|11803544|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
7489103|NCT02122770|11803539|FG000|Part A: Drug-drug Interaction 2|Other|0
7489104|NCT02122770|11803540|FG001|Part A: Drug-drug Interaction 2|Other|0
7489105|NCT02122770|11803541|FG002|Part A: Drug-drug Interaction 2|Other|1
7489106|NCT02122770|11803542|FG003|Part A: Drug-drug Interaction 2|Other|0
7489107|NCT02122770|11803543|FG004|Part A: Drug-drug Interaction 2|Other|0
7489108|NCT02122770|11803544|FG005|Part A: Drug-drug Interaction 2|Other|0
7489109|NCT02122770|11803539|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7489110|NCT02122770|11803540|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
7489111|NCT02122770|11803541|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7489112|NCT02122770|11803542|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7489113|NCT02122770|11803543|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7489114|NCT02122770|11803544|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
7489115|NCT02122770|11803539|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7489116|NCT02122770|11803540|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
7489117|NCT02122770|11803541|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7489118|NCT02122770|11803542|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
7489119|NCT02122770|11803543|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7489120|NCT02122770|11803544|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
7489121|NCT02122770|11803539|FG000|Part B: Standard of Care|Adverse Event|0
7489122|NCT02122770|11803540|FG001|Part B: Standard of Care|Adverse Event|0
7489123|NCT02122770|11803541|FG002|Part B: Standard of Care|Adverse Event|0
7489124|NCT02122770|11803542|FG003|Part B: Standard of Care|Adverse Event|0
7489125|NCT02122770|11803543|FG004|Part B: Standard of Care|Adverse Event|4
7489126|NCT02122770|11803544|FG005|Part B: Standard of Care|Adverse Event|1
7489127|NCT02122770|11803539|FG000|Part B: Standard of Care|Other|0
7489128|NCT02122770|11803540|FG001|Part B: Standard of Care|Other|0
7489129|NCT02122770|11803541|FG002|Part B: Standard of Care|Other|0
7489130|NCT02122770|11803542|FG003|Part B: Standard of Care|Other|0
7489131|NCT02122770|11803543|FG004|Part B: Standard of Care|Other|0
7489132|NCT02122770|11803544|FG005|Part B: Standard of Care|Other|2
7489133|NCT02122770|11803539|FG000|Part B: Standard of Care|Withdrawal by Subject|0
7489134|NCT02122770|11803540|FG001|Part B: Standard of Care|Withdrawal by Subject|0
7489135|NCT02122770|11803541|FG002|Part B: Standard of Care|Withdrawal by Subject|0
7489136|NCT02122770|11803542|FG003|Part B: Standard of Care|Withdrawal by Subject|0
7489137|NCT02122770|11803543|FG004|Part B: Standard of Care|Withdrawal by Subject|4
7489138|NCT02122770|11803544|FG005|Part B: Standard of Care|Withdrawal by Subject|2
7489139|NCT02122770|11803539|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
7489140|NCT02122770|11803540|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
7489141|NCT02122770|11803541|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
7489142|NCT02122770|11803542|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
7489143|NCT02122770|11803543|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
7489144|NCT02122770|11803544|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
7489145|NCT02122770|11803539|FG000|Part B: Standard of Care|Progressive Disease|0
7489146|NCT02122770|11803540|FG001|Part B: Standard of Care|Progressive Disease|0
7489147|NCT02122770|11803541|FG002|Part B: Standard of Care|Progressive Disease|0
7489148|NCT02122770|11803542|FG003|Part B: Standard of Care|Progressive Disease|0
7489149|NCT02122770|11803543|FG004|Part B: Standard of Care|Progressive Disease|10
7489150|NCT02122770|11803544|FG005|Part B: Standard of Care|Progressive Disease|8
7489151|NCT02122783|11803569|FG000|Overall Study|Adverse Event|0
7489152|NCT02122783|11803570|FG001|Overall Study|Adverse Event|1
7489153|NCT02122887|11803591|FG000|Overall Study|Withdrawal by Subject|20
7489154|NCT02122887|11803592|FG001|Overall Study|Withdrawal by Subject|2
7489155|NCT02123134|11803622|FG000|Overall Study|Withdrawal of consent|3
7489156|NCT02123134|11803623|FG001|Overall Study|Withdrawal of consent|2
7489157|NCT02123134|11803622|FG000|Overall Study|Administrative decision|0
7489158|NCT02123134|11803623|FG001|Overall Study|Administrative decision|1
7489159|NCT02123251|11803631|FG000|Overall Study|Death|1
7489160|NCT02123251|11803632|FG001|Overall Study|Death|1
7489161|NCT02123251|11803631|FG000|Overall Study|Withdrawal by Subject|0
7489162|NCT02123251|11803632|FG001|Overall Study|Withdrawal by Subject|3
7489163|NCT02123251|11803631|FG000|Overall Study|Lost Medicaid eligibility|29
7489164|NCT02123251|11803632|FG001|Overall Study|Lost Medicaid eligibility|22
7489165|NCT02123251|11803631|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
7489166|NCT02123251|11803632|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
7489167|NCT02123446|11803648|FG000|Washout Period (1 Day)|Physician Decision|1
7489168|NCT02123446|11803649|FG001|Washout Period (1 Day)|Physician Decision|0
7489169|NCT02123459|11803655|FG000|Washout Period (1 Day)|Adverse Event|1
7489170|NCT02123459|11803656|FG001|Washout Period (1 Day)|Adverse Event|0
7489171|NCT02123472|11803662|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
7489172|NCT02123472|11803663|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7489173|NCT02123511|11803680|FG000|Overall Study|Cancelled treatment|1
7489174|NCT02123511|11803681|FG001|Overall Study|Cancelled treatment|0
7489175|NCT02123511|11803680|FG000|Overall Study|Incomplete data|1
7489176|NCT02123511|11803681|FG001|Overall Study|Incomplete data|3
7489177|NCT02123511|11803680|FG000|Overall Study|Ineligible|0
7489178|NCT02123511|11803681|FG001|Overall Study|Ineligible|1
7489179|NCT02123576|11803689|FG000|Overall Study|Adverse Event|1
7489180|NCT02123576|11803690|FG001|Overall Study|Adverse Event|0
7489181|NCT02123797|11803702|FG000|Baseline Intervention|Death|9
7489182|NCT02123797|11803703|FG001|Baseline Intervention|Death|16
7489183|NCT02123797|11803704|FG002|Baseline Intervention|Death|0
7489184|NCT02123797|11803705|FG003|Baseline Intervention|Death|0
7489185|NCT02123797|11803706|FG004|Baseline Intervention|Death|0
7489186|NCT02123797|11803702|FG000|Baseline Intervention|Withdrawal by Subject|2
7489187|NCT02123797|11803703|FG001|Baseline Intervention|Withdrawal by Subject|8
7489188|NCT02123797|11803704|FG002|Baseline Intervention|Withdrawal by Subject|0
7489189|NCT02123797|11803705|FG003|Baseline Intervention|Withdrawal by Subject|0
7489190|NCT02123797|11803706|FG004|Baseline Intervention|Withdrawal by Subject|0
7489191|NCT02123797|11803702|FG000|Baseline Intervention|Relocation|2
7489192|NCT02123797|11803703|FG001|Baseline Intervention|Relocation|0
7489193|NCT02123797|11803704|FG002|Baseline Intervention|Relocation|0
7489194|NCT02123797|11803705|FG003|Baseline Intervention|Relocation|0
7489195|NCT02123797|11803706|FG004|Baseline Intervention|Relocation|0
7489196|NCT02123797|11803702|FG000|Baseline Intervention|Out of window for initial survey|6
7489197|NCT02123797|11803703|FG001|Baseline Intervention|Out of window for initial survey|13
7489198|NCT02123797|11803704|FG002|Baseline Intervention|Out of window for initial survey|0
7489199|NCT02123797|11803705|FG003|Baseline Intervention|Out of window for initial survey|0
7489200|NCT02123797|11803706|FG004|Baseline Intervention|Out of window for initial survey|0
7489201|NCT02123797|11803702|FG000|Baseline Intervention|Lost to Follow-up|0
7489202|NCT02123797|11803703|FG001|Baseline Intervention|Lost to Follow-up|5
7489203|NCT02123797|11803704|FG002|Baseline Intervention|Lost to Follow-up|0
7489204|NCT02123797|11803705|FG003|Baseline Intervention|Lost to Follow-up|0
7489205|NCT02123797|11803706|FG004|Baseline Intervention|Lost to Follow-up|0
7489206|NCT02123797|11803702|FG000|Baseline Intervention|Other Disease|3
7489207|NCT02123797|11803703|FG001|Baseline Intervention|Other Disease|0
7489208|NCT02123797|11803704|FG002|Baseline Intervention|Other Disease|0
7489209|NCT02123797|11803705|FG003|Baseline Intervention|Other Disease|0
7489210|NCT02123797|11803706|FG004|Baseline Intervention|Other Disease|0
7489211|NCT02123797|11803702|FG000|3-month Follow up (Cumulative Counts)|Death|33
7489212|NCT02123797|11803703|FG001|3-month Follow up (Cumulative Counts)|Death|57
7489213|NCT02123797|11803704|FG002|3-month Follow up (Cumulative Counts)|Death|0
7489214|NCT02123797|11803705|FG003|3-month Follow up (Cumulative Counts)|Death|0
7489215|NCT02123797|11803706|FG004|3-month Follow up (Cumulative Counts)|Death|0
7489216|NCT02123797|11803702|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
7489217|NCT02123797|11803703|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
7489218|NCT02123797|11803704|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
7489219|NCT02123797|11803705|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
7489220|NCT02123797|11803706|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7489221|NCT02123797|11803702|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
7489222|NCT02123797|11803703|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
7489223|NCT02123797|11803704|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489224|NCT02123797|11803705|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489225|NCT02123797|11803706|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489226|NCT02123797|11803702|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
7489227|NCT02123797|11803703|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
7489228|NCT02123797|11803704|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
7489229|NCT02123797|11803705|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
7489230|NCT02123797|11803706|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
7489231|NCT02123797|11803702|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
7489232|NCT02123797|11803703|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
7489233|NCT02123797|11803704|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7489234|NCT02123797|11803705|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7489235|NCT02123797|11803706|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
7489236|NCT02123797|11803702|FG000|6-month Follow up (Cumulative Counts)|Death|51
7489237|NCT02123797|11803703|FG001|6-month Follow up (Cumulative Counts)|Death|97
7489238|NCT02123797|11803704|FG002|6-month Follow up (Cumulative Counts)|Death|0
7489239|NCT02123797|11803705|FG003|6-month Follow up (Cumulative Counts)|Death|0
7489240|NCT02123797|11803706|FG004|6-month Follow up (Cumulative Counts)|Death|0
7489241|NCT02123797|11803702|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7489242|NCT02123797|11803703|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
7489243|NCT02123797|11803704|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
7489244|NCT02123797|11803705|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
7489245|NCT02123797|11803706|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
7489246|NCT02123797|11803702|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
7489247|NCT02123797|11803703|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
7489248|NCT02123797|11803704|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489249|NCT02123797|11803705|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489250|NCT02123797|11803706|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
7489251|NCT02123797|11803702|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
7489252|NCT02123797|11803703|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
7489253|NCT02123797|11803704|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
7489254|NCT02123797|11803705|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
7489255|NCT02123797|11803706|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
7489256|NCT02123966|11803737|FG000|Overall Study|Intercurrent Illness|1
7489257|NCT02124161|11803781|FG000|Overall Study|Other unspecified|0
7489258|NCT02124161|11803782|FG001|Overall Study|Other unspecified|1
7489259|NCT02124161|11803781|FG000|Overall Study|Death|1
7489260|NCT02124161|11803782|FG001|Overall Study|Death|0
7489261|NCT02124161|11803781|FG000|Overall Study|Protocol Violation|2
7489262|NCT02124161|11803782|FG001|Overall Study|Protocol Violation|1
7489263|NCT02124161|11803781|FG000|Overall Study|Withdrawal by Subject|1
7489264|NCT02124161|11803782|FG001|Overall Study|Withdrawal by Subject|2
7489265|NCT02124161|11803781|FG000|Overall Study|Adverse Event|2
7489266|NCT02124161|11803782|FG001|Overall Study|Adverse Event|0
7489267|NCT02124161|11803781|FG000|Overall Study|Does not meet entrance criteria|2
7489268|NCT02124161|11803782|FG001|Overall Study|Does not meet entrance criteria|3
7489269|NCT02124161|11803781|FG000|Overall Study|No longer meets eligibility criteria|5
7489270|NCT02124161|11803782|FG001|Overall Study|No longer meets eligibility criteria|4
7489271|NCT02124161|11803781|FG000|Overall Study|Lost to Follow-up|3
7489272|NCT02124161|11803782|FG001|Overall Study|Lost to Follow-up|4
7489273|NCT02124265|11803795|FG000|Overall Study|Adverse Event|1
7489274|NCT02124564|11803827|FG000|Treatment Period|Adverse Event|2
7489275|NCT02124564|11803827|FG000|Treatment Period|Lack of Efficacy|3
7489276|NCT02124564|11803827|FG000|Treatment Period|Withdrawal by Subject|2
7489277|NCT02124707|11803837|FG000|Overall Study|Adverse Event|5
7489278|NCT02124707|11803837|FG000|Overall Study|Physician Decision|1
7489279|NCT02124707|11803837|FG000|Overall Study|Death|1
7489280|NCT02124746|11803845|FG000|Overall Study|Adverse Event|2
7489281|NCT02124746|11803846|FG001|Overall Study|Adverse Event|1
7489282|NCT02124746|11803847|FG002|Overall Study|Adverse Event|2
7489283|NCT02124746|11803845|FG000|Overall Study|Death|2
7489284|NCT02124746|11803846|FG001|Overall Study|Death|1
7489285|NCT02124746|11803847|FG002|Overall Study|Death|3
7489286|NCT02124746|11803845|FG000|Overall Study|Lack of Efficacy|3
7489287|NCT02124746|11803846|FG001|Overall Study|Lack of Efficacy|2
7489288|NCT02124746|11803847|FG002|Overall Study|Lack of Efficacy|2
7489289|NCT02124746|11803845|FG000|Overall Study|Physician Decision|6
7489290|NCT02124746|11803846|FG001|Overall Study|Physician Decision|4
7489291|NCT02124746|11803847|FG002|Overall Study|Physician Decision|5
7489292|NCT02124746|11803845|FG000|Overall Study|Non-Compliance with Study Drug|0
7489293|NCT02124746|11803846|FG001|Overall Study|Non-Compliance with Study Drug|1
7489294|NCT02124746|11803847|FG002|Overall Study|Non-Compliance with Study Drug|0
7489295|NCT02124746|11803845|FG000|Overall Study|Withdrawal by Subject|3
7489296|NCT02124746|11803846|FG001|Overall Study|Withdrawal by Subject|3
7489297|NCT02124746|11803847|FG002|Overall Study|Withdrawal by Subject|0
7489298|NCT02124746|11803845|FG000|Overall Study|Study Terminated by Sponsor|0
7489299|NCT02124746|11803846|FG001|Overall Study|Study Terminated by Sponsor|0
7489300|NCT02124746|11803847|FG002|Overall Study|Study Terminated by Sponsor|6
7489301|NCT02124746|11803845|FG000|Overall Study|Disease Progression|3
7489302|NCT02124746|11803846|FG001|Overall Study|Disease Progression|6
7489303|NCT02124746|11803847|FG002|Overall Study|Disease Progression|4
7489304|NCT02124759|11803858|FG000|Overall Study|Withdrawal by Subject|3
7489305|NCT02124759|11803859|FG001|Overall Study|Withdrawal by Subject|1
7489306|NCT02124759|11803860|FG002|Overall Study|Withdrawal by Subject|1
7489307|NCT02124759|11803858|FG000|Overall Study|Screen Fail|2
7489308|NCT02124759|11803859|FG001|Overall Study|Screen Fail|2
7489309|NCT02124759|11803860|FG002|Overall Study|Screen Fail|3
7489310|NCT02124772|11803886|FG000|Overall Study|Lack of Efficacy|2
7489311|NCT02124772|11803887|FG001|Overall Study|Lack of Efficacy|0
7489312|NCT02124772|11803888|FG002|Overall Study|Lack of Efficacy|0
7489313|NCT02124772|11803889|FG003|Overall Study|Lack of Efficacy|1
7489314|NCT02124772|11803890|FG004|Overall Study|Lack of Efficacy|2
7489315|NCT02124772|11803891|FG005|Overall Study|Lack of Efficacy|3
7489316|NCT02124772|11803892|FG006|Overall Study|Lack of Efficacy|0
7489317|NCT02124772|11803893|FG007|Overall Study|Lack of Efficacy|2
7489318|NCT02124772|11803894|FG008|Overall Study|Lack of Efficacy|0
7489319|NCT02124772|11803895|FG009|Overall Study|Lack of Efficacy|1
7489320|NCT02124772|11803896|FG010|Overall Study|Lack of Efficacy|0
7489321|NCT02124772|11803897|FG011|Overall Study|Lack of Efficacy|0
7489322|NCT02124772|11803898|FG012|Overall Study|Lack of Efficacy|1
7489323|NCT02124772|11803886|FG000|Overall Study|Adverse Event|1
7489324|NCT02124772|11803887|FG001|Overall Study|Adverse Event|4
7489325|NCT02124772|11803888|FG002|Overall Study|Adverse Event|1
7489326|NCT02124772|11803889|FG003|Overall Study|Adverse Event|5
7489327|NCT02124772|11803890|FG004|Overall Study|Adverse Event|2
7489328|NCT02124772|11803891|FG005|Overall Study|Adverse Event|1
7489329|NCT02124772|11803892|FG006|Overall Study|Adverse Event|1
7489330|NCT02124772|11803893|FG007|Overall Study|Adverse Event|5
7489331|NCT02124772|11803894|FG008|Overall Study|Adverse Event|0
7489332|NCT02124772|11803895|FG009|Overall Study|Adverse Event|3
7489333|NCT02124772|11803896|FG010|Overall Study|Adverse Event|1
7489334|NCT02124772|11803897|FG011|Overall Study|Adverse Event|3
7489335|NCT02124772|11803898|FG012|Overall Study|Adverse Event|1
7489336|NCT02124772|11803886|FG000|Overall Study|Withdrawal consent|0
7489337|NCT02124772|11803887|FG001|Overall Study|Withdrawal consent|1
7489338|NCT02124772|11803888|FG002|Overall Study|Withdrawal consent|1
7489339|NCT02124772|11803889|FG003|Overall Study|Withdrawal consent|1
7489340|NCT02124772|11803890|FG004|Overall Study|Withdrawal consent|0
7489341|NCT02124772|11803891|FG005|Overall Study|Withdrawal consent|1
7489342|NCT02124772|11803892|FG006|Overall Study|Withdrawal consent|1
7489343|NCT02124772|11803893|FG007|Overall Study|Withdrawal consent|0
7489344|NCT02124772|11803894|FG008|Overall Study|Withdrawal consent|0
7489345|NCT02124772|11803895|FG009|Overall Study|Withdrawal consent|1
7489346|NCT02124772|11803896|FG010|Overall Study|Withdrawal consent|0
7489347|NCT02124772|11803897|FG011|Overall Study|Withdrawal consent|1
7489348|NCT02124772|11803898|FG012|Overall Study|Withdrawal consent|0
7489349|NCT02124772|11803886|FG000|Overall Study|Investigator discretion|0
7489350|NCT02124772|11803887|FG001|Overall Study|Investigator discretion|2
7489351|NCT02124772|11803888|FG002|Overall Study|Investigator discretion|2
7489352|NCT02124772|11803889|FG003|Overall Study|Investigator discretion|1
7489353|NCT02124772|11803890|FG004|Overall Study|Investigator discretion|1
7489354|NCT02124772|11803891|FG005|Overall Study|Investigator discretion|0
7489355|NCT02124772|11803892|FG006|Overall Study|Investigator discretion|1
7489356|NCT02124772|11803893|FG007|Overall Study|Investigator discretion|0
7489357|NCT02124772|11803894|FG008|Overall Study|Investigator discretion|0
7489358|NCT02124772|11803895|FG009|Overall Study|Investigator discretion|1
7489359|NCT02124772|11803896|FG010|Overall Study|Investigator discretion|0
7489360|NCT02124772|11803897|FG011|Overall Study|Investigator discretion|1
7489361|NCT02124772|11803898|FG012|Overall Study|Investigator discretion|0
7489362|NCT02124772|11803886|FG000|Overall Study|Progressive disease|0
7489363|NCT02124772|11803887|FG001|Overall Study|Progressive disease|0
7489364|NCT02124772|11803888|FG002|Overall Study|Progressive disease|0
7489365|NCT02124772|11803889|FG003|Overall Study|Progressive disease|0
7489366|NCT02124772|11803890|FG004|Overall Study|Progressive disease|0
7489367|NCT02124772|11803891|FG005|Overall Study|Progressive disease|0
7489368|NCT02124772|11803892|FG006|Overall Study|Progressive disease|1
7489369|NCT02124772|11803893|FG007|Overall Study|Progressive disease|1
7489370|NCT02124772|11803894|FG008|Overall Study|Progressive disease|0
7489371|NCT02124772|11803895|FG009|Overall Study|Progressive disease|0
7489372|NCT02124772|11803896|FG010|Overall Study|Progressive disease|0
7489373|NCT02124772|11803897|FG011|Overall Study|Progressive disease|0
7489374|NCT02124772|11803898|FG012|Overall Study|Progressive disease|0
7489375|NCT02124772|11803886|FG000|Overall Study|Other|0
7489376|NCT02124772|11803887|FG001|Overall Study|Other|7
7489377|NCT02124772|11803888|FG002|Overall Study|Other|2
7489378|NCT02124772|11803889|FG003|Overall Study|Other|5
7489379|NCT02124772|11803890|FG004|Overall Study|Other|4
7489380|NCT02124772|11803891|FG005|Overall Study|Other|3
7489381|NCT02124772|11803892|FG006|Overall Study|Other|4
7489382|NCT02124772|11803893|FG007|Overall Study|Other|1
7489383|NCT02124772|11803894|FG008|Overall Study|Other|1
7489384|NCT02124772|11803895|FG009|Overall Study|Other|1
7489385|NCT02124772|11803896|FG010|Overall Study|Other|1
7489386|NCT02124772|11803897|FG011|Overall Study|Other|1
7489387|NCT02124772|11803898|FG012|Overall Study|Other|0
7489388|NCT02124798|11803950|FG000|Overall Study|Adverse Event|3
7489389|NCT02124798|11803950|FG000|Overall Study|Lost to Follow-up|1
7489390|NCT02124811|11803956|FG000|Overall Study|Early termination|2
7489391|NCT02124811|11803957|FG001|Overall Study|Early termination|2
7489392|NCT02124811|11803956|FG000|Overall Study|Withdrawal by Subject|1
7489393|NCT02124811|11803957|FG001|Overall Study|Withdrawal by Subject|0
7489394|NCT02125279|11803978|FG000|Overall Study|Lack of Efficacy|2
7489395|NCT02125279|11803978|FG000|Overall Study|Withdrawal by Subject|6
7489396|NCT02125279|11803978|FG000|Overall Study|Protocol Violation|1
7489397|NCT02125279|11803978|FG000|Overall Study|Lost to Follow-up|4
7489398|NCT02125331|11804000|FG000|Overall Study|Protocol Violation|1
7489399|NCT02125331|11804001|FG001|Overall Study|Protocol Violation|0
7489400|NCT02125331|11804000|FG000|Overall Study|technical problem|2
7489401|NCT02125331|11804001|FG001|Overall Study|technical problem|0
7489402|NCT02125331|11804000|FG000|Overall Study|screen failure|2
7489403|NCT02125331|11804001|FG001|Overall Study|screen failure|0
7489404|NCT02125604|11804007|FG000|Overall Study|Other|4
7489405|NCT02125604|11804007|FG000|Overall Study|Investigator Decision|1
7489406|NCT02125604|11804007|FG000|Overall Study|Lost to Follow-up|2
7489407|NCT02125604|11804007|FG000|Overall Study|Consent Withdrawn|4
7489408|NCT02125604|11804007|FG000|Overall Study|Adverse Event|20
7489409|NCT02125734|11804017|FG000|Period 2|Adverse Event|0
7489410|NCT02125734|11804018|FG001|Period 2|Adverse Event|1
7489411|NCT02125838|11804026|FG000|Overall Study|Lost to Follow-up|4
7489412|NCT02125838|11804027|FG001|Overall Study|Lost to Follow-up|4
7489413|NCT02125877|11804035|FG000|Overall Study|Physician Decision|1
7489414|NCT02125877|11804036|FG001|Overall Study|Physician Decision|0
7489415|NCT02125877|11804035|FG000|Overall Study|Death|0
7489416|NCT02125877|11804036|FG001|Overall Study|Death|1
7489417|NCT02125877|11804035|FG000|Overall Study|Administrative problems|0
7489418|NCT02125877|11804036|FG001|Overall Study|Administrative problems|1
7489419|NCT02125877|11804035|FG000|Overall Study|Participant/guardian decision|0
7489420|NCT02125877|11804036|FG001|Overall Study|Participant/guardian decision|2
7489421|NCT02125877|11804035|FG000|Overall Study|Withdrawal by Subject|2
7489422|NCT02125877|11804036|FG001|Overall Study|Withdrawal by Subject|1
7489423|NCT02125877|11804035|FG000|Overall Study|Protocol deviation|4
7489424|NCT02125877|11804036|FG001|Overall Study|Protocol deviation|1
7489425|NCT02125877|11804035|FG000|Overall Study|Adverse Event|6
7489426|NCT02125877|11804036|FG001|Overall Study|Adverse Event|4
7489427|NCT02126670|11804066|FG000|Overall Study|Withdrawal by Subject|1
7489428|NCT02126670|11804067|FG001|Overall Study|Withdrawal by Subject|0
7489429|NCT02126670|11804068|FG002|Overall Study|Withdrawal by Subject|0
7489430|NCT02126670|11804069|FG003|Overall Study|Withdrawal by Subject|1
7489431|NCT02126826|11804099|FG000|Overall Study|Withdrawal by Subject|0
7489432|NCT02126826|11804100|FG001|Overall Study|Withdrawal by Subject|0
7489433|NCT02126826|11804101|FG002|Overall Study|Withdrawal by Subject|0
7489434|NCT02126826|11804102|FG003|Overall Study|Withdrawal by Subject|1
7489435|NCT02126826|11804103|FG004|Overall Study|Withdrawal by Subject|0
7489436|NCT02126826|11804104|FG005|Overall Study|Withdrawal by Subject|0
7489437|NCT02126826|11804105|FG006|Overall Study|Withdrawal by Subject|0
7489438|NCT02126839|11804128|FG000|Overall Study|Adverse Event|0
7489439|NCT02126839|11804129|FG001|Overall Study|Adverse Event|1
7489440|NCT02126839|11804128|FG000|Overall Study|Withdrawal by Subject|1
7489441|NCT02126839|11804129|FG001|Overall Study|Withdrawal by Subject|0
7489442|NCT02126839|11804128|FG000|Overall Study|Withdrawal by parent/guardian|1
7489443|NCT02126839|11804129|FG001|Overall Study|Withdrawal by parent/guardian|0
7489444|NCT02126839|11804128|FG000|Overall Study|Protocol Violation|2
7489445|NCT02126839|11804129|FG001|Overall Study|Protocol Violation|3
7489446|NCT02126839|11804128|FG000|Overall Study|Sponsor request|0
7489447|NCT02126839|11804129|FG001|Overall Study|Sponsor request|1
7489448|NCT02126839|11804128|FG000|Overall Study|Lost to Follow-up|1
7489449|NCT02126839|11804129|FG001|Overall Study|Lost to Follow-up|4
7489450|NCT02126839|11804128|FG000|Overall Study|Other|5
7489451|NCT02126839|11804129|FG001|Overall Study|Other|5
7489454|NCT02127125|11804153|FG000|Overall Study|Lost to Follow-up|0
7489455|NCT02127125|11804154|FG001|Overall Study|Lost to Follow-up|0
7489456|NCT02127125|11804155|FG002|Overall Study|Lost to Follow-up|0
7489457|NCT02127125|11804156|FG003|Overall Study|Lost to Follow-up|0
7489458|NCT02127125|11804157|FG004|Overall Study|Lost to Follow-up|2
7489459|NCT02127125|11804158|FG005|Overall Study|Lost to Follow-up|1
7489460|NCT02127125|11804159|FG006|Overall Study|Lost to Follow-up|0
7489461|NCT02127125|11804160|FG007|Overall Study|Lost to Follow-up|0
7489462|NCT02127125|11804161|FG008|Overall Study|Lost to Follow-up|0
7489463|NCT02127125|11804153|FG000|Overall Study|Withdrawal by Subject|0
7489464|NCT02127125|11804154|FG001|Overall Study|Withdrawal by Subject|0
7489465|NCT02127125|11804155|FG002|Overall Study|Withdrawal by Subject|0
7489466|NCT02127125|11804156|FG003|Overall Study|Withdrawal by Subject|1
7489467|NCT02127125|11804157|FG004|Overall Study|Withdrawal by Subject|0
7489468|NCT02127125|11804158|FG005|Overall Study|Withdrawal by Subject|0
7489469|NCT02127125|11804159|FG006|Overall Study|Withdrawal by Subject|0
7489470|NCT02127125|11804160|FG007|Overall Study|Withdrawal by Subject|0
7489471|NCT02127125|11804161|FG008|Overall Study|Withdrawal by Subject|0
7489472|NCT02127125|11804153|FG000|Overall Study|Physician Decision|0
7489473|NCT02127125|11804154|FG001|Overall Study|Physician Decision|0
7489474|NCT02127125|11804155|FG002|Overall Study|Physician Decision|1
7489475|NCT02127125|11804156|FG003|Overall Study|Physician Decision|0
7489476|NCT02127125|11804157|FG004|Overall Study|Physician Decision|1
7489477|NCT02127125|11804158|FG005|Overall Study|Physician Decision|2
7489478|NCT02127125|11804159|FG006|Overall Study|Physician Decision|0
7489479|NCT02127125|11804160|FG007|Overall Study|Physician Decision|0
7489480|NCT02127125|11804161|FG008|Overall Study|Physician Decision|0
7489481|NCT02127281|11804183|FG000|Overall Study|Lost to Follow-up|1
7489482|NCT02127281|11804184|FG001|Overall Study|Lost to Follow-up|0
7489483|NCT02127307|11804190|FG000|Overall Study|Protocol Violation|36
7489484|NCT02127307|11804190|FG000|Overall Study|Lost to Follow-up|2
7489485|NCT02127307|11804190|FG000|Overall Study|Death|101
7489486|NCT02127307|11804190|FG000|Overall Study|Other than specified above|169
7489487|NCT02127372|11804196|FG000|Overall Study|Withdrawal by Subject|1
7489488|NCT02127372|11804197|FG001|Overall Study|Withdrawal by Subject|0
7535012|NCT02706938|11882555|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
7535013|NCT02706938|11882554|FG000|Second Period, 6 Weeks|Adverse Event|0
7535014|NCT02706938|11882555|FG001|Second Period, 6 Weeks|Adverse Event|7
7535015|NCT02706938|11882554|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
7535016|NCT02706938|11882555|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
7535029|NCT02707601|11882613|FG000|Overall Study|Death|0
7535030|NCT02707601|11882614|FG001|Overall Study|Death|1
7535031|NCT02707601|11882613|FG000|Overall Study|Lack of Efficacy|0
7535032|NCT02707601|11882614|FG001|Overall Study|Lack of Efficacy|1
7535033|NCT02707601|11882613|FG000|Overall Study|Investigator's Discretion|1
7535034|NCT02707601|11882614|FG001|Overall Study|Investigator's Discretion|0
7535035|NCT02707601|11882613|FG000|Overall Study|Withdrew Consent|0
7535036|NCT02707601|11882614|FG001|Overall Study|Withdrew Consent|1
7535037|NCT02707601|11882613|FG000|Overall Study|Lost to Follow-up|1
7535038|NCT02707601|11882614|FG001|Overall Study|Lost to Follow-up|1
7535039|NCT02707601|11882613|FG000|Overall Study|Participants Randomized but Not Treated|2
7535040|NCT02707601|11882614|FG001|Overall Study|Participants Randomized but Not Treated|0
7535041|NCT02707640|11882626|FG000|Overall Study|Adverse Event|4
7535042|NCT02707640|11882627|FG001|Overall Study|Adverse Event|2
7535043|NCT02707640|11882626|FG000|Overall Study|Death|1
7535044|NCT02707640|11882627|FG001|Overall Study|Death|2
7535045|NCT02707640|11882626|FG000|Overall Study|Physician Decision|2
7535046|NCT02707640|11882627|FG001|Overall Study|Physician Decision|0
7535047|NCT02707640|11882626|FG000|Overall Study|Withdrawal by Subject|0
7535048|NCT02707640|11882627|FG001|Overall Study|Withdrawal by Subject|1
7535049|NCT02707640|11882626|FG000|Overall Study|Participant's Personal Decision|1
7535050|NCT02707640|11882627|FG001|Overall Study|Participant's Personal Decision|2
7535051|NCT02707640|11882626|FG000|Overall Study|Sponsor Discretion|1
7535052|NCT02707640|11882627|FG001|Overall Study|Sponsor Discretion|0
7535053|NCT02707757|11882635|FG000|Overall Study|Protocol Violation|3
7535054|NCT02707757|11882636|FG001|Overall Study|Protocol Violation|2
7535055|NCT02707757|11882635|FG000|Overall Study|Withdrawal by Subject|2
7535056|NCT02707757|11882636|FG001|Overall Study|Withdrawal by Subject|0
7535057|NCT02707757|11882635|FG000|Overall Study|Death|0
7535058|NCT02707757|11882636|FG001|Overall Study|Death|1
7535059|NCT02707757|11882635|FG000|Overall Study|Adverse Event|6
7535060|NCT02707757|11882636|FG001|Overall Study|Adverse Event|4
7535061|NCT02707757|11882635|FG000|Overall Study|Renal transplant/elective operation|1
7535062|NCT02707757|11882636|FG001|Overall Study|Renal transplant/elective operation|5
7535063|NCT02707861|11882655|FG000|Overall Study|Went onto commercial drug|30
7535064|NCT02707861|11882656|FG001|Overall Study|Went onto commercial drug|23
7535065|NCT02707861|11882655|FG000|Overall Study|Adverse Event|2
7535066|NCT02707861|11882656|FG001|Overall Study|Adverse Event|3
7535067|NCT02707861|11882655|FG000|Overall Study|Death|5
7535068|NCT02707861|11882656|FG001|Overall Study|Death|2
7535069|NCT02707861|11882655|FG000|Overall Study|Lack of Efficacy|0
7535070|NCT02707861|11882656|FG001|Overall Study|Lack of Efficacy|2
7535071|NCT02707861|11882655|FG000|Overall Study|Physician Decision|1
7535072|NCT02707861|11882656|FG001|Overall Study|Physician Decision|4
7535073|NCT02707861|11882655|FG000|Overall Study|Withdrawal by Subject|2
7535074|NCT02707861|11882656|FG001|Overall Study|Withdrawal by Subject|1
7535075|NCT02707861|11882655|FG000|Overall Study|Lost to Follow-up|1
7535076|NCT02707861|11882656|FG001|Overall Study|Lost to Follow-up|3
7535077|NCT02707952|11882666|FG000|Overall Study|Adverse Event|1
7535078|NCT02707952|11882667|FG001|Overall Study|Adverse Event|0
7535079|NCT02707952|11882668|FG002|Overall Study|Adverse Event|0
7535080|NCT02707952|11882669|FG003|Overall Study|Adverse Event|0
7489489|NCT02127931|11804258|FG000|Overall Study|Glitch in Game|1
7489490|NCT02127970|11804265|FG000|Overall Study|Adverse Event|2
7489491|NCT02127970|11804266|FG001|Overall Study|Adverse Event|1
7489492|NCT02127970|11804265|FG000|Overall Study|Death|1
7489493|NCT02127970|11804266|FG001|Overall Study|Death|1
7489494|NCT02127970|11804265|FG000|Overall Study|Lost to Follow-up|14
7489495|NCT02127970|11804266|FG001|Overall Study|Lost to Follow-up|14
7489496|NCT02127970|11804265|FG000|Overall Study|Reason not Specified|4
7489497|NCT02127970|11804266|FG001|Overall Study|Reason not Specified|7
7489498|NCT02127970|11804265|FG000|Overall Study|Pregnancy|0
7489499|NCT02127970|11804266|FG001|Overall Study|Pregnancy|1
7489500|NCT02127970|11804265|FG000|Overall Study|Subject Withdrew Consent|5
7489501|NCT02127970|11804266|FG001|Overall Study|Subject Withdrew Consent|3
7489502|NCT02128217|11804278|FG000|Overall Study|Lost to Follow-up|0
7489503|NCT02128217|11804279|FG001|Overall Study|Lost to Follow-up|1
7489504|NCT02128269|11804294|FG000|Treatment Period|Adverse Event|1
7489505|NCT02128269|11804294|FG000|Treatment Period|Physician Decision|1
7489506|NCT02128490|11804303|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7489507|NCT02128490|11804304|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7489508|NCT02128490|11804305|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7489509|NCT02128490|11804306|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7489510|NCT02128490|11804307|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7489511|NCT02128490|11804303|FG000|Overall Study|Major Protocol Deviation|1
7489512|NCT02128490|11804304|FG001|Overall Study|Major Protocol Deviation|2
7489513|NCT02128490|11804305|FG002|Overall Study|Major Protocol Deviation|0
7489514|NCT02128490|11804306|FG003|Overall Study|Major Protocol Deviation|2
7489515|NCT02128490|11804307|FG004|Overall Study|Major Protocol Deviation|2
7489516|NCT02128490|11804303|FG000|Overall Study|Lost to Follow-up|0
7489517|NCT02128490|11804304|FG001|Overall Study|Lost to Follow-up|0
7489518|NCT02128490|11804305|FG002|Overall Study|Lost to Follow-up|1
7489519|NCT02128490|11804306|FG003|Overall Study|Lost to Follow-up|1
7489520|NCT02128490|11804307|FG004|Overall Study|Lost to Follow-up|1
7489521|NCT02128490|11804303|FG000|Overall Study|Voluntary Withdrawal|3
7489522|NCT02128490|11804304|FG001|Overall Study|Voluntary Withdrawal|3
7489523|NCT02128490|11804305|FG002|Overall Study|Voluntary Withdrawal|1
7489524|NCT02128490|11804306|FG003|Overall Study|Voluntary Withdrawal|1
7489525|NCT02128490|11804307|FG004|Overall Study|Voluntary Withdrawal|2
7489526|NCT02128490|11804303|FG000|Overall Study|Lack of Efficacy|0
7489527|NCT02128490|11804304|FG001|Overall Study|Lack of Efficacy|1
7489528|NCT02128490|11804305|FG002|Overall Study|Lack of Efficacy|0
7489529|NCT02128490|11804306|FG003|Overall Study|Lack of Efficacy|0
7489530|NCT02128490|11804307|FG004|Overall Study|Lack of Efficacy|0
7489531|NCT02128490|11804303|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
7489532|NCT02128490|11804304|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
7489533|NCT02128490|11804305|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
7489534|NCT02128490|11804306|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
7489535|NCT02128490|11804307|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
7489536|NCT02128490|11804303|FG000|Overall Study|Other Miscellaneous Reasons|0
7489537|NCT02128490|11804304|FG001|Overall Study|Other Miscellaneous Reasons|0
7489538|NCT02128490|11804305|FG002|Overall Study|Other Miscellaneous Reasons|2
7489539|NCT02128490|11804306|FG003|Overall Study|Other Miscellaneous Reasons|1
7489540|NCT02128490|11804307|FG004|Overall Study|Other Miscellaneous Reasons|1
7489541|NCT02128542|11804321|FG000|Overall Study|Lost to Follow-up|3
7489542|NCT02128542|11804322|FG001|Overall Study|Lost to Follow-up|0
7489543|NCT02128542|11804321|FG000|Overall Study|Withdrew Consent|1
7489544|NCT02128542|11804322|FG001|Overall Study|Withdrew Consent|0
7489545|NCT02128724|11804334|FG000|Overall Study|Death|1
7489546|NCT02128724|11804335|FG001|Overall Study|Death|0
7489547|NCT02128724|11804336|FG002|Overall Study|Death|0
7489548|NCT02128724|11804337|FG003|Overall Study|Death|0
7489549|NCT02128724|11804334|FG000|Overall Study|Adverse Event|0
7489550|NCT02128724|11804335|FG001|Overall Study|Adverse Event|1
7489551|NCT02128724|11804336|FG002|Overall Study|Adverse Event|0
7489552|NCT02128724|11804337|FG003|Overall Study|Adverse Event|0
7489553|NCT02128724|11804334|FG000|Overall Study|Physician Decision|0
7489554|NCT02128724|11804335|FG001|Overall Study|Physician Decision|0
7489555|NCT02128724|11804336|FG002|Overall Study|Physician Decision|0
7489556|NCT02128724|11804337|FG003|Overall Study|Physician Decision|2
7489557|NCT02128724|11804334|FG000|Overall Study|Withdrawal by Subject|0
7489558|NCT02128724|11804335|FG001|Overall Study|Withdrawal by Subject|0
7489559|NCT02128724|11804336|FG002|Overall Study|Withdrawal by Subject|0
7489560|NCT02128724|11804337|FG003|Overall Study|Withdrawal by Subject|1
7489565|NCT02128932|11804388|FG000|Overall Study|Withdrawal by Subject|11
7489566|NCT02128932|11804389|FG001|Overall Study|Withdrawal by Subject|7
7489567|NCT02128932|11804390|FG002|Overall Study|Withdrawal by Subject|8
7489568|NCT02128932|11804388|FG000|Overall Study|Death|2
7489569|NCT02128932|11804389|FG001|Overall Study|Death|0
7489570|NCT02128932|11804390|FG002|Overall Study|Death|2
7489571|NCT02128932|11804388|FG000|Overall Study|Lost to Follow-up|2
7489572|NCT02128932|11804389|FG001|Overall Study|Lost to Follow-up|1
7489573|NCT02128932|11804390|FG002|Overall Study|Lost to Follow-up|1
7489574|NCT02128932|11804388|FG000|Overall Study|No reason for withdrawal|12
7489575|NCT02128932|11804389|FG001|Overall Study|No reason for withdrawal|11
7489576|NCT02128932|11804390|FG002|Overall Study|No reason for withdrawal|7
7489577|NCT02128997|11804400|FG000|Overall Study|Lost to Follow-up|6
7489578|NCT02128997|11804401|FG001|Overall Study|Lost to Follow-up|11
7489579|NCT02129062|11804407|FG000|Overall Study|Death|1
7489580|NCT02129062|11804407|FG000|Overall Study|Disease Progression|2
7489581|NCT02129192|11804424|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
7489582|NCT02129192|11804425|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
7489583|NCT02129205|11804444|FG000|Overall Study|Withdrawal by Subject|0
7489584|NCT02129205|11804445|FG001|Overall Study|Withdrawal by Subject|0
7489585|NCT02129205|11804446|FG002|Overall Study|Withdrawal by Subject|0
7489586|NCT02129205|11804447|FG003|Overall Study|Withdrawal by Subject|0
7489587|NCT02129205|11804448|FG004|Overall Study|Withdrawal by Subject|1
7489588|NCT02129205|11804449|FG005|Overall Study|Withdrawal by Subject|1
7489589|NCT02129205|11804450|FG006|Overall Study|Withdrawal by Subject|1
7489590|NCT02129205|11804451|FG007|Overall Study|Withdrawal by Subject|0
7489591|NCT02129205|11804452|FG008|Overall Study|Withdrawal by Subject|1
7489592|NCT02129205|11804453|FG009|Overall Study|Withdrawal by Subject|0
7489593|NCT02129205|11804444|FG000|Overall Study|Other|1
7489594|NCT02129205|11804445|FG001|Overall Study|Other|0
7489595|NCT02129205|11804446|FG002|Overall Study|Other|0
7489596|NCT02129205|11804447|FG003|Overall Study|Other|0
7489597|NCT02129205|11804448|FG004|Overall Study|Other|2
7489598|NCT02129205|11804449|FG005|Overall Study|Other|3
7489599|NCT02129205|11804450|FG006|Overall Study|Other|3
7489600|NCT02129205|11804451|FG007|Overall Study|Other|2
7489601|NCT02129205|11804452|FG008|Overall Study|Other|1
7489602|NCT02129205|11804453|FG009|Overall Study|Other|0
7489603|NCT02129608|11804508|FG000|Overall Study|Lost to Follow-up|0
7489604|NCT02129608|11804509|FG001|Overall Study|Lost to Follow-up|1
7489605|NCT02129608|11804510|FG002|Overall Study|Lost to Follow-up|1
7489606|NCT02129608|11804508|FG000|Overall Study|Withdrawal by Subject|0
7489607|NCT02129608|11804509|FG001|Overall Study|Withdrawal by Subject|0
7489608|NCT02129608|11804510|FG002|Overall Study|Withdrawal by Subject|2
7489609|NCT02129777|11804554|FG000|Double-Blind Period|Adverse Event|0
7489610|NCT02129777|11804555|FG001|Double-Blind Period|Adverse Event|0
7489611|NCT02129777|11804556|FG002|Double-Blind Period|Adverse Event|0
7489612|NCT02129777|11804557|FG003|Double-Blind Period|Adverse Event|0
7489613|NCT02129777|11804558|FG004|Double-Blind Period|Adverse Event|1
7489614|NCT02129777|11804559|FG005|Double-Blind Period|Adverse Event|0
7489615|NCT02129777|11804560|FG006|Double-Blind Period|Adverse Event|0
7489616|NCT02129777|11804554|FG000|Double-Blind Period|Lost to Follow-up|1
7489617|NCT02129777|11804555|FG001|Double-Blind Period|Lost to Follow-up|1
7489618|NCT02129777|11804556|FG002|Double-Blind Period|Lost to Follow-up|1
7489619|NCT02129777|11804557|FG003|Double-Blind Period|Lost to Follow-up|2
7489620|NCT02129777|11804558|FG004|Double-Blind Period|Lost to Follow-up|0
7489621|NCT02129777|11804559|FG005|Double-Blind Period|Lost to Follow-up|0
7489622|NCT02129777|11804560|FG006|Double-Blind Period|Lost to Follow-up|0
7489623|NCT02129777|11804554|FG000|Double-Blind Period|Withdrawal by Subject|2
7489624|NCT02129777|11804555|FG001|Double-Blind Period|Withdrawal by Subject|4
7489625|NCT02129777|11804556|FG002|Double-Blind Period|Withdrawal by Subject|3
7489626|NCT02129777|11804557|FG003|Double-Blind Period|Withdrawal by Subject|2
7489627|NCT02129777|11804558|FG004|Double-Blind Period|Withdrawal by Subject|3
7489628|NCT02129777|11804559|FG005|Double-Blind Period|Withdrawal by Subject|0
7489629|NCT02129777|11804560|FG006|Double-Blind Period|Withdrawal by Subject|0
7489630|NCT02129777|11804554|FG000|Double-Blind Period|Pregnancy|0
7489631|NCT02129777|11804555|FG001|Double-Blind Period|Pregnancy|0
7489632|NCT02129777|11804556|FG002|Double-Blind Period|Pregnancy|0
7489633|NCT02129777|11804557|FG003|Double-Blind Period|Pregnancy|0
7489634|NCT02129777|11804558|FG004|Double-Blind Period|Pregnancy|1
7489635|NCT02129777|11804559|FG005|Double-Blind Period|Pregnancy|0
7489636|NCT02129777|11804560|FG006|Double-Blind Period|Pregnancy|0
7489637|NCT02129777|11804554|FG000|Double-Blind Period|Lack of Efficacy|3
7489638|NCT02129777|11804555|FG001|Double-Blind Period|Lack of Efficacy|1
7489639|NCT02129777|11804556|FG002|Double-Blind Period|Lack of Efficacy|0
7489640|NCT02129777|11804557|FG003|Double-Blind Period|Lack of Efficacy|3
7489641|NCT02129777|11804558|FG004|Double-Blind Period|Lack of Efficacy|2
7489642|NCT02129777|11804559|FG005|Double-Blind Period|Lack of Efficacy|0
7489643|NCT02129777|11804560|FG006|Double-Blind Period|Lack of Efficacy|0
7489644|NCT02129777|11804554|FG000|Double-Blind Period|Other|1
7489645|NCT02129777|11804555|FG001|Double-Blind Period|Other|2
7489646|NCT02129777|11804556|FG002|Double-Blind Period|Other|0
7489647|NCT02129777|11804557|FG003|Double-Blind Period|Other|0
7489648|NCT02129777|11804558|FG004|Double-Blind Period|Other|0
7489649|NCT02129777|11804559|FG005|Double-Blind Period|Other|0
7489650|NCT02129777|11804560|FG006|Double-Blind Period|Other|0
7489651|NCT02129777|11804554|FG000|Open-Label Period|Lack of Efficacy|0
7489652|NCT02129777|11804555|FG001|Open-Label Period|Lack of Efficacy|0
7489653|NCT02129777|11804556|FG002|Open-Label Period|Lack of Efficacy|0
7489654|NCT02129777|11804557|FG003|Open-Label Period|Lack of Efficacy|0
7489655|NCT02129777|11804558|FG004|Open-Label Period|Lack of Efficacy|0
7489656|NCT02129777|11804559|FG005|Open-Label Period|Lack of Efficacy|0
7489657|NCT02129777|11804560|FG006|Open-Label Period|Lack of Efficacy|5
7489658|NCT02129777|11804554|FG000|Open-Label Period|Lost to Follow-up|0
7489659|NCT02129777|11804555|FG001|Open-Label Period|Lost to Follow-up|0
7489660|NCT02129777|11804556|FG002|Open-Label Period|Lost to Follow-up|0
7489661|NCT02129777|11804557|FG003|Open-Label Period|Lost to Follow-up|0
7489662|NCT02129777|11804558|FG004|Open-Label Period|Lost to Follow-up|0
7489663|NCT02129777|11804559|FG005|Open-Label Period|Lost to Follow-up|1
7489664|NCT02129777|11804560|FG006|Open-Label Period|Lost to Follow-up|1
7489665|NCT02129777|11804554|FG000|Open-Label Period|Withdrawal by Subject|0
7489666|NCT02129777|11804555|FG001|Open-Label Period|Withdrawal by Subject|0
7489667|NCT02129777|11804556|FG002|Open-Label Period|Withdrawal by Subject|0
7489668|NCT02129777|11804557|FG003|Open-Label Period|Withdrawal by Subject|0
7489669|NCT02129777|11804558|FG004|Open-Label Period|Withdrawal by Subject|0
7489670|NCT02129777|11804559|FG005|Open-Label Period|Withdrawal by Subject|1
7489671|NCT02129777|11804560|FG006|Open-Label Period|Withdrawal by Subject|3
7489672|NCT02129777|11804554|FG000|Open-Label Period|Study Termination|0
7489673|NCT02129777|11804555|FG001|Open-Label Period|Study Termination|0
7489674|NCT02129777|11804556|FG002|Open-Label Period|Study Termination|0
7489675|NCT02129777|11804557|FG003|Open-Label Period|Study Termination|0
7489676|NCT02129777|11804558|FG004|Open-Label Period|Study Termination|0
7489677|NCT02129777|11804559|FG005|Open-Label Period|Study Termination|10
7489678|NCT02129777|11804560|FG006|Open-Label Period|Study Termination|39
7489679|NCT02129803|11804581|FG000|Overall Study|Protocol Violation|4
7489680|NCT02129803|11804582|FG001|Overall Study|Protocol Violation|0
7489681|NCT02129803|11804581|FG000|Overall Study|Physician Decision|0
7489682|NCT02129803|11804582|FG001|Overall Study|Physician Decision|1
7489683|NCT02129803|11804581|FG000|Overall Study|Difficulty sleeping|1
7489684|NCT02129803|11804582|FG001|Overall Study|Difficulty sleeping|0
7489685|NCT02129803|11804581|FG000|Overall Study|Morning headache|0
7489686|NCT02129803|11804582|FG001|Overall Study|Morning headache|1
7489687|NCT02129803|11804581|FG000|Overall Study|Withdrawal by Subject|1
7489688|NCT02129803|11804582|FG001|Overall Study|Withdrawal by Subject|1
7489689|NCT02130024|11804590|FG000|Overall Study|Adverse Event|10
7489690|NCT02130024|11804591|FG001|Overall Study|Adverse Event|11
7489691|NCT02130024|11804590|FG000|Overall Study|Death|2
7489692|NCT02130024|11804591|FG001|Overall Study|Death|2
7489693|NCT02130024|11804590|FG000|Overall Study|Lost to Follow-up|1
7489694|NCT02130024|11804591|FG001|Overall Study|Lost to Follow-up|1
7489695|NCT02130024|11804590|FG000|Overall Study|Physician Decision|1
7489696|NCT02130024|11804591|FG001|Overall Study|Physician Decision|3
7489697|NCT02130024|11804590|FG000|Overall Study|Protocol Deviation|4
7489698|NCT02130024|11804591|FG001|Overall Study|Protocol Deviation|0
7489699|NCT02130024|11804590|FG000|Overall Study|Site Administration Problems|1
7489700|NCT02130024|11804591|FG001|Overall Study|Site Administration Problems|0
7489701|NCT02130024|11804590|FG000|Overall Study|Subject Withdrew Consent|6
7489702|NCT02130024|11804591|FG001|Overall Study|Subject Withdrew Consent|14
7489703|NCT02130193|11804608|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
7489704|NCT02130193|11804609|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
7489705|NCT02130193|11804610|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
7489706|NCT02130193|11804608|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
7489707|NCT02130193|11804609|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
7489708|NCT02130193|11804610|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
7489709|NCT02130193|11804608|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
7489710|NCT02130193|11804609|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
7489711|NCT02130193|11804610|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
7489712|NCT02130193|11804608|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
7489713|NCT02130193|11804609|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7489714|NCT02130193|11804610|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7489715|NCT02130284|11804628|FG000|Overall Study|Withdrawal by Subject|3
7489716|NCT02130284|11804628|FG000|Overall Study|Subject Withdrew Consent|1
7489717|NCT02130284|11804628|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
7489718|NCT02130284|11804628|FG000|Overall Study|Subject was screened as backup for study|3
7489719|NCT02130284|11804628|FG000|Overall Study|Screen Failure|1
7489720|NCT02130297|11804632|FG000|Overall Study|Lost to Follow-up|4
7489722|NCT02130557|11804642|FG000|Overall Study|Withdrawal by Subject|12
7489723|NCT02130557|11804643|FG001|Overall Study|Withdrawal by Subject|12
7489724|NCT02130557|11804642|FG000|Overall Study|Investigator Request|0
7489725|NCT02130557|11804643|FG001|Overall Study|Investigator Request|2
7489726|NCT02130557|11804642|FG000|Overall Study|Deceased|14
7489727|NCT02130557|11804643|FG001|Overall Study|Deceased|14
7489728|NCT02130557|11804642|FG000|Overall Study|Lost to Follow-up|6
7489729|NCT02130557|11804643|FG001|Overall Study|Lost to Follow-up|7
7489730|NCT02130557|11804642|FG000|Overall Study|Other|2
7489731|NCT02130557|11804643|FG001|Overall Study|Other|1
7489732|NCT02130557|11804642|FG000|Overall Study|Missing|2
7489733|NCT02130557|11804643|FG001|Overall Study|Missing|1
7489734|NCT02130570|11804651|FG000|Overall Study|Death|3
7489735|NCT02130570|11804652|FG001|Overall Study|Death|5
7489736|NCT02130570|11804651|FG000|Overall Study|Withdrawal by Subject|6
7489737|NCT02130570|11804652|FG001|Overall Study|Withdrawal by Subject|3
7489738|NCT02130570|11804651|FG000|Overall Study|Part of practice that discontinued study|0
7489739|NCT02130570|11804652|FG001|Overall Study|Part of practice that discontinued study|5
7489740|NCT02130765|11804716|FG000|Overall Study|Did not receive treatment|4
7489741|NCT02130765|11804717|FG001|Overall Study|Did not receive treatment|0
7489742|NCT02130765|11804718|FG002|Overall Study|Did not receive treatment|0
7489743|NCT02130765|11804719|FG003|Overall Study|Did not receive treatment|0
7489744|NCT02130986|11804733|FG000|Overall Study|Withdrawal by Subject|4
7489745|NCT02130986|11804734|FG001|Overall Study|Withdrawal by Subject|4
7489746|NCT02130986|11804733|FG000|Overall Study|Lost to Follow-up|151
7489747|NCT02130986|11804734|FG001|Overall Study|Lost to Follow-up|160
7489748|NCT02131064|11804756|FG000|Overall Study|Death|5
7489749|NCT02131064|11804757|FG001|Overall Study|Death|6
7489750|NCT02131064|11804756|FG000|Overall Study|Lost to Follow-up|4
7489751|NCT02131064|11804757|FG001|Overall Study|Lost to Follow-up|8
7489752|NCT02131064|11804756|FG000|Overall Study|Withdrawal by Subject|14
7489753|NCT02131064|11804757|FG001|Overall Study|Withdrawal by Subject|18
7489754|NCT02131064|11804756|FG000|Overall Study|Other|2
7489755|NCT02131064|11804757|FG001|Overall Study|Other|2
7489756|NCT02131129|11804766|FG000|Overall Study|Withdrawal by Subject|1
7489757|NCT02131129|11804767|FG001|Overall Study|Withdrawal by Subject|0
7489758|NCT02131233|11804775|FG000|Overall Study|Not Treated|2
7489759|NCT02131233|11804776|FG001|Overall Study|Not Treated|3
7489760|NCT02131233|11804775|FG000|Overall Study|Adverse Event|7
7489761|NCT02131233|11804776|FG001|Overall Study|Adverse Event|6
7489762|NCT02131233|11804775|FG000|Overall Study|Death|0
7489763|NCT02131233|11804776|FG001|Overall Study|Death|1
7489764|NCT02131233|11804775|FG000|Overall Study|Lack of Efficacy|6
7489765|NCT02131233|11804776|FG001|Overall Study|Lack of Efficacy|3
7489766|NCT02131233|11804775|FG000|Overall Study|Lost to Follow-up|14
7489767|NCT02131233|11804776|FG001|Overall Study|Lost to Follow-up|13
7489768|NCT02131233|11804775|FG000|Overall Study|Non-Compliance With Study Drug|8
7489769|NCT02131233|11804776|FG001|Overall Study|Non-Compliance With Study Drug|5
7489770|NCT02131233|11804775|FG000|Overall Study|Physician Decision|7
7489771|NCT02131233|11804776|FG001|Overall Study|Physician Decision|0
7489772|NCT02131233|11804775|FG000|Overall Study|Pregnancy|4
7489773|NCT02131233|11804776|FG001|Overall Study|Pregnancy|0
7489774|NCT02131233|11804775|FG000|Overall Study|Withdrawal by Subject|18
7489775|NCT02131233|11804776|FG001|Overall Study|Withdrawal by Subject|11
7489776|NCT02131259|11804782|FG000|Overall Study|Progressive disease|751
7489777|NCT02131259|11804782|FG000|Overall Study|Adverse Event|341
7489778|NCT02131259|11804782|FG000|Overall Study|Lost to Follow-up|7
7489779|NCT02131259|11804782|FG000|Overall Study|Relocation|32
7489780|NCT02131259|11804782|FG000|Overall Study|Other|63
7489781|NCT02131259|11804782|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
7489782|NCT02131259|11804782|FG000|Overall Study|Progressive disease/relocation|1
7489783|NCT02131259|11804782|FG000|Overall Study|Progressive disease/other|2
7489784|NCT02131259|11804782|FG000|Overall Study|AE/lost to follow-up|1
7489785|NCT02131259|11804782|FG000|Overall Study|AE/other|1
7489786|NCT02131259|11804782|FG000|Overall Study|Progressive disease/AE/other|1
7489787|NCT02131259|11804782|FG000|Overall Study|Missing|3
7489788|NCT02131272|11804788|FG000|Overall Study|Withdrawal by parent|0
7489789|NCT02131272|11804789|FG001|Overall Study|Withdrawal by parent|1
7489790|NCT02131272|11804788|FG000|Overall Study|Withdrawal by Subject|0
7489791|NCT02131272|11804789|FG001|Overall Study|Withdrawal by Subject|1
7489792|NCT02131272|11804788|FG000|Overall Study|Withdrawal Criteria|1
7489793|NCT02131272|11804789|FG001|Overall Study|Withdrawal Criteria|0
7489794|NCT02131311|11804795|FG000|Overall Study|Adverse Event|2
7489795|NCT02131311|11804795|FG000|Overall Study|Protocol Violation|1
7489796|NCT02131311|11804795|FG000|Overall Study|Lost to Follow-up|1
7489797|NCT02131324|11804802|FG000|Overall Study|Withdrawal by Subject|1
7489798|NCT02131324|11804803|FG001|Overall Study|Withdrawal by Subject|2
7489799|NCT02131324|11804802|FG000|Overall Study|Lost to Follow-up|1
7489800|NCT02131324|11804803|FG001|Overall Study|Lost to Follow-up|1
7489801|NCT02131532|11804872|FG000|Overall Study|Withdrawal by Subject|1
7489802|NCT02131532|11804872|FG000|Overall Study|Physician Decision|1
7489803|NCT02131532|11804872|FG000|Overall Study|Other health conditions|2
7489804|NCT02131636|11804879|FG000|Overall Study|Personal Reasons|4
7489805|NCT02131636|11804880|FG001|Overall Study|Personal Reasons|4
7489806|NCT02131636|11804879|FG000|Overall Study|Lost to Follow-up|4
7489807|NCT02131636|11804880|FG001|Overall Study|Lost to Follow-up|0
7489808|NCT02131636|11804879|FG000|Overall Study|Adverse Event|4
7489809|NCT02131636|11804880|FG001|Overall Study|Adverse Event|1
7489810|NCT02131662|11804891|FG000|Overall Study|Protocol Violation|1
7489811|NCT02131662|11804892|FG001|Overall Study|Protocol Violation|0
7489812|NCT02131662|11804893|FG002|Overall Study|Protocol Violation|0
7489813|NCT02131662|11804894|FG003|Overall Study|Protocol Violation|0
7489814|NCT02131662|11804895|FG004|Overall Study|Protocol Violation|0
7489815|NCT02131662|11804891|FG000|Overall Study|Other|2
7489816|NCT02131662|11804892|FG001|Overall Study|Other|4
7489817|NCT02131662|11804893|FG002|Overall Study|Other|3
7489818|NCT02131662|11804894|FG003|Overall Study|Other|3
7489819|NCT02131662|11804895|FG004|Overall Study|Other|4
7489820|NCT02131662|11804891|FG000|Overall Study|Adverse Event|0
7489821|NCT02131662|11804892|FG001|Overall Study|Adverse Event|1
7489822|NCT02131662|11804893|FG002|Overall Study|Adverse Event|1
7489823|NCT02131662|11804894|FG003|Overall Study|Adverse Event|1
7489824|NCT02131662|11804895|FG004|Overall Study|Adverse Event|3
7489825|NCT02131662|11804891|FG000|Overall Study|Pregnancy|0
7489826|NCT02131662|11804892|FG001|Overall Study|Pregnancy|1
7489827|NCT02131662|11804893|FG002|Overall Study|Pregnancy|0
7489828|NCT02131662|11804894|FG003|Overall Study|Pregnancy|1
7489829|NCT02131662|11804895|FG004|Overall Study|Pregnancy|0
7489830|NCT02131662|11804891|FG000|Overall Study|Wish for pregnancy|0
7489831|NCT02131662|11804892|FG001|Overall Study|Wish for pregnancy|0
7489832|NCT02131662|11804893|FG002|Overall Study|Wish for pregnancy|0
7489833|NCT02131662|11804894|FG003|Overall Study|Wish for pregnancy|0
7489834|NCT02131662|11804895|FG004|Overall Study|Wish for pregnancy|1
7489835|NCT02131662|11804891|FG000|Overall Study|Lack of Efficacy|1
7489836|NCT02131662|11804892|FG001|Overall Study|Lack of Efficacy|0
7489837|NCT02131662|11804893|FG002|Overall Study|Lack of Efficacy|0
7489838|NCT02131662|11804894|FG003|Overall Study|Lack of Efficacy|0
7489839|NCT02131662|11804895|FG004|Overall Study|Lack of Efficacy|1
7489840|NCT02131662|11804891|FG000|Overall Study|Withdrawal by Subject|1
7489841|NCT02131662|11804892|FG001|Overall Study|Withdrawal by Subject|5
7489842|NCT02131662|11804893|FG002|Overall Study|Withdrawal by Subject|1
7489843|NCT02131662|11804894|FG003|Overall Study|Withdrawal by Subject|5
7489844|NCT02131662|11804895|FG004|Overall Study|Withdrawal by Subject|6
7489845|NCT02131662|11804891|FG000|Overall Study|Lost to Follow-up|1
7489846|NCT02131662|11804892|FG001|Overall Study|Lost to Follow-up|3
7489847|NCT02131662|11804893|FG002|Overall Study|Lost to Follow-up|0
7489848|NCT02131662|11804894|FG003|Overall Study|Lost to Follow-up|9
7489849|NCT02131662|11804895|FG004|Overall Study|Lost to Follow-up|0
7489850|NCT02131662|11804891|FG000|Overall Study|Not treated|2
7489851|NCT02131662|11804892|FG001|Overall Study|Not treated|0
7489852|NCT02131662|11804893|FG002|Overall Study|Not treated|2
7489853|NCT02131662|11804894|FG003|Overall Study|Not treated|2
7489854|NCT02131662|11804895|FG004|Overall Study|Not treated|3
7489855|NCT02131766|11804911|FG000|Overall Study|Withdrawal by Subject|4
7489856|NCT02132117|11804920|FG000|Overall Study|Adverse Event|6
7489857|NCT02132117|11804921|FG001|Overall Study|Adverse Event|1
7489858|NCT02132117|11804920|FG000|Overall Study|Lost to Follow-up|2
7489859|NCT02132117|11804921|FG001|Overall Study|Lost to Follow-up|2
7489860|NCT02132117|11804920|FG000|Overall Study|Personal Reasons|1
7489861|NCT02132117|11804921|FG001|Overall Study|Personal Reasons|2
7489862|NCT02132117|11804920|FG000|Overall Study|Other Miscellaneous Reasons|2
7489863|NCT02132117|11804921|FG001|Overall Study|Other Miscellaneous Reasons|0
7489864|NCT02132130|11804931|FG000|Overall Study|Lost to Follow-up|0
7489865|NCT02132130|11804932|FG001|Overall Study|Lost to Follow-up|2
7489866|NCT02132130|11804933|FG002|Overall Study|Lost to Follow-up|0
7489867|NCT02132130|11804934|FG003|Overall Study|Lost to Follow-up|0
7489868|NCT02132130|11804931|FG000|Overall Study|Withdrawal by Subject|0
7489869|NCT02132130|11804932|FG001|Overall Study|Withdrawal by Subject|0
7489870|NCT02132130|11804933|FG002|Overall Study|Withdrawal by Subject|0
7489871|NCT02132130|11804934|FG003|Overall Study|Withdrawal by Subject|1
7489872|NCT02132195|11804960|FG000|Initial Assignment|Relapsed|14
7489873|NCT02132195|11804961|FG001|Initial Assignment|Relapsed|0
7489874|NCT02132195|11804962|FG002|Initial Assignment|Relapsed|0
7489875|NCT02132195|11804960|FG000|Rescue Therapy|Relapsed|0
7489876|NCT02132195|11804961|FG001|Rescue Therapy|Relapsed|0
7489877|NCT02132195|11804962|FG002|Rescue Therapy|Relapsed|7
7489878|NCT02132195|11804960|FG000|Rescue Therapy|Physician Decision|0
7489879|NCT02132195|11804961|FG001|Rescue Therapy|Physician Decision|0
7489880|NCT02132195|11804962|FG002|Rescue Therapy|Physician Decision|1
7489881|NCT02132195|11804960|FG000|Rescue Therapy|Withdrawal by Subject|0
7489882|NCT02132195|11804961|FG001|Rescue Therapy|Withdrawal by Subject|0
7489883|NCT02132195|11804962|FG002|Rescue Therapy|Withdrawal by Subject|1
7489884|NCT02132195|11804960|FG000|Rescue Therapy|Adverse Event|0
7489885|NCT02132195|11804961|FG001|Rescue Therapy|Adverse Event|0
7489886|NCT02132195|11804962|FG002|Rescue Therapy|Adverse Event|2
7489887|NCT02132247|11804972|FG000|Overall Study|Protocol Violation|1
7489888|NCT02132247|11804973|FG001|Overall Study|Protocol Violation|0
7489889|NCT02132312|11804981|FG000|Overall Study|Adverse Event|2
7489890|NCT02132312|11804982|FG001|Overall Study|Adverse Event|0
7489891|NCT02132312|11804981|FG000|Overall Study|Physician Decision|1
7489892|NCT02132312|11804982|FG001|Overall Study|Physician Decision|1
7489893|NCT02132312|11804981|FG000|Overall Study|Protocol Violation|0
7489894|NCT02132312|11804982|FG001|Overall Study|Protocol Violation|1
7489895|NCT02132312|11804981|FG000|Overall Study|Withdrawal by Subject|1
7489896|NCT02132312|11804982|FG001|Overall Study|Withdrawal by Subject|0
7489897|NCT02132312|11804981|FG000|Overall Study|Lost to Follow-up|2
7489898|NCT02132312|11804982|FG001|Overall Study|Lost to Follow-up|1
7489899|NCT02132637|11805023|FG000|Study Period 1|Withdrawal by Subject|0
7489900|NCT02132637|11805024|FG001|Study Period 1|Withdrawal by Subject|4
7489901|NCT02132637|11805023|FG000|Study Period 1|Physician Decision|1
7489902|NCT02132637|11805024|FG001|Study Period 1|Physician Decision|0
7489903|NCT02132637|11805023|FG000|Study Period 2 (Crossover)|Adverse Event|0
7489904|NCT02132637|11805024|FG001|Study Period 2 (Crossover)|Adverse Event|1
7489905|NCT02132637|11805023|FG000|Study Period 2 (Crossover)|Physician Decision|2
7489906|NCT02132637|11805024|FG001|Study Period 2 (Crossover)|Physician Decision|0
7489907|NCT02132754|11805074|FG000|Overall Study|Adverse Event|0
7489908|NCT02132754|11805075|FG001|Overall Study|Adverse Event|0
7489909|NCT02132754|11805076|FG002|Overall Study|Adverse Event|0
7489910|NCT02132754|11805077|FG003|Overall Study|Adverse Event|0
7489911|NCT02132754|11805078|FG004|Overall Study|Adverse Event|0
7489912|NCT02132754|11805079|FG005|Overall Study|Adverse Event|0
7489913|NCT02132754|11805080|FG006|Overall Study|Adverse Event|0
7489914|NCT02132754|11805081|FG007|Overall Study|Adverse Event|0
7489915|NCT02132754|11805082|FG008|Overall Study|Adverse Event|0
7489916|NCT02132754|11805083|FG009|Overall Study|Adverse Event|0
7489917|NCT02132754|11805084|FG010|Overall Study|Adverse Event|0
7489918|NCT02132754|11805085|FG011|Overall Study|Adverse Event|0
7489919|NCT02132754|11805086|FG012|Overall Study|Adverse Event|0
7489920|NCT02132754|11805087|FG013|Overall Study|Adverse Event|0
7489921|NCT02132754|11805088|FG014|Overall Study|Adverse Event|0
7489922|NCT02132754|11805089|FG015|Overall Study|Adverse Event|0
7489923|NCT02132754|11805090|FG016|Overall Study|Adverse Event|0
7489924|NCT02132754|11805091|FG017|Overall Study|Adverse Event|1
7489925|NCT02132754|11805092|FG018|Overall Study|Adverse Event|0
7489926|NCT02132754|11805093|FG019|Overall Study|Adverse Event|0
7489927|NCT02132754|11805094|FG020|Overall Study|Adverse Event|0
7489928|NCT02132754|11805095|FG021|Overall Study|Adverse Event|0
7489929|NCT02132754|11805096|FG022|Overall Study|Adverse Event|0
7489930|NCT02132754|11805097|FG023|Overall Study|Adverse Event|0
7489931|NCT02132754|11805098|FG024|Overall Study|Adverse Event|0
7489932|NCT02132754|11805099|FG025|Overall Study|Adverse Event|1
7489933|NCT02132754|11805100|FG026|Overall Study|Adverse Event|1
7489934|NCT02132754|11805101|FG027|Overall Study|Adverse Event|0
7489935|NCT02132754|11805102|FG028|Overall Study|Adverse Event|0
7489936|NCT02132754|11805103|FG029|Overall Study|Adverse Event|0
7489937|NCT02132754|11805104|FG030|Overall Study|Adverse Event|1
7489938|NCT02132754|11805105|FG031|Overall Study|Adverse Event|0
7489939|NCT02132754|11805106|FG032|Overall Study|Adverse Event|1
7489940|NCT02132754|11805107|FG033|Overall Study|Adverse Event|1
7489941|NCT02132754|11805074|FG000|Overall Study|Clinical Progression|0
7489942|NCT02132754|11805075|FG001|Overall Study|Clinical Progression|0
7489943|NCT02132754|11805076|FG002|Overall Study|Clinical Progression|0
7489944|NCT02132754|11805077|FG003|Overall Study|Clinical Progression|0
7489945|NCT02132754|11805078|FG004|Overall Study|Clinical Progression|0
7489946|NCT02132754|11805079|FG005|Overall Study|Clinical Progression|0
7489947|NCT02132754|11805080|FG006|Overall Study|Clinical Progression|0
7489948|NCT02132754|11805081|FG007|Overall Study|Clinical Progression|0
7489949|NCT02132754|11805082|FG008|Overall Study|Clinical Progression|0
7489950|NCT02132754|11805083|FG009|Overall Study|Clinical Progression|1
7489951|NCT02132754|11805084|FG010|Overall Study|Clinical Progression|0
7489952|NCT02132754|11805085|FG011|Overall Study|Clinical Progression|0
7489953|NCT02132754|11805086|FG012|Overall Study|Clinical Progression|0
7489954|NCT02132754|11805087|FG013|Overall Study|Clinical Progression|0
7489955|NCT02132754|11805088|FG014|Overall Study|Clinical Progression|0
7489956|NCT02132754|11805089|FG015|Overall Study|Clinical Progression|0
7489957|NCT02132754|11805090|FG016|Overall Study|Clinical Progression|1
7489958|NCT02132754|11805091|FG017|Overall Study|Clinical Progression|1
7489959|NCT02132754|11805092|FG018|Overall Study|Clinical Progression|0
7489960|NCT02132754|11805093|FG019|Overall Study|Clinical Progression|1
7489961|NCT02132754|11805094|FG020|Overall Study|Clinical Progression|0
7489962|NCT02132754|11805095|FG021|Overall Study|Clinical Progression|0
7489963|NCT02132754|11805096|FG022|Overall Study|Clinical Progression|1
7489964|NCT02132754|11805097|FG023|Overall Study|Clinical Progression|0
7489965|NCT02132754|11805098|FG024|Overall Study|Clinical Progression|1
7489966|NCT02132754|11805099|FG025|Overall Study|Clinical Progression|1
7489967|NCT02132754|11805100|FG026|Overall Study|Clinical Progression|0
7489968|NCT02132754|11805101|FG027|Overall Study|Clinical Progression|1
7489969|NCT02132754|11805102|FG028|Overall Study|Clinical Progression|1
7489970|NCT02132754|11805103|FG029|Overall Study|Clinical Progression|0
7489971|NCT02132754|11805104|FG030|Overall Study|Clinical Progression|1
7489972|NCT02132754|11805105|FG031|Overall Study|Clinical Progression|0
7489973|NCT02132754|11805106|FG032|Overall Study|Clinical Progression|0
7489974|NCT02132754|11805107|FG033|Overall Study|Clinical Progression|2
7489975|NCT02132754|11805074|FG000|Overall Study|Death|0
7489976|NCT02132754|11805075|FG001|Overall Study|Death|0
7489977|NCT02132754|11805076|FG002|Overall Study|Death|0
7489978|NCT02132754|11805077|FG003|Overall Study|Death|0
7489979|NCT02132754|11805078|FG004|Overall Study|Death|0
7489980|NCT02132754|11805079|FG005|Overall Study|Death|0
7489981|NCT02132754|11805080|FG006|Overall Study|Death|0
7489982|NCT02132754|11805081|FG007|Overall Study|Death|0
7489983|NCT02132754|11805082|FG008|Overall Study|Death|0
7489984|NCT02132754|11805083|FG009|Overall Study|Death|0
7489985|NCT02132754|11805084|FG010|Overall Study|Death|0
7489986|NCT02132754|11805085|FG011|Overall Study|Death|0
7489987|NCT02132754|11805086|FG012|Overall Study|Death|0
7489988|NCT02132754|11805087|FG013|Overall Study|Death|0
7489989|NCT02132754|11805088|FG014|Overall Study|Death|0
7489990|NCT02132754|11805089|FG015|Overall Study|Death|1
7489991|NCT02132754|11805090|FG016|Overall Study|Death|0
7489992|NCT02132754|11805091|FG017|Overall Study|Death|0
7489993|NCT02132754|11805092|FG018|Overall Study|Death|0
7489994|NCT02132754|11805093|FG019|Overall Study|Death|1
7489995|NCT02132754|11805094|FG020|Overall Study|Death|0
7489996|NCT02132754|11805095|FG021|Overall Study|Death|1
7489997|NCT02132754|11805096|FG022|Overall Study|Death|0
7489998|NCT02132754|11805097|FG023|Overall Study|Death|0
7489999|NCT02132754|11805098|FG024|Overall Study|Death|0
7490000|NCT02132754|11805099|FG025|Overall Study|Death|0
7490001|NCT02132754|11805100|FG026|Overall Study|Death|1
7490002|NCT02132754|11805101|FG027|Overall Study|Death|0
7490003|NCT02132754|11805102|FG028|Overall Study|Death|0
7490004|NCT02132754|11805103|FG029|Overall Study|Death|0
7490005|NCT02132754|11805104|FG030|Overall Study|Death|0
7490006|NCT02132754|11805105|FG031|Overall Study|Death|0
7490007|NCT02132754|11805106|FG032|Overall Study|Death|0
7490008|NCT02132754|11805107|FG033|Overall Study|Death|2
7490009|NCT02132754|11805074|FG000|Overall Study|Excluded Medication|0
7490010|NCT02132754|11805075|FG001|Overall Study|Excluded Medication|0
7490011|NCT02132754|11805076|FG002|Overall Study|Excluded Medication|0
7490012|NCT02132754|11805077|FG003|Overall Study|Excluded Medication|0
7490013|NCT02132754|11805078|FG004|Overall Study|Excluded Medication|0
7490014|NCT02132754|11805079|FG005|Overall Study|Excluded Medication|0
7490015|NCT02132754|11805080|FG006|Overall Study|Excluded Medication|0
7490016|NCT02132754|11805081|FG007|Overall Study|Excluded Medication|0
7490017|NCT02132754|11805082|FG008|Overall Study|Excluded Medication|0
7490018|NCT02132754|11805083|FG009|Overall Study|Excluded Medication|0
7490019|NCT02132754|11805084|FG010|Overall Study|Excluded Medication|0
7490020|NCT02132754|11805085|FG011|Overall Study|Excluded Medication|0
7490021|NCT02132754|11805086|FG012|Overall Study|Excluded Medication|0
7490022|NCT02132754|11805087|FG013|Overall Study|Excluded Medication|0
7490023|NCT02132754|11805088|FG014|Overall Study|Excluded Medication|0
7490024|NCT02132754|11805089|FG015|Overall Study|Excluded Medication|0
7490025|NCT02132754|11805090|FG016|Overall Study|Excluded Medication|0
7490026|NCT02132754|11805091|FG017|Overall Study|Excluded Medication|0
7490027|NCT02132754|11805092|FG018|Overall Study|Excluded Medication|0
7490028|NCT02132754|11805093|FG019|Overall Study|Excluded Medication|0
7490029|NCT02132754|11805094|FG020|Overall Study|Excluded Medication|1
7490030|NCT02132754|11805095|FG021|Overall Study|Excluded Medication|0
7490031|NCT02132754|11805096|FG022|Overall Study|Excluded Medication|0
7490032|NCT02132754|11805097|FG023|Overall Study|Excluded Medication|0
7490033|NCT02132754|11805098|FG024|Overall Study|Excluded Medication|0
7490034|NCT02132754|11805099|FG025|Overall Study|Excluded Medication|0
7490035|NCT02132754|11805100|FG026|Overall Study|Excluded Medication|0
7490036|NCT02132754|11805101|FG027|Overall Study|Excluded Medication|0
7490037|NCT02132754|11805102|FG028|Overall Study|Excluded Medication|0
7490038|NCT02132754|11805103|FG029|Overall Study|Excluded Medication|0
7490039|NCT02132754|11805104|FG030|Overall Study|Excluded Medication|0
7490040|NCT02132754|11805105|FG031|Overall Study|Excluded Medication|0
7490041|NCT02132754|11805106|FG032|Overall Study|Excluded Medication|0
7490042|NCT02132754|11805107|FG033|Overall Study|Excluded Medication|1
7490043|NCT02132754|11805074|FG000|Overall Study|Physician Decision|0
7490044|NCT02132754|11805075|FG001|Overall Study|Physician Decision|0
7490045|NCT02132754|11805076|FG002|Overall Study|Physician Decision|0
7490046|NCT02132754|11805077|FG003|Overall Study|Physician Decision|0
7490047|NCT02132754|11805078|FG004|Overall Study|Physician Decision|0
7490048|NCT02132754|11805079|FG005|Overall Study|Physician Decision|0
7490049|NCT02132754|11805080|FG006|Overall Study|Physician Decision|0
7490050|NCT02132754|11805081|FG007|Overall Study|Physician Decision|0
7490051|NCT02132754|11805082|FG008|Overall Study|Physician Decision|0
7490052|NCT02132754|11805083|FG009|Overall Study|Physician Decision|1
7490053|NCT02132754|11805084|FG010|Overall Study|Physician Decision|0
7490054|NCT02132754|11805085|FG011|Overall Study|Physician Decision|1
7490055|NCT02132754|11805086|FG012|Overall Study|Physician Decision|1
7490056|NCT02132754|11805087|FG013|Overall Study|Physician Decision|0
7490057|NCT02132754|11805088|FG014|Overall Study|Physician Decision|0
7490058|NCT02132754|11805089|FG015|Overall Study|Physician Decision|1
7490059|NCT02132754|11805090|FG016|Overall Study|Physician Decision|0
7490060|NCT02132754|11805091|FG017|Overall Study|Physician Decision|0
7490061|NCT02132754|11805092|FG018|Overall Study|Physician Decision|0
7490062|NCT02132754|11805093|FG019|Overall Study|Physician Decision|0
7490063|NCT02132754|11805094|FG020|Overall Study|Physician Decision|0
7490064|NCT02132754|11805095|FG021|Overall Study|Physician Decision|0
7490065|NCT02132754|11805096|FG022|Overall Study|Physician Decision|0
7490066|NCT02132754|11805097|FG023|Overall Study|Physician Decision|0
7490067|NCT02132754|11805098|FG024|Overall Study|Physician Decision|1
7490068|NCT02132754|11805099|FG025|Overall Study|Physician Decision|0
7490069|NCT02132754|11805100|FG026|Overall Study|Physician Decision|0
7490070|NCT02132754|11805101|FG027|Overall Study|Physician Decision|0
7490071|NCT02132754|11805102|FG028|Overall Study|Physician Decision|0
7490072|NCT02132754|11805103|FG029|Overall Study|Physician Decision|0
7490073|NCT02132754|11805104|FG030|Overall Study|Physician Decision|0
7490074|NCT02132754|11805105|FG031|Overall Study|Physician Decision|1
7490075|NCT02132754|11805106|FG032|Overall Study|Physician Decision|0
7490076|NCT02132754|11805107|FG033|Overall Study|Physician Decision|3
7490077|NCT02132754|11805074|FG000|Overall Study|Progressive Disease|1
7490078|NCT02132754|11805075|FG001|Overall Study|Progressive Disease|1
7490079|NCT02132754|11805076|FG002|Overall Study|Progressive Disease|1
7490080|NCT02132754|11805077|FG003|Overall Study|Progressive Disease|1
7490081|NCT02132754|11805078|FG004|Overall Study|Progressive Disease|1
7490082|NCT02132754|11805079|FG005|Overall Study|Progressive Disease|1
7490083|NCT02132754|11805080|FG006|Overall Study|Progressive Disease|1
7490084|NCT02132754|11805081|FG007|Overall Study|Progressive Disease|1
7490085|NCT02132754|11805082|FG008|Overall Study|Progressive Disease|1
7490086|NCT02132754|11805083|FG009|Overall Study|Progressive Disease|3
7490087|NCT02132754|11805084|FG010|Overall Study|Progressive Disease|3
7490088|NCT02132754|11805085|FG011|Overall Study|Progressive Disease|2
7490089|NCT02132754|11805086|FG012|Overall Study|Progressive Disease|2
7490090|NCT02132754|11805087|FG013|Overall Study|Progressive Disease|3
7490091|NCT02132754|11805088|FG014|Overall Study|Progressive Disease|2
7490092|NCT02132754|11805089|FG015|Overall Study|Progressive Disease|1
7490093|NCT02132754|11805090|FG016|Overall Study|Progressive Disease|2
7490094|NCT02132754|11805091|FG017|Overall Study|Progressive Disease|1
7490095|NCT02132754|11805092|FG018|Overall Study|Progressive Disease|3
7490096|NCT02132754|11805093|FG019|Overall Study|Progressive Disease|1
7490097|NCT02132754|11805094|FG020|Overall Study|Progressive Disease|1
7490098|NCT02132754|11805095|FG021|Overall Study|Progressive Disease|3
7490099|NCT02132754|11805096|FG022|Overall Study|Progressive Disease|2
7490100|NCT02132754|11805097|FG023|Overall Study|Progressive Disease|3
7490101|NCT02132754|11805098|FG024|Overall Study|Progressive Disease|0
7490102|NCT02132754|11805099|FG025|Overall Study|Progressive Disease|1
7490103|NCT02132754|11805100|FG026|Overall Study|Progressive Disease|2
7490104|NCT02132754|11805101|FG027|Overall Study|Progressive Disease|1
7490105|NCT02132754|11805102|FG028|Overall Study|Progressive Disease|2
7490106|NCT02132754|11805103|FG029|Overall Study|Progressive Disease|3
7490107|NCT02132754|11805104|FG030|Overall Study|Progressive Disease|1
7490108|NCT02132754|11805105|FG031|Overall Study|Progressive Disease|1
7490109|NCT02132754|11805106|FG032|Overall Study|Progressive Disease|3
7490110|NCT02132754|11805107|FG033|Overall Study|Progressive Disease|6
7490111|NCT02132754|11805074|FG000|Overall Study|Screen Failure|0
7490112|NCT02132754|11805075|FG001|Overall Study|Screen Failure|0
7490113|NCT02132754|11805076|FG002|Overall Study|Screen Failure|0
7490114|NCT02132754|11805077|FG003|Overall Study|Screen Failure|0
7490115|NCT02132754|11805078|FG004|Overall Study|Screen Failure|0
7490116|NCT02132754|11805079|FG005|Overall Study|Screen Failure|0
7490117|NCT02132754|11805080|FG006|Overall Study|Screen Failure|0
7490118|NCT02132754|11805081|FG007|Overall Study|Screen Failure|0
7490119|NCT02132754|11805082|FG008|Overall Study|Screen Failure|0
7490120|NCT02132754|11805083|FG009|Overall Study|Screen Failure|0
7490121|NCT02132754|11805084|FG010|Overall Study|Screen Failure|0
7490122|NCT02132754|11805085|FG011|Overall Study|Screen Failure|0
7490123|NCT02132754|11805086|FG012|Overall Study|Screen Failure|0
7490124|NCT02132754|11805087|FG013|Overall Study|Screen Failure|0
7490125|NCT02132754|11805088|FG014|Overall Study|Screen Failure|0
7490126|NCT02132754|11805089|FG015|Overall Study|Screen Failure|0
7490127|NCT02132754|11805090|FG016|Overall Study|Screen Failure|0
7490128|NCT02132754|11805091|FG017|Overall Study|Screen Failure|0
7490129|NCT02132754|11805092|FG018|Overall Study|Screen Failure|0
7490130|NCT02132754|11805093|FG019|Overall Study|Screen Failure|1
7490131|NCT02132754|11805094|FG020|Overall Study|Screen Failure|0
7490132|NCT02132754|11805095|FG021|Overall Study|Screen Failure|1
7490133|NCT02132754|11805096|FG022|Overall Study|Screen Failure|0
7490134|NCT02132754|11805097|FG023|Overall Study|Screen Failure|0
7490135|NCT02132754|11805098|FG024|Overall Study|Screen Failure|0
7490136|NCT02132754|11805099|FG025|Overall Study|Screen Failure|0
7490137|NCT02132754|11805100|FG026|Overall Study|Screen Failure|0
7490138|NCT02132754|11805101|FG027|Overall Study|Screen Failure|0
7490139|NCT02132754|11805102|FG028|Overall Study|Screen Failure|0
7490140|NCT02132754|11805103|FG029|Overall Study|Screen Failure|0
7490141|NCT02132754|11805104|FG030|Overall Study|Screen Failure|0
7490142|NCT02132754|11805105|FG031|Overall Study|Screen Failure|0
7490143|NCT02132754|11805106|FG032|Overall Study|Screen Failure|0
7490144|NCT02132754|11805107|FG033|Overall Study|Screen Failure|0
7490145|NCT02132754|11805074|FG000|Overall Study|Transferred to Extension Study|0
7490146|NCT02132754|11805075|FG001|Overall Study|Transferred to Extension Study|0
7490147|NCT02132754|11805076|FG002|Overall Study|Transferred to Extension Study|0
7490148|NCT02132754|11805077|FG003|Overall Study|Transferred to Extension Study|0
7490149|NCT02132754|11805078|FG004|Overall Study|Transferred to Extension Study|0
7490150|NCT02132754|11805079|FG005|Overall Study|Transferred to Extension Study|0
7490151|NCT02132754|11805080|FG006|Overall Study|Transferred to Extension Study|0
7490152|NCT02132754|11805081|FG007|Overall Study|Transferred to Extension Study|0
7490153|NCT02132754|11805082|FG008|Overall Study|Transferred to Extension Study|0
7490154|NCT02132754|11805083|FG009|Overall Study|Transferred to Extension Study|0
7490155|NCT02132754|11805084|FG010|Overall Study|Transferred to Extension Study|0
7490156|NCT02132754|11805085|FG011|Overall Study|Transferred to Extension Study|0
7490157|NCT02132754|11805086|FG012|Overall Study|Transferred to Extension Study|0
7490158|NCT02132754|11805087|FG013|Overall Study|Transferred to Extension Study|0
7490159|NCT02132754|11805088|FG014|Overall Study|Transferred to Extension Study|0
7490160|NCT02132754|11805089|FG015|Overall Study|Transferred to Extension Study|0
7490161|NCT02132754|11805090|FG016|Overall Study|Transferred to Extension Study|0
7490162|NCT02132754|11805091|FG017|Overall Study|Transferred to Extension Study|0
7490163|NCT02132754|11805092|FG018|Overall Study|Transferred to Extension Study|0
7490164|NCT02132754|11805093|FG019|Overall Study|Transferred to Extension Study|0
7490165|NCT02132754|11805094|FG020|Overall Study|Transferred to Extension Study|0
7490166|NCT02132754|11805095|FG021|Overall Study|Transferred to Extension Study|0
7490167|NCT02132754|11805096|FG022|Overall Study|Transferred to Extension Study|0
7490168|NCT02132754|11805097|FG023|Overall Study|Transferred to Extension Study|0
7490169|NCT02132754|11805098|FG024|Overall Study|Transferred to Extension Study|0
7490170|NCT02132754|11805099|FG025|Overall Study|Transferred to Extension Study|0
7490171|NCT02132754|11805100|FG026|Overall Study|Transferred to Extension Study|0
7490172|NCT02132754|11805101|FG027|Overall Study|Transferred to Extension Study|0
7490173|NCT02132754|11805102|FG028|Overall Study|Transferred to Extension Study|0
7490174|NCT02132754|11805103|FG029|Overall Study|Transferred to Extension Study|0
7490175|NCT02132754|11805104|FG030|Overall Study|Transferred to Extension Study|0
7490176|NCT02132754|11805105|FG031|Overall Study|Transferred to Extension Study|0
7490177|NCT02132754|11805106|FG032|Overall Study|Transferred to Extension Study|0
7490178|NCT02132754|11805107|FG033|Overall Study|Transferred to Extension Study|6
7490179|NCT02132754|11805074|FG000|Overall Study|Withdrawal by Subject|0
7490180|NCT02132754|11805075|FG001|Overall Study|Withdrawal by Subject|0
7490181|NCT02132754|11805076|FG002|Overall Study|Withdrawal by Subject|0
7490182|NCT02132754|11805077|FG003|Overall Study|Withdrawal by Subject|0
7490183|NCT02132754|11805078|FG004|Overall Study|Withdrawal by Subject|0
7490184|NCT02132754|11805079|FG005|Overall Study|Withdrawal by Subject|0
7490185|NCT02132754|11805080|FG006|Overall Study|Withdrawal by Subject|0
7490186|NCT02132754|11805081|FG007|Overall Study|Withdrawal by Subject|0
7490187|NCT02132754|11805082|FG008|Overall Study|Withdrawal by Subject|0
7490188|NCT02132754|11805083|FG009|Overall Study|Withdrawal by Subject|1
7490189|NCT02132754|11805084|FG010|Overall Study|Withdrawal by Subject|0
7490190|NCT02132754|11805085|FG011|Overall Study|Withdrawal by Subject|0
7490191|NCT02132754|11805086|FG012|Overall Study|Withdrawal by Subject|1
7490192|NCT02132754|11805087|FG013|Overall Study|Withdrawal by Subject|0
7490193|NCT02132754|11805088|FG014|Overall Study|Withdrawal by Subject|1
7490194|NCT02132754|11805089|FG015|Overall Study|Withdrawal by Subject|2
7490195|NCT02132754|11805090|FG016|Overall Study|Withdrawal by Subject|1
7490196|NCT02132754|11805091|FG017|Overall Study|Withdrawal by Subject|0
7490197|NCT02132754|11805092|FG018|Overall Study|Withdrawal by Subject|0
7490198|NCT02132754|11805093|FG019|Overall Study|Withdrawal by Subject|0
7490199|NCT02132754|11805094|FG020|Overall Study|Withdrawal by Subject|1
7490200|NCT02132754|11805095|FG021|Overall Study|Withdrawal by Subject|0
7490201|NCT02132754|11805096|FG022|Overall Study|Withdrawal by Subject|0
7490202|NCT02132754|11805097|FG023|Overall Study|Withdrawal by Subject|0
7490203|NCT02132754|11805098|FG024|Overall Study|Withdrawal by Subject|1
7490204|NCT02132754|11805099|FG025|Overall Study|Withdrawal by Subject|0
7490205|NCT02132754|11805100|FG026|Overall Study|Withdrawal by Subject|0
7490206|NCT02132754|11805101|FG027|Overall Study|Withdrawal by Subject|1
7490207|NCT02132754|11805102|FG028|Overall Study|Withdrawal by Subject|0
7490208|NCT02132754|11805103|FG029|Overall Study|Withdrawal by Subject|0
7490209|NCT02132754|11805104|FG030|Overall Study|Withdrawal by Subject|0
7490210|NCT02132754|11805105|FG031|Overall Study|Withdrawal by Subject|1
7490211|NCT02132754|11805106|FG032|Overall Study|Withdrawal by Subject|0
7490212|NCT02132754|11805107|FG033|Overall Study|Withdrawal by Subject|2
7490213|NCT02132767|11805219|FG000|Overall Study|Death|3
7490214|NCT02132767|11805220|FG001|Overall Study|Death|2
7490215|NCT02132767|11805219|FG000|Overall Study|Withdrawal by Subject|10
7490216|NCT02132767|11805220|FG001|Overall Study|Withdrawal by Subject|9
7490217|NCT02132767|11805219|FG000|Overall Study|Lost to Follow-up|4
7490218|NCT02132767|11805220|FG001|Overall Study|Lost to Follow-up|4
7490219|NCT02132949|11805264|FG000|Overall Study|Death|7
7490220|NCT02132949|11805265|FG001|Overall Study|Death|13
7490221|NCT02132949|11805264|FG000|Overall Study|Lost to Follow-up|14
7490222|NCT02132949|11805265|FG001|Overall Study|Lost to Follow-up|4
7490223|NCT02132949|11805264|FG000|Overall Study|Withdrawal by Subject|6
7490224|NCT02132949|11805265|FG001|Overall Study|Withdrawal by Subject|5
7490225|NCT02132949|11805264|FG000|Overall Study|Noncompliance|5
7490226|NCT02132949|11805265|FG001|Overall Study|Noncompliance|1
7490227|NCT02132949|11805264|FG000|Overall Study|Physician Decision|3
7490228|NCT02132949|11805265|FG001|Overall Study|Physician Decision|1
7490229|NCT02132949|11805264|FG000|Overall Study|Disease Progression|3
7490230|NCT02132949|11805265|FG001|Overall Study|Disease Progression|0
7490231|NCT02132949|11805264|FG000|Overall Study|Adverse Event|2
7490232|NCT02132949|11805265|FG001|Overall Study|Adverse Event|1
7490233|NCT02132949|11805264|FG000|Overall Study|Withdrew Prior to Treatment|1
7490234|NCT02132949|11805265|FG001|Overall Study|Withdrew Prior to Treatment|2
7490235|NCT02132949|11805264|FG000|Overall Study|Reason Unspecified|0
7490236|NCT02132949|11805265|FG001|Overall Study|Reason Unspecified|1
7490237|NCT02133001|11805273|FG000|Double Blind (Day 1-25)|Adverse Event|1
7490238|NCT02133001|11805274|FG001|Double Blind (Day 1-25)|Adverse Event|5
7490239|NCT02133001|11805273|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
7490240|NCT02133001|11805274|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
7490241|NCT02133001|11805273|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
7490242|NCT02133001|11805274|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
7490243|NCT02133001|11805273|FG000|Double Blind (Day 1-25)|Other|2
7490244|NCT02133001|11805274|FG001|Double Blind (Day 1-25)|Other|2
7490245|NCT02133001|11805273|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
7490246|NCT02133001|11805274|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
7490247|NCT02133001|11805273|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7490248|NCT02133001|11805274|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
7490249|NCT02133001|11805273|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7490250|NCT02133001|11805274|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
7490251|NCT02133001|11805273|FG000|Follow-Up Phase (Day 26-81)|Other|0
7490252|NCT02133001|11805274|FG001|Follow-Up Phase (Day 26-81)|Other|1
7490253|NCT02133131|11805298|FG000|Overall Study|Adverse Event|0
7490254|NCT02133131|11805299|FG001|Overall Study|Adverse Event|0
7490255|NCT02133131|11805300|FG002|Overall Study|Adverse Event|0
7490256|NCT02133131|11805301|FG003|Overall Study|Adverse Event|1
7490257|NCT02133131|11805302|FG004|Overall Study|Adverse Event|0
7490258|NCT02133131|11805303|FG005|Overall Study|Adverse Event|0
7490259|NCT02133131|11805304|FG006|Overall Study|Adverse Event|0
7490260|NCT02133131|11805298|FG000|Overall Study|Lost to Follow-up|1
7490261|NCT02133131|11805299|FG001|Overall Study|Lost to Follow-up|0
7490262|NCT02133131|11805300|FG002|Overall Study|Lost to Follow-up|0
7490263|NCT02133131|11805301|FG003|Overall Study|Lost to Follow-up|1
7490264|NCT02133131|11805302|FG004|Overall Study|Lost to Follow-up|0
7490265|NCT02133131|11805303|FG005|Overall Study|Lost to Follow-up|0
7490266|NCT02133131|11805304|FG006|Overall Study|Lost to Follow-up|0
7490267|NCT02133131|11805298|FG000|Overall Study|Status not recorded|4
7490268|NCT02133131|11805299|FG001|Overall Study|Status not recorded|5
7490269|NCT02133131|11805300|FG002|Overall Study|Status not recorded|1
7490270|NCT02133131|11805301|FG003|Overall Study|Status not recorded|4
7490271|NCT02133131|11805302|FG004|Overall Study|Status not recorded|0
7490272|NCT02133131|11805303|FG005|Overall Study|Status not recorded|0
7490273|NCT02133131|11805304|FG006|Overall Study|Status not recorded|0
7490274|NCT02133131|11805298|FG000|Overall Study|Ongoing in study|0
7490275|NCT02133131|11805299|FG001|Overall Study|Ongoing in study|0
7490276|NCT02133131|11805300|FG002|Overall Study|Ongoing in study|0
7490277|NCT02133131|11805301|FG003|Overall Study|Ongoing in study|0
7490278|NCT02133131|11805302|FG004|Overall Study|Ongoing in study|15
7490279|NCT02133131|11805303|FG005|Overall Study|Ongoing in study|14
7490280|NCT02133131|11805304|FG006|Overall Study|Ongoing in study|11
7490281|NCT02133131|11805298|FG000|Overall Study|Protocol Violation|0
7490282|NCT02133131|11805299|FG001|Overall Study|Protocol Violation|0
7490283|NCT02133131|11805300|FG002|Overall Study|Protocol Violation|0
7490284|NCT02133131|11805301|FG003|Overall Study|Protocol Violation|0
7490285|NCT02133131|11805302|FG004|Overall Study|Protocol Violation|0
7490286|NCT02133131|11805303|FG005|Overall Study|Protocol Violation|0
7490287|NCT02133131|11805304|FG006|Overall Study|Protocol Violation|1
7490288|NCT02133352|11805335|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
7490289|NCT02133508|11805339|FG000|Overall Study|Decision of Investigator or Sponsor|1
7490290|NCT02133508|11805339|FG000|Overall Study|Death|12
7490291|NCT02133508|11805339|FG000|Overall Study|Lost to Follow-up|2
7490292|NCT02133664|11805345|FG000|Overall Study|Lost to Follow-up|2
7490293|NCT02133664|11805346|FG001|Overall Study|Lost to Follow-up|1
7490294|NCT02133664|11805345|FG000|Overall Study|Adverse Event|3
7490295|NCT02133664|11805346|FG001|Overall Study|Adverse Event|6
7490296|NCT02133742|11805352|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
7490297|NCT02133742|11805352|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
7490298|NCT02133742|11805352|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
7490299|NCT02133742|11805352|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
7490300|NCT02133742|11805352|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
7490301|NCT02134015|11805373|FG000|Overall Study|Protocol Violation|0
7490302|NCT02134015|11805374|FG001|Overall Study|Protocol Violation|1
7490303|NCT02134015|11805373|FG000|Overall Study|Death|2
7490304|NCT02134015|11805374|FG001|Overall Study|Death|1
7490305|NCT02134015|11805373|FG000|Overall Study|Reason not provided|1
7490306|NCT02134015|11805374|FG001|Overall Study|Reason not provided|2
7490307|NCT02134015|11805373|FG000|Overall Study|Clinical progression|14
7490308|NCT02134015|11805374|FG001|Overall Study|Clinical progression|7
7490309|NCT02134015|11805373|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
7490310|NCT02134015|11805374|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
7490311|NCT02134015|11805373|FG000|Overall Study|Study terminated by sponsor|2
7490312|NCT02134015|11805374|FG001|Overall Study|Study terminated by sponsor|3
7490313|NCT02134015|11805373|FG000|Overall Study|Adverse Event|9
7490314|NCT02134015|11805374|FG001|Overall Study|Adverse Event|10
7490315|NCT02134015|11805373|FG000|Overall Study|Withdrawal by Subject|3
7490316|NCT02134015|11805374|FG001|Overall Study|Withdrawal by Subject|7
7490317|NCT02134353|11805423|FG000|Overall Study|Adverse Event|10
7490318|NCT02134353|11805424|FG001|Overall Study|Adverse Event|6
7490319|NCT02134353|11805423|FG000|Overall Study|Lost to Follow-up|1
7490320|NCT02134353|11805424|FG001|Overall Study|Lost to Follow-up|1
7490321|NCT02134353|11805423|FG000|Overall Study|Lack of Efficacy|2
7490322|NCT02134353|11805424|FG001|Overall Study|Lack of Efficacy|1
7490323|NCT02134353|11805423|FG000|Overall Study|Withdrawal by Subject|12
7490324|NCT02134353|11805424|FG001|Overall Study|Withdrawal by Subject|13
7490325|NCT02134353|11805423|FG000|Overall Study|Death|0
7490326|NCT02134353|11805424|FG001|Overall Study|Death|1
7490327|NCT02134353|11805423|FG000|Overall Study|Pregnancy|0
7490328|NCT02134353|11805424|FG001|Overall Study|Pregnancy|1
7490329|NCT02134353|11805423|FG000|Overall Study|Relocation|1
7490330|NCT02134353|11805424|FG001|Overall Study|Relocation|0
7490331|NCT02134353|11805423|FG000|Overall Study|Other - Patient's Choice|0
7490332|NCT02134353|11805424|FG001|Overall Study|Other - Patient's Choice|1
7490333|NCT02134587|11805434|FG000|Overall Study|Did not completed all meetings|30
7490334|NCT02134977|11805461|FG000|Overall Study|Protocol Deviation|102
7490335|NCT02135107|11805489|FG000|Treatment Period|Withdrawal by Subject|11
7490336|NCT02135107|11805490|FG001|Treatment Period|Withdrawal by Subject|0
7490337|NCT02135107|11805491|FG002|Treatment Period|Withdrawal by Subject|0
7490338|NCT02135107|11805492|FG003|Treatment Period|Withdrawal by Subject|0
7490339|NCT02135107|11805489|FG000|Treatment Period|Adverse Event|5
7490340|NCT02135107|11805490|FG001|Treatment Period|Adverse Event|2
7490341|NCT02135107|11805491|FG002|Treatment Period|Adverse Event|0
7490342|NCT02135107|11805492|FG003|Treatment Period|Adverse Event|0
7490343|NCT02135107|11805489|FG000|Treatment Period|Pregnancy|1
7490344|NCT02135107|11805490|FG001|Treatment Period|Pregnancy|0
7490345|NCT02135107|11805491|FG002|Treatment Period|Pregnancy|0
7490346|NCT02135107|11805492|FG003|Treatment Period|Pregnancy|0
7490347|NCT02135107|11805489|FG000|Treatment Period|Other|115
7490348|NCT02135107|11805490|FG001|Treatment Period|Other|24
7317647|NCT00723892|11546653|FG000|Overall Study|Participant not tracked|33
7317648|NCT00723892|11546654|FG001|Overall Study|Participant not tracked|35
7317649|NCT00723892|11546653|FG000|Overall Study|Virological criterion|24
7317650|NCT00723892|11546654|FG001|Overall Study|Virological criterion|9
7317651|NCT00723892|11546653|FG000|Overall Study|Withdrawal by Subject|6
7317652|NCT00723892|11546654|FG001|Overall Study|Withdrawal by Subject|9
7317653|NCT00723892|11546653|FG000|Overall Study|End planned|11
7317654|NCT00723892|11546654|FG001|Overall Study|End planned|7
7317655|NCT00723892|11546653|FG000|Overall Study|Bad tolerance|5
7317656|NCT00723892|11546654|FG001|Overall Study|Bad tolerance|5
7317657|NCT00723892|11546653|FG000|Overall Study|Multiple reasons|17
7317658|NCT00723892|11546654|FG001|Overall Study|Multiple reasons|12
7317659|NCT00723892|11546653|FG000|Overall Study|Other|6
7317660|NCT00723892|11546654|FG001|Overall Study|Other|3
7317661|NCT00723892|11546653|FG000|Overall Study|Study end|1
7317662|NCT00723892|11546654|FG001|Overall Study|Study end|3
7317663|NCT00723892|11546653|FG000|Overall Study|Weight loss|1
7317664|NCT00723892|11546654|FG001|Overall Study|Weight loss|3
7317665|NCT00723892|11546653|FG000|Overall Study|Alcohol abuse|0
7317666|NCT00723892|11546654|FG001|Overall Study|Alcohol abuse|1
7317667|NCT00723892|11546653|FG000|Overall Study|Intercurrent infection|2
7317668|NCT00723892|11546654|FG001|Overall Study|Intercurrent infection|0
7317669|NCT00723892|11546653|FG000|Overall Study|Drug addiction|1
7317670|NCT00723892|11546654|FG001|Overall Study|Drug addiction|0
7317671|NCT00723957|11546666|FG000|Overall Study|Adverse event unrelated to study drug|1
7317672|NCT00723957|11546667|FG001|Overall Study|Adverse event unrelated to study drug|4
7317673|NCT00723957|11546666|FG000|Overall Study|Death|3
7317674|NCT00723957|11546667|FG001|Overall Study|Death|4
7317675|NCT00723957|11546666|FG000|Overall Study|Disease progression|27
7317676|NCT00723957|11546667|FG001|Overall Study|Disease progression|25
7317677|NCT00723957|11546666|FG000|Overall Study|Maximum clinical benefit|4
7317678|NCT00723957|11546667|FG001|Overall Study|Maximum clinical benefit|5
7317679|NCT00723957|11546666|FG000|Overall Study|Investigator decision|1
7317680|NCT00723957|11546667|FG001|Overall Study|Investigator decision|1
7317681|NCT00723957|11546666|FG000|Overall Study|Study drug toxicity|4
7490349|NCT02135107|11805491|FG002|Treatment Period|Other|0
7490350|NCT02135107|11805492|FG003|Treatment Period|Other|0
7490351|NCT02135107|11805489|FG000|Maintenance Therapy Period|Adverse Event|0
7490352|NCT02135107|11805490|FG001|Maintenance Therapy Period|Adverse Event|0
7490353|NCT02135107|11805491|FG002|Maintenance Therapy Period|Adverse Event|3
7490354|NCT02135107|11805492|FG003|Maintenance Therapy Period|Adverse Event|7
7490355|NCT02135107|11805489|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
7490356|NCT02135107|11805490|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
7490357|NCT02135107|11805491|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
7490358|NCT02135107|11805492|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
7490359|NCT02135107|11805489|FG000|Maintenance Therapy Period|Pregnancy|0
7490360|NCT02135107|11805490|FG001|Maintenance Therapy Period|Pregnancy|0
7490361|NCT02135107|11805491|FG002|Maintenance Therapy Period|Pregnancy|0
7490362|NCT02135107|11805492|FG003|Maintenance Therapy Period|Pregnancy|1
7490363|NCT02135107|11805489|FG000|Maintenance Therapy Period|Other|0
7490364|NCT02135107|11805490|FG001|Maintenance Therapy Period|Other|0
7490365|NCT02135107|11805491|FG002|Maintenance Therapy Period|Other|7
7490366|NCT02135107|11805492|FG003|Maintenance Therapy Period|Other|8
7490367|NCT02135445|11805525|FG000|Overall Study|Lost to Follow-up|1
7490368|NCT02135445|11805526|FG001|Overall Study|Lost to Follow-up|0
7490369|NCT02135445|11805525|FG000|Overall Study|Withdrawal by Subject|1
7490370|NCT02135445|11805526|FG001|Overall Study|Withdrawal by Subject|0
7490371|NCT02135614|11805534|FG000|Overall Study|Randomized but Not Treated|2
7490372|NCT02135614|11805535|FG001|Overall Study|Randomized but Not Treated|1
7490373|NCT02135614|11805534|FG000|Overall Study|Adverse Event|0
7490374|NCT02135614|11805535|FG001|Overall Study|Adverse Event|1
7490375|NCT02135614|11805534|FG000|Overall Study|Death|1
7490376|NCT02135614|11805535|FG001|Overall Study|Death|0
7490377|NCT02135614|11805534|FG000|Overall Study|Investigator's Discretion|0
7490378|NCT02135614|11805535|FG001|Overall Study|Investigator's Discretion|1
7490379|NCT02135614|11805534|FG000|Overall Study|Withdrew Consent|2
7490380|NCT02135614|11805535|FG001|Overall Study|Withdrew Consent|2
7490381|NCT02135614|11805534|FG000|Overall Study|Lost to Follow-up|3
7490382|NCT02135614|11805535|FG001|Overall Study|Lost to Follow-up|0
7535081|NCT02707952|11882666|FG000|Overall Study|Lost to Follow-up|1
7535082|NCT02707952|11882667|FG001|Overall Study|Lost to Follow-up|0
7535083|NCT02707952|11882668|FG002|Overall Study|Lost to Follow-up|0
7535084|NCT02707952|11882669|FG003|Overall Study|Lost to Follow-up|0
7535085|NCT02707952|11882666|FG000|Overall Study|Withdrawal by Subject|0
7535086|NCT02707952|11882667|FG001|Overall Study|Withdrawal by Subject|1
7535087|NCT02707952|11882668|FG002|Overall Study|Withdrawal by Subject|2
7535088|NCT02707952|11882669|FG003|Overall Study|Withdrawal by Subject|0
7317682|NCT00723957|11546667|FG001|Overall Study|Study drug toxicity|6
7490383|NCT02135692|11805552|FG000|Overall Study|Adverse Event|3
7490384|NCT02135692|11805552|FG000|Overall Study|Lack of Efficacy|2
7490385|NCT02135692|11805552|FG000|Overall Study|Protocol Violation|2
7490386|NCT02135692|11805552|FG000|Overall Study|Subject met Liver Stopping Criteria|1
7490387|NCT02135692|11805552|FG000|Overall Study|Product commercially available|159
7490388|NCT02135692|11805552|FG000|Overall Study|Study closed/terminated|153
7490389|NCT02135692|11805552|FG000|Overall Study|Lost to Follow-up|4
7490390|NCT02135692|11805552|FG000|Overall Study|Withdrawal by Subject|15
7490391|NCT02135848|11805558|FG000|Overall Study|Adverse Event|2
7490392|NCT02135848|11805559|FG001|Overall Study|Adverse Event|0
7490393|NCT02135848|11805558|FG000|Overall Study|Withdrawal by Subject|1
7490394|NCT02135848|11805559|FG001|Overall Study|Withdrawal by Subject|1
7490395|NCT02136576|11805652|FG000|Overall Study|Lost to Follow-up|2
7490396|NCT02136576|11805653|FG001|Overall Study|Lost to Follow-up|0
7490397|NCT02136576|11805654|FG002|Overall Study|Lost to Follow-up|0
7490398|NCT02136680|11805664|FG000|Overall Study|No Longer Interested|1
7490399|NCT02136680|11805665|FG001|Overall Study|No Longer Interested|1
7490400|NCT02136680|11805664|FG000|Overall Study|No longer receiving care at clinic|3
7490401|NCT02136680|11805665|FG001|Overall Study|No longer receiving care at clinic|5
7490402|NCT02136680|11805664|FG000|Overall Study|Moved away|5
7490403|NCT02136680|11805665|FG001|Overall Study|Moved away|4
7490404|NCT02136680|11805664|FG000|Overall Study|Unable to schedule|17
7490405|NCT02136680|11805665|FG001|Overall Study|Unable to schedule|16
7490406|NCT02136680|11805664|FG000|Overall Study|Study ended before interview due|6
7490407|NCT02136680|11805665|FG001|Overall Study|Study ended before interview due|3
7490408|NCT02136914|11805677|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
7490409|NCT02136914|11805678|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
7490410|NCT02136914|11805677|FG000|Overall Study|Withdrawal by Subject|3
7490411|NCT02136914|11805678|FG001|Overall Study|Withdrawal by Subject|10
7490488|NCT02137369|11805700|FG000|Overall Study|Moved away|2
7490412|NCT02136914|11805677|FG000|Overall Study|Subject Unwilling to Proceed|7
7490413|NCT02136914|11805678|FG001|Overall Study|Subject Unwilling to Proceed|2
7490414|NCT02136914|11805677|FG000|Overall Study|Lost to Follow-up|1
7490415|NCT02136914|11805678|FG001|Overall Study|Lost to Follow-up|1
7490416|NCT02136914|11805677|FG000|Overall Study|Did Not Receive Study Drug|2
7490417|NCT02136914|11805678|FG001|Overall Study|Did Not Receive Study Drug|0
7490418|NCT02136914|11805677|FG000|Overall Study|Lack of Efficacy|1
7490419|NCT02136914|11805678|FG001|Overall Study|Lack of Efficacy|0
7490420|NCT02136914|11805677|FG000|Overall Study|Death|0
7490421|NCT02136914|11805678|FG001|Overall Study|Death|1
7490422|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Adverse Event|3
7490423|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Adverse Event|3
7490424|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Adverse Event|0
7490425|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Adverse Event|0
7490426|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Adverse Event|0
7490427|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
7490428|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
7490429|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7490430|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7490431|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
7490432|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Physician Decision|1
7490433|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Physician Decision|3
7490434|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Physician Decision|0
7490435|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Physician Decision|0
7490436|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Physician Decision|0
7490437|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
7490438|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
7490439|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
7490440|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
7490441|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
7490442|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
7490443|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
7490444|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
7490445|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
7490446|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
7490447|NCT02137226|11805686|FG000|Period 1 (Initial Randomization)|Other Reason|1
7490448|NCT02137226|11805687|FG001|Period 1 (Initial Randomization)|Other Reason|3
7490449|NCT02137226|11805688|FG002|Period 1 (Initial Randomization)|Other Reason|0
7490450|NCT02137226|11805689|FG003|Period 1 (Initial Randomization)|Other Reason|0
7490451|NCT02137226|11805690|FG004|Period 1 (Initial Randomization)|Other Reason|0
7490452|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Adverse Event|0
7490453|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Adverse Event|0
7490454|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Adverse Event|3
7490455|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Adverse Event|1
7490456|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Adverse Event|4
7490457|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7490458|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
7490459|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
7490460|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
7490461|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
7490462|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Physician Decision|0
7490463|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Physician Decision|0
7490464|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Physician Decision|0
7490465|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Physician Decision|1
7490466|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Physician Decision|0
7490467|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
7490468|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
7490469|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
7490470|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
7490471|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
7490472|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
7490473|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
7490474|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
7490475|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
7490476|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
7490477|NCT02137226|11805686|FG000|Period 2 (Re - Randomization)|Other Reason|0
7490478|NCT02137226|11805687|FG001|Period 2 (Re - Randomization)|Other Reason|0
7490479|NCT02137226|11805688|FG002|Period 2 (Re - Randomization)|Other Reason|1
7490480|NCT02137226|11805689|FG003|Period 2 (Re - Randomization)|Other Reason|1
7490481|NCT02137226|11805690|FG004|Period 2 (Re - Randomization)|Other Reason|1
7490482|NCT02137369|11805700|FG000|Overall Study|Withdrawal by Subject|3
7490483|NCT02137369|11805701|FG001|Overall Study|Withdrawal by Subject|2
7490484|NCT02137369|11805700|FG000|Overall Study|Adverse Event|2
7490485|NCT02137369|11805701|FG001|Overall Study|Adverse Event|0
7490486|NCT02137369|11805700|FG000|Overall Study|Lost to Follow-up|1
7490487|NCT02137369|11805701|FG001|Overall Study|Lost to Follow-up|0
7490489|NCT02137369|11805701|FG001|Overall Study|Moved away|0
7490490|NCT02137772|11805778|FG000|Overall Study|Adverse Event|6
7490491|NCT02137772|11805779|FG001|Overall Study|Adverse Event|3
7490492|NCT02137772|11805778|FG000|Overall Study|Death|71
7490493|NCT02137772|11805779|FG001|Overall Study|Death|44
7490494|NCT02137772|11805778|FG000|Overall Study|Lost to Follow-up|8
7490495|NCT02137772|11805779|FG001|Overall Study|Lost to Follow-up|4
7490496|NCT02137772|11805778|FG000|Overall Study|Physician Decision|15
7490497|NCT02137772|11805779|FG001|Overall Study|Physician Decision|5
7490498|NCT02137772|11805778|FG000|Overall Study|Withdrawal by Subject|28
7490499|NCT02137772|11805779|FG001|Overall Study|Withdrawal by Subject|17
7490500|NCT02137772|11805778|FG000|Overall Study|Non-compliance with study drug|1
7490501|NCT02137772|11805779|FG001|Overall Study|Non-compliance with study drug|0
7490502|NCT02137772|11805778|FG000|Overall Study|Not treated|3
7490503|NCT02137772|11805779|FG001|Overall Study|Not treated|2
7490504|NCT02137785|11805787|FG000|Overall Study|Lost to Follow-up|1
7490505|NCT02137785|11805788|FG001|Overall Study|Lost to Follow-up|0
7490506|NCT02137785|11805787|FG000|Overall Study|Withdrawal by Subject|1
7490507|NCT02137785|11805788|FG001|Overall Study|Withdrawal by Subject|4
7490508|NCT02137785|11805787|FG000|Overall Study|subject moved out of state|1
7490509|NCT02137785|11805788|FG001|Overall Study|subject moved out of state|0
7490510|NCT02137837|11805797|FG000|Overall Study|Adverse Event|0
7490511|NCT02137837|11805798|FG001|Overall Study|Adverse Event|2
7490512|NCT02137837|11805799|FG002|Overall Study|Adverse Event|1
7490513|NCT02137837|11805797|FG000|Overall Study|Refusal unrelated to adverse event|2
7490514|NCT02137837|11805798|FG001|Overall Study|Refusal unrelated to adverse event|2
7490515|NCT02137837|11805799|FG002|Overall Study|Refusal unrelated to adverse event|1
7490516|NCT02137837|11805797|FG000|Overall Study|Progression/relapse|9
7490517|NCT02137837|11805798|FG001|Overall Study|Progression/relapse|7
7490518|NCT02137837|11805799|FG002|Overall Study|Progression/relapse|7
7490519|NCT02137837|11805797|FG000|Overall Study|Not protocol specified|2
7490520|NCT02137837|11805798|FG001|Overall Study|Not protocol specified|1
7490521|NCT02137837|11805799|FG002|Overall Study|Not protocol specified|3
7490522|NCT02138110|11805864|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
7490523|NCT02138110|11805864|FG000|Overall Scaffold Implantation|Death|3
7490524|NCT02138136|11805868|FG000|Overall Study|Protocol Violation|4
7490525|NCT02138136|11805868|FG000|Overall Study|Physician Decision|7
7490526|NCT02138136|11805868|FG000|Overall Study|Lack of Efficacy|35
7490527|NCT02138136|11805868|FG000|Overall Study|Pregnancy|2
7490528|NCT02138136|11805868|FG000|Overall Study|Adverse Event|18
7490529|NCT02138136|11805868|FG000|Overall Study|Withdrawal by Subject|36
7490530|NCT02138136|11805868|FG000|Overall Study|Lost to Follow-up|32
7490531|NCT02138136|11805868|FG000|Overall Study|Withdrawn by Sponsor|5
7490532|NCT02138214|11805876|FG000|Overall Study|Withdrawal by Subject|0
7490533|NCT02138214|11805877|FG001|Overall Study|Withdrawal by Subject|1
7490534|NCT02138214|11805878|FG002|Overall Study|Withdrawal by Subject|0
7490535|NCT02138214|11805876|FG000|Overall Study|Lost to Follow-up|0
7490536|NCT02138214|11805877|FG001|Overall Study|Lost to Follow-up|2
7490537|NCT02138214|11805878|FG002|Overall Study|Lost to Follow-up|4
7490538|NCT02138214|11805876|FG000|Overall Study|Screen Failure|0
7490539|NCT02138214|11805877|FG001|Overall Study|Screen Failure|1
7490540|NCT02138214|11805878|FG002|Overall Study|Screen Failure|0
7490541|NCT02138253|11805925|FG000|Overall Study|Adverse Event|3
7490542|NCT02138253|11805926|FG001|Overall Study|Adverse Event|3
7490543|NCT02138253|11805925|FG000|Overall Study|Lost to Follow-up|2
7490544|NCT02138253|11805926|FG001|Overall Study|Lost to Follow-up|1
7490545|NCT02138253|11805925|FG000|Overall Study|Physician Decision|2
7490546|NCT02138253|11805926|FG001|Overall Study|Physician Decision|0
7490547|NCT02138253|11805925|FG000|Overall Study|Non compliance|1
7490548|NCT02138253|11805926|FG001|Overall Study|Non compliance|0
7490549|NCT02138253|11805925|FG000|Overall Study|Withdrawal by Subject|1
7490550|NCT02138253|11805926|FG001|Overall Study|Withdrawal by Subject|0
7490551|NCT02138747|11805958|FG000|Treatment Period 1|Adverse Event|10
7490552|NCT02138747|11805959|FG001|Treatment Period 1|Adverse Event|14
7490553|NCT02138747|11805960|FG002|Treatment Period 1|Adverse Event|2
7490554|NCT02138747|11805961|FG003|Treatment Period 1|Adverse Event|1
7490555|NCT02138747|11805958|FG000|Treatment Period 1|Lost to Follow-up|0
7490556|NCT02138747|11805959|FG001|Treatment Period 1|Lost to Follow-up|1
7490557|NCT02138747|11805960|FG002|Treatment Period 1|Lost to Follow-up|1
7490558|NCT02138747|11805961|FG003|Treatment Period 1|Lost to Follow-up|0
7490559|NCT02138747|11805958|FG000|Treatment Period 1|Protocol Violation|0
7490560|NCT02138747|11805959|FG001|Treatment Period 1|Protocol Violation|2
7490561|NCT02138747|11805960|FG002|Treatment Period 1|Protocol Violation|0
7490562|NCT02138747|11805961|FG003|Treatment Period 1|Protocol Violation|0
7490563|NCT02138747|11805958|FG000|Treatment Period 1|Withdrawal by Subject|8
7490564|NCT02138747|11805959|FG001|Treatment Period 1|Withdrawal by Subject|4
7490565|NCT02138747|11805960|FG002|Treatment Period 1|Withdrawal by Subject|1
7490566|NCT02138747|11805961|FG003|Treatment Period 1|Withdrawal by Subject|3
7490567|NCT02138747|11805958|FG000|Treatment Period 1|Other - Miscellaneous|2
7490568|NCT02138747|11805959|FG001|Treatment Period 1|Other - Miscellaneous|4
7490569|NCT02138747|11805960|FG002|Treatment Period 1|Other - Miscellaneous|0
7490570|NCT02138747|11805961|FG003|Treatment Period 1|Other - Miscellaneous|0
7490571|NCT02138747|11805958|FG000|Treatment Period 2|Adverse Event|6
7490572|NCT02138747|11805959|FG001|Treatment Period 2|Adverse Event|3
7490573|NCT02138747|11805960|FG002|Treatment Period 2|Adverse Event|1
7490574|NCT02138747|11805961|FG003|Treatment Period 2|Adverse Event|1
7490575|NCT02138747|11805958|FG000|Treatment Period 2|Lost to Follow-up|2
7490576|NCT02138747|11805959|FG001|Treatment Period 2|Lost to Follow-up|0
7490577|NCT02138747|11805960|FG002|Treatment Period 2|Lost to Follow-up|0
7490578|NCT02138747|11805961|FG003|Treatment Period 2|Lost to Follow-up|0
7490579|NCT02138747|11805958|FG000|Treatment Period 2|Protocol Violation|1
7490580|NCT02138747|11805959|FG001|Treatment Period 2|Protocol Violation|0
7490581|NCT02138747|11805960|FG002|Treatment Period 2|Protocol Violation|0
7490582|NCT02138747|11805961|FG003|Treatment Period 2|Protocol Violation|0
7490583|NCT02138747|11805958|FG000|Treatment Period 2|Withdrawal by Subject|5
7490584|NCT02138747|11805959|FG001|Treatment Period 2|Withdrawal by Subject|4
7490585|NCT02138747|11805960|FG002|Treatment Period 2|Withdrawal by Subject|1
7490586|NCT02138747|11805961|FG003|Treatment Period 2|Withdrawal by Subject|2
7490587|NCT02138747|11805958|FG000|Treatment Period 2|Other - Miscellaneous|3
7490588|NCT02138747|11805959|FG001|Treatment Period 2|Other - Miscellaneous|0
7490589|NCT02138747|11805960|FG002|Treatment Period 2|Other - Miscellaneous|0
7490590|NCT02138747|11805961|FG003|Treatment Period 2|Other - Miscellaneous|0
7490591|NCT02138786|11805974|FG000|Overall Study|Adverse Event|0
7490592|NCT02138786|11805975|FG001|Overall Study|Adverse Event|2
7490593|NCT02138786|11805976|FG002|Overall Study|Adverse Event|1
7490594|NCT02138786|11805974|FG000|Overall Study|Death|1
7490595|NCT02138786|11805975|FG001|Overall Study|Death|7
7490596|NCT02138786|11805976|FG002|Overall Study|Death|2
7490597|NCT02138786|11805974|FG000|Overall Study|Disease Progression|1
7490598|NCT02138786|11805975|FG001|Overall Study|Disease Progression|1
7490599|NCT02138786|11805976|FG002|Overall Study|Disease Progression|3
7490600|NCT02138786|11805974|FG000|Overall Study|Withdrawal by Subject|1
7490601|NCT02138786|11805975|FG001|Overall Study|Withdrawal by Subject|2
7490602|NCT02138786|11805976|FG002|Overall Study|Withdrawal by Subject|0
7490603|NCT02138786|11805974|FG000|Overall Study|Patient's Wish|0
7490604|NCT02138786|11805975|FG001|Overall Study|Patient's Wish|2
7490605|NCT02138786|11805976|FG002|Overall Study|Patient's Wish|0
7490606|NCT02138786|11805974|FG000|Overall Study|Sponsor Terminated Study|0
7490607|NCT02138786|11805975|FG001|Overall Study|Sponsor Terminated Study|1
7490608|NCT02138786|11805976|FG002|Overall Study|Sponsor Terminated Study|1
7490609|NCT02138786|11805974|FG000|Overall Study|Non-Compliance|0
7490610|NCT02138786|11805975|FG001|Overall Study|Non-Compliance|0
7490611|NCT02138786|11805976|FG002|Overall Study|Non-Compliance|1
7490612|NCT02138825|11805984|FG000|Main Study Treatment|Adverse Event|11
7490613|NCT02138825|11805985|FG001|Main Study Treatment|Adverse Event|3
7490614|NCT02138825|11805984|FG000|Main Study Treatment|Death|1
7490615|NCT02138825|11805985|FG001|Main Study Treatment|Death|2
7490616|NCT02138825|11805984|FG000|Main Study Treatment|Protocol Violation|2
7490617|NCT02138825|11805985|FG001|Main Study Treatment|Protocol Violation|2
7490618|NCT02138825|11805984|FG000|Main Study Treatment|Sponsor decision|12
7490619|NCT02138825|11805985|FG001|Main Study Treatment|Sponsor decision|18
7490620|NCT02138825|11805984|FG000|Main Study Treatment|Study terminated by sponsor|10
7490621|NCT02138825|11805985|FG001|Main Study Treatment|Study terminated by sponsor|9
7490622|NCT02138825|11805984|FG000|Main Study Treatment|Withdrawal by Subject|3
7490623|NCT02138825|11805985|FG001|Main Study Treatment|Withdrawal by Subject|1
7490624|NCT02138825|11805984|FG000|Main Study Treatment|Medical decision|1
7490625|NCT02138825|11805985|FG001|Main Study Treatment|Medical decision|0
7490626|NCT02138825|11805984|FG000|Long-term Extension|Study termination by sponsor|32
7490627|NCT02138825|11805985|FG001|Long-term Extension|Study termination by sponsor|38
7490628|NCT02138825|11805984|FG000|Safety Follow-up|Adverse Event|4
7490629|NCT02138825|11805985|FG001|Safety Follow-up|Adverse Event|3
7490630|NCT02138825|11805984|FG000|Safety Follow-up|Death|11
7490631|NCT02138825|11805985|FG001|Safety Follow-up|Death|5
7490632|NCT02138825|11805984|FG000|Safety Follow-up|Withdrawal by Subject|5
7490633|NCT02138825|11805985|FG001|Safety Follow-up|Withdrawal by Subject|3
7490634|NCT02138825|11805984|FG000|Safety Follow-up|clinic worsening|1
7490635|NCT02138825|11805985|FG001|Safety Follow-up|clinic worsening|0
7490636|NCT02138825|11805984|FG000|Safety Follow-up|withdrawal by PI|1
7490637|NCT02138825|11805985|FG001|Safety Follow-up|withdrawal by PI|0
7490638|NCT02138825|11805984|FG000|Safety Follow-up|logistical difficulties|0
7490639|NCT02138825|11805985|FG001|Safety Follow-up|logistical difficulties|1
7490640|NCT02138825|11805984|FG000|Safety Follow-up|progressive disease|0
7490641|NCT02138825|11805985|FG001|Safety Follow-up|progressive disease|2
7490642|NCT02138825|11805984|FG000|Safety Follow-up|too unwell to attend the visit|0
7490643|NCT02138825|11805985|FG001|Safety Follow-up|too unwell to attend the visit|1
7490644|NCT02138825|11805984|FG000|Safety Follow-up|treatment unblinded|0
7490645|NCT02138825|11805985|FG001|Safety Follow-up|treatment unblinded|1
7490646|NCT02138825|11805984|FG000|Safety Follow-up|withdrawn due to lung transplant|0
7490647|NCT02138825|11805985|FG001|Safety Follow-up|withdrawn due to lung transplant|1
7490648|NCT02138838|11805998|FG000|Overall Study|Study Closure|7
7490649|NCT02138838|11805999|FG001|Overall Study|Study Closure|6
7490650|NCT02138838|11805998|FG000|Overall Study|Withdrawal by Subject|1
7490651|NCT02138838|11805999|FG001|Overall Study|Withdrawal by Subject|5
7490652|NCT02138890|11806007|FG000|Overall Study|Adverse Event|1
7490653|NCT02138890|11806008|FG001|Overall Study|Adverse Event|0
7490654|NCT02138916|11806018|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
7490655|NCT02138916|11806019|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
7490656|NCT02138916|11806020|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
7490657|NCT02138916|11806018|FG000|Overall Study|Death|14
7490658|NCT02138916|11806019|FG001|Overall Study|Death|11
7490659|NCT02138916|11806020|FG002|Overall Study|Death|12
7490660|NCT02138916|11806018|FG000|Overall Study|Withdrawal by Subject|27
7490661|NCT02138916|11806019|FG001|Overall Study|Withdrawal by Subject|31
7490662|NCT02138916|11806020|FG002|Overall Study|Withdrawal by Subject|32
7490663|NCT02138916|11806018|FG000|Overall Study|Study specific withdrawal criteria|0
7490664|NCT02138916|11806019|FG001|Overall Study|Study specific withdrawal criteria|0
7490665|NCT02138916|11806020|FG002|Overall Study|Study specific withdrawal criteria|1
7490666|NCT02138916|11806018|FG000|Overall Study|incorrect enrolment|1
7490667|NCT02138916|11806019|FG001|Overall Study|incorrect enrolment|1
7490668|NCT02138916|11806020|FG002|Overall Study|incorrect enrolment|0
7490669|NCT02138916|11806018|FG000|Overall Study|Severe non-compliance|1
7490670|NCT02138916|11806019|FG001|Overall Study|Severe non-compliance|2
7490671|NCT02138916|11806020|FG002|Overall Study|Severe non-compliance|1
7490672|NCT02138916|11806018|FG000|Overall Study|Lost to Follow-up|4
7490673|NCT02138916|11806019|FG001|Overall Study|Lost to Follow-up|2
7490674|NCT02138916|11806020|FG002|Overall Study|Lost to Follow-up|3
7490675|NCT02138916|11806018|FG000|Overall Study|Adverse Event|4
7490676|NCT02138916|11806019|FG001|Overall Study|Adverse Event|4
7490677|NCT02138916|11806020|FG002|Overall Study|Adverse Event|3
7490678|NCT02139046|11806045|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7490679|NCT02139046|11806046|FG001|Overall Study|Pretreatment Event/Adverse Event|9
7490680|NCT02139046|11806047|FG002|Overall Study|Pretreatment Event/Adverse Event|10
7490681|NCT02139046|11806048|FG003|Overall Study|Pretreatment Event/Adverse Event|13
7490682|NCT02139046|11806049|FG004|Overall Study|Pretreatment Event/Adverse Event|7
7490683|NCT02139046|11806045|FG000|Overall Study|Major Protocol Deviation|9
7490684|NCT02139046|11806046|FG001|Overall Study|Major Protocol Deviation|10
7490685|NCT02139046|11806047|FG002|Overall Study|Major Protocol Deviation|16
7490686|NCT02139046|11806048|FG003|Overall Study|Major Protocol Deviation|12
7490687|NCT02139046|11806049|FG004|Overall Study|Major Protocol Deviation|6
7490688|NCT02139046|11806045|FG000|Overall Study|Lost to Follow-up|13
7490689|NCT02139046|11806046|FG001|Overall Study|Lost to Follow-up|16
7490690|NCT02139046|11806047|FG002|Overall Study|Lost to Follow-up|16
7490691|NCT02139046|11806048|FG003|Overall Study|Lost to Follow-up|18
7490692|NCT02139046|11806049|FG004|Overall Study|Lost to Follow-up|13
7490693|NCT02139046|11806045|FG000|Overall Study|Voluntary Withdrawal|20
7490694|NCT02139046|11806046|FG001|Overall Study|Voluntary Withdrawal|8
7490695|NCT02139046|11806047|FG002|Overall Study|Voluntary Withdrawal|10
7490696|NCT02139046|11806048|FG003|Overall Study|Voluntary Withdrawal|15
7490697|NCT02139046|11806049|FG004|Overall Study|Voluntary Withdrawal|16
7490698|NCT02139046|11806045|FG000|Overall Study|Lack of Efficacy|0
7490699|NCT02139046|11806046|FG001|Overall Study|Lack of Efficacy|1
7490700|NCT02139046|11806047|FG002|Overall Study|Lack of Efficacy|2
7490701|NCT02139046|11806048|FG003|Overall Study|Lack of Efficacy|1
7490702|NCT02139046|11806049|FG004|Overall Study|Lack of Efficacy|2
7490703|NCT02139046|11806045|FG000|Overall Study|Withdrawal due to a Gout Flare|1
7490704|NCT02139046|11806046|FG001|Overall Study|Withdrawal due to a Gout Flare|1
7490705|NCT02139046|11806047|FG002|Overall Study|Withdrawal due to a Gout Flare|1
7490706|NCT02139046|11806048|FG003|Overall Study|Withdrawal due to a Gout Flare|0
7490707|NCT02139046|11806049|FG004|Overall Study|Withdrawal due to a Gout Flare|1
7490708|NCT02139046|11806045|FG000|Overall Study|Other Miscellaneous Reasons|10
7490709|NCT02139046|11806046|FG001|Overall Study|Other Miscellaneous Reasons|9
7490710|NCT02139046|11806047|FG002|Overall Study|Other Miscellaneous Reasons|4
7490711|NCT02139046|11806048|FG003|Overall Study|Other Miscellaneous Reasons|9
7490712|NCT02139046|11806049|FG004|Overall Study|Other Miscellaneous Reasons|12
7490713|NCT02139124|11806066|FG000|Overall Study|Adverse Event|2
7490714|NCT02139124|11806067|FG001|Overall Study|Adverse Event|0
7490715|NCT02139124|11806068|FG002|Overall Study|Adverse Event|1
7490716|NCT02139124|11806069|FG003|Overall Study|Adverse Event|2
7490717|NCT02139124|11806070|FG004|Overall Study|Adverse Event|5
7490718|NCT02139124|11806066|FG000|Overall Study|Withdrawal by Subject|2
7490719|NCT02139124|11806067|FG001|Overall Study|Withdrawal by Subject|2
7490720|NCT02139124|11806068|FG002|Overall Study|Withdrawal by Subject|2
7490721|NCT02139124|11806069|FG003|Overall Study|Withdrawal by Subject|2
7490722|NCT02139124|11806070|FG004|Overall Study|Withdrawal by Subject|3
7490723|NCT02139124|11806066|FG000|Overall Study|Protocol Violation|0
7490724|NCT02139124|11806067|FG001|Overall Study|Protocol Violation|0
7490725|NCT02139124|11806068|FG002|Overall Study|Protocol Violation|0
7490726|NCT02139124|11806069|FG003|Overall Study|Protocol Violation|1
7490727|NCT02139124|11806070|FG004|Overall Study|Protocol Violation|1
7490728|NCT02139124|11806066|FG000|Overall Study|non-compliant|1
7490729|NCT02139124|11806067|FG001|Overall Study|non-compliant|0
7490730|NCT02139124|11806068|FG002|Overall Study|non-compliant|0
7490731|NCT02139124|11806069|FG003|Overall Study|non-compliant|2
7490732|NCT02139124|11806070|FG004|Overall Study|non-compliant|0
7490733|NCT02139124|11806066|FG000|Overall Study|incarceration|0
7490734|NCT02139124|11806067|FG001|Overall Study|incarceration|0
7490735|NCT02139124|11806068|FG002|Overall Study|incarceration|1
7490736|NCT02139124|11806069|FG003|Overall Study|incarceration|0
7490737|NCT02139124|11806070|FG004|Overall Study|incarceration|0
7490738|NCT02139124|11806066|FG000|Overall Study|subject moved|1
7490739|NCT02139124|11806067|FG001|Overall Study|subject moved|0
7490740|NCT02139124|11806068|FG002|Overall Study|subject moved|0
7490741|NCT02139124|11806069|FG003|Overall Study|subject moved|0
7490742|NCT02139124|11806070|FG004|Overall Study|subject moved|0
7490743|NCT02139124|11806066|FG000|Overall Study|Lost to Follow-up|3
7490744|NCT02139124|11806067|FG001|Overall Study|Lost to Follow-up|2
7490745|NCT02139124|11806068|FG002|Overall Study|Lost to Follow-up|0
7490746|NCT02139124|11806069|FG003|Overall Study|Lost to Follow-up|5
7490747|NCT02139124|11806070|FG004|Overall Study|Lost to Follow-up|4
7490748|NCT02139280|11806112|FG000|Overall Study|No longer eligible|2
7490749|NCT02139280|11806113|FG001|Overall Study|No longer eligible|0
7490750|NCT02139306|11806121|FG000|Overall Study|Withdrawal by Subject|4
7490751|NCT02139306|11806122|FG001|Overall Study|Withdrawal by Subject|6
7490752|NCT02139306|11806121|FG000|Overall Study|Adverse Event|3
7490753|NCT02139306|11806122|FG001|Overall Study|Adverse Event|4
7490754|NCT02139306|11806121|FG000|Overall Study|Physician Decision|0
7490755|NCT02139306|11806122|FG001|Overall Study|Physician Decision|1
7490756|NCT02139306|11806121|FG000|Overall Study|Other Unspecified|2
7490757|NCT02139306|11806122|FG001|Overall Study|Other Unspecified|3
7490758|NCT02139306|11806121|FG000|Overall Study|Protocol Violation|4
7490759|NCT02139306|11806122|FG001|Overall Study|Protocol Violation|0
7490760|NCT02139592|11806133|FG000|Overall Study|Case Report Forms Uncollected|8
7490761|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
7490762|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7490763|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7490764|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7490765|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7490766|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7490767|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
7490768|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7490769|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7490770|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7490771|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7490772|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7490773|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
7490774|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7490775|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7490776|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7490777|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7490778|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7490779|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
7490780|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7490781|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7490782|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7490783|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7490784|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7535089|NCT02707965|11882690|FG000|Overall Study|Withdrawal by Subject|0
7490785|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
7490786|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7490787|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7490788|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7490789|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7490790|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7490791|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
7490792|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7490793|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7490794|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7490795|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7490796|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7490797|NCT02139644|11806142|FG000|Run-In Period (Pre-assignment)|Other|6
7490798|NCT02139644|11806143|FG001|Run-In Period (Pre-assignment)|Other|0
7490799|NCT02139644|11806144|FG002|Run-In Period (Pre-assignment)|Other|0
7490800|NCT02139644|11806145|FG003|Run-In Period (Pre-assignment)|Other|0
7490801|NCT02139644|11806146|FG004|Run-In Period (Pre-assignment)|Other|0
7490802|NCT02139644|11806147|FG005|Run-In Period (Pre-assignment)|Other|0
7490803|NCT02139644|11806142|FG000|Treatment Period|Adverse Event|0
7490804|NCT02139644|11806143|FG001|Treatment Period|Adverse Event|0
7490805|NCT02139644|11806144|FG002|Treatment Period|Adverse Event|3
7490806|NCT02139644|11806145|FG003|Treatment Period|Adverse Event|2
7490807|NCT02139644|11806146|FG004|Treatment Period|Adverse Event|1
7490808|NCT02139644|11806147|FG005|Treatment Period|Adverse Event|6
7490809|NCT02139644|11806142|FG000|Treatment Period|Withdrawal by Subject|0
7490810|NCT02139644|11806143|FG001|Treatment Period|Withdrawal by Subject|0
7490811|NCT02139644|11806144|FG002|Treatment Period|Withdrawal by Subject|2
7490812|NCT02139644|11806145|FG003|Treatment Period|Withdrawal by Subject|2
7490813|NCT02139644|11806146|FG004|Treatment Period|Withdrawal by Subject|3
7490814|NCT02139644|11806147|FG005|Treatment Period|Withdrawal by Subject|2
7490815|NCT02139644|11806142|FG000|Treatment Period|Non-compliance|0
7490816|NCT02139644|11806143|FG001|Treatment Period|Non-compliance|0
7490817|NCT02139644|11806144|FG002|Treatment Period|Non-compliance|0
7490818|NCT02139644|11806145|FG003|Treatment Period|Non-compliance|1
7490819|NCT02139644|11806146|FG004|Treatment Period|Non-compliance|0
7490820|NCT02139644|11806147|FG005|Treatment Period|Non-compliance|0
7490821|NCT02139644|11806142|FG000|Treatment Period|Protocol Violation|0
7490822|NCT02139644|11806143|FG001|Treatment Period|Protocol Violation|0
7490823|NCT02139644|11806144|FG002|Treatment Period|Protocol Violation|0
7490824|NCT02139644|11806145|FG003|Treatment Period|Protocol Violation|1
7490825|NCT02139644|11806146|FG004|Treatment Period|Protocol Violation|1
7490826|NCT02139644|11806147|FG005|Treatment Period|Protocol Violation|1
7490827|NCT02139644|11806142|FG000|Treatment Period|Disease progression|0
7490828|NCT02139644|11806143|FG001|Treatment Period|Disease progression|0
7490829|NCT02139644|11806144|FG002|Treatment Period|Disease progression|0
7490830|NCT02139644|11806145|FG003|Treatment Period|Disease progression|1
7490831|NCT02139644|11806146|FG004|Treatment Period|Disease progression|1
7490832|NCT02139644|11806147|FG005|Treatment Period|Disease progression|2
7490833|NCT02139644|11806142|FG000|Treatment Period|Lost to Follow-up|0
7490834|NCT02139644|11806143|FG001|Treatment Period|Lost to Follow-up|0
7490835|NCT02139644|11806144|FG002|Treatment Period|Lost to Follow-up|1
7490836|NCT02139644|11806145|FG003|Treatment Period|Lost to Follow-up|1
7490837|NCT02139644|11806146|FG004|Treatment Period|Lost to Follow-up|1
7490838|NCT02139644|11806147|FG005|Treatment Period|Lost to Follow-up|1
7490839|NCT02139644|11806142|FG000|Treatment Period|Lack of Efficacy|0
7490840|NCT02139644|11806143|FG001|Treatment Period|Lack of Efficacy|0
7490841|NCT02139644|11806144|FG002|Treatment Period|Lack of Efficacy|1
7490842|NCT02139644|11806145|FG003|Treatment Period|Lack of Efficacy|0
7490843|NCT02139644|11806146|FG004|Treatment Period|Lack of Efficacy|1
7490844|NCT02139644|11806147|FG005|Treatment Period|Lack of Efficacy|4
7490845|NCT02139644|11806142|FG000|Treatment Period|Other|0
7490846|NCT02139644|11806143|FG001|Treatment Period|Other|3
7490847|NCT02139644|11806144|FG002|Treatment Period|Other|1
7490848|NCT02139644|11806145|FG003|Treatment Period|Other|1
7490849|NCT02139644|11806146|FG004|Treatment Period|Other|0
7490850|NCT02139644|11806147|FG005|Treatment Period|Other|1
7490851|NCT02139826|11806168|FG000|Overall Study|Adverse Event|1
7490852|NCT02139943|11806188|FG000|Overall Study|Adverse Event|0
7490853|NCT02139943|11806189|FG001|Overall Study|Adverse Event|1
7490854|NCT02139943|11806190|FG002|Overall Study|Adverse Event|2
7490855|NCT02139943|11806188|FG000|Overall Study|Lost to Follow-up|3
7490856|NCT02139943|11806189|FG001|Overall Study|Lost to Follow-up|2
7490857|NCT02139943|11806190|FG002|Overall Study|Lost to Follow-up|2
7490858|NCT02139943|11806188|FG000|Overall Study|Withdrawal by Subject|4
7490859|NCT02139943|11806189|FG001|Overall Study|Withdrawal by Subject|3
7490860|NCT02139943|11806190|FG002|Overall Study|Withdrawal by Subject|0
7490861|NCT02139943|11806188|FG000|Overall Study|Other|0
7490862|NCT02139943|11806189|FG001|Overall Study|Other|0
7490863|NCT02139943|11806190|FG002|Overall Study|Other|1
7490864|NCT02139943|11806188|FG000|Overall Study|Participant wishes to discontinue|2
7490865|NCT02139943|11806189|FG001|Overall Study|Participant wishes to discontinue|0
7490866|NCT02139943|11806190|FG002|Overall Study|Participant wishes to discontinue|0
7490867|NCT02139943|11806188|FG000|Overall Study|Participant in Poor Compliance|1
7490868|NCT02139943|11806189|FG001|Overall Study|Participant in Poor Compliance|0
7490869|NCT02139943|11806190|FG002|Overall Study|Participant in Poor Compliance|1
7490870|NCT02139943|11806188|FG000|Overall Study|eGFR Withdrawal Criteria|0
7490871|NCT02139943|11806189|FG001|Overall Study|eGFR Withdrawal Criteria|0
7490872|NCT02139943|11806190|FG002|Overall Study|eGFR Withdrawal Criteria|1
7490873|NCT02139982|11806212|FG000|Overall Study|Lack of Efficacy|0
7490874|NCT02139982|11806213|FG001|Overall Study|Lack of Efficacy|1
7490875|NCT02139982|11806214|FG002|Overall Study|Lack of Efficacy|0
7490876|NCT02139982|11806215|FG003|Overall Study|Lack of Efficacy|1
7490877|NCT02139982|11806216|FG004|Overall Study|Lack of Efficacy|0
7490878|NCT02139982|11806217|FG005|Overall Study|Lack of Efficacy|0
7490879|NCT02139982|11806218|FG006|Overall Study|Lack of Efficacy|0
7490880|NCT02139982|11806219|FG007|Overall Study|Lack of Efficacy|0
7490881|NCT02139982|11806220|FG008|Overall Study|Lack of Efficacy|0
7490882|NCT02139982|11806221|FG009|Overall Study|Lack of Efficacy|0
7490883|NCT02140060|11806249|FG000|Overall Study|Adverse Event|0
7490884|NCT02140060|11806250|FG001|Overall Study|Adverse Event|0
7490885|NCT02140060|11806251|FG002|Overall Study|Adverse Event|0
7490886|NCT02140060|11806252|FG003|Overall Study|Adverse Event|1
7490887|NCT02140060|11806253|FG004|Overall Study|Adverse Event|1
7490888|NCT02140060|11806254|FG005|Overall Study|Adverse Event|1
7490889|NCT02140060|11806249|FG000|Overall Study|Lack of Efficacy|0
7490890|NCT02140060|11806250|FG001|Overall Study|Lack of Efficacy|0
7490891|NCT02140060|11806251|FG002|Overall Study|Lack of Efficacy|0
7490892|NCT02140060|11806252|FG003|Overall Study|Lack of Efficacy|1
7490893|NCT02140060|11806253|FG004|Overall Study|Lack of Efficacy|0
7490894|NCT02140060|11806254|FG005|Overall Study|Lack of Efficacy|0
7490895|NCT02140164|11806269|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
7490896|NCT02140411|11806277|FG000|Overall Study|Adverse Event|1
7490897|NCT02140567|11806281|FG000|Overall Study|Problems with recording equipment|6
7490898|NCT02140645|11806301|FG000|Overall Study|Not linked|5489
7490899|NCT02140645|11806302|FG001|Overall Study|Not linked|61654
7490900|NCT02140645|11806303|FG002|Overall Study|Not linked|4236
7490901|NCT02140645|11806304|FG003|Overall Study|Not linked|13833
7490902|NCT02140645|11806305|FG004|Overall Study|Not linked|3286
7490903|NCT02140645|11806306|FG005|Overall Study|Not linked|70896
7490904|NCT02140762|11806317|FG000|Overall Study|Adverse Event|1
7490905|NCT02140762|11806318|FG001|Overall Study|Adverse Event|1
7490906|NCT02140762|11806317|FG000|Overall Study|Lost to Follow-up|9
7490907|NCT02140762|11806318|FG001|Overall Study|Lost to Follow-up|5
7490908|NCT02140762|11806317|FG000|Overall Study|Protocol Violation|1
7490909|NCT02140762|11806318|FG001|Overall Study|Protocol Violation|1
7490910|NCT02140762|11806317|FG000|Overall Study|Withdrawal by Subject|6
7490911|NCT02140762|11806318|FG001|Overall Study|Withdrawal by Subject|4
7490912|NCT02140762|11806317|FG000|Overall Study|Other|0
7490913|NCT02140762|11806318|FG001|Overall Study|Other|1
7490914|NCT02140775|11806331|FG000|Overall Study|Withdrawal by Subject|30
7490915|NCT02140775|11806332|FG001|Overall Study|Withdrawal by Subject|7
7490916|NCT02140970|11806351|FG000|Overall Study|Lost to Follow-up|1
7490917|NCT02140970|11806352|FG001|Overall Study|Lost to Follow-up|2
7490918|NCT02140970|11806351|FG000|Overall Study|Misplaced consent, subject withdrawn|1
7490919|NCT02140970|11806352|FG001|Overall Study|Misplaced consent, subject withdrawn|0
7490920|NCT02140970|11806351|FG000|Overall Study|Did not meet inclusion criteria|0
7490921|NCT02140970|11806352|FG001|Overall Study|Did not meet inclusion criteria|1
7490922|NCT02141204|11806360|FG000|Overall Study|Lost to Follow-up|2
7490923|NCT02141204|11806361|FG001|Overall Study|Lost to Follow-up|1
7490924|NCT02141204|11806360|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
7490925|NCT02141204|11806361|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
7490926|NCT02141204|11806360|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7490927|NCT02141204|11806361|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
7490928|NCT02141204|11806360|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
7490929|NCT02141204|11806361|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
7490930|NCT02141217|11806369|FG000|Overall Study|Adverse Event|1
7490931|NCT02141217|11806370|FG001|Overall Study|Adverse Event|2
7490932|NCT02141217|11806369|FG000|Overall Study|Protocol Violation|1
7490933|NCT02141217|11806370|FG001|Overall Study|Protocol Violation|4
7490934|NCT02141217|11806369|FG000|Overall Study|Withdrawal by Subject|6
7490935|NCT02141217|11806370|FG001|Overall Study|Withdrawal by Subject|0
7490936|NCT02141217|11806369|FG000|Overall Study|Lost to Follow-up|1
7490937|NCT02141217|11806370|FG001|Overall Study|Lost to Follow-up|1
7490938|NCT02141217|11806369|FG000|Overall Study|Physician Decision|1
7490939|NCT02141217|11806370|FG001|Overall Study|Physician Decision|0
7490940|NCT02141217|11806369|FG000|Overall Study|Surgical Intervention|1
7490941|NCT02141217|11806370|FG001|Overall Study|Surgical Intervention|1
7490942|NCT02141295|11806382|FG000|Overall Study|Adverse Event|1
7490943|NCT02141295|11806383|FG001|Overall Study|Adverse Event|18
7490944|NCT02141295|11806384|FG002|Overall Study|Adverse Event|11
7490945|NCT02141295|11806382|FG000|Overall Study|Physician Decision|2
7490946|NCT02141295|11806383|FG001|Overall Study|Physician Decision|19
7490947|NCT02141295|11806384|FG002|Overall Study|Physician Decision|14
7490948|NCT02141295|11806382|FG000|Overall Study|Study terminated by sponsor|0
7490949|NCT02141295|11806383|FG001|Overall Study|Study terminated by sponsor|6
7490950|NCT02141295|11806384|FG002|Overall Study|Study terminated by sponsor|6
7490951|NCT02141295|11806382|FG000|Overall Study|Non-compliance|0
7490952|NCT02141295|11806383|FG001|Overall Study|Non-compliance|1
7490953|NCT02141295|11806384|FG002|Overall Study|Non-compliance|0
7490954|NCT02141295|11806382|FG000|Overall Study|Progressive disease|3
7490955|NCT02141295|11806383|FG001|Overall Study|Progressive disease|32
7490956|NCT02141295|11806384|FG002|Overall Study|Progressive disease|50
7490957|NCT02141295|11806382|FG000|Overall Study|Reason not specified|0
7490958|NCT02141295|11806383|FG001|Overall Study|Reason not specified|9
7490959|NCT02141295|11806384|FG002|Overall Study|Reason not specified|10
7490960|NCT02141295|11806382|FG000|Overall Study|Withdrawal by Subject|0
7490961|NCT02141295|11806383|FG001|Overall Study|Withdrawal by Subject|9
7490962|NCT02141295|11806384|FG002|Overall Study|Withdrawal by Subject|4
7490963|NCT02141360|11806396|FG000|Overall Study|Withdrawal by Subject|6
7490964|NCT02141360|11806397|FG001|Overall Study|Withdrawal by Subject|0
7490965|NCT02141360|11806398|FG002|Overall Study|Withdrawal by Subject|0
7490966|NCT02141360|11806396|FG000|Overall Study|Study Terminated before Visit|1
7490967|NCT02141360|11806397|FG001|Overall Study|Study Terminated before Visit|0
7490968|NCT02141360|11806398|FG002|Overall Study|Study Terminated before Visit|0
7490969|NCT02141399|11806406|FG000|Overall Study|Adverse Event|158
7490970|NCT02141399|11806406|FG000|Overall Study|Lack of Efficacy|62
7490971|NCT02141399|11806406|FG000|Overall Study|Lost to Follow-up|151
7490972|NCT02141399|11806406|FG000|Overall Study|Non-compliance with study drug|18
7490973|NCT02141399|11806406|FG000|Overall Study|Other|45
7490974|NCT02141399|11806406|FG000|Overall Study|Physician Decision|17
7490975|NCT02141399|11806406|FG000|Overall Study|Pregnancy|3
7490976|NCT02141399|11806406|FG000|Overall Study|Protocol Violation|38
7490977|NCT02141399|11806406|FG000|Overall Study|Withdrawal by Subject|238
7490978|NCT02141399|11806406|FG000|Overall Study|Failure to meet eligibility criteria|14
7490979|NCT02141490|11806433|FG000|Overall Study|Screening failures|4
7490980|NCT02141490|11806434|FG001|Overall Study|Screening failures|0
7490981|NCT02141490|11806435|FG002|Overall Study|Screening failures|0
7490982|NCT02141516|11806448|FG000|Overall Study|Adverse Event|0
7490983|NCT02141516|11806449|FG001|Overall Study|Adverse Event|1
7490984|NCT02141516|11806450|FG002|Overall Study|Adverse Event|0
7490985|NCT02141516|11806448|FG000|Overall Study|Lost to Follow-up|0
7490986|NCT02141516|11806449|FG001|Overall Study|Lost to Follow-up|1
7490987|NCT02141516|11806450|FG002|Overall Study|Lost to Follow-up|0
7490988|NCT02141516|11806448|FG000|Overall Study|Other|0
7490989|NCT02141516|11806449|FG001|Overall Study|Other|3
7490990|NCT02141516|11806450|FG002|Overall Study|Other|0
7490991|NCT02141620|11806484|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
7490992|NCT02141620|11806485|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
7490993|NCT02141633|11806493|FG000|Overall Study|Physician Decision|1
7490994|NCT02141633|11806494|FG001|Overall Study|Physician Decision|0
7490995|NCT02141659|11806506|FG000|Overall Study|Major Protocol Deviation|0
7490996|NCT02141659|11806507|FG001|Overall Study|Major Protocol Deviation|1
7490997|NCT02141659|11806508|FG002|Overall Study|Major Protocol Deviation|0
7490998|NCT02141659|11806509|FG003|Overall Study|Major Protocol Deviation|0
7490999|NCT02141659|11806510|FG004|Overall Study|Major Protocol Deviation|0
7491000|NCT02141659|11806511|FG005|Overall Study|Major Protocol Deviation|0
7491001|NCT02141659|11806506|FG000|Overall Study|Lack of Efficacy|0
7491002|NCT02141659|11806507|FG001|Overall Study|Lack of Efficacy|0
7491003|NCT02141659|11806508|FG002|Overall Study|Lack of Efficacy|0
7491004|NCT02141659|11806509|FG003|Overall Study|Lack of Efficacy|0
7491005|NCT02141659|11806510|FG004|Overall Study|Lack of Efficacy|0
7491006|NCT02141659|11806511|FG005|Overall Study|Lack of Efficacy|1
7491007|NCT02141659|11806506|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
7491008|NCT02141659|11806507|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
7491009|NCT02141659|11806508|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
7491010|NCT02141659|11806509|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
7491011|NCT02141659|11806510|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
7491012|NCT02141659|11806511|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
7491013|NCT02141672|11806528|FG000|Overall Study|Adverse Event|0
7491014|NCT02141672|11806529|FG001|Overall Study|Adverse Event|1
7491015|NCT02141672|11806530|FG002|Overall Study|Adverse Event|0
7491016|NCT02141672|11806528|FG000|Overall Study|Death|10
7491017|NCT02141672|11806529|FG001|Overall Study|Death|2
7491018|NCT02141672|11806530|FG002|Overall Study|Death|1
7491019|NCT02141672|11806528|FG000|Overall Study|Lack of Efficacy|0
7491020|NCT02141672|11806529|FG001|Overall Study|Lack of Efficacy|0
7491021|NCT02141672|11806530|FG002|Overall Study|Lack of Efficacy|2
7491022|NCT02141672|11806528|FG000|Overall Study|Lost to Follow-up|1
7491023|NCT02141672|11806529|FG001|Overall Study|Lost to Follow-up|1
7491024|NCT02141672|11806530|FG002|Overall Study|Lost to Follow-up|3
7491025|NCT02141672|11806528|FG000|Overall Study|Physician Decision|1
7491026|NCT02141672|11806529|FG001|Overall Study|Physician Decision|2
7491027|NCT02141672|11806530|FG002|Overall Study|Physician Decision|5
7491028|NCT02141672|11806528|FG000|Overall Study|Protocol Violation|0
7491029|NCT02141672|11806529|FG001|Overall Study|Protocol Violation|0
7491030|NCT02141672|11806530|FG002|Overall Study|Protocol Violation|1
7491031|NCT02141672|11806528|FG000|Overall Study|Withdrawal by Subject|3
7491032|NCT02141672|11806529|FG001|Overall Study|Withdrawal by Subject|2
7491033|NCT02141672|11806530|FG002|Overall Study|Withdrawal by Subject|5
7491034|NCT02141672|11806528|FG000|Overall Study|refused to follow-up|1
7491035|NCT02141672|11806529|FG001|Overall Study|refused to follow-up|0
7491036|NCT02141672|11806530|FG002|Overall Study|refused to follow-up|1
7535090|NCT02707965|11882691|FG001|Overall Study|Withdrawal by Subject|0
7491037|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
7491038|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7491039|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7491040|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7491041|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7491042|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7491043|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
7491044|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7491045|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7491046|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7491047|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7491048|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7491049|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
7491050|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7491051|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7491052|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7491053|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7491054|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7491055|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Other|14
7491056|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Other|0
7491057|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Other|0
7491058|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Other|0
7491059|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Other|0
7491060|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Other|0
7491061|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
7491062|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7491063|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7491064|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7491065|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7491066|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7491067|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
7491068|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7491069|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7491070|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7491071|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7491072|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7491073|NCT02141854|11806543|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7491074|NCT02141854|11806544|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7491075|NCT02141854|11806545|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7491076|NCT02141854|11806546|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7491077|NCT02141854|11806547|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7491078|NCT02141854|11806548|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7491079|NCT02141854|11806543|FG000|Treatment Period|Protocol Violation|0
7491080|NCT02141854|11806544|FG001|Treatment Period|Protocol Violation|1
7491081|NCT02141854|11806545|FG002|Treatment Period|Protocol Violation|0
7491082|NCT02141854|11806546|FG003|Treatment Period|Protocol Violation|2
7491083|NCT02141854|11806547|FG004|Treatment Period|Protocol Violation|2
7491084|NCT02141854|11806548|FG005|Treatment Period|Protocol Violation|1
7491085|NCT02141854|11806543|FG000|Treatment Period|Noncompliance|0
7491086|NCT02141854|11806544|FG001|Treatment Period|Noncompliance|0
7491087|NCT02141854|11806545|FG002|Treatment Period|Noncompliance|0
7491088|NCT02141854|11806546|FG003|Treatment Period|Noncompliance|1
7491089|NCT02141854|11806547|FG004|Treatment Period|Noncompliance|0
7491090|NCT02141854|11806548|FG005|Treatment Period|Noncompliance|0
7491091|NCT02141854|11806543|FG000|Treatment Period|Lack of Efficacy|0
7491092|NCT02141854|11806544|FG001|Treatment Period|Lack of Efficacy|0
7491093|NCT02141854|11806545|FG002|Treatment Period|Lack of Efficacy|0
7491094|NCT02141854|11806546|FG003|Treatment Period|Lack of Efficacy|1
7491095|NCT02141854|11806547|FG004|Treatment Period|Lack of Efficacy|1
7491096|NCT02141854|11806548|FG005|Treatment Period|Lack of Efficacy|7
7491097|NCT02141854|11806543|FG000|Treatment Period|Pregnancy|0
7491098|NCT02141854|11806544|FG001|Treatment Period|Pregnancy|1
7491099|NCT02141854|11806545|FG002|Treatment Period|Pregnancy|0
7491100|NCT02141854|11806546|FG003|Treatment Period|Pregnancy|0
7491101|NCT02141854|11806547|FG004|Treatment Period|Pregnancy|0
7491102|NCT02141854|11806548|FG005|Treatment Period|Pregnancy|0
7491103|NCT02141854|11806543|FG000|Treatment Period|Other|0
7491104|NCT02141854|11806544|FG001|Treatment Period|Other|1
7491105|NCT02141854|11806545|FG002|Treatment Period|Other|2
7491106|NCT02141854|11806546|FG003|Treatment Period|Other|0
7491107|NCT02141854|11806547|FG004|Treatment Period|Other|1
7491108|NCT02141854|11806548|FG005|Treatment Period|Other|2
7491109|NCT02141854|11806543|FG000|Treatment Period|Adverse Event|0
7491110|NCT02141854|11806544|FG001|Treatment Period|Adverse Event|2
7491111|NCT02141854|11806545|FG002|Treatment Period|Adverse Event|2
7491112|NCT02141854|11806546|FG003|Treatment Period|Adverse Event|0
7491113|NCT02141854|11806547|FG004|Treatment Period|Adverse Event|2
7491114|NCT02141854|11806548|FG005|Treatment Period|Adverse Event|2
7491115|NCT02141854|11806543|FG000|Treatment Period|Withdrawal by Subject|0
7491116|NCT02141854|11806544|FG001|Treatment Period|Withdrawal by Subject|2
7491117|NCT02141854|11806545|FG002|Treatment Period|Withdrawal by Subject|3
7491118|NCT02141854|11806546|FG003|Treatment Period|Withdrawal by Subject|3
7491119|NCT02141854|11806547|FG004|Treatment Period|Withdrawal by Subject|4
7491120|NCT02141854|11806548|FG005|Treatment Period|Withdrawal by Subject|7
7491121|NCT02141854|11806543|FG000|Treatment Period|Disease progression|0
7491122|NCT02141854|11806544|FG001|Treatment Period|Disease progression|2
7491123|NCT02141854|11806545|FG002|Treatment Period|Disease progression|1
7491124|NCT02141854|11806546|FG003|Treatment Period|Disease progression|3
7491125|NCT02141854|11806547|FG004|Treatment Period|Disease progression|0
7491126|NCT02141854|11806548|FG005|Treatment Period|Disease progression|18
7491127|NCT02141854|11806543|FG000|Treatment Period|Lost to Follow-up|0
7491128|NCT02141854|11806544|FG001|Treatment Period|Lost to Follow-up|1
7491129|NCT02141854|11806545|FG002|Treatment Period|Lost to Follow-up|1
7491130|NCT02141854|11806546|FG003|Treatment Period|Lost to Follow-up|1
7491131|NCT02141854|11806547|FG004|Treatment Period|Lost to Follow-up|0
7491132|NCT02141854|11806548|FG005|Treatment Period|Lost to Follow-up|1
7491133|NCT02141984|11806564|FG000|Overall Study|Lack of Efficacy|2
7491134|NCT02141997|11806572|FG000|Overall Study|Adverse Event|0
7491135|NCT02141997|11806573|FG001|Overall Study|Adverse Event|2
7491136|NCT02141997|11806574|FG002|Overall Study|Adverse Event|0
7491137|NCT02141997|11806575|FG003|Overall Study|Adverse Event|1
7491138|NCT02141997|11806572|FG000|Overall Study|Participant noncompliance|1
7491139|NCT02141997|11806573|FG001|Overall Study|Participant noncompliance|0
7491140|NCT02141997|11806574|FG002|Overall Study|Participant noncompliance|0
7491141|NCT02141997|11806575|FG003|Overall Study|Participant noncompliance|0
7491142|NCT02141997|11806572|FG000|Overall Study|Withdrew consent|1
7491143|NCT02141997|11806573|FG001|Overall Study|Withdrew consent|0
7491144|NCT02141997|11806574|FG002|Overall Study|Withdrew consent|3
7491145|NCT02141997|11806575|FG003|Overall Study|Withdrew consent|0
7491146|NCT02141997|11806572|FG000|Overall Study|Other|1
7491147|NCT02141997|11806573|FG001|Overall Study|Other|4
7491148|NCT02141997|11806574|FG002|Overall Study|Other|0
7491149|NCT02141997|11806575|FG003|Overall Study|Other|0
7491150|NCT02142283|11806664|FG000|Overall Study|Death|20
7491151|NCT02142283|11806665|FG001|Overall Study|Death|18
7491152|NCT02142283|11806664|FG000|Overall Study|Withdrawal by Subject|1
7491153|NCT02142283|11806665|FG001|Overall Study|Withdrawal by Subject|3
7491154|NCT02142387|11806686|FG000|Overall Study|<19 years old|49
7491155|NCT02142387|11806687|FG001|Overall Study|<19 years old|326
7491156|NCT02142387|11806686|FG000|Overall Study|non-cardiac etiology|504
7491157|NCT02142387|11806687|FG001|Overall Study|non-cardiac etiology|3431
7491158|NCT02142387|11806686|FG000|Overall Study|CPR not performed|74
7491159|NCT02142387|11806687|FG001|Overall Study|CPR not performed|473
7491160|NCT02142387|11806686|FG000|Overall Study|witnessed by paramedic|139
7491161|NCT02142387|11806687|FG001|Overall Study|witnessed by paramedic|917
7491162|NCT02142387|11806686|FG000|Overall Study|incomplete data|1
7491163|NCT02142387|11806687|FG001|Overall Study|incomplete data|9
7491164|NCT02142387|11806686|FG000|Overall Study|occurred not at home|298
7491165|NCT02142387|11806687|FG001|Overall Study|occurred not at home|2474
7491166|NCT02142504|11806696|FG000|Overall Study|Protocol Violation|2
7491167|NCT02142504|11806697|FG001|Overall Study|Protocol Violation|1
7491168|NCT02142504|11806698|FG002|Overall Study|Protocol Violation|2
7491169|NCT02142504|11806696|FG000|Overall Study|Adverse Event|2
7491170|NCT02142504|11806697|FG001|Overall Study|Adverse Event|3
7491171|NCT02142504|11806698|FG002|Overall Study|Adverse Event|4
7491172|NCT02142504|11806696|FG000|Overall Study|Lost to Follow-up|12
7491173|NCT02142504|11806697|FG001|Overall Study|Lost to Follow-up|19
7491174|NCT02142504|11806698|FG002|Overall Study|Lost to Follow-up|17
7491175|NCT02142504|11806696|FG000|Overall Study|Withdrawal by Subject|7
7491176|NCT02142504|11806697|FG001|Overall Study|Withdrawal by Subject|9
7491177|NCT02142504|11806698|FG002|Overall Study|Withdrawal by Subject|11
7491178|NCT02142504|11806696|FG000|Overall Study|Pregnancy|4
7491179|NCT02142504|11806697|FG001|Overall Study|Pregnancy|4
7491180|NCT02142504|11806698|FG002|Overall Study|Pregnancy|2
7491181|NCT02142504|11806696|FG000|Overall Study|Physician Decision|0
7491182|NCT02142504|11806697|FG001|Overall Study|Physician Decision|1
7491183|NCT02142504|11806698|FG002|Overall Study|Physician Decision|3
7491184|NCT02142504|11806696|FG000|Overall Study|Reason Not Specified|4
7491185|NCT02142504|11806697|FG001|Overall Study|Reason Not Specified|5
7491186|NCT02142504|11806698|FG002|Overall Study|Reason Not Specified|4
7491187|NCT02142712|11806714|FG000|Overall Study|Lost to Follow-up|1
7491188|NCT02142712|11806715|FG001|Overall Study|Lost to Follow-up|1
7491189|NCT02142712|11806716|FG002|Overall Study|Lost to Follow-up|1
7491190|NCT02142712|11806717|FG003|Overall Study|Lost to Follow-up|0
7491191|NCT02142894|11806726|FG000|Overall Study|Protocol Violation|8
7491192|NCT02143024|11806732|FG000|Overall Study|Lost to Follow-up|1
7491193|NCT02143024|11806733|FG001|Overall Study|Lost to Follow-up|1
7491194|NCT02143024|11806732|FG000|Overall Study|Withdrawal by Subject|1
7491195|NCT02143024|11806733|FG001|Overall Study|Withdrawal by Subject|0
7491196|NCT02143102|11806741|FG000|Overall Study|Lost to Follow-up|11
7491197|NCT02143102|11806742|FG001|Overall Study|Lost to Follow-up|0
7491198|NCT02143141|11806750|FG000|Overall Study|pain scores at 24 hours not collected|1
7491199|NCT02143141|11806751|FG001|Overall Study|pain scores at 24 hours not collected|0
7491200|NCT02143583|11806764|FG000|Overall Study|Withdrawal by Subject|1
7491201|NCT02143583|11806765|FG001|Overall Study|Withdrawal by Subject|0
7491202|NCT02143583|11806766|FG002|Overall Study|Withdrawal by Subject|1
7491203|NCT02143583|11806764|FG000|Overall Study|husband illness|0
7491204|NCT02143583|11806765|FG001|Overall Study|husband illness|0
7491205|NCT02143583|11806766|FG002|Overall Study|husband illness|1
7535091|NCT02707965|11882692|FG002|Overall Study|Withdrawal by Subject|1
7535092|NCT02707965|11882693|FG003|Overall Study|Withdrawal by Subject|0
7535093|NCT02707965|11882694|FG004|Overall Study|Withdrawal by Subject|0
7535094|NCT02707965|11882695|FG005|Overall Study|Withdrawal by Subject|0
7535095|NCT02707965|11882696|FG006|Overall Study|Withdrawal by Subject|0
7535096|NCT02707965|11882697|FG007|Overall Study|Withdrawal by Subject|2
7535097|NCT02707965|11882698|FG008|Overall Study|Withdrawal by Subject|0
7535098|NCT02707965|11882699|FG009|Overall Study|Withdrawal by Subject|0
7535099|NCT02707965|11882700|FG010|Overall Study|Withdrawal by Subject|0
7535100|NCT02707965|11882701|FG011|Overall Study|Withdrawal by Subject|0
7535101|NCT02707965|11882702|FG012|Overall Study|Withdrawal by Subject|0
7535102|NCT02707965|11882703|FG013|Overall Study|Withdrawal by Subject|0
7535103|NCT02707965|11882704|FG014|Overall Study|Withdrawal by Subject|0
7535104|NCT02707965|11882705|FG015|Overall Study|Withdrawal by Subject|0
7535105|NCT02707965|11882690|FG000|Overall Study|PI decisions|0
7535106|NCT02707965|11882691|FG001|Overall Study|PI decisions|0
7535107|NCT02707965|11882692|FG002|Overall Study|PI decisions|0
7535108|NCT02707965|11882693|FG003|Overall Study|PI decisions|0
7535109|NCT02707965|11882694|FG004|Overall Study|PI decisions|0
7535110|NCT02707965|11882695|FG005|Overall Study|PI decisions|0
7535111|NCT02707965|11882696|FG006|Overall Study|PI decisions|0
7535112|NCT02707965|11882697|FG007|Overall Study|PI decisions|0
7535113|NCT02707965|11882698|FG008|Overall Study|PI decisions|0
7535114|NCT02707965|11882699|FG009|Overall Study|PI decisions|0
7535115|NCT02707965|11882700|FG010|Overall Study|PI decisions|0
7535116|NCT02707965|11882701|FG011|Overall Study|PI decisions|0
7535117|NCT02707965|11882702|FG012|Overall Study|PI decisions|0
7535118|NCT02707965|11882703|FG013|Overall Study|PI decisions|0
7535119|NCT02707965|11882704|FG014|Overall Study|PI decisions|2
7535120|NCT02707965|11882705|FG015|Overall Study|PI decisions|0
7535121|NCT02707965|11882690|FG000|Overall Study|Protocol deviation|1
7535122|NCT02707965|11882691|FG001|Overall Study|Protocol deviation|1
7535123|NCT02707965|11882692|FG002|Overall Study|Protocol deviation|0
7535124|NCT02707965|11882693|FG003|Overall Study|Protocol deviation|0
7535125|NCT02707965|11882694|FG004|Overall Study|Protocol deviation|0
7535126|NCT02707965|11882695|FG005|Overall Study|Protocol deviation|0
7535127|NCT02707965|11882696|FG006|Overall Study|Protocol deviation|0
7535128|NCT02707965|11882697|FG007|Overall Study|Protocol deviation|1
7535129|NCT02707965|11882698|FG008|Overall Study|Protocol deviation|0
7535130|NCT02707965|11882699|FG009|Overall Study|Protocol deviation|0
7535131|NCT02707965|11882700|FG010|Overall Study|Protocol deviation|0
7535132|NCT02707965|11882701|FG011|Overall Study|Protocol deviation|0
7535133|NCT02707965|11882702|FG012|Overall Study|Protocol deviation|0
7535134|NCT02707965|11882703|FG013|Overall Study|Protocol deviation|0
7535135|NCT02707965|11882704|FG014|Overall Study|Protocol deviation|0
7535136|NCT02707965|11882705|FG015|Overall Study|Protocol deviation|0
7535137|NCT02707991|11882740|FG000|Overall Study|Protocol Violation|1
7535138|NCT02707991|11882741|FG001|Overall Study|Protocol Violation|0
7535139|NCT02707991|11882740|FG000|Overall Study|Became ineligible|0
7535140|NCT02707991|11882741|FG001|Overall Study|Became ineligible|1
7535141|NCT02708095|11882750|FG000|Overall Study|Adverse Event|4
7535142|NCT02708095|11882751|FG001|Overall Study|Adverse Event|10
7535143|NCT02708095|11882752|FG002|Overall Study|Adverse Event|11
7535144|NCT02708095|11882750|FG000|Overall Study|Lack of Efficacy|9
7535145|NCT02708095|11882751|FG001|Overall Study|Lack of Efficacy|3
7535146|NCT02708095|11882752|FG002|Overall Study|Lack of Efficacy|0
7535147|NCT02708095|11882750|FG000|Overall Study|Lost to Follow-up|2
7535148|NCT02708095|11882751|FG001|Overall Study|Lost to Follow-up|0
7535149|NCT02708095|11882752|FG002|Overall Study|Lost to Follow-up|0
7535150|NCT02708095|11882750|FG000|Overall Study|Physician Decision|2
7535151|NCT02708095|11882751|FG001|Overall Study|Physician Decision|3
7535152|NCT02708095|11882752|FG002|Overall Study|Physician Decision|2
7535153|NCT02708095|11882750|FG000|Overall Study|Protocol Violation|0
7535154|NCT02708095|11882751|FG001|Overall Study|Protocol Violation|0
7535155|NCT02708095|11882752|FG002|Overall Study|Protocol Violation|1
7535156|NCT02708095|11882750|FG000|Overall Study|Withdrawal by Subject|5
7535157|NCT02708095|11882751|FG001|Overall Study|Withdrawal by Subject|3
7535158|NCT02708095|11882752|FG002|Overall Study|Withdrawal by Subject|4
7535159|NCT02708121|11882764|FG000|Overall Study|Withdrawn by Study Team|1
7535160|NCT02708121|11882765|FG001|Overall Study|Withdrawn by Study Team|1
7535161|NCT02708121|11882764|FG000|Overall Study|Withdrawal by Subject|0
7535162|NCT02708121|11882765|FG001|Overall Study|Withdrawal by Subject|4
7535163|NCT02708277|11882808|FG000|Overall Study|Lost to Follow-up|7
7535164|NCT02708277|11882809|FG001|Overall Study|Lost to Follow-up|4
7535165|NCT02708355|11882827|FG000|Overall Study|Adverse Event|1
7535166|NCT02708355|11882828|FG001|Overall Study|Adverse Event|0
7535167|NCT02708355|11882829|FG002|Overall Study|Adverse Event|0
7535168|NCT02708485|11882846|FG000|Overall Study|Withdrawal by Subject|3
7535169|NCT02708485|11882847|FG001|Overall Study|Withdrawal by Subject|2
7535170|NCT02708498|11882861|FG000|Overall Study|Death|20
7491206|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
7491207|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
7491208|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
7491209|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
7491210|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Adverse Event|7
7491211|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Adverse Event|8
7491212|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Adverse Event|8
7491213|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Adverse Event|9
7491214|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
7491215|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
7491216|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7491217|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7491218|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7491219|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7491220|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
7491221|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
7491222|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Pregnancy|0
7491223|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Pregnancy|2
7491224|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Pregnancy|2
7491225|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Pregnancy|0
7491226|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Non-compliance|1
7491227|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Non-compliance|0
7491228|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Non-compliance|0
7491229|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Non-compliance|3
7491230|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Other|3
7491231|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Other|0
7491232|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Other|3
7491233|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Other|2
7491234|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7491235|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7491236|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
7491237|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
7491238|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
7491239|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7491240|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7491241|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7491242|NCT02143713|11806791|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
7491243|NCT02143713|11806792|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
7491244|NCT02143713|11806793|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
7491245|NCT02143713|11806794|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
7491246|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7491247|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
7491248|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7491249|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
7491250|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
7491251|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
7491252|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
7491253|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
7491254|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
7491255|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7491256|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
7491257|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
7491258|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
7491259|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7491260|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
7491261|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
7491262|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7491263|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7491264|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
7491265|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
7491266|NCT02143713|11806791|FG000|Post-treatment Follow-up (12 Months)|Other|3
7491267|NCT02143713|11806792|FG001|Post-treatment Follow-up (12 Months)|Other|4
7491268|NCT02143713|11806793|FG002|Post-treatment Follow-up (12 Months)|Other|7
7491269|NCT02143713|11806794|FG003|Post-treatment Follow-up (12 Months)|Other|7
7491270|NCT02143778|11806805|FG000|Overall Study|Withdrawal by Subject|2
7491271|NCT02143778|11806805|FG000|Overall Study|Device malfunction|1
7491272|NCT02143843|11806810|FG000|Overall Study|Adverse Event|8
7491273|NCT02143843|11806810|FG000|Overall Study|Lack of Efficacy|2
7491274|NCT02143843|11806810|FG000|Overall Study|Withdrawal by Subject|2
7491275|NCT02143947|11806816|FG000|Overall Study|Lost to Follow-up|4
7491276|NCT02143947|11806817|FG001|Overall Study|Lost to Follow-up|2
7491277|NCT02144012|11806831|FG000|Overall Study|Adverse Event|1
7491278|NCT02144012|11806832|FG001|Overall Study|Adverse Event|0
7491279|NCT02144012|11806831|FG000|Overall Study|Death|1
7491280|NCT02144012|11806832|FG001|Overall Study|Death|0
7491281|NCT02144012|11806831|FG000|Overall Study|Withdrawal by Subject|11
7491282|NCT02144012|11806832|FG001|Overall Study|Withdrawal by Subject|3
7491283|NCT02144012|11806831|FG000|Overall Study|Study Terminated by Sponsor|18
7491284|NCT02144012|11806832|FG001|Overall Study|Study Terminated by Sponsor|12
7491285|NCT02144012|11806831|FG000|Overall Study|Other|3
7491286|NCT02144012|11806832|FG001|Overall Study|Other|0
7491287|NCT02144077|11806840|FG000|Overall Study|Withdrawal by Subject|3
7491288|NCT02144077|11806841|FG001|Overall Study|Withdrawal by Subject|3
7491289|NCT02144077|11806840|FG000|Overall Study|Adverse Event|2
7491290|NCT02144077|11806841|FG001|Overall Study|Adverse Event|3
7491291|NCT02144077|11806840|FG000|Overall Study|Lost to Follow-up|2
7491292|NCT02144077|11806841|FG001|Overall Study|Lost to Follow-up|2
7491293|NCT02144077|11806840|FG000|Overall Study|Protocol Violation|1
7491294|NCT02144077|11806841|FG001|Overall Study|Protocol Violation|2
7491295|NCT02144077|11806840|FG000|Overall Study|Death|0
7491296|NCT02144077|11806841|FG001|Overall Study|Death|1
7491297|NCT02144077|11806840|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
7491298|NCT02144077|11806841|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
7491299|NCT02144220|11806847|FG000|Overall Study|technology incompatibility|9
7491300|NCT02144220|11806847|FG000|Overall Study|Lack of Efficacy|4
7491301|NCT02144220|11806847|FG000|Overall Study|Physician Decision|3
7491302|NCT02144220|11806847|FG000|Overall Study|Withdrawal by Subject|2
7491303|NCT02144220|11806847|FG000|Overall Study|Protocol Violation|1
7491304|NCT02144285|11806883|FG000|Overall Study|Withdrawal by Subject|0
7491305|NCT02144285|11806884|FG001|Overall Study|Withdrawal by Subject|0
7491306|NCT02144285|11806885|FG002|Overall Study|Withdrawal by Subject|0
7491307|NCT02144285|11806886|FG003|Overall Study|Withdrawal by Subject|0
7491308|NCT02144285|11806887|FG004|Overall Study|Withdrawal by Subject|1
7491309|NCT02144285|11806888|FG005|Overall Study|Withdrawal by Subject|0
7491310|NCT02144285|11806889|FG006|Overall Study|Withdrawal by Subject|0
7491311|NCT02144285|11806890|FG007|Overall Study|Withdrawal by Subject|0
7491312|NCT02144285|11806891|FG008|Overall Study|Withdrawal by Subject|0
7491313|NCT02144285|11806892|FG009|Overall Study|Withdrawal by Subject|0
7491314|NCT02144337|11806930|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7491315|NCT02144337|11806931|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
7491316|NCT02144337|11806930|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
7491317|NCT02144337|11806931|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
7491318|NCT02144337|11806930|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
7491319|NCT02144337|11806931|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
7491320|NCT02144337|11806930|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
7491321|NCT02144337|11806931|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
7491322|NCT02144337|11806930|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
7491323|NCT02144337|11806931|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
7491324|NCT02144610|11806971|FG000|Overall Study|Physician Decision|1
7491325|NCT02144610|11806972|FG001|Overall Study|Physician Decision|0
7491326|NCT02144610|11806971|FG000|Overall Study|Withdrawal by Subject|1
7491327|NCT02144610|11806972|FG001|Overall Study|Withdrawal by Subject|5
7491328|NCT02144610|11806971|FG000|Overall Study|Death|2
7491329|NCT02144610|11806972|FG001|Overall Study|Death|2
7491330|NCT02144610|11806971|FG000|Overall Study|Study Discontinuation by Sponsor|19
7491331|NCT02144610|11806972|FG001|Overall Study|Study Discontinuation by Sponsor|14
7491332|NCT02144610|11806971|FG000|Overall Study|Other|0
7491333|NCT02144610|11806972|FG001|Overall Study|Other|1
7491334|NCT02144701|11806989|FG000|Overall Study|development of relapse, GVHD or death|9
7491335|NCT02144701|11806990|FG001|Overall Study|development of relapse, GVHD or death|3
7491336|NCT02145026|11807009|FG000|Overall Study|Adverse Event|2
7491337|NCT02145026|11807009|FG000|Overall Study|Death|4
7491338|NCT02145026|11807009|FG000|Overall Study|Withdrawal by Subject|2
7491339|NCT02145026|11807009|FG000|Overall Study|Physician Decision|4
7491340|NCT02145078|11807017|FG000|Overall Study|Death|1
7491341|NCT02145078|11807017|FG000|Overall Study|Reason not given|3
7491342|NCT02145156|11807024|FG000|Overall Study|No match to vaccination records|60
7491343|NCT02145156|11807025|FG001|Overall Study|No match to vaccination records|52
7491344|NCT02145156|11807026|FG002|Overall Study|No match to vaccination records|41
7491345|NCT02145182|11807036|FG000|Overall Study|Adverse Event|4
7491346|NCT02145182|11807037|FG001|Overall Study|Adverse Event|1
7491347|NCT02145182|11807036|FG000|Overall Study|Death|7
7491348|NCT02145182|11807037|FG001|Overall Study|Death|7
7491349|NCT02145182|11807036|FG000|Overall Study|Lost to Follow-up|2
7491350|NCT02145182|11807037|FG001|Overall Study|Lost to Follow-up|2
7491351|NCT02145182|11807036|FG000|Overall Study|Pre-transplant Withdrawal|0
7491352|NCT02145182|11807037|FG001|Overall Study|Pre-transplant Withdrawal|2
7491353|NCT02145182|11807036|FG000|Overall Study|Withdrawal by Subject|5
7491354|NCT02145182|11807037|FG001|Overall Study|Withdrawal by Subject|4
7491355|NCT02145429|11807063|FG000|Overall Study|Death|4
7491356|NCT02145429|11807064|FG001|Overall Study|Death|5
7491357|NCT02145429|11807063|FG000|Overall Study|Lost to Follow-up|4
7491358|NCT02145429|11807064|FG001|Overall Study|Lost to Follow-up|3
7491359|NCT02145429|11807063|FG000|Overall Study|Withdrawal by Subject|8
7491360|NCT02145429|11807064|FG001|Overall Study|Withdrawal by Subject|3
7491361|NCT02145468|11807072|FG000|Overall Study|Withdrawal by Subject|5
7491362|NCT02145468|11807073|FG001|Overall Study|Withdrawal by Subject|8
7491363|NCT02146105|11807105|FG000|Overall Study|Adverse Event|1
7491364|NCT02146105|11807105|FG000|Overall Study|Withdrawal by Subject|5
7491365|NCT02146131|11807111|FG000|Overall Study|Physician Decision|61
7491366|NCT02146131|11807112|FG001|Overall Study|Physician Decision|56
7491367|NCT02146248|11807118|FG000|Overall Study|Withdrawal by Subject|2
7491368|NCT02146274|11807126|FG000|Overall Study|Protocol Violation|73
7491369|NCT02146326|11807137|FG000|Overall Study|Lost to Follow-up|3
7491370|NCT02146326|11807138|FG001|Overall Study|Lost to Follow-up|3
7491371|NCT02146326|11807139|FG002|Overall Study|Lost to Follow-up|11
7491372|NCT02146326|11807140|FG003|Overall Study|Lost to Follow-up|19
7491373|NCT02146326|11807137|FG000|Overall Study|Withdrawal by Subject|2
7491374|NCT02146326|11807138|FG001|Overall Study|Withdrawal by Subject|1
7491375|NCT02146326|11807139|FG002|Overall Study|Withdrawal by Subject|15
7491376|NCT02146326|11807140|FG003|Overall Study|Withdrawal by Subject|11
7491377|NCT02146326|11807137|FG000|Overall Study|Separated from mental health center|23
7491378|NCT02146326|11807138|FG001|Overall Study|Separated from mental health center|33
7491379|NCT02146326|11807139|FG002|Overall Study|Separated from mental health center|0
7491380|NCT02146326|11807140|FG003|Overall Study|Separated from mental health center|0
7491381|NCT02146326|11807137|FG000|Overall Study|Incarcerated|0
7491382|NCT02146326|11807138|FG001|Overall Study|Incarcerated|0
7491383|NCT02146326|11807139|FG002|Overall Study|Incarcerated|3
7491384|NCT02146326|11807140|FG003|Overall Study|Incarcerated|8
7491385|NCT02146326|11807137|FG000|Overall Study|Death|0
7491386|NCT02146326|11807138|FG001|Overall Study|Death|0
7491387|NCT02146326|11807139|FG002|Overall Study|Death|4
7491388|NCT02146326|11807140|FG003|Overall Study|Death|4
7491389|NCT02146326|11807137|FG000|Overall Study|Unable to complete interview|0
7491390|NCT02146326|11807138|FG001|Overall Study|Unable to complete interview|0
7491391|NCT02146326|11807139|FG002|Overall Study|Unable to complete interview|10
7491392|NCT02146326|11807140|FG003|Overall Study|Unable to complete interview|6
7491393|NCT02146352|11807156|FG000|Overall Study|Death|1
7491394|NCT02146352|11807156|FG000|Overall Study|Patient entered hospice care|1
7491395|NCT02146365|11807166|FG000|Overall Study|Lost to Follow-up|2
7491396|NCT02146365|11807167|FG001|Overall Study|Lost to Follow-up|1
7491397|NCT02146365|11807168|FG002|Overall Study|Lost to Follow-up|3
7491398|NCT02146365|11807169|FG003|Overall Study|Lost to Follow-up|3
7491399|NCT02146365|11807170|FG004|Overall Study|Lost to Follow-up|1
7491400|NCT02146365|11807171|FG005|Overall Study|Lost to Follow-up|1
7491401|NCT02146365|11807172|FG006|Overall Study|Lost to Follow-up|0
7491402|NCT02146365|11807173|FG007|Overall Study|Lost to Follow-up|1
7491403|NCT02146365|11807166|FG000|Overall Study|Withdrawal by Subject|1
7491404|NCT02146365|11807167|FG001|Overall Study|Withdrawal by Subject|2
7491405|NCT02146365|11807168|FG002|Overall Study|Withdrawal by Subject|1
7491406|NCT02146365|11807169|FG003|Overall Study|Withdrawal by Subject|5
7491407|NCT02146365|11807170|FG004|Overall Study|Withdrawal by Subject|1
7491408|NCT02146365|11807171|FG005|Overall Study|Withdrawal by Subject|0
7491409|NCT02146365|11807172|FG006|Overall Study|Withdrawal by Subject|0
7491410|NCT02146365|11807173|FG007|Overall Study|Withdrawal by Subject|0
7491411|NCT02146365|11807166|FG000|Overall Study|Unable to Comply with Protocol|0
7491412|NCT02146365|11807167|FG001|Overall Study|Unable to Comply with Protocol|1
7491413|NCT02146365|11807168|FG002|Overall Study|Unable to Comply with Protocol|1
7491414|NCT02146365|11807169|FG003|Overall Study|Unable to Comply with Protocol|0
7491415|NCT02146365|11807170|FG004|Overall Study|Unable to Comply with Protocol|0
7491416|NCT02146365|11807171|FG005|Overall Study|Unable to Comply with Protocol|0
7491417|NCT02146365|11807172|FG006|Overall Study|Unable to Comply with Protocol|0
7491418|NCT02146365|11807173|FG007|Overall Study|Unable to Comply with Protocol|0
7491419|NCT02146365|11807166|FG000|Overall Study|Other|1
7491420|NCT02146365|11807167|FG001|Overall Study|Other|0
7491421|NCT02146365|11807168|FG002|Overall Study|Other|2
7491422|NCT02146365|11807169|FG003|Overall Study|Other|1
7491423|NCT02146365|11807170|FG004|Overall Study|Other|0
7491424|NCT02146365|11807171|FG005|Overall Study|Other|0
7491425|NCT02146365|11807172|FG006|Overall Study|Other|0
7491426|NCT02146365|11807173|FG007|Overall Study|Other|0
7491427|NCT02146430|11807195|FG000|Overall Study|Protocol Violation|5
7491428|NCT02146430|11807196|FG001|Overall Study|Protocol Violation|4
7491429|NCT02146430|11807197|FG002|Overall Study|Protocol Violation|8
7491430|NCT02146430|11807198|FG003|Overall Study|Protocol Violation|6
7491431|NCT02146430|11807195|FG000|Overall Study|Lack of Efficacy|13
7491432|NCT02146430|11807196|FG001|Overall Study|Lack of Efficacy|11
7491433|NCT02146430|11807197|FG002|Overall Study|Lack of Efficacy|8
7491434|NCT02146430|11807198|FG003|Overall Study|Lack of Efficacy|5
7491435|NCT02146430|11807195|FG000|Overall Study|Adverse Event|20
7491436|NCT02146430|11807196|FG001|Overall Study|Adverse Event|40
7491437|NCT02146430|11807197|FG002|Overall Study|Adverse Event|32
7491438|NCT02146430|11807198|FG003|Overall Study|Adverse Event|49
7491439|NCT02146430|11807195|FG000|Overall Study|Reason missing or not reported|2
7491440|NCT02146430|11807196|FG001|Overall Study|Reason missing or not reported|3
7491441|NCT02146430|11807197|FG002|Overall Study|Reason missing or not reported|4
7491442|NCT02146430|11807198|FG003|Overall Study|Reason missing or not reported|5
7491443|NCT02146430|11807195|FG000|Overall Study|Withdrawal by Subject|27
7491444|NCT02146430|11807196|FG001|Overall Study|Withdrawal by Subject|29
7491445|NCT02146430|11807197|FG002|Overall Study|Withdrawal by Subject|30
7491446|NCT02146430|11807198|FG003|Overall Study|Withdrawal by Subject|34
7491447|NCT02146599|11807221|FG000|Overall Study|Failed to meet inclusion criteria|5
7491448|NCT02146833|11807225|FG000|Overall Study|Death|10
7491449|NCT02146833|11807225|FG000|Overall Study|No longer consented to study treatment|1
7491450|NCT02147067|11807231|FG000|Overall Study|Withdrawal by Subject|2
7491451|NCT02147067|11807232|FG001|Overall Study|Withdrawal by Subject|2
7491452|NCT02147093|11807240|FG000|Period 1|Lost to Follow-up|0
7491453|NCT02147093|11807241|FG001|Period 1|Lost to Follow-up|1
7491454|NCT02147093|11807240|FG000|Period 2|Protocol Violation|2
7491455|NCT02147093|11807241|FG001|Period 2|Protocol Violation|0
7491456|NCT02147132|11807247|FG000|Overall Study|Lost to Follow-up|1
7491457|NCT02147132|11807248|FG001|Overall Study|Lost to Follow-up|0
7491458|NCT02147132|11807249|FG002|Overall Study|Lost to Follow-up|0
7491459|NCT02147132|11807250|FG003|Overall Study|Lost to Follow-up|0
7491460|NCT02147158|11807266|FG000|Treatment Course 1|Adverse Event|1
7491461|NCT02147158|11807267|FG001|Treatment Course 1|Adverse Event|4
7491462|NCT02147158|11807268|FG002|Treatment Course 1|Adverse Event|3
7491463|NCT02147158|11807269|FG003|Treatment Course 1|Adverse Event|4
7491464|NCT02147158|11807270|FG004|Treatment Course 1|Adverse Event|1
7491465|NCT02147158|11807271|FG005|Treatment Course 1|Adverse Event|2
7491466|NCT02147158|11807266|FG000|Treatment Course 1|Lost to Follow-up|2
7491467|NCT02147158|11807267|FG001|Treatment Course 1|Lost to Follow-up|4
7491468|NCT02147158|11807268|FG002|Treatment Course 1|Lost to Follow-up|3
7491469|NCT02147158|11807269|FG003|Treatment Course 1|Lost to Follow-up|3
7491470|NCT02147158|11807270|FG004|Treatment Course 1|Lost to Follow-up|2
7491471|NCT02147158|11807271|FG005|Treatment Course 1|Lost to Follow-up|4
7491472|NCT02147158|11807266|FG000|Treatment Course 1|Protocol Violation|0
7491473|NCT02147158|11807267|FG001|Treatment Course 1|Protocol Violation|0
7491474|NCT02147158|11807268|FG002|Treatment Course 1|Protocol Violation|1
7491475|NCT02147158|11807269|FG003|Treatment Course 1|Protocol Violation|1
7491476|NCT02147158|11807270|FG004|Treatment Course 1|Protocol Violation|0
7491477|NCT02147158|11807271|FG005|Treatment Course 1|Protocol Violation|0
7491478|NCT02147158|11807266|FG000|Treatment Course 1|Withdrawal of Consent|1
7491479|NCT02147158|11807267|FG001|Treatment Course 1|Withdrawal of Consent|1
7491480|NCT02147158|11807268|FG002|Treatment Course 1|Withdrawal of Consent|1
7491481|NCT02147158|11807269|FG003|Treatment Course 1|Withdrawal of Consent|5
7491482|NCT02147158|11807270|FG004|Treatment Course 1|Withdrawal of Consent|3
7491483|NCT02147158|11807271|FG005|Treatment Course 1|Withdrawal of Consent|2
7491484|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Adverse Event|1
7491485|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Adverse Event|0
7491486|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Adverse Event|0
7491487|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Adverse Event|1
7491488|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Adverse Event|0
7491489|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Adverse Event|0
7491490|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
7491491|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
7491492|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
7491493|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
7491494|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
7491495|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
7491496|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Protocol Violation|1
7491497|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Protocol Violation|0
7491498|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Protocol Violation|2
7491499|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Protocol Violation|0
7491500|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Protocol Violation|1
7491501|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Protocol Violation|0
7491502|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
7491503|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
7491504|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
7491505|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
7491506|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
7491507|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
7491508|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
7491509|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
7491510|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
7491511|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
7491512|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
7491513|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
7491514|NCT02147158|11807266|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7491515|NCT02147158|11807267|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7491516|NCT02147158|11807268|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
7491517|NCT02147158|11807269|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
7491518|NCT02147158|11807270|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7491519|NCT02147158|11807271|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
7491520|NCT02147158|11807266|FG000|Treatment Course 2|Adverse Event|0
7491521|NCT02147158|11807267|FG001|Treatment Course 2|Adverse Event|4
7491522|NCT02147158|11807268|FG002|Treatment Course 2|Adverse Event|2
7491523|NCT02147158|11807269|FG003|Treatment Course 2|Adverse Event|1
7491524|NCT02147158|11807270|FG004|Treatment Course 2|Adverse Event|0
7491525|NCT02147158|11807271|FG005|Treatment Course 2|Adverse Event|1
7491526|NCT02147158|11807266|FG000|Treatment Course 2|Withdrawal of Consent|0
7491527|NCT02147158|11807267|FG001|Treatment Course 2|Withdrawal of Consent|1
7491528|NCT02147158|11807268|FG002|Treatment Course 2|Withdrawal of Consent|2
7491529|NCT02147158|11807269|FG003|Treatment Course 2|Withdrawal of Consent|3
7491530|NCT02147158|11807270|FG004|Treatment Course 2|Withdrawal of Consent|0
7491531|NCT02147158|11807271|FG005|Treatment Course 2|Withdrawal of Consent|0
7491532|NCT02147158|11807266|FG000|Treatment Course 2|Lost to Follow-up|1
7491533|NCT02147158|11807267|FG001|Treatment Course 2|Lost to Follow-up|0
7491534|NCT02147158|11807268|FG002|Treatment Course 2|Lost to Follow-up|1
7491535|NCT02147158|11807269|FG003|Treatment Course 2|Lost to Follow-up|1
7491536|NCT02147158|11807270|FG004|Treatment Course 2|Lost to Follow-up|0
7491537|NCT02147158|11807271|FG005|Treatment Course 2|Lost to Follow-up|1
7491538|NCT02147158|11807266|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
7491539|NCT02147158|11807267|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
7491540|NCT02147158|11807268|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
7491541|NCT02147158|11807269|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
7491542|NCT02147158|11807270|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
7491543|NCT02147158|11807271|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
7491544|NCT02147158|11807266|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
7491545|NCT02147158|11807267|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
7491546|NCT02147158|11807268|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
7491547|NCT02147158|11807269|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
7491548|NCT02147158|11807270|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
7491549|NCT02147158|11807271|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
7491550|NCT02147158|11807266|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
7491551|NCT02147158|11807267|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
7491552|NCT02147158|11807268|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
7491553|NCT02147158|11807269|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
7491554|NCT02147158|11807270|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
7491555|NCT02147158|11807271|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
7491556|NCT02147158|11807266|FG000|Off-Treatment Interval 2|Protocol Violation|0
7491557|NCT02147158|11807267|FG001|Off-Treatment Interval 2|Protocol Violation|0
7491558|NCT02147158|11807268|FG002|Off-Treatment Interval 2|Protocol Violation|0
7491559|NCT02147158|11807269|FG003|Off-Treatment Interval 2|Protocol Violation|1
7491560|NCT02147158|11807270|FG004|Off-Treatment Interval 2|Protocol Violation|0
7491561|NCT02147158|11807271|FG005|Off-Treatment Interval 2|Protocol Violation|0
7491562|NCT02147158|11807266|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7491563|NCT02147158|11807267|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
7491564|NCT02147158|11807268|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7491565|NCT02147158|11807269|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
7491566|NCT02147158|11807270|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
7491567|NCT02147158|11807271|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
7491568|NCT02147197|11807291|FG000|Overall Study|Adverse Event|1
7491569|NCT02147197|11807292|FG001|Overall Study|Adverse Event|0
7491570|NCT02147197|11807293|FG002|Overall Study|Adverse Event|0
7491571|NCT02147197|11807291|FG000|Overall Study|Withdrawal of Consent|4
7491572|NCT02147197|11807292|FG001|Overall Study|Withdrawal of Consent|3
7491573|NCT02147197|11807293|FG002|Overall Study|Withdrawal of Consent|2
7491574|NCT02147197|11807291|FG000|Overall Study|Lost to Follow-up|2
7491575|NCT02147197|11807292|FG001|Overall Study|Lost to Follow-up|3
7491576|NCT02147197|11807293|FG002|Overall Study|Lost to Follow-up|1
7491577|NCT02147197|11807291|FG000|Overall Study|Protocol Violation|1
7491578|NCT02147197|11807292|FG001|Overall Study|Protocol Violation|0
7491579|NCT02147197|11807293|FG002|Overall Study|Protocol Violation|3
7491580|NCT02147197|11807291|FG000|Overall Study|Other Miscellaneous Reasons|1
7491581|NCT02147197|11807292|FG001|Overall Study|Other Miscellaneous Reasons|0
7491582|NCT02147197|11807293|FG002|Overall Study|Other Miscellaneous Reasons|3
7491583|NCT02147288|11807303|FG000|Overall Study|post-operative hematoma|1
7491584|NCT02147288|11807304|FG001|Overall Study|post-operative hematoma|1
7491585|NCT02147288|11807305|FG002|Overall Study|post-operative hematoma|0
7491586|NCT02147288|11807306|FG003|Overall Study|post-operative hematoma|0
7491587|NCT02147288|11807307|FG004|Overall Study|post-operative hematoma|0
7491588|NCT02147288|11807308|FG005|Overall Study|post-operative hematoma|0
7491589|NCT02147288|11807309|FG006|Overall Study|post-operative hematoma|0
7491590|NCT02147288|11807310|FG007|Overall Study|post-operative hematoma|0
7491591|NCT02147288|11807311|FG008|Overall Study|post-operative hematoma|0
7491592|NCT02147288|11807312|FG009|Overall Study|post-operative hematoma|0
7491593|NCT02147288|11807303|FG000|Overall Study|complications from concurrent hernia rep|0
7491594|NCT02147288|11807304|FG001|Overall Study|complications from concurrent hernia rep|1
7491595|NCT02147288|11807305|FG002|Overall Study|complications from concurrent hernia rep|0
7491596|NCT02147288|11807306|FG003|Overall Study|complications from concurrent hernia rep|0
7491597|NCT02147288|11807307|FG004|Overall Study|complications from concurrent hernia rep|0
7491598|NCT02147288|11807308|FG005|Overall Study|complications from concurrent hernia rep|0
7491599|NCT02147288|11807309|FG006|Overall Study|complications from concurrent hernia rep|0
7491600|NCT02147288|11807310|FG007|Overall Study|complications from concurrent hernia rep|0
7491601|NCT02147288|11807311|FG008|Overall Study|complications from concurrent hernia rep|0
7491602|NCT02147288|11807312|FG009|Overall Study|complications from concurrent hernia rep|0
7491603|NCT02147353|11807324|FG000|Overall Study|Lost to Follow-up|2
7491604|NCT02147353|11807325|FG001|Overall Study|Lost to Follow-up|0
7491605|NCT02147353|11807324|FG000|Overall Study|unable to make visits|4
7491606|NCT02147353|11807325|FG001|Overall Study|unable to make visits|0
7491607|NCT02147353|11807324|FG000|Overall Study|medication noncompliance|3
7491608|NCT02147353|11807325|FG001|Overall Study|medication noncompliance|0
7491609|NCT02147561|11807340|FG000|Overall Study|Lost to Follow-up|3
7491610|NCT02147561|11807340|FG000|Overall Study|Subjects who didn't receive BOTOX|1
7491611|NCT02147587|11807346|FG000|Overall Study|Adverse Event|9
7491612|NCT02147587|11807347|FG001|Overall Study|Adverse Event|4
7491613|NCT02147587|11807346|FG000|Overall Study|Lack of Efficacy|2
7491614|NCT02147587|11807347|FG001|Overall Study|Lack of Efficacy|1
7491615|NCT02147626|11807364|FG000|Overall Study|Lost to Follow-up|4
7491616|NCT02147626|11807365|FG001|Overall Study|Lost to Follow-up|4
7491617|NCT02147626|11807364|FG000|Overall Study|Pregnancy|1
7491618|NCT02147626|11807365|FG001|Overall Study|Pregnancy|2
7491619|NCT02147626|11807364|FG000|Overall Study|Withdrawal by Subject|0
7491620|NCT02147626|11807365|FG001|Overall Study|Withdrawal by Subject|1
7491621|NCT02147691|11807373|FG000|Overall Study|Withdrawal by Subject|2
7491622|NCT02147691|11807374|FG001|Overall Study|Withdrawal by Subject|0
7491623|NCT02147691|11807373|FG000|Overall Study|Adverse Event|2
7491624|NCT02147691|11807374|FG001|Overall Study|Adverse Event|0
7491625|NCT02147691|11807373|FG000|Overall Study|Lost to Follow-up|0
7491626|NCT02147691|11807374|FG001|Overall Study|Lost to Follow-up|1
7491627|NCT02148211|11807424|FG000|Overall Study|Lost to Follow-up|352
7491628|NCT02148250|11807428|FG000|Screening|Withdrawal by Subject|5
7491629|NCT02148250|11807429|FG001|Screening|Withdrawal by Subject|0
7491630|NCT02148445|11807447|FG000|Overall Study|Death|1
7491631|NCT02148445|11807448|FG001|Overall Study|Death|3
7491632|NCT02148718|11807473|FG000|Overall Study|Protocol Violation|26
7491633|NCT02148718|11807473|FG000|Overall Study|Discontinued Study Prematurely|5
7491634|NCT02148952|11807502|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
7491635|NCT02148952|11807503|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
7491636|NCT02148952|11807502|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
7491637|NCT02148952|11807503|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
7491638|NCT02148952|11807502|FG000|Follow-Up|Lost to Follow-up|219
7491639|NCT02148952|11807503|FG001|Follow-Up|Lost to Follow-up|231
7491640|NCT02148952|11807502|FG000|Follow-Up|Withdrawal by Subject|46
7491641|NCT02148952|11807503|FG001|Follow-Up|Withdrawal by Subject|48
7491642|NCT02149108|11807519|FG000|Overall Study|Not treated|1
7491643|NCT02149108|11807520|FG001|Overall Study|Not treated|2
7491644|NCT02149108|11807519|FG000|Overall Study|Progressive Disease (PD)|324
7491645|NCT02149108|11807520|FG001|Overall Study|Progressive Disease (PD)|318
7491646|NCT02149108|11807519|FG000|Overall Study|Worsening/adverse event cancer disease|31
7491647|NCT02149108|11807520|FG001|Overall Study|Worsening/adverse event cancer disease|32
7491648|NCT02149108|11807519|FG000|Overall Study|Other Adverse Event (AE)|8
7491649|NCT02149108|11807520|FG001|Overall Study|Other Adverse Event (AE)|18
7491650|NCT02149108|11807519|FG000|Overall Study|Other not defined above|0
7491651|NCT02149108|11807520|FG001|Overall Study|Other not defined above|2
7491652|NCT02149108|11807519|FG000|Overall Study|Refusal to continue trial medication|15
7491653|NCT02149108|11807520|FG001|Overall Study|Refusal to continue trial medication|11
7491654|NCT02149108|11807519|FG000|Overall Study|Lost to Follow-up|1
7491655|NCT02149108|11807520|FG001|Overall Study|Lost to Follow-up|0
7491656|NCT02149199|11807539|FG000|Overall Study|Study specific withdrawal criteria|4
7491657|NCT02149199|11807540|FG001|Overall Study|Study specific withdrawal criteria|21
7491658|NCT02149199|11807541|FG002|Overall Study|Study specific withdrawal criteria|6
7491659|NCT02149199|11807539|FG000|Overall Study|Other|20
7491660|NCT02149199|11807540|FG001|Overall Study|Other|25
7491661|NCT02149199|11807541|FG002|Overall Study|Other|20
7491662|NCT02149199|11807539|FG000|Overall Study|Eligibility criteria not fulfilled|9
7491663|NCT02149199|11807540|FG001|Overall Study|Eligibility criteria not fulfilled|14
7491664|NCT02149199|11807541|FG002|Overall Study|Eligibility criteria not fulfilled|8
7491665|NCT02149199|11807539|FG000|Overall Study|Withdrawal by Subject|75
7491666|NCT02149199|11807540|FG001|Overall Study|Withdrawal by Subject|93
7491667|NCT02149199|11807541|FG002|Overall Study|Withdrawal by Subject|77
7491668|NCT02149199|11807539|FG000|Overall Study|Protocol Violation|16
7491669|NCT02149199|11807540|FG001|Overall Study|Protocol Violation|13
7491670|NCT02149199|11807541|FG002|Overall Study|Protocol Violation|15
7491671|NCT02149199|11807539|FG000|Overall Study|Lost to Follow-up|3
7491672|NCT02149199|11807540|FG001|Overall Study|Lost to Follow-up|12
7491673|NCT02149199|11807541|FG002|Overall Study|Lost to Follow-up|11
7491674|NCT02149199|11807539|FG000|Overall Study|Death|0
7491675|NCT02149199|11807540|FG001|Overall Study|Death|0
7491676|NCT02149199|11807541|FG002|Overall Study|Death|1
7491677|NCT02149199|11807539|FG000|Overall Study|Adverse Event|6
7491678|NCT02149199|11807540|FG001|Overall Study|Adverse Event|15
7491679|NCT02149199|11807541|FG002|Overall Study|Adverse Event|9
7491680|NCT02149264|11807549|FG000|Overall Study|Withdrawal by Subject|9
7491681|NCT02149264|11807549|FG000|Overall Study|Adverse Event|7
7491682|NCT02149264|11807549|FG000|Overall Study|Physician Decision|3
7491683|NCT02149264|11807549|FG000|Overall Study|Protocol Violation|1
7491684|NCT02149420|11807573|FG000|Core Study|Administrative problems|0
7491685|NCT02149420|11807574|FG001|Core Study|Administrative problems|1
7491686|NCT02149420|11807575|FG002|Core Study|Administrative problems|2
7491687|NCT02149420|11807573|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
7491688|NCT02149420|11807574|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7491689|NCT02149420|11807575|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
7491690|NCT02149810|11807599|FG000|Overall Study|Physician Decision|1
7491691|NCT02149810|11807600|FG001|Overall Study|Physician Decision|2
7491692|NCT02149810|11807599|FG000|Overall Study|Lost to Follow-up|2
7491693|NCT02149810|11807600|FG001|Overall Study|Lost to Follow-up|1
7491694|NCT02149810|11807599|FG000|Overall Study|Withdrawal by Subject|5
7491695|NCT02149810|11807600|FG001|Overall Study|Withdrawal by Subject|1
7491696|NCT02149836|11807606|FG000|Overall Study|Withdrawal by Subject|1
7491697|NCT02149875|11807613|FG000|Overall Study|Lost to Follow-up|3
7491698|NCT02149875|11807614|FG001|Overall Study|Lost to Follow-up|4
7491699|NCT02149875|11807615|FG002|Overall Study|Lost to Follow-up|5
7491700|NCT02149875|11807613|FG000|Overall Study|Withdrawal by Subject|3
7491701|NCT02149875|11807614|FG001|Overall Study|Withdrawal by Subject|2
7491702|NCT02149875|11807615|FG002|Overall Study|Withdrawal by Subject|2
7491703|NCT02149875|11807613|FG000|Overall Study|Physician Decision|1
7491704|NCT02149875|11807614|FG001|Overall Study|Physician Decision|2
7491705|NCT02149875|11807615|FG002|Overall Study|Physician Decision|2
7491706|NCT02150057|11807629|FG000|Overall Study|Lost to Follow-up|6
7491707|NCT02150057|11807630|FG001|Overall Study|Lost to Follow-up|4
7491708|NCT02150213|11807646|FG000|Overall Study|Lost to Follow-up|1
7491709|NCT02150213|11807646|FG000|Overall Study|Withdrawal by Subject|1
7491710|NCT02150343|11807654|FG000|Overall Study|Adverse Event|2
7491711|NCT02150343|11807655|FG001|Overall Study|Adverse Event|0
7491712|NCT02150343|11807656|FG002|Overall Study|Adverse Event|1
7491713|NCT02150343|11807657|FG003|Overall Study|Adverse Event|1
7491714|NCT02150343|11807654|FG000|Overall Study|Withdrawal by Subject|13
7491715|NCT02150343|11807655|FG001|Overall Study|Withdrawal by Subject|10
7491716|NCT02150343|11807656|FG002|Overall Study|Withdrawal by Subject|9
7491717|NCT02150343|11807657|FG003|Overall Study|Withdrawal by Subject|4
7491718|NCT02150343|11807654|FG000|Overall Study|Lost to Follow-up|4
7491719|NCT02150343|11807655|FG001|Overall Study|Lost to Follow-up|4
7491720|NCT02150343|11807656|FG002|Overall Study|Lost to Follow-up|2
7491721|NCT02150343|11807657|FG003|Overall Study|Lost to Follow-up|3
7491722|NCT02150343|11807654|FG000|Overall Study|Other|2
7491723|NCT02150343|11807655|FG001|Overall Study|Other|6
7491724|NCT02150343|11807656|FG002|Overall Study|Other|0
7491725|NCT02150343|11807657|FG003|Overall Study|Other|2
7491726|NCT02150954|11807705|FG000|Overall Study|Protocol Violation|1
7491727|NCT02150954|11807706|FG001|Overall Study|Protocol Violation|0
7491728|NCT02151058|11807715|FG000|Overall Study|Withdrawal by Subject|1
7491729|NCT02151058|11807716|FG001|Overall Study|Withdrawal by Subject|1
7491730|NCT02151058|11807717|FG002|Overall Study|Withdrawal by Subject|3
7491731|NCT02151058|11807715|FG000|Overall Study|Lost to Follow-up|1
7491732|NCT02151058|11807716|FG001|Overall Study|Lost to Follow-up|0
7491733|NCT02151058|11807717|FG002|Overall Study|Lost to Follow-up|2
7491734|NCT02151110|11807733|FG000|Overall Study|Withdrawal by Subject|0
7491735|NCT02151110|11807734|FG001|Overall Study|Withdrawal by Subject|0
7491736|NCT02151110|11807735|FG002|Overall Study|Withdrawal by Subject|0
7491737|NCT02151110|11807736|FG003|Overall Study|Withdrawal by Subject|0
7491738|NCT02151110|11807737|FG004|Overall Study|Withdrawal by Subject|0
7491739|NCT02151110|11807738|FG005|Overall Study|Withdrawal by Subject|0
7491740|NCT02151110|11807739|FG006|Overall Study|Withdrawal by Subject|0
7491741|NCT02151110|11807740|FG007|Overall Study|Withdrawal by Subject|1
7491742|NCT02151110|11807733|FG000|Overall Study|Lost to Follow-up|0
7491743|NCT02151110|11807734|FG001|Overall Study|Lost to Follow-up|0
7491744|NCT02151110|11807735|FG002|Overall Study|Lost to Follow-up|0
7491745|NCT02151110|11807736|FG003|Overall Study|Lost to Follow-up|0
7491746|NCT02151110|11807737|FG004|Overall Study|Lost to Follow-up|0
7491747|NCT02151110|11807738|FG005|Overall Study|Lost to Follow-up|0
7491748|NCT02151110|11807739|FG006|Overall Study|Lost to Follow-up|0
7491749|NCT02151110|11807740|FG007|Overall Study|Lost to Follow-up|2
7491750|NCT02151149|11807767|FG000|Treatment Period|Death|2
7491751|NCT02151149|11807768|FG001|Treatment Period|Death|3
7491752|NCT02151149|11807767|FG000|Treatment Period|Adverse Event|17
7491753|NCT02151149|11807768|FG001|Treatment Period|Adverse Event|14
7491754|NCT02151149|11807767|FG000|Treatment Period|Progressive Disease|25
7491755|NCT02151149|11807768|FG001|Treatment Period|Progressive Disease|24
7491756|NCT02151149|11807767|FG000|Treatment Period|Symptomatic Deterioration|2
7491757|NCT02151149|11807768|FG001|Treatment Period|Symptomatic Deterioration|10
7491758|NCT02151149|11807767|FG000|Treatment Period|Withdrawal by Subject|13
7491759|NCT02151149|11807768|FG001|Treatment Period|Withdrawal by Subject|11
7491760|NCT02151149|11807767|FG000|Treatment Period|Miscellaneous|8
7491761|NCT02151149|11807768|FG001|Treatment Period|Miscellaneous|7
7491762|NCT02151149|11807767|FG000|Treatment Period|Participants randomized but not treated|3
7491763|NCT02151149|11807768|FG001|Treatment Period|Participants randomized but not treated|2
7491764|NCT02151149|11807767|FG000|Follow-Up Period|Lost to Follow-up|2
7491765|NCT02151149|11807768|FG001|Follow-Up Period|Lost to Follow-up|3
7491766|NCT02151149|11807767|FG000|Follow-Up Period|Death|37
7491767|NCT02151149|11807768|FG001|Follow-Up Period|Death|34
7491768|NCT02151266|11807784|FG000|Overall Study|Lost to Follow-up|1
7491769|NCT02151266|11807785|FG001|Overall Study|Lost to Follow-up|4
7491770|NCT02151266|11807786|FG002|Overall Study|Lost to Follow-up|1
7491771|NCT02151266|11807784|FG000|Overall Study|Did NOT receive intervention|3
7491772|NCT02151266|11807785|FG001|Overall Study|Did NOT receive intervention|6
7491773|NCT02151266|11807786|FG002|Overall Study|Did NOT receive intervention|2
7491774|NCT02151266|11807784|FG000|Overall Study|Not able to exercise|4
7491775|NCT02151266|11807785|FG001|Overall Study|Not able to exercise|5
7491776|NCT02151266|11807786|FG002|Overall Study|Not able to exercise|4
7535171|NCT02708498|11882862|FG001|Overall Study|Death|19
7535172|NCT02708498|11882863|FG002|Overall Study|Death|0
7535173|NCT02708498|11882864|FG003|Overall Study|Death|0
7317683|NCT00723957|11546666|FG000|Overall Study|Withdrawal by Subject|7
7535174|NCT02708498|11882865|FG004|Overall Study|Death|1
7535175|NCT02708498|11882866|FG005|Overall Study|Death|0
7535176|NCT02708498|11882867|FG006|Overall Study|Death|0
7535177|NCT02708498|11882868|FG007|Overall Study|Death|0
7535178|NCT02708498|11882861|FG000|Overall Study|Unknown reason, missing data|0
7535179|NCT02708498|11882862|FG001|Overall Study|Unknown reason, missing data|0
7535180|NCT02708498|11882863|FG002|Overall Study|Unknown reason, missing data|62
7535181|NCT02708498|11882864|FG003|Overall Study|Unknown reason, missing data|51
7535182|NCT02708498|11882865|FG004|Overall Study|Unknown reason, missing data|195
7535183|NCT02708498|11882866|FG005|Overall Study|Unknown reason, missing data|132
7535184|NCT02708498|11882867|FG006|Overall Study|Unknown reason, missing data|0
7535185|NCT02708498|11882868|FG007|Overall Study|Unknown reason, missing data|0
7537760|NCT02569242|11886871|FG000|Overall Study|Death|1
7537761|NCT02569242|11886872|FG001|Overall Study|Death|0
7537762|NCT02569242|11886871|FG000|Overall Study|Withdrawal by Subject|0
7537763|NCT02569242|11886872|FG001|Overall Study|Withdrawal by Subject|1
7537764|NCT02524379|11886878|FG000|Overall Study|Death|1
7491777|NCT02151461|11807815|FG000|Overall Study|Adverse Event|5
7491778|NCT02151461|11807816|FG001|Overall Study|Adverse Event|1
7491779|NCT02151461|11807817|FG002|Overall Study|Adverse Event|0
7491780|NCT02151461|11807818|FG003|Overall Study|Adverse Event|2
7491781|NCT02151461|11807815|FG000|Overall Study|Lost to Follow-up|0
7491782|NCT02151461|11807816|FG001|Overall Study|Lost to Follow-up|0
7491783|NCT02151461|11807817|FG002|Overall Study|Lost to Follow-up|1
7491784|NCT02151461|11807818|FG003|Overall Study|Lost to Follow-up|1
7491785|NCT02151461|11807815|FG000|Overall Study|Withdrawal by Subject|1
7491786|NCT02151461|11807816|FG001|Overall Study|Withdrawal by Subject|0
7491787|NCT02151461|11807817|FG002|Overall Study|Withdrawal by Subject|1
7491788|NCT02151461|11807818|FG003|Overall Study|Withdrawal by Subject|1
7491789|NCT02151461|11807815|FG000|Overall Study|Treatment discontinuation|0
7491790|NCT02151461|11807816|FG001|Overall Study|Treatment discontinuation|0
7491791|NCT02151461|11807817|FG002|Overall Study|Treatment discontinuation|1
7491792|NCT02151461|11807818|FG003|Overall Study|Treatment discontinuation|0
7491793|NCT02151591|11807847|FG000|Overall Study|Lost to Follow-up|6
7491794|NCT02151591|11807848|FG001|Overall Study|Lost to Follow-up|3
7491795|NCT02151643|11807859|FG000|Overall Study|Adverse Event|2
7491796|NCT02151643|11807860|FG001|Overall Study|Adverse Event|0
7491797|NCT02151643|11807861|FG002|Overall Study|Adverse Event|1
7491798|NCT02151643|11807862|FG003|Overall Study|Adverse Event|4
7491799|NCT02151643|11807863|FG004|Overall Study|Adverse Event|0
7491800|NCT02151643|11807859|FG000|Overall Study|Withdrawal by Subject|0
7491801|NCT02151643|11807860|FG001|Overall Study|Withdrawal by Subject|1
7491802|NCT02151643|11807861|FG002|Overall Study|Withdrawal by Subject|1
7491803|NCT02151643|11807862|FG003|Overall Study|Withdrawal by Subject|1
7491804|NCT02151643|11807863|FG004|Overall Study|Withdrawal by Subject|1
7491805|NCT02151643|11807859|FG000|Overall Study|Hyperphosphataemia|1
7491806|NCT02151643|11807860|FG001|Overall Study|Hyperphosphataemia|0
7491807|NCT02151643|11807861|FG002|Overall Study|Hyperphosphataemia|0
7491808|NCT02151643|11807862|FG003|Overall Study|Hyperphosphataemia|0
7491809|NCT02151643|11807863|FG004|Overall Study|Hyperphosphataemia|1
7491810|NCT02151643|11807859|FG000|Overall Study|High Ferritin levels|3
7491811|NCT02151643|11807860|FG001|Overall Study|High Ferritin levels|3
7491812|NCT02151643|11807861|FG002|Overall Study|High Ferritin levels|2
7491813|NCT02151643|11807862|FG003|Overall Study|High Ferritin levels|2
7491814|NCT02151643|11807863|FG004|Overall Study|High Ferritin levels|1
7491815|NCT02151682|11807877|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7491816|NCT02151682|11807878|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
7491817|NCT02151682|11807879|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7491818|NCT02151682|11807880|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7491819|NCT02151682|11807881|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7491820|NCT02151682|11807882|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
7491821|NCT02151682|11807877|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7491822|NCT02151682|11807878|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
7491823|NCT02151682|11807879|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7491824|NCT02151682|11807880|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7491825|NCT02151682|11807881|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7491826|NCT02151682|11807882|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
7491827|NCT02151682|11807877|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7491828|NCT02151682|11807878|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
7491829|NCT02151682|11807879|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7491830|NCT02151682|11807880|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7491831|NCT02151682|11807881|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7491832|NCT02151682|11807882|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
7491833|NCT02151682|11807877|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7491834|NCT02151682|11807878|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
7491835|NCT02151682|11807879|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7491836|NCT02151682|11807880|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7491837|NCT02151682|11807881|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7491838|NCT02151682|11807882|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
7491839|NCT02151682|11807877|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
7491840|NCT02151682|11807878|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7491841|NCT02151682|11807879|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7491842|NCT02151682|11807880|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7491843|NCT02151682|11807881|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7491844|NCT02151682|11807882|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
7491845|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
7491846|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
7491847|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
7491848|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
7491849|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
7491850|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
7491851|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Death|0
7491852|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Death|0
7491853|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Death|0
7491854|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Death|2
7491855|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Death|0
7491856|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Death|0
7491857|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7491858|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7491859|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7491860|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
7491861|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7491862|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
7491863|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7491864|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7491865|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
7491866|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7491867|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7491868|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
7491869|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7491870|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7491871|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
7491872|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7491873|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7491874|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
7491875|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
7491876|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
7491877|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
7491878|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
7491879|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
7491880|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
7491881|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Missing|0
7491882|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Missing|0
7491883|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Missing|0
7491884|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Missing|1
7491885|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Missing|0
7491886|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Missing|0
7491887|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Various other|0
7491888|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Various other|0
7491889|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Various other|6
7491890|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Various other|0
7491891|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Various other|0
7491892|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Various other|0
7491893|NCT02151682|11807877|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7491894|NCT02151682|11807878|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7491895|NCT02151682|11807879|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
7491896|NCT02151682|11807880|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7491897|NCT02151682|11807881|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7491898|NCT02151682|11807882|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
7491899|NCT02151682|11807877|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7491900|NCT02151682|11807878|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7491901|NCT02151682|11807879|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7491902|NCT02151682|11807880|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7491903|NCT02151682|11807881|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
7491904|NCT02151682|11807882|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
7491905|NCT02151682|11807877|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
7491906|NCT02151682|11807878|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
7491907|NCT02151682|11807879|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
7491908|NCT02151682|11807880|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
7491909|NCT02151682|11807881|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
7491910|NCT02151682|11807882|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
7491911|NCT02151682|11807877|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7491912|NCT02151682|11807878|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7491913|NCT02151682|11807879|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7491914|NCT02151682|11807880|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7491915|NCT02151682|11807881|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
7491916|NCT02151682|11807882|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
7491917|NCT02151682|11807877|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7491918|NCT02151682|11807878|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7491919|NCT02151682|11807879|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7535186|NCT02708524|11882888|FG000|Overall Study|Adverse Event|0
7491920|NCT02151682|11807880|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7491921|NCT02151682|11807881|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
7491922|NCT02151682|11807882|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
7491923|NCT02151773|11807900|FG000|Overall Study|Protocol Deviation|64
7491924|NCT02151786|11807904|FG000|Overall Study|Unavailability of Case Report Form|26
7491925|NCT02151786|11807904|FG000|Overall Study|Outside the Contract Period|1
7491926|NCT02151786|11807904|FG000|Overall Study|Randomized, not Treated|1
7491927|NCT02151786|11807904|FG000|Overall Study|Unavailability of Information|8
7491928|NCT02151851|11807910|FG000|Overall Study|Lack of Efficacy|67
7491929|NCT02151851|11807911|FG001|Overall Study|Lack of Efficacy|94
7491930|NCT02151851|11807910|FG000|Overall Study|Protocol Violation|0
7491931|NCT02151851|11807911|FG001|Overall Study|Protocol Violation|1
7491932|NCT02151851|11807910|FG000|Overall Study|Withdrawal by Subject|2
7491933|NCT02151851|11807911|FG001|Overall Study|Withdrawal by Subject|5
7491934|NCT02151851|11807910|FG000|Overall Study|Medical impairment|1
7491935|NCT02151851|11807911|FG001|Overall Study|Medical impairment|0
7491936|NCT02151851|11807910|FG000|Overall Study|Low compliance to study visits|0
7491937|NCT02151851|11807911|FG001|Overall Study|Low compliance to study visits|1
7491938|NCT02151851|11807910|FG000|Overall Study|Subject entered into study in error|0
7491939|NCT02151851|11807911|FG001|Overall Study|Subject entered into study in error|1
7491940|NCT02151851|11807910|FG000|Overall Study|Adverse Event|6
7491941|NCT02151851|11807911|FG001|Overall Study|Adverse Event|28
7491942|NCT02151903|11807930|FG000|Overall Study|Withdrawal by Subject|1
7491943|NCT02151903|11807931|FG001|Overall Study|Withdrawal by Subject|0
7491944|NCT02151903|11807930|FG000|Overall Study|Progressive disease|2
7491945|NCT02151903|11807931|FG001|Overall Study|Progressive disease|1
7491946|NCT02152007|11807989|FG000|Overall Study|Withdrawal by Subject|1
7491947|NCT02152137|11808003|FG000|Overall Study|Withdrawal by Subject|1
7491948|NCT02152137|11808003|FG000|Overall Study|Originally assigned to Arm B|3
7491949|NCT02152163|11808009|FG000|Overall Study|Physician Decision|12
7491950|NCT02152163|11808010|FG001|Overall Study|Physician Decision|13
7491951|NCT02152345|11808018|FG000|Overall Study|Case Cancellations|2
7491952|NCT02152345|11808019|FG001|Overall Study|Case Cancellations|4
7491953|NCT02152345|11808018|FG000|Overall Study|Withdrawal by Subject|2
7491954|NCT02152345|11808019|FG001|Overall Study|Withdrawal by Subject|1
7491955|NCT02152371|11808027|FG000|Overall Study|Adverse Event|6
7491956|NCT02152371|11808028|FG001|Overall Study|Adverse Event|2
7491957|NCT02152371|11808027|FG000|Overall Study|Withdrawal by Subject|3
7491958|NCT02152371|11808028|FG001|Overall Study|Withdrawal by Subject|7
7491959|NCT02152371|11808027|FG000|Overall Study|Protocol Violation|2
7491960|NCT02152371|11808028|FG001|Overall Study|Protocol Violation|3
7491961|NCT02152371|11808027|FG000|Overall Study|Lost to Follow-up|1
7491962|NCT02152371|11808028|FG001|Overall Study|Lost to Follow-up|0
7491963|NCT02152371|11808027|FG000|Overall Study|Lack of Efficacy|0
7491964|NCT02152371|11808028|FG001|Overall Study|Lack of Efficacy|1
7491965|NCT02152371|11808027|FG000|Overall Study|Physician Decision|0
7491966|NCT02152371|11808028|FG001|Overall Study|Physician Decision|2
7491967|NCT02152371|11808027|FG000|Overall Study|Reason Not Given|0
7491968|NCT02152371|11808028|FG001|Overall Study|Reason Not Given|1
7491969|NCT02152384|11808034|FG000|Period 1|Withdrawal by Subject|0
7491970|NCT02152384|11808035|FG001|Period 1|Withdrawal by Subject|1
7491971|NCT02152384|11808034|FG000|Period 1|Adverse Event|1
7491972|NCT02152384|11808035|FG001|Period 1|Adverse Event|1
7491973|NCT02152605|11808063|FG000|Overall Study|Adverse Event|6
7491974|NCT02152605|11808064|FG001|Overall Study|Adverse Event|8
7491975|NCT02152605|11808063|FG000|Overall Study|Lack of Efficacy|7
7491976|NCT02152605|11808064|FG001|Overall Study|Lack of Efficacy|4
7491977|NCT02152605|11808063|FG000|Overall Study|Protocol deviation|1
7491978|NCT02152605|11808064|FG001|Overall Study|Protocol deviation|4
7491979|NCT02152605|11808063|FG000|Overall Study|Lost to Follow-up|1
7491980|NCT02152605|11808064|FG001|Overall Study|Lost to Follow-up|0
7491981|NCT02152605|11808063|FG000|Overall Study|Withdrew consent|4
7491982|NCT02152605|11808064|FG001|Overall Study|Withdrew consent|2
7491995|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Technical problems|0
7491996|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Technical problems|0
7491997|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Technical problems|0
7491998|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Technical problems|1
7491999|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
7492000|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
7492001|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
7492002|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
7492003|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
7492004|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
7492005|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
7492006|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
7492007|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Adverse Event|3
7492008|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Adverse Event|6
7492009|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Adverse Event|1
7492010|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Adverse Event|2
7492011|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Death|0
7492012|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Death|3
7492013|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Death|1
7492014|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Death|0
7492015|NCT02152761|11808097|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
7492016|NCT02152761|11808098|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
7492017|NCT02152761|11808099|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
7492018|NCT02152761|11808100|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
7492019|NCT02152761|11808097|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7492020|NCT02152761|11808098|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
7492021|NCT02152761|11808099|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
7492022|NCT02152761|11808100|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
7492023|NCT02152761|11808097|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
7492024|NCT02152761|11808098|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
7492025|NCT02152761|11808099|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7492026|NCT02152761|11808100|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
7492027|NCT02152761|11808097|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
7492028|NCT02152761|11808098|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7492029|NCT02152761|11808099|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7492030|NCT02152761|11808100|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
7492031|NCT02152761|11808097|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
7492032|NCT02152761|11808098|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
7492033|NCT02152761|11808099|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
7492034|NCT02152761|11808100|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
7492035|NCT02153073|11808125|FG000|Overall Study|Case Report Forms Uncollected|230
7492036|NCT02153073|11808125|FG000|Overall Study|Protocol Deviation|68
7492037|NCT02153086|11808129|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
7492038|NCT02153086|11808129|FG000|Overall Study|Other|2
7492039|NCT02153112|11808172|FG000|Overall Study|Adverse Event|0
7492040|NCT02153112|11808173|FG001|Overall Study|Adverse Event|0
7492041|NCT02153112|11808174|FG002|Overall Study|Adverse Event|1
7492042|NCT02153112|11808175|FG003|Overall Study|Adverse Event|0
7492043|NCT02153112|11808176|FG004|Overall Study|Adverse Event|0
7492044|NCT02153112|11808177|FG005|Overall Study|Adverse Event|0
7492045|NCT02153112|11808178|FG006|Overall Study|Adverse Event|0
7492046|NCT02153112|11808179|FG007|Overall Study|Adverse Event|0
7492047|NCT02153112|11808180|FG008|Overall Study|Adverse Event|0
7492048|NCT02153112|11808181|FG009|Overall Study|Adverse Event|0
7492049|NCT02153112|11808172|FG000|Overall Study|Lost to Follow-up|1
7492050|NCT02153112|11808173|FG001|Overall Study|Lost to Follow-up|1
7492051|NCT02153112|11808174|FG002|Overall Study|Lost to Follow-up|0
7492052|NCT02153112|11808175|FG003|Overall Study|Lost to Follow-up|0
7492053|NCT02153112|11808176|FG004|Overall Study|Lost to Follow-up|2
7492054|NCT02153112|11808177|FG005|Overall Study|Lost to Follow-up|1
7492055|NCT02153112|11808178|FG006|Overall Study|Lost to Follow-up|1
7492056|NCT02153112|11808179|FG007|Overall Study|Lost to Follow-up|0
7492057|NCT02153112|11808180|FG008|Overall Study|Lost to Follow-up|1
7492058|NCT02153112|11808181|FG009|Overall Study|Lost to Follow-up|1
7492059|NCT02153112|11808172|FG000|Overall Study|Withdrawal by Subject|3
7492060|NCT02153112|11808173|FG001|Overall Study|Withdrawal by Subject|1
7492061|NCT02153112|11808174|FG002|Overall Study|Withdrawal by Subject|2
7492062|NCT02153112|11808175|FG003|Overall Study|Withdrawal by Subject|2
7492063|NCT02153112|11808176|FG004|Overall Study|Withdrawal by Subject|1
7492064|NCT02153112|11808177|FG005|Overall Study|Withdrawal by Subject|1
7492065|NCT02153112|11808178|FG006|Overall Study|Withdrawal by Subject|7
7492066|NCT02153112|11808179|FG007|Overall Study|Withdrawal by Subject|2
7492067|NCT02153112|11808180|FG008|Overall Study|Withdrawal by Subject|13
7492068|NCT02153112|11808181|FG009|Overall Study|Withdrawal by Subject|12
7492069|NCT02153112|11808172|FG000|Overall Study|Reason not Specified|0
7492070|NCT02153112|11808173|FG001|Overall Study|Reason not Specified|0
7492071|NCT02153112|11808174|FG002|Overall Study|Reason not Specified|0
7492072|NCT02153112|11808175|FG003|Overall Study|Reason not Specified|0
7492073|NCT02153112|11808176|FG004|Overall Study|Reason not Specified|0
7492074|NCT02153112|11808177|FG005|Overall Study|Reason not Specified|0
7492075|NCT02153112|11808178|FG006|Overall Study|Reason not Specified|0
7492076|NCT02153112|11808179|FG007|Overall Study|Reason not Specified|0
7492077|NCT02153112|11808180|FG008|Overall Study|Reason not Specified|1
7492078|NCT02153112|11808181|FG009|Overall Study|Reason not Specified|1
7492079|NCT02153346|11808205|FG000|Overall Study|Lost to Follow-up|11
7492080|NCT02153359|11808210|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
7492081|NCT02153359|11808211|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
7492082|NCT02153398|11808225|FG000|Overall Study|Withdrawal by Subject|1
7492083|NCT02153398|11808226|FG001|Overall Study|Withdrawal by Subject|0
7492084|NCT02153398|11808227|FG002|Overall Study|Withdrawal by Subject|0
7492085|NCT02153398|11808228|FG003|Overall Study|Withdrawal by Subject|0
7492086|NCT02153398|11808229|FG004|Overall Study|Withdrawal by Subject|0
7492087|NCT02153398|11808225|FG000|Overall Study|Adverse Event|0
7492088|NCT02153398|11808226|FG001|Overall Study|Adverse Event|0
7492089|NCT02153398|11808227|FG002|Overall Study|Adverse Event|1
7492090|NCT02153398|11808228|FG003|Overall Study|Adverse Event|1
7492091|NCT02153398|11808229|FG004|Overall Study|Adverse Event|0
7492092|NCT02153736|11808292|FG000|Overall Study|Lost to Follow-up|1
7492093|NCT02153736|11808293|FG001|Overall Study|Lost to Follow-up|0
7492094|NCT02153736|11808292|FG000|Overall Study|Medical status change made ineligible|1
7492095|NCT02153736|11808293|FG001|Overall Study|Medical status change made ineligible|0
7492096|NCT02153736|11808292|FG000|Overall Study|Death|0
7492097|NCT02153736|11808293|FG001|Overall Study|Death|1
7492098|NCT02153736|11808292|FG000|Overall Study|Withdrawal by Subject|0
7492099|NCT02153736|11808293|FG001|Overall Study|Withdrawal by Subject|1
7492100|NCT02153788|11808301|FG000|Overall Study|Physician Decision|2
7492101|NCT02153788|11808302|FG001|Overall Study|Physician Decision|1
7492102|NCT02153827|11808310|FG000|Overall Study|Lost to Follow-up|3
7492103|NCT02153827|11808311|FG001|Overall Study|Lost to Follow-up|9
7492104|NCT02153905|11808319|FG000|Overall Study|Death|1
7492105|NCT02153905|11808320|FG001|Overall Study|Death|0
7492106|NCT02153918|11808326|FG000|Overall Study|Refused further treatment|1
7492107|NCT02154061|11808370|FG000|Overall Study|Pregnancy|1
7492108|NCT02154061|11808371|FG001|Overall Study|Pregnancy|0
7492109|NCT02154061|11808370|FG000|Overall Study|enrolled but not vaccinated|1
7492110|NCT02154061|11808371|FG001|Overall Study|enrolled but not vaccinated|0
7492111|NCT02154139|11808377|FG000|Overall Study|Injection not administered|2
7492112|NCT02154139|11808377|FG000|Overall Study|Other|2
7492113|NCT02154139|11808377|FG000|Overall Study|Investigator transferred|3
7492114|NCT02154347|11808396|FG000|Double-blind Period|Adverse Event|1
7492115|NCT02154347|11808397|FG001|Double-blind Period|Adverse Event|2
7492116|NCT02154347|11808396|FG000|Double-blind Period|Lack of Efficacy|1
7492117|NCT02154347|11808397|FG001|Double-blind Period|Lack of Efficacy|0
7492118|NCT02154347|11808396|FG000|Double-blind Period|Physician Decision|0
7492119|NCT02154347|11808397|FG001|Double-blind Period|Physician Decision|1
7492120|NCT02154347|11808396|FG000|Double-blind Period|Withdrawal by Subject|1
7492121|NCT02154347|11808397|FG001|Double-blind Period|Withdrawal by Subject|1
7492122|NCT02154347|11808396|FG000|Open-label Period|Adverse Event|3
7492123|NCT02154347|11808397|FG001|Open-label Period|Adverse Event|4
7492124|NCT02154347|11808396|FG000|Open-label Period|Lack of Efficacy|4
7492125|NCT02154347|11808397|FG001|Open-label Period|Lack of Efficacy|19
7492126|NCT02154347|11808396|FG000|Open-label Period|Protocol Violation|0
7492127|NCT02154347|11808397|FG001|Open-label Period|Protocol Violation|1
7492128|NCT02154347|11808396|FG000|Open-label Period|Withdrawal by Subject|0
7492129|NCT02154347|11808397|FG001|Open-label Period|Withdrawal by Subject|1
7492130|NCT02154425|11808413|FG000|Screening Period|Adverse Event|1
7492131|NCT02154581|11808432|FG000|Overall Study|Lost to Follow-up|7
7492132|NCT02154581|11808433|FG001|Overall Study|Lost to Follow-up|8
7492133|NCT02155283|11808496|FG000|Overall Study|Lost to Follow-up|3
7492134|NCT02155283|11808496|FG000|Overall Study|Withdrawal by Subject|1
7492135|NCT02155283|11808496|FG000|Overall Study|Protocol Violation|3
7492136|NCT02155309|11808502|FG000|Overall Study|Protocol Violation|0
7492137|NCT02155309|11808503|FG001|Overall Study|Protocol Violation|0
7492138|NCT02155309|11808504|FG002|Overall Study|Protocol Violation|1
7492139|NCT02155322|11808511|FG000|Overall Study|Adverse Event|1
7492140|NCT02155322|11808511|FG000|Overall Study|Physician Decision|1
7492141|NCT02155322|11808511|FG000|Overall Study|Relapse/Recurrence|8
7492142|NCT02155322|11808511|FG000|Overall Study|Withdrawal by Subject|4
7492143|NCT02155608|11808580|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
7492144|NCT02155608|11808581|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
7492145|NCT02155608|11808580|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7492146|NCT02155608|11808581|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
7492147|NCT02155660|11808597|FG000|Overall Study|Other Reason|8
7492148|NCT02155660|11808598|FG001|Overall Study|Other Reason|6
7492149|NCT02155660|11808599|FG002|Overall Study|Other Reason|10
7492150|NCT02155660|11808600|FG003|Overall Study|Other Reason|10
7492151|NCT02155660|11808597|FG000|Overall Study|Study-specific withdrawal criteria|0
7492152|NCT02155660|11808598|FG001|Overall Study|Study-specific withdrawal criteria|1
7492153|NCT02155660|11808599|FG002|Overall Study|Study-specific withdrawal criteria|1
7492154|NCT02155660|11808600|FG003|Overall Study|Study-specific withdrawal criteria|1
7492155|NCT02155660|11808597|FG000|Overall Study|Severe non-compliance|0
7492156|NCT02155660|11808598|FG001|Overall Study|Severe non-compliance|4
7492157|NCT02155660|11808599|FG002|Overall Study|Severe non-compliance|0
7492158|NCT02155660|11808600|FG003|Overall Study|Severe non-compliance|1
7492159|NCT02155660|11808597|FG000|Overall Study|Adverse Event|2
7492160|NCT02155660|11808598|FG001|Overall Study|Adverse Event|6
7492161|NCT02155660|11808599|FG002|Overall Study|Adverse Event|3
7492162|NCT02155660|11808600|FG003|Overall Study|Adverse Event|1
7492163|NCT02155660|11808597|FG000|Overall Study|Lost to Follow-up|3
7492164|NCT02155660|11808598|FG001|Overall Study|Lost to Follow-up|6
7492165|NCT02155660|11808599|FG002|Overall Study|Lost to Follow-up|5
7492166|NCT02155660|11808600|FG003|Overall Study|Lost to Follow-up|8
7492167|NCT02155660|11808597|FG000|Overall Study|Death|17
7492168|NCT02155660|11808598|FG001|Overall Study|Death|19
7492169|NCT02155660|11808599|FG002|Overall Study|Death|17
7492170|NCT02155660|11808600|FG003|Overall Study|Death|19
7492171|NCT02155660|11808597|FG000|Overall Study|Withdrawal by Subject|28
7492172|NCT02155660|11808598|FG001|Overall Study|Withdrawal by Subject|31
7492173|NCT02155660|11808599|FG002|Overall Study|Withdrawal by Subject|24
7492174|NCT02155660|11808600|FG003|Overall Study|Withdrawal by Subject|21
7492185|NCT02155738|11808638|FG000|Overall Study|Missing critical information|1
7492186|NCT02155738|11808639|FG001|Overall Study|Missing critical information|0
7492187|NCT02155738|11808640|FG002|Overall Study|Missing critical information|0
7492188|NCT02155738|11808641|FG003|Overall Study|Missing critical information|1
7492189|NCT02155829|11808653|FG000|Overall Study|Adverse Event|1
7492190|NCT02155829|11808654|FG001|Overall Study|Adverse Event|0
7492191|NCT02155829|11808653|FG000|Overall Study|Withdrawal by Subject|3
7492192|NCT02155829|11808654|FG001|Overall Study|Withdrawal by Subject|3
7492193|NCT02155829|11808653|FG000|Overall Study|Protocol Violation|2
7492194|NCT02155829|11808654|FG001|Overall Study|Protocol Violation|0
7492195|NCT02155881|11808663|FG000|Overall Study|Withdrawal by Subject|0
7492196|NCT02155881|11808664|FG001|Overall Study|Withdrawal by Subject|2
7492197|NCT02155881|11808663|FG000|Overall Study|Inappropriately randomized|2
7492198|NCT02155881|11808664|FG001|Overall Study|Inappropriately randomized|2
7492199|NCT02155985|11808673|FG000|Overall Study|Withdrawal by Subject|0
7492200|NCT02155985|11808674|FG001|Overall Study|Withdrawal by Subject|0
7492201|NCT02155985|11808675|FG002|Overall Study|Withdrawal by Subject|1
7492202|NCT02155985|11808673|FG000|Overall Study|Lost to Follow-up|1
7492203|NCT02155985|11808674|FG001|Overall Study|Lost to Follow-up|0
7492204|NCT02155985|11808675|FG002|Overall Study|Lost to Follow-up|0
7492205|NCT02156076|11808687|FG000|Treatment Period|no longer meets study criteria|0
7492206|NCT02156076|11808688|FG001|Treatment Period|no longer meets study criteria|0
7492207|NCT02156076|11808689|FG002|Treatment Period|no longer meets study criteria|1
7492208|NCT02156076|11808690|FG003|Treatment Period|no longer meets study criteria|0
7492209|NCT02156076|11808687|FG000|Treatment Period|Poor/non-compliance|0
7492210|NCT02156076|11808688|FG001|Treatment Period|Poor/non-compliance|1
7492211|NCT02156076|11808689|FG002|Treatment Period|Poor/non-compliance|0
7492212|NCT02156076|11808690|FG003|Treatment Period|Poor/non-compliance|0
7492213|NCT02156076|11808687|FG000|Treatment Period|Lost to Follow-up|0
7492214|NCT02156076|11808688|FG001|Treatment Period|Lost to Follow-up|0
7492215|NCT02156076|11808689|FG002|Treatment Period|Lost to Follow-up|0
7492216|NCT02156076|11808690|FG003|Treatment Period|Lost to Follow-up|1
7492217|NCT02156076|11808687|FG000|Treatment Period|Withdrawal by Subject|0
7492218|NCT02156076|11808688|FG001|Treatment Period|Withdrawal by Subject|0
7492219|NCT02156076|11808689|FG002|Treatment Period|Withdrawal by Subject|1
7492220|NCT02156076|11808690|FG003|Treatment Period|Withdrawal by Subject|0
7492221|NCT02156076|11808687|FG000|Treatment Period|Subject request to discontinue treatment|0
7492222|NCT02156076|11808688|FG001|Treatment Period|Subject request to discontinue treatment|1
7492223|NCT02156076|11808689|FG002|Treatment Period|Subject request to discontinue treatment|0
7492224|NCT02156076|11808690|FG003|Treatment Period|Subject request to discontinue treatment|0
7492225|NCT02156076|11808687|FG000|Treatment Period|Adverse Event|0
7492226|NCT02156076|11808688|FG001|Treatment Period|Adverse Event|0
7492227|NCT02156076|11808689|FG002|Treatment Period|Adverse Event|0
7492228|NCT02156076|11808690|FG003|Treatment Period|Adverse Event|1
7492229|NCT02156076|11808687|FG000|Follow-up Period|Withdrawal by Subject|1
7492230|NCT02156076|11808688|FG001|Follow-up Period|Withdrawal by Subject|0
7492231|NCT02156076|11808689|FG002|Follow-up Period|Withdrawal by Subject|0
7492232|NCT02156076|11808690|FG003|Follow-up Period|Withdrawal by Subject|0
7492233|NCT02156271|11808728|FG000|Overall Study|Physician Decision|4
7492234|NCT02156271|11808729|FG001|Overall Study|Physician Decision|3
7492235|NCT02156466|11808740|FG000|Overall Study|Adverse Event|0
7492236|NCT02156466|11808741|FG001|Overall Study|Adverse Event|0
7492237|NCT02156466|11808742|FG002|Overall Study|Adverse Event|1
7492238|NCT02156466|11808743|FG003|Overall Study|Adverse Event|1
7492239|NCT02156466|11808744|FG004|Overall Study|Adverse Event|0
7492240|NCT02156466|11808740|FG000|Overall Study|Quantiferon Positivity|0
7492241|NCT02156466|11808741|FG001|Overall Study|Quantiferon Positivity|0
7492242|NCT02156466|11808742|FG002|Overall Study|Quantiferon Positivity|0
7492243|NCT02156466|11808743|FG003|Overall Study|Quantiferon Positivity|1
7492244|NCT02156466|11808744|FG004|Overall Study|Quantiferon Positivity|0
7492245|NCT02156492|11808768|FG000|Period 1|No Reason Given|0
7492246|NCT02156492|11808769|FG001|Period 1|No Reason Given|1
7492247|NCT02156492|11808770|FG002|Period 1|No Reason Given|0
7492248|NCT02156492|11808768|FG000|Period 3|Adverse Event|0
7492249|NCT02156492|11808769|FG001|Period 3|Adverse Event|1
7492250|NCT02156492|11808770|FG002|Period 3|Adverse Event|0
7492251|NCT02156804|11808801|FG000|Overall Study|Withdrawal by Subject|1
7492252|NCT02157298|11808837|FG000|Overall Study|Adverse Event|1
7492253|NCT02157298|11808838|FG001|Overall Study|Adverse Event|0
7492254|NCT02157298|11808837|FG000|Overall Study|Subject no longer meets study criteria|1
7492255|NCT02157298|11808838|FG001|Overall Study|Subject no longer meets study criteria|2
7492256|NCT02157298|11808837|FG000|Overall Study|Poor/Non-compliance|1
7492257|NCT02157298|11808838|FG001|Overall Study|Poor/Non-compliance|0
7492258|NCT02157298|11808837|FG000|Overall Study|Withdrawal by Subject|1
7492259|NCT02157298|11808838|FG001|Overall Study|Withdrawal by Subject|0
7492260|NCT02157376|11808846|FG000|Overall Study|Death|10
7492261|NCT02157376|11808847|FG001|Overall Study|Death|4
7492262|NCT02157376|11808846|FG000|Overall Study|Eligibility criteria not fulfilled|0
7492263|NCT02157376|11808847|FG001|Overall Study|Eligibility criteria not fulfilled|1
7492264|NCT02157376|11808846|FG000|Overall Study|Withdrawal by Subject|3
7492265|NCT02157376|11808847|FG001|Overall Study|Withdrawal by Subject|8
7492266|NCT02157376|11808846|FG000|Overall Study|Not treated|8
7492267|NCT02157376|11808847|FG001|Overall Study|Not treated|3
7492268|NCT02157376|11808846|FG000|Overall Study|Investigator's misjudgement|1
7492269|NCT02157376|11808847|FG001|Overall Study|Investigator's misjudgement|2
7492270|NCT02157506|11808858|FG000|Overall Study|Adverse Event|0
7492271|NCT02157506|11808859|FG001|Overall Study|Adverse Event|1
7492272|NCT02157506|11808860|FG002|Overall Study|Adverse Event|0
7492273|NCT02157506|11808861|FG003|Overall Study|Adverse Event|0
7492274|NCT02157506|11808862|FG004|Overall Study|Adverse Event|0
7492275|NCT02157506|11808858|FG000|Overall Study|Lost to Follow-up|0
7492276|NCT02157506|11808859|FG001|Overall Study|Lost to Follow-up|0
7492277|NCT02157506|11808860|FG002|Overall Study|Lost to Follow-up|1
7492278|NCT02157506|11808861|FG003|Overall Study|Lost to Follow-up|0
7492279|NCT02157506|11808862|FG004|Overall Study|Lost to Follow-up|0
7492280|NCT02157519|11808876|FG000|Overall Study|Death|3
7492281|NCT02157519|11808877|FG001|Overall Study|Death|1
7492282|NCT02157519|11808876|FG000|Overall Study|Withdrawal by Subject|7
7492283|NCT02157519|11808877|FG001|Overall Study|Withdrawal by Subject|0
7492284|NCT02157519|11808876|FG000|Overall Study|Lost to Follow-up|1
7492285|NCT02157519|11808877|FG001|Overall Study|Lost to Follow-up|0
7492286|NCT02157779|11808895|FG000|Overall Study|Logistical|9
7492287|NCT02157779|11808896|FG001|Overall Study|Logistical|3
7492288|NCT02157779|11808895|FG000|Overall Study|Stopped attending, reason unknown|11
7492289|NCT02157779|11808896|FG001|Overall Study|Stopped attending, reason unknown|7
7492290|NCT02157779|11808895|FG000|Overall Study|No response to outreach after Baseline|1
7492291|NCT02157779|11808896|FG001|Overall Study|No response to outreach after Baseline|1
7492292|NCT02157779|11808895|FG000|Overall Study|Moved|1
7492293|NCT02157779|11808896|FG001|Overall Study|Moved|0
7492294|NCT02157779|11808895|FG000|Overall Study|Medical|1
7492295|NCT02157779|11808896|FG001|Overall Study|Medical|0
7492296|NCT02157779|11808895|FG000|Overall Study|Legal issue|1
7492297|NCT02157779|11808896|FG001|Overall Study|Legal issue|0
7492298|NCT02157935|11808917|FG000|Overall Study|Withdrawal by Subject|25
7492299|NCT02157935|11808918|FG001|Overall Study|Withdrawal by Subject|39
7492300|NCT02157935|11808917|FG000|Overall Study|Screen failure|1
7492301|NCT02157935|11808918|FG001|Overall Study|Screen failure|2
7492302|NCT02157935|11808917|FG000|Overall Study|Protocol Violation|1
7492303|NCT02157935|11808918|FG001|Overall Study|Protocol Violation|0
7492304|NCT02157935|11808917|FG000|Overall Study|Progressive disease|0
7492305|NCT02157935|11808918|FG001|Overall Study|Progressive disease|2
7492306|NCT02157935|11808917|FG000|Overall Study|Other|5
7492307|NCT02157935|11808918|FG001|Overall Study|Other|12
7492308|NCT02157935|11808917|FG000|Overall Study|Lack of Efficacy|0
7492309|NCT02157935|11808918|FG001|Overall Study|Lack of Efficacy|1
7492310|NCT02157935|11808917|FG000|Overall Study|Death|4
7492311|NCT02157935|11808918|FG001|Overall Study|Death|4
7492312|NCT02157935|11808917|FG000|Overall Study|Adverse Event|3
7492313|NCT02157935|11808918|FG001|Overall Study|Adverse Event|5
7492314|NCT02157948|11808926|FG000|Overall Study|Withdrawal by Subject|4
7492315|NCT02157948|11808927|FG001|Overall Study|Withdrawal by Subject|5
7492316|NCT02157948|11808926|FG000|Overall Study|Lost to Follow-up|3
7492317|NCT02157948|11808927|FG001|Overall Study|Lost to Follow-up|2
7492318|NCT02157948|11808926|FG000|Overall Study|Protocol Specified Criteria|2
7492319|NCT02157948|11808927|FG001|Overall Study|Protocol Specified Criteria|1
7492320|NCT02157948|11808926|FG000|Overall Study|Decision by Sponsor|0
7492321|NCT02157948|11808927|FG001|Overall Study|Decision by Sponsor|1
7492322|NCT02158039|11808933|FG000|Overall Study|Withdrawal by Subject|1
7492323|NCT02158039|11808933|FG000|Overall Study|Screen Failure|9
7492324|NCT02158247|11808939|FG000|Overall Study|Invisible vocal cords|5
7492325|NCT02158364|11808964|FG000|Overall Study|Case report forms uncollected|10
7492326|NCT02158364|11808964|FG000|Overall Study|Protocol Deviation|50
7492327|NCT02158442|11808970|FG000|Overall Study|Withdrawal by Subject|1
7492328|NCT02158442|11808971|FG001|Overall Study|Withdrawal by Subject|0
7492329|NCT02158442|11808970|FG000|Overall Study|Perfusion staff not available|1
7492330|NCT02158442|11808971|FG001|Overall Study|Perfusion staff not available|0
7535187|NCT02708524|11882889|FG001|Overall Study|Adverse Event|1
7535188|NCT02708524|11882890|FG002|Overall Study|Adverse Event|0
7535189|NCT02708524|11882891|FG003|Overall Study|Adverse Event|0
7535190|NCT02708524|11882888|FG000|Overall Study|Lens Discomfort|1
7492331|NCT02158533|11809005|FG000|Stage 1|Adverse Event|6
7492332|NCT02158533|11809006|FG001|Stage 1|Adverse Event|4
7492333|NCT02158533|11809007|FG002|Stage 1|Adverse Event|7
7492334|NCT02158533|11809008|FG003|Stage 1|Adverse Event|0
7492335|NCT02158533|11809009|FG004|Stage 1|Adverse Event|0
7492336|NCT02158533|11809010|FG005|Stage 1|Adverse Event|0
7492337|NCT02158533|11809005|FG000|Stage 1|Withdrawal by Subject|3
7492338|NCT02158533|11809006|FG001|Stage 1|Withdrawal by Subject|2
7492339|NCT02158533|11809007|FG002|Stage 1|Withdrawal by Subject|1
7492340|NCT02158533|11809008|FG003|Stage 1|Withdrawal by Subject|0
7492341|NCT02158533|11809009|FG004|Stage 1|Withdrawal by Subject|0
7492342|NCT02158533|11809010|FG005|Stage 1|Withdrawal by Subject|0
7492343|NCT02158533|11809005|FG000|Stage 1|Lack of Efficacy|1
7492344|NCT02158533|11809006|FG001|Stage 1|Lack of Efficacy|0
7492345|NCT02158533|11809007|FG002|Stage 1|Lack of Efficacy|0
7492346|NCT02158533|11809008|FG003|Stage 1|Lack of Efficacy|0
7492347|NCT02158533|11809009|FG004|Stage 1|Lack of Efficacy|0
7492348|NCT02158533|11809010|FG005|Stage 1|Lack of Efficacy|0
7492349|NCT02158533|11809005|FG000|Stage 1|Lost to Follow-up|3
7492350|NCT02158533|11809006|FG001|Stage 1|Lost to Follow-up|1
7492351|NCT02158533|11809007|FG002|Stage 1|Lost to Follow-up|0
7492352|NCT02158533|11809008|FG003|Stage 1|Lost to Follow-up|0
7492353|NCT02158533|11809009|FG004|Stage 1|Lost to Follow-up|0
7492354|NCT02158533|11809010|FG005|Stage 1|Lost to Follow-up|0
7492355|NCT02158533|11809005|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
7492356|NCT02158533|11809006|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
7492357|NCT02158533|11809007|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
7492358|NCT02158533|11809008|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
7492359|NCT02158533|11809009|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
7492360|NCT02158533|11809010|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
7492361|NCT02158533|11809005|FG000|Stage 1|Non-compliance with study visits|1
7492362|NCT02158533|11809006|FG001|Stage 1|Non-compliance with study visits|0
7492363|NCT02158533|11809007|FG002|Stage 1|Non-compliance with study visits|0
7492364|NCT02158533|11809008|FG003|Stage 1|Non-compliance with study visits|0
7492365|NCT02158533|11809009|FG004|Stage 1|Non-compliance with study visits|0
7492366|NCT02158533|11809010|FG005|Stage 1|Non-compliance with study visits|0
7492367|NCT02158533|11809005|FG000|Stage 2|Adverse Event|0
7492368|NCT02158533|11809006|FG001|Stage 2|Adverse Event|0
7492369|NCT02158533|11809007|FG002|Stage 2|Adverse Event|0
7492370|NCT02158533|11809008|FG003|Stage 2|Adverse Event|0
7492371|NCT02158533|11809009|FG004|Stage 2|Adverse Event|0
7492372|NCT02158533|11809010|FG005|Stage 2|Adverse Event|1
7492373|NCT02158533|11809005|FG000|Stage 2|Lack of Efficacy|0
7492374|NCT02158533|11809006|FG001|Stage 2|Lack of Efficacy|0
7492375|NCT02158533|11809007|FG002|Stage 2|Lack of Efficacy|0
7492376|NCT02158533|11809008|FG003|Stage 2|Lack of Efficacy|0
7492377|NCT02158533|11809009|FG004|Stage 2|Lack of Efficacy|1
7492378|NCT02158533|11809010|FG005|Stage 2|Lack of Efficacy|0
7492379|NCT02158533|11809005|FG000|Stage 2|Lost to Follow-up|0
7492380|NCT02158533|11809006|FG001|Stage 2|Lost to Follow-up|0
7492381|NCT02158533|11809007|FG002|Stage 2|Lost to Follow-up|0
7492382|NCT02158533|11809008|FG003|Stage 2|Lost to Follow-up|1
7492383|NCT02158533|11809009|FG004|Stage 2|Lost to Follow-up|1
7492384|NCT02158533|11809010|FG005|Stage 2|Lost to Follow-up|2
7492385|NCT02158533|11809005|FG000|Stage 2|Withdrawal by Subject|0
7492386|NCT02158533|11809006|FG001|Stage 2|Withdrawal by Subject|0
7492387|NCT02158533|11809007|FG002|Stage 2|Withdrawal by Subject|0
7492388|NCT02158533|11809008|FG003|Stage 2|Withdrawal by Subject|0
7492389|NCT02158533|11809009|FG004|Stage 2|Withdrawal by Subject|1
7492390|NCT02158533|11809010|FG005|Stage 2|Withdrawal by Subject|2
7492391|NCT02158533|11809005|FG000|Stage 2|Physician Decision|0
7492392|NCT02158533|11809006|FG001|Stage 2|Physician Decision|0
7492393|NCT02158533|11809007|FG002|Stage 2|Physician Decision|0
7492394|NCT02158533|11809008|FG003|Stage 2|Physician Decision|0
7492395|NCT02158533|11809009|FG004|Stage 2|Physician Decision|1
7492396|NCT02158533|11809010|FG005|Stage 2|Physician Decision|0
7492397|NCT02158533|11809005|FG000|Stage 2|Pregnancy|0
7492398|NCT02158533|11809006|FG001|Stage 2|Pregnancy|0
7492399|NCT02158533|11809007|FG002|Stage 2|Pregnancy|0
7492400|NCT02158533|11809008|FG003|Stage 2|Pregnancy|1
7492401|NCT02158533|11809009|FG004|Stage 2|Pregnancy|0
7492402|NCT02158533|11809010|FG005|Stage 2|Pregnancy|0
7492403|NCT02158533|11809005|FG000|Stage 2|Psychiatrist decision to try new tx|0
7492404|NCT02158533|11809006|FG001|Stage 2|Psychiatrist decision to try new tx|0
7492405|NCT02158533|11809007|FG002|Stage 2|Psychiatrist decision to try new tx|0
7492406|NCT02158533|11809008|FG003|Stage 2|Psychiatrist decision to try new tx|1
7492407|NCT02158533|11809009|FG004|Stage 2|Psychiatrist decision to try new tx|0
7492408|NCT02158533|11809010|FG005|Stage 2|Psychiatrist decision to try new tx|0
7492409|NCT02158533|11809005|FG000|Stage 2|Non-adherence with study visits|0
7492410|NCT02158533|11809006|FG001|Stage 2|Non-adherence with study visits|0
7492411|NCT02158533|11809007|FG002|Stage 2|Non-adherence with study visits|0
7492412|NCT02158533|11809008|FG003|Stage 2|Non-adherence with study visits|0
7492413|NCT02158533|11809009|FG004|Stage 2|Non-adherence with study visits|0
7492414|NCT02158533|11809010|FG005|Stage 2|Non-adherence with study visits|1
7492415|NCT02158546|11809028|FG000|Overall Study|Physician Decision|0
7492416|NCT02158546|11809029|FG001|Overall Study|Physician Decision|1
7492417|NCT02158546|11809030|FG002|Overall Study|Physician Decision|0
7492418|NCT02158546|11809031|FG003|Overall Study|Physician Decision|0
7492419|NCT02158546|11809028|FG000|Overall Study|Non-compliance|0
7492420|NCT02158546|11809029|FG001|Overall Study|Non-compliance|1
7492421|NCT02158546|11809030|FG002|Overall Study|Non-compliance|0
7492422|NCT02158546|11809031|FG003|Overall Study|Non-compliance|1
7492423|NCT02158546|11809028|FG000|Overall Study|Failure to meet eligibility criteria|0
7492424|NCT02158546|11809029|FG001|Overall Study|Failure to meet eligibility criteria|1
7492425|NCT02158546|11809030|FG002|Overall Study|Failure to meet eligibility criteria|0
7492426|NCT02158546|11809031|FG003|Overall Study|Failure to meet eligibility criteria|0
7492427|NCT02158546|11809028|FG000|Overall Study|Lack of Efficacy|1
7492428|NCT02158546|11809029|FG001|Overall Study|Lack of Efficacy|1
7492429|NCT02158546|11809030|FG002|Overall Study|Lack of Efficacy|0
7492430|NCT02158546|11809031|FG003|Overall Study|Lack of Efficacy|0
7492431|NCT02158546|11809028|FG000|Overall Study|Adverse Event|2
7492432|NCT02158546|11809029|FG001|Overall Study|Adverse Event|2
7492433|NCT02158546|11809030|FG002|Overall Study|Adverse Event|0
7492434|NCT02158546|11809031|FG003|Overall Study|Adverse Event|0
7492435|NCT02158546|11809028|FG000|Overall Study|Withdrawal by Subject|6
7492436|NCT02158546|11809029|FG001|Overall Study|Withdrawal by Subject|2
7492437|NCT02158546|11809030|FG002|Overall Study|Withdrawal by Subject|1
7492438|NCT02158546|11809031|FG003|Overall Study|Withdrawal by Subject|0
7492439|NCT02158546|11809028|FG000|Overall Study|Lost to Follow-up|5
7492440|NCT02158546|11809029|FG001|Overall Study|Lost to Follow-up|4
7492441|NCT02158546|11809030|FG002|Overall Study|Lost to Follow-up|0
7492442|NCT02158546|11809031|FG003|Overall Study|Lost to Follow-up|1
7492443|NCT02158546|11809028|FG000|Overall Study|Site Excluded|5
7492444|NCT02158546|11809029|FG001|Overall Study|Site Excluded|5
7492445|NCT02158546|11809030|FG002|Overall Study|Site Excluded|3
7492446|NCT02158546|11809031|FG003|Overall Study|Site Excluded|4
7492447|NCT02158663|11809047|FG000|Overall Study|Withdrawal by Subject|5
7492448|NCT02158663|11809048|FG001|Overall Study|Withdrawal by Subject|4
7492449|NCT02158728|11809056|FG000|Overall Study|no procedure according to CIP done|3
7492450|NCT02158728|11809056|FG000|Overall Study|no qualified dataset|24
7492451|NCT02158806|11809062|FG000|Overall Study|Death|2
7492452|NCT02158806|11809063|FG001|Overall Study|Death|0
7492453|NCT02158806|11809062|FG000|Overall Study|Withdrawal by Subject|2
7492454|NCT02158806|11809063|FG001|Overall Study|Withdrawal by Subject|0
7492455|NCT02158806|11809062|FG000|Overall Study|Lost to Follow-up|0
7492456|NCT02158806|11809063|FG001|Overall Study|Lost to Follow-up|3
7492457|NCT02158806|11809062|FG000|Overall Study|Moved out of area|0
7492458|NCT02158806|11809063|FG001|Overall Study|Moved out of area|1
7492459|NCT02158806|11809062|FG000|Overall Study|Transferred to palliative care|0
7492460|NCT02158806|11809063|FG001|Overall Study|Transferred to palliative care|1
7492461|NCT02158884|11809069|FG000|Baseline Assessment|Missed performance assessment|3
7492462|NCT02158884|11809069|FG000|Baseline Assessment|Missed SMFA|1
7492463|NCT02158884|11809069|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
7492464|NCT02158884|11809069|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
7492465|NCT02158884|11809069|FG000|6 Month Assessment|Missed SMFA|20
7492466|NCT02158884|11809069|FG000|12 Month Assessment|Missed SMFA|17
7492467|NCT02158936|11809076|FG000|Overall Study|Study closed/ terminated|57
7492468|NCT02158936|11809077|FG001|Overall Study|Study closed/ terminated|77
7492469|NCT02158936|11809076|FG000|Overall Study|Azacitidine tx discontinued|53
7492470|NCT02158936|11809077|FG001|Overall Study|Azacitidine tx discontinued|46
7492471|NCT02158936|11809076|FG000|Overall Study|Adverse Event|39
7492472|NCT02158936|11809077|FG001|Overall Study|Adverse Event|24
7492473|NCT02158936|11809076|FG000|Overall Study|Withdrawal by Subject|15
7492474|NCT02158936|11809077|FG001|Overall Study|Withdrawal by Subject|16
7492475|NCT02158936|11809076|FG000|Overall Study|Physician Decision|15
7492476|NCT02158936|11809077|FG001|Overall Study|Physician Decision|13
7492477|NCT02158936|11809076|FG000|Overall Study|Lost to Follow-up|0
7492478|NCT02158936|11809077|FG001|Overall Study|Lost to Follow-up|1
7492479|NCT02158949|11809085|FG000|Overall Study|Withdrawal by Subject|1
7492480|NCT02158949|11809086|FG001|Overall Study|Withdrawal by Subject|0
7492481|NCT02158949|11809085|FG000|Overall Study|Lost to Follow-up|5
7492482|NCT02158949|11809086|FG001|Overall Study|Lost to Follow-up|11
7492483|NCT02158975|11809092|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
7492484|NCT02159053|11809100|FG000|Overall Study|Death|2
7492485|NCT02159053|11809101|FG001|Overall Study|Death|0
7492486|NCT02159053|11809102|FG002|Overall Study|Death|1
7492487|NCT02159053|11809100|FG000|Overall Study|Physician Decision|0
7492488|NCT02159053|11809101|FG001|Overall Study|Physician Decision|1
7492489|NCT02159053|11809102|FG002|Overall Study|Physician Decision|1
7492490|NCT02159053|11809100|FG000|Overall Study|Lack of Efficacy|3
7492491|NCT02159053|11809101|FG001|Overall Study|Lack of Efficacy|4
7492492|NCT02159053|11809102|FG002|Overall Study|Lack of Efficacy|7
7492493|NCT02159053|11809100|FG000|Overall Study|Adverse Event|7
7492494|NCT02159053|11809101|FG001|Overall Study|Adverse Event|6
7492495|NCT02159053|11809102|FG002|Overall Study|Adverse Event|5
7492496|NCT02159053|11809100|FG000|Overall Study|Participants/guardian decision|8
7492497|NCT02159053|11809101|FG001|Overall Study|Participants/guardian decision|10
7492498|NCT02159053|11809102|FG002|Overall Study|Participants/guardian decision|6
7492499|NCT02159183|11809132|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
7492500|NCT02159183|11809133|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
7492501|NCT02159183|11809132|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
7492502|NCT02159183|11809133|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
7492503|NCT02159183|11809132|FG000|Analysis After the 36 Months Follow-up|Death|0
7492504|NCT02159183|11809133|FG001|Analysis After the 36 Months Follow-up|Death|1
7492505|NCT02159183|11809132|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
7492506|NCT02159183|11809133|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
7492507|NCT02159183|11809132|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
7492508|NCT02159183|11809133|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
7492509|NCT02159352|11809141|FG000|Overall Study|Adverse Event|3
7492510|NCT02159352|11809142|FG001|Overall Study|Adverse Event|1
7492511|NCT02159352|11809141|FG000|Overall Study|Withdrawal by Subject|0
7492512|NCT02159352|11809142|FG001|Overall Study|Withdrawal by Subject|1
7492513|NCT02159365|11809167|FG000|Overall Study|Disease Progression|23
7492514|NCT02159365|11809167|FG000|Overall Study|Other reasons|11
7492515|NCT02159365|11809167|FG000|Overall Study|Administrative reason by Sponsor|9
7492516|NCT02159365|11809167|FG000|Overall Study|Adverse Event unrelated to study drug|9
7492517|NCT02159365|11809167|FG000|Overall Study|Study drug toxicity|7
7492518|NCT02159365|11809167|FG000|Overall Study|Maximum clinical benefit|3
7492519|NCT02159365|11809167|FG000|Overall Study|Subject request to discontinue treatment|3
7492520|NCT02159365|11809167|FG000|Overall Study|Subject withdrew consent|3
7492521|NCT02159365|11809167|FG000|Overall Study|Death|1
7492522|NCT02159365|11809167|FG000|Overall Study|Lost to Follow-up|1
7492523|NCT02159469|11809171|FG000|Overall Study|Missing Completion status|1
7492524|NCT02159469|11809171|FG000|Overall Study|Adverse Event|5
7492525|NCT02159469|11809171|FG000|Overall Study|Non-compliance|2
7492526|NCT02159469|11809171|FG000|Overall Study|Withdrawal by Subject|9
7492527|NCT02159469|11809171|FG000|Overall Study|Lost to Follow-up|1
7492528|NCT02159469|11809171|FG000|Overall Study|Sponsor's request|2
7492529|NCT02159469|11809171|FG000|Overall Study|Met Stopping Criteria|3
7492530|NCT02159469|11809171|FG000|Overall Study|Other|1
7492531|NCT02159469|11809171|FG000|Overall Study|Multiple|29
7492532|NCT02159482|11809176|FG000|Overall Study|Withdrawal by Subject|2
7492533|NCT02159482|11809176|FG000|Overall Study|Physician Decision|3
7492534|NCT02159521|11809180|FG000|Overall Study|Enrolled but not treated|3
7492535|NCT02159521|11809180|FG000|Overall Study|Withdrawal by Subject|7
7492536|NCT02159521|11809180|FG000|Overall Study|Lost to Follow-up|6
7492537|NCT02159521|11809180|FG000|Overall Study|Death|1
7492538|NCT02159521|11809180|FG000|Overall Study|Other than specified|1
7492539|NCT02159729|11809200|FG000|Overall Study|Adverse Event|0
7492540|NCT02159729|11809201|FG001|Overall Study|Adverse Event|1
7492541|NCT02159729|11809200|FG000|Overall Study|Subject's Request|13
7492542|NCT02159729|11809201|FG001|Overall Study|Subject's Request|10
7492543|NCT02159729|11809200|FG000|Overall Study|Lost to Follow-up|24
7492544|NCT02159729|11809201|FG001|Overall Study|Lost to Follow-up|9
7492545|NCT02159729|11809200|FG000|Overall Study|Non compliance|2
7492546|NCT02159729|11809201|FG001|Overall Study|Non compliance|0
7492547|NCT02159729|11809200|FG000|Overall Study|Other Unspecified|3
7492548|NCT02159729|11809201|FG001|Overall Study|Other Unspecified|1
7492549|NCT02159807|11809214|FG000|Overall Study|Adverse Event|0
7492550|NCT02159807|11809215|FG001|Overall Study|Adverse Event|0
7492551|NCT02159807|11809216|FG002|Overall Study|Adverse Event|1
7492552|NCT02159807|11809214|FG000|Overall Study|No CSF|1
7492553|NCT02159807|11809215|FG001|Overall Study|No CSF|1
7492554|NCT02159807|11809216|FG002|Overall Study|No CSF|1
7492555|NCT02159807|11809214|FG000|Overall Study|elevated blood pressure|0
7492556|NCT02159807|11809215|FG001|Overall Study|elevated blood pressure|0
7492557|NCT02159807|11809216|FG002|Overall Study|elevated blood pressure|1
7492558|NCT02159950|11809245|FG000|Overall Study|Adverse Event|0
7492559|NCT02159950|11809246|FG001|Overall Study|Adverse Event|1
7492560|NCT02159950|11809245|FG000|Overall Study|Progression|0
7492561|NCT02159950|11809246|FG001|Overall Study|Progression|1
7492562|NCT02160002|11809265|FG000|Overall Study|Withdrawal by Subject|2
7492563|NCT02160002|11809266|FG001|Overall Study|Withdrawal by Subject|1
7492564|NCT02160041|11809272|FG000|Overall Study|Adverse Event|11
7492565|NCT02160041|11809272|FG000|Overall Study|Death|2
7492566|NCT02160041|11809272|FG000|Overall Study|disease progression|57
7492567|NCT02160041|11809272|FG000|Overall Study|Protocol Violation|1
7492568|NCT02160041|11809272|FG000|Overall Study|non-compliance with study|1
7492569|NCT02160041|11809272|FG000|Overall Study|Physician Decision|3
7492570|NCT02160041|11809272|FG000|Overall Study|Withdrawal by Subject|8
7492571|NCT02160041|11809272|FG000|Overall Study|study terminated by by sponsor|1
7492572|NCT02160145|11809278|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
7492573|NCT02160145|11809279|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
7492574|NCT02160145|11809280|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
7492575|NCT02160145|11809278|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
7492576|NCT02160145|11809279|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7492577|NCT02160145|11809280|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
7492578|NCT02160145|11809278|FG000|Randomized Double-blind Period|Subject decision|0
7492579|NCT02160145|11809279|FG001|Randomized Double-blind Period|Subject decision|21
7492580|NCT02160145|11809280|FG002|Randomized Double-blind Period|Subject decision|20
7492581|NCT02160145|11809278|FG000|Randomized Double-blind Period|Lost to Follow-up|0
7492582|NCT02160145|11809279|FG001|Randomized Double-blind Period|Lost to Follow-up|1
7492583|NCT02160145|11809280|FG002|Randomized Double-blind Period|Lost to Follow-up|3
7492584|NCT02160145|11809278|FG000|Randomized Double-blind Period|Physician Decision|0
7492585|NCT02160145|11809279|FG001|Randomized Double-blind Period|Physician Decision|7
7492586|NCT02160145|11809280|FG002|Randomized Double-blind Period|Physician Decision|5
7492587|NCT02160314|11809298|FG000|Overall Study|Adverse Event|0
7492588|NCT02160314|11809299|FG001|Overall Study|Adverse Event|6
7492589|NCT02160314|11809298|FG000|Overall Study|Protocol Violation|0
7492590|NCT02160314|11809299|FG001|Overall Study|Protocol Violation|4
7492591|NCT02160314|11809298|FG000|Overall Study|Withdrawal by Subject|1
7492592|NCT02160314|11809299|FG001|Overall Study|Withdrawal by Subject|2
7492593|NCT02160314|11809298|FG000|Overall Study|Lost to Follow-up|0
7492594|NCT02160314|11809299|FG001|Overall Study|Lost to Follow-up|1
7492595|NCT02160626|11809312|FG000|Overall Study|Adverse Event|1
7492596|NCT02160626|11809313|FG001|Overall Study|Adverse Event|0
7492597|NCT02160626|11809314|FG002|Overall Study|Adverse Event|0
7492598|NCT02160626|11809312|FG000|Overall Study|Schedule not conducive to study visits|0
7492599|NCT02160626|11809313|FG001|Overall Study|Schedule not conducive to study visits|0
7492600|NCT02160626|11809314|FG002|Overall Study|Schedule not conducive to study visits|1
7492601|NCT02160626|11809312|FG000|Overall Study|Withdrawal by Subject|0
7492602|NCT02160626|11809313|FG001|Overall Study|Withdrawal by Subject|1
7492603|NCT02160626|11809314|FG002|Overall Study|Withdrawal by Subject|0
7492604|NCT02160782|11809329|FG000|Open-label Period: Maralixibat|Adverse Event|2
7492605|NCT02160782|11809330|FG001|Open-label Period: Maralixibat|Adverse Event|0
7492606|NCT02160782|11809331|FG002|Open-label Period: Maralixibat|Adverse Event|0
7492607|NCT02160782|11809332|FG003|Open-label Period: Maralixibat|Adverse Event|0
7492608|NCT02160782|11809333|FG004|Open-label Period: Maralixibat|Adverse Event|0
7492609|NCT02160782|11809329|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7492610|NCT02160782|11809330|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7492611|NCT02160782|11809331|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7492612|NCT02160782|11809332|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
7492613|NCT02160782|11809333|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
7492614|NCT02160782|11809329|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7492615|NCT02160782|11809330|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7492616|NCT02160782|11809331|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7492617|NCT02160782|11809332|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
7492618|NCT02160782|11809333|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
7492619|NCT02160782|11809329|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7492620|NCT02160782|11809330|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7492621|NCT02160782|11809331|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7492622|NCT02160782|11809332|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
7492623|NCT02160782|11809333|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
7492624|NCT02160782|11809329|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
7492625|NCT02160782|11809330|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
7492626|NCT02160782|11809331|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
7492627|NCT02160782|11809332|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
7492628|NCT02160782|11809333|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
7492629|NCT02160782|11809329|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
7492630|NCT02160782|11809330|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
7492631|NCT02160782|11809331|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
7492632|NCT02160782|11809332|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
7492633|NCT02160782|11809333|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
7492634|NCT02160782|11809329|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7492635|NCT02160782|11809330|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7492636|NCT02160782|11809331|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7492637|NCT02160782|11809332|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
7492638|NCT02160782|11809333|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
7492639|NCT02160899|11809396|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7492640|NCT02160899|11809397|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7492641|NCT02160899|11809398|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
7492642|NCT02160899|11809399|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
7492643|NCT02160899|11809400|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
7492644|NCT02160899|11809401|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
7492645|NCT02160977|11809417|FG000|Six Weeks After Surgery|Lost to Follow-up|1
7492646|NCT02160977|11809418|FG001|Six Weeks After Surgery|Lost to Follow-up|0
7492647|NCT02160977|11809417|FG000|Three Months After Surgery|Lost to Follow-up|0
7492648|NCT02160977|11809418|FG001|Three Months After Surgery|Lost to Follow-up|2
7492649|NCT02160977|11809417|FG000|Six Months After Surgery|Lost to Follow-up|2
7492650|NCT02160977|11809418|FG001|Six Months After Surgery|Lost to Follow-up|1
7492651|NCT02161146|11809447|FG000|Overall Study|Adverse Event|1
7492652|NCT02161146|11809448|FG001|Overall Study|Adverse Event|1
7492653|NCT02161146|11809449|FG002|Overall Study|Adverse Event|0
7492654|NCT02161146|11809450|FG003|Overall Study|Adverse Event|1
7492655|NCT02161146|11809451|FG004|Overall Study|Adverse Event|0
7492656|NCT02161146|11809447|FG000|Overall Study|Lost to Follow-up|0
7492657|NCT02161146|11809448|FG001|Overall Study|Lost to Follow-up|1
7492658|NCT02161146|11809449|FG002|Overall Study|Lost to Follow-up|0
7492659|NCT02161146|11809450|FG003|Overall Study|Lost to Follow-up|0
7492660|NCT02161146|11809451|FG004|Overall Study|Lost to Follow-up|0
7492661|NCT02161146|11809447|FG000|Overall Study|Personal Reasons|0
7492662|NCT02161146|11809448|FG001|Overall Study|Personal Reasons|1
7492663|NCT02161146|11809449|FG002|Overall Study|Personal Reasons|0
7492664|NCT02161146|11809450|FG003|Overall Study|Personal Reasons|2
7492665|NCT02161146|11809451|FG004|Overall Study|Personal Reasons|1
7492666|NCT02161146|11809447|FG000|Overall Study|Other Miscellaneous Reasons|0
7492667|NCT02161146|11809448|FG001|Overall Study|Other Miscellaneous Reasons|1
7492668|NCT02161146|11809449|FG002|Overall Study|Other Miscellaneous Reasons|0
7492669|NCT02161146|11809450|FG003|Overall Study|Other Miscellaneous Reasons|0
7492670|NCT02161146|11809451|FG004|Overall Study|Other Miscellaneous Reasons|0
7492671|NCT02161185|11809461|FG000|Treatment Phase|Administrative/Other|7
7492672|NCT02161406|11809467|FG000|Overall Study|Death|2
7492673|NCT02161406|11809468|FG001|Overall Study|Death|1
7492674|NCT02161406|11809467|FG000|Overall Study|Lost to Follow-up|2
7492675|NCT02161406|11809468|FG001|Overall Study|Lost to Follow-up|1
7492676|NCT02161406|11809467|FG000|Overall Study|Withdrawal by Subject|2
7492677|NCT02161406|11809468|FG001|Overall Study|Withdrawal by Subject|4
7492678|NCT02161406|11809467|FG000|Overall Study|investigator withdrew subject|3
7492679|NCT02161406|11809468|FG001|Overall Study|investigator withdrew subject|1
7492680|NCT02161406|11809467|FG000|Overall Study|Lack of Efficacy|1
7492681|NCT02161406|11809468|FG001|Overall Study|Lack of Efficacy|1
7492682|NCT02161406|11809467|FG000|Overall Study|relocation|0
7492683|NCT02161406|11809468|FG001|Overall Study|relocation|1
7492684|NCT02161458|11809478|FG000|Overall Study|Withdrawal by Subject|0
7492685|NCT02161458|11809479|FG001|Overall Study|Withdrawal by Subject|4
7492686|NCT02161458|11809480|FG002|Overall Study|Withdrawal by Subject|4
7492687|NCT02161458|11809481|FG003|Overall Study|Withdrawal by Subject|0
7492688|NCT02161458|11809478|FG000|Overall Study|Lost to Follow-up|0
7492689|NCT02161458|11809479|FG001|Overall Study|Lost to Follow-up|2
7492690|NCT02161458|11809480|FG002|Overall Study|Lost to Follow-up|1
7492691|NCT02161458|11809481|FG003|Overall Study|Lost to Follow-up|0
7492692|NCT02161549|11809515|FG000|Overall Study|Physician Decision|6
7492693|NCT02161549|11809516|FG001|Overall Study|Physician Decision|2
7492694|NCT02161562|11809524|FG000|Overall Study|Withdrawal by Subject|5
7492695|NCT02161562|11809525|FG001|Overall Study|Withdrawal by Subject|8
7492696|NCT02161562|11809524|FG000|Overall Study|Protocol Violation|9
7492697|NCT02161562|11809525|FG001|Overall Study|Protocol Violation|4
7492698|NCT02161562|11809524|FG000|Overall Study|Pregnancy|1
7492699|NCT02161562|11809525|FG001|Overall Study|Pregnancy|2
7492700|NCT02161562|11809524|FG000|Overall Study|Lost to Follow-up|3
7492701|NCT02161562|11809525|FG001|Overall Study|Lost to Follow-up|1
7492702|NCT02161562|11809524|FG000|Overall Study|Lack of Efficacy|4
7492703|NCT02161562|11809525|FG001|Overall Study|Lack of Efficacy|1
7492704|NCT02161562|11809524|FG000|Overall Study|Adverse Event|1
7492705|NCT02161562|11809525|FG001|Overall Study|Adverse Event|1
7492706|NCT02161562|11809524|FG000|Overall Study|Participant moved back to home country|1
7492707|NCT02161562|11809525|FG001|Overall Study|Participant moved back to home country|0
7492708|NCT02161562|11809524|FG000|Overall Study|Withdrew due to being out of the country|1
7492709|NCT02161562|11809525|FG001|Overall Study|Withdrew due to being out of the country|0
7492710|NCT02161562|11809524|FG000|Overall Study|Participant moved out of province|1
7492711|NCT02161562|11809525|FG001|Overall Study|Participant moved out of province|0
7492712|NCT02161575|11809544|FG000|Overall Study|Protocol Violation|8
7492713|NCT02161575|11809544|FG000|Overall Study|Lack of Efficacy|1
7492714|NCT02161575|11809544|FG000|Overall Study|Adverse Event|2
7492715|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
7492716|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
7492717|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
7492718|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
7492719|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
7492720|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
7492721|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
7492722|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7492723|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
7492724|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
7492725|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7492726|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
7492727|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
7492728|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
7492729|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
7492730|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
7492731|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7492732|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
7492733|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
7492734|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7492735|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
7492736|NCT02161718|11809559|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
7492737|NCT02161718|11809560|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7492738|NCT02161718|11809561|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
7492739|NCT02161718|11809559|FG000|Post- Randomization Period|Withdrawal by Subject|0
7492740|NCT02161718|11809560|FG001|Post- Randomization Period|Withdrawal by Subject|23
7492741|NCT02161718|11809561|FG002|Post- Randomization Period|Withdrawal by Subject|18
7492742|NCT02161718|11809559|FG000|Post- Randomization Period|Lost to Follow-up|0
7492743|NCT02161718|11809560|FG001|Post- Randomization Period|Lost to Follow-up|9
7492744|NCT02161718|11809561|FG002|Post- Randomization Period|Lost to Follow-up|15
7492745|NCT02161718|11809559|FG000|Post- Randomization Period|Adverse Event|0
7492746|NCT02161718|11809560|FG001|Post- Randomization Period|Adverse Event|9
7492747|NCT02161718|11809561|FG002|Post- Randomization Period|Adverse Event|10
7492748|NCT02161718|11809559|FG000|Post- Randomization Period|Non- compliance with study drug|0
7492749|NCT02161718|11809560|FG001|Post- Randomization Period|Non- compliance with study drug|8
7492750|NCT02161718|11809561|FG002|Post- Randomization Period|Non- compliance with study drug|2
7492751|NCT02161718|11809559|FG000|Post- Randomization Period|Physician Decision|0
7492752|NCT02161718|11809560|FG001|Post- Randomization Period|Physician Decision|2
7492753|NCT02161718|11809561|FG002|Post- Randomization Period|Physician Decision|4
7492754|NCT02161718|11809559|FG000|Post- Randomization Period|Protocol Violation|0
7492755|NCT02161718|11809560|FG001|Post- Randomization Period|Protocol Violation|2
7492756|NCT02161718|11809561|FG002|Post- Randomization Period|Protocol Violation|3
7492757|NCT02161718|11809559|FG000|Post- Randomization Period|Lack of Efficacy|0
7492758|NCT02161718|11809560|FG001|Post- Randomization Period|Lack of Efficacy|0
7492759|NCT02161718|11809561|FG002|Post- Randomization Period|Lack of Efficacy|1
7492760|NCT02161718|11809559|FG000|Post- Randomization Period|Non-compliance with study procedures|0
7492761|NCT02161718|11809560|FG001|Post- Randomization Period|Non-compliance with study procedures|2
7492762|NCT02161718|11809561|FG002|Post- Randomization Period|Non-compliance with study procedures|4
7492763|NCT02161718|11809559|FG000|Post- Randomization Period|Received prohibitive treatment|0
7492764|NCT02161718|11809560|FG001|Post- Randomization Period|Received prohibitive treatment|1
7492765|NCT02161718|11809561|FG002|Post- Randomization Period|Received prohibitive treatment|2
7492766|NCT02161718|11809559|FG000|Post- Randomization Period|Relocation|0
7492767|NCT02161718|11809560|FG001|Post- Randomization Period|Relocation|3
7492768|NCT02161718|11809561|FG002|Post- Randomization Period|Relocation|0
7492769|NCT02161731|11809568|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
7492770|NCT02161731|11809569|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
7492771|NCT02161731|11809568|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
7492772|NCT02161731|11809569|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
7492773|NCT02161757|11809579|FG000|Randomised Through Start Treatment|Did not receive treatment|3
7492774|NCT02161757|11809580|FG001|Randomised Through Start Treatment|Did not receive treatment|2
7492775|NCT02161757|11809581|FG002|Randomised Through Start Treatment|Did not receive treatment|0
7492776|NCT02161757|11809579|FG000|Treatment Through Study Completion|Adverse Event|1
7492777|NCT02161757|11809580|FG001|Treatment Through Study Completion|Adverse Event|1
7492778|NCT02161757|11809581|FG002|Treatment Through Study Completion|Adverse Event|0
7492779|NCT02161757|11809579|FG000|Treatment Through Study Completion|Protocol Violation|0
7492780|NCT02161757|11809580|FG001|Treatment Through Study Completion|Protocol Violation|1
7492781|NCT02161757|11809581|FG002|Treatment Through Study Completion|Protocol Violation|2
7492782|NCT02161757|11809579|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
7492783|NCT02161757|11809580|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
7492784|NCT02161757|11809581|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
7492785|NCT02161757|11809579|FG000|Treatment Through Study Completion|Lost to Follow-up|7
7492786|NCT02161757|11809580|FG001|Treatment Through Study Completion|Lost to Follow-up|2
7492787|NCT02161757|11809581|FG002|Treatment Through Study Completion|Lost to Follow-up|4
7492788|NCT02161757|11809579|FG000|Treatment Through Study Completion|Other|20
7492789|NCT02161757|11809580|FG001|Treatment Through Study Completion|Other|19
7492790|NCT02161757|11809581|FG002|Treatment Through Study Completion|Other|12
7492791|NCT02161757|11809579|FG000|Treatment Through Study Completion|Death|2
7492792|NCT02161757|11809580|FG001|Treatment Through Study Completion|Death|1
7492793|NCT02161757|11809581|FG002|Treatment Through Study Completion|Death|1
7492794|NCT02162719|11809648|FG000|Overall Study|Death|41
7492795|NCT02162719|11809649|FG001|Overall Study|Death|46
7492796|NCT02162719|11809648|FG000|Overall Study|Lost to Follow-up|1
7492797|NCT02162719|11809649|FG001|Overall Study|Lost to Follow-up|3
7492798|NCT02162719|11809648|FG000|Overall Study|Disease Progression|2
7492799|NCT02162719|11809649|FG001|Overall Study|Disease Progression|1
7492800|NCT02162719|11809648|FG000|Overall Study|Withdrawal by Subject|8
7492801|NCT02162719|11809649|FG001|Overall Study|Withdrawal by Subject|2
7492802|NCT02162719|11809648|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
7492803|NCT02162719|11809649|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
7492804|NCT02162758|11809657|FG000|Overall Study|Study termination|0
7492805|NCT02162758|11809658|FG001|Overall Study|Study termination|1
7492806|NCT02162771|11809666|FG000|Core Study Period (Part 2)|Progressive Disease|2
7492807|NCT02162771|11809667|FG001|Core Study Period (Part 2)|Progressive Disease|3
7492808|NCT02162771|11809666|FG000|Core Study Period (Part 2)|Adverse Event|4
7492809|NCT02162771|11809667|FG001|Core Study Period (Part 2)|Adverse Event|1
7492810|NCT02162771|11809666|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
7492811|NCT02162771|11809667|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
7492812|NCT02162771|11809666|FG000|Core Study Period (Part 2)|Physician Decision|0
7492813|NCT02162771|11809667|FG001|Core Study Period (Part 2)|Physician Decision|2
7492814|NCT02162771|11809666|FG000|Core Study Period (Part 2)|Death|1
7492815|NCT02162771|11809667|FG001|Core Study Period (Part 2)|Death|0
7492816|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
7492817|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
7492818|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
7492819|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
7492820|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Death|2
7492821|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Death|1
7492822|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
7492823|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
7492824|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
7492825|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
7492826|NCT02162771|11809666|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
7492827|NCT02162771|11809667|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
7492828|NCT02162862|11809676|FG000|Overall Study|Lost to Follow-up|0
7492829|NCT02162862|11809677|FG001|Overall Study|Lost to Follow-up|11
7492830|NCT02162862|11809678|FG002|Overall Study|Lost to Follow-up|0
7492831|NCT02162862|11809676|FG000|Overall Study|Subject did not feel the med was needed|0
7492832|NCT02162862|11809677|FG001|Overall Study|Subject did not feel the med was needed|0
7492833|NCT02162862|11809678|FG002|Overall Study|Subject did not feel the med was needed|4
7492834|NCT02163057|11809699|FG000|Overall Study|Participant Refusal to Continue|2
7492835|NCT02163057|11809700|FG001|Overall Study|Participant Refusal to Continue|2
7492836|NCT02163057|11809699|FG000|Overall Study|Participant Significant Noncompliance|0
7492837|NCT02163057|11809700|FG001|Overall Study|Participant Significant Noncompliance|1
7492838|NCT02163057|11809699|FG000|Overall Study|Progression of Disease|1
7492839|NCT02163057|11809700|FG001|Overall Study|Progression of Disease|2
7492840|NCT02163226|11809710|FG000|Overall Study|Death|2
7492841|NCT02163226|11809711|FG001|Overall Study|Death|1
7492842|NCT02163226|11809710|FG000|Overall Study|Withdrawal by Subject|5
7492843|NCT02163226|11809711|FG001|Overall Study|Withdrawal by Subject|2
7492844|NCT02163226|11809710|FG000|Overall Study|Returned home, local radiotherapy|3
7492845|NCT02163226|11809711|FG001|Overall Study|Returned home, local radiotherapy|0
7492846|NCT02163226|11809710|FG000|Overall Study|Repeat imaging showed no disease|2
7492847|NCT02163226|11809711|FG001|Overall Study|Repeat imaging showed no disease|0
7492848|NCT02163226|11809710|FG000|Overall Study|Incomplete radiotherapy|3
7492849|NCT02163226|11809711|FG001|Overall Study|Incomplete radiotherapy|0
7492850|NCT02163226|11809710|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
7492851|NCT02163226|11809711|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
7492852|NCT02163226|11809710|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
7492853|NCT02163226|11809711|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
7492854|NCT02163226|11809710|FG000|Overall Study|ineligible|0
7492855|NCT02163226|11809711|FG001|Overall Study|ineligible|3
7492856|NCT02163447|11809743|FG000|Overall Study|Withdrawal by Subject|2
7492857|NCT02163447|11809744|FG001|Overall Study|Withdrawal by Subject|0
7492858|NCT02163447|11809745|FG002|Overall Study|Withdrawal by Subject|1
7492859|NCT02163447|11809743|FG000|Overall Study|Lost to Follow-up|1
7492860|NCT02163447|11809744|FG001|Overall Study|Lost to Follow-up|3
7492861|NCT02163447|11809745|FG002|Overall Study|Lost to Follow-up|0
7492862|NCT02163447|11809743|FG000|Overall Study|Moved out of study area|2
7492863|NCT02163447|11809744|FG001|Overall Study|Moved out of study area|3
7492864|NCT02163447|11809745|FG002|Overall Study|Moved out of study area|2
7492865|NCT02163447|11809743|FG000|Overall Study|Became HIV infected at time of delivery|1
7492866|NCT02163447|11809744|FG001|Overall Study|Became HIV infected at time of delivery|0
7492867|NCT02163447|11809745|FG002|Overall Study|Became HIV infected at time of delivery|0
7492868|NCT02163499|11809772|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
7492869|NCT02163499|11809772|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
7492870|NCT02163499|11809772|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
7492871|NCT02163499|11809772|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
7492872|NCT02163499|11809772|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
7492873|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Adverse Event|51
7492874|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
7492875|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
7492876|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
7492877|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
7492878|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
7492879|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Physician Decision|8
7492880|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
7492881|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
7492882|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Death|8
7492883|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
7492884|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
7492885|NCT02163499|11809772|FG000|Extended Dosing Phase: ZS|Various reasons|16
7492886|NCT02163538|11809782|FG000|Overall Study|Protocol Violation|1
7492887|NCT02163538|11809783|FG001|Overall Study|Protocol Violation|0
7492888|NCT02163538|11809782|FG000|Overall Study|Physician Decision|0
7492889|NCT02163538|11809783|FG001|Overall Study|Physician Decision|1
7492890|NCT02163759|11809801|FG000|Overall Study|Withdrawal by Subject|1
7492891|NCT02163759|11809802|FG001|Overall Study|Withdrawal by Subject|5
7492892|NCT02163759|11809803|FG002|Overall Study|Withdrawal by Subject|1
7492893|NCT02163759|11809801|FG000|Overall Study|Adverse Event|0
7492894|NCT02163759|11809802|FG001|Overall Study|Adverse Event|0
7492895|NCT02163759|11809803|FG002|Overall Study|Adverse Event|1
7492896|NCT02163759|11809801|FG000|Overall Study|Death|0
7492897|NCT02163759|11809802|FG001|Overall Study|Death|0
7492898|NCT02163759|11809803|FG002|Overall Study|Death|1
7492899|NCT02163902|11809842|FG000|Overall Study|Subject's Request|3
7492900|NCT02163902|11809843|FG001|Overall Study|Subject's Request|4
7492901|NCT02163902|11809842|FG000|Overall Study|Lost to Follow-up|6
7492902|NCT02163902|11809843|FG001|Overall Study|Lost to Follow-up|7
7492903|NCT02163902|11809842|FG000|Overall Study|Administrative Decision|2
7492904|NCT02163902|11809843|FG001|Overall Study|Administrative Decision|2
7492905|NCT02163915|11809854|FG000|Overall Study|Withdrawal by Subject|2
7492906|NCT02163915|11809855|FG001|Overall Study|Withdrawal by Subject|0
7492907|NCT02163915|11809856|FG002|Overall Study|Withdrawal by Subject|2
7492908|NCT02163915|11809857|FG003|Overall Study|Withdrawal by Subject|2
7492909|NCT02163915|11809858|FG004|Overall Study|Withdrawal by Subject|2
7492910|NCT02163915|11809854|FG000|Overall Study|Study termination|1
7492911|NCT02163915|11809855|FG001|Overall Study|Study termination|0
7492912|NCT02163915|11809856|FG002|Overall Study|Study termination|0
7492913|NCT02163915|11809857|FG003|Overall Study|Study termination|0
7492914|NCT02163915|11809858|FG004|Overall Study|Study termination|2
7492915|NCT02163915|11809854|FG000|Overall Study|Physician Decision|0
7492916|NCT02163915|11809855|FG001|Overall Study|Physician Decision|0
7492917|NCT02163915|11809856|FG002|Overall Study|Physician Decision|0
7492918|NCT02163915|11809857|FG003|Overall Study|Physician Decision|1
7492919|NCT02163915|11809858|FG004|Overall Study|Physician Decision|0
7492920|NCT02163993|11809895|FG000|Treatment Period|Adverse Event|0
7492921|NCT02163993|11809896|FG001|Treatment Period|Adverse Event|1
7492922|NCT02163993|11809897|FG002|Treatment Period|Adverse Event|0
7492923|NCT02163993|11809898|FG003|Treatment Period|Adverse Event|0
7492924|NCT02163993|11809899|FG004|Treatment Period|Adverse Event|1
7492925|NCT02163993|11809895|FG000|Treatment Period|Lost to Follow-up|2
7492926|NCT02163993|11809896|FG001|Treatment Period|Lost to Follow-up|3
7492927|NCT02163993|11809897|FG002|Treatment Period|Lost to Follow-up|1
7492928|NCT02163993|11809898|FG003|Treatment Period|Lost to Follow-up|3
7492929|NCT02163993|11809899|FG004|Treatment Period|Lost to Follow-up|1
7492930|NCT02163993|11809895|FG000|Treatment Period|Physician Decision|1
7492931|NCT02163993|11809896|FG001|Treatment Period|Physician Decision|0
7492932|NCT02163993|11809897|FG002|Treatment Period|Physician Decision|0
7492933|NCT02163993|11809898|FG003|Treatment Period|Physician Decision|0
7492934|NCT02163993|11809899|FG004|Treatment Period|Physician Decision|0
7492935|NCT02163993|11809895|FG000|Treatment Period|Protocol Violation|2
7492936|NCT02163993|11809896|FG001|Treatment Period|Protocol Violation|1
7492937|NCT02163993|11809897|FG002|Treatment Period|Protocol Violation|0
7492938|NCT02163993|11809898|FG003|Treatment Period|Protocol Violation|1
7492939|NCT02163993|11809899|FG004|Treatment Period|Protocol Violation|2
7492940|NCT02163993|11809895|FG000|Treatment Period|Withdrawal by Subject|6
7492941|NCT02163993|11809896|FG001|Treatment Period|Withdrawal by Subject|4
7492942|NCT02163993|11809897|FG002|Treatment Period|Withdrawal by Subject|1
7492943|NCT02163993|11809898|FG003|Treatment Period|Withdrawal by Subject|4
7492944|NCT02163993|11809899|FG004|Treatment Period|Withdrawal by Subject|1
7492945|NCT02163993|11809895|FG000|Treatment Period|Not treated|1
7492946|NCT02163993|11809896|FG001|Treatment Period|Not treated|0
7492947|NCT02163993|11809897|FG002|Treatment Period|Not treated|0
7492948|NCT02163993|11809898|FG003|Treatment Period|Not treated|1
7492949|NCT02163993|11809899|FG004|Treatment Period|Not treated|2
7492950|NCT02163993|11809895|FG000|Post-treatment Period|Adverse Event|0
7492951|NCT02163993|11809896|FG001|Post-treatment Period|Adverse Event|0
7492952|NCT02163993|11809897|FG002|Post-treatment Period|Adverse Event|1
7492953|NCT02163993|11809898|FG003|Post-treatment Period|Adverse Event|0
7492954|NCT02163993|11809899|FG004|Post-treatment Period|Adverse Event|0
7492955|NCT02163993|11809895|FG000|Post-treatment Period|Lost to Follow-up|2
7492956|NCT02163993|11809896|FG001|Post-treatment Period|Lost to Follow-up|2
7492957|NCT02163993|11809897|FG002|Post-treatment Period|Lost to Follow-up|3
7492958|NCT02163993|11809898|FG003|Post-treatment Period|Lost to Follow-up|1
7492959|NCT02163993|11809899|FG004|Post-treatment Period|Lost to Follow-up|0
7492960|NCT02163993|11809895|FG000|Post-treatment Period|Protocol Violation|0
7492961|NCT02163993|11809896|FG001|Post-treatment Period|Protocol Violation|0
7492962|NCT02163993|11809897|FG002|Post-treatment Period|Protocol Violation|0
7492963|NCT02163993|11809898|FG003|Post-treatment Period|Protocol Violation|0
7492964|NCT02163993|11809899|FG004|Post-treatment Period|Protocol Violation|1
7492965|NCT02163993|11809895|FG000|Post-treatment Period|Withdrawal by Subject|2
7492966|NCT02163993|11809896|FG001|Post-treatment Period|Withdrawal by Subject|4
7492967|NCT02163993|11809897|FG002|Post-treatment Period|Withdrawal by Subject|0
7492968|NCT02163993|11809898|FG003|Post-treatment Period|Withdrawal by Subject|1
7492969|NCT02163993|11809899|FG004|Post-treatment Period|Withdrawal by Subject|2
7492970|NCT02164318|11809935|FG000|Overall Study|Withdrawal by Subject|0
7492971|NCT02164318|11809936|FG001|Overall Study|Withdrawal by Subject|1
7492972|NCT02164318|11809937|FG002|Overall Study|Withdrawal by Subject|0
7492973|NCT02164318|11809938|FG003|Overall Study|Withdrawal by Subject|1
7492974|NCT02164383|11809950|FG000|Overall Study|Lost to Follow-up|1
7492975|NCT02164383|11809951|FG001|Overall Study|Lost to Follow-up|0
7492976|NCT02164513|11809986|FG000|Overall Study|Adverse Event|162
7492977|NCT02164513|11809987|FG001|Overall Study|Adverse Event|180
7492978|NCT02164513|11809988|FG002|Overall Study|Adverse Event|111
7492979|NCT02164513|11809986|FG000|Overall Study|Other: Study Closed or terminated|5
7492980|NCT02164513|11809987|FG001|Overall Study|Other: Study Closed or terminated|2
7492981|NCT02164513|11809988|FG002|Overall Study|Other: Study Closed or terminated|4
7492982|NCT02164513|11809986|FG000|Overall Study|Lost to Follow-up|30
7492983|NCT02164513|11809987|FG001|Overall Study|Lost to Follow-up|36
7492984|NCT02164513|11809988|FG002|Overall Study|Lost to Follow-up|22
7492985|NCT02164513|11809986|FG000|Overall Study|Physician Decision|47
7492986|NCT02164513|11809987|FG001|Overall Study|Physician Decision|57
7492987|NCT02164513|11809988|FG002|Overall Study|Physician Decision|28
7492988|NCT02164513|11809986|FG000|Overall Study|Withdrawal by Subject|192
7492989|NCT02164513|11809987|FG001|Overall Study|Withdrawal by Subject|261
7492990|NCT02164513|11809988|FG002|Overall Study|Withdrawal by Subject|130
7492991|NCT02164513|11809986|FG000|Overall Study|Other: Reason not provided by site|1
7492992|NCT02164513|11809987|FG001|Overall Study|Other: Reason not provided by site|0
7492993|NCT02164513|11809988|FG002|Overall Study|Other: Reason not provided by site|0
7492994|NCT02164539|11810003|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7492995|NCT02164539|11810004|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7492996|NCT02164539|11810005|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7492997|NCT02164539|11810006|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
7492998|NCT02164539|11810007|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
7492999|NCT02164539|11810008|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
7493000|NCT02164539|11810009|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
7493001|NCT02164539|11810003|FG000|Treatment Phase B (1 Week)|Adverse Event|0
7493002|NCT02164539|11810004|FG001|Treatment Phase B (1 Week)|Adverse Event|0
7493003|NCT02164539|11810005|FG002|Treatment Phase B (1 Week)|Adverse Event|0
7493004|NCT02164539|11810006|FG003|Treatment Phase B (1 Week)|Adverse Event|0
7493005|NCT02164539|11810007|FG004|Treatment Phase B (1 Week)|Adverse Event|2
7493006|NCT02164539|11810008|FG005|Treatment Phase B (1 Week)|Adverse Event|0
7493007|NCT02164539|11810009|FG006|Treatment Phase B (1 Week)|Adverse Event|0
7493008|NCT02164539|11810003|FG000|Treatment Phase B (1 Week)|Physician Decision|0
7493009|NCT02164539|11810004|FG001|Treatment Phase B (1 Week)|Physician Decision|0
7493010|NCT02164539|11810005|FG002|Treatment Phase B (1 Week)|Physician Decision|0
7493011|NCT02164539|11810006|FG003|Treatment Phase B (1 Week)|Physician Decision|0
7493012|NCT02164539|11810007|FG004|Treatment Phase B (1 Week)|Physician Decision|1
7493013|NCT02164539|11810008|FG005|Treatment Phase B (1 Week)|Physician Decision|0
7493014|NCT02164539|11810009|FG006|Treatment Phase B (1 Week)|Physician Decision|1
7493015|NCT02164539|11810003|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
7493016|NCT02164539|11810004|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493017|NCT02164539|11810005|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493018|NCT02164539|11810006|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493019|NCT02164539|11810007|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493020|NCT02164539|11810008|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493021|NCT02164539|11810009|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
7493022|NCT02164539|11810003|FG000|Treatment Phase C (1 Week)|Adverse Event|0
7493023|NCT02164539|11810004|FG001|Treatment Phase C (1 Week)|Adverse Event|0
7493024|NCT02164539|11810005|FG002|Treatment Phase C (1 Week)|Adverse Event|0
7493025|NCT02164539|11810006|FG003|Treatment Phase C (1 Week)|Adverse Event|0
7493026|NCT02164539|11810007|FG004|Treatment Phase C (1 Week)|Adverse Event|0
7493027|NCT02164539|11810008|FG005|Treatment Phase C (1 Week)|Adverse Event|0
7493028|NCT02164539|11810009|FG006|Treatment Phase C (1 Week)|Adverse Event|1
7493029|NCT02164539|11810003|FG000|Treatment Phase C (1 Week)|Physician Decision|0
7493030|NCT02164539|11810004|FG001|Treatment Phase C (1 Week)|Physician Decision|0
7493031|NCT02164539|11810005|FG002|Treatment Phase C (1 Week)|Physician Decision|0
7493032|NCT02164539|11810006|FG003|Treatment Phase C (1 Week)|Physician Decision|0
7493033|NCT02164539|11810007|FG004|Treatment Phase C (1 Week)|Physician Decision|0
7493034|NCT02164539|11810008|FG005|Treatment Phase C (1 Week)|Physician Decision|0
7493035|NCT02164539|11810009|FG006|Treatment Phase C (1 Week)|Physician Decision|1
7493036|NCT02164864|11810032|FG000|Overall Study|Trial disease worsening|7
7493037|NCT02164864|11810033|FG001|Overall Study|Trial disease worsening|5
7493038|NCT02164864|11810034|FG002|Overall Study|Trial disease worsening|1
7493039|NCT02164864|11810032|FG000|Overall Study|Other pre-existing disease worsening|6
7493040|NCT02164864|11810033|FG001|Overall Study|Other pre-existing disease worsening|4
7493041|NCT02164864|11810034|FG002|Overall Study|Other pre-existing disease worsening|9
7493042|NCT02164864|11810032|FG000|Overall Study|Other Adverse Event (AE)|52
7493043|NCT02164864|11810033|FG001|Overall Study|Other Adverse Event (AE)|32
7493044|NCT02164864|11810034|FG002|Overall Study|Other Adverse Event (AE)|49
7493045|NCT02164864|11810032|FG000|Overall Study|Protocol Violation|2
7493046|NCT02164864|11810033|FG001|Overall Study|Protocol Violation|4
7493047|NCT02164864|11810034|FG002|Overall Study|Protocol Violation|1
7493048|NCT02164864|11810032|FG000|Overall Study|Lost to Follow-up|4
7493049|NCT02164864|11810033|FG001|Overall Study|Lost to Follow-up|3
7493050|NCT02164864|11810034|FG002|Overall Study|Lost to Follow-up|2
7493051|NCT02164864|11810032|FG000|Overall Study|Consent withdrawn, not due to AE|21
7493052|NCT02164864|11810033|FG001|Overall Study|Consent withdrawn, not due to AE|8
7493053|NCT02164864|11810034|FG002|Overall Study|Consent withdrawn, not due to AE|56
7493054|NCT02164864|11810032|FG000|Overall Study|Other than stated|3
7493055|NCT02164864|11810033|FG001|Overall Study|Other than stated|4
7493056|NCT02164864|11810034|FG002|Overall Study|Other than stated|14
7493057|NCT02164916|11810047|FG000|Overall Study|Adverse Event|3
7493058|NCT02164916|11810048|FG001|Overall Study|Adverse Event|8
7493059|NCT02164916|11810047|FG000|Overall Study|Death|1
7493060|NCT02164916|11810048|FG001|Overall Study|Death|1
7493061|NCT02164916|11810047|FG000|Overall Study|Refusal unrelated to adverse event|3
7493062|NCT02164916|11810048|FG001|Overall Study|Refusal unrelated to adverse event|7
7493063|NCT02164916|11810047|FG000|Overall Study|Progression|37
7493064|NCT02164916|11810048|FG001|Overall Study|Progression|26
7493065|NCT02164916|11810047|FG000|Overall Study|Not protocol specified|5
7493066|NCT02164916|11810048|FG001|Overall Study|Not protocol specified|1
7493067|NCT02164916|11810047|FG000|Overall Study|Reason under review|1
7493068|NCT02164916|11810048|FG001|Overall Study|Reason under review|6
7493069|NCT02164916|11810047|FG000|Overall Study|Not eligible|2
7493070|NCT02164916|11810048|FG001|Overall Study|Not eligible|5
7493071|NCT02164929|11810063|FG000|Overall Study|Converted to open procedure|1
7493072|NCT02164929|11810064|FG001|Overall Study|Converted to open procedure|0
7493073|NCT02164929|11810065|FG002|Overall Study|Converted to open procedure|0
7493074|NCT02164929|11810066|FG003|Overall Study|Converted to open procedure|2
7493075|NCT02164929|11810063|FG000|Overall Study|Failed regional block|0
7493076|NCT02164929|11810064|FG001|Overall Study|Failed regional block|0
7493077|NCT02164929|11810065|FG002|Overall Study|Failed regional block|1
7493078|NCT02164929|11810066|FG003|Overall Study|Failed regional block|0
7493079|NCT02164981|11810079|FG000|Started|Withdrawal by Subject|2
7493080|NCT02164981|11810080|FG001|Started|Withdrawal by Subject|1
7493081|NCT02164981|11810081|FG002|Started|Withdrawal by Subject|0
7493082|NCT02164981|11810079|FG000|Started|Protocol Violation|2
7493083|NCT02164981|11810080|FG001|Started|Protocol Violation|0
7493084|NCT02164981|11810081|FG002|Started|Protocol Violation|0
7493085|NCT02164981|11810079|FG000|Started|Adverse Event|1
7493086|NCT02164981|11810080|FG001|Started|Adverse Event|2
7493087|NCT02164981|11810081|FG002|Started|Adverse Event|0
7493088|NCT02164981|11810079|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7493089|NCT02164981|11810080|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
7493090|NCT02164981|11810081|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
7493091|NCT02164981|11810079|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
7493092|NCT02164981|11810080|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
7493093|NCT02164981|11810081|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
7493094|NCT02164981|11810079|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7493095|NCT02164981|11810080|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
7493096|NCT02164981|11810081|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
7535191|NCT02708524|11882889|FG001|Overall Study|Lens Discomfort|0
7535192|NCT02708524|11882890|FG002|Overall Study|Lens Discomfort|1
7535193|NCT02708524|11882891|FG003|Overall Study|Lens Discomfort|0
7535194|NCT02708524|11882888|FG000|Overall Study|Lost to Follow-up|1
7535195|NCT02708524|11882889|FG001|Overall Study|Lost to Follow-up|1
7535196|NCT02708524|11882890|FG002|Overall Study|Lost to Follow-up|1
7535197|NCT02708524|11882891|FG003|Overall Study|Lost to Follow-up|0
7535198|NCT02708524|11882888|FG000|Overall Study|Protocol Violation|0
7535199|NCT02708524|11882889|FG001|Overall Study|Protocol Violation|1
7535200|NCT02708524|11882890|FG002|Overall Study|Protocol Violation|0
7535201|NCT02708524|11882891|FG003|Overall Study|Protocol Violation|0
7535202|NCT02708524|11882888|FG000|Overall Study|Withdrawal by Subject|1
7535203|NCT02708524|11882889|FG001|Overall Study|Withdrawal by Subject|1
7535204|NCT02708524|11882890|FG002|Overall Study|Withdrawal by Subject|0
7535205|NCT02708524|11882891|FG003|Overall Study|Withdrawal by Subject|0
7535206|NCT02708524|11882888|FG000|Overall Study|Dispensed incorrect study lens|0
7535207|NCT02708524|11882889|FG001|Overall Study|Dispensed incorrect study lens|1
7535208|NCT02708524|11882890|FG002|Overall Study|Dispensed incorrect study lens|1
7535209|NCT02708524|11882891|FG003|Overall Study|Dispensed incorrect study lens|0
7535210|NCT02708524|11882888|FG000|Overall Study|Did not wear lens at final visit|0
7535211|NCT02708524|11882889|FG001|Overall Study|Did not wear lens at final visit|1
7535212|NCT02708524|11882890|FG002|Overall Study|Did not wear lens at final visit|0
7535213|NCT02708524|11882891|FG003|Overall Study|Did not wear lens at final visit|0
7535214|NCT02708524|11882888|FG000|Overall Study|Subject lost study lens|1
7535215|NCT02708524|11882889|FG001|Overall Study|Subject lost study lens|0
7535216|NCT02708524|11882890|FG002|Overall Study|Subject lost study lens|0
7535217|NCT02708524|11882891|FG003|Overall Study|Subject lost study lens|0
7535218|NCT02708966|11882933|FG000|Overall Study|Lost to Follow-up|2
7535219|NCT02708966|11882934|FG001|Overall Study|Lost to Follow-up|2
7535220|NCT02709005|11882942|FG000|Overall Study|Lost to Follow-up|1
7535221|NCT02709005|11882943|FG001|Overall Study|Lost to Follow-up|1
7535222|NCT02709005|11882942|FG000|Overall Study|Withdrawal by Subject|3
7535223|NCT02709005|11882943|FG001|Overall Study|Withdrawal by Subject|0
7535224|NCT02709096|11882962|FG000|Overall Study|non-compliance|1
7535225|NCT02709096|11882963|FG001|Overall Study|non-compliance|1
7535226|NCT02709109|11882973|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
7493097|NCT02165202|11810123|FG000|Oral Phase|Refused further participation|5
7493098|NCT02165202|11810124|FG001|Oral Phase|Refused further participation|1
7493099|NCT02165202|11810123|FG000|Oral Phase|Study product Related Toxicity|1
7493100|NCT02165202|11810124|FG001|Oral Phase|Study product Related Toxicity|0
7493101|NCT02165202|11810123|FG000|Oral Phase|Unable to contact Participant|1
7493102|NCT02165202|11810124|FG001|Oral Phase|Unable to contact Participant|1
7493103|NCT02165202|11810123|FG000|Oral Phase|Clinical reasons|1
7493104|NCT02165202|11810124|FG001|Oral Phase|Clinical reasons|0
7493105|NCT02165202|11810123|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
7493106|NCT02165202|11810124|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
7493107|NCT02165202|11810123|FG000|Oral Phase|CMC advised termination|1
7493108|NCT02165202|11810124|FG001|Oral Phase|CMC advised termination|0
7493109|NCT02165202|11810123|FG000|Oral Phase|Relocated, no follow-up planned|1
7493110|NCT02165202|11810124|FG001|Oral Phase|Relocated, no follow-up planned|0
7493111|NCT02165202|11810123|FG000|Oral Phase|Abnormal EKG|0
7493112|NCT02165202|11810124|FG001|Oral Phase|Abnormal EKG|1
7493113|NCT02165202|11810123|FG000|Injection Phase|Abnormal Lab Value|5
7493114|NCT02165202|11810124|FG001|Injection Phase|Abnormal Lab Value|1
7493115|NCT02165202|11810123|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
7493116|NCT02165202|11810124|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
7493117|NCT02165202|11810123|FG000|Injection Phase|Unable to attend within Visit Window|1
7493118|NCT02165202|11810124|FG001|Injection Phase|Unable to attend within Visit Window|0
7493119|NCT02165202|11810123|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
7493120|NCT02165202|11810124|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
7493121|NCT02165202|11810123|FG000|Injection Phase|End of Study|2
7493122|NCT02165202|11810124|FG001|Injection Phase|End of Study|1
7493123|NCT02165202|11810123|FG000|Injection Phase|Study Product related Toxicity|1
7493124|NCT02165202|11810124|FG001|Injection Phase|Study Product related Toxicity|0
7493125|NCT02165202|11810123|FG000|Injection Phase|No longer interested|0
7493126|NCT02165202|11810124|FG001|Injection Phase|No longer interested|1
7493127|NCT02165202|11810123|FG000|Injection Phase|Participant unwilling to comply|1
7493128|NCT02165202|11810124|FG001|Injection Phase|Participant unwilling to comply|0
7493129|NCT02165397|11810137|FG000|Overall Study|Death|7
7493130|NCT02165397|11810138|FG001|Overall Study|Death|10
7493131|NCT02165397|11810139|FG002|Overall Study|Death|8
7493132|NCT02165397|11810137|FG000|Overall Study|Lost to Follow-up|1
7493133|NCT02165397|11810138|FG001|Overall Study|Lost to Follow-up|3
7493134|NCT02165397|11810139|FG002|Overall Study|Lost to Follow-up|0
7493135|NCT02165397|11810137|FG000|Overall Study|Withdrawal by Subject|6
7493136|NCT02165397|11810138|FG001|Overall Study|Withdrawal by Subject|6
7493137|NCT02165397|11810139|FG002|Overall Study|Withdrawal by Subject|1
7493138|NCT02165397|11810137|FG000|Overall Study|Other, Not Specified|0
7493139|NCT02165397|11810138|FG001|Overall Study|Other, Not Specified|0
7493140|NCT02165397|11810139|FG002|Overall Study|Other, Not Specified|1
7493141|NCT02165735|11810177|FG000|Overall Study|Lost to Follow-up|12
7493142|NCT02165735|11810178|FG001|Overall Study|Lost to Follow-up|10
7493143|NCT02165735|11810177|FG000|Overall Study|Withdrawal by Subject|3
7493144|NCT02165735|11810178|FG001|Overall Study|Withdrawal by Subject|0
7493145|NCT02165735|11810177|FG000|Overall Study|Participant indicated lack of time|1
7493146|NCT02165735|11810178|FG001|Overall Study|Participant indicated lack of time|3
7493147|NCT02165735|11810177|FG000|Overall Study|Protocol Violation|0
7493148|NCT02165735|11810178|FG001|Overall Study|Protocol Violation|1
7493149|NCT02165826|11810196|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
7493150|NCT02165826|11810197|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
7493151|NCT02165826|11810198|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
7493152|NCT02165826|11810196|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
7493153|NCT02165826|11810197|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
7493154|NCT02165826|11810198|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
7493155|NCT02165826|11810196|FG000|Main Treatment Period|Lost to Follow-up|4
7493156|NCT02165826|11810197|FG001|Main Treatment Period|Lost to Follow-up|2
7493157|NCT02165826|11810198|FG002|Main Treatment Period|Lost to Follow-up|1
7493158|NCT02165826|11810196|FG000|Main Treatment Period|Voluntary Withdrawal|23
7493159|NCT02165826|11810197|FG001|Main Treatment Period|Voluntary Withdrawal|23
7493160|NCT02165826|11810198|FG002|Main Treatment Period|Voluntary Withdrawal|21
7493161|NCT02165826|11810196|FG000|Main Treatment Period|Lack of Efficacy|2
7493162|NCT02165826|11810197|FG001|Main Treatment Period|Lack of Efficacy|0
7493163|NCT02165826|11810198|FG002|Main Treatment Period|Lack of Efficacy|0
7493164|NCT02165826|11810196|FG000|Main Treatment Period|Reason Not Specified|8
7493165|NCT02165826|11810197|FG001|Main Treatment Period|Reason Not Specified|5
7493166|NCT02165826|11810198|FG002|Main Treatment Period|Reason Not Specified|16
7493167|NCT02165826|11810196|FG000|Main Treatment Period|Did Not Receive Study Drug|0
7493168|NCT02165826|11810197|FG001|Main Treatment Period|Did Not Receive Study Drug|2
7493169|NCT02165826|11810198|FG002|Main Treatment Period|Did Not Receive Study Drug|0
7493170|NCT02165826|11810196|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
7493171|NCT02165826|11810197|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
7493172|NCT02165826|11810198|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
7493173|NCT02165826|11810196|FG000|Down-Titration Period|Voluntary Withdrawal|2
7493174|NCT02165826|11810197|FG001|Down-Titration Period|Voluntary Withdrawal|1
7493175|NCT02165826|11810198|FG002|Down-Titration Period|Voluntary Withdrawal|2
7493176|NCT02165826|11810196|FG000|Down-Titration Period|Reason Not Specified|1
7493177|NCT02165826|11810197|FG001|Down-Titration Period|Reason Not Specified|0
7493178|NCT02165826|11810198|FG002|Down-Titration Period|Reason Not Specified|2
7493179|NCT02166047|11810249|FG000|Overall Study|Withdrawal by Participant|0
7493180|NCT02166047|11810250|FG001|Overall Study|Withdrawal by Participant|1
7493181|NCT02166047|11810251|FG002|Overall Study|Withdrawal by Participant|2
7493182|NCT02166047|11810252|FG003|Overall Study|Withdrawal by Participant|0
7493183|NCT02166047|11810253|FG004|Overall Study|Withdrawal by Participant|0
7493184|NCT02166047|11810254|FG005|Overall Study|Withdrawal by Participant|0
7493185|NCT02166047|11810255|FG006|Overall Study|Withdrawal by Participant|1
7493186|NCT02166047|11810256|FG007|Overall Study|Withdrawal by Participant|0
7493187|NCT02166047|11810257|FG008|Overall Study|Withdrawal by Participant|0
7493188|NCT02166047|11810258|FG009|Overall Study|Withdrawal by Participant|0
7493189|NCT02166047|11810259|FG010|Overall Study|Withdrawal by Participant|0
7493190|NCT02166047|11810260|FG011|Overall Study|Withdrawal by Participant|0
7493191|NCT02166047|11810249|FG000|Overall Study|Adverse Event|0
7493192|NCT02166047|11810250|FG001|Overall Study|Adverse Event|0
7493193|NCT02166047|11810251|FG002|Overall Study|Adverse Event|0
7493194|NCT02166047|11810252|FG003|Overall Study|Adverse Event|0
7493195|NCT02166047|11810253|FG004|Overall Study|Adverse Event|1
7493196|NCT02166047|11810254|FG005|Overall Study|Adverse Event|0
7493197|NCT02166047|11810255|FG006|Overall Study|Adverse Event|1
7493198|NCT02166047|11810256|FG007|Overall Study|Adverse Event|0
7493199|NCT02166047|11810257|FG008|Overall Study|Adverse Event|0
7493200|NCT02166047|11810258|FG009|Overall Study|Adverse Event|0
7493201|NCT02166047|11810259|FG010|Overall Study|Adverse Event|2
7493202|NCT02166047|11810260|FG011|Overall Study|Adverse Event|0
7493203|NCT02166333|11810290|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
7493204|NCT02166333|11810291|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7493205|NCT02166333|11810292|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7493206|NCT02166333|11810293|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
7493207|NCT02166333|11810294|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
7493208|NCT02166333|11810295|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
7493209|NCT02166333|11810290|FG000|Stage 1|Death|4
7493210|NCT02166333|11810291|FG001|Stage 1|Death|0
7493211|NCT02166333|11810292|FG002|Stage 1|Death|2
7493212|NCT02166333|11810293|FG003|Stage 1|Death|0
7493213|NCT02166333|11810294|FG004|Stage 1|Death|3
7493214|NCT02166333|11810295|FG005|Stage 1|Death|2
7493215|NCT02166333|11810290|FG000|Stage 1|Lost to Follow-up|12
7493216|NCT02166333|11810291|FG001|Stage 1|Lost to Follow-up|0
7493217|NCT02166333|11810292|FG002|Stage 1|Lost to Follow-up|6
7493218|NCT02166333|11810293|FG003|Stage 1|Lost to Follow-up|0
7493219|NCT02166333|11810294|FG004|Stage 1|Lost to Follow-up|3
7493220|NCT02166333|11810295|FG005|Stage 1|Lost to Follow-up|3
7493221|NCT02166333|11810290|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
7493222|NCT02166333|11810291|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7493223|NCT02166333|11810292|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
7493224|NCT02166333|11810293|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
7493225|NCT02166333|11810294|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
7493226|NCT02166333|11810295|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
7493227|NCT02166333|11810290|FG000|Stage 2|Death|4
7493228|NCT02166333|11810291|FG001|Stage 2|Death|2
7493229|NCT02166333|11810292|FG002|Stage 2|Death|1
7493230|NCT02166333|11810293|FG003|Stage 2|Death|0
7493231|NCT02166333|11810294|FG004|Stage 2|Death|0
7493232|NCT02166333|11810295|FG005|Stage 2|Death|1
7493233|NCT02166333|11810290|FG000|Stage 2|Lost to Follow-up|23
7493234|NCT02166333|11810291|FG001|Stage 2|Lost to Follow-up|4
7493235|NCT02166333|11810292|FG002|Stage 2|Lost to Follow-up|11
7493236|NCT02166333|11810293|FG003|Stage 2|Lost to Follow-up|9
7493237|NCT02166333|11810294|FG004|Stage 2|Lost to Follow-up|3
7493238|NCT02166333|11810295|FG005|Stage 2|Lost to Follow-up|6
7493239|NCT02166476|11810316|FG000|Overall Study|Withdrawal by Subject|5
7493240|NCT02166476|11810317|FG001|Overall Study|Withdrawal by Subject|7
7493241|NCT02166476|11810316|FG000|Overall Study|Adverse Event|3
7493242|NCT02166476|11810317|FG001|Overall Study|Adverse Event|3
7493243|NCT02166476|11810316|FG000|Overall Study|Lost to Follow-up|5
7493244|NCT02166476|11810317|FG001|Overall Study|Lost to Follow-up|10
7493245|NCT02166476|11810316|FG000|Overall Study|Physician Decision|1
7493246|NCT02166476|11810317|FG001|Overall Study|Physician Decision|0
7493247|NCT02166476|11810316|FG000|Overall Study|Unable to Come for Visit|0
7493248|NCT02166476|11810317|FG001|Overall Study|Unable to Come for Visit|3
7493249|NCT02166606|11810326|FG000|Overall Study|Adverse Event|3
7493250|NCT02166606|11810326|FG000|Overall Study|Death|31
7493251|NCT02166606|11810326|FG000|Overall Study|Protocol Violation|7
7493252|NCT02166606|11810326|FG000|Overall Study|Lost to Follow-up|30
7493253|NCT02166606|11810326|FG000|Overall Study|Withdrawal by Subject|1
7493254|NCT02166606|11810326|FG000|Overall Study|Physician Decision|1
7493255|NCT02166606|11810326|FG000|Overall Study|Device upgrade|1
7493256|NCT02166606|11810326|FG000|Overall Study|Enrolled after End of Enrollment|4
7493257|NCT02166697|11810330|FG000|Overall Study|Protocol Violation|347
7493258|NCT02167035|11810336|FG000|Overall Study|Adverse Event|2
7493259|NCT02167035|11810337|FG001|Overall Study|Adverse Event|2
7493260|NCT02167035|11810336|FG000|Overall Study|Lost to Follow-up|3
7493261|NCT02167035|11810337|FG001|Overall Study|Lost to Follow-up|3
7493262|NCT02167035|11810336|FG000|Overall Study|Randomized to incorrect Study Medication|0
7493263|NCT02167035|11810337|FG001|Overall Study|Randomized to incorrect Study Medication|1
7493264|NCT02167139|11810356|FG000|Randomised, Double-blind|Withdrawal by Subject|11
7493265|NCT02167139|11810357|FG001|Randomised, Double-blind|Withdrawal by Subject|8
7493266|NCT02167139|11810358|FG002|Randomised, Double-blind|Withdrawal by Subject|0
7493267|NCT02167139|11810359|FG003|Randomised, Double-blind|Withdrawal by Subject|0
7493268|NCT02167139|11810356|FG000|Randomised, Double-blind|Adverse Event|2
7493269|NCT02167139|11810357|FG001|Randomised, Double-blind|Adverse Event|9
7493270|NCT02167139|11810358|FG002|Randomised, Double-blind|Adverse Event|0
7493271|NCT02167139|11810359|FG003|Randomised, Double-blind|Adverse Event|0
7493272|NCT02167139|11810356|FG000|Randomised, Double-blind|Lack of Efficacy|1
7493273|NCT02167139|11810357|FG001|Randomised, Double-blind|Lack of Efficacy|2
7493274|NCT02167139|11810358|FG002|Randomised, Double-blind|Lack of Efficacy|0
7493275|NCT02167139|11810359|FG003|Randomised, Double-blind|Lack of Efficacy|0
7493276|NCT02167139|11810356|FG000|Randomised, Double-blind|Other|3
7493277|NCT02167139|11810357|FG001|Randomised, Double-blind|Other|0
7493278|NCT02167139|11810358|FG002|Randomised, Double-blind|Other|0
7493279|NCT02167139|11810359|FG003|Randomised, Double-blind|Other|0
7493280|NCT02167139|11810356|FG000|Transition-extension|Adverse Event|2
7493281|NCT02167139|11810357|FG001|Transition-extension|Adverse Event|0
7493282|NCT02167139|11810358|FG002|Transition-extension|Adverse Event|2
7493283|NCT02167139|11810359|FG003|Transition-extension|Adverse Event|3
7493284|NCT02167139|11810356|FG000|Transition-extension|Withdrawal by Subject|2
7493285|NCT02167139|11810357|FG001|Transition-extension|Withdrawal by Subject|0
7493286|NCT02167139|11810358|FG002|Transition-extension|Withdrawal by Subject|4
7493287|NCT02167139|11810359|FG003|Transition-extension|Withdrawal by Subject|1
7493288|NCT02167139|11810356|FG000|Transition-extension|Lack of Efficacy|0
7493289|NCT02167139|11810357|FG001|Transition-extension|Lack of Efficacy|0
7493290|NCT02167139|11810358|FG002|Transition-extension|Lack of Efficacy|1
7493291|NCT02167139|11810359|FG003|Transition-extension|Lack of Efficacy|1
7493292|NCT02167139|11810356|FG000|Transition-extension|Other|1
7493293|NCT02167139|11810357|FG001|Transition-extension|Other|0
7493294|NCT02167139|11810358|FG002|Transition-extension|Other|1
7493295|NCT02167139|11810359|FG003|Transition-extension|Other|0
7493296|NCT02167139|11810356|FG000|Transition-extension|Lost to Follow-up|1
7493297|NCT02167139|11810357|FG001|Transition-extension|Lost to Follow-up|0
7493298|NCT02167139|11810358|FG002|Transition-extension|Lost to Follow-up|0
7493299|NCT02167139|11810359|FG003|Transition-extension|Lost to Follow-up|0
7493300|NCT02167256|11810389|FG000|Overall Study|Adverse Event|13
7493301|NCT02167256|11810390|FG001|Overall Study|Adverse Event|6
7493302|NCT02167256|11810389|FG000|Overall Study|Withdrawal by Subject|4
7493303|NCT02167256|11810390|FG001|Overall Study|Withdrawal by Subject|4
7493304|NCT02167256|11810389|FG000|Overall Study|non-compliance|3
7493305|NCT02167256|11810390|FG001|Overall Study|non-compliance|0
7493306|NCT02167256|11810389|FG000|Overall Study|Study partner unable to participate|1
7493307|NCT02167256|11810390|FG001|Overall Study|Study partner unable to participate|0
7493308|NCT02167451|11810396|FG000|Overall Study|Withdrawal by Subject|1
7493309|NCT02167594|11810403|FG000|Overall Study|Withdrawal by Subject|2
7493310|NCT02167594|11810404|FG001|Overall Study|Withdrawal by Subject|0
7493311|NCT02167594|11810405|FG002|Overall Study|Withdrawal by Subject|0
7493312|NCT02167594|11810403|FG000|Overall Study|Death|0
7493313|NCT02167594|11810404|FG001|Overall Study|Death|1
7493314|NCT02167594|11810405|FG002|Overall Study|Death|0
7493315|NCT02167893|11810433|FG000|Overall Study|Investigator transferred|85
7493316|NCT02167893|11810433|FG000|Overall Study|Investigator health reasons|10
7493317|NCT02167893|11810433|FG000|Overall Study|Case report forms not collected|68
7493318|NCT02168101|11810455|FG000|Overall Study|Death|2
7493319|NCT02168101|11810456|FG001|Overall Study|Death|2
7493320|NCT02168101|11810457|FG002|Overall Study|Death|1
7493321|NCT02168387|11810495|FG000|Overall Study|Planned exubation|6
7493322|NCT02168387|11810496|FG001|Overall Study|Planned exubation|3
7493323|NCT02168387|11810495|FG000|Overall Study|Death|1
7493324|NCT02168387|11810496|FG001|Overall Study|Death|0
7493325|NCT02168439|11810504|FG000|Overall Study|Protocol Violation|0
7493326|NCT02168439|11810505|FG001|Overall Study|Protocol Violation|2
7493327|NCT02168478|11810511|FG000|Overall Study|Withdrawal by Subject|1
7493328|NCT02168478|11810511|FG000|Overall Study|Did Not Consent to Participation|2
7493329|NCT02168478|11810511|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
7493330|NCT02168491|11810515|FG000|Overall Study|Withdrawal by Subject|1
7493331|NCT02168777|11810538|FG000|Overall Study|Withdrawal by Subject|1
7493332|NCT02168777|11810539|FG001|Overall Study|Withdrawal by Subject|0
7493333|NCT02168777|11810540|FG002|Overall Study|Withdrawal by Subject|2
7493334|NCT02168777|11810538|FG000|Overall Study|Adverse Event|1
7493335|NCT02168777|11810539|FG001|Overall Study|Adverse Event|0
7493336|NCT02168777|11810540|FG002|Overall Study|Adverse Event|1
7493337|NCT02168777|11810538|FG000|Overall Study|Disease recurrence|0
7493338|NCT02168777|11810539|FG001|Overall Study|Disease recurrence|0
7493339|NCT02168777|11810540|FG002|Overall Study|Disease recurrence|1
7493340|NCT02168777|11810538|FG000|Overall Study|Radiological disease progression|0
7493341|NCT02168777|11810539|FG001|Overall Study|Radiological disease progression|5
7493342|NCT02168777|11810540|FG002|Overall Study|Radiological disease progression|5
7493343|NCT02168777|11810538|FG000|Overall Study|Clinical disease progression|0
7493344|NCT02168777|11810539|FG001|Overall Study|Clinical disease progression|1
7493345|NCT02168777|11810540|FG002|Overall Study|Clinical disease progression|2
7493346|NCT02168777|11810538|FG000|Overall Study|Other reason|0
7493347|NCT02168777|11810539|FG001|Overall Study|Other reason|1
7493348|NCT02168777|11810540|FG002|Overall Study|Other reason|0
7493349|NCT02168803|11810554|FG000|Overall Study|Lost to Follow-up|1
7493350|NCT02168803|11810555|FG001|Overall Study|Lost to Follow-up|0
7493351|NCT02168803|11810556|FG002|Overall Study|Lost to Follow-up|1
7493352|NCT02168803|11810554|FG000|Overall Study|Withdrawal by Subject|1
7493353|NCT02168803|11810555|FG001|Overall Study|Withdrawal by Subject|1
7493354|NCT02168803|11810556|FG002|Overall Study|Withdrawal by Subject|2
7493355|NCT02168803|11810554|FG000|Overall Study|Physician Decision|0
7493356|NCT02168803|11810555|FG001|Overall Study|Physician Decision|1
7493357|NCT02168803|11810556|FG002|Overall Study|Physician Decision|0
7493358|NCT02168803|11810554|FG000|Overall Study|Adverse Event|0
7493359|NCT02168803|11810555|FG001|Overall Study|Adverse Event|1
7493360|NCT02168803|11810556|FG002|Overall Study|Adverse Event|1
7493361|NCT02168803|11810554|FG000|Overall Study|Death|0
7493362|NCT02168803|11810555|FG001|Overall Study|Death|0
7493363|NCT02168803|11810556|FG002|Overall Study|Death|1
7493364|NCT02168803|11810554|FG000|Overall Study|Sponsor Decision|0
7493365|NCT02168803|11810555|FG001|Overall Study|Sponsor Decision|0
7493366|NCT02168803|11810556|FG002|Overall Study|Sponsor Decision|1
7493367|NCT02168816|11810573|FG000|Overall Study|Lost to Follow-up|2
7493368|NCT02168816|11810574|FG001|Overall Study|Lost to Follow-up|2
7493369|NCT02168842|11810582|FG000|Overall Study|Withdrawal by Subject|5
7493370|NCT02168842|11810583|FG001|Overall Study|Withdrawal by Subject|3
7493371|NCT02168842|11810582|FG000|Overall Study|Lost to Follow-up|0
7493372|NCT02168842|11810583|FG001|Overall Study|Lost to Follow-up|2
7493373|NCT02168842|11810582|FG000|Overall Study|Death|2
7493374|NCT02168842|11810583|FG001|Overall Study|Death|1
7493375|NCT02168842|11810582|FG000|Overall Study|Physician Decision|1
7493376|NCT02168842|11810583|FG001|Overall Study|Physician Decision|2
7493377|NCT02168946|11810612|FG000|Overall Study|Adverse Event|8
7493378|NCT02168946|11810613|FG001|Overall Study|Adverse Event|5
7493379|NCT02168946|11810612|FG000|Overall Study|Lost to Follow-up|3
7493380|NCT02168946|11810613|FG001|Overall Study|Lost to Follow-up|0
7493381|NCT02168946|11810612|FG000|Overall Study|Subject unable to come back for visits|1
7493382|NCT02168946|11810613|FG001|Overall Study|Subject unable to come back for visits|0
7493383|NCT02169219|11810633|FG000|Overall Study|Lack of Efficacy|6
7493384|NCT02169271|11810644|FG000|Overall Study|Protocol Violation|1
7493385|NCT02169271|11810645|FG001|Overall Study|Protocol Violation|2
7493386|NCT02169284|11810653|FG000|Overall Study|Physician Decision|0
7493387|NCT02169284|11810654|FG001|Overall Study|Physician Decision|1
7493388|NCT02169336|11810665|FG000|Overall Study|Lack of Efficacy|1
7493389|NCT02169336|11810666|FG001|Overall Study|Lack of Efficacy|1
7493390|NCT02169336|11810667|FG002|Overall Study|Lack of Efficacy|0
7493391|NCT02169336|11810665|FG000|Overall Study|Adverse Event|2
7493392|NCT02169336|11810666|FG001|Overall Study|Adverse Event|3
7493393|NCT02169336|11810667|FG002|Overall Study|Adverse Event|1
7493394|NCT02169336|11810665|FG000|Overall Study|Withdrawal by Subject|1
7493395|NCT02169336|11810666|FG001|Overall Study|Withdrawal by Subject|0
7493396|NCT02169336|11810667|FG002|Overall Study|Withdrawal by Subject|0
7493397|NCT02169336|11810665|FG000|Overall Study|Physician Decision|0
7493398|NCT02169336|11810666|FG001|Overall Study|Physician Decision|0
7493399|NCT02169336|11810667|FG002|Overall Study|Physician Decision|1
7493400|NCT02169336|11810665|FG000|Overall Study|Subject declined to continue dosing|0
7493401|NCT02169336|11810666|FG001|Overall Study|Subject declined to continue dosing|0
7493402|NCT02169336|11810667|FG002|Overall Study|Subject declined to continue dosing|1
7493403|NCT02169414|11810679|FG000|Overall Study|Withdrawal by Subject|1
7493404|NCT02169414|11810680|FG001|Overall Study|Withdrawal by Subject|0
7493405|NCT02169414|11810681|FG002|Overall Study|Withdrawal by Subject|0
7493406|NCT02169414|11810682|FG003|Overall Study|Withdrawal by Subject|0
7493407|NCT02169414|11810679|FG000|Overall Study|Adverse Event|0
7493408|NCT02169414|11810680|FG001|Overall Study|Adverse Event|1
7493409|NCT02169414|11810681|FG002|Overall Study|Adverse Event|0
7493410|NCT02169414|11810682|FG003|Overall Study|Adverse Event|0
7493411|NCT02169505|11810765|FG000|Overall Study|Withdrawal by Subject|1
7493412|NCT02169674|11810771|FG000|Overall Study|Withdrawal by Subject|2
7493413|NCT02169674|11810772|FG001|Overall Study|Withdrawal by Subject|1
7493414|NCT02169674|11810771|FG000|Overall Study|Seroprotected|30
7493415|NCT02169674|11810772|FG001|Overall Study|Seroprotected|76
7493416|NCT02169674|11810771|FG000|Overall Study|Lost to Follow-up|0
7493417|NCT02169674|11810772|FG001|Overall Study|Lost to Follow-up|1
7493418|NCT02169739|11810780|FG000|Overall Study|Lost to Follow-up|0
7493419|NCT02169739|11810781|FG001|Overall Study|Lost to Follow-up|4
7493420|NCT02169791|11810788|FG000|Overall Study|Death|6
7493421|NCT02169791|11810788|FG000|Overall Study|patient withdrew consent|1
7493422|NCT02170025|11810820|FG000|Overall Study|Adverse Event|2
7493423|NCT02170025|11810821|FG001|Overall Study|Adverse Event|0
7493424|NCT02170051|11810829|FG000|Overall Study|Withdrawal by Subject|10
7493425|NCT02170051|11810830|FG001|Overall Study|Withdrawal by Subject|10
7493426|NCT02170051|11810829|FG000|Overall Study|Lost to Follow-up|1
7493427|NCT02170051|11810830|FG001|Overall Study|Lost to Follow-up|3
7493428|NCT02170064|11810839|FG000|Overall Study|Withdrawal by Subject|5
7493429|NCT02170064|11810840|FG001|Overall Study|Withdrawal by Subject|1
7493430|NCT02170064|11810841|FG002|Overall Study|Withdrawal by Subject|1
7493431|NCT02170064|11810839|FG000|Overall Study|Physician Decision|1
7493432|NCT02170064|11810840|FG001|Overall Study|Physician Decision|1
7493433|NCT02170064|11810841|FG002|Overall Study|Physician Decision|0
7493434|NCT02170077|11810852|FG000|Overall Study|Withdrawal by Subject|3
7493435|NCT02170077|11810853|FG001|Overall Study|Withdrawal by Subject|4
7493436|NCT02170077|11810854|FG002|Overall Study|Withdrawal by Subject|2
7493437|NCT02170077|11810852|FG000|Overall Study|Adverse Event|4
7493438|NCT02170077|11810853|FG001|Overall Study|Adverse Event|4
7493439|NCT02170077|11810854|FG002|Overall Study|Adverse Event|4
7493440|NCT02170077|11810852|FG000|Overall Study|Lost to Follow-up|0
7493441|NCT02170077|11810853|FG001|Overall Study|Lost to Follow-up|1
7493442|NCT02170077|11810854|FG002|Overall Study|Lost to Follow-up|0
7493443|NCT02170077|11810852|FG000|Overall Study|Exclusion criteria|2
7493444|NCT02170077|11810853|FG001|Overall Study|Exclusion criteria|2
7493445|NCT02170077|11810854|FG002|Overall Study|Exclusion criteria|5
7493446|NCT02170077|11810852|FG000|Overall Study|Exacerbation of seizures|0
7493447|NCT02170077|11810853|FG001|Overall Study|Exacerbation of seizures|2
7493448|NCT02170077|11810854|FG002|Overall Study|Exacerbation of seizures|1
7493449|NCT02170207|11810862|FG000|Overall Study|Case report forms unavailable|5
7493450|NCT02170389|11810896|FG000|Overall Study|Study terminated prior to start of treat|1
7493451|NCT02170688|11810939|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
7493452|NCT02170688|11810940|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
7493453|NCT02170688|11810941|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
7493454|NCT02170688|11810942|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
7493455|NCT02170688|11810943|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
7493456|NCT02170688|11810939|FG000|Overall Study|Full dose not received|0
7493457|NCT02170688|11810940|FG001|Overall Study|Full dose not received|1
7493458|NCT02170688|11810941|FG002|Overall Study|Full dose not received|0
7493459|NCT02170688|11810942|FG003|Overall Study|Full dose not received|0
7493460|NCT02170688|11810943|FG004|Overall Study|Full dose not received|0
7493461|NCT02170688|11810939|FG000|Overall Study|Physician Decision|0
7493462|NCT02170688|11810940|FG001|Overall Study|Physician Decision|0
7493463|NCT02170688|11810941|FG002|Overall Study|Physician Decision|1
7493464|NCT02170688|11810942|FG003|Overall Study|Physician Decision|0
7493465|NCT02170688|11810943|FG004|Overall Study|Physician Decision|0
7493466|NCT02170727|11810957|FG000|Overall Study|Lost to Follow-up|1
7493467|NCT02170727|11810958|FG001|Overall Study|Lost to Follow-up|0
7493468|NCT02170727|11810957|FG000|Overall Study|Withdrawal by Subject|2
7493469|NCT02170727|11810958|FG001|Overall Study|Withdrawal by Subject|0
7493470|NCT02170779|11810969|FG000|Overall Study|Withdrawal by Subject|1
7493471|NCT02170779|11810970|FG001|Overall Study|Withdrawal by Subject|0
7493472|NCT02170779|11810969|FG000|Overall Study|Lost to Follow-up|0
7493473|NCT02170779|11810970|FG001|Overall Study|Lost to Follow-up|1
7493474|NCT02171065|11811007|FG000|Overall Study|Withdrawal by Subject|1
7493475|NCT02171065|11811008|FG001|Overall Study|Withdrawal by Subject|0
7493476|NCT02171065|11811009|FG002|Overall Study|Withdrawal by Subject|0
7493477|NCT02171065|11811007|FG000|Overall Study|Lost to Follow-up|0
7493478|NCT02171065|11811008|FG001|Overall Study|Lost to Follow-up|0
7493479|NCT02171065|11811009|FG002|Overall Study|Lost to Follow-up|1
7493480|NCT02171130|11811019|FG000|Overall Study|Death|1
7493481|NCT02171130|11811019|FG000|Overall Study|Discontinued; Clinical Material Issue|16
7493482|NCT02171130|11811019|FG000|Overall Study|Discontinued; Site Termination|5
7493483|NCT02171130|11811019|FG000|Overall Study|Withdrawal by Subject|3
7493484|NCT02171130|11811019|FG000|Overall Study|Physician Decision|1
7493485|NCT02171130|11811019|FG000|Overall Study|Lost to Follow-up|1
7493486|NCT02171130|11811019|FG000|Overall Study|Met Exclusion Criteria|1
7493487|NCT02171260|11811094|FG000|Overall Study|Death|0
7493488|NCT02171260|11811095|FG001|Overall Study|Death|0
7493489|NCT02171260|11811096|FG002|Overall Study|Death|0
7493490|NCT02171260|11811097|FG003|Overall Study|Death|1
7493491|NCT02171260|11811094|FG000|Overall Study|Physician Decision|1
7493492|NCT02171260|11811095|FG001|Overall Study|Physician Decision|0
7493493|NCT02171260|11811096|FG002|Overall Study|Physician Decision|1
7493494|NCT02171260|11811097|FG003|Overall Study|Physician Decision|0
7493495|NCT02171260|11811094|FG000|Overall Study|Withdrawal by Subject|1
7493496|NCT02171260|11811095|FG001|Overall Study|Withdrawal by Subject|0
7493497|NCT02171260|11811096|FG002|Overall Study|Withdrawal by Subject|0
7493498|NCT02171260|11811097|FG003|Overall Study|Withdrawal by Subject|0
7493499|NCT02171260|11811094|FG000|Overall Study|Evidence of progressive disease|4
7493500|NCT02171260|11811095|FG001|Overall Study|Evidence of progressive disease|6
7493501|NCT02171260|11811096|FG002|Overall Study|Evidence of progressive disease|4
7493502|NCT02171260|11811097|FG003|Overall Study|Evidence of progressive disease|4
7493503|NCT02171429|11811116|FG000|Overall Study|Other|0
7493504|NCT02171429|11811117|FG001|Overall Study|Other|1
7493505|NCT02171429|11811118|FG002|Overall Study|Other|1
7493506|NCT02171429|11811116|FG000|Overall Study|Non-Compliance|0
7493507|NCT02171429|11811117|FG001|Overall Study|Non-Compliance|0
7493508|NCT02171429|11811118|FG002|Overall Study|Non-Compliance|1
7493509|NCT02171429|11811116|FG000|Overall Study|Physician Decision|0
7493510|NCT02171429|11811117|FG001|Overall Study|Physician Decision|0
7493511|NCT02171429|11811118|FG002|Overall Study|Physician Decision|1
7493512|NCT02171429|11811116|FG000|Overall Study|Withdrawal by Subject|1
7493513|NCT02171429|11811117|FG001|Overall Study|Withdrawal by Subject|1
7493514|NCT02171429|11811118|FG002|Overall Study|Withdrawal by Subject|1
7493515|NCT02171429|11811116|FG000|Overall Study|Lost to Follow-up|0
7493516|NCT02171429|11811117|FG001|Overall Study|Lost to Follow-up|1
7493517|NCT02171429|11811118|FG002|Overall Study|Lost to Follow-up|0
7493518|NCT02171429|11811116|FG000|Overall Study|Death|0
7493519|NCT02171429|11811117|FG001|Overall Study|Death|0
7493520|NCT02171429|11811118|FG002|Overall Study|Death|1
7493521|NCT02172040|11811163|FG000|Overall Study|Adverse Event|0
7493522|NCT02172040|11811164|FG001|Overall Study|Adverse Event|2
7493523|NCT02172040|11811165|FG002|Overall Study|Adverse Event|0
7493524|NCT02172040|11811166|FG003|Overall Study|Adverse Event|0
7493525|NCT02172040|11811163|FG000|Overall Study|Protocol Violation|0
7493526|NCT02172040|11811164|FG001|Overall Study|Protocol Violation|1
7493527|NCT02172040|11811165|FG002|Overall Study|Protocol Violation|0
7493528|NCT02172040|11811166|FG003|Overall Study|Protocol Violation|0
7493529|NCT02172040|11811163|FG000|Overall Study|Withdrawal by Subject|0
7493530|NCT02172040|11811164|FG001|Overall Study|Withdrawal by Subject|0
7493531|NCT02172040|11811165|FG002|Overall Study|Withdrawal by Subject|1
7493532|NCT02172040|11811166|FG003|Overall Study|Withdrawal by Subject|0
7493533|NCT02172040|11811163|FG000|Overall Study|Not available for Day 13 & 14 visits|0
7493534|NCT02172040|11811164|FG001|Overall Study|Not available for Day 13 & 14 visits|0
7493535|NCT02172040|11811165|FG002|Overall Study|Not available for Day 13 & 14 visits|1
7493536|NCT02172040|11811166|FG003|Overall Study|Not available for Day 13 & 14 visits|0
7493537|NCT02172040|11811163|FG000|Overall Study|Family emergency abroad|0
7493538|NCT02172040|11811164|FG001|Overall Study|Family emergency abroad|0
7493539|NCT02172040|11811165|FG002|Overall Study|Family emergency abroad|0
7493540|NCT02172040|11811166|FG003|Overall Study|Family emergency abroad|1
7493541|NCT02172625|11811179|FG000|Overall Study|Adverse Event|0
7493542|NCT02172625|11811180|FG001|Overall Study|Adverse Event|1
7493543|NCT02172625|11811179|FG000|Overall Study|Pregnancy|0
7493544|NCT02172625|11811180|FG001|Overall Study|Pregnancy|1
7493545|NCT02172625|11811179|FG000|Overall Study|car accident|0
7493546|NCT02172625|11811180|FG001|Overall Study|car accident|1
7493547|NCT02172664|11811190|FG000|Overall Study|Lost to Follow-up|4
7493548|NCT02172664|11811191|FG001|Overall Study|Lost to Follow-up|4
7493549|NCT02172664|11811190|FG000|Overall Study|Death|1
7493550|NCT02172664|11811191|FG001|Overall Study|Death|1
7493551|NCT02172664|11811190|FG000|Overall Study|Moved out of area|1
7493552|NCT02172664|11811191|FG001|Overall Study|Moved out of area|1
7493553|NCT02172911|11811224|FG000|Overall Study|Serious Adverse Event|0
7493554|NCT02172911|11811225|FG001|Overall Study|Serious Adverse Event|1
7493555|NCT02172911|11811224|FG000|Overall Study|Progression of Disease|0
7493556|NCT02172911|11811225|FG001|Overall Study|Progression of Disease|1
7493557|NCT02172911|11811224|FG000|Overall Study|Loss of insurance coverage|1
7493558|NCT02172911|11811225|FG001|Overall Study|Loss of insurance coverage|0
7493559|NCT02172950|11811233|FG000|Overall Study|Physician Decision|3
7493560|NCT02172950|11811234|FG001|Overall Study|Physician Decision|3
7493561|NCT02172950|11811233|FG000|Overall Study|Lack of Efficacy|1
7493562|NCT02172950|11811234|FG001|Overall Study|Lack of Efficacy|0
7493563|NCT02172950|11811233|FG000|Overall Study|Adverse Event|4
7493564|NCT02172950|11811234|FG001|Overall Study|Adverse Event|1
7493565|NCT02172950|11811233|FG000|Overall Study|Withdrawal by Subject|10
7493566|NCT02172950|11811234|FG001|Overall Study|Withdrawal by Subject|0
7493567|NCT02172950|11811233|FG000|Overall Study|Protocol Violation|1
7493568|NCT02172950|11811234|FG001|Overall Study|Protocol Violation|0
7493569|NCT02172950|11811233|FG000|Overall Study|Lost to Follow-up|1
7493570|NCT02172950|11811234|FG001|Overall Study|Lost to Follow-up|0
7493571|NCT02172950|11811233|FG000|Overall Study|Death|1
7493572|NCT02172950|11811234|FG001|Overall Study|Death|0
7493573|NCT02172950|11811233|FG000|Overall Study|Patient traveling|1
7493574|NCT02172950|11811234|FG001|Overall Study|Patient traveling|0
7493575|NCT02172950|11811233|FG000|Overall Study|Patient went to other country|1
7493576|NCT02172950|11811234|FG001|Overall Study|Patient went to other country|0
7493577|NCT02172950|11811233|FG000|Overall Study|Patient relocated overseas|1
7493578|NCT02172950|11811234|FG001|Overall Study|Patient relocated overseas|1
7493579|NCT02172950|11811233|FG000|Overall Study|Patient moving|1
7493580|NCT02172950|11811234|FG001|Overall Study|Patient moving|0
7493581|NCT02173054|11811244|FG000|Overall Study|lack of compliance|1
7493582|NCT02173054|11811245|FG001|Overall Study|lack of compliance|0
7493583|NCT02173054|11811246|FG002|Overall Study|lack of compliance|0
7493584|NCT02173054|11811244|FG000|Overall Study|Withdrawal by Subject|0
7493585|NCT02173054|11811245|FG001|Overall Study|Withdrawal by Subject|0
7493586|NCT02173054|11811246|FG002|Overall Study|Withdrawal by Subject|1
7493587|NCT02173158|11811254|FG000|Efficacy Phase|Adverse Event|1
7535227|NCT02709109|11882974|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
7535228|NCT02709109|11882975|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
7535229|NCT02709109|11882976|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
7535230|NCT02709109|11882973|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7493588|NCT02173548|11811345|FG000|Overall Study|Lost to Follow-up|0
7493589|NCT02173548|11811346|FG001|Overall Study|Lost to Follow-up|2
7493590|NCT02173548|11811345|FG000|Overall Study|Withdrawal by Subject|1
7493591|NCT02173548|11811346|FG001|Overall Study|Withdrawal by Subject|0
7493592|NCT02173704|11811354|FG000|Overall Study|Adverse Event|1
7493593|NCT02173704|11811355|FG001|Overall Study|Adverse Event|0
7493594|NCT02173704|11811354|FG000|Overall Study|Lost to Follow-up|1
7493595|NCT02173704|11811355|FG001|Overall Study|Lost to Follow-up|0
7493596|NCT02173704|11811354|FG000|Overall Study|Other|1
7493597|NCT02173704|11811355|FG001|Overall Study|Other|0
7493598|NCT02173704|11811354|FG000|Overall Study|Protocol Violation|1
7493599|NCT02173704|11811355|FG001|Overall Study|Protocol Violation|0
7493600|NCT02173704|11811354|FG000|Overall Study|Withdrawal by Subject|9
7493601|NCT02173704|11811355|FG001|Overall Study|Withdrawal by Subject|4
7493602|NCT02173769|11811361|FG000|Overall Study|Protocol Violation|4
7493603|NCT02174276|11811379|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
7493604|NCT02174276|11811380|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7493605|NCT02174276|11811381|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7493606|NCT02174276|11811382|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
7493607|NCT02174276|11811379|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7493608|NCT02174276|11811380|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7493609|NCT02174276|11811381|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
7493610|NCT02174276|11811382|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
7493611|NCT02174276|11811379|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7493612|NCT02174276|11811380|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
7493613|NCT02174276|11811381|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
7493614|NCT02174276|11811382|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
7493615|NCT02174276|11811379|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7493616|NCT02174276|11811380|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7493617|NCT02174276|11811381|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
7493618|NCT02174276|11811382|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
7493619|NCT02174276|11811379|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
7493620|NCT02174276|11811380|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
7493621|NCT02174276|11811381|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
7493622|NCT02174276|11811382|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
7493623|NCT02174276|11811379|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7493624|NCT02174276|11811380|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
7493625|NCT02174276|11811381|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
7493626|NCT02174276|11811382|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
7493627|NCT02174523|11811427|FG000|Overall Study|Withdrawal by Subject|1
7493628|NCT02174523|11811428|FG001|Overall Study|Withdrawal by Subject|0
7493629|NCT02174562|11811435|FG000|Overall Study|Withdrawal by Subject|7
7493630|NCT02174562|11811436|FG001|Overall Study|Withdrawal by Subject|2
7493631|NCT02174562|11811435|FG000|Overall Study|Death|2
7493632|NCT02174562|11811436|FG001|Overall Study|Death|0
7493633|NCT02174562|11811435|FG000|Overall Study|Lost to Follow-up|0
7493634|NCT02174562|11811436|FG001|Overall Study|Lost to Follow-up|3
7493635|NCT02174627|11811444|FG000|Overall Study|Missing|0
7493636|NCT02174627|11811445|FG001|Overall Study|Missing|1
7493637|NCT02174627|11811444|FG000|Overall Study|Incorrect enrolment before randomization|0
7493638|NCT02174627|11811445|FG001|Overall Study|Incorrect enrolment before randomization|1
7493639|NCT02174627|11811444|FG000|Overall Study|Participant decision|84
7493640|NCT02174627|11811445|FG001|Overall Study|Participant decision|128
7493641|NCT02174731|11811453|FG000|Overall Study|Participant decision|67
7493642|NCT02174731|11811454|FG001|Overall Study|Participant decision|64
7493643|NCT02174731|11811453|FG000|Overall Study|Incorrect enrolment before randomization|0
7493644|NCT02174731|11811454|FG001|Overall Study|Incorrect enrolment before randomization|1
7493645|NCT02174731|11811453|FG000|Overall Study|Missing|2
7493646|NCT02174731|11811454|FG001|Overall Study|Missing|0
7493647|NCT02174848|11811462|FG000|Overall Study|Adverse Event|2
7493648|NCT02174848|11811463|FG001|Overall Study|Adverse Event|1
7493649|NCT02174848|11811462|FG000|Overall Study|Withdrawal by Subject|3
7493650|NCT02174848|11811463|FG001|Overall Study|Withdrawal by Subject|3
7493651|NCT02174848|11811462|FG000|Overall Study|Lost to Follow-up|0
7493652|NCT02174848|11811463|FG001|Overall Study|Lost to Follow-up|1
7493653|NCT02174848|11811462|FG000|Overall Study|Worsening of disease|1
7493654|NCT02174848|11811463|FG001|Overall Study|Worsening of disease|1
7493655|NCT02174848|11811462|FG000|Overall Study|Unable to comply with study requirements|1
7493656|NCT02174848|11811463|FG001|Overall Study|Unable to comply with study requirements|0
7493657|NCT02175121|11811488|FG000|Overall Study|Lack of Efficacy|1
7493658|NCT02175121|11811489|FG001|Overall Study|Lack of Efficacy|0
7493659|NCT02175121|11811490|FG002|Overall Study|Lack of Efficacy|0
7493660|NCT02175121|11811491|FG003|Overall Study|Lack of Efficacy|0
7493661|NCT02175121|11811492|FG004|Overall Study|Lack of Efficacy|0
7493662|NCT02175121|11811488|FG000|Overall Study|Lost to Follow-up|0
7493663|NCT02175121|11811489|FG001|Overall Study|Lost to Follow-up|1
7493664|NCT02175121|11811490|FG002|Overall Study|Lost to Follow-up|0
7493665|NCT02175121|11811491|FG003|Overall Study|Lost to Follow-up|1
7493666|NCT02175121|11811492|FG004|Overall Study|Lost to Follow-up|0
7493667|NCT02175121|11811488|FG000|Overall Study|Personal emergency|0
7493668|NCT02175121|11811489|FG001|Overall Study|Personal emergency|0
7493669|NCT02175121|11811490|FG002|Overall Study|Personal emergency|0
7493670|NCT02175121|11811491|FG003|Overall Study|Personal emergency|0
7493671|NCT02175121|11811492|FG004|Overall Study|Personal emergency|1
7493672|NCT02175121|11811488|FG000|Overall Study|Schedule conflict|0
7493673|NCT02175121|11811489|FG001|Overall Study|Schedule conflict|0
7493674|NCT02175121|11811490|FG002|Overall Study|Schedule conflict|1
7493675|NCT02175121|11811491|FG003|Overall Study|Schedule conflict|0
7493676|NCT02175121|11811492|FG004|Overall Study|Schedule conflict|0
7493677|NCT02175121|11811488|FG000|Overall Study|Time issues|0
7493678|NCT02175121|11811489|FG001|Overall Study|Time issues|0
7493679|NCT02175121|11811490|FG002|Overall Study|Time issues|1
7493680|NCT02175121|11811491|FG003|Overall Study|Time issues|0
7493681|NCT02175121|11811492|FG004|Overall Study|Time issues|0
7493682|NCT02175199|11811510|FG000|Overall Study|Withdrawal by Subject|1
7493683|NCT02175199|11811511|FG001|Overall Study|Withdrawal by Subject|5
7493684|NCT02175199|11811510|FG000|Overall Study|Randomized in Error|1
7493685|NCT02175199|11811511|FG001|Overall Study|Randomized in Error|0
7493686|NCT02175199|11811510|FG000|Overall Study|Sponsor Decision|1
7493687|NCT02175199|11811511|FG001|Overall Study|Sponsor Decision|0
7493688|NCT02175225|11811529|FG000|Overall Study|Withdrawal by Subject|1
7493689|NCT02175225|11811530|FG001|Overall Study|Withdrawal by Subject|2
7493690|NCT02175225|11811529|FG000|Overall Study|Lost to Follow-up|6
7493691|NCT02175225|11811530|FG001|Overall Study|Lost to Follow-up|7
7493692|NCT02175225|11811529|FG000|Overall Study|Study drug not administered|1
7493693|NCT02175225|11811530|FG001|Overall Study|Study drug not administered|2
7493694|NCT02175277|11811536|FG000|Overall Study|Protocol-specified Criteria|1
7493695|NCT02175368|11811540|FG000|Overall Study|Lost to Follow-up|1
7493696|NCT02175641|11811555|FG000|Overall Study|Death|3
7493697|NCT02175641|11811556|FG001|Overall Study|Death|4
7493698|NCT02175641|11811555|FG000|Overall Study|Lost to Follow-up|4
7493699|NCT02175641|11811556|FG001|Overall Study|Lost to Follow-up|4
7493700|NCT02175641|11811555|FG000|Overall Study|Withdrawal by Subject|7
7493701|NCT02175641|11811556|FG001|Overall Study|Withdrawal by Subject|4
7493702|NCT02175641|11811555|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
7493703|NCT02175641|11811556|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
7493704|NCT02175641|11811555|FG000|Overall Study|Developed Contraindicated Condition|8
7493705|NCT02175641|11811556|FG001|Overall Study|Developed Contraindicated Condition|0
7493706|NCT02175745|11811562|FG000|Overall Study|Not Eligible|1
7493707|NCT02175758|11811572|FG000|Treatment Phase|Lost to Follow-up|0
7493708|NCT02175758|11811573|FG001|Treatment Phase|Lost to Follow-up|1
7493709|NCT02175758|11811574|FG002|Treatment Phase|Lost to Follow-up|0
7493710|NCT02175758|11811575|FG003|Treatment Phase|Lost to Follow-up|0
7493711|NCT02175758|11811576|FG004|Treatment Phase|Lost to Follow-up|0
7493712|NCT02175758|11811577|FG005|Treatment Phase|Lost to Follow-up|0
7493713|NCT02175758|11811572|FG000|Treatment Phase|Adverse Event|0
7493714|NCT02175758|11811573|FG001|Treatment Phase|Adverse Event|0
7493715|NCT02175758|11811574|FG002|Treatment Phase|Adverse Event|0
7493716|NCT02175758|11811575|FG003|Treatment Phase|Adverse Event|0
7493717|NCT02175758|11811576|FG004|Treatment Phase|Adverse Event|1
7493718|NCT02175758|11811577|FG005|Treatment Phase|Adverse Event|0
7493719|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
7493720|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493721|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493722|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493723|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493724|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493725|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493726|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493727|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7493728|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
7493729|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493730|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493731|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493732|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493733|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493734|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493735|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493736|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7493737|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
7493738|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493739|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493740|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493819|NCT02175771|11811626|FG001|Treatment Period|Disease progression|0
7493741|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493742|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493743|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493744|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493745|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7493746|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
7493747|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
7493748|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
7493749|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
7493750|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
7493751|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
7493752|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
7493753|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
7493754|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
7493755|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
7493756|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493757|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493758|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493759|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493760|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493761|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493762|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493763|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7493764|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
7493765|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493766|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493767|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493768|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493769|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493770|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493771|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493772|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7493773|NCT02175771|11811625|FG000|Run-In Period (Pre-assignment)|Other|8
7493774|NCT02175771|11811626|FG001|Run-In Period (Pre-assignment)|Other|0
7493775|NCT02175771|11811627|FG002|Run-In Period (Pre-assignment)|Other|0
7493776|NCT02175771|11811628|FG003|Run-In Period (Pre-assignment)|Other|0
7493777|NCT02175771|11811629|FG004|Run-In Period (Pre-assignment)|Other|0
7493778|NCT02175771|11811630|FG005|Run-In Period (Pre-assignment)|Other|0
7493779|NCT02175771|11811631|FG006|Run-In Period (Pre-assignment)|Other|0
7493780|NCT02175771|11811632|FG007|Run-In Period (Pre-assignment)|Other|0
7493781|NCT02175771|11811633|FG008|Run-In Period (Pre-assignment)|Other|0
7493782|NCT02175771|11811625|FG000|Treatment Period|Adverse Event|0
7493783|NCT02175771|11811626|FG001|Treatment Period|Adverse Event|2
7493784|NCT02175771|11811627|FG002|Treatment Period|Adverse Event|1
7493785|NCT02175771|11811628|FG003|Treatment Period|Adverse Event|1
7493786|NCT02175771|11811629|FG004|Treatment Period|Adverse Event|1
7493787|NCT02175771|11811630|FG005|Treatment Period|Adverse Event|3
7493788|NCT02175771|11811631|FG006|Treatment Period|Adverse Event|2
7493789|NCT02175771|11811632|FG007|Treatment Period|Adverse Event|0
7493790|NCT02175771|11811633|FG008|Treatment Period|Adverse Event|1
7493791|NCT02175771|11811625|FG000|Treatment Period|Withdrawal by Subject|0
7493792|NCT02175771|11811626|FG001|Treatment Period|Withdrawal by Subject|9
7493793|NCT02175771|11811627|FG002|Treatment Period|Withdrawal by Subject|3
7493794|NCT02175771|11811628|FG003|Treatment Period|Withdrawal by Subject|6
7493795|NCT02175771|11811629|FG004|Treatment Period|Withdrawal by Subject|2
7493796|NCT02175771|11811630|FG005|Treatment Period|Withdrawal by Subject|4
7493797|NCT02175771|11811631|FG006|Treatment Period|Withdrawal by Subject|2
7493798|NCT02175771|11811632|FG007|Treatment Period|Withdrawal by Subject|9
7493799|NCT02175771|11811633|FG008|Treatment Period|Withdrawal by Subject|2
7493800|NCT02175771|11811625|FG000|Treatment Period|Noncompliance|0
7493801|NCT02175771|11811626|FG001|Treatment Period|Noncompliance|1
7493802|NCT02175771|11811627|FG002|Treatment Period|Noncompliance|2
7493803|NCT02175771|11811628|FG003|Treatment Period|Noncompliance|0
7493804|NCT02175771|11811629|FG004|Treatment Period|Noncompliance|0
7493805|NCT02175771|11811630|FG005|Treatment Period|Noncompliance|0
7493806|NCT02175771|11811631|FG006|Treatment Period|Noncompliance|0
7493807|NCT02175771|11811632|FG007|Treatment Period|Noncompliance|0
7493808|NCT02175771|11811633|FG008|Treatment Period|Noncompliance|1
7493809|NCT02175771|11811625|FG000|Treatment Period|Protocol Violation|0
7493810|NCT02175771|11811626|FG001|Treatment Period|Protocol Violation|0
7493811|NCT02175771|11811627|FG002|Treatment Period|Protocol Violation|0
7493812|NCT02175771|11811628|FG003|Treatment Period|Protocol Violation|0
7493813|NCT02175771|11811629|FG004|Treatment Period|Protocol Violation|0
7493814|NCT02175771|11811630|FG005|Treatment Period|Protocol Violation|0
7493815|NCT02175771|11811631|FG006|Treatment Period|Protocol Violation|0
7493816|NCT02175771|11811632|FG007|Treatment Period|Protocol Violation|1
7493817|NCT02175771|11811633|FG008|Treatment Period|Protocol Violation|0
7493818|NCT02175771|11811625|FG000|Treatment Period|Disease progression|0
7493820|NCT02175771|11811627|FG002|Treatment Period|Disease progression|0
7493821|NCT02175771|11811628|FG003|Treatment Period|Disease progression|0
7493822|NCT02175771|11811629|FG004|Treatment Period|Disease progression|0
7493823|NCT02175771|11811630|FG005|Treatment Period|Disease progression|0
7493824|NCT02175771|11811631|FG006|Treatment Period|Disease progression|0
7493825|NCT02175771|11811632|FG007|Treatment Period|Disease progression|2
7493826|NCT02175771|11811633|FG008|Treatment Period|Disease progression|0
7493827|NCT02175771|11811625|FG000|Treatment Period|Lost to Follow-up|0
7493828|NCT02175771|11811626|FG001|Treatment Period|Lost to Follow-up|3
7493829|NCT02175771|11811627|FG002|Treatment Period|Lost to Follow-up|1
7493830|NCT02175771|11811628|FG003|Treatment Period|Lost to Follow-up|3
7493831|NCT02175771|11811629|FG004|Treatment Period|Lost to Follow-up|1
7493832|NCT02175771|11811630|FG005|Treatment Period|Lost to Follow-up|2
7493833|NCT02175771|11811631|FG006|Treatment Period|Lost to Follow-up|1
7493834|NCT02175771|11811632|FG007|Treatment Period|Lost to Follow-up|2
7493835|NCT02175771|11811633|FG008|Treatment Period|Lost to Follow-up|2
7493836|NCT02175771|11811625|FG000|Treatment Period|Lack of Efficacy|0
7493837|NCT02175771|11811626|FG001|Treatment Period|Lack of Efficacy|0
7493838|NCT02175771|11811627|FG002|Treatment Period|Lack of Efficacy|0
7493839|NCT02175771|11811628|FG003|Treatment Period|Lack of Efficacy|0
7493840|NCT02175771|11811629|FG004|Treatment Period|Lack of Efficacy|0
7493841|NCT02175771|11811630|FG005|Treatment Period|Lack of Efficacy|1
7493842|NCT02175771|11811631|FG006|Treatment Period|Lack of Efficacy|0
7493843|NCT02175771|11811632|FG007|Treatment Period|Lack of Efficacy|1
7493844|NCT02175771|11811633|FG008|Treatment Period|Lack of Efficacy|0
7493845|NCT02175771|11811625|FG000|Treatment Period|Other|0
7493846|NCT02175771|11811626|FG001|Treatment Period|Other|1
7493847|NCT02175771|11811627|FG002|Treatment Period|Other|0
7493848|NCT02175771|11811628|FG003|Treatment Period|Other|3
7493849|NCT02175771|11811629|FG004|Treatment Period|Other|1
7493850|NCT02175771|11811630|FG005|Treatment Period|Other|0
7493851|NCT02175771|11811631|FG006|Treatment Period|Other|0
7493852|NCT02175771|11811632|FG007|Treatment Period|Other|2
7493853|NCT02175771|11811633|FG008|Treatment Period|Other|0
7493854|NCT02175966|11811653|FG000|Follow-up Period|Lack of Efficacy|10
7493855|NCT02175966|11811654|FG001|Follow-up Period|Lack of Efficacy|6
7493856|NCT02176018|11811688|FG000|Overall Study|Adverse Event|0
7493857|NCT02176018|11811689|FG001|Overall Study|Adverse Event|2
7493858|NCT02176018|11811688|FG000|Overall Study|Lost to Follow-up|3
7493859|NCT02176018|11811689|FG001|Overall Study|Lost to Follow-up|1
7493860|NCT02176018|11811688|FG000|Overall Study|Protocol Violation|1
7493861|NCT02176018|11811689|FG001|Overall Study|Protocol Violation|1
7493862|NCT02176018|11811688|FG000|Overall Study|Withdrawal by Subject|1
7493863|NCT02176018|11811689|FG001|Overall Study|Withdrawal by Subject|2
7493864|NCT02176226|11811709|FG000|Overall Study|Lost to Follow-up|3
7493865|NCT02176226|11811709|FG000|Overall Study|Withdrew prior to treatment|6
7493866|NCT02176291|11811715|FG000|Overall Study|Death|1
7493867|NCT02176291|11811716|FG001|Overall Study|Death|0
7493868|NCT02176291|11811715|FG000|Overall Study|non compliance with protocol|2
7493869|NCT02176291|11811716|FG001|Overall Study|non compliance with protocol|0
7493870|NCT02176291|11811715|FG000|Overall Study|Withdrawal by Subject|2
7493871|NCT02176291|11811716|FG001|Overall Study|Withdrawal by Subject|0
7493872|NCT02176356|11811726|FG000|Overall Study|Screen Failure|14
7493873|NCT02176356|11811726|FG000|Overall Study|Lost to Follow-up|4
7493874|NCT02176356|11811726|FG000|Overall Study|Personal Reasons|3
7493875|NCT02176356|11811726|FG000|Overall Study|Other Miscellaneous Reasons|2
7493876|NCT02176421|11811748|FG000|Overall Study|Lost to Follow-up|4
7493877|NCT02176421|11811748|FG000|Overall Study|Adverse Event|1
7493878|NCT02176525|11811775|FG000|Overall Study|Adverse Event|0
7493879|NCT02176525|11811776|FG001|Overall Study|Adverse Event|0
7493880|NCT02176525|11811777|FG002|Overall Study|Adverse Event|0
7493881|NCT02176525|11811778|FG003|Overall Study|Adverse Event|1
7493882|NCT02176525|11811779|FG004|Overall Study|Adverse Event|1
7493883|NCT02176525|11811780|FG005|Overall Study|Adverse Event|0
7493884|NCT02176525|11811781|FG006|Overall Study|Adverse Event|1
7493885|NCT02176525|11811782|FG007|Overall Study|Adverse Event|0
7493886|NCT02176525|11811775|FG000|Overall Study|not treated|1
7493887|NCT02176525|11811776|FG001|Overall Study|not treated|0
7493888|NCT02176525|11811777|FG002|Overall Study|not treated|0
7493889|NCT02176525|11811778|FG003|Overall Study|not treated|0
7493890|NCT02176525|11811779|FG004|Overall Study|not treated|0
7493891|NCT02176525|11811780|FG005|Overall Study|not treated|1
7493892|NCT02176525|11811781|FG006|Overall Study|not treated|0
7493893|NCT02176525|11811782|FG007|Overall Study|not treated|0
7493894|NCT02176642|11811810|FG000|Overall Study|Withdrawal by Subject|0
7493895|NCT02176642|11811811|FG001|Overall Study|Withdrawal by Subject|1
7493896|NCT02176655|11811817|FG000|Overall Study|Subjects did not treat|6
7493897|NCT02176928|11811828|FG000|Overall Study|Lost to Follow-up|2
7493898|NCT02176928|11811829|FG001|Overall Study|Lost to Follow-up|4
7493899|NCT02177032|11811839|FG000|Overall Study|ADMINISTRATIVE REASON|2
7493900|NCT02177032|11811840|FG001|Overall Study|ADMINISTRATIVE REASON|0
7493901|NCT02177032|11811841|FG002|Overall Study|ADMINISTRATIVE REASON|1
7493902|NCT02177032|11811842|FG003|Overall Study|ADMINISTRATIVE REASON|0
7493903|NCT02177032|11811839|FG000|Overall Study|Lost to Follow-up|0
7493904|NCT02177032|11811840|FG001|Overall Study|Lost to Follow-up|2
7493905|NCT02177032|11811841|FG002|Overall Study|Lost to Follow-up|0
7493906|NCT02177032|11811842|FG003|Overall Study|Lost to Follow-up|0
7493907|NCT02177032|11811839|FG000|Overall Study|OTHER|2
7493908|NCT02177032|11811840|FG001|Overall Study|OTHER|0
7493909|NCT02177032|11811841|FG002|Overall Study|OTHER|1
7493910|NCT02177032|11811842|FG003|Overall Study|OTHER|0
7493911|NCT02177032|11811839|FG000|Overall Study|Withdrawal by Subject|1
7493912|NCT02177032|11811840|FG001|Overall Study|Withdrawal by Subject|0
7493913|NCT02177032|11811841|FG002|Overall Study|Withdrawal by Subject|1
7493914|NCT02177032|11811842|FG003|Overall Study|Withdrawal by Subject|0
7493915|NCT02177123|11811863|FG000|Overall Study|Lost to Follow-up|6
7493916|NCT02177123|11811863|FG000|Overall Study|Withdrawal by Subject|4
7493917|NCT02177123|11811863|FG000|Overall Study|Adverse Event|4
7493918|NCT02177123|11811863|FG000|Overall Study|Physician Decision|3
7493919|NCT02177123|11811863|FG000|Overall Study|Excluded by Sponsor - other reason|2
7493920|NCT02177123|11811863|FG000|Overall Study|Excluded for medical reasons|2
7493921|NCT02177123|11811863|FG000|Overall Study|Death|1
7493922|NCT02177123|11811863|FG000|Overall Study|Other|1
7493923|NCT02177123|11811863|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
7493924|NCT02177136|11811873|FG000|DB Phase|Withdrawal by Subject|2
7493925|NCT02177136|11811874|FG001|DB Phase|Withdrawal by Subject|0
7493926|NCT02177136|11811875|FG002|DB Phase|Withdrawal by Subject|0
7493927|NCT02177136|11811876|FG003|DB Phase|Withdrawal by Subject|0
7493928|NCT02177136|11811873|FG000|DB Phase|Discontinued Due to Pruritus|1
7493929|NCT02177136|11811874|FG001|DB Phase|Discontinued Due to Pruritus|3
7493930|NCT02177136|11811875|FG002|DB Phase|Discontinued Due to Pruritus|0
7493931|NCT02177136|11811876|FG003|DB Phase|Discontinued Due to Pruritus|0
7493932|NCT02177136|11811873|FG000|DB Phase|Adverse Event|3
7493933|NCT02177136|11811874|FG001|DB Phase|Adverse Event|2
7493934|NCT02177136|11811875|FG002|DB Phase|Adverse Event|3
7493935|NCT02177136|11811876|FG003|DB Phase|Adverse Event|0
7493936|NCT02177136|11811873|FG000|DB Phase|Protocol Violation|0
7493937|NCT02177136|11811874|FG001|DB Phase|Protocol Violation|0
7493938|NCT02177136|11811875|FG002|DB Phase|Protocol Violation|1
7493939|NCT02177136|11811876|FG003|DB Phase|Protocol Violation|0
7493940|NCT02177136|11811873|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
7493941|NCT02177136|11811874|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
7493942|NCT02177136|11811875|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
7493943|NCT02177136|11811876|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
7493944|NCT02177136|11811873|FG000|LTSE Phase|Withdrawal by Subject|0
7493945|NCT02177136|11811874|FG001|LTSE Phase|Withdrawal by Subject|0
7493946|NCT02177136|11811875|FG002|LTSE Phase|Withdrawal by Subject|0
7493947|NCT02177136|11811876|FG003|LTSE Phase|Withdrawal by Subject|6
7493948|NCT02177136|11811873|FG000|LTSE Phase|Adverse Event|0
7493949|NCT02177136|11811874|FG001|LTSE Phase|Adverse Event|0
7493950|NCT02177136|11811875|FG002|LTSE Phase|Adverse Event|0
7493951|NCT02177136|11811876|FG003|LTSE Phase|Adverse Event|10
7493952|NCT02177136|11811873|FG000|LTSE Phase|Discontinued Due to Pruritus|0
7493953|NCT02177136|11811874|FG001|LTSE Phase|Discontinued Due to Pruritus|0
7493954|NCT02177136|11811875|FG002|LTSE Phase|Discontinued Due to Pruritus|0
7493955|NCT02177136|11811876|FG003|LTSE Phase|Discontinued Due to Pruritus|4
7493956|NCT02177136|11811873|FG000|LTSE Phase|Physician Decision|0
7493957|NCT02177136|11811874|FG001|LTSE Phase|Physician Decision|0
7493958|NCT02177136|11811875|FG002|LTSE Phase|Physician Decision|0
7493959|NCT02177136|11811876|FG003|LTSE Phase|Physician Decision|2
7493960|NCT02177136|11811873|FG000|LTSE Phase|Lost to Follow-up|0
7493961|NCT02177136|11811874|FG001|LTSE Phase|Lost to Follow-up|0
7493962|NCT02177136|11811875|FG002|LTSE Phase|Lost to Follow-up|0
7493963|NCT02177136|11811876|FG003|LTSE Phase|Lost to Follow-up|1
7493964|NCT02177136|11811873|FG000|LTSE Phase|Participant Moved|0
7493965|NCT02177136|11811874|FG001|LTSE Phase|Participant Moved|0
7493966|NCT02177136|11811875|FG002|LTSE Phase|Participant Moved|0
7493967|NCT02177136|11811876|FG003|LTSE Phase|Participant Moved|1
7493968|NCT02177786|11811900|FG000|Overall Study|Withdrew Consent|2
7493969|NCT02177786|11811901|FG001|Overall Study|Withdrew Consent|6
7493970|NCT02177786|11811902|FG002|Overall Study|Withdrew Consent|9
7493971|NCT02177786|11811903|FG003|Overall Study|Withdrew Consent|5
7493972|NCT02177786|11811900|FG000|Overall Study|Progression to End Stage Renal Disease|2
7493973|NCT02177786|11811901|FG001|Overall Study|Progression to End Stage Renal Disease|3
7493974|NCT02177786|11811902|FG002|Overall Study|Progression to End Stage Renal Disease|2
7493975|NCT02177786|11811903|FG003|Overall Study|Progression to End Stage Renal Disease|1
7493976|NCT02177786|11811900|FG000|Overall Study|Adverse Event|1
7493977|NCT02177786|11811901|FG001|Overall Study|Adverse Event|1
7493978|NCT02177786|11811902|FG002|Overall Study|Adverse Event|2
7493979|NCT02177786|11811903|FG003|Overall Study|Adverse Event|3
7493980|NCT02177786|11811900|FG000|Overall Study|Death|1
7493981|NCT02177786|11811901|FG001|Overall Study|Death|1
7493982|NCT02177786|11811902|FG002|Overall Study|Death|1
7493983|NCT02177786|11811903|FG003|Overall Study|Death|1
7493984|NCT02177786|11811900|FG000|Overall Study|Lost to Follow-up|0
7493985|NCT02177786|11811901|FG001|Overall Study|Lost to Follow-up|0
7493986|NCT02177786|11811902|FG002|Overall Study|Lost to Follow-up|2
7493987|NCT02177786|11811903|FG003|Overall Study|Lost to Follow-up|2
7493988|NCT02177786|11811900|FG000|Overall Study|Non-Compliance with Study Drug|0
7493989|NCT02177786|11811901|FG001|Overall Study|Non-Compliance with Study Drug|1
7493990|NCT02177786|11811902|FG002|Overall Study|Non-Compliance with Study Drug|0
7493991|NCT02177786|11811903|FG003|Overall Study|Non-Compliance with Study Drug|1
7493992|NCT02177786|11811900|FG000|Overall Study|Protocol Violation|0
7493993|NCT02177786|11811901|FG001|Overall Study|Protocol Violation|0
7493994|NCT02177786|11811902|FG002|Overall Study|Protocol Violation|2
7493995|NCT02177786|11811903|FG003|Overall Study|Protocol Violation|0
7493996|NCT02177786|11811900|FG000|Overall Study|Progressive Disease|0
7493997|NCT02177786|11811901|FG001|Overall Study|Progressive Disease|1
7493998|NCT02177786|11811902|FG002|Overall Study|Progressive Disease|0
7493999|NCT02177786|11811903|FG003|Overall Study|Progressive Disease|0
7494000|NCT02177786|11811900|FG000|Overall Study|Missing study completion status|0
7494001|NCT02177786|11811901|FG001|Overall Study|Missing study completion status|1
7494002|NCT02177786|11811902|FG002|Overall Study|Missing study completion status|0
7494003|NCT02177786|11811903|FG003|Overall Study|Missing study completion status|0
7494004|NCT02177812|11811922|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494005|NCT02177812|11811923|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494006|NCT02177812|11811924|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494007|NCT02177812|11811925|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494008|NCT02177812|11811926|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494009|NCT02177812|11811927|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7494010|NCT02177812|11811928|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
7494011|NCT02177812|11811929|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
7494012|NCT02177812|11811930|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
7494013|NCT02177812|11811922|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494014|NCT02177812|11811923|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494015|NCT02177812|11811924|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494016|NCT02177812|11811925|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494017|NCT02177812|11811926|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494018|NCT02177812|11811927|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
7494019|NCT02177812|11811928|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
7494020|NCT02177812|11811929|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494021|NCT02177812|11811930|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
7494022|NCT02177812|11811922|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
7494023|NCT02177812|11811923|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
7494024|NCT02177812|11811924|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
7494025|NCT02177812|11811925|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
7494026|NCT02177812|11811926|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
7494027|NCT02177812|11811927|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
7494028|NCT02177812|11811928|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
7494029|NCT02177812|11811929|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
7494030|NCT02177812|11811930|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
7494031|NCT02177838|11811959|FG000|Overall Study|Withdrawal by Subject|1
7494032|NCT02177838|11811959|FG000|Overall Study|Physician Decision|1
7494033|NCT02177838|11811959|FG000|Overall Study|Death|1
7494034|NCT02177942|11811965|FG000|Overall Study|Adverse Event|1
7494035|NCT02177942|11811966|FG001|Overall Study|Adverse Event|0
7494036|NCT02177942|11811965|FG000|Overall Study|Lost to Follow-up|1
7494037|NCT02177942|11811966|FG001|Overall Study|Lost to Follow-up|1
7494038|NCT02177942|11811965|FG000|Overall Study|Protocol Violation|4
7494039|NCT02177942|11811966|FG001|Overall Study|Protocol Violation|6
7494040|NCT02177942|11811965|FG000|Overall Study|Withdrawal by Subject|71
7494041|NCT02177942|11811966|FG001|Overall Study|Withdrawal by Subject|81
7494042|NCT02178059|11811976|FG000|Washout|Physician Decision|1
7494043|NCT02178059|11811977|FG001|Washout|Physician Decision|0
7494044|NCT02178475|11811987|FG000|Overall Study|Withdrawal by Subject|7
7494045|NCT02178475|11811987|FG000|Overall Study|Lost to Follow-up|10
7494046|NCT02178475|11811987|FG000|Overall Study|Death|13
7494047|NCT02178475|11811987|FG000|Overall Study|Protocol-specified Criteria|99
7494048|NCT02178553|11812000|FG000|Overall Study|Did not proceed to open thoracotomy|7
7494049|NCT02178553|11812001|FG001|Overall Study|Did not proceed to open thoracotomy|3
7494050|NCT02178553|11812000|FG000|Overall Study|Physician Decision|0
7494051|NCT02178553|11812001|FG001|Overall Study|Physician Decision|4
7494052|NCT02178553|11812000|FG000|Overall Study|Technical problem with injection|1
7494053|NCT02178553|11812001|FG001|Overall Study|Technical problem with injection|3
7494054|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
7494055|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
7494056|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7494057|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
7494058|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
7494059|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
7494060|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
7494061|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
7494062|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
7494063|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
7494064|NCT02178592|11812009|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
7494065|NCT02178592|11812010|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
7494066|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
7494067|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
7494068|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
7494069|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
7494070|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
7494071|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
7494072|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
7494073|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
7494074|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
7494075|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
7494076|NCT02178592|11812009|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
7494077|NCT02178592|11812010|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
7494078|NCT02178787|11812033|FG000|Overall Study|Lost to Follow-up|1
7494079|NCT02178787|11812034|FG001|Overall Study|Lost to Follow-up|0
7494080|NCT02178787|11812033|FG000|Overall Study|Withdrawal by Subject|0
7494081|NCT02178787|11812034|FG001|Overall Study|Withdrawal by Subject|2
7494082|NCT02178787|11812033|FG000|Overall Study|No TCD window|3
7494083|NCT02178787|11812034|FG001|Overall Study|No TCD window|7
7494084|NCT02178787|11812033|FG000|Overall Study|Physician Decision|1
7494085|NCT02178787|11812034|FG001|Overall Study|Physician Decision|0
7494086|NCT02178995|11812061|FG000|Double Blind|Adverse Event|0
7494087|NCT02178995|11812062|FG001|Double Blind|Adverse Event|0
7494088|NCT02178995|11812063|FG002|Double Blind|Adverse Event|0
7494089|NCT02178995|11812064|FG003|Double Blind|Adverse Event|0
7494090|NCT02178995|11812065|FG004|Double Blind|Adverse Event|0
7494091|NCT02178995|11812066|FG005|Double Blind|Adverse Event|1
7494092|NCT02178995|11812067|FG006|Double Blind|Adverse Event|0
7494093|NCT02178995|11812068|FG007|Double Blind|Adverse Event|1
7494094|NCT02178995|11812069|FG008|Double Blind|Adverse Event|1
7494095|NCT02178995|11812061|FG000|Double Blind|Lost to Follow-up|0
7494096|NCT02178995|11812062|FG001|Double Blind|Lost to Follow-up|1
7494097|NCT02178995|11812063|FG002|Double Blind|Lost to Follow-up|0
7494098|NCT02178995|11812064|FG003|Double Blind|Lost to Follow-up|0
7494099|NCT02178995|11812065|FG004|Double Blind|Lost to Follow-up|0
7494100|NCT02178995|11812066|FG005|Double Blind|Lost to Follow-up|0
7494101|NCT02178995|11812067|FG006|Double Blind|Lost to Follow-up|0
7494102|NCT02178995|11812068|FG007|Double Blind|Lost to Follow-up|1
7494103|NCT02178995|11812069|FG008|Double Blind|Lost to Follow-up|0
7494104|NCT02178995|11812061|FG000|Open Label|Adverse Event|2
7494105|NCT02178995|11812062|FG001|Open Label|Adverse Event|0
7494106|NCT02178995|11812063|FG002|Open Label|Adverse Event|0
7494107|NCT02178995|11812064|FG003|Open Label|Adverse Event|0
7494108|NCT02178995|11812065|FG004|Open Label|Adverse Event|0
7494109|NCT02178995|11812066|FG005|Open Label|Adverse Event|0
7494110|NCT02178995|11812067|FG006|Open Label|Adverse Event|0
7494111|NCT02178995|11812068|FG007|Open Label|Adverse Event|0
7494112|NCT02178995|11812069|FG008|Open Label|Adverse Event|0
7494113|NCT02179177|11812115|FG000|Overall Study|Lost to Follow-up|1
7494114|NCT02179177|11812116|FG001|Overall Study|Lost to Follow-up|1
7494115|NCT02179177|11812115|FG000|Overall Study|Withdrawal by Subject|1
7494116|NCT02179177|11812116|FG001|Overall Study|Withdrawal by Subject|1
7494117|NCT02179190|11812122|FG000|Enrollment|Exit Prior to Device Attempt|11
7494118|NCT02179190|11812122|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
7494119|NCT02179190|11812122|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
7494120|NCT02179190|11812122|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
7494121|NCT02179190|11812122|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
7494122|NCT02179190|11812122|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
7494123|NCT02179398|11812128|FG000|Overall Study|Lack of obligatory data|3
7494124|NCT02179398|11812129|FG001|Overall Study|Lack of obligatory data|3
7494125|NCT02179398|11812128|FG000|Overall Study|Lost to Follow-up|0
7494126|NCT02179398|11812129|FG001|Overall Study|Lost to Follow-up|1
7494127|NCT02179515|11812160|FG000|Overall Study|switched to alternative treatment|0
7494128|NCT02179515|11812161|FG001|Overall Study|switched to alternative treatment|1
7494129|NCT02179515|11812162|FG002|Overall Study|switched to alternative treatment|1
7494130|NCT02179515|11812160|FG000|Overall Study|Death|0
7494131|NCT02179515|11812161|FG001|Overall Study|Death|1
7494132|NCT02179515|11812162|FG002|Overall Study|Death|1
7494133|NCT02179515|11812160|FG000|Overall Study|refused further treatment|0
7494134|NCT02179515|11812161|FG001|Overall Study|refused further treatment|3
7494135|NCT02179515|11812162|FG002|Overall Study|refused further treatment|4
7494136|NCT02179515|11812160|FG000|Overall Study|Disease progression on study|2
7494137|NCT02179515|11812161|FG001|Overall Study|Disease progression on study|11
7494138|NCT02179515|11812162|FG002|Overall Study|Disease progression on study|8
7494139|NCT02179918|11812218|FG000|Overall Study|Death|0
7494140|NCT02179918|11812219|FG001|Overall Study|Death|0
7494141|NCT02179918|11812220|FG002|Overall Study|Death|0
7494142|NCT02179918|11812221|FG003|Overall Study|Death|1
7494143|NCT02179918|11812222|FG004|Overall Study|Death|0
7494144|NCT02179918|11812218|FG000|Overall Study|Lost to Follow-up|0
7494145|NCT02179918|11812219|FG001|Overall Study|Lost to Follow-up|0
7494146|NCT02179918|11812220|FG002|Overall Study|Lost to Follow-up|1
7494147|NCT02179918|11812221|FG003|Overall Study|Lost to Follow-up|0
7494148|NCT02179918|11812222|FG004|Overall Study|Lost to Follow-up|0
7494149|NCT02179918|11812218|FG000|Overall Study|Progressive Disease|4
7494150|NCT02179918|11812219|FG001|Overall Study|Progressive Disease|1
7494151|NCT02179918|11812220|FG002|Overall Study|Progressive Disease|1
7494152|NCT02179918|11812221|FG003|Overall Study|Progressive Disease|2
7494153|NCT02179918|11812222|FG004|Overall Study|Progressive Disease|6
7494154|NCT02179918|11812218|FG000|Overall Study|Other|0
7494155|NCT02179918|11812219|FG001|Overall Study|Other|1
7494156|NCT02179918|11812220|FG002|Overall Study|Other|0
7494157|NCT02179918|11812221|FG003|Overall Study|Other|0
7494158|NCT02179918|11812222|FG004|Overall Study|Other|1
7494159|NCT02179918|11812218|FG000|Overall Study|Subject refused further follow-up|0
7494160|NCT02179918|11812219|FG001|Overall Study|Subject refused further follow-up|1
7494161|NCT02179918|11812220|FG002|Overall Study|Subject refused further follow-up|0
7494162|NCT02179918|11812221|FG003|Overall Study|Subject refused further follow-up|0
7494163|NCT02179918|11812222|FG004|Overall Study|Subject refused further follow-up|1
7494164|NCT02180061|11812237|FG000|Overall Study|Adverse Event|4
7494165|NCT02180061|11812238|FG001|Overall Study|Adverse Event|2
7494166|NCT02180061|11812237|FG000|Overall Study|Clinical Progression|5
7494167|NCT02180061|11812238|FG001|Overall Study|Clinical Progression|1
7494168|NCT02180061|11812237|FG000|Overall Study|Progressive Disease|15
7494169|NCT02180061|11812238|FG001|Overall Study|Progressive Disease|5
7494170|NCT02180061|11812237|FG000|Overall Study|Physician Decision|1
7494171|NCT02180061|11812238|FG001|Overall Study|Physician Decision|0
7494172|NCT02180165|11812257|FG000|Overall Study|Not Treated|0
7494173|NCT02180165|11812258|FG001|Overall Study|Not Treated|0
7494174|NCT02180165|11812259|FG002|Overall Study|Not Treated|1
7494175|NCT02180165|11812260|FG003|Overall Study|Not Treated|0
7494176|NCT02180165|11812257|FG000|Overall Study|Adverse Event|7
7494177|NCT02180165|11812258|FG001|Overall Study|Adverse Event|0
7494178|NCT02180165|11812259|FG002|Overall Study|Adverse Event|18
7494179|NCT02180165|11812260|FG003|Overall Study|Adverse Event|3
7494180|NCT02180165|11812257|FG000|Overall Study|Lack of Efficacy|0
7494181|NCT02180165|11812258|FG001|Overall Study|Lack of Efficacy|1
7494182|NCT02180165|11812259|FG002|Overall Study|Lack of Efficacy|3
7494183|NCT02180165|11812260|FG003|Overall Study|Lack of Efficacy|2
7494184|NCT02180165|11812257|FG000|Overall Study|Physician Decision|1
7494185|NCT02180165|11812258|FG001|Overall Study|Physician Decision|0
7494186|NCT02180165|11812259|FG002|Overall Study|Physician Decision|5
7494187|NCT02180165|11812260|FG003|Overall Study|Physician Decision|0
7494188|NCT02180165|11812257|FG000|Overall Study|Withdrawal by Subject|3
7494189|NCT02180165|11812258|FG001|Overall Study|Withdrawal by Subject|0
7494190|NCT02180165|11812259|FG002|Overall Study|Withdrawal by Subject|2
7494191|NCT02180165|11812260|FG003|Overall Study|Withdrawal by Subject|1
7494192|NCT02180438|11812276|FG000|Overall Study|Lost to Follow-up|1
7494193|NCT02180659|11812293|FG000|Overall Study|Adverse Event|1
7494194|NCT02180659|11812294|FG001|Overall Study|Adverse Event|0
7494195|NCT02180659|11812293|FG000|Overall Study|Lost to Follow-up|4
7494196|NCT02180659|11812294|FG001|Overall Study|Lost to Follow-up|2
7494197|NCT02180659|11812293|FG000|Overall Study|Subject incarcerated during conduct|1
7494198|NCT02180659|11812294|FG001|Overall Study|Subject incarcerated during conduct|0
7494199|NCT02180659|11812293|FG000|Overall Study|Withdrawal by Subject|0
7494200|NCT02180659|11812294|FG001|Overall Study|Withdrawal by Subject|2
7494201|NCT02180659|11812293|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
7494202|NCT02180659|11812294|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
7494203|NCT02180672|11812302|FG000|Overall Study|Lost to Follow-up|5
7494204|NCT02180672|11812303|FG001|Overall Study|Lost to Follow-up|7
7494205|NCT02181296|11812364|FG000|Overall Study|Lost to Follow-up|7
7494206|NCT02181296|11812365|FG001|Overall Study|Lost to Follow-up|6
7494207|NCT02181504|11812413|FG000|Overall Study|Adverse Event|1
7494208|NCT02181504|11812414|FG001|Overall Study|Adverse Event|1
7494209|NCT02181504|11812415|FG002|Overall Study|Adverse Event|1
7494210|NCT02181556|11812441|FG000|Overall Study|Withdrawal by Subject|1
7494211|NCT02181634|11812445|FG000|Overall Study|Lack of Efficacy|33
7494212|NCT02181634|11812445|FG000|Overall Study|Adverse Event|17
7494213|NCT02181634|11812445|FG000|Overall Study|Physician Decision|8
7494214|NCT02181634|11812445|FG000|Overall Study|Withdrawal by Subject|5
7494215|NCT02181634|11812445|FG000|Overall Study|Death|2
7494216|NCT02181634|11812445|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
7494217|NCT02181634|11812445|FG000|Overall Study|Ineligible|1
7494218|NCT02181634|11812445|FG000|Overall Study|Max number of dose reduction|1
7494219|NCT02181634|11812445|FG000|Overall Study|Symptomatic progression|1
7494220|NCT02181634|11812445|FG000|Overall Study|Patient opted to proceed to surgery|1
7494221|NCT02181673|11812451|FG000|Up to Week 24|Adverse Event|2
7494222|NCT02181673|11812452|FG001|Up to Week 24|Adverse Event|0
7494223|NCT02181673|11812453|FG002|Up to Week 24|Adverse Event|3
7494224|NCT02181673|11812451|FG000|Up to Week 24|Death|1
7494225|NCT02181673|11812452|FG001|Up to Week 24|Death|0
7494226|NCT02181673|11812453|FG002|Up to Week 24|Death|0
7494227|NCT02181673|11812451|FG000|Up to Week 24|Lack of Efficacy|1
7494228|NCT02181673|11812452|FG001|Up to Week 24|Lack of Efficacy|0
7494229|NCT02181673|11812453|FG002|Up to Week 24|Lack of Efficacy|0
7494230|NCT02181673|11812451|FG000|Up to Week 24|Lost to Follow-up|1
7494231|NCT02181673|11812452|FG001|Up to Week 24|Lost to Follow-up|0
7494232|NCT02181673|11812453|FG002|Up to Week 24|Lost to Follow-up|0
7494233|NCT02181673|11812451|FG000|Up to Week 24|Physician Decision|0
7494234|NCT02181673|11812452|FG001|Up to Week 24|Physician Decision|0
7494235|NCT02181673|11812453|FG002|Up to Week 24|Physician Decision|3
7494236|NCT02181673|11812451|FG000|Up to Week 24|Withdrawal by Subject|10
7494237|NCT02181673|11812452|FG001|Up to Week 24|Withdrawal by Subject|0
7494238|NCT02181673|11812453|FG002|Up to Week 24|Withdrawal by Subject|1
7494239|NCT02181673|11812451|FG000|Up to Week 24|Other|2
7494240|NCT02181673|11812452|FG001|Up to Week 24|Other|0
7494241|NCT02181673|11812453|FG002|Up to Week 24|Other|3
7494242|NCT02181673|11812451|FG000|Up to Week 24|Randomized not Treated|0
7494243|NCT02181673|11812452|FG001|Up to Week 24|Randomized not Treated|0
7494244|NCT02181673|11812453|FG002|Up to Week 24|Randomized not Treated|1
7494245|NCT02181673|11812451|FG000|Week 24-Week 60|Adverse Event|0
7494246|NCT02181673|11812452|FG001|Week 24-Week 60|Adverse Event|4
7494247|NCT02181673|11812453|FG002|Week 24-Week 60|Adverse Event|10
7494248|NCT02181673|11812451|FG000|Week 24-Week 60|Other|0
7494249|NCT02181673|11812452|FG001|Week 24-Week 60|Other|2
7494250|NCT02181673|11812453|FG002|Week 24-Week 60|Other|1
7494251|NCT02181673|11812451|FG000|Week 24-Week 60|Withdrawal by Subject|0
7494252|NCT02181673|11812452|FG001|Week 24-Week 60|Withdrawal by Subject|2
7494253|NCT02181673|11812453|FG002|Week 24-Week 60|Withdrawal by Subject|2
7494254|NCT02181673|11812451|FG000|Week 24-Week 60|Pregnancy|0
7494255|NCT02181673|11812452|FG001|Week 24-Week 60|Pregnancy|0
7494256|NCT02181673|11812453|FG002|Week 24-Week 60|Pregnancy|1
7494257|NCT02181673|11812451|FG000|Week 24-Week 60|Lack of Efficacy|0
7494258|NCT02181673|11812452|FG001|Week 24-Week 60|Lack of Efficacy|0
7494259|NCT02181673|11812453|FG002|Week 24-Week 60|Lack of Efficacy|1
7494260|NCT02181673|11812451|FG000|Week 24-Week 60|Lost to Follow-up|0
7494261|NCT02181673|11812452|FG001|Week 24-Week 60|Lost to Follow-up|0
7494262|NCT02181673|11812453|FG002|Week 24-Week 60|Lost to Follow-up|1
7494263|NCT02181673|11812451|FG000|Week 24-Week 60|Physician Decision|0
7494264|NCT02181673|11812452|FG001|Week 24-Week 60|Physician Decision|0
7494265|NCT02181673|11812453|FG002|Week 24-Week 60|Physician Decision|1
7494266|NCT02181738|11812464|FG000|Overall Study|Death|1
7494267|NCT02181738|11812465|FG001|Overall Study|Death|1
7494268|NCT02181738|11812466|FG002|Overall Study|Death|6
7494269|NCT02181738|11812467|FG003|Overall Study|Death|1
7494270|NCT02181738|11812464|FG000|Overall Study|Subject Withdrew Consent|1
7494271|NCT02181738|11812465|FG001|Overall Study|Subject Withdrew Consent|3
7494272|NCT02181738|11812466|FG002|Overall Study|Subject Withdrew Consent|2
7494273|NCT02181738|11812467|FG003|Overall Study|Subject Withdrew Consent|1
7494274|NCT02181738|11812464|FG000|Overall Study|Lost to Follow-up|0
7494275|NCT02181738|11812465|FG001|Overall Study|Lost to Follow-up|4
7494276|NCT02181738|11812466|FG002|Overall Study|Lost to Follow-up|2
7494277|NCT02181738|11812467|FG003|Overall Study|Lost to Follow-up|0
7494278|NCT02181738|11812464|FG000|Overall Study|Patient Return to Home Country|0
7494279|NCT02181738|11812465|FG001|Overall Study|Patient Return to Home Country|1
7494280|NCT02181738|11812466|FG002|Overall Study|Patient Return to Home Country|0
7494281|NCT02181738|11812467|FG003|Overall Study|Patient Return to Home Country|0
7494282|NCT02181803|11812486|FG000|Overall Study|Withdrawal by Subject|0
7494283|NCT02181803|11812487|FG001|Overall Study|Withdrawal by Subject|2
7494284|NCT02181803|11812488|FG002|Overall Study|Withdrawal by Subject|0
7494285|NCT02181803|11812489|FG003|Overall Study|Withdrawal by Subject|0
7494286|NCT02181803|11812490|FG004|Overall Study|Withdrawal by Subject|0
7494287|NCT02181803|11812491|FG005|Overall Study|Withdrawal by Subject|0
7494288|NCT02181803|11812492|FG006|Overall Study|Withdrawal by Subject|0
7494289|NCT02181803|11812493|FG007|Overall Study|Withdrawal by Subject|0
7494290|NCT02181803|11812494|FG008|Overall Study|Withdrawal by Subject|0
7494291|NCT02181803|11812486|FG000|Overall Study|Physician Decision|0
7494292|NCT02181803|11812487|FG001|Overall Study|Physician Decision|0
7494293|NCT02181803|11812488|FG002|Overall Study|Physician Decision|0
7494294|NCT02181803|11812489|FG003|Overall Study|Physician Decision|1
7494295|NCT02181803|11812490|FG004|Overall Study|Physician Decision|0
7494296|NCT02181803|11812491|FG005|Overall Study|Physician Decision|0
7494297|NCT02181803|11812492|FG006|Overall Study|Physician Decision|0
7494298|NCT02181803|11812493|FG007|Overall Study|Physician Decision|1
7494299|NCT02181803|11812494|FG008|Overall Study|Physician Decision|0
7494300|NCT02181803|11812486|FG000|Overall Study|Adverse Event|0
7494301|NCT02181803|11812487|FG001|Overall Study|Adverse Event|2
7494302|NCT02181803|11812488|FG002|Overall Study|Adverse Event|0
7494303|NCT02181803|11812489|FG003|Overall Study|Adverse Event|1
7494304|NCT02181803|11812490|FG004|Overall Study|Adverse Event|0
7494305|NCT02181803|11812491|FG005|Overall Study|Adverse Event|0
7494306|NCT02181803|11812492|FG006|Overall Study|Adverse Event|1
7494307|NCT02181803|11812493|FG007|Overall Study|Adverse Event|0
7494308|NCT02181803|11812494|FG008|Overall Study|Adverse Event|0
7535231|NCT02709109|11882974|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
7535232|NCT02709109|11882975|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7535233|NCT02709109|11882976|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
7535234|NCT02709109|11882973|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
7535235|NCT02709109|11882974|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7535236|NCT02709109|11882975|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7535237|NCT02709109|11882976|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
7535238|NCT02709109|11882973|FG000|Washout Period (28 Days)|Other|2
7535239|NCT02709109|11882974|FG001|Washout Period (28 Days)|Other|2
7535240|NCT02709109|11882975|FG002|Washout Period (28 Days)|Other|3
7535241|NCT02709109|11882976|FG003|Washout Period (28 Days)|Other|0
7535242|NCT02709109|11882973|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
7535243|NCT02709109|11882974|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
7535244|NCT02709109|11882975|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
7535245|NCT02709109|11882976|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
7535246|NCT02709109|11882973|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
7535247|NCT02709109|11882974|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
7535248|NCT02709109|11882975|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
7535249|NCT02709109|11882976|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
7535250|NCT02709109|11882973|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7535251|NCT02709109|11882974|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7535252|NCT02709109|11882975|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
7535253|NCT02709109|11882976|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
7494309|NCT02181816|11812539|FG000|Overall Study|Case Report Forms Uncollected|38
7494310|NCT02181816|11812539|FG000|Overall Study|Protocol Deviation|21
7494311|NCT02181842|11812547|FG000|Overall Study|Case Report Forms Uncollected|2
7494312|NCT02182440|11812564|FG000|Overall Study|Adverse Event|0
7494313|NCT02182440|11812565|FG001|Overall Study|Adverse Event|1
7494314|NCT02182440|11812566|FG002|Overall Study|Adverse Event|0
7494315|NCT02182440|11812567|FG003|Overall Study|Adverse Event|0
7494316|NCT02182440|11812564|FG000|Overall Study|Death|31
7494317|NCT02182440|11812565|FG001|Overall Study|Death|8
7494318|NCT02182440|11812566|FG002|Overall Study|Death|5
7494319|NCT02182440|11812567|FG003|Overall Study|Death|16
7494320|NCT02182440|11812564|FG000|Overall Study|Protocol Violation|0
7494321|NCT02182440|11812565|FG001|Overall Study|Protocol Violation|1
7494322|NCT02182440|11812566|FG002|Overall Study|Protocol Violation|0
7494323|NCT02182440|11812567|FG003|Overall Study|Protocol Violation|0
7494324|NCT02182440|11812564|FG000|Overall Study|Physician Decision|1
7494325|NCT02182440|11812565|FG001|Overall Study|Physician Decision|0
7494326|NCT02182440|11812566|FG002|Overall Study|Physician Decision|0
7494327|NCT02182440|11812567|FG003|Overall Study|Physician Decision|0
7494328|NCT02182440|11812564|FG000|Overall Study|Withdrawal by Subject|1
7494329|NCT02182440|11812565|FG001|Overall Study|Withdrawal by Subject|1
7494330|NCT02182440|11812566|FG002|Overall Study|Withdrawal by Subject|3
7494331|NCT02182440|11812567|FG003|Overall Study|Withdrawal by Subject|4
7494332|NCT02182440|11812564|FG000|Overall Study|different, e.g adm other hospital|12
7494333|NCT02182440|11812565|FG001|Overall Study|different, e.g adm other hospital|3
7494334|NCT02182440|11812566|FG002|Overall Study|different, e.g adm other hospital|3
7494335|NCT02182440|11812567|FG003|Overall Study|different, e.g adm other hospital|10
7494336|NCT02182830|11812594|FG000|Overall Study|Not Treated|1
7494337|NCT02182830|11812595|FG001|Overall Study|Not Treated|1
7494338|NCT02182830|11812594|FG000|Overall Study|Trial stopped, reason missing|3
7494339|NCT02182830|11812595|FG001|Overall Study|Trial stopped, reason missing|3
7494340|NCT02182830|11812594|FG000|Overall Study|Consent withdrawn|8
7494341|NCT02182830|11812595|FG001|Overall Study|Consent withdrawn|8
7494342|NCT02182830|11812594|FG000|Overall Study|Lost to Follow-up|3
7494343|NCT02182830|11812595|FG001|Overall Study|Lost to Follow-up|3
7494344|NCT02182843|11812601|FG000|Overall Study|Withdrawal by Subject|7
7494345|NCT02182843|11812601|FG000|Overall Study|Lost to Follow-up|2
7494346|NCT02182843|11812601|FG000|Overall Study|Adverse Event|1
7494347|NCT02182895|11812607|FG000|Overall Study|Discharged from hospital within 24 hours|2
7494348|NCT02182895|11812608|FG001|Overall Study|Discharged from hospital within 24 hours|4
7494349|NCT02182947|11812614|FG000|Overall Study|Withdrawal by Subject|7
7494350|NCT02182947|11812614|FG000|Overall Study|Lost to Follow-up|3
7494351|NCT02182947|11812614|FG000|Overall Study|Failed screening activities|8
7494352|NCT02182973|11812620|FG000|Overall Study|Withdrawal by Subject|3
7494353|NCT02182973|11812621|FG001|Overall Study|Withdrawal by Subject|0
7494354|NCT02182999|11812630|FG000|Overall Study|Adverse Event|4
7494355|NCT02182999|11812631|FG001|Overall Study|Adverse Event|3
7494356|NCT02182999|11812630|FG000|Overall Study|Physician Decision|1
7494357|NCT02182999|11812631|FG001|Overall Study|Physician Decision|0
7494358|NCT02183519|11812639|FG000|Overall Study|computer error|3
7494359|NCT02183519|11812640|FG001|Overall Study|computer error|0
7494360|NCT02183519|11812639|FG000|Overall Study|Did not respond to cough inducter|0
7494361|NCT02183519|11812640|FG001|Overall Study|Did not respond to cough inducter|3
7494362|NCT02183675|11812652|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
7494363|NCT02183675|11812653|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
7494364|NCT02183675|11812654|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
7494365|NCT02183675|11812655|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
7494366|NCT02183675|11812656|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
7494367|NCT02183675|11812657|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
7494368|NCT02184143|11812678|FG000|Overall Study|Withdrawal by Subject|4
7494369|NCT02184143|11812679|FG001|Overall Study|Withdrawal by Subject|4
7494370|NCT02184143|11812678|FG000|Overall Study|Lost to Follow-up|5
7494371|NCT02184143|11812679|FG001|Overall Study|Lost to Follow-up|3
7494372|NCT02184143|11812678|FG000|Overall Study|Death|1
7494373|NCT02184143|11812679|FG001|Overall Study|Death|0
7494374|NCT02184442|11812706|FG000|Overall Study|Death|61
7494375|NCT02184442|11812707|FG001|Overall Study|Death|65
7494376|NCT02184442|11812706|FG000|Overall Study|Withdrawal by Subject|3
7494377|NCT02184442|11812707|FG001|Overall Study|Withdrawal by Subject|11
7494378|NCT02184455|11812713|FG000|Overall Study|Lost to Follow-up|1
7494379|NCT02184572|11812732|FG000|Overall Study|Lost to Follow-up|29
7494380|NCT02184572|11812733|FG001|Overall Study|Lost to Follow-up|21
7494381|NCT02184572|11812732|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
7494382|NCT02184572|11812733|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
7494383|NCT02184572|11812732|FG000|Overall Study|Loss Of Kaiser Insurance|1
7494384|NCT02184572|11812733|FG001|Overall Study|Loss Of Kaiser Insurance|0
7494385|NCT02184572|11812732|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
7494386|NCT02184572|11812733|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
7494387|NCT02184572|11812732|FG000|Overall Study|Traveling Outside The Country|1
7494388|NCT02184572|11812733|FG001|Overall Study|Traveling Outside The Country|0
7494389|NCT02184572|11812732|FG000|Overall Study|Withdrawal by Subject|14
7494390|NCT02184572|11812733|FG001|Overall Study|Withdrawal by Subject|9
7494391|NCT02184611|11812743|FG000|Overall Study|Lack of Efficacy|11
7494392|NCT02184611|11812744|FG001|Overall Study|Lack of Efficacy|15
7494393|NCT02184611|11812743|FG000|Overall Study|Withdrawal by Subject|5
7494394|NCT02184611|11812744|FG001|Overall Study|Withdrawal by Subject|6
7494395|NCT02184611|11812743|FG000|Overall Study|Adverse Event|4
7494396|NCT02184611|11812744|FG001|Overall Study|Adverse Event|5
7494397|NCT02184611|11812743|FG000|Overall Study|Protocol Violation|1
7494398|NCT02184611|11812744|FG001|Overall Study|Protocol Violation|1
7494399|NCT02184611|11812743|FG000|Overall Study|Protocol defined stopping criteria|0
7494400|NCT02184611|11812744|FG001|Overall Study|Protocol defined stopping criteria|1
7494401|NCT02184988|11812771|FG000|Overall Study|Pregnancy|2
7494402|NCT02184988|11812771|FG000|Overall Study|Adverse Event|2
7494403|NCT02184988|11812771|FG000|Overall Study|moving away/travelling/unable to complet|6
7494404|NCT02184988|11812771|FG000|Overall Study|work scheduling issues|4
7494405|NCT02184988|11812771|FG000|Overall Study|various other reasons|9
7494406|NCT02184988|11812771|FG000|Overall Study|Lost to Follow-up|32
7494407|NCT02185014|11812775|FG000|Overall Study|Adverse Event|18
7494408|NCT02185014|11812775|FG000|Overall Study|Withdrew Consent|8
7494409|NCT02185014|11812775|FG000|Overall Study|Lost to Follow-up|4
7494410|NCT02185014|11812775|FG000|Overall Study|Lack of Efficacy|14
7494411|NCT02185014|11812775|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
7494412|NCT02185014|11812775|FG000|Overall Study|Subject Noncompliance|1
7494413|NCT02185014|11812775|FG000|Overall Study|Other|4
7494414|NCT02185040|11812784|FG000|Part 1 Treatment Phase|Miscellaneous|0
7494415|NCT02185040|11812785|FG001|Part 1 Treatment Phase|Miscellaneous|0
7494416|NCT02185040|11812786|FG002|Part 1 Treatment Phase|Miscellaneous|1
7494417|NCT02185040|11812787|FG003|Part 1 Treatment Phase|Miscellaneous|0
7494418|NCT02185040|11812788|FG004|Part 1 Treatment Phase|Miscellaneous|0
7494419|NCT02185040|11812789|FG005|Part 1 Treatment Phase|Miscellaneous|0
7494420|NCT02185040|11812790|FG006|Part 1 Treatment Phase|Miscellaneous|0
7494421|NCT02185040|11812784|FG000|Part 1 Treatment Phase|Adverse Event|1
7494422|NCT02185040|11812785|FG001|Part 1 Treatment Phase|Adverse Event|0
7494423|NCT02185040|11812786|FG002|Part 1 Treatment Phase|Adverse Event|0
7494424|NCT02185040|11812787|FG003|Part 1 Treatment Phase|Adverse Event|2
7494425|NCT02185040|11812788|FG004|Part 1 Treatment Phase|Adverse Event|3
7494426|NCT02185040|11812789|FG005|Part 1 Treatment Phase|Adverse Event|0
7494427|NCT02185040|11812790|FG006|Part 1 Treatment Phase|Adverse Event|0
7494428|NCT02185040|11812784|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
7494429|NCT02185040|11812785|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
7494430|NCT02185040|11812786|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
7494431|NCT02185040|11812787|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
7494432|NCT02185040|11812788|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
7494433|NCT02185040|11812789|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
7494434|NCT02185040|11812790|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
7494435|NCT02185040|11812784|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
7494436|NCT02185040|11812785|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
7494437|NCT02185040|11812786|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
7494438|NCT02185040|11812787|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
7494439|NCT02185040|11812788|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
7494440|NCT02185040|11812789|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
7494441|NCT02185040|11812790|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
7494442|NCT02185040|11812784|FG000|Active Treatment Extension Phase|Miscellaneous|0
7494443|NCT02185040|11812785|FG001|Active Treatment Extension Phase|Miscellaneous|0
7494444|NCT02185040|11812786|FG002|Active Treatment Extension Phase|Miscellaneous|0
7494445|NCT02185040|11812787|FG003|Active Treatment Extension Phase|Miscellaneous|0
7494446|NCT02185040|11812788|FG004|Active Treatment Extension Phase|Miscellaneous|0
7494447|NCT02185040|11812789|FG005|Active Treatment Extension Phase|Miscellaneous|1
7494448|NCT02185040|11812790|FG006|Active Treatment Extension Phase|Miscellaneous|0
7494449|NCT02185040|11812784|FG000|Active Treatment Extension Phase|Adverse Event|0
7494450|NCT02185040|11812785|FG001|Active Treatment Extension Phase|Adverse Event|0
7494451|NCT02185040|11812786|FG002|Active Treatment Extension Phase|Adverse Event|0
7494452|NCT02185040|11812787|FG003|Active Treatment Extension Phase|Adverse Event|0
7494453|NCT02185040|11812788|FG004|Active Treatment Extension Phase|Adverse Event|0
7494454|NCT02185040|11812789|FG005|Active Treatment Extension Phase|Adverse Event|1
7494455|NCT02185040|11812790|FG006|Active Treatment Extension Phase|Adverse Event|4
7494456|NCT02185040|11812784|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
7494457|NCT02185040|11812785|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
7494458|NCT02185040|11812786|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
7494459|NCT02185040|11812787|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
7494460|NCT02185040|11812788|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
7494461|NCT02185040|11812789|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
7494462|NCT02185040|11812790|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
7494463|NCT02185040|11812784|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
7494464|NCT02185040|11812785|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
7494465|NCT02185040|11812786|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
7494466|NCT02185040|11812787|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
7494467|NCT02185040|11812788|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
7494468|NCT02185040|11812789|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
7494469|NCT02185040|11812790|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
7494470|NCT02185053|11812810|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
7494471|NCT02185053|11812811|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7494472|NCT02185053|11812812|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
7494473|NCT02185053|11812810|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
7494474|NCT02185053|11812811|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7494475|NCT02185053|11812812|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
7494476|NCT02185053|11812810|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7494477|NCT02185053|11812811|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
7494478|NCT02185053|11812812|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
7494479|NCT02185053|11812810|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
7494480|NCT02185053|11812811|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
7494481|NCT02185053|11812812|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
7494482|NCT02185053|11812810|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7494483|NCT02185053|11812811|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
7494484|NCT02185053|11812812|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
7494485|NCT02185053|11812810|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7494486|NCT02185053|11812811|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
7494487|NCT02185053|11812812|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
7494488|NCT02185053|11812810|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7494489|NCT02185053|11812811|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
7494490|NCT02185053|11812812|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
7494491|NCT02185053|11812810|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7494492|NCT02185053|11812811|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
7494493|NCT02185053|11812812|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
7494494|NCT02185521|11812858|FG000|Overall Study|Withdrawal by Subject|1
7494495|NCT02185521|11812858|FG000|Overall Study|Protocol Violation|1
7494496|NCT02185534|11812869|FG000|First Period|Withdrawal by Subject|0
7494497|NCT02185534|11812870|FG001|First Period|Withdrawal by Subject|0
7494498|NCT02185534|11812871|FG002|First Period|Withdrawal by Subject|0
7494499|NCT02185534|11812872|FG003|First Period|Withdrawal by Subject|1
7494500|NCT02185534|11812873|FG004|First Period|Withdrawal by Subject|0
7494501|NCT02185534|11812874|FG005|First Period|Withdrawal by Subject|0
7494502|NCT02185534|11812869|FG000|First Washout Period|Withdrawal by Subject|1
7494503|NCT02185534|11812870|FG001|First Washout Period|Withdrawal by Subject|0
7494504|NCT02185534|11812871|FG002|First Washout Period|Withdrawal by Subject|0
7494505|NCT02185534|11812872|FG003|First Washout Period|Withdrawal by Subject|0
7494506|NCT02185534|11812873|FG004|First Washout Period|Withdrawal by Subject|1
7494507|NCT02185534|11812874|FG005|First Washout Period|Withdrawal by Subject|0
7494508|NCT02185534|11812869|FG000|First Washout Period|Protocol Violation|0
7494509|NCT02185534|11812870|FG001|First Washout Period|Protocol Violation|0
7494510|NCT02185534|11812871|FG002|First Washout Period|Protocol Violation|0
7494511|NCT02185534|11812872|FG003|First Washout Period|Protocol Violation|0
7494512|NCT02185534|11812873|FG004|First Washout Period|Protocol Violation|0
7494513|NCT02185534|11812874|FG005|First Washout Period|Protocol Violation|1
7494514|NCT02185794|11812896|FG000|Overall Study|Enrolled but Never Dosed|1
7494515|NCT02185794|11812897|FG001|Overall Study|Enrolled but Never Dosed|6
7494516|NCT02185794|11812898|FG002|Overall Study|Enrolled but Never Dosed|3
7494517|NCT02185794|11812899|FG003|Overall Study|Enrolled but Never Dosed|1
7494518|NCT02185794|11812900|FG004|Overall Study|Enrolled but Never Dosed|1
7494519|NCT02185794|11812901|FG005|Overall Study|Enrolled but Never Dosed|0
7494520|NCT02185794|11812896|FG000|Overall Study|Investigator's Discretion|1
7494521|NCT02185794|11812897|FG001|Overall Study|Investigator's Discretion|0
7494522|NCT02185794|11812898|FG002|Overall Study|Investigator's Discretion|1
7494523|NCT02185794|11812899|FG003|Overall Study|Investigator's Discretion|2
7494524|NCT02185794|11812900|FG004|Overall Study|Investigator's Discretion|2
7494525|NCT02185794|11812901|FG005|Overall Study|Investigator's Discretion|15
7494526|NCT02185794|11812896|FG000|Overall Study|Withdrew Consent|2
7494527|NCT02185794|11812897|FG001|Overall Study|Withdrew Consent|5
7494528|NCT02185794|11812898|FG002|Overall Study|Withdrew Consent|10
7494529|NCT02185794|11812899|FG003|Overall Study|Withdrew Consent|2
7494530|NCT02185794|11812900|FG004|Overall Study|Withdrew Consent|0
7494531|NCT02185794|11812901|FG005|Overall Study|Withdrew Consent|0
7494532|NCT02185794|11812896|FG000|Overall Study|Lost to Follow-up|1
7494533|NCT02185794|11812897|FG001|Overall Study|Lost to Follow-up|2
7494534|NCT02185794|11812898|FG002|Overall Study|Lost to Follow-up|2
7494535|NCT02185794|11812899|FG003|Overall Study|Lost to Follow-up|3
7494536|NCT02185794|11812900|FG004|Overall Study|Lost to Follow-up|0
7494537|NCT02185794|11812901|FG005|Overall Study|Lost to Follow-up|1
7494538|NCT02186015|11812931|FG000|Overall Study|Physician Decision|1
7494539|NCT02186015|11812932|FG001|Overall Study|Physician Decision|0
7494540|NCT02186171|11812941|FG000|Overall Study|Withdrawal by Subject|1
7494541|NCT02186171|11812942|FG001|Overall Study|Withdrawal by Subject|9
7494542|NCT02186171|11812941|FG000|Overall Study|Lost to Follow-up|2
7494543|NCT02186171|11812942|FG001|Overall Study|Lost to Follow-up|2
7494544|NCT02186171|11812941|FG000|Overall Study|Death|1
7494545|NCT02186171|11812942|FG001|Overall Study|Death|2
7494546|NCT02186171|11812941|FG000|Overall Study|Protocol-specified Criteria|0
7494547|NCT02186171|11812942|FG001|Overall Study|Protocol-specified Criteria|2
7494548|NCT02186223|11812959|FG000|Overall Study|Not eligible for device placement|6
7494549|NCT02186223|11812959|FG000|Overall Study|Unable to obtain femoral access|3
7494550|NCT02186223|11812959|FG000|Overall Study|Death|3
7494551|NCT02186223|11812959|FG000|Overall Study|Device in place less than 48 hours|9
7494552|NCT02186301|11812967|FG000|Overall Study|Progressive Disease|7
7494553|NCT02186301|11812968|FG001|Overall Study|Progressive Disease|22
7494554|NCT02186301|11812969|FG002|Overall Study|Progressive Disease|27
7494555|NCT02186301|11812967|FG000|Overall Study|Adverse Event|5
7494556|NCT02186301|11812968|FG001|Overall Study|Adverse Event|5
7494557|NCT02186301|11812969|FG002|Overall Study|Adverse Event|5
7494558|NCT02186301|11812967|FG000|Overall Study|Death|1
7494559|NCT02186301|11812968|FG001|Overall Study|Death|0
7494560|NCT02186301|11812969|FG002|Overall Study|Death|0
7494561|NCT02186301|11812967|FG000|Overall Study|Withdrawal by Subject|5
7494562|NCT02186301|11812968|FG001|Overall Study|Withdrawal by Subject|1
7494563|NCT02186301|11812969|FG002|Overall Study|Withdrawal by Subject|3
7494564|NCT02186301|11812967|FG000|Overall Study|Physician Decision|1
7494565|NCT02186301|11812968|FG001|Overall Study|Physician Decision|0
7494566|NCT02186301|11812969|FG002|Overall Study|Physician Decision|1
7494567|NCT02186301|11812967|FG000|Overall Study|Study Terminated by Sponsor|1
7494568|NCT02186301|11812968|FG001|Overall Study|Study Terminated by Sponsor|0
7494569|NCT02186301|11812969|FG002|Overall Study|Study Terminated by Sponsor|11
7494570|NCT02186301|11812967|FG000|Overall Study|Protocol Deviation|0
7494571|NCT02186301|11812968|FG001|Overall Study|Protocol Deviation|2
7494572|NCT02186301|11812969|FG002|Overall Study|Protocol Deviation|0
7494573|NCT02186301|11812967|FG000|Overall Study|Missing|0
7494574|NCT02186301|11812968|FG001|Overall Study|Missing|0
7494575|NCT02186301|11812969|FG002|Overall Study|Missing|2
7494576|NCT02186301|11812967|FG000|Overall Study|Other|0
7494577|NCT02186301|11812968|FG001|Overall Study|Other|0
7494578|NCT02186301|11812969|FG002|Overall Study|Other|1
7494579|NCT02186561|11812983|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
7494580|NCT02186561|11812983|FG000|Enrollment|Enrollment Cap Reached|5
7494581|NCT02186561|11812983|FG000|Enrollment|Insurance Denial|2
7494582|NCT02186561|11812983|FG000|Enrollment|Withdrawal by Subject|2
7494583|NCT02186561|11812983|FG000|Enrollment|Investigator Withdrew Consent|1
7494584|NCT02186561|11812983|FG000|30-Day Post Index Procedure Visit|Death|1
7494585|NCT02186561|11812983|FG000|1- Year Post Index Procedure Visit|Death|1
7494586|NCT02186561|11812983|FG000|1- Year Post Index Procedure Visit|Missed|1
7494587|NCT02186652|11812999|FG000|Overall Study|Lost to Follow-up|2
7494588|NCT02186652|11813000|FG001|Overall Study|Lost to Follow-up|0
7494589|NCT02186821|11813035|FG000|Overall Study|Adverse Event|9
7494590|NCT02186821|11813035|FG000|Overall Study|Death|2
7494591|NCT02186821|11813035|FG000|Overall Study|Disease progression|32
7494592|NCT02186821|11813035|FG000|Overall Study|Protocol Violation|1
7494593|NCT02186821|11813035|FG000|Overall Study|Physician Decision|1
7494594|NCT02186821|11813035|FG000|Overall Study|Study terminated by sponsor|2
7494595|NCT02186873|11813041|FG000|Overall Study|Adverse Event|1
7494596|NCT02186873|11813042|FG001|Overall Study|Adverse Event|3
7494597|NCT02186873|11813041|FG000|Overall Study|Lack of Efficacy|0
7494598|NCT02186873|11813042|FG001|Overall Study|Lack of Efficacy|1
7494599|NCT02186873|11813041|FG000|Overall Study|Lost to Follow-up|1
7494600|NCT02186873|11813042|FG001|Overall Study|Lost to Follow-up|2
7494601|NCT02186873|11813041|FG000|Overall Study|Withdrawal by Subject|7
7494602|NCT02186873|11813042|FG001|Overall Study|Withdrawal by Subject|2
7494603|NCT02187029|11813079|FG000|Overall Study|Adverse Event|0
7494604|NCT02187029|11813080|FG001|Overall Study|Adverse Event|1
7494605|NCT02187029|11813081|FG002|Overall Study|Adverse Event|1
7494606|NCT02187029|11813082|FG003|Overall Study|Adverse Event|0
7494607|NCT02187029|11813079|FG000|Overall Study|Study Terminated by Sponsor|0
7494608|NCT02187029|11813080|FG001|Overall Study|Study Terminated by Sponsor|0
7494609|NCT02187029|11813081|FG002|Overall Study|Study Terminated by Sponsor|10
7494610|NCT02187029|11813082|FG003|Overall Study|Study Terminated by Sponsor|3
7494611|NCT02187029|11813079|FG000|Overall Study|Withdrawal by Subject|1
7494612|NCT02187029|11813080|FG001|Overall Study|Withdrawal by Subject|0
7494613|NCT02187029|11813081|FG002|Overall Study|Withdrawal by Subject|0
7494614|NCT02187029|11813082|FG003|Overall Study|Withdrawal by Subject|0
7494615|NCT02187042|11813094|FG000|Overall Study|Death|1
7494616|NCT02187042|11813095|FG001|Overall Study|Death|1
7494617|NCT02187042|11813094|FG000|Overall Study|Toxicity|6
7494618|NCT02187042|11813095|FG001|Overall Study|Toxicity|5
7494619|NCT02187042|11813094|FG000|Overall Study|Participant choice|1
7494620|NCT02187042|11813095|FG001|Overall Study|Participant choice|0
7494621|NCT02187042|11813094|FG000|Overall Study|Doctor choice|1
7494622|NCT02187042|11813095|FG001|Overall Study|Doctor choice|0
7494623|NCT02187042|11813094|FG000|Overall Study|Progressive disease|4
7494624|NCT02187042|11813095|FG001|Overall Study|Progressive disease|8
7494625|NCT02187055|11813105|FG000|Overall Study|Lack of Efficacy|10
7494626|NCT02187055|11813106|FG001|Overall Study|Lack of Efficacy|3
7494627|NCT02187055|11813107|FG002|Overall Study|Lack of Efficacy|7
7494628|NCT02187055|11813105|FG000|Overall Study|Lost to Follow-up|2
7494629|NCT02187055|11813106|FG001|Overall Study|Lost to Follow-up|7
7494630|NCT02187055|11813107|FG002|Overall Study|Lost to Follow-up|3
7494631|NCT02187055|11813105|FG000|Overall Study|No longer meets eligibility criteria|0
7494632|NCT02187055|11813106|FG001|Overall Study|No longer meets eligibility criteria|2
7494633|NCT02187055|11813107|FG002|Overall Study|No longer meets eligibility criteria|0
7494634|NCT02187055|11813105|FG000|Overall Study|No longer willing to participate|6
7494635|NCT02187055|11813106|FG001|Overall Study|No longer willing to participate|8
7494636|NCT02187055|11813107|FG002|Overall Study|No longer willing to participate|10
7494637|NCT02187055|11813105|FG000|Overall Study|Other|5
7494638|NCT02187055|11813106|FG001|Overall Study|Other|6
7494639|NCT02187055|11813107|FG002|Overall Study|Other|3
7494640|NCT02187055|11813105|FG000|Overall Study|Protocol Violation|9
7494641|NCT02187055|11813106|FG001|Overall Study|Protocol Violation|9
7494642|NCT02187055|11813107|FG002|Overall Study|Protocol Violation|4
7494643|NCT02187055|11813105|FG000|Overall Study|Pregnancy|3
7494644|NCT02187055|11813106|FG001|Overall Study|Pregnancy|1
7494645|NCT02187055|11813107|FG002|Overall Study|Pregnancy|0
7494646|NCT02187055|11813105|FG000|Overall Study|Withdrawal by Subject|11
7494647|NCT02187055|11813106|FG001|Overall Study|Withdrawal by Subject|11
7494648|NCT02187055|11813107|FG002|Overall Study|Withdrawal by Subject|11
7494649|NCT02187055|11813105|FG000|Overall Study|Adverse Event|21
7494650|NCT02187055|11813106|FG001|Overall Study|Adverse Event|26
7494651|NCT02187055|11813107|FG002|Overall Study|Adverse Event|36
7494652|NCT02187055|11813105|FG000|Overall Study|Death|2
7494653|NCT02187055|11813106|FG001|Overall Study|Death|0
7494654|NCT02187055|11813107|FG002|Overall Study|Death|0
7494655|NCT02187159|11813119|FG000|Overall Study|Protocol Violation|4
7494656|NCT02187159|11813120|FG001|Overall Study|Protocol Violation|6
7494657|NCT02187159|11813121|FG002|Overall Study|Protocol Violation|3
7494658|NCT02187159|11813122|FG003|Overall Study|Protocol Violation|4
7494659|NCT02187159|11813119|FG000|Overall Study|Lack of Efficacy|10
7494660|NCT02187159|11813120|FG001|Overall Study|Lack of Efficacy|5
7494661|NCT02187159|11813121|FG002|Overall Study|Lack of Efficacy|4
7494662|NCT02187159|11813122|FG003|Overall Study|Lack of Efficacy|7
7494663|NCT02187159|11813119|FG000|Overall Study|Adverse Event|28
7494664|NCT02187159|11813120|FG001|Overall Study|Adverse Event|33
7494665|NCT02187159|11813121|FG002|Overall Study|Adverse Event|42
7494666|NCT02187159|11813122|FG003|Overall Study|Adverse Event|50
7494667|NCT02187159|11813119|FG000|Overall Study|Withdrawal by Subject|24
7494668|NCT02187159|11813120|FG001|Overall Study|Withdrawal by Subject|28
7494669|NCT02187159|11813121|FG002|Overall Study|Withdrawal by Subject|25
7494670|NCT02187159|11813122|FG003|Overall Study|Withdrawal by Subject|26
7494671|NCT02187159|11813119|FG000|Overall Study|Other|3
7494672|NCT02187159|11813120|FG001|Overall Study|Other|7
7494673|NCT02187159|11813121|FG002|Overall Study|Other|3
7494674|NCT02187159|11813122|FG003|Overall Study|Other|9
7494675|NCT02187172|11813134|FG000|Overall Study|Lost to Follow-up|1
7494676|NCT02187172|11813135|FG001|Overall Study|Lost to Follow-up|2
7494677|NCT02187172|11813134|FG000|Overall Study|Lack of Efficacy|1
7494678|NCT02187172|11813135|FG001|Overall Study|Lack of Efficacy|2
7494679|NCT02187172|11813134|FG000|Overall Study|Adverse Event|0
7494680|NCT02187172|11813135|FG001|Overall Study|Adverse Event|1
7494681|NCT02187172|11813134|FG000|Overall Study|Physician Decision|1
7494682|NCT02187172|11813135|FG001|Overall Study|Physician Decision|1
7494683|NCT02187471|11813147|FG000|Overall Study|Protocol Violation|4
7494684|NCT02187471|11813148|FG001|Overall Study|Protocol Violation|5
7494685|NCT02187471|11813149|FG002|Overall Study|Protocol Violation|4
7494686|NCT02187471|11813150|FG003|Overall Study|Protocol Violation|4
7494687|NCT02187471|11813147|FG000|Overall Study|Missing|0
7494688|NCT02187471|11813148|FG001|Overall Study|Missing|0
7494689|NCT02187471|11813149|FG002|Overall Study|Missing|0
7494690|NCT02187471|11813150|FG003|Overall Study|Missing|1
7494691|NCT02187471|11813147|FG000|Overall Study|Lack of Efficacy|18
7494692|NCT02187471|11813148|FG001|Overall Study|Lack of Efficacy|9
7494693|NCT02187471|11813149|FG002|Overall Study|Lack of Efficacy|13
7494694|NCT02187471|11813150|FG003|Overall Study|Lack of Efficacy|11
7494695|NCT02187471|11813147|FG000|Overall Study|Adverse Event|24
7494696|NCT02187471|11813148|FG001|Overall Study|Adverse Event|34
7494697|NCT02187471|11813149|FG002|Overall Study|Adverse Event|44
7494698|NCT02187471|11813150|FG003|Overall Study|Adverse Event|36
7494699|NCT02187471|11813147|FG000|Overall Study|Withdrawal by Subject|23
7494700|NCT02187471|11813148|FG001|Overall Study|Withdrawal by Subject|29
7494701|NCT02187471|11813149|FG002|Overall Study|Withdrawal by Subject|22
7494702|NCT02187471|11813150|FG003|Overall Study|Withdrawal by Subject|24
7494703|NCT02187471|11813147|FG000|Overall Study|Other|7
7494704|NCT02187471|11813148|FG001|Overall Study|Other|5
7494705|NCT02187471|11813149|FG002|Overall Study|Other|3
7494706|NCT02187471|11813150|FG003|Overall Study|Other|4
7494707|NCT02187744|11813163|FG000|Study|Participant refused further follow-up|1
7494708|NCT02187744|11813164|FG001|Study|Participant refused further follow-up|0
7494709|NCT02187744|11813163|FG000|Study|Other|2
7494710|NCT02187744|11813164|FG001|Study|Other|1
7494711|NCT02187744|11813163|FG000|Study|Lost to Follow-up|0
7494712|NCT02187744|11813164|FG001|Study|Lost to Follow-up|2
7494713|NCT02187744|11813163|FG000|Study|Related adverse event, not serious|0
7494714|NCT02187744|11813164|FG001|Study|Related adverse event, not serious|2
7494715|NCT02187744|11813163|FG000|Study|Death|1
7494716|NCT02187744|11813164|FG001|Study|Death|0
7494717|NCT02187744|11813163|FG000|Study|Related adverse event, serious non-fatal|0
7494718|NCT02187744|11813164|FG001|Study|Related adverse event, serious non-fatal|1
7494719|NCT02187744|11813163|FG000|Treatment|Death|1
7494720|NCT02187744|11813164|FG001|Treatment|Death|0
7494721|NCT02187744|11813163|FG000|Treatment|Related adverse event, serious non-fatal|0
7535254|NCT02709109|11882973|FG000|Treatment Period 2 (28 Days)|Other|0
7494722|NCT02187744|11813164|FG001|Treatment|Related adverse event, serious non-fatal|1
7494723|NCT02187744|11813163|FG000|Treatment|Related adverse event, not serious|0
7494724|NCT02187744|11813164|FG001|Treatment|Related adverse event, not serious|2
7494725|NCT02187744|11813163|FG000|Treatment|Lost to Follow-up|0
7494726|NCT02187744|11813164|FG001|Treatment|Lost to Follow-up|1
7494727|NCT02187744|11813163|FG000|Treatment|Other|2
7494728|NCT02187744|11813164|FG001|Treatment|Other|0
7494729|NCT02187744|11813163|FG000|Treatment|Participant refused continued treatment|1
7494730|NCT02187744|11813164|FG001|Treatment|Participant refused continued treatment|1
7494731|NCT02187783|11813170|FG000|Overall Study|Adverse Event|8
7494732|NCT02187783|11813170|FG000|Overall Study|Death|3
7494733|NCT02187783|11813170|FG000|Overall Study|Progressive disease|80
7494734|NCT02187783|11813170|FG000|Overall Study|Protocol Violation|3
7494735|NCT02187783|11813170|FG000|Overall Study|Physician Decision|2
7494736|NCT02187783|11813170|FG000|Overall Study|Withdrawal by Subject|9
7494737|NCT02187783|11813170|FG000|Overall Study|Study terminated by sponsor|1
7494738|NCT02187809|11813174|FG000|Overall Study|The study was terminated|3
7494739|NCT02187861|11813182|FG000|Overall Study|Adverse Event|2
7494740|NCT02187861|11813183|FG001|Overall Study|Adverse Event|1
7494741|NCT02187861|11813184|FG002|Overall Study|Adverse Event|2
7494742|NCT02187861|11813185|FG003|Overall Study|Adverse Event|1
7494743|NCT02187861|11813182|FG000|Overall Study|Death|0
7494744|NCT02187861|11813183|FG001|Overall Study|Death|3
7494745|NCT02187861|11813184|FG002|Overall Study|Death|1
7494746|NCT02187861|11813185|FG003|Overall Study|Death|2
7494747|NCT02187861|11813182|FG000|Overall Study|Physician Decision|0
7494748|NCT02187861|11813183|FG001|Overall Study|Physician Decision|1
7494749|NCT02187861|11813184|FG002|Overall Study|Physician Decision|0
7494750|NCT02187861|11813185|FG003|Overall Study|Physician Decision|3
7494751|NCT02187861|11813182|FG000|Overall Study|Progressive Disease|4
7494752|NCT02187861|11813183|FG001|Overall Study|Progressive Disease|42
7494753|NCT02187861|11813184|FG002|Overall Study|Progressive Disease|19
7494754|NCT02187861|11813185|FG003|Overall Study|Progressive Disease|22
7494755|NCT02187861|11813182|FG000|Overall Study|Withdrawal by Subject|0
7494756|NCT02187861|11813183|FG001|Overall Study|Withdrawal by Subject|0
7494757|NCT02187861|11813184|FG002|Overall Study|Withdrawal by Subject|3
7494758|NCT02187861|11813185|FG003|Overall Study|Withdrawal by Subject|3
7494759|NCT02187861|11813182|FG000|Overall Study|Other|0
7494760|NCT02187861|11813183|FG001|Overall Study|Other|1
7494761|NCT02187861|11813184|FG002|Overall Study|Other|7
7494762|NCT02187861|11813185|FG003|Overall Study|Other|1
7494763|NCT02188160|11813206|FG000|Overall Study|Adverse Event|1
7494764|NCT02188160|11813207|FG001|Overall Study|Adverse Event|0
7494765|NCT02188160|11813206|FG000|Overall Study|Use of an excluded medication|0
7494766|NCT02188160|11813207|FG001|Overall Study|Use of an excluded medication|1
7494767|NCT02188303|11813221|FG000|Overall Study|Adverse Event|0
7494768|NCT02188303|11813222|FG001|Overall Study|Adverse Event|0
7494769|NCT02188303|11813223|FG002|Overall Study|Adverse Event|0
7494770|NCT02188303|11813224|FG003|Overall Study|Adverse Event|0
7494771|NCT02188303|11813225|FG004|Overall Study|Adverse Event|0
7494772|NCT02188303|11813226|FG005|Overall Study|Adverse Event|2
7494773|NCT02188303|11813227|FG006|Overall Study|Adverse Event|0
7494774|NCT02188303|11813228|FG007|Overall Study|Adverse Event|2
7494775|NCT02188303|11813221|FG000|Overall Study|Dose Termination Criteria Met|0
7494776|NCT02188303|11813222|FG001|Overall Study|Dose Termination Criteria Met|0
7494777|NCT02188303|11813223|FG002|Overall Study|Dose Termination Criteria Met|0
7494778|NCT02188303|11813224|FG003|Overall Study|Dose Termination Criteria Met|0
7494779|NCT02188303|11813225|FG004|Overall Study|Dose Termination Criteria Met|0
7494780|NCT02188303|11813226|FG005|Overall Study|Dose Termination Criteria Met|0
7494781|NCT02188303|11813227|FG006|Overall Study|Dose Termination Criteria Met|2
7494782|NCT02188303|11813228|FG007|Overall Study|Dose Termination Criteria Met|4
7494783|NCT02188459|11813254|FG000|Overall Study|Lost to Follow-up|3
7494784|NCT02188459|11813255|FG001|Overall Study|Lost to Follow-up|4
7494785|NCT02188459|11813254|FG000|Overall Study|Early Termination|0
7494786|NCT02188459|11813255|FG001|Overall Study|Early Termination|3
7494787|NCT02188485|11813267|FG000|Overall Study|Withdrawal by Subject|2
7494788|NCT02188485|11813268|FG001|Overall Study|Withdrawal by Subject|1
7494789|NCT02188485|11813267|FG000|Overall Study|PI withdrew, lack of capacity|0
7494790|NCT02188485|11813268|FG001|Overall Study|PI withdrew, lack of capacity|2
7494791|NCT02188589|11813283|FG000|Overall Study|Withdrawal by Subject|5
7494792|NCT02188719|11813292|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7494793|NCT02188719|11813293|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
7494794|NCT02188719|11813294|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7494795|NCT02188719|11813295|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
7494796|NCT02188784|11813305|FG000|Overall Study|Death|3
7494797|NCT02188784|11813306|FG001|Overall Study|Death|1
7494798|NCT02188784|11813305|FG000|Overall Study|Lost to Follow-up|1
7494799|NCT02188784|11813306|FG001|Overall Study|Lost to Follow-up|0
7494800|NCT02188784|11813305|FG000|Overall Study|Withdrawal by Subject|3
7494801|NCT02188784|11813306|FG001|Overall Study|Withdrawal by Subject|9
7494802|NCT02188784|11813305|FG000|Overall Study|Physician Decision|2
7494803|NCT02188784|11813306|FG001|Overall Study|Physician Decision|3
7494804|NCT02188849|11813314|FG000|Overall Study|Lost to Follow-up|3
7494805|NCT02188849|11813315|FG001|Overall Study|Lost to Follow-up|8
7494806|NCT02189252|11813349|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7494807|NCT02189252|11813350|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
7494808|NCT02189252|11813351|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7494809|NCT02189252|11813352|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
7494810|NCT02189252|11813349|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7494811|NCT02189252|11813350|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
7494812|NCT02189252|11813351|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7494813|NCT02189252|11813352|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
7494814|NCT02189473|11813383|FG000|Overall Study|Death|22
7494815|NCT02189473|11813384|FG001|Overall Study|Death|23
7494816|NCT02189473|11813383|FG000|Overall Study|Lost to Follow-up|1
7494817|NCT02189473|11813384|FG001|Overall Study|Lost to Follow-up|2
7494818|NCT02189759|11813407|FG000|Overall Study|Lost to Follow-up|0
7494819|NCT02189759|11813408|FG001|Overall Study|Lost to Follow-up|0
7494820|NCT02189759|11813409|FG002|Overall Study|Lost to Follow-up|2
7494821|NCT02189759|11813410|FG003|Overall Study|Lost to Follow-up|5
7494822|NCT02189837|11813426|FG000|Overall Study|Withdrawal by Subject|2
7494823|NCT02189837|11813427|FG001|Overall Study|Withdrawal by Subject|1
7494824|NCT02189837|11813428|FG002|Overall Study|Withdrawal by Subject|3
7494825|NCT02189837|11813429|FG003|Overall Study|Withdrawal by Subject|1
7494826|NCT02189837|11813426|FG000|Overall Study|Sponsor Decision|0
7494827|NCT02189837|11813427|FG001|Overall Study|Sponsor Decision|0
7494828|NCT02189837|11813428|FG002|Overall Study|Sponsor Decision|0
7494829|NCT02189837|11813429|FG003|Overall Study|Sponsor Decision|1
7494830|NCT02189863|11813448|FG000|First 2 Weeks|Motion Sickness|4
7494831|NCT02189863|11813449|FG001|First 2 Weeks|Motion Sickness|2
7494832|NCT02189941|11813471|FG000|Overall Study|Non-compliance|0
7494833|NCT02189941|11813472|FG001|Overall Study|Non-compliance|0
7494834|NCT02189941|11813473|FG002|Overall Study|Non-compliance|1
7494835|NCT02190279|11813502|FG000|Overall Study|Withdrawal consent|1
7494836|NCT02190279|11813503|FG001|Overall Study|Withdrawal consent|0
7494837|NCT02190279|11813504|FG002|Overall Study|Withdrawal consent|1
7494838|NCT02190279|11813502|FG000|Overall Study|Lost to Follow-up|2
7494839|NCT02190279|11813503|FG001|Overall Study|Lost to Follow-up|0
7494840|NCT02190279|11813504|FG002|Overall Study|Lost to Follow-up|0
7494841|NCT02190279|11813502|FG000|Overall Study|Refused further treatment|0
7494842|NCT02190279|11813503|FG001|Overall Study|Refused further treatment|0
7494843|NCT02190279|11813504|FG002|Overall Study|Refused further treatment|1
7494844|NCT02190279|11813502|FG000|Overall Study|Screening failure|0
7494845|NCT02190279|11813503|FG001|Overall Study|Screening failure|0
7494846|NCT02190279|11813504|FG002|Overall Study|Screening failure|1
7494847|NCT02190435|11813516|FG000|Overall Study|First 12 patients were lead-ins|12
7494848|NCT02190435|11813517|FG001|Overall Study|First 12 patients were lead-ins|0
7494849|NCT02190435|11813516|FG000|Overall Study|3 consented screen fails|3
7494850|NCT02190435|11813517|FG001|Overall Study|3 consented screen fails|0
7494851|NCT02190591|11813530|FG000|Overall Study|Withdrawal by Subject|1
7494852|NCT02190591|11813531|FG001|Overall Study|Withdrawal by Subject|8
7494853|NCT02190591|11813530|FG000|Overall Study|Protocol Violation|1
7494854|NCT02190591|11813531|FG001|Overall Study|Protocol Violation|0
7494855|NCT02190591|11813530|FG000|Overall Study|did not use peanut ball as instructed|0
7494856|NCT02190591|11813531|FG001|Overall Study|did not use peanut ball as instructed|2
7494857|NCT02190591|11813530|FG000|Overall Study|face presentation so she was ineligible|0
7494858|NCT02190591|11813531|FG001|Overall Study|face presentation so she was ineligible|1
7494859|NCT02190604|11813556|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494860|NCT02190604|11813557|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494861|NCT02190604|11813558|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494862|NCT02190604|11813559|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494863|NCT02190604|11813560|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494864|NCT02190604|11813561|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494865|NCT02190604|11813562|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494866|NCT02190604|11813563|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494867|NCT02190604|11813564|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494868|NCT02190604|11813565|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494869|NCT02190604|11813566|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494870|NCT02190604|11813567|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494871|NCT02190604|11813568|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494872|NCT02190604|11813569|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494873|NCT02190604|11813570|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
7494874|NCT02190604|11813571|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494875|NCT02190604|11813572|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494876|NCT02190604|11813573|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494877|NCT02190604|11813574|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
7494878|NCT02190604|11813556|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494879|NCT02190604|11813557|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494880|NCT02190604|11813558|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494881|NCT02190604|11813559|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494882|NCT02190604|11813560|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494883|NCT02190604|11813561|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494884|NCT02190604|11813562|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494885|NCT02190604|11813563|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494886|NCT02190604|11813564|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494887|NCT02190604|11813565|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494888|NCT02190604|11813566|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494889|NCT02190604|11813567|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494890|NCT02190604|11813568|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494891|NCT02190604|11813569|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
7494892|NCT02190604|11813570|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494893|NCT02190604|11813571|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494894|NCT02190604|11813572|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494895|NCT02190604|11813573|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7494896|NCT02190604|11813574|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
7535255|NCT02709109|11882974|FG001|Treatment Period 2 (28 Days)|Other|0
7535256|NCT02709109|11882975|FG002|Treatment Period 2 (28 Days)|Other|1
7535257|NCT02709109|11882976|FG003|Treatment Period 2 (28 Days)|Other|0
7535258|NCT02709330|11882987|FG000|Overall Study|Death|5
7535259|NCT02709330|11882988|FG001|Overall Study|Death|0
7535260|NCT02709330|11882987|FG000|Overall Study|Lost to Follow-up|2
7535261|NCT02709330|11882988|FG001|Overall Study|Lost to Follow-up|0
7535262|NCT02709330|11882987|FG000|Overall Study|Physician Decision|2
7535263|NCT02709330|11882988|FG001|Overall Study|Physician Decision|0
7535264|NCT02709330|11882987|FG000|Overall Study|Withdrawal by Subject|4
7535265|NCT02709330|11882988|FG001|Overall Study|Withdrawal by Subject|0
7535266|NCT02709369|11882994|FG000|Overall Study|Lost to Follow-up|15
7535267|NCT02709369|11882994|FG000|Overall Study|Withdrawal by Subject|10
7535268|NCT02709369|11882994|FG000|Overall Study|Did not received intervention|2
7535269|NCT02709486|11883001|FG000|Overall Study|Adverse Event|2
7535270|NCT02709486|11883002|FG001|Overall Study|Adverse Event|5
7535271|NCT02709486|11883003|FG002|Overall Study|Adverse Event|3
7535272|NCT02709486|11883001|FG000|Overall Study|Death|0
7535273|NCT02709486|11883002|FG001|Overall Study|Death|0
7535274|NCT02709486|11883003|FG002|Overall Study|Death|2
7535275|NCT02709486|11883001|FG000|Overall Study|Insufficient clinical response|7
7535276|NCT02709486|11883002|FG001|Overall Study|Insufficient clinical response|3
7535277|NCT02709486|11883003|FG002|Overall Study|Insufficient clinical response|3
7535278|NCT02709486|11883001|FG000|Overall Study|Lost to Follow-up|3
7535279|NCT02709486|11883002|FG001|Overall Study|Lost to Follow-up|2
7535280|NCT02709486|11883003|FG002|Overall Study|Lost to Follow-up|2
7535281|NCT02709486|11883001|FG000|Overall Study|Other|0
7535282|NCT02709486|11883002|FG001|Overall Study|Other|2
7535283|NCT02709486|11883003|FG002|Overall Study|Other|3
7535284|NCT02709486|11883001|FG000|Overall Study|Withdrawal by Subject|32
7535285|NCT02709486|11883002|FG001|Overall Study|Withdrawal by Subject|22
7535286|NCT02709486|11883003|FG002|Overall Study|Withdrawal by Subject|32
7535287|NCT02709538|11883014|FG000|Overall Study|Adverse Event|13
7535288|NCT02709538|11883015|FG001|Overall Study|Adverse Event|2
7535289|NCT02709538|11883016|FG002|Overall Study|Adverse Event|3
7535290|NCT02709538|11883014|FG000|Overall Study|Lack of Efficacy|1
7535291|NCT02709538|11883015|FG001|Overall Study|Lack of Efficacy|0
7535292|NCT02709538|11883016|FG002|Overall Study|Lack of Efficacy|0
7535293|NCT02709538|11883014|FG000|Overall Study|Lost to Follow-up|24
7535294|NCT02709538|11883015|FG001|Overall Study|Lost to Follow-up|8
7535295|NCT02709538|11883016|FG002|Overall Study|Lost to Follow-up|4
7535296|NCT02709538|11883014|FG000|Overall Study|Physician Decision|1
7535297|NCT02709538|11883015|FG001|Overall Study|Physician Decision|0
7535298|NCT02709538|11883016|FG002|Overall Study|Physician Decision|0
7535299|NCT02709538|11883014|FG000|Overall Study|Withdrawal by Subject|40
7535300|NCT02709538|11883015|FG001|Overall Study|Withdrawal by Subject|7
7535301|NCT02709538|11883016|FG002|Overall Study|Withdrawal by Subject|4
7535302|NCT02709538|11883014|FG000|Overall Study|Non-compliance with study procedures|5
7535303|NCT02709538|11883015|FG001|Overall Study|Non-compliance with study procedures|0
7535304|NCT02709538|11883016|FG002|Overall Study|Non-compliance with study procedures|0
7535305|NCT02709538|11883014|FG000|Overall Study|Non-compliance with study drug|2
7535306|NCT02709538|11883015|FG001|Overall Study|Non-compliance with study drug|0
7535307|NCT02709538|11883016|FG002|Overall Study|Non-compliance with study drug|0
7535308|NCT02709538|11883014|FG000|Overall Study|Protocol deviation|10
7535309|NCT02709538|11883015|FG001|Overall Study|Protocol deviation|4
7535310|NCT02709538|11883016|FG002|Overall Study|Protocol deviation|4
7535311|NCT02709538|11883014|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
7535312|NCT02709538|11883015|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
7535313|NCT02709538|11883016|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
7535314|NCT02709538|11883014|FG000|Overall Study|Other|16
7535315|NCT02709538|11883015|FG001|Overall Study|Other|7
7535316|NCT02709538|11883016|FG002|Overall Study|Other|5
7535317|NCT02709577|11883026|FG000|Overall Study|non-accommodating anatomy|0
7535318|NCT02709577|11883027|FG001|Overall Study|non-accommodating anatomy|1
7535319|NCT02709577|11883028|FG002|Overall Study|non-accommodating anatomy|0
7535320|NCT02709577|11883029|FG003|Overall Study|non-accommodating anatomy|0
7535321|NCT02709577|11883026|FG000|Overall Study|procedural complication|0
7535322|NCT02709577|11883027|FG001|Overall Study|procedural complication|1
7535323|NCT02709577|11883028|FG002|Overall Study|procedural complication|0
7494897|NCT02191046|11813664|FG000|Overall Study|low compliance|5
7494898|NCT02191046|11813665|FG001|Overall Study|low compliance|1
7494899|NCT02191137|11813671|FG000|Treatment|Death|4
7494900|NCT02191137|11813671|FG000|Treatment|Withdrawal by Subject|3
7494901|NCT02191137|11813671|FG000|Treatment|Adverse Event|2
7494902|NCT02191137|11813671|FG000|Treatment|Other|1
7494903|NCT02191137|11813671|FG000|Follow-up|Lost to Follow-up|2
7494904|NCT02191137|11813671|FG000|Follow-up|Ongoing/unknown|2
7494905|NCT02191137|11813671|FG000|Follow-up|Adverse Event|1
7494906|NCT02191267|11813678|FG000|Overall Study|Withdrawal by Subject|1
7494907|NCT02191267|11813679|FG001|Overall Study|Withdrawal by Subject|0
7494908|NCT02191267|11813680|FG002|Overall Study|Withdrawal by Subject|0
7494909|NCT02191397|11813690|FG000|Overall Study|Adverse Event|28
7494910|NCT02191397|11813691|FG001|Overall Study|Adverse Event|17
7494911|NCT02191397|11813690|FG000|Overall Study|Lack of Efficacy|10
7494912|NCT02191397|11813691|FG001|Overall Study|Lack of Efficacy|5
7494913|NCT02191397|11813690|FG000|Overall Study|Protocol Violation|0
7494914|NCT02191397|11813691|FG001|Overall Study|Protocol Violation|3
7494915|NCT02191397|11813690|FG000|Overall Study|Met protocol-defined stopping criteria|5
7494916|NCT02191397|11813691|FG001|Overall Study|Met protocol-defined stopping criteria|4
7494917|NCT02191397|11813690|FG000|Overall Study|Lost to Follow-up|10
7494918|NCT02191397|11813691|FG001|Overall Study|Lost to Follow-up|11
7494919|NCT02191397|11813690|FG000|Overall Study|Physician Decision|8
7494920|NCT02191397|11813691|FG001|Overall Study|Physician Decision|3
7494921|NCT02191397|11813690|FG000|Overall Study|Withdrawal by Subject|22
7494922|NCT02191397|11813691|FG001|Overall Study|Withdrawal by Subject|27
7494923|NCT02191579|11813699|FG000|Treatment 1|Multiple Reasons Specified|27
7494924|NCT02191579|11813700|FG001|Treatment 1|Multiple Reasons Specified|58
7494925|NCT02191579|11813699|FG000|Treatment 2|Multiple Reasons Specified|0
7494926|NCT02191579|11813700|FG001|Treatment 2|Multiple Reasons Specified|25
7494927|NCT02191605|11813711|FG000|Overall Study|Lost to Follow-up|9
7494928|NCT02191605|11813712|FG001|Overall Study|Lost to Follow-up|4
7494929|NCT02191605|11813713|FG002|Overall Study|Lost to Follow-up|7
7494930|NCT02191605|11813714|FG003|Overall Study|Lost to Follow-up|3
7494931|NCT02191605|11813715|FG004|Overall Study|Lost to Follow-up|4
7494932|NCT02191618|11813727|FG000|Overall Study|Withdrawal by Subject|3
7494933|NCT02191618|11813727|FG000|Overall Study|Missed Visit|4
7494934|NCT02192099|11813747|FG000|Overall Study|Adverse Event|1
7494935|NCT02192099|11813747|FG000|Overall Study|Lost to Follow-up|2
7494936|NCT02192099|11813747|FG000|Overall Study|Physician Decision|1
7494937|NCT02192099|11813747|FG000|Overall Study|Pregnancy|1
7494938|NCT02192099|11813747|FG000|Overall Study|Protocol Violation|8
7494939|NCT02192099|11813747|FG000|Overall Study|Study Terminated by Sponsor|32
7494940|NCT02192099|11813747|FG000|Overall Study|Withdrawal by Subject|11
7494941|NCT02192099|11813747|FG000|Overall Study|Miscellaneous Reasons|5
7494942|NCT02192164|11813751|FG000|Overall Study|Other|8
7494943|NCT02192164|11813751|FG000|Overall Study|Withdrawal by Subject|1
7494944|NCT02192164|11813751|FG000|Overall Study|Physician Decision|4
7494945|NCT02192164|11813751|FG000|Overall Study|Did not meet the exclusion criteria|1
7494946|NCT02192190|11813764|FG000|Overall Study|Adverse Event|1
7494947|NCT02192190|11813765|FG001|Overall Study|Adverse Event|1
7494948|NCT02192190|11813766|FG002|Overall Study|Adverse Event|0
7494949|NCT02192190|11813767|FG003|Overall Study|Adverse Event|0
7494950|NCT02192190|11813768|FG004|Overall Study|Adverse Event|0
7494951|NCT02192190|11813769|FG005|Overall Study|Adverse Event|0
7494952|NCT02192190|11813764|FG000|Overall Study|Lost to Follow-up|3
7494953|NCT02192190|11813765|FG001|Overall Study|Lost to Follow-up|3
7494954|NCT02192190|11813766|FG002|Overall Study|Lost to Follow-up|2
7494955|NCT02192190|11813767|FG003|Overall Study|Lost to Follow-up|1
7494956|NCT02192190|11813768|FG004|Overall Study|Lost to Follow-up|4
7494957|NCT02192190|11813769|FG005|Overall Study|Lost to Follow-up|3
7494958|NCT02192190|11813764|FG000|Overall Study|Physician Decision|2
7494959|NCT02192190|11813765|FG001|Overall Study|Physician Decision|0
7494960|NCT02192190|11813766|FG002|Overall Study|Physician Decision|0
7494961|NCT02192190|11813767|FG003|Overall Study|Physician Decision|0
7494962|NCT02192190|11813768|FG004|Overall Study|Physician Decision|0
7494963|NCT02192190|11813769|FG005|Overall Study|Physician Decision|0
7494964|NCT02192190|11813764|FG000|Overall Study|Terminated by Sponsor|43
7494965|NCT02192190|11813765|FG001|Overall Study|Terminated by Sponsor|23
7494966|NCT02192190|11813766|FG002|Overall Study|Terminated by Sponsor|20
7494967|NCT02192190|11813767|FG003|Overall Study|Terminated by Sponsor|23
7494968|NCT02192190|11813768|FG004|Overall Study|Terminated by Sponsor|21
7494969|NCT02192190|11813769|FG005|Overall Study|Terminated by Sponsor|23
7494970|NCT02192190|11813764|FG000|Overall Study|Withdrawal by Subject|4
7494971|NCT02192190|11813765|FG001|Overall Study|Withdrawal by Subject|1
7494972|NCT02192190|11813766|FG002|Overall Study|Withdrawal by Subject|2
7494973|NCT02192190|11813767|FG003|Overall Study|Withdrawal by Subject|1
7494974|NCT02192190|11813768|FG004|Overall Study|Withdrawal by Subject|5
7494975|NCT02192190|11813769|FG005|Overall Study|Withdrawal by Subject|3
7494976|NCT02192190|11813764|FG000|Overall Study|Could not Keep Visit Schedule|1
7494977|NCT02192190|11813765|FG001|Overall Study|Could not Keep Visit Schedule|0
7494978|NCT02192190|11813766|FG002|Overall Study|Could not Keep Visit Schedule|0
7494979|NCT02192190|11813767|FG003|Overall Study|Could not Keep Visit Schedule|0
7494980|NCT02192190|11813768|FG004|Overall Study|Could not Keep Visit Schedule|0
7494981|NCT02192190|11813769|FG005|Overall Study|Could not Keep Visit Schedule|0
7494982|NCT02192190|11813764|FG000|Overall Study|Positive Drug Screen|0
7494983|NCT02192190|11813765|FG001|Overall Study|Positive Drug Screen|0
7494984|NCT02192190|11813766|FG002|Overall Study|Positive Drug Screen|0
7494985|NCT02192190|11813767|FG003|Overall Study|Positive Drug Screen|1
7494986|NCT02192190|11813768|FG004|Overall Study|Positive Drug Screen|0
7494987|NCT02192190|11813769|FG005|Overall Study|Positive Drug Screen|0
7494988|NCT02192190|11813764|FG000|Overall Study|Inadequate Pain Relief|0
7494989|NCT02192190|11813765|FG001|Overall Study|Inadequate Pain Relief|1
7494990|NCT02192190|11813766|FG002|Overall Study|Inadequate Pain Relief|1
7494991|NCT02192190|11813767|FG003|Overall Study|Inadequate Pain Relief|0
7494992|NCT02192190|11813768|FG004|Overall Study|Inadequate Pain Relief|0
7494993|NCT02192190|11813769|FG005|Overall Study|Inadequate Pain Relief|0
7494994|NCT02192606|11813805|FG000|Overall Study|surgery type was changed|1
7494995|NCT02192606|11813806|FG001|Overall Study|surgery type was changed|1
7494996|NCT02192606|11813805|FG000|Overall Study|Physician Decision|1
7494997|NCT02192606|11813806|FG001|Overall Study|Physician Decision|2
7494998|NCT02192606|11813805|FG000|Overall Study|3D equipment rep unable to join|0
7494999|NCT02192606|11813806|FG001|Overall Study|3D equipment rep unable to join|1
7495000|NCT02192905|11813838|FG000|Overall Study|Lost to Follow-up|1
7495001|NCT02192970|11813845|FG000|Overall Study|Lost to Follow-up|6
7495002|NCT02192970|11813846|FG001|Overall Study|Lost to Follow-up|0
7495003|NCT02193074|11813854|FG000|Overall Study|Withdrawal by Subject|1
7495004|NCT02193074|11813855|FG001|Overall Study|Withdrawal by Subject|2
7495005|NCT02193074|11813854|FG000|Overall Study|Adverse Event|16
7495006|NCT02193074|11813855|FG001|Overall Study|Adverse Event|13
7495007|NCT02193087|11813865|FG000|Overall Study|Adverse Event|2
7495008|NCT02193087|11813866|FG001|Overall Study|Adverse Event|0
7495009|NCT02193087|11813867|FG002|Overall Study|Adverse Event|0
7495010|NCT02193087|11813868|FG003|Overall Study|Adverse Event|11
7495011|NCT02193087|11813865|FG000|Overall Study|Lost to Follow-up|14
7495012|NCT02193087|11813866|FG001|Overall Study|Lost to Follow-up|6
7495013|NCT02193087|11813867|FG002|Overall Study|Lost to Follow-up|4
7495014|NCT02193087|11813868|FG003|Overall Study|Lost to Follow-up|37
7495015|NCT02193087|11813865|FG000|Overall Study|Protocol Violation|2
7495016|NCT02193087|11813866|FG001|Overall Study|Protocol Violation|0
7495017|NCT02193087|11813867|FG002|Overall Study|Protocol Violation|1
7495018|NCT02193087|11813868|FG003|Overall Study|Protocol Violation|2
7495019|NCT02193087|11813865|FG000|Overall Study|Withdrawal by Subject|10
7495020|NCT02193087|11813866|FG001|Overall Study|Withdrawal by Subject|3
7495021|NCT02193087|11813867|FG002|Overall Study|Withdrawal by Subject|1
7495022|NCT02193087|11813868|FG003|Overall Study|Withdrawal by Subject|19
7495023|NCT02193087|11813865|FG000|Overall Study|Other Reason Not Specified|7
7495024|NCT02193087|11813866|FG001|Overall Study|Other Reason Not Specified|2
7495025|NCT02193087|11813867|FG002|Overall Study|Other Reason Not Specified|1
7495026|NCT02193087|11813868|FG003|Overall Study|Other Reason Not Specified|9
7495027|NCT02193087|11813865|FG000|Overall Study|Did Not Receive Any Vaccination|2
7495028|NCT02193087|11813866|FG001|Overall Study|Did Not Receive Any Vaccination|3
7495029|NCT02193087|11813867|FG002|Overall Study|Did Not Receive Any Vaccination|0
7495030|NCT02193087|11813868|FG003|Overall Study|Did Not Receive Any Vaccination|1
7495031|NCT02193165|11813892|FG000|4 Week Product Use|Lost to Follow-up|1
7495032|NCT02193165|11813893|FG001|4 Week Product Use|Lost to Follow-up|1
7495033|NCT02193165|11813894|FG002|4 Week Product Use|Lost to Follow-up|1
7495034|NCT02193165|11813892|FG000|6 Week Product Use|Lost to Follow-up|0
7495035|NCT02193165|11813893|FG001|6 Week Product Use|Lost to Follow-up|1
7495036|NCT02193165|11813894|FG002|6 Week Product Use|Lost to Follow-up|0
7495037|NCT02193178|11813902|FG000|Overall Study|Lost to Follow-up|1
7495038|NCT02193178|11813902|FG000|Overall Study|Dry eyes|1
7495039|NCT02193776|11813937|FG000|Overall Study|Consent withdrawn|1
7495040|NCT02193776|11813938|FG001|Overall Study|Consent withdrawn|0
7495041|NCT02193776|11813939|FG002|Overall Study|Consent withdrawn|0
7495042|NCT02193776|11813940|FG003|Overall Study|Consent withdrawn|0
7495043|NCT02193776|11813937|FG000|Overall Study|Failure to comply with protocol|0
7495044|NCT02193776|11813938|FG001|Overall Study|Failure to comply with protocol|1
7495045|NCT02193776|11813939|FG002|Overall Study|Failure to comply with protocol|0
7495046|NCT02193776|11813940|FG003|Overall Study|Failure to comply with protocol|0
7495047|NCT02193776|11813937|FG000|Overall Study|Investigator/Sponsor decision|1
7495048|NCT02193776|11813938|FG001|Overall Study|Investigator/Sponsor decision|1
7495049|NCT02193776|11813939|FG002|Overall Study|Investigator/Sponsor decision|0
7495050|NCT02193776|11813940|FG003|Overall Study|Investigator/Sponsor decision|0
7495051|NCT02193776|11813937|FG000|Overall Study|Death|1
7495052|NCT02193776|11813938|FG001|Overall Study|Death|0
7495053|NCT02193776|11813939|FG002|Overall Study|Death|0
7495054|NCT02193776|11813940|FG003|Overall Study|Death|0
7495055|NCT02193776|11813937|FG000|Overall Study|Adverse event/Specific toxicity|5
7495056|NCT02193776|11813938|FG001|Overall Study|Adverse event/Specific toxicity|5
7495057|NCT02193776|11813939|FG002|Overall Study|Adverse event/Specific toxicity|2
7495058|NCT02193776|11813940|FG003|Overall Study|Adverse event/Specific toxicity|2
7495059|NCT02193828|11813968|FG000|Overall Study|Withdrawal by Subject|0
7495060|NCT02193828|11813969|FG001|Overall Study|Withdrawal by Subject|0
7495061|NCT02193828|11813970|FG002|Overall Study|Withdrawal by Subject|1
7495062|NCT02193828|11813971|FG003|Overall Study|Withdrawal by Subject|1
7495063|NCT02193880|11813981|FG000|Overall Study|patients did not collect enough HPC|3
7495064|NCT02194062|11813988|FG000|Overall Study|Lost to Follow-up|2
7495065|NCT02194062|11813989|FG001|Overall Study|Lost to Follow-up|2
7495066|NCT02194062|11813990|FG002|Overall Study|Lost to Follow-up|5
7495067|NCT02194465|11814020|FG000|Overall Study|Adverse Event|6
7495068|NCT02194465|11814021|FG001|Overall Study|Adverse Event|1
7495069|NCT02194465|11814022|FG002|Overall Study|Adverse Event|4
7495070|NCT02194465|11814023|FG003|Overall Study|Adverse Event|4
7495071|NCT02194465|11814024|FG004|Overall Study|Adverse Event|4
7495072|NCT02194465|11814025|FG005|Overall Study|Adverse Event|2
7495073|NCT02194465|11814026|FG006|Overall Study|Adverse Event|0
7495074|NCT02194465|11814020|FG000|Overall Study|Lost to Follow-up|0
7495075|NCT02194465|11814021|FG001|Overall Study|Lost to Follow-up|0
7495076|NCT02194465|11814022|FG002|Overall Study|Lost to Follow-up|0
7495077|NCT02194465|11814023|FG003|Overall Study|Lost to Follow-up|1
7495078|NCT02194465|11814024|FG004|Overall Study|Lost to Follow-up|0
7495079|NCT02194465|11814025|FG005|Overall Study|Lost to Follow-up|1
7495080|NCT02194465|11814026|FG006|Overall Study|Lost to Follow-up|0
7495081|NCT02194465|11814020|FG000|Overall Study|Physician Decision|1
7495082|NCT02194465|11814021|FG001|Overall Study|Physician Decision|0
7495083|NCT02194465|11814022|FG002|Overall Study|Physician Decision|0
7495084|NCT02194465|11814023|FG003|Overall Study|Physician Decision|0
7495085|NCT02194465|11814024|FG004|Overall Study|Physician Decision|0
7495086|NCT02194465|11814025|FG005|Overall Study|Physician Decision|0
7495087|NCT02194465|11814026|FG006|Overall Study|Physician Decision|0
7495088|NCT02194465|11814020|FG000|Overall Study|Protocol Violation|1
7495089|NCT02194465|11814021|FG001|Overall Study|Protocol Violation|1
7495090|NCT02194465|11814022|FG002|Overall Study|Protocol Violation|2
7495091|NCT02194465|11814023|FG003|Overall Study|Protocol Violation|1
7495092|NCT02194465|11814024|FG004|Overall Study|Protocol Violation|1
7495093|NCT02194465|11814025|FG005|Overall Study|Protocol Violation|0
7495094|NCT02194465|11814026|FG006|Overall Study|Protocol Violation|0
7495095|NCT02194465|11814020|FG000|Overall Study|Withdrawal by Subject|1
7495096|NCT02194465|11814021|FG001|Overall Study|Withdrawal by Subject|3
7495097|NCT02194465|11814022|FG002|Overall Study|Withdrawal by Subject|1
7495098|NCT02194465|11814023|FG003|Overall Study|Withdrawal by Subject|2
7495099|NCT02194465|11814024|FG004|Overall Study|Withdrawal by Subject|2
7495100|NCT02194465|11814025|FG005|Overall Study|Withdrawal by Subject|1
7495101|NCT02194465|11814026|FG006|Overall Study|Withdrawal by Subject|2
7495102|NCT02194465|11814020|FG000|Overall Study|Discontinued follow-up period|0
7495103|NCT02194465|11814021|FG001|Overall Study|Discontinued follow-up period|2
7495104|NCT02194465|11814022|FG002|Overall Study|Discontinued follow-up period|1
7495105|NCT02194465|11814023|FG003|Overall Study|Discontinued follow-up period|0
7495106|NCT02194465|11814024|FG004|Overall Study|Discontinued follow-up period|2
7495107|NCT02194465|11814025|FG005|Overall Study|Discontinued follow-up period|0
7495108|NCT02194465|11814026|FG006|Overall Study|Discontinued follow-up period|0
7495109|NCT02194621|11814049|FG000|Overall Study|6 withdrew prior to randomization|2
7495110|NCT02194621|11814050|FG001|Overall Study|6 withdrew prior to randomization|2
7495111|NCT02194621|11814051|FG002|Overall Study|6 withdrew prior to randomization|2
7495112|NCT02194621|11814049|FG000|Overall Study|Withdrawal by Subject|4
7495113|NCT02194621|11814050|FG001|Overall Study|Withdrawal by Subject|4
7495114|NCT02194621|11814051|FG002|Overall Study|Withdrawal by Subject|7
7495115|NCT02194699|11814061|FG000|Randomised|Did not receive treatment|1
7495116|NCT02194699|11814062|FG001|Randomised|Did not receive treatment|5
7495117|NCT02194699|11814061|FG000|Randomised|Without potential for 52 weeks of IP|5
7495118|NCT02194699|11814062|FG001|Randomised|Without potential for 52 weeks of IP|5
7495119|NCT02194699|11814061|FG000|Randomised|Duplicate patient|2
7495120|NCT02194699|11814062|FG001|Randomised|Duplicate patient|1
7495121|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
7495122|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
7495123|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Death|1
7495124|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Death|3
7495125|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
7495126|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
7495127|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7495128|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
7495129|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
7495130|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
7495131|NCT02194699|11814061|FG000|With Potential to Receive 52 Weeks of IP|Other|24
7495132|NCT02194699|11814062|FG001|With Potential to Receive 52 Weeks of IP|Other|16
7495133|NCT02194933|11814078|FG000|Overall Study|Lost to Follow-up|1
7495134|NCT02194933|11814079|FG001|Overall Study|Lost to Follow-up|2
7495135|NCT02194933|11814078|FG000|Overall Study|Participant met withdrawal criteria|1
7495136|NCT02194933|11814079|FG001|Overall Study|Participant met withdrawal criteria|3
7495137|NCT02194933|11814078|FG000|Overall Study|Withdrawal by Subject|0
7495138|NCT02194933|11814079|FG001|Overall Study|Withdrawal by Subject|2
7495139|NCT02194933|11814078|FG000|Overall Study|Lack of Efficacy|1
7495140|NCT02194933|11814079|FG001|Overall Study|Lack of Efficacy|2
7495141|NCT02194985|11814087|FG000|Overall Study|Adverse Event|1
7495142|NCT02194985|11814087|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
7495143|NCT02194985|11814087|FG000|Overall Study|Physician Decision|4
7495144|NCT02194985|11814087|FG000|Overall Study|Lost to Follow-up|1
7495145|NCT02194985|11814087|FG000|Overall Study|Withdrawal by Subject|2
7495146|NCT02194998|11814095|FG000|On-HCV Treatment|Did not pick up study medication|0
7495147|NCT02194998|11814096|FG001|On-HCV Treatment|Did not pick up study medication|1
7495148|NCT02194998|11814097|FG002|On-HCV Treatment|Did not pick up study medication|0
7495149|NCT02194998|11814098|FG003|On-HCV Treatment|Did not pick up study medication|0
7495150|NCT02194998|11814095|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7495151|NCT02194998|11814096|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7495152|NCT02194998|11814097|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
7495153|NCT02194998|11814098|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
7495154|NCT02195011|11814110|FG000|Overall Study|Adverse Event|4
7495155|NCT02195011|11814111|FG001|Overall Study|Adverse Event|0
7495156|NCT02195011|11814110|FG000|Overall Study|Progressive Disease|18
7495157|NCT02195011|11814111|FG001|Overall Study|Progressive Disease|1
7495158|NCT02195011|11814110|FG000|Overall Study|Withdrawal by Subject|3
7495159|NCT02195011|11814111|FG001|Overall Study|Withdrawal by Subject|0
7495160|NCT02195427|11814206|FG000|Overall Study|Did not consent to study extension|13
7495161|NCT02195427|11814207|FG001|Overall Study|Did not consent to study extension|9
7495162|NCT02195427|11814206|FG000|Overall Study|Withdrawal by Subject|4
7495163|NCT02195427|11814207|FG001|Overall Study|Withdrawal by Subject|2
7495164|NCT02195427|11814206|FG000|Overall Study|Lost to Follow-up|0
7495165|NCT02195427|11814207|FG001|Overall Study|Lost to Follow-up|1
7495166|NCT02195427|11814206|FG000|Overall Study|Protocol Violation|7
7495167|NCT02195427|11814207|FG001|Overall Study|Protocol Violation|14
7495168|NCT02195427|11814206|FG000|Overall Study|Conditional re-treatment at W52|2
7495169|NCT02195427|11814207|FG001|Overall Study|Conditional re-treatment at W52|1
7495170|NCT02195518|11814217|FG000|Overall Study|Adverse Event|1
7495171|NCT02195518|11814217|FG000|Overall Study|Protocol Violation|4
7495172|NCT02195518|11814217|FG000|Overall Study|Pregnancy|2
7495173|NCT02195518|11814217|FG000|Overall Study|Withdrawal by Subject|1
7495174|NCT02195518|11814217|FG000|Overall Study|Lost to Follow-up|1
7495175|NCT02195531|11814224|FG000|Overall Study|Withdrawal by Subject|1
7495176|NCT02195531|11814225|FG001|Overall Study|Withdrawal by Subject|1
7495177|NCT02195531|11814226|FG002|Overall Study|Withdrawal by Subject|1
7495178|NCT02195583|11814234|FG000|Overall Study|Lost to Follow-up|1
7495179|NCT02195583|11814234|FG000|Overall Study|Withdrawal by Subject|4
7317684|NCT00723957|11546667|FG001|Overall Study|Withdrawal by Subject|5
7317685|NCT00723957|11546666|FG000|Overall Study|Reason not analyzed|1
7317686|NCT00723957|11546667|FG001|Overall Study|Reason not analyzed|0
7317687|NCT00723957|11546666|FG000|Overall Study|Never received treatment|3
7495180|NCT02195583|11814234|FG000|Overall Study|Adverse Event|2
7495181|NCT02195583|11814234|FG000|Overall Study|Other Reason|2
7495182|NCT02195687|11814260|FG000|Overall Study|Personal Reasons|1
7495183|NCT02195687|11814261|FG001|Overall Study|Personal Reasons|1
7495184|NCT02195687|11814260|FG000|Overall Study|Lost to Follow-up|4
7495185|NCT02195687|11814261|FG001|Overall Study|Lost to Follow-up|1
7495186|NCT02195700|11814269|FG000|Overall Study|Protocol Violation|0
7495187|NCT02195700|11814270|FG001|Overall Study|Protocol Violation|2
7495188|NCT02195700|11814269|FG000|Overall Study|Noncompliance|1
7495189|NCT02195700|11814270|FG001|Overall Study|Noncompliance|0
7495190|NCT02195700|11814269|FG000|Overall Study|Adverse Event|1
7495191|NCT02195700|11814270|FG001|Overall Study|Adverse Event|2
7495192|NCT02195700|11814269|FG000|Overall Study|Withdrawal by Subject|3
7495193|NCT02195700|11814270|FG001|Overall Study|Withdrawal by Subject|2
7495194|NCT02195700|11814269|FG000|Overall Study|Lost to Follow-up|1
7495195|NCT02195700|11814270|FG001|Overall Study|Lost to Follow-up|1
7495196|NCT02195869|11814285|FG000|Overall Study|cGVHD Progression|5
7495197|NCT02195869|11814285|FG000|Overall Study|Malignancy Progression/relapse|2
7495198|NCT02195869|11814285|FG000|Overall Study|Adverse Event|15
7495199|NCT02195869|11814285|FG000|Overall Study|Withdrawal by Subject|7
7495200|NCT02195869|11814285|FG000|Overall Study|Physician Decision|4
7495201|NCT02195869|11814285|FG000|Overall Study|Study Terminated by Sponsor|7
7495202|NCT02195869|11814285|FG000|Overall Study|Noncompliance with study drug|2
7495203|NCT02196038|11814320|FG000|Overall Study|Death|16
7495204|NCT02196038|11814321|FG001|Overall Study|Death|21
7495205|NCT02196038|11814320|FG000|Overall Study|Withdrawal by Subject|0
7495206|NCT02196038|11814321|FG001|Overall Study|Withdrawal by Subject|1
7495207|NCT02196038|11814320|FG000|Overall Study|Lost to Follow-up|1
7495208|NCT02196038|11814321|FG001|Overall Study|Lost to Follow-up|0
7495209|NCT02196077|11814327|FG000|Overall Study|Adverse Event|4
7495210|NCT02196077|11814327|FG000|Overall Study|Lack of Efficacy|1
7495211|NCT02196077|11814327|FG000|Overall Study|Withdrawal by Subject|14
7495212|NCT02196077|11814327|FG000|Overall Study|Physician Decision|1
7495213|NCT02196077|11814327|FG000|Overall Study|Lost to Follow-up|3
7495214|NCT02196077|11814327|FG000|Overall Study|Protocol Violation|24
7495215|NCT02196259|11814351|FG000|Overall Study|Researcher choice|0
7495216|NCT02196259|11814352|FG001|Overall Study|Researcher choice|0
7495217|NCT02196259|11814353|FG002|Overall Study|Researcher choice|1
7495218|NCT02196259|11814351|FG000|Overall Study|Partial data analysis|0
7495219|NCT02196259|11814352|FG001|Overall Study|Partial data analysis|3
7495220|NCT02196259|11814353|FG002|Overall Study|Partial data analysis|0
7495221|NCT02196324|11814362|FG000|Overall Study|Withdrawal by Subject|8
7495222|NCT02196324|11814363|FG001|Overall Study|Withdrawal by Subject|4
7495223|NCT02196324|11814362|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
7495224|NCT02196324|11814363|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
7495225|NCT02196324|11814362|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
7495226|NCT02196324|11814363|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
7495227|NCT02196324|11814362|FG000|Overall Study|Other|1
7495228|NCT02196324|11814363|FG001|Overall Study|Other|0
7495229|NCT02196506|11814371|FG000|Phase A|Participant Met Withdrawal Criteria|34
7495230|NCT02196506|11814372|FG001|Phase A|Participant Met Withdrawal Criteria|0
7495231|NCT02196506|11814373|FG002|Phase A|Participant Met Withdrawal Criteria|0
7495232|NCT02196506|11814374|FG003|Phase A|Participant Met Withdrawal Criteria|0
7495233|NCT02196506|11814371|FG000|Phase A|Withdrawal by Subject|34
7495234|NCT02196506|11814372|FG001|Phase A|Withdrawal by Subject|0
7495235|NCT02196506|11814373|FG002|Phase A|Withdrawal by Subject|0
7495236|NCT02196506|11814374|FG003|Phase A|Withdrawal by Subject|0
7495237|NCT02196506|11814371|FG000|Phase A|Adverse Event|22
7495238|NCT02196506|11814372|FG001|Phase A|Adverse Event|0
7495239|NCT02196506|11814373|FG002|Phase A|Adverse Event|0
7495240|NCT02196506|11814374|FG003|Phase A|Adverse Event|0
7495241|NCT02196506|11814371|FG000|Phase A|Lost to Follow-up|9
7495242|NCT02196506|11814372|FG001|Phase A|Lost to Follow-up|0
7495243|NCT02196506|11814373|FG002|Phase A|Lost to Follow-up|0
7495244|NCT02196506|11814374|FG003|Phase A|Lost to Follow-up|0
7495245|NCT02196506|11814371|FG000|Phase A|Protocol deviation|12
7495246|NCT02196506|11814372|FG001|Phase A|Protocol deviation|0
7495247|NCT02196506|11814373|FG002|Phase A|Protocol deviation|0
7495248|NCT02196506|11814374|FG003|Phase A|Protocol deviation|0
7495249|NCT02196506|11814371|FG000|Phase A|Participant withdrawn by investigator|10
7495250|NCT02196506|11814372|FG001|Phase A|Participant withdrawn by investigator|0
7495251|NCT02196506|11814373|FG002|Phase A|Participant withdrawn by investigator|0
7495252|NCT02196506|11814374|FG003|Phase A|Participant withdrawn by investigator|0
7495253|NCT02196506|11814371|FG000|Phase B|Participant Met Withdrawal Criteria|0
7495254|NCT02196506|11814372|FG001|Phase B|Participant Met Withdrawal Criteria|0
7495255|NCT02196506|11814373|FG002|Phase B|Participant Met Withdrawal Criteria|1
7495256|NCT02196506|11814374|FG003|Phase B|Participant Met Withdrawal Criteria|0
7495257|NCT02196506|11814371|FG000|Phase B|Lack of Efficacy|0
7495258|NCT02196506|11814372|FG001|Phase B|Lack of Efficacy|1
7495259|NCT02196506|11814373|FG002|Phase B|Lack of Efficacy|2
7495260|NCT02196506|11814374|FG003|Phase B|Lack of Efficacy|0
7495261|NCT02196506|11814371|FG000|Phase B|Withdrawal by Participant|0
7495262|NCT02196506|11814372|FG001|Phase B|Withdrawal by Participant|8
7495263|NCT02196506|11814373|FG002|Phase B|Withdrawal by Participant|1
7495264|NCT02196506|11814374|FG003|Phase B|Withdrawal by Participant|0
7495265|NCT02196506|11814371|FG000|Phase B|Adverse Event|0
7495266|NCT02196506|11814372|FG001|Phase B|Adverse Event|4
7495267|NCT02196506|11814373|FG002|Phase B|Adverse Event|1
7495268|NCT02196506|11814374|FG003|Phase B|Adverse Event|0
7495269|NCT02196506|11814371|FG000|Phase B|Lost to Follow-up|0
7495270|NCT02196506|11814372|FG001|Phase B|Lost to Follow-up|2
7495271|NCT02196506|11814373|FG002|Phase B|Lost to Follow-up|1
7495272|NCT02196506|11814374|FG003|Phase B|Lost to Follow-up|0
7495273|NCT02196506|11814371|FG000|Phase A+|Participant Met Withdrawal Criteria|0
7495274|NCT02196506|11814372|FG001|Phase A+|Participant Met Withdrawal Criteria|0
7495275|NCT02196506|11814373|FG002|Phase A+|Participant Met Withdrawal Criteria|0
7495276|NCT02196506|11814374|FG003|Phase A+|Participant Met Withdrawal Criteria|1
7495277|NCT02196506|11814371|FG000|Phase A+|Withdrawal by Participant|0
7495278|NCT02196506|11814372|FG001|Phase A+|Withdrawal by Participant|0
7495279|NCT02196506|11814373|FG002|Phase A+|Withdrawal by Participant|0
7495280|NCT02196506|11814374|FG003|Phase A+|Withdrawal by Participant|5
7495281|NCT02196506|11814371|FG000|Phase A+|Adverse Event|0
7495282|NCT02196506|11814372|FG001|Phase A+|Adverse Event|0
7495283|NCT02196506|11814373|FG002|Phase A+|Adverse Event|0
7495284|NCT02196506|11814374|FG003|Phase A+|Adverse Event|1
7495285|NCT02196506|11814371|FG000|Phase A+|Lost to Follow-up|0
7495286|NCT02196506|11814372|FG001|Phase A+|Lost to Follow-up|0
7495287|NCT02196506|11814373|FG002|Phase A+|Lost to Follow-up|0
7495288|NCT02196506|11814374|FG003|Phase A+|Lost to Follow-up|6
7495289|NCT02196506|11814371|FG000|Phase A+|Participant withdrawn by investigator|0
7495290|NCT02196506|11814372|FG001|Phase A+|Participant withdrawn by investigator|0
7495291|NCT02196506|11814373|FG002|Phase A+|Participant withdrawn by investigator|0
7495292|NCT02196506|11814374|FG003|Phase A+|Participant withdrawn by investigator|1
7495293|NCT02196558|11814383|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
7495294|NCT02196558|11814384|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
7495295|NCT02196558|11814385|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
7495296|NCT02196558|11814383|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
7495297|NCT02196558|11814384|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
7495298|NCT02196558|11814385|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
7495299|NCT02196558|11814383|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
7495300|NCT02196558|11814384|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
7495301|NCT02196558|11814385|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
7495302|NCT02196558|11814383|FG000|Extension Phase (40 Weeks)|Adverse Event|1
7495303|NCT02196558|11814384|FG001|Extension Phase (40 Weeks)|Adverse Event|2
7495304|NCT02196558|11814385|FG002|Extension Phase (40 Weeks)|Adverse Event|0
7495305|NCT02196558|11814383|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7495306|NCT02196558|11814384|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7535324|NCT02709577|11883029|FG003|Overall Study|procedural complication|0
7495307|NCT02196558|11814385|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
7495308|NCT02196675|11814396|FG000|Overall Study|Withdrawal by Subject|1
7495309|NCT02196675|11814397|FG001|Overall Study|Withdrawal by Subject|0
7495310|NCT02196675|11814398|FG002|Overall Study|Withdrawal by Subject|0
7495311|NCT02196675|11814396|FG000|Overall Study|Intra-operative surgical exclusion|1
7495312|NCT02196675|11814397|FG001|Overall Study|Intra-operative surgical exclusion|1
7495313|NCT02196675|11814398|FG002|Overall Study|Intra-operative surgical exclusion|0
7495314|NCT02196675|11814396|FG000|Overall Study|Protocol Violation|0
7495315|NCT02196675|11814397|FG001|Overall Study|Protocol Violation|1
7495316|NCT02196675|11814398|FG002|Overall Study|Protocol Violation|0
7495317|NCT02196675|11814396|FG000|Overall Study|Death|0
7495318|NCT02196675|11814397|FG001|Overall Study|Death|0
7495319|NCT02196675|11814398|FG002|Overall Study|Death|1
7495320|NCT02196701|11814417|FG000|Overall Study|Adverse Event|1
7495321|NCT02196701|11814417|FG000|Overall Study|Lost to Follow-up|1
7495322|NCT02196701|11814417|FG000|Overall Study|Non-adherence to Protocol|1
7495323|NCT02196714|11814424|FG000|Overall Study|Protocol Violation|0
7495324|NCT02196714|11814425|FG001|Overall Study|Protocol Violation|0
7495325|NCT02196714|11814426|FG002|Overall Study|Protocol Violation|1
7495326|NCT02196714|11814427|FG003|Overall Study|Protocol Violation|0
7495327|NCT02197130|11814535|FG000|Overall Study|Adverse Event|13
7495328|NCT02197130|11814536|FG001|Overall Study|Adverse Event|4
7495329|NCT02197130|11814537|FG002|Overall Study|Adverse Event|23
7495330|NCT02197130|11814535|FG000|Overall Study|Death|0
7495331|NCT02197130|11814536|FG001|Overall Study|Death|1
7495332|NCT02197130|11814537|FG002|Overall Study|Death|0
7495333|NCT02197130|11814535|FG000|Overall Study|Lost to Follow-up|2
7495334|NCT02197130|11814536|FG001|Overall Study|Lost to Follow-up|0
7495335|NCT02197130|11814537|FG002|Overall Study|Lost to Follow-up|1
7495336|NCT02197130|11814535|FG000|Overall Study|Does not meet entrance criteria|0
7495337|NCT02197130|11814536|FG001|Overall Study|Does not meet entrance criteria|0
7495338|NCT02197130|11814537|FG002|Overall Study|Does not meet entrance criteria|1
7495339|NCT02197130|11814535|FG000|Overall Study|Withdrawal by Subject|0
7495340|NCT02197130|11814536|FG001|Overall Study|Withdrawal by Subject|3
7495341|NCT02197130|11814537|FG002|Overall Study|Withdrawal by Subject|4
7495342|NCT02197130|11814535|FG000|Overall Study|Other|1
7495343|NCT02197130|11814536|FG001|Overall Study|Other|0
7495344|NCT02197130|11814537|FG002|Overall Study|Other|3
7495345|NCT02197247|11814545|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
7495346|NCT02197247|11814545|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
7495347|NCT02197247|11814545|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
7495348|NCT02197247|11814545|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
7495349|NCT02197247|11814545|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
7495350|NCT02197247|11814545|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
7495351|NCT02197247|11814545|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
7495352|NCT02197247|11814545|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
7495353|NCT02197377|11814566|FG000|Overall Study|Insertion Failure|0
7495354|NCT02197377|11814567|FG001|Overall Study|Insertion Failure|3
7495355|NCT02197416|11814576|FG000|Overall Study|Other reasons|0
7495356|NCT02197416|11814577|FG001|Overall Study|Other reasons|2
7495357|NCT02197416|11814578|FG002|Overall Study|Other reasons|5
7495358|NCT02197416|11814576|FG000|Overall Study|Withdrawal by Subject|0
7495359|NCT02197416|11814577|FG001|Overall Study|Withdrawal by Subject|2
7495360|NCT02197416|11814578|FG002|Overall Study|Withdrawal by Subject|1
7495361|NCT02197416|11814576|FG000|Overall Study|Protocol Violation|1
7495362|NCT02197416|11814577|FG001|Overall Study|Protocol Violation|0
7495363|NCT02197416|11814578|FG002|Overall Study|Protocol Violation|1
7495364|NCT02197416|11814576|FG000|Overall Study|Adverse Event|0
7495365|NCT02197416|11814577|FG001|Overall Study|Adverse Event|0
7495366|NCT02197416|11814578|FG002|Overall Study|Adverse Event|1
7495367|NCT02197520|11814597|FG000|Period 1|Withdrawal by Subject|1
7495368|NCT02197520|11814598|FG001|Period 1|Withdrawal by Subject|0
7495369|NCT02197520|11814597|FG000|Period 2|Adverse Event|0
7495370|NCT02197520|11814598|FG001|Period 2|Adverse Event|2
7495371|NCT02197520|11814597|FG000|Period 2|Withdrawal by Subject|1
7495372|NCT02197520|11814598|FG001|Period 2|Withdrawal by Subject|0
7495373|NCT02197572|11814606|FG000|Overall Study|Progressive Disease|28
7495374|NCT02197572|11814606|FG000|Overall Study|Withdrawal by Subject|9
7495375|NCT02197572|11814606|FG000|Overall Study|Adverse Event|3
7495376|NCT02197572|11814606|FG000|Overall Study|Reason Not Specified|4
7495377|NCT02197806|11814618|FG000|Overall Study|Adverse Event|0
7495378|NCT02197806|11814619|FG001|Overall Study|Adverse Event|1
7495379|NCT02197806|11814620|FG002|Overall Study|Adverse Event|0
7495380|NCT02197806|11814621|FG003|Overall Study|Adverse Event|1
7495381|NCT02197897|11814631|FG000|Overall Study|not eligible|1
7495382|NCT02198040|11814638|FG000|Overall Study|Work reasons|0
7495383|NCT02198040|11814639|FG001|Overall Study|Work reasons|1
7495384|NCT02198040|11814640|FG002|Overall Study|Work reasons|0
7495385|NCT02198040|11814638|FG000|Overall Study|Withdrawal by Subject|0
7495386|NCT02198040|11814639|FG001|Overall Study|Withdrawal by Subject|0
7495387|NCT02198040|11814640|FG002|Overall Study|Withdrawal by Subject|1
7495388|NCT02198235|11814653|FG000|Overall Study|Lost to Follow-up|3
7495389|NCT02198235|11814654|FG001|Overall Study|Lost to Follow-up|2
7495390|NCT02198235|11814655|FG002|Overall Study|Lost to Follow-up|2
7495391|NCT02198651|11814672|FG000|Lead-in Period|Withdrew consent|13
7495392|NCT02198651|11814673|FG001|Lead-in Period|Withdrew consent|0
7495393|NCT02198651|11814674|FG002|Lead-in Period|Withdrew consent|0
7495394|NCT02198651|11814675|FG003|Lead-in Period|Withdrew consent|0
7495395|NCT02198651|11814676|FG004|Lead-in Period|Withdrew consent|0
7495396|NCT02198651|11814672|FG000|Lead-in Period|Adverse Event|2
7495397|NCT02198651|11814673|FG001|Lead-in Period|Adverse Event|0
7495398|NCT02198651|11814674|FG002|Lead-in Period|Adverse Event|0
7495399|NCT02198651|11814675|FG003|Lead-in Period|Adverse Event|0
7495400|NCT02198651|11814676|FG004|Lead-in Period|Adverse Event|0
7495401|NCT02198651|11814672|FG000|Lead-in Period|Other, not specified|22
7495402|NCT02198651|11814673|FG001|Lead-in Period|Other, not specified|0
7495403|NCT02198651|11814674|FG002|Lead-in Period|Other, not specified|0
7495404|NCT02198651|11814675|FG003|Lead-in Period|Other, not specified|0
7495405|NCT02198651|11814676|FG004|Lead-in Period|Other, not specified|0
7495406|NCT02198651|11814672|FG000|Double-blind Period|Withdrew consent|0
7495407|NCT02198651|11814673|FG001|Double-blind Period|Withdrew consent|4
7495408|NCT02198651|11814674|FG002|Double-blind Period|Withdrew consent|0
7495409|NCT02198651|11814675|FG003|Double-blind Period|Withdrew consent|0
7495410|NCT02198651|11814676|FG004|Double-blind Period|Withdrew consent|0
7495411|NCT02198651|11814672|FG000|Double-blind Period|Adverse Event|0
7495412|NCT02198651|11814673|FG001|Double-blind Period|Adverse Event|1
7495413|NCT02198651|11814674|FG002|Double-blind Period|Adverse Event|0
7495414|NCT02198651|11814675|FG003|Double-blind Period|Adverse Event|0
7495415|NCT02198651|11814676|FG004|Double-blind Period|Adverse Event|0
7495416|NCT02198651|11814672|FG000|Double-blind Period|Other, not specified|0
7495417|NCT02198651|11814673|FG001|Double-blind Period|Other, not specified|4
7495418|NCT02198651|11814674|FG002|Double-blind Period|Other, not specified|1
7495419|NCT02198651|11814675|FG003|Double-blind Period|Other, not specified|0
7495420|NCT02198651|11814676|FG004|Double-blind Period|Other, not specified|0
7495421|NCT02198651|11814672|FG000|Open-label Rescue Period|Withdrew consent|0
7495422|NCT02198651|11814673|FG001|Open-label Rescue Period|Withdrew consent|0
7495423|NCT02198651|11814674|FG002|Open-label Rescue Period|Withdrew consent|0
7495424|NCT02198651|11814675|FG003|Open-label Rescue Period|Withdrew consent|2
7495425|NCT02198651|11814676|FG004|Open-label Rescue Period|Withdrew consent|0
7495426|NCT02198651|11814672|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7495427|NCT02198651|11814673|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7495428|NCT02198651|11814674|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7495429|NCT02198651|11814675|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
7495430|NCT02198651|11814676|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
7495431|NCT02198664|11814691|FG000|Overall Study|Adverse Event|2
7495432|NCT02198664|11814692|FG001|Overall Study|Adverse Event|0
7495433|NCT02198664|11814691|FG000|Overall Study|Withdrawal by Subject|11
7495434|NCT02198664|11814692|FG001|Overall Study|Withdrawal by Subject|8
7495435|NCT02198664|11814691|FG000|Overall Study|Failure to tolerate|2
7495436|NCT02198664|11814692|FG001|Overall Study|Failure to tolerate|0
7495437|NCT02198664|11814691|FG000|Overall Study|Not stated|1
7495438|NCT02198664|11814692|FG001|Overall Study|Not stated|0
7495439|NCT02198963|11814700|FG000|Overall Study|Adverse Event|1
7495440|NCT02198963|11814700|FG000|Overall Study|Withdrawal by Subject|6
7495441|NCT02199028|11814711|FG000|Week 1|Adverse Event|1
7495442|NCT02199028|11814712|FG001|Week 1|Adverse Event|0
7495443|NCT02199028|11814711|FG000|Week 3|Adverse Event|1
7495444|NCT02199028|11814712|FG001|Week 3|Adverse Event|0
7495445|NCT02199080|11814724|FG000|Overall Study|Protocol Violation|12
7495446|NCT02199314|11814740|FG000|Overall Study|Withdrawal by Subject|6
7495447|NCT02199314|11814740|FG000|Overall Study|Physician Decision|10
7495448|NCT02199509|11814755|FG000|Overall Study|Suicidal Ideation|0
7495449|NCT02199509|11814756|FG001|Overall Study|Suicidal Ideation|1
7495450|NCT02199509|11814755|FG000|Overall Study|Misunderstood titration schedule|1
7495451|NCT02199509|11814756|FG001|Overall Study|Misunderstood titration schedule|0
7535325|NCT02709577|11883026|FG000|Overall Study|Withdrawal by Subject|2
7535326|NCT02709577|11883027|FG001|Overall Study|Withdrawal by Subject|3
7535327|NCT02709577|11883028|FG002|Overall Study|Withdrawal by Subject|2
7535328|NCT02709577|11883029|FG003|Overall Study|Withdrawal by Subject|0
7535329|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
7535330|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7535331|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7535332|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7535333|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
7535334|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
7535335|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
7535336|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
7535337|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
7535338|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
7535339|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
7535340|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7535341|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7495452|NCT02199795|11814799|FG000|Overall Study|no longer met inclusion criteria|1
7495453|NCT02199795|11814800|FG001|Overall Study|no longer met inclusion criteria|0
7495454|NCT02199795|11814799|FG000|Overall Study|withdrew due to shoulder pain|1
7495455|NCT02199795|11814800|FG001|Overall Study|withdrew due to shoulder pain|0
7495456|NCT02200211|11814825|FG000|Overall Study|Lost to Follow-up|7
7495457|NCT02200211|11814826|FG001|Overall Study|Lost to Follow-up|7
7495458|NCT02200211|11814827|FG002|Overall Study|Lost to Follow-up|1
7495459|NCT02200211|11814828|FG003|Overall Study|Lost to Follow-up|2
7495460|NCT02200211|11814825|FG000|Overall Study|Withdrawal by Subject|1
7495461|NCT02200211|11814826|FG001|Overall Study|Withdrawal by Subject|0
7495462|NCT02200211|11814827|FG002|Overall Study|Withdrawal by Subject|0
7495463|NCT02200211|11814828|FG003|Overall Study|Withdrawal by Subject|0
7495470|NCT02200510|11814865|FG000|Overall Study|Death|1
7495471|NCT02200510|11814866|FG001|Overall Study|Death|1
7495472|NCT02200510|11814865|FG000|Overall Study|Protocol Violation|0
7495473|NCT02200510|11814866|FG001|Overall Study|Protocol Violation|1
7495474|NCT02200510|11814865|FG000|Overall Study|Lost to Follow-up|7
7495475|NCT02200510|11814866|FG001|Overall Study|Lost to Follow-up|1
7495476|NCT02200510|11814865|FG000|Overall Study|potential COI - joined study team|1
7495477|NCT02200510|11814866|FG001|Overall Study|potential COI - joined study team|0
7495484|NCT02201277|11814947|FG000|Overall Study|Death|3
7495485|NCT02201277|11814948|FG001|Overall Study|Death|4
7495486|NCT02201277|11814947|FG000|Overall Study|Lost to Follow-up|2
7495487|NCT02201277|11814948|FG001|Overall Study|Lost to Follow-up|1
7495488|NCT02201277|11814947|FG000|Overall Study|Failed retrieval|1
7495489|NCT02201277|11814948|FG001|Overall Study|Failed retrieval|0
7495490|NCT02201277|11814947|FG000|Overall Study|Physician Decision|1
7495491|NCT02201277|11814948|FG001|Overall Study|Physician Decision|0
7495492|NCT02201290|11814958|FG000|Overall Study|Withdrawal by Subject|2
7495493|NCT02201290|11814958|FG000|Overall Study|Lack of Efficacy|2
7495494|NCT02201290|11814958|FG000|Overall Study|Adverse Event|1
7495495|NCT02201329|11814962|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
7495496|NCT02201329|11814962|FG000|Overall Study|Withdrawal by Subject|2
7495497|NCT02201524|11814988|FG000|Overall Study|Adverse Event|0
7495498|NCT02201524|11814989|FG001|Overall Study|Adverse Event|2
7495499|NCT02201524|11814990|FG002|Overall Study|Adverse Event|1
7495500|NCT02201524|11814991|FG003|Overall Study|Adverse Event|0
7495501|NCT02201524|11814988|FG000|Overall Study|Insufficient clinical response|1
7495502|NCT02201524|11814989|FG001|Overall Study|Insufficient clinical response|0
7495503|NCT02201524|11814990|FG002|Overall Study|Insufficient clinical response|0
7495504|NCT02201524|11814991|FG003|Overall Study|Insufficient clinical response|0
7495505|NCT02201524|11814988|FG000|Overall Study|Lost to Follow-up|0
7495506|NCT02201524|11814989|FG001|Overall Study|Lost to Follow-up|0
7495507|NCT02201524|11814990|FG002|Overall Study|Lost to Follow-up|2
7495508|NCT02201524|11814991|FG003|Overall Study|Lost to Follow-up|0
7495509|NCT02201524|11814988|FG000|Overall Study|No longer meets eligibility criteria|0
7495510|NCT02201524|11814989|FG001|Overall Study|No longer meets eligibility criteria|0
7495511|NCT02201524|11814990|FG002|Overall Study|No longer meets eligibility criteria|0
7495512|NCT02201524|11814991|FG003|Overall Study|No longer meets eligibility criteria|2
7495513|NCT02201524|11814988|FG000|Overall Study|Protocol Violation|0
7495514|NCT02201524|11814989|FG001|Overall Study|Protocol Violation|0
7495515|NCT02201524|11814990|FG002|Overall Study|Protocol Violation|0
7495516|NCT02201524|11814991|FG003|Overall Study|Protocol Violation|1
7495517|NCT02201524|11814988|FG000|Overall Study|Withdrawal by Subject|0
7495518|NCT02201524|11814989|FG001|Overall Study|Withdrawal by Subject|0
7495519|NCT02201524|11814990|FG002|Overall Study|Withdrawal by Subject|1
7495520|NCT02201524|11814991|FG003|Overall Study|Withdrawal by Subject|1
7495521|NCT02201524|11814988|FG000|Overall Study|Other|1
7495522|NCT02201524|11814989|FG001|Overall Study|Other|1
7495523|NCT02201524|11814990|FG002|Overall Study|Other|0
7495524|NCT02201524|11814991|FG003|Overall Study|Other|0
7495525|NCT02201771|11815004|FG000|Overall Study|Death|3
7495526|NCT02201771|11815005|FG001|Overall Study|Death|2
7495527|NCT02201771|11815006|FG002|Overall Study|Death|0
7495528|NCT02201771|11815004|FG000|Overall Study|Protocol Violation|10
7495529|NCT02201771|11815005|FG001|Overall Study|Protocol Violation|8
7495530|NCT02201771|11815006|FG002|Overall Study|Protocol Violation|10
7495531|NCT02201784|11815016|FG000|Overall Study|Failure to achieve adequate block|2
7495532|NCT02201784|11815017|FG001|Overall Study|Failure to achieve adequate block|0
7495533|NCT02201901|11815026|FG000|Overall Study|Randomized but never treated|0
7495534|NCT02201901|11815027|FG001|Overall Study|Randomized but never treated|1
7495535|NCT02201901|11815028|FG002|Overall Study|Randomized but never treated|0
7495536|NCT02201901|11815026|FG000|Overall Study|Lack of Efficacy|7
7495537|NCT02201901|11815027|FG001|Overall Study|Lack of Efficacy|1
7495538|NCT02201901|11815028|FG002|Overall Study|Lack of Efficacy|6
7495539|NCT02201901|11815026|FG000|Overall Study|Death|3
7495540|NCT02201901|11815027|FG001|Overall Study|Death|3
7495541|NCT02201901|11815028|FG002|Overall Study|Death|3
7495542|NCT02201901|11815026|FG000|Overall Study|Lost to Follow-up|2
7495543|NCT02201901|11815027|FG001|Overall Study|Lost to Follow-up|3
7495544|NCT02201901|11815028|FG002|Overall Study|Lost to Follow-up|2
7495545|NCT02201901|11815026|FG000|Overall Study|Withdrew Consent|2
7495546|NCT02201901|11815027|FG001|Overall Study|Withdrew Consent|0
7495547|NCT02201901|11815028|FG002|Overall Study|Withdrew Consent|2
7495548|NCT02201901|11815026|FG000|Overall Study|Adverse Event|1
7495549|NCT02201901|11815027|FG001|Overall Study|Adverse Event|1
7495550|NCT02201901|11815028|FG002|Overall Study|Adverse Event|0
7495551|NCT02201940|11815039|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
7495552|NCT02201940|11815040|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
7495553|NCT02201940|11815039|FG000|Overall Study|Lack of Efficacy|2
7495554|NCT02201940|11815040|FG001|Overall Study|Lack of Efficacy|113
7495555|NCT02201940|11815039|FG000|Overall Study|Lost to Follow-up|5
7495556|NCT02201940|11815040|FG001|Overall Study|Lost to Follow-up|0
7495557|NCT02201940|11815039|FG000|Overall Study|Withdrew Consent|2
7495558|NCT02201940|11815040|FG001|Overall Study|Withdrew Consent|1
7495559|NCT02201940|11815039|FG000|Overall Study|Investigator's Discretion|1
7495560|NCT02201940|11815040|FG001|Overall Study|Investigator's Discretion|1
7495561|NCT02201940|11815039|FG000|Overall Study|Death|1
7495562|NCT02201940|11815040|FG001|Overall Study|Death|0
7495563|NCT02201940|11815039|FG000|Overall Study|Adverse Event|0
7495564|NCT02201940|11815040|FG001|Overall Study|Adverse Event|1
7495565|NCT02201953|11815048|FG000|Overall Study|Randomized but Never Treated|1
7495566|NCT02201953|11815049|FG001|Overall Study|Randomized but Never Treated|5
7495567|NCT02201953|11815048|FG000|Overall Study|Lack of Efficacy|9
7495568|NCT02201953|11815049|FG001|Overall Study|Lack of Efficacy|30
7495569|NCT02201953|11815048|FG000|Overall Study|Lost to Follow-up|8
7495570|NCT02201953|11815049|FG001|Overall Study|Lost to Follow-up|8
7495571|NCT02201953|11815048|FG000|Overall Study|Withdrew Consent|2
7495572|NCT02201953|11815049|FG001|Overall Study|Withdrew Consent|5
7495573|NCT02201953|11815048|FG000|Overall Study|Adverse Event|0
7495574|NCT02201953|11815049|FG001|Overall Study|Adverse Event|5
7495575|NCT02201953|11815048|FG000|Overall Study|Death|0
7495576|NCT02201953|11815049|FG001|Overall Study|Death|3
7495577|NCT02202031|11815057|FG000|Overall Study|Lost to Follow-up|1
7495578|NCT02202031|11815058|FG001|Overall Study|Lost to Follow-up|0
7495579|NCT02202031|11815057|FG000|Overall Study|Too Busy|1
7495580|NCT02202031|11815058|FG001|Overall Study|Too Busy|3
7495581|NCT02202031|11815057|FG000|Overall Study|Illness/Medical Reason|0
7495582|NCT02202031|11815058|FG001|Overall Study|Illness/Medical Reason|2
7495583|NCT02202031|11815057|FG000|Overall Study|Intolerance/Lack of Improvement|3
7495584|NCT02202031|11815058|FG001|Overall Study|Intolerance/Lack of Improvement|0
7495585|NCT02202109|11815066|FG000|Overall Study|Lost to Follow-up|88
7495586|NCT02202109|11815067|FG001|Overall Study|Lost to Follow-up|87
7495587|NCT02202109|11815066|FG000|Overall Study|Withdrawal by Subject|2
7495588|NCT02202109|11815067|FG001|Overall Study|Withdrawal by Subject|0
7495589|NCT02202161|11815085|FG000|Overall Study|Adverse Event|1
7495590|NCT02202161|11815086|FG001|Overall Study|Adverse Event|1
7495591|NCT02202161|11815087|FG002|Overall Study|Adverse Event|0
7495592|NCT02202161|11815088|FG003|Overall Study|Adverse Event|0
7495593|NCT02202161|11815089|FG004|Overall Study|Adverse Event|0
7495594|NCT02202161|11815090|FG005|Overall Study|Adverse Event|1
7495595|NCT02202161|11815091|FG006|Overall Study|Adverse Event|0
7495596|NCT02202161|11815092|FG007|Overall Study|Adverse Event|0
7495597|NCT02202161|11815085|FG000|Overall Study|Did not meet continuation criteria|0
7495598|NCT02202161|11815086|FG001|Overall Study|Did not meet continuation criteria|0
7495599|NCT02202161|11815087|FG002|Overall Study|Did not meet continuation criteria|0
7495600|NCT02202161|11815088|FG003|Overall Study|Did not meet continuation criteria|0
7495601|NCT02202161|11815089|FG004|Overall Study|Did not meet continuation criteria|0
7495602|NCT02202161|11815090|FG005|Overall Study|Did not meet continuation criteria|0
7495603|NCT02202161|11815091|FG006|Overall Study|Did not meet continuation criteria|0
7495604|NCT02202161|11815092|FG007|Overall Study|Did not meet continuation criteria|3
7495605|NCT02202161|11815085|FG000|Overall Study|Physician Decision|0
7495606|NCT02202161|11815086|FG001|Overall Study|Physician Decision|0
7495607|NCT02202161|11815087|FG002|Overall Study|Physician Decision|0
7495608|NCT02202161|11815088|FG003|Overall Study|Physician Decision|0
7495609|NCT02202161|11815089|FG004|Overall Study|Physician Decision|0
7495610|NCT02202161|11815090|FG005|Overall Study|Physician Decision|0
7495611|NCT02202161|11815091|FG006|Overall Study|Physician Decision|0
7495612|NCT02202161|11815092|FG007|Overall Study|Physician Decision|3
7495613|NCT02202161|11815085|FG000|Overall Study|Withdrawal by Subject|0
7495614|NCT02202161|11815086|FG001|Overall Study|Withdrawal by Subject|0
7495615|NCT02202161|11815087|FG002|Overall Study|Withdrawal by Subject|0
7495616|NCT02202161|11815088|FG003|Overall Study|Withdrawal by Subject|0
7495617|NCT02202161|11815089|FG004|Overall Study|Withdrawal by Subject|1
7495618|NCT02202161|11815090|FG005|Overall Study|Withdrawal by Subject|0
7495619|NCT02202161|11815091|FG006|Overall Study|Withdrawal by Subject|0
7495620|NCT02202161|11815092|FG007|Overall Study|Withdrawal by Subject|0
7495621|NCT02202317|11815120|FG000|Overall Study|Lost to Follow-up|1
7495622|NCT02202499|11815127|FG000|Overall Study|Cancer diagnosis|0
7495623|NCT02202499|11815128|FG001|Overall Study|Cancer diagnosis|0
7495624|NCT02202499|11815129|FG002|Overall Study|Cancer diagnosis|1
7495625|NCT02202499|11815127|FG000|Overall Study|Moved from area|0
7495626|NCT02202499|11815128|FG001|Overall Study|Moved from area|0
7495627|NCT02202499|11815129|FG002|Overall Study|Moved from area|1
7495628|NCT02202499|11815127|FG000|Overall Study|Declined before randomization|1
7495629|NCT02202499|11815128|FG001|Overall Study|Declined before randomization|0
7495630|NCT02202499|11815129|FG002|Overall Study|Declined before randomization|0
7495631|NCT02202499|11815127|FG000|Overall Study|Auto accident|1
7495632|NCT02202499|11815128|FG001|Overall Study|Auto accident|0
7495633|NCT02202499|11815129|FG002|Overall Study|Auto accident|0
7495634|NCT02202538|11815142|FG000|Overall Study|Withdrawal by Subject|5
7495635|NCT02202538|11815142|FG000|Overall Study|Did not meet all inclusion criteria|2
7495636|NCT02202538|11815142|FG000|Overall Study|Investigator Decision|1
7495637|NCT02202551|11815150|FG000|Overall Study|Adverse Event|8
7495638|NCT02202551|11815151|FG001|Overall Study|Adverse Event|19
7495639|NCT02202551|11815152|FG002|Overall Study|Adverse Event|5
7495640|NCT02202551|11815153|FG003|Overall Study|Adverse Event|9
7495641|NCT02202551|11815150|FG000|Overall Study|Death|3
7495642|NCT02202551|11815151|FG001|Overall Study|Death|2
7495643|NCT02202551|11815152|FG002|Overall Study|Death|1
7495644|NCT02202551|11815153|FG003|Overall Study|Death|1
7495645|NCT02202551|11815150|FG000|Overall Study|Lost to Follow-up|0
7495646|NCT02202551|11815151|FG001|Overall Study|Lost to Follow-up|1
7495647|NCT02202551|11815152|FG002|Overall Study|Lost to Follow-up|0
7495648|NCT02202551|11815153|FG003|Overall Study|Lost to Follow-up|1
7495649|NCT02202551|11815150|FG000|Overall Study|Needed to take excluded medication|0
7495650|NCT02202551|11815151|FG001|Overall Study|Needed to take excluded medication|2
7495651|NCT02202551|11815152|FG002|Overall Study|Needed to take excluded medication|0
7495652|NCT02202551|11815153|FG003|Overall Study|Needed to take excluded medication|1
7495653|NCT02202551|11815150|FG000|Overall Study|Subject moved away|0
7495654|NCT02202551|11815151|FG001|Overall Study|Subject moved away|1
7495655|NCT02202551|11815152|FG002|Overall Study|Subject moved away|0
7495656|NCT02202551|11815153|FG003|Overall Study|Subject moved away|0
7495657|NCT02202551|11815150|FG000|Overall Study|DBS surgery|3
7495658|NCT02202551|11815151|FG001|Overall Study|DBS surgery|0
7495659|NCT02202551|11815152|FG002|Overall Study|DBS surgery|0
7495660|NCT02202551|11815153|FG003|Overall Study|DBS surgery|0
7495661|NCT02202551|11815150|FG000|Overall Study|Dyskinesia upon taper|1
7495662|NCT02202551|11815151|FG001|Overall Study|Dyskinesia upon taper|0
7495663|NCT02202551|11815152|FG002|Overall Study|Dyskinesia upon taper|0
7495664|NCT02202551|11815153|FG003|Overall Study|Dyskinesia upon taper|0
7495665|NCT02202551|11815150|FG000|Overall Study|Lack of Efficacy|0
7495666|NCT02202551|11815151|FG001|Overall Study|Lack of Efficacy|1
7495667|NCT02202551|11815152|FG002|Overall Study|Lack of Efficacy|0
7495668|NCT02202551|11815153|FG003|Overall Study|Lack of Efficacy|0
7495669|NCT02202551|11815150|FG000|Overall Study|Physician Decision|1
7495670|NCT02202551|11815151|FG001|Overall Study|Physician Decision|0
7495671|NCT02202551|11815152|FG002|Overall Study|Physician Decision|0
7495672|NCT02202551|11815153|FG003|Overall Study|Physician Decision|0
7495673|NCT02202551|11815150|FG000|Overall Study|Site closure|3
7495674|NCT02202551|11815151|FG001|Overall Study|Site closure|0
7495675|NCT02202551|11815152|FG002|Overall Study|Site closure|0
7495676|NCT02202551|11815153|FG003|Overall Study|Site closure|1
7495677|NCT02202551|11815150|FG000|Overall Study|Unable to complete visits per protocol|1
7495678|NCT02202551|11815151|FG001|Overall Study|Unable to complete visits per protocol|0
7495679|NCT02202551|11815152|FG002|Overall Study|Unable to complete visits per protocol|0
7495680|NCT02202551|11815153|FG003|Overall Study|Unable to complete visits per protocol|0
7495681|NCT02202551|11815150|FG000|Overall Study|Worsening Dyskinesia|0
7495682|NCT02202551|11815151|FG001|Overall Study|Worsening Dyskinesia|0
7495683|NCT02202551|11815152|FG002|Overall Study|Worsening Dyskinesia|0
7495684|NCT02202551|11815153|FG003|Overall Study|Worsening Dyskinesia|1
7495685|NCT02202551|11815150|FG000|Overall Study|Protocol Violation|0
7495686|NCT02202551|11815151|FG001|Overall Study|Protocol Violation|1
7495687|NCT02202551|11815152|FG002|Overall Study|Protocol Violation|0
7495688|NCT02202551|11815153|FG003|Overall Study|Protocol Violation|0
7495689|NCT02202551|11815150|FG000|Overall Study|Sponsor's decision|2
7495690|NCT02202551|11815151|FG001|Overall Study|Sponsor's decision|0
7495691|NCT02202551|11815152|FG002|Overall Study|Sponsor's decision|0
7495692|NCT02202551|11815153|FG003|Overall Study|Sponsor's decision|0
7495693|NCT02202551|11815150|FG000|Overall Study|Subject unwilling to proceed|1
7495694|NCT02202551|11815151|FG001|Overall Study|Subject unwilling to proceed|5
7495695|NCT02202551|11815152|FG002|Overall Study|Subject unwilling to proceed|3
7495696|NCT02202551|11815153|FG003|Overall Study|Subject unwilling to proceed|5
7495697|NCT02202551|11815150|FG000|Overall Study|Subject consent withdrawn|0
7495698|NCT02202551|11815151|FG001|Overall Study|Subject consent withdrawn|3
7495699|NCT02202551|11815152|FG002|Overall Study|Subject consent withdrawn|1
7495700|NCT02202551|11815153|FG003|Overall Study|Subject consent withdrawn|2
7495701|NCT02202551|11815150|FG000|Overall Study|eGFR<50mL/min/m2|2
7495702|NCT02202551|11815151|FG001|Overall Study|eGFR<50mL/min/m2|2
7495703|NCT02202551|11815152|FG002|Overall Study|eGFR<50mL/min/m2|0
7495704|NCT02202551|11815153|FG003|Overall Study|eGFR<50mL/min/m2|1
7495705|NCT02202616|11815167|FG000|Overall Study|Screen failed|24
7495706|NCT02202616|11815167|FG000|Overall Study|Adverse Event|32
7495707|NCT02202616|11815167|FG000|Overall Study|Protocol deviation|18
7495708|NCT02202616|11815167|FG000|Overall Study|Patient withdrew consent|12
7495709|NCT02202616|11815167|FG000|Overall Study|Lost to Follow-up|6
7495710|NCT02202616|11815167|FG000|Overall Study|Administrative problems|6
7495711|NCT02202616|11815167|FG000|Overall Study|Abnormal test procedure result|1
7495712|NCT02202616|11815167|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7495713|NCT02202759|11815187|FG000|Overall Study|Study Terminated by Sponsor|3
7495714|NCT02202759|11815188|FG001|Overall Study|Study Terminated by Sponsor|3
7495715|NCT02202759|11815189|FG002|Overall Study|Study Terminated by Sponsor|3
7495716|NCT02202759|11815187|FG000|Overall Study|Withdrawal by Subject|2
7495717|NCT02202759|11815188|FG001|Overall Study|Withdrawal by Subject|1
7495718|NCT02202759|11815189|FG002|Overall Study|Withdrawal by Subject|1
7495719|NCT02202759|11815187|FG000|Overall Study|Reason not Specified|4
7495720|NCT02202759|11815188|FG001|Overall Study|Reason not Specified|11
7495721|NCT02202759|11815189|FG002|Overall Study|Reason not Specified|10
7495722|NCT02202785|11815199|FG000|Overall Study|Study Terminated by Sponsor|1
7495723|NCT02202785|11815200|FG001|Overall Study|Study Terminated by Sponsor|6
7495724|NCT02202785|11815201|FG002|Overall Study|Study Terminated by Sponsor|4
7495725|NCT02202785|11815199|FG000|Overall Study|Withdrawal by Subject|0
7495726|NCT02202785|11815200|FG001|Overall Study|Withdrawal by Subject|1
7495727|NCT02202785|11815201|FG002|Overall Study|Withdrawal by Subject|0
7495728|NCT02202785|11815199|FG000|Overall Study|Lost to Follow-up|0
7495729|NCT02202785|11815200|FG001|Overall Study|Lost to Follow-up|1
7495730|NCT02202785|11815201|FG002|Overall Study|Lost to Follow-up|0
7495731|NCT02202785|11815199|FG000|Overall Study|Reason not Specified|10
7495732|NCT02202785|11815200|FG001|Overall Study|Reason not Specified|7
7495733|NCT02202785|11815201|FG002|Overall Study|Reason not Specified|13
7495734|NCT02202837|11815211|FG000|Overall Study|Enbrel treatment discontinued|36
7495735|NCT02202837|11815212|FG001|Overall Study|Enbrel treatment discontinued|4
7495736|NCT02202837|11815211|FG000|Overall Study|Other|10
7495737|NCT02202837|11815212|FG001|Overall Study|Other|0
7495738|NCT02202837|11815211|FG000|Overall Study|Lost to Follow-up|7
7495739|NCT02202837|11815212|FG001|Overall Study|Lost to Follow-up|1
7495740|NCT02202850|11815220|FG000|Overall Study|Other|2
7495741|NCT02202850|11815221|FG001|Overall Study|Other|2
7495742|NCT02202850|11815220|FG000|Overall Study|Enbrel treatment discontinued|15
7495743|NCT02202850|11815221|FG001|Overall Study|Enbrel treatment discontinued|3
7495744|NCT02202850|11815220|FG000|Overall Study|Lost to Follow-up|7
7495745|NCT02202850|11815221|FG001|Overall Study|Lost to Follow-up|1
7495746|NCT02202980|11815241|FG000|Overall Study|Lack of Efficacy|1
7495747|NCT02202980|11815242|FG001|Overall Study|Lack of Efficacy|0
7495748|NCT02202980|11815243|FG002|Overall Study|Lack of Efficacy|7
7495749|NCT02202980|11815244|FG003|Overall Study|Lack of Efficacy|0
7495750|NCT02202980|11815245|FG004|Overall Study|Lack of Efficacy|3
7495751|NCT02202980|11815246|FG005|Overall Study|Lack of Efficacy|1
7495752|NCT02202980|11815247|FG006|Overall Study|Lack of Efficacy|11
7495753|NCT02202980|11815248|FG007|Overall Study|Lack of Efficacy|2
7495754|NCT02202980|11815249|FG008|Overall Study|Lack of Efficacy|2
7495755|NCT02202980|11815250|FG009|Overall Study|Lack of Efficacy|0
7495756|NCT02202980|11815251|FG010|Overall Study|Lack of Efficacy|0
7495757|NCT02202980|11815252|FG011|Overall Study|Lack of Efficacy|3
7495758|NCT02202980|11815253|FG012|Overall Study|Lack of Efficacy|10
7495759|NCT02202980|11815254|FG013|Overall Study|Lack of Efficacy|0
7495760|NCT02202980|11815241|FG000|Overall Study|Protocol Violation|0
7495761|NCT02202980|11815242|FG001|Overall Study|Protocol Violation|0
7495762|NCT02202980|11815243|FG002|Overall Study|Protocol Violation|0
7495763|NCT02202980|11815244|FG003|Overall Study|Protocol Violation|3
7495764|NCT02202980|11815245|FG004|Overall Study|Protocol Violation|3
7495765|NCT02202980|11815246|FG005|Overall Study|Protocol Violation|0
7495766|NCT02202980|11815247|FG006|Overall Study|Protocol Violation|0
7495767|NCT02202980|11815248|FG007|Overall Study|Protocol Violation|0
7495768|NCT02202980|11815249|FG008|Overall Study|Protocol Violation|0
7495769|NCT02202980|11815250|FG009|Overall Study|Protocol Violation|0
7495770|NCT02202980|11815251|FG010|Overall Study|Protocol Violation|0
7495771|NCT02202980|11815252|FG011|Overall Study|Protocol Violation|0
7495772|NCT02202980|11815253|FG012|Overall Study|Protocol Violation|0
7495773|NCT02202980|11815254|FG013|Overall Study|Protocol Violation|0
7495774|NCT02202980|11815241|FG000|Overall Study|Lost to Follow-up|0
7495775|NCT02202980|11815242|FG001|Overall Study|Lost to Follow-up|1
7495776|NCT02202980|11815243|FG002|Overall Study|Lost to Follow-up|1
7495777|NCT02202980|11815244|FG003|Overall Study|Lost to Follow-up|1
7495778|NCT02202980|11815245|FG004|Overall Study|Lost to Follow-up|0
7495779|NCT02202980|11815246|FG005|Overall Study|Lost to Follow-up|0
7495780|NCT02202980|11815247|FG006|Overall Study|Lost to Follow-up|0
7495781|NCT02202980|11815248|FG007|Overall Study|Lost to Follow-up|1
7495782|NCT02202980|11815249|FG008|Overall Study|Lost to Follow-up|1
7495783|NCT02202980|11815250|FG009|Overall Study|Lost to Follow-up|0
7495784|NCT02202980|11815251|FG010|Overall Study|Lost to Follow-up|0
7495785|NCT02202980|11815252|FG011|Overall Study|Lost to Follow-up|0
7495786|NCT02202980|11815253|FG012|Overall Study|Lost to Follow-up|1
7495787|NCT02202980|11815254|FG013|Overall Study|Lost to Follow-up|0
7495788|NCT02202980|11815241|FG000|Overall Study|Withdrew Consent|0
7495789|NCT02202980|11815242|FG001|Overall Study|Withdrew Consent|1
7495790|NCT02202980|11815243|FG002|Overall Study|Withdrew Consent|2
7495791|NCT02202980|11815244|FG003|Overall Study|Withdrew Consent|0
7495792|NCT02202980|11815245|FG004|Overall Study|Withdrew Consent|0
7495793|NCT02202980|11815246|FG005|Overall Study|Withdrew Consent|0
7495794|NCT02202980|11815247|FG006|Overall Study|Withdrew Consent|0
7495795|NCT02202980|11815248|FG007|Overall Study|Withdrew Consent|0
7495796|NCT02202980|11815249|FG008|Overall Study|Withdrew Consent|1
7495797|NCT02202980|11815250|FG009|Overall Study|Withdrew Consent|0
7495798|NCT02202980|11815251|FG010|Overall Study|Withdrew Consent|0
7495799|NCT02202980|11815252|FG011|Overall Study|Withdrew Consent|0
7495800|NCT02202980|11815253|FG012|Overall Study|Withdrew Consent|0
7495801|NCT02202980|11815254|FG013|Overall Study|Withdrew Consent|0
7495802|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
7495803|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7495804|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7495805|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
7495806|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
7495807|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7495808|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7495809|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
7495810|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
7495811|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7495812|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7495813|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
7495814|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
7495815|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7495816|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7495817|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
7495818|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
7495819|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7495820|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7495821|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
7495822|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
7495823|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
7495824|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
7495825|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
7495826|NCT02203032|11815293|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
7495827|NCT02203032|11815294|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7495828|NCT02203032|11815295|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7495829|NCT02203032|11815296|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
7495830|NCT02203032|11815293|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
7495831|NCT02203032|11815294|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
7495832|NCT02203032|11815295|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
7495833|NCT02203032|11815296|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
7495834|NCT02203032|11815293|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
7495835|NCT02203032|11815294|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
7495836|NCT02203032|11815295|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
7495837|NCT02203032|11815296|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
7495838|NCT02203032|11815293|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
7495839|NCT02203032|11815294|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
7495840|NCT02203032|11815295|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
7495841|NCT02203032|11815296|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
7495842|NCT02203032|11815293|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
7495843|NCT02203032|11815294|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
7495844|NCT02203032|11815295|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
7495845|NCT02203032|11815296|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
7495846|NCT02203032|11815293|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
7495847|NCT02203032|11815294|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
7495848|NCT02203032|11815295|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
7495849|NCT02203032|11815296|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
7495850|NCT02203071|11815306|FG000|Overall Study|Lost to Follow-up|3
7495851|NCT02203071|11815307|FG001|Overall Study|Lost to Follow-up|1
7495852|NCT02203149|11815318|FG000|Part 1|Adverse Event|0
7495853|NCT02203149|11815319|FG001|Part 1|Adverse Event|1
7495854|NCT02203149|11815320|FG002|Part 1|Adverse Event|0
7495855|NCT02203149|11815321|FG003|Part 1|Adverse Event|0
7495856|NCT02203149|11815322|FG004|Part 1|Adverse Event|0
7495857|NCT02203149|11815318|FG000|Part 2|Death|0
7495858|NCT02203149|11815319|FG001|Part 2|Death|0
7495859|NCT02203149|11815320|FG002|Part 2|Death|1
7495860|NCT02203149|11815321|FG003|Part 2|Death|1
7495861|NCT02203149|11815322|FG004|Part 2|Death|0
7495862|NCT02203149|11815318|FG000|Part 2|Withdrawal by Subject|0
7495863|NCT02203149|11815319|FG001|Part 2|Withdrawal by Subject|0
7495864|NCT02203149|11815320|FG002|Part 2|Withdrawal by Subject|0
7495865|NCT02203149|11815321|FG003|Part 2|Withdrawal by Subject|1
7495866|NCT02203149|11815322|FG004|Part 2|Withdrawal by Subject|0
7495867|NCT02203149|11815318|FG000|Part 2|Adverse Event|0
7495868|NCT02203149|11815319|FG001|Part 2|Adverse Event|0
7495869|NCT02203149|11815320|FG002|Part 2|Adverse Event|0
7495870|NCT02203149|11815321|FG003|Part 2|Adverse Event|1
7495871|NCT02203149|11815322|FG004|Part 2|Adverse Event|1
7495872|NCT02203331|11815354|FG000|Overall Study|Pregnancy|1
7495873|NCT02203331|11815355|FG001|Overall Study|Pregnancy|0
7495874|NCT02203331|11815356|FG002|Overall Study|Pregnancy|0
7495875|NCT02203331|11815357|FG003|Overall Study|Pregnancy|0
7495876|NCT02203331|11815358|FG004|Overall Study|Pregnancy|2
7495877|NCT02203331|11815359|FG005|Overall Study|Pregnancy|0
7495878|NCT02203331|11815354|FG000|Overall Study|Withdrawal by Subject|1
7495879|NCT02203331|11815355|FG001|Overall Study|Withdrawal by Subject|0
7495880|NCT02203331|11815356|FG002|Overall Study|Withdrawal by Subject|1
7495881|NCT02203331|11815357|FG003|Overall Study|Withdrawal by Subject|0
7495882|NCT02203331|11815358|FG004|Overall Study|Withdrawal by Subject|0
7495883|NCT02203331|11815359|FG005|Overall Study|Withdrawal by Subject|3
7495884|NCT02203331|11815354|FG000|Overall Study|Adverse Event|4
7495885|NCT02203331|11815355|FG001|Overall Study|Adverse Event|8
7495886|NCT02203331|11815356|FG002|Overall Study|Adverse Event|3
7495887|NCT02203331|11815357|FG003|Overall Study|Adverse Event|4
7495888|NCT02203331|11815358|FG004|Overall Study|Adverse Event|3
7495889|NCT02203331|11815359|FG005|Overall Study|Adverse Event|3
7495890|NCT02203331|11815354|FG000|Overall Study|Other Reasons|1
7495891|NCT02203331|11815355|FG001|Overall Study|Other Reasons|2
7495892|NCT02203331|11815356|FG002|Overall Study|Other Reasons|0
7495893|NCT02203331|11815357|FG003|Overall Study|Other Reasons|2
7495894|NCT02203331|11815358|FG004|Overall Study|Other Reasons|0
7495895|NCT02203331|11815359|FG005|Overall Study|Other Reasons|0
7495896|NCT02203331|11815354|FG000|Overall Study|Lack of Efficacy|0
7495897|NCT02203331|11815355|FG001|Overall Study|Lack of Efficacy|2
7495898|NCT02203331|11815356|FG002|Overall Study|Lack of Efficacy|1
7495899|NCT02203331|11815357|FG003|Overall Study|Lack of Efficacy|0
7495900|NCT02203331|11815358|FG004|Overall Study|Lack of Efficacy|0
7495901|NCT02203331|11815359|FG005|Overall Study|Lack of Efficacy|1
7495902|NCT02203331|11815354|FG000|Overall Study|Protocol Violation|0
7495903|NCT02203331|11815355|FG001|Overall Study|Protocol Violation|2
7495904|NCT02203331|11815356|FG002|Overall Study|Protocol Violation|0
7495905|NCT02203331|11815357|FG003|Overall Study|Protocol Violation|1
7495906|NCT02203331|11815358|FG004|Overall Study|Protocol Violation|1
7495907|NCT02203331|11815359|FG005|Overall Study|Protocol Violation|0
7495908|NCT02203331|11815354|FG000|Overall Study|Lost to Follow-up|0
7495909|NCT02203331|11815355|FG001|Overall Study|Lost to Follow-up|0
7495910|NCT02203331|11815356|FG002|Overall Study|Lost to Follow-up|0
7495911|NCT02203331|11815357|FG003|Overall Study|Lost to Follow-up|0
7495912|NCT02203331|11815358|FG004|Overall Study|Lost to Follow-up|1
7495913|NCT02203331|11815359|FG005|Overall Study|Lost to Follow-up|0
7495914|NCT02203357|11815376|FG000|Overall Study|Lost to Follow-up|58
7495915|NCT02203357|11815377|FG001|Overall Study|Lost to Follow-up|66
7495916|NCT02203357|11815378|FG002|Overall Study|Lost to Follow-up|70
7495917|NCT02203591|11815405|FG000|Overall Study|Did not meet treatment day baseline|147
7495918|NCT02203591|11815406|FG001|Overall Study|Did not meet treatment day baseline|141
7495919|NCT02203591|11815407|FG002|Overall Study|Did not meet treatment day baseline|150
7495920|NCT02203591|11815408|FG003|Overall Study|Did not meet treatment day baseline|45
7495921|NCT02203591|11815409|FG004|Overall Study|Did not meet treatment day baseline|33
7495922|NCT02203591|11815410|FG005|Overall Study|Did not meet treatment day baseline|35
7495923|NCT02203591|11815411|FG006|Overall Study|Did not meet treatment day baseline|29
7495924|NCT02203591|11815412|FG007|Overall Study|Did not meet treatment day baseline|12
7495925|NCT02203591|11815405|FG000|Overall Study|Discontinued early due to compromised test sites|0
7495926|NCT02203591|11815406|FG001|Overall Study|Discontinued early due to compromised test sites|1
7495927|NCT02203591|11815407|FG002|Overall Study|Discontinued early due to compromised test sites|1
7495928|NCT02203591|11815408|FG003|Overall Study|Discontinued early due to compromised test sites|0
7495929|NCT02203591|11815409|FG004|Overall Study|Discontinued early due to compromised test sites|1
7495930|NCT02203591|11815410|FG005|Overall Study|Discontinued early due to compromised test sites|0
7495931|NCT02203591|11815411|FG006|Overall Study|Discontinued early due to compromised test sites|0
7495932|NCT02203591|11815412|FG007|Overall Study|Discontinued early due to compromised test sites|1
7495933|NCT02203721|11815445|FG000|Overall Study|Lost to Follow-up|1
7495934|NCT02203721|11815446|FG001|Overall Study|Lost to Follow-up|0
7495935|NCT02203721|11815445|FG000|Overall Study|Death|0
7495936|NCT02203721|11815446|FG001|Overall Study|Death|2
7495937|NCT02203721|11815445|FG000|Overall Study|Illness|0
7495938|NCT02203721|11815446|FG001|Overall Study|Illness|1
7495939|NCT02203838|11815484|FG000|Overall Study|Lack of Efficacy|7
7495940|NCT02203838|11815485|FG001|Overall Study|Lack of Efficacy|0
7495941|NCT02203838|11815486|FG002|Overall Study|Lack of Efficacy|1
7495942|NCT02203838|11815487|FG003|Overall Study|Lack of Efficacy|1
7495943|NCT02203838|11815484|FG000|Overall Study|Adverse Event|46
7495944|NCT02203838|11815485|FG001|Overall Study|Adverse Event|6
7495945|NCT02203838|11815486|FG002|Overall Study|Adverse Event|3
7495946|NCT02203838|11815487|FG003|Overall Study|Adverse Event|2
7495947|NCT02203838|11815484|FG000|Overall Study|Lost to Follow-up|39
7495948|NCT02203838|11815485|FG001|Overall Study|Lost to Follow-up|3
7495949|NCT02203838|11815486|FG002|Overall Study|Lost to Follow-up|2
7495950|NCT02203838|11815487|FG003|Overall Study|Lost to Follow-up|1
7495951|NCT02203838|11815484|FG000|Overall Study|Protocol Violation|7
7495952|NCT02203838|11815485|FG001|Overall Study|Protocol Violation|3
7495953|NCT02203838|11815486|FG002|Overall Study|Protocol Violation|0
7495954|NCT02203838|11815487|FG003|Overall Study|Protocol Violation|0
7495955|NCT02203838|11815484|FG000|Overall Study|Withdrawal by Subject|83
7495956|NCT02203838|11815485|FG001|Overall Study|Withdrawal by Subject|10
7495957|NCT02203838|11815486|FG002|Overall Study|Withdrawal by Subject|8
7495958|NCT02203838|11815487|FG003|Overall Study|Withdrawal by Subject|11
7495959|NCT02203838|11815484|FG000|Overall Study|Physician Decision|27
7495960|NCT02203838|11815485|FG001|Overall Study|Physician Decision|0
7495961|NCT02203838|11815486|FG002|Overall Study|Physician Decision|2
7495962|NCT02203838|11815487|FG003|Overall Study|Physician Decision|3
7495963|NCT02203838|11815484|FG000|Overall Study|Other|1
7495964|NCT02203838|11815485|FG001|Overall Study|Other|0
7495965|NCT02203838|11815486|FG002|Overall Study|Other|0
7495966|NCT02203838|11815487|FG003|Overall Study|Other|0
7495967|NCT02203851|11815497|FG000|Overall Study|Lost to Follow-up|4
7495968|NCT02203851|11815497|FG000|Overall Study|Withdrawal by Subject|6
7495969|NCT02203851|11815497|FG000|Overall Study|Other|1
7495970|NCT02203916|11815511|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7495971|NCT02203916|11815512|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7495972|NCT02203916|11815513|FG002|Overall Study|Pretreatment Event/Adverse Event|2
7495973|NCT02203916|11815511|FG000|Overall Study|Major Protocol Deviation|1
7495974|NCT02203916|11815512|FG001|Overall Study|Major Protocol Deviation|1
7495975|NCT02203916|11815513|FG002|Overall Study|Major Protocol Deviation|0
7495976|NCT02203916|11815511|FG000|Overall Study|Lost to Follow-up|0
7495977|NCT02203916|11815512|FG001|Overall Study|Lost to Follow-up|1
7495978|NCT02203916|11815513|FG002|Overall Study|Lost to Follow-up|0
7495979|NCT02203916|11815511|FG000|Overall Study|Voluntary Withdrawal|3
7495980|NCT02203916|11815512|FG001|Overall Study|Voluntary Withdrawal|3
7495981|NCT02203916|11815513|FG002|Overall Study|Voluntary Withdrawal|8
7495982|NCT02203916|11815511|FG000|Overall Study|Lack of Efficacy|3
7495983|NCT02203916|11815512|FG001|Overall Study|Lack of Efficacy|0
7495984|NCT02203916|11815513|FG002|Overall Study|Lack of Efficacy|0
7495985|NCT02203916|11815511|FG000|Overall Study|Reason Not Specified|0
7495986|NCT02203916|11815512|FG001|Overall Study|Reason Not Specified|2
7495987|NCT02203916|11815513|FG002|Overall Study|Reason Not Specified|1
7495988|NCT02204007|11815523|FG000|Overall Study|Surgery Canceled|1
7495989|NCT02204007|11815524|FG001|Overall Study|Surgery Canceled|1
7495990|NCT02204293|11815558|FG000|Core Study Part I|Met one or more exclusion criteria|1
7495991|NCT02204293|11815559|FG001|Core Study Part I|Met one or more exclusion criteria|0
7495992|NCT02204293|11815560|FG002|Core Study Part I|Met one or more exclusion criteria|0
7495993|NCT02204293|11815561|FG003|Core Study Part I|Met one or more exclusion criteria|0
7495994|NCT02204293|11815562|FG004|Core Study Part I|Met one or more exclusion criteria|0
7495995|NCT02204293|11815563|FG005|Core Study Part I|Met one or more exclusion criteria|0
7495996|NCT02204293|11815558|FG000|Core Study Part I|Adverse Event|1
7495997|NCT02204293|11815559|FG001|Core Study Part I|Adverse Event|0
7495998|NCT02204293|11815560|FG002|Core Study Part I|Adverse Event|0
7495999|NCT02204293|11815561|FG003|Core Study Part I|Adverse Event|0
7496000|NCT02204293|11815562|FG004|Core Study Part I|Adverse Event|0
7496001|NCT02204293|11815563|FG005|Core Study Part I|Adverse Event|0
7496002|NCT02204293|11815558|FG000|Core Study Part I|Physician Decision|0
7496003|NCT02204293|11815559|FG001|Core Study Part I|Physician Decision|3
7496004|NCT02204293|11815560|FG002|Core Study Part I|Physician Decision|0
7496005|NCT02204293|11815561|FG003|Core Study Part I|Physician Decision|0
7496006|NCT02204293|11815562|FG004|Core Study Part I|Physician Decision|0
7496007|NCT02204293|11815563|FG005|Core Study Part I|Physician Decision|0
7496008|NCT02204293|11815558|FG000|LTE Phase|Study Suspended|0
7496009|NCT02204293|11815559|FG001|LTE Phase|Study Suspended|0
7496010|NCT02204293|11815560|FG002|LTE Phase|Study Suspended|0
7496011|NCT02204293|11815561|FG003|LTE Phase|Study Suspended|0
7496012|NCT02204293|11815562|FG004|LTE Phase|Study Suspended|0
7496013|NCT02204293|11815563|FG005|LTE Phase|Study Suspended|7
7496014|NCT02204319|11815577|FG000|Overall Study|Pregnancy|1
7496015|NCT02204319|11815577|FG000|Overall Study|Withdrawal by Subject|2
7496016|NCT02204371|11815582|FG000|Overall Study|Adverse Event|1
7496017|NCT02204410|11815586|FG000|Overall Study|Lost to Follow-up|5
7496018|NCT02204410|11815586|FG000|Overall Study|Physician Decision|2
7496019|NCT02204410|11815586|FG000|Overall Study|Protocol Violation|1
7496020|NCT02204410|11815586|FG000|Overall Study|Withdrawal by Subject|3
7496021|NCT02204449|11815592|FG000|Overall Study|Lost to Follow-up|7
7496022|NCT02204449|11815593|FG001|Overall Study|Lost to Follow-up|9
7496023|NCT02204449|11815592|FG000|Overall Study|Death|0
7496024|NCT02204449|11815593|FG001|Overall Study|Death|1
7496025|NCT02204449|11815592|FG000|Overall Study|Withdrawal by Subject|0
7496026|NCT02204449|11815593|FG001|Overall Study|Withdrawal by Subject|1
7496027|NCT02204579|11815603|FG000|Overall Study|Screen failures|2
7496028|NCT02204917|11815629|FG000|Overall Study|Protocol Violation|1
7496029|NCT02204982|11815638|FG000|Overall Study|Patient ineligible-medical monitor|1
7496030|NCT02204982|11815639|FG001|Overall Study|Patient ineligible-medical monitor|0
7496031|NCT02204982|11815638|FG000|Overall Study|Withdrawal by Subject|1
7496032|NCT02204982|11815639|FG001|Overall Study|Withdrawal by Subject|0
7496033|NCT02204982|11815638|FG000|Overall Study|Adverse Event|1
7496034|NCT02204982|11815639|FG001|Overall Study|Adverse Event|0
7496035|NCT02204982|11815638|FG000|Overall Study|Adverse Event and Investigator decision|1
7496036|NCT02204982|11815639|FG001|Overall Study|Adverse Event and Investigator decision|0
7496037|NCT02204982|11815638|FG000|Overall Study|Physician Decision|0
7496038|NCT02204982|11815639|FG001|Overall Study|Physician Decision|2
7496039|NCT02204982|11815638|FG000|Overall Study|Protocol-Specified Disease Progression|0
7496040|NCT02204982|11815639|FG001|Overall Study|Protocol-Specified Disease Progression|4
7496041|NCT02204982|11815638|FG000|Overall Study|Termination of Study bySponsor|0
7496042|NCT02204982|11815639|FG001|Overall Study|Termination of Study bySponsor|1
7496043|NCT02205333|11815673|FG000|Overall Study|Death|5
7496044|NCT02205333|11815674|FG001|Overall Study|Death|6
7496045|NCT02205333|11815675|FG002|Overall Study|Death|2
7496046|NCT02205333|11815676|FG003|Overall Study|Death|6
7496047|NCT02205333|11815677|FG004|Overall Study|Death|5
7496048|NCT02205333|11815678|FG005|Overall Study|Death|3
7496049|NCT02205333|11815679|FG006|Overall Study|Death|3
7496050|NCT02205333|11815680|FG007|Overall Study|Death|2
7496051|NCT02205333|11815681|FG008|Overall Study|Death|0
7496052|NCT02205333|11815673|FG000|Overall Study|Withdrawal by Subject|1
7496053|NCT02205333|11815674|FG001|Overall Study|Withdrawal by Subject|0
7496054|NCT02205333|11815675|FG002|Overall Study|Withdrawal by Subject|0
7496055|NCT02205333|11815676|FG003|Overall Study|Withdrawal by Subject|1
7496056|NCT02205333|11815677|FG004|Overall Study|Withdrawal by Subject|0
7496057|NCT02205333|11815678|FG005|Overall Study|Withdrawal by Subject|0
7496058|NCT02205333|11815679|FG006|Overall Study|Withdrawal by Subject|2
7496059|NCT02205333|11815680|FG007|Overall Study|Withdrawal by Subject|0
7496060|NCT02205333|11815681|FG008|Overall Study|Withdrawal by Subject|0
7496061|NCT02205476|11815703|FG000|Overall Study|Study termination by Sponsor|7
7496062|NCT02205476|11815704|FG001|Overall Study|Study termination by Sponsor|3
7496063|NCT02205814|11815737|FG000|Overall Study|Lost to Follow-up|0
7496064|NCT02205814|11815738|FG001|Overall Study|Lost to Follow-up|0
7496065|NCT02205814|11815739|FG002|Overall Study|Lost to Follow-up|0
7496066|NCT02205814|11815740|FG003|Overall Study|Lost to Follow-up|1
7496067|NCT02205814|11815737|FG000|Overall Study|Lack of Efficacy|1
7496068|NCT02205814|11815738|FG001|Overall Study|Lack of Efficacy|0
7496069|NCT02205814|11815739|FG002|Overall Study|Lack of Efficacy|1
7496070|NCT02205814|11815740|FG003|Overall Study|Lack of Efficacy|1
7496071|NCT02205814|11815737|FG000|Overall Study|Physician Decision|0
7496072|NCT02205814|11815738|FG001|Overall Study|Physician Decision|0
7496073|NCT02205814|11815739|FG002|Overall Study|Physician Decision|1
7496074|NCT02205814|11815740|FG003|Overall Study|Physician Decision|0
7496075|NCT02205814|11815737|FG000|Overall Study|Protocol Violation|1
7496076|NCT02205814|11815738|FG001|Overall Study|Protocol Violation|0
7496077|NCT02205814|11815739|FG002|Overall Study|Protocol Violation|0
7496078|NCT02205814|11815740|FG003|Overall Study|Protocol Violation|1
7496079|NCT02205814|11815737|FG000|Overall Study|Withdrawal by Subject|0
7496080|NCT02205814|11815738|FG001|Overall Study|Withdrawal by Subject|1
7496081|NCT02205814|11815739|FG002|Overall Study|Withdrawal by Subject|2
7496082|NCT02205814|11815740|FG003|Overall Study|Withdrawal by Subject|1
7496083|NCT02205814|11815737|FG000|Overall Study|not compliant with study procedures|0
7496084|NCT02205814|11815738|FG001|Overall Study|not compliant with study procedures|0
7496085|NCT02205814|11815739|FG002|Overall Study|not compliant with study procedures|1
7496086|NCT02205814|11815740|FG003|Overall Study|not compliant with study procedures|0
7496087|NCT02206061|11815770|FG000|Overall Study|Withdrawal by Subject|4
7496088|NCT02206061|11815771|FG001|Overall Study|Withdrawal by Subject|7
7496089|NCT02206061|11815772|FG002|Overall Study|Withdrawal by Subject|1
7496090|NCT02206061|11815770|FG000|Overall Study|Lost to Follow-up|14
7496091|NCT02206061|11815771|FG001|Overall Study|Lost to Follow-up|7
7496092|NCT02206061|11815772|FG002|Overall Study|Lost to Follow-up|20
7496093|NCT02206152|11815780|FG000|Pre-Randomization|Withdrawal by Subject|2
7496094|NCT02206607|11815795|FG000|Open-Label Run-In|Withdrawal by Subject|3
7496095|NCT02206607|11815796|FG001|Open-Label Run-In|Withdrawal by Subject|0
7496096|NCT02206607|11815797|FG002|Open-Label Run-In|Withdrawal by Subject|0
7496097|NCT02206607|11815798|FG003|Open-Label Run-In|Withdrawal by Subject|0
7496098|NCT02206607|11815799|FG004|Open-Label Run-In|Withdrawal by Subject|0
7496099|NCT02206607|11815795|FG000|Second Intervention Period|Insufficient Clinical Response|0
7496100|NCT02206607|11815796|FG001|Second Intervention Period|Insufficient Clinical Response|0
7496101|NCT02206607|11815797|FG002|Second Intervention Period|Insufficient Clinical Response|0
7496102|NCT02206607|11815798|FG003|Second Intervention Period|Insufficient Clinical Response|1
7496103|NCT02206607|11815799|FG004|Second Intervention Period|Insufficient Clinical Response|0
7496104|NCT02206620|11815815|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7496105|NCT02206620|11815816|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
7496106|NCT02206620|11815815|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
7496107|NCT02206620|11815816|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
7496108|NCT02206685|11815830|FG000|Overall Study|Surgery cancelled/changed|2
7496109|NCT02206685|11815831|FG001|Overall Study|Surgery cancelled/changed|3
7496110|NCT02206685|11815830|FG000|Overall Study|Withdrawal by Subject|1
7496111|NCT02206685|11815831|FG001|Overall Study|Withdrawal by Subject|2
7496112|NCT02206685|11815830|FG000|Overall Study|Protocol Violation|2
7496113|NCT02206685|11815831|FG001|Overall Study|Protocol Violation|2
7496114|NCT02206828|11815846|FG000|Overall Study|Lost to Follow-up|7
7496115|NCT02207088|11815873|FG000|Overall Study|Adverse Event|2
7496116|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7496117|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
7496118|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
7496119|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
7496120|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
7496121|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7496122|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
7496123|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
7496124|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7496125|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7496126|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
7496127|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
7496128|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
7496129|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7496130|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
7496131|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
7496132|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7496133|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7496134|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
7496135|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
7496136|NCT02207231|11815880|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7496137|NCT02207231|11815881|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
7496138|NCT02207231|11815882|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
7496139|NCT02207231|11815883|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
7496140|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
7496141|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
7496142|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
7496143|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
7496144|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
7496145|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
7496146|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
7496147|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
7496148|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7496149|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
7496150|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
7496151|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
7496152|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
7496153|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
7496154|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
7496155|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
7496156|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
7496157|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
7496158|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
7496159|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
7496160|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7496161|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
7496162|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7496163|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
7496164|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
7496165|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
7496166|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
7496167|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
7496168|NCT02207231|11815880|FG000|Active Controlled Period: Week 16 - 48|Other|0
7496169|NCT02207231|11815881|FG001|Active Controlled Period: Week 16 - 48|Other|2
7496170|NCT02207231|11815882|FG002|Active Controlled Period: Week 16 - 48|Other|3
7496171|NCT02207231|11815883|FG003|Active Controlled Period: Week 16 - 48|Other|0
7496172|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7496173|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
7496174|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
7496175|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
7496176|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
7496177|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
7496178|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
7496179|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
7496180|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7496181|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
7496182|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
7496183|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
7496184|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7496185|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
7496186|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
7496187|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
7496188|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7496189|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
7496190|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
7496191|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
7496547|NCT02207413|11815986|FG003|Overall Study|Lost to Follow-up|1
7496192|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7496193|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
7496194|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
7496195|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
7496196|NCT02207231|11815880|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
7496197|NCT02207231|11815881|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
7496198|NCT02207231|11815882|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
7496199|NCT02207231|11815883|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
7496200|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
7496201|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
7496202|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
7496203|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496204|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496205|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496206|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496207|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496208|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496209|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496210|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
7496211|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
7496212|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496213|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
7496214|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496215|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496216|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496217|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496218|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496219|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496220|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496221|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
7496222|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
7496223|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
7496224|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
7496225|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496226|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496227|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496228|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496229|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496230|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496231|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496232|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
7496233|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
7496234|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
7496235|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496236|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496237|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496238|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496239|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496240|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496241|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496242|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496243|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
7496244|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7496245|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
7496246|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
7496247|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496248|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496249|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496250|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496251|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496252|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496253|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496254|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
7496255|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496256|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
7496257|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
7496258|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496259|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496260|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496261|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496262|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496263|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496264|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496265|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
7496266|NCT02207244|11815904|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
7496267|NCT02207244|11815905|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
7496268|NCT02207244|11815906|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
7496269|NCT02207244|11815907|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
7496270|NCT02207244|11815908|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
7496271|NCT02207244|11815909|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
7496272|NCT02207244|11815910|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
7496273|NCT02207244|11815911|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
7496274|NCT02207244|11815912|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
7496275|NCT02207244|11815913|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
7496276|NCT02207244|11815914|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
7496277|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496278|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496279|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496280|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496281|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
7496282|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
7496283|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496284|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496285|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496286|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496287|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
7496288|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496289|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496290|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496291|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496292|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496293|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
7496294|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496295|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496296|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496297|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496298|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
7496299|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496300|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496301|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496302|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
7496303|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7496304|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
7496305|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496306|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496307|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496308|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496309|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
7496310|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496311|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496312|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496313|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7496314|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
7496315|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
7496316|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496317|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496318|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496319|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496320|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
7496321|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496322|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496323|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496324|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7496325|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496326|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
7496327|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496328|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496329|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496330|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496331|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
7496332|NCT02207244|11815904|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
7496333|NCT02207244|11815905|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
7496334|NCT02207244|11815906|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
7496335|NCT02207244|11815907|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
7496336|NCT02207244|11815908|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
7496337|NCT02207244|11815909|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
7496338|NCT02207244|11815910|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
7496339|NCT02207244|11815911|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
7496340|NCT02207244|11815912|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
7496341|NCT02207244|11815913|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
7496342|NCT02207244|11815914|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
7496343|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496344|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496345|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496346|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496347|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496348|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496349|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
7496350|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
7496351|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
7496352|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
7496353|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
7496354|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496355|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496356|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496357|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496358|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496359|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496360|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496361|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
7496362|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496363|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496364|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
7496365|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496366|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496367|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496368|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496369|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496370|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496371|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
7496372|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
7496373|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7496374|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
7496375|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
7496376|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496377|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496378|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496379|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496380|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496381|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496382|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7496383|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
7496384|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496385|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
7496386|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
7496387|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496388|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496389|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496390|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496391|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496392|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496393|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7496394|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
7496395|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7496396|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
7496397|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
7496398|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496399|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496400|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496401|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496402|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496403|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496404|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496405|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7496406|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
7496407|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496408|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
7496409|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496410|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496411|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496412|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496413|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496414|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496415|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496416|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496417|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
7496418|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496419|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
7496420|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
7496421|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
7496422|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
7496423|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
7496424|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
7496425|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
7496426|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
7496427|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
7496428|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
7496429|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
7496430|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
7496431|NCT02207244|11815904|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496432|NCT02207244|11815905|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496433|NCT02207244|11815906|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496434|NCT02207244|11815907|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496435|NCT02207244|11815908|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496436|NCT02207244|11815909|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496437|NCT02207244|11815910|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
7496438|NCT02207244|11815911|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496439|NCT02207244|11815912|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496440|NCT02207244|11815913|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496441|NCT02207244|11815914|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
7496442|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496443|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496444|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496445|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496446|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496447|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496448|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496449|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496450|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
7496451|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
7496452|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
7496453|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496454|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496455|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496456|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496457|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496458|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496459|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496460|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496461|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
7496462|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
7496463|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
7496464|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496465|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496466|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496467|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496468|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496469|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496470|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496471|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496472|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
7496473|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
7496474|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
7496475|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496476|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496477|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496478|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496479|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496480|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496481|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496482|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496483|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
7496484|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
7496485|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
7496486|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Death|0
7496487|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Death|0
7496488|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Death|0
7496489|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Death|0
7496490|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Death|0
7496491|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Death|0
7496492|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Death|0
7496493|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Death|0
7496494|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Death|1
7496495|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Death|0
7496496|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Death|1
7496497|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Other|0
7496498|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Other|0
7496499|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Other|0
7496500|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Other|0
7496501|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Other|0
7496502|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Other|0
7496503|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Other|0
7496504|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Other|0
7496505|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Other|8
7496506|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Other|0
7496507|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Other|19
7496508|NCT02207244|11815904|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496509|NCT02207244|11815905|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496510|NCT02207244|11815906|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496511|NCT02207244|11815907|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496512|NCT02207244|11815908|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496513|NCT02207244|11815909|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496514|NCT02207244|11815910|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496515|NCT02207244|11815911|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496516|NCT02207244|11815912|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496517|NCT02207244|11815913|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
7496518|NCT02207244|11815914|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
7496519|NCT02207374|11815955|FG000|Overall Study|Withdrawal by Subject|5
7496520|NCT02207374|11815956|FG001|Overall Study|Withdrawal by Subject|9
7496521|NCT02207374|11815957|FG002|Overall Study|Withdrawal by Subject|4
7496522|NCT02207374|11815955|FG000|Overall Study|Death|1
7496523|NCT02207374|11815956|FG001|Overall Study|Death|0
7496524|NCT02207374|11815957|FG002|Overall Study|Death|1
7496525|NCT02207374|11815955|FG000|Overall Study|Missing follow-up information|0
7496526|NCT02207374|11815956|FG001|Overall Study|Missing follow-up information|1
7496527|NCT02207374|11815957|FG002|Overall Study|Missing follow-up information|1
7496528|NCT02207400|11815967|FG000|Overall Study|Adverse Event|1
7496529|NCT02207400|11815968|FG001|Overall Study|Adverse Event|1
7496530|NCT02207400|11815967|FG000|Overall Study|Lost to Follow-up|6
7496531|NCT02207400|11815968|FG001|Overall Study|Lost to Follow-up|7
7496532|NCT02207400|11815967|FG000|Overall Study|Protocol Violation|1
7496533|NCT02207400|11815968|FG001|Overall Study|Protocol Violation|1
7496534|NCT02207400|11815967|FG000|Overall Study|Withdrawal by Subject|8
7496535|NCT02207400|11815968|FG001|Overall Study|Withdrawal by Subject|4
7496536|NCT02207400|11815967|FG000|Overall Study|Positive Urine Pregnancy Test|0
7496537|NCT02207400|11815968|FG001|Overall Study|Positive Urine Pregnancy Test|1
7496538|NCT02207413|11815983|FG000|Overall Study|Withdrawal by Subject|1
7496539|NCT02207413|11815984|FG001|Overall Study|Withdrawal by Subject|0
7496540|NCT02207413|11815985|FG002|Overall Study|Withdrawal by Subject|0
7496541|NCT02207413|11815986|FG003|Overall Study|Withdrawal by Subject|0
7496542|NCT02207413|11815987|FG004|Overall Study|Withdrawal by Subject|3
7496543|NCT02207413|11815988|FG005|Overall Study|Withdrawal by Subject|7
7496544|NCT02207413|11815983|FG000|Overall Study|Lost to Follow-up|0
7496545|NCT02207413|11815984|FG001|Overall Study|Lost to Follow-up|0
7496546|NCT02207413|11815985|FG002|Overall Study|Lost to Follow-up|0
7496548|NCT02207413|11815987|FG004|Overall Study|Lost to Follow-up|1
7496549|NCT02207413|11815988|FG005|Overall Study|Lost to Follow-up|5
7496550|NCT02207413|11815983|FG000|Overall Study|Adverse Event|0
7496551|NCT02207413|11815984|FG001|Overall Study|Adverse Event|0
7496552|NCT02207413|11815985|FG002|Overall Study|Adverse Event|0
7496553|NCT02207413|11815986|FG003|Overall Study|Adverse Event|0
7496554|NCT02207413|11815987|FG004|Overall Study|Adverse Event|2
7496555|NCT02207413|11815988|FG005|Overall Study|Adverse Event|1
7496556|NCT02207413|11815983|FG000|Overall Study|Migrated/moved from study area|0
7496557|NCT02207413|11815984|FG001|Overall Study|Migrated/moved from study area|0
7496558|NCT02207413|11815985|FG002|Overall Study|Migrated/moved from study area|0
7496559|NCT02207413|11815986|FG003|Overall Study|Migrated/moved from study area|0
7496560|NCT02207413|11815987|FG004|Overall Study|Migrated/moved from study area|1
7496561|NCT02207413|11815988|FG005|Overall Study|Migrated/moved from study area|0
7496562|NCT02207491|11816019|FG000|Overall Study|Adverse Event|20
7496563|NCT02207491|11816020|FG001|Overall Study|Adverse Event|4
7496564|NCT02207491|11816019|FG000|Overall Study|Withdrawal by Subject|3
7496565|NCT02207491|11816020|FG001|Overall Study|Withdrawal by Subject|2
7496566|NCT02207491|11816019|FG000|Overall Study|Non-compliant|0
7496567|NCT02207491|11816020|FG001|Overall Study|Non-compliant|1
7496568|NCT02207491|11816019|FG000|Overall Study|Lost to Follow-up|0
7496569|NCT02207491|11816020|FG001|Overall Study|Lost to Follow-up|1
7496570|NCT02207491|11816019|FG000|Overall Study|Lack of Efficacy|3
7496571|NCT02207491|11816020|FG001|Overall Study|Lack of Efficacy|0
7496572|NCT02207491|11816019|FG000|Overall Study|Physician Decision|2
7496573|NCT02207491|11816020|FG001|Overall Study|Physician Decision|0
7496574|NCT02207491|11816019|FG000|Overall Study|Protocol Violation|3
7496575|NCT02207491|11816020|FG001|Overall Study|Protocol Violation|5
7496576|NCT02207530|11816026|FG000|Overall Study|Worsening condition under investigation|78
7496577|NCT02207530|11816026|FG000|Overall Study|Patient decision to stop study treatment|5
7496578|NCT02207530|11816026|FG000|Overall Study|Adverse Event|8
7496579|NCT02207556|11816032|FG000|Overall Study|Physician Decision|1
7496580|NCT02207556|11816033|FG001|Overall Study|Physician Decision|0
7496581|NCT02207556|11816032|FG000|Overall Study|Withdrawal by Subject|1
7496582|NCT02207556|11816033|FG001|Overall Study|Withdrawal by Subject|0
7496583|NCT02207556|11816032|FG000|Overall Study|Death|0
7496584|NCT02207556|11816033|FG001|Overall Study|Death|5
7535342|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7535343|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
7535344|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
7535345|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7535346|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7535347|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7535348|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
7535349|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
7535350|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
7535351|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
7535352|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
7535353|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
7535354|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
7535355|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7535356|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7535357|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7535358|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
7535359|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
7535360|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7535361|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7535362|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7535363|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
7535364|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
7535365|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7535366|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7535367|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7535368|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
7535369|NCT02709746|11883059|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
7535370|NCT02709746|11883060|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7496605|NCT02207608|11816048|FG000|Overall Study|Adverse Event|1
7496606|NCT02207608|11816049|FG001|Overall Study|Adverse Event|0
7496607|NCT02207621|11816058|FG000|Overall Study|Adverse Event|71
7496608|NCT02207621|11816059|FG001|Overall Study|Adverse Event|15
7496609|NCT02207621|11816060|FG002|Overall Study|Adverse Event|132
7496610|NCT02207621|11816058|FG000|Overall Study|Withdrawal by Subject|9
7496611|NCT02207621|11816059|FG001|Overall Study|Withdrawal by Subject|9
7496612|NCT02207621|11816060|FG002|Overall Study|Withdrawal by Subject|13
7496613|NCT02207621|11816058|FG000|Overall Study|Non-Compliant|3
7496614|NCT02207621|11816059|FG001|Overall Study|Non-Compliant|3
7496615|NCT02207621|11816060|FG002|Overall Study|Non-Compliant|1
7496616|NCT02207621|11816058|FG000|Overall Study|Lost to Follow-up|1
7496617|NCT02207621|11816059|FG001|Overall Study|Lost to Follow-up|0
7496618|NCT02207621|11816060|FG002|Overall Study|Lost to Follow-up|3
7496619|NCT02207621|11816058|FG000|Overall Study|Lack of Efficacy|10
7496620|NCT02207621|11816059|FG001|Overall Study|Lack of Efficacy|2
7496621|NCT02207621|11816060|FG002|Overall Study|Lack of Efficacy|4
7496622|NCT02207621|11816058|FG000|Overall Study|Disallowed Concurrent Medication|2
7496623|NCT02207621|11816059|FG001|Overall Study|Disallowed Concurrent Medication|5
7496624|NCT02207621|11816060|FG002|Overall Study|Disallowed Concurrent Medication|2
7496625|NCT02207621|11816058|FG000|Overall Study|Physician Decision|1
7496626|NCT02207621|11816059|FG001|Overall Study|Physician Decision|2
7496627|NCT02207621|11816060|FG002|Overall Study|Physician Decision|2
7496628|NCT02207621|11816058|FG000|Overall Study|Protocol Violation|4
7496629|NCT02207621|11816059|FG001|Overall Study|Protocol Violation|10
7496630|NCT02207621|11816060|FG002|Overall Study|Protocol Violation|6
7496631|NCT02207621|11816058|FG000|Overall Study|Death|2
7496632|NCT02207621|11816059|FG001|Overall Study|Death|0
7496633|NCT02207621|11816060|FG002|Overall Study|Death|0
7496634|NCT02207621|11816058|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
7496635|NCT02207621|11816059|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
7496636|NCT02207621|11816060|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
7496637|NCT02207634|11816071|FG000|Overall Study|Withdrawal by Subject|21
7496638|NCT02207634|11816072|FG001|Overall Study|Withdrawal by Subject|31
7496639|NCT02207634|11816071|FG000|Overall Study|Lost to Follow-up|1
7496640|NCT02207634|11816072|FG001|Overall Study|Lost to Follow-up|0
7496641|NCT02207725|11816082|FG000|Overall Study|Did Not Receive Treatment|0
7496642|NCT02207725|11816083|FG001|Overall Study|Did Not Receive Treatment|1
7496643|NCT02207725|11816084|FG002|Overall Study|Did Not Receive Treatment|1
7496644|NCT02207725|11816085|FG003|Overall Study|Did Not Receive Treatment|1
7496645|NCT02207816|11816109|FG000|Overall Study|Serious Adverse Event|0
7496646|NCT02207816|11816110|FG001|Overall Study|Serious Adverse Event|5
7496647|NCT02207816|11816111|FG002|Overall Study|Serious Adverse Event|2
7496648|NCT02207816|11816109|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
7496649|NCT02207816|11816110|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
7496650|NCT02207816|11816111|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
7496651|NCT02207816|11816109|FG000|Overall Study|Withdrawal by Subject|4
7496652|NCT02207816|11816110|FG001|Overall Study|Withdrawal by Subject|9
7496653|NCT02207816|11816111|FG002|Overall Study|Withdrawal by Subject|7
7496654|NCT02207816|11816109|FG000|Overall Study|Migrated/Moved From Study Area|41
7496655|NCT02207816|11816110|FG001|Overall Study|Migrated/Moved From Study Area|60
7496656|NCT02207816|11816111|FG002|Overall Study|Migrated/Moved From Study Area|51
7496657|NCT02207816|11816109|FG000|Overall Study|Lost to Follow-up|3
7496658|NCT02207816|11816110|FG001|Overall Study|Lost to Follow-up|9
7496659|NCT02207816|11816111|FG002|Overall Study|Lost to Follow-up|1
7496660|NCT02207816|11816109|FG000|Overall Study|Other|1
7496661|NCT02207816|11816110|FG001|Overall Study|Other|2
7496662|NCT02207816|11816111|FG002|Overall Study|Other|4
7496663|NCT02207829|11816124|FG000|Overall Study|Adverse Event|10
7496664|NCT02207829|11816125|FG001|Overall Study|Adverse Event|9
7496665|NCT02207829|11816124|FG000|Overall Study|Lack of Efficacy|7
7496666|NCT02207829|11816125|FG001|Overall Study|Lack of Efficacy|5
7496667|NCT02207829|11816124|FG000|Overall Study|Lost to Follow-up|2
7496668|NCT02207829|11816125|FG001|Overall Study|Lost to Follow-up|2
7496669|NCT02207829|11816124|FG000|Overall Study|Protocol deviation|5
7496670|NCT02207829|11816125|FG001|Overall Study|Protocol deviation|4
7496671|NCT02207829|11816124|FG000|Overall Study|Withdrew consent|18
7496672|NCT02207829|11816125|FG001|Overall Study|Withdrew consent|14
7496673|NCT02207907|11816133|FG000|Overall Study|Lost to Follow-up|3
7496674|NCT02207907|11816134|FG001|Overall Study|Lost to Follow-up|1
7496675|NCT02207907|11816133|FG000|Overall Study|Withdrawal by Subject|5
7496676|NCT02207907|11816134|FG001|Overall Study|Withdrawal by Subject|6
7496677|NCT02207907|11816133|FG000|Overall Study|Did not meet study criteria|3
7496678|NCT02207907|11816134|FG001|Overall Study|Did not meet study criteria|0
7496679|NCT02207907|11816133|FG000|Overall Study|Pregnancy|0
7496680|NCT02207907|11816134|FG001|Overall Study|Pregnancy|1
7496681|NCT02207946|11816143|FG000|Overall Study|Lost to Follow-up|1
7496682|NCT02207946|11816144|FG001|Overall Study|Lost to Follow-up|0
7496683|NCT02207946|11816143|FG000|Overall Study|Adverse Event|0
7496684|NCT02207946|11816144|FG001|Overall Study|Adverse Event|1
7496685|NCT02208050|11816176|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
7496686|NCT02208050|11816177|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
7496687|NCT02208063|11816199|FG000|Overall Study|Death|3
7496688|NCT02208063|11816200|FG001|Overall Study|Death|5
7496689|NCT02208063|11816199|FG000|Overall Study|Not Specified in report|3
7496690|NCT02208063|11816200|FG001|Overall Study|Not Specified in report|4
7496691|NCT02208063|11816199|FG000|Overall Study|Withdrawal by Subject|5
7496692|NCT02208063|11816200|FG001|Overall Study|Withdrawal by Subject|2
7496693|NCT02208063|11816199|FG000|Overall Study|Lost to Follow-up|1
7496694|NCT02208063|11816200|FG001|Overall Study|Lost to Follow-up|0
7496695|NCT02208089|11816208|FG000|Overall Study|Withdrawal by Subject|1
7496696|NCT02208089|11816209|FG001|Overall Study|Withdrawal by Subject|0
7496697|NCT02208089|11816208|FG000|Overall Study|Lost to Follow-up|6
7496698|NCT02208089|11816209|FG001|Overall Study|Lost to Follow-up|0
7496699|NCT02208843|11816258|FG000|Overall Study|Clinical symptoms of progression|2
7496700|NCT02208843|11816258|FG000|Overall Study|Progression disease according to RECIST|24
7496701|NCT02208843|11816258|FG000|Overall Study|Adverse Event|12
7496702|NCT02208843|11816258|FG000|Overall Study|Protocol Violation|1
7496703|NCT02208843|11816258|FG000|Overall Study|Withdrawal by Subject|1
7496704|NCT02208843|11816258|FG000|Overall Study|Switched to commercial afatinib|20
7496705|NCT02208999|11816264|FG000|Overall Study|Lost to Follow-up|1
7496706|NCT02209181|11816292|FG000|Overall Study|Adverse Event|1
7496707|NCT02209181|11816293|FG001|Overall Study|Adverse Event|0
7496708|NCT02209181|11816294|FG002|Overall Study|Adverse Event|1
7496709|NCT02209181|11816295|FG003|Overall Study|Adverse Event|0
7496710|NCT02209181|11816292|FG000|Overall Study|Withdrawal by Subject|0
7496711|NCT02209181|11816293|FG001|Overall Study|Withdrawal by Subject|1
7496712|NCT02209181|11816294|FG002|Overall Study|Withdrawal by Subject|0
7496713|NCT02209181|11816295|FG003|Overall Study|Withdrawal by Subject|0
7496714|NCT02209454|11816327|FG000|Second Period|Adverse Event|1
7496715|NCT02209454|11816328|FG001|Second Period|Adverse Event|0
7496716|NCT02209506|11816339|FG000|Overall Study|Withdrawal by Subject|0
7496717|NCT02209506|11816340|FG001|Overall Study|Withdrawal by Subject|0
7496718|NCT02209506|11816341|FG002|Overall Study|Withdrawal by Subject|0
7496719|NCT02209506|11816342|FG003|Overall Study|Withdrawal by Subject|0
7496720|NCT02209506|11816343|FG004|Overall Study|Withdrawal by Subject|1
7496721|NCT02209597|11816378|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
7496722|NCT02209597|11816378|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
7496723|NCT02209597|11816378|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
7496724|NCT02209597|11816378|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
7496725|NCT02209766|11816402|FG000|Overall Study|Withdrawal by Subject|0
7496726|NCT02209766|11816403|FG001|Overall Study|Withdrawal by Subject|0
7496727|NCT02209766|11816404|FG002|Overall Study|Withdrawal by Subject|0
7496728|NCT02209766|11816405|FG003|Overall Study|Withdrawal by Subject|1
7496729|NCT02209766|11816406|FG004|Overall Study|Withdrawal by Subject|0
7496730|NCT02210000|11816427|FG000|Overall Study|Study Terminated|11
7496731|NCT02210000|11816428|FG001|Overall Study|Study Terminated|12
7496732|NCT02210000|11816427|FG000|Overall Study|Withdrawal by Subject|7
7496733|NCT02210000|11816428|FG001|Overall Study|Withdrawal by Subject|1
7496734|NCT02210000|11816427|FG000|Overall Study|Adverse Event|1
7496735|NCT02210000|11816428|FG001|Overall Study|Adverse Event|5
7496736|NCT02210000|11816427|FG000|Overall Study|Lost to Follow-up|0
7496737|NCT02210000|11816428|FG001|Overall Study|Lost to Follow-up|2
7496738|NCT02210000|11816427|FG000|Overall Study|Physician Decision|0
7496739|NCT02210000|11816428|FG001|Overall Study|Physician Decision|1
7496740|NCT02210091|11816448|FG000|Overall Study|Physician Decision|0
7496741|NCT02210091|11816449|FG001|Overall Study|Physician Decision|1
7496742|NCT02210091|11816448|FG000|Overall Study|Withdrawal by Sponsor|0
7496743|NCT02210091|11816449|FG001|Overall Study|Withdrawal by Sponsor|1
7496744|NCT02210208|11816480|FG000|Period A (Graft Site)|Withdrawal by Subject|1
7496745|NCT02210208|11816480|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
7496746|NCT02210208|11816480|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
7496747|NCT02210221|11816486|FG000|Overall Study|Lack of Efficacy|7
7496748|NCT02210221|11816486|FG000|Overall Study|Withdrawal by Subject|43
7496749|NCT02210689|11816532|FG000|Overall Study|Withdrawal by Subject|7
7496750|NCT02210689|11816533|FG001|Overall Study|Withdrawal by Subject|4
7496751|NCT02210689|11816534|FG002|Overall Study|Withdrawal by Subject|2
7496752|NCT02210689|11816532|FG000|Overall Study|Adverse Event|0
7496753|NCT02210689|11816533|FG001|Overall Study|Adverse Event|1
7496754|NCT02210689|11816534|FG002|Overall Study|Adverse Event|0
7496755|NCT02210689|11816532|FG000|Overall Study|Protocol Violation|1
7496756|NCT02210689|11816533|FG001|Overall Study|Protocol Violation|0
7496757|NCT02210689|11816534|FG002|Overall Study|Protocol Violation|0
7496758|NCT02210689|11816532|FG000|Overall Study|Lost to Follow-up|11
7496759|NCT02210689|11816533|FG001|Overall Study|Lost to Follow-up|9
7496760|NCT02210689|11816534|FG002|Overall Study|Lost to Follow-up|5
7496761|NCT02210689|11816532|FG000|Overall Study|Pregnancy|0
7496762|NCT02210689|11816533|FG001|Overall Study|Pregnancy|1
7496763|NCT02210689|11816534|FG002|Overall Study|Pregnancy|0
7496764|NCT02210689|11816532|FG000|Overall Study|Lack of Efficacy|0
7496765|NCT02210689|11816533|FG001|Overall Study|Lack of Efficacy|1
7496766|NCT02210689|11816534|FG002|Overall Study|Lack of Efficacy|5
7496767|NCT02210689|11816532|FG000|Overall Study|Prohibited medication|2
7496768|NCT02210689|11816533|FG001|Overall Study|Prohibited medication|8
7496769|NCT02210689|11816534|FG002|Overall Study|Prohibited medication|1
7496770|NCT02210689|11816532|FG000|Overall Study|Negative Nugent score at baseline|6
7496771|NCT02210689|11816533|FG001|Overall Study|Negative Nugent score at baseline|2
7496772|NCT02210689|11816534|FG002|Overall Study|Negative Nugent score at baseline|2
7496773|NCT02210689|11816532|FG000|Overall Study|Other|25
7496774|NCT02210689|11816533|FG001|Overall Study|Other|21
7496775|NCT02210689|11816534|FG002|Overall Study|Other|8
7496776|NCT02210780|11816544|FG000|Overall Study|Adverse Event|0
7496777|NCT02210780|11816545|FG001|Overall Study|Adverse Event|5
7496778|NCT02210780|11816544|FG000|Overall Study|Lost to Follow-up|2
7496779|NCT02210780|11816545|FG001|Overall Study|Lost to Follow-up|1
7496780|NCT02210780|11816544|FG000|Overall Study|Withdrawal by Subject|1
7496781|NCT02210780|11816545|FG001|Overall Study|Withdrawal by Subject|1
7496782|NCT02210780|11816544|FG000|Overall Study|Physician Decision|1
7496783|NCT02210780|11816545|FG001|Overall Study|Physician Decision|0
7496784|NCT02210780|11816544|FG000|Overall Study|Protocol Violation|1
7496785|NCT02210780|11816545|FG001|Overall Study|Protocol Violation|0
7496786|NCT02210780|11816544|FG000|Overall Study|Other than specified above|0
7496787|NCT02210780|11816545|FG001|Overall Study|Other than specified above|1
7496788|NCT02211014|11816553|FG000|Overall Study|Adverse Event|0
7496789|NCT02211014|11816554|FG001|Overall Study|Adverse Event|2
7496790|NCT02211014|11816553|FG000|Overall Study|Physician Decision|1
7496791|NCT02211014|11816554|FG001|Overall Study|Physician Decision|2
7496792|NCT02211014|11816553|FG000|Overall Study|Started another cancer therapy|1
7496793|NCT02211014|11816554|FG001|Overall Study|Started another cancer therapy|0
7496794|NCT02211014|11816553|FG000|Overall Study|Withdrawal by Subject|0
7496795|NCT02211014|11816554|FG001|Overall Study|Withdrawal by Subject|1
7496796|NCT02211014|11816553|FG000|Overall Study|In agreement with patient, no benefit|0
7496797|NCT02211014|11816554|FG001|Overall Study|In agreement with patient, no benefit|1
7496798|NCT02211261|11816587|FG000|Overall Study|Withdrawal by Subject|0
7496799|NCT02211261|11816588|FG001|Overall Study|Withdrawal by Subject|0
7496800|NCT02211261|11816589|FG002|Overall Study|Withdrawal by Subject|1
7496801|NCT02211261|11816590|FG003|Overall Study|Withdrawal by Subject|0
7496802|NCT02211261|11816591|FG004|Overall Study|Withdrawal by Subject|2
7496803|NCT02211261|11816592|FG005|Overall Study|Withdrawal by Subject|0
7496804|NCT02211261|11816593|FG006|Overall Study|Withdrawal by Subject|0
7496805|NCT02211261|11816594|FG007|Overall Study|Withdrawal by Subject|0
7496806|NCT02211261|11816595|FG008|Overall Study|Withdrawal by Subject|0
7496807|NCT02211261|11816596|FG009|Overall Study|Withdrawal by Subject|0
7496808|NCT02211261|11816597|FG010|Overall Study|Withdrawal by Subject|0
7496809|NCT02211261|11816587|FG000|Overall Study|Other|0
7496810|NCT02211261|11816588|FG001|Overall Study|Other|0
7496811|NCT02211261|11816589|FG002|Overall Study|Other|0
7496812|NCT02211261|11816590|FG003|Overall Study|Other|0
7496813|NCT02211261|11816591|FG004|Overall Study|Other|0
7496814|NCT02211261|11816592|FG005|Overall Study|Other|1
7496815|NCT02211261|11816593|FG006|Overall Study|Other|0
7496816|NCT02211261|11816594|FG007|Overall Study|Other|0
7496817|NCT02211261|11816595|FG008|Overall Study|Other|0
7496818|NCT02211261|11816596|FG009|Overall Study|Other|2
7496819|NCT02211261|11816597|FG010|Overall Study|Other|0
7496820|NCT02211261|11816587|FG000|Overall Study|Lost to Follow-up|0
7496821|NCT02211261|11816588|FG001|Overall Study|Lost to Follow-up|0
7496822|NCT02211261|11816589|FG002|Overall Study|Lost to Follow-up|0
7496823|NCT02211261|11816590|FG003|Overall Study|Lost to Follow-up|0
7496824|NCT02211261|11816591|FG004|Overall Study|Lost to Follow-up|0
7496825|NCT02211261|11816592|FG005|Overall Study|Lost to Follow-up|0
7496826|NCT02211261|11816593|FG006|Overall Study|Lost to Follow-up|0
7496827|NCT02211261|11816594|FG007|Overall Study|Lost to Follow-up|1
7496828|NCT02211261|11816595|FG008|Overall Study|Lost to Follow-up|0
7496829|NCT02211261|11816596|FG009|Overall Study|Lost to Follow-up|0
7496830|NCT02211261|11816597|FG010|Overall Study|Lost to Follow-up|0
7496831|NCT02211313|11816632|FG000|Overall Study|Treatment Failure|5
7496832|NCT02211313|11816633|FG001|Overall Study|Treatment Failure|2
7496833|NCT02211313|11816632|FG000|Overall Study|No Follow up Questionnaires|1
7496834|NCT02211313|11816633|FG001|Overall Study|No Follow up Questionnaires|1
7496835|NCT02211638|11816665|FG000|Overall Study|Case Report Forms Uncollected|291
7496836|NCT02211638|11816665|FG000|Overall Study|Protocol Violation|692
7496837|NCT02212197|11816691|FG000|Overall Study|Need for radiotherapy|1
7496838|NCT02212197|11816692|FG001|Overall Study|Need for radiotherapy|0
7496839|NCT02212197|11816693|FG002|Overall Study|Need for radiotherapy|0
7496840|NCT02212301|11816701|FG000|Period 1|Lost to Follow-up|0
7496841|NCT02212301|11816702|FG001|Period 1|Lost to Follow-up|1
7496842|NCT02212379|11816709|FG000|From Baseline to Week 48|Lack of Efficacy|1
7496843|NCT02212379|11816709|FG000|From Baseline to Week 48|Adverse Event|7
7496844|NCT02212379|11816709|FG000|From Baseline to Week 48|Withdrawal by Subject|1
7496845|NCT02212379|11816709|FG000|From Week 48 to Week 96|Lack of Efficacy|1
7496846|NCT02212379|11816709|FG000|From Week 48 to Week 96|Adverse Event|1
7496847|NCT02212379|11816709|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
7496848|NCT02212457|11816722|FG000|Overall Study|Adverse Event|1
7496849|NCT02212457|11816723|FG001|Overall Study|Adverse Event|2
7496850|NCT02212457|11816724|FG002|Overall Study|Adverse Event|2
7496851|NCT02212457|11816725|FG003|Overall Study|Adverse Event|2
7496852|NCT02212457|11816726|FG004|Overall Study|Adverse Event|0
7496853|NCT02212457|11816727|FG005|Overall Study|Adverse Event|1
7496854|NCT02212457|11816722|FG000|Overall Study|Withdrawal by Subject|8
7496855|NCT02212457|11816723|FG001|Overall Study|Withdrawal by Subject|10
7496856|NCT02212457|11816724|FG002|Overall Study|Withdrawal by Subject|8
7496857|NCT02212457|11816725|FG003|Overall Study|Withdrawal by Subject|6
7496858|NCT02212457|11816726|FG004|Overall Study|Withdrawal by Subject|5
7496859|NCT02212457|11816727|FG005|Overall Study|Withdrawal by Subject|4
7496860|NCT02212457|11816722|FG000|Overall Study|Lost to Follow-up|6
7496861|NCT02212457|11816723|FG001|Overall Study|Lost to Follow-up|7
7496862|NCT02212457|11816724|FG002|Overall Study|Lost to Follow-up|4
7496863|NCT02212457|11816725|FG003|Overall Study|Lost to Follow-up|1
7496864|NCT02212457|11816726|FG004|Overall Study|Lost to Follow-up|8
7496865|NCT02212457|11816727|FG005|Overall Study|Lost to Follow-up|4
7496866|NCT02212457|11816722|FG000|Overall Study|Protocol Violation|2
7496867|NCT02212457|11816723|FG001|Overall Study|Protocol Violation|1
7496868|NCT02212457|11816724|FG002|Overall Study|Protocol Violation|0
7496869|NCT02212457|11816725|FG003|Overall Study|Protocol Violation|1
7496870|NCT02212457|11816726|FG004|Overall Study|Protocol Violation|2
7496871|NCT02212457|11816727|FG005|Overall Study|Protocol Violation|3
7496872|NCT02212457|11816722|FG000|Overall Study|Other|2
7496873|NCT02212457|11816723|FG001|Overall Study|Other|1
7496874|NCT02212457|11816724|FG002|Overall Study|Other|2
7496875|NCT02212457|11816725|FG003|Overall Study|Other|1
7496876|NCT02212457|11816726|FG004|Overall Study|Other|0
7496877|NCT02212457|11816727|FG005|Overall Study|Other|1
7496878|NCT02212678|11816752|FG000|Overall Study|Adverse Event|1
7496879|NCT02212730|11816758|FG000|Overall Study|Tumor not of the required cell histology|1
7496880|NCT02212730|11816759|FG001|Overall Study|Tumor not of the required cell histology|0
7496881|NCT02212730|11816758|FG000|Overall Study|Withdrawal by Subject|1
7496882|NCT02212730|11816759|FG001|Overall Study|Withdrawal by Subject|0
7496883|NCT02212730|11816758|FG000|Overall Study|Disease progression prior to RCC surgery|0
7496884|NCT02212730|11816759|FG001|Overall Study|Disease progression prior to RCC surgery|1
7496885|NCT02213042|11816788|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
7496886|NCT02213042|11816789|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
7496887|NCT02213042|11816790|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
7496888|NCT02213042|11816788|FG000|Overall Study|Adverse Event|2
7496889|NCT02213042|11816789|FG001|Overall Study|Adverse Event|1
7496890|NCT02213042|11816790|FG002|Overall Study|Adverse Event|0
7496891|NCT02213042|11816788|FG000|Overall Study|Withdrawal by Subject|0
7496892|NCT02213042|11816789|FG001|Overall Study|Withdrawal by Subject|1
7496893|NCT02213042|11816790|FG002|Overall Study|Withdrawal by Subject|1
7496894|NCT02213042|11816788|FG000|Overall Study|Protocol Violation|1
7496895|NCT02213042|11816789|FG001|Overall Study|Protocol Violation|0
7496896|NCT02213042|11816790|FG002|Overall Study|Protocol Violation|0
7496897|NCT02213042|11816788|FG000|Overall Study|Investigator discretion|0
7496898|NCT02213042|11816789|FG001|Overall Study|Investigator discretion|0
7496899|NCT02213042|11816790|FG002|Overall Study|Investigator discretion|1
7496900|NCT02213055|11816802|FG000|Overall Study|Protocol was not Followed at Enrollment|5
7496901|NCT02213055|11816803|FG001|Overall Study|Protocol was not Followed at Enrollment|0
7496902|NCT02213055|11816802|FG000|Overall Study|Protocol was not Followed during Study|1
7496903|NCT02213055|11816803|FG001|Overall Study|Protocol was not Followed during Study|0
7496904|NCT02213055|11816802|FG000|Overall Study|Documentation Issue at Enrollment|1
7496905|NCT02213055|11816803|FG001|Overall Study|Documentation Issue at Enrollment|0
7496906|NCT02213055|11816802|FG000|Overall Study|Documentation Issue during Study|10
7496907|NCT02213055|11816803|FG001|Overall Study|Documentation Issue during Study|0
7496908|NCT02213055|11816802|FG000|Overall Study|Did not have Live Lice|8
7496909|NCT02213055|11816803|FG001|Overall Study|Did not have Live Lice|0
7496910|NCT02213055|11816802|FG000|Overall Study|Had another Treatment during the Study|3
7496911|NCT02213055|11816803|FG001|Overall Study|Had another Treatment during the Study|0
7496912|NCT02213055|11816802|FG000|Overall Study|Did not meet Inclusion Criteria|6
7496913|NCT02213055|11816803|FG001|Overall Study|Did not meet Inclusion Criteria|0
7496914|NCT02213055|11816802|FG000|Overall Study|Did not Return to School|5
7496915|NCT02213055|11816803|FG001|Overall Study|Did not Return to School|0
7496916|NCT02213094|11816824|FG000|Overall Study|Adverse Event|1
7496917|NCT02213094|11816825|FG001|Overall Study|Adverse Event|0
7496918|NCT02213133|11816834|FG000|Overall Study|Participant discontinued study therapy|2
7496919|NCT02213133|11816835|FG001|Overall Study|Participant discontinued study therapy|0
7496920|NCT02213133|11816836|FG002|Overall Study|Participant discontinued study therapy|0
7496921|NCT02213133|11816834|FG000|Overall Study|Participant withdrew informed consent|2
7496922|NCT02213133|11816835|FG001|Overall Study|Participant withdrew informed consent|1
7496923|NCT02213133|11816836|FG002|Overall Study|Participant withdrew informed consent|2
7496924|NCT02213133|11816834|FG000|Overall Study|Disease progression|11
7496925|NCT02213133|11816835|FG001|Overall Study|Disease progression|2
7496926|NCT02213133|11816836|FG002|Overall Study|Disease progression|0
7496927|NCT02213133|11816834|FG000|Overall Study|Adverse Event (AE)|1
7496928|NCT02213133|11816835|FG001|Overall Study|Adverse Event (AE)|0
7496929|NCT02213133|11816836|FG002|Overall Study|Adverse Event (AE)|0
7496930|NCT02213133|11816834|FG000|Overall Study|Death|16
7496931|NCT02213133|11816835|FG001|Overall Study|Death|2
7496932|NCT02213133|11816836|FG002|Overall Study|Death|1
7496933|NCT02213133|11816834|FG000|Overall Study|Other|5
7496934|NCT02213133|11816835|FG001|Overall Study|Other|0
7496935|NCT02213133|11816836|FG002|Overall Study|Other|0
7496936|NCT02213198|11816847|FG000|Baseline|No show for intake|7
7496937|NCT02213198|11816848|FG001|Baseline|No show for intake|9
7496938|NCT02213198|11816847|FG000|Baseline|Withdrawal by Subject|34
7496939|NCT02213198|11816848|FG001|Baseline|Withdrawal by Subject|11
7496940|NCT02213198|11816847|FG000|Baseline|transferred out of clinic|7
7496941|NCT02213198|11816848|FG001|Baseline|transferred out of clinic|9
7496942|NCT02213198|11816847|FG000|Baseline|Lost to Follow-up|40
7496943|NCT02213198|11816848|FG001|Baseline|Lost to Follow-up|21
7496944|NCT02213198|11816847|FG000|Baseline|incarcerated,violent|0
7496945|NCT02213198|11816848|FG001|Baseline|incarcerated,violent|1
7496946|NCT02213198|11816847|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7496947|NCT02213198|11816848|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
7496948|NCT02213198|11816847|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
7496949|NCT02213198|11816848|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
7496950|NCT02213198|11816847|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
7496951|NCT02213198|11816848|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
7496952|NCT02213198|11816847|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
7496953|NCT02213198|11816848|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
7496954|NCT02213198|11816847|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
7496955|NCT02213198|11816848|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
7496956|NCT02213198|11816847|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
7496957|NCT02213198|11816848|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
7496958|NCT02213263|11816864|FG000|Overall Study|Insufficient clinical response|4
7496959|NCT02213263|11816865|FG001|Overall Study|Insufficient clinical response|3
7496960|NCT02213263|11816864|FG000|Overall Study|Lost to Follow-up|0
7496961|NCT02213263|11816865|FG001|Overall Study|Lost to Follow-up|1
7496962|NCT02213263|11816864|FG000|Overall Study|No longer willing to participate|3
7496963|NCT02213263|11816865|FG001|Overall Study|No longer willing to participate|4
7496964|NCT02213263|11816864|FG000|Overall Study|Progressive disease|20
7496965|NCT02213263|11816865|FG001|Overall Study|Progressive disease|14
7496966|NCT02213263|11816864|FG000|Overall Study|Protocol Violation|0
7496967|NCT02213263|11816865|FG001|Overall Study|Protocol Violation|1
7496968|NCT02213263|11816864|FG000|Overall Study|Adverse Event|1
7496969|NCT02213263|11816865|FG001|Overall Study|Adverse Event|3
7496970|NCT02213458|11816886|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
7496971|NCT02213458|11816887|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
7496972|NCT02213458|11816886|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
7496973|NCT02213458|11816887|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
7496974|NCT02213458|11816886|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
7496975|NCT02213458|11816887|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
7496976|NCT02213458|11816886|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
7496977|NCT02213458|11816887|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
7496978|NCT02213458|11816886|FG000|Overall Study|Refused re-consent|6
7496979|NCT02213458|11816887|FG001|Overall Study|Refused re-consent|0
7496980|NCT02213458|11816886|FG000|Overall Study|Lost to Follow-up|2
7496981|NCT02213458|11816887|FG001|Overall Study|Lost to Follow-up|2
7496982|NCT02213458|11816886|FG000|Overall Study|Withdrawal by Subject|26
7496983|NCT02213458|11816887|FG001|Overall Study|Withdrawal by Subject|8
7496984|NCT02213510|11816895|FG000|Overall Study|Death|0
7496985|NCT02213510|11816896|FG001|Overall Study|Death|1
7496986|NCT02213510|11816895|FG000|Overall Study|Lost to Follow-up|1
7496987|NCT02213510|11816896|FG001|Overall Study|Lost to Follow-up|0
7496988|NCT02213666|11816902|FG000|Overall Study|Withdrawal by Subject|1
7496989|NCT02214121|11816927|FG000|Part A|Patient decision|2
7496990|NCT02214121|11816928|FG001|Part A|Patient decision|0
7496991|NCT02214121|11816929|FG002|Part A|Patient decision|0
7496992|NCT02214121|11816927|FG000|Part A|Dev. of study-specific withdrawal crit.|4
7496993|NCT02214121|11816928|FG001|Part A|Dev. of study-specific withdrawal crit.|0
7496994|NCT02214121|11816929|FG002|Part A|Dev. of study-specific withdrawal crit.|0
7496995|NCT02214121|11816927|FG000|Part A|Other|1
7496996|NCT02214121|11816928|FG001|Part A|Other|0
7496997|NCT02214121|11816929|FG002|Part A|Other|0
7496998|NCT02214121|11816927|FG000|Part B|Patient decision|0
7496999|NCT02214121|11816928|FG001|Part B|Patient decision|1
7497000|NCT02214121|11816929|FG002|Part B|Patient decision|0
7497001|NCT02214121|11816927|FG000|Part B|Dev. of study-specific withdrawal crit.|0
7497002|NCT02214121|11816928|FG001|Part B|Dev. of study-specific withdrawal crit.|2
7497003|NCT02214121|11816929|FG002|Part B|Dev. of study-specific withdrawal crit.|0
7497004|NCT02214121|11816927|FG000|Part B|Lost to Follow-up|0
7497005|NCT02214121|11816928|FG001|Part B|Lost to Follow-up|0
7497006|NCT02214121|11816929|FG002|Part B|Lost to Follow-up|1
7497007|NCT02214186|11816964|FG000|Overall Study|Lost to Follow-up|1
7497008|NCT02214186|11816965|FG001|Overall Study|Lost to Follow-up|1
7497009|NCT02214186|11816964|FG000|Overall Study|Protocol Violation|1
7497010|NCT02214186|11816965|FG001|Overall Study|Protocol Violation|1
7497011|NCT02214225|11816988|FG000|Overall Study|Lost to Follow-up|46
7497012|NCT02214225|11816989|FG001|Overall Study|Lost to Follow-up|18
7497013|NCT02214225|11816990|FG002|Overall Study|Lost to Follow-up|18
7497014|NCT02214225|11816988|FG000|Overall Study|Withdrawal by Subject|2
7497015|NCT02214225|11816989|FG001|Overall Study|Withdrawal by Subject|0
7497016|NCT02214225|11816990|FG002|Overall Study|Withdrawal by Subject|2
7497017|NCT02214225|11816988|FG000|Overall Study|Death|5
7497018|NCT02214225|11816989|FG001|Overall Study|Death|0
7497019|NCT02214225|11816990|FG002|Overall Study|Death|1
7497020|NCT02214225|11816988|FG000|Overall Study|randomized in error, not vaccinated|2
7497021|NCT02214225|11816989|FG001|Overall Study|randomized in error, not vaccinated|1
7497022|NCT02214225|11816990|FG002|Overall Study|randomized in error, not vaccinated|1
7497023|NCT02215252|11817118|FG000|Overall Study|Adverse Event|1
7497024|NCT02215252|11817119|FG001|Overall Study|Adverse Event|5
7497025|NCT02215252|11817120|FG002|Overall Study|Adverse Event|2
7497026|NCT02215252|11817118|FG000|Overall Study|Lost to Follow-up|0
7497027|NCT02215252|11817119|FG001|Overall Study|Lost to Follow-up|0
7497028|NCT02215252|11817120|FG002|Overall Study|Lost to Follow-up|1
7497029|NCT02215252|11817118|FG000|Overall Study|Does not Meet Entrance Criteria|0
7497030|NCT02215252|11817119|FG001|Overall Study|Does not Meet Entrance Criteria|1
7497031|NCT02215252|11817120|FG002|Overall Study|Does not Meet Entrance Criteria|0
7497032|NCT02215252|11817118|FG000|Overall Study|Protocol Violation|0
7497033|NCT02215252|11817119|FG001|Overall Study|Protocol Violation|1
7497034|NCT02215252|11817120|FG002|Overall Study|Protocol Violation|0
7497035|NCT02215252|11817118|FG000|Overall Study|Withdrawal by Subject|1
7497036|NCT02215252|11817119|FG001|Overall Study|Withdrawal by Subject|0
7497037|NCT02215252|11817120|FG002|Overall Study|Withdrawal by Subject|0
7497038|NCT02215252|11817118|FG000|Overall Study|Other|0
7497039|NCT02215252|11817119|FG001|Overall Study|Other|1
7497040|NCT02215252|11817120|FG002|Overall Study|Other|1
7497041|NCT02215616|11817136|FG000|Overall Study|Sponsor requested to stop study drug|0
7497042|NCT02215616|11817137|FG001|Overall Study|Sponsor requested to stop study drug|0
7497043|NCT02215616|11817138|FG002|Overall Study|Sponsor requested to stop study drug|1
7497044|NCT02215616|11817139|FG003|Overall Study|Sponsor requested to stop study drug|4
7497045|NCT02215616|11817136|FG000|Overall Study|Death|1
7497046|NCT02215616|11817137|FG001|Overall Study|Death|0
7497047|NCT02215616|11817138|FG002|Overall Study|Death|0
7497048|NCT02215616|11817139|FG003|Overall Study|Death|0
7497049|NCT02215616|11817136|FG000|Overall Study|Adverse Event|7
7497050|NCT02215616|11817137|FG001|Overall Study|Adverse Event|4
7497051|NCT02215616|11817138|FG002|Overall Study|Adverse Event|9
7497052|NCT02215616|11817139|FG003|Overall Study|Adverse Event|2
7497053|NCT02215616|11817136|FG000|Overall Study|Withdrawal by Subject|1
7497054|NCT02215616|11817137|FG001|Overall Study|Withdrawal by Subject|8
7497055|NCT02215616|11817138|FG002|Overall Study|Withdrawal by Subject|2
7497056|NCT02215616|11817139|FG003|Overall Study|Withdrawal by Subject|5
7497057|NCT02215616|11817136|FG000|Overall Study|Non-compliance|0
7497058|NCT02215616|11817137|FG001|Overall Study|Non-compliance|2
7497059|NCT02215616|11817138|FG002|Overall Study|Non-compliance|1
7497060|NCT02215616|11817139|FG003|Overall Study|Non-compliance|0
7497061|NCT02215616|11817136|FG000|Overall Study|Protocol Violation|0
7497062|NCT02215616|11817137|FG001|Overall Study|Protocol Violation|2
7497063|NCT02215616|11817138|FG002|Overall Study|Protocol Violation|0
7497064|NCT02215616|11817139|FG003|Overall Study|Protocol Violation|0
7497065|NCT02215616|11817136|FG000|Overall Study|Lost to Follow-up|1
7497066|NCT02215616|11817137|FG001|Overall Study|Lost to Follow-up|1
7497067|NCT02215616|11817138|FG002|Overall Study|Lost to Follow-up|0
7497068|NCT02215616|11817139|FG003|Overall Study|Lost to Follow-up|1
7497069|NCT02215616|11817136|FG000|Overall Study|Other than specified|1
7497070|NCT02215616|11817137|FG001|Overall Study|Other than specified|0
7497071|NCT02215616|11817138|FG002|Overall Study|Other than specified|1
7497072|NCT02215616|11817139|FG003|Overall Study|Other than specified|1
7497073|NCT02215954|11817152|FG000|Overall Study|Adverse Event|0
7497074|NCT02215954|11817153|FG001|Overall Study|Adverse Event|0
7497075|NCT02215954|11817154|FG002|Overall Study|Adverse Event|1
7497076|NCT02215954|11817152|FG000|Overall Study|Withdrawal by Subject|0
7497077|NCT02215954|11817153|FG001|Overall Study|Withdrawal by Subject|0
7497078|NCT02215954|11817154|FG002|Overall Study|Withdrawal by Subject|2
7497079|NCT02215954|11817152|FG000|Overall Study|Not exposed|1
7497080|NCT02215954|11817153|FG001|Overall Study|Not exposed|1
7497081|NCT02215954|11817154|FG002|Overall Study|Not exposed|3
7553106|NCT03006393|11913853|FG000|Overall Study|Lost to Follow-up|0
7497082|NCT02215967|11817167|FG000|Overall Study|Patient became ineligible for treatment|0
7497083|NCT02215967|11817168|FG001|Overall Study|Patient became ineligible for treatment|0
7497084|NCT02215967|11817169|FG002|Overall Study|Patient became ineligible for treatment|0
7497085|NCT02215967|11817170|FG003|Overall Study|Patient became ineligible for treatment|3
7497086|NCT02215967|11817167|FG000|Overall Study|Patient did not get CAR T-Cells|0
7497087|NCT02215967|11817168|FG001|Overall Study|Patient did not get CAR T-Cells|0
7497088|NCT02215967|11817169|FG002|Overall Study|Patient did not get CAR T-Cells|1
7497089|NCT02215967|11817170|FG003|Overall Study|Patient did not get CAR T-Cells|0
7497090|NCT02216071|11817182|FG000|Overall Study|Withdrawal by Subject|7
7497091|NCT02216071|11817183|FG001|Overall Study|Withdrawal by Subject|2
7497092|NCT02216071|11817182|FG000|Overall Study|Lost to Follow-up|3
7497093|NCT02216071|11817183|FG001|Overall Study|Lost to Follow-up|3
7497094|NCT02216071|11817182|FG000|Overall Study|Protocol Violation|3
7497095|NCT02216071|11817183|FG001|Overall Study|Protocol Violation|5
7497096|NCT02216071|11817182|FG000|Overall Study|Other|2
7497097|NCT02216071|11817183|FG001|Overall Study|Other|2
7497098|NCT02216123|11817200|FG000|Overall Study|Lost to Follow-up|4
7497099|NCT02216123|11817201|FG001|Overall Study|Lost to Follow-up|2
7497100|NCT02216123|11817200|FG000|Overall Study|Withdrawal by Subject|2
7497101|NCT02216123|11817201|FG001|Overall Study|Withdrawal by Subject|0
7535371|NCT02709746|11883061|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7535372|NCT02709746|11883062|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7535373|NCT02709746|11883063|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
7535374|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7535375|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
7535376|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7535377|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
7535378|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
7535379|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Other|0
7535380|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Other|6
7535381|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Other|5
7535382|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Other|6
7535383|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Other|7
7535384|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7535385|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7535386|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
7535387|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
7535388|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
7535389|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7535390|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
7535391|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
7535392|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
7535393|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
7535394|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
7535395|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
7535396|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
7535397|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
7535398|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
7535399|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
7535400|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7535401|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7535402|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
7535403|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
7535404|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7535405|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7535406|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
7535407|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7535408|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
7535409|NCT02709746|11883059|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7535410|NCT02709746|11883060|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
7535411|NCT02709746|11883061|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7535412|NCT02709746|11883062|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
7535413|NCT02709746|11883063|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
7535414|NCT02709785|11883078|FG000|Overall Study|Withdrawal by Subject|1
7535415|NCT02709785|11883079|FG001|Overall Study|Withdrawal by Subject|2
7535416|NCT02709785|11883080|FG002|Overall Study|Withdrawal by Subject|1
7535417|NCT02709889|11883096|FG000|Overall Study|Withdrawal by Subject|11
7535418|NCT02709889|11883097|FG001|Overall Study|Withdrawal by Subject|10
7535419|NCT02709889|11883098|FG002|Overall Study|Withdrawal by Subject|2
7535420|NCT02709889|11883099|FG003|Overall Study|Withdrawal by Subject|12
7535421|NCT02709889|11883096|FG000|Overall Study|Death|25
7497102|NCT02216214|11817226|FG000|Overall Study|Randomized Never Received Study Drug|1
7497103|NCT02216214|11817227|FG001|Overall Study|Randomized Never Received Study Drug|0
7497104|NCT02216214|11817226|FG000|Overall Study|Adverse Event|10
7497105|NCT02216214|11817227|FG001|Overall Study|Adverse Event|8
7497106|NCT02216214|11817226|FG000|Overall Study|Lack of Efficacy|2
7497107|NCT02216214|11817227|FG001|Overall Study|Lack of Efficacy|2
7497108|NCT02216214|11817226|FG000|Overall Study|Lost to Follow-up|3
7497109|NCT02216214|11817227|FG001|Overall Study|Lost to Follow-up|2
7497110|NCT02216214|11817226|FG000|Overall Study|Protocol Violation|4
7497111|NCT02216214|11817227|FG001|Overall Study|Protocol Violation|2
7497112|NCT02216214|11817226|FG000|Overall Study|Withdrawal by Subject|22
7497113|NCT02216214|11817227|FG001|Overall Study|Withdrawal by Subject|20
7497114|NCT02216214|11817226|FG000|Overall Study|Study Terminated By Sponsor|0
7497115|NCT02216214|11817227|FG001|Overall Study|Study Terminated By Sponsor|1
7497116|NCT02216214|11817226|FG000|Overall Study|Miscellaneous|1
7497117|NCT02216214|11817227|FG001|Overall Study|Miscellaneous|1
7497118|NCT02216357|11817235|FG000|Overall Study|Inclusion or exclusion criteria not met|2
7497119|NCT02216357|11817236|FG001|Overall Study|Inclusion or exclusion criteria not met|1
7497120|NCT02216526|11817249|FG000|Overall Study|Adverse Event|1
7497121|NCT02216526|11817250|FG001|Overall Study|Adverse Event|1
7497122|NCT02216526|11817251|FG002|Overall Study|Adverse Event|0
7497123|NCT02216526|11817249|FG000|Overall Study|Death|0
7497124|NCT02216526|11817250|FG001|Overall Study|Death|1
7497125|NCT02216526|11817251|FG002|Overall Study|Death|3
7497126|NCT02216526|11817249|FG000|Overall Study|Protocol Violation|2
7497127|NCT02216526|11817250|FG001|Overall Study|Protocol Violation|0
7497128|NCT02216526|11817251|FG002|Overall Study|Protocol Violation|2
7497129|NCT02216526|11817249|FG000|Overall Study|Hospitalization|2
7497130|NCT02216526|11817250|FG001|Overall Study|Hospitalization|1
7497131|NCT02216526|11817251|FG002|Overall Study|Hospitalization|3
7497132|NCT02216591|11817261|FG000|Overall Study|Lost to Follow-up|0
7497133|NCT02216591|11817262|FG001|Overall Study|Lost to Follow-up|1
7497134|NCT02216773|11817279|FG000|Overall Study|Disease progression|4
7497135|NCT02216773|11817280|FG001|Overall Study|Disease progression|2
7497136|NCT02216773|11817279|FG000|Overall Study|Insufficient FLRV|4
7497137|NCT02216773|11817280|FG001|Overall Study|Insufficient FLRV|0
7497138|NCT02216773|11817279|FG000|Overall Study|Abandoned|4
7497139|NCT02216773|11817280|FG001|Overall Study|Abandoned|3
7497140|NCT02216812|11817288|FG000|Overall Study|Lost to Follow-up|10
7497141|NCT02216812|11817289|FG001|Overall Study|Lost to Follow-up|5
7497142|NCT02217280|11817304|FG000|Overall Study|Withdrawal by Subject|2
7497143|NCT02217280|11817304|FG000|Overall Study|Post-consent sceen fail|2
7497144|NCT02217332|11817309|FG000|Overall Study|Adverse Event|3
7497145|NCT02217332|11817309|FG000|Overall Study|Dose interruption >1 month|1
7497146|NCT02217332|11817309|FG000|Overall Study|Protocol Violation (eligibility)|1
7497147|NCT02217332|11817309|FG000|Overall Study|Withdrawal by Subject|1
7497148|NCT02217332|11817309|FG000|Overall Study|Lost to Follow-up|1
7497149|NCT02217410|11817316|FG000|Overall Study|Graft Loss|0
7497150|NCT02217410|11817317|FG001|Overall Study|Graft Loss|0
7497151|NCT02217410|11817318|FG002|Overall Study|Graft Loss|2
7497152|NCT02217410|11817316|FG000|Overall Study|Withdrawal by Subject|0
7497153|NCT02217410|11817317|FG001|Overall Study|Withdrawal by Subject|0
7497154|NCT02217410|11817318|FG002|Overall Study|Withdrawal by Subject|2
7497155|NCT02217410|11817316|FG000|Overall Study|Lost to Follow-up|0
7497156|NCT02217410|11817317|FG001|Overall Study|Lost to Follow-up|0
7497157|NCT02217410|11817318|FG002|Overall Study|Lost to Follow-up|1
7497158|NCT02217410|11817316|FG000|Overall Study|Lack of Efficacy|0
7497159|NCT02217410|11817317|FG001|Overall Study|Lack of Efficacy|1
7497160|NCT02217410|11817318|FG002|Overall Study|Lack of Efficacy|0
7497161|NCT02217410|11817316|FG000|Overall Study|Physician Decision|1
7497162|NCT02217410|11817317|FG001|Overall Study|Physician Decision|3
7497163|NCT02217410|11817318|FG002|Overall Study|Physician Decision|0
7497164|NCT02217436|11817333|FG000|Overall Study|Protocol Violation|1
7497165|NCT02217436|11817334|FG001|Overall Study|Protocol Violation|1
7497166|NCT02217436|11817333|FG000|Overall Study|Incomplete data|0
7497167|NCT02217436|11817334|FG001|Overall Study|Incomplete data|1
7497168|NCT02217475|11817343|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7497169|NCT02217475|11817344|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
7497170|NCT02217475|11817345|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
7497171|NCT02217475|11817343|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
7497172|NCT02217475|11817344|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
7497173|NCT02217475|11817345|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
7497174|NCT02217475|11817343|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
7497175|NCT02217475|11817344|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7497176|NCT02217475|11817345|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
7497177|NCT02217475|11817343|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
7497178|NCT02217475|11817344|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
7497179|NCT02217475|11817345|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
7497180|NCT02217475|11817343|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7497181|NCT02217475|11817344|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
7497182|NCT02217475|11817345|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
7497183|NCT02217475|11817343|FG000|Discontinued After Period 1|Adverse Event|1
7497184|NCT02217475|11817344|FG001|Discontinued After Period 1|Adverse Event|2
7497185|NCT02217475|11817345|FG002|Discontinued After Period 1|Adverse Event|0
7497186|NCT02217475|11817343|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
7497187|NCT02217475|11817344|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
7497188|NCT02217475|11817345|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
7497189|NCT02217475|11817343|FG000|Discontinued After Period 1|Physician Decision|0
7497190|NCT02217475|11817344|FG001|Discontinued After Period 1|Physician Decision|0
7497191|NCT02217475|11817345|FG002|Discontinued After Period 1|Physician Decision|1
7497192|NCT02217475|11817343|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
7497193|NCT02217475|11817344|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
7497194|NCT02217475|11817345|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
7497195|NCT02217475|11817343|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
7497196|NCT02217475|11817344|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
7497197|NCT02217475|11817345|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
7497198|NCT02217475|11817343|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7497199|NCT02217475|11817344|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
7497200|NCT02217475|11817345|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
7497201|NCT02217475|11817343|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
7497202|NCT02217475|11817344|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
7497203|NCT02217475|11817345|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
7497204|NCT02217475|11817343|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7497205|NCT02217475|11817344|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
7497206|NCT02217475|11817345|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
7497207|NCT02217501|11817364|FG000|Overall Study|Death|3
7497208|NCT02217501|11817365|FG001|Overall Study|Death|4
7497209|NCT02217527|11817373|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
7497210|NCT02217527|11817374|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
7497211|NCT02217527|11817373|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
7497212|NCT02217527|11817374|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
7497213|NCT02217566|11817380|FG000|Overall Study|Lost to Follow-up|2
7497214|NCT02217566|11817380|FG000|Overall Study|Death|3
7497215|NCT02217566|11817380|FG000|Overall Study|Early study termination|6
7497216|NCT02217878|11817402|FG000|Overall Study|required morphine due to chest pain|1
7497217|NCT02217878|11817403|FG001|Overall Study|required morphine due to chest pain|2
7497218|NCT02217878|11817402|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
7497219|NCT02217878|11817403|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
7497220|NCT02217982|11817434|FG000|Overall Study|Trial discontinued|1
7497221|NCT02217982|11817435|FG001|Overall Study|Trial discontinued|0
7497222|NCT02217982|11817434|FG000|Overall Study|Adverse Event|0
7497223|NCT02217982|11817435|FG001|Overall Study|Adverse Event|1
7497224|NCT02218008|11817444|FG000|Stage 1 (S1)|Adverse Event|6
7497225|NCT02218008|11817445|FG001|Stage 1 (S1)|Adverse Event|5
7497226|NCT02218008|11817446|FG002|Stage 1 (S1)|Adverse Event|11
7497227|NCT02218008|11817447|FG003|Stage 1 (S1)|Adverse Event|0
7497228|NCT02218008|11817448|FG004|Stage 1 (S1)|Adverse Event|0
7497229|NCT02218008|11817449|FG005|Stage 1 (S1)|Adverse Event|0
7497230|NCT02218008|11817444|FG000|Stage 1 (S1)|Withdrawal by Subject|6
7497231|NCT02218008|11817445|FG001|Stage 1 (S1)|Withdrawal by Subject|1
7497232|NCT02218008|11817446|FG002|Stage 1 (S1)|Withdrawal by Subject|1
7497233|NCT02218008|11817447|FG003|Stage 1 (S1)|Withdrawal by Subject|0
7497234|NCT02218008|11817448|FG004|Stage 1 (S1)|Withdrawal by Subject|0
7497235|NCT02218008|11817449|FG005|Stage 1 (S1)|Withdrawal by Subject|0
7497236|NCT02218008|11817444|FG000|Stage 1 (S1)|Lack of Efficacy|3
7497237|NCT02218008|11817445|FG001|Stage 1 (S1)|Lack of Efficacy|0
7497238|NCT02218008|11817446|FG002|Stage 1 (S1)|Lack of Efficacy|0
7497239|NCT02218008|11817447|FG003|Stage 1 (S1)|Lack of Efficacy|0
7497240|NCT02218008|11817448|FG004|Stage 1 (S1)|Lack of Efficacy|0
7497241|NCT02218008|11817449|FG005|Stage 1 (S1)|Lack of Efficacy|0
7497242|NCT02218008|11817444|FG000|Stage 1 (S1)|Lost to Follow-up|3
7497243|NCT02218008|11817445|FG001|Stage 1 (S1)|Lost to Follow-up|0
7497244|NCT02218008|11817446|FG002|Stage 1 (S1)|Lost to Follow-up|1
7497245|NCT02218008|11817447|FG003|Stage 1 (S1)|Lost to Follow-up|0
7497246|NCT02218008|11817448|FG004|Stage 1 (S1)|Lost to Follow-up|0
7497247|NCT02218008|11817449|FG005|Stage 1 (S1)|Lost to Follow-up|0
7497248|NCT02218008|11817444|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
7497249|NCT02218008|11817445|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
7497250|NCT02218008|11817446|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
7497251|NCT02218008|11817447|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
7497252|NCT02218008|11817448|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
7497253|NCT02218008|11817449|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
7497254|NCT02218008|11817444|FG000|Stage 1 (S1)|Non-compliance; drug use|1
7497255|NCT02218008|11817445|FG001|Stage 1 (S1)|Non-compliance; drug use|0
7497256|NCT02218008|11817446|FG002|Stage 1 (S1)|Non-compliance; drug use|0
7497257|NCT02218008|11817447|FG003|Stage 1 (S1)|Non-compliance; drug use|0
7497258|NCT02218008|11817448|FG004|Stage 1 (S1)|Non-compliance; drug use|0
7497259|NCT02218008|11817449|FG005|Stage 1 (S1)|Non-compliance; drug use|0
7497260|NCT02218008|11817444|FG000|Stage 1 (S1)|Pregnancy|0
7497261|NCT02218008|11817445|FG001|Stage 1 (S1)|Pregnancy|0
7497262|NCT02218008|11817446|FG002|Stage 1 (S1)|Pregnancy|1
7497263|NCT02218008|11817447|FG003|Stage 1 (S1)|Pregnancy|0
7497264|NCT02218008|11817448|FG004|Stage 1 (S1)|Pregnancy|0
7497265|NCT02218008|11817449|FG005|Stage 1 (S1)|Pregnancy|0
7497266|NCT02218008|11817444|FG000|Stage 1 (S1)|Protocol Violation|0
7497267|NCT02218008|11817445|FG001|Stage 1 (S1)|Protocol Violation|0
7497268|NCT02218008|11817446|FG002|Stage 1 (S1)|Protocol Violation|1
7497269|NCT02218008|11817447|FG003|Stage 1 (S1)|Protocol Violation|0
7497270|NCT02218008|11817448|FG004|Stage 1 (S1)|Protocol Violation|0
7497271|NCT02218008|11817449|FG005|Stage 1 (S1)|Protocol Violation|0
7497272|NCT02218008|11817444|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
7497273|NCT02218008|11817445|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7497274|NCT02218008|11817446|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7497275|NCT02218008|11817447|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7497276|NCT02218008|11817448|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7497277|NCT02218008|11817449|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
7497278|NCT02218008|11817444|FG000|Stage 2 (S2)|Adverse Event|0
7497279|NCT02218008|11817445|FG001|Stage 2 (S2)|Adverse Event|0
7497280|NCT02218008|11817446|FG002|Stage 2 (S2)|Adverse Event|0
7497281|NCT02218008|11817447|FG003|Stage 2 (S2)|Adverse Event|2
7497282|NCT02218008|11817448|FG004|Stage 2 (S2)|Adverse Event|3
7497283|NCT02218008|11817449|FG005|Stage 2 (S2)|Adverse Event|3
7497284|NCT02218008|11817444|FG000|Stage 2 (S2)|Withdrawal by Subject|0
7497285|NCT02218008|11817445|FG001|Stage 2 (S2)|Withdrawal by Subject|0
7497286|NCT02218008|11817446|FG002|Stage 2 (S2)|Withdrawal by Subject|0
7497287|NCT02218008|11817447|FG003|Stage 2 (S2)|Withdrawal by Subject|1
7497288|NCT02218008|11817448|FG004|Stage 2 (S2)|Withdrawal by Subject|1
7497289|NCT02218008|11817449|FG005|Stage 2 (S2)|Withdrawal by Subject|0
7497290|NCT02218008|11817444|FG000|Stage 2 (S2)|Lack of Efficacy|0
7497291|NCT02218008|11817445|FG001|Stage 2 (S2)|Lack of Efficacy|0
7497292|NCT02218008|11817446|FG002|Stage 2 (S2)|Lack of Efficacy|0
7497293|NCT02218008|11817447|FG003|Stage 2 (S2)|Lack of Efficacy|0
7497294|NCT02218008|11817448|FG004|Stage 2 (S2)|Lack of Efficacy|0
7497295|NCT02218008|11817449|FG005|Stage 2 (S2)|Lack of Efficacy|2
7497296|NCT02218008|11817444|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7497297|NCT02218008|11817445|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7497298|NCT02218008|11817446|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7497299|NCT02218008|11817447|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
7497300|NCT02218008|11817448|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7497301|NCT02218008|11817449|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
7497302|NCT02218008|11817444|FG000|Stage 2 (S2)|Lost to Follow-up|0
7497303|NCT02218008|11817445|FG001|Stage 2 (S2)|Lost to Follow-up|0
7497304|NCT02218008|11817446|FG002|Stage 2 (S2)|Lost to Follow-up|0
7497305|NCT02218008|11817447|FG003|Stage 2 (S2)|Lost to Follow-up|0
7497306|NCT02218008|11817448|FG004|Stage 2 (S2)|Lost to Follow-up|0
7497307|NCT02218008|11817449|FG005|Stage 2 (S2)|Lost to Follow-up|1
7497308|NCT02218216|11817496|FG000|Overall Study|Study terminated before completed|6
7497309|NCT02218216|11817497|FG001|Overall Study|Study terminated before completed|0
7497310|NCT02218216|11817498|FG002|Overall Study|Study terminated before completed|0
7497311|NCT02218268|11817510|FG000|24 Hour Washout|Physician Decision|11
7497312|NCT02218268|11817511|FG001|24 Hour Washout|Physician Decision|9
7497313|NCT02218372|11817537|FG000|Overall Study|Adverse Event|1
7497314|NCT02218372|11817538|FG001|Overall Study|Adverse Event|1
7497315|NCT02218372|11817537|FG000|Overall Study|Miscellaneous|2
7497316|NCT02218372|11817538|FG001|Overall Study|Miscellaneous|1
7497317|NCT02218372|11817537|FG000|Overall Study|Randomized but did not receive treatment|2
7497318|NCT02218372|11817538|FG001|Overall Study|Randomized but did not receive treatment|3
7497319|NCT02218372|11817537|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7497320|NCT02218372|11817538|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7497321|NCT02218489|11817569|FG000|Overall Study|Withdrawal by Subject|4
7497322|NCT02218489|11817570|FG001|Overall Study|Withdrawal by Subject|3
7497323|NCT02218489|11817569|FG000|Overall Study|Lost to Follow-up|1
7497324|NCT02218489|11817570|FG001|Overall Study|Lost to Follow-up|0
7497325|NCT02218541|11817579|FG000|Overall Study|Lost to Follow-up|2
7497326|NCT02218541|11817580|FG001|Overall Study|Lost to Follow-up|1
7497327|NCT02218541|11817579|FG000|Overall Study|Implant Failure|4
7497328|NCT02218541|11817580|FG001|Overall Study|Implant Failure|1
7497329|NCT02218736|11817589|FG000|Overall Study|Withdrawal by Subject|10
7497330|NCT02218736|11817590|FG001|Overall Study|Withdrawal by Subject|9
7497331|NCT02218736|11817589|FG000|Overall Study|Protocol Violation|2
7497332|NCT02218736|11817590|FG001|Overall Study|Protocol Violation|0
7497333|NCT02219009|11817598|FG000|Overall Study|Withdrawal by Subject|5
7497334|NCT02219009|11817599|FG001|Overall Study|Withdrawal by Subject|1
7497335|NCT02219009|11817598|FG000|Overall Study|Adverse Event|2
7497336|NCT02219009|11817599|FG001|Overall Study|Adverse Event|4
7497337|NCT02219009|11817598|FG000|Overall Study|Lost to Follow-up|2
7497338|NCT02219009|11817599|FG001|Overall Study|Lost to Follow-up|2
7497339|NCT02219009|11817598|FG000|Overall Study|Protocol deviation|1
7497340|NCT02219009|11817599|FG001|Overall Study|Protocol deviation|0
7497341|NCT02219009|11817598|FG000|Overall Study|Physician Decision|0
7497342|NCT02219009|11817599|FG001|Overall Study|Physician Decision|1
7497343|NCT02219048|11817607|FG000|Overall Study|Adverse Event|2
7497344|NCT02219048|11817608|FG001|Overall Study|Adverse Event|5
7497345|NCT02219048|11817607|FG000|Overall Study|No longer meets eligibility criteria|1
7497346|NCT02219048|11817608|FG001|Overall Study|No longer meets eligibility criteria|0
7497347|NCT02219048|11817607|FG000|Overall Study|Study terminated by sponsor|16
7497348|NCT02219048|11817608|FG001|Overall Study|Study terminated by sponsor|15
7497349|NCT02219048|11817607|FG000|Overall Study|Withdrawal by Subject|2
7497350|NCT02219048|11817608|FG001|Overall Study|Withdrawal by Subject|0
7497351|NCT02219048|11817607|FG000|Overall Study|Other|0
7497352|NCT02219048|11817608|FG001|Overall Study|Other|1
7497353|NCT02219087|11817616|FG000|Overall Study|Randomization envelope pulled out of seq|0
7497354|NCT02219087|11817617|FG001|Overall Study|Randomization envelope pulled out of seq|1
7497355|NCT02219308|11817687|FG000|Overall Study|Withdrawal by Subject|1
7497356|NCT02219308|11817688|FG001|Overall Study|Withdrawal by Subject|2
7497357|NCT02219334|11817705|FG000|Overall Study|Withdrawal by Subject|1
7497358|NCT02219334|11817706|FG001|Overall Study|Withdrawal by Subject|0
7497359|NCT02219334|11817705|FG000|Overall Study|Protocol Violation|7
7497360|NCT02219334|11817706|FG001|Overall Study|Protocol Violation|3
7497361|NCT02219464|11817725|FG000|Overall Study|Withdrawal by Subject|1
7497362|NCT02219464|11817726|FG001|Overall Study|Withdrawal by Subject|0
7497363|NCT02219464|11817725|FG000|Overall Study|case cancelled|1
7497364|NCT02219464|11817726|FG001|Overall Study|case cancelled|0
7497365|NCT02219464|11817725|FG000|Overall Study|catheter malfunction|1
7497366|NCT02219464|11817726|FG001|Overall Study|catheter malfunction|0
7497367|NCT02219477|11817735|FG000|Overall Study|Adverse Event|0
7497368|NCT02219477|11817736|FG001|Overall Study|Adverse Event|1
7497369|NCT02219477|11817737|FG002|Overall Study|Adverse Event|1
7497370|NCT02219477|11817735|FG000|Overall Study|Withdrawal by Subject|0
7497371|NCT02219477|11817736|FG001|Overall Study|Withdrawal by Subject|1
7497372|NCT02219477|11817737|FG002|Overall Study|Withdrawal by Subject|0
7497373|NCT02219685|11817769|FG000|Blinded Treatment Phase|Lost to Follow-up|1
7497374|NCT02219685|11817770|FG001|Blinded Treatment Phase|Lost to Follow-up|0
7497375|NCT02219685|11817769|FG000|Blinded Treatment Phase|Withdrew Consent|1
7497376|NCT02219685|11817770|FG001|Blinded Treatment Phase|Withdrew Consent|0
7497377|NCT02219932|11817789|FG000|Overall Study|Other|5
7497378|NCT02219932|11817790|FG001|Overall Study|Other|11
7497379|NCT02219932|11817789|FG000|Overall Study|Death|1
7497380|NCT02219932|11817790|FG001|Overall Study|Death|1
7497381|NCT02219932|11817789|FG000|Overall Study|Investigator Decision|0
7497382|NCT02219932|11817790|FG001|Overall Study|Investigator Decision|1
7497383|NCT02219932|11817789|FG000|Overall Study|Consent Withdrawn|11
7497384|NCT02219932|11817790|FG001|Overall Study|Consent Withdrawn|7
7497385|NCT02219932|11817789|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
7497386|NCT02219932|11817790|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
7497387|NCT02219932|11817789|FG000|Overall Study|Protocol Violation|10
7497388|NCT02219932|11817790|FG001|Overall Study|Protocol Violation|6
7497389|NCT02219932|11817789|FG000|Overall Study|Pregnancy|1
7497390|NCT02219932|11817790|FG001|Overall Study|Pregnancy|0
7497391|NCT02219932|11817789|FG000|Overall Study|Lost to Follow-up|4
7497392|NCT02219932|11817790|FG001|Overall Study|Lost to Follow-up|2
7497393|NCT02219932|11817789|FG000|Overall Study|Adverse Event|23
7497394|NCT02219932|11817790|FG001|Overall Study|Adverse Event|21
7497395|NCT02220205|11817813|FG000|Overall Study|Withdrawal by Subject|1
7497396|NCT02220205|11817814|FG001|Overall Study|Withdrawal by Subject|0
7497397|NCT02220712|11817820|FG000|Overall Study|Adverse Event|1
7497398|NCT02220712|11817820|FG000|Overall Study|Withdrawal by Subject|2
7497399|NCT02220712|11817820|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
7497400|NCT02220725|11817832|FG000|Overall Study|Lost to Follow-up|0
7497401|NCT02220725|11817833|FG001|Overall Study|Lost to Follow-up|0
7497402|NCT02220725|11817834|FG002|Overall Study|Lost to Follow-up|0
7497403|NCT02220725|11817835|FG003|Overall Study|Lost to Follow-up|1
7497404|NCT02220725|11817832|FG000|Overall Study|Withdrawal by Subject|0
7497405|NCT02220725|11817833|FG001|Overall Study|Withdrawal by Subject|0
7497406|NCT02220725|11817834|FG002|Overall Study|Withdrawal by Subject|0
7497407|NCT02220725|11817835|FG003|Overall Study|Withdrawal by Subject|1
7497408|NCT02220764|11817850|FG000|Overall Study|Lost to Follow-up|3
7497409|NCT02220764|11817851|FG001|Overall Study|Lost to Follow-up|1
7497410|NCT02220764|11817850|FG000|Overall Study|Death|1
7497411|NCT02220764|11817851|FG001|Overall Study|Death|0
7497412|NCT02220907|11817857|FG000|Overall Study|Adverse Event|7
7497413|NCT02220907|11817857|FG000|Overall Study|Physician Decision|1
7497414|NCT02220907|11817857|FG000|Overall Study|Withdrawal by Subject|2
7497415|NCT02220907|11817857|FG000|Overall Study|Conflict with the stopping criteria|1
7497416|NCT02220920|11817863|FG000|Overall Study|Adverse Event|1
7497417|NCT02220920|11817864|FG001|Overall Study|Adverse Event|0
7497418|NCT02220920|11817863|FG000|Overall Study|Lack of Efficacy|0
7497419|NCT02220920|11817864|FG001|Overall Study|Lack of Efficacy|1
7497420|NCT02220920|11817863|FG000|Overall Study|Withdrawal by Subject|1
7497421|NCT02220920|11817864|FG001|Overall Study|Withdrawal by Subject|0
7497422|NCT02220920|11817863|FG000|Overall Study|Conflict with the stopping criteria|1
7497423|NCT02220920|11817864|FG001|Overall Study|Conflict with the stopping criteria|2
7497424|NCT02220998|11817872|FG000|Overall Study|Randomized but Never Treated|1
7497425|NCT02220998|11817873|FG001|Overall Study|Randomized but Never Treated|2
7497426|NCT02220998|11817872|FG000|Overall Study|Death|2
7497427|NCT02220998|11817873|FG001|Overall Study|Death|0
7497428|NCT02220998|11817872|FG000|Overall Study|Lack of Efficacy|0
7497429|NCT02220998|11817873|FG001|Overall Study|Lack of Efficacy|5
7497430|NCT02220998|11817872|FG000|Overall Study|Lost to Follow-up|4
7497431|NCT02220998|11817873|FG001|Overall Study|Lost to Follow-up|4
7497432|NCT02221284|11817900|FG000|Overall Study|Case Report Forms Uncollected|56
7497433|NCT02221284|11817900|FG000|Overall Study|Protocol Deviation|5
7497434|NCT02221648|11817925|FG000|Overall Study|Withdrawal by Subject|3
7497435|NCT02221648|11817926|FG001|Overall Study|Withdrawal by Subject|3
7497436|NCT02221674|11817939|FG000|Overall Study|Lost to Follow-up|1
7497437|NCT02221674|11817940|FG001|Overall Study|Lost to Follow-up|0
7497438|NCT02221674|11817941|FG002|Overall Study|Lost to Follow-up|0
7497439|NCT02221882|11817973|FG000|Overall Study|Withdrawal by Subject|0
7497440|NCT02221882|11817974|FG001|Overall Study|Withdrawal by Subject|0
7497441|NCT02221882|11817975|FG002|Overall Study|Withdrawal by Subject|4
7497442|NCT02221882|11817976|FG003|Overall Study|Withdrawal by Subject|2
7497443|NCT02221882|11817977|FG004|Overall Study|Withdrawal by Subject|2
7497444|NCT02221882|11817978|FG005|Overall Study|Withdrawal by Subject|2
7497445|NCT02221882|11817973|FG000|Overall Study|Death|0
7497446|NCT02221882|11817974|FG001|Overall Study|Death|1
7497447|NCT02221882|11817975|FG002|Overall Study|Death|0
7497448|NCT02221882|11817976|FG003|Overall Study|Death|0
7497449|NCT02221882|11817977|FG004|Overall Study|Death|0
7497450|NCT02221882|11817978|FG005|Overall Study|Death|0
7497451|NCT02222207|11818022|FG000|Overall Study|Death|1
7497452|NCT02222207|11818022|FG000|Overall Study|Other reasons|2
7497453|NCT02222207|11818022|FG000|Overall Study|Adverse Event|1
7497454|NCT02222246|11818028|FG000|Overall Study|No Emergency Department Visits|27
7497455|NCT02222246|11818029|FG001|Overall Study|No Emergency Department Visits|26
7497456|NCT02222246|11818028|FG000|Overall Study|Physician Decision|0
7497457|NCT02222246|11818029|FG001|Overall Study|Physician Decision|1
7497458|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7497459|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
7497460|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
7497461|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
7497462|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
7497463|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
7497464|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
7497465|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
7497466|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
7497467|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
7497468|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
7497469|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
7497470|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
7497471|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
7497472|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
7497473|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
7497474|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
7497475|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
7497476|NCT02222493|11818052|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
7497477|NCT02222493|11818053|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
7497478|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
7497479|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
7497480|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
7497481|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
7497482|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
7497483|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
7497484|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
7497485|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
7497486|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
7497487|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
7497488|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7497489|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
7497490|NCT02222493|11818052|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
7497491|NCT02222493|11818053|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
7497492|NCT02222493|11818052|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
7497493|NCT02222493|11818053|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
7497494|NCT02222493|11818052|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
7497495|NCT02222493|11818053|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
7497496|NCT02222493|11818052|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
7497497|NCT02222493|11818053|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
7497498|NCT02222493|11818052|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
7497499|NCT02222493|11818053|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
7497500|NCT02222493|11818052|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
7497501|NCT02222493|11818053|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
7497502|NCT02222558|11818072|FG000|Period 1: Single Dose|Withdrawal by Subject|4
7497503|NCT02222558|11818073|FG001|Period 1: Single Dose|Withdrawal by Subject|0
7497504|NCT02222558|11818074|FG002|Period 1: Single Dose|Withdrawal by Subject|0
7497505|NCT02222558|11818075|FG003|Period 1: Single Dose|Withdrawal by Subject|0
7497506|NCT02222558|11818076|FG004|Period 1: Single Dose|Withdrawal by Subject|0
7497507|NCT02222558|11818077|FG005|Period 1: Single Dose|Withdrawal by Subject|0
7497508|NCT02222558|11818072|FG000|Period 3|Withdrawal by Subject|0
7497509|NCT02222558|11818073|FG001|Period 3|Withdrawal by Subject|0
7497510|NCT02222558|11818074|FG002|Period 3|Withdrawal by Subject|0
7497511|NCT02222558|11818075|FG003|Period 3|Withdrawal by Subject|0
7497512|NCT02222558|11818076|FG004|Period 3|Withdrawal by Subject|0
7497513|NCT02222558|11818077|FG005|Period 3|Withdrawal by Subject|1
7497514|NCT02222688|11818111|FG000|Overall Study|Withdrawal by Subject|0
7497515|NCT02222688|11818112|FG001|Overall Study|Withdrawal by Subject|0
7497516|NCT02222688|11818113|FG002|Overall Study|Withdrawal by Subject|0
7497517|NCT02222688|11818114|FG003|Overall Study|Withdrawal by Subject|2
7497518|NCT02222688|11818115|FG004|Overall Study|Withdrawal by Subject|1
7497519|NCT02222688|11818116|FG005|Overall Study|Withdrawal by Subject|0
7497520|NCT02222688|11818117|FG006|Overall Study|Withdrawal by Subject|1
7497521|NCT02222688|11818111|FG000|Overall Study|Disease progression|1
7497522|NCT02222688|11818112|FG001|Overall Study|Disease progression|0
7497523|NCT02222688|11818113|FG002|Overall Study|Disease progression|0
7497524|NCT02222688|11818114|FG003|Overall Study|Disease progression|0
7497525|NCT02222688|11818115|FG004|Overall Study|Disease progression|0
7497526|NCT02222688|11818116|FG005|Overall Study|Disease progression|0
7497527|NCT02222688|11818117|FG006|Overall Study|Disease progression|0
7497528|NCT02222714|11818140|FG000|Overall Study|Death|0
7497529|NCT02222714|11818141|FG001|Overall Study|Death|2
7497530|NCT02222714|11818142|FG002|Overall Study|Death|3
7497531|NCT02222714|11818143|FG003|Overall Study|Death|4
7497532|NCT02222714|11818144|FG004|Overall Study|Death|6
7497533|NCT02222714|11818140|FG000|Overall Study|Withdrawal by Subject|0
7497534|NCT02222714|11818141|FG001|Overall Study|Withdrawal by Subject|0
7497535|NCT02222714|11818142|FG002|Overall Study|Withdrawal by Subject|1
7497536|NCT02222714|11818143|FG003|Overall Study|Withdrawal by Subject|0
7497537|NCT02222714|11818144|FG004|Overall Study|Withdrawal by Subject|1
7497538|NCT02222818|11818161|FG000|Period 1|Eligibility criteria not met|0
7497539|NCT02222818|11818162|FG001|Period 1|Eligibility criteria not met|3
7497540|NCT02222896|11818176|FG000|Abdomen|Did not qualify|34
7497541|NCT02222896|11818177|FG001|Abdomen|Did not qualify|10
7497542|NCT02222896|11818178|FG002|Abdomen|Did not qualify|32
7497543|NCT02222896|11818176|FG000|Groin|Did not qualify|43
7497544|NCT02222896|11818177|FG001|Groin|Did not qualify|9
7497545|NCT02222896|11818178|FG002|Groin|Did not qualify|40
7497546|NCT02222922|11818198|FG000|Overall Study|Death|0
7497547|NCT02222922|11818199|FG001|Overall Study|Death|0
7497548|NCT02222922|11818200|FG002|Overall Study|Death|0
7497549|NCT02222922|11818201|FG003|Overall Study|Death|0
7497550|NCT02222922|11818202|FG004|Overall Study|Death|13
7497551|NCT02222922|11818203|FG005|Overall Study|Death|0
7497552|NCT02222922|11818204|FG006|Overall Study|Death|0
7497553|NCT02222922|11818205|FG007|Overall Study|Death|0
7497554|NCT02222922|11818206|FG008|Overall Study|Death|2
7497555|NCT02222922|11818198|FG000|Overall Study|Lost to Follow-up|0
7497556|NCT02222922|11818199|FG001|Overall Study|Lost to Follow-up|0
7497557|NCT02222922|11818200|FG002|Overall Study|Lost to Follow-up|1
7497558|NCT02222922|11818201|FG003|Overall Study|Lost to Follow-up|0
7497559|NCT02222922|11818202|FG004|Overall Study|Lost to Follow-up|9
7497560|NCT02222922|11818203|FG005|Overall Study|Lost to Follow-up|1
7497561|NCT02222922|11818204|FG006|Overall Study|Lost to Follow-up|0
7497562|NCT02222922|11818205|FG007|Overall Study|Lost to Follow-up|0
7497563|NCT02222922|11818206|FG008|Overall Study|Lost to Follow-up|0
7497564|NCT02222922|11818198|FG000|Overall Study|Other|0
7497565|NCT02222922|11818199|FG001|Overall Study|Other|0
7497566|NCT02222922|11818200|FG002|Overall Study|Other|0
7497567|NCT02222922|11818201|FG003|Overall Study|Other|2
7497568|NCT02222922|11818202|FG004|Overall Study|Other|10
7497569|NCT02222922|11818203|FG005|Overall Study|Other|2
7497570|NCT02222922|11818204|FG006|Overall Study|Other|2
7497571|NCT02222922|11818205|FG007|Overall Study|Other|4
7497572|NCT02222922|11818206|FG008|Overall Study|Other|1
7497573|NCT02222922|11818198|FG000|Overall Study|Participant refused further follow-up|1
7497574|NCT02222922|11818199|FG001|Overall Study|Participant refused further follow-up|0
7497575|NCT02222922|11818200|FG002|Overall Study|Participant refused further follow-up|0
7497576|NCT02222922|11818201|FG003|Overall Study|Participant refused further follow-up|1
7497577|NCT02222922|11818202|FG004|Overall Study|Participant refused further follow-up|6
7497578|NCT02222922|11818203|FG005|Overall Study|Participant refused further follow-up|0
7497579|NCT02222922|11818204|FG006|Overall Study|Participant refused further follow-up|0
7497580|NCT02222922|11818205|FG007|Overall Study|Participant refused further follow-up|0
7497581|NCT02222922|11818206|FG008|Overall Study|Participant refused further follow-up|3
7497582|NCT02223364|11818282|FG000|Overall Study|Protocol Violation|3
7497583|NCT02223364|11818283|FG001|Overall Study|Protocol Violation|0
7497584|NCT02223364|11818284|FG002|Overall Study|Protocol Violation|3
7497585|NCT02223364|11818282|FG000|Overall Study|subject expired before surgery|1
7497586|NCT02223364|11818283|FG001|Overall Study|subject expired before surgery|0
7497587|NCT02223364|11818284|FG002|Overall Study|subject expired before surgery|0
7497588|NCT02223364|11818282|FG000|Overall Study|Physician Decision|1
7497589|NCT02223364|11818283|FG001|Overall Study|Physician Decision|0
7497590|NCT02223364|11818284|FG002|Overall Study|Physician Decision|0
7497591|NCT02223390|11818294|FG000|Overall Study|Lost to Follow-up|9
7497592|NCT02223390|11818295|FG001|Overall Study|Lost to Follow-up|4
7497593|NCT02223715|11818370|FG000|Overall Study|Death|31
7497594|NCT02223715|11818370|FG000|Overall Study|Lost to Follow-up|73
7497595|NCT02223754|11818379|FG000|Period 1|Adverse Event|1
7497596|NCT02223754|11818380|FG001|Period 1|Adverse Event|0
7497597|NCT02223754|11818379|FG000|Period 1|Lost to Follow-up|0
7497598|NCT02223754|11818380|FG001|Period 1|Lost to Follow-up|1
7497599|NCT02223754|11818379|FG000|Period 1|Protocol Violation|2
7497600|NCT02223754|11818380|FG001|Period 1|Protocol Violation|4
7497601|NCT02223754|11818379|FG000|Period 1|Withdrawal by Subject|0
7497602|NCT02223754|11818380|FG001|Period 1|Withdrawal by Subject|4
7497603|NCT02223754|11818379|FG000|Period 1|Test Article No Longer Available|1
7497604|NCT02223754|11818380|FG001|Period 1|Test Article No Longer Available|5
7497605|NCT02223754|11818379|FG000|Period 1|Unsatisfactory Visual Response|0
7497606|NCT02223754|11818380|FG001|Period 1|Unsatisfactory Visual Response|1
7497607|NCT02223754|11818379|FG000|Period 2|Adverse Event|0
7497608|NCT02223754|11818380|FG001|Period 2|Adverse Event|1
7497609|NCT02223754|11818379|FG000|Period 2|Protocol Violation|1
7497610|NCT02223754|11818380|FG001|Period 2|Protocol Violation|0
7497611|NCT02223754|11818379|FG000|Period 2|Lens Discomfort|1
7497612|NCT02223754|11818380|FG001|Period 2|Lens Discomfort|1
7497613|NCT02223754|11818379|FG000|Period 2|Lost to Follow-up|1
7497614|NCT02223754|11818380|FG001|Period 2|Lost to Follow-up|0
7497615|NCT02223754|11818379|FG000|Period 2|Test Article No Longer Available|0
7497616|NCT02223754|11818380|FG001|Period 2|Test Article No Longer Available|1
7497617|NCT02223793|11818390|FG000|Overall Study|Lost to Follow-up|10
7497618|NCT02223793|11818391|FG001|Overall Study|Lost to Follow-up|1
7497619|NCT02223793|11818392|FG002|Overall Study|Lost to Follow-up|2
7497620|NCT02223793|11818390|FG000|Overall Study|Withdrawal by Subject|3
7497621|NCT02223793|11818391|FG001|Overall Study|Withdrawal by Subject|2
7497622|NCT02223793|11818392|FG002|Overall Study|Withdrawal by Subject|3
7497623|NCT02223793|11818390|FG000|Overall Study|Moved/studycenter unable to participate|4
7497624|NCT02223793|11818391|FG001|Overall Study|Moved/studycenter unable to participate|6
7497625|NCT02223793|11818392|FG002|Overall Study|Moved/studycenter unable to participate|8
7535422|NCT02709889|11883097|FG001|Overall Study|Death|38
7535423|NCT02709889|11883098|FG002|Overall Study|Death|4
7535424|NCT02709889|11883099|FG003|Overall Study|Death|44
7535425|NCT02709889|11883096|FG000|Overall Study|Physician Decision|1
7535426|NCT02709889|11883097|FG001|Overall Study|Physician Decision|2
7535427|NCT02709889|11883098|FG002|Overall Study|Physician Decision|3
7535428|NCT02709889|11883099|FG003|Overall Study|Physician Decision|5
7535429|NCT02709889|11883096|FG000|Overall Study|Lost to Follow-up|2
7535430|NCT02709889|11883097|FG001|Overall Study|Lost to Follow-up|0
7535431|NCT02709889|11883098|FG002|Overall Study|Lost to Follow-up|0
7535432|NCT02709889|11883099|FG003|Overall Study|Lost to Follow-up|4
7535433|NCT02709889|11883096|FG000|Overall Study|Study Terminated by Sponsor|4
7535434|NCT02709889|11883097|FG001|Overall Study|Study Terminated by Sponsor|6
7535435|NCT02709889|11883098|FG002|Overall Study|Study Terminated by Sponsor|2
7535436|NCT02709889|11883099|FG003|Overall Study|Study Terminated by Sponsor|17
7535437|NCT02709889|11883096|FG000|Overall Study|Other, Not Specified|0
7535438|NCT02709889|11883097|FG001|Overall Study|Other, Not Specified|1
7535439|NCT02709889|11883098|FG002|Overall Study|Other, Not Specified|1
7535440|NCT02709889|11883099|FG003|Overall Study|Other, Not Specified|6
7535441|NCT02710045|11883147|FG000|Overall Study|Death|1
7535442|NCT02710045|11883148|FG001|Overall Study|Death|2
7535443|NCT02710045|11883149|FG002|Overall Study|Death|0
7535444|NCT02710045|11883147|FG000|Overall Study|Withdrawal by Subject|6
7535445|NCT02710045|11883148|FG001|Overall Study|Withdrawal by Subject|6
7535446|NCT02710045|11883149|FG002|Overall Study|Withdrawal by Subject|2
7535447|NCT02710045|11883147|FG000|Overall Study|Protocol Violation|1
7535448|NCT02710045|11883148|FG001|Overall Study|Protocol Violation|2
7535449|NCT02710045|11883149|FG002|Overall Study|Protocol Violation|3
7535450|NCT02710045|11883147|FG000|Overall Study|Lost to Follow-up|3
7535451|NCT02710045|11883148|FG001|Overall Study|Lost to Follow-up|6
7535452|NCT02710045|11883149|FG002|Overall Study|Lost to Follow-up|7
7535453|NCT02710045|11883147|FG000|Overall Study|Physician Decision|0
7535454|NCT02710045|11883148|FG001|Overall Study|Physician Decision|0
7535455|NCT02710045|11883149|FG002|Overall Study|Physician Decision|1
7535456|NCT02710045|11883147|FG000|Overall Study|Poor Attendance|0
7535457|NCT02710045|11883148|FG001|Overall Study|Poor Attendance|1
7535458|NCT02710045|11883149|FG002|Overall Study|Poor Attendance|0
7535459|NCT02710071|11883159|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
7535460|NCT02710071|11883160|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
7535461|NCT02710071|11883159|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
7535462|NCT02710071|11883160|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
7535463|NCT02710136|11883169|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
7535464|NCT02710136|11883170|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
7535465|NCT02710214|11883179|FG000|Overall Study|Lost to Follow-up|1
7497626|NCT02223858|11818402|FG000|Overall Study|Death|1
7497627|NCT02223858|11818403|FG001|Overall Study|Death|1
7497628|NCT02223858|11818402|FG000|Overall Study|Lost to Follow-up|6
7497629|NCT02223858|11818403|FG001|Overall Study|Lost to Follow-up|11
7497630|NCT02223858|11818402|FG000|Overall Study|Withdrawal by Subject|8
7497631|NCT02223858|11818403|FG001|Overall Study|Withdrawal by Subject|5
7497632|NCT02223858|11818402|FG000|Overall Study|Refused|9
7497633|NCT02223858|11818403|FG001|Overall Study|Refused|9
7497634|NCT02224053|11818413|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
7497635|NCT02224053|11818413|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
7497636|NCT02224053|11818413|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
7497637|NCT02224053|11818413|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
7497638|NCT02224053|11818413|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
7497639|NCT02224157|11818421|FG000|Overall Study|Severe non-compliance to protocol|2
7497640|NCT02224157|11818422|FG001|Overall Study|Severe non-compliance to protocol|2
7497641|NCT02224157|11818421|FG000|Overall Study|Other|13
7497642|NCT02224157|11818422|FG001|Overall Study|Other|10
7497643|NCT02224157|11818421|FG000|Overall Study|Subject decision|58
7497644|NCT02224157|11818422|FG001|Overall Study|Subject decision|50
7497645|NCT02224157|11818421|FG000|Overall Study|Prematurely closed site|4
7497646|NCT02224157|11818422|FG001|Overall Study|Prematurely closed site|2
7497647|NCT02224157|11818421|FG000|Overall Study|Eligibility criteria not fulfilled|4
7497648|NCT02224157|11818422|FG001|Overall Study|Eligibility criteria not fulfilled|8
7497649|NCT02224157|11818421|FG000|Overall Study|Lost to Follow-up|27
7497650|NCT02224157|11818422|FG001|Overall Study|Lost to Follow-up|35
7497651|NCT02224157|11818421|FG000|Overall Study|Death|1
7497652|NCT02224157|11818422|FG001|Overall Study|Death|1
7497653|NCT02224157|11818421|FG000|Overall Study|Adverse Event|1
7497654|NCT02224157|11818422|FG001|Overall Study|Adverse Event|3
7497655|NCT02224274|11818430|FG000|Overall Study|Death|1
7497656|NCT02224274|11818431|FG001|Overall Study|Death|0
7497672|NCT02224625|11818491|FG000|Irritation|Adverse Event|6
7497673|NCT02224625|11818491|FG000|Sensitization|Adverse Event|55
7497674|NCT02224638|11818505|FG000|Overall Study|Adverse Event|1
7497675|NCT02224638|11818506|FG001|Overall Study|Adverse Event|1
7497676|NCT02224664|11818514|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
7497677|NCT02224664|11818515|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7497678|NCT02224664|11818516|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7497679|NCT02224664|11818517|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7497680|NCT02224664|11818518|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
7497681|NCT02224664|11818514|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
7497682|NCT02224664|11818515|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
7497683|NCT02224664|11818516|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
7497684|NCT02224664|11818517|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
7497685|NCT02224664|11818518|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
7497686|NCT02224664|11818514|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7497687|NCT02224664|11818515|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7497688|NCT02224664|11818516|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
7497689|NCT02224664|11818517|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
7497690|NCT02224664|11818518|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
7497714|NCT02224846|11818567|FG000|Period 1 (Month 3)|Adverse Event|2
7497715|NCT02224846|11818568|FG001|Period 1 (Month 3)|Adverse Event|1
7497716|NCT02224846|11818567|FG000|Period 1 (Month 3)|Lost to Follow-up|3
7497717|NCT02224846|11818568|FG001|Period 1 (Month 3)|Lost to Follow-up|8
7497718|NCT02224846|11818567|FG000|Period 1 (Month 3)|Protocol Violation|4
7497719|NCT02224846|11818568|FG001|Period 1 (Month 3)|Protocol Violation|8
7497720|NCT02224846|11818567|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
7497721|NCT02224846|11818568|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
7497722|NCT02224846|11818567|FG000|Period 1 (Month 3)|Sponsor Decision|2
7497723|NCT02224846|11818568|FG001|Period 1 (Month 3)|Sponsor Decision|1
7497724|NCT02224846|11818567|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
7497725|NCT02224846|11818568|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
7497726|NCT02224846|11818567|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
7497727|NCT02224846|11818568|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
7497728|NCT02224846|11818567|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
7497729|NCT02224846|11818568|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
7497730|NCT02224846|11818567|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
7497731|NCT02224846|11818568|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
7497732|NCT02224846|11818567|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
7497733|NCT02224846|11818568|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
7497734|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
7497735|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
7497736|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Death|1
7497737|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Death|0
7497738|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
7497739|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
7497740|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
7497741|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
7497742|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
7497743|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
7497744|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
7497745|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
7497746|NCT02224846|11818567|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
7497747|NCT02224846|11818568|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
7497748|NCT02225223|11818588|FG000|Overall Study|Death|10
7497749|NCT02225223|11818589|FG001|Overall Study|Death|1
7497750|NCT02225223|11818588|FG000|Overall Study|Lost to Follow-up|5
7497751|NCT02225223|11818589|FG001|Overall Study|Lost to Follow-up|0
7497752|NCT02225223|11818588|FG000|Overall Study|Other|1
7497753|NCT02225223|11818589|FG001|Overall Study|Other|2
7497754|NCT02225223|11818588|FG000|Overall Study|Physician Decision|1
7497755|NCT02225223|11818589|FG001|Overall Study|Physician Decision|0
7497756|NCT02225223|11818588|FG000|Overall Study|Withdrawal by Subject|2
7497757|NCT02225223|11818589|FG001|Overall Study|Withdrawal by Subject|2
7497758|NCT02225353|11818598|FG000|Overall Study|Lost to Follow-up|0
7497759|NCT02225353|11818599|FG001|Overall Study|Lost to Follow-up|1
7497760|NCT02225353|11818600|FG002|Overall Study|Lost to Follow-up|3
7497761|NCT02225353|11818598|FG000|Overall Study|Protocol Violation|4
7497762|NCT02225353|11818599|FG001|Overall Study|Protocol Violation|5
7497763|NCT02225353|11818600|FG002|Overall Study|Protocol Violation|12
7497764|NCT02225587|11818613|FG000|Overall Study|Adverse Event|5
7497765|NCT02225587|11818614|FG001|Overall Study|Adverse Event|5
7497766|NCT02225587|11818613|FG000|Overall Study|Lost to Follow-up|5
7497767|NCT02225587|11818614|FG001|Overall Study|Lost to Follow-up|5
7497768|NCT02225587|11818613|FG000|Overall Study|Non-Compliance With Study Drug|1
7497769|NCT02225587|11818614|FG001|Overall Study|Non-Compliance With Study Drug|0
7497770|NCT02225587|11818613|FG000|Overall Study|Physician Decision|2
7497771|NCT02225587|11818614|FG001|Overall Study|Physician Decision|0
7497772|NCT02225587|11818613|FG000|Overall Study|Protocol Violation|1
7497773|NCT02225587|11818614|FG001|Overall Study|Protocol Violation|0
7497774|NCT02225587|11818613|FG000|Overall Study|Participant Moved|1
7497775|NCT02225587|11818614|FG001|Overall Study|Participant Moved|0
7497776|NCT02225587|11818613|FG000|Overall Study|Withdrawal by Subject|13
7497777|NCT02225587|11818614|FG001|Overall Study|Withdrawal by Subject|28
7497778|NCT02225665|11818622|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
7497779|NCT02225665|11818623|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
7497780|NCT02225665|11818622|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
7497781|NCT02225665|11818623|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
7497782|NCT02225743|11818629|FG000|Overall Study|Withdrawal by Subject|18
7497783|NCT02226003|11818650|FG000|Overall Study|Lost to Follow-up|2
7497784|NCT02226003|11818651|FG001|Overall Study|Lost to Follow-up|1
7497785|NCT02226003|11818652|FG002|Overall Study|Lost to Follow-up|3
7497786|NCT02226003|11818650|FG000|Overall Study|Withdrawal by Subject|0
7497787|NCT02226003|11818651|FG001|Overall Study|Withdrawal by Subject|0
7497788|NCT02226003|11818652|FG002|Overall Study|Withdrawal by Subject|3
7497789|NCT02226120|11818660|FG000|Overall Study|Adverse Event|60
7497790|NCT02226120|11818660|FG000|Overall Study|Death|172
7497791|NCT02226120|11818660|FG000|Overall Study|Study terminated by sponsor|1
7497792|NCT02226120|11818660|FG000|Overall Study|Technical problems|4
7497793|NCT02226120|11818660|FG000|Overall Study|Lost to Follow-up|13
7497794|NCT02226120|11818660|FG000|Overall Study|Physician Decision|21
7497795|NCT02226120|11818660|FG000|Overall Study|Withdrawal by parent/guardian|36
7497796|NCT02226120|11818660|FG000|Overall Study|Non-compliance with study drug|10
7497797|NCT02226120|11818660|FG000|Overall Study|Protocol deviation|1
7497798|NCT02226120|11818660|FG000|Overall Study|missing treatment disposition pages|2
7497799|NCT02226172|11818673|FG000|Overall Study|Participant refused further follow-up|4
7497800|NCT02226172|11818673|FG000|Overall Study|Other|5
7497801|NCT02226172|11818673|FG000|Overall Study|Death|1
7497802|NCT02226172|11818673|FG000|Overall Study|Study terminated by sponsor|1
7497803|NCT02226172|11818673|FG000|Overall Study|Adverse Event|6
7497804|NCT02226198|11818677|FG000|Lead-in Phase|Protocol Violation|1
7497805|NCT02226198|11818678|FG001|Lead-in Phase|Protocol Violation|0
7497806|NCT02226198|11818679|FG002|Lead-in Phase|Protocol Violation|0
7497807|NCT02226198|11818677|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7497808|NCT02226198|11818678|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
7497809|NCT02226198|11818679|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
7497810|NCT02226549|11818707|FG000|Overall Study|Randomized but Never Treated|1
7497811|NCT02226549|11818708|FG001|Overall Study|Randomized but Never Treated|0
7497812|NCT02226549|11818707|FG000|Overall Study|Lost to Follow-up|0
7497813|NCT02226549|11818708|FG001|Overall Study|Lost to Follow-up|1
7497814|NCT02226562|11818716|FG000|Overall Study|Lost to Follow-up|0
7497815|NCT02226562|11818717|FG001|Overall Study|Lost to Follow-up|1
7497816|NCT02226653|11818725|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
7497817|NCT02226653|11818726|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
7497818|NCT02226653|11818725|FG000|Treatment Period 5 Fed State|Adverse Event|0
7497819|NCT02226653|11818726|FG001|Treatment Period 5 Fed State|Adverse Event|1
7497820|NCT02227108|11818750|FG000|Overall Study|Did not receive treatment|2
7497821|NCT02227108|11818750|FG000|Overall Study|Other|3
7497822|NCT02227108|11818750|FG000|Overall Study|Progressive disease|17
7497823|NCT02227108|11818750|FG000|Overall Study|Initiation of alternative therapy|2
7497824|NCT02227108|11818750|FG000|Overall Study|Investigator discretion|1
7497825|NCT02227108|11818750|FG000|Overall Study|Adverse Event|6
7497826|NCT02227368|11818786|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
7497827|NCT02227368|11818787|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
7497828|NCT02227368|11818786|FG000|Overall Study|Lost to Follow-up|1
7497829|NCT02227368|11818787|FG001|Overall Study|Lost to Follow-up|0
7497830|NCT02227368|11818786|FG000|Overall Study|Adverse Event|1
7497831|NCT02227368|11818787|FG001|Overall Study|Adverse Event|0
7497832|NCT02227446|11818795|FG000|Overall Study|not eligible post randomization|18
7497833|NCT02227446|11818796|FG001|Overall Study|not eligible post randomization|29
7497834|NCT02227446|11818795|FG000|Overall Study|Withdrawal by Subject|4
7497835|NCT02227446|11818796|FG001|Overall Study|Withdrawal by Subject|5
7497836|NCT02227784|11818856|FG000|Double-Blind Phase|Adverse Event|3
7497837|NCT02227784|11818857|FG001|Double-Blind Phase|Adverse Event|2
7497838|NCT02227784|11818858|FG002|Double-Blind Phase|Adverse Event|1
7497839|NCT02227784|11818859|FG003|Double-Blind Phase|Adverse Event|3
7497840|NCT02227784|11818860|FG004|Double-Blind Phase|Adverse Event|0
7497841|NCT02227784|11818856|FG000|Double-Blind Phase|Physician Decision|1
7497842|NCT02227784|11818857|FG001|Double-Blind Phase|Physician Decision|0
7497843|NCT02227784|11818858|FG002|Double-Blind Phase|Physician Decision|0
7497844|NCT02227784|11818859|FG003|Double-Blind Phase|Physician Decision|1
7497845|NCT02227784|11818860|FG004|Double-Blind Phase|Physician Decision|0
7497846|NCT02227784|11818856|FG000|Double-Blind Phase|Protocol Violation|0
7497847|NCT02227784|11818857|FG001|Double-Blind Phase|Protocol Violation|0
7497848|NCT02227784|11818858|FG002|Double-Blind Phase|Protocol Violation|1
7497849|NCT02227784|11818859|FG003|Double-Blind Phase|Protocol Violation|1
7497850|NCT02227784|11818860|FG004|Double-Blind Phase|Protocol Violation|0
7497851|NCT02227784|11818856|FG000|Double-Blind Phase|Sponsor Decision|34
7497852|NCT02227784|11818857|FG001|Double-Blind Phase|Sponsor Decision|15
7497853|NCT02227784|11818858|FG002|Double-Blind Phase|Sponsor Decision|14
7497854|NCT02227784|11818859|FG003|Double-Blind Phase|Sponsor Decision|32
7497855|NCT02227784|11818860|FG004|Double-Blind Phase|Sponsor Decision|0
7497856|NCT02227784|11818856|FG000|Double-Blind Phase|Withdrawal by Subject|2
7497857|NCT02227784|11818857|FG001|Double-Blind Phase|Withdrawal by Subject|1
7497858|NCT02227784|11818858|FG002|Double-Blind Phase|Withdrawal by Subject|5
7497859|NCT02227784|11818859|FG003|Double-Blind Phase|Withdrawal by Subject|2
7497860|NCT02227784|11818860|FG004|Double-Blind Phase|Withdrawal by Subject|0
7497861|NCT02227784|11818856|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
7497862|NCT02227784|11818857|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
7497863|NCT02227784|11818858|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
7497864|NCT02227784|11818859|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
7497865|NCT02227784|11818860|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
7497866|NCT02227784|11818856|FG000|Open-Label Extension Phase (OLE)|Death|0
7497867|NCT02227784|11818857|FG001|Open-Label Extension Phase (OLE)|Death|0
7497868|NCT02227784|11818858|FG002|Open-Label Extension Phase (OLE)|Death|0
7497869|NCT02227784|11818859|FG003|Open-Label Extension Phase (OLE)|Death|0
7497870|NCT02227784|11818860|FG004|Open-Label Extension Phase (OLE)|Death|1
7497871|NCT02227784|11818856|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7497872|NCT02227784|11818857|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7497873|NCT02227784|11818858|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7497874|NCT02227784|11818859|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7497875|NCT02227784|11818860|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
7497876|NCT02227784|11818856|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7497877|NCT02227784|11818857|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7497878|NCT02227784|11818858|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7497879|NCT02227784|11818859|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
7497880|NCT02227784|11818860|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
7497881|NCT02227849|11818888|FG000|Overall Study|Adverse Event|4
7497882|NCT02227849|11818888|FG000|Overall Study|Physician Decision|1
7497883|NCT02227849|11818888|FG000|Overall Study|Withdrawal by Subject|3
7497884|NCT02228096|11818894|FG000|Overall Study|Study terminated by Sponsor|24
7497885|NCT02228096|11818894|FG000|Overall Study|Lack of Efficacy|18
7497886|NCT02228096|11818894|FG000|Overall Study|Death|12
7497887|NCT02228096|11818894|FG000|Overall Study|Physician Decision|3
7497888|NCT02228096|11818894|FG000|Overall Study|Subject/guardian decision|2
7497889|NCT02228096|11818894|FG000|Overall Study|New therapy for study indication|1
7497890|NCT02228096|11818894|FG000|Overall Study|Enrolled, not infused|11
7497891|NCT02228395|11818916|FG000|First Intervention Period|No longer willing to participate|1
7497892|NCT02228395|11818917|FG001|First Intervention Period|No longer willing to participate|0
7497893|NCT02228395|11818918|FG002|First Intervention Period|No longer willing to participate|0
7497894|NCT02228395|11818916|FG000|First Intervention Period|Unable to comply with study dates|0
7497895|NCT02228395|11818917|FG001|First Intervention Period|Unable to comply with study dates|1
7497896|NCT02228395|11818918|FG002|First Intervention Period|Unable to comply with study dates|1
7497897|NCT02228460|11818937|FG000|Overall Study|Adverse Event|1
7497898|NCT02228460|11818937|FG000|Overall Study|Lost to Follow-up|1
7497899|NCT02228564|11818951|FG000|Overall Study|Withdrawal by Subject|10
7497900|NCT02228564|11818951|FG000|Overall Study|Death|11
7497901|NCT02228564|11818951|FG000|Overall Study|Physician Decision|5
7497902|NCT02228564|11818951|FG000|Overall Study|Lost to Follow-up|17
7497903|NCT02228564|11818951|FG000|Overall Study|Other|6
7497904|NCT02228590|11818955|FG000|Overall Study|Withdrawal by Subject|1
7497905|NCT02228720|11818969|FG000|Open Label - Day 30|Lost to Follow-up|1
7497906|NCT02228967|11818984|FG000|Overall Study|Lost to Follow-up|146
7497907|NCT02228967|11818985|FG001|Overall Study|Lost to Follow-up|142
7497908|NCT02228967|11818984|FG000|Overall Study|Withdrawal by Subject|13
7497909|NCT02228967|11818985|FG001|Overall Study|Withdrawal by Subject|18
7497910|NCT02228980|11818995|FG000|Overall Study|Adverse Event|14
7497911|NCT02228980|11818996|FG001|Overall Study|Adverse Event|0
7497912|NCT02228980|11818997|FG002|Overall Study|Adverse Event|0
7497913|NCT02228980|11818998|FG003|Overall Study|Adverse Event|0
7497914|NCT02228980|11818995|FG000|Overall Study|Protocol Violation|7
7497915|NCT02228980|11818996|FG001|Overall Study|Protocol Violation|0
7497916|NCT02228980|11818997|FG002|Overall Study|Protocol Violation|0
7497917|NCT02228980|11818998|FG003|Overall Study|Protocol Violation|0
7497918|NCT02228980|11818995|FG000|Overall Study|Withdrawal by Subject|3
7497919|NCT02228980|11818996|FG001|Overall Study|Withdrawal by Subject|3
7497920|NCT02228980|11818997|FG002|Overall Study|Withdrawal by Subject|2
7497921|NCT02228980|11818998|FG003|Overall Study|Withdrawal by Subject|3
7497922|NCT02229214|11819014|FG000|Overall Study|Adverse Event|2
7497923|NCT02229214|11819015|FG001|Overall Study|Adverse Event|0
7497924|NCT02229214|11819014|FG000|Overall Study|Withdrawal by Subject|4
7497925|NCT02229214|11819015|FG001|Overall Study|Withdrawal by Subject|0
7497926|NCT02229227|11819025|FG000|Overall Study|Adverse Event|14
7497927|NCT02229227|11819026|FG001|Overall Study|Adverse Event|9
7497928|NCT02229227|11819025|FG000|Overall Study|Lack of Efficacy|3
7497929|NCT02229227|11819026|FG001|Overall Study|Lack of Efficacy|3
7497930|NCT02229227|11819025|FG000|Overall Study|Protocol Violation|6
7497931|NCT02229227|11819026|FG001|Overall Study|Protocol Violation|8
7497932|NCT02229227|11819025|FG000|Overall Study|Protocol defined stopping criteria|1
7497933|NCT02229227|11819026|FG001|Overall Study|Protocol defined stopping criteria|3
7497934|NCT02229227|11819025|FG000|Overall Study|Lost to Follow-up|3
7497935|NCT02229227|11819026|FG001|Overall Study|Lost to Follow-up|3
7497936|NCT02229227|11819025|FG000|Overall Study|Study terminated by sponsor|11
7497937|NCT02229227|11819026|FG001|Overall Study|Study terminated by sponsor|11
7497938|NCT02229227|11819025|FG000|Overall Study|Withdrawal by Subject|8
7497939|NCT02229227|11819026|FG001|Overall Study|Withdrawal by Subject|12
7497940|NCT02229227|11819025|FG000|Overall Study|Other|0
7497941|NCT02229227|11819026|FG001|Overall Study|Other|1
7497942|NCT02229227|11819025|FG000|Overall Study|Physician Decision|5
7497943|NCT02229227|11819026|FG001|Overall Study|Physician Decision|12
7497944|NCT02229383|11819039|FG000|Overall Study|Adverse Event|7
7497945|NCT02229383|11819040|FG001|Overall Study|Adverse Event|4
7497946|NCT02229383|11819039|FG000|Overall Study|Death|0
7497947|NCT02229383|11819040|FG001|Overall Study|Death|1
7497948|NCT02229383|11819039|FG000|Overall Study|Lost to Follow-up|5
7497949|NCT02229383|11819040|FG001|Overall Study|Lost to Follow-up|3
7497950|NCT02229383|11819039|FG000|Overall Study|Withdrawal by Subject|4
7497951|NCT02229383|11819040|FG001|Overall Study|Withdrawal by Subject|6
7497952|NCT02229383|11819039|FG000|Overall Study|Did not receive treatment|1
7497953|NCT02229383|11819040|FG001|Overall Study|Did not receive treatment|0
7497954|NCT02229383|11819039|FG000|Overall Study|Other|3
7497955|NCT02229383|11819040|FG001|Overall Study|Other|8
7497956|NCT02229396|11819049|FG000|Overall Study|Adverse Event|6
7497957|NCT02229396|11819050|FG001|Overall Study|Adverse Event|12
7497958|NCT02229396|11819051|FG002|Overall Study|Adverse Event|12
7497959|NCT02229396|11819049|FG000|Overall Study|Death|2
7497960|NCT02229396|11819050|FG001|Overall Study|Death|3
7497961|NCT02229396|11819051|FG002|Overall Study|Death|1
7497962|NCT02229396|11819049|FG000|Overall Study|Lost to Follow-up|14
7497963|NCT02229396|11819050|FG001|Overall Study|Lost to Follow-up|14
7497964|NCT02229396|11819051|FG002|Overall Study|Lost to Follow-up|21
7497965|NCT02229396|11819049|FG000|Overall Study|Protocol Violation|2
7497966|NCT02229396|11819050|FG001|Overall Study|Protocol Violation|1
7497967|NCT02229396|11819051|FG002|Overall Study|Protocol Violation|0
7497968|NCT02229396|11819049|FG000|Overall Study|Patient Incorrectly Randomized|0
7497969|NCT02229396|11819050|FG001|Overall Study|Patient Incorrectly Randomized|0
7497970|NCT02229396|11819051|FG002|Overall Study|Patient Incorrectly Randomized|1
7497971|NCT02229396|11819049|FG000|Overall Study|Other|10
7497972|NCT02229396|11819050|FG001|Overall Study|Other|18
7497973|NCT02229396|11819051|FG002|Overall Study|Other|15
7497974|NCT02229396|11819049|FG000|Overall Study|Withdrawal by Subject|42
7497975|NCT02229396|11819050|FG001|Overall Study|Withdrawal by Subject|28
7497976|NCT02229396|11819051|FG002|Overall Study|Withdrawal by Subject|41
7497977|NCT02229396|11819049|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7497978|NCT02229396|11819050|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7497979|NCT02229396|11819051|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
7497980|NCT02229396|11819049|FG000|Overall Study|Withdrew; No Record on Termination Page|2
7497981|NCT02229396|11819050|FG001|Overall Study|Withdrew; No Record on Termination Page|0
7497982|NCT02229396|11819051|FG002|Overall Study|Withdrew; No Record on Termination Page|1
7497983|NCT02229539|11819117|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7497984|NCT02229539|11819118|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
7497985|NCT02229539|11819119|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
7497986|NCT02229539|11819117|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7497987|NCT02229539|11819118|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
7497988|NCT02229539|11819119|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
7497989|NCT02229539|11819117|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7497990|NCT02229539|11819118|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
7497991|NCT02229539|11819119|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
7497992|NCT02229539|11819117|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
7497993|NCT02229539|11819118|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
7497994|NCT02229539|11819119|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
7497995|NCT02229539|11819117|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7497996|NCT02229539|11819118|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
7497997|NCT02229539|11819119|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
7497998|NCT02229539|11819117|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
7497999|NCT02229539|11819118|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7498000|NCT02229539|11819119|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
7498001|NCT02229539|11819117|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
7498002|NCT02229539|11819118|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7498003|NCT02229539|11819119|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
7498004|NCT02229539|11819117|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7498005|NCT02229539|11819118|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
7498006|NCT02229539|11819119|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
7498007|NCT02229539|11819117|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
7498008|NCT02229539|11819118|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
7498009|NCT02229539|11819119|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
7498010|NCT02229552|11819127|FG000|Baseline|Withdrawal by Subject|6
7498011|NCT02229552|11819127|FG000|1-year Follow up|Withdrawal by Subject|7
7498012|NCT02229552|11819127|FG000|1-year Follow up|Lost to Follow-up|18
7498013|NCT02229552|11819127|FG000|2-Year Follow up|Withdrawal by Subject|9
7498014|NCT02229552|11819127|FG000|2-Year Follow up|Lost to Follow-up|17
7498015|NCT02229851|11819134|FG000|Main Phase (Double-blind Phase)|Unclassified|1
7498016|NCT02229851|11819135|FG001|Main Phase (Double-blind Phase)|Unclassified|2
7498017|NCT02229851|11819136|FG002|Main Phase (Double-blind Phase)|Unclassified|0
7498018|NCT02229851|11819137|FG003|Main Phase (Double-blind Phase)|Unclassified|0
7498019|NCT02229851|11819138|FG004|Main Phase (Double-blind Phase)|Unclassified|0
7498020|NCT02229851|11819139|FG005|Main Phase (Double-blind Phase)|Unclassified|0
7498021|NCT02229851|11819140|FG006|Main Phase (Double-blind Phase)|Unclassified|0
7498022|NCT02229851|11819134|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498023|NCT02229851|11819135|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
7498024|NCT02229851|11819136|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498025|NCT02229851|11819137|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498026|NCT02229851|11819138|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498027|NCT02229851|11819139|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498028|NCT02229851|11819140|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
7498029|NCT02229851|11819134|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7498030|NCT02229851|11819135|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
7498031|NCT02229851|11819136|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
7498032|NCT02229851|11819137|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7498033|NCT02229851|11819138|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7498034|NCT02229851|11819139|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7498035|NCT02229851|11819140|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
7498036|NCT02229851|11819134|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
7498037|NCT02229851|11819135|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
7498038|NCT02229851|11819136|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
7498039|NCT02229851|11819137|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
7498040|NCT02229851|11819138|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
7498041|NCT02229851|11819139|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
7498042|NCT02229851|11819140|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
7498043|NCT02229851|11819134|FG000|Main Phase (Double-blind Phase)|Death|1
7498044|NCT02229851|11819135|FG001|Main Phase (Double-blind Phase)|Death|1
7498045|NCT02229851|11819136|FG002|Main Phase (Double-blind Phase)|Death|0
7498046|NCT02229851|11819137|FG003|Main Phase (Double-blind Phase)|Death|0
7498047|NCT02229851|11819138|FG004|Main Phase (Double-blind Phase)|Death|0
7498048|NCT02229851|11819139|FG005|Main Phase (Double-blind Phase)|Death|0
7498049|NCT02229851|11819140|FG006|Main Phase (Double-blind Phase)|Death|0
7498050|NCT02229851|11819134|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7498051|NCT02229851|11819135|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7498052|NCT02229851|11819136|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7498053|NCT02229851|11819137|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
7498054|NCT02229851|11819138|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7498055|NCT02229851|11819139|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7498056|NCT02229851|11819140|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
7498057|NCT02229851|11819134|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7498058|NCT02229851|11819135|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7498059|NCT02229851|11819136|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
7535466|NCT02710214|11883180|FG001|Overall Study|Lost to Follow-up|0
7498060|NCT02229851|11819137|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7498061|NCT02229851|11819138|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
7498062|NCT02229851|11819139|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
7498063|NCT02229851|11819140|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
7498064|NCT02229851|11819134|FG000|Extension Phase (Open-label Phase)|Death|0
7498065|NCT02229851|11819135|FG001|Extension Phase (Open-label Phase)|Death|0
7498066|NCT02229851|11819136|FG002|Extension Phase (Open-label Phase)|Death|0
7498067|NCT02229851|11819137|FG003|Extension Phase (Open-label Phase)|Death|1
7498068|NCT02229851|11819138|FG004|Extension Phase (Open-label Phase)|Death|0
7498069|NCT02229851|11819139|FG005|Extension Phase (Open-label Phase)|Death|1
7498070|NCT02229851|11819140|FG006|Extension Phase (Open-label Phase)|Death|1
7498071|NCT02229864|11819155|FG000|Overall Study|Death|2
7498072|NCT02229864|11819155|FG000|Overall Study|Lost to Follow-up|1
7498073|NCT02230085|11819159|FG000|Overall Study|Physician Decision|1
7498074|NCT02230085|11819159|FG000|Overall Study|Withdrawal by Subject|3
7498075|NCT02230306|11819163|FG000|Overall Study|Did not receive study treatment|1
7498076|NCT02230332|11819169|FG000|Overall Study|Adverse Event|2
7498077|NCT02230332|11819170|FG001|Overall Study|Adverse Event|1
7498078|NCT02230332|11819169|FG000|Overall Study|Lost to Follow-up|1
7498079|NCT02230332|11819170|FG001|Overall Study|Lost to Follow-up|0
7498080|NCT02230332|11819169|FG000|Overall Study|Protocol Violation|1
7498081|NCT02230332|11819170|FG001|Overall Study|Protocol Violation|0
7498082|NCT02230384|11819178|FG000|Phase 1|Lost to Follow-up|1
7498083|NCT02230384|11819179|FG001|Phase 1|Lost to Follow-up|0
7498084|NCT02230384|11819178|FG000|Phase 1|Physician Decision|0
7498085|NCT02230384|11819179|FG001|Phase 1|Physician Decision|1
7498086|NCT02230384|11819178|FG000|Phase 2 - Switch|Withdrawal by Subject|0
7498087|NCT02230384|11819179|FG001|Phase 2 - Switch|Withdrawal by Subject|1
7498088|NCT02230384|11819178|FG000|Phase 2 - Switch|Lost to Follow-up|1
7498089|NCT02230384|11819179|FG001|Phase 2 - Switch|Lost to Follow-up|0
7498090|NCT02230384|11819178|FG000|Phase 2 - Switch|Adverse Event|2
7498091|NCT02230384|11819179|FG001|Phase 2 - Switch|Adverse Event|0
7498092|NCT02230527|11819195|FG000|Overall Study|Withdrawal by Subject|1
7498093|NCT02230527|11819196|FG001|Overall Study|Withdrawal by Subject|1
7498094|NCT02230527|11819195|FG000|Overall Study|Death|1
7498095|NCT02230527|11819196|FG001|Overall Study|Death|0
7498096|NCT02230527|11819195|FG000|Overall Study|Lost to Follow-up|2
7498097|NCT02230527|11819196|FG001|Overall Study|Lost to Follow-up|1
7498098|NCT02230527|11819195|FG000|Overall Study|Other|1
7498099|NCT02230527|11819196|FG001|Overall Study|Other|0
7498100|NCT02230670|11819250|FG000|Overall Study|Adverse Event|1
7498101|NCT02230670|11819251|FG001|Overall Study|Adverse Event|2
7498102|NCT02230670|11819250|FG000|Overall Study|Withdrawal by Subject|2
7498103|NCT02230670|11819251|FG001|Overall Study|Withdrawal by Subject|2
7498104|NCT02230670|11819250|FG000|Overall Study|Physician Decision|0
7498105|NCT02230670|11819251|FG001|Overall Study|Physician Decision|1
7498106|NCT02230670|11819250|FG000|Overall Study|Protocol Violation|0
7498107|NCT02230670|11819251|FG001|Overall Study|Protocol Violation|1
7498108|NCT02230670|11819250|FG000|Overall Study|Progression to Child-Pugh C|1
7498109|NCT02230670|11819251|FG001|Overall Study|Progression to Child-Pugh C|2
7498110|NCT02230683|11819257|FG000|Overall Study|Adverse Event|1
7498111|NCT02230904|11819291|FG000|Overall Study|Safety follow up could not take place|0
7498112|NCT02230904|11819292|FG001|Overall Study|Safety follow up could not take place|1
7498113|NCT02230956|11819303|FG000|Overall Study|Adverse Event|1
7498114|NCT02230956|11819304|FG001|Overall Study|Adverse Event|1
7498115|NCT02230956|11819305|FG002|Overall Study|Adverse Event|0
7498116|NCT02230956|11819303|FG000|Overall Study|Lack of Efficacy|1
7498117|NCT02230956|11819304|FG001|Overall Study|Lack of Efficacy|1
7498118|NCT02230956|11819305|FG002|Overall Study|Lack of Efficacy|1
7498119|NCT02230956|11819303|FG000|Overall Study|Lost to Follow-up|1
7498120|NCT02230956|11819304|FG001|Overall Study|Lost to Follow-up|1
7498121|NCT02230956|11819305|FG002|Overall Study|Lost to Follow-up|2
7498122|NCT02230956|11819303|FG000|Overall Study|Personal Reasons|2
7498123|NCT02230956|11819304|FG001|Overall Study|Personal Reasons|1
7498124|NCT02230956|11819305|FG002|Overall Study|Personal Reasons|1
7498125|NCT02230956|11819303|FG000|Overall Study|Protocol Violation|0
7498126|NCT02230956|11819304|FG001|Overall Study|Protocol Violation|1
7498127|NCT02230956|11819305|FG002|Overall Study|Protocol Violation|1
7498128|NCT02230956|11819303|FG000|Overall Study|Other Miscellaneous Reason|0
7498129|NCT02230956|11819304|FG001|Overall Study|Other Miscellaneous Reason|1
7498130|NCT02230956|11819305|FG002|Overall Study|Other Miscellaneous Reason|2
7498131|NCT02231164|11819333|FG000|Overall Study|Adverse Event|1
7498132|NCT02231164|11819334|FG001|Overall Study|Adverse Event|1
7498133|NCT02231164|11819333|FG000|Overall Study|Lack of Efficacy|4
7498134|NCT02231164|11819334|FG001|Overall Study|Lack of Efficacy|3
7498135|NCT02231164|11819333|FG000|Overall Study|Withdrawal by Subject|1
7498136|NCT02231164|11819334|FG001|Overall Study|Withdrawal by Subject|2
7498137|NCT02231580|11819356|FG000|Overall Study|Adverse Event|5
7498138|NCT02231580|11819357|FG001|Overall Study|Adverse Event|0
7498139|NCT02231918|11819368|FG000|Overall Study|Withdrawal by Subject|0
7498140|NCT02231918|11819369|FG001|Overall Study|Withdrawal by Subject|1
7498141|NCT02231918|11819370|FG002|Overall Study|Withdrawal by Subject|0
7498142|NCT02231918|11819368|FG000|Overall Study|Adverse Event|0
7498143|NCT02231918|11819369|FG001|Overall Study|Adverse Event|0
7498144|NCT02231918|11819370|FG002|Overall Study|Adverse Event|1
7535467|NCT02710214|11883179|FG000|Overall Study|Lack of Efficacy|0
7535468|NCT02710214|11883180|FG001|Overall Study|Lack of Efficacy|1
7535469|NCT02710214|11883179|FG000|Overall Study|Death|0
7535470|NCT02710214|11883180|FG001|Overall Study|Death|1
7535471|NCT02710292|11883190|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
7535472|NCT02710292|11883191|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
7535473|NCT02710292|11883190|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
7535474|NCT02710292|11883191|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
7535475|NCT02710422|11883200|FG000|Overall Study|Termination of study|9
7535476|NCT02710422|11883201|FG001|Overall Study|Termination of study|9
7535477|NCT02711306|11883292|FG000|Overall Study|Withdrawal by Subject|2
7535478|NCT02711306|11883293|FG001|Overall Study|Withdrawal by Subject|2
7535479|NCT02711345|11883309|FG000|Overall Study|Adverse Event|0
7535480|NCT02711345|11883310|FG001|Overall Study|Adverse Event|0
7535481|NCT02711345|11883311|FG002|Overall Study|Adverse Event|0
7535482|NCT02711345|11883312|FG003|Overall Study|Adverse Event|1
7535483|NCT02711345|11883313|FG004|Overall Study|Adverse Event|1
7535484|NCT02711345|11883314|FG005|Overall Study|Adverse Event|2
7535485|NCT02711345|11883315|FG006|Overall Study|Adverse Event|1
7535486|NCT02711345|11883316|FG007|Overall Study|Adverse Event|0
7535487|NCT02711345|11883317|FG008|Overall Study|Adverse Event|0
7535488|NCT02711345|11883318|FG009|Overall Study|Adverse Event|2
7535489|NCT02711345|11883309|FG000|Overall Study|Physician Decision|0
7535490|NCT02711345|11883310|FG001|Overall Study|Physician Decision|0
7535491|NCT02711345|11883311|FG002|Overall Study|Physician Decision|1
7535492|NCT02711345|11883312|FG003|Overall Study|Physician Decision|0
7535493|NCT02711345|11883313|FG004|Overall Study|Physician Decision|0
7535494|NCT02711345|11883314|FG005|Overall Study|Physician Decision|0
7535495|NCT02711345|11883315|FG006|Overall Study|Physician Decision|0
7535496|NCT02711345|11883316|FG007|Overall Study|Physician Decision|0
7535497|NCT02711345|11883317|FG008|Overall Study|Physician Decision|1
7535498|NCT02711345|11883318|FG009|Overall Study|Physician Decision|0
7535499|NCT02711345|11883309|FG000|Overall Study|Progressive disease|1
7535500|NCT02711345|11883310|FG001|Overall Study|Progressive disease|3
7535501|NCT02711345|11883311|FG002|Overall Study|Progressive disease|5
7535502|NCT02711345|11883312|FG003|Overall Study|Progressive disease|3
7535503|NCT02711345|11883313|FG004|Overall Study|Progressive disease|7
7535504|NCT02711345|11883314|FG005|Overall Study|Progressive disease|2
7535505|NCT02711345|11883315|FG006|Overall Study|Progressive disease|8
7535506|NCT02711345|11883316|FG007|Overall Study|Progressive disease|4
7535507|NCT02711345|11883317|FG008|Overall Study|Progressive disease|5
7535508|NCT02711345|11883318|FG009|Overall Study|Progressive disease|6
7535509|NCT02711345|11883309|FG000|Overall Study|Subject/guardian decision|0
7498145|NCT02232061|11819388|FG000|Overall Study|Administrative problems|1
7498146|NCT02232061|11819388|FG000|Overall Study|Withdrawal by Subject|1
7498147|NCT02232074|11819394|FG000|Overall Study|Withdrawal by Subject|5
7498148|NCT02232074|11819395|FG001|Overall Study|Withdrawal by Subject|3
7498149|NCT02232074|11819394|FG000|Overall Study|No legal concerns at baseline|36
7498150|NCT02232074|11819395|FG001|Overall Study|No legal concerns at baseline|41
7498151|NCT02232074|11819394|FG000|Overall Study|deemed ineligible|0
7498152|NCT02232074|11819395|FG001|Overall Study|deemed ineligible|1
7498153|NCT02232178|11819421|FG000|Overall Study|Lost to Follow-up|0
7498154|NCT02232178|11819422|FG001|Overall Study|Lost to Follow-up|1
7498155|NCT02232178|11819423|FG002|Overall Study|Lost to Follow-up|0
7498156|NCT02232178|11819421|FG000|Overall Study|ineligibility|0
7498157|NCT02232178|11819422|FG001|Overall Study|ineligibility|0
7498158|NCT02232178|11819423|FG002|Overall Study|ineligibility|1
7498159|NCT02232178|11819421|FG000|Overall Study|surgical complication|1
7498160|NCT02232178|11819422|FG001|Overall Study|surgical complication|0
7498161|NCT02232178|11819423|FG002|Overall Study|surgical complication|0
7498162|NCT02232243|11819434|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7498163|NCT02232243|11819435|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
7498164|NCT02232243|11819436|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
7498165|NCT02232425|11819447|FG000|Overall Study|Lost to Follow-up|6
7498166|NCT02232425|11819448|FG001|Overall Study|Lost to Follow-up|2
7498167|NCT02232425|11819447|FG000|Overall Study|Adverse Event|2
7498168|NCT02232425|11819448|FG001|Overall Study|Adverse Event|0
7498169|NCT02232425|11819447|FG000|Overall Study|Withdrawal by Subject|5
7498170|NCT02232425|11819448|FG001|Overall Study|Withdrawal by Subject|6
7498171|NCT02232425|11819447|FG000|Overall Study|Lack of Efficacy|1
7498172|NCT02232425|11819448|FG001|Overall Study|Lack of Efficacy|0
7498173|NCT02232698|11819456|FG000|Overall Study|Pregnancy|1
7498174|NCT02232698|11819457|FG001|Overall Study|Pregnancy|1
7498175|NCT02232698|11819456|FG000|Overall Study|Met exclusion criteria|1
7498176|NCT02232698|11819457|FG001|Overall Study|Met exclusion criteria|1
7498177|NCT02232698|11819456|FG000|Overall Study|Had device-associated symptoms|7
7498178|NCT02232698|11819457|FG001|Overall Study|Had device-associated symptoms|0
7498179|NCT02232698|11819456|FG000|Overall Study|Non-compliance with study device|1
7498180|NCT02232698|11819457|FG001|Overall Study|Non-compliance with study device|4
7498181|NCT02232698|11819456|FG000|Overall Study|Allocated to control group|0
7498182|NCT02232698|11819457|FG001|Overall Study|Allocated to control group|3
7498183|NCT02232698|11819456|FG000|Overall Study|Withdrawal by Subject|0
7498184|NCT02232698|11819457|FG001|Overall Study|Withdrawal by Subject|11
7498185|NCT02232802|11819465|FG000|Period 1|Sponsor request|1
7498186|NCT02232802|11819466|FG001|Period 1|Sponsor request|0
7498187|NCT02232802|11819465|FG000|Period 1|Adverse Event|1
7498188|NCT02232802|11819466|FG001|Period 1|Adverse Event|1
7498189|NCT02232893|11819474|FG000|Overall Study|Withdrawal by Subject|4
7498190|NCT02232893|11819475|FG001|Overall Study|Withdrawal by Subject|1
7498191|NCT02232893|11819474|FG000|Overall Study|Adverse Event|0
7498192|NCT02232893|11819475|FG001|Overall Study|Adverse Event|1
7498193|NCT02232893|11819474|FG000|Overall Study|Sponsor request early termination|0
7498194|NCT02232893|11819475|FG001|Overall Study|Sponsor request early termination|1
7498195|NCT02232893|11819474|FG000|Overall Study|Developed exclusion criteria|0
7498196|NCT02232893|11819475|FG001|Overall Study|Developed exclusion criteria|1
7498197|NCT02232893|11819474|FG000|Overall Study|Other|0
7498198|NCT02232893|11819475|FG001|Overall Study|Other|3
7498199|NCT02232984|11819481|FG000|Overall Study|Withdrawal by Subject|5
7498200|NCT02232984|11819481|FG000|Overall Study|Death|1
7498201|NCT02232984|11819481|FG000|Overall Study|Investigator withdrawal|10
7498202|NCT02232984|11819481|FG000|Overall Study|Device implant unsuccessful|53
7498203|NCT02232984|11819481|FG000|Overall Study|not disclosed by site|7
7498204|NCT02232984|11819481|FG000|Overall Study|Protocol Violation|1
7498205|NCT02233309|11819510|FG000|Overall Study|Physician Decision|5
7498206|NCT02233413|11819516|FG000|Overall Study|Lost to Follow-up|7
7498207|NCT02233413|11819517|FG001|Overall Study|Lost to Follow-up|9
7498208|NCT02233413|11819516|FG000|Overall Study|Withdrawal by Subject|4
7498209|NCT02233413|11819517|FG001|Overall Study|Withdrawal by Subject|5
7498210|NCT02233543|11819549|FG000|Period 1|Withdrawal by Subject|1
7498211|NCT02233543|11819550|FG001|Period 1|Withdrawal by Subject|0
7498212|NCT02233543|11819549|FG000|Period 1|Participants required other treatment.|2
7498213|NCT02233543|11819550|FG001|Period 1|Participants required other treatment.|3
7498214|NCT02233543|11819549|FG000|Period 2|Adverse Event|1
7498215|NCT02233543|11819550|FG001|Period 2|Adverse Event|0
7498216|NCT02233543|11819549|FG000|Period 2|Participant required other treatment.|0
7498217|NCT02233543|11819550|FG001|Period 2|Participant required other treatment.|1
7498218|NCT02233543|11819549|FG000|Period 2|COPD exacerbation|1
7498219|NCT02233543|11819550|FG001|Period 2|COPD exacerbation|0
7498220|NCT02233647|11819556|FG000|Overall Study|Adverse Event|1
7498221|NCT02233738|11819562|FG000|Overall Study|Lost to Follow-up|5
7498222|NCT02233738|11819563|FG001|Overall Study|Lost to Follow-up|12
7498223|NCT02233738|11819562|FG000|Overall Study|Death|0
7498224|NCT02233738|11819563|FG001|Overall Study|Death|1
7498225|NCT02233738|11819562|FG000|Overall Study|Withdrawal by Subject|0
7498226|NCT02233738|11819563|FG001|Overall Study|Withdrawal by Subject|1
7498227|NCT02233738|11819562|FG000|Overall Study|Did not return after Baseline|3
7535510|NCT02711345|11883310|FG001|Overall Study|Subject/guardian decision|0
7498228|NCT02233738|11819563|FG001|Overall Study|Did not return after Baseline|2
7498229|NCT02233803|11819740|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
7498230|NCT02233803|11819741|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
7498231|NCT02233803|11819740|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
7498232|NCT02233803|11819741|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
7498233|NCT02233803|11819740|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
7498234|NCT02233803|11819741|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
7498235|NCT02233803|11819740|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
7498236|NCT02233803|11819741|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
7498237|NCT02233803|11819740|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
7498238|NCT02233803|11819741|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
7498239|NCT02233803|11819740|FG000|Washout Period (4-Wks)|Physician Decision|1
7498240|NCT02233803|11819741|FG001|Washout Period (4-Wks)|Physician Decision|0
7498241|NCT02233803|11819740|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
7498242|NCT02233803|11819741|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
7498243|NCT02233803|11819740|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
7498244|NCT02233803|11819741|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
7498245|NCT02233803|11819740|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
7498246|NCT02233803|11819741|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
7498247|NCT02233946|11819756|FG000|Baseline|Withdrawal by Subject|2
7498248|NCT02233946|11819757|FG001|Baseline|Withdrawal by Subject|0
7498249|NCT02233946|11819756|FG000|3-months Follow-up|Lost to Follow-up|53
7498250|NCT02233946|11819757|FG001|3-months Follow-up|Lost to Follow-up|29
7498251|NCT02233946|11819756|FG000|6-months Follow-up|Lost to Follow-up|21
7498252|NCT02233946|11819757|FG001|6-months Follow-up|Lost to Follow-up|2
7498253|NCT02233946|11819756|FG000|9-month Follow-up|Lost to Follow-up|20
7498254|NCT02233946|11819757|FG001|9-month Follow-up|Lost to Follow-up|11
7498255|NCT02233946|11819756|FG000|12-month Follow-up|Lost to Follow-up|28
7498256|NCT02233946|11819757|FG001|12-month Follow-up|Lost to Follow-up|11
7498257|NCT02234063|11819789|FG000|Overall Study|Lost to Follow-up|235
7498258|NCT02234063|11819790|FG001|Overall Study|Lost to Follow-up|42
7498259|NCT02234063|11819789|FG000|Overall Study|Withdrawal by Subject|20
7498260|NCT02234063|11819790|FG001|Overall Study|Withdrawal by Subject|1
7498261|NCT02234141|11819822|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
7498262|NCT02234141|11819823|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
7498263|NCT02234141|11819824|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
7498264|NCT02234141|11819825|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
7498265|NCT02234141|11819826|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
7498344|NCT02234583|11819909|FG000|Overall Study|Withdrawal by Subject|109
7498266|NCT02234141|11819827|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
7498267|NCT02234141|11819828|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
7498268|NCT02234141|11819822|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
7498269|NCT02234141|11819823|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
7498270|NCT02234141|11819824|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
7498271|NCT02234141|11819825|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
7498272|NCT02234141|11819826|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
7498273|NCT02234141|11819827|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
7498274|NCT02234141|11819828|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
7498275|NCT02234141|11819822|FG000|Treatment Period (24 Weeks)|Death|1
7498276|NCT02234141|11819823|FG001|Treatment Period (24 Weeks)|Death|2
7498277|NCT02234141|11819824|FG002|Treatment Period (24 Weeks)|Death|0
7498278|NCT02234141|11819825|FG003|Treatment Period (24 Weeks)|Death|1
7498279|NCT02234141|11819826|FG004|Treatment Period (24 Weeks)|Death|0
7498280|NCT02234141|11819827|FG005|Treatment Period (24 Weeks)|Death|0
7498281|NCT02234141|11819828|FG006|Treatment Period (24 Weeks)|Death|0
7498282|NCT02234141|11819822|FG000|Treatment Period (24 Weeks)|Adverse Event|3
7498283|NCT02234141|11819823|FG001|Treatment Period (24 Weeks)|Adverse Event|1
7498284|NCT02234141|11819824|FG002|Treatment Period (24 Weeks)|Adverse Event|2
7498285|NCT02234141|11819825|FG003|Treatment Period (24 Weeks)|Adverse Event|3
7498286|NCT02234141|11819826|FG004|Treatment Period (24 Weeks)|Adverse Event|0
7498287|NCT02234141|11819827|FG005|Treatment Period (24 Weeks)|Adverse Event|0
7498288|NCT02234141|11819828|FG006|Treatment Period (24 Weeks)|Adverse Event|0
7498289|NCT02234141|11819822|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
7498290|NCT02234141|11819823|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
7498291|NCT02234141|11819824|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
7498292|NCT02234141|11819825|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
7498293|NCT02234141|11819826|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
7498294|NCT02234141|11819827|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
7498295|NCT02234141|11819828|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
7498296|NCT02234141|11819822|FG000|Long-Term Treatment Period|Death|0
7498297|NCT02234141|11819823|FG001|Long-Term Treatment Period|Death|0
7498298|NCT02234141|11819824|FG002|Long-Term Treatment Period|Death|0
7498299|NCT02234141|11819825|FG003|Long-Term Treatment Period|Death|0
7498300|NCT02234141|11819826|FG004|Long-Term Treatment Period|Death|0
7498301|NCT02234141|11819827|FG005|Long-Term Treatment Period|Death|1
7498302|NCT02234141|11819828|FG006|Long-Term Treatment Period|Death|0
7498303|NCT02234141|11819822|FG000|Long-Term Treatment Period|Investigator's discretion|1
7498304|NCT02234141|11819823|FG001|Long-Term Treatment Period|Investigator's discretion|3
7498305|NCT02234141|11819824|FG002|Long-Term Treatment Period|Investigator's discretion|2
7498306|NCT02234141|11819825|FG003|Long-Term Treatment Period|Investigator's discretion|0
7498307|NCT02234141|11819826|FG004|Long-Term Treatment Period|Investigator's discretion|0
7498308|NCT02234141|11819827|FG005|Long-Term Treatment Period|Investigator's discretion|0
7498309|NCT02234141|11819828|FG006|Long-Term Treatment Period|Investigator's discretion|1
7498310|NCT02234141|11819822|FG000|Long-Term Treatment Period|Adverse Event|4
7498311|NCT02234141|11819823|FG001|Long-Term Treatment Period|Adverse Event|0
7498312|NCT02234141|11819824|FG002|Long-Term Treatment Period|Adverse Event|5
7498313|NCT02234141|11819825|FG003|Long-Term Treatment Period|Adverse Event|0
7498314|NCT02234141|11819826|FG004|Long-Term Treatment Period|Adverse Event|1
7498315|NCT02234141|11819827|FG005|Long-Term Treatment Period|Adverse Event|1
7498316|NCT02234141|11819828|FG006|Long-Term Treatment Period|Adverse Event|1
7498317|NCT02234141|11819822|FG000|Long-Term Treatment Period|Withdrew Consent|0
7498318|NCT02234141|11819823|FG001|Long-Term Treatment Period|Withdrew Consent|1
7498319|NCT02234141|11819824|FG002|Long-Term Treatment Period|Withdrew Consent|1
7498320|NCT02234141|11819825|FG003|Long-Term Treatment Period|Withdrew Consent|0
7498321|NCT02234141|11819826|FG004|Long-Term Treatment Period|Withdrew Consent|0
7498322|NCT02234141|11819827|FG005|Long-Term Treatment Period|Withdrew Consent|0
7498323|NCT02234141|11819828|FG006|Long-Term Treatment Period|Withdrew Consent|0
7498324|NCT02234141|11819822|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
7498325|NCT02234141|11819823|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
7498326|NCT02234141|11819824|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
7498327|NCT02234141|11819825|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
7498328|NCT02234141|11819826|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
7498329|NCT02234141|11819827|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
7498330|NCT02234141|11819828|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
7498331|NCT02234284|11819846|FG000|Overall Study|Death|4
7498332|NCT02234284|11819847|FG001|Overall Study|Death|2
7498333|NCT02234284|11819846|FG000|Overall Study|Withdrawal by Subject|1
7498334|NCT02234284|11819847|FG001|Overall Study|Withdrawal by Subject|0
7498335|NCT02234284|11819846|FG000|Overall Study|Lost to Follow-up|20
7498336|NCT02234284|11819847|FG001|Overall Study|Lost to Follow-up|7
7498337|NCT02234362|11819857|FG000|Overall Study|Not eligible after first screening visit|17
7498338|NCT02234362|11819857|FG000|Overall Study|Lost to Follow-up|6
7498339|NCT02234362|11819857|FG000|Overall Study|Withdrawal by Subject|3
7498340|NCT02234479|11819867|FG000|Overall Study|Withdrawal by Subject|1
7498341|NCT02234479|11819868|FG001|Overall Study|Withdrawal by Subject|3
7498342|NCT02234583|11819909|FG000|Overall Study|Adverse Event|172
7498343|NCT02234583|11819910|FG001|Overall Study|Adverse Event|156
7498345|NCT02234583|11819910|FG001|Overall Study|Withdrawal by Subject|157
7498346|NCT02234583|11819909|FG000|Overall Study|Lost to Follow-up|0
7498347|NCT02234583|11819910|FG001|Overall Study|Lost to Follow-up|1
7498348|NCT02234583|11819909|FG000|Overall Study|Lack of Efficacy|58
7498349|NCT02234583|11819910|FG001|Overall Study|Lack of Efficacy|103
7498350|NCT02234583|11819909|FG000|Overall Study|Protocol Violation|35
7498351|NCT02234583|11819910|FG001|Overall Study|Protocol Violation|42
7498352|NCT02234583|11819909|FG000|Overall Study|Other|39
7498353|NCT02234583|11819910|FG001|Overall Study|Other|97
7498354|NCT02234596|11819922|FG000|Overall Study|Participant not treated|2
7498355|NCT02234622|11819928|FG000|Overall Study|Withdrawal by Subject|16
7498356|NCT02234622|11819929|FG001|Overall Study|Withdrawal by Subject|22
7498357|NCT02234622|11819928|FG000|Overall Study|Lost to Follow-up|27
7498358|NCT02234622|11819929|FG001|Overall Study|Lost to Follow-up|14
7498359|NCT02235077|11819965|FG000|Overall Study|Death|5
7498360|NCT02235077|11819966|FG001|Overall Study|Death|7
7498361|NCT02235077|11819965|FG000|Overall Study|Lost to Follow-up|5
7498362|NCT02235077|11819966|FG001|Overall Study|Lost to Follow-up|6
7498363|NCT02235077|11819965|FG000|Overall Study|Withdrawal by Subject|8
7498364|NCT02235077|11819966|FG001|Overall Study|Withdrawal by Subject|5
7498365|NCT02235077|11819965|FG000|Overall Study|Physician Decision|0
7498366|NCT02235077|11819966|FG001|Overall Study|Physician Decision|1
7498367|NCT02235298|11819978|FG000|Overall Study|Lost to Follow-up|6
7498368|NCT02235298|11819979|FG001|Overall Study|Lost to Follow-up|5
7498369|NCT02235298|11819978|FG000|Overall Study|Adverse Event|2
7498370|NCT02235298|11819979|FG001|Overall Study|Adverse Event|2
7498371|NCT02235298|11819978|FG000|Overall Study|Withdrawal by Subject|0
7498372|NCT02235298|11819979|FG001|Overall Study|Withdrawal by Subject|1
7498373|NCT02235311|11819987|FG000|Overall Study|Lost to Follow-up|0
7498374|NCT02235311|11819988|FG001|Overall Study|Lost to Follow-up|1
7498375|NCT02235311|11819987|FG000|Overall Study|Protocol Violation|0
7498376|NCT02235311|11819988|FG001|Overall Study|Protocol Violation|1
7498377|NCT02235454|11819994|FG000|Overall Study|Withdrawal by Subject|2
7498378|NCT02236130|11820039|FG000|Overall Study|Lost to Follow-up|7
7498379|NCT02236130|11820040|FG001|Overall Study|Lost to Follow-up|12
7498380|NCT02236520|11820059|FG000|Overall Study|Physician Decision|0
7498381|NCT02236520|11820060|FG001|Overall Study|Physician Decision|5
7498382|NCT02236520|11820061|FG002|Overall Study|Physician Decision|0
7498383|NCT02236520|11820062|FG003|Overall Study|Physician Decision|0
7498384|NCT02236520|11820059|FG000|Overall Study|Withdrawal by Subject|1
7498385|NCT02236520|11820060|FG001|Overall Study|Withdrawal by Subject|0
7498386|NCT02236520|11820061|FG002|Overall Study|Withdrawal by Subject|0
7498387|NCT02236520|11820062|FG003|Overall Study|Withdrawal by Subject|1
7498388|NCT02236520|11820059|FG000|Overall Study|Pregnancy|1
7498389|NCT02236520|11820060|FG001|Overall Study|Pregnancy|0
7498390|NCT02236520|11820061|FG002|Overall Study|Pregnancy|0
7498391|NCT02236520|11820062|FG003|Overall Study|Pregnancy|0
7498392|NCT02236559|11820074|FG000|Overall Study|Met Exclusion|3
7498393|NCT02236559|11820075|FG001|Overall Study|Met Exclusion|6
7498394|NCT02236559|11820074|FG000|Overall Study|Did not Meet Inclusion|3
7498395|NCT02236559|11820075|FG001|Overall Study|Did not Meet Inclusion|3
7498396|NCT02236559|11820074|FG000|Overall Study|Subject Did Not Consent|4
7498397|NCT02236559|11820075|FG001|Overall Study|Subject Did Not Consent|2
7498398|NCT02236559|11820074|FG000|Overall Study|Physician Decision|1
7498399|NCT02236559|11820075|FG001|Overall Study|Physician Decision|1
7498400|NCT02236559|11820074|FG000|Overall Study|Withdrawal by Subject|1
7498401|NCT02236559|11820075|FG001|Overall Study|Withdrawal by Subject|0
7498402|NCT02236598|11820083|FG000|Overall Study|Adverse Event|0
7498403|NCT02236598|11820084|FG001|Overall Study|Adverse Event|1
7498404|NCT02236598|11820083|FG000|Overall Study|Withdrawal by Subject|0
7498405|NCT02236598|11820084|FG001|Overall Study|Withdrawal by Subject|1
7498406|NCT02236611|11820092|FG000|Overall Study|Adverse Event|10
7498407|NCT02236611|11820093|FG001|Overall Study|Adverse Event|16
7498408|NCT02236611|11820092|FG000|Overall Study|Lack of Efficacy|4
7498409|NCT02236611|11820093|FG001|Overall Study|Lack of Efficacy|7
7498410|NCT02236611|11820092|FG000|Overall Study|Lost to Follow-up|0
7498411|NCT02236611|11820093|FG001|Overall Study|Lost to Follow-up|2
7498412|NCT02236611|11820092|FG000|Overall Study|Protocol deviation|3
7498413|NCT02236611|11820093|FG001|Overall Study|Protocol deviation|5
7498414|NCT02236611|11820092|FG000|Overall Study|Withdrew consent|9
7498415|NCT02236611|11820093|FG001|Overall Study|Withdrew consent|4
7498416|NCT02236988|11820107|FG000|Overall Study|Lost to Follow-up|0
7498417|NCT02236988|11820108|FG001|Overall Study|Lost to Follow-up|0
7498418|NCT02236988|11820109|FG002|Overall Study|Lost to Follow-up|0
7498419|NCT02236988|11820110|FG003|Overall Study|Lost to Follow-up|1
7498420|NCT02236988|11820107|FG000|Overall Study|Unable to Comply with Study Visits|0
7498421|NCT02236988|11820108|FG001|Overall Study|Unable to Comply with Study Visits|0
7498422|NCT02236988|11820109|FG002|Overall Study|Unable to Comply with Study Visits|0
7498423|NCT02236988|11820110|FG003|Overall Study|Unable to Comply with Study Visits|2
7498424|NCT02237001|11820161|FG000|Overall Study|Lost to Follow-up|2
7498425|NCT02237001|11820161|FG000|Overall Study|Withdrawal by Subject|1
7498426|NCT02237001|11820161|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
7498427|NCT02237001|11820161|FG000|Overall Study|Re-operation|4
7498428|NCT02237001|11820161|FG000|Overall Study|Incarceration|1
7498429|NCT02237118|11820182|FG000|Overall Study|Protocol Violation|0
7498430|NCT02237118|11820183|FG001|Overall Study|Protocol Violation|1
7498431|NCT02237118|11820182|FG000|Overall Study|consent withdrawn|1
7498432|NCT02237118|11820183|FG001|Overall Study|consent withdrawn|0
7498433|NCT02237157|11820197|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
7498434|NCT02237157|11820198|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7498435|NCT02237157|11820199|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7498436|NCT02237157|11820200|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
7498437|NCT02237157|11820197|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
7498438|NCT02237157|11820198|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7498439|NCT02237157|11820199|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7498440|NCT02237157|11820200|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
7498441|NCT02237196|11820211|FG000|Overall Study|Adverse Event|0
7498442|NCT02237196|11820212|FG001|Overall Study|Adverse Event|1
7498443|NCT02237196|11820213|FG002|Overall Study|Adverse Event|1
7498444|NCT02237196|11820214|FG003|Overall Study|Adverse Event|0
7498445|NCT02237196|11820211|FG000|Overall Study|Lost to Follow-up|4
7498446|NCT02237196|11820212|FG001|Overall Study|Lost to Follow-up|2
7498447|NCT02237196|11820213|FG002|Overall Study|Lost to Follow-up|4
7498448|NCT02237196|11820214|FG003|Overall Study|Lost to Follow-up|6
7498449|NCT02237196|11820211|FG000|Overall Study|Physician Decision|2
7498450|NCT02237196|11820212|FG001|Overall Study|Physician Decision|0
7498451|NCT02237196|11820213|FG002|Overall Study|Physician Decision|0
7498452|NCT02237196|11820214|FG003|Overall Study|Physician Decision|1
7498453|NCT02237196|11820211|FG000|Overall Study|Pregnancy|0
7498454|NCT02237196|11820212|FG001|Overall Study|Pregnancy|0
7498455|NCT02237196|11820213|FG002|Overall Study|Pregnancy|1
7498456|NCT02237196|11820214|FG003|Overall Study|Pregnancy|1
7498457|NCT02237196|11820211|FG000|Overall Study|Withdrawal by Subject|1
7498458|NCT02237196|11820212|FG001|Overall Study|Withdrawal by Subject|1
7498459|NCT02237196|11820213|FG002|Overall Study|Withdrawal by Subject|4
7498460|NCT02237196|11820214|FG003|Overall Study|Withdrawal by Subject|1
7498461|NCT02237196|11820211|FG000|Overall Study|Site Error|1
7498462|NCT02237196|11820212|FG001|Overall Study|Site Error|2
7498463|NCT02237196|11820213|FG002|Overall Study|Site Error|0
7498464|NCT02237196|11820214|FG003|Overall Study|Site Error|2
7498465|NCT02237911|11820251|FG000|Overall Study|Withdrawal by Subject|4
7498466|NCT02237911|11820252|FG001|Overall Study|Withdrawal by Subject|7
7498467|NCT02237911|11820253|FG002|Overall Study|Withdrawal by Subject|2
7498468|NCT02237911|11820251|FG000|Overall Study|Lost to Follow-up|3
7498469|NCT02237911|11820252|FG001|Overall Study|Lost to Follow-up|1
7498470|NCT02237911|11820253|FG002|Overall Study|Lost to Follow-up|1
7498471|NCT02238067|11820291|FG000|Overall Study|Not completed survey at Month 6|45
7498472|NCT02238080|11820295|FG000|Overall Study|Death|13
7498473|NCT02238080|11820295|FG000|Overall Study|Treatment interrupted|6
7498474|NCT02238080|11820295|FG000|Overall Study|Withdrawal by Subject|2
7498475|NCT02238080|11820295|FG000|Overall Study|Other|4
7498476|NCT02238379|11820301|FG000|Overall Study|Lost to Follow-up|1
7498477|NCT02238379|11820302|FG001|Overall Study|Lost to Follow-up|0
7498478|NCT02238483|11820310|FG000|Overall Study|Withdrawal by Subject|2
7498479|NCT02238483|11820311|FG001|Overall Study|Withdrawal by Subject|7
7498480|NCT02238483|11820310|FG000|Overall Study|Lost to Follow-up|1
7498481|NCT02238483|11820311|FG001|Overall Study|Lost to Follow-up|1
7498482|NCT02238483|11820310|FG000|Overall Study|Protocol Violation|1
7498483|NCT02238483|11820311|FG001|Overall Study|Protocol Violation|2
7498484|NCT02238483|11820310|FG000|Overall Study|Death|1
7498485|NCT02238483|11820311|FG001|Overall Study|Death|0
7498486|NCT02238483|11820310|FG000|Overall Study|Adverse Event|7
7498487|NCT02238483|11820311|FG001|Overall Study|Adverse Event|3
7498488|NCT02238483|11820310|FG000|Overall Study|Withdrawn due to physician decision|1
7498489|NCT02238483|11820311|FG001|Overall Study|Withdrawn due to physician decision|0
7498490|NCT02238483|11820310|FG000|Overall Study|Completion status not recorded|1
7498491|NCT02238483|11820311|FG001|Overall Study|Completion status not recorded|1
7498492|NCT02238483|11820310|FG000|Overall Study|Illness in family member|1
7498493|NCT02238483|11820311|FG001|Overall Study|Illness in family member|0
7498494|NCT02238626|11820321|FG000|Overall Study|Adverse Event|3
7498495|NCT02238626|11820322|FG001|Overall Study|Adverse Event|5
7498496|NCT02238626|11820323|FG002|Overall Study|Adverse Event|0
7498497|NCT02238626|11820324|FG003|Overall Study|Adverse Event|3
7498498|NCT02238626|11820321|FG000|Overall Study|Lost to Follow-up|2
7498499|NCT02238626|11820322|FG001|Overall Study|Lost to Follow-up|4
7498500|NCT02238626|11820323|FG002|Overall Study|Lost to Follow-up|2
7498501|NCT02238626|11820324|FG003|Overall Study|Lost to Follow-up|2
7498502|NCT02238626|11820321|FG000|Overall Study|Withdrawal by Subject|0
7498503|NCT02238626|11820322|FG001|Overall Study|Withdrawal by Subject|3
7498504|NCT02238626|11820323|FG002|Overall Study|Withdrawal by Subject|0
7498505|NCT02238626|11820324|FG003|Overall Study|Withdrawal by Subject|1
7498506|NCT02238626|11820321|FG000|Overall Study|Death|0
7498507|NCT02238626|11820322|FG001|Overall Study|Death|0
7498508|NCT02238626|11820323|FG002|Overall Study|Death|1
7498509|NCT02238626|11820324|FG003|Overall Study|Death|1
7498510|NCT02238626|11820321|FG000|Overall Study|Other|0
7498511|NCT02238626|11820322|FG001|Overall Study|Other|2
7498512|NCT02238626|11820323|FG002|Overall Study|Other|0
7498513|NCT02238626|11820324|FG003|Overall Study|Other|0
7498514|NCT02239094|11820371|FG000|Overall Study|Withdrawal by Subject|1
7498515|NCT02239094|11820371|FG000|Overall Study|Remitted before started|1
7498516|NCT02239120|11820377|FG000|Overall Study|Death|56
7498517|NCT02239120|11820378|FG001|Overall Study|Death|58
7498518|NCT02239120|11820377|FG000|Overall Study|Lost to Follow-up|19
7498519|NCT02239120|11820378|FG001|Overall Study|Lost to Follow-up|14
7498520|NCT02239224|11820388|FG000|Overall Study|Administrative|0
7498521|NCT02239224|11820389|FG001|Overall Study|Administrative|0
7498522|NCT02239224|11820390|FG002|Overall Study|Administrative|3
7498523|NCT02239224|11820391|FG003|Overall Study|Administrative|1
7498524|NCT02239263|11820401|FG000|Overall Study|Protocol Violation|6
7498525|NCT02239328|11820411|FG000|Overall Study|Benign disease noted at time of surgery|6
7498526|NCT02239328|11820411|FG000|Overall Study|Equipment or website malfunction|2
7498527|NCT02239510|11820421|FG000|Overall Study|Lost to Follow-up|2
7498528|NCT02239510|11820422|FG001|Overall Study|Lost to Follow-up|1
7498529|NCT02239536|11820430|FG000|Overall Study|Non-neoplastic polyp|23
7498530|NCT02239536|11820431|FG001|Overall Study|Non-neoplastic polyp|17
7498531|NCT02239601|11820466|FG000|Overall Study|Withdrawal by Subject|3
7498532|NCT02239601|11820467|FG001|Overall Study|Withdrawal by Subject|4
7498533|NCT02239601|11820466|FG000|Overall Study|Protocol Violation|4
7498534|NCT02239601|11820467|FG001|Overall Study|Protocol Violation|2
7498535|NCT02239640|11820478|FG000|Overall Study|Withdrawal by Subject|3
7498536|NCT02239640|11820478|FG000|Overall Study|Lost to Follow-up|72
7498537|NCT02239640|11820478|FG000|Overall Study|Death|142
7498538|NCT02239679|11820491|FG000|Overall Study|Lost to Follow-up|1
7498539|NCT02239679|11820492|FG001|Overall Study|Lost to Follow-up|0
7498540|NCT02239679|11820493|FG002|Overall Study|Lost to Follow-up|0
7498541|NCT02239679|11820491|FG000|Overall Study|Withdrawal by Subject|2
7498542|NCT02239679|11820492|FG001|Overall Study|Withdrawal by Subject|3
7498543|NCT02239679|11820493|FG002|Overall Study|Withdrawal by Subject|1
7498544|NCT02239692|11820503|FG000|Overall Study|Incomplete colonoscopy|1
7498545|NCT02239692|11820504|FG001|Overall Study|Incomplete colonoscopy|2
7498546|NCT02239692|11820503|FG000|Overall Study|Adverse Event|0
7498547|NCT02239692|11820504|FG001|Overall Study|Adverse Event|1
7498548|NCT02239692|11820503|FG000|Overall Study|Physician Decision|0
7498549|NCT02239692|11820504|FG001|Overall Study|Physician Decision|1
7498550|NCT02239692|11820503|FG000|Overall Study|Lost to Follow-up|1
7498551|NCT02239692|11820504|FG001|Overall Study|Lost to Follow-up|4
7498552|NCT02239692|11820503|FG000|Overall Study|Withdrawal by Subject|3
7498553|NCT02239692|11820504|FG001|Overall Study|Withdrawal by Subject|5
7498554|NCT02239692|11820503|FG000|Overall Study|Other reason|1
7498555|NCT02239692|11820504|FG001|Overall Study|Other reason|0
7498556|NCT02239939|11820555|FG000|Overall Study|Adverse Event|1
7498557|NCT02239939|11820556|FG001|Overall Study|Adverse Event|0
7498558|NCT02239939|11820555|FG000|Overall Study|Withdrawal by Subject|1
7498559|NCT02239939|11820556|FG001|Overall Study|Withdrawal by Subject|1
7498560|NCT02239939|11820555|FG000|Overall Study|Lost to Follow-up|0
7498561|NCT02239939|11820556|FG001|Overall Study|Lost to Follow-up|1
7498562|NCT02239978|11820566|FG000|Overall Study|Withdrawal by Subject|2
7498563|NCT02239978|11820567|FG001|Overall Study|Withdrawal by Subject|0
7535511|NCT02711345|11883311|FG002|Overall Study|Subject/guardian decision|0
7535512|NCT02711345|11883312|FG003|Overall Study|Subject/guardian decision|0
7535513|NCT02711345|11883313|FG004|Overall Study|Subject/guardian decision|0
7535514|NCT02711345|11883314|FG005|Overall Study|Subject/guardian decision|2
7535515|NCT02711345|11883315|FG006|Overall Study|Subject/guardian decision|3
7535516|NCT02711345|11883316|FG007|Overall Study|Subject/guardian decision|1
7535517|NCT02711345|11883317|FG008|Overall Study|Subject/guardian decision|0
7535518|NCT02711345|11883318|FG009|Overall Study|Subject/guardian decision|4
7535519|NCT02711345|11883309|FG000|Overall Study|Death|1
7535520|NCT02711345|11883310|FG001|Overall Study|Death|0
7535521|NCT02711345|11883311|FG002|Overall Study|Death|0
7535522|NCT02711345|11883312|FG003|Overall Study|Death|0
7535523|NCT02711345|11883313|FG004|Overall Study|Death|0
7535524|NCT02711345|11883314|FG005|Overall Study|Death|0
7535525|NCT02711345|11883315|FG006|Overall Study|Death|0
7535526|NCT02711345|11883316|FG007|Overall Study|Death|1
7535527|NCT02711345|11883317|FG008|Overall Study|Death|0
7535528|NCT02711345|11883318|FG009|Overall Study|Death|0
7535529|NCT02711553|11883349|FG000|Overall Study|Withdrawal by Subject|2
7535530|NCT02711553|11883350|FG001|Overall Study|Withdrawal by Subject|1
7535531|NCT02711553|11883351|FG002|Overall Study|Withdrawal by Subject|1
7535532|NCT02711553|11883352|FG003|Overall Study|Withdrawal by Subject|0
7535533|NCT02711553|11883349|FG000|Overall Study|Lost to Follow-up|3
7535534|NCT02711553|11883350|FG001|Overall Study|Lost to Follow-up|3
7535535|NCT02711553|11883351|FG002|Overall Study|Lost to Follow-up|6
7535536|NCT02711553|11883352|FG003|Overall Study|Lost to Follow-up|3
7535537|NCT02711553|11883349|FG000|Overall Study|On Study Treatment at Study Conclusion|1
7535538|NCT02711553|11883350|FG001|Overall Study|On Study Treatment at Study Conclusion|1
7535539|NCT02711553|11883351|FG002|Overall Study|On Study Treatment at Study Conclusion|3
7535540|NCT02711553|11883352|FG003|Overall Study|On Study Treatment at Study Conclusion|1
7535541|NCT02711800|11883364|FG000|Overall Study|Lost to Follow-up|1
7535542|NCT02711800|11883364|FG000|Overall Study|Withdrawal by Subject|1
7535543|NCT02711956|11883392|FG000|Overall Study|Adverse Event|0
7535544|NCT02711956|11883393|FG001|Overall Study|Adverse Event|0
7535545|NCT02711956|11883394|FG002|Overall Study|Adverse Event|0
7535546|NCT02711956|11883395|FG003|Overall Study|Adverse Event|1
7535547|NCT02711956|11883396|FG004|Overall Study|Adverse Event|2
7535548|NCT02711956|11883397|FG005|Overall Study|Adverse Event|0
7535549|NCT02711956|11883398|FG006|Overall Study|Adverse Event|0
7535550|NCT02711956|11883399|FG007|Overall Study|Adverse Event|1
7535551|NCT02711956|11883400|FG008|Overall Study|Adverse Event|1
7535552|NCT02711956|11883401|FG009|Overall Study|Adverse Event|1
7535553|NCT02711956|11883402|FG010|Overall Study|Adverse Event|1
7535554|NCT02711956|11883403|FG011|Overall Study|Adverse Event|0
7535555|NCT02711956|11883404|FG012|Overall Study|Adverse Event|0
7535556|NCT02711956|11883405|FG013|Overall Study|Adverse Event|0
7535557|NCT02711956|11883406|FG014|Overall Study|Adverse Event|2
7535558|NCT02711956|11883392|FG000|Overall Study|Physician Decision|0
7535559|NCT02711956|11883393|FG001|Overall Study|Physician Decision|0
7535560|NCT02711956|11883394|FG002|Overall Study|Physician Decision|0
7535561|NCT02711956|11883395|FG003|Overall Study|Physician Decision|2
7535562|NCT02711956|11883396|FG004|Overall Study|Physician Decision|0
7535563|NCT02711956|11883397|FG005|Overall Study|Physician Decision|0
7535564|NCT02711956|11883398|FG006|Overall Study|Physician Decision|0
7535565|NCT02711956|11883399|FG007|Overall Study|Physician Decision|0
7535566|NCT02711956|11883400|FG008|Overall Study|Physician Decision|0
7535567|NCT02711956|11883401|FG009|Overall Study|Physician Decision|0
7535568|NCT02711956|11883402|FG010|Overall Study|Physician Decision|0
7535569|NCT02711956|11883403|FG011|Overall Study|Physician Decision|0
7535570|NCT02711956|11883404|FG012|Overall Study|Physician Decision|0
7535571|NCT02711956|11883405|FG013|Overall Study|Physician Decision|0
7535572|NCT02711956|11883406|FG014|Overall Study|Physician Decision|0
7535573|NCT02711956|11883392|FG000|Overall Study|Withdrawal by Subject|0
7535574|NCT02711956|11883393|FG001|Overall Study|Withdrawal by Subject|0
7535575|NCT02711956|11883394|FG002|Overall Study|Withdrawal by Subject|0
7535576|NCT02711956|11883395|FG003|Overall Study|Withdrawal by Subject|0
7535577|NCT02711956|11883396|FG004|Overall Study|Withdrawal by Subject|0
7535578|NCT02711956|11883397|FG005|Overall Study|Withdrawal by Subject|0
7535579|NCT02711956|11883398|FG006|Overall Study|Withdrawal by Subject|1
7535580|NCT02711956|11883399|FG007|Overall Study|Withdrawal by Subject|0
7535581|NCT02711956|11883400|FG008|Overall Study|Withdrawal by Subject|0
7535582|NCT02711956|11883401|FG009|Overall Study|Withdrawal by Subject|0
7535583|NCT02711956|11883402|FG010|Overall Study|Withdrawal by Subject|0
7535584|NCT02711956|11883403|FG011|Overall Study|Withdrawal by Subject|1
7535585|NCT02711956|11883404|FG012|Overall Study|Withdrawal by Subject|6
7535586|NCT02711956|11883405|FG013|Overall Study|Withdrawal by Subject|0
7498564|NCT02240108|11820592|FG000|Overall Study|Other than specified|8
7498565|NCT02240108|11820593|FG001|Overall Study|Other than specified|6
7498566|NCT02240108|11820592|FG000|Overall Study|Adverse Event|1
7498567|NCT02240108|11820593|FG001|Overall Study|Adverse Event|9
7498568|NCT02240108|11820592|FG000|Overall Study|Pregnancy|1
7498569|NCT02240108|11820593|FG001|Overall Study|Pregnancy|0
7498570|NCT02240108|11820592|FG000|Overall Study|Withdrawal by Subject|4
7498571|NCT02240108|11820593|FG001|Overall Study|Withdrawal by Subject|9
7498572|NCT02240108|11820592|FG000|Overall Study|StudyTerminated by Sponsor|0
7498573|NCT02240108|11820593|FG001|Overall Study|StudyTerminated by Sponsor|1
7498574|NCT02240121|11820601|FG000|Overall Study|Protocol Violation|1
7498575|NCT02240121|11820602|FG001|Overall Study|Protocol Violation|2
7498576|NCT02240121|11820601|FG000|Overall Study|Physician Decision|0
7498577|NCT02240121|11820602|FG001|Overall Study|Physician Decision|1
7498578|NCT02240121|11820601|FG000|Overall Study|Change in protocol interpretation|1
7498579|NCT02240121|11820602|FG001|Overall Study|Change in protocol interpretation|0
7498580|NCT02240121|11820601|FG000|Overall Study|Lack of Efficacy|2
7498581|NCT02240121|11820602|FG001|Overall Study|Lack of Efficacy|3
7498582|NCT02240121|11820601|FG000|Overall Study|Site closed|1
7498583|NCT02240121|11820602|FG001|Overall Study|Site closed|1
7498584|NCT02240121|11820601|FG000|Overall Study|Pregnancy|1
7498585|NCT02240121|11820602|FG001|Overall Study|Pregnancy|0
7498586|NCT02240121|11820601|FG000|Overall Study|Adverse Event|2
7498587|NCT02240121|11820602|FG001|Overall Study|Adverse Event|4
7498588|NCT02240121|11820601|FG000|Overall Study|Withdrawal by Subject|6
7498589|NCT02240121|11820602|FG001|Overall Study|Withdrawal by Subject|2
7498590|NCT02240121|11820601|FG000|Overall Study|Lost to Follow-up|3
7498591|NCT02240121|11820602|FG001|Overall Study|Lost to Follow-up|4
7498592|NCT02240121|11820601|FG000|Overall Study|Other than specified|1
7498593|NCT02240121|11820602|FG001|Overall Study|Other than specified|3
7498594|NCT02240368|11820622|FG000|Overall Study|Surgery lasted less then 20 minutes|1
7498595|NCT02240368|11820623|FG001|Overall Study|Surgery lasted less then 20 minutes|0
7498596|NCT02240368|11820624|FG002|Overall Study|Surgery lasted less then 20 minutes|0
7498597|NCT02240368|11820622|FG000|Overall Study|Entropy failed to detect more than 50%|0
7498598|NCT02240368|11820623|FG001|Overall Study|Entropy failed to detect more than 50%|0
7498599|NCT02240368|11820624|FG002|Overall Study|Entropy failed to detect more than 50%|1
7498600|NCT02240628|11820643|FG000|Overall Study|Physician Decision|6
7498601|NCT02240628|11820644|FG001|Overall Study|Physician Decision|5
7498602|NCT02240680|11820682|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
7498603|NCT02240680|11820683|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
7498604|NCT02240680|11820684|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
7498605|NCT02240680|11820685|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
7498606|NCT02240680|11820682|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
7498607|NCT02240680|11820683|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
7498608|NCT02240680|11820684|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7498609|NCT02240680|11820685|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
7498610|NCT02240680|11820682|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
7498611|NCT02240680|11820683|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7498612|NCT02240680|11820684|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7498613|NCT02240680|11820685|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
7498614|NCT02240680|11820682|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
7498615|NCT02240680|11820683|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
7498616|NCT02240680|11820684|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7498617|NCT02240680|11820685|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
7498618|NCT02240680|11820682|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
7498619|NCT02240680|11820683|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
7498620|NCT02240680|11820684|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
7498621|NCT02240680|11820685|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
7498622|NCT02240680|11820682|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7498623|NCT02240680|11820683|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
7498624|NCT02240680|11820684|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
7498625|NCT02240680|11820685|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
7498626|NCT02240680|11820682|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7498627|NCT02240680|11820683|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7498628|NCT02240680|11820684|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
7498629|NCT02240680|11820685|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
7498630|NCT02240680|11820682|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7498631|NCT02240680|11820683|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7498632|NCT02240680|11820684|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
7498633|NCT02240680|11820685|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
7498634|NCT02240693|11820698|FG000|Overall Study|Adverse Event|0
7498635|NCT02240693|11820699|FG001|Overall Study|Adverse Event|0
7498636|NCT02240693|11820700|FG002|Overall Study|Adverse Event|0
7498637|NCT02240693|11820701|FG003|Overall Study|Adverse Event|0
7498638|NCT02240693|11820702|FG004|Overall Study|Adverse Event|1
7498639|NCT02240693|11820698|FG000|Overall Study|Withdrawal by Subject|0
7498640|NCT02240693|11820699|FG001|Overall Study|Withdrawal by Subject|0
7498641|NCT02240693|11820700|FG002|Overall Study|Withdrawal by Subject|2
7498642|NCT02240693|11820701|FG003|Overall Study|Withdrawal by Subject|1
7498643|NCT02240693|11820702|FG004|Overall Study|Withdrawal by Subject|0
7498644|NCT02240693|11820698|FG000|Overall Study|Other than specified|0
7498645|NCT02240693|11820699|FG001|Overall Study|Other than specified|0
7498646|NCT02240693|11820700|FG002|Overall Study|Other than specified|2
7498647|NCT02240693|11820701|FG003|Overall Study|Other than specified|0
7498648|NCT02240693|11820702|FG004|Overall Study|Other than specified|0
7498649|NCT02240706|11820721|FG000|Overall Study|Lack of Efficacy|2
7498650|NCT02240706|11820722|FG001|Overall Study|Lack of Efficacy|2
7498651|NCT02240706|11820723|FG002|Overall Study|Lack of Efficacy|2
7498652|NCT02240706|11820724|FG003|Overall Study|Lack of Efficacy|2
7498653|NCT02240706|11820725|FG004|Overall Study|Lack of Efficacy|5
7498654|NCT02240706|11820726|FG005|Overall Study|Lack of Efficacy|0
7498655|NCT02240706|11820727|FG006|Overall Study|Lack of Efficacy|0
7498656|NCT02240706|11820721|FG000|Overall Study|Adverse Event|1
7498657|NCT02240706|11820722|FG001|Overall Study|Adverse Event|0
7498658|NCT02240706|11820723|FG002|Overall Study|Adverse Event|1
7498659|NCT02240706|11820724|FG003|Overall Study|Adverse Event|0
7498660|NCT02240706|11820725|FG004|Overall Study|Adverse Event|2
7498661|NCT02240706|11820726|FG005|Overall Study|Adverse Event|0
7498662|NCT02240706|11820727|FG006|Overall Study|Adverse Event|0
7498663|NCT02240706|11820721|FG000|Overall Study|Progressive disease|0
7498664|NCT02240706|11820722|FG001|Overall Study|Progressive disease|0
7498665|NCT02240706|11820723|FG002|Overall Study|Progressive disease|0
7498666|NCT02240706|11820724|FG003|Overall Study|Progressive disease|0
7498667|NCT02240706|11820725|FG004|Overall Study|Progressive disease|1
7498668|NCT02240706|11820726|FG005|Overall Study|Progressive disease|0
7498669|NCT02240706|11820727|FG006|Overall Study|Progressive disease|0
7498670|NCT02240706|11820721|FG000|Overall Study|Dose limiting toxicity|0
7498671|NCT02240706|11820722|FG001|Overall Study|Dose limiting toxicity|0
7498672|NCT02240706|11820723|FG002|Overall Study|Dose limiting toxicity|0
7498673|NCT02240706|11820724|FG003|Overall Study|Dose limiting toxicity|0
7498674|NCT02240706|11820725|FG004|Overall Study|Dose limiting toxicity|1
7498675|NCT02240706|11820726|FG005|Overall Study|Dose limiting toxicity|0
7498676|NCT02240706|11820727|FG006|Overall Study|Dose limiting toxicity|0
7498677|NCT02240706|11820721|FG000|Overall Study|Refused to continue taking medication|0
7498678|NCT02240706|11820722|FG001|Overall Study|Refused to continue taking medication|1
7498679|NCT02240706|11820723|FG002|Overall Study|Refused to continue taking medication|3
7498680|NCT02240706|11820724|FG003|Overall Study|Refused to continue taking medication|1
7498681|NCT02240706|11820725|FG004|Overall Study|Refused to continue taking medication|2
7498682|NCT02240706|11820726|FG005|Overall Study|Refused to continue taking medication|0
7498683|NCT02240706|11820727|FG006|Overall Study|Refused to continue taking medication|0
7498684|NCT02240706|11820721|FG000|Overall Study|Insurance billing concerns|0
7498685|NCT02240706|11820722|FG001|Overall Study|Insurance billing concerns|0
7498686|NCT02240706|11820723|FG002|Overall Study|Insurance billing concerns|0
7498687|NCT02240706|11820724|FG003|Overall Study|Insurance billing concerns|1
7498688|NCT02240706|11820725|FG004|Overall Study|Insurance billing concerns|0
7498689|NCT02240706|11820726|FG005|Overall Study|Insurance billing concerns|0
7498690|NCT02240706|11820727|FG006|Overall Study|Insurance billing concerns|0
7498691|NCT02241512|11820758|FG000|Overall Study|Pump malfunction, drug not delivered|1
7498692|NCT02241512|11820759|FG001|Overall Study|Pump malfunction, drug not delivered|0
7498693|NCT02241733|11820785|FG000|Overall Study|Lost to Follow-up|9
7498694|NCT02241733|11820786|FG001|Overall Study|Lost to Follow-up|4
7498695|NCT02241733|11820785|FG000|Overall Study|Physician Decision|6
7498696|NCT02241733|11820786|FG001|Overall Study|Physician Decision|2
7498697|NCT02241733|11820785|FG000|Overall Study|Withdrawal by Subject|0
7498698|NCT02241733|11820786|FG001|Overall Study|Withdrawal by Subject|2
7498699|NCT02241733|11820785|FG000|Overall Study|Death|0
7498700|NCT02241733|11820786|FG001|Overall Study|Death|2
7498701|NCT02241785|11820792|FG000|Overall Study|Sponsor Termination|43
7498702|NCT02241785|11820792|FG000|Overall Study|Withdrawal by Subject|1
7498703|NCT02241785|11820792|FG000|Overall Study|Lost to Follow-up|2
7498704|NCT02241785|11820792|FG000|Overall Study|Adverse Event|1
7498705|NCT02241889|11820796|FG000|Overall Study|device issues|0
7498706|NCT02241889|11820797|FG001|Overall Study|device issues|0
7498707|NCT02241889|11820798|FG002|Overall Study|device issues|1
7498708|NCT02241889|11820799|FG003|Overall Study|device issues|0
7498709|NCT02241889|11820800|FG004|Overall Study|device issues|0
7498710|NCT02241889|11820801|FG005|Overall Study|device issues|0
7498711|NCT02241889|11820796|FG000|Overall Study|Withdrawal by Subject|0
7498712|NCT02241889|11820797|FG001|Overall Study|Withdrawal by Subject|0
7498713|NCT02241889|11820798|FG002|Overall Study|Withdrawal by Subject|0
7498714|NCT02241889|11820799|FG003|Overall Study|Withdrawal by Subject|0
7498715|NCT02241889|11820800|FG004|Overall Study|Withdrawal by Subject|0
7498716|NCT02241889|11820801|FG005|Overall Study|Withdrawal by Subject|1
7498717|NCT02242045|11820830|FG000|Overall Study|Investigator's Discretion|1
7498718|NCT02242045|11820830|FG000|Overall Study|Progressive Disease|2
7498719|NCT02242045|11820830|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
7498720|NCT02242045|11820830|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
7498721|NCT02242201|11820837|FG000|Overall Study|preoperative identified neuropathy|2
7498722|NCT02242201|11820838|FG001|Overall Study|preoperative identified neuropathy|0
7498723|NCT02242201|11820839|FG002|Overall Study|preoperative identified neuropathy|0
7498724|NCT02242201|11820837|FG000|Overall Study|planned post-op anticoagulation|1
7498725|NCT02242201|11820838|FG001|Overall Study|planned post-op anticoagulation|0
7498726|NCT02242201|11820839|FG002|Overall Study|planned post-op anticoagulation|0
7498727|NCT02242201|11820837|FG000|Overall Study|changed surgical procedure|1
7498728|NCT02242201|11820838|FG001|Overall Study|changed surgical procedure|0
7498729|NCT02242201|11820839|FG002|Overall Study|changed surgical procedure|0
7498730|NCT02242201|11820837|FG000|Overall Study|postponed surgery|0
7498731|NCT02242201|11820838|FG001|Overall Study|postponed surgery|0
7498732|NCT02242201|11820839|FG002|Overall Study|postponed surgery|1
7498733|NCT02242201|11820837|FG000|Overall Study|preoperative opioid consumption|0
7498734|NCT02242201|11820838|FG001|Overall Study|preoperative opioid consumption|1
7498735|NCT02242201|11820839|FG002|Overall Study|preoperative opioid consumption|0
7498736|NCT02242305|11820849|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
7498737|NCT02242305|11820850|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
7498738|NCT02242305|11820849|FG000|Overall Study|Adverse Event|1
7498739|NCT02242305|11820850|FG001|Overall Study|Adverse Event|0
7498740|NCT02242305|11820849|FG000|Overall Study|Non-compliance dosing regimen or visit|2
7498741|NCT02242305|11820850|FG001|Overall Study|Non-compliance dosing regimen or visit|2
7498742|NCT02242305|11820849|FG000|Overall Study|Subject withdraws inform consent|0
7498743|NCT02242305|11820850|FG001|Overall Study|Subject withdraws inform consent|4
7498744|NCT02242305|11820849|FG000|Overall Study|Lost to Follow-up|2
7498745|NCT02242305|11820850|FG001|Overall Study|Lost to Follow-up|0
7498746|NCT02242487|11820858|FG000|Overall Study|Adverse Event|13
7498747|NCT02242487|11820859|FG001|Overall Study|Adverse Event|15
7498748|NCT02242487|11820858|FG000|Overall Study|Lack of Efficacy|4
7498749|NCT02242487|11820859|FG001|Overall Study|Lack of Efficacy|6
7498750|NCT02242487|11820858|FG000|Overall Study|Protocol Violation|2
7498751|NCT02242487|11820859|FG001|Overall Study|Protocol Violation|0
7498752|NCT02242487|11820858|FG000|Overall Study|Lost to Follow-up|2
7498753|NCT02242487|11820859|FG001|Overall Study|Lost to Follow-up|1
7498754|NCT02242487|11820858|FG000|Overall Study|Other - Miscellaneous|4
7498755|NCT02242487|11820859|FG001|Overall Study|Other - Miscellaneous|6
7498756|NCT02242487|11820858|FG000|Overall Study|Withdrawal by Subject|37
7498757|NCT02242487|11820859|FG001|Overall Study|Withdrawal by Subject|19
7498758|NCT02242643|11820886|FG000|Overall Study|Protocol Violation|1
7498759|NCT02242643|11820887|FG001|Overall Study|Protocol Violation|2
7498760|NCT02242643|11820886|FG000|Overall Study|Withdrawal by Subject|15
7498761|NCT02242643|11820887|FG001|Overall Study|Withdrawal by Subject|10
7498762|NCT02242643|11820886|FG000|Overall Study|Migrated/moved from study area|1
7498763|NCT02242643|11820887|FG001|Overall Study|Migrated/moved from study area|3
7498764|NCT02242643|11820886|FG000|Overall Study|Lost to Follow-up|54
7498765|NCT02242643|11820887|FG001|Overall Study|Lost to Follow-up|61
7498766|NCT02242643|11820886|FG000|Overall Study|Child placed in foster care by family|0
7498767|NCT02242643|11820887|FG001|Overall Study|Child placed in foster care by family|1
7498768|NCT02242643|11820886|FG000|Overall Study|Non-compliance|1
7498769|NCT02242643|11820887|FG001|Overall Study|Non-compliance|0
7498770|NCT02242643|11820886|FG000|Overall Study|Consent withdrawal by parent|1
7498771|NCT02242643|11820887|FG001|Overall Study|Consent withdrawal by parent|0
7498772|NCT02242643|11820886|FG000|Overall Study|Protocol requirements not followed|1
7498773|NCT02242643|11820887|FG001|Overall Study|Protocol requirements not followed|0
7498774|NCT02242643|11820886|FG000|Overall Study|Language barrier|1
7498775|NCT02242643|11820887|FG001|Overall Study|Language barrier|0
7498776|NCT02242643|11820886|FG000|Overall Study|Withdrawal by subject at Visit 2|0
7498777|NCT02242643|11820887|FG001|Overall Study|Withdrawal by subject at Visit 2|1
7498778|NCT02242903|11820902|FG000|Overall Study|Withdrawal by Subject|1
7498779|NCT02242903|11820903|FG001|Overall Study|Withdrawal by Subject|0
7498780|NCT02242903|11820904|FG002|Overall Study|Withdrawal by Subject|0
7498781|NCT02242903|11820905|FG003|Overall Study|Withdrawal by Subject|0
7498782|NCT02242903|11820906|FG004|Overall Study|Withdrawal by Subject|0
7498783|NCT02242903|11820907|FG005|Overall Study|Withdrawal by Subject|0
7498784|NCT02242903|11820908|FG006|Overall Study|Withdrawal by Subject|0
7498785|NCT02242981|11820930|FG000|Overall Study|Withdrawal by Subject|1
7498786|NCT02243046|11820950|FG000|Overall Study|Lost to Follow-up|1
7498787|NCT02243046|11820951|FG001|Overall Study|Lost to Follow-up|1
7498788|NCT02243046|11820952|FG002|Overall Study|Lost to Follow-up|4
7498789|NCT02243176|11820962|FG000|Overall Study|Other reason|1
7498790|NCT02243176|11820963|FG001|Overall Study|Other reason|2
7498791|NCT02243176|11820962|FG000|Overall Study|protocol specified withdrawal critera|1
7498792|NCT02243176|11820963|FG001|Overall Study|protocol specified withdrawal critera|3
7498793|NCT02243176|11820962|FG000|Overall Study|Protocol Violation|2
7498794|NCT02243176|11820963|FG001|Overall Study|Protocol Violation|1
7498795|NCT02243176|11820962|FG000|Overall Study|Withdrawal by Subject|8
7498796|NCT02243176|11820963|FG001|Overall Study|Withdrawal by Subject|7
7498797|NCT02243176|11820962|FG000|Overall Study|Adverse Event|2
7498798|NCT02243176|11820963|FG001|Overall Study|Adverse Event|2
7498799|NCT02243202|11820973|FG000|Overall Study|Adverse Event|5
7498800|NCT02243202|11820974|FG001|Overall Study|Adverse Event|6
7498801|NCT02243202|11820975|FG002|Overall Study|Adverse Event|10
7498802|NCT02243202|11820976|FG003|Overall Study|Adverse Event|4
7498803|NCT02243202|11820973|FG000|Overall Study|Lost to Follow-up|9
7498804|NCT02243202|11820974|FG001|Overall Study|Lost to Follow-up|9
7498805|NCT02243202|11820975|FG002|Overall Study|Lost to Follow-up|14
7498806|NCT02243202|11820976|FG003|Overall Study|Lost to Follow-up|11
7498807|NCT02243202|11820973|FG000|Overall Study|Protocol Violation|3
7498808|NCT02243202|11820974|FG001|Overall Study|Protocol Violation|1
7498809|NCT02243202|11820975|FG002|Overall Study|Protocol Violation|2
7498810|NCT02243202|11820976|FG003|Overall Study|Protocol Violation|1
7498811|NCT02243202|11820973|FG000|Overall Study|Withdrawal by Subject|7
7498812|NCT02243202|11820974|FG001|Overall Study|Withdrawal by Subject|6
7498813|NCT02243202|11820975|FG002|Overall Study|Withdrawal by Subject|4
7498814|NCT02243202|11820976|FG003|Overall Study|Withdrawal by Subject|4
7498815|NCT02243202|11820973|FG000|Overall Study|Other|1
7498816|NCT02243202|11820974|FG001|Overall Study|Other|3
7498817|NCT02243202|11820975|FG002|Overall Study|Other|1
7498818|NCT02243202|11820976|FG003|Overall Study|Other|2
7498819|NCT02243202|11820973|FG000|Overall Study|Randomized but not received treatment|0
7498820|NCT02243202|11820974|FG001|Overall Study|Randomized but not received treatment|0
7498821|NCT02243202|11820975|FG002|Overall Study|Randomized but not received treatment|0
7498822|NCT02243202|11820976|FG003|Overall Study|Randomized but not received treatment|1
7498823|NCT02243280|11820997|FG000|Treated|Adverse Event|1
7498824|NCT02243280|11820998|FG001|Treated|Adverse Event|0
7498825|NCT02243280|11820999|FG002|Treated|Adverse Event|0
7498826|NCT02243280|11821000|FG003|Treated|Adverse Event|0
7498827|NCT02243280|11821001|FG004|Treated|Adverse Event|0
7498828|NCT02243280|11821002|FG005|Treated|Adverse Event|0
7498829|NCT02243280|11821003|FG006|Treated|Adverse Event|0
7498830|NCT02243280|11821004|FG007|Treated|Adverse Event|0
7498831|NCT02243280|11821005|FG008|Treated|Adverse Event|0
7498832|NCT02243280|11821006|FG009|Treated|Adverse Event|0
7498833|NCT02243280|11821007|FG010|Treated|Adverse Event|1
7498834|NCT02243280|11820997|FG000|Treated|Lost to Follow-up|0
7498835|NCT02243280|11820998|FG001|Treated|Lost to Follow-up|0
7498836|NCT02243280|11820999|FG002|Treated|Lost to Follow-up|0
7498837|NCT02243280|11821000|FG003|Treated|Lost to Follow-up|0
7498838|NCT02243280|11821001|FG004|Treated|Lost to Follow-up|0
7498839|NCT02243280|11821002|FG005|Treated|Lost to Follow-up|0
7498840|NCT02243280|11821003|FG006|Treated|Lost to Follow-up|0
7498841|NCT02243280|11821004|FG007|Treated|Lost to Follow-up|0
7498842|NCT02243280|11821005|FG008|Treated|Lost to Follow-up|1
7498843|NCT02243280|11821006|FG009|Treated|Lost to Follow-up|0
7498844|NCT02243280|11821007|FG010|Treated|Lost to Follow-up|2
7498845|NCT02243293|11821042|FG000|Overall Study|Adverse Event|1
7498846|NCT02243293|11821043|FG001|Overall Study|Adverse Event|0
7498847|NCT02243293|11821044|FG002|Overall Study|Adverse Event|0
7498848|NCT02243293|11821045|FG003|Overall Study|Adverse Event|0
7498849|NCT02243293|11821046|FG004|Overall Study|Adverse Event|0
7498850|NCT02243293|11821047|FG005|Overall Study|Adverse Event|0
7498851|NCT02243293|11821048|FG006|Overall Study|Adverse Event|0
7498852|NCT02243293|11821049|FG007|Overall Study|Adverse Event|0
7498853|NCT02243293|11821050|FG008|Overall Study|Adverse Event|0
7498854|NCT02243293|11821051|FG009|Overall Study|Adverse Event|0
7498855|NCT02243293|11821052|FG010|Overall Study|Adverse Event|0
7498856|NCT02243293|11821053|FG011|Overall Study|Adverse Event|0
7498857|NCT02243293|11821054|FG012|Overall Study|Adverse Event|0
7498858|NCT02243293|11821055|FG013|Overall Study|Adverse Event|0
7498859|NCT02243293|11821056|FG014|Overall Study|Adverse Event|0
7498860|NCT02243293|11821057|FG015|Overall Study|Adverse Event|1
7498861|NCT02243293|11821058|FG016|Overall Study|Adverse Event|0
7498862|NCT02243293|11821059|FG017|Overall Study|Adverse Event|0
7498863|NCT02243293|11821060|FG018|Overall Study|Adverse Event|0
7498864|NCT02243293|11821061|FG019|Overall Study|Adverse Event|0
7498865|NCT02243293|11821062|FG020|Overall Study|Adverse Event|1
7498866|NCT02243293|11821063|FG021|Overall Study|Adverse Event|0
7498867|NCT02243293|11821042|FG000|Overall Study|Withdrawal by Subject|1
7498868|NCT02243293|11821043|FG001|Overall Study|Withdrawal by Subject|0
7498869|NCT02243293|11821044|FG002|Overall Study|Withdrawal by Subject|0
7498870|NCT02243293|11821045|FG003|Overall Study|Withdrawal by Subject|0
7498871|NCT02243293|11821046|FG004|Overall Study|Withdrawal by Subject|0
7498872|NCT02243293|11821047|FG005|Overall Study|Withdrawal by Subject|0
7498873|NCT02243293|11821048|FG006|Overall Study|Withdrawal by Subject|0
7498874|NCT02243293|11821049|FG007|Overall Study|Withdrawal by Subject|0
7498875|NCT02243293|11821050|FG008|Overall Study|Withdrawal by Subject|0
7498876|NCT02243293|11821051|FG009|Overall Study|Withdrawal by Subject|1
7498877|NCT02243293|11821052|FG010|Overall Study|Withdrawal by Subject|0
7498878|NCT02243293|11821053|FG011|Overall Study|Withdrawal by Subject|1
7498879|NCT02243293|11821054|FG012|Overall Study|Withdrawal by Subject|0
7498880|NCT02243293|11821055|FG013|Overall Study|Withdrawal by Subject|0
7498881|NCT02243293|11821056|FG014|Overall Study|Withdrawal by Subject|0
7498882|NCT02243293|11821057|FG015|Overall Study|Withdrawal by Subject|0
7498883|NCT02243293|11821058|FG016|Overall Study|Withdrawal by Subject|0
7498884|NCT02243293|11821059|FG017|Overall Study|Withdrawal by Subject|0
7498885|NCT02243293|11821060|FG018|Overall Study|Withdrawal by Subject|0
7498886|NCT02243293|11821061|FG019|Overall Study|Withdrawal by Subject|0
7498887|NCT02243293|11821062|FG020|Overall Study|Withdrawal by Subject|0
7498888|NCT02243293|11821063|FG021|Overall Study|Withdrawal by Subject|1
7498889|NCT02243293|11821042|FG000|Overall Study|Lost to Follow-up|0
7498890|NCT02243293|11821043|FG001|Overall Study|Lost to Follow-up|1
7498891|NCT02243293|11821044|FG002|Overall Study|Lost to Follow-up|1
7498892|NCT02243293|11821045|FG003|Overall Study|Lost to Follow-up|1
7498893|NCT02243293|11821046|FG004|Overall Study|Lost to Follow-up|0
7498894|NCT02243293|11821047|FG005|Overall Study|Lost to Follow-up|0
7498895|NCT02243293|11821048|FG006|Overall Study|Lost to Follow-up|3
7498896|NCT02243293|11821049|FG007|Overall Study|Lost to Follow-up|0
7498897|NCT02243293|11821050|FG008|Overall Study|Lost to Follow-up|0
7498898|NCT02243293|11821051|FG009|Overall Study|Lost to Follow-up|0
7498899|NCT02243293|11821052|FG010|Overall Study|Lost to Follow-up|0
7498900|NCT02243293|11821053|FG011|Overall Study|Lost to Follow-up|2
7498901|NCT02243293|11821054|FG012|Overall Study|Lost to Follow-up|0
7498902|NCT02243293|11821055|FG013|Overall Study|Lost to Follow-up|0
7498903|NCT02243293|11821056|FG014|Overall Study|Lost to Follow-up|0
7498904|NCT02243293|11821057|FG015|Overall Study|Lost to Follow-up|0
7498905|NCT02243293|11821058|FG016|Overall Study|Lost to Follow-up|3
7498906|NCT02243293|11821059|FG017|Overall Study|Lost to Follow-up|1
7498907|NCT02243293|11821060|FG018|Overall Study|Lost to Follow-up|0
7498908|NCT02243293|11821061|FG019|Overall Study|Lost to Follow-up|0
7498909|NCT02243293|11821062|FG020|Overall Study|Lost to Follow-up|1
7498910|NCT02243293|11821063|FG021|Overall Study|Lost to Follow-up|2
7498911|NCT02243293|11821042|FG000|Overall Study|Enrolled into a Re-treatment Study|0
7498912|NCT02243293|11821043|FG001|Overall Study|Enrolled into a Re-treatment Study|0
7498913|NCT02243293|11821044|FG002|Overall Study|Enrolled into a Re-treatment Study|0
7498914|NCT02243293|11821045|FG003|Overall Study|Enrolled into a Re-treatment Study|0
7498915|NCT02243293|11821046|FG004|Overall Study|Enrolled into a Re-treatment Study|0
7498916|NCT02243293|11821047|FG005|Overall Study|Enrolled into a Re-treatment Study|0
7498917|NCT02243293|11821048|FG006|Overall Study|Enrolled into a Re-treatment Study|0
7498918|NCT02243293|11821049|FG007|Overall Study|Enrolled into a Re-treatment Study|0
7498919|NCT02243293|11821050|FG008|Overall Study|Enrolled into a Re-treatment Study|0
7498920|NCT02243293|11821051|FG009|Overall Study|Enrolled into a Re-treatment Study|0
7498921|NCT02243293|11821052|FG010|Overall Study|Enrolled into a Re-treatment Study|0
7498922|NCT02243293|11821053|FG011|Overall Study|Enrolled into a Re-treatment Study|0
7498923|NCT02243293|11821054|FG012|Overall Study|Enrolled into a Re-treatment Study|0
7498924|NCT02243293|11821055|FG013|Overall Study|Enrolled into a Re-treatment Study|0
7498925|NCT02243293|11821056|FG014|Overall Study|Enrolled into a Re-treatment Study|1
7498926|NCT02243293|11821057|FG015|Overall Study|Enrolled into a Re-treatment Study|0
7498927|NCT02243293|11821058|FG016|Overall Study|Enrolled into a Re-treatment Study|0
7498928|NCT02243293|11821059|FG017|Overall Study|Enrolled into a Re-treatment Study|0
7498929|NCT02243293|11821060|FG018|Overall Study|Enrolled into a Re-treatment Study|0
7498930|NCT02243293|11821061|FG019|Overall Study|Enrolled into a Re-treatment Study|0
7498931|NCT02243293|11821062|FG020|Overall Study|Enrolled into a Re-treatment Study|0
7498932|NCT02243293|11821063|FG021|Overall Study|Enrolled into a Re-treatment Study|0
7498933|NCT02243293|11821042|FG000|Overall Study|Randomized but did'nt receive study drug|0
7498934|NCT02243293|11821043|FG001|Overall Study|Randomized but did'nt receive study drug|0
7498935|NCT02243293|11821044|FG002|Overall Study|Randomized but did'nt receive study drug|0
7498936|NCT02243293|11821045|FG003|Overall Study|Randomized but did'nt receive study drug|0
7498937|NCT02243293|11821046|FG004|Overall Study|Randomized but did'nt receive study drug|1
7498938|NCT02243293|11821047|FG005|Overall Study|Randomized but did'nt receive study drug|0
7498939|NCT02243293|11821048|FG006|Overall Study|Randomized but did'nt receive study drug|0
7498940|NCT02243293|11821049|FG007|Overall Study|Randomized but did'nt receive study drug|0
7498941|NCT02243293|11821050|FG008|Overall Study|Randomized but did'nt receive study drug|0
7498942|NCT02243293|11821051|FG009|Overall Study|Randomized but did'nt receive study drug|1
7498943|NCT02243293|11821052|FG010|Overall Study|Randomized but did'nt receive study drug|0
7498944|NCT02243293|11821053|FG011|Overall Study|Randomized but did'nt receive study drug|0
7498945|NCT02243293|11821054|FG012|Overall Study|Randomized but did'nt receive study drug|0
7498946|NCT02243293|11821055|FG013|Overall Study|Randomized but did'nt receive study drug|0
7498947|NCT02243293|11821056|FG014|Overall Study|Randomized but did'nt receive study drug|0
7498948|NCT02243293|11821057|FG015|Overall Study|Randomized but did'nt receive study drug|0
7498949|NCT02243293|11821058|FG016|Overall Study|Randomized but did'nt receive study drug|0
7498950|NCT02243293|11821059|FG017|Overall Study|Randomized but did'nt receive study drug|0
7498951|NCT02243293|11821060|FG018|Overall Study|Randomized but did'nt receive study drug|0
7498952|NCT02243293|11821061|FG019|Overall Study|Randomized but did'nt receive study drug|1
7498953|NCT02243293|11821062|FG020|Overall Study|Randomized but did'nt receive study drug|0
7498954|NCT02243293|11821063|FG021|Overall Study|Randomized but did'nt receive study drug|0
7498955|NCT02243371|11821102|FG000|Overall Study|Progressive Disease (clinic & radio)|35
7498956|NCT02243371|11821103|FG001|Overall Study|Progressive Disease (clinic & radio)|24
7498957|NCT02243371|11821102|FG000|Overall Study|Death (unrelated)|2
7498958|NCT02243371|11821103|FG001|Overall Study|Death (unrelated)|4
7498959|NCT02243371|11821102|FG000|Overall Study|Adverse Event (unrelated)|0
7498960|NCT02243371|11821103|FG001|Overall Study|Adverse Event (unrelated)|1
7498961|NCT02243371|11821102|FG000|Overall Study|Lack of Clinical Benefit|0
7498962|NCT02243371|11821103|FG001|Overall Study|Lack of Clinical Benefit|1
7498963|NCT02243371|11821102|FG000|Overall Study|Withdrawal by Subject|0
7498964|NCT02243371|11821103|FG001|Overall Study|Withdrawal by Subject|2
7498965|NCT02243696|11821122|FG000|Overall Study|Death|282
7498966|NCT02243696|11821122|FG000|Overall Study|Withdrawal by Subject|79
7498967|NCT02243696|11821122|FG000|Overall Study|Lost to Follow-up|57
7498968|NCT02243696|11821122|FG000|Overall Study|Subject No Longer has Study System|42
7498969|NCT02243696|11821122|FG000|Overall Study|Subject Withdrawn by Investigator|273
7498970|NCT02243696|11821122|FG000|Overall Study|Study Terminated for EP PASSION|961
7498971|NCT02243865|11821128|FG000|Overall Study|Protocol Violation|1
7498972|NCT02243865|11821129|FG001|Overall Study|Protocol Violation|3
7498973|NCT02243865|11821128|FG000|Overall Study|Lost to Follow-up|1
7498974|NCT02243865|11821129|FG001|Overall Study|Lost to Follow-up|1
7498975|NCT02243865|11821128|FG000|Overall Study|Withdrawal by Subject|1
7498976|NCT02243865|11821129|FG001|Overall Study|Withdrawal by Subject|0
7498977|NCT02243865|11821128|FG000|Overall Study|Adverse Event|1
7498978|NCT02243865|11821129|FG001|Overall Study|Adverse Event|1
7498979|NCT02244424|11821148|FG000|Overall Study|Lost to Follow-up|20
7498980|NCT02244424|11821149|FG001|Overall Study|Lost to Follow-up|10
7498981|NCT02244580|11821155|FG000|Overall Study|No cancer tissues available|241
7498982|NCT02244619|11821165|FG000|Overall Study|Did not receive study intervention|8
7498983|NCT02244619|11821166|FG001|Overall Study|Did not receive study intervention|21
7498984|NCT02244957|11821188|FG000|Overall Study|Lack of Efficacy|1
7498985|NCT02244957|11821189|FG001|Overall Study|Lack of Efficacy|0
7498986|NCT02244996|11821199|FG000|Overall Study|Lack of Efficacy|2
7498987|NCT02244996|11821200|FG001|Overall Study|Lack of Efficacy|6
7498988|NCT02245412|11821222|FG000|Treatment Period|Death|1
7498989|NCT02245412|11821223|FG001|Treatment Period|Death|1
7498990|NCT02245412|11821224|FG002|Treatment Period|Death|0
7498991|NCT02245412|11821222|FG000|Treatment Period|Physician Decision|1
7498992|NCT02245412|11821223|FG001|Treatment Period|Physician Decision|1
7498993|NCT02245412|11821224|FG002|Treatment Period|Physician Decision|0
7498994|NCT02245412|11821222|FG000|Treatment Period|Withdrawal by Subject|2
7498995|NCT02245412|11821223|FG001|Treatment Period|Withdrawal by Subject|1
7498996|NCT02245412|11821224|FG002|Treatment Period|Withdrawal by Subject|0
7498997|NCT02245412|11821222|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
7498998|NCT02245412|11821223|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
7498999|NCT02245412|11821224|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
7499000|NCT02245412|11821222|FG000|Follow-Up Period|Death|4
7499001|NCT02245412|11821223|FG001|Follow-Up Period|Death|2
7499002|NCT02245412|11821224|FG002|Follow-Up Period|Death|1
7499003|NCT02245412|11821222|FG000|Follow-Up Period|Physician Decision|1
7499004|NCT02245412|11821223|FG001|Follow-Up Period|Physician Decision|0
7499005|NCT02245412|11821224|FG002|Follow-Up Period|Physician Decision|0
7499006|NCT02245412|11821222|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
7499007|NCT02245412|11821223|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
7499008|NCT02245412|11821224|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
7499009|NCT02245568|11821241|FG000|Overall Study|Study terminated by Sponsor|346
7499010|NCT02245568|11821241|FG000|Overall Study|Adverse Event|144
7499011|NCT02245568|11821241|FG000|Overall Study|Lack of Efficacy|98
7499012|NCT02245568|11821241|FG000|Overall Study|Withdrawal by Caregiver|85
7499013|NCT02245568|11821241|FG000|Overall Study|Withdrawal by Subject|77
7499014|NCT02245568|11821241|FG000|Overall Study|Withdrawal by Legal Representative|31
7499015|NCT02245568|11821241|FG000|Overall Study|Missing (Site closure)|16
7499016|NCT02245568|11821241|FG000|Overall Study|Physician Decision|14
7499017|NCT02245568|11821241|FG000|Overall Study|Non-compliance with study drug|11
7499018|NCT02245568|11821241|FG000|Overall Study|Death|9
7499019|NCT02245568|11821241|FG000|Overall Study|Blue staining|6
7499020|NCT02245568|11821241|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
7499021|NCT02245568|11821241|FG000|Overall Study|Intolerance/dosing issues/interruption|5
7499022|NCT02245568|11821241|FG000|Overall Study|Lost to Follow-up|5
7499023|NCT02245620|11821247|FG000|Overall Study|Physician Decision|1
7499024|NCT02245620|11821248|FG001|Overall Study|Physician Decision|1
7499025|NCT02245737|11821257|FG000|Overall Study|Adverse Event|23
7499026|NCT02245737|11821258|FG001|Overall Study|Adverse Event|26
7499027|NCT02245737|11821259|FG002|Overall Study|Adverse Event|33
7499028|NCT02245737|11821257|FG000|Overall Study|Condition Worsened|9
7499029|NCT02245737|11821258|FG001|Overall Study|Condition Worsened|10
7499030|NCT02245737|11821259|FG002|Overall Study|Condition Worsened|9
7499031|NCT02245737|11821257|FG000|Overall Study|Death|2
7499032|NCT02245737|11821258|FG001|Overall Study|Death|4
7499033|NCT02245737|11821259|FG002|Overall Study|Death|4
7499034|NCT02245737|11821257|FG000|Overall Study|Eligibility Criteria No Longer Met|2
7499035|NCT02245737|11821258|FG001|Overall Study|Eligibility Criteria No Longer Met|4
7499036|NCT02245737|11821259|FG002|Overall Study|Eligibility Criteria No Longer Met|4
7499037|NCT02245737|11821257|FG000|Overall Study|Initiation of Symptomatic AD medication|2
7499038|NCT02245737|11821258|FG001|Overall Study|Initiation of Symptomatic AD medication|0
7499039|NCT02245737|11821259|FG002|Overall Study|Initiation of Symptomatic AD medication|0
7499040|NCT02245737|11821257|FG000|Overall Study|Lost to Follow-up|2
7499041|NCT02245737|11821258|FG001|Overall Study|Lost to Follow-up|5
7499042|NCT02245737|11821259|FG002|Overall Study|Lost to Follow-up|4
7499043|NCT02245737|11821257|FG000|Overall Study|Other-determined by Investigator|9
7499044|NCT02245737|11821258|FG001|Overall Study|Other-determined by Investigator|10
7499045|NCT02245737|11821259|FG002|Overall Study|Other-determined by Investigator|10
7499046|NCT02245737|11821257|FG000|Overall Study|Physician Decision|6
7499047|NCT02245737|11821258|FG001|Overall Study|Physician Decision|3
7499048|NCT02245737|11821259|FG002|Overall Study|Physician Decision|6
7499049|NCT02245737|11821257|FG000|Overall Study|Protocol Violation|3
7499050|NCT02245737|11821258|FG001|Overall Study|Protocol Violation|2
7499051|NCT02245737|11821259|FG002|Overall Study|Protocol Violation|3
7499052|NCT02245737|11821257|FG000|Overall Study|Withdrawal by Subject|40
7499053|NCT02245737|11821258|FG001|Overall Study|Withdrawal by Subject|41
7499054|NCT02245737|11821259|FG002|Overall Study|Withdrawal by Subject|44
7499055|NCT02245737|11821257|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
7499056|NCT02245737|11821258|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
7499057|NCT02245737|11821259|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
7499058|NCT02245737|11821257|FG000|Overall Study|Sponsor Decision|445
7499059|NCT02245737|11821258|FG001|Overall Study|Sponsor Decision|430
7499060|NCT02245737|11821259|FG002|Overall Study|Sponsor Decision|432
7499061|NCT02246166|11821308|FG000|Overall Study|Protocol Violation|1
7499062|NCT02246166|11821309|FG001|Overall Study|Protocol Violation|0
7499063|NCT02246218|11821317|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7499064|NCT02246218|11821318|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7499065|NCT02246218|11821317|FG000|Overall Study|Stopping Rule: Liver Transplant|2
7499066|NCT02246218|11821318|FG001|Overall Study|Stopping Rule: Liver Transplant|4
7499067|NCT02246218|11821317|FG000|Overall Study|Adverse Event|1
7499068|NCT02246218|11821318|FG001|Overall Study|Adverse Event|1
7499069|NCT02246218|11821317|FG000|Overall Study|Lost to Follow-up|1
7499070|NCT02246218|11821318|FG001|Overall Study|Lost to Follow-up|0
7499071|NCT02246439|11821344|FG000|Overall Study|Adverse Event|3
7499072|NCT02246439|11821345|FG001|Overall Study|Adverse Event|0
7499073|NCT02246439|11821344|FG000|Overall Study|Lost to Follow-up|7
7499074|NCT02246439|11821345|FG001|Overall Study|Lost to Follow-up|5
7499075|NCT02246439|11821344|FG000|Overall Study|Protocol Violation|0
7499076|NCT02246439|11821345|FG001|Overall Study|Protocol Violation|2
7499077|NCT02246439|11821344|FG000|Overall Study|Physician Decision|0
7499078|NCT02246439|11821345|FG001|Overall Study|Physician Decision|1
7499079|NCT02246439|11821344|FG000|Overall Study|Unkonwn|1
7499080|NCT02246439|11821345|FG001|Overall Study|Unkonwn|3
7499081|NCT02246439|11821344|FG000|Overall Study|Withdrawal by Subject|1
7499082|NCT02246439|11821345|FG001|Overall Study|Withdrawal by Subject|0
7499083|NCT02246478|11821355|FG000|Multiple-dose Phase|Protocol Violation|1
7499084|NCT02246478|11821356|FG001|Multiple-dose Phase|Protocol Violation|0
7499085|NCT02246478|11821357|FG002|Multiple-dose Phase|Protocol Violation|0
7499086|NCT02246478|11821358|FG003|Multiple-dose Phase|Protocol Violation|1
7499087|NCT02246582|11821375|FG000|Overall Study|Withdrawal by Subject|3
7499088|NCT02246582|11821376|FG001|Overall Study|Withdrawal by Subject|4
7499089|NCT02246647|11821391|FG000|Overall Study|Withdrawal by Subject|1
7499090|NCT02246647|11821392|FG001|Overall Study|Withdrawal by Subject|1
7499091|NCT02246660|11821415|FG000|Overall Study|Withdrawal by Subject|0
7499092|NCT02246660|11821416|FG001|Overall Study|Withdrawal by Subject|1
7499093|NCT02246660|11821417|FG002|Overall Study|Withdrawal by Subject|0
7499094|NCT02246660|11821415|FG000|Overall Study|Death|0
7499095|NCT02246660|11821416|FG001|Overall Study|Death|0
7499096|NCT02246660|11821417|FG002|Overall Study|Death|1
7499097|NCT02246673|11821430|FG000|Overall Study|Sponsor Decision|1
7499098|NCT02246673|11821431|FG001|Overall Study|Sponsor Decision|0
7499099|NCT02246673|11821432|FG002|Overall Study|Sponsor Decision|0
7499100|NCT02246673|11821433|FG003|Overall Study|Sponsor Decision|0
7499101|NCT02246673|11821434|FG004|Overall Study|Sponsor Decision|0
7499102|NCT02246673|11821430|FG000|Overall Study|Withdrawal by Subject|0
7499103|NCT02246673|11821431|FG001|Overall Study|Withdrawal by Subject|0
7499104|NCT02246673|11821432|FG002|Overall Study|Withdrawal by Subject|0
7499105|NCT02246673|11821433|FG003|Overall Study|Withdrawal by Subject|0
7499106|NCT02246673|11821434|FG004|Overall Study|Withdrawal by Subject|1
7499107|NCT02246673|11821430|FG000|Overall Study|Lost to Follow-up|0
7499108|NCT02246673|11821431|FG001|Overall Study|Lost to Follow-up|0
7499109|NCT02246673|11821432|FG002|Overall Study|Lost to Follow-up|0
7499110|NCT02246673|11821433|FG003|Overall Study|Lost to Follow-up|1
7499111|NCT02246673|11821434|FG004|Overall Study|Lost to Follow-up|0
7499112|NCT02246673|11821430|FG000|Overall Study|Protocol Violation|0
7499113|NCT02246673|11821431|FG001|Overall Study|Protocol Violation|0
7499114|NCT02246673|11821432|FG002|Overall Study|Protocol Violation|0
7499115|NCT02246673|11821433|FG003|Overall Study|Protocol Violation|1
7499116|NCT02246673|11821434|FG004|Overall Study|Protocol Violation|0
7499117|NCT02246764|11821479|FG000|Overall Study|Adverse Event|15
7499118|NCT02246764|11821480|FG001|Overall Study|Adverse Event|29
7499119|NCT02246764|11821481|FG002|Overall Study|Adverse Event|1
7499120|NCT02246764|11821479|FG000|Overall Study|Withdrawal by Subject|0
7499121|NCT02246764|11821480|FG001|Overall Study|Withdrawal by Subject|0
7499122|NCT02246764|11821481|FG002|Overall Study|Withdrawal by Subject|1
7499123|NCT02246764|11821479|FG000|Overall Study|Disallowed Concomitant Medication|1
7499124|NCT02246764|11821480|FG001|Overall Study|Disallowed Concomitant Medication|0
7499125|NCT02246764|11821481|FG002|Overall Study|Disallowed Concomitant Medication|0
7499126|NCT02246764|11821479|FG000|Overall Study|Physician Decision|0
7499127|NCT02246764|11821480|FG001|Overall Study|Physician Decision|2
7499128|NCT02246764|11821481|FG002|Overall Study|Physician Decision|1
7499129|NCT02246764|11821479|FG000|Overall Study|Protocol Violation|2
7499130|NCT02246764|11821480|FG001|Overall Study|Protocol Violation|1
7499131|NCT02246764|11821481|FG002|Overall Study|Protocol Violation|1
7499132|NCT02246777|11821489|FG000|Overall Study|Adverse Event|2
7499133|NCT02246777|11821489|FG000|Overall Study|Change of residence|1
7499134|NCT02246998|11821502|FG000|Overall Study|Adverse Event|0
7499135|NCT02246998|11821503|FG001|Overall Study|Adverse Event|1
7499136|NCT02246998|11821504|FG002|Overall Study|Adverse Event|1
7499137|NCT02246998|11821505|FG003|Overall Study|Adverse Event|0
7499138|NCT02246998|11821502|FG000|Overall Study|Lost to Follow-up|1
7499139|NCT02246998|11821503|FG001|Overall Study|Lost to Follow-up|0
7499140|NCT02246998|11821504|FG002|Overall Study|Lost to Follow-up|0
7499141|NCT02246998|11821505|FG003|Overall Study|Lost to Follow-up|1
7499142|NCT02246998|11821502|FG000|Overall Study|Randomized but Never Dosed|1
7499143|NCT02246998|11821503|FG001|Overall Study|Randomized but Never Dosed|2
7499144|NCT02246998|11821504|FG002|Overall Study|Randomized but Never Dosed|2
7499145|NCT02246998|11821505|FG003|Overall Study|Randomized but Never Dosed|1
7499146|NCT02247011|11821520|FG000|Overall Study|Poor quality of radiological results|125
7499147|NCT02247401|11821574|FG000|Overall Study|Adverse Event|1
7499148|NCT02247401|11821575|FG001|Overall Study|Adverse Event|0
7499149|NCT02247401|11821576|FG002|Overall Study|Adverse Event|0
7499150|NCT02247401|11821574|FG000|Overall Study|Withdrawal by Subject|4
7499151|NCT02247401|11821575|FG001|Overall Study|Withdrawal by Subject|1
7499152|NCT02247401|11821576|FG002|Overall Study|Withdrawal by Subject|1
7499153|NCT02247401|11821574|FG000|Overall Study|Lost to Follow-up|1
7499154|NCT02247401|11821575|FG001|Overall Study|Lost to Follow-up|1
7499155|NCT02247401|11821576|FG002|Overall Study|Lost to Follow-up|1
7499156|NCT02247440|11821585|FG000|Overall Study|Withdrawal by Subject|1
7499157|NCT02247440|11821585|FG000|Overall Study|Lack of Efficacy|3
7499158|NCT02247466|11821591|FG000|Overall Study|Procedure changed to open surgery|0
7499159|NCT02247466|11821592|FG001|Overall Study|Procedure changed to open surgery|3
7499160|NCT02247479|11821601|FG000|Overall Study|Adverse Event|8
7499161|NCT02247479|11821602|FG001|Overall Study|Adverse Event|9
7499162|NCT02247479|11821603|FG002|Overall Study|Adverse Event|8
7499163|NCT02247479|11821601|FG000|Overall Study|Death|5
7499164|NCT02247479|11821602|FG001|Overall Study|Death|4
7499165|NCT02247479|11821603|FG002|Overall Study|Death|6
7499166|NCT02247479|11821601|FG000|Overall Study|Lost to Follow-up|3
7499167|NCT02247479|11821602|FG001|Overall Study|Lost to Follow-up|3
7499168|NCT02247479|11821603|FG002|Overall Study|Lost to Follow-up|1
7499169|NCT02247479|11821601|FG000|Overall Study|Non-compliance|0
7499170|NCT02247479|11821602|FG001|Overall Study|Non-compliance|0
7499171|NCT02247479|11821603|FG002|Overall Study|Non-compliance|1
7499172|NCT02247479|11821601|FG000|Overall Study|Withdrawal by Subject|25
7499173|NCT02247479|11821602|FG001|Overall Study|Withdrawal by Subject|29
7499174|NCT02247479|11821603|FG002|Overall Study|Withdrawal by Subject|24
7499175|NCT02247479|11821601|FG000|Overall Study|Study Terminated by Sponsor|98
7499176|NCT02247479|11821602|FG001|Overall Study|Study Terminated by Sponsor|88
7499177|NCT02247479|11821603|FG002|Overall Study|Study Terminated by Sponsor|94
7499178|NCT02247479|11821601|FG000|Overall Study|Physician Decision|1
7499179|NCT02247479|11821602|FG001|Overall Study|Physician Decision|0
7499180|NCT02247479|11821603|FG002|Overall Study|Physician Decision|2
7499181|NCT02247479|11821601|FG000|Overall Study|Unspecified Reason|2
7499182|NCT02247479|11821602|FG001|Overall Study|Unspecified Reason|5
7499183|NCT02247479|11821603|FG002|Overall Study|Unspecified Reason|2
7499184|NCT02247531|11821614|FG000|Overall Study|Adverse Event|3
7499185|NCT02247531|11821615|FG001|Overall Study|Adverse Event|4
7499186|NCT02247531|11821616|FG002|Overall Study|Adverse Event|9
7499187|NCT02247531|11821614|FG000|Overall Study|Death|8
7499188|NCT02247531|11821615|FG001|Overall Study|Death|9
7499189|NCT02247531|11821616|FG002|Overall Study|Death|5
7499190|NCT02247531|11821614|FG000|Overall Study|Lost to Follow-up|1
7499191|NCT02247531|11821615|FG001|Overall Study|Lost to Follow-up|8
7499192|NCT02247531|11821616|FG002|Overall Study|Lost to Follow-up|3
7499193|NCT02247531|11821614|FG000|Overall Study|Non-compliance|2
7499194|NCT02247531|11821615|FG001|Overall Study|Non-compliance|2
7499195|NCT02247531|11821616|FG002|Overall Study|Non-compliance|0
7499196|NCT02247531|11821614|FG000|Overall Study|Withdrawal by Subject|26
7499197|NCT02247531|11821615|FG001|Overall Study|Withdrawal by Subject|31
7499198|NCT02247531|11821616|FG002|Overall Study|Withdrawal by Subject|25
7499199|NCT02247531|11821614|FG000|Overall Study|Study Terminated by Sponsor|64
7499200|NCT02247531|11821615|FG001|Overall Study|Study Terminated by Sponsor|66
7499201|NCT02247531|11821616|FG002|Overall Study|Study Terminated by Sponsor|62
7499202|NCT02247531|11821614|FG000|Overall Study|Physician Decision|0
7499203|NCT02247531|11821615|FG001|Overall Study|Physician Decision|2
7499204|NCT02247531|11821616|FG002|Overall Study|Physician Decision|2
7499205|NCT02247531|11821614|FG000|Overall Study|Unspecified Reason|2
7499206|NCT02247531|11821615|FG001|Overall Study|Unspecified Reason|3
7499207|NCT02247531|11821616|FG002|Overall Study|Unspecified Reason|4
7499208|NCT02247804|11821646|FG000|Treatment Period 1|Adverse Event|9
7499209|NCT02247804|11821647|FG001|Treatment Period 1|Adverse Event|2
7499210|NCT02247804|11821648|FG002|Treatment Period 1|Adverse Event|0
7499211|NCT02247804|11821646|FG000|Treatment Period 1|Lack of Efficacy|0
7499212|NCT02247804|11821647|FG001|Treatment Period 1|Lack of Efficacy|0
7499213|NCT02247804|11821648|FG002|Treatment Period 1|Lack of Efficacy|2
7499214|NCT02247804|11821646|FG000|Treatment Period 1|Lost to Follow-up|1
7499215|NCT02247804|11821647|FG001|Treatment Period 1|Lost to Follow-up|0
7499216|NCT02247804|11821648|FG002|Treatment Period 1|Lost to Follow-up|2
7499217|NCT02247804|11821646|FG000|Treatment Period 1|Personal Reasons|7
7499218|NCT02247804|11821647|FG001|Treatment Period 1|Personal Reasons|1
7499219|NCT02247804|11821648|FG002|Treatment Period 1|Personal Reasons|2
7499220|NCT02247804|11821646|FG000|Treatment Period 1|Protocol Deviation|0
7499221|NCT02247804|11821647|FG001|Treatment Period 1|Protocol Deviation|0
7499222|NCT02247804|11821648|FG002|Treatment Period 1|Protocol Deviation|1
7499223|NCT02247804|11821646|FG000|Treatment Period 1|Randomized but not Treated|5
7499224|NCT02247804|11821647|FG001|Treatment Period 1|Randomized but not Treated|1
7499225|NCT02247804|11821648|FG002|Treatment Period 1|Randomized but not Treated|1
7499226|NCT02247804|11821646|FG000|Treatment Period 2|Adverse Event|6
7499227|NCT02247804|11821647|FG001|Treatment Period 2|Adverse Event|3
7499228|NCT02247804|11821648|FG002|Treatment Period 2|Adverse Event|3
7499229|NCT02247804|11821646|FG000|Treatment Period 2|Lack of Efficacy|0
7499230|NCT02247804|11821647|FG001|Treatment Period 2|Lack of Efficacy|0
7499231|NCT02247804|11821648|FG002|Treatment Period 2|Lack of Efficacy|1
7499232|NCT02247804|11821646|FG000|Treatment Period 2|Lost to Follow-up|0
7499233|NCT02247804|11821647|FG001|Treatment Period 2|Lost to Follow-up|1
7499234|NCT02247804|11821648|FG002|Treatment Period 2|Lost to Follow-up|1
7499235|NCT02247804|11821646|FG000|Treatment Period 2|Personal Reasons|2
7499236|NCT02247804|11821647|FG001|Treatment Period 2|Personal Reasons|1
7499237|NCT02247804|11821648|FG002|Treatment Period 2|Personal Reasons|1
7499238|NCT02247804|11821646|FG000|Treatment Period 2|Reason not Specified|0
7499239|NCT02247804|11821647|FG001|Treatment Period 2|Reason not Specified|0
7499240|NCT02247804|11821648|FG002|Treatment Period 2|Reason not Specified|2
7499241|NCT02247804|11821646|FG000|Treatment Period 3|Adverse Event|4
7499242|NCT02247804|11821647|FG001|Treatment Period 3|Adverse Event|3
7499243|NCT02247804|11821648|FG002|Treatment Period 3|Adverse Event|3
7499244|NCT02247804|11821646|FG000|Treatment Period 3|Lack of Efficacy|0
7499245|NCT02247804|11821647|FG001|Treatment Period 3|Lack of Efficacy|1
7499246|NCT02247804|11821648|FG002|Treatment Period 3|Lack of Efficacy|0
7499247|NCT02247804|11821646|FG000|Treatment Period 3|Lost to Follow-up|1
7499248|NCT02247804|11821647|FG001|Treatment Period 3|Lost to Follow-up|2
7499249|NCT02247804|11821648|FG002|Treatment Period 3|Lost to Follow-up|2
7499250|NCT02247804|11821646|FG000|Treatment Period 3|Personal Reasons|4
7499251|NCT02247804|11821647|FG001|Treatment Period 3|Personal Reasons|3
7499252|NCT02247804|11821648|FG002|Treatment Period 3|Personal Reasons|2
7499253|NCT02247804|11821646|FG000|Treatment Period 3|Reason not Specified|2
7499254|NCT02247804|11821647|FG001|Treatment Period 3|Reason not Specified|1
7499255|NCT02247804|11821648|FG002|Treatment Period 3|Reason not Specified|3
7499256|NCT02247960|11821658|FG000|Patient Consent and Randomization|Physician Decision|2
7499257|NCT02247960|11821659|FG001|Patient Consent and Randomization|Physician Decision|2
7499258|NCT02247960|11821658|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
7499259|NCT02247960|11821659|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
7499260|NCT02247960|11821658|FG000|Catheter Removed|Lost to Follow-up|7
7499261|NCT02247960|11821659|FG001|Catheter Removed|Lost to Follow-up|10
7499262|NCT02248480|11821689|FG000|Overall Study|Lack of Efficacy|4
7499263|NCT02248480|11821690|FG001|Overall Study|Lack of Efficacy|6
7499264|NCT02248480|11821689|FG000|Overall Study|Adverse Event|11
7499265|NCT02248480|11821690|FG001|Overall Study|Adverse Event|2
7499266|NCT02248480|11821689|FG000|Overall Study|Withdrawal by Subject|2
7499267|NCT02248480|11821690|FG001|Overall Study|Withdrawal by Subject|4
7499268|NCT02248480|11821689|FG000|Overall Study|Entry Criteria Not Met|0
7499269|NCT02248480|11821690|FG001|Overall Study|Entry Criteria Not Met|1
7499270|NCT02248480|11821689|FG000|Overall Study|Other:Physician Decision|0
7499271|NCT02248480|11821690|FG001|Overall Study|Other:Physician Decision|1
7499272|NCT02248649|11821719|FG000|Overall Study|Death|7
7499273|NCT02248649|11821720|FG001|Overall Study|Death|11
7499274|NCT02248649|11821719|FG000|Overall Study|Lost to Follow-up|14
7499275|NCT02248649|11821720|FG001|Overall Study|Lost to Follow-up|10
7499276|NCT02248675|11821741|FG000|Overall Study|Lost to Follow-up|3
7499277|NCT02248675|11821742|FG001|Overall Study|Lost to Follow-up|1
7535587|NCT02711956|11883406|FG014|Overall Study|Withdrawal by Subject|1
7535588|NCT02711956|11883392|FG000|Overall Study|Clinical progression|1
7535589|NCT02711956|11883393|FG001|Overall Study|Clinical progression|0
7535590|NCT02711956|11883394|FG002|Overall Study|Clinical progression|0
7535591|NCT02711956|11883395|FG003|Overall Study|Clinical progression|0
7535592|NCT02711956|11883396|FG004|Overall Study|Clinical progression|0
7535593|NCT02711956|11883397|FG005|Overall Study|Clinical progression|0
7535594|NCT02711956|11883398|FG006|Overall Study|Clinical progression|1
7535595|NCT02711956|11883399|FG007|Overall Study|Clinical progression|0
7535596|NCT02711956|11883400|FG008|Overall Study|Clinical progression|1
7535597|NCT02711956|11883401|FG009|Overall Study|Clinical progression|0
7535598|NCT02711956|11883402|FG010|Overall Study|Clinical progression|0
7535599|NCT02711956|11883403|FG011|Overall Study|Clinical progression|2
7535600|NCT02711956|11883404|FG012|Overall Study|Clinical progression|4
7535601|NCT02711956|11883405|FG013|Overall Study|Clinical progression|1
7535602|NCT02711956|11883406|FG014|Overall Study|Clinical progression|1
7535603|NCT02711956|11883392|FG000|Overall Study|Radiographic progression|1
7535604|NCT02711956|11883393|FG001|Overall Study|Radiographic progression|1
7535605|NCT02711956|11883394|FG002|Overall Study|Radiographic progression|2
7535606|NCT02711956|11883395|FG003|Overall Study|Radiographic progression|0
7535607|NCT02711956|11883396|FG004|Overall Study|Radiographic progression|1
7535608|NCT02711956|11883397|FG005|Overall Study|Radiographic progression|0
7535609|NCT02711956|11883398|FG006|Overall Study|Radiographic progression|0
7535610|NCT02711956|11883399|FG007|Overall Study|Radiographic progression|0
7535611|NCT02711956|11883400|FG008|Overall Study|Radiographic progression|2
7535612|NCT02711956|11883401|FG009|Overall Study|Radiographic progression|1
7535613|NCT02711956|11883402|FG010|Overall Study|Radiographic progression|0
7535614|NCT02711956|11883403|FG011|Overall Study|Radiographic progression|5
7499278|NCT02248818|11821780|FG000|Screening|Protocol Violation|0
7499279|NCT02248818|11821781|FG001|Screening|Protocol Violation|0
7499280|NCT02248818|11821782|FG002|Screening|Protocol Violation|0
7499281|NCT02248818|11821783|FG003|Screening|Protocol Violation|0
7499282|NCT02248818|11821784|FG004|Screening|Protocol Violation|0
7499283|NCT02248818|11821785|FG005|Screening|Protocol Violation|0
7499284|NCT02248818|11821786|FG006|Screening|Protocol Violation|0
7499285|NCT02248818|11821787|FG007|Screening|Protocol Violation|0
7499286|NCT02248818|11821788|FG008|Screening|Protocol Violation|7
7499287|NCT02248818|11821780|FG000|Screening|Study fully enrolled|0
7499288|NCT02248818|11821781|FG001|Screening|Study fully enrolled|0
7499289|NCT02248818|11821782|FG002|Screening|Study fully enrolled|0
7499290|NCT02248818|11821783|FG003|Screening|Study fully enrolled|0
7499291|NCT02248818|11821784|FG004|Screening|Study fully enrolled|0
7499292|NCT02248818|11821785|FG005|Screening|Study fully enrolled|0
7499293|NCT02248818|11821786|FG006|Screening|Study fully enrolled|0
7499294|NCT02248818|11821787|FG007|Screening|Study fully enrolled|0
7499295|NCT02248818|11821788|FG008|Screening|Study fully enrolled|14
7499296|NCT02248818|11821780|FG000|Screening|Physician Decision|0
7499297|NCT02248818|11821781|FG001|Screening|Physician Decision|0
7499298|NCT02248818|11821782|FG002|Screening|Physician Decision|0
7499299|NCT02248818|11821783|FG003|Screening|Physician Decision|0
7499300|NCT02248818|11821784|FG004|Screening|Physician Decision|0
7499301|NCT02248818|11821785|FG005|Screening|Physician Decision|0
7499302|NCT02248818|11821786|FG006|Screening|Physician Decision|0
7499303|NCT02248818|11821787|FG007|Screening|Physician Decision|0
7499304|NCT02248818|11821788|FG008|Screening|Physician Decision|73
7499305|NCT02248818|11821780|FG000|Screening|Withdrawal by Subject|0
7499306|NCT02248818|11821781|FG001|Screening|Withdrawal by Subject|0
7499307|NCT02248818|11821782|FG002|Screening|Withdrawal by Subject|0
7499308|NCT02248818|11821783|FG003|Screening|Withdrawal by Subject|0
7499309|NCT02248818|11821784|FG004|Screening|Withdrawal by Subject|0
7499310|NCT02248818|11821785|FG005|Screening|Withdrawal by Subject|0
7499311|NCT02248818|11821786|FG006|Screening|Withdrawal by Subject|0
7499312|NCT02248818|11821787|FG007|Screening|Withdrawal by Subject|0
7499313|NCT02248818|11821788|FG008|Screening|Withdrawal by Subject|6
7499314|NCT02248818|11821780|FG000|Screening|Lost to Follow-up|0
7499315|NCT02248818|11821781|FG001|Screening|Lost to Follow-up|0
7499316|NCT02248818|11821782|FG002|Screening|Lost to Follow-up|0
7499317|NCT02248818|11821783|FG003|Screening|Lost to Follow-up|0
7499318|NCT02248818|11821784|FG004|Screening|Lost to Follow-up|0
7499319|NCT02248818|11821785|FG005|Screening|Lost to Follow-up|0
7499320|NCT02248818|11821786|FG006|Screening|Lost to Follow-up|0
7499321|NCT02248818|11821787|FG007|Screening|Lost to Follow-up|0
7499322|NCT02248818|11821788|FG008|Screening|Lost to Follow-up|7
7499323|NCT02248818|11821780|FG000|Randomised Study|Administrative - randomization error|0
7499324|NCT02248818|11821781|FG001|Randomised Study|Administrative - randomization error|0
7499325|NCT02248818|11821782|FG002|Randomised Study|Administrative - randomization error|0
7499326|NCT02248818|11821783|FG003|Randomised Study|Administrative - randomization error|0
7499327|NCT02248818|11821784|FG004|Randomised Study|Administrative - randomization error|0
7499328|NCT02248818|11821785|FG005|Randomised Study|Administrative - randomization error|8
7499329|NCT02248818|11821786|FG006|Randomised Study|Administrative - randomization error|0
7499330|NCT02248818|11821787|FG007|Randomised Study|Administrative - randomization error|0
7499331|NCT02248818|11821788|FG008|Randomised Study|Administrative - randomization error|0
7499332|NCT02248857|11821809|FG000|3 Month|Withdrawal by Subject|9
7499333|NCT02248857|11821810|FG001|3 Month|Withdrawal by Subject|3
7499334|NCT02248857|11821811|FG002|3 Month|Withdrawal by Subject|4
7499335|NCT02248857|11821809|FG000|3 Month|Unable to reach for 3 month|35
7499336|NCT02248857|11821810|FG001|3 Month|Unable to reach for 3 month|29
7499337|NCT02248857|11821811|FG002|3 Month|Unable to reach for 3 month|26
7499338|NCT02248857|11821809|FG000|3 Month|Partially completed, unable to finish|2
7499339|NCT02248857|11821810|FG001|3 Month|Partially completed, unable to finish|2
7499340|NCT02248857|11821811|FG002|3 Month|Partially completed, unable to finish|1
7499341|NCT02248857|11821809|FG000|6 Month|Lost to Follow-up|27
7499342|NCT02248857|11821810|FG001|6 Month|Lost to Follow-up|26
7499343|NCT02248857|11821811|FG002|6 Month|Lost to Follow-up|15
7499344|NCT02248857|11821809|FG000|6 Month|Partially completed, unable to finish|0
7499345|NCT02248857|11821810|FG001|6 Month|Partially completed, unable to finish|1
7499346|NCT02248857|11821811|FG002|6 Month|Partially completed, unable to finish|0
7499347|NCT02248857|11821809|FG000|6 Month|Withdrawal by Subject|0
7499348|NCT02248857|11821810|FG001|6 Month|Withdrawal by Subject|2
7499349|NCT02248857|11821811|FG002|6 Month|Withdrawal by Subject|2
7499350|NCT02248857|11821809|FG000|6 Month|Death|1
7499351|NCT02248857|11821810|FG001|6 Month|Death|0
7499352|NCT02248857|11821811|FG002|6 Month|Death|0
7499353|NCT02248961|11821829|FG000|Overall Study|Adverse Event|1
7499354|NCT02248961|11821830|FG001|Overall Study|Adverse Event|0
7499355|NCT02248961|11821829|FG000|Overall Study|Withdrawal by Subject|1
7499356|NCT02248961|11821830|FG001|Overall Study|Withdrawal by Subject|2
7499357|NCT02248961|11821829|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
7499358|NCT02248961|11821830|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
7499359|NCT02248974|11821838|FG000|1-Day Follow-Up|Lost to Follow-up|4
7499360|NCT02248974|11821839|FG001|1-Day Follow-Up|Lost to Follow-up|0
7499361|NCT02248974|11821838|FG000|1-Day Follow-Up|Withdrawal by Subject|5
7499362|NCT02248974|11821839|FG001|1-Day Follow-Up|Withdrawal by Subject|0
7499363|NCT02248974|11821838|FG000|1-Day Follow-Up|Enrolled in another study|1
7499364|NCT02248974|11821839|FG001|1-Day Follow-Up|Enrolled in another study|0
7499365|NCT02248974|11821838|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
7499366|NCT02248974|11821839|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
7499367|NCT02248974|11821838|FG000|1-Week Follow-Up|Enrolled in another study|1
7499368|NCT02248974|11821839|FG001|1-Week Follow-Up|Enrolled in another study|1
7499369|NCT02248974|11821838|FG000|1-Week Follow-Up|Transferred to another facility|1
7499370|NCT02248974|11821839|FG001|1-Week Follow-Up|Transferred to another facility|0
7499371|NCT02248974|11821838|FG000|1-Week Follow-Up|Cognitive Difficulty|1
7499372|NCT02248974|11821839|FG001|1-Week Follow-Up|Cognitive Difficulty|0
7499373|NCT02248974|11821838|FG000|1-Week Follow-Up|Death|1
7499374|NCT02248974|11821839|FG001|1-Week Follow-Up|Death|1
7499375|NCT02248974|11821838|FG000|1-Week Follow-Up|Excluded because of age|0
7499376|NCT02248974|11821839|FG001|1-Week Follow-Up|Excluded because of age|1
7499377|NCT02248974|11821838|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
7499378|NCT02248974|11821839|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
7499379|NCT02248974|11821838|FG000|1-Week Follow-Up|Timing: implanted before survey|0
7499380|NCT02248974|11821839|FG001|1-Week Follow-Up|Timing: implanted before survey|2
7499381|NCT02248974|11821838|FG000|1-Week Follow-Up|Withdrawal by Subject|0
7499382|NCT02248974|11821839|FG001|1-Week Follow-Up|Withdrawal by Subject|2
7499383|NCT02248974|11821838|FG000|1-Week Follow-Up|Lost to Follow-up|0
7499384|NCT02248974|11821839|FG001|1-Week Follow-Up|Lost to Follow-up|8
7499385|NCT02248974|11821838|FG000|1-Month Follow-Up|Lost to Follow-up|2
7499386|NCT02248974|11821839|FG001|1-Month Follow-Up|Lost to Follow-up|3
7499387|NCT02249091|11821859|FG000|Overall Study|Lack of Efficacy|8
7499388|NCT02249091|11821860|FG001|Overall Study|Lack of Efficacy|3
7499389|NCT02249091|11821859|FG000|Overall Study|Physician Decision|4
7499390|NCT02249091|11821860|FG001|Overall Study|Physician Decision|1
7499391|NCT02249091|11821859|FG000|Overall Study|Withdrawal by Subject|2
7499392|NCT02249091|11821860|FG001|Overall Study|Withdrawal by Subject|2
7499393|NCT02249091|11821859|FG000|Overall Study|Death|3
7499394|NCT02249091|11821860|FG001|Overall Study|Death|4
7499395|NCT02249091|11821859|FG000|Overall Study|Adverse Event|1
7499396|NCT02249091|11821860|FG001|Overall Study|Adverse Event|0
7499397|NCT02249091|11821859|FG000|Overall Study|Stable disease with following SCT|0
7499398|NCT02249091|11821860|FG001|Overall Study|Stable disease with following SCT|1
7499399|NCT02249091|11821859|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
7499400|NCT02249091|11821860|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
7499401|NCT02249091|11821859|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
7499402|NCT02249091|11821860|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
7499403|NCT02249091|11821859|FG000|Overall Study|Refractory AML|1
7499404|NCT02249091|11821860|FG001|Overall Study|Refractory AML|1
7499405|NCT02249182|11821884|FG000|Treatment Phase|Lost to Follow-up|4
7499406|NCT02249182|11821885|FG001|Treatment Phase|Lost to Follow-up|0
7499407|NCT02249182|11821886|FG002|Treatment Phase|Lost to Follow-up|0
7499408|NCT02249182|11821887|FG003|Treatment Phase|Lost to Follow-up|0
7499409|NCT02249182|11821888|FG004|Treatment Phase|Lost to Follow-up|0
7499410|NCT02249767|11821936|FG000|Overall Study|Did not use medication|8
7499411|NCT02249767|11821937|FG001|Overall Study|Did not use medication|9
7499412|NCT02249767|11821938|FG002|Overall Study|Did not use medication|8
7499413|NCT02249832|11821958|FG000|Overall Study|Withdrawal by Subject|3
7499414|NCT02249832|11821958|FG000|Overall Study|Lost to Follow-up|10
7499415|NCT02249949|11821967|FG000|Overall Study|Cancelled prior to treatment|2
7499416|NCT02250183|11821980|FG000|Overall Study|Withdrawal by Subject|2
7499417|NCT02250183|11821980|FG000|Overall Study|Adverse Event|5
7499418|NCT02250183|11821980|FG000|Overall Study|Lost to Follow-up|1
7499419|NCT02250274|11821989|FG000|Overall Study|Insufficient blood draw amount|7
7499420|NCT02250274|11821990|FG001|Overall Study|Insufficient blood draw amount|6
7499421|NCT02250443|11822012|FG000|Overall Study|Administrative problems|7
7499422|NCT02250443|11822012|FG000|Overall Study|Adverse Event|3
7499423|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
7499424|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7499425|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
7499426|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
7499427|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7499428|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
7499429|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
7499430|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
7499431|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
7499432|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
7499433|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7499434|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
7499435|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7499436|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
7499437|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
7499438|NCT02250651|11822051|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
7535615|NCT02711956|11883404|FG012|Overall Study|Radiographic progression|3
7499439|NCT02250651|11822052|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
7499440|NCT02250651|11822053|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
7499441|NCT02250651|11822051|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
7499442|NCT02250651|11822052|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
7499443|NCT02250651|11822053|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
7499444|NCT02250651|11822051|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7499445|NCT02250651|11822052|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
7499446|NCT02250651|11822053|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
7499447|NCT02250651|11822051|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7499448|NCT02250651|11822052|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
7499449|NCT02250651|11822053|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
7499450|NCT02250651|11822051|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7499451|NCT02250651|11822052|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
7499452|NCT02250651|11822053|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
7499453|NCT02250651|11822051|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7499454|NCT02250651|11822052|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
7499455|NCT02250651|11822053|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
7499456|NCT02250651|11822051|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
7499457|NCT02250651|11822052|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7499458|NCT02250651|11822053|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
7499459|NCT02250651|11822051|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7499460|NCT02250651|11822052|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
7499461|NCT02250651|11822053|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
7499462|NCT02250651|11822051|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7499463|NCT02250651|11822052|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
7499464|NCT02250651|11822053|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
7499465|NCT02250651|11822051|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
7499466|NCT02250651|11822052|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7499467|NCT02250651|11822053|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
7499468|NCT02251275|11822092|FG000|Overall Study|Adverse Event|23
7499469|NCT02251275|11822093|FG001|Overall Study|Adverse Event|60
7499470|NCT02251275|11822094|FG002|Overall Study|Adverse Event|28
7499471|NCT02251275|11822095|FG003|Overall Study|Adverse Event|0
7499472|NCT02251275|11822096|FG004|Overall Study|Adverse Event|0
7499473|NCT02251275|11822092|FG000|Overall Study|Lost to Follow-up|5
7499474|NCT02251275|11822093|FG001|Overall Study|Lost to Follow-up|6
7499475|NCT02251275|11822094|FG002|Overall Study|Lost to Follow-up|4
7499476|NCT02251275|11822095|FG003|Overall Study|Lost to Follow-up|0
7499477|NCT02251275|11822096|FG004|Overall Study|Lost to Follow-up|0
7499478|NCT02251275|11822092|FG000|Overall Study|Physician Decision|19
7499479|NCT02251275|11822093|FG001|Overall Study|Physician Decision|30
7499480|NCT02251275|11822094|FG002|Overall Study|Physician Decision|26
7499481|NCT02251275|11822095|FG003|Overall Study|Physician Decision|0
7499482|NCT02251275|11822096|FG004|Overall Study|Physician Decision|1
7499483|NCT02251275|11822092|FG000|Overall Study|Protocol Deviation|0
7499484|NCT02251275|11822093|FG001|Overall Study|Protocol Deviation|0
7499485|NCT02251275|11822094|FG002|Overall Study|Protocol Deviation|1
7499486|NCT02251275|11822095|FG003|Overall Study|Protocol Deviation|0
7499487|NCT02251275|11822096|FG004|Overall Study|Protocol Deviation|0
7499488|NCT02251275|11822092|FG000|Overall Study|Withdrawal by Subject|25
7499489|NCT02251275|11822093|FG001|Overall Study|Withdrawal by Subject|51
7499490|NCT02251275|11822094|FG002|Overall Study|Withdrawal by Subject|35
7499491|NCT02251275|11822095|FG003|Overall Study|Withdrawal by Subject|1
7499492|NCT02251275|11822096|FG004|Overall Study|Withdrawal by Subject|0
7499493|NCT02251652|11822138|FG000|Overall Study|Withdrawal by Subject|1
7499494|NCT02251717|11822146|FG000|Overall Study|Adverse Event|0
7499495|NCT02251717|11822147|FG001|Overall Study|Adverse Event|1
7499496|NCT02251717|11822146|FG000|Overall Study|Withdrew Consent|1
7499497|NCT02251717|11822147|FG001|Overall Study|Withdrew Consent|0
7499498|NCT02251743|11822155|FG000|Overall Study|Withdrawal by Subject|1
7499499|NCT02251743|11822156|FG001|Overall Study|Withdrawal by Subject|1
7499500|NCT02251912|11822181|FG000|Overall Study|Withdrawal by Subject|2
7499501|NCT02251912|11822182|FG001|Overall Study|Withdrawal by Subject|3
7499502|NCT02251912|11822181|FG000|Overall Study|Adverse Event|0
7499503|NCT02251912|11822182|FG001|Overall Study|Adverse Event|2
7499504|NCT02251990|11822194|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
7499505|NCT02251990|11822195|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
7499506|NCT02251990|11822194|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
7499507|NCT02251990|11822195|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
7499508|NCT02251990|11822194|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
7499509|NCT02251990|11822195|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
7499510|NCT02251990|11822194|FG000|Period 1 (Double-blind [DB])|Not Treated|1
7499511|NCT02251990|11822195|FG001|Period 1 (Double-blind [DB])|Not Treated|0
7499512|NCT02251990|11822194|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
7499513|NCT02251990|11822195|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
7499514|NCT02251990|11822194|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
7499515|NCT02251990|11822195|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
7499516|NCT02252016|11822204|FG000|Overall Study|Lost to Follow-up|2
7499517|NCT02252016|11822205|FG001|Overall Study|Lost to Follow-up|1
7499518|NCT02252016|11822204|FG000|Overall Study|Physician Decision|1
7499519|NCT02252016|11822205|FG001|Overall Study|Physician Decision|0
7499520|NCT02252016|11822204|FG000|Overall Study|Withdrawal by Subject|0
7499521|NCT02252016|11822205|FG001|Overall Study|Withdrawal by Subject|2
7499530|NCT02252081|11822235|FG000|Overall Study|Withdrawal by Subject|2
7499531|NCT02252081|11822236|FG001|Overall Study|Withdrawal by Subject|1
7499532|NCT02252081|11822235|FG000|Overall Study|Adverse Event|4
7499533|NCT02252081|11822236|FG001|Overall Study|Adverse Event|1
7499534|NCT02252081|11822235|FG000|Overall Study|non compliance & others|0
7499535|NCT02252081|11822236|FG001|Overall Study|non compliance & others|2
7499536|NCT02252146|11822254|FG000|Overall Study|Lack of Efficacy|4
7499537|NCT02252146|11822254|FG000|Overall Study|Entered hospice care|1
7499538|NCT02252146|11822254|FG000|Overall Study|Inability to travel to study site|1
7499539|NCT02252211|11822260|FG000|Overall Study|Adverse Event|0
7499540|NCT02252211|11822261|FG001|Overall Study|Adverse Event|1
7499541|NCT02252211|11822262|FG002|Overall Study|Adverse Event|0
7499542|NCT02252211|11822260|FG000|Overall Study|Progressive disease|3
7499543|NCT02252211|11822261|FG001|Overall Study|Progressive disease|2
7499544|NCT02252211|11822262|FG002|Overall Study|Progressive disease|0
7499545|NCT02252211|11822260|FG000|Overall Study|Withdrawal by Subject|1
7499546|NCT02252211|11822261|FG001|Overall Study|Withdrawal by Subject|0
7499547|NCT02252211|11822262|FG002|Overall Study|Withdrawal by Subject|0
7499548|NCT02252211|11822260|FG000|Overall Study|Serious Adverse Event During Screening|1
7499549|NCT02252211|11822261|FG001|Overall Study|Serious Adverse Event During Screening|0
7499550|NCT02252211|11822262|FG002|Overall Study|Serious Adverse Event During Screening|1
7499551|NCT02252406|11822280|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
7499552|NCT02252406|11822281|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
7499553|NCT02252406|11822280|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
7499554|NCT02252406|11822281|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
7499555|NCT02252406|11822280|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
7499556|NCT02252406|11822281|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
7499557|NCT02252406|11822280|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7499558|NCT02252406|11822281|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
7499559|NCT02252406|11822280|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
7499560|NCT02252406|11822281|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
7499561|NCT02252536|11822298|FG000|Overall Study|Lost to Follow-up|5
7499562|NCT02252536|11822299|FG001|Overall Study|Lost to Follow-up|3
7499563|NCT02252588|11822317|FG000|Overall Study|Withdrawal by Subject|4
7499564|NCT02252588|11822318|FG001|Overall Study|Withdrawal by Subject|0
7499565|NCT02252939|11822336|FG000|Overall Study|Lost to Follow-up|3
7499566|NCT02252965|11822347|FG000|Overall Study|Adverse Event|9
7499567|NCT02252965|11822348|FG001|Overall Study|Adverse Event|14
7499568|NCT02252965|11822347|FG000|Overall Study|Lost to Follow-up|16
7499569|NCT02252965|11822348|FG001|Overall Study|Lost to Follow-up|8
7499570|NCT02252965|11822347|FG000|Overall Study|Protocol Violation|4
7499571|NCT02252965|11822348|FG001|Overall Study|Protocol Violation|5
7499572|NCT02252965|11822347|FG000|Overall Study|Lack of Efficacy|0
7499573|NCT02252965|11822348|FG001|Overall Study|Lack of Efficacy|2
7499574|NCT02252965|11822347|FG000|Overall Study|Withdrawal by Subject|7
7499575|NCT02252965|11822348|FG001|Overall Study|Withdrawal by Subject|9
7499576|NCT02252965|11822347|FG000|Overall Study|Other|4
7499577|NCT02252965|11822348|FG001|Overall Study|Other|5
7499578|NCT02253147|11822356|FG000|Overall Study|Protocol Violation|30
7499579|NCT02253147|11822356|FG000|Overall Study|Did not consent to study extension|9
7499580|NCT02253147|11822356|FG000|Overall Study|Conditional re-treatment at W52|5
7499581|NCT02253147|11822356|FG000|Overall Study|Lost to Follow-up|2
7499582|NCT02253147|11822356|FG000|Overall Study|Withdrawal by Subject|1
7499583|NCT02253433|11822400|FG000|Overall Study|Unable to Contact|9
7499584|NCT02253433|11822401|FG001|Overall Study|Unable to Contact|16
7499585|NCT02253433|11822400|FG000|Overall Study|Death|1
7499586|NCT02253433|11822401|FG001|Overall Study|Death|1
7499587|NCT02253433|11822400|FG000|Overall Study|No Longer Interested|3
7499588|NCT02253433|11822401|FG001|Overall Study|No Longer Interested|15
7499589|NCT02253433|11822400|FG000|Overall Study|Out of Study Area|2
7499590|NCT02253433|11822401|FG001|Overall Study|Out of Study Area|7
7499591|NCT02253433|11822400|FG000|Overall Study|Uncomfortable with home visitors|0
7499592|NCT02253433|11822401|FG001|Overall Study|Uncomfortable with home visitors|3
7499593|NCT02253433|11822400|FG000|Overall Study|Unstable Housing/Homeless|0
7499594|NCT02253433|11822401|FG001|Overall Study|Unstable Housing/Homeless|7
7499595|NCT02253433|11822400|FG000|Overall Study|Too Busy|0
7499596|NCT02253433|11822401|FG001|Overall Study|Too Busy|4
7499597|NCT02253433|11822400|FG000|Overall Study|Medical or Other Concerns|1
7499598|NCT02253433|11822401|FG001|Overall Study|Medical or Other Concerns|2
7499599|NCT02253654|11822414|FG000|Overall Study|Withdrawal by Subject|12
7499600|NCT02253654|11822415|FG001|Overall Study|Withdrawal by Subject|4
7499601|NCT02253654|11822414|FG000|Overall Study|Decision by Sponsor|1
7499602|NCT02253654|11822415|FG001|Overall Study|Decision by Sponsor|1
7499603|NCT02253654|11822414|FG000|Overall Study|Lost to Follow-up|2
7499604|NCT02253654|11822415|FG001|Overall Study|Lost to Follow-up|5
7499605|NCT02253654|11822414|FG000|Overall Study|Death|4
7499606|NCT02253654|11822415|FG001|Overall Study|Death|7
7499607|NCT02253654|11822414|FG000|Overall Study|Did Not Receive Study Treatment|4
7499608|NCT02253654|11822415|FG001|Overall Study|Did Not Receive Study Treatment|1
7499609|NCT02253992|11822424|FG000|Overall Study|Study drug toxicity|1
7499610|NCT02253992|11822425|FG001|Overall Study|Study drug toxicity|0
7499611|NCT02253992|11822426|FG002|Overall Study|Study drug toxicity|10
7499612|NCT02253992|11822424|FG000|Overall Study|Disease progression|4
7499613|NCT02253992|11822425|FG001|Overall Study|Disease progression|3
7499614|NCT02253992|11822426|FG002|Overall Study|Disease progression|98
7499615|NCT02253992|11822424|FG000|Overall Study|Withdrawal by Subject|0
7499616|NCT02253992|11822425|FG001|Overall Study|Withdrawal by Subject|0
7499617|NCT02253992|11822426|FG002|Overall Study|Withdrawal by Subject|3
7499618|NCT02253992|11822424|FG000|Overall Study|Adverse Event|0
7499619|NCT02253992|11822425|FG001|Overall Study|Adverse Event|0
7499620|NCT02253992|11822426|FG002|Overall Study|Adverse Event|8
7499621|NCT02253992|11822424|FG000|Overall Study|Death|0
7499622|NCT02253992|11822425|FG001|Overall Study|Death|0
7499623|NCT02253992|11822426|FG002|Overall Study|Death|1
7499624|NCT02253992|11822424|FG000|Overall Study|Subject discontinued study drug|1
7499625|NCT02253992|11822425|FG001|Overall Study|Subject discontinued study drug|0
7499626|NCT02253992|11822426|FG002|Overall Study|Subject discontinued study drug|1
7499627|NCT02253992|11822424|FG000|Overall Study|Completed treatment as per protocol|0
7499628|NCT02253992|11822425|FG001|Overall Study|Completed treatment as per protocol|1
7499629|NCT02253992|11822426|FG002|Overall Study|Completed treatment as per protocol|22
7499630|NCT02253992|11822424|FG000|Overall Study|Other|0
7499631|NCT02253992|11822425|FG001|Overall Study|Other|0
7499632|NCT02253992|11822426|FG002|Overall Study|Other|1
7499633|NCT02254291|11822473|FG000|Overall Study|Withdrawal by Subject|0
7499634|NCT02254291|11822474|FG001|Overall Study|Withdrawal by Subject|3
7499635|NCT02254291|11822475|FG002|Overall Study|Withdrawal by Subject|1
7499636|NCT02254291|11822473|FG000|Overall Study|Missing follow-up information|0
7499637|NCT02254291|11822474|FG001|Overall Study|Missing follow-up information|0
7499638|NCT02254291|11822475|FG002|Overall Study|Missing follow-up information|1
7499639|NCT02254304|11822485|FG000|Overall Study|Adverse Event|2
7499640|NCT02254304|11822486|FG001|Overall Study|Adverse Event|1
7499641|NCT02254304|11822485|FG000|Overall Study|Lost to Follow-up|2
7499642|NCT02254304|11822486|FG001|Overall Study|Lost to Follow-up|2
7499643|NCT02254304|11822485|FG000|Overall Study|Protocol Violation|1
7499644|NCT02254304|11822486|FG001|Overall Study|Protocol Violation|0
7499645|NCT02254304|11822485|FG000|Overall Study|Withdrawal by Subject|3
7499646|NCT02254304|11822486|FG001|Overall Study|Withdrawal by Subject|0
7499647|NCT02254304|11822485|FG000|Overall Study|Injection site pain and Injection fear|1
7499648|NCT02254304|11822486|FG001|Overall Study|Injection site pain and Injection fear|0
7499649|NCT02254304|11822485|FG000|Overall Study|Personal causes|4
7499650|NCT02254304|11822486|FG001|Overall Study|Personal causes|1
7499651|NCT02254304|11822485|FG000|Overall Study|Personal decision|1
7499652|NCT02254304|11822486|FG001|Overall Study|Personal decision|0
7499653|NCT02254408|11822496|FG000|Overall Study|Randomized But Not Treated|1
7499654|NCT02254408|11822497|FG001|Overall Study|Randomized But Not Treated|3
7499655|NCT02254408|11822496|FG000|Overall Study|Adverse Event|1
7499656|NCT02254408|11822497|FG001|Overall Study|Adverse Event|0
7499657|NCT02254408|11822496|FG000|Overall Study|Death|2
7499658|NCT02254408|11822497|FG001|Overall Study|Death|3
7499659|NCT02254408|11822496|FG000|Overall Study|Investigator's Discretion|0
7499660|NCT02254408|11822497|FG001|Overall Study|Investigator's Discretion|1
7499661|NCT02254408|11822496|FG000|Overall Study|Withdrawal by Subject|3
7499662|NCT02254408|11822497|FG001|Overall Study|Withdrawal by Subject|3
7499663|NCT02254408|11822496|FG000|Overall Study|Lost to Follow-up|1
7499664|NCT02254408|11822497|FG001|Overall Study|Lost to Follow-up|0
7499665|NCT02254421|11822505|FG000|Overall Study|Randomized but Not Treated|1
7499666|NCT02254421|11822506|FG001|Overall Study|Randomized but Not Treated|0
7499667|NCT02254421|11822505|FG000|Overall Study|Death|0
7499668|NCT02254421|11822506|FG001|Overall Study|Death|2
7499669|NCT02254421|11822505|FG000|Overall Study|Withdrew Consent|1
7499670|NCT02254421|11822506|FG001|Overall Study|Withdrew Consent|1
7499671|NCT02254460|11822512|FG000|Overall Study|Adverse Event|1
7499672|NCT02254460|11822513|FG001|Overall Study|Adverse Event|0
7499673|NCT02254486|11822530|FG000|Overall Study|Adverse Event|1
7499674|NCT02254486|11822531|FG001|Overall Study|Adverse Event|1
7499675|NCT02254486|11822530|FG000|Overall Study|Lack of Efficacy|1
7499676|NCT02254486|11822531|FG001|Overall Study|Lack of Efficacy|0
7499677|NCT02254486|11822530|FG000|Overall Study|Lost to Follow-up|2
7499678|NCT02254486|11822531|FG001|Overall Study|Lost to Follow-up|4
7499679|NCT02254486|11822530|FG000|Overall Study|Protocol Violation|1
7499680|NCT02254486|11822531|FG001|Overall Study|Protocol Violation|2
7499681|NCT02254486|11822530|FG000|Overall Study|Withdrawal by Subject|17
7499682|NCT02254486|11822531|FG001|Overall Study|Withdrawal by Subject|15
7499683|NCT02254486|11822530|FG000|Overall Study|GFR<60mL/min|16
7499684|NCT02254486|11822531|FG001|Overall Study|GFR<60mL/min|21
7499685|NCT02254486|11822530|FG000|Overall Study|Various|12
7499686|NCT02254486|11822531|FG001|Overall Study|Various|12
7499687|NCT02254551|11822537|FG000|Dose Escalation|Physician Decision|1
7499688|NCT02254551|11822537|FG000|Dose Escalation|Dose-limiting toxicity|2
7499689|NCT02254681|11822544|FG000|Overall Study|Lack of Efficacy|6
7499690|NCT02254772|11822549|FG000|Overall Study|Ineligible|1
7499691|NCT02254772|11822549|FG000|Overall Study|Withdrawal by Subject|1
7499692|NCT02255149|11822566|FG000|Overall Study|Lost to Follow-up|2
7499693|NCT02255149|11822566|FG000|Overall Study|Withdrawal by Subject|1
7499694|NCT02255149|11822566|FG000|Overall Study|Withdrawal by PI|1
7499695|NCT02255149|11822566|FG000|Overall Study|Implant Failure|1
7499696|NCT02255279|11822585|FG000|Overall Study|Lost to Follow-up|2
7499697|NCT02255279|11822586|FG001|Overall Study|Lost to Follow-up|2
7499698|NCT02255279|11822585|FG000|Overall Study|Protocol Violation|0
7499699|NCT02255279|11822586|FG001|Overall Study|Protocol Violation|1
7499700|NCT02255279|11822585|FG000|Overall Study|Withdrawal by Subject|3
7499701|NCT02255279|11822586|FG001|Overall Study|Withdrawal by Subject|6
7499702|NCT02255422|11822622|FG000|Overall Study|Withdrawal by Subject|0
7499703|NCT02255422|11822623|FG001|Overall Study|Withdrawal by Subject|0
7499704|NCT02255422|11822624|FG002|Overall Study|Withdrawal by Subject|0
7499705|NCT02255422|11822625|FG003|Overall Study|Withdrawal by Subject|0
7499706|NCT02255422|11822626|FG004|Overall Study|Withdrawal by Subject|0
7499707|NCT02255422|11822627|FG005|Overall Study|Withdrawal by Subject|0
7499708|NCT02255422|11822628|FG006|Overall Study|Withdrawal by Subject|2
7499709|NCT02255422|11822622|FG000|Overall Study|Lost to Follow-up|0
7499710|NCT02255422|11822623|FG001|Overall Study|Lost to Follow-up|0
7499711|NCT02255422|11822624|FG002|Overall Study|Lost to Follow-up|1
7499712|NCT02255422|11822625|FG003|Overall Study|Lost to Follow-up|0
7499713|NCT02255422|11822626|FG004|Overall Study|Lost to Follow-up|0
7499714|NCT02255422|11822627|FG005|Overall Study|Lost to Follow-up|0
7499715|NCT02255422|11822628|FG006|Overall Study|Lost to Follow-up|0
7499716|NCT02255461|11822649|FG000|Overall Study|Adverse Event|0
7499717|NCT02255461|11822650|FG001|Overall Study|Adverse Event|1
7499718|NCT02255461|11822651|FG002|Overall Study|Adverse Event|0
7499719|NCT02255461|11822652|FG003|Overall Study|Adverse Event|0
7499720|NCT02255461|11822653|FG004|Overall Study|Adverse Event|1
7499721|NCT02255461|11822649|FG000|Overall Study|Withdrawal by Subject|0
7499722|NCT02255461|11822650|FG001|Overall Study|Withdrawal by Subject|0
7499723|NCT02255461|11822651|FG002|Overall Study|Withdrawal by Subject|1
7499724|NCT02255461|11822652|FG003|Overall Study|Withdrawal by Subject|0
7499725|NCT02255461|11822653|FG004|Overall Study|Withdrawal by Subject|1
7499726|NCT02255461|11822649|FG000|Overall Study|Not meet dose reduction BSA requirement|0
7499727|NCT02255461|11822650|FG001|Overall Study|Not meet dose reduction BSA requirement|1
7499728|NCT02255461|11822651|FG002|Overall Study|Not meet dose reduction BSA requirement|0
7499729|NCT02255461|11822652|FG003|Overall Study|Not meet dose reduction BSA requirement|0
7499730|NCT02255461|11822653|FG004|Overall Study|Not meet dose reduction BSA requirement|0
7499731|NCT02255474|11822673|FG000|Overall Study|Lost to Follow-up|1
7499732|NCT02255474|11822674|FG001|Overall Study|Lost to Follow-up|1
7499733|NCT02255474|11822675|FG002|Overall Study|Lost to Follow-up|3
7499734|NCT02255474|11822673|FG000|Overall Study|Withdrawal by Subject|1
7499735|NCT02255474|11822674|FG001|Overall Study|Withdrawal by Subject|1
7499736|NCT02255474|11822675|FG002|Overall Study|Withdrawal by Subject|0
7499737|NCT02255500|11822686|FG000|Overall Study|Withdrawal by Subject|1
7499738|NCT02255500|11822687|FG001|Overall Study|Withdrawal by Subject|0
7499739|NCT02255552|11822704|FG000|Overall Study|Participants enrolled into another study|0
7499740|NCT02255552|11822705|FG001|Overall Study|Participants enrolled into another study|11
7499741|NCT02255552|11822704|FG000|Overall Study|Withdrawal by Subject|1
7499742|NCT02255552|11822705|FG001|Overall Study|Withdrawal by Subject|4
7499743|NCT02255565|11822714|FG000|Overall Study|Withdrawal by Subject|0
7499744|NCT02255565|11822715|FG001|Overall Study|Withdrawal by Subject|1
7499745|NCT02255565|11822716|FG002|Overall Study|Withdrawal by Subject|0
7499746|NCT02255760|11822775|FG000|Overall Study|Lost to Follow-up|0
7499747|NCT02255760|11822776|FG001|Overall Study|Lost to Follow-up|1
7499748|NCT02255760|11822777|FG002|Overall Study|Lost to Follow-up|0
7499749|NCT02255760|11822778|FG003|Overall Study|Lost to Follow-up|0
7499750|NCT02255760|11822779|FG004|Overall Study|Lost to Follow-up|0
7499751|NCT02255981|11822795|FG000|Overall Study|Lost to Follow-up|3
7499752|NCT02255981|11822795|FG000|Overall Study|Withdrawal by Subject|1
7499753|NCT02256267|11822836|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
7499754|NCT02256267|11822836|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
7535616|NCT02711956|11883405|FG013|Overall Study|Radiographic progression|0
7535617|NCT02711956|11883406|FG014|Overall Study|Radiographic progression|1
7535618|NCT02711956|11883392|FG000|Overall Study|PSA progression with clinical progression|0
7535619|NCT02711956|11883393|FG001|Overall Study|PSA progression with clinical progression|0
7535620|NCT02711956|11883394|FG002|Overall Study|PSA progression with clinical progression|0
7535621|NCT02711956|11883395|FG003|Overall Study|PSA progression with clinical progression|0
7535622|NCT02711956|11883396|FG004|Overall Study|PSA progression with clinical progression|1
7535623|NCT02711956|11883397|FG005|Overall Study|PSA progression with clinical progression|0
7535624|NCT02711956|11883398|FG006|Overall Study|PSA progression with clinical progression|0
7499755|NCT02256384|11822861|FG000|Overall Study|Withdrawal by Subject|12
7499756|NCT02256384|11822861|FG000|Overall Study|Equipment not capturing data|2
7499757|NCT02256436|11822871|FG000|Overall Study|Adverse Event|9
7499758|NCT02256436|11822872|FG001|Overall Study|Adverse Event|14
7499759|NCT02256436|11822871|FG000|Overall Study|Death|216
7499760|NCT02256436|11822872|FG001|Overall Study|Death|208
7499761|NCT02256436|11822871|FG000|Overall Study|Lost to Follow-up|1
7499762|NCT02256436|11822872|FG001|Overall Study|Lost to Follow-up|2
7499763|NCT02256436|11822871|FG000|Overall Study|Physician Decision|1
7499764|NCT02256436|11822872|FG001|Overall Study|Physician Decision|0
7499765|NCT02256436|11822871|FG000|Overall Study|Protocol Violation|0
7499766|NCT02256436|11822872|FG001|Overall Study|Protocol Violation|1
7499767|NCT02256436|11822871|FG000|Overall Study|Withdrawal by Subject|26
7499768|NCT02256436|11822872|FG001|Overall Study|Withdrawal by Subject|10
7499769|NCT02256436|11822871|FG000|Overall Study|Transferred to Extension Study|11
7499770|NCT02256436|11822872|FG001|Overall Study|Transferred to Extension Study|23
7499771|NCT02256436|11822871|FG000|Overall Study|Did Not Continue on Extension Study|8
7499772|NCT02256436|11822872|FG001|Overall Study|Did Not Continue on Extension Study|12
7499773|NCT02256488|11822883|FG000|Overall Study|Lost to Follow-up|6
7499774|NCT02256488|11822884|FG001|Overall Study|Lost to Follow-up|6
7499775|NCT02256488|11822885|FG002|Overall Study|Lost to Follow-up|9
7499776|NCT02256488|11822886|FG003|Overall Study|Lost to Follow-up|3
7499777|NCT02256488|11822883|FG000|Overall Study|OTHER|1
7499778|NCT02256488|11822884|FG001|Overall Study|OTHER|0
7499779|NCT02256488|11822885|FG002|Overall Study|OTHER|1
7499780|NCT02256488|11822886|FG003|Overall Study|OTHER|1
7499781|NCT02256488|11822883|FG000|Overall Study|Withdrawal by Subject|1
7499782|NCT02256488|11822884|FG001|Overall Study|Withdrawal by Subject|0
7499783|NCT02256488|11822885|FG002|Overall Study|Withdrawal by Subject|0
7499784|NCT02256488|11822886|FG003|Overall Study|Withdrawal by Subject|2
7499785|NCT02256540|11822897|FG000|Overall Study|Withdrawal by Subject|0
7499786|NCT02256540|11822898|FG001|Overall Study|Withdrawal by Subject|1
7499787|NCT02256540|11822899|FG002|Overall Study|Withdrawal by Subject|1
7499788|NCT02256540|11822897|FG000|Overall Study|Back pain preventing exercise|0
7499789|NCT02256540|11822898|FG001|Overall Study|Back pain preventing exercise|0
7499790|NCT02256540|11822899|FG002|Overall Study|Back pain preventing exercise|1
7499791|NCT02256553|11822907|FG000|Period I|Adverse Event|5
7499792|NCT02256553|11822907|FG000|Period I|Protocol Violation|1
7499793|NCT02256553|11822907|FG000|Period II|Adverse Event|1
7499794|NCT02256553|11822907|FG000|Period II|Subject Moved|1
7499795|NCT02256553|11822907|FG000|Period III|Adverse Event|3
7499796|NCT02256839|11822915|FG000|Overall Study|Did not meet Eligibility Criteria|2
7499797|NCT02256839|11822916|FG001|Overall Study|Did not meet Eligibility Criteria|3
7499798|NCT02256891|11822924|FG000|Overall Study|Death|0
7499799|NCT02256891|11822925|FG001|Overall Study|Death|2
7499800|NCT02256891|11822924|FG000|Overall Study|Lost to Follow-up|0
7499801|NCT02256891|11822925|FG001|Overall Study|Lost to Follow-up|3
7499802|NCT02256891|11822924|FG000|Overall Study|Physician Decision|7
7499803|NCT02256891|11822925|FG001|Overall Study|Physician Decision|3
7499804|NCT02256891|11822924|FG000|Overall Study|Screen Fail|5
7499805|NCT02256891|11822925|FG001|Overall Study|Screen Fail|4
7499806|NCT02256891|11822924|FG000|Overall Study|Equipment Malfunction|0
7499807|NCT02256891|11822925|FG001|Overall Study|Equipment Malfunction|1
7499808|NCT02256917|11822933|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
7499809|NCT02256917|11822933|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
7499810|NCT02256917|11822933|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
7499811|NCT02256917|11822933|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
7499812|NCT02256917|11822933|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
7499813|NCT02256969|11822947|FG000|Overall Study|Screenfailed or withdrew|2
7499814|NCT02256969|11822948|FG001|Overall Study|Screenfailed or withdrew|1
7499815|NCT02256969|11822949|FG002|Overall Study|Screenfailed or withdrew|1
7499816|NCT02256982|11822959|FG000|Overall Study|Disease Progression|0
7499817|NCT02256982|11822960|FG001|Overall Study|Disease Progression|1
7499818|NCT02257372|11823019|FG000|Overall Study|Adverse Event|3
7499819|NCT02257372|11823020|FG001|Overall Study|Adverse Event|7
7499820|NCT02257372|11823019|FG000|Overall Study|Lack of Efficacy|2
7499821|NCT02257372|11823020|FG001|Overall Study|Lack of Efficacy|1
7499822|NCT02257372|11823019|FG000|Overall Study|Protocol Violation|1
7499823|NCT02257372|11823020|FG001|Overall Study|Protocol Violation|1
7499824|NCT02257372|11823019|FG000|Overall Study|Lost to Follow-up|0
7499825|NCT02257372|11823020|FG001|Overall Study|Lost to Follow-up|1
7499826|NCT02257372|11823019|FG000|Overall Study|Withdrew consent|1
7499827|NCT02257372|11823020|FG001|Overall Study|Withdrew consent|0
7499828|NCT02257385|11823028|FG000|Overall Study|Adverse Event|12
7499829|NCT02257385|11823029|FG001|Overall Study|Adverse Event|8
7499830|NCT02257385|11823028|FG000|Overall Study|Lack of Efficacy|1
7499831|NCT02257385|11823029|FG001|Overall Study|Lack of Efficacy|2
7499832|NCT02257385|11823028|FG000|Overall Study|Protocol Violation|5
7499833|NCT02257385|11823029|FG001|Overall Study|Protocol Violation|7
7499834|NCT02257385|11823028|FG000|Overall Study|Lost to Follow-up|0
7499835|NCT02257385|11823029|FG001|Overall Study|Lost to Follow-up|1
7499836|NCT02257385|11823028|FG000|Overall Study|Withdrawal by Subject|4
7499837|NCT02257385|11823029|FG001|Overall Study|Withdrawal by Subject|4
7499847|NCT02257632|11823094|FG000|Overall Study|Withdrawal by Subject|0
7499848|NCT02257632|11823095|FG001|Overall Study|Withdrawal by Subject|1
7499849|NCT02257632|11823094|FG000|Overall Study|Adverse Event|1
7499850|NCT02257632|11823095|FG001|Overall Study|Adverse Event|2
7499851|NCT02257684|11823103|FG000|Overall Study|Adverse Event|2
7499852|NCT02257684|11823103|FG000|Overall Study|Lack of Efficacy|1
7499853|NCT02257684|11823103|FG000|Overall Study|Sponsor's Decision|1
7499854|NCT02258074|11823146|FG000|Overall Study|Withdrawal by Subject|1
7499855|NCT02258074|11823147|FG001|Overall Study|Withdrawal by Subject|0
7499856|NCT02258074|11823148|FG002|Overall Study|Withdrawal by Subject|0
7499857|NCT02258074|11823149|FG003|Overall Study|Withdrawal by Subject|0
7499858|NCT02258334|11823186|FG000|Overall Study|Adverse Event|1
7499859|NCT02258334|11823187|FG001|Overall Study|Adverse Event|0
7499860|NCT02258334|11823188|FG002|Overall Study|Adverse Event|0
7499861|NCT02258334|11823189|FG003|Overall Study|Adverse Event|0
7499862|NCT02258464|11823224|FG000|Overall Study|Progressive disease (PD)|9
7499863|NCT02258464|11823225|FG001|Overall Study|Progressive disease (PD)|17
7499864|NCT02258464|11823224|FG000|Overall Study|Study drug never administered|1
7499865|NCT02258464|11823225|FG001|Overall Study|Study drug never administered|1
7499866|NCT02258464|11823224|FG000|Overall Study|AE not related to clinical PD|1
7499867|NCT02258464|11823225|FG001|Overall Study|AE not related to clinical PD|3
7499868|NCT02258464|11823224|FG000|Overall Study|Withdrawal by Subject|5
7499869|NCT02258464|11823225|FG001|Overall Study|Withdrawal by Subject|4
7499870|NCT02258464|11823224|FG000|Overall Study|AE related to clinical PD|1
7499871|NCT02258464|11823225|FG001|Overall Study|AE related to clinical PD|0
7499872|NCT02258529|11823243|FG000|Overall Study|Study Terminated by Sponsor|9
7499873|NCT02258529|11823243|FG000|Overall Study|Adverse Event|1
7499874|NCT02259010|11823247|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
7499875|NCT02259088|11823255|FG000|Overall Study|Adverse Event|6
7499876|NCT02259088|11823256|FG001|Overall Study|Adverse Event|4
7499877|NCT02259088|11823255|FG000|Overall Study|Lost to Follow-up|2
7499878|NCT02259088|11823256|FG001|Overall Study|Lost to Follow-up|0
7499879|NCT02259088|11823255|FG000|Overall Study|Death|2
7499880|NCT02259088|11823256|FG001|Overall Study|Death|0
7499881|NCT02259088|11823255|FG000|Overall Study|Physician Decision|5
7499882|NCT02259088|11823256|FG001|Overall Study|Physician Decision|2
7499883|NCT02259088|11823255|FG000|Overall Study|Protocol deviation|5
7499884|NCT02259088|11823256|FG001|Overall Study|Protocol deviation|0
7499885|NCT02259088|11823255|FG000|Overall Study|Subject/guardian decision|8
7499886|NCT02259088|11823256|FG001|Overall Study|Subject/guardian decision|8
7499887|NCT02259114|11823267|FG000|Overall Study|Progressive Disease|14
7499888|NCT02259114|11823268|FG001|Overall Study|Progressive Disease|2
7499889|NCT02259114|11823269|FG002|Overall Study|Progressive Disease|10
7499890|NCT02259114|11823270|FG003|Overall Study|Progressive Disease|2
7499891|NCT02259114|11823271|FG004|Overall Study|Progressive Disease|5
7499892|NCT02259114|11823267|FG000|Overall Study|Adverse Event|2
7499893|NCT02259114|11823268|FG001|Overall Study|Adverse Event|1
7499894|NCT02259114|11823269|FG002|Overall Study|Adverse Event|0
7499895|NCT02259114|11823270|FG003|Overall Study|Adverse Event|0
7499896|NCT02259114|11823271|FG004|Overall Study|Adverse Event|1
7499897|NCT02259114|11823267|FG000|Overall Study|Death|3
7499898|NCT02259114|11823268|FG001|Overall Study|Death|0
7499899|NCT02259114|11823269|FG002|Overall Study|Death|1
7499900|NCT02259114|11823270|FG003|Overall Study|Death|0
7499901|NCT02259114|11823271|FG004|Overall Study|Death|0
7499902|NCT02259114|11823267|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7499903|NCT02259114|11823268|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7499904|NCT02259114|11823269|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
7499905|NCT02259114|11823270|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7499906|NCT02259114|11823271|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
7499907|NCT02259114|11823267|FG000|Overall Study|Withdrawal by Subject|0
7499908|NCT02259114|11823268|FG001|Overall Study|Withdrawal by Subject|0
7499909|NCT02259114|11823269|FG002|Overall Study|Withdrawal by Subject|1
7499910|NCT02259114|11823270|FG003|Overall Study|Withdrawal by Subject|1
7499911|NCT02259114|11823271|FG004|Overall Study|Withdrawal by Subject|0
7499912|NCT02259114|11823267|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
7499913|NCT02259114|11823268|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
7499914|NCT02259114|11823269|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
7499915|NCT02259114|11823270|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
7499916|NCT02259114|11823271|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
7499917|NCT02259114|11823267|FG000|Overall Study|Not Treated|1
7499918|NCT02259114|11823268|FG001|Overall Study|Not Treated|0
7499919|NCT02259114|11823269|FG002|Overall Study|Not Treated|0
7499920|NCT02259114|11823270|FG003|Overall Study|Not Treated|0
7499921|NCT02259114|11823271|FG004|Overall Study|Not Treated|0
7499922|NCT02259231|11823290|FG000|Overall Study|Adverse Event|1
7499923|NCT02259231|11823291|FG001|Overall Study|Adverse Event|1
7499924|NCT02259231|11823292|FG002|Overall Study|Adverse Event|2
7499925|NCT02259231|11823293|FG003|Overall Study|Adverse Event|0
7499926|NCT02259231|11823294|FG004|Overall Study|Adverse Event|0
7499927|NCT02259231|11823295|FG005|Overall Study|Adverse Event|0
7499928|NCT02259231|11823296|FG006|Overall Study|Adverse Event|0
7499929|NCT02259231|11823290|FG000|Overall Study|Progressive Disease|4
7499930|NCT02259231|11823291|FG001|Overall Study|Progressive Disease|5
7499931|NCT02259231|11823292|FG002|Overall Study|Progressive Disease|4
7499932|NCT02259231|11823293|FG003|Overall Study|Progressive Disease|5
7499933|NCT02259231|11823294|FG004|Overall Study|Progressive Disease|4
7499934|NCT02259231|11823295|FG005|Overall Study|Progressive Disease|5
7499935|NCT02259231|11823296|FG006|Overall Study|Progressive Disease|4
7499936|NCT02259231|11823290|FG000|Overall Study|Sponsor termination of study|1
7499937|NCT02259231|11823291|FG001|Overall Study|Sponsor termination of study|0
7499938|NCT02259231|11823292|FG002|Overall Study|Sponsor termination of study|0
7499939|NCT02259231|11823293|FG003|Overall Study|Sponsor termination of study|1
7499940|NCT02259231|11823294|FG004|Overall Study|Sponsor termination of study|2
7499941|NCT02259231|11823295|FG005|Overall Study|Sponsor termination of study|1
7499942|NCT02259231|11823296|FG006|Overall Study|Sponsor termination of study|1
7499943|NCT02259348|11823312|FG000|Overall Study|Donors|6
7499944|NCT02259348|11823312|FG000|Overall Study|Death|4
7499945|NCT02259400|11823318|FG000|Overall Study|Death|0
7499946|NCT02259400|11823319|FG001|Overall Study|Death|2
7499947|NCT02259582|11823328|FG000|Overall Study|Physician Decision|0
7499948|NCT02259582|11823329|FG001|Overall Study|Physician Decision|1
7499949|NCT02259582|11823330|FG002|Overall Study|Physician Decision|0
7499950|NCT02259582|11823328|FG000|Overall Study|Death|0
7499951|NCT02259582|11823329|FG001|Overall Study|Death|0
7499952|NCT02259582|11823330|FG002|Overall Study|Death|1
7499953|NCT02259582|11823328|FG000|Overall Study|Adverse Event|1
7499954|NCT02259582|11823329|FG001|Overall Study|Adverse Event|0
7499955|NCT02259582|11823330|FG002|Overall Study|Adverse Event|1
7499956|NCT02259582|11823328|FG000|Overall Study|Withdrawal by Subject|0
7499957|NCT02259582|11823329|FG001|Overall Study|Withdrawal by Subject|0
7499958|NCT02259582|11823330|FG002|Overall Study|Withdrawal by Subject|1
7499959|NCT02259582|11823328|FG000|Overall Study|Disease progression|14
7499960|NCT02259582|11823329|FG001|Overall Study|Disease progression|15
7499961|NCT02259582|11823330|FG002|Overall Study|Disease progression|17
7499962|NCT02259582|11823328|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
7499963|NCT02259582|11823329|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
7499964|NCT02259582|11823330|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
7499965|NCT02260154|11823351|FG000|Overall Study|Screening failure|2
7499966|NCT02260180|11823359|FG000|Overall Study|Adverse Event|2
7499967|NCT02260180|11823360|FG001|Overall Study|Adverse Event|0
7499968|NCT02260180|11823361|FG002|Overall Study|Adverse Event|1
7499969|NCT02260258|11823371|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
7499970|NCT02260258|11823372|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
7499971|NCT02260388|11823383|FG000|Overall Study|Lost to Follow-up|2
7499972|NCT02260388|11823384|FG001|Overall Study|Lost to Follow-up|8
7499973|NCT02260388|11823385|FG002|Overall Study|Lost to Follow-up|3
7499974|NCT02260388|11823386|FG003|Overall Study|Lost to Follow-up|4
7499975|NCT02260492|11823412|FG000|Overall Study|Adverse Event|6
7499976|NCT02260492|11823413|FG001|Overall Study|Adverse Event|1
7499977|NCT02260492|11823414|FG002|Overall Study|Adverse Event|2
7499978|NCT02260492|11823412|FG000|Overall Study|Death|0
7499979|NCT02260492|11823413|FG001|Overall Study|Death|1
7499980|NCT02260492|11823414|FG002|Overall Study|Death|0
7499981|NCT02260492|11823412|FG000|Overall Study|Lost to Follow-up|12
7499982|NCT02260492|11823413|FG001|Overall Study|Lost to Follow-up|9
7499983|NCT02260492|11823414|FG002|Overall Study|Lost to Follow-up|0
7499984|NCT02260492|11823412|FG000|Overall Study|Physician Decision|2
7499985|NCT02260492|11823413|FG001|Overall Study|Physician Decision|0
7499986|NCT02260492|11823414|FG002|Overall Study|Physician Decision|1
7499987|NCT02260492|11823412|FG000|Overall Study|Withdrawal by Subject|3
7499988|NCT02260492|11823413|FG001|Overall Study|Withdrawal by Subject|2
7499989|NCT02260492|11823414|FG002|Overall Study|Withdrawal by Subject|2
7499990|NCT02260635|11823453|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
7499991|NCT02260635|11823454|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
7499992|NCT02260635|11823453|FG000|Open-Label Extension|Study Termination|25
7499993|NCT02260635|11823454|FG001|Open-Label Extension|Study Termination|25
7499994|NCT02260635|11823453|FG000|Open-Label Extension|Withdrawal by Subject|1
7499995|NCT02260635|11823454|FG001|Open-Label Extension|Withdrawal by Subject|0
7499996|NCT02260648|11823465|FG000|Overall Study|Adverse Event|3
7499997|NCT02260648|11823466|FG001|Overall Study|Adverse Event|0
7499998|NCT02260648|11823467|FG002|Overall Study|Adverse Event|1
7499999|NCT02260648|11823465|FG000|Overall Study|Withdrawal by Subject|1
7500000|NCT02260648|11823466|FG001|Overall Study|Withdrawal by Subject|1
7500001|NCT02260648|11823467|FG002|Overall Study|Withdrawal by Subject|0
7500002|NCT02260648|11823465|FG000|Overall Study|Protocol Violation|1
7500003|NCT02260648|11823466|FG001|Overall Study|Protocol Violation|0
7500004|NCT02260648|11823467|FG002|Overall Study|Protocol Violation|0
7500005|NCT02260648|11823465|FG000|Overall Study|Discontinue Due to Study Termination|13
7500006|NCT02260648|11823466|FG001|Overall Study|Discontinue Due to Study Termination|12
7500007|NCT02260648|11823467|FG002|Overall Study|Discontinue Due to Study Termination|7
7500008|NCT02260791|11823477|FG000|Overall Study|Lost to Follow-up|4
7500009|NCT02260791|11823478|FG001|Overall Study|Lost to Follow-up|4
7500010|NCT02260791|11823477|FG000|Overall Study|Lack of Efficacy|2
7500011|NCT02260791|11823478|FG001|Overall Study|Lack of Efficacy|1
7500012|NCT02260791|11823477|FG000|Overall Study|Adverse Event|13
7500013|NCT02260791|11823478|FG001|Overall Study|Adverse Event|9
7500014|NCT02260791|11823477|FG000|Overall Study|Death|1
7500015|NCT02260791|11823478|FG001|Overall Study|Death|0
7500016|NCT02260791|11823477|FG000|Overall Study|Withdrawal by Subject|11
7500017|NCT02260791|11823478|FG001|Overall Study|Withdrawal by Subject|16
7500018|NCT02260791|11823477|FG000|Overall Study|Screen failure|0
7500019|NCT02260791|11823478|FG001|Overall Study|Screen failure|1
7500020|NCT02260791|11823477|FG000|Overall Study|Protocol deviation|2
7500021|NCT02260791|11823478|FG001|Overall Study|Protocol deviation|3
7500022|NCT02260804|11823486|FG000|Induction Study Period|Protocol Violation|2
7500023|NCT02260804|11823487|FG001|Induction Study Period|Protocol Violation|0
7500024|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
7500025|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
7500026|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
7500027|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
7500028|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
7500029|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
7500030|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
7500031|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
7500032|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
7500033|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
7500034|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Death|0
7500035|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Death|1
7500036|NCT02260804|11823486|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
7500037|NCT02260804|11823487|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
7500038|NCT02260804|11823486|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
7500039|NCT02260804|11823487|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
7500040|NCT02260804|11823486|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
7500041|NCT02260804|11823487|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
7500042|NCT02260804|11823486|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
7500043|NCT02260804|11823487|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
7500044|NCT02260817|11823495|FG000|Overall Study|Lost to Follow-up|0
7500045|NCT02260817|11823496|FG001|Overall Study|Lost to Follow-up|14
7500046|NCT02260817|11823495|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
7500047|NCT02260817|11823496|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
7500048|NCT02260817|11823495|FG000|Overall Study|Observation, no biopsy|0
7500049|NCT02260817|11823496|FG001|Overall Study|Observation, no biopsy|1
7500050|NCT02260817|11823495|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
7500051|NCT02260817|11823496|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
7500052|NCT02260817|11823495|FG000|Overall Study|Protocol Violation|0
7500053|NCT02260817|11823496|FG001|Overall Study|Protocol Violation|14
7500054|NCT02260882|11823504|FG000|Overall Study|Protocol Violation|0
7500055|NCT02260882|11823505|FG001|Overall Study|Protocol Violation|1
7500056|NCT02260921|11823514|FG000|Overall Study|Adverse Event|1
7500057|NCT02260921|11823515|FG001|Overall Study|Adverse Event|0
7500058|NCT02260921|11823514|FG000|Overall Study|Lost to Follow-up|4
7500059|NCT02260921|11823515|FG001|Overall Study|Lost to Follow-up|3
7500060|NCT02260921|11823514|FG000|Overall Study|Withdraw Consent|4
7500061|NCT02260921|11823515|FG001|Overall Study|Withdraw Consent|1
7500062|NCT02260921|11823514|FG000|Overall Study|Death|1
7500063|NCT02260921|11823515|FG001|Overall Study|Death|0
7500064|NCT02260921|11823514|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
7500065|NCT02260921|11823515|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
7500066|NCT02260934|11823523|FG000|Overall Study|Lost to Follow-up|2
7500067|NCT02260934|11823524|FG001|Overall Study|Lost to Follow-up|1
7500068|NCT02260934|11823523|FG000|Overall Study|Withdrawal by Subject|0
7500069|NCT02260934|11823524|FG001|Overall Study|Withdrawal by Subject|2
7500070|NCT02260934|11823523|FG000|Overall Study|Participant Relocated|1
7500071|NCT02260934|11823524|FG001|Overall Study|Participant Relocated|0
7500072|NCT02260934|11823523|FG000|Overall Study|Site error|0
7500073|NCT02260934|11823524|FG001|Overall Study|Site error|1
7500074|NCT02260986|11823540|FG000|Overall Study|Adverse Event|24
7500075|NCT02260986|11823541|FG001|Overall Study|Adverse Event|0
7500076|NCT02260986|11823542|FG002|Overall Study|Adverse Event|11
7500077|NCT02260986|11823540|FG000|Overall Study|Lack of Efficacy|27
7500078|NCT02260986|11823541|FG001|Overall Study|Lack of Efficacy|3
7500079|NCT02260986|11823542|FG002|Overall Study|Lack of Efficacy|0
7500080|NCT02260986|11823540|FG000|Overall Study|Protocol Violation|14
7500081|NCT02260986|11823541|FG001|Overall Study|Protocol Violation|5
7500082|NCT02260986|11823542|FG002|Overall Study|Protocol Violation|16
7500083|NCT02260986|11823540|FG000|Overall Study|Car accident|0
7500084|NCT02260986|11823541|FG001|Overall Study|Car accident|0
7500085|NCT02260986|11823542|FG002|Overall Study|Car accident|1
7500086|NCT02260986|11823540|FG000|Overall Study|Withdrawal by Subject|17
7500087|NCT02260986|11823541|FG001|Overall Study|Withdrawal by Subject|4
7500088|NCT02260986|11823542|FG002|Overall Study|Withdrawal by Subject|9
7500089|NCT02260986|11823540|FG000|Overall Study|Incorrect randomization|0
7500090|NCT02260986|11823541|FG001|Overall Study|Incorrect randomization|1
7500091|NCT02260986|11823542|FG002|Overall Study|Incorrect randomization|0
7500092|NCT02260986|11823540|FG000|Overall Study|Lack of investigation product supply|2
7500093|NCT02260986|11823541|FG001|Overall Study|Lack of investigation product supply|0
7500094|NCT02260986|11823542|FG002|Overall Study|Lack of investigation product supply|1
7500095|NCT02260986|11823540|FG000|Overall Study|Lost to Follow-up|4
7500096|NCT02260986|11823541|FG001|Overall Study|Lost to Follow-up|0
7500097|NCT02260986|11823542|FG002|Overall Study|Lost to Follow-up|3
7500098|NCT02260986|11823540|FG000|Overall Study|Pregnancy|2
7500099|NCT02260986|11823541|FG001|Overall Study|Pregnancy|0
7500100|NCT02260986|11823542|FG002|Overall Study|Pregnancy|0
7500101|NCT02261467|11823578|FG000|Overall Study|Enrolled in Error|1
7500102|NCT02261467|11823579|FG001|Overall Study|Enrolled in Error|0
7500103|NCT02261467|11823578|FG000|Overall Study|Protocol Violation|0
7500104|NCT02261467|11823579|FG001|Overall Study|Protocol Violation|1
7500105|NCT02261467|11823578|FG000|Overall Study|Personal Reasons|17
7500106|NCT02261467|11823579|FG001|Overall Study|Personal Reasons|22
7500107|NCT02261467|11823578|FG000|Overall Study|Lost to Follow-up|2
7500108|NCT02261467|11823579|FG001|Overall Study|Lost to Follow-up|13
7500109|NCT02261467|11823578|FG000|Overall Study|Adverse Event|1
7500110|NCT02261467|11823579|FG001|Overall Study|Adverse Event|1
7500111|NCT02261493|11823588|FG000|Overall Study|Noncompliance|0
7500112|NCT02261493|11823589|FG001|Overall Study|Noncompliance|0
7500113|NCT02261493|11823590|FG002|Overall Study|Noncompliance|2
7500114|NCT02261493|11823588|FG000|Overall Study|Physician Decision|0
7500115|NCT02261493|11823589|FG001|Overall Study|Physician Decision|1
7500116|NCT02261493|11823590|FG002|Overall Study|Physician Decision|0
7500117|NCT02261493|11823588|FG000|Overall Study|Undisclosed alcohol abuse|0
7500118|NCT02261493|11823589|FG001|Overall Study|Undisclosed alcohol abuse|1
7500119|NCT02261493|11823590|FG002|Overall Study|Undisclosed alcohol abuse|0
7500120|NCT02261493|11823588|FG000|Overall Study|Protocol Violation|1
7500121|NCT02261493|11823589|FG001|Overall Study|Protocol Violation|0
7500122|NCT02261493|11823590|FG002|Overall Study|Protocol Violation|0
7500123|NCT02261493|11823588|FG000|Overall Study|Personal Reasons|14
7500124|NCT02261493|11823589|FG001|Overall Study|Personal Reasons|14
7500125|NCT02261493|11823590|FG002|Overall Study|Personal Reasons|16
7500126|NCT02261493|11823588|FG000|Overall Study|Lost to Follow-up|14
7500127|NCT02261493|11823589|FG001|Overall Study|Lost to Follow-up|27
7500128|NCT02261493|11823590|FG002|Overall Study|Lost to Follow-up|8
7500129|NCT02261493|11823588|FG000|Overall Study|Pregnancy|1
7500130|NCT02261493|11823589|FG001|Overall Study|Pregnancy|2
7500131|NCT02261493|11823590|FG002|Overall Study|Pregnancy|0
7500132|NCT02261493|11823588|FG000|Overall Study|Lack of Efficacy|0
7500133|NCT02261493|11823589|FG001|Overall Study|Lack of Efficacy|1
7500134|NCT02261493|11823590|FG002|Overall Study|Lack of Efficacy|0
7500135|NCT02261493|11823588|FG000|Overall Study|Adverse Event|0
7500136|NCT02261493|11823589|FG001|Overall Study|Adverse Event|1
7500137|NCT02261493|11823590|FG002|Overall Study|Adverse Event|0
7500138|NCT02261974|11823668|FG000|Overall Study|Withdrawal by Subject|3
7500139|NCT02261974|11823669|FG001|Overall Study|Withdrawal by Subject|2
7500140|NCT02261974|11823668|FG000|Overall Study|Pregnancy|0
7500141|NCT02261974|11823669|FG001|Overall Study|Pregnancy|1
7500142|NCT02261974|11823668|FG000|Overall Study|Missed treatment cut-off date|6
7500143|NCT02261974|11823669|FG001|Overall Study|Missed treatment cut-off date|3
7500144|NCT02261974|11823668|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
7500145|NCT02261974|11823669|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
7500146|NCT02261974|11823668|FG000|Overall Study|Lost to Follow-up|2
7500147|NCT02261974|11823669|FG001|Overall Study|Lost to Follow-up|0
7500148|NCT02261974|11823668|FG000|Overall Study|Adverse Event|1
7500149|NCT02261974|11823669|FG001|Overall Study|Adverse Event|0
7500150|NCT02262260|11823699|FG000|Overall Study|Adverse Event|4
7500151|NCT02262260|11823700|FG001|Overall Study|Adverse Event|1
7500152|NCT02262260|11823699|FG000|Overall Study|Withdrawal of consent|4
7500153|NCT02262260|11823700|FG001|Overall Study|Withdrawal of consent|2
7500154|NCT02262260|11823699|FG000|Overall Study|Lost to Follow-up|1
7500155|NCT02262260|11823700|FG001|Overall Study|Lost to Follow-up|2
7500156|NCT02262260|11823699|FG000|Overall Study|Protocol deviation|2
7500157|NCT02262260|11823700|FG001|Overall Study|Protocol deviation|5
7500158|NCT02262364|11823706|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
7500159|NCT02262377|11823712|FG000|Overall Study|Lost to Follow-up|5
7500160|NCT02262377|11823713|FG001|Overall Study|Lost to Follow-up|6
7500161|NCT02262377|11823712|FG000|Overall Study|Found ineligible after enrollment|3
7500162|NCT02262377|11823713|FG001|Overall Study|Found ineligible after enrollment|0
7500163|NCT02262377|11823712|FG000|Overall Study|Withdrawal by Subject|4
7500164|NCT02262377|11823713|FG001|Overall Study|Withdrawal by Subject|0
7500165|NCT02262728|11823727|FG000|Follow-up Phase (3 Years)|Death|0
7500166|NCT02262728|11823728|FG001|Follow-up Phase (3 Years)|Death|1
7500167|NCT02262728|11823727|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
7500168|NCT02262728|11823728|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
7500169|NCT02262728|11823727|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
7500170|NCT02262728|11823728|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
7500171|NCT02262754|11823737|FG000|Overall Study|Adverse Event|3
7500172|NCT02262754|11823738|FG001|Overall Study|Adverse Event|4
7500173|NCT02262754|11823739|FG002|Overall Study|Adverse Event|0
7500174|NCT02262754|11823737|FG000|Overall Study|Lack of Efficacy|2
7500175|NCT02262754|11823738|FG001|Overall Study|Lack of Efficacy|0
7500176|NCT02262754|11823739|FG002|Overall Study|Lack of Efficacy|1
7500177|NCT02262754|11823737|FG000|Overall Study|Lost to Follow-up|0
7500178|NCT02262754|11823738|FG001|Overall Study|Lost to Follow-up|0
7500179|NCT02262754|11823739|FG002|Overall Study|Lost to Follow-up|1
7500180|NCT02262754|11823737|FG000|Overall Study|No longer meets eligibility criteria|0
7500181|NCT02262754|11823738|FG001|Overall Study|No longer meets eligibility criteria|1
7500182|NCT02262754|11823739|FG002|Overall Study|No longer meets eligibility criteria|0
7500183|NCT02262754|11823737|FG000|Overall Study|Study terminated by sponsor|5
7500184|NCT02262754|11823738|FG001|Overall Study|Study terminated by sponsor|4
7500185|NCT02262754|11823739|FG002|Overall Study|Study terminated by sponsor|4
7500186|NCT02262754|11823737|FG000|Overall Study|Protocol Violation|1
7500187|NCT02262754|11823738|FG001|Overall Study|Protocol Violation|0
7500188|NCT02262754|11823739|FG002|Overall Study|Protocol Violation|0
7500189|NCT02262754|11823737|FG000|Overall Study|Withdrawal by Subject|1
7500190|NCT02262754|11823738|FG001|Overall Study|Withdrawal by Subject|0
7500191|NCT02262754|11823739|FG002|Overall Study|Withdrawal by Subject|1
7500192|NCT02262754|11823737|FG000|Overall Study|Other|4
7500193|NCT02262754|11823738|FG001|Overall Study|Other|0
7500194|NCT02262754|11823739|FG002|Overall Study|Other|2
7500195|NCT02263079|11823765|FG000|Overall Study|Physician Decision|1
7500196|NCT02263079|11823766|FG001|Overall Study|Physician Decision|0
7500197|NCT02263079|11823767|FG002|Overall Study|Physician Decision|0
7500198|NCT02263079|11823765|FG000|Overall Study|Withdrawal by Subject|2
7500199|NCT02263079|11823766|FG001|Overall Study|Withdrawal by Subject|8
7500200|NCT02263079|11823767|FG002|Overall Study|Withdrawal by Subject|0
7500201|NCT02263326|11823805|FG000|Overall Study|Lost to Follow-up|1
7500202|NCT02263326|11823806|FG001|Overall Study|Lost to Follow-up|1
7500203|NCT02263547|11823812|FG000|Overall Study|Adverse Event|1
7500204|NCT02263547|11823812|FG000|Overall Study|Lost to Follow-up|2
7500205|NCT02264574|11823859|FG000|Overall Study|Death|21
7500206|NCT02264574|11823860|FG001|Overall Study|Death|21
7500207|NCT02264574|11823859|FG000|Overall Study|Withdrawal by Subject|8
7500208|NCT02264574|11823860|FG001|Overall Study|Withdrawal by Subject|6
7500209|NCT02264574|11823859|FG000|Overall Study|Other, Not Specified|0
7500210|NCT02264574|11823860|FG001|Overall Study|Other, Not Specified|3
7500211|NCT02264639|11823871|FG000|Overall Study|Death (after completing single-dose phase)|1
7500212|NCT02264639|11823872|FG001|Overall Study|Death (after completing single-dose phase)|0
7500213|NCT02264639|11823873|FG002|Overall Study|Death (after completing single-dose phase)|0
7500214|NCT02264639|11823874|FG003|Overall Study|Death (after completing single-dose phase)|0
7500215|NCT02264639|11823875|FG004|Overall Study|Death (after completing single-dose phase)|0
7500216|NCT02264639|11823871|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
7500217|NCT02264639|11823872|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7500218|NCT02264639|11823873|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7500219|NCT02264639|11823874|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7500220|NCT02264639|11823875|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
7500221|NCT02264639|11823871|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
7500222|NCT02264639|11823872|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
7500223|NCT02264639|11823873|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
7500224|NCT02264639|11823874|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
7500225|NCT02264639|11823875|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
7500226|NCT02264639|11823871|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7500227|NCT02264639|11823872|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7500228|NCT02264639|11823873|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7500229|NCT02264639|11823874|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
7500230|NCT02264639|11823875|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
7500231|NCT02264821|11823893|FG000|Overall Study|Protocol Violation|1
7500232|NCT02264821|11823894|FG001|Overall Study|Protocol Violation|3
7500233|NCT02264821|11823895|FG002|Overall Study|Protocol Violation|6
7500234|NCT02264990|11823905|FG000|Overall Study|Death|255
7500235|NCT02264990|11823906|FG001|Overall Study|Death|250
7500236|NCT02264990|11823905|FG000|Overall Study|Withdrawal by Subject|4
7500237|NCT02264990|11823906|FG001|Overall Study|Withdrawal by Subject|5
7500238|NCT02264990|11823905|FG000|Overall Study|Lost to Follow-up|1
7500239|NCT02264990|11823906|FG001|Overall Study|Lost to Follow-up|3
7500240|NCT02264990|11823905|FG000|Overall Study|Other|0
7500241|NCT02264990|11823906|FG001|Overall Study|Other|1
7500242|NCT02265237|11823924|FG000|As Treated (Overall Study)|Adverse Event|1
7500243|NCT02265237|11823925|FG001|As Treated (Overall Study)|Adverse Event|1
7500244|NCT02265237|11823926|FG002|As Treated (Overall Study)|Adverse Event|0
7500245|NCT02265237|11823927|FG003|As Treated (Overall Study)|Adverse Event|0
7500246|NCT02265237|11823924|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
7500247|NCT02265237|11823925|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
7500248|NCT02265237|11823926|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
7500249|NCT02265237|11823927|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
7500250|NCT02265237|11823924|FG000|As Treated (Overall Study)|Lost to Follow-up|1
7500251|NCT02265237|11823925|FG001|As Treated (Overall Study)|Lost to Follow-up|2
7500252|NCT02265237|11823926|FG002|As Treated (Overall Study)|Lost to Follow-up|6
7500253|NCT02265237|11823927|FG003|As Treated (Overall Study)|Lost to Follow-up|0
7500254|NCT02265237|11823924|FG000|As Treated (Overall Study)|Other|2
7500255|NCT02265237|11823925|FG001|As Treated (Overall Study)|Other|0
7500256|NCT02265237|11823926|FG002|As Treated (Overall Study)|Other|3
7500257|NCT02265237|11823927|FG003|As Treated (Overall Study)|Other|1
7500258|NCT02265510|11823956|FG000|Overall Study|Withdrawal by Subject|1
7500259|NCT02265510|11823957|FG001|Overall Study|Withdrawal by Subject|1
7500260|NCT02265510|11823958|FG002|Overall Study|Withdrawal by Subject|2
7500261|NCT02265510|11823959|FG003|Overall Study|Withdrawal by Subject|1
7500262|NCT02265510|11823960|FG004|Overall Study|Withdrawal by Subject|0
7500263|NCT02265510|11823961|FG005|Overall Study|Withdrawal by Subject|2
7500264|NCT02265510|11823962|FG006|Overall Study|Withdrawal by Subject|0
7500265|NCT02265510|11823963|FG007|Overall Study|Withdrawal by Subject|2
7500266|NCT02265510|11823964|FG008|Overall Study|Withdrawal by Subject|0
7500267|NCT02265510|11823965|FG009|Overall Study|Withdrawal by Subject|0
7500268|NCT02265510|11823966|FG010|Overall Study|Withdrawal by Subject|0
7500269|NCT02265510|11823967|FG011|Overall Study|Withdrawal by Subject|0
7500270|NCT02265510|11823968|FG012|Overall Study|Withdrawal by Subject|1
7500271|NCT02265510|11823969|FG013|Overall Study|Withdrawal by Subject|0
7500272|NCT02265510|11823956|FG000|Overall Study|Disease Progression|0
7500273|NCT02265510|11823957|FG001|Overall Study|Disease Progression|1
7500274|NCT02265510|11823958|FG002|Overall Study|Disease Progression|2
7500275|NCT02265510|11823959|FG003|Overall Study|Disease Progression|1
7500276|NCT02265510|11823960|FG004|Overall Study|Disease Progression|1
7500277|NCT02265510|11823961|FG005|Overall Study|Disease Progression|0
7500278|NCT02265510|11823962|FG006|Overall Study|Disease Progression|0
7500279|NCT02265510|11823963|FG007|Overall Study|Disease Progression|0
7500280|NCT02265510|11823964|FG008|Overall Study|Disease Progression|0
7500281|NCT02265510|11823965|FG009|Overall Study|Disease Progression|0
7500282|NCT02265510|11823966|FG010|Overall Study|Disease Progression|0
7500283|NCT02265510|11823967|FG011|Overall Study|Disease Progression|0
7500284|NCT02265510|11823968|FG012|Overall Study|Disease Progression|0
7500285|NCT02265510|11823969|FG013|Overall Study|Disease Progression|0
7500286|NCT02265510|11823956|FG000|Overall Study|Death|2
7500287|NCT02265510|11823957|FG001|Overall Study|Death|0
7500288|NCT02265510|11823958|FG002|Overall Study|Death|2
7500289|NCT02265510|11823959|FG003|Overall Study|Death|2
7500290|NCT02265510|11823960|FG004|Overall Study|Death|1
7500291|NCT02265510|11823961|FG005|Overall Study|Death|3
7500292|NCT02265510|11823962|FG006|Overall Study|Death|2
7500293|NCT02265510|11823963|FG007|Overall Study|Death|1
7500294|NCT02265510|11823964|FG008|Overall Study|Death|3
7500295|NCT02265510|11823965|FG009|Overall Study|Death|3
7500296|NCT02265510|11823966|FG010|Overall Study|Death|4
7500297|NCT02265510|11823967|FG011|Overall Study|Death|12
7500298|NCT02265510|11823968|FG012|Overall Study|Death|7
7500299|NCT02265510|11823969|FG013|Overall Study|Death|6
7500300|NCT02265510|11823956|FG000|Overall Study|Lost to Follow-up|0
7500301|NCT02265510|11823957|FG001|Overall Study|Lost to Follow-up|0
7500302|NCT02265510|11823958|FG002|Overall Study|Lost to Follow-up|0
7500303|NCT02265510|11823959|FG003|Overall Study|Lost to Follow-up|0
7500304|NCT02265510|11823960|FG004|Overall Study|Lost to Follow-up|1
7500305|NCT02265510|11823961|FG005|Overall Study|Lost to Follow-up|0
7500306|NCT02265510|11823962|FG006|Overall Study|Lost to Follow-up|0
7500307|NCT02265510|11823963|FG007|Overall Study|Lost to Follow-up|0
7500308|NCT02265510|11823964|FG008|Overall Study|Lost to Follow-up|0
7500309|NCT02265510|11823965|FG009|Overall Study|Lost to Follow-up|2
7500310|NCT02265510|11823966|FG010|Overall Study|Lost to Follow-up|0
7500311|NCT02265510|11823967|FG011|Overall Study|Lost to Follow-up|0
7500312|NCT02265510|11823968|FG012|Overall Study|Lost to Follow-up|0
7500313|NCT02265510|11823969|FG013|Overall Study|Lost to Follow-up|2
7500314|NCT02265510|11823956|FG000|Overall Study|Other|0
7500315|NCT02265510|11823957|FG001|Overall Study|Other|1
7500316|NCT02265510|11823958|FG002|Overall Study|Other|0
7500317|NCT02265510|11823959|FG003|Overall Study|Other|0
7500318|NCT02265510|11823960|FG004|Overall Study|Other|0
7500319|NCT02265510|11823961|FG005|Overall Study|Other|0
7500320|NCT02265510|11823962|FG006|Overall Study|Other|0
7500321|NCT02265510|11823963|FG007|Overall Study|Other|0
7500322|NCT02265510|11823964|FG008|Overall Study|Other|0
7500323|NCT02265510|11823965|FG009|Overall Study|Other|0
7500324|NCT02265510|11823966|FG010|Overall Study|Other|0
7500325|NCT02265510|11823967|FG011|Overall Study|Other|0
7500326|NCT02265510|11823968|FG012|Overall Study|Other|0
7500327|NCT02265510|11823969|FG013|Overall Study|Other|0
7500328|NCT02265510|11823956|FG000|Overall Study|Study Terminated by Sponsor|0
7500329|NCT02265510|11823957|FG001|Overall Study|Study Terminated by Sponsor|0
7500330|NCT02265510|11823958|FG002|Overall Study|Study Terminated by Sponsor|0
7500331|NCT02265510|11823959|FG003|Overall Study|Study Terminated by Sponsor|0
7500332|NCT02265510|11823960|FG004|Overall Study|Study Terminated by Sponsor|0
7500333|NCT02265510|11823961|FG005|Overall Study|Study Terminated by Sponsor|1
7500334|NCT02265510|11823962|FG006|Overall Study|Study Terminated by Sponsor|1
7500335|NCT02265510|11823963|FG007|Overall Study|Study Terminated by Sponsor|1
7500336|NCT02265510|11823964|FG008|Overall Study|Study Terminated by Sponsor|1
7500337|NCT02265510|11823965|FG009|Overall Study|Study Terminated by Sponsor|2
7500338|NCT02265510|11823966|FG010|Overall Study|Study Terminated by Sponsor|1
7500339|NCT02265510|11823967|FG011|Overall Study|Study Terminated by Sponsor|4
7500340|NCT02265510|11823968|FG012|Overall Study|Study Terminated by Sponsor|1
7500341|NCT02265510|11823969|FG013|Overall Study|Study Terminated by Sponsor|2
7500342|NCT02265705|11824027|FG000|Treatment Period Week 0-24|Adverse Event|3
7500343|NCT02265705|11824028|FG001|Treatment Period Week 0-24|Adverse Event|2
7500344|NCT02265705|11824029|FG002|Treatment Period Week 0-24|Adverse Event|0
7500345|NCT02265705|11824030|FG003|Treatment Period Week 0-24|Adverse Event|0
7500346|NCT02265705|11824031|FG004|Treatment Period Week 0-24|Adverse Event|0
7500347|NCT02265705|11824032|FG005|Treatment Period Week 0-24|Adverse Event|0
7500348|NCT02265705|11824033|FG006|Treatment Period Week 0-24|Adverse Event|0
7500349|NCT02265705|11824027|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
7500350|NCT02265705|11824028|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
7500351|NCT02265705|11824029|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
7500352|NCT02265705|11824030|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
7500353|NCT02265705|11824031|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
7500354|NCT02265705|11824032|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
7500355|NCT02265705|11824033|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
7500356|NCT02265705|11824027|FG000|Treatment Period Week 0-24|Physician Decision|1
7500357|NCT02265705|11824028|FG001|Treatment Period Week 0-24|Physician Decision|0
7500358|NCT02265705|11824029|FG002|Treatment Period Week 0-24|Physician Decision|0
7500359|NCT02265705|11824030|FG003|Treatment Period Week 0-24|Physician Decision|0
7500360|NCT02265705|11824031|FG004|Treatment Period Week 0-24|Physician Decision|0
7500361|NCT02265705|11824032|FG005|Treatment Period Week 0-24|Physician Decision|0
7500362|NCT02265705|11824033|FG006|Treatment Period Week 0-24|Physician Decision|0
7500363|NCT02265705|11824027|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
7500364|NCT02265705|11824028|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
7500365|NCT02265705|11824029|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
7500366|NCT02265705|11824030|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
7500367|NCT02265705|11824031|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
7500368|NCT02265705|11824032|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
7500369|NCT02265705|11824033|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
7500370|NCT02265705|11824027|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
7500371|NCT02265705|11824028|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
7500372|NCT02265705|11824029|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
7500373|NCT02265705|11824030|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
7500374|NCT02265705|11824031|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
7500375|NCT02265705|11824032|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
7500376|NCT02265705|11824033|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
7500377|NCT02265705|11824027|FG000|Rescue Period|Withdrawal by Subject|0
7500378|NCT02265705|11824028|FG001|Rescue Period|Withdrawal by Subject|0
7500379|NCT02265705|11824029|FG002|Rescue Period|Withdrawal by Subject|1
7500380|NCT02265705|11824030|FG003|Rescue Period|Withdrawal by Subject|0
7500381|NCT02265705|11824031|FG004|Rescue Period|Withdrawal by Subject|0
7500382|NCT02265705|11824032|FG005|Rescue Period|Withdrawal by Subject|0
7500383|NCT02265705|11824033|FG006|Rescue Period|Withdrawal by Subject|0
7500384|NCT02265705|11824027|FG000|Rescue Period|Death|0
7500385|NCT02265705|11824028|FG001|Rescue Period|Death|0
7500386|NCT02265705|11824029|FG002|Rescue Period|Death|1
7500387|NCT02265705|11824030|FG003|Rescue Period|Death|0
7500388|NCT02265705|11824031|FG004|Rescue Period|Death|0
7500389|NCT02265705|11824032|FG005|Rescue Period|Death|0
7500390|NCT02265705|11824033|FG006|Rescue Period|Death|0
7500391|NCT02265705|11824027|FG000|Rescue Period|Lack of Efficacy|0
7500392|NCT02265705|11824028|FG001|Rescue Period|Lack of Efficacy|0
7500393|NCT02265705|11824029|FG002|Rescue Period|Lack of Efficacy|1
7500394|NCT02265705|11824030|FG003|Rescue Period|Lack of Efficacy|0
7500395|NCT02265705|11824031|FG004|Rescue Period|Lack of Efficacy|0
7500396|NCT02265705|11824032|FG005|Rescue Period|Lack of Efficacy|0
7500397|NCT02265705|11824033|FG006|Rescue Period|Lack of Efficacy|0
7500398|NCT02265705|11824027|FG000|Open Label Period|Adverse Event|0
7500399|NCT02265705|11824028|FG001|Open Label Period|Adverse Event|0
7500400|NCT02265705|11824029|FG002|Open Label Period|Adverse Event|0
7500401|NCT02265705|11824030|FG003|Open Label Period|Adverse Event|2
7500402|NCT02265705|11824031|FG004|Open Label Period|Adverse Event|2
7500403|NCT02265705|11824032|FG005|Open Label Period|Adverse Event|0
7500404|NCT02265705|11824033|FG006|Open Label Period|Adverse Event|0
7500405|NCT02265705|11824027|FG000|Open Label Period|Physician Decision|0
7500406|NCT02265705|11824028|FG001|Open Label Period|Physician Decision|0
7500407|NCT02265705|11824029|FG002|Open Label Period|Physician Decision|0
7500408|NCT02265705|11824030|FG003|Open Label Period|Physician Decision|0
7500409|NCT02265705|11824031|FG004|Open Label Period|Physician Decision|1
7500410|NCT02265705|11824032|FG005|Open Label Period|Physician Decision|0
7500411|NCT02265705|11824033|FG006|Open Label Period|Physician Decision|0
7500412|NCT02265705|11824027|FG000|Open Label Period|Withdrawal by Subject|0
7500413|NCT02265705|11824028|FG001|Open Label Period|Withdrawal by Subject|0
7500414|NCT02265705|11824029|FG002|Open Label Period|Withdrawal by Subject|0
7500415|NCT02265705|11824030|FG003|Open Label Period|Withdrawal by Subject|0
7500416|NCT02265705|11824031|FG004|Open Label Period|Withdrawal by Subject|2
7500417|NCT02265705|11824032|FG005|Open Label Period|Withdrawal by Subject|0
7500418|NCT02265705|11824033|FG006|Open Label Period|Withdrawal by Subject|0
7500419|NCT02265705|11824027|FG000|Follow-up Period|Sponsor Decision|0
7500420|NCT02265705|11824028|FG001|Follow-up Period|Sponsor Decision|0
7500421|NCT02265705|11824029|FG002|Follow-up Period|Sponsor Decision|0
7500422|NCT02265705|11824030|FG003|Follow-up Period|Sponsor Decision|0
7500423|NCT02265705|11824031|FG004|Follow-up Period|Sponsor Decision|0
7500424|NCT02265705|11824032|FG005|Follow-up Period|Sponsor Decision|1
7500425|NCT02265705|11824033|FG006|Follow-up Period|Sponsor Decision|6
7500426|NCT02265705|11824027|FG000|Follow-up Period|Adverse Event|0
7500427|NCT02265705|11824028|FG001|Follow-up Period|Adverse Event|0
7500428|NCT02265705|11824029|FG002|Follow-up Period|Adverse Event|0
7500429|NCT02265705|11824030|FG003|Follow-up Period|Adverse Event|0
7500430|NCT02265705|11824031|FG004|Follow-up Period|Adverse Event|0
7500431|NCT02265705|11824032|FG005|Follow-up Period|Adverse Event|0
7500432|NCT02265705|11824033|FG006|Follow-up Period|Adverse Event|3
7500433|NCT02265705|11824027|FG000|Follow-up Period|Physician Decision|0
7500434|NCT02265705|11824028|FG001|Follow-up Period|Physician Decision|0
7500435|NCT02265705|11824029|FG002|Follow-up Period|Physician Decision|0
7500436|NCT02265705|11824030|FG003|Follow-up Period|Physician Decision|0
7500437|NCT02265705|11824031|FG004|Follow-up Period|Physician Decision|0
7500438|NCT02265705|11824032|FG005|Follow-up Period|Physician Decision|0
7500439|NCT02265705|11824033|FG006|Follow-up Period|Physician Decision|1
7500440|NCT02265705|11824027|FG000|Follow-up Period|Withdrawal by Subject|0
7500441|NCT02265705|11824028|FG001|Follow-up Period|Withdrawal by Subject|0
7500442|NCT02265705|11824029|FG002|Follow-up Period|Withdrawal by Subject|0
7500443|NCT02265705|11824030|FG003|Follow-up Period|Withdrawal by Subject|0
7500444|NCT02265705|11824031|FG004|Follow-up Period|Withdrawal by Subject|0
7500445|NCT02265705|11824032|FG005|Follow-up Period|Withdrawal by Subject|0
7500446|NCT02265705|11824033|FG006|Follow-up Period|Withdrawal by Subject|1
7500447|NCT02265744|11824049|FG000|Overall Study|Poor/Non-compliance|1
7500448|NCT02265744|11824050|FG001|Overall Study|Poor/Non-compliance|1
7500449|NCT02265744|11824051|FG002|Overall Study|Poor/Non-compliance|0
7500450|NCT02265744|11824052|FG003|Overall Study|Poor/Non-compliance|0
7500451|NCT02265744|11824053|FG004|Overall Study|Poor/Non-compliance|2
7500452|NCT02265744|11824049|FG000|Overall Study|Lost to Follow-up|0
7500453|NCT02265744|11824050|FG001|Overall Study|Lost to Follow-up|0
7500454|NCT02265744|11824051|FG002|Overall Study|Lost to Follow-up|0
7500455|NCT02265744|11824052|FG003|Overall Study|Lost to Follow-up|1
7500456|NCT02265744|11824053|FG004|Overall Study|Lost to Follow-up|0
7500457|NCT02265744|11824049|FG000|Overall Study|Death|0
7500458|NCT02265744|11824050|FG001|Overall Study|Death|0
7500459|NCT02265744|11824051|FG002|Overall Study|Death|0
7500460|NCT02265744|11824052|FG003|Overall Study|Death|2
7500461|NCT02265744|11824053|FG004|Overall Study|Death|0
7500462|NCT02265744|11824049|FG000|Overall Study|Withdrawal by Subject|2
7500463|NCT02265744|11824050|FG001|Overall Study|Withdrawal by Subject|0
7500464|NCT02265744|11824051|FG002|Overall Study|Withdrawal by Subject|0
7500465|NCT02265744|11824052|FG003|Overall Study|Withdrawal by Subject|2
7500466|NCT02265744|11824053|FG004|Overall Study|Withdrawal by Subject|0
7500467|NCT02265744|11824049|FG000|Overall Study|Participant request to discontinue|2
7500468|NCT02265744|11824050|FG001|Overall Study|Participant request to discontinue|2
7500469|NCT02265744|11824051|FG002|Overall Study|Participant request to discontinue|2
7500470|NCT02265744|11824052|FG003|Overall Study|Participant request to discontinue|0
7500471|NCT02265744|11824053|FG004|Overall Study|Participant request to discontinue|0
7500472|NCT02265744|11824049|FG000|Overall Study|Adverse Event|8
7500473|NCT02265744|11824050|FG001|Overall Study|Adverse Event|4
7500474|NCT02265744|11824051|FG002|Overall Study|Adverse Event|9
7500475|NCT02265744|11824052|FG003|Overall Study|Adverse Event|8
7500476|NCT02265744|11824053|FG004|Overall Study|Adverse Event|2
7500477|NCT02265744|11824049|FG000|Overall Study|Lack of Efficacy|2
7500478|NCT02265744|11824050|FG001|Overall Study|Lack of Efficacy|4
7500479|NCT02265744|11824051|FG002|Overall Study|Lack of Efficacy|3
7500480|NCT02265744|11824052|FG003|Overall Study|Lack of Efficacy|4
7500481|NCT02265744|11824053|FG004|Overall Study|Lack of Efficacy|5
7500482|NCT02265744|11824049|FG000|Overall Study|Reason not provided by Investigator|1
7500483|NCT02265744|11824050|FG001|Overall Study|Reason not provided by Investigator|0
7500484|NCT02265744|11824051|FG002|Overall Study|Reason not provided by Investigator|0
7500485|NCT02265744|11824052|FG003|Overall Study|Reason not provided by Investigator|2
7500486|NCT02265744|11824053|FG004|Overall Study|Reason not provided by Investigator|0
7500487|NCT02265744|11824049|FG000|Overall Study|Administrative reason by sponsor|3
7500488|NCT02265744|11824050|FG001|Overall Study|Administrative reason by sponsor|2
7500489|NCT02265744|11824051|FG002|Overall Study|Administrative reason by sponsor|2
7500490|NCT02265744|11824052|FG003|Overall Study|Administrative reason by sponsor|3
7500491|NCT02265744|11824053|FG004|Overall Study|Administrative reason by sponsor|3
7500492|NCT02265744|11824049|FG000|Overall Study|Subject no longer meets study criteria|0
7500493|NCT02265744|11824050|FG001|Overall Study|Subject no longer meets study criteria|0
7500494|NCT02265744|11824051|FG002|Overall Study|Subject no longer meets study criteria|0
7500495|NCT02265744|11824052|FG003|Overall Study|Subject no longer meets study criteria|0
7500496|NCT02265744|11824053|FG004|Overall Study|Subject no longer meets study criteria|1
7500497|NCT02265744|11824049|FG000|Overall Study|Pregnancy|1
7500498|NCT02265744|11824050|FG001|Overall Study|Pregnancy|2
7500499|NCT02265744|11824051|FG002|Overall Study|Pregnancy|1
7500500|NCT02265744|11824052|FG003|Overall Study|Pregnancy|1
7500501|NCT02265744|11824053|FG004|Overall Study|Pregnancy|0
7500502|NCT02265796|11824071|FG000|Overall Study|Death|1
7500503|NCT02265796|11824072|FG001|Overall Study|Death|0
7500504|NCT02265796|11824071|FG000|Overall Study|started on excluded medication|1
7500505|NCT02265796|11824072|FG001|Overall Study|started on excluded medication|0
7500506|NCT02265796|11824071|FG000|Overall Study|Withdrawal by Subject|1
7500507|NCT02265796|11824072|FG001|Overall Study|Withdrawal by Subject|1
7535625|NCT02711956|11883399|FG007|Overall Study|PSA progression with clinical progression|0
7535626|NCT02711956|11883400|FG008|Overall Study|PSA progression with clinical progression|0
7535627|NCT02711956|11883401|FG009|Overall Study|PSA progression with clinical progression|0
7535628|NCT02711956|11883402|FG010|Overall Study|PSA progression with clinical progression|0
7535629|NCT02711956|11883403|FG011|Overall Study|PSA progression with clinical progression|0
7535630|NCT02711956|11883404|FG012|Overall Study|PSA progression with clinical progression|1
7535631|NCT02711956|11883405|FG013|Overall Study|PSA progression with clinical progression|1
7535632|NCT02711956|11883406|FG014|Overall Study|PSA progression with clinical progression|0
7535633|NCT02711956|11883392|FG000|Overall Study|PSA progression with radiographic progression|0
7535634|NCT02711956|11883393|FG001|Overall Study|PSA progression with radiographic progression|1
7535635|NCT02711956|11883394|FG002|Overall Study|PSA progression with radiographic progression|0
7535636|NCT02711956|11883395|FG003|Overall Study|PSA progression with radiographic progression|0
7535637|NCT02711956|11883396|FG004|Overall Study|PSA progression with radiographic progression|0
7535638|NCT02711956|11883397|FG005|Overall Study|PSA progression with radiographic progression|2
7535639|NCT02711956|11883398|FG006|Overall Study|PSA progression with radiographic progression|2
7535640|NCT02711956|11883399|FG007|Overall Study|PSA progression with radiographic progression|1
7535641|NCT02711956|11883400|FG008|Overall Study|PSA progression with radiographic progression|0
7535642|NCT02711956|11883401|FG009|Overall Study|PSA progression with radiographic progression|1
7535643|NCT02711956|11883402|FG010|Overall Study|PSA progression with radiographic progression|0
7535644|NCT02711956|11883403|FG011|Overall Study|PSA progression with radiographic progression|1
7535645|NCT02711956|11883404|FG012|Overall Study|PSA progression with radiographic progression|2
7535646|NCT02711956|11883405|FG013|Overall Study|PSA progression with radiographic progression|3
7535647|NCT02711956|11883406|FG014|Overall Study|PSA progression with radiographic progression|3
7535648|NCT02711995|11883447|FG000|Washout (90 Days)|Conflicting medication|1
7535649|NCT02712008|11883456|FG000|Baseline (Day 1) up to Week 12|Death|3
7535650|NCT02712008|11883457|FG001|Baseline (Day 1) up to Week 12|Death|0
7535651|NCT02712008|11883458|FG002|Baseline (Day 1) up to Week 12|Death|0
7535652|NCT02712008|11883459|FG003|Baseline (Day 1) up to Week 12|Death|0
7535653|NCT02712008|11883460|FG004|Baseline (Day 1) up to Week 12|Death|0
7535654|NCT02712008|11883461|FG005|Baseline (Day 1) up to Week 12|Death|0
7535655|NCT02712008|11883462|FG006|Baseline (Day 1) up to Week 12|Death|0
7535656|NCT02712008|11883463|FG007|Baseline (Day 1) up to Week 12|Death|0
7535657|NCT02712008|11883456|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535658|NCT02712008|11883457|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
7535659|NCT02712008|11883458|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7535660|NCT02712008|11883459|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535661|NCT02712008|11883460|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535662|NCT02712008|11883461|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535663|NCT02712008|11883462|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535664|NCT02712008|11883463|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535665|NCT02712008|11883456|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7535666|NCT02712008|11883457|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535667|NCT02712008|11883458|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
7535668|NCT02712008|11883459|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535669|NCT02712008|11883460|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535670|NCT02712008|11883461|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535671|NCT02712008|11883462|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535672|NCT02712008|11883463|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535673|NCT02712008|11883456|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535674|NCT02712008|11883457|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535675|NCT02712008|11883458|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
7535676|NCT02712008|11883459|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535677|NCT02712008|11883460|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535678|NCT02712008|11883461|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535679|NCT02712008|11883462|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535680|NCT02712008|11883463|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
7535681|NCT02712008|11883456|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535682|NCT02712008|11883457|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
7535683|NCT02712008|11883458|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535684|NCT02712008|11883459|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535685|NCT02712008|11883460|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535686|NCT02712008|11883461|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535687|NCT02712008|11883462|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535688|NCT02712008|11883463|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
7535689|NCT02712008|11883456|FG000|From Week 12 up to Week 36|Adverse Event|0
7535690|NCT02712008|11883457|FG001|From Week 12 up to Week 36|Adverse Event|0
7500508|NCT02265952|11824100|FG000|Open Label Extension (OLE) Period|Physician Decision|0
7500509|NCT02265952|11824101|FG001|Open Label Extension (OLE) Period|Physician Decision|7
7500510|NCT02265952|11824100|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7500511|NCT02265952|11824101|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
7500512|NCT02266004|11824116|FG000|Overall Study|unrelated adverse event|1
7500513|NCT02266004|11824116|FG000|Overall Study|Physician Decision|1
7500514|NCT02266147|11824133|FG000|PART 1: Dose Escalation|Physician Decision|0
7500515|NCT02266147|11824134|FG001|PART 1: Dose Escalation|Physician Decision|0
7500516|NCT02266147|11824135|FG002|PART 1: Dose Escalation|Physician Decision|1
7500517|NCT02266147|11824136|FG003|PART 1: Dose Escalation|Physician Decision|0
7500518|NCT02266147|11824133|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
7500519|NCT02266147|11824134|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
7500520|NCT02266147|11824135|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
7500521|NCT02266147|11824136|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
7500522|NCT02266147|11824133|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7500523|NCT02266147|11824134|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
7500524|NCT02266147|11824135|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
7500525|NCT02266147|11824136|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
7500526|NCT02266147|11824133|FG000|PART 1: Dose Escalation|Other|1
7500527|NCT02266147|11824134|FG001|PART 1: Dose Escalation|Other|1
7500528|NCT02266147|11824135|FG002|PART 1: Dose Escalation|Other|0
7500529|NCT02266147|11824136|FG003|PART 1: Dose Escalation|Other|0
7500530|NCT02266147|11824133|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
7500531|NCT02266147|11824134|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
7500532|NCT02266147|11824135|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
7500533|NCT02266147|11824136|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
7500534|NCT02266147|11824133|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
7500535|NCT02266147|11824134|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7500536|NCT02266147|11824135|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
7500537|NCT02266147|11824136|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
7500538|NCT02266225|11824148|FG000|Overall Study|Lost to Follow-up|2
7500539|NCT02266225|11824148|FG000|Overall Study|Death|1
7500540|NCT02266225|11824148|FG000|Overall Study|Withdrawal by Subject|13
7500541|NCT02266381|11824183|FG000|Overall Study|Physician Decision|3
7500542|NCT02266381|11824184|FG001|Overall Study|Physician Decision|5
7500543|NCT02266381|11824185|FG002|Overall Study|Physician Decision|4
7500544|NCT02266433|11824197|FG000|Overall Study|Lost to Follow-up|54
7500545|NCT02266433|11824198|FG001|Overall Study|Lost to Follow-up|46
7500546|NCT02266433|11824197|FG000|Overall Study|Withdrawal by Subject|5
7500547|NCT02266433|11824198|FG001|Overall Study|Withdrawal by Subject|7
7500548|NCT02266706|11824232|FG000|Overall Study|Withdrawal by Subject|0
7500549|NCT02266706|11824233|FG001|Overall Study|Withdrawal by Subject|1
7500550|NCT02266706|11824234|FG002|Overall Study|Withdrawal by Subject|1
7500551|NCT02266706|11824235|FG003|Overall Study|Withdrawal by Subject|0
7500552|NCT02266706|11824236|FG004|Overall Study|Withdrawal by Subject|0
7500553|NCT02266706|11824237|FG005|Overall Study|Withdrawal by Subject|1
7500554|NCT02266706|11824238|FG006|Overall Study|Withdrawal by Subject|0
7500555|NCT02266706|11824239|FG007|Overall Study|Withdrawal by Subject|0
7500556|NCT02266706|11824240|FG008|Overall Study|Withdrawal by Subject|0
7500557|NCT02266706|11824232|FG000|Overall Study|Screen failure|0
7500558|NCT02266706|11824233|FG001|Overall Study|Screen failure|0
7500559|NCT02266706|11824234|FG002|Overall Study|Screen failure|0
7500560|NCT02266706|11824235|FG003|Overall Study|Screen failure|0
7500561|NCT02266706|11824236|FG004|Overall Study|Screen failure|0
7500562|NCT02266706|11824237|FG005|Overall Study|Screen failure|1
7500563|NCT02266706|11824238|FG006|Overall Study|Screen failure|1
7500564|NCT02266706|11824239|FG007|Overall Study|Screen failure|0
7500565|NCT02266706|11824240|FG008|Overall Study|Screen failure|0
7500566|NCT02266706|11824232|FG000|Overall Study|Enrollment in another study|0
7500567|NCT02266706|11824233|FG001|Overall Study|Enrollment in another study|0
7500568|NCT02266706|11824234|FG002|Overall Study|Enrollment in another study|0
7500569|NCT02266706|11824235|FG003|Overall Study|Enrollment in another study|1
7500570|NCT02266706|11824236|FG004|Overall Study|Enrollment in another study|0
7500571|NCT02266706|11824237|FG005|Overall Study|Enrollment in another study|0
7500572|NCT02266706|11824238|FG006|Overall Study|Enrollment in another study|0
7500573|NCT02266706|11824239|FG007|Overall Study|Enrollment in another study|0
7500574|NCT02266706|11824240|FG008|Overall Study|Enrollment in another study|0
7500575|NCT02266875|11824280|FG000|Overall Study|Withdrawal by Subject|9
7500576|NCT02266875|11824281|FG001|Overall Study|Withdrawal by Subject|0
7500577|NCT02266875|11824280|FG000|Overall Study|Lost to Follow-up|2
7500578|NCT02266875|11824281|FG001|Overall Study|Lost to Follow-up|0
7500579|NCT02266888|11824289|FG000|Overall Study|Death|2
7500580|NCT02266888|11824290|FG001|Overall Study|Death|2
7500581|NCT02266888|11824291|FG002|Overall Study|Death|4
7500582|NCT02266888|11824292|FG003|Overall Study|Death|2
7500583|NCT02266888|11824289|FG000|Overall Study|Physician Decision|0
7500584|NCT02266888|11824290|FG001|Overall Study|Physician Decision|1
7500585|NCT02266888|11824291|FG002|Overall Study|Physician Decision|2
7500586|NCT02266888|11824292|FG003|Overall Study|Physician Decision|2
7500587|NCT02266888|11824289|FG000|Overall Study|Study Terminated|5
7500588|NCT02266888|11824290|FG001|Overall Study|Study Terminated|1
7500589|NCT02266888|11824291|FG002|Overall Study|Study Terminated|0
7500590|NCT02266888|11824292|FG003|Overall Study|Study Terminated|0
7500591|NCT02266888|11824289|FG000|Overall Study|No Longer Eligible|0
7500592|NCT02266888|11824290|FG001|Overall Study|No Longer Eligible|0
7500593|NCT02266888|11824291|FG002|Overall Study|No Longer Eligible|0
7500594|NCT02266888|11824292|FG003|Overall Study|No Longer Eligible|2
7500595|NCT02266888|11824289|FG000|Overall Study|Randomization Closed|0
7500596|NCT02266888|11824290|FG001|Overall Study|Randomization Closed|0
7500597|NCT02266888|11824291|FG002|Overall Study|Randomization Closed|4
7500598|NCT02266888|11824292|FG003|Overall Study|Randomization Closed|0
7500599|NCT02266888|11824289|FG000|Overall Study|Personnel unavailable at transplant|0
7500600|NCT02266888|11824290|FG001|Overall Study|Personnel unavailable at transplant|0
7500601|NCT02266888|11824291|FG002|Overall Study|Personnel unavailable at transplant|0
7500602|NCT02266888|11824292|FG003|Overall Study|Personnel unavailable at transplant|1
7500603|NCT02266888|11824289|FG000|Overall Study|Transfer of care|0
7500604|NCT02266888|11824290|FG001|Overall Study|Transfer of care|0
7500605|NCT02266888|11824291|FG002|Overall Study|Transfer of care|1
7500606|NCT02266888|11824292|FG003|Overall Study|Transfer of care|0
7500607|NCT02267135|11824306|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
7500608|NCT02267135|11824307|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
7500609|NCT02267135|11824306|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
7500610|NCT02267135|11824307|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
7500611|NCT02267135|11824306|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
7500612|NCT02267135|11824307|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
7500613|NCT02267135|11824306|FG000|Period 2 (Randomized Set)|Adverse Event|2
7500614|NCT02267135|11824307|FG001|Period 2 (Randomized Set)|Adverse Event|0
7500615|NCT02267135|11824306|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
7500616|NCT02267135|11824307|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
7500617|NCT02267187|11824316|FG000|Overall Study|Physician Decision|2
7500618|NCT02267187|11824316|FG000|Overall Study|Screen fail|3
7500619|NCT02267278|11824339|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
7500620|NCT02267278|11824339|FG000|Overall Study|transformation to acute leukemia (AML)|1
7500621|NCT02267278|11824339|FG000|Overall Study|Developed new cancer diagnoses|2
7500622|NCT02267278|11824339|FG000|Overall Study|prescribed prohibited medication|1
7500623|NCT02267317|11824346|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
7500624|NCT02267317|11824347|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7500625|NCT02267317|11824348|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7500626|NCT02267317|11824349|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7500627|NCT02267317|11824350|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7500628|NCT02267317|11824351|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
7500629|NCT02267317|11824346|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
7500630|NCT02267317|11824347|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7500631|NCT02267317|11824348|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7500632|NCT02267317|11824349|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7500633|NCT02267317|11824350|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7500634|NCT02267317|11824351|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
7500635|NCT02267746|11824438|FG000|Overall Study|Adverse Event|0
7500636|NCT02267746|11824439|FG001|Overall Study|Adverse Event|2
7500637|NCT02267746|11824440|FG002|Overall Study|Adverse Event|1
7500638|NCT02267746|11824438|FG000|Overall Study|Protocol Violation|8
7500639|NCT02267746|11824439|FG001|Overall Study|Protocol Violation|7
7500640|NCT02267746|11824440|FG002|Overall Study|Protocol Violation|3
7500641|NCT02267746|11824438|FG000|Overall Study|Lack of Efficacy|11
7500642|NCT02267746|11824439|FG001|Overall Study|Lack of Efficacy|11
7500643|NCT02267746|11824440|FG002|Overall Study|Lack of Efficacy|15
7500644|NCT02267746|11824438|FG000|Overall Study|Protocol Violation|1
7500645|NCT02267746|11824439|FG001|Overall Study|Protocol Violation|2
7500646|NCT02267746|11824440|FG002|Overall Study|Protocol Violation|1
7500647|NCT02267746|11824438|FG000|Overall Study|Miscellaneous|1
7500648|NCT02267746|11824439|FG001|Overall Study|Miscellaneous|0
7500649|NCT02267746|11824440|FG002|Overall Study|Miscellaneous|1
7500650|NCT02267824|11824472|FG000|Overall Study|Pregnancy|1
7500651|NCT02267824|11824473|FG001|Overall Study|Pregnancy|1
7500652|NCT02267824|11824472|FG000|Overall Study|Lost to Follow-up|4
7500653|NCT02267824|11824473|FG001|Overall Study|Lost to Follow-up|0
7500654|NCT02267824|11824472|FG000|Overall Study|Protocol Violation|3
7500655|NCT02267824|11824473|FG001|Overall Study|Protocol Violation|0
7500656|NCT02267824|11824472|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
7500657|NCT02267824|11824473|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
7500658|NCT02268045|11824499|FG000|Overall Study|Death|4
7500659|NCT02268045|11824500|FG001|Overall Study|Death|4
7500660|NCT02268045|11824499|FG000|Overall Study|Disease Progression|2
7500661|NCT02268045|11824500|FG001|Overall Study|Disease Progression|1
7500662|NCT02268045|11824499|FG000|Overall Study|Adverse Event|7
7500663|NCT02268045|11824500|FG001|Overall Study|Adverse Event|7
7500664|NCT02268045|11824499|FG000|Overall Study|Withdrawal by Subject|2
7500665|NCT02268045|11824500|FG001|Overall Study|Withdrawal by Subject|6
7500666|NCT02268045|11824499|FG000|Overall Study|Physician Decision|0
7500667|NCT02268045|11824500|FG001|Overall Study|Physician Decision|1
7500668|NCT02268045|11824499|FG000|Overall Study|Protocol Violation|1
7500669|NCT02268045|11824500|FG001|Overall Study|Protocol Violation|1
7500670|NCT02268058|11824512|FG000|Overall Study|Protocol Violation|1
7500671|NCT02268058|11824513|FG001|Overall Study|Protocol Violation|0
7500672|NCT02268058|11824514|FG002|Overall Study|Protocol Violation|0
7500673|NCT02268058|11824515|FG003|Overall Study|Protocol Violation|0
7500674|NCT02268084|11824527|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
7500675|NCT02268084|11824528|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
7500676|NCT02268084|11824527|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
7500677|NCT02268084|11824528|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
7500678|NCT02268214|11824543|FG000|Overall Study|Subject no longer meets study criteria|0
7500679|NCT02268214|11824544|FG001|Overall Study|Subject no longer meets study criteria|2
7500680|NCT02268214|11824545|FG002|Overall Study|Subject no longer meets study criteria|0
7500681|NCT02268214|11824543|FG000|Overall Study|Pregnancy|2
7500682|NCT02268214|11824544|FG001|Overall Study|Pregnancy|2
7500683|NCT02268214|11824545|FG002|Overall Study|Pregnancy|1
7500684|NCT02268214|11824543|FG000|Overall Study|Lost to Follow-up|3
7500685|NCT02268214|11824544|FG001|Overall Study|Lost to Follow-up|3
7500686|NCT02268214|11824545|FG002|Overall Study|Lost to Follow-up|4
7500687|NCT02268214|11824543|FG000|Overall Study|Lack of Efficacy|1
7500688|NCT02268214|11824544|FG001|Overall Study|Lack of Efficacy|0
7500689|NCT02268214|11824545|FG002|Overall Study|Lack of Efficacy|2
7500690|NCT02268214|11824543|FG000|Overall Study|Adverse Event|11
7500691|NCT02268214|11824544|FG001|Overall Study|Adverse Event|14
7500692|NCT02268214|11824545|FG002|Overall Study|Adverse Event|9
7500693|NCT02268214|11824543|FG000|Overall Study|Withdrawal by Subject|4
7500694|NCT02268214|11824544|FG001|Overall Study|Withdrawal by Subject|5
7500695|NCT02268214|11824545|FG002|Overall Study|Withdrawal by Subject|10
7500696|NCT02268214|11824543|FG000|Overall Study|Subject request to discontinue treatment|10
7500697|NCT02268214|11824544|FG001|Overall Study|Subject request to discontinue treatment|8
7500698|NCT02268214|11824545|FG002|Overall Study|Subject request to discontinue treatment|6
7500699|NCT02268214|11824543|FG000|Overall Study|Poor/non-compliance|2
7500700|NCT02268214|11824544|FG001|Overall Study|Poor/non-compliance|1
7500701|NCT02268214|11824545|FG002|Overall Study|Poor/non-compliance|2
7500702|NCT02268214|11824543|FG000|Overall Study|Other reasons|7
7500703|NCT02268214|11824544|FG001|Overall Study|Other reasons|3
7500704|NCT02268214|11824545|FG002|Overall Study|Other reasons|3
7500705|NCT02268214|11824543|FG000|Overall Study|Not entering long-term period|2
7500706|NCT02268214|11824544|FG001|Overall Study|Not entering long-term period|3
7500707|NCT02268214|11824545|FG002|Overall Study|Not entering long-term period|5
7500708|NCT02268396|11824553|FG000|Overall Study|Adverse Event|3
7500709|NCT02268396|11824553|FG000|Overall Study|Administrative|2
7500710|NCT02268396|11824553|FG000|Overall Study|Withdrawal by Subject|1
7500711|NCT02268396|11824553|FG000|Overall Study|Lost to Follow-up|2
7500712|NCT02268396|11824553|FG000|Overall Study|Protocol-Specified Criteria|2
7500713|NCT02268396|11824553|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
7500714|NCT02268526|11824569|FG000|Overall Study|Adverse Event|0
7500715|NCT02268526|11824570|FG001|Overall Study|Adverse Event|2
7500716|NCT02268526|11824571|FG002|Overall Study|Adverse Event|1
7500717|NCT02268526|11824569|FG000|Overall Study|Death|1
7500718|NCT02268526|11824570|FG001|Overall Study|Death|11
7500719|NCT02268526|11824571|FG002|Overall Study|Death|0
7500720|NCT02268526|11824569|FG000|Overall Study|protocol deviation|0
7500721|NCT02268526|11824570|FG001|Overall Study|protocol deviation|1
7500722|NCT02268526|11824571|FG002|Overall Study|protocol deviation|0
7500723|NCT02268526|11824569|FG000|Overall Study|Physician Decision|0
7500724|NCT02268526|11824570|FG001|Overall Study|Physician Decision|0
7500725|NCT02268526|11824571|FG002|Overall Study|Physician Decision|1
7500726|NCT02268526|11824569|FG000|Overall Study|Subject/guardian decision|0
7500727|NCT02268526|11824570|FG001|Overall Study|Subject/guardian decision|7
7500728|NCT02268526|11824571|FG002|Overall Study|Subject/guardian decision|3
7500729|NCT02268786|11824583|FG000|Overall Study|No Euploid Embryos available|42
7500730|NCT02268786|11824584|FG001|Overall Study|No Euploid Embryos available|0
7500731|NCT02268786|11824583|FG000|Overall Study|Withdrawal by Subject|7
7500732|NCT02268786|11824584|FG001|Overall Study|Withdrawal by Subject|14
7500733|NCT02268786|11824583|FG000|Overall Study|Thaw Failure|6
7500734|NCT02268786|11824584|FG001|Overall Study|Thaw Failure|4
7500735|NCT02268786|11824583|FG000|Overall Study|Protocol Violation|1
7500736|NCT02268786|11824584|FG001|Overall Study|Protocol Violation|0
7500737|NCT02268812|11824594|FG000|Overall Study|Adverse Event|8
7500738|NCT02268812|11824595|FG001|Overall Study|Adverse Event|26
7500739|NCT02268812|11824596|FG002|Overall Study|Adverse Event|7
7500740|NCT02268812|11824597|FG003|Overall Study|Adverse Event|10
7500741|NCT02268812|11824594|FG000|Overall Study|Protocol deviation|0
7500742|NCT02268812|11824595|FG001|Overall Study|Protocol deviation|0
7500743|NCT02268812|11824596|FG002|Overall Study|Protocol deviation|1
7500744|NCT02268812|11824597|FG003|Overall Study|Protocol deviation|0
7500745|NCT02268812|11824594|FG000|Overall Study|Withdrawal by Subject|0
7500746|NCT02268812|11824595|FG001|Overall Study|Withdrawal by Subject|1
7500747|NCT02268812|11824596|FG002|Overall Study|Withdrawal by Subject|0
7500748|NCT02268812|11824597|FG003|Overall Study|Withdrawal by Subject|0
7500749|NCT02268812|11824594|FG000|Overall Study|Physician Decision|3
7500750|NCT02268812|11824595|FG001|Overall Study|Physician Decision|1
7500751|NCT02268812|11824596|FG002|Overall Study|Physician Decision|0
7500752|NCT02268812|11824597|FG003|Overall Study|Physician Decision|1
7500753|NCT02268812|11824594|FG000|Overall Study|Other|5
7500754|NCT02268812|11824595|FG001|Overall Study|Other|4
7500755|NCT02268812|11824596|FG002|Overall Study|Other|1
7500756|NCT02268812|11824597|FG003|Overall Study|Other|3
7500799|NCT02268864|11824635|FG000|Overall Study|Withdrawal by Subject|2
7500800|NCT02268864|11824636|FG001|Overall Study|Withdrawal by Subject|0
7500801|NCT02268864|11824637|FG002|Overall Study|Withdrawal by Subject|0
7500802|NCT02268864|11824635|FG000|Overall Study|Death|0
7500803|NCT02268864|11824636|FG001|Overall Study|Death|1
7500804|NCT02268864|11824637|FG002|Overall Study|Death|0
7500805|NCT02269098|11824683|FG000|Overall Study|Lost to Follow-up|14
7500806|NCT02269098|11824684|FG001|Overall Study|Lost to Follow-up|9
7500807|NCT02269124|11824693|FG000|Overall Study|Lost to Follow-up|1
7500808|NCT02269124|11824694|FG001|Overall Study|Lost to Follow-up|0
7500809|NCT02269124|11824693|FG000|Overall Study|Withdrawal by Subject|0
7500810|NCT02269124|11824694|FG001|Overall Study|Withdrawal by Subject|2
7500811|NCT02269163|11824703|FG000|Overall Study|Lost to Follow-up|1
7500812|NCT02269163|11824704|FG001|Overall Study|Lost to Follow-up|0
7500813|NCT02269163|11824703|FG000|Overall Study|Major protocol violation|0
7500814|NCT02269163|11824704|FG001|Overall Study|Major protocol violation|1
7500815|NCT02269163|11824703|FG000|Overall Study|Other|2
7500816|NCT02269163|11824704|FG001|Overall Study|Other|2
7500817|NCT02269163|11824703|FG000|Overall Study|Withdrawal by Subject|0
7500818|NCT02269163|11824704|FG001|Overall Study|Withdrawal by Subject|3
7500819|NCT02269163|11824703|FG000|Overall Study|Physician Decision|0
7500820|NCT02269163|11824704|FG001|Overall Study|Physician Decision|1
7500821|NCT02269241|11824712|FG000|Overall Study|Lost to Follow-up|269
7500822|NCT02269241|11824712|FG000|Overall Study|Withdrawal by Subject|155
7500823|NCT02269241|11824712|FG000|Overall Study|Protocol Violation|1
7500824|NCT02269241|11824712|FG000|Overall Study|Physician Decision|7
7500825|NCT02269241|11824712|FG000|Overall Study|Pregnancy|15
7500826|NCT02269241|11824712|FG000|Overall Study|Wish for pregnancy|5
7500827|NCT02269241|11824712|FG000|Overall Study|Development of an exclusion criteria|16
7500828|NCT02269241|11824712|FG000|Overall Study|Adverse Event|113
7500829|NCT02269241|11824712|FG000|Overall Study|At the specific request of the sponsor|20
7500830|NCT02269241|11824712|FG000|Overall Study|Several reasons not classified|53
7500831|NCT02269241|11824712|FG000|Overall Study|Screening failures|546
7500832|NCT02269423|11824721|FG000|Overall Study|Discontinued due to change in residence|0
7500833|NCT02269423|11824722|FG001|Overall Study|Discontinued due to change in residence|1
7500834|NCT02269423|11824723|FG002|Overall Study|Discontinued due to change in residence|0
7500835|NCT02269423|11824724|FG003|Overall Study|Discontinued due to change in residence|1
7500836|NCT02269475|11824736|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
7500837|NCT02269475|11824737|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
7500838|NCT02269475|11824736|FG000|Overall Study|Withdrawal by Subject|0
7500839|NCT02269475|11824737|FG001|Overall Study|Withdrawal by Subject|1
7500840|NCT02269657|11824757|FG000|Overall Study|Protocol Violation|3
7500841|NCT02269709|11824763|FG000|Time of Enrollment|Withdrawal by Subject|3
7500842|NCT02269709|11824763|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
7500843|NCT02269709|11824763|FG000|Six Month Follow-up|Lost to Follow-up|12
7500844|NCT02269787|11824770|FG000|Overall Study|Lost to Follow-up|20
7500845|NCT02269787|11824771|FG001|Overall Study|Lost to Follow-up|6
7500846|NCT02269787|11824770|FG000|Overall Study|Death|2
7500847|NCT02269787|11824771|FG001|Overall Study|Death|3
7500848|NCT02269787|11824770|FG000|Overall Study|Incapacitated|0
7500849|NCT02269787|11824771|FG001|Overall Study|Incapacitated|1
7500850|NCT02269943|11824779|FG000|Treatment Period|Death|0
7500851|NCT02269943|11824780|FG001|Treatment Period|Death|1
7500852|NCT02269943|11824779|FG000|Treatment Period|Adverse Event|1
7500853|NCT02269943|11824780|FG001|Treatment Period|Adverse Event|10
7500854|NCT02269943|11824779|FG000|Treatment Period|Progressive Disease|5
7500855|NCT02269943|11824780|FG001|Treatment Period|Progressive Disease|17
7500856|NCT02269943|11824779|FG000|Treatment Period|Symptomatic Deterioration|0
7500857|NCT02269943|11824780|FG001|Treatment Period|Symptomatic Deterioration|2
7500858|NCT02269943|11824779|FG000|Follow-Up Survival Period|Death|3
7500859|NCT02269943|11824780|FG001|Follow-Up Survival Period|Death|16
7500860|NCT02269943|11824779|FG000|Follow-Up Survival Period|Lost to Follow-up|0
7500861|NCT02269943|11824780|FG001|Follow-Up Survival Period|Lost to Follow-up|2
7500862|NCT02269943|11824779|FG000|Follow-Up Survival Period|Alive|2
7500863|NCT02269943|11824780|FG001|Follow-Up Survival Period|Alive|8
7500864|NCT02270242|11824801|FG000|Overall Study|Withdrawal by Subject|18
7500865|NCT02270242|11824802|FG001|Overall Study|Withdrawal by Subject|25
7500866|NCT02270242|11824801|FG000|Overall Study|Lost to Follow-up|41
7500867|NCT02270242|11824802|FG001|Overall Study|Lost to Follow-up|27
7500868|NCT02270242|11824801|FG000|Overall Study|Physician Decision|0
7500869|NCT02270242|11824802|FG001|Overall Study|Physician Decision|1
7500870|NCT02270515|11824817|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
7500871|NCT02270515|11824817|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
7500872|NCT02270515|11824817|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
7500873|NCT02270515|11824817|FG000|Intervention Period 1: 0-6 Months|Death|7
7500874|NCT02270515|11824817|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
7500875|NCT02270515|11824817|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
7500876|NCT02270515|11824817|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
7500877|NCT02270515|11824817|FG000|Intervention Period 2: 6-12 Months|Death|5
7500878|NCT02270515|11824817|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
7500879|NCT02270515|11824817|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
7500880|NCT02270515|11824817|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
7500881|NCT02270515|11824817|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
7500882|NCT02270515|11824817|FG000|Intervention Period 3: 12-18 Months|Death|3
7500883|NCT02270515|11824817|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
7500884|NCT02270671|11824839|FG000|Overall Study|Withdrawal by Subject|1
7500885|NCT02270671|11824840|FG001|Overall Study|Withdrawal by Subject|1
7500886|NCT02270671|11824839|FG000|Overall Study|Protocol Violation|0
7500887|NCT02270671|11824840|FG001|Overall Study|Protocol Violation|1
7500888|NCT02270671|11824839|FG000|Overall Study|Missed Post-intervention Data Collection|2
7500889|NCT02270671|11824840|FG001|Overall Study|Missed Post-intervention Data Collection|2
7500890|NCT02270671|11824839|FG000|Overall Study|Lost to Follow-up|2
7500891|NCT02270671|11824840|FG001|Overall Study|Lost to Follow-up|1
7500892|NCT02270736|11824849|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7500893|NCT02270736|11824850|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
7500894|NCT02270736|11824851|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7500895|NCT02270736|11824852|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7500896|NCT02270736|11824853|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
7500897|NCT02270736|11824849|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
7500898|NCT02270736|11824850|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7500899|NCT02270736|11824851|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
7500900|NCT02270736|11824852|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7500901|NCT02270736|11824853|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
7500902|NCT02270736|11824849|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7500903|NCT02270736|11824850|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
7500904|NCT02270736|11824851|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7500905|NCT02270736|11824852|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7500906|NCT02270736|11824853|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
7500907|NCT02270736|11824849|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7535691|NCT02712008|11883458|FG002|From Week 12 up to Week 36|Adverse Event|0
7500908|NCT02270736|11824850|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7500909|NCT02270736|11824851|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
7500910|NCT02270736|11824852|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7500911|NCT02270736|11824853|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
7500912|NCT02270736|11824849|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
7500913|NCT02270736|11824850|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
7500914|NCT02270736|11824851|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
7500915|NCT02270736|11824852|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
7500916|NCT02270736|11824853|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
7500917|NCT02270736|11824849|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7500918|NCT02270736|11824850|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7500919|NCT02270736|11824851|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7500920|NCT02270736|11824852|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
7500921|NCT02270736|11824853|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
7500922|NCT02270736|11824849|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
7500923|NCT02270736|11824850|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
7500924|NCT02270736|11824851|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
7500925|NCT02270736|11824852|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
7500926|NCT02270736|11824853|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
7500927|NCT02270736|11824849|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7500928|NCT02270736|11824850|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7500929|NCT02270736|11824851|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7500930|NCT02270736|11824852|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
7500931|NCT02270736|11824853|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
7500932|NCT02270736|11824849|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7500933|NCT02270736|11824850|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7500934|NCT02270736|11824851|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7500935|NCT02270736|11824852|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
7500936|NCT02270736|11824853|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
7500937|NCT02270944|11824868|FG000|Overall Study|Lost to Follow-up|9
7500938|NCT02270944|11824869|FG001|Overall Study|Lost to Follow-up|4
7500939|NCT02270944|11824868|FG000|Overall Study|Withdrawal by Subject|2
7500940|NCT02270944|11824869|FG001|Overall Study|Withdrawal by Subject|1
7500941|NCT02270983|11824879|FG000|Overall Study|Adverse Event|3
7500942|NCT02270983|11824880|FG001|Overall Study|Adverse Event|2
7500943|NCT02270983|11824881|FG002|Overall Study|Adverse Event|6
7500944|NCT02270983|11824879|FG000|Overall Study|Lack of Efficacy|2
7500945|NCT02270983|11824880|FG001|Overall Study|Lack of Efficacy|1
7500946|NCT02270983|11824881|FG002|Overall Study|Lack of Efficacy|1
7500947|NCT02270983|11824879|FG000|Overall Study|Withdrawal by Subject|1
7500948|NCT02270983|11824880|FG001|Overall Study|Withdrawal by Subject|0
7500949|NCT02270983|11824881|FG002|Overall Study|Withdrawal by Subject|2
7500950|NCT02270983|11824879|FG000|Overall Study|Lost to Follow-up|1
7500951|NCT02270983|11824880|FG001|Overall Study|Lost to Follow-up|1
7500952|NCT02270983|11824881|FG002|Overall Study|Lost to Follow-up|2
7500953|NCT02270983|11824879|FG000|Overall Study|Protocol Violation|1
7500954|NCT02270983|11824880|FG001|Overall Study|Protocol Violation|1
7500955|NCT02270983|11824881|FG002|Overall Study|Protocol Violation|1
7500956|NCT02270983|11824879|FG000|Overall Study|family emergency|0
7500957|NCT02270983|11824880|FG001|Overall Study|family emergency|1
7500958|NCT02270983|11824881|FG002|Overall Study|family emergency|0
7500959|NCT02270983|11824879|FG000|Overall Study|study procedure non-compliance|1
7500960|NCT02270983|11824880|FG001|Overall Study|study procedure non-compliance|0
7500961|NCT02270983|11824881|FG002|Overall Study|study procedure non-compliance|0
7500962|NCT02270983|11824879|FG000|Overall Study|moved away from study site|0
7500963|NCT02270983|11824880|FG001|Overall Study|moved away from study site|1
7500964|NCT02270983|11824881|FG002|Overall Study|moved away from study site|0
7500965|NCT02271529|11824947|FG000|Overall Study|Withdrawal by Subject|1
7500966|NCT02271854|11824968|FG000|Overall Study|Withdrawal by Subject|2
7500967|NCT02271854|11824968|FG000|Overall Study|Unable or unwilling to cooperate with st|1
7500968|NCT02271854|11824968|FG000|Overall Study|Lost to Follow-up|1
7500969|NCT02271880|11824975|FG000|Overall Study|Premature discontinuation of study|3
7500970|NCT02271880|11824976|FG001|Overall Study|Premature discontinuation of study|4
7500971|NCT02271945|11824990|FG000|Overall Study|Death|3
7500972|NCT02271945|11824991|FG001|Overall Study|Death|3
7500973|NCT02271945|11824990|FG000|Overall Study|Withdrawal by Subject|1
7500974|NCT02271945|11824991|FG001|Overall Study|Withdrawal by Subject|1
7500975|NCT02271945|11824990|FG000|Overall Study|Other|1
7500976|NCT02271945|11824991|FG001|Overall Study|Other|1
7500977|NCT02271984|11824997|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500978|NCT02271984|11824998|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500979|NCT02271984|11824999|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500980|NCT02271984|11825000|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500981|NCT02271984|11825001|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500982|NCT02271984|11825002|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7500983|NCT02271984|11825003|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500984|NCT02271984|11825004|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
7500985|NCT02271984|11825005|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500986|NCT02271984|11825006|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500987|NCT02271984|11825007|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500988|NCT02271984|11825008|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
7500989|NCT02272413|11825034|FG000|Randomized Through Treatment Start|Not treated|3
7500990|NCT02272413|11825035|FG001|Randomized Through Treatment Start|Not treated|5
7500991|NCT02272413|11825034|FG000|Pre-switch Period|Adverse Event|38
7500992|NCT02272413|11825035|FG001|Pre-switch Period|Adverse Event|37
7500993|NCT02272413|11825034|FG000|Pre-switch Period|Death|26
7500994|NCT02272413|11825035|FG001|Pre-switch Period|Death|26
7500995|NCT02272413|11825034|FG000|Pre-switch Period|Withdrawal by Subject|27
7500996|NCT02272413|11825035|FG001|Pre-switch Period|Withdrawal by Subject|15
7500997|NCT02272413|11825034|FG000|Pre-switch Period|Physician Decision|6
7500998|NCT02272413|11825035|FG001|Pre-switch Period|Physician Decision|18
7500999|NCT02272413|11825034|FG000|Pre-switch Period|Progressive disease|185
7501000|NCT02272413|11825035|FG001|Pre-switch Period|Progressive disease|173
7501001|NCT02272413|11825034|FG000|Pre-switch Period|Lost to Follow-up|0
7501002|NCT02272413|11825035|FG001|Pre-switch Period|Lost to Follow-up|2
7501003|NCT02272413|11825034|FG000|Pre-switch Period|Protocol Violation|1
7501004|NCT02272413|11825035|FG001|Pre-switch Period|Protocol Violation|0
7501005|NCT02272413|11825034|FG000|Pre-switch Period|Other than listed|10
7501006|NCT02272413|11825035|FG001|Pre-switch Period|Other than listed|11
7501007|NCT02272413|11825034|FG000|Post-switch Period|Adverse Event|4
7501008|NCT02272413|11825035|FG001|Post-switch Period|Adverse Event|4
7501009|NCT02272413|11825034|FG000|Post-switch Period|Death|3
7501010|NCT02272413|11825035|FG001|Post-switch Period|Death|2
7501011|NCT02272413|11825034|FG000|Post-switch Period|Withdrawal by Subject|1
7501012|NCT02272413|11825035|FG001|Post-switch Period|Withdrawal by Subject|2
7501013|NCT02272413|11825034|FG000|Post-switch Period|Physician Decision|1
7501014|NCT02272413|11825035|FG001|Post-switch Period|Physician Decision|1
7501015|NCT02272413|11825034|FG000|Post-switch Period|Progressive disease|21
7501016|NCT02272413|11825035|FG001|Post-switch Period|Progressive disease|21
7501017|NCT02272413|11825034|FG000|Post-switch Period|Study terminated by sponsor|8
7501018|NCT02272413|11825035|FG001|Post-switch Period|Study terminated by sponsor|11
7501019|NCT02272413|11825034|FG000|Post-switch Period|Other than listed|4
7501020|NCT02272413|11825035|FG001|Post-switch Period|Other than listed|5
7501021|NCT02272634|11825046|FG000|Overall Study|Adverse Event|1
7501022|NCT02272634|11825047|FG001|Overall Study|Adverse Event|0
7501023|NCT02272634|11825048|FG002|Overall Study|Adverse Event|0
7501024|NCT02272634|11825046|FG000|Overall Study|Protocol Violation|0
7501025|NCT02272634|11825047|FG001|Overall Study|Protocol Violation|0
7501026|NCT02272634|11825048|FG002|Overall Study|Protocol Violation|1
7501027|NCT02272634|11825046|FG000|Overall Study|Withdrawal by Subject|0
7501028|NCT02272634|11825047|FG001|Overall Study|Withdrawal by Subject|1
7501029|NCT02272634|11825048|FG002|Overall Study|Withdrawal by Subject|0
7501030|NCT02272725|11825065|FG000|Overall Study|equipment malfunction|2
7501031|NCT02272725|11825066|FG001|Overall Study|equipment malfunction|0
7501032|NCT02272777|11825074|FG000|Overall Study|Adverse Event|0
7501033|NCT02272777|11825075|FG001|Overall Study|Adverse Event|1
7501034|NCT02272777|11825074|FG000|Overall Study|Withdrawal by Subject|0
7501035|NCT02272777|11825075|FG001|Overall Study|Withdrawal by Subject|3
7501036|NCT02272777|11825074|FG000|Overall Study|Lost to Follow-up|2
7501037|NCT02272777|11825075|FG001|Overall Study|Lost to Follow-up|0
7501038|NCT02272777|11825074|FG000|Overall Study|Other|2
7501039|NCT02272777|11825075|FG001|Overall Study|Other|0
7501040|NCT02272816|11825081|FG000|Overall Study|Adverse Event|1
7501041|NCT02272842|11825087|FG000|Overall Study|Lost to Follow-up|8
7501042|NCT02272842|11825088|FG001|Overall Study|Lost to Follow-up|8
7501043|NCT02272842|11825087|FG000|Overall Study|Withdrawal by Subject|8
7501044|NCT02272842|11825088|FG001|Overall Study|Withdrawal by Subject|2
7501045|NCT02272985|11825095|FG000|Overall Study|Withdrawal by Subject|1
7501046|NCT02272985|11825095|FG000|Overall Study|hip fracture|1
7501047|NCT02272985|11825095|FG000|Overall Study|kidney transplantation|1
7501048|NCT02273037|11825102|FG000|Overall Study|Lost to Follow-up|1
7501049|NCT02273037|11825103|FG001|Overall Study|Lost to Follow-up|0
7501050|NCT02273037|11825102|FG000|Overall Study|Delivered before monitoring initiated|1
7501051|NCT02273037|11825103|FG001|Overall Study|Delivered before monitoring initiated|3
7501052|NCT02273037|11825102|FG000|Overall Study|Breech delivery|2
7501053|NCT02273037|11825103|FG001|Overall Study|Breech delivery|3
7501054|NCT02273037|11825102|FG000|Overall Study|Multiple delivery|2
7501055|NCT02273037|11825103|FG001|Overall Study|Multiple delivery|2
7501056|NCT02273037|11825102|FG000|Overall Study|Other complication|2
7501057|NCT02273037|11825103|FG001|Overall Study|Other complication|0
7501058|NCT02273050|11825114|FG000|Overall Study|Adverse Event|4
7501059|NCT02273050|11825115|FG001|Overall Study|Adverse Event|3
7501060|NCT02273050|11825116|FG002|Overall Study|Adverse Event|3
7501061|NCT02273050|11825114|FG000|Overall Study|Death|0
7501062|NCT02273050|11825115|FG001|Overall Study|Death|0
7501063|NCT02273050|11825116|FG002|Overall Study|Death|1
7501064|NCT02273050|11825114|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
7501065|NCT02273050|11825115|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
7501066|NCT02273050|11825116|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
7501067|NCT02273050|11825114|FG000|Overall Study|Lack of Efficacy|0
7501068|NCT02273050|11825115|FG001|Overall Study|Lack of Efficacy|1
7501069|NCT02273050|11825116|FG002|Overall Study|Lack of Efficacy|1
7501070|NCT02273050|11825114|FG000|Overall Study|Withdrawal by Subject|17
7501071|NCT02273050|11825115|FG001|Overall Study|Withdrawal by Subject|14
7501072|NCT02273050|11825116|FG002|Overall Study|Withdrawal by Subject|16
7501073|NCT02273050|11825114|FG000|Overall Study|Lost to Follow-up|0
7501074|NCT02273050|11825115|FG001|Overall Study|Lost to Follow-up|2
7501075|NCT02273050|11825116|FG002|Overall Study|Lost to Follow-up|3
7501076|NCT02273050|11825114|FG000|Overall Study|Protocol Violation|3
7501077|NCT02273050|11825115|FG001|Overall Study|Protocol Violation|1
7501078|NCT02273050|11825116|FG002|Overall Study|Protocol Violation|4
7501079|NCT02273141|11825148|FG000|Overall Study|Adverse Event|0
7501080|NCT02273141|11825149|FG001|Overall Study|Adverse Event|1
7501081|NCT02273141|11825148|FG000|Overall Study|Lost to Follow-up|1
7501082|NCT02273141|11825149|FG001|Overall Study|Lost to Follow-up|3
7501083|NCT02273141|11825148|FG000|Overall Study|Withdrawal by Subject|10
7501084|NCT02273141|11825149|FG001|Overall Study|Withdrawal by Subject|15
7501085|NCT02273141|11825148|FG000|Overall Study|Various|6
7501086|NCT02273141|11825149|FG001|Overall Study|Various|6
7501087|NCT02273167|11825158|FG000|Overall Study|Adverse Event|1
7501088|NCT02273167|11825159|FG001|Overall Study|Adverse Event|0
7501089|NCT02273167|11825160|FG002|Overall Study|Adverse Event|0
7501090|NCT02273167|11825158|FG000|Overall Study|Protocol Violation|3
7501091|NCT02273167|11825159|FG001|Overall Study|Protocol Violation|1
7501092|NCT02273167|11825160|FG002|Overall Study|Protocol Violation|1
7501093|NCT02273167|11825158|FG000|Overall Study|Lost to Follow-up|0
7501094|NCT02273167|11825159|FG001|Overall Study|Lost to Follow-up|1
7501095|NCT02273167|11825160|FG002|Overall Study|Lost to Follow-up|1
7501096|NCT02273167|11825158|FG000|Overall Study|Withdrawal by Subject|10
7501097|NCT02273167|11825159|FG001|Overall Study|Withdrawal by Subject|12
7501098|NCT02273167|11825160|FG002|Overall Study|Withdrawal by Subject|11
7501099|NCT02273167|11825158|FG000|Overall Study|Various|10
7501100|NCT02273167|11825159|FG001|Overall Study|Various|9
7501101|NCT02273167|11825160|FG002|Overall Study|Various|8
7501102|NCT02273180|11825171|FG000|Overall Study|Adverse Event|2
7501103|NCT02273180|11825172|FG001|Overall Study|Adverse Event|2
7501104|NCT02273180|11825171|FG000|Overall Study|Lack of Efficacy|1
7501105|NCT02273180|11825172|FG001|Overall Study|Lack of Efficacy|0
7501106|NCT02273180|11825171|FG000|Overall Study|Protocol Violation|1
7501107|NCT02273180|11825172|FG001|Overall Study|Protocol Violation|7
7501108|NCT02273180|11825171|FG000|Overall Study|Randomized but not treated|1
7501109|NCT02273180|11825172|FG001|Overall Study|Randomized but not treated|0
7501110|NCT02273180|11825171|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
7501111|NCT02273180|11825172|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
7501112|NCT02273180|11825171|FG000|Overall Study|Other than specified above|21
7501113|NCT02273180|11825172|FG001|Overall Study|Other than specified above|10
7535692|NCT02712008|11883459|FG003|From Week 12 up to Week 36|Adverse Event|0
7535693|NCT02712008|11883460|FG004|From Week 12 up to Week 36|Adverse Event|1
7535694|NCT02712008|11883461|FG005|From Week 12 up to Week 36|Adverse Event|0
7535695|NCT02712008|11883462|FG006|From Week 12 up to Week 36|Adverse Event|0
7535696|NCT02712008|11883463|FG007|From Week 12 up to Week 36|Adverse Event|2
7535697|NCT02712008|11883456|FG000|From Week 12 up to Week 36|Death|1
7535698|NCT02712008|11883457|FG001|From Week 12 up to Week 36|Death|0
7535699|NCT02712008|11883458|FG002|From Week 12 up to Week 36|Death|0
7535700|NCT02712008|11883459|FG003|From Week 12 up to Week 36|Death|0
7535701|NCT02712008|11883460|FG004|From Week 12 up to Week 36|Death|0
7535702|NCT02712008|11883461|FG005|From Week 12 up to Week 36|Death|0
7535703|NCT02712008|11883462|FG006|From Week 12 up to Week 36|Death|1
7535704|NCT02712008|11883463|FG007|From Week 12 up to Week 36|Death|0
7535705|NCT02712008|11883456|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7535706|NCT02712008|11883457|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7535707|NCT02712008|11883458|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7535708|NCT02712008|11883459|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
7535709|NCT02712008|11883460|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7535710|NCT02712008|11883461|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7535711|NCT02712008|11883462|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
7535712|NCT02712008|11883463|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7535713|NCT02712008|11883456|FG000|From Week 12 up to Week 36|Physician Decision|0
7535714|NCT02712008|11883457|FG001|From Week 12 up to Week 36|Physician Decision|0
7535715|NCT02712008|11883458|FG002|From Week 12 up to Week 36|Physician Decision|0
7535716|NCT02712008|11883459|FG003|From Week 12 up to Week 36|Physician Decision|1
7535717|NCT02712008|11883460|FG004|From Week 12 up to Week 36|Physician Decision|1
7535718|NCT02712008|11883461|FG005|From Week 12 up to Week 36|Physician Decision|0
7535719|NCT02712008|11883462|FG006|From Week 12 up to Week 36|Physician Decision|0
7535720|NCT02712008|11883463|FG007|From Week 12 up to Week 36|Physician Decision|0
7535721|NCT02712008|11883456|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
7535722|NCT02712008|11883457|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
7535723|NCT02712008|11883458|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
7535724|NCT02712008|11883459|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
7535725|NCT02712008|11883460|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
7535726|NCT02712008|11883461|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
7535727|NCT02712008|11883462|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
7535728|NCT02712008|11883463|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
7535729|NCT02712320|11883493|FG000|Overall Study|Lost to Follow-up|1
7535730|NCT02712320|11883493|FG000|Overall Study|Withdrawal by Subject|1
7501114|NCT02273596|11825204|FG000|24-Week Treatment Period|Adverse Event|3
7501115|NCT02273596|11825204|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
7501116|NCT02273596|11825204|FG000|24-Week Treatment Period|Participant was unable to Come|1
7501117|NCT02273596|11825204|FG000|24-Week Treatment Period|Physician Decision|1
7501118|NCT02273596|11825204|FG000|24-Week Treatment Period|Protocol Deviation|1
7501119|NCT02273596|11825204|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
7501120|NCT02273596|11825204|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
7501121|NCT02273596|11825204|FG000|Extension Period|Lost to Follow-up|1
7501122|NCT02273596|11825204|FG000|Extension Period|Protocol Deviation|1
7501123|NCT02273726|11825216|FG000|Overall Study|Death|70
7501124|NCT02273726|11825217|FG001|Overall Study|Death|62
7501125|NCT02273726|11825216|FG000|Overall Study|Withdrawal by Subject|41
7501126|NCT02273726|11825217|FG001|Overall Study|Withdrawal by Subject|29
7501127|NCT02273726|11825216|FG000|Overall Study|Kidney transplant|31
7501128|NCT02273726|11825217|FG001|Overall Study|Kidney transplant|39
7501129|NCT02273726|11825216|FG000|Overall Study|Physician Decision|30
7501130|NCT02273726|11825217|FG001|Overall Study|Physician Decision|15
7501131|NCT02273726|11825216|FG000|Overall Study|Adverse Event|27
7501132|NCT02273726|11825217|FG001|Overall Study|Adverse Event|9
7501133|NCT02273726|11825216|FG000|Overall Study|Lost to Follow-up|6
7501134|NCT02273726|11825217|FG001|Overall Study|Lost to Follow-up|3
7501135|NCT02273726|11825216|FG000|Overall Study|Lack of Efficacy|6
7501136|NCT02273726|11825217|FG001|Overall Study|Lack of Efficacy|1
7501137|NCT02273726|11825216|FG000|Overall Study|Protocol Violation|4
7501138|NCT02273726|11825217|FG001|Overall Study|Protocol Violation|0
7501139|NCT02273726|11825216|FG000|Overall Study|Other than specified|28
7501140|NCT02273726|11825217|FG001|Overall Study|Other than specified|30
7501141|NCT02273739|11825227|FG000|Overall Study|Progression of Disease|3
7501142|NCT02273739|11825228|FG001|Overall Study|Progression of Disease|4
7501143|NCT02273739|11825229|FG002|Overall Study|Progression of Disease|5
7501144|NCT02273739|11825230|FG003|Overall Study|Progression of Disease|2
7501145|NCT02273739|11825227|FG000|Overall Study|Death|0
7501146|NCT02273739|11825228|FG001|Overall Study|Death|0
7501147|NCT02273739|11825229|FG002|Overall Study|Death|0
7501148|NCT02273739|11825230|FG003|Overall Study|Death|2
7501149|NCT02273739|11825227|FG000|Overall Study|Adverse Event|0
7501150|NCT02273739|11825228|FG001|Overall Study|Adverse Event|0
7501151|NCT02273739|11825229|FG002|Overall Study|Adverse Event|0
7501152|NCT02273739|11825230|FG003|Overall Study|Adverse Event|1
7501153|NCT02273739|11825227|FG000|Overall Study|Withdrawal by Subject|0
7501154|NCT02273739|11825228|FG001|Overall Study|Withdrawal by Subject|0
7501155|NCT02273739|11825229|FG002|Overall Study|Withdrawal by Subject|2
7501156|NCT02273739|11825230|FG003|Overall Study|Withdrawal by Subject|1
7501157|NCT02273739|11825227|FG000|Overall Study|Physician Decision|0
7501158|NCT02273739|11825228|FG001|Overall Study|Physician Decision|0
7501159|NCT02273739|11825229|FG002|Overall Study|Physician Decision|0
7501160|NCT02273739|11825230|FG003|Overall Study|Physician Decision|1
7501161|NCT02273908|11825247|FG000|Overall Study|Adverse Event|16
7501162|NCT02273908|11825248|FG001|Overall Study|Adverse Event|0
7501163|NCT02273908|11825247|FG000|Overall Study|Lost to Follow-up|10
7501164|NCT02273908|11825248|FG001|Overall Study|Lost to Follow-up|1
7501165|NCT02273908|11825247|FG000|Overall Study|Did not meet entrance criteria|3
7501166|NCT02273908|11825248|FG001|Overall Study|Did not meet entrance criteria|2
7501167|NCT02273908|11825247|FG000|Overall Study|Withdrawal by Subject|4
7501168|NCT02273908|11825248|FG001|Overall Study|Withdrawal by Subject|2
7501169|NCT02273960|11825262|FG000|Short Term Period|Lost to Follow-up|1
7501170|NCT02273960|11825263|FG001|Short Term Period|Lost to Follow-up|0
7501171|NCT02273960|11825264|FG002|Short Term Period|Lost to Follow-up|0
7501172|NCT02273960|11825265|FG003|Short Term Period|Lost to Follow-up|0
7501173|NCT02273960|11825262|FG000|Short Term Period|Lack of Efficacy|0
7501174|NCT02273960|11825263|FG001|Short Term Period|Lack of Efficacy|0
7501175|NCT02273960|11825264|FG002|Short Term Period|Lack of Efficacy|0
7501176|NCT02273960|11825265|FG003|Short Term Period|Lack of Efficacy|1
7501177|NCT02273960|11825262|FG000|Short Term Period|ST complete, not entering LTE|4
7501178|NCT02273960|11825263|FG001|Short Term Period|ST complete, not entering LTE|6
7501179|NCT02273960|11825264|FG002|Short Term Period|ST complete, not entering LTE|4
7501180|NCT02273960|11825265|FG003|Short Term Period|ST complete, not entering LTE|5
7501181|NCT02273960|11825262|FG000|Long Term Extension|Death|0
7501182|NCT02273960|11825263|FG001|Long Term Extension|Death|0
7501183|NCT02273960|11825264|FG002|Long Term Extension|Death|0
7501184|NCT02273960|11825265|FG003|Long Term Extension|Death|1
7501185|NCT02273973|11825277|FG000|Overall Study|Adverse Event|4
7501186|NCT02273973|11825278|FG001|Overall Study|Adverse Event|0
7501187|NCT02273973|11825277|FG000|Overall Study|Withdrawal by Subject|2
7501188|NCT02273973|11825278|FG001|Overall Study|Withdrawal by Subject|3
7501189|NCT02273973|11825277|FG000|Overall Study|Death|1
7501190|NCT02273973|11825278|FG001|Overall Study|Death|0
7501191|NCT02273973|11825277|FG000|Overall Study|Non-compliance|1
7501192|NCT02273973|11825278|FG001|Overall Study|Non-compliance|0
7501193|NCT02273973|11825277|FG000|Overall Study|Protocol Violation|1
7501194|NCT02273973|11825278|FG001|Overall Study|Protocol Violation|0
7501195|NCT02273973|11825277|FG000|Overall Study|Progression of disease|0
7501196|NCT02273973|11825278|FG001|Overall Study|Progression of disease|2
7501197|NCT02273973|11825277|FG000|Overall Study|Lost to Follow-up|0
7501198|NCT02273973|11825278|FG001|Overall Study|Lost to Follow-up|1
7501199|NCT02273973|11825277|FG000|Overall Study|Physician Decision|0
7501200|NCT02273973|11825278|FG001|Overall Study|Physician Decision|1
7501201|NCT02273973|11825277|FG000|Overall Study|Reason not specified|0
7501202|NCT02273973|11825278|FG001|Overall Study|Reason not specified|1
7501203|NCT02274038|11825284|FG000|Overall Study|Death|1
7501204|NCT02274311|11825290|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
7501205|NCT02274493|11825296|FG000|Overall Study|Withdrawal by Subject|1
7501206|NCT02274558|11825303|FG000|Overall Study|Adverse Event|2
7501207|NCT02274558|11825304|FG001|Overall Study|Adverse Event|4
7501208|NCT02274558|11825305|FG002|Overall Study|Adverse Event|2
7501209|NCT02274558|11825303|FG000|Overall Study|Non-compliance|2
7501210|NCT02274558|11825304|FG001|Overall Study|Non-compliance|1
7501211|NCT02274558|11825305|FG002|Overall Study|Non-compliance|0
7501212|NCT02274558|11825303|FG000|Overall Study|Withdrawal by Subject|1
7501213|NCT02274558|11825304|FG001|Overall Study|Withdrawal by Subject|5
7501214|NCT02274558|11825305|FG002|Overall Study|Withdrawal by Subject|4
7501215|NCT02274558|11825303|FG000|Overall Study|Death|0
7501216|NCT02274558|11825304|FG001|Overall Study|Death|0
7501217|NCT02274558|11825305|FG002|Overall Study|Death|1
7501218|NCT02274558|11825303|FG000|Overall Study|Lost to Follow-up|2
7501219|NCT02274558|11825304|FG001|Overall Study|Lost to Follow-up|1
7501220|NCT02274558|11825305|FG002|Overall Study|Lost to Follow-up|1
7501221|NCT02274558|11825303|FG000|Overall Study|Physician Decision|0
7501222|NCT02274558|11825304|FG001|Overall Study|Physician Decision|2
7501223|NCT02274558|11825305|FG002|Overall Study|Physician Decision|1
7501224|NCT02274766|11825340|FG000|Overall Study|Withdrawal by Subject|3
7501225|NCT02274766|11825341|FG001|Overall Study|Withdrawal by Subject|6
7501226|NCT02274766|11825340|FG000|Overall Study|Did Not Receive Study Drug|1
7501227|NCT02274766|11825341|FG001|Overall Study|Did Not Receive Study Drug|1
7501228|NCT02274766|11825340|FG000|Overall Study|Subject Unwilling to Proceed|0
7501229|NCT02274766|11825341|FG001|Overall Study|Subject Unwilling to Proceed|1
7501230|NCT02274766|11825340|FG000|Overall Study|Adverse Event|0
7501231|NCT02274766|11825341|FG001|Overall Study|Adverse Event|1
7501232|NCT02274792|11825347|FG000|Overall Study|Withdrawal by Subject|13
7501233|NCT02274792|11825347|FG000|Overall Study|Lost to Follow-up|8
7501234|NCT02274792|11825347|FG000|Overall Study|Protocol Specified Criteria|2
7501235|NCT02274792|11825347|FG000|Overall Study|Sponsor Decision|2
7501236|NCT02274857|11825362|FG000|Overall Study|Adverse Event|1
7501237|NCT02274857|11825363|FG001|Overall Study|Adverse Event|0
7501238|NCT02274857|11825362|FG000|Overall Study|Death|1
7501239|NCT02274857|11825363|FG001|Overall Study|Death|2
7501240|NCT02274857|11825362|FG000|Overall Study|Lost to Follow-up|3
7501241|NCT02274857|11825363|FG001|Overall Study|Lost to Follow-up|0
7501242|NCT02274857|11825362|FG000|Overall Study|Physician Decision|2
7501243|NCT02274857|11825363|FG001|Overall Study|Physician Decision|0
7501244|NCT02274857|11825362|FG000|Overall Study|Trial screen failure|0
7501245|NCT02274857|11825363|FG001|Overall Study|Trial screen failure|2
7501246|NCT02274857|11825362|FG000|Overall Study|Withdrawal by Subject|11
7501247|NCT02274857|11825363|FG001|Overall Study|Withdrawal by Subject|2
7501248|NCT02274857|11825362|FG000|Overall Study|Other|2
7501249|NCT02274857|11825363|FG001|Overall Study|Other|0
7501250|NCT02274948|11825384|FG000|Overall Study|Lost to Follow-up|28
7501251|NCT02274948|11825385|FG001|Overall Study|Lost to Follow-up|25
7501252|NCT02274948|11825384|FG000|Overall Study|Withdrawal by Subject|64
7501253|NCT02274948|11825385|FG001|Overall Study|Withdrawal by Subject|58
7501254|NCT02274948|11825384|FG000|Overall Study|Stopped on family Practitioner advice|2
7501255|NCT02274948|11825385|FG001|Overall Study|Stopped on family Practitioner advice|5
7501256|NCT02274948|11825384|FG000|Overall Study|Left the area|4
7501257|NCT02274948|11825385|FG001|Overall Study|Left the area|3
7501258|NCT02275026|11825392|FG000|Overall Study|Ineligible after cognitive baseline testing|11
7501259|NCT02275026|11825392|FG000|Overall Study|Withdrawal by Subject|4
7501260|NCT02275026|11825392|FG000|Overall Study|Ineligible due to medical history|13
7501261|NCT02275026|11825392|FG000|Overall Study|MRI malfunction precluded testing|1
7501262|NCT02275026|11825392|FG000|Overall Study|Ineligible after MRI findings|1
7501263|NCT02275026|11825392|FG000|Overall Study|Lost to Follow-up|2
7501264|NCT02275026|11825392|FG000|Overall Study|Scanner failure|1
7501265|NCT02275052|11825399|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7501266|NCT02275052|11825400|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7501267|NCT02275052|11825401|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7501268|NCT02275052|11825402|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7501269|NCT02275052|11825399|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7501270|NCT02275052|11825400|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
7501271|NCT02275052|11825401|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7501272|NCT02275052|11825402|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
7501273|NCT02275052|11825399|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
7501274|NCT02275052|11825400|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
7501275|NCT02275052|11825401|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7501276|NCT02275052|11825402|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
7501277|NCT02275052|11825399|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
7501278|NCT02275052|11825400|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7501279|NCT02275052|11825401|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7501280|NCT02275052|11825402|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
7501281|NCT02275052|11825399|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
7501282|NCT02275052|11825400|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7501283|NCT02275052|11825401|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7501284|NCT02275052|11825402|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
7501285|NCT02275052|11825399|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
7501286|NCT02275052|11825400|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
7501287|NCT02275052|11825401|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
7501288|NCT02275052|11825402|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
7501289|NCT02275052|11825399|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
7501290|NCT02275052|11825400|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
7501291|NCT02275052|11825401|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
7501292|NCT02275052|11825402|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
7501293|NCT02275052|11825399|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7501294|NCT02275052|11825400|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
7501295|NCT02275052|11825401|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
7501296|NCT02275052|11825402|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
7501297|NCT02275052|11825399|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7501298|NCT02275052|11825400|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
7501299|NCT02275052|11825401|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
7501300|NCT02275052|11825402|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
7501301|NCT02275052|11825399|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7501302|NCT02275052|11825400|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
7501303|NCT02275052|11825401|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
7501304|NCT02275052|11825402|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
7501305|NCT02275052|11825399|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7501306|NCT02275052|11825400|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7501307|NCT02275052|11825401|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
7501308|NCT02275052|11825402|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
7501309|NCT02275065|11825413|FG000|Overall Study|Randomized but not treated|1
7501310|NCT02275065|11825414|FG001|Overall Study|Randomized but not treated|0
7501311|NCT02275065|11825415|FG002|Overall Study|Randomized but not treated|1
7501312|NCT02275065|11825416|FG003|Overall Study|Randomized but not treated|1
7501313|NCT02275065|11825417|FG004|Overall Study|Randomized but not treated|0
7501314|NCT02275117|11825434|FG000|Overall Study|Adverse Event|0
7501315|NCT02275117|11825435|FG001|Overall Study|Adverse Event|0
7501316|NCT02275117|11825436|FG002|Overall Study|Adverse Event|0
7501317|NCT02275117|11825437|FG003|Overall Study|Adverse Event|0
7501318|NCT02275117|11825438|FG004|Overall Study|Adverse Event|1
7501319|NCT02275117|11825434|FG000|Overall Study|Lack of Efficacy|6
7501320|NCT02275117|11825435|FG001|Overall Study|Lack of Efficacy|7
7501321|NCT02275117|11825436|FG002|Overall Study|Lack of Efficacy|5
7501322|NCT02275117|11825437|FG003|Overall Study|Lack of Efficacy|2
7501323|NCT02275117|11825438|FG004|Overall Study|Lack of Efficacy|10
7501324|NCT02275117|11825434|FG000|Overall Study|Lost to Follow-up|11
7501325|NCT02275117|11825435|FG001|Overall Study|Lost to Follow-up|16
7501326|NCT02275117|11825436|FG002|Overall Study|Lost to Follow-up|15
7501327|NCT02275117|11825437|FG003|Overall Study|Lost to Follow-up|16
7501328|NCT02275117|11825438|FG004|Overall Study|Lost to Follow-up|8
7501329|NCT02275117|11825434|FG000|Overall Study|Physician Decision|0
7501330|NCT02275117|11825435|FG001|Overall Study|Physician Decision|1
7501331|NCT02275117|11825436|FG002|Overall Study|Physician Decision|1
7501332|NCT02275117|11825437|FG003|Overall Study|Physician Decision|0
7501333|NCT02275117|11825438|FG004|Overall Study|Physician Decision|1
7501334|NCT02275117|11825434|FG000|Overall Study|Protocol Violation|1
7501335|NCT02275117|11825435|FG001|Overall Study|Protocol Violation|0
7501336|NCT02275117|11825436|FG002|Overall Study|Protocol Violation|1
7501337|NCT02275117|11825437|FG003|Overall Study|Protocol Violation|1
7501338|NCT02275117|11825438|FG004|Overall Study|Protocol Violation|0
7501339|NCT02275117|11825434|FG000|Overall Study|Withdrawal by Subject|6
7501340|NCT02275117|11825435|FG001|Overall Study|Withdrawal by Subject|4
7501341|NCT02275117|11825436|FG002|Overall Study|Withdrawal by Subject|7
7501342|NCT02275117|11825437|FG003|Overall Study|Withdrawal by Subject|3
7501343|NCT02275117|11825438|FG004|Overall Study|Withdrawal by Subject|3
7501344|NCT02275117|11825434|FG000|Overall Study|Terminated by Sponsor|4
7501345|NCT02275117|11825435|FG001|Overall Study|Terminated by Sponsor|4
7501346|NCT02275117|11825436|FG002|Overall Study|Terminated by Sponsor|4
7501347|NCT02275117|11825437|FG003|Overall Study|Terminated by Sponsor|6
7501348|NCT02275117|11825438|FG004|Overall Study|Terminated by Sponsor|4
7501349|NCT02275117|11825434|FG000|Overall Study|Worsening of Study Indication|0
7501350|NCT02275117|11825435|FG001|Overall Study|Worsening of Study Indication|1
7501351|NCT02275117|11825436|FG002|Overall Study|Worsening of Study Indication|2
7501352|NCT02275117|11825437|FG003|Overall Study|Worsening of Study Indication|0
7501353|NCT02275117|11825438|FG004|Overall Study|Worsening of Study Indication|0
7501354|NCT02275117|11825434|FG000|Overall Study|Study Burden|5
7501355|NCT02275117|11825435|FG001|Overall Study|Study Burden|4
7501356|NCT02275117|11825436|FG002|Overall Study|Study Burden|7
7501357|NCT02275117|11825437|FG003|Overall Study|Study Burden|5
7501358|NCT02275117|11825438|FG004|Overall Study|Study Burden|7
7501359|NCT02275117|11825434|FG000|Overall Study|Other|1
7501360|NCT02275117|11825435|FG001|Overall Study|Other|0
7501361|NCT02275117|11825436|FG002|Overall Study|Other|0
7501362|NCT02275117|11825437|FG003|Overall Study|Other|0
7501363|NCT02275117|11825438|FG004|Overall Study|Other|2
7501364|NCT02275338|11825464|FG000|Overall Study|Adverse Event|15
7501365|NCT02275338|11825464|FG000|Overall Study|Lack of Efficacy|3
7501366|NCT02275338|11825464|FG000|Overall Study|Withdrawal by Subject|4
7501367|NCT02275338|11825464|FG000|Overall Study|Disease progression (death)|1
7501368|NCT02275338|11825464|FG000|Overall Study|Ineligible to start Phase 2|4
7501369|NCT02275338|11825464|FG000|Overall Study|Reason not specified|5
7501370|NCT02275338|11825464|FG000|Overall Study|Does not meet entry criteria|1
7501371|NCT02275364|11825469|FG000|Period 1|Withdrawal by Subject|1
7501372|NCT02275364|11825470|FG001|Period 1|Withdrawal by Subject|0
7501373|NCT02275364|11825469|FG000|Period 1|Other reason|1
7501374|NCT02275364|11825470|FG001|Period 1|Other reason|0
7501375|NCT02275611|11825491|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
7501376|NCT02275611|11825492|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
7501377|NCT02275611|11825493|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
7501378|NCT02275611|11825494|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
7501401|NCT02275819|11825530|FG000|Overall Study|Adverse Event|0
7501402|NCT02275819|11825531|FG001|Overall Study|Adverse Event|1
7501403|NCT02276027|11825545|FG000|Overall Study|Death|1
7501404|NCT02276027|11825546|FG001|Overall Study|Death|0
7501405|NCT02276027|11825547|FG002|Overall Study|Death|0
7501406|NCT02276027|11825548|FG003|Overall Study|Death|2
7501407|NCT02276027|11825545|FG000|Overall Study|Physician Decision|0
7501408|NCT02276027|11825546|FG001|Overall Study|Physician Decision|0
7501409|NCT02276027|11825547|FG002|Overall Study|Physician Decision|0
7501410|NCT02276027|11825548|FG003|Overall Study|Physician Decision|1
7501411|NCT02276027|11825545|FG000|Overall Study|Progressive disease|1
7501412|NCT02276027|11825546|FG001|Overall Study|Progressive disease|13
7501413|NCT02276027|11825547|FG002|Overall Study|Progressive disease|12
7501414|NCT02276027|11825548|FG003|Overall Study|Progressive disease|14
7501415|NCT02276027|11825545|FG000|Overall Study|Subject/guardian decision|0
7501416|NCT02276027|11825546|FG001|Overall Study|Subject/guardian decision|1
7501417|NCT02276027|11825547|FG002|Overall Study|Subject/guardian decision|0
7501418|NCT02276027|11825548|FG003|Overall Study|Subject/guardian decision|3
7501419|NCT02276027|11825545|FG000|Overall Study|Adverse Event|0
7501420|NCT02276027|11825546|FG001|Overall Study|Adverse Event|2
7501421|NCT02276027|11825547|FG002|Overall Study|Adverse Event|8
7501422|NCT02276027|11825548|FG003|Overall Study|Adverse Event|2
7501423|NCT02276040|11825558|FG000|Overall Study|Physician Decision|15
7501424|NCT02276053|11825562|FG000|Overall Study|Death|2
7501425|NCT02276053|11825562|FG000|Overall Study|Adverse Event|5
7501426|NCT02276053|11825562|FG000|Overall Study|Lack of Efficacy|2
7501427|NCT02276053|11825562|FG000|Overall Study|Withdrawal by Subject|1
7501428|NCT02276053|11825562|FG000|Overall Study|Patient does not meet selection criteria|3
7501429|NCT02276053|11825562|FG000|Overall Study|Patient needs to increase baseline AED|1
7501430|NCT02276222|11825569|FG000|Overall Study|Adverse Event|62
7501431|NCT02276222|11825570|FG001|Overall Study|Adverse Event|11
7501432|NCT02276222|11825569|FG000|Overall Study|Death|3
7501433|NCT02276222|11825570|FG001|Overall Study|Death|4
7501434|NCT02276222|11825569|FG000|Overall Study|Lack of Efficacy|13
7501435|NCT02276222|11825570|FG001|Overall Study|Lack of Efficacy|3
7501436|NCT02276222|11825569|FG000|Overall Study|Protocol Violation|3
7501437|NCT02276222|11825570|FG001|Overall Study|Protocol Violation|2
7501438|NCT02276222|11825569|FG000|Overall Study|Withdrawal by Subject|79
7501439|NCT02276222|11825570|FG001|Overall Study|Withdrawal by Subject|33
7501440|NCT02276222|11825569|FG000|Overall Study|non compliance with study medication|6
7501441|NCT02276222|11825570|FG001|Overall Study|non compliance with study medication|2
7501442|NCT02276222|11825569|FG000|Overall Study|sponsor decision|0
7501443|NCT02276222|11825570|FG001|Overall Study|sponsor decision|3
7501444|NCT02276222|11825569|FG000|Overall Study|Lost to Follow-up|15
7501445|NCT02276222|11825570|FG001|Overall Study|Lost to Follow-up|5
7501446|NCT02276222|11825569|FG000|Overall Study|Physician Decision|2
7501447|NCT02276222|11825570|FG001|Overall Study|Physician Decision|1
7501448|NCT02276222|11825569|FG000|Overall Study|sheduling conflict|1
7501449|NCT02276222|11825570|FG001|Overall Study|sheduling conflict|0
7501450|NCT02276222|11825569|FG000|Overall Study|subject withdrew after randomization|1
7501451|NCT02276222|11825570|FG001|Overall Study|subject withdrew after randomization|0
7501452|NCT02276482|11825587|FG000|Overall Study|Adverse Event|1
7501453|NCT02276482|11825588|FG001|Overall Study|Adverse Event|0
7501454|NCT02276482|11825587|FG000|Overall Study|Withdrawal by Subject|1
7501455|NCT02276482|11825588|FG001|Overall Study|Withdrawal by Subject|0
7501456|NCT02276482|11825587|FG000|Overall Study|Gram-negative infection|1
7501457|NCT02276482|11825588|FG001|Overall Study|Gram-negative infection|0
7501458|NCT02276482|11825587|FG000|Overall Study|Reason not specified|0
7501459|NCT02276482|11825588|FG001|Overall Study|Reason not specified|1
7501460|NCT02276612|11825596|FG000|Overall Study|Death|1
7501461|NCT02276612|11825597|FG001|Overall Study|Death|0
7501462|NCT02276612|11825596|FG000|Overall Study|Pregnancy|1
7501463|NCT02276612|11825597|FG001|Overall Study|Pregnancy|0
7501464|NCT02276612|11825596|FG000|Overall Study|Withdrew Consent|1
7501465|NCT02276612|11825597|FG001|Overall Study|Withdrew Consent|0
7501466|NCT02276612|11825596|FG000|Overall Study|Lost to Follow-up|1
7501467|NCT02276612|11825597|FG001|Overall Study|Lost to Follow-up|0
7501468|NCT02276807|11825618|FG000|Overall Study|Withdrawal by Subject|8
7501469|NCT02276807|11825619|FG001|Overall Study|Withdrawal by Subject|7
7501470|NCT02276807|11825618|FG000|Overall Study|Lost to Follow-up|10
7501471|NCT02276807|11825619|FG001|Overall Study|Lost to Follow-up|10
7501472|NCT02276872|11825628|FG000|Overall Study|Adverse Event|1
7501473|NCT02276872|11825629|FG001|Overall Study|Adverse Event|0
7501474|NCT02276872|11825630|FG002|Overall Study|Adverse Event|0
7501475|NCT02277691|11825706|FG000|Overall Study|Pretreatment Event/Adverse Event|33
7501476|NCT02277691|11825706|FG000|Overall Study|Voluntary Withdrawal|7
7501477|NCT02277691|11825706|FG000|Overall Study|Lack of Efficacy|5
7501478|NCT02277691|11825706|FG000|Overall Study|Used Other Antihypertensive Drug|1
7501479|NCT02277743|11825713|FG000|Overall Study|Protocol Violation|1
7501480|NCT02277743|11825714|FG001|Overall Study|Protocol Violation|1
7501481|NCT02277743|11825715|FG002|Overall Study|Protocol Violation|1
7501482|NCT02277743|11825713|FG000|Overall Study|Adverse Event|10
7501483|NCT02277743|11825714|FG001|Overall Study|Adverse Event|6
7501484|NCT02277743|11825715|FG002|Overall Study|Adverse Event|6
7501485|NCT02277743|11825713|FG000|Overall Study|Lack of Efficacy|11
7501486|NCT02277743|11825714|FG001|Overall Study|Lack of Efficacy|4
7501487|NCT02277743|11825715|FG002|Overall Study|Lack of Efficacy|3
7501488|NCT02277743|11825713|FG000|Overall Study|Other than specified above|18
7501489|NCT02277743|11825714|FG001|Overall Study|Other than specified above|5
7501490|NCT02277743|11825715|FG002|Overall Study|Other than specified above|16
7501491|NCT02277769|11825726|FG000|Overall Study|Protocol Violation|3
7501492|NCT02277769|11825727|FG001|Overall Study|Protocol Violation|3
7501493|NCT02277769|11825728|FG002|Overall Study|Protocol Violation|5
7501494|NCT02277769|11825726|FG000|Overall Study|Lack of Efficacy|17
7501495|NCT02277769|11825727|FG001|Overall Study|Lack of Efficacy|0
7501496|NCT02277769|11825728|FG002|Overall Study|Lack of Efficacy|4
7501497|NCT02277769|11825726|FG000|Overall Study|Adverse Event|14
7501498|NCT02277769|11825727|FG001|Overall Study|Adverse Event|2
7501499|NCT02277769|11825728|FG002|Overall Study|Adverse Event|4
7501500|NCT02277769|11825726|FG000|Overall Study|Other than specified above|12
7501501|NCT02277769|11825727|FG001|Overall Study|Other than specified above|8
7501502|NCT02277769|11825728|FG002|Overall Study|Other than specified above|5
7501503|NCT02277990|11825749|FG000|Overall Study|Death|170
7501504|NCT02277990|11825750|FG001|Overall Study|Death|188
7501505|NCT02277990|11825749|FG000|Overall Study|Withdrawal by Subject|64
7501506|NCT02277990|11825750|FG001|Overall Study|Withdrawal by Subject|53
7501507|NCT02277990|11825749|FG000|Overall Study|Physician Decision|40
7501508|NCT02277990|11825750|FG001|Overall Study|Physician Decision|34
7501509|NCT02277990|11825749|FG000|Overall Study|Lost to Follow-up|66
7501510|NCT02277990|11825750|FG001|Overall Study|Lost to Follow-up|69
7501511|NCT02277990|11825749|FG000|Overall Study|Had other reason|26
7501512|NCT02277990|11825750|FG001|Overall Study|Had other reason|32
7501513|NCT02278003|11825758|FG000|Overall Study|Withdrawal by Subject|11
7501514|NCT02278003|11825759|FG001|Overall Study|Withdrawal by Subject|0
7501515|NCT02278003|11825758|FG000|Overall Study|Not Treated|1
7501516|NCT02278003|11825759|FG001|Overall Study|Not Treated|0
7501517|NCT02278003|11825758|FG000|Overall Study|Recognition task improperly completed|7
7501518|NCT02278003|11825759|FG001|Overall Study|Recognition task improperly completed|0
7501519|NCT02278263|11825781|FG000|Overall Study|Protocol Violation|7
7501520|NCT02278263|11825782|FG001|Overall Study|Protocol Violation|0
7501521|NCT02278263|11825783|FG002|Overall Study|Protocol Violation|9
7501522|NCT02278328|11825803|FG000|Neuropsych Screening|found ineligible on neuropsych|1
7501523|NCT02278328|11825804|FG001|Neuropsych Screening|found ineligible on neuropsych|0
7553107|NCT03006393|11913854|FG001|Overall Study|Lost to Follow-up|1
7501524|NCT02278328|11825805|FG002|Neuropsych Screening|found ineligible on neuropsych|0
7501525|NCT02278328|11825803|FG000|Neuropsych Screening|Withdrawal by Subject|0
7501526|NCT02278328|11825804|FG001|Neuropsych Screening|Withdrawal by Subject|1
7501527|NCT02278328|11825805|FG002|Neuropsych Screening|Withdrawal by Subject|0
7501528|NCT02278328|11825803|FG000|Neuropsych Screening|incomplete consent|0
7501529|NCT02278328|11825804|FG001|Neuropsych Screening|incomplete consent|0
7501530|NCT02278328|11825805|FG002|Neuropsych Screening|incomplete consent|2
7501531|NCT02278341|11825813|FG000|Overall Study|Randomized but never received study drug|1
7501532|NCT02278341|11825814|FG001|Overall Study|Randomized but never received study drug|1
7501533|NCT02278341|11825813|FG000|Overall Study|Adverse Event|3
7501534|NCT02278341|11825814|FG001|Overall Study|Adverse Event|0
7501535|NCT02278341|11825813|FG000|Overall Study|Death|68
7501536|NCT02278341|11825814|FG001|Overall Study|Death|56
7501537|NCT02278341|11825813|FG000|Overall Study|Withdrawal by Subject|30
7501538|NCT02278341|11825814|FG001|Overall Study|Withdrawal by Subject|19
7501539|NCT02278341|11825813|FG000|Overall Study|Lost to Follow-up|0
7501540|NCT02278341|11825814|FG001|Overall Study|Lost to Follow-up|1
7501541|NCT02278341|11825813|FG000|Overall Study|Physician Decision|1
7501542|NCT02278341|11825814|FG001|Overall Study|Physician Decision|1
7501543|NCT02278341|11825813|FG000|Overall Study|Miscellaneous|15
7501544|NCT02278341|11825814|FG001|Overall Study|Miscellaneous|14
7501545|NCT02278354|11825823|FG000|Overall Study|Lost to Follow-up|2
7501546|NCT02278354|11825824|FG001|Overall Study|Lost to Follow-up|2
7501547|NCT02278354|11825823|FG000|Overall Study|Withdrawal by Subject|0
7501548|NCT02278354|11825824|FG001|Overall Study|Withdrawal by Subject|1
7501549|NCT02278354|11825823|FG000|Overall Study|<10 professional fights|2
7501550|NCT02278354|11825824|FG001|Overall Study|<10 professional fights|0
7501551|NCT02278367|11825834|FG000|Overall Study|Physician Decision|5
7501552|NCT02278367|11825835|FG001|Overall Study|Physician Decision|0
7501553|NCT02278367|11825834|FG000|Overall Study|Withdrawal by Subject|5
7501554|NCT02278367|11825835|FG001|Overall Study|Withdrawal by Subject|0
7501555|NCT02278471|11825843|FG000|Overall Study|Lost to Follow-up|6
7501556|NCT02278471|11825844|FG001|Overall Study|Lost to Follow-up|15
7501557|NCT02278471|11825843|FG000|Overall Study|Death|2
7501558|NCT02278471|11825844|FG001|Overall Study|Death|2
7501559|NCT02278471|11825843|FG000|Overall Study|Withdrawal by Subject|0
7501560|NCT02278471|11825844|FG001|Overall Study|Withdrawal by Subject|3
7501561|NCT02278614|11825871|FG000|Overall Study|Withdrawal by Subject|3
7501562|NCT02278614|11825872|FG001|Overall Study|Withdrawal by Subject|5
7501563|NCT02278614|11825871|FG000|Overall Study|Adverse Event|1
7501564|NCT02278614|11825872|FG001|Overall Study|Adverse Event|0
7501565|NCT02278614|11825871|FG000|Overall Study|left eye was not eligible|1
7501566|NCT02278614|11825872|FG001|Overall Study|left eye was not eligible|0
7501567|NCT02278939|11825888|FG000|Overall Study|lack of time|1
7501568|NCT02278939|11825889|FG001|Overall Study|lack of time|0
7501569|NCT02278939|11825888|FG000|Overall Study|Lost to Follow-up|1
7501570|NCT02278939|11825889|FG001|Overall Study|Lost to Follow-up|1
7501571|NCT02278939|11825888|FG000|Overall Study|death in family|1
7501572|NCT02278939|11825889|FG001|Overall Study|death in family|0
7501573|NCT02278939|11825888|FG000|Overall Study|family emergency unable to commit|2
7501574|NCT02278939|11825889|FG001|Overall Study|family emergency unable to commit|0
7501575|NCT02278952|11825895|FG000|Overall Study|Insufficient Sample|6
7501576|NCT02279043|11825908|FG000|Overall Study|Post-rand. exclusion - not eligible|1
7501577|NCT02279043|11825909|FG001|Overall Study|Post-rand. exclusion - not eligible|1
7501578|NCT02279043|11825910|FG002|Overall Study|Post-rand. exclusion - not eligible|0
7501579|NCT02279043|11825908|FG000|Overall Study|Lost to Follow-up|46
7501580|NCT02279043|11825909|FG001|Overall Study|Lost to Follow-up|88
7501581|NCT02279043|11825910|FG002|Overall Study|Lost to Follow-up|0
7501582|NCT02279407|11825942|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
7501583|NCT02279407|11825943|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
7501584|NCT02279407|11825944|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
7501585|NCT02279407|11825945|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
7501586|NCT02279407|11825942|FG000|Overall Study|Withdrawal by Subject|1
7501587|NCT02279407|11825943|FG001|Overall Study|Withdrawal by Subject|0
7501588|NCT02279407|11825944|FG002|Overall Study|Withdrawal by Subject|1
7501589|NCT02279407|11825945|FG003|Overall Study|Withdrawal by Subject|1
7501590|NCT02279407|11825942|FG000|Overall Study|Adverse Event|1
7501591|NCT02279407|11825943|FG001|Overall Study|Adverse Event|1
7501592|NCT02279407|11825944|FG002|Overall Study|Adverse Event|2
7501593|NCT02279407|11825945|FG003|Overall Study|Adverse Event|0
7501594|NCT02279420|11825955|FG000|Overall Study|Lost to Follow-up|23
7501595|NCT02279498|11825961|FG000|Overall Study|Adverse Event|3
7501596|NCT02279498|11825962|FG001|Overall Study|Adverse Event|0
7501597|NCT02279498|11825961|FG000|Overall Study|Lack of Efficacy|4
7501598|NCT02279498|11825962|FG001|Overall Study|Lack of Efficacy|0
7501599|NCT02279498|11825961|FG000|Overall Study|Lost to Follow-up|0
7501600|NCT02279498|11825962|FG001|Overall Study|Lost to Follow-up|1
7501601|NCT02279498|11825961|FG000|Overall Study|Withdrawal by Subject|9
7501602|NCT02279498|11825962|FG001|Overall Study|Withdrawal by Subject|2
7501603|NCT02279498|11825961|FG000|Overall Study|Undefined|2
7501604|NCT02279498|11825962|FG001|Overall Study|Undefined|1
7501605|NCT02279524|11825972|FG000|Overall Study|Withdrawal by Subject|3
7501606|NCT02279524|11825973|FG001|Overall Study|Withdrawal by Subject|6
7501607|NCT02279524|11825974|FG002|Overall Study|Withdrawal by Subject|3
7501608|NCT02279524|11825972|FG000|Overall Study|Adverse Event|4
7501609|NCT02279524|11825973|FG001|Overall Study|Adverse Event|3
7501610|NCT02279524|11825974|FG002|Overall Study|Adverse Event|2
7501611|NCT02279524|11825972|FG000|Overall Study|Lost to Follow-up|1
7501612|NCT02279524|11825973|FG001|Overall Study|Lost to Follow-up|1
7501613|NCT02279524|11825974|FG002|Overall Study|Lost to Follow-up|0
7501614|NCT02279524|11825972|FG000|Overall Study|Disallowed medication|1
7501615|NCT02279524|11825973|FG001|Overall Study|Disallowed medication|1
7501616|NCT02279524|11825974|FG002|Overall Study|Disallowed medication|2
7501617|NCT02279524|11825972|FG000|Overall Study|Bariatric surgery|1
7501618|NCT02279524|11825973|FG001|Overall Study|Bariatric surgery|0
7501619|NCT02279524|11825974|FG002|Overall Study|Bariatric surgery|0
7501620|NCT02279732|11826017|FG000|Overall Study|Death|23
7501621|NCT02279732|11826018|FG001|Overall Study|Death|20
7501622|NCT02279732|11826017|FG000|Overall Study|Disease Progression|13
7501623|NCT02279732|11826018|FG001|Overall Study|Disease Progression|3
7501624|NCT02279732|11826017|FG000|Overall Study|Withdrawal by Subject|2
7501625|NCT02279732|11826018|FG001|Overall Study|Withdrawal by Subject|7
7501626|NCT02279732|11826017|FG000|Overall Study|Adverse Event|1
7501627|NCT02279732|11826018|FG001|Overall Study|Adverse Event|2
7501628|NCT02279732|11826017|FG000|Overall Study|Administrative Reason By Sponsor|0
7501629|NCT02279732|11826018|FG001|Overall Study|Administrative Reason By Sponsor|2
7501630|NCT02279732|11826017|FG000|Overall Study|Study Drug Toxicity|2
7501631|NCT02279732|11826018|FG001|Overall Study|Study Drug Toxicity|0
7501632|NCT02279732|11826017|FG000|Overall Study|Lost to Follow-up|0
7501633|NCT02279732|11826018|FG001|Overall Study|Lost to Follow-up|1
7501634|NCT02279732|11826017|FG000|Overall Study|Maximum Clinical Benefit|1
7501635|NCT02279732|11826018|FG001|Overall Study|Maximum Clinical Benefit|0
7501636|NCT02279732|11826017|FG000|Overall Study|Subject Requested to Discontinue|0
7501637|NCT02279732|11826018|FG001|Overall Study|Subject Requested to Discontinue|1
7501638|NCT02279732|11826017|FG000|Overall Study|Other|53
7501639|NCT02279732|11826018|FG001|Overall Study|Other|67
7501640|NCT02279732|11826017|FG000|Overall Study|Other|3
7501641|NCT02279732|11826018|FG001|Overall Study|Other|3
7501642|NCT02279862|11826026|FG000|Overall Study|Study drug toxicity|3
7501643|NCT02279862|11826027|FG001|Overall Study|Study drug toxicity|6
7501644|NCT02279862|11826026|FG000|Overall Study|No longer meets criteria|0
7501645|NCT02279862|11826027|FG001|Overall Study|No longer meets criteria|1
7501646|NCT02279862|11826026|FG000|Overall Study|Administrative reason by sponsor|0
7501647|NCT02279862|11826027|FG001|Overall Study|Administrative reason by sponsor|1
7501648|NCT02279862|11826026|FG000|Overall Study|Disease progression|5
7501649|NCT02279862|11826027|FG001|Overall Study|Disease progression|2
7501650|NCT02279862|11826026|FG000|Overall Study|Study closed by sponsor|16
7501651|NCT02279862|11826027|FG001|Overall Study|Study closed by sponsor|13
7501652|NCT02279862|11826026|FG000|Overall Study|Other|1
7501653|NCT02279862|11826027|FG001|Overall Study|Other|2
7501654|NCT02279862|11826026|FG000|Overall Study|Withdrawal by Subject|1
7501655|NCT02279862|11826027|FG001|Overall Study|Withdrawal by Subject|0
7501656|NCT02280044|11826035|FG000|Overall Study|Planned alternate|0
7501657|NCT02280044|11826036|FG001|Overall Study|Planned alternate|2
7501658|NCT02280096|11826044|FG000|Overall Study|Pregnancy|1
7501659|NCT02280096|11826045|FG001|Overall Study|Pregnancy|0
7501660|NCT02280096|11826044|FG000|Overall Study|Functional neurological disorder|1
7501661|NCT02280096|11826045|FG001|Overall Study|Functional neurological disorder|0
7501662|NCT02280096|11826044|FG000|Overall Study|Lack of attachment|0
7501663|NCT02280096|11826045|FG001|Overall Study|Lack of attachment|1
7501664|NCT02280187|11826070|FG000|Overall Study|Lost to Follow-up|218
7501665|NCT02280291|11826091|FG000|Overall Study|Lost to Follow-up|2
7501666|NCT02280291|11826092|FG001|Overall Study|Lost to Follow-up|1
7501667|NCT02280291|11826093|FG002|Overall Study|Lost to Follow-up|3
7501668|NCT02280291|11826094|FG003|Overall Study|Lost to Follow-up|8
7501669|NCT02280291|11826091|FG000|Overall Study|Protocol Violation|1
7501670|NCT02280291|11826092|FG001|Overall Study|Protocol Violation|0
7501671|NCT02280291|11826093|FG002|Overall Study|Protocol Violation|0
7501672|NCT02280291|11826094|FG003|Overall Study|Protocol Violation|0
7501673|NCT02280291|11826091|FG000|Overall Study|Other|1
7501674|NCT02280291|11826092|FG001|Overall Study|Other|1
7501675|NCT02280291|11826093|FG002|Overall Study|Other|0
7501676|NCT02280291|11826094|FG003|Overall Study|Other|0
7501677|NCT02280304|11826108|FG000|Overall Study|Lost to Follow-up|7
7501678|NCT02280304|11826109|FG001|Overall Study|Lost to Follow-up|8
7501679|NCT02280408|11826158|FG000|Overall Study|Lost to Follow-up|0
7501680|NCT02280408|11826159|FG001|Overall Study|Lost to Follow-up|2
7501681|NCT02280408|11826160|FG002|Overall Study|Lost to Follow-up|0
7501682|NCT02280408|11826161|FG003|Overall Study|Lost to Follow-up|0
7501683|NCT02280421|11826173|FG000|Washout (2 Weeks)|Adverse Event|0
7501684|NCT02280421|11826174|FG001|Washout (2 Weeks)|Adverse Event|1
7501685|NCT02280421|11826173|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7501686|NCT02280421|11826174|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
7501687|NCT02280473|11826194|FG000|Overall Study|Adverse Event|1
7501688|NCT02280473|11826195|FG001|Overall Study|Adverse Event|1
7501689|NCT02280473|11826194|FG000|Overall Study|Lack of Efficacy|0
7501690|NCT02280473|11826195|FG001|Overall Study|Lack of Efficacy|1
7501691|NCT02280473|11826194|FG000|Overall Study|Lost to Follow-up|0
7501692|NCT02280473|11826195|FG001|Overall Study|Lost to Follow-up|1
7501693|NCT02280499|11826201|FG000|Overall Study|Death|14
7501694|NCT02280499|11826201|FG000|Overall Study|Lost to Follow-up|42
7501695|NCT02280499|11826201|FG000|Overall Study|Adverse Event|5
7535731|NCT02712320|11883493|FG000|Overall Study|Transferred to another facility|1
7535732|NCT02712320|11883493|FG000|Overall Study|Treating with the prohibited medications|2
7535733|NCT02712333|11883499|FG000|First Period|Withdrawal by Subject|3
7535734|NCT02712333|11883500|FG001|First Period|Withdrawal by Subject|2
7535735|NCT02712398|11883528|FG000|Overall Study|Withdrawal by Subject|6
7535736|NCT02712398|11883528|FG000|Overall Study|Lost to Follow-up|6
7535737|NCT02712398|11883528|FG000|Overall Study|Sponsor Decision|1
7535738|NCT02712398|11883528|FG000|Overall Study|Physician Decision|1
7535739|NCT02712398|11883528|FG000|Overall Study|Death|2
7535740|NCT02712398|11883528|FG000|Overall Study|Re-operation|21
7535741|NCT02712424|11883534|FG000|Overall Study|Lost to Follow-up|34
7535742|NCT02712424|11883535|FG001|Overall Study|Lost to Follow-up|32
7535743|NCT02712554|11883543|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
7535744|NCT02712554|11883544|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
7535745|NCT02712554|11883543|FG000|Part B: Qualification Phase|Sponsor Decision|0
7535746|NCT02712554|11883544|FG001|Part B: Qualification Phase|Sponsor Decision|4
7535747|NCT02712554|11883543|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
7535748|NCT02712554|11883544|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
7535749|NCT02712554|11883543|FG000|Part B: Qualification Phase|Adverse Event|0
7535750|NCT02712554|11883544|FG001|Part B: Qualification Phase|Adverse Event|1
7535751|NCT02712554|11883543|FG000|Part B: Treatment Phase|Adverse Event|0
7535752|NCT02712554|11883544|FG001|Part B: Treatment Phase|Adverse Event|1
7535753|NCT02712554|11883543|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
7535754|NCT02712554|11883544|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
7535755|NCT02712554|11883543|FG000|Part B: Treatment Phase|Other|0
7535756|NCT02712554|11883544|FG001|Part B: Treatment Phase|Other|1
7535757|NCT02712788|11883569|FG000|Overall Study|Physician Decision|1
7535758|NCT02712788|11883570|FG001|Overall Study|Physician Decision|0
7535759|NCT02712788|11883569|FG000|Overall Study|Protocol Violation|1
7535760|NCT02712788|11883570|FG001|Overall Study|Protocol Violation|0
7535761|NCT02712983|11883585|FG000|Treatment Phase|Adverse Event|3
7535762|NCT02712983|11883586|FG001|Treatment Phase|Adverse Event|1
7535763|NCT02712983|11883587|FG002|Treatment Phase|Adverse Event|1
7535764|NCT02712983|11883588|FG003|Treatment Phase|Adverse Event|4
7535765|NCT02712983|11883589|FG004|Treatment Phase|Adverse Event|3
7535766|NCT02712983|11883590|FG005|Treatment Phase|Adverse Event|0
7535767|NCT02712983|11883591|FG006|Treatment Phase|Adverse Event|6
7535768|NCT02712983|11883592|FG007|Treatment Phase|Adverse Event|6
7535769|NCT02712983|11883593|FG008|Treatment Phase|Adverse Event|1
7535770|NCT02712983|11883585|FG000|Treatment Phase|Protocol Deviation|0
7535771|NCT02712983|11883586|FG001|Treatment Phase|Protocol Deviation|0
7535772|NCT02712983|11883587|FG002|Treatment Phase|Protocol Deviation|0
7535773|NCT02712983|11883588|FG003|Treatment Phase|Protocol Deviation|2
7535774|NCT02712983|11883589|FG004|Treatment Phase|Protocol Deviation|0
7535775|NCT02712983|11883590|FG005|Treatment Phase|Protocol Deviation|0
7535776|NCT02712983|11883591|FG006|Treatment Phase|Protocol Deviation|1
7535777|NCT02712983|11883592|FG007|Treatment Phase|Protocol Deviation|0
7535778|NCT02712983|11883593|FG008|Treatment Phase|Protocol Deviation|0
7535779|NCT02712983|11883585|FG000|Treatment Phase|Technical Problems|0
7535780|NCT02712983|11883586|FG001|Treatment Phase|Technical Problems|0
7535781|NCT02712983|11883587|FG002|Treatment Phase|Technical Problems|0
7535782|NCT02712983|11883588|FG003|Treatment Phase|Technical Problems|0
7535783|NCT02712983|11883589|FG004|Treatment Phase|Technical Problems|0
7535784|NCT02712983|11883590|FG005|Treatment Phase|Technical Problems|0
7535785|NCT02712983|11883591|FG006|Treatment Phase|Technical Problems|1
7535786|NCT02712983|11883592|FG007|Treatment Phase|Technical Problems|0
7535787|NCT02712983|11883593|FG008|Treatment Phase|Technical Problems|0
7535788|NCT02712983|11883585|FG000|Treatment Phase|Physician Decision|0
7535789|NCT02712983|11883586|FG001|Treatment Phase|Physician Decision|0
7535790|NCT02712983|11883587|FG002|Treatment Phase|Physician Decision|0
7535791|NCT02712983|11883588|FG003|Treatment Phase|Physician Decision|0
7535792|NCT02712983|11883589|FG004|Treatment Phase|Physician Decision|0
7535793|NCT02712983|11883590|FG005|Treatment Phase|Physician Decision|0
7535794|NCT02712983|11883591|FG006|Treatment Phase|Physician Decision|0
7535795|NCT02712983|11883592|FG007|Treatment Phase|Physician Decision|1
7535796|NCT02712983|11883593|FG008|Treatment Phase|Physician Decision|1
7535797|NCT02712983|11883585|FG000|Treatment Phase|Subject Decision|2
7535798|NCT02712983|11883586|FG001|Treatment Phase|Subject Decision|0
7535799|NCT02712983|11883587|FG002|Treatment Phase|Subject Decision|0
7535800|NCT02712983|11883588|FG003|Treatment Phase|Subject Decision|2
7535801|NCT02712983|11883589|FG004|Treatment Phase|Subject Decision|1
7535802|NCT02712983|11883590|FG005|Treatment Phase|Subject Decision|0
7535803|NCT02712983|11883591|FG006|Treatment Phase|Subject Decision|1
7535804|NCT02712983|11883592|FG007|Treatment Phase|Subject Decision|2
7535805|NCT02712983|11883593|FG008|Treatment Phase|Subject Decision|0
7535806|NCT02712983|11883585|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7535807|NCT02712983|11883586|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7535808|NCT02712983|11883587|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7535809|NCT02712983|11883588|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7535810|NCT02712983|11883589|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7501696|NCT02280863|11826239|FG000|Integrated Platform|Met stopping criteria|0
7501697|NCT02280863|11826240|FG001|Integrated Platform|Met stopping criteria|1
7501698|NCT02281318|11826256|FG000|Overall Study|Adverse Event|2
7501699|NCT02281318|11826257|FG001|Overall Study|Adverse Event|2
7501700|NCT02281318|11826256|FG000|Overall Study|Lack of Efficacy|2
7501701|NCT02281318|11826257|FG001|Overall Study|Lack of Efficacy|0
7501702|NCT02281318|11826256|FG000|Overall Study|Lost to Follow-up|2
7501703|NCT02281318|11826257|FG001|Overall Study|Lost to Follow-up|1
7501704|NCT02281318|11826256|FG000|Overall Study|Physician Decision|2
7501705|NCT02281318|11826257|FG001|Overall Study|Physician Decision|0
7501706|NCT02281318|11826256|FG000|Overall Study|Withdrawal by Subject|6
7501707|NCT02281318|11826257|FG001|Overall Study|Withdrawal by Subject|2
7501708|NCT02281357|11826269|FG000|Overall Study|Adverse Event|2
7501709|NCT02281357|11826270|FG001|Overall Study|Adverse Event|1
7501710|NCT02281357|11826269|FG000|Overall Study|Lost to Follow-up|1
7501711|NCT02281357|11826270|FG001|Overall Study|Lost to Follow-up|0
7501712|NCT02281357|11826269|FG000|Overall Study|Withdrawal by Subject|4
7501713|NCT02281357|11826270|FG001|Overall Study|Withdrawal by Subject|3
7501714|NCT02281552|11826335|FG000|Overall Study|Medication error|1
7501715|NCT02281552|11826336|FG001|Overall Study|Medication error|0
7501716|NCT02281552|11826335|FG000|Overall Study|Insufficient clinical response|0
7501717|NCT02281552|11826336|FG001|Overall Study|Insufficient clinical response|1
7501718|NCT02281552|11826335|FG000|Overall Study|Adverse Event|3
7501719|NCT02281552|11826336|FG001|Overall Study|Adverse Event|9
7501720|NCT02281760|11826359|FG000|Overall Study|Withdrawal by Subject|1
7501721|NCT02281773|11826368|FG000|Overall Study|Adverse Event|6
7501722|NCT02281773|11826369|FG001|Overall Study|Adverse Event|1
7501723|NCT02281773|11826370|FG002|Overall Study|Adverse Event|4
7501724|NCT02281773|11826371|FG003|Overall Study|Adverse Event|8
7501725|NCT02281773|11826372|FG004|Overall Study|Adverse Event|9
7501726|NCT02281773|11826368|FG000|Overall Study|Protocol Violation|1
7501727|NCT02281773|11826369|FG001|Overall Study|Protocol Violation|0
7501728|NCT02281773|11826370|FG002|Overall Study|Protocol Violation|0
7501729|NCT02281773|11826371|FG003|Overall Study|Protocol Violation|2
7501730|NCT02281773|11826372|FG004|Overall Study|Protocol Violation|2
7501731|NCT02281773|11826368|FG000|Overall Study|Lost to Follow-up|2
7501732|NCT02281773|11826369|FG001|Overall Study|Lost to Follow-up|2
7501733|NCT02281773|11826370|FG002|Overall Study|Lost to Follow-up|6
7501734|NCT02281773|11826371|FG003|Overall Study|Lost to Follow-up|2
7501735|NCT02281773|11826372|FG004|Overall Study|Lost to Follow-up|10
7501736|NCT02281773|11826368|FG000|Overall Study|Withdrawal by Subject|2
7501737|NCT02281773|11826369|FG001|Overall Study|Withdrawal by Subject|8
7501738|NCT02281773|11826370|FG002|Overall Study|Withdrawal by Subject|6
7501739|NCT02281773|11826371|FG003|Overall Study|Withdrawal by Subject|6
7501740|NCT02281773|11826372|FG004|Overall Study|Withdrawal by Subject|8
7501741|NCT02281773|11826368|FG000|Overall Study|Other Reason|0
7501742|NCT02281773|11826369|FG001|Overall Study|Other Reason|4
7501743|NCT02281773|11826370|FG002|Overall Study|Other Reason|2
7501744|NCT02281773|11826371|FG003|Overall Study|Other Reason|3
7501745|NCT02281773|11826372|FG004|Overall Study|Other Reason|1
7501746|NCT02282163|11826402|FG000|Overall Study|Protocol Violation|1
7501747|NCT02282293|11826417|FG000|Overall Study|Lost to Follow-up|2
7501748|NCT02282293|11826418|FG001|Overall Study|Lost to Follow-up|2
7501749|NCT02282293|11826417|FG000|Overall Study|Unable to comply with study procedures|1
7501750|NCT02282293|11826418|FG001|Overall Study|Unable to comply with study procedures|0
7501751|NCT02282293|11826417|FG000|Overall Study|Moved out of study area|0
7501752|NCT02282293|11826418|FG001|Overall Study|Moved out of study area|1
7501753|NCT02282527|11826430|FG000|Overall Study|Lost to Follow-up|0
7501754|NCT02282527|11826431|FG001|Overall Study|Lost to Follow-up|1
7501755|NCT02282527|11826430|FG000|Overall Study|Lack of home health aid|1
7501756|NCT02282527|11826431|FG001|Overall Study|Lack of home health aid|0
7501757|NCT02282605|11826443|FG000|Overall Study|negative SA result on Day -1|3
7501758|NCT02282605|11826444|FG001|Overall Study|negative SA result on Day -1|0
7501759|NCT02282605|11826445|FG002|Overall Study|negative SA result on Day -1|0
7501760|NCT02282631|11826455|FG000|Overall Study|Lost to Follow-up|2
7501761|NCT02282631|11826456|FG001|Overall Study|Lost to Follow-up|0
7501762|NCT02282813|11826480|FG000|Overall Study|Withdrawal by Subject|4
7501763|NCT02282813|11826481|FG001|Overall Study|Withdrawal by Subject|5
7501764|NCT02282813|11826482|FG002|Overall Study|Withdrawal by Subject|0
7501765|NCT02282813|11826480|FG000|Overall Study|Adverse Event|3
7501766|NCT02282813|11826481|FG001|Overall Study|Adverse Event|10
7501767|NCT02282813|11826482|FG002|Overall Study|Adverse Event|1
7501768|NCT02282813|11826480|FG000|Overall Study|Subject non-compliance|1
7501769|NCT02282813|11826481|FG001|Overall Study|Subject non-compliance|4
7501770|NCT02282813|11826482|FG002|Overall Study|Subject non-compliance|0
7501771|NCT02282813|11826480|FG000|Overall Study|Physician Decision|0
7501772|NCT02282813|11826481|FG001|Overall Study|Physician Decision|3
7501773|NCT02282813|11826482|FG002|Overall Study|Physician Decision|1
7501774|NCT02282813|11826480|FG000|Overall Study|Lost to Follow-up|2
7501775|NCT02282813|11826481|FG001|Overall Study|Lost to Follow-up|0
7501776|NCT02282813|11826482|FG002|Overall Study|Lost to Follow-up|1
7501777|NCT02282813|11826480|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
7501778|NCT02282813|11826481|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
7501779|NCT02282813|11826482|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
7501780|NCT02282813|11826480|FG000|Overall Study|Lack of Efficacy|1
7501781|NCT02282813|11826481|FG001|Overall Study|Lack of Efficacy|0
7501782|NCT02282813|11826482|FG002|Overall Study|Lack of Efficacy|0
7501783|NCT02282813|11826480|FG000|Overall Study|Administrative reasons|0
7501784|NCT02282813|11826481|FG001|Overall Study|Administrative reasons|1
7501785|NCT02282813|11826482|FG002|Overall Study|Administrative reasons|0
7501786|NCT02282982|11826500|FG000|Overall Study|Lost to Follow-up|15
7501787|NCT02282982|11826500|FG000|Overall Study|Withdrew consent|2
7501788|NCT02282982|11826500|FG000|Overall Study|Death|4
7501789|NCT02282982|11826500|FG000|Overall Study|Lack of product|156
7501790|NCT02282982|11826500|FG000|Overall Study|Palivizumab is ended|11
7501791|NCT02282982|11826500|FG000|Overall Study|Other, not specified|18
7501792|NCT02283268|11826504|FG000|Overall Study|Withdrawal by Subject|1
7501793|NCT02283294|11826518|FG000|Overall Study|Lost to Follow-up|1
7501794|NCT02283294|11826519|FG001|Overall Study|Lost to Follow-up|1
7501795|NCT02283294|11826518|FG000|Overall Study|Withdrawal by Subject|1
7501796|NCT02283294|11826519|FG001|Overall Study|Withdrawal by Subject|6
7501797|NCT02283294|11826518|FG000|Overall Study|Protocol Violation|1
7501798|NCT02283294|11826519|FG001|Overall Study|Protocol Violation|0
7501799|NCT02283294|11826518|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
7501800|NCT02283294|11826519|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
7501801|NCT02283411|11826535|FG000|Overall Study|Withdrawal by Subject|3
7501802|NCT02283411|11826535|FG000|Overall Study|Screen Failed|28
7501803|NCT02283658|11826548|FG000|Overall Study|Withdrawal by Subject|1
7501804|NCT02283762|11826558|FG000|Main Treatment Phase (MT)|Adverse Event|9
7501805|NCT02283762|11826559|FG001|Main Treatment Phase (MT)|Adverse Event|9
7501806|NCT02283762|11826558|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
7501807|NCT02283762|11826559|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
7501808|NCT02283762|11826558|FG000|Main Treatment Phase (MT)|Physician Decision|1
7501809|NCT02283762|11826559|FG001|Main Treatment Phase (MT)|Physician Decision|1
7501810|NCT02283762|11826558|FG000|Main Treatment Phase (MT)|Pregnancy|0
7501811|NCT02283762|11826559|FG001|Main Treatment Phase (MT)|Pregnancy|1
7501812|NCT02283762|11826558|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
7501813|NCT02283762|11826559|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
7501814|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
7501815|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
7501816|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7501817|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
7501818|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
7501819|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
7501820|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
7501821|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
7501822|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
7501823|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
7501824|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
7501825|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
7501826|NCT02283762|11826558|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
7501827|NCT02283762|11826559|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
7501828|NCT02283788|11826571|FG000|Overall Study|Adverse Event|1
7501829|NCT02283788|11826572|FG001|Overall Study|Adverse Event|3
7501830|NCT02283788|11826573|FG002|Overall Study|Adverse Event|5
7501831|NCT02283788|11826574|FG003|Overall Study|Adverse Event|1
7501832|NCT02283788|11826571|FG000|Overall Study|Withdrawal by Subject|0
7501833|NCT02283788|11826572|FG001|Overall Study|Withdrawal by Subject|1
7501834|NCT02283788|11826573|FG002|Overall Study|Withdrawal by Subject|0
7501835|NCT02283788|11826574|FG003|Overall Study|Withdrawal by Subject|1
7501836|NCT02284009|11826626|FG000|Overall Study|Adverse Event|3
7501837|NCT02284009|11826627|FG001|Overall Study|Adverse Event|0
7501838|NCT02284009|11826626|FG000|Overall Study|Lost to Follow-up|1
7501839|NCT02284009|11826627|FG001|Overall Study|Lost to Follow-up|3
7501840|NCT02284009|11826626|FG000|Overall Study|Physician Decision|0
7501841|NCT02284009|11826627|FG001|Overall Study|Physician Decision|2
7501842|NCT02284009|11826626|FG000|Overall Study|Withdrawal by Subject|2
7501843|NCT02284009|11826627|FG001|Overall Study|Withdrawal by Subject|5
7501844|NCT02284178|11826657|FG000|Overall Study|Met exclusion criteria|49
7501845|NCT02284178|11826658|FG001|Overall Study|Met exclusion criteria|54
7501846|NCT02284243|11826666|FG000|Overall Study|Lack of Efficacy|3
7501847|NCT02284243|11826667|FG001|Overall Study|Lack of Efficacy|3
7501848|NCT02284243|11826666|FG000|Overall Study|Adverse Event|1
7501849|NCT02284243|11826667|FG001|Overall Study|Adverse Event|0
7501850|NCT02284347|11826673|FG000|Overall Study|Lost to Follow-up|2
7501851|NCT02284347|11826673|FG000|Overall Study|Withdrawn prior to treatment|1
7501852|NCT02284893|11826763|FG000|26 Week (Short Term)|Adverse Event|1
7501853|NCT02284893|11826764|FG001|26 Week (Short Term)|Adverse Event|9
7501854|NCT02284893|11826763|FG000|26 Week (Short Term)|Discontinuation by the subject|2
7501855|NCT02284893|11826764|FG001|26 Week (Short Term)|Discontinuation by the subject|2
7501856|NCT02284893|11826763|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
7501857|NCT02284893|11826764|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
7501858|NCT02284893|11826763|FG000|26 Week (Short Term)|Lost to Follow-up|3
7501859|NCT02284893|11826764|FG001|26 Week (Short Term)|Lost to Follow-up|1
7501860|NCT02284893|11826763|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
7501861|NCT02284893|11826764|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
7501862|NCT02284893|11826763|FG000|26 Week (Short Term)|Other|1
7501863|NCT02284893|11826764|FG001|26 Week (Short Term)|Other|1
7501864|NCT02284893|11826763|FG000|52 Week (Long Term)|Adverse Event|3
7501865|NCT02284893|11826764|FG001|52 Week (Long Term)|Adverse Event|1
7501866|NCT02284893|11826763|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
7501867|NCT02284893|11826764|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
7501868|NCT02284893|11826763|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
7501869|NCT02284893|11826764|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
7501870|NCT02284893|11826763|FG000|52 Week (Long Term)|Lost to Follow-up|2
7501871|NCT02284893|11826764|FG001|52 Week (Long Term)|Lost to Follow-up|2
7501872|NCT02284893|11826763|FG000|52 Week (Long Term)|Non-Compliance|2
7501873|NCT02284893|11826764|FG001|52 Week (Long Term)|Non-Compliance|3
7501874|NCT02285010|11826772|FG000|Overall Study|not abdominal hysterectomy|2
7501875|NCT02285010|11826773|FG001|Overall Study|not abdominal hysterectomy|0
7501876|NCT02285010|11826772|FG000|Overall Study|Not spinal anesthesia|3
7501877|NCT02285010|11826773|FG001|Overall Study|Not spinal anesthesia|1
7501878|NCT02285153|11826791|FG000|Overall Study|Adverse Event|1
7501879|NCT02285153|11826792|FG001|Overall Study|Adverse Event|0
7501880|NCT02285361|11826807|FG000|Overall Study|Protocol Violation|43
7501881|NCT02285361|11826807|FG000|Overall Study|Lost to Follow-up|5
7501882|NCT02285361|11826807|FG000|Overall Study|Not taken GIOTRIF|2
7501883|NCT02285361|11826807|FG000|Overall Study|Consented prior to the contract date|1
7501884|NCT02285777|11826831|FG000|Overall Study|Withdrawal by Subject|1
7501885|NCT02285777|11826832|FG001|Overall Study|Withdrawal by Subject|1
7501886|NCT02285777|11826831|FG000|Overall Study|Lost to Follow-up|4
7501887|NCT02285777|11826832|FG001|Overall Study|Lost to Follow-up|2
7501888|NCT02285855|11826840|FG000|Overall Study|Withdrawal by Subject|2
7501889|NCT02285855|11826841|FG001|Overall Study|Withdrawal by Subject|1
7501890|NCT02285920|11826864|FG000|Overall Study|Kidney transplantation|2
7501891|NCT02285920|11826865|FG001|Overall Study|Kidney transplantation|2
7501892|NCT02285920|11826866|FG002|Overall Study|Kidney transplantation|2
7501893|NCT02285920|11826867|FG003|Overall Study|Kidney transplantation|0
7501894|NCT02285920|11826864|FG000|Overall Study|Change to peritoneal dialysis|0
7501895|NCT02285920|11826865|FG001|Overall Study|Change to peritoneal dialysis|0
7501896|NCT02285920|11826866|FG002|Overall Study|Change to peritoneal dialysis|1
7501897|NCT02285920|11826867|FG003|Overall Study|Change to peritoneal dialysis|0
7501898|NCT02285920|11826864|FG000|Overall Study|Transfer to non-participating unit|0
7501899|NCT02285920|11826865|FG001|Overall Study|Transfer to non-participating unit|1
7501900|NCT02285920|11826866|FG002|Overall Study|Transfer to non-participating unit|0
7501901|NCT02285920|11826867|FG003|Overall Study|Transfer to non-participating unit|0
7501902|NCT02285920|11826864|FG000|Overall Study|Dialysis discontinuation|0
7501903|NCT02285920|11826865|FG001|Overall Study|Dialysis discontinuation|1
7501904|NCT02285920|11826866|FG002|Overall Study|Dialysis discontinuation|0
7501905|NCT02285920|11826867|FG003|Overall Study|Dialysis discontinuation|0
7501906|NCT02285920|11826864|FG000|Overall Study|Death|2
7501907|NCT02285920|11826865|FG001|Overall Study|Death|0
7501908|NCT02285920|11826866|FG002|Overall Study|Death|2
7501909|NCT02285920|11826867|FG003|Overall Study|Death|1
7501910|NCT02285998|11826879|FG000|Overall Study|Adverse Event|9
7501911|NCT02285998|11826880|FG001|Overall Study|Adverse Event|8
7501912|NCT02285998|11826879|FG000|Overall Study|Physician Decision|1
7501913|NCT02285998|11826880|FG001|Overall Study|Physician Decision|2
7501914|NCT02285998|11826879|FG000|Overall Study|Lost to Follow-up|176
7501915|NCT02285998|11826880|FG001|Overall Study|Lost to Follow-up|172
7501916|NCT02285998|11826879|FG000|Overall Study|Withdrawal by Subject|53
7501917|NCT02285998|11826880|FG001|Overall Study|Withdrawal by Subject|61
7501918|NCT02285998|11826879|FG000|Overall Study|Other Reasons|7
7501919|NCT02285998|11826880|FG001|Overall Study|Other Reasons|10
7501920|NCT02286102|11826888|FG000|Overall Study|Screen Failure|1
7501921|NCT02286102|11826889|FG001|Overall Study|Screen Failure|1
7501922|NCT02286193|11826895|FG000|Overall Study|Referred: CRS unable to make contact|62
7501923|NCT02286193|11826895|FG000|Overall Study|Referred: unable to reach/resource sent|104
7501924|NCT02286193|11826895|FG000|Overall Study|Referred: Declined service|38
7501925|NCT02286466|11826902|FG000|Overall Study|Death|1
7501926|NCT02286466|11826903|FG001|Overall Study|Death|3
7501927|NCT02286466|11826902|FG000|Overall Study|Withdrawal by Subject|5
7501928|NCT02286466|11826903|FG001|Overall Study|Withdrawal by Subject|2
7501929|NCT02286466|11826902|FG000|Overall Study|Lost to Follow-up|1
7501930|NCT02286466|11826903|FG001|Overall Study|Lost to Follow-up|4
7501931|NCT02286466|11826902|FG000|Overall Study|Declined Clinician Assessment|0
7501932|NCT02286466|11826903|FG001|Overall Study|Declined Clinician Assessment|1
7501933|NCT02286713|11826984|FG000|One Week Follow-Up|Death|1
7501934|NCT02286713|11826985|FG001|One Week Follow-Up|Death|0
7501935|NCT02286713|11826984|FG000|One Week Follow-Up|Lost to Follow-up|17
7501936|NCT02286713|11826985|FG001|One Week Follow-Up|Lost to Follow-up|21
7501937|NCT02286713|11826984|FG000|One Week Follow-Up|Withdrawal by Subject|6
7501938|NCT02286713|11826985|FG001|One Week Follow-Up|Withdrawal by Subject|3
7501939|NCT02286713|11826984|FG000|Three Month Follow-Up|Death|1
7501940|NCT02286713|11826985|FG001|Three Month Follow-Up|Death|1
7501941|NCT02286713|11826984|FG000|Three Month Follow-Up|Lost to Follow-up|26
7501942|NCT02286713|11826985|FG001|Three Month Follow-Up|Lost to Follow-up|24
7501943|NCT02286713|11826984|FG000|Three Month Follow-Up|Withdrawal by Subject|1
7501944|NCT02286713|11826985|FG001|Three Month Follow-Up|Withdrawal by Subject|1
7501945|NCT02286713|11826984|FG000|Six Month Follow-Up|Death|2
7501946|NCT02286713|11826985|FG001|Six Month Follow-Up|Death|0
7501947|NCT02286713|11826984|FG000|Six Month Follow-Up|Lost to Follow-up|30
7501948|NCT02286713|11826985|FG001|Six Month Follow-Up|Lost to Follow-up|27
7501949|NCT02286843|11827004|FG000|Overall Study|Not Treated|4
7501950|NCT02286843|11827004|FG000|Overall Study|Protocol Violation|1
7501951|NCT02286843|11827004|FG000|Overall Study|Withdrawal by Subject|1
7501952|NCT02286895|11827010|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
7501953|NCT02286895|11827011|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
7501954|NCT02286895|11827010|FG000|Assessed for Measles Seroconversion|Missing measurement|6
7501955|NCT02286895|11827011|FG001|Assessed for Measles Seroconversion|Missing measurement|3
7501956|NCT02286895|11827010|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
7501957|NCT02286895|11827011|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
7501958|NCT02286947|11827026|FG000|Overall Study|Withdrawal by Subject|2
7501959|NCT02286960|11827034|FG000|Overall Study|Lost to Follow-up|3
7501960|NCT02286960|11827035|FG001|Overall Study|Lost to Follow-up|3
7501961|NCT02287038|11827043|FG000|Overall Study|Stopped attending appointments|3
7501962|NCT02287038|11827044|FG001|Overall Study|Stopped attending appointments|2
7501963|NCT02287038|11827043|FG000|Overall Study|Anxiety after starting medication|0
7501964|NCT02287038|11827044|FG001|Overall Study|Anxiety after starting medication|1
7501965|NCT02287038|11827043|FG000|Overall Study|Nausea after starting medication|1
7501966|NCT02287038|11827044|FG001|Overall Study|Nausea after starting medication|0
7501967|NCT02287038|11827043|FG000|Overall Study|Abnormal ECG after starting medication|1
7501968|NCT02287038|11827044|FG001|Overall Study|Abnormal ECG after starting medication|0
7501969|NCT02287402|11827060|FG000|Treatment Period|Adverse Event|17
7501970|NCT02287402|11827060|FG000|Treatment Period|Voluntary Withdrawal|10
7501971|NCT02287402|11827060|FG000|Follow-up|Lost to Follow-up|1
7501972|NCT02287402|11827060|FG000|Follow-up|Voluntary Withdrawal|2
7501973|NCT02287467|11827070|FG000|Overall Study|Protocol Violation|12
7501974|NCT02287467|11827071|FG001|Overall Study|Protocol Violation|9
7501975|NCT02287610|11827080|FG000|Overall Study|Lost to Follow-up|3
7501976|NCT02287610|11827080|FG000|Overall Study|Withdrawal by Subject|8
7501977|NCT02287610|11827080|FG000|Overall Study|Excluded-investigator non-responsiveness|5
7501978|NCT02287623|11827086|FG000|Overall Study|Protocol Violation|0
7501979|NCT02287623|11827087|FG001|Overall Study|Protocol Violation|1
7501980|NCT02287883|11827145|FG000|Overall Study|Death|8
7501981|NCT02287883|11827146|FG001|Overall Study|Death|7
7501982|NCT02287883|11827145|FG000|Overall Study|No longer eligible|222
7501983|NCT02287883|11827146|FG001|Overall Study|No longer eligible|182
7501984|NCT02287883|11827145|FG000|Overall Study|Non-response to survey|229
7501985|NCT02287883|11827146|FG001|Overall Study|Non-response to survey|237
7501986|NCT02287896|11827154|FG000|Second Injection Visit|Withdrawal by Subject|0
7501987|NCT02287896|11827155|FG001|Second Injection Visit|Withdrawal by Subject|1
7501988|NCT02287922|11827188|FG000|Overall Study|Adverse Event|1
7501989|NCT02287922|11827189|FG001|Overall Study|Adverse Event|1
7501990|NCT02287922|11827190|FG002|Overall Study|Adverse Event|3
7501991|NCT02287922|11827191|FG003|Overall Study|Adverse Event|4
7501992|NCT02287922|11827188|FG000|Overall Study|Withdrawal by Subject|1
7501993|NCT02287922|11827189|FG001|Overall Study|Withdrawal by Subject|1
7501994|NCT02287922|11827190|FG002|Overall Study|Withdrawal by Subject|1
7501995|NCT02287922|11827191|FG003|Overall Study|Withdrawal by Subject|2
7501996|NCT02287922|11827188|FG000|Overall Study|Lost to Follow-up|0
7501997|NCT02287922|11827189|FG001|Overall Study|Lost to Follow-up|0
7501998|NCT02287922|11827190|FG002|Overall Study|Lost to Follow-up|1
7501999|NCT02287922|11827191|FG003|Overall Study|Lost to Follow-up|0
7502000|NCT02287922|11827188|FG000|Overall Study|Sponsor's decision|0
7502001|NCT02287922|11827189|FG001|Overall Study|Sponsor's decision|0
7502002|NCT02287922|11827190|FG002|Overall Study|Sponsor's decision|0
7502003|NCT02287922|11827191|FG003|Overall Study|Sponsor's decision|1
7502004|NCT02287922|11827188|FG000|Overall Study|Other|1
7502005|NCT02287922|11827189|FG001|Overall Study|Other|0
7502006|NCT02287922|11827190|FG002|Overall Study|Other|2
7502007|NCT02287922|11827191|FG003|Overall Study|Other|0
7502008|NCT02288091|11827202|FG000|Overall Study|Lost to Follow-up|1
7502009|NCT02288091|11827202|FG000|Overall Study|Screen fail|7
7502010|NCT02288182|11827227|FG000|Overall Study|Adverse Event|0
7502011|NCT02288182|11827228|FG001|Overall Study|Adverse Event|1
7502012|NCT02288182|11827227|FG000|Overall Study|Lost to Follow-up|0
7502013|NCT02288182|11827228|FG001|Overall Study|Lost to Follow-up|1
7502014|NCT02288312|11827248|FG000|Overall Study|Pregnancy|1
7502015|NCT02288312|11827249|FG001|Overall Study|Pregnancy|0
7502016|NCT02288312|11827250|FG002|Overall Study|Pregnancy|0
7502017|NCT02288325|11827258|FG000|Run-in Period|Adverse Event|48
7502018|NCT02288325|11827259|FG001|Run-in Period|Adverse Event|0
7502019|NCT02288325|11827260|FG002|Run-in Period|Adverse Event|0
7502020|NCT02288325|11827258|FG000|Run-in Period|Lack of Efficacy|16
7502021|NCT02288325|11827259|FG001|Run-in Period|Lack of Efficacy|0
7502022|NCT02288325|11827260|FG002|Run-in Period|Lack of Efficacy|0
7502023|NCT02288325|11827258|FG000|Run-in Period|Withdrawal of Consent|28
7502024|NCT02288325|11827259|FG001|Run-in Period|Withdrawal of Consent|0
7502025|NCT02288325|11827260|FG002|Run-in Period|Withdrawal of Consent|0
7502026|NCT02288325|11827258|FG000|Run-in Period|Lost to Follow-up|25
7502027|NCT02288325|11827259|FG001|Run-in Period|Lost to Follow-up|0
7502028|NCT02288325|11827260|FG002|Run-in Period|Lost to Follow-up|0
7502029|NCT02288325|11827258|FG000|Run-in Period|Protocol Violation|17
7502030|NCT02288325|11827259|FG001|Run-in Period|Protocol Violation|0
7502031|NCT02288325|11827260|FG002|Run-in Period|Protocol Violation|0
7502032|NCT02288325|11827258|FG000|Run-in Period|Non-Compliance With Study Drug|3
7502033|NCT02288325|11827259|FG001|Run-in Period|Non-Compliance With Study Drug|0
7502034|NCT02288325|11827260|FG002|Run-in Period|Non-Compliance With Study Drug|0
7502035|NCT02288325|11827258|FG000|Run-in Period|Reason not Specified|8
7502036|NCT02288325|11827259|FG001|Run-in Period|Reason not Specified|0
7502037|NCT02288325|11827260|FG002|Run-in Period|Reason not Specified|0
7502038|NCT02288325|11827258|FG000|Stabilization Period|Adverse Event|13
7502039|NCT02288325|11827259|FG001|Stabilization Period|Adverse Event|0
7502040|NCT02288325|11827260|FG002|Stabilization Period|Adverse Event|0
7502041|NCT02288325|11827258|FG000|Stabilization Period|Lack of Efficacy|22
7502042|NCT02288325|11827259|FG001|Stabilization Period|Lack of Efficacy|0
7502043|NCT02288325|11827260|FG002|Stabilization Period|Lack of Efficacy|0
7502044|NCT02288325|11827258|FG000|Stabilization Period|Withdrawal of Consent|23
7502045|NCT02288325|11827259|FG001|Stabilization Period|Withdrawal of Consent|0
7502046|NCT02288325|11827260|FG002|Stabilization Period|Withdrawal of Consent|0
7502047|NCT02288325|11827258|FG000|Stabilization Period|Lost to Follow-up|12
7502048|NCT02288325|11827259|FG001|Stabilization Period|Lost to Follow-up|0
7502049|NCT02288325|11827260|FG002|Stabilization Period|Lost to Follow-up|0
7502050|NCT02288325|11827258|FG000|Stabilization Period|Protocol Violation|8
7502051|NCT02288325|11827259|FG001|Stabilization Period|Protocol Violation|0
7502052|NCT02288325|11827260|FG002|Stabilization Period|Protocol Violation|0
7502053|NCT02288325|11827258|FG000|Stabilization Period|Non-Compliance With Study Drug|5
7502054|NCT02288325|11827259|FG001|Stabilization Period|Non-Compliance With Study Drug|0
7502055|NCT02288325|11827260|FG002|Stabilization Period|Non-Compliance With Study Drug|0
7502056|NCT02288325|11827258|FG000|Stabilization Period|Reason not Specified|15
7502057|NCT02288325|11827259|FG001|Stabilization Period|Reason not Specified|0
7502058|NCT02288325|11827260|FG002|Stabilization Period|Reason not Specified|0
7502059|NCT02288325|11827258|FG000|Double-blind Treatment Period|Adverse Event|0
7502060|NCT02288325|11827259|FG001|Double-blind Treatment Period|Adverse Event|2
7502061|NCT02288325|11827260|FG002|Double-blind Treatment Period|Adverse Event|5
7502062|NCT02288325|11827258|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7502063|NCT02288325|11827259|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
7502064|NCT02288325|11827260|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
7502065|NCT02288325|11827258|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7502066|NCT02288325|11827259|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7502067|NCT02288325|11827260|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7502068|NCT02288325|11827258|FG000|Double-blind Treatment Period|Protocol Violation|0
7502069|NCT02288325|11827259|FG001|Double-blind Treatment Period|Protocol Violation|1
7502070|NCT02288325|11827260|FG002|Double-blind Treatment Period|Protocol Violation|2
7502071|NCT02288325|11827258|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
7502072|NCT02288325|11827259|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
7502073|NCT02288325|11827260|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
7502074|NCT02288325|11827258|FG000|Double-blind Treatment Period|Multiple Reasons|0
7502075|NCT02288325|11827259|FG001|Double-blind Treatment Period|Multiple Reasons|8
7502076|NCT02288325|11827260|FG002|Double-blind Treatment Period|Multiple Reasons|2
7502077|NCT02288559|11827289|FG000|Overall Study|Adverse Event|1
7502078|NCT02288559|11827290|FG001|Overall Study|Adverse Event|1
7502079|NCT02288559|11827291|FG002|Overall Study|Adverse Event|5
7502080|NCT02288559|11827292|FG003|Overall Study|Adverse Event|0
7502081|NCT02288559|11827289|FG000|Overall Study|Death|0
7502082|NCT02288559|11827290|FG001|Overall Study|Death|0
7502083|NCT02288559|11827291|FG002|Overall Study|Death|1
7502084|NCT02288559|11827292|FG003|Overall Study|Death|0
7502085|NCT02288559|11827289|FG000|Overall Study|Lost to Follow-up|0
7502086|NCT02288559|11827290|FG001|Overall Study|Lost to Follow-up|0
7502087|NCT02288559|11827291|FG002|Overall Study|Lost to Follow-up|0
7502088|NCT02288559|11827292|FG003|Overall Study|Lost to Follow-up|1
7502089|NCT02288559|11827289|FG000|Overall Study|Withdrawal by Subject|0
7502090|NCT02288559|11827290|FG001|Overall Study|Withdrawal by Subject|0
7502091|NCT02288559|11827291|FG002|Overall Study|Withdrawal by Subject|2
7502092|NCT02288559|11827292|FG003|Overall Study|Withdrawal by Subject|1
7502093|NCT02288559|11827289|FG000|Overall Study|Reason Not Specified|0
7502094|NCT02288559|11827290|FG001|Overall Study|Reason Not Specified|0
7502095|NCT02288559|11827291|FG002|Overall Study|Reason Not Specified|3
7502096|NCT02288559|11827292|FG003|Overall Study|Reason Not Specified|0
7535811|NCT02712983|11883590|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7502097|NCT02289079|11827310|FG000|Overall Study|Physician Decision|2
7502098|NCT02289079|11827311|FG001|Overall Study|Physician Decision|0
7502099|NCT02289079|11827310|FG000|Overall Study|Lost to Follow-up|0
7502100|NCT02289079|11827311|FG001|Overall Study|Lost to Follow-up|1
7502101|NCT02289352|11827342|FG000|Overall Study|Withdrawal by Subject|1
7502102|NCT02289352|11827343|FG001|Overall Study|Withdrawal by Subject|1
7502103|NCT02289352|11827344|FG002|Overall Study|Withdrawal by Subject|0
7502104|NCT02289417|11827356|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
7502105|NCT02289417|11827357|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502106|NCT02289417|11827358|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
7502107|NCT02289417|11827359|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502108|NCT02289417|11827360|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502109|NCT02289417|11827361|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502110|NCT02289417|11827362|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502111|NCT02289417|11827363|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502112|NCT02289417|11827364|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
7502113|NCT02289417|11827356|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
7502114|NCT02289417|11827357|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
7502115|NCT02289417|11827358|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
7502116|NCT02289417|11827359|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502117|NCT02289417|11827360|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502118|NCT02289417|11827361|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502119|NCT02289417|11827362|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502120|NCT02289417|11827363|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502121|NCT02289417|11827364|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
7502122|NCT02289417|11827356|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502123|NCT02289417|11827357|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
7502124|NCT02289417|11827358|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502125|NCT02289417|11827359|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502126|NCT02289417|11827360|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502127|NCT02289417|11827361|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502128|NCT02289417|11827362|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502129|NCT02289417|11827363|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502130|NCT02289417|11827364|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
7502131|NCT02289417|11827356|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
7502132|NCT02289417|11827357|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502133|NCT02289417|11827358|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502134|NCT02289417|11827359|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502135|NCT02289417|11827360|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502136|NCT02289417|11827361|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502137|NCT02289417|11827362|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502138|NCT02289417|11827363|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502139|NCT02289417|11827364|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
7502140|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
7502141|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
7502142|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
7502143|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
7502144|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
7502145|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
7502146|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
7502147|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
7502148|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
7502149|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502150|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502151|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
7502152|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502153|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502154|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502155|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502156|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502157|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
7502158|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7502159|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
7502160|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
7502161|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
7502162|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
7502163|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
7502164|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7502165|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7502166|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
7502167|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7502168|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7553108|NCT03006458|11913860|FG000|First Intervention|Unsatisfied Vision|0
7502169|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7502170|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7502171|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7502172|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
7502173|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7502174|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7502175|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
7502176|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502177|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502178|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502179|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502180|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502181|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502182|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
7502183|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502184|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
7502185|NCT02289417|11827356|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502186|NCT02289417|11827357|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502187|NCT02289417|11827358|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502188|NCT02289417|11827359|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7502189|NCT02289417|11827360|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502190|NCT02289417|11827361|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502191|NCT02289417|11827362|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
7502192|NCT02289417|11827363|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502193|NCT02289417|11827364|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
7502194|NCT02289417|11827356|FG000|Extension Phase Weeks 52-104|Adverse Event|0
7502195|NCT02289417|11827357|FG001|Extension Phase Weeks 52-104|Adverse Event|0
7502196|NCT02289417|11827358|FG002|Extension Phase Weeks 52-104|Adverse Event|0
7502197|NCT02289417|11827359|FG003|Extension Phase Weeks 52-104|Adverse Event|0
7502198|NCT02289417|11827360|FG004|Extension Phase Weeks 52-104|Adverse Event|0
7502199|NCT02289417|11827361|FG005|Extension Phase Weeks 52-104|Adverse Event|0
7502200|NCT02289417|11827362|FG006|Extension Phase Weeks 52-104|Adverse Event|0
7502201|NCT02289417|11827363|FG007|Extension Phase Weeks 52-104|Adverse Event|2
7502202|NCT02289417|11827364|FG008|Extension Phase Weeks 52-104|Adverse Event|3
7502203|NCT02289417|11827356|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502204|NCT02289417|11827357|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502205|NCT02289417|11827358|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502206|NCT02289417|11827359|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502207|NCT02289417|11827360|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502208|NCT02289417|11827361|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502209|NCT02289417|11827362|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
7502210|NCT02289417|11827363|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
7502211|NCT02289417|11827364|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
7502212|NCT02289417|11827356|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502213|NCT02289417|11827357|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502214|NCT02289417|11827358|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502215|NCT02289417|11827359|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502216|NCT02289417|11827360|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502217|NCT02289417|11827361|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502218|NCT02289417|11827362|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
7502219|NCT02289417|11827363|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
7502220|NCT02289417|11827364|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
7502221|NCT02289417|11827356|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
7502222|NCT02289417|11827357|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
7502223|NCT02289417|11827358|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
7502224|NCT02289417|11827359|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
7502225|NCT02289417|11827360|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
7502226|NCT02289417|11827361|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
7502227|NCT02289417|11827362|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
7502228|NCT02289417|11827363|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
7502229|NCT02289417|11827364|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
7502230|NCT02289456|11827380|FG000|Induction Period|Death|2
7502231|NCT02289456|11827380|FG000|Induction Period|Adverse Event|11
7502232|NCT02289456|11827380|FG000|Induction Period|Progressive Disease (PD)|4
7502233|NCT02289456|11827380|FG000|Induction Period|Symptomatic Deterioration|4
7502234|NCT02289456|11827380|FG000|Induction Period|Withdrawal by Subject|2
7502235|NCT02289456|11827380|FG000|Induction Period|Miscellaneous|1
7502236|NCT02289456|11827380|FG000|Monotherapy Period|Death|1
7502237|NCT02289456|11827380|FG000|Monotherapy Period|Adverse Event|1
7502238|NCT02289456|11827380|FG000|Monotherapy Period|Progressive Disease (PD)|8
7502239|NCT02289456|11827380|FG000|Monotherapy Period|Symptomatic Deterioration|1
7502240|NCT02289456|11827380|FG000|Monotherapy Period|Withdrawal by Subject|2
7502241|NCT02289456|11827380|FG000|Monotherapy Period|Study Terminated by Sponsor|2
7502242|NCT02289456|11827380|FG000|Monotherapy Period|Miscellaneous|1
7502243|NCT02289469|11827391|FG000|Overall Study|Unable to match a control|6
7502244|NCT02289469|11827392|FG001|Overall Study|Unable to match a control|0
7502245|NCT02289690|11827408|FG000|Overall Study|Adverse Event Related to Progression|0
7502246|NCT02289690|11827409|FG001|Overall Study|Adverse Event Related to Progression|1
7502247|NCT02289690|11827410|FG002|Overall Study|Adverse Event Related to Progression|1
7502248|NCT02289690|11827411|FG003|Overall Study|Adverse Event Related to Progression|0
7502249|NCT02289690|11827412|FG004|Overall Study|Adverse Event Related to Progression|1
7502250|NCT02289690|11827413|FG005|Overall Study|Adverse Event Related to Progression|0
7502251|NCT02289690|11827414|FG006|Overall Study|Adverse Event Related to Progression|1
7502252|NCT02289690|11827415|FG007|Overall Study|Adverse Event Related to Progression|0
7502253|NCT02289690|11827416|FG008|Overall Study|Adverse Event Related to Progression|0
7502254|NCT02289690|11827417|FG009|Overall Study|Adverse Event Related to Progression|0
7502255|NCT02289690|11827408|FG000|Overall Study|Withdrawal by Subject|1
7502256|NCT02289690|11827409|FG001|Overall Study|Withdrawal by Subject|0
7502257|NCT02289690|11827410|FG002|Overall Study|Withdrawal by Subject|0
7502258|NCT02289690|11827411|FG003|Overall Study|Withdrawal by Subject|0
7502259|NCT02289690|11827412|FG004|Overall Study|Withdrawal by Subject|1
7502260|NCT02289690|11827413|FG005|Overall Study|Withdrawal by Subject|1
7502261|NCT02289690|11827414|FG006|Overall Study|Withdrawal by Subject|0
7502262|NCT02289690|11827415|FG007|Overall Study|Withdrawal by Subject|0
7502263|NCT02289690|11827416|FG008|Overall Study|Withdrawal by Subject|4
7502264|NCT02289690|11827417|FG009|Overall Study|Withdrawal by Subject|2
7502265|NCT02289690|11827408|FG000|Overall Study|Progressive Disease, Per Protocol|3
7502266|NCT02289690|11827409|FG001|Overall Study|Progressive Disease, Per Protocol|2
7502267|NCT02289690|11827410|FG002|Overall Study|Progressive Disease, Per Protocol|3
7502268|NCT02289690|11827411|FG003|Overall Study|Progressive Disease, Per Protocol|2
7502269|NCT02289690|11827412|FG004|Overall Study|Progressive Disease, Per Protocol|5
7502270|NCT02289690|11827413|FG005|Overall Study|Progressive Disease, Per Protocol|13
7502271|NCT02289690|11827414|FG006|Overall Study|Progressive Disease, Per Protocol|2
7502272|NCT02289690|11827415|FG007|Overall Study|Progressive Disease, Per Protocol|0
7502273|NCT02289690|11827416|FG008|Overall Study|Progressive Disease, Per Protocol|0
7502274|NCT02289690|11827417|FG009|Overall Study|Progressive Disease, Per Protocol|0
7502275|NCT02289690|11827408|FG000|Overall Study|Lost to Follow-up|0
7502276|NCT02289690|11827409|FG001|Overall Study|Lost to Follow-up|0
7502277|NCT02289690|11827410|FG002|Overall Study|Lost to Follow-up|0
7502278|NCT02289690|11827411|FG003|Overall Study|Lost to Follow-up|0
7502279|NCT02289690|11827412|FG004|Overall Study|Lost to Follow-up|0
7502280|NCT02289690|11827413|FG005|Overall Study|Lost to Follow-up|0
7502281|NCT02289690|11827414|FG006|Overall Study|Lost to Follow-up|0
7502282|NCT02289690|11827415|FG007|Overall Study|Lost to Follow-up|1
7502283|NCT02289690|11827416|FG008|Overall Study|Lost to Follow-up|0
7502284|NCT02289690|11827417|FG009|Overall Study|Lost to Follow-up|2
7502285|NCT02289690|11827408|FG000|Overall Study|Death|0
7502286|NCT02289690|11827409|FG001|Overall Study|Death|0
7502287|NCT02289690|11827410|FG002|Overall Study|Death|0
7502288|NCT02289690|11827411|FG003|Overall Study|Death|0
7502289|NCT02289690|11827412|FG004|Overall Study|Death|0
7502290|NCT02289690|11827413|FG005|Overall Study|Death|0
7502291|NCT02289690|11827414|FG006|Overall Study|Death|0
7502292|NCT02289690|11827415|FG007|Overall Study|Death|49
7502293|NCT02289690|11827416|FG008|Overall Study|Death|45
7502294|NCT02289690|11827417|FG009|Overall Study|Death|41
7502295|NCT02289690|11827408|FG000|Overall Study|Sponsor Discontinued Study|0
7502296|NCT02289690|11827409|FG001|Overall Study|Sponsor Discontinued Study|0
7502297|NCT02289690|11827410|FG002|Overall Study|Sponsor Discontinued Study|0
7502298|NCT02289690|11827411|FG003|Overall Study|Sponsor Discontinued Study|0
7502299|NCT02289690|11827412|FG004|Overall Study|Sponsor Discontinued Study|0
7502300|NCT02289690|11827413|FG005|Overall Study|Sponsor Discontinued Study|0
7502301|NCT02289690|11827414|FG006|Overall Study|Sponsor Discontinued Study|0
7502302|NCT02289690|11827415|FG007|Overall Study|Sponsor Discontinued Study|9
7502303|NCT02289690|11827416|FG008|Overall Study|Sponsor Discontinued Study|7
7502304|NCT02289690|11827417|FG009|Overall Study|Sponsor Discontinued Study|15
7502305|NCT02289690|11827408|FG000|Overall Study|Other|0
7502306|NCT02289690|11827409|FG001|Overall Study|Other|0
7502307|NCT02289690|11827410|FG002|Overall Study|Other|0
7502308|NCT02289690|11827411|FG003|Overall Study|Other|1
7502309|NCT02289690|11827412|FG004|Overall Study|Other|1
7502310|NCT02289690|11827413|FG005|Overall Study|Other|0
7502311|NCT02289690|11827414|FG006|Overall Study|Other|1
7502312|NCT02289690|11827415|FG007|Overall Study|Other|2
7502313|NCT02289690|11827416|FG008|Overall Study|Other|3
7502314|NCT02289690|11827417|FG009|Overall Study|Other|1
7502315|NCT02289729|11827453|FG000|Overall Study|Lack of Efficacy|3
7502316|NCT02289729|11827453|FG000|Overall Study|Very Narrow Therapeutic Margin|1
7502317|NCT02289729|11827453|FG000|Overall Study|Withdrawal by Subject|1
7502318|NCT02289729|11827453|FG000|Overall Study|Death|1
7502319|NCT02289742|11827459|FG000|First Wear Period|Adverse event prior to treatment|0
7502320|NCT02289742|11827460|FG001|First Wear Period|Adverse event prior to treatment|1
7502321|NCT02289742|11827461|FG002|First Wear Period|Adverse event prior to treatment|0
7502322|NCT02289742|11827462|FG003|First Wear Period|Adverse event prior to treatment|0
7502323|NCT02289742|11827459|FG000|First Wear Period|Adverse Event|0
7502324|NCT02289742|11827460|FG001|First Wear Period|Adverse Event|0
7502325|NCT02289742|11827461|FG002|First Wear Period|Adverse Event|1
7502326|NCT02289742|11827462|FG003|First Wear Period|Adverse Event|0
7502327|NCT02289742|11827459|FG000|First Wear Period|Other prior to treatment|0
7502328|NCT02289742|11827460|FG001|First Wear Period|Other prior to treatment|0
7502329|NCT02289742|11827461|FG002|First Wear Period|Other prior to treatment|0
7502330|NCT02289742|11827462|FG003|First Wear Period|Other prior to treatment|1
7502331|NCT02289742|11827459|FG000|Third Wear Period|Adverse Event|0
7502332|NCT02289742|11827460|FG001|Third Wear Period|Adverse Event|1
7502333|NCT02289742|11827461|FG002|Third Wear Period|Adverse Event|0
7502334|NCT02289742|11827462|FG003|Third Wear Period|Adverse Event|0
7502335|NCT02289742|11827459|FG000|Third Wear Period|Reason not given|0
7502336|NCT02289742|11827460|FG001|Third Wear Period|Reason not given|0
7502337|NCT02289742|11827461|FG002|Third Wear Period|Reason not given|0
7502338|NCT02289742|11827462|FG003|Third Wear Period|Reason not given|1
7502339|NCT02289820|11827487|FG000|Overall Study|Withdrawal by Subject|2
7502340|NCT02289820|11827488|FG001|Overall Study|Withdrawal by Subject|1
7502341|NCT02289820|11827489|FG002|Overall Study|Withdrawal by Subject|2
7502342|NCT02289820|11827490|FG003|Overall Study|Withdrawal by Subject|1
7502343|NCT02289820|11827491|FG004|Overall Study|Withdrawal by Subject|0
7502344|NCT02289820|11827492|FG005|Overall Study|Withdrawal by Subject|0
7502345|NCT02289820|11827493|FG006|Overall Study|Withdrawal by Subject|1
7502346|NCT02289820|11827487|FG000|Overall Study|Death|0
7502347|NCT02289820|11827488|FG001|Overall Study|Death|0
7502348|NCT02289820|11827489|FG002|Overall Study|Death|1
7502349|NCT02289820|11827490|FG003|Overall Study|Death|0
7502350|NCT02289820|11827491|FG004|Overall Study|Death|0
7502351|NCT02289820|11827492|FG005|Overall Study|Death|0
7502352|NCT02289820|11827493|FG006|Overall Study|Death|0
7502353|NCT02289820|11827487|FG000|Overall Study|Lost to Follow-up|0
7502354|NCT02289820|11827488|FG001|Overall Study|Lost to Follow-up|0
7502355|NCT02289820|11827489|FG002|Overall Study|Lost to Follow-up|3
7502356|NCT02289820|11827490|FG003|Overall Study|Lost to Follow-up|1
7502357|NCT02289820|11827491|FG004|Overall Study|Lost to Follow-up|0
7502358|NCT02289820|11827492|FG005|Overall Study|Lost to Follow-up|1
7502359|NCT02289820|11827493|FG006|Overall Study|Lost to Follow-up|1
7502360|NCT02289820|11827487|FG000|Overall Study|withdrawal of consent|0
7502361|NCT02289820|11827488|FG001|Overall Study|withdrawal of consent|1
7502362|NCT02289820|11827489|FG002|Overall Study|withdrawal of consent|0
7502363|NCT02289820|11827490|FG003|Overall Study|withdrawal of consent|0
7502364|NCT02289820|11827491|FG004|Overall Study|withdrawal of consent|0
7502365|NCT02289820|11827492|FG005|Overall Study|withdrawal of consent|0
7502366|NCT02289820|11827493|FG006|Overall Study|withdrawal of consent|0
7502367|NCT02289833|11827515|FG000|Overall Study|Study discontinuation|0
7502368|NCT02289833|11827516|FG001|Overall Study|Study discontinuation|1
7502369|NCT02289833|11827515|FG000|Overall Study|Lost to Follow-up|4
7502370|NCT02289833|11827516|FG001|Overall Study|Lost to Follow-up|0
7502371|NCT02289833|11827515|FG000|Overall Study|Death|23
7502372|NCT02289833|11827516|FG001|Overall Study|Death|16
7502373|NCT02289898|11827527|FG000|Overall Study|Death|5
7502374|NCT02289898|11827528|FG001|Overall Study|Death|4
7502375|NCT02289898|11827529|FG002|Overall Study|Death|3
7502376|NCT02289898|11827527|FG000|Overall Study|Physician Decision|2
7502377|NCT02289898|11827528|FG001|Overall Study|Physician Decision|5
7502378|NCT02289898|11827529|FG002|Overall Study|Physician Decision|2
7502379|NCT02289898|11827527|FG000|Overall Study|Withdrawal by Subject|0
7502380|NCT02289898|11827528|FG001|Overall Study|Withdrawal by Subject|4
7502381|NCT02289898|11827529|FG002|Overall Study|Withdrawal by Subject|1
7502382|NCT02289898|11827527|FG000|Overall Study|Adverse Event|3
7502383|NCT02289898|11827528|FG001|Overall Study|Adverse Event|5
7502384|NCT02289898|11827529|FG002|Overall Study|Adverse Event|5
7502385|NCT02289898|11827527|FG000|Overall Study|Disease progression|34
7502386|NCT02289898|11827528|FG001|Overall Study|Disease progression|28
7502387|NCT02289898|11827529|FG002|Overall Study|Disease progression|34
7502388|NCT02289898|11827527|FG000|Overall Study|Use of another anticancer therapy|0
7502389|NCT02289898|11827528|FG001|Overall Study|Use of another anticancer therapy|0
7502390|NCT02289898|11827529|FG002|Overall Study|Use of another anticancer therapy|1
7502391|NCT02289898|11827527|FG000|Overall Study|Other|8
7502392|NCT02289898|11827528|FG001|Overall Study|Other|7
7502393|NCT02289898|11827529|FG002|Overall Study|Other|10
7502394|NCT02289950|11827538|FG000|Overall Study|Progressive disease by RECIST 1.1|99
7502395|NCT02289950|11827539|FG001|Overall Study|Progressive disease by RECIST 1.1|52
7502396|NCT02289950|11827538|FG000|Overall Study|Progressive disease by Clinical Assessment|4
7502561|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Death|100
7502397|NCT02289950|11827539|FG001|Overall Study|Progressive disease by Clinical Assessment|4
7502398|NCT02289950|11827538|FG000|Overall Study|Lost to Follow-up|1
7502399|NCT02289950|11827539|FG001|Overall Study|Lost to Follow-up|0
7502400|NCT02289950|11827538|FG000|Overall Study|Physician Decision|9
7502401|NCT02289950|11827539|FG001|Overall Study|Physician Decision|3
7502402|NCT02289950|11827538|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
7502403|NCT02289950|11827539|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
7502404|NCT02289950|11827538|FG000|Overall Study|Withdrawal by Subject|1
7502405|NCT02289950|11827539|FG001|Overall Study|Withdrawal by Subject|3
7502406|NCT02289950|11827538|FG000|Overall Study|Test article held for greater than 28 days|0
7502407|NCT02289950|11827539|FG001|Overall Study|Test article held for greater than 28 days|1
7502408|NCT02289950|11827538|FG000|Overall Study|Adverse Event|11
7502409|NCT02289950|11827539|FG001|Overall Study|Adverse Event|3
7502410|NCT02289950|11827538|FG000|Overall Study|Death|1
7502411|NCT02289950|11827539|FG001|Overall Study|Death|1
7502412|NCT02289950|11827538|FG000|Overall Study|Other|5
7502413|NCT02289950|11827539|FG001|Overall Study|Other|2
7502414|NCT02289950|11827538|FG000|Overall Study|Not Treated|2
7502415|NCT02289950|11827539|FG001|Overall Study|Not Treated|1
7502416|NCT02289963|11827547|FG000|Overall Study|Adverse Event|1
7502417|NCT02289963|11827548|FG001|Overall Study|Adverse Event|2
7502418|NCT02289963|11827547|FG000|Overall Study|Poor compliance to protocol|1
7502419|NCT02289963|11827548|FG001|Overall Study|Poor compliance to protocol|0
7502420|NCT02289963|11827547|FG000|Overall Study|Withdrawal by Subject|1
7502421|NCT02289963|11827548|FG001|Overall Study|Withdrawal by Subject|0
7502422|NCT02289963|11827547|FG000|Overall Study|Last injection missed|2
7502423|NCT02289963|11827548|FG001|Overall Study|Last injection missed|2
7502424|NCT02289963|11827547|FG000|Overall Study|End treatment visit outside visit window|0
7502425|NCT02289963|11827548|FG001|Overall Study|End treatment visit outside visit window|4
7502426|NCT02289963|11827547|FG000|Overall Study|Other than specified above|0
7502427|NCT02289963|11827548|FG001|Overall Study|Other than specified above|2
7502428|NCT02290028|11827563|FG000|Overall Study|Death|217
7502429|NCT02290028|11827563|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
7502430|NCT02290028|11827563|FG000|Overall Study|No longer under care of study physician|76
7502431|NCT02290028|11827563|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
7502432|NCT02290028|11827563|FG000|Overall Study|Withdrawal by Subject|52
7502433|NCT02290028|11827563|FG000|Overall Study|Study site closure|44
7502434|NCT02290028|11827563|FG000|Overall Study|Lost to Follow-up|34
7502435|NCT02290028|11827563|FG000|Overall Study|Miscellaneous|10
7502436|NCT02290028|11827563|FG000|Overall Study|Transition to EP PASSION|1295
7502437|NCT02290028|11827563|FG000|Overall Study|Planned study completion at 12 months|257
7502438|NCT02290223|11827596|FG000|6 Months|Lost to Follow-up|9
7502439|NCT02290223|11827597|FG001|6 Months|Lost to Follow-up|6
7502440|NCT02290223|11827596|FG000|6 Months|Withdrawal by Subject|5
7502441|NCT02290223|11827597|FG001|6 Months|Withdrawal by Subject|0
7502442|NCT02290223|11827596|FG000|6 Months|deceased (not related to study)|2
7502443|NCT02290223|11827597|FG001|6 Months|deceased (not related to study)|0
7502444|NCT02290223|11827596|FG000|12 Months|Lost to Follow-up|16
7502445|NCT02290223|11827597|FG001|12 Months|Lost to Follow-up|10
7502446|NCT02290223|11827596|FG000|12 Months|Refusal|0
7502447|NCT02290223|11827597|FG001|12 Months|Refusal|1
7502448|NCT02290340|11827607|FG000|Overall Study|Lost to Follow-up|0
7502449|NCT02290340|11827608|FG001|Overall Study|Lost to Follow-up|0
7502450|NCT02290340|11827609|FG002|Overall Study|Lost to Follow-up|0
7502451|NCT02290340|11827610|FG003|Overall Study|Lost to Follow-up|1
7502452|NCT02290340|11827607|FG000|Overall Study|Withdrawal by Subject|1
7502453|NCT02290340|11827608|FG001|Overall Study|Withdrawal by Subject|0
7502454|NCT02290340|11827609|FG002|Overall Study|Withdrawal by Subject|0
7502455|NCT02290340|11827610|FG003|Overall Study|Withdrawal by Subject|0
7502456|NCT02290340|11827607|FG000|Overall Study|Other|1
7502457|NCT02290340|11827608|FG001|Overall Study|Other|0
7502458|NCT02290340|11827609|FG002|Overall Study|Other|0
7502459|NCT02290340|11827610|FG003|Overall Study|Other|1
7502460|NCT02290405|11827625|FG000|Overall Study|Withdrawal by Subject|1
7502461|NCT02290405|11827626|FG001|Overall Study|Withdrawal by Subject|0
7502462|NCT02290691|11827666|FG000|Overall Study|Noncompliance|0
7502463|NCT02290691|11827667|FG001|Overall Study|Noncompliance|1
7502464|NCT02290691|11827666|FG000|Overall Study|Withdrawal by Subject|1
7502465|NCT02290691|11827667|FG001|Overall Study|Withdrawal by Subject|1
7502466|NCT02290691|11827666|FG000|Overall Study|Lost to Follow-up|7
7502467|NCT02290691|11827667|FG001|Overall Study|Lost to Follow-up|7
7502468|NCT02290821|11827675|FG000|Overall Study|Withdrawal by Subject|1
7502469|NCT02290821|11827676|FG001|Overall Study|Withdrawal by Subject|1
7502470|NCT02290821|11827675|FG000|Overall Study|Unable or unwilling to cooperate with|2
7502471|NCT02290821|11827676|FG001|Overall Study|Unable or unwilling to cooperate with|0
7502472|NCT02290821|11827675|FG000|Overall Study|Lost to Follow-up|3
7502473|NCT02290821|11827676|FG001|Overall Study|Lost to Follow-up|2
7502474|NCT02290873|11827685|FG000|Overall Study|Withdrawal by Subject|0
7502475|NCT02290873|11827686|FG001|Overall Study|Withdrawal by Subject|1
7502476|NCT02290873|11827687|FG002|Overall Study|Withdrawal by Subject|1
7502477|NCT02290873|11827685|FG000|Overall Study|Nellcor device error|1
7502478|NCT02290873|11827686|FG001|Overall Study|Nellcor device error|0
7502479|NCT02290873|11827687|FG002|Overall Study|Nellcor device error|0
7502480|NCT02290873|11827685|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
7502481|NCT02290873|11827686|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
7502482|NCT02290873|11827687|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
7502483|NCT02290873|11827685|FG000|Overall Study|Protocol Violation|0
7502484|NCT02290873|11827686|FG001|Overall Study|Protocol Violation|0
7502485|NCT02290873|11827687|FG002|Overall Study|Protocol Violation|1
7502486|NCT02290925|11827698|FG000|First Period of Three Months|Lost to Follow-up|2
7502487|NCT02290925|11827699|FG001|First Period of Three Months|Lost to Follow-up|1
7502488|NCT02290925|11827698|FG000|First Period of Three Months|Death|1
7502489|NCT02290925|11827699|FG001|First Period of Three Months|Death|0
7502490|NCT02290925|11827698|FG000|First Period of Three Months|Insulin Started|1
7502491|NCT02290925|11827699|FG001|First Period of Three Months|Insulin Started|1
7502492|NCT02290925|11827698|FG000|Second Period of 3 Months|Lost to Follow-up|1
7502493|NCT02290925|11827699|FG001|Second Period of 3 Months|Lost to Follow-up|3
7502494|NCT02290925|11827698|FG000|Second Period of 3 Months|insulin started|0
7502495|NCT02290925|11827699|FG001|Second Period of 3 Months|insulin started|1
7502496|NCT02291029|11827723|FG000|Overall Study|Withdrawal by Subject|0
7502497|NCT02291029|11827724|FG001|Overall Study|Withdrawal by Subject|0
7502498|NCT02291029|11827725|FG002|Overall Study|Withdrawal by Subject|1
7502499|NCT02291029|11827726|FG003|Overall Study|Withdrawal by Subject|0
7502500|NCT02291029|11827727|FG004|Overall Study|Withdrawal by Subject|0
7502501|NCT02291029|11827728|FG005|Overall Study|Withdrawal by Subject|0
7502502|NCT02291029|11827723|FG000|Overall Study|Adverse Event|0
7502503|NCT02291029|11827724|FG001|Overall Study|Adverse Event|1
7502504|NCT02291029|11827725|FG002|Overall Study|Adverse Event|0
7502505|NCT02291029|11827726|FG003|Overall Study|Adverse Event|0
7502506|NCT02291029|11827727|FG004|Overall Study|Adverse Event|0
7502507|NCT02291029|11827728|FG005|Overall Study|Adverse Event|0
7502508|NCT02291237|11827748|FG000|Overall Study|Study Terminated by Sponsor|72
7502509|NCT02291237|11827749|FG001|Overall Study|Study Terminated by Sponsor|67
7502510|NCT02291237|11827748|FG000|Overall Study|Adverse Event|1
7502511|NCT02291237|11827749|FG001|Overall Study|Adverse Event|3
7502512|NCT02291237|11827748|FG000|Overall Study|Investigator's Discretion|0
7502513|NCT02291237|11827749|FG001|Overall Study|Investigator's Discretion|3
7502514|NCT02291237|11827748|FG000|Overall Study|Withdrew Consent|11
7502515|NCT02291237|11827749|FG001|Overall Study|Withdrew Consent|11
7502516|NCT02291237|11827748|FG000|Overall Study|Lost to Follow-up|0
7502517|NCT02291237|11827749|FG001|Overall Study|Lost to Follow-up|2
7502518|NCT02291237|11827748|FG000|Overall Study|Subject Required Prohibited Medication|2
7502519|NCT02291237|11827749|FG001|Overall Study|Subject Required Prohibited Medication|0
7502520|NCT02291289|11827759|FG000|Induction Treatment|Not Dosed|2
7502521|NCT02291289|11827760|FG001|Induction Treatment|Not Dosed|0
7502522|NCT02291289|11827761|FG002|Induction Treatment|Not Dosed|0
7502523|NCT02291289|11827762|FG003|Induction Treatment|Not Dosed|9
7502524|NCT02291289|11827763|FG004|Induction Treatment|Not Dosed|0
7502525|NCT02291289|11827764|FG005|Induction Treatment|Not Dosed|0
7502526|NCT02291289|11827765|FG006|Induction Treatment|Not Dosed|0
7502527|NCT02291289|11827766|FG007|Induction Treatment|Not Dosed|0
7502528|NCT02291289|11827767|FG008|Induction Treatment|Not Dosed|0
7502529|NCT02291289|11827768|FG009|Induction Treatment|Not Dosed|1
7502530|NCT02291289|11827769|FG010|Induction Treatment|Not Dosed|0
7502531|NCT02291289|11827770|FG011|Induction Treatment|Not Dosed|0
7502532|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7502533|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
7502534|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
7502535|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
7502536|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
7502537|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
7502538|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
7502539|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
7502540|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
7502541|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
7502542|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
7502543|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
7502544|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Protocol Violation|0
7502545|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Protocol Violation|1
7502546|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Protocol Violation|0
7502547|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Protocol Violation|0
7502548|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Protocol Violation|2
7502549|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Protocol Violation|1
7502550|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Protocol Violation|0
7502551|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Protocol Violation|0
7502552|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Protocol Violation|0
7502553|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Protocol Violation|0
7502554|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Protocol Violation|0
7502555|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Protocol Violation|0
7502556|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Death|0
7502557|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Death|23
7502558|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Death|13
7502559|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Death|0
7502560|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Death|185
7502562|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Death|0
7502563|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Death|1
7502564|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Death|1
7502565|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Death|0
7502566|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Death|26
7502567|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Death|11
7502568|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Adverse Event|0
7502569|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Adverse Event|0
7502570|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Adverse Event|0
7502571|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Adverse Event|0
7502572|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Adverse Event|1
7502573|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Adverse Event|0
7502574|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Adverse Event|0
7502575|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Adverse Event|0
7502576|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Adverse Event|0
7502577|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Adverse Event|0
7502578|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Adverse Event|0
7502579|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Adverse Event|0
7502580|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
7502581|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
7502582|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
7502583|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
7502584|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
7502585|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
7502586|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
7502587|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
7502588|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
7502589|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
7502590|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
7502591|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
7502592|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Other|0
7502593|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Other|0
7502594|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Other|1
7502595|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Other|0
7502596|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Other|29
7502597|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Other|8
7502598|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Other|0
7502599|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Other|0
7502600|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Other|1
7502601|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Other|0
7502602|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Other|0
7502603|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Other|0
7502604|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Physician Decision|0
7502605|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Physician Decision|0
7502606|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Physician Decision|0
7502607|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Physician Decision|0
7502608|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Physician Decision|2
7502609|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Physician Decision|0
7502610|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Physician Decision|0
7502611|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Physician Decision|0
7502612|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Physician Decision|0
7502613|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Physician Decision|0
7502614|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Physician Decision|0
7502615|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Physician Decision|1
7502616|NCT02291289|11827759|FG000|Maintenance Treatment Phase|Multiple Reasons|0
7502617|NCT02291289|11827760|FG001|Maintenance Treatment Phase|Multiple Reasons|0
7502618|NCT02291289|11827761|FG002|Maintenance Treatment Phase|Multiple Reasons|0
7502619|NCT02291289|11827762|FG003|Maintenance Treatment Phase|Multiple Reasons|0
7502620|NCT02291289|11827763|FG004|Maintenance Treatment Phase|Multiple Reasons|4
7502621|NCT02291289|11827764|FG005|Maintenance Treatment Phase|Multiple Reasons|1
7502622|NCT02291289|11827765|FG006|Maintenance Treatment Phase|Multiple Reasons|0
7502623|NCT02291289|11827766|FG007|Maintenance Treatment Phase|Multiple Reasons|0
7502624|NCT02291289|11827767|FG008|Maintenance Treatment Phase|Multiple Reasons|0
7502625|NCT02291289|11827768|FG009|Maintenance Treatment Phase|Multiple Reasons|0
7502626|NCT02291289|11827769|FG010|Maintenance Treatment Phase|Multiple Reasons|0
7502627|NCT02291289|11827770|FG011|Maintenance Treatment Phase|Multiple Reasons|0
7502628|NCT02291289|11827759|FG000|Maintenance Treatment Phase|No Treatment Received|0
7502629|NCT02291289|11827760|FG001|Maintenance Treatment Phase|No Treatment Received|0
7502630|NCT02291289|11827761|FG002|Maintenance Treatment Phase|No Treatment Received|2
7502631|NCT02291289|11827762|FG003|Maintenance Treatment Phase|No Treatment Received|0
7502632|NCT02291289|11827763|FG004|Maintenance Treatment Phase|No Treatment Received|4
7502633|NCT02291289|11827764|FG005|Maintenance Treatment Phase|No Treatment Received|5
7502634|NCT02291289|11827765|FG006|Maintenance Treatment Phase|No Treatment Received|0
7502635|NCT02291289|11827766|FG007|Maintenance Treatment Phase|No Treatment Received|0
7502636|NCT02291289|11827767|FG008|Maintenance Treatment Phase|No Treatment Received|0
7502637|NCT02291289|11827768|FG009|Maintenance Treatment Phase|No Treatment Received|0
7502638|NCT02291289|11827769|FG010|Maintenance Treatment Phase|No Treatment Received|1
7502639|NCT02291289|11827770|FG011|Maintenance Treatment Phase|No Treatment Received|0
7502640|NCT02291419|11827814|FG000|Overall Study|Early study termination|1
7502641|NCT02291419|11827815|FG001|Overall Study|Early study termination|5
7502642|NCT02291432|11827821|FG000|Overall Study|Withdrawal by Subject|2
7502643|NCT02291510|11827829|FG000|Overall Study|Adverse Event|0
7502644|NCT02291510|11827830|FG001|Overall Study|Adverse Event|0
7502645|NCT02291510|11827831|FG002|Overall Study|Adverse Event|0
7502646|NCT02291510|11827832|FG003|Overall Study|Adverse Event|1
7502647|NCT02291549|11827844|FG000|Overall Study|Lost to Follow-up|1
7502648|NCT02291549|11827845|FG001|Overall Study|Lost to Follow-up|0
7502649|NCT02291549|11827844|FG000|Overall Study|Withdrawal by Subject|0
7502650|NCT02291549|11827845|FG001|Overall Study|Withdrawal by Subject|1
7502651|NCT02291601|11827853|FG000|Abdomen|Did not qualify|333
7502652|NCT02291601|11827854|FG001|Abdomen|Did not qualify|54
7502653|NCT02291601|11827855|FG002|Abdomen|Did not qualify|339
7502654|NCT02291601|11827853|FG000|Groin|Did not qualify|183
7502655|NCT02291601|11827854|FG001|Groin|Did not qualify|30
7502656|NCT02291601|11827855|FG002|Groin|Did not qualify|177
7502657|NCT02291614|11827877|FG000|Overall Study|Lost to Follow-up|0
7502658|NCT02291614|11827878|FG001|Overall Study|Lost to Follow-up|0
7502659|NCT02291614|11827879|FG002|Overall Study|Lost to Follow-up|0
7502660|NCT02291614|11827880|FG003|Overall Study|Lost to Follow-up|0
7502661|NCT02291614|11827881|FG004|Overall Study|Lost to Follow-up|0
7502662|NCT02291614|11827882|FG005|Overall Study|Lost to Follow-up|0
7502663|NCT02291614|11827883|FG006|Overall Study|Lost to Follow-up|0
7502664|NCT02291614|11827884|FG007|Overall Study|Lost to Follow-up|1
7502665|NCT02291614|11827885|FG008|Overall Study|Lost to Follow-up|0
7502666|NCT02291614|11827886|FG009|Overall Study|Lost to Follow-up|0
7502667|NCT02291614|11827887|FG010|Overall Study|Lost to Follow-up|0
7502668|NCT02291614|11827877|FG000|Overall Study|Withdrawal by Subject|0
7502669|NCT02291614|11827878|FG001|Overall Study|Withdrawal by Subject|1
7502670|NCT02291614|11827879|FG002|Overall Study|Withdrawal by Subject|0
7502671|NCT02291614|11827880|FG003|Overall Study|Withdrawal by Subject|0
7502672|NCT02291614|11827881|FG004|Overall Study|Withdrawal by Subject|0
7502673|NCT02291614|11827882|FG005|Overall Study|Withdrawal by Subject|0
7502674|NCT02291614|11827883|FG006|Overall Study|Withdrawal by Subject|0
7502675|NCT02291614|11827884|FG007|Overall Study|Withdrawal by Subject|0
7502676|NCT02291614|11827885|FG008|Overall Study|Withdrawal by Subject|0
7502677|NCT02291614|11827886|FG009|Overall Study|Withdrawal by Subject|2
7502678|NCT02291614|11827887|FG010|Overall Study|Withdrawal by Subject|2
7502679|NCT02291614|11827877|FG000|Overall Study|Decision by sponsor|0
7502680|NCT02291614|11827878|FG001|Overall Study|Decision by sponsor|0
7502681|NCT02291614|11827879|FG002|Overall Study|Decision by sponsor|0
7502682|NCT02291614|11827880|FG003|Overall Study|Decision by sponsor|1
7502683|NCT02291614|11827881|FG004|Overall Study|Decision by sponsor|0
7502684|NCT02291614|11827882|FG005|Overall Study|Decision by sponsor|0
7502685|NCT02291614|11827883|FG006|Overall Study|Decision by sponsor|0
7502686|NCT02291614|11827884|FG007|Overall Study|Decision by sponsor|0
7502687|NCT02291614|11827885|FG008|Overall Study|Decision by sponsor|0
7502688|NCT02291614|11827886|FG009|Overall Study|Decision by sponsor|0
7502689|NCT02291614|11827887|FG010|Overall Study|Decision by sponsor|0
7502690|NCT02291614|11827877|FG000|Overall Study|Death|0
7502691|NCT02291614|11827878|FG001|Overall Study|Death|0
7502692|NCT02291614|11827879|FG002|Overall Study|Death|1
7502693|NCT02291614|11827880|FG003|Overall Study|Death|0
7502694|NCT02291614|11827881|FG004|Overall Study|Death|1
7502695|NCT02291614|11827882|FG005|Overall Study|Death|1
7502696|NCT02291614|11827883|FG006|Overall Study|Death|1
7502697|NCT02291614|11827884|FG007|Overall Study|Death|0
7502698|NCT02291614|11827885|FG008|Overall Study|Death|0
7502699|NCT02291614|11827886|FG009|Overall Study|Death|0
7502700|NCT02291614|11827887|FG010|Overall Study|Death|0
7502701|NCT02291679|11827920|FG000|Overall Study|Adverse Event|2
7502702|NCT02291679|11827921|FG001|Overall Study|Adverse Event|12
7502703|NCT02291679|11827922|FG002|Overall Study|Adverse Event|19
7502704|NCT02291679|11827920|FG000|Overall Study|Protocol Violation|5
7502705|NCT02291679|11827921|FG001|Overall Study|Protocol Violation|1
7502706|NCT02291679|11827922|FG002|Overall Study|Protocol Violation|7
7502707|NCT02291679|11827920|FG000|Overall Study|Withdrew Consent|18
7502708|NCT02291679|11827921|FG001|Overall Study|Withdrew Consent|10
7502709|NCT02291679|11827922|FG002|Overall Study|Withdrew Consent|15
7502710|NCT02291679|11827920|FG000|Overall Study|Lost to Follow-up|12
7502711|NCT02291679|11827921|FG001|Overall Study|Lost to Follow-up|10
7502712|NCT02291679|11827922|FG002|Overall Study|Lost to Follow-up|9
7502713|NCT02291679|11827920|FG000|Overall Study|Insufficient Therapeutic Response|5
7502714|NCT02291679|11827921|FG001|Overall Study|Insufficient Therapeutic Response|5
7502715|NCT02291679|11827922|FG002|Overall Study|Insufficient Therapeutic Response|7
7502716|NCT02291679|11827920|FG000|Overall Study|Other|2
7502717|NCT02291679|11827921|FG001|Overall Study|Other|4
7502718|NCT02291679|11827922|FG002|Overall Study|Other|2
7502719|NCT02291861|11827946|FG000|Overall Study|Adverse Event|2
7502720|NCT02291861|11827947|FG001|Overall Study|Adverse Event|4
7502721|NCT02291861|11827948|FG002|Overall Study|Adverse Event|1
7502722|NCT02291861|11827949|FG003|Overall Study|Adverse Event|2
7502723|NCT02291861|11827946|FG000|Overall Study|Death|0
7502724|NCT02291861|11827947|FG001|Overall Study|Death|0
7502725|NCT02291861|11827948|FG002|Overall Study|Death|1
7502726|NCT02291861|11827949|FG003|Overall Study|Death|1
7502727|NCT02291861|11827946|FG000|Overall Study|Protocol Violation|1
7502728|NCT02291861|11827947|FG001|Overall Study|Protocol Violation|0
7502729|NCT02291861|11827948|FG002|Overall Study|Protocol Violation|0
7502730|NCT02291861|11827949|FG003|Overall Study|Protocol Violation|1
7502731|NCT02291861|11827946|FG000|Overall Study|Withdrawal by Subject|1
7502732|NCT02291861|11827947|FG001|Overall Study|Withdrawal by Subject|2
7502733|NCT02291861|11827948|FG002|Overall Study|Withdrawal by Subject|1
7502734|NCT02291861|11827949|FG003|Overall Study|Withdrawal by Subject|4
7502735|NCT02291861|11827946|FG000|Overall Study|Noncompliance|1
7502736|NCT02291861|11827947|FG001|Overall Study|Noncompliance|1
7502737|NCT02291861|11827948|FG002|Overall Study|Noncompliance|2
7502738|NCT02291861|11827949|FG003|Overall Study|Noncompliance|1
7502739|NCT02291861|11827946|FG000|Overall Study|Lost to Follow-up|2
7502740|NCT02291861|11827947|FG001|Overall Study|Lost to Follow-up|1
7502741|NCT02291861|11827948|FG002|Overall Study|Lost to Follow-up|4
7502742|NCT02291861|11827949|FG003|Overall Study|Lost to Follow-up|0
7502743|NCT02291861|11827946|FG000|Overall Study|Other|0
7502744|NCT02291861|11827947|FG001|Overall Study|Other|0
7502745|NCT02291861|11827948|FG002|Overall Study|Other|0
7502746|NCT02291861|11827949|FG003|Overall Study|Other|1
7502747|NCT02291913|11827959|FG000|Overall Study|Progressive Disease|32
7502748|NCT02291913|11827959|FG000|Overall Study|Adverse Event|11
7502749|NCT02291913|11827959|FG000|Overall Study|Death|2
7502750|NCT02291913|11827959|FG000|Overall Study|Physician Decision|1
7502751|NCT02291913|11827959|FG000|Overall Study|Withdrawal by Subject|1
7502752|NCT02291913|11827959|FG000|Overall Study|Protocol Violation|1
7502753|NCT02292212|11827976|FG000|ViE Phase|Withdrawal by Subject|1
7502754|NCT02292212|11827976|FG000|ViE Phase|Protocol Violation|2
7502755|NCT02292446|11828000|FG000|Overall Study|Adverse Event|12
7502756|NCT02292446|11828000|FG000|Overall Study|Death|1
7502757|NCT02292446|11828000|FG000|Overall Study|Disease progression|2
7502758|NCT02292446|11828000|FG000|Overall Study|Subject/guardian decision|2
7502759|NCT02292446|11828000|FG000|Overall Study|Withdrawal by Subject|3
7502760|NCT02292719|11828022|FG000|Overall Study|Withdrawal by Subject|0
7502761|NCT02292719|11828023|FG001|Overall Study|Withdrawal by Subject|0
7502762|NCT02292719|11828024|FG002|Overall Study|Withdrawal by Subject|0
7502763|NCT02292719|11828025|FG003|Overall Study|Withdrawal by Subject|1
7502764|NCT02292719|11828026|FG004|Overall Study|Withdrawal by Subject|1
7502765|NCT02292719|11828027|FG005|Overall Study|Withdrawal by Subject|0
7502766|NCT02292719|11828022|FG000|Overall Study|Subject enrolled in new study.|0
7502767|NCT02292719|11828023|FG001|Overall Study|Subject enrolled in new study.|0
7502768|NCT02292719|11828024|FG002|Overall Study|Subject enrolled in new study.|1
7502769|NCT02292719|11828025|FG003|Overall Study|Subject enrolled in new study.|0
7502770|NCT02292719|11828026|FG004|Overall Study|Subject enrolled in new study.|0
7502771|NCT02292719|11828027|FG005|Overall Study|Subject enrolled in new study.|0
7502772|NCT02292771|11828043|FG000|Overall Study|Withdrawal by Subject|2
7502773|NCT02292771|11828044|FG001|Overall Study|Withdrawal by Subject|1
7502774|NCT02292771|11828043|FG000|Overall Study|Lost to Follow-up|2
7502775|NCT02292771|11828044|FG001|Overall Study|Lost to Follow-up|1
7502776|NCT02292784|11828057|FG000|Overall Study|Lost to Follow-up|1
7502777|NCT02292784|11828058|FG001|Overall Study|Lost to Follow-up|17
7502778|NCT02292784|11828059|FG002|Overall Study|Lost to Follow-up|18
7502779|NCT02292784|11828057|FG000|Overall Study|Withdrawal by Subject|0
7502780|NCT02292784|11828058|FG001|Overall Study|Withdrawal by Subject|3
7502781|NCT02292784|11828059|FG002|Overall Study|Withdrawal by Subject|3
7502782|NCT02292849|11828070|FG000|Overall Study|Lost to Follow-up|0
7502783|NCT02292849|11828071|FG001|Overall Study|Lost to Follow-up|2
7502784|NCT02292849|11828072|FG002|Overall Study|Lost to Follow-up|2
7502785|NCT02292849|11828070|FG000|Overall Study|Physician Decision|4
7502786|NCT02292849|11828071|FG001|Overall Study|Physician Decision|0
7502787|NCT02292849|11828072|FG002|Overall Study|Physician Decision|0
7502788|NCT02292927|11828082|FG000|Overall Study|Protocol Violation|13
7502789|NCT02292927|11828083|FG001|Overall Study|Protocol Violation|7
7502790|NCT02293395|11828112|FG000|Overall Study|Lost to Follow-up|1
7502791|NCT02293395|11828113|FG001|Overall Study|Lost to Follow-up|0
7502792|NCT02293395|11828112|FG000|Overall Study|Withdrawal by Subject|8
7502793|NCT02293395|11828113|FG001|Overall Study|Withdrawal by Subject|7
7502794|NCT02293460|11828119|FG000|Overall Study|Protocol Violation|1
7502795|NCT02293460|11828119|FG000|Overall Study|Lack of Efficacy|2
7502796|NCT02293460|11828119|FG000|Overall Study|Adverse Event|2
7502797|NCT02293460|11828119|FG000|Overall Study|Withdrawal by Subject|1
7502798|NCT02293499|11828126|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7502799|NCT02293499|11828127|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
7502800|NCT02293499|11828128|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
7502801|NCT02293499|11828126|FG000|Intervention - Camp|Withdrawal by Subject|3
7502802|NCT02293499|11828127|FG001|Intervention - Camp|Withdrawal by Subject|6
7502803|NCT02293499|11828128|FG002|Intervention - Camp|Withdrawal by Subject|2
7502804|NCT02293499|11828126|FG000|Intervention - Camp|these are those not showing up at camp|24
7502805|NCT02293499|11828127|FG001|Intervention - Camp|these are those not showing up at camp|28
7502806|NCT02293499|11828128|FG002|Intervention - Camp|these are those not showing up at camp|4
7502807|NCT02293499|11828126|FG000|3 Month Follow Up|Withdrawal by Subject|1
7502808|NCT02293499|11828127|FG001|3 Month Follow Up|Withdrawal by Subject|0
7502809|NCT02293499|11828128|FG002|3 Month Follow Up|Withdrawal by Subject|4
7502810|NCT02293499|11828126|FG000|3 Month Follow Up|Lost to Follow-up|14
7502811|NCT02293499|11828127|FG001|3 Month Follow Up|Lost to Follow-up|15
7502812|NCT02293499|11828128|FG002|3 Month Follow Up|Lost to Follow-up|6
7502813|NCT02293499|11828126|FG000|6 Month Follow Up|Lost to Follow-up|17
7502814|NCT02293499|11828127|FG001|6 Month Follow Up|Lost to Follow-up|27
7502815|NCT02293499|11828128|FG002|6 Month Follow Up|Lost to Follow-up|6
7502816|NCT02293499|11828126|FG000|6 Month Follow Up|Withdrawal by Subject|0
7502817|NCT02293499|11828127|FG001|6 Month Follow Up|Withdrawal by Subject|0
7502818|NCT02293499|11828128|FG002|6 Month Follow Up|Withdrawal by Subject|1
7502819|NCT02293499|11828126|FG000|9 Month Follow Up|Withdrawal by Subject|2
7502820|NCT02293499|11828127|FG001|9 Month Follow Up|Withdrawal by Subject|0
7502821|NCT02293499|11828128|FG002|9 Month Follow Up|Withdrawal by Subject|0
7502822|NCT02293499|11828126|FG000|9 Month Follow Up|Lost to Follow-up|24
7502823|NCT02293499|11828127|FG001|9 Month Follow Up|Lost to Follow-up|28
7502824|NCT02293499|11828128|FG002|9 Month Follow Up|Lost to Follow-up|4
7502825|NCT02293499|11828126|FG000|12 Month Follow Up|Lost to Follow-up|26
7502826|NCT02293499|11828127|FG001|12 Month Follow Up|Lost to Follow-up|25
7502827|NCT02293499|11828128|FG002|12 Month Follow Up|Lost to Follow-up|6
7502828|NCT02293499|11828126|FG000|12 Month Follow Up|Withdrawal by Subject|0
7502829|NCT02293499|11828127|FG001|12 Month Follow Up|Withdrawal by Subject|1
7502830|NCT02293499|11828128|FG002|12 Month Follow Up|Withdrawal by Subject|0
7502831|NCT02293499|11828126|FG000|15 Month Follow Up|Lost to Follow-up|22
7502832|NCT02293499|11828127|FG001|15 Month Follow Up|Lost to Follow-up|22
7502833|NCT02293499|11828128|FG002|15 Month Follow Up|Lost to Follow-up|7
7502834|NCT02293538|11828156|FG000|Overall Study|Adverse Event|0
7502835|NCT02293538|11828157|FG001|Overall Study|Adverse Event|1
7502836|NCT02293538|11828156|FG000|Overall Study|Lost to Follow-up|1
7502837|NCT02293538|11828157|FG001|Overall Study|Lost to Follow-up|0
7502838|NCT02293538|11828156|FG000|Overall Study|Withdrawal by Subject|0
7502839|NCT02293538|11828157|FG001|Overall Study|Withdrawal by Subject|1
7502840|NCT02293837|11828172|FG000|Overall Study|Lost to Follow-up|0
7502841|NCT02293837|11828173|FG001|Overall Study|Lost to Follow-up|2
7502842|NCT02293837|11828174|FG002|Overall Study|Lost to Follow-up|1
7502843|NCT02293837|11828175|FG003|Overall Study|Lost to Follow-up|0
7502844|NCT02293837|11828172|FG000|Overall Study|Withdrawal by Subject|2
7502845|NCT02293837|11828173|FG001|Overall Study|Withdrawal by Subject|1
7502846|NCT02293837|11828174|FG002|Overall Study|Withdrawal by Subject|2
7502847|NCT02293837|11828175|FG003|Overall Study|Withdrawal by Subject|1
7502848|NCT02293837|11828172|FG000|Overall Study|COVID-19 Related|1
7502849|NCT02293837|11828173|FG001|Overall Study|COVID-19 Related|1
7502850|NCT02293837|11828174|FG002|Overall Study|COVID-19 Related|0
7502851|NCT02293837|11828175|FG003|Overall Study|COVID-19 Related|0
7502852|NCT02293837|11828172|FG000|Overall Study|Participant ill and could not be infused|0
7502853|NCT02293837|11828173|FG001|Overall Study|Participant ill and could not be infused|0
7502854|NCT02293837|11828174|FG002|Overall Study|Participant ill and could not be infused|1
7502855|NCT02293837|11828175|FG003|Overall Study|Participant ill and could not be infused|0
7502856|NCT02293863|11828192|FG000|Overall Study|Death|4
7502857|NCT02293863|11828193|FG001|Overall Study|Death|6
7502858|NCT02293863|11828194|FG002|Overall Study|Death|4
7502859|NCT02293863|11828192|FG000|Overall Study|Lost to Follow-up|2
7502860|NCT02293863|11828193|FG001|Overall Study|Lost to Follow-up|2
7502861|NCT02293863|11828194|FG002|Overall Study|Lost to Follow-up|2
7502862|NCT02293863|11828192|FG000|Overall Study|Withdrawal by Subject|3
7502863|NCT02293863|11828193|FG001|Overall Study|Withdrawal by Subject|3
7502864|NCT02293863|11828194|FG002|Overall Study|Withdrawal by Subject|1
7502865|NCT02293863|11828192|FG000|Overall Study|Reason Not Specified|0
7502866|NCT02293863|11828193|FG001|Overall Study|Reason Not Specified|2
7502867|NCT02293863|11828194|FG002|Overall Study|Reason Not Specified|2
7502868|NCT02293902|11828207|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
7502869|NCT02293902|11828208|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
7502870|NCT02293902|11828209|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
7502871|NCT02293902|11828210|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
7502872|NCT02293902|11828211|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
7502873|NCT02293902|11828207|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
7502874|NCT02293902|11828208|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
7502875|NCT02293902|11828209|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
7502876|NCT02293902|11828210|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7502877|NCT02293902|11828211|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
7502878|NCT02293902|11828207|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
7502879|NCT02293902|11828208|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7502880|NCT02293902|11828209|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7502881|NCT02293902|11828210|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7502882|NCT02293902|11828211|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
7502883|NCT02293902|11828207|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
7502884|NCT02293902|11828208|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
7502885|NCT02293902|11828209|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7502886|NCT02293902|11828210|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
7502887|NCT02293902|11828211|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
7502888|NCT02293902|11828207|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7502889|NCT02293902|11828208|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7502890|NCT02293902|11828209|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
7502891|NCT02293902|11828210|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7502892|NCT02293902|11828211|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
7502893|NCT02293993|11828233|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7502894|NCT02293993|11828234|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7553109|NCT03006458|11913861|FG001|First Intervention|Unsatisfied Vision|3
7502895|NCT02293993|11828235|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
7502896|NCT02293993|11828236|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
7502897|NCT02293993|11828233|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7502898|NCT02293993|11828234|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
7502899|NCT02293993|11828235|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
7502900|NCT02293993|11828236|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
7502901|NCT02293993|11828233|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7502902|NCT02293993|11828234|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7502903|NCT02293993|11828235|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
7502904|NCT02293993|11828236|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
7502905|NCT02293993|11828233|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7502906|NCT02293993|11828234|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
7502907|NCT02293993|11828235|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
7502908|NCT02293993|11828236|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
7502909|NCT02293993|11828233|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7502910|NCT02293993|11828234|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
7502911|NCT02293993|11828235|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7502912|NCT02293993|11828236|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
7502913|NCT02294019|11828254|FG000|Overall Study|Adverse Event|2
7502914|NCT02294019|11828254|FG000|Overall Study|Protocol Violation|68
7502915|NCT02294019|11828254|FG000|Overall Study|Lost to Follow-up|31
7502916|NCT02294019|11828254|FG000|Overall Study|Other|1
7502917|NCT02294019|11828254|FG000|Overall Study|Withdrawal by Subject|1
7502918|NCT02294058|11828261|FG000|Overall Study|Adverse Event|16
7502919|NCT02294058|11828262|FG001|Overall Study|Adverse Event|7
7502920|NCT02294058|11828263|FG002|Overall Study|Adverse Event|13
7502921|NCT02294058|11828261|FG000|Overall Study|Lack of Efficacy|3
7502922|NCT02294058|11828262|FG001|Overall Study|Lack of Efficacy|3
7502923|NCT02294058|11828263|FG002|Overall Study|Lack of Efficacy|0
7502924|NCT02294058|11828261|FG000|Overall Study|Lost to Follow-up|1
7502925|NCT02294058|11828262|FG001|Overall Study|Lost to Follow-up|0
7502926|NCT02294058|11828263|FG002|Overall Study|Lost to Follow-up|2
7502927|NCT02294058|11828261|FG000|Overall Study|Withdrawal by Subject|10
7502928|NCT02294058|11828262|FG001|Overall Study|Withdrawal by Subject|14
7502929|NCT02294058|11828263|FG002|Overall Study|Withdrawal by Subject|13
7502930|NCT02294058|11828261|FG000|Overall Study|Physician Decision|2
7502931|NCT02294058|11828262|FG001|Overall Study|Physician Decision|1
7502932|NCT02294058|11828263|FG002|Overall Study|Physician Decision|0
7502933|NCT02294058|11828261|FG000|Overall Study|Miscellaneous|4
7502934|NCT02294058|11828262|FG001|Overall Study|Miscellaneous|1
7502935|NCT02294058|11828263|FG002|Overall Study|Miscellaneous|1
7502936|NCT02294175|11828274|FG000|Overall Study|Withdrawal by Subject|1
7502937|NCT02294175|11828275|FG001|Overall Study|Withdrawal by Subject|2
7502938|NCT02294175|11828274|FG000|Overall Study|pt taking excluded medication|3
7502939|NCT02294175|11828275|FG001|Overall Study|pt taking excluded medication|1
7502940|NCT02294175|11828274|FG000|Overall Study|Protocol Violation|1
7502941|NCT02294175|11828275|FG001|Overall Study|Protocol Violation|0
7502942|NCT02294175|11828274|FG000|Overall Study|Lost to Follow-up|0
7502943|NCT02294175|11828275|FG001|Overall Study|Lost to Follow-up|1
7502944|NCT02294175|11828274|FG000|Overall Study|wound healed|0
7502945|NCT02294175|11828275|FG001|Overall Study|wound healed|2
7502946|NCT02294227|11828284|FG000|Overall Study|Death|0
7502947|NCT02294227|11828285|FG001|Overall Study|Death|0
7502948|NCT02294227|11828286|FG002|Overall Study|Death|1
7502949|NCT02294227|11828284|FG000|Overall Study|Subject/Guardian Decision|6
7502950|NCT02294227|11828285|FG001|Overall Study|Subject/Guardian Decision|3
7502951|NCT02294227|11828286|FG002|Overall Study|Subject/Guardian Decision|7
7502952|NCT02294227|11828284|FG000|Overall Study|Physician Decision|1
7502953|NCT02294227|11828285|FG001|Overall Study|Physician Decision|2
7502954|NCT02294227|11828286|FG002|Overall Study|Physician Decision|1
7502955|NCT02294227|11828284|FG000|Overall Study|Lost to Follow-up|1
7502956|NCT02294227|11828285|FG001|Overall Study|Lost to Follow-up|0
7502957|NCT02294227|11828286|FG002|Overall Study|Lost to Follow-up|0
7502958|NCT02294227|11828284|FG000|Overall Study|Lack of Efficacy|11
7502959|NCT02294227|11828285|FG001|Overall Study|Lack of Efficacy|12
7502960|NCT02294227|11828286|FG002|Overall Study|Lack of Efficacy|8
7502961|NCT02294227|11828284|FG000|Overall Study|Adverse Event|6
7502962|NCT02294227|11828285|FG001|Overall Study|Adverse Event|8
7502963|NCT02294227|11828286|FG002|Overall Study|Adverse Event|2
7502964|NCT02294318|11828302|FG000|Overall Study|Worsening of drinking|3
7502965|NCT02294318|11828303|FG001|Overall Study|Worsening of drinking|0
7502966|NCT02294318|11828302|FG000|Overall Study|Not exposed to intervention|0
7502967|NCT02294318|11828303|FG001|Overall Study|Not exposed to intervention|2
7502968|NCT02294396|11828313|FG000|Overall Study|Adverse Event|26
7502969|NCT02294396|11828314|FG001|Overall Study|Adverse Event|25
7502970|NCT02294396|11828315|FG002|Overall Study|Adverse Event|21
7502971|NCT02294396|11828316|FG003|Overall Study|Adverse Event|24
7502972|NCT02294396|11828313|FG000|Overall Study|Electrocardiogram adviser's judgment|1
7502973|NCT02294396|11828314|FG001|Overall Study|Electrocardiogram adviser's judgment|0
7502974|NCT02294396|11828315|FG002|Overall Study|Electrocardiogram adviser's judgment|0
7502975|NCT02294396|11828316|FG003|Overall Study|Electrocardiogram adviser's judgment|1
7502976|NCT02294396|11828313|FG000|Overall Study|Withdrawal by Subject|8
7502977|NCT02294396|11828314|FG001|Overall Study|Withdrawal by Subject|6
7502978|NCT02294396|11828315|FG002|Overall Study|Withdrawal by Subject|6
7502979|NCT02294396|11828316|FG003|Overall Study|Withdrawal by Subject|8
7502980|NCT02294396|11828313|FG000|Overall Study|Lost to Follow-up|0
7502981|NCT02294396|11828314|FG001|Overall Study|Lost to Follow-up|0
7502982|NCT02294396|11828315|FG002|Overall Study|Lost to Follow-up|1
7502983|NCT02294396|11828316|FG003|Overall Study|Lost to Follow-up|1
7502984|NCT02294396|11828313|FG000|Overall Study|Protocol Deviation|3
7502985|NCT02294396|11828314|FG001|Overall Study|Protocol Deviation|2
7502986|NCT02294396|11828315|FG002|Overall Study|Protocol Deviation|2
7502987|NCT02294396|11828316|FG003|Overall Study|Protocol Deviation|1
7502988|NCT02294396|11828313|FG000|Overall Study|Miscellaneous|2
7502989|NCT02294396|11828314|FG001|Overall Study|Miscellaneous|0
7502990|NCT02294396|11828315|FG002|Overall Study|Miscellaneous|5
7502991|NCT02294396|11828316|FG003|Overall Study|Miscellaneous|2
7502992|NCT02294474|11828328|FG000|Overall Study|Adverse Event|7
7502993|NCT02294474|11828329|FG001|Overall Study|Adverse Event|7
7502994|NCT02294474|11828328|FG000|Overall Study|Lack of Efficacy|2
7502995|NCT02294474|11828329|FG001|Overall Study|Lack of Efficacy|1
7502996|NCT02294474|11828328|FG000|Overall Study|Protocol Violation|4
7502997|NCT02294474|11828329|FG001|Overall Study|Protocol Violation|2
7502998|NCT02294474|11828328|FG000|Overall Study|Other than specified above|12
7502999|NCT02294474|11828329|FG001|Overall Study|Other than specified above|12
7503000|NCT02294604|11828339|FG000|Overall Study|Did not provide samples for culture|0
7503001|NCT02294604|11828340|FG001|Overall Study|Did not provide samples for culture|1
7503002|NCT02294604|11828341|FG002|Overall Study|Did not provide samples for culture|0
7503003|NCT02294604|11828339|FG000|Overall Study|Culture contamination|1
7503004|NCT02294604|11828340|FG001|Overall Study|Culture contamination|2
7503005|NCT02294604|11828341|FG002|Overall Study|Culture contamination|0
7503006|NCT02294682|11828368|FG000|Overall Study|Could not swallow pills|1
7503007|NCT02294682|11828369|FG001|Overall Study|Could not swallow pills|0
7503008|NCT02294734|11828377|FG000|Overall Study|Adverse Event|5
7503009|NCT02294734|11828378|FG001|Overall Study|Adverse Event|5
7503010|NCT02294734|11828377|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
7503011|NCT02294734|11828378|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
7503012|NCT02294734|11828377|FG000|Overall Study|Lost to Follow-up|2
7503013|NCT02294734|11828378|FG001|Overall Study|Lost to Follow-up|0
7503014|NCT02294734|11828377|FG000|Overall Study|Physician Decision|2
7503015|NCT02294734|11828378|FG001|Overall Study|Physician Decision|1
7503016|NCT02294734|11828377|FG000|Overall Study|Withdrawal by Subject|4
7503017|NCT02294734|11828378|FG001|Overall Study|Withdrawal by Subject|2
7503018|NCT02294773|11828388|FG000|Overall Study|Withdrawal by Subject|0
7503019|NCT02294773|11828389|FG001|Overall Study|Withdrawal by Subject|2
7503020|NCT02294786|11828397|FG000|Overall Study|Withdrawal by Subject|0
7503021|NCT02294786|11828398|FG001|Overall Study|Withdrawal by Subject|1
7503022|NCT02294786|11828397|FG000|Overall Study|Physician Decision|6
7503023|NCT02294786|11828398|FG001|Overall Study|Physician Decision|7
7503024|NCT02294786|11828397|FG000|Overall Study|Lost to Follow-up|1
7503025|NCT02294786|11828398|FG001|Overall Study|Lost to Follow-up|2
7503026|NCT02294786|11828397|FG000|Overall Study|Protocol Violation|1
7503027|NCT02294786|11828398|FG001|Overall Study|Protocol Violation|0
7503028|NCT02294786|11828397|FG000|Overall Study|Adverse Event|1
7503029|NCT02294786|11828398|FG001|Overall Study|Adverse Event|1
7503030|NCT02294786|11828397|FG000|Overall Study|Death|2
7503031|NCT02294786|11828398|FG001|Overall Study|Death|3
7503032|NCT02295020|11828407|FG000|Overall Study|Adverse Event|0
7503033|NCT02295020|11828408|FG001|Overall Study|Adverse Event|1
7503034|NCT02295020|11828407|FG000|Overall Study|Withdrawal by Subject|3
7503035|NCT02295020|11828408|FG001|Overall Study|Withdrawal by Subject|2
7503036|NCT02295280|11828422|FG000|Overall Study|Adverse Event|0
7503037|NCT02295280|11828423|FG001|Overall Study|Adverse Event|1
7503038|NCT02295644|11828450|FG000|Overall Study|Did not meet inclusion criterion|0
7503039|NCT02295644|11828451|FG001|Overall Study|Did not meet inclusion criterion|0
7503040|NCT02295644|11828452|FG002|Overall Study|Did not meet inclusion criterion|1
7503041|NCT02295644|11828453|FG003|Overall Study|Did not meet inclusion criterion|2
7503042|NCT02295774|11828472|FG000|Overall Study|Physician Decision|1
7503043|NCT02295774|11828472|FG000|Overall Study|Withdrawal by Subject|2
7503044|NCT02295995|11828479|FG000|Overall Study|Lost to Follow-up|5
7503045|NCT02295995|11828480|FG001|Overall Study|Lost to Follow-up|1
7503046|NCT02296112|11828496|FG000|Overall Study|Disease progression|7
7503047|NCT02296112|11828496|FG000|Overall Study|Toxicity|1
7503048|NCT02296112|11828496|FG000|Overall Study|Began an alternate therapy|1
7503049|NCT02296138|11828507|FG000|Overall Study|Adverse Event|348
7503050|NCT02296138|11828508|FG001|Overall Study|Adverse Event|259
7503051|NCT02296138|11828507|FG000|Overall Study|Lack of Efficacy|59
7503052|NCT02296138|11828508|FG001|Overall Study|Lack of Efficacy|37
7503053|NCT02296138|11828507|FG000|Overall Study|Protocol Violation|35
7503054|NCT02296138|11828508|FG001|Overall Study|Protocol Violation|36
7503055|NCT02296138|11828507|FG000|Overall Study|Lost to Follow-up|9
7503056|NCT02296138|11828508|FG001|Overall Study|Lost to Follow-up|12
7503057|NCT02296138|11828507|FG000|Overall Study|Withdrawal by Subject|184
7503058|NCT02296138|11828508|FG001|Overall Study|Withdrawal by Subject|131
7503059|NCT02296138|11828507|FG000|Overall Study|Not Treated|1
7503060|NCT02296138|11828508|FG001|Overall Study|Not Treated|1
7503061|NCT02296138|11828507|FG000|Overall Study|Patients with data irregularities|10
7503062|NCT02296138|11828508|FG001|Overall Study|Patients with data irregularities|11
7503063|NCT02296138|11828507|FG000|Overall Study|Other than specified|15
7503064|NCT02296138|11828508|FG001|Overall Study|Other than specified|13
7503065|NCT02296190|11828524|FG000|Overall Study|Lost to Follow-up|0
7503066|NCT02296190|11828525|FG001|Overall Study|Lost to Follow-up|0
7503067|NCT02296190|11828526|FG002|Overall Study|Lost to Follow-up|0
7503068|NCT02296190|11828527|FG003|Overall Study|Lost to Follow-up|0
7503069|NCT02296190|11828528|FG004|Overall Study|Lost to Follow-up|1
7503070|NCT02296190|11828529|FG005|Overall Study|Lost to Follow-up|0
7503071|NCT02296190|11828524|FG000|Overall Study|Failure to induce PSVT|6
7503072|NCT02296190|11828525|FG001|Overall Study|Failure to induce PSVT|10
7503073|NCT02296190|11828526|FG002|Overall Study|Failure to induce PSVT|5
7503074|NCT02296190|11828527|FG003|Overall Study|Failure to induce PSVT|13
7503075|NCT02296190|11828528|FG004|Overall Study|Failure to induce PSVT|8
7503076|NCT02296190|11828529|FG005|Overall Study|Failure to induce PSVT|0
7503077|NCT02296190|11828524|FG000|Overall Study|Physician Decision|1
7503078|NCT02296190|11828525|FG001|Overall Study|Physician Decision|1
7503079|NCT02296190|11828526|FG002|Overall Study|Physician Decision|0
7503080|NCT02296190|11828527|FG003|Overall Study|Physician Decision|1
7503081|NCT02296190|11828528|FG004|Overall Study|Physician Decision|2
7503082|NCT02296190|11828529|FG005|Overall Study|Physician Decision|0
7503083|NCT02296190|11828524|FG000|Overall Study|Withdrawal by Subject|0
7503084|NCT02296190|11828525|FG001|Overall Study|Withdrawal by Subject|1
7503085|NCT02296190|11828526|FG002|Overall Study|Withdrawal by Subject|0
7503086|NCT02296190|11828527|FG003|Overall Study|Withdrawal by Subject|0
7503087|NCT02296190|11828528|FG004|Overall Study|Withdrawal by Subject|0
7503088|NCT02296190|11828529|FG005|Overall Study|Withdrawal by Subject|0
7503089|NCT02296190|11828524|FG000|Overall Study|PSVT < 5 minutes|5
7503090|NCT02296190|11828525|FG001|Overall Study|PSVT < 5 minutes|6
7503091|NCT02296190|11828526|FG002|Overall Study|PSVT < 5 minutes|6
7503092|NCT02296190|11828527|FG003|Overall Study|PSVT < 5 minutes|6
7503093|NCT02296190|11828528|FG004|Overall Study|PSVT < 5 minutes|5
7503094|NCT02296190|11828529|FG005|Overall Study|PSVT < 5 minutes|0
7503095|NCT02296190|11828524|FG000|Overall Study|Patient was given Propofol|0
7503096|NCT02296190|11828525|FG001|Overall Study|Patient was given Propofol|1
7503097|NCT02296190|11828526|FG002|Overall Study|Patient was given Propofol|0
7503098|NCT02296190|11828527|FG003|Overall Study|Patient was given Propofol|1
7503099|NCT02296190|11828528|FG004|Overall Study|Patient was given Propofol|0
7503100|NCT02296190|11828529|FG005|Overall Study|Patient was given Propofol|0
7503101|NCT02296190|11828524|FG000|Overall Study|Patient with Atrial Tachycardia|0
7503102|NCT02296190|11828525|FG001|Overall Study|Patient with Atrial Tachycardia|0
7503103|NCT02296190|11828526|FG002|Overall Study|Patient with Atrial Tachycardia|0
7503104|NCT02296190|11828527|FG003|Overall Study|Patient with Atrial Tachycardia|1
7503105|NCT02296190|11828528|FG004|Overall Study|Patient with Atrial Tachycardia|0
7503106|NCT02296190|11828529|FG005|Overall Study|Patient with Atrial Tachycardia|0
7503107|NCT02296190|11828524|FG000|Overall Study|Blood pressure <100 after sedation|0
7503108|NCT02296190|11828525|FG001|Overall Study|Blood pressure <100 after sedation|0
7503109|NCT02296190|11828526|FG002|Overall Study|Blood pressure <100 after sedation|0
7503110|NCT02296190|11828527|FG003|Overall Study|Blood pressure <100 after sedation|1
7503111|NCT02296190|11828528|FG004|Overall Study|Blood pressure <100 after sedation|0
7503112|NCT02296190|11828529|FG005|Overall Study|Blood pressure <100 after sedation|0
7503113|NCT02296190|11828524|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
7503114|NCT02296190|11828525|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
7503115|NCT02296190|11828526|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
7503116|NCT02296190|11828527|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
7503117|NCT02296190|11828528|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
7503118|NCT02296190|11828529|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
7503119|NCT02296190|11828524|FG000|Overall Study|Patient on antiarrhythmic medication|1
7503120|NCT02296190|11828525|FG001|Overall Study|Patient on antiarrhythmic medication|0
7503121|NCT02296190|11828526|FG002|Overall Study|Patient on antiarrhythmic medication|0
7503122|NCT02296190|11828527|FG003|Overall Study|Patient on antiarrhythmic medication|0
7503123|NCT02296190|11828528|FG004|Overall Study|Patient on antiarrhythmic medication|0
7503124|NCT02296190|11828529|FG005|Overall Study|Patient on antiarrhythmic medication|0
7503125|NCT02296190|11828524|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
7503126|NCT02296190|11828525|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
7503127|NCT02296190|11828526|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
7503128|NCT02296190|11828527|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
7503129|NCT02296190|11828528|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
7503130|NCT02296190|11828529|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
7503131|NCT02296190|11828524|FG000|Overall Study|Lab result not available in time|1
7503132|NCT02296190|11828525|FG001|Overall Study|Lab result not available in time|0
7503133|NCT02296190|11828526|FG002|Overall Study|Lab result not available in time|0
7553110|NCT03006562|11913878|FG000|Overall Study|Lost to Follow-up|0
7503134|NCT02296190|11828527|FG003|Overall Study|Lab result not available in time|0
7503135|NCT02296190|11828528|FG004|Overall Study|Lab result not available in time|0
7503136|NCT02296190|11828529|FG005|Overall Study|Lab result not available in time|0
7503137|NCT02296242|11828547|FG000|Overall Study|Death|1
7503138|NCT02296242|11828548|FG001|Overall Study|Death|1
7503139|NCT02296242|11828549|FG002|Overall Study|Death|1
7503140|NCT02296242|11828550|FG003|Overall Study|Death|1
7503141|NCT02296242|11828551|FG004|Overall Study|Death|1
7503142|NCT02296242|11828547|FG000|Overall Study|Withdrawal by Subject|0
7503143|NCT02296242|11828548|FG001|Overall Study|Withdrawal by Subject|0
7503144|NCT02296242|11828549|FG002|Overall Study|Withdrawal by Subject|1
7503145|NCT02296242|11828550|FG003|Overall Study|Withdrawal by Subject|1
7503146|NCT02296242|11828551|FG004|Overall Study|Withdrawal by Subject|3
7503147|NCT02296242|11828547|FG000|Overall Study|Disease Progression|1
7503148|NCT02296242|11828548|FG001|Overall Study|Disease Progression|3
7503149|NCT02296242|11828549|FG002|Overall Study|Disease Progression|2
7503150|NCT02296242|11828550|FG003|Overall Study|Disease Progression|8
7503151|NCT02296242|11828551|FG004|Overall Study|Disease Progression|11
7503152|NCT02296242|11828547|FG000|Overall Study|Unacceptable Toxicity|0
7503153|NCT02296242|11828548|FG001|Overall Study|Unacceptable Toxicity|0
7503154|NCT02296242|11828549|FG002|Overall Study|Unacceptable Toxicity|0
7503155|NCT02296242|11828550|FG003|Overall Study|Unacceptable Toxicity|0
7503156|NCT02296242|11828551|FG004|Overall Study|Unacceptable Toxicity|1
7503157|NCT02296242|11828547|FG000|Overall Study|Patient Condition Changed|0
7503158|NCT02296242|11828548|FG001|Overall Study|Patient Condition Changed|0
7503159|NCT02296242|11828549|FG002|Overall Study|Patient Condition Changed|2
7503160|NCT02296242|11828550|FG003|Overall Study|Patient Condition Changed|0
7503161|NCT02296242|11828551|FG004|Overall Study|Patient Condition Changed|1
7503162|NCT02296242|11828547|FG000|Overall Study|At Least 3 Drug Interruptions|0
7503163|NCT02296242|11828548|FG001|Overall Study|At Least 3 Drug Interruptions|0
7503164|NCT02296242|11828549|FG002|Overall Study|At Least 3 Drug Interruptions|1
7503165|NCT02296242|11828550|FG003|Overall Study|At Least 3 Drug Interruptions|1
7503166|NCT02296242|11828551|FG004|Overall Study|At Least 3 Drug Interruptions|1
7503167|NCT02296242|11828547|FG000|Overall Study|Lost to Follow-up|1
7503168|NCT02296242|11828548|FG001|Overall Study|Lost to Follow-up|0
7503169|NCT02296242|11828549|FG002|Overall Study|Lost to Follow-up|0
7503170|NCT02296242|11828550|FG003|Overall Study|Lost to Follow-up|0
7503171|NCT02296242|11828551|FG004|Overall Study|Lost to Follow-up|0
7503172|NCT02296242|11828547|FG000|Overall Study|Need for Hydroxyurea|2
7503173|NCT02296242|11828548|FG001|Overall Study|Need for Hydroxyurea|0
7503174|NCT02296242|11828549|FG002|Overall Study|Need for Hydroxyurea|0
7503175|NCT02296242|11828550|FG003|Overall Study|Need for Hydroxyurea|0
7503176|NCT02296242|11828551|FG004|Overall Study|Need for Hydroxyurea|0
7503177|NCT02296242|11828547|FG000|Overall Study|Screened for Other Protocol|0
7503178|NCT02296242|11828548|FG001|Overall Study|Screened for Other Protocol|1
7503179|NCT02296242|11828549|FG002|Overall Study|Screened for Other Protocol|0
7503180|NCT02296242|11828550|FG003|Overall Study|Screened for Other Protocol|0
7503181|NCT02296242|11828551|FG004|Overall Study|Screened for Other Protocol|0
7503182|NCT02296242|11828547|FG000|Overall Study|Physician Decision|0
7503183|NCT02296242|11828548|FG001|Overall Study|Physician Decision|1
7503184|NCT02296242|11828549|FG002|Overall Study|Physician Decision|0
7503185|NCT02296242|11828550|FG003|Overall Study|Physician Decision|1
7503186|NCT02296242|11828551|FG004|Overall Study|Physician Decision|0
7503187|NCT02296242|11828547|FG000|Overall Study|Alternative Treatment|0
7503188|NCT02296242|11828548|FG001|Overall Study|Alternative Treatment|0
7503189|NCT02296242|11828549|FG002|Overall Study|Alternative Treatment|0
7503190|NCT02296242|11828550|FG003|Overall Study|Alternative Treatment|1
7503191|NCT02296242|11828551|FG004|Overall Study|Alternative Treatment|0
7503192|NCT02296242|11828547|FG000|Overall Study|Adverse Event|0
7503193|NCT02296242|11828548|FG001|Overall Study|Adverse Event|0
7503194|NCT02296242|11828549|FG002|Overall Study|Adverse Event|0
7503195|NCT02296242|11828550|FG003|Overall Study|Adverse Event|1
7503196|NCT02296242|11828551|FG004|Overall Study|Adverse Event|0
7503197|NCT02296242|11828547|FG000|Overall Study|Lack of Efficacy|0
7503198|NCT02296242|11828548|FG001|Overall Study|Lack of Efficacy|0
7503199|NCT02296242|11828549|FG002|Overall Study|Lack of Efficacy|0
7503200|NCT02296242|11828550|FG003|Overall Study|Lack of Efficacy|0
7503201|NCT02296242|11828551|FG004|Overall Study|Lack of Efficacy|3
7535812|NCT02712983|11883591|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7535813|NCT02712983|11883592|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
7535814|NCT02712983|11883593|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7535815|NCT02712983|11883585|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535816|NCT02712983|11883586|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535817|NCT02712983|11883587|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535818|NCT02712983|11883588|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
7535819|NCT02712983|11883589|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535820|NCT02712983|11883590|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535821|NCT02712983|11883591|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535822|NCT02712983|11883592|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535823|NCT02712983|11883593|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
7535824|NCT02712983|11883585|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7503202|NCT02296320|11828574|FG000|Overall Study|Withdrawal by Subject|4
7503203|NCT02296320|11828575|FG001|Overall Study|Withdrawal by Subject|0
7503204|NCT02296320|11828576|FG002|Overall Study|Withdrawal by Subject|2
7503205|NCT02296320|11828574|FG000|Overall Study|Death|24
7503206|NCT02296320|11828575|FG001|Overall Study|Death|3
7503207|NCT02296320|11828576|FG002|Overall Study|Death|27
7503208|NCT02296320|11828574|FG000|Overall Study|Lost to Follow-up|5
7503209|NCT02296320|11828575|FG001|Overall Study|Lost to Follow-up|2
7503210|NCT02296320|11828576|FG002|Overall Study|Lost to Follow-up|7
7503211|NCT02296320|11828574|FG000|Overall Study|Not treated|2
7503212|NCT02296320|11828575|FG001|Overall Study|Not treated|0
7503213|NCT02296320|11828576|FG002|Overall Study|Not treated|0
7503214|NCT02296320|11828574|FG000|Overall Study|Not - specified|0
7503215|NCT02296320|11828575|FG001|Overall Study|Not - specified|0
7503216|NCT02296320|11828576|FG002|Overall Study|Not - specified|1
7503217|NCT02296424|11828599|FG000|Part 1|New therapy for study indication|0
7503218|NCT02296424|11828600|FG001|Part 1|New therapy for study indication|1
7503219|NCT02296424|11828601|FG002|Part 1|New therapy for study indication|0
7503220|NCT02296424|11828602|FG003|Part 1|New therapy for study indication|0
7503221|NCT02296424|11828599|FG000|Part 1|Protocol Violation|0
7503222|NCT02296424|11828600|FG001|Part 1|Protocol Violation|1
7503223|NCT02296424|11828601|FG002|Part 1|Protocol Violation|0
7503224|NCT02296424|11828602|FG003|Part 1|Protocol Violation|0
7503225|NCT02296424|11828599|FG000|Part 1|Withdrawal by Subject|0
7503226|NCT02296424|11828600|FG001|Part 1|Withdrawal by Subject|2
7503227|NCT02296424|11828601|FG002|Part 1|Withdrawal by Subject|0
7503228|NCT02296424|11828602|FG003|Part 1|Withdrawal by Subject|0
7503229|NCT02296424|11828599|FG000|Part 1|Study terminated by sponsor|0
7503230|NCT02296424|11828600|FG001|Part 1|Study terminated by sponsor|1
7503231|NCT02296424|11828601|FG002|Part 1|Study terminated by sponsor|0
7503232|NCT02296424|11828602|FG003|Part 1|Study terminated by sponsor|0
7503233|NCT02296424|11828599|FG000|Part 1|Adverse Event|2
7503234|NCT02296424|11828600|FG001|Part 1|Adverse Event|11
7503235|NCT02296424|11828601|FG002|Part 1|Adverse Event|0
7503236|NCT02296424|11828602|FG003|Part 1|Adverse Event|0
7503237|NCT02296424|11828599|FG000|Part 1|Lack of Efficacy|5
7503238|NCT02296424|11828600|FG001|Part 1|Lack of Efficacy|17
7503239|NCT02296424|11828601|FG002|Part 1|Lack of Efficacy|0
7503240|NCT02296424|11828602|FG003|Part 1|Lack of Efficacy|0
7503241|NCT02296424|11828599|FG000|Part 1|16 directly started part II|16
7503242|NCT02296424|11828600|FG001|Part 1|16 directly started part II|0
7503243|NCT02296424|11828601|FG002|Part 1|16 directly started part II|0
7503244|NCT02296424|11828602|FG003|Part 1|16 directly started part II|0
7503245|NCT02296424|11828599|FG000|Part 2|Lack of Efficacy|0
7503246|NCT02296424|11828600|FG001|Part 2|Lack of Efficacy|0
7503247|NCT02296424|11828601|FG002|Part 2|Lack of Efficacy|1
7503248|NCT02296424|11828602|FG003|Part 2|Lack of Efficacy|0
7503249|NCT02296424|11828599|FG000|Part 2|Adverse Event|0
7503250|NCT02296424|11828600|FG001|Part 2|Adverse Event|0
7503251|NCT02296424|11828601|FG002|Part 2|Adverse Event|1
7503252|NCT02296424|11828602|FG003|Part 2|Adverse Event|0
7503253|NCT02296424|11828599|FG000|Part 2|Lost to Follow-up|0
7503254|NCT02296424|11828600|FG001|Part 2|Lost to Follow-up|0
7503255|NCT02296424|11828601|FG002|Part 2|Lost to Follow-up|1
7503256|NCT02296424|11828602|FG003|Part 2|Lost to Follow-up|0
7503257|NCT02296476|11828613|FG000|Overall Study|Disease Progression|6
7503258|NCT02296476|11828614|FG001|Overall Study|Disease Progression|4
7503259|NCT02296476|11828615|FG002|Overall Study|Disease Progression|2
7503260|NCT02296840|11828662|FG000|Overall Study|Adverse Event|1
7503261|NCT02296840|11828663|FG001|Overall Study|Adverse Event|1
7503262|NCT02296840|11828662|FG000|Overall Study|Protocol Violation|2
7503263|NCT02296840|11828663|FG001|Overall Study|Protocol Violation|1
7503264|NCT02296840|11828662|FG000|Overall Study|Lost to Follow-up|6
7503265|NCT02296840|11828663|FG001|Overall Study|Lost to Follow-up|17
7503266|NCT02296892|11828681|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
7503267|NCT02296892|11828682|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
7503268|NCT02296892|11828683|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
7503269|NCT02296892|11828681|FG000|Overall Study|Lost to Follow-up|5
7503270|NCT02296892|11828682|FG001|Overall Study|Lost to Follow-up|0
7503271|NCT02296892|11828683|FG002|Overall Study|Lost to Follow-up|1
7503272|NCT02296931|11828693|FG000|Overall Study|Protocol Violation|0
7503273|NCT02296931|11828694|FG001|Overall Study|Protocol Violation|2
7503284|NCT02297516|11828734|FG000|Single Treatment Phase (6 Months)|Medical reason|1
7503285|NCT02297516|11828735|FG001|Single Treatment Phase (6 Months)|Medical reason|0
7503286|NCT02297516|11828734|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
7503287|NCT02297516|11828735|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
7503288|NCT02297516|11828734|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
7553111|NCT03006562|11913879|FG001|Overall Study|Lost to Follow-up|1
7503289|NCT02297516|11828735|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
7503290|NCT02297815|11828750|FG000|Overall Study|Lost to Follow-up|236
7503291|NCT02297815|11828751|FG001|Overall Study|Lost to Follow-up|140
7503292|NCT02297841|11828759|FG000|Overall Study|Withdrawal by Subject|1
7503293|NCT02297841|11828759|FG000|Overall Study|Protocol Violation|7
7503294|NCT02298023|11828766|FG000|Overall Study|Withdrawal by Subject|1
7503295|NCT02298023|11828767|FG001|Overall Study|Withdrawal by Subject|0
7503296|NCT02298023|11828768|FG002|Overall Study|Withdrawal by Subject|0
7503297|NCT02298179|11828791|FG000|Overall Study|Lost to Follow-up|0
7503298|NCT02298179|11828792|FG001|Overall Study|Lost to Follow-up|0
7503299|NCT02298179|11828793|FG002|Overall Study|Lost to Follow-up|1
7503300|NCT02298179|11828794|FG003|Overall Study|Lost to Follow-up|0
7503301|NCT02298179|11828795|FG004|Overall Study|Lost to Follow-up|0
7503302|NCT02298179|11828796|FG005|Overall Study|Lost to Follow-up|0
7503303|NCT02298179|11828797|FG006|Overall Study|Lost to Follow-up|0
7503304|NCT02298179|11828798|FG007|Overall Study|Lost to Follow-up|1
7503305|NCT02298179|11828799|FG008|Overall Study|Lost to Follow-up|0
7503306|NCT02298179|11828800|FG009|Overall Study|Lost to Follow-up|0
7503307|NCT02298179|11828801|FG010|Overall Study|Lost to Follow-up|0
7503308|NCT02298179|11828802|FG011|Overall Study|Lost to Follow-up|0
7503309|NCT02298192|11828830|FG000|Overall Study|Unclassified|3
7503310|NCT02298192|11828831|FG001|Overall Study|Unclassified|2
7503311|NCT02298192|11828830|FG000|Overall Study|Withdrawal criteria|2
7503312|NCT02298192|11828831|FG001|Overall Study|Withdrawal criteria|0
7503313|NCT02298192|11828830|FG000|Overall Study|Withdrawal by Subject|6
7503314|NCT02298192|11828831|FG001|Overall Study|Withdrawal by Subject|1
7503315|NCT02298192|11828830|FG000|Overall Study|Lost to Follow-up|2
7503316|NCT02298192|11828831|FG001|Overall Study|Lost to Follow-up|1
7503317|NCT02298192|11828830|FG000|Overall Study|Adverse Event|6
7503318|NCT02298192|11828831|FG001|Overall Study|Adverse Event|2
7503319|NCT02298868|11828883|FG000|Overall Study|Adverse Event|1
7503320|NCT02298868|11828883|FG000|Overall Study|Death|1
7503321|NCT02298868|11828883|FG000|Overall Study|Patient underwent transplant|1
7503322|NCT02298946|11828893|FG000|Overall Study|Did not receive treatment|2
7503323|NCT02298946|11828894|FG001|Overall Study|Did not receive treatment|0
7503324|NCT02298946|11828893|FG000|Overall Study|Unevaluable|2
7503325|NCT02298946|11828894|FG001|Overall Study|Unevaluable|1
7503326|NCT02299076|11828907|FG000|Overall Study|Fraudulent Entries|20
7503327|NCT02299076|11828908|FG001|Overall Study|Fraudulent Entries|14
7503328|NCT02299167|11828952|FG000|Overall Study|patients were excluded from the study|11
7503329|NCT02299336|11828969|FG000|Overall Study|Withdrawal by Subject|11
7503330|NCT02299336|11828969|FG000|Overall Study|Adverse Event|1
7503331|NCT02299336|11828969|FG000|Overall Study|Death|1
7503332|NCT02299336|11828969|FG000|Overall Study|Lost to Follow-up|1
7503333|NCT02299375|11828984|FG000|Overall Study|Adverse Event, serious fatal|1
7503334|NCT02299375|11828985|FG001|Overall Study|Adverse Event, serious fatal|3
7503335|NCT02299375|11828984|FG000|Overall Study|Adverse Event, non-fatal|8
7503336|NCT02299375|11828985|FG001|Overall Study|Adverse Event, non-fatal|9
7503337|NCT02299375|11828984|FG000|Overall Study|Lack of Efficacy|1
7503338|NCT02299375|11828985|FG001|Overall Study|Lack of Efficacy|3
7503339|NCT02299375|11828984|FG000|Overall Study|Protocol Violation|1
7503340|NCT02299375|11828985|FG001|Overall Study|Protocol Violation|3
7503341|NCT02299375|11828984|FG000|Overall Study|Other: Met stopping criteria|1
7503342|NCT02299375|11828985|FG001|Overall Study|Other: Met stopping criteria|0
7503343|NCT02299375|11828984|FG000|Overall Study|Other: Study closed/terminated|66
7503344|NCT02299375|11828985|FG001|Overall Study|Other: Study closed/terminated|55
7503345|NCT02299375|11828984|FG000|Overall Study|Lost to Follow-up|0
7503346|NCT02299375|11828985|FG001|Overall Study|Lost to Follow-up|2
7503347|NCT02299375|11828984|FG000|Overall Study|Physician Decision|1
7503348|NCT02299375|11828985|FG001|Overall Study|Physician Decision|1
7503349|NCT02299375|11828984|FG000|Overall Study|Withdrawal by Subject|1
7503350|NCT02299375|11828985|FG001|Overall Study|Withdrawal by Subject|4
7503351|NCT02299388|11828994|FG000|Overall Study|Withdrawal by Subject|0
7503352|NCT02299388|11828995|FG001|Overall Study|Withdrawal by Subject|1
7503353|NCT02299427|11829003|FG000|Overall Study|Withdrawal by Subject|1
7503354|NCT02299427|11829004|FG001|Overall Study|Withdrawal by Subject|0
7503355|NCT02299427|11829003|FG000|Overall Study|Lost to Follow-up|1
7503356|NCT02299427|11829004|FG001|Overall Study|Lost to Follow-up|3
7503357|NCT02299427|11829003|FG000|Overall Study|not adherent to dog website use|21
7503358|NCT02299427|11829004|FG001|Overall Study|not adherent to dog website use|0
7503359|NCT02299635|11829032|FG000|Overall Study|Adverse Event|2
7503360|NCT02299635|11829032|FG000|Overall Study|Death|1
7503361|NCT02299635|11829032|FG000|Overall Study|Global deterioration of health status|1
7503362|NCT02299635|11829032|FG000|Overall Study|Objective progression or relapse|10
7503363|NCT02299635|11829032|FG000|Overall Study|Withdrawal by Subject|2
7503364|NCT02299635|11829032|FG000|Overall Study|Other|3
7503365|NCT02300103|11829090|FG000|Overall Study|Lack of Efficacy|3
7503366|NCT02300103|11829090|FG000|Overall Study|Protocol Violation|1
7503367|NCT02300103|11829090|FG000|Overall Study|Withdrew Consent|2
7503368|NCT02300129|11829094|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7503369|NCT02300129|11829095|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
7503370|NCT02300129|11829096|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7503371|NCT02300129|11829097|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
7503372|NCT02300129|11829094|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7503373|NCT02300129|11829095|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7503374|NCT02300129|11829096|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
7503375|NCT02300129|11829097|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
7503376|NCT02300129|11829094|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
7503377|NCT02300129|11829095|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7503378|NCT02300129|11829096|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7503379|NCT02300129|11829097|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
7503380|NCT02300220|11829109|FG000|Overall Study|Lost to Follow-up|1
7503381|NCT02300220|11829110|FG001|Overall Study|Lost to Follow-up|2
7503382|NCT02300220|11829109|FG000|Overall Study|Death|1
7503383|NCT02300220|11829110|FG001|Overall Study|Death|1
7503384|NCT02300220|11829109|FG000|Overall Study|Adverse Event|1
7503385|NCT02300220|11829110|FG001|Overall Study|Adverse Event|1
7503386|NCT02300220|11829109|FG000|Overall Study|Protocol Violation|1
7503387|NCT02300220|11829110|FG001|Overall Study|Protocol Violation|0
7503388|NCT02300220|11829109|FG000|Overall Study|Withdrawal by Subject|0
7503389|NCT02300220|11829110|FG001|Overall Study|Withdrawal by Subject|2
7503390|NCT02300220|11829109|FG000|Overall Study|Did not tolerate IMP|0
7503391|NCT02300220|11829110|FG001|Overall Study|Did not tolerate IMP|1
7503392|NCT02300259|11829119|FG000|Period 1|Adverse Event|0
7503393|NCT02300259|11829120|FG001|Period 1|Adverse Event|0
7503394|NCT02300259|11829121|FG002|Period 1|Adverse Event|1
7503395|NCT02300259|11829119|FG000|Period 1|Withdrawal by Subject|0
7503396|NCT02300259|11829120|FG001|Period 1|Withdrawal by Subject|0
7503397|NCT02300259|11829121|FG002|Period 1|Withdrawal by Subject|1
7503398|NCT02300259|11829119|FG000|Period 2|Adverse Event|1
7503399|NCT02300259|11829120|FG001|Period 2|Adverse Event|0
7503400|NCT02300259|11829121|FG002|Period 2|Adverse Event|0
7503401|NCT02300259|11829119|FG000|Period 2|Withdrawal by Subject|0
7503402|NCT02300259|11829120|FG001|Period 2|Withdrawal by Subject|0
7503403|NCT02300259|11829121|FG002|Period 2|Withdrawal by Subject|1
7503404|NCT02300298|11829149|FG000|Disposition for Nintedanib|Progressive disease|10
7503405|NCT02300298|11829150|FG001|Disposition for Nintedanib|Progressive disease|0
7503406|NCT02300298|11829149|FG000|Disposition for Docetaxel|Progressive disease|0
7503407|NCT02300298|11829150|FG001|Disposition for Docetaxel|Progressive disease|6
7503408|NCT02300298|11829149|FG000|Disposition for Docetaxel|other adverse event|0
7503409|NCT02300298|11829150|FG001|Disposition for Docetaxel|other adverse event|4
7503410|NCT02300311|11829156|FG000|Overall Study|Other than the reason specified|1
7503411|NCT02300311|11829157|FG001|Overall Study|Other than the reason specified|0
7503412|NCT02300311|11829156|FG000|Overall Study|Refused to continue taking medication|18
7503413|NCT02300311|11829157|FG001|Overall Study|Refused to continue taking medication|0
7503414|NCT02300558|11829167|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
7503415|NCT02300558|11829167|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
7503416|NCT02300558|11829167|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
7503417|NCT02300558|11829167|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
7503418|NCT02300610|11829178|FG000|Overall Study|Withdrawal by Subject|1
7503419|NCT02300610|11829179|FG001|Overall Study|Withdrawal by Subject|0
7503420|NCT02300610|11829180|FG002|Overall Study|Withdrawal by Subject|1
7503421|NCT02300987|11829217|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
7503422|NCT02300987|11829218|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
7503423|NCT02300987|11829217|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
7503424|NCT02300987|11829218|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
7503425|NCT02300987|11829217|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
7503426|NCT02300987|11829218|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
7503427|NCT02300987|11829217|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
7503428|NCT02300987|11829218|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
7503429|NCT02300987|11829217|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
7503430|NCT02300987|11829218|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
7503431|NCT02301143|11829238|FG000|Induction Period|Enrolled But Not Treated|1
7503432|NCT02301143|11829239|FG001|Induction Period|Enrolled But Not Treated|0
7503433|NCT02301143|11829238|FG000|Induction Period|Death|1
7503434|NCT02301143|11829239|FG001|Induction Period|Death|0
7503435|NCT02301143|11829238|FG000|Induction Period|Adverse Event|22
7503436|NCT02301143|11829239|FG001|Induction Period|Adverse Event|0
7503437|NCT02301143|11829238|FG000|Induction Period|Progressive Disease|8
7503438|NCT02301143|11829239|FG001|Induction Period|Progressive Disease|0
7503439|NCT02301143|11829238|FG000|Induction Period|Withdrawal by Subject|3
7503440|NCT02301143|11829239|FG001|Induction Period|Withdrawal by Subject|0
7503441|NCT02301143|11829238|FG000|Induction Period|Noncompliance with Study Drug|1
7503442|NCT02301143|11829239|FG001|Induction Period|Noncompliance with Study Drug|0
7503443|NCT02301143|11829238|FG000|Induction Period|Physician Decision|4
7503444|NCT02301143|11829239|FG001|Induction Period|Physician Decision|0
7503524|NCT02301897|11829343|FG002|Treatment Course 1|Withdrawal by Subject|2
7503445|NCT02301143|11829238|FG000|Induction Period|Symptomatic Deterioration|2
7503446|NCT02301143|11829239|FG001|Induction Period|Symptomatic Deterioration|0
7503447|NCT02301143|11829238|FG000|Induction Period|Protocol Violation|2
7503448|NCT02301143|11829239|FG001|Induction Period|Protocol Violation|0
7503449|NCT02301143|11829238|FG000|Induction Period|Other|1
7503450|NCT02301143|11829239|FG001|Induction Period|Other|0
7503451|NCT02301143|11829238|FG000|Investigator's Choice|Adverse Event|0
7503452|NCT02301143|11829239|FG001|Investigator's Choice|Adverse Event|3
7503453|NCT02301143|11829238|FG000|Investigator's Choice|Progressive Disease|0
7503454|NCT02301143|11829239|FG001|Investigator's Choice|Progressive Disease|3
7503455|NCT02301143|11829238|FG000|Investigator's Choice|Noncompliance With Study Drug|0
7503456|NCT02301143|11829239|FG001|Investigator's Choice|Noncompliance With Study Drug|1
7503457|NCT02301143|11829238|FG000|Investigator's Choice|Symptomatic Deterioration|0
7503458|NCT02301143|11829239|FG001|Investigator's Choice|Symptomatic Deterioration|1
7503459|NCT02301143|11829238|FG000|Investigator's Choice|Other|0
7503460|NCT02301143|11829239|FG001|Investigator's Choice|Other|1
7503461|NCT02301143|11829238|FG000|Investigator's Choice|Unresectable Surgery|0
7503462|NCT02301143|11829239|FG001|Investigator's Choice|Unresectable Surgery|1
7503463|NCT02301169|11829252|FG000|Overall Study|Adverse Event|1
7503464|NCT02301169|11829253|FG001|Overall Study|Adverse Event|0
7503465|NCT02301390|11829281|FG000|Overall Study|Withdrawal by Subject|3
7503466|NCT02301390|11829282|FG001|Overall Study|Withdrawal by Subject|5
7503467|NCT02301390|11829281|FG000|Overall Study|Protocol Violation|1
7503468|NCT02301390|11829282|FG001|Overall Study|Protocol Violation|0
7503469|NCT02301390|11829281|FG000|Overall Study|Physician Decision|1
7503470|NCT02301390|11829282|FG001|Overall Study|Physician Decision|0
7503471|NCT02301390|11829281|FG000|Overall Study|Lost to Follow-up|0
7503472|NCT02301390|11829282|FG001|Overall Study|Lost to Follow-up|1
7503473|NCT02301390|11829281|FG000|Overall Study|Death|2
7503474|NCT02301390|11829282|FG001|Overall Study|Death|2
7503475|NCT02301390|11829281|FG000|Overall Study|Procedure not completed|0
7503476|NCT02301390|11829282|FG001|Overall Study|Procedure not completed|4
7503477|NCT02301390|11829281|FG000|Overall Study|Missed multiple visits|1
7503478|NCT02301390|11829282|FG001|Overall Study|Missed multiple visits|1
7503479|NCT02301390|11829281|FG000|Overall Study|study terminated|2
7503480|NCT02301390|11829282|FG001|Overall Study|study terminated|0
7503481|NCT02301403|11829290|FG000|Overall Study|Withdrawal by Subject|28
7503482|NCT02301403|11829291|FG001|Overall Study|Withdrawal by Subject|41
7503483|NCT02301429|11829306|FG000|Overall Study|not acceptable vascular anatomy|3
7503484|NCT02301546|11829312|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
7503485|NCT02301546|11829313|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
7503486|NCT02301546|11829312|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
7503487|NCT02301546|11829313|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
7503488|NCT02301546|11829312|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
7503489|NCT02301546|11829313|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
7503490|NCT02301546|11829312|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7503491|NCT02301546|11829313|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
7503492|NCT02301546|11829312|FG000|Long Term Effectiveness (~1 Year)|Death|2
7503493|NCT02301546|11829313|FG001|Long Term Effectiveness (~1 Year)|Death|0
7503494|NCT02301546|11829312|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
7503495|NCT02301546|11829313|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
7503496|NCT02301546|11829312|FG000|Long Term Effectiveness (~1 Year)|moved away|1
7503497|NCT02301546|11829313|FG001|Long Term Effectiveness (~1 Year)|moved away|2
7503498|NCT02301624|11829321|FG000|Blind Induction Phase|Withdrawal by Subject|1
7503499|NCT02301624|11829322|FG001|Blind Induction Phase|Withdrawal by Subject|0
7503500|NCT02301624|11829321|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
7503501|NCT02301624|11829322|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
7503502|NCT02301624|11829321|FG000|Open-label Maintenance Phase|Adverse Event|2
7503503|NCT02301624|11829322|FG001|Open-label Maintenance Phase|Adverse Event|5
7503504|NCT02301624|11829321|FG000|Open-label Maintenance Phase|Physician Decision|3
7503505|NCT02301624|11829322|FG001|Open-label Maintenance Phase|Physician Decision|3
7503506|NCT02301624|11829321|FG000|Open-label Maintenance Phase|Death|2
7503507|NCT02301624|11829322|FG001|Open-label Maintenance Phase|Death|1
7503508|NCT02301624|11829321|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
7503509|NCT02301624|11829322|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
7503510|NCT02301897|11829341|FG000|Treatment Course 1|Non-Compliance|0
7503511|NCT02301897|11829342|FG001|Treatment Course 1|Non-Compliance|0
7503512|NCT02301897|11829343|FG002|Treatment Course 1|Non-Compliance|1
7503513|NCT02301897|11829341|FG000|Treatment Course 1|Adverse Event|1
7503514|NCT02301897|11829342|FG001|Treatment Course 1|Adverse Event|1
7503515|NCT02301897|11829343|FG002|Treatment Course 1|Adverse Event|0
7503516|NCT02301897|11829341|FG000|Treatment Course 1|Lost to Follow-up|1
7503517|NCT02301897|11829342|FG001|Treatment Course 1|Lost to Follow-up|2
7503518|NCT02301897|11829343|FG002|Treatment Course 1|Lost to Follow-up|1
7503519|NCT02301897|11829341|FG000|Treatment Course 1|Withdrawal by Sponsor|0
7503520|NCT02301897|11829342|FG001|Treatment Course 1|Withdrawal by Sponsor|0
7503521|NCT02301897|11829343|FG002|Treatment Course 1|Withdrawal by Sponsor|2
7503522|NCT02301897|11829341|FG000|Treatment Course 1|Withdrawal by Subject|0
7503523|NCT02301897|11829342|FG001|Treatment Course 1|Withdrawal by Subject|0
7503525|NCT02301897|11829341|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
7503526|NCT02301897|11829342|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
7503527|NCT02301897|11829343|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
7503528|NCT02301897|11829341|FG000|Treatment Course 2|Lost to Follow-up|0
7503529|NCT02301897|11829342|FG001|Treatment Course 2|Lost to Follow-up|2
7503530|NCT02301897|11829343|FG002|Treatment Course 2|Lost to Follow-up|0
7503531|NCT02301897|11829341|FG000|Treatment Course 2|Pregnancy|0
7503532|NCT02301897|11829342|FG001|Treatment Course 2|Pregnancy|1
7503533|NCT02301897|11829343|FG002|Treatment Course 2|Pregnancy|1
7503534|NCT02301897|11829341|FG000|Treatment Course 2|Withdrawal by Subject|0
7503535|NCT02301897|11829342|FG001|Treatment Course 2|Withdrawal by Subject|2
7503536|NCT02301897|11829343|FG002|Treatment Course 2|Withdrawal by Subject|0
7503537|NCT02301897|11829341|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
7503538|NCT02301897|11829342|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
7503539|NCT02301897|11829343|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
7503540|NCT02301936|11829353|FG000|Overall Study|Lost to Follow-up|1
7503541|NCT02301936|11829354|FG001|Overall Study|Lost to Follow-up|0
7503542|NCT02301975|11829363|FG000|Overall Study|Adverse Event|8
7503543|NCT02301975|11829364|FG001|Overall Study|Adverse Event|3
7503544|NCT02301975|11829365|FG002|Overall Study|Adverse Event|2
7503545|NCT02301975|11829363|FG000|Overall Study|Lack of Efficacy|1
7503546|NCT02301975|11829364|FG001|Overall Study|Lack of Efficacy|1
7503547|NCT02301975|11829365|FG002|Overall Study|Lack of Efficacy|1
7503548|NCT02301975|11829363|FG000|Overall Study|Protocol Violation|3
7503549|NCT02301975|11829364|FG001|Overall Study|Protocol Violation|5
7503550|NCT02301975|11829365|FG002|Overall Study|Protocol Violation|3
7503551|NCT02301975|11829363|FG000|Overall Study|Lost to Follow-up|0
7503552|NCT02301975|11829364|FG001|Overall Study|Lost to Follow-up|2
7503553|NCT02301975|11829365|FG002|Overall Study|Lost to Follow-up|2
7503554|NCT02301975|11829363|FG000|Overall Study|Physician Decision|4
7503555|NCT02301975|11829364|FG001|Overall Study|Physician Decision|2
7503556|NCT02301975|11829365|FG002|Overall Study|Physician Decision|3
7503557|NCT02301975|11829363|FG000|Overall Study|Withdrawal by Subject|15
7503558|NCT02301975|11829364|FG001|Overall Study|Withdrawal by Subject|12
7503559|NCT02301975|11829365|FG002|Overall Study|Withdrawal by Subject|11
7503560|NCT02301988|11829375|FG000|Overall Study|Withdrawal by Subject|2
7503561|NCT02301988|11829376|FG001|Overall Study|Withdrawal by Subject|1
7503562|NCT02301988|11829375|FG000|Overall Study|Physician Decision|2
7503563|NCT02301988|11829376|FG001|Overall Study|Physician Decision|2
7503564|NCT02301988|11829375|FG000|Overall Study|Unknown Reason|1
7503565|NCT02301988|11829376|FG001|Overall Study|Unknown Reason|3
7503566|NCT02301988|11829375|FG000|Overall Study|Lack of Efficacy|3
7503567|NCT02301988|11829376|FG001|Overall Study|Lack of Efficacy|2
7503568|NCT02301988|11829375|FG000|Overall Study|Death|1
7503569|NCT02301988|11829376|FG001|Overall Study|Death|0
7503570|NCT02301988|11829375|FG000|Overall Study|Adverse Event|1
7503571|NCT02301988|11829376|FG001|Overall Study|Adverse Event|1
7503572|NCT02302066|11829386|FG000|Overall Study|Adverse Event|1
7503573|NCT02302066|11829387|FG001|Overall Study|Adverse Event|1
7503574|NCT02302066|11829388|FG002|Overall Study|Adverse Event|3
7503575|NCT02302066|11829389|FG003|Overall Study|Adverse Event|0
7503576|NCT02302066|11829386|FG000|Overall Study|Lost to Follow-up|4
7503577|NCT02302066|11829387|FG001|Overall Study|Lost to Follow-up|5
7503578|NCT02302066|11829388|FG002|Overall Study|Lost to Follow-up|24
7503579|NCT02302066|11829389|FG003|Overall Study|Lost to Follow-up|7
7503580|NCT02302066|11829386|FG000|Overall Study|Withdrawal by Subject|25
7503581|NCT02302066|11829387|FG001|Overall Study|Withdrawal by Subject|58
7503582|NCT02302066|11829388|FG002|Overall Study|Withdrawal by Subject|124
7503583|NCT02302066|11829389|FG003|Overall Study|Withdrawal by Subject|33
7503584|NCT02302066|11829386|FG000|Overall Study|Pregnancy|2
7503585|NCT02302066|11829387|FG001|Overall Study|Pregnancy|10
7503586|NCT02302066|11829388|FG002|Overall Study|Pregnancy|12
7503587|NCT02302066|11829389|FG003|Overall Study|Pregnancy|0
7503588|NCT02302066|11829386|FG000|Overall Study|Reason Not Specified|1
7503589|NCT02302066|11829387|FG001|Overall Study|Reason Not Specified|1
7503590|NCT02302066|11829388|FG002|Overall Study|Reason Not Specified|9
7503591|NCT02302066|11829389|FG003|Overall Study|Reason Not Specified|1
7503600|NCT02302339|11829457|FG000|Overall Study|Lost to Follow-up|1
7503601|NCT02302339|11829458|FG001|Overall Study|Lost to Follow-up|0
7503602|NCT02302339|11829459|FG002|Overall Study|Lost to Follow-up|0
7503603|NCT02302339|11829460|FG003|Overall Study|Lost to Follow-up|0
7503604|NCT02302339|11829457|FG000|Overall Study|Withdrawal by Subject|0
7503605|NCT02302339|11829458|FG001|Overall Study|Withdrawal by Subject|2
7503606|NCT02302339|11829459|FG002|Overall Study|Withdrawal by Subject|1
7503607|NCT02302339|11829460|FG003|Overall Study|Withdrawal by Subject|0
7503608|NCT02302716|11829481|FG000|Overall Study|Adverse Event|1
7503609|NCT02302716|11829482|FG001|Overall Study|Adverse Event|1
7503610|NCT02302716|11829481|FG000|Overall Study|Death|0
7503611|NCT02302716|11829482|FG001|Overall Study|Death|1
7503612|NCT02302716|11829481|FG000|Overall Study|Lack of Efficacy|0
7503613|NCT02302716|11829482|FG001|Overall Study|Lack of Efficacy|1
7503614|NCT02302716|11829481|FG000|Overall Study|Lost to Follow-up|2
7503615|NCT02302716|11829482|FG001|Overall Study|Lost to Follow-up|4
7503616|NCT02302716|11829481|FG000|Overall Study|Physician Decision|3
7503617|NCT02302716|11829482|FG001|Overall Study|Physician Decision|4
7503618|NCT02302716|11829481|FG000|Overall Study|Withdrawal by Subject|13
7503619|NCT02302716|11829482|FG001|Overall Study|Withdrawal by Subject|7
7503620|NCT02302716|11829481|FG000|Overall Study|Protocol Violation|0
7503621|NCT02302716|11829482|FG001|Overall Study|Protocol Violation|1
7503622|NCT02302807|11829490|FG000|Overall Study|Withdrawal by Subject|28
7503623|NCT02302807|11829491|FG001|Overall Study|Withdrawal by Subject|11
7503624|NCT02302807|11829490|FG000|Overall Study|Lost to Follow-up|4
7503625|NCT02302807|11829491|FG001|Overall Study|Lost to Follow-up|6
7503626|NCT02302807|11829490|FG000|Overall Study|Death|397
7503627|NCT02302807|11829491|FG001|Overall Study|Death|385
7503628|NCT02302807|11829490|FG000|Overall Study|Study Terminated By Sponsor|35
7503629|NCT02302807|11829491|FG001|Overall Study|Study Terminated By Sponsor|64
7503630|NCT02302807|11829490|FG000|Overall Study|Physician Decision|0
7503631|NCT02302807|11829491|FG001|Overall Study|Physician Decision|1
7503632|NCT02302846|11829510|FG000|Overall Study|Withdrawal by Subject|1
7503633|NCT02303041|11829516|FG000|Overall Study|Adverse Event|1
7503634|NCT02303041|11829517|FG001|Overall Study|Adverse Event|2
7503635|NCT02303262|11829548|FG000|Overall Study|Withdrawal by Subject|2
7503636|NCT02303574|11829564|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503637|NCT02303574|11829565|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503638|NCT02303574|11829566|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
7503639|NCT02303574|11829567|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503640|NCT02303574|11829568|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503641|NCT02303574|11829569|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503642|NCT02303574|11829570|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503643|NCT02303574|11829571|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503644|NCT02303574|11829572|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503645|NCT02303574|11829573|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
7503646|NCT02303574|11829564|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503647|NCT02303574|11829565|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503648|NCT02303574|11829566|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503649|NCT02303574|11829567|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503650|NCT02303574|11829568|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503651|NCT02303574|11829569|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503652|NCT02303574|11829570|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503653|NCT02303574|11829571|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
7503654|NCT02303574|11829572|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503655|NCT02303574|11829573|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
7503656|NCT02303704|11829608|FG000|Overall Study|Protocol Violation|5
7503657|NCT02303704|11829609|FG001|Overall Study|Protocol Violation|9
7503658|NCT02304380|11829648|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7503659|NCT02304380|11829649|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7503660|NCT02304380|11829650|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7503661|NCT02304380|11829651|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
7503662|NCT02304380|11829652|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7503663|NCT02304380|11829653|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
7503664|NCT02304484|11829689|FG000|Overall Study|Death|9
7503665|NCT02304484|11829689|FG000|Overall Study|Withdrawal by Subject|14
7503666|NCT02304484|11829689|FG000|Overall Study|Lost to Follow-up|2
7503667|NCT02304705|11829695|FG000|Overall Study|Withdrawal by Subject|2
7503668|NCT02304705|11829696|FG001|Overall Study|Withdrawal by Subject|0
7503669|NCT02304705|11829695|FG000|Overall Study|Physician Decision|2
7503670|NCT02304705|11829696|FG001|Overall Study|Physician Decision|4
7503671|NCT02304705|11829695|FG000|Overall Study|Death|0
7503672|NCT02304705|11829696|FG001|Overall Study|Death|1
7503673|NCT02304705|11829695|FG000|Overall Study|Lost to Follow-up|0
7503674|NCT02304705|11829696|FG001|Overall Study|Lost to Follow-up|2
7535825|NCT02712983|11883586|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7535826|NCT02712983|11883587|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7535827|NCT02712983|11883588|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7535828|NCT02712983|11883589|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7535829|NCT02712983|11883590|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7535830|NCT02712983|11883591|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
7535831|NCT02712983|11883592|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
7535832|NCT02712983|11883593|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
7535833|NCT02712996|11883615|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
7535834|NCT02712996|11883616|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
7535835|NCT02713204|11883640|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
7535836|NCT02713204|11883641|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
7535837|NCT02713204|11883642|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
7535838|NCT02713204|11883643|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
7535839|NCT02713204|11883644|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
7535840|NCT02713204|11883645|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
7535841|NCT02713204|11883646|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
7535842|NCT02713204|11883647|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
7503675|NCT02304926|11829713|FG000|Overall Study|Lost to Follow-up|2
7503676|NCT02304926|11829714|FG001|Overall Study|Lost to Follow-up|1
7503677|NCT02305238|11829738|FG000|Overall Study|Death|2
7503678|NCT02305238|11829739|FG001|Overall Study|Death|1
7503679|NCT02305238|11829740|FG002|Overall Study|Death|0
7503680|NCT02305238|11829738|FG000|Overall Study|Progressive disease|4
7503681|NCT02305238|11829739|FG001|Overall Study|Progressive disease|4
7503682|NCT02305238|11829740|FG002|Overall Study|Progressive disease|0
7503683|NCT02305238|11829738|FG000|Overall Study|Logistical difficulties|1
7503684|NCT02305238|11829739|FG001|Overall Study|Logistical difficulties|3
7503685|NCT02305238|11829740|FG002|Overall Study|Logistical difficulties|0
7503686|NCT02305238|11829738|FG000|Overall Study|Protocol Violation|0
7503687|NCT02305238|11829739|FG001|Overall Study|Protocol Violation|3
7503688|NCT02305238|11829740|FG002|Overall Study|Protocol Violation|0
7503689|NCT02305238|11829738|FG000|Overall Study|Physician Decision|2
7503690|NCT02305238|11829739|FG001|Overall Study|Physician Decision|1
7503691|NCT02305238|11829740|FG002|Overall Study|Physician Decision|0
7503692|NCT02305238|11829738|FG000|Overall Study|Adverse Event|4
7503693|NCT02305238|11829739|FG001|Overall Study|Adverse Event|2
7503694|NCT02305238|11829740|FG002|Overall Study|Adverse Event|0
7503695|NCT02305238|11829738|FG000|Overall Study|Withdrawal by Subject|3
7503696|NCT02305238|11829739|FG001|Overall Study|Withdrawal by Subject|4
7503697|NCT02305238|11829740|FG002|Overall Study|Withdrawal by Subject|0
7503698|NCT02305238|11829738|FG000|Overall Study|Randomized failure|0
7503699|NCT02305238|11829739|FG001|Overall Study|Randomized failure|0
7503700|NCT02305238|11829740|FG002|Overall Study|Randomized failure|8
7503701|NCT02305238|11829738|FG000|Overall Study|Required procedure failed|0
7503702|NCT02305238|11829739|FG001|Overall Study|Required procedure failed|1
7503703|NCT02305238|11829740|FG002|Overall Study|Required procedure failed|0
7503704|NCT02305381|11829801|FG000|Overall Study|Unclassified|5
7503705|NCT02305381|11829802|FG001|Overall Study|Unclassified|5
7503706|NCT02305381|11829803|FG002|Overall Study|Unclassified|7
7503707|NCT02305446|11829811|FG000|Overall Study|Adverse Event|1
7503708|NCT02305563|11829820|FG000|Treatment Period|Disease progression|0
7503709|NCT02305563|11829821|FG001|Treatment Period|Disease progression|0
7503710|NCT02305563|11829822|FG002|Treatment Period|Disease progression|15
7503711|NCT02305563|11829823|FG003|Treatment Period|Disease progression|6
7503712|NCT02305563|11829824|FG004|Treatment Period|Disease progression|6
7503713|NCT02305563|11829820|FG000|Treatment Period|Study drug toxicity|0
7503714|NCT02305563|11829821|FG001|Treatment Period|Study drug toxicity|0
7503715|NCT02305563|11829822|FG002|Treatment Period|Study drug toxicity|0
7503716|NCT02305563|11829823|FG003|Treatment Period|Study drug toxicity|1
7503717|NCT02305563|11829824|FG004|Treatment Period|Study drug toxicity|2
7503718|NCT02305563|11829820|FG000|Treatment Period|Death|0
7503719|NCT02305563|11829821|FG001|Treatment Period|Death|0
7503720|NCT02305563|11829822|FG002|Treatment Period|Death|1
7503721|NCT02305563|11829823|FG003|Treatment Period|Death|2
7503722|NCT02305563|11829824|FG004|Treatment Period|Death|1
7503723|NCT02305563|11829820|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
7503724|NCT02305563|11829821|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
7503725|NCT02305563|11829822|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
7503726|NCT02305563|11829823|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
7503727|NCT02305563|11829824|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
7503728|NCT02305563|11829820|FG000|Treatment Period|Participant request to stop therapy|0
7503729|NCT02305563|11829821|FG001|Treatment Period|Participant request to stop therapy|2
7503730|NCT02305563|11829822|FG002|Treatment Period|Participant request to stop therapy|0
7503731|NCT02305563|11829823|FG003|Treatment Period|Participant request to stop therapy|1
7503732|NCT02305563|11829824|FG004|Treatment Period|Participant request to stop therapy|0
7503733|NCT02305563|11829820|FG000|Treatment Period|Participant withdrew consent|0
7503734|NCT02305563|11829821|FG001|Treatment Period|Participant withdrew consent|0
7503735|NCT02305563|11829822|FG002|Treatment Period|Participant withdrew consent|1
7503736|NCT02305563|11829823|FG003|Treatment Period|Participant withdrew consent|1
7503737|NCT02305563|11829824|FG004|Treatment Period|Participant withdrew consent|1
7503738|NCT02305563|11829820|FG000|Treatment Period|Maximum clinical benefit|0
7503739|NCT02305563|11829821|FG001|Treatment Period|Maximum clinical benefit|0
7503740|NCT02305563|11829822|FG002|Treatment Period|Maximum clinical benefit|0
7503741|NCT02305563|11829823|FG003|Treatment Period|Maximum clinical benefit|0
7503742|NCT02305563|11829824|FG004|Treatment Period|Maximum clinical benefit|1
7503743|NCT02305563|11829820|FG000|Treatment Period|Poor/non-compliance|0
7503744|NCT02305563|11829821|FG001|Treatment Period|Poor/non-compliance|0
7503745|NCT02305563|11829822|FG002|Treatment Period|Poor/non-compliance|0
7503746|NCT02305563|11829823|FG003|Treatment Period|Poor/non-compliance|0
7503747|NCT02305563|11829824|FG004|Treatment Period|Poor/non-compliance|1
7503748|NCT02305563|11829820|FG000|Treatment Period|Administrative reason by Sponsor|0
7503749|NCT02305563|11829821|FG001|Treatment Period|Administrative reason by Sponsor|0
7503750|NCT02305563|11829822|FG002|Treatment Period|Administrative reason by Sponsor|0
7503833|NCT02305849|11829869|FG003|Overall Study|Withdrawal by Subject|4
7503751|NCT02305563|11829823|FG003|Treatment Period|Administrative reason by Sponsor|0
7503752|NCT02305563|11829824|FG004|Treatment Period|Administrative reason by Sponsor|1
7503753|NCT02305563|11829820|FG000|Treatment Period|other reason|2
7503754|NCT02305563|11829821|FG001|Treatment Period|other reason|0
7503755|NCT02305563|11829822|FG002|Treatment Period|other reason|2
7503756|NCT02305563|11829823|FG003|Treatment Period|other reason|2
7503757|NCT02305563|11829824|FG004|Treatment Period|other reason|1
7503758|NCT02305563|11829820|FG000|Treatment Period|Randomized but not treated|0
7503759|NCT02305563|11829821|FG001|Treatment Period|Randomized but not treated|0
7503760|NCT02305563|11829822|FG002|Treatment Period|Randomized but not treated|0
7503761|NCT02305563|11829823|FG003|Treatment Period|Randomized but not treated|0
7503762|NCT02305563|11829824|FG004|Treatment Period|Randomized but not treated|2
7503763|NCT02305563|11829820|FG000|Treatment Period|added ULO, then disease progression|0
7503764|NCT02305563|11829821|FG001|Treatment Period|added ULO, then disease progression|0
7503765|NCT02305563|11829822|FG002|Treatment Period|added ULO, then disease progression|0
7503766|NCT02305563|11829823|FG003|Treatment Period|added ULO, then disease progression|0
7503767|NCT02305563|11829824|FG004|Treatment Period|added ULO, then disease progression|4
7503768|NCT02305563|11829820|FG000|Treatment Period|added ULO; then other reason|0
7503769|NCT02305563|11829821|FG001|Treatment Period|added ULO; then other reason|0
7503770|NCT02305563|11829822|FG002|Treatment Period|added ULO; then other reason|0
7503771|NCT02305563|11829823|FG003|Treatment Period|added ULO; then other reason|0
7503772|NCT02305563|11829824|FG004|Treatment Period|added ULO; then other reason|1
7503773|NCT02305563|11829820|FG000|Treatment Period|added ULO, then request to stop|0
7503774|NCT02305563|11829821|FG001|Treatment Period|added ULO, then request to stop|0
7503775|NCT02305563|11829822|FG002|Treatment Period|added ULO, then request to stop|0
7503776|NCT02305563|11829823|FG003|Treatment Period|added ULO, then request to stop|0
7503777|NCT02305563|11829824|FG004|Treatment Period|added ULO, then request to stop|1
7503778|NCT02305563|11829820|FG000|Follow-up Period|Death|0
7503779|NCT02305563|11829821|FG001|Follow-up Period|Death|0
7503780|NCT02305563|11829822|FG002|Follow-up Period|Death|5
7503781|NCT02305563|11829823|FG003|Follow-up Period|Death|4
7503782|NCT02305563|11829824|FG004|Follow-up Period|Death|7
7503783|NCT02305563|11829820|FG000|Follow-up Period|Participant withdrew consent|0
7503784|NCT02305563|11829821|FG001|Follow-up Period|Participant withdrew consent|0
7503785|NCT02305563|11829822|FG002|Follow-up Period|Participant withdrew consent|2
7503786|NCT02305563|11829823|FG003|Follow-up Period|Participant withdrew consent|1
7503787|NCT02305563|11829824|FG004|Follow-up Period|Participant withdrew consent|0
7503788|NCT02305563|11829820|FG000|Follow-up Period|other reason|0
7503789|NCT02305563|11829821|FG001|Follow-up Period|other reason|0
7503790|NCT02305563|11829822|FG002|Follow-up Period|other reason|0
7503791|NCT02305563|11829823|FG003|Follow-up Period|other reason|0
7503792|NCT02305563|11829824|FG004|Follow-up Period|other reason|1
7503793|NCT02305563|11829820|FG000|Follow-up Period|Followup no longer required per protocol|3
7503794|NCT02305563|11829821|FG001|Follow-up Period|Followup no longer required per protocol|3
7503795|NCT02305563|11829822|FG002|Follow-up Period|Followup no longer required per protocol|4
7503796|NCT02305563|11829823|FG003|Follow-up Period|Followup no longer required per protocol|1
7503797|NCT02305563|11829824|FG004|Follow-up Period|Followup no longer required per protocol|4
7503798|NCT02305758|11829847|FG000|Overall Study|Death|27
7503799|NCT02305758|11829848|FG001|Overall Study|Death|27
7503800|NCT02305758|11829847|FG000|Overall Study|Withdrew consent|9
7503801|NCT02305758|11829848|FG001|Overall Study|Withdrew consent|2
7503802|NCT02305758|11829847|FG000|Overall Study|Lost to Follow-up|6
7503803|NCT02305758|11829848|FG001|Overall Study|Lost to Follow-up|1
7503804|NCT02305758|11829847|FG000|Overall Study|Study Terminated by Sponsor|21
7503805|NCT02305758|11829848|FG001|Overall Study|Study Terminated by Sponsor|34
7503806|NCT02305758|11829847|FG000|Overall Study|Other, not specified|2
7503807|NCT02305758|11829848|FG001|Overall Study|Other, not specified|1
7503808|NCT02305797|11829856|FG000|Overall Study|Adverse Event|11
7503809|NCT02305797|11829857|FG001|Overall Study|Adverse Event|2
7503810|NCT02305797|11829856|FG000|Overall Study|Withdrawal by Subject|9
7503811|NCT02305797|11829857|FG001|Overall Study|Withdrawal by Subject|10
7503812|NCT02305797|11829856|FG000|Overall Study|Lack of Efficacy|6
7503813|NCT02305797|11829857|FG001|Overall Study|Lack of Efficacy|0
7503814|NCT02305797|11829856|FG000|Overall Study|Lost to Follow-up|5
7503815|NCT02305797|11829857|FG001|Overall Study|Lost to Follow-up|11
7503816|NCT02305797|11829856|FG000|Overall Study|Pregnancy|0
7503817|NCT02305797|11829857|FG001|Overall Study|Pregnancy|2
7503818|NCT02305797|11829856|FG000|Overall Study|Noncompliance|14
7503819|NCT02305797|11829857|FG001|Overall Study|Noncompliance|12
7503820|NCT02305797|11829856|FG000|Overall Study|Reason not collected|0
7503821|NCT02305797|11829857|FG001|Overall Study|Reason not collected|1
7503822|NCT02305849|11829866|FG000|Overall Study|Adverse Event|10
7503823|NCT02305849|11829867|FG001|Overall Study|Adverse Event|12
7503824|NCT02305849|11829868|FG002|Overall Study|Adverse Event|7
7503825|NCT02305849|11829869|FG003|Overall Study|Adverse Event|3
7503826|NCT02305849|11829866|FG000|Overall Study|Lack of Efficacy|10
7503827|NCT02305849|11829867|FG001|Overall Study|Lack of Efficacy|6
7503828|NCT02305849|11829868|FG002|Overall Study|Lack of Efficacy|3
7503829|NCT02305849|11829869|FG003|Overall Study|Lack of Efficacy|9
7503830|NCT02305849|11829866|FG000|Overall Study|Withdrawal by Subject|2
7503831|NCT02305849|11829867|FG001|Overall Study|Withdrawal by Subject|2
7503832|NCT02305849|11829868|FG002|Overall Study|Withdrawal by Subject|1
7503834|NCT02305849|11829866|FG000|Overall Study|Lost to Follow-up|0
7503835|NCT02305849|11829867|FG001|Overall Study|Lost to Follow-up|2
7503836|NCT02305849|11829868|FG002|Overall Study|Lost to Follow-up|0
7503837|NCT02305849|11829869|FG003|Overall Study|Lost to Follow-up|0
7503838|NCT02305849|11829866|FG000|Overall Study|Protocol Violation|3
7503839|NCT02305849|11829867|FG001|Overall Study|Protocol Violation|2
7503840|NCT02305849|11829868|FG002|Overall Study|Protocol Violation|1
7503841|NCT02305849|11829869|FG003|Overall Study|Protocol Violation|1
7503842|NCT02305849|11829866|FG000|Overall Study|Lab data met discontinuation criteria|0
7503843|NCT02305849|11829867|FG001|Overall Study|Lab data met discontinuation criteria|1
7503844|NCT02305849|11829868|FG002|Overall Study|Lab data met discontinuation criteria|2
7503845|NCT02305849|11829869|FG003|Overall Study|Lab data met discontinuation criteria|1
7503846|NCT02305849|11829866|FG000|Overall Study|Miscellaneous|1
7503847|NCT02305849|11829867|FG001|Overall Study|Miscellaneous|2
7503848|NCT02305849|11829868|FG002|Overall Study|Miscellaneous|4
7503849|NCT02305849|11829869|FG003|Overall Study|Miscellaneous|1
7503850|NCT02305849|11829866|FG000|Overall Study|Not fulfill eligibility criteria|1
7503851|NCT02305849|11829867|FG001|Overall Study|Not fulfill eligibility criteria|1
7503852|NCT02305849|11829868|FG002|Overall Study|Not fulfill eligibility criteria|0
7503853|NCT02305849|11829869|FG003|Overall Study|Not fulfill eligibility criteria|0
7503854|NCT02305888|11829903|FG000|Overall Study|Lost to Follow-up|0
7503855|NCT02305888|11829904|FG001|Overall Study|Lost to Follow-up|0
7503856|NCT02305888|11829905|FG002|Overall Study|Lost to Follow-up|1
7503857|NCT02305888|11829903|FG000|Overall Study|Adverse Event|0
7503858|NCT02305888|11829904|FG001|Overall Study|Adverse Event|1
7503859|NCT02305888|11829905|FG002|Overall Study|Adverse Event|0
7503860|NCT02306265|11829913|FG000|Overall Study|Withdrawal by Subject|1
7503861|NCT02306694|11829918|FG000|Overall Study|Withdrawal by Subject|3
7503862|NCT02306694|11829918|FG000|Overall Study|Lost to Follow-up|1
7503863|NCT02306850|11829933|FG000|Overall Study|Lack of Efficacy|2
7503864|NCT02307266|11829949|FG000|Overall Study|Adverse Event|3
7503865|NCT02307266|11829950|FG001|Overall Study|Adverse Event|1
7503866|NCT02307266|11829951|FG002|Overall Study|Adverse Event|5
7503867|NCT02307266|11829949|FG000|Overall Study|Withdrawal by Subject|2
7503868|NCT02307266|11829950|FG001|Overall Study|Withdrawal by Subject|0
7503869|NCT02307266|11829951|FG002|Overall Study|Withdrawal by Subject|1
7503870|NCT02307266|11829949|FG000|Overall Study|Lost to Follow-up|3
7503871|NCT02307266|11829950|FG001|Overall Study|Lost to Follow-up|0
7503872|NCT02307266|11829951|FG002|Overall Study|Lost to Follow-up|0
7503873|NCT02307370|11829963|FG000|Overall Study|Death|5
7503874|NCT02307370|11829963|FG000|Overall Study|Lost to Follow-up|1
7503875|NCT02307370|11829963|FG000|Overall Study|Withdrawal by Subject|1
7503876|NCT02307370|11829963|FG000|Overall Study|Declined Addendum ICF|6
7503877|NCT02307370|11829963|FG000|Overall Study|No response during telephone contact|5
7503878|NCT02307370|11829963|FG000|Overall Study|Protocol Violation|1
7503879|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
7503880|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
7503881|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
7503882|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
7503883|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
7503884|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
7503885|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
7503886|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
7503887|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
7503888|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
7503889|NCT02307513|11829971|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7503890|NCT02307513|11829972|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
7503891|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
7503892|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
7503893|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
7503894|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
7503895|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7503896|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
7503897|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7503898|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
7503899|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7503900|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
7503901|NCT02307513|11829971|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
7503902|NCT02307513|11829972|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
7503903|NCT02307513|11829971|FG000|Long-term Extension|Physician Decision|1
7503904|NCT02307513|11829972|FG001|Long-term Extension|Physician Decision|0
7503905|NCT02307682|11829995|FG000|Overall Study|Adverse Event|9
7503906|NCT02307682|11829996|FG001|Overall Study|Adverse Event|8
7503907|NCT02307682|11829997|FG002|Overall Study|Adverse Event|12
7503908|NCT02307682|11829995|FG000|Overall Study|Lack of Efficacy|1
7503909|NCT02307682|11829996|FG001|Overall Study|Lack of Efficacy|0
7503910|NCT02307682|11829997|FG002|Overall Study|Lack of Efficacy|1
7503911|NCT02307682|11829995|FG000|Overall Study|Physician Decision|2
7503912|NCT02307682|11829996|FG001|Overall Study|Physician Decision|2
7503913|NCT02307682|11829997|FG002|Overall Study|Physician Decision|8
7503914|NCT02307682|11829995|FG000|Overall Study|Progressive Disease|1
7503915|NCT02307682|11829996|FG001|Overall Study|Progressive Disease|0
7503916|NCT02307682|11829997|FG002|Overall Study|Progressive Disease|0
7503917|NCT02307682|11829995|FG000|Overall Study|Withdrawal by Subject|26
7503918|NCT02307682|11829996|FG001|Overall Study|Withdrawal by Subject|34
7503919|NCT02307682|11829997|FG002|Overall Study|Withdrawal by Subject|23
7503920|NCT02307682|11829995|FG000|Overall Study|Death|9
7503921|NCT02307682|11829996|FG001|Overall Study|Death|7
7503922|NCT02307682|11829997|FG002|Overall Study|Death|12
7503923|NCT02307682|11829995|FG000|Overall Study|Lost to Follow-up|1
7503924|NCT02307682|11829996|FG001|Overall Study|Lost to Follow-up|5
7503925|NCT02307682|11829997|FG002|Overall Study|Lost to Follow-up|6
7503926|NCT02307682|11829995|FG000|Overall Study|Protocol Deviation|0
7503927|NCT02307682|11829996|FG001|Overall Study|Protocol Deviation|0
7503928|NCT02307682|11829997|FG002|Overall Study|Protocol Deviation|2
7503929|NCT02307682|11829995|FG000|Overall Study|Other|1
7503930|NCT02307682|11829996|FG001|Overall Study|Other|1
7503931|NCT02307682|11829997|FG002|Overall Study|Other|0
7503932|NCT02308007|11830031|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
7503933|NCT02308007|11830032|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
7503934|NCT02308007|11830033|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
7503935|NCT02308007|11830031|FG000|Overall Study|Positive for STD at Baseline|7
7503936|NCT02308007|11830032|FG001|Overall Study|Positive for STD at Baseline|11
7503937|NCT02308007|11830033|FG002|Overall Study|Positive for STD at Baseline|7
7503938|NCT02308007|11830031|FG000|Overall Study|Lost to Follow-up|3
7503939|NCT02308007|11830032|FG001|Overall Study|Lost to Follow-up|0
7503940|NCT02308007|11830033|FG002|Overall Study|Lost to Follow-up|1
7503941|NCT02308020|11830047|FG000|Overall Study|Lost to Follow-up|1
7503942|NCT02308020|11830048|FG001|Overall Study|Lost to Follow-up|7
7503943|NCT02308020|11830049|FG002|Overall Study|Lost to Follow-up|0
7503944|NCT02308020|11830050|FG003|Overall Study|Lost to Follow-up|0
7503945|NCT02308020|11830051|FG004|Overall Study|Lost to Follow-up|1
7503946|NCT02308020|11830052|FG005|Overall Study|Lost to Follow-up|2
7503947|NCT02308020|11830047|FG000|Overall Study|Sponsor Decision|0
7503948|NCT02308020|11830048|FG001|Overall Study|Sponsor Decision|8
7503949|NCT02308020|11830049|FG002|Overall Study|Sponsor Decision|0
7503950|NCT02308020|11830050|FG003|Overall Study|Sponsor Decision|2
7503951|NCT02308020|11830051|FG004|Overall Study|Sponsor Decision|2
7503952|NCT02308020|11830052|FG005|Overall Study|Sponsor Decision|1
7503953|NCT02308020|11830047|FG000|Overall Study|Withdrawal by Subject|3
7503954|NCT02308020|11830048|FG001|Overall Study|Withdrawal by Subject|5
7503955|NCT02308020|11830049|FG002|Overall Study|Withdrawal by Subject|3
7503956|NCT02308020|11830050|FG003|Overall Study|Withdrawal by Subject|2
7503957|NCT02308020|11830051|FG004|Overall Study|Withdrawal by Subject|1
7503958|NCT02308020|11830052|FG005|Overall Study|Withdrawal by Subject|2
7503959|NCT02308033|11830074|FG000|Overall Study|Normal Gram stain at Baseline|13
7503960|NCT02308033|11830075|FG001|Overall Study|Normal Gram stain at Baseline|10
7503961|NCT02308033|11830074|FG000|Overall Study|Positive for STD at Baseline|7
7503962|NCT02308033|11830075|FG001|Overall Study|Positive for STD at Baseline|4
7503963|NCT02308033|11830074|FG000|Overall Study|Lost to Follow-up|6
7503964|NCT02308033|11830075|FG001|Overall Study|Lost to Follow-up|5
7503965|NCT02308046|11830083|FG000|Overall Study|Negative yeast culture at Baseline|32
7503966|NCT02308046|11830084|FG001|Overall Study|Negative yeast culture at Baseline|33
7503967|NCT02308046|11830083|FG000|Overall Study|Positive for STD at Baseline|1
7503968|NCT02308046|11830084|FG001|Overall Study|Positive for STD at Baseline|2
7503969|NCT02308046|11830083|FG000|Overall Study|Lost to Follow-up|1
7503970|NCT02308046|11830084|FG001|Overall Study|Lost to Follow-up|3
7503971|NCT02308124|11830093|FG000|Overall Study|Lost to Follow-up|6
7503972|NCT02308124|11830094|FG001|Overall Study|Lost to Follow-up|6
7503973|NCT02308124|11830095|FG002|Overall Study|Lost to Follow-up|6
7503974|NCT02308124|11830093|FG000|Overall Study|Adverse Event|0
7503975|NCT02308124|11830094|FG001|Overall Study|Adverse Event|2
7503976|NCT02308124|11830095|FG002|Overall Study|Adverse Event|2
7503977|NCT02308163|11830107|FG000|Overall Study|Not fulfill eligible criteria|1
7503978|NCT02308163|11830108|FG001|Overall Study|Not fulfill eligible criteria|2
7503979|NCT02308163|11830109|FG002|Overall Study|Not fulfill eligible criteria|0
7503980|NCT02308163|11830110|FG003|Overall Study|Not fulfill eligible criteria|1
7503981|NCT02308163|11830111|FG004|Overall Study|Not fulfill eligible criteria|1
7503982|NCT02308163|11830107|FG000|Overall Study|Adverse Event|9
7503983|NCT02308163|11830108|FG001|Overall Study|Adverse Event|5
7503984|NCT02308163|11830109|FG002|Overall Study|Adverse Event|2
7503985|NCT02308163|11830110|FG003|Overall Study|Adverse Event|2
7503986|NCT02308163|11830111|FG004|Overall Study|Adverse Event|11
7503987|NCT02308163|11830107|FG000|Overall Study|Lack of Efficacy|11
7503988|NCT02308163|11830108|FG001|Overall Study|Lack of Efficacy|3
7503989|NCT02308163|11830109|FG002|Overall Study|Lack of Efficacy|8
7503990|NCT02308163|11830110|FG003|Overall Study|Lack of Efficacy|4
7503991|NCT02308163|11830111|FG004|Overall Study|Lack of Efficacy|6
7503992|NCT02308163|11830107|FG000|Overall Study|Withdrawal of consent|2
7503993|NCT02308163|11830108|FG001|Overall Study|Withdrawal of consent|3
7503994|NCT02308163|11830109|FG002|Overall Study|Withdrawal of consent|0
7503995|NCT02308163|11830110|FG003|Overall Study|Withdrawal of consent|2
7503996|NCT02308163|11830111|FG004|Overall Study|Withdrawal of consent|6
7503997|NCT02308163|11830107|FG000|Overall Study|Protocol Violation|3
7503998|NCT02308163|11830108|FG001|Overall Study|Protocol Violation|3
7503999|NCT02308163|11830109|FG002|Overall Study|Protocol Violation|3
7504000|NCT02308163|11830110|FG003|Overall Study|Protocol Violation|2
7504001|NCT02308163|11830111|FG004|Overall Study|Protocol Violation|5
7504002|NCT02308163|11830107|FG000|Overall Study|Lab data met discontinuation criteria|3
7504003|NCT02308163|11830108|FG001|Overall Study|Lab data met discontinuation criteria|0
7504004|NCT02308163|11830109|FG002|Overall Study|Lab data met discontinuation criteria|0
7504005|NCT02308163|11830110|FG003|Overall Study|Lab data met discontinuation criteria|2
7504006|NCT02308163|11830111|FG004|Overall Study|Lab data met discontinuation criteria|0
7504007|NCT02308163|11830107|FG000|Overall Study|Miscellaneous|2
7504008|NCT02308163|11830108|FG001|Overall Study|Miscellaneous|2
7504009|NCT02308163|11830109|FG002|Overall Study|Miscellaneous|1
7504010|NCT02308163|11830110|FG003|Overall Study|Miscellaneous|0
7504011|NCT02308163|11830111|FG004|Overall Study|Miscellaneous|5
7504012|NCT02308228|11830149|FG000|Overall Study|Adverse Event|3
7504013|NCT02308228|11830150|FG001|Overall Study|Adverse Event|4
7504014|NCT02308228|11830149|FG000|Overall Study|Withdrawal by Subject|5
7504015|NCT02308228|11830150|FG001|Overall Study|Withdrawal by Subject|3
7504016|NCT02308540|11830188|FG000|Overall Study|Lost to Follow-up|0
7504017|NCT02308540|11830189|FG001|Overall Study|Lost to Follow-up|0
7504018|NCT02308540|11830190|FG002|Overall Study|Lost to Follow-up|0
7504019|NCT02308540|11830191|FG003|Overall Study|Lost to Follow-up|0
7504020|NCT02308540|11830192|FG004|Overall Study|Lost to Follow-up|0
7504021|NCT02308540|11830193|FG005|Overall Study|Lost to Follow-up|1
7504022|NCT02308696|11830244|FG000|Overall Study|Lost to Follow-up|28
7504023|NCT02308696|11830245|FG001|Overall Study|Lost to Follow-up|21
7504024|NCT02308696|11830244|FG000|Overall Study|Death|8
7504025|NCT02308696|11830245|FG001|Overall Study|Death|4
7504026|NCT02308696|11830244|FG000|Overall Study|Moved to a Higher Level of Care|17
7504027|NCT02308696|11830245|FG001|Overall Study|Moved to a Higher Level of Care|6
7504028|NCT02308748|11830251|FG000|Period 1|Withdrawal by Subject|0
7504029|NCT02308748|11830252|FG001|Period 1|Withdrawal by Subject|0
7504030|NCT02308748|11830253|FG002|Period 1|Withdrawal by Subject|1
7504031|NCT02308748|11830254|FG003|Period 1|Withdrawal by Subject|0
7504032|NCT02308748|11830255|FG004|Period 1|Withdrawal by Subject|0
7504033|NCT02308748|11830256|FG005|Period 1|Withdrawal by Subject|0
7504034|NCT02308748|11830257|FG006|Period 1|Withdrawal by Subject|0
7504035|NCT02308748|11830258|FG007|Period 1|Withdrawal by Subject|0
7504036|NCT02308748|11830259|FG008|Period 1|Withdrawal by Subject|0
7504037|NCT02308748|11830260|FG009|Period 1|Withdrawal by Subject|0
7504038|NCT02308748|11830251|FG000|Period 2|Adverse Event|0
7504039|NCT02308748|11830252|FG001|Period 2|Adverse Event|0
7504040|NCT02308748|11830253|FG002|Period 2|Adverse Event|0
7504041|NCT02308748|11830254|FG003|Period 2|Adverse Event|0
7504042|NCT02308748|11830255|FG004|Period 2|Adverse Event|0
7504043|NCT02308748|11830256|FG005|Period 2|Adverse Event|0
7504044|NCT02308748|11830257|FG006|Period 2|Adverse Event|0
7504045|NCT02308748|11830258|FG007|Period 2|Adverse Event|1
7504046|NCT02308748|11830259|FG008|Period 2|Adverse Event|0
7504047|NCT02308748|11830260|FG009|Period 2|Adverse Event|0
7504048|NCT02308748|11830251|FG000|Period 3|Protocol Violation|0
7504049|NCT02308748|11830252|FG001|Period 3|Protocol Violation|0
7504050|NCT02308748|11830253|FG002|Period 3|Protocol Violation|0
7504051|NCT02308748|11830254|FG003|Period 3|Protocol Violation|0
7504052|NCT02308748|11830255|FG004|Period 3|Protocol Violation|0
7504053|NCT02308748|11830256|FG005|Period 3|Protocol Violation|0
7504054|NCT02308748|11830257|FG006|Period 3|Protocol Violation|0
7504055|NCT02308748|11830258|FG007|Period 3|Protocol Violation|0
7504056|NCT02308748|11830259|FG008|Period 3|Protocol Violation|0
7504057|NCT02308748|11830260|FG009|Period 3|Protocol Violation|1
7504058|NCT02308748|11830251|FG000|Period 5|Adverse Event|1
7504059|NCT02308748|11830252|FG001|Period 5|Adverse Event|0
7504060|NCT02308748|11830253|FG002|Period 5|Adverse Event|0
7504061|NCT02308748|11830254|FG003|Period 5|Adverse Event|0
7504062|NCT02308748|11830255|FG004|Period 5|Adverse Event|0
7504063|NCT02308748|11830256|FG005|Period 5|Adverse Event|0
7504064|NCT02308748|11830257|FG006|Period 5|Adverse Event|0
7504065|NCT02308748|11830258|FG007|Period 5|Adverse Event|0
7504066|NCT02308748|11830259|FG008|Period 5|Adverse Event|1
7504067|NCT02308748|11830260|FG009|Period 5|Adverse Event|0
7504068|NCT02309099|11830282|FG000|Overall Study|Adverse Event|2
7504069|NCT02309099|11830283|FG001|Overall Study|Adverse Event|0
7504070|NCT02309112|11830292|FG000|Overall Study|Withdrawal by Subject|1
7504071|NCT02309112|11830293|FG001|Overall Study|Withdrawal by Subject|0
7504072|NCT02309112|11830294|FG002|Overall Study|Withdrawal by Subject|1
7504073|NCT02309112|11830292|FG000|Overall Study|Lost to Follow-up|0
7504074|NCT02309112|11830293|FG001|Overall Study|Lost to Follow-up|1
7504075|NCT02309112|11830294|FG002|Overall Study|Lost to Follow-up|0
7504076|NCT02309138|11830306|FG000|Overall Study|Withdrawal by Subject|44
7504077|NCT02309138|11830307|FG001|Overall Study|Withdrawal by Subject|15
7504078|NCT02309138|11830306|FG000|Overall Study|Protocol Violation|4
7504079|NCT02309138|11830307|FG001|Overall Study|Protocol Violation|2
7504080|NCT02309138|11830306|FG000|Overall Study|delivered before visit 2|0
7504081|NCT02309138|11830307|FG001|Overall Study|delivered before visit 2|1
7504082|NCT02309294|11830323|FG000|Overall Study|Withdrawal by Subject|2
7504083|NCT02309359|11830332|FG000|Overall Study|Adverse Event|4
7504084|NCT02309359|11830333|FG001|Overall Study|Adverse Event|5
7504085|NCT02309359|11830334|FG002|Overall Study|Adverse Event|5
7504086|NCT02309359|11830335|FG003|Overall Study|Adverse Event|4
7504087|NCT02309359|11830336|FG004|Overall Study|Adverse Event|4
7504088|NCT02309359|11830332|FG000|Overall Study|Death|1
7504089|NCT02309359|11830333|FG001|Overall Study|Death|0
7504090|NCT02309359|11830334|FG002|Overall Study|Death|0
7504091|NCT02309359|11830335|FG003|Overall Study|Death|0
7504092|NCT02309359|11830336|FG004|Overall Study|Death|0
7504093|NCT02309359|11830332|FG000|Overall Study|Withdrawal by Subject|2
7504094|NCT02309359|11830333|FG001|Overall Study|Withdrawal by Subject|2
7504095|NCT02309359|11830334|FG002|Overall Study|Withdrawal by Subject|4
7504096|NCT02309359|11830335|FG003|Overall Study|Withdrawal by Subject|4
7504097|NCT02309359|11830336|FG004|Overall Study|Withdrawal by Subject|0
7504098|NCT02309359|11830332|FG000|Overall Study|Lack of Efficacy|3
7504099|NCT02309359|11830333|FG001|Overall Study|Lack of Efficacy|1
7504100|NCT02309359|11830334|FG002|Overall Study|Lack of Efficacy|0
7504101|NCT02309359|11830335|FG003|Overall Study|Lack of Efficacy|0
7504102|NCT02309359|11830336|FG004|Overall Study|Lack of Efficacy|3
7504103|NCT02309359|11830332|FG000|Overall Study|Lost to Follow-up|0
7504104|NCT02309359|11830333|FG001|Overall Study|Lost to Follow-up|0
7504105|NCT02309359|11830334|FG002|Overall Study|Lost to Follow-up|0
7504106|NCT02309359|11830335|FG003|Overall Study|Lost to Follow-up|1
7504107|NCT02309359|11830336|FG004|Overall Study|Lost to Follow-up|0
7504108|NCT02309359|11830332|FG000|Overall Study|Other|2
7504109|NCT02309359|11830333|FG001|Overall Study|Other|0
7504110|NCT02309359|11830334|FG002|Overall Study|Other|2
7504111|NCT02309359|11830335|FG003|Overall Study|Other|3
7504112|NCT02309359|11830336|FG004|Overall Study|Other|2
7504113|NCT02309372|11830351|FG000|Overall Study|Lost to Follow-up|3
7504114|NCT02309372|11830352|FG001|Overall Study|Lost to Follow-up|2
7504115|NCT02309411|11830361|FG000|Overall Study|Physician Decision|1
7504116|NCT02309411|11830362|FG001|Overall Study|Physician Decision|0
7504117|NCT02309411|11830363|FG002|Overall Study|Physician Decision|0
7504118|NCT02309411|11830361|FG000|Overall Study|Withdrawal by Subject|1
7504119|NCT02309411|11830362|FG001|Overall Study|Withdrawal by Subject|1
7504120|NCT02309411|11830363|FG002|Overall Study|Withdrawal by Subject|0
7504121|NCT02309515|11830381|FG000|Overall Study|Withdrawal by Subject|0
7504122|NCT02309515|11830382|FG001|Overall Study|Withdrawal by Subject|1
7504123|NCT02309723|11830391|FG000|Overall Study|Withdrawal by Subject|24
7504124|NCT02309723|11830392|FG001|Overall Study|Withdrawal by Subject|23
7504125|NCT02309723|11830393|FG002|Overall Study|Withdrawal by Subject|24
7504126|NCT02310100|11830410|FG000|Overall Study|Physician Decision|3
7504127|NCT02310100|11830410|FG000|Overall Study|Withdrawal by Subject|10
7504128|NCT02310100|11830410|FG000|Overall Study|Enrollment closure|1
7504129|NCT02310100|11830410|FG000|Overall Study|Unapproved ablation operator|1
7504130|NCT02310100|11830410|FG000|Overall Study|Visit compliance|1
7504131|NCT02310100|11830410|FG000|Overall Study|Lost to Follow-up|2
7504132|NCT02310126|11830417|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
7504133|NCT02310126|11830418|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
7504134|NCT02310126|11830417|FG000|Period 1 (15 Minutes)|Protocol Violation|0
7504135|NCT02310126|11830418|FG001|Period 1 (15 Minutes)|Protocol Violation|1
7504136|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7504137|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7504138|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7504139|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
7504140|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
7504141|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
7504142|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7504143|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7504144|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7504145|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
7504146|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|Other|1
7504147|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|Other|1
7504148|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|Other|0
7504149|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|Other|0
7504150|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|Other|0
7504151|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
7504152|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
7504153|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
7504154|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
7504155|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
7504156|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7504157|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7504158|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7504159|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
7504160|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
7504161|NCT02310568|11830429|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7504162|NCT02310568|11830430|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7504163|NCT02310568|11830431|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7504164|NCT02310568|11830432|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
7504165|NCT02310568|11830433|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
7504166|NCT02310568|11830429|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7504167|NCT02310568|11830430|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7504168|NCT02310568|11830431|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7504169|NCT02310568|11830432|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
7504170|NCT02310568|11830433|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
7504171|NCT02310568|11830429|FG000|Stage 2 (4 Weeks)|Other|0
7504172|NCT02310568|11830430|FG001|Stage 2 (4 Weeks)|Other|1
7504173|NCT02310568|11830431|FG002|Stage 2 (4 Weeks)|Other|1
7504174|NCT02310568|11830432|FG003|Stage 2 (4 Weeks)|Other|0
7504175|NCT02310568|11830433|FG004|Stage 2 (4 Weeks)|Other|0
7504176|NCT02310568|11830429|FG000|Stage 2 (4 Weeks)|Adverse Event|0
7504177|NCT02310568|11830430|FG001|Stage 2 (4 Weeks)|Adverse Event|0
7504178|NCT02310568|11830431|FG002|Stage 2 (4 Weeks)|Adverse Event|0
7504179|NCT02310568|11830432|FG003|Stage 2 (4 Weeks)|Adverse Event|1
7504180|NCT02310568|11830433|FG004|Stage 2 (4 Weeks)|Adverse Event|1
7504181|NCT02310568|11830429|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
7504182|NCT02310568|11830430|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
7504183|NCT02310568|11830431|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
7504184|NCT02310568|11830432|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
7504185|NCT02310568|11830433|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
7504186|NCT02310568|11830429|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
7504187|NCT02310568|11830430|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
7504188|NCT02310568|11830431|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
7504189|NCT02310568|11830432|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
7504190|NCT02310568|11830433|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
7504191|NCT02310581|11830455|FG000|Overall Study|Adverse Event|1
7504192|NCT02310581|11830456|FG001|Overall Study|Adverse Event|1
7504193|NCT02310581|11830457|FG002|Overall Study|Adverse Event|1
7504194|NCT02310581|11830458|FG003|Overall Study|Adverse Event|0
7504195|NCT02310581|11830455|FG000|Overall Study|Withdrawal by Subject|2
7504196|NCT02310581|11830456|FG001|Overall Study|Withdrawal by Subject|1
7504197|NCT02310581|11830457|FG002|Overall Study|Withdrawal by Subject|0
7504198|NCT02310581|11830458|FG003|Overall Study|Withdrawal by Subject|1
7504199|NCT02310646|11830470|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
7504200|NCT02310646|11830471|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
7504201|NCT02310646|11830470|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
7504202|NCT02310646|11830471|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
7504203|NCT02310672|11830493|FG000|Overall Study|Death|1
7504204|NCT02310672|11830493|FG000|Overall Study|Lost to Follow-up|1
7504205|NCT02310672|11830493|FG000|Overall Study|Withdrawal by Subject|1
7504206|NCT02310672|11830493|FG000|Overall Study|Sponsor's decision|12
7504207|NCT02310750|11830508|FG000|HP Period 1|Lost to Follow-up|0
7504208|NCT02310750|11830509|FG001|HP Period 1|Lost to Follow-up|0
7504209|NCT02310750|11830510|FG002|HP Period 1|Lost to Follow-up|0
7504210|NCT02310750|11830511|FG003|HP Period 1|Lost to Follow-up|0
7504211|NCT02310750|11830512|FG004|HP Period 1|Lost to Follow-up|0
7504212|NCT02310750|11830513|FG005|HP Period 1|Lost to Follow-up|0
7504213|NCT02310750|11830514|FG006|HP Period 1|Lost to Follow-up|1
7504214|NCT02310750|11830515|FG007|HP Period 1|Lost to Follow-up|0
7504215|NCT02310750|11830516|FG008|HP Period 1|Lost to Follow-up|0
7504216|NCT02310750|11830517|FG009|HP Period 1|Lost to Follow-up|0
7504217|NCT02310750|11830518|FG010|HP Period 1|Lost to Follow-up|0
7504218|NCT02310750|11830519|FG011|HP Period 1|Lost to Follow-up|0
7504219|NCT02310750|11830520|FG012|HP Period 1|Lost to Follow-up|0
7504220|NCT02310750|11830521|FG013|HP Period 1|Lost to Follow-up|0
7504221|NCT02310750|11830522|FG014|HP Period 1|Lost to Follow-up|0
7504222|NCT02310750|11830523|FG015|HP Period 1|Lost to Follow-up|0
7504223|NCT02310750|11830508|FG000|HP Period 1|Withdrawal by Subject|1
7504224|NCT02310750|11830509|FG001|HP Period 1|Withdrawal by Subject|0
7504225|NCT02310750|11830510|FG002|HP Period 1|Withdrawal by Subject|0
7504226|NCT02310750|11830511|FG003|HP Period 1|Withdrawal by Subject|1
7504227|NCT02310750|11830512|FG004|HP Period 1|Withdrawal by Subject|0
7504228|NCT02310750|11830513|FG005|HP Period 1|Withdrawal by Subject|0
7504229|NCT02310750|11830514|FG006|HP Period 1|Withdrawal by Subject|0
7504230|NCT02310750|11830515|FG007|HP Period 1|Withdrawal by Subject|0
7504231|NCT02310750|11830516|FG008|HP Period 1|Withdrawal by Subject|0
7504232|NCT02310750|11830517|FG009|HP Period 1|Withdrawal by Subject|0
7504233|NCT02310750|11830518|FG010|HP Period 1|Withdrawal by Subject|0
7504234|NCT02310750|11830519|FG011|HP Period 1|Withdrawal by Subject|0
7504235|NCT02310750|11830520|FG012|HP Period 1|Withdrawal by Subject|0
7504236|NCT02310750|11830521|FG013|HP Period 1|Withdrawal by Subject|0
7504237|NCT02310750|11830522|FG014|HP Period 1|Withdrawal by Subject|0
7504238|NCT02310750|11830523|FG015|HP Period 1|Withdrawal by Subject|0
7504239|NCT02310750|11830508|FG000|HP Washout 1|Lost to Follow-up|0
7504240|NCT02310750|11830509|FG001|HP Washout 1|Lost to Follow-up|0
7504241|NCT02310750|11830510|FG002|HP Washout 1|Lost to Follow-up|1
7504242|NCT02310750|11830511|FG003|HP Washout 1|Lost to Follow-up|1
7504243|NCT02310750|11830512|FG004|HP Washout 1|Lost to Follow-up|2
7504244|NCT02310750|11830513|FG005|HP Washout 1|Lost to Follow-up|2
7504245|NCT02310750|11830514|FG006|HP Washout 1|Lost to Follow-up|3
7504246|NCT02310750|11830515|FG007|HP Washout 1|Lost to Follow-up|0
7504247|NCT02310750|11830516|FG008|HP Washout 1|Lost to Follow-up|0
7504248|NCT02310750|11830517|FG009|HP Washout 1|Lost to Follow-up|0
7504249|NCT02310750|11830518|FG010|HP Washout 1|Lost to Follow-up|0
7504250|NCT02310750|11830519|FG011|HP Washout 1|Lost to Follow-up|0
7504251|NCT02310750|11830520|FG012|HP Washout 1|Lost to Follow-up|0
7504252|NCT02310750|11830521|FG013|HP Washout 1|Lost to Follow-up|0
7504253|NCT02310750|11830522|FG014|HP Washout 1|Lost to Follow-up|0
7504254|NCT02310750|11830523|FG015|HP Washout 1|Lost to Follow-up|0
7504255|NCT02310750|11830508|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504256|NCT02310750|11830509|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504257|NCT02310750|11830510|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504258|NCT02310750|11830511|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7504259|NCT02310750|11830512|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504260|NCT02310750|11830513|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
7504261|NCT02310750|11830514|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504262|NCT02310750|11830515|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504263|NCT02310750|11830516|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
7504264|NCT02310750|11830517|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
7504265|NCT02310750|11830518|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504266|NCT02310750|11830519|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504267|NCT02310750|11830520|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504268|NCT02310750|11830521|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504269|NCT02310750|11830522|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504270|NCT02310750|11830523|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
7504271|NCT02310750|11830508|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504272|NCT02310750|11830509|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504273|NCT02310750|11830510|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504274|NCT02310750|11830511|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504275|NCT02310750|11830512|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504276|NCT02310750|11830513|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504277|NCT02310750|11830514|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504278|NCT02310750|11830515|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504279|NCT02310750|11830516|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504280|NCT02310750|11830517|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
7504281|NCT02310750|11830518|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504282|NCT02310750|11830519|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504283|NCT02310750|11830520|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504284|NCT02310750|11830521|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504285|NCT02310750|11830522|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504286|NCT02310750|11830523|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
7504287|NCT02310750|11830508|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504288|NCT02310750|11830509|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504289|NCT02310750|11830510|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504290|NCT02310750|11830511|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504291|NCT02310750|11830512|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504292|NCT02310750|11830513|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504293|NCT02310750|11830514|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504294|NCT02310750|11830515|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7504295|NCT02310750|11830516|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7504296|NCT02310750|11830517|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
7504297|NCT02310750|11830518|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504298|NCT02310750|11830519|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504299|NCT02310750|11830520|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504300|NCT02310750|11830521|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504301|NCT02310750|11830522|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504302|NCT02310750|11830523|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
7504303|NCT02310750|11830508|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504304|NCT02310750|11830509|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504305|NCT02310750|11830510|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504306|NCT02310750|11830511|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504307|NCT02310750|11830512|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504308|NCT02310750|11830513|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504309|NCT02310750|11830514|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504310|NCT02310750|11830515|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7504311|NCT02310750|11830516|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
7504312|NCT02310750|11830517|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504313|NCT02310750|11830518|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504314|NCT02310750|11830519|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504315|NCT02310750|11830520|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504316|NCT02310750|11830521|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504317|NCT02310750|11830522|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504318|NCT02310750|11830523|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
7504319|NCT02310750|11830508|FG000|HP Washout 2|Lost to Follow-up|0
7504320|NCT02310750|11830509|FG001|HP Washout 2|Lost to Follow-up|0
7504321|NCT02310750|11830510|FG002|HP Washout 2|Lost to Follow-up|0
7504322|NCT02310750|11830511|FG003|HP Washout 2|Lost to Follow-up|0
7504323|NCT02310750|11830512|FG004|HP Washout 2|Lost to Follow-up|1
7504324|NCT02310750|11830513|FG005|HP Washout 2|Lost to Follow-up|0
7504325|NCT02310750|11830514|FG006|HP Washout 2|Lost to Follow-up|7
7504326|NCT02310750|11830515|FG007|HP Washout 2|Lost to Follow-up|0
7504327|NCT02310750|11830516|FG008|HP Washout 2|Lost to Follow-up|0
7504328|NCT02310750|11830517|FG009|HP Washout 2|Lost to Follow-up|0
7504329|NCT02310750|11830518|FG010|HP Washout 2|Lost to Follow-up|0
7504330|NCT02310750|11830519|FG011|HP Washout 2|Lost to Follow-up|0
7504331|NCT02310750|11830520|FG012|HP Washout 2|Lost to Follow-up|0
7504332|NCT02310750|11830521|FG013|HP Washout 2|Lost to Follow-up|0
7504333|NCT02310750|11830522|FG014|HP Washout 2|Lost to Follow-up|0
7504334|NCT02310750|11830523|FG015|HP Washout 2|Lost to Follow-up|0
7504335|NCT02310763|11830607|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7504336|NCT02310763|11830608|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7504337|NCT02310763|11830609|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
7504338|NCT02310763|11830607|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
7504339|NCT02310763|11830608|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7504340|NCT02310763|11830609|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
7504341|NCT02310763|11830607|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
7504342|NCT02310763|11830608|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7504343|NCT02310763|11830609|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
7504344|NCT02310763|11830607|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
7504345|NCT02310763|11830608|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
7504346|NCT02310763|11830609|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
7504347|NCT02310763|11830607|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7504348|NCT02310763|11830608|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7504349|NCT02310763|11830609|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
7504350|NCT02310789|11830639|FG000|Overall Study|Adverse Event|1
7504351|NCT02310906|11830647|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7504352|NCT02310906|11830648|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7504353|NCT02310906|11830649|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
7504354|NCT02310906|11830650|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
7504355|NCT02310906|11830647|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7504356|NCT02310906|11830648|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
7504357|NCT02310906|11830649|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
7504358|NCT02310906|11830650|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
7504359|NCT02310906|11830647|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7504360|NCT02310906|11830648|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7504361|NCT02310906|11830649|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
7504362|NCT02310906|11830650|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
7504363|NCT02310906|11830647|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7504364|NCT02310906|11830648|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7504365|NCT02310906|11830649|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
7504366|NCT02310906|11830650|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
7504367|NCT02311153|11830673|FG000|Overall Study|Lost to Follow-up|5
7504368|NCT02311153|11830674|FG001|Overall Study|Lost to Follow-up|7
7504369|NCT02311361|11830697|FG000|Overall Study|Did not receive treatment|0
7504370|NCT02311361|11830698|FG001|Overall Study|Did not receive treatment|1
7504371|NCT02311361|11830699|FG002|Overall Study|Did not receive treatment|0
7504372|NCT02311361|11830700|FG003|Overall Study|Did not receive treatment|1
7504373|NCT02311881|11830717|FG000|Overall Study|Did not meet the study criteria|2
7504374|NCT02311881|11830718|FG001|Overall Study|Did not meet the study criteria|2
7504375|NCT02311881|11830719|FG002|Overall Study|Did not meet the study criteria|0
7504376|NCT02311881|11830717|FG000|Overall Study|Adverse Event|7
7504377|NCT02311881|11830718|FG001|Overall Study|Adverse Event|15
7504378|NCT02311881|11830719|FG002|Overall Study|Adverse Event|8
7504379|NCT02311881|11830717|FG000|Overall Study|Lost to Follow-up|3
7504380|NCT02311881|11830718|FG001|Overall Study|Lost to Follow-up|3
7504381|NCT02311881|11830719|FG002|Overall Study|Lost to Follow-up|2
7504382|NCT02311881|11830717|FG000|Overall Study|Protocol Violation|1
7504383|NCT02311881|11830718|FG001|Overall Study|Protocol Violation|2
7504384|NCT02311881|11830719|FG002|Overall Study|Protocol Violation|3
7504385|NCT02311881|11830717|FG000|Overall Study|Withdrawal of consent|14
7504386|NCT02311881|11830718|FG001|Overall Study|Withdrawal of consent|16
7504387|NCT02311881|11830719|FG002|Overall Study|Withdrawal of consent|17
7504388|NCT02311881|11830717|FG000|Overall Study|Other|0
7504389|NCT02311881|11830718|FG001|Overall Study|Other|0
7504390|NCT02311881|11830719|FG002|Overall Study|Other|1
7504391|NCT02311881|11830717|FG000|Overall Study|Lack of Efficacy|1
7504392|NCT02311881|11830718|FG001|Overall Study|Lack of Efficacy|2
7504393|NCT02311881|11830719|FG002|Overall Study|Lack of Efficacy|0
7504394|NCT02311881|11830717|FG000|Overall Study|Subject has border line pregnancy test|1
7504395|NCT02311881|11830718|FG001|Overall Study|Subject has border line pregnancy test|0
7504396|NCT02311881|11830719|FG002|Overall Study|Subject has border line pregnancy test|0
7504397|NCT02311881|11830717|FG000|Overall Study|Withdrawal by Subject|3
7504398|NCT02311881|11830718|FG001|Overall Study|Withdrawal by Subject|1
7504399|NCT02311881|11830719|FG002|Overall Study|Withdrawal by Subject|4
7504400|NCT02311881|11830717|FG000|Overall Study|Sponsor Decision|1
7504401|NCT02311881|11830718|FG001|Overall Study|Sponsor Decision|1
7504402|NCT02311881|11830719|FG002|Overall Study|Sponsor Decision|1
7504403|NCT02311881|11830717|FG000|Overall Study|Protocol Deviation|1
7504404|NCT02311881|11830718|FG001|Overall Study|Protocol Deviation|0
7504405|NCT02311881|11830719|FG002|Overall Study|Protocol Deviation|0
7504406|NCT02311881|11830717|FG000|Overall Study|Non-Compliance|1
7504407|NCT02311881|11830718|FG001|Overall Study|Non-Compliance|0
7504408|NCT02311881|11830719|FG002|Overall Study|Non-Compliance|2
7504409|NCT02311881|11830717|FG000|Overall Study|Physician Decision|0
7504410|NCT02311881|11830718|FG001|Overall Study|Physician Decision|0
7504411|NCT02311881|11830719|FG002|Overall Study|Physician Decision|1
7504412|NCT02311881|11830717|FG000|Overall Study|Medical Monitor Discretion|0
7504413|NCT02311881|11830718|FG001|Overall Study|Medical Monitor Discretion|0
7504414|NCT02311881|11830719|FG002|Overall Study|Medical Monitor Discretion|1
7504415|NCT02311881|11830717|FG000|Overall Study|Participant taking another medication|0
7504416|NCT02311881|11830718|FG001|Overall Study|Participant taking another medication|0
7504417|NCT02311881|11830719|FG002|Overall Study|Participant taking another medication|1
7504418|NCT02311881|11830717|FG000|Overall Study|Serious Adverse Event|0
7504419|NCT02311881|11830718|FG001|Overall Study|Serious Adverse Event|1
7504420|NCT02311881|11830719|FG002|Overall Study|Serious Adverse Event|0
7504421|NCT02311894|11830730|FG000|Overall Study|Discontinued in error|1
7504422|NCT02311894|11830730|FG000|Overall Study|Lost to Follow-up|1
7504423|NCT02311894|11830730|FG000|Overall Study|Adverse Event|1
7504424|NCT02311894|11830730|FG000|Overall Study|Withdrawal by Subject|1
7504425|NCT02312063|11830764|FG000|Overall Study|Withdrawal by Subject|0
7504426|NCT02312063|11830765|FG001|Overall Study|Withdrawal by Subject|1
7504427|NCT02312206|11830779|FG000|Overall Study|Adverse Event|3
7504428|NCT02312206|11830780|FG001|Overall Study|Adverse Event|6
7504429|NCT02312206|11830779|FG000|Overall Study|Withdrawal by Subject|7
7504430|NCT02312206|11830780|FG001|Overall Study|Withdrawal by Subject|6
7504431|NCT02312206|11830779|FG000|Overall Study|Physician Decision|7
7504432|NCT02312206|11830780|FG001|Overall Study|Physician Decision|6
7504433|NCT02312206|11830779|FG000|Overall Study|Death|30
7504434|NCT02312206|11830780|FG001|Overall Study|Death|36
7504435|NCT02312206|11830779|FG000|Overall Study|Study Terminated by Sponsor|81
7504436|NCT02312206|11830780|FG001|Overall Study|Study Terminated by Sponsor|74
7504437|NCT02312206|11830779|FG000|Overall Study|Disease Progression|1
7504438|NCT02312206|11830780|FG001|Overall Study|Disease Progression|0
7504439|NCT02312206|11830779|FG000|Overall Study|Patient progression and new therapy|1
7504440|NCT02312206|11830780|FG001|Overall Study|Patient progression and new therapy|0
7504441|NCT02312206|11830779|FG000|Overall Study|Patient transferred to hospice|0
7504442|NCT02312206|11830780|FG001|Overall Study|Patient transferred to hospice|1
7504443|NCT02312206|11830779|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
7504444|NCT02312206|11830780|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
7504445|NCT02312219|11830788|FG000|Overall Study|Withdrawal by Subject|1
7504446|NCT02312219|11830789|FG001|Overall Study|Withdrawal by Subject|2
7504447|NCT02312219|11830788|FG000|Overall Study|could not schedule imaging in time|0
7504448|NCT02312219|11830789|FG001|Overall Study|could not schedule imaging in time|2
7504449|NCT02312219|11830788|FG000|Overall Study|Other|0
7504450|NCT02312219|11830789|FG001|Overall Study|Other|1
7504451|NCT02312219|11830788|FG000|Overall Study|Not randomized. Ineligible|0
7504452|NCT02312219|11830789|FG001|Overall Study|Not randomized. Ineligible|1
7504453|NCT02312687|11830832|FG000|Overall Study|Other, Not Specified|1
7504454|NCT02312856|11830876|FG000|Overall Study|Death|1
7504455|NCT02312856|11830876|FG000|Overall Study|Lost to Follow-up|3
7504456|NCT02312934|11830886|FG000|Overall Study|Lost to Follow-up|1
7504457|NCT02312934|11830887|FG001|Overall Study|Lost to Follow-up|0
7504458|NCT02312934|11830886|FG000|Overall Study|Physician Decision|1
7504459|NCT02312934|11830887|FG001|Overall Study|Physician Decision|0
7504460|NCT02313155|11830900|FG000|Overall Study|Lost to Follow-up|0
7504461|NCT02313155|11830901|FG001|Overall Study|Lost to Follow-up|1
7504462|NCT02313233|11830909|FG000|Overall Study|Withdrawal by Subject|1
7504463|NCT02313233|11830910|FG001|Overall Study|Withdrawal by Subject|2
7504464|NCT02313233|11830909|FG000|Overall Study|Administrative reason|1
7504465|NCT02313233|11830910|FG001|Overall Study|Administrative reason|1
7504466|NCT02313558|11830937|FG000|Overall Study|Withdrawal by Subject|2
7504467|NCT02313558|11830938|FG001|Overall Study|Withdrawal by Subject|0
7504468|NCT02313558|11830937|FG000|Overall Study|Lost to Follow-up|4
7504469|NCT02313558|11830938|FG001|Overall Study|Lost to Follow-up|4
7504470|NCT02313766|11830973|FG000|Overall Study|surgery cancelled|1
7504471|NCT02313766|11830974|FG001|Overall Study|surgery cancelled|0
7504472|NCT02313766|11830975|FG002|Overall Study|surgery cancelled|0
7504473|NCT02313766|11830973|FG000|Overall Study|Lost to Follow-up|0
7504474|NCT02313766|11830974|FG001|Overall Study|Lost to Follow-up|2
7504475|NCT02313766|11830975|FG002|Overall Study|Lost to Follow-up|0
7504476|NCT02313766|11830973|FG000|Overall Study|Adverse Event|0
7504477|NCT02313766|11830974|FG001|Overall Study|Adverse Event|1
7504478|NCT02313766|11830975|FG002|Overall Study|Adverse Event|0
7504479|NCT02313909|11830985|FG000|Overall Study|Consent withdrawn by participant|33
7504480|NCT02313909|11830986|FG001|Overall Study|Consent withdrawn by participant|33
7504481|NCT02313909|11830985|FG000|Overall Study|Lost to Follow-up|24
7504482|NCT02313909|11830986|FG001|Overall Study|Lost to Follow-up|17
7535843|NCT02713204|11883640|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535844|NCT02713204|11883641|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535845|NCT02713204|11883642|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
7535846|NCT02713204|11883643|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535847|NCT02713204|11883644|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535848|NCT02713204|11883645|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7504483|NCT02314026|11831002|FG000|Overall Study|Protocol Violation|28
7504484|NCT02314052|11831006|FG000|Cycle One|Adverse Event|0
7504485|NCT02314052|11831007|FG001|Cycle One|Adverse Event|0
7504486|NCT02314052|11831008|FG002|Cycle One|Adverse Event|0
7504487|NCT02314052|11831009|FG003|Cycle One|Adverse Event|1
7504488|NCT02314052|11831010|FG004|Cycle One|Adverse Event|0
7504489|NCT02314052|11831011|FG005|Cycle One|Adverse Event|0
7504490|NCT02314117|11831040|FG000|Overall Study|Lost to Follow-up|9
7504491|NCT02314117|11831041|FG001|Overall Study|Lost to Follow-up|14
7504492|NCT02314117|11831040|FG000|Overall Study|Withdrawal by Subject|3
7504493|NCT02314117|11831041|FG001|Overall Study|Withdrawal by Subject|2
7504494|NCT02314143|11831051|FG000|Overall Study|Adverse Event|0
7504495|NCT02314143|11831052|FG001|Overall Study|Adverse Event|6
7504496|NCT02314143|11831053|FG002|Overall Study|Adverse Event|4
7504497|NCT02314143|11831051|FG000|Overall Study|Other (Study Closed/Terminated)|5
7504498|NCT02314143|11831052|FG001|Overall Study|Other (Study Closed/Terminated)|3
7504499|NCT02314143|11831053|FG002|Overall Study|Other (Study Closed/Terminated)|4
7504500|NCT02314143|11831051|FG000|Overall Study|Physician Decision|2
7504501|NCT02314143|11831052|FG001|Overall Study|Physician Decision|1
7504502|NCT02314143|11831053|FG002|Overall Study|Physician Decision|0
7504503|NCT02314143|11831051|FG000|Overall Study|Withdrawal by Subject|1
7504504|NCT02314143|11831052|FG001|Overall Study|Withdrawal by Subject|0
7504505|NCT02314143|11831053|FG002|Overall Study|Withdrawal by Subject|1
7504506|NCT02314247|11831064|FG000|Overall Study|Adverse Event|2
7504507|NCT02314247|11831065|FG001|Overall Study|Adverse Event|1
7504508|NCT02314247|11831066|FG002|Overall Study|Adverse Event|0
7504509|NCT02314247|11831064|FG000|Overall Study|Withdrawal by Subject|1
7504510|NCT02314247|11831065|FG001|Overall Study|Withdrawal by Subject|3
7504511|NCT02314247|11831066|FG002|Overall Study|Withdrawal by Subject|1
7504512|NCT02314247|11831064|FG000|Overall Study|Progression of Disease|6
7504513|NCT02314247|11831065|FG001|Overall Study|Progression of Disease|2
7504514|NCT02314247|11831066|FG002|Overall Study|Progression of Disease|0
7504515|NCT02314637|11831113|FG000|Overall Study|Adverse Event|4
7504516|NCT02314637|11831114|FG001|Overall Study|Adverse Event|8
7504517|NCT02314637|11831113|FG000|Overall Study|Lack of Efficacy|1
7504518|NCT02314637|11831114|FG001|Overall Study|Lack of Efficacy|0
7504519|NCT02314637|11831113|FG000|Overall Study|Physician Decision|5
7504520|NCT02314637|11831114|FG001|Overall Study|Physician Decision|2
7504521|NCT02314637|11831113|FG000|Overall Study|Withdrawal by Subject|5
7504522|NCT02314637|11831114|FG001|Overall Study|Withdrawal by Subject|4
7504523|NCT02314637|11831113|FG000|Overall Study|Other Reason|1
7504524|NCT02314637|11831114|FG001|Overall Study|Other Reason|0
7504525|NCT02314728|11831126|FG000|Overall Study|Protocol Violation|1
7504526|NCT02314728|11831127|FG001|Overall Study|Protocol Violation|0
7504527|NCT02314728|11831126|FG000|Overall Study|Lost to Follow-up|0
7504528|NCT02314728|11831127|FG001|Overall Study|Lost to Follow-up|1
7504529|NCT02314780|11831138|FG000|Overall Study|organizational reasons|0
7504530|NCT02314780|11831139|FG001|Overall Study|organizational reasons|2
7504531|NCT02314780|11831140|FG002|Overall Study|organizational reasons|0
7504532|NCT02314780|11831138|FG000|Overall Study|Adverse Event|0
7504533|NCT02314780|11831139|FG001|Overall Study|Adverse Event|1
7504534|NCT02314780|11831140|FG002|Overall Study|Adverse Event|0
7504535|NCT02315560|11831201|FG000|Overall Study|noncompliance by subjects|3
7504536|NCT02315625|11831207|FG000|First Intervention|Disease Progression|1
7504537|NCT02315625|11831208|FG001|First Intervention|Disease Progression|0
7504538|NCT02315625|11831207|FG000|Second Intervention|Physician Decision|2
7504539|NCT02315625|11831208|FG001|Second Intervention|Physician Decision|1
7504540|NCT02315625|11831207|FG000|Second Intervention|Study closure|1
7504541|NCT02315625|11831208|FG001|Second Intervention|Study closure|0
7504542|NCT02315625|11831207|FG000|Second Intervention|Disease Progression|1
7504543|NCT02315625|11831208|FG001|Second Intervention|Disease Progression|0
7504544|NCT02315664|11831218|FG000|Overall Study|Lost to Follow-up|1
7504545|NCT02315664|11831219|FG001|Overall Study|Lost to Follow-up|1
7504546|NCT02315664|11831218|FG000|Overall Study|Withdrawal by Subject|0
7504547|NCT02315664|11831219|FG001|Overall Study|Withdrawal by Subject|3
7504552|NCT02316223|11831260|FG000|Overall Study|Lack of Efficacy|0
7504553|NCT02316223|11831261|FG001|Overall Study|Lack of Efficacy|1
7504554|NCT02316223|11831262|FG002|Overall Study|Lack of Efficacy|1
7504555|NCT02316223|11831260|FG000|Overall Study|Lost to Follow-up|27
7504556|NCT02316223|11831261|FG001|Overall Study|Lost to Follow-up|34
7504557|NCT02316223|11831262|FG002|Overall Study|Lost to Follow-up|36
7504558|NCT02316223|11831260|FG000|Overall Study|COPD Diagnosis|3
7504559|NCT02316223|11831261|FG001|Overall Study|COPD Diagnosis|2
7504560|NCT02316223|11831262|FG002|Overall Study|COPD Diagnosis|3
7504561|NCT02316223|11831260|FG000|Overall Study|Reside outside study area|1
7504562|NCT02316223|11831261|FG001|Overall Study|Reside outside study area|1
7504563|NCT02316223|11831262|FG002|Overall Study|Reside outside study area|1
7504564|NCT02316223|11831260|FG000|Overall Study|No asthma|2
7504565|NCT02316223|11831261|FG001|Overall Study|No asthma|0
7504566|NCT02316223|11831262|FG002|Overall Study|No asthma|0
7504567|NCT02316223|11831260|FG000|Overall Study|Discontinued by PI|11
7504568|NCT02316223|11831261|FG001|Overall Study|Discontinued by PI|19
7504569|NCT02316223|11831262|FG002|Overall Study|Discontinued by PI|3
7504570|NCT02316353|11831272|FG000|Overall Study|Pregnancy|1
7504571|NCT02316353|11831273|FG001|Overall Study|Pregnancy|3
7504572|NCT02316353|11831272|FG000|Overall Study|Adverse Event|1
7504573|NCT02316353|11831273|FG001|Overall Study|Adverse Event|3
7504574|NCT02316353|11831272|FG000|Overall Study|Withdrawal by Subject|6
7504575|NCT02316353|11831273|FG001|Overall Study|Withdrawal by Subject|2
7504576|NCT02316548|11831310|FG000|Overall Study|Protocol Violation|0
7504577|NCT02316548|11831311|FG001|Overall Study|Protocol Violation|1
7504578|NCT02316613|11831317|FG000|Overall Study|Death|63
7504579|NCT02316613|11831317|FG000|Overall Study|Lost to Follow-up|9
7504580|NCT02316613|11831317|FG000|Overall Study|Lymphoma transformation|2
7504581|NCT02316613|11831317|FG000|Overall Study|Participant moved/changed medical team|11
7504582|NCT02316613|11831317|FG000|Overall Study|No data and duplicate cases|5
7504583|NCT02316613|11831317|FG000|Overall Study|Did not met selection criteria|14
7504584|NCT02316717|11831344|FG000|Overall Study|Adverse Event|2
7504585|NCT02316717|11831345|FG001|Overall Study|Adverse Event|2
7504586|NCT02316717|11831346|FG002|Overall Study|Adverse Event|0
7504587|NCT02316717|11831344|FG000|Overall Study|Lost to Follow-up|1
7504588|NCT02316717|11831345|FG001|Overall Study|Lost to Follow-up|2
7504589|NCT02316717|11831346|FG002|Overall Study|Lost to Follow-up|1
7504590|NCT02316717|11831344|FG000|Overall Study|Non compliance|3
7504591|NCT02316717|11831345|FG001|Overall Study|Non compliance|1
7504592|NCT02316717|11831346|FG002|Overall Study|Non compliance|0
7504593|NCT02316717|11831344|FG000|Overall Study|Protocol Violation|2
7504594|NCT02316717|11831345|FG001|Overall Study|Protocol Violation|0
7504595|NCT02316717|11831346|FG002|Overall Study|Protocol Violation|0
7504596|NCT02316717|11831344|FG000|Overall Study|Withdrawal by Subject|2
7504597|NCT02316717|11831345|FG001|Overall Study|Withdrawal by Subject|1
7504598|NCT02316717|11831346|FG002|Overall Study|Withdrawal by Subject|1
7504599|NCT02316717|11831344|FG000|Overall Study|Death|0
7504600|NCT02316717|11831345|FG001|Overall Study|Death|0
7504601|NCT02316717|11831346|FG002|Overall Study|Death|1
7504602|NCT02316717|11831344|FG000|Overall Study|Physician Decision|0
7504603|NCT02316717|11831345|FG001|Overall Study|Physician Decision|1
7504604|NCT02316717|11831346|FG002|Overall Study|Physician Decision|0
7504605|NCT02316717|11831344|FG000|Overall Study|TBC|1
7504606|NCT02316717|11831345|FG001|Overall Study|TBC|0
7504607|NCT02316717|11831346|FG002|Overall Study|TBC|0
7504608|NCT02316769|11831359|FG000|Overall Study|Physician Decision|1
7504609|NCT02316769|11831360|FG001|Overall Study|Physician Decision|0
7504610|NCT02316769|11831359|FG000|Overall Study|Withdrawal by Subject|1
7504611|NCT02316769|11831360|FG001|Overall Study|Withdrawal by Subject|0
7504612|NCT02316847|11831368|FG000|Overall Study|Adverse Event|0
7504613|NCT02316847|11831369|FG001|Overall Study|Adverse Event|3
7504614|NCT02316847|11831368|FG000|Overall Study|Lost to Follow-up|0
7504615|NCT02316847|11831369|FG001|Overall Study|Lost to Follow-up|2
7504616|NCT02316847|11831368|FG000|Overall Study|Physician Decision|0
7504617|NCT02316847|11831369|FG001|Overall Study|Physician Decision|1
7504618|NCT02316847|11831368|FG000|Overall Study|Pregnancy|0
7504619|NCT02316847|11831369|FG001|Overall Study|Pregnancy|1
7504620|NCT02316847|11831368|FG000|Overall Study|Withdrawal by Subject|2
7504621|NCT02316847|11831369|FG001|Overall Study|Withdrawal by Subject|9
7504622|NCT02316847|11831368|FG000|Overall Study|Noncompliance with study drug|0
7504623|NCT02316847|11831369|FG001|Overall Study|Noncompliance with study drug|3
7504624|NCT02316847|11831368|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
7504625|NCT02316847|11831369|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
7504626|NCT02317016|11831377|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
7504627|NCT02317016|11831377|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
7504628|NCT02317016|11831377|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
7504629|NCT02317016|11831377|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
7504630|NCT02317016|11831377|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
7504631|NCT02317016|11831377|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
7504632|NCT02317016|11831377|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
7504633|NCT02317432|11831396|FG000|Overall Study|Death|4
7504634|NCT02317432|11831397|FG001|Overall Study|Death|1
7504635|NCT02317432|11831396|FG000|Overall Study|Lost to Follow-up|0
7504636|NCT02317432|11831397|FG001|Overall Study|Lost to Follow-up|5
7504637|NCT02317432|11831396|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
7504638|NCT02317432|11831397|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
7504639|NCT02317510|11831405|FG000|Overall Study|Adverse Event|0
7504640|NCT02317510|11831406|FG001|Overall Study|Adverse Event|1
7504641|NCT02317562|11831424|FG000|Overall Study|Physician Decision|1
7504642|NCT02317562|11831424|FG000|Overall Study|early termination of the study|8
7504643|NCT02317562|11831424|FG000|Overall Study|Lack of Efficacy|4
7504644|NCT02317562|11831424|FG000|Overall Study|Withdrawal by Subject|1
7504645|NCT02317575|11831428|FG000|Period 1|Difficulty with venous cannulation|0
7504646|NCT02317575|11831429|FG001|Period 1|Difficulty with venous cannulation|1
7504647|NCT02317575|11831430|FG002|Period 1|Difficulty with venous cannulation|0
7504648|NCT02317575|11831431|FG003|Period 1|Difficulty with venous cannulation|0
7504649|NCT02317575|11831432|FG004|Period 1|Difficulty with venous cannulation|0
7504650|NCT02317575|11831428|FG000|Period 1|Withdrawal by Subject|1
7504651|NCT02317575|11831429|FG001|Period 1|Withdrawal by Subject|0
7504652|NCT02317575|11831430|FG002|Period 1|Withdrawal by Subject|0
7504653|NCT02317575|11831431|FG003|Period 1|Withdrawal by Subject|0
7504654|NCT02317575|11831432|FG004|Period 1|Withdrawal by Subject|0
7504655|NCT02317614|11831452|FG000|Overall Study|Lost to Follow-up|1
7504656|NCT02317614|11831453|FG001|Overall Study|Lost to Follow-up|1
7504657|NCT02317614|11831452|FG000|Overall Study|Withdrawal by Subject|1
7504658|NCT02317614|11831453|FG001|Overall Study|Withdrawal by Subject|0
7504659|NCT02317614|11831452|FG000|Overall Study|Death|1
7504660|NCT02317614|11831453|FG001|Overall Study|Death|1
7504661|NCT02317809|11831477|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
7504662|NCT02317809|11831478|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
7504663|NCT02317809|11831477|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
7504664|NCT02317809|11831478|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
7504665|NCT02318134|11831489|FG000|Overall Study|Withdrawal by Subject|2
7504666|NCT02318134|11831490|FG001|Overall Study|Withdrawal by Subject|1
7504667|NCT02318368|11831529|FG000|Overall Study|Withdrawal by Subject|2
7504668|NCT02318368|11831530|FG001|Overall Study|Withdrawal by Subject|0
7504669|NCT02318368|11831529|FG000|Overall Study|Study terminated by the sponsor|5
7504670|NCT02318368|11831530|FG001|Overall Study|Study terminated by the sponsor|2
7504671|NCT02318368|11831529|FG000|Overall Study|Death|0
7504672|NCT02318368|11831530|FG001|Overall Study|Death|1
7504673|NCT02318602|11831543|FG000|Overall Study|Adverse Event|0
7504674|NCT02318602|11831544|FG001|Overall Study|Adverse Event|1
7504675|NCT02318602|11831545|FG002|Overall Study|Adverse Event|1
7504676|NCT02318602|11831543|FG000|Overall Study|Withdrawal by Subject|0
7504677|NCT02318602|11831544|FG001|Overall Study|Withdrawal by Subject|3
7504678|NCT02318602|11831545|FG002|Overall Study|Withdrawal by Subject|0
7504679|NCT02318602|11831543|FG000|Overall Study|Death|1
7504680|NCT02318602|11831544|FG001|Overall Study|Death|0
7504681|NCT02318602|11831545|FG002|Overall Study|Death|0
7504682|NCT02318602|11831543|FG000|Overall Study|Guardian decision to withdraw|0
7504683|NCT02318602|11831544|FG001|Overall Study|Guardian decision to withdraw|0
7504684|NCT02318602|11831545|FG002|Overall Study|Guardian decision to withdraw|1
7504685|NCT02318667|11831559|FG000|Overall Study|Adverse Event|1
7504686|NCT02318667|11831559|FG000|Overall Study|Lack of Efficacy|6
7504687|NCT02318667|11831559|FG000|Overall Study|Protocol Violation|2
7504688|NCT02318693|11831569|FG000|Overall Study|Protocol Violation|0
7504689|NCT02318693|11831570|FG001|Overall Study|Protocol Violation|1
7504690|NCT02318706|11831580|FG000|Double-blind Phase|Adverse Event|7
7504691|NCT02318706|11831581|FG001|Double-blind Phase|Adverse Event|4
7504692|NCT02318706|11831582|FG002|Double-blind Phase|Adverse Event|3
7504693|NCT02318706|11831583|FG003|Double-blind Phase|Adverse Event|10
7504694|NCT02318706|11831584|FG004|Double-blind Phase|Adverse Event|0
7504695|NCT02318706|11831580|FG000|Double-blind Phase|Lost to Follow-up|1
7504696|NCT02318706|11831581|FG001|Double-blind Phase|Lost to Follow-up|0
7504697|NCT02318706|11831582|FG002|Double-blind Phase|Lost to Follow-up|0
7504698|NCT02318706|11831583|FG003|Double-blind Phase|Lost to Follow-up|0
7504699|NCT02318706|11831584|FG004|Double-blind Phase|Lost to Follow-up|0
7504700|NCT02318706|11831580|FG000|Double-blind Phase|Protocol Violation|4
7504701|NCT02318706|11831581|FG001|Double-blind Phase|Protocol Violation|2
7504702|NCT02318706|11831582|FG002|Double-blind Phase|Protocol Violation|4
7504703|NCT02318706|11831583|FG003|Double-blind Phase|Protocol Violation|3
7504704|NCT02318706|11831584|FG004|Double-blind Phase|Protocol Violation|0
7504705|NCT02318706|11831580|FG000|Double-blind Phase|Withdrawal by Subject|9
7504706|NCT02318706|11831581|FG001|Double-blind Phase|Withdrawal by Subject|5
7504707|NCT02318706|11831582|FG002|Double-blind Phase|Withdrawal by Subject|7
7504708|NCT02318706|11831583|FG003|Double-blind Phase|Withdrawal by Subject|10
7504709|NCT02318706|11831584|FG004|Double-blind Phase|Withdrawal by Subject|0
7504710|NCT02318706|11831580|FG000|Double-blind Phase|Other|4
7504711|NCT02318706|11831581|FG001|Double-blind Phase|Other|1
7504712|NCT02318706|11831582|FG002|Double-blind Phase|Other|2
7504713|NCT02318706|11831583|FG003|Double-blind Phase|Other|1
7504714|NCT02318706|11831584|FG004|Double-blind Phase|Other|0
7504715|NCT02318706|11831580|FG000|Double-blind Phase|Death|0
7504716|NCT02318706|11831581|FG001|Double-blind Phase|Death|0
7504717|NCT02318706|11831582|FG002|Double-blind Phase|Death|2
7504718|NCT02318706|11831583|FG003|Double-blind Phase|Death|0
7504719|NCT02318706|11831584|FG004|Double-blind Phase|Death|0
7504720|NCT02318706|11831580|FG000|Open-label Extension Phase|Adverse Event|0
7504721|NCT02318706|11831581|FG001|Open-label Extension Phase|Adverse Event|0
7504722|NCT02318706|11831582|FG002|Open-label Extension Phase|Adverse Event|0
7504723|NCT02318706|11831583|FG003|Open-label Extension Phase|Adverse Event|0
7504724|NCT02318706|11831584|FG004|Open-label Extension Phase|Adverse Event|21
7504725|NCT02318706|11831580|FG000|Open-label Extension Phase|Lack of Efficacy|0
7504726|NCT02318706|11831581|FG001|Open-label Extension Phase|Lack of Efficacy|0
7504727|NCT02318706|11831582|FG002|Open-label Extension Phase|Lack of Efficacy|0
7504728|NCT02318706|11831583|FG003|Open-label Extension Phase|Lack of Efficacy|0
7504729|NCT02318706|11831584|FG004|Open-label Extension Phase|Lack of Efficacy|1
7504730|NCT02318706|11831580|FG000|Open-label Extension Phase|Death|0
7504731|NCT02318706|11831581|FG001|Open-label Extension Phase|Death|0
7504732|NCT02318706|11831582|FG002|Open-label Extension Phase|Death|0
7504733|NCT02318706|11831583|FG003|Open-label Extension Phase|Death|0
7504734|NCT02318706|11831584|FG004|Open-label Extension Phase|Death|1
7504735|NCT02318706|11831580|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7504736|NCT02318706|11831581|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7504737|NCT02318706|11831582|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7504738|NCT02318706|11831583|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7504739|NCT02318706|11831584|FG004|Open-label Extension Phase|Withdrawal by Subject|19
7504740|NCT02318719|11831600|FG000|Double-blind Phase|Adverse Event|7
7504741|NCT02318719|11831601|FG001|Double-blind Phase|Adverse Event|6
7504742|NCT02318719|11831602|FG002|Double-blind Phase|Adverse Event|12
7504743|NCT02318719|11831603|FG003|Double-blind Phase|Adverse Event|4
7504744|NCT02318719|11831604|FG004|Double-blind Phase|Adverse Event|0
7504745|NCT02318719|11831600|FG000|Double-blind Phase|Lack of Efficacy|5
7504746|NCT02318719|11831601|FG001|Double-blind Phase|Lack of Efficacy|0
7504747|NCT02318719|11831602|FG002|Double-blind Phase|Lack of Efficacy|1
7504748|NCT02318719|11831603|FG003|Double-blind Phase|Lack of Efficacy|1
7504749|NCT02318719|11831604|FG004|Double-blind Phase|Lack of Efficacy|0
7504750|NCT02318719|11831600|FG000|Double-blind Phase|Protocol Violation|0
7504751|NCT02318719|11831601|FG001|Double-blind Phase|Protocol Violation|1
7504752|NCT02318719|11831602|FG002|Double-blind Phase|Protocol Violation|3
7504753|NCT02318719|11831603|FG003|Double-blind Phase|Protocol Violation|0
7504754|NCT02318719|11831604|FG004|Double-blind Phase|Protocol Violation|0
7504755|NCT02318719|11831600|FG000|Double-blind Phase|Withdrawal by Subject|25
7504756|NCT02318719|11831601|FG001|Double-blind Phase|Withdrawal by Subject|7
7504757|NCT02318719|11831602|FG002|Double-blind Phase|Withdrawal by Subject|9
7504758|NCT02318719|11831603|FG003|Double-blind Phase|Withdrawal by Subject|10
7504759|NCT02318719|11831604|FG004|Double-blind Phase|Withdrawal by Subject|0
7504760|NCT02318719|11831600|FG000|Double-blind Phase|Other|1
7504761|NCT02318719|11831601|FG001|Double-blind Phase|Other|2
7504762|NCT02318719|11831602|FG002|Double-blind Phase|Other|0
7504763|NCT02318719|11831603|FG003|Double-blind Phase|Other|0
7504764|NCT02318719|11831604|FG004|Double-blind Phase|Other|0
7504765|NCT02318719|11831600|FG000|Open-label Extension Phase|Adverse Event|0
7504766|NCT02318719|11831601|FG001|Open-label Extension Phase|Adverse Event|0
7504767|NCT02318719|11831602|FG002|Open-label Extension Phase|Adverse Event|0
7504768|NCT02318719|11831603|FG003|Open-label Extension Phase|Adverse Event|0
7504769|NCT02318719|11831604|FG004|Open-label Extension Phase|Adverse Event|15
7504770|NCT02318719|11831600|FG000|Open-label Extension Phase|Death|0
7504771|NCT02318719|11831601|FG001|Open-label Extension Phase|Death|0
7504772|NCT02318719|11831602|FG002|Open-label Extension Phase|Death|0
7504773|NCT02318719|11831603|FG003|Open-label Extension Phase|Death|0
7504774|NCT02318719|11831604|FG004|Open-label Extension Phase|Death|1
7504775|NCT02318719|11831600|FG000|Open-label Extension Phase|Lack of Efficacy|0
7504776|NCT02318719|11831601|FG001|Open-label Extension Phase|Lack of Efficacy|0
7504777|NCT02318719|11831602|FG002|Open-label Extension Phase|Lack of Efficacy|0
7504778|NCT02318719|11831603|FG003|Open-label Extension Phase|Lack of Efficacy|0
7504779|NCT02318719|11831604|FG004|Open-label Extension Phase|Lack of Efficacy|1
7504780|NCT02318719|11831600|FG000|Open-label Extension Phase|Withdrawal by Subject|0
7504781|NCT02318719|11831601|FG001|Open-label Extension Phase|Withdrawal by Subject|0
7504782|NCT02318719|11831602|FG002|Open-label Extension Phase|Withdrawal by Subject|0
7504783|NCT02318719|11831603|FG003|Open-label Extension Phase|Withdrawal by Subject|0
7504784|NCT02318719|11831604|FG004|Open-label Extension Phase|Withdrawal by Subject|31
7504785|NCT02318719|11831600|FG000|Open-label Extension Phase|Other|0
7504786|NCT02318719|11831601|FG001|Open-label Extension Phase|Other|0
7504787|NCT02318719|11831602|FG002|Open-label Extension Phase|Other|0
7504788|NCT02318719|11831603|FG003|Open-label Extension Phase|Other|0
7504789|NCT02318719|11831604|FG004|Open-label Extension Phase|Other|7
7504790|NCT02318797|11831618|FG000|Overall Study|Death|3
7504791|NCT02318797|11831619|FG001|Overall Study|Death|6
7504792|NCT02318797|11831618|FG000|Overall Study|Lost to Follow-up|85
7504793|NCT02318797|11831619|FG001|Overall Study|Lost to Follow-up|96
7504794|NCT02318940|11831627|FG000|Overall Study|lost the record|1
7504795|NCT02318940|11831628|FG001|Overall Study|lost the record|0
7504796|NCT02319031|11831662|FG000|Treatment Period|Death|1
7504797|NCT02319031|11831663|FG001|Treatment Period|Death|0
7504798|NCT02319044|11831672|FG000|Overall Study|Death, PI/sponsor decision, med history|0
7504799|NCT02319044|11831673|FG001|Overall Study|Death, PI/sponsor decision, med history|1
7504800|NCT02319044|11831674|FG002|Overall Study|Death, PI/sponsor decision, med history|4
7504801|NCT02319044|11831672|FG000|Overall Study|Withdrawal by Subject|3
7504802|NCT02319044|11831673|FG001|Overall Study|Withdrawal by Subject|3
7504803|NCT02319044|11831674|FG002|Overall Study|Withdrawal by Subject|6
7504804|NCT02319044|11831672|FG000|Overall Study|Condition under investigation worsened|100
7504805|NCT02319044|11831673|FG001|Overall Study|Condition under investigation worsened|50
7504806|NCT02319044|11831674|FG002|Overall Study|Condition under investigation worsened|46
7504807|NCT02319044|11831672|FG000|Overall Study|Adverse Event|17
7504808|NCT02319044|11831673|FG001|Overall Study|Adverse Event|2
7504809|NCT02319044|11831674|FG002|Overall Study|Adverse Event|8
7504810|NCT02319044|11831672|FG000|Overall Study|Study specific discontinuation criteria|2
7504811|NCT02319044|11831673|FG001|Overall Study|Study specific discontinuation criteria|2
7504812|NCT02319044|11831674|FG002|Overall Study|Study specific discontinuation criteria|1
7504813|NCT02319044|11831672|FG000|Overall Study|Not treated|0
7504814|NCT02319044|11831673|FG001|Overall Study|Not treated|2
7504815|NCT02319044|11831674|FG002|Overall Study|Not treated|2
7504816|NCT02319148|11831686|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
7504817|NCT02319148|11831687|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
7504818|NCT02319148|11831688|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
7504819|NCT02319148|11831689|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
7504820|NCT02319148|11831686|FG000|Second Intervention Period|No longer willing to participate|0
7504821|NCT02319148|11831687|FG001|Second Intervention Period|No longer willing to participate|1
7504822|NCT02319148|11831688|FG002|Second Intervention Period|No longer willing to participate|0
7504823|NCT02319148|11831689|FG003|Second Intervention Period|No longer willing to participate|0
7504824|NCT02319148|11831686|FG000|Second Intervention Period|Other|0
7504825|NCT02319148|11831687|FG001|Second Intervention Period|Other|0
7504826|NCT02319148|11831688|FG002|Second Intervention Period|Other|0
7504827|NCT02319148|11831689|FG003|Second Intervention Period|Other|1
7504828|NCT02319525|11831797|FG000|Overall Study|Withdrawal by Subject|2
7504829|NCT02319525|11831798|FG001|Overall Study|Withdrawal by Subject|1
7504830|NCT02319642|11831806|FG000|Overall Study|Adverse Event|2
7504831|NCT02319642|11831807|FG001|Overall Study|Adverse Event|4
7504832|NCT02319642|11831806|FG000|Overall Study|Lack of Efficacy|1
7504833|NCT02319642|11831807|FG001|Overall Study|Lack of Efficacy|1
7504834|NCT02319642|11831806|FG000|Overall Study|Withdrawal by Subject|1
7504835|NCT02319642|11831807|FG001|Overall Study|Withdrawal by Subject|1
7504836|NCT02319668|11831817|FG000|Overall Study|Other (Not specified)|0
7504837|NCT02319668|11831818|FG001|Overall Study|Other (Not specified)|2
7504838|NCT02319759|11831829|FG000|Week 0 - 16|Lack of Efficacy|1
7504839|NCT02319759|11831830|FG001|Week 0 - 16|Lack of Efficacy|0
7504840|NCT02319759|11831831|FG002|Week 0 - 16|Lack of Efficacy|0
7504841|NCT02319759|11831832|FG003|Week 0 - 16|Lack of Efficacy|0
7504842|NCT02319759|11831833|FG004|Week 0 - 16|Lack of Efficacy|0
7504843|NCT02319759|11831829|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
7504844|NCT02319759|11831830|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
7504845|NCT02319759|11831831|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
7504846|NCT02319759|11831832|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
7504847|NCT02319759|11831833|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
7504848|NCT02319759|11831829|FG000|Week 16 - 24|Lack of Efficacy|1
7504849|NCT02319759|11831830|FG001|Week 16 - 24|Lack of Efficacy|0
7504850|NCT02319759|11831831|FG002|Week 16 - 24|Lack of Efficacy|1
7504851|NCT02319759|11831832|FG003|Week 16 - 24|Lack of Efficacy|0
7504852|NCT02319759|11831833|FG004|Week 16 - 24|Lack of Efficacy|0
7504853|NCT02319759|11831829|FG000|Week 16 - 24|Lost to Follow-up|1
7504854|NCT02319759|11831830|FG001|Week 16 - 24|Lost to Follow-up|0
7504855|NCT02319759|11831831|FG002|Week 16 - 24|Lost to Follow-up|0
7504856|NCT02319759|11831832|FG003|Week 16 - 24|Lost to Follow-up|0
7504857|NCT02319759|11831833|FG004|Week 16 - 24|Lost to Follow-up|0
7504858|NCT02319759|11831829|FG000|Week 16 - 24|Withdrawal by Subject|0
7504859|NCT02319759|11831830|FG001|Week 16 - 24|Withdrawal by Subject|0
7504860|NCT02319759|11831831|FG002|Week 16 - 24|Withdrawal by Subject|2
7504861|NCT02319759|11831832|FG003|Week 16 - 24|Withdrawal by Subject|0
7504862|NCT02319759|11831833|FG004|Week 16 - 24|Withdrawal by Subject|0
7504863|NCT02319759|11831829|FG000|Week 24 - 56|Adverse Event|0
7504864|NCT02319759|11831830|FG001|Week 24 - 56|Adverse Event|0
7504865|NCT02319759|11831831|FG002|Week 24 - 56|Adverse Event|2
7504866|NCT02319759|11831832|FG003|Week 24 - 56|Adverse Event|0
7504867|NCT02319759|11831833|FG004|Week 24 - 56|Adverse Event|0
7504868|NCT02319759|11831829|FG000|Week 24 - 56|Lack of Efficacy|0
7504869|NCT02319759|11831830|FG001|Week 24 - 56|Lack of Efficacy|0
7504870|NCT02319759|11831831|FG002|Week 24 - 56|Lack of Efficacy|0
7504871|NCT02319759|11831832|FG003|Week 24 - 56|Lack of Efficacy|2
7504872|NCT02319759|11831833|FG004|Week 24 - 56|Lack of Efficacy|1
7504873|NCT02319759|11831829|FG000|Week 24 - 56|Withdrawal by Subject|0
7504874|NCT02319759|11831830|FG001|Week 24 - 56|Withdrawal by Subject|1
7504875|NCT02319759|11831831|FG002|Week 24 - 56|Withdrawal by Subject|0
7504876|NCT02319759|11831832|FG003|Week 24 - 56|Withdrawal by Subject|0
7504877|NCT02319759|11831833|FG004|Week 24 - 56|Withdrawal by Subject|0
7504878|NCT02319759|11831829|FG000|Week 24 - 56|Lost to Follow-up|0
7504879|NCT02319759|11831830|FG001|Week 24 - 56|Lost to Follow-up|0
7504880|NCT02319759|11831831|FG002|Week 24 - 56|Lost to Follow-up|0
7504881|NCT02319759|11831832|FG003|Week 24 - 56|Lost to Follow-up|0
7504882|NCT02319759|11831833|FG004|Week 24 - 56|Lost to Follow-up|1
7504883|NCT02320058|11831866|FG000|Overall Study|Death|25
7504884|NCT02320058|11831867|FG001|Overall Study|Death|10
7504885|NCT02320058|11831866|FG000|Overall Study|Lost to Follow-up|4
7504886|NCT02320058|11831867|FG001|Overall Study|Lost to Follow-up|0
7504887|NCT02320058|11831866|FG000|Overall Study|Other reasons|4
7504888|NCT02320058|11831867|FG001|Overall Study|Other reasons|1
7504889|NCT02320058|11831866|FG000|Overall Study|Withdrawal by Subject|8
7504890|NCT02320058|11831867|FG001|Overall Study|Withdrawal by Subject|2
7504891|NCT02320058|11831866|FG000|Overall Study|Not reported|1
7504892|NCT02320058|11831867|FG001|Overall Study|Not reported|0
7504893|NCT02320123|11831875|FG000|Overall Study|Lost to Follow-up|4
7504894|NCT02320123|11831876|FG001|Overall Study|Lost to Follow-up|6
7504895|NCT02320123|11831875|FG000|Overall Study|Death|6
7504896|NCT02320123|11831876|FG001|Overall Study|Death|5
7504897|NCT02320149|11831888|FG000|Overall Study|Adverse Event|3
7504898|NCT02320149|11831889|FG001|Overall Study|Adverse Event|7
7504899|NCT02320149|11831888|FG000|Overall Study|Withdrawal of Consent|28
7504900|NCT02320149|11831889|FG001|Overall Study|Withdrawal of Consent|32
7504901|NCT02320149|11831888|FG000|Overall Study|Lost to Follow-up|21
7504902|NCT02320149|11831889|FG001|Overall Study|Lost to Follow-up|34
7504903|NCT02320149|11831888|FG000|Overall Study|Protocol Violation|2
7504904|NCT02320149|11831889|FG001|Overall Study|Protocol Violation|1
7504905|NCT02320149|11831888|FG000|Overall Study|Noncompliance with Study Treatment|7
7504906|NCT02320149|11831889|FG001|Overall Study|Noncompliance with Study Treatment|2
7504907|NCT02320149|11831888|FG000|Overall Study|Lack of Efficacy|0
7504908|NCT02320149|11831889|FG001|Overall Study|Lack of Efficacy|1
7504909|NCT02320149|11831888|FG000|Overall Study|Other Miscellaneous Reasons|2
7504910|NCT02320149|11831889|FG001|Overall Study|Other Miscellaneous Reasons|3
7504911|NCT02320253|11831919|FG000|Overall Study|Withdrawal by Subject|3
7504912|NCT02320253|11831920|FG001|Overall Study|Withdrawal by Subject|0
7504913|NCT02320253|11831921|FG002|Overall Study|Withdrawal by Subject|0
7504914|NCT02320253|11831919|FG000|Overall Study|Lost to Follow-up|2
7504915|NCT02320253|11831920|FG001|Overall Study|Lost to Follow-up|2
7504916|NCT02320253|11831921|FG002|Overall Study|Lost to Follow-up|1
7504917|NCT02320253|11831919|FG000|Overall Study|Death|1
7504918|NCT02320253|11831920|FG001|Overall Study|Death|0
7504919|NCT02320253|11831921|FG002|Overall Study|Death|1
7504920|NCT02320487|11831929|FG000|Overall Study|Reason not Specified|1
7504921|NCT02320487|11831929|FG000|Overall Study|Physician Decision|5
7504922|NCT02320487|11831929|FG000|Overall Study|Withdrawal by Subject|1
7504923|NCT02320487|11831929|FG000|Overall Study|Death|3
7504924|NCT02320487|11831929|FG000|Overall Study|Adverse Event|11
7504925|NCT02320721|11831944|FG000|Overall Study|Adverse Event|6
7504926|NCT02320721|11831945|FG001|Overall Study|Adverse Event|6
7504927|NCT02320721|11831944|FG000|Overall Study|Lack of Efficacy|2
7504928|NCT02320721|11831945|FG001|Overall Study|Lack of Efficacy|0
7504929|NCT02320721|11831944|FG000|Overall Study|Poor compliance to protocol|3
7504930|NCT02320721|11831945|FG001|Overall Study|Poor compliance to protocol|7
7504931|NCT02320721|11831944|FG000|Overall Study|Randomized but not treated|0
7504932|NCT02320721|11831945|FG001|Overall Study|Randomized but not treated|1
7504933|NCT02320721|11831944|FG000|Overall Study|Hypoglycemia|1
7504934|NCT02320721|11831945|FG001|Overall Study|Hypoglycemia|0
7504935|NCT02320721|11831944|FG000|Overall Study|Other than specified above|15
7504936|NCT02320721|11831945|FG001|Overall Study|Other than specified above|20
7535849|NCT02713204|11883646|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535850|NCT02713204|11883647|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
7535851|NCT02713204|11883640|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535852|NCT02713204|11883641|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
7535853|NCT02713204|11883642|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535854|NCT02713204|11883643|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535855|NCT02713204|11883644|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535856|NCT02713204|11883645|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535857|NCT02713204|11883646|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535858|NCT02713204|11883647|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
7535859|NCT02713204|11883640|FG000|From Week 12 up to Week 36|Adverse Event|1
7535860|NCT02713204|11883641|FG001|From Week 12 up to Week 36|Adverse Event|0
7535861|NCT02713204|11883642|FG002|From Week 12 up to Week 36|Adverse Event|0
7535862|NCT02713204|11883643|FG003|From Week 12 up to Week 36|Adverse Event|1
7535863|NCT02713204|11883644|FG004|From Week 12 up to Week 36|Adverse Event|1
7535864|NCT02713204|11883645|FG005|From Week 12 up to Week 36|Adverse Event|0
7535865|NCT02713204|11883646|FG006|From Week 12 up to Week 36|Adverse Event|2
7535866|NCT02713204|11883647|FG007|From Week 12 up to Week 36|Adverse Event|1
7535867|NCT02713204|11883640|FG000|From Week 12 up to Week 36|Death|0
7535868|NCT02713204|11883641|FG001|From Week 12 up to Week 36|Death|0
7535869|NCT02713204|11883642|FG002|From Week 12 up to Week 36|Death|0
7535870|NCT02713204|11883643|FG003|From Week 12 up to Week 36|Death|1
7535871|NCT02713204|11883644|FG004|From Week 12 up to Week 36|Death|0
7535872|NCT02713204|11883645|FG005|From Week 12 up to Week 36|Death|1
7535873|NCT02713204|11883646|FG006|From Week 12 up to Week 36|Death|0
7535874|NCT02713204|11883647|FG007|From Week 12 up to Week 36|Death|3
7535875|NCT02713204|11883640|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
7535876|NCT02713204|11883641|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
7535877|NCT02713204|11883642|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
7535878|NCT02713204|11883643|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
7535879|NCT02713204|11883644|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
7535880|NCT02713204|11883645|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
7535881|NCT02713204|11883646|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
7535882|NCT02713204|11883647|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
7535883|NCT02713204|11883640|FG000|From Week 12 up to Week 36|Participant Re-located|0
7535884|NCT02713204|11883641|FG001|From Week 12 up to Week 36|Participant Re-located|0
7535885|NCT02713204|11883642|FG002|From Week 12 up to Week 36|Participant Re-located|0
7535886|NCT02713204|11883643|FG003|From Week 12 up to Week 36|Participant Re-located|0
7535887|NCT02713204|11883644|FG004|From Week 12 up to Week 36|Participant Re-located|1
7535888|NCT02713204|11883645|FG005|From Week 12 up to Week 36|Participant Re-located|0
7535889|NCT02713204|11883646|FG006|From Week 12 up to Week 36|Participant Re-located|0
7535890|NCT02713204|11883647|FG007|From Week 12 up to Week 36|Participant Re-located|0
7535891|NCT02713243|11883678|FG000|Overall Study|Abnormal laboratory value(s)#|1
7504937|NCT02320903|11831974|FG000|Overall Study|Withdrawal by Subject|0
7504938|NCT02320903|11831975|FG001|Overall Study|Withdrawal by Subject|9
7504939|NCT02320903|11831976|FG002|Overall Study|Withdrawal by Subject|9
7504940|NCT02320903|11831974|FG000|Overall Study|Exited therapy; no longer eligible|8
7504941|NCT02320903|11831975|FG001|Overall Study|Exited therapy; no longer eligible|2
7504942|NCT02320903|11831976|FG002|Overall Study|Exited therapy; no longer eligible|2
7504943|NCT02320903|11831974|FG000|Overall Study|Lost to Follow-up|0
7504944|NCT02320903|11831975|FG001|Overall Study|Lost to Follow-up|5
7504945|NCT02320903|11831976|FG002|Overall Study|Lost to Follow-up|5
7504946|NCT02321098|11831988|FG000|12 Weeks Treament|Lost to Follow-up|1
7504947|NCT02321098|11831989|FG001|12 Weeks Treament|Lost to Follow-up|1
7504948|NCT02321098|11831990|FG002|12 Weeks Treament|Lost to Follow-up|0
7504949|NCT02321098|11831988|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
7504950|NCT02321098|11831989|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
7504951|NCT02321098|11831990|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
7504952|NCT02321098|11831988|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
7504953|NCT02321098|11831989|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
7504954|NCT02321098|11831990|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
7504955|NCT02321098|11831988|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
7504956|NCT02321098|11831989|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
7504957|NCT02321098|11831990|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
7504958|NCT02321319|11832012|FG000|Overall Study|Product discontinued|5
7504963|NCT02321462|11832028|FG000|Overall Study|Withdrawal by Subject|5
7504964|NCT02321462|11832029|FG001|Overall Study|Withdrawal by Subject|2
7504965|NCT02321462|11832028|FG000|Overall Study|Subject withdrawn before any treatment|1
7504966|NCT02321462|11832029|FG001|Overall Study|Subject withdrawn before any treatment|1
7504967|NCT02321800|11832054|FG000|Overall Study|Withdrawal by Subject|3
7504968|NCT02321800|11832055|FG001|Overall Study|Withdrawal by Subject|3
7504969|NCT02321800|11832054|FG000|Overall Study|Death|1
7504970|NCT02321800|11832055|FG001|Overall Study|Death|0
7504971|NCT02321800|11832054|FG000|Overall Study|Protocol Violation|1
7504972|NCT02321800|11832055|FG001|Overall Study|Protocol Violation|0
7504973|NCT02321800|11832054|FG000|Overall Study|Lost to Follow-up|10
7504974|NCT02321800|11832055|FG001|Overall Study|Lost to Follow-up|4
7504975|NCT02321800|11832054|FG000|Overall Study|Adverse Event|2
7504976|NCT02321800|11832055|FG001|Overall Study|Adverse Event|3
7504977|NCT02321800|11832054|FG000|Overall Study|Other, Miscellaneous|3
7504978|NCT02321800|11832055|FG001|Overall Study|Other, Miscellaneous|1
7504979|NCT02321930|11832061|FG000|Overall Study|Lost to Follow-up|1
7504980|NCT02322021|11832069|FG000|Core Phase|Adverse Event|1
7504981|NCT02322021|11832070|FG001|Core Phase|Adverse Event|3
7504982|NCT02322021|11832071|FG002|Core Phase|Adverse Event|4
7504983|NCT02322021|11832072|FG003|Core Phase|Adverse Event|2
7504984|NCT02322021|11832073|FG004|Core Phase|Adverse Event|0
7504985|NCT02322021|11832069|FG000|Core Phase|Participant Choice|4
7504986|NCT02322021|11832070|FG001|Core Phase|Participant Choice|5
7504987|NCT02322021|11832071|FG002|Core Phase|Participant Choice|4
7504988|NCT02322021|11832072|FG003|Core Phase|Participant Choice|2
7504989|NCT02322021|11832073|FG004|Core Phase|Participant Choice|0
7504990|NCT02322021|11832069|FG000|Core Phase|Lost to Follow-up|0
7504991|NCT02322021|11832070|FG001|Core Phase|Lost to Follow-up|0
7504992|NCT02322021|11832071|FG002|Core Phase|Lost to Follow-up|0
7504993|NCT02322021|11832072|FG003|Core Phase|Lost to Follow-up|1
7504994|NCT02322021|11832073|FG004|Core Phase|Lost to Follow-up|0
7504995|NCT02322021|11832069|FG000|Core Phase|Other|0
7504996|NCT02322021|11832070|FG001|Core Phase|Other|0
7504997|NCT02322021|11832071|FG002|Core Phase|Other|1
7504998|NCT02322021|11832072|FG003|Core Phase|Other|0
7504999|NCT02322021|11832073|FG004|Core Phase|Other|0
7505000|NCT02322021|11832069|FG000|Extension Phase|Adverse Event|0
7505001|NCT02322021|11832070|FG001|Extension Phase|Adverse Event|0
7505002|NCT02322021|11832071|FG002|Extension Phase|Adverse Event|0
7505003|NCT02322021|11832072|FG003|Extension Phase|Adverse Event|0
7505004|NCT02322021|11832073|FG004|Extension Phase|Adverse Event|3
7505005|NCT02322021|11832069|FG000|Extension Phase|Participant Choice|0
7505006|NCT02322021|11832070|FG001|Extension Phase|Participant Choice|0
7505007|NCT02322021|11832071|FG002|Extension Phase|Participant Choice|0
7505008|NCT02322021|11832072|FG003|Extension Phase|Participant Choice|0
7505009|NCT02322021|11832073|FG004|Extension Phase|Participant Choice|6
7505010|NCT02322021|11832069|FG000|Extension Phase|Other|0
7505011|NCT02322021|11832070|FG001|Extension Phase|Other|0
7505012|NCT02322021|11832071|FG002|Extension Phase|Other|0
7505013|NCT02322021|11832072|FG003|Extension Phase|Other|0
7505014|NCT02322021|11832073|FG004|Extension Phase|Other|3
7505015|NCT02322021|11832069|FG000|Extension Phase|Lost to Follow-up|0
7505016|NCT02322021|11832070|FG001|Extension Phase|Lost to Follow-up|0
7505017|NCT02322021|11832071|FG002|Extension Phase|Lost to Follow-up|0
7505018|NCT02322021|11832072|FG003|Extension Phase|Lost to Follow-up|0
7505019|NCT02322021|11832073|FG004|Extension Phase|Lost to Follow-up|1
7505020|NCT02322021|11832069|FG000|Extension Phase|Study terminated by sponsor|0
7505021|NCT02322021|11832070|FG001|Extension Phase|Study terminated by sponsor|0
7505022|NCT02322021|11832071|FG002|Extension Phase|Study terminated by sponsor|0
7505023|NCT02322021|11832072|FG003|Extension Phase|Study terminated by sponsor|0
7505024|NCT02322021|11832073|FG004|Extension Phase|Study terminated by sponsor|28
7505025|NCT02322047|11832092|FG000|Overall Study|Physician Decision|1
7505026|NCT02322047|11832093|FG001|Overall Study|Physician Decision|0
7505027|NCT02322047|11832094|FG002|Overall Study|Physician Decision|0
7505028|NCT02322047|11832095|FG003|Overall Study|Physician Decision|0
7505029|NCT02322047|11832092|FG000|Overall Study|Withdrawal by Subject|1
7505030|NCT02322047|11832093|FG001|Overall Study|Withdrawal by Subject|0
7505031|NCT02322047|11832094|FG002|Overall Study|Withdrawal by Subject|0
7505032|NCT02322047|11832095|FG003|Overall Study|Withdrawal by Subject|1
7505033|NCT02322047|11832092|FG000|Overall Study|Adverse Event|0
7505034|NCT02322047|11832093|FG001|Overall Study|Adverse Event|1
7505035|NCT02322047|11832094|FG002|Overall Study|Adverse Event|0
7505036|NCT02322047|11832095|FG003|Overall Study|Adverse Event|0
7505037|NCT02322047|11832092|FG000|Overall Study|Lost to Follow-up|0
7505038|NCT02322047|11832093|FG001|Overall Study|Lost to Follow-up|0
7505039|NCT02322047|11832094|FG002|Overall Study|Lost to Follow-up|1
7505040|NCT02322047|11832095|FG003|Overall Study|Lost to Follow-up|1
7505041|NCT02322125|11832105|FG000|Overall Study|Withdrawal by Subject|2
7535892|NCT02713243|11883679|FG001|Overall Study|Abnormal laboratory value(s)#|0
7535893|NCT02713243|11883678|FG000|Overall Study|Administrative problems|0
7535894|NCT02713243|11883679|FG001|Overall Study|Administrative problems|1
7535895|NCT02713243|11883678|FG000|Overall Study|Protocol deviation|0
7535896|NCT02713243|11883679|FG001|Overall Study|Protocol deviation|1
7535897|NCT02713490|11883695|FG000|Overall Study|Withdrawal by Subject|2
7535898|NCT02713490|11883696|FG001|Overall Study|Withdrawal by Subject|1
7535899|NCT02713490|11883695|FG000|Overall Study|Did not receive study drug|1
7535900|NCT02713490|11883696|FG001|Overall Study|Did not receive study drug|0
7535901|NCT02713490|11883695|FG000|Overall Study|Met exclusion criteria|0
7535902|NCT02713490|11883696|FG001|Overall Study|Met exclusion criteria|1
7535903|NCT02713529|11883709|FG000|Overall Study|Withdrawal by Subject|3
7535904|NCT02713529|11883710|FG001|Overall Study|Withdrawal by Subject|1
7535905|NCT02713529|11883711|FG002|Overall Study|Withdrawal by Subject|4
7535906|NCT02713529|11883712|FG003|Overall Study|Withdrawal by Subject|2
7535907|NCT02713529|11883713|FG004|Overall Study|Withdrawal by Subject|0
7535908|NCT02713529|11883714|FG005|Overall Study|Withdrawal by Subject|1
7535909|NCT02713529|11883715|FG006|Overall Study|Withdrawal by Subject|1
7535910|NCT02713529|11883709|FG000|Overall Study|Lost to Follow-up|1
7535911|NCT02713529|11883710|FG001|Overall Study|Lost to Follow-up|0
7535912|NCT02713529|11883711|FG002|Overall Study|Lost to Follow-up|1
7535913|NCT02713529|11883712|FG003|Overall Study|Lost to Follow-up|0
7535914|NCT02713529|11883713|FG004|Overall Study|Lost to Follow-up|0
7535915|NCT02713529|11883714|FG005|Overall Study|Lost to Follow-up|0
7535916|NCT02713529|11883715|FG006|Overall Study|Lost to Follow-up|0
7535917|NCT02713529|11883709|FG000|Overall Study|Death|3
7535918|NCT02713529|11883710|FG001|Overall Study|Death|3
7535919|NCT02713529|11883711|FG002|Overall Study|Death|26
7535920|NCT02713529|11883712|FG003|Overall Study|Death|27
7535921|NCT02713529|11883713|FG004|Overall Study|Death|3
7535922|NCT02713529|11883714|FG005|Overall Study|Death|13
7535923|NCT02713529|11883715|FG006|Overall Study|Death|3
7535924|NCT02713542|11883737|FG000|Overall Study|Use of prohibited medication|14
7535925|NCT02713542|11883738|FG001|Overall Study|Use of prohibited medication|5
7535926|NCT02713542|11883737|FG000|Overall Study|Withdrawal by Subject|4
7535927|NCT02713542|11883738|FG001|Overall Study|Withdrawal by Subject|1
7535928|NCT02713594|11883746|FG000|Overall Study|Withdrawal by Subject|32
7535929|NCT02713594|11883747|FG001|Overall Study|Withdrawal by Subject|22
7535930|NCT02713594|11883746|FG000|Overall Study|Lost to Follow-up|358
7535931|NCT02713594|11883747|FG001|Overall Study|Lost to Follow-up|374
7535932|NCT02713789|11883796|FG000|Overall Study|Lost to Follow-up|0
7535933|NCT02713789|11883797|FG001|Overall Study|Lost to Follow-up|1
7535934|NCT02713789|11883798|FG002|Overall Study|Lost to Follow-up|1
7535935|NCT02713828|11883808|FG000|Overall Study|Death|2
7535936|NCT02713828|11883809|FG001|Overall Study|Death|0
7535937|NCT02713828|11883808|FG000|Overall Study|Withdrawal by Subject|1
7535938|NCT02713828|11883809|FG001|Overall Study|Withdrawal by Subject|0
7535939|NCT02713828|11883808|FG000|Overall Study|study terminated but patient allowed to|2
7535940|NCT02713828|11883809|FG001|Overall Study|study terminated but patient allowed to|0
7535941|NCT02714153|11883814|FG000|Overall Study|Death|1
7535942|NCT02714426|11883840|FG000|Overall Study|Withdrawal by Subject|2
7535943|NCT02714426|11883841|FG001|Overall Study|Withdrawal by Subject|2
7535944|NCT02714569|11883867|FG000|Part A Second Intervention|Withdrawal by Subject|0
7535945|NCT02714569|11883868|FG001|Part A Second Intervention|Withdrawal by Subject|1
7535946|NCT02714569|11883869|FG002|Part A Second Intervention|Withdrawal by Subject|0
7535947|NCT02714569|11883870|FG003|Part A Second Intervention|Withdrawal by Subject|0
7535948|NCT02714569|11883871|FG004|Part A Second Intervention|Withdrawal by Subject|0
7535949|NCT02714569|11883872|FG005|Part A Second Intervention|Withdrawal by Subject|0
7535950|NCT02714569|11883873|FG006|Part A Second Intervention|Withdrawal by Subject|0
7535951|NCT02714569|11883874|FG007|Part A Second Intervention|Withdrawal by Subject|0
7535952|NCT02714569|11883875|FG008|Part A Second Intervention|Withdrawal by Subject|0
7535953|NCT02714569|11883876|FG009|Part A Second Intervention|Withdrawal by Subject|0
7535954|NCT02714569|11883877|FG010|Part A Second Intervention|Withdrawal by Subject|0
7505042|NCT02322190|11832109|FG000|Overall Study|Death on study|1
7505043|NCT02322190|11832110|FG001|Overall Study|Death on study|0
7505044|NCT02322216|11832117|FG000|Overall Study|Adverse Event|1
7505045|NCT02322216|11832118|FG001|Overall Study|Adverse Event|0
7505046|NCT02322216|11832117|FG000|Overall Study|Withdrawal by Subject|1
7505047|NCT02322216|11832118|FG001|Overall Study|Withdrawal by Subject|4
7505048|NCT02322229|11832125|FG000|Overall Study|Physician Decision|2
7505049|NCT02322281|11832142|FG000|Overall Study|Progressive Disease|42
7505050|NCT02322281|11832143|FG001|Overall Study|Progressive Disease|14
7505051|NCT02322281|11832144|FG002|Overall Study|Progressive Disease|49
7505052|NCT02322281|11832142|FG000|Overall Study|Adverse Event|3
7505053|NCT02322281|11832143|FG001|Overall Study|Adverse Event|4
7505054|NCT02322281|11832144|FG002|Overall Study|Adverse Event|6
7505055|NCT02322281|11832142|FG000|Overall Study|Death|3
7505056|NCT02322281|11832143|FG001|Overall Study|Death|3
7505057|NCT02322281|11832144|FG002|Overall Study|Death|3
7505058|NCT02322281|11832142|FG000|Overall Study|Withdrawal by Subject|1
7505059|NCT02322281|11832143|FG001|Overall Study|Withdrawal by Subject|1
7505060|NCT02322281|11832144|FG002|Overall Study|Withdrawal by Subject|6
7505061|NCT02322281|11832142|FG000|Overall Study|Physician Decision|2
7505062|NCT02322281|11832143|FG001|Overall Study|Physician Decision|0
7505063|NCT02322281|11832144|FG002|Overall Study|Physician Decision|5
7505064|NCT02322281|11832142|FG000|Overall Study|Study Terminated by Sponsor|2
7505065|NCT02322281|11832143|FG001|Overall Study|Study Terminated by Sponsor|0
7505066|NCT02322281|11832144|FG002|Overall Study|Study Terminated by Sponsor|0
7505067|NCT02322281|11832142|FG000|Overall Study|Missing|0
7505068|NCT02322281|11832143|FG001|Overall Study|Missing|0
7505069|NCT02322281|11832144|FG002|Overall Study|Missing|1
7505070|NCT02322281|11832142|FG000|Overall Study|Miscellaneous|0
7505071|NCT02322281|11832143|FG001|Overall Study|Miscellaneous|0
7505072|NCT02322281|11832144|FG002|Overall Study|Miscellaneous|4
7505073|NCT02322411|11832178|FG000|Overall Study|Lost to Follow-up|4
7505074|NCT02322411|11832179|FG001|Overall Study|Lost to Follow-up|7
7505075|NCT02322411|11832178|FG000|Overall Study|Withdrawal by Subject|1
7505076|NCT02322411|11832179|FG001|Overall Study|Withdrawal by Subject|0
7505077|NCT02322749|11832189|FG000|Period 2|Adverse Event|0
7505078|NCT02322749|11832190|FG001|Period 2|Adverse Event|0
7505079|NCT02322749|11832191|FG002|Period 2|Adverse Event|0
7505080|NCT02322749|11832192|FG003|Period 2|Adverse Event|1
7505081|NCT02322749|11832193|FG004|Period 2|Adverse Event|0
7505082|NCT02322749|11832194|FG005|Period 2|Adverse Event|0
7505083|NCT02322749|11832189|FG000|Period 2|Withdrawal by Subject|0
7505084|NCT02322749|11832190|FG001|Period 2|Withdrawal by Subject|0
7505085|NCT02322749|11832191|FG002|Period 2|Withdrawal by Subject|0
7505086|NCT02322749|11832192|FG003|Period 2|Withdrawal by Subject|1
7505087|NCT02322749|11832193|FG004|Period 2|Withdrawal by Subject|0
7505088|NCT02322749|11832194|FG005|Period 2|Withdrawal by Subject|0
7505089|NCT02322749|11832189|FG000|Period 3|Withdrawal by Subject|0
7505090|NCT02322749|11832190|FG001|Period 3|Withdrawal by Subject|0
7505091|NCT02322749|11832191|FG002|Period 3|Withdrawal by Subject|1
7505092|NCT02322749|11832192|FG003|Period 3|Withdrawal by Subject|0
7505093|NCT02322749|11832193|FG004|Period 3|Withdrawal by Subject|0
7505094|NCT02322749|11832194|FG005|Period 3|Withdrawal by Subject|0
7505095|NCT02322775|11832205|FG000|Overall Study|Adverse Event|1
7505096|NCT02322775|11832206|FG001|Overall Study|Adverse Event|0
7505097|NCT02322775|11832205|FG000|Overall Study|Lost to Follow-up|0
7505098|NCT02322775|11832206|FG001|Overall Study|Lost to Follow-up|1
7505099|NCT02322775|11832205|FG000|Overall Study|Protocol Violation|1
7505100|NCT02322775|11832206|FG001|Overall Study|Protocol Violation|0
7505101|NCT02322775|11832205|FG000|Overall Study|Withdrawal by Subject|3
7505102|NCT02322775|11832206|FG001|Overall Study|Withdrawal by Subject|4
7505103|NCT02322775|11832205|FG000|Overall Study|Not willing to perform all FU visits|0
7505104|NCT02322775|11832206|FG001|Overall Study|Not willing to perform all FU visits|1
7505105|NCT02322814|11832230|FG000|Overall Study|Ongoing Study|0
7505106|NCT02322814|11832231|FG001|Overall Study|Ongoing Study|13
7505107|NCT02322814|11832232|FG002|Overall Study|Ongoing Study|14
7505108|NCT02322814|11832233|FG003|Overall Study|Ongoing Study|20
7505109|NCT02322814|11832234|FG004|Overall Study|Ongoing Study|22
7505110|NCT02322814|11832230|FG000|Overall Study|Progressive Disease|0
7505111|NCT02322814|11832231|FG001|Overall Study|Progressive Disease|2
7505112|NCT02322814|11832232|FG002|Overall Study|Progressive Disease|0
7505113|NCT02322814|11832233|FG003|Overall Study|Progressive Disease|1
7505114|NCT02322814|11832234|FG004|Overall Study|Progressive Disease|0
7505115|NCT02322814|11832230|FG000|Overall Study|Lost to Follow-up|1
7505116|NCT02322814|11832231|FG001|Overall Study|Lost to Follow-up|2
7505117|NCT02322814|11832232|FG002|Overall Study|Lost to Follow-up|1
7505118|NCT02322814|11832233|FG003|Overall Study|Lost to Follow-up|0
7505119|NCT02322814|11832234|FG004|Overall Study|Lost to Follow-up|0
7505120|NCT02322814|11832230|FG000|Overall Study|Other|2
7505121|NCT02322814|11832231|FG001|Overall Study|Other|0
7505122|NCT02322814|11832232|FG002|Overall Study|Other|0
7505123|NCT02322814|11832233|FG003|Overall Study|Other|0
7505124|NCT02322814|11832234|FG004|Overall Study|Other|0
7505125|NCT02322814|11832230|FG000|Overall Study|Protocol Violation|1
7505126|NCT02322814|11832231|FG001|Overall Study|Protocol Violation|0
7505127|NCT02322814|11832232|FG002|Overall Study|Protocol Violation|0
7505128|NCT02322814|11832233|FG003|Overall Study|Protocol Violation|0
7505129|NCT02322814|11832234|FG004|Overall Study|Protocol Violation|0
7505130|NCT02322814|11832230|FG000|Overall Study|Death|7
7505131|NCT02322814|11832231|FG001|Overall Study|Death|22
7505132|NCT02322814|11832232|FG002|Overall Study|Death|30
7505133|NCT02322814|11832233|FG003|Overall Study|Death|10
7505134|NCT02322814|11832234|FG004|Overall Study|Death|6
7505135|NCT02322814|11832230|FG000|Overall Study|Withdrawal by Subject|5
7505136|NCT02322814|11832231|FG001|Overall Study|Withdrawal by Subject|4
7505137|NCT02322814|11832232|FG002|Overall Study|Withdrawal by Subject|2
7505138|NCT02322814|11832233|FG003|Overall Study|Withdrawal by Subject|1
7505139|NCT02322814|11832234|FG004|Overall Study|Withdrawal by Subject|3
7505140|NCT02322866|11832247|FG000|Overall Study|Adverse Event|6
7505141|NCT02322866|11832248|FG001|Overall Study|Adverse Event|11
7505142|NCT02322866|11832247|FG000|Overall Study|Withdrawal of Consent|16
7505143|NCT02322866|11832248|FG001|Overall Study|Withdrawal of Consent|25
7505144|NCT02322866|11832247|FG000|Overall Study|Lost to Follow-up|36
7505145|NCT02322866|11832248|FG001|Overall Study|Lost to Follow-up|39
7505146|NCT02322866|11832247|FG000|Overall Study|Protocol Violation|1
7505147|NCT02322866|11832248|FG001|Overall Study|Protocol Violation|0
7505148|NCT02322866|11832247|FG000|Overall Study|Noncompliance with Treatment|3
7505149|NCT02322866|11832248|FG001|Overall Study|Noncompliance with Treatment|4
7505150|NCT02322866|11832247|FG000|Overall Study|Lack of Efficacy|3
7505151|NCT02322866|11832248|FG001|Overall Study|Lack of Efficacy|1
7505152|NCT02322866|11832247|FG000|Overall Study|Other Miscellaneous Reasons|6
7505153|NCT02322866|11832248|FG001|Overall Study|Other Miscellaneous Reasons|6
7505154|NCT02322879|11832256|FG000|First Intervention|Physician Decision|1
7505155|NCT02322879|11832257|FG001|First Intervention|Physician Decision|0
7505156|NCT02322892|11832265|FG000|Overall Study|Surgery cancelled|1
7505157|NCT02322892|11832266|FG001|Overall Study|Surgery cancelled|2
7505158|NCT02322892|11832265|FG000|Overall Study|Met exclusion criteria|0
7505159|NCT02322892|11832266|FG001|Overall Study|Met exclusion criteria|1
7505160|NCT02322892|11832265|FG000|Overall Study|Protocol Violation|1
7505161|NCT02322892|11832266|FG001|Overall Study|Protocol Violation|0
7505162|NCT02323113|11832300|FG000|Overall Study|Adverse Event|3
7505163|NCT02323113|11832301|FG001|Overall Study|Adverse Event|3
7505164|NCT02323113|11832302|FG002|Overall Study|Adverse Event|2
7505165|NCT02323113|11832303|FG003|Overall Study|Adverse Event|5
7505166|NCT02323113|11832304|FG004|Overall Study|Adverse Event|8
7505167|NCT02323113|11832305|FG005|Overall Study|Adverse Event|3
7505168|NCT02323113|11832306|FG006|Overall Study|Adverse Event|6
7505169|NCT02323113|11832307|FG007|Overall Study|Adverse Event|0
7505170|NCT02323113|11832300|FG000|Overall Study|Progressive Disease|0
7505171|NCT02323113|11832301|FG001|Overall Study|Progressive Disease|1
7505172|NCT02323113|11832302|FG002|Overall Study|Progressive Disease|1
7505173|NCT02323113|11832303|FG003|Overall Study|Progressive Disease|0
7505174|NCT02323113|11832304|FG004|Overall Study|Progressive Disease|0
7505175|NCT02323113|11832305|FG005|Overall Study|Progressive Disease|3
7505176|NCT02323113|11832306|FG006|Overall Study|Progressive Disease|0
7505177|NCT02323113|11832307|FG007|Overall Study|Progressive Disease|0
7505178|NCT02323113|11832300|FG000|Overall Study|Symptomatic Deterioration|0
7505179|NCT02323113|11832301|FG001|Overall Study|Symptomatic Deterioration|0
7505180|NCT02323113|11832302|FG002|Overall Study|Symptomatic Deterioration|1
7505181|NCT02323113|11832303|FG003|Overall Study|Symptomatic Deterioration|0
7505182|NCT02323113|11832304|FG004|Overall Study|Symptomatic Deterioration|1
7505183|NCT02323113|11832305|FG005|Overall Study|Symptomatic Deterioration|0
7505184|NCT02323113|11832306|FG006|Overall Study|Symptomatic Deterioration|0
7505185|NCT02323113|11832307|FG007|Overall Study|Symptomatic Deterioration|0
7505186|NCT02323113|11832300|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7505187|NCT02323113|11832301|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7505188|NCT02323113|11832302|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7505189|NCT02323113|11832303|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7505190|NCT02323113|11832304|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7505191|NCT02323113|11832305|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
7505192|NCT02323113|11832306|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7505193|NCT02323113|11832307|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7505194|NCT02323113|11832300|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505195|NCT02323113|11832301|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
7505196|NCT02323113|11832302|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505197|NCT02323113|11832303|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505198|NCT02323113|11832304|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505199|NCT02323113|11832305|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505200|NCT02323113|11832306|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505201|NCT02323113|11832307|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
7505202|NCT02323204|11832330|FG000|Baseline Survey Completion|Withdrawal by Subject|10
7505203|NCT02323204|11832331|FG001|Baseline Survey Completion|Withdrawal by Subject|9
7505204|NCT02323204|11832332|FG002|Baseline Survey Completion|Withdrawal by Subject|5
7505205|NCT02323204|11832333|FG003|Baseline Survey Completion|Withdrawal by Subject|3
7505206|NCT02323204|11832330|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
7505207|NCT02323204|11832331|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
7505208|NCT02323204|11832332|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
7505209|NCT02323204|11832333|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
7505210|NCT02323204|11832330|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
7505211|NCT02323204|11832331|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
7505212|NCT02323204|11832332|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
7505213|NCT02323204|11832333|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
7505214|NCT02323204|11832330|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7505215|NCT02323204|11832331|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
7505216|NCT02323204|11832332|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
7505217|NCT02323204|11832333|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
7505218|NCT02323204|11832330|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7505219|NCT02323204|11832331|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
7505220|NCT02323204|11832332|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
7505221|NCT02323204|11832333|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
7505222|NCT02323204|11832330|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
7505223|NCT02323204|11832331|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
7505224|NCT02323204|11832332|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
7505225|NCT02323204|11832333|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
7505226|NCT02323204|11832330|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7505227|NCT02323204|11832331|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7505228|NCT02323204|11832332|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
7505229|NCT02323204|11832333|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
7505230|NCT02323204|11832330|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
7505231|NCT02323204|11832331|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
7505232|NCT02323204|11832332|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
7505233|NCT02323204|11832333|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
7505234|NCT02323204|11832330|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7505235|NCT02323204|11832331|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
7505236|NCT02323204|11832332|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
7505237|NCT02323204|11832333|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
7505238|NCT02323334|11832357|FG000|Period 3|Lost to Follow-up|0
7505239|NCT02323334|11832358|FG001|Period 3|Lost to Follow-up|0
7505240|NCT02323334|11832359|FG002|Period 3|Lost to Follow-up|1
7505241|NCT02323334|11832360|FG003|Period 3|Lost to Follow-up|0
7505242|NCT02323334|11832361|FG004|Period 3|Lost to Follow-up|0
7505243|NCT02323334|11832362|FG005|Period 3|Lost to Follow-up|0
7505244|NCT02323334|11832363|FG006|Period 3|Lost to Follow-up|0
7505245|NCT02323334|11832364|FG007|Period 3|Lost to Follow-up|0
7505246|NCT02323334|11832365|FG008|Period 3|Lost to Follow-up|0
7505247|NCT02323334|11832366|FG009|Period 3|Lost to Follow-up|0
7505248|NCT02323334|11832367|FG010|Period 3|Lost to Follow-up|0
7505249|NCT02323334|11832368|FG011|Period 3|Lost to Follow-up|0
7505250|NCT02323334|11832369|FG012|Period 3|Lost to Follow-up|0
7505251|NCT02323334|11832370|FG013|Period 3|Lost to Follow-up|0
7505252|NCT02323334|11832371|FG014|Period 3|Lost to Follow-up|0
7505253|NCT02323334|11832372|FG015|Period 3|Lost to Follow-up|0
7505254|NCT02323334|11832373|FG016|Period 3|Lost to Follow-up|0
7505255|NCT02323334|11832357|FG000|Period 3|Withdrawal by Subject|1
7505256|NCT02323334|11832358|FG001|Period 3|Withdrawal by Subject|0
7505257|NCT02323334|11832359|FG002|Period 3|Withdrawal by Subject|0
7505258|NCT02323334|11832360|FG003|Period 3|Withdrawal by Subject|0
7505259|NCT02323334|11832361|FG004|Period 3|Withdrawal by Subject|0
7505260|NCT02323334|11832362|FG005|Period 3|Withdrawal by Subject|0
7505261|NCT02323334|11832363|FG006|Period 3|Withdrawal by Subject|0
7505262|NCT02323334|11832364|FG007|Period 3|Withdrawal by Subject|0
7505263|NCT02323334|11832365|FG008|Period 3|Withdrawal by Subject|0
7505264|NCT02323334|11832366|FG009|Period 3|Withdrawal by Subject|0
7505265|NCT02323334|11832367|FG010|Period 3|Withdrawal by Subject|0
7505266|NCT02323334|11832368|FG011|Period 3|Withdrawal by Subject|0
7505267|NCT02323334|11832369|FG012|Period 3|Withdrawal by Subject|0
7505268|NCT02323334|11832370|FG013|Period 3|Withdrawal by Subject|0
7505269|NCT02323334|11832371|FG014|Period 3|Withdrawal by Subject|0
7505270|NCT02323334|11832372|FG015|Period 3|Withdrawal by Subject|0
7505271|NCT02323334|11832373|FG016|Period 3|Withdrawal by Subject|0
7505272|NCT02323646|11832438|FG000|Treatment Course 1|Adverse Event|1
7505273|NCT02323646|11832439|FG001|Treatment Course 1|Adverse Event|0
7505274|NCT02323646|11832440|FG002|Treatment Course 1|Adverse Event|1
7505275|NCT02323646|11832438|FG000|Treatment Course 1|Heavy Bleeding|1
7505276|NCT02323646|11832439|FG001|Treatment Course 1|Heavy Bleeding|1
7505277|NCT02323646|11832440|FG002|Treatment Course 1|Heavy Bleeding|0
7505278|NCT02323646|11832438|FG000|Treatment Course 1|Lost to Follow-up|1
7505279|NCT02323646|11832439|FG001|Treatment Course 1|Lost to Follow-up|0
7505280|NCT02323646|11832440|FG002|Treatment Course 1|Lost to Follow-up|2
7505281|NCT02323646|11832438|FG000|Treatment Course 1|Withdrawal by Subject|0
7505282|NCT02323646|11832439|FG001|Treatment Course 1|Withdrawal by Subject|2
7505283|NCT02323646|11832440|FG002|Treatment Course 1|Withdrawal by Subject|0
7505284|NCT02323646|11832438|FG000|Treatment Course 2|Adverse Event|1
7505285|NCT02323646|11832439|FG001|Treatment Course 2|Adverse Event|0
7505286|NCT02323646|11832440|FG002|Treatment Course 2|Adverse Event|1
7505287|NCT02323646|11832438|FG000|Treatment Course 2|Lost to Follow-up|0
7505288|NCT02323646|11832439|FG001|Treatment Course 2|Lost to Follow-up|0
7505289|NCT02323646|11832440|FG002|Treatment Course 2|Lost to Follow-up|1
7505290|NCT02323646|11832438|FG000|Treatment Course 2|Non-compliance|0
7505291|NCT02323646|11832439|FG001|Treatment Course 2|Non-compliance|1
7505292|NCT02323646|11832440|FG002|Treatment Course 2|Non-compliance|1
7505293|NCT02324049|11832452|FG000|Part C|Study terminated|11
7505294|NCT02324153|11832468|FG000|Overall Study|Withdrawal by Subject|4
7505295|NCT02324153|11832469|FG001|Overall Study|Withdrawal by Subject|1
7505296|NCT02324153|11832468|FG000|Overall Study|Surgery postponed after randomization|3
7505297|NCT02324153|11832469|FG001|Overall Study|Surgery postponed after randomization|0
7505298|NCT02324153|11832468|FG000|Overall Study|Developed delirium preoperatively|1
7505299|NCT02324153|11832469|FG001|Overall Study|Developed delirium preoperatively|0
7505300|NCT02324205|11832475|FG000|Overall Study|Withdrawal by Subject|37
7505301|NCT02324270|11832482|FG000|Overall Study|Withdrawal by Subject|0
7505302|NCT02324270|11832483|FG001|Overall Study|Withdrawal by Subject|1
7505303|NCT02324270|11832484|FG002|Overall Study|Withdrawal by Subject|0
7505304|NCT02324270|11832482|FG000|Overall Study|Lost to Follow-up|4
7505305|NCT02324270|11832483|FG001|Overall Study|Lost to Follow-up|3
7505306|NCT02324270|11832484|FG002|Overall Study|Lost to Follow-up|4
7505307|NCT02324270|11832482|FG000|Overall Study|Protocol Violation|0
7505308|NCT02324270|11832483|FG001|Overall Study|Protocol Violation|1
7505309|NCT02324270|11832484|FG002|Overall Study|Protocol Violation|1
7505310|NCT02324270|11832482|FG000|Overall Study|Non Compliance with Study Drug|1
7505311|NCT02324270|11832483|FG001|Overall Study|Non Compliance with Study Drug|2
7505312|NCT02324270|11832484|FG002|Overall Study|Non Compliance with Study Drug|0
7505313|NCT02324361|11832503|FG000|Overall Study|Lost to Follow-up|5
7505314|NCT02324361|11832504|FG001|Overall Study|Lost to Follow-up|2
7505315|NCT02324465|11832512|FG000|Overall Study|device failure|0
7505316|NCT02324465|11832513|FG001|Overall Study|device failure|1
7505317|NCT02324569|11832549|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7505318|NCT02324569|11832550|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7505319|NCT02324569|11832549|FG000|Overall Study|Voluntary Withdrawal|3
7505320|NCT02324569|11832550|FG001|Overall Study|Voluntary Withdrawal|6
7505321|NCT02324569|11832549|FG000|Overall Study|Lack of Efficacy|2
7505322|NCT02324569|11832550|FG001|Overall Study|Lack of Efficacy|3
7505323|NCT02324569|11832549|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
7505324|NCT02324569|11832550|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
7505325|NCT02324569|11832549|FG000|Overall Study|Inconvenient Schedule|2
7505326|NCT02324569|11832550|FG001|Overall Study|Inconvenient Schedule|0
7505327|NCT02324699|11832574|FG000|Overall Study|study terminated|1
7505328|NCT02324842|11832581|FG000|Overall Study|Lost to Follow-up|1
7505329|NCT02324842|11832582|FG001|Overall Study|Lost to Follow-up|1
7505330|NCT02324842|11832583|FG002|Overall Study|Lost to Follow-up|2
7505331|NCT02325219|11832612|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
7505332|NCT02325219|11832613|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
7505333|NCT02325219|11832614|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
7505334|NCT02325219|11832615|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
7505335|NCT02325219|11832616|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
7505336|NCT02325219|11832612|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
7505337|NCT02325219|11832613|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7505338|NCT02325219|11832614|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7505339|NCT02325219|11832615|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7505340|NCT02325219|11832616|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7505341|NCT02325219|11832612|FG000|Controlled Period (Week 0 - 16)|Other|0
7505342|NCT02325219|11832613|FG001|Controlled Period (Week 0 - 16)|Other|0
7505343|NCT02325219|11832614|FG002|Controlled Period (Week 0 - 16)|Other|1
7505344|NCT02325219|11832615|FG003|Controlled Period (Week 0 - 16)|Other|0
7505345|NCT02325219|11832616|FG004|Controlled Period (Week 0 - 16)|Other|0
7505346|NCT02325219|11832612|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7505347|NCT02325219|11832613|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
7505348|NCT02325219|11832614|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
7505349|NCT02325219|11832615|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
7505350|NCT02325219|11832616|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
7505351|NCT02325219|11832612|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7505352|NCT02325219|11832613|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
7505353|NCT02325219|11832614|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7505354|NCT02325219|11832615|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7505355|NCT02325219|11832616|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
7505356|NCT02325219|11832612|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7505357|NCT02325219|11832613|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
7505358|NCT02325219|11832614|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7505359|NCT02325219|11832615|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
7505360|NCT02325219|11832616|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
7505361|NCT02325401|11832632|FG000|Overall Study|Withdrawal by Subject|0
7505362|NCT02325401|11832633|FG001|Overall Study|Withdrawal by Subject|1
7505363|NCT02325401|11832634|FG002|Overall Study|Withdrawal by Subject|1
7505364|NCT02325414|11832650|FG000|Overall Study|Withdrawal by Subject|3
7505365|NCT02325414|11832651|FG001|Overall Study|Withdrawal by Subject|1
7505366|NCT02325414|11832650|FG000|Overall Study|Lost to Follow-up|5
7505367|NCT02325414|11832651|FG001|Overall Study|Lost to Follow-up|5
7505368|NCT02325518|11832661|FG000|Overall Study|Adverse Event|4
7505369|NCT02325518|11832662|FG001|Overall Study|Adverse Event|1
7505370|NCT02325518|11832661|FG000|Overall Study|Physician Decision|0
7505371|NCT02325518|11832662|FG001|Overall Study|Physician Decision|1
7505372|NCT02325518|11832661|FG000|Overall Study|Withdrawal by Subject|0
7505373|NCT02325518|11832662|FG001|Overall Study|Withdrawal by Subject|1
7505374|NCT02325713|11832698|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505375|NCT02325713|11832699|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505376|NCT02325713|11832700|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505377|NCT02325713|11832701|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505378|NCT02325713|11832702|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505379|NCT02325713|11832703|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505380|NCT02325713|11832704|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505381|NCT02325713|11832705|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505382|NCT02325713|11832706|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505383|NCT02325713|11832707|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505384|NCT02325713|11832708|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
7505385|NCT02325713|11832709|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505386|NCT02325713|11832710|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505387|NCT02325713|11832711|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505388|NCT02325713|11832712|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505389|NCT02325713|11832713|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
7505390|NCT02325713|11832698|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
7505391|NCT02325713|11832699|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505392|NCT02325713|11832700|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505393|NCT02325713|11832701|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505394|NCT02325713|11832702|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505395|NCT02325713|11832703|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505396|NCT02325713|11832704|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505397|NCT02325713|11832705|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505398|NCT02325713|11832706|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505399|NCT02325713|11832707|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505400|NCT02325713|11832708|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505401|NCT02325713|11832709|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505402|NCT02325713|11832710|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505403|NCT02325713|11832711|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505404|NCT02325713|11832712|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505405|NCT02325713|11832713|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
7505406|NCT02325713|11832698|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505407|NCT02325713|11832699|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505408|NCT02325713|11832700|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505409|NCT02325713|11832701|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505410|NCT02325713|11832702|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505411|NCT02325713|11832703|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505412|NCT02325713|11832704|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505413|NCT02325713|11832705|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505414|NCT02325713|11832706|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505415|NCT02325713|11832707|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
7505416|NCT02325713|11832708|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505417|NCT02325713|11832709|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505418|NCT02325713|11832710|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505419|NCT02325713|11832711|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505420|NCT02325713|11832712|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505421|NCT02325713|11832713|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
7505422|NCT02325739|11832739|FG000|Phase I Part|Adverse Event|1
7505423|NCT02325739|11832740|FG001|Phase I Part|Adverse Event|0
7505424|NCT02325739|11832741|FG002|Phase I Part|Adverse Event|1
7505425|NCT02325739|11832742|FG003|Phase I Part|Adverse Event|2
7505426|NCT02325739|11832743|FG004|Phase I Part|Adverse Event|3
7505427|NCT02325739|11832744|FG005|Phase I Part|Adverse Event|1
7505428|NCT02325739|11832745|FG006|Phase I Part|Adverse Event|0
7505429|NCT02325739|11832746|FG007|Phase I Part|Adverse Event|2
7505430|NCT02325739|11832747|FG008|Phase I Part|Adverse Event|0
7505431|NCT02325739|11832748|FG009|Phase I Part|Adverse Event|0
7505432|NCT02325739|11832749|FG010|Phase I Part|Adverse Event|0
7505433|NCT02325739|11832739|FG000|Phase I Part|Progressive disease|9
7505434|NCT02325739|11832740|FG001|Phase I Part|Progressive disease|6
7505435|NCT02325739|11832741|FG002|Phase I Part|Progressive disease|3
7505436|NCT02325739|11832742|FG003|Phase I Part|Progressive disease|23
7505437|NCT02325739|11832743|FG004|Phase I Part|Progressive disease|14
7505438|NCT02325739|11832744|FG005|Phase I Part|Progressive disease|6
7505439|NCT02325739|11832745|FG006|Phase I Part|Progressive disease|6
7505440|NCT02325739|11832746|FG007|Phase I Part|Progressive disease|3
7505441|NCT02325739|11832747|FG008|Phase I Part|Progressive disease|0
7505442|NCT02325739|11832748|FG009|Phase I Part|Progressive disease|0
7505443|NCT02325739|11832749|FG010|Phase I Part|Progressive disease|0
7505444|NCT02325739|11832739|FG000|Phase I Part|Subject/guardian decision|1
7505445|NCT02325739|11832740|FG001|Phase I Part|Subject/guardian decision|0
7505446|NCT02325739|11832741|FG002|Phase I Part|Subject/guardian decision|1
7505447|NCT02325739|11832742|FG003|Phase I Part|Subject/guardian decision|1
7505448|NCT02325739|11832743|FG004|Phase I Part|Subject/guardian decision|0
7505449|NCT02325739|11832744|FG005|Phase I Part|Subject/guardian decision|0
7505450|NCT02325739|11832745|FG006|Phase I Part|Subject/guardian decision|0
7505451|NCT02325739|11832746|FG007|Phase I Part|Subject/guardian decision|1
7505452|NCT02325739|11832747|FG008|Phase I Part|Subject/guardian decision|0
7505453|NCT02325739|11832748|FG009|Phase I Part|Subject/guardian decision|0
7505454|NCT02325739|11832749|FG010|Phase I Part|Subject/guardian decision|0
7505455|NCT02325739|11832739|FG000|Phase I Part|Death|0
7505456|NCT02325739|11832740|FG001|Phase I Part|Death|0
7505457|NCT02325739|11832741|FG002|Phase I Part|Death|0
7505458|NCT02325739|11832742|FG003|Phase I Part|Death|0
7505459|NCT02325739|11832743|FG004|Phase I Part|Death|2
7505460|NCT02325739|11832744|FG005|Phase I Part|Death|0
7505461|NCT02325739|11832745|FG006|Phase I Part|Death|0
7505462|NCT02325739|11832746|FG007|Phase I Part|Death|0
7505463|NCT02325739|11832747|FG008|Phase I Part|Death|0
7505464|NCT02325739|11832748|FG009|Phase I Part|Death|0
7505465|NCT02325739|11832749|FG010|Phase I Part|Death|0
7505466|NCT02325739|11832739|FG000|Phase II Part|Adverse Event|0
7505467|NCT02325739|11832740|FG001|Phase II Part|Adverse Event|0
7505468|NCT02325739|11832741|FG002|Phase II Part|Adverse Event|0
7505469|NCT02325739|11832742|FG003|Phase II Part|Adverse Event|0
7505470|NCT02325739|11832743|FG004|Phase II Part|Adverse Event|0
7505471|NCT02325739|11832744|FG005|Phase II Part|Adverse Event|0
7505472|NCT02325739|11832745|FG006|Phase II Part|Adverse Event|0
7505473|NCT02325739|11832746|FG007|Phase II Part|Adverse Event|0
7505474|NCT02325739|11832747|FG008|Phase II Part|Adverse Event|4
7505475|NCT02325739|11832748|FG009|Phase II Part|Adverse Event|5
7505476|NCT02325739|11832749|FG010|Phase II Part|Adverse Event|1
7505477|NCT02325739|11832739|FG000|Phase II Part|Physician Decision|0
7505478|NCT02325739|11832740|FG001|Phase II Part|Physician Decision|0
7505479|NCT02325739|11832741|FG002|Phase II Part|Physician Decision|0
7505480|NCT02325739|11832742|FG003|Phase II Part|Physician Decision|0
7505481|NCT02325739|11832743|FG004|Phase II Part|Physician Decision|0
7505482|NCT02325739|11832744|FG005|Phase II Part|Physician Decision|0
7505483|NCT02325739|11832745|FG006|Phase II Part|Physician Decision|0
7505484|NCT02325739|11832746|FG007|Phase II Part|Physician Decision|0
7505485|NCT02325739|11832747|FG008|Phase II Part|Physician Decision|0
7505486|NCT02325739|11832748|FG009|Phase II Part|Physician Decision|1
7505487|NCT02325739|11832749|FG010|Phase II Part|Physician Decision|0
7505488|NCT02325739|11832739|FG000|Phase II Part|Progressive disease|0
7505489|NCT02325739|11832740|FG001|Phase II Part|Progressive disease|0
7505490|NCT02325739|11832741|FG002|Phase II Part|Progressive disease|0
7505491|NCT02325739|11832742|FG003|Phase II Part|Progressive disease|0
7505492|NCT02325739|11832743|FG004|Phase II Part|Progressive disease|0
7505493|NCT02325739|11832744|FG005|Phase II Part|Progressive disease|0
7505494|NCT02325739|11832745|FG006|Phase II Part|Progressive disease|0
7505495|NCT02325739|11832746|FG007|Phase II Part|Progressive disease|0
7505496|NCT02325739|11832747|FG008|Phase II Part|Progressive disease|22
7505497|NCT02325739|11832748|FG009|Phase II Part|Progressive disease|29
7505498|NCT02325739|11832749|FG010|Phase II Part|Progressive disease|18
7505499|NCT02325739|11832739|FG000|Phase II Part|Subject/guardian decision|0
7505500|NCT02325739|11832740|FG001|Phase II Part|Subject/guardian decision|0
7505501|NCT02325739|11832741|FG002|Phase II Part|Subject/guardian decision|0
7505502|NCT02325739|11832742|FG003|Phase II Part|Subject/guardian decision|0
7505503|NCT02325739|11832743|FG004|Phase II Part|Subject/guardian decision|0
7505504|NCT02325739|11832744|FG005|Phase II Part|Subject/guardian decision|0
7505505|NCT02325739|11832745|FG006|Phase II Part|Subject/guardian decision|0
7505506|NCT02325739|11832746|FG007|Phase II Part|Subject/guardian decision|0
7505507|NCT02325739|11832747|FG008|Phase II Part|Subject/guardian decision|4
7505508|NCT02325739|11832748|FG009|Phase II Part|Subject/guardian decision|1
7505509|NCT02325739|11832749|FG010|Phase II Part|Subject/guardian decision|1
7505510|NCT02325791|11832798|FG000|Overall Study|Adverse Event|0
7505511|NCT02325791|11832799|FG001|Overall Study|Adverse Event|1
7505512|NCT02325791|11832800|FG002|Overall Study|Adverse Event|1
7505513|NCT02325791|11832801|FG003|Overall Study|Adverse Event|0
7505514|NCT02325791|11832798|FG000|Overall Study|Death|0
7505515|NCT02325791|11832799|FG001|Overall Study|Death|3
7505516|NCT02325791|11832800|FG002|Overall Study|Death|0
7505517|NCT02325791|11832801|FG003|Overall Study|Death|1
7505518|NCT02325791|11832798|FG000|Overall Study|Lost to Follow-up|0
7505519|NCT02325791|11832799|FG001|Overall Study|Lost to Follow-up|15
7505520|NCT02325791|11832800|FG002|Overall Study|Lost to Follow-up|14
7505521|NCT02325791|11832801|FG003|Overall Study|Lost to Follow-up|9
7505522|NCT02325791|11832798|FG000|Overall Study|Physician Decision|0
7505523|NCT02325791|11832799|FG001|Overall Study|Physician Decision|1
7505524|NCT02325791|11832800|FG002|Overall Study|Physician Decision|1
7505525|NCT02325791|11832801|FG003|Overall Study|Physician Decision|0
7505526|NCT02325791|11832798|FG000|Overall Study|Protocol Violation|0
7505527|NCT02325791|11832799|FG001|Overall Study|Protocol Violation|0
7505528|NCT02325791|11832800|FG002|Overall Study|Protocol Violation|1
7505529|NCT02325791|11832801|FG003|Overall Study|Protocol Violation|0
7505530|NCT02325791|11832798|FG000|Overall Study|Withdrawal by Subject|0
7505531|NCT02325791|11832799|FG001|Overall Study|Withdrawal by Subject|5
7505532|NCT02325791|11832800|FG002|Overall Study|Withdrawal by Subject|8
7505533|NCT02325791|11832801|FG003|Overall Study|Withdrawal by Subject|16
7505534|NCT02326025|11832825|FG000|Overall Study|Adverse Event|3
7505535|NCT02326025|11832826|FG001|Overall Study|Adverse Event|0
7505536|NCT02326025|11832825|FG000|Overall Study|Physician Decision|1
7505537|NCT02326025|11832826|FG001|Overall Study|Physician Decision|2
7505538|NCT02326025|11832825|FG000|Overall Study|Physician and Participant Decision|1
7505539|NCT02326025|11832826|FG001|Overall Study|Physician and Participant Decision|0
7505540|NCT02326025|11832825|FG000|Overall Study|Withdrawal by Subject|0
7505541|NCT02326025|11832826|FG001|Overall Study|Withdrawal by Subject|2
7505542|NCT02326025|11832825|FG000|Overall Study|Protocol Violation|0
7505543|NCT02326025|11832826|FG001|Overall Study|Protocol Violation|1
7505544|NCT02326220|11832847|FG000|Double-blind Treatment Period|Adverse Event|1
7505545|NCT02326220|11832848|FG001|Double-blind Treatment Period|Adverse Event|2
7505546|NCT02326220|11832849|FG002|Double-blind Treatment Period|Adverse Event|0
7505547|NCT02326220|11832847|FG000|Double-blind Treatment Period|Protocol Violation|0
7505548|NCT02326220|11832848|FG001|Double-blind Treatment Period|Protocol Violation|1
7505549|NCT02326220|11832849|FG002|Double-blind Treatment Period|Protocol Violation|0
7505550|NCT02326220|11832847|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7505551|NCT02326220|11832848|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7505552|NCT02326220|11832849|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7505553|NCT02326220|11832847|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7505554|NCT02326220|11832848|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7505555|NCT02326220|11832849|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7505556|NCT02326220|11832847|FG000|Open-label Treatment Period|Lost to Follow-up|0
7505557|NCT02326220|11832848|FG001|Open-label Treatment Period|Lost to Follow-up|0
7505558|NCT02326220|11832849|FG002|Open-label Treatment Period|Lost to Follow-up|1
7505559|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505560|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
7505561|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7505562|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505563|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505564|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505565|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505566|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505567|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505568|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505569|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505570|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505571|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505572|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505573|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505574|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7505575|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
7505576|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505577|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505578|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505579|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505580|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505581|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505582|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505583|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505584|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505585|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505586|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505587|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505588|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505589|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7505590|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7505591|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7505592|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505593|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505594|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505595|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505596|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505597|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505598|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505599|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505600|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505601|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505602|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505603|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505604|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505605|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505606|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
7505607|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505608|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505609|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505610|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505611|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505612|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505613|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505614|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505615|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505616|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505617|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505618|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
7505619|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505620|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505621|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
7505622|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505623|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505624|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505625|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505626|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505627|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505628|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505629|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505630|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505631|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505632|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505633|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
7505634|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505635|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505636|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
7505637|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505638|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505639|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505640|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505641|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505642|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505643|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505644|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505645|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505646|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505647|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505648|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
7505649|NCT02326272|11832871|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505650|NCT02326272|11832872|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505651|NCT02326272|11832873|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
7505652|NCT02326272|11832874|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505653|NCT02326272|11832875|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505654|NCT02326272|11832876|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505655|NCT02326272|11832877|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505656|NCT02326272|11832878|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505657|NCT02326272|11832879|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505658|NCT02326272|11832880|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505659|NCT02326272|11832881|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505660|NCT02326272|11832882|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505661|NCT02326272|11832883|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505662|NCT02326272|11832884|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505663|NCT02326272|11832885|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
7505664|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505665|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505666|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505667|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505668|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7505669|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
7505670|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7505671|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7505672|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7505673|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505674|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505675|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505676|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505677|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505678|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7505679|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505680|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505681|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505682|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505683|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505684|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
7505685|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7505686|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505687|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7505688|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7505689|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505690|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505691|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505692|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505693|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7505694|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505695|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505696|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505697|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505698|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505699|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7505700|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505701|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7505702|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505703|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505704|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505705|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505706|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505707|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505708|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7505709|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505710|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505711|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505712|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7505713|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505714|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7505715|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7505716|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7505717|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505718|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7505719|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505720|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505721|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505722|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505723|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7505724|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505725|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505726|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505727|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505728|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505729|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505730|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505731|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
7505732|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505733|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505734|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505735|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505736|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505737|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505738|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
7505739|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505740|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505741|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505742|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505743|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505744|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505745|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7505746|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505747|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505748|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505749|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505750|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505751|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505752|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505753|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7505754|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505755|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505756|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505757|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505758|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505759|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505760|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505761|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505762|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
7505763|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505764|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505765|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505766|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505767|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505768|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
7505769|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505770|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505771|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505772|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505773|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505774|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7505775|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7505776|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
7505777|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
7505778|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505779|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505780|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505781|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505782|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505783|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7505784|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505785|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505786|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505787|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505788|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505789|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
7505790|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505791|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505792|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505793|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505794|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505795|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505796|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505797|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505798|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
7505799|NCT02326272|11832871|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505800|NCT02326272|11832872|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505801|NCT02326272|11832873|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505802|NCT02326272|11832874|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505803|NCT02326272|11832875|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505804|NCT02326272|11832876|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505805|NCT02326272|11832877|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
7505806|NCT02326272|11832878|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505807|NCT02326272|11832879|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505808|NCT02326272|11832880|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505809|NCT02326272|11832881|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505810|NCT02326272|11832882|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505811|NCT02326272|11832883|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505812|NCT02326272|11832884|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505813|NCT02326272|11832885|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
7505814|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7505815|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7505816|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7505817|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7505818|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7505819|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7505820|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7505821|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7505822|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7505823|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7505824|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7505825|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Death|0
7505826|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Death|1
7505827|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7505828|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Death|0
7505829|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505830|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505831|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505832|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505833|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505834|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505835|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505836|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505837|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505838|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505839|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7505840|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
7505841|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7505842|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7505843|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
7505844|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505845|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505846|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505847|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505848|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505849|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505850|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505851|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505852|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505853|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505854|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7505855|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505856|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7505857|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505858|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7505859|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505860|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505861|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505862|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505863|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505864|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505865|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505866|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505867|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505868|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505869|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505870|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
7505871|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505872|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505873|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7505874|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505875|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505876|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505877|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505878|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505879|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505880|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505881|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505882|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505883|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505884|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
7505885|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505886|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
7505887|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7505888|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7505889|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505890|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505891|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505892|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505893|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505894|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505895|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505896|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505897|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505898|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505899|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505900|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7505901|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505902|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7505903|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7505904|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505905|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505906|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505907|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505908|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505909|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505910|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505911|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505912|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505913|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505914|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505915|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
7505916|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7505917|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7505918|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7505919|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505920|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505921|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505922|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505923|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505924|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505925|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505926|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505927|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505928|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505929|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505930|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
7505931|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505932|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7505933|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
7506276|NCT02327130|11833016|FG000|Overall Study|Physician Decision|2
7505934|NCT02326272|11832871|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505935|NCT02326272|11832872|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505936|NCT02326272|11832873|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505937|NCT02326272|11832874|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505938|NCT02326272|11832875|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505939|NCT02326272|11832876|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505940|NCT02326272|11832877|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505941|NCT02326272|11832878|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505942|NCT02326272|11832879|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505943|NCT02326272|11832880|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505944|NCT02326272|11832881|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505945|NCT02326272|11832882|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505946|NCT02326272|11832883|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
7505947|NCT02326272|11832884|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505948|NCT02326272|11832885|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
7505949|NCT02326298|11832897|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505950|NCT02326298|11832898|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505951|NCT02326298|11832899|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7505952|NCT02326298|11832900|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505953|NCT02326298|11832901|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505954|NCT02326298|11832902|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505955|NCT02326298|11832903|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505956|NCT02326298|11832904|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505957|NCT02326298|11832905|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505958|NCT02326298|11832906|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505959|NCT02326298|11832907|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505960|NCT02326298|11832908|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505961|NCT02326298|11832909|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505962|NCT02326298|11832910|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
7505963|NCT02326298|11832897|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
7505964|NCT02326298|11832898|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505965|NCT02326298|11832899|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505966|NCT02326298|11832900|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505967|NCT02326298|11832901|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505968|NCT02326298|11832902|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505969|NCT02326298|11832903|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505970|NCT02326298|11832904|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505971|NCT02326298|11832905|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505972|NCT02326298|11832906|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505973|NCT02326298|11832907|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505974|NCT02326298|11832908|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505975|NCT02326298|11832909|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505976|NCT02326298|11832910|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
7505977|NCT02326298|11832897|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7505978|NCT02326298|11832898|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
7505979|NCT02326298|11832899|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505980|NCT02326298|11832900|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505981|NCT02326298|11832901|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505982|NCT02326298|11832902|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505983|NCT02326298|11832903|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505984|NCT02326298|11832904|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505985|NCT02326298|11832905|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505986|NCT02326298|11832906|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505987|NCT02326298|11832907|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505988|NCT02326298|11832908|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505989|NCT02326298|11832909|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505990|NCT02326298|11832910|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
7505991|NCT02326298|11832897|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
7505992|NCT02326298|11832898|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
7505993|NCT02326298|11832899|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505994|NCT02326298|11832900|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505995|NCT02326298|11832901|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505996|NCT02326298|11832902|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505997|NCT02326298|11832903|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505998|NCT02326298|11832904|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7505999|NCT02326298|11832905|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506000|NCT02326298|11832906|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506001|NCT02326298|11832907|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506002|NCT02326298|11832908|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506003|NCT02326298|11832909|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506004|NCT02326298|11832910|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7506005|NCT02326298|11832897|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506006|NCT02326298|11832898|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506007|NCT02326298|11832899|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
7506008|NCT02326298|11832900|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506009|NCT02326298|11832901|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506010|NCT02326298|11832902|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506011|NCT02326298|11832903|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506012|NCT02326298|11832904|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506013|NCT02326298|11832905|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506014|NCT02326298|11832906|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506015|NCT02326298|11832907|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506016|NCT02326298|11832908|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506017|NCT02326298|11832909|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506018|NCT02326298|11832910|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
7506019|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506020|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506021|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506022|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506023|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506024|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7506025|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
7506026|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7506027|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7506028|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7506029|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506030|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506031|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506032|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7506033|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506034|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506035|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506036|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506037|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506038|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
7506039|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
7506040|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506041|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
7506042|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506043|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506044|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506045|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506046|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
7506047|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506048|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506049|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506050|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506051|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506052|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
7506053|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506054|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506055|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506056|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506057|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506058|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506059|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506060|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
7506061|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506062|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506063|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506064|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506065|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506066|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506067|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
7506068|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506069|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506070|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506071|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506072|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506073|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506074|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
7506075|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506076|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506077|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506078|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506079|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506080|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506081|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506082|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
7506083|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506084|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506085|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506086|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506087|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506088|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
7506089|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506090|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506091|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506092|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506093|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506094|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506095|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7506096|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
7506097|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506098|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506099|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506100|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506101|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506102|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7506103|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506104|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506105|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506106|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506107|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506108|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506109|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506110|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7506111|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506112|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506113|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506114|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506115|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506116|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7506117|NCT02326298|11832897|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506118|NCT02326298|11832898|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506119|NCT02326298|11832899|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506120|NCT02326298|11832900|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506121|NCT02326298|11832901|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506122|NCT02326298|11832902|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
7224646|NCT00057330|11433950|FG001|Overall Study|Withdrawal by Subject|84
7506123|NCT02326298|11832903|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506124|NCT02326298|11832904|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506125|NCT02326298|11832905|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506126|NCT02326298|11832906|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506127|NCT02326298|11832907|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506128|NCT02326298|11832908|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506129|NCT02326298|11832909|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506130|NCT02326298|11832910|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
7506131|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Death|0
7506132|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Death|0
7506133|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Death|0
7506134|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Death|0
7506135|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Death|0
7506136|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Death|0
7506137|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Death|0
7506138|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Death|0
7506139|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Death|0
7506140|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Death|0
7506141|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Death|0
7506142|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Death|1
7506143|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Death|0
7506144|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Death|0
7506145|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506146|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506147|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506148|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506149|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506150|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506151|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506152|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506153|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506154|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506155|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506156|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7506157|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
7506158|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
7506159|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506160|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506161|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506162|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506163|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506164|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506165|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506166|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506167|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506168|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506169|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506170|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7506171|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
7506172|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
7506173|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506174|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506175|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506176|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506177|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506178|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506179|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506180|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506181|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506182|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506183|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506184|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506185|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
7506186|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
7506187|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506188|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506189|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506190|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506191|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506192|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506193|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506194|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506195|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506196|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506197|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7506198|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
7506199|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
7506200|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7506201|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506202|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506203|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506204|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506205|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506206|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506207|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506208|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506209|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506210|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506211|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
7506212|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
7506213|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
7506214|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
7506215|NCT02326298|11832897|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506216|NCT02326298|11832898|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506217|NCT02326298|11832899|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506218|NCT02326298|11832900|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506219|NCT02326298|11832901|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506220|NCT02326298|11832902|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506221|NCT02326298|11832903|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506222|NCT02326298|11832904|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506223|NCT02326298|11832905|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506224|NCT02326298|11832906|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506225|NCT02326298|11832907|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
7506226|NCT02326298|11832908|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7506227|NCT02326298|11832909|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
7506228|NCT02326298|11832910|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
7506229|NCT02326467|11832930|FG000|Overall Study|Withdrawal by Subject|1
7506230|NCT02326597|11832937|FG000|Overall Study|Lost to Follow-up|42
7506231|NCT02326597|11832938|FG001|Overall Study|Lost to Follow-up|32
7506232|NCT02326883|11832966|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
7506233|NCT02326883|11832967|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
7506234|NCT02326883|11832968|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
7506235|NCT02327013|11832979|FG000|Overall Study|Adverse Event|4
7506236|NCT02327013|11832980|FG001|Overall Study|Adverse Event|4
7506237|NCT02327013|11832981|FG002|Overall Study|Adverse Event|3
7506238|NCT02327013|11832982|FG003|Overall Study|Adverse Event|0
7506239|NCT02327013|11832983|FG004|Overall Study|Adverse Event|1
7506240|NCT02327013|11832979|FG000|Overall Study|Lack of Efficacy|2
7506241|NCT02327013|11832980|FG001|Overall Study|Lack of Efficacy|0
7506242|NCT02327013|11832981|FG002|Overall Study|Lack of Efficacy|5
7506243|NCT02327013|11832982|FG003|Overall Study|Lack of Efficacy|0
7506244|NCT02327013|11832983|FG004|Overall Study|Lack of Efficacy|1
7506245|NCT02327013|11832979|FG000|Overall Study|Non-compliance with IMP|1
7506246|NCT02327013|11832980|FG001|Overall Study|Non-compliance with IMP|2
7506247|NCT02327013|11832981|FG002|Overall Study|Non-compliance with IMP|7
7506248|NCT02327013|11832982|FG003|Overall Study|Non-compliance with IMP|0
7506249|NCT02327013|11832983|FG004|Overall Study|Non-compliance with IMP|0
7506250|NCT02327013|11832979|FG000|Overall Study|Withdrawal of Consent|1
7506251|NCT02327013|11832980|FG001|Overall Study|Withdrawal of Consent|0
7506252|NCT02327013|11832981|FG002|Overall Study|Withdrawal of Consent|3
7506253|NCT02327013|11832982|FG003|Overall Study|Withdrawal of Consent|0
7506254|NCT02327013|11832983|FG004|Overall Study|Withdrawal of Consent|0
7506255|NCT02327013|11832979|FG000|Overall Study|Lost to Follow-up|2
7506256|NCT02327013|11832980|FG001|Overall Study|Lost to Follow-up|4
7506257|NCT02327013|11832981|FG002|Overall Study|Lost to Follow-up|5
7506258|NCT02327013|11832982|FG003|Overall Study|Lost to Follow-up|0
7506259|NCT02327013|11832983|FG004|Overall Study|Lost to Follow-up|0
7506260|NCT02327013|11832979|FG000|Overall Study|Administrative or other reason(s)|1
7506261|NCT02327013|11832980|FG001|Overall Study|Administrative or other reason(s)|5
7506262|NCT02327013|11832981|FG002|Overall Study|Administrative or other reason(s)|11
7506263|NCT02327013|11832982|FG003|Overall Study|Administrative or other reason(s)|1
7506264|NCT02327013|11832983|FG004|Overall Study|Administrative or other reason(s)|1
7506265|NCT02327013|11832979|FG000|Overall Study|Protocol Violation|0
7506266|NCT02327013|11832980|FG001|Overall Study|Protocol Violation|0
7506267|NCT02327013|11832981|FG002|Overall Study|Protocol Violation|3
7506268|NCT02327013|11832982|FG003|Overall Study|Protocol Violation|0
7506269|NCT02327013|11832983|FG004|Overall Study|Protocol Violation|1
7506270|NCT02327013|11832979|FG000|Overall Study|Withdrawal before treatment|2
7506271|NCT02327013|11832980|FG001|Overall Study|Withdrawal before treatment|1
7506272|NCT02327013|11832981|FG002|Overall Study|Withdrawal before treatment|5
7506273|NCT02327013|11832982|FG003|Overall Study|Withdrawal before treatment|0
7506274|NCT02327013|11832983|FG004|Overall Study|Withdrawal before treatment|0
7506275|NCT02327130|11833016|FG000|Overall Study|Discharged in less than 5 days|5
7506277|NCT02327130|11833016|FG000|Overall Study|Unable to provide breath sample|1
7506278|NCT02327130|11833016|FG000|Overall Study|Incorrectly place ventilator adaptor|1
7506279|NCT02327130|11833016|FG000|Overall Study|Met exclusion criteria|3
7506280|NCT02327169|11833045|FG000|Overall Study|Progressive Disease|1
7506281|NCT02327169|11833046|FG001|Overall Study|Progressive Disease|3
7506282|NCT02327169|11833047|FG002|Overall Study|Progressive Disease|4
7506283|NCT02327169|11833048|FG003|Overall Study|Progressive Disease|3
7506284|NCT02327169|11833049|FG004|Overall Study|Progressive Disease|4
7506285|NCT02327169|11833050|FG005|Overall Study|Progressive Disease|3
7506286|NCT02327169|11833051|FG006|Overall Study|Progressive Disease|3
7506287|NCT02327169|11833052|FG007|Overall Study|Progressive Disease|3
7506288|NCT02327169|11833053|FG008|Overall Study|Progressive Disease|4
7506289|NCT02327169|11833054|FG009|Overall Study|Progressive Disease|4
7506290|NCT02327169|11833055|FG010|Overall Study|Progressive Disease|4
7506291|NCT02327169|11833056|FG011|Overall Study|Progressive Disease|3
7506292|NCT02327169|11833057|FG012|Overall Study|Progressive Disease|1
7506293|NCT02327169|11833058|FG013|Overall Study|Progressive Disease|3
7506294|NCT02327169|11833059|FG014|Overall Study|Progressive Disease|3
7506295|NCT02327169|11833045|FG000|Overall Study|Adverse Event|2
7506296|NCT02327169|11833046|FG001|Overall Study|Adverse Event|0
7506297|NCT02327169|11833047|FG002|Overall Study|Adverse Event|1
7506298|NCT02327169|11833048|FG003|Overall Study|Adverse Event|0
7506299|NCT02327169|11833049|FG004|Overall Study|Adverse Event|1
7506300|NCT02327169|11833050|FG005|Overall Study|Adverse Event|0
7506301|NCT02327169|11833051|FG006|Overall Study|Adverse Event|0
7506302|NCT02327169|11833052|FG007|Overall Study|Adverse Event|0
7506303|NCT02327169|11833053|FG008|Overall Study|Adverse Event|0
7506304|NCT02327169|11833054|FG009|Overall Study|Adverse Event|2
7506305|NCT02327169|11833055|FG010|Overall Study|Adverse Event|0
7506306|NCT02327169|11833056|FG011|Overall Study|Adverse Event|3
7506307|NCT02327169|11833057|FG012|Overall Study|Adverse Event|0
7506308|NCT02327169|11833058|FG013|Overall Study|Adverse Event|2
7506309|NCT02327169|11833059|FG014|Overall Study|Adverse Event|1
7506310|NCT02327169|11833045|FG000|Overall Study|Symptomatic Deterioration|0
7506311|NCT02327169|11833046|FG001|Overall Study|Symptomatic Deterioration|0
7506312|NCT02327169|11833047|FG002|Overall Study|Symptomatic Deterioration|1
7506313|NCT02327169|11833048|FG003|Overall Study|Symptomatic Deterioration|0
7506314|NCT02327169|11833049|FG004|Overall Study|Symptomatic Deterioration|1
7506315|NCT02327169|11833050|FG005|Overall Study|Symptomatic Deterioration|1
7506316|NCT02327169|11833051|FG006|Overall Study|Symptomatic Deterioration|0
7506317|NCT02327169|11833052|FG007|Overall Study|Symptomatic Deterioration|0
7506318|NCT02327169|11833053|FG008|Overall Study|Symptomatic Deterioration|2
7506319|NCT02327169|11833054|FG009|Overall Study|Symptomatic Deterioration|1
7506320|NCT02327169|11833055|FG010|Overall Study|Symptomatic Deterioration|0
7506321|NCT02327169|11833056|FG011|Overall Study|Symptomatic Deterioration|0
7506322|NCT02327169|11833057|FG012|Overall Study|Symptomatic Deterioration|0
7506323|NCT02327169|11833058|FG013|Overall Study|Symptomatic Deterioration|2
7506324|NCT02327169|11833059|FG014|Overall Study|Symptomatic Deterioration|1
7506325|NCT02327169|11833045|FG000|Overall Study|Reason Not Specified|0
7506326|NCT02327169|11833046|FG001|Overall Study|Reason Not Specified|0
7506327|NCT02327169|11833047|FG002|Overall Study|Reason Not Specified|1
7506328|NCT02327169|11833048|FG003|Overall Study|Reason Not Specified|0
7506329|NCT02327169|11833049|FG004|Overall Study|Reason Not Specified|0
7506330|NCT02327169|11833050|FG005|Overall Study|Reason Not Specified|0
7506331|NCT02327169|11833051|FG006|Overall Study|Reason Not Specified|0
7506332|NCT02327169|11833052|FG007|Overall Study|Reason Not Specified|0
7506333|NCT02327169|11833053|FG008|Overall Study|Reason Not Specified|0
7506334|NCT02327169|11833054|FG009|Overall Study|Reason Not Specified|1
7506335|NCT02327169|11833055|FG010|Overall Study|Reason Not Specified|2
7506336|NCT02327169|11833056|FG011|Overall Study|Reason Not Specified|1
7506337|NCT02327169|11833057|FG012|Overall Study|Reason Not Specified|0
7506338|NCT02327169|11833058|FG013|Overall Study|Reason Not Specified|0
7506339|NCT02327169|11833059|FG014|Overall Study|Reason Not Specified|2
7506340|NCT02327169|11833045|FG000|Overall Study|Withdrawal by Subject|1
7506341|NCT02327169|11833046|FG001|Overall Study|Withdrawal by Subject|0
7506342|NCT02327169|11833047|FG002|Overall Study|Withdrawal by Subject|0
7506343|NCT02327169|11833048|FG003|Overall Study|Withdrawal by Subject|0
7506344|NCT02327169|11833049|FG004|Overall Study|Withdrawal by Subject|1
7506345|NCT02327169|11833050|FG005|Overall Study|Withdrawal by Subject|0
7506346|NCT02327169|11833051|FG006|Overall Study|Withdrawal by Subject|0
7506347|NCT02327169|11833052|FG007|Overall Study|Withdrawal by Subject|1
7506348|NCT02327169|11833053|FG008|Overall Study|Withdrawal by Subject|0
7506349|NCT02327169|11833054|FG009|Overall Study|Withdrawal by Subject|0
7506350|NCT02327169|11833055|FG010|Overall Study|Withdrawal by Subject|0
7506351|NCT02327169|11833056|FG011|Overall Study|Withdrawal by Subject|0
7506352|NCT02327169|11833057|FG012|Overall Study|Withdrawal by Subject|0
7506353|NCT02327169|11833058|FG013|Overall Study|Withdrawal by Subject|0
7506354|NCT02327169|11833059|FG014|Overall Study|Withdrawal by Subject|3
7506355|NCT02327169|11833045|FG000|Overall Study|Lost to Follow-up|0
7506356|NCT02327169|11833046|FG001|Overall Study|Lost to Follow-up|0
7506357|NCT02327169|11833047|FG002|Overall Study|Lost to Follow-up|0
7506358|NCT02327169|11833048|FG003|Overall Study|Lost to Follow-up|0
7506359|NCT02327169|11833049|FG004|Overall Study|Lost to Follow-up|1
7506360|NCT02327169|11833050|FG005|Overall Study|Lost to Follow-up|0
7506361|NCT02327169|11833051|FG006|Overall Study|Lost to Follow-up|0
7506362|NCT02327169|11833052|FG007|Overall Study|Lost to Follow-up|0
7506363|NCT02327169|11833053|FG008|Overall Study|Lost to Follow-up|0
7506364|NCT02327169|11833054|FG009|Overall Study|Lost to Follow-up|0
7506365|NCT02327169|11833055|FG010|Overall Study|Lost to Follow-up|0
7506366|NCT02327169|11833056|FG011|Overall Study|Lost to Follow-up|0
7506367|NCT02327169|11833057|FG012|Overall Study|Lost to Follow-up|0
7506368|NCT02327169|11833058|FG013|Overall Study|Lost to Follow-up|0
7506369|NCT02327169|11833059|FG014|Overall Study|Lost to Follow-up|0
7506370|NCT02327260|11833104|FG000|Overall Study|Lost to Follow-up|2
7506371|NCT02327260|11833105|FG001|Overall Study|Lost to Follow-up|3
7506372|NCT02327260|11833106|FG002|Overall Study|Lost to Follow-up|2
7506373|NCT02327260|11833104|FG000|Overall Study|invalid phone number|1
7506374|NCT02327260|11833105|FG001|Overall Study|invalid phone number|1
7506375|NCT02327260|11833106|FG002|Overall Study|invalid phone number|0
7506376|NCT02327260|11833104|FG000|Overall Study|non-adherence to protocol|2
7506377|NCT02327260|11833105|FG001|Overall Study|non-adherence to protocol|0
7506378|NCT02327260|11833106|FG002|Overall Study|non-adherence to protocol|0
7506379|NCT02327260|11833104|FG000|Overall Study|cognitive concerns|1
7506380|NCT02327260|11833105|FG001|Overall Study|cognitive concerns|0
7506381|NCT02327260|11833106|FG002|Overall Study|cognitive concerns|0
7506382|NCT02327325|11833118|FG000|Overall Study|Withdrawal by Subject|1
7506383|NCT02327325|11833119|FG001|Overall Study|Withdrawal by Subject|4
7506384|NCT02327325|11833120|FG002|Overall Study|Withdrawal by Subject|4
7506385|NCT02327325|11833118|FG000|Overall Study|Excluded by Study Team|0
7506386|NCT02327325|11833119|FG001|Overall Study|Excluded by Study Team|0
7506387|NCT02327325|11833120|FG002|Overall Study|Excluded by Study Team|1
7506388|NCT02328027|11833151|FG000|Overall Study|Withdrawal by Subject|0
7506389|NCT02328027|11833152|FG001|Overall Study|Withdrawal by Subject|1
7506390|NCT02328040|11833159|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
7506391|NCT02328040|11833160|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
7506392|NCT02328326|11833168|FG000|Overall Study|Withdrawal by Subject|10
7506393|NCT02328326|11833169|FG001|Overall Study|Withdrawal by Subject|3
7506394|NCT02328326|11833168|FG000|Overall Study|Death|2
7506395|NCT02328326|11833169|FG001|Overall Study|Death|1
7506396|NCT02328326|11833168|FG000|Overall Study|Lost to Follow-up|10
7506397|NCT02328326|11833169|FG001|Overall Study|Lost to Follow-up|4
7506398|NCT02328547|11833192|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7506399|NCT02328547|11833193|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
7506400|NCT02328547|11833192|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
7506401|NCT02328547|11833193|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
7506402|NCT02328937|11833226|FG000|Period 1|Lost to Follow-up|0
7506403|NCT02328937|11833227|FG001|Period 1|Lost to Follow-up|0
7506404|NCT02328937|11833228|FG002|Period 1|Lost to Follow-up|0
7506405|NCT02328937|11833229|FG003|Period 1|Lost to Follow-up|1
7506406|NCT02328937|11833230|FG004|Period 1|Lost to Follow-up|0
7506407|NCT02328937|11833231|FG005|Period 1|Lost to Follow-up|0
7506408|NCT02328937|11833226|FG000|Period 2|Adverse Event|0
7506409|NCT02328937|11833227|FG001|Period 2|Adverse Event|0
7506410|NCT02328937|11833228|FG002|Period 2|Adverse Event|1
7506411|NCT02328937|11833229|FG003|Period 2|Adverse Event|0
7506412|NCT02328937|11833230|FG004|Period 2|Adverse Event|0
7506413|NCT02328937|11833231|FG005|Period 2|Adverse Event|0
7506414|NCT02329223|11833251|FG000|Overall Study|Withdrawal by Subject|1
7506415|NCT02329223|11833252|FG001|Overall Study|Withdrawal by Subject|2
7506416|NCT02329223|11833253|FG002|Overall Study|Withdrawal by Subject|5
7506417|NCT02329223|11833251|FG000|Overall Study|Physician Decision|0
7506418|NCT02329223|11833252|FG001|Overall Study|Physician Decision|0
7506419|NCT02329223|11833253|FG002|Overall Study|Physician Decision|1
7506420|NCT02329223|11833251|FG000|Overall Study|Adverse Event|0
7506421|NCT02329223|11833252|FG001|Overall Study|Adverse Event|1
7506422|NCT02329223|11833253|FG002|Overall Study|Adverse Event|0
7506423|NCT02329431|11833263|FG000|Overall Study|Lost to Follow-up|20
7506424|NCT02329431|11833264|FG001|Overall Study|Lost to Follow-up|13
7506425|NCT02329730|11833296|FG000|Overall Study|Protocol Violation|0
7506426|NCT02329730|11833297|FG001|Overall Study|Protocol Violation|0
7506427|NCT02329730|11833298|FG002|Overall Study|Protocol Violation|0
7506428|NCT02329730|11833299|FG003|Overall Study|Protocol Violation|0
7506429|NCT02329730|11833300|FG004|Overall Study|Protocol Violation|2
7506430|NCT02329730|11833301|FG005|Overall Study|Protocol Violation|2
7506431|NCT02329730|11833302|FG006|Overall Study|Protocol Violation|0
7506432|NCT02329730|11833303|FG007|Overall Study|Protocol Violation|0
7506433|NCT02329730|11833304|FG008|Overall Study|Protocol Violation|0
7506434|NCT02329730|11833305|FG009|Overall Study|Protocol Violation|0
7506435|NCT02329730|11833306|FG010|Overall Study|Protocol Violation|0
7506436|NCT02329730|11833307|FG011|Overall Study|Protocol Violation|0
7506437|NCT02329730|11833296|FG000|Overall Study|Withdrawal by Subject|0
7506438|NCT02329730|11833297|FG001|Overall Study|Withdrawal by Subject|0
7506439|NCT02329730|11833298|FG002|Overall Study|Withdrawal by Subject|0
7506440|NCT02329730|11833299|FG003|Overall Study|Withdrawal by Subject|0
7506441|NCT02329730|11833300|FG004|Overall Study|Withdrawal by Subject|1
7506442|NCT02329730|11833301|FG005|Overall Study|Withdrawal by Subject|0
7506443|NCT02329730|11833302|FG006|Overall Study|Withdrawal by Subject|1
7506444|NCT02329730|11833303|FG007|Overall Study|Withdrawal by Subject|1
7506445|NCT02329730|11833304|FG008|Overall Study|Withdrawal by Subject|1
7506446|NCT02329730|11833305|FG009|Overall Study|Withdrawal by Subject|1
7506447|NCT02329730|11833306|FG010|Overall Study|Withdrawal by Subject|0
7506448|NCT02329730|11833307|FG011|Overall Study|Withdrawal by Subject|0
7506449|NCT02329743|11833328|FG000|Overall Study|Adverse Event|1
7506450|NCT02329743|11833329|FG001|Overall Study|Adverse Event|1
7506451|NCT02329743|11833330|FG002|Overall Study|Adverse Event|3
7506452|NCT02329743|11833328|FG000|Overall Study|Lost to Follow-up|1
7506453|NCT02329743|11833329|FG001|Overall Study|Lost to Follow-up|0
7506454|NCT02329743|11833330|FG002|Overall Study|Lost to Follow-up|1
7506455|NCT02329743|11833328|FG000|Overall Study|Withdrawal by Subject|4
7506456|NCT02329743|11833329|FG001|Overall Study|Withdrawal by Subject|4
7506457|NCT02329743|11833330|FG002|Overall Study|Withdrawal by Subject|1
7506458|NCT02329743|11833328|FG000|Overall Study|Other|0
7506459|NCT02329743|11833329|FG001|Overall Study|Other|2
7506460|NCT02329743|11833330|FG002|Overall Study|Other|3
7506461|NCT02330055|11833349|FG000|Overall Study|technical issues|2
7506462|NCT02330055|11833350|FG001|Overall Study|technical issues|0
7506463|NCT02330055|11833349|FG000|Overall Study|participant forgot to wear device|5
7506464|NCT02330055|11833350|FG001|Overall Study|participant forgot to wear device|5
7506465|NCT02330055|11833349|FG000|Overall Study|data for less than 60 minutes|3
7506466|NCT02330055|11833350|FG001|Overall Study|data for less than 60 minutes|3
7506467|NCT02330055|11833349|FG000|Overall Study|participant did not sleep|0
7506468|NCT02330055|11833350|FG001|Overall Study|participant did not sleep|1
7506469|NCT02330081|11833356|FG000|Overall Study|Adverse Event|1
7506470|NCT02330081|11833356|FG000|Overall Study|Donation did not meet criteria|1
7506471|NCT02330081|11833356|FG000|Overall Study|Protocol Violation|6
7506472|NCT02330549|11833414|FG000|Overall Study|Adverse Event|1
7506473|NCT02330549|11833415|FG001|Overall Study|Adverse Event|0
7506474|NCT02330549|11833414|FG000|Overall Study|Subject withdrew consent|2
7506475|NCT02330549|11833415|FG001|Overall Study|Subject withdrew consent|1
7506476|NCT02330549|11833414|FG000|Overall Study|Failure to meet randomization criteria|1
7506477|NCT02330549|11833415|FG001|Overall Study|Failure to meet randomization criteria|0
7535955|NCT02714569|11883867|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535956|NCT02714569|11883868|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535957|NCT02714569|11883869|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535958|NCT02714569|11883870|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
7535959|NCT02714569|11883871|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535960|NCT02714569|11883872|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535961|NCT02714569|11883873|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535962|NCT02714569|11883874|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535963|NCT02714569|11883875|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535964|NCT02714569|11883876|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535965|NCT02714569|11883877|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
7535966|NCT02714569|11883867|FG000|Part A Third Intervention|Adverse Event|0
7535967|NCT02714569|11883868|FG001|Part A Third Intervention|Adverse Event|0
7535968|NCT02714569|11883869|FG002|Part A Third Intervention|Adverse Event|1
7535969|NCT02714569|11883870|FG003|Part A Third Intervention|Adverse Event|0
7535970|NCT02714569|11883871|FG004|Part A Third Intervention|Adverse Event|0
7535971|NCT02714569|11883872|FG005|Part A Third Intervention|Adverse Event|0
7535972|NCT02714569|11883873|FG006|Part A Third Intervention|Adverse Event|0
7535973|NCT02714569|11883874|FG007|Part A Third Intervention|Adverse Event|0
7535974|NCT02714569|11883875|FG008|Part A Third Intervention|Adverse Event|0
7535975|NCT02714569|11883876|FG009|Part A Third Intervention|Adverse Event|0
7535976|NCT02714569|11883877|FG010|Part A Third Intervention|Adverse Event|0
7535977|NCT02714569|11883867|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7535978|NCT02714569|11883868|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535979|NCT02714569|11883869|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535980|NCT02714569|11883870|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535981|NCT02714569|11883871|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535982|NCT02714569|11883872|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
7535983|NCT02714569|11883873|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7506478|NCT02331368|11833503|FG000|Overall Study|Withdrawal by Subject|3
7506479|NCT02331394|11833507|FG000|Overall Study|Disease progression|1
7506480|NCT02331446|11833526|FG000|Overall Study|Lost to Follow-up|2
7506481|NCT02331446|11833527|FG001|Overall Study|Lost to Follow-up|1
7506482|NCT02331446|11833528|FG002|Overall Study|Lost to Follow-up|0
7506483|NCT02331446|11833529|FG003|Overall Study|Lost to Follow-up|1
7506484|NCT02331446|11833526|FG000|Overall Study|Personal Problem|2
7506485|NCT02331446|11833527|FG001|Overall Study|Personal Problem|0
7506486|NCT02331446|11833528|FG002|Overall Study|Personal Problem|0
7506487|NCT02331446|11833529|FG003|Overall Study|Personal Problem|0
7506488|NCT02331446|11833526|FG000|Overall Study|Disease|0
7506489|NCT02331446|11833527|FG001|Overall Study|Disease|2
7506490|NCT02331446|11833528|FG002|Overall Study|Disease|2
7506491|NCT02331446|11833529|FG003|Overall Study|Disease|1
7506492|NCT02331446|11833526|FG000|Overall Study|Physician Decision|0
7506493|NCT02331446|11833527|FG001|Overall Study|Physician Decision|1
7506494|NCT02331446|11833528|FG002|Overall Study|Physician Decision|0
7506495|NCT02331446|11833529|FG003|Overall Study|Physician Decision|1
7506496|NCT02331446|11833526|FG000|Overall Study|Lost before baseline analysis|0
7506497|NCT02331446|11833527|FG001|Overall Study|Lost before baseline analysis|1
7506498|NCT02331446|11833528|FG002|Overall Study|Lost before baseline analysis|1
7506499|NCT02331446|11833529|FG003|Overall Study|Lost before baseline analysis|0
7506500|NCT02331680|11833551|FG000|Overall Study|Adverse Event|3
7506501|NCT02331680|11833552|FG001|Overall Study|Adverse Event|0
7506502|NCT02331680|11833553|FG002|Overall Study|Adverse Event|2
7506503|NCT02331680|11833551|FG000|Overall Study|Physician Decision|1
7506504|NCT02331680|11833552|FG001|Overall Study|Physician Decision|1
7506505|NCT02331680|11833553|FG002|Overall Study|Physician Decision|2
7506506|NCT02331680|11833551|FG000|Overall Study|Withdrawal by Subject|0
7506507|NCT02331680|11833552|FG001|Overall Study|Withdrawal by Subject|1
7506508|NCT02331680|11833553|FG002|Overall Study|Withdrawal by Subject|2
7506509|NCT02331680|11833551|FG000|Overall Study|Met withdrawal criteria|2
7506510|NCT02331680|11833552|FG001|Overall Study|Met withdrawal criteria|2
7506511|NCT02331680|11833553|FG002|Overall Study|Met withdrawal criteria|5
7506512|NCT02331680|11833551|FG000|Overall Study|Non-compliance with study drug|0
7506513|NCT02331680|11833552|FG001|Overall Study|Non-compliance with study drug|0
7506514|NCT02331680|11833553|FG002|Overall Study|Non-compliance with study drug|1
7506515|NCT02331680|11833551|FG000|Overall Study|Protocol Violation|0
7506516|NCT02331680|11833552|FG001|Overall Study|Protocol Violation|0
7506517|NCT02331680|11833553|FG002|Overall Study|Protocol Violation|3
7506518|NCT02332239|11833576|FG000|Overall Study|Lost to Follow-up|4
7506519|NCT02332239|11833577|FG001|Overall Study|Lost to Follow-up|6
7506520|NCT02332291|11833587|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
7506521|NCT02332291|11833588|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
7506522|NCT02332291|11833587|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
7506523|NCT02332291|11833588|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
7506524|NCT02332291|11833587|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
7506525|NCT02332291|11833588|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
7506526|NCT02332291|11833587|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
7506527|NCT02332291|11833588|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
7506528|NCT02332291|11833587|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
7506529|NCT02332291|11833588|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
7506530|NCT02332291|11833587|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
7506531|NCT02332291|11833588|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
7506532|NCT02332707|11833616|FG000|Overall Study|Adverse Event|0
7506533|NCT02332707|11833617|FG001|Overall Study|Adverse Event|0
7506534|NCT02332707|11833618|FG002|Overall Study|Adverse Event|0
7506535|NCT02332707|11833619|FG003|Overall Study|Adverse Event|0
7506536|NCT02332707|11833620|FG004|Overall Study|Adverse Event|0
7506537|NCT02332707|11833621|FG005|Overall Study|Adverse Event|0
7506538|NCT02332707|11833622|FG006|Overall Study|Adverse Event|0
7506539|NCT02332707|11833623|FG007|Overall Study|Adverse Event|0
7506540|NCT02332707|11833624|FG008|Overall Study|Adverse Event|0
7506541|NCT02332707|11833625|FG009|Overall Study|Adverse Event|0
7506542|NCT02332707|11833626|FG010|Overall Study|Adverse Event|0
7506543|NCT02332707|11833627|FG011|Overall Study|Adverse Event|0
7506544|NCT02332707|11833628|FG012|Overall Study|Adverse Event|1
7506545|NCT02332707|11833629|FG013|Overall Study|Adverse Event|0
7506546|NCT02332707|11833630|FG014|Overall Study|Adverse Event|0
7506547|NCT02332707|11833631|FG015|Overall Study|Adverse Event|0
7506548|NCT02332707|11833632|FG016|Overall Study|Adverse Event|0
7506549|NCT02332707|11833633|FG017|Overall Study|Adverse Event|0
7506550|NCT02332707|11833616|FG000|Overall Study|Lost to Follow-up|0
7506551|NCT02332707|11833617|FG001|Overall Study|Lost to Follow-up|0
7506552|NCT02332707|11833618|FG002|Overall Study|Lost to Follow-up|0
7506553|NCT02332707|11833619|FG003|Overall Study|Lost to Follow-up|0
7506554|NCT02332707|11833620|FG004|Overall Study|Lost to Follow-up|0
7506555|NCT02332707|11833621|FG005|Overall Study|Lost to Follow-up|1
7506556|NCT02332707|11833622|FG006|Overall Study|Lost to Follow-up|0
7506557|NCT02332707|11833623|FG007|Overall Study|Lost to Follow-up|0
7506558|NCT02332707|11833624|FG008|Overall Study|Lost to Follow-up|0
7506559|NCT02332707|11833625|FG009|Overall Study|Lost to Follow-up|0
7506560|NCT02332707|11833626|FG010|Overall Study|Lost to Follow-up|2
7506561|NCT02332707|11833627|FG011|Overall Study|Lost to Follow-up|0
7506562|NCT02332707|11833628|FG012|Overall Study|Lost to Follow-up|3
7506563|NCT02332707|11833629|FG013|Overall Study|Lost to Follow-up|0
7506564|NCT02332707|11833630|FG014|Overall Study|Lost to Follow-up|0
7506565|NCT02332707|11833631|FG015|Overall Study|Lost to Follow-up|0
7506566|NCT02332707|11833632|FG016|Overall Study|Lost to Follow-up|0
7506567|NCT02332707|11833633|FG017|Overall Study|Lost to Follow-up|0
7506568|NCT02332707|11833616|FG000|Overall Study|Physician Decision|0
7506569|NCT02332707|11833617|FG001|Overall Study|Physician Decision|0
7506570|NCT02332707|11833618|FG002|Overall Study|Physician Decision|0
7506571|NCT02332707|11833619|FG003|Overall Study|Physician Decision|1
7506572|NCT02332707|11833620|FG004|Overall Study|Physician Decision|0
7506573|NCT02332707|11833621|FG005|Overall Study|Physician Decision|0
7506574|NCT02332707|11833622|FG006|Overall Study|Physician Decision|0
7506575|NCT02332707|11833623|FG007|Overall Study|Physician Decision|0
7506576|NCT02332707|11833624|FG008|Overall Study|Physician Decision|0
7506577|NCT02332707|11833625|FG009|Overall Study|Physician Decision|0
7506578|NCT02332707|11833626|FG010|Overall Study|Physician Decision|0
7506579|NCT02332707|11833627|FG011|Overall Study|Physician Decision|0
7506580|NCT02332707|11833628|FG012|Overall Study|Physician Decision|1
7506581|NCT02332707|11833629|FG013|Overall Study|Physician Decision|0
7506582|NCT02332707|11833630|FG014|Overall Study|Physician Decision|0
7506583|NCT02332707|11833631|FG015|Overall Study|Physician Decision|0
7506584|NCT02332707|11833632|FG016|Overall Study|Physician Decision|0
7506585|NCT02332707|11833633|FG017|Overall Study|Physician Decision|0
7506586|NCT02332707|11833616|FG000|Overall Study|Withdrawal by Subject|0
7506587|NCT02332707|11833617|FG001|Overall Study|Withdrawal by Subject|0
7506588|NCT02332707|11833618|FG002|Overall Study|Withdrawal by Subject|1
7506589|NCT02332707|11833619|FG003|Overall Study|Withdrawal by Subject|0
7506590|NCT02332707|11833620|FG004|Overall Study|Withdrawal by Subject|0
7506591|NCT02332707|11833621|FG005|Overall Study|Withdrawal by Subject|0
7506592|NCT02332707|11833622|FG006|Overall Study|Withdrawal by Subject|0
7506593|NCT02332707|11833623|FG007|Overall Study|Withdrawal by Subject|0
7506594|NCT02332707|11833624|FG008|Overall Study|Withdrawal by Subject|0
7506595|NCT02332707|11833625|FG009|Overall Study|Withdrawal by Subject|3
7506596|NCT02332707|11833626|FG010|Overall Study|Withdrawal by Subject|0
7506597|NCT02332707|11833627|FG011|Overall Study|Withdrawal by Subject|0
7506598|NCT02332707|11833628|FG012|Overall Study|Withdrawal by Subject|0
7506599|NCT02332707|11833629|FG013|Overall Study|Withdrawal by Subject|0
7506600|NCT02332707|11833630|FG014|Overall Study|Withdrawal by Subject|0
7506601|NCT02332707|11833631|FG015|Overall Study|Withdrawal by Subject|0
7506602|NCT02332707|11833632|FG016|Overall Study|Withdrawal by Subject|0
7506603|NCT02332707|11833633|FG017|Overall Study|Withdrawal by Subject|0
7506604|NCT02332720|11833694|FG000|Part A and Part B|Lost to Follow-up|1
7506605|NCT02332720|11833695|FG001|Part A and Part B|Lost to Follow-up|0
7506606|NCT02332720|11833696|FG002|Part A and Part B|Lost to Follow-up|0
7506607|NCT02332720|11833697|FG003|Part A and Part B|Lost to Follow-up|0
7506608|NCT02332720|11833698|FG004|Part A and Part B|Lost to Follow-up|0
7506609|NCT02332720|11833699|FG005|Part A and Part B|Lost to Follow-up|2
7506610|NCT02332720|11833700|FG006|Part A and Part B|Lost to Follow-up|1
7506611|NCT02332720|11833701|FG007|Part A and Part B|Lost to Follow-up|1
7506612|NCT02332720|11833702|FG008|Part A and Part B|Lost to Follow-up|0
7506613|NCT02332720|11833703|FG009|Part A and Part B|Lost to Follow-up|0
7506614|NCT02332720|11833704|FG010|Part A and Part B|Lost to Follow-up|0
7506615|NCT02332720|11833705|FG011|Part A and Part B|Lost to Follow-up|0
7506616|NCT02332720|11833706|FG012|Part A and Part B|Lost to Follow-up|0
7506617|NCT02332720|11833707|FG013|Part A and Part B|Lost to Follow-up|0
7506618|NCT02332720|11833708|FG014|Part A and Part B|Lost to Follow-up|0
7506619|NCT02332720|11833709|FG015|Part A and Part B|Lost to Follow-up|1
7506620|NCT02332720|11833710|FG016|Part A and Part B|Lost to Follow-up|0
7506621|NCT02332720|11833711|FG017|Part A and Part B|Lost to Follow-up|0
7506622|NCT02332720|11833712|FG018|Part A and Part B|Lost to Follow-up|0
7506623|NCT02332720|11833713|FG019|Part A and Part B|Lost to Follow-up|0
7506624|NCT02332720|11833714|FG020|Part A and Part B|Lost to Follow-up|0
7506625|NCT02332720|11833715|FG021|Part A and Part B|Lost to Follow-up|0
7506626|NCT02332720|11833716|FG022|Part A and Part B|Lost to Follow-up|0
7506627|NCT02332720|11833694|FG000|Part A and Part B|Adverse Event|0
7506628|NCT02332720|11833695|FG001|Part A and Part B|Adverse Event|0
7506629|NCT02332720|11833696|FG002|Part A and Part B|Adverse Event|0
7506630|NCT02332720|11833697|FG003|Part A and Part B|Adverse Event|0
7506631|NCT02332720|11833698|FG004|Part A and Part B|Adverse Event|0
7506632|NCT02332720|11833699|FG005|Part A and Part B|Adverse Event|0
7506633|NCT02332720|11833700|FG006|Part A and Part B|Adverse Event|0
7506634|NCT02332720|11833701|FG007|Part A and Part B|Adverse Event|0
7506635|NCT02332720|11833702|FG008|Part A and Part B|Adverse Event|0
7506636|NCT02332720|11833703|FG009|Part A and Part B|Adverse Event|0
7506637|NCT02332720|11833704|FG010|Part A and Part B|Adverse Event|0
7506638|NCT02332720|11833705|FG011|Part A and Part B|Adverse Event|0
7506639|NCT02332720|11833706|FG012|Part A and Part B|Adverse Event|0
7506640|NCT02332720|11833707|FG013|Part A and Part B|Adverse Event|0
7506641|NCT02332720|11833708|FG014|Part A and Part B|Adverse Event|0
7506642|NCT02332720|11833709|FG015|Part A and Part B|Adverse Event|0
7506643|NCT02332720|11833710|FG016|Part A and Part B|Adverse Event|0
7506644|NCT02332720|11833711|FG017|Part A and Part B|Adverse Event|1
7506645|NCT02332720|11833712|FG018|Part A and Part B|Adverse Event|0
7506646|NCT02332720|11833713|FG019|Part A and Part B|Adverse Event|0
7506647|NCT02332720|11833714|FG020|Part A and Part B|Adverse Event|0
7506648|NCT02332720|11833715|FG021|Part A and Part B|Adverse Event|0
7506649|NCT02332720|11833716|FG022|Part A and Part B|Adverse Event|0
7506650|NCT02332720|11833694|FG000|Part A and Part B|Physician Decision|0
7506651|NCT02332720|11833695|FG001|Part A and Part B|Physician Decision|0
7506652|NCT02332720|11833696|FG002|Part A and Part B|Physician Decision|0
7506653|NCT02332720|11833697|FG003|Part A and Part B|Physician Decision|0
7506654|NCT02332720|11833698|FG004|Part A and Part B|Physician Decision|0
7506655|NCT02332720|11833699|FG005|Part A and Part B|Physician Decision|0
7506656|NCT02332720|11833700|FG006|Part A and Part B|Physician Decision|0
7506657|NCT02332720|11833701|FG007|Part A and Part B|Physician Decision|0
7506658|NCT02332720|11833702|FG008|Part A and Part B|Physician Decision|0
7506659|NCT02332720|11833703|FG009|Part A and Part B|Physician Decision|0
7506660|NCT02332720|11833704|FG010|Part A and Part B|Physician Decision|0
7506661|NCT02332720|11833705|FG011|Part A and Part B|Physician Decision|0
7506662|NCT02332720|11833706|FG012|Part A and Part B|Physician Decision|0
7506663|NCT02332720|11833707|FG013|Part A and Part B|Physician Decision|0
7506664|NCT02332720|11833708|FG014|Part A and Part B|Physician Decision|0
7506665|NCT02332720|11833709|FG015|Part A and Part B|Physician Decision|0
7506666|NCT02332720|11833710|FG016|Part A and Part B|Physician Decision|0
7506667|NCT02332720|11833711|FG017|Part A and Part B|Physician Decision|0
7506668|NCT02332720|11833712|FG018|Part A and Part B|Physician Decision|1
7506669|NCT02332720|11833713|FG019|Part A and Part B|Physician Decision|0
7506670|NCT02332720|11833714|FG020|Part A and Part B|Physician Decision|0
7506671|NCT02332720|11833715|FG021|Part A and Part B|Physician Decision|0
7506672|NCT02332720|11833716|FG022|Part A and Part B|Physician Decision|0
7506673|NCT02332720|11833694|FG000|Part A and Part B|Withdrawal by Subject|0
7506674|NCT02332720|11833695|FG001|Part A and Part B|Withdrawal by Subject|0
7506675|NCT02332720|11833696|FG002|Part A and Part B|Withdrawal by Subject|0
7506676|NCT02332720|11833697|FG003|Part A and Part B|Withdrawal by Subject|0
7506677|NCT02332720|11833698|FG004|Part A and Part B|Withdrawal by Subject|0
7506678|NCT02332720|11833699|FG005|Part A and Part B|Withdrawal by Subject|1
7506679|NCT02332720|11833700|FG006|Part A and Part B|Withdrawal by Subject|0
7506680|NCT02332720|11833701|FG007|Part A and Part B|Withdrawal by Subject|0
7506681|NCT02332720|11833702|FG008|Part A and Part B|Withdrawal by Subject|0
7506682|NCT02332720|11833703|FG009|Part A and Part B|Withdrawal by Subject|0
7506683|NCT02332720|11833704|FG010|Part A and Part B|Withdrawal by Subject|0
7506684|NCT02332720|11833705|FG011|Part A and Part B|Withdrawal by Subject|0
7506685|NCT02332720|11833706|FG012|Part A and Part B|Withdrawal by Subject|0
7506686|NCT02332720|11833707|FG013|Part A and Part B|Withdrawal by Subject|0
7506687|NCT02332720|11833708|FG014|Part A and Part B|Withdrawal by Subject|0
7506688|NCT02332720|11833709|FG015|Part A and Part B|Withdrawal by Subject|0
7506689|NCT02332720|11833710|FG016|Part A and Part B|Withdrawal by Subject|0
7506690|NCT02332720|11833711|FG017|Part A and Part B|Withdrawal by Subject|0
7506691|NCT02332720|11833712|FG018|Part A and Part B|Withdrawal by Subject|0
7506692|NCT02332720|11833713|FG019|Part A and Part B|Withdrawal by Subject|1
7506693|NCT02332720|11833714|FG020|Part A and Part B|Withdrawal by Subject|0
7506694|NCT02332720|11833715|FG021|Part A and Part B|Withdrawal by Subject|0
7506695|NCT02332720|11833716|FG022|Part A and Part B|Withdrawal by Subject|0
7506696|NCT02332798|11833781|FG000|Overall Study|Unwilling to Participate in Study|0
7506697|NCT02332798|11833782|FG001|Overall Study|Unwilling to Participate in Study|1
7506698|NCT02332798|11833783|FG002|Overall Study|Unwilling to Participate in Study|1
7506699|NCT02332798|11833781|FG000|Overall Study|Positive Urine Drug Test|0
7506700|NCT02332798|11833782|FG001|Overall Study|Positive Urine Drug Test|1
7506701|NCT02332798|11833783|FG002|Overall Study|Positive Urine Drug Test|0
7506702|NCT02332798|11833781|FG000|Overall Study|Abnormal Laboratory Findings|1
7506703|NCT02332798|11833782|FG001|Overall Study|Abnormal Laboratory Findings|0
7506704|NCT02332798|11833783|FG002|Overall Study|Abnormal Laboratory Findings|0
7506705|NCT02332824|11833797|FG000|Overall Study|Pretreatment Event/Adverse Event|4
7506706|NCT02332824|11833798|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7506707|NCT02332824|11833799|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7506708|NCT02332824|11833800|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7506709|NCT02332824|11833801|FG004|Overall Study|Pretreatment Event/Adverse Event|4
7506710|NCT02332824|11833802|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7506711|NCT02332824|11833797|FG000|Overall Study|Voluntary Withdrawal|1
7506712|NCT02332824|11833798|FG001|Overall Study|Voluntary Withdrawal|0
7506713|NCT02332824|11833799|FG002|Overall Study|Voluntary Withdrawal|0
7506714|NCT02332824|11833800|FG003|Overall Study|Voluntary Withdrawal|0
7506715|NCT02332824|11833801|FG004|Overall Study|Voluntary Withdrawal|0
7506716|NCT02332824|11833802|FG005|Overall Study|Voluntary Withdrawal|0
7506717|NCT02332824|11833797|FG000|Overall Study|Inconvenient schedule|1
7506718|NCT02332824|11833798|FG001|Overall Study|Inconvenient schedule|1
7506719|NCT02332824|11833799|FG002|Overall Study|Inconvenient schedule|0
7506720|NCT02332824|11833800|FG003|Overall Study|Inconvenient schedule|0
7506721|NCT02332824|11833801|FG004|Overall Study|Inconvenient schedule|0
7506722|NCT02332824|11833802|FG005|Overall Study|Inconvenient schedule|0
7506723|NCT02332824|11833797|FG000|Overall Study|Transfer|0
7506724|NCT02332824|11833798|FG001|Overall Study|Transfer|0
7506725|NCT02332824|11833799|FG002|Overall Study|Transfer|1
7506726|NCT02332824|11833800|FG003|Overall Study|Transfer|1
7506727|NCT02332824|11833801|FG004|Overall Study|Transfer|0
7506728|NCT02332824|11833802|FG005|Overall Study|Transfer|0
7506729|NCT02332876|11833827|FG000|Overall Study|Lost to Follow-up|1
7506730|NCT02332876|11833828|FG001|Overall Study|Lost to Follow-up|1
7506731|NCT02332889|11833834|FG000|Overall Study|Physician Decision|1
7553115|NCT03006887|11913896|FG000|Overall Study|Adverse Event|1
7553116|NCT03007472|11913918|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
7553117|NCT03007472|11913918|FG000|Overall Study|Death|2
7553118|NCT03007472|11913918|FG000|Overall Study|Loss to Follow Up|1
7553119|NCT03007953|11913924|FG000|Overall Study|Withdrawal by Subject|5
7553120|NCT03007953|11913925|FG001|Overall Study|Withdrawal by Subject|2
7553121|NCT03007953|11913924|FG000|Overall Study|Death|5
7553122|NCT03007953|11913925|FG001|Overall Study|Death|7
7506740|NCT02333331|11833880|FG000|Overall Study|Adverse Event|1
7506741|NCT02333331|11833881|FG001|Overall Study|Adverse Event|0
7506742|NCT02333331|11833882|FG002|Overall Study|Adverse Event|4
7506743|NCT02333331|11833883|FG003|Overall Study|Adverse Event|1
7506744|NCT02333331|11833880|FG000|Overall Study|Death|0
7506745|NCT02333331|11833881|FG001|Overall Study|Death|0
7506746|NCT02333331|11833882|FG002|Overall Study|Death|2
7506747|NCT02333331|11833883|FG003|Overall Study|Death|0
7506748|NCT02333331|11833880|FG000|Overall Study|Lost to Follow-up|0
7506749|NCT02333331|11833881|FG001|Overall Study|Lost to Follow-up|0
7506750|NCT02333331|11833882|FG002|Overall Study|Lost to Follow-up|1
7506751|NCT02333331|11833883|FG003|Overall Study|Lost to Follow-up|0
7506752|NCT02333331|11833880|FG000|Overall Study|Physician Decision|0
7506753|NCT02333331|11833881|FG001|Overall Study|Physician Decision|1
7506754|NCT02333331|11833882|FG002|Overall Study|Physician Decision|0
7506755|NCT02333331|11833883|FG003|Overall Study|Physician Decision|0
7506756|NCT02333331|11833880|FG000|Overall Study|Protocol Deviation|0
7506757|NCT02333331|11833881|FG001|Overall Study|Protocol Deviation|3
7506758|NCT02333331|11833882|FG002|Overall Study|Protocol Deviation|2
7506759|NCT02333331|11833883|FG003|Overall Study|Protocol Deviation|1
7506760|NCT02333331|11833880|FG000|Overall Study|Patient/Guardian Decision|1
7506761|NCT02333331|11833881|FG001|Overall Study|Patient/Guardian Decision|2
7506762|NCT02333331|11833882|FG002|Overall Study|Patient/Guardian Decision|9
7506763|NCT02333331|11833883|FG003|Overall Study|Patient/Guardian Decision|1
7506764|NCT02333383|11833893|FG000|Overall Study|Adalimumab discontinuation|21
7506765|NCT02333383|11833893|FG000|Overall Study|Lost to Follow-up|15
7506766|NCT02333383|11833893|FG000|Overall Study|Withdrawal by Subject|3
7506767|NCT02333383|11833893|FG000|Overall Study|Transfer to another hospital|2
7506768|NCT02333487|11833900|FG000|Overall Study|Adverse Event|0
7506769|NCT02333487|11833901|FG001|Overall Study|Adverse Event|2
7506770|NCT02333487|11833902|FG002|Overall Study|Adverse Event|0
7506771|NCT02333630|11833913|FG000|Overall Study|Lost to Follow-up|5
7506772|NCT02333630|11833914|FG001|Overall Study|Lost to Follow-up|2
7506773|NCT02334215|11833940|FG000|Overall Study|Death|1
7506774|NCT02334215|11833941|FG001|Overall Study|Death|1
7506775|NCT02334215|11833942|FG002|Overall Study|Death|0
7506776|NCT02334215|11833940|FG000|Overall Study|Lost to Follow-up|1
7506777|NCT02334215|11833941|FG001|Overall Study|Lost to Follow-up|0
7506778|NCT02334215|11833942|FG002|Overall Study|Lost to Follow-up|4
7506779|NCT02334215|11833940|FG000|Overall Study|Withdrawal by Subject|2
7506780|NCT02334215|11833941|FG001|Overall Study|Withdrawal by Subject|2
7506781|NCT02334215|11833942|FG002|Overall Study|Withdrawal by Subject|1
7506782|NCT02334215|11833940|FG000|Overall Study|Not released from incarceration on time|3
7506783|NCT02334215|11833941|FG001|Overall Study|Not released from incarceration on time|3
7506784|NCT02334215|11833942|FG002|Overall Study|Not released from incarceration on time|3
7506785|NCT02334215|11833940|FG000|Overall Study|Incarcerated|0
7506786|NCT02334215|11833941|FG001|Overall Study|Incarcerated|0
7506787|NCT02334215|11833942|FG002|Overall Study|Incarcerated|7
7506788|NCT02334306|11833967|FG000|Double-blind Period|Adverse Event|0
7506789|NCT02334306|11833968|FG001|Double-blind Period|Adverse Event|1
7506790|NCT02334306|11833967|FG000|Double-blind Period|Withdrawal by Subject|1
7506791|NCT02334306|11833968|FG001|Double-blind Period|Withdrawal by Subject|1
7506792|NCT02334384|11833981|FG000|Overall Study|Lost to Follow-up|1
7506793|NCT02334384|11833982|FG001|Overall Study|Lost to Follow-up|1
7506794|NCT02334423|11833990|FG000|Overall Study|Protocol Violation|10
7506795|NCT02334423|11833991|FG001|Overall Study|Protocol Violation|3
7506796|NCT02334683|11834016|FG000|First 12 Week Period|Lost to Follow-up|1
7506797|NCT02334683|11834017|FG001|First 12 Week Period|Lost to Follow-up|0
7506798|NCT02334683|11834016|FG000|Second 12 Week Period|Adverse Event|0
7506799|NCT02334683|11834017|FG001|Second 12 Week Period|Adverse Event|1
7506800|NCT02334748|11834023|FG000|Overall Study|Adverse Event|1
7506801|NCT02334748|11834023|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
7506802|NCT02334748|11834023|FG000|Overall Study|Patient no longer required study drug|2
7506803|NCT02334748|11834023|FG000|Overall Study|Lack of Efficacy|4
7506804|NCT02335346|11834158|FG000|Overall Study|Adverse Event|11
7506805|NCT02335346|11834158|FG000|Overall Study|Withdrawal by Subject|1
7506806|NCT02335450|11834162|FG000|Overall Study|Pregnancy|1
7506807|NCT02335489|11834172|FG000|Overall Study|Sponsor terminated study|4
7506808|NCT02335489|11834172|FG000|Overall Study|Lost to Follow-up|1
7506809|NCT02335489|11834172|FG000|Overall Study|Withdrawal by Subject|2
7506810|NCT02335489|11834172|FG000|Overall Study|Physician Decision|2
7506811|NCT02335489|11834172|FG000|Overall Study|Lack of Efficacy|1
7506812|NCT02335983|11834199|FG000|Overall Study|Sponsor Decision|0
7506813|NCT02335983|11834200|FG001|Overall Study|Sponsor Decision|0
7506814|NCT02335983|11834201|FG002|Overall Study|Sponsor Decision|1
7506815|NCT02335983|11834202|FG003|Overall Study|Sponsor Decision|1
7506816|NCT02335983|11834203|FG004|Overall Study|Sponsor Decision|0
7506817|NCT02335983|11834204|FG005|Overall Study|Sponsor Decision|1
7506818|NCT02335983|11834199|FG000|Overall Study|Withdrawal by Subject|3
7506819|NCT02335983|11834200|FG001|Overall Study|Withdrawal by Subject|2
7506820|NCT02335983|11834201|FG002|Overall Study|Withdrawal by Subject|2
7506821|NCT02335983|11834202|FG003|Overall Study|Withdrawal by Subject|1
7506822|NCT02335983|11834203|FG004|Overall Study|Withdrawal by Subject|3
7506823|NCT02335983|11834204|FG005|Overall Study|Withdrawal by Subject|9
7506824|NCT02335983|11834199|FG000|Overall Study|Death|0
7506825|NCT02335983|11834200|FG001|Overall Study|Death|0
7506826|NCT02335983|11834201|FG002|Overall Study|Death|2
7506827|NCT02335983|11834202|FG003|Overall Study|Death|0
7506828|NCT02335983|11834203|FG004|Overall Study|Death|0
7506829|NCT02335983|11834204|FG005|Overall Study|Death|0
7506830|NCT02335983|11834199|FG000|Overall Study|Lost to Follow-up|0
7506831|NCT02335983|11834200|FG001|Overall Study|Lost to Follow-up|0
7506832|NCT02335983|11834201|FG002|Overall Study|Lost to Follow-up|0
7506833|NCT02335983|11834202|FG003|Overall Study|Lost to Follow-up|0
7506834|NCT02335983|11834203|FG004|Overall Study|Lost to Follow-up|0
7506835|NCT02335983|11834204|FG005|Overall Study|Lost to Follow-up|1
7506836|NCT02335983|11834199|FG000|Overall Study|Protocol Specified Criteria|5
7506837|NCT02335983|11834200|FG001|Overall Study|Protocol Specified Criteria|7
7506838|NCT02335983|11834201|FG002|Overall Study|Protocol Specified Criteria|27
7506839|NCT02335983|11834202|FG003|Overall Study|Protocol Specified Criteria|7
7506840|NCT02335983|11834203|FG004|Overall Study|Protocol Specified Criteria|5
7506841|NCT02335983|11834204|FG005|Overall Study|Protocol Specified Criteria|21
7506842|NCT02336074|11834229|FG000|Overall Study|Adverse Event|0
7506843|NCT02336074|11834230|FG001|Overall Study|Adverse Event|2
7506844|NCT02336165|11834246|FG000|Overall Study|Death|3
7506845|NCT02336165|11834247|FG001|Overall Study|Death|0
7506846|NCT02336165|11834248|FG002|Overall Study|Death|0
7506847|NCT02336165|11834249|FG003|Overall Study|Death|0
7506848|NCT02336165|11834250|FG004|Overall Study|Death|1
7506849|NCT02336165|11834246|FG000|Overall Study|Physician Decision|2
7506850|NCT02336165|11834247|FG001|Overall Study|Physician Decision|2
7506851|NCT02336165|11834248|FG002|Overall Study|Physician Decision|1
7506852|NCT02336165|11834249|FG003|Overall Study|Physician Decision|1
7506853|NCT02336165|11834250|FG004|Overall Study|Physician Decision|0
7506854|NCT02336165|11834246|FG000|Overall Study|Withdrawal by Subject|0
7506855|NCT02336165|11834247|FG001|Overall Study|Withdrawal by Subject|0
7506856|NCT02336165|11834248|FG002|Overall Study|Withdrawal by Subject|1
7506857|NCT02336165|11834249|FG003|Overall Study|Withdrawal by Subject|0
7506858|NCT02336165|11834250|FG004|Overall Study|Withdrawal by Subject|1
7506859|NCT02336165|11834246|FG000|Overall Study|Adverse Event|4
7506860|NCT02336165|11834247|FG001|Overall Study|Adverse Event|1
7506861|NCT02336165|11834248|FG002|Overall Study|Adverse Event|2
7506862|NCT02336165|11834249|FG003|Overall Study|Adverse Event|4
7506863|NCT02336165|11834250|FG004|Overall Study|Adverse Event|1
7506864|NCT02336165|11834246|FG000|Overall Study|Progressive disease|23
7506865|NCT02336165|11834247|FG001|Overall Study|Progressive disease|22
7506866|NCT02336165|11834248|FG002|Overall Study|Progressive disease|27
7506867|NCT02336165|11834249|FG003|Overall Study|Progressive disease|24
7506868|NCT02336165|11834250|FG004|Overall Study|Progressive disease|19
7506869|NCT02336165|11834246|FG000|Overall Study|Non-compliance|1
7506870|NCT02336165|11834247|FG001|Overall Study|Non-compliance|0
7506871|NCT02336165|11834248|FG002|Overall Study|Non-compliance|0
7506872|NCT02336165|11834249|FG003|Overall Study|Non-compliance|1
7506873|NCT02336165|11834250|FG004|Overall Study|Non-compliance|0
7506874|NCT02336165|11834246|FG000|Overall Study|Other|1
7506875|NCT02336165|11834247|FG001|Overall Study|Other|0
7506876|NCT02336165|11834248|FG002|Overall Study|Other|0
7506877|NCT02336165|11834249|FG003|Overall Study|Other|1
7506878|NCT02336165|11834250|FG004|Overall Study|Other|0
7506879|NCT02336178|11834266|FG000|Overall Study|Lost to Follow-up|1
7506880|NCT02336178|11834266|FG000|Overall Study|Protocol Violation|1
7506881|NCT02336178|11834266|FG000|Overall Study|Withdrawal by Subject|1
7506882|NCT02336178|11834266|FG000|Overall Study|Other|1
7506883|NCT02336282|11834278|FG000|Overall Study|Unrelated illness|1
7506884|NCT02336282|11834278|FG000|Overall Study|Uncomfortable with technology|1
7506885|NCT02336282|11834278|FG000|Overall Study|Lost to Follow-up|1
7506886|NCT02336282|11834278|FG000|Overall Study|Not enough time to complete sessions|2
7506887|NCT02336373|11834294|FG000|Overall Study|Protocol closed early|4
7506888|NCT02336373|11834294|FG000|Overall Study|Physician Decision|14
7506889|NCT02336451|11834309|FG000|Overall Study|Adverse Event|1
7506890|NCT02336451|11834310|FG001|Overall Study|Adverse Event|2
7506891|NCT02336451|11834311|FG002|Overall Study|Adverse Event|0
7506892|NCT02336451|11834312|FG003|Overall Study|Adverse Event|6
7506893|NCT02336451|11834313|FG004|Overall Study|Adverse Event|4
7506894|NCT02336451|11834309|FG000|Overall Study|Death|6
7506895|NCT02336451|11834310|FG001|Overall Study|Death|2
7506896|NCT02336451|11834311|FG002|Overall Study|Death|3
7506897|NCT02336451|11834312|FG003|Overall Study|Death|6
7506898|NCT02336451|11834313|FG004|Overall Study|Death|6
7506899|NCT02336451|11834309|FG000|Overall Study|Physician Decision|9
7506900|NCT02336451|11834310|FG001|Overall Study|Physician Decision|6
7506901|NCT02336451|11834311|FG002|Overall Study|Physician Decision|7
7506902|NCT02336451|11834312|FG003|Overall Study|Physician Decision|16
7506903|NCT02336451|11834313|FG004|Overall Study|Physician Decision|3
7506904|NCT02336451|11834309|FG000|Overall Study|Progressive disease|23
7506905|NCT02336451|11834310|FG001|Overall Study|Progressive disease|26
7506906|NCT02336451|11834311|FG002|Overall Study|Progressive disease|2
7506907|NCT02336451|11834312|FG003|Overall Study|Progressive disease|14
7506908|NCT02336451|11834313|FG004|Overall Study|Progressive disease|4
7506909|NCT02336451|11834309|FG000|Overall Study|Protocol Violation|1
7506910|NCT02336451|11834310|FG001|Overall Study|Protocol Violation|0
7506911|NCT02336451|11834311|FG002|Overall Study|Protocol Violation|0
7506912|NCT02336451|11834312|FG003|Overall Study|Protocol Violation|0
7506913|NCT02336451|11834313|FG004|Overall Study|Protocol Violation|0
7506914|NCT02336451|11834309|FG000|Overall Study|Patient/guardian decision|2
7506915|NCT02336451|11834310|FG001|Overall Study|Patient/guardian decision|4
7506916|NCT02336451|11834311|FG002|Overall Study|Patient/guardian decision|0
7506917|NCT02336451|11834312|FG003|Overall Study|Patient/guardian decision|2
7506918|NCT02336451|11834313|FG004|Overall Study|Patient/guardian decision|1
7506919|NCT02336555|11834329|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7506920|NCT02336555|11834330|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7506921|NCT02336555|11834329|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
7506922|NCT02336555|11834330|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
7506923|NCT02336555|11834329|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
7506924|NCT02336555|11834330|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
7506925|NCT02336607|11834360|FG000|Overall Study|Physician Decision|1
7506926|NCT02336607|11834361|FG001|Overall Study|Physician Decision|4
7506927|NCT02336607|11834362|FG002|Overall Study|Physician Decision|3
7506928|NCT02336607|11834363|FG003|Overall Study|Physician Decision|15
7506929|NCT02336607|11834360|FG000|Overall Study|Lack of Efficacy|1
7506930|NCT02336607|11834361|FG001|Overall Study|Lack of Efficacy|0
7506931|NCT02336607|11834362|FG002|Overall Study|Lack of Efficacy|0
7506932|NCT02336607|11834363|FG003|Overall Study|Lack of Efficacy|2
7506933|NCT02336607|11834360|FG000|Overall Study|Lost to Follow-up|2
7506934|NCT02336607|11834361|FG001|Overall Study|Lost to Follow-up|1
7506935|NCT02336607|11834362|FG002|Overall Study|Lost to Follow-up|0
7506936|NCT02336607|11834363|FG003|Overall Study|Lost to Follow-up|21
7506937|NCT02336607|11834360|FG000|Overall Study|Protocol Violation|0
7506938|NCT02336607|11834361|FG001|Overall Study|Protocol Violation|1
7506939|NCT02336607|11834362|FG002|Overall Study|Protocol Violation|1
7506940|NCT02336607|11834363|FG003|Overall Study|Protocol Violation|3
7506941|NCT02336607|11834360|FG000|Overall Study|Adverse Event|0
7506942|NCT02336607|11834361|FG001|Overall Study|Adverse Event|2
7506943|NCT02336607|11834362|FG002|Overall Study|Adverse Event|2
7506944|NCT02336607|11834363|FG003|Overall Study|Adverse Event|26
7506945|NCT02336607|11834360|FG000|Overall Study|Withdrawal by Subject|0
7506946|NCT02336607|11834361|FG001|Overall Study|Withdrawal by Subject|2
7506947|NCT02336607|11834362|FG002|Overall Study|Withdrawal by Subject|0
7506948|NCT02336607|11834363|FG003|Overall Study|Withdrawal by Subject|20
7506949|NCT02336737|11834373|FG000|Overall Study|Withdrawal by Subject|5
7506950|NCT02336737|11834373|FG000|Overall Study|Physician Decision|8
7506951|NCT02336815|11834380|FG000|Overall Study|Disease Progression|45
7506952|NCT02336815|11834381|FG001|Overall Study|Disease Progression|70
7506953|NCT02336815|11834380|FG000|Overall Study|Adverse Event|18
7506954|NCT02336815|11834381|FG001|Overall Study|Adverse Event|39
7506955|NCT02336815|11834380|FG000|Overall Study|Physician Decision|11
7506956|NCT02336815|11834381|FG001|Overall Study|Physician Decision|4
7506957|NCT02336815|11834380|FG000|Overall Study|Withdrawal by Subject|3
7506958|NCT02336815|11834381|FG001|Overall Study|Withdrawal by Subject|2
7506959|NCT02336815|11834380|FG000|Overall Study|Lost to Follow-up|1
7506960|NCT02336815|11834381|FG001|Overall Study|Lost to Follow-up|3
7506961|NCT02336815|11834380|FG000|Overall Study|Other|1
7506962|NCT02336815|11834381|FG001|Overall Study|Other|5
7506963|NCT02337361|11834420|FG000|3-month Follow-up|Lost to Follow-up|19
7506964|NCT02337361|11834421|FG001|3-month Follow-up|Lost to Follow-up|14
7506965|NCT02337361|11834420|FG000|6-month Follow-up|Lost to Follow-up|2
7506966|NCT02337361|11834421|FG001|6-month Follow-up|Lost to Follow-up|4
7506967|NCT02337387|11834432|FG000|Overall Study|Adverse Event|0
7506968|NCT02337387|11834433|FG001|Overall Study|Adverse Event|1
7506969|NCT02337387|11834434|FG002|Overall Study|Adverse Event|0
7506970|NCT02337387|11834435|FG003|Overall Study|Adverse Event|0
7506971|NCT02337387|11834432|FG000|Overall Study|Sponsor Decision to Terminate Study|14
7506972|NCT02337387|11834433|FG001|Overall Study|Sponsor Decision to Terminate Study|7
7506973|NCT02337387|11834434|FG002|Overall Study|Sponsor Decision to Terminate Study|3
7506974|NCT02337387|11834435|FG003|Overall Study|Sponsor Decision to Terminate Study|3
7506975|NCT02337478|11834449|FG000|Overall Study|Lack of Efficacy|5
7506976|NCT02337491|11834455|FG000|Overall Study|Death|1
7506977|NCT02337491|11834456|FG001|Overall Study|Death|1
7506978|NCT02337491|11834455|FG000|Overall Study|Adverse Event|0
7506979|NCT02337491|11834456|FG001|Overall Study|Adverse Event|1
7506980|NCT02337491|11834455|FG000|Overall Study|Withdrawal by Subject|3
7506981|NCT02337491|11834456|FG001|Overall Study|Withdrawal by Subject|0
7506982|NCT02337491|11834455|FG000|Overall Study|Progressive Disease|44
7506983|NCT02337491|11834456|FG001|Overall Study|Progressive Disease|28
7506984|NCT02337491|11834455|FG000|Overall Study|On Treatment|2
7506985|NCT02337491|11834456|FG001|Overall Study|On Treatment|0
7506986|NCT02337907|11834486|FG000|Overall Study|Other than listed|1
7506987|NCT02337907|11834487|FG001|Overall Study|Other than listed|0
7506988|NCT02337907|11834488|FG002|Overall Study|Other than listed|0
7506989|NCT02337907|11834489|FG003|Overall Study|Other than listed|1
7506990|NCT02337907|11834490|FG004|Overall Study|Other than listed|1
7506991|NCT02337907|11834491|FG005|Overall Study|Other than listed|0
7506992|NCT02337907|11834486|FG000|Overall Study|Withdrawal by Subject|2
7506993|NCT02337907|11834487|FG001|Overall Study|Withdrawal by Subject|3
7506994|NCT02337907|11834488|FG002|Overall Study|Withdrawal by Subject|0
7506995|NCT02337907|11834489|FG003|Overall Study|Withdrawal by Subject|2
7506996|NCT02337907|11834490|FG004|Overall Study|Withdrawal by Subject|5
7506997|NCT02337907|11834491|FG005|Overall Study|Withdrawal by Subject|0
7506998|NCT02337907|11834486|FG000|Overall Study|Lost to Follow-up|0
7506999|NCT02337907|11834487|FG001|Overall Study|Lost to Follow-up|0
7507000|NCT02337907|11834488|FG002|Overall Study|Lost to Follow-up|0
7507001|NCT02337907|11834489|FG003|Overall Study|Lost to Follow-up|0
7507002|NCT02337907|11834490|FG004|Overall Study|Lost to Follow-up|0
7507003|NCT02337907|11834491|FG005|Overall Study|Lost to Follow-up|1
7507004|NCT02337907|11834486|FG000|Overall Study|Adverse Event|1
7507005|NCT02337907|11834487|FG001|Overall Study|Adverse Event|1
7507006|NCT02337907|11834488|FG002|Overall Study|Adverse Event|1
7507007|NCT02337907|11834489|FG003|Overall Study|Adverse Event|1
7507008|NCT02337907|11834490|FG004|Overall Study|Adverse Event|4
7507009|NCT02337907|11834491|FG005|Overall Study|Adverse Event|0
7507010|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Adverse Event|7
7507011|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Adverse Event|0
7507012|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Adverse Event|0
7507013|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
7507014|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
7507015|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
7507016|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
7507017|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7507018|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
7507019|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
7507020|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
7507021|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
7507022|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
7507023|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7507024|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
7507025|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
7507026|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7507027|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
7507028|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
7507029|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7507030|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
7507031|NCT02337946|11834515|FG000|Protocol Treatment 1 Period|Reason not specified|8
7507032|NCT02337946|11834516|FG001|Protocol Treatment 1 Period|Reason not specified|0
7507033|NCT02337946|11834517|FG002|Protocol Treatment 1 Period|Reason not specified|0
7507034|NCT02337946|11834515|FG000|In-between Period|Without Informed Consent|1
7507035|NCT02337946|11834516|FG001|In-between Period|Without Informed Consent|0
7507036|NCT02337946|11834517|FG002|In-between Period|Without Informed Consent|0
7507037|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Adverse Event|0
7507038|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Adverse Event|9
7507039|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Adverse Event|9
7507040|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
7507041|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
7507042|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
7507043|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
7507044|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
7507045|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
7507046|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7507047|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
7507048|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
7507049|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
7507050|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
7507051|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
7507052|NCT02337946|11834515|FG000|Protocol Treatment 2 Period|Reason not specified|0
7507053|NCT02337946|11834516|FG001|Protocol Treatment 2 Period|Reason not specified|4
7507054|NCT02337946|11834517|FG002|Protocol Treatment 2 Period|Reason not specified|4
7507055|NCT02338154|11834542|FG000|Overall Study|Death|46
7507056|NCT02338154|11834542|FG000|Overall Study|Valve Implant Failure|17
7507057|NCT02338154|11834542|FG000|Overall Study|Valve Explant|11
7507058|NCT02338154|11834542|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
7507059|NCT02338154|11834542|FG000|Overall Study|Lost to Follow-up|8
7507060|NCT02338154|11834542|FG000|Overall Study|Other Reason|3
7507061|NCT02338154|11834542|FG000|Overall Study|Patients Without Exit Form|47
7507062|NCT02338154|11834542|FG000|Overall Study|Missing Exit Reason on Exit Form|1
7507063|NCT02338193|11834557|FG000|Overall Study|Withdrawal by Subject|0
7507064|NCT02338193|11834558|FG001|Overall Study|Withdrawal by Subject|0
7507065|NCT02338193|11834559|FG002|Overall Study|Withdrawal by Subject|2
7507066|NCT02338193|11834557|FG000|Overall Study|Pregnancy|0
7507067|NCT02338193|11834558|FG001|Overall Study|Pregnancy|1
7507068|NCT02338193|11834559|FG002|Overall Study|Pregnancy|1
7507069|NCT02338193|11834557|FG000|Overall Study|Noncompliant with visits|2
7507070|NCT02338193|11834558|FG001|Overall Study|Noncompliant with visits|2
7507071|NCT02338193|11834559|FG002|Overall Study|Noncompliant with visits|7
7507072|NCT02338193|11834557|FG000|Overall Study|moved out of state|0
7507073|NCT02338193|11834558|FG001|Overall Study|moved out of state|1
7507074|NCT02338193|11834559|FG002|Overall Study|moved out of state|0
7507075|NCT02338193|11834557|FG000|Overall Study|intolerant of side effects|1
7507076|NCT02338193|11834558|FG001|Overall Study|intolerant of side effects|0
7507077|NCT02338193|11834559|FG002|Overall Study|intolerant of side effects|0
7507078|NCT02338362|11834580|FG000|Overall Study|Withdrawal by Subject|1
7507079|NCT02338362|11834581|FG001|Overall Study|Withdrawal by Subject|1
7507080|NCT02338492|11834587|FG000|Overall Study|Death|32
7507081|NCT02338492|11834587|FG000|Overall Study|Adverse Event|3
7507082|NCT02338492|11834587|FG000|Overall Study|Lost to Follow-up|4
7507083|NCT02338492|11834587|FG000|Overall Study|Reason not captured above|6
7507084|NCT02338843|11834599|FG000|Overall Study|Adverse Event|2
7507085|NCT02338843|11834600|FG001|Overall Study|Adverse Event|1
7507086|NCT02338843|11834599|FG000|Overall Study|Death|40
7507087|NCT02338843|11834600|FG001|Overall Study|Death|53
7507088|NCT02338843|11834599|FG000|Overall Study|Physician Decision|1
7507089|NCT02338843|11834600|FG001|Overall Study|Physician Decision|0
7507090|NCT02338843|11834599|FG000|Overall Study|Withdrawal by Subject|0
7507091|NCT02338843|11834600|FG001|Overall Study|Withdrawal by Subject|2
7507092|NCT02338843|11834599|FG000|Overall Study|Subject Recovered|0
7507093|NCT02338843|11834600|FG001|Overall Study|Subject Recovered|2
7507094|NCT02338843|11834599|FG000|Overall Study|Discontinued prior to randomizat|1
7507095|NCT02338843|11834600|FG001|Overall Study|Discontinued prior to randomizat|0
7507096|NCT02338882|11834608|FG000|Overall Study|Death|1
7507097|NCT02338882|11834609|FG001|Overall Study|Death|0
7507098|NCT02338882|11834608|FG000|Overall Study|Lost to Follow-up|6
7507099|NCT02338882|11834609|FG001|Overall Study|Lost to Follow-up|3
7507100|NCT02338999|11834715|FG000|First Intervention|Withdrawal by Subject|3
7507101|NCT02338999|11834716|FG001|First Intervention|Withdrawal by Subject|1
7507102|NCT02338999|11834715|FG000|Washout Period|Withdrawal by Subject|0
7507103|NCT02338999|11834716|FG001|Washout Period|Withdrawal by Subject|2
7507104|NCT02338999|11834715|FG000|Second Intervention|Withdrawal by Subject|0
7507105|NCT02338999|11834716|FG001|Second Intervention|Withdrawal by Subject|2
7507106|NCT02339155|11834728|FG000|Overall Study|Adverse Event|0
7507107|NCT02339155|11834729|FG001|Overall Study|Adverse Event|6
7507108|NCT02339155|11834728|FG000|Overall Study|Death|1
7507109|NCT02339155|11834729|FG001|Overall Study|Death|1
7507110|NCT02339155|11834728|FG000|Overall Study|Lost to Follow-up|8
7507111|NCT02339155|11834729|FG001|Overall Study|Lost to Follow-up|9
7507112|NCT02339155|11834728|FG000|Overall Study|Physician Decision|2
7507113|NCT02339155|11834729|FG001|Overall Study|Physician Decision|1
7507114|NCT02339155|11834728|FG000|Overall Study|Withdrawal by Subject|4
7507115|NCT02339155|11834729|FG001|Overall Study|Withdrawal by Subject|4
7507116|NCT02339285|11834752|FG000|Overall Study|Withdrawal by Subject|0
7507117|NCT02339285|11834753|FG001|Overall Study|Withdrawal by Subject|1
7507118|NCT02339285|11834754|FG002|Overall Study|Withdrawal by Subject|1
7507119|NCT02339285|11834752|FG000|Overall Study|Lost to Follow-up|1
7507120|NCT02339285|11834753|FG001|Overall Study|Lost to Follow-up|1
7507121|NCT02339285|11834754|FG002|Overall Study|Lost to Follow-up|1
7507122|NCT02339285|11834752|FG000|Overall Study|Protocol Deviation|0
7507123|NCT02339285|11834753|FG001|Overall Study|Protocol Deviation|1
7507124|NCT02339285|11834754|FG002|Overall Study|Protocol Deviation|0
7535984|NCT02714569|11883874|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535985|NCT02714569|11883875|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535986|NCT02714569|11883876|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535987|NCT02714569|11883877|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
7535988|NCT02714569|11883867|FG000|Part B (Overall)|Lost to Follow-up|0
7535989|NCT02714569|11883868|FG001|Part B (Overall)|Lost to Follow-up|0
7535990|NCT02714569|11883869|FG002|Part B (Overall)|Lost to Follow-up|0
7535991|NCT02714569|11883870|FG003|Part B (Overall)|Lost to Follow-up|0
7535992|NCT02714569|11883871|FG004|Part B (Overall)|Lost to Follow-up|0
7535993|NCT02714569|11883872|FG005|Part B (Overall)|Lost to Follow-up|0
7535994|NCT02714569|11883873|FG006|Part B (Overall)|Lost to Follow-up|1
7535995|NCT02714569|11883874|FG007|Part B (Overall)|Lost to Follow-up|0
7535996|NCT02714569|11883875|FG008|Part B (Overall)|Lost to Follow-up|0
7535997|NCT02714569|11883876|FG009|Part B (Overall)|Lost to Follow-up|0
7535998|NCT02714569|11883877|FG010|Part B (Overall)|Lost to Follow-up|0
7507129|NCT02339584|11834796|FG000|Overall Study|Adverse Event|11
7507130|NCT02339584|11834797|FG001|Overall Study|Adverse Event|7
7507131|NCT02339584|11834796|FG000|Overall Study|Lack of Efficacy|0
7507132|NCT02339584|11834797|FG001|Overall Study|Lack of Efficacy|1
7507133|NCT02339584|11834796|FG000|Overall Study|Physician Decision|1
7507134|NCT02339584|11834797|FG001|Overall Study|Physician Decision|2
7507135|NCT02339584|11834796|FG000|Overall Study|Protocol Violation|1
7507136|NCT02339584|11834797|FG001|Overall Study|Protocol Violation|1
7507137|NCT02339584|11834796|FG000|Overall Study|Withdrawal by Subject|2
7507138|NCT02339584|11834797|FG001|Overall Study|Withdrawal by Subject|4
7507139|NCT02339909|11834815|FG000|Overall Study|Became ineligible after randomisation|89
7507140|NCT02339909|11834816|FG001|Overall Study|Became ineligible after randomisation|63
7507141|NCT02339909|11834817|FG002|Overall Study|Became ineligible after randomisation|71
7507142|NCT02340000|11834827|FG000|Time Period 1|Withdrawal by Subject|6
7507143|NCT02340000|11834828|FG001|Time Period 1|Withdrawal by Subject|8
7507144|NCT02340000|11834827|FG000|Time Period 1|Lost to Follow-up|6
7507145|NCT02340000|11834828|FG001|Time Period 1|Lost to Follow-up|7
7507146|NCT02340000|11834827|FG000|Time Period 2|Withdrawal by Subject|9
7507147|NCT02340000|11834828|FG001|Time Period 2|Withdrawal by Subject|7
7507148|NCT02340000|11834827|FG000|Time Period 2|Lost to Follow-up|10
7507149|NCT02340000|11834828|FG001|Time Period 2|Lost to Follow-up|8
7507150|NCT02340078|11834841|FG000|Overall Study|Protocol Violation|1
7507151|NCT02340520|11834898|FG000|Overall Study|Lost to Follow-up|1
7507152|NCT02340520|11834898|FG000|Overall Study|Patient did not take drug as specified|1
7507153|NCT02340520|11834898|FG000|Overall Study|Withdrawal by Subject|1
7507154|NCT02340663|11834904|FG000|Overall Study|Lost to Follow-up|1
7507155|NCT02340663|11834905|FG001|Overall Study|Lost to Follow-up|0
7507156|NCT02340663|11834904|FG000|Overall Study|Protocol Violation|1
7507157|NCT02340663|11834905|FG001|Overall Study|Protocol Violation|0
7507158|NCT02340663|11834904|FG000|Overall Study|Withdrawal by Subject|3
7507159|NCT02340663|11834905|FG001|Overall Study|Withdrawal by Subject|1
7507160|NCT02340780|11834947|FG000|Overall Study|Ineligible|1
7507161|NCT02340806|11834953|FG000|Overall Study|Protocol Violation|2
7507162|NCT02340806|11834954|FG001|Overall Study|Protocol Violation|0
7507163|NCT02340806|11834953|FG000|Overall Study|epidural catheter replaced|2
7507164|NCT02340806|11834954|FG001|Overall Study|epidural catheter replaced|1
7507165|NCT02340806|11834953|FG000|Overall Study|history of chronic pain medication|1
7507166|NCT02340806|11834954|FG001|Overall Study|history of chronic pain medication|0
7507167|NCT02340806|11834953|FG000|Overall Study|re-dose < 90 min of CSE|1
7507168|NCT02340806|11834954|FG001|Overall Study|re-dose < 90 min of CSE|3
7507169|NCT02340819|11834960|FG000|Overall Study|Adverse Event|1
7507170|NCT02340819|11834960|FG000|Overall Study|Withdrawal by Subject|2
7507171|NCT02340819|11834960|FG000|Overall Study|Discontinued with other reason|1
7507172|NCT02340949|11834966|FG000|Overall Study|Adverse Event|4
7507173|NCT02340949|11834967|FG001|Overall Study|Adverse Event|2
7507174|NCT02340949|11834966|FG000|Overall Study|Withdrawal by Subject|2
7507175|NCT02340949|11834967|FG001|Overall Study|Withdrawal by Subject|0
7507176|NCT02340949|11834966|FG000|Overall Study|Progression disease|6
7507177|NCT02340949|11834967|FG001|Overall Study|Progression disease|2
7507178|NCT02340949|11834966|FG000|Overall Study|Death|3
7507179|NCT02340949|11834967|FG001|Overall Study|Death|0
7507180|NCT02340949|11834966|FG000|Overall Study|Physician Decision|1
7507181|NCT02340949|11834967|FG001|Overall Study|Physician Decision|0
7507182|NCT02340962|11834975|FG000|Overall Study|Lost to Follow-up|1
7507183|NCT02340962|11834976|FG001|Overall Study|Lost to Follow-up|0
7507184|NCT02340975|11834988|FG000|Overall Study|Death|6
7507185|NCT02340975|11834989|FG001|Overall Study|Death|23
7507186|NCT02340975|11834990|FG002|Overall Study|Death|21
7507187|NCT02340975|11834991|FG003|Overall Study|Death|7
7507188|NCT02340975|11834992|FG004|Overall Study|Death|21
7507189|NCT02340975|11834993|FG005|Overall Study|Death|13
7507190|NCT02340975|11834988|FG000|Overall Study|Lost to Follow-up|0
7507191|NCT02340975|11834989|FG001|Overall Study|Lost to Follow-up|0
7507192|NCT02340975|11834990|FG002|Overall Study|Lost to Follow-up|0
7507193|NCT02340975|11834991|FG003|Overall Study|Lost to Follow-up|0
7507194|NCT02340975|11834992|FG004|Overall Study|Lost to Follow-up|2
7507195|NCT02340975|11834993|FG005|Overall Study|Lost to Follow-up|0
7507196|NCT02340975|11834988|FG000|Overall Study|Withdrawal by Subject|0
7507197|NCT02340975|11834989|FG001|Overall Study|Withdrawal by Subject|0
7507198|NCT02340975|11834990|FG002|Overall Study|Withdrawal by Subject|3
7507199|NCT02340975|11834991|FG003|Overall Study|Withdrawal by Subject|3
7507200|NCT02340975|11834992|FG004|Overall Study|Withdrawal by Subject|2
7507201|NCT02340975|11834993|FG005|Overall Study|Withdrawal by Subject|0
7507202|NCT02340975|11834988|FG000|Overall Study|Other|0
7507203|NCT02340975|11834989|FG001|Overall Study|Other|4
7507204|NCT02340975|11834990|FG002|Overall Study|Other|0
7507205|NCT02340975|11834991|FG003|Overall Study|Other|2
7507206|NCT02340975|11834992|FG004|Overall Study|Other|0
7507207|NCT02340975|11834993|FG005|Overall Study|Other|6
7507208|NCT02341417|11835020|FG000|Overall Study|Withdrawal by Subject|0
7507209|NCT02341417|11835021|FG001|Overall Study|Withdrawal by Subject|2
7507210|NCT02341417|11835022|FG002|Overall Study|Withdrawal by Subject|0
7507211|NCT02341417|11835020|FG000|Overall Study|Decision by sponsor|2
7507212|NCT02341417|11835021|FG001|Overall Study|Decision by sponsor|0
7507213|NCT02341417|11835022|FG002|Overall Study|Decision by sponsor|0
7507214|NCT02341417|11835020|FG000|Overall Study|Death|0
7507215|NCT02341417|11835021|FG001|Overall Study|Death|0
7507216|NCT02341417|11835022|FG002|Overall Study|Death|1
7507217|NCT02341456|11835034|FG000|Overall Study|Disease progression|2
7507218|NCT02341456|11835035|FG001|Overall Study|Disease progression|3
7507219|NCT02341456|11835036|FG002|Overall Study|Disease progression|1
7507220|NCT02341456|11835034|FG000|Overall Study|Death|1
7507221|NCT02341456|11835035|FG001|Overall Study|Death|1
7507222|NCT02341456|11835036|FG002|Overall Study|Death|1
7507223|NCT02341456|11835034|FG000|Overall Study|Withdrawal by Subject|0
7507224|NCT02341456|11835035|FG001|Overall Study|Withdrawal by Subject|1
7507225|NCT02341456|11835036|FG002|Overall Study|Withdrawal by Subject|1
7507226|NCT02341456|11835034|FG000|Overall Study|Moved to local access programme.|0
7507227|NCT02341456|11835035|FG001|Overall Study|Moved to local access programme.|1
7507228|NCT02341456|11835036|FG002|Overall Study|Moved to local access programme.|1
7507229|NCT02341456|11835034|FG000|Overall Study|Physician Decision|1
7507230|NCT02341456|11835035|FG001|Overall Study|Physician Decision|0
7507231|NCT02341456|11835036|FG002|Overall Study|Physician Decision|0
7507232|NCT02341482|11835044|FG000|Overall Study|Adverse Event|1
7507233|NCT02342171|11835097|FG000|Overall Study|Death|4
7507234|NCT02342171|11835098|FG001|Overall Study|Death|87
7507235|NCT02342171|11835097|FG000|Overall Study|Received favipiravir|10
7507236|NCT02342171|11835098|FG001|Overall Study|Received favipiravir|0
7507237|NCT02342171|11835097|FG000|Overall Study|Missing cycle treshold value|1
7507238|NCT02342171|11835098|FG001|Overall Study|Missing cycle treshold value|0
7507239|NCT02342171|11835097|FG000|Overall Study|Unknown outcome|0
7507240|NCT02342171|11835098|FG001|Overall Study|Unknown outcome|1
7507241|NCT02342171|11835097|FG000|Overall Study|Missing age data|0
7507242|NCT02342171|11835098|FG001|Overall Study|Missing age data|1
7507243|NCT02342223|11835112|FG000|Overall Study|Lost to Follow-up|1
7507244|NCT02342288|11835118|FG000|Overall Study|no protocol anesthesiologist available|3
7507245|NCT02342288|11835119|FG001|Overall Study|no protocol anesthesiologist available|2
7507246|NCT02342288|11835118|FG000|Overall Study|anesthesia leak in system|1
7507247|NCT02342288|11835119|FG001|Overall Study|anesthesia leak in system|0
7507248|NCT02342288|11835118|FG000|Overall Study|Withdrawal by Subject|1
7507249|NCT02342288|11835119|FG001|Overall Study|Withdrawal by Subject|0
7507250|NCT02342288|11835118|FG000|Overall Study|coordinator contaminated with blood|0
7507251|NCT02342288|11835119|FG001|Overall Study|coordinator contaminated with blood|1
7507252|NCT02342288|11835118|FG000|Overall Study|subject cannot tolerate numbing drops|0
7507253|NCT02342288|11835119|FG001|Overall Study|subject cannot tolerate numbing drops|1
7507254|NCT02342288|11835118|FG000|Overall Study|coordinator not available|0
7507255|NCT02342288|11835119|FG001|Overall Study|coordinator not available|2
7507256|NCT02342418|11835229|FG000|Overall Study|Adverse Event|0
7507257|NCT02342418|11835230|FG001|Overall Study|Adverse Event|1
7507258|NCT02342548|11835243|FG000|Overall Study|Adverse Event|12
7507259|NCT02342548|11835244|FG001|Overall Study|Adverse Event|17
7507260|NCT02342548|11835245|FG002|Overall Study|Adverse Event|13
7507261|NCT02342548|11835243|FG000|Overall Study|Lost to Follow-up|0
7507262|NCT02342548|11835244|FG001|Overall Study|Lost to Follow-up|1
7507263|NCT02342548|11835245|FG002|Overall Study|Lost to Follow-up|0
7507264|NCT02342548|11835243|FG000|Overall Study|Study terminated by sponsor|20
7507265|NCT02342548|11835244|FG001|Overall Study|Study terminated by sponsor|39
7507266|NCT02342548|11835245|FG002|Overall Study|Study terminated by sponsor|25
7507267|NCT02342548|11835243|FG000|Overall Study|Protocol Violation|0
7507268|NCT02342548|11835244|FG001|Overall Study|Protocol Violation|1
7507269|NCT02342548|11835245|FG002|Overall Study|Protocol Violation|0
7507270|NCT02342548|11835243|FG000|Overall Study|Withdrawal by Subject|1
7507271|NCT02342548|11835244|FG001|Overall Study|Withdrawal by Subject|3
7507272|NCT02342548|11835245|FG002|Overall Study|Withdrawal by Subject|4
7507273|NCT02342548|11835243|FG000|Overall Study|Other|1
7507274|NCT02342548|11835244|FG001|Overall Study|Other|1
7507275|NCT02342548|11835245|FG002|Overall Study|Other|1
7507276|NCT02342639|11835263|FG000|Overall Study|Acute illness, unrelated to study drug|2
7507277|NCT02342639|11835264|FG001|Overall Study|Acute illness, unrelated to study drug|3
7507278|NCT02342639|11835263|FG000|Overall Study|Protocol Violation|0
7507279|NCT02342639|11835264|FG001|Overall Study|Protocol Violation|2
7507280|NCT02342678|11835274|FG000|Overall Study|Lost to Follow-up|0
7507281|NCT02342678|11835275|FG001|Overall Study|Lost to Follow-up|1
7507282|NCT02342678|11835274|FG000|Overall Study|Too busy to complete study|0
7507283|NCT02342678|11835275|FG001|Overall Study|Too busy to complete study|2
7507284|NCT02342678|11835274|FG000|Overall Study|Family illness/emergency|0
7507285|NCT02342678|11835275|FG001|Overall Study|Family illness/emergency|1
7507286|NCT02342678|11835274|FG000|Overall Study|Illness/medical reason|1
7507287|NCT02342678|11835275|FG001|Overall Study|Illness/medical reason|1
7507288|NCT02342704|11835283|FG000|Overall Study|Physician Decision|0
7507289|NCT02342704|11835284|FG001|Overall Study|Physician Decision|3
7507290|NCT02342704|11835283|FG000|Overall Study|Sponsor Termination|49
7507291|NCT02342704|11835284|FG001|Overall Study|Sponsor Termination|43
7507292|NCT02342704|11835283|FG000|Overall Study|Other|0
7507293|NCT02342704|11835284|FG001|Overall Study|Other|1
7507294|NCT02342704|11835283|FG000|Overall Study|Withdrawal by Subject|1
7507295|NCT02342704|11835284|FG001|Overall Study|Withdrawal by Subject|0
7507296|NCT02342704|11835283|FG000|Overall Study|Lost to Follow-up|2
7507297|NCT02342704|11835284|FG001|Overall Study|Lost to Follow-up|1
7507298|NCT02342704|11835283|FG000|Overall Study|Adverse Event|1
7507299|NCT02342704|11835284|FG001|Overall Study|Adverse Event|3
7507300|NCT02342743|11835290|FG000|Baseline Period|Withdrawal by Subject|3
7507301|NCT02342743|11835290|FG000|Baseline Period|Lost to Follow-up|2
7507302|NCT02342743|11835290|FG000|Baseline Period|Change in prophylactic medication|3
7507303|NCT02342743|11835290|FG000|Baseline Period|Screening failure regarding baseline|7
7507304|NCT02342743|11835290|FG000|Treatment Period|Withdrawal by Subject|2
7507305|NCT02342743|11835290|FG000|Treatment Period|Lost to Follow-up|8
7507306|NCT02342743|11835290|FG000|Treatment Period|Change in prophylactic medication|1
7507307|NCT02342886|11835299|FG000|Overall Study|Treatment non-compliance|1
7507308|NCT02342886|11835300|FG001|Overall Study|Treatment non-compliance|0
7507309|NCT02342886|11835301|FG002|Overall Study|Treatment non-compliance|0
7507310|NCT02342886|11835302|FG003|Overall Study|Treatment non-compliance|1
7507311|NCT02342886|11835303|FG004|Overall Study|Treatment non-compliance|0
7507312|NCT02342886|11835299|FG000|Overall Study|Late exclusion: rifampicin resistance|1
7507313|NCT02342886|11835300|FG001|Overall Study|Late exclusion: rifampicin resistance|0
7507314|NCT02342886|11835301|FG002|Overall Study|Late exclusion: rifampicin resistance|0
7507315|NCT02342886|11835302|FG003|Overall Study|Late exclusion: rifampicin resistance|0
7507316|NCT02342886|11835303|FG004|Overall Study|Late exclusion: rifampicin resistance|0
7507317|NCT02342886|11835299|FG000|Overall Study|Adverse event/specific toxicity|4
7507318|NCT02342886|11835300|FG001|Overall Study|Adverse event/specific toxicity|3
7507319|NCT02342886|11835301|FG002|Overall Study|Adverse event/specific toxicity|11
7507320|NCT02342886|11835302|FG003|Overall Study|Adverse event/specific toxicity|2
7507321|NCT02342886|11835303|FG004|Overall Study|Adverse event/specific toxicity|1
7507322|NCT02342886|11835299|FG000|Overall Study|Lost to Follow-up|1
7507323|NCT02342886|11835300|FG001|Overall Study|Lost to Follow-up|0
7507324|NCT02342886|11835301|FG002|Overall Study|Lost to Follow-up|0
7507325|NCT02342886|11835302|FG003|Overall Study|Lost to Follow-up|0
7507326|NCT02342886|11835303|FG004|Overall Study|Lost to Follow-up|0
7507327|NCT02342886|11835299|FG000|Overall Study|Death|1
7507328|NCT02342886|11835300|FG001|Overall Study|Death|2
7507329|NCT02342886|11835301|FG002|Overall Study|Death|1
7507330|NCT02342886|11835302|FG003|Overall Study|Death|0
7507331|NCT02342886|11835303|FG004|Overall Study|Death|1
7507332|NCT02342886|11835299|FG000|Overall Study|Withdrawal by Subject|0
7507333|NCT02342886|11835300|FG001|Overall Study|Withdrawal by Subject|1
7507334|NCT02342886|11835301|FG002|Overall Study|Withdrawal by Subject|0
7507335|NCT02342886|11835302|FG003|Overall Study|Withdrawal by Subject|1
7507336|NCT02342886|11835303|FG004|Overall Study|Withdrawal by Subject|0
7507337|NCT02342886|11835299|FG000|Overall Study|Investigator/sponsor decision|0
7507338|NCT02342886|11835300|FG001|Overall Study|Investigator/sponsor decision|2
7507339|NCT02342886|11835301|FG002|Overall Study|Investigator/sponsor decision|0
7507340|NCT02342886|11835302|FG003|Overall Study|Investigator/sponsor decision|3
7507341|NCT02342886|11835303|FG004|Overall Study|Investigator/sponsor decision|1
7507342|NCT02342886|11835299|FG000|Overall Study|Pregnancy|0
7507343|NCT02342886|11835300|FG001|Overall Study|Pregnancy|0
7507344|NCT02342886|11835301|FG002|Overall Study|Pregnancy|2
7507345|NCT02342886|11835302|FG003|Overall Study|Pregnancy|0
7507346|NCT02342886|11835303|FG004|Overall Study|Pregnancy|0
7507347|NCT02342886|11835299|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
7507348|NCT02342886|11835300|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
7507349|NCT02342886|11835301|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
7507350|NCT02342886|11835302|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
7507351|NCT02342886|11835303|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
7507352|NCT02342886|11835299|FG000|Overall Study|Protocol Violation|0
7507353|NCT02342886|11835300|FG001|Overall Study|Protocol Violation|0
7507354|NCT02342886|11835301|FG002|Overall Study|Protocol Violation|0
7507355|NCT02342886|11835302|FG003|Overall Study|Protocol Violation|2
7507356|NCT02342886|11835303|FG004|Overall Study|Protocol Violation|0
7507357|NCT02343003|11835317|FG000|Overall Study|Withdrawal by Subject|9
7507358|NCT02343003|11835318|FG001|Overall Study|Withdrawal by Subject|4
7507359|NCT02343003|11835317|FG000|Overall Study|Lost to Follow-up|5
7507360|NCT02343003|11835318|FG001|Overall Study|Lost to Follow-up|1
7507361|NCT02343003|11835317|FG000|Overall Study|Protocol Violation|1
7507362|NCT02343003|11835318|FG001|Overall Study|Protocol Violation|0
7507363|NCT02343003|11835317|FG000|Overall Study|Death|0
7507364|NCT02343003|11835318|FG001|Overall Study|Death|1
7507365|NCT02343003|11835317|FG000|Overall Study|exclusion criteria met|1
7507366|NCT02343003|11835318|FG001|Overall Study|exclusion criteria met|1
7507367|NCT02343003|11835317|FG000|Overall Study|terminated by sponsor|2
7507368|NCT02343003|11835318|FG001|Overall Study|terminated by sponsor|0
7507369|NCT02343406|11835366|FG000|Overall Study|Progressive disease|72
7507370|NCT02343406|11835367|FG001|Overall Study|Progressive disease|70
7507371|NCT02343406|11835368|FG002|Overall Study|Progressive disease|43
7507372|NCT02343406|11835369|FG003|Overall Study|Progressive disease|15
7507373|NCT02343406|11835370|FG004|Overall Study|Progressive disease|5
7507374|NCT02343406|11835366|FG000|Overall Study|Adverse Event|6
7507375|NCT02343406|11835367|FG001|Overall Study|Adverse Event|8
7507376|NCT02343406|11835368|FG002|Overall Study|Adverse Event|6
7507377|NCT02343406|11835369|FG003|Overall Study|Adverse Event|3
7507378|NCT02343406|11835370|FG004|Overall Study|Adverse Event|0
7507379|NCT02343406|11835366|FG000|Overall Study|Withdrawal by Subject|6
7507380|NCT02343406|11835367|FG001|Overall Study|Withdrawal by Subject|4
7507381|NCT02343406|11835368|FG002|Overall Study|Withdrawal by Subject|8
7507382|NCT02343406|11835369|FG003|Overall Study|Withdrawal by Subject|3
7507383|NCT02343406|11835370|FG004|Overall Study|Withdrawal by Subject|0
7507384|NCT02343406|11835366|FG000|Overall Study|Death|2
7507385|NCT02343406|11835367|FG001|Overall Study|Death|1
7507386|NCT02343406|11835368|FG002|Overall Study|Death|0
7507387|NCT02343406|11835369|FG003|Overall Study|Death|0
7507388|NCT02343406|11835370|FG004|Overall Study|Death|0
7507389|NCT02343406|11835366|FG000|Overall Study|Start of a new anti-cancer treatment|0
7507390|NCT02343406|11835367|FG001|Overall Study|Start of a new anti-cancer treatment|1
7507391|NCT02343406|11835368|FG002|Overall Study|Start of a new anti-cancer treatment|0
7507392|NCT02343406|11835369|FG003|Overall Study|Start of a new anti-cancer treatment|1
7507393|NCT02343406|11835370|FG004|Overall Study|Start of a new anti-cancer treatment|0
7507394|NCT02343406|11835366|FG000|Overall Study|Other primary malignancy|0
7507395|NCT02343406|11835367|FG001|Overall Study|Other primary malignancy|1
7507396|NCT02343406|11835368|FG002|Overall Study|Other primary malignancy|0
7507397|NCT02343406|11835369|FG003|Overall Study|Other primary malignancy|0
7507398|NCT02343406|11835370|FG004|Overall Study|Other primary malignancy|0
7507399|NCT02343406|11835366|FG000|Overall Study|Other, not specified|2
7507400|NCT02343406|11835367|FG001|Overall Study|Other, not specified|1
7507401|NCT02343406|11835368|FG002|Overall Study|Other, not specified|1
7507402|NCT02343406|11835369|FG003|Overall Study|Other, not specified|4
7507403|NCT02343406|11835370|FG004|Overall Study|Other, not specified|0
7507404|NCT02343458|11835385|FG000|Overall Study|Adverse Event|15
7507405|NCT02343458|11835386|FG001|Overall Study|Adverse Event|14
7507406|NCT02343458|11835387|FG002|Overall Study|Adverse Event|15
7507407|NCT02343458|11835388|FG003|Overall Study|Adverse Event|3
7507408|NCT02343458|11835385|FG000|Overall Study|Lack of Efficacy|3
7507409|NCT02343458|11835386|FG001|Overall Study|Lack of Efficacy|8
7507410|NCT02343458|11835387|FG002|Overall Study|Lack of Efficacy|4
7507411|NCT02343458|11835388|FG003|Overall Study|Lack of Efficacy|8
7507412|NCT02343458|11835385|FG000|Overall Study|Withdrawal by Subject|18
7507413|NCT02343458|11835386|FG001|Overall Study|Withdrawal by Subject|17
7507414|NCT02343458|11835387|FG002|Overall Study|Withdrawal by Subject|23
7507415|NCT02343458|11835388|FG003|Overall Study|Withdrawal by Subject|14
7507416|NCT02343458|11835385|FG000|Overall Study|Physician Decision|1
7507417|NCT02343458|11835386|FG001|Overall Study|Physician Decision|4
7507418|NCT02343458|11835387|FG002|Overall Study|Physician Decision|2
7507419|NCT02343458|11835388|FG003|Overall Study|Physician Decision|2
7507420|NCT02343458|11835385|FG000|Overall Study|Lost to Follow-up|5
7507421|NCT02343458|11835386|FG001|Overall Study|Lost to Follow-up|5
7507422|NCT02343458|11835387|FG002|Overall Study|Lost to Follow-up|3
7507423|NCT02343458|11835388|FG003|Overall Study|Lost to Follow-up|1
7507424|NCT02343458|11835385|FG000|Overall Study|Protocol Violation|2
7507425|NCT02343458|11835386|FG001|Overall Study|Protocol Violation|5
7507426|NCT02343458|11835387|FG002|Overall Study|Protocol Violation|2
7507427|NCT02343458|11835388|FG003|Overall Study|Protocol Violation|2
7507428|NCT02343458|11835385|FG000|Overall Study|Protocol Specified Criteria|17
7507429|NCT02343458|11835386|FG001|Overall Study|Protocol Specified Criteria|13
7507430|NCT02343458|11835387|FG002|Overall Study|Protocol Specified Criteria|14
7507431|NCT02343458|11835388|FG003|Overall Study|Protocol Specified Criteria|8
7507432|NCT02343939|11835425|FG000|Overall Study|Death|0
7507433|NCT02343939|11835426|FG001|Overall Study|Death|15
7507434|NCT02343939|11835427|FG002|Overall Study|Death|4
7507435|NCT02343939|11835428|FG003|Overall Study|Death|2
7507436|NCT02343939|11835429|FG004|Overall Study|Death|5
7507437|NCT02343939|11835430|FG005|Overall Study|Death|11
7507438|NCT02343939|11835431|FG006|Overall Study|Death|8
7507439|NCT02343939|11835432|FG007|Overall Study|Death|22
7507440|NCT02343939|11835433|FG008|Overall Study|Death|1
7507441|NCT02343939|11835425|FG000|Overall Study|Study terminated by sponsor|0
7507442|NCT02343939|11835426|FG001|Overall Study|Study terminated by sponsor|27
7507443|NCT02343939|11835427|FG002|Overall Study|Study terminated by sponsor|0
7507444|NCT02343939|11835428|FG003|Overall Study|Study terminated by sponsor|1
7507445|NCT02343939|11835429|FG004|Overall Study|Study terminated by sponsor|1
7507446|NCT02343939|11835430|FG005|Overall Study|Study terminated by sponsor|5
7507447|NCT02343939|11835431|FG006|Overall Study|Study terminated by sponsor|3
7507448|NCT02343939|11835432|FG007|Overall Study|Study terminated by sponsor|4
7507449|NCT02343939|11835433|FG008|Overall Study|Study terminated by sponsor|0
7507450|NCT02343939|11835425|FG000|Overall Study|Withdrew consent|3
7507451|NCT02343939|11835426|FG001|Overall Study|Withdrew consent|6
7507452|NCT02343939|11835427|FG002|Overall Study|Withdrew consent|1
7507453|NCT02343939|11835428|FG003|Overall Study|Withdrew consent|2
7507454|NCT02343939|11835429|FG004|Overall Study|Withdrew consent|2
7507455|NCT02343939|11835430|FG005|Overall Study|Withdrew consent|0
7507456|NCT02343939|11835431|FG006|Overall Study|Withdrew consent|0
7507457|NCT02343939|11835432|FG007|Overall Study|Withdrew consent|8
7507458|NCT02343939|11835433|FG008|Overall Study|Withdrew consent|6
7507459|NCT02343939|11835425|FG000|Overall Study|Treatment failure|0
7507460|NCT02343939|11835426|FG001|Overall Study|Treatment failure|0
7507461|NCT02343939|11835427|FG002|Overall Study|Treatment failure|0
7507462|NCT02343939|11835428|FG003|Overall Study|Treatment failure|0
7507463|NCT02343939|11835429|FG004|Overall Study|Treatment failure|0
7507464|NCT02343939|11835430|FG005|Overall Study|Treatment failure|0
7507465|NCT02343939|11835431|FG006|Overall Study|Treatment failure|2
7507466|NCT02343939|11835432|FG007|Overall Study|Treatment failure|1
7507467|NCT02343939|11835433|FG008|Overall Study|Treatment failure|0
7507468|NCT02343939|11835425|FG000|Overall Study|Investigator's discretion|0
7507469|NCT02343939|11835426|FG001|Overall Study|Investigator's discretion|0
7507470|NCT02343939|11835427|FG002|Overall Study|Investigator's discretion|0
7507471|NCT02343939|11835428|FG003|Overall Study|Investigator's discretion|1
7507472|NCT02343939|11835429|FG004|Overall Study|Investigator's discretion|0
7507473|NCT02343939|11835430|FG005|Overall Study|Investigator's discretion|0
7507474|NCT02343939|11835431|FG006|Overall Study|Investigator's discretion|1
7507475|NCT02343939|11835432|FG007|Overall Study|Investigator's discretion|0
7507476|NCT02343939|11835433|FG008|Overall Study|Investigator's discretion|0
7507477|NCT02343939|11835425|FG000|Overall Study|Adverse Event|0
7507478|NCT02343939|11835426|FG001|Overall Study|Adverse Event|0
7507479|NCT02343939|11835427|FG002|Overall Study|Adverse Event|0
7507480|NCT02343939|11835428|FG003|Overall Study|Adverse Event|0
7507481|NCT02343939|11835429|FG004|Overall Study|Adverse Event|0
7507482|NCT02343939|11835430|FG005|Overall Study|Adverse Event|1
7507483|NCT02343939|11835431|FG006|Overall Study|Adverse Event|0
7507484|NCT02343939|11835432|FG007|Overall Study|Adverse Event|0
7507485|NCT02343939|11835433|FG008|Overall Study|Adverse Event|0
7507486|NCT02343939|11835425|FG000|Overall Study|Never Treated With ENTO|0
7507487|NCT02343939|11835426|FG001|Overall Study|Never Treated With ENTO|0
7507488|NCT02343939|11835427|FG002|Overall Study|Never Treated With ENTO|0
7507489|NCT02343939|11835428|FG003|Overall Study|Never Treated With ENTO|0
7507490|NCT02343939|11835429|FG004|Overall Study|Never Treated With ENTO|0
7507491|NCT02343939|11835430|FG005|Overall Study|Never Treated With ENTO|0
7507492|NCT02343939|11835431|FG006|Overall Study|Never Treated With ENTO|1
7507493|NCT02343939|11835432|FG007|Overall Study|Never Treated With ENTO|2
7507494|NCT02343939|11835433|FG008|Overall Study|Never Treated With ENTO|0
7507495|NCT02344004|11835469|FG000|Overall Study|Adverse Event|11
7507496|NCT02344004|11835470|FG001|Overall Study|Adverse Event|1
7507497|NCT02344004|11835469|FG000|Overall Study|Death|9
7507498|NCT02344004|11835470|FG001|Overall Study|Death|7
7507499|NCT02344004|11835469|FG000|Overall Study|Physician Decision|4
7507500|NCT02344004|11835470|FG001|Overall Study|Physician Decision|1
7507501|NCT02344004|11835469|FG000|Overall Study|Withdrawal by Subject|22
7507502|NCT02344004|11835470|FG001|Overall Study|Withdrawal by Subject|5
7507503|NCT02344004|11835469|FG000|Overall Study|Rescue Medication|2
7507504|NCT02344004|11835470|FG001|Overall Study|Rescue Medication|0
7507505|NCT02344004|11835469|FG000|Overall Study|Other Not Specified|12
7507506|NCT02344004|11835470|FG001|Overall Study|Other Not Specified|0
7507507|NCT02344004|11835469|FG000|Overall Study|Protocol Violation|1
7507508|NCT02344004|11835470|FG001|Overall Study|Protocol Violation|0
7507509|NCT02344173|11835477|FG000|Procedure|Ablation Procedure Not Performed|7
7507510|NCT02344173|11835477|FG000|12-month Visit|Death|8
7507511|NCT02344173|11835477|FG000|12-month Visit|Withdrawal by Subject|30
7507512|NCT02344173|11835477|FG000|12-month Visit|Lost to Follow-up|58
7507513|NCT02344342|11835537|FG000|Overall Study|Industry partner dropped out|11
7507514|NCT02344342|11835538|FG001|Overall Study|Industry partner dropped out|9
7507515|NCT02344342|11835539|FG002|Overall Study|Industry partner dropped out|14
7507516|NCT02344342|11835540|FG003|Overall Study|Industry partner dropped out|10
7507517|NCT02344576|11835571|FG000|Enrollment|Agreed to Medical Record Review Only|7
7507518|NCT02344576|11835572|FG001|Enrollment|Agreed to Medical Record Review Only|8
7507519|NCT02344576|11835573|FG002|Enrollment|Agreed to Medical Record Review Only|0
7507520|NCT02344576|11835574|FG003|Enrollment|Agreed to Medical Record Review Only|0
7507521|NCT02344576|11835571|FG000|1-Month Follow-Up|Death|13
7507522|NCT02344576|11835572|FG001|1-Month Follow-Up|Death|8
7507523|NCT02344576|11835573|FG002|1-Month Follow-Up|Death|0
7507524|NCT02344576|11835574|FG003|1-Month Follow-Up|Death|0
7507525|NCT02344576|11835571|FG000|1-Month Follow-Up|Withdrawal by Subject|3
7507526|NCT02344576|11835572|FG001|1-Month Follow-Up|Withdrawal by Subject|14
7507527|NCT02344576|11835573|FG002|1-Month Follow-Up|Withdrawal by Subject|8
7507528|NCT02344576|11835574|FG003|1-Month Follow-Up|Withdrawal by Subject|10
7507529|NCT02344576|11835571|FG000|1-Month Follow-Up|Lost to Follow-up|2
7507530|NCT02344576|11835572|FG001|1-Month Follow-Up|Lost to Follow-up|5
7507531|NCT02344576|11835573|FG002|1-Month Follow-Up|Lost to Follow-up|11
7507532|NCT02344576|11835574|FG003|1-Month Follow-Up|Lost to Follow-up|3
7507533|NCT02344576|11835571|FG000|6-Month Follow-Up|Death|14
7507534|NCT02344576|11835572|FG001|6-Month Follow-Up|Death|14
7507535|NCT02344576|11835573|FG002|6-Month Follow-Up|Death|0
7507536|NCT02344576|11835574|FG003|6-Month Follow-Up|Death|0
7507537|NCT02344576|11835571|FG000|6-Month Follow-Up|Withdrawal by Subject|1
7507538|NCT02344576|11835572|FG001|6-Month Follow-Up|Withdrawal by Subject|0
7507539|NCT02344576|11835573|FG002|6-Month Follow-Up|Withdrawal by Subject|1
7507540|NCT02344576|11835574|FG003|6-Month Follow-Up|Withdrawal by Subject|2
7507541|NCT02344576|11835571|FG000|6-Month Follow-Up|Lost to Follow-up|4
7507542|NCT02344576|11835572|FG001|6-Month Follow-Up|Lost to Follow-up|5
7507543|NCT02344576|11835573|FG002|6-Month Follow-Up|Lost to Follow-up|13
7507544|NCT02344576|11835574|FG003|6-Month Follow-Up|Lost to Follow-up|6
7507545|NCT02344745|11835597|FG000|Overall Study|Data collection sheets were lost|2
7507546|NCT02344745|11835598|FG001|Overall Study|Data collection sheets were lost|0
7507547|NCT02345161|11835617|FG000|Overall Study|Withdrawal by Subject|25
7507548|NCT02345161|11835618|FG001|Overall Study|Withdrawal by Subject|33
7507549|NCT02345161|11835617|FG000|Overall Study|Adverse Event|16
7507550|NCT02345161|11835618|FG001|Overall Study|Adverse Event|19
7507551|NCT02345161|11835617|FG000|Overall Study|Physician Decision|4
7507552|NCT02345161|11835618|FG001|Overall Study|Physician Decision|4
7507553|NCT02345161|11835617|FG000|Overall Study|Lost to Follow-up|0
7507554|NCT02345161|11835618|FG001|Overall Study|Lost to Follow-up|1
7507555|NCT02345226|11835631|FG000|Double-Blind Phase|Adverse Event|5
7507556|NCT02345226|11835632|FG001|Double-Blind Phase|Adverse Event|6
7507557|NCT02345226|11835631|FG000|Double-Blind Phase|Death|3
7507558|NCT02345226|11835632|FG001|Double-Blind Phase|Death|0
7507559|NCT02345226|11835631|FG000|Double-Blind Phase|Pregnancy|0
7507560|NCT02345226|11835632|FG001|Double-Blind Phase|Pregnancy|1
7507561|NCT02345226|11835631|FG000|Double-Blind Phase|Lack of Efficacy|1
7507562|NCT02345226|11835632|FG001|Double-Blind Phase|Lack of Efficacy|0
7507563|NCT02345226|11835631|FG000|Double-Blind Phase|Investigator's Discretion|4
7507564|NCT02345226|11835632|FG001|Double-Blind Phase|Investigator's Discretion|3
7507565|NCT02345226|11835631|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7507566|NCT02345226|11835632|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7507567|NCT02345226|11835631|FG000|Double-Blind Phase|Withdrew Consent|41
7507568|NCT02345226|11835632|FG001|Double-Blind Phase|Withdrew Consent|39
7507569|NCT02345226|11835631|FG000|Double-Blind Phase|Lost to Follow-up|12
7507570|NCT02345226|11835632|FG001|Double-Blind Phase|Lost to Follow-up|16
7507571|NCT02345226|11835631|FG000|Double-Blind Phase|Randomized but Never Treated|2
7507572|NCT02345226|11835632|FG001|Double-Blind Phase|Randomized but Never Treated|4
7507573|NCT02345226|11835631|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7507574|NCT02345226|11835632|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7507575|NCT02345252|11835642|FG000|Double-Blind Phase|Adverse Event|2
7507576|NCT02345252|11835643|FG001|Double-Blind Phase|Adverse Event|3
7507577|NCT02345252|11835642|FG000|Double-Blind Phase|Death|1
7507578|NCT02345252|11835643|FG001|Double-Blind Phase|Death|2
7507579|NCT02345252|11835642|FG000|Double-Blind Phase|Lack of Efficacy|1
7507580|NCT02345252|11835643|FG001|Double-Blind Phase|Lack of Efficacy|0
7507581|NCT02345252|11835642|FG000|Double-Blind Phase|Investigator's Discretion|4
7507582|NCT02345252|11835643|FG001|Double-Blind Phase|Investigator's Discretion|6
7507583|NCT02345252|11835642|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7507584|NCT02345252|11835643|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
7507585|NCT02345252|11835642|FG000|Double-Blind Phase|Protocol Violation|2
7507586|NCT02345252|11835643|FG001|Double-Blind Phase|Protocol Violation|1
7507587|NCT02345252|11835642|FG000|Double-Blind Phase|Withdrew Consent|21
7507588|NCT02345252|11835643|FG001|Double-Blind Phase|Withdrew Consent|23
7507589|NCT02345252|11835642|FG000|Double-Blind Phase|Lost to Follow-up|8
7507590|NCT02345252|11835643|FG001|Double-Blind Phase|Lost to Follow-up|10
7507591|NCT02345252|11835642|FG000|Double-Blind Phase|Randomized but Never Treated|0
7507592|NCT02345252|11835643|FG001|Double-Blind Phase|Randomized but Never Treated|2
7507593|NCT02345330|11835651|FG000|Overall Study|Death|1
7507594|NCT02345330|11835651|FG000|Overall Study|Progressive Disease|2
7507595|NCT02345434|11835657|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
7507596|NCT02345434|11835658|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
7507597|NCT02345512|11835673|FG000|Overall Study|Adverse Event|1
7507598|NCT02345512|11835673|FG000|Overall Study|Withdrawal by Subject|1
7507599|NCT02345811|11835695|FG000|First Intervention|Withdrawal by Subject|1
7507600|NCT02345811|11835696|FG001|First Intervention|Withdrawal by Subject|1
7507601|NCT02345889|11835708|FG000|Overall Study|Inadequate Bowel Prep|17
7507602|NCT02345889|11835709|FG001|Overall Study|Inadequate Bowel Prep|16
7507603|NCT02345889|11835710|FG002|Overall Study|Inadequate Bowel Prep|18
7507604|NCT02345889|11835711|FG003|Overall Study|Inadequate Bowel Prep|14
7507605|NCT02345889|11835708|FG000|Overall Study|Polyposis identified during procedure|1
7507606|NCT02345889|11835709|FG001|Overall Study|Polyposis identified during procedure|1
7507607|NCT02345889|11835710|FG002|Overall Study|Polyposis identified during procedure|0
7507608|NCT02345889|11835711|FG003|Overall Study|Polyposis identified during procedure|1
7507609|NCT02345889|11835708|FG000|Overall Study|Recognized ineligible post-randomization|1
7507610|NCT02345889|11835709|FG001|Overall Study|Recognized ineligible post-randomization|0
7507611|NCT02345889|11835710|FG002|Overall Study|Recognized ineligible post-randomization|2
7507612|NCT02345889|11835711|FG003|Overall Study|Recognized ineligible post-randomization|1
7507613|NCT02345889|11835708|FG000|Overall Study|Ulcerative Colitis identified|1
7507614|NCT02345889|11835709|FG001|Overall Study|Ulcerative Colitis identified|0
7507615|NCT02345889|11835710|FG002|Overall Study|Ulcerative Colitis identified|0
7507616|NCT02345889|11835711|FG003|Overall Study|Ulcerative Colitis identified|0
7507617|NCT02345889|11835708|FG000|Overall Study|Cecum not intubated|1
7507618|NCT02345889|11835709|FG001|Overall Study|Cecum not intubated|0
7507619|NCT02345889|11835710|FG002|Overall Study|Cecum not intubated|0
7507620|NCT02345889|11835711|FG003|Overall Study|Cecum not intubated|0
7507621|NCT02346136|11835723|FG000|Overall Study|Withdrawal by Subject|7
7507622|NCT02346136|11835724|FG001|Overall Study|Withdrawal by Subject|5
7507623|NCT02346136|11835723|FG000|Overall Study|Death|1
7507624|NCT02346136|11835724|FG001|Overall Study|Death|0
7507625|NCT02346136|11835723|FG000|Overall Study|Study termination|14
7507626|NCT02346136|11835724|FG001|Overall Study|Study termination|18
7507627|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
7507628|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
7507629|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
7507630|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
7507631|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
7507632|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
7507633|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
7507634|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
7507635|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
7507636|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
7507637|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
7507638|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
7507639|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
7507640|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
7507641|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
7507642|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
7507643|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
7507644|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
7507645|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
7507646|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
7507647|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
7508312|NCT02347098|11835856|FG000|Overall Study|Withdrawal by Subject|1
7507648|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
7507649|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
7507650|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
7507651|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507652|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
7507653|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507654|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507655|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507656|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507657|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507658|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507659|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507660|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507661|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507662|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507663|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507664|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507665|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507666|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507667|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507668|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507669|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507670|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507671|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507672|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507673|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507674|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
7507675|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507676|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
7507677|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507678|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507679|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507680|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507681|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507682|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507683|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507684|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507685|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507686|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507687|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507688|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507689|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507690|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507691|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507692|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507693|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507694|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507695|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507696|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507697|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
7507698|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
7535999|NCT02714569|11883867|FG000|Part B (Overall)|Withdrawal by Subject|0
7224647|NCT00057330|11433949|FG000|Overall Study|Lost to Follow-up|745
7507699|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7507700|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
7507701|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
7507702|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
7507703|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507704|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507705|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507706|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507707|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507708|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507709|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507710|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507711|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507712|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507713|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507714|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507715|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507716|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507717|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507718|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507719|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507720|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507721|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507722|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
7507723|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
7507724|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7507725|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
7507726|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
7507727|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507728|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507729|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507730|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507731|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507732|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507733|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507734|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507735|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507736|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507737|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507738|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507739|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507740|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507741|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507742|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507743|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507744|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507745|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507746|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
7507747|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
7507748|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
7507749|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
7507750|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
7507751|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
7507752|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
7507753|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
7507754|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
7507755|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
7507756|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
7507757|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
7507758|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
7507759|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
7507760|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
7507761|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
7507762|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
7507763|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
7507764|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
7507765|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
7536000|NCT02714569|11883868|FG001|Part B (Overall)|Withdrawal by Subject|0
7507766|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
7507767|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
7507768|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
7507769|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
7507770|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
7507771|NCT02346240|11835734|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507772|NCT02346240|11835735|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507773|NCT02346240|11835736|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
7507774|NCT02346240|11835737|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507775|NCT02346240|11835738|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507776|NCT02346240|11835739|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507777|NCT02346240|11835740|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507778|NCT02346240|11835741|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507779|NCT02346240|11835742|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507780|NCT02346240|11835743|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507781|NCT02346240|11835744|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507782|NCT02346240|11835745|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507783|NCT02346240|11835746|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507784|NCT02346240|11835747|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507785|NCT02346240|11835748|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507786|NCT02346240|11835749|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507787|NCT02346240|11835750|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507788|NCT02346240|11835751|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507789|NCT02346240|11835752|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507790|NCT02346240|11835753|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507791|NCT02346240|11835754|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507792|NCT02346240|11835755|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507793|NCT02346240|11835756|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507794|NCT02346240|11835757|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
7507795|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507796|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507797|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507798|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507799|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507800|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507801|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507802|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7507803|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7507804|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507805|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507806|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507807|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507808|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7507809|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
7507810|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
7507811|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
7507812|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507813|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507814|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507815|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507816|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507817|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507818|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
7507819|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507820|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507821|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507822|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507823|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507824|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507825|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507826|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507827|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507828|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507829|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507830|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507831|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507832|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
7507833|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507834|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
7507835|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507836|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507837|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507838|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507839|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507840|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507841|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507842|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
7507843|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507844|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507845|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507846|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507847|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507848|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507849|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507850|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507851|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507852|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507853|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507854|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507855|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507856|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507857|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
7507858|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507859|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507860|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507861|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507862|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507863|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507864|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507865|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507866|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
7507867|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507868|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507869|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507870|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507871|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507872|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507873|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507874|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507875|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507876|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507877|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507878|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7507879|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507880|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7507881|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
7507882|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
7507883|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
7507884|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507885|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507886|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507887|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507888|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507889|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507890|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
7507891|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507892|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507893|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507894|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507895|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507896|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507897|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507898|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507899|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507900|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507901|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507902|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507903|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507904|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7507905|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
7507906|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
7507907|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
7507908|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507909|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507910|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507911|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507912|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507913|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507914|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
7507915|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507916|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507917|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7508313|NCT02347098|11835857|FG001|Overall Study|Withdrawal by Subject|0
7507918|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507919|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507920|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507921|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
7507922|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507923|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507924|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507925|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507926|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507927|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507928|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507929|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507930|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507931|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507932|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507933|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507934|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507935|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507936|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507937|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507938|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
7507939|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507940|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507941|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507942|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507943|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507944|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507945|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507946|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507947|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7507948|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507949|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507950|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7507951|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507952|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7507953|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
7507954|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507955|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507956|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507957|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507958|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507959|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507960|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507961|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7536001|NCT02714569|11883869|FG002|Part B (Overall)|Withdrawal by Subject|0
7507962|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
7507963|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507964|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507965|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507966|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507967|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507968|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507969|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507970|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507971|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507972|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
7507973|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507974|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507975|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507976|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507977|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507978|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507979|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507980|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507981|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507982|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507983|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507984|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507985|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507986|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
7507987|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507988|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7317688|NCT00723957|11546667|FG001|Overall Study|Never received treatment|3
7507989|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507990|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507991|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507992|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507993|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507994|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507995|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507996|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507997|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
7507998|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7507999|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508000|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508001|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508002|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508003|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508004|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508005|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508006|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508007|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508008|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508009|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508010|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
7508011|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508012|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508013|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508014|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508015|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508016|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508017|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508018|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508019|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7536002|NCT02714569|11883870|FG003|Part B (Overall)|Withdrawal by Subject|0
7508020|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508021|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508022|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508023|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508024|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508025|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
7508026|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508027|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508028|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508029|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508030|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508031|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508032|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508033|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508034|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
7508035|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508036|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508037|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508038|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508039|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508040|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508041|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508042|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508043|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508044|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508045|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508046|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508047|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508048|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508049|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
7508050|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508051|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508052|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508053|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508054|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508055|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508056|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508057|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508058|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
7508059|NCT02346240|11835734|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508060|NCT02346240|11835735|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508061|NCT02346240|11835736|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508062|NCT02346240|11835737|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508063|NCT02346240|11835738|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508064|NCT02346240|11835739|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508065|NCT02346240|11835740|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508066|NCT02346240|11835741|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508067|NCT02346240|11835742|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508068|NCT02346240|11835743|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508069|NCT02346240|11835744|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508070|NCT02346240|11835745|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508071|NCT02346240|11835746|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508072|NCT02346240|11835747|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508073|NCT02346240|11835748|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
7508074|NCT02346240|11835749|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508075|NCT02346240|11835750|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508076|NCT02346240|11835751|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508077|NCT02346240|11835752|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508078|NCT02346240|11835753|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508079|NCT02346240|11835754|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508080|NCT02346240|11835755|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508081|NCT02346240|11835756|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508082|NCT02346240|11835757|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
7508083|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508084|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508085|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508086|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508087|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508088|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508089|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508090|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508091|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508092|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508093|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508094|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508095|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508096|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508097|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508098|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508099|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
7508100|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
7508101|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
7508102|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
7508103|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7508104|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
7508105|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7508106|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
7508107|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
7508108|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
7508109|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
7508110|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
7508111|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
7508112|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
7508113|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
7508114|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
7508115|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
7508116|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
7508117|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
7508118|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
7508119|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
7508120|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
7508121|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
7508122|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
7508123|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
7508124|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
7508125|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
7508126|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
7508127|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
7508128|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
7508129|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
7508130|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
7508131|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508132|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508133|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508134|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508135|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508136|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508137|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508138|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508139|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508140|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508141|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508142|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508143|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508144|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508145|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508146|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508147|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508148|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508149|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7508150|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508151|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508152|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
7508153|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508154|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
7508155|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508156|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508157|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508158|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508159|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508160|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508161|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508162|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508163|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508164|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508165|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508166|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508167|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508168|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508169|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508170|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508171|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508314|NCT02347098|11835856|FG000|Overall Study|Lost to Follow-up|2
7508172|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508173|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508174|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508175|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508176|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
7508177|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508178|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
7508179|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508180|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508181|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508182|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508183|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508184|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508185|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508186|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508187|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508188|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508189|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508190|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508191|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508192|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508193|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508194|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508195|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508196|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7508197|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
7508198|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
7508199|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
7508200|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7508201|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7508202|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
7508203|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508204|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508205|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508206|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508207|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508208|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508209|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508210|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508211|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508212|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508213|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508214|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508215|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508216|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508217|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508218|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508219|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508220|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508221|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
7508222|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7508223|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
7508224|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
7508225|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7508226|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
7508227|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508228|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508229|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508230|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508231|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508232|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508233|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508234|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508235|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508236|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508237|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508238|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508239|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508240|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508241|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508242|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508243|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508244|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508245|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7508246|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508247|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
7508248|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
7508249|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
7508250|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
7508251|NCT02346240|11835734|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508252|NCT02346240|11835735|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508253|NCT02346240|11835736|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508254|NCT02346240|11835737|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508255|NCT02346240|11835738|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508256|NCT02346240|11835739|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508257|NCT02346240|11835740|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508258|NCT02346240|11835741|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508259|NCT02346240|11835742|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508260|NCT02346240|11835743|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508261|NCT02346240|11835744|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508262|NCT02346240|11835745|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508263|NCT02346240|11835746|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508264|NCT02346240|11835747|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508265|NCT02346240|11835748|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508266|NCT02346240|11835749|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508267|NCT02346240|11835750|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508268|NCT02346240|11835751|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508269|NCT02346240|11835752|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
7508270|NCT02346240|11835753|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508271|NCT02346240|11835754|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508272|NCT02346240|11835755|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508273|NCT02346240|11835756|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508274|NCT02346240|11835757|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
7508275|NCT02346370|11835782|FG000|Overall Study|Not treated|1
7508276|NCT02346370|11835783|FG001|Overall Study|Not treated|0
7508277|NCT02346370|11835784|FG002|Overall Study|Not treated|0
7508278|NCT02346370|11835782|FG000|Overall Study|Withdrawal of consent|1
7508279|NCT02346370|11835783|FG001|Overall Study|Withdrawal of consent|0
7508280|NCT02346370|11835784|FG002|Overall Study|Withdrawal of consent|0
7508281|NCT02346370|11835782|FG000|Overall Study|Death|1
7508282|NCT02346370|11835783|FG001|Overall Study|Death|3
7508283|NCT02346370|11835784|FG002|Overall Study|Death|1
7508284|NCT02346370|11835782|FG000|Overall Study|Sponsor discontinued study|5
7508285|NCT02346370|11835783|FG001|Overall Study|Sponsor discontinued study|0
7508286|NCT02346370|11835784|FG002|Overall Study|Sponsor discontinued study|2
7508287|NCT02346370|11835782|FG000|Overall Study|Radiologic progression|0
7508288|NCT02346370|11835783|FG001|Overall Study|Radiologic progression|0
7508289|NCT02346370|11835784|FG002|Overall Study|Radiologic progression|1
7508290|NCT02346370|11835782|FG000|Overall Study|Physician Decision|0
7508291|NCT02346370|11835783|FG001|Overall Study|Physician Decision|1
7508292|NCT02346370|11835784|FG002|Overall Study|Physician Decision|0
7508293|NCT02346708|11835818|FG000|Overall Study|Adverse Event|2
7508294|NCT02346708|11835819|FG001|Overall Study|Adverse Event|0
7508295|NCT02346708|11835818|FG000|Overall Study|Protocol Violation|0
7508296|NCT02346708|11835819|FG001|Overall Study|Protocol Violation|1
7508297|NCT02346721|11835826|FG000|Overall Study|Withdrew Consent|3
7508298|NCT02346721|11835826|FG000|Overall Study|Lack of Efficacy|1
7508299|NCT02347072|11835840|FG000|Overall Study|Adverse Event|2
7508300|NCT02347072|11835840|FG000|Overall Study|Withdrawal by Subject|6
7508301|NCT02347072|11835840|FG000|Overall Study|Physician Decision|1
7508302|NCT02347072|11835840|FG000|Overall Study|Lost to Follow-up|2
7508303|NCT02347072|11835840|FG000|Overall Study|Protocol Violation|1
7508304|NCT02347072|11835840|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
7508305|NCT02347085|11835848|FG000|Overall Study|Adverse Event|2
7508306|NCT02347085|11835848|FG000|Overall Study|Lack of Efficacy|1
7508307|NCT02347085|11835848|FG000|Overall Study|Withdrawal by Subject|4
7508308|NCT02347085|11835848|FG000|Overall Study|Lost to Follow-up|1
7508309|NCT02347085|11835848|FG000|Overall Study|Protocol Criteria|2
7508310|NCT02347098|11835856|FG000|Overall Study|Death|1
7508311|NCT02347098|11835857|FG001|Overall Study|Death|0
7508315|NCT02347098|11835857|FG001|Overall Study|Lost to Follow-up|2
7508316|NCT02347098|11835856|FG000|Overall Study|Refuse Follow-up Visit|1
7508317|NCT02347098|11835857|FG001|Overall Study|Refuse Follow-up Visit|5
7508318|NCT02347098|11835856|FG000|Overall Study|no visit due to illness|2
7508319|NCT02347098|11835857|FG001|Overall Study|no visit due to illness|1
7508320|NCT02347176|11835876|FG000|Overall Study|Lost to Follow-up|2
7508321|NCT02347176|11835877|FG001|Overall Study|Lost to Follow-up|3
7508322|NCT02347176|11835878|FG002|Overall Study|Lost to Follow-up|1
7508323|NCT02347176|11835879|FG003|Overall Study|Lost to Follow-up|1
7508324|NCT02347176|11835876|FG000|Overall Study|Withdrawal by Subject|9
7508325|NCT02347176|11835877|FG001|Overall Study|Withdrawal by Subject|5
7508326|NCT02347176|11835878|FG002|Overall Study|Withdrawal by Subject|5
7508327|NCT02347176|11835879|FG003|Overall Study|Withdrawal by Subject|3
7508328|NCT02347176|11835876|FG000|Overall Study|Other|1
7508329|NCT02347176|11835877|FG001|Overall Study|Other|2
7508330|NCT02347176|11835878|FG002|Overall Study|Other|2
7508331|NCT02347176|11835879|FG003|Overall Study|Other|0
7508332|NCT02347189|11835889|FG000|Overall Study|No implant attempted of study device|9
7508333|NCT02347189|11835889|FG000|Overall Study|No primary outcome data available|2
7508334|NCT02347332|11835906|FG000|Overall Study|Not treated|5
7508335|NCT02347332|11835907|FG001|Overall Study|Not treated|2
7508336|NCT02347332|11835906|FG000|Overall Study|Progressive disease|141
7508337|NCT02347332|11835907|FG001|Overall Study|Progressive disease|159
7508338|NCT02347332|11835906|FG000|Overall Study|Adverse Event|50
7508339|NCT02347332|11835907|FG001|Overall Study|Adverse Event|41
7508340|NCT02347332|11835906|FG000|Overall Study|Death (Unknown, Various reasons)|6
7508341|NCT02347332|11835907|FG001|Overall Study|Death (Unknown, Various reasons)|6
7508342|NCT02347332|11835906|FG000|Overall Study|Protocol Violation|1
7508343|NCT02347332|11835907|FG001|Overall Study|Protocol Violation|1
7508344|NCT02347332|11835906|FG000|Overall Study|Lost to Follow-up|2
7508345|NCT02347332|11835907|FG001|Overall Study|Lost to Follow-up|1
7508346|NCT02347332|11835906|FG000|Overall Study|Physician Decision|4
7508347|NCT02347332|11835907|FG001|Overall Study|Physician Decision|3
7508348|NCT02347332|11835906|FG000|Overall Study|Withdrawal by Subject|20
7508349|NCT02347332|11835907|FG001|Overall Study|Withdrawal by Subject|14
7508350|NCT02347332|11835906|FG000|Overall Study|Protocol requirement|1
7508351|NCT02347332|11835907|FG001|Overall Study|Protocol requirement|1
7508352|NCT02347332|11835906|FG000|Overall Study|Switch Post-Trial program|0
7508353|NCT02347332|11835907|FG001|Overall Study|Switch Post-Trial program|1
7508354|NCT02347631|11835966|FG000|First Intervention (2 Months)|Adverse Event|1
7508355|NCT02347631|11835967|FG001|First Intervention (2 Months)|Adverse Event|1
7508356|NCT02347631|11835966|FG000|First Intervention (2 Months)|Pregnancy|1
7508357|NCT02347631|11835967|FG001|First Intervention (2 Months)|Pregnancy|0
7508358|NCT02347631|11835966|FG000|First Intervention (2 Months)|Moved out of area|0
7508359|NCT02347631|11835967|FG001|First Intervention (2 Months)|Moved out of area|2
7508360|NCT02347631|11835966|FG000|First Intervention (2 Months)|Lost to Follow-up|5
7508361|NCT02347631|11835967|FG001|First Intervention (2 Months)|Lost to Follow-up|3
7508362|NCT02347631|11835966|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
7508363|NCT02347631|11835967|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
7508364|NCT02347631|11835966|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
7508365|NCT02347631|11835967|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
7508366|NCT02347631|11835966|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
7508367|NCT02347631|11835967|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
7508368|NCT02347631|11835966|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
7508369|NCT02347631|11835967|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
7508370|NCT02347657|11835977|FG000|Overall Study|Physician Decision|0
7508371|NCT02347657|11835978|FG001|Overall Study|Physician Decision|1
7508372|NCT02347657|11835977|FG000|Overall Study|Adverse Event|8
7508373|NCT02347657|11835978|FG001|Overall Study|Adverse Event|4
7508374|NCT02347657|11835977|FG000|Overall Study|Withdrawal by Subject|6
7508375|NCT02347657|11835978|FG001|Overall Study|Withdrawal by Subject|7
7508376|NCT02347657|11835977|FG000|Overall Study|Randomized but not treated|1
7508377|NCT02347657|11835978|FG001|Overall Study|Randomized but not treated|0
7508378|NCT02347657|11835977|FG000|Overall Study|Other|3
7508379|NCT02347657|11835978|FG001|Overall Study|Other|3
7508380|NCT02347761|11835988|FG000|All Collected|Death|1
7508381|NCT02347761|11835989|FG001|All Collected|Death|0
7508382|NCT02347761|11835990|FG002|All Collected|Death|0
7508383|NCT02347761|11835988|FG000|All Collected|Lost to Follow-up|3
7508384|NCT02347761|11835989|FG001|All Collected|Lost to Follow-up|2
7508385|NCT02347761|11835990|FG002|All Collected|Lost to Follow-up|3
7508386|NCT02347761|11835988|FG000|All Collected|Withdrawal by Subject|11
7508387|NCT02347761|11835989|FG001|All Collected|Withdrawal by Subject|11
7508388|NCT02347761|11835990|FG002|All Collected|Withdrawal by Subject|22
7508389|NCT02347761|11835988|FG000|All Collected|invetigator disretion|2
7508390|NCT02347761|11835989|FG001|All Collected|invetigator disretion|0
7508391|NCT02347761|11835990|FG002|All Collected|invetigator disretion|0
7508392|NCT02347761|11835988|FG000|All Collected|instillation site pain|0
7508393|NCT02347761|11835989|FG001|All Collected|instillation site pain|0
7508394|NCT02347761|11835990|FG002|All Collected|instillation site pain|1
7508395|NCT02347761|11835988|FG000|All Collected|exacerbation of COPD|0
7508396|NCT02347761|11835989|FG001|All Collected|exacerbation of COPD|0
7508397|NCT02347761|11835990|FG002|All Collected|exacerbation of COPD|1
7508398|NCT02347761|11835988|FG000|All Collected|moved/travel|0
7508399|NCT02347761|11835989|FG001|All Collected|moved/travel|1
7508400|NCT02347761|11835990|FG002|All Collected|moved/travel|0
7508401|NCT02347761|11835988|FG000|On Study Treatment|Lack of Efficacy|2
7508402|NCT02347761|11835989|FG001|On Study Treatment|Lack of Efficacy|3
7508403|NCT02347761|11835990|FG002|On Study Treatment|Lack of Efficacy|4
7508404|NCT02347761|11835988|FG000|On Study Treatment|non-compliance with study medication|0
7508405|NCT02347761|11835989|FG001|On Study Treatment|non-compliance with study medication|0
7508406|NCT02347761|11835990|FG002|On Study Treatment|non-compliance with study medication|2
7508407|NCT02347761|11835988|FG000|On Study Treatment|Withdrawal by Subject|7
7508408|NCT02347761|11835989|FG001|On Study Treatment|Withdrawal by Subject|3
7508409|NCT02347761|11835990|FG002|On Study Treatment|Withdrawal by Subject|5
7508410|NCT02347761|11835988|FG000|On Study Treatment|move/travel|2
7508411|NCT02347761|11835989|FG001|On Study Treatment|move/travel|6
7508412|NCT02347761|11835990|FG002|On Study Treatment|move/travel|5
7508413|NCT02347761|11835988|FG000|On Study Treatment|dissastisfaction with device|2
7508414|NCT02347761|11835989|FG001|On Study Treatment|dissastisfaction with device|1
7508415|NCT02347761|11835990|FG002|On Study Treatment|dissastisfaction with device|4
7508416|NCT02347761|11835988|FG000|On Study Treatment|Lost to Follow-up|2
7508417|NCT02347761|11835989|FG001|On Study Treatment|Lost to Follow-up|1
7508418|NCT02347761|11835990|FG002|On Study Treatment|Lost to Follow-up|1
7508419|NCT02347761|11835988|FG000|On Study Treatment|investigator discretion|2
7508420|NCT02347761|11835989|FG001|On Study Treatment|investigator discretion|0
7508421|NCT02347761|11835990|FG002|On Study Treatment|investigator discretion|0
7508422|NCT02347761|11835988|FG000|On Study Treatment|durg not working|0
7508423|NCT02347761|11835989|FG001|On Study Treatment|durg not working|1
7508424|NCT02347761|11835990|FG002|On Study Treatment|durg not working|1
7508425|NCT02347761|11835988|FG000|On Study Treatment|Adverse Event|10
7508426|NCT02347761|11835989|FG001|On Study Treatment|Adverse Event|8
7508427|NCT02347761|11835990|FG002|On Study Treatment|Adverse Event|20
7508428|NCT02347774|11836001|FG000|Study Participation|Lost to Follow-up|3
7508429|NCT02347774|11836002|FG001|Study Participation|Lost to Follow-up|6
7508430|NCT02347774|11836003|FG002|Study Participation|Lost to Follow-up|2
7508431|NCT02347774|11836001|FG000|Study Participation|Withdrawal by Subject|8
7508432|NCT02347774|11836002|FG001|Study Participation|Withdrawal by Subject|9
7508433|NCT02347774|11836003|FG002|Study Participation|Withdrawal by Subject|15
7508434|NCT02347774|11836001|FG000|Study Participation|Adverse Event|1
7508435|NCT02347774|11836002|FG001|Study Participation|Adverse Event|4
7508436|NCT02347774|11836003|FG002|Study Participation|Adverse Event|6
7508437|NCT02347774|11836001|FG000|Study Participation|withdrew consent|1
7508438|NCT02347774|11836002|FG001|Study Participation|withdrew consent|1
7508439|NCT02347774|11836003|FG002|Study Participation|withdrew consent|1
7508440|NCT02347774|11836001|FG000|Study Participation|Met Prolonged QT criteria|1
7508441|NCT02347774|11836002|FG001|Study Participation|Met Prolonged QT criteria|0
7508442|NCT02347774|11836003|FG002|Study Participation|Met Prolonged QT criteria|0
7508443|NCT02347774|11836001|FG000|Study Participation|non-compliance with study drug|0
7508444|NCT02347774|11836002|FG001|Study Participation|non-compliance with study drug|1
7508445|NCT02347774|11836003|FG002|Study Participation|non-compliance with study drug|0
7508446|NCT02347774|11836001|FG000|Study Participation|incarceration|1
7508447|NCT02347774|11836002|FG001|Study Participation|incarceration|0
7508448|NCT02347774|11836003|FG002|Study Participation|incarceration|0
7508449|NCT02347774|11836001|FG000|Study Participation|randomized in error|0
7508450|NCT02347774|11836002|FG001|Study Participation|randomized in error|0
7508451|NCT02347774|11836003|FG002|Study Participation|randomized in error|1
7508452|NCT02347774|11836001|FG000|On Study Treatment|Adverse Event|9
7508453|NCT02347774|11836002|FG001|On Study Treatment|Adverse Event|15
7508454|NCT02347774|11836003|FG002|On Study Treatment|Adverse Event|19
7508455|NCT02347774|11836001|FG000|On Study Treatment|Lack of Efficacy|3
7508456|NCT02347774|11836002|FG001|On Study Treatment|Lack of Efficacy|0
7508457|NCT02347774|11836003|FG002|On Study Treatment|Lack of Efficacy|2
7508458|NCT02347774|11836001|FG000|On Study Treatment|non-complicance with study medication|0
7508459|NCT02347774|11836002|FG001|On Study Treatment|non-complicance with study medication|2
7508460|NCT02347774|11836003|FG002|On Study Treatment|non-complicance with study medication|0
7508461|NCT02347774|11836001|FG000|On Study Treatment|Protocol Violation|0
7508462|NCT02347774|11836002|FG001|On Study Treatment|Protocol Violation|0
7508463|NCT02347774|11836003|FG002|On Study Treatment|Protocol Violation|1
7508464|NCT02347774|11836001|FG000|On Study Treatment|withdrew consent|9
7508465|NCT02347774|11836002|FG001|On Study Treatment|withdrew consent|8
7508466|NCT02347774|11836003|FG002|On Study Treatment|withdrew consent|12
7508467|NCT02347774|11836001|FG000|On Study Treatment|Lost to Follow-up|2
7508468|NCT02347774|11836002|FG001|On Study Treatment|Lost to Follow-up|6
7508469|NCT02347774|11836003|FG002|On Study Treatment|Lost to Follow-up|1
7508470|NCT02347774|11836001|FG000|On Study Treatment|Met Prolonged QT criteria|1
7508471|NCT02347774|11836002|FG001|On Study Treatment|Met Prolonged QT criteria|0
7508472|NCT02347774|11836003|FG002|On Study Treatment|Met Prolonged QT criteria|0
7508473|NCT02347774|11836001|FG000|On Study Treatment|ranomized in error|0
7508474|NCT02347774|11836002|FG001|On Study Treatment|ranomized in error|0
7508475|NCT02347774|11836003|FG002|On Study Treatment|ranomized in error|1
7536003|NCT02714569|11883871|FG004|Part B (Overall)|Withdrawal by Subject|0
7536004|NCT02714569|11883872|FG005|Part B (Overall)|Withdrawal by Subject|0
7536005|NCT02714569|11883873|FG006|Part B (Overall)|Withdrawal by Subject|0
7536006|NCT02714569|11883874|FG007|Part B (Overall)|Withdrawal by Subject|1
7536007|NCT02714569|11883875|FG008|Part B (Overall)|Withdrawal by Subject|0
7536008|NCT02714569|11883876|FG009|Part B (Overall)|Withdrawal by Subject|1
7536009|NCT02714569|11883877|FG010|Part B (Overall)|Withdrawal by Subject|0
7536010|NCT02714569|11883867|FG000|Part B (Overall)|Adverse Event|0
7536011|NCT02714569|11883868|FG001|Part B (Overall)|Adverse Event|0
7536012|NCT02714569|11883869|FG002|Part B (Overall)|Adverse Event|0
7536013|NCT02714569|11883870|FG003|Part B (Overall)|Adverse Event|0
7536014|NCT02714569|11883871|FG004|Part B (Overall)|Adverse Event|0
7536015|NCT02714569|11883872|FG005|Part B (Overall)|Adverse Event|0
7536016|NCT02714569|11883873|FG006|Part B (Overall)|Adverse Event|0
7536017|NCT02714569|11883874|FG007|Part B (Overall)|Adverse Event|0
7536018|NCT02714569|11883875|FG008|Part B (Overall)|Adverse Event|0
7536019|NCT02714569|11883876|FG009|Part B (Overall)|Adverse Event|1
7536020|NCT02714569|11883877|FG010|Part B (Overall)|Adverse Event|0
7536021|NCT02714595|11883939|FG000|Overall Study|Lost to Follow-up|1
7536022|NCT02714595|11883940|FG001|Overall Study|Lost to Follow-up|0
7536023|NCT02714595|11883939|FG000|Overall Study|Withdrawal by Subject|1
7536024|NCT02714595|11883940|FG001|Overall Study|Withdrawal by Subject|2
7536025|NCT02714595|11883939|FG000|Overall Study|Lack of Efficacy|0
7536026|NCT02714595|11883940|FG001|Overall Study|Lack of Efficacy|1
7536027|NCT02714595|11883939|FG000|Overall Study|Death|30
7536028|NCT02714595|11883940|FG001|Overall Study|Death|9
7536029|NCT02714595|11883939|FG000|Overall Study|Other-Miscellaneous|0
7536030|NCT02714595|11883940|FG001|Overall Study|Other-Miscellaneous|1
7536031|NCT02714868|11883966|FG000|Overall Study|Withdrawal by Subject|3
7536032|NCT02714868|11883967|FG001|Overall Study|Withdrawal by Subject|0
7536033|NCT02714868|11883966|FG000|Overall Study|PI withdrawal safety risk self/others|1
7536034|NCT02714868|11883967|FG001|Overall Study|PI withdrawal safety risk self/others|0
7536035|NCT02714868|11883966|FG000|Overall Study|PI withdraw did not meet inclusion|1
7536036|NCT02714868|11883967|FG001|Overall Study|PI withdraw did not meet inclusion|0
7536037|NCT02715258|11884001|FG000|Overall Study|Withdrawal by Subject|6
7536038|NCT02715258|11884002|FG001|Overall Study|Withdrawal by Subject|1
7536039|NCT02715258|11884001|FG000|Overall Study|Lost to Follow-up|7
7536040|NCT02715258|11884002|FG001|Overall Study|Lost to Follow-up|1
7536041|NCT02715258|11884001|FG000|Overall Study|Terminated by Sponsor|0
7536042|NCT02715258|11884002|FG001|Overall Study|Terminated by Sponsor|1
7536043|NCT02715258|11884001|FG000|Overall Study|Death|0
7536044|NCT02715258|11884002|FG001|Overall Study|Death|1
7536045|NCT02715258|11884001|FG000|Overall Study|Subject non-compliant|1
7536046|NCT02715258|11884002|FG001|Overall Study|Subject non-compliant|1
7536047|NCT02715258|11884001|FG000|Overall Study|GCP violation|2
7536048|NCT02715258|11884002|FG001|Overall Study|GCP violation|1
7536049|NCT02715726|11884018|FG000|Overall Study|Adverse Event|2
7536050|NCT02715726|11884019|FG001|Overall Study|Adverse Event|6
7536051|NCT02715726|11884018|FG000|Overall Study|Protocol Violation|1
7536052|NCT02715726|11884019|FG001|Overall Study|Protocol Violation|0
7536053|NCT02715726|11884018|FG000|Overall Study|Death|2
7536054|NCT02715726|11884019|FG001|Overall Study|Death|1
7536055|NCT02715726|11884018|FG000|Overall Study|Participant moved|1
7536056|NCT02715726|11884019|FG001|Overall Study|Participant moved|3
7508476|NCT02347787|11836013|FG000|6 Month Follow-Up|Lost to Follow-up|63
7508477|NCT02347787|11836014|FG001|6 Month Follow-Up|Lost to Follow-up|47
7508478|NCT02347787|11836013|FG000|6 Month Follow-Up|Withdrawal by Subject|3
7508479|NCT02347787|11836014|FG001|6 Month Follow-Up|Withdrawal by Subject|9
7508480|NCT02347787|11836013|FG000|9 Month Follow-Up|Lost to Follow-up|52
7508481|NCT02347787|11836014|FG001|9 Month Follow-Up|Lost to Follow-up|59
7508482|NCT02347787|11836013|FG000|9 Month Follow-Up|Withdrawal by Subject|9
7508483|NCT02347787|11836014|FG001|9 Month Follow-Up|Withdrawal by Subject|12
7508484|NCT02347813|11836027|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
7508485|NCT02347813|11836028|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
7508486|NCT02347813|11836027|FG000|First Intervention, 24 Weeks|Adverse Event|1
7508487|NCT02347813|11836028|FG001|First Intervention, 24 Weeks|Adverse Event|1
7508500|NCT02348489|11836057|FG000|Overall Study|Death|336
7508501|NCT02348489|11836058|FG001|Overall Study|Death|335
7508502|NCT02348489|11836057|FG000|Overall Study|Withdrawal by Subject|14
7508503|NCT02348489|11836058|FG001|Overall Study|Withdrawal by Subject|27
7508504|NCT02348489|11836057|FG000|Overall Study|Lost to Follow-up|3
7508505|NCT02348489|11836058|FG001|Overall Study|Lost to Follow-up|5
7508506|NCT02348723|11836131|FG000|Overall Study|No ablation|21
7508507|NCT02348723|11836132|FG001|Overall Study|No ablation|20
7508508|NCT02348723|11836131|FG000|Overall Study|Non-compliant with Protocol|1
7508509|NCT02348723|11836132|FG001|Overall Study|Non-compliant with Protocol|0
7508510|NCT02348723|11836131|FG000|Overall Study|Lost to Follow-up|1
7508511|NCT02348723|11836132|FG001|Overall Study|Lost to Follow-up|1
7508512|NCT02348723|11836131|FG000|Overall Study|Consent withdrawn|1
7508513|NCT02348723|11836132|FG001|Overall Study|Consent withdrawn|3
7508514|NCT02348723|11836131|FG000|Overall Study|Reason other than specified|1
7508515|NCT02348723|11836132|FG001|Overall Study|Reason other than specified|1
7508516|NCT02348723|11836131|FG000|Overall Study|Adverse Event|3
7508517|NCT02348723|11836132|FG001|Overall Study|Adverse Event|1
7508518|NCT02348840|11836151|FG000|Overall Study|Withdrawal by Subject|2
7508519|NCT02348840|11836152|FG001|Overall Study|Withdrawal by Subject|1
7508520|NCT02348840|11836153|FG002|Overall Study|Withdrawal by Subject|0
7508521|NCT02348840|11836154|FG003|Overall Study|Withdrawal by Subject|0
7508522|NCT02349048|11836203|FG000|Overall Study|Withdrawal by Subject|4
7508523|NCT02349048|11836204|FG001|Overall Study|Withdrawal by Subject|0
7508524|NCT02349048|11836203|FG000|Overall Study|Lost to Follow-up|1
7508525|NCT02349048|11836204|FG001|Overall Study|Lost to Follow-up|0
7508526|NCT02349061|11836212|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
7508527|NCT02349061|11836213|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
7508528|NCT02349061|11836214|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
7508529|NCT02349061|11836212|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
7508530|NCT02349061|11836213|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7508531|NCT02349061|11836214|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
7508532|NCT02349061|11836212|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
7508533|NCT02349061|11836213|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
7508534|NCT02349061|11836214|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
7508535|NCT02349061|11836212|FG000|Main Study: PCP (Up to Week 24)|Other|1
7508536|NCT02349061|11836213|FG001|Main Study: PCP (Up to Week 24)|Other|1
7508537|NCT02349061|11836214|FG002|Main Study: PCP (Up to Week 24)|Other|0
7508538|NCT02349061|11836212|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
7508539|NCT02349061|11836213|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7508540|NCT02349061|11836214|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
7508541|NCT02349061|11836212|FG000|Main Study: Week 24 to 56|Adverse Event|0
7508542|NCT02349061|11836213|FG001|Main Study: Week 24 to 56|Adverse Event|2
7508543|NCT02349061|11836214|FG002|Main Study: Week 24 to 56|Adverse Event|1
7508544|NCT02349061|11836212|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
7508545|NCT02349061|11836213|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
7508546|NCT02349061|11836214|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
7508547|NCT02349061|11836212|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
7508548|NCT02349061|11836213|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
7508549|NCT02349061|11836214|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
7508550|NCT02349061|11836212|FG000|Main Study: Week 24 to 56|Physician Decision|0
7508551|NCT02349061|11836213|FG001|Main Study: Week 24 to 56|Physician Decision|0
7508552|NCT02349061|11836214|FG002|Main Study: Week 24 to 56|Physician Decision|1
7508553|NCT02349061|11836212|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
7508554|NCT02349061|11836213|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
7508555|NCT02349061|11836214|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
7508556|NCT02349061|11836212|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7508557|NCT02349061|11836213|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
7508558|NCT02349061|11836214|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
7508559|NCT02349061|11836212|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
7508560|NCT02349061|11836213|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
7508561|NCT02349061|11836214|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
7508562|NCT02349061|11836212|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
7508563|NCT02349061|11836213|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
7508564|NCT02349061|11836214|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
7508565|NCT02349295|11836240|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
7508566|NCT02349295|11836241|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
7508567|NCT02349295|11836242|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
7508568|NCT02349295|11836243|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508569|NCT02349295|11836244|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508570|NCT02349295|11836245|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508571|NCT02349295|11836246|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508572|NCT02349295|11836247|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508573|NCT02349295|11836248|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508574|NCT02349295|11836249|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508575|NCT02349295|11836250|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508576|NCT02349295|11836251|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508577|NCT02349295|11836252|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508578|NCT02349295|11836253|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
7508579|NCT02349295|11836240|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
7508580|NCT02349295|11836241|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
7508581|NCT02349295|11836242|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
7508582|NCT02349295|11836243|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508583|NCT02349295|11836244|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7509038|NCT02352493|11836792|FG004|Overall Study|Lost to Follow-up|0
7508584|NCT02349295|11836245|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508585|NCT02349295|11836246|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508586|NCT02349295|11836247|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508587|NCT02349295|11836248|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508588|NCT02349295|11836249|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508589|NCT02349295|11836250|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508590|NCT02349295|11836251|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508591|NCT02349295|11836252|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508592|NCT02349295|11836253|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
7508593|NCT02349295|11836240|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7508594|NCT02349295|11836241|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
7508595|NCT02349295|11836242|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
7508596|NCT02349295|11836243|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508597|NCT02349295|11836244|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508598|NCT02349295|11836245|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508599|NCT02349295|11836246|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508600|NCT02349295|11836247|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508601|NCT02349295|11836248|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508602|NCT02349295|11836249|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508603|NCT02349295|11836250|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508604|NCT02349295|11836251|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508605|NCT02349295|11836252|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508606|NCT02349295|11836253|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
7508607|NCT02349295|11836240|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7508608|NCT02349295|11836241|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
7508609|NCT02349295|11836242|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
7508610|NCT02349295|11836243|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508611|NCT02349295|11836244|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508612|NCT02349295|11836245|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508613|NCT02349295|11836246|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508614|NCT02349295|11836247|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508615|NCT02349295|11836248|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508616|NCT02349295|11836249|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508617|NCT02349295|11836250|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508618|NCT02349295|11836251|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508619|NCT02349295|11836252|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508620|NCT02349295|11836253|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
7508621|NCT02349295|11836240|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508622|NCT02349295|11836241|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7508623|NCT02349295|11836242|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
7508624|NCT02349295|11836243|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508625|NCT02349295|11836244|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508626|NCT02349295|11836245|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508627|NCT02349295|11836246|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508628|NCT02349295|11836247|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508629|NCT02349295|11836248|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508630|NCT02349295|11836249|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508631|NCT02349295|11836250|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508632|NCT02349295|11836251|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508633|NCT02349295|11836252|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508634|NCT02349295|11836253|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
7508635|NCT02349295|11836240|FG000|IR (Week 16-24)|Lack of Efficacy|0
7508636|NCT02349295|11836241|FG001|IR (Week 16-24)|Lack of Efficacy|0
7508637|NCT02349295|11836242|FG002|IR (Week 16-24)|Lack of Efficacy|0
7508638|NCT02349295|11836243|FG003|IR (Week 16-24)|Lack of Efficacy|1
7508639|NCT02349295|11836244|FG004|IR (Week 16-24)|Lack of Efficacy|0
7508640|NCT02349295|11836245|FG005|IR (Week 16-24)|Lack of Efficacy|0
7508641|NCT02349295|11836246|FG006|IR (Week 16-24)|Lack of Efficacy|0
7508642|NCT02349295|11836247|FG007|IR (Week 16-24)|Lack of Efficacy|0
7508643|NCT02349295|11836248|FG008|IR (Week 16-24)|Lack of Efficacy|0
7508644|NCT02349295|11836249|FG009|IR (Week 16-24)|Lack of Efficacy|0
7508645|NCT02349295|11836250|FG010|IR (Week 16-24)|Lack of Efficacy|0
7508646|NCT02349295|11836251|FG011|IR (Week 16-24)|Lack of Efficacy|0
7508647|NCT02349295|11836252|FG012|IR (Week 16-24)|Lack of Efficacy|0
7508648|NCT02349295|11836253|FG013|IR (Week 16-24)|Lack of Efficacy|0
7508649|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508650|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508651|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508652|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508653|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508654|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508655|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508656|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
7508657|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
7508658|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
7508659|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
7508660|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508661|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508662|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
7508663|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508664|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508665|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508666|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508667|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508668|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508669|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508670|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7508671|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
7508672|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7508673|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
7508674|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508675|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508676|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
7508677|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508678|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508679|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508680|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508681|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508682|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508683|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508684|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
7508685|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508686|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
7508687|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508688|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508689|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508690|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
7508691|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Death|0
7508692|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Death|0
7508693|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Death|0
7508694|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Death|0
7508695|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Death|0
7508696|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Death|0
7508697|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Death|0
7508698|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Death|1
7508699|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Death|1
7508700|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Death|1
7508701|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Death|0
7508702|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Death|0
7508703|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Death|0
7508704|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Death|0
7508705|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508706|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508707|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508708|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508709|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508710|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508711|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508712|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
7508713|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
7508714|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
7508715|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
7508716|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508717|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508718|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
7508719|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508720|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508721|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508722|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508723|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508724|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7509039|NCT02352493|11836793|FG005|Overall Study|Lost to Follow-up|0
7508725|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508726|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7508727|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
7508728|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508729|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508730|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508731|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508732|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
7508733|NCT02349295|11836240|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508734|NCT02349295|11836241|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508735|NCT02349295|11836242|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508736|NCT02349295|11836243|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508737|NCT02349295|11836244|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508738|NCT02349295|11836245|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508739|NCT02349295|11836246|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508740|NCT02349295|11836247|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7508741|NCT02349295|11836248|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
7508742|NCT02349295|11836249|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508743|NCT02349295|11836250|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508744|NCT02349295|11836251|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508745|NCT02349295|11836252|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508746|NCT02349295|11836253|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
7508747|NCT02349295|11836240|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508748|NCT02349295|11836241|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508749|NCT02349295|11836242|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508750|NCT02349295|11836243|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508751|NCT02349295|11836244|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508752|NCT02349295|11836245|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508753|NCT02349295|11836246|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508754|NCT02349295|11836247|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508755|NCT02349295|11836248|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508756|NCT02349295|11836249|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508757|NCT02349295|11836250|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
7508758|NCT02349295|11836251|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7508759|NCT02349295|11836252|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
7508760|NCT02349295|11836253|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
7508761|NCT02349295|11836240|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508762|NCT02349295|11836241|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508763|NCT02349295|11836242|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508764|NCT02349295|11836243|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508765|NCT02349295|11836244|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508766|NCT02349295|11836245|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508767|NCT02349295|11836246|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508768|NCT02349295|11836247|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508769|NCT02349295|11836248|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508770|NCT02349295|11836249|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508771|NCT02349295|11836250|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508772|NCT02349295|11836251|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
7508773|NCT02349295|11836252|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
7508774|NCT02349295|11836253|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
7508775|NCT02349295|11836240|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508776|NCT02349295|11836241|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508777|NCT02349295|11836242|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508778|NCT02349295|11836243|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508779|NCT02349295|11836244|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508780|NCT02349295|11836245|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508781|NCT02349295|11836246|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508782|NCT02349295|11836247|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508783|NCT02349295|11836248|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508784|NCT02349295|11836249|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508785|NCT02349295|11836250|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508786|NCT02349295|11836251|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7508787|NCT02349295|11836252|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
7508788|NCT02349295|11836253|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
7508789|NCT02349295|11836240|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508790|NCT02349295|11836241|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508791|NCT02349295|11836242|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7509040|NCT02352493|11836794|FG006|Overall Study|Lost to Follow-up|0
7508792|NCT02349295|11836243|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508793|NCT02349295|11836244|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508794|NCT02349295|11836245|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508795|NCT02349295|11836246|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508796|NCT02349295|11836247|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508797|NCT02349295|11836248|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508798|NCT02349295|11836249|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508799|NCT02349295|11836250|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508800|NCT02349295|11836251|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
7508801|NCT02349295|11836252|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508802|NCT02349295|11836253|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
7508803|NCT02349295|11836240|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508804|NCT02349295|11836241|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508805|NCT02349295|11836242|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508806|NCT02349295|11836243|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508807|NCT02349295|11836244|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508808|NCT02349295|11836245|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508809|NCT02349295|11836246|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508810|NCT02349295|11836247|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508811|NCT02349295|11836248|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508812|NCT02349295|11836249|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508813|NCT02349295|11836250|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508814|NCT02349295|11836251|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
7508815|NCT02349295|11836252|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508816|NCT02349295|11836253|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
7508817|NCT02349360|11836280|FG000|Overall Study|Withdrawal by Subject|0
7508818|NCT02349360|11836281|FG001|Overall Study|Withdrawal by Subject|1
7508819|NCT02349412|11836289|FG000|Overall Study|Withdrawal by Subject|7
7508820|NCT02349412|11836290|FG001|Overall Study|Withdrawal by Subject|7
7508821|NCT02349425|11836300|FG000|Period 1|Adverse Event|1
7508822|NCT02349425|11836301|FG001|Period 1|Adverse Event|1
7508823|NCT02349425|11836302|FG002|Period 1|Adverse Event|0
7508824|NCT02349425|11836303|FG003|Period 1|Adverse Event|0
7508825|NCT02349425|11836300|FG000|Period 2|Adverse Event|0
7508826|NCT02349425|11836301|FG001|Period 2|Adverse Event|1
7508827|NCT02349425|11836302|FG002|Period 2|Adverse Event|1
7508828|NCT02349425|11836303|FG003|Period 2|Adverse Event|0
7508829|NCT02349451|11836352|FG000|Overall Study|Withdrawal by Subject|0
7508830|NCT02349451|11836353|FG001|Overall Study|Withdrawal by Subject|1
7508831|NCT02349451|11836354|FG002|Overall Study|Withdrawal by Subject|2
7508832|NCT02349451|11836355|FG003|Overall Study|Withdrawal by Subject|1
7508833|NCT02349542|11836381|FG000|Overall Study|Withdrawal by Subject|5
7508834|NCT02349633|11836399|FG000|Overall Study|Death|0
7508835|NCT02349633|11836400|FG001|Overall Study|Death|1
7508836|NCT02349633|11836401|FG002|Overall Study|Death|0
7508837|NCT02349633|11836402|FG003|Overall Study|Death|0
7508838|NCT02349633|11836403|FG004|Overall Study|Death|0
7508839|NCT02349633|11836404|FG005|Overall Study|Death|1
7508840|NCT02349633|11836405|FG006|Overall Study|Death|1
7508841|NCT02349633|11836406|FG007|Overall Study|Death|1
7508842|NCT02349633|11836407|FG008|Overall Study|Death|0
7508843|NCT02349633|11836408|FG009|Overall Study|Death|1
7508844|NCT02349633|11836409|FG010|Overall Study|Death|0
7508845|NCT02349633|11836410|FG011|Overall Study|Death|0
7508846|NCT02349633|11836411|FG012|Overall Study|Death|0
7508847|NCT02349633|11836412|FG013|Overall Study|Death|0
7508848|NCT02349633|11836399|FG000|Overall Study|Withdrawal by Subject|0
7508849|NCT02349633|11836400|FG001|Overall Study|Withdrawal by Subject|0
7508850|NCT02349633|11836401|FG002|Overall Study|Withdrawal by Subject|0
7508851|NCT02349633|11836402|FG003|Overall Study|Withdrawal by Subject|1
7508852|NCT02349633|11836403|FG004|Overall Study|Withdrawal by Subject|0
7508853|NCT02349633|11836404|FG005|Overall Study|Withdrawal by Subject|0
7508854|NCT02349633|11836405|FG006|Overall Study|Withdrawal by Subject|0
7508855|NCT02349633|11836406|FG007|Overall Study|Withdrawal by Subject|2
7508856|NCT02349633|11836407|FG008|Overall Study|Withdrawal by Subject|2
7508857|NCT02349633|11836408|FG009|Overall Study|Withdrawal by Subject|1
7508858|NCT02349633|11836409|FG010|Overall Study|Withdrawal by Subject|0
7508859|NCT02349633|11836410|FG011|Overall Study|Withdrawal by Subject|0
7508860|NCT02349633|11836411|FG012|Overall Study|Withdrawal by Subject|0
7508861|NCT02349633|11836412|FG013|Overall Study|Withdrawal by Subject|0
7508862|NCT02349633|11836399|FG000|Overall Study|Withdrawal of informed consent|0
7508863|NCT02349633|11836400|FG001|Overall Study|Withdrawal of informed consent|0
7508864|NCT02349633|11836401|FG002|Overall Study|Withdrawal of informed consent|0
7508865|NCT02349633|11836402|FG003|Overall Study|Withdrawal of informed consent|1
7508866|NCT02349633|11836403|FG004|Overall Study|Withdrawal of informed consent|1
7508867|NCT02349633|11836404|FG005|Overall Study|Withdrawal of informed consent|0
7508868|NCT02349633|11836405|FG006|Overall Study|Withdrawal of informed consent|0
7508869|NCT02349633|11836406|FG007|Overall Study|Withdrawal of informed consent|3
7508870|NCT02349633|11836407|FG008|Overall Study|Withdrawal of informed consent|0
7508871|NCT02349633|11836408|FG009|Overall Study|Withdrawal of informed consent|0
7508872|NCT02349633|11836409|FG010|Overall Study|Withdrawal of informed consent|0
7508873|NCT02349633|11836410|FG011|Overall Study|Withdrawal of informed consent|0
7508874|NCT02349633|11836411|FG012|Overall Study|Withdrawal of informed consent|0
7508875|NCT02349633|11836412|FG013|Overall Study|Withdrawal of informed consent|0
7508876|NCT02349633|11836399|FG000|Overall Study|Transition to compassionate use|0
7508877|NCT02349633|11836400|FG001|Overall Study|Transition to compassionate use|0
7508878|NCT02349633|11836401|FG002|Overall Study|Transition to compassionate use|0
7508879|NCT02349633|11836402|FG003|Overall Study|Transition to compassionate use|0
7508880|NCT02349633|11836403|FG004|Overall Study|Transition to compassionate use|1
7508881|NCT02349633|11836404|FG005|Overall Study|Transition to compassionate use|0
7508882|NCT02349633|11836405|FG006|Overall Study|Transition to compassionate use|0
7508883|NCT02349633|11836406|FG007|Overall Study|Transition to compassionate use|3
7508884|NCT02349633|11836407|FG008|Overall Study|Transition to compassionate use|0
7508885|NCT02349633|11836408|FG009|Overall Study|Transition to compassionate use|1
7508886|NCT02349633|11836409|FG010|Overall Study|Transition to compassionate use|0
7508887|NCT02349633|11836410|FG011|Overall Study|Transition to compassionate use|0
7508888|NCT02349633|11836411|FG012|Overall Study|Transition to compassionate use|0
7508889|NCT02349633|11836412|FG013|Overall Study|Transition to compassionate use|0
7508890|NCT02349633|11836399|FG000|Overall Study|Early termination of survival follow-up|0
7508891|NCT02349633|11836400|FG001|Overall Study|Early termination of survival follow-up|0
7508892|NCT02349633|11836401|FG002|Overall Study|Early termination of survival follow-up|0
7508893|NCT02349633|11836402|FG003|Overall Study|Early termination of survival follow-up|0
7508894|NCT02349633|11836403|FG004|Overall Study|Early termination of survival follow-up|0
7508895|NCT02349633|11836404|FG005|Overall Study|Early termination of survival follow-up|0
7508896|NCT02349633|11836405|FG006|Overall Study|Early termination of survival follow-up|0
7508897|NCT02349633|11836406|FG007|Overall Study|Early termination of survival follow-up|4
7508898|NCT02349633|11836407|FG008|Overall Study|Early termination of survival follow-up|0
7508899|NCT02349633|11836408|FG009|Overall Study|Early termination of survival follow-up|0
7508900|NCT02349633|11836409|FG010|Overall Study|Early termination of survival follow-up|0
7508901|NCT02349633|11836410|FG011|Overall Study|Early termination of survival follow-up|0
7508902|NCT02349633|11836411|FG012|Overall Study|Early termination of survival follow-up|0
7508903|NCT02349633|11836412|FG013|Overall Study|Early termination of survival follow-up|0
7508904|NCT02349633|11836399|FG000|Overall Study|Termination by sponsor|0
7508905|NCT02349633|11836400|FG001|Overall Study|Termination by sponsor|0
7508906|NCT02349633|11836401|FG002|Overall Study|Termination by sponsor|0
7508907|NCT02349633|11836402|FG003|Overall Study|Termination by sponsor|0
7508908|NCT02349633|11836403|FG004|Overall Study|Termination by sponsor|0
7508909|NCT02349633|11836404|FG005|Overall Study|Termination by sponsor|0
7508910|NCT02349633|11836405|FG006|Overall Study|Termination by sponsor|0
7508911|NCT02349633|11836406|FG007|Overall Study|Termination by sponsor|1
7508912|NCT02349633|11836407|FG008|Overall Study|Termination by sponsor|0
7508913|NCT02349633|11836408|FG009|Overall Study|Termination by sponsor|2
7508914|NCT02349633|11836409|FG010|Overall Study|Termination by sponsor|0
7508915|NCT02349633|11836410|FG011|Overall Study|Termination by sponsor|0
7508916|NCT02349633|11836411|FG012|Overall Study|Termination by sponsor|0
7508917|NCT02349633|11836412|FG013|Overall Study|Termination by sponsor|0
7508918|NCT02349633|11836399|FG000|Overall Study|Other|0
7508919|NCT02349633|11836400|FG001|Overall Study|Other|0
7508920|NCT02349633|11836401|FG002|Overall Study|Other|0
7508921|NCT02349633|11836402|FG003|Overall Study|Other|0
7508922|NCT02349633|11836403|FG004|Overall Study|Other|0
7508923|NCT02349633|11836404|FG005|Overall Study|Other|0
7508924|NCT02349633|11836405|FG006|Overall Study|Other|0
7508925|NCT02349633|11836406|FG007|Overall Study|Other|2
7508926|NCT02349633|11836407|FG008|Overall Study|Other|0
7508927|NCT02349633|11836408|FG009|Overall Study|Other|0
7508928|NCT02349633|11836409|FG010|Overall Study|Other|0
7508929|NCT02349633|11836410|FG011|Overall Study|Other|0
7508930|NCT02349633|11836411|FG012|Overall Study|Other|0
7508931|NCT02349633|11836412|FG013|Overall Study|Other|0
7508932|NCT02349711|11836492|FG000|Overall Study|Withdrawal by Subject|2
7508933|NCT02349711|11836493|FG001|Overall Study|Withdrawal by Subject|1
7508934|NCT02349711|11836492|FG000|Overall Study|Lost to Follow-up|1
7508935|NCT02349711|11836493|FG001|Overall Study|Lost to Follow-up|1
7508936|NCT02349789|11836499|FG000|Overall Study|Withdrawal by Subject|2
7508937|NCT02350127|11836505|FG000|4-Month Assessment|Withdrawal by Subject|10
7508938|NCT02350127|11836506|FG001|4-Month Assessment|Withdrawal by Subject|9
7508939|NCT02350127|11836505|FG000|4-Month Assessment|Death|1
7508940|NCT02350127|11836506|FG001|4-Month Assessment|Death|0
7508941|NCT02350127|11836505|FG000|8-Month Assessment|Death|1
7508942|NCT02350127|11836506|FG001|8-Month Assessment|Death|1
7508943|NCT02350127|11836505|FG000|8-Month Assessment|Withdrawal by Subject|5
7508944|NCT02350127|11836506|FG001|8-Month Assessment|Withdrawal by Subject|8
7508945|NCT02350309|11836519|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
7508946|NCT02350309|11836520|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
7508947|NCT02350309|11836521|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
7508948|NCT02350309|11836522|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
7508949|NCT02350309|11836523|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
7508950|NCT02350309|11836524|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
7508951|NCT02350309|11836519|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
7508952|NCT02350309|11836520|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
7508953|NCT02350309|11836521|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
7508954|NCT02350309|11836522|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
7508955|NCT02350309|11836523|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
7508956|NCT02350309|11836524|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
7508957|NCT02350478|11836541|FG000|Overall Study|Lost to Follow-up|5
7508958|NCT02350478|11836542|FG001|Overall Study|Lost to Follow-up|1
7508959|NCT02351167|11836658|FG000|Overall Study|Withdrawal by Subject|19
7508960|NCT02351167|11836659|FG001|Overall Study|Withdrawal by Subject|18
7508961|NCT02351167|11836660|FG002|Overall Study|Withdrawal by Subject|21
7508962|NCT02351349|11836688|FG000|Overall Study|Withdrawal by Subject|2
7508963|NCT02351349|11836689|FG001|Overall Study|Withdrawal by Subject|3
7508964|NCT02351817|11836725|FG000|Period 1|Adverse Event|1
7508965|NCT02351817|11836726|FG001|Period 1|Adverse Event|2
7508966|NCT02351817|11836725|FG000|Period 1|Lack of Efficacy|0
7508967|NCT02351817|11836726|FG001|Period 1|Lack of Efficacy|1
7508968|NCT02351817|11836725|FG000|Period 2|Adverse Event|0
7508969|NCT02351817|11836726|FG001|Period 2|Adverse Event|2
7508970|NCT02351817|11836725|FG000|Period 2|Protocol Violation|1
7508971|NCT02351817|11836726|FG001|Period 2|Protocol Violation|0
7508972|NCT02351934|11836735|FG000|Allocation|POD weight<pre-op weight|3
7508973|NCT02351934|11836736|FG001|Allocation|POD weight<pre-op weight|0
7508974|NCT02351934|11836735|FG000|Allocation|Hypotension preventing administration|2
7508975|NCT02351934|11836736|FG001|Allocation|Hypotension preventing administration|0
7508976|NCT02351934|11836735|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
7508977|NCT02351934|11836736|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
7508978|NCT02351934|11836735|FG000|Follow-Up|POD weight<pre-op weight|3
7508979|NCT02351934|11836736|FG001|Follow-Up|POD weight<pre-op weight|0
7508980|NCT02351934|11836735|FG000|Follow-Up|Acute Kidney Injury|1
7508981|NCT02351934|11836736|FG001|Follow-Up|Acute Kidney Injury|0
7508982|NCT02351934|11836735|FG000|Follow-Up|Early dismissal|3
7508983|NCT02351934|11836736|FG001|Follow-Up|Early dismissal|0
7508984|NCT02351934|11836735|FG000|Follow-Up|Hypotension|3
7508985|NCT02351934|11836736|FG001|Follow-Up|Hypotension|0
7508986|NCT02351934|11836735|FG000|Follow-Up|No documentation|2
7508987|NCT02351934|11836736|FG001|Follow-Up|No documentation|0
7508988|NCT02351934|11836735|FG000|Follow-Up|1 ERAS Component Noncompliant|0
7508989|NCT02351934|11836736|FG001|Follow-Up|1 ERAS Component Noncompliant|6
7508990|NCT02351934|11836735|FG000|Follow-Up|2 ERAS Components Noncompliant|0
7508991|NCT02351934|11836736|FG001|Follow-Up|2 ERAS Components Noncompliant|4
7508992|NCT02351960|11836744|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7508993|NCT02351960|11836745|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7508994|NCT02351960|11836744|FG000|Overall Study|Voluntary Withdrawal|5
7508995|NCT02351960|11836745|FG001|Overall Study|Voluntary Withdrawal|4
7508996|NCT02351960|11836744|FG000|Overall Study|Significant Protocol Deviation|0
7508997|NCT02351960|11836745|FG001|Overall Study|Significant Protocol Deviation|5
7508998|NCT02352493|11836788|FG000|Overall Study|Pregnancy|0
7508999|NCT02352493|11836789|FG001|Overall Study|Pregnancy|0
7509000|NCT02352493|11836790|FG002|Overall Study|Pregnancy|0
7509001|NCT02352493|11836791|FG003|Overall Study|Pregnancy|0
7509002|NCT02352493|11836792|FG004|Overall Study|Pregnancy|0
7509003|NCT02352493|11836793|FG005|Overall Study|Pregnancy|0
7509004|NCT02352493|11836794|FG006|Overall Study|Pregnancy|1
7509005|NCT02352493|11836795|FG007|Overall Study|Pregnancy|0
7509006|NCT02352493|11836796|FG008|Overall Study|Pregnancy|1
7509007|NCT02352493|11836797|FG009|Overall Study|Pregnancy|0
7509008|NCT02352493|11836798|FG010|Overall Study|Pregnancy|0
7509009|NCT02352493|11836799|FG011|Overall Study|Pregnancy|0
7509010|NCT02352493|11836800|FG012|Overall Study|Pregnancy|0
7509011|NCT02352493|11836801|FG013|Overall Study|Pregnancy|0
7509012|NCT02352493|11836802|FG014|Overall Study|Pregnancy|0
7509013|NCT02352493|11836803|FG015|Overall Study|Pregnancy|0
7509014|NCT02352493|11836804|FG016|Overall Study|Pregnancy|0
7509015|NCT02352493|11836805|FG017|Overall Study|Pregnancy|0
7509016|NCT02352493|11836788|FG000|Overall Study|Withdrawal by Subject|0
7509017|NCT02352493|11836789|FG001|Overall Study|Withdrawal by Subject|0
7509018|NCT02352493|11836790|FG002|Overall Study|Withdrawal by Subject|0
7509019|NCT02352493|11836791|FG003|Overall Study|Withdrawal by Subject|0
7509020|NCT02352493|11836792|FG004|Overall Study|Withdrawal by Subject|0
7509021|NCT02352493|11836793|FG005|Overall Study|Withdrawal by Subject|0
7509022|NCT02352493|11836794|FG006|Overall Study|Withdrawal by Subject|0
7509023|NCT02352493|11836795|FG007|Overall Study|Withdrawal by Subject|0
7509024|NCT02352493|11836796|FG008|Overall Study|Withdrawal by Subject|1
7509025|NCT02352493|11836797|FG009|Overall Study|Withdrawal by Subject|0
7509026|NCT02352493|11836798|FG010|Overall Study|Withdrawal by Subject|0
7509027|NCT02352493|11836799|FG011|Overall Study|Withdrawal by Subject|0
7509028|NCT02352493|11836800|FG012|Overall Study|Withdrawal by Subject|0
7509029|NCT02352493|11836801|FG013|Overall Study|Withdrawal by Subject|0
7509030|NCT02352493|11836802|FG014|Overall Study|Withdrawal by Subject|1
7509031|NCT02352493|11836803|FG015|Overall Study|Withdrawal by Subject|0
7509032|NCT02352493|11836804|FG016|Overall Study|Withdrawal by Subject|0
7509033|NCT02352493|11836805|FG017|Overall Study|Withdrawal by Subject|0
7509034|NCT02352493|11836788|FG000|Overall Study|Lost to Follow-up|0
7509035|NCT02352493|11836789|FG001|Overall Study|Lost to Follow-up|0
7509036|NCT02352493|11836790|FG002|Overall Study|Lost to Follow-up|0
7509037|NCT02352493|11836791|FG003|Overall Study|Lost to Follow-up|0
7509041|NCT02352493|11836795|FG007|Overall Study|Lost to Follow-up|0
7509042|NCT02352493|11836796|FG008|Overall Study|Lost to Follow-up|0
7509043|NCT02352493|11836797|FG009|Overall Study|Lost to Follow-up|1
7509044|NCT02352493|11836798|FG010|Overall Study|Lost to Follow-up|0
7509045|NCT02352493|11836799|FG011|Overall Study|Lost to Follow-up|0
7509046|NCT02352493|11836800|FG012|Overall Study|Lost to Follow-up|1
7509047|NCT02352493|11836801|FG013|Overall Study|Lost to Follow-up|2
7509048|NCT02352493|11836802|FG014|Overall Study|Lost to Follow-up|0
7509049|NCT02352493|11836803|FG015|Overall Study|Lost to Follow-up|0
7509050|NCT02352493|11836804|FG016|Overall Study|Lost to Follow-up|0
7509051|NCT02352493|11836805|FG017|Overall Study|Lost to Follow-up|0
7509052|NCT02352779|11836863|FG000|Overall Study|Personal Issues|1
7509053|NCT02352779|11836864|FG001|Overall Study|Personal Issues|1
7509054|NCT02352779|11836865|FG002|Overall Study|Personal Issues|0
7509055|NCT02352779|11836863|FG000|Overall Study|Too Many Forms|2
7509056|NCT02352779|11836864|FG001|Overall Study|Too Many Forms|0
7509057|NCT02352779|11836865|FG002|Overall Study|Too Many Forms|0
7509058|NCT02352779|11836863|FG000|Overall Study|Feeling Overwhelmed|1
7509059|NCT02352779|11836864|FG001|Overall Study|Feeling Overwhelmed|0
7509060|NCT02352779|11836865|FG002|Overall Study|Feeling Overwhelmed|0
7509061|NCT02352779|11836863|FG000|Overall Study|Disliked Intervention|1
7509062|NCT02352779|11836864|FG001|Overall Study|Disliked Intervention|0
7509063|NCT02352779|11836865|FG002|Overall Study|Disliked Intervention|0
7509064|NCT02352779|11836863|FG000|Overall Study|Changed Mind|1
7509065|NCT02352779|11836864|FG001|Overall Study|Changed Mind|0
7509066|NCT02352779|11836865|FG002|Overall Study|Changed Mind|0
7509067|NCT02352779|11836863|FG000|Overall Study|Study Related Symptoms|1
7509068|NCT02352779|11836864|FG001|Overall Study|Study Related Symptoms|0
7509069|NCT02352779|11836865|FG002|Overall Study|Study Related Symptoms|0
7509070|NCT02352779|11836863|FG000|Overall Study|Absence of Symptoms|1
7509071|NCT02352779|11836864|FG001|Overall Study|Absence of Symptoms|0
7509072|NCT02352779|11836865|FG002|Overall Study|Absence of Symptoms|0
7509073|NCT02352779|11836863|FG000|Overall Study|Other Medical Reason|0
7509074|NCT02352779|11836864|FG001|Overall Study|Other Medical Reason|0
7509075|NCT02352779|11836865|FG002|Overall Study|Other Medical Reason|1
7509076|NCT02352779|11836863|FG000|Overall Study|No Reason|0
7509077|NCT02352779|11836864|FG001|Overall Study|No Reason|0
7509078|NCT02352779|11836865|FG002|Overall Study|No Reason|1
7509079|NCT02353169|11836923|FG000|Overall Study|QTc > 450 msec|1
7509080|NCT02353169|11836924|FG001|Overall Study|QTc > 450 msec|1
7509081|NCT02353169|11836925|FG002|Overall Study|QTc > 450 msec|1
7509082|NCT02353169|11836926|FG003|Overall Study|QTc > 450 msec|1
7509083|NCT02353169|11836923|FG000|Overall Study|OR team declined|2
7509084|NCT02353169|11836924|FG001|Overall Study|OR team declined|0
7509085|NCT02353169|11836925|FG002|Overall Study|OR team declined|0
7509086|NCT02353169|11836926|FG003|Overall Study|OR team declined|0
7509087|NCT02353169|11836923|FG000|Overall Study|Inhalational induction|0
7509088|NCT02353169|11836924|FG001|Overall Study|Inhalational induction|2
7509089|NCT02353169|11836925|FG002|Overall Study|Inhalational induction|0
7509090|NCT02353169|11836926|FG003|Overall Study|Inhalational induction|0
7509091|NCT02353169|11836923|FG000|Overall Study|ECG data error|0
7509092|NCT02353169|11836924|FG001|Overall Study|ECG data error|3
7509093|NCT02353169|11836925|FG002|Overall Study|ECG data error|2
7509094|NCT02353169|11836926|FG003|Overall Study|ECG data error|2
7509095|NCT02353169|11836923|FG000|Overall Study|Pre-op medication|0
7509096|NCT02353169|11836924|FG001|Overall Study|Pre-op medication|0
7509097|NCT02353169|11836925|FG002|Overall Study|Pre-op medication|1
7509098|NCT02353169|11836926|FG003|Overall Study|Pre-op medication|0
7509099|NCT02353442|11836959|FG000|Overall Study|Withdrawal by Subject|3
7509100|NCT02353442|11836960|FG001|Overall Study|Withdrawal by Subject|4
7509107|NCT02354222|11837023|FG000|Overall Study|Adverse Event|0
7509108|NCT02354222|11837024|FG001|Overall Study|Adverse Event|3
7509109|NCT02354222|11837023|FG000|Overall Study|Physician Decision|1
7509110|NCT02354222|11837024|FG001|Overall Study|Physician Decision|1
7509111|NCT02354222|11837023|FG000|Overall Study|Pregnancy|1
7509112|NCT02354222|11837024|FG001|Overall Study|Pregnancy|0
7509113|NCT02354222|11837023|FG000|Overall Study|Withdrawal by Subject|2
7509114|NCT02354222|11837024|FG001|Overall Study|Withdrawal by Subject|3
7509115|NCT02354222|11837023|FG000|Overall Study|Conflict with the stopping criteria|0
7509116|NCT02354222|11837024|FG001|Overall Study|Conflict with the stopping criteria|4
7509117|NCT02354235|11837032|FG000|Overall Study|Adverse Event|2
7509118|NCT02354235|11837033|FG001|Overall Study|Adverse Event|2
7509119|NCT02354235|11837032|FG000|Overall Study|Physician Decision|0
7509120|NCT02354235|11837033|FG001|Overall Study|Physician Decision|1
7509121|NCT02354235|11837032|FG000|Overall Study|Withdrawal by Subject|1
7509122|NCT02354235|11837033|FG001|Overall Study|Withdrawal by Subject|3
7509123|NCT02354235|11837032|FG000|Overall Study|Conflict with the stopping criteria|0
7509124|NCT02354235|11837033|FG001|Overall Study|Conflict with the stopping criteria|1
7509125|NCT02354417|11837066|FG000|Overall Study|Physician Decision|1
7509126|NCT02354508|11837091|FG000|Period 1: Core Phase|Adverse Event|1
7509127|NCT02354508|11837092|FG001|Period 1: Core Phase|Adverse Event|1
7509128|NCT02354508|11837093|FG002|Period 1: Core Phase|Adverse Event|2
7509129|NCT02354508|11837091|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
7509130|NCT02354508|11837092|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
7509131|NCT02354508|11837093|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
7509132|NCT02354508|11837091|FG000|Period 1: Core Phase|Withdrawal by Subject|0
7509133|NCT02354508|11837092|FG001|Period 1: Core Phase|Withdrawal by Subject|1
7509134|NCT02354508|11837093|FG002|Period 1: Core Phase|Withdrawal by Subject|2
7509135|NCT02354508|11837091|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
7509136|NCT02354508|11837092|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
7509137|NCT02354508|11837093|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
7509138|NCT02354508|11837091|FG000|Period 2: Extension Phase|Withdrawal by Subject|0
7509139|NCT02354508|11837092|FG001|Period 2: Extension Phase|Withdrawal by Subject|1
7509140|NCT02354508|11837093|FG002|Period 2: Extension Phase|Withdrawal by Subject|0
7509141|NCT02354508|11837091|FG000|Period 2: Extension Phase|Physician Decision|5
7509142|NCT02354508|11837092|FG001|Period 2: Extension Phase|Physician Decision|0
7509143|NCT02354508|11837093|FG002|Period 2: Extension Phase|Physician Decision|1
7509144|NCT02354508|11837091|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
7509145|NCT02354508|11837092|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7509146|NCT02354508|11837093|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
7509147|NCT02354508|11837091|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7509148|NCT02354508|11837092|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
7509149|NCT02354508|11837093|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
7509150|NCT02354508|11837091|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3
7509151|NCT02354508|11837092|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0
7509152|NCT02354508|11837093|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1
7509157|NCT02354599|11837169|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7509158|NCT02354599|11837170|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7509159|NCT02354599|11837171|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7509160|NCT02354599|11837172|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7509161|NCT02354599|11837173|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7509162|NCT02354599|11837174|FG005|Overall Study|Pretreatment Event/Adverse Event|1
7509163|NCT02354599|11837169|FG000|Overall Study|Withdrawal by Subject|1
7509164|NCT02354599|11837170|FG001|Overall Study|Withdrawal by Subject|1
7509165|NCT02354599|11837171|FG002|Overall Study|Withdrawal by Subject|0
7509166|NCT02354599|11837172|FG003|Overall Study|Withdrawal by Subject|0
7509167|NCT02354599|11837173|FG004|Overall Study|Withdrawal by Subject|0
7509168|NCT02354599|11837174|FG005|Overall Study|Withdrawal by Subject|0
7509169|NCT02354690|11837194|FG000|Overall Study|Physician Decision|1
7509170|NCT02354976|11837237|FG000|Overall Study|Other - reason not specified|1
7509171|NCT02354976|11837238|FG001|Overall Study|Other - reason not specified|0
7509172|NCT02354976|11837239|FG002|Overall Study|Other - reason not specified|1
7509173|NCT02354976|11837237|FG000|Overall Study|Study-specifc withdrawal criteria|0
7509174|NCT02354976|11837238|FG001|Overall Study|Study-specifc withdrawal criteria|1
7509175|NCT02354976|11837239|FG002|Overall Study|Study-specifc withdrawal criteria|0
7509176|NCT02354976|11837237|FG000|Overall Study|Adverse Event|1
7509177|NCT02354976|11837238|FG001|Overall Study|Adverse Event|0
7509178|NCT02354976|11837239|FG002|Overall Study|Adverse Event|2
7509179|NCT02355028|11837249|FG000|Overall Study|Adverse Event|2
7509180|NCT02355028|11837250|FG001|Overall Study|Adverse Event|0
7509181|NCT02355028|11837249|FG000|Overall Study|Withdrawal by Subject|1
7509182|NCT02355028|11837250|FG001|Overall Study|Withdrawal by Subject|1
7509183|NCT02355028|11837249|FG000|Overall Study|Deemed ineligible after randomization|8
7509184|NCT02355028|11837250|FG001|Overall Study|Deemed ineligible after randomization|4
7509185|NCT02355665|11837305|FG000|Overall Study|Adverse Event|16
7509186|NCT02355665|11837306|FG001|Overall Study|Adverse Event|24
7509187|NCT02355665|11837305|FG000|Overall Study|Protocol Violation|2
7509188|NCT02355665|11837306|FG001|Overall Study|Protocol Violation|0
7509189|NCT02355665|11837305|FG000|Overall Study|Withdrawal by Subject|90
7509190|NCT02355665|11837306|FG001|Overall Study|Withdrawal by Subject|100
7509191|NCT02355665|11837305|FG000|Overall Study|Lost to Follow-up|131
7509192|NCT02355665|11837306|FG001|Overall Study|Lost to Follow-up|103
7509193|NCT02355665|11837305|FG000|Overall Study|Death|4
7509194|NCT02355665|11837306|FG001|Overall Study|Death|2
7509195|NCT02355665|11837305|FG000|Overall Study|Compliance, PI decision, move, eligible|6
7509196|NCT02355665|11837306|FG001|Overall Study|Compliance, PI decision, move, eligible|3
7509197|NCT02355691|11837314|FG000|Overall Study|Loss of Research Personnel|7
7509198|NCT02355691|11837315|FG001|Overall Study|Loss of Research Personnel|9
7509199|NCT02355743|11837321|FG000|Overall Study|Withdrawal by Subject|1
7509200|NCT02355743|11837321|FG000|Overall Study|Lost to Follow-up|1
7536057|NCT02715726|11884018|FG000|Overall Study|Other than specified above|11
7536058|NCT02715726|11884019|FG001|Overall Study|Other than specified above|15
7536059|NCT02715726|11884018|FG000|Overall Study|Randomized but not treated|1
7536060|NCT02715726|11884019|FG001|Overall Study|Randomized but not treated|2
7536061|NCT02715804|11884027|FG000|Overall Study|Death|222
7536062|NCT02715804|11884028|FG001|Overall Study|Death|106
7536063|NCT02715804|11884027|FG000|Overall Study|Withdrawal by Subject|5
7536064|NCT02715804|11884028|FG001|Overall Study|Withdrawal by Subject|4
7536065|NCT02715804|11884027|FG000|Overall Study|Other than specified|2
7536066|NCT02715804|11884028|FG001|Overall Study|Other than specified|3
7536067|NCT02716194|11884037|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
7536068|NCT02716194|11884038|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
7536069|NCT02716194|11884039|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
7536070|NCT02716298|11884060|FG000|First Intervention (1 Month)|Lens discomfort|1
7536071|NCT02716298|11884061|FG001|First Intervention (1 Month)|Lens discomfort|1
7536072|NCT02716584|11884087|FG000|Overall Study|Lost to Follow-up|8
7536073|NCT02716584|11884088|FG001|Overall Study|Lost to Follow-up|5
7536074|NCT02716779|11884119|FG000|Monotherapy|Adverse Event|0
7536075|NCT02716779|11884120|FG001|Monotherapy|Adverse Event|1
7536076|NCT02716779|11884121|FG002|Monotherapy|Adverse Event|1
7536077|NCT02716779|11884119|FG000|Combination Therapy|Adverse Event|0
7536078|NCT02716779|11884120|FG001|Combination Therapy|Adverse Event|2
7536079|NCT02716779|11884121|FG002|Combination Therapy|Adverse Event|1
7536080|NCT02716805|11884135|FG000|Overall Study|Progressive disease|2
7536081|NCT02716805|11884136|FG001|Overall Study|Progressive disease|0
7536082|NCT02716805|11884137|FG002|Overall Study|Progressive disease|0
7536083|NCT02716805|11884138|FG003|Overall Study|Progressive disease|0
7536084|NCT02716896|11884175|FG000|Overall Study|Physician Decision|0
7536085|NCT02716896|11884176|FG001|Overall Study|Physician Decision|1
7536086|NCT02716987|11884188|FG000|Overall Study|Ligand synthesis failure|0
7536087|NCT02716987|11884189|FG001|Overall Study|Ligand synthesis failure|0
7536088|NCT02716987|11884190|FG002|Overall Study|Ligand synthesis failure|1
7536089|NCT02716987|11884191|FG003|Overall Study|Ligand synthesis failure|0
7536090|NCT02716987|11884192|FG004|Overall Study|Ligand synthesis failure|0
7536091|NCT02716987|11884193|FG005|Overall Study|Ligand synthesis failure|0
7536092|NCT02716987|11884188|FG000|Overall Study|Withdrawal by Subject|0
7536093|NCT02716987|11884189|FG001|Overall Study|Withdrawal by Subject|0
7536094|NCT02716987|11884190|FG002|Overall Study|Withdrawal by Subject|0
7536095|NCT02716987|11884191|FG003|Overall Study|Withdrawal by Subject|0
7536096|NCT02716987|11884192|FG004|Overall Study|Withdrawal by Subject|1
7536097|NCT02716987|11884193|FG005|Overall Study|Withdrawal by Subject|1
7536098|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
7536099|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
7536100|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7536101|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7536102|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
7509201|NCT02356211|11837376|FG000|Overall Study|Withdrawal by Subject|2
7509202|NCT02356211|11837377|FG001|Overall Study|Withdrawal by Subject|2
7509203|NCT02356211|11837376|FG000|Overall Study|ineligible|1
7509204|NCT02356211|11837377|FG001|Overall Study|ineligible|8
7509205|NCT02356562|11837393|FG000|Overall Study|Withdrawal by Subject|0
7509206|NCT02356562|11837394|FG001|Overall Study|Withdrawal by Subject|1
7509207|NCT02356562|11837393|FG000|Overall Study|Re-entered treatment in a previous study|1
7509208|NCT02356562|11837394|FG001|Overall Study|Re-entered treatment in a previous study|0
7509209|NCT02356562|11837393|FG000|Overall Study|site closure|1
7509210|NCT02356562|11837394|FG001|Overall Study|site closure|0
7509211|NCT02356588|11837403|FG000|Overall Study|Lack of Efficacy|4
7509212|NCT02356588|11837404|FG001|Overall Study|Lack of Efficacy|10
7509213|NCT02356588|11837403|FG000|Overall Study|Adverse Event|0
7509214|NCT02356588|11837404|FG001|Overall Study|Adverse Event|2
7509215|NCT02356588|11837403|FG000|Overall Study|Withdrawal by Subject|1
7509216|NCT02356588|11837404|FG001|Overall Study|Withdrawal by Subject|0
7509217|NCT02356588|11837403|FG000|Overall Study|Protocol Violation|0
7509218|NCT02356588|11837404|FG001|Overall Study|Protocol Violation|1
7509219|NCT02356783|11837421|FG000|Overall Study|Lost to Follow-up|1
7509220|NCT02356783|11837422|FG001|Overall Study|Lost to Follow-up|3
7509221|NCT02356887|11837428|FG000|Overall Study|poor compliance|2
7509222|NCT02357134|11837455|FG000|Overall Study|Lost to Follow-up|1
7509223|NCT02357134|11837456|FG001|Overall Study|Lost to Follow-up|0
7509224|NCT02357134|11837457|FG002|Overall Study|Lost to Follow-up|0
7509225|NCT02357134|11837458|FG003|Overall Study|Lost to Follow-up|0
7509226|NCT02357147|11837470|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7509227|NCT02357147|11837471|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
7509228|NCT02357147|11837470|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
7509229|NCT02357147|11837471|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
7509230|NCT02357147|11837470|FG000|Combination Treatment Phase|Investigator Discretion|1
7509231|NCT02357147|11837471|FG001|Combination Treatment Phase|Investigator Discretion|1
7509232|NCT02357147|11837470|FG000|Combination Treatment Phase|Withdrawal by Subject|4
7509233|NCT02357147|11837471|FG001|Combination Treatment Phase|Withdrawal by Subject|2
7509234|NCT02357147|11837470|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
7509235|NCT02357147|11837471|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
7509236|NCT02357147|11837470|FG000|Combination Treatment Phase|Adverse Event|12
7509237|NCT02357147|11837471|FG001|Combination Treatment Phase|Adverse Event|4
7509238|NCT02357147|11837470|FG000|Combination Treatment Phase|Death|1
7509239|NCT02357147|11837471|FG001|Combination Treatment Phase|Death|1
7509240|NCT02357147|11837470|FG000|Combination Treatment Phase|Sponsor Decision|0
7509241|NCT02357147|11837471|FG001|Combination Treatment Phase|Sponsor Decision|12
7509242|NCT02357147|11837470|FG000|Combination Treatment Phase|Other|1
7509243|NCT02357147|11837471|FG001|Combination Treatment Phase|Other|0
7509244|NCT02357147|11837470|FG000|Combination Treatment Phase|Not treated|0
7509245|NCT02357147|11837471|FG001|Combination Treatment Phase|Not treated|2
7509246|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
7509247|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
7509248|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7509249|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
7509250|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
7509251|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
7509252|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Adverse Event|0
7509253|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Adverse Event|3
7509254|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Sponsor Decision|0
7509255|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Sponsor Decision|15
7509256|NCT02357147|11837470|FG000|Maintenance Treatment Phase|Not Treated|1
7509257|NCT02357147|11837471|FG001|Maintenance Treatment Phase|Not Treated|0
7509258|NCT02357342|11837509|FG000|First 6 Months|Death|2
7509259|NCT02357342|11837510|FG001|First 6 Months|Death|0
7509260|NCT02357368|11837520|FG000|Overall Study|Lost to Follow-up|0
7509261|NCT02357368|11837521|FG001|Overall Study|Lost to Follow-up|0
7509262|NCT02357368|11837522|FG002|Overall Study|Lost to Follow-up|0
7509263|NCT02357368|11837523|FG003|Overall Study|Lost to Follow-up|1
7509264|NCT02357368|11837520|FG000|Overall Study|Pregnancy|3
7509265|NCT02357368|11837521|FG001|Overall Study|Pregnancy|2
7509266|NCT02357368|11837522|FG002|Overall Study|Pregnancy|0
7509267|NCT02357368|11837523|FG003|Overall Study|Pregnancy|0
7509268|NCT02357368|11837520|FG000|Overall Study|Withdrawal by Subject|3
7509269|NCT02357368|11837521|FG001|Overall Study|Withdrawal by Subject|1
7509270|NCT02357368|11837522|FG002|Overall Study|Withdrawal by Subject|1
7509271|NCT02357368|11837523|FG003|Overall Study|Withdrawal by Subject|2
7509272|NCT02357420|11837546|FG000|Overall Study|Adverse Event|3
7509273|NCT02357420|11837547|FG001|Overall Study|Adverse Event|3
7509274|NCT02357420|11837548|FG002|Overall Study|Adverse Event|8
7509275|NCT02357420|11837549|FG003|Overall Study|Adverse Event|9
7509276|NCT02357420|11837546|FG000|Overall Study|Investigator Decision|1
7509277|NCT02357420|11837547|FG001|Overall Study|Investigator Decision|0
7509278|NCT02357420|11837548|FG002|Overall Study|Investigator Decision|0
7509279|NCT02357420|11837549|FG003|Overall Study|Investigator Decision|0
7509280|NCT02357420|11837546|FG000|Overall Study|Prohibited Medication|1
7509281|NCT02357420|11837547|FG001|Overall Study|Prohibited Medication|1
7509282|NCT02357420|11837548|FG002|Overall Study|Prohibited Medication|0
7509283|NCT02357420|11837549|FG003|Overall Study|Prohibited Medication|0
7509284|NCT02357420|11837546|FG000|Overall Study|Protocol Non-compliance|0
7509285|NCT02357420|11837547|FG001|Overall Study|Protocol Non-compliance|0
7509286|NCT02357420|11837548|FG002|Overall Study|Protocol Non-compliance|0
7509287|NCT02357420|11837549|FG003|Overall Study|Protocol Non-compliance|1
7509288|NCT02357420|11837546|FG000|Overall Study|Withdrawn Consent|4
7509289|NCT02357420|11837547|FG001|Overall Study|Withdrawn Consent|8
7509290|NCT02357420|11837548|FG002|Overall Study|Withdrawn Consent|6
7509291|NCT02357420|11837549|FG003|Overall Study|Withdrawn Consent|6
7509292|NCT02357420|11837546|FG000|Overall Study|Lost to Follow-up|3
7509293|NCT02357420|11837547|FG001|Overall Study|Lost to Follow-up|0
7509294|NCT02357420|11837548|FG002|Overall Study|Lost to Follow-up|2
7509295|NCT02357420|11837549|FG003|Overall Study|Lost to Follow-up|3
7509296|NCT02357459|11837562|FG000|Overall Study|Adverse Event|0
7509297|NCT02357459|11837563|FG001|Overall Study|Adverse Event|1
7509298|NCT02357459|11837564|FG002|Overall Study|Adverse Event|1
7509299|NCT02357459|11837562|FG000|Overall Study|Withdrawal by Subject|5
7509300|NCT02357459|11837563|FG001|Overall Study|Withdrawal by Subject|3
7509301|NCT02357459|11837564|FG002|Overall Study|Withdrawal by Subject|3
7509302|NCT02357459|11837562|FG000|Overall Study|Physician Decision|0
7509303|NCT02357459|11837563|FG001|Overall Study|Physician Decision|2
7509304|NCT02357459|11837564|FG002|Overall Study|Physician Decision|0
7509305|NCT02357459|11837562|FG000|Overall Study|Protocol Violation|1
7509306|NCT02357459|11837563|FG001|Overall Study|Protocol Violation|1
7509307|NCT02357459|11837564|FG002|Overall Study|Protocol Violation|0
7509308|NCT02357459|11837562|FG000|Overall Study|Lost to Follow-up|1
7509309|NCT02357459|11837563|FG001|Overall Study|Lost to Follow-up|3
7509310|NCT02357459|11837564|FG002|Overall Study|Lost to Follow-up|0
7509311|NCT02357459|11837562|FG000|Overall Study|Lack of Efficacy|7
7509312|NCT02357459|11837563|FG001|Overall Study|Lack of Efficacy|4
7509313|NCT02357459|11837564|FG002|Overall Study|Lack of Efficacy|4
7509314|NCT02357459|11837562|FG000|Overall Study|Patient Relocated|2
7509315|NCT02357459|11837563|FG001|Overall Study|Patient Relocated|0
7509316|NCT02357459|11837564|FG002|Overall Study|Patient Relocated|0
7509317|NCT02357459|11837562|FG000|Overall Study|Instruction from PCP|1
7509318|NCT02357459|11837563|FG001|Overall Study|Instruction from PCP|0
7509319|NCT02357459|11837564|FG002|Overall Study|Instruction from PCP|0
7509320|NCT02357459|11837562|FG000|Overall Study|Incarceration|0
7509321|NCT02357459|11837563|FG001|Overall Study|Incarceration|0
7509322|NCT02357459|11837564|FG002|Overall Study|Incarceration|1
7509323|NCT02357459|11837562|FG000|Overall Study|Pre-planned Knee surgery|0
7509324|NCT02357459|11837563|FG001|Overall Study|Pre-planned Knee surgery|0
7509325|NCT02357459|11837564|FG002|Overall Study|Pre-planned Knee surgery|2
7509326|NCT02357459|11837562|FG000|Overall Study|Job Commitments|0
7509327|NCT02357459|11837563|FG001|Overall Study|Job Commitments|0
7509328|NCT02357459|11837564|FG002|Overall Study|Job Commitments|1
7509329|NCT02357576|11837582|FG000|Treatment Period|Withdrawal by Subject|0
7509330|NCT02357576|11837583|FG001|Treatment Period|Withdrawal by Subject|1
7509331|NCT02357576|11837582|FG000|Treatment Period|Physician Decision|0
7509332|NCT02357576|11837583|FG001|Treatment Period|Physician Decision|1
7509333|NCT02357576|11837582|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7509334|NCT02357576|11837583|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
7509335|NCT02357576|11837582|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
7509336|NCT02357576|11837583|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
7509337|NCT02357576|11837582|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
7509338|NCT02357576|11837583|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
7509339|NCT02357576|11837582|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
7509340|NCT02357576|11837583|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
7509341|NCT02357901|11837620|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
7509342|NCT02357901|11837621|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7509343|NCT02357901|11837622|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7509344|NCT02357901|11837623|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
7509345|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
7509346|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
7509347|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
7509348|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
7509349|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
7509350|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
7509351|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
7509352|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
7509353|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
7509354|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
7509355|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
7509356|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
7509357|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
7509358|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
7509359|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
7509360|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
7509361|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7509362|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
7509363|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
7509364|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
7509365|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
7509366|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7509367|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
7509368|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
7509369|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7509370|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7509371|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
7509372|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
7509373|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7509374|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
7509375|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
7509376|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
7509377|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7509378|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
7509379|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7509380|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
7509381|NCT02357901|11837620|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
7509382|NCT02357901|11837621|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
7509383|NCT02357901|11837622|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
7509384|NCT02357901|11837623|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
7509385|NCT02357940|11837633|FG000|Overall Study|Adverse Event|0
7509386|NCT02357940|11837634|FG001|Overall Study|Adverse Event|1
7509387|NCT02357940|11837633|FG000|Overall Study|Investigator's judgement|0
7509388|NCT02357940|11837634|FG001|Overall Study|Investigator's judgement|1
7509389|NCT02357979|11837642|FG000|Overall Study|Lost to Follow-up|5
7509390|NCT02357979|11837643|FG001|Overall Study|Lost to Follow-up|5
7509391|NCT02358044|11837651|FG000|Overall Study|Adverse Event|0
7509392|NCT02358044|11837652|FG001|Overall Study|Adverse Event|1
7509393|NCT02358044|11837651|FG000|Overall Study|Lost to Follow-up|2
7509394|NCT02358044|11837652|FG001|Overall Study|Lost to Follow-up|1
7509395|NCT02358044|11837651|FG000|Overall Study|Physician Decision|0
7509396|NCT02358044|11837652|FG001|Overall Study|Physician Decision|1
7509397|NCT02358044|11837651|FG000|Overall Study|Withdrawal by Subject|0
7509398|NCT02358044|11837652|FG001|Overall Study|Withdrawal by Subject|4
7509399|NCT02358343|11837672|FG000|Screening Intervention|Death|0
7509400|NCT02358343|11837673|FG001|Screening Intervention|Death|2
7509401|NCT02358343|11837674|FG002|Screening Intervention|Death|0
7509402|NCT02358343|11837675|FG003|Screening Intervention|Death|0
7509403|NCT02358343|11837676|FG004|Screening Intervention|Death|0
7509404|NCT02358343|11837672|FG000|Screening Intervention|Withdrawal by Subject|1
7509405|NCT02358343|11837673|FG001|Screening Intervention|Withdrawal by Subject|0
7509406|NCT02358343|11837674|FG002|Screening Intervention|Withdrawal by Subject|0
7509407|NCT02358343|11837675|FG003|Screening Intervention|Withdrawal by Subject|0
7509408|NCT02358343|11837676|FG004|Screening Intervention|Withdrawal by Subject|0
7509409|NCT02358343|11837672|FG000|Screening Intervention|Determined Ineligible|5
7509410|NCT02358343|11837673|FG001|Screening Intervention|Determined Ineligible|6
7509411|NCT02358343|11837674|FG002|Screening Intervention|Determined Ineligible|0
7509412|NCT02358343|11837675|FG003|Screening Intervention|Determined Ineligible|0
7509413|NCT02358343|11837676|FG004|Screening Intervention|Determined Ineligible|0
7509414|NCT02358343|11837672|FG000|Comparative Efficacy Trial / Observation|Death|0
7509415|NCT02358343|11837673|FG001|Comparative Efficacy Trial / Observation|Death|0
7509416|NCT02358343|11837674|FG002|Comparative Efficacy Trial / Observation|Death|2
7509417|NCT02358343|11837675|FG003|Comparative Efficacy Trial / Observation|Death|0
7509418|NCT02358343|11837676|FG004|Comparative Efficacy Trial / Observation|Death|0
7509419|NCT02358343|11837672|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7509420|NCT02358343|11837673|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
7509421|NCT02358343|11837674|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7509422|NCT02358343|11837675|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7509423|NCT02358343|11837676|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
7509424|NCT02358343|11837672|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7509425|NCT02358343|11837673|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7509426|NCT02358343|11837674|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
7509427|NCT02358343|11837675|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7509428|NCT02358343|11837676|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
7509429|NCT02358369|11837690|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
7509430|NCT02358369|11837691|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7509431|NCT02358369|11837692|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7509432|NCT02358369|11837693|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7509433|NCT02358369|11837694|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
7509434|NCT02358369|11837690|FG000|Treatment Period A/B|Adverse Event|0
7509435|NCT02358369|11837691|FG001|Treatment Period A/B|Adverse Event|0
7509436|NCT02358369|11837692|FG002|Treatment Period A/B|Adverse Event|1
7509437|NCT02358369|11837693|FG003|Treatment Period A/B|Adverse Event|2
7509438|NCT02358369|11837694|FG004|Treatment Period A/B|Adverse Event|0
7509439|NCT02358369|11837690|FG000|Treatment Period A/B|Death|0
7509440|NCT02358369|11837691|FG001|Treatment Period A/B|Death|0
7509441|NCT02358369|11837692|FG002|Treatment Period A/B|Death|1
7509442|NCT02358369|11837693|FG003|Treatment Period A/B|Death|0
7509443|NCT02358369|11837694|FG004|Treatment Period A/B|Death|0
7509444|NCT02358369|11837690|FG000|Treatment Period A/B|Withdrawal by Subject|0
7509445|NCT02358369|11837691|FG001|Treatment Period A/B|Withdrawal by Subject|2
7509446|NCT02358369|11837692|FG002|Treatment Period A/B|Withdrawal by Subject|0
7509447|NCT02358369|11837693|FG003|Treatment Period A/B|Withdrawal by Subject|2
7509448|NCT02358369|11837694|FG004|Treatment Period A/B|Withdrawal by Subject|0
7509449|NCT02358369|11837690|FG000|Treatment Period C|Adverse Event|0
7509450|NCT02358369|11837691|FG001|Treatment Period C|Adverse Event|0
7509451|NCT02358369|11837692|FG002|Treatment Period C|Adverse Event|0
7509452|NCT02358369|11837693|FG003|Treatment Period C|Adverse Event|0
7509453|NCT02358369|11837694|FG004|Treatment Period C|Adverse Event|7
7509454|NCT02358473|11837704|FG000|Overall Study|Disease Progession|6
7509455|NCT02358473|11837704|FG000|Overall Study|Adverse Event|3
7509456|NCT02358473|11837704|FG000|Overall Study|Withdrawal by Subject|2
7509457|NCT02358473|11837704|FG000|Overall Study|Physician Decision|2
7509458|NCT02358668|11837720|FG000|Overall Study|Adverse Event|2
7509459|NCT02358668|11837721|FG001|Overall Study|Adverse Event|0
7509460|NCT02358668|11837722|FG002|Overall Study|Adverse Event|0
7509461|NCT02358668|11837720|FG000|Overall Study|Withdrawal by Subject|0
7509462|NCT02358668|11837721|FG001|Overall Study|Withdrawal by Subject|1
7509463|NCT02358668|11837722|FG002|Overall Study|Withdrawal by Subject|0
7509464|NCT02358863|11837730|FG000|Overall Study|Physician Decision|3
7509465|NCT02359045|11837768|FG000|Overall Study|Eligibility criteria not fulfilled|3
7509466|NCT02359045|11837769|FG001|Overall Study|Eligibility criteria not fulfilled|1
7509467|NCT02359045|11837768|FG000|Overall Study|Lost to Follow-up|1
7509468|NCT02359045|11837769|FG001|Overall Study|Lost to Follow-up|1
7509469|NCT02359045|11837768|FG000|Overall Study|Adverse Event|0
7509470|NCT02359045|11837769|FG001|Overall Study|Adverse Event|1
7509471|NCT02359435|11837819|FG000|Overall Study|Lost to Follow-up|4
7509472|NCT02359435|11837820|FG001|Overall Study|Lost to Follow-up|4
7509473|NCT02359552|11837828|FG000|Overall Study|Lost to Follow-up|3
7509474|NCT02359552|11837829|FG001|Overall Study|Lost to Follow-up|4
7509475|NCT02359851|11837835|FG000|Overall Study|Death|1
7509476|NCT02359851|11837835|FG000|Overall Study|Disease progression|1
7509477|NCT02359877|11837843|FG000|Overall Study|Withdrawal by Subject|1
7509478|NCT02359877|11837844|FG001|Overall Study|Withdrawal by Subject|0
7509479|NCT02359877|11837845|FG002|Overall Study|Withdrawal by Subject|0
7509480|NCT02359877|11837846|FG003|Overall Study|Withdrawal by Subject|2
7509481|NCT02359877|11837843|FG000|Overall Study|Adverse Event|0
7509482|NCT02359877|11837844|FG001|Overall Study|Adverse Event|0
7509483|NCT02359877|11837845|FG002|Overall Study|Adverse Event|0
7509484|NCT02359877|11837846|FG003|Overall Study|Adverse Event|1
7509485|NCT02359890|11837874|FG000|Overall Study|Not meeting eligibility|4
7509486|NCT02359890|11837874|FG000|Overall Study|Never treated with study catheter|6
7509487|NCT02359903|11837880|FG000|Overall Study|Adverse Event|0
7509488|NCT02359903|11837881|FG001|Overall Study|Adverse Event|2
7509489|NCT02360098|11837947|FG000|Overall Study|Physician Decision|7
7509490|NCT02360228|11837980|FG000|Overall Study|Withdrawal by Subject|1
7509491|NCT02360228|11837981|FG001|Overall Study|Withdrawal by Subject|0
7509492|NCT02360228|11837982|FG002|Overall Study|Withdrawal by Subject|0
7509493|NCT02360228|11837980|FG000|Overall Study|Self-discontinued medication|0
7509494|NCT02360228|11837981|FG001|Overall Study|Self-discontinued medication|1
7509495|NCT02360228|11837982|FG002|Overall Study|Self-discontinued medication|0
7509496|NCT02360228|11837980|FG000|Overall Study|Unstable symptoms during screening|0
7509497|NCT02360228|11837981|FG001|Overall Study|Unstable symptoms during screening|0
7509498|NCT02360228|11837982|FG002|Overall Study|Unstable symptoms during screening|1
7509499|NCT02360293|11837992|FG000|Overall Study|Lost to Follow-up|73
7509500|NCT02360293|11837993|FG001|Overall Study|Lost to Follow-up|95
7509501|NCT02360293|11837992|FG000|Overall Study|Withdrawal by Subject|2
7509502|NCT02360293|11837993|FG001|Overall Study|Withdrawal by Subject|1
7509503|NCT02360293|11837992|FG000|Overall Study|Excluded|1
7509504|NCT02360293|11837993|FG001|Overall Study|Excluded|0
7509505|NCT02360397|11838021|FG000|Overall Study|Incomplete screening|3
7509506|NCT02360397|11838021|FG000|Overall Study|Adverse Event|1
7509507|NCT02360475|11838030|FG000|Overall Study|Lost to Follow-up|4
7509508|NCT02360475|11838031|FG001|Overall Study|Lost to Follow-up|12
7509509|NCT02360475|11838032|FG002|Overall Study|Lost to Follow-up|6
7509510|NCT02360475|11838033|FG003|Overall Study|Lost to Follow-up|4
7509511|NCT02360475|11838030|FG000|Overall Study|Withdrawal by Subject|0
7509512|NCT02360475|11838031|FG001|Overall Study|Withdrawal by Subject|1
7509513|NCT02360475|11838032|FG002|Overall Study|Withdrawal by Subject|2
7509514|NCT02360475|11838033|FG003|Overall Study|Withdrawal by Subject|0
7509515|NCT02360475|11838030|FG000|Overall Study|Migrated/moved from study area|0
7509516|NCT02360475|11838031|FG001|Overall Study|Migrated/moved from study area|0
7509517|NCT02360475|11838032|FG002|Overall Study|Migrated/moved from study area|0
7509518|NCT02360475|11838033|FG003|Overall Study|Migrated/moved from study area|1
7509519|NCT02360605|11838054|FG000|Overall Study|Withdrawal by Subject|4
7509520|NCT02360605|11838055|FG001|Overall Study|Withdrawal by Subject|9
7509521|NCT02360605|11838054|FG000|Overall Study|Lost to Follow-up|7
7509522|NCT02360605|11838055|FG001|Overall Study|Lost to Follow-up|8
7509523|NCT02360605|11838054|FG000|Overall Study|Death|0
7509524|NCT02360605|11838055|FG001|Overall Study|Death|1
7509525|NCT02360995|11838086|FG000|Overall Study|Lost to Follow-up|2
7509526|NCT02360995|11838087|FG001|Overall Study|Lost to Follow-up|0
7509527|NCT02360995|11838088|FG002|Overall Study|Lost to Follow-up|2
7509528|NCT02360995|11838086|FG000|Overall Study|Withdrawal by Subject|0
7509529|NCT02360995|11838087|FG001|Overall Study|Withdrawal by Subject|1
7509530|NCT02360995|11838088|FG002|Overall Study|Withdrawal by Subject|0
7509531|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
7509532|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
7509533|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
7509534|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
7509535|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
7509536|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
7509537|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
7509538|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
7509539|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7509540|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
7509541|NCT02361216|11838098|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
7509542|NCT02361216|11838099|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
7509543|NCT02361307|11838110|FG000|Overall Study|Unstable medical condition.|0
7509544|NCT02361307|11838111|FG001|Overall Study|Unstable medical condition.|1
7509545|NCT02361762|11838137|FG000|Overall Study|Withdrawal by Subject|0
7509546|NCT02361762|11838138|FG001|Overall Study|Withdrawal by Subject|1
7509547|NCT02361762|11838137|FG000|Overall Study|Lost to Follow-up|0
7509548|NCT02361762|11838138|FG001|Overall Study|Lost to Follow-up|1
7509549|NCT02362269|11838159|FG000|Overall Study|Moved|1
7509550|NCT02362269|11838160|FG001|Overall Study|Moved|0
7509551|NCT02362269|11838159|FG000|Overall Study|Lost to Follow-up|0
7509552|NCT02362269|11838160|FG001|Overall Study|Lost to Follow-up|6
7509553|NCT02362282|11838168|FG000|Overall Study|Withdrawal by Subject|1
7509554|NCT02362282|11838169|FG001|Overall Study|Withdrawal by Subject|0
7509555|NCT02362360|11838184|FG000|Period 1|Lack of Efficacy|1
7509556|NCT02362360|11838185|FG001|Period 1|Lack of Efficacy|0
7509557|NCT02362360|11838184|FG000|Period 1|Withdrawal by Subject|2
7509558|NCT02362360|11838185|FG001|Period 1|Withdrawal by Subject|1
7509559|NCT02362412|11838195|FG000|Treatment Period III|Lost to Follow-up|0
7509560|NCT02362412|11838196|FG001|Treatment Period III|Lost to Follow-up|1
7509561|NCT02362425|11838212|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
7509562|NCT02362425|11838213|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7509563|NCT02362425|11838214|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7509564|NCT02362425|11838215|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
7509565|NCT02362425|11838212|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
7509566|NCT02362425|11838213|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7509567|NCT02362425|11838214|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7509568|NCT02362425|11838215|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
7509569|NCT02362425|11838212|FG000|Phase 1 (up to 6 Months)|Screening failure|1
7509570|NCT02362425|11838213|FG001|Phase 1 (up to 6 Months)|Screening failure|0
7509571|NCT02362425|11838214|FG002|Phase 1 (up to 6 Months)|Screening failure|0
7509572|NCT02362425|11838215|FG003|Phase 1 (up to 6 Months)|Screening failure|0
7509573|NCT02362425|11838212|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
7509574|NCT02362425|11838213|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7509575|NCT02362425|11838214|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7509576|NCT02362425|11838215|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
7509577|NCT02362425|11838212|FG000|Phase 1 (up to 6 Months)|Study closure|9
7509578|NCT02362425|11838213|FG001|Phase 1 (up to 6 Months)|Study closure|0
7509579|NCT02362425|11838214|FG002|Phase 1 (up to 6 Months)|Study closure|0
7509580|NCT02362425|11838215|FG003|Phase 1 (up to 6 Months)|Study closure|0
7509581|NCT02362425|11838212|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7509582|NCT02362425|11838213|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7509583|NCT02362425|11838214|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
7509584|NCT02362425|11838215|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
7509585|NCT02362425|11838212|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7509586|NCT02362425|11838213|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7509587|NCT02362425|11838214|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
7509588|NCT02362425|11838215|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
7536103|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7509589|NCT02362425|11838212|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7509590|NCT02362425|11838213|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7509591|NCT02362425|11838214|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
7509592|NCT02362425|11838215|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
7509593|NCT02362646|11838237|FG000|Overall Study|Death|15
7509594|NCT02362646|11838238|FG001|Overall Study|Death|8
7509595|NCT02362646|11838237|FG000|Overall Study|Withdrawal by Subject|2
7509596|NCT02362646|11838238|FG001|Overall Study|Withdrawal by Subject|2
7509597|NCT02362646|11838237|FG000|Overall Study|received transplant|21
7509598|NCT02362646|11838238|FG001|Overall Study|received transplant|14
7509599|NCT02362724|11838261|FG000|Overall Study|Withdrawal by Subject|3
7509600|NCT02362724|11838262|FG001|Overall Study|Withdrawal by Subject|1
7509601|NCT02362724|11838261|FG000|Overall Study|Adverse Event|3
7509602|NCT02362724|11838262|FG001|Overall Study|Adverse Event|0
7509603|NCT02362789|11838270|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
7509604|NCT02362789|11838271|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7509605|NCT02362789|11838272|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
7509606|NCT02362789|11838270|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
7509607|NCT02362789|11838271|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
7509608|NCT02362789|11838272|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
7509609|NCT02362789|11838270|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
7509610|NCT02362789|11838271|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
7509611|NCT02362789|11838272|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
7509612|NCT02362789|11838270|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
7509613|NCT02362789|11838271|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
7509614|NCT02362789|11838272|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
7509615|NCT02362789|11838270|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
7509616|NCT02362789|11838271|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
7509617|NCT02362789|11838272|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
7509618|NCT02363283|11838288|FG000|Overall Study|Withdrawal by Subject|1
7509619|NCT02363283|11838288|FG000|Overall Study|Not eligible due to transaminitis|1
7509620|NCT02363322|11838294|FG000|Overall Study|Lost to Follow-up|1
7509621|NCT02363322|11838295|FG001|Overall Study|Lost to Follow-up|0
7509622|NCT02363439|11838301|FG000|Overall Study|Lack of Efficacy|4
7509623|NCT02363478|11838305|FG000|Overall Study|Lost to Follow-up|4
7509624|NCT02363478|11838305|FG000|Overall Study|Adverse Event|4
7509625|NCT02363686|11838319|FG000|Overall Study|Withdrawal by Subject|22
7509626|NCT02363686|11838319|FG000|Overall Study|incomplete FEES examinations|13
7509627|NCT02363738|11838325|FG000|Overall Study|Adverse Event|5
7509628|NCT02363738|11838326|FG001|Overall Study|Adverse Event|2
7509629|NCT02363738|11838325|FG000|Overall Study|Lack of Efficacy|1
7509630|NCT02363738|11838326|FG001|Overall Study|Lack of Efficacy|2
7509631|NCT02363738|11838325|FG000|Overall Study|Lost to Follow-up|2
7509632|NCT02363738|11838326|FG001|Overall Study|Lost to Follow-up|1
7536104|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
7536105|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7536106|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7536107|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7536108|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
7536109|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
7536110|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7536111|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7536112|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
7536113|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
7536114|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
7536115|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7536116|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7536117|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
7536118|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
7536119|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
7536120|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7536121|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7536122|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7536123|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
7536124|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
7536125|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7536126|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7536127|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
7536128|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
7536129|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
7536130|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7536131|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7509633|NCT02363946|11838368|FG000|Overall Study|Lost to Follow-up|0
7509634|NCT02363946|11838369|FG001|Overall Study|Lost to Follow-up|0
7509635|NCT02363946|11838370|FG002|Overall Study|Lost to Follow-up|0
7509636|NCT02363946|11838371|FG003|Overall Study|Lost to Follow-up|0
7509637|NCT02363946|11838372|FG004|Overall Study|Lost to Follow-up|0
7509638|NCT02363946|11838373|FG005|Overall Study|Lost to Follow-up|0
7509639|NCT02363946|11838374|FG006|Overall Study|Lost to Follow-up|0
7509640|NCT02363946|11838375|FG007|Overall Study|Lost to Follow-up|1
7509641|NCT02363946|11838376|FG008|Overall Study|Lost to Follow-up|0
7509642|NCT02363946|11838377|FG009|Overall Study|Lost to Follow-up|0
7509643|NCT02363946|11838378|FG010|Overall Study|Lost to Follow-up|0
7509644|NCT02363946|11838379|FG011|Overall Study|Lost to Follow-up|0
7509645|NCT02363946|11838380|FG012|Overall Study|Lost to Follow-up|0
7509646|NCT02363959|11838410|FG000|Overall Study|Medical instability|1
7509647|NCT02363959|11838411|FG001|Overall Study|Medical instability|0
7509648|NCT02364037|11838423|FG000|Overall Study|Withdrawal by Subject|7
7509649|NCT02364037|11838424|FG001|Overall Study|Withdrawal by Subject|4
7509650|NCT02364037|11838423|FG000|Overall Study|Lost to Follow-up|37
7509651|NCT02364037|11838424|FG001|Overall Study|Lost to Follow-up|49
7509652|NCT02364180|11838434|FG000|Overall Study|Screen Fail|1
7509653|NCT02364336|11838450|FG000|Overall Study|Adverse Event|0
7509654|NCT02364336|11838451|FG001|Overall Study|Adverse Event|1
7509655|NCT02364388|11838458|FG000|Overall Study|Protocol Violation|1
7509656|NCT02364388|11838458|FG000|Overall Study|Technical Failure|3
7509657|NCT02364388|11838458|FG000|Overall Study|No OA/US data|2
7509658|NCT02364388|11838458|FG000|Overall Study|No Biopsy|2
7509659|NCT02364947|11838502|FG000|Overall Study|Withdrawal by Subject|10
7509660|NCT02364947|11838503|FG001|Overall Study|Withdrawal by Subject|8
7509661|NCT02364947|11838504|FG002|Overall Study|Withdrawal by Subject|9
7509662|NCT02364947|11838502|FG000|Overall Study|Adverse Event|45
7509663|NCT02364947|11838503|FG001|Overall Study|Adverse Event|33
7509664|NCT02364947|11838504|FG002|Overall Study|Adverse Event|11
7509665|NCT02364947|11838502|FG000|Overall Study|Protocol Violation|1
7509666|NCT02364947|11838503|FG001|Overall Study|Protocol Violation|1
7509667|NCT02364947|11838504|FG002|Overall Study|Protocol Violation|1
7509668|NCT02364947|11838502|FG000|Overall Study|Physician Decision|3
7509669|NCT02364947|11838503|FG001|Overall Study|Physician Decision|2
7509670|NCT02364947|11838504|FG002|Overall Study|Physician Decision|5
7509671|NCT02364947|11838502|FG000|Overall Study|Death|0
7509672|NCT02364947|11838503|FG001|Overall Study|Death|1
7509673|NCT02364947|11838504|FG002|Overall Study|Death|0
7509674|NCT02364999|11838514|FG000|Overall Study|Death|136
7509675|NCT02364999|11838515|FG001|Overall Study|Death|138
7509676|NCT02364999|11838514|FG000|Overall Study|Lost to Follow-up|10
7509677|NCT02364999|11838515|FG001|Overall Study|Lost to Follow-up|15
7509678|NCT02364999|11838514|FG000|Overall Study|Protocol Violation|3
7509679|NCT02364999|11838515|FG001|Overall Study|Protocol Violation|2
7509680|NCT02364999|11838514|FG000|Overall Study|Withdrawal by Subject|14
7509681|NCT02364999|11838515|FG001|Overall Study|Withdrawal by Subject|14
7509682|NCT02364999|11838514|FG000|Overall Study|Other|0
7509683|NCT02364999|11838515|FG001|Overall Study|Other|1
7509684|NCT02364999|11838514|FG000|Overall Study|Randomized but did not receive treatment|2
7509685|NCT02364999|11838515|FG001|Overall Study|Randomized but did not receive treatment|3
7509686|NCT02365064|11838524|FG000|Overall Study|Patients met baseline exclusion requirem|2
7509687|NCT02365064|11838525|FG001|Overall Study|Patients met baseline exclusion requirem|15
7509688|NCT02365064|11838524|FG000|Overall Study|Withdrawal by Subject|6
7509689|NCT02365064|11838525|FG001|Overall Study|Withdrawal by Subject|9
7509690|NCT02365064|11838524|FG000|Overall Study|Treatment intolerance|2
7509691|NCT02365064|11838525|FG001|Overall Study|Treatment intolerance|4
7509692|NCT02365285|11838535|FG000|Overall Study|Physician Decision|0
7509693|NCT02365285|11838536|FG001|Overall Study|Physician Decision|1
7509694|NCT02365285|11838537|FG002|Overall Study|Physician Decision|1
7509695|NCT02365285|11838538|FG003|Overall Study|Physician Decision|0
7509696|NCT02365285|11838535|FG000|Overall Study|Adverse Event|0
7509697|NCT02365285|11838536|FG001|Overall Study|Adverse Event|0
7509698|NCT02365285|11838537|FG002|Overall Study|Adverse Event|0
7509699|NCT02365285|11838538|FG003|Overall Study|Adverse Event|2
7509700|NCT02365298|11838550|FG000|Period 2|incorrect Rx dispensed|1
7509701|NCT02365298|11838551|FG001|Period 2|incorrect Rx dispensed|0
7509702|NCT02365298|11838550|FG000|Period 2|Discontinued at request of Sponsor|1
7509703|NCT02365298|11838551|FG001|Period 2|Discontinued at request of Sponsor|0
7509704|NCT02365298|11838550|FG000|Period 2|Test Article longer available|0
7509705|NCT02365298|11838551|FG001|Period 2|Test Article longer available|1
7509706|NCT02365298|11838550|FG000|Period 2|Protocol Violation|0
7509707|NCT02365298|11838551|FG001|Period 2|Protocol Violation|1
7509708|NCT02365480|11838559|FG000|Overall Study|Withdrawal by Subject|2
7509709|NCT02365480|11838560|FG001|Overall Study|Withdrawal by Subject|0
7509710|NCT02365506|11838569|FG000|Overall Study|Investigator's Discretion|0
7509711|NCT02365506|11838570|FG001|Overall Study|Investigator's Discretion|0
7509712|NCT02365506|11838571|FG002|Overall Study|Investigator's Discretion|1
7509713|NCT02365519|11838581|FG000|Randomized and Treated|Adverse Event|0
7509714|NCT02365519|11838582|FG001|Randomized and Treated|Adverse Event|1
7509715|NCT02365519|11838583|FG002|Randomized and Treated|Adverse Event|0
7509716|NCT02365519|11838581|FG000|Randomized and Treated|Withdrawal by Subject|0
7509717|NCT02365519|11838582|FG001|Randomized and Treated|Withdrawal by Subject|1
7509718|NCT02365519|11838583|FG002|Randomized and Treated|Withdrawal by Subject|1
7509719|NCT02365558|11838592|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
7509720|NCT02365558|11838593|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
7509721|NCT02365558|11838592|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
7509722|NCT02365558|11838593|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
7509723|NCT02365584|11838604|FG000|Overall Study|Adverse Event|2
7509724|NCT02365584|11838605|FG001|Overall Study|Adverse Event|2
7509725|NCT02365584|11838604|FG000|Overall Study|Withdrawal by Subject|1
7509726|NCT02365584|11838605|FG001|Overall Study|Withdrawal by Subject|0
7509727|NCT02365584|11838604|FG000|Overall Study|Disease Progression|9
7509728|NCT02365584|11838605|FG001|Overall Study|Disease Progression|12
7509729|NCT02365636|11838614|FG000|Overall Study|Adverse Event|3
7509730|NCT02365636|11838615|FG001|Overall Study|Adverse Event|3
7509731|NCT02365636|11838616|FG002|Overall Study|Adverse Event|2
7509732|NCT02365636|11838614|FG000|Overall Study|Protocol Violation|1
7509733|NCT02365636|11838615|FG001|Overall Study|Protocol Violation|4
7509734|NCT02365636|11838616|FG002|Overall Study|Protocol Violation|0
7509735|NCT02365636|11838614|FG000|Overall Study|Lost to Follow-up|0
7509736|NCT02365636|11838615|FG001|Overall Study|Lost to Follow-up|0
7509737|NCT02365636|11838616|FG002|Overall Study|Lost to Follow-up|1
7509738|NCT02365636|11838614|FG000|Overall Study|Other|2
7509739|NCT02365636|11838615|FG001|Overall Study|Other|0
7509740|NCT02365636|11838616|FG002|Overall Study|Other|0
7509741|NCT02366091|11838650|FG000|Overall Study|Withdrawal by Subject|3
7509742|NCT02366091|11838651|FG001|Overall Study|Withdrawal by Subject|7
7509743|NCT02366091|11838652|FG002|Overall Study|Withdrawal by Subject|3
7509744|NCT02366091|11838653|FG003|Overall Study|Withdrawal by Subject|1
7509745|NCT02366130|11838663|FG000|Overall Study|Withdrawal by Subject|3
7509746|NCT02366130|11838663|FG000|Overall Study|Ineligible|6
7509747|NCT02366143|11838670|FG000|Overall Study|Death|307
7509748|NCT02366143|11838671|FG001|Overall Study|Death|278
7509749|NCT02366143|11838672|FG002|Overall Study|Death|280
7509750|NCT02366143|11838670|FG000|Overall Study|Lost to Follow-up|2
7509751|NCT02366143|11838671|FG001|Overall Study|Lost to Follow-up|4
7509752|NCT02366143|11838672|FG002|Overall Study|Lost to Follow-up|2
7509753|NCT02366143|11838670|FG000|Overall Study|Physician Decision|1
7509754|NCT02366143|11838671|FG001|Overall Study|Physician Decision|2
7509755|NCT02366143|11838672|FG002|Overall Study|Physician Decision|1
7509756|NCT02366143|11838670|FG000|Overall Study|Protocol Violation|0
7509757|NCT02366143|11838671|FG001|Overall Study|Protocol Violation|0
7509758|NCT02366143|11838672|FG002|Overall Study|Protocol Violation|2
7509759|NCT02366143|11838670|FG000|Overall Study|Withdrawal by Subject|16
7509760|NCT02366143|11838671|FG001|Overall Study|Withdrawal by Subject|17
7509761|NCT02366143|11838672|FG002|Overall Study|Withdrawal by Subject|22
7509762|NCT02366143|11838670|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
7509763|NCT02366143|11838671|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
7509764|NCT02366143|11838672|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
7509765|NCT02366143|11838670|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7509766|NCT02366143|11838671|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
7509767|NCT02366143|11838672|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
7509768|NCT02366143|11838670|FG000|Overall Study|Randomization Error|1
7509769|NCT02366143|11838671|FG001|Overall Study|Randomization Error|0
7509770|NCT02366143|11838672|FG002|Overall Study|Randomization Error|0
7509771|NCT02366143|11838670|FG000|Overall Study|PI Move and Site Closure|1
7509772|NCT02366143|11838671|FG001|Overall Study|PI Move and Site Closure|0
7509773|NCT02366143|11838672|FG002|Overall Study|PI Move and Site Closure|1
7509774|NCT02366143|11838670|FG000|Overall Study|Study Terminated By Sponsor|0
7509775|NCT02366143|11838671|FG001|Overall Study|Study Terminated By Sponsor|0
7509776|NCT02366143|11838672|FG002|Overall Study|Study Terminated By Sponsor|2
7509777|NCT02366143|11838670|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
7509778|NCT02366143|11838671|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
7509779|NCT02366143|11838672|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
7509780|NCT02366143|11838670|FG000|Overall Study|Patient moved to roll-over study|1
7509781|NCT02366143|11838671|FG001|Overall Study|Patient moved to roll-over study|19
7509782|NCT02366143|11838672|FG002|Overall Study|Patient moved to roll-over study|28
7509783|NCT02366143|11838670|FG000|Overall Study|Patient moved to commercial stock|0
7509784|NCT02366143|11838671|FG001|Overall Study|Patient moved to commercial stock|0
7509785|NCT02366143|11838672|FG002|Overall Study|Patient moved to commercial stock|1
7509786|NCT02366143|11838670|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7509787|NCT02366143|11838671|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
7509788|NCT02366143|11838672|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
7509789|NCT02366143|11838670|FG000|Overall Study|Patient rolling over to patient assistance program|0
7509790|NCT02366143|11838671|FG001|Overall Study|Patient rolling over to patient assistance program|0
7509791|NCT02366143|11838672|FG002|Overall Study|Patient rolling over to patient assistance program|1
7509792|NCT02366143|11838670|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7509793|NCT02366143|11838671|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
7509794|NCT02366143|11838672|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
7509795|NCT02366143|11838670|FG000|Overall Study|Requester's instructions|1
7509796|NCT02366143|11838671|FG001|Overall Study|Requester's instructions|1
7509797|NCT02366143|11838672|FG002|Overall Study|Requester's instructions|1
7509798|NCT02366143|11838670|FG000|Overall Study|Uneligible|0
7509799|NCT02366143|11838671|FG001|Overall Study|Uneligible|1
7509800|NCT02366143|11838672|FG002|Overall Study|Uneligible|0
7509801|NCT02366143|11838670|FG000|Overall Study|Post Trial Migration|0
7509802|NCT02366143|11838671|FG001|Overall Study|Post Trial Migration|1
7509803|NCT02366143|11838672|FG002|Overall Study|Post Trial Migration|0
7509804|NCT02366143|11838670|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
7509805|NCT02366143|11838671|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
7509806|NCT02366143|11838672|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
7509807|NCT02366143|11838670|FG000|Overall Study|Patient switched to PTAP|0
7509808|NCT02366143|11838671|FG001|Overall Study|Patient switched to PTAP|1
7509809|NCT02366143|11838672|FG002|Overall Study|Patient switched to PTAP|0
7509810|NCT02366143|11838670|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
7509811|NCT02366143|11838671|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
7509812|NCT02366143|11838672|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
7509813|NCT02366195|11838684|FG000|Overall Study|Protocol-specified criteria|3
7509814|NCT02366195|11838684|FG000|Overall Study|Withdrawal by Subject|9
7509815|NCT02366195|11838684|FG000|Overall Study|Lost to Follow-up|1
7509816|NCT02366195|11838684|FG000|Overall Study|Death|41
7509817|NCT02366312|11838690|FG000|Overall Study|Lost to Follow-up|0
7509818|NCT02366312|11838691|FG001|Overall Study|Lost to Follow-up|1
7509819|NCT02366468|11838712|FG000|Overall Study|Adverse Event|2
7509820|NCT02366468|11838713|FG001|Overall Study|Adverse Event|0
7509821|NCT02366468|11838712|FG000|Overall Study|Withdrawal by Subject|1
7509822|NCT02366468|11838713|FG001|Overall Study|Withdrawal by Subject|5
7509823|NCT02366468|11838712|FG000|Overall Study|Lost to Follow-up|2
7509824|NCT02366468|11838713|FG001|Overall Study|Lost to Follow-up|0
7509825|NCT02366468|11838712|FG000|Overall Study|Death|1
7509826|NCT02366468|11838713|FG001|Overall Study|Death|2
7509827|NCT02366468|11838712|FG000|Overall Study|Other|0
7509828|NCT02366468|11838713|FG001|Overall Study|Other|2
7509829|NCT02366637|11838729|FG000|First Intervention Period|Adverse Event|0
7509830|NCT02366637|11838730|FG001|First Intervention Period|Adverse Event|1
7509831|NCT02366637|11838729|FG000|First Intervention Period|Study Terminated by Sponsor|6
7509832|NCT02366637|11838730|FG001|First Intervention Period|Study Terminated by Sponsor|4
7509833|NCT02366637|11838729|FG000|Second Intervention Period|Study Terminated by Sponsor|1
7509834|NCT02366637|11838730|FG001|Second Intervention Period|Study Terminated by Sponsor|1
7509835|NCT02366689|11838748|FG000|Overall Study|Withdrawal by Subject|1
7509836|NCT02366689|11838749|FG001|Overall Study|Withdrawal by Subject|0
7509837|NCT02366689|11838750|FG002|Overall Study|Withdrawal by Subject|1
7509838|NCT02366689|11838748|FG000|Overall Study|Lost to Follow-up|3
7509839|NCT02366689|11838749|FG001|Overall Study|Lost to Follow-up|2
7509840|NCT02366689|11838750|FG002|Overall Study|Lost to Follow-up|0
7509841|NCT02366689|11838748|FG000|Overall Study|Pregnancy|0
7509842|NCT02366689|11838749|FG001|Overall Study|Pregnancy|1
7509843|NCT02366689|11838750|FG002|Overall Study|Pregnancy|1
7509844|NCT02366767|11838760|FG000|Overall Study|left for home after 1 day at camp|1
7509845|NCT02366767|11838761|FG001|Overall Study|left for home after 1 day at camp|0
7509846|NCT02366910|11838785|FG000|Overall Study|Withdrawal by Subject|2
7509847|NCT02366910|11838785|FG000|Overall Study|Screen Failure|3
7509848|NCT02366923|11838791|FG000|Overall Study|Withdrawal by Subject|1
7509849|NCT02366923|11838791|FG000|Overall Study|Positive Slit Lamp Findings|2
7509850|NCT02366923|11838791|FG000|Overall Study|High Astigmatism|3
7509851|NCT02366936|11838796|FG000|Overall Study|Withdrawal by Subject|2
7509852|NCT02366936|11838796|FG000|Overall Study|Lost to Follow-up|4
7509853|NCT02366936|11838796|FG000|Overall Study|Physician Decision|2
7509854|NCT02367131|11838833|FG000|Overall Study|Adverse Event|64
7509855|NCT02367131|11838833|FG000|Overall Study|No visit since the first visit|4
7509856|NCT02367131|11838833|FG000|Overall Study|Request by patient|54
7509857|NCT02367131|11838833|FG000|Overall Study|Improvement/remission|2
7509858|NCT02367131|11838833|FG000|Overall Study|No change/progressive disease|78
7509859|NCT02367131|11838833|FG000|Overall Study|Other than stated above|20
7509860|NCT02367352|11838837|FG000|Overall Study|Progressive disease|7
7509861|NCT02367352|11838838|FG001|Overall Study|Progressive disease|0
7509862|NCT02367352|11838839|FG002|Overall Study|Progressive disease|0
7509863|NCT02367352|11838837|FG000|Overall Study|Participant Received Alternative Therapy|1
7509864|NCT02367352|11838838|FG001|Overall Study|Participant Received Alternative Therapy|0
7509865|NCT02367352|11838839|FG002|Overall Study|Participant Received Alternative Therapy|0
7509866|NCT02367352|11838837|FG000|Overall Study|Adverse Event|1
7509867|NCT02367352|11838838|FG001|Overall Study|Adverse Event|0
7509868|NCT02367352|11838839|FG002|Overall Study|Adverse Event|0
7509869|NCT02367521|11838860|FG000|Overall Study|severe headache after intervention|2
7509870|NCT02367521|11838861|FG001|Overall Study|severe headache after intervention|0
7509871|NCT02367521|11838860|FG000|Overall Study|unable to find transportation|2
7509872|NCT02367521|11838861|FG001|Overall Study|unable to find transportation|0
7509873|NCT02367716|11838876|FG000|Overall Study|Patient did not meet inclusion criteria|1
7509874|NCT02367729|11838883|FG000|Overall Study|Organic disorder diagnosed|2
7509875|NCT02367729|11838884|FG001|Overall Study|Organic disorder diagnosed|1
7509876|NCT02367729|11838883|FG000|Overall Study|Adverse Event|1
7509877|NCT02367729|11838884|FG001|Overall Study|Adverse Event|2
7509878|NCT02367729|11838883|FG000|Overall Study|Withdrawal by Subject|0
7509879|NCT02367729|11838884|FG001|Overall Study|Withdrawal by Subject|5
7509880|NCT02367781|11838893|FG000|Overall Study|Withdrawal by Subject|20
7509881|NCT02367781|11838894|FG001|Overall Study|Withdrawal by Subject|13
7509882|NCT02367781|11838893|FG000|Overall Study|Protocol Violation|0
7509883|NCT02367781|11838894|FG001|Overall Study|Protocol Violation|1
7509884|NCT02367781|11838893|FG000|Overall Study|Physician Decision|7
7509885|NCT02367781|11838894|FG001|Overall Study|Physician Decision|0
7509886|NCT02367781|11838893|FG000|Overall Study|Randomized in Error|5
7509887|NCT02367781|11838894|FG001|Overall Study|Randomized in Error|4
7509888|NCT02367781|11838893|FG000|Overall Study|Non-Compliance|1
7509889|NCT02367781|11838894|FG001|Overall Study|Non-Compliance|0
7509890|NCT02367781|11838893|FG000|Overall Study|Lost to Follow-up|1
7509891|NCT02367781|11838894|FG001|Overall Study|Lost to Follow-up|2
7509892|NCT02367781|11838893|FG000|Overall Study|Death|330
7509893|NCT02367781|11838894|FG001|Overall Study|Death|176
7509894|NCT02367781|11838893|FG000|Overall Study|Patient Moving to Roll-Over Study|17
7509895|NCT02367781|11838894|FG001|Overall Study|Patient Moving to Roll-Over Study|5
7509896|NCT02367781|11838893|FG000|Overall Study|Prolonged Hospitalization|1
7509897|NCT02367781|11838894|FG001|Overall Study|Prolonged Hospitalization|0
7509898|NCT02367781|11838893|FG000|Overall Study|Death Prior First Dose|1
7509899|NCT02367781|11838894|FG001|Overall Study|Death Prior First Dose|0
7509900|NCT02367781|11838893|FG000|Overall Study|Administrative-Change Facility|1
7509901|NCT02367781|11838894|FG001|Overall Study|Administrative-Change Facility|0
7509902|NCT02367781|11838893|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
7509903|NCT02367781|11838894|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
7509904|NCT02367781|11838893|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
7509905|NCT02367781|11838894|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
7509906|NCT02367781|11838893|FG000|Overall Study|Study Terminated by Sponsor|3
7509907|NCT02367781|11838894|FG001|Overall Study|Study Terminated by Sponsor|1
7509908|NCT02367781|11838893|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
7509909|NCT02367781|11838894|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
7509910|NCT02367781|11838893|FG000|Overall Study|Sponsor Decision|2
7509911|NCT02367781|11838894|FG001|Overall Study|Sponsor Decision|0
7509912|NCT02367781|11838893|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
7509913|NCT02367781|11838894|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
7509914|NCT02367833|11838919|FG000|Overall Study|Withdrawal by Subject|1
7509915|NCT02367833|11838920|FG001|Overall Study|Withdrawal by Subject|1
7509916|NCT02367833|11838921|FG002|Overall Study|Withdrawal by Subject|0
7509917|NCT02367885|11838978|FG000|Overall Study|Lost to Follow-up|1
7509918|NCT02367885|11838979|FG001|Overall Study|Lost to Follow-up|0
7509919|NCT02367885|11838980|FG002|Overall Study|Lost to Follow-up|0
7509920|NCT02367885|11838978|FG000|Overall Study|Withdrawal by Subject|1
7509921|NCT02367885|11838979|FG001|Overall Study|Withdrawal by Subject|0
7509922|NCT02367885|11838980|FG002|Overall Study|Withdrawal by Subject|0
7509923|NCT02367911|11838993|FG000|Overall Study|Withdrawal by Subject|3
7509924|NCT02367911|11838994|FG001|Overall Study|Withdrawal by Subject|2
7509925|NCT02367911|11838993|FG000|Overall Study|Lost to Follow-up|2
7509926|NCT02367911|11838994|FG001|Overall Study|Lost to Follow-up|2
7509927|NCT02368210|11839011|FG000|Overall Study|Withdrawal by Subject|1
7509928|NCT02368210|11839012|FG001|Overall Study|Withdrawal by Subject|0
7509929|NCT02368210|11839011|FG000|Overall Study|Adverse Event|0
7509930|NCT02368210|11839012|FG001|Overall Study|Adverse Event|1
7509931|NCT02368314|11839020|FG000|Overall Study|Withdrawal by Subject|2
7509932|NCT02368314|11839021|FG001|Overall Study|Withdrawal by Subject|1
7509933|NCT02368314|11839020|FG000|Overall Study|Adverse Event|1
7509934|NCT02368314|11839021|FG001|Overall Study|Adverse Event|2
7509935|NCT02368691|11839046|FG000|Overall Study|Death|13
7509936|NCT02368691|11839046|FG000|Overall Study|Lack of Efficacy|15
7509937|NCT02368691|11839046|FG000|Overall Study|Physician Decision|4
7509938|NCT02369159|11839061|FG000|Overall Study|Adverse Event|0
7509939|NCT02369159|11839062|FG001|Overall Study|Adverse Event|1
7509940|NCT02369159|11839061|FG000|Overall Study|Lost to Follow-up|1
7509941|NCT02369159|11839062|FG001|Overall Study|Lost to Follow-up|1
7509942|NCT02369159|11839061|FG000|Overall Study|Withdrawal by Subject|7
7509943|NCT02369159|11839062|FG001|Overall Study|Withdrawal by Subject|0
7509944|NCT02369341|11839112|FG000|Overall Study|Migrated/moved from study area|1
7509945|NCT02369341|11839113|FG001|Overall Study|Migrated/moved from study area|0
7509946|NCT02369510|11839130|FG000|Overall Study|Spilled Medication|1
7509947|NCT02369510|11839131|FG001|Overall Study|Spilled Medication|2
7509948|NCT02369510|11839132|FG002|Overall Study|Spilled Medication|1
7509949|NCT02369510|11839130|FG000|Overall Study|Epidural Activation|1
7509950|NCT02369510|11839131|FG001|Overall Study|Epidural Activation|1
7509951|NCT02369510|11839132|FG002|Overall Study|Epidural Activation|5
7509952|NCT02369848|11839170|FG000|Overall Study|Death|1
7509953|NCT02369848|11839170|FG000|Overall Study|Withdrawal by Subject|2
7509954|NCT02369848|11839170|FG000|Overall Study|Lost to Follow-up|1
7509955|NCT02369874|11839177|FG000|Overall Study|Lost to Follow-up|2
7509956|NCT02369874|11839178|FG001|Overall Study|Lost to Follow-up|2
7509957|NCT02369874|11839179|FG002|Overall Study|Lost to Follow-up|2
7509958|NCT02369874|11839177|FG000|Overall Study|Withdrawal by Subject|7
7509959|NCT02369874|11839178|FG001|Overall Study|Withdrawal by Subject|9
7509960|NCT02369874|11839179|FG002|Overall Study|Withdrawal by Subject|27
7509961|NCT02369874|11839177|FG000|Overall Study|Miscellaneous|1
7509962|NCT02369874|11839178|FG001|Overall Study|Miscellaneous|1
7509963|NCT02369874|11839179|FG002|Overall Study|Miscellaneous|0
7509964|NCT02369874|11839177|FG000|Overall Study|On Treatment/Off Study|34
7509965|NCT02369874|11839178|FG001|Overall Study|On Treatment/Off Study|45
7509966|NCT02369874|11839179|FG002|Overall Study|On Treatment/Off Study|32
7509967|NCT02370043|11839205|FG000|Overall Study|Withdrawal by Subject|0
7509968|NCT02370043|11839206|FG001|Overall Study|Withdrawal by Subject|0
7509969|NCT02370043|11839207|FG002|Overall Study|Withdrawal by Subject|0
7509970|NCT02370043|11839208|FG003|Overall Study|Withdrawal by Subject|0
7509971|NCT02370043|11839209|FG004|Overall Study|Withdrawal by Subject|1
7509972|NCT02370043|11839210|FG005|Overall Study|Withdrawal by Subject|1
7509973|NCT02370095|11839249|FG000|Overall Study|Withdrawal by Subject|0
7509974|NCT02370095|11839250|FG001|Overall Study|Withdrawal by Subject|1
7509975|NCT02370121|11839258|FG000|Overall Study|Lost to Follow-up|1
7509976|NCT02370121|11839259|FG001|Overall Study|Lost to Follow-up|1
7509977|NCT02370160|11839265|FG000|Overall Study|Death|3
7509978|NCT02370160|11839266|FG001|Overall Study|Death|4
7509979|NCT02370160|11839267|FG002|Overall Study|Death|1
7509988|NCT02370251|11839293|FG000|Overall Study|Received less than 8 days of Omegaven|7
7509989|NCT02370251|11839293|FG000|Overall Study|Death|4
7509990|NCT02370368|11839299|FG000|Overall Study|Adverse Event|1
7509991|NCT02370368|11839300|FG001|Overall Study|Adverse Event|2
7509992|NCT02370368|11839299|FG000|Overall Study|Withdrawal by Subject|5
7509993|NCT02370368|11839300|FG001|Overall Study|Withdrawal by Subject|4
7509994|NCT02370394|11839308|FG000|Overall Study|Lost to Follow-up|2
7509995|NCT02370394|11839309|FG001|Overall Study|Lost to Follow-up|1
7509996|NCT02370394|11839308|FG000|Overall Study|Withdrawal by Subject|0
7509997|NCT02370394|11839309|FG001|Overall Study|Withdrawal by Subject|1
7509998|NCT02370420|11839331|FG000|Overall Study|Physician Decision|3
7509999|NCT02370420|11839332|FG001|Overall Study|Physician Decision|3
7510000|NCT02370420|11839331|FG000|Overall Study|Lost to Follow-up|11
7510001|NCT02370420|11839332|FG001|Overall Study|Lost to Follow-up|9
7510002|NCT02370498|11839340|FG000|Overall Study|Adverse Event|10
7510003|NCT02370498|11839341|FG001|Overall Study|Adverse Event|8
7510004|NCT02370498|11839340|FG000|Overall Study|Death|263
7510005|NCT02370498|11839341|FG001|Overall Study|Death|265
7510006|NCT02370498|11839340|FG000|Overall Study|Protocol Violation|1
7510007|NCT02370498|11839341|FG001|Overall Study|Protocol Violation|2
7510008|NCT02370498|11839340|FG000|Overall Study|Withdrawal by Subject|7
7510009|NCT02370498|11839341|FG001|Overall Study|Withdrawal by Subject|12
7510010|NCT02370498|11839340|FG000|Overall Study|Sponsor's decision|15
7510011|NCT02370498|11839341|FG001|Overall Study|Sponsor's decision|9
7510012|NCT02370511|11839351|FG000|Overall Study|Death|10
7510013|NCT02370511|11839352|FG001|Overall Study|Death|7
7510014|NCT02370511|11839353|FG002|Overall Study|Death|1
7510015|NCT02370511|11839351|FG000|Overall Study|Withdrawal by Subject|2
7510016|NCT02370511|11839352|FG001|Overall Study|Withdrawal by Subject|0
7510017|NCT02370511|11839353|FG002|Overall Study|Withdrawal by Subject|0
7510018|NCT02370511|11839351|FG000|Overall Study|Lost to Follow-up|0
7510019|NCT02370511|11839352|FG001|Overall Study|Lost to Follow-up|4
7510020|NCT02370511|11839353|FG002|Overall Study|Lost to Follow-up|0
7510021|NCT02370537|11839364|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7510022|NCT02370537|11839365|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
7510023|NCT02370537|11839366|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
7510024|NCT02370537|11839364|FG000|Part A (Open-label Recruitment)|Adverse Event|0
7510025|NCT02370537|11839365|FG001|Part A (Open-label Recruitment)|Adverse Event|0
7510026|NCT02370537|11839366|FG002|Part A (Open-label Recruitment)|Adverse Event|1
7510027|NCT02370537|11839364|FG000|Part B|Not randomised to receive treatment|1
7510028|NCT02370537|11839365|FG001|Part B|Not randomised to receive treatment|2
7510029|NCT02370537|11839366|FG002|Part B|Not randomised to receive treatment|259
7510030|NCT02370537|11839364|FG000|Part B|Withdrawal by Subject|0
7510031|NCT02370537|11839365|FG001|Part B|Withdrawal by Subject|1
7510032|NCT02370537|11839366|FG002|Part B|Withdrawal by Subject|0
7510033|NCT02370602|11839389|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7510034|NCT02370602|11839390|FG001|Overall Study|Pretreatment Event/Adverse Event|0
7510035|NCT02370602|11839391|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7510036|NCT02370602|11839392|FG003|Overall Study|Pretreatment Event/Adverse Event|0
7510037|NCT02370602|11839393|FG004|Overall Study|Pretreatment Event/Adverse Event|0
7510038|NCT02370602|11839394|FG005|Overall Study|Pretreatment Event/Adverse Event|0
7510039|NCT02370615|11839413|FG000|Overall Study|Adverse Event|1
7510040|NCT02370615|11839414|FG001|Overall Study|Adverse Event|0
7510041|NCT02370641|11839429|FG000|Overall Study|dropped study|4
7510042|NCT02370641|11839430|FG001|Overall Study|dropped study|2
7510043|NCT02370667|11839439|FG000|Overall Study|Lost to Follow-up|0
7510044|NCT02370667|11839440|FG001|Overall Study|Lost to Follow-up|1
7510045|NCT02370667|11839441|FG002|Overall Study|Lost to Follow-up|0
7510046|NCT02370784|11839461|FG000|Overall Study|Patient started prohibited medication|0
7510047|NCT02370784|11839462|FG001|Overall Study|Patient started prohibited medication|1
7536132|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
7536133|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7536134|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
7536135|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7536136|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7536137|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
7536138|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
7536139|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7536140|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7536141|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7536142|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
7536143|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Technical error|1
7536144|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Technical error|0
7536145|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Technical error|0
7536146|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Technical error|0
7536147|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Technical error|0
7536148|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Patient decision|5
7536149|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Patient decision|2
7536150|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Patient decision|0
7536151|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Patient decision|0
7536152|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Patient decision|0
7536153|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
7536154|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7536155|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7536156|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7536157|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
7536158|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
7536159|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
7536160|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
7536161|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
7536162|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
7536163|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7536164|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
7536165|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7536166|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7536167|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
7536168|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
7536169|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
7536170|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
7536171|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
7536172|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
7536173|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7536174|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
7536175|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7536176|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7536177|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
7536178|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
7536179|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7536180|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7536181|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7536182|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
7536183|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7536184|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
7536185|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7536186|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7536187|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
7536188|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
7553123|NCT03007953|11913924|FG000|Overall Study|Lost to Follow-up|3
7510049|NCT02371616|11839530|FG000|Overall Study|Protocol Violation|2
7510050|NCT02371616|11839531|FG001|Overall Study|Protocol Violation|1
7510051|NCT02371616|11839530|FG000|Overall Study|Adverse Event|0
7510052|NCT02371616|11839531|FG001|Overall Study|Adverse Event|1
7510053|NCT02371616|11839530|FG000|Overall Study|Withdrawal of Consent|1
7510054|NCT02371616|11839531|FG001|Overall Study|Withdrawal of Consent|0
7510055|NCT02371616|11839530|FG000|Overall Study|Other (Not specified)|1
7510056|NCT02371616|11839531|FG001|Overall Study|Other (Not specified)|5
7510057|NCT02371629|11839539|FG000|Overall Study|Patient decision|14
7510058|NCT02371629|11839540|FG001|Overall Study|Patient decision|10
7510059|NCT02371629|11839539|FG000|Overall Study|Adverse Event|8
7510060|NCT02371629|11839540|FG001|Overall Study|Adverse Event|8
7510061|NCT02371629|11839539|FG000|Overall Study|Physician Decision|2
7510062|NCT02371629|11839540|FG001|Overall Study|Physician Decision|3
7510063|NCT02371629|11839539|FG000|Overall Study|Death|1
7510064|NCT02371629|11839540|FG001|Overall Study|Death|1
7510065|NCT02371629|11839539|FG000|Overall Study|Noncompliance with study treatment|1
7510066|NCT02371629|11839540|FG001|Overall Study|Noncompliance with study treatment|0
7510067|NCT02371629|11839539|FG000|Overall Study|Lack of Efficacy|0
7510068|NCT02371629|11839540|FG001|Overall Study|Lack of Efficacy|2
7510069|NCT02371629|11839539|FG000|Overall Study|Protocol deviation|0
7510070|NCT02371629|11839540|FG001|Overall Study|Protocol deviation|1
7510071|NCT02371746|11839562|FG000|Overall Study|Consent withdrawn|0
7510072|NCT02371746|11839563|FG001|Overall Study|Consent withdrawn|0
7510073|NCT02371746|11839564|FG002|Overall Study|Consent withdrawn|0
7510074|NCT02371746|11839565|FG003|Overall Study|Consent withdrawn|0
7510075|NCT02371746|11839566|FG004|Overall Study|Consent withdrawn|0
7510076|NCT02371746|11839567|FG005|Overall Study|Consent withdrawn|0
7510077|NCT02371746|11839568|FG006|Overall Study|Consent withdrawn|1
7510078|NCT02371759|11839592|FG000|Overall Study|Protocol Violation|3
7510079|NCT02371759|11839593|FG001|Overall Study|Protocol Violation|1
7510080|NCT02371759|11839594|FG002|Overall Study|Protocol Violation|1
7510081|NCT02371759|11839595|FG003|Overall Study|Protocol Violation|0
7510082|NCT02371759|11839596|FG004|Overall Study|Protocol Violation|3
7510083|NCT02371759|11839597|FG005|Overall Study|Protocol Violation|1
7510084|NCT02371759|11839598|FG006|Overall Study|Protocol Violation|0
7510085|NCT02371759|11839599|FG007|Overall Study|Protocol Violation|3
7510086|NCT02371759|11839592|FG000|Overall Study|Withdrawal by Subject|0
7510087|NCT02371759|11839593|FG001|Overall Study|Withdrawal by Subject|0
7510088|NCT02371759|11839594|FG002|Overall Study|Withdrawal by Subject|0
7510089|NCT02371759|11839595|FG003|Overall Study|Withdrawal by Subject|0
7510090|NCT02371759|11839596|FG004|Overall Study|Withdrawal by Subject|0
7510091|NCT02371759|11839597|FG005|Overall Study|Withdrawal by Subject|0
7510092|NCT02371759|11839598|FG006|Overall Study|Withdrawal by Subject|0
7510093|NCT02371759|11839599|FG007|Overall Study|Withdrawal by Subject|1
7510094|NCT02371980|11839646|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
7510095|NCT02371980|11839647|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
7510096|NCT02371980|11839648|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
7510097|NCT02371980|11839649|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
7510098|NCT02371980|11839650|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
7510099|NCT02371980|11839646|FG000|Open-label Period|Significant Protocol Deviation|19
7510100|NCT02371980|11839647|FG001|Open-label Period|Significant Protocol Deviation|0
7510101|NCT02371980|11839648|FG002|Open-label Period|Significant Protocol Deviation|0
7510102|NCT02371980|11839649|FG003|Open-label Period|Significant Protocol Deviation|0
7510103|NCT02371980|11839650|FG004|Open-label Period|Significant Protocol Deviation|0
7510104|NCT02371980|11839646|FG000|Open-label Period|Noncompliance with Study Drug|10
7510105|NCT02371980|11839647|FG001|Open-label Period|Noncompliance with Study Drug|0
7510106|NCT02371980|11839648|FG002|Open-label Period|Noncompliance with Study Drug|0
7510107|NCT02371980|11839649|FG003|Open-label Period|Noncompliance with Study Drug|0
7510108|NCT02371980|11839650|FG004|Open-label Period|Noncompliance with Study Drug|0
7510109|NCT02371980|11839646|FG000|Open-label Period|Lost to Follow-up|55
7510110|NCT02371980|11839647|FG001|Open-label Period|Lost to Follow-up|0
7510111|NCT02371980|11839648|FG002|Open-label Period|Lost to Follow-up|0
7510112|NCT02371980|11839649|FG003|Open-label Period|Lost to Follow-up|0
7510113|NCT02371980|11839650|FG004|Open-label Period|Lost to Follow-up|0
7510114|NCT02371980|11839646|FG000|Open-label Period|Voluntary Withdrawal|91
7510115|NCT02371980|11839647|FG001|Open-label Period|Voluntary Withdrawal|0
7510116|NCT02371980|11839648|FG002|Open-label Period|Voluntary Withdrawal|0
7510117|NCT02371980|11839649|FG003|Open-label Period|Voluntary Withdrawal|0
7510118|NCT02371980|11839650|FG004|Open-label Period|Voluntary Withdrawal|0
7510119|NCT02371980|11839646|FG000|Open-label Period|Pregnancy|1
7510120|NCT02371980|11839647|FG001|Open-label Period|Pregnancy|0
7510121|NCT02371980|11839648|FG002|Open-label Period|Pregnancy|0
7510122|NCT02371980|11839649|FG003|Open-label Period|Pregnancy|0
7510123|NCT02371980|11839650|FG004|Open-label Period|Pregnancy|0
7510124|NCT02371980|11839646|FG000|Open-label Period|Lack of Efficacy|116
7510125|NCT02371980|11839647|FG001|Open-label Period|Lack of Efficacy|0
7510126|NCT02371980|11839648|FG002|Open-label Period|Lack of Efficacy|0
7510127|NCT02371980|11839649|FG003|Open-label Period|Lack of Efficacy|0
7510128|NCT02371980|11839650|FG004|Open-label Period|Lack of Efficacy|0
7510129|NCT02371980|11839646|FG000|Open-label Period|Did not Meet Randomization Criteria|162
7510130|NCT02371980|11839647|FG001|Open-label Period|Did not Meet Randomization Criteria|0
7510131|NCT02371980|11839648|FG002|Open-label Period|Did not Meet Randomization Criteria|0
7510132|NCT02371980|11839649|FG003|Open-label Period|Did not Meet Randomization Criteria|0
7510133|NCT02371980|11839650|FG004|Open-label Period|Did not Meet Randomization Criteria|0
7510134|NCT02371980|11839646|FG000|Open-label Period|Reason not Specified|9
7510135|NCT02371980|11839647|FG001|Open-label Period|Reason not Specified|0
7510136|NCT02371980|11839648|FG002|Open-label Period|Reason not Specified|0
7510137|NCT02371980|11839649|FG003|Open-label Period|Reason not Specified|0
7510138|NCT02371980|11839650|FG004|Open-label Period|Reason not Specified|0
7510139|NCT02371980|11839646|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
7510140|NCT02371980|11839647|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
7510141|NCT02371980|11839648|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
7510142|NCT02371980|11839649|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
7510143|NCT02371980|11839650|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
7510144|NCT02371980|11839646|FG000|Double-blind Period|Significant Protocol Deviation|0
7510145|NCT02371980|11839647|FG001|Double-blind Period|Significant Protocol Deviation|2
7510146|NCT02371980|11839648|FG002|Double-blind Period|Significant Protocol Deviation|7
7510147|NCT02371980|11839649|FG003|Double-blind Period|Significant Protocol Deviation|3
7510148|NCT02371980|11839650|FG004|Double-blind Period|Significant Protocol Deviation|3
7510149|NCT02371980|11839646|FG000|Double-blind Period|Noncompliance with Study Drug|0
7510150|NCT02371980|11839647|FG001|Double-blind Period|Noncompliance with Study Drug|1
7510151|NCT02371980|11839648|FG002|Double-blind Period|Noncompliance with Study Drug|2
7510152|NCT02371980|11839649|FG003|Double-blind Period|Noncompliance with Study Drug|2
7510153|NCT02371980|11839650|FG004|Double-blind Period|Noncompliance with Study Drug|3
7510154|NCT02371980|11839646|FG000|Double-blind Period|Lost to Follow-up|0
7510155|NCT02371980|11839647|FG001|Double-blind Period|Lost to Follow-up|8
7510156|NCT02371980|11839648|FG002|Double-blind Period|Lost to Follow-up|8
7510157|NCT02371980|11839649|FG003|Double-blind Period|Lost to Follow-up|6
7510158|NCT02371980|11839650|FG004|Double-blind Period|Lost to Follow-up|5
7510159|NCT02371980|11839646|FG000|Double-blind Period|Voluntary Withdrawal|0
7510160|NCT02371980|11839647|FG001|Double-blind Period|Voluntary Withdrawal|12
7510161|NCT02371980|11839648|FG002|Double-blind Period|Voluntary Withdrawal|8
7510162|NCT02371980|11839649|FG003|Double-blind Period|Voluntary Withdrawal|9
7510163|NCT02371980|11839650|FG004|Double-blind Period|Voluntary Withdrawal|11
7510164|NCT02371980|11839646|FG000|Double-blind Period|Relapse|0
7510165|NCT02371980|11839647|FG001|Double-blind Period|Relapse|50
7510166|NCT02371980|11839648|FG002|Double-blind Period|Relapse|25
7510167|NCT02371980|11839649|FG003|Double-blind Period|Relapse|25
7510168|NCT02371980|11839650|FG004|Double-blind Period|Relapse|26
7510169|NCT02371980|11839646|FG000|Double-blind Period|Reason not Specified|0
7510170|NCT02371980|11839647|FG001|Double-blind Period|Reason not Specified|3
7510171|NCT02371980|11839648|FG002|Double-blind Period|Reason not Specified|3
7510172|NCT02371980|11839649|FG003|Double-blind Period|Reason not Specified|2
7510173|NCT02371980|11839650|FG004|Double-blind Period|Reason not Specified|1
7510174|NCT02371980|11839646|FG000|Double-blind Period|Missing|0
7510175|NCT02371980|11839647|FG001|Double-blind Period|Missing|1
7510176|NCT02371980|11839648|FG002|Double-blind Period|Missing|0
7510177|NCT02371980|11839649|FG003|Double-blind Period|Missing|0
7510178|NCT02371980|11839650|FG004|Double-blind Period|Missing|0
7510179|NCT02372006|11839664|FG000|Overall Study|Progressive disease|8
7510180|NCT02372006|11839665|FG001|Overall Study|Progressive disease|7
7510181|NCT02372006|11839666|FG002|Overall Study|Progressive disease|34
7510182|NCT02372006|11839664|FG000|Overall Study|Dose limiting toxicity|0
7510183|NCT02372006|11839665|FG001|Overall Study|Dose limiting toxicity|1
7510184|NCT02372006|11839666|FG002|Overall Study|Dose limiting toxicity|0
7510185|NCT02372006|11839664|FG000|Overall Study|Adverse Event|0
7510186|NCT02372006|11839665|FG001|Overall Study|Adverse Event|0
7510187|NCT02372006|11839666|FG002|Overall Study|Adverse Event|3
7510188|NCT02372006|11839664|FG000|Overall Study|Withdrawal by Subject|0
7510189|NCT02372006|11839665|FG001|Overall Study|Withdrawal by Subject|1
7510190|NCT02372006|11839666|FG002|Overall Study|Withdrawal by Subject|1
7510191|NCT02372006|11839664|FG000|Overall Study|Other reason for not completing|0
7510192|NCT02372006|11839665|FG001|Overall Study|Other reason for not completing|0
7510193|NCT02372006|11839666|FG002|Overall Study|Other reason for not completing|1
7510194|NCT02372058|11839675|FG000|Overall Study|Withdrawal by Subject|3
7510195|NCT02372071|11839681|FG000|Overall Study|Protocol Violation|18
7510196|NCT02372253|11839697|FG000|Overall Study|Non Compliance|2
7510197|NCT02372253|11839698|FG001|Overall Study|Non Compliance|0
7510198|NCT02372383|11839718|FG000|First Intervention (1 Day)|Unable to collect blood|0
7510199|NCT02372383|11839719|FG001|First Intervention (1 Day)|Unable to collect blood|1
7510200|NCT02372383|11839720|FG002|First Intervention (1 Day)|Unable to collect blood|0
7510201|NCT02372396|11839732|FG000|Overall Study|Lost to Follow-up|7
7510202|NCT02372396|11839733|FG001|Overall Study|Lost to Follow-up|9
7510203|NCT02372799|11839758|FG000|Treatment Period|Adverse Event|3
7510204|NCT02372799|11839759|FG001|Treatment Period|Adverse Event|10
7510205|NCT02372799|11839760|FG002|Treatment Period|Adverse Event|6
7510206|NCT02372799|11839758|FG000|Treatment Period|Insufficient therapeutic response|2
7510207|NCT02372799|11839759|FG001|Treatment Period|Insufficient therapeutic response|2
7510208|NCT02372799|11839760|FG002|Treatment Period|Insufficient therapeutic response|0
7510209|NCT02372799|11839758|FG000|Treatment Period|Withdrawal by Subject|10
7510210|NCT02372799|11839759|FG001|Treatment Period|Withdrawal by Subject|10
7510211|NCT02372799|11839760|FG002|Treatment Period|Withdrawal by Subject|2
7510212|NCT02372799|11839758|FG000|Treatment Period|Lost to Follow-up|11
7510213|NCT02372799|11839759|FG001|Treatment Period|Lost to Follow-up|5
7510214|NCT02372799|11839760|FG002|Treatment Period|Lost to Follow-up|3
7510215|NCT02372799|11839758|FG000|Treatment Period|Protocol Violation|3
7510216|NCT02372799|11839759|FG001|Treatment Period|Protocol Violation|0
7510217|NCT02372799|11839760|FG002|Treatment Period|Protocol Violation|0
7510218|NCT02372799|11839758|FG000|Treatment Period|Non-compliance with study drug|4
7510219|NCT02372799|11839759|FG001|Treatment Period|Non-compliance with study drug|4
7510220|NCT02372799|11839760|FG002|Treatment Period|Non-compliance with study drug|4
7510221|NCT02372799|11839758|FG000|Treatment Period|Miscellaneous Reasons|1
7510222|NCT02372799|11839759|FG001|Treatment Period|Miscellaneous Reasons|1
7510223|NCT02372799|11839760|FG002|Treatment Period|Miscellaneous Reasons|0
7510224|NCT02372799|11839758|FG000|Down-taper Period|Lost to Follow-up|1
7510225|NCT02372799|11839759|FG001|Down-taper Period|Lost to Follow-up|2
7510226|NCT02372799|11839760|FG002|Down-taper Period|Lost to Follow-up|2
7510227|NCT02373098|11839770|FG000|Overall Study|Lost to Follow-up|1
7510228|NCT02373098|11839771|FG001|Overall Study|Lost to Follow-up|0
7510229|NCT02373098|11839770|FG000|Overall Study|Protocol Violation|3
7510230|NCT02373098|11839771|FG001|Overall Study|Protocol Violation|0
7510231|NCT02373098|11839770|FG000|Overall Study|Withdrawal by Subject|5
7510232|NCT02373098|11839771|FG001|Overall Study|Withdrawal by Subject|0
7510233|NCT02373098|11839770|FG000|Overall Study|Adverse Event|3
7510234|NCT02373098|11839771|FG001|Overall Study|Adverse Event|0
7510235|NCT02373202|11839801|FG000|Overall Study|Adverse Event|2
7510236|NCT02373202|11839802|FG001|Overall Study|Adverse Event|5
7510237|NCT02373202|11839803|FG002|Overall Study|Adverse Event|2
7510238|NCT02373202|11839804|FG003|Overall Study|Adverse Event|1
7510239|NCT02373202|11839801|FG000|Overall Study|Lack of Efficacy|0
7510240|NCT02373202|11839802|FG001|Overall Study|Lack of Efficacy|0
7510241|NCT02373202|11839803|FG002|Overall Study|Lack of Efficacy|1
7510242|NCT02373202|11839804|FG003|Overall Study|Lack of Efficacy|0
7510243|NCT02373202|11839801|FG000|Overall Study|Other|0
7510244|NCT02373202|11839802|FG001|Overall Study|Other|1
7510245|NCT02373202|11839803|FG002|Overall Study|Other|0
7510246|NCT02373202|11839804|FG003|Overall Study|Other|0
7510247|NCT02373813|11839826|FG000|Run-In Period|Other, Not Specified|5
7510248|NCT02373813|11839827|FG001|Run-In Period|Other, Not Specified|0
7510249|NCT02373813|11839828|FG002|Run-In Period|Other, Not Specified|0
7510250|NCT02373813|11839829|FG003|Run-In Period|Other, Not Specified|0
7510251|NCT02373813|11839826|FG000|Run-In Period|Withdrawal by Subject|16
7510252|NCT02373813|11839827|FG001|Run-In Period|Withdrawal by Subject|0
7510253|NCT02373813|11839828|FG002|Run-In Period|Withdrawal by Subject|0
7510254|NCT02373813|11839829|FG003|Run-In Period|Withdrawal by Subject|0
7510255|NCT02373813|11839826|FG000|Run-In Period|Decision by Sponsor|11
7510256|NCT02373813|11839827|FG001|Run-In Period|Decision by Sponsor|0
7510257|NCT02373813|11839828|FG002|Run-In Period|Decision by Sponsor|0
7510258|NCT02373813|11839829|FG003|Run-In Period|Decision by Sponsor|0
7510259|NCT02373813|11839826|FG000|Run-In Period|Protocol Violation|75
7510260|NCT02373813|11839827|FG001|Run-In Period|Protocol Violation|0
7510261|NCT02373813|11839828|FG002|Run-In Period|Protocol Violation|0
7510262|NCT02373813|11839829|FG003|Run-In Period|Protocol Violation|0
7510263|NCT02373813|11839826|FG000|Run-In Period|Lost to Follow-up|2
7510264|NCT02373813|11839827|FG001|Run-In Period|Lost to Follow-up|0
7510265|NCT02373813|11839828|FG002|Run-In Period|Lost to Follow-up|0
7510266|NCT02373813|11839829|FG003|Run-In Period|Lost to Follow-up|0
7510267|NCT02373813|11839826|FG000|Run-In Period|Adverse Event|3
7510268|NCT02373813|11839827|FG001|Run-In Period|Adverse Event|0
7510269|NCT02373813|11839828|FG002|Run-In Period|Adverse Event|0
7510270|NCT02373813|11839829|FG003|Run-In Period|Adverse Event|0
7510271|NCT02373813|11839826|FG000|Run-In Period|Noncompliance|1
7510272|NCT02373813|11839827|FG001|Run-In Period|Noncompliance|0
7510273|NCT02373813|11839828|FG002|Run-In Period|Noncompliance|0
7510274|NCT02373813|11839829|FG003|Run-In Period|Noncompliance|0
7510275|NCT02373813|11839826|FG000|Run-In Period|Ineligibility Determined|3
7510276|NCT02373813|11839827|FG001|Run-In Period|Ineligibility Determined|0
7510277|NCT02373813|11839828|FG002|Run-In Period|Ineligibility Determined|0
7510278|NCT02373813|11839829|FG003|Run-In Period|Ineligibility Determined|0
7510279|NCT02373813|11839826|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
7510280|NCT02373813|11839827|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
7510281|NCT02373813|11839828|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
7510282|NCT02373813|11839829|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
7510283|NCT02373813|11839826|FG000|Double-Blind Treatment Period|Protocol Violation|0
7510284|NCT02373813|11839827|FG001|Double-Blind Treatment Period|Protocol Violation|2
7510285|NCT02373813|11839828|FG002|Double-Blind Treatment Period|Protocol Violation|0
7510286|NCT02373813|11839829|FG003|Double-Blind Treatment Period|Protocol Violation|0
7510287|NCT02373813|11839826|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7510288|NCT02373813|11839827|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7510289|NCT02373813|11839828|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
7510290|NCT02373813|11839829|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7510291|NCT02373813|11839826|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7510292|NCT02373813|11839827|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
7510293|NCT02373813|11839828|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
7510294|NCT02373813|11839829|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
7510295|NCT02374099|11839859|FG000|Overall Study|Adverse Event|1
7510296|NCT02374099|11839860|FG001|Overall Study|Adverse Event|0
7510297|NCT02374099|11839859|FG000|Overall Study|Progressive Disease|35
7510298|NCT02374099|11839860|FG001|Overall Study|Progressive Disease|40
7510299|NCT02374099|11839859|FG000|Overall Study|Withdrawal by Subject|5
7510300|NCT02374099|11839860|FG001|Overall Study|Withdrawal by Subject|1
7510301|NCT02374099|11839859|FG000|Overall Study|Miscellaneous|2
7510302|NCT02374099|11839860|FG001|Overall Study|Miscellaneous|3
7510303|NCT02374099|11839859|FG000|Overall Study|Randomized, but not treated|2
7510304|NCT02374099|11839860|FG001|Overall Study|Randomized, but not treated|1
7510305|NCT02374099|11839859|FG000|Overall Study|Study Terminated by Sponsor|3
7510306|NCT02374099|11839860|FG001|Overall Study|Study Terminated by Sponsor|4
7510307|NCT02374255|11839893|FG000|Overall Study|Withdrawal by Subject|2
7510308|NCT02374255|11839894|FG001|Overall Study|Withdrawal by Subject|0
7510309|NCT02374255|11839895|FG002|Overall Study|Withdrawal by Subject|0
7510310|NCT02374255|11839896|FG003|Overall Study|Withdrawal by Subject|0
7510311|NCT02374307|11839914|FG000|3-months Follow-up|Lost to Follow-up|1
7510312|NCT02374307|11839915|FG001|3-months Follow-up|Lost to Follow-up|2
7510313|NCT02374307|11839914|FG000|3-months Follow-up|Withdrawal by Subject|1
7510314|NCT02374307|11839915|FG001|3-months Follow-up|Withdrawal by Subject|4
7510315|NCT02374307|11839914|FG000|3-months Follow-up|Death|1
7510316|NCT02374307|11839915|FG001|3-months Follow-up|Death|2
7510317|NCT02374307|11839914|FG000|3-months Follow-up|Missed first follow-up|5
7510318|NCT02374307|11839915|FG001|3-months Follow-up|Missed first follow-up|1
7510319|NCT02374307|11839914|FG000|6-months Follow-up|Lost to Follow-up|1
7510320|NCT02374307|11839915|FG001|6-months Follow-up|Lost to Follow-up|2
7510321|NCT02374307|11839914|FG000|6-months Follow-up|Death|2
7510322|NCT02374307|11839915|FG001|6-months Follow-up|Death|1
7510323|NCT02374307|11839914|FG000|6-months Follow-up|Withdrawal by Subject|0
7510324|NCT02374307|11839915|FG001|6-months Follow-up|Withdrawal by Subject|3
7510325|NCT02374346|11839921|FG000|Overall Study|operated or discharged during weekend|48
7510326|NCT02374463|11839947|FG000|Overall Study|Withdrawal by Subject|3
7510327|NCT02374463|11839948|FG001|Overall Study|Withdrawal by Subject|3
7510328|NCT02374593|11839957|FG000|Overall Study|non-compliant|2
7510329|NCT02374593|11839958|FG001|Overall Study|non-compliant|0
7510330|NCT02374671|11839971|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
7510331|NCT02374671|11839972|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
7510332|NCT02374671|11839973|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
7510333|NCT02374671|11839971|FG000|Observation (Deferred Implantation)|Adverse Event|0
7510334|NCT02374671|11839972|FG001|Observation (Deferred Implantation)|Adverse Event|0
7510335|NCT02374671|11839973|FG002|Observation (Deferred Implantation)|Adverse Event|1
7510336|NCT02374671|11839971|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
7510337|NCT02374671|11839972|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7510338|NCT02374671|11839973|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
7510339|NCT02374671|11839971|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
7510340|NCT02374671|11839972|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
7510341|NCT02374671|11839973|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
7510342|NCT02374671|11839971|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7510343|NCT02374671|11839972|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7510344|NCT02374671|11839973|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7510345|NCT02374918|11839983|FG000|Overall Study|Protocol Violation|2
7510346|NCT02374918|11839984|FG001|Overall Study|Protocol Violation|0
7510347|NCT02374918|11839985|FG002|Overall Study|Protocol Violation|2
7510348|NCT02374918|11839986|FG003|Overall Study|Protocol Violation|1
7510349|NCT02374918|11839983|FG000|Overall Study|Withdrawal by Subject|1
7510350|NCT02374918|11839984|FG001|Overall Study|Withdrawal by Subject|1
7510351|NCT02374918|11839985|FG002|Overall Study|Withdrawal by Subject|1
7510352|NCT02374918|11839986|FG003|Overall Study|Withdrawal by Subject|0
7510353|NCT02374918|11839983|FG000|Overall Study|Lack of Efficacy|0
7510354|NCT02374918|11839984|FG001|Overall Study|Lack of Efficacy|0
7510355|NCT02374918|11839985|FG002|Overall Study|Lack of Efficacy|1
7510356|NCT02374918|11839986|FG003|Overall Study|Lack of Efficacy|1
7510357|NCT02374957|11839996|FG000|Overall Study|Patient did not complete forms correctly|1
7510358|NCT02374957|11839997|FG001|Overall Study|Patient did not complete forms correctly|0
7510359|NCT02375347|11840003|FG000|Overall Study|Protocol Violation|1
7510360|NCT02375373|11840007|FG000|Overall Study|Withdrawal by Subject|11
7510361|NCT02375698|11840013|FG000|Overall Study|Withdrawal by Subject|0
7510362|NCT02375698|11840014|FG001|Overall Study|Withdrawal by Subject|2
7510363|NCT02375698|11840013|FG000|Overall Study|Physician Decision|2
7510364|NCT02375698|11840014|FG001|Overall Study|Physician Decision|0
7510365|NCT02375724|11840022|FG000|Overall Study|Lack of Efficacy|1
7510366|NCT02375724|11840023|FG001|Overall Study|Lack of Efficacy|1
7510367|NCT02375724|11840022|FG000|Overall Study|Withdrawal by Subject|1
7510368|NCT02375724|11840023|FG001|Overall Study|Withdrawal by Subject|1
7510369|NCT02375724|11840022|FG000|Overall Study|Lost to Follow-up|1
7510370|NCT02375724|11840023|FG001|Overall Study|Lost to Follow-up|0
7510371|NCT02375724|11840022|FG000|Overall Study|Protocol Violation|1
7510372|NCT02375724|11840023|FG001|Overall Study|Protocol Violation|0
7510373|NCT02375724|11840022|FG000|Overall Study|Adverse Event|2
7510374|NCT02375724|11840023|FG001|Overall Study|Adverse Event|4
7510375|NCT02375971|11840032|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7510376|NCT02375971|11840033|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
7510377|NCT02375971|11840034|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
7510378|NCT02375971|11840032|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
7510379|NCT02375971|11840033|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
7510380|NCT02375971|11840034|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
7510381|NCT02375971|11840032|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7510382|NCT02375971|11840033|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
7510383|NCT02375971|11840034|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
7510384|NCT02375971|11840032|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
7510385|NCT02375971|11840033|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
7510386|NCT02375971|11840034|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
7510387|NCT02375971|11840032|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
7510388|NCT02375971|11840033|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
7510389|NCT02375971|11840034|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
7510390|NCT02375971|11840032|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7510391|NCT02375971|11840033|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
7510392|NCT02375971|11840034|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
7510393|NCT02375971|11840032|FG000|Follow-Up Phase (up to Day 169)|Death|4
7510394|NCT02375971|11840033|FG001|Follow-Up Phase (up to Day 169)|Death|4
7510395|NCT02375971|11840034|FG002|Follow-Up Phase (up to Day 169)|Death|4
7510396|NCT02375971|11840032|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7510397|NCT02375971|11840033|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
7510398|NCT02375971|11840034|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
7510399|NCT02376166|11840055|FG000|Overall Study|Adverse Event|1
7510400|NCT02376166|11840055|FG000|Overall Study|Discontinued metformin early|2
7510410|NCT02377063|11840133|FG000|Overall Study|Non-compliance|5
7510411|NCT02377349|11840139|FG000|Overall Study|Serious Adverse Event|1
7510412|NCT02377349|11840140|FG001|Overall Study|Serious Adverse Event|0
7510413|NCT02377349|11840139|FG000|Overall Study|Protocol Violation|3
7510414|NCT02377349|11840140|FG001|Overall Study|Protocol Violation|2
7510415|NCT02377349|11840139|FG000|Overall Study|Withdrawal by Subject|5
7510416|NCT02377349|11840140|FG001|Overall Study|Withdrawal by Subject|3
7510417|NCT02377349|11840139|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
7510418|NCT02377349|11840140|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
7510419|NCT02377349|11840139|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
7510420|NCT02377349|11840140|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
7510421|NCT02377349|11840139|FG000|Overall Study|Other|0
7510422|NCT02377349|11840140|FG001|Overall Study|Other|1
7510423|NCT02377362|11840168|FG000|Part A Second Treatment|Protocol Violation|0
7510424|NCT02377362|11840169|FG001|Part A Second Treatment|Protocol Violation|0
7510425|NCT02377362|11840170|FG002|Part A Second Treatment|Protocol Violation|0
7510426|NCT02377362|11840171|FG003|Part A Second Treatment|Protocol Violation|0
7510427|NCT02377362|11840172|FG004|Part A Second Treatment|Protocol Violation|1
7510428|NCT02377362|11840173|FG005|Part A Second Treatment|Protocol Violation|0
7510429|NCT02377362|11840174|FG006|Part A Second Treatment|Protocol Violation|0
7510430|NCT02377362|11840175|FG007|Part A Second Treatment|Protocol Violation|0
7510431|NCT02377362|11840176|FG008|Part A Second Treatment|Protocol Violation|0
7510432|NCT02377362|11840177|FG009|Part A Second Treatment|Protocol Violation|0
7510433|NCT02377362|11840178|FG010|Part A Second Treatment|Protocol Violation|0
7510434|NCT02377362|11840179|FG011|Part A Second Treatment|Protocol Violation|0
7510435|NCT02377362|11840180|FG012|Part A Second Treatment|Protocol Violation|0
7510436|NCT02377362|11840168|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
7510437|NCT02377362|11840169|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
7510438|NCT02377362|11840170|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
7510439|NCT02377362|11840171|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
7510440|NCT02377362|11840172|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
7510441|NCT02377362|11840173|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
7510442|NCT02377362|11840174|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
7510443|NCT02377362|11840175|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
7510444|NCT02377362|11840176|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
7510445|NCT02377362|11840177|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
7510446|NCT02377362|11840178|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
7510447|NCT02377362|11840179|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
7510448|NCT02377362|11840180|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
7510449|NCT02377362|11840168|FG000|Part B Overall|Protocol Violation|0
7510450|NCT02377362|11840169|FG001|Part B Overall|Protocol Violation|0
7510451|NCT02377362|11840170|FG002|Part B Overall|Protocol Violation|0
7510452|NCT02377362|11840171|FG003|Part B Overall|Protocol Violation|0
7510453|NCT02377362|11840172|FG004|Part B Overall|Protocol Violation|0
7510454|NCT02377362|11840173|FG005|Part B Overall|Protocol Violation|0
7510455|NCT02377362|11840174|FG006|Part B Overall|Protocol Violation|0
7510456|NCT02377362|11840175|FG007|Part B Overall|Protocol Violation|0
7510457|NCT02377362|11840176|FG008|Part B Overall|Protocol Violation|0
7510458|NCT02377362|11840177|FG009|Part B Overall|Protocol Violation|1
7510459|NCT02377362|11840178|FG010|Part B Overall|Protocol Violation|0
7510460|NCT02377362|11840179|FG011|Part B Overall|Protocol Violation|0
7510461|NCT02377362|11840180|FG012|Part B Overall|Protocol Violation|0
7510462|NCT02377362|11840168|FG000|Part B Overall|Adverse Event|0
7510463|NCT02377362|11840169|FG001|Part B Overall|Adverse Event|0
7510464|NCT02377362|11840170|FG002|Part B Overall|Adverse Event|0
7510465|NCT02377362|11840171|FG003|Part B Overall|Adverse Event|0
7510466|NCT02377362|11840172|FG004|Part B Overall|Adverse Event|0
7510467|NCT02377362|11840173|FG005|Part B Overall|Adverse Event|0
7510468|NCT02377362|11840174|FG006|Part B Overall|Adverse Event|1
7510469|NCT02377362|11840175|FG007|Part B Overall|Adverse Event|1
7510470|NCT02377362|11840176|FG008|Part B Overall|Adverse Event|0
7510471|NCT02377362|11840177|FG009|Part B Overall|Adverse Event|0
7510472|NCT02377362|11840178|FG010|Part B Overall|Adverse Event|0
7510473|NCT02377362|11840179|FG011|Part B Overall|Adverse Event|0
7510474|NCT02377362|11840180|FG012|Part B Overall|Adverse Event|0
7510475|NCT02377362|11840168|FG000|Part B Overall|Withdrawal by Subject|0
7510476|NCT02377362|11840169|FG001|Part B Overall|Withdrawal by Subject|0
7510477|NCT02377362|11840170|FG002|Part B Overall|Withdrawal by Subject|0
7510478|NCT02377362|11840171|FG003|Part B Overall|Withdrawal by Subject|0
7510479|NCT02377362|11840172|FG004|Part B Overall|Withdrawal by Subject|0
7510480|NCT02377362|11840173|FG005|Part B Overall|Withdrawal by Subject|0
7510481|NCT02377362|11840174|FG006|Part B Overall|Withdrawal by Subject|1
7510482|NCT02377362|11840175|FG007|Part B Overall|Withdrawal by Subject|0
7510483|NCT02377362|11840176|FG008|Part B Overall|Withdrawal by Subject|0
7510484|NCT02377362|11840177|FG009|Part B Overall|Withdrawal by Subject|0
7510485|NCT02377362|11840178|FG010|Part B Overall|Withdrawal by Subject|0
7510486|NCT02377362|11840179|FG011|Part B Overall|Withdrawal by Subject|1
7510487|NCT02377362|11840180|FG012|Part B Overall|Withdrawal by Subject|0
7510488|NCT02377427|11840220|FG000|Part A (Up to Week 20)|Physician Decision|1
7510489|NCT02377427|11840221|FG001|Part A (Up to Week 20)|Physician Decision|0
7510490|NCT02377427|11840222|FG002|Part A (Up to Week 20)|Physician Decision|0
7510491|NCT02377427|11840223|FG003|Part A (Up to Week 20)|Physician Decision|0
7510492|NCT02377427|11840224|FG004|Part A (Up to Week 20)|Physician Decision|0
7510493|NCT02377427|11840220|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
7510494|NCT02377427|11840221|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7510578|NCT02379052|11840499|FG000|Overall Study|Lost to Follow-up|2
7510495|NCT02377427|11840222|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7510496|NCT02377427|11840223|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7510497|NCT02377427|11840224|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
7510498|NCT02377427|11840220|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
7510499|NCT02377427|11840221|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
7510500|NCT02377427|11840222|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
7510501|NCT02377427|11840223|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
7510502|NCT02377427|11840224|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
7510503|NCT02377427|11840220|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7510504|NCT02377427|11840221|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7510505|NCT02377427|11840222|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
7510506|NCT02377427|11840223|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7510507|NCT02377427|11840224|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
7510508|NCT02377466|11840239|FG000|Overall Study|Other: Randomized and not treated|0
7510509|NCT02377466|11840240|FG001|Overall Study|Other: Randomized and not treated|2
7510510|NCT02377817|11840283|FG000|Overall Study|Transportation/childcare barriers.|2
7510511|NCT02377817|11840284|FG001|Overall Study|Transportation/childcare barriers.|0
7510512|NCT02377817|11840283|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
7510513|NCT02377817|11840284|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
7510514|NCT02377921|11840294|FG000|Overall Study|Subject non-compliance|1
7510515|NCT02377921|11840295|FG001|Overall Study|Subject non-compliance|1
7510516|NCT02378220|11840341|FG000|Overall Study|Death|6
7510517|NCT02378220|11840342|FG001|Overall Study|Death|1
7510518|NCT02378480|11840364|FG000|Overall Study|Physician Decision|1
7510519|NCT02378480|11840365|FG001|Overall Study|Physician Decision|1
7510520|NCT02378480|11840364|FG000|Overall Study|Death|1
7510521|NCT02378480|11840365|FG001|Overall Study|Death|2
7510522|NCT02378480|11840364|FG000|Overall Study|Randomized, but Not Treated|6
7510523|NCT02378480|11840365|FG001|Overall Study|Randomized, but Not Treated|4
7510524|NCT02378480|11840364|FG000|Overall Study|Adverse Event|0
7510525|NCT02378480|11840365|FG001|Overall Study|Adverse Event|1
7510526|NCT02378480|11840364|FG000|Overall Study|Missed EOT/PTE Visit|1
7510527|NCT02378480|11840365|FG001|Overall Study|Missed EOT/PTE Visit|2
7510528|NCT02378480|11840364|FG000|Overall Study|Withdrawal by Subject|9
7510529|NCT02378480|11840365|FG001|Overall Study|Withdrawal by Subject|4
7510530|NCT02378480|11840364|FG000|Overall Study|Lost to Follow-up|10
7510531|NCT02378480|11840365|FG001|Overall Study|Lost to Follow-up|18
7510532|NCT02378506|11840371|FG000|Overall Study|Lack of Efficacy|3
7510533|NCT02378506|11840371|FG000|Overall Study|Withdrawal by Subject|4
7510534|NCT02378506|11840371|FG000|Overall Study|Protocol Violation|2
7510535|NCT02378506|11840371|FG000|Overall Study|Death|1
7510536|NCT02378506|11840371|FG000|Overall Study|Adverse Event|14
7510537|NCT02378506|11840371|FG000|Overall Study|Randomized But Not Treated|1
7510538|NCT02378662|11840377|FG000|Overall Study|Early Discontinuation|2
7510539|NCT02378662|11840378|FG001|Overall Study|Early Discontinuation|0
7510540|NCT02378883|11840446|FG000|Enrollment|Subject did not meet Inclusion criteria|6
7510541|NCT02378883|11840446|FG000|Enrollment|Attempt to use Apollo was not performed|3
7510542|NCT02378883|11840446|FG000|30 Day Follow-Up|Withdrawal by Subject|1
7510543|NCT02378883|11840446|FG000|30 Day Follow-Up|Physician Decision|2
7510544|NCT02378883|11840446|FG000|30 Day Follow-Up|Missed Visit|2
7510545|NCT02378883|11840446|FG000|30 Day Follow-Up|Death|1
7510546|NCT02378883|11840446|FG000|12 Months Follow-Up|Lost to Follow-up|3
7510547|NCT02378883|11840446|FG000|12 Months Follow-Up|Death|2
7510548|NCT02378935|11840458|FG000|Overall Study|Lack of Efficacy|10
7510549|NCT02378935|11840459|FG001|Overall Study|Lack of Efficacy|0
7510550|NCT02378935|11840460|FG002|Overall Study|Lack of Efficacy|2
7510551|NCT02378935|11840461|FG003|Overall Study|Lack of Efficacy|6
7510552|NCT02378935|11840462|FG004|Overall Study|Lack of Efficacy|0
7510553|NCT02378935|11840463|FG005|Overall Study|Lack of Efficacy|0
7510554|NCT02378935|11840464|FG006|Overall Study|Lack of Efficacy|0
7510555|NCT02378935|11840458|FG000|Overall Study|Death|0
7510556|NCT02378935|11840459|FG001|Overall Study|Death|0
7510557|NCT02378935|11840460|FG002|Overall Study|Death|1
7510558|NCT02378935|11840461|FG003|Overall Study|Death|0
7510559|NCT02378935|11840462|FG004|Overall Study|Death|0
7510560|NCT02378935|11840463|FG005|Overall Study|Death|0
7510561|NCT02378935|11840464|FG006|Overall Study|Death|0
7510562|NCT02378961|11840484|FG000|Overall Study|Lack of Efficacy|4
7510563|NCT02378961|11840485|FG001|Overall Study|Lack of Efficacy|2
7510564|NCT02378961|11840486|FG002|Overall Study|Lack of Efficacy|0
7510565|NCT02378961|11840487|FG003|Overall Study|Lack of Efficacy|1
7510566|NCT02378961|11840484|FG000|Overall Study|Death|0
7510567|NCT02378961|11840485|FG001|Overall Study|Death|0
7510568|NCT02378961|11840486|FG002|Overall Study|Death|1
7510569|NCT02378961|11840487|FG003|Overall Study|Death|0
7510570|NCT02379052|11840499|FG000|Overall Study|Protocol Violation|0
7510571|NCT02379052|11840500|FG001|Overall Study|Protocol Violation|1
7510572|NCT02379052|11840499|FG000|Overall Study|Adverse Event|0
7510573|NCT02379052|11840500|FG001|Overall Study|Adverse Event|1
7510574|NCT02379052|11840499|FG000|Overall Study|Physician Decision|1
7510575|NCT02379052|11840500|FG001|Overall Study|Physician Decision|1
7510576|NCT02379052|11840499|FG000|Overall Study|Withdrawal by Subject|2
7510577|NCT02379052|11840500|FG001|Overall Study|Withdrawal by Subject|0
7510579|NCT02379052|11840500|FG001|Overall Study|Lost to Follow-up|1
7510580|NCT02379052|11840499|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
7510581|NCT02379052|11840500|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
7510582|NCT02379052|11840499|FG000|Overall Study|Subject was Incarcerated|0
7510583|NCT02379052|11840500|FG001|Overall Study|Subject was Incarcerated|1
7510584|NCT02379078|11840508|FG000|Overall Study|Lost to Follow-up|33
7510585|NCT02379078|11840509|FG001|Overall Study|Lost to Follow-up|30
7510586|NCT02379078|11840508|FG000|Overall Study|Withdrawal by Subject|6
7510587|NCT02379078|11840509|FG001|Overall Study|Withdrawal by Subject|5
7510588|NCT02379091|11840519|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7510589|NCT02379091|11840520|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7510590|NCT02379091|11840521|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7510591|NCT02379091|11840522|FG003|Overall Study|Pretreatment Event/Adverse Event|1
7510592|NCT02379091|11840519|FG000|Overall Study|Principal Investigator Discretion|0
7510593|NCT02379091|11840520|FG001|Overall Study|Principal Investigator Discretion|1
7510594|NCT02379091|11840521|FG002|Overall Study|Principal Investigator Discretion|0
7510595|NCT02379091|11840522|FG003|Overall Study|Principal Investigator Discretion|0
7510596|NCT02379091|11840519|FG000|Overall Study|Lost to Follow-up|0
7510597|NCT02379091|11840520|FG001|Overall Study|Lost to Follow-up|0
7510598|NCT02379091|11840521|FG002|Overall Study|Lost to Follow-up|0
7510599|NCT02379091|11840522|FG003|Overall Study|Lost to Follow-up|1
7510600|NCT02379091|11840519|FG000|Overall Study|Voluntary Withdrawal|2
7510601|NCT02379091|11840520|FG001|Overall Study|Voluntary Withdrawal|5
7510602|NCT02379091|11840521|FG002|Overall Study|Voluntary Withdrawal|2
7510603|NCT02379091|11840522|FG003|Overall Study|Voluntary Withdrawal|4
7510604|NCT02379091|11840519|FG000|Overall Study|Study Termination|7
7510605|NCT02379091|11840520|FG001|Overall Study|Study Termination|2
7510606|NCT02379091|11840521|FG002|Overall Study|Study Termination|5
7510607|NCT02379091|11840522|FG003|Overall Study|Study Termination|8
7510608|NCT02379091|11840519|FG000|Overall Study|Lack of Efficacy|3
7510609|NCT02379091|11840520|FG001|Overall Study|Lack of Efficacy|0
7510610|NCT02379091|11840521|FG002|Overall Study|Lack of Efficacy|0
7510611|NCT02379091|11840522|FG003|Overall Study|Lack of Efficacy|0
7510612|NCT02379221|11840547|FG000|Overall Study|Lost to Follow-up|1
7510613|NCT02379637|11840566|FG000|Overall Study|Protocol Violation|0
7510614|NCT02379637|11840567|FG001|Overall Study|Protocol Violation|1
7510615|NCT02379637|11840566|FG000|Overall Study|Adverse Event|1
7510616|NCT02379637|11840567|FG001|Overall Study|Adverse Event|0
7510617|NCT02379637|11840566|FG000|Overall Study|Withdrawal by Subject|1
7510618|NCT02379637|11840567|FG001|Overall Study|Withdrawal by Subject|0
7510619|NCT02379728|11840575|FG000|Overall Study|Lost to Follow-up|1
7510620|NCT02379728|11840576|FG001|Overall Study|Lost to Follow-up|0
7510621|NCT02379728|11840577|FG002|Overall Study|Lost to Follow-up|3
7510622|NCT02379728|11840578|FG003|Overall Study|Lost to Follow-up|0
7510623|NCT02379728|11840575|FG000|Overall Study|Withdrawal by Subject|5
7510624|NCT02379728|11840576|FG001|Overall Study|Withdrawal by Subject|0
7510625|NCT02379728|11840577|FG002|Overall Study|Withdrawal by Subject|5
7510626|NCT02379728|11840578|FG003|Overall Study|Withdrawal by Subject|3
7510627|NCT02379728|11840575|FG000|Overall Study|Protocol Violation|0
7510628|NCT02379728|11840576|FG001|Overall Study|Protocol Violation|0
7510629|NCT02379728|11840577|FG002|Overall Study|Protocol Violation|2
7510630|NCT02379728|11840578|FG003|Overall Study|Protocol Violation|0
7510631|NCT02379923|11840596|FG000|Overall Study|Death|5
7510632|NCT02380248|11840612|FG000|Overall Study|Lost to Follow-up|11
7510633|NCT02380248|11840612|FG000|Overall Study|Withdrawal by Subject|3
7536189|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
7536190|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
7536191|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
7536192|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
7536193|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
7536194|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
7536195|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
7536196|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
7536197|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
7536198|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
7536199|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7536200|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7536201|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7536202|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
7536203|NCT02717195|11884222|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
7536204|NCT02717195|11884223|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7536205|NCT02717195|11884224|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7536206|NCT02717195|11884225|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7536207|NCT02717195|11884226|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
7536208|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
7536209|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
7536210|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
7536211|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
7510685|NCT02380677|11840687|FG007|Overall Study|Withdrawal by Subject|0
7536212|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
7536213|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7536214|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
7536215|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
7536216|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
7536217|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
7536218|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7536219|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
7536220|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
7536221|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
7536222|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
7536223|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
7536224|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
7536225|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
7536226|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
7536227|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
7536228|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7536229|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
7536230|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
7536231|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
7536232|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
7536233|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7536234|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7536235|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
7536236|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
7536237|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
7536238|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7536239|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7553124|NCT03007953|11913925|FG001|Overall Study|Lost to Follow-up|2
7510634|NCT02380287|11840629|FG000|Overall Study|Adverse Event|0
7510635|NCT02380287|11840630|FG001|Overall Study|Adverse Event|0
7510636|NCT02380287|11840631|FG002|Overall Study|Adverse Event|1
7510637|NCT02380287|11840632|FG003|Overall Study|Adverse Event|0
7510638|NCT02380287|11840633|FG004|Overall Study|Adverse Event|0
7510639|NCT02380287|11840634|FG005|Overall Study|Adverse Event|0
7510640|NCT02380287|11840635|FG006|Overall Study|Adverse Event|0
7510641|NCT02380287|11840636|FG007|Overall Study|Adverse Event|0
7510642|NCT02380677|11840680|FG000|Overall Study|Adverse Event|0
7510643|NCT02380677|11840681|FG001|Overall Study|Adverse Event|0
7510644|NCT02380677|11840682|FG002|Overall Study|Adverse Event|0
7510645|NCT02380677|11840683|FG003|Overall Study|Adverse Event|1
7510646|NCT02380677|11840684|FG004|Overall Study|Adverse Event|1
7510647|NCT02380677|11840685|FG005|Overall Study|Adverse Event|4
7510648|NCT02380677|11840686|FG006|Overall Study|Adverse Event|2
7510649|NCT02380677|11840687|FG007|Overall Study|Adverse Event|2
7510650|NCT02380677|11840688|FG008|Overall Study|Adverse Event|2
7510651|NCT02380677|11840689|FG009|Overall Study|Adverse Event|1
7510652|NCT02380677|11840690|FG010|Overall Study|Adverse Event|2
7510653|NCT02380677|11840691|FG011|Overall Study|Adverse Event|1
7510654|NCT02380677|11840680|FG000|Overall Study|Physician Decision|1
7510655|NCT02380677|11840681|FG001|Overall Study|Physician Decision|0
7510656|NCT02380677|11840682|FG002|Overall Study|Physician Decision|1
7510657|NCT02380677|11840683|FG003|Overall Study|Physician Decision|1
7510658|NCT02380677|11840684|FG004|Overall Study|Physician Decision|0
7510659|NCT02380677|11840685|FG005|Overall Study|Physician Decision|0
7510660|NCT02380677|11840686|FG006|Overall Study|Physician Decision|0
7510661|NCT02380677|11840687|FG007|Overall Study|Physician Decision|0
7510662|NCT02380677|11840688|FG008|Overall Study|Physician Decision|0
7510663|NCT02380677|11840689|FG009|Overall Study|Physician Decision|0
7510664|NCT02380677|11840690|FG010|Overall Study|Physician Decision|0
7510665|NCT02380677|11840691|FG011|Overall Study|Physician Decision|0
7510666|NCT02380677|11840680|FG000|Overall Study|Lack of Efficacy|0
7510667|NCT02380677|11840681|FG001|Overall Study|Lack of Efficacy|1
7510668|NCT02380677|11840682|FG002|Overall Study|Lack of Efficacy|2
7510669|NCT02380677|11840683|FG003|Overall Study|Lack of Efficacy|0
7510670|NCT02380677|11840684|FG004|Overall Study|Lack of Efficacy|4
7510671|NCT02380677|11840685|FG005|Overall Study|Lack of Efficacy|1
7510672|NCT02380677|11840686|FG006|Overall Study|Lack of Efficacy|1
7510673|NCT02380677|11840687|FG007|Overall Study|Lack of Efficacy|2
7510674|NCT02380677|11840688|FG008|Overall Study|Lack of Efficacy|2
7510675|NCT02380677|11840689|FG009|Overall Study|Lack of Efficacy|0
7510676|NCT02380677|11840690|FG010|Overall Study|Lack of Efficacy|2
7510677|NCT02380677|11840691|FG011|Overall Study|Lack of Efficacy|1
7510678|NCT02380677|11840680|FG000|Overall Study|Withdrawal by Subject|0
7510679|NCT02380677|11840681|FG001|Overall Study|Withdrawal by Subject|0
7510680|NCT02380677|11840682|FG002|Overall Study|Withdrawal by Subject|0
7510681|NCT02380677|11840683|FG003|Overall Study|Withdrawal by Subject|0
7510682|NCT02380677|11840684|FG004|Overall Study|Withdrawal by Subject|0
7510683|NCT02380677|11840685|FG005|Overall Study|Withdrawal by Subject|0
7510684|NCT02380677|11840686|FG006|Overall Study|Withdrawal by Subject|0
7510686|NCT02380677|11840688|FG008|Overall Study|Withdrawal by Subject|0
7510687|NCT02380677|11840689|FG009|Overall Study|Withdrawal by Subject|1
7510688|NCT02380677|11840690|FG010|Overall Study|Withdrawal by Subject|0
7510689|NCT02380677|11840691|FG011|Overall Study|Withdrawal by Subject|3
7510690|NCT02380677|11840680|FG000|Overall Study|Other|0
7510691|NCT02380677|11840681|FG001|Overall Study|Other|0
7510692|NCT02380677|11840682|FG002|Overall Study|Other|0
7510693|NCT02380677|11840683|FG003|Overall Study|Other|1
7510694|NCT02380677|11840684|FG004|Overall Study|Other|1
7510695|NCT02380677|11840685|FG005|Overall Study|Other|1
7510696|NCT02380677|11840686|FG006|Overall Study|Other|0
7510697|NCT02380677|11840687|FG007|Overall Study|Other|0
7510698|NCT02380677|11840688|FG008|Overall Study|Other|0
7510699|NCT02380677|11840689|FG009|Overall Study|Other|0
7510700|NCT02380677|11840690|FG010|Overall Study|Other|0
7510701|NCT02380677|11840691|FG011|Overall Study|Other|0
7510702|NCT02380690|11840721|FG000|Overall Study|Lost to Follow-up|14
7510703|NCT02380690|11840722|FG001|Overall Study|Lost to Follow-up|4
7510704|NCT02380690|11840721|FG000|Overall Study|Withdrawal by Subject|20
7510705|NCT02380690|11840722|FG001|Overall Study|Withdrawal by Subject|8
7510706|NCT02380703|11840730|FG000|Overall Study|Withdrawal by Subject|12
7510707|NCT02380703|11840731|FG001|Overall Study|Withdrawal by Subject|9
7510708|NCT02380703|11840730|FG000|Overall Study|Lost to Follow-up|12
7510709|NCT02380703|11840731|FG001|Overall Study|Lost to Follow-up|12
7510710|NCT02380703|11840730|FG000|Overall Study|Caregiver death|1
7510711|NCT02380703|11840731|FG001|Overall Study|Caregiver death|0
7510712|NCT02380703|11840730|FG000|Overall Study|Person with dementia (PWD) death|7
7510713|NCT02380703|11840731|FG001|Overall Study|Person with dementia (PWD) death|8
7510714|NCT02380703|11840730|FG000|Overall Study|Entered Long-term Care|4
7510715|NCT02380703|11840731|FG001|Overall Study|Entered Long-term Care|7
7510716|NCT02380742|11840739|FG000|Overall Study|Withdrawal by Subject|1
7510717|NCT02380742|11840740|FG001|Overall Study|Withdrawal by Subject|0
7510718|NCT02380859|11840748|FG000|Overall Study|Withdrawal by Subject|2
7510719|NCT02380859|11840749|FG001|Overall Study|Withdrawal by Subject|0
7510720|NCT02381795|11840819|FG000|Overall Study|Withdrawal by Subject|1
7510721|NCT02381795|11840819|FG000|Overall Study|Study Terminated|2
7510722|NCT02382016|11840825|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
7510723|NCT02382016|11840826|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
7510724|NCT02382016|11840825|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
7510725|NCT02382016|11840826|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
7510726|NCT02382016|11840825|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
7510727|NCT02382016|11840826|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
7510728|NCT02382016|11840825|FG000|Open-label (OL) Treatment Period|Physician Decision|3
7510729|NCT02382016|11840826|FG001|Open-label (OL) Treatment Period|Physician Decision|0
7510730|NCT02382016|11840825|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
7510731|NCT02382016|11840826|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
7510732|NCT02382016|11840825|FG000|Open-label (OL) Treatment Period|Death|4
7510733|NCT02382016|11840826|FG001|Open-label (OL) Treatment Period|Death|0
7510734|NCT02382016|11840825|FG000|OL Extension Period|Physician Decision|3
7510735|NCT02382016|11840826|FG001|OL Extension Period|Physician Decision|0
7510736|NCT02382016|11840825|FG000|OL Extension Period|Death|2
7510737|NCT02382016|11840826|FG001|OL Extension Period|Death|0
7510738|NCT02382016|11840825|FG000|OL Extension Period|Withdrawal by Subject|1
7510739|NCT02382016|11840826|FG001|OL Extension Period|Withdrawal by Subject|0
7510740|NCT02382133|11840834|FG000|Overall Study|Death|22
7510741|NCT02382133|11840834|FG000|Overall Study|transfer out of ICU|4
7510742|NCT02382133|11840834|FG000|Overall Study|Physician Decision|2
7510743|NCT02382133|11840834|FG000|Overall Study|arterial catheter loss|4
7510744|NCT02382133|11840834|FG000|Overall Study|pressure injury both sites|1
7510745|NCT02382276|11840841|FG000|Overall Study|Withdrawal by Subject|4
7510746|NCT02382276|11840842|FG001|Overall Study|Withdrawal by Subject|8
7510747|NCT02382276|11840843|FG002|Overall Study|Withdrawal by Subject|5
7510748|NCT02382276|11840841|FG000|Overall Study|Adverse Event|7
7510749|NCT02382276|11840842|FG001|Overall Study|Adverse Event|2
7510750|NCT02382276|11840843|FG002|Overall Study|Adverse Event|32
7510751|NCT02382276|11840841|FG000|Overall Study|Physician Decision|0
7510752|NCT02382276|11840842|FG001|Overall Study|Physician Decision|0
7510753|NCT02382276|11840843|FG002|Overall Study|Physician Decision|2
7510754|NCT02382640|11840853|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
7510755|NCT02382640|11840854|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7510756|NCT02382640|11840855|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7510757|NCT02382640|11840856|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
7510758|NCT02382796|11840883|FG000|Overall Study|Global deterioration of health status|1
7510759|NCT02382796|11840883|FG000|Overall Study|Objective progression or relapse|3
7510760|NCT02382796|11840883|FG000|Overall Study|Commercial dacomitinib became available|3
7510761|NCT02382939|11840937|FG000|Overall Study|Adverse Event|1
7510762|NCT02382939|11840938|FG001|Overall Study|Adverse Event|1
7510763|NCT02382939|11840937|FG000|Overall Study|Withdrawal by Subject|2
7510764|NCT02382939|11840938|FG001|Overall Study|Withdrawal by Subject|2
7510765|NCT02382991|11840947|FG000|Overall Study|Adverse Event|1
7510766|NCT02382991|11840948|FG001|Overall Study|Adverse Event|2
7510767|NCT02382991|11840947|FG000|Overall Study|Lost to Follow-up|1
7510768|NCT02382991|11840948|FG001|Overall Study|Lost to Follow-up|0
7510769|NCT02382991|11840947|FG000|Overall Study|Withdrawal by Subject|0
7510770|NCT02382991|11840948|FG001|Overall Study|Withdrawal by Subject|1
7510771|NCT02383017|11840955|FG000|Overall Study|Injury Sustained Outside Study|1
7510772|NCT02383017|11840956|FG001|Overall Study|Injury Sustained Outside Study|0
7510773|NCT02383017|11840955|FG000|Overall Study|Compliance|3
7510774|NCT02383017|11840956|FG001|Overall Study|Compliance|2
7510775|NCT02383017|11840955|FG000|Overall Study|Found to be Hypogonadal|1
7510776|NCT02383017|11840956|FG001|Overall Study|Found to be Hypogonadal|0
7510777|NCT02383056|11840978|FG000|Overall Study|Adverse Event|1
7510778|NCT02383056|11840979|FG001|Overall Study|Adverse Event|0
7510779|NCT02383056|11840978|FG000|Overall Study|Lost to Follow-up|0
7510780|NCT02383056|11840979|FG001|Overall Study|Lost to Follow-up|2
7510781|NCT02383173|11840987|FG000|Overall Study|Palliative Care Team withdrew|0
7510782|NCT02383173|11840988|FG001|Overall Study|Palliative Care Team withdrew|2
7510783|NCT02383355|11840996|FG000|Overall Study|Adverse Event|2
7510784|NCT02383355|11840997|FG001|Overall Study|Adverse Event|0
7510785|NCT02383472|11841018|FG000|Overall Study|Withdrawal by Subject|1
7510786|NCT02383472|11841019|FG001|Overall Study|Withdrawal by Subject|1
7510787|NCT02383576|11841029|FG000|Overall Study|Death|53
7510788|NCT02383576|11841030|FG001|Overall Study|Death|33
7510789|NCT02383576|11841029|FG000|Overall Study|Lost to Follow-up|7
7510790|NCT02383576|11841030|FG001|Overall Study|Lost to Follow-up|1
7510791|NCT02383576|11841029|FG000|Overall Study|Withdrew Consent|1
7510792|NCT02383576|11841030|FG001|Overall Study|Withdrew Consent|6
7510793|NCT02383576|11841029|FG000|Overall Study|Investigator's Decision|0
7510794|NCT02383576|11841030|FG001|Overall Study|Investigator's Decision|1
7510795|NCT02383576|11841029|FG000|Overall Study|Administrative/Other|2
7510796|NCT02383576|11841030|FG001|Overall Study|Administrative/Other|4
7510797|NCT02383589|11841038|FG000|Treatment Period|Adverse Event|1
7510798|NCT02383589|11841039|FG001|Treatment Period|Adverse Event|3
7510799|NCT02383589|11841038|FG000|Treatment Period|Lost to Follow-up|0
7510800|NCT02383589|11841039|FG001|Treatment Period|Lost to Follow-up|1
7510801|NCT02383589|11841038|FG000|Treatment Period|Withdrawal by Subject|0
7510802|NCT02383589|11841039|FG001|Treatment Period|Withdrawal by Subject|5
7510803|NCT02383589|11841038|FG000|Treatment Period|Non-compliance with study drug|0
7510804|NCT02383589|11841039|FG001|Treatment Period|Non-compliance with study drug|1
7510805|NCT02383589|11841038|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
7510806|NCT02383589|11841039|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
7510807|NCT02383589|11841038|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
7510808|NCT02383589|11841039|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
7510809|NCT02383589|11841038|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
7510810|NCT02383589|11841039|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
7510811|NCT02383758|11841062|FG000|Overall Study|Withdrawal by Subject|0
7510812|NCT02383758|11841063|FG001|Overall Study|Withdrawal by Subject|2
7510813|NCT02383862|11841071|FG000|3 Month Follow up|Lost to Follow-up|23
7510814|NCT02383862|11841072|FG001|3 Month Follow up|Lost to Follow-up|21
7510815|NCT02383940|11841087|FG000|Overall Study|Adverse Event|1
7510816|NCT02383940|11841088|FG001|Overall Study|Adverse Event|0
7510817|NCT02383940|11841087|FG000|Overall Study|Lost to Follow-up|2
7510818|NCT02383940|11841088|FG001|Overall Study|Lost to Follow-up|2
7510819|NCT02383940|11841087|FG000|Overall Study|Physician Decision|2
7510820|NCT02383940|11841088|FG001|Overall Study|Physician Decision|0
7510821|NCT02383940|11841087|FG000|Overall Study|Withdrawal by Subject|1
7510822|NCT02383940|11841088|FG001|Overall Study|Withdrawal by Subject|1
7510823|NCT02383940|11841087|FG000|Overall Study|Randomized but not treated|2
7510824|NCT02383940|11841088|FG001|Overall Study|Randomized but not treated|0
7510825|NCT02383940|11841087|FG000|Overall Study|Other than specified above|1
7510826|NCT02383940|11841088|FG001|Overall Study|Other than specified above|0
7510827|NCT02384382|11841133|FG000|Overall Study|Transitioned to study-NCT02960022|5
7510828|NCT02384382|11841133|FG000|Overall Study|Death|1
7510829|NCT02384382|11841133|FG000|Overall Study|Adverse Event|1
7510830|NCT02384382|11841133|FG000|Overall Study|Disease progression|16
7510831|NCT02384395|11841137|FG000|Overall Study|Physician Decision|4
7510832|NCT02384395|11841137|FG000|Overall Study|Withdrawal by Subject|3
7510833|NCT02384395|11841137|FG000|Overall Study|Lost to Follow-up|3
7510834|NCT02384460|11841143|FG000|Overall Study|Protocol Violation|0
7510835|NCT02384460|11841144|FG001|Overall Study|Protocol Violation|1
7510836|NCT02384460|11841143|FG000|Overall Study|Returned to previous therapeutic regimen|0
7510837|NCT02384460|11841144|FG001|Overall Study|Returned to previous therapeutic regimen|1
7510838|NCT02384460|11841143|FG000|Overall Study|Adverse Event|5
7510839|NCT02384460|11841144|FG001|Overall Study|Adverse Event|2
7510840|NCT02384460|11841143|FG000|Overall Study|Withdrawal by Subject|0
7510841|NCT02384460|11841144|FG001|Overall Study|Withdrawal by Subject|3
7510842|NCT02384460|11841143|FG000|Overall Study|Elective medical treatment|1
7510843|NCT02384460|11841144|FG001|Overall Study|Elective medical treatment|0
7510844|NCT02384460|11841143|FG000|Overall Study|Non-compliance|1
7510845|NCT02384460|11841144|FG001|Overall Study|Non-compliance|0
7510846|NCT02384538|11841152|FG000|Overall Study|Adverse Event|1
7510847|NCT02384538|11841153|FG001|Overall Study|Adverse Event|4
7510848|NCT02384538|11841152|FG000|Overall Study|Lack of Efficacy|4
7510849|NCT02384538|11841153|FG001|Overall Study|Lack of Efficacy|4
7510850|NCT02384538|11841152|FG000|Overall Study|Withdrew Consent|0
7510851|NCT02384538|11841153|FG001|Overall Study|Withdrew Consent|4
7510852|NCT02384538|11841152|FG000|Overall Study|Other|1
7510853|NCT02384538|11841153|FG001|Overall Study|Other|3
7510854|NCT02384941|11841162|FG000|Overall Study|Adverse Event|11
7510855|NCT02384941|11841163|FG001|Overall Study|Adverse Event|13
7510856|NCT02384941|11841164|FG002|Overall Study|Adverse Event|17
7510857|NCT02384941|11841162|FG000|Overall Study|Lost to Follow-up|3
7510858|NCT02384941|11841163|FG001|Overall Study|Lost to Follow-up|2
7510859|NCT02384941|11841164|FG002|Overall Study|Lost to Follow-up|1
7510860|NCT02384941|11841162|FG000|Overall Study|Non-Compliance With Study Drug|2
7510861|NCT02384941|11841163|FG001|Overall Study|Non-Compliance With Study Drug|0
7510862|NCT02384941|11841164|FG002|Overall Study|Non-Compliance With Study Drug|1
7510863|NCT02384941|11841162|FG000|Overall Study|Physician Decision|1
7510864|NCT02384941|11841163|FG001|Overall Study|Physician Decision|1
7510865|NCT02384941|11841164|FG002|Overall Study|Physician Decision|0
7510866|NCT02384941|11841162|FG000|Overall Study|Protocol Violation|3
7510867|NCT02384941|11841163|FG001|Overall Study|Protocol Violation|0
7510868|NCT02384941|11841164|FG002|Overall Study|Protocol Violation|0
7510869|NCT02384941|11841162|FG000|Overall Study|Withdrawal by Subject|26
7510870|NCT02384941|11841163|FG001|Overall Study|Withdrawal by Subject|19
7510871|NCT02384941|11841164|FG002|Overall Study|Withdrawal by Subject|20
7510872|NCT02384941|11841162|FG000|Overall Study|Pregnancy|0
7510873|NCT02384941|11841163|FG001|Overall Study|Pregnancy|0
7510874|NCT02384941|11841164|FG002|Overall Study|Pregnancy|1
7510875|NCT02384941|11841162|FG000|Overall Study|Other than specified above|4
7510876|NCT02384941|11841163|FG001|Overall Study|Other than specified above|0
7510877|NCT02384941|11841164|FG002|Overall Study|Other than specified above|1
7510878|NCT02385084|11841173|FG000|Period 2|Protocol Violation|0
7510879|NCT02385084|11841174|FG001|Period 2|Protocol Violation|0
7510880|NCT02385084|11841175|FG002|Period 2|Protocol Violation|1
7510881|NCT02385084|11841176|FG003|Period 2|Protocol Violation|0
7510882|NCT02385084|11841177|FG004|Period 2|Protocol Violation|0
7510883|NCT02385084|11841178|FG005|Period 2|Protocol Violation|0
7510884|NCT02385526|11841225|FG000|Overall Study|Withdrawal by Subject|0
7510885|NCT02385526|11841226|FG001|Overall Study|Withdrawal by Subject|2
7510886|NCT02385526|11841227|FG002|Overall Study|Withdrawal by Subject|0
7510887|NCT02385526|11841225|FG000|Overall Study|Lost to Follow-up|0
7510888|NCT02385526|11841226|FG001|Overall Study|Lost to Follow-up|1
7510889|NCT02385526|11841227|FG002|Overall Study|Lost to Follow-up|0
7510890|NCT02385526|11841225|FG000|Overall Study|Physician Decision|1
7510891|NCT02385526|11841226|FG001|Overall Study|Physician Decision|0
7510892|NCT02385526|11841227|FG002|Overall Study|Physician Decision|0
7510893|NCT02385526|11841225|FG000|Overall Study|Protocol Violation|1
7510894|NCT02385526|11841226|FG001|Overall Study|Protocol Violation|0
7510895|NCT02385526|11841227|FG002|Overall Study|Protocol Violation|0
7510896|NCT02385669|11841235|FG000|Overall Study|Adverse Event|2
7510897|NCT02385708|11841241|FG000|Overall Study|Withdrawal by Subject|0
7510898|NCT02385708|11841242|FG001|Overall Study|Withdrawal by Subject|2
7510899|NCT02385708|11841241|FG000|Overall Study|Withdrawn - surgery canceled|2
7510900|NCT02385708|11841242|FG001|Overall Study|Withdrawn - surgery canceled|5
7510901|NCT02385708|11841241|FG000|Overall Study|Investigator decision|5
7510902|NCT02385708|11841242|FG001|Overall Study|Investigator decision|7
7510903|NCT02385708|11841241|FG000|Overall Study|Protocol Violation|1
7510904|NCT02385708|11841242|FG001|Overall Study|Protocol Violation|1
7510905|NCT02385799|11841254|FG000|Overall Study|Lost to Follow-up|1
7510906|NCT02385799|11841255|FG001|Overall Study|Lost to Follow-up|2
7510907|NCT02385799|11841254|FG000|Overall Study|Adverse Event|4
7510908|NCT02385799|11841255|FG001|Overall Study|Adverse Event|2
7510909|NCT02385799|11841254|FG000|Overall Study|Withdrawal by Subject|0
7510910|NCT02385799|11841255|FG001|Overall Study|Withdrawal by Subject|4
7510911|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
7510912|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
7510913|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7510914|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7510915|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
7510916|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Adverse Event|2
7510917|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Adverse Event|1
7510918|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Adverse Event|0
7510919|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Adverse Event|0
7510920|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Adverse Event|0
7510921|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2
7510922|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2
7510923|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0
7510924|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0
7510925|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0
7510926|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7510927|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
7510928|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7510929|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7510930|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
7510931|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3
7510932|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1
7510933|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7510934|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7510935|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0
7510936|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Other|1
7510937|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Other|0
7510938|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Other|0
7510939|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Other|0
7510940|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Other|0
7510941|NCT02386098|11841266|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
7510942|NCT02386098|11841267|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
7510943|NCT02386098|11841268|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7510944|NCT02386098|11841269|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7510945|NCT02386098|11841270|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
7510946|NCT02386189|11841284|FG000|Overall Study|Lost to Follow-up|2
7510947|NCT02386189|11841285|FG001|Overall Study|Lost to Follow-up|3
7510948|NCT02386189|11841284|FG000|Overall Study|Withdrawal by Subject|1
7510949|NCT02386189|11841285|FG001|Overall Study|Withdrawal by Subject|0
7510950|NCT02386189|11841284|FG000|Overall Study|Death|1
7510951|NCT02386189|11841285|FG001|Overall Study|Death|0
7510952|NCT02386345|11841300|FG000|Overall Study|Not treated|14
7510953|NCT02386345|11841300|FG000|Overall Study|Lost to Follow-up|1
7510954|NCT02386345|11841300|FG000|Overall Study|Adverse Event|5
7510955|NCT02386345|11841300|FG000|Overall Study|Repeat Procedure|10
7510956|NCT02386345|11841300|FG000|Overall Study|Did not complete 12-month follow-up|72
7510957|NCT02387164|11841333|FG000|Overall Study|Lost to Follow-up|2
7510958|NCT02387164|11841334|FG001|Overall Study|Lost to Follow-up|0
7510959|NCT02387164|11841333|FG000|Overall Study|Diagnosed|1
7510960|NCT02387164|11841334|FG001|Overall Study|Diagnosed|2
7510961|NCT02387216|11841342|FG000|Overall Study|Progressive disease|2
7510962|NCT02387216|11841343|FG001|Overall Study|Progressive disease|0
7510963|NCT02387216|11841342|FG000|Overall Study|Withdrawal by Subject|3
7510964|NCT02387216|11841343|FG001|Overall Study|Withdrawal by Subject|5
7510965|NCT02387216|11841342|FG000|Overall Study|Physician Decision|2
7510966|NCT02387216|11841343|FG001|Overall Study|Physician Decision|0
7510967|NCT02387216|11841342|FG000|Overall Study|Sponsor Decision|28
7510968|NCT02387216|11841343|FG001|Overall Study|Sponsor Decision|12
7510969|NCT02387216|11841342|FG000|Overall Study|Death|60
7510970|NCT02387216|11841343|FG001|Overall Study|Death|23
7510971|NCT02387216|11841342|FG000|Overall Study|Other|5
7510972|NCT02387216|11841343|FG001|Overall Study|Other|4
7510973|NCT02387216|11841342|FG000|Overall Study|Lost to Follow-up|0
7510974|NCT02387216|11841343|FG001|Overall Study|Lost to Follow-up|3
7510975|NCT02387372|11841378|FG000|Overall Study|Not Treated|1
7510976|NCT02387372|11841379|FG001|Overall Study|Not Treated|0
7510977|NCT02387580|11841440|FG000|Overall Study|Withdrawal by Subject|0
7510978|NCT02387580|11841441|FG001|Overall Study|Withdrawal by Subject|0
7510979|NCT02387580|11841442|FG002|Overall Study|Withdrawal by Subject|0
7510980|NCT02387580|11841443|FG003|Overall Study|Withdrawal by Subject|1
7510981|NCT02387580|11841444|FG004|Overall Study|Withdrawal by Subject|0
7510982|NCT02387580|11841445|FG005|Overall Study|Withdrawal by Subject|0
7510983|NCT02387762|11841481|FG000|Overall Study|Withdrawal by Subject|1
7510984|NCT02387762|11841482|FG001|Overall Study|Withdrawal by Subject|0
7510985|NCT02387840|11841522|FG000|Overall Study|Death|0
7510986|NCT02387840|11841523|FG001|Overall Study|Death|0
7510987|NCT02387840|11841524|FG002|Overall Study|Death|0
7510988|NCT02387840|11841525|FG003|Overall Study|Death|0
7510989|NCT02387840|11841526|FG004|Overall Study|Death|0
7510990|NCT02387840|11841527|FG005|Overall Study|Death|1
7510991|NCT02387957|11841554|FG000|Overall Study|The study was discontinued|21
7510992|NCT02387957|11841555|FG001|Overall Study|The study was discontinued|21
7510993|NCT02387957|11841556|FG002|Overall Study|The study was discontinued|20
7510994|NCT02387970|11841566|FG000|Overall Study|Did not complete 1-year follow up|1
7510995|NCT02387970|11841567|FG001|Overall Study|Did not complete 1-year follow up|2
7510996|NCT02387983|11841573|FG000|Overall Study|Adverse Event|4
7510997|NCT02387983|11841573|FG000|Overall Study|Protocol Violation|1
7510998|NCT02387983|11841573|FG000|Overall Study|Withdrawal by Subject|2
7510999|NCT02388074|11841577|FG000|Overall Study|Lost in Transit|2
7511000|NCT02388074|11841577|FG000|Overall Study|Sample Not Returned|1
7511001|NCT02388165|11841583|FG000|Overall Study|Study terminated by sponsor|5
7511002|NCT02388165|11841584|FG001|Overall Study|Study terminated by sponsor|5
7511003|NCT02388165|11841583|FG000|Overall Study|Other|11
7511004|NCT02388165|11841584|FG001|Overall Study|Other|13
7511005|NCT02388165|11841583|FG000|Overall Study|No longer meet eligibility criteria|40
7511006|NCT02388165|11841584|FG001|Overall Study|No longer meet eligibility criteria|43
7511007|NCT02388165|11841583|FG000|Overall Study|Withdrawal of consent|31
7511008|NCT02388165|11841584|FG001|Overall Study|Withdrawal of consent|32
7511009|NCT02388165|11841583|FG000|Overall Study|Lost to Follow-up|19
7511010|NCT02388165|11841584|FG001|Overall Study|Lost to Follow-up|20
7511011|NCT02388165|11841583|FG000|Overall Study|Death|13
7511012|NCT02388165|11841584|FG001|Overall Study|Death|10
7511013|NCT02388165|11841583|FG000|Overall Study|Adverse Event|3
7511014|NCT02388165|11841584|FG001|Overall Study|Adverse Event|5
7511015|NCT02388165|11841583|FG000|Overall Study|Did not meet entrance criteria|5
7511016|NCT02388165|11841584|FG001|Overall Study|Did not meet entrance criteria|2
7511017|NCT02388191|11841592|FG000|Overall Study|Patient did not receive IUD|1
7511018|NCT02388191|11841593|FG001|Overall Study|Patient did not receive IUD|0
7511019|NCT02388269|11841603|FG000|Overall Study|Adverse Event|2
7511020|NCT02388269|11841604|FG001|Overall Study|Adverse Event|0
7511021|NCT02388269|11841605|FG002|Overall Study|Adverse Event|0
7511022|NCT02388269|11841603|FG000|Overall Study|Withdrawal by Subject|1
7511023|NCT02388269|11841604|FG001|Overall Study|Withdrawal by Subject|2
7511024|NCT02388269|11841605|FG002|Overall Study|Withdrawal by Subject|0
7511025|NCT02388269|11841603|FG000|Overall Study|less than 50% stimulations|1
7511026|NCT02388269|11841604|FG001|Overall Study|less than 50% stimulations|0
7511027|NCT02388269|11841605|FG002|Overall Study|less than 50% stimulations|0
7511028|NCT02388269|11841603|FG000|Overall Study|no diary data|3
7511029|NCT02388269|11841604|FG001|Overall Study|no diary data|0
7511030|NCT02388269|11841605|FG002|Overall Study|no diary data|0
7511031|NCT02388269|11841603|FG000|Overall Study|Protocol Violation|2
7511032|NCT02388269|11841604|FG001|Overall Study|Protocol Violation|0
7511033|NCT02388269|11841605|FG002|Overall Study|Protocol Violation|0
7511034|NCT02388269|11841603|FG000|Overall Study|Screen Failure|0
7511035|NCT02388269|11841604|FG001|Overall Study|Screen Failure|0
7511036|NCT02388269|11841605|FG002|Overall Study|Screen Failure|10
7511037|NCT02388295|11841632|FG000|Dose Escalation Week 1|Adverse Event|1
7511038|NCT02388295|11841633|FG001|Dose Escalation Week 1|Adverse Event|2
7511039|NCT02388295|11841634|FG002|Dose Escalation Week 1|Adverse Event|1
7511040|NCT02388295|11841632|FG000|Dose Escalation Week 1|Determined not eligible|1
7511041|NCT02388295|11841633|FG001|Dose Escalation Week 1|Determined not eligible|1
7511042|NCT02388295|11841634|FG002|Dose Escalation Week 1|Determined not eligible|1
7511043|NCT02388295|11841632|FG000|Dose Escalation Week 2|Protocol Violation|0
7511044|NCT02388295|11841633|FG001|Dose Escalation Week 2|Protocol Violation|1
7511045|NCT02388295|11841634|FG002|Dose Escalation Week 2|Protocol Violation|0
7511046|NCT02388295|11841632|FG000|Dose Escalation Week 2|Determined not eligible|1
7511047|NCT02388295|11841633|FG001|Dose Escalation Week 2|Determined not eligible|1
7511048|NCT02388295|11841634|FG002|Dose Escalation Week 2|Determined not eligible|1
7511049|NCT02388295|11841632|FG000|Treatment Weeks 3 to 12|Adverse Event|1
7511050|NCT02388295|11841633|FG001|Treatment Weeks 3 to 12|Adverse Event|1
7511051|NCT02388295|11841634|FG002|Treatment Weeks 3 to 12|Adverse Event|0
7511052|NCT02388347|11841656|FG000|Overall Study|Withdrawal by Subject|0
7511053|NCT02388347|11841657|FG001|Overall Study|Withdrawal by Subject|0
7511054|NCT02388347|11841658|FG002|Overall Study|Withdrawal by Subject|1
7511055|NCT02388347|11841659|FG003|Overall Study|Withdrawal by Subject|0
7511056|NCT02388347|11841660|FG004|Overall Study|Withdrawal by Subject|0
7511057|NCT02388724|11841712|FG000|Overall Study|Reason not Specified|0
7511058|NCT02388724|11841713|FG001|Overall Study|Reason not Specified|1
7511059|NCT02388724|11841712|FG000|Overall Study|Major Protocol Deviation|3
7511060|NCT02388724|11841713|FG001|Overall Study|Major Protocol Deviation|3
7511061|NCT02388724|11841712|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7511062|NCT02388724|11841713|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7511063|NCT02388724|11841712|FG000|Overall Study|Voluntary Withdrawal|6
7511064|NCT02388724|11841713|FG001|Overall Study|Voluntary Withdrawal|5
7511065|NCT02388724|11841712|FG000|Overall Study|Randomized but not Treated|0
7511066|NCT02388724|11841713|FG001|Overall Study|Randomized but not Treated|2
7511067|NCT02388737|11841722|FG000|Overall Study|Pretreatment Event/Adverse Event|13
7511068|NCT02388737|11841723|FG001|Overall Study|Pretreatment Event/Adverse Event|11
7511069|NCT02388737|11841724|FG002|Overall Study|Pretreatment Event/Adverse Event|12
7511070|NCT02388737|11841722|FG000|Overall Study|Major Protocol Deviation|18
7511071|NCT02388737|11841723|FG001|Overall Study|Major Protocol Deviation|25
7511072|NCT02388737|11841724|FG002|Overall Study|Major Protocol Deviation|22
7511073|NCT02388737|11841722|FG000|Overall Study|Lost to Follow-up|5
7511074|NCT02388737|11841723|FG001|Overall Study|Lost to Follow-up|1
7511075|NCT02388737|11841724|FG002|Overall Study|Lost to Follow-up|4
7511076|NCT02388737|11841722|FG000|Overall Study|Voluntary Withdrawal|10
7511077|NCT02388737|11841723|FG001|Overall Study|Voluntary Withdrawal|18
7511078|NCT02388737|11841724|FG002|Overall Study|Voluntary Withdrawal|17
7511079|NCT02388737|11841722|FG000|Overall Study|Lack of Efficacy|3
7511080|NCT02388737|11841723|FG001|Overall Study|Lack of Efficacy|0
7511081|NCT02388737|11841724|FG002|Overall Study|Lack of Efficacy|3
7511082|NCT02388737|11841722|FG000|Overall Study|Reason Not Specified|5
7511083|NCT02388737|11841723|FG001|Overall Study|Reason Not Specified|5
7511084|NCT02388737|11841724|FG002|Overall Study|Reason Not Specified|4
7511085|NCT02388763|11841732|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7511086|NCT02388763|11841733|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
7511087|NCT02388763|11841732|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7511088|NCT02388763|11841733|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
7536240|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
7536241|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7536242|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
7536243|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
7536244|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
7536245|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
7536246|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
7536247|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
7536248|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
7536249|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
7536250|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
7536251|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
7536252|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
7536253|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
7536254|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
7536255|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
7536256|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
7536257|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
7536258|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
7536259|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
7536260|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
7536261|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
7536262|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
7536263|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7536264|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7536265|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7536266|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
7536267|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
7536268|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7536269|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7536270|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
7536271|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7536272|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
7536273|NCT02717195|11884222|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7536274|NCT02717195|11884223|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7536275|NCT02717195|11884224|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
7511089|NCT02388932|11841750|FG000|Overall Study|Death|1
7511090|NCT02388997|11841757|FG000|Overall Study|Adverse Event|1
7511091|NCT02388997|11841758|FG001|Overall Study|Adverse Event|2
7511092|NCT02388997|11841757|FG000|Overall Study|Withdrawal by Subject|2
7511093|NCT02388997|11841758|FG001|Overall Study|Withdrawal by Subject|1
7511094|NCT02388997|11841757|FG000|Overall Study|Lung function exclusion criteria|0
7511095|NCT02388997|11841758|FG001|Overall Study|Lung function exclusion criteria|2
7511096|NCT02388997|11841757|FG000|Overall Study|Tested positive for virus during run-in|0
7511097|NCT02388997|11841758|FG001|Overall Study|Tested positive for virus during run-in|1
7511098|NCT02389452|11841791|FG000|Overall Study|Lost to Follow-up|13
7511099|NCT02389452|11841791|FG000|Overall Study|Adverse Event|1
7511100|NCT02389452|11841791|FG000|Overall Study|Withdrawal by Subject|5
7511101|NCT02389452|11841791|FG000|Overall Study|Enrolled but Not Eligible for Study|6
7511102|NCT02389621|11841798|FG000|Treatment Period|Withdrawal by Subject|1
7511103|NCT02389621|11841799|FG001|Treatment Period|Withdrawal by Subject|1
7511104|NCT02389621|11841798|FG000|Posttreatment Period|Adverse Event|3
7511105|NCT02389621|11841799|FG001|Posttreatment Period|Adverse Event|1
7511106|NCT02389621|11841798|FG000|Posttreatment Period|Withdrawal by Subject|3
7511107|NCT02389621|11841799|FG001|Posttreatment Period|Withdrawal by Subject|2
7511108|NCT02389621|11841798|FG000|Posttreatment Period|Lost to Follow-up|1
7511109|NCT02389621|11841799|FG001|Posttreatment Period|Lost to Follow-up|1
7511110|NCT02389621|11841798|FG000|Posttreatment Period|Other - Miscellaneous|2
7511111|NCT02389621|11841799|FG001|Posttreatment Period|Other - Miscellaneous|0
7511112|NCT02389764|11841824|FG000|Overall Study|Lack of Efficacy|9
7511113|NCT02389816|11841831|FG000|Overall Study|Randomized but Not Treated|1
7511114|NCT02389816|11841832|FG001|Overall Study|Randomized but Not Treated|0
7511115|NCT02389816|11841833|FG002|Overall Study|Randomized but Not Treated|0
7511116|NCT02389816|11841831|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
7511117|NCT02389816|11841832|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
7511118|NCT02389816|11841833|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
7511119|NCT02389816|11841831|FG000|Overall Study|Major Protocol Deviation|1
7511120|NCT02389816|11841832|FG001|Overall Study|Major Protocol Deviation|0
7511121|NCT02389816|11841833|FG002|Overall Study|Major Protocol Deviation|0
7511122|NCT02389816|11841831|FG000|Overall Study|Lost to Follow-up|1
7511123|NCT02389816|11841832|FG001|Overall Study|Lost to Follow-up|0
7511124|NCT02389816|11841833|FG002|Overall Study|Lost to Follow-up|0
7511125|NCT02389816|11841831|FG000|Overall Study|Withdrawal of Consent|6
7511126|NCT02389816|11841832|FG001|Overall Study|Withdrawal of Consent|4
7511127|NCT02389816|11841833|FG002|Overall Study|Withdrawal of Consent|4
7511128|NCT02389816|11841831|FG000|Overall Study|Lack of Efficacy|1
7511129|NCT02389816|11841832|FG001|Overall Study|Lack of Efficacy|0
7511130|NCT02389816|11841833|FG002|Overall Study|Lack of Efficacy|0
7511131|NCT02389816|11841831|FG000|Overall Study|Non Compliance with Study Drug|1
7511132|NCT02389816|11841832|FG001|Overall Study|Non Compliance with Study Drug|1
7511133|NCT02389816|11841833|FG002|Overall Study|Non Compliance with Study Drug|1
7511134|NCT02389816|11841831|FG000|Overall Study|Reason not Specified|0
7511135|NCT02389816|11841832|FG001|Overall Study|Reason not Specified|2
7511136|NCT02389816|11841833|FG002|Overall Study|Reason not Specified|0
7511137|NCT02389829|11841843|FG000|Overall Study|Lost to Follow-up|0
7511138|NCT02389829|11841844|FG001|Overall Study|Lost to Follow-up|1
7511139|NCT02389894|11841882|FG000|Overall Study|Death|4
7511140|NCT02389894|11841883|FG001|Overall Study|Death|5
7511141|NCT02389894|11841884|FG002|Overall Study|Death|3
7511142|NCT02389894|11841882|FG000|Overall Study|Withdrawal by Subject|2
7511143|NCT02389894|11841883|FG001|Overall Study|Withdrawal by Subject|4
7511144|NCT02389894|11841884|FG002|Overall Study|Withdrawal by Subject|5
7511145|NCT02389894|11841882|FG000|Overall Study|Lost to Follow-up|2
7511146|NCT02389894|11841883|FG001|Overall Study|Lost to Follow-up|1
7511147|NCT02389894|11841884|FG002|Overall Study|Lost to Follow-up|1
7511148|NCT02389998|11841903|FG000|Overall Study|car accident|1
7511149|NCT02389998|11841904|FG001|Overall Study|car accident|0
7511150|NCT02390076|11841932|FG000|Overall Study|Lost to Follow-up|2
7511151|NCT02390076|11841933|FG001|Overall Study|Lost to Follow-up|1
7511152|NCT02390076|11841934|FG002|Overall Study|Lost to Follow-up|4
7511153|NCT02390167|11841942|FG000|Overall Study|Lost to Follow-up|1
7511154|NCT02390219|11841950|FG000|Overall Study|Death|1
7511155|NCT02390219|11841950|FG000|Overall Study|Physician Decision|1
7511156|NCT02390219|11841950|FG000|Overall Study|Adverse Event|6
7511157|NCT02390219|11841950|FG000|Overall Study|Withdrawal by Subject|1
7511158|NCT02390219|11841950|FG000|Overall Study|Lost to Follow-up|2
7511159|NCT02390219|11841950|FG000|Overall Study|Other|2
7511160|NCT02390557|11841957|FG000|Wave 2|Survey non-respondent|72
7511161|NCT02390557|11841958|FG001|Wave 2|Survey non-respondent|41
7511162|NCT02390557|11841959|FG002|Wave 2|Survey non-respondent|23
7511163|NCT02391038|11842002|FG000|Overall Study|Progressive disease|3
7511164|NCT02391038|11842003|FG001|Overall Study|Progressive disease|3
7511165|NCT02391038|11842004|FG002|Overall Study|Progressive disease|6
7511166|NCT02391116|11842013|FG000|Treatment|Withdrawal by Subject|1
7511167|NCT02391116|11842013|FG000|Treatment|Protocol Violation|1
7511168|NCT02391116|11842013|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
7511169|NCT02391116|11842013|FG000|Treatment|AE with Clinical PD|3
7511170|NCT02391116|11842013|FG000|Safety Follow-up|Adverse Event|1
7511171|NCT02391116|11842013|FG000|Safety Follow-up|Withdrawal by Subject|4
7511172|NCT02391116|11842013|FG000|Safety Follow-up|Switching to Other Therapy|4
7511173|NCT02391116|11842013|FG000|Safety Follow-up|No Follow Up|1
7511174|NCT02391116|11842013|FG000|Safety Follow-up|Deterioration of General Conditions|3
7511175|NCT02391116|11842013|FG000|Active Follow-up|Withdrawal by Subject|1
7511176|NCT02391116|11842013|FG000|Active Follow-up|Switching to Other Therapy|2
7511177|NCT02391116|11842013|FG000|Survival Follow-up|Withdrawal by Subject|3
7511178|NCT02391116|11842013|FG000|Survival Follow-up|Switching to Other Therapy|1
7511179|NCT02391311|11842026|FG000|Overall Study|Lost to Follow-up|2
7511180|NCT02391311|11842027|FG001|Overall Study|Lost to Follow-up|1
7511181|NCT02391311|11842026|FG000|Overall Study|deemed ineligible after baseline|1
7511182|NCT02391311|11842027|FG001|Overall Study|deemed ineligible after baseline|1
7511183|NCT02391337|11842035|FG000|6 Months Follow-up|Death|5
7511184|NCT02391337|11842036|FG001|6 Months Follow-up|Death|4
7511185|NCT02391337|11842035|FG000|6 Months Follow-up|Withdrawal by Subject|1
7511186|NCT02391337|11842036|FG001|6 Months Follow-up|Withdrawal by Subject|1
7511187|NCT02391337|11842035|FG000|12 Months Follow-up|Death|2
7511188|NCT02391337|11842036|FG001|12 Months Follow-up|Death|0
7511189|NCT02391337|11842035|FG000|12 Months Follow-up|Withdrawal by Subject|0
7511190|NCT02391337|11842036|FG001|12 Months Follow-up|Withdrawal by Subject|1
7511191|NCT02391337|11842035|FG000|12 Months Follow-up|Lost to Follow-up|0
7511192|NCT02391337|11842036|FG001|12 Months Follow-up|Lost to Follow-up|2
7511193|NCT02391363|11842053|FG000|Overall Study|Lost to Follow-up|5
7511194|NCT02391363|11842054|FG001|Overall Study|Lost to Follow-up|5
7511195|NCT02391363|11842053|FG000|Overall Study|Withdrawal by Subject|6
7511196|NCT02391363|11842054|FG001|Overall Study|Withdrawal by Subject|3
7511197|NCT02391545|11842062|FG000|Overall Study|Death|0
7511198|NCT02391545|11842063|FG001|Overall Study|Death|2
7511199|NCT02391545|11842062|FG000|Overall Study|Lost to Follow-up|0
7511200|NCT02391545|11842063|FG001|Overall Study|Lost to Follow-up|1
7511201|NCT02391545|11842062|FG000|Overall Study|Termination of study by sponsor|20
7511202|NCT02391545|11842063|FG001|Overall Study|Termination of study by sponsor|20
7511203|NCT02391545|11842062|FG000|Overall Study|Withdrawal by Subject|0
7511204|NCT02391545|11842063|FG001|Overall Study|Withdrawal by Subject|1
7511205|NCT02391545|11842062|FG000|Overall Study|Other Reasons|6
7511206|NCT02391545|11842063|FG001|Overall Study|Other Reasons|4
7511207|NCT02391584|11842072|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
7511208|NCT02391584|11842073|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
7511209|NCT02391584|11842072|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
7511210|NCT02391584|11842073|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
7511211|NCT02391584|11842072|FG000|3 Month|Lost to Follow-up|1
7511212|NCT02391584|11842073|FG001|3 Month|Lost to Follow-up|0
7511213|NCT02391584|11842072|FG000|6 Month|Withdrawal by Subject|1
7511214|NCT02391584|11842073|FG001|6 Month|Withdrawal by Subject|0
7511215|NCT02391584|11842072|FG000|12 Month (End of Study)|Lost to Follow-up|2
7511216|NCT02391584|11842073|FG001|12 Month (End of Study)|Lost to Follow-up|0
7511217|NCT02391948|11842107|FG000|6-month Assessment|Death|0
7511218|NCT02391948|11842108|FG001|6-month Assessment|Death|0
7511219|NCT02391948|11842109|FG002|6-month Assessment|Death|0
7511220|NCT02391948|11842110|FG003|6-month Assessment|Death|0
7511221|NCT02391948|11842111|FG004|6-month Assessment|Death|1
7511222|NCT02391948|11842107|FG000|6-month Assessment|Withdrawal by Subject|0
7511223|NCT02391948|11842108|FG001|6-month Assessment|Withdrawal by Subject|0
7511224|NCT02391948|11842109|FG002|6-month Assessment|Withdrawal by Subject|1
7511225|NCT02391948|11842110|FG003|6-month Assessment|Withdrawal by Subject|2
7511226|NCT02391948|11842111|FG004|6-month Assessment|Withdrawal by Subject|0
7511227|NCT02391948|11842107|FG000|6-month Assessment|Lost to Follow-up|4
7511228|NCT02391948|11842108|FG001|6-month Assessment|Lost to Follow-up|5
7511229|NCT02391948|11842109|FG002|6-month Assessment|Lost to Follow-up|2
7511230|NCT02391948|11842110|FG003|6-month Assessment|Lost to Follow-up|3
7511231|NCT02391948|11842111|FG004|6-month Assessment|Lost to Follow-up|1
7511232|NCT02391948|11842107|FG000|6-month Assessment|Medical issue/illness|1
7511233|NCT02391948|11842108|FG001|6-month Assessment|Medical issue/illness|1
7511234|NCT02391948|11842109|FG002|6-month Assessment|Medical issue/illness|0
7511235|NCT02391948|11842110|FG003|6-month Assessment|Medical issue/illness|0
7511236|NCT02391948|11842111|FG004|6-month Assessment|Medical issue/illness|0
7511237|NCT02391948|11842107|FG000|6-month Assessment|Not able to schedule visit in timeframe|6
7511238|NCT02391948|11842108|FG001|6-month Assessment|Not able to schedule visit in timeframe|8
7511239|NCT02391948|11842109|FG002|6-month Assessment|Not able to schedule visit in timeframe|4
7511240|NCT02391948|11842110|FG003|6-month Assessment|Not able to schedule visit in timeframe|5
7511241|NCT02391948|11842111|FG004|6-month Assessment|Not able to schedule visit in timeframe|0
7511242|NCT02391948|11842107|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68
7511243|NCT02391948|11842108|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42
7511244|NCT02391948|11842109|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24
7511245|NCT02391948|11842110|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35
7511246|NCT02391948|11842111|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24
7511247|NCT02391948|11842107|FG000|12-month Assessment|Death|0
7511248|NCT02391948|11842108|FG001|12-month Assessment|Death|0
7511249|NCT02391948|11842109|FG002|12-month Assessment|Death|0
7511250|NCT02391948|11842110|FG003|12-month Assessment|Death|1
7511251|NCT02391948|11842111|FG004|12-month Assessment|Death|0
7511252|NCT02391948|11842107|FG000|12-month Assessment|Withdrawal by Subject|1
7511253|NCT02391948|11842108|FG001|12-month Assessment|Withdrawal by Subject|0
7511254|NCT02391948|11842109|FG002|12-month Assessment|Withdrawal by Subject|0
7511255|NCT02391948|11842110|FG003|12-month Assessment|Withdrawal by Subject|1
7511256|NCT02391948|11842111|FG004|12-month Assessment|Withdrawal by Subject|0
7511257|NCT02391948|11842107|FG000|12-month Assessment|Lost to Follow-up|5
7511258|NCT02391948|11842108|FG001|12-month Assessment|Lost to Follow-up|4
7511259|NCT02391948|11842109|FG002|12-month Assessment|Lost to Follow-up|4
7511260|NCT02391948|11842110|FG003|12-month Assessment|Lost to Follow-up|4
7511261|NCT02391948|11842111|FG004|12-month Assessment|Lost to Follow-up|5
7511262|NCT02391948|11842107|FG000|12-month Assessment|Medical issue/illness|0
7511263|NCT02391948|11842108|FG001|12-month Assessment|Medical issue/illness|1
7511264|NCT02391948|11842109|FG002|12-month Assessment|Medical issue/illness|0
7511265|NCT02391948|11842110|FG003|12-month Assessment|Medical issue/illness|1
7511266|NCT02391948|11842111|FG004|12-month Assessment|Medical issue/illness|0
7511267|NCT02391948|11842107|FG000|12-month Assessment|Not able to schedule visit in timeframe|2
7511268|NCT02391948|11842108|FG001|12-month Assessment|Not able to schedule visit in timeframe|4
7511269|NCT02391948|11842109|FG002|12-month Assessment|Not able to schedule visit in timeframe|0
7511270|NCT02391948|11842110|FG003|12-month Assessment|Not able to schedule visit in timeframe|2
7511271|NCT02391948|11842111|FG004|12-month Assessment|Not able to schedule visit in timeframe|1
7511272|NCT02391948|11842107|FG000|18-month Assessment|Death|0
7511273|NCT02391948|11842108|FG001|18-month Assessment|Death|0
7511274|NCT02391948|11842109|FG002|18-month Assessment|Death|0
7511275|NCT02391948|11842110|FG003|18-month Assessment|Death|1
7511276|NCT02391948|11842111|FG004|18-month Assessment|Death|1
7511277|NCT02391948|11842107|FG000|18-month Assessment|Withdrawal by Subject|1
7511278|NCT02391948|11842108|FG001|18-month Assessment|Withdrawal by Subject|0
7511279|NCT02391948|11842109|FG002|18-month Assessment|Withdrawal by Subject|0
7511280|NCT02391948|11842110|FG003|18-month Assessment|Withdrawal by Subject|1
7511281|NCT02391948|11842111|FG004|18-month Assessment|Withdrawal by Subject|0
7511282|NCT02391948|11842107|FG000|18-month Assessment|Lost to Follow-up|2
7511283|NCT02391948|11842108|FG001|18-month Assessment|Lost to Follow-up|6
7511284|NCT02391948|11842109|FG002|18-month Assessment|Lost to Follow-up|2
7511285|NCT02391948|11842110|FG003|18-month Assessment|Lost to Follow-up|2
7511286|NCT02391948|11842111|FG004|18-month Assessment|Lost to Follow-up|3
7511287|NCT02391948|11842107|FG000|18-month Assessment|Not able to schedule visit in timeframe|3
7511288|NCT02391948|11842108|FG001|18-month Assessment|Not able to schedule visit in timeframe|3
7511289|NCT02391948|11842109|FG002|18-month Assessment|Not able to schedule visit in timeframe|2
7511290|NCT02391948|11842110|FG003|18-month Assessment|Not able to schedule visit in timeframe|1
7511291|NCT02391948|11842111|FG004|18-month Assessment|Not able to schedule visit in timeframe|4
7511292|NCT02391948|11842107|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
7511293|NCT02391948|11842108|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
7511294|NCT02391948|11842109|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7511295|NCT02391948|11842110|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
7511296|NCT02391948|11842111|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
7511297|NCT02391948|11842107|FG000|24-month Assessment|Death|0
7511298|NCT02391948|11842108|FG001|24-month Assessment|Death|0
7511299|NCT02391948|11842109|FG002|24-month Assessment|Death|0
7511300|NCT02391948|11842110|FG003|24-month Assessment|Death|0
7511301|NCT02391948|11842111|FG004|24-month Assessment|Death|1
7511302|NCT02391948|11842107|FG000|24-month Assessment|Withdrawal by Subject|1
7511303|NCT02391948|11842108|FG001|24-month Assessment|Withdrawal by Subject|1
7511304|NCT02391948|11842109|FG002|24-month Assessment|Withdrawal by Subject|0
7511305|NCT02391948|11842110|FG003|24-month Assessment|Withdrawal by Subject|0
7511306|NCT02391948|11842111|FG004|24-month Assessment|Withdrawal by Subject|1
7511307|NCT02391948|11842107|FG000|24-month Assessment|Lost to Follow-up|5
7511308|NCT02391948|11842108|FG001|24-month Assessment|Lost to Follow-up|4
7511309|NCT02391948|11842109|FG002|24-month Assessment|Lost to Follow-up|0
7511310|NCT02391948|11842110|FG003|24-month Assessment|Lost to Follow-up|0
7511311|NCT02391948|11842111|FG004|24-month Assessment|Lost to Follow-up|0
7511312|NCT02391948|11842107|FG000|24-month Assessment|Medical issue/illness|0
7511313|NCT02391948|11842108|FG001|24-month Assessment|Medical issue/illness|0
7511314|NCT02391948|11842109|FG002|24-month Assessment|Medical issue/illness|1
7511315|NCT02391948|11842110|FG003|24-month Assessment|Medical issue/illness|0
7511316|NCT02391948|11842111|FG004|24-month Assessment|Medical issue/illness|0
7511317|NCT02391948|11842107|FG000|24-month Assessment|Not able to schedule visit in timeframe|8
7511318|NCT02391948|11842108|FG001|24-month Assessment|Not able to schedule visit in timeframe|5
7511319|NCT02391948|11842109|FG002|24-month Assessment|Not able to schedule visit in timeframe|2
7511320|NCT02391948|11842110|FG003|24-month Assessment|Not able to schedule visit in timeframe|9
7511321|NCT02391948|11842111|FG004|24-month Assessment|Not able to schedule visit in timeframe|8
7511322|NCT02391961|11842128|FG000|First Intervention (4 Weeks)|Adverse Event|2
7511323|NCT02391961|11842129|FG001|First Intervention (4 Weeks)|Adverse Event|0
7511324|NCT02391961|11842128|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
7511325|NCT02391961|11842129|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
7511326|NCT02391961|11842128|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7511327|NCT02391961|11842129|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7511328|NCT02392000|11842144|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
7511329|NCT02392000|11842144|FG000|Overall Study|Withdrawal by Subject|1
7511330|NCT02392000|11842144|FG000|Overall Study|Lost to Follow-up|8
7511331|NCT02392104|11842149|FG000|Overall Study|discontinuation of warfarin|3
7511332|NCT02392104|11842149|FG000|Overall Study|bleeding event|1
7511333|NCT02392104|11842149|FG000|Overall Study|transferred care to another doctor|2
7511334|NCT02392104|11842149|FG000|Overall Study|INR goal range changed|1
7511335|NCT02392104|11842149|FG000|Overall Study|admitted to skilled nursing facility|3
7511336|NCT02392104|11842149|FG000|Overall Study|INRs drawn by visiting nurse services|1
7511337|NCT02392195|11842153|FG000|Overall Study|Lost to Follow-up|4
7511338|NCT02392195|11842153|FG000|Overall Study|Withdrawal by Subject|4
7511339|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
7511340|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
7511341|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
7511342|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
7511343|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
7511344|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
7511345|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7511346|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7511347|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7511348|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7511349|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
7511350|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
7511351|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7511352|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7511353|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7511354|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7511355|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7511356|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7511357|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
7511358|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
7511359|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
7511360|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
7511361|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
7511362|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
7511363|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
7511364|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
7511365|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
7511366|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
7511367|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
7511368|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
7511369|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Other|1
7511370|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Other|0
7511371|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Other|0
7511372|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Other|0
7511373|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Other|0
7511374|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Other|0
7511375|NCT02392234|11842168|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7511376|NCT02392234|11842169|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7511461|NCT02392611|11842277|FG008|Overall Study|Enrolled, not treated|0
7511377|NCT02392234|11842170|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7511378|NCT02392234|11842171|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7511379|NCT02392234|11842172|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
7511380|NCT02392234|11842173|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
7511381|NCT02392234|11842168|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
7511382|NCT02392234|11842169|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
7511383|NCT02392234|11842170|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
7511384|NCT02392234|11842171|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
7511385|NCT02392234|11842172|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
7511386|NCT02392234|11842173|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
7511387|NCT02392247|11842184|FG000|Overall Study|Withdrawal by Subject|1
7511388|NCT02392247|11842184|FG000|Overall Study|Surgery cancelled; no data|1
7511389|NCT02392403|11842206|FG000|Overall Study|Adverse Event|1
7511390|NCT02392403|11842206|FG000|Overall Study|Death|1
7511391|NCT02392403|11842206|FG000|Overall Study|Withdrawal by Subject|1
7511392|NCT02392481|11842214|FG000|Overall Study|Adverse Event|0
7511393|NCT02392481|11842215|FG001|Overall Study|Adverse Event|0
7511394|NCT02392481|11842216|FG002|Overall Study|Adverse Event|1
7511395|NCT02392481|11842217|FG003|Overall Study|Adverse Event|2
7511396|NCT02392481|11842214|FG000|Overall Study|Withdrawal by Subject|0
7511397|NCT02392481|11842215|FG001|Overall Study|Withdrawal by Subject|0
7511398|NCT02392481|11842216|FG002|Overall Study|Withdrawal by Subject|1
7511399|NCT02392481|11842217|FG003|Overall Study|Withdrawal by Subject|0
7511400|NCT02392507|11842241|FG000|Induction Regimen|Death|3
7511401|NCT02392507|11842241|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
7511402|NCT02392507|11842241|FG000|Induction Regimen|Physician Decision|1
7511403|NCT02392507|11842241|FG000|Induction Regimen|Withdrawal by Subject|2
7511404|NCT02392507|11842241|FG000|Maintenance Regimen|Death|1
7511405|NCT02392507|11842241|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
7511406|NCT02392559|11842252|FG000|Overall Study|Withdrawal by Subject|0
7511407|NCT02392559|11842253|FG001|Overall Study|Withdrawal by Subject|1
7511408|NCT02392611|11842269|FG000|Overall Study|Adverse Event|0
7511409|NCT02392611|11842270|FG001|Overall Study|Adverse Event|0
7511410|NCT02392611|11842271|FG002|Overall Study|Adverse Event|0
7511411|NCT02392611|11842272|FG003|Overall Study|Adverse Event|1
7511412|NCT02392611|11842273|FG004|Overall Study|Adverse Event|0
7511413|NCT02392611|11842274|FG005|Overall Study|Adverse Event|0
7511414|NCT02392611|11842275|FG006|Overall Study|Adverse Event|0
7511415|NCT02392611|11842276|FG007|Overall Study|Adverse Event|0
7511416|NCT02392611|11842277|FG008|Overall Study|Adverse Event|0
7511417|NCT02392611|11842269|FG000|Overall Study|Progressive disease|0
7511418|NCT02392611|11842270|FG001|Overall Study|Progressive disease|0
7511419|NCT02392611|11842271|FG002|Overall Study|Progressive disease|0
7511420|NCT02392611|11842272|FG003|Overall Study|Progressive disease|2
7511421|NCT02392611|11842273|FG004|Overall Study|Progressive disease|1
7511422|NCT02392611|11842274|FG005|Overall Study|Progressive disease|0
7511423|NCT02392611|11842275|FG006|Overall Study|Progressive disease|0
7511424|NCT02392611|11842276|FG007|Overall Study|Progressive disease|0
7511425|NCT02392611|11842277|FG008|Overall Study|Progressive disease|0
7511426|NCT02392611|11842269|FG000|Overall Study|Death|1
7511427|NCT02392611|11842270|FG001|Overall Study|Death|0
7511428|NCT02392611|11842271|FG002|Overall Study|Death|0
7511429|NCT02392611|11842272|FG003|Overall Study|Death|0
7511430|NCT02392611|11842273|FG004|Overall Study|Death|0
7511431|NCT02392611|11842274|FG005|Overall Study|Death|1
7511432|NCT02392611|11842275|FG006|Overall Study|Death|0
7511433|NCT02392611|11842276|FG007|Overall Study|Death|0
7511434|NCT02392611|11842277|FG008|Overall Study|Death|0
7511435|NCT02392611|11842269|FG000|Overall Study|Withdrawal by Subject|0
7511436|NCT02392611|11842270|FG001|Overall Study|Withdrawal by Subject|0
7511437|NCT02392611|11842271|FG002|Overall Study|Withdrawal by Subject|0
7511438|NCT02392611|11842272|FG003|Overall Study|Withdrawal by Subject|1
7511439|NCT02392611|11842273|FG004|Overall Study|Withdrawal by Subject|0
7511440|NCT02392611|11842274|FG005|Overall Study|Withdrawal by Subject|0
7511441|NCT02392611|11842275|FG006|Overall Study|Withdrawal by Subject|0
7511442|NCT02392611|11842276|FG007|Overall Study|Withdrawal by Subject|0
7511443|NCT02392611|11842277|FG008|Overall Study|Withdrawal by Subject|0
7511444|NCT02392611|11842269|FG000|Overall Study|Lost to Follow-up|0
7511445|NCT02392611|11842270|FG001|Overall Study|Lost to Follow-up|0
7511446|NCT02392611|11842271|FG002|Overall Study|Lost to Follow-up|0
7511447|NCT02392611|11842272|FG003|Overall Study|Lost to Follow-up|0
7511448|NCT02392611|11842273|FG004|Overall Study|Lost to Follow-up|0
7511449|NCT02392611|11842274|FG005|Overall Study|Lost to Follow-up|0
7511450|NCT02392611|11842275|FG006|Overall Study|Lost to Follow-up|1
7511451|NCT02392611|11842276|FG007|Overall Study|Lost to Follow-up|0
7511452|NCT02392611|11842277|FG008|Overall Study|Lost to Follow-up|0
7511453|NCT02392611|11842269|FG000|Overall Study|Enrolled, not treated|0
7511454|NCT02392611|11842270|FG001|Overall Study|Enrolled, not treated|0
7511455|NCT02392611|11842271|FG002|Overall Study|Enrolled, not treated|0
7511456|NCT02392611|11842272|FG003|Overall Study|Enrolled, not treated|2
7511457|NCT02392611|11842273|FG004|Overall Study|Enrolled, not treated|0
7511458|NCT02392611|11842274|FG005|Overall Study|Enrolled, not treated|0
7511459|NCT02392611|11842275|FG006|Overall Study|Enrolled, not treated|0
7511460|NCT02392611|11842276|FG007|Overall Study|Enrolled, not treated|0
7511462|NCT02392624|11842300|FG000|Overall Study|Withdrawal by Subject|15
7511463|NCT02392624|11842301|FG001|Overall Study|Withdrawal by Subject|12
7511464|NCT02392624|11842302|FG002|Overall Study|Withdrawal by Subject|9
7511465|NCT02392624|11842300|FG000|Overall Study|Adverse Event|4
7511466|NCT02392624|11842301|FG001|Overall Study|Adverse Event|1
7511467|NCT02392624|11842302|FG002|Overall Study|Adverse Event|2
7511468|NCT02392624|11842300|FG000|Overall Study|Pregnancy|1
7511469|NCT02392624|11842301|FG001|Overall Study|Pregnancy|0
7511470|NCT02392624|11842302|FG002|Overall Study|Pregnancy|0
7511471|NCT02392624|11842300|FG000|Overall Study|Protocol Violation|0
7511472|NCT02392624|11842301|FG001|Overall Study|Protocol Violation|0
7511473|NCT02392624|11842302|FG002|Overall Study|Protocol Violation|1
7511474|NCT02392624|11842300|FG000|Overall Study|Sponsor/Investigator Decision|2
7511475|NCT02392624|11842301|FG001|Overall Study|Sponsor/Investigator Decision|1
7511476|NCT02392624|11842302|FG002|Overall Study|Sponsor/Investigator Decision|0
7511477|NCT02392624|11842300|FG000|Overall Study|Other|49
7511478|NCT02392624|11842301|FG001|Overall Study|Other|1
7511479|NCT02392624|11842302|FG002|Overall Study|Other|1
7511480|NCT02393209|11842332|FG000|Overall Study|Study Terminated by Sponsor|1
7511481|NCT02393209|11842333|FG001|Overall Study|Study Terminated by Sponsor|1
7511482|NCT02393209|11842334|FG002|Overall Study|Study Terminated by Sponsor|0
7511483|NCT02393209|11842335|FG003|Overall Study|Study Terminated by Sponsor|0
7511484|NCT02393209|11842332|FG000|Overall Study|Withdrawal by Patient|1
7511485|NCT02393209|11842333|FG001|Overall Study|Withdrawal by Patient|0
7511486|NCT02393209|11842334|FG002|Overall Study|Withdrawal by Patient|0
7511487|NCT02393209|11842335|FG003|Overall Study|Withdrawal by Patient|0
7511488|NCT02393209|11842332|FG000|Overall Study|Death|2
7511489|NCT02393209|11842333|FG001|Overall Study|Death|2
7511490|NCT02393209|11842334|FG002|Overall Study|Death|0
7511491|NCT02393209|11842335|FG003|Overall Study|Death|0
7511492|NCT02393209|11842332|FG000|Overall Study|Death due to Disease Progression|2
7511493|NCT02393209|11842333|FG001|Overall Study|Death due to Disease Progression|2
7511494|NCT02393209|11842334|FG002|Overall Study|Death due to Disease Progression|0
7511495|NCT02393209|11842335|FG003|Overall Study|Death due to Disease Progression|0
7511496|NCT02393209|11842332|FG000|Overall Study|Death from Legionella Infection|0
7511497|NCT02393209|11842333|FG001|Overall Study|Death from Legionella Infection|1
7511498|NCT02393209|11842334|FG002|Overall Study|Death from Legionella Infection|0
7511499|NCT02393209|11842335|FG003|Overall Study|Death from Legionella Infection|0
7511500|NCT02393209|11842332|FG000|Overall Study|Patient Seen by Another Oncologist|0
7511501|NCT02393209|11842333|FG001|Overall Study|Patient Seen by Another Oncologist|1
7511502|NCT02393209|11842334|FG002|Overall Study|Patient Seen by Another Oncologist|0
7511503|NCT02393209|11842335|FG003|Overall Study|Patient Seen by Another Oncologist|0
7511504|NCT02393209|11842332|FG000|Overall Study|Lost to Follow-up|0
7511505|NCT02393209|11842333|FG001|Overall Study|Lost to Follow-up|1
7511506|NCT02393209|11842334|FG002|Overall Study|Lost to Follow-up|0
7511507|NCT02393209|11842335|FG003|Overall Study|Lost to Follow-up|0
7511508|NCT02393547|11842380|FG000|Overall Study|Adverse Event|2
7511509|NCT02393547|11842380|FG000|Overall Study|Withdrawal by Subject|3
7511510|NCT02393547|11842380|FG000|Overall Study|Lost to Follow-up|1
7511511|NCT02393755|11842395|FG000|Overall Study|Withdrawal by Subject|0
7511512|NCT02393755|11842396|FG001|Overall Study|Withdrawal by Subject|3
7511513|NCT02393755|11842395|FG000|Overall Study|Adverse Event|0
7511514|NCT02393755|11842396|FG001|Overall Study|Adverse Event|2
7511515|NCT02393755|11842395|FG000|Overall Study|Physician Decision|0
7511516|NCT02393755|11842396|FG001|Overall Study|Physician Decision|2
7511517|NCT02393950|11842403|FG000|Overall Study|Adverse Event|1
7511518|NCT02393950|11842404|FG001|Overall Study|Adverse Event|0
7511519|NCT02393950|11842403|FG000|Overall Study|Withdrawal by Subject|0
7511520|NCT02393950|11842404|FG001|Overall Study|Withdrawal by Subject|1
7511521|NCT02394275|11842439|FG000|Overall Study|Adverse Event|22
7511522|NCT02394275|11842439|FG000|Overall Study|Lost to Follow-up|7
7511523|NCT02394340|11842444|FG000|Overall Study|Failed drug screen test|1
7511524|NCT02394340|11842444|FG000|Overall Study|Adverse Event|1
7511525|NCT02394561|11842459|FG000|CORE Phase|Adverse Event|7
7511526|NCT02394561|11842460|FG001|CORE Phase|Adverse Event|9
7511527|NCT02394561|11842459|FG000|CORE Phase|Death|0
7511528|NCT02394561|11842460|FG001|CORE Phase|Death|1
7511529|NCT02394561|11842459|FG000|CORE Phase|Pregnancy|1
7511530|NCT02394561|11842460|FG001|CORE Phase|Pregnancy|0
7511531|NCT02394561|11842459|FG000|CORE Phase|Lost to Follow-up|1
7511532|NCT02394561|11842460|FG001|CORE Phase|Lost to Follow-up|0
7511533|NCT02394561|11842459|FG000|CORE Phase|Physician Decision|1
7511534|NCT02394561|11842460|FG001|CORE Phase|Physician Decision|1
7511535|NCT02394561|11842459|FG000|CORE Phase|Withdrawal by Subject|2
7511536|NCT02394561|11842460|FG001|CORE Phase|Withdrawal by Subject|2
7511537|NCT02394561|11842459|FG000|CORE Phase|Lack of Efficacy|1
7511538|NCT02394561|11842460|FG001|CORE Phase|Lack of Efficacy|6
7511539|NCT02394561|11842459|FG000|Extension Phase|Adverse Event|6
7511540|NCT02394561|11842460|FG001|Extension Phase|Adverse Event|1
7511541|NCT02394561|11842459|FG000|Extension Phase|Death|0
7511542|NCT02394561|11842460|FG001|Extension Phase|Death|1
7511543|NCT02394561|11842459|FG000|Extension Phase|Protocol Violation|1
7511544|NCT02394561|11842460|FG001|Extension Phase|Protocol Violation|0
7511545|NCT02394561|11842459|FG000|Extension Phase|Lost to Follow-up|1
7511546|NCT02394561|11842460|FG001|Extension Phase|Lost to Follow-up|0
7511547|NCT02394561|11842459|FG000|Extension Phase|Physician Decision|0
7511548|NCT02394561|11842460|FG001|Extension Phase|Physician Decision|2
7511549|NCT02394561|11842459|FG000|Extension Phase|Withdrawal by Subject|0
7511550|NCT02394561|11842460|FG001|Extension Phase|Withdrawal by Subject|5
7511551|NCT02394561|11842459|FG000|Extension Phase|Lack of Efficacy|3
7511552|NCT02394561|11842460|FG001|Extension Phase|Lack of Efficacy|3
7511553|NCT02394600|11842471|FG000|Overall Study|Adverse Event|3
7511554|NCT02394600|11842472|FG001|Overall Study|Adverse Event|0
7511555|NCT02394600|11842471|FG000|Overall Study|Lost to Follow-up|0
7511556|NCT02394600|11842472|FG001|Overall Study|Lost to Follow-up|1
7511557|NCT02394600|11842471|FG000|Overall Study|Withdrawal by Subject|0
7511558|NCT02394600|11842472|FG001|Overall Study|Withdrawal by Subject|1
7511559|NCT02394600|11842471|FG000|Overall Study|Protocol Violation|1
7511560|NCT02394600|11842472|FG001|Overall Study|Protocol Violation|0
7511561|NCT02394730|11842480|FG000|Overall Study|Lost to Follow-up|1
7511562|NCT02394730|11842481|FG001|Overall Study|Lost to Follow-up|0
7511563|NCT02394730|11842480|FG000|Overall Study|Withdrawal by Subject|0
7511564|NCT02394730|11842481|FG001|Overall Study|Withdrawal by Subject|1
7511565|NCT02394756|11842487|FG000|Period 1|Lens Discomfort|0
7511566|NCT02394756|11842488|FG001|Period 1|Lens Discomfort|0
7511567|NCT02394756|11842489|FG002|Period 1|Lens Discomfort|0
7511568|NCT02394756|11842490|FG003|Period 1|Lens Discomfort|0
7511569|NCT02394756|11842491|FG004|Period 1|Lens Discomfort|0
7511570|NCT02394756|11842492|FG005|Period 1|Lens Discomfort|1
7511571|NCT02394756|11842487|FG000|Period 1|Withdrawal by Subject|0
7511572|NCT02394756|11842488|FG001|Period 1|Withdrawal by Subject|1
7511573|NCT02394756|11842489|FG002|Period 1|Withdrawal by Subject|1
7511574|NCT02394756|11842490|FG003|Period 1|Withdrawal by Subject|1
7511575|NCT02394756|11842491|FG004|Period 1|Withdrawal by Subject|0
7511576|NCT02394756|11842492|FG005|Period 1|Withdrawal by Subject|0
7511577|NCT02394756|11842487|FG000|Period 2|Unsatisfactory Visual Response|0
7511578|NCT02394756|11842488|FG001|Period 2|Unsatisfactory Visual Response|0
7511579|NCT02394756|11842489|FG002|Period 2|Unsatisfactory Visual Response|0
7511580|NCT02394756|11842490|FG003|Period 2|Unsatisfactory Visual Response|0
7511581|NCT02394756|11842491|FG004|Period 2|Unsatisfactory Visual Response|1
7511582|NCT02394756|11842492|FG005|Period 2|Unsatisfactory Visual Response|0
7511583|NCT02394808|11842513|FG000|Period 1|Unsatisfactory lens fitting|0
7511584|NCT02394808|11842514|FG001|Period 1|Unsatisfactory lens fitting|1
7511585|NCT02394808|11842513|FG000|Period 2|Lost to Follow-up|1
7511586|NCT02394808|11842514|FG001|Period 2|Lost to Follow-up|0
7511587|NCT02394925|11842526|FG000|Overall Study|Adverse Event|1
7511588|NCT02394925|11842526|FG000|Overall Study|Lens Discomfort|3
7511589|NCT02394925|11842526|FG000|Overall Study|Lens handling difficulities|5
7511590|NCT02394925|11842526|FG000|Overall Study|Lost to Follow-up|9
7511591|NCT02394925|11842526|FG000|Overall Study|Protocol Violation|5
7511592|NCT02394925|11842526|FG000|Overall Study|No longer meet eligibility criteria|1
7511593|NCT02394925|11842526|FG000|Overall Study|Unsatisfactory Visual Response|5
7511594|NCT02395042|11842542|FG000|Treatment 1 Period|Adverse Event|1
7511595|NCT02395042|11842543|FG001|Treatment 1 Period|Adverse Event|3
7511596|NCT02395042|11842544|FG002|Treatment 1 Period|Adverse Event|1
7511597|NCT02395042|11842542|FG000|Treatment 1 Period|Lack of Efficacy|1
7511598|NCT02395042|11842543|FG001|Treatment 1 Period|Lack of Efficacy|1
7511599|NCT02395042|11842544|FG002|Treatment 1 Period|Lack of Efficacy|0
7511600|NCT02395042|11842542|FG000|Treatment 1 Period|Lost to Follow-up|1
7511601|NCT02395042|11842543|FG001|Treatment 1 Period|Lost to Follow-up|0
7511602|NCT02395042|11842544|FG002|Treatment 1 Period|Lost to Follow-up|0
7511603|NCT02395042|11842542|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
7511604|NCT02395042|11842543|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
7511605|NCT02395042|11842544|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
7511606|NCT02395042|11842542|FG000|Treatment 2 Period|Lack of Efficacy|1
7511607|NCT02395042|11842543|FG001|Treatment 2 Period|Lack of Efficacy|1
7511608|NCT02395042|11842544|FG002|Treatment 2 Period|Lack of Efficacy|0
7511609|NCT02395055|11842557|FG000|Overall Study|Withdrawal by Subject|7
7511610|NCT02395055|11842558|FG001|Overall Study|Withdrawal by Subject|3
7511611|NCT02395081|11842567|FG000|Overall Study|Withdrawal by Subject|1
7511612|NCT02395081|11842568|FG001|Overall Study|Withdrawal by Subject|1
7511613|NCT02395081|11842569|FG002|Overall Study|Withdrawal by Subject|0
7511614|NCT02395081|11842567|FG000|Overall Study|Moved where blood couldn't be collected|4
7511615|NCT02395081|11842568|FG001|Overall Study|Moved where blood couldn't be collected|1
7511616|NCT02395081|11842569|FG002|Overall Study|Moved where blood couldn't be collected|3
7511617|NCT02395081|11842567|FG000|Overall Study|Fetal Loss|2
7511618|NCT02395081|11842568|FG001|Overall Study|Fetal Loss|3
7511619|NCT02395081|11842569|FG002|Overall Study|Fetal Loss|1
7511620|NCT02395133|11842584|FG000|Overall Study|Adverse Event|4
7511621|NCT02395133|11842585|FG001|Overall Study|Adverse Event|1
7511622|NCT02395133|11842586|FG002|Overall Study|Adverse Event|3
7511623|NCT02395133|11842587|FG003|Overall Study|Adverse Event|0
7511624|NCT02395133|11842584|FG000|Overall Study|Lack of Efficacy|1
7511625|NCT02395133|11842585|FG001|Overall Study|Lack of Efficacy|0
7511626|NCT02395133|11842586|FG002|Overall Study|Lack of Efficacy|1
7511627|NCT02395133|11842587|FG003|Overall Study|Lack of Efficacy|1
7511628|NCT02395133|11842584|FG000|Overall Study|Protocol Violation|1
7511629|NCT02395133|11842585|FG001|Overall Study|Protocol Violation|1
7511630|NCT02395133|11842586|FG002|Overall Study|Protocol Violation|0
7511631|NCT02395133|11842587|FG003|Overall Study|Protocol Violation|3
7511632|NCT02395133|11842584|FG000|Overall Study|Lost to Follow-up|0
7511633|NCT02395133|11842585|FG001|Overall Study|Lost to Follow-up|1
7511634|NCT02395133|11842586|FG002|Overall Study|Lost to Follow-up|1
7511635|NCT02395133|11842587|FG003|Overall Study|Lost to Follow-up|0
7511636|NCT02395133|11842584|FG000|Overall Study|Pregnancy|0
7511637|NCT02395133|11842585|FG001|Overall Study|Pregnancy|0
7511638|NCT02395133|11842586|FG002|Overall Study|Pregnancy|3
7511639|NCT02395133|11842587|FG003|Overall Study|Pregnancy|0
7511640|NCT02395133|11842584|FG000|Overall Study|Consent withdrawn with no reason given|1
7511641|NCT02395133|11842585|FG001|Overall Study|Consent withdrawn with no reason given|3
7511642|NCT02395133|11842586|FG002|Overall Study|Consent withdrawn with no reason given|0
7511643|NCT02395133|11842587|FG003|Overall Study|Consent withdrawn with no reason given|2
7511644|NCT02395133|11842584|FG000|Overall Study|Consent withdrawn with personal reason|0
7511645|NCT02395133|11842585|FG001|Overall Study|Consent withdrawn with personal reason|1
7511646|NCT02395133|11842586|FG002|Overall Study|Consent withdrawn with personal reason|0
7511647|NCT02395133|11842587|FG003|Overall Study|Consent withdrawn with personal reason|3
7511648|NCT02395133|11842584|FG000|Overall Study|Sponsor decision|2
7511649|NCT02395133|11842585|FG001|Overall Study|Sponsor decision|0
7511650|NCT02395133|11842586|FG002|Overall Study|Sponsor decision|0
7511651|NCT02395133|11842587|FG003|Overall Study|Sponsor decision|1
7511652|NCT02395133|11842584|FG000|Overall Study|Other than specified above|5
7511653|NCT02395133|11842585|FG001|Overall Study|Other than specified above|2
7511654|NCT02395133|11842586|FG002|Overall Study|Other than specified above|2
7511655|NCT02395133|11842587|FG003|Overall Study|Other than specified above|4
7511656|NCT02395172|11842599|FG000|Overall Study|Participants randomized but not treated|3
7511657|NCT02395172|11842600|FG001|Overall Study|Participants randomized but not treated|31
7511658|NCT02395302|11842614|FG000|Overall Study|Screen Failure|3
7511659|NCT02395302|11842614|FG000|Overall Study|Run In Failure|7
7511660|NCT02395302|11842614|FG000|Overall Study|Withdrawal by Subject|2
7511661|NCT02395302|11842614|FG000|Overall Study|Physician Decision|2
7511662|NCT02395471|11842620|FG000|Overall Study|Lost to Follow-up|2
7511663|NCT02395471|11842621|FG001|Overall Study|Lost to Follow-up|0
7511664|NCT02395471|11842620|FG000|Overall Study|Withdrawal by Subject|2
7511665|NCT02395471|11842621|FG001|Overall Study|Withdrawal by Subject|1
7511666|NCT02395471|11842620|FG000|Overall Study|Physician Decision|1
7511667|NCT02395471|11842621|FG001|Overall Study|Physician Decision|0
7511668|NCT02395471|11842620|FG000|Overall Study|Protocol Violation|0
7511669|NCT02395471|11842621|FG001|Overall Study|Protocol Violation|1
7511670|NCT02395471|11842620|FG000|Overall Study|Failure to swollow sponge twice|1
7511671|NCT02395471|11842621|FG001|Overall Study|Failure to swollow sponge twice|0
7511672|NCT02395471|11842620|FG000|Overall Study|Patient did not return for procedure|0
7511673|NCT02395471|11842621|FG001|Overall Study|Patient did not return for procedure|1
7511674|NCT02395471|11842620|FG000|Overall Study|Subject not eligible|1
7511675|NCT02395471|11842621|FG001|Overall Study|Subject not eligible|0
7511676|NCT02395536|11842638|FG000|Overall Study|Lost to Follow-up|4
7511677|NCT02395536|11842639|FG001|Overall Study|Lost to Follow-up|4
7511678|NCT02395536|11842638|FG000|Overall Study|Death|2
7511679|NCT02395536|11842639|FG001|Overall Study|Death|0
7511680|NCT02395536|11842638|FG000|Overall Study|Physician Decision|4
7511681|NCT02395536|11842639|FG001|Overall Study|Physician Decision|6
7511682|NCT02395536|11842638|FG000|Overall Study|Withdrawal by Subject|9
7511683|NCT02395536|11842639|FG001|Overall Study|Withdrawal by Subject|17
7511684|NCT02395536|11842638|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
7511685|NCT02395536|11842639|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
7511686|NCT02395536|11842638|FG000|Overall Study|Insurance issue|0
7511687|NCT02395536|11842639|FG001|Overall Study|Insurance issue|1
7511688|NCT02395627|11842648|FG000|Overall Study|Withdrawal by Subject|0
7511689|NCT02395627|11842649|FG001|Overall Study|Withdrawal by Subject|2
7511690|NCT02395627|11842650|FG002|Overall Study|Withdrawal by Subject|0
7511691|NCT02395627|11842648|FG000|Overall Study|Did not receive pembrolizumab|3
7511692|NCT02395627|11842649|FG001|Overall Study|Did not receive pembrolizumab|1
7511693|NCT02395627|11842650|FG002|Overall Study|Did not receive pembrolizumab|0
7511694|NCT02395653|11842660|FG000|Overall Study|Exclusion Criteria Met at Screening|4
7511695|NCT02395653|11842660|FG000|Overall Study|Consent Withdrawn at Screening|1
7511696|NCT02395653|11842660|FG000|Overall Study|SSEC Application But With 0 Dose|1
7511697|NCT02395653|11842660|FG000|Overall Study|Investigator Decision at Screening|1
7511698|NCT02395653|11842660|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
7511699|NCT02395653|11842660|FG000|Overall Study|Withdrawal by Subject|1
7511700|NCT02395653|11842660|FG000|Overall Study|Lost to Follow-up|1
7511701|NCT02395822|11842672|FG000|Overall Study|Withdrawal by Subject|1
7511702|NCT02395822|11842672|FG000|Overall Study|Death|1
7511703|NCT02396212|11842729|FG000|Overall Study|Adverse Event|1
7511704|NCT02396212|11842729|FG000|Overall Study|Lack of Efficacy|2
7511705|NCT02396316|11842743|FG000|Overall Study|Physician Decision|1
7511706|NCT02396316|11842744|FG001|Overall Study|Physician Decision|0
7511707|NCT02396316|11842743|FG000|Overall Study|Progressive disease|6
7511708|NCT02396316|11842744|FG001|Overall Study|Progressive disease|3
7511709|NCT02396316|11842743|FG000|Overall Study|Protocol Violation|0
7511710|NCT02396316|11842744|FG001|Overall Study|Protocol Violation|1
7511711|NCT02396316|11842743|FG000|Overall Study|Treatment unblinded|0
7511712|NCT02396316|11842744|FG001|Overall Study|Treatment unblinded|1
7511713|NCT02396381|11842756|FG000|Overall Study|Adverse Event|3
7511714|NCT02396381|11842757|FG001|Overall Study|Adverse Event|2
7511715|NCT02396381|11842756|FG000|Overall Study|Withdrawal by Subject|33
7511716|NCT02396381|11842757|FG001|Overall Study|Withdrawal by Subject|24
7511717|NCT02396381|11842756|FG000|Overall Study|Lost to Follow-up|49
7511718|NCT02396381|11842757|FG001|Overall Study|Lost to Follow-up|31
7511719|NCT02396381|11842756|FG000|Overall Study|Protocol Violation|1
7511720|NCT02396381|11842757|FG001|Overall Study|Protocol Violation|0
7511721|NCT02396381|11842756|FG000|Overall Study|Site terminated by sponsor|7
7511722|NCT02396381|11842757|FG001|Overall Study|Site terminated by sponsor|8
7511723|NCT02396381|11842756|FG000|Overall Study|Physician Decision|5
7511724|NCT02396381|11842757|FG001|Overall Study|Physician Decision|5
7511725|NCT02396381|11842756|FG000|Overall Study|Pregnancy|2
7511726|NCT02396381|11842757|FG001|Overall Study|Pregnancy|0
7511727|NCT02396381|11842756|FG000|Overall Study|Non-compliance with study procedures|1
7511728|NCT02396381|11842757|FG001|Overall Study|Non-compliance with study procedures|0
7511729|NCT02396381|11842756|FG000|Overall Study|Moved out of town/state|1
7511730|NCT02396381|11842757|FG001|Overall Study|Moved out of town/state|3
7511731|NCT02396381|11842756|FG000|Overall Study|Could not complete visit|1
7511732|NCT02396381|11842757|FG001|Overall Study|Could not complete visit|0
7511733|NCT02396381|11842756|FG000|Overall Study|Possible conflict of interest|1
7511734|NCT02396381|11842757|FG001|Overall Study|Possible conflict of interest|0
7511735|NCT02396381|11842756|FG000|Overall Study|Randomization/Screening Error|3
7511736|NCT02396381|11842757|FG001|Overall Study|Randomization/Screening Error|1
7511737|NCT02396420|11842766|FG000|Overall Study|Death|1
7511738|NCT02396537|11842777|FG000|Overall Study|Protocol Violation|0
7511739|NCT02396537|11842778|FG001|Overall Study|Protocol Violation|1
7536276|NCT02717195|11884225|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7536277|NCT02717195|11884226|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
7511740|NCT02396758|11842801|FG000|Overall Study|Withdrawal by Subject|2
7511741|NCT02396758|11842802|FG001|Overall Study|Withdrawal by Subject|0
7511742|NCT02396758|11842803|FG002|Overall Study|Withdrawal by Subject|0
7511743|NCT02396758|11842804|FG003|Overall Study|Withdrawal by Subject|1
7511744|NCT02396758|11842801|FG000|Overall Study|Lost to Follow-up|8
7511745|NCT02396758|11842802|FG001|Overall Study|Lost to Follow-up|5
7511746|NCT02396758|11842803|FG002|Overall Study|Lost to Follow-up|3
7511747|NCT02396758|11842804|FG003|Overall Study|Lost to Follow-up|3
7511748|NCT02396758|11842801|FG000|Overall Study|Death|1
7511749|NCT02396758|11842802|FG001|Overall Study|Death|1
7511750|NCT02396758|11842803|FG002|Overall Study|Death|0
7511751|NCT02396758|11842804|FG003|Overall Study|Death|1
7511752|NCT02396758|11842801|FG000|Overall Study|Randomized but not treated|1
7511753|NCT02396758|11842802|FG001|Overall Study|Randomized but not treated|0
7511754|NCT02396758|11842803|FG002|Overall Study|Randomized but not treated|1
7511755|NCT02396758|11842804|FG003|Overall Study|Randomized but not treated|0
7511756|NCT02396849|11842816|FG000|Overall Study|Lost to Follow-up|1
7511757|NCT02396849|11842817|FG001|Overall Study|Lost to Follow-up|1
7511758|NCT02396849|11842816|FG000|Overall Study|Did not tolerate intervention|1
7511759|NCT02396849|11842817|FG001|Overall Study|Did not tolerate intervention|1
7511760|NCT02396953|11842828|FG000|Overall Study|Withdrawal by Subject|0
7511761|NCT02396953|11842829|FG001|Overall Study|Withdrawal by Subject|0
7511762|NCT02396953|11842830|FG002|Overall Study|Withdrawal by Subject|1
7511763|NCT02396953|11842828|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
7511764|NCT02396953|11842829|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
7511765|NCT02396953|11842830|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
7511766|NCT02396953|11842828|FG000|Overall Study|Personal Reasons|1
7511767|NCT02396953|11842829|FG001|Overall Study|Personal Reasons|1
7511768|NCT02396953|11842830|FG002|Overall Study|Personal Reasons|0
7511769|NCT02397057|11842847|FG000|Overall Study|Withdrawal by Subject|6
7511770|NCT02397057|11842848|FG001|Overall Study|Withdrawal by Subject|7
7511771|NCT02397057|11842847|FG000|Overall Study|Lost to Follow-up|4
7511772|NCT02397057|11842848|FG001|Overall Study|Lost to Follow-up|3
7511773|NCT02397057|11842847|FG000|Overall Study|Death|1
7511774|NCT02397057|11842848|FG001|Overall Study|Death|0
7511775|NCT02397057|11842847|FG000|Overall Study|Adverse Event|0
7511776|NCT02397057|11842848|FG001|Overall Study|Adverse Event|1
7511777|NCT02397057|11842847|FG000|Overall Study|Physician Decision|0
7511778|NCT02397057|11842848|FG001|Overall Study|Physician Decision|1
7511779|NCT02397057|11842847|FG000|Overall Study|Subject did not receive study drug|0
7511780|NCT02397057|11842848|FG001|Overall Study|Subject did not receive study drug|1
7511809|NCT02397278|11842892|FG000|Overall Study|Withdrawal by Subject|0
7511810|NCT02397278|11842893|FG001|Overall Study|Withdrawal by Subject|2
7511811|NCT02397278|11842892|FG000|Overall Study|Deemed ineligible following surgery|1
7511812|NCT02397278|11842893|FG001|Overall Study|Deemed ineligible following surgery|1
7511813|NCT02397408|11842908|FG000|Overall Study|Physician Decision|4
7511814|NCT02397408|11842908|FG000|Overall Study|Surgery not completed within protocol timeframe|2
7511815|NCT02397447|11842914|FG000|Overall Study|Lost to Follow-up|2
7511816|NCT02397447|11842915|FG001|Overall Study|Lost to Follow-up|2
7511817|NCT02397460|11842929|FG000|Treatment Period 2|Adverse Event|0
7511818|NCT02397460|11842930|FG001|Treatment Period 2|Adverse Event|0
7511819|NCT02397460|11842931|FG002|Treatment Period 2|Adverse Event|0
7511820|NCT02397460|11842932|FG003|Treatment Period 2|Adverse Event|0
7511821|NCT02397460|11842933|FG004|Treatment Period 2|Adverse Event|0
7511822|NCT02397460|11842934|FG005|Treatment Period 2|Adverse Event|0
7511823|NCT02397460|11842935|FG006|Treatment Period 2|Adverse Event|0
7511824|NCT02397460|11842936|FG007|Treatment Period 2|Adverse Event|1
7511825|NCT02397460|11842929|FG000|Treatment Period 4|Adverse Event|0
7511826|NCT02397460|11842930|FG001|Treatment Period 4|Adverse Event|1
7511827|NCT02397460|11842931|FG002|Treatment Period 4|Adverse Event|0
7511828|NCT02397460|11842932|FG003|Treatment Period 4|Adverse Event|0
7511829|NCT02397460|11842933|FG004|Treatment Period 4|Adverse Event|0
7511830|NCT02397460|11842934|FG005|Treatment Period 4|Adverse Event|0
7511831|NCT02397460|11842935|FG006|Treatment Period 4|Adverse Event|0
7511832|NCT02397460|11842936|FG007|Treatment Period 4|Adverse Event|0
7511833|NCT02397460|11842929|FG000|Treatment Period 4|Physician Decision|0
7511834|NCT02397460|11842930|FG001|Treatment Period 4|Physician Decision|0
7511835|NCT02397460|11842931|FG002|Treatment Period 4|Physician Decision|0
7511836|NCT02397460|11842932|FG003|Treatment Period 4|Physician Decision|0
7511837|NCT02397460|11842933|FG004|Treatment Period 4|Physician Decision|1
7511838|NCT02397460|11842934|FG005|Treatment Period 4|Physician Decision|0
7511839|NCT02397460|11842935|FG006|Treatment Period 4|Physician Decision|0
7511840|NCT02397460|11842936|FG007|Treatment Period 4|Physician Decision|0
7511841|NCT02397473|11843012|FG000|Treatment Phase|Adverse Event|1
7511842|NCT02397473|11843013|FG001|Treatment Phase|Adverse Event|2
7511843|NCT02397473|11843012|FG000|Treatment Phase|Lack of Efficacy|8
7511844|NCT02397473|11843013|FG001|Treatment Phase|Lack of Efficacy|1
7511845|NCT02397473|11843012|FG000|Treatment Phase|Lost to Follow-up|1
7511846|NCT02397473|11843013|FG001|Treatment Phase|Lost to Follow-up|0
7511847|NCT02397473|11843012|FG000|Treatment Phase|Withdrawal by Subject|2
7511848|NCT02397473|11843013|FG001|Treatment Phase|Withdrawal by Subject|1
7511849|NCT02397473|11843012|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
7511850|NCT02397473|11843013|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
7511851|NCT02397473|11843012|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
7511852|NCT02397473|11843013|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
7511853|NCT02397473|11843012|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
7511854|NCT02397473|11843013|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
7511855|NCT02397473|11843012|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7511856|NCT02397473|11843013|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7511857|NCT02397473|11843012|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7511858|NCT02397473|11843013|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7511859|NCT02397655|11843027|FG000|Overall Study|data not completed|1301
7511860|NCT02397694|11843033|FG000|Double-Blinded Phase|Adverse Event|1
7511861|NCT02397694|11843034|FG001|Double-Blinded Phase|Adverse Event|0
7511862|NCT02397694|11843033|FG000|Double-Blinded Phase|Non-compliance with study drug|0
7511863|NCT02397694|11843034|FG001|Double-Blinded Phase|Non-compliance with study drug|2
7511864|NCT02397694|11843033|FG000|Double-Blinded Phase|Withdrawal by Subject|1
7511865|NCT02397694|11843034|FG001|Double-Blinded Phase|Withdrawal by Subject|0
7511866|NCT02397694|11843033|FG000|Double-Blinded Phase|Lost to Follow-up|1
7511867|NCT02397694|11843034|FG001|Double-Blinded Phase|Lost to Follow-up|1
7511868|NCT02397694|11843033|FG000|Open Label Extension Phase|Protocol Violation|1
7511869|NCT02397694|11843034|FG001|Open Label Extension Phase|Protocol Violation|0
7511870|NCT02397694|11843033|FG000|Open Label Extension Phase|Withdrew Consent|3
7511871|NCT02397694|11843034|FG001|Open Label Extension Phase|Withdrew Consent|1
7511872|NCT02397694|11843033|FG000|Open Label Extension Phase|Lost to Follow-up|4
7511873|NCT02397694|11843034|FG001|Open Label Extension Phase|Lost to Follow-up|0
7511874|NCT02397837|11843069|FG000|Overall Study|Withdrawal by Subject|6
7511875|NCT02397837|11843070|FG001|Overall Study|Withdrawal by Subject|5
7511876|NCT02397837|11843069|FG000|Overall Study|Physician Decision|1
7511877|NCT02397837|11843070|FG001|Overall Study|Physician Decision|1
7511878|NCT02397889|11843078|FG000|Overall Study|Physician Decision|1
7511879|NCT02397889|11843079|FG001|Overall Study|Physician Decision|0
7511880|NCT02397915|11843085|FG000|Period 1|Protocol Violation|0
7511881|NCT02397915|11843086|FG001|Period 1|Protocol Violation|1
7511882|NCT02397915|11843087|FG002|Period 1|Protocol Violation|0
7511883|NCT02397915|11843088|FG003|Period 1|Protocol Violation|0
7511884|NCT02397915|11843085|FG000|Period 1|Physician Decision|1
7511885|NCT02397915|11843086|FG001|Period 1|Physician Decision|0
7511886|NCT02397915|11843087|FG002|Period 1|Physician Decision|0
7511887|NCT02397915|11843088|FG003|Period 1|Physician Decision|0
7511888|NCT02398188|11843102|FG000|Overall Study|Adverse Event|2
7511889|NCT02398188|11843103|FG001|Overall Study|Adverse Event|3
7511890|NCT02398188|11843102|FG000|Overall Study|Lost to Follow-up|5
7511891|NCT02398188|11843103|FG001|Overall Study|Lost to Follow-up|0
7511892|NCT02398188|11843102|FG000|Overall Study|Non-compliance|4
7511893|NCT02398188|11843103|FG001|Overall Study|Non-compliance|4
7511894|NCT02398188|11843102|FG000|Overall Study|Protocol Violation|6
7511895|NCT02398188|11843103|FG001|Overall Study|Protocol Violation|10
7511896|NCT02398188|11843102|FG000|Overall Study|Sponsor Decision|2
7511897|NCT02398188|11843103|FG001|Overall Study|Sponsor Decision|1
7511898|NCT02398188|11843102|FG000|Overall Study|Pregnancy|1
7511899|NCT02398188|11843103|FG001|Overall Study|Pregnancy|0
7511900|NCT02398188|11843102|FG000|Overall Study|Withdrawal by Subject|7
7511901|NCT02398188|11843103|FG001|Overall Study|Withdrawal by Subject|16
7511902|NCT02398227|11843111|FG000|Overall Study|Lost to Follow-up|21
7511903|NCT02398227|11843112|FG001|Overall Study|Lost to Follow-up|12
7511904|NCT02398227|11843111|FG000|Overall Study|Withdrawal by Subject|5
7511905|NCT02398227|11843112|FG001|Overall Study|Withdrawal by Subject|6
7511906|NCT02398227|11843111|FG000|Overall Study|Removed from treatment and dropped out|1
7511907|NCT02398227|11843112|FG001|Overall Study|Removed from treatment and dropped out|0
7511908|NCT02399163|11843131|FG000|Overall Study|Adverse Event|2
7511909|NCT02399163|11843131|FG000|Overall Study|Protocol Deviation|2
7511910|NCT02399163|11843131|FG000|Overall Study|Withdrawal by Participant|5
7511911|NCT02399254|11843147|FG000|Overall Study|Physician Decision|2
7511912|NCT02399475|11843158|FG000|Overall Study|Physician Decision|1
7511913|NCT02399475|11843159|FG001|Overall Study|Physician Decision|0
7511914|NCT02400307|11843185|FG000|Overall Study|Enrolled and Never Dosed|1
7511915|NCT02400307|11843186|FG001|Overall Study|Enrolled and Never Dosed|0
7511916|NCT02400333|11843196|FG000|Overall Study|Withdrawal by Subject|0
7511917|NCT02400333|11843197|FG001|Overall Study|Withdrawal by Subject|1
7511918|NCT02400333|11843198|FG002|Overall Study|Withdrawal by Subject|0
7511919|NCT02400333|11843199|FG003|Overall Study|Withdrawal by Subject|1
7511920|NCT02400333|11843196|FG000|Overall Study|Protocol Violation|1
7511921|NCT02400333|11843197|FG001|Overall Study|Protocol Violation|0
7511922|NCT02400333|11843198|FG002|Overall Study|Protocol Violation|2
7511923|NCT02400333|11843199|FG003|Overall Study|Protocol Violation|1
7511924|NCT02400346|11843210|FG000|Overall Study|Adverse Event|24
7511925|NCT02400346|11843210|FG000|Overall Study|Lack of Efficacy|9
7511926|NCT02400346|11843210|FG000|Overall Study|Non-compliance with IMP|1
7511927|NCT02400346|11843210|FG000|Overall Study|Withdrawal by Subject|7
7511928|NCT02400346|11843210|FG000|Overall Study|Administrative or other reason(s)|2
7511929|NCT02400346|11843210|FG000|Overall Study|Lost to Follow-up|1
7511930|NCT02400580|11843226|FG000|Overall Study|Withdrawal by Subject|1
7511931|NCT02400580|11843227|FG001|Overall Study|Withdrawal by Subject|1
7511932|NCT02400580|11843226|FG000|Overall Study|Adverse Event|1
7511933|NCT02400580|11843227|FG001|Overall Study|Adverse Event|0
7511934|NCT02400749|11843244|FG000|Week 0 -16|Withdrawal by Subject|5
7511935|NCT02400749|11843245|FG001|Week 0 -16|Withdrawal by Subject|5
7511936|NCT02400749|11843244|FG000|Week 0 -16|Adverse Event|3
7511937|NCT02400749|11843245|FG001|Week 0 -16|Adverse Event|1
7511938|NCT02400749|11843244|FG000|Week 0 -16|Lost to Follow-up|2
7511939|NCT02400749|11843245|FG001|Week 0 -16|Lost to Follow-up|0
7511940|NCT02400749|11843244|FG000|Week 0 -16|Protocol Violation|1
7511941|NCT02400749|11843245|FG001|Week 0 -16|Protocol Violation|0
7511942|NCT02400749|11843244|FG000|Week 17 - 32|Withdrawal by Subject|3
7511943|NCT02400749|11843245|FG001|Week 17 - 32|Withdrawal by Subject|2
7511944|NCT02400749|11843244|FG000|Week 17 - 32|Adverse Event|2
7511945|NCT02400749|11843245|FG001|Week 17 - 32|Adverse Event|1
7511946|NCT02400905|11843251|FG000|Overall Study|Death|24
7511947|NCT02400905|11843251|FG000|Overall Study|Lost to Follow-up|18
7511948|NCT02400905|11843251|FG000|Overall Study|Withdrawal by Subject|16
7511949|NCT02400905|11843251|FG000|Overall Study|Physician Decision|4
7511950|NCT02400905|11843251|FG000|Overall Study|Other|1
7511951|NCT02401230|11843286|FG000|Overall Study|Adverse Event|3
7511952|NCT02401230|11843287|FG001|Overall Study|Adverse Event|2
7511953|NCT02401230|11843288|FG002|Overall Study|Adverse Event|0
7511954|NCT02401230|11843286|FG000|Overall Study|Withdrawal by Subject|2
7511955|NCT02401230|11843287|FG001|Overall Study|Withdrawal by Subject|1
7511956|NCT02401230|11843288|FG002|Overall Study|Withdrawal by Subject|1
7511957|NCT02401230|11843286|FG000|Overall Study|Lost to Follow-up|1
7511958|NCT02401230|11843287|FG001|Overall Study|Lost to Follow-up|3
7511959|NCT02401230|11843288|FG002|Overall Study|Lost to Follow-up|3
7511960|NCT02401256|11843300|FG000|Overall Study|Adverse Event|5
7511961|NCT02401256|11843300|FG000|Overall Study|Withdrawal by Subject|12
7511962|NCT02401412|11843308|FG000|Overall Study|Lost to Follow-up|1
7511963|NCT02401412|11843309|FG001|Overall Study|Lost to Follow-up|0
7511964|NCT02401412|11843308|FG000|Overall Study|Discontinued Intervention|15
7511965|NCT02401412|11843309|FG001|Overall Study|Discontinued Intervention|21
7511966|NCT02401412|11843308|FG000|Overall Study|Withdrawal by Subject|4
7511967|NCT02401412|11843309|FG001|Overall Study|Withdrawal by Subject|4
7511968|NCT02401412|11843308|FG000|Overall Study|Subject withdrawal prior to intervention|0
7511969|NCT02401412|11843309|FG001|Overall Study|Subject withdrawal prior to intervention|1
7511970|NCT02401412|11843308|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
7511971|NCT02401412|11843309|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
7511972|NCT02401529|11843336|FG000|Overall Study|Lost to Follow-up|2
7511973|NCT02401529|11843337|FG001|Overall Study|Lost to Follow-up|1
7511974|NCT02401529|11843336|FG000|Overall Study|Physician Decision|2
7511975|NCT02401529|11843337|FG001|Overall Study|Physician Decision|6
7511976|NCT02401529|11843336|FG000|Overall Study|Protocol Violation|5
7511977|NCT02401529|11843337|FG001|Overall Study|Protocol Violation|0
7511978|NCT02401672|11843374|FG000|Overall Study|Withdrawal by Subject|1
7511979|NCT02401672|11843375|FG001|Overall Study|Withdrawal by Subject|3
7511980|NCT02401867|11843381|FG000|Specimen Collection|Didn't receive 1 or more tests|10
7511981|NCT02401867|11843381|FG000|Analysis|Cervical assay could not be conducted|9
7511982|NCT02402166|11843416|FG000|Overall Study|Adverse Event|2
7511983|NCT02402166|11843416|FG000|Overall Study|Withdrawal by Subject|2
7511984|NCT02402166|11843416|FG000|Overall Study|Lost to Follow-up|1
7511985|NCT02402218|11843437|FG000|Overall Study|Did not pickup study medication|12
7511986|NCT02402218|11843438|FG001|Overall Study|Did not pickup study medication|9
7511987|NCT02402218|11843439|FG002|Overall Study|Did not pickup study medication|13
7511988|NCT02402218|11843437|FG000|Overall Study|Lack of Efficacy|0
7511989|NCT02402218|11843438|FG001|Overall Study|Lack of Efficacy|1
7511990|NCT02402218|11843439|FG002|Overall Study|Lack of Efficacy|1
7511991|NCT02402218|11843437|FG000|Overall Study|Death|1
7511992|NCT02402218|11843438|FG001|Overall Study|Death|0
7511993|NCT02402218|11843439|FG002|Overall Study|Death|0
7511994|NCT02402218|11843437|FG000|Overall Study|Reinfection|0
7511995|NCT02402218|11843438|FG001|Overall Study|Reinfection|0
7511996|NCT02402218|11843439|FG002|Overall Study|Reinfection|1
7511997|NCT02402218|11843437|FG000|Overall Study|Adverse Event|0
7511998|NCT02402218|11843438|FG001|Overall Study|Adverse Event|2
7511999|NCT02402218|11843439|FG002|Overall Study|Adverse Event|1
7512000|NCT02402218|11843437|FG000|Overall Study|Withdrawal by Subject|1
7512001|NCT02402218|11843438|FG001|Overall Study|Withdrawal by Subject|1
7512002|NCT02402218|11843439|FG002|Overall Study|Withdrawal by Subject|1
7512003|NCT02402322|11843459|FG000|Pretreatment|Withdrawal by Subject|3
7512004|NCT02402322|11843460|FG001|Pretreatment|Withdrawal by Subject|1
7512005|NCT02402322|11843461|FG002|Pretreatment|Withdrawal by Subject|1
7512006|NCT02402322|11843459|FG000|Follow-up|Withdrawal by Subject|6
7512007|NCT02402322|11843460|FG001|Follow-up|Withdrawal by Subject|3
7512008|NCT02402322|11843461|FG002|Follow-up|Withdrawal by Subject|24
7512009|NCT02402907|11843493|FG000|Overall Study|Delivered vaginally|9
7512010|NCT02402907|11843494|FG001|Overall Study|Delivered vaginally|3
7512011|NCT02402907|11843493|FG000|Overall Study|Delivered outside of Sinai|1
7512012|NCT02402907|11843494|FG001|Overall Study|Delivered outside of Sinai|1
7512013|NCT02402907|11843493|FG000|Overall Study|Lost to follow up after C-Section|10
7512014|NCT02402907|11843494|FG001|Overall Study|Lost to follow up after C-Section|23
7512015|NCT02402933|11843500|FG000|Overall Study|Withdrawal by Subject|4
7512016|NCT02402933|11843500|FG000|Overall Study|Discontinued; Site Termination|10
7512017|NCT02403180|11843506|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
7512018|NCT02403180|11843507|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
7512019|NCT02403180|11843506|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
7512020|NCT02403180|11843507|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
7512021|NCT02403206|11843515|FG000|Overall Study|Lost to Follow-up|4
7512022|NCT02403206|11843516|FG001|Overall Study|Lost to Follow-up|3
7512023|NCT02403206|11843515|FG000|Overall Study|Physician Decision|2
7512024|NCT02403206|11843516|FG001|Overall Study|Physician Decision|0
7512025|NCT02403206|11843515|FG000|Overall Study|Withdrawal by Subject|3
7512026|NCT02403206|11843516|FG001|Overall Study|Withdrawal by Subject|3
7512027|NCT02403206|11843515|FG000|Overall Study|Reason not given|2
7512028|NCT02403206|11843516|FG001|Overall Study|Reason not given|4
7512029|NCT02403271|11843523|FG000|Period 1|Other varied reasons|1
7512030|NCT02403271|11843524|FG001|Period 1|Other varied reasons|0
7512031|NCT02403271|11843523|FG000|Period 2|Withdrawal by Subject|0
7512032|NCT02403271|11843524|FG001|Period 2|Withdrawal by Subject|14
7512033|NCT02403271|11843523|FG000|Period 2|Death|0
7512034|NCT02403271|11843524|FG001|Period 2|Death|84
7512035|NCT02403271|11843523|FG000|Period 2|Lost to Follow-up|0
7512036|NCT02403271|11843524|FG001|Period 2|Lost to Follow-up|2
7512037|NCT02403271|11843523|FG000|Period 2|Study Terminated by Sponsor|0
7512038|NCT02403271|11843524|FG001|Period 2|Study Terminated by Sponsor|14
7512039|NCT02403271|11843523|FG000|Period 2|Other varied reasons|0
7512040|NCT02403271|11843524|FG001|Period 2|Other varied reasons|10
7512041|NCT02403635|11843545|FG000|Overall Study|Not eligible|9
7512062|NCT02403817|11843585|FG000|Overall Study|Withdrawal by Subject|5
7512063|NCT02403817|11843586|FG001|Overall Study|Withdrawal by Subject|0
7512064|NCT02404025|11843625|FG000|Overall Study|Adverse Event|1
7512065|NCT02404025|11843625|FG000|Overall Study|Lack of Efficacy|3
7512066|NCT02404103|11843631|FG000|Overall Study|Adverse Event|1
7512067|NCT02404103|11843632|FG001|Overall Study|Adverse Event|0
7512068|NCT02404103|11843631|FG000|Overall Study|Lost to Follow-up|3
7512069|NCT02404103|11843632|FG001|Overall Study|Lost to Follow-up|3
7512070|NCT02404220|11843658|FG000|Overall Study|Adverse Event|0
7512071|NCT02404220|11843659|FG001|Overall Study|Adverse Event|0
7512072|NCT02404220|11843660|FG002|Overall Study|Adverse Event|1
7512073|NCT02404220|11843661|FG003|Overall Study|Adverse Event|0
7512074|NCT02404220|11843658|FG000|Overall Study|Death|5
7512075|NCT02404220|11843659|FG001|Overall Study|Death|5
7512076|NCT02404220|11843660|FG002|Overall Study|Death|3
7512077|NCT02404220|11843661|FG003|Overall Study|Death|8
7512078|NCT02404220|11843658|FG000|Overall Study|Progressive Disease|0
7512079|NCT02404220|11843659|FG001|Overall Study|Progressive Disease|0
7512080|NCT02404220|11843660|FG002|Overall Study|Progressive Disease|1
7512081|NCT02404220|11843661|FG003|Overall Study|Progressive Disease|1
7512082|NCT02404220|11843658|FG000|Overall Study|Study Terminated by Sponsor|0
7512083|NCT02404220|11843659|FG001|Overall Study|Study Terminated by Sponsor|0
7512084|NCT02404220|11843660|FG002|Overall Study|Study Terminated by Sponsor|2
7512085|NCT02404220|11843661|FG003|Overall Study|Study Terminated by Sponsor|1
7512086|NCT02404220|11843658|FG000|Overall Study|Withdrawal by Subject|0
7512087|NCT02404220|11843659|FG001|Overall Study|Withdrawal by Subject|1
7512088|NCT02404220|11843660|FG002|Overall Study|Withdrawal by Subject|0
7512089|NCT02404220|11843661|FG003|Overall Study|Withdrawal by Subject|0
7512090|NCT02404220|11843658|FG000|Overall Study|Enrolled but Never Treated|0
7512091|NCT02404220|11843659|FG001|Overall Study|Enrolled but Never Treated|2
7512092|NCT02404220|11843660|FG002|Overall Study|Enrolled but Never Treated|0
7512093|NCT02404220|11843661|FG003|Overall Study|Enrolled but Never Treated|0
7512094|NCT02404311|11843691|FG000|Part A: Month 0-18|Death|2
7512095|NCT02404311|11843692|FG001|Part A: Month 0-18|Death|0
7512096|NCT02404311|11843693|FG002|Part A: Month 0-18|Death|0
7512097|NCT02404311|11843694|FG003|Part A: Month 0-18|Death|0
7512098|NCT02404311|11843695|FG004|Part A: Month 0-18|Death|0
7512099|NCT02404311|11843691|FG000|Part A: Month 0-18|Physician Decision|1
7512100|NCT02404311|11843692|FG001|Part A: Month 0-18|Physician Decision|0
7512101|NCT02404311|11843693|FG002|Part A: Month 0-18|Physician Decision|0
7512102|NCT02404311|11843694|FG003|Part A: Month 0-18|Physician Decision|0
7512103|NCT02404311|11843695|FG004|Part A: Month 0-18|Physician Decision|0
7512104|NCT02404311|11843691|FG000|Part A: Month 0-18|Lost to Follow-up|4
7512105|NCT02404311|11843692|FG001|Part A: Month 0-18|Lost to Follow-up|2
7512106|NCT02404311|11843693|FG002|Part A: Month 0-18|Lost to Follow-up|0
7512107|NCT02404311|11843694|FG003|Part A: Month 0-18|Lost to Follow-up|0
7512108|NCT02404311|11843695|FG004|Part A: Month 0-18|Lost to Follow-up|0
7512109|NCT02404311|11843691|FG000|Part A: Month 0-18|Withdrawal by Subject|6
7512110|NCT02404311|11843692|FG001|Part A: Month 0-18|Withdrawal by Subject|2
7512111|NCT02404311|11843693|FG002|Part A: Month 0-18|Withdrawal by Subject|0
7512112|NCT02404311|11843694|FG003|Part A: Month 0-18|Withdrawal by Subject|0
7512113|NCT02404311|11843695|FG004|Part A: Month 0-18|Withdrawal by Subject|0
7512114|NCT02404311|11843691|FG000|Part A: Month 0-18|HIV Infection|6
7512115|NCT02404311|11843692|FG001|Part A: Month 0-18|HIV Infection|2
7512116|NCT02404311|11843693|FG002|Part A: Month 0-18|HIV Infection|0
7512117|NCT02404311|11843694|FG003|Part A: Month 0-18|HIV Infection|0
7512118|NCT02404311|11843695|FG004|Part A: Month 0-18|HIV Infection|0
7512119|NCT02404311|11843691|FG000|Part A: Month 0-18|Participant unable to adhere|7
7512120|NCT02404311|11843692|FG001|Part A: Month 0-18|Participant unable to adhere|0
7512121|NCT02404311|11843693|FG002|Part A: Month 0-18|Participant unable to adhere|0
7512122|NCT02404311|11843694|FG003|Part A: Month 0-18|Participant unable to adhere|0
7512123|NCT02404311|11843695|FG004|Part A: Month 0-18|Participant unable to adhere|0
7512124|NCT02404350|11843711|FG000|Overall Study|Adverse Event|2
7512125|NCT02404350|11843712|FG001|Overall Study|Adverse Event|2
7512126|NCT02404350|11843713|FG002|Overall Study|Adverse Event|3
7512127|NCT02404350|11843714|FG003|Overall Study|Adverse Event|9
7512128|NCT02404350|11843711|FG000|Overall Study|Lack of Efficacy|3
7512129|NCT02404350|11843712|FG001|Overall Study|Lack of Efficacy|1
7512130|NCT02404350|11843713|FG002|Overall Study|Lack of Efficacy|0
7512131|NCT02404350|11843714|FG003|Overall Study|Lack of Efficacy|3
7512132|NCT02404350|11843711|FG000|Overall Study|Lost to Follow-up|2
7512133|NCT02404350|11843712|FG001|Overall Study|Lost to Follow-up|0
7512134|NCT02404350|11843713|FG002|Overall Study|Lost to Follow-up|0
7512135|NCT02404350|11843714|FG003|Overall Study|Lost to Follow-up|1
7512136|NCT02404350|11843711|FG000|Overall Study|Physician Decision|1
7512137|NCT02404350|11843712|FG001|Overall Study|Physician Decision|0
7512138|NCT02404350|11843713|FG002|Overall Study|Physician Decision|0
7512139|NCT02404350|11843714|FG003|Overall Study|Physician Decision|2
7512140|NCT02404350|11843711|FG000|Overall Study|Pregnancy|0
7512141|NCT02404350|11843712|FG001|Overall Study|Pregnancy|0
7512142|NCT02404350|11843713|FG002|Overall Study|Pregnancy|0
7512143|NCT02404350|11843714|FG003|Overall Study|Pregnancy|1
7512144|NCT02404350|11843711|FG000|Overall Study|Withdrawal by Subject|7
7512145|NCT02404350|11843712|FG001|Overall Study|Withdrawal by Subject|3
7512146|NCT02404350|11843713|FG002|Overall Study|Withdrawal by Subject|3
7512147|NCT02404350|11843714|FG003|Overall Study|Withdrawal by Subject|19
7512148|NCT02404350|11843711|FG000|Overall Study|Due to Non-compliance with treatment|0
7512149|NCT02404350|11843712|FG001|Overall Study|Due to Non-compliance with treatment|0
7512150|NCT02404350|11843713|FG002|Overall Study|Due to Non-compliance with treatment|0
7512151|NCT02404350|11843714|FG003|Overall Study|Due to Non-compliance with treatment|1
7512152|NCT02404350|11843711|FG000|Overall Study|Due to Technical problems|0
7512153|NCT02404350|11843712|FG001|Overall Study|Due to Technical problems|0
7512154|NCT02404350|11843713|FG002|Overall Study|Due to Technical problems|0
7512155|NCT02404350|11843714|FG003|Overall Study|Due to Technical problems|1
7512156|NCT02404389|11843730|FG000|Overall Study|Adverse Event|1
7512157|NCT02404389|11843731|FG001|Overall Study|Adverse Event|0
7512158|NCT02404389|11843732|FG002|Overall Study|Adverse Event|1
7512159|NCT02404389|11843733|FG003|Overall Study|Adverse Event|0
7512160|NCT02404389|11843734|FG004|Overall Study|Adverse Event|2
7512161|NCT02404389|11843730|FG000|Overall Study|Subject/guardian decision|1
7512162|NCT02404389|11843731|FG001|Overall Study|Subject/guardian decision|0
7512163|NCT02404389|11843732|FG002|Overall Study|Subject/guardian decision|0
7512164|NCT02404389|11843733|FG003|Overall Study|Subject/guardian decision|1
7512165|NCT02404389|11843734|FG004|Overall Study|Subject/guardian decision|1
7512266|NCT02404493|11843813|FG000|Overall Study|Adverse Event|1
7512267|NCT02404493|11843814|FG001|Overall Study|Adverse Event|1
7512268|NCT02404649|11843840|FG000|Overall Study|Adverse Event|1
7512269|NCT02404649|11843841|FG001|Overall Study|Adverse Event|2
7512270|NCT02404805|11843864|FG000|Overall Study|Withdrawal by Subject|1
7512271|NCT02404805|11843865|FG001|Overall Study|Withdrawal by Subject|0
7512272|NCT02404805|11843866|FG002|Overall Study|Withdrawal by Subject|0
7512273|NCT02404805|11843867|FG003|Overall Study|Withdrawal by Subject|0
7512274|NCT02404805|11843868|FG004|Overall Study|Withdrawal by Subject|0
7512275|NCT02404805|11843869|FG005|Overall Study|Withdrawal by Subject|0
7512276|NCT02405091|11843881|FG000|Overall Study|Adverse Event|16
7512277|NCT02405091|11843882|FG001|Overall Study|Adverse Event|10
7512278|NCT02405091|11843883|FG002|Overall Study|Adverse Event|0
7512279|NCT02405091|11843881|FG000|Overall Study|Protocol Violation|1
7512280|NCT02405091|11843882|FG001|Overall Study|Protocol Violation|0
7512281|NCT02405091|11843883|FG002|Overall Study|Protocol Violation|0
7512282|NCT02405091|11843881|FG000|Overall Study|Noncompliance|1
7512283|NCT02405091|11843882|FG001|Overall Study|Noncompliance|6
7512284|NCT02405091|11843883|FG002|Overall Study|Noncompliance|2
7512285|NCT02405091|11843881|FG000|Overall Study|Withdrawal by Subject|4
7512286|NCT02405091|11843882|FG001|Overall Study|Withdrawal by Subject|8
7512287|NCT02405091|11843883|FG002|Overall Study|Withdrawal by Subject|0
7512288|NCT02405091|11843881|FG000|Overall Study|Death|0
7512289|NCT02405091|11843882|FG001|Overall Study|Death|1
7512290|NCT02405091|11843883|FG002|Overall Study|Death|0
7512291|NCT02405091|11843881|FG000|Overall Study|Lost to Follow-up|5
7512292|NCT02405091|11843882|FG001|Overall Study|Lost to Follow-up|6
7512293|NCT02405091|11843883|FG002|Overall Study|Lost to Follow-up|0
7512294|NCT02405091|11843881|FG000|Overall Study|Physician Decision|2
7512295|NCT02405091|11843882|FG001|Overall Study|Physician Decision|2
7512296|NCT02405091|11843883|FG002|Overall Study|Physician Decision|0
7512297|NCT02405442|11843924|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
7512298|NCT02405442|11843925|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
7512299|NCT02405442|11843926|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
7512300|NCT02405442|11843927|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
7512301|NCT02405442|11843924|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7512302|NCT02405442|11843925|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
7512303|NCT02405442|11843926|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
7512304|NCT02405442|11843927|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
7512305|NCT02405442|11843924|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7512306|NCT02405442|11843925|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
7512307|NCT02405442|11843926|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7512308|NCT02405442|11843927|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
7512309|NCT02405442|11843924|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7512310|NCT02405442|11843925|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
7512311|NCT02405442|11843926|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7512312|NCT02405442|11843927|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
7512313|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
7512314|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7512315|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
7512316|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
7512317|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
7512318|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7512319|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
7512320|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
7512321|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
7512322|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
7512323|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
7512324|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
7512325|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
7512326|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
7512327|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
7512328|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
7512329|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7512330|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
7512331|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7512332|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
7512333|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7512334|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
7512335|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7512336|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
7512337|NCT02405442|11843924|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7512338|NCT02405442|11843925|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
7512339|NCT02405442|11843926|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7512340|NCT02405442|11843927|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
7512341|NCT02405442|11843924|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7512342|NCT02405442|11843925|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
7512343|NCT02405442|11843926|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7512344|NCT02405442|11843927|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
7512345|NCT02405442|11843924|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7512346|NCT02405442|11843925|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
7512347|NCT02405442|11843926|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7512348|NCT02405442|11843927|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
7512349|NCT02405442|11843924|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
7512350|NCT02405442|11843925|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7512351|NCT02405442|11843926|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7512352|NCT02405442|11843927|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
7536278|NCT02717494|11884251|FG000|First Intervention (Step 1)|Lost to Follow-up|4
7536279|NCT02717494|11884252|FG001|First Intervention (Step 1)|Lost to Follow-up|7
7536280|NCT02717494|11884253|FG002|First Intervention (Step 1)|Lost to Follow-up|3
7536281|NCT02717494|11884251|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
7536282|NCT02717494|11884252|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
7536283|NCT02717494|11884253|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
7536284|NCT02717494|11884251|FG000|First Intervention (Step 1)|Death|0
7536285|NCT02717494|11884252|FG001|First Intervention (Step 1)|Death|0
7536286|NCT02717494|11884253|FG002|First Intervention (Step 1)|Death|1
7536287|NCT02717494|11884251|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7536288|NCT02717494|11884252|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
7536289|NCT02717494|11884253|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
7536290|NCT02717546|11884279|FG000|Overall Study|Lost to Follow-up|12
7536291|NCT02717754|11884289|FG000|Overall Study|Incorrect Infusion Duration|0
7536292|NCT02717754|11884290|FG001|Overall Study|Incorrect Infusion Duration|0
7536293|NCT02717754|11884291|FG002|Overall Study|Incorrect Infusion Duration|0
7536294|NCT02717754|11884292|FG003|Overall Study|Incorrect Infusion Duration|10
7536295|NCT02717754|11884293|FG004|Overall Study|Incorrect Infusion Duration|20
7536296|NCT02717754|11884294|FG005|Overall Study|Incorrect Infusion Duration|20
7536297|NCT02718131|11884319|FG000|Overall Study|Withdrawal by Subject|1
7536298|NCT02718131|11884320|FG001|Overall Study|Withdrawal by Subject|0
7536299|NCT02718131|11884319|FG000|Overall Study|Adverse Event|1
7536300|NCT02718131|11884320|FG001|Overall Study|Adverse Event|0
7536301|NCT02718131|11884319|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
7536302|NCT02718131|11884320|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
7536303|NCT02718326|11884339|FG000|Overall Study|Adverse Event|4
7536304|NCT02718326|11884340|FG001|Overall Study|Adverse Event|9
7536305|NCT02718326|11884341|FG002|Overall Study|Adverse Event|0
7536306|NCT02718326|11884339|FG000|Overall Study|Death|8
7536307|NCT02718326|11884340|FG001|Overall Study|Death|1
7536308|NCT02718326|11884341|FG002|Overall Study|Death|2
7536309|NCT02718326|11884339|FG000|Overall Study|Withdrawal by Subject|4
7536310|NCT02718326|11884340|FG001|Overall Study|Withdrawal by Subject|9
7536311|NCT02718326|11884341|FG002|Overall Study|Withdrawal by Subject|6
7536312|NCT02718326|11884339|FG000|Overall Study|Lost to Follow-up|18
7536313|NCT02718326|11884340|FG001|Overall Study|Lost to Follow-up|5
7536314|NCT02718326|11884341|FG002|Overall Study|Lost to Follow-up|14
7536315|NCT02718326|11884339|FG000|Overall Study|Protocol Deviation|1
7536316|NCT02718326|11884340|FG001|Overall Study|Protocol Deviation|0
7536317|NCT02718326|11884341|FG002|Overall Study|Protocol Deviation|0
7536318|NCT02718326|11884339|FG000|Overall Study|Pregnancy|1
7536319|NCT02718326|11884340|FG001|Overall Study|Pregnancy|0
7536320|NCT02718326|11884341|FG002|Overall Study|Pregnancy|0
7512353|NCT02405780|11843945|FG000|Period I|Adverse Event|8
7512354|NCT02405780|11843946|FG001|Period I|Adverse Event|0
7512355|NCT02405780|11843947|FG002|Period I|Adverse Event|3
7512356|NCT02405780|11843948|FG003|Period I|Adverse Event|7
7512357|NCT02405780|11843945|FG000|Period I|Medical reasons|1
7512358|NCT02405780|11843946|FG001|Period I|Medical reasons|1
7512359|NCT02405780|11843947|FG002|Period I|Medical reasons|0
7512360|NCT02405780|11843948|FG003|Period I|Medical reasons|1
7512361|NCT02405780|11843945|FG000|Period I|Screening Failure|1
7512362|NCT02405780|11843946|FG001|Period I|Screening Failure|0
7512363|NCT02405780|11843947|FG002|Period I|Screening Failure|1
7512364|NCT02405780|11843948|FG003|Period I|Screening Failure|0
7512365|NCT02405780|11843945|FG000|Period I|Withdrawal by Subject|9
7512366|NCT02405780|11843946|FG001|Period I|Withdrawal by Subject|1
7512367|NCT02405780|11843947|FG002|Period I|Withdrawal by Subject|3
7512368|NCT02405780|11843948|FG003|Period I|Withdrawal by Subject|4
7512369|NCT02405780|11843945|FG000|Period I|Non-compliance with study procedures|8
7512370|NCT02405780|11843946|FG001|Period I|Non-compliance with study procedures|6
7512371|NCT02405780|11843947|FG002|Period I|Non-compliance with study procedures|8
7512372|NCT02405780|11843948|FG003|Period I|Non-compliance with study procedures|11
7512373|NCT02405780|11843945|FG000|Period II|Adverse Event|3
7512374|NCT02405780|11843946|FG001|Period II|Adverse Event|5
7512375|NCT02405780|11843947|FG002|Period II|Adverse Event|4
7512376|NCT02405780|11843948|FG003|Period II|Adverse Event|11
7512377|NCT02405780|11843945|FG000|Period II|Medical reason|0
7512378|NCT02405780|11843946|FG001|Period II|Medical reason|1
7512379|NCT02405780|11843947|FG002|Period II|Medical reason|0
7512380|NCT02405780|11843948|FG003|Period II|Medical reason|0
7512381|NCT02405780|11843945|FG000|Period II|Pregnancy|0
7512382|NCT02405780|11843946|FG001|Period II|Pregnancy|0
7512383|NCT02405780|11843947|FG002|Period II|Pregnancy|1
7512384|NCT02405780|11843948|FG003|Period II|Pregnancy|0
7512385|NCT02405780|11843945|FG000|Period II|Withdrawal by Subject|7
7512386|NCT02405780|11843946|FG001|Period II|Withdrawal by Subject|4
7512387|NCT02405780|11843947|FG002|Period II|Withdrawal by Subject|0
7512388|NCT02405780|11843948|FG003|Period II|Withdrawal by Subject|3
7512389|NCT02405780|11843945|FG000|Period II|Non-compliance with study procedures|5
7512390|NCT02405780|11843946|FG001|Period II|Non-compliance with study procedures|2
7512391|NCT02405780|11843947|FG002|Period II|Non-compliance with study procedures|7
7512392|NCT02405780|11843948|FG003|Period II|Non-compliance with study procedures|4
7512393|NCT02405962|11843975|FG000|Overall Study|Lost to Follow-up|1
7512394|NCT02405962|11843976|FG001|Overall Study|Lost to Follow-up|4
7512395|NCT02405962|11843975|FG000|Overall Study|A participant has moved to another place|0
7512396|NCT02405962|11843976|FG001|Overall Study|A participant has moved to another place|1
7512397|NCT02406248|11843982|FG000|Overall Study|Death|7
7512398|NCT02406248|11843982|FG000|Overall Study|Withdrawal by Subject|2
7512399|NCT02406261|11843988|FG000|Period 1|Lost to Follow-up|2
7512400|NCT02406261|11843989|FG001|Period 1|Lost to Follow-up|0
7512401|NCT02406261|11843988|FG000|Period 1|Adverse Event|1
7512402|NCT02406261|11843989|FG001|Period 1|Adverse Event|0
7512403|NCT02406261|11843988|FG000|Period 2|Physician Decision|0
7512404|NCT02406261|11843989|FG001|Period 2|Physician Decision|1
7512405|NCT02406261|11843988|FG000|Period 2|Protocol Violation|0
7512406|NCT02406261|11843989|FG001|Period 2|Protocol Violation|1
7512407|NCT02406261|11843988|FG000|Period 2|Withdrawal by Subject|0
7512408|NCT02406261|11843989|FG001|Period 2|Withdrawal by Subject|1
7512409|NCT02406586|11844025|FG000|Overall Study|Lost to Follow-up|0
7512410|NCT02406586|11844026|FG001|Overall Study|Lost to Follow-up|4
7512411|NCT02406586|11844027|FG002|Overall Study|Lost to Follow-up|2
7512412|NCT02406586|11844025|FG000|Overall Study|Withdrawal by Subject|1
7512413|NCT02406586|11844026|FG001|Overall Study|Withdrawal by Subject|0
7512414|NCT02406586|11844027|FG002|Overall Study|Withdrawal by Subject|0
7512415|NCT02406612|11844040|FG000|Overall Study|Screening Failure|3
7512416|NCT02406612|11844041|FG001|Overall Study|Screening Failure|0
7512417|NCT02406612|11844040|FG000|Overall Study|Intra-procedural Exclusion|1
7512418|NCT02406612|11844041|FG001|Overall Study|Intra-procedural Exclusion|3
7512419|NCT02406612|11844040|FG000|Overall Study|Guidewire Failure|0
7512420|NCT02406612|11844041|FG001|Overall Study|Guidewire Failure|1
7512421|NCT02406651|11844047|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
7512422|NCT02406677|11844054|FG000|Overall Study|Death|16
7512423|NCT02406677|11844055|FG001|Overall Study|Death|8
7512424|NCT02406677|11844054|FG000|Overall Study|Discharged without P2Y12|1
7512425|NCT02406677|11844055|FG001|Overall Study|Discharged without P2Y12|3
7512426|NCT02406677|11844054|FG000|Overall Study|Discharged on prasugrel|283
7512427|NCT02406677|11844055|FG001|Overall Study|Discharged on prasugrel|587
7512428|NCT02406677|11844054|FG000|Overall Study|Withdrawal by Subject|1
7512429|NCT02406677|11844055|FG001|Overall Study|Withdrawal by Subject|0
7512430|NCT02406742|11844068|FG000|Overall Study|Progression of Disease|5
7512431|NCT02406742|11844069|FG001|Overall Study|Progression of Disease|1
7512432|NCT02406742|11844070|FG002|Overall Study|Progression of Disease|6
7512433|NCT02406742|11844068|FG000|Overall Study|Adverse Event|3
7512434|NCT02406742|11844069|FG001|Overall Study|Adverse Event|0
7512435|NCT02406742|11844070|FG002|Overall Study|Adverse Event|2
7512436|NCT02406742|11844068|FG000|Overall Study|Death|1
7512437|NCT02406742|11844069|FG001|Overall Study|Death|0
7512438|NCT02406742|11844070|FG002|Overall Study|Death|0
7512439|NCT02406742|11844068|FG000|Overall Study|Lack of Efficacy|0
7512440|NCT02406742|11844069|FG001|Overall Study|Lack of Efficacy|0
7512441|NCT02406742|11844070|FG002|Overall Study|Lack of Efficacy|1
7512442|NCT02406742|11844068|FG000|Overall Study|Withdrawal by Participant|1
7512443|NCT02406742|11844069|FG001|Overall Study|Withdrawal by Participant|2
7512444|NCT02406742|11844070|FG002|Overall Study|Withdrawal by Participant|0
7512445|NCT02406742|11844068|FG000|Overall Study|Physician Decision|1
7512446|NCT02406742|11844069|FG001|Overall Study|Physician Decision|2
7512447|NCT02406742|11844070|FG002|Overall Study|Physician Decision|1
7512448|NCT02406742|11844068|FG000|Overall Study|Transition to other treatment|2
7512449|NCT02406742|11844069|FG001|Overall Study|Transition to other treatment|0
7512450|NCT02406742|11844070|FG002|Overall Study|Transition to other treatment|1
7512451|NCT02406742|11844068|FG000|Overall Study|Other Reasons|1
7512452|NCT02406742|11844069|FG001|Overall Study|Other Reasons|11
7512453|NCT02406742|11844070|FG002|Overall Study|Other Reasons|5
7512454|NCT02407054|11844132|FG000|Overall Study|Adverse Event|1
7512455|NCT02407054|11844133|FG001|Overall Study|Adverse Event|4
7512456|NCT02407054|11844134|FG002|Overall Study|Adverse Event|1
7512457|NCT02407054|11844132|FG000|Overall Study|Non-compliance with Study|0
7512458|NCT02407054|11844133|FG001|Overall Study|Non-compliance with Study|2
7512459|NCT02407054|11844134|FG002|Overall Study|Non-compliance with Study|1
7512460|NCT02407054|11844132|FG000|Overall Study|Physician Decision|1
7512461|NCT02407054|11844133|FG001|Overall Study|Physician Decision|3
7512462|NCT02407054|11844134|FG002|Overall Study|Physician Decision|3
7512463|NCT02407054|11844132|FG000|Overall Study|Withdrawal by Subject|5
7512464|NCT02407054|11844133|FG001|Overall Study|Withdrawal by Subject|9
7512465|NCT02407054|11844134|FG002|Overall Study|Withdrawal by Subject|2
7512466|NCT02407223|11844155|FG000|Overall Study|Adverse Event|1
7512467|NCT02407223|11844156|FG001|Overall Study|Adverse Event|0
7512468|NCT02407223|11844157|FG002|Overall Study|Adverse Event|1
7512469|NCT02407223|11844155|FG000|Overall Study|Lack of Efficacy|6
7512470|NCT02407223|11844156|FG001|Overall Study|Lack of Efficacy|6
7512471|NCT02407223|11844157|FG002|Overall Study|Lack of Efficacy|4
7512472|NCT02407223|11844155|FG000|Overall Study|Lost to Follow-up|1
7512473|NCT02407223|11844156|FG001|Overall Study|Lost to Follow-up|0
7512474|NCT02407223|11844157|FG002|Overall Study|Lost to Follow-up|2
7512475|NCT02407223|11844155|FG000|Overall Study|Withdrawal by Subject|2
7512476|NCT02407223|11844156|FG001|Overall Study|Withdrawal by Subject|4
7512477|NCT02407223|11844157|FG002|Overall Study|Withdrawal by Subject|4
7512478|NCT02407223|11844155|FG000|Overall Study|Study Terminated by Sponsor|77
7512479|NCT02407223|11844156|FG001|Overall Study|Study Terminated by Sponsor|80
7512480|NCT02407223|11844157|FG002|Overall Study|Study Terminated by Sponsor|86
7512481|NCT02407223|11844155|FG000|Overall Study|Subject Refused Further Study Treatment|0
7512482|NCT02407223|11844156|FG001|Overall Study|Subject Refused Further Study Treatment|1
7512483|NCT02407223|11844157|FG002|Overall Study|Subject Refused Further Study Treatment|0
7512484|NCT02407223|11844155|FG000|Overall Study|Other|29
7512485|NCT02407223|11844156|FG001|Overall Study|Other|27
7512486|NCT02407223|11844157|FG002|Overall Study|Other|25
7512487|NCT02407249|11844167|FG000|Overall Study|Did not complete 12-month follow-up|13
7512488|NCT02407249|11844167|FG000|Overall Study|Not treated|13
7512489|NCT02407457|11844173|FG000|1 Month|Death|3
7512490|NCT02407457|11844174|FG001|1 Month|Death|0
7512491|NCT02407457|11844173|FG000|1 Month|Lost to Follow-up|1
7512492|NCT02407457|11844174|FG001|1 Month|Lost to Follow-up|1
7512493|NCT02407457|11844173|FG000|1 Month|missed visit|2
7512494|NCT02407457|11844174|FG001|1 Month|missed visit|6
7512495|NCT02407457|11844173|FG000|6-Month|Death|2
7512496|NCT02407457|11844174|FG001|6-Month|Death|8
7512497|NCT02407457|11844173|FG000|6-Month|Lost to Follow-up|2
7512498|NCT02407457|11844174|FG001|6-Month|Lost to Follow-up|2
7512499|NCT02407457|11844173|FG000|6-Month|missed visit|15
7512500|NCT02407457|11844174|FG001|6-Month|missed visit|12
7512501|NCT02407457|11844173|FG000|6-Month|Over Due|1
7512502|NCT02407457|11844174|FG001|6-Month|Over Due|2
7512503|NCT02407457|11844173|FG000|6-Month|Open Repair|0
7512504|NCT02407457|11844174|FG001|6-Month|Open Repair|1
7512505|NCT02407457|11844173|FG000|1 Year|Death|6
7512506|NCT02407457|11844174|FG001|1 Year|Death|11
7512507|NCT02407457|11844173|FG000|1 Year|Lost to Follow-up|3
7512508|NCT02407457|11844174|FG001|1 Year|Lost to Follow-up|2
7512509|NCT02407457|11844173|FG000|1 Year|Missed Visit|18
7512510|NCT02407457|11844174|FG001|1 Year|Missed Visit|10
7512511|NCT02407457|11844173|FG000|1 Year|Over Due|6
7512512|NCT02407457|11844174|FG001|1 Year|Over Due|4
7512513|NCT02407457|11844173|FG000|1 Year|Open Repair|0
7512514|NCT02407457|11844174|FG001|1 Year|Open Repair|1
7512515|NCT02407457|11844173|FG000|2-year|Death|14
7512516|NCT02407457|11844174|FG001|2-year|Death|8
7512517|NCT02407457|11844173|FG000|2-year|Lost to Follow-up|6
7512518|NCT02407457|11844174|FG001|2-year|Lost to Follow-up|9
7512519|NCT02407457|11844173|FG000|2-year|Missed Visit|13
7512520|NCT02407457|11844174|FG001|2-year|Missed Visit|11
7512521|NCT02407457|11844173|FG000|2-year|Over Due|1
7512522|NCT02407457|11844174|FG001|2-year|Over Due|5
7512523|NCT02407457|11844173|FG000|2-year|Open Repair|0
7512524|NCT02407457|11844174|FG001|2-year|Open Repair|2
7512525|NCT02407457|11844173|FG000|3-year|Death|11
7512526|NCT02407457|11844174|FG001|3-year|Death|10
7512527|NCT02407457|11844173|FG000|3-year|Lost to Follow-up|6
7512528|NCT02407457|11844174|FG001|3-year|Lost to Follow-up|9
7512529|NCT02407457|11844173|FG000|3-year|Missed Visit|21
7512530|NCT02407457|11844174|FG001|3-year|Missed Visit|16
7512531|NCT02407457|11844173|FG000|3-year|Over Due|4
7512532|NCT02407457|11844174|FG001|3-year|Over Due|3
7512533|NCT02407457|11844173|FG000|4-year|Death|14
7512534|NCT02407457|11844174|FG001|4-year|Death|7
7512535|NCT02407457|11844173|FG000|4-year|Lost to Follow-up|9
7512536|NCT02407457|11844174|FG001|4-year|Lost to Follow-up|12
7512537|NCT02407457|11844173|FG000|4-year|Over Due|10
7512538|NCT02407457|11844174|FG001|4-year|Over Due|5
7512539|NCT02407457|11844173|FG000|4-year|Missed Visit|13
7512540|NCT02407457|11844174|FG001|4-year|Missed Visit|13
7512541|NCT02407457|11844173|FG000|4-year|Pending visit|19
7512542|NCT02407457|11844174|FG001|4-year|Pending visit|14
7512543|NCT02407457|11844173|FG000|4-year|Not Due|16
7512544|NCT02407457|11844174|FG001|4-year|Not Due|10
7512545|NCT02407457|11844173|FG000|5-year|Death|6
7512546|NCT02407457|11844174|FG001|5-year|Death|1
7512547|NCT02407457|11844173|FG000|5-year|Lost to Follow-up|4
7512548|NCT02407457|11844174|FG001|5-year|Lost to Follow-up|4
7512549|NCT02407457|11844173|FG000|5-year|Missed Visit|10
7512550|NCT02407457|11844174|FG001|5-year|Missed Visit|9
7512551|NCT02407457|11844173|FG000|5-year|Pending Visit|18
7512552|NCT02407457|11844174|FG001|5-year|Pending Visit|17
7512553|NCT02407457|11844173|FG000|5-year|Not Due|54
7512554|NCT02407457|11844174|FG001|5-year|Not Due|46
7512555|NCT02407704|11844184|FG000|Overall Study|Lost to Follow-up|0
7512556|NCT02407704|11844185|FG001|Overall Study|Lost to Follow-up|0
7512557|NCT02407704|11844186|FG002|Overall Study|Lost to Follow-up|0
7512558|NCT02407704|11844187|FG003|Overall Study|Lost to Follow-up|2
7512559|NCT02407704|11844184|FG000|Overall Study|Protocol Violation|0
7512560|NCT02407704|11844185|FG001|Overall Study|Protocol Violation|0
7512561|NCT02407704|11844186|FG002|Overall Study|Protocol Violation|0
7512562|NCT02407704|11844187|FG003|Overall Study|Protocol Violation|1
7512563|NCT02407704|11844184|FG000|Overall Study|Withdrawal by Subject|0
7512564|NCT02407704|11844185|FG001|Overall Study|Withdrawal by Subject|0
7512565|NCT02407704|11844186|FG002|Overall Study|Withdrawal by Subject|1
7512566|NCT02407704|11844187|FG003|Overall Study|Withdrawal by Subject|0
7512567|NCT02407990|11844226|FG000|Overall Study|Death|2
7512568|NCT02407990|11844227|FG001|Overall Study|Death|22
7512569|NCT02407990|11844228|FG002|Overall Study|Death|23
7512570|NCT02407990|11844229|FG003|Overall Study|Death|7
7512571|NCT02407990|11844230|FG004|Overall Study|Death|17
7512572|NCT02407990|11844231|FG005|Overall Study|Death|16
7512573|NCT02407990|11844232|FG006|Overall Study|Death|10
7512574|NCT02407990|11844233|FG007|Overall Study|Death|248
7512575|NCT02407990|11844226|FG000|Overall Study|Lost to Follow-up|0
7512576|NCT02407990|11844227|FG001|Overall Study|Lost to Follow-up|1
7512577|NCT02407990|11844228|FG002|Overall Study|Lost to Follow-up|0
7512578|NCT02407990|11844229|FG003|Overall Study|Lost to Follow-up|0
7512579|NCT02407990|11844230|FG004|Overall Study|Lost to Follow-up|0
7512580|NCT02407990|11844231|FG005|Overall Study|Lost to Follow-up|0
7512581|NCT02407990|11844232|FG006|Overall Study|Lost to Follow-up|0
7512582|NCT02407990|11844233|FG007|Overall Study|Lost to Follow-up|17
7512583|NCT02407990|11844226|FG000|Overall Study|Progressive Disease|0
7512584|NCT02407990|11844227|FG001|Overall Study|Progressive Disease|0
7512585|NCT02407990|11844228|FG002|Overall Study|Progressive Disease|0
7512586|NCT02407990|11844229|FG003|Overall Study|Progressive Disease|0
7512587|NCT02407990|11844230|FG004|Overall Study|Progressive Disease|0
7512588|NCT02407990|11844231|FG005|Overall Study|Progressive Disease|0
7512589|NCT02407990|11844232|FG006|Overall Study|Progressive Disease|0
7512590|NCT02407990|11844233|FG007|Overall Study|Progressive Disease|1
7512591|NCT02407990|11844226|FG000|Overall Study|Withdrawal by Subject|0
7512592|NCT02407990|11844227|FG001|Overall Study|Withdrawal by Subject|0
7512593|NCT02407990|11844228|FG002|Overall Study|Withdrawal by Subject|0
7512594|NCT02407990|11844229|FG003|Overall Study|Withdrawal by Subject|0
7512595|NCT02407990|11844230|FG004|Overall Study|Withdrawal by Subject|1
7512596|NCT02407990|11844231|FG005|Overall Study|Withdrawal by Subject|0
7512597|NCT02407990|11844232|FG006|Overall Study|Withdrawal by Subject|0
7512598|NCT02407990|11844233|FG007|Overall Study|Withdrawal by Subject|30
7512599|NCT02407990|11844226|FG000|Overall Study|Study Terminated by Sponsor|1
7512600|NCT02407990|11844227|FG001|Overall Study|Study Terminated by Sponsor|3
7512601|NCT02407990|11844228|FG002|Overall Study|Study Terminated by Sponsor|3
7512602|NCT02407990|11844229|FG003|Overall Study|Study Terminated by Sponsor|0
7512603|NCT02407990|11844230|FG004|Overall Study|Study Terminated by Sponsor|3
7512604|NCT02407990|11844231|FG005|Overall Study|Study Terminated by Sponsor|4
7512605|NCT02407990|11844232|FG006|Overall Study|Study Terminated by Sponsor|3
7512606|NCT02407990|11844233|FG007|Overall Study|Study Terminated by Sponsor|37
7512607|NCT02407990|11844226|FG000|Overall Study|Logistics|0
7512608|NCT02407990|11844227|FG001|Overall Study|Logistics|0
7512609|NCT02407990|11844228|FG002|Overall Study|Logistics|0
7512610|NCT02407990|11844229|FG003|Overall Study|Logistics|0
7512611|NCT02407990|11844230|FG004|Overall Study|Logistics|0
7512612|NCT02407990|11844231|FG005|Overall Study|Logistics|0
7512613|NCT02407990|11844232|FG006|Overall Study|Logistics|0
7512614|NCT02407990|11844233|FG007|Overall Study|Logistics|1
7512615|NCT02407990|11844226|FG000|Overall Study|Rolled into long-term extension study|0
7512616|NCT02407990|11844227|FG001|Overall Study|Rolled into long-term extension study|0
7512617|NCT02407990|11844228|FG002|Overall Study|Rolled into long-term extension study|0
7512618|NCT02407990|11844229|FG003|Overall Study|Rolled into long-term extension study|0
7512619|NCT02407990|11844230|FG004|Overall Study|Rolled into long-term extension study|0
7512620|NCT02407990|11844231|FG005|Overall Study|Rolled into long-term extension study|0
7512621|NCT02407990|11844232|FG006|Overall Study|Rolled into long-term extension study|0
7512622|NCT02407990|11844233|FG007|Overall Study|Rolled into long-term extension study|1
7512623|NCT02408016|11844260|FG000|Overall Study|Death|6
7512624|NCT02408016|11844261|FG001|Overall Study|Death|1
7512625|NCT02408016|11844262|FG002|Overall Study|Death|0
7512626|NCT02408016|11844260|FG000|Overall Study|Physician Decision|0
7512627|NCT02408016|11844261|FG001|Overall Study|Physician Decision|2
7512628|NCT02408016|11844262|FG002|Overall Study|Physician Decision|0
7512629|NCT02408120|11844272|FG000|Overall Study|Withdrawal by Subject|0
7512630|NCT02408120|11844273|FG001|Overall Study|Withdrawal by Subject|1
7512631|NCT02408120|11844272|FG000|Overall Study|Treatment Refusal|1
7512632|NCT02408120|11844273|FG001|Overall Study|Treatment Refusal|0
7512633|NCT02408120|11844272|FG000|Overall Study|Received Steroids|1
7512634|NCT02408120|11844273|FG001|Overall Study|Received Steroids|1
7512635|NCT02408120|11844272|FG000|Overall Study|Discharged same day|1
7512636|NCT02408120|11844273|FG001|Overall Study|Discharged same day|1
7512637|NCT02408120|11844272|FG000|Overall Study|Did not receive insulin|1
7512638|NCT02408120|11844273|FG001|Overall Study|Did not receive insulin|2
7512639|NCT02408484|11844302|FG000|Overall Study|Withdrawal by Subject|3
7512640|NCT02408484|11844302|FG000|Overall Study|Not treated during study period|1
7512641|NCT02408523|11844324|FG000|Overall Study|Adverse Event|4
7512642|NCT02408523|11844325|FG001|Overall Study|Adverse Event|10
7512643|NCT02408523|11844324|FG000|Overall Study|Lack of Efficacy|0
7512644|NCT02408523|11844325|FG001|Overall Study|Lack of Efficacy|1
7512645|NCT02408523|11844324|FG000|Overall Study|Protocol Violation|1
7512646|NCT02408523|11844325|FG001|Overall Study|Protocol Violation|2
7512647|NCT02408523|11844324|FG000|Overall Study|Lost to Follow-up|2
7512648|NCT02408523|11844325|FG001|Overall Study|Lost to Follow-up|3
7512649|NCT02408523|11844324|FG000|Overall Study|Withdrawal by Subject|3
7512650|NCT02408523|11844325|FG001|Overall Study|Withdrawal by Subject|1
7512651|NCT02408523|11844324|FG000|Overall Study|Sponsor request|1
7512652|NCT02408523|11844325|FG001|Overall Study|Sponsor request|0
7512653|NCT02408523|11844324|FG000|Overall Study|Did not satisfy extension conditions|0
7512654|NCT02408523|11844325|FG001|Overall Study|Did not satisfy extension conditions|1
7512655|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
7512656|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7512657|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7512658|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7512659|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
7512660|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
7512661|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7512662|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7512663|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7512664|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
7512665|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
7512666|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7512667|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7512668|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7512669|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
7512670|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
7512671|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7512672|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7512673|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7512674|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
7512675|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
7512676|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7512677|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7512678|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7512679|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
7512680|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
7512681|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7512682|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7512683|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7512684|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
7512685|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
7512686|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7512687|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7512688|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7512689|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
7512690|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
7512691|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7512692|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7512693|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7512694|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
7512695|NCT02409667|11844418|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
7512696|NCT02409667|11844419|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7512697|NCT02409667|11844420|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7512698|NCT02409667|11844421|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7512699|NCT02409667|11844422|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
7512700|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7512701|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
7512702|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
7512703|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
7512704|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
7512705|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7512706|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7512707|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7512708|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
7512709|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
7512710|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
7512711|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
7512712|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
7512713|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
7512714|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
7512715|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7512716|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
7512717|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
7512718|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7512719|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
7512720|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7512721|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
7512722|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
7512723|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
7512724|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
7512725|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7512726|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7512727|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7512728|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
7512729|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
7512730|NCT02409667|11844418|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7512731|NCT02409667|11844419|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7512732|NCT02409667|11844420|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
7512733|NCT02409667|11844421|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7512734|NCT02409667|11844422|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
7512735|NCT02409680|11844435|FG000|Overall Study|Lost to Follow-up|15
7512736|NCT02409680|11844436|FG001|Overall Study|Lost to Follow-up|30
7512737|NCT02409719|11844444|FG000|Overall Study|Lost to Follow-up|3
7512738|NCT02409719|11844445|FG001|Overall Study|Lost to Follow-up|3
7512739|NCT02409732|11844451|FG000|Overall Study|Withdrawal by Subject|4
7512740|NCT02409732|11844451|FG000|Overall Study|Lost to Follow-up|2
7512741|NCT02410200|11844487|FG000|Overall Study|Adverse Event|2
7512742|NCT02410252|11844498|FG000|Overall Study|Withdrawal by Subject|4
7512743|NCT02410252|11844498|FG000|Overall Study|Physician Decision|2
7512744|NCT02410278|11844506|FG000|Run-in Period|Adverse Event|5
7512745|NCT02410278|11844507|FG001|Run-in Period|Adverse Event|0
7512746|NCT02410278|11844508|FG002|Run-in Period|Adverse Event|0
7512747|NCT02410278|11844506|FG000|Run-in Period|GSRS Threshold Not Met|30
7512748|NCT02410278|11844507|FG001|Run-in Period|GSRS Threshold Not Met|0
7512749|NCT02410278|11844508|FG002|Run-in Period|GSRS Threshold Not Met|0
7512750|NCT02410278|11844506|FG000|Run-in Period|Lost to Follow-up|1
7512751|NCT02410278|11844507|FG001|Run-in Period|Lost to Follow-up|0
7512752|NCT02410278|11844508|FG002|Run-in Period|Lost to Follow-up|0
7512753|NCT02410278|11844506|FG000|Run-in Period|Withdrawal by Subject|1
7512754|NCT02410278|11844507|FG001|Run-in Period|Withdrawal by Subject|0
7512755|NCT02410278|11844508|FG002|Run-in Period|Withdrawal by Subject|0
7512756|NCT02410278|11844506|FG000|Run-in Period|Pregnancy|1
7512757|NCT02410278|11844507|FG001|Run-in Period|Pregnancy|0
7512758|NCT02410278|11844508|FG002|Run-in Period|Pregnancy|0
7512759|NCT02410278|11844506|FG000|Study Treatment Period|Adverse Event|0
7512760|NCT02410278|11844507|FG001|Study Treatment Period|Adverse Event|6
7512761|NCT02410278|11844508|FG002|Study Treatment Period|Adverse Event|3
7512762|NCT02410278|11844506|FG000|Study Treatment Period|Physician Decision|0
7512763|NCT02410278|11844507|FG001|Study Treatment Period|Physician Decision|0
7512764|NCT02410278|11844508|FG002|Study Treatment Period|Physician Decision|1
7512765|NCT02410278|11844506|FG000|Study Treatment Period|Withdrawal by Subject|0
7512766|NCT02410278|11844507|FG001|Study Treatment Period|Withdrawal by Subject|1
7512767|NCT02410278|11844508|FG002|Study Treatment Period|Withdrawal by Subject|0
7512768|NCT02410278|11844506|FG000|Study Treatment Period|Other|0
7512769|NCT02410278|11844507|FG001|Study Treatment Period|Other|3
7512770|NCT02410278|11844508|FG002|Study Treatment Period|Other|0
7512771|NCT02410278|11844506|FG000|Study Treatment Period|GSRS Threshold Not Met|0
7512772|NCT02410278|11844507|FG001|Study Treatment Period|GSRS Threshold Not Met|1
7512773|NCT02410278|11844508|FG002|Study Treatment Period|GSRS Threshold Not Met|0
7512774|NCT02410629|11844535|FG000|Overall Study|Family cannot commit to the study|2
7512775|NCT02410629|11844536|FG001|Overall Study|Family cannot commit to the study|1
7512776|NCT02410629|11844535|FG000|Overall Study|Subject returned to work|1
7512777|NCT02410629|11844536|FG001|Overall Study|Subject returned to work|0
7512778|NCT02410629|11844535|FG000|Overall Study|Subject moved back to home country|0
7512779|NCT02410629|11844536|FG001|Overall Study|Subject moved back to home country|1
7512780|NCT02410629|11844535|FG000|Overall Study|Subject underwent heart surgery|0
7512781|NCT02410629|11844536|FG001|Overall Study|Subject underwent heart surgery|1
7512782|NCT02410772|11844551|FG000|Overall Study|Death|3
7512783|NCT02410772|11844552|FG001|Overall Study|Death|4
7512784|NCT02410772|11844553|FG002|Overall Study|Death|8
7512785|NCT02410772|11844551|FG000|Overall Study|Lost to Follow-up|31
7512786|NCT02410772|11844552|FG001|Overall Study|Lost to Follow-up|23
7512787|NCT02410772|11844553|FG002|Overall Study|Lost to Follow-up|22
7512788|NCT02410772|11844551|FG000|Overall Study|Pregnancy|8
7512789|NCT02410772|11844552|FG001|Overall Study|Pregnancy|4
7512790|NCT02410772|11844553|FG002|Overall Study|Pregnancy|5
7512791|NCT02410772|11844551|FG000|Overall Study|Protocol Violation|8
7512792|NCT02410772|11844552|FG001|Overall Study|Protocol Violation|8
7512793|NCT02410772|11844553|FG002|Overall Study|Protocol Violation|4
7512794|NCT02410772|11844551|FG000|Overall Study|Baseline Drug Resistance|49
7512795|NCT02410772|11844552|FG001|Overall Study|Baseline Drug Resistance|40
7512796|NCT02410772|11844553|FG002|Overall Study|Baseline Drug Resistance|51
7512797|NCT02410772|11844551|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
7512798|NCT02410772|11844552|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
7512799|NCT02410772|11844553|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
7512800|NCT02410772|11844551|FG000|Overall Study|Reinfection with a new strain of MTB|0
7512801|NCT02410772|11844552|FG001|Overall Study|Reinfection with a new strain of MTB|1
7512802|NCT02410772|11844553|FG002|Overall Study|Reinfection with a new strain of MTB|0
7512803|NCT02410811|11844570|FG000|Overall Study|Withdrawal by Subject|0
7512804|NCT02410811|11844571|FG001|Overall Study|Withdrawal by Subject|0
7512805|NCT02410811|11844572|FG002|Overall Study|Withdrawal by Subject|1
7512806|NCT02410811|11844573|FG003|Overall Study|Withdrawal by Subject|0
7512807|NCT02410824|11844583|FG000|First Intervention (One Week)|Headache|0
7512808|NCT02410824|11844584|FG001|First Intervention (One Week)|Headache|1
7512809|NCT02410837|11844591|FG000|Overall Study|Death|387
7512810|NCT02410837|11844591|FG000|Overall Study|Lost to Follow-up|50
7512811|NCT02410837|11844591|FG000|Overall Study|Withdrawal by Subject|44
7512812|NCT02410837|11844591|FG000|Overall Study|Physician Decision|6
7512813|NCT02410837|11844591|FG000|Overall Study|Moved to nursing home, cannot communicat|1
7512814|NCT02411084|11844606|FG000|Overall Study|Lack of Efficacy|6
7512815|NCT02411084|11844607|FG001|Overall Study|Lack of Efficacy|3
7512816|NCT02411084|11844606|FG000|Overall Study|Death|5
7512817|NCT02411084|11844607|FG001|Overall Study|Death|4
7512818|NCT02411084|11844606|FG000|Overall Study|Adverse Event|2
7512819|NCT02411084|11844607|FG001|Overall Study|Adverse Event|1
7512820|NCT02411084|11844606|FG000|Overall Study|Other reasons|0
7512821|NCT02411084|11844607|FG001|Overall Study|Other reasons|5
7512822|NCT02411110|11844615|FG000|Treatment Period 1|Adverse Event|4
7512823|NCT02411110|11844616|FG001|Treatment Period 1|Adverse Event|2
7512824|NCT02411110|11844615|FG000|Treatment Period 1|Lost to Follow-up|1
7512825|NCT02411110|11844616|FG001|Treatment Period 1|Lost to Follow-up|0
7512826|NCT02411110|11844615|FG000|Treatment Period 1|Personal Reasons|2
7512827|NCT02411110|11844616|FG001|Treatment Period 1|Personal Reasons|5
7512828|NCT02411110|11844615|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
7512829|NCT02411110|11844616|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
7512830|NCT02411110|11844615|FG000|Treatment Period 2|Adverse Event|1
7512831|NCT02411110|11844616|FG001|Treatment Period 2|Adverse Event|0
7512832|NCT02411110|11844615|FG000|Treatment Period 2|Lost to Follow-up|0
7512833|NCT02411110|11844616|FG001|Treatment Period 2|Lost to Follow-up|2
7512834|NCT02411110|11844615|FG000|Treatment Period 2|Personal Reasons|0
7512835|NCT02411110|11844616|FG001|Treatment Period 2|Personal Reasons|2
7512836|NCT02411201|11844624|FG000|Overall Study|Adverse Event|2
7512837|NCT02411201|11844624|FG000|Overall Study|Withdrawal by Subject|2
7512838|NCT02411201|11844624|FG000|Overall Study|Age group completed|2
7512839|NCT02411292|11844630|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
7512840|NCT02411292|11844630|FG000|Overall Study|Death|2
7512841|NCT02411292|11844630|FG000|Overall Study|Lost to Follow-up|3
7512842|NCT02411396|11844636|FG000|Overall Study|Lost to Follow-up|31
7512843|NCT02411396|11844636|FG000|Overall Study|Death|10
7512844|NCT02411539|11844660|FG000|Overall Study|Lost to Follow-up|2
7512845|NCT02411539|11844661|FG001|Overall Study|Lost to Follow-up|0
7512846|NCT02411539|11844660|FG000|Overall Study|Confounding medical condition|0
7512847|NCT02411539|11844661|FG001|Overall Study|Confounding medical condition|1
7512848|NCT02411578|11844681|FG000|Crossover Trial Phase|Pregnancy|0
7512849|NCT02411578|11844682|FG001|Crossover Trial Phase|Pregnancy|1
7512850|NCT02411591|11844693|FG000|Overall Study|Adverse Event|0
7512851|NCT02411591|11844694|FG001|Overall Study|Adverse Event|4
7512852|NCT02411591|11844695|FG002|Overall Study|Adverse Event|2
7512853|NCT02411591|11844693|FG000|Overall Study|Withdrawal by Subject|0
7512854|NCT02411591|11844694|FG001|Overall Study|Withdrawal by Subject|3
7512855|NCT02411591|11844695|FG002|Overall Study|Withdrawal by Subject|0
7512856|NCT02411591|11844693|FG000|Overall Study|Physician Decision|0
7512857|NCT02411591|11844694|FG001|Overall Study|Physician Decision|3
7512858|NCT02411591|11844695|FG002|Overall Study|Physician Decision|1
7512859|NCT02411747|11844713|FG000|Overall Study|Withdrawal by Subject|1
7512860|NCT02411747|11844714|FG001|Overall Study|Withdrawal by Subject|0
7512861|NCT02411747|11844713|FG000|Overall Study|Protocol Violation|2
7512862|NCT02411747|11844714|FG001|Overall Study|Protocol Violation|4
7512863|NCT02412111|11844757|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
7512864|NCT02412111|11844758|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7512865|NCT02412111|11844759|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
7512866|NCT02412111|11844757|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
7512867|NCT02412111|11844758|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7512868|NCT02412111|11844759|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
7512869|NCT02412111|11844757|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
7512870|NCT02412111|11844758|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
7512871|NCT02412111|11844759|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
7512872|NCT02412111|11844757|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7512873|NCT02412111|11844758|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
7512874|NCT02412111|11844759|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
7512875|NCT02412111|11844757|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7512876|NCT02412111|11844758|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
7512877|NCT02412111|11844759|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
7512878|NCT02412111|11844757|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
7512879|NCT02412111|11844758|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
7512880|NCT02412111|11844759|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
7512881|NCT02412111|11844757|FG000|Active Comparator Period (8 Weeks)|Other|0
7512882|NCT02412111|11844758|FG001|Active Comparator Period (8 Weeks)|Other|0
7512883|NCT02412111|11844759|FG002|Active Comparator Period (8 Weeks)|Other|2
7512899|NCT02412371|11844809|FG000|Overall Study|Withdrawal by Subject|0
7512900|NCT02412371|11844810|FG001|Overall Study|Withdrawal by Subject|2
7512901|NCT02412371|11844811|FG002|Overall Study|Withdrawal by Subject|0
7512902|NCT02412371|11844812|FG003|Overall Study|Withdrawal by Subject|1
7512903|NCT02412371|11844813|FG004|Overall Study|Withdrawal by Subject|1
7512904|NCT02412371|11844814|FG005|Overall Study|Withdrawal by Subject|0
7512905|NCT02412371|11844809|FG000|Overall Study|Sponsor Discontinued Study|1
7512906|NCT02412371|11844810|FG001|Overall Study|Sponsor Discontinued Study|4
7512907|NCT02412371|11844811|FG002|Overall Study|Sponsor Discontinued Study|6
7512908|NCT02412371|11844812|FG003|Overall Study|Sponsor Discontinued Study|4
7512909|NCT02412371|11844813|FG004|Overall Study|Sponsor Discontinued Study|5
7512910|NCT02412371|11844814|FG005|Overall Study|Sponsor Discontinued Study|0
7512911|NCT02412371|11844809|FG000|Overall Study|Death|4
7512912|NCT02412371|11844810|FG001|Overall Study|Death|2
7512913|NCT02412371|11844811|FG002|Overall Study|Death|1
7512914|NCT02412371|11844812|FG003|Overall Study|Death|3
7512915|NCT02412371|11844813|FG004|Overall Study|Death|5
7512916|NCT02412371|11844814|FG005|Overall Study|Death|2
7512917|NCT02412371|11844809|FG000|Overall Study|Other|2
7512918|NCT02412371|11844810|FG001|Overall Study|Other|1
7512919|NCT02412371|11844811|FG002|Overall Study|Other|0
7512920|NCT02412371|11844812|FG003|Overall Study|Other|0
7512921|NCT02412371|11844813|FG004|Overall Study|Other|1
7512922|NCT02412371|11844814|FG005|Overall Study|Other|3
7512923|NCT02412436|11844829|FG000|Overall Study|Protocol-mandated Discontinuation|7
7512924|NCT02412436|11844829|FG000|Overall Study|Lost to Follow-up|6
7512925|NCT02412436|11844829|FG000|Overall Study|Unable to get to clinic|3
7512926|NCT02412436|11844829|FG000|Overall Study|Death|1
7512927|NCT02412436|11844829|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7512928|NCT02412488|11844833|FG000|Overall Study|Lost to Follow-up|10
7512929|NCT02412488|11844833|FG000|Overall Study|Withdrawal by Subject|5
7512930|NCT02412488|11844833|FG000|Overall Study|Physician Decision|1
7512931|NCT02412488|11844833|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
7512932|NCT02412488|11844833|FG000|Overall Study|Reveal LINQ explant|1
7512933|NCT02412631|11844844|FG000|Overall Study|Adverse Event|1
7512934|NCT02412631|11844845|FG001|Overall Study|Adverse Event|2
7512935|NCT02412631|11844844|FG000|Overall Study|Lost to Follow-up|5
7512936|NCT02412631|11844845|FG001|Overall Study|Lost to Follow-up|9
7512937|NCT02412631|11844844|FG000|Overall Study|Withdrawal by Subject|9
7512938|NCT02412631|11844845|FG001|Overall Study|Withdrawal by Subject|3
7512939|NCT02412631|11844844|FG000|Overall Study|Early stop by FDA|5
7512940|NCT02412631|11844845|FG001|Overall Study|Early stop by FDA|2
7512941|NCT02412631|11844844|FG000|Overall Study|Unspecified reason|6
7512942|NCT02412631|11844845|FG001|Overall Study|Unspecified reason|8
7512943|NCT02412657|11844867|FG000|Overall Study|Lost to Follow-up|1
7512944|NCT02412657|11844868|FG001|Overall Study|Lost to Follow-up|0
7512945|NCT02412657|11844869|FG002|Overall Study|Lost to Follow-up|0
7512946|NCT02412657|11844867|FG000|Overall Study|Protocol Violation|0
7512947|NCT02412657|11844868|FG001|Overall Study|Protocol Violation|2
7512948|NCT02412657|11844869|FG002|Overall Study|Protocol Violation|3
7512949|NCT02412722|11844883|FG000|Overall Study|Adverse Event|0
7512950|NCT02412722|11844884|FG001|Overall Study|Adverse Event|2
7512951|NCT02412722|11844885|FG002|Overall Study|Adverse Event|0
7512952|NCT02412722|11844886|FG003|Overall Study|Adverse Event|3
7512953|NCT02412722|11844887|FG004|Overall Study|Adverse Event|0
7512954|NCT02412722|11844888|FG005|Overall Study|Adverse Event|3
7512955|NCT02412722|11844883|FG000|Overall Study|Progressive Disease|6
7512956|NCT02412722|11844884|FG001|Overall Study|Progressive Disease|4
7512957|NCT02412722|11844885|FG002|Overall Study|Progressive Disease|4
7512958|NCT02412722|11844886|FG003|Overall Study|Progressive Disease|9
7512959|NCT02412722|11844887|FG004|Overall Study|Progressive Disease|3
7512960|NCT02412722|11844888|FG005|Overall Study|Progressive Disease|3
7512961|NCT02412722|11844883|FG000|Overall Study|Withdrawal by Subject|2
7512962|NCT02412722|11844884|FG001|Overall Study|Withdrawal by Subject|0
7512963|NCT02412722|11844885|FG002|Overall Study|Withdrawal by Subject|1
7512964|NCT02412722|11844886|FG003|Overall Study|Withdrawal by Subject|2
7512965|NCT02412722|11844887|FG004|Overall Study|Withdrawal by Subject|1
7512966|NCT02412722|11844888|FG005|Overall Study|Withdrawal by Subject|1
7512967|NCT02412722|11844883|FG000|Overall Study|Lost to Follow-up|0
7512968|NCT02412722|11844884|FG001|Overall Study|Lost to Follow-up|0
7512969|NCT02412722|11844885|FG002|Overall Study|Lost to Follow-up|0
7512970|NCT02412722|11844886|FG003|Overall Study|Lost to Follow-up|0
7512971|NCT02412722|11844887|FG004|Overall Study|Lost to Follow-up|1
7512972|NCT02412722|11844888|FG005|Overall Study|Lost to Follow-up|0
7512973|NCT02412722|11844883|FG000|Overall Study|Received drug in run-in and discontinued|0
7512974|NCT02412722|11844884|FG001|Overall Study|Received drug in run-in and discontinued|2
7512975|NCT02412722|11844885|FG002|Overall Study|Received drug in run-in and discontinued|0
7512976|NCT02412722|11844886|FG003|Overall Study|Received drug in run-in and discontinued|0
7512977|NCT02412722|11844887|FG004|Overall Study|Received drug in run-in and discontinued|0
7512978|NCT02412722|11844888|FG005|Overall Study|Received drug in run-in and discontinued|0
7512979|NCT02412722|11844883|FG000|Overall Study|Reason not Specified|3
7512980|NCT02412722|11844884|FG001|Overall Study|Reason not Specified|0
7512981|NCT02412722|11844885|FG002|Overall Study|Reason not Specified|2
7512982|NCT02412722|11844886|FG003|Overall Study|Reason not Specified|1
7512983|NCT02412722|11844887|FG004|Overall Study|Reason not Specified|2
7512984|NCT02412722|11844888|FG005|Overall Study|Reason not Specified|6
7512985|NCT02412761|11844922|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7512986|NCT02412761|11844923|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7512987|NCT02412761|11844924|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
7512988|NCT02412761|11844925|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
7512989|NCT02412761|11844926|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
7512990|NCT02412761|11844927|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
7512991|NCT02412852|11844939|FG000|Overall Study|Withdrawal by Subject|0
7512992|NCT02412852|11844940|FG001|Overall Study|Withdrawal by Subject|1
7512993|NCT02412852|11844941|FG002|Overall Study|Withdrawal by Subject|0
7512994|NCT02412852|11844942|FG003|Overall Study|Withdrawal by Subject|0
7512995|NCT02412852|11844939|FG000|Overall Study|Physician Decision|0
7512996|NCT02412852|11844940|FG001|Overall Study|Physician Decision|0
7512997|NCT02412852|11844941|FG002|Overall Study|Physician Decision|0
7512998|NCT02412852|11844942|FG003|Overall Study|Physician Decision|1
7513003|NCT02413229|11845030|FG000|Overall Study|Adverse Event|0
7513004|NCT02413229|11845031|FG001|Overall Study|Adverse Event|0
7513005|NCT02413229|11845032|FG002|Overall Study|Adverse Event|0
7513006|NCT02413229|11845033|FG003|Overall Study|Adverse Event|1
7513007|NCT02413229|11845034|FG004|Overall Study|Adverse Event|0
7513008|NCT02413229|11845035|FG005|Overall Study|Adverse Event|0
7513009|NCT02413229|11845036|FG006|Overall Study|Adverse Event|0
7513010|NCT02413229|11845037|FG007|Overall Study|Adverse Event|1
7513011|NCT02413229|11845030|FG000|Overall Study|Lost to Follow-up|0
7513012|NCT02413229|11845031|FG001|Overall Study|Lost to Follow-up|0
7513013|NCT02413229|11845032|FG002|Overall Study|Lost to Follow-up|1
7513014|NCT02413229|11845033|FG003|Overall Study|Lost to Follow-up|0
7513015|NCT02413229|11845034|FG004|Overall Study|Lost to Follow-up|2
7513016|NCT02413229|11845035|FG005|Overall Study|Lost to Follow-up|0
7513017|NCT02413229|11845036|FG006|Overall Study|Lost to Follow-up|0
7513018|NCT02413229|11845037|FG007|Overall Study|Lost to Follow-up|0
7513019|NCT02413229|11845030|FG000|Overall Study|Withdrawal by Subject|1
7513020|NCT02413229|11845031|FG001|Overall Study|Withdrawal by Subject|1
7513021|NCT02413229|11845032|FG002|Overall Study|Withdrawal by Subject|0
7513022|NCT02413229|11845033|FG003|Overall Study|Withdrawal by Subject|0
7513023|NCT02413229|11845034|FG004|Overall Study|Withdrawal by Subject|1
7513024|NCT02413229|11845035|FG005|Overall Study|Withdrawal by Subject|0
7513025|NCT02413229|11845036|FG006|Overall Study|Withdrawal by Subject|0
7513026|NCT02413229|11845037|FG007|Overall Study|Withdrawal by Subject|2
7513027|NCT02413229|11845030|FG000|Overall Study|Progressive Disease|0
7513028|NCT02413229|11845031|FG001|Overall Study|Progressive Disease|0
7513029|NCT02413229|11845032|FG002|Overall Study|Progressive Disease|0
7513030|NCT02413229|11845033|FG003|Overall Study|Progressive Disease|0
7513031|NCT02413229|11845034|FG004|Overall Study|Progressive Disease|0
7513032|NCT02413229|11845035|FG005|Overall Study|Progressive Disease|0
7513033|NCT02413229|11845036|FG006|Overall Study|Progressive Disease|0
7513034|NCT02413229|11845037|FG007|Overall Study|Progressive Disease|1
7513035|NCT02413255|11845072|FG000|Overall Study|Voluntary Withdrawal|0
7513036|NCT02413255|11845073|FG001|Overall Study|Voluntary Withdrawal|0
7513037|NCT02413255|11845074|FG002|Overall Study|Voluntary Withdrawal|0
7513038|NCT02413255|11845075|FG003|Overall Study|Voluntary Withdrawal|0
7513039|NCT02413255|11845076|FG004|Overall Study|Voluntary Withdrawal|0
7513040|NCT02413255|11845077|FG005|Overall Study|Voluntary Withdrawal|0
7513041|NCT02413255|11845078|FG006|Overall Study|Voluntary Withdrawal|0
7513042|NCT02413255|11845079|FG007|Overall Study|Voluntary Withdrawal|0
7513043|NCT02413255|11845080|FG008|Overall Study|Voluntary Withdrawal|0
7513044|NCT02413255|11845081|FG009|Overall Study|Voluntary Withdrawal|0
7513045|NCT02413255|11845082|FG010|Overall Study|Voluntary Withdrawal|0
7513046|NCT02413255|11845083|FG011|Overall Study|Voluntary Withdrawal|0
7513047|NCT02413255|11845084|FG012|Overall Study|Voluntary Withdrawal|0
7513048|NCT02413255|11845085|FG013|Overall Study|Voluntary Withdrawal|0
7513049|NCT02413255|11845086|FG014|Overall Study|Voluntary Withdrawal|1
7513050|NCT02413255|11845087|FG015|Overall Study|Voluntary Withdrawal|0
7513051|NCT02413255|11845088|FG016|Overall Study|Voluntary Withdrawal|0
7513052|NCT02413294|11845139|FG000|Overall Study|Withdrawal by Subject|1
7513053|NCT02413333|11845156|FG000|Period 1|Adverse Event|1
7513054|NCT02413333|11845157|FG001|Period 1|Adverse Event|0
7513055|NCT02413333|11845156|FG000|Period 1|Reason Not Specified|0
7513056|NCT02413333|11845157|FG001|Period 1|Reason Not Specified|1
7513057|NCT02413333|11845156|FG000|Period 2|Protocol Deviation|1
7513058|NCT02413333|11845157|FG001|Period 2|Protocol Deviation|0
7536321|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Adverse Event|9
7536322|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Adverse Event|14
7536323|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Adverse Event|13
7536324|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
7536325|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
7536326|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
7536327|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
7536328|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
7536329|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
7536330|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
7536331|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
7536332|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
7536333|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Physician's decision|5
7536334|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Physician's decision|0
7536335|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Physician's decision|4
7536336|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Progressive disease|11
7536337|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Progressive disease|7
7536338|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Progressive disease|10
7536339|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
7536340|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
7536341|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
7536342|NCT02718417|11884354|FG000|Chemotherapy Phase (CP)|Other|2
7536343|NCT02718417|11884355|FG001|Chemotherapy Phase (CP)|Other|0
7536344|NCT02718417|11884356|FG002|Chemotherapy Phase (CP)|Other|1
7536345|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Adverse Event|21
7536346|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Adverse Event|26
7536347|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Adverse Event|0
7536348|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
7536349|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
7536350|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
7536351|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
7536352|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
7536353|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
7536354|NCT02718417|11884354|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
7553125|NCT03007953|11913924|FG000|Overall Study|Enrolled in Hospice|3
7513059|NCT02413346|11845165|FG000|Overall Study|Adverse Event|6
7513060|NCT02413346|11845166|FG001|Overall Study|Adverse Event|6
7513061|NCT02413346|11845165|FG000|Overall Study|Withdrawal by Subject|30
7513062|NCT02413346|11845166|FG001|Overall Study|Withdrawal by Subject|40
7513063|NCT02413346|11845165|FG000|Overall Study|Lost to Follow-up|17
7513064|NCT02413346|11845166|FG001|Overall Study|Lost to Follow-up|21
7513065|NCT02413346|11845165|FG000|Overall Study|Protocol Violation|2
7513066|NCT02413346|11845166|FG001|Overall Study|Protocol Violation|0
7513067|NCT02413346|11845165|FG000|Overall Study|Other Miscellaneous Reasons|4
7513068|NCT02413346|11845166|FG001|Overall Study|Other Miscellaneous Reasons|3
7513069|NCT02413372|11845175|FG000|Treatment|Lost to Follow-up|0
7513070|NCT02413372|11845176|FG001|Treatment|Lost to Follow-up|2
7513071|NCT02413372|11845177|FG002|Treatment|Lost to Follow-up|1
7513072|NCT02413372|11845175|FG000|Treatment|Withdrawal by Subject|1
7513073|NCT02413372|11845176|FG001|Treatment|Withdrawal by Subject|0
7513074|NCT02413372|11845177|FG002|Treatment|Withdrawal by Subject|0
7513075|NCT02413372|11845175|FG000|Follow-up|Lost to Follow-up|1
7513076|NCT02413372|11845176|FG001|Follow-up|Lost to Follow-up|1
7513077|NCT02413372|11845177|FG002|Follow-up|Lost to Follow-up|0
7513078|NCT02413372|11845175|FG000|Follow-up|Subject Withdrew Consent|1
7513079|NCT02413372|11845176|FG001|Follow-up|Subject Withdrew Consent|0
7513080|NCT02413372|11845177|FG002|Follow-up|Subject Withdrew Consent|1
7513081|NCT02413372|11845175|FG000|Follow-up|Subject unable to return for visit|0
7513082|NCT02413372|11845176|FG001|Follow-up|Subject unable to return for visit|0
7513083|NCT02413372|11845177|FG002|Follow-up|Subject unable to return for visit|1
7513084|NCT02413398|11845187|FG000|Overall Study|Lost to Follow-up|2
7513085|NCT02413398|11845188|FG001|Overall Study|Lost to Follow-up|4
7513086|NCT02413398|11845187|FG000|Overall Study|Withdrawal by Subject|1
7513087|NCT02413398|11845188|FG001|Overall Study|Withdrawal by Subject|1
7513088|NCT02413398|11845187|FG000|Overall Study|Other Eligibility criteria|1
7513089|NCT02413398|11845188|FG001|Overall Study|Other Eligibility criteria|2
7513090|NCT02413489|11845206|FG000|Overall Study|Death|11
7513091|NCT02413489|11845207|FG001|Overall Study|Death|3
7513092|NCT02413489|11845208|FG002|Overall Study|Death|4
7513093|NCT02413489|11845206|FG000|Overall Study|Withdrawal by Subject|2
7513094|NCT02413489|11845207|FG001|Overall Study|Withdrawal by Subject|0
7513095|NCT02413489|11845208|FG002|Overall Study|Withdrawal by Subject|0
7513096|NCT02413489|11845206|FG000|Overall Study|Study Terminated By Sponsor|2
7513097|NCT02413489|11845207|FG001|Overall Study|Study Terminated By Sponsor|13
7513098|NCT02413489|11845208|FG002|Overall Study|Study Terminated By Sponsor|1
7513099|NCT02413593|11845220|FG000|Overall Study|Lost to Follow-up|3
7513100|NCT02413593|11845220|FG000|Overall Study|Adverse Event|1
7513101|NCT02413996|11845241|FG000|Overall Study|not comfortable with the intervention|9
7513102|NCT02413996|11845242|FG001|Overall Study|not comfortable with the intervention|2
7513103|NCT02414828|11845275|FG000|Overall Study|Lost to Follow-up|0
7513104|NCT02414828|11845276|FG001|Overall Study|Lost to Follow-up|1
7513105|NCT02414828|11845277|FG002|Overall Study|Lost to Follow-up|1
7513106|NCT02414828|11845278|FG003|Overall Study|Lost to Follow-up|2
7513107|NCT02414841|11845291|FG000|Overall Study|Withdrawal by Subject|7
7513108|NCT02414841|11845292|FG001|Overall Study|Withdrawal by Subject|5
7513109|NCT02414841|11845291|FG000|Overall Study|Lost to Follow-up|13
7513110|NCT02414841|11845292|FG001|Overall Study|Lost to Follow-up|6
7513111|NCT02414841|11845291|FG000|Overall Study|Death|17
7513112|NCT02414841|11845292|FG001|Overall Study|Death|14
7513113|NCT02414841|11845291|FG000|Overall Study|Received a Kidney Transplant|13
7513114|NCT02414841|11845292|FG001|Overall Study|Received a Kidney Transplant|4
7513115|NCT02414841|11845291|FG000|Overall Study|Randomized But Not Treated|6
7513116|NCT02414841|11845292|FG001|Overall Study|Randomized But Not Treated|4
7513117|NCT02414854|11845304|FG000|Overall Study|Adverse Event|9
7513118|NCT02414854|11845305|FG001|Overall Study|Adverse Event|7
7513119|NCT02414854|11845306|FG002|Overall Study|Adverse Event|1
7513120|NCT02414854|11845307|FG003|Overall Study|Adverse Event|12
7513121|NCT02414854|11845304|FG000|Overall Study|Poor compliance to protocol|1
7513122|NCT02414854|11845305|FG001|Overall Study|Poor compliance to protocol|1
7513123|NCT02414854|11845306|FG002|Overall Study|Poor compliance to protocol|2
7513124|NCT02414854|11845307|FG003|Overall Study|Poor compliance to protocol|2
7513125|NCT02414854|11845304|FG000|Overall Study|Other than specified above|12
7513126|NCT02414854|11845305|FG001|Overall Study|Other than specified above|37
7513127|NCT02414854|11845306|FG002|Overall Study|Other than specified above|17
7513128|NCT02414854|11845307|FG003|Overall Study|Other than specified above|37
7513129|NCT02414932|11845319|FG000|Overall Study|Withdrawal by Subject|2
7513130|NCT02414932|11845320|FG001|Overall Study|Withdrawal by Subject|3
7513131|NCT02414932|11845319|FG000|Overall Study|Adverse Event|1
7513132|NCT02414932|11845320|FG001|Overall Study|Adverse Event|0
7513133|NCT02414958|11845329|FG000|Overall Study|Adverse Event|6
7513134|NCT02414958|11845330|FG001|Overall Study|Adverse Event|6
7513135|NCT02414958|11845331|FG002|Overall Study|Adverse Event|3
7513136|NCT02414958|11845329|FG000|Overall Study|Protocol Violation|10
7513137|NCT02414958|11845330|FG001|Overall Study|Protocol Violation|3
7513138|NCT02414958|11845331|FG002|Overall Study|Protocol Violation|1
7513139|NCT02414958|11845329|FG000|Overall Study|Lost to Follow-up|7
7513140|NCT02414958|11845330|FG001|Overall Study|Lost to Follow-up|4
7513141|NCT02414958|11845331|FG002|Overall Study|Lost to Follow-up|0
7513142|NCT02414958|11845329|FG000|Overall Study|Withdrawal by Subject|5
7513143|NCT02414958|11845330|FG001|Overall Study|Withdrawal by Subject|3
7513144|NCT02414958|11845331|FG002|Overall Study|Withdrawal by Subject|5
7513145|NCT02414958|11845329|FG000|Overall Study|Other than specified|4
7513146|NCT02414958|11845330|FG001|Overall Study|Other than specified|4
7513147|NCT02414958|11845331|FG002|Overall Study|Other than specified|5
7513148|NCT02415127|11845341|FG000|Overall Study|Adverse Event|1
7513149|NCT02415127|11845342|FG001|Overall Study|Adverse Event|0
7513150|NCT02415400|11845361|FG000|Overall Study|Adverse Event|0
7513151|NCT02415400|11845362|FG001|Overall Study|Adverse Event|1
7513152|NCT02415400|11845363|FG002|Overall Study|Adverse Event|1
7513153|NCT02415400|11845364|FG003|Overall Study|Adverse Event|2
7513154|NCT02415400|11845361|FG000|Overall Study|Participant request to stop therapy|4
7513155|NCT02415400|11845362|FG001|Overall Study|Participant request to stop therapy|3
7513156|NCT02415400|11845363|FG002|Overall Study|Participant request to stop therapy|8
7513157|NCT02415400|11845364|FG003|Overall Study|Participant request to stop therapy|6
7513158|NCT02415400|11845361|FG000|Overall Study|Participant withdrew consent|14
7513159|NCT02415400|11845362|FG001|Overall Study|Participant withdrew consent|12
7513160|NCT02415400|11845363|FG002|Overall Study|Participant withdrew consent|30
7513161|NCT02415400|11845364|FG003|Overall Study|Participant withdrew consent|21
7513162|NCT02415400|11845361|FG000|Overall Study|Death|39
7513163|NCT02415400|11845362|FG001|Overall Study|Death|41
7513164|NCT02415400|11845363|FG002|Overall Study|Death|35
7513165|NCT02415400|11845364|FG003|Overall Study|Death|42
7513166|NCT02415400|11845361|FG000|Overall Study|Lost to Follow-up|3
7513167|NCT02415400|11845362|FG001|Overall Study|Lost to Follow-up|3
7513168|NCT02415400|11845363|FG002|Overall Study|Lost to Follow-up|2
7513169|NCT02415400|11845364|FG003|Overall Study|Lost to Follow-up|5
7513170|NCT02415400|11845361|FG000|Overall Study|Poor/Non-Compliance|0
7513171|NCT02415400|11845362|FG001|Overall Study|Poor/Non-Compliance|1
7513172|NCT02415400|11845363|FG002|Overall Study|Poor/Non-Compliance|3
7513173|NCT02415400|11845364|FG003|Overall Study|Poor/Non-Compliance|4
7513174|NCT02415400|11845361|FG000|Overall Study|Participant no longer meets criteria|2
7513175|NCT02415400|11845362|FG001|Overall Study|Participant no longer meets criteria|0
7513176|NCT02415400|11845363|FG002|Overall Study|Participant no longer meets criteria|0
7513177|NCT02415400|11845364|FG003|Overall Study|Participant no longer meets criteria|1
7513178|NCT02415400|11845361|FG000|Overall Study|Participant doesn't answer phone|1
7513179|NCT02415400|11845362|FG001|Overall Study|Participant doesn't answer phone|0
7513180|NCT02415400|11845363|FG002|Overall Study|Participant doesn't answer phone|0
7513181|NCT02415400|11845364|FG003|Overall Study|Participant doesn't answer phone|0
7513182|NCT02415400|11845361|FG000|Overall Study|Participant wanted home visits|1
7513183|NCT02415400|11845362|FG001|Overall Study|Participant wanted home visits|0
7513184|NCT02415400|11845363|FG002|Overall Study|Participant wanted home visits|0
7513185|NCT02415400|11845364|FG003|Overall Study|Participant wanted home visits|0
7513186|NCT02415400|11845361|FG000|Overall Study|Randomized in error|2
7513187|NCT02415400|11845362|FG001|Overall Study|Randomized in error|0
7513188|NCT02415400|11845363|FG002|Overall Study|Randomized in error|0
7513189|NCT02415400|11845364|FG003|Overall Study|Randomized in error|0
7513190|NCT02415400|11845361|FG000|Overall Study|No study drug on site|0
7513191|NCT02415400|11845362|FG001|Overall Study|No study drug on site|1
7513192|NCT02415400|11845363|FG002|Overall Study|No study drug on site|0
7513193|NCT02415400|11845364|FG003|Overall Study|No study drug on site|0
7513194|NCT02415400|11845361|FG000|Overall Study|Stroke and stroke rehabilitation|0
7513195|NCT02415400|11845362|FG001|Overall Study|Stroke and stroke rehabilitation|0
7513196|NCT02415400|11845363|FG002|Overall Study|Stroke and stroke rehabilitation|1
7513197|NCT02415400|11845364|FG003|Overall Study|Stroke and stroke rehabilitation|0
7513198|NCT02415400|11845361|FG000|Overall Study|Coagulation values cannot be set|0
7513199|NCT02415400|11845362|FG001|Overall Study|Coagulation values cannot be set|0
7513200|NCT02415400|11845363|FG002|Overall Study|Coagulation values cannot be set|1
7513201|NCT02415400|11845364|FG003|Overall Study|Coagulation values cannot be set|0
7513202|NCT02415400|11845361|FG000|Overall Study|State regulations prevent participation|0
7513203|NCT02415400|11845362|FG001|Overall Study|State regulations prevent participation|0
7513204|NCT02415400|11845363|FG002|Overall Study|State regulations prevent participation|1
7513205|NCT02415400|11845364|FG003|Overall Study|State regulations prevent participation|0
7513206|NCT02415400|11845361|FG000|Overall Study|Poor treatment monitoring|0
7513207|NCT02415400|11845362|FG001|Overall Study|Poor treatment monitoring|0
7513208|NCT02415400|11845363|FG002|Overall Study|Poor treatment monitoring|1
7513209|NCT02415400|11845364|FG003|Overall Study|Poor treatment monitoring|0
7513210|NCT02415400|11845361|FG000|Overall Study|Participant in jail|0
7513211|NCT02415400|11845362|FG001|Overall Study|Participant in jail|0
7513212|NCT02415400|11845363|FG002|Overall Study|Participant in jail|1
7513213|NCT02415400|11845364|FG003|Overall Study|Participant in jail|0
7513214|NCT02415400|11845361|FG000|Overall Study|Investigator decision|0
7513215|NCT02415400|11845362|FG001|Overall Study|Investigator decision|0
7513216|NCT02415400|11845363|FG002|Overall Study|Investigator decision|1
7513217|NCT02415400|11845364|FG003|Overall Study|Investigator decision|1
7513218|NCT02415400|11845361|FG000|Overall Study|Site closure; participant won't transfer|0
7513219|NCT02415400|11845362|FG001|Overall Study|Site closure; participant won't transfer|0
7513220|NCT02415400|11845363|FG002|Overall Study|Site closure; participant won't transfer|0
7513221|NCT02415400|11845364|FG003|Overall Study|Site closure; participant won't transfer|1
7513222|NCT02415595|11845437|FG000|Overall Study|Administrative reason by sponsor|39
7513223|NCT02415595|11845438|FG001|Overall Study|Administrative reason by sponsor|40
7513224|NCT02415595|11845439|FG002|Overall Study|Administrative reason by sponsor|41
7513225|NCT02415595|11845440|FG003|Overall Study|Administrative reason by sponsor|39
7513226|NCT02415595|11845437|FG000|Overall Study|Adverse Event|1
7513227|NCT02415595|11845438|FG001|Overall Study|Adverse Event|3
7513228|NCT02415595|11845439|FG002|Overall Study|Adverse Event|5
7513229|NCT02415595|11845440|FG003|Overall Study|Adverse Event|10
7513230|NCT02415595|11845437|FG000|Overall Study|Lack of Efficacy|4
7513231|NCT02415595|11845438|FG001|Overall Study|Lack of Efficacy|4
7513232|NCT02415595|11845439|FG002|Overall Study|Lack of Efficacy|0
7513233|NCT02415595|11845440|FG003|Overall Study|Lack of Efficacy|0
7513234|NCT02415595|11845437|FG000|Overall Study|Lost to Follow-up|1
7513235|NCT02415595|11845438|FG001|Overall Study|Lost to Follow-up|3
7513236|NCT02415595|11845439|FG002|Overall Study|Lost to Follow-up|1
7513237|NCT02415595|11845440|FG003|Overall Study|Lost to Follow-up|1
7513238|NCT02415595|11845437|FG000|Overall Study|Poor/Non-compliance|1
7513239|NCT02415595|11845438|FG001|Overall Study|Poor/Non-compliance|0
7513240|NCT02415595|11845439|FG002|Overall Study|Poor/Non-compliance|1
7513241|NCT02415595|11845440|FG003|Overall Study|Poor/Non-compliance|0
7513242|NCT02415595|11845437|FG000|Overall Study|Reached stopping criteria|0
7513243|NCT02415595|11845438|FG001|Overall Study|Reached stopping criteria|1
7513244|NCT02415595|11845439|FG002|Overall Study|Reached stopping criteria|1
7513245|NCT02415595|11845440|FG003|Overall Study|Reached stopping criteria|0
7513246|NCT02415595|11845437|FG000|Overall Study|Withdrawal by Subject|4
7513247|NCT02415595|11845438|FG001|Overall Study|Withdrawal by Subject|0
7513248|NCT02415595|11845439|FG002|Overall Study|Withdrawal by Subject|1
7513249|NCT02415595|11845440|FG003|Overall Study|Withdrawal by Subject|3
7513250|NCT02415595|11845437|FG000|Overall Study|Other|0
7513251|NCT02415595|11845438|FG001|Overall Study|Other|1
7513252|NCT02415595|11845439|FG002|Overall Study|Other|1
7513253|NCT02415595|11845440|FG003|Overall Study|Other|0
7513254|NCT02415959|11845544|FG000|Overall Study|Adverse Event|0
7513255|NCT02415959|11845545|FG001|Overall Study|Adverse Event|1
7513256|NCT02415959|11845546|FG002|Overall Study|Adverse Event|0
7513257|NCT02415959|11845547|FG003|Overall Study|Adverse Event|0
7513258|NCT02415959|11845548|FG004|Overall Study|Adverse Event|0
7513259|NCT02415959|11845544|FG000|Overall Study|Protocol Violation|0
7513260|NCT02415959|11845545|FG001|Overall Study|Protocol Violation|0
7513261|NCT02415959|11845546|FG002|Overall Study|Protocol Violation|0
7513262|NCT02415959|11845547|FG003|Overall Study|Protocol Violation|1
7513263|NCT02415959|11845548|FG004|Overall Study|Protocol Violation|0
7513264|NCT02416180|11845577|FG000|Overall Study|Withdrawal by Subject|1
7513265|NCT02416453|11845601|FG000|Overall Study|Adverse Event|0
7513266|NCT02416453|11845602|FG001|Overall Study|Adverse Event|0
7513267|NCT02416453|11845603|FG002|Overall Study|Adverse Event|0
7513268|NCT02416453|11845604|FG003|Overall Study|Adverse Event|2
7513269|NCT02416453|11845605|FG004|Overall Study|Adverse Event|0
7513270|NCT02416453|11845606|FG005|Overall Study|Adverse Event|1
7513271|NCT02416453|11845607|FG006|Overall Study|Adverse Event|0
7513272|NCT02416453|11845608|FG007|Overall Study|Adverse Event|0
7513273|NCT02416453|11845609|FG008|Overall Study|Adverse Event|0
7513274|NCT02416453|11845610|FG009|Overall Study|Adverse Event|0
7513275|NCT02416453|11845611|FG010|Overall Study|Adverse Event|0
7513276|NCT02416453|11845601|FG000|Overall Study|Lost to Follow-up|1
7513277|NCT02416453|11845602|FG001|Overall Study|Lost to Follow-up|3
7513278|NCT02416453|11845603|FG002|Overall Study|Lost to Follow-up|0
7513279|NCT02416453|11845604|FG003|Overall Study|Lost to Follow-up|8
7513280|NCT02416453|11845605|FG004|Overall Study|Lost to Follow-up|0
7513281|NCT02416453|11845606|FG005|Overall Study|Lost to Follow-up|5
7513282|NCT02416453|11845607|FG006|Overall Study|Lost to Follow-up|1
7513283|NCT02416453|11845608|FG007|Overall Study|Lost to Follow-up|3
7513284|NCT02416453|11845609|FG008|Overall Study|Lost to Follow-up|1
7513285|NCT02416453|11845610|FG009|Overall Study|Lost to Follow-up|0
7513286|NCT02416453|11845611|FG010|Overall Study|Lost to Follow-up|0
7513287|NCT02416453|11845601|FG000|Overall Study|Physician Decision|0
7513288|NCT02416453|11845602|FG001|Overall Study|Physician Decision|0
7513289|NCT02416453|11845603|FG002|Overall Study|Physician Decision|0
7513290|NCT02416453|11845604|FG003|Overall Study|Physician Decision|0
7513291|NCT02416453|11845605|FG004|Overall Study|Physician Decision|0
7513292|NCT02416453|11845606|FG005|Overall Study|Physician Decision|1
7513293|NCT02416453|11845607|FG006|Overall Study|Physician Decision|1
7513294|NCT02416453|11845608|FG007|Overall Study|Physician Decision|1
7513295|NCT02416453|11845609|FG008|Overall Study|Physician Decision|0
7513296|NCT02416453|11845610|FG009|Overall Study|Physician Decision|0
7513297|NCT02416453|11845611|FG010|Overall Study|Physician Decision|0
7513298|NCT02416453|11845601|FG000|Overall Study|Withdrawal by Subject|2
7513299|NCT02416453|11845602|FG001|Overall Study|Withdrawal by Subject|0
7513300|NCT02416453|11845603|FG002|Overall Study|Withdrawal by Subject|0
7513301|NCT02416453|11845604|FG003|Overall Study|Withdrawal by Subject|5
7513302|NCT02416453|11845605|FG004|Overall Study|Withdrawal by Subject|1
7513303|NCT02416453|11845606|FG005|Overall Study|Withdrawal by Subject|8
7513304|NCT02416453|11845607|FG006|Overall Study|Withdrawal by Subject|0
7513305|NCT02416453|11845608|FG007|Overall Study|Withdrawal by Subject|8
7513306|NCT02416453|11845609|FG008|Overall Study|Withdrawal by Subject|4
7513307|NCT02416453|11845610|FG009|Overall Study|Withdrawal by Subject|0
7513308|NCT02416453|11845611|FG010|Overall Study|Withdrawal by Subject|0
7513309|NCT02416453|11845601|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513310|NCT02416453|11845602|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513311|NCT02416453|11845603|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
7513312|NCT02416453|11845604|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513313|NCT02416453|11845605|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513314|NCT02416453|11845606|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513315|NCT02416453|11845607|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513316|NCT02416453|11845608|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513317|NCT02416453|11845609|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513318|NCT02416453|11845610|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513319|NCT02416453|11845611|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
7513320|NCT02416453|11845601|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513321|NCT02416453|11845602|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513322|NCT02416453|11845603|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513323|NCT02416453|11845604|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513324|NCT02416453|11845605|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513325|NCT02416453|11845606|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
7513326|NCT02416453|11845607|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513327|NCT02416453|11845608|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513328|NCT02416453|11845609|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513329|NCT02416453|11845610|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513330|NCT02416453|11845611|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
7513331|NCT02416791|11845674|FG000|6 Months|Lost to Follow-up|0
7513332|NCT02416791|11845675|FG001|6 Months|Lost to Follow-up|0
7513333|NCT02416791|11845676|FG002|6 Months|Lost to Follow-up|1
7513334|NCT02416908|11845687|FG000|Dose Escalation Phase|Adverse Event|0
7513335|NCT02416908|11845688|FG001|Dose Escalation Phase|Adverse Event|0
7513336|NCT02416908|11845689|FG002|Dose Escalation Phase|Adverse Event|3
7513337|NCT02416908|11845690|FG003|Dose Escalation Phase|Adverse Event|0
7513338|NCT02416908|11845687|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7513339|NCT02416908|11845688|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7513340|NCT02416908|11845689|FG002|Dose Escalation Phase|Withdrawal by Subject|1
7513341|NCT02416908|11845690|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7513342|NCT02416934|11845699|FG000|Overall Study|given steroids|1
7513343|NCT02416934|11845700|FG001|Overall Study|given steroids|2
7513344|NCT02416934|11845699|FG000|Overall Study|Lost to Follow-up|0
7513345|NCT02416934|11845700|FG001|Overall Study|Lost to Follow-up|2
7513346|NCT02416934|11845699|FG000|Overall Study|Withdrawal by Subject|1
7513347|NCT02416934|11845700|FG001|Overall Study|Withdrawal by Subject|0
7513348|NCT02416934|11845699|FG000|Overall Study|recruited during continuing renewal proc|0
7513349|NCT02416934|11845700|FG001|Overall Study|recruited during continuing renewal proc|1
7513350|NCT02416934|11845699|FG000|Overall Study|Protocol Violation|0
7513351|NCT02416934|11845700|FG001|Overall Study|Protocol Violation|1
7513352|NCT02416934|11845699|FG000|Overall Study|surgery started late|0
7513353|NCT02416934|11845700|FG001|Overall Study|surgery started late|1
7513354|NCT02416934|11845699|FG000|Overall Study|re-operation|1
7513355|NCT02416934|11845700|FG001|Overall Study|re-operation|0
7513356|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
7513357|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
7513358|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7513359|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7513360|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7513361|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
7513362|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7513363|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7513364|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7513365|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
7513366|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7513367|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7513368|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7513369|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
7513370|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7513371|NCT02417064|11845728|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7513372|NCT02417064|11845729|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
7513373|NCT02417064|11845730|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
7513374|NCT02417064|11845728|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
7513375|NCT02417064|11845729|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
7513376|NCT02417064|11845730|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
7513377|NCT02417064|11845728|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
7513378|NCT02417064|11845729|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
7513379|NCT02417064|11845730|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
7513380|NCT02417064|11845728|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7513381|NCT02417064|11845729|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
7513382|NCT02417064|11845730|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
7513383|NCT02417064|11845728|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
7513384|NCT02417064|11845729|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
7513385|NCT02417064|11845730|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
7513386|NCT02417064|11845728|FG000|Follow-up Phase (24 Weeks)|Other|2
7513387|NCT02417064|11845729|FG001|Follow-up Phase (24 Weeks)|Other|2
7513388|NCT02417064|11845730|FG002|Follow-up Phase (24 Weeks)|Other|3
7513389|NCT02417233|11845751|FG000|Overall Study|Death|4
7513390|NCT02417233|11845752|FG001|Overall Study|Death|10
7513391|NCT02417233|11845753|FG002|Overall Study|Death|14
7513392|NCT02417233|11845751|FG000|Overall Study|Lost to Follow-up|27
7513393|NCT02417233|11845752|FG001|Overall Study|Lost to Follow-up|39
7513394|NCT02417233|11845753|FG002|Overall Study|Lost to Follow-up|34
7513395|NCT02417233|11845751|FG000|Overall Study|Protocol Violation|2
7513396|NCT02417233|11845752|FG001|Overall Study|Protocol Violation|0
7513397|NCT02417233|11845753|FG002|Overall Study|Protocol Violation|2
7513398|NCT02417233|11845751|FG000|Overall Study|Withdrawal by Subject|2
7513399|NCT02417233|11845752|FG001|Overall Study|Withdrawal by Subject|1
7513400|NCT02417233|11845753|FG002|Overall Study|Withdrawal by Subject|8
7513401|NCT02417233|11845751|FG000|Overall Study|Relocation out of study area|1
7513402|NCT02417233|11845752|FG001|Overall Study|Relocation out of study area|0
7513403|NCT02417233|11845753|FG002|Overall Study|Relocation out of study area|1
7513404|NCT02417233|11845751|FG000|Overall Study|Mentally unstable|0
7513405|NCT02417233|11845752|FG001|Overall Study|Mentally unstable|1
7513406|NCT02417233|11845753|FG002|Overall Study|Mentally unstable|0
7513407|NCT02417246|11845764|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7513408|NCT02417246|11845765|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
7513409|NCT02417246|11845764|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
7513410|NCT02417246|11845765|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
7513411|NCT02417246|11845764|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
7513412|NCT02417246|11845765|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
7513413|NCT02417246|11845764|FG000|Phase 2 1st Generic Administered|Physician Decision|1
7513414|NCT02417246|11845765|FG001|Phase 2 1st Generic Administered|Physician Decision|0
7513415|NCT02417441|11845784|FG000|Overall Study|Inconclusive due to missing data|52
7513416|NCT02417441|11845785|FG001|Overall Study|Inconclusive due to missing data|19
7513417|NCT02417753|11845798|FG000|Overall Study|Death|1
7513418|NCT02417935|11845818|FG000|Treatment Period|Adverse Event|12
7513419|NCT02417935|11845819|FG001|Treatment Period|Adverse Event|10
7513420|NCT02417935|11845818|FG000|Treatment Period|Lost to Follow-up|1
7513421|NCT02417935|11845819|FG001|Treatment Period|Lost to Follow-up|0
7513422|NCT02417935|11845818|FG000|Treatment Period|Entry Criteria not met|0
7513423|NCT02417935|11845819|FG001|Treatment Period|Entry Criteria not met|1
7513424|NCT02417935|11845818|FG000|Treatment Period|Protocol Violation|2
7513425|NCT02417935|11845819|FG001|Treatment Period|Protocol Violation|1
7513426|NCT02417935|11845818|FG000|Treatment Period|Withdrawal by Subject|3
7513427|NCT02417935|11845819|FG001|Treatment Period|Withdrawal by Subject|3
7513428|NCT02417935|11845818|FG000|Treatment Period|Physician Decision|3
7513429|NCT02417935|11845819|FG001|Treatment Period|Physician Decision|1
7513430|NCT02417961|11845825|FG000|Overall Study|Adverse Event|1
7513431|NCT02417961|11845825|FG000|Overall Study|Lost to Follow-up|1
7513432|NCT02417961|11845825|FG000|Overall Study|Withdrawal by Subject|2
7513433|NCT02418000|11845834|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
7513434|NCT02418000|11845835|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7513435|NCT02418000|11845836|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7513436|NCT02418000|11845837|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7513437|NCT02418000|11845838|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
7513438|NCT02418000|11845834|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
7513439|NCT02418000|11845835|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7513440|NCT02418000|11845836|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7513441|NCT02418000|11845837|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7513442|NCT02418000|11845838|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
7513443|NCT02418000|11845834|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
7513444|NCT02418000|11845835|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7513445|NCT02418000|11845836|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7513446|NCT02418000|11845837|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7513447|NCT02418000|11845838|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
7513448|NCT02418000|11845834|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7513449|NCT02418000|11845835|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
7513450|NCT02418000|11845836|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7513451|NCT02418000|11845837|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7513452|NCT02418000|11845838|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
7513453|NCT02418000|11845834|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7513454|NCT02418000|11845835|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
7513455|NCT02418000|11845836|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7513456|NCT02418000|11845837|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7513457|NCT02418000|11845838|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
7513458|NCT02418000|11845834|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513459|NCT02418000|11845835|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513460|NCT02418000|11845836|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
7513461|NCT02418000|11845837|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513462|NCT02418000|11845838|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513463|NCT02418000|11845834|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513464|NCT02418000|11845835|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513465|NCT02418000|11845836|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513466|NCT02418000|11845837|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
7513467|NCT02418000|11845838|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513468|NCT02418000|11845834|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7513469|NCT02418000|11845835|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7513470|NCT02418000|11845836|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7513471|NCT02418000|11845837|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
7513472|NCT02418000|11845838|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
7513473|NCT02418000|11845834|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513474|NCT02418000|11845835|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513475|NCT02418000|11845836|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513476|NCT02418000|11845837|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
7513477|NCT02418000|11845838|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
7513478|NCT02418156|11845871|FG000|Overall Study|Lost to Follow-up|12
7513479|NCT02418156|11845871|FG000|Overall Study|Death|2
7513480|NCT02418156|11845871|FG000|Overall Study|Physician Decision|1
7513481|NCT02418156|11845871|FG000|Overall Study|Withdrawal by Subject|1
7513482|NCT02418156|11845871|FG000|Overall Study|Subject refused to return|1
7513483|NCT02418182|11845877|FG000|Overall Study|Unable to re-consent|18
7513484|NCT02418182|11845878|FG001|Overall Study|Unable to re-consent|15
7513485|NCT02418182|11845877|FG000|Overall Study|Lost to Follow-up|0
7513486|NCT02418182|11845878|FG001|Overall Study|Lost to Follow-up|2
7513487|NCT02418455|11845901|FG000|48-Week Treatment Period|Other- Not Specified|1
7513488|NCT02418455|11845901|FG000|Continuation Period|Sponsor Decision|7
7513489|NCT02418468|11845909|FG000|Overall Study|Adverse Event|1
7513490|NCT02418468|11845910|FG001|Overall Study|Adverse Event|0
7513491|NCT02418468|11845909|FG000|Overall Study|Withdrawal of informed consent|1
7513492|NCT02418468|11845910|FG001|Overall Study|Withdrawal of informed consent|1
7513493|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7513494|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
7513495|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7513496|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
7513497|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
7513498|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
7513499|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
7513500|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
7513501|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
7513502|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
7513503|NCT02418585|11845931|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
7513504|NCT02418585|11845932|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
7513505|NCT02418585|11845931|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7513506|NCT02418585|11845932|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
7513507|NCT02418585|11845931|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
7513508|NCT02418585|11845932|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
7513509|NCT02418585|11845931|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
7513510|NCT02418585|11845932|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
7513511|NCT02418585|11845931|FG000|Follow-up Phase (24 Weeks)|Other|3
7513512|NCT02418585|11845932|FG001|Follow-up Phase (24 Weeks)|Other|2
7513513|NCT02418754|11845956|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
7513514|NCT02418754|11845957|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
7513515|NCT02418754|11845958|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
7513516|NCT02418754|11845959|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
7513517|NCT02418754|11845960|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
7513518|NCT02418754|11845956|FG000|Period 1 (Day 1 to Week 12)|Death|1
7513519|NCT02418754|11845957|FG001|Period 1 (Day 1 to Week 12)|Death|0
7513520|NCT02418754|11845958|FG002|Period 1 (Day 1 to Week 12)|Death|0
7513521|NCT02418754|11845959|FG003|Period 1 (Day 1 to Week 12)|Death|0
7513522|NCT02418754|11845960|FG004|Period 1 (Day 1 to Week 12)|Death|0
7513523|NCT02418754|11845956|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
7513524|NCT02418754|11845957|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
7513525|NCT02418754|11845958|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
7513526|NCT02418754|11845959|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
7513527|NCT02418754|11845960|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
7513528|NCT02418754|11845956|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7513529|NCT02418754|11845957|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
7513530|NCT02418754|11845958|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
7513531|NCT02418754|11845959|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7513532|NCT02418754|11845960|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
7513533|NCT02418754|11845956|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7513534|NCT02418754|11845957|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7513535|NCT02418754|11845958|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
7513536|NCT02418754|11845959|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7513537|NCT02418754|11845960|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
7513538|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
7513539|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
7513540|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
7513541|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7513542|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
7513543|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
7513544|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7513545|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7513546|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7513547|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
7513548|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7513549|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
7513550|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
7513551|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
7513552|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
7513553|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
7513554|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7513555|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
7513556|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
7513557|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
7513558|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
7513559|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7513560|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7513561|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
7513562|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
7513563|NCT02418754|11845956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7513564|NCT02418754|11845957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7513565|NCT02418754|11845958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7513566|NCT02418754|11845959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
7513567|NCT02418754|11845960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
7513568|NCT02418819|11845974|FG000|Overall Study|Adverse Event|0
7513569|NCT02418819|11845975|FG001|Overall Study|Adverse Event|0
7513570|NCT02418819|11845976|FG002|Overall Study|Adverse Event|1
7513571|NCT02418819|11845977|FG003|Overall Study|Adverse Event|0
7513572|NCT02418819|11845974|FG000|Overall Study|Lost to Follow-up|1
7513573|NCT02418819|11845975|FG001|Overall Study|Lost to Follow-up|0
7513574|NCT02418819|11845976|FG002|Overall Study|Lost to Follow-up|0
7513575|NCT02418819|11845977|FG003|Overall Study|Lost to Follow-up|0
7513576|NCT02418819|11845974|FG000|Overall Study|No longer meets eligibility criteria|0
7513577|NCT02418819|11845975|FG001|Overall Study|No longer meets eligibility criteria|0
7513578|NCT02418819|11845976|FG002|Overall Study|No longer meets eligibility criteria|1
7513579|NCT02418819|11845977|FG003|Overall Study|No longer meets eligibility criteria|0
7513580|NCT02418819|11845974|FG000|Overall Study|No longer willing to participate|0
7513581|NCT02418819|11845975|FG001|Overall Study|No longer willing to participate|0
7513582|NCT02418819|11845976|FG002|Overall Study|No longer willing to participate|2
7513583|NCT02418819|11845977|FG003|Overall Study|No longer willing to participate|1
7513584|NCT02418845|11845989|FG000|Overall Study|Lost to Follow-up|7
7513585|NCT02418845|11845990|FG001|Overall Study|Lost to Follow-up|2
7513586|NCT02418845|11845989|FG000|Overall Study|Lack of Efficacy|0
7513587|NCT02418845|11845990|FG001|Overall Study|Lack of Efficacy|3
7513588|NCT02418845|11845989|FG000|Overall Study|Physician Decision|5
7513589|NCT02418845|11845990|FG001|Overall Study|Physician Decision|5
7513590|NCT02418845|11845989|FG000|Overall Study|Protocol Violation|1
7513591|NCT02418845|11845990|FG001|Overall Study|Protocol Violation|0
7513592|NCT02418845|11845989|FG000|Overall Study|Withdrawal by Subject|3
7513593|NCT02418845|11845990|FG001|Overall Study|Withdrawal by Subject|2
7513594|NCT02418910|11845996|FG000|Overall Study|Lost to Follow-up|3
7513595|NCT02418910|11845996|FG000|Overall Study|Withdrawal by Subject|4
7513596|NCT02418949|11846004|FG000|Overall Study|Withdrawal by Subject|1
7513597|NCT02418949|11846005|FG001|Overall Study|Withdrawal by Subject|0
7513598|NCT02418949|11846006|FG002|Overall Study|Withdrawal by Subject|1
7513599|NCT02418949|11846007|FG003|Overall Study|Withdrawal by Subject|1
7513600|NCT02418949|11846004|FG000|Overall Study|Lost to Follow-up|1
7513601|NCT02418949|11846005|FG001|Overall Study|Lost to Follow-up|0
7513602|NCT02418949|11846006|FG002|Overall Study|Lost to Follow-up|1
7513603|NCT02418949|11846007|FG003|Overall Study|Lost to Follow-up|0
7513604|NCT02418949|11846004|FG000|Overall Study|Physician Decision|1
7513605|NCT02418949|11846005|FG001|Overall Study|Physician Decision|1
7513606|NCT02418949|11846006|FG002|Overall Study|Physician Decision|1
7513607|NCT02418949|11846007|FG003|Overall Study|Physician Decision|0
7513608|NCT02419001|11846019|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
7513609|NCT02419001|11846020|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
7513610|NCT02419313|11846026|FG000|First Intervention|Lost to Follow-up|2
7513611|NCT02419313|11846027|FG001|First Intervention|Lost to Follow-up|0
7513612|NCT02419313|11846026|FG000|Second Intervention|Lost to Follow-up|1
7513613|NCT02419313|11846027|FG001|Second Intervention|Lost to Follow-up|0
7513614|NCT02419469|11846033|FG000|Overall Study|Withdrawal by Subject|1
7513615|NCT02419508|11846039|FG000|Overall Study|Adverse Event|9
7513616|NCT02419508|11846040|FG001|Overall Study|Adverse Event|3
7513617|NCT02419508|11846039|FG000|Overall Study|Withdrawal by Subject|1
7513618|NCT02419508|11846040|FG001|Overall Study|Withdrawal by Subject|0
7513619|NCT02419508|11846039|FG000|Overall Study|Other - Reason not specified|0
7513620|NCT02419508|11846040|FG001|Overall Study|Other - Reason not specified|1
7513621|NCT02419573|11846056|FG000|Overall Study|Lost to Follow-up|3
7513622|NCT02419573|11846057|FG001|Overall Study|Lost to Follow-up|0
7513623|NCT02419573|11846056|FG000|Overall Study|Withdrawal by Subject|1
7513624|NCT02419573|11846057|FG001|Overall Study|Withdrawal by Subject|0
7513625|NCT02419612|11846065|FG000|Short-term Treatment Period|Adverse Event|1
7513626|NCT02419612|11846066|FG001|Short-term Treatment Period|Adverse Event|1
7513627|NCT02419612|11846065|FG000|Short-term Treatment Period|Death|0
7513628|NCT02419612|11846066|FG001|Short-term Treatment Period|Death|2
7513629|NCT02419612|11846065|FG000|Short-term Treatment Period|Lost to Follow-up|6
7513630|NCT02419612|11846066|FG001|Short-term Treatment Period|Lost to Follow-up|6
7513631|NCT02419612|11846065|FG000|Short-term Treatment Period|Withdrawal by Subject|9
7513632|NCT02419612|11846066|FG001|Short-term Treatment Period|Withdrawal by Subject|9
7513633|NCT02419612|11846065|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7513634|NCT02419612|11846066|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
7513635|NCT02419612|11846065|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
7513636|NCT02419612|11846066|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
7513637|NCT02419612|11846065|FG000|Short-term Treatment Period|Worsening of liver function|0
7513638|NCT02419612|11846066|FG001|Short-term Treatment Period|Worsening of liver function|1
7513639|NCT02419612|11846065|FG000|Short-term Treatment Period|Subject moved out of state|0
7513640|NCT02419612|11846066|FG001|Short-term Treatment Period|Subject moved out of state|1
7513641|NCT02419612|11846065|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
7513642|NCT02419612|11846066|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
7513643|NCT02419612|11846065|FG000|Long-term Treatment Period|Lost to Follow-up|6
7513644|NCT02419612|11846066|FG001|Long-term Treatment Period|Lost to Follow-up|4
7513645|NCT02419612|11846065|FG000|Long-term Treatment Period|Lack of Efficacy|1
7513646|NCT02419612|11846066|FG001|Long-term Treatment Period|Lack of Efficacy|1
7513647|NCT02419612|11846065|FG000|Long-term Treatment Period|Death|0
7513648|NCT02419612|11846066|FG001|Long-term Treatment Period|Death|1
7513649|NCT02419612|11846065|FG000|Long-term Treatment Period|Adverse Event|0
7513650|NCT02419612|11846066|FG001|Long-term Treatment Period|Adverse Event|5
7513651|NCT02419612|11846065|FG000|Long-term Treatment Period|Other|4
7513652|NCT02419612|11846066|FG001|Long-term Treatment Period|Other|4
7513653|NCT02419612|11846065|FG000|Long-term Treatment Period|Subject Decision|2
7513654|NCT02419612|11846066|FG001|Long-term Treatment Period|Subject Decision|4
7513655|NCT02419612|11846065|FG000|Long-term Treatment Period|Withdrawal by Subject|8
7513656|NCT02419612|11846066|FG001|Long-term Treatment Period|Withdrawal by Subject|2
7513657|NCT02419755|11846083|FG000|Overall Study|Death|1
7513658|NCT02419755|11846084|FG001|Overall Study|Death|3
7513659|NCT02419755|11846083|FG000|Overall Study|Relapse|0
7513660|NCT02419755|11846084|FG001|Overall Study|Relapse|1
7513661|NCT02419755|11846083|FG000|Overall Study|Ineligible|1
7513662|NCT02419755|11846084|FG001|Overall Study|Ineligible|0
7513663|NCT02419755|11846083|FG000|Overall Study|Withdrawal by Subject|1
7513664|NCT02419755|11846084|FG001|Overall Study|Withdrawal by Subject|0
7513665|NCT02419937|11846096|FG000|Overall Study|Lost to Follow-up|1
7513666|NCT02419937|11846097|FG001|Overall Study|Lost to Follow-up|0
7513667|NCT02420093|11846123|FG000|Overall Study|Withdrawal by Subject|1
7513668|NCT02420093|11846124|FG001|Overall Study|Withdrawal by Subject|1
7513669|NCT02420223|11846136|FG000|Overall Study|Adverse Event|1
7513670|NCT02420223|11846137|FG001|Overall Study|Adverse Event|0
7513671|NCT02420223|11846136|FG000|Overall Study|Physician Decision|0
7513672|NCT02420223|11846137|FG001|Overall Study|Physician Decision|2
7513673|NCT02420262|11846145|FG000|Overall Study|Adverse Event|1
7513674|NCT02420262|11846146|FG001|Overall Study|Adverse Event|0
7513675|NCT02420262|11846145|FG000|Overall Study|Withdrawal by Subject|1
7513676|NCT02420262|11846146|FG001|Overall Study|Withdrawal by Subject|4
7513677|NCT02420262|11846145|FG000|Overall Study|Unclassified|0
7513678|NCT02420262|11846146|FG001|Overall Study|Unclassified|1
7513679|NCT02420327|11846152|FG000|Overall Study|Adverse Event|7
7513680|NCT02420327|11846152|FG000|Overall Study|Pregnancy|1
7513681|NCT02420327|11846152|FG000|Overall Study|Withdrawal by Subject|6
7513682|NCT02420327|11846152|FG000|Overall Study|Lost to Follow-up|1
7513683|NCT02420327|11846152|FG000|Overall Study|Protocol Violation|1
7513684|NCT02420353|11846164|FG000|Overall Study|Withdrawal by Subject|0
7513685|NCT02420353|11846165|FG001|Overall Study|Withdrawal by Subject|1
7513686|NCT02420379|11846173|FG000|Overall Study|Withdrawal by Subject|0
7513687|NCT02420379|11846174|FG001|Overall Study|Withdrawal by Subject|3
7513688|NCT02420379|11846173|FG000|Overall Study|Unable to complete due to schooling|0
7513689|NCT02420379|11846174|FG001|Overall Study|Unable to complete due to schooling|1
7513690|NCT02420379|11846173|FG000|Overall Study|Transitioned to commercial drug|1
7513691|NCT02420379|11846174|FG001|Overall Study|Transitioned to commercial drug|0
7513692|NCT02420691|11846184|FG000|Overall Study|Adverse Event|3
7513693|NCT02420691|11846184|FG000|Overall Study|Withdrawal by Subject|3
7513694|NCT02421120|11846232|FG000|Overall Study|Adverse Event|1
7553126|NCT03007953|11913925|FG001|Overall Study|Enrolled in Hospice|2
7553127|NCT03007966|11913933|FG000|Overall Study|Did not meeting inclusion/exclusion|1
7553128|NCT03007966|11913934|FG001|Overall Study|Did not meeting inclusion/exclusion|0
7553129|NCT03008070|11913944|FG000|Overall Study|Adverse Event|3
7553130|NCT03008070|11913945|FG001|Overall Study|Adverse Event|3
7553131|NCT03008070|11913946|FG002|Overall Study|Adverse Event|3
7553132|NCT03008070|11913944|FG000|Overall Study|Lost to Follow-up|1
7553133|NCT03008070|11913945|FG001|Overall Study|Lost to Follow-up|1
7553134|NCT03008070|11913946|FG002|Overall Study|Lost to Follow-up|0
7553135|NCT03008070|11913944|FG000|Overall Study|Non compliance|0
7553136|NCT03008070|11913945|FG001|Overall Study|Non compliance|1
7553137|NCT03008070|11913946|FG002|Overall Study|Non compliance|1
7553138|NCT03008070|11913944|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
7553139|NCT03008070|11913945|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
7553140|NCT03008070|11913946|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
7553141|NCT03008070|11913944|FG000|Overall Study|Withdrawal by Subject|2
7553142|NCT03008070|11913945|FG001|Overall Study|Withdrawal by Subject|0
7553143|NCT03008070|11913946|FG002|Overall Study|Withdrawal by Subject|1
7553144|NCT03008070|11913944|FG000|Overall Study|Use of prohibited drug|0
7553145|NCT03008070|11913945|FG001|Overall Study|Use of prohibited drug|0
7553146|NCT03008070|11913946|FG002|Overall Study|Use of prohibited drug|2
7553147|NCT03008460|11913971|FG000|Overall Study|Protocol deviation|0
7553148|NCT03008460|11913972|FG001|Overall Study|Protocol deviation|2
7553149|NCT03008460|11913971|FG000|Overall Study|Study drug not dispensed|0
7553150|NCT03008460|11913972|FG001|Overall Study|Study drug not dispensed|1
7553151|NCT03008460|11913971|FG000|Overall Study|Adverse Event|0
7553152|NCT03008460|11913972|FG001|Overall Study|Adverse Event|1
7553153|NCT03008460|11913971|FG000|Overall Study|Withdrawal by Subject|5
7536355|NCT02718417|11884355|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
7536356|NCT02718417|11884356|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
7536357|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Physician's decision|6
7536358|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Physician's decision|7
7536359|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Physician's decision|0
7536360|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Progressive disease|100
7536361|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Progressive disease|88
7536362|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Progressive disease|0
7536363|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Other|2
7536364|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Other|1
7536365|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Other|0
7536366|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
7536367|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
7536368|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
7536369|NCT02718417|11884354|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
7536370|NCT02718417|11884355|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
7536371|NCT02718417|11884356|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
7536372|NCT02718417|11884354|FG000|Observation Phase (OP)|Adverse Event|0
7536373|NCT02718417|11884355|FG001|Observation Phase (OP)|Adverse Event|0
7536374|NCT02718417|11884356|FG002|Observation Phase (OP)|Adverse Event|1
7536375|NCT02718417|11884354|FG000|Observation Phase (OP)|Death leading to discontinuation|0
7536376|NCT02718417|11884355|FG001|Observation Phase (OP)|Death leading to discontinuation|0
7536377|NCT02718417|11884356|FG002|Observation Phase (OP)|Death leading to discontinuation|2
7536378|NCT02718417|11884354|FG000|Observation Phase (OP)|Lost to Follow-up|0
7536379|NCT02718417|11884355|FG001|Observation Phase (OP)|Lost to Follow-up|0
7536380|NCT02718417|11884356|FG002|Observation Phase (OP)|Lost to Follow-up|1
7536381|NCT02718417|11884354|FG000|Observation Phase (OP)|Physician Decision|0
7536382|NCT02718417|11884355|FG001|Observation Phase (OP)|Physician Decision|0
7536383|NCT02718417|11884356|FG002|Observation Phase (OP)|Physician Decision|9
7536384|NCT02718417|11884354|FG000|Observation Phase (OP)|Progressive disease|0
7536385|NCT02718417|11884355|FG001|Observation Phase (OP)|Progressive disease|0
7536386|NCT02718417|11884356|FG002|Observation Phase (OP)|Progressive disease|92
7536387|NCT02718417|11884354|FG000|Observation Phase (OP)|Study terminated by sponsor|0
7536388|NCT02718417|11884355|FG001|Observation Phase (OP)|Study terminated by sponsor|0
7536389|NCT02718417|11884356|FG002|Observation Phase (OP)|Study terminated by sponsor|135
7536390|NCT02718417|11884354|FG000|Observation Phase (OP)|Withdrawal by Subject|0
7536391|NCT02718417|11884355|FG001|Observation Phase (OP)|Withdrawal by Subject|0
7536392|NCT02718417|11884356|FG002|Observation Phase (OP)|Withdrawal by Subject|34
7536393|NCT02718417|11884354|FG000|Observation Phase (OP)|Global deterioration of health status|0
7536394|NCT02718417|11884355|FG001|Observation Phase (OP)|Global deterioration of health status|0
7513725|NCT02421419|11846327|FG000|Overall Study|Physician Decision|0
7513726|NCT02421419|11846328|FG001|Overall Study|Physician Decision|0
7513727|NCT02421419|11846329|FG002|Overall Study|Physician Decision|1
7513728|NCT02421510|11846340|FG000|Overall Study|Other|4
7513729|NCT02421510|11846341|FG001|Overall Study|Other|2
7513730|NCT02421510|11846342|FG002|Overall Study|Other|3
7513731|NCT02421510|11846340|FG000|Overall Study|Protocol Violation|1
7513732|NCT02421510|11846341|FG001|Overall Study|Protocol Violation|2
7513733|NCT02421510|11846342|FG002|Overall Study|Protocol Violation|0
7513734|NCT02421510|11846340|FG000|Overall Study|Death|1
7513735|NCT02421510|11846341|FG001|Overall Study|Death|0
7513736|NCT02421510|11846342|FG002|Overall Study|Death|0
7513737|NCT02421510|11846340|FG000|Overall Study|Noncompliance with study drug|1
7513738|NCT02421510|11846341|FG001|Overall Study|Noncompliance with study drug|0
7513739|NCT02421510|11846342|FG002|Overall Study|Noncompliance with study drug|0
7513740|NCT02421510|11846340|FG000|Overall Study|Physician Decision|1
7513741|NCT02421510|11846341|FG001|Overall Study|Physician Decision|1
7513742|NCT02421510|11846342|FG002|Overall Study|Physician Decision|3
7513743|NCT02421510|11846340|FG000|Overall Study|Adverse Event|9
7513744|NCT02421510|11846341|FG001|Overall Study|Adverse Event|10
7513745|NCT02421510|11846342|FG002|Overall Study|Adverse Event|18
7513746|NCT02421510|11846340|FG000|Overall Study|Pregnancy|1
7513747|NCT02421510|11846341|FG001|Overall Study|Pregnancy|1
7513748|NCT02421510|11846342|FG002|Overall Study|Pregnancy|0
7513749|NCT02421510|11846340|FG000|Overall Study|Withdrawal by Subject|14
7513750|NCT02421510|11846341|FG001|Overall Study|Withdrawal by Subject|18
7513751|NCT02421510|11846342|FG002|Overall Study|Withdrawal by Subject|12
7513752|NCT02421510|11846340|FG000|Overall Study|Lost to Follow-up|1
7513753|NCT02421510|11846341|FG001|Overall Study|Lost to Follow-up|1
7513754|NCT02421510|11846342|FG002|Overall Study|Lost to Follow-up|0
7513755|NCT02421588|11846352|FG000|Overall Study|Non-treatment-related AE|8
7513756|NCT02421588|11846353|FG001|Overall Study|Non-treatment-related AE|8
7513757|NCT02421588|11846352|FG000|Overall Study|Progressive disease|152
7513758|NCT02421588|11846353|FG001|Overall Study|Progressive disease|135
7513759|NCT02421588|11846352|FG000|Overall Study|Death|11
7513760|NCT02421588|11846353|FG001|Overall Study|Death|3
7513761|NCT02421588|11846352|FG000|Overall Study|Physician Decision|8
7513762|NCT02421588|11846353|FG001|Overall Study|Physician Decision|17
7513763|NCT02421588|11846352|FG000|Overall Study|Other reason not specified|3
7513764|NCT02421588|11846353|FG001|Overall Study|Other reason not specified|1
7513765|NCT02421588|11846352|FG000|Overall Study|Symptomatic deterioration|13
7513766|NCT02421588|11846353|FG001|Overall Study|Symptomatic deterioration|19
7513767|NCT02421588|11846352|FG000|Overall Study|Treatment-related AE|10
7513768|NCT02421588|11846353|FG001|Overall Study|Treatment-related AE|14
7513769|NCT02421588|11846352|FG000|Overall Study|Withdrawal by Subject|14
7513770|NCT02421588|11846353|FG001|Overall Study|Withdrawal by Subject|16
7513771|NCT02421588|11846352|FG000|Overall Study|Not treated|2
7513772|NCT02421588|11846353|FG001|Overall Study|Not treated|8
7513773|NCT02421601|11846359|FG000|Overall Study|Adverse Event|4
7513774|NCT02421601|11846359|FG000|Overall Study|Lack of Efficacy|5
7513775|NCT02421601|11846359|FG000|Overall Study|Physician Decision|1
7513776|NCT02421601|11846359|FG000|Overall Study|Withdrawal by Subject|31
7513777|NCT02421601|11846359|FG000|Overall Study|Others|41
7513778|NCT02421666|11846365|FG000|6-month Follow-up|Lost to Follow-up|8
7513779|NCT02421666|11846366|FG001|6-month Follow-up|Lost to Follow-up|7
7513780|NCT02421666|11846365|FG000|6-month Follow-up|Withdrawal by Subject|5
7513781|NCT02421666|11846366|FG001|6-month Follow-up|Withdrawal by Subject|6
7513782|NCT02421666|11846365|FG000|12-month Follow-up|Lost to Follow-up|5
7513783|NCT02421666|11846366|FG001|12-month Follow-up|Lost to Follow-up|5
7513784|NCT02421666|11846365|FG000|12-month Follow-up|Withdrawal by Subject|6
7513785|NCT02421666|11846366|FG001|12-month Follow-up|Withdrawal by Subject|11
7513786|NCT02421887|11846383|FG000|Overall Study|Lost to Follow-up|5
7513787|NCT02421887|11846384|FG001|Overall Study|Lost to Follow-up|0
7513788|NCT02421887|11846383|FG000|Overall Study|Withdrawal by Subject|8
7513789|NCT02421887|11846384|FG001|Overall Study|Withdrawal by Subject|5
7513790|NCT02421887|11846383|FG000|Overall Study|Physician Decision|2
7513791|NCT02421887|11846384|FG001|Overall Study|Physician Decision|4
7513792|NCT02421887|11846383|FG000|Overall Study|Adverse Event|2
7513793|NCT02421887|11846384|FG001|Overall Study|Adverse Event|0
7513794|NCT02421952|11846390|FG000|Overall Study|Diary Not Returned|93
7513795|NCT02421952|11846390|FG000|Overall Study|Failed seriation task|13
7513796|NCT02421952|11846390|FG000|Overall Study|Subject uncooperative for baseline test|2
7513797|NCT02421952|11846390|FG000|Overall Study|Surgery cancelled|1
7513798|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
7513799|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
7513800|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
7513801|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
7513802|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
7513803|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
7513804|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
7513805|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
7513806|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
7513807|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
7513808|NCT02422186|11846399|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
7513809|NCT02422186|11846400|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
7513810|NCT02422186|11846399|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
7513811|NCT02422186|11846400|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
7513812|NCT02422186|11846399|FG000|Follow-up Phase (2 Weeks)|Other|3
7513813|NCT02422186|11846400|FG001|Follow-up Phase (2 Weeks)|Other|0
7513814|NCT02422264|11846410|FG000|Overall Study|Serious Adverse Event|1
7513815|NCT02422264|11846411|FG001|Overall Study|Serious Adverse Event|0
7513816|NCT02422264|11846410|FG000|Overall Study|Withdrawal by Subject|1
7513817|NCT02422264|11846411|FG001|Overall Study|Withdrawal by Subject|2
7513818|NCT02422264|11846410|FG000|Overall Study|Migrated/moved from study area|3
7513819|NCT02422264|11846411|FG001|Overall Study|Migrated/moved from study area|1
7513820|NCT02422264|11846410|FG000|Overall Study|Subject vaccinated outside of the study|0
7513821|NCT02422264|11846411|FG001|Overall Study|Subject vaccinated outside of the study|1
7513822|NCT02423109|11846463|FG000|Lens 1|Adverse Event|1
7513823|NCT02423109|11846464|FG001|Lens 1|Adverse Event|0
7513824|NCT02423291|11846491|FG000|Overall Study|Lack of Efficacy|14
7513825|NCT02423291|11846491|FG000|Overall Study|Adverse Event|1
7513826|NCT02423343|11846510|FG000|Overall Study|Withdrawal by Subject|0
7513827|NCT02423343|11846511|FG001|Overall Study|Withdrawal by Subject|1
7513828|NCT02423343|11846512|FG002|Overall Study|Withdrawal by Subject|0
7513829|NCT02423343|11846513|FG003|Overall Study|Withdrawal by Subject|0
7513830|NCT02423343|11846514|FG004|Overall Study|Withdrawal by Subject|0
7513831|NCT02423343|11846515|FG005|Overall Study|Withdrawal by Subject|0
7513832|NCT02423343|11846510|FG000|Overall Study|Progressive Disease|0
7513833|NCT02423343|11846511|FG001|Overall Study|Progressive Disease|0
7513834|NCT02423343|11846512|FG002|Overall Study|Progressive Disease|0
7513835|NCT02423343|11846513|FG003|Overall Study|Progressive Disease|0
7513836|NCT02423343|11846514|FG004|Overall Study|Progressive Disease|2
7513837|NCT02423343|11846515|FG005|Overall Study|Progressive Disease|0
7513838|NCT02423343|11846510|FG000|Overall Study|Adverse Event|0
7513839|NCT02423343|11846511|FG001|Overall Study|Adverse Event|0
7513840|NCT02423343|11846512|FG002|Overall Study|Adverse Event|0
7513841|NCT02423343|11846513|FG003|Overall Study|Adverse Event|0
7513842|NCT02423343|11846514|FG004|Overall Study|Adverse Event|2
7513843|NCT02423343|11846515|FG005|Overall Study|Adverse Event|0
7513844|NCT02423343|11846510|FG000|Overall Study|Death|0
7513845|NCT02423343|11846511|FG001|Overall Study|Death|0
7513846|NCT02423343|11846512|FG002|Overall Study|Death|0
7513847|NCT02423343|11846513|FG003|Overall Study|Death|0
7513848|NCT02423343|11846514|FG004|Overall Study|Death|1
7513849|NCT02423343|11846515|FG005|Overall Study|Death|0
7513850|NCT02423798|11846571|FG000|Overall Study|Withdrawal by Subject|3
7513851|NCT02424097|11846601|FG000|Overall Study|Lost to Follow-up|1
7513852|NCT02424097|11846602|FG001|Overall Study|Lost to Follow-up|2
7513853|NCT02424149|11846610|FG000|Overall Study|surgery cancelled|2
7513854|NCT02424149|11846611|FG001|Overall Study|surgery cancelled|0
7513855|NCT02424149|11846610|FG000|Overall Study|Withdrawal by Subject|0
7513856|NCT02424149|11846611|FG001|Overall Study|Withdrawal by Subject|1
7513857|NCT02424253|11846623|FG000|Overall Study|Other, unspecified|1
7513858|NCT02424253|11846624|FG001|Overall Study|Other, unspecified|0
7513859|NCT02424253|11846623|FG000|Overall Study|Compliance problems|1
7513860|NCT02424253|11846624|FG001|Overall Study|Compliance problems|0
7513861|NCT02424253|11846623|FG000|Overall Study|Physician Decision|2
7513862|NCT02424253|11846624|FG001|Overall Study|Physician Decision|0
7513863|NCT02424253|11846623|FG000|Overall Study|Lack of Efficacy|0
7513864|NCT02424253|11846624|FG001|Overall Study|Lack of Efficacy|7
7513865|NCT02424253|11846623|FG000|Overall Study|Adverse Event|2
7513866|NCT02424253|11846624|FG001|Overall Study|Adverse Event|0
7513867|NCT02424253|11846623|FG000|Overall Study|Consent withdrawn by subject|4
7513868|NCT02424253|11846624|FG001|Overall Study|Consent withdrawn by subject|1
7513869|NCT02424253|11846623|FG000|Overall Study|Lost to Follow-up|1
7513870|NCT02424253|11846624|FG001|Overall Study|Lost to Follow-up|1
7513871|NCT02424344|11846632|FG000|Overall Study|Lack of Efficacy|0
7513872|NCT02424344|11846633|FG001|Overall Study|Lack of Efficacy|1
7513873|NCT02424344|11846632|FG000|Overall Study|Withdrawal by Subject|2
7513874|NCT02424344|11846633|FG001|Overall Study|Withdrawal by Subject|1
7513875|NCT02424344|11846632|FG000|Overall Study|Lost to Follow-up|1
7513876|NCT02424344|11846633|FG001|Overall Study|Lost to Follow-up|0
7513877|NCT02424344|11846632|FG000|Overall Study|Adverse Event|4
7513878|NCT02424344|11846633|FG001|Overall Study|Adverse Event|8
7513879|NCT02424383|11846650|FG000|Overall Study|Withdrawal by Subject|32
7513880|NCT02424383|11846650|FG000|Overall Study|Death|170
7513881|NCT02424383|11846650|FG000|Overall Study|Sponsor's decision|3
7513882|NCT02424383|11846650|FG000|Overall Study|Investigator's decision|44
7513883|NCT02424383|11846650|FG000|Overall Study|Lost to Follow-up|81
7513884|NCT02424383|11846650|FG000|Overall Study|Other|7
7513885|NCT02424383|11846650|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
7513886|NCT02424539|11846668|FG000|Overall Study|Adverse Event|0
7513887|NCT02424539|11846669|FG001|Overall Study|Adverse Event|0
7513888|NCT02424539|11846670|FG002|Overall Study|Adverse Event|1
7513889|NCT02424539|11846668|FG000|Overall Study|Physician Decision|0
7513890|NCT02424539|11846669|FG001|Overall Study|Physician Decision|0
7513891|NCT02424539|11846670|FG002|Overall Study|Physician Decision|1
7513892|NCT02424539|11846668|FG000|Overall Study|Withdrawal by Subject|3
7513893|NCT02424539|11846669|FG001|Overall Study|Withdrawal by Subject|1
7513894|NCT02424539|11846670|FG002|Overall Study|Withdrawal by Subject|0
7513895|NCT02424539|11846668|FG000|Overall Study|Other: Reached stopping criteria|11
7513896|NCT02424539|11846669|FG001|Overall Study|Other: Reached stopping criteria|7
7513897|NCT02424539|11846670|FG002|Overall Study|Other: Reached stopping criteria|6
7513898|NCT02424578|11846680|FG000|Overall Study|Withdrawal by Subject|0
7513899|NCT02424578|11846681|FG001|Overall Study|Withdrawal by Subject|1
7513900|NCT02424591|11846689|FG000|Overall Study|Protocol Violation|2
7513901|NCT02424591|11846690|FG001|Overall Study|Protocol Violation|3
7513902|NCT02424630|11846698|FG000|Overall Study|No rotator cuff tear|1
7513903|NCT02424630|11846699|FG001|Overall Study|No rotator cuff tear|2
7513904|NCT02424630|11846698|FG000|Overall Study|Open procedure|0
7513905|NCT02424630|11846699|FG001|Overall Study|Open procedure|1
7513906|NCT02424734|11846708|FG000|Overall Study|Treatment stopped to be discharged home|2
7513907|NCT02424734|11846709|FG001|Overall Study|Treatment stopped to be discharged home|2
7513908|NCT02424734|11846710|FG002|Overall Study|Treatment stopped to be discharged home|0
7513909|NCT02425098|11846768|FG000|Overall Study|Lost to Follow-up|7
7513910|NCT02425098|11846769|FG001|Overall Study|Lost to Follow-up|7
7513911|NCT02425098|11846768|FG000|Overall Study|Withdrawal by Subject|4
7513912|NCT02425098|11846769|FG001|Overall Study|Withdrawal by Subject|8
7513913|NCT02425098|11846768|FG000|Overall Study|Pregnancy|2
7513914|NCT02425098|11846769|FG001|Overall Study|Pregnancy|0
7513915|NCT02425098|11846768|FG000|Overall Study|Reason not Specified|0
7513916|NCT02425098|11846769|FG001|Overall Study|Reason not Specified|1
7513917|NCT02425111|11846775|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
7513918|NCT02425111|11846775|FG000|Part A: Treatment Period|Lack of Efficacy|15
7513919|NCT02425111|11846775|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
7513920|NCT02425111|11846775|FG000|Part A: Treatment Period|Lost to Follow-up|2
7513921|NCT02425111|11846775|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
7513922|NCT02425111|11846775|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
7513943|NCT02426086|11846817|FG000|Overall Study|Death|33
7513944|NCT02426086|11846818|FG001|Overall Study|Death|36
7513945|NCT02426086|11846817|FG000|Overall Study|Lost to Follow-up|2
7513946|NCT02426086|11846818|FG001|Overall Study|Lost to Follow-up|0
7513947|NCT02426086|11846817|FG000|Overall Study|Study Terminated by Sponsor|5
7513948|NCT02426086|11846818|FG001|Overall Study|Study Terminated by Sponsor|14
7513949|NCT02426086|11846817|FG000|Overall Study|Withdrawal by Subject|8
7513950|NCT02426086|11846818|FG001|Overall Study|Withdrawal by Subject|9
7513951|NCT02426138|11846831|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7513952|NCT02426138|11846832|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7513953|NCT02426541|11846853|FG000|Overall Study|Protocol Violation|1
7513954|NCT02426541|11846854|FG001|Overall Study|Protocol Violation|0
7513955|NCT02426580|11846862|FG000|Overall Study|Death|2
7513956|NCT02426580|11846863|FG001|Overall Study|Death|2
7513957|NCT02426580|11846862|FG000|Overall Study|Lost to Follow-up|0
7513958|NCT02426580|11846863|FG001|Overall Study|Lost to Follow-up|9
7513959|NCT02426580|11846862|FG000|Overall Study|transfer to hemodialysis|5
7513960|NCT02426580|11846863|FG001|Overall Study|transfer to hemodialysis|5
7513961|NCT02426580|11846862|FG000|Overall Study|Kidney transplant|3
7513962|NCT02426580|11846863|FG001|Overall Study|Kidney transplant|0
7513963|NCT02426580|11846862|FG000|Overall Study|Allergic to egg white|1
7513964|NCT02426580|11846863|FG001|Overall Study|Allergic to egg white|0
7513965|NCT02426918|11846872|FG000|Overall Study|Adverse Event|2
7513966|NCT02426918|11846873|FG001|Overall Study|Adverse Event|2
7513967|NCT02426918|11846874|FG002|Overall Study|Adverse Event|0
7513968|NCT02426918|11846872|FG000|Overall Study|Physician Decision|1
7513969|NCT02426918|11846873|FG001|Overall Study|Physician Decision|1
7513970|NCT02426918|11846874|FG002|Overall Study|Physician Decision|1
7513971|NCT02426918|11846872|FG000|Overall Study|Withdrawal by Subject|5
7513972|NCT02426918|11846873|FG001|Overall Study|Withdrawal by Subject|5
7513973|NCT02426918|11846874|FG002|Overall Study|Withdrawal by Subject|4
7513974|NCT02426918|11846872|FG000|Overall Study|Other|9
7513975|NCT02426918|11846873|FG001|Overall Study|Other|11
7513976|NCT02426918|11846874|FG002|Overall Study|Other|9
7513977|NCT02427100|11846884|FG000|Overall Study|Lost to Follow-up|0
7513978|NCT02427100|11846885|FG001|Overall Study|Lost to Follow-up|2
7513979|NCT02427399|11846896|FG000|Overall Study|Protocol Violation|14
7513980|NCT02427399|11846897|FG001|Overall Study|Protocol Violation|16
7513981|NCT02427399|11846898|FG002|Overall Study|Protocol Violation|12
7513982|NCT02427399|11846899|FG003|Overall Study|Protocol Violation|18
7513983|NCT02427399|11846900|FG004|Overall Study|Protocol Violation|15
7513984|NCT02427477|11846914|FG000|Period 1|Adverse Event|1
7513985|NCT02427477|11846915|FG001|Period 1|Adverse Event|0
7513986|NCT02427607|11846921|FG000|Overall Study|Withdrawal by Subject|1
7513987|NCT02427646|11846927|FG000|Overall Study|Lack of Efficacy|2
7513988|NCT02427646|11846928|FG001|Overall Study|Lack of Efficacy|3
7513989|NCT02427646|11846927|FG000|Overall Study|Physician Decision|1
7513990|NCT02427646|11846928|FG001|Overall Study|Physician Decision|4
7513991|NCT02427646|11846927|FG000|Overall Study|Protocol Violation|3
7513992|NCT02427646|11846928|FG001|Overall Study|Protocol Violation|3
7513993|NCT02427646|11846927|FG000|Overall Study|Bothersome hand weakness|2
7513994|NCT02427646|11846928|FG001|Overall Study|Bothersome hand weakness|4
7513995|NCT02427802|11846975|FG000|Overall Study|Adverse Event|11
7513996|NCT02427802|11846976|FG001|Overall Study|Adverse Event|3
7513997|NCT02427802|11846977|FG002|Overall Study|Adverse Event|7
7513998|NCT02427802|11846975|FG000|Overall Study|Death|0
7513999|NCT02427802|11846976|FG001|Overall Study|Death|4
7514000|NCT02427802|11846977|FG002|Overall Study|Death|1
7514001|NCT02427802|11846975|FG000|Overall Study|Lost to Follow-up|13
7514002|NCT02427802|11846976|FG001|Overall Study|Lost to Follow-up|8
7514003|NCT02427802|11846977|FG002|Overall Study|Lost to Follow-up|8
7514004|NCT02427802|11846975|FG000|Overall Study|Physician Decision|4
7514005|NCT02427802|11846976|FG001|Overall Study|Physician Decision|2
7514006|NCT02427802|11846977|FG002|Overall Study|Physician Decision|4
7514007|NCT02427802|11846975|FG000|Overall Study|Withdrawal by Subject|10
7514008|NCT02427802|11846976|FG001|Overall Study|Withdrawal by Subject|5
7514009|NCT02427802|11846977|FG002|Overall Study|Withdrawal by Subject|11
7514010|NCT02427802|11846975|FG000|Overall Study|Protocol Violation|3
7514011|NCT02427802|11846976|FG001|Overall Study|Protocol Violation|1
7514012|NCT02427802|11846977|FG002|Overall Study|Protocol Violation|1
7514013|NCT02427802|11846975|FG000|Overall Study|protocol specific treatment unrelated|18
7514014|NCT02427802|11846976|FG001|Overall Study|protocol specific treatment unrelated|11
7514015|NCT02427802|11846977|FG002|Overall Study|protocol specific treatment unrelated|11
7514016|NCT02427841|11846985|FG000|Overall Study|Physician Decision|8
7514017|NCT02427984|11846992|FG000|Overall Study|Lost to Follow-up|13
7514018|NCT02427984|11846993|FG001|Overall Study|Lost to Follow-up|5
7514019|NCT02427984|11846994|FG002|Overall Study|Lost to Follow-up|18
7514020|NCT02428296|11847003|FG000|Overall Study|Adverse Event|7
7514021|NCT02428296|11847003|FG000|Overall Study|Withdrawal by Subject|2
7514022|NCT02428413|11847017|FG000|Overall Study|Device to measure WAG malfunctioned|3
7514023|NCT02428413|11847018|FG001|Overall Study|Device to measure WAG malfunctioned|5
7514024|NCT02428413|11847017|FG000|Overall Study|Protocol Violation|1
7514025|NCT02428413|11847018|FG001|Overall Study|Protocol Violation|2
7514026|NCT02428413|11847017|FG000|Overall Study|Case Cancelled|2
7514027|NCT02428413|11847018|FG001|Overall Study|Case Cancelled|0
7514028|NCT02428413|11847017|FG000|Overall Study|Missed Cases|1
7514029|NCT02428413|11847018|FG001|Overall Study|Missed Cases|2
7514030|NCT02428413|11847017|FG000|Overall Study|Nurse Refusal|1
7514031|NCT02428413|11847018|FG001|Overall Study|Nurse Refusal|0
7514032|NCT02428608|11847044|FG000|Overall Study|Pregnancy|2
7514033|NCT02428608|11847044|FG000|Overall Study|Lost to Follow-up|37
7514034|NCT02428608|11847044|FG000|Overall Study|Withdrawal by Subject|2
7514035|NCT02428608|11847044|FG000|Overall Study|scheduling conflicts|15
7514036|NCT02428608|11847044|FG000|Overall Study|moved away|10
7514037|NCT02428608|11847044|FG000|Overall Study|Death|1
7514038|NCT02428608|11847044|FG000|Overall Study|various|16
7514039|NCT02428699|11847049|FG000|Washout Period 1|Screen Failure|1
7514040|NCT02428699|11847050|FG001|Washout Period 1|Screen Failure|2
7514041|NCT02428855|11847061|FG000|Overall Study|Withdrawal by Subject|2
7514042|NCT02429258|11847092|FG000|Overall Study|Withdrawal by Subject|2
7514043|NCT02429258|11847093|FG001|Overall Study|Withdrawal by Subject|0
7514044|NCT02429258|11847092|FG000|Overall Study|Protocol Violation|0
7514045|NCT02429258|11847093|FG001|Overall Study|Protocol Violation|1
7514046|NCT02429310|11847101|FG000|Overall Study|Lost to Follow-up|1
7514047|NCT02429310|11847102|FG001|Overall Study|Lost to Follow-up|2
7514048|NCT02429310|11847101|FG000|Overall Study|Protocol Violation|1
7514049|NCT02429310|11847102|FG001|Overall Study|Protocol Violation|1
7514050|NCT02429427|11847110|FG000|Overall Study|Adverse Event|220
7514051|NCT02429427|11847111|FG001|Overall Study|Adverse Event|92
7514052|NCT02429427|11847110|FG000|Overall Study|Protocol Violation|10
7514053|NCT02429427|11847111|FG001|Overall Study|Protocol Violation|6
7514054|NCT02429427|11847110|FG000|Overall Study|Lost to Follow-up|15
7514055|NCT02429427|11847111|FG001|Overall Study|Lost to Follow-up|6
7514056|NCT02429427|11847110|FG000|Overall Study|Withdrawal by Subject|64
7514057|NCT02429427|11847111|FG001|Overall Study|Withdrawal by Subject|34
7514058|NCT02429427|11847110|FG000|Overall Study|Other|62
7514059|NCT02429427|11847111|FG001|Overall Study|Other|41
7514060|NCT02429778|11847119|FG000|Overall Study|Lost to Follow-up|2
7514061|NCT02429778|11847120|FG001|Overall Study|Lost to Follow-up|0
7514062|NCT02429778|11847119|FG000|Overall Study|Withdrawal by Subject|5
7514063|NCT02429778|11847120|FG001|Overall Study|Withdrawal by Subject|0
7514064|NCT02429856|11847128|FG000|Overall Study|Death|12
7514065|NCT02429856|11847129|FG001|Overall Study|Death|13
7514066|NCT02429856|11847128|FG000|Overall Study|Lost to Follow-up|6
7514067|NCT02429856|11847129|FG001|Overall Study|Lost to Follow-up|5
7514068|NCT02429856|11847128|FG000|Overall Study|Withdrawal by Subject|1
7514069|NCT02429856|11847129|FG001|Overall Study|Withdrawal by Subject|1
7514070|NCT02429934|11847143|FG000|Overall Study|Withdrawal by Subject|0
7514071|NCT02429934|11847144|FG001|Overall Study|Withdrawal by Subject|2
7514072|NCT02429934|11847143|FG000|Overall Study|Adverse Event|2
7514073|NCT02429934|11847144|FG001|Overall Study|Adverse Event|0
7514074|NCT02429934|11847143|FG000|Overall Study|Lost to Follow-up|1
7514075|NCT02429934|11847144|FG001|Overall Study|Lost to Follow-up|1
7514076|NCT02429934|11847143|FG000|Overall Study|Physician Decision|1
7514077|NCT02429934|11847144|FG001|Overall Study|Physician Decision|0
7514078|NCT02430311|11847167|FG000|Part A|Adverse Event|0
7514079|NCT02430311|11847168|FG001|Part A|Adverse Event|1
7514080|NCT02430311|11847167|FG000|Part A|Withdrawal by Subject|1
7514081|NCT02430311|11847168|FG001|Part A|Withdrawal by Subject|0
7514082|NCT02430311|11847167|FG000|Part B|Meet study-specific withdrawal criteria|6
7514083|NCT02430311|11847168|FG001|Part B|Meet study-specific withdrawal criteria|6
7514084|NCT02430311|11847167|FG000|Part B|Withdrawal by Subject|2
7514085|NCT02430311|11847168|FG001|Part B|Withdrawal by Subject|2
7514086|NCT02430311|11847167|FG000|Part B|Adverse Event|1
7514087|NCT02430311|11847168|FG001|Part B|Adverse Event|0
7514088|NCT02430311|11847167|FG000|Part B|Death|1
7514089|NCT02430311|11847168|FG001|Part B|Death|0
7514093|NCT02430870|11847233|FG000|Part 2|Voluntary Withdrawal|0
7514094|NCT02430870|11847234|FG001|Part 2|Voluntary Withdrawal|0
7514095|NCT02430870|11847235|FG002|Part 2|Voluntary Withdrawal|0
7514096|NCT02430870|11847236|FG003|Part 2|Voluntary Withdrawal|0
7514097|NCT02430870|11847237|FG004|Part 2|Voluntary Withdrawal|0
7514098|NCT02430870|11847238|FG005|Part 2|Voluntary Withdrawal|0
7514099|NCT02430870|11847239|FG006|Part 2|Voluntary Withdrawal|1
7514100|NCT02430870|11847240|FG007|Part 2|Voluntary Withdrawal|0
7514101|NCT02430870|11847233|FG000|Part 2|Other Reason Not Specified|0
7514102|NCT02430870|11847234|FG001|Part 2|Other Reason Not Specified|0
7514103|NCT02430870|11847235|FG002|Part 2|Other Reason Not Specified|0
7514104|NCT02430870|11847236|FG003|Part 2|Other Reason Not Specified|0
7514105|NCT02430870|11847237|FG004|Part 2|Other Reason Not Specified|0
7514106|NCT02430870|11847238|FG005|Part 2|Other Reason Not Specified|0
7514107|NCT02430870|11847239|FG006|Part 2|Other Reason Not Specified|0
7514108|NCT02430870|11847240|FG007|Part 2|Other Reason Not Specified|1
7514109|NCT02431260|11847298|FG000|Overall Study|Subject Decision|0
7514110|NCT02431260|11847299|FG001|Overall Study|Subject Decision|1
7514111|NCT02431260|11847300|FG002|Overall Study|Subject Decision|1
7514112|NCT02431260|11847301|FG003|Overall Study|Subject Decision|0
7514113|NCT02431260|11847302|FG004|Overall Study|Subject Decision|0
7514114|NCT02431260|11847303|FG005|Overall Study|Subject Decision|0
7514115|NCT02431260|11847304|FG006|Overall Study|Subject Decision|0
7514116|NCT02431260|11847305|FG007|Overall Study|Subject Decision|0
7514117|NCT02431260|11847306|FG008|Overall Study|Subject Decision|1
7514118|NCT02431260|11847307|FG009|Overall Study|Subject Decision|1
7514119|NCT02431260|11847308|FG010|Overall Study|Subject Decision|0
7514120|NCT02431260|11847309|FG011|Overall Study|Subject Decision|1
7514121|NCT02431260|11847310|FG012|Overall Study|Subject Decision|0
7514122|NCT02431260|11847311|FG013|Overall Study|Subject Decision|0
7514123|NCT02431260|11847298|FG000|Overall Study|Death|4
7514124|NCT02431260|11847299|FG001|Overall Study|Death|4
7514125|NCT02431260|11847300|FG002|Overall Study|Death|3
7514126|NCT02431260|11847301|FG003|Overall Study|Death|4
7514127|NCT02431260|11847302|FG004|Overall Study|Death|2
7514128|NCT02431260|11847303|FG005|Overall Study|Death|2
7514129|NCT02431260|11847304|FG006|Overall Study|Death|3
7514130|NCT02431260|11847305|FG007|Overall Study|Death|1
7514131|NCT02431260|11847306|FG008|Overall Study|Death|6
7514132|NCT02431260|11847307|FG009|Overall Study|Death|6
7514133|NCT02431260|11847308|FG010|Overall Study|Death|3
7514134|NCT02431260|11847309|FG011|Overall Study|Death|2
7514135|NCT02431260|11847310|FG012|Overall Study|Death|5
7514136|NCT02431260|11847311|FG013|Overall Study|Death|1
7514137|NCT02431260|11847298|FG000|Overall Study|Lost to Follow-up|0
7514138|NCT02431260|11847299|FG001|Overall Study|Lost to Follow-up|0
7514139|NCT02431260|11847300|FG002|Overall Study|Lost to Follow-up|0
7514140|NCT02431260|11847301|FG003|Overall Study|Lost to Follow-up|0
7514141|NCT02431260|11847302|FG004|Overall Study|Lost to Follow-up|0
7514142|NCT02431260|11847303|FG005|Overall Study|Lost to Follow-up|1
7514143|NCT02431260|11847304|FG006|Overall Study|Lost to Follow-up|0
7514144|NCT02431260|11847305|FG007|Overall Study|Lost to Follow-up|0
7514145|NCT02431260|11847306|FG008|Overall Study|Lost to Follow-up|0
7514146|NCT02431260|11847307|FG009|Overall Study|Lost to Follow-up|0
7514147|NCT02431260|11847308|FG010|Overall Study|Lost to Follow-up|0
7514148|NCT02431260|11847309|FG011|Overall Study|Lost to Follow-up|0
7514149|NCT02431260|11847310|FG012|Overall Study|Lost to Follow-up|0
7514150|NCT02431260|11847311|FG013|Overall Study|Lost to Follow-up|0
7514151|NCT02431260|11847298|FG000|Overall Study|Study Terminated by the Sponsor|0
7514152|NCT02431260|11847299|FG001|Overall Study|Study Terminated by the Sponsor|0
7514153|NCT02431260|11847300|FG002|Overall Study|Study Terminated by the Sponsor|2
7514154|NCT02431260|11847301|FG003|Overall Study|Study Terminated by the Sponsor|1
7514155|NCT02431260|11847302|FG004|Overall Study|Study Terminated by the Sponsor|1
7514156|NCT02431260|11847303|FG005|Overall Study|Study Terminated by the Sponsor|0
7514157|NCT02431260|11847304|FG006|Overall Study|Study Terminated by the Sponsor|1
7514158|NCT02431260|11847305|FG007|Overall Study|Study Terminated by the Sponsor|2
7514159|NCT02431260|11847306|FG008|Overall Study|Study Terminated by the Sponsor|1
7514160|NCT02431260|11847307|FG009|Overall Study|Study Terminated by the Sponsor|1
7514161|NCT02431260|11847308|FG010|Overall Study|Study Terminated by the Sponsor|1
7514162|NCT02431260|11847309|FG011|Overall Study|Study Terminated by the Sponsor|0
7514163|NCT02431260|11847310|FG012|Overall Study|Study Terminated by the Sponsor|4
7514164|NCT02431260|11847311|FG013|Overall Study|Study Terminated by the Sponsor|0
7514165|NCT02431260|11847298|FG000|Overall Study|Physician Decision|0
7514166|NCT02431260|11847299|FG001|Overall Study|Physician Decision|0
7514167|NCT02431260|11847300|FG002|Overall Study|Physician Decision|0
7514168|NCT02431260|11847301|FG003|Overall Study|Physician Decision|0
7514169|NCT02431260|11847302|FG004|Overall Study|Physician Decision|0
7514170|NCT02431260|11847303|FG005|Overall Study|Physician Decision|1
7514171|NCT02431260|11847304|FG006|Overall Study|Physician Decision|0
7514172|NCT02431260|11847305|FG007|Overall Study|Physician Decision|0
7514173|NCT02431260|11847306|FG008|Overall Study|Physician Decision|0
7514174|NCT02431260|11847307|FG009|Overall Study|Physician Decision|0
7514175|NCT02431260|11847308|FG010|Overall Study|Physician Decision|0
7514176|NCT02431260|11847309|FG011|Overall Study|Physician Decision|0
7514177|NCT02431260|11847310|FG012|Overall Study|Physician Decision|0
7514178|NCT02431260|11847311|FG013|Overall Study|Physician Decision|0
7514179|NCT02431260|11847298|FG000|Overall Study|Other Unspecified|0
7514180|NCT02431260|11847299|FG001|Overall Study|Other Unspecified|0
7514181|NCT02431260|11847300|FG002|Overall Study|Other Unspecified|0
7514182|NCT02431260|11847301|FG003|Overall Study|Other Unspecified|0
7514183|NCT02431260|11847302|FG004|Overall Study|Other Unspecified|0
7514184|NCT02431260|11847303|FG005|Overall Study|Other Unspecified|0
7514185|NCT02431260|11847304|FG006|Overall Study|Other Unspecified|0
7514186|NCT02431260|11847305|FG007|Overall Study|Other Unspecified|0
7514187|NCT02431260|11847306|FG008|Overall Study|Other Unspecified|0
7514188|NCT02431260|11847307|FG009|Overall Study|Other Unspecified|0
7514189|NCT02431260|11847308|FG010|Overall Study|Other Unspecified|0
7514190|NCT02431260|11847309|FG011|Overall Study|Other Unspecified|1
7514191|NCT02431260|11847310|FG012|Overall Study|Other Unspecified|1
7514192|NCT02431260|11847311|FG013|Overall Study|Other Unspecified|0
7514193|NCT02431364|11847376|FG000|Overall Study|Adverse Event|0
7514194|NCT02431364|11847377|FG001|Overall Study|Adverse Event|1
7514195|NCT02431364|11847378|FG002|Overall Study|Adverse Event|0
7514196|NCT02431364|11847379|FG003|Overall Study|Adverse Event|0
7514197|NCT02431364|11847380|FG004|Overall Study|Adverse Event|0
7514198|NCT02431364|11847376|FG000|Overall Study|Randomized but never treated|0
7514199|NCT02431364|11847377|FG001|Overall Study|Randomized but never treated|0
7514200|NCT02431364|11847378|FG002|Overall Study|Randomized but never treated|0
7514201|NCT02431364|11847379|FG003|Overall Study|Randomized but never treated|1
7514202|NCT02431364|11847380|FG004|Overall Study|Randomized but never treated|0
7514203|NCT02431468|11847408|FG000|Overall Study|Adverse Event|2
7514204|NCT02431468|11847409|FG001|Overall Study|Adverse Event|4
7514205|NCT02431468|11847410|FG002|Overall Study|Adverse Event|5
7514206|NCT02431468|11847408|FG000|Overall Study|Withdrawal by Subject|4
7514207|NCT02431468|11847409|FG001|Overall Study|Withdrawal by Subject|12
7514208|NCT02431468|11847410|FG002|Overall Study|Withdrawal by Subject|2
7514209|NCT02431468|11847408|FG000|Overall Study|noncompliance, investigator termination,|2
7514210|NCT02431468|11847409|FG001|Overall Study|noncompliance, investigator termination,|2
7514211|NCT02431468|11847410|FG002|Overall Study|noncompliance, investigator termination,|2
7514212|NCT02431533|11847426|FG000|Overall Study|Withdrawal by Subject|1
7514213|NCT02431533|11847427|FG001|Overall Study|Withdrawal by Subject|3
7514214|NCT02431533|11847426|FG000|Overall Study|Developed Exclusionary criteria|1
7514215|NCT02431533|11847427|FG001|Overall Study|Developed Exclusionary criteria|0
7514216|NCT02431559|11847437|FG000|Overall Study|Adverse Event|0
7514217|NCT02431559|11847438|FG001|Overall Study|Adverse Event|1
7514218|NCT02431559|11847439|FG002|Overall Study|Adverse Event|0
7514219|NCT02431559|11847440|FG003|Overall Study|Adverse Event|4
7514220|NCT02431559|11847437|FG000|Overall Study|Progressive disease|2
7514221|NCT02431559|11847438|FG001|Overall Study|Progressive disease|1
7514222|NCT02431559|11847439|FG002|Overall Study|Progressive disease|4
7514223|NCT02431559|11847440|FG003|Overall Study|Progressive disease|22
7514224|NCT02431559|11847437|FG000|Overall Study|Withdrawal by Subject|0
7514225|NCT02431559|11847438|FG001|Overall Study|Withdrawal by Subject|1
7514226|NCT02431559|11847439|FG002|Overall Study|Withdrawal by Subject|0
7514227|NCT02431559|11847440|FG003|Overall Study|Withdrawal by Subject|4
7514228|NCT02431559|11847437|FG000|Overall Study|Physician Decision|0
7514229|NCT02431559|11847438|FG001|Overall Study|Physician Decision|0
7514230|NCT02431559|11847439|FG002|Overall Study|Physician Decision|0
7514231|NCT02431559|11847440|FG003|Overall Study|Physician Decision|1
7514232|NCT02431676|11847501|FG000|Overall Study|no lab obtained|0
7514233|NCT02431676|11847502|FG001|Overall Study|no lab obtained|1
7514234|NCT02431676|11847503|FG002|Overall Study|no lab obtained|2
7514235|NCT02431793|11847529|FG000|Overall Study|Ineligible doe to not filling Rx|11
7514236|NCT02431793|11847530|FG001|Overall Study|Ineligible doe to not filling Rx|7
7514237|NCT02431793|11847531|FG002|Overall Study|Ineligible doe to not filling Rx|8
7514238|NCT02431793|11847529|FG000|Overall Study|Withdrawal by Subject|7
7514239|NCT02431793|11847530|FG001|Overall Study|Withdrawal by Subject|5
7514240|NCT02431793|11847531|FG002|Overall Study|Withdrawal by Subject|5
7514241|NCT02431793|11847529|FG000|Overall Study|Lost to Follow-up|101
7514242|NCT02431793|11847530|FG001|Overall Study|Lost to Follow-up|122
7514243|NCT02431793|11847531|FG002|Overall Study|Lost to Follow-up|104
7514244|NCT02431806|11847543|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
7514245|NCT02431806|11847544|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
7514246|NCT02431806|11847545|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
7514247|NCT02431806|11847546|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
7514248|NCT02431806|11847543|FG000|Double-blind Treatment Period|Adverse Event|4
7514249|NCT02431806|11847544|FG001|Double-blind Treatment Period|Adverse Event|7
7514250|NCT02431806|11847545|FG002|Double-blind Treatment Period|Adverse Event|11
7514251|NCT02431806|11847546|FG003|Double-blind Treatment Period|Adverse Event|7
7514252|NCT02431806|11847543|FG000|Double-blind Treatment Period|Lack of Efficacy|2
7514253|NCT02431806|11847544|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7514254|NCT02431806|11847545|FG002|Double-blind Treatment Period|Lack of Efficacy|2
7514255|NCT02431806|11847546|FG003|Double-blind Treatment Period|Lack of Efficacy|2
7514256|NCT02431806|11847543|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
7514257|NCT02431806|11847544|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
7514258|NCT02431806|11847545|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
7514259|NCT02431806|11847546|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
7514260|NCT02431806|11847543|FG000|Double-blind Treatment Period|Lost to Follow-up|7
7514261|NCT02431806|11847544|FG001|Double-blind Treatment Period|Lost to Follow-up|4
7514262|NCT02431806|11847545|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7514263|NCT02431806|11847546|FG003|Double-blind Treatment Period|Lost to Follow-up|8
7514264|NCT02431806|11847543|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
7514265|NCT02431806|11847544|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
7514266|NCT02431806|11847545|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
7514267|NCT02431806|11847546|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
7514268|NCT02431806|11847543|FG000|Double-blind Treatment Period|Reason Not Specified|0
7514269|NCT02431806|11847544|FG001|Double-blind Treatment Period|Reason Not Specified|1
7514270|NCT02431806|11847545|FG002|Double-blind Treatment Period|Reason Not Specified|5
7514271|NCT02431806|11847546|FG003|Double-blind Treatment Period|Reason Not Specified|2
7514272|NCT02432040|11847558|FG000|Overall Study|Lack of Efficacy|3
7514273|NCT02432040|11847559|FG001|Overall Study|Lack of Efficacy|0
7514274|NCT02432040|11847558|FG000|Overall Study|Lost to Follow-up|4
7514275|NCT02432040|11847559|FG001|Overall Study|Lost to Follow-up|5
7514276|NCT02432040|11847558|FG000|Overall Study|Physician Decision|1
7514277|NCT02432040|11847559|FG001|Overall Study|Physician Decision|1
7514278|NCT02432105|11847568|FG000|Overall Study|Lost to Follow-up|1
7514279|NCT02432105|11847569|FG001|Overall Study|Lost to Follow-up|1
7514280|NCT02432105|11847570|FG002|Overall Study|Lost to Follow-up|0
7514281|NCT02432105|11847568|FG000|Overall Study|Withdrawal by Subject|1
7514282|NCT02432105|11847569|FG001|Overall Study|Withdrawal by Subject|0
7514283|NCT02432105|11847570|FG002|Overall Study|Withdrawal by Subject|1
7514284|NCT02432105|11847568|FG000|Overall Study|Culture positive for yeast|0
7514285|NCT02432105|11847569|FG001|Overall Study|Culture positive for yeast|1
7514286|NCT02432105|11847570|FG002|Overall Study|Culture positive for yeast|0
7514287|NCT02432105|11847568|FG000|Overall Study|Randomized in error|0
7514288|NCT02432105|11847569|FG001|Overall Study|Randomized in error|0
7514289|NCT02432105|11847570|FG002|Overall Study|Randomized in error|2
7514290|NCT02432144|11847579|FG000|Overall Study|Participant Non-Compliance|1
7514291|NCT02432235|11847612|FG000|Overall Study|Death|1
7514292|NCT02432235|11847613|FG001|Overall Study|Death|1
7514293|NCT02432235|11847614|FG002|Overall Study|Death|2
7514294|NCT02432235|11847615|FG003|Overall Study|Death|2
7514295|NCT02432235|11847616|FG004|Overall Study|Death|1
7514296|NCT02432235|11847617|FG005|Overall Study|Death|3
7514297|NCT02432235|11847618|FG006|Overall Study|Death|11
7514298|NCT02432235|11847619|FG007|Overall Study|Death|15
7514299|NCT02432235|11847620|FG008|Overall Study|Death|15
7514300|NCT02432235|11847621|FG009|Overall Study|Death|3
7514301|NCT02432235|11847622|FG010|Overall Study|Death|1
7514302|NCT02432235|11847623|FG011|Overall Study|Death|0
7514303|NCT02432235|11847612|FG000|Overall Study|Withdrawal by Subject|0
7514304|NCT02432235|11847613|FG001|Overall Study|Withdrawal by Subject|1
7514305|NCT02432235|11847614|FG002|Overall Study|Withdrawal by Subject|0
7514306|NCT02432235|11847615|FG003|Overall Study|Withdrawal by Subject|0
7514307|NCT02432235|11847616|FG004|Overall Study|Withdrawal by Subject|0
7514308|NCT02432235|11847617|FG005|Overall Study|Withdrawal by Subject|2
7514309|NCT02432235|11847618|FG006|Overall Study|Withdrawal by Subject|5
7514310|NCT02432235|11847619|FG007|Overall Study|Withdrawal by Subject|3
7514311|NCT02432235|11847620|FG008|Overall Study|Withdrawal by Subject|1
7514312|NCT02432235|11847621|FG009|Overall Study|Withdrawal by Subject|0
7514313|NCT02432235|11847622|FG010|Overall Study|Withdrawal by Subject|0
7514314|NCT02432235|11847623|FG011|Overall Study|Withdrawal by Subject|0
7514315|NCT02432235|11847612|FG000|Overall Study|Lost to Follow-up|0
7514316|NCT02432235|11847613|FG001|Overall Study|Lost to Follow-up|0
7514317|NCT02432235|11847614|FG002|Overall Study|Lost to Follow-up|0
7514318|NCT02432235|11847615|FG003|Overall Study|Lost to Follow-up|0
7514319|NCT02432235|11847616|FG004|Overall Study|Lost to Follow-up|0
7514320|NCT02432235|11847617|FG005|Overall Study|Lost to Follow-up|1
7514321|NCT02432235|11847618|FG006|Overall Study|Lost to Follow-up|0
7514322|NCT02432235|11847619|FG007|Overall Study|Lost to Follow-up|0
7514323|NCT02432235|11847620|FG008|Overall Study|Lost to Follow-up|1
7514324|NCT02432235|11847621|FG009|Overall Study|Lost to Follow-up|0
7514325|NCT02432235|11847622|FG010|Overall Study|Lost to Follow-up|0
7514326|NCT02432235|11847623|FG011|Overall Study|Lost to Follow-up|0
7514327|NCT02432235|11847612|FG000|Overall Study|Miscellaneous|0
7514328|NCT02432235|11847613|FG001|Overall Study|Miscellaneous|0
7514329|NCT02432235|11847614|FG002|Overall Study|Miscellaneous|0
7514330|NCT02432235|11847615|FG003|Overall Study|Miscellaneous|0
7514331|NCT02432235|11847616|FG004|Overall Study|Miscellaneous|1
7514332|NCT02432235|11847617|FG005|Overall Study|Miscellaneous|6
7514333|NCT02432235|11847618|FG006|Overall Study|Miscellaneous|2
7514334|NCT02432235|11847619|FG007|Overall Study|Miscellaneous|2
7514335|NCT02432235|11847620|FG008|Overall Study|Miscellaneous|4
7514336|NCT02432235|11847621|FG009|Overall Study|Miscellaneous|0
7514337|NCT02432235|11847622|FG010|Overall Study|Miscellaneous|0
7514338|NCT02432235|11847623|FG011|Overall Study|Miscellaneous|1
7514339|NCT02432703|11847677|FG000|Overall Study|Adverse Event|1
7514340|NCT02432703|11847678|FG001|Overall Study|Adverse Event|4
7514341|NCT02432703|11847677|FG000|Overall Study|Lack of Efficacy|1
7514342|NCT02432703|11847678|FG001|Overall Study|Lack of Efficacy|0
7514343|NCT02432703|11847677|FG000|Overall Study|Lost to Follow-up|5
7514344|NCT02432703|11847678|FG001|Overall Study|Lost to Follow-up|3
7514345|NCT02432703|11847677|FG000|Overall Study|Withdrawal by Subject|9
7514346|NCT02432703|11847678|FG001|Overall Study|Withdrawal by Subject|6
7514347|NCT02432703|11847677|FG000|Overall Study|Other|6
7514348|NCT02432703|11847678|FG001|Overall Study|Other|5
7514349|NCT02433080|11847705|FG000|Overall Study|Lost to Follow-up|1
7514350|NCT02433080|11847706|FG001|Overall Study|Lost to Follow-up|2
7514351|NCT02433080|11847705|FG000|Overall Study|Withdrawal by Subject|0
7514352|NCT02433080|11847706|FG001|Overall Study|Withdrawal by Subject|2
7514353|NCT02433288|11847715|FG000|Overall Study|Severe non-compliance to protocol|13
7514354|NCT02433288|11847716|FG001|Overall Study|Severe non-compliance to protocol|7
7514355|NCT02433288|11847715|FG000|Overall Study|Eligibility criteria not fullfilled|7
7514356|NCT02433288|11847716|FG001|Overall Study|Eligibility criteria not fullfilled|3
7514357|NCT02433288|11847715|FG000|Overall Study|Withdrawal by Subject|101
7514358|NCT02433288|11847716|FG001|Overall Study|Withdrawal by Subject|99
7514359|NCT02433288|11847715|FG000|Overall Study|Lost to Follow-up|2
7514360|NCT02433288|11847716|FG001|Overall Study|Lost to Follow-up|14
7514361|NCT02433288|11847715|FG000|Overall Study|Death|0
7514362|NCT02433288|11847716|FG001|Overall Study|Death|3
7514363|NCT02433340|11847726|FG000|Overall Study|Adverse Event|0
7514364|NCT02433340|11847727|FG001|Overall Study|Adverse Event|0
7514365|NCT02433340|11847728|FG002|Overall Study|Adverse Event|1
7514366|NCT02433340|11847729|FG003|Overall Study|Adverse Event|0
7514367|NCT02433340|11847726|FG000|Overall Study|Withdrawal by Subject|1
7514368|NCT02433340|11847727|FG001|Overall Study|Withdrawal by Subject|0
7514369|NCT02433340|11847728|FG002|Overall Study|Withdrawal by Subject|1
7514370|NCT02433340|11847729|FG003|Overall Study|Withdrawal by Subject|2
7514371|NCT02433340|11847726|FG000|Overall Study|Lost to Follow-up|0
7514372|NCT02433340|11847727|FG001|Overall Study|Lost to Follow-up|1
7514373|NCT02433340|11847728|FG002|Overall Study|Lost to Follow-up|0
7514374|NCT02433340|11847729|FG003|Overall Study|Lost to Follow-up|0
7514375|NCT02433340|11847726|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
7514376|NCT02433340|11847727|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
7514377|NCT02433340|11847728|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
7514378|NCT02433340|11847729|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
7514379|NCT02433340|11847726|FG000|Overall Study|Other|0
7514380|NCT02433340|11847727|FG001|Overall Study|Other|1
7514381|NCT02433340|11847728|FG002|Overall Study|Other|0
7514382|NCT02433340|11847729|FG003|Overall Study|Other|0
7514383|NCT02433379|11847750|FG000|Overall Study|Screen Failures|55
7514384|NCT02433379|11847750|FG000|Overall Study|Death|57
7514385|NCT02433379|11847750|FG000|Overall Study|Total Withdrawals|209
7514386|NCT02433483|11847756|FG000|Overall Study|Unacceptable toxicity|1
7514387|NCT02433483|11847756|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
7514388|NCT02433678|11847787|FG000|Overall Study|Lost to Follow-up|1
7514389|NCT02433678|11847788|FG001|Overall Study|Lost to Follow-up|2
7514390|NCT02433834|11847794|FG000|Overall Study|Protocol-specified criteria|7
7514391|NCT02433834|11847794|FG000|Overall Study|Protocol Violation|3
7514392|NCT02433834|11847794|FG000|Overall Study|Lost to Follow-up|6
7514393|NCT02433834|11847794|FG000|Overall Study|Withdrawal by Subject|14
7514394|NCT02433834|11847794|FG000|Overall Study|Adverse Event|6
7514395|NCT02433834|11847794|FG000|Overall Study|Physician Decision|1
7514403|NCT02434328|11847820|FG000|Overall Study|Adverse Event|9
7514404|NCT02434328|11847821|FG001|Overall Study|Adverse Event|4
7514405|NCT02434328|11847820|FG000|Overall Study|Lack of Efficacy|0
7514406|NCT02434328|11847821|FG001|Overall Study|Lack of Efficacy|2
7514407|NCT02434328|11847820|FG000|Overall Study|Physician Decision|0
7514408|NCT02434328|11847821|FG001|Overall Study|Physician Decision|1
7514409|NCT02434328|11847820|FG000|Overall Study|Withdrawal by Subject|12
7514410|NCT02434328|11847821|FG001|Overall Study|Withdrawal by Subject|21
7514411|NCT02434328|11847820|FG000|Overall Study|Death|4
7514412|NCT02434328|11847821|FG001|Overall Study|Death|7
7514413|NCT02434328|11847820|FG000|Overall Study|Lost to Follow-up|1
7514414|NCT02434328|11847821|FG001|Overall Study|Lost to Follow-up|6
7514415|NCT02434328|11847820|FG000|Overall Study|Other|4
7514416|NCT02434328|11847821|FG001|Overall Study|Other|1
7514417|NCT02434471|11847828|FG000|Overall Study|Physician Decision|9
7514418|NCT02434770|11847853|FG000|Week 1 to Week 18|Lost to Follow-up|0
7514419|NCT02434770|11847854|FG001|Week 1 to Week 18|Lost to Follow-up|0
7514420|NCT02434770|11847855|FG002|Week 1 to Week 18|Lost to Follow-up|2
7514421|NCT02434770|11847853|FG000|Week 1 to Week 18|Withdrawal by Subject|6
7514422|NCT02434770|11847854|FG001|Week 1 to Week 18|Withdrawal by Subject|12
7514423|NCT02434770|11847855|FG002|Week 1 to Week 18|Withdrawal by Subject|5
7514424|NCT02434770|11847853|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
7514425|NCT02434770|11847854|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
7514426|NCT02434770|11847855|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
7514427|NCT02434770|11847853|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
7514428|NCT02434770|11847854|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
7514429|NCT02434770|11847855|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
7514430|NCT02434770|11847853|FG000|Week 1 to Week 18|Death|1
7514431|NCT02434770|11847854|FG001|Week 1 to Week 18|Death|0
7514432|NCT02434770|11847855|FG002|Week 1 to Week 18|Death|0
7514433|NCT02434770|11847853|FG000|Week 18 to Week|Lost to Follow-up|2
7514434|NCT02434770|11847854|FG001|Week 18 to Week|Lost to Follow-up|2
7514435|NCT02434770|11847855|FG002|Week 18 to Week|Lost to Follow-up|1
7514436|NCT02434770|11847853|FG000|Week 18 to Week|Withdrawal by Subject|0
7514437|NCT02434770|11847854|FG001|Week 18 to Week|Withdrawal by Subject|0
7514438|NCT02434770|11847855|FG002|Week 18 to Week|Withdrawal by Subject|2
7514439|NCT02434770|11847853|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
7514440|NCT02434770|11847854|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
7514441|NCT02434770|11847855|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
7514442|NCT02434939|11847867|FG000|Overall Study|Lack of Efficacy|34
7514443|NCT02434939|11847868|FG001|Overall Study|Lack of Efficacy|48
7514444|NCT02434939|11847867|FG000|Overall Study|Withdrawal by Subject|3
7514445|NCT02434939|11847868|FG001|Overall Study|Withdrawal by Subject|0
7514446|NCT02434939|11847867|FG000|Overall Study|Adverse Event|0
7514447|NCT02434939|11847868|FG001|Overall Study|Adverse Event|1
7514448|NCT02435069|11847875|FG000|Dose Response - First Intervention|Adverse Event|0
7514449|NCT02435069|11847876|FG001|Dose Response - First Intervention|Adverse Event|1
7514450|NCT02435069|11847877|FG002|Dose Response - First Intervention|Adverse Event|1
7514451|NCT02435069|11847878|FG003|Dose Response - First Intervention|Adverse Event|0
7514452|NCT02435069|11847879|FG004|Dose Response - First Intervention|Adverse Event|0
7514453|NCT02435069|11847875|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
7514454|NCT02435069|11847876|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
7514455|NCT02435069|11847877|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
7514456|NCT02435069|11847878|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
7514457|NCT02435069|11847879|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
7514458|NCT02435147|11847899|FG000|Overall Study|non-evaluable DXA scan|11
7514459|NCT02435277|11847907|FG000|Overall Study|Adverse Event|1
7514460|NCT02435277|11847908|FG001|Overall Study|Adverse Event|1
7514461|NCT02435277|11847909|FG002|Overall Study|Adverse Event|0
7514462|NCT02435277|11847910|FG003|Overall Study|Adverse Event|0
7514463|NCT02435277|11847907|FG000|Overall Study|Withdrawal by Subject|1
7514464|NCT02435277|11847908|FG001|Overall Study|Withdrawal by Subject|0
7514465|NCT02435277|11847909|FG002|Overall Study|Withdrawal by Subject|0
7514466|NCT02435277|11847910|FG003|Overall Study|Withdrawal by Subject|0
7514467|NCT02435381|11847920|FG000|Overall Study|Lost to Follow-up|2
7514468|NCT02435381|11847921|FG001|Overall Study|Lost to Follow-up|1
7514469|NCT02435680|11847949|FG000|Overall Study|Physician Decision|3
7514470|NCT02435680|11847950|FG001|Overall Study|Physician Decision|0
7514471|NCT02435680|11847951|FG002|Overall Study|Physician Decision|0
7514472|NCT02435680|11847949|FG000|Overall Study|subject / guardian decision|0
7514473|NCT02435680|11847950|FG001|Overall Study|subject / guardian decision|3
7514474|NCT02435680|11847951|FG002|Overall Study|subject / guardian decision|2
7514475|NCT02435680|11847949|FG000|Overall Study|Adverse Event|8
7514476|NCT02435680|11847950|FG001|Overall Study|Adverse Event|3
7514477|NCT02435680|11847951|FG002|Overall Study|Adverse Event|2
7514478|NCT02435680|11847949|FG000|Overall Study|progressive disease|10
7514479|NCT02435680|11847950|FG001|Overall Study|progressive disease|7
7514480|NCT02435680|11847951|FG002|Overall Study|progressive disease|11
7514481|NCT02435680|11847949|FG000|Overall Study|not treated|0
7514482|NCT02435680|11847950|FG001|Overall Study|not treated|0
7514483|NCT02435680|11847951|FG002|Overall Study|not treated|1
7514484|NCT02435836|11847972|FG000|Overall Study|Lost to Follow-up|21
7514485|NCT02435836|11847972|FG000|Overall Study|Lack of Efficacy|1
7514486|NCT02435836|11847972|FG000|Overall Study|Withdrawal by Subject|236
7514487|NCT02435836|11847972|FG000|Overall Study|Insufficient Clinical Response|26
7514488|NCT02435836|11847972|FG000|Overall Study|Adverse Event|44
7514489|NCT02435836|11847972|FG000|Overall Study|Sponsor discontinued trial|167
7514490|NCT02435836|11847972|FG000|Overall Study|Noncompliance|27
7514491|NCT02435836|11847972|FG000|Overall Study|Protocol Violation|6
7514492|NCT02435836|11847972|FG000|Overall Study|Met Withdrawal Criteria|7
7514493|NCT02435836|11847972|FG000|Overall Study|AE of Worsening Schizophrenia|96
7514494|NCT02435914|11847985|FG000|Overall Study|Ocular Adverse Event|1
7514495|NCT02435914|11847986|FG001|Overall Study|Ocular Adverse Event|0
7514496|NCT02435914|11847987|FG002|Overall Study|Ocular Adverse Event|0
7514497|NCT02435914|11847988|FG003|Overall Study|Ocular Adverse Event|0
7514498|NCT02435914|11847985|FG000|Overall Study|Withdrawal by Subject|0
7514499|NCT02435914|11847986|FG001|Overall Study|Withdrawal by Subject|1
7514500|NCT02435914|11847987|FG002|Overall Study|Withdrawal by Subject|0
7514501|NCT02435914|11847988|FG003|Overall Study|Withdrawal by Subject|0
7514502|NCT02435914|11847985|FG000|Overall Study|Other Miscellaneous Reason|0
7514503|NCT02435914|11847986|FG001|Overall Study|Other Miscellaneous Reason|0
7514504|NCT02435914|11847987|FG002|Overall Study|Other Miscellaneous Reason|1
7514505|NCT02435914|11847988|FG003|Overall Study|Other Miscellaneous Reason|0
7514506|NCT02435966|11848001|FG000|Overall Study|Withdrawal by Subject|0
7514507|NCT02435966|11848002|FG001|Overall Study|Withdrawal by Subject|1
7514508|NCT02435966|11848003|FG002|Overall Study|Withdrawal by Subject|0
7514509|NCT02435992|11848016|FG000|Overall Study|non compliance with protocol|2
7514510|NCT02435992|11848017|FG001|Overall Study|non compliance with protocol|0
7514511|NCT02435992|11848018|FG002|Overall Study|non compliance with protocol|1
7514512|NCT02435992|11848019|FG003|Overall Study|non compliance with protocol|0
7514513|NCT02435992|11848020|FG004|Overall Study|non compliance with protocol|0
7514514|NCT02435992|11848016|FG000|Overall Study|Adverse Event|11
7514515|NCT02435992|11848017|FG001|Overall Study|Adverse Event|6
7514516|NCT02435992|11848018|FG002|Overall Study|Adverse Event|12
7514517|NCT02435992|11848019|FG003|Overall Study|Adverse Event|0
7514518|NCT02435992|11848020|FG004|Overall Study|Adverse Event|0
7514519|NCT02435992|11848016|FG000|Overall Study|Lack of Efficacy|4
7514520|NCT02435992|11848017|FG001|Overall Study|Lack of Efficacy|10
7514521|NCT02435992|11848018|FG002|Overall Study|Lack of Efficacy|9
7514522|NCT02435992|11848019|FG003|Overall Study|Lack of Efficacy|0
7514523|NCT02435992|11848020|FG004|Overall Study|Lack of Efficacy|0
7514524|NCT02435992|11848016|FG000|Overall Study|Withdrawal by Subject|10
7514525|NCT02435992|11848017|FG001|Overall Study|Withdrawal by Subject|8
7514526|NCT02435992|11848018|FG002|Overall Study|Withdrawal by Subject|20
7514527|NCT02435992|11848019|FG003|Overall Study|Withdrawal by Subject|0
7514528|NCT02435992|11848020|FG004|Overall Study|Withdrawal by Subject|0
7514529|NCT02435992|11848016|FG000|Overall Study|Other Reason|1
7514530|NCT02435992|11848017|FG001|Overall Study|Other Reason|0
7514531|NCT02435992|11848018|FG002|Overall Study|Other Reason|0
7514532|NCT02435992|11848019|FG003|Overall Study|Other Reason|0
7514533|NCT02435992|11848020|FG004|Overall Study|Other Reason|0
7514534|NCT02435992|11848016|FG000|Overall Study|Physician Decision|0
7514535|NCT02435992|11848017|FG001|Overall Study|Physician Decision|0
7514536|NCT02435992|11848018|FG002|Overall Study|Physician Decision|1
7514537|NCT02435992|11848019|FG003|Overall Study|Physician Decision|0
7514538|NCT02435992|11848020|FG004|Overall Study|Physician Decision|0
7514539|NCT02436005|11848032|FG000|Second Intervention|Adverse Event|0
7514540|NCT02436005|11848033|FG001|Second Intervention|Adverse Event|1
7514541|NCT02436135|11848048|FG000|Overall Study|Progressive Disease|3
7514542|NCT02436135|11848049|FG001|Overall Study|Progressive Disease|1
7514543|NCT02436135|11848048|FG000|Overall Study|Investigator Discretion|1
7514544|NCT02436135|11848049|FG001|Overall Study|Investigator Discretion|2
7514545|NCT02436135|11848048|FG000|Overall Study|Adverse Event|1
7514546|NCT02436135|11848049|FG001|Overall Study|Adverse Event|0
7514547|NCT02436135|11848048|FG000|Overall Study|Withdrawal by Participant|1
7514548|NCT02436135|11848049|FG001|Overall Study|Withdrawal by Participant|0
7514549|NCT02436135|11848048|FG000|Overall Study|Study Terminated By Sponsor|0
7514550|NCT02436135|11848049|FG001|Overall Study|Study Terminated By Sponsor|1
7514551|NCT02436200|11848055|FG000|Overall Study|Significant outlier|1
7514552|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Adverse Event|12
7514553|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Adverse Event|3
7514554|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Adverse Event|4
7514555|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Adverse Event|2
7514556|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
7514557|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
7514558|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
7514559|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
7514560|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
7514561|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
7514562|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
7514563|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
7514564|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
7514565|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
7514566|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
7514567|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
7514568|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Protocol Violation|0
7514569|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Protocol Violation|1
7514570|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Protocol Violation|1
7514571|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Protocol Violation|0
7514572|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
7514573|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
7514574|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
7514575|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
7514576|NCT02436239|11848063|FG000|Open-Lable Treatment Period|Other Reason|1
7514577|NCT02436239|11848064|FG001|Open-Lable Treatment Period|Other Reason|1
7514578|NCT02436239|11848065|FG002|Open-Lable Treatment Period|Other Reason|0
7514579|NCT02436239|11848066|FG003|Open-Lable Treatment Period|Other Reason|0
7514580|NCT02436239|11848063|FG000|Down-Taper Period|Withdrawal by Subject|4
7514581|NCT02436239|11848064|FG001|Down-Taper Period|Withdrawal by Subject|4
7514582|NCT02436239|11848065|FG002|Down-Taper Period|Withdrawal by Subject|1
7514583|NCT02436239|11848066|FG003|Down-Taper Period|Withdrawal by Subject|2
7514584|NCT02436304|11848079|FG000|Overall Study|Lost to Follow-up|0
7514585|NCT02436304|11848080|FG001|Overall Study|Lost to Follow-up|1
7514586|NCT02436304|11848081|FG002|Overall Study|Lost to Follow-up|0
7514587|NCT02436304|11848079|FG000|Overall Study|Withdrawal by Subject|0
7514588|NCT02436304|11848080|FG001|Overall Study|Withdrawal by Subject|1
7514589|NCT02436304|11848081|FG002|Overall Study|Withdrawal by Subject|0
7514590|NCT02436304|11848079|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
7514591|NCT02436304|11848080|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
7514592|NCT02436304|11848081|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
7514593|NCT02436330|11848092|FG000|Cohort 1|Lost to Follow-up|5
7514594|NCT02436330|11848093|FG001|Cohort 1|Lost to Follow-up|2
7514595|NCT02436330|11848092|FG000|Cohort 1|Withdrawal by Subject|0
7514596|NCT02436330|11848093|FG001|Cohort 1|Withdrawal by Subject|1
7514597|NCT02436330|11848092|FG000|Cohort 2|Lost to Follow-up|2
7514598|NCT02436330|11848093|FG001|Cohort 2|Lost to Follow-up|0
7514599|NCT02436330|11848092|FG000|Cohort 2|Withdrawal by Subject|2
7514600|NCT02436330|11848093|FG001|Cohort 2|Withdrawal by Subject|3
7514601|NCT02436330|11848092|FG000|Cohort 3|Lost to Follow-up|1
7514602|NCT02436330|11848093|FG001|Cohort 3|Lost to Follow-up|0
7514603|NCT02436330|11848092|FG000|Cohort 3|Withdrawal by Subject|4
7514604|NCT02436330|11848093|FG001|Cohort 3|Withdrawal by Subject|0
7514605|NCT02436330|11848092|FG000|Cohort 4|Lost to Follow-up|1
7514606|NCT02436330|11848093|FG001|Cohort 4|Lost to Follow-up|0
7514607|NCT02436330|11848092|FG000|Cohort 4|Withdrawal by Subject|1
7514608|NCT02436330|11848093|FG001|Cohort 4|Withdrawal by Subject|0
7514609|NCT02436330|11848092|FG000|Cohort 5|Lost to Follow-up|3
7514610|NCT02436330|11848093|FG001|Cohort 5|Lost to Follow-up|2
7514611|NCT02436330|11848092|FG000|Cohort 5|Withdrawal by Subject|3
7514612|NCT02436330|11848093|FG001|Cohort 5|Withdrawal by Subject|2
7514613|NCT02436330|11848092|FG000|Cohort 6|Lost to Follow-up|2
7514614|NCT02436330|11848093|FG001|Cohort 6|Lost to Follow-up|0
7514615|NCT02436330|11848092|FG000|Cohort 6|Withdrawal by Subject|1
7514616|NCT02436330|11848093|FG001|Cohort 6|Withdrawal by Subject|1
7514617|NCT02436356|11848108|FG000|Overall Study|Excluded by MRI Screening|0
7514618|NCT02436356|11848109|FG001|Overall Study|Excluded by MRI Screening|0
7514619|NCT02436356|11848110|FG002|Overall Study|Excluded by MRI Screening|2
7514620|NCT02436356|11848108|FG000|Overall Study|Lost to Follow-up|0
7514621|NCT02436356|11848109|FG001|Overall Study|Lost to Follow-up|1
7514622|NCT02436356|11848110|FG002|Overall Study|Lost to Follow-up|0
7514623|NCT02436356|11848108|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
7514624|NCT02436356|11848109|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
7514625|NCT02436356|11848110|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
7514626|NCT02436356|11848108|FG000|Overall Study|Excluded due to other medical conditions|3
7514627|NCT02436356|11848109|FG001|Overall Study|Excluded due to other medical conditions|0
7514628|NCT02436356|11848110|FG002|Overall Study|Excluded due to other medical conditions|0
7514629|NCT02436356|11848108|FG000|Overall Study|Withdrawal by Subject|1
7514630|NCT02436356|11848109|FG001|Overall Study|Withdrawal by Subject|0
7514631|NCT02436356|11848110|FG002|Overall Study|Withdrawal by Subject|0
7514632|NCT02436408|11848123|FG000|Overall Study|Death|1
7514633|NCT02436577|11848133|FG000|Overall Study|Protocol Deviation|0
7514634|NCT02436577|11848134|FG001|Overall Study|Protocol Deviation|1
7514635|NCT02436577|11848135|FG002|Overall Study|Protocol Deviation|0
7514636|NCT02436577|11848136|FG003|Overall Study|Protocol Deviation|0
7514637|NCT02436577|11848137|FG004|Overall Study|Protocol Deviation|0
7224648|NCT00057330|11433950|FG001|Overall Study|Lost to Follow-up|617
7514638|NCT02436577|11848138|FG005|Overall Study|Protocol Deviation|0
7514639|NCT02436681|11848158|FG000|Overall Study|Lost to Follow-up|10
7514640|NCT02436681|11848158|FG000|Overall Study|Withdrawal by Subject|2
7514641|NCT02436681|11848158|FG000|Overall Study|Death|2
7514642|NCT02436759|11848164|FG000|Overall Study|Adverse Event|3
7514643|NCT02436759|11848165|FG001|Overall Study|Adverse Event|0
7514644|NCT02436759|11848164|FG000|Overall Study|Protocol Violation|1
7514645|NCT02436759|11848165|FG001|Overall Study|Protocol Violation|0
7514646|NCT02436759|11848164|FG000|Overall Study|Withdrawal by Subject|0
7514647|NCT02436759|11848165|FG001|Overall Study|Withdrawal by Subject|1
7514648|NCT02436811|11848174|FG000|Overall Study|Lost to Follow-up|2
7514649|NCT02436811|11848175|FG001|Overall Study|Lost to Follow-up|9
7514650|NCT02436811|11848176|FG002|Overall Study|Lost to Follow-up|7
7514651|NCT02436876|11848188|FG000|Overall Study|Lost to Follow-up|0
7514652|NCT02436876|11848189|FG001|Overall Study|Lost to Follow-up|1
7514653|NCT02436876|11848190|FG002|Overall Study|Lost to Follow-up|1
7514654|NCT02436876|11848191|FG003|Overall Study|Lost to Follow-up|1
7514655|NCT02436876|11848188|FG000|Overall Study|Withdrawal by Subject|1
7514656|NCT02436876|11848189|FG001|Overall Study|Withdrawal by Subject|0
7514657|NCT02436876|11848190|FG002|Overall Study|Withdrawal by Subject|0
7514658|NCT02436876|11848191|FG003|Overall Study|Withdrawal by Subject|1
7514659|NCT02436876|11848188|FG000|Overall Study|Physician Decision|0
7514660|NCT02436876|11848189|FG001|Overall Study|Physician Decision|2
7514661|NCT02436876|11848190|FG002|Overall Study|Physician Decision|1
7514662|NCT02436876|11848191|FG003|Overall Study|Physician Decision|0
7514663|NCT02436876|11848188|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
7514664|NCT02436876|11848189|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
7514665|NCT02436876|11848190|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
7514666|NCT02436876|11848191|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
7514667|NCT02436889|11848208|FG000|Overall Study|No improvement in symptoms|1
7514668|NCT02436889|11848209|FG001|Overall Study|No improvement in symptoms|0
7514669|NCT02436889|11848208|FG000|Overall Study|Does not like/could not tolerate medicat|0
7514670|NCT02436889|11848209|FG001|Overall Study|Does not like/could not tolerate medicat|1
7514671|NCT02436915|11848217|FG000|Overall Study|Withdrawal by Subject|0
7514672|NCT02436915|11848218|FG001|Overall Study|Withdrawal by Subject|1
7514673|NCT02437084|11848226|FG000|Overall Study|Withdrawal by Subject|2
7514674|NCT02437084|11848226|FG000|Overall Study|Physician Decision|1
7514675|NCT02437162|11848233|FG000|Overall Study|Protocol Violation|0
7514676|NCT02437162|11848234|FG001|Overall Study|Protocol Violation|1
7514677|NCT02437162|11848235|FG002|Overall Study|Protocol Violation|0
7514678|NCT02437162|11848233|FG000|Overall Study|Randomized but not treated|0
7514679|NCT02437162|11848234|FG001|Overall Study|Randomized but not treated|0
7514680|NCT02437162|11848235|FG002|Overall Study|Randomized but not treated|1
7514681|NCT02437162|11848233|FG000|Overall Study|Study discontinued by Sponsor|93
7514682|NCT02437162|11848234|FG001|Overall Study|Study discontinued by Sponsor|98
7514683|NCT02437162|11848235|FG002|Overall Study|Study discontinued by Sponsor|97
7514684|NCT02437162|11848233|FG000|Overall Study|Withdrawal by Subject|13
7514685|NCT02437162|11848234|FG001|Overall Study|Withdrawal by Subject|7
7514686|NCT02437162|11848235|FG002|Overall Study|Withdrawal by Subject|9
7514687|NCT02437162|11848233|FG000|Overall Study|Adverse Event|0
7514688|NCT02437162|11848234|FG001|Overall Study|Adverse Event|1
7514689|NCT02437162|11848235|FG002|Overall Study|Adverse Event|0
7514690|NCT02437162|11848233|FG000|Overall Study|Lost to Follow-up|1
7514691|NCT02437162|11848234|FG001|Overall Study|Lost to Follow-up|0
7514692|NCT02437162|11848235|FG002|Overall Study|Lost to Follow-up|1
7514693|NCT02437162|11848233|FG000|Overall Study|Death|0
7514694|NCT02437162|11848234|FG001|Overall Study|Death|1
7514695|NCT02437162|11848235|FG002|Overall Study|Death|0
7514696|NCT02437162|11848233|FG000|Overall Study|Other|0
7514697|NCT02437162|11848234|FG001|Overall Study|Other|0
7514698|NCT02437162|11848235|FG002|Overall Study|Other|1
7514699|NCT02437188|11848250|FG000|Overall Study|Randomized but did not receive surgery|4
7514700|NCT02437188|11848251|FG001|Overall Study|Randomized but did not receive surgery|8
7514701|NCT02437188|11848250|FG000|Overall Study|Adverse Event|0
7514702|NCT02437188|11848251|FG001|Overall Study|Adverse Event|1
7514703|NCT02437305|11848273|FG000|Overall Study|Lost to Follow-up|18
7514704|NCT02437305|11848274|FG001|Overall Study|Lost to Follow-up|12
7514705|NCT02437409|11848293|FG000|Overall Study|Withdrawal by Subject|3
7514706|NCT02437409|11848293|FG000|Overall Study|Screening failure|12
7514707|NCT02437513|11848307|FG000|Overall Study|Withdrawal by Subject|2
7514708|NCT02437864|11848318|FG000|Overall Study|Protocol Violation|4
7514709|NCT02437864|11848319|FG001|Overall Study|Protocol Violation|0
7514710|NCT02437890|11848330|FG000|Overall Study|Non-compliance to study drug|0
7514711|NCT02437890|11848331|FG001|Overall Study|Non-compliance to study drug|1
7514712|NCT02437890|11848332|FG002|Overall Study|Non-compliance to study drug|0
7514713|NCT02437890|11848333|FG003|Overall Study|Non-compliance to study drug|0
7514714|NCT02437890|11848334|FG004|Overall Study|Non-compliance to study drug|1
7514715|NCT02437890|11848330|FG000|Overall Study|Sponsor's decision|1
7514716|NCT02437890|11848331|FG001|Overall Study|Sponsor's decision|1
7514717|NCT02437890|11848332|FG002|Overall Study|Sponsor's decision|4
7514718|NCT02437890|11848333|FG003|Overall Study|Sponsor's decision|0
7514719|NCT02437890|11848334|FG004|Overall Study|Sponsor's decision|2
7514720|NCT02437890|11848330|FG000|Overall Study|Physician Decision|0
7514721|NCT02437890|11848331|FG001|Overall Study|Physician Decision|0
7514722|NCT02437890|11848332|FG002|Overall Study|Physician Decision|0
7514723|NCT02437890|11848333|FG003|Overall Study|Physician Decision|1
7514724|NCT02437890|11848334|FG004|Overall Study|Physician Decision|0
7514725|NCT02437890|11848330|FG000|Overall Study|Unable to attend visit(s)|1
7514726|NCT02437890|11848331|FG001|Overall Study|Unable to attend visit(s)|0
7514727|NCT02437890|11848332|FG002|Overall Study|Unable to attend visit(s)|0
7514728|NCT02437890|11848333|FG003|Overall Study|Unable to attend visit(s)|0
7514729|NCT02437890|11848334|FG004|Overall Study|Unable to attend visit(s)|0
7514730|NCT02437890|11848330|FG000|Overall Study|Lack of Efficacy|1
7514731|NCT02437890|11848331|FG001|Overall Study|Lack of Efficacy|3
7514732|NCT02437890|11848332|FG002|Overall Study|Lack of Efficacy|0
7514733|NCT02437890|11848333|FG003|Overall Study|Lack of Efficacy|3
7514734|NCT02437890|11848334|FG004|Overall Study|Lack of Efficacy|1
7514735|NCT02437890|11848330|FG000|Overall Study|Adverse Event|4
7514736|NCT02437890|11848331|FG001|Overall Study|Adverse Event|9
7514737|NCT02437890|11848332|FG002|Overall Study|Adverse Event|5
7514738|NCT02437890|11848333|FG003|Overall Study|Adverse Event|11
7514739|NCT02437890|11848334|FG004|Overall Study|Adverse Event|7
7514740|NCT02437890|11848330|FG000|Overall Study|Withdrawal by Subject|1
7514741|NCT02437890|11848331|FG001|Overall Study|Withdrawal by Subject|2
7514742|NCT02437890|11848332|FG002|Overall Study|Withdrawal by Subject|6
7514743|NCT02437890|11848333|FG003|Overall Study|Withdrawal by Subject|5
7514744|NCT02437890|11848334|FG004|Overall Study|Withdrawal by Subject|5
7514745|NCT02437890|11848330|FG000|Overall Study|Death|0
7514746|NCT02437890|11848331|FG001|Overall Study|Death|0
7514747|NCT02437890|11848332|FG002|Overall Study|Death|0
7514748|NCT02437890|11848333|FG003|Overall Study|Death|2
7514749|NCT02437890|11848334|FG004|Overall Study|Death|0
7514750|NCT02437903|11848350|FG000|Overall Study|Adverse Event|1
7514751|NCT02437903|11848350|FG000|Overall Study|Withdrawal by Subject|1
7514752|NCT02437903|11848350|FG000|Overall Study|Lost to Follow-up|3
7514753|NCT02438137|11848357|FG000|Overall Study|Lost to Follow-up|3
7514754|NCT02438137|11848358|FG001|Overall Study|Lost to Follow-up|2
7514755|NCT02438137|11848357|FG000|Overall Study|Adverse Event|1
7514756|NCT02438137|11848358|FG001|Overall Study|Adverse Event|0
7514757|NCT02438137|11848357|FG000|Overall Study|Withdrawal by Subject|4
7514758|NCT02438137|11848358|FG001|Overall Study|Withdrawal by Subject|3
7514759|NCT02438137|11848357|FG000|Overall Study|Physician Decision|0
7514760|NCT02438137|11848358|FG001|Overall Study|Physician Decision|1
7514761|NCT02438280|11848368|FG000|Overall Study|Physician Decision|1
7514762|NCT02438280|11848369|FG001|Overall Study|Physician Decision|0
7514763|NCT02438371|11848378|FG000|Overall Study|Lost to Follow-up|3
7514764|NCT02438371|11848379|FG001|Overall Study|Lost to Follow-up|2
7514765|NCT02438371|11848378|FG000|Overall Study|Withdrawal by Subject|1
7514766|NCT02438371|11848379|FG001|Overall Study|Withdrawal by Subject|1
7514767|NCT02438384|11848388|FG000|Overall Study|Lost to Follow-up|8
7514768|NCT02438384|11848389|FG001|Overall Study|Lost to Follow-up|6
7514769|NCT02438384|11848390|FG002|Overall Study|Lost to Follow-up|4
7514770|NCT02438787|11848439|FG000|Overall Study|Adverse Event|1
7514771|NCT02438787|11848440|FG001|Overall Study|Adverse Event|0
7514772|NCT02438787|11848441|FG002|Overall Study|Adverse Event|2
7514773|NCT02438787|11848439|FG000|Overall Study|Lack of Efficacy|1
7514774|NCT02438787|11848440|FG001|Overall Study|Lack of Efficacy|2
7514775|NCT02438787|11848441|FG002|Overall Study|Lack of Efficacy|0
7514776|NCT02438787|11848439|FG000|Overall Study|Lost to Follow-up|0
7514777|NCT02438787|11848440|FG001|Overall Study|Lost to Follow-up|1
7514778|NCT02438787|11848441|FG002|Overall Study|Lost to Follow-up|0
7514779|NCT02438787|11848439|FG000|Overall Study|Protocol Violation|0
7514780|NCT02438787|11848440|FG001|Overall Study|Protocol Violation|0
7514781|NCT02438787|11848441|FG002|Overall Study|Protocol Violation|1
7514782|NCT02438787|11848439|FG000|Overall Study|Withdrawal by Subject|15
7514783|NCT02438787|11848440|FG001|Overall Study|Withdrawal by Subject|7
7514784|NCT02438787|11848441|FG002|Overall Study|Withdrawal by Subject|10
7514785|NCT02438787|11848439|FG000|Overall Study|Study discontinued by sponsor|64
7514786|NCT02438787|11848440|FG001|Overall Study|Study discontinued by sponsor|72
7514787|NCT02438787|11848441|FG002|Overall Study|Study discontinued by sponsor|69
7514788|NCT02438787|11848439|FG000|Overall Study|Other|0
7514789|NCT02438787|11848440|FG001|Overall Study|Other|1
7514790|NCT02438787|11848441|FG002|Overall Study|Other|0
7514791|NCT02438787|11848439|FG000|Overall Study|Site terminated by sponsor|0
7514792|NCT02438787|11848440|FG001|Overall Study|Site terminated by sponsor|0
7514793|NCT02438787|11848441|FG002|Overall Study|Site terminated by sponsor|1
7514794|NCT02438813|11848454|FG000|Overall Study|Patient Decision|59
7514795|NCT02438813|11848454|FG000|Overall Study|Patient Lost to Follow-Up|137
7514796|NCT02438813|11848454|FG000|Overall Study|Study Ended by Sponsor|80
7514797|NCT02438813|11848454|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
7514798|NCT02438826|11848470|FG000|Double-Blind Treatment Phase|Adverse Event|1
7514799|NCT02438826|11848471|FG001|Double-Blind Treatment Phase|Adverse Event|1
7514800|NCT02438826|11848472|FG002|Double-Blind Treatment Phase|Adverse Event|0
7514801|NCT02438826|11848473|FG003|Double-Blind Treatment Phase|Adverse Event|0
7514802|NCT02438826|11848470|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
7514803|NCT02438826|11848471|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
7514804|NCT02438826|11848472|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
7514805|NCT02438826|11848473|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
7514806|NCT02438826|11848470|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
7514807|NCT02438826|11848471|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
7514808|NCT02438826|11848472|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
7514809|NCT02438826|11848473|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
7514810|NCT02438826|11848470|FG000|Double-Blind Treatment Phase|Protocol Violation|1
7514811|NCT02438826|11848471|FG001|Double-Blind Treatment Phase|Protocol Violation|2
7514812|NCT02438826|11848472|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7514813|NCT02438826|11848473|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7514814|NCT02438826|11848470|FG000|Double-Blind Treatment Phase|Screen Failure|2
7514815|NCT02438826|11848471|FG001|Double-Blind Treatment Phase|Screen Failure|0
7514816|NCT02438826|11848472|FG002|Double-Blind Treatment Phase|Screen Failure|0
7514817|NCT02438826|11848473|FG003|Double-Blind Treatment Phase|Screen Failure|0
7514818|NCT02438826|11848470|FG000|Open-Label Treatment Phase|Adverse Event|11
7514819|NCT02438826|11848471|FG001|Open-Label Treatment Phase|Adverse Event|6
7514820|NCT02438826|11848472|FG002|Open-Label Treatment Phase|Adverse Event|0
7514821|NCT02438826|11848473|FG003|Open-Label Treatment Phase|Adverse Event|0
7514822|NCT02438826|11848470|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
7514823|NCT02438826|11848471|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
7514824|NCT02438826|11848472|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
7514825|NCT02438826|11848473|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
7514826|NCT02438826|11848470|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
7514827|NCT02438826|11848471|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
7514828|NCT02438826|11848472|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
7514829|NCT02438826|11848473|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
7514830|NCT02438826|11848470|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
7514831|NCT02438826|11848471|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
7514832|NCT02438826|11848472|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
7514833|NCT02438826|11848473|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
7514834|NCT02438826|11848470|FG000|Post-Treatment Phase|Adverse Event|3
7514835|NCT02438826|11848471|FG001|Post-Treatment Phase|Adverse Event|0
7514836|NCT02438826|11848472|FG002|Post-Treatment Phase|Adverse Event|0
7514837|NCT02438826|11848473|FG003|Post-Treatment Phase|Adverse Event|0
7514838|NCT02438826|11848470|FG000|Post-Treatment Phase|Lack of Efficacy|4
7514839|NCT02438826|11848471|FG001|Post-Treatment Phase|Lack of Efficacy|0
7514840|NCT02438826|11848472|FG002|Post-Treatment Phase|Lack of Efficacy|0
7514841|NCT02438826|11848473|FG003|Post-Treatment Phase|Lack of Efficacy|0
7514842|NCT02438826|11848470|FG000|Post-Treatment Phase|Physician Decision|1
7514843|NCT02438826|11848471|FG001|Post-Treatment Phase|Physician Decision|0
7514844|NCT02438826|11848472|FG002|Post-Treatment Phase|Physician Decision|0
7514845|NCT02438826|11848473|FG003|Post-Treatment Phase|Physician Decision|0
7514846|NCT02438826|11848470|FG000|Post-Treatment Phase|Withdrawal by Subject|1
7514847|NCT02438826|11848471|FG001|Post-Treatment Phase|Withdrawal by Subject|1
7514848|NCT02438826|11848472|FG002|Post-Treatment Phase|Withdrawal by Subject|0
7514849|NCT02438826|11848473|FG003|Post-Treatment Phase|Withdrawal by Subject|0
7514850|NCT02439138|11848488|FG000|Overall Study|Adverse Event|1
7514851|NCT02439138|11848488|FG000|Overall Study|PI decision to terminate the study|2
7514852|NCT02439320|11848516|FG000|Overall Study|Adverse Event|0
7514853|NCT02439320|11848517|FG001|Overall Study|Adverse Event|2
7514854|NCT02439320|11848518|FG002|Overall Study|Adverse Event|0
7514855|NCT02439320|11848516|FG000|Overall Study|Lost to Follow-up|37
7514856|NCT02439320|11848517|FG001|Overall Study|Lost to Follow-up|34
7514857|NCT02439320|11848518|FG002|Overall Study|Lost to Follow-up|42
7514858|NCT02439320|11848516|FG000|Overall Study|Death|0
7514859|NCT02439320|11848517|FG001|Overall Study|Death|1
7514860|NCT02439320|11848518|FG002|Overall Study|Death|0
7514861|NCT02439320|11848516|FG000|Overall Study|Noncompliance with Protocol|10
7514862|NCT02439320|11848517|FG001|Overall Study|Noncompliance with Protocol|11
7514863|NCT02439320|11848518|FG002|Overall Study|Noncompliance with Protocol|7
7514864|NCT02439320|11848516|FG000|Overall Study|Pregnancy|0
7514865|NCT02439320|11848517|FG001|Overall Study|Pregnancy|1
7514866|NCT02439320|11848518|FG002|Overall Study|Pregnancy|1
7514867|NCT02439320|11848516|FG000|Overall Study|Withdrawal by Subject|12
7514868|NCT02439320|11848517|FG001|Overall Study|Withdrawal by Subject|16
7514869|NCT02439320|11848518|FG002|Overall Study|Withdrawal by Subject|14
7514870|NCT02439320|11848516|FG000|Overall Study|Physician Decision|2
7514871|NCT02439320|11848517|FG001|Overall Study|Physician Decision|1
7514872|NCT02439320|11848518|FG002|Overall Study|Physician Decision|0
7514873|NCT02439320|11848516|FG000|Overall Study|Sponsor Request|0
7514874|NCT02439320|11848517|FG001|Overall Study|Sponsor Request|2
7514875|NCT02439320|11848518|FG002|Overall Study|Sponsor Request|1
7514876|NCT02439320|11848516|FG000|Overall Study|Randomization Failure|35
7514877|NCT02439320|11848517|FG001|Overall Study|Randomization Failure|46
7514878|NCT02439320|11848518|FG002|Overall Study|Randomization Failure|34
7536395|NCT02718417|11884356|FG002|Observation Phase (OP)|Global deterioration of health status|1
7536396|NCT02718417|11884354|FG000|Observation Phase (OP)|Other|0
7536397|NCT02718417|11884355|FG001|Observation Phase (OP)|Other|0
7536398|NCT02718417|11884356|FG002|Observation Phase (OP)|Other|7
7514879|NCT02440568|11848606|FG000|Overall Study|Death|1
7514880|NCT02440568|11848607|FG001|Overall Study|Death|3
7514881|NCT02440568|11848608|FG002|Overall Study|Death|4
7514882|NCT02440568|11848609|FG003|Overall Study|Death|2
7514883|NCT02440568|11848606|FG000|Overall Study|Lack of Efficacy|2
7514884|NCT02440568|11848607|FG001|Overall Study|Lack of Efficacy|0
7514885|NCT02440568|11848608|FG002|Overall Study|Lack of Efficacy|1
7514886|NCT02440568|11848609|FG003|Overall Study|Lack of Efficacy|0
7514887|NCT02440568|11848606|FG000|Overall Study|Lost to Follow-up|1
7514888|NCT02440568|11848607|FG001|Overall Study|Lost to Follow-up|0
7514889|NCT02440568|11848608|FG002|Overall Study|Lost to Follow-up|0
7514890|NCT02440568|11848609|FG003|Overall Study|Lost to Follow-up|0
7514891|NCT02440594|11848628|FG000|Overall Study|Lost to Follow-up|34
7514892|NCT02440594|11848629|FG001|Overall Study|Lost to Follow-up|33
7514893|NCT02440594|11848630|FG002|Overall Study|Lost to Follow-up|54
7514894|NCT02440594|11848631|FG003|Overall Study|Lost to Follow-up|47
7514895|NCT02440594|11848632|FG004|Overall Study|Lost to Follow-up|5
7514896|NCT02440594|11848633|FG005|Overall Study|Lost to Follow-up|4
7514897|NCT02440594|11848634|FG006|Overall Study|Lost to Follow-up|28
7514898|NCT02440594|11848635|FG007|Overall Study|Lost to Follow-up|48
7514899|NCT02440594|11848628|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
7514900|NCT02440594|11848629|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
7514901|NCT02440594|11848630|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
7514902|NCT02440594|11848631|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
7514903|NCT02440594|11848632|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
7514904|NCT02440594|11848633|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
7514905|NCT02440594|11848634|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
7514906|NCT02440594|11848635|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
7514907|NCT02440594|11848628|FG000|Overall Study|Withdrawal by Subject|81
7514908|NCT02440594|11848629|FG001|Overall Study|Withdrawal by Subject|67
7514909|NCT02440594|11848630|FG002|Overall Study|Withdrawal by Subject|59
7514910|NCT02440594|11848631|FG003|Overall Study|Withdrawal by Subject|38
7514911|NCT02440594|11848632|FG004|Overall Study|Withdrawal by Subject|2
7514912|NCT02440594|11848633|FG005|Overall Study|Withdrawal by Subject|2
7514913|NCT02440594|11848634|FG006|Overall Study|Withdrawal by Subject|7
7514914|NCT02440594|11848635|FG007|Overall Study|Withdrawal by Subject|7
7514915|NCT02440594|11848628|FG000|Overall Study|Administratively w/drawn|3
7514916|NCT02440594|11848629|FG001|Overall Study|Administratively w/drawn|2
7514917|NCT02440594|11848630|FG002|Overall Study|Administratively w/drawn|0
7514918|NCT02440594|11848631|FG003|Overall Study|Administratively w/drawn|0
7514919|NCT02440594|11848632|FG004|Overall Study|Administratively w/drawn|0
7514920|NCT02440594|11848633|FG005|Overall Study|Administratively w/drawn|0
7514921|NCT02440594|11848634|FG006|Overall Study|Administratively w/drawn|2
7514922|NCT02440594|11848635|FG007|Overall Study|Administratively w/drawn|1
7514923|NCT02440789|11848677|FG000|Overall Study|Withdrawal by Subject|3
7514924|NCT02440789|11848677|FG000|Overall Study|Not willing to adhere to reqs|1
7514925|NCT02441114|11848685|FG000|Washout2|Withdrawal by Subject|4
7514926|NCT02441179|11848691|FG000|Overall Study|Withdrawal by Subject|1
7514927|NCT02441179|11848692|FG001|Overall Study|Withdrawal by Subject|1
7514928|NCT02441218|11848701|FG000|Overall Study|Death|503
7514929|NCT02441218|11848702|FG001|Overall Study|Death|553
7514930|NCT02441218|11848701|FG000|Overall Study|Withdrawal by Subject|73
7514931|NCT02441218|11848702|FG001|Overall Study|Withdrawal by Subject|58
7514932|NCT02441218|11848701|FG000|Overall Study|Lost to Follow-up|2
7514933|NCT02441218|11848702|FG001|Overall Study|Lost to Follow-up|1
7514934|NCT02441283|11848708|FG000|Overall Study|Withdrew consent|15
7514935|NCT02441283|11848708|FG000|Overall Study|Lost to Follow-up|42
7514936|NCT02441283|11848708|FG000|Overall Study|Death|1
7514937|NCT02441283|11848708|FG000|Overall Study|Other, not specified|32
7514938|NCT02441309|11848715|FG000|Overall Study|Disease progression|2
7514939|NCT02441309|11848716|FG001|Overall Study|Disease progression|1
7514940|NCT02441309|11848717|FG002|Overall Study|Disease progression|2
7514941|NCT02441309|11848715|FG000|Overall Study|Adverse Event|0
7514942|NCT02441309|11848716|FG001|Overall Study|Adverse Event|1
7514943|NCT02441309|11848717|FG002|Overall Study|Adverse Event|0
7514944|NCT02441309|11848715|FG000|Overall Study|Withdrawal by Subject|1
7514945|NCT02441309|11848716|FG001|Overall Study|Withdrawal by Subject|0
7514946|NCT02441309|11848717|FG002|Overall Study|Withdrawal by Subject|1
7514947|NCT02441517|11848728|FG000|Overall Study|Lost to Follow-up|1
7514948|NCT02441517|11848728|FG000|Overall Study|Withdrawal by Subject|2
7514949|NCT02441517|11848728|FG000|Overall Study|Study Terminated by Sponsor|1
7514950|NCT02441946|11848735|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7514951|NCT02441946|11848736|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
7514952|NCT02441946|11848737|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
7514953|NCT02441946|11848735|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
7514954|NCT02441946|11848736|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7514955|NCT02441946|11848737|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
7514956|NCT02441946|11848735|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7514957|NCT02441946|11848736|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
7514958|NCT02441946|11848737|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
7514959|NCT02441946|11848735|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7514960|NCT02441946|11848736|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
7514961|NCT02441946|11848737|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
7514962|NCT02441946|11848735|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
7514963|NCT02441946|11848736|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7514964|NCT02441946|11848737|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
7514965|NCT02441946|11848735|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
7514966|NCT02441946|11848736|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7514967|NCT02441946|11848737|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
7514968|NCT02441946|11848735|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
7514969|NCT02441946|11848736|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7514970|NCT02441946|11848737|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
7514971|NCT02441946|11848735|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
7514972|NCT02441946|11848736|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7514973|NCT02441946|11848737|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
7514974|NCT02441946|11848735|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
7514975|NCT02441946|11848736|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7514976|NCT02441946|11848737|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
7514977|NCT02441946|11848735|FG000|Extension Period (8 Weeks)|Adverse Event|1
7514978|NCT02441946|11848736|FG001|Extension Period (8 Weeks)|Adverse Event|0
7514979|NCT02441946|11848737|FG002|Extension Period (8 Weeks)|Adverse Event|0
7514980|NCT02441946|11848735|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
7514981|NCT02441946|11848736|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
7514982|NCT02441946|11848737|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
7514983|NCT02442206|11848750|FG000|Period 1|Adverse Event|1
7514984|NCT02442206|11848751|FG001|Period 1|Adverse Event|1
7514985|NCT02442206|11848750|FG000|Period 1|withdrew consent|0
7514986|NCT02442206|11848751|FG001|Period 1|withdrew consent|1
7514987|NCT02442206|11848750|FG000|Period 1|COPD exacerbation|0
7514988|NCT02442206|11848751|FG001|Period 1|COPD exacerbation|1
7514989|NCT02442206|11848750|FG000|Period 2|Adverse Event|1
7514990|NCT02442206|11848751|FG001|Period 2|Adverse Event|0
7514991|NCT02442271|11848758|FG000|Overall Study|Adverse Event|1
7514992|NCT02442271|11848758|FG000|Overall Study|Withdrew Consent|1
7514993|NCT02442271|11848758|FG000|Overall Study|Lost to Follow-up|1
7514994|NCT02442271|11848758|FG000|Overall Study|Other|1
7514995|NCT02442284|11848776|FG000|Overall Study|Adverse Event|1
7514996|NCT02442284|11848776|FG000|Overall Study|Withdrew Consent|2
7514997|NCT02442284|11848776|FG000|Overall Study|Lost to Follow-up|3
7514998|NCT02442284|11848776|FG000|Overall Study|Other|1
7514999|NCT02442310|11848780|FG000|Overall Study|Adverse Event|2
7515000|NCT02442310|11848780|FG000|Overall Study|Withdrawal by Subject|1
7515001|NCT02442336|11848790|FG000|Overall Study|6 patients assisted with the intervention development only.|6
7515002|NCT02442336|11848790|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
7515003|NCT02442336|11848790|FG000|Overall Study|Lost to Follow-up|11
7515004|NCT02442622|11848796|FG000|Overall Study|Withdrawal by Subject|3
7515005|NCT02442622|11848797|FG001|Overall Study|Withdrawal by Subject|1
7515006|NCT02442804|11848828|FG000|Overall Study|Withdrawal by Subject|0
7515007|NCT02442804|11848829|FG001|Overall Study|Withdrawal by Subject|1
7515008|NCT02442804|11848828|FG000|Overall Study|Adverse Event|1
7515009|NCT02442804|11848829|FG001|Overall Study|Adverse Event|0
7515010|NCT02442830|11848837|FG000|Overall Study|Technical Failure|0
7515011|NCT02442830|11848838|FG001|Overall Study|Technical Failure|1
7515012|NCT02443103|11848884|FG000|Overall Study|Adverse Event|2
7515013|NCT02443103|11848884|FG000|Overall Study|Noncompliance|1
7515014|NCT02443155|11848892|FG000|Overall Study|Adverse Event|3
7515015|NCT02443155|11848893|FG001|Overall Study|Adverse Event|4
7515016|NCT02443155|11848894|FG002|Overall Study|Adverse Event|1
7515017|NCT02443155|11848895|FG003|Overall Study|Adverse Event|2
7515018|NCT02443155|11848892|FG000|Overall Study|Unclassified|0
7515019|NCT02443155|11848893|FG001|Overall Study|Unclassified|0
7515020|NCT02443155|11848894|FG002|Overall Study|Unclassified|2
7515021|NCT02443155|11848895|FG003|Overall Study|Unclassified|1
7515022|NCT02443155|11848892|FG000|Overall Study|Withdrawal by Subject|4
7515023|NCT02443155|11848893|FG001|Overall Study|Withdrawal by Subject|7
7515024|NCT02443155|11848894|FG002|Overall Study|Withdrawal by Subject|3
7515025|NCT02443155|11848895|FG003|Overall Study|Withdrawal by Subject|9
7515026|NCT02443155|11848892|FG000|Overall Study|Pregnancy|3
7515027|NCT02443155|11848893|FG001|Overall Study|Pregnancy|1
7515028|NCT02443155|11848894|FG002|Overall Study|Pregnancy|1
7515029|NCT02443155|11848895|FG003|Overall Study|Pregnancy|2
7515030|NCT02443155|11848892|FG000|Overall Study|Lost to Follow-up|1
7515031|NCT02443155|11848893|FG001|Overall Study|Lost to Follow-up|2
7515032|NCT02443155|11848894|FG002|Overall Study|Lost to Follow-up|0
7515033|NCT02443155|11848895|FG003|Overall Study|Lost to Follow-up|1
7515034|NCT02443155|11848892|FG000|Overall Study|Protocol Violation|1
7515035|NCT02443155|11848893|FG001|Overall Study|Protocol Violation|0
7515036|NCT02443155|11848894|FG002|Overall Study|Protocol Violation|1
7515037|NCT02443155|11848895|FG003|Overall Study|Protocol Violation|1
7515038|NCT02443155|11848892|FG000|Overall Study|Death|0
7515039|NCT02443155|11848893|FG001|Overall Study|Death|0
7515040|NCT02443155|11848894|FG002|Overall Study|Death|1
7515041|NCT02443155|11848895|FG003|Overall Study|Death|0
7515042|NCT02443298|11848908|FG000|Overall Study|Adverse Event|3
7515043|NCT02443298|11848909|FG001|Overall Study|Adverse Event|3
7515044|NCT02443298|11848908|FG000|Overall Study|Withdrawal by Subject|1
7515045|NCT02443298|11848909|FG001|Overall Study|Withdrawal by Subject|2
7515046|NCT02443337|11848917|FG000|Overall Study|Adverse Event|0
7515047|NCT02443337|11848918|FG001|Overall Study|Adverse Event|1
7515048|NCT02443337|11848917|FG000|Overall Study|Clinical Progressive Disease|3
7515049|NCT02443337|11848918|FG001|Overall Study|Clinical Progressive Disease|0
7515050|NCT02443337|11848917|FG000|Overall Study|Withdrawal by Subject|2
7515051|NCT02443337|11848918|FG001|Overall Study|Withdrawal by Subject|1
7515052|NCT02443402|11848931|FG000|Overall Study|Withdrawal by Subject|3
7515053|NCT02443402|11848932|FG001|Overall Study|Withdrawal by Subject|1
7515054|NCT02443402|11848931|FG000|Overall Study|Screen Failure|1
7515055|NCT02443402|11848932|FG001|Overall Study|Screen Failure|2
7515056|NCT02443688|11848963|FG000|Overall Study|Adverse Event|2
7515057|NCT02443688|11848964|FG001|Overall Study|Adverse Event|3
7515058|NCT02443688|11848965|FG002|Overall Study|Adverse Event|2
7515059|NCT02443688|11848963|FG000|Overall Study|Lost to Follow-up|1
7515060|NCT02443688|11848964|FG001|Overall Study|Lost to Follow-up|0
7515061|NCT02443688|11848965|FG002|Overall Study|Lost to Follow-up|0
7515062|NCT02443688|11848963|FG000|Overall Study|Physician Decision|3
7515063|NCT02443688|11848964|FG001|Overall Study|Physician Decision|0
7515064|NCT02443688|11848965|FG002|Overall Study|Physician Decision|1
7515065|NCT02443688|11848963|FG000|Overall Study|Pregnancy|0
7515066|NCT02443688|11848964|FG001|Overall Study|Pregnancy|0
7515067|NCT02443688|11848965|FG002|Overall Study|Pregnancy|1
7515068|NCT02443688|11848963|FG000|Overall Study|Withdrawal by Subject|3
7515069|NCT02443688|11848964|FG001|Overall Study|Withdrawal by Subject|3
7515070|NCT02443688|11848965|FG002|Overall Study|Withdrawal by Subject|4
7515071|NCT02443688|11848963|FG000|Overall Study|Non-compliance with study drug|1
7515072|NCT02443688|11848964|FG001|Overall Study|Non-compliance with study drug|2
7515073|NCT02443688|11848965|FG002|Overall Study|Non-compliance with study drug|4
7515074|NCT02443688|11848963|FG000|Overall Study|Sponsor Request|2
7515075|NCT02443688|11848964|FG001|Overall Study|Sponsor Request|1
7515076|NCT02443688|11848965|FG002|Overall Study|Sponsor Request|0
7515077|NCT02443740|11848981|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
7515078|NCT02443740|11848982|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
7515079|NCT02443740|11848983|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
7515080|NCT02443740|11848984|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
7515081|NCT02443740|11848985|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
7515082|NCT02443740|11848986|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
7515083|NCT02443740|11848987|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
7515084|NCT02443740|11848988|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
7515085|NCT02443740|11848989|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
7515086|NCT02443740|11848990|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
7515087|NCT02443740|11848991|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
7515088|NCT02443740|11848981|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
7515089|NCT02443740|11848982|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
7515090|NCT02443740|11848983|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
7515091|NCT02443740|11848984|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
7515092|NCT02443740|11848985|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
7515093|NCT02443740|11848986|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
7515094|NCT02443740|11848987|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
7515095|NCT02443740|11848988|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
7515096|NCT02443740|11848989|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
7515097|NCT02443740|11848990|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
7515098|NCT02443740|11848991|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
7515099|NCT02443740|11848981|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515100|NCT02443740|11848982|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515101|NCT02443740|11848983|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515102|NCT02443740|11848984|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515103|NCT02443740|11848985|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515104|NCT02443740|11848986|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
7515105|NCT02443740|11848987|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515106|NCT02443740|11848988|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515107|NCT02443740|11848989|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515108|NCT02443740|11848990|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515109|NCT02443740|11848991|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
7515110|NCT02443805|11849032|FG000|Overall Study|Adverse Event|100
7515111|NCT02443805|11849033|FG001|Overall Study|Adverse Event|18
7515112|NCT02443805|11849032|FG000|Overall Study|Withdrawal by Subject|73
7515113|NCT02443805|11849033|FG001|Overall Study|Withdrawal by Subject|74
7515114|NCT02443805|11849032|FG000|Overall Study|Lost to Follow-up|19
7515115|NCT02443805|11849033|FG001|Overall Study|Lost to Follow-up|14
7515116|NCT02443805|11849032|FG000|Overall Study|Pregnancy|6
7515117|NCT02443805|11849033|FG001|Overall Study|Pregnancy|5
7515118|NCT02443805|11849032|FG000|Overall Study|Protocol Violation|2
7515119|NCT02443805|11849033|FG001|Overall Study|Protocol Violation|4
7515120|NCT02443805|11849032|FG000|Overall Study|Lack of Efficacy|1
7515121|NCT02443805|11849033|FG001|Overall Study|Lack of Efficacy|1
7515122|NCT02443805|11849032|FG000|Overall Study|Non-compliance with study drug|6
7515123|NCT02443805|11849033|FG001|Overall Study|Non-compliance with study drug|4
7515124|NCT02443805|11849032|FG000|Overall Study|Withdrawal by parent/guardian|3
7515125|NCT02443805|11849033|FG001|Overall Study|Withdrawal by parent/guardian|5
7515126|NCT02443805|11849032|FG000|Overall Study|Any other reason not above-mentioned|3
7515127|NCT02443805|11849033|FG001|Overall Study|Any other reason not above-mentioned|2
7515128|NCT02443883|11849043|FG000|Overall Study|Adverse Event|0
7515129|NCT02443883|11849044|FG001|Overall Study|Adverse Event|1
7515130|NCT02443883|11849045|FG002|Overall Study|Adverse Event|0
7515131|NCT02443883|11849046|FG003|Overall Study|Adverse Event|0
7515132|NCT02443883|11849043|FG000|Overall Study|Lost to Follow-up|3
7515133|NCT02443883|11849044|FG001|Overall Study|Lost to Follow-up|2
7515134|NCT02443883|11849045|FG002|Overall Study|Lost to Follow-up|1
7515135|NCT02443883|11849046|FG003|Overall Study|Lost to Follow-up|0
7515136|NCT02443883|11849043|FG000|Overall Study|Physician Decision|1
7515137|NCT02443883|11849044|FG001|Overall Study|Physician Decision|1
7515138|NCT02443883|11849045|FG002|Overall Study|Physician Decision|0
7515139|NCT02443883|11849046|FG003|Overall Study|Physician Decision|3
7515140|NCT02443883|11849043|FG000|Overall Study|Withdrawal by Subject|1
7515141|NCT02443883|11849044|FG001|Overall Study|Withdrawal by Subject|0
7515142|NCT02443883|11849045|FG002|Overall Study|Withdrawal by Subject|0
7515143|NCT02443883|11849046|FG003|Overall Study|Withdrawal by Subject|2
7515144|NCT02443883|11849043|FG000|Overall Study|Randomized, but never treated|1
7515145|NCT02443883|11849044|FG001|Overall Study|Randomized, but never treated|0
7515146|NCT02443883|11849045|FG002|Overall Study|Randomized, but never treated|0
7515147|NCT02443883|11849046|FG003|Overall Study|Randomized, but never treated|0
7515148|NCT02444182|11849069|FG000|Overall Study|non-compliance|2
7515149|NCT02444182|11849070|FG001|Overall Study|non-compliance|1
7515150|NCT02444182|11849069|FG000|Overall Study|Lost to Follow-up|0
7515151|NCT02444182|11849070|FG001|Overall Study|Lost to Follow-up|4
7515152|NCT02444533|11849087|FG000|Overall Study|Not able to complete forms|0
7515153|NCT02444533|11849088|FG001|Overall Study|Not able to complete forms|2
7515154|NCT02444533|11849087|FG000|Overall Study|Only gave post-procedure complications|2
7515155|NCT02444533|11849088|FG001|Overall Study|Only gave post-procedure complications|2
7515156|NCT02444793|11849130|FG000|Overall Study|Lost to Follow-up|2
7515157|NCT02444793|11849131|FG001|Overall Study|Lost to Follow-up|2
7515158|NCT02444793|11849132|FG002|Overall Study|Lost to Follow-up|0
7515159|NCT02444793|11849133|FG003|Overall Study|Lost to Follow-up|0
7515160|NCT02444793|11849130|FG000|Overall Study|Death|0
7515161|NCT02444793|11849131|FG001|Overall Study|Death|3
7515162|NCT02444793|11849132|FG002|Overall Study|Death|0
7515163|NCT02444793|11849133|FG003|Overall Study|Death|0
7515164|NCT02444793|11849130|FG000|Overall Study|Other|0
7515165|NCT02444793|11849131|FG001|Overall Study|Other|0
7515166|NCT02444793|11849132|FG002|Overall Study|Other|2
7515167|NCT02444793|11849133|FG003|Overall Study|Other|0
7515168|NCT02444793|11849130|FG000|Overall Study|Objective progression or relapse|9
7515169|NCT02444793|11849131|FG001|Overall Study|Objective progression or relapse|1
7515170|NCT02444793|11849132|FG002|Overall Study|Objective progression or relapse|2
7515171|NCT02444793|11849133|FG003|Overall Study|Objective progression or relapse|3
7515172|NCT02445573|11849204|FG000|Overall Study|Withdrawal by Subject|1
7515173|NCT02445573|11849205|FG001|Overall Study|Withdrawal by Subject|1
7515174|NCT02445573|11849204|FG000|Overall Study|Lost to Follow-up|0
7515175|NCT02445573|11849205|FG001|Overall Study|Lost to Follow-up|1
7515176|NCT02445586|11849211|FG000|Overall Study|Death|14
7515177|NCT02445586|11849211|FG000|Overall Study|Withdrawal by Subject|13
7515178|NCT02445586|11849211|FG000|Overall Study|Disease Progression|10
7515179|NCT02445586|11849211|FG000|Overall Study|Protocol Violation|1
7515180|NCT02445586|11849211|FG000|Overall Study|Medical Condition|1
7515181|NCT02445755|11849220|FG000|Overall Study|Withdrawal by Subject|2
7515182|NCT02445755|11849220|FG000|Overall Study|Protocol Violation|6
7515183|NCT02445755|11849220|FG000|Overall Study|Screen Failure|5
7515184|NCT02445794|11849231|FG000|Overall Study|Adverse Event|0
7515185|NCT02445794|11849232|FG001|Overall Study|Adverse Event|0
7515186|NCT02445794|11849233|FG002|Overall Study|Adverse Event|2
7515187|NCT02445794|11849234|FG003|Overall Study|Adverse Event|0
7515188|NCT02445963|11849288|FG000|Overall Study|Lost to Follow-up|1
7515189|NCT02445963|11849289|FG001|Overall Study|Lost to Follow-up|0
7515190|NCT02445963|11849290|FG002|Overall Study|Lost to Follow-up|0
7515191|NCT02445963|11849291|FG003|Overall Study|Lost to Follow-up|0
7515192|NCT02445963|11849288|FG000|Overall Study|Change in employment|1
7515193|NCT02445963|11849289|FG001|Overall Study|Change in employment|0
7515194|NCT02445963|11849290|FG002|Overall Study|Change in employment|0
7515195|NCT02445963|11849291|FG003|Overall Study|Change in employment|0
7515196|NCT02445963|11849288|FG000|Overall Study|Symptoms post-vaccination|0
7515197|NCT02445963|11849289|FG001|Overall Study|Symptoms post-vaccination|0
7515198|NCT02445963|11849290|FG002|Overall Study|Symptoms post-vaccination|1
7515199|NCT02445963|11849291|FG003|Overall Study|Symptoms post-vaccination|0
7515200|NCT02446015|11849305|FG000|Overall Study|Adverse Event|0
7515201|NCT02446015|11849306|FG001|Overall Study|Adverse Event|1
7515202|NCT02446015|11849305|FG000|Overall Study|Withdrawal by Subject|1
7515203|NCT02446015|11849306|FG001|Overall Study|Withdrawal by Subject|0
7515204|NCT02446171|11849317|FG000|Overall Study|Withdrawal by Subject|0
7515205|NCT02446171|11849318|FG001|Overall Study|Withdrawal by Subject|0
7515206|NCT02446171|11849319|FG002|Overall Study|Withdrawal by Subject|2
7515207|NCT02446171|11849320|FG003|Overall Study|Withdrawal by Subject|0
7515208|NCT02446418|11849359|FG000|Overall Study|Adverse Event|4
7515209|NCT02446418|11849360|FG001|Overall Study|Adverse Event|8
7515210|NCT02446418|11849359|FG000|Overall Study|Physician Decision|5
7515211|NCT02446418|11849360|FG001|Overall Study|Physician Decision|1
7515212|NCT02446418|11849359|FG000|Overall Study|Withdrawal by Subject|3
7515213|NCT02446418|11849360|FG001|Overall Study|Withdrawal by Subject|3
7515214|NCT02446418|11849359|FG000|Overall Study|Lost to Follow-up|2
7515215|NCT02446418|11849360|FG001|Overall Study|Lost to Follow-up|2
7515216|NCT02446418|11849359|FG000|Overall Study|Protocol Violation|1
7515217|NCT02446418|11849360|FG001|Overall Study|Protocol Violation|2
7515218|NCT02446418|11849359|FG000|Overall Study|Lack of Efficacy|2
7515219|NCT02446418|11849360|FG001|Overall Study|Lack of Efficacy|0
7515220|NCT02446418|11849359|FG000|Overall Study|Protocol defined stopping criteria reach|1
7515221|NCT02446418|11849360|FG001|Overall Study|Protocol defined stopping criteria reach|0
7515222|NCT02446691|11849392|FG000|Overall Study|Withdrawal by Subject|2
7515223|NCT02446691|11849392|FG000|Overall Study|Lost to Follow-up|8
7515224|NCT02446691|11849392|FG000|Overall Study|Protocol Violation|1
7515225|NCT02446717|11849401|FG000|Overall Study|Adverse Event|0
7515226|NCT02446717|11849402|FG001|Overall Study|Adverse Event|0
7515227|NCT02446717|11849403|FG002|Overall Study|Adverse Event|1
7515228|NCT02446717|11849404|FG003|Overall Study|Adverse Event|0
7515229|NCT02446717|11849405|FG004|Overall Study|Adverse Event|0
7515230|NCT02446717|11849401|FG000|Overall Study|Lost to Follow-up|0
7515231|NCT02446717|11849402|FG001|Overall Study|Lost to Follow-up|1
7515232|NCT02446717|11849403|FG002|Overall Study|Lost to Follow-up|1
7515233|NCT02446717|11849404|FG003|Overall Study|Lost to Follow-up|0
7515234|NCT02446717|11849405|FG004|Overall Study|Lost to Follow-up|1
7515235|NCT02446717|11849401|FG000|Overall Study|Withdrew consent|0
7515236|NCT02446717|11849402|FG001|Overall Study|Withdrew consent|0
7515237|NCT02446717|11849403|FG002|Overall Study|Withdrew consent|0
7515238|NCT02446717|11849404|FG003|Overall Study|Withdrew consent|1
7515239|NCT02446717|11849405|FG004|Overall Study|Withdrew consent|0
7515240|NCT02446743|11849419|FG000|Overall Study|Withdrawal by Subject|1
7515241|NCT02446743|11849420|FG001|Overall Study|Withdrawal by Subject|1
7515242|NCT02446743|11849419|FG000|Overall Study|Lost to Follow-up|1
7515243|NCT02446743|11849420|FG001|Overall Study|Lost to Follow-up|0
7515244|NCT02446743|11849419|FG000|Overall Study|Adverse Event|1
7515245|NCT02446743|11849420|FG001|Overall Study|Adverse Event|1
7515246|NCT02446743|11849419|FG000|Overall Study|Other|2
7515247|NCT02446743|11849420|FG001|Overall Study|Other|3
7515248|NCT02446769|11849435|FG000|Screening Period|Screen Failure|11
7515249|NCT02446769|11849436|FG001|Screening Period|Screen Failure|0
7515250|NCT02446769|11849437|FG002|Screening Period|Screen Failure|0
7515251|NCT02446769|11849435|FG000|Study Period|Randomized in Error|0
7515252|NCT02446769|11849436|FG001|Study Period|Randomized in Error|2
7515253|NCT02446769|11849437|FG002|Study Period|Randomized in Error|0
7515254|NCT02446886|11849455|FG000|Overall Study|Adverse Event|1
7515255|NCT02446886|11849456|FG001|Overall Study|Adverse Event|3
7515256|NCT02446886|11849455|FG000|Overall Study|Withdrawal by Subject|1
7515257|NCT02446886|11849456|FG001|Overall Study|Withdrawal by Subject|1
7515258|NCT02446899|11849465|FG000|Overall Study|Adverse Event|4
7515259|NCT02446899|11849466|FG001|Overall Study|Adverse Event|7
7515260|NCT02446899|11849465|FG000|Overall Study|Condition Under Investigation Worsened|1
7515261|NCT02446899|11849466|FG001|Overall Study|Condition Under Investigation Worsened|4
7515262|NCT02446899|11849465|FG000|Overall Study|Study Specific Withdrawal Criteria|1
7515263|NCT02446899|11849466|FG001|Overall Study|Study Specific Withdrawal Criteria|0
7515264|NCT02446899|11849465|FG000|Overall Study|Lack of Efficacy|2
7515265|NCT02446899|11849466|FG001|Overall Study|Lack of Efficacy|8
7515266|NCT02446899|11849465|FG000|Overall Study|Lost to Follow-up|1
7515267|NCT02446899|11849466|FG001|Overall Study|Lost to Follow-up|3
7515268|NCT02446899|11849465|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7515269|NCT02446899|11849466|FG001|Overall Study|Severe Non-Compliance to Protocol|1
7515270|NCT02446899|11849465|FG000|Overall Study|Withdrawal by Subject|11
7515271|NCT02446899|11849466|FG001|Overall Study|Withdrawal by Subject|19
7515272|NCT02446899|11849465|FG000|Overall Study|Miscellaneous|5
7515273|NCT02446899|11849466|FG001|Overall Study|Miscellaneous|4
7515274|NCT02446899|11849465|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7515275|NCT02446899|11849466|FG001|Overall Study|Failure to Meet Randomization Criteria|2
7515276|NCT02446912|11849475|FG000|Overall Study|Adverse Event|3
7515277|NCT02446912|11849476|FG001|Overall Study|Adverse Event|13
7515278|NCT02446912|11849477|FG002|Overall Study|Adverse Event|5
7515279|NCT02446912|11849475|FG000|Overall Study|Condition under investigation worsened|0
7515280|NCT02446912|11849476|FG001|Overall Study|Condition under investigation worsened|1
7515281|NCT02446912|11849477|FG002|Overall Study|Condition under investigation worsened|1
7515282|NCT02446912|11849475|FG000|Overall Study|Study-specific withdrawal criteria|1
7515283|NCT02446912|11849476|FG001|Overall Study|Study-specific withdrawal criteria|0
7515284|NCT02446912|11849477|FG002|Overall Study|Study-specific withdrawal criteria|0
7515285|NCT02446912|11849475|FG000|Overall Study|Lack of Efficacy|1
7515286|NCT02446912|11849476|FG001|Overall Study|Lack of Efficacy|4
7515287|NCT02446912|11849477|FG002|Overall Study|Lack of Efficacy|7
7515288|NCT02446912|11849475|FG000|Overall Study|Lost to Follow-up|0
7515289|NCT02446912|11849476|FG001|Overall Study|Lost to Follow-up|0
7515290|NCT02446912|11849477|FG002|Overall Study|Lost to Follow-up|2
7515291|NCT02446912|11849475|FG000|Overall Study|Severe non-compliance to protocol|1
7515292|NCT02446912|11849476|FG001|Overall Study|Severe non-compliance to protocol|0
7515293|NCT02446912|11849477|FG002|Overall Study|Severe non-compliance to protocol|1
7515294|NCT02446912|11849475|FG000|Overall Study|Withdrawal by Subject|10
7515295|NCT02446912|11849476|FG001|Overall Study|Withdrawal by Subject|15
7515296|NCT02446912|11849477|FG002|Overall Study|Withdrawal by Subject|15
7515297|NCT02446912|11849475|FG000|Overall Study|Miscellaneous|2
7515298|NCT02446912|11849476|FG001|Overall Study|Miscellaneous|2
7515299|NCT02446912|11849477|FG002|Overall Study|Miscellaneous|4
7515300|NCT02446990|11849487|FG000|Overall Study|Death|485
7515301|NCT02446990|11849488|FG001|Overall Study|Death|458
7515302|NCT02446990|11849487|FG000|Overall Study|Lost to Follow-up|3
7515303|NCT02446990|11849488|FG001|Overall Study|Lost to Follow-up|1
7515304|NCT02446990|11849487|FG000|Overall Study|Physician Decision|1
7515305|NCT02446990|11849488|FG001|Overall Study|Physician Decision|0
7515306|NCT02446990|11849487|FG000|Overall Study|Withdrawal by Subject|231
7515307|NCT02446990|11849488|FG001|Overall Study|Withdrawal by Subject|199
7515308|NCT02447003|11849496|FG000|Overall Study|Other|0
7515309|NCT02447003|11849497|FG001|Overall Study|Other|4
7515310|NCT02447003|11849496|FG000|Overall Study|Site discontinued|0
7515311|NCT02447003|11849497|FG001|Overall Study|Site discontinued|2
7515312|NCT02447003|11849496|FG000|Overall Study|Physician Decision|0
7515313|NCT02447003|11849497|FG001|Overall Study|Physician Decision|1
7515314|NCT02447003|11849496|FG000|Overall Study|Withdrawal by Subject|4
7515315|NCT02447003|11849497|FG001|Overall Study|Withdrawal by Subject|3
7515316|NCT02447003|11849496|FG000|Overall Study|Sponsor Decision|6
7515317|NCT02447003|11849497|FG001|Overall Study|Sponsor Decision|11
7515318|NCT02447003|11849496|FG000|Overall Study|Progressive Disease|1
7515319|NCT02447003|11849497|FG001|Overall Study|Progressive Disease|0
7515320|NCT02447003|11849496|FG000|Overall Study|Lost to Follow-up|5
7515321|NCT02447003|11849497|FG001|Overall Study|Lost to Follow-up|0
7515322|NCT02447003|11849496|FG000|Overall Study|Death|154
7515323|NCT02447003|11849497|FG001|Overall Study|Death|63
7515324|NCT02447029|11849507|FG000|Overall Study|Withdrawal by Subject|3
7515325|NCT02447029|11849508|FG001|Overall Study|Withdrawal by Subject|2
7515326|NCT02447081|11849514|FG000|Overall Study|Death|161
7515327|NCT02447081|11849514|FG000|Overall Study|Lost to Follow-up|36
7515328|NCT02447081|11849514|FG000|Overall Study|Visit not completed|17
7515329|NCT02447081|11849514|FG000|Overall Study|unsuccessful implant procedure|10
7515330|NCT02447172|11849521|FG000|Overall Study|Adverse Event|11
7515331|NCT02447172|11849522|FG001|Overall Study|Adverse Event|8
7515332|NCT02447172|11849523|FG002|Overall Study|Adverse Event|7
7515333|NCT02447172|11849521|FG000|Overall Study|Death|3
7515334|NCT02447172|11849522|FG001|Overall Study|Death|1
7515335|NCT02447172|11849523|FG002|Overall Study|Death|0
7515336|NCT02447172|11849521|FG000|Overall Study|Protocol Violation|2
7515337|NCT02447172|11849522|FG001|Overall Study|Protocol Violation|1
7515338|NCT02447172|11849523|FG002|Overall Study|Protocol Violation|2
7515339|NCT02447172|11849521|FG000|Overall Study|Lost to Follow-up|7
7515340|NCT02447172|11849522|FG001|Overall Study|Lost to Follow-up|4
7515341|NCT02447172|11849523|FG002|Overall Study|Lost to Follow-up|4
7515342|NCT02447172|11849521|FG000|Overall Study|Withdrawal by Subject|5
7515343|NCT02447172|11849522|FG001|Overall Study|Withdrawal by Subject|1
7515344|NCT02447172|11849523|FG002|Overall Study|Withdrawal by Subject|3
7515345|NCT02447172|11849521|FG000|Overall Study|protocol specific treatment unrelated|3
7515346|NCT02447172|11849522|FG001|Overall Study|protocol specific treatment unrelated|0
7515347|NCT02447172|11849523|FG002|Overall Study|protocol specific treatment unrelated|2
7515348|NCT02447250|11849531|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
7515349|NCT02447250|11849531|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
7515350|NCT02447250|11849531|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
7515351|NCT02447302|11849539|FG000|Overall Study|Physician Decision|1
7515352|NCT02447302|11849540|FG001|Overall Study|Physician Decision|0
7515353|NCT02447302|11849541|FG002|Overall Study|Physician Decision|0
7515354|NCT02447302|11849539|FG000|Overall Study|Adverse Event|4
7515355|NCT02447302|11849540|FG001|Overall Study|Adverse Event|3
7515356|NCT02447302|11849541|FG002|Overall Study|Adverse Event|0
7515357|NCT02447302|11849539|FG000|Overall Study|Withdrawal by Subject|0
7515358|NCT02447302|11849540|FG001|Overall Study|Withdrawal by Subject|1
7515359|NCT02447302|11849541|FG002|Overall Study|Withdrawal by Subject|5
7515360|NCT02447302|11849539|FG000|Overall Study|Sponsor Decision|0
7515361|NCT02447302|11849540|FG001|Overall Study|Sponsor Decision|0
7515362|NCT02447302|11849541|FG002|Overall Study|Sponsor Decision|1
7515363|NCT02447328|11849549|FG000|Overall Study|Withdrawal by Subject|1
7515364|NCT02447432|11849555|FG000|Epoch 001|Adverse Event|1
7515365|NCT02447432|11849556|FG001|Epoch 001|Adverse Event|1
7515366|NCT02447432|11849555|FG000|Epoch 001|Withdrawal by Subject|0
7515367|NCT02447432|11849556|FG001|Epoch 001|Withdrawal by Subject|4
7515368|NCT02447432|11849555|FG000|Epoch 001|Migrated/moved from study area|3
7515369|NCT02447432|11849556|FG001|Epoch 001|Migrated/moved from study area|5
7515370|NCT02447432|11849555|FG000|Epoch 001|Lost to Follow-up|1
7515371|NCT02447432|11849556|FG001|Epoch 001|Lost to Follow-up|3
7515372|NCT02447458|11849568|FG000|Overall Study|Other|0
7515373|NCT02447458|11849569|FG001|Overall Study|Other|0
7515374|NCT02447458|11849570|FG002|Overall Study|Other|1
7515375|NCT02447458|11849571|FG003|Overall Study|Other|0
7515376|NCT02447458|11849572|FG004|Overall Study|Other|0
7515377|NCT02447458|11849573|FG005|Overall Study|Other|0
7515378|NCT02447497|11849596|FG000|Overall Study|Did not meet treatment day baseline.|6
7515379|NCT02447497|11849597|FG001|Overall Study|Did not meet treatment day baseline.|5
7515380|NCT02447497|11849598|FG002|Overall Study|Did not meet treatment day baseline.|2
7515381|NCT02447497|11849599|FG003|Overall Study|Did not meet treatment day baseline.|2
7515382|NCT02447497|11849596|FG000|Overall Study|Dressing was compromised|0
7515383|NCT02447497|11849597|FG001|Overall Study|Dressing was compromised|1
7515384|NCT02447497|11849598|FG002|Overall Study|Dressing was compromised|0
7515385|NCT02447497|11849599|FG003|Overall Study|Dressing was compromised|0
7515386|NCT02447744|11849623|FG000|Overall Study|Withdrawal by Subject|3
7515387|NCT02447744|11849624|FG001|Overall Study|Withdrawal by Subject|1
7515388|NCT02447744|11849623|FG000|Overall Study|Data not collected b/c logistic reasons|3
7515389|NCT02447744|11849624|FG001|Overall Study|Data not collected b/c logistic reasons|0
7515390|NCT02447848|11849630|FG000|Overall Study|Patient discharged|3
7515391|NCT02447848|11849630|FG000|Overall Study|Lack of Efficacy|4
7515392|NCT02447848|11849630|FG000|Overall Study|Withdrawal by Subject|4
7515393|NCT02447952|11849638|FG000|Overall Study|Adverse Event|2
7515394|NCT02447952|11849638|FG000|Overall Study|Physician Decision|1
7515395|NCT02447952|11849638|FG000|Overall Study|Withdrawal by Subject|4
7515396|NCT02447991|11849644|FG000|Overall Study|Withdrawn by subject - no data|0
7515397|NCT02447991|11849645|FG001|Overall Study|Withdrawn by subject - no data|2
7515398|NCT02447991|11849644|FG000|Overall Study|Withdrawn by Subject - with data|4
7515399|NCT02447991|11849645|FG001|Overall Study|Withdrawn by Subject - with data|4
7515400|NCT02447991|11849644|FG000|Overall Study|Lost to Follow-up - no data|3
7515401|NCT02447991|11849645|FG001|Overall Study|Lost to Follow-up - no data|6
7515402|NCT02447991|11849644|FG000|Overall Study|Lost to follow-up - with data|0
7515403|NCT02447991|11849645|FG001|Overall Study|Lost to follow-up - with data|3
7515404|NCT02447991|11849644|FG000|Overall Study|End of study - no treatment results|3
7515405|NCT02447991|11849645|FG001|Overall Study|End of study - no treatment results|6
7515406|NCT02447991|11849644|FG000|Overall Study|End of study - partial treatment results|0
7515407|NCT02447991|11849645|FG001|Overall Study|End of study - partial treatment results|9
7515408|NCT02448043|11849657|FG000|Overall Study|Withdrawal by Subject|2
7515409|NCT02448043|11849658|FG001|Overall Study|Withdrawal by Subject|2
7515410|NCT02448043|11849657|FG000|Overall Study|Protocol Violation|1
7515411|NCT02448043|11849658|FG001|Overall Study|Protocol Violation|2
7515412|NCT02448446|11849717|FG000|Overall Study|Withdrawal by Subject|1
7515413|NCT02448446|11849718|FG001|Overall Study|Withdrawal by Subject|0
7515414|NCT02448537|11849727|FG000|Overall Study|Withdrawal by Subject|1
7515415|NCT02448537|11849728|FG001|Overall Study|Withdrawal by Subject|1
7515416|NCT02448537|11849729|FG002|Overall Study|Withdrawal by Subject|1
7515417|NCT02448563|11849741|FG000|Overall Study|Lost to Follow-up|16
7515418|NCT02448563|11849742|FG001|Overall Study|Lost to Follow-up|10
7515419|NCT02448563|11849741|FG000|Overall Study|Withdrawal by Subject|0
7515420|NCT02448563|11849742|FG001|Overall Study|Withdrawal by Subject|1
7536399|NCT02718417|11884354|FG000|Follow-up Phase|Adverse Event|3
7536400|NCT02718417|11884355|FG001|Follow-up Phase|Adverse Event|1
7536401|NCT02718417|11884356|FG002|Follow-up Phase|Adverse Event|1
7536402|NCT02718417|11884354|FG000|Follow-up Phase|Other|4
7536403|NCT02718417|11884355|FG001|Follow-up Phase|Other|6
7536404|NCT02718417|11884356|FG002|Follow-up Phase|Other|4
7536405|NCT02718417|11884354|FG000|Follow-up Phase|Withdrawal by Subject|19
7536406|NCT02718417|11884355|FG001|Follow-up Phase|Withdrawal by Subject|17
7536407|NCT02718417|11884356|FG002|Follow-up Phase|Withdrawal by Subject|5
7536408|NCT02718417|11884354|FG000|Follow-up Phase|Study terminated by sponsor|100
7536409|NCT02718417|11884355|FG001|Follow-up Phase|Study terminated by sponsor|138
7536410|NCT02718417|11884356|FG002|Follow-up Phase|Study terminated by sponsor|6
7536411|NCT02718417|11884354|FG000|Follow-up Phase|Lost to Follow-up|2
7536412|NCT02718417|11884355|FG001|Follow-up Phase|Lost to Follow-up|3
7536413|NCT02718417|11884356|FG002|Follow-up Phase|Lost to Follow-up|0
7536414|NCT02718417|11884354|FG000|Follow-up Phase|Death leading to discontinuation|7
7536415|NCT02718417|11884355|FG001|Follow-up Phase|Death leading to discontinuation|7
7536416|NCT02718417|11884356|FG002|Follow-up Phase|Death leading to discontinuation|3
7536417|NCT02718417|11884354|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
7536418|NCT02718417|11884355|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
7536419|NCT02718417|11884356|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
7536420|NCT02718417|11884354|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
7536421|NCT02718417|11884355|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
7536422|NCT02718417|11884356|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
7536423|NCT02718417|11884354|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
7536424|NCT02718417|11884355|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
7536425|NCT02718417|11884356|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
7536426|NCT02718417|11884354|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
7536427|NCT02718417|11884355|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
7536428|NCT02718417|11884356|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
7536429|NCT02718417|11884354|FG000|Long-term Follow-up Phase|Other|0
7536430|NCT02718417|11884355|FG001|Long-term Follow-up Phase|Other|2
7536431|NCT02718417|11884356|FG002|Long-term Follow-up Phase|Other|0
7536432|NCT02718625|11884373|FG000|Overall Study|Adverse Event|0
7536433|NCT02718625|11884374|FG001|Overall Study|Adverse Event|1
7536434|NCT02718625|11884373|FG000|Overall Study|Termination of Study by Sponsor|0
7515421|NCT02448706|11849781|FG000|Overall Study|Withdrawal by Subject|4
7515422|NCT02448706|11849782|FG001|Overall Study|Withdrawal by Subject|3
7515423|NCT02448706|11849781|FG000|Overall Study|Protocol Violation|1
7515424|NCT02448706|11849782|FG001|Overall Study|Protocol Violation|1
7515425|NCT02448719|11849801|FG000|Overall Study|Withdrawal by Subject|0
7515426|NCT02448719|11849802|FG001|Overall Study|Withdrawal by Subject|0
7515427|NCT02448719|11849803|FG002|Overall Study|Withdrawal by Subject|0
7515428|NCT02448719|11849804|FG003|Overall Study|Withdrawal by Subject|0
7515429|NCT02448719|11849805|FG004|Overall Study|Withdrawal by Subject|1
7515430|NCT02448719|11849806|FG005|Overall Study|Withdrawal by Subject|0
7515431|NCT02448719|11849807|FG006|Overall Study|Withdrawal by Subject|0
7515432|NCT02448719|11849808|FG007|Overall Study|Withdrawal by Subject|0
7515433|NCT02448719|11849809|FG008|Overall Study|Withdrawal by Subject|0
7515434|NCT02448719|11849810|FG009|Overall Study|Withdrawal by Subject|0
7515435|NCT02448719|11849811|FG010|Overall Study|Withdrawal by Subject|0
7515440|NCT02448810|11849885|FG000|Overall Study|Adverse Event|0
7515441|NCT02448810|11849886|FG001|Overall Study|Adverse Event|0
7515442|NCT02448810|11849887|FG002|Overall Study|Adverse Event|1
7515443|NCT02448810|11849888|FG003|Overall Study|Adverse Event|0
7515444|NCT02448810|11849889|FG004|Overall Study|Adverse Event|0
7515445|NCT02448810|11849890|FG005|Overall Study|Adverse Event|0
7515446|NCT02448810|11849891|FG006|Overall Study|Adverse Event|0
7515447|NCT02448810|11849892|FG007|Overall Study|Adverse Event|0
7515448|NCT02448810|11849885|FG000|Overall Study|Withdrawal by Subject|0
7515449|NCT02448810|11849886|FG001|Overall Study|Withdrawal by Subject|0
7515450|NCT02448810|11849887|FG002|Overall Study|Withdrawal by Subject|1
7515451|NCT02448810|11849888|FG003|Overall Study|Withdrawal by Subject|0
7515452|NCT02448810|11849889|FG004|Overall Study|Withdrawal by Subject|3
7515453|NCT02448810|11849890|FG005|Overall Study|Withdrawal by Subject|5
7515454|NCT02448810|11849891|FG006|Overall Study|Withdrawal by Subject|0
7515455|NCT02448810|11849892|FG007|Overall Study|Withdrawal by Subject|2
7515456|NCT02448810|11849885|FG000|Overall Study|Other (study terminated by sponsor)|0
7515457|NCT02448810|11849886|FG001|Overall Study|Other (study terminated by sponsor)|0
7515458|NCT02448810|11849887|FG002|Overall Study|Other (study terminated by sponsor)|0
7515459|NCT02448810|11849888|FG003|Overall Study|Other (study terminated by sponsor)|0
7515460|NCT02448810|11849889|FG004|Overall Study|Other (study terminated by sponsor)|4
7515461|NCT02448810|11849890|FG005|Overall Study|Other (study terminated by sponsor)|2
7515462|NCT02448810|11849891|FG006|Overall Study|Other (study terminated by sponsor)|2
7515463|NCT02448810|11849892|FG007|Overall Study|Other (study terminated by sponsor)|1
7515464|NCT02448810|11849885|FG000|Overall Study|Death|1
7515465|NCT02448810|11849886|FG001|Overall Study|Death|0
7515466|NCT02448810|11849887|FG002|Overall Study|Death|1
7515467|NCT02448810|11849888|FG003|Overall Study|Death|0
7515468|NCT02448810|11849889|FG004|Overall Study|Death|1
7515469|NCT02448810|11849890|FG005|Overall Study|Death|0
7515470|NCT02448810|11849891|FG006|Overall Study|Death|0
7515471|NCT02448810|11849892|FG007|Overall Study|Death|0
7515472|NCT02448810|11849885|FG000|Overall Study|Other (Progressive disease)|2
7515473|NCT02448810|11849886|FG001|Overall Study|Other (Progressive disease)|2
7515474|NCT02448810|11849887|FG002|Overall Study|Other (Progressive disease)|0
7515475|NCT02448810|11849888|FG003|Overall Study|Other (Progressive disease)|3
7515476|NCT02448810|11849889|FG004|Overall Study|Other (Progressive disease)|23
7515477|NCT02448810|11849890|FG005|Overall Study|Other (Progressive disease)|9
7515478|NCT02448810|11849891|FG006|Overall Study|Other (Progressive disease)|14
7515479|NCT02448810|11849892|FG007|Overall Study|Other (Progressive disease)|5
7515480|NCT02448810|11849885|FG000|Overall Study|Lost to Follow-up|0
7515481|NCT02448810|11849886|FG001|Overall Study|Lost to Follow-up|1
7515482|NCT02448810|11849887|FG002|Overall Study|Lost to Follow-up|0
7515483|NCT02448810|11849888|FG003|Overall Study|Lost to Follow-up|0
7515484|NCT02448810|11849889|FG004|Overall Study|Lost to Follow-up|0
7515485|NCT02448810|11849890|FG005|Overall Study|Lost to Follow-up|0
7515486|NCT02448810|11849891|FG006|Overall Study|Lost to Follow-up|0
7515487|NCT02448810|11849892|FG007|Overall Study|Lost to Follow-up|0
7515488|NCT02448810|11849885|FG000|Overall Study|Other (unspecified)|0
7515489|NCT02448810|11849886|FG001|Overall Study|Other (unspecified)|0
7515490|NCT02448810|11849887|FG002|Overall Study|Other (unspecified)|0
7515491|NCT02448810|11849888|FG003|Overall Study|Other (unspecified)|0
7515492|NCT02448810|11849889|FG004|Overall Study|Other (unspecified)|0
7515493|NCT02448810|11849890|FG005|Overall Study|Other (unspecified)|0
7515494|NCT02448810|11849891|FG006|Overall Study|Other (unspecified)|2
7515495|NCT02448810|11849892|FG007|Overall Study|Other (unspecified)|0
7515496|NCT02448875|11849926|FG000|Overall Study|Adverse Event|2
7515497|NCT02448875|11849927|FG001|Overall Study|Adverse Event|1
7515498|NCT02448875|11849928|FG002|Overall Study|Adverse Event|0
7515499|NCT02448875|11849926|FG000|Overall Study|Lost to Follow-up|1
7515500|NCT02448875|11849927|FG001|Overall Study|Lost to Follow-up|0
7515501|NCT02448875|11849928|FG002|Overall Study|Lost to Follow-up|0
7515502|NCT02448875|11849926|FG000|Overall Study|Investigator Decision|3
7515503|NCT02448875|11849927|FG001|Overall Study|Investigator Decision|0
7515504|NCT02448875|11849928|FG002|Overall Study|Investigator Decision|1
7515505|NCT02448875|11849926|FG000|Overall Study|Withdrawal by Subject|1
7515506|NCT02448875|11849927|FG001|Overall Study|Withdrawal by Subject|0
7515507|NCT02448875|11849928|FG002|Overall Study|Withdrawal by Subject|0
7515508|NCT02449018|11849949|FG000|Overall Study|Abnormal laboratory value|0
7515509|NCT02449018|11849950|FG001|Overall Study|Abnormal laboratory value|1
7515510|NCT02449018|11849949|FG000|Overall Study|Administrative problems|1
7515511|NCT02449018|11849950|FG001|Overall Study|Administrative problems|0
7515512|NCT02449018|11849949|FG000|Overall Study|Adverse Event|5
7515513|NCT02449018|11849950|FG001|Overall Study|Adverse Event|1
7515514|NCT02449018|11849949|FG000|Overall Study|Protocol deviation|4
7515515|NCT02449018|11849950|FG001|Overall Study|Protocol deviation|0
7515516|NCT02449018|11849949|FG000|Overall Study|Patient decision|2
7515517|NCT02449018|11849950|FG001|Overall Study|Patient decision|0
7515518|NCT02449044|11849956|FG000|Overall Study|Lost to Follow-up|2
7515519|NCT02449044|11849956|FG000|Overall Study|Withdrawal by Subject|13
7515520|NCT02449044|11849956|FG000|Overall Study|Adverse Event|30
7515521|NCT02449044|11849956|FG000|Overall Study|Met Withdrawal Criteria|7
7515522|NCT02449044|11849956|FG000|Overall Study|Physician Decision|9
7515523|NCT02449044|11849956|FG000|Overall Study|Sponsor Discontinued Trial|3
7515524|NCT02449889|11850021|FG000|Overall Study|Adverse Event|1
7515525|NCT02449889|11850022|FG001|Overall Study|Adverse Event|2
7515526|NCT02449889|11850023|FG002|Overall Study|Adverse Event|0
7515527|NCT02449889|11850021|FG000|Overall Study|Protocol Violation|0
7515528|NCT02449889|11850022|FG001|Overall Study|Protocol Violation|4
7515529|NCT02449889|11850023|FG002|Overall Study|Protocol Violation|1
7515530|NCT02449902|11850033|FG000|Overall Study|Adverse Event|0
7515531|NCT02449902|11850034|FG001|Overall Study|Adverse Event|1
7515532|NCT02449902|11850033|FG000|Overall Study|Withdrawal by Subject|0
7515533|NCT02449902|11850034|FG001|Overall Study|Withdrawal by Subject|1
7515534|NCT02449915|11850044|FG000|Overall Study|Exclusion criteria - drug use|1
7515535|NCT02449915|11850045|FG001|Overall Study|Exclusion criteria - drug use|0
7515536|NCT02449915|11850044|FG000|Overall Study|Withdrawal by Subject|0
7515537|NCT02449915|11850045|FG001|Overall Study|Withdrawal by Subject|2
7515538|NCT02449915|11850044|FG000|Overall Study|Intraoperative surgical findings|1
7515539|NCT02449915|11850045|FG001|Overall Study|Intraoperative surgical findings|1
7515540|NCT02449915|11850044|FG000|Overall Study|Abnormal preop lab|0
7515541|NCT02449915|11850045|FG001|Overall Study|Abnormal preop lab|1
7515542|NCT02450487|11850060|FG000|Overall Study|Lost to Follow-up|3
7515543|NCT02450526|11850069|FG000|DB Period (Cycle 1)|Adverse Event|0
7515544|NCT02450526|11850070|FG001|DB Period (Cycle 1)|Adverse Event|0
7515545|NCT02450526|11850071|FG002|DB Period (Cycle 1)|Adverse Event|2
7515546|NCT02450526|11850072|FG003|DB Period (Cycle 1)|Adverse Event|0
7515547|NCT02450526|11850073|FG004|DB Period (Cycle 1)|Adverse Event|0
7515548|NCT02450526|11850069|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
7515549|NCT02450526|11850070|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
7515550|NCT02450526|11850071|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
7515551|NCT02450526|11850072|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
7515552|NCT02450526|11850073|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
7515553|NCT02450526|11850069|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
7515554|NCT02450526|11850070|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
7515555|NCT02450526|11850071|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
7515556|NCT02450526|11850072|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
7515557|NCT02450526|11850073|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
7515558|NCT02450526|11850069|FG000|DB Period (Cycle 1)|Protocol Violation|2
7515559|NCT02450526|11850070|FG001|DB Period (Cycle 1)|Protocol Violation|0
7515560|NCT02450526|11850071|FG002|DB Period (Cycle 1)|Protocol Violation|0
7515561|NCT02450526|11850072|FG003|DB Period (Cycle 1)|Protocol Violation|1
7515562|NCT02450526|11850073|FG004|DB Period (Cycle 1)|Protocol Violation|0
7515563|NCT02450526|11850069|FG000|OL Period (Cycles 2-5)|Adverse Event|0
7515564|NCT02450526|11850070|FG001|OL Period (Cycles 2-5)|Adverse Event|0
7515565|NCT02450526|11850071|FG002|OL Period (Cycles 2-5)|Adverse Event|0
7515566|NCT02450526|11850072|FG003|OL Period (Cycles 2-5)|Adverse Event|0
7515567|NCT02450526|11850073|FG004|OL Period (Cycles 2-5)|Adverse Event|2
7515568|NCT02450526|11850069|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7515569|NCT02450526|11850070|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7515570|NCT02450526|11850071|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7515571|NCT02450526|11850072|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
7515572|NCT02450526|11850073|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
7515573|NCT02450526|11850069|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
7515574|NCT02450526|11850070|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
7515575|NCT02450526|11850071|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
7515576|NCT02450526|11850072|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
7515577|NCT02450526|11850073|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
7515578|NCT02450526|11850069|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
7515579|NCT02450526|11850070|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
7515580|NCT02450526|11850071|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
7515581|NCT02450526|11850072|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
7515582|NCT02450526|11850073|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
7515583|NCT02450539|11850095|FG000|Overall Study|Withdrawal by Subject|12
7515584|NCT02450539|11850096|FG001|Overall Study|Withdrawal by Subject|6
7515585|NCT02450539|11850095|FG000|Overall Study|Lost to Follow-up|4
7515586|NCT02450539|11850096|FG001|Overall Study|Lost to Follow-up|1
7515587|NCT02450552|11850108|FG000|Overall Study|Withdrawal by Subject|4
7515588|NCT02450552|11850109|FG001|Overall Study|Withdrawal by Subject|0
7515589|NCT02450552|11850110|FG002|Overall Study|Withdrawal by Subject|4
7515590|NCT02450552|11850108|FG000|Overall Study|Physician Decision|1
7515591|NCT02450552|11850109|FG001|Overall Study|Physician Decision|0
7515592|NCT02450552|11850110|FG002|Overall Study|Physician Decision|1
7515593|NCT02450578|11850122|FG000|Overall Study|ECG abnormality so not treated|1
7515594|NCT02450578|11850123|FG001|Overall Study|ECG abnormality so not treated|0
7515595|NCT02450578|11850124|FG002|Overall Study|ECG abnormality so not treated|0
7515596|NCT02450578|11850125|FG003|Overall Study|ECG abnormality so not treated|0
7515597|NCT02450903|11850163|FG000|Overall Study|Adverse Event|3
7515598|NCT02450903|11850163|FG000|Overall Study|Progressive disease|15
7515599|NCT02450903|11850163|FG000|Overall Study|Switched to commercial drug|1
7515600|NCT02450903|11850163|FG000|Overall Study|Subject/guardian decision|1
7515601|NCT02451007|11850167|FG000|Overall Study|Withdrawal by Subject|4
7515602|NCT02451007|11850167|FG000|Overall Study|Adverse Event|1
7515603|NCT02451007|11850167|FG000|Overall Study|Disease Progression|2
7515604|NCT02451124|11850171|FG000|Overall Study|Withdrawal by Subject|1
7515605|NCT02451137|11850181|FG000|Overall Study|Randomized but not treated|19
7515606|NCT02451137|11850182|FG001|Overall Study|Randomized but not treated|27
7515607|NCT02451137|11850181|FG000|Overall Study|Adverse Event|43
7515608|NCT02451137|11850182|FG001|Overall Study|Adverse Event|42
7515609|NCT02451137|11850181|FG000|Overall Study|Lack of Efficacy|4
7515610|NCT02451137|11850182|FG001|Overall Study|Lack of Efficacy|9
7515611|NCT02451137|11850181|FG000|Overall Study|Participant decision:discontinue insulin|41
7515612|NCT02451137|11850182|FG001|Overall Study|Participant decision:discontinue insulin|43
7515613|NCT02451137|11850181|FG000|Overall Study|Hypoglycemia|2
7515614|NCT02451137|11850182|FG001|Overall Study|Hypoglycemia|1
7515615|NCT02451137|11850181|FG000|Overall Study|Investigator's decision|23
7515616|NCT02451137|11850182|FG001|Overall Study|Investigator's decision|19
7515617|NCT02451137|11850181|FG000|Overall Study|Lost to Follow-up|53
7515618|NCT02451137|11850182|FG001|Overall Study|Lost to Follow-up|61
7515619|NCT02451137|11850181|FG000|Overall Study|Physician Decision|6
7515620|NCT02451137|11850182|FG001|Overall Study|Physician Decision|5
7515621|NCT02451137|11850181|FG000|Overall Study|Sponsor decision|13
7515622|NCT02451137|11850182|FG001|Overall Study|Sponsor decision|25
7515623|NCT02451137|11850181|FG000|Overall Study|Withdrawal by Subject|40
7515624|NCT02451137|11850182|FG001|Overall Study|Withdrawal by Subject|63
7515625|NCT02451137|11850181|FG000|Overall Study|Other than specified above|2
7515626|NCT02451137|11850182|FG001|Overall Study|Other than specified above|3
7515627|NCT02451670|11850240|FG000|Overall Study|Did not have qualifying follow-up visit.|714
7515628|NCT02451670|11850241|FG001|Overall Study|Did not have qualifying follow-up visit.|696
7515629|NCT02451696|11850249|FG000|Overall Study|Surgery postponed|1
7515630|NCT02451696|11850250|FG001|Overall Study|Surgery postponed|0
7515631|NCT02451917|11850270|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
7515632|NCT02451917|11850271|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
7515633|NCT02451917|11850270|FG000|First Intervention (24 Weeks)|Death|0
7515634|NCT02451917|11850271|FG001|First Intervention (24 Weeks)|Death|1
7515635|NCT02451917|11850270|FG000|First Intervention (24 Weeks)|Adverse Event|0
7515636|NCT02451917|11850271|FG001|First Intervention (24 Weeks)|Adverse Event|2
7515637|NCT02451930|11850283|FG000|Overall Study|Death|0
7515638|NCT02451930|11850284|FG001|Overall Study|Death|15
7515639|NCT02451930|11850283|FG000|Overall Study|Lost to Follow-up|0
7515640|NCT02451930|11850284|FG001|Overall Study|Lost to Follow-up|3
7515641|NCT02451930|11850283|FG000|Overall Study|Sponsor Decision|2
7515642|NCT02451930|11850284|FG001|Overall Study|Sponsor Decision|10
7515643|NCT02451930|11850283|FG000|Overall Study|Withdrawal by Subject|0
7515644|NCT02451930|11850284|FG001|Overall Study|Withdrawal by Subject|1
7515645|NCT02451930|11850283|FG000|Overall Study|Other|0
7515646|NCT02451930|11850284|FG001|Overall Study|Other|1
7515647|NCT02452034|11850315|FG000|Overall Study|Adverse Event|0
7515648|NCT02452034|11850316|FG001|Overall Study|Adverse Event|0
7515649|NCT02452034|11850317|FG002|Overall Study|Adverse Event|0
7515650|NCT02452034|11850318|FG003|Overall Study|Adverse Event|0
7515651|NCT02452034|11850319|FG004|Overall Study|Adverse Event|0
7515652|NCT02452034|11850320|FG005|Overall Study|Adverse Event|1
7515653|NCT02452034|11850315|FG000|Overall Study|Death|0
7515654|NCT02452034|11850316|FG001|Overall Study|Death|0
7515655|NCT02452034|11850317|FG002|Overall Study|Death|0
7515656|NCT02452034|11850318|FG003|Overall Study|Death|0
7515657|NCT02452034|11850319|FG004|Overall Study|Death|1
7515658|NCT02452034|11850320|FG005|Overall Study|Death|1
7515659|NCT02452034|11850315|FG000|Overall Study|Physician Decision|0
7515660|NCT02452034|11850316|FG001|Overall Study|Physician Decision|1
7515661|NCT02452034|11850317|FG002|Overall Study|Physician Decision|1
7515662|NCT02452034|11850318|FG003|Overall Study|Physician Decision|0
7515663|NCT02452034|11850319|FG004|Overall Study|Physician Decision|0
7515664|NCT02452034|11850320|FG005|Overall Study|Physician Decision|0
7515665|NCT02452034|11850315|FG000|Overall Study|Protocol Violation|0
7515666|NCT02452034|11850316|FG001|Overall Study|Protocol Violation|0
7515667|NCT02452034|11850317|FG002|Overall Study|Protocol Violation|0
7515668|NCT02452034|11850318|FG003|Overall Study|Protocol Violation|0
7515669|NCT02452034|11850319|FG004|Overall Study|Protocol Violation|0
7515670|NCT02452034|11850320|FG005|Overall Study|Protocol Violation|1
7515671|NCT02452034|11850315|FG000|Overall Study|Screen Failure|1
7515672|NCT02452034|11850316|FG001|Overall Study|Screen Failure|0
7515673|NCT02452034|11850317|FG002|Overall Study|Screen Failure|0
7515674|NCT02452034|11850318|FG003|Overall Study|Screen Failure|1
7515675|NCT02452034|11850319|FG004|Overall Study|Screen Failure|0
7515676|NCT02452034|11850320|FG005|Overall Study|Screen Failure|0
7515677|NCT02452034|11850315|FG000|Overall Study|Withdrawn by Parent/Guardian|1
7515678|NCT02452034|11850316|FG001|Overall Study|Withdrawn by Parent/Guardian|0
7515679|NCT02452034|11850317|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7515680|NCT02452034|11850318|FG003|Overall Study|Withdrawn by Parent/Guardian|0
7515681|NCT02452034|11850319|FG004|Overall Study|Withdrawn by Parent/Guardian|0
7515682|NCT02452034|11850320|FG005|Overall Study|Withdrawn by Parent/Guardian|0
7515683|NCT02452047|11850337|FG000|Overall Study|Adverse Event|0
7515684|NCT02452047|11850338|FG001|Overall Study|Adverse Event|1
7515685|NCT02452047|11850339|FG002|Overall Study|Adverse Event|1
7515686|NCT02452047|11850337|FG000|Overall Study|Death|1
7515687|NCT02452047|11850338|FG001|Overall Study|Death|3
7515688|NCT02452047|11850339|FG002|Overall Study|Death|1
7515689|NCT02452047|11850337|FG000|Overall Study|Physician Decision|1
7515690|NCT02452047|11850338|FG001|Overall Study|Physician Decision|0
7515691|NCT02452047|11850339|FG002|Overall Study|Physician Decision|0
7515692|NCT02452047|11850337|FG000|Overall Study|Lost to Follow-up|1
7515693|NCT02452047|11850338|FG001|Overall Study|Lost to Follow-up|1
7515694|NCT02452047|11850339|FG002|Overall Study|Lost to Follow-up|0
7515695|NCT02452047|11850337|FG000|Overall Study|Withdrawal by Subject|1
7515696|NCT02452047|11850338|FG001|Overall Study|Withdrawal by Subject|0
7515697|NCT02452047|11850339|FG002|Overall Study|Withdrawal by Subject|0
7515698|NCT02452190|11850358|FG000|Overall Study|Withdrawal by Sponsor|1
7515699|NCT02452190|11850359|FG001|Overall Study|Withdrawal by Sponsor|3
7515700|NCT02452190|11850358|FG000|Overall Study|Pregnancy|1
7515701|NCT02452190|11850359|FG001|Overall Study|Pregnancy|0
7515702|NCT02452190|11850358|FG000|Overall Study|Investigator's Decision|2
7515703|NCT02452190|11850359|FG001|Overall Study|Investigator's Decision|0
7515704|NCT02452190|11850358|FG000|Overall Study|Lack of Efficacy|3
7515705|NCT02452190|11850359|FG001|Overall Study|Lack of Efficacy|1
7515706|NCT02452190|11850358|FG000|Overall Study|Lost to Follow-up|4
7515707|NCT02452190|11850359|FG001|Overall Study|Lost to Follow-up|3
7515708|NCT02452190|11850358|FG000|Overall Study|Adverse Event|2
7515709|NCT02452190|11850359|FG001|Overall Study|Adverse Event|5
7515710|NCT02452190|11850358|FG000|Overall Study|Withdrawal by Subject|20
7515711|NCT02452190|11850359|FG001|Overall Study|Withdrawal by Subject|11
7515712|NCT02452190|11850358|FG000|Overall Study|Noncompliance with study drug|1
7515713|NCT02452190|11850359|FG001|Overall Study|Noncompliance with study drug|0
7515714|NCT02452190|11850358|FG000|Overall Study|Participant traveled abroad|1
7515715|NCT02452190|11850359|FG001|Overall Study|Participant traveled abroad|0
7515716|NCT02452190|11850358|FG000|Overall Study|Death|0
7515717|NCT02452190|11850359|FG001|Overall Study|Death|1
7515718|NCT02452320|11850367|FG000|Overall Study|Adverse Event|0
7515719|NCT02452320|11850368|FG001|Overall Study|Adverse Event|1
7515720|NCT02452424|11850389|FG000|Overall Study|Death|2
7515721|NCT02452424|11850390|FG001|Overall Study|Death|2
7515722|NCT02452424|11850391|FG002|Overall Study|Death|2
7515723|NCT02452424|11850392|FG003|Overall Study|Death|6
7515724|NCT02452424|11850393|FG004|Overall Study|Death|2
7515725|NCT02452424|11850394|FG005|Overall Study|Death|0
7515726|NCT02452424|11850395|FG006|Overall Study|Death|5
7515727|NCT02452424|11850396|FG007|Overall Study|Death|1
7515728|NCT02452424|11850397|FG008|Overall Study|Death|3
7515729|NCT02452424|11850398|FG009|Overall Study|Death|1
7515730|NCT02452424|11850399|FG010|Overall Study|Death|0
7515731|NCT02452424|11850389|FG000|Overall Study|Lost to Follow-up|0
7515732|NCT02452424|11850390|FG001|Overall Study|Lost to Follow-up|1
7515733|NCT02452424|11850391|FG002|Overall Study|Lost to Follow-up|1
7515734|NCT02452424|11850392|FG003|Overall Study|Lost to Follow-up|0
7515735|NCT02452424|11850393|FG004|Overall Study|Lost to Follow-up|0
7515736|NCT02452424|11850394|FG005|Overall Study|Lost to Follow-up|0
7515737|NCT02452424|11850395|FG006|Overall Study|Lost to Follow-up|0
7515738|NCT02452424|11850396|FG007|Overall Study|Lost to Follow-up|0
7515739|NCT02452424|11850397|FG008|Overall Study|Lost to Follow-up|0
7515740|NCT02452424|11850398|FG009|Overall Study|Lost to Follow-up|0
7515741|NCT02452424|11850399|FG010|Overall Study|Lost to Follow-up|0
7515742|NCT02452424|11850389|FG000|Overall Study|Withdrawal by Subject|0
7515743|NCT02452424|11850390|FG001|Overall Study|Withdrawal by Subject|0
7515744|NCT02452424|11850391|FG002|Overall Study|Withdrawal by Subject|3
7515745|NCT02452424|11850392|FG003|Overall Study|Withdrawal by Subject|2
7515746|NCT02452424|11850393|FG004|Overall Study|Withdrawal by Subject|0
7515747|NCT02452424|11850394|FG005|Overall Study|Withdrawal by Subject|0
7515748|NCT02452424|11850395|FG006|Overall Study|Withdrawal by Subject|1
7515749|NCT02452424|11850396|FG007|Overall Study|Withdrawal by Subject|0
7515750|NCT02452424|11850397|FG008|Overall Study|Withdrawal by Subject|1
7515751|NCT02452424|11850398|FG009|Overall Study|Withdrawal by Subject|1
7515752|NCT02452424|11850399|FG010|Overall Study|Withdrawal by Subject|0
7515753|NCT02452424|11850389|FG000|Overall Study|Other|0
7515754|NCT02452424|11850390|FG001|Overall Study|Other|0
7515755|NCT02452424|11850391|FG002|Overall Study|Other|1
7515756|NCT02452424|11850392|FG003|Overall Study|Other|0
7515757|NCT02452424|11850393|FG004|Overall Study|Other|0
7515758|NCT02452424|11850394|FG005|Overall Study|Other|1
7515759|NCT02452424|11850395|FG006|Overall Study|Other|4
7515760|NCT02452424|11850396|FG007|Overall Study|Other|3
7515761|NCT02452424|11850397|FG008|Overall Study|Other|0
7515762|NCT02452424|11850398|FG009|Overall Study|Other|0
7515763|NCT02452424|11850399|FG010|Overall Study|Other|1
7515764|NCT02452424|11850389|FG000|Overall Study|Progressive disease (per RECIST)|0
7515765|NCT02452424|11850390|FG001|Overall Study|Progressive disease (per RECIST)|0
7515766|NCT02452424|11850391|FG002|Overall Study|Progressive disease (per RECIST)|0
7515767|NCT02452424|11850392|FG003|Overall Study|Progressive disease (per RECIST)|0
7515768|NCT02452424|11850393|FG004|Overall Study|Progressive disease (per RECIST)|0
7515769|NCT02452424|11850394|FG005|Overall Study|Progressive disease (per RECIST)|0
7515770|NCT02452424|11850395|FG006|Overall Study|Progressive disease (per RECIST)|0
7515771|NCT02452424|11850396|FG007|Overall Study|Progressive disease (per RECIST)|0
7515772|NCT02452424|11850397|FG008|Overall Study|Progressive disease (per RECIST)|2
7515773|NCT02452424|11850398|FG009|Overall Study|Progressive disease (per RECIST)|0
7515774|NCT02452424|11850399|FG010|Overall Study|Progressive disease (per RECIST)|0
7515775|NCT02452424|11850389|FG000|Overall Study|Adverse Event|0
7515776|NCT02452424|11850390|FG001|Overall Study|Adverse Event|0
7515777|NCT02452424|11850391|FG002|Overall Study|Adverse Event|0
7515778|NCT02452424|11850392|FG003|Overall Study|Adverse Event|0
7515779|NCT02452424|11850393|FG004|Overall Study|Adverse Event|0
7515780|NCT02452424|11850394|FG005|Overall Study|Adverse Event|0
7515781|NCT02452424|11850395|FG006|Overall Study|Adverse Event|0
7515782|NCT02452424|11850396|FG007|Overall Study|Adverse Event|0
7515783|NCT02452424|11850397|FG008|Overall Study|Adverse Event|0
7515784|NCT02452424|11850398|FG009|Overall Study|Adverse Event|0
7515785|NCT02452424|11850399|FG010|Overall Study|Adverse Event|1
7515786|NCT02452463|11850428|FG000|Overall Study|Death|1
7515787|NCT02452463|11850429|FG001|Overall Study|Death|0
7515788|NCT02452463|11850430|FG002|Overall Study|Death|0
7515789|NCT02452463|11850428|FG000|Overall Study|Study Suspended|1
7515790|NCT02452463|11850429|FG001|Overall Study|Study Suspended|0
7515791|NCT02452463|11850430|FG002|Overall Study|Study Suspended|0
7515792|NCT02452463|11850428|FG000|Overall Study|Recommended by DSMB|0
7515793|NCT02452463|11850429|FG001|Overall Study|Recommended by DSMB|1
7515794|NCT02452463|11850430|FG002|Overall Study|Recommended by DSMB|0
7515795|NCT02452463|11850428|FG000|Overall Study|Withdrawal by Subject|0
7515796|NCT02452463|11850429|FG001|Overall Study|Withdrawal by Subject|1
7515797|NCT02452463|11850430|FG002|Overall Study|Withdrawal by Subject|0
7515798|NCT02452476|11850440|FG000|Overall Study|Death|4
7515799|NCT02452476|11850441|FG001|Overall Study|Death|7
7515800|NCT02452476|11850440|FG000|Overall Study|Lost to Follow-up|1
7515801|NCT02452476|11850441|FG001|Overall Study|Lost to Follow-up|1
7515802|NCT02452476|11850440|FG000|Overall Study|Physician Decision|1
7515803|NCT02452476|11850441|FG001|Overall Study|Physician Decision|1
7515804|NCT02452476|11850440|FG000|Overall Study|Not treated|5
7515805|NCT02452476|11850441|FG001|Overall Study|Not treated|1
7515806|NCT02452762|11850458|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
7515807|NCT02452762|11850459|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
7515808|NCT02452762|11850458|FG000|Overall Study|Withdrawal by Subject|1
7515809|NCT02452762|11850459|FG001|Overall Study|Withdrawal by Subject|0
7515810|NCT02452892|11850474|FG000|Week 1 Initial Randommization|Adverse Event|1
7515811|NCT02452892|11850475|FG001|Week 1 Initial Randommization|Adverse Event|0
7515812|NCT02452892|11850476|FG002|Week 1 Initial Randommization|Adverse Event|0
7515813|NCT02452892|11850477|FG003|Week 1 Initial Randommization|Adverse Event|0
7515814|NCT02452892|11850474|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
7515815|NCT02452892|11850475|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
7515816|NCT02452892|11850476|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
7515817|NCT02452892|11850477|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
7515818|NCT02452892|11850474|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7515819|NCT02452892|11850475|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7515820|NCT02452892|11850476|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
7515821|NCT02452892|11850477|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
7515822|NCT02452892|11850474|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
7515823|NCT02452892|11850475|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7515824|NCT02452892|11850476|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7515825|NCT02452892|11850477|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
7515826|NCT02452892|11850474|FG000|Follow-up|Withdrawal by Subject|0
7515827|NCT02452892|11850475|FG001|Follow-up|Withdrawal by Subject|0
7515828|NCT02452892|11850476|FG002|Follow-up|Withdrawal by Subject|0
7515829|NCT02452892|11850477|FG003|Follow-up|Withdrawal by Subject|1
7515830|NCT02452892|11850474|FG000|Follow-up|Subject left town on Day 42|1
7515831|NCT02452892|11850475|FG001|Follow-up|Subject left town on Day 42|0
7515832|NCT02452892|11850476|FG002|Follow-up|Subject left town on Day 42|0
7515833|NCT02452892|11850477|FG003|Follow-up|Subject left town on Day 42|0
7515834|NCT02453048|11850510|FG000|Overall Study|Only part of initial 6 mo. study|0
7515835|NCT02453048|11850511|FG001|Overall Study|Only part of initial 6 mo. study|0
7515836|NCT02453048|11850512|FG002|Overall Study|Only part of initial 6 mo. study|0
7515837|NCT02453048|11850513|FG003|Overall Study|Only part of initial 6 mo. study|0
7515838|NCT02453048|11850514|FG004|Overall Study|Only part of initial 6 mo. study|6
7515839|NCT02453048|11850510|FG000|Overall Study|Lost to Follow-up|0
7515840|NCT02453048|11850511|FG001|Overall Study|Lost to Follow-up|1
7515841|NCT02453048|11850512|FG002|Overall Study|Lost to Follow-up|2
7515842|NCT02453048|11850513|FG003|Overall Study|Lost to Follow-up|0
7515843|NCT02453048|11850514|FG004|Overall Study|Lost to Follow-up|0
7515844|NCT02453191|11850530|FG000|Overall Study|Withdrawal by Subject|1
7515845|NCT02453256|11850536|FG000|Double Blind Period|Death|1
7515846|NCT02453256|11850537|FG001|Double Blind Period|Death|1
7515847|NCT02453256|11850536|FG000|Double Blind Period|Adverse Event|3
7515848|NCT02453256|11850537|FG001|Double Blind Period|Adverse Event|2
7515849|NCT02453256|11850536|FG000|Double Blind Period|Withdrawal by Subject|9
7515850|NCT02453256|11850537|FG001|Double Blind Period|Withdrawal by Subject|5
7515851|NCT02453256|11850536|FG000|Double Blind Period|Other|0
7515852|NCT02453256|11850537|FG001|Double Blind Period|Other|1
7515853|NCT02453256|11850536|FG000|Open Label Period|Adverse Event|1
7515854|NCT02453256|11850537|FG001|Open Label Period|Adverse Event|3
7515855|NCT02453256|11850536|FG000|Open Label Period|Death|0
7515856|NCT02453256|11850537|FG001|Open Label Period|Death|1
7515857|NCT02453256|11850536|FG000|Open Label Period|Lost to Follow-up|1
7515858|NCT02453256|11850537|FG001|Open Label Period|Lost to Follow-up|0
7515859|NCT02453256|11850536|FG000|Open Label Period|Other|0
7515860|NCT02453256|11850537|FG001|Open Label Period|Other|2
7515861|NCT02453256|11850536|FG000|Open Label Period|Withdrawal by Subject|5
7515862|NCT02453256|11850537|FG001|Open Label Period|Withdrawal by Subject|1
7515878|NCT02453321|11850568|FG000|Overall Study|Weakness|1
7515879|NCT02453321|11850569|FG001|Overall Study|Weakness|1
7515880|NCT02453321|11850570|FG002|Overall Study|Weakness|2
7515881|NCT02453321|11850568|FG000|Overall Study|Deep Venous Thrombosis|0
7515882|NCT02453321|11850569|FG001|Overall Study|Deep Venous Thrombosis|1
7515883|NCT02453321|11850570|FG002|Overall Study|Deep Venous Thrombosis|0
7515884|NCT02453334|11850583|FG000|Overall Study|Death|15
7515885|NCT02453334|11850584|FG001|Overall Study|Death|13
7515886|NCT02453334|11850583|FG000|Overall Study|Adverse Event|2
7515887|NCT02453334|11850584|FG001|Overall Study|Adverse Event|1
7515888|NCT02453334|11850583|FG000|Overall Study|Lost to Follow-up|5
7515889|NCT02453334|11850584|FG001|Overall Study|Lost to Follow-up|9
7515890|NCT02453334|11850583|FG000|Overall Study|Physician Decision|1
7515891|NCT02453334|11850584|FG001|Overall Study|Physician Decision|0
7515892|NCT02453334|11850583|FG000|Overall Study|Withdrawal by Subject|17
7515893|NCT02453334|11850584|FG001|Overall Study|Withdrawal by Subject|13
7515894|NCT02453334|11850583|FG000|Overall Study|Other reason|1
7515895|NCT02453334|11850584|FG001|Overall Study|Other reason|4
7515896|NCT02453386|11850610|FG000|Overall Study|Adverse Event|22
7515897|NCT02453386|11850611|FG001|Overall Study|Adverse Event|30
7515898|NCT02453386|11850612|FG002|Overall Study|Adverse Event|15
7515899|NCT02453386|11850610|FG000|Overall Study|Protocol Violation|1
7515900|NCT02453386|11850611|FG001|Overall Study|Protocol Violation|0
7515901|NCT02453386|11850612|FG002|Overall Study|Protocol Violation|1
7515902|NCT02453386|11850610|FG000|Overall Study|Withdrawal by Subject|10
7515903|NCT02453386|11850611|FG001|Overall Study|Withdrawal by Subject|9
7515904|NCT02453386|11850612|FG002|Overall Study|Withdrawal by Subject|9
7515905|NCT02453386|11850610|FG000|Overall Study|Sponsor Terminated Study|14
7515906|NCT02453386|11850611|FG001|Overall Study|Sponsor Terminated Study|8
7515907|NCT02453386|11850612|FG002|Overall Study|Sponsor Terminated Study|11
7515908|NCT02453386|11850610|FG000|Overall Study|Subject Terminated by Sponsor|1
7515909|NCT02453386|11850611|FG001|Overall Study|Subject Terminated by Sponsor|1
7515910|NCT02453386|11850612|FG002|Overall Study|Subject Terminated by Sponsor|1
7515911|NCT02453386|11850610|FG000|Overall Study|Sponsor Terminated by Investigator|0
7515912|NCT02453386|11850611|FG001|Overall Study|Sponsor Terminated by Investigator|1
7515913|NCT02453386|11850612|FG002|Overall Study|Sponsor Terminated by Investigator|2
7515914|NCT02453386|11850610|FG000|Overall Study|Lost to Follow-up|0
7515915|NCT02453386|11850611|FG001|Overall Study|Lost to Follow-up|0
7515916|NCT02453386|11850612|FG002|Overall Study|Lost to Follow-up|1
7515917|NCT02453386|11850610|FG000|Overall Study|Other|1
7515918|NCT02453386|11850611|FG001|Overall Study|Other|0
7515919|NCT02453386|11850612|FG002|Overall Study|Other|1
7515920|NCT02453555|11850629|FG000|24-week Double-blind Treatment Period|Adverse Event|2
7515921|NCT02453555|11850630|FG001|24-week Double-blind Treatment Period|Adverse Event|0
7515922|NCT02453555|11850631|FG002|24-week Double-blind Treatment Period|Adverse Event|0
7515923|NCT02453555|11850632|FG003|24-week Double-blind Treatment Period|Adverse Event|0
7515924|NCT02453555|11850633|FG004|24-week Double-blind Treatment Period|Adverse Event|0
7515925|NCT02453555|11850634|FG005|24-week Double-blind Treatment Period|Adverse Event|0
7515926|NCT02453555|11850629|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
7515927|NCT02453555|11850630|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
7515928|NCT02453555|11850631|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
7515929|NCT02453555|11850632|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
7515930|NCT02453555|11850633|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
7515931|NCT02453555|11850634|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
7515932|NCT02453555|11850629|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
7515933|NCT02453555|11850630|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
7515934|NCT02453555|11850631|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7515935|NCT02453555|11850632|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7515936|NCT02453555|11850633|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7515937|NCT02453555|11850634|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
7515938|NCT02453555|11850629|FG000|24-week Double-blind Treatment Period|Other than specified above|0
7515939|NCT02453555|11850630|FG001|24-week Double-blind Treatment Period|Other than specified above|3
7515940|NCT02453555|11850631|FG002|24-week Double-blind Treatment Period|Other than specified above|0
7515941|NCT02453555|11850632|FG003|24-week Double-blind Treatment Period|Other than specified above|0
7515942|NCT02453555|11850633|FG004|24-week Double-blind Treatment Period|Other than specified above|0
7515943|NCT02453555|11850634|FG005|24-week Double-blind Treatment Period|Other than specified above|0
7515944|NCT02453555|11850629|FG000|Extension Period|Adverse Event|0
7515945|NCT02453555|11850630|FG001|Extension Period|Adverse Event|0
7515946|NCT02453555|11850631|FG002|Extension Period|Adverse Event|1
7515947|NCT02453555|11850632|FG003|Extension Period|Adverse Event|2
7515948|NCT02453555|11850633|FG004|Extension Period|Adverse Event|1
7515949|NCT02453555|11850634|FG005|Extension Period|Adverse Event|1
7515950|NCT02453555|11850629|FG000|Extension Period|Protocol Violation|0
7515951|NCT02453555|11850630|FG001|Extension Period|Protocol Violation|0
7515952|NCT02453555|11850631|FG002|Extension Period|Protocol Violation|1
7515953|NCT02453555|11850632|FG003|Extension Period|Protocol Violation|0
7515954|NCT02453555|11850633|FG004|Extension Period|Protocol Violation|0
7515955|NCT02453555|11850634|FG005|Extension Period|Protocol Violation|0
7515956|NCT02453555|11850629|FG000|Extension Period|Withdrawal by Subject|0
7515957|NCT02453555|11850630|FG001|Extension Period|Withdrawal by Subject|0
7515958|NCT02453555|11850631|FG002|Extension Period|Withdrawal by Subject|1
7515959|NCT02453555|11850632|FG003|Extension Period|Withdrawal by Subject|0
7515960|NCT02453555|11850633|FG004|Extension Period|Withdrawal by Subject|0
7515961|NCT02453555|11850634|FG005|Extension Period|Withdrawal by Subject|0
7515962|NCT02453685|11850678|FG000|Overall Study|Adverse Event|0
7515963|NCT02453685|11850679|FG001|Overall Study|Adverse Event|1
7515964|NCT02453685|11850678|FG000|Overall Study|Protocol Violation|7
7515965|NCT02453685|11850679|FG001|Overall Study|Protocol Violation|4
7515966|NCT02453685|11850678|FG000|Overall Study|Lost to Follow-up|0
7515967|NCT02453685|11850679|FG001|Overall Study|Lost to Follow-up|1
7515968|NCT02453685|11850678|FG000|Overall Study|Withdrawal by Subject|8
7515969|NCT02453685|11850679|FG001|Overall Study|Withdrawal by Subject|4
7515970|NCT02453685|11850678|FG000|Overall Study|Unclassified|4
7515971|NCT02453685|11850679|FG001|Overall Study|Unclassified|2
7515972|NCT02453711|11850694|FG000|Overall Study|Withdrawal by Subject|5
7515973|NCT02453711|11850695|FG001|Overall Study|Withdrawal by Subject|4
7515974|NCT02453711|11850696|FG002|Overall Study|Withdrawal by Subject|6
7515975|NCT02453711|11850697|FG003|Overall Study|Withdrawal by Subject|4
7515976|NCT02453711|11850698|FG004|Overall Study|Withdrawal by Subject|1
7515977|NCT02453711|11850699|FG005|Overall Study|Withdrawal by Subject|1
7515978|NCT02453711|11850700|FG006|Overall Study|Withdrawal by Subject|0
7515979|NCT02453711|11850701|FG007|Overall Study|Withdrawal by Subject|1
7515980|NCT02453711|11850702|FG008|Overall Study|Withdrawal by Subject|7
7515981|NCT02453711|11850694|FG000|Overall Study|Lost to Follow-up|5
7515982|NCT02453711|11850695|FG001|Overall Study|Lost to Follow-up|3
7515983|NCT02453711|11850696|FG002|Overall Study|Lost to Follow-up|2
7515984|NCT02453711|11850697|FG003|Overall Study|Lost to Follow-up|3
7515985|NCT02453711|11850698|FG004|Overall Study|Lost to Follow-up|1
7515986|NCT02453711|11850699|FG005|Overall Study|Lost to Follow-up|5
7515987|NCT02453711|11850700|FG006|Overall Study|Lost to Follow-up|2
7515988|NCT02453711|11850701|FG007|Overall Study|Lost to Follow-up|6
7515989|NCT02453711|11850702|FG008|Overall Study|Lost to Follow-up|6
7515990|NCT02453711|11850694|FG000|Overall Study|Death|0
7515991|NCT02453711|11850695|FG001|Overall Study|Death|0
7515992|NCT02453711|11850696|FG002|Overall Study|Death|0
7515993|NCT02453711|11850697|FG003|Overall Study|Death|0
7515994|NCT02453711|11850698|FG004|Overall Study|Death|0
7515995|NCT02453711|11850699|FG005|Overall Study|Death|0
7515996|NCT02453711|11850700|FG006|Overall Study|Death|1
7515997|NCT02453711|11850701|FG007|Overall Study|Death|0
7515998|NCT02453711|11850702|FG008|Overall Study|Death|0
7515999|NCT02453711|11850694|FG000|Overall Study|Unclassified|1
7516000|NCT02453711|11850695|FG001|Overall Study|Unclassified|0
7516001|NCT02453711|11850696|FG002|Overall Study|Unclassified|1
7516002|NCT02453711|11850697|FG003|Overall Study|Unclassified|0
7516003|NCT02453711|11850698|FG004|Overall Study|Unclassified|0
7516004|NCT02453711|11850699|FG005|Overall Study|Unclassified|0
7516005|NCT02453711|11850700|FG006|Overall Study|Unclassified|0
7516006|NCT02453711|11850701|FG007|Overall Study|Unclassified|0
7516007|NCT02453711|11850702|FG008|Overall Study|Unclassified|0
7516008|NCT02453841|11850729|FG000|Overall Study|Protocol Violation|1
7516009|NCT02453841|11850729|FG000|Overall Study|Unable to obtain blood samples|2
7516010|NCT02454101|11850741|FG000|Overall Study|Adverse Event|2
7516011|NCT02454101|11850742|FG001|Overall Study|Adverse Event|3
7516012|NCT02454101|11850741|FG000|Overall Study|Lost to Follow-up|3
7516013|NCT02454101|11850742|FG001|Overall Study|Lost to Follow-up|4
7516014|NCT02454478|11850804|FG000|Overall Study|Incomplete DLT Evaluation|1
7516015|NCT02454530|11850810|FG000|Overall Study|Other|8
7516016|NCT02454530|11850811|FG001|Overall Study|Other|13
7516017|NCT02454530|11850810|FG000|Overall Study|Missing information|56
7516018|NCT02454530|11850811|FG001|Overall Study|Missing information|69
7516019|NCT02454530|11850810|FG000|Overall Study|Death|2
7516020|NCT02454530|11850811|FG001|Overall Study|Death|41
7516021|NCT02454530|11850810|FG000|Overall Study|Lost to Follow-up|4
7516022|NCT02454530|11850811|FG001|Overall Study|Lost to Follow-up|4
7516023|NCT02454608|11850821|FG000|Double-Blind Period|Lack of Efficacy|0
7516024|NCT02454608|11850822|FG001|Double-Blind Period|Lack of Efficacy|2
7516025|NCT02454608|11850823|FG002|Double-Blind Period|Lack of Efficacy|0
7516026|NCT02454608|11850821|FG000|Open Label Period|Lost to Follow-up|0
7516027|NCT02454608|11850822|FG001|Open Label Period|Lost to Follow-up|0
7516028|NCT02454608|11850823|FG002|Open Label Period|Lost to Follow-up|11
7516029|NCT02454608|11850821|FG000|Open Label Period|Withdrawal by Subject|0
7516030|NCT02454608|11850822|FG001|Open Label Period|Withdrawal by Subject|0
7516031|NCT02454608|11850823|FG002|Open Label Period|Withdrawal by Subject|8
7516032|NCT02454959|11850831|FG000|Overall Study|Protocol-Specified Criteria|3
7516033|NCT02454959|11850831|FG000|Overall Study|Physician Decision|1
7516034|NCT02454959|11850831|FG000|Overall Study|Withdrawal by Subject|3
7516035|NCT02454959|11850831|FG000|Overall Study|Adverse Event|2
7516036|NCT02454972|11850846|FG000|Overall Study|Progressive disease|17
7516037|NCT02454972|11850847|FG001|Overall Study|Progressive disease|16
7516038|NCT02454972|11850848|FG002|Overall Study|Progressive disease|59
7516039|NCT02454972|11850849|FG003|Overall Study|Progressive disease|23
7516040|NCT02454972|11850850|FG004|Overall Study|Progressive disease|16
7516041|NCT02454972|11850851|FG005|Overall Study|Progressive disease|12
7516042|NCT02454972|11850852|FG006|Overall Study|Progressive disease|19
7516043|NCT02454972|11850853|FG007|Overall Study|Progressive disease|27
7516044|NCT02454972|11850854|FG008|Overall Study|Progressive disease|84
7516045|NCT02454972|11850846|FG000|Overall Study|Death|0
7516046|NCT02454972|11850847|FG001|Overall Study|Death|0
7516047|NCT02454972|11850848|FG002|Overall Study|Death|5
7516048|NCT02454972|11850849|FG003|Overall Study|Death|1
7516049|NCT02454972|11850850|FG004|Overall Study|Death|0
7516050|NCT02454972|11850851|FG005|Overall Study|Death|0
7516051|NCT02454972|11850852|FG006|Overall Study|Death|0
7516052|NCT02454972|11850853|FG007|Overall Study|Death|0
7516053|NCT02454972|11850854|FG008|Overall Study|Death|2
7516054|NCT02454972|11850846|FG000|Overall Study|Physician Decision|0
7516055|NCT02454972|11850847|FG001|Overall Study|Physician Decision|1
7516056|NCT02454972|11850848|FG002|Overall Study|Physician Decision|2
7516057|NCT02454972|11850849|FG003|Overall Study|Physician Decision|1
7516058|NCT02454972|11850850|FG004|Overall Study|Physician Decision|2
7516059|NCT02454972|11850851|FG005|Overall Study|Physician Decision|0
7516060|NCT02454972|11850852|FG006|Overall Study|Physician Decision|0
7516061|NCT02454972|11850853|FG007|Overall Study|Physician Decision|1
7516062|NCT02454972|11850854|FG008|Overall Study|Physician Decision|4
7516063|NCT02454972|11850846|FG000|Overall Study|Non treatment-related adverse event|2
7516064|NCT02454972|11850847|FG001|Overall Study|Non treatment-related adverse event|0
7516065|NCT02454972|11850848|FG002|Overall Study|Non treatment-related adverse event|1
7516066|NCT02454972|11850849|FG003|Overall Study|Non treatment-related adverse event|0
7516067|NCT02454972|11850850|FG004|Overall Study|Non treatment-related adverse event|0
7516068|NCT02454972|11850851|FG005|Overall Study|Non treatment-related adverse event|1
7516069|NCT02454972|11850852|FG006|Overall Study|Non treatment-related adverse event|0
7516070|NCT02454972|11850853|FG007|Overall Study|Non treatment-related adverse event|1
7516071|NCT02454972|11850854|FG008|Overall Study|Non treatment-related adverse event|0
7516072|NCT02454972|11850846|FG000|Overall Study|Treatment-related adverse events|0
7516073|NCT02454972|11850847|FG001|Overall Study|Treatment-related adverse events|1
7516074|NCT02454972|11850848|FG002|Overall Study|Treatment-related adverse events|1
7516075|NCT02454972|11850849|FG003|Overall Study|Treatment-related adverse events|0
7516076|NCT02454972|11850850|FG004|Overall Study|Treatment-related adverse events|2
7516077|NCT02454972|11850851|FG005|Overall Study|Treatment-related adverse events|0
7516078|NCT02454972|11850852|FG006|Overall Study|Treatment-related adverse events|0
7516079|NCT02454972|11850853|FG007|Overall Study|Treatment-related adverse events|2
7516080|NCT02454972|11850854|FG008|Overall Study|Treatment-related adverse events|2
7516081|NCT02454972|11850846|FG000|Overall Study|Patient moves to compassionate use|0
7516082|NCT02454972|11850847|FG001|Overall Study|Patient moves to compassionate use|0
7516083|NCT02454972|11850848|FG002|Overall Study|Patient moves to compassionate use|0
7516084|NCT02454972|11850849|FG003|Overall Study|Patient moves to compassionate use|0
7516085|NCT02454972|11850850|FG004|Overall Study|Patient moves to compassionate use|0
7516086|NCT02454972|11850851|FG005|Overall Study|Patient moves to compassionate use|0
7516087|NCT02454972|11850852|FG006|Overall Study|Patient moves to compassionate use|2
7516088|NCT02454972|11850853|FG007|Overall Study|Patient moves to compassionate use|0
7516089|NCT02454972|11850854|FG008|Overall Study|Patient moves to compassionate use|11
7516090|NCT02454972|11850846|FG000|Overall Study|Withdrawal by Subject|0
7516091|NCT02454972|11850847|FG001|Overall Study|Withdrawal by Subject|1
7516092|NCT02454972|11850848|FG002|Overall Study|Withdrawal by Subject|5
7516093|NCT02454972|11850849|FG003|Overall Study|Withdrawal by Subject|2
7516094|NCT02454972|11850850|FG004|Overall Study|Withdrawal by Subject|3
7516095|NCT02454972|11850851|FG005|Overall Study|Withdrawal by Subject|2
7516096|NCT02454972|11850852|FG006|Overall Study|Withdrawal by Subject|0
7516097|NCT02454972|11850853|FG007|Overall Study|Withdrawal by Subject|1
7516098|NCT02454972|11850854|FG008|Overall Study|Withdrawal by Subject|2
7516099|NCT02454972|11850846|FG000|Overall Study|Multiple delay/holds on treatment|0
7516100|NCT02454972|11850847|FG001|Overall Study|Multiple delay/holds on treatment|0
7516101|NCT02454972|11850848|FG002|Overall Study|Multiple delay/holds on treatment|0
7516102|NCT02454972|11850849|FG003|Overall Study|Multiple delay/holds on treatment|1
7516103|NCT02454972|11850850|FG004|Overall Study|Multiple delay/holds on treatment|0
7516104|NCT02454972|11850851|FG005|Overall Study|Multiple delay/holds on treatment|0
7516105|NCT02454972|11850852|FG006|Overall Study|Multiple delay/holds on treatment|0
7516106|NCT02454972|11850853|FG007|Overall Study|Multiple delay/holds on treatment|0
7516107|NCT02454972|11850854|FG008|Overall Study|Multiple delay/holds on treatment|0
7516108|NCT02454972|11850846|FG000|Overall Study|Never treated|0
7516109|NCT02454972|11850847|FG001|Overall Study|Never treated|0
7516110|NCT02454972|11850848|FG002|Overall Study|Never treated|3
7516111|NCT02454972|11850849|FG003|Overall Study|Never treated|1
7516112|NCT02454972|11850850|FG004|Overall Study|Never treated|1
7516113|NCT02454972|11850851|FG005|Overall Study|Never treated|0
7516114|NCT02454972|11850852|FG006|Overall Study|Never treated|0
7516115|NCT02454972|11850853|FG007|Overall Study|Never treated|0
7516116|NCT02454972|11850854|FG008|Overall Study|Never treated|5
7516117|NCT02455050|11850870|FG000|Treatment Period 1|Lost to Follow-up|1
7516118|NCT02455050|11850871|FG001|Treatment Period 1|Lost to Follow-up|1
7516119|NCT02455050|11850872|FG002|Treatment Period 1|Lost to Follow-up|1
7516120|NCT02455050|11850873|FG003|Treatment Period 1|Lost to Follow-up|2
7516121|NCT02455050|11850870|FG000|Treatment Period 2|Lost to Follow-up|1
7516122|NCT02455050|11850871|FG001|Treatment Period 2|Lost to Follow-up|0
7516123|NCT02455050|11850872|FG002|Treatment Period 2|Lost to Follow-up|2
7516124|NCT02455050|11850873|FG003|Treatment Period 2|Lost to Follow-up|1
7516125|NCT02455076|11850898|FG000|Inpatient|Withdrawal by Subject|1
7516126|NCT02455076|11850899|FG001|Inpatient|Withdrawal by Subject|0
7516127|NCT02455076|11850900|FG002|Inpatient|Withdrawal by Subject|0
7516128|NCT02455076|11850901|FG003|Inpatient|Withdrawal by Subject|0
7516129|NCT02455076|11850902|FG004|Inpatient|Withdrawal by Subject|0
7516130|NCT02455076|11850898|FG000|Inpatient|Discharged <24 h after admission|0
7516131|NCT02455076|11850899|FG001|Inpatient|Discharged <24 h after admission|1
7516132|NCT02455076|11850900|FG002|Inpatient|Discharged <24 h after admission|0
7516133|NCT02455076|11850901|FG003|Inpatient|Discharged <24 h after admission|0
7516134|NCT02455076|11850902|FG004|Inpatient|Discharged <24 h after admission|0
7516135|NCT02455076|11850898|FG000|Inpatient|Adverse Event|3
7516136|NCT02455076|11850899|FG001|Inpatient|Adverse Event|0
7516137|NCT02455076|11850900|FG002|Inpatient|Adverse Event|0
7516138|NCT02455076|11850901|FG003|Inpatient|Adverse Event|0
7516139|NCT02455076|11850902|FG004|Inpatient|Adverse Event|0
7516140|NCT02455076|11850898|FG000|Outpatient|Adverse Event|0
7516141|NCT02455076|11850899|FG001|Outpatient|Adverse Event|0
7516142|NCT02455076|11850900|FG002|Outpatient|Adverse Event|0
7516143|NCT02455076|11850901|FG003|Outpatient|Adverse Event|5
7516144|NCT02455076|11850902|FG004|Outpatient|Adverse Event|0
7516145|NCT02455076|11850898|FG000|Outpatient|Lost to Follow-up|0
7516146|NCT02455076|11850899|FG001|Outpatient|Lost to Follow-up|0
7516147|NCT02455076|11850900|FG002|Outpatient|Lost to Follow-up|0
7516148|NCT02455076|11850901|FG003|Outpatient|Lost to Follow-up|1
7516149|NCT02455076|11850902|FG004|Outpatient|Lost to Follow-up|12
7516150|NCT02455336|11850920|FG000|Overall Study|Withdrawal by Subject|0
7516151|NCT02455336|11850921|FG001|Overall Study|Withdrawal by Subject|2
7516152|NCT02455336|11850920|FG000|Overall Study|Adverse Event|3
7516153|NCT02455336|11850921|FG001|Overall Study|Adverse Event|0
7516154|NCT02455336|11850920|FG000|Overall Study|Non-responder to treatment|2
7516155|NCT02455336|11850921|FG001|Overall Study|Non-responder to treatment|0
7516156|NCT02455388|11850929|FG000|Overall Study|Protocol Violation|1
7516157|NCT02455388|11850930|FG001|Overall Study|Protocol Violation|0
7516158|NCT02455388|11850931|FG002|Overall Study|Protocol Violation|4
7516159|NCT02455388|11850929|FG000|Overall Study|Withdrawal by Subject|0
7516160|NCT02455388|11850930|FG001|Overall Study|Withdrawal by Subject|0
7516161|NCT02455388|11850931|FG002|Overall Study|Withdrawal by Subject|7
7516162|NCT02455518|11850947|FG000|Overall Study|Protocol Violation|0
7516163|NCT02455518|11850948|FG001|Overall Study|Protocol Violation|1
7516164|NCT02455518|11850949|FG002|Overall Study|Protocol Violation|1
7516165|NCT02455518|11850950|FG003|Overall Study|Protocol Violation|3
7516166|NCT02456103|11850960|FG000|Overall Study|Study Closure|207
7516167|NCT02456103|11850960|FG000|Overall Study|Physician Decision|1
7516168|NCT02456103|11850960|FG000|Overall Study|Required prohibited medications|5
7516169|NCT02456103|11850960|FG000|Overall Study|Protocol Violation|1
7516170|NCT02456103|11850960|FG000|Overall Study|Adverse Event|5
7516171|NCT02456103|11850960|FG000|Overall Study|Abnormal Laboratory Value|2
7516172|NCT02456103|11850960|FG000|Overall Study|Lost to Follow-up|1
7516173|NCT02456103|11850960|FG000|Overall Study|Withdrawal by Subject|24
7516174|NCT02456636|11850967|FG000|Overall Study|Death|0
7516175|NCT02456636|11850968|FG001|Overall Study|Death|3
7516176|NCT02456636|11850969|FG002|Overall Study|Death|0
7516177|NCT02456636|11850967|FG000|Overall Study|Pregnancy|1
7516178|NCT02456636|11850968|FG001|Overall Study|Pregnancy|3
7516179|NCT02456636|11850969|FG002|Overall Study|Pregnancy|5
7516180|NCT02456636|11850967|FG000|Overall Study|Physician Decision|4
7516181|NCT02456636|11850968|FG001|Overall Study|Physician Decision|5
7516182|NCT02456636|11850969|FG002|Overall Study|Physician Decision|4
7516183|NCT02456636|11850967|FG000|Overall Study|Withdrawal by Subject|13
7516184|NCT02456636|11850968|FG001|Overall Study|Withdrawal by Subject|14
7516185|NCT02456636|11850969|FG002|Overall Study|Withdrawal by Subject|16
7516186|NCT02456636|11850967|FG000|Overall Study|Lost to Follow-up|50
7516187|NCT02456636|11850968|FG001|Overall Study|Lost to Follow-up|44
7516188|NCT02456636|11850969|FG002|Overall Study|Lost to Follow-up|50
7516189|NCT02456662|11850979|FG000|Overall Study|Lost to Follow-up|2
7516190|NCT02456662|11850980|FG001|Overall Study|Lost to Follow-up|1
7516191|NCT02456727|11850988|FG000|Overall Study|Lost to Follow-up|63
7516192|NCT02456727|11850989|FG001|Overall Study|Lost to Follow-up|65
7516193|NCT02456727|11850988|FG000|Overall Study|Death|2
7516194|NCT02456727|11850989|FG001|Overall Study|Death|1
7516195|NCT02456727|11850988|FG000|Overall Study|Withdrawal by Subject|1
7516196|NCT02456727|11850989|FG001|Overall Study|Withdrawal by Subject|10
7516197|NCT02456727|11850988|FG000|Overall Study|Never Initiated Treatment|43
7516198|NCT02456727|11850989|FG001|Overall Study|Never Initiated Treatment|30
7516199|NCT02456909|11851022|FG000|Overall Study|Did not receive allocated intervention|24
7516200|NCT02456909|11851023|FG001|Overall Study|Did not receive allocated intervention|26
7516201|NCT02456909|11851022|FG000|Overall Study|Did not complete the primary outcome|0
7516202|NCT02456909|11851023|FG001|Overall Study|Did not complete the primary outcome|1
7516203|NCT02457065|11851031|FG000|Overall Study|Lost to Follow-up|9
7516204|NCT02457065|11851032|FG001|Overall Study|Lost to Follow-up|11
7536435|NCT02718625|11884374|FG001|Overall Study|Termination of Study by Sponsor|1
7536436|NCT02718898|11884382|FG000|Blinded Treatment Period|Adverse Event|5
7536437|NCT02718898|11884383|FG001|Blinded Treatment Period|Adverse Event|1
7536438|NCT02718898|11884384|FG002|Blinded Treatment Period|Adverse Event|0
7536439|NCT02718898|11884385|FG003|Blinded Treatment Period|Adverse Event|0
7536440|NCT02718898|11884386|FG004|Blinded Treatment Period|Adverse Event|0
7536441|NCT02718898|11884387|FG005|Blinded Treatment Period|Adverse Event|0
7536442|NCT02718898|11884388|FG006|Blinded Treatment Period|Adverse Event|0
7536443|NCT02718898|11884382|FG000|Blinded Treatment Period|Physician Decision|1
7536444|NCT02718898|11884383|FG001|Blinded Treatment Period|Physician Decision|0
7536445|NCT02718898|11884384|FG002|Blinded Treatment Period|Physician Decision|0
7536446|NCT02718898|11884385|FG003|Blinded Treatment Period|Physician Decision|0
7536447|NCT02718898|11884386|FG004|Blinded Treatment Period|Physician Decision|0
7536448|NCT02718898|11884387|FG005|Blinded Treatment Period|Physician Decision|0
7536449|NCT02718898|11884388|FG006|Blinded Treatment Period|Physician Decision|0
7536450|NCT02718898|11884382|FG000|Blinded Treatment Period|Lack of Efficacy|1
7536451|NCT02718898|11884383|FG001|Blinded Treatment Period|Lack of Efficacy|0
7536452|NCT02718898|11884384|FG002|Blinded Treatment Period|Lack of Efficacy|0
7536453|NCT02718898|11884385|FG003|Blinded Treatment Period|Lack of Efficacy|0
7536454|NCT02718898|11884386|FG004|Blinded Treatment Period|Lack of Efficacy|0
7536455|NCT02718898|11884387|FG005|Blinded Treatment Period|Lack of Efficacy|0
7536456|NCT02718898|11884388|FG006|Blinded Treatment Period|Lack of Efficacy|0
7536457|NCT02718898|11884382|FG000|Blinded Treatment Period|Lost to Follow-up|2
7536458|NCT02718898|11884383|FG001|Blinded Treatment Period|Lost to Follow-up|0
7536459|NCT02718898|11884384|FG002|Blinded Treatment Period|Lost to Follow-up|0
7536460|NCT02718898|11884385|FG003|Blinded Treatment Period|Lost to Follow-up|0
7536461|NCT02718898|11884386|FG004|Blinded Treatment Period|Lost to Follow-up|0
7536462|NCT02718898|11884387|FG005|Blinded Treatment Period|Lost to Follow-up|0
7536463|NCT02718898|11884388|FG006|Blinded Treatment Period|Lost to Follow-up|0
7536464|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0
7536465|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0
7536466|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1
7536467|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1
7536468|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0
7536469|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0
7536470|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0
7536471|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7536472|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7536473|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7536474|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
7536475|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7536476|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7516205|NCT02457182|11851040|FG000|Overall Study|Lost to Follow-up|1
7516206|NCT02457182|11851041|FG001|Overall Study|Lost to Follow-up|0
7516207|NCT02457195|11851047|FG000|Overall Study|Adverse Event|3
7516208|NCT02457195|11851047|FG000|Overall Study|Protocol Violation|2
7516209|NCT02457195|11851047|FG000|Overall Study|Withdrawal by Subject|4
7516210|NCT02457247|11851055|FG000|Period 1|Pretreatment Event/Adverse Event|0
7516211|NCT02457247|11851056|FG001|Period 1|Pretreatment Event/Adverse Event|1
7516212|NCT02457247|11851057|FG002|Period 1|Pretreatment Event/Adverse Event|0
7516213|NCT02457247|11851058|FG003|Period 1|Pretreatment Event/Adverse Event|0
7516214|NCT02457247|11851055|FG000|Period 1|Significant Protocol Deviation|1
7516215|NCT02457247|11851056|FG001|Period 1|Significant Protocol Deviation|1
7516216|NCT02457247|11851057|FG002|Period 1|Significant Protocol Deviation|0
7516217|NCT02457247|11851058|FG003|Period 1|Significant Protocol Deviation|0
7516218|NCT02457247|11851055|FG000|Period 1|Voluntary Withdrawal|1
7516219|NCT02457247|11851056|FG001|Period 1|Voluntary Withdrawal|0
7516220|NCT02457247|11851057|FG002|Period 1|Voluntary Withdrawal|0
7516221|NCT02457247|11851058|FG003|Period 1|Voluntary Withdrawal|0
7516222|NCT02457247|11851055|FG000|Period 2|Pretreatment Event/Adverse Event|0
7516223|NCT02457247|11851056|FG001|Period 2|Pretreatment Event/Adverse Event|1
7516224|NCT02457247|11851057|FG002|Period 2|Pretreatment Event/Adverse Event|0
7516225|NCT02457247|11851058|FG003|Period 2|Pretreatment Event/Adverse Event|0
7516226|NCT02457247|11851055|FG000|Period 2|Significant Protocol Deviation|1
7516227|NCT02457247|11851056|FG001|Period 2|Significant Protocol Deviation|0
7516228|NCT02457247|11851057|FG002|Period 2|Significant Protocol Deviation|0
7516229|NCT02457247|11851058|FG003|Period 2|Significant Protocol Deviation|0
7516230|NCT02457247|11851055|FG000|Period 2|Lost to Follow-up|0
7516231|NCT02457247|11851056|FG001|Period 2|Lost to Follow-up|1
7516232|NCT02457247|11851057|FG002|Period 2|Lost to Follow-up|0
7516233|NCT02457247|11851058|FG003|Period 2|Lost to Follow-up|0
7516234|NCT02457247|11851055|FG000|Period 2|Voluntary Withdrawal|1
7516235|NCT02457247|11851056|FG001|Period 2|Voluntary Withdrawal|1
7516236|NCT02457247|11851057|FG002|Period 2|Voluntary Withdrawal|0
7516237|NCT02457247|11851058|FG003|Period 2|Voluntary Withdrawal|0
7516238|NCT02457325|11851090|FG000|First Intervention (1 Day)|Lost to Follow-up|2
7516239|NCT02457325|11851091|FG001|First Intervention (1 Day)|Lost to Follow-up|2
7516240|NCT02457520|11851108|FG000|Active Treatment Phase|Adverse Event|10
7516241|NCT02457520|11851108|FG000|Active Treatment Phase|Lost to Follow-up|8
7516242|NCT02457520|11851108|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
7516243|NCT02457520|11851108|FG000|Active Treatment Phase|other|4
7516244|NCT02457520|11851108|FG000|Active Treatment Phase|Physician Decision|1
7516245|NCT02457520|11851108|FG000|Active Treatment Phase|Protocol Violation|1
7516246|NCT02457520|11851108|FG000|Active Treatment Phase|Withdrawal by Subject|7
7516247|NCT02457520|11851108|FG000|Post-treatment Period|Other: Retreatment Required|7
7516248|NCT02457520|11851108|FG000|Post-treatment Period|Lost to Follow-up|23
7516249|NCT02457520|11851108|FG000|Post-treatment Period|Other|3
7516250|NCT02457520|11851108|FG000|Post-treatment Period|Physician Decision|1
7516251|NCT02457520|11851108|FG000|Post-treatment Period|Withdrawal by Subject|14
7516252|NCT02457546|11851140|FG000|Overall Study|Other reasons|4
7516253|NCT02457546|11851141|FG001|Overall Study|Other reasons|1
7516254|NCT02457546|11851140|FG000|Overall Study|Refused to complete study/procedures|1
7516255|NCT02457546|11851141|FG001|Overall Study|Refused to complete study/procedures|1
7516256|NCT02457546|11851140|FG000|Overall Study|Lost to Follow-up|4
7516257|NCT02457546|11851141|FG001|Overall Study|Lost to Follow-up|1
7516258|NCT02457546|11851140|FG000|Overall Study|Adverse Event|0
7516259|NCT02457546|11851141|FG001|Overall Study|Adverse Event|1
7516260|NCT02457611|11851147|FG000|Overall Study|Lost to Follow-up|3
7516261|NCT02457637|11851151|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
7516262|NCT02457793|11851166|FG000|Overall Study|Reason not specified|0
7516263|NCT02457793|11851167|FG001|Overall Study|Reason not specified|0
7516264|NCT02457793|11851168|FG002|Overall Study|Reason not specified|0
7516265|NCT02457793|11851169|FG003|Overall Study|Reason not specified|1
7516266|NCT02457793|11851170|FG004|Overall Study|Reason not specified|1
7516267|NCT02457793|11851171|FG005|Overall Study|Reason not specified|1
7516268|NCT02457793|11851166|FG000|Overall Study|Withdrawal by Subject|0
7516269|NCT02457793|11851167|FG001|Overall Study|Withdrawal by Subject|4
7516270|NCT02457793|11851168|FG002|Overall Study|Withdrawal by Subject|2
7516271|NCT02457793|11851169|FG003|Overall Study|Withdrawal by Subject|2
7516272|NCT02457793|11851170|FG004|Overall Study|Withdrawal by Subject|2
7516273|NCT02457793|11851171|FG005|Overall Study|Withdrawal by Subject|2
7516274|NCT02457793|11851166|FG000|Overall Study|Adverse Event|0
7516275|NCT02457793|11851167|FG001|Overall Study|Adverse Event|0
7516276|NCT02457793|11851168|FG002|Overall Study|Adverse Event|0
7516277|NCT02457793|11851169|FG003|Overall Study|Adverse Event|1
7516278|NCT02457793|11851170|FG004|Overall Study|Adverse Event|0
7516279|NCT02457793|11851171|FG005|Overall Study|Adverse Event|0
7516280|NCT02457793|11851166|FG000|Overall Study|Physician Decision|1
7516281|NCT02457793|11851167|FG001|Overall Study|Physician Decision|0
7516282|NCT02457793|11851168|FG002|Overall Study|Physician Decision|1
7516283|NCT02457793|11851169|FG003|Overall Study|Physician Decision|1
7516284|NCT02457793|11851170|FG004|Overall Study|Physician Decision|1
7516285|NCT02457793|11851171|FG005|Overall Study|Physician Decision|3
7516286|NCT02457819|11851186|FG000|Overall Study|reason not given|8
7516287|NCT02457819|11851186|FG000|Overall Study|Withdrawal by Subject|24
7516288|NCT02457819|11851186|FG000|Overall Study|Protocol Violation|1
7516289|NCT02457819|11851186|FG000|Overall Study|non compliance with study drug|4
7516290|NCT02457819|11851186|FG000|Overall Study|Lost to Follow-up|10
7516291|NCT02457819|11851186|FG000|Overall Study|Lack of Efficacy|19
7516292|NCT02457819|11851186|FG000|Overall Study|Adverse Event|33
7516293|NCT02458092|11851196|FG000|Overall Study|Withdrawal by Subject|1
7516294|NCT02458092|11851197|FG001|Overall Study|Withdrawal by Subject|0
7516295|NCT02458287|11851212|FG000|Overall Study|Adverse Event|0
7516296|NCT02458287|11851213|FG001|Overall Study|Adverse Event|0
7516297|NCT02458287|11851214|FG002|Overall Study|Adverse Event|0
7516298|NCT02458287|11851215|FG003|Overall Study|Adverse Event|1
7516299|NCT02458287|11851212|FG000|Overall Study|Lost to Follow-up|0
7516300|NCT02458287|11851213|FG001|Overall Study|Lost to Follow-up|1
7516301|NCT02458287|11851214|FG002|Overall Study|Lost to Follow-up|1
7516302|NCT02458287|11851215|FG003|Overall Study|Lost to Follow-up|0
7516303|NCT02458287|11851212|FG000|Overall Study|Protocol Violation|0
7516304|NCT02458287|11851213|FG001|Overall Study|Protocol Violation|1
7516305|NCT02458287|11851214|FG002|Overall Study|Protocol Violation|0
7516306|NCT02458287|11851215|FG003|Overall Study|Protocol Violation|0
7516307|NCT02458287|11851212|FG000|Overall Study|Withdrawal by Subject|0
7516308|NCT02458287|11851213|FG001|Overall Study|Withdrawal by Subject|2
7516309|NCT02458287|11851214|FG002|Overall Study|Withdrawal by Subject|2
7516310|NCT02458287|11851215|FG003|Overall Study|Withdrawal by Subject|1
7516311|NCT02458287|11851212|FG000|Overall Study|Relocated Out of State|0
7516312|NCT02458287|11851213|FG001|Overall Study|Relocated Out of State|0
7516313|NCT02458287|11851214|FG002|Overall Study|Relocated Out of State|0
7516314|NCT02458287|11851215|FG003|Overall Study|Relocated Out of State|1
7516315|NCT02458469|11851247|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
7516316|NCT02458469|11851248|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
7516317|NCT02458469|11851249|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
7516318|NCT02458469|11851250|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
7516319|NCT02458469|11851251|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
7516320|NCT02458469|11851252|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
7516321|NCT02458469|11851247|FG000|First Intervention (2 Weeks)|Physician Decision|1
7516322|NCT02458469|11851248|FG001|First Intervention (2 Weeks)|Physician Decision|0
7516323|NCT02458469|11851249|FG002|First Intervention (2 Weeks)|Physician Decision|0
7516324|NCT02458469|11851250|FG003|First Intervention (2 Weeks)|Physician Decision|0
7516325|NCT02458469|11851251|FG004|First Intervention (2 Weeks)|Physician Decision|0
7516491|NCT02461589|11851666|FG005|Overall Study|Death|0
7516326|NCT02458469|11851252|FG005|First Intervention (2 Weeks)|Physician Decision|0
7516327|NCT02458469|11851247|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7516328|NCT02458469|11851248|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7516329|NCT02458469|11851249|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7516330|NCT02458469|11851250|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7516331|NCT02458469|11851251|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
7516332|NCT02458469|11851252|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
7516333|NCT02458638|11851260|FG000|Overall Study|Death|309
7516334|NCT02458638|11851260|FG000|Overall Study|End of Cohort/End of Study|67
7516335|NCT02458638|11851260|FG000|Overall Study|Lost to Follow-up|31
7516336|NCT02458638|11851260|FG000|Overall Study|Other Reasons|4
7516337|NCT02458638|11851260|FG000|Overall Study|Physician Decision|1
7516338|NCT02458638|11851260|FG000|Overall Study|Withdrawal by Subject|47
7516339|NCT02459093|11851284|FG000|Overall Study|Protocol Violation|6
7516340|NCT02459093|11851285|FG001|Overall Study|Protocol Violation|11
7516341|NCT02459093|11851284|FG000|Overall Study|Lost to Follow-up|6
7516342|NCT02459093|11851285|FG001|Overall Study|Lost to Follow-up|7
7516343|NCT02459262|11851315|FG000|Overall Study|Withdrawal by Subject|0
7516344|NCT02459262|11851316|FG001|Overall Study|Withdrawal by Subject|0
7516345|NCT02459262|11851317|FG002|Overall Study|Withdrawal by Subject|0
7516346|NCT02459262|11851318|FG003|Overall Study|Withdrawal by Subject|0
7516347|NCT02459262|11851319|FG004|Overall Study|Withdrawal by Subject|0
7516348|NCT02459262|11851320|FG005|Overall Study|Withdrawal by Subject|0
7516349|NCT02459262|11851321|FG006|Overall Study|Withdrawal by Subject|0
7516350|NCT02459262|11851322|FG007|Overall Study|Withdrawal by Subject|0
7516351|NCT02459262|11851323|FG008|Overall Study|Withdrawal by Subject|0
7516352|NCT02459262|11851324|FG009|Overall Study|Withdrawal by Subject|1
7516353|NCT02459262|11851325|FG010|Overall Study|Withdrawal by Subject|0
7516354|NCT02459418|11851360|FG000|Overall Study|Exclusion Criteria|4
7516355|NCT02459418|11851361|FG001|Overall Study|Exclusion Criteria|0
7516356|NCT02459418|11851360|FG000|Overall Study|Protocol Violation|0
7516357|NCT02459418|11851361|FG001|Overall Study|Protocol Violation|2
7516358|NCT02459418|11851360|FG000|Overall Study|Physician Decision|0
7516359|NCT02459418|11851361|FG001|Overall Study|Physician Decision|2
7516360|NCT02459418|11851360|FG000|Overall Study|Endometrial thickness of >5 mm|1
7516361|NCT02459418|11851361|FG001|Overall Study|Endometrial thickness of >5 mm|0
7516362|NCT02459418|11851360|FG000|Overall Study|Adverse Event|0
7516363|NCT02459418|11851361|FG001|Overall Study|Adverse Event|1
7516364|NCT02459418|11851360|FG000|Overall Study|Withdrawal by Subject|1
7516365|NCT02459418|11851361|FG001|Overall Study|Withdrawal by Subject|1
7516366|NCT02459418|11851360|FG000|Overall Study|Elevated Creatine Kinase|1
7516367|NCT02459418|11851361|FG001|Overall Study|Elevated Creatine Kinase|0
7516368|NCT02459418|11851360|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
7516369|NCT02459418|11851361|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
7516370|NCT02459587|11851372|FG000|3-Month Follow-up Assessment|Death|0
7516371|NCT02459587|11851373|FG001|3-Month Follow-up Assessment|Death|2
7516372|NCT02459587|11851372|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
7516373|NCT02459587|11851373|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
7516374|NCT02459587|11851372|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
7516375|NCT02459587|11851373|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
7516376|NCT02459587|11851372|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
7516377|NCT02459587|11851373|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
7516378|NCT02459587|11851372|FG000|6-month Follow-up Assessment|Death|2
7516379|NCT02459587|11851373|FG001|6-month Follow-up Assessment|Death|1
7516380|NCT02459587|11851372|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
7516381|NCT02459587|11851373|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
7516382|NCT02459587|11851372|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
7516383|NCT02459587|11851373|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
7516384|NCT02459587|11851372|FG000|12-month Follow-up Assessment|Death|2
7516385|NCT02459587|11851373|FG001|12-month Follow-up Assessment|Death|0
7516386|NCT02459587|11851372|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
7516387|NCT02459587|11851373|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
7516388|NCT02459587|11851372|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
7516389|NCT02459587|11851373|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
7516390|NCT02459587|11851372|FG000|12-month Follow-up Assessment|Researcher withdrew|0
7516391|NCT02459587|11851373|FG001|12-month Follow-up Assessment|Researcher withdrew|1
7516392|NCT02459665|11851384|FG000|Overall Study|Withdrawal by Subject|0
7516393|NCT02459665|11851385|FG001|Overall Study|Withdrawal by Subject|1
7516394|NCT02459665|11851386|FG002|Overall Study|Withdrawal by Subject|1
7516395|NCT02459665|11851387|FG003|Overall Study|Withdrawal by Subject|2
7516396|NCT02459899|11851421|FG000|Overall Study|Adverse Event|1
7516397|NCT02459899|11851422|FG001|Overall Study|Adverse Event|1
7516398|NCT02459899|11851423|FG002|Overall Study|Adverse Event|0
7516399|NCT02459899|11851424|FG003|Overall Study|Adverse Event|0
7516400|NCT02459899|11851421|FG000|Overall Study|Lost to Follow-up|1
7516401|NCT02459899|11851422|FG001|Overall Study|Lost to Follow-up|2
7516402|NCT02459899|11851423|FG002|Overall Study|Lost to Follow-up|0
7516403|NCT02459899|11851424|FG003|Overall Study|Lost to Follow-up|1
7516404|NCT02459899|11851421|FG000|Overall Study|Non-compliance with the treatment|0
7516405|NCT02459899|11851422|FG001|Overall Study|Non-compliance with the treatment|0
7516406|NCT02459899|11851423|FG002|Overall Study|Non-compliance with the treatment|0
7516407|NCT02459899|11851424|FG003|Overall Study|Non-compliance with the treatment|1
7516408|NCT02459899|11851421|FG000|Overall Study|Withdrawal by Subject|1
7516409|NCT02459899|11851422|FG001|Overall Study|Withdrawal by Subject|3
7516410|NCT02459899|11851423|FG002|Overall Study|Withdrawal by Subject|0
7516411|NCT02459899|11851424|FG003|Overall Study|Withdrawal by Subject|0
7516412|NCT02459951|11851434|FG000|Overall Study|Unable to meet holding requirement|1
7516413|NCT02459964|11851442|FG000|Overall Study|Withdrawal by Subject|0
7516414|NCT02459964|11851443|FG001|Overall Study|Withdrawal by Subject|0
7516415|NCT02459964|11851444|FG002|Overall Study|Withdrawal by Subject|1
7516416|NCT02459964|11851442|FG000|Overall Study|Abnormal EKG changes|0
7516417|NCT02459964|11851443|FG001|Overall Study|Abnormal EKG changes|0
7516418|NCT02459964|11851444|FG002|Overall Study|Abnormal EKG changes|1
7516419|NCT02460263|11851457|FG000|Transition Period|Withdrawal by Subject|1
7516420|NCT02460263|11851457|FG000|Transition Period|Death|1
7516421|NCT02460380|11851467|FG000|Overall Study|Withdrawal by Subject|10
7516422|NCT02460380|11851468|FG001|Overall Study|Withdrawal by Subject|5
7516423|NCT02460562|11851477|FG000|Overall Study|Lost to Follow-up|15
7516424|NCT02460562|11851478|FG001|Overall Study|Lost to Follow-up|16
7516425|NCT02460575|11851486|FG000|Overall Study|Lost to Follow-up|1
7516426|NCT02460575|11851487|FG001|Overall Study|Lost to Follow-up|0
7516427|NCT02460679|11851502|FG000|Overall Study|Investigator Decision|1
7516428|NCT02460679|11851502|FG000|Overall Study|Withdrawal by Subject|4
7516429|NCT02460822|11851506|FG000|Overall Study|Withdrawal by Subject|1
7516430|NCT02460978|11851513|FG000|Overall Study|Adverse Event|17
7516431|NCT02460978|11851514|FG001|Overall Study|Adverse Event|11
7516432|NCT02460978|11851515|FG002|Overall Study|Adverse Event|11
7516433|NCT02460978|11851513|FG000|Overall Study|Withdrawal by Subject|5
7516434|NCT02460978|11851514|FG001|Overall Study|Withdrawal by Subject|5
7516435|NCT02460978|11851515|FG002|Overall Study|Withdrawal by Subject|14
7516436|NCT02460978|11851513|FG000|Overall Study|Lost to Follow-up|2
7516437|NCT02460978|11851514|FG001|Overall Study|Lost to Follow-up|3
7516438|NCT02460978|11851515|FG002|Overall Study|Lost to Follow-up|1
7516439|NCT02460978|11851513|FG000|Overall Study|Protocol Violation|1
7516440|NCT02460978|11851514|FG001|Overall Study|Protocol Violation|1
7516441|NCT02460978|11851515|FG002|Overall Study|Protocol Violation|1
7516442|NCT02460978|11851513|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
7516443|NCT02460978|11851514|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
7516444|NCT02460978|11851515|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
7516445|NCT02460978|11851513|FG000|Overall Study|Pregnancy|0
7516446|NCT02460978|11851514|FG001|Overall Study|Pregnancy|0
7516447|NCT02460978|11851515|FG002|Overall Study|Pregnancy|2
7516448|NCT02460991|11851525|FG000|Overall Study|Withdrawal by Subject|0
7516449|NCT02460991|11851526|FG001|Overall Study|Withdrawal by Subject|2
7516450|NCT02461134|11851537|FG000|Overall Study|Adverse Event|1
7516451|NCT02461160|11851554|FG000|Overall Study|Lost to Follow-up|0
7516452|NCT02461160|11851555|FG001|Overall Study|Lost to Follow-up|0
7516453|NCT02461160|11851556|FG002|Overall Study|Lost to Follow-up|0
7516454|NCT02461160|11851557|FG003|Overall Study|Lost to Follow-up|0
7516455|NCT02461160|11851558|FG004|Overall Study|Lost to Follow-up|0
7516456|NCT02461160|11851559|FG005|Overall Study|Lost to Follow-up|0
7516457|NCT02461160|11851560|FG006|Overall Study|Lost to Follow-up|0
7516458|NCT02461160|11851561|FG007|Overall Study|Lost to Follow-up|1
7516459|NCT02461160|11851562|FG008|Overall Study|Lost to Follow-up|0
7516460|NCT02461160|11851563|FG009|Overall Study|Lost to Follow-up|0
7516461|NCT02461160|11851564|FG010|Overall Study|Lost to Follow-up|0
7516462|NCT02461160|11851565|FG011|Overall Study|Lost to Follow-up|0
7516463|NCT02461160|11851566|FG012|Overall Study|Lost to Follow-up|0
7516464|NCT02461290|11851615|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
7516465|NCT02461290|11851615|FG000|Overall Study|Lost to Follow-up|3
7516466|NCT02461589|11851661|FG000|Overall Study|Withdrawal by Subject|5
7516467|NCT02461589|11851662|FG001|Overall Study|Withdrawal by Subject|1
7516468|NCT02461589|11851663|FG002|Overall Study|Withdrawal by Subject|3
7516469|NCT02461589|11851664|FG003|Overall Study|Withdrawal by Subject|2
7516470|NCT02461589|11851665|FG004|Overall Study|Withdrawal by Subject|1
7516471|NCT02461589|11851666|FG005|Overall Study|Withdrawal by Subject|2
7516472|NCT02461589|11851667|FG006|Overall Study|Withdrawal by Subject|1
7516473|NCT02461589|11851668|FG007|Overall Study|Withdrawal by Subject|3
7516474|NCT02461589|11851669|FG008|Overall Study|Withdrawal by Subject|3
7516475|NCT02461589|11851670|FG009|Overall Study|Withdrawal by Subject|1
7516476|NCT02461589|11851661|FG000|Overall Study|Lost to Follow-up|0
7516477|NCT02461589|11851662|FG001|Overall Study|Lost to Follow-up|0
7516478|NCT02461589|11851663|FG002|Overall Study|Lost to Follow-up|2
7516479|NCT02461589|11851664|FG003|Overall Study|Lost to Follow-up|3
7516480|NCT02461589|11851665|FG004|Overall Study|Lost to Follow-up|1
7516481|NCT02461589|11851666|FG005|Overall Study|Lost to Follow-up|1
7516482|NCT02461589|11851667|FG006|Overall Study|Lost to Follow-up|3
7516483|NCT02461589|11851668|FG007|Overall Study|Lost to Follow-up|1
7516484|NCT02461589|11851669|FG008|Overall Study|Lost to Follow-up|3
7516485|NCT02461589|11851670|FG009|Overall Study|Lost to Follow-up|1
7516486|NCT02461589|11851661|FG000|Overall Study|Death|0
7516487|NCT02461589|11851662|FG001|Overall Study|Death|0
7516488|NCT02461589|11851663|FG002|Overall Study|Death|0
7516489|NCT02461589|11851664|FG003|Overall Study|Death|0
7516490|NCT02461589|11851665|FG004|Overall Study|Death|0
7516492|NCT02461589|11851667|FG006|Overall Study|Death|0
7516493|NCT02461589|11851668|FG007|Overall Study|Death|1
7516494|NCT02461589|11851669|FG008|Overall Study|Death|0
7516495|NCT02461589|11851670|FG009|Overall Study|Death|0
7516496|NCT02461589|11851661|FG000|Overall Study|Unclassified|0
7516497|NCT02461589|11851662|FG001|Overall Study|Unclassified|0
7516498|NCT02461589|11851663|FG002|Overall Study|Unclassified|0
7516499|NCT02461589|11851664|FG003|Overall Study|Unclassified|0
7516500|NCT02461589|11851665|FG004|Overall Study|Unclassified|0
7516501|NCT02461589|11851666|FG005|Overall Study|Unclassified|0
7516502|NCT02461589|11851667|FG006|Overall Study|Unclassified|1
7516503|NCT02461589|11851668|FG007|Overall Study|Unclassified|0
7516504|NCT02461589|11851669|FG008|Overall Study|Unclassified|0
7516505|NCT02461589|11851670|FG009|Overall Study|Unclassified|2
7516506|NCT02461589|11851661|FG000|Overall Study|Missing follow-up information|1
7516507|NCT02461589|11851662|FG001|Overall Study|Missing follow-up information|1
7516508|NCT02461589|11851663|FG002|Overall Study|Missing follow-up information|0
7516509|NCT02461589|11851664|FG003|Overall Study|Missing follow-up information|0
7516510|NCT02461589|11851665|FG004|Overall Study|Missing follow-up information|0
7516511|NCT02461589|11851666|FG005|Overall Study|Missing follow-up information|0
7516512|NCT02461589|11851667|FG006|Overall Study|Missing follow-up information|1
7516513|NCT02461589|11851668|FG007|Overall Study|Missing follow-up information|0
7516514|NCT02461589|11851669|FG008|Overall Study|Missing follow-up information|0
7516515|NCT02461589|11851670|FG009|Overall Study|Missing follow-up information|0
7516516|NCT02461589|11851661|FG000|Overall Study|Withdrawal from trial before exposure|0
7516517|NCT02461589|11851662|FG001|Overall Study|Withdrawal from trial before exposure|0
7516518|NCT02461589|11851663|FG002|Overall Study|Withdrawal from trial before exposure|0
7516519|NCT02461589|11851664|FG003|Overall Study|Withdrawal from trial before exposure|0
7516520|NCT02461589|11851665|FG004|Overall Study|Withdrawal from trial before exposure|0
7516521|NCT02461589|11851666|FG005|Overall Study|Withdrawal from trial before exposure|0
7516522|NCT02461589|11851667|FG006|Overall Study|Withdrawal from trial before exposure|0
7516523|NCT02461589|11851668|FG007|Overall Study|Withdrawal from trial before exposure|0
7516524|NCT02461589|11851669|FG008|Overall Study|Withdrawal from trial before exposure|0
7516525|NCT02461589|11851670|FG009|Overall Study|Withdrawal from trial before exposure|1
7516526|NCT02461628|11851694|FG000|Overall Study|Refused to complete survey|4
7516527|NCT02461628|11851695|FG001|Overall Study|Refused to complete survey|7
7516528|NCT02461745|11851712|FG000|Overall Study|Lack of Efficacy|9
7516529|NCT02461745|11851713|FG001|Overall Study|Lack of Efficacy|1
7516530|NCT02461745|11851712|FG000|Overall Study|Lost to Follow-up|2
7516531|NCT02461745|11851713|FG001|Overall Study|Lost to Follow-up|2
7516532|NCT02461745|11851712|FG000|Overall Study|Withdrawal by Subject|3
7516533|NCT02461745|11851713|FG001|Overall Study|Withdrawal by Subject|1
7516534|NCT02461758|11851725|FG000|Overall Study|Lost to Follow-up|0
7516535|NCT02461758|11851726|FG001|Overall Study|Lost to Follow-up|1
7516536|NCT02461758|11851727|FG002|Overall Study|Lost to Follow-up|1
7516537|NCT02461758|11851728|FG003|Overall Study|Lost to Follow-up|0
7516538|NCT02462057|11851776|FG000|Overall Study|Left Vitality|32
7516539|NCT02462057|11851777|FG001|Overall Study|Left Vitality|27
7516540|NCT02462057|11851778|FG002|Overall Study|Left Vitality|23
7516541|NCT02462057|11851779|FG003|Overall Study|Left Vitality|35
7516542|NCT02462057|11851780|FG004|Overall Study|Left Vitality|33
7516543|NCT02462057|11851776|FG000|Overall Study|Joined HealthyFood Before Intervention|22
7516544|NCT02462057|11851777|FG001|Overall Study|Joined HealthyFood Before Intervention|13
7516545|NCT02462057|11851778|FG002|Overall Study|Joined HealthyFood Before Intervention|23
7516546|NCT02462057|11851779|FG003|Overall Study|Joined HealthyFood Before Intervention|16
7516547|NCT02462057|11851780|FG004|Overall Study|Joined HealthyFood Before Intervention|17
7516548|NCT02462083|11851801|FG000|Overall Study|Sponsor request|39
7516549|NCT02462083|11851801|FG000|Overall Study|Withdrawal by Subject|87
7516550|NCT02462083|11851801|FG000|Overall Study|Lost to Follow-up|41
7516551|NCT02462083|11851801|FG000|Overall Study|Lack of Efficacy|151
7516552|NCT02462083|11851801|FG000|Overall Study|Pregnancy|1
7516553|NCT02462083|11851801|FG000|Overall Study|Protocol Violation|6
7516554|NCT02462083|11851801|FG000|Overall Study|Adverse Event|33
7516555|NCT02462083|11851801|FG000|Overall Study|Worsening condition|16
7516556|NCT02462083|11851801|FG000|Overall Study|Other than specified|45
7516557|NCT02462473|11851850|FG000|Overall Study|Death|1
7516558|NCT02462473|11851850|FG000|Overall Study|Other|3
7516559|NCT02462486|11851857|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7516560|NCT02462486|11851858|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7516561|NCT02462486|11851859|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
7516562|NCT02462486|11851857|FG000|Overall Study|Adverse Event|53
7516563|NCT02462486|11851858|FG001|Overall Study|Adverse Event|48
7516564|NCT02462486|11851859|FG002|Overall Study|Adverse Event|21
7516565|NCT02462486|11851857|FG000|Overall Study|Lack of Efficacy|6
7516566|NCT02462486|11851858|FG001|Overall Study|Lack of Efficacy|12
7516567|NCT02462486|11851859|FG002|Overall Study|Lack of Efficacy|3
7516568|NCT02462486|11851857|FG000|Overall Study|Lost to Follow-up|3
7516569|NCT02462486|11851858|FG001|Overall Study|Lost to Follow-up|4
7516570|NCT02462486|11851859|FG002|Overall Study|Lost to Follow-up|2
7516571|NCT02462486|11851857|FG000|Overall Study|Withdrawal by Subject|25
7516572|NCT02462486|11851858|FG001|Overall Study|Withdrawal by Subject|22
7516573|NCT02462486|11851859|FG002|Overall Study|Withdrawal by Subject|19
7516574|NCT02462486|11851857|FG000|Overall Study|Protocol Violation|3
7516575|NCT02462486|11851858|FG001|Overall Study|Protocol Violation|1
7516576|NCT02462486|11851859|FG002|Overall Study|Protocol Violation|1
7516577|NCT02462486|11851857|FG000|Overall Study|Reason not Specified|3
7516578|NCT02462486|11851858|FG001|Overall Study|Reason not Specified|4
7516579|NCT02462486|11851859|FG002|Overall Study|Reason not Specified|3
7516580|NCT02462720|11851867|FG000|Part 2|Withdrawal by Subject|1
7516581|NCT02462720|11851868|FG001|Part 2|Withdrawal by Subject|0
7516582|NCT02462720|11851867|FG000|Part 2|Protocol Violation|0
7516583|NCT02462720|11851868|FG001|Part 2|Protocol Violation|1
7516584|NCT02462759|11851878|FG000|Part 1: Double Blind|Death|1
7516585|NCT02462759|11851879|FG001|Part 1: Double Blind|Death|0
7516586|NCT02462759|11851880|FG002|Part 1: Double Blind|Death|0
7516587|NCT02462928|11851894|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7516588|NCT02462928|11851895|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
7516589|NCT02462928|11851896|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
7516590|NCT02462928|11851894|FG000|Overall Study|Adverse Event|47
7516591|NCT02462928|11851895|FG001|Overall Study|Adverse Event|51
7516592|NCT02462928|11851896|FG002|Overall Study|Adverse Event|25
7516593|NCT02462928|11851894|FG000|Overall Study|Lack of Efficacy|3
7516594|NCT02462928|11851895|FG001|Overall Study|Lack of Efficacy|8
7516595|NCT02462928|11851896|FG002|Overall Study|Lack of Efficacy|3
7516596|NCT02462928|11851894|FG000|Overall Study|Lost to Follow-up|4
7516597|NCT02462928|11851895|FG001|Overall Study|Lost to Follow-up|4
7516598|NCT02462928|11851896|FG002|Overall Study|Lost to Follow-up|1
7516599|NCT02462928|11851894|FG000|Overall Study|Withdrawal by Patient|31
7516600|NCT02462928|11851895|FG001|Overall Study|Withdrawal by Patient|21
7516601|NCT02462928|11851896|FG002|Overall Study|Withdrawal by Patient|21
7516602|NCT02462928|11851894|FG000|Overall Study|Protocol Violation|0
7516603|NCT02462928|11851895|FG001|Overall Study|Protocol Violation|1
7516604|NCT02462928|11851896|FG002|Overall Study|Protocol Violation|0
7516605|NCT02462928|11851894|FG000|Overall Study|Reason not Specified|4
7516606|NCT02462928|11851895|FG001|Overall Study|Reason not Specified|6
7516607|NCT02462928|11851896|FG002|Overall Study|Reason not Specified|5
7516608|NCT02463032|11851919|FG000|Overall Study|Lack of Efficacy|61
7516609|NCT02463032|11851920|FG001|Overall Study|Lack of Efficacy|50
7516610|NCT02463032|11851919|FG000|Overall Study|Death|8
7516611|NCT02463032|11851920|FG001|Overall Study|Death|8
7516612|NCT02463032|11851919|FG000|Overall Study|Adverse Event|2
7516613|NCT02463032|11851920|FG001|Overall Study|Adverse Event|6
7516614|NCT02463071|11851929|FG000|Overall Study|Adverse Event|3
7516615|NCT02463071|11851930|FG001|Overall Study|Adverse Event|5
7516616|NCT02463071|11851931|FG002|Overall Study|Adverse Event|1
7516617|NCT02463071|11851929|FG000|Overall Study|Death|1
7516618|NCT02463071|11851930|FG001|Overall Study|Death|0
7516619|NCT02463071|11851931|FG002|Overall Study|Death|0
7516620|NCT02463071|11851929|FG000|Overall Study|Eligibility criteria not fulfilled|1
7516621|NCT02463071|11851930|FG001|Overall Study|Eligibility criteria not fulfilled|0
7516622|NCT02463071|11851931|FG002|Overall Study|Eligibility criteria not fulfilled|0
7516623|NCT02463071|11851929|FG000|Overall Study|Reason not specified|7
7516624|NCT02463071|11851930|FG001|Overall Study|Reason not specified|9
7516625|NCT02463071|11851931|FG002|Overall Study|Reason not specified|4
7516626|NCT02463071|11851929|FG000|Overall Study|Protocol Violation|0
7516627|NCT02463071|11851930|FG001|Overall Study|Protocol Violation|2
7516628|NCT02463071|11851931|FG002|Overall Study|Protocol Violation|0
7516629|NCT02463071|11851929|FG000|Overall Study|Lost to Follow-up|0
7516630|NCT02463071|11851930|FG001|Overall Study|Lost to Follow-up|0
7516631|NCT02463071|11851931|FG002|Overall Study|Lost to Follow-up|1
7516632|NCT02463097|11851939|FG000|Overall Study|Withdrawal by Subject|1
7516633|NCT02463331|11851949|FG000|Overall Study|Adverse Event|4
7516634|NCT02463331|11851950|FG001|Overall Study|Adverse Event|2
7516635|NCT02463331|11851949|FG000|Overall Study|Lost to Follow-up|1
7516636|NCT02463331|11851950|FG001|Overall Study|Lost to Follow-up|1
7516637|NCT02463331|11851949|FG000|Overall Study|Pregnancy|2
7516638|NCT02463331|11851950|FG001|Overall Study|Pregnancy|3
7516639|NCT02463331|11851949|FG000|Overall Study|Lack of Efficacy|6
7516640|NCT02463331|11851950|FG001|Overall Study|Lack of Efficacy|0
7516641|NCT02463331|11851949|FG000|Overall Study|Physician Decision|3
7516642|NCT02463331|11851950|FG001|Overall Study|Physician Decision|0
7516643|NCT02463357|11851961|FG000|Overall Study|Withdrawal by Subject|1
7516644|NCT02463357|11851962|FG001|Overall Study|Withdrawal by Subject|0
7516645|NCT02463357|11851963|FG002|Overall Study|Withdrawal by Subject|0
7516646|NCT02463357|11851964|FG003|Overall Study|Withdrawal by Subject|0
7516647|NCT02463357|11851965|FG004|Overall Study|Withdrawal by Subject|0
7516648|NCT02463357|11851961|FG000|Overall Study|Withdrawal by Subject|0
7516649|NCT02463357|11851962|FG001|Overall Study|Withdrawal by Subject|0
7516650|NCT02463357|11851963|FG002|Overall Study|Withdrawal by Subject|0
7516651|NCT02463357|11851964|FG003|Overall Study|Withdrawal by Subject|0
7516652|NCT02463357|11851965|FG004|Overall Study|Withdrawal by Subject|1
7516653|NCT02463409|11851977|FG000|Overall Study|Withdrawal by Subject|1
7516654|NCT02463409|11851977|FG000|Overall Study|Screen failure|1
7516655|NCT02464059|11852004|FG000|Overall Study|Lost to Follow-up|6
7516656|NCT02465034|11852079|FG000|Overall Study|Withdrawal by Subject|1
7516657|NCT02465034|11852080|FG001|Overall Study|Withdrawal by Subject|1
7516658|NCT02465034|11852079|FG000|Overall Study|Screen fail|2
7516659|NCT02465034|11852080|FG001|Overall Study|Screen fail|0
7516660|NCT02465034|11852079|FG000|Overall Study|Could not be scheduled for study visit|0
7516661|NCT02465034|11852080|FG001|Overall Study|Could not be scheduled for study visit|5
7516662|NCT02465203|11852119|FG000|Overall Study|Protocol Violation|1
7516663|NCT02465203|11852120|FG001|Overall Study|Protocol Violation|1
7516664|NCT02465203|11852121|FG002|Overall Study|Protocol Violation|1
7516665|NCT02465203|11852119|FG000|Overall Study|Study terminated by sponsor|50
7516666|NCT02465203|11852120|FG001|Overall Study|Study terminated by sponsor|34
7516667|NCT02465203|11852121|FG002|Overall Study|Study terminated by sponsor|11
7516668|NCT02465203|11852119|FG000|Overall Study|New therapy for study indication|4
7516669|NCT02465203|11852120|FG001|Overall Study|New therapy for study indication|0
7516670|NCT02465203|11852121|FG002|Overall Study|New therapy for study indication|0
7516671|NCT02465203|11852119|FG000|Overall Study|Patient/guardian decision|1
7516672|NCT02465203|11852120|FG001|Overall Study|Patient/guardian decision|1
7516673|NCT02465203|11852121|FG002|Overall Study|Patient/guardian decision|1
7516674|NCT02465437|11852162|FG000|Overall Study|Physician Decision|0
7516675|NCT02465437|11852163|FG001|Overall Study|Physician Decision|0
7516676|NCT02465437|11852164|FG002|Overall Study|Physician Decision|1
7516677|NCT02465437|11852165|FG003|Overall Study|Physician Decision|0
7516678|NCT02465437|11852162|FG000|Overall Study|Withdrawal by Subject|1
7516679|NCT02465437|11852163|FG001|Overall Study|Withdrawal by Subject|0
7516680|NCT02465437|11852164|FG002|Overall Study|Withdrawal by Subject|0
7516681|NCT02465437|11852165|FG003|Overall Study|Withdrawal by Subject|1
7516682|NCT02465437|11852162|FG000|Overall Study|Adverse Event|0
7516683|NCT02465437|11852163|FG001|Overall Study|Adverse Event|1
7516684|NCT02465437|11852164|FG002|Overall Study|Adverse Event|0
7516685|NCT02465437|11852165|FG003|Overall Study|Adverse Event|0
7516686|NCT02465463|11852201|FG000|Overall Study|Lost to Follow-up|2
7516687|NCT02465463|11852202|FG001|Overall Study|Lost to Follow-up|1
7516688|NCT02465463|11852201|FG000|Overall Study|Death|1
7516689|NCT02465463|11852202|FG001|Overall Study|Death|0
7516690|NCT02465463|11852201|FG000|Overall Study|Protocol Violation|1
7516691|NCT02465463|11852202|FG001|Overall Study|Protocol Violation|0
7516692|NCT02465489|11852209|FG000|Overall Study|Adverse Event|5
7516693|NCT02465515|11852223|FG000|Overall Study|Investigator site closed|4
7516694|NCT02465515|11852224|FG001|Overall Study|Investigator site closed|5
7516695|NCT02465515|11852223|FG000|Overall Study|Withdrawal by Subject|74
7516696|NCT02465515|11852224|FG001|Overall Study|Withdrawal by Subject|43
7516697|NCT02465515|11852223|FG000|Overall Study|Physician Decision|8
7516698|NCT02465515|11852224|FG001|Overall Study|Physician Decision|12
7516699|NCT02465515|11852223|FG000|Overall Study|Lost to Follow-up|68
7516700|NCT02465515|11852224|FG001|Overall Study|Lost to Follow-up|51
7516701|NCT02465528|11852234|FG000|Overall Study|Progressive disease|0
7516702|NCT02465528|11852235|FG001|Overall Study|Progressive disease|2
7516703|NCT02465528|11852236|FG002|Overall Study|Progressive disease|9
7516704|NCT02465528|11852237|FG003|Overall Study|Progressive disease|4
7516705|NCT02465528|11852234|FG000|Overall Study|Study terminated by sponsor|1
7516706|NCT02465528|11852235|FG001|Overall Study|Study terminated by sponsor|2
7516707|NCT02465528|11852236|FG002|Overall Study|Study terminated by sponsor|0
7516708|NCT02465528|11852237|FG003|Overall Study|Study terminated by sponsor|0
7516709|NCT02465528|11852234|FG000|Overall Study|Withdrawal by Subject|0
7516710|NCT02465528|11852235|FG001|Overall Study|Withdrawal by Subject|0
7516711|NCT02465528|11852236|FG002|Overall Study|Withdrawal by Subject|2
7516712|NCT02465528|11852237|FG003|Overall Study|Withdrawal by Subject|0
7516713|NCT02465528|11852234|FG000|Overall Study|Adverse Event|0
7516714|NCT02465528|11852235|FG001|Overall Study|Adverse Event|0
7516715|NCT02465528|11852236|FG002|Overall Study|Adverse Event|0
7516716|NCT02465528|11852237|FG003|Overall Study|Adverse Event|1
7516717|NCT02465528|11852234|FG000|Overall Study|Physician Decision|0
7516718|NCT02465528|11852235|FG001|Overall Study|Physician Decision|0
7516719|NCT02465528|11852236|FG002|Overall Study|Physician Decision|1
7516720|NCT02465528|11852237|FG003|Overall Study|Physician Decision|0
7536477|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
7536478|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7536479|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7536480|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
7536481|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
7536482|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7536483|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7536484|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
7536485|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7536486|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7536487|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
7536488|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
7536489|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7536490|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7536491|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
7536492|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536493|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536494|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536495|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
7536496|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536497|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536498|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
7536499|NCT02718898|11884382|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536500|NCT02718898|11884383|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536501|NCT02718898|11884384|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536502|NCT02718898|11884385|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
7536503|NCT02718898|11884386|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536504|NCT02718898|11884387|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536505|NCT02718898|11884388|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
7536506|NCT02718898|11884382|FG000|Post Treatment Follow-up Period|Adverse Event|0
7536507|NCT02718898|11884383|FG001|Post Treatment Follow-up Period|Adverse Event|0
7536508|NCT02718898|11884384|FG002|Post Treatment Follow-up Period|Adverse Event|0
7536509|NCT02718898|11884385|FG003|Post Treatment Follow-up Period|Adverse Event|0
7536510|NCT02718898|11884386|FG004|Post Treatment Follow-up Period|Adverse Event|0
7536511|NCT02718898|11884387|FG005|Post Treatment Follow-up Period|Adverse Event|1
7536512|NCT02718898|11884388|FG006|Post Treatment Follow-up Period|Adverse Event|1
7536513|NCT02718898|11884382|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0
7536514|NCT02718898|11884383|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0
7536515|NCT02718898|11884384|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0
7536516|NCT02718898|11884385|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0
7536517|NCT02718898|11884386|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1
7536518|NCT02718898|11884387|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5
7536519|NCT02718898|11884388|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1
7536520|NCT02718898|11884382|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7536521|NCT02718898|11884383|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7536522|NCT02718898|11884384|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7536523|NCT02718898|11884385|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7536524|NCT02718898|11884386|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0
7536525|NCT02718898|11884387|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5
7536526|NCT02718898|11884388|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3
7536527|NCT02719028|11884414|FG000|Overall Study|Adverse Event|2
7536528|NCT02719028|11884415|FG001|Overall Study|Adverse Event|1
7516721|NCT02465567|11852253|FG000|Overall Study|Adverse Event|118
7516722|NCT02465567|11852254|FG001|Overall Study|Adverse Event|113
7516723|NCT02465567|11852255|FG002|Overall Study|Adverse Event|147
7516724|NCT02465567|11852256|FG003|Overall Study|Adverse Event|138
7516725|NCT02465567|11852253|FG000|Overall Study|Lack of Efficacy|103
7516726|NCT02465567|11852254|FG001|Overall Study|Lack of Efficacy|102
7516727|NCT02465567|11852255|FG002|Overall Study|Lack of Efficacy|171
7516728|NCT02465567|11852256|FG003|Overall Study|Lack of Efficacy|135
7516729|NCT02465567|11852253|FG000|Overall Study|Withdrawal by Subject|104
7516730|NCT02465567|11852254|FG001|Overall Study|Withdrawal by Subject|94
7516731|NCT02465567|11852255|FG002|Overall Study|Withdrawal by Subject|123
7516732|NCT02465567|11852256|FG003|Overall Study|Withdrawal by Subject|130
7516733|NCT02465567|11852253|FG000|Overall Study|Physician Decision|23
7516734|NCT02465567|11852254|FG001|Overall Study|Physician Decision|33
7516735|NCT02465567|11852255|FG002|Overall Study|Physician Decision|38
7516736|NCT02465567|11852256|FG003|Overall Study|Physician Decision|28
7516737|NCT02465567|11852253|FG000|Overall Study|Major Protocol Deviation|24
7516738|NCT02465567|11852254|FG001|Overall Study|Major Protocol Deviation|26
7516739|NCT02465567|11852255|FG002|Overall Study|Major Protocol Deviation|22
7516740|NCT02465567|11852256|FG003|Overall Study|Major Protocol Deviation|25
7516741|NCT02465567|11852253|FG000|Overall Study|Lost to Follow-up|25
7516742|NCT02465567|11852254|FG001|Overall Study|Lost to Follow-up|21
7516743|NCT02465567|11852255|FG002|Overall Study|Lost to Follow-up|19
7516744|NCT02465567|11852256|FG003|Overall Study|Lost to Follow-up|15
7516745|NCT02465567|11852253|FG000|Overall Study|Protocol Specified Criteria|20
7516746|NCT02465567|11852254|FG001|Overall Study|Protocol Specified Criteria|10
7516747|NCT02465567|11852255|FG002|Overall Study|Protocol Specified Criteria|9
7516748|NCT02465567|11852256|FG003|Overall Study|Protocol Specified Criteria|12
7516749|NCT02465567|11852253|FG000|Overall Study|Administrative Reasons|12
7516750|NCT02465567|11852254|FG001|Overall Study|Administrative Reasons|9
7516751|NCT02465567|11852255|FG002|Overall Study|Administrative Reasons|11
7516752|NCT02465567|11852256|FG003|Overall Study|Administrative Reasons|5
7516753|NCT02465567|11852253|FG000|Overall Study|Randomized but not treated|1
7516754|NCT02465567|11852254|FG001|Overall Study|Randomized but not treated|5
7516755|NCT02465567|11852255|FG002|Overall Study|Randomized but not treated|4
7516756|NCT02465567|11852256|FG003|Overall Study|Randomized but not treated|5
7516757|NCT02465567|11852253|FG000|Overall Study|enrolled in >1 studies|18
7516758|NCT02465567|11852254|FG001|Overall Study|enrolled in >1 studies|11
7516759|NCT02465567|11852255|FG002|Overall Study|enrolled in >1 studies|19
7516760|NCT02465567|11852256|FG003|Overall Study|enrolled in >1 studies|15
7516761|NCT02465567|11852253|FG000|Overall Study|missing PI Signature|1
7516762|NCT02465567|11852254|FG001|Overall Study|missing PI Signature|0
7516763|NCT02465567|11852255|FG002|Overall Study|missing PI Signature|0
7516764|NCT02465567|11852256|FG003|Overall Study|missing PI Signature|0
7516765|NCT02465866|11852280|FG000|Period 3|Withdrawal by Subject|0
7516766|NCT02465866|11852281|FG001|Period 3|Withdrawal by Subject|1
7516767|NCT02465866|11852282|FG002|Period 3|Withdrawal by Subject|0
7516768|NCT02465866|11852283|FG003|Period 3|Withdrawal by Subject|0
7516769|NCT02465931|11852295|FG000|Overall Study|Lost to Follow-up|9
7516770|NCT02465931|11852296|FG001|Overall Study|Lost to Follow-up|11
7516771|NCT02465931|11852295|FG000|Overall Study|Protocol Violation|1
7516772|NCT02465931|11852296|FG001|Overall Study|Protocol Violation|0
7516773|NCT02465931|11852295|FG000|Overall Study|Withdrawal by Subject|1
7516774|NCT02465931|11852296|FG001|Overall Study|Withdrawal by Subject|0
7516775|NCT02466386|11852327|FG000|Overall Study|Adverse Event|5
7516776|NCT02466386|11852327|FG000|Overall Study|Protocol Violation|2
7516777|NCT02466386|11852327|FG000|Overall Study|Withdrawal by Subject|14
7516778|NCT02466386|11852327|FG000|Overall Study|Lost to Follow-up|5
7516779|NCT02466386|11852327|FG000|Overall Study|Lack of Efficacy|8
7516780|NCT02466386|11852327|FG000|Overall Study|Other|10
7516781|NCT02466399|11852333|FG000|Overall Study|Adverse Event|1
7516782|NCT02466399|11852334|FG001|Overall Study|Adverse Event|0
7516783|NCT02466399|11852333|FG000|Overall Study|Early exit due to family emergency|1
7516784|NCT02466399|11852334|FG001|Overall Study|Early exit due to family emergency|0
7516785|NCT02466425|11852352|FG000|Overall Study|Adverse Event|3
7516786|NCT02466425|11852353|FG001|Overall Study|Adverse Event|11
7516787|NCT02466425|11852352|FG000|Overall Study|Lack of Efficacy|4
7516788|NCT02466425|11852353|FG001|Overall Study|Lack of Efficacy|1
7516789|NCT02466425|11852352|FG000|Overall Study|Lost to Follow-up|3
7516790|NCT02466425|11852353|FG001|Overall Study|Lost to Follow-up|0
7516791|NCT02466425|11852352|FG000|Overall Study|Protocol Violation|1
7516792|NCT02466425|11852353|FG001|Overall Study|Protocol Violation|0
7516793|NCT02466425|11852352|FG000|Overall Study|Withdrawal by Subject|0
7516794|NCT02466425|11852353|FG001|Overall Study|Withdrawal by Subject|1
7516795|NCT02466425|11852352|FG000|Overall Study|Other|1
7516796|NCT02466425|11852353|FG001|Overall Study|Other|3
7516797|NCT02466425|11852352|FG000|Overall Study|Withdrawal by Parent/Guardian|2
7516798|NCT02466425|11852353|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7516799|NCT02466516|11852364|FG000|Overall Study|Adverse Event|1
7516800|NCT02466516|11852365|FG001|Overall Study|Adverse Event|1
7516801|NCT02466516|11852366|FG002|Overall Study|Adverse Event|0
7516802|NCT02466516|11852367|FG003|Overall Study|Adverse Event|0
7516803|NCT02466516|11852368|FG004|Overall Study|Adverse Event|0
7516804|NCT02466516|11852364|FG000|Overall Study|Withdrew Consent|1
7516805|NCT02466516|11852365|FG001|Overall Study|Withdrew Consent|0
7516806|NCT02466516|11852366|FG002|Overall Study|Withdrew Consent|0
7516807|NCT02466516|11852367|FG003|Overall Study|Withdrew Consent|0
7516808|NCT02466516|11852368|FG004|Overall Study|Withdrew Consent|0
7516809|NCT02466516|11852364|FG000|Overall Study|Lost to Follow-up|2
7516810|NCT02466516|11852365|FG001|Overall Study|Lost to Follow-up|0
7516811|NCT02466516|11852366|FG002|Overall Study|Lost to Follow-up|1
7516812|NCT02466516|11852367|FG003|Overall Study|Lost to Follow-up|0
7516813|NCT02466516|11852368|FG004|Overall Study|Lost to Follow-up|0
7516814|NCT02466555|11852380|FG000|Overall Study|Lost to Follow-up|2
7516815|NCT02466659|11852403|FG000|Overall Study|Lost to Follow-up|5
7516816|NCT02466659|11852404|FG001|Overall Study|Lost to Follow-up|2
7516817|NCT02467192|11852443|FG000|Overall Study|Death|1
7516818|NCT02467192|11852443|FG000|Overall Study|revealed to have pneumonia before|2
7516819|NCT02468193|11852526|FG000|Overall Study|Adverse Event|4
7516820|NCT02468193|11852526|FG000|Overall Study|Subject/ Guardian decision|2
7516821|NCT02468557|11852546|FG000|Overall Study|Adverse Event|1
7516822|NCT02468557|11852546|FG000|Overall Study|Death|1
7516823|NCT02468557|11852546|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
7516824|NCT02468557|11852546|FG000|Overall Study|All Enrolled but Never Dosed|4
7516825|NCT02468648|11852563|FG000|Overall Study|Death|1
7516826|NCT02468674|11852576|FG000|Overall Study|Adverse Event|0
7516827|NCT02468674|11852577|FG001|Overall Study|Adverse Event|0
7516828|NCT02468674|11852578|FG002|Overall Study|Adverse Event|0
7516829|NCT02468674|11852579|FG003|Overall Study|Adverse Event|1
7516830|NCT02468674|11852580|FG004|Overall Study|Adverse Event|0
7516831|NCT02468674|11852581|FG005|Overall Study|Adverse Event|1
7516832|NCT02468674|11852582|FG006|Overall Study|Adverse Event|0
7516833|NCT02468674|11852583|FG007|Overall Study|Adverse Event|0
7516834|NCT02468674|11852584|FG008|Overall Study|Adverse Event|0
7516835|NCT02468674|11852576|FG000|Overall Study|Lost to Follow-up|1
7516836|NCT02468674|11852577|FG001|Overall Study|Lost to Follow-up|0
7516837|NCT02468674|11852578|FG002|Overall Study|Lost to Follow-up|0
7516838|NCT02468674|11852579|FG003|Overall Study|Lost to Follow-up|0
7516839|NCT02468674|11852580|FG004|Overall Study|Lost to Follow-up|0
7516840|NCT02468674|11852581|FG005|Overall Study|Lost to Follow-up|0
7516841|NCT02468674|11852582|FG006|Overall Study|Lost to Follow-up|0
7516842|NCT02468674|11852583|FG007|Overall Study|Lost to Follow-up|1
7516843|NCT02468674|11852584|FG008|Overall Study|Lost to Follow-up|1
7516844|NCT02468674|11852576|FG000|Overall Study|Physician Decision|0
7516845|NCT02468674|11852577|FG001|Overall Study|Physician Decision|0
7516846|NCT02468674|11852578|FG002|Overall Study|Physician Decision|0
7516847|NCT02468674|11852579|FG003|Overall Study|Physician Decision|0
7516848|NCT02468674|11852580|FG004|Overall Study|Physician Decision|0
7516849|NCT02468674|11852581|FG005|Overall Study|Physician Decision|0
7516850|NCT02468674|11852582|FG006|Overall Study|Physician Decision|1
7516851|NCT02468674|11852583|FG007|Overall Study|Physician Decision|0
7516852|NCT02468674|11852584|FG008|Overall Study|Physician Decision|0
7516853|NCT02468674|11852576|FG000|Overall Study|Patient/Guardian Decision|0
7516854|NCT02468674|11852577|FG001|Overall Study|Patient/Guardian Decision|0
7516855|NCT02468674|11852578|FG002|Overall Study|Patient/Guardian Decision|0
7516856|NCT02468674|11852579|FG003|Overall Study|Patient/Guardian Decision|0
7516857|NCT02468674|11852580|FG004|Overall Study|Patient/Guardian Decision|1
7516858|NCT02468674|11852581|FG005|Overall Study|Patient/Guardian Decision|0
7516859|NCT02468674|11852582|FG006|Overall Study|Patient/Guardian Decision|0
7516860|NCT02468674|11852583|FG007|Overall Study|Patient/Guardian Decision|2
7516861|NCT02468674|11852584|FG008|Overall Study|Patient/Guardian Decision|1
7516862|NCT02468674|11852576|FG000|Overall Study|Protocol Deviation|0
7516863|NCT02468674|11852577|FG001|Overall Study|Protocol Deviation|0
7516864|NCT02468674|11852578|FG002|Overall Study|Protocol Deviation|0
7516865|NCT02468674|11852579|FG003|Overall Study|Protocol Deviation|0
7516866|NCT02468674|11852580|FG004|Overall Study|Protocol Deviation|0
7516867|NCT02468674|11852581|FG005|Overall Study|Protocol Deviation|0
7516868|NCT02468674|11852582|FG006|Overall Study|Protocol Deviation|0
7516869|NCT02468674|11852583|FG007|Overall Study|Protocol Deviation|1
7516870|NCT02468674|11852584|FG008|Overall Study|Protocol Deviation|1
7516871|NCT02468934|11852626|FG000|Overall Study|Withdrawal by Subject|4
7516872|NCT02468934|11852626|FG000|Overall Study|Screen Failure|3
7516873|NCT02469038|11852634|FG000|Overall Study|Physician Decision|4
7516874|NCT02469038|11852635|FG001|Overall Study|Physician Decision|5
7516875|NCT02469064|11852643|FG000|Overall Study|Request not to receive intervention.|1
7516876|NCT02469064|11852644|FG001|Overall Study|Request not to receive intervention.|3
7516877|NCT02469077|11852652|FG000|Post Randomization/Intervention Period|Scheduling issues|3
7516878|NCT02469077|11852653|FG001|Post Randomization/Intervention Period|Scheduling issues|2
7516879|NCT02469077|11852652|FG000|Post Randomization/Intervention Period|Relocated|1
7516880|NCT02469077|11852653|FG001|Post Randomization/Intervention Period|Relocated|1
7516881|NCT02469077|11852652|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
7516882|NCT02469077|11852653|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
7516883|NCT02469077|11852652|FG000|Post Intervention /Followup|Withdrawal by Subject|2
7516884|NCT02469077|11852653|FG001|Post Intervention /Followup|Withdrawal by Subject|1
7516885|NCT02469090|11852665|FG000|Period 1: Dose Titration Phase|Adverse Event|12
7516886|NCT02469090|11852666|FG001|Period 1: Dose Titration Phase|Adverse Event|0
7516887|NCT02469090|11852667|FG002|Period 1: Dose Titration Phase|Adverse Event|0
7516888|NCT02469090|11852665|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
7516889|NCT02469090|11852666|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7516890|NCT02469090|11852667|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
7516891|NCT02469090|11852665|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
7516892|NCT02469090|11852666|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
7516893|NCT02469090|11852667|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
7516894|NCT02469090|11852665|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
7516895|NCT02469090|11852666|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
7516896|NCT02469090|11852667|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
7516897|NCT02469090|11852665|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
7516898|NCT02469090|11852666|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
7516899|NCT02469090|11852667|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
7516900|NCT02469090|11852665|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
7516901|NCT02469090|11852666|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
7516902|NCT02469090|11852667|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
7516903|NCT02469090|11852665|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7516904|NCT02469090|11852666|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
7516905|NCT02469090|11852667|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
7516906|NCT02469090|11852665|FG000|Period 2: Maintenance Treatment Phase|Death|0
7516907|NCT02469090|11852666|FG001|Period 2: Maintenance Treatment Phase|Death|0
7516908|NCT02469090|11852667|FG002|Period 2: Maintenance Treatment Phase|Death|1
7516909|NCT02469168|11852680|FG000|Overall Study|Trial closed|1
7516910|NCT02469168|11852681|FG001|Overall Study|Trial closed|0
7516911|NCT02469246|11852689|FG000|Double-Blind Phase|Randomized and Never Treated|5
7516912|NCT02469246|11852690|FG001|Double-Blind Phase|Randomized and Never Treated|6
7516913|NCT02469246|11852689|FG000|Double-Blind Phase|Adverse Event|12
7516914|NCT02469246|11852690|FG001|Double-Blind Phase|Adverse Event|9
7516915|NCT02469246|11852689|FG000|Double-Blind Phase|Death|2
7516916|NCT02469246|11852690|FG001|Double-Blind Phase|Death|0
7516917|NCT02469246|11852689|FG000|Double-Blind Phase|Lack of Efficacy|2
7516918|NCT02469246|11852690|FG001|Double-Blind Phase|Lack of Efficacy|1
7516919|NCT02469246|11852689|FG000|Double-Blind Phase|Investigator's Discretion|8
7516920|NCT02469246|11852690|FG001|Double-Blind Phase|Investigator's Discretion|8
7516921|NCT02469246|11852689|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
7516922|NCT02469246|11852690|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7516923|NCT02469246|11852689|FG000|Double-Blind Phase|Protocol Violation|1
7516924|NCT02469246|11852690|FG001|Double-Blind Phase|Protocol Violation|1
7516925|NCT02469246|11852689|FG000|Double-Blind Phase|Withdrew Consent|25
7516926|NCT02469246|11852690|FG001|Double-Blind Phase|Withdrew Consent|25
7516927|NCT02469246|11852689|FG000|Double-Blind Phase|Lost to Follow-up|9
7516928|NCT02469246|11852690|FG001|Double-Blind Phase|Lost to Follow-up|5
7516929|NCT02469298|11852702|FG000|Overall Study|Protocol Violation|0
7516930|NCT02469298|11852703|FG001|Overall Study|Protocol Violation|1
7516931|NCT02469298|11852704|FG002|Overall Study|Protocol Violation|1
7516932|NCT02469298|11852705|FG003|Overall Study|Protocol Violation|0
7516933|NCT02469298|11852702|FG000|Overall Study|Lost to Follow-up|1
7516934|NCT02469298|11852703|FG001|Overall Study|Lost to Follow-up|0
7516935|NCT02469298|11852704|FG002|Overall Study|Lost to Follow-up|1
7516936|NCT02469298|11852705|FG003|Overall Study|Lost to Follow-up|0
7516937|NCT02469298|11852702|FG000|Overall Study|Physician Decision|0
7516938|NCT02469298|11852703|FG001|Overall Study|Physician Decision|0
7516939|NCT02469298|11852704|FG002|Overall Study|Physician Decision|0
7516940|NCT02469298|11852705|FG003|Overall Study|Physician Decision|1
7516941|NCT02469298|11852702|FG000|Overall Study|Withdrawal by Subject|0
7516942|NCT02469298|11852703|FG001|Overall Study|Withdrawal by Subject|0
7516943|NCT02469298|11852704|FG002|Overall Study|Withdrawal by Subject|0
7516944|NCT02469298|11852705|FG003|Overall Study|Withdrawal by Subject|1
7516945|NCT02469610|11852742|FG000|Overall Study|Death|1
7516946|NCT02469610|11852743|FG001|Overall Study|Death|0
7516947|NCT02469610|11852742|FG000|Overall Study|Lost to Follow-up|1
7516948|NCT02469610|11852743|FG001|Overall Study|Lost to Follow-up|0
7516949|NCT02469610|11852742|FG000|Overall Study|exclusion criteria|2
7516950|NCT02469610|11852743|FG001|Overall Study|exclusion criteria|1
7516951|NCT02469623|11852749|FG000|Overall Study|Not consented for long-term follow-up|4
7516952|NCT02469623|11852749|FG000|Overall Study|Lost to Follow-up|4
7516953|NCT02469623|11852749|FG000|Overall Study|Withdrawal by Subject|2
7516954|NCT02469623|11852749|FG000|Overall Study|Death|3
7516955|NCT02469857|11852769|FG000|Overall Study|Death|24
7516956|NCT02469857|11852770|FG001|Overall Study|Death|29
7516957|NCT02469857|11852769|FG000|Overall Study|Discontinuation|1
7516958|NCT02469857|11852770|FG001|Overall Study|Discontinuation|3
7516959|NCT02469896|11852792|FG000|Overall Study|Withdrawal by Subject|2
7516960|NCT02469896|11852793|FG001|Overall Study|Withdrawal by Subject|0
7516961|NCT02469961|11852805|FG000|Overall Study|Physician Decision|4
7516962|NCT02469961|11852806|FG001|Overall Study|Physician Decision|1
7516963|NCT02470403|11852860|FG000|Overall Study|Adverse Event|1
7516964|NCT02470403|11852861|FG001|Overall Study|Adverse Event|0
7516965|NCT02470403|11852862|FG002|Overall Study|Adverse Event|0
7516966|NCT02470403|11852863|FG003|Overall Study|Adverse Event|0
7516967|NCT02470403|11852864|FG004|Overall Study|Adverse Event|0
7516968|NCT02470403|11852860|FG000|Overall Study|Lost to Follow-up|0
7516969|NCT02470403|11852861|FG001|Overall Study|Lost to Follow-up|1
7516970|NCT02470403|11852862|FG002|Overall Study|Lost to Follow-up|0
7516971|NCT02470403|11852863|FG003|Overall Study|Lost to Follow-up|0
7516972|NCT02470403|11852864|FG004|Overall Study|Lost to Follow-up|0
7516973|NCT02470403|11852860|FG000|Overall Study|Subject/guardian decision|1
7516974|NCT02470403|11852861|FG001|Overall Study|Subject/guardian decision|0
7516975|NCT02470403|11852862|FG002|Overall Study|Subject/guardian decision|0
7516976|NCT02470403|11852863|FG003|Overall Study|Subject/guardian decision|4
7516977|NCT02470403|11852864|FG004|Overall Study|Subject/guardian decision|0
7516978|NCT02470429|11852881|FG000|Overall Study|Adverse Event|1
7516979|NCT02470429|11852882|FG001|Overall Study|Adverse Event|0
7516980|NCT02470429|11852881|FG000|Overall Study|Withdrawal by Subject|1
7516981|NCT02470429|11852882|FG001|Overall Study|Withdrawal by Subject|0
7516982|NCT02470806|11852911|FG000|Overall Study|Lost to Follow-up|1
7516983|NCT02470806|11852912|FG001|Overall Study|Lost to Follow-up|1
7516984|NCT02470806|11852911|FG000|Overall Study|Adverse Event|5
7516985|NCT02470806|11852912|FG001|Overall Study|Adverse Event|2
7516986|NCT02470806|11852911|FG000|Overall Study|Protocol Violation|4
7516987|NCT02470806|11852912|FG001|Overall Study|Protocol Violation|11
7516988|NCT02470806|11852911|FG000|Overall Study|Physician Decision|0
7516989|NCT02470806|11852912|FG001|Overall Study|Physician Decision|3
7516990|NCT02470806|11852911|FG000|Overall Study|Withdrawal by Subject|3
7516991|NCT02470806|11852912|FG001|Overall Study|Withdrawal by Subject|10
7516992|NCT02470806|11852911|FG000|Overall Study|Lack of Efficacy|5
7516993|NCT02470806|11852912|FG001|Overall Study|Lack of Efficacy|15
7516994|NCT02471014|11852936|FG000|Overall Study|Lost to Follow-up|2
7516995|NCT02471014|11852937|FG001|Overall Study|Lost to Follow-up|2
7516996|NCT02471183|11852943|FG000|Main Treatment Period|Adverse Event|1
7516997|NCT02471183|11852943|FG000|Main Treatment Period|Withdrawal by Subject|1
7516998|NCT02471183|11852943|FG000|Extended Treatment Period|Lack of Efficacy|1
7516999|NCT02471404|11852958|FG000|Overall Study|Adverse Event|7
7517000|NCT02471404|11852959|FG001|Overall Study|Adverse Event|1
7517001|NCT02471404|11852960|FG002|Overall Study|Adverse Event|2
7517002|NCT02471404|11852958|FG000|Overall Study|Developed Study Withdrawal Criteria|4
7517003|NCT02471404|11852959|FG001|Overall Study|Developed Study Withdrawal Criteria|1
7517004|NCT02471404|11852960|FG002|Overall Study|Developed Study Withdrawal Criteria|2
7517005|NCT02471404|11852958|FG000|Overall Study|Failure to Meet Randomization Criteria|2
7517006|NCT02471404|11852959|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7517007|NCT02471404|11852960|FG002|Overall Study|Failure to Meet Randomization Criteria|1
7517008|NCT02471404|11852958|FG000|Overall Study|Lost to Follow-up|1
7517009|NCT02471404|11852959|FG001|Overall Study|Lost to Follow-up|1
7517010|NCT02471404|11852960|FG002|Overall Study|Lost to Follow-up|3
7517011|NCT02471404|11852958|FG000|Overall Study|Protocol Violation|1
7517012|NCT02471404|11852959|FG001|Overall Study|Protocol Violation|0
7517013|NCT02471404|11852960|FG002|Overall Study|Protocol Violation|0
7517014|NCT02471404|11852958|FG000|Overall Study|Withdrawal by Subject|8
7517015|NCT02471404|11852959|FG001|Overall Study|Withdrawal by Subject|4
7517016|NCT02471404|11852960|FG002|Overall Study|Withdrawal by Subject|5
7517017|NCT02471404|11852958|FG000|Overall Study|Other reasons not specified|10
7517018|NCT02471404|11852959|FG001|Overall Study|Other reasons not specified|7
7517019|NCT02471404|11852960|FG002|Overall Study|Other reasons not specified|12
7517020|NCT02471586|11852980|FG000|Overall Study|Lost to Follow-up|3
7517021|NCT02471586|11852981|FG001|Overall Study|Lost to Follow-up|8
7517022|NCT02471586|11852982|FG002|Overall Study|Lost to Follow-up|4
7517023|NCT02471586|11852980|FG000|Overall Study|Death|2
7517024|NCT02471586|11852981|FG001|Overall Study|Death|2
7517025|NCT02471586|11852982|FG002|Overall Study|Death|0
7517026|NCT02471612|11852992|FG000|Overall Study|Lost to Follow-up|2
7517027|NCT02471716|11853023|FG000|Overall Study|Withdrawal by Subject|0
7517028|NCT02471716|11853024|FG001|Overall Study|Withdrawal by Subject|1
7517029|NCT02471716|11853025|FG002|Overall Study|Withdrawal by Subject|0
7517030|NCT02471716|11853026|FG003|Overall Study|Withdrawal by Subject|2
7517031|NCT02471716|11853027|FG004|Overall Study|Withdrawal by Subject|5
7517032|NCT02471716|11853023|FG000|Overall Study|Study Terminiated by sponsor|0
7517033|NCT02471716|11853024|FG001|Overall Study|Study Terminiated by sponsor|0
7517034|NCT02471716|11853025|FG002|Overall Study|Study Terminiated by sponsor|0
7517035|NCT02471716|11853026|FG003|Overall Study|Study Terminiated by sponsor|1
7517036|NCT02471716|11853027|FG004|Overall Study|Study Terminiated by sponsor|0
7517037|NCT02471716|11853023|FG000|Overall Study|Lost to Follow-up|0
7517038|NCT02471716|11853024|FG001|Overall Study|Lost to Follow-up|0
7517039|NCT02471716|11853025|FG002|Overall Study|Lost to Follow-up|0
7517040|NCT02471716|11853026|FG003|Overall Study|Lost to Follow-up|3
7517041|NCT02471716|11853027|FG004|Overall Study|Lost to Follow-up|2
7517042|NCT02471716|11853023|FG000|Overall Study|Death|0
7517043|NCT02471716|11853024|FG001|Overall Study|Death|0
7517044|NCT02471716|11853025|FG002|Overall Study|Death|0
7517045|NCT02471716|11853026|FG003|Overall Study|Death|1
7517046|NCT02471716|11853027|FG004|Overall Study|Death|0
7517047|NCT02471716|11853023|FG000|Overall Study|Other|0
7517048|NCT02471716|11853024|FG001|Overall Study|Other|0
7517049|NCT02471716|11853025|FG002|Overall Study|Other|0
7517050|NCT02471716|11853026|FG003|Overall Study|Other|8
7517051|NCT02471716|11853027|FG004|Overall Study|Other|9
7517052|NCT02471755|11853043|FG000|Overall Study|Withdrawal by Subject|1
7517053|NCT02471755|11853044|FG001|Overall Study|Withdrawal by Subject|0
7517054|NCT02471755|11853043|FG000|Overall Study|Lost to Follow-up|0
7517055|NCT02471755|11853044|FG001|Overall Study|Lost to Follow-up|1
7517056|NCT02472145|11853053|FG000|Overall Study|Death|10
7517057|NCT02472145|11853054|FG001|Overall Study|Death|101
7517058|NCT02472145|11853055|FG002|Overall Study|Death|99
7517059|NCT02472145|11853053|FG000|Overall Study|Lost to Follow-up|0
7517060|NCT02472145|11853054|FG001|Overall Study|Lost to Follow-up|1
7517061|NCT02472145|11853055|FG002|Overall Study|Lost to Follow-up|0
7517062|NCT02472145|11853053|FG000|Overall Study|Withdrawal by Subject|0
7517063|NCT02472145|11853054|FG001|Overall Study|Withdrawal by Subject|9
7517064|NCT02472145|11853055|FG002|Overall Study|Withdrawal by Subject|13
7517065|NCT02472145|11853053|FG000|Overall Study|Sponsor decision|0
7517066|NCT02472145|11853054|FG001|Overall Study|Sponsor decision|3
7517067|NCT02472145|11853055|FG002|Overall Study|Sponsor decision|2
7517068|NCT02472145|11853053|FG000|Overall Study|Other|0
7517069|NCT02472145|11853054|FG001|Overall Study|Other|45
7517070|NCT02472145|11853055|FG002|Overall Study|Other|43
7517071|NCT02472353|11853095|FG000|Overall Study|Lost to Follow-up|1
7517072|NCT02472353|11853096|FG001|Overall Study|Lost to Follow-up|1
7517073|NCT02472353|11853095|FG000|Overall Study|Withdrawal by Subject|2
7517074|NCT02472353|11853096|FG001|Overall Study|Withdrawal by Subject|1
7517075|NCT02472353|11853095|FG000|Overall Study|Study Termination|1
7517076|NCT02472353|11853096|FG001|Overall Study|Study Termination|4
7517077|NCT02472366|11853104|FG000|Overall Study|Lost to Follow-up|1
7517078|NCT02472366|11853105|FG001|Overall Study|Lost to Follow-up|0
7517079|NCT02472405|11853111|FG000|Overall Study|Lost to Follow-up|9
7517080|NCT02472405|11853111|FG000|Overall Study|Adverse Event|1
7517081|NCT02472652|11853137|FG000|Overall Study|Lost to Follow-up|1
7517082|NCT02472756|11853150|FG000|Induction (Approximately 6 Months)|Adverse Event|1
7517083|NCT02472756|11853150|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
7517084|NCT02472756|11853150|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
7517085|NCT02472756|11853150|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
7517086|NCT02472756|11853150|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
7517087|NCT02472795|11853159|FG000|Overall Study|Adverse Event|0
7517088|NCT02472795|11853160|FG001|Overall Study|Adverse Event|1
7517089|NCT02472795|11853161|FG002|Overall Study|Adverse Event|0
7517090|NCT02472795|11853162|FG003|Overall Study|Adverse Event|0
7517091|NCT02472795|11853163|FG004|Overall Study|Adverse Event|2
7517092|NCT02472795|11853159|FG000|Overall Study|Withdrawal by Subject|0
7517093|NCT02472795|11853160|FG001|Overall Study|Withdrawal by Subject|0
7517094|NCT02472795|11853161|FG002|Overall Study|Withdrawal by Subject|0
7517095|NCT02472795|11853162|FG003|Overall Study|Withdrawal by Subject|0
7517096|NCT02472795|11853163|FG004|Overall Study|Withdrawal by Subject|1
7517097|NCT02472847|11853177|FG000|Overall Study|Withdrawal by Subject|1
7517098|NCT02472847|11853178|FG001|Overall Study|Withdrawal by Subject|5
7517099|NCT02472886|11853187|FG000|Overall Study|Lack of Efficacy|0
7517100|NCT02472886|11853188|FG001|Overall Study|Lack of Efficacy|2
7517101|NCT02472886|11853189|FG002|Overall Study|Lack of Efficacy|1
7517102|NCT02472977|11853205|FG000|Overall Study|Disease progression|4
7517103|NCT02472977|11853206|FG001|Overall Study|Disease progression|25
7517104|NCT02472977|11853207|FG002|Overall Study|Disease progression|6
7517105|NCT02472977|11853205|FG000|Overall Study|Withdrawal by Subject|0
7517106|NCT02472977|11853206|FG001|Overall Study|Withdrawal by Subject|1
7517107|NCT02472977|11853207|FG002|Overall Study|Withdrawal by Subject|0
7517108|NCT02472977|11853205|FG000|Overall Study|Study drug toxicity|2
7517109|NCT02472977|11853206|FG001|Overall Study|Study drug toxicity|0
7517110|NCT02472977|11853207|FG002|Overall Study|Study drug toxicity|2
7517111|NCT02472977|11853205|FG000|Overall Study|Subject request to discontinue treatment|0
7517112|NCT02472977|11853206|FG001|Overall Study|Subject request to discontinue treatment|1
7517113|NCT02472977|11853207|FG002|Overall Study|Subject request to discontinue treatment|0
7517114|NCT02473250|11853215|FG000|Overall Study|Lost to Follow-up|10
7517115|NCT02473250|11853215|FG000|Overall Study|Physician Decision|5
7517116|NCT02473250|11853215|FG000|Overall Study|Did not tolerate medication washout|3
7517117|NCT02473250|11853215|FG000|Overall Study|Antidepressant effect of divalproex|2
7517118|NCT02473289|11853222|FG000|Overall Study|Adverse Event|2
7517119|NCT02473289|11853223|FG001|Overall Study|Adverse Event|3
7517120|NCT02473289|11853222|FG000|Overall Study|Lost to Follow-up|1
7517121|NCT02473289|11853223|FG001|Overall Study|Lost to Follow-up|1
7517122|NCT02473289|11853222|FG000|Overall Study|Protocol Violation|0
7517123|NCT02473289|11853223|FG001|Overall Study|Protocol Violation|1
7517124|NCT02473289|11853222|FG000|Overall Study|Withdrawal of consent|6
7517125|NCT02473289|11853223|FG001|Overall Study|Withdrawal of consent|7
7517126|NCT02473289|11853222|FG000|Overall Study|Treatment Unblinded + Adverse event|0
7517127|NCT02473289|11853223|FG001|Overall Study|Treatment Unblinded + Adverse event|1
7517128|NCT02473289|11853222|FG000|Overall Study|Other|2
7517129|NCT02473289|11853223|FG001|Overall Study|Other|0
7517130|NCT02473367|11853229|FG000|Wait 1|Withdrawal by Subject|1
7517131|NCT02473367|11853229|FG000|Period 4|Lost to Follow-up|1
7517132|NCT02473393|11853243|FG000|Overall Study|Adverse Event|0
7517133|NCT02473393|11853244|FG001|Overall Study|Adverse Event|0
7517134|NCT02473393|11853245|FG002|Overall Study|Adverse Event|1
7517135|NCT02473393|11853246|FG003|Overall Study|Adverse Event|0
7517136|NCT02473393|11853243|FG000|Overall Study|Withdrawal by Subject|0
7517137|NCT02473393|11853244|FG001|Overall Study|Withdrawal by Subject|0
7517138|NCT02473393|11853245|FG002|Overall Study|Withdrawal by Subject|1
7517139|NCT02473393|11853246|FG003|Overall Study|Withdrawal by Subject|1
7517140|NCT02473471|11853256|FG000|Overall Study|poor oral hygiene|2
7517141|NCT02473471|11853256|FG000|Overall Study|Lost to Follow-up|1
7517142|NCT02473510|11853268|FG000|Overall Study|Lost to Follow-up|1
7517143|NCT02473510|11853269|FG001|Overall Study|Lost to Follow-up|2
7536529|NCT02719028|11884416|FG002|Overall Study|Adverse Event|4
7536530|NCT02719028|11884417|FG003|Overall Study|Adverse Event|8
7536531|NCT02719028|11884414|FG000|Overall Study|Physician Decision|0
7536532|NCT02719028|11884415|FG001|Overall Study|Physician Decision|1
7536533|NCT02719028|11884416|FG002|Overall Study|Physician Decision|1
7536534|NCT02719028|11884417|FG003|Overall Study|Physician Decision|1
7536535|NCT02719028|11884414|FG000|Overall Study|Use of prohibited medication|0
7536536|NCT02719028|11884415|FG001|Overall Study|Use of prohibited medication|0
7536537|NCT02719028|11884416|FG002|Overall Study|Use of prohibited medication|1
7536538|NCT02719028|11884417|FG003|Overall Study|Use of prohibited medication|0
7536539|NCT02719028|11884414|FG000|Overall Study|Protocol Violation|0
7536540|NCT02719028|11884415|FG001|Overall Study|Protocol Violation|0
7536541|NCT02719028|11884416|FG002|Overall Study|Protocol Violation|0
7536542|NCT02719028|11884417|FG003|Overall Study|Protocol Violation|1
7536543|NCT02719171|11884445|FG000|Overall Study|Adverse Event|1
7536544|NCT02719171|11884446|FG001|Overall Study|Adverse Event|2
7536545|NCT02719171|11884447|FG002|Overall Study|Adverse Event|0
7536546|NCT02719171|11884448|FG003|Overall Study|Adverse Event|0
7536547|NCT02719171|11884449|FG004|Overall Study|Adverse Event|2
7536548|NCT02719171|11884445|FG000|Overall Study|Lost to Follow-up|0
7536549|NCT02719171|11884446|FG001|Overall Study|Lost to Follow-up|0
7536550|NCT02719171|11884447|FG002|Overall Study|Lost to Follow-up|1
7536551|NCT02719171|11884448|FG003|Overall Study|Lost to Follow-up|0
7536552|NCT02719171|11884449|FG004|Overall Study|Lost to Follow-up|0
7536553|NCT02719171|11884445|FG000|Overall Study|Subject Withdrawal|0
7536554|NCT02719171|11884446|FG001|Overall Study|Subject Withdrawal|2
7536555|NCT02719171|11884447|FG002|Overall Study|Subject Withdrawal|2
7536556|NCT02719171|11884448|FG003|Overall Study|Subject Withdrawal|1
7536557|NCT02719171|11884449|FG004|Overall Study|Subject Withdrawal|0
7536558|NCT02719171|11884445|FG000|Overall Study|Other|0
7536559|NCT02719171|11884446|FG001|Overall Study|Other|0
7536560|NCT02719171|11884447|FG002|Overall Study|Other|0
7536561|NCT02719171|11884448|FG003|Overall Study|Other|1
7536562|NCT02719171|11884449|FG004|Overall Study|Other|0
7536563|NCT02719353|11884464|FG000|First Intervention|Physician Decision|0
7536564|NCT02719353|11884465|FG001|First Intervention|Physician Decision|1
7536565|NCT02719743|11884493|FG000|Overall Study|Consent withdrawal|0
7536566|NCT02719743|11884494|FG001|Overall Study|Consent withdrawal|2
7536567|NCT02719743|11884495|FG002|Overall Study|Consent withdrawal|0
7536568|NCT02719743|11884496|FG003|Overall Study|Consent withdrawal|1
7536569|NCT02719743|11884497|FG004|Overall Study|Consent withdrawal|0
7536570|NCT02719743|11884493|FG000|Overall Study|Migrated/moved from study area|0
7536571|NCT02719743|11884494|FG001|Overall Study|Migrated/moved from study area|0
7536572|NCT02719743|11884495|FG002|Overall Study|Migrated/moved from study area|0
7536573|NCT02719743|11884496|FG003|Overall Study|Migrated/moved from study area|0
7536574|NCT02719743|11884497|FG004|Overall Study|Migrated/moved from study area|2
7536575|NCT02719743|11884493|FG000|Overall Study|Lost to Follow-up|1
7536576|NCT02719743|11884494|FG001|Overall Study|Lost to Follow-up|1
7536577|NCT02719743|11884495|FG002|Overall Study|Lost to Follow-up|0
7536578|NCT02719743|11884496|FG003|Overall Study|Lost to Follow-up|0
7536579|NCT02719743|11884497|FG004|Overall Study|Lost to Follow-up|0
7536580|NCT02720042|11884518|FG000|Overall Study|Death|3
7536581|NCT02720042|11884518|FG000|Overall Study|Lost to Follow-up|4
7536582|NCT02720042|11884518|FG000|Overall Study|Withdrawal by Subject|1
7536583|NCT02720042|11884518|FG000|Overall Study|Physician Decision|3
7536584|NCT02720042|11884518|FG000|Overall Study|Phasix Mesh explanted|1
7536585|NCT02720042|11884518|FG000|Overall Study|unable due to non-study-related illness|3
7536586|NCT02720081|11884524|FG000|Overall Study|Adverse Event|0
7536587|NCT02720081|11884525|FG001|Overall Study|Adverse Event|3
7536588|NCT02720081|11884524|FG000|Overall Study|Protocol Violation|4
7536589|NCT02720081|11884525|FG001|Overall Study|Protocol Violation|1
7536590|NCT02720198|11884537|FG000|Overall Study|Withdrawal by Subject|0
7536591|NCT02720198|11884538|FG001|Overall Study|Withdrawal by Subject|1
7536592|NCT02720484|11884548|FG000|Treatment on Study|Adverse Event|1
7536593|NCT02720484|11884548|FG000|Treatment on Study|Withdrawal by Subject|1
7536594|NCT02720484|11884548|FG000|Treatment on Study|Progressive Disease|4
7536595|NCT02720484|11884548|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
7536596|NCT02720484|11884548|FG000|Follow Up for 2 Years|Death|3
7536597|NCT02720484|11884548|FG000|Follow Up for 2 Years|Lost to Follow-up|2
7536598|NCT02720536|11884552|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
7536599|NCT02720536|11884552|FG000|Overall Study|PR - pregnancy|2
7536600|NCT02720536|11884552|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
7536601|NCT02720536|11884552|FG000|Overall Study|PR - death|1
7536602|NCT02720536|11884552|FG000|Overall Study|PR - adverse event|1
7536603|NCT02720536|11884552|FG000|Overall Study|PR - abnormal lab value(s)|1
7536604|NCT02720536|11884552|FG000|Overall Study|PR- unwilling to comply with procedures|1
7536605|NCT02720757|11884566|FG000|Overall Study|Other reason|5
7536606|NCT02720757|11884566|FG000|Overall Study|Loss of contact|4
7536607|NCT02720757|11884566|FG000|Overall Study|Informed consent withdrawal|1
7536608|NCT02720757|11884566|FG000|Overall Study|Patients wish to withdraw|2
7517144|NCT02473614|11853275|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
7517145|NCT02473614|11853276|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
7517146|NCT02473640|11853283|FG000|Treatment Period 1|Adverse Event|1
7517147|NCT02473913|11853311|FG000|Overall Study|Lost to Follow-up|3
7517148|NCT02473913|11853312|FG001|Overall Study|Lost to Follow-up|3
7517149|NCT02473952|11853320|FG000|Overall Study|Adverse Event|2
7517150|NCT02473952|11853321|FG001|Overall Study|Adverse Event|2
7517151|NCT02473952|11853320|FG000|Overall Study|Withdrawal by Subject|0
7517152|NCT02473952|11853321|FG001|Overall Study|Withdrawal by Subject|6
7517153|NCT02473965|11853329|FG000|Overall Study|Adverse Event|6
7517154|NCT02473965|11853330|FG001|Overall Study|Adverse Event|4
7517155|NCT02473965|11853329|FG000|Overall Study|MG worsening|4
7517156|NCT02473965|11853330|FG001|Overall Study|MG worsening|1
7517157|NCT02473965|11853329|FG000|Overall Study|Withdrawal by Subject|2
7517158|NCT02473965|11853330|FG001|Overall Study|Withdrawal by Subject|3
7517159|NCT02473965|11853329|FG000|Overall Study|Physician Decision|0
7517160|NCT02473965|11853330|FG001|Overall Study|Physician Decision|2
7517161|NCT02474069|11853340|FG000|Selection Phase (SP)|Adverse Event|8
7517162|NCT02474069|11853341|FG001|Selection Phase (SP)|Adverse Event|0
7517163|NCT02474069|11853342|FG002|Selection Phase (SP)|Adverse Event|0
7517164|NCT02474069|11853340|FG000|Selection Phase (SP)|Lack of Efficacy|1
7517165|NCT02474069|11853341|FG001|Selection Phase (SP)|Lack of Efficacy|0
7517166|NCT02474069|11853342|FG002|Selection Phase (SP)|Lack of Efficacy|0
7517167|NCT02474069|11853340|FG000|Selection Phase (SP)|Lost to Follow-up|4
7517168|NCT02474069|11853341|FG001|Selection Phase (SP)|Lost to Follow-up|0
7517169|NCT02474069|11853342|FG002|Selection Phase (SP)|Lost to Follow-up|0
7517170|NCT02474069|11853340|FG000|Selection Phase (SP)|Physician Decision|1
7517171|NCT02474069|11853341|FG001|Selection Phase (SP)|Physician Decision|0
7517172|NCT02474069|11853342|FG002|Selection Phase (SP)|Physician Decision|0
7517173|NCT02474069|11853340|FG000|Selection Phase (SP)|Protocol Violation|1
7517174|NCT02474069|11853341|FG001|Selection Phase (SP)|Protocol Violation|0
7517175|NCT02474069|11853342|FG002|Selection Phase (SP)|Protocol Violation|0
7517176|NCT02474069|11853340|FG000|Selection Phase (SP)|No longer requires treatment|1
7517177|NCT02474069|11853341|FG001|Selection Phase (SP)|No longer requires treatment|0
7517178|NCT02474069|11853342|FG002|Selection Phase (SP)|No longer requires treatment|0
7517179|NCT02474069|11853340|FG000|Selection Phase (SP)|Technical Problem|1
7517180|NCT02474069|11853341|FG001|Selection Phase (SP)|Technical Problem|0
7517181|NCT02474069|11853342|FG002|Selection Phase (SP)|Technical Problem|0
7517182|NCT02474069|11853340|FG000|Selection Phase (SP)|Withdrawal by Subject|3
7517183|NCT02474069|11853341|FG001|Selection Phase (SP)|Withdrawal by Subject|0
7517184|NCT02474069|11853342|FG002|Selection Phase (SP)|Withdrawal by Subject|0
7517185|NCT02474069|11853340|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
7517186|NCT02474069|11853341|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
7517187|NCT02474069|11853342|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
7517188|NCT02474069|11853340|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
7517189|NCT02474069|11853341|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
7517190|NCT02474069|11853342|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
7517191|NCT02474069|11853340|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
7517192|NCT02474069|11853341|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
7517193|NCT02474069|11853342|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
7517194|NCT02474069|11853340|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7517195|NCT02474069|11853341|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
7517196|NCT02474069|11853342|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
7517197|NCT02474069|11853340|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
7517198|NCT02474069|11853341|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7517199|NCT02474069|11853342|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
7517200|NCT02474082|11853354|FG000|Overall Study|Adverse Event|2
7517201|NCT02474082|11853355|FG001|Overall Study|Adverse Event|32
7517202|NCT02474082|11853354|FG000|Overall Study|Withdrawal of informed consent|1
7517203|NCT02474082|11853355|FG001|Overall Study|Withdrawal of informed consent|11
7517204|NCT02474082|11853354|FG000|Overall Study|Lost to Follow-up|2
7517205|NCT02474082|11853355|FG001|Overall Study|Lost to Follow-up|2
7517206|NCT02474082|11853354|FG000|Overall Study|Dose tapering not achieved|0
7517207|NCT02474082|11853355|FG001|Overall Study|Dose tapering not achieved|4
7517208|NCT02474082|11853354|FG000|Overall Study|Participant/guardian decision|1
7517209|NCT02474082|11853355|FG001|Overall Study|Participant/guardian decision|2
7517210|NCT02474082|11853354|FG000|Overall Study|Non-compliance with study treatment|0
7517211|NCT02474082|11853355|FG001|Overall Study|Non-compliance with study treatment|2
7517212|NCT02474082|11853354|FG000|Overall Study|Protocol deviation|0
7517213|NCT02474082|11853355|FG001|Overall Study|Protocol deviation|1
7517214|NCT02474199|11853363|FG000|Overall Study|Lost to Follow-up|1
7517215|NCT02474199|11853364|FG001|Overall Study|Lost to Follow-up|0
7517216|NCT02474199|11853365|FG002|Overall Study|Lost to Follow-up|0
7517217|NCT02474199|11853366|FG003|Overall Study|Lost to Follow-up|0
7517218|NCT02474199|11853363|FG000|Overall Study|Withdrawal by Subject|1
7517219|NCT02474199|11853364|FG001|Overall Study|Withdrawal by Subject|2
7517220|NCT02474199|11853365|FG002|Overall Study|Withdrawal by Subject|0
7517221|NCT02474199|11853366|FG003|Overall Study|Withdrawal by Subject|1
7517222|NCT02474199|11853363|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7517223|NCT02474199|11853364|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
7517224|NCT02474199|11853365|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7517225|NCT02474199|11853366|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
7517226|NCT02474199|11853363|FG000|Overall Study|Did not meet eligibility criteria|0
7517227|NCT02474199|11853364|FG001|Overall Study|Did not meet eligibility criteria|0
7517228|NCT02474199|11853365|FG002|Overall Study|Did not meet eligibility criteria|2
7517229|NCT02474199|11853366|FG003|Overall Study|Did not meet eligibility criteria|2
7517230|NCT02474355|11853373|FG000|Overall Study|Other|43
7517231|NCT02474355|11853373|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
7517232|NCT02474355|11853373|FG000|Overall Study|Lost to Follow-up|98
7517233|NCT02474355|11853373|FG000|Overall Study|Withdrawal by Subject|124
7517234|NCT02474355|11853373|FG000|Overall Study|Death|1361
7517235|NCT02474589|11853423|FG000|Overall Study|Adverse Event|6
7517236|NCT02474589|11853424|FG001|Overall Study|Adverse Event|2
7517237|NCT02474589|11853423|FG000|Overall Study|Lost to Follow-up|6
7517238|NCT02474589|11853424|FG001|Overall Study|Lost to Follow-up|1
7517239|NCT02474589|11853423|FG000|Overall Study|Protocol Violation|4
7517240|NCT02474589|11853424|FG001|Overall Study|Protocol Violation|1
7517241|NCT02474589|11853423|FG000|Overall Study|Withdrawal by Subject|4
7517242|NCT02474589|11853424|FG001|Overall Study|Withdrawal by Subject|0
7517243|NCT02474589|11853423|FG000|Overall Study|Inability to complete study procedures|5
7517244|NCT02474589|11853424|FG001|Overall Study|Inability to complete study procedures|1
7517245|NCT02475265|11853460|FG000|Overall Study|Physician Decision|1
7517246|NCT02475265|11853460|FG000|Overall Study|Withdrawal by Subject|2
7517247|NCT02475278|11853464|FG000|Overall Study|Lost to Follow-up|1
7517248|NCT02475278|11853464|FG000|Overall Study|Reason Not Specified|1
7517249|NCT02475369|11853468|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
7517250|NCT02475369|11853469|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
7517251|NCT02475395|11853482|FG000|Overall Study|Protocol Violation|30
7517252|NCT02475395|11853483|FG001|Overall Study|Protocol Violation|3
7517253|NCT02475564|11853491|FG000|Overall Study|Withdrawal by Subject|1
7517254|NCT02475564|11853492|FG001|Overall Study|Withdrawal by Subject|0
7517255|NCT02475564|11853491|FG000|Overall Study|Lost to Follow-up|2
7517256|NCT02475564|11853492|FG001|Overall Study|Lost to Follow-up|1
7517257|NCT02475564|11853491|FG000|Overall Study|Intense Menstrual bleeding|1
7517258|NCT02475564|11853492|FG001|Overall Study|Intense Menstrual bleeding|0
7517259|NCT02475629|11853498|FG000|Overall Study|Adverse Event|1
7517260|NCT02475629|11853498|FG000|Overall Study|Death|4
7517261|NCT02475629|11853498|FG000|Overall Study|Physician Decision|1
7517262|NCT02475629|11853498|FG000|Overall Study|Withdrawal by Subject|1
7517263|NCT02475629|11853498|FG000|Overall Study|Lost to Follow-up|1
7517264|NCT02475629|11853498|FG000|Overall Study|Subject non-compliance|1
7517265|NCT02475655|11853504|FG000|Overall Study|Lost to Follow-up|0
7517266|NCT02475655|11853505|FG001|Overall Study|Lost to Follow-up|1
7517267|NCT02475733|11853513|FG000|Overall Study|Withdrawal by Subject|1
7517268|NCT02475733|11853514|FG001|Overall Study|Withdrawal by Subject|0
7517269|NCT02475733|11853513|FG000|Overall Study|Physician Decision|1
7517270|NCT02475733|11853514|FG001|Overall Study|Physician Decision|0
7517271|NCT02475850|11853531|FG000|Overall Study|Death|155
7517272|NCT02475850|11853532|FG001|Overall Study|Death|141
7517273|NCT02475850|11853531|FG000|Overall Study|Lost to Follow-up|217
7517274|NCT02475850|11853532|FG001|Overall Study|Lost to Follow-up|188
7517275|NCT02475850|11853531|FG000|Overall Study|Withdrawal by Subject|221
7517276|NCT02475850|11853532|FG001|Overall Study|Withdrawal by Subject|155
7517277|NCT02475954|11853541|FG000|Overall Study|Withdrawal by Subject|2
7517278|NCT02475954|11853542|FG001|Overall Study|Withdrawal by Subject|2
7517279|NCT02475954|11853541|FG000|Overall Study|Lost to Follow-up|11
7517280|NCT02475954|11853542|FG001|Overall Study|Lost to Follow-up|9
7517281|NCT02475954|11853541|FG000|Overall Study|Death|1
7517282|NCT02475954|11853542|FG001|Overall Study|Death|1
7517283|NCT02475980|11853549|FG000|Overall Study|Lost to Follow-up|4
7517284|NCT02475980|11853549|FG000|Overall Study|Withdrawal by Subject|1
7517285|NCT02476175|11853569|FG000|Overall Study|Adverse Event|2
7517286|NCT02476422|11853586|FG000|Overall Study|Subject/guardian decision|0
7517287|NCT02476422|11853587|FG001|Overall Study|Subject/guardian decision|1
7517288|NCT02476578|11853621|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
7517289|NCT02476578|11853622|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
7517290|NCT02476578|11853621|FG000|Overall Study|Lost to Follow-up|6
7517291|NCT02476578|11853622|FG001|Overall Study|Lost to Follow-up|13
7517292|NCT02476617|11853628|FG000|Overall Study|Adverse Event|1
7517293|NCT02476617|11853628|FG000|Overall Study|Lost to Follow-up|1
7517294|NCT02477020|11853653|FG000|Overall Study|Pretreatment Event/Adverse Event|6
7517295|NCT02477020|11853654|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7517296|NCT02477020|11853653|FG000|Overall Study|Voluntary Withdrawal|7
7517297|NCT02477020|11853654|FG001|Overall Study|Voluntary Withdrawal|16
7517298|NCT02477020|11853653|FG000|Overall Study|Reason not Specified|3
7517299|NCT02477020|11853654|FG001|Overall Study|Reason not Specified|1
7517300|NCT02477020|11853653|FG000|Overall Study|Lack of Efficacy|14
7517301|NCT02477020|11853654|FG001|Overall Study|Lack of Efficacy|5
7517302|NCT02477111|11853660|FG000|Overall Study|Death|5
7517303|NCT02477111|11853660|FG000|Overall Study|Withdrawal by Subject|2
7517304|NCT02477111|11853660|FG000|Overall Study|missed visit|4
7517305|NCT02477215|11853670|FG000|Dose Escalation Phase|Physician Decision|1
7517306|NCT02477215|11853671|FG001|Dose Escalation Phase|Physician Decision|2
7517307|NCT02477215|11853672|FG002|Dose Escalation Phase|Physician Decision|0
7517308|NCT02477215|11853670|FG000|Fixed Dose Phase|Physician Decision|0
7517309|NCT02477215|11853671|FG001|Fixed Dose Phase|Physician Decision|7
7517310|NCT02477215|11853672|FG002|Fixed Dose Phase|Physician Decision|0
7517311|NCT02477332|11853703|FG000|Overall Study|Adverse Event|0
7517312|NCT02477332|11853704|FG001|Overall Study|Adverse Event|1
7517313|NCT02477332|11853705|FG002|Overall Study|Adverse Event|1
7517314|NCT02477332|11853706|FG003|Overall Study|Adverse Event|2
7517315|NCT02477332|11853707|FG004|Overall Study|Adverse Event|1
7517316|NCT02477332|11853708|FG005|Overall Study|Adverse Event|2
7517317|NCT02477332|11853703|FG000|Overall Study|Lack of Efficacy|1
7517318|NCT02477332|11853704|FG001|Overall Study|Lack of Efficacy|2
7517319|NCT02477332|11853705|FG002|Overall Study|Lack of Efficacy|1
7517320|NCT02477332|11853706|FG003|Overall Study|Lack of Efficacy|2
7517321|NCT02477332|11853707|FG004|Overall Study|Lack of Efficacy|1
7517322|NCT02477332|11853708|FG005|Overall Study|Lack of Efficacy|1
7517323|NCT02477332|11853703|FG000|Overall Study|Non-compliance with study treatment|0
7517324|NCT02477332|11853704|FG001|Overall Study|Non-compliance with study treatment|1
7517325|NCT02477332|11853705|FG002|Overall Study|Non-compliance with study treatment|2
7517326|NCT02477332|11853706|FG003|Overall Study|Non-compliance with study treatment|0
7517327|NCT02477332|11853707|FG004|Overall Study|Non-compliance with study treatment|0
7517328|NCT02477332|11853708|FG005|Overall Study|Non-compliance with study treatment|0
7517329|NCT02477332|11853703|FG000|Overall Study|Pregnancy|0
7517330|NCT02477332|11853704|FG001|Overall Study|Pregnancy|0
7517331|NCT02477332|11853705|FG002|Overall Study|Pregnancy|0
7517332|NCT02477332|11853706|FG003|Overall Study|Pregnancy|1
7517333|NCT02477332|11853707|FG004|Overall Study|Pregnancy|0
7517334|NCT02477332|11853708|FG005|Overall Study|Pregnancy|0
7517335|NCT02477332|11853703|FG000|Overall Study|Protocol Violation|2
7517336|NCT02477332|11853704|FG001|Overall Study|Protocol Violation|0
7517337|NCT02477332|11853705|FG002|Overall Study|Protocol Violation|3
7517338|NCT02477332|11853706|FG003|Overall Study|Protocol Violation|3
7517339|NCT02477332|11853707|FG004|Overall Study|Protocol Violation|1
7517340|NCT02477332|11853708|FG005|Overall Study|Protocol Violation|1
7517341|NCT02477332|11853703|FG000|Overall Study|Technical problems|0
7517342|NCT02477332|11853704|FG001|Overall Study|Technical problems|0
7517343|NCT02477332|11853705|FG002|Overall Study|Technical problems|1
7517344|NCT02477332|11853706|FG003|Overall Study|Technical problems|0
7517345|NCT02477332|11853707|FG004|Overall Study|Technical problems|0
7517346|NCT02477332|11853708|FG005|Overall Study|Technical problems|0
7517347|NCT02477332|11853703|FG000|Overall Study|Lost to Follow-up|0
7517348|NCT02477332|11853704|FG001|Overall Study|Lost to Follow-up|0
7517349|NCT02477332|11853705|FG002|Overall Study|Lost to Follow-up|2
7517350|NCT02477332|11853706|FG003|Overall Study|Lost to Follow-up|0
7517351|NCT02477332|11853707|FG004|Overall Study|Lost to Follow-up|0
7517352|NCT02477332|11853708|FG005|Overall Study|Lost to Follow-up|0
7517353|NCT02477332|11853703|FG000|Overall Study|Physician Decision|0
7517354|NCT02477332|11853704|FG001|Overall Study|Physician Decision|0
7517355|NCT02477332|11853705|FG002|Overall Study|Physician Decision|1
7517356|NCT02477332|11853706|FG003|Overall Study|Physician Decision|3
7517357|NCT02477332|11853707|FG004|Overall Study|Physician Decision|0
7517358|NCT02477332|11853708|FG005|Overall Study|Physician Decision|1
7517359|NCT02477332|11853703|FG000|Overall Study|Withdrawal by Subject|0
7517360|NCT02477332|11853704|FG001|Overall Study|Withdrawal by Subject|3
7517361|NCT02477332|11853705|FG002|Overall Study|Withdrawal by Subject|1
7517362|NCT02477332|11853706|FG003|Overall Study|Withdrawal by Subject|2
7517363|NCT02477332|11853707|FG004|Overall Study|Withdrawal by Subject|1
7517364|NCT02477332|11853708|FG005|Overall Study|Withdrawal by Subject|0
7517365|NCT02477527|11853733|FG000|Overall Study|Lost to Follow-up|2
7517366|NCT02477527|11853733|FG000|Overall Study|Withdrawal by Subject|1
7517367|NCT02477527|11853733|FG000|Overall Study|Screen Failure|3
7517368|NCT02477553|11853739|FG000|Overall Study|Screening up-to-date|12
7517369|NCT02477553|11853740|FG001|Overall Study|Screening up-to-date|13
7517370|NCT02477553|11853739|FG000|Overall Study|No MD visit|1
7517371|NCT02477553|11853740|FG001|Overall Study|No MD visit|1
7517372|NCT02477553|11853739|FG000|Overall Study|Workup consistent w/CRC|1
7517373|NCT02477553|11853740|FG001|Overall Study|Workup consistent w/CRC|1
7517374|NCT02477553|11853739|FG000|Overall Study|Technical issues with intervention|2
7517375|NCT02477553|11853740|FG001|Overall Study|Technical issues with intervention|0
7517376|NCT02477553|11853739|FG000|Overall Study|Elevated risk for CRC|2
7517377|NCT02477553|11853740|FG001|Overall Study|Elevated risk for CRC|2
7517378|NCT02477553|11853739|FG000|Overall Study|MD advised against screening|1
7517379|NCT02477553|11853740|FG001|Overall Study|MD advised against screening|3
7517380|NCT02477553|11853739|FG000|Overall Study|patient deceased|1
7517381|NCT02477553|11853740|FG001|Overall Study|patient deceased|0
7517382|NCT02477605|11853748|FG000|Overall Study|Discontinued prior to treatment|1
7517383|NCT02477605|11853749|FG001|Overall Study|Discontinued prior to treatment|0
7517384|NCT02477605|11853748|FG000|Overall Study|Lost to Follow-up|0
7517385|NCT02477605|11853749|FG001|Overall Study|Lost to Follow-up|2
7517386|NCT02477605|11853748|FG000|Overall Study|Withdrawal by Subject|0
7517387|NCT02477605|11853749|FG001|Overall Study|Withdrawal by Subject|1
7517388|NCT02477605|11853748|FG000|Overall Study|Administered gas during surgery|0
7517389|NCT02477605|11853749|FG001|Overall Study|Administered gas during surgery|1
7517390|NCT02477670|11853761|FG000|Stage 1|Adverse Event|2
7517391|NCT02477670|11853762|FG001|Stage 1|Adverse Event|7
7517392|NCT02477670|11853763|FG002|Stage 1|Adverse Event|0
7517393|NCT02477670|11853764|FG003|Stage 1|Adverse Event|0
7517394|NCT02477670|11853765|FG004|Stage 1|Adverse Event|0
7517395|NCT02477670|11853766|FG005|Stage 1|Adverse Event|0
7517396|NCT02477670|11853767|FG006|Stage 1|Adverse Event|0
7517397|NCT02477670|11853761|FG000|Stage 1|Lost to Follow-up|0
7517398|NCT02477670|11853762|FG001|Stage 1|Lost to Follow-up|2
7517399|NCT02477670|11853763|FG002|Stage 1|Lost to Follow-up|0
7517400|NCT02477670|11853764|FG003|Stage 1|Lost to Follow-up|0
7517401|NCT02477670|11853765|FG004|Stage 1|Lost to Follow-up|0
7517402|NCT02477670|11853766|FG005|Stage 1|Lost to Follow-up|0
7517403|NCT02477670|11853767|FG006|Stage 1|Lost to Follow-up|0
7517404|NCT02477670|11853761|FG000|Stage 1|Withdrawal by Subject|1
7517405|NCT02477670|11853762|FG001|Stage 1|Withdrawal by Subject|2
7517406|NCT02477670|11853763|FG002|Stage 1|Withdrawal by Subject|0
7517407|NCT02477670|11853764|FG003|Stage 1|Withdrawal by Subject|0
7517408|NCT02477670|11853765|FG004|Stage 1|Withdrawal by Subject|0
7517409|NCT02477670|11853766|FG005|Stage 1|Withdrawal by Subject|0
7517410|NCT02477670|11853767|FG006|Stage 1|Withdrawal by Subject|0
7517411|NCT02477670|11853761|FG000|Stage 1|Non-compliance with Study Drug|1
7517412|NCT02477670|11853762|FG001|Stage 1|Non-compliance with Study Drug|2
7517413|NCT02477670|11853763|FG002|Stage 1|Non-compliance with Study Drug|0
7517414|NCT02477670|11853764|FG003|Stage 1|Non-compliance with Study Drug|0
7517415|NCT02477670|11853765|FG004|Stage 1|Non-compliance with Study Drug|0
7517416|NCT02477670|11853766|FG005|Stage 1|Non-compliance with Study Drug|0
7517417|NCT02477670|11853767|FG006|Stage 1|Non-compliance with Study Drug|0
7517418|NCT02477670|11853761|FG000|Stage 2|Adverse Event|0
7517419|NCT02477670|11853762|FG001|Stage 2|Adverse Event|0
7517420|NCT02477670|11853763|FG002|Stage 2|Adverse Event|1
7517421|NCT02477670|11853764|FG003|Stage 2|Adverse Event|0
7517422|NCT02477670|11853765|FG004|Stage 2|Adverse Event|0
7517423|NCT02477670|11853766|FG005|Stage 2|Adverse Event|0
7517424|NCT02477670|11853767|FG006|Stage 2|Adverse Event|0
7517425|NCT02477670|11853761|FG000|Stage 2|Antipsychotic Medication Changed|0
7517426|NCT02477670|11853762|FG001|Stage 2|Antipsychotic Medication Changed|0
7517427|NCT02477670|11853763|FG002|Stage 2|Antipsychotic Medication Changed|1
7517428|NCT02477670|11853764|FG003|Stage 2|Antipsychotic Medication Changed|0
7517429|NCT02477670|11853765|FG004|Stage 2|Antipsychotic Medication Changed|0
7517430|NCT02477670|11853766|FG005|Stage 2|Antipsychotic Medication Changed|0
7517431|NCT02477670|11853767|FG006|Stage 2|Antipsychotic Medication Changed|0
7517432|NCT02477670|11853761|FG000|Stage 2|Withdrawal by Subject|0
7517433|NCT02477670|11853762|FG001|Stage 2|Withdrawal by Subject|0
7517434|NCT02477670|11853763|FG002|Stage 2|Withdrawal by Subject|0
7517435|NCT02477670|11853764|FG003|Stage 2|Withdrawal by Subject|1
7517436|NCT02477670|11853765|FG004|Stage 2|Withdrawal by Subject|0
7517437|NCT02477670|11853766|FG005|Stage 2|Withdrawal by Subject|0
7517438|NCT02477670|11853767|FG006|Stage 2|Withdrawal by Subject|0
7517439|NCT02477800|11853785|FG000|Placebo-Controlled Period|Adverse Event|16
7517440|NCT02477800|11853786|FG001|Placebo-Controlled Period|Adverse Event|25
7517441|NCT02477800|11853787|FG002|Placebo-Controlled Period|Adverse Event|28
7517442|NCT02477800|11853788|FG003|Placebo-Controlled Period|Adverse Event|0
7517443|NCT02477800|11853789|FG004|Placebo-Controlled Period|Adverse Event|0
7517444|NCT02477800|11853790|FG005|Placebo-Controlled Period|Adverse Event|0
7517445|NCT02477800|11853791|FG006|Placebo-Controlled Period|Adverse Event|0
7517446|NCT02477800|11853785|FG000|Placebo-Controlled Period|Change of Treatment|1
7517447|NCT02477800|11853786|FG001|Placebo-Controlled Period|Change of Treatment|2
7517448|NCT02477800|11853787|FG002|Placebo-Controlled Period|Change of Treatment|1
7517449|NCT02477800|11853788|FG003|Placebo-Controlled Period|Change of Treatment|0
7517450|NCT02477800|11853789|FG004|Placebo-Controlled Period|Change of Treatment|0
7517451|NCT02477800|11853790|FG005|Placebo-Controlled Period|Change of Treatment|0
7517452|NCT02477800|11853791|FG006|Placebo-Controlled Period|Change of Treatment|0
7517453|NCT02477800|11853785|FG000|Placebo-Controlled Period|Consent Withdrawn|26
7517454|NCT02477800|11853786|FG001|Placebo-Controlled Period|Consent Withdrawn|16
7517455|NCT02477800|11853787|FG002|Placebo-Controlled Period|Consent Withdrawn|27
7517456|NCT02477800|11853788|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7517457|NCT02477800|11853789|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7517458|NCT02477800|11853790|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7517459|NCT02477800|11853791|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7517460|NCT02477800|11853785|FG000|Placebo-Controlled Period|Death|0
7517461|NCT02477800|11853786|FG001|Placebo-Controlled Period|Death|3
7517462|NCT02477800|11853787|FG002|Placebo-Controlled Period|Death|2
7517463|NCT02477800|11853788|FG003|Placebo-Controlled Period|Death|0
7517464|NCT02477800|11853789|FG004|Placebo-Controlled Period|Death|0
7517465|NCT02477800|11853790|FG005|Placebo-Controlled Period|Death|0
7517466|NCT02477800|11853791|FG006|Placebo-Controlled Period|Death|0
7517467|NCT02477800|11853785|FG000|Placebo-Controlled Period|Disease Progression|1
7517468|NCT02477800|11853786|FG001|Placebo-Controlled Period|Disease Progression|0
7517469|NCT02477800|11853787|FG002|Placebo-Controlled Period|Disease Progression|1
7517470|NCT02477800|11853788|FG003|Placebo-Controlled Period|Disease Progression|0
7517471|NCT02477800|11853789|FG004|Placebo-Controlled Period|Disease Progression|0
7517472|NCT02477800|11853790|FG005|Placebo-Controlled Period|Disease Progression|0
7517473|NCT02477800|11853791|FG006|Placebo-Controlled Period|Disease Progression|0
7517474|NCT02477800|11853785|FG000|Placebo-Controlled Period|Investigator Decision|3
7517475|NCT02477800|11853786|FG001|Placebo-Controlled Period|Investigator Decision|2
7517476|NCT02477800|11853787|FG002|Placebo-Controlled Period|Investigator Decision|1
7517477|NCT02477800|11853788|FG003|Placebo-Controlled Period|Investigator Decision|0
7517478|NCT02477800|11853789|FG004|Placebo-Controlled Period|Investigator Decision|0
7517479|NCT02477800|11853790|FG005|Placebo-Controlled Period|Investigator Decision|0
7517480|NCT02477800|11853791|FG006|Placebo-Controlled Period|Investigator Decision|0
7517481|NCT02477800|11853785|FG000|Placebo-Controlled Period|Lost to Follow-up|1
7517482|NCT02477800|11853786|FG001|Placebo-Controlled Period|Lost to Follow-up|3
7517483|NCT02477800|11853787|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7517484|NCT02477800|11853788|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7517485|NCT02477800|11853789|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7517486|NCT02477800|11853790|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7517487|NCT02477800|11853791|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7517488|NCT02477800|11853785|FG000|Placebo-Controlled Period|Relocation|2
7517489|NCT02477800|11853786|FG001|Placebo-Controlled Period|Relocation|0
7517490|NCT02477800|11853787|FG002|Placebo-Controlled Period|Relocation|0
7517491|NCT02477800|11853788|FG003|Placebo-Controlled Period|Relocation|0
7517492|NCT02477800|11853789|FG004|Placebo-Controlled Period|Relocation|0
7517493|NCT02477800|11853790|FG005|Placebo-Controlled Period|Relocation|0
7517494|NCT02477800|11853791|FG006|Placebo-Controlled Period|Relocation|0
7517495|NCT02477800|11853785|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
7517496|NCT02477800|11853786|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
7517497|NCT02477800|11853787|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
7517498|NCT02477800|11853788|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
7517499|NCT02477800|11853789|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
7517500|NCT02477800|11853790|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
7517501|NCT02477800|11853791|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
7517502|NCT02477800|11853785|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
7517503|NCT02477800|11853786|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
7517504|NCT02477800|11853787|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
7517505|NCT02477800|11853788|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
7517506|NCT02477800|11853789|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
7517507|NCT02477800|11853790|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
7517508|NCT02477800|11853791|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
7517509|NCT02477800|11853785|FG000|Placebo-Controlled Period|Study Visit Burden|5
7517510|NCT02477800|11853786|FG001|Placebo-Controlled Period|Study Visit Burden|3
7517511|NCT02477800|11853787|FG002|Placebo-Controlled Period|Study Visit Burden|11
7517512|NCT02477800|11853788|FG003|Placebo-Controlled Period|Study Visit Burden|0
7517513|NCT02477800|11853789|FG004|Placebo-Controlled Period|Study Visit Burden|0
7517514|NCT02477800|11853790|FG005|Placebo-Controlled Period|Study Visit Burden|0
7517515|NCT02477800|11853791|FG006|Placebo-Controlled Period|Study Visit Burden|0
7517516|NCT02477800|11853785|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7517517|NCT02477800|11853786|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
7517518|NCT02477800|11853787|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
7517519|NCT02477800|11853788|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517520|NCT02477800|11853789|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517521|NCT02477800|11853790|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517522|NCT02477800|11853791|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517523|NCT02477800|11853785|FG000|Placebo-Controlled Period|Reason not Specified|161
7517524|NCT02477800|11853786|FG001|Placebo-Controlled Period|Reason not Specified|161
7517525|NCT02477800|11853787|FG002|Placebo-Controlled Period|Reason not Specified|189
7517526|NCT02477800|11853788|FG003|Placebo-Controlled Period|Reason not Specified|0
7517527|NCT02477800|11853789|FG004|Placebo-Controlled Period|Reason not Specified|0
7517528|NCT02477800|11853790|FG005|Placebo-Controlled Period|Reason not Specified|0
7517529|NCT02477800|11853791|FG006|Placebo-Controlled Period|Reason not Specified|0
7517530|NCT02477800|11853785|FG000|Long Term Extension Period|Adverse Event|0
7517531|NCT02477800|11853786|FG001|Long Term Extension Period|Adverse Event|0
7517532|NCT02477800|11853787|FG002|Long Term Extension Period|Adverse Event|0
7517533|NCT02477800|11853788|FG003|Long Term Extension Period|Adverse Event|6
7517534|NCT02477800|11853789|FG004|Long Term Extension Period|Adverse Event|2
7517535|NCT02477800|11853790|FG005|Long Term Extension Period|Adverse Event|4
7517536|NCT02477800|11853791|FG006|Long Term Extension Period|Adverse Event|3
7517537|NCT02477800|11853785|FG000|Long Term Extension Period|Death|0
7517538|NCT02477800|11853786|FG001|Long Term Extension Period|Death|0
7517539|NCT02477800|11853787|FG002|Long Term Extension Period|Death|0
7517540|NCT02477800|11853788|FG003|Long Term Extension Period|Death|1
7517541|NCT02477800|11853789|FG004|Long Term Extension Period|Death|1
7517542|NCT02477800|11853790|FG005|Long Term Extension Period|Death|1
7517543|NCT02477800|11853791|FG006|Long Term Extension Period|Death|2
7517544|NCT02477800|11853785|FG000|Long Term Extension Period|Consent Withdrawn|0
7517545|NCT02477800|11853786|FG001|Long Term Extension Period|Consent Withdrawn|0
7517546|NCT02477800|11853787|FG002|Long Term Extension Period|Consent Withdrawn|0
7517547|NCT02477800|11853788|FG003|Long Term Extension Period|Consent Withdrawn|10
7517548|NCT02477800|11853789|FG004|Long Term Extension Period|Consent Withdrawn|4
7517549|NCT02477800|11853790|FG005|Long Term Extension Period|Consent Withdrawn|13
7517550|NCT02477800|11853791|FG006|Long Term Extension Period|Consent Withdrawn|16
7517551|NCT02477800|11853785|FG000|Long Term Extension Period|Disease Progression|0
7517552|NCT02477800|11853786|FG001|Long Term Extension Period|Disease Progression|0
7517553|NCT02477800|11853787|FG002|Long Term Extension Period|Disease Progression|0
7517554|NCT02477800|11853788|FG003|Long Term Extension Period|Disease Progression|3
7517555|NCT02477800|11853789|FG004|Long Term Extension Period|Disease Progression|1
7517556|NCT02477800|11853790|FG005|Long Term Extension Period|Disease Progression|1
7517557|NCT02477800|11853791|FG006|Long Term Extension Period|Disease Progression|0
7517558|NCT02477800|11853785|FG000|Long Term Extension Period|Investigator Decision|0
7517559|NCT02477800|11853786|FG001|Long Term Extension Period|Investigator Decision|0
7517560|NCT02477800|11853787|FG002|Long Term Extension Period|Investigator Decision|0
7517561|NCT02477800|11853788|FG003|Long Term Extension Period|Investigator Decision|0
7517562|NCT02477800|11853789|FG004|Long Term Extension Period|Investigator Decision|0
7517563|NCT02477800|11853790|FG005|Long Term Extension Period|Investigator Decision|0
7517564|NCT02477800|11853791|FG006|Long Term Extension Period|Investigator Decision|2
7517565|NCT02477800|11853785|FG000|Long Term Extension Period|Lost to Follow-up|0
7517566|NCT02477800|11853786|FG001|Long Term Extension Period|Lost to Follow-up|0
7517567|NCT02477800|11853787|FG002|Long Term Extension Period|Lost to Follow-up|0
7517568|NCT02477800|11853788|FG003|Long Term Extension Period|Lost to Follow-up|0
7517569|NCT02477800|11853789|FG004|Long Term Extension Period|Lost to Follow-up|1
7517570|NCT02477800|11853790|FG005|Long Term Extension Period|Lost to Follow-up|3
7517571|NCT02477800|11853791|FG006|Long Term Extension Period|Lost to Follow-up|0
7517572|NCT02477800|11853785|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
7517573|NCT02477800|11853786|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
7517574|NCT02477800|11853787|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
7517575|NCT02477800|11853788|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
7517576|NCT02477800|11853789|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
7517577|NCT02477800|11853790|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
7517578|NCT02477800|11853791|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
7517579|NCT02477800|11853785|FG000|Long Term Extension Period|Study Visit Burden|0
7517580|NCT02477800|11853786|FG001|Long Term Extension Period|Study Visit Burden|0
7517581|NCT02477800|11853787|FG002|Long Term Extension Period|Study Visit Burden|0
7517582|NCT02477800|11853788|FG003|Long Term Extension Period|Study Visit Burden|3
7517583|NCT02477800|11853789|FG004|Long Term Extension Period|Study Visit Burden|0
7517584|NCT02477800|11853790|FG005|Long Term Extension Period|Study Visit Burden|2
7517585|NCT02477800|11853791|FG006|Long Term Extension Period|Study Visit Burden|2
7517586|NCT02477800|11853785|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7517587|NCT02477800|11853786|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7517588|NCT02477800|11853787|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
7517668|NCT02479139|11853901|FG004|Overall Study|Other Miscellaneous Reasons|1
7517589|NCT02477800|11853788|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7517590|NCT02477800|11853789|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7517591|NCT02477800|11853790|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
7517592|NCT02477800|11853791|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
7517593|NCT02477800|11853785|FG000|Long Term Extension Period|Reason not Specified|0
7517594|NCT02477800|11853786|FG001|Long Term Extension Period|Reason not Specified|0
7517595|NCT02477800|11853787|FG002|Long Term Extension Period|Reason not Specified|0
7517596|NCT02477800|11853788|FG003|Long Term Extension Period|Reason not Specified|126
7517597|NCT02477800|11853789|FG004|Long Term Extension Period|Reason not Specified|140
7517598|NCT02477800|11853790|FG005|Long Term Extension Period|Reason not Specified|270
7517599|NCT02477800|11853791|FG006|Long Term Extension Period|Reason not Specified|224
7517600|NCT02477839|11853805|FG000|Overall Study|Adverse Event|0
7517601|NCT02477839|11853806|FG001|Overall Study|Adverse Event|1
7517602|NCT02477839|11853805|FG000|Overall Study|Protocol Violation|0
7517603|NCT02477839|11853806|FG001|Overall Study|Protocol Violation|2
7517604|NCT02477839|11853805|FG000|Overall Study|Withdrawal by Subject|3
7517605|NCT02477839|11853806|FG001|Overall Study|Withdrawal by Subject|3
7517606|NCT02477839|11853805|FG000|Overall Study|Participant had PGS during V6|0
7517607|NCT02477839|11853806|FG001|Overall Study|Participant had PGS during V6|1
7517608|NCT02477839|11853805|FG000|Overall Study|Parents decided to stop medication|0
7517609|NCT02477839|11853806|FG001|Overall Study|Parents decided to stop medication|1
7517610|NCT02477839|11853805|FG000|Overall Study|Lack of tolerability|0
7517611|NCT02477839|11853806|FG001|Overall Study|Lack of tolerability|1
7517612|NCT02477839|11853805|FG000|Overall Study|Exclusion criterion|0
7517613|NCT02477839|11853806|FG001|Overall Study|Exclusion criterion|1
7517614|NCT02478164|11853814|FG000|Overall Study|Lack of Efficacy|13
7517615|NCT02478164|11853814|FG000|Overall Study|Adverse Event|1
7517616|NCT02478164|11853814|FG000|Overall Study|Withdrawal by Subject|1
7517617|NCT02478359|11853820|FG000|Overall Study|Disenrolled from health plan|106
7517618|NCT02478359|11853821|FG001|Overall Study|Disenrolled from health plan|65
7517619|NCT02478372|11853831|FG000|Overall Study|Protocol Violation|12
7517620|NCT02478372|11853832|FG001|Overall Study|Protocol Violation|8
7517621|NCT02478372|11853831|FG000|Overall Study|Lost to Follow-up|1
7517622|NCT02478372|11853832|FG001|Overall Study|Lost to Follow-up|4
7517623|NCT02478372|11853831|FG000|Overall Study|Death|0
7517624|NCT02478372|11853832|FG001|Overall Study|Death|2
7517625|NCT02478398|11853840|FG000|Overall Study|Adverse Event|20
7517626|NCT02478398|11853841|FG001|Overall Study|Adverse Event|5
7517627|NCT02478398|11853840|FG000|Overall Study|Lost to Follow-up|5
7517628|NCT02478398|11853841|FG001|Overall Study|Lost to Follow-up|4
7517629|NCT02478398|11853840|FG000|Overall Study|Non-Compliance With Study Drug|5
7517630|NCT02478398|11853841|FG001|Overall Study|Non-Compliance With Study Drug|1
7517631|NCT02478398|11853840|FG000|Overall Study|Protocol Violation|3
7517632|NCT02478398|11853841|FG001|Overall Study|Protocol Violation|1
7517633|NCT02478398|11853840|FG000|Overall Study|Withdrawal By Parent/Guardian|9
7517634|NCT02478398|11853841|FG001|Overall Study|Withdrawal By Parent/Guardian|6
7517635|NCT02478398|11853840|FG000|Overall Study|Withdrawal By Participant|10
7517636|NCT02478398|11853841|FG001|Overall Study|Withdrawal By Participant|4
7517637|NCT02478463|11853848|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
7517638|NCT02478463|11853848|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
7517639|NCT02478463|11853848|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
7517640|NCT02478632|11853876|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
7517641|NCT02478632|11853877|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
7517642|NCT02478632|11853876|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
7517643|NCT02478632|11853877|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
7517644|NCT02478632|11853876|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
7517645|NCT02478632|11853877|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
7517646|NCT02479139|11853897|FG000|Overall Study|Lost to Follow-up|2
7517647|NCT02479139|11853898|FG001|Overall Study|Lost to Follow-up|4
7517648|NCT02479139|11853899|FG002|Overall Study|Lost to Follow-up|4
7517649|NCT02479139|11853900|FG003|Overall Study|Lost to Follow-up|2
7517650|NCT02479139|11853901|FG004|Overall Study|Lost to Follow-up|3
7517651|NCT02479139|11853902|FG005|Overall Study|Lost to Follow-up|5
7517652|NCT02479139|11853897|FG000|Overall Study|Withdrew Consent|5
7517653|NCT02479139|11853898|FG001|Overall Study|Withdrew Consent|6
7517654|NCT02479139|11853899|FG002|Overall Study|Withdrew Consent|1
7517655|NCT02479139|11853900|FG003|Overall Study|Withdrew Consent|4
7517656|NCT02479139|11853901|FG004|Overall Study|Withdrew Consent|1
7517657|NCT02479139|11853902|FG005|Overall Study|Withdrew Consent|1
7517658|NCT02479139|11853897|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
7517659|NCT02479139|11853898|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
7517660|NCT02479139|11853899|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
7517661|NCT02479139|11853900|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
7517662|NCT02479139|11853901|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
7517663|NCT02479139|11853902|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
7517664|NCT02479139|11853897|FG000|Overall Study|Other Miscellaneous Reasons|1
7517665|NCT02479139|11853898|FG001|Overall Study|Other Miscellaneous Reasons|0
7517666|NCT02479139|11853899|FG002|Overall Study|Other Miscellaneous Reasons|1
7517667|NCT02479139|11853900|FG003|Overall Study|Other Miscellaneous Reasons|1
7517669|NCT02479139|11853902|FG005|Overall Study|Other Miscellaneous Reasons|0
7517670|NCT02479412|11853925|FG000|Overall Study|Adverse Event|0
7517671|NCT02479412|11853926|FG001|Overall Study|Adverse Event|0
7517672|NCT02479412|11853927|FG002|Overall Study|Adverse Event|1
7517673|NCT02479412|11853928|FG003|Overall Study|Adverse Event|0
7517674|NCT02479412|11853929|FG004|Overall Study|Adverse Event|0
7517675|NCT02479412|11853930|FG005|Overall Study|Adverse Event|0
7517676|NCT02479412|11853931|FG006|Overall Study|Adverse Event|0
7517677|NCT02479412|11853932|FG007|Overall Study|Adverse Event|0
7517678|NCT02479412|11853933|FG008|Overall Study|Adverse Event|0
7517679|NCT02479412|11853925|FG000|Overall Study|Study-specific withdrawal criteria|0
7517680|NCT02479412|11853926|FG001|Overall Study|Study-specific withdrawal criteria|0
7517681|NCT02479412|11853927|FG002|Overall Study|Study-specific withdrawal criteria|1
7517682|NCT02479412|11853928|FG003|Overall Study|Study-specific withdrawal criteria|1
7517683|NCT02479412|11853929|FG004|Overall Study|Study-specific withdrawal criteria|0
7517684|NCT02479412|11853930|FG005|Overall Study|Study-specific withdrawal criteria|0
7517685|NCT02479412|11853931|FG006|Overall Study|Study-specific withdrawal criteria|0
7517686|NCT02479412|11853932|FG007|Overall Study|Study-specific withdrawal criteria|1
7517687|NCT02479412|11853933|FG008|Overall Study|Study-specific withdrawal criteria|1
7517688|NCT02479412|11853925|FG000|Overall Study|Randomization to wrong PK sampling group|0
7517689|NCT02479412|11853926|FG001|Overall Study|Randomization to wrong PK sampling group|0
7517690|NCT02479412|11853927|FG002|Overall Study|Randomization to wrong PK sampling group|0
7517691|NCT02479412|11853928|FG003|Overall Study|Randomization to wrong PK sampling group|0
7517692|NCT02479412|11853929|FG004|Overall Study|Randomization to wrong PK sampling group|1
7517693|NCT02479412|11853930|FG005|Overall Study|Randomization to wrong PK sampling group|0
7517694|NCT02479412|11853931|FG006|Overall Study|Randomization to wrong PK sampling group|0
7517695|NCT02479412|11853932|FG007|Overall Study|Randomization to wrong PK sampling group|0
7517696|NCT02479412|11853933|FG008|Overall Study|Randomization to wrong PK sampling group|0
7517697|NCT02479802|11853958|FG000|Overall Study|Lost to Follow-up|1
7517698|NCT02479802|11853958|FG000|Overall Study|Adverse Event|1
7517699|NCT02479880|11853964|FG000|Overall Study|Study Terminated by Sponsor|13
7517700|NCT02479880|11853965|FG001|Overall Study|Study Terminated by Sponsor|12
7517701|NCT02479880|11853964|FG000|Overall Study|Pregnancy|0
7517702|NCT02479880|11853965|FG001|Overall Study|Pregnancy|1
7517703|NCT02480010|11853973|FG000|Overall Study|Adverse Event|3
7517704|NCT02480010|11853974|FG001|Overall Study|Adverse Event|1
7517705|NCT02480010|11853973|FG000|Overall Study|Death|1
7517706|NCT02480010|11853974|FG001|Overall Study|Death|0
7517707|NCT02480010|11853973|FG000|Overall Study|Insufficient therapeutic response|31
7517708|NCT02480010|11853974|FG001|Overall Study|Insufficient therapeutic response|29
7517709|NCT02480010|11853973|FG000|Overall Study|Refused Treatment|0
7517710|NCT02480010|11853974|FG001|Overall Study|Refused Treatment|3
7517711|NCT02480114|11853982|FG000|Overall Study|Not completing surveys|3
7517712|NCT02480114|11853983|FG001|Overall Study|Not completing surveys|2
7517713|NCT02480114|11853982|FG000|Overall Study|Withdrawal by Subject|2
7517714|NCT02480114|11853983|FG001|Overall Study|Withdrawal by Subject|4
7517715|NCT02480114|11853982|FG000|Overall Study|Disease progression|3
7517716|NCT02480114|11853983|FG001|Overall Study|Disease progression|0
7517717|NCT02480114|11853982|FG000|Overall Study|Improper completion of survey|1
7517718|NCT02480114|11853983|FG001|Overall Study|Improper completion of survey|1
7517719|NCT02480114|11853982|FG000|Overall Study|Not eligible|0
7517720|NCT02480114|11853983|FG001|Overall Study|Not eligible|1
7517721|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7517722|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
7517723|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
7517724|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7517725|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
7517726|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
7517727|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
7517728|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
7517729|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
7517730|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
7517731|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
7517732|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
7517733|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
7517734|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
7517735|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
7517736|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
7517737|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
7517738|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
7517739|NCT02480153|11853991|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7517740|NCT02480153|11853992|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
7517741|NCT02480153|11853993|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
7517742|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
7517743|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
7536640|NCT02721966|11884634|FG001|Overall Study|Death|0
7517744|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
7517745|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7517746|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
7517747|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
7517748|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
7517749|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
7517750|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
7517751|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
7517752|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
7517753|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
7517754|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
7517755|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7517756|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
7517757|NCT02480153|11853991|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7517758|NCT02480153|11853992|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
7517759|NCT02480153|11853993|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
7517760|NCT02480153|11853991|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
7517761|NCT02480153|11853992|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
7517762|NCT02480153|11853993|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
7517763|NCT02480153|11853991|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
7517764|NCT02480153|11853992|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
7517765|NCT02480153|11853993|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
7517766|NCT02480153|11853991|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
7517767|NCT02480153|11853992|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
7517768|NCT02480153|11853993|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
7517769|NCT02480153|11853991|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7517770|NCT02480153|11853992|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
7517771|NCT02480153|11853993|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
7517772|NCT02480153|11853991|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
7517773|NCT02480153|11853992|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
7517774|NCT02480153|11853993|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
7517775|NCT02480621|11854063|FG000|Randomization|Withdrawal by Subject|1
7517776|NCT02480621|11854064|FG001|Randomization|Withdrawal by Subject|0
7517777|NCT02480621|11854063|FG000|Randomization|Surgeon did not give intervention|0
7517778|NCT02480621|11854064|FG001|Randomization|Surgeon did not give intervention|1
7517779|NCT02480621|11854063|FG000|Follow Up|Lost to Follow-up|4
7517780|NCT02480621|11854064|FG001|Follow Up|Lost to Follow-up|2
7517781|NCT02480712|11854070|FG000|Overall Study|Enrolled but Never Treated|1
7517782|NCT02480712|11854070|FG000|Overall Study|Lost to Follow-up|5
7517783|NCT02480712|11854070|FG000|Overall Study|Withdrew Consent|3
7517784|NCT02480712|11854070|FG000|Overall Study|Death|1
7517785|NCT02480712|11854070|FG000|Overall Study|Lack of Efficacy|1
7517786|NCT02480764|11854083|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7517787|NCT02480764|11854084|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7517788|NCT02480764|11854085|FG002|Overall Study|Pretreatment Event/Adverse Event|3
7517789|NCT02480764|11854083|FG000|Overall Study|Major Protocol Deviation|1
7517790|NCT02480764|11854084|FG001|Overall Study|Major Protocol Deviation|4
7517791|NCT02480764|11854085|FG002|Overall Study|Major Protocol Deviation|3
7517792|NCT02480764|11854083|FG000|Overall Study|Lost to Follow-up|0
7517793|NCT02480764|11854084|FG001|Overall Study|Lost to Follow-up|1
7517794|NCT02480764|11854085|FG002|Overall Study|Lost to Follow-up|2
7517795|NCT02480764|11854083|FG000|Overall Study|Voluntary Withdrawal|6
7517796|NCT02480764|11854084|FG001|Overall Study|Voluntary Withdrawal|5
7517797|NCT02480764|11854085|FG002|Overall Study|Voluntary Withdrawal|10
7517798|NCT02480764|11854083|FG000|Overall Study|Lack of Efficacy|0
7517799|NCT02480764|11854084|FG001|Overall Study|Lack of Efficacy|3
7517800|NCT02480764|11854085|FG002|Overall Study|Lack of Efficacy|3
7517801|NCT02480764|11854083|FG000|Overall Study|Reason not Specified|0
7517802|NCT02480764|11854084|FG001|Overall Study|Reason not Specified|1
7517803|NCT02480764|11854085|FG002|Overall Study|Reason not Specified|0
7517804|NCT02481050|11854108|FG000|Overall Study|Adverse Event|1
7517805|NCT02481050|11854108|FG000|Overall Study|Disease Progression|47
7517806|NCT02481050|11854108|FG000|Overall Study|Withdrawal by Subject|7
7517807|NCT02481050|11854108|FG000|Overall Study|Other|3
7517808|NCT02481869|11854253|FG000|Overall Study|Lost to Follow-up|3
7517809|NCT02481869|11854254|FG001|Overall Study|Lost to Follow-up|4
7517810|NCT02481869|11854253|FG000|Overall Study|Withdrawal by Subject|2
7517811|NCT02481869|11854254|FG001|Overall Study|Withdrawal by Subject|0
7517812|NCT02481934|11854261|FG000|Overall Study|Death|2
7517813|NCT02481947|11854267|FG000|Overall Study|Withdrawal by Subject|24
7517814|NCT02481947|11854268|FG001|Overall Study|Withdrawal by Subject|10
7517815|NCT02481947|11854267|FG000|Overall Study|Lost to Follow-up|11
7517816|NCT02481947|11854268|FG001|Overall Study|Lost to Follow-up|5
7517817|NCT02481947|11854267|FG000|Overall Study|Adverse Event|6
7517818|NCT02481947|11854268|FG001|Overall Study|Adverse Event|11
7517819|NCT02481947|11854267|FG000|Overall Study|Physician Decision|4
7517820|NCT02481947|11854268|FG001|Overall Study|Physician Decision|5
7517821|NCT02481947|11854267|FG000|Overall Study|Protocol Violation|1
7517822|NCT02481947|11854268|FG001|Overall Study|Protocol Violation|5
7517823|NCT02482129|11854285|FG000|Overall Study|Adverse Event-prior to treatment|0
7517824|NCT02482129|11854286|FG001|Overall Study|Adverse Event-prior to treatment|1
7517825|NCT02482129|11854285|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
7517826|NCT02482129|11854286|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
7517827|NCT02482129|11854285|FG000|Overall Study|Unable to draw blood-prior to treatment|1
7517828|NCT02482129|11854286|FG001|Overall Study|Unable to draw blood-prior to treatment|0
7517829|NCT02482129|11854285|FG000|Overall Study|Criteria not met-prior to treatment|1
7517830|NCT02482129|11854286|FG001|Overall Study|Criteria not met-prior to treatment|0
7517831|NCT02482129|11854285|FG000|Overall Study|Adverse Event|1
7517832|NCT02482129|11854286|FG001|Overall Study|Adverse Event|0
7517833|NCT02482129|11854285|FG000|Overall Study|Withdrawal by Subject|2
7517834|NCT02482129|11854286|FG001|Overall Study|Withdrawal by Subject|0
7517835|NCT02482129|11854285|FG000|Overall Study|Criteria not met|1
7517836|NCT02482129|11854286|FG001|Overall Study|Criteria not met|0
7517837|NCT02482298|11854297|FG000|Overall Study|Withdrawal by Subject|2
7517838|NCT02482298|11854298|FG001|Overall Study|Withdrawal by Subject|1
7517839|NCT02482298|11854299|FG002|Overall Study|Withdrawal by Subject|2
7517840|NCT02482298|11854297|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
7517841|NCT02482298|11854298|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
7517842|NCT02482298|11854299|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
7517843|NCT02482298|11854297|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7517844|NCT02482298|11854298|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
7517845|NCT02482298|11854299|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
7517846|NCT02482298|11854297|FG000|Overall Study|Lost to Follow-up|0
7517847|NCT02482298|11854298|FG001|Overall Study|Lost to Follow-up|1
7517848|NCT02482298|11854299|FG002|Overall Study|Lost to Follow-up|0
7517849|NCT02482428|11854312|FG000|Overall Study|Lost to Follow-up|4
7517850|NCT02482428|11854313|FG001|Overall Study|Lost to Follow-up|9
7517851|NCT02482428|11854314|FG002|Overall Study|Lost to Follow-up|1
7517852|NCT02482428|11854315|FG003|Overall Study|Lost to Follow-up|2
7517853|NCT02482428|11854316|FG004|Overall Study|Lost to Follow-up|4
7517854|NCT02482428|11854312|FG000|Overall Study|Physician Decision|0
7517855|NCT02482428|11854313|FG001|Overall Study|Physician Decision|0
7517856|NCT02482428|11854314|FG002|Overall Study|Physician Decision|0
7517857|NCT02482428|11854315|FG003|Overall Study|Physician Decision|0
7517858|NCT02482428|11854316|FG004|Overall Study|Physician Decision|1
7517859|NCT02482428|11854312|FG000|Overall Study|protocol deviation|1
7517860|NCT02482428|11854313|FG001|Overall Study|protocol deviation|1
7517861|NCT02482428|11854314|FG002|Overall Study|protocol deviation|0
7517862|NCT02482428|11854315|FG003|Overall Study|protocol deviation|0
7517863|NCT02482428|11854316|FG004|Overall Study|protocol deviation|0
7517864|NCT02482428|11854312|FG000|Overall Study|subject/guardian decision|4
7517865|NCT02482428|11854313|FG001|Overall Study|subject/guardian decision|2
7517866|NCT02482428|11854314|FG002|Overall Study|subject/guardian decision|0
7517867|NCT02482428|11854315|FG003|Overall Study|subject/guardian decision|0
7517868|NCT02482428|11854316|FG004|Overall Study|subject/guardian decision|2
7517869|NCT02482571|11854330|FG000|Overall Study|Adverse Event|1
7517870|NCT02482571|11854330|FG000|Overall Study|Scanner or Respiract failure|3
7517871|NCT02482571|11854330|FG000|Overall Study|Withdrawal by Subject|4
7517872|NCT02482805|11854386|FG000|Overall Study|Lost to Follow-up|4
7517873|NCT02482805|11854387|FG001|Overall Study|Lost to Follow-up|4
7517874|NCT02482805|11854388|FG002|Overall Study|Lost to Follow-up|0
7536609|NCT02720757|11884566|FG000|Overall Study|Missing|3
7536610|NCT02720757|11884566|FG000|Overall Study|General exclusion|3
7536611|NCT02721147|11884584|FG000|Overall Study|Lost to Follow-up|2
7536612|NCT02721147|11884585|FG001|Overall Study|Lost to Follow-up|0
7536613|NCT02721147|11884586|FG002|Overall Study|Lost to Follow-up|0
7536614|NCT02721251|11884597|FG000|Overall Study|Withdrawal by Subject|8
7536615|NCT02721251|11884598|FG001|Overall Study|Withdrawal by Subject|7
7536616|NCT02721251|11884599|FG002|Overall Study|Withdrawal by Subject|9
7536617|NCT02721251|11884597|FG000|Overall Study|poor adherence|2
7536618|NCT02721251|11884598|FG001|Overall Study|poor adherence|2
7536619|NCT02721251|11884599|FG002|Overall Study|poor adherence|2
7536620|NCT02721355|11884610|FG000|Overall Study|Lost to Follow-up|6
7536621|NCT02721355|11884611|FG001|Overall Study|Lost to Follow-up|1
7536622|NCT02721875|11884623|FG000|Overall Study|Progressive disease/relapse|1
7536623|NCT02721875|11884624|FG001|Overall Study|Progressive disease/relapse|0
7536624|NCT02721966|11884633|FG000|Overall Study|Protocol Violation|1
7536625|NCT02721966|11884634|FG001|Overall Study|Protocol Violation|0
7536626|NCT02721966|11884635|FG002|Overall Study|Protocol Violation|0
7536627|NCT02721966|11884636|FG003|Overall Study|Protocol Violation|0
7536628|NCT02721966|11884637|FG004|Overall Study|Protocol Violation|0
7536629|NCT02721966|11884633|FG000|Overall Study|Withdrawal by Subject|9
7536630|NCT02721966|11884634|FG001|Overall Study|Withdrawal by Subject|2
7536631|NCT02721966|11884635|FG002|Overall Study|Withdrawal by Subject|3
7536632|NCT02721966|11884636|FG003|Overall Study|Withdrawal by Subject|7
7536633|NCT02721966|11884637|FG004|Overall Study|Withdrawal by Subject|0
7536634|NCT02721966|11884633|FG000|Overall Study|Adverse Event|4
7536635|NCT02721966|11884634|FG001|Overall Study|Adverse Event|4
7536636|NCT02721966|11884635|FG002|Overall Study|Adverse Event|3
7536637|NCT02721966|11884636|FG003|Overall Study|Adverse Event|0
7536638|NCT02721966|11884637|FG004|Overall Study|Adverse Event|0
7536639|NCT02721966|11884633|FG000|Overall Study|Death|1
7536641|NCT02721966|11884635|FG002|Overall Study|Death|0
7536642|NCT02721966|11884636|FG003|Overall Study|Death|0
7536643|NCT02721966|11884637|FG004|Overall Study|Death|0
7536644|NCT02721966|11884633|FG000|Overall Study|Lack of Efficacy|7
7536645|NCT02721966|11884634|FG001|Overall Study|Lack of Efficacy|4
7536646|NCT02721966|11884635|FG002|Overall Study|Lack of Efficacy|0
7536647|NCT02721966|11884636|FG003|Overall Study|Lack of Efficacy|0
7536648|NCT02721966|11884637|FG004|Overall Study|Lack of Efficacy|0
7536649|NCT02721966|11884633|FG000|Overall Study|Lost to Follow-up|0
7536650|NCT02721966|11884634|FG001|Overall Study|Lost to Follow-up|0
7536651|NCT02721966|11884635|FG002|Overall Study|Lost to Follow-up|3
7536652|NCT02721966|11884636|FG003|Overall Study|Lost to Follow-up|0
7536653|NCT02721966|11884637|FG004|Overall Study|Lost to Follow-up|0
7536654|NCT02721966|11884633|FG000|Overall Study|Physician Decision|1
7536655|NCT02721966|11884634|FG001|Overall Study|Physician Decision|1
7536656|NCT02721966|11884635|FG002|Overall Study|Physician Decision|0
7536657|NCT02721966|11884636|FG003|Overall Study|Physician Decision|0
7536658|NCT02721966|11884637|FG004|Overall Study|Physician Decision|0
7536659|NCT02721966|11884633|FG000|Overall Study|Pregnancy|1
7536660|NCT02721966|11884634|FG001|Overall Study|Pregnancy|0
7536661|NCT02721966|11884635|FG002|Overall Study|Pregnancy|0
7536662|NCT02721966|11884636|FG003|Overall Study|Pregnancy|0
7536663|NCT02721966|11884637|FG004|Overall Study|Pregnancy|0
7536664|NCT02721966|11884633|FG000|Overall Study|Did not continue to period 2|5
7536665|NCT02721966|11884634|FG001|Overall Study|Did not continue to period 2|12
7536666|NCT02721966|11884635|FG002|Overall Study|Did not continue to period 2|0
7536667|NCT02721966|11884636|FG003|Overall Study|Did not continue to period 2|0
7536668|NCT02721966|11884637|FG004|Overall Study|Did not continue to period 2|5
7536669|NCT02722044|11884645|FG000|Overall Study|Adverse Event|2
7536670|NCT02722044|11884645|FG000|Overall Study|Physician Decision|1
7536671|NCT02722044|11884645|FG000|Overall Study|Withdrawal by Subject|1
7536672|NCT02722044|11884645|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
7536673|NCT02722148|11884650|FG000|Overall Study|Lost to Follow-up|2
7536674|NCT02722148|11884650|FG000|Overall Study|Non compliant with treatment regimen|3
7536675|NCT02722278|11884666|FG000|Overall Study|Withdrawal by Subject|5
7517875|NCT02482935|11854411|FG000|Period 1|Withdrawal by Subject|1
7517876|NCT02482935|11854412|FG001|Period 1|Withdrawal by Subject|0
7517877|NCT02483416|11854427|FG000|Overall Study|Other reason|0
7517878|NCT02483416|11854428|FG001|Overall Study|Other reason|1
7517879|NCT02483416|11854427|FG000|Overall Study|Treatment stop|3
7517880|NCT02483416|11854428|FG001|Overall Study|Treatment stop|0
7517881|NCT02483520|11854437|FG000|Overall Study|Lost to Follow-up|3
7517882|NCT02483520|11854438|FG001|Overall Study|Lost to Follow-up|4
7517883|NCT02483520|11854437|FG000|Overall Study|Withdrawal by Subject|4
7517884|NCT02483520|11854438|FG001|Overall Study|Withdrawal by Subject|14
7517885|NCT02483520|11854437|FG000|Overall Study|Hospitalized|2
7517886|NCT02483520|11854438|FG001|Overall Study|Hospitalized|3
7517887|NCT02483520|11854437|FG000|Overall Study|Moved to LTC|2
7517888|NCT02483520|11854438|FG001|Overall Study|Moved to LTC|3
7517889|NCT02483572|11854446|FG000|Overall Study|Withdrawal by Subject|1
7517890|NCT02483572|11854447|FG001|Overall Study|Withdrawal by Subject|0
7517891|NCT02483572|11854446|FG000|Overall Study|Lost to Follow-up|1
7517892|NCT02483572|11854447|FG001|Overall Study|Lost to Follow-up|0
7517893|NCT02483572|11854446|FG000|Overall Study|Physician Decision|0
7517894|NCT02483572|11854447|FG001|Overall Study|Physician Decision|1
7517895|NCT02483611|11854456|FG000|Overall Study|Protocol Violation|0
7517896|NCT02483611|11854457|FG001|Overall Study|Protocol Violation|0
7517897|NCT02483611|11854458|FG002|Overall Study|Protocol Violation|1
7517898|NCT02483975|11854477|FG000|Overall Study|Adverse Event|0
7517899|NCT02483975|11854478|FG001|Overall Study|Adverse Event|1
7517900|NCT02483975|11854477|FG000|Overall Study|Lost to Follow-up|0
7517901|NCT02483975|11854478|FG001|Overall Study|Lost to Follow-up|1
7517902|NCT02483975|11854477|FG000|Overall Study|Physician Decision|2
7517903|NCT02483975|11854478|FG001|Overall Study|Physician Decision|0
7517904|NCT02484547|11854500|FG000|Placebo-Controlled Period|Adverse Event|10
7517905|NCT02484547|11854501|FG001|Placebo-Controlled Period|Adverse Event|13
7517906|NCT02484547|11854502|FG002|Placebo-Controlled Period|Adverse Event|20
7517907|NCT02484547|11854503|FG003|Placebo-Controlled Period|Adverse Event|0
7517908|NCT02484547|11854504|FG004|Placebo-Controlled Period|Adverse Event|0
7517909|NCT02484547|11854505|FG005|Placebo-Controlled Period|Adverse Event|0
7517910|NCT02484547|11854506|FG006|Placebo-Controlled Period|Adverse Event|0
7517911|NCT02484547|11854500|FG000|Placebo-Controlled Period|Change of Treatment|0
7517912|NCT02484547|11854501|FG001|Placebo-Controlled Period|Change of Treatment|0
7517913|NCT02484547|11854502|FG002|Placebo-Controlled Period|Change of Treatment|1
7517914|NCT02484547|11854503|FG003|Placebo-Controlled Period|Change of Treatment|0
7517915|NCT02484547|11854504|FG004|Placebo-Controlled Period|Change of Treatment|0
7517916|NCT02484547|11854505|FG005|Placebo-Controlled Period|Change of Treatment|0
7517917|NCT02484547|11854506|FG006|Placebo-Controlled Period|Change of Treatment|0
7517918|NCT02484547|11854500|FG000|Placebo-Controlled Period|Consent Withdrawn|15
7517919|NCT02484547|11854501|FG001|Placebo-Controlled Period|Consent Withdrawn|32
7517920|NCT02484547|11854502|FG002|Placebo-Controlled Period|Consent Withdrawn|26
7517921|NCT02484547|11854503|FG003|Placebo-Controlled Period|Consent Withdrawn|0
7517922|NCT02484547|11854504|FG004|Placebo-Controlled Period|Consent Withdrawn|0
7517923|NCT02484547|11854505|FG005|Placebo-Controlled Period|Consent Withdrawn|0
7517924|NCT02484547|11854506|FG006|Placebo-Controlled Period|Consent Withdrawn|0
7517925|NCT02484547|11854500|FG000|Placebo-Controlled Period|Death|5
7517926|NCT02484547|11854501|FG001|Placebo-Controlled Period|Death|0
7517927|NCT02484547|11854502|FG002|Placebo-Controlled Period|Death|6
7517928|NCT02484547|11854503|FG003|Placebo-Controlled Period|Death|0
7517929|NCT02484547|11854504|FG004|Placebo-Controlled Period|Death|0
7517930|NCT02484547|11854505|FG005|Placebo-Controlled Period|Death|0
7517931|NCT02484547|11854506|FG006|Placebo-Controlled Period|Death|0
7517932|NCT02484547|11854500|FG000|Placebo-Controlled Period|Disease Progression|2
7517933|NCT02484547|11854501|FG001|Placebo-Controlled Period|Disease Progression|0
7517934|NCT02484547|11854502|FG002|Placebo-Controlled Period|Disease Progression|1
7517935|NCT02484547|11854503|FG003|Placebo-Controlled Period|Disease Progression|0
7517936|NCT02484547|11854504|FG004|Placebo-Controlled Period|Disease Progression|0
7517937|NCT02484547|11854505|FG005|Placebo-Controlled Period|Disease Progression|0
7517938|NCT02484547|11854506|FG006|Placebo-Controlled Period|Disease Progression|0
7517939|NCT02484547|11854500|FG000|Placebo-Controlled Period|Investigator Decision|2
7517940|NCT02484547|11854501|FG001|Placebo-Controlled Period|Investigator Decision|2
7517941|NCT02484547|11854502|FG002|Placebo-Controlled Period|Investigator Decision|5
7517942|NCT02484547|11854503|FG003|Placebo-Controlled Period|Investigator Decision|0
7517943|NCT02484547|11854504|FG004|Placebo-Controlled Period|Investigator Decision|0
7517944|NCT02484547|11854505|FG005|Placebo-Controlled Period|Investigator Decision|0
7517945|NCT02484547|11854506|FG006|Placebo-Controlled Period|Investigator Decision|0
7517946|NCT02484547|11854500|FG000|Placebo-Controlled Period|Lost to Follow-up|3
7517947|NCT02484547|11854501|FG001|Placebo-Controlled Period|Lost to Follow-up|1
7517948|NCT02484547|11854502|FG002|Placebo-Controlled Period|Lost to Follow-up|3
7517949|NCT02484547|11854503|FG003|Placebo-Controlled Period|Lost to Follow-up|0
7517950|NCT02484547|11854504|FG004|Placebo-Controlled Period|Lost to Follow-up|0
7517951|NCT02484547|11854505|FG005|Placebo-Controlled Period|Lost to Follow-up|0
7517952|NCT02484547|11854506|FG006|Placebo-Controlled Period|Lost to Follow-up|0
7517953|NCT02484547|11854500|FG000|Placebo-Controlled Period|Relocation|1
7517954|NCT02484547|11854501|FG001|Placebo-Controlled Period|Relocation|1
7517955|NCT02484547|11854502|FG002|Placebo-Controlled Period|Relocation|1
7517956|NCT02484547|11854503|FG003|Placebo-Controlled Period|Relocation|0
7517957|NCT02484547|11854504|FG004|Placebo-Controlled Period|Relocation|0
7517958|NCT02484547|11854505|FG005|Placebo-Controlled Period|Relocation|0
7517959|NCT02484547|11854506|FG006|Placebo-Controlled Period|Relocation|0
7517960|NCT02484547|11854500|FG000|Placebo-Controlled Period|Study Visit Burden|2
7517961|NCT02484547|11854501|FG001|Placebo-Controlled Period|Study Visit Burden|8
7517962|NCT02484547|11854502|FG002|Placebo-Controlled Period|Study Visit Burden|5
7517963|NCT02484547|11854503|FG003|Placebo-Controlled Period|Study Visit Burden|0
7517964|NCT02484547|11854504|FG004|Placebo-Controlled Period|Study Visit Burden|0
7517965|NCT02484547|11854505|FG005|Placebo-Controlled Period|Study Visit Burden|0
7517966|NCT02484547|11854506|FG006|Placebo-Controlled Period|Study Visit Burden|0
7517967|NCT02484547|11854500|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
7517968|NCT02484547|11854501|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7517969|NCT02484547|11854502|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7413147|NCT01423617|11685271|FG000|Overall Study|Lost to Follow-up|0
7413148|NCT01423617|11685272|FG001|Overall Study|Lost to Follow-up|1
7413149|NCT01423812|11685296|FG000|Overall Study|Lost to Follow-up|2
7413150|NCT01423812|11685297|FG001|Overall Study|Lost to Follow-up|2
7517970|NCT02484547|11854503|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517971|NCT02484547|11854504|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517972|NCT02484547|11854505|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7517973|NCT02484547|11854506|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7413151|NCT01423812|11685296|FG000|Overall Study|Withdrawal by Subject|1
7517974|NCT02484547|11854500|FG000|Placebo-Controlled Period|Reason not Specified|216
7517975|NCT02484547|11854501|FG001|Placebo-Controlled Period|Reason not Specified|194
7517976|NCT02484547|11854502|FG002|Placebo-Controlled Period|Reason not Specified|183
7517977|NCT02484547|11854503|FG003|Placebo-Controlled Period|Reason not Specified|0
7517978|NCT02484547|11854504|FG004|Placebo-Controlled Period|Reason not Specified|0
7517979|NCT02484547|11854505|FG005|Placebo-Controlled Period|Reason not Specified|0
7517980|NCT02484547|11854506|FG006|Placebo-Controlled Period|Reason not Specified|0
7517981|NCT02484547|11854500|FG000|Long-Term Extension Period|Adverse Event|0
7517982|NCT02484547|11854501|FG001|Long-Term Extension Period|Adverse Event|0
7517983|NCT02484547|11854502|FG002|Long-Term Extension Period|Adverse Event|0
7517984|NCT02484547|11854503|FG003|Long-Term Extension Period|Adverse Event|0
7517985|NCT02484547|11854504|FG004|Long-Term Extension Period|Adverse Event|1
7517986|NCT02484547|11854505|FG005|Long-Term Extension Period|Adverse Event|3
7517987|NCT02484547|11854506|FG006|Long-Term Extension Period|Adverse Event|2
7517988|NCT02484547|11854500|FG000|Long-Term Extension Period|Death|0
7517989|NCT02484547|11854501|FG001|Long-Term Extension Period|Death|0
7517990|NCT02484547|11854502|FG002|Long-Term Extension Period|Death|0
7517991|NCT02484547|11854503|FG003|Long-Term Extension Period|Death|0
7517992|NCT02484547|11854504|FG004|Long-Term Extension Period|Death|0
7517993|NCT02484547|11854505|FG005|Long-Term Extension Period|Death|3
7517994|NCT02484547|11854506|FG006|Long-Term Extension Period|Death|0
7517995|NCT02484547|11854500|FG000|Long-Term Extension Period|Disease Progression|0
7517996|NCT02484547|11854501|FG001|Long-Term Extension Period|Disease Progression|0
7517997|NCT02484547|11854502|FG002|Long-Term Extension Period|Disease Progression|0
7517998|NCT02484547|11854503|FG003|Long-Term Extension Period|Disease Progression|0
7517999|NCT02484547|11854504|FG004|Long-Term Extension Period|Disease Progression|2
7518000|NCT02484547|11854505|FG005|Long-Term Extension Period|Disease Progression|4
7518001|NCT02484547|11854506|FG006|Long-Term Extension Period|Disease Progression|0
7518002|NCT02484547|11854500|FG000|Long-Term Extension Period|Lost to Follow-up|0
7518003|NCT02484547|11854501|FG001|Long-Term Extension Period|Lost to Follow-up|0
7518004|NCT02484547|11854502|FG002|Long-Term Extension Period|Lost to Follow-up|0
7518005|NCT02484547|11854503|FG003|Long-Term Extension Period|Lost to Follow-up|1
7518006|NCT02484547|11854504|FG004|Long-Term Extension Period|Lost to Follow-up|1
7518007|NCT02484547|11854505|FG005|Long-Term Extension Period|Lost to Follow-up|2
7518008|NCT02484547|11854506|FG006|Long-Term Extension Period|Lost to Follow-up|0
7518009|NCT02484547|11854500|FG000|Long-Term Extension Period|Loss of Capacity|0
7518010|NCT02484547|11854501|FG001|Long-Term Extension Period|Loss of Capacity|0
7518011|NCT02484547|11854502|FG002|Long-Term Extension Period|Loss of Capacity|0
7518012|NCT02484547|11854503|FG003|Long-Term Extension Period|Loss of Capacity|0
7518013|NCT02484547|11854504|FG004|Long-Term Extension Period|Loss of Capacity|1
7518014|NCT02484547|11854505|FG005|Long-Term Extension Period|Loss of Capacity|0
7518015|NCT02484547|11854506|FG006|Long-Term Extension Period|Loss of Capacity|0
7518016|NCT02484547|11854500|FG000|Long-Term Extension Period|Change of Treatment|0
7518017|NCT02484547|11854501|FG001|Long-Term Extension Period|Change of Treatment|0
7518018|NCT02484547|11854502|FG002|Long-Term Extension Period|Change of Treatment|0
7518019|NCT02484547|11854503|FG003|Long-Term Extension Period|Change of Treatment|0
7518020|NCT02484547|11854504|FG004|Long-Term Extension Period|Change of Treatment|0
7518021|NCT02484547|11854505|FG005|Long-Term Extension Period|Change of Treatment|0
7518022|NCT02484547|11854506|FG006|Long-Term Extension Period|Change of Treatment|1
7518023|NCT02484547|11854500|FG000|Long-Term Extension Period|Consent Withdrawn|0
7518024|NCT02484547|11854501|FG001|Long-Term Extension Period|Consent Withdrawn|0
7413152|NCT01423812|11685297|FG001|Overall Study|Withdrawal by Subject|2
7413153|NCT01423916|11685308|FG000|Overall Study|Adverse Event|5
7518025|NCT02484547|11854502|FG002|Long-Term Extension Period|Consent Withdrawn|0
7518026|NCT02484547|11854503|FG003|Long-Term Extension Period|Consent Withdrawn|6
7518027|NCT02484547|11854504|FG004|Long-Term Extension Period|Consent Withdrawn|7
7518028|NCT02484547|11854505|FG005|Long-Term Extension Period|Consent Withdrawn|13
7518029|NCT02484547|11854506|FG006|Long-Term Extension Period|Consent Withdrawn|17
7518030|NCT02484547|11854500|FG000|Long-Term Extension Period|Investigator Decision|0
7518031|NCT02484547|11854501|FG001|Long-Term Extension Period|Investigator Decision|0
7518032|NCT02484547|11854502|FG002|Long-Term Extension Period|Investigator Decision|0
7518033|NCT02484547|11854503|FG003|Long-Term Extension Period|Investigator Decision|2
7518034|NCT02484547|11854504|FG004|Long-Term Extension Period|Investigator Decision|1
7518035|NCT02484547|11854505|FG005|Long-Term Extension Period|Investigator Decision|0
7518036|NCT02484547|11854506|FG006|Long-Term Extension Period|Investigator Decision|1
7518037|NCT02484547|11854500|FG000|Long-Term Extension Period|Relocation|0
7518038|NCT02484547|11854501|FG001|Long-Term Extension Period|Relocation|0
7518039|NCT02484547|11854502|FG002|Long-Term Extension Period|Relocation|0
7518040|NCT02484547|11854503|FG003|Long-Term Extension Period|Relocation|1
7518041|NCT02484547|11854504|FG004|Long-Term Extension Period|Relocation|1
7518042|NCT02484547|11854505|FG005|Long-Term Extension Period|Relocation|0
7518043|NCT02484547|11854506|FG006|Long-Term Extension Period|Relocation|0
7518044|NCT02484547|11854500|FG000|Long-Term Extension Period|Study Visit Burden|0
7518045|NCT02484547|11854501|FG001|Long-Term Extension Period|Study Visit Burden|0
7518046|NCT02484547|11854502|FG002|Long-Term Extension Period|Study Visit Burden|0
7518047|NCT02484547|11854503|FG003|Long-Term Extension Period|Study Visit Burden|2
7518048|NCT02484547|11854504|FG004|Long-Term Extension Period|Study Visit Burden|0
7518049|NCT02484547|11854505|FG005|Long-Term Extension Period|Study Visit Burden|0
7518050|NCT02484547|11854506|FG006|Long-Term Extension Period|Study Visit Burden|3
7518051|NCT02484547|11854500|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7518052|NCT02484547|11854501|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7518053|NCT02484547|11854502|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7518054|NCT02484547|11854503|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
7518055|NCT02484547|11854504|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
7518056|NCT02484547|11854505|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
7518057|NCT02484547|11854506|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
7518058|NCT02484547|11854500|FG000|Long-Term Extension Period|Reason not Specified|0
7518059|NCT02484547|11854501|FG001|Long-Term Extension Period|Reason not Specified|0
7518060|NCT02484547|11854502|FG002|Long-Term Extension Period|Reason not Specified|0
7518061|NCT02484547|11854503|FG003|Long-Term Extension Period|Reason not Specified|119
7518062|NCT02484547|11854504|FG004|Long-Term Extension Period|Reason not Specified|117
7518063|NCT02484547|11854505|FG005|Long-Term Extension Period|Reason not Specified|223
7518064|NCT02484547|11854506|FG006|Long-Term Extension Period|Reason not Specified|231
7518065|NCT02484651|11854520|FG000|Overall Study|Patients' data files were corrupted.|1
7518066|NCT02484651|11854521|FG001|Overall Study|Patients' data files were corrupted.|1
7518067|NCT02484651|11854520|FG000|Overall Study|BIS monitoring failed.|1
7518068|NCT02484651|11854521|FG001|Overall Study|BIS monitoring failed.|1
7518069|NCT02484651|11854520|FG000|Overall Study|Time of the procedure less than 90 min.|1
7518070|NCT02484651|11854521|FG001|Overall Study|Time of the procedure less than 90 min.|2
7518071|NCT02484690|11854533|FG000|Overall Study|Adverse Event|1
7518072|NCT02484690|11854534|FG001|Overall Study|Adverse Event|3
7518073|NCT02484690|11854535|FG002|Overall Study|Adverse Event|0
7518074|NCT02484690|11854536|FG003|Overall Study|Adverse Event|0
7518075|NCT02484690|11854537|FG004|Overall Study|Adverse Event|5
7518076|NCT02484690|11854533|FG000|Overall Study|Death|0
7518077|NCT02484690|11854534|FG001|Overall Study|Death|0
7518078|NCT02484690|11854535|FG002|Overall Study|Death|0
7518079|NCT02484690|11854536|FG003|Overall Study|Death|0
7518080|NCT02484690|11854537|FG004|Overall Study|Death|1
7518081|NCT02484690|11854533|FG000|Overall Study|Withdrawal by Subject|1
7518082|NCT02484690|11854534|FG001|Overall Study|Withdrawal by Subject|3
7518083|NCT02484690|11854535|FG002|Overall Study|Withdrawal by Subject|1
7518084|NCT02484690|11854536|FG003|Overall Study|Withdrawal by Subject|2
7518085|NCT02484690|11854537|FG004|Overall Study|Withdrawal by Subject|0
7518086|NCT02484690|11854533|FG000|Overall Study|Physician Decision|2
7518087|NCT02484690|11854534|FG001|Overall Study|Physician Decision|0
7518088|NCT02484690|11854535|FG002|Overall Study|Physician Decision|1
7518089|NCT02484690|11854536|FG003|Overall Study|Physician Decision|0
7518090|NCT02484690|11854537|FG004|Overall Study|Physician Decision|0
7518091|NCT02484690|11854533|FG000|Overall Study|Lost to Follow-up|0
7518092|NCT02484690|11854534|FG001|Overall Study|Lost to Follow-up|0
7518093|NCT02484690|11854535|FG002|Overall Study|Lost to Follow-up|1
7518094|NCT02484690|11854536|FG003|Overall Study|Lost to Follow-up|0
7518095|NCT02484690|11854537|FG004|Overall Study|Lost to Follow-up|0
7518096|NCT02484729|11854560|FG000|Overall Study|Failure of IntelliCap Error|0
7518097|NCT02484729|11854561|FG001|Overall Study|Failure of IntelliCap Error|0
7518098|NCT02484729|11854562|FG002|Overall Study|Failure of IntelliCap Error|0
7518099|NCT02484729|11854563|FG003|Overall Study|Failure of IntelliCap Error|0
7518100|NCT02484729|11854564|FG004|Overall Study|Failure of IntelliCap Error|0
7518101|NCT02484729|11854565|FG005|Overall Study|Failure of IntelliCap Error|0
7518102|NCT02484729|11854566|FG006|Overall Study|Failure of IntelliCap Error|0
7518103|NCT02484729|11854567|FG007|Overall Study|Failure of IntelliCap Error|0
7518104|NCT02484729|11854568|FG008|Overall Study|Failure of IntelliCap Error|0
7518105|NCT02484729|11854569|FG009|Overall Study|Failure of IntelliCap Error|1
7518106|NCT02484911|11854646|FG000|Overall Study|Withdrawal by Subject|2
7518107|NCT02484911|11854647|FG001|Overall Study|Withdrawal by Subject|1
7518108|NCT02484911|11854646|FG000|Overall Study|Protocol Violation|2
7518109|NCT02484911|11854647|FG001|Overall Study|Protocol Violation|1
7518110|NCT02485158|11854654|FG000|Overall Study|Withdrawal by Subject|3
7518111|NCT02485158|11854654|FG000|Overall Study|expected drug side effect|1
7518112|NCT02485301|11854665|FG000|Overall Study|Serious Adverse Events|2
7518113|NCT02485301|11854666|FG001|Overall Study|Serious Adverse Events|1
7518114|NCT02485301|11854665|FG000|Overall Study|Protocol Violation|0
7518115|NCT02485301|11854666|FG001|Overall Study|Protocol Violation|1
7518116|NCT02485301|11854665|FG000|Overall Study|Withdrawal by Subject|6
7518117|NCT02485301|11854666|FG001|Overall Study|Withdrawal by Subject|7
7518118|NCT02485301|11854665|FG000|Overall Study|Migrated/moved from study area|10
7518119|NCT02485301|11854666|FG001|Overall Study|Migrated/moved from study area|19
7518120|NCT02485301|11854665|FG000|Overall Study|Lost to Follow-up|17
7518121|NCT02485301|11854666|FG001|Overall Study|Lost to Follow-up|17
7518122|NCT02485301|11854665|FG000|Overall Study|Other|3
7518123|NCT02485301|11854666|FG001|Overall Study|Other|4
7518124|NCT02485353|11854672|FG000|Overall Study|Death|1
7518125|NCT02485353|11854672|FG000|Overall Study|Disease Progression|1
7518126|NCT02485483|11854678|FG000|Overall Study|Depression at baseline|15
7518127|NCT02485483|11854679|FG001|Overall Study|Depression at baseline|0
7518128|NCT02485483|11854678|FG000|Overall Study|Discontinued after baseline|39
7518129|NCT02485483|11854679|FG001|Overall Study|Discontinued after baseline|0
7518130|NCT02485704|11854700|FG000|Overall Study|Lost to Follow-up|4
7518131|NCT02485704|11854701|FG001|Overall Study|Lost to Follow-up|5
7518132|NCT02485704|11854700|FG000|Overall Study|Withdrawal by Subject|0
7518133|NCT02485704|11854701|FG001|Overall Study|Withdrawal by Subject|3
7518134|NCT02485704|11854700|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
7518135|NCT02485704|11854701|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
7518136|NCT02485717|11854710|FG000|Overall Study|Lost to Follow-up|6
7518137|NCT02485717|11854711|FG001|Overall Study|Lost to Follow-up|0
7518138|NCT02485717|11854712|FG002|Overall Study|Lost to Follow-up|0
7518139|NCT02485717|11854710|FG000|Overall Study|Withdrawal by Subject|0
7518140|NCT02485717|11854711|FG001|Overall Study|Withdrawal by Subject|0
7518141|NCT02485717|11854712|FG002|Overall Study|Withdrawal by Subject|1
7518142|NCT02485717|11854710|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
7518143|NCT02485717|11854711|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
7518144|NCT02485717|11854712|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
7518145|NCT02485717|11854710|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
7518146|NCT02485717|11854711|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
7518147|NCT02485717|11854712|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
7518148|NCT02485925|11854735|FG000|Overall Study|Withdrawal by Subject|3
7518149|NCT02485925|11854735|FG000|Overall Study|Death|1
7518150|NCT02485925|11854735|FG000|Overall Study|Lost to Follow-up|11
7518151|NCT02486302|11854772|FG000|Overall Study|Discontinued prematurely|410
7518152|NCT02486302|11854772|FG000|Overall Study|Documentation not completed|255
7518153|NCT02486302|11854772|FG000|Overall Study|Excluded due to legal reasons|8
7518154|NCT02486302|11854772|FG000|Overall Study|Not treated|3
7518155|NCT02486406|11854798|FG000|Overall Study|Withdrew consent|1
7518156|NCT02486406|11854799|FG001|Overall Study|Withdrew consent|0
7518157|NCT02486406|11854800|FG002|Overall Study|Withdrew consent|0
7518158|NCT02486406|11854801|FG003|Overall Study|Withdrew consent|1
7518159|NCT02486406|11854798|FG000|Overall Study|Lost to Follow-up|1
7518160|NCT02486406|11854799|FG001|Overall Study|Lost to Follow-up|3
7518161|NCT02486406|11854800|FG002|Overall Study|Lost to Follow-up|1
7518162|NCT02486406|11854801|FG003|Overall Study|Lost to Follow-up|3
7518163|NCT02486406|11854798|FG000|Overall Study|Other, not specified|0
7518164|NCT02486406|11854799|FG001|Overall Study|Other, not specified|0
7518165|NCT02486406|11854800|FG002|Overall Study|Other, not specified|1
7518166|NCT02486406|11854801|FG003|Overall Study|Other, not specified|0
7518167|NCT02486588|11854839|FG000|Overall Study|Randomized in error- ineligible|738
7518168|NCT02486588|11854840|FG001|Overall Study|Randomized in error- ineligible|750
7518169|NCT02486588|11854841|FG002|Overall Study|Randomized in error- ineligible|755
7518170|NCT02486588|11854842|FG003|Overall Study|Randomized in error- ineligible|738
7518171|NCT02486588|11854843|FG004|Overall Study|Randomized in error- ineligible|746
7518172|NCT02486588|11854844|FG005|Overall Study|Randomized in error- ineligible|746
7518173|NCT02486627|11854865|FG000|Overall Study|Death|1
7518174|NCT02486627|11854866|FG001|Overall Study|Death|0
7518175|NCT02486627|11854865|FG000|Overall Study|Other Unspecified|0
7518176|NCT02486627|11854866|FG001|Overall Study|Other Unspecified|2
7518177|NCT02486627|11854865|FG000|Overall Study|Consent Withdrawn by Participant|4
7518178|NCT02486627|11854866|FG001|Overall Study|Consent Withdrawn by Participant|3
7518179|NCT02486627|11854865|FG000|Overall Study|Significant Participant Noncompliance|1
7518180|NCT02486627|11854866|FG001|Overall Study|Significant Participant Noncompliance|1
7518181|NCT02486627|11854865|FG000|Overall Study|Lost to Follow-up|1
7518182|NCT02486627|11854866|FG001|Overall Study|Lost to Follow-up|3
7518183|NCT02486653|11854874|FG000|Overall Study|Withdrawal by Subject|1
7518184|NCT02486653|11854875|FG001|Overall Study|Withdrawal by Subject|3
7518185|NCT02486653|11854874|FG000|Overall Study|Protocol Violation|1
7518186|NCT02486653|11854875|FG001|Overall Study|Protocol Violation|0
7518187|NCT02486653|11854874|FG000|Overall Study|surgery cancelled|4
7518188|NCT02486653|11854875|FG001|Overall Study|surgery cancelled|1
7518189|NCT02486692|11854883|FG000|Overall Study|did not login for randomization|4
7518190|NCT02486692|11854884|FG001|Overall Study|did not login for randomization|7
7518191|NCT02486757|11854890|FG000|Overall Study|Lost to Follow-up|1
7518192|NCT02486796|11854896|FG000|Overall Study|Withdrawal by Subject|1
7518193|NCT02486796|11854897|FG001|Overall Study|Withdrawal by Subject|1
7518194|NCT02486796|11854896|FG000|Overall Study|Physician Decision|1
7518195|NCT02486796|11854897|FG001|Overall Study|Physician Decision|0
7518196|NCT02486952|11854912|FG000|Overall Study|Not Started Induction Therapy|3
7518197|NCT02486952|11854912|FG000|Overall Study|Adverse Event|1
7518198|NCT02486952|11854912|FG000|Overall Study|Death|15
7518199|NCT02486952|11854912|FG000|Overall Study|Lack of Efficacy|3
7518200|NCT02486952|11854912|FG000|Overall Study|Lost to Follow-up|26
7518201|NCT02486952|11854912|FG000|Overall Study|Other|2
7518202|NCT02487030|11854923|FG000|Overall Study|Lack of Efficacy|2
7518203|NCT02487030|11854924|FG001|Overall Study|Lack of Efficacy|4
7518204|NCT02487030|11854925|FG002|Overall Study|Lack of Efficacy|1
7518205|NCT02487030|11854926|FG003|Overall Study|Lack of Efficacy|0
7518206|NCT02487030|11854927|FG004|Overall Study|Lack of Efficacy|1
7518207|NCT02487030|11854928|FG005|Overall Study|Lack of Efficacy|0
7518208|NCT02487030|11854929|FG006|Overall Study|Lack of Efficacy|0
7518209|NCT02487030|11854923|FG000|Overall Study|Lost to Follow-up|0
7518210|NCT02487030|11854924|FG001|Overall Study|Lost to Follow-up|0
7518211|NCT02487030|11854925|FG002|Overall Study|Lost to Follow-up|1
7518212|NCT02487030|11854926|FG003|Overall Study|Lost to Follow-up|1
7518213|NCT02487030|11854927|FG004|Overall Study|Lost to Follow-up|0
7518214|NCT02487030|11854928|FG005|Overall Study|Lost to Follow-up|1
7518215|NCT02487030|11854929|FG006|Overall Study|Lost to Follow-up|0
7518216|NCT02487030|11854923|FG000|Overall Study|Adverse Event|0
7518217|NCT02487030|11854924|FG001|Overall Study|Adverse Event|0
7518218|NCT02487030|11854925|FG002|Overall Study|Adverse Event|0
7518219|NCT02487030|11854926|FG003|Overall Study|Adverse Event|1
7518220|NCT02487030|11854927|FG004|Overall Study|Adverse Event|0
7518221|NCT02487030|11854928|FG005|Overall Study|Adverse Event|0
7518222|NCT02487030|11854929|FG006|Overall Study|Adverse Event|0
7518223|NCT02487030|11854923|FG000|Overall Study|Death|0
7518224|NCT02487030|11854924|FG001|Overall Study|Death|0
7518225|NCT02487030|11854925|FG002|Overall Study|Death|0
7518226|NCT02487030|11854926|FG003|Overall Study|Death|0
7518227|NCT02487030|11854927|FG004|Overall Study|Death|1
7518228|NCT02487030|11854928|FG005|Overall Study|Death|0
7518229|NCT02487030|11854929|FG006|Overall Study|Death|0
7518230|NCT02487199|11854953|FG000|Overall Study|Withdrew Consent|0
7518231|NCT02487199|11854954|FG001|Overall Study|Withdrew Consent|1
7518232|NCT02487446|11854985|FG000|Period 1|Physician Decision|0
7518233|NCT02487446|11854986|FG001|Period 1|Physician Decision|1
7518234|NCT02487446|11854985|FG000|Period 1|Lack of Efficacy|1
7518235|NCT02487446|11854986|FG001|Period 1|Lack of Efficacy|0
7518236|NCT02487446|11854985|FG000|Period 1|Protocol deviation|3
7518237|NCT02487446|11854986|FG001|Period 1|Protocol deviation|2
7518238|NCT02487446|11854985|FG000|Period 1|Lost to Follow-up|2
7518239|NCT02487446|11854986|FG001|Period 1|Lost to Follow-up|0
7518240|NCT02487446|11854985|FG000|Period 1|Withdrawal by Subject|2
7518241|NCT02487446|11854986|FG001|Period 1|Withdrawal by Subject|0
7518242|NCT02487446|11854985|FG000|Period 1|Adverse Event|5
7518243|NCT02487446|11854986|FG001|Period 1|Adverse Event|5
7518244|NCT02487446|11854985|FG000|Washout|Lost to Follow-up|0
7518245|NCT02487446|11854986|FG001|Washout|Lost to Follow-up|2
7518246|NCT02487446|11854985|FG000|Washout|Withdrawal by Subject|1
7518247|NCT02487446|11854986|FG001|Washout|Withdrawal by Subject|4
7518248|NCT02487446|11854985|FG000|Washout|Adverse Event|2
7518249|NCT02487446|11854986|FG001|Washout|Adverse Event|2
7518250|NCT02487446|11854985|FG000|Period 2|Protocol deviation|0
7518251|NCT02487446|11854986|FG001|Period 2|Protocol deviation|1
7518252|NCT02487446|11854985|FG000|Period 2|Lost to Follow-up|1
7518253|NCT02487446|11854986|FG001|Period 2|Lost to Follow-up|1
7518254|NCT02487446|11854985|FG000|Period 2|Withdrawal by Subject|1
7518255|NCT02487446|11854986|FG001|Period 2|Withdrawal by Subject|1
7518256|NCT02487446|11854985|FG000|Period 2|Adverse Event|6
7518257|NCT02487446|11854986|FG001|Period 2|Adverse Event|2
7518258|NCT02487472|11854993|FG000|Overall Study|Did not complete telephonic interviews|9
7518259|NCT02487472|11854993|FG000|Overall Study|Other|2
7518260|NCT02487498|11855008|FG000|Period: Period 1|Adverse Event|2
7518261|NCT02487498|11855009|FG001|Period: Period 1|Adverse Event|4
7518262|NCT02487498|11855008|FG000|Period: Period 1|Subject/guardian decision|2
7518263|NCT02487498|11855009|FG001|Period: Period 1|Subject/guardian decision|4
7518264|NCT02487498|11855008|FG000|Period: Period 1|Lost to Follow-up|0
7518265|NCT02487498|11855009|FG001|Period: Period 1|Lost to Follow-up|2
7518266|NCT02487498|11855008|FG000|Period: Period 1|Lack of Efficacy|1
7518267|NCT02487498|11855009|FG001|Period: Period 1|Lack of Efficacy|0
7518268|NCT02487498|11855008|FG000|Period: Period 1|Physician Decision|0
7518269|NCT02487498|11855009|FG001|Period: Period 1|Physician Decision|1
7518270|NCT02487498|11855008|FG000|Period: Period 1|Protocol deviation|1
7518271|NCT02487498|11855009|FG001|Period: Period 1|Protocol deviation|0
7518272|NCT02487498|11855008|FG000|Period: Washout|Subject/guardian decision|0
7518273|NCT02487498|11855009|FG001|Period: Washout|Subject/guardian decision|5
7518274|NCT02487498|11855008|FG000|Period: Washout|Lack of Efficacy|1
7518275|NCT02487498|11855009|FG001|Period: Washout|Lack of Efficacy|1
7518276|NCT02487498|11855008|FG000|Period: Washout|Physician Decision|1
7518277|NCT02487498|11855009|FG001|Period: Washout|Physician Decision|0
7518278|NCT02487498|11855008|FG000|Period: Washout|Non-compliance with study treatment|0
7518279|NCT02487498|11855009|FG001|Period: Washout|Non-compliance with study treatment|1
7518280|NCT02487498|11855008|FG000|Period: Period 2|Adverse Event|2
7518281|NCT02487498|11855009|FG001|Period: Period 2|Adverse Event|2
7518282|NCT02487498|11855008|FG000|Period: Period 2|Subject/guardian decision|2
7518283|NCT02487498|11855009|FG001|Period: Period 2|Subject/guardian decision|1
7518284|NCT02487498|11855008|FG000|Period: Period 2|Lost to Follow-up|1
7518285|NCT02487498|11855009|FG001|Period: Period 2|Lost to Follow-up|1
7518286|NCT02487498|11855008|FG000|Period: Period 2|Death|0
7518287|NCT02487498|11855009|FG001|Period: Period 2|Death|1
7518288|NCT02487498|11855008|FG000|Period: Period 2|Physician Decision|1
7518289|NCT02487498|11855009|FG001|Period: Period 2|Physician Decision|0
7518290|NCT02487771|11855034|FG000|Overall Study|Lost to Follow-up|2
7518291|NCT02487771|11855035|FG001|Overall Study|Lost to Follow-up|3
7518292|NCT02487771|11855034|FG000|Overall Study|Moved out of area|5
7518293|NCT02487771|11855035|FG001|Overall Study|Moved out of area|6
7518294|NCT02487771|11855034|FG000|Overall Study|Withdrawal by Subject|3
7518295|NCT02487771|11855035|FG001|Overall Study|Withdrawal by Subject|5
7518296|NCT02487810|11855043|FG000|Overall Study|Withdrawal by Subject|1
7518297|NCT02487810|11855044|FG001|Overall Study|Withdrawal by Subject|0
7518298|NCT02488005|11855067|FG000|Overall Study|Lost to Follow-up|2
7518299|NCT02488109|11855082|FG000|Treatment in Hospital|Withdrawal by Subject|0
7518300|NCT02488109|11855083|FG001|Treatment in Hospital|Withdrawal by Subject|5
7518301|NCT02488109|11855082|FG000|12-month Follow-Up|Lost to Follow-up|4
7518302|NCT02488109|11855083|FG001|12-month Follow-Up|Lost to Follow-up|7
7518303|NCT02488239|11855091|FG000|Overall Study|Death|3
7518304|NCT02488239|11855091|FG000|Overall Study|Withdrawal by Subject|3
7518305|NCT02488239|11855091|FG000|Overall Study|Physician Decision|2
7518306|NCT02488239|11855091|FG000|Overall Study|Consent ineligible|1
7518307|NCT02488239|11855091|FG000|Overall Study|Did not undergo implant procedure|1
7518308|NCT02488330|11855109|FG000|Overall Study|Adverse Event|1
7518309|NCT02488330|11855109|FG000|Overall Study|Physician Decision|2
7518310|NCT02488330|11855109|FG000|Overall Study|Death|2
7518311|NCT02488330|11855109|FG000|Overall Study|Disease Progression|3
7518312|NCT02488330|11855109|FG000|Overall Study|Study Termination by Sponsor|4
7518313|NCT02488681|11855113|FG000|Overall Study|Implant unsuccessful|7
7518314|NCT02488824|11855119|FG000|Overall Study|Adverse Event|1
7518315|NCT02488824|11855120|FG001|Overall Study|Adverse Event|1
7518316|NCT02488915|11855126|FG000|Overall Study|Death|21
7518317|NCT02488915|11855126|FG000|Overall Study|Lost to Follow-up|4
7518318|NCT02488915|11855126|FG000|Overall Study|Withdrawal by Subject|1
7518319|NCT02488980|11855133|FG000|Overall Study|Protocol Violation|2
7518320|NCT02488980|11855134|FG001|Overall Study|Protocol Violation|2
7518321|NCT02488980|11855135|FG002|Overall Study|Protocol Violation|2
7518322|NCT02489045|11855143|FG000|Overall Study|unable to collect usable data|53
7518323|NCT02489045|11855143|FG000|Follow-up|Lost to Follow-up|10
7518324|NCT02489279|11855177|FG000|Overall Study|Lost to Follow-up|12
7518325|NCT02489279|11855178|FG001|Overall Study|Lost to Follow-up|10
7518326|NCT02489344|11855184|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
7518327|NCT02489344|11855184|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
7518328|NCT02489344|11855184|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
7518329|NCT02489344|11855184|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
7518330|NCT02489500|11855194|FG000|Overall Study|Death|1
7518331|NCT02489500|11855195|FG001|Overall Study|Death|1
7518332|NCT02489630|11855203|FG000|Overall Study|Oversedation|1
7518333|NCT02489630|11855204|FG001|Overall Study|Oversedation|1
7518334|NCT02489630|11855203|FG000|Overall Study|Time to med. admin. > protocol limit|1
7518335|NCT02489630|11855204|FG001|Overall Study|Time to med. admin. > protocol limit|1
7518336|NCT02489773|11855221|FG000|Overall Study|Lost to Follow-up|4
7518337|NCT02489773|11855222|FG001|Overall Study|Lost to Follow-up|1
7518338|NCT02489773|11855221|FG000|Overall Study|Physician Decision|1
7518339|NCT02489773|11855222|FG001|Overall Study|Physician Decision|0
7518340|NCT02489773|11855221|FG000|Overall Study|Withdrawal by Subject|1
7518341|NCT02489773|11855222|FG001|Overall Study|Withdrawal by Subject|0
7518342|NCT02489773|11855221|FG000|Overall Study|Leave the country or the state|1
7518343|NCT02489773|11855222|FG001|Overall Study|Leave the country or the state|1
7518344|NCT02489799|11855230|FG000|Overall Study|Lost to Follow-up|4
7518345|NCT02489799|11855231|FG001|Overall Study|Lost to Follow-up|1
7518346|NCT02489799|11855230|FG000|Overall Study|Failure to Maintain Eligibility|4
7518347|NCT02489799|11855231|FG001|Overall Study|Failure to Maintain Eligibility|6
7518348|NCT02489799|11855230|FG000|Overall Study|Withdrawal by Subject|1
7518349|NCT02489799|11855231|FG001|Overall Study|Withdrawal by Subject|1
7518350|NCT02489799|11855230|FG000|Overall Study|Death|0
7518351|NCT02489799|11855231|FG001|Overall Study|Death|1
7518352|NCT02489968|11855239|FG000|Open-label Treatment Period|Adverse Event|14
7518353|NCT02489968|11855240|FG001|Open-label Treatment Period|Adverse Event|7
7518354|NCT02489968|11855241|FG002|Open-label Treatment Period|Adverse Event|0
7518355|NCT02489968|11855242|FG003|Open-label Treatment Period|Adverse Event|0
7518356|NCT02489968|11855243|FG004|Open-label Treatment Period|Adverse Event|0
7518357|NCT02489968|11855244|FG005|Open-label Treatment Period|Adverse Event|0
7518358|NCT02489968|11855239|FG000|Open-label Treatment Period|Protocol Violation|2
7518359|NCT02489968|11855240|FG001|Open-label Treatment Period|Protocol Violation|2
7518360|NCT02489968|11855241|FG002|Open-label Treatment Period|Protocol Violation|0
7518361|NCT02489968|11855242|FG003|Open-label Treatment Period|Protocol Violation|0
7518362|NCT02489968|11855243|FG004|Open-label Treatment Period|Protocol Violation|0
7518363|NCT02489968|11855244|FG005|Open-label Treatment Period|Protocol Violation|0
7518364|NCT02489968|11855239|FG000|Open-label Treatment Period|Lost to Follow-up|0
7518365|NCT02489968|11855240|FG001|Open-label Treatment Period|Lost to Follow-up|3
7518366|NCT02489968|11855241|FG002|Open-label Treatment Period|Lost to Follow-up|0
7518367|NCT02489968|11855242|FG003|Open-label Treatment Period|Lost to Follow-up|0
7518368|NCT02489968|11855243|FG004|Open-label Treatment Period|Lost to Follow-up|0
7518369|NCT02489968|11855244|FG005|Open-label Treatment Period|Lost to Follow-up|0
7518370|NCT02489968|11855239|FG000|Open-label Treatment Period|Withdrawal by Subject|4
7518371|NCT02489968|11855240|FG001|Open-label Treatment Period|Withdrawal by Subject|7
7518372|NCT02489968|11855241|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7518373|NCT02489968|11855242|FG003|Open-label Treatment Period|Withdrawal by Subject|0
7518374|NCT02489968|11855243|FG004|Open-label Treatment Period|Withdrawal by Subject|0
7518375|NCT02489968|11855244|FG005|Open-label Treatment Period|Withdrawal by Subject|0
7518376|NCT02489968|11855239|FG000|Open-label Treatment Period|Other than specified above|204
7518377|NCT02489968|11855240|FG001|Open-label Treatment Period|Other than specified above|189
7518378|NCT02489968|11855241|FG002|Open-label Treatment Period|Other than specified above|0
7518379|NCT02489968|11855242|FG003|Open-label Treatment Period|Other than specified above|0
7518380|NCT02489968|11855243|FG004|Open-label Treatment Period|Other than specified above|0
7518381|NCT02489968|11855244|FG005|Open-label Treatment Period|Other than specified above|0
7518382|NCT02489968|11855239|FG000|Double-blind Treatment Period|Adverse Event|0
7518383|NCT02489968|11855240|FG001|Double-blind Treatment Period|Adverse Event|0
7518384|NCT02489968|11855241|FG002|Double-blind Treatment Period|Adverse Event|2
7518385|NCT02489968|11855242|FG003|Double-blind Treatment Period|Adverse Event|6
7518386|NCT02489968|11855243|FG004|Double-blind Treatment Period|Adverse Event|4
7518387|NCT02489968|11855244|FG005|Double-blind Treatment Period|Adverse Event|5
7518388|NCT02489968|11855239|FG000|Double-blind Treatment Period|Protocol Violation|0
7518389|NCT02489968|11855240|FG001|Double-blind Treatment Period|Protocol Violation|0
7518390|NCT02489968|11855241|FG002|Double-blind Treatment Period|Protocol Violation|0
7518391|NCT02489968|11855242|FG003|Double-blind Treatment Period|Protocol Violation|0
7518392|NCT02489968|11855243|FG004|Double-blind Treatment Period|Protocol Violation|1
7518393|NCT02489968|11855244|FG005|Double-blind Treatment Period|Protocol Violation|1
7518394|NCT02489968|11855239|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7518395|NCT02489968|11855240|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7518396|NCT02489968|11855241|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7518397|NCT02489968|11855242|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
7518398|NCT02489968|11855243|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
7518399|NCT02489968|11855244|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
7518400|NCT02489968|11855239|FG000|Double-blind Treatment Period|Other than specified above|0
7518480|NCT02491892|11855422|FG001|Overall Study|Refused Treatment|0
7518401|NCT02489968|11855240|FG001|Double-blind Treatment Period|Other than specified above|0
7518402|NCT02489968|11855241|FG002|Double-blind Treatment Period|Other than specified above|0
7518403|NCT02489968|11855242|FG003|Double-blind Treatment Period|Other than specified above|0
7518404|NCT02489968|11855243|FG004|Double-blind Treatment Period|Other than specified above|1
7518405|NCT02489968|11855244|FG005|Double-blind Treatment Period|Other than specified above|0
7518406|NCT02489981|11855256|FG000|Overall Study|Adverse Event|21
7518407|NCT02489981|11855256|FG000|Overall Study|Insufficient effectiveness|16
7518408|NCT02489981|11855256|FG000|Overall Study|Improved|31
7518409|NCT02489981|11855256|FG000|Overall Study|Lost to Follow-up|31
7518410|NCT02489981|11855256|FG000|Overall Study|Other than listed|28
7518411|NCT02490371|11855271|FG000|Overall Study|Lost to Follow-up|1
7518412|NCT02490371|11855272|FG001|Overall Study|Lost to Follow-up|1
7518413|NCT02490475|11855282|FG000|Period 1: First 6 Cycles|Adverse Event|2
7518414|NCT02490475|11855283|FG001|Period 1: First 6 Cycles|Adverse Event|1
7518415|NCT02490475|11855284|FG002|Period 1: First 6 Cycles|Adverse Event|0
7518416|NCT02490475|11855285|FG003|Period 1: First 6 Cycles|Adverse Event|1
7518417|NCT02490475|11855282|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7518418|NCT02490475|11855283|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
7518419|NCT02490475|11855284|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7518420|NCT02490475|11855285|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
7518421|NCT02490475|11855282|FG000|Period 1: First 6 Cycles|Refused Treatment|1
7518422|NCT02490475|11855283|FG001|Period 1: First 6 Cycles|Refused Treatment|0
7518423|NCT02490475|11855284|FG002|Period 1: First 6 Cycles|Refused Treatment|0
7518424|NCT02490475|11855285|FG003|Period 1: First 6 Cycles|Refused Treatment|0
7518425|NCT02490475|11855282|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7518426|NCT02490475|11855283|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
7518427|NCT02490475|11855284|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
7518428|NCT02490475|11855285|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
7518429|NCT02490475|11855282|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
7518430|NCT02490475|11855283|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7518431|NCT02490475|11855284|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
7518432|NCT02490475|11855285|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
7518433|NCT02490475|11855282|FG000|Period 2: Extension Phase|Refused Treatment|0
7518434|NCT02490475|11855283|FG001|Period 2: Extension Phase|Refused Treatment|0
7518435|NCT02490475|11855284|FG002|Period 2: Extension Phase|Refused Treatment|0
7518436|NCT02490475|11855285|FG003|Period 2: Extension Phase|Refused Treatment|1
7518437|NCT02490475|11855282|FG000|Period 2: Extension Phase|Adverse Event|0
7518438|NCT02490475|11855283|FG001|Period 2: Extension Phase|Adverse Event|0
7518439|NCT02490475|11855284|FG002|Period 2: Extension Phase|Adverse Event|1
7518440|NCT02490475|11855285|FG003|Period 2: Extension Phase|Adverse Event|0
7518441|NCT02490878|11855326|FG000|Overall Study|deemed ineligible|0
7518442|NCT02490878|11855327|FG001|Overall Study|deemed ineligible|1
7518443|NCT02490878|11855326|FG000|Overall Study|progression prior to treatment|0
7518444|NCT02490878|11855327|FG001|Overall Study|progression prior to treatment|1
7518445|NCT02490878|11855326|FG000|Overall Study|only submitted baseline QOL|0
7518446|NCT02490878|11855327|FG001|Overall Study|only submitted baseline QOL|1
7518447|NCT02491073|11855335|FG000|Overall Study|screen failure|1
7518448|NCT02491073|11855336|FG001|Overall Study|screen failure|0
7518449|NCT02491463|11855379|FG000|Overall Study|Withdrawal by Subject|1
7518450|NCT02491463|11855380|FG001|Overall Study|Withdrawal by Subject|2
7518451|NCT02491463|11855381|FG002|Overall Study|Withdrawal by Subject|0
7518452|NCT02491463|11855382|FG003|Overall Study|Withdrawal by Subject|0
7518453|NCT02491463|11855379|FG000|Overall Study|Migrated/moved from study area|1
7518454|NCT02491463|11855380|FG001|Overall Study|Migrated/moved from study area|5
7518455|NCT02491463|11855381|FG002|Overall Study|Migrated/moved from study area|1
7518456|NCT02491463|11855382|FG003|Overall Study|Migrated/moved from study area|1
7518457|NCT02491463|11855379|FG000|Overall Study|Lost to Follow-up|0
7518458|NCT02491463|11855380|FG001|Overall Study|Lost to Follow-up|3
7518459|NCT02491463|11855381|FG002|Overall Study|Lost to Follow-up|3
7518460|NCT02491463|11855382|FG003|Overall Study|Lost to Follow-up|0
7518461|NCT02491671|11855394|FG000|Overall Study|Adverse Event|6
7518462|NCT02491671|11855395|FG001|Overall Study|Adverse Event|8
7518463|NCT02491671|11855394|FG000|Overall Study|Death|0
7518464|NCT02491671|11855395|FG001|Overall Study|Death|2
7518465|NCT02491671|11855394|FG000|Overall Study|Use of sealants other than Hemopatch|5
7518466|NCT02491671|11855395|FG001|Overall Study|Use of sealants other than Hemopatch|3
7518467|NCT02491684|11855403|FG000|Treatment Phase|Adverse Event|2
7518468|NCT02491684|11855404|FG001|Treatment Phase|Adverse Event|2
7518469|NCT02491684|11855403|FG000|Treatment Phase|Incorrect randomisation|1
7518470|NCT02491684|11855404|FG001|Treatment Phase|Incorrect randomisation|0
7518471|NCT02491684|11855403|FG000|Treatment Phase|Investigator and Sponsor decision|0
7518472|NCT02491684|11855404|FG001|Treatment Phase|Investigator and Sponsor decision|1
7518473|NCT02491892|11855421|FG000|Overall Study|Adverse Event|1
7518474|NCT02491892|11855422|FG001|Overall Study|Adverse Event|1
7518475|NCT02491892|11855421|FG000|Overall Study|Death|1
7518476|NCT02491892|11855422|FG001|Overall Study|Death|1
7518477|NCT02491892|11855421|FG000|Overall Study|Lack of Efficacy|37
7518478|NCT02491892|11855422|FG001|Overall Study|Lack of Efficacy|36
7518479|NCT02491892|11855421|FG000|Overall Study|Refused Treatment|1
7518481|NCT02491892|11855421|FG000|Overall Study|Lost to Follow-up|1
7518482|NCT02491892|11855422|FG001|Overall Study|Lost to Follow-up|0
7518483|NCT02492100|11855432|FG000|Overall Study|Death|1
7536676|NCT02722278|11884667|FG001|Overall Study|Withdrawal by Subject|3
7536677|NCT02722278|11884666|FG000|Overall Study|Adverse Event|4
7536678|NCT02722278|11884667|FG001|Overall Study|Adverse Event|1
7536679|NCT02722278|11884666|FG000|Overall Study|Lost to Follow-up|2
7536680|NCT02722278|11884667|FG001|Overall Study|Lost to Follow-up|0
7536681|NCT02722278|11884666|FG000|Overall Study|Protocol Violation|1
7536682|NCT02722278|11884667|FG001|Overall Study|Protocol Violation|0
7536683|NCT02722278|11884666|FG000|Overall Study|High PSA pre-study/ not eligible|0
7536684|NCT02722278|11884667|FG001|Overall Study|High PSA pre-study/ not eligible|1
7536685|NCT02722278|11884666|FG000|Overall Study|Subject declined after tx assignment|0
7536686|NCT02722278|11884667|FG001|Overall Study|Subject declined after tx assignment|1
7536687|NCT02722278|11884666|FG000|Overall Study|Site closure not study related|0
7536688|NCT02722278|11884667|FG001|Overall Study|Site closure not study related|1
7536689|NCT02722304|11884680|FG000|Overall Study|Study Terminated by Sponsor|1
7536690|NCT02722304|11884681|FG001|Overall Study|Study Terminated by Sponsor|0
7536691|NCT02722304|11884682|FG002|Overall Study|Study Terminated by Sponsor|2
7536692|NCT02722304|11884683|FG003|Overall Study|Study Terminated by Sponsor|1
7536693|NCT02722304|11884684|FG004|Overall Study|Study Terminated by Sponsor|1
7536694|NCT02722304|11884680|FG000|Overall Study|Other|0
7536695|NCT02722304|11884681|FG001|Overall Study|Other|0
7536696|NCT02722304|11884682|FG002|Overall Study|Other|0
7536697|NCT02722304|11884683|FG003|Overall Study|Other|1
7536698|NCT02722304|11884684|FG004|Overall Study|Other|1
7536699|NCT02722499|11884711|FG000|Overall Study|Lost to Follow-up|2
7536700|NCT02722499|11884712|FG001|Overall Study|Lost to Follow-up|0
7536701|NCT02722499|11884713|FG002|Overall Study|Lost to Follow-up|1
7536702|NCT02722928|11884740|FG000|Overall Study|Standard CT was not as required per prot|5
7536703|NCT02722928|11884741|FG001|Overall Study|Standard CT was not as required per prot|13
7518484|NCT02492763|11855467|FG000|Overall Study|Withdrawal by Subject|0
7518485|NCT02492763|11855468|FG001|Overall Study|Withdrawal by Subject|2
7518486|NCT02492763|11855469|FG002|Overall Study|Withdrawal by Subject|1
7518487|NCT02492763|11855470|FG003|Overall Study|Withdrawal by Subject|0
7518488|NCT02492763|11855467|FG000|Overall Study|Adverse Event|3
7518489|NCT02492763|11855468|FG001|Overall Study|Adverse Event|1
7518490|NCT02492763|11855469|FG002|Overall Study|Adverse Event|1
7518491|NCT02492763|11855470|FG003|Overall Study|Adverse Event|2
7518492|NCT02492763|11855467|FG000|Overall Study|Death|0
7518493|NCT02492763|11855468|FG001|Overall Study|Death|0
7518494|NCT02492763|11855469|FG002|Overall Study|Death|1
7518495|NCT02492763|11855470|FG003|Overall Study|Death|0
7518496|NCT02492763|11855467|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
7518497|NCT02492763|11855468|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
7518498|NCT02492763|11855469|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
7518499|NCT02492763|11855470|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
7518500|NCT02492763|11855467|FG000|Overall Study|Lost to Follow-up|0
7518501|NCT02492763|11855468|FG001|Overall Study|Lost to Follow-up|0
7518502|NCT02492763|11855469|FG002|Overall Study|Lost to Follow-up|1
7518503|NCT02492763|11855470|FG003|Overall Study|Lost to Follow-up|0
7518504|NCT02492763|11855467|FG000|Overall Study|Non-Compliance With Study Drug|0
7518505|NCT02492763|11855468|FG001|Overall Study|Non-Compliance With Study Drug|1
7518506|NCT02492763|11855469|FG002|Overall Study|Non-Compliance With Study Drug|0
7518507|NCT02492763|11855470|FG003|Overall Study|Non-Compliance With Study Drug|0
7518508|NCT02492763|11855467|FG000|Overall Study|Screen Failure|0
7518509|NCT02492763|11855468|FG001|Overall Study|Screen Failure|0
7518510|NCT02492763|11855469|FG002|Overall Study|Screen Failure|0
7518511|NCT02492763|11855470|FG003|Overall Study|Screen Failure|1
7413154|NCT01423916|11685309|FG001|Overall Study|Adverse Event|9
7413155|NCT01423916|11685310|FG002|Overall Study|Adverse Event|2
7413156|NCT01423916|11685308|FG000|Overall Study|Met Withdrawal Criteria|1
7413157|NCT01423916|11685309|FG001|Overall Study|Met Withdrawal Criteria|1
7413158|NCT01423916|11685310|FG002|Overall Study|Met Withdrawal Criteria|1
7413159|NCT01423916|11685308|FG000|Overall Study|Physician Decision|1
7518512|NCT02492763|11855467|FG000|Overall Study|Study Terminated by Sponsor|13
7518513|NCT02492763|11855468|FG001|Overall Study|Study Terminated by Sponsor|10
7518514|NCT02492763|11855469|FG002|Overall Study|Study Terminated by Sponsor|6
7518515|NCT02492763|11855470|FG003|Overall Study|Study Terminated by Sponsor|10
7518516|NCT02492841|11855487|FG000|Overall Study|Lost to Follow-up|34
7518517|NCT02492841|11855488|FG001|Overall Study|Lost to Follow-up|31
7518518|NCT02492841|11855489|FG002|Overall Study|Lost to Follow-up|35
7518519|NCT02492880|11855509|FG000|Overall Study|Lost to Follow-up|1
7518520|NCT02492880|11855509|FG000|Overall Study|Protocol Violation|1
7518521|NCT02492958|11855517|FG000|Overall Study|Withdrawal by Subject|0
7518522|NCT02492958|11855518|FG001|Overall Study|Withdrawal by Subject|0
7518523|NCT02492958|11855519|FG002|Overall Study|Withdrawal by Subject|1
7518524|NCT02492958|11855520|FG003|Overall Study|Withdrawal by Subject|0
7518525|NCT02492958|11855517|FG000|Overall Study|Adverse Event|1
7518526|NCT02492958|11855518|FG001|Overall Study|Adverse Event|0
7518527|NCT02492958|11855519|FG002|Overall Study|Adverse Event|1
7518528|NCT02492958|11855520|FG003|Overall Study|Adverse Event|0
7518529|NCT02492984|11855532|FG000|Overall Study|Adverse Event|1
7518530|NCT02492984|11855533|FG001|Overall Study|Adverse Event|0
7518531|NCT02492984|11855532|FG000|Overall Study|Protocol Violation|1
7518532|NCT02492984|11855533|FG001|Overall Study|Protocol Violation|0
7518533|NCT02492984|11855532|FG000|Overall Study|Withdrawal by Subject|1
7518534|NCT02492984|11855533|FG001|Overall Study|Withdrawal by Subject|0
7518535|NCT02492997|11855544|FG000|Overall Study|Withdrawal by Subject|1
7518536|NCT02492997|11855545|FG001|Overall Study|Withdrawal by Subject|0
7518537|NCT02492997|11855544|FG000|Overall Study|Gained Weight|1
7518538|NCT02492997|11855545|FG001|Overall Study|Gained Weight|0
7518539|NCT02492997|11855544|FG000|Overall Study|Lost to Follow-up|0
7518540|NCT02492997|11855545|FG001|Overall Study|Lost to Follow-up|1
7518541|NCT02493062|11855564|FG000|Overall Study|Physician Decision|12
7518542|NCT02493127|11855574|FG000|Overall Study|Lost to Follow-up|1
7518543|NCT02493127|11855575|FG001|Overall Study|Lost to Follow-up|1
7413160|NCT01423916|11685309|FG001|Overall Study|Physician Decision|0
7518544|NCT02493361|11855592|FG000|Overall Study|Withdrawal by Subject|3
7518545|NCT02493517|11855611|FG000|Overall Study|Protocol Violation|1
7518546|NCT02493517|11855612|FG001|Overall Study|Protocol Violation|2
7518547|NCT02493517|11855611|FG000|Overall Study|Withdrawal by Subject|1
7518548|NCT02493517|11855612|FG001|Overall Study|Withdrawal by Subject|2
7518549|NCT02493517|11855611|FG000|Overall Study|Adverse Event|0
7518550|NCT02493517|11855612|FG001|Overall Study|Adverse Event|2
7518551|NCT02493517|11855611|FG000|Overall Study|Missed study visit|0
7518552|NCT02493517|11855612|FG001|Overall Study|Missed study visit|1
7317689|NCT00724061|11546677|FG000|Dose Escalation Phase|Adverse Event|2
7518553|NCT02493712|11855641|FG000|Overall Study|Withdrawal by Subject|1
7518554|NCT02493712|11855642|FG001|Overall Study|Withdrawal by Subject|0
7317690|NCT00724061|11546677|FG000|Dose Escalation Phase|Disease Progression|3
7518555|NCT02493712|11855643|FG002|Overall Study|Withdrawal by Subject|2
7518556|NCT02493712|11855641|FG000|Overall Study|Protocol Violation|0
7518557|NCT02493712|11855642|FG001|Overall Study|Protocol Violation|0
7518558|NCT02493712|11855643|FG002|Overall Study|Protocol Violation|1
7518559|NCT02493712|11855641|FG000|Overall Study|Lost to Follow-up|1
7518560|NCT02493712|11855642|FG001|Overall Study|Lost to Follow-up|0
7518561|NCT02493712|11855643|FG002|Overall Study|Lost to Follow-up|0
7518562|NCT02493712|11855641|FG000|Overall Study|Physician Decision|0
7518563|NCT02493712|11855642|FG001|Overall Study|Physician Decision|1
7518564|NCT02493712|11855643|FG002|Overall Study|Physician Decision|0
7518565|NCT02493712|11855641|FG000|Overall Study|Lack of Efficacy|0
7518566|NCT02493712|11855642|FG001|Overall Study|Lack of Efficacy|5
7518567|NCT02493712|11855643|FG002|Overall Study|Lack of Efficacy|3
7518568|NCT02493764|11855653|FG000|Overall Study|Adverse Event|2
7518569|NCT02493764|11855654|FG001|Overall Study|Adverse Event|2
7518570|NCT02493764|11855653|FG000|Overall Study|Death|44
7518571|NCT02493764|11855654|FG001|Overall Study|Death|58
7518572|NCT02493764|11855653|FG000|Overall Study|Lost to Follow-up|2
7518573|NCT02493764|11855654|FG001|Overall Study|Lost to Follow-up|1
7518574|NCT02493764|11855653|FG000|Overall Study|Protocol Violation|6
7518575|NCT02493764|11855654|FG001|Overall Study|Protocol Violation|7
7518576|NCT02493764|11855653|FG000|Overall Study|Physician Decision|1
7518577|NCT02493764|11855654|FG001|Overall Study|Physician Decision|1
7518578|NCT02493764|11855653|FG000|Overall Study|Participant moved|17
7518579|NCT02493764|11855654|FG001|Overall Study|Participant moved|5
7518580|NCT02493764|11855653|FG000|Overall Study|Withdrawal parent/guardian|0
7518581|NCT02493764|11855654|FG001|Overall Study|Withdrawal parent/guardian|1
7518582|NCT02493764|11855653|FG000|Overall Study|Withdrawal by Subject|11
7518583|NCT02493764|11855654|FG001|Overall Study|Withdrawal by Subject|7
7518584|NCT02493777|11855662|FG000|Overall Study|Lost to Follow-up|0
7518585|NCT02493777|11855663|FG001|Overall Study|Lost to Follow-up|1
7518586|NCT02493855|11855672|FG000|Overall Study|Non-compliance|1
7518587|NCT02493855|11855673|FG001|Overall Study|Non-compliance|0
7518588|NCT02493855|11855674|FG002|Overall Study|Non-compliance|0
7518589|NCT02493855|11855672|FG000|Overall Study|Adverse Event|0
7518590|NCT02493855|11855673|FG001|Overall Study|Adverse Event|1
7518591|NCT02493855|11855674|FG002|Overall Study|Adverse Event|0
7518592|NCT02493855|11855672|FG000|Overall Study|Withdrawal by Subject|1
7518593|NCT02493855|11855673|FG001|Overall Study|Withdrawal by Subject|0
7518594|NCT02493855|11855674|FG002|Overall Study|Withdrawal by Subject|0
7518595|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Adverse Event|22
7518596|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Adverse Event|0
7518597|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
7518598|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
7518599|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
7518600|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
7518601|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Protocol Violation|2
7518602|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Protocol Violation|0
7518603|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
7518604|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
7518605|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
7518606|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
7518607|NCT02493868|11855682|FG000|Induction Phase: DE Participants|Other|8
7518608|NCT02493868|11855683|FG001|Induction Phase: DE Participants|Other|0
7518609|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
7518610|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
7518611|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
7518612|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
7518613|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
7518614|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
7518615|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
7518616|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
7518617|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
7518618|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
7518619|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
7518620|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
7518621|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
7518622|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
7518623|NCT02493868|11855682|FG000|Optimization Phase: DE+TE Participants|Other|10
7518624|NCT02493868|11855683|FG001|Optimization Phase: DE+TE Participants|Other|2
7518625|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
7518626|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
7518627|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
7518628|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
7518629|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7518630|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
7518631|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
7518632|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
7518633|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
7518634|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
7518635|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
7518636|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
7518637|NCT02493868|11855682|FG000|Maintenance Phase: DE+TE Participants|Other|4
7518638|NCT02493868|11855683|FG001|Maintenance Phase: DE+TE Participants|Other|9
7518639|NCT02493868|11855682|FG000|Follow-up Phase|Lost to Follow-up|1
7518640|NCT02493868|11855683|FG001|Follow-up Phase|Lost to Follow-up|0
7518641|NCT02493868|11855682|FG000|Follow-up Phase|Withdrawal by Subject|3
7518642|NCT02493868|11855683|FG001|Follow-up Phase|Withdrawal by Subject|0
7518643|NCT02493868|11855682|FG000|Follow-up Phase|Investigator Decision|5
7518644|NCT02493868|11855683|FG001|Follow-up Phase|Investigator Decision|1
7518645|NCT02493868|11855682|FG000|Follow-up Phase|Other|2
7518646|NCT02493868|11855683|FG001|Follow-up Phase|Other|1
7518671|NCT02494401|11855754|FG000|Overall Study|Lost to Follow-up|22
7518672|NCT02494401|11855755|FG001|Overall Study|Lost to Follow-up|25
7518673|NCT02494401|11855754|FG000|Overall Study|Withdrawal by Subject|3
7518674|NCT02494401|11855755|FG001|Overall Study|Withdrawal by Subject|2
7553154|NCT03008460|11913972|FG001|Overall Study|Withdrawal by Subject|6
7553155|NCT03008460|11913971|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
7553156|NCT03008460|11913972|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
7553157|NCT03008460|11913971|FG000|Overall Study|End of study visit outside permitted time window|0
7553158|NCT03008460|11913972|FG001|Overall Study|End of study visit outside permitted time window|1
7553159|NCT03008460|11913971|FG000|Overall Study|Lost to Follow-up|1
7553160|NCT03008460|11913972|FG001|Overall Study|Lost to Follow-up|3
7553161|NCT03008915|11914018|FG000|Treatment 1|Withdrawal by Subject|0
7553162|NCT03008915|11914019|FG001|Treatment 1|Withdrawal by Subject|1
7553163|NCT03010254|11914054|FG000|Overall Study|Adverse Event|0
7553164|NCT03010254|11914055|FG001|Overall Study|Adverse Event|1
7553165|NCT03010254|11914054|FG000|Overall Study|Lost to Follow-up|4
7553166|NCT03010254|11914055|FG001|Overall Study|Lost to Follow-up|0
7553167|NCT03010254|11914054|FG000|Overall Study|Withdrawal by Subject|1
7518690|NCT02494596|11855791|FG000|Overall Study|Insufficient Therapeutic Response|3
7518691|NCT02494596|11855792|FG001|Overall Study|Insufficient Therapeutic Response|3
7518692|NCT02494596|11855793|FG002|Overall Study|Insufficient Therapeutic Response|1
7518693|NCT02494596|11855791|FG000|Overall Study|Adverse Event|0
7518694|NCT02494596|11855792|FG001|Overall Study|Adverse Event|1
7518695|NCT02494596|11855793|FG002|Overall Study|Adverse Event|0
7518696|NCT02494596|11855791|FG000|Overall Study|Refused Treatment|0
7518697|NCT02494596|11855792|FG001|Overall Study|Refused Treatment|1
7518698|NCT02494596|11855793|FG002|Overall Study|Refused Treatment|0
7518699|NCT02494778|11855808|FG000|Overall Study|Death|3
7518700|NCT02494778|11855808|FG000|Overall Study|Other|173
7518701|NCT02494778|11855808|FG000|Overall Study|Lack of Efficacy|4
7518702|NCT02494778|11855808|FG000|Overall Study|Adverse Event|18
7518703|NCT02494778|11855808|FG000|Overall Study|Withdrawal by Subject|20
7518704|NCT02494778|11855808|FG000|Overall Study|Lost to Follow-up|2
7518705|NCT02494778|11855808|FG000|Overall Study|Noncompliant with study drug admin.|1
7518706|NCT02495025|11855823|FG000|Overall Study|Lost to Follow-up|21
7518707|NCT02495025|11855824|FG001|Overall Study|Lost to Follow-up|14
7518708|NCT02495025|11855823|FG000|Overall Study|Withdrawal by Subject|5
7518709|NCT02495025|11855824|FG001|Overall Study|Withdrawal by Subject|0
7518710|NCT02495168|11855857|FG000|Overall Study|Other than Specified|18
7518711|NCT02495168|11855858|FG001|Overall Study|Other than Specified|22
7518712|NCT02495168|11855859|FG002|Overall Study|Other than Specified|5
7518713|NCT02495168|11855857|FG000|Overall Study|Did not Complete Final Visit On Time|4
7518714|NCT02495168|11855858|FG001|Overall Study|Did not Complete Final Visit On Time|3
7518715|NCT02495168|11855859|FG002|Overall Study|Did not Complete Final Visit On Time|2
7518716|NCT02495168|11855857|FG000|Overall Study|Physician Decision|1
7518717|NCT02495168|11855858|FG001|Overall Study|Physician Decision|1
7518718|NCT02495168|11855859|FG002|Overall Study|Physician Decision|0
7518719|NCT02495168|11855857|FG000|Overall Study|Lost to Follow-up|10
7518720|NCT02495168|11855858|FG001|Overall Study|Lost to Follow-up|6
7518721|NCT02495168|11855859|FG002|Overall Study|Lost to Follow-up|1
7518722|NCT02495168|11855857|FG000|Overall Study|Withdrawal by Subject|1
7518723|NCT02495168|11855858|FG001|Overall Study|Withdrawal by Subject|4
7518724|NCT02495168|11855859|FG002|Overall Study|Withdrawal by Subject|2
7518725|NCT02495168|11855857|FG000|Overall Study|Protocol Violation|0
7518726|NCT02495168|11855858|FG001|Overall Study|Protocol Violation|10
7518727|NCT02495168|11855859|FG002|Overall Study|Protocol Violation|1
7518728|NCT02495168|11855857|FG000|Overall Study|Adverse Event|4
7518729|NCT02495168|11855858|FG001|Overall Study|Adverse Event|8
7518730|NCT02495168|11855859|FG002|Overall Study|Adverse Event|3
7518731|NCT02495168|11855857|FG000|Overall Study|Lack of Efficacy|0
7518732|NCT02495168|11855858|FG001|Overall Study|Lack of Efficacy|0
7518733|NCT02495168|11855859|FG002|Overall Study|Lack of Efficacy|3
7518734|NCT02495233|11855869|FG000|Overall Study|Miscellaneous|0
7518735|NCT02495233|11855870|FG001|Overall Study|Miscellaneous|1
7518736|NCT02495389|11855889|FG000|Overall Study|Withdrawal by Subject|40
7518737|NCT02495844|11855933|FG000|Overall Study|Lack of Efficacy|1
7518738|NCT02495844|11855934|FG001|Overall Study|Lack of Efficacy|2
7518739|NCT02495844|11855933|FG000|Overall Study|AE, non-fatal|0
7518740|NCT02495844|11855934|FG001|Overall Study|AE, non-fatal|1
7518741|NCT02495844|11855933|FG000|Overall Study|Hepatitis Positivity|0
7518742|NCT02495844|11855934|FG001|Overall Study|Hepatitis Positivity|1
7518743|NCT02495857|11855945|FG000|Overall Study|Adverse Event|5
7518744|NCT02495857|11855946|FG001|Overall Study|Adverse Event|0
7518745|NCT02495857|11855947|FG002|Overall Study|Adverse Event|1
7518746|NCT02495857|11855945|FG000|Overall Study|Withdrawal by Subject|9
7518747|NCT02495857|11855946|FG001|Overall Study|Withdrawal by Subject|6
7518748|NCT02495857|11855947|FG002|Overall Study|Withdrawal by Subject|10
7518749|NCT02495857|11855945|FG000|Overall Study|Physician Decision|0
7518750|NCT02495857|11855946|FG001|Overall Study|Physician Decision|1
7518751|NCT02495857|11855947|FG002|Overall Study|Physician Decision|0
7518752|NCT02495857|11855945|FG000|Overall Study|Protocol Violation|1
7518753|NCT02495857|11855946|FG001|Overall Study|Protocol Violation|1
7518754|NCT02495857|11855947|FG002|Overall Study|Protocol Violation|2
7518755|NCT02495857|11855945|FG000|Overall Study|Lost to Follow-up|4
7518756|NCT02495857|11855946|FG001|Overall Study|Lost to Follow-up|5
7518757|NCT02495857|11855947|FG002|Overall Study|Lost to Follow-up|3
7518758|NCT02495857|11855945|FG000|Overall Study|Other|3
7518759|NCT02495857|11855946|FG001|Overall Study|Other|3
7518760|NCT02495857|11855947|FG002|Overall Study|Other|2
7518761|NCT02495883|11855957|FG000|Overall Study|Excessive head motion|1
7518762|NCT02495883|11855958|FG001|Overall Study|Excessive head motion|0
7518763|NCT02495948|11855963|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7518764|NCT02495948|11855964|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7518765|NCT02495948|11855963|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7518766|NCT02495948|11855964|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
7518767|NCT02496000|11855974|FG000|Overall Study|Withdrawal by Subject|1
7518768|NCT02496000|11855975|FG001|Overall Study|Withdrawal by Subject|2
7518769|NCT02496000|11855976|FG002|Overall Study|Withdrawal by Subject|0
7518770|NCT02496000|11855974|FG000|Overall Study|Lost to Follow-up|1
7518771|NCT02496000|11855975|FG001|Overall Study|Lost to Follow-up|0
7518772|NCT02496000|11855976|FG002|Overall Study|Lost to Follow-up|1
7518773|NCT02496000|11855974|FG000|Overall Study|Protocol Violation|0
7518774|NCT02496000|11855975|FG001|Overall Study|Protocol Violation|0
7518775|NCT02496000|11855976|FG002|Overall Study|Protocol Violation|1
7518776|NCT02496000|11855974|FG000|Overall Study|Non-compliance or lack of cooperation|0
7518777|NCT02496000|11855975|FG001|Overall Study|Non-compliance or lack of cooperation|2
7518778|NCT02496000|11855976|FG002|Overall Study|Non-compliance or lack of cooperation|0
7518779|NCT02496000|11855974|FG000|Overall Study|undetermined|0
7518780|NCT02496000|11855975|FG001|Overall Study|undetermined|1
7518781|NCT02496000|11855976|FG002|Overall Study|undetermined|0
7518782|NCT02496091|11855985|FG000|Overall Study|Eligibility criteria not fulfilled|2
7518783|NCT02496221|11855990|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
7518784|NCT02496221|11855991|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
7518785|NCT02496221|11855990|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
7518786|NCT02496221|11855991|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
7518787|NCT02496221|11855990|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
7518788|NCT02496221|11855991|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
7518789|NCT02496533|11856001|FG000|Overall Study|Lack of data on outcome|3
7518790|NCT02496533|11856002|FG001|Overall Study|Lack of data on outcome|0
7518791|NCT02496533|11856001|FG000|Overall Study|Patient did not complete all measures|0
7518792|NCT02496533|11856002|FG001|Overall Study|Patient did not complete all measures|4
7518793|NCT02496533|11856001|FG000|Overall Study|Late for radiologic testing|0
7518794|NCT02496533|11856002|FG001|Overall Study|Late for radiologic testing|2
7518795|NCT02496702|11856010|FG000|Overall Study|Lost to Follow-up|8
7518796|NCT02496702|11856011|FG001|Overall Study|Lost to Follow-up|6
7518797|NCT02496702|11856010|FG000|Overall Study|Only partially tested|0
7518798|NCT02496702|11856011|FG001|Overall Study|Only partially tested|2
7518799|NCT02496767|11856021|FG000|Open-label Lead-in Phase|Adverse Event|176
7518800|NCT02496767|11856022|FG001|Open-label Lead-in Phase|Adverse Event|0
7518801|NCT02496767|11856023|FG002|Open-label Lead-in Phase|Adverse Event|0
7518802|NCT02496767|11856024|FG003|Open-label Lead-in Phase|Adverse Event|0
7518803|NCT02496767|11856025|FG004|Open-label Lead-in Phase|Adverse Event|0
7518804|NCT02496767|11856026|FG005|Open-label Lead-in Phase|Adverse Event|0
7518805|NCT02496767|11856027|FG006|Open-label Lead-in Phase|Adverse Event|0
7518806|NCT02496767|11856028|FG007|Open-label Lead-in Phase|Adverse Event|0
7518807|NCT02496767|11856021|FG000|Open-label Lead-in Phase|Protocol Violation|2
7518808|NCT02496767|11856022|FG001|Open-label Lead-in Phase|Protocol Violation|0
7518809|NCT02496767|11856023|FG002|Open-label Lead-in Phase|Protocol Violation|0
7518810|NCT02496767|11856024|FG003|Open-label Lead-in Phase|Protocol Violation|0
7518811|NCT02496767|11856025|FG004|Open-label Lead-in Phase|Protocol Violation|0
7518812|NCT02496767|11856026|FG005|Open-label Lead-in Phase|Protocol Violation|0
7518813|NCT02496767|11856027|FG006|Open-label Lead-in Phase|Protocol Violation|0
7518814|NCT02496767|11856028|FG007|Open-label Lead-in Phase|Protocol Violation|0
7518815|NCT02496767|11856021|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
7518816|NCT02496767|11856022|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
7518817|NCT02496767|11856023|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
7518818|NCT02496767|11856024|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
7518819|NCT02496767|11856025|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
7518820|NCT02496767|11856026|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
7518821|NCT02496767|11856027|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
7518822|NCT02496767|11856028|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
7518823|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7518824|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
7518825|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
7518826|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
7518827|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
7518828|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
7518829|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
7518830|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
7518831|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
7518832|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
7518833|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
7518834|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
7518835|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
7518836|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
7518837|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
7518838|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
7518839|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Death|0
7518840|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Death|10
7518841|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Death|6
7518842|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Death|2
7518843|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Death|4
7518844|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Death|0
7518845|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Death|0
7518846|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Death|0
7518847|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Various|0
7518848|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Various|9
7518849|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Various|4
7518850|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Various|5
7518851|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Various|2
7518852|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Various|0
7518853|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Various|0
7518854|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Various|0
7518855|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7518856|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
7518857|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
7518858|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
7518859|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
7518860|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7518861|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7518862|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7518863|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518864|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
7518865|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
7518866|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518867|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518868|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518869|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518870|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
7518871|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7518872|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7518873|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7518874|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7518875|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
7518876|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7518877|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7518878|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7518879|NCT02496767|11856021|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518880|NCT02496767|11856022|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
7518881|NCT02496767|11856023|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518882|NCT02496767|11856024|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518883|NCT02496767|11856025|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518884|NCT02496767|11856026|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518885|NCT02496767|11856027|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518886|NCT02496767|11856028|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
7518887|NCT02496767|11856021|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
7518888|NCT02496767|11856022|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
7518889|NCT02496767|11856023|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
7518890|NCT02496767|11856024|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
7518891|NCT02496767|11856025|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
7518892|NCT02496767|11856026|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
7518893|NCT02496767|11856027|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
7518894|NCT02496767|11856028|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
7518895|NCT02496767|11856021|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
7518896|NCT02496767|11856022|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
7518897|NCT02496767|11856023|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
7518898|NCT02496767|11856024|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
7518899|NCT02496767|11856025|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
7518900|NCT02496767|11856026|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
7518901|NCT02496767|11856027|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
7518902|NCT02496767|11856028|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
7518903|NCT02496767|11856021|FG000|Double-blind, Withdrawal Phase|Death|0
7518904|NCT02496767|11856022|FG001|Double-blind, Withdrawal Phase|Death|0
7518905|NCT02496767|11856023|FG002|Double-blind, Withdrawal Phase|Death|0
7518906|NCT02496767|11856024|FG003|Double-blind, Withdrawal Phase|Death|0
7518907|NCT02496767|11856025|FG004|Double-blind, Withdrawal Phase|Death|0
7518908|NCT02496767|11856026|FG005|Double-blind, Withdrawal Phase|Death|0
7518909|NCT02496767|11856027|FG006|Double-blind, Withdrawal Phase|Death|1
7518910|NCT02496767|11856028|FG007|Double-blind, Withdrawal Phase|Death|2
7518911|NCT02496767|11856021|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7518912|NCT02496767|11856022|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7518913|NCT02496767|11856023|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7518914|NCT02496767|11856024|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7518915|NCT02496767|11856025|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
7518916|NCT02496767|11856026|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7518917|NCT02496767|11856027|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7518918|NCT02496767|11856028|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
7518919|NCT02496884|11856046|FG000|Overall Study|Counted twice as enrolled|2
7518920|NCT02496884|11856047|FG001|Overall Study|Counted twice as enrolled|0
7518921|NCT02496884|11856048|FG002|Overall Study|Counted twice as enrolled|0
7518922|NCT02496884|11856049|FG003|Overall Study|Counted twice as enrolled|0
7518923|NCT02496884|11856046|FG000|Overall Study|Withdrawal by Subject|0
7518924|NCT02496884|11856047|FG001|Overall Study|Withdrawal by Subject|3
7518925|NCT02496884|11856048|FG002|Overall Study|Withdrawal by Subject|0
7518926|NCT02496884|11856049|FG003|Overall Study|Withdrawal by Subject|0
7518927|NCT02497001|11856063|FG000|Overall Study|Lost to Follow-up|10
7518928|NCT02497001|11856064|FG001|Overall Study|Lost to Follow-up|2
7518929|NCT02497001|11856065|FG002|Overall Study|Lost to Follow-up|0
7518930|NCT02497001|11856066|FG003|Overall Study|Lost to Follow-up|2
7518931|NCT02497001|11856063|FG000|Overall Study|Adverse Event|28
7518932|NCT02497001|11856064|FG001|Overall Study|Adverse Event|30
7518933|NCT02497001|11856065|FG002|Overall Study|Adverse Event|11
7518934|NCT02497001|11856066|FG003|Overall Study|Adverse Event|11
7518935|NCT02497001|11856063|FG000|Overall Study|Withdrawal by Subject|14
7518936|NCT02497001|11856064|FG001|Overall Study|Withdrawal by Subject|37
7518937|NCT02497001|11856065|FG002|Overall Study|Withdrawal by Subject|19
7518938|NCT02497001|11856066|FG003|Overall Study|Withdrawal by Subject|15
7518939|NCT02497001|11856063|FG000|Overall Study|Physician Decision|5
7518940|NCT02497001|11856064|FG001|Overall Study|Physician Decision|11
7518941|NCT02497001|11856065|FG002|Overall Study|Physician Decision|5
7518942|NCT02497001|11856066|FG003|Overall Study|Physician Decision|1
7518943|NCT02497001|11856063|FG000|Overall Study|subjects that were not treated|1
7518944|NCT02497001|11856064|FG001|Overall Study|subjects that were not treated|2
7518945|NCT02497001|11856065|FG002|Overall Study|subjects that were not treated|2
7518946|NCT02497001|11856066|FG003|Overall Study|subjects that were not treated|1
7518947|NCT02497001|11856063|FG000|Overall Study|Major Protocol Deviation|3
7518948|NCT02497001|11856064|FG001|Overall Study|Major Protocol Deviation|4
7518949|NCT02497001|11856065|FG002|Overall Study|Major Protocol Deviation|4
7518950|NCT02497001|11856066|FG003|Overall Study|Major Protocol Deviation|4
7518951|NCT02497001|11856063|FG000|Overall Study|Lack of Efficacy|10
7518952|NCT02497001|11856064|FG001|Overall Study|Lack of Efficacy|16
7518953|NCT02497001|11856065|FG002|Overall Study|Lack of Efficacy|6
7518954|NCT02497001|11856066|FG003|Overall Study|Lack of Efficacy|6
7518955|NCT02497001|11856063|FG000|Overall Study|Protocol Violation|3
7518956|NCT02497001|11856064|FG001|Overall Study|Protocol Violation|1
7518957|NCT02497001|11856065|FG002|Overall Study|Protocol Violation|3
7518958|NCT02497001|11856066|FG003|Overall Study|Protocol Violation|1
7518959|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
7518960|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Adverse Event|52
7518961|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
7518962|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
7518963|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Other|13
7518964|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
7518965|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
7518966|NCT02497287|11856116|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
7518967|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
7518968|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
7518969|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
7518970|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
7518971|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Other|21
7518972|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
7518973|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
7518974|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
7518975|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
7518976|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Death|2
7518977|NCT02497287|11856116|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
7518978|NCT02497287|11856116|FG000|Follow-up Phase (4 Week)|PI Decision|12
7518979|NCT02497287|11856116|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
7518980|NCT02497287|11856116|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
7518981|NCT02497287|11856116|FG000|Follow-up Phase (4 Week)|Adverse Event|3
7518982|NCT02497287|11856116|FG000|Follow-up Phase (4 Week)|Other|1
7518983|NCT02497391|11856122|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
7518984|NCT02497391|11856123|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
7518985|NCT02497391|11856124|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
7518986|NCT02497391|11856125|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
7518987|NCT02497391|11856126|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
7518988|NCT02497391|11856127|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
7518989|NCT02497391|11856122|FG000|Period 2 (14 Days)|Sponsor Decision|3
7518990|NCT02497391|11856123|FG001|Period 2 (14 Days)|Sponsor Decision|1
7518991|NCT02497391|11856124|FG002|Period 2 (14 Days)|Sponsor Decision|2
7518992|NCT02497391|11856125|FG003|Period 2 (14 Days)|Sponsor Decision|3
7518993|NCT02497391|11856126|FG004|Period 2 (14 Days)|Sponsor Decision|2
7518994|NCT02497391|11856127|FG005|Period 2 (14 Days)|Sponsor Decision|3
7518995|NCT02497391|11856122|FG000|Period 3 (14 Days)|Adverse Event|0
7518996|NCT02497391|11856123|FG001|Period 3 (14 Days)|Adverse Event|1
7518997|NCT02497391|11856124|FG002|Period 3 (14 Days)|Adverse Event|0
7518998|NCT02497391|11856125|FG003|Period 3 (14 Days)|Adverse Event|0
7518999|NCT02497391|11856126|FG004|Period 3 (14 Days)|Adverse Event|0
7519000|NCT02497391|11856127|FG005|Period 3 (14 Days)|Adverse Event|0
7519001|NCT02497391|11856122|FG000|Period 3 (14 Days)|Sponsor Decision|0
7519002|NCT02497391|11856123|FG001|Period 3 (14 Days)|Sponsor Decision|0
7519003|NCT02497391|11856124|FG002|Period 3 (14 Days)|Sponsor Decision|0
7519004|NCT02497391|11856125|FG003|Period 3 (14 Days)|Sponsor Decision|0
7519005|NCT02497391|11856126|FG004|Period 3 (14 Days)|Sponsor Decision|1
7519006|NCT02497391|11856127|FG005|Period 3 (14 Days)|Sponsor Decision|0
7519007|NCT02497391|11856122|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
7519008|NCT02497391|11856123|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
7519009|NCT02497391|11856124|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
7519010|NCT02497391|11856125|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
7519011|NCT02497391|11856126|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
7519012|NCT02497391|11856127|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
7519013|NCT02497404|11856135|FG000|Overall Study|Adverse Event|1
7519014|NCT02497469|11856141|FG000|Overall Study|Randomized but not Treated|0
7519015|NCT02497469|11856142|FG001|Overall Study|Randomized but not Treated|2
7519016|NCT02497469|11856141|FG000|Overall Study|Pretreatment Event/Adverse Event|18
7519017|NCT02497469|11856142|FG001|Overall Study|Pretreatment Event/Adverse Event|16
7519018|NCT02497469|11856141|FG000|Overall Study|Leukopenia or Lymphopenia|1
7519019|NCT02497469|11856142|FG001|Overall Study|Leukopenia or Lymphopenia|0
7519020|NCT02497469|11856141|FG000|Overall Study|Significant Protocol Deviation|4
7519021|NCT02497469|11856142|FG001|Overall Study|Significant Protocol Deviation|5
7519022|NCT02497469|11856141|FG000|Overall Study|Lost to Follow-up|14
7519023|NCT02497469|11856142|FG001|Overall Study|Lost to Follow-up|4
7519024|NCT02497469|11856141|FG000|Overall Study|Voluntary Withdrawal|39
7519025|NCT02497469|11856142|FG001|Overall Study|Voluntary Withdrawal|41
7519026|NCT02497469|11856141|FG000|Overall Study|Pregnancy|1
7519027|NCT02497469|11856142|FG001|Overall Study|Pregnancy|1
7519028|NCT02497469|11856141|FG000|Overall Study|Lack of Efficacy|86
7519029|NCT02497469|11856142|FG001|Overall Study|Lack of Efficacy|40
7519030|NCT02497469|11856141|FG000|Overall Study|Reason not Specified|6
7519031|NCT02497469|11856142|FG001|Overall Study|Reason not Specified|6
7519032|NCT02497755|11856150|FG000|Overall Study|Protocol Violation|1
7519033|NCT02497755|11856151|FG001|Overall Study|Protocol Violation|0
7519034|NCT02497781|11856160|FG000|Overall Study|Withdrawal by Subject|2
7519035|NCT02497781|11856161|FG001|Overall Study|Withdrawal by Subject|0
7519036|NCT02497781|11856160|FG000|Overall Study|Lack of Efficacy|0
7519037|NCT02497781|11856161|FG001|Overall Study|Lack of Efficacy|1
7519038|NCT02497781|11856160|FG000|Overall Study|Randomised but not treated|1
7519039|NCT02497781|11856161|FG001|Overall Study|Randomised but not treated|1
7519040|NCT02497781|11856160|FG000|Overall Study|Lost to Follow-up|1
7519041|NCT02497781|11856161|FG001|Overall Study|Lost to Follow-up|1
7519042|NCT02497976|11856177|FG000|Overall Study|Withdrawal by Subject|2
7519043|NCT02497976|11856178|FG001|Overall Study|Withdrawal by Subject|0
7519044|NCT02497976|11856177|FG000|Overall Study|Moved out of area|0
7519045|NCT02497976|11856178|FG001|Overall Study|Moved out of area|1
7519046|NCT02498067|11856184|FG000|Overall Study|Lost to Follow-up|22
7519047|NCT02498067|11856184|FG000|Overall Study|Did not meet inclusion criteria|11
7519048|NCT02498236|11856198|FG000|Overall Study|Did not show for testing|1
7519049|NCT02498236|11856199|FG001|Overall Study|Did not show for testing|0
7519050|NCT02498236|11856200|FG002|Overall Study|Did not show for testing|0
7519051|NCT02498236|11856201|FG003|Overall Study|Did not show for testing|0
7519052|NCT02498236|11856202|FG004|Overall Study|Did not show for testing|0
7519053|NCT02498236|11856203|FG005|Overall Study|Did not show for testing|0
7519054|NCT02498236|11856204|FG006|Overall Study|Did not show for testing|0
7519055|NCT02498236|11856205|FG007|Overall Study|Did not show for testing|1
7519056|NCT02498236|11856198|FG000|Overall Study|Equipment failure|0
7519057|NCT02498236|11856199|FG001|Overall Study|Equipment failure|0
7519058|NCT02498236|11856200|FG002|Overall Study|Equipment failure|0
7519059|NCT02498236|11856201|FG003|Overall Study|Equipment failure|0
7519060|NCT02498236|11856202|FG004|Overall Study|Equipment failure|0
7519061|NCT02498236|11856203|FG005|Overall Study|Equipment failure|0
7519062|NCT02498236|11856204|FG006|Overall Study|Equipment failure|1
7519063|NCT02498236|11856205|FG007|Overall Study|Equipment failure|0
7519064|NCT02498236|11856198|FG000|Overall Study|Withdrawal by Subject|0
7519065|NCT02498236|11856199|FG001|Overall Study|Withdrawal by Subject|0
7519066|NCT02498236|11856200|FG002|Overall Study|Withdrawal by Subject|0
7519067|NCT02498236|11856201|FG003|Overall Study|Withdrawal by Subject|0
7519068|NCT02498236|11856202|FG004|Overall Study|Withdrawal by Subject|1
7519069|NCT02498236|11856203|FG005|Overall Study|Withdrawal by Subject|0
7519070|NCT02498236|11856204|FG006|Overall Study|Withdrawal by Subject|0
7519071|NCT02498236|11856205|FG007|Overall Study|Withdrawal by Subject|0
7519072|NCT02498418|11856229|FG000|Overall Study|Lack of Efficacy|0
7519073|NCT02498418|11856230|FG001|Overall Study|Lack of Efficacy|0
7519074|NCT02498418|11856231|FG002|Overall Study|Lack of Efficacy|1
7519075|NCT02498418|11856229|FG000|Overall Study|Withdrawal by Subject|2
7519076|NCT02498418|11856230|FG001|Overall Study|Withdrawal by Subject|0
7519077|NCT02498418|11856231|FG002|Overall Study|Withdrawal by Subject|3
7519078|NCT02498418|11856229|FG000|Overall Study|Lost to Follow-up|0
7519079|NCT02498418|11856230|FG001|Overall Study|Lost to Follow-up|1
7519080|NCT02498418|11856231|FG002|Overall Study|Lost to Follow-up|1
7519081|NCT02498418|11856229|FG000|Overall Study|Participant taken prohibited medication|0
7519082|NCT02498418|11856230|FG001|Overall Study|Participant taken prohibited medication|1
7519083|NCT02498418|11856231|FG002|Overall Study|Participant taken prohibited medication|1
7519084|NCT02498652|11856259|FG000|Overall Study|Protocol Violation|0
7519085|NCT02498652|11856260|FG001|Overall Study|Protocol Violation|1
7519086|NCT02498678|11856286|FG000|Overall Study|interference from the surgical team|0
7519087|NCT02498678|11856287|FG001|Overall Study|interference from the surgical team|2
7519088|NCT02498821|11856304|FG000|Overall Study|Screen failure|3
7519089|NCT02498821|11856305|FG001|Overall Study|Screen failure|5
7519090|NCT02499029|11856322|FG000|Overall Study|Lost to Follow-up|2
7519091|NCT02499029|11856323|FG001|Overall Study|Lost to Follow-up|2
7519092|NCT02499029|11856322|FG000|Overall Study|Physician Decision|2
7519093|NCT02499029|11856323|FG001|Overall Study|Physician Decision|1
7519094|NCT02499029|11856322|FG000|Overall Study|Death|1
7519095|NCT02499029|11856323|FG001|Overall Study|Death|0
7553168|NCT03010254|11914055|FG001|Overall Study|Withdrawal by Subject|1
7553169|NCT03010254|11914054|FG000|Overall Study|Other|2
7553170|NCT03010254|11914055|FG001|Overall Study|Other|3
7553171|NCT03010462|11914070|FG000|Overall Study|Withdrawal by Subject|3
7553172|NCT03010462|11914071|FG001|Overall Study|Withdrawal by Subject|1
7553173|NCT03010501|11914086|FG000|Study Week 1|Withdrawal by Subject|2
7553174|NCT03010501|11914087|FG001|Study Week 1|Withdrawal by Subject|1
7553175|NCT03010501|11914088|FG002|Study Week 1|Withdrawal by Subject|0
7553176|NCT03010501|11914089|FG003|Study Week 1|Withdrawal by Subject|2
7553177|NCT03010501|11914090|FG004|Study Week 1|Withdrawal by Subject|0
7553178|NCT03010501|11914091|FG005|Study Week 1|Withdrawal by Subject|0
7553179|NCT03010501|11914086|FG000|Study Week 3|Withdrawal by Subject|0
7553180|NCT03010501|11914087|FG001|Study Week 3|Withdrawal by Subject|0
7553181|NCT03010501|11914088|FG002|Study Week 3|Withdrawal by Subject|0
7553182|NCT03010501|11914089|FG003|Study Week 3|Withdrawal by Subject|1
7553183|NCT03010501|11914090|FG004|Study Week 3|Withdrawal by Subject|0
7553184|NCT03010501|11914091|FG005|Study Week 3|Withdrawal by Subject|0
7519113|NCT02499159|11856348|FG000|Randomization|Protocol Violation|1
7519114|NCT02499159|11856349|FG001|Randomization|Protocol Violation|1
7519115|NCT02499159|11856348|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7519116|NCT02499159|11856349|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
7519117|NCT02499159|11856348|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
7519118|NCT02499159|11856349|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
7519119|NCT02499159|11856348|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
7519120|NCT02499159|11856349|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
7519121|NCT02499159|11856348|FG000|30-Day Follow-Up Phone Call|Other|1
7519122|NCT02499159|11856349|FG001|30-Day Follow-Up Phone Call|Other|0
7519123|NCT02499172|11856359|FG000|Overall Study|Financial reason|0
7519124|NCT02499172|11856360|FG001|Overall Study|Financial reason|0
7519125|NCT02499172|11856361|FG002|Overall Study|Financial reason|523
7519126|NCT02499172|11856362|FG003|Overall Study|Financial reason|436
7519127|NCT02499172|11856359|FG000|Overall Study|Lost to Follow-up|65
7519128|NCT02499172|11856360|FG001|Overall Study|Lost to Follow-up|64
7519129|NCT02499172|11856361|FG002|Overall Study|Lost to Follow-up|0
7519130|NCT02499172|11856362|FG003|Overall Study|Lost to Follow-up|0
7519131|NCT02499263|11856372|FG000|Overall Study|Lost to Follow-up|9
7519132|NCT02499263|11856372|FG000|Overall Study|Participant's withdrawal of consent|4
7519133|NCT02499263|11856372|FG000|Overall Study|Lack of Efficacy|22
7519134|NCT02499263|11856372|FG000|Overall Study|investigator's judgment|12
7519135|NCT02499263|11856372|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
7519136|NCT02499263|11856372|FG000|Overall Study|Participant's decision|3
7519137|NCT02499263|11856372|FG000|Overall Study|Pregnancy|1
7519138|NCT02499406|11856380|FG000|Overall Study|missed 3 treatment sessions|4
7519139|NCT02499575|11856403|FG000|Overall Study|Protocol Violation|0
7519140|NCT02499575|11856404|FG001|Overall Study|Protocol Violation|1
7519141|NCT02499770|11856416|FG000|Overall Study|Death|17
7519142|NCT02499770|11856417|FG001|Overall Study|Death|56
7519143|NCT02499770|11856416|FG000|Overall Study|Study completion|1
7519144|NCT02499770|11856417|FG001|Overall Study|Study completion|10
7519145|NCT02499770|11856416|FG000|Overall Study|Withdrawal by Subject|0
7519146|NCT02499770|11856417|FG001|Overall Study|Withdrawal by Subject|7
7519147|NCT02499770|11856416|FG000|Overall Study|Lost to Follow-up|0
7519148|NCT02499770|11856417|FG001|Overall Study|Lost to Follow-up|2
7519149|NCT02499770|11856416|FG000|Overall Study|Subject declined further treatment|1
7519150|NCT02499770|11856417|FG001|Overall Study|Subject declined further treatment|0
7519151|NCT02499770|11856416|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
7519152|NCT02499770|11856417|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
7519153|NCT02499770|11856416|FG000|Overall Study|Randomized but not enrolled|0
7519154|NCT02499770|11856417|FG001|Overall Study|Randomized but not enrolled|1
7519155|NCT02499783|11856431|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
7519156|NCT02499783|11856432|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
7519157|NCT02499783|11856433|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
7519158|NCT02499783|11856431|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
7519159|NCT02499783|11856432|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7519160|NCT02499783|11856433|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
7519161|NCT02499783|11856431|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7519162|NCT02499783|11856432|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
7519163|NCT02499783|11856433|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
7519164|NCT02499783|11856431|FG000|DB Period: Weeks 0-8|Adverse Event|8
7519165|NCT02499783|11856432|FG001|DB Period: Weeks 0-8|Adverse Event|6
7519166|NCT02499783|11856433|FG002|DB Period: Weeks 0-8|Adverse Event|0
7519167|NCT02499783|11856431|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
7519168|NCT02499783|11856432|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
7519169|NCT02499783|11856433|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
7519170|NCT02499783|11856431|FG000|DB Period: Weeks 0-8|Other|1
7519171|NCT02499783|11856432|FG001|DB Period: Weeks 0-8|Other|1
7519172|NCT02499783|11856433|FG002|DB Period: Weeks 0-8|Other|0
7519173|NCT02499783|11856431|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
7519174|NCT02499783|11856432|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
7519175|NCT02499783|11856433|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
7519176|NCT02499783|11856431|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7519177|NCT02499783|11856432|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
7519178|NCT02499783|11856433|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
7519179|NCT02499783|11856431|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7519180|NCT02499783|11856432|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
7519181|NCT02499783|11856433|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
7519182|NCT02499783|11856431|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7519183|NCT02499783|11856432|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
7519184|NCT02499783|11856433|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
7519187|NCT02500043|11856449|FG000|Overall Study|Randomized, but not Treated|2
7519188|NCT02500043|11856450|FG001|Overall Study|Randomized, but not Treated|2
7519189|NCT02500043|11856449|FG000|Overall Study|Ongoing at Date of Cut-Off|19
7519190|NCT02500043|11856450|FG001|Overall Study|Ongoing at Date of Cut-Off|3
7519191|NCT02500043|11856449|FG000|Overall Study|Adverse Event|33
7519192|NCT02500043|11856450|FG001|Overall Study|Adverse Event|11
7519193|NCT02500043|11856449|FG000|Overall Study|Clinical Progression|54
7519194|NCT02500043|11856450|FG001|Overall Study|Clinical Progression|35
7519195|NCT02500043|11856449|FG000|Overall Study|Radiological Progression|192
7519196|NCT02500043|11856450|FG001|Overall Study|Radiological Progression|110
7519197|NCT02500043|11856449|FG000|Overall Study|Physician's Decision|11
7519198|NCT02500043|11856450|FG001|Overall Study|Physician's Decision|3
7519199|NCT02500043|11856449|FG000|Overall Study|Withdrawal by Subject|14
7519200|NCT02500043|11856450|FG001|Overall Study|Withdrawal by Subject|4
7519201|NCT02500043|11856449|FG000|Overall Study|Death|11
7519202|NCT02500043|11856450|FG001|Overall Study|Death|2
7519203|NCT02500043|11856449|FG000|Overall Study|Protocol Deviation|1
7519204|NCT02500043|11856450|FG001|Overall Study|Protocol Deviation|0
7519205|NCT02500056|11856458|FG000|Overall Study|Lost to Follow-up|3
7519206|NCT02500056|11856459|FG001|Overall Study|Lost to Follow-up|7
7519207|NCT02500056|11856458|FG000|Overall Study|Recurrence|1
7519208|NCT02500056|11856459|FG001|Overall Study|Recurrence|0
7519209|NCT02500056|11856458|FG000|Overall Study|Death|3
7519210|NCT02500056|11856459|FG001|Overall Study|Death|1
7536704|NCT02722928|11884740|FG000|Overall Study|Required Intraoperative MRI|5
7536705|NCT02722928|11884741|FG001|Overall Study|Required Intraoperative MRI|7
7536706|NCT02722967|11884754|FG000|Overall Study|Adverse Event|1
7536707|NCT02722967|11884755|FG001|Overall Study|Adverse Event|0
7536708|NCT02722967|11884756|FG002|Overall Study|Adverse Event|0
7536709|NCT02722967|11884754|FG000|Overall Study|Lost to Follow-up|0
7536710|NCT02722967|11884755|FG001|Overall Study|Lost to Follow-up|1
7536711|NCT02722967|11884756|FG002|Overall Study|Lost to Follow-up|0
7536712|NCT02722967|11884754|FG000|Overall Study|Non-compliance with patch wearing|2
7536713|NCT02722967|11884755|FG001|Overall Study|Non-compliance with patch wearing|1
7536714|NCT02722967|11884756|FG002|Overall Study|Non-compliance with patch wearing|1
7536715|NCT02722967|11884754|FG000|Overall Study|Withdrawal by Subject|1
7536716|NCT02722967|11884755|FG001|Overall Study|Withdrawal by Subject|0
7536717|NCT02722967|11884756|FG002|Overall Study|Withdrawal by Subject|1
7536718|NCT02722967|11884754|FG000|Overall Study|Physician Decision|1
7536719|NCT02722967|11884755|FG001|Overall Study|Physician Decision|0
7536720|NCT02722967|11884756|FG002|Overall Study|Physician Decision|0
7536721|NCT02722967|11884754|FG000|Overall Study|Non-adherence of the patch to the skin|0
7536722|NCT02722967|11884755|FG001|Overall Study|Non-adherence of the patch to the skin|0
7536723|NCT02722967|11884756|FG002|Overall Study|Non-adherence of the patch to the skin|2
7536724|NCT02723006|11884767|FG000|Overall Study|Withdrawal by Subject|0
7536725|NCT02723006|11884768|FG001|Overall Study|Withdrawal by Subject|1
7536726|NCT02723006|11884769|FG002|Overall Study|Withdrawal by Subject|1
7536727|NCT02723006|11884767|FG000|Overall Study|Study Terminated by Sponsor|1
7536728|NCT02723006|11884768|FG001|Overall Study|Study Terminated by Sponsor|6
7536729|NCT02723006|11884769|FG002|Overall Study|Study Terminated by Sponsor|6
7536730|NCT02723084|11884779|FG000|Overall Study|Withdrawal by Subject|1
7536731|NCT02723084|11884780|FG001|Overall Study|Withdrawal by Subject|1
7536732|NCT02723084|11884779|FG000|Overall Study|Lost to Follow-up|3
7536733|NCT02723084|11884780|FG001|Overall Study|Lost to Follow-up|0
7536734|NCT02723175|11884788|FG000|Overall Study|Lost to 1 Month Follow Up|3
7536735|NCT02723175|11884789|FG001|Overall Study|Lost to 1 Month Follow Up|2
7536736|NCT02723175|11884788|FG000|Overall Study|Lost to 3 Month Follow Up|1
7536737|NCT02723175|11884789|FG001|Overall Study|Lost to 3 Month Follow Up|1
7536738|NCT02723188|11884798|FG000|Overall Study|Withdrawal by Subject|1
7536739|NCT02723188|11884799|FG001|Overall Study|Withdrawal by Subject|0
7536740|NCT02723188|11884800|FG002|Overall Study|Withdrawal by Subject|0
7536741|NCT02723201|11884811|FG000|Second Intervention Period|Protocol Violation|1
7536742|NCT02723201|11884812|FG001|Second Intervention Period|Protocol Violation|0
7536743|NCT02723201|11884813|FG002|Second Intervention Period|Protocol Violation|0
7536744|NCT02723201|11884811|FG000|Second Intervention Period|Adverse Event|1
7536745|NCT02723201|11884812|FG001|Second Intervention Period|Adverse Event|0
7536746|NCT02723201|11884813|FG002|Second Intervention Period|Adverse Event|0
7536747|NCT02723344|11884829|FG000|Overall Study|Lost to Follow-up|0
7536748|NCT02723344|11884830|FG001|Overall Study|Lost to Follow-up|4
7536749|NCT02723591|11884838|FG000|Overall Study|Adverse Event|48
7536750|NCT02723591|11884839|FG001|Overall Study|Adverse Event|40
7536751|NCT02723591|11884838|FG000|Overall Study|Death|2
7536752|NCT02723591|11884839|FG001|Overall Study|Death|2
7536753|NCT02723591|11884838|FG000|Overall Study|Lack of Efficacy|4
7536754|NCT02723591|11884839|FG001|Overall Study|Lack of Efficacy|3
7536755|NCT02723591|11884838|FG000|Overall Study|Lost to Follow-up|1
7536756|NCT02723591|11884839|FG001|Overall Study|Lost to Follow-up|7
7536757|NCT02723591|11884838|FG000|Overall Study|Protocol Violation|20
7536758|NCT02723591|11884839|FG001|Overall Study|Protocol Violation|23
7536759|NCT02723591|11884838|FG000|Overall Study|Withdrawal by Subject|4
7536760|NCT02723591|11884839|FG001|Overall Study|Withdrawal by Subject|8
7536761|NCT02723591|11884838|FG000|Overall Study|Randomized but Never Received StudyDrug|12
7536762|NCT02723591|11884839|FG001|Overall Study|Randomized but Never Received StudyDrug|12
7536763|NCT02723591|11884838|FG000|Overall Study|Miscellaneous|5
7536764|NCT02723591|11884839|FG001|Overall Study|Miscellaneous|6
7536765|NCT02723630|11884851|FG000|Intervention Period 1|Adverse Event|1
7519211|NCT02500537|11856474|FG000|Overall Study|Death|2
7519212|NCT02500537|11856475|FG001|Overall Study|Death|0
7519213|NCT02500537|11856474|FG000|Overall Study|Lost to Follow-up|0
7519214|NCT02500537|11856475|FG001|Overall Study|Lost to Follow-up|1
7519215|NCT02500537|11856474|FG000|Overall Study|Withdrawal by Subject|1
7519216|NCT02500537|11856475|FG001|Overall Study|Withdrawal by Subject|0
7519217|NCT02500550|11856482|FG000|Overall Study|Death|7
7519218|NCT02500641|11856510|FG000|Overall Study|Adverse Event|0
7519219|NCT02500641|11856511|FG001|Overall Study|Adverse Event|2
7519220|NCT02500641|11856510|FG000|Overall Study|Withdrawal by Subject|4
7519221|NCT02500641|11856511|FG001|Overall Study|Withdrawal by Subject|5
7519222|NCT02500641|11856510|FG000|Overall Study|Unable to follow study procedures|3
7519223|NCT02500641|11856511|FG001|Overall Study|Unable to follow study procedures|2
7519224|NCT02500641|11856510|FG000|Overall Study|Protocol Violation|1
7519225|NCT02500641|11856511|FG001|Overall Study|Protocol Violation|2
7519226|NCT02500641|11856510|FG000|Overall Study|Lost to Follow-up|1
7519227|NCT02500641|11856511|FG001|Overall Study|Lost to Follow-up|0
7519228|NCT02500641|11856510|FG000|Overall Study|Sponsor decision|1
7519229|NCT02500641|11856511|FG001|Overall Study|Sponsor decision|0
7519230|NCT02500641|11856510|FG000|Overall Study|Non compliance to study drug|0
7519231|NCT02500641|11856511|FG001|Overall Study|Non compliance to study drug|1
7519232|NCT02500706|11856520|FG000|Overall Study|Adverse Event|0
7519233|NCT02500706|11856521|FG001|Overall Study|Adverse Event|0
7519234|NCT02500706|11856522|FG002|Overall Study|Adverse Event|1
7519235|NCT02500706|11856520|FG000|Overall Study|Lost to Follow-up|0
7519236|NCT02500706|11856521|FG001|Overall Study|Lost to Follow-up|1
7519237|NCT02500706|11856522|FG002|Overall Study|Lost to Follow-up|1
7519238|NCT02500706|11856520|FG000|Overall Study|Withdrawal by Subject|4
7519239|NCT02500706|11856521|FG001|Overall Study|Withdrawal by Subject|6
7519240|NCT02500706|11856522|FG002|Overall Study|Withdrawal by Subject|4
7519241|NCT02500706|11856520|FG000|Overall Study|Unclassified|0
7519242|NCT02500706|11856521|FG001|Overall Study|Unclassified|0
7519243|NCT02500706|11856522|FG002|Overall Study|Unclassified|1
7519244|NCT02500719|11856532|FG000|Overall Study|Lost to Follow-up|2
7519245|NCT02500719|11856533|FG001|Overall Study|Lost to Follow-up|3
7519246|NCT02500719|11856532|FG000|Overall Study|Trauma history|1
7519247|NCT02500719|11856533|FG001|Overall Study|Trauma history|0
7519248|NCT02500719|11856532|FG000|Overall Study|MRI data found to be unusable during analysis|0
7519249|NCT02500719|11856533|FG001|Overall Study|MRI data found to be unusable during analysis|1
7519250|NCT02500719|11856532|FG000|Overall Study|Did not meet criteria for PTSD|0
7519251|NCT02500719|11856533|FG001|Overall Study|Did not meet criteria for PTSD|1
7519252|NCT02500719|11856532|FG000|Overall Study|Claustrophobia|0
7519253|NCT02500719|11856533|FG001|Overall Study|Claustrophobia|1
7519254|NCT02500719|11856532|FG000|Overall Study|History of head trauma|0
7519255|NCT02500719|11856533|FG001|Overall Study|History of head trauma|1
7519256|NCT02500732|11856541|FG000|Overall Study|Physician Decision|0
7519257|NCT02500732|11856542|FG001|Overall Study|Physician Decision|1
7519258|NCT02500758|11856550|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
7519259|NCT02500758|11856551|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
7519260|NCT02500758|11856550|FG000|Washout (1 Week)|Lost to Follow-up|2
7519261|NCT02500758|11856551|FG001|Washout (1 Week)|Lost to Follow-up|2
7519262|NCT02500758|11856550|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
7519263|NCT02500758|11856551|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
7519264|NCT02500758|11856550|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
7519265|NCT02500758|11856551|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
7519266|NCT02500758|11856550|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
7519267|NCT02500758|11856551|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
7519268|NCT02500979|11856573|FG000|Period 1|Hyperglycemia|1
7519269|NCT02500979|11856574|FG001|Period 1|Hyperglycemia|0
7519270|NCT02500979|11856573|FG000|Period 1|Severe non-compliance to protocol|0
7519271|NCT02500979|11856574|FG001|Period 1|Severe non-compliance to protocol|1
7519272|NCT02500979|11856573|FG000|Period 1|Adverse Event|1
7519273|NCT02500979|11856574|FG001|Period 1|Adverse Event|0
7519274|NCT02500979|11856573|FG000|Period 1|Subject decision|2
7519275|NCT02500979|11856574|FG001|Period 1|Subject decision|0
7519276|NCT02500979|11856573|FG000|Period 2|Change in risk|1
7519277|NCT02500979|11856574|FG001|Period 2|Change in risk|0
7519278|NCT02501161|11856592|FG000|Overall Study|Adverse Event|2
7519279|NCT02501161|11856593|FG001|Overall Study|Adverse Event|6
7519280|NCT02501161|11856592|FG000|Overall Study|Lost to Follow-up|7
7519281|NCT02501161|11856593|FG001|Overall Study|Lost to Follow-up|4
7519282|NCT02501161|11856592|FG000|Overall Study|Withdrawal by Subject|10
7519283|NCT02501161|11856593|FG001|Overall Study|Withdrawal by Subject|15
7519284|NCT02501161|11856592|FG000|Overall Study|Other|3
7519285|NCT02501161|11856593|FG001|Overall Study|Other|0
7519286|NCT02501473|11856623|FG000|Overall Study|Study Terminated|2
7519287|NCT02501473|11856624|FG001|Overall Study|Study Terminated|3
7519288|NCT02501473|11856625|FG002|Overall Study|Study Terminated|7
7519289|NCT02501473|11856626|FG003|Overall Study|Study Terminated|9
7519290|NCT02501473|11856627|FG004|Overall Study|Study Terminated|2
7519291|NCT02501473|11856628|FG005|Overall Study|Study Terminated|10
7519292|NCT02501473|11856629|FG006|Overall Study|Study Terminated|1
7519293|NCT02501473|11856630|FG007|Overall Study|Study Terminated|0
7519294|NCT02501473|11856623|FG000|Overall Study|Withdrawal by Subject|0
7519295|NCT02501473|11856624|FG001|Overall Study|Withdrawal by Subject|0
7519296|NCT02501473|11856625|FG002|Overall Study|Withdrawal by Subject|3
7519297|NCT02501473|11856626|FG003|Overall Study|Withdrawal by Subject|3
7519298|NCT02501473|11856627|FG004|Overall Study|Withdrawal by Subject|2
7519299|NCT02501473|11856628|FG005|Overall Study|Withdrawal by Subject|2
7519300|NCT02501473|11856629|FG006|Overall Study|Withdrawal by Subject|0
7519301|NCT02501473|11856630|FG007|Overall Study|Withdrawal by Subject|0
7519302|NCT02501473|11856623|FG000|Overall Study|Death|0
7519303|NCT02501473|11856624|FG001|Overall Study|Death|0
7519304|NCT02501473|11856625|FG002|Overall Study|Death|1
7519305|NCT02501473|11856626|FG003|Overall Study|Death|1
7519306|NCT02501473|11856627|FG004|Overall Study|Death|0
7519307|NCT02501473|11856628|FG005|Overall Study|Death|1
7519308|NCT02501473|11856629|FG006|Overall Study|Death|0
7519309|NCT02501473|11856630|FG007|Overall Study|Death|0
7519310|NCT02501473|11856623|FG000|Overall Study|Lost to Follow-up|1
7519311|NCT02501473|11856624|FG001|Overall Study|Lost to Follow-up|0
7519312|NCT02501473|11856625|FG002|Overall Study|Lost to Follow-up|1
7519313|NCT02501473|11856626|FG003|Overall Study|Lost to Follow-up|0
7519314|NCT02501473|11856627|FG004|Overall Study|Lost to Follow-up|0
7519315|NCT02501473|11856628|FG005|Overall Study|Lost to Follow-up|1
7519316|NCT02501473|11856629|FG006|Overall Study|Lost to Follow-up|0
7519317|NCT02501473|11856630|FG007|Overall Study|Lost to Follow-up|0
7519318|NCT02501473|11856623|FG000|Overall Study|Reason not specified|0
7519319|NCT02501473|11856624|FG001|Overall Study|Reason not specified|0
7519320|NCT02501473|11856625|FG002|Overall Study|Reason not specified|1
7519321|NCT02501473|11856626|FG003|Overall Study|Reason not specified|1
7519322|NCT02501473|11856627|FG004|Overall Study|Reason not specified|0
7519323|NCT02501473|11856628|FG005|Overall Study|Reason not specified|0
7519324|NCT02501473|11856629|FG006|Overall Study|Reason not specified|0
7519325|NCT02501473|11856630|FG007|Overall Study|Reason not specified|0
7519326|NCT02501629|11856664|FG000|Overall Study|Death|0
7519327|NCT02501629|11856665|FG001|Overall Study|Death|1
7519328|NCT02501629|11856664|FG000|Overall Study|Withdrawn from study by sponsor|1
7519329|NCT02501629|11856665|FG001|Overall Study|Withdrawn from study by sponsor|0
7519330|NCT02501629|11856664|FG000|Overall Study|Early termination by sponsor|1
7519331|NCT02501629|11856665|FG001|Overall Study|Early termination by sponsor|0
7519332|NCT02501629|11856664|FG000|Overall Study|Withdrawal by Subject|3
7519333|NCT02501629|11856665|FG001|Overall Study|Withdrawal by Subject|5
7519334|NCT02501629|11856664|FG000|Overall Study|Subject did not return to site|0
7519335|NCT02501629|11856665|FG001|Overall Study|Subject did not return to site|1
7519336|NCT02501642|11856673|FG000|Overall Study|Lost to Follow-up|7
7519337|NCT02501642|11856674|FG001|Overall Study|Lost to Follow-up|11
7519338|NCT02501811|11856684|FG000|Overall Study|Death|1
7519339|NCT02501811|11856685|FG001|Overall Study|Death|3
7519340|NCT02501811|11856686|FG002|Overall Study|Death|2
7519341|NCT02501811|11856687|FG003|Overall Study|Death|3
7519342|NCT02501811|11856684|FG000|Overall Study|Withdrawal by Subject|3
7519343|NCT02501811|11856685|FG001|Overall Study|Withdrawal by Subject|3
7519344|NCT02501811|11856686|FG002|Overall Study|Withdrawal by Subject|2
7519345|NCT02501811|11856687|FG003|Overall Study|Withdrawal by Subject|3
7519346|NCT02501811|11856684|FG000|Overall Study|Lost to Follow-up|0
7519347|NCT02501811|11856685|FG001|Overall Study|Lost to Follow-up|0
7519348|NCT02501811|11856686|FG002|Overall Study|Lost to Follow-up|2
7519349|NCT02501811|11856687|FG003|Overall Study|Lost to Follow-up|1
7519350|NCT02501902|11856705|FG000|Overall Study|Subject Refused Further Follow-up|0
7519351|NCT02501902|11856706|FG001|Overall Study|Subject Refused Further Follow-up|0
7519352|NCT02501902|11856707|FG002|Overall Study|Subject Refused Further Follow-up|0
7519353|NCT02501902|11856708|FG003|Overall Study|Subject Refused Further Follow-up|0
7519354|NCT02501902|11856709|FG004|Overall Study|Subject Refused Further Follow-up|0
7519355|NCT02501902|11856710|FG005|Overall Study|Subject Refused Further Follow-up|0
7519356|NCT02501902|11856711|FG006|Overall Study|Subject Refused Further Follow-up|0
7519357|NCT02501902|11856712|FG007|Overall Study|Subject Refused Further Follow-up|1
7519358|NCT02501902|11856705|FG000|Overall Study|Study Terminated by Sponsor|0
7519359|NCT02501902|11856706|FG001|Overall Study|Study Terminated by Sponsor|3
7519360|NCT02501902|11856707|FG002|Overall Study|Study Terminated by Sponsor|0
7519361|NCT02501902|11856708|FG003|Overall Study|Study Terminated by Sponsor|1
7519362|NCT02501902|11856709|FG004|Overall Study|Study Terminated by Sponsor|1
7519363|NCT02501902|11856710|FG005|Overall Study|Study Terminated by Sponsor|0
7519364|NCT02501902|11856711|FG006|Overall Study|Study Terminated by Sponsor|2
7519365|NCT02501902|11856712|FG007|Overall Study|Study Terminated by Sponsor|4
7519366|NCT02501902|11856705|FG000|Overall Study|Death|3
7519367|NCT02501902|11856706|FG001|Overall Study|Death|4
7519368|NCT02501902|11856707|FG002|Overall Study|Death|4
7519369|NCT02501902|11856708|FG003|Overall Study|Death|10
7519370|NCT02501902|11856709|FG004|Overall Study|Death|10
7519371|NCT02501902|11856710|FG005|Overall Study|Death|11
7519372|NCT02501902|11856711|FG006|Overall Study|Death|7
7519373|NCT02501902|11856712|FG007|Overall Study|Death|15
7519374|NCT02501928|11856738|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7519375|NCT02501928|11856739|FG001|Overall Study|Withdrawal By Parent/Guardian|0
7519376|NCT02501928|11856740|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7519377|NCT02501928|11856741|FG003|Overall Study|Withdrawal By Parent/Guardian|0
7519378|NCT02501928|11856742|FG004|Overall Study|Withdrawal By Parent/Guardian|1
7519379|NCT02501928|11856743|FG005|Overall Study|Withdrawal By Parent/Guardian|0
7519380|NCT02502097|11856768|FG000|Period 1|Adverse Event|0
7519381|NCT02502097|11856769|FG001|Period 1|Adverse Event|0
7519382|NCT02502097|11856770|FG002|Period 1|Adverse Event|1
7519383|NCT02502097|11856771|FG003|Period 1|Adverse Event|0
7519384|NCT02502097|11856768|FG000|Wash Out Period|Adverse Event|0
7519385|NCT02502097|11856769|FG001|Wash Out Period|Adverse Event|1
7519386|NCT02502097|11856770|FG002|Wash Out Period|Adverse Event|1
7519387|NCT02502097|11856771|FG003|Wash Out Period|Adverse Event|1
7519388|NCT02502097|11856768|FG000|Period 2|Adverse Event|0
7519389|NCT02502097|11856769|FG001|Period 2|Adverse Event|0
7519390|NCT02502097|11856770|FG002|Period 2|Adverse Event|1
7519391|NCT02502097|11856771|FG003|Period 2|Adverse Event|0
7519392|NCT02502149|11856778|FG000|Intermediate|Discontinued prematurely|1
7519393|NCT02502149|11856779|FG001|Intermediate|Discontinued prematurely|0
7519394|NCT02502149|11856780|FG002|Intermediate|Discontinued prematurely|0
7519395|NCT02502149|11856781|FG003|Intermediate|Discontinued prematurely|0
7519396|NCT02502149|11856782|FG004|Intermediate|Discontinued prematurely|0
7519397|NCT02502526|11856824|FG000|Overall Study|Lost to Follow-up|2
7519398|NCT02502526|11856825|FG001|Overall Study|Lost to Follow-up|2
7519399|NCT02502526|11856826|FG002|Overall Study|Lost to Follow-up|3
7519400|NCT02502526|11856824|FG000|Overall Study|Withdrawal by Subject|0
7519401|NCT02502526|11856825|FG001|Overall Study|Withdrawal by Subject|1
7519402|NCT02502526|11856826|FG002|Overall Study|Withdrawal by Subject|1
7519403|NCT02502526|11856824|FG000|Overall Study|Disqualified due to cataract grading|0
7519404|NCT02502526|11856825|FG001|Overall Study|Disqualified due to cataract grading|0
7519405|NCT02502526|11856826|FG002|Overall Study|Disqualified due to cataract grading|1
7519406|NCT02502526|11856824|FG000|Overall Study|Enrollment suspension|4
7519407|NCT02502526|11856825|FG001|Overall Study|Enrollment suspension|1
7519408|NCT02502526|11856826|FG002|Overall Study|Enrollment suspension|1
7519409|NCT02502734|11856835|FG000|Double-blind Treatment Period 1|Adverse Event|1
7519410|NCT02502734|11856836|FG001|Double-blind Treatment Period 1|Adverse Event|0
7519411|NCT02502734|11856835|FG000|Washout Period|Adverse Event|1
7519412|NCT02502734|11856836|FG001|Washout Period|Adverse Event|0
7519413|NCT02502864|11856844|FG000|Overall Study|Withdrawal by Subject|1
7519414|NCT02503085|11856848|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7519415|NCT02503085|11856849|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7519416|NCT02503085|11856850|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
7519417|NCT02503085|11856851|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
7519418|NCT02503202|11856863|FG000|Base Study: Up to Month 6|Death|1
7519419|NCT02503202|11856864|FG001|Base Study: Up to Month 6|Death|1
7519420|NCT02503202|11856865|FG002|Base Study: Up to Month 6|Death|0
7519421|NCT02503202|11856866|FG003|Base Study: Up to Month 6|Death|0
7519422|NCT02503202|11856867|FG004|Base Study: Up to Month 6|Death|0
7519423|NCT02503202|11856863|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
7519424|NCT02503202|11856864|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
7519425|NCT02503202|11856865|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
7519426|NCT02503202|11856866|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
7519427|NCT02503202|11856867|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
7519428|NCT02503202|11856863|FG000|Base Study: Up to Month 6|Physician Decision|0
7519429|NCT02503202|11856864|FG001|Base Study: Up to Month 6|Physician Decision|0
7519430|NCT02503202|11856865|FG002|Base Study: Up to Month 6|Physician Decision|0
7519431|NCT02503202|11856866|FG003|Base Study: Up to Month 6|Physician Decision|0
7519432|NCT02503202|11856867|FG004|Base Study: Up to Month 6|Physician Decision|1
7519433|NCT02503202|11856863|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
7519434|NCT02503202|11856864|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
7519435|NCT02503202|11856865|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
7519436|NCT02503202|11856866|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
7519437|NCT02503202|11856867|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
7519438|NCT02503202|11856863|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
7519439|NCT02503202|11856864|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
7519440|NCT02503202|11856865|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
7519441|NCT02503202|11856866|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
7519442|NCT02503202|11856867|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
7519443|NCT02503202|11856863|FG000|Extension: Month 6 to 24|Protocol Violation|0
7519444|NCT02503202|11856864|FG001|Extension: Month 6 to 24|Protocol Violation|0
7519445|NCT02503202|11856865|FG002|Extension: Month 6 to 24|Protocol Violation|0
7519446|NCT02503202|11856866|FG003|Extension: Month 6 to 24|Protocol Violation|1
7519447|NCT02503202|11856867|FG004|Extension: Month 6 to 24|Protocol Violation|0
7519448|NCT02503202|11856863|FG000|Extension: Month 6 to 24|Death|1
7519449|NCT02503202|11856864|FG001|Extension: Month 6 to 24|Death|0
7519450|NCT02503202|11856865|FG002|Extension: Month 6 to 24|Death|0
7519451|NCT02503202|11856866|FG003|Extension: Month 6 to 24|Death|0
7519452|NCT02503202|11856867|FG004|Extension: Month 6 to 24|Death|0
7519453|NCT02503202|11856863|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
7519454|NCT02503202|11856864|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
7519455|NCT02503202|11856865|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
7519456|NCT02503202|11856866|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
7519457|NCT02503202|11856867|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
7519458|NCT02503202|11856863|FG000|Extension: Month 6 to 24|Physician Decision|1
7519459|NCT02503202|11856864|FG001|Extension: Month 6 to 24|Physician Decision|0
7519460|NCT02503202|11856865|FG002|Extension: Month 6 to 24|Physician Decision|1
7519461|NCT02503202|11856866|FG003|Extension: Month 6 to 24|Physician Decision|3
7519462|NCT02503202|11856867|FG004|Extension: Month 6 to 24|Physician Decision|0
7519463|NCT02503202|11856863|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
7519464|NCT02503202|11856864|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
7519465|NCT02503202|11856865|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
7519466|NCT02503202|11856866|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
7519467|NCT02503202|11856867|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
7519468|NCT02503215|11856879|FG000|Overall Study|Unable to wear compression stockings|1
7519469|NCT02503215|11856879|FG000|Overall Study|Unable to use positive airway pressure|2
7519470|NCT02503332|11856896|FG000|Overall Study|Adverse Event|17
7519471|NCT02503332|11856897|FG001|Overall Study|Adverse Event|5
7519472|NCT02503332|11856898|FG002|Overall Study|Adverse Event|3
7519473|NCT02503332|11856899|FG003|Overall Study|Adverse Event|1
7519474|NCT02503332|11856896|FG000|Overall Study|Investigator's Decision|5
7519475|NCT02503332|11856897|FG001|Overall Study|Investigator's Decision|1
7519476|NCT02503332|11856898|FG002|Overall Study|Investigator's Decision|0
7519477|NCT02503332|11856899|FG003|Overall Study|Investigator's Decision|0
7519478|NCT02503332|11856896|FG000|Overall Study|Sponsor's Decision|1
7519479|NCT02503332|11856897|FG001|Overall Study|Sponsor's Decision|0
7519480|NCT02503332|11856898|FG002|Overall Study|Sponsor's Decision|0
7519481|NCT02503332|11856899|FG003|Overall Study|Sponsor's Decision|1
7519482|NCT02503332|11856896|FG000|Overall Study|Subject Request|6
7519483|NCT02503332|11856897|FG001|Overall Study|Subject Request|5
7519484|NCT02503332|11856898|FG002|Overall Study|Subject Request|2
7519485|NCT02503332|11856899|FG003|Overall Study|Subject Request|1
7519486|NCT02503332|11856896|FG000|Overall Study|Death|0
7519487|NCT02503332|11856897|FG001|Overall Study|Death|2
7519488|NCT02503332|11856898|FG002|Overall Study|Death|2
7519489|NCT02503332|11856899|FG003|Overall Study|Death|0
7519490|NCT02503332|11856896|FG000|Overall Study|Other|5
7519491|NCT02503332|11856897|FG001|Overall Study|Other|6
7519492|NCT02503332|11856898|FG002|Overall Study|Other|1
7519493|NCT02503332|11856899|FG003|Overall Study|Other|1
7519494|NCT02503501|11856929|FG000|Overall Study|Physician Decision|1
7519495|NCT02503501|11856930|FG001|Overall Study|Physician Decision|0
7519496|NCT02503501|11856929|FG000|Overall Study|Protocol Violation|0
7519497|NCT02503501|11856930|FG001|Overall Study|Protocol Violation|1
7519498|NCT02503501|11856929|FG000|Overall Study|Withdrawal by Subject|0
7519499|NCT02503501|11856930|FG001|Overall Study|Withdrawal by Subject|2
7519500|NCT02503540|11856936|FG000|Overall Study|Death|2
7519501|NCT02503540|11856936|FG000|Overall Study|Withdrawal by Subject|1
7519502|NCT02503787|11856950|FG000|Enrollment|Withdrawal by Subject|6
7519503|NCT02503787|11856950|FG000|Enrollment|Inclusion/exclusion criteria not met|4
7519504|NCT02503787|11856950|FG000|Enrollment|Physician Decision|2
7519505|NCT02503787|11856950|FG000|Enrollment|Insurance issue|2
7519506|NCT02503787|11856950|FG000|Enrollment|Lost to Follow-up|1
7519507|NCT02503787|11856950|FG000|Enrollment|Study closure|1
7519508|NCT02503787|11856950|FG000|Enrollment|Adverse Event|1
7519509|NCT02503787|11856950|FG000|Enrollment|Protocol Violation|1
7519510|NCT02503787|11856950|FG000|Enrollment|Inability to implant system|1
7519511|NCT02503787|11856950|FG000|Enrollment|Unable to be programmed|1
7519512|NCT02503787|11856950|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
7519513|NCT02503787|11856950|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
7519514|NCT02503787|11856950|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
7519515|NCT02503787|11856950|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
7519516|NCT02503787|11856950|FG000|Implant to 3 Month Endpoint|Adverse Event|2
7519517|NCT02503787|11856950|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
7519518|NCT02503865|11856974|FG000|Overall Study|Moved out of area|1
7519519|NCT02503865|11856975|FG001|Overall Study|Moved out of area|8
7519520|NCT02503865|11856976|FG002|Overall Study|Moved out of area|0
7519521|NCT02503865|11856974|FG000|Overall Study|Refused treatment|4
7519522|NCT02503865|11856975|FG001|Overall Study|Refused treatment|39
7519523|NCT02503865|11856976|FG002|Overall Study|Refused treatment|2
7519524|NCT02504216|11856996|FG000|Overall Study|Lost to Follow-up|3
7519525|NCT02504216|11856997|FG001|Overall Study|Lost to Follow-up|3
7519526|NCT02504216|11856996|FG000|Overall Study|Withdrawal by Subject|8
7519527|NCT02504216|11856997|FG001|Overall Study|Withdrawal by Subject|12
7519528|NCT02504268|11857006|FG000|Overall Study|Adverse Event|18
7519529|NCT02504268|11857007|FG001|Overall Study|Adverse Event|8
7519530|NCT02504268|11857008|FG002|Overall Study|Adverse Event|14
7519531|NCT02504268|11857009|FG003|Overall Study|Adverse Event|0
7519532|NCT02504268|11857010|FG004|Overall Study|Adverse Event|0
7519533|NCT02504268|11857011|FG005|Overall Study|Adverse Event|0
7519534|NCT02504268|11857012|FG006|Overall Study|Adverse Event|0
7519535|NCT02504268|11857013|FG007|Overall Study|Adverse Event|0
7519536|NCT02504268|11857014|FG008|Overall Study|Adverse Event|0
7519537|NCT02504268|11857006|FG000|Overall Study|Withdrawal of Consent|11
7519538|NCT02504268|11857007|FG001|Overall Study|Withdrawal of Consent|10
7519539|NCT02504268|11857008|FG002|Overall Study|Withdrawal of Consent|3
7519540|NCT02504268|11857009|FG003|Overall Study|Withdrawal of Consent|0
7519541|NCT02504268|11857010|FG004|Overall Study|Withdrawal of Consent|0
7519542|NCT02504268|11857011|FG005|Overall Study|Withdrawal of Consent|0
7519543|NCT02504268|11857012|FG006|Overall Study|Withdrawal of Consent|0
7519544|NCT02504268|11857013|FG007|Overall Study|Withdrawal of Consent|0
7519545|NCT02504268|11857014|FG008|Overall Study|Withdrawal of Consent|0
7519546|NCT02504268|11857006|FG000|Overall Study|Pregnancy|2
7519547|NCT02504268|11857007|FG001|Overall Study|Pregnancy|0
7519548|NCT02504268|11857008|FG002|Overall Study|Pregnancy|0
7519549|NCT02504268|11857009|FG003|Overall Study|Pregnancy|0
7519550|NCT02504268|11857010|FG004|Overall Study|Pregnancy|0
7519551|NCT02504268|11857011|FG005|Overall Study|Pregnancy|0
7519552|NCT02504268|11857012|FG006|Overall Study|Pregnancy|0
7519553|NCT02504268|11857013|FG007|Overall Study|Pregnancy|0
7519554|NCT02504268|11857014|FG008|Overall Study|Pregnancy|0
7519555|NCT02504268|11857006|FG000|Overall Study|Lost to Follow-up|3
7519556|NCT02504268|11857007|FG001|Overall Study|Lost to Follow-up|6
7519557|NCT02504268|11857008|FG002|Overall Study|Lost to Follow-up|4
7519558|NCT02504268|11857009|FG003|Overall Study|Lost to Follow-up|0
7519559|NCT02504268|11857010|FG004|Overall Study|Lost to Follow-up|0
7519560|NCT02504268|11857011|FG005|Overall Study|Lost to Follow-up|0
7519561|NCT02504268|11857012|FG006|Overall Study|Lost to Follow-up|0
7519562|NCT02504268|11857013|FG007|Overall Study|Lost to Follow-up|0
7519563|NCT02504268|11857014|FG008|Overall Study|Lost to Follow-up|0
7519564|NCT02504268|11857006|FG000|Overall Study|Death|1
7519565|NCT02504268|11857007|FG001|Overall Study|Death|1
7519566|NCT02504268|11857008|FG002|Overall Study|Death|0
7519567|NCT02504268|11857009|FG003|Overall Study|Death|0
7519568|NCT02504268|11857010|FG004|Overall Study|Death|0
7519569|NCT02504268|11857011|FG005|Overall Study|Death|0
7519570|NCT02504268|11857012|FG006|Overall Study|Death|0
7519571|NCT02504268|11857013|FG007|Overall Study|Death|0
7519572|NCT02504268|11857014|FG008|Overall Study|Death|0
7519573|NCT02504268|11857006|FG000|Overall Study|Subject Request to Discontinue|11
7519574|NCT02504268|11857007|FG001|Overall Study|Subject Request to Discontinue|3
7519575|NCT02504268|11857008|FG002|Overall Study|Subject Request to Discontinue|6
7519576|NCT02504268|11857009|FG003|Overall Study|Subject Request to Discontinue|0
7519577|NCT02504268|11857010|FG004|Overall Study|Subject Request to Discontinue|0
7519578|NCT02504268|11857011|FG005|Overall Study|Subject Request to Discontinue|0
7519579|NCT02504268|11857012|FG006|Overall Study|Subject Request to Discontinue|0
7519580|NCT02504268|11857013|FG007|Overall Study|Subject Request to Discontinue|0
7519581|NCT02504268|11857014|FG008|Overall Study|Subject Request to Discontinue|0
7519582|NCT02504268|11857006|FG000|Overall Study|No Longer Meets Study Criteria|2
7519583|NCT02504268|11857007|FG001|Overall Study|No Longer Meets Study Criteria|3
7519584|NCT02504268|11857008|FG002|Overall Study|No Longer Meets Study Criteria|0
7519585|NCT02504268|11857009|FG003|Overall Study|No Longer Meets Study Criteria|0
7519586|NCT02504268|11857010|FG004|Overall Study|No Longer Meets Study Criteria|0
7519587|NCT02504268|11857011|FG005|Overall Study|No Longer Meets Study Criteria|0
7519588|NCT02504268|11857012|FG006|Overall Study|No Longer Meets Study Criteria|0
7519589|NCT02504268|11857013|FG007|Overall Study|No Longer Meets Study Criteria|0
7519590|NCT02504268|11857014|FG008|Overall Study|No Longer Meets Study Criteria|0
7519591|NCT02504268|11857006|FG000|Overall Study|Lack of Efficacy|11
7519592|NCT02504268|11857007|FG001|Overall Study|Lack of Efficacy|35
7519593|NCT02504268|11857008|FG002|Overall Study|Lack of Efficacy|9
7519594|NCT02504268|11857009|FG003|Overall Study|Lack of Efficacy|0
7519595|NCT02504268|11857010|FG004|Overall Study|Lack of Efficacy|0
7519596|NCT02504268|11857011|FG005|Overall Study|Lack of Efficacy|0
7519597|NCT02504268|11857012|FG006|Overall Study|Lack of Efficacy|0
7519598|NCT02504268|11857013|FG007|Overall Study|Lack of Efficacy|0
7519599|NCT02504268|11857014|FG008|Overall Study|Lack of Efficacy|0
7519600|NCT02504268|11857006|FG000|Overall Study|Poor/Non-Compliance|3
7519601|NCT02504268|11857007|FG001|Overall Study|Poor/Non-Compliance|2
7519602|NCT02504268|11857008|FG002|Overall Study|Poor/Non-Compliance|3
7519603|NCT02504268|11857009|FG003|Overall Study|Poor/Non-Compliance|0
7519604|NCT02504268|11857010|FG004|Overall Study|Poor/Non-Compliance|0
7519605|NCT02504268|11857011|FG005|Overall Study|Poor/Non-Compliance|0
7519606|NCT02504268|11857012|FG006|Overall Study|Poor/Non-Compliance|0
7519607|NCT02504268|11857013|FG007|Overall Study|Poor/Non-Compliance|0
7519608|NCT02504268|11857014|FG008|Overall Study|Poor/Non-Compliance|0
7519609|NCT02504268|11857006|FG000|Overall Study|Not Disclosed|1
7519610|NCT02504268|11857007|FG001|Overall Study|Not Disclosed|0
7519611|NCT02504268|11857008|FG002|Overall Study|Not Disclosed|2
7519612|NCT02504268|11857009|FG003|Overall Study|Not Disclosed|0
7519613|NCT02504268|11857010|FG004|Overall Study|Not Disclosed|0
7519614|NCT02504268|11857011|FG005|Overall Study|Not Disclosed|0
7519615|NCT02504268|11857012|FG006|Overall Study|Not Disclosed|0
7519616|NCT02504268|11857013|FG007|Overall Study|Not Disclosed|0
7519617|NCT02504268|11857014|FG008|Overall Study|Not Disclosed|0
7519618|NCT02504294|11857036|FG000|Overall Study|Adverse Event|15
7519619|NCT02504294|11857037|FG001|Overall Study|Adverse Event|12
7519620|NCT02504294|11857036|FG000|Overall Study|Withdrawal by Subject|7
7519621|NCT02504294|11857037|FG001|Overall Study|Withdrawal by Subject|1
7519622|NCT02504294|11857036|FG000|Overall Study|Protocol Violation|27
7519623|NCT02504294|11857037|FG001|Overall Study|Protocol Violation|26
7519624|NCT02504294|11857036|FG000|Overall Study|Physician Decision|1
7519625|NCT02504294|11857037|FG001|Overall Study|Physician Decision|2
7519626|NCT02504294|11857036|FG000|Overall Study|Lost to Follow-up|6
7519627|NCT02504294|11857037|FG001|Overall Study|Lost to Follow-up|7
7519628|NCT02504320|11857047|FG000|Treatment Period 1|Positive Drug Screen|0
7519629|NCT02504320|11857048|FG001|Treatment Period 1|Positive Drug Screen|0
7519630|NCT02504320|11857049|FG002|Treatment Period 1|Positive Drug Screen|1
7519631|NCT02504320|11857050|FG003|Treatment Period 1|Positive Drug Screen|0
7519632|NCT02504320|11857047|FG000|Treatment Period 2|Positive Drug Screen|0
7519633|NCT02504320|11857048|FG001|Treatment Period 2|Positive Drug Screen|1
7519634|NCT02504320|11857049|FG002|Treatment Period 2|Positive Drug Screen|0
7519635|NCT02504320|11857050|FG003|Treatment Period 2|Positive Drug Screen|0
7519636|NCT02504320|11857047|FG000|Treatment Period 3|Positive Drug Screen|0
7519637|NCT02504320|11857048|FG001|Treatment Period 3|Positive Drug Screen|0
7519638|NCT02504320|11857049|FG002|Treatment Period 3|Positive Drug Screen|0
7519639|NCT02504320|11857050|FG003|Treatment Period 3|Positive Drug Screen|1
7519640|NCT02504320|11857047|FG000|Treatment Period 3|Adverse Event|0
7519641|NCT02504320|11857048|FG001|Treatment Period 3|Adverse Event|0
7519642|NCT02504320|11857049|FG002|Treatment Period 3|Adverse Event|1
7519643|NCT02504320|11857050|FG003|Treatment Period 3|Adverse Event|0
7519644|NCT02504424|11857060|FG000|Overall Study|Withdrawal by Subject|2
7519645|NCT02504502|11857067|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
7519646|NCT02504502|11857068|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
7519647|NCT02504502|11857067|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
7519648|NCT02504502|11857068|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
7519649|NCT02504541|11857074|FG000|Overall Study|Adverse Event|4
7519650|NCT02504541|11857074|FG000|Overall Study|Withdrawal by Subject|4
7519651|NCT02504541|11857074|FG000|Overall Study|Lost to Follow-up|1
7519652|NCT02504541|11857074|FG000|Overall Study|Met Stopping Criteria|1
7519653|NCT02504541|11857074|FG000|Overall Study|Protocol Violation|2
7519654|NCT02504541|11857074|FG000|Overall Study|Termination by Sponsor|1
7519655|NCT02504541|11857074|FG000|Overall Study|Other|2
7519656|NCT02504541|11857074|FG000|Overall Study|Multiple|5
7519657|NCT02504671|11857107|FG000|Overall Study|Withdrawal by Subject|1
7519658|NCT02504671|11857108|FG001|Overall Study|Withdrawal by Subject|5
7519659|NCT02504671|11857109|FG002|Overall Study|Withdrawal by Subject|4
7519660|NCT02504671|11857110|FG003|Overall Study|Withdrawal by Subject|4
7519661|NCT02504671|11857111|FG004|Overall Study|Withdrawal by Subject|5
7519662|NCT02504671|11857112|FG005|Overall Study|Withdrawal by Subject|3
7519663|NCT02504671|11857107|FG000|Overall Study|Lack of Efficacy|1
7519664|NCT02504671|11857108|FG001|Overall Study|Lack of Efficacy|3
7519665|NCT02504671|11857109|FG002|Overall Study|Lack of Efficacy|1
7519666|NCT02504671|11857110|FG003|Overall Study|Lack of Efficacy|0
7519667|NCT02504671|11857111|FG004|Overall Study|Lack of Efficacy|4
7519668|NCT02504671|11857112|FG005|Overall Study|Lack of Efficacy|4
7519669|NCT02504671|11857107|FG000|Overall Study|Adverse Event|1
7519670|NCT02504671|11857108|FG001|Overall Study|Adverse Event|1
7519671|NCT02504671|11857109|FG002|Overall Study|Adverse Event|0
7519672|NCT02504671|11857110|FG003|Overall Study|Adverse Event|1
7519673|NCT02504671|11857111|FG004|Overall Study|Adverse Event|0
7519674|NCT02504671|11857112|FG005|Overall Study|Adverse Event|2
7519675|NCT02504671|11857107|FG000|Overall Study|Protocol Violation|2
7519676|NCT02504671|11857108|FG001|Overall Study|Protocol Violation|1
7519677|NCT02504671|11857109|FG002|Overall Study|Protocol Violation|0
7519678|NCT02504671|11857110|FG003|Overall Study|Protocol Violation|0
7519679|NCT02504671|11857111|FG004|Overall Study|Protocol Violation|0
7519680|NCT02504671|11857112|FG005|Overall Study|Protocol Violation|1
7519681|NCT02504671|11857107|FG000|Overall Study|Lost to Follow-up|0
7519682|NCT02504671|11857108|FG001|Overall Study|Lost to Follow-up|0
7519683|NCT02504671|11857109|FG002|Overall Study|Lost to Follow-up|2
7519684|NCT02504671|11857110|FG003|Overall Study|Lost to Follow-up|0
7519685|NCT02504671|11857111|FG004|Overall Study|Lost to Follow-up|0
7519686|NCT02504671|11857112|FG005|Overall Study|Lost to Follow-up|1
7519687|NCT02504671|11857107|FG000|Overall Study|Protocol defined stopping criteria|7
7519688|NCT02504671|11857108|FG001|Overall Study|Protocol defined stopping criteria|4
7519689|NCT02504671|11857109|FG002|Overall Study|Protocol defined stopping criteria|3
7519690|NCT02504671|11857110|FG003|Overall Study|Protocol defined stopping criteria|5
7519691|NCT02504671|11857111|FG004|Overall Study|Protocol defined stopping criteria|3
7519692|NCT02504671|11857112|FG005|Overall Study|Protocol defined stopping criteria|3
7519693|NCT02504827|11857144|FG000|Overall Study|Could not produce sputum|1
7519694|NCT02504892|11857148|FG000|Overall Study|Adverse event-pneumonitis|2
7519695|NCT02505217|11857163|FG000|Overall Study|Withdrawal by Subject|1
7519696|NCT02505217|11857164|FG001|Overall Study|Withdrawal by Subject|2
7519697|NCT02505334|11857176|FG000|Main Treatment Period|Adverse Event|3
7519698|NCT02505334|11857177|FG001|Main Treatment Period|Adverse Event|3
7519699|NCT02505334|11857176|FG000|Main Treatment Period|Lack of Efficacy|7
7519700|NCT02505334|11857177|FG001|Main Treatment Period|Lack of Efficacy|17
7519701|NCT02505334|11857176|FG000|Main Treatment Period|Protocol Violation|0
7519702|NCT02505334|11857177|FG001|Main Treatment Period|Protocol Violation|1
7519703|NCT02505334|11857176|FG000|Main Treatment Period|Withdrawal by Subject|1
7519704|NCT02505334|11857177|FG001|Main Treatment Period|Withdrawal by Subject|8
7519705|NCT02505334|11857176|FG000|Main Treatment Period|Unclassified|4
7519706|NCT02505334|11857177|FG001|Main Treatment Period|Unclassified|10
7519707|NCT02505334|11857176|FG000|Extension Treatment Period|Adverse Event|5
7519708|NCT02505334|11857177|FG001|Extension Treatment Period|Adverse Event|0
7519709|NCT02505334|11857176|FG000|Extension Treatment Period|Lack of Efficacy|4
7519710|NCT02505334|11857177|FG001|Extension Treatment Period|Lack of Efficacy|0
7519711|NCT02505334|11857176|FG000|Extension Treatment Period|Withdrawal by Subject|6
7519712|NCT02505334|11857177|FG001|Extension Treatment Period|Withdrawal by Subject|0
7519713|NCT02505334|11857176|FG000|Extension Treatment Period|Unclassified|3
7519714|NCT02505334|11857177|FG001|Extension Treatment Period|Unclassified|0
7519715|NCT02505542|11857183|FG000|Part A: Open-Label Period|Adverse Event|31
7519716|NCT02505542|11857184|FG001|Part A: Open-Label Period|Adverse Event|0
7519717|NCT02505542|11857185|FG002|Part A: Open-Label Period|Adverse Event|0
7519718|NCT02505542|11857186|FG003|Part A: Open-Label Period|Adverse Event|0
7519719|NCT02505542|11857183|FG000|Part A: Open-Label Period|Lack of Efficacy|5
7519720|NCT02505542|11857184|FG001|Part A: Open-Label Period|Lack of Efficacy|0
7519721|NCT02505542|11857185|FG002|Part A: Open-Label Period|Lack of Efficacy|0
7519722|NCT02505542|11857186|FG003|Part A: Open-Label Period|Lack of Efficacy|0
7519723|NCT02505542|11857183|FG000|Part A: Open-Label Period|Protocol Violation|1
7519724|NCT02505542|11857184|FG001|Part A: Open-Label Period|Protocol Violation|0
7519725|NCT02505542|11857185|FG002|Part A: Open-Label Period|Protocol Violation|0
7519726|NCT02505542|11857186|FG003|Part A: Open-Label Period|Protocol Violation|0
7519727|NCT02505542|11857183|FG000|Part A: Open-Label Period|Lost to Follow-up|5
7519728|NCT02505542|11857184|FG001|Part A: Open-Label Period|Lost to Follow-up|0
7519729|NCT02505542|11857185|FG002|Part A: Open-Label Period|Lost to Follow-up|0
7519730|NCT02505542|11857186|FG003|Part A: Open-Label Period|Lost to Follow-up|0
7519731|NCT02505542|11857183|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
7519732|NCT02505542|11857184|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
7519733|NCT02505542|11857185|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
7519734|NCT02505542|11857186|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
7519735|NCT02505542|11857183|FG000|Part A: Open-Label Period|New medical history available|1
7519736|NCT02505542|11857184|FG001|Part A: Open-Label Period|New medical history available|0
7519737|NCT02505542|11857185|FG002|Part A: Open-Label Period|New medical history available|0
7519738|NCT02505542|11857186|FG003|Part A: Open-Label Period|New medical history available|0
7519739|NCT02505542|11857183|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
7519740|NCT02505542|11857184|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7519741|NCT02505542|11857185|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7519742|NCT02505542|11857186|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
7519743|NCT02505542|11857183|FG000|Part A: Open-Label Period|Pregnancy|2
7519744|NCT02505542|11857184|FG001|Part A: Open-Label Period|Pregnancy|0
7519745|NCT02505542|11857185|FG002|Part A: Open-Label Period|Pregnancy|0
7519746|NCT02505542|11857186|FG003|Part A: Open-Label Period|Pregnancy|0
7519747|NCT02505542|11857183|FG000|Part A: Open-Label Period|Sponsor directive|1
7519748|NCT02505542|11857184|FG001|Part A: Open-Label Period|Sponsor directive|0
7519749|NCT02505542|11857185|FG002|Part A: Open-Label Period|Sponsor directive|0
7519750|NCT02505542|11857186|FG003|Part A: Open-Label Period|Sponsor directive|0
7519751|NCT02505542|11857183|FG000|Part A: Open-Label Period|Medical monitor decision|1
7519752|NCT02505542|11857184|FG001|Part A: Open-Label Period|Medical monitor decision|0
7519753|NCT02505542|11857185|FG002|Part A: Open-Label Period|Medical monitor decision|0
7519754|NCT02505542|11857186|FG003|Part A: Open-Label Period|Medical monitor decision|0
7519755|NCT02505542|11857183|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
7519756|NCT02505542|11857184|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
7519757|NCT02505542|11857185|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
7519758|NCT02505542|11857186|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
7519759|NCT02505542|11857183|FG000|Part A: Open-Label Period|Non-compliance|1
7519760|NCT02505542|11857184|FG001|Part A: Open-Label Period|Non-compliance|0
7519761|NCT02505542|11857185|FG002|Part A: Open-Label Period|Non-compliance|0
7519762|NCT02505542|11857186|FG003|Part A: Open-Label Period|Non-compliance|0
7519763|NCT02505542|11857183|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
7519764|NCT02505542|11857184|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7519765|NCT02505542|11857185|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7519766|NCT02505542|11857186|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
7519767|NCT02505542|11857183|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
7519768|NCT02505542|11857184|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7519769|NCT02505542|11857185|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7519770|NCT02505542|11857186|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
7519771|NCT02505542|11857183|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
7519772|NCT02505542|11857184|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7519773|NCT02505542|11857185|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7519774|NCT02505542|11857186|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
7519775|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Adverse Event|0
7519776|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Adverse Event|0
7519777|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Adverse Event|1
7519778|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Adverse Event|3
7519779|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
7519780|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
7519781|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
7519782|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
7519783|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
7519784|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
7519785|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
7519786|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
7519787|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Planning pregnancy|0
7519788|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Planning pregnancy|1
7519789|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Planning pregnancy|0
7519790|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Planning pregnancy|0
7519791|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Week 94 missed|0
7519792|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Week 94 missed|0
7519793|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Week 94 missed|1
7519794|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Week 94 missed|0
7519795|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
7519796|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
7519797|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
7519798|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
7519799|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
7519800|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
7519801|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
7519802|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
7519803|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Miscalculation|0
7519804|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Miscalculation|1
7519805|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Miscalculation|0
7519806|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Miscalculation|0
7519807|NCT02505542|11857183|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
7519808|NCT02505542|11857184|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
7519809|NCT02505542|11857185|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
7519810|NCT02505542|11857186|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
7519811|NCT02505867|11857214|FG000|Overall Study|Lack of Efficacy|6
7519812|NCT02505867|11857215|FG001|Overall Study|Lack of Efficacy|6
7519813|NCT02505945|11857232|FG000|Overall Study|Withdrawal by Subject|13
7519814|NCT02505945|11857233|FG001|Overall Study|Withdrawal by Subject|2
7519815|NCT02505945|11857232|FG000|Overall Study|Adverse Event|1
7519816|NCT02505945|11857233|FG001|Overall Study|Adverse Event|0
7519817|NCT02505945|11857232|FG000|Overall Study|Physician Decision|2
7519818|NCT02505945|11857233|FG001|Overall Study|Physician Decision|1
7519819|NCT02505945|11857232|FG000|Overall Study|Lost to Follow-up|6
7519820|NCT02505945|11857233|FG001|Overall Study|Lost to Follow-up|1
7519821|NCT02506036|11857241|FG000|First Intervention (4-6 Weeks)|Death|1
7519822|NCT02506036|11857242|FG001|First Intervention (4-6 Weeks)|Death|0
7519823|NCT02506036|11857241|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
7519824|NCT02506036|11857242|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
7519825|NCT02506036|11857241|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
7519826|NCT02506036|11857242|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
7519827|NCT02506257|11857265|FG000|Overall Study|Adverse Event|0
7519828|NCT02506257|11857266|FG001|Overall Study|Adverse Event|2
7519829|NCT02506257|11857267|FG002|Overall Study|Adverse Event|3
7519830|NCT02506257|11857268|FG003|Overall Study|Adverse Event|0
7519831|NCT02506257|11857265|FG000|Overall Study|Protocol Violation|0
7519832|NCT02506257|11857266|FG001|Overall Study|Protocol Violation|0
7519833|NCT02506257|11857267|FG002|Overall Study|Protocol Violation|1
7519834|NCT02506257|11857268|FG003|Overall Study|Protocol Violation|0
7519835|NCT02506816|11857351|FG000|Overall Study|Adverse Event|3
7519836|NCT02506881|11857372|FG000|First Intervention (Day 1)|Protocol Violation|0
7519837|NCT02506881|11857373|FG001|First Intervention (Day 1)|Protocol Violation|0
7519838|NCT02506881|11857374|FG002|First Intervention (Day 1)|Protocol Violation|1
7519839|NCT02506881|11857375|FG003|First Intervention (Day 1)|Protocol Violation|0
7519840|NCT02506881|11857372|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
7519841|NCT02506881|11857373|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7519842|NCT02506881|11857374|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7519843|NCT02506881|11857375|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
7519844|NCT02506881|11857372|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
7519845|NCT02506881|11857373|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
7519846|NCT02506881|11857374|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
7519847|NCT02506881|11857375|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
7519848|NCT02507219|11857402|FG000|Overall Study|Physician Decision|1
7519849|NCT02507219|11857403|FG001|Overall Study|Physician Decision|0
7519850|NCT02507219|11857404|FG002|Overall Study|Physician Decision|0
7519851|NCT02507219|11857405|FG003|Overall Study|Physician Decision|0
7519852|NCT02507219|11857406|FG004|Overall Study|Physician Decision|0
7519853|NCT02507219|11857407|FG005|Overall Study|Physician Decision|0
7519854|NCT02507219|11857402|FG000|Overall Study|Withdrawal by Subject|0
7519855|NCT02507219|11857403|FG001|Overall Study|Withdrawal by Subject|0
7519856|NCT02507219|11857404|FG002|Overall Study|Withdrawal by Subject|0
7519857|NCT02507219|11857405|FG003|Overall Study|Withdrawal by Subject|0
7519858|NCT02507219|11857406|FG004|Overall Study|Withdrawal by Subject|1
7519859|NCT02507219|11857407|FG005|Overall Study|Withdrawal by Subject|0
7519860|NCT02507297|11857417|FG000|Overall Study|Withdrawal by Subject|1
7519861|NCT02507297|11857418|FG001|Overall Study|Withdrawal by Subject|0
7519862|NCT02507297|11857417|FG000|Overall Study|Lost to Follow-up|0
7519863|NCT02507297|11857418|FG001|Overall Study|Lost to Follow-up|1
7519864|NCT02507349|11857426|FG000|Overall Study|Death|12
7519865|NCT02507349|11857427|FG001|Overall Study|Death|16
7519866|NCT02507349|11857426|FG000|Overall Study|Withdrawal by Subject|1
7519867|NCT02507349|11857427|FG001|Overall Study|Withdrawal by Subject|1
7519868|NCT02507349|11857426|FG000|Overall Study|Lost to Follow-up|174
7519869|NCT02507349|11857427|FG001|Overall Study|Lost to Follow-up|144
7519870|NCT02507375|11857435|FG000|Overall Study|Progressive Disease|4
7519871|NCT02507375|11857436|FG001|Overall Study|Progressive Disease|5
7519872|NCT02507375|11857435|FG000|Overall Study|Death|0
7519873|NCT02507375|11857436|FG001|Overall Study|Death|1
7519874|NCT02507375|11857435|FG000|Overall Study|Refused treatment|0
7519875|NCT02507375|11857436|FG001|Overall Study|Refused treatment|1
7519876|NCT02507375|11857435|FG000|Overall Study|Adverse Event|0
7519877|NCT02507375|11857436|FG001|Overall Study|Adverse Event|1
7519878|NCT02507752|11857456|FG000|Overall Study|Adverse Event|1
7519879|NCT02507752|11857456|FG000|Overall Study|Protocol Violation|6
7519880|NCT02507752|11857456|FG000|Overall Study|Lost to Follow-up|7
7519881|NCT02507752|11857456|FG000|Overall Study|Infusion reaction at first infusion|1
7519882|NCT02507752|11857456|FG000|Overall Study|Participant didn't perform visit Week 12|1
7519883|NCT02507752|11857456|FG000|Overall Study|Participant didn't perform visit Week 24|1
7519884|NCT02508116|11857475|FG000|Overall Study|Lost to Follow-up|2
7519885|NCT02508116|11857476|FG001|Overall Study|Lost to Follow-up|3
7519886|NCT02508116|11857475|FG000|Overall Study|Withdrawal by Subject|3
7519887|NCT02508116|11857476|FG001|Overall Study|Withdrawal by Subject|2
7519888|NCT02508116|11857475|FG000|Overall Study|Protocol Violation|1
7519889|NCT02508116|11857476|FG001|Overall Study|Protocol Violation|2
7519890|NCT02508116|11857475|FG000|Overall Study|Physician Decision|2
7519891|NCT02508116|11857476|FG001|Overall Study|Physician Decision|0
7519892|NCT02508194|11857484|FG000|Overall Study|Death|5
7519893|NCT02508194|11857485|FG001|Overall Study|Death|3
7519894|NCT02508194|11857484|FG000|Overall Study|Lost to Follow-up|25
7519895|NCT02508194|11857485|FG001|Overall Study|Lost to Follow-up|18
7519896|NCT02508194|11857484|FG000|Overall Study|Withdrawal by Subject|20
7519897|NCT02508194|11857485|FG001|Overall Study|Withdrawal by Subject|18
7519898|NCT02508194|11857484|FG000|Overall Study|Error in Randomization|1
7519899|NCT02508194|11857485|FG001|Overall Study|Error in Randomization|3
7519900|NCT02508194|11857484|FG000|Overall Study|Principal Investigator Decision|1
7519901|NCT02508194|11857485|FG001|Overall Study|Principal Investigator Decision|2
7519902|NCT02508428|11857524|FG000|Overall Study|Death|32
7519903|NCT02508428|11857525|FG001|Overall Study|Death|33
7519904|NCT02508428|11857524|FG000|Overall Study|Liner revised|3
7519905|NCT02508428|11857525|FG001|Overall Study|Liner revised|19
7519906|NCT02508428|11857524|FG000|Overall Study|Incomplete follow-up|17
7519907|NCT02508428|11857525|FG001|Overall Study|Incomplete follow-up|15
7519908|NCT02508649|11857548|FG000|Overall Study|Withdrawal by Subject|4
7519909|NCT02508649|11857549|FG001|Overall Study|Withdrawal by Subject|6
7519910|NCT02508649|11857550|FG002|Overall Study|Withdrawal by Subject|5
7519911|NCT02508649|11857551|FG003|Overall Study|Withdrawal by Subject|6
7519912|NCT02508649|11857548|FG000|Overall Study|Investigator withdrew the subject|1
7519913|NCT02508649|11857549|FG001|Overall Study|Investigator withdrew the subject|2
7519914|NCT02508649|11857550|FG002|Overall Study|Investigator withdrew the subject|1
7519915|NCT02508649|11857551|FG003|Overall Study|Investigator withdrew the subject|0
7519916|NCT02508649|11857548|FG000|Overall Study|Post randomization screening failure|12
7519917|NCT02508649|11857549|FG001|Overall Study|Post randomization screening failure|4
7519918|NCT02508649|11857550|FG002|Overall Study|Post randomization screening failure|9
7519919|NCT02508649|11857551|FG003|Overall Study|Post randomization screening failure|3
7519920|NCT02508649|11857548|FG000|Overall Study|Lost to Follow-up|1
7519921|NCT02508649|11857549|FG001|Overall Study|Lost to Follow-up|1
7519922|NCT02508649|11857550|FG002|Overall Study|Lost to Follow-up|0
7519923|NCT02508649|11857551|FG003|Overall Study|Lost to Follow-up|1
7519924|NCT02508701|11857568|FG000|Overall Study|Lost to Follow-up|9
7519925|NCT02508701|11857569|FG001|Overall Study|Lost to Follow-up|5
7519926|NCT02508701|11857570|FG002|Overall Study|Lost to Follow-up|5
7519927|NCT02508701|11857571|FG003|Overall Study|Lost to Follow-up|3
7519928|NCT02508935|11857585|FG000|Overall Study|Withdrawal by Subject|1
7519929|NCT02508935|11857585|FG000|Overall Study|Withdrawal by Caregiver|8
7519930|NCT02508935|11857585|FG000|Overall Study|Pain Score <4|1
7519931|NCT02508935|11857585|FG000|Overall Study|Emesis|3
7519932|NCT02508935|11857585|FG000|Overall Study|Adverse Event|3
7519933|NCT02508935|11857585|FG000|Overall Study|Protocol Violation|1
7519934|NCT02508935|11857585|FG000|Overall Study|Physician Decision|1
7519935|NCT02508935|11857585|FG000|Overall Study|Trial terminated by sponsor|5
7519936|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Adverse Event|5
7519937|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
7519938|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
7519939|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
7519940|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Other|2
7519941|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Protocol Violation|1
7519942|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
7519943|NCT02509026|11857591|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
7519944|NCT02509026|11857591|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
7519945|NCT02509026|11857591|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
7519946|NCT02509026|11857591|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
7519947|NCT02509026|11857591|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
7519948|NCT02509026|11857591|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
7519949|NCT02509078|11857640|FG000|Overall Study|Protocol Violation|1
7519950|NCT02509078|11857641|FG001|Overall Study|Protocol Violation|1
7536766|NCT02723630|11884852|FG001|Intervention Period 1|Adverse Event|0
7536767|NCT02723630|11884853|FG002|Intervention Period 1|Adverse Event|0
7536768|NCT02723630|11884854|FG003|Intervention Period 1|Adverse Event|0
7536769|NCT02723630|11884855|FG004|Intervention Period 1|Adverse Event|0
7536770|NCT02723630|11884856|FG005|Intervention Period 1|Adverse Event|0
7536771|NCT02723630|11884851|FG000|Intervention Period 3|consumption of restricted item|0
7536772|NCT02723630|11884852|FG001|Intervention Period 3|consumption of restricted item|1
7536773|NCT02723630|11884853|FG002|Intervention Period 3|consumption of restricted item|0
7536774|NCT02723630|11884854|FG003|Intervention Period 3|consumption of restricted item|0
7536775|NCT02723630|11884855|FG004|Intervention Period 3|consumption of restricted item|0
7536776|NCT02723630|11884856|FG005|Intervention Period 3|consumption of restricted item|0
7536777|NCT02723786|11884869|FG000|Overall Study|Lost to Follow-up|1
7536778|NCT02724020|11884896|FG000|Overall Study|Death|16
7536779|NCT02724020|11884897|FG001|Overall Study|Death|18
7536780|NCT02724020|11884898|FG002|Overall Study|Death|19
7536781|NCT02724020|11884896|FG000|Overall Study|Lost to Follow-up|0
7536782|NCT02724020|11884897|FG001|Overall Study|Lost to Follow-up|3
7536783|NCT02724020|11884898|FG002|Overall Study|Lost to Follow-up|0
7536784|NCT02724020|11884896|FG000|Overall Study|Site Terminated by Sponsor|15
7536785|NCT02724020|11884897|FG001|Overall Study|Site Terminated by Sponsor|8
7536786|NCT02724020|11884898|FG002|Overall Study|Site Terminated by Sponsor|8
7536787|NCT02724020|11884896|FG000|Overall Study|Withdrawal by Subject|1
7536788|NCT02724020|11884897|FG001|Overall Study|Withdrawal by Subject|3
7536789|NCT02724020|11884898|FG002|Overall Study|Withdrawal by Subject|5
7536790|NCT02724111|11884921|FG000|Overall Study|Protocol Violation|2
7536791|NCT02724111|11884922|FG001|Overall Study|Protocol Violation|5
7536792|NCT02724462|11884939|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
7536793|NCT02724462|11884940|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
7536794|NCT02724462|11884939|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
7536795|NCT02724462|11884940|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
7536796|NCT02724462|11884939|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
7536797|NCT02724462|11884940|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
7536798|NCT02724462|11884939|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
7536799|NCT02724462|11884940|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
7536800|NCT02724462|11884939|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
7536801|NCT02724462|11884940|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
7536802|NCT02724462|11884939|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
7536803|NCT02724462|11884940|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
7536804|NCT02724592|11884948|FG000|Overall Study|Lost to Follow-up|4
7536805|NCT02724592|11884949|FG001|Overall Study|Lost to Follow-up|1
7536806|NCT02724644|11884957|FG000|Overall Study|Adverse Event|7
7536807|NCT02724644|11884958|FG001|Overall Study|Adverse Event|1
7536808|NCT02724644|11884957|FG000|Overall Study|Lost to Follow-up|6
7536809|NCT02724644|11884958|FG001|Overall Study|Lost to Follow-up|2
7536810|NCT02724644|11884957|FG000|Overall Study|Withdrawal by Subject|7
7536811|NCT02724644|11884958|FG001|Overall Study|Withdrawal by Subject|1
7536812|NCT02724644|11884957|FG000|Overall Study|Administrative|1
7536813|NCT02724644|11884958|FG001|Overall Study|Administrative|0
7536814|NCT02724839|11884980|FG000|Overall Study|Withdrawal by Subject|1
7536815|NCT02724839|11884981|FG001|Overall Study|Withdrawal by Subject|1
7536816|NCT02724839|11884982|FG002|Overall Study|Withdrawal by Subject|0
7536817|NCT02724839|11884980|FG000|Overall Study|Lost to Follow-up|0
7536818|NCT02724839|11884981|FG001|Overall Study|Lost to Follow-up|3
7536819|NCT02724839|11884982|FG002|Overall Study|Lost to Follow-up|2
7536820|NCT02724839|11884980|FG000|Overall Study|Physician Decision|0
7536821|NCT02724839|11884981|FG001|Overall Study|Physician Decision|0
7536822|NCT02724839|11884982|FG002|Overall Study|Physician Decision|3
7536823|NCT02724956|11884999|FG000|Overall Study|Physician Decision|1
7536824|NCT02724956|11885000|FG001|Overall Study|Physician Decision|0
7536825|NCT02724956|11884999|FG000|Overall Study|Lack of Efficacy|0
7536826|NCT02724956|11885000|FG001|Overall Study|Lack of Efficacy|1
7536827|NCT02724956|11884999|FG000|Overall Study|Withdrawal by Subject|0
7536828|NCT02724956|11885000|FG001|Overall Study|Withdrawal by Subject|1
7536829|NCT02725008|11885008|FG000|Overall Study|Lost to Follow-up|7
7536830|NCT02725008|11885009|FG001|Overall Study|Lost to Follow-up|9
7536831|NCT02725008|11885008|FG000|Overall Study|Withdrawal by Subject|2
7536832|NCT02725008|11885009|FG001|Overall Study|Withdrawal by Subject|2
7536833|NCT02725008|11885008|FG000|Overall Study|Admitted to hospital|0
7536834|NCT02725008|11885009|FG001|Overall Study|Admitted to hospital|1
7536835|NCT02725268|11885019|FG000|Overall Study|Death|58
7536836|NCT02725268|11885020|FG001|Overall Study|Death|59
7536837|NCT02725268|11885021|FG002|Overall Study|Death|30
7519951|NCT02509117|11857659|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519952|NCT02509117|11857660|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
7519953|NCT02509117|11857661|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519954|NCT02509117|11857662|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519955|NCT02509117|11857663|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519956|NCT02509117|11857664|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519957|NCT02509117|11857665|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519958|NCT02509117|11857666|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519959|NCT02509117|11857667|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519960|NCT02509117|11857668|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
7519961|NCT02509117|11857659|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519962|NCT02509117|11857660|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519963|NCT02509117|11857661|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519964|NCT02509117|11857662|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519965|NCT02509117|11857663|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519966|NCT02509117|11857664|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519967|NCT02509117|11857665|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519968|NCT02509117|11857666|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519969|NCT02509117|11857667|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
7519970|NCT02509117|11857668|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
7519971|NCT02509117|11857659|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519972|NCT02509117|11857660|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519973|NCT02509117|11857661|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519974|NCT02509117|11857662|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519975|NCT02509117|11857663|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519976|NCT02509117|11857664|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519977|NCT02509117|11857665|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519978|NCT02509117|11857666|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519979|NCT02509117|11857667|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
7519980|NCT02509117|11857668|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
7519981|NCT02509156|11857708|FG000|Randomized Phase|Death|1
7519982|NCT02509156|11857709|FG001|Randomized Phase|Death|0
7519983|NCT02509156|11857708|FG000|Randomized Phase|Withdrawal by Subject|1
7519984|NCT02509156|11857709|FG001|Randomized Phase|Withdrawal by Subject|1
7519985|NCT02510001|11857778|FG000|Overall Study|Early disease progression|0
7519986|NCT02510001|11857779|FG001|Overall Study|Early disease progression|0
7519987|NCT02510001|11857780|FG002|Overall Study|Early disease progression|0
7519988|NCT02510001|11857781|FG003|Overall Study|Early disease progression|1
7519989|NCT02510001|11857782|FG004|Overall Study|Early disease progression|1
7519990|NCT02510001|11857783|FG005|Overall Study|Early disease progression|1
7519991|NCT02510001|11857784|FG006|Overall Study|Early disease progression|0
7519992|NCT02510001|11857785|FG007|Overall Study|Early disease progression|0
7519993|NCT02510001|11857778|FG000|Overall Study|Adverse Event|0
7519994|NCT02510001|11857779|FG001|Overall Study|Adverse Event|0
7519995|NCT02510001|11857780|FG002|Overall Study|Adverse Event|0
7519996|NCT02510001|11857781|FG003|Overall Study|Adverse Event|1
7519997|NCT02510001|11857782|FG004|Overall Study|Adverse Event|2
7519998|NCT02510001|11857783|FG005|Overall Study|Adverse Event|1
7519999|NCT02510001|11857784|FG006|Overall Study|Adverse Event|2
7520000|NCT02510001|11857785|FG007|Overall Study|Adverse Event|5
7520001|NCT02510001|11857778|FG000|Overall Study|Physician Decision|0
7520002|NCT02510001|11857779|FG001|Overall Study|Physician Decision|0
7520003|NCT02510001|11857780|FG002|Overall Study|Physician Decision|0
7520004|NCT02510001|11857781|FG003|Overall Study|Physician Decision|0
7520005|NCT02510001|11857782|FG004|Overall Study|Physician Decision|1
7520006|NCT02510001|11857783|FG005|Overall Study|Physician Decision|0
7520007|NCT02510001|11857784|FG006|Overall Study|Physician Decision|0
7520008|NCT02510001|11857785|FG007|Overall Study|Physician Decision|0
7520009|NCT02510001|11857778|FG000|Overall Study|Withdrawal by Subject|0
7520010|NCT02510001|11857779|FG001|Overall Study|Withdrawal by Subject|0
7520011|NCT02510001|11857780|FG002|Overall Study|Withdrawal by Subject|0
7520012|NCT02510001|11857781|FG003|Overall Study|Withdrawal by Subject|0
7520013|NCT02510001|11857782|FG004|Overall Study|Withdrawal by Subject|0
7520014|NCT02510001|11857783|FG005|Overall Study|Withdrawal by Subject|0
7520015|NCT02510001|11857784|FG006|Overall Study|Withdrawal by Subject|0
7520016|NCT02510001|11857785|FG007|Overall Study|Withdrawal by Subject|2
7520017|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7520018|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
7520019|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
7520020|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
7520021|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
7520022|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
7520023|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
7520024|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
7520025|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
7520026|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
7520027|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
7520028|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
7520029|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
7520030|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
7520031|NCT02510014|11857823|FG000|Run-In Period (Days -14 to Day -1)|Other|19
7520032|NCT02510014|11857824|FG001|Run-In Period (Days -14 to Day -1)|Other|1
7520033|NCT02510014|11857823|FG000|Treatment Period|Adverse Event|11
7520034|NCT02510014|11857824|FG001|Treatment Period|Adverse Event|4
7520035|NCT02510014|11857823|FG000|Treatment Period|Withdrawal symptoms|3
7520036|NCT02510014|11857824|FG001|Treatment Period|Withdrawal symptoms|0
7520037|NCT02510014|11857823|FG000|Treatment Period|Lost to Follow-up|80
7520038|NCT02510014|11857824|FG001|Treatment Period|Lost to Follow-up|19
7520039|NCT02510014|11857823|FG000|Treatment Period|Physician Decision|5
7520040|NCT02510014|11857824|FG001|Treatment Period|Physician Decision|0
7520041|NCT02510014|11857823|FG000|Treatment Period|Withdrawal by Subject|67
7520042|NCT02510014|11857824|FG001|Treatment Period|Withdrawal by Subject|24
7520043|NCT02510014|11857823|FG000|Treatment Period|Withdrawn by the investigator|7
7520044|NCT02510014|11857824|FG001|Treatment Period|Withdrawn by the investigator|1
7520045|NCT02510014|11857823|FG000|Treatment Period|Protocol Violation|4
7520046|NCT02510014|11857824|FG001|Treatment Period|Protocol Violation|4
7520047|NCT02510014|11857823|FG000|Treatment Period|Incarceration, pregnancy, misc|29
7520048|NCT02510014|11857824|FG001|Treatment Period|Incarceration, pregnancy, misc|5
7520049|NCT02510664|11857842|FG000|Overall Study|Transferred Care|9
7520050|NCT02510664|11857843|FG001|Overall Study|Transferred Care|9
7520051|NCT02510664|11857844|FG002|Overall Study|Transferred Care|0
7520052|NCT02510664|11857842|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
7520053|NCT02510664|11857843|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
7520054|NCT02510664|11857844|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
7520055|NCT02510664|11857842|FG000|Overall Study|Time Constraints|1
7520056|NCT02510664|11857843|FG001|Overall Study|Time Constraints|1
7520057|NCT02510664|11857844|FG002|Overall Study|Time Constraints|0
7520058|NCT02510794|11857861|FG000|Overall Study|Adverse Event|0
7520059|NCT02510794|11857862|FG001|Overall Study|Adverse Event|1
7520060|NCT02510794|11857863|FG002|Overall Study|Adverse Event|0
7520061|NCT02510794|11857864|FG003|Overall Study|Adverse Event|0
7520062|NCT02510794|11857861|FG000|Overall Study|Death|1
7520063|NCT02510794|11857862|FG001|Overall Study|Death|2
7520064|NCT02510794|11857863|FG002|Overall Study|Death|1
7520065|NCT02510794|11857864|FG003|Overall Study|Death|1
7520066|NCT02510794|11857861|FG000|Overall Study|Lack of Efficacy|3
7520067|NCT02510794|11857862|FG001|Overall Study|Lack of Efficacy|1
7520068|NCT02510794|11857863|FG002|Overall Study|Lack of Efficacy|1
7520069|NCT02510794|11857864|FG003|Overall Study|Lack of Efficacy|0
7520070|NCT02510794|11857861|FG000|Overall Study|Participant moved out of the area|0
7520071|NCT02510794|11857862|FG001|Overall Study|Participant moved out of the area|0
7520072|NCT02510794|11857863|FG002|Overall Study|Participant moved out of the area|0
7520073|NCT02510794|11857864|FG003|Overall Study|Participant moved out of the area|1
7520074|NCT02510794|11857861|FG000|Overall Study|Physician Decision|3
7520075|NCT02510794|11857862|FG001|Overall Study|Physician Decision|0
7520076|NCT02510794|11857863|FG002|Overall Study|Physician Decision|0
7520077|NCT02510794|11857864|FG003|Overall Study|Physician Decision|0
7520078|NCT02510794|11857861|FG000|Overall Study|Protocol Violation|0
7520079|NCT02510794|11857862|FG001|Overall Study|Protocol Violation|0
7520080|NCT02510794|11857863|FG002|Overall Study|Protocol Violation|1
7520081|NCT02510794|11857864|FG003|Overall Study|Protocol Violation|0
7520082|NCT02510794|11857861|FG000|Overall Study|Withdrawal by Subject|1
7520083|NCT02510794|11857862|FG001|Overall Study|Withdrawal by Subject|2
7520084|NCT02510794|11857863|FG002|Overall Study|Withdrawal by Subject|4
7520085|NCT02510794|11857864|FG003|Overall Study|Withdrawal by Subject|3
7520173|NCT02512302|11858049|FG006|Period 4|Adverse Event|1
7520086|NCT02510820|11857876|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
7520087|NCT02510820|11857877|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
7520088|NCT02510820|11857876|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7520089|NCT02510820|11857877|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7520090|NCT02511184|11857886|FG000|Overall Study|Death|1
7520091|NCT02511184|11857887|FG001|Overall Study|Death|0
7520092|NCT02511184|11857886|FG000|Overall Study|Lost to Follow-up|0
7520093|NCT02511184|11857887|FG001|Overall Study|Lost to Follow-up|1
7520094|NCT02511184|11857886|FG000|Overall Study|Study terminated by sponsor|1
7520095|NCT02511184|11857887|FG001|Overall Study|Study terminated by sponsor|5
7520096|NCT02511184|11857886|FG000|Overall Study|Withdrawal by Subject|0
7520097|NCT02511184|11857887|FG001|Overall Study|Withdrawal by Subject|1
7520098|NCT02511431|11857913|FG000|Treatment|Lost to Follow-up|0
7520099|NCT02511431|11857914|FG001|Treatment|Lost to Follow-up|0
7520100|NCT02511431|11857915|FG002|Treatment|Lost to Follow-up|1
7520101|NCT02511431|11857916|FG003|Treatment|Lost to Follow-up|0
7520102|NCT02511431|11857917|FG004|Treatment|Lost to Follow-up|0
7520103|NCT02511431|11857918|FG005|Treatment|Lost to Follow-up|1
7520104|NCT02511678|11857969|FG000|Overall Study|Withdrawal by Subject|2
7520105|NCT02511678|11857969|FG000|Overall Study|Lost to Follow-up|4
7520106|NCT02511678|11857969|FG000|Overall Study|Death|19
7520107|NCT02511678|11857969|FG000|Overall Study|Adverse Event|1
7520108|NCT02511678|11857969|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
7520109|NCT02511678|11857969|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
7520110|NCT02511678|11857969|FG000|Overall Study|Required Radiofrequency Ablation|1
7520111|NCT02511678|11857969|FG000|Overall Study|Biopsy was Negative|1
7520112|NCT02511678|11857969|FG000|Overall Study|Protocol Violation|1
7520113|NCT02511678|11857969|FG000|Overall Study|Received Radiation Treatment|1
7520114|NCT02511782|11857993|FG000|Overall Study|Withdrawal by Subject|1
7520115|NCT02511782|11857994|FG001|Overall Study|Withdrawal by Subject|0
7520116|NCT02511782|11857995|FG002|Overall Study|Withdrawal by Subject|0
7520117|NCT02512042|11858005|FG000|Overall Study|Adverse Event|0
7520118|NCT02512042|11858006|FG001|Overall Study|Adverse Event|4
7520119|NCT02512042|11858005|FG000|Overall Study|Withdrawal by Subject|6
7520120|NCT02512042|11858006|FG001|Overall Study|Withdrawal by Subject|6
7520121|NCT02512042|11858005|FG000|Overall Study|Non-compliance with study drug|1
7520122|NCT02512042|11858006|FG001|Overall Study|Non-compliance with study drug|2
7520123|NCT02512042|11858005|FG000|Overall Study|Lost to Follow-up|5
7520124|NCT02512042|11858006|FG001|Overall Study|Lost to Follow-up|2
7520125|NCT02512042|11858005|FG000|Overall Study|Other|11
7520126|NCT02512042|11858006|FG001|Overall Study|Other|11
7520127|NCT02512068|11858014|FG000|Overall Study|Pretreatment Event/Adverse Event|8
7520128|NCT02512068|11858015|FG001|Overall Study|Pretreatment Event/Adverse Event|6
7520129|NCT02512068|11858014|FG000|Overall Study|Major Protocol Deviation|1
7520130|NCT02512068|11858015|FG001|Overall Study|Major Protocol Deviation|0
7520131|NCT02512068|11858014|FG000|Overall Study|Voluntary Withdrawal|0
7520132|NCT02512068|11858015|FG001|Overall Study|Voluntary Withdrawal|1
7520133|NCT02512068|11858014|FG000|Overall Study|Lack of Efficacy|0
7520134|NCT02512068|11858015|FG001|Overall Study|Lack of Efficacy|1
7520135|NCT02512068|11858014|FG000|Overall Study|Reason Not Specified|3
7520136|NCT02512068|11858015|FG001|Overall Study|Reason Not Specified|5
7520137|NCT02512302|11858043|FG000|Period 1|Adverse Event|0
7520138|NCT02512302|11858044|FG001|Period 1|Adverse Event|1
7520139|NCT02512302|11858045|FG002|Period 1|Adverse Event|0
7520140|NCT02512302|11858046|FG003|Period 1|Adverse Event|0
7520141|NCT02512302|11858047|FG004|Period 1|Adverse Event|0
7520142|NCT02512302|11858048|FG005|Period 1|Adverse Event|0
7520143|NCT02512302|11858049|FG006|Period 1|Adverse Event|0
7520144|NCT02512302|11858050|FG007|Period 1|Adverse Event|0
7520145|NCT02512302|11858051|FG008|Period 1|Adverse Event|0
7520146|NCT02512302|11858052|FG009|Period 1|Adverse Event|0
7520147|NCT02512302|11858043|FG000|Period 2|Adverse Event|0
7520148|NCT02512302|11858044|FG001|Period 2|Adverse Event|0
7520149|NCT02512302|11858045|FG002|Period 2|Adverse Event|0
7520150|NCT02512302|11858046|FG003|Period 2|Adverse Event|0
7520151|NCT02512302|11858047|FG004|Period 2|Adverse Event|0
7520152|NCT02512302|11858048|FG005|Period 2|Adverse Event|0
7520153|NCT02512302|11858049|FG006|Period 2|Adverse Event|0
7520154|NCT02512302|11858050|FG007|Period 2|Adverse Event|0
7520155|NCT02512302|11858051|FG008|Period 2|Adverse Event|0
7520156|NCT02512302|11858052|FG009|Period 2|Adverse Event|1
7520157|NCT02512302|11858043|FG000|Period 3|Lost to Follow-up|0
7520158|NCT02512302|11858044|FG001|Period 3|Lost to Follow-up|0
7520159|NCT02512302|11858045|FG002|Period 3|Lost to Follow-up|1
7520160|NCT02512302|11858046|FG003|Period 3|Lost to Follow-up|0
7520161|NCT02512302|11858047|FG004|Period 3|Lost to Follow-up|0
7520162|NCT02512302|11858048|FG005|Period 3|Lost to Follow-up|0
7520163|NCT02512302|11858049|FG006|Period 3|Lost to Follow-up|0
7520164|NCT02512302|11858050|FG007|Period 3|Lost to Follow-up|0
7520165|NCT02512302|11858051|FG008|Period 3|Lost to Follow-up|0
7520166|NCT02512302|11858052|FG009|Period 3|Lost to Follow-up|0
7520167|NCT02512302|11858043|FG000|Period 4|Adverse Event|0
7520168|NCT02512302|11858044|FG001|Period 4|Adverse Event|0
7520169|NCT02512302|11858045|FG002|Period 4|Adverse Event|0
7520170|NCT02512302|11858046|FG003|Period 4|Adverse Event|0
7520171|NCT02512302|11858047|FG004|Period 4|Adverse Event|0
7520172|NCT02512302|11858048|FG005|Period 4|Adverse Event|0
7520174|NCT02512302|11858050|FG007|Period 4|Adverse Event|0
7520175|NCT02512302|11858051|FG008|Period 4|Adverse Event|0
7520176|NCT02512302|11858052|FG009|Period 4|Adverse Event|0
7520177|NCT02512861|11858147|FG000|Overall Study|Protocol Violation|3
7520178|NCT02512861|11858148|FG001|Overall Study|Protocol Violation|7
7520179|NCT02512861|11858147|FG000|Overall Study|Physician Decision|3
7520180|NCT02512861|11858148|FG001|Overall Study|Physician Decision|1
7520181|NCT02512861|11858147|FG000|Overall Study|Withdrawal by Subject|0
7520182|NCT02512861|11858148|FG001|Overall Study|Withdrawal by Subject|1
7520183|NCT02512965|11858170|FG000|Overall Study|Withdrawal by Subject|0
7520184|NCT02512965|11858171|FG001|Overall Study|Withdrawal by Subject|4
7520185|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
7520186|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7520187|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7520188|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
7520189|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
7520190|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7536838|NCT02725268|11885022|FG003|Overall Study|Death|16
7520191|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7520192|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
7520193|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
7520194|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7520195|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7520196|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
7520197|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
7520198|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7520199|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7520200|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
7520201|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
7520202|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7520203|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7520204|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
7520205|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
7520206|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7520207|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7520208|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
7520209|NCT02513160|11858201|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
7520210|NCT02513160|11858202|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7520211|NCT02513160|11858203|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7520212|NCT02513160|11858204|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
7520213|NCT02513160|11858201|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7520214|NCT02513160|11858202|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
7520215|NCT02513160|11858203|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
7520216|NCT02513160|11858204|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
7520217|NCT02513160|11858201|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
7520218|NCT02513160|11858202|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7520219|NCT02513160|11858203|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7520220|NCT02513160|11858204|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
7520221|NCT02513160|11858201|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
7520222|NCT02513160|11858202|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7520223|NCT02513160|11858203|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7520224|NCT02513160|11858204|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
7520225|NCT02513160|11858201|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
7520226|NCT02513160|11858202|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7520227|NCT02513160|11858203|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7520228|NCT02513160|11858204|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
7520229|NCT02513160|11858201|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7520230|NCT02513160|11858202|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
7520231|NCT02513160|11858203|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7520232|NCT02513160|11858204|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
7520233|NCT02513459|11858234|FG000|Overall Study|Adverse Event|7
7520234|NCT02513459|11858234|FG000|Overall Study|Withdrew consent|5
7520235|NCT02513459|11858234|FG000|Overall Study|Loss of efficacy|2
7520236|NCT02513459|11858234|FG000|Overall Study|Pregnancy|2
7520237|NCT02513459|11858234|FG000|Overall Study|Subject decision|2
7520238|NCT02513459|11858234|FG000|Overall Study|Lack of response|1
7520239|NCT02513459|11858234|FG000|Overall Study|Reproductive plans|1
7520240|NCT02513459|11858234|FG000|Overall Study|Surgery planned-- not done|1
7520241|NCT02513550|11858255|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
7520242|NCT02513550|11858256|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
7520243|NCT02513550|11858257|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
7520244|NCT02513550|11858258|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7520245|NCT02513550|11858259|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7520246|NCT02513550|11858260|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7520247|NCT02513550|11858255|FG000|Double Blind Treatment Period|Adverse Event|5
7520248|NCT02513550|11858256|FG001|Double Blind Treatment Period|Adverse Event|13
7520249|NCT02513550|11858257|FG002|Double Blind Treatment Period|Adverse Event|17
7520250|NCT02513550|11858258|FG003|Double Blind Treatment Period|Adverse Event|0
7520251|NCT02513550|11858259|FG004|Double Blind Treatment Period|Adverse Event|1
7520252|NCT02513550|11858260|FG005|Double Blind Treatment Period|Adverse Event|0
7520253|NCT02513550|11858255|FG000|Double Blind Treatment Period|Lost to Follow-up|9
7520254|NCT02513550|11858256|FG001|Double Blind Treatment Period|Lost to Follow-up|7
7520255|NCT02513550|11858257|FG002|Double Blind Treatment Period|Lost to Follow-up|11
7520256|NCT02513550|11858258|FG003|Double Blind Treatment Period|Lost to Follow-up|0
7520257|NCT02513550|11858259|FG004|Double Blind Treatment Period|Lost to Follow-up|0
7520258|NCT02513550|11858260|FG005|Double Blind Treatment Period|Lost to Follow-up|1
7520259|NCT02513550|11858255|FG000|Double Blind Treatment Period|Lack of Efficacy|4
7520260|NCT02513550|11858256|FG001|Double Blind Treatment Period|Lack of Efficacy|5
7520261|NCT02513550|11858257|FG002|Double Blind Treatment Period|Lack of Efficacy|6
7520262|NCT02513550|11858258|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7520263|NCT02513550|11858259|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7520264|NCT02513550|11858260|FG005|Double Blind Treatment Period|Lack of Efficacy|0
7520265|NCT02513550|11858255|FG000|Double Blind Treatment Period|Protocol Violation|1
7520266|NCT02513550|11858256|FG001|Double Blind Treatment Period|Protocol Violation|1
7520267|NCT02513550|11858257|FG002|Double Blind Treatment Period|Protocol Violation|4
7520268|NCT02513550|11858258|FG003|Double Blind Treatment Period|Protocol Violation|0
7520269|NCT02513550|11858259|FG004|Double Blind Treatment Period|Protocol Violation|0
7520270|NCT02513550|11858260|FG005|Double Blind Treatment Period|Protocol Violation|0
7520271|NCT02513550|11858255|FG000|Double Blind Treatment Period|Physician Decision|2
7520272|NCT02513550|11858256|FG001|Double Blind Treatment Period|Physician Decision|0
7520273|NCT02513550|11858257|FG002|Double Blind Treatment Period|Physician Decision|4
7520274|NCT02513550|11858258|FG003|Double Blind Treatment Period|Physician Decision|0
7520275|NCT02513550|11858259|FG004|Double Blind Treatment Period|Physician Decision|0
7520276|NCT02513550|11858260|FG005|Double Blind Treatment Period|Physician Decision|0
7520277|NCT02513550|11858255|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
7520278|NCT02513550|11858256|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
7520279|NCT02513550|11858257|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
7520280|NCT02513550|11858258|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
7520281|NCT02513550|11858259|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
7520282|NCT02513550|11858260|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
7520283|NCT02513550|11858255|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7520284|NCT02513550|11858256|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7520285|NCT02513550|11858257|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
7520286|NCT02513550|11858258|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7520287|NCT02513550|11858259|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7520288|NCT02513550|11858260|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
7520289|NCT02513550|11858255|FG000|Double Blind Treatment Period|Due to personal business|2
7520290|NCT02513550|11858256|FG001|Double Blind Treatment Period|Due to personal business|0
7520291|NCT02513550|11858257|FG002|Double Blind Treatment Period|Due to personal business|1
7520292|NCT02513550|11858258|FG003|Double Blind Treatment Period|Due to personal business|0
7520293|NCT02513550|11858259|FG004|Double Blind Treatment Period|Due to personal business|0
7520294|NCT02513550|11858260|FG005|Double Blind Treatment Period|Due to personal business|0
7520295|NCT02513550|11858255|FG000|Double Blind Treatment Period|Death|1
7520296|NCT02513550|11858256|FG001|Double Blind Treatment Period|Death|0
7520297|NCT02513550|11858257|FG002|Double Blind Treatment Period|Death|2
7520298|NCT02513550|11858258|FG003|Double Blind Treatment Period|Death|0
7520299|NCT02513550|11858259|FG004|Double Blind Treatment Period|Death|0
7520300|NCT02513550|11858260|FG005|Double Blind Treatment Period|Death|0
7520301|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
7520302|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
7520303|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
7520304|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7520305|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7520306|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
7520307|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
7520308|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
7520309|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
7520310|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7520311|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7520312|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
7520313|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
7520314|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
7520315|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
7520316|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
7520317|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
7520318|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
7520319|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Adverse Event|1
7520320|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Adverse Event|1
7520321|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Adverse Event|4
7520322|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Adverse Event|0
7520323|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Adverse Event|0
7520324|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Adverse Event|0
7520325|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Physician Decision|2
7520326|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Physician Decision|0
7520327|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Physician Decision|0
7520328|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Physician Decision|0
7520329|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Physician Decision|0
7520330|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Physician Decision|0
7520331|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Death|0
7520332|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Death|0
7520333|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Death|1
7520334|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Death|0
7520335|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Death|0
7520336|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Death|0
7520337|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
7520338|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
7520339|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
7520340|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
7520341|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
7520342|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
7520343|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7520344|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7520345|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
7520346|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7520347|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7520348|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
7520349|NCT02513550|11858255|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
7520350|NCT02513550|11858256|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
7520351|NCT02513550|11858257|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
7520352|NCT02513550|11858258|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
7520353|NCT02513550|11858259|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
7520354|NCT02513550|11858260|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
7520355|NCT02513732|11858290|FG000|Overall Study|Lost to Follow-up|11
7520356|NCT02513732|11858290|FG000|Overall Study|Death|9
7520357|NCT02513732|11858290|FG000|Overall Study|Changing hospital|2
7520358|NCT02513745|11858296|FG000|Overall Study|Criteria at time of surgery not met.|3
7520359|NCT02513745|11858297|FG001|Overall Study|Criteria at time of surgery not met.|3
7520360|NCT02513771|11858305|FG000|Overall Study|Lost to Follow-up|1
7520361|NCT02513771|11858306|FG001|Overall Study|Lost to Follow-up|1
7520362|NCT02513771|11858305|FG000|Overall Study|Not being able to get to clinic|1
7520363|NCT02513771|11858306|FG001|Overall Study|Not being able to get to clinic|0
7520364|NCT02513823|11858312|FG000|Overall Study|Lost to Follow-up|4
7520365|NCT02513823|11858312|FG000|Overall Study|Physician Decision|1
7520366|NCT02514122|11858354|FG000|Overall Study|Withdrawal by Subject|2
7520367|NCT02514122|11858355|FG001|Overall Study|Withdrawal by Subject|0
7520368|NCT02514174|11858361|FG000|Overall Study|Patient refused to continue medication|1
7520369|NCT02514174|11858361|FG000|Overall Study|Adverse Event|2
7520370|NCT02514174|11858361|FG000|Overall Study|Study closed by sponsor|9
7520371|NCT02514174|11858361|FG000|Overall Study|Progressive disease|11
7520372|NCT02514174|11858361|FG000|Overall Study|Treatment change|1
7520373|NCT02514174|11858361|FG000|Overall Study|Treated off study with Afatinib.|1
7520374|NCT02514473|11858367|FG000|Overall Study|Adverse Event|0
7520375|NCT02514473|11858368|FG001|Overall Study|Adverse Event|2
7520376|NCT02514473|11858367|FG000|Overall Study|Withdrawal by Subject|2
7520377|NCT02514473|11858368|FG001|Overall Study|Withdrawal by Subject|1
7520378|NCT02514473|11858367|FG000|Overall Study|Lost to Follow-up|0
7520379|NCT02514473|11858368|FG001|Overall Study|Lost to Follow-up|1
7520380|NCT02514473|11858367|FG000|Overall Study|Other|1
7520381|NCT02514473|11858368|FG001|Overall Study|Other|1
7520382|NCT02514551|11858377|FG000|Overall Study|Lost to Follow-up|0
7520383|NCT02514551|11858378|FG001|Overall Study|Lost to Follow-up|1
7520384|NCT02514551|11858377|FG000|Overall Study|Participant Never Treated|0
7520385|NCT02514551|11858378|FG001|Overall Study|Participant Never Treated|2
7520386|NCT02514577|11858387|FG000|Overall Study|Lost to Follow-up|6
7520387|NCT02514577|11858388|FG001|Overall Study|Lost to Follow-up|6
7520388|NCT02514577|11858387|FG000|Overall Study|Protocol Violation|1
7520389|NCT02514577|11858388|FG001|Overall Study|Protocol Violation|0
7520390|NCT02514577|11858387|FG000|Overall Study|Withdrawal by Subject|6
7520391|NCT02514577|11858388|FG001|Overall Study|Withdrawal by Subject|6
7520392|NCT02514577|11858387|FG000|Overall Study|Adverse Event|1
7520393|NCT02514577|11858388|FG001|Overall Study|Adverse Event|1
7520394|NCT02514746|11858396|FG000|Overall Study|Chronically Ill|1
7520395|NCT02514746|11858397|FG001|Overall Study|Chronically Ill|2
7520396|NCT02514746|11858396|FG000|Overall Study|Physician Decision|4
7520397|NCT02514746|11858397|FG001|Overall Study|Physician Decision|2
7520398|NCT02514746|11858396|FG000|Overall Study|Withdrawal by Subject|12
7520399|NCT02514746|11858397|FG001|Overall Study|Withdrawal by Subject|10
7520400|NCT02514746|11858396|FG000|Overall Study|Other|5
7520401|NCT02514746|11858397|FG001|Overall Study|Other|1
7520402|NCT02514772|11858407|FG000|Overall Study|Adverse Event|1
7520403|NCT02514772|11858408|FG001|Overall Study|Adverse Event|0
7520404|NCT02514772|11858407|FG000|Overall Study|Death|0
7520405|NCT02514772|11858408|FG001|Overall Study|Death|1
7520406|NCT02514772|11858407|FG000|Overall Study|Withdrawal by Subject|2
7520407|NCT02514772|11858408|FG001|Overall Study|Withdrawal by Subject|1
7520408|NCT02514824|11858418|FG000|Overall Study|Withdrawal by Subject|1
7520409|NCT02514824|11858419|FG001|Overall Study|Withdrawal by Subject|0
7520410|NCT02514824|11858420|FG002|Overall Study|Withdrawal by Subject|0
7520411|NCT02514824|11858421|FG003|Overall Study|Withdrawal by Subject|0
7520412|NCT02514824|11858418|FG000|Overall Study|Dose-Limiting Toxicity|0
7520413|NCT02514824|11858419|FG001|Overall Study|Dose-Limiting Toxicity|1
7520414|NCT02514824|11858420|FG002|Overall Study|Dose-Limiting Toxicity|0
7520415|NCT02514824|11858421|FG003|Overall Study|Dose-Limiting Toxicity|0
7520416|NCT02515045|11858439|FG000|Overall Study|Adverse Event|0
7520417|NCT02515045|11858440|FG001|Overall Study|Adverse Event|3
7520418|NCT02515045|11858441|FG002|Overall Study|Adverse Event|3
7520419|NCT02515045|11858439|FG000|Overall Study|Lost to Follow-up|0
7520420|NCT02515045|11858440|FG001|Overall Study|Lost to Follow-up|1
7520421|NCT02515045|11858441|FG002|Overall Study|Lost to Follow-up|1
7520422|NCT02515097|11858460|FG000|Overall Study|Lost to Follow-up|4
7520423|NCT02515097|11858461|FG001|Overall Study|Lost to Follow-up|2
7520424|NCT02515097|11858460|FG000|Overall Study|Withdrawal by Subject|1
7520425|NCT02515097|11858461|FG001|Overall Study|Withdrawal by Subject|3
7520426|NCT02515097|11858460|FG000|Overall Study|Adverse Event|2
7520427|NCT02515097|11858461|FG001|Overall Study|Adverse Event|1
7520428|NCT02515279|11858476|FG000|Overall Study|Adverse Event|7
7520429|NCT02515279|11858476|FG000|Overall Study|Lack of Efficacy|31
7520430|NCT02515279|11858476|FG000|Overall Study|Lost to Follow-up|9
7520431|NCT02515279|11858476|FG000|Overall Study|Withdrawal by Subject|18
7520432|NCT02515279|11858476|FG000|Overall Study|End-of-treatment visit not attended|17
7520433|NCT02515279|11858476|FG000|Overall Study|Other|22
7520434|NCT02515331|11858496|FG000|Overall Study|Withdrawal by Subject|0
7520435|NCT02515331|11858497|FG001|Overall Study|Withdrawal by Subject|0
7520436|NCT02515331|11858498|FG002|Overall Study|Withdrawal by Subject|1
7520437|NCT02515331|11858496|FG000|Overall Study|Protocol deviation|0
7520438|NCT02515331|11858497|FG001|Overall Study|Protocol deviation|0
7520439|NCT02515331|11858498|FG002|Overall Study|Protocol deviation|3
7520440|NCT02515331|11858496|FG000|Overall Study|Adverse Event|2
7520441|NCT02515331|11858497|FG001|Overall Study|Adverse Event|0
7520442|NCT02515331|11858498|FG002|Overall Study|Adverse Event|0
7520443|NCT02515630|11858508|FG000|Overall Study|Withdrawal by Subject|5
7520444|NCT02515630|11858508|FG000|Overall Study|Adverse Event|4
7520445|NCT02515630|11858508|FG000|Overall Study|Physician Decision|4
7520446|NCT02515630|11858508|FG000|Overall Study|Death|2
7520447|NCT02515630|11858508|FG000|Overall Study|Disease Progression|1
7520448|NCT02515669|11858528|FG000|228 Week Open-Label Phase|Other|0
7520449|NCT02515669|11858529|FG001|228 Week Open-Label Phase|Other|0
7520450|NCT02515669|11858530|FG002|228 Week Open-Label Phase|Other|1
7520451|NCT02515669|11858531|FG003|228 Week Open-Label Phase|Other|4
7520452|NCT02515669|11858528|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
7520453|NCT02515669|11858529|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
7520454|NCT02515669|11858530|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
7520455|NCT02515669|11858531|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
7520456|NCT02515669|11858528|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7520457|NCT02515669|11858529|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
7520458|NCT02515669|11858530|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
7520459|NCT02515669|11858531|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
7520460|NCT02515669|11858528|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
7520461|NCT02515669|11858529|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
7520462|NCT02515669|11858530|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
7520463|NCT02515669|11858531|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
7520464|NCT02515669|11858528|FG000|228 Week Open-Label Phase|Missing|0
7520465|NCT02515669|11858529|FG001|228 Week Open-Label Phase|Missing|2
7520466|NCT02515669|11858530|FG002|228 Week Open-Label Phase|Missing|2
7520467|NCT02515669|11858531|FG003|228 Week Open-Label Phase|Missing|2
7520468|NCT02515942|11858594|FG000|Overall Study|Adverse Event|5
7520469|NCT02515942|11858595|FG001|Overall Study|Adverse Event|0
7520470|NCT02515942|11858596|FG002|Overall Study|Adverse Event|0
7520471|NCT02515942|11858594|FG000|Overall Study|Death|0
7520472|NCT02515942|11858595|FG001|Overall Study|Death|0
7520473|NCT02515942|11858596|FG002|Overall Study|Death|1
7520474|NCT02515942|11858594|FG000|Overall Study|Lack of Efficacy|0
7520475|NCT02515942|11858595|FG001|Overall Study|Lack of Efficacy|0
7520476|NCT02515942|11858596|FG002|Overall Study|Lack of Efficacy|1
7520477|NCT02515942|11858594|FG000|Overall Study|Lost to Follow-up|2
7520478|NCT02515942|11858595|FG001|Overall Study|Lost to Follow-up|0
7520479|NCT02515942|11858596|FG002|Overall Study|Lost to Follow-up|0
7520480|NCT02515942|11858594|FG000|Overall Study|Withdrawal by Subject|0
7520481|NCT02515942|11858595|FG001|Overall Study|Withdrawal by Subject|3
7520482|NCT02515942|11858596|FG002|Overall Study|Withdrawal by Subject|2
7520483|NCT02515994|11858608|FG000|Overall Study|Protocol Violation|3
7520484|NCT02515994|11858609|FG001|Overall Study|Protocol Violation|5
7520485|NCT02515994|11858608|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
7520486|NCT02515994|11858609|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7520487|NCT02515994|11858608|FG000|Overall Study|Adverse Event|3
7520488|NCT02515994|11858609|FG001|Overall Study|Adverse Event|1
7520489|NCT02515994|11858608|FG000|Overall Study|Withdrawal by Subject|2
7520490|NCT02515994|11858609|FG001|Overall Study|Withdrawal by Subject|0
7520491|NCT02516098|11858631|FG000|Period 1|Protocol Violation|1
7520492|NCT02516098|11858632|FG001|Period 1|Protocol Violation|0
7520493|NCT02516098|11858631|FG000|Washout After Period 1|Adverse Event|0
7520494|NCT02516098|11858632|FG001|Washout After Period 1|Adverse Event|1
7520495|NCT02516098|11858631|FG000|Period 2|Withdrawal by Subject|0
7520496|NCT02516098|11858632|FG001|Period 2|Withdrawal by Subject|1
7520497|NCT02516163|11858644|FG000|Overall Study|Withdrawal by Subject|1
7520498|NCT02516163|11858644|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
7520499|NCT02516163|11858644|FG000|Overall Study|Unfit/delay in surgery|3
7520500|NCT02516163|11858644|FG000|Overall Study|Use of incorrect measurement technique|5
7520501|NCT02516163|11858644|FG000|Overall Study|Data not recorded|2
7520502|NCT02516163|11858644|FG000|Overall Study|MRI contraindication exclusion|6
7520503|NCT02516202|11858651|FG000|Overall Study|Withdrawal by Subject|1
7520504|NCT02516202|11858652|FG001|Overall Study|Withdrawal by Subject|0
7520505|NCT02516202|11858653|FG002|Overall Study|Withdrawal by Subject|1
7520506|NCT02516202|11858651|FG000|Overall Study|Lost to Follow-up|1
7520507|NCT02516202|11858652|FG001|Overall Study|Lost to Follow-up|1
7520508|NCT02516202|11858653|FG002|Overall Study|Lost to Follow-up|1
7520509|NCT02516202|11858651|FG000|Overall Study|Stopped Follow-up|0
7520510|NCT02516202|11858652|FG001|Overall Study|Stopped Follow-up|0
7520511|NCT02516202|11858653|FG002|Overall Study|Stopped Follow-up|1
7520512|NCT02516306|11858663|FG000|Period 2: Day 8 - 91|Protocol Violation|1
7520513|NCT02516306|11858664|FG001|Period 2: Day 8 - 91|Protocol Violation|2
7520514|NCT02516332|11858673|FG000|Overall Study|Withdrawal by Subject|2
7520515|NCT02516332|11858674|FG001|Overall Study|Withdrawal by Subject|1
7520516|NCT02516332|11858675|FG002|Overall Study|Withdrawal by Subject|2
7520517|NCT02516410|11858685|FG000|Overall Study|Adverse Event|0
7520518|NCT02516410|11858686|FG001|Overall Study|Adverse Event|1
7520519|NCT02516410|11858685|FG000|Overall Study|Withdrawal by Subject|0
7520520|NCT02516410|11858686|FG001|Overall Study|Withdrawal by Subject|1
7520521|NCT02516592|11858699|FG000|Overall Study|Patient withdrew consent|5
7520522|NCT02516592|11858700|FG001|Overall Study|Patient withdrew consent|2
7520523|NCT02516592|11858699|FG000|Overall Study|Protocol deviation|4
7520524|NCT02516592|11858700|FG001|Overall Study|Protocol deviation|4
7520525|NCT02516592|11858699|FG000|Overall Study|Lost to Follow-up|2
7520526|NCT02516592|11858700|FG001|Overall Study|Lost to Follow-up|3
7520527|NCT02516592|11858699|FG000|Overall Study|Patient/guardian decision|2
7520528|NCT02516592|11858700|FG001|Overall Study|Patient/guardian decision|1
7520529|NCT02516592|11858699|FG000|Overall Study|Adverse Event|1
7520530|NCT02516592|11858700|FG001|Overall Study|Adverse Event|2
7520531|NCT02516592|11858699|FG000|Overall Study|Abnormal test procedure result|1
7520532|NCT02516592|11858700|FG001|Overall Study|Abnormal test procedure result|0
7520533|NCT02516592|11858699|FG000|Overall Study|Death|1
7520534|NCT02516592|11858700|FG001|Overall Study|Death|1
7520535|NCT02516605|11858711|FG000|Overall Study|Protocol Violation|0
7520536|NCT02516605|11858712|FG001|Overall Study|Protocol Violation|0
7520537|NCT02516605|11858713|FG002|Overall Study|Protocol Violation|0
7520538|NCT02516605|11858714|FG003|Overall Study|Protocol Violation|0
7520539|NCT02516605|11858715|FG004|Overall Study|Protocol Violation|1
7520540|NCT02516605|11858711|FG000|Overall Study|Withdrawal by Subject|0
7520541|NCT02516605|11858712|FG001|Overall Study|Withdrawal by Subject|0
7520542|NCT02516605|11858713|FG002|Overall Study|Withdrawal by Subject|0
7520543|NCT02516605|11858714|FG003|Overall Study|Withdrawal by Subject|1
7520544|NCT02516605|11858715|FG004|Overall Study|Withdrawal by Subject|0
7520545|NCT02516982|11858735|FG000|Overall Study|Called in to antenatal appointment|32
7520546|NCT02516982|11858736|FG001|Overall Study|Called in to antenatal appointment|35
7520547|NCT02516982|11858737|FG002|Overall Study|Called in to antenatal appointment|0
7520548|NCT02516982|11858738|FG003|Overall Study|Called in to antenatal appointment|0
7520549|NCT02516982|11858735|FG000|Overall Study|Withdrawal by Subject|0
7520550|NCT02516982|11858736|FG001|Overall Study|Withdrawal by Subject|0
7520551|NCT02516982|11858737|FG002|Overall Study|Withdrawal by Subject|1
7520552|NCT02516982|11858738|FG003|Overall Study|Withdrawal by Subject|2
7520553|NCT02516982|11858735|FG000|Overall Study|Protocol Violation|0
7520554|NCT02516982|11858736|FG001|Overall Study|Protocol Violation|0
7520555|NCT02516982|11858737|FG002|Overall Study|Protocol Violation|1
7520556|NCT02516982|11858738|FG003|Overall Study|Protocol Violation|1
7520557|NCT02516982|11858735|FG000|Overall Study|Did not install the app|0
7520558|NCT02516982|11858736|FG001|Overall Study|Did not install the app|0
7520559|NCT02516982|11858737|FG002|Overall Study|Did not install the app|46
7520560|NCT02516982|11858738|FG003|Overall Study|Did not install the app|47
7520561|NCT02517268|11858764|FG000|Overall Study|Withdrawal by Subject|1
7520562|NCT02517268|11858765|FG001|Overall Study|Withdrawal by Subject|0
7520563|NCT02517463|11858773|FG000|Overall Study|Lost to Follow-up|5
7520564|NCT02517463|11858774|FG001|Overall Study|Lost to Follow-up|2
7520565|NCT02517515|11858782|FG000|Overall Study|Adverse Event|0
7520566|NCT02517515|11858783|FG001|Overall Study|Adverse Event|1
7520567|NCT02517515|11858782|FG000|Overall Study|Withdrew Consent|0
7520568|NCT02517515|11858783|FG001|Overall Study|Withdrew Consent|1
7520569|NCT02517515|11858782|FG000|Overall Study|Lost to Follow-up|1
7520570|NCT02517515|11858783|FG001|Overall Study|Lost to Follow-up|0
7520571|NCT02517515|11858782|FG000|Overall Study|Other|1
7520572|NCT02517515|11858783|FG001|Overall Study|Other|0
7520573|NCT02517528|11858790|FG000|Overall Study|Withdrawal by Subject|1
7520574|NCT02517541|11858794|FG000|Baseline Period (Own Product)|Protocol Violation|1
7520575|NCT02517541|11858794|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
7520576|NCT02517541|11858794|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
7520577|NCT02517541|11858794|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
7520578|NCT02517541|11858794|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
7520579|NCT02517541|11858794|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
7536839|NCT02725268|11885019|FG000|Overall Study|Lost to Follow-up|4
7536840|NCT02725268|11885020|FG001|Overall Study|Lost to Follow-up|3
7536841|NCT02725268|11885021|FG002|Overall Study|Lost to Follow-up|0
7536842|NCT02725268|11885022|FG003|Overall Study|Lost to Follow-up|1
7536843|NCT02725268|11885019|FG000|Overall Study|Site Terminated by Sponsor|0
7536844|NCT02725268|11885020|FG001|Overall Study|Site Terminated by Sponsor|1
7536845|NCT02725268|11885021|FG002|Overall Study|Site Terminated by Sponsor|0
7536846|NCT02725268|11885022|FG003|Overall Study|Site Terminated by Sponsor|0
7536847|NCT02725268|11885019|FG000|Overall Study|Withdrawal by Subject|8
7536848|NCT02725268|11885020|FG001|Overall Study|Withdrawal by Subject|6
7536849|NCT02725268|11885021|FG002|Overall Study|Withdrawal by Subject|8
7536850|NCT02725268|11885022|FG003|Overall Study|Withdrawal by Subject|1
7536851|NCT02725268|11885019|FG000|Overall Study|Reason not Specified|2
7536852|NCT02725268|11885020|FG001|Overall Study|Reason not Specified|1
7536853|NCT02725268|11885021|FG002|Overall Study|Reason not Specified|0
7536854|NCT02725268|11885022|FG003|Overall Study|Reason not Specified|0
7536855|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Adverse Event|3
7536856|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Adverse Event|5
7536857|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Adverse Event|4
7536858|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1
7536859|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4
7536860|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1
7536861|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0
7536862|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1
7536863|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0
7536864|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Other|1
7536865|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Other|4
7536866|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Other|5
7536867|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0
7536868|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1
7536869|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4
7536870|NCT02725411|11885035|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
7536871|NCT02725411|11885036|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7536872|NCT02725411|11885037|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
7536873|NCT02725411|11885035|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
7536874|NCT02725411|11885036|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
7536875|NCT02725411|11885037|FG002|Follow-up Period (24 Weeks)|Adverse Event|0
7536876|NCT02725411|11885035|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7536877|NCT02725411|11885036|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2
7536878|NCT02725411|11885037|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0
7536879|NCT02725411|11885035|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7536880|NCT02725411|11885036|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1
7536881|NCT02725411|11885037|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0
7536882|NCT02725411|11885035|FG000|Follow-up Period (24 Weeks)|Other|1
7536883|NCT02725411|11885036|FG001|Follow-up Period (24 Weeks)|Other|4
7536884|NCT02725411|11885037|FG002|Follow-up Period (24 Weeks)|Other|2
7536885|NCT02725411|11885035|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7536886|NCT02725411|11885036|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7536887|NCT02725411|11885037|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
7536888|NCT02725476|11885047|FG000|Overall Study|Physician Decision|2
7536889|NCT02725476|11885048|FG001|Overall Study|Physician Decision|0
7536890|NCT02725476|11885047|FG000|Overall Study|Adverse Event|1
7536891|NCT02725476|11885048|FG001|Overall Study|Adverse Event|1
7536892|NCT02725515|11885056|FG000|Overall Study|Refused infusion (no study treatment)|1
7536893|NCT02725515|11885057|FG001|Overall Study|Refused infusion (no study treatment)|0
7536894|NCT02725515|11885056|FG000|Overall Study|Loss of Improvement per Protocol|14
7536895|NCT02725515|11885057|FG001|Overall Study|Loss of Improvement per Protocol|25
7536896|NCT02725515|11885056|FG000|Overall Study|Withdrawal by Subject|2
7536897|NCT02725515|11885057|FG001|Overall Study|Withdrawal by Subject|1
7536898|NCT02725515|11885056|FG000|Overall Study|Non-Compliance With Study Drug|0
7536899|NCT02725515|11885057|FG001|Overall Study|Non-Compliance With Study Drug|3
7536900|NCT02725515|11885056|FG000|Overall Study|Lost to Follow-up|1
7536901|NCT02725515|11885057|FG001|Overall Study|Lost to Follow-up|1
7536902|NCT02725515|11885056|FG000|Overall Study|Adverse Event|7
7536903|NCT02725515|11885057|FG001|Overall Study|Adverse Event|2
7536904|NCT02725515|11885056|FG000|Overall Study|No Documented Disease Improvement|0
7536905|NCT02725515|11885057|FG001|Overall Study|No Documented Disease Improvement|1
7536906|NCT02725515|11885056|FG000|Overall Study|Completed Study Under Original Protocol|0
7536907|NCT02725515|11885057|FG001|Overall Study|Completed Study Under Original Protocol|1
7536908|NCT02725515|11885056|FG000|Overall Study|Lack of Response|0
7536909|NCT02725515|11885057|FG001|Overall Study|Lack of Response|1
7536910|NCT02725710|11885069|FG000|Overall Study|Lost to Follow-up|1
7536911|NCT02725710|11885070|FG001|Overall Study|Lost to Follow-up|0
7536912|NCT02725788|11885078|FG000|Overall Study|Lost to Follow-up|1
7536913|NCT02725788|11885079|FG001|Overall Study|Lost to Follow-up|1
7536914|NCT02725788|11885078|FG000|Overall Study|Protocol Violation|0
7536915|NCT02725788|11885079|FG001|Overall Study|Protocol Violation|1
7520580|NCT02517866|11858829|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7520581|NCT02517866|11858830|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7520582|NCT02517866|11858831|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7520583|NCT02517866|11858829|FG000|Overall Study|Significant Protocol Deviation|4
7520584|NCT02517866|11858830|FG001|Overall Study|Significant Protocol Deviation|1
7520585|NCT02517866|11858831|FG002|Overall Study|Significant Protocol Deviation|0
7520586|NCT02517866|11858829|FG000|Overall Study|Lost to Follow-up|1
7520587|NCT02517866|11858830|FG001|Overall Study|Lost to Follow-up|0
7520588|NCT02517866|11858831|FG002|Overall Study|Lost to Follow-up|0
7520589|NCT02517866|11858829|FG000|Overall Study|Voluntary Withdrawal|2
7520590|NCT02517866|11858830|FG001|Overall Study|Voluntary Withdrawal|2
7520591|NCT02517866|11858831|FG002|Overall Study|Voluntary Withdrawal|0
7520592|NCT02517866|11858829|FG000|Overall Study|Investigator Decision|2
7520593|NCT02517866|11858830|FG001|Overall Study|Investigator Decision|1
7520594|NCT02517866|11858831|FG002|Overall Study|Investigator Decision|0
7520595|NCT02517866|11858829|FG000|Overall Study|Reason not specified|2
7520596|NCT02517866|11858830|FG001|Overall Study|Reason not specified|0
7520597|NCT02517866|11858831|FG002|Overall Study|Reason not specified|0
7520598|NCT02517905|11858843|FG000|Overall Study|Lost to Follow-up|4
7520599|NCT02517905|11858844|FG001|Overall Study|Lost to Follow-up|0
7520600|NCT02517905|11858843|FG000|Overall Study|Withdrawal by Subject|4
7520601|NCT02517905|11858844|FG001|Overall Study|Withdrawal by Subject|0
7520602|NCT02517905|11858843|FG000|Overall Study|Screen failure|2
7520603|NCT02517905|11858844|FG001|Overall Study|Screen failure|2
7520604|NCT02518048|11858859|FG000|Overall Study|Withdrawal by Subject|1
7520605|NCT02518113|11858868|FG000|Overall Study|Adverse Event|1
7520606|NCT02518113|11858869|FG001|Overall Study|Adverse Event|0
7520607|NCT02518113|11858870|FG002|Overall Study|Adverse Event|1
7520608|NCT02518113|11858871|FG003|Overall Study|Adverse Event|0
7520609|NCT02518113|11858868|FG000|Overall Study|Death|1
7520610|NCT02518113|11858869|FG001|Overall Study|Death|2
7520611|NCT02518113|11858870|FG002|Overall Study|Death|0
7520612|NCT02518113|11858871|FG003|Overall Study|Death|0
7520613|NCT02518113|11858868|FG000|Overall Study|Physician Decision|0
7520614|NCT02518113|11858869|FG001|Overall Study|Physician Decision|1
7520615|NCT02518113|11858870|FG002|Overall Study|Physician Decision|0
7520616|NCT02518113|11858871|FG003|Overall Study|Physician Decision|0
7520617|NCT02518113|11858868|FG000|Overall Study|Progressive Disease|1
7520618|NCT02518113|11858869|FG001|Overall Study|Progressive Disease|2
7520619|NCT02518113|11858870|FG002|Overall Study|Progressive Disease|3
7520620|NCT02518113|11858871|FG003|Overall Study|Progressive Disease|0
7520621|NCT02518464|11858905|FG000|Overall Study|Adverse Event|2
7520622|NCT02518490|11858909|FG000|Overall Study|Withdrawal by Subject|1
7520623|NCT02518490|11858910|FG001|Overall Study|Withdrawal by Subject|1
7520624|NCT02518620|11858919|FG000|Overall Study|Adverse Event|23
7520625|NCT02518620|11858920|FG001|Overall Study|Adverse Event|11
7520626|NCT02518620|11858919|FG000|Overall Study|Lack of Efficacy|2
7520627|NCT02518620|11858920|FG001|Overall Study|Lack of Efficacy|0
7520628|NCT02518620|11858919|FG000|Overall Study|Non-Compliance with Study Drug|1
7520629|NCT02518620|11858920|FG001|Overall Study|Non-Compliance with Study Drug|0
7520630|NCT02518620|11858919|FG000|Overall Study|Physician Decision|1
7520631|NCT02518620|11858920|FG001|Overall Study|Physician Decision|1
7520632|NCT02518620|11858919|FG000|Overall Study|Sponsor's Decision|0
7520633|NCT02518620|11858920|FG001|Overall Study|Sponsor's Decision|3
7520634|NCT02518620|11858919|FG000|Overall Study|Lost to Follow-up|1
7520635|NCT02518620|11858920|FG001|Overall Study|Lost to Follow-up|1
7520636|NCT02518620|11858919|FG000|Overall Study|Withdrawal by Subject|17
7520637|NCT02518620|11858920|FG001|Overall Study|Withdrawal by Subject|9
7520638|NCT02518620|11858919|FG000|Overall Study|Death|1
7520639|NCT02518620|11858920|FG001|Overall Study|Death|0
7520640|NCT02518620|11858919|FG000|Overall Study|Pregnancy Wish|3
7520641|NCT02518620|11858920|FG001|Overall Study|Pregnancy Wish|0
7520642|NCT02518620|11858919|FG000|Overall Study|Pregnancy|1
7520643|NCT02518620|11858920|FG001|Overall Study|Pregnancy|0
7520644|NCT02518620|11858919|FG000|Overall Study|Relocation|2
7520645|NCT02518620|11858920|FG001|Overall Study|Relocation|1
7520646|NCT02518685|11858930|FG000|Overall Study|Adverse Event|29
7520647|NCT02518685|11858931|FG001|Overall Study|Adverse Event|1
7520648|NCT02518685|11858930|FG000|Overall Study|Withdrawal by Subject|10
7520649|NCT02518685|11858931|FG001|Overall Study|Withdrawal by Subject|3
7520650|NCT02518685|11858930|FG000|Overall Study|relocation, study fatigue|7
7520651|NCT02518685|11858931|FG001|Overall Study|relocation, study fatigue|2
7520652|NCT02518685|11858930|FG000|Overall Study|Pregnancy|1
7520653|NCT02518685|11858931|FG001|Overall Study|Pregnancy|0
7520654|NCT02518685|11858930|FG000|Overall Study|Physician Decision|1
7520655|NCT02518685|11858931|FG001|Overall Study|Physician Decision|0
7520656|NCT02518685|11858930|FG000|Overall Study|Lost to Follow-up|1
7520657|NCT02518685|11858931|FG001|Overall Study|Lost to Follow-up|4
7520658|NCT02518919|11858941|FG000|Overall Study|Protocol Violation|1
7520659|NCT02518919|11858942|FG001|Overall Study|Protocol Violation|1
7520660|NCT02518919|11858943|FG002|Overall Study|Protocol Violation|2
7520661|NCT02518971|11858953|FG000|Overall Study|Lost to Follow-up|0
7520662|NCT02518971|11858954|FG001|Overall Study|Lost to Follow-up|1
7520663|NCT02518971|11858953|FG000|Overall Study|Physician Decision|6
7520664|NCT02518971|11858954|FG001|Overall Study|Physician Decision|6
7520665|NCT02518971|11858953|FG000|Overall Study|Protocol Violation|6
7520666|NCT02518971|11858954|FG001|Overall Study|Protocol Violation|4
7520667|NCT02518971|11858953|FG000|Overall Study|Withdrawal by Subject|4
7520668|NCT02518971|11858954|FG001|Overall Study|Withdrawal by Subject|5
7520669|NCT02518971|11858953|FG000|Overall Study|Side effects|1
7520670|NCT02518971|11858954|FG001|Overall Study|Side effects|0
7520671|NCT02518971|11858953|FG000|Overall Study|medication lost in mail|0
7520672|NCT02518971|11858954|FG001|Overall Study|medication lost in mail|1
7520673|NCT02518971|11858953|FG000|Overall Study|eligibility criteria no longer met|6
7520674|NCT02518971|11858954|FG001|Overall Study|eligibility criteria no longer met|3
7520675|NCT02519231|11859009|FG000|Overall Study|Lost to Follow-up|2
7520676|NCT02519231|11859010|FG001|Overall Study|Lost to Follow-up|5
7520677|NCT02519231|11859009|FG000|Overall Study|Withdrawal by Subject|0
7520678|NCT02519231|11859010|FG001|Overall Study|Withdrawal by Subject|1
7520679|NCT02519504|11859037|FG000|Overall Study|Protocol Violation|6
7520680|NCT02519504|11859038|FG001|Overall Study|Protocol Violation|5
7520681|NCT02519504|11859037|FG000|Overall Study|Ineligible for direct testing|12
7520682|NCT02519504|11859038|FG001|Overall Study|Ineligible for direct testing|12
7520683|NCT02519504|11859037|FG000|Overall Study|Did not participate in direct testing|95
7520684|NCT02519504|11859038|FG001|Overall Study|Did not participate in direct testing|86
7520685|NCT02519595|11859047|FG000|Overall Study|Protocol Violation|8
7520686|NCT02519595|11859048|FG001|Overall Study|Protocol Violation|22
7520687|NCT02519595|11859049|FG002|Overall Study|Protocol Violation|16
7520688|NCT02519842|11859072|FG000|Base Study: Cycle 1|Screening Failure|1
7520689|NCT02519842|11859073|FG001|Base Study: Cycle 1|Screening Failure|1
7520690|NCT02519842|11859074|FG002|Base Study: Cycle 1|Screening Failure|0
7520691|NCT02519842|11859072|FG000|Base Study: Cycle 1|Adverse Event|1
7520692|NCT02519842|11859073|FG001|Base Study: Cycle 1|Adverse Event|0
7520693|NCT02519842|11859074|FG002|Base Study: Cycle 1|Adverse Event|0
7520694|NCT02519842|11859072|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7520695|NCT02519842|11859073|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
7520696|NCT02519842|11859074|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
7520697|NCT02519842|11859072|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
7520698|NCT02519842|11859073|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
7520699|NCT02519842|11859074|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
7520700|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
7520701|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
7520702|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
7520703|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
7520704|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
7520705|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
7520706|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7520707|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
7520708|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
7520709|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7520710|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
7520711|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
7520712|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Death|0
7520713|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Death|0
7520714|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Death|1
7520715|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7520716|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
7520717|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
7520718|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7520719|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
7520720|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
7520721|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7520722|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
7520723|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
7520724|NCT02519842|11859072|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7520725|NCT02519842|11859073|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
7520726|NCT02519842|11859074|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
7520727|NCT02519855|11859084|FG000|Overall Study|Adverse Event|0
7520728|NCT02519855|11859085|FG001|Overall Study|Adverse Event|1
7520729|NCT02519855|11859084|FG000|Overall Study|Lost to Follow-up|3
7520730|NCT02519855|11859085|FG001|Overall Study|Lost to Follow-up|3
7520731|NCT02520089|11859093|FG000|Overall Study|Lost to Follow-up|3
7520732|NCT02520089|11859094|FG001|Overall Study|Lost to Follow-up|4
7520733|NCT02520284|11859103|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
7520734|NCT02520284|11859104|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
7520735|NCT02520284|11859105|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
7520736|NCT02520284|11859103|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7520737|NCT02520284|11859104|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7520738|NCT02520284|11859105|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
7520739|NCT02520284|11859103|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7520740|NCT02520284|11859104|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
7520741|NCT02520284|11859105|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
7520742|NCT02520284|11859103|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
7520743|NCT02520284|11859104|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
7520744|NCT02520284|11859105|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
7520745|NCT02520284|11859103|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7520746|NCT02520284|11859104|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
7520747|NCT02520284|11859105|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
7520748|NCT02520284|11859103|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7520749|NCT02520284|11859104|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
7520750|NCT02520284|11859105|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
7520751|NCT02520284|11859103|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7520752|NCT02520284|11859104|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
7520753|NCT02520284|11859105|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
7520754|NCT02520284|11859103|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
7520755|NCT02520284|11859104|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
7520756|NCT02520284|11859105|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
7520757|NCT02520284|11859103|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
7520758|NCT02520284|11859104|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
7520759|NCT02520284|11859105|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
7520760|NCT02520284|11859103|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
7520761|NCT02520284|11859104|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
7520762|NCT02520284|11859105|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
7520763|NCT02520284|11859103|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
7520764|NCT02520284|11859104|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7520765|NCT02520284|11859105|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
7520766|NCT02520310|11859119|FG000|At 6 Months Clinical Follow-up|Death|1
7520767|NCT02520310|11859119|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
7520768|NCT02520310|11859119|FG000|AT 3 Year Clinical Follow-up|Death|2
7520769|NCT02520310|11859119|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
7520770|NCT02520310|11859119|FG000|AT 4 Year Clinical Follow-up|Death|1
7520771|NCT02520310|11859119|FG000|AT 4 Year Clinical Follow-up|missed visit|1
7520772|NCT02520388|11859127|FG000|Overall Study|Physician Decision|1
7520773|NCT02520388|11859128|FG001|Overall Study|Physician Decision|0
7520774|NCT02520388|11859127|FG000|Overall Study|Subject or parent/guardian request|0
7520775|NCT02520388|11859128|FG001|Overall Study|Subject or parent/guardian request|6
7520776|NCT02520388|11859127|FG000|Overall Study|Adverse Event|1
7520777|NCT02520388|11859128|FG001|Overall Study|Adverse Event|4
7520778|NCT02520388|11859127|FG000|Overall Study|Lost to Follow-up|3
7520779|NCT02520388|11859128|FG001|Overall Study|Lost to Follow-up|2
7520780|NCT02520388|11859127|FG000|Overall Study|Other (reason not defined)|4
7520781|NCT02520388|11859128|FG001|Overall Study|Other (reason not defined)|4
7520782|NCT02520531|11859159|FG000|Overall Study|Revision of study device components|2
7520783|NCT02520531|11859160|FG001|Overall Study|Revision of study device components|2
7520784|NCT02520531|11859159|FG000|Overall Study|Death|1
7520785|NCT02520531|11859160|FG001|Overall Study|Death|2
7520786|NCT02520531|11859159|FG000|Overall Study|Lost to Follow-up|1
7520787|NCT02520531|11859160|FG001|Overall Study|Lost to Follow-up|1
7520788|NCT02520531|11859159|FG000|Overall Study|Meet exclusion criterion|0
7520789|NCT02520531|11859160|FG001|Overall Study|Meet exclusion criterion|1
7520790|NCT02520531|11859159|FG000|Overall Study|Withdrawal by Subject|1
7520791|NCT02520531|11859160|FG001|Overall Study|Withdrawal by Subject|0
7520792|NCT02520531|11859159|FG000|Overall Study|Not study device|1
7520793|NCT02520531|11859160|FG001|Overall Study|Not study device|0
7520794|NCT02521376|11859192|FG000|Overall Study|Enrolled, But Not Treated|1
7520795|NCT02521376|11859193|FG001|Overall Study|Enrolled, But Not Treated|0
7520796|NCT02521376|11859194|FG002|Overall Study|Enrolled, But Not Treated|0
7520797|NCT02521376|11859195|FG003|Overall Study|Enrolled, But Not Treated|0
7520798|NCT02521792|11859233|FG000|Overall Study|Study Terminated|6
7520799|NCT02521870|11859245|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520800|NCT02521870|11859246|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
7520801|NCT02521870|11859247|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520802|NCT02521870|11859248|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520803|NCT02521870|11859249|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520804|NCT02521870|11859250|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520805|NCT02521870|11859251|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520806|NCT02521870|11859252|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520807|NCT02521870|11859253|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520808|NCT02521870|11859254|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520809|NCT02521870|11859255|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520810|NCT02521870|11859256|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
7520811|NCT02521870|11859245|FG000|Phase 1: Dose Escalation|Adverse Event|2
7520812|NCT02521870|11859246|FG001|Phase 1: Dose Escalation|Adverse Event|1
7520813|NCT02521870|11859247|FG002|Phase 1: Dose Escalation|Adverse Event|0
7520814|NCT02521870|11859248|FG003|Phase 1: Dose Escalation|Adverse Event|0
7520815|NCT02521870|11859249|FG004|Phase 1: Dose Escalation|Adverse Event|0
7520816|NCT02521870|11859250|FG005|Phase 1: Dose Escalation|Adverse Event|0
7520817|NCT02521870|11859251|FG006|Phase 1: Dose Escalation|Adverse Event|0
7520818|NCT02521870|11859252|FG007|Phase 1: Dose Escalation|Adverse Event|0
7520819|NCT02521870|11859253|FG008|Phase 1: Dose Escalation|Adverse Event|0
7520820|NCT02521870|11859254|FG009|Phase 1: Dose Escalation|Adverse Event|0
7520821|NCT02521870|11859255|FG010|Phase 1: Dose Escalation|Adverse Event|0
7520822|NCT02521870|11859256|FG011|Phase 1: Dose Escalation|Adverse Event|0
7520823|NCT02521870|11859245|FG000|Phase 1: Dose Escalation|Progressive Disease|3
7520824|NCT02521870|11859246|FG001|Phase 1: Dose Escalation|Progressive Disease|2
7520825|NCT02521870|11859247|FG002|Phase 1: Dose Escalation|Progressive Disease|4
7520826|NCT02521870|11859248|FG003|Phase 1: Dose Escalation|Progressive Disease|6
7520827|NCT02521870|11859249|FG004|Phase 1: Dose Escalation|Progressive Disease|0
7520828|NCT02521870|11859250|FG005|Phase 1: Dose Escalation|Progressive Disease|0
7520829|NCT02521870|11859251|FG006|Phase 1: Dose Escalation|Progressive Disease|0
7520830|NCT02521870|11859252|FG007|Phase 1: Dose Escalation|Progressive Disease|0
7520831|NCT02521870|11859253|FG008|Phase 1: Dose Escalation|Progressive Disease|0
7520832|NCT02521870|11859254|FG009|Phase 1: Dose Escalation|Progressive Disease|0
7520833|NCT02521870|11859255|FG010|Phase 1: Dose Escalation|Progressive Disease|0
7520834|NCT02521870|11859256|FG011|Phase 1: Dose Escalation|Progressive Disease|0
7520835|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520836|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520837|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520838|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520839|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
7520840|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
7520841|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
7520842|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520843|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
7520844|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
7520845|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
7520846|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
7520847|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Adverse Event|0
7520848|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Adverse Event|0
7520849|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Adverse Event|0
7520850|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Adverse Event|0
7520851|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Adverse Event|11
7520852|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Adverse Event|2
7520853|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Adverse Event|0
7520854|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Adverse Event|1
7520855|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Adverse Event|5
7520856|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Adverse Event|0
7520857|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Adverse Event|1
7520858|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Adverse Event|0
7520859|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Progressive Disease|0
7520860|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Progressive Disease|0
7520861|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Progressive Disease|0
7520862|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Progressive Disease|0
7520863|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Progressive Disease|22
7520864|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Progressive Disease|18
7520865|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Progressive Disease|17
7520866|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Progressive Disease|7
7520867|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Progressive Disease|5
7520868|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Progressive Disease|17
7520869|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Progressive Disease|17
7520870|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Progressive Disease|21
7520871|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Death|0
7520872|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Death|0
7520873|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Death|0
7520874|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Death|0
7520875|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Death|1
7520876|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Death|1
7520877|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Death|3
7520878|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Death|1
7520879|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Death|1
7520880|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Death|5
7520881|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Death|2
7520882|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Death|2
7520883|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Other|0
7520884|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Other|0
7520885|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Other|0
7520886|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Other|0
7520887|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Other|10
7520888|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Other|3
7520889|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Other|2
7520890|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Other|0
7520891|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Other|10
7520892|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Other|5
7520893|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Other|1
7520894|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Other|7
7520895|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
7520896|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
7520897|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
7520898|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
7520899|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
7520900|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
7520901|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
7520902|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
7520903|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
7520904|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
7520905|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
7520906|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
7520907|NCT02521870|11859245|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520908|NCT02521870|11859246|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520909|NCT02521870|11859247|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520910|NCT02521870|11859248|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520911|NCT02521870|11859249|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
7520912|NCT02521870|11859250|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520913|NCT02521870|11859251|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520914|NCT02521870|11859252|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520915|NCT02521870|11859253|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520916|NCT02521870|11859254|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520917|NCT02521870|11859255|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520918|NCT02521870|11859256|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
7520919|NCT02521948|11859286|FG000|Overall Study|Adverse Event|2
7520920|NCT02521948|11859286|FG000|Overall Study|Death|4
7520921|NCT02521948|11859286|FG000|Overall Study|Lost to Follow-up|1
7520922|NCT02521948|11859286|FG000|Overall Study|Did not attend one or both follow-ups|6
7520923|NCT02522286|11859323|FG000|Overall Study|Withdrawal by Subject|3
7520924|NCT02522286|11859324|FG001|Overall Study|Withdrawal by Subject|0
7520925|NCT02522286|11859325|FG002|Overall Study|Withdrawal by Subject|0
7520926|NCT02522286|11859326|FG003|Overall Study|Withdrawal by Subject|3
7520927|NCT02522299|11859338|FG000|Overall Study|Adverse Event|2
7520928|NCT02522299|11859339|FG001|Overall Study|Adverse Event|0
7520929|NCT02522299|11859338|FG000|Overall Study|Physician Decision|0
7520930|NCT02522299|11859339|FG001|Overall Study|Physician Decision|1
7520931|NCT02522299|11859338|FG000|Overall Study|Withdrawal by Subject|2
7520932|NCT02522299|11859339|FG001|Overall Study|Withdrawal by Subject|0
7520933|NCT02522325|11859359|FG000|Overall Study|Adverse Event|0
7520934|NCT02522325|11859360|FG001|Overall Study|Adverse Event|1
7520935|NCT02522377|11859368|FG000|Overall Study|Withdrawal by Subject|1
7520936|NCT02522377|11859369|FG001|Overall Study|Withdrawal by Subject|0
7520937|NCT02522377|11859368|FG000|Overall Study|Remission Achieved|3
7520938|NCT02522377|11859369|FG001|Overall Study|Remission Achieved|0
7520939|NCT02522403|11859377|FG000|Overall Study|Lost to Follow-up|2
7520940|NCT02522403|11859378|FG001|Overall Study|Lost to Follow-up|2
7520941|NCT02522403|11859377|FG000|Overall Study|Withdrawal by Subject|2
7520942|NCT02522403|11859378|FG001|Overall Study|Withdrawal by Subject|4
7520943|NCT02522481|11859393|FG000|Overall Study|discontinued|1
7520944|NCT02522481|11859393|FG000|Overall Study|Not dosed|2
7520955|NCT02522624|11859415|FG000|Overall Study|Technical failure|1
7520956|NCT02522624|11859416|FG001|Overall Study|Technical failure|0
7520957|NCT02522728|11859424|FG000|Overall Study|Withdrawal by Subject|6
7520958|NCT02522728|11859425|FG001|Overall Study|Withdrawal by Subject|6
7520959|NCT02522728|11859424|FG000|Overall Study|Death|4
7520960|NCT02522728|11859425|FG001|Overall Study|Death|3
7520961|NCT02522728|11859424|FG000|Overall Study|Adverse Event|2
7520962|NCT02522728|11859425|FG001|Overall Study|Adverse Event|1
7520963|NCT02522728|11859424|FG000|Overall Study|Did not receive randomized study device|0
7520964|NCT02522728|11859425|FG001|Overall Study|Did not receive randomized study device|1
7520965|NCT02522767|11859433|FG000|Double-blind|Withdrawal by Subject|8
7520966|NCT02522767|11859434|FG001|Double-blind|Withdrawal by Subject|11
7520967|NCT02522767|11859433|FG000|Double-blind|Lost to Follow-up|1
7520968|NCT02522767|11859434|FG001|Double-blind|Lost to Follow-up|0
7520969|NCT02522767|11859433|FG000|Double-blind|Adverse Event|1
7520970|NCT02522767|11859434|FG001|Double-blind|Adverse Event|10
7520971|NCT02522767|11859433|FG000|Double-blind|Protocol Violation|0
7520972|NCT02522767|11859434|FG001|Double-blind|Protocol Violation|1
7520973|NCT02522767|11859433|FG000|Double-blind|Lack of Efficacy|0
7520974|NCT02522767|11859434|FG001|Double-blind|Lack of Efficacy|2
7520975|NCT02522767|11859433|FG000|Double-blind|Protocol Deviation|1
7520976|NCT02522767|11859434|FG001|Double-blind|Protocol Deviation|0
7520977|NCT02522767|11859433|FG000|Open-label|Withdrawal by Subject|2
7520978|NCT02522767|11859434|FG001|Open-label|Withdrawal by Subject|3
7520979|NCT02522767|11859433|FG000|Open-label|Lost to Follow-up|0
7520980|NCT02522767|11859434|FG001|Open-label|Lost to Follow-up|1
7520981|NCT02522767|11859433|FG000|Open-label|Adverse Event|2
7520982|NCT02522767|11859434|FG001|Open-label|Adverse Event|1
7520983|NCT02522767|11859433|FG000|Open-label|Lack of Efficacy|1
7520984|NCT02522767|11859434|FG001|Open-label|Lack of Efficacy|1
7520985|NCT02522767|11859433|FG000|Open-label|Protocol Violation|0
7520986|NCT02522767|11859434|FG001|Open-label|Protocol Violation|1
7520987|NCT02522780|11859444|FG000|Overall Study|Consent withdrawn by subject|5
7520988|NCT02522780|11859445|FG001|Overall Study|Consent withdrawn by subject|7
7520989|NCT02522780|11859444|FG000|Overall Study|Protocol deviation|1
7520990|NCT02522780|11859445|FG001|Overall Study|Protocol deviation|3
7520991|NCT02522780|11859444|FG000|Overall Study|Subject refused endoscopic procedure|0
7520992|NCT02522780|11859445|FG001|Overall Study|Subject refused endoscopic procedure|1
7520993|NCT02522780|11859444|FG000|Overall Study|Adverse event, non-fatal|11
7520994|NCT02522780|11859445|FG001|Overall Study|Adverse event, non-fatal|16
7520995|NCT02522884|11859461|FG000|Overall Study|Withdrawal by Subject|6
7520996|NCT02522884|11859461|FG000|Overall Study|Death|3
7520997|NCT02522884|11859461|FG000|Overall Study|Missed 12-month Follow-up|9
7520998|NCT02523599|11859497|FG000|Overall Study|Adverse Event|1
7520999|NCT02523599|11859498|FG001|Overall Study|Adverse Event|0
7521000|NCT02523599|11859497|FG000|Overall Study|Physician Decision|1
7521001|NCT02523599|11859498|FG001|Overall Study|Physician Decision|0
7521002|NCT02523599|11859497|FG000|Overall Study|Lost to Follow-up|4
7521003|NCT02523599|11859498|FG001|Overall Study|Lost to Follow-up|1
7521004|NCT02523599|11859497|FG000|Overall Study|Did not return for Day 30 visit|2
7521005|NCT02523599|11859498|FG001|Overall Study|Did not return for Day 30 visit|0
7521006|NCT02524145|11859547|FG000|Overall Study|Withdrawal by Subject|2
7521007|NCT02524145|11859548|FG001|Overall Study|Withdrawal by Subject|2
7521008|NCT02524145|11859549|FG002|Overall Study|Withdrawal by Subject|3
7521009|NCT02524158|11859559|FG000|12-weeks Assessment|Withdrawal by Subject|1
7521010|NCT02524158|11859560|FG001|12-weeks Assessment|Withdrawal by Subject|1
7521011|NCT02524158|11859559|FG000|12-weeks Assessment|Lost to Follow-up|18
7521012|NCT02524158|11859560|FG001|12-weeks Assessment|Lost to Follow-up|12
7521013|NCT02524158|11859559|FG000|6-month Assessment|Withdrawal by Subject|1
7521014|NCT02524158|11859560|FG001|6-month Assessment|Withdrawal by Subject|1
7521015|NCT02524158|11859559|FG000|6-month Assessment|Lost to Follow-up|21
7521016|NCT02524158|11859560|FG001|6-month Assessment|Lost to Follow-up|20
7521017|NCT02524665|11859589|FG000|Overall Study|Lost to Follow-up|1
7521018|NCT02524730|11859594|FG000|Overall Study|Lost to Follow-up|5
7521019|NCT02524730|11859594|FG000|Overall Study|Withdrawal by Subject|18
7521020|NCT02524730|11859594|FG000|Overall Study|Death|10
7521021|NCT02524730|11859594|FG000|Overall Study|Adverse Event|8
7521022|NCT02524730|11859594|FG000|Overall Study|Protocol Violation|1
7521023|NCT02524730|11859594|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
7521024|NCT02524847|11859602|FG000|Overall Study|Adverse Event|4
7521025|NCT02524847|11859602|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
7521026|NCT02524847|11859602|FG000|Overall Study|Condition no Longer Requires Treatment|4
7521027|NCT02524847|11859602|FG000|Overall Study|Death|1
7521028|NCT02524847|11859602|FG000|Overall Study|Reason not Specified|1
7521029|NCT02525094|11859645|FG000|Overall Study|Lost to Follow-up|2
7521030|NCT02525094|11859646|FG001|Overall Study|Lost to Follow-up|1
7521031|NCT02525094|11859645|FG000|Overall Study|Withdrawal by Subject|5
7521032|NCT02525094|11859646|FG001|Overall Study|Withdrawal by Subject|6
7521033|NCT02525094|11859645|FG000|Overall Study|Not Treated|1
7521034|NCT02525094|11859646|FG001|Overall Study|Not Treated|1
7521035|NCT02525133|11859655|FG000|Overall Study|Adverse Event|0
7521036|NCT02525133|11859656|FG001|Overall Study|Adverse Event|1
7521037|NCT02525133|11859655|FG000|Overall Study|Death|0
7521038|NCT02525133|11859656|FG001|Overall Study|Death|1
7521039|NCT02525133|11859655|FG000|Overall Study|did not meet randomization criteria|1
7521040|NCT02525133|11859656|FG001|Overall Study|did not meet randomization criteria|0
7521041|NCT02525133|11859655|FG000|Overall Study|Lost to Follow-up|5
7521042|NCT02525133|11859656|FG001|Overall Study|Lost to Follow-up|1
7521043|NCT02525133|11859655|FG000|Overall Study|randomized not enrolled|3
7521044|NCT02525133|11859656|FG001|Overall Study|randomized not enrolled|0
7521045|NCT02525133|11859655|FG000|Overall Study|Withdrawal by Subject|1
7521046|NCT02525133|11859656|FG001|Overall Study|Withdrawal by Subject|0
7521047|NCT02525471|11859668|FG000|Overall Study|Screen Failure|6
7521048|NCT02525471|11859668|FG000|Overall Study|Withdrawal by Subject|4
7521049|NCT02525471|11859668|FG000|Overall Study|Death|1
7521050|NCT02525588|11859714|FG000|Overall Study|Death|3
7521051|NCT02525588|11859715|FG001|Overall Study|Death|1
7521052|NCT02525588|11859714|FG000|Overall Study|Lost to Follow-up|2
7521053|NCT02525588|11859715|FG001|Overall Study|Lost to Follow-up|0
7521054|NCT02525588|11859714|FG000|Overall Study|Withdrawal by Subject|1
7521055|NCT02525588|11859715|FG001|Overall Study|Withdrawal by Subject|1
7521056|NCT02525588|11859714|FG000|Overall Study|Adverse Event|0
7521057|NCT02525588|11859715|FG001|Overall Study|Adverse Event|1
7521058|NCT02525627|11859723|FG000|Overall Study|Revision|1
7521059|NCT02525627|11859724|FG001|Overall Study|Revision|1
7521060|NCT02525627|11859723|FG000|Overall Study|Withdrawal by Subject|1
7521061|NCT02525627|11859724|FG001|Overall Study|Withdrawal by Subject|2
7521062|NCT02525627|11859723|FG000|Overall Study|Death|1
7521063|NCT02525627|11859724|FG001|Overall Study|Death|0
7521064|NCT02525627|11859723|FG000|Overall Study|Site terminated|11
7521065|NCT02525627|11859724|FG001|Overall Study|Site terminated|10
7521066|NCT02525744|11859743|FG000|Period 1|Physician Decision|0
7521067|NCT02525744|11859744|FG001|Period 1|Physician Decision|0
7521068|NCT02525744|11859745|FG002|Period 1|Physician Decision|1
7521069|NCT02525744|11859746|FG003|Period 1|Physician Decision|0
7521070|NCT02525744|11859743|FG000|Period 3|Adverse Event|0
7521071|NCT02525744|11859744|FG001|Period 3|Adverse Event|1
7521072|NCT02525744|11859745|FG002|Period 3|Adverse Event|0
7521073|NCT02525744|11859746|FG003|Period 3|Adverse Event|0
7521074|NCT02525744|11859743|FG000|Period 4|Withdrawal by Subject|1
7521075|NCT02525744|11859744|FG001|Period 4|Withdrawal by Subject|0
7521076|NCT02525744|11859745|FG002|Period 4|Withdrawal by Subject|0
7521077|NCT02525744|11859746|FG003|Period 4|Withdrawal by Subject|0
7521078|NCT02525744|11859743|FG000|Period 5|Physician Decision|1
7521079|NCT02525744|11859744|FG001|Period 5|Physician Decision|0
7521080|NCT02525744|11859745|FG002|Period 5|Physician Decision|0
7521081|NCT02525744|11859746|FG003|Period 5|Physician Decision|0
7521082|NCT02525861|11859758|FG000|Overall Study|Adverse Event|1
7521083|NCT02525861|11859759|FG001|Overall Study|Adverse Event|0
7521084|NCT02525861|11859758|FG000|Overall Study|Withdrawal by Subject|0
7521085|NCT02525861|11859759|FG001|Overall Study|Withdrawal by Subject|1
7521086|NCT02525861|11859758|FG000|Overall Study|Physician Decision|0
7521087|NCT02525861|11859759|FG001|Overall Study|Physician Decision|1
7521088|NCT02525874|11859767|FG000|Overall Study|Other|1
7521089|NCT02525874|11859767|FG000|Overall Study|Investigator Decision|1
7521090|NCT02525874|11859767|FG000|Overall Study|Consent withdrawn|22
7521091|NCT02525874|11859767|FG000|Overall Study|Non-compliance with study drug|3
7521092|NCT02525874|11859767|FG000|Overall Study|Adverse Event|17
7521093|NCT02525874|11859767|FG000|Overall Study|Lost to Follow-up|7
7521094|NCT02525874|11859767|FG000|Overall Study|Disease progression, defined by protocol|2
7521095|NCT02525874|11859767|FG000|Overall Study|Disease relapse|4
7521096|NCT02525874|11859767|FG000|Overall Study|Alternative Treatment for MS|2
7521097|NCT02525874|11859767|FG000|Overall Study|New lesions in Brain|1
7521098|NCT02526160|11859773|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
7521099|NCT02526160|11859774|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
7521100|NCT02526160|11859773|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
7521101|NCT02526160|11859774|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
7521102|NCT02526160|11859773|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
7521103|NCT02526160|11859774|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
7521104|NCT02526160|11859773|FG000|Open-Label Treatment Extension Period I|Death|0
7521105|NCT02526160|11859774|FG001|Open-Label Treatment Extension Period I|Death|1
7521106|NCT02526160|11859773|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
7521107|NCT02526160|11859774|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
7521108|NCT02526160|11859773|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
7521109|NCT02526160|11859774|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
7521110|NCT02526160|11859773|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
7521111|NCT02526160|11859774|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
7521112|NCT02526160|11859773|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
7521113|NCT02526160|11859774|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
7521114|NCT02526212|11859787|FG000|Overall Study|Incarceration|1
7521115|NCT02526212|11859788|FG001|Overall Study|Incarceration|0
7521116|NCT02526212|11859787|FG000|Overall Study|Lost to Follow-up|1
7521117|NCT02526212|11859788|FG001|Overall Study|Lost to Follow-up|0
7521118|NCT02526212|11859787|FG000|Overall Study|Death|0
7521119|NCT02526212|11859788|FG001|Overall Study|Death|1
7521120|NCT02526290|11859814|FG000|Overall Study|Adverse Event|3
7521121|NCT02526290|11859814|FG000|Overall Study|Withdrawal by Subject|4
7521122|NCT02526290|11859814|FG000|Overall Study|Physician Decision|1
7521123|NCT02526524|11859824|FG000|Overall Study|Withdrawal by Subject|3
7521124|NCT02526524|11859825|FG001|Overall Study|Withdrawal by Subject|3
7521125|NCT02526524|11859826|FG002|Overall Study|Withdrawal by Subject|6
7521126|NCT02526524|11859827|FG003|Overall Study|Withdrawal by Subject|1
7521127|NCT02526524|11859828|FG004|Overall Study|Withdrawal by Subject|9
7521128|NCT02526524|11859829|FG005|Overall Study|Withdrawal by Subject|5
7521129|NCT02526524|11859824|FG000|Overall Study|Adverse Event|3
7521130|NCT02526524|11859825|FG001|Overall Study|Adverse Event|2
7521131|NCT02526524|11859826|FG002|Overall Study|Adverse Event|4
7521132|NCT02526524|11859827|FG003|Overall Study|Adverse Event|2
7521133|NCT02526524|11859828|FG004|Overall Study|Adverse Event|6
7521134|NCT02526524|11859829|FG005|Overall Study|Adverse Event|8
7521135|NCT02526524|11859824|FG000|Overall Study|Lost to Follow-up|2
7521136|NCT02526524|11859825|FG001|Overall Study|Lost to Follow-up|3
7521137|NCT02526524|11859826|FG002|Overall Study|Lost to Follow-up|8
7521138|NCT02526524|11859827|FG003|Overall Study|Lost to Follow-up|1
7521139|NCT02526524|11859828|FG004|Overall Study|Lost to Follow-up|2
7521140|NCT02526524|11859829|FG005|Overall Study|Lost to Follow-up|5
7521141|NCT02526524|11859824|FG000|Overall Study|Protocol Violation|3
7521142|NCT02526524|11859825|FG001|Overall Study|Protocol Violation|1
7521143|NCT02526524|11859826|FG002|Overall Study|Protocol Violation|5
7521144|NCT02526524|11859827|FG003|Overall Study|Protocol Violation|3
7521145|NCT02526524|11859828|FG004|Overall Study|Protocol Violation|4
7521146|NCT02526524|11859829|FG005|Overall Study|Protocol Violation|3
7521147|NCT02526524|11859824|FG000|Overall Study|Loss of Glucose Control|0
7521148|NCT02526524|11859825|FG001|Overall Study|Loss of Glucose Control|0
7521149|NCT02526524|11859826|FG002|Overall Study|Loss of Glucose Control|3
7521150|NCT02526524|11859827|FG003|Overall Study|Loss of Glucose Control|0
7521151|NCT02526524|11859828|FG004|Overall Study|Loss of Glucose Control|2
7521152|NCT02526524|11859829|FG005|Overall Study|Loss of Glucose Control|0
7521153|NCT02526524|11859824|FG000|Overall Study|Physician Decision|0
7521154|NCT02526524|11859825|FG001|Overall Study|Physician Decision|0
7521155|NCT02526524|11859826|FG002|Overall Study|Physician Decision|0
7521156|NCT02526524|11859827|FG003|Overall Study|Physician Decision|0
7521157|NCT02526524|11859828|FG004|Overall Study|Physician Decision|1
7521158|NCT02526524|11859829|FG005|Overall Study|Physician Decision|0
7521159|NCT02526524|11859824|FG000|Overall Study|Sponsor Decision|1
7521160|NCT02526524|11859825|FG001|Overall Study|Sponsor Decision|0
7521161|NCT02526524|11859826|FG002|Overall Study|Sponsor Decision|0
7521162|NCT02526524|11859827|FG003|Overall Study|Sponsor Decision|0
7521163|NCT02526524|11859828|FG004|Overall Study|Sponsor Decision|0
7521164|NCT02526524|11859829|FG005|Overall Study|Sponsor Decision|0
7521165|NCT02526550|11859843|FG000|Overall Study|Lost to Follow-up|1
7536916|NCT02725866|11885094|FG000|Overall Study|Failure to return|6
7536917|NCT02725866|11885094|FG000|Overall Study|Withdrew consent|3
7536918|NCT02725866|11885094|FG000|Overall Study|Insufficient virological response|1
7536919|NCT02725866|11885094|FG000|Overall Study|Other, not specified|4
7536920|NCT02726022|11885098|FG000|Overall Study|Adverse Event|14
7536921|NCT02726022|11885098|FG000|Overall Study|Treatment Failure|8
7536922|NCT02726022|11885098|FG000|Overall Study|Poor Compliance|13
7536923|NCT02726022|11885098|FG000|Overall Study|Treatment Failure and Poor Compliance|1
7536924|NCT02726074|11885102|FG000|Overall Study|Withdrawal by Subject|4
7536925|NCT02726074|11885102|FG000|Overall Study|Adverse Event|14
7536926|NCT02726074|11885102|FG000|Overall Study|Protocol Violation|3
7536927|NCT02726074|11885102|FG000|Overall Study|Lost to Follow-up|2
7536928|NCT02726074|11885102|FG000|Overall Study|Others|3
7536929|NCT02726113|11885108|FG000|Total Enrollment|Physician Decision|0
7536930|NCT02726113|11885109|FG001|Total Enrollment|Physician Decision|1
7536931|NCT02726113|11885108|FG000|Total Enrollment|Protocol Violation|1
7536932|NCT02726113|11885109|FG001|Total Enrollment|Protocol Violation|0
7536933|NCT02726113|11885108|FG000|Total Enrollment|Withdrawal by Subject|2
7536934|NCT02726113|11885109|FG001|Total Enrollment|Withdrawal by Subject|1
7536935|NCT02726113|11885108|FG000|Total Enrollment|Insurance non-coverage for surgery|1
7536936|NCT02726113|11885109|FG001|Total Enrollment|Insurance non-coverage for surgery|1
7536937|NCT02726113|11885108|FG000|Genomic Analysis|Protocol Violation|1
7536938|NCT02726113|11885109|FG001|Genomic Analysis|Protocol Violation|0
7536939|NCT02726113|11885108|FG000|Genomic Analysis|Withdrawal by Subject|2
7536940|NCT02726113|11885109|FG001|Genomic Analysis|Withdrawal by Subject|1
7536941|NCT02726113|11885108|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
7536942|NCT02726113|11885109|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
7536943|NCT02726945|11885162|FG000|Overall Study|Withdrawal by Subject|0
7536944|NCT02726945|11885163|FG001|Overall Study|Withdrawal by Subject|0
7536945|NCT02726945|11885164|FG002|Overall Study|Withdrawal by Subject|1
7536946|NCT02726945|11885162|FG000|Overall Study|Elected to have total knee replacement|0
7536947|NCT02726945|11885163|FG001|Overall Study|Elected to have total knee replacement|1
7536948|NCT02726945|11885164|FG002|Overall Study|Elected to have total knee replacement|0
7536949|NCT02727192|11885183|FG000|Overall Study|Lost to Follow-up|1
7536950|NCT02727192|11885184|FG001|Overall Study|Lost to Follow-up|0
7536951|NCT02727192|11885185|FG002|Overall Study|Lost to Follow-up|0
7536952|NCT02727322|11885194|FG000|Overall Study|Withdrawal by Subject|1
7536953|NCT02727322|11885195|FG001|Overall Study|Withdrawal by Subject|1
7536954|NCT02727322|11885194|FG000|Overall Study|Protocol Violation|1
7536955|NCT02727322|11885195|FG001|Overall Study|Protocol Violation|0
7536956|NCT02727660|11885208|FG000|Overall Study|Lack of Efficacy|40
7536957|NCT02727660|11885209|FG001|Overall Study|Lack of Efficacy|40
7536958|NCT02727660|11885210|FG002|Overall Study|Lack of Efficacy|70
7536959|NCT02727660|11885208|FG000|Overall Study|Adverse Event|28
7536960|NCT02727660|11885209|FG001|Overall Study|Adverse Event|21
7536961|NCT02727660|11885210|FG002|Overall Study|Adverse Event|32
7536962|NCT02727660|11885208|FG000|Overall Study|Withdrawal by Subject|26
7536963|NCT02727660|11885209|FG001|Overall Study|Withdrawal by Subject|25
7536964|NCT02727660|11885210|FG002|Overall Study|Withdrawal by Subject|30
7536965|NCT02727660|11885208|FG000|Overall Study|Physician Decision|3
7536966|NCT02727660|11885209|FG001|Overall Study|Physician Decision|8
7536967|NCT02727660|11885210|FG002|Overall Study|Physician Decision|14
7536968|NCT02727660|11885208|FG000|Overall Study|Lost to Follow-up|5
7536969|NCT02727660|11885209|FG001|Overall Study|Lost to Follow-up|9
7536970|NCT02727660|11885210|FG002|Overall Study|Lost to Follow-up|8
7536971|NCT02727660|11885208|FG000|Overall Study|Protocol Violation|7
7536972|NCT02727660|11885209|FG001|Overall Study|Protocol Violation|5
7536973|NCT02727660|11885210|FG002|Overall Study|Protocol Violation|5
7536974|NCT02727660|11885208|FG000|Overall Study|Protocol Specified Disc. Criteria|5
7521166|NCT02526693|11859882|FG000|Overall Study|Physician Decision|3
7521167|NCT02526693|11859883|FG001|Overall Study|Physician Decision|1
7521168|NCT02527148|11859895|FG000|Overall Study|Did not receive study intervention|1
7521169|NCT02527148|11859896|FG001|Overall Study|Did not receive study intervention|0
7521170|NCT02527161|11859904|FG000|Overall Study|Failed MRI|52
7521171|NCT02527161|11859904|FG000|Overall Study|Withdrawal by Subject|19
7521172|NCT02527161|11859904|FG000|Overall Study|Delay in or unfit for surgery|16
7521173|NCT02527161|11859904|FG000|Overall Study|MRI contraindication|6
7521174|NCT02527161|11859904|FG000|Overall Study|Consent violation|4
7521175|NCT02527161|11859904|FG000|Overall Study|Only Recruited to Part A|27
7521176|NCT02527161|11859904|FG000|Overall Study|Physician Decision|1
7521177|NCT02527161|11859904|FG000|Overall Study|Adverse Event|1
7521178|NCT02527161|11859904|FG000|Overall Study|Lost to Follow-up|6
7521179|NCT02527343|11859920|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
7521180|NCT02527343|11859921|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
7521181|NCT02527343|11859922|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
7521182|NCT02527343|11859923|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
7521183|NCT02527343|11859924|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
7521184|NCT02527343|11859925|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
7521185|NCT02527343|11859920|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
7521186|NCT02527343|11859921|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7521187|NCT02527343|11859922|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7521188|NCT02527343|11859923|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7521189|NCT02527343|11859924|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7521190|NCT02527343|11859925|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
7521191|NCT02527343|11859920|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7521192|NCT02527343|11859921|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
7521193|NCT02527343|11859922|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7521194|NCT02527343|11859923|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7521195|NCT02527343|11859924|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7521196|NCT02527343|11859925|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
7521197|NCT02527343|11859920|FG000|RT Period: Weeks 1 to 52|Other|4
7521198|NCT02527343|11859921|FG001|RT Period: Weeks 1 to 52|Other|3
7521199|NCT02527343|11859922|FG002|RT Period: Weeks 1 to 52|Other|0
7521200|NCT02527343|11859923|FG003|RT Period: Weeks 1 to 52|Other|0
7521201|NCT02527343|11859924|FG004|RT Period: Weeks 1 to 52|Other|0
7521202|NCT02527343|11859925|FG005|RT Period: Weeks 1 to 52|Other|0
7521203|NCT02527343|11859920|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7521204|NCT02527343|11859921|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7521205|NCT02527343|11859922|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
7521206|NCT02527343|11859923|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7521207|NCT02527343|11859924|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7521208|NCT02527343|11859925|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
7521209|NCT02527343|11859920|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7521210|NCT02527343|11859921|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7521211|NCT02527343|11859922|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7521212|NCT02527343|11859923|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
7521213|NCT02527343|11859924|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7521214|NCT02527343|11859925|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
7521215|NCT02527343|11859920|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7521216|NCT02527343|11859921|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7521217|NCT02527343|11859922|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7521218|NCT02527343|11859923|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7521219|NCT02527343|11859924|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
7521220|NCT02527343|11859925|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
7521221|NCT02527343|11859920|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7521222|NCT02527343|11859921|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7521223|NCT02527343|11859922|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7521224|NCT02527343|11859923|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
7521225|NCT02527343|11859924|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
7521226|NCT02527343|11859925|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
7521227|NCT02527343|11859920|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7521228|NCT02527343|11859921|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7521229|NCT02527343|11859922|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7521230|NCT02527343|11859923|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
7521231|NCT02527343|11859924|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
7521232|NCT02527343|11859925|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
7521233|NCT02527343|11859920|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
7521234|NCT02527343|11859921|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
7521235|NCT02527343|11859922|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
7521236|NCT02527343|11859923|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
7521237|NCT02527343|11859924|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
7521238|NCT02527343|11859925|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
7521239|NCT02527343|11859920|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
7521240|NCT02527343|11859921|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
7521241|NCT02527343|11859922|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
7521242|NCT02527343|11859923|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
7521243|NCT02527343|11859924|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
7521244|NCT02527343|11859925|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
7521245|NCT02527343|11859920|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7521246|NCT02527343|11859921|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7521247|NCT02527343|11859922|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7521248|NCT02527343|11859923|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7521249|NCT02527343|11859924|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
7521250|NCT02527343|11859925|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
7521251|NCT02527343|11859920|FG000|PT Follow-up: Weeks 104 to 169|Other|0
7521252|NCT02527343|11859921|FG001|PT Follow-up: Weeks 104 to 169|Other|0
7521253|NCT02527343|11859922|FG002|PT Follow-up: Weeks 104 to 169|Other|0
7521254|NCT02527343|11859923|FG003|PT Follow-up: Weeks 104 to 169|Other|0
7521255|NCT02527343|11859924|FG004|PT Follow-up: Weeks 104 to 169|Other|0
7521256|NCT02527343|11859925|FG005|PT Follow-up: Weeks 104 to 169|Other|1
7521257|NCT02527421|11859942|FG000|Overall Study|Withdrawal by Subject|1
7521258|NCT02527421|11859943|FG001|Overall Study|Withdrawal by Subject|0
7521259|NCT02528188|11859976|FG000|Overall Study|Adverse Event|23
7521260|NCT02528188|11859977|FG001|Overall Study|Adverse Event|22
7521261|NCT02528188|11859978|FG002|Overall Study|Adverse Event|8
7521262|NCT02528188|11859976|FG000|Overall Study|Protocol Violation|4
7521263|NCT02528188|11859977|FG001|Overall Study|Protocol Violation|6
7521264|NCT02528188|11859978|FG002|Overall Study|Protocol Violation|4
7521265|NCT02528188|11859976|FG000|Overall Study|Lack of Efficacy|19
7521266|NCT02528188|11859977|FG001|Overall Study|Lack of Efficacy|21
7521267|NCT02528188|11859978|FG002|Overall Study|Lack of Efficacy|22
7521268|NCT02528188|11859976|FG000|Overall Study|Withdrawal by Subject|97
7521269|NCT02528188|11859977|FG001|Overall Study|Withdrawal by Subject|104
7521270|NCT02528188|11859978|FG002|Overall Study|Withdrawal by Subject|100
7521271|NCT02528188|11859976|FG000|Overall Study|Lost to Follow-up|25
7521272|NCT02528188|11859977|FG001|Overall Study|Lost to Follow-up|21
7521273|NCT02528188|11859978|FG002|Overall Study|Lost to Follow-up|31
7521274|NCT02528188|11859976|FG000|Overall Study|Death|4
7521275|NCT02528188|11859977|FG001|Overall Study|Death|4
7521276|NCT02528188|11859978|FG002|Overall Study|Death|0
7521277|NCT02528188|11859976|FG000|Overall Study|Other|89
7521278|NCT02528188|11859977|FG001|Overall Study|Other|91
7521279|NCT02528188|11859978|FG002|Overall Study|Other|74
7521280|NCT02528188|11859976|FG000|Overall Study|Randomized but not treated|6
7521281|NCT02528188|11859977|FG001|Overall Study|Randomized but not treated|7
7521282|NCT02528188|11859978|FG002|Overall Study|Randomized but not treated|12
7521283|NCT02528214|11859988|FG000|Overall Study|Protocol Violation|0
7521284|NCT02528214|11859989|FG001|Overall Study|Protocol Violation|1
7521285|NCT02528214|11859988|FG000|Overall Study|Adverse Event|0
7521286|NCT02528214|11859989|FG001|Overall Study|Adverse Event|1
7521287|NCT02528214|11859988|FG000|Overall Study|Other than specified above|0
7521288|NCT02528214|11859989|FG001|Overall Study|Other than specified above|1
7521289|NCT02528253|11860001|FG000|Overall Study|Adverse Event|3
7521290|NCT02528253|11860002|FG001|Overall Study|Adverse Event|4
7521291|NCT02528253|11860003|FG002|Overall Study|Adverse Event|4
7521292|NCT02528253|11860004|FG003|Overall Study|Adverse Event|8
7521293|NCT02528253|11860005|FG004|Overall Study|Adverse Event|18
7521294|NCT02528253|11860001|FG000|Overall Study|Death|2
7521295|NCT02528253|11860002|FG001|Overall Study|Death|2
7521296|NCT02528253|11860003|FG002|Overall Study|Death|1
7521297|NCT02528253|11860004|FG003|Overall Study|Death|0
7521298|NCT02528253|11860005|FG004|Overall Study|Death|1
7521299|NCT02528253|11860001|FG000|Overall Study|Insufficient clinical response|7
7521300|NCT02528253|11860002|FG001|Overall Study|Insufficient clinical response|10
7521301|NCT02528253|11860003|FG002|Overall Study|Insufficient clinical response|13
7521302|NCT02528253|11860004|FG003|Overall Study|Insufficient clinical response|12
7521303|NCT02528253|11860005|FG004|Overall Study|Insufficient clinical response|16
7521304|NCT02528253|11860001|FG000|Overall Study|Lost to Follow-up|16
7521305|NCT02528253|11860002|FG001|Overall Study|Lost to Follow-up|9
7521306|NCT02528253|11860003|FG002|Overall Study|Lost to Follow-up|31
7521307|NCT02528253|11860004|FG003|Overall Study|Lost to Follow-up|16
7521308|NCT02528253|11860005|FG004|Overall Study|Lost to Follow-up|34
7521309|NCT02528253|11860001|FG000|Overall Study|Other|21
7521310|NCT02528253|11860002|FG001|Overall Study|Other|22
7521311|NCT02528253|11860003|FG002|Overall Study|Other|58
7521312|NCT02528253|11860004|FG003|Overall Study|Other|52
7521313|NCT02528253|11860005|FG004|Overall Study|Other|76
7521314|NCT02528253|11860001|FG000|Overall Study|Withdrawal by Subject|25
7521315|NCT02528253|11860002|FG001|Overall Study|Withdrawal by Subject|20
7521316|NCT02528253|11860003|FG002|Overall Study|Withdrawal by Subject|29
7521317|NCT02528253|11860004|FG003|Overall Study|Withdrawal by Subject|48
7521318|NCT02528253|11860005|FG004|Overall Study|Withdrawal by Subject|73
7521319|NCT02528253|11860001|FG000|Overall Study|Protocol Violation|1
7521320|NCT02528253|11860002|FG001|Overall Study|Protocol Violation|2
7521321|NCT02528253|11860003|FG002|Overall Study|Protocol Violation|4
7521322|NCT02528253|11860004|FG003|Overall Study|Protocol Violation|0
7521323|NCT02528253|11860005|FG004|Overall Study|Protocol Violation|4
7521324|NCT02528253|11860001|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7521325|NCT02528253|11860002|FG001|Overall Study|Withdrawn Due to Pregnancy|1
7521326|NCT02528253|11860003|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7521327|NCT02528253|11860004|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7521328|NCT02528253|11860005|FG004|Overall Study|Withdrawn Due to Pregnancy|1
7521329|NCT02528305|11860036|FG000|Overall Study|Withdrawal by Subject|1
7521330|NCT02528305|11860036|FG000|Overall Study|Adverse Event|1
7521331|NCT02528305|11860036|FG000|Overall Study|Physician Decision|1
7521332|NCT02528331|11860063|FG000|Overall Study|Withdrawal by Subject|2
7521333|NCT02528357|11860086|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521334|NCT02528357|11860087|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
7521335|NCT02528357|11860088|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521336|NCT02528357|11860089|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521337|NCT02528357|11860090|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521338|NCT02528357|11860091|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521339|NCT02528357|11860092|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521340|NCT02528357|11860093|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521341|NCT02528357|11860094|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521342|NCT02528357|11860095|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521343|NCT02528357|11860096|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521344|NCT02528357|11860097|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521345|NCT02528357|11860098|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521346|NCT02528357|11860099|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521347|NCT02528357|11860100|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521348|NCT02528357|11860101|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521349|NCT02528357|11860102|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521350|NCT02528357|11860103|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521351|NCT02528357|11860104|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
7521352|NCT02528357|11860086|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521353|NCT02528357|11860087|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521354|NCT02528357|11860088|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521355|NCT02528357|11860089|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7521356|NCT02528357|11860090|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521357|NCT02528357|11860091|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
7521358|NCT02528357|11860092|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521359|NCT02528357|11860093|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
7521360|NCT02528357|11860094|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521361|NCT02528357|11860095|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521362|NCT02528357|11860096|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521363|NCT02528357|11860097|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521364|NCT02528357|11860098|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521365|NCT02528357|11860099|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521366|NCT02528357|11860100|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521367|NCT02528357|11860101|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521368|NCT02528357|11860102|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521369|NCT02528357|11860103|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521370|NCT02528357|11860104|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
7521371|NCT02528357|11860086|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521372|NCT02528357|11860087|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521373|NCT02528357|11860088|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7521374|NCT02528357|11860089|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521375|NCT02528357|11860090|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
7521376|NCT02528357|11860091|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521377|NCT02528357|11860092|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
7521378|NCT02528357|11860093|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
7521379|NCT02528357|11860094|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521380|NCT02528357|11860095|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521381|NCT02528357|11860096|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521382|NCT02528357|11860097|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521383|NCT02528357|11860098|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521384|NCT02528357|11860099|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521385|NCT02528357|11860100|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521386|NCT02528357|11860101|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521387|NCT02528357|11860102|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521388|NCT02528357|11860103|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521389|NCT02528357|11860104|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
7521390|NCT02528357|11860086|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521391|NCT02528357|11860087|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521392|NCT02528357|11860088|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521393|NCT02528357|11860089|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521394|NCT02528357|11860090|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521395|NCT02528357|11860091|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521396|NCT02528357|11860092|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521397|NCT02528357|11860093|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521398|NCT02528357|11860094|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521399|NCT02528357|11860095|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521400|NCT02528357|11860096|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521401|NCT02528357|11860097|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521402|NCT02528357|11860098|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521403|NCT02528357|11860099|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521404|NCT02528357|11860100|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521405|NCT02528357|11860101|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521406|NCT02528357|11860102|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521407|NCT02528357|11860103|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521408|NCT02528357|11860104|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521409|NCT02528357|11860086|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521410|NCT02528357|11860087|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521411|NCT02528357|11860088|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521412|NCT02528357|11860089|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521413|NCT02528357|11860090|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521414|NCT02528357|11860091|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521415|NCT02528357|11860092|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521416|NCT02528357|11860093|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521417|NCT02528357|11860094|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521418|NCT02528357|11860095|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521419|NCT02528357|11860096|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521420|NCT02528357|11860097|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521421|NCT02528357|11860098|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521422|NCT02528357|11860099|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
7521423|NCT02528357|11860100|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
7521424|NCT02528357|11860101|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521425|NCT02528357|11860102|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521426|NCT02528357|11860103|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521427|NCT02528357|11860104|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
7521428|NCT02528357|11860086|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521429|NCT02528357|11860087|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521430|NCT02528357|11860088|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521431|NCT02528357|11860089|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521432|NCT02528357|11860090|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521433|NCT02528357|11860091|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521434|NCT02528357|11860092|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521435|NCT02528357|11860093|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521436|NCT02528357|11860094|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521437|NCT02528357|11860095|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521438|NCT02528357|11860096|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521439|NCT02528357|11860097|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521440|NCT02528357|11860098|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521441|NCT02528357|11860099|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
7521442|NCT02528357|11860100|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521574|NCT02530619|11860383|FG000|Follow-up Period (6 Months)|Death|4
7521443|NCT02528357|11860101|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521444|NCT02528357|11860102|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521445|NCT02528357|11860103|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521446|NCT02528357|11860104|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
7521447|NCT02528357|11860086|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521448|NCT02528357|11860087|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521449|NCT02528357|11860088|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521450|NCT02528357|11860089|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521451|NCT02528357|11860090|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521452|NCT02528357|11860091|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521453|NCT02528357|11860092|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521454|NCT02528357|11860093|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521455|NCT02528357|11860094|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521456|NCT02528357|11860095|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521457|NCT02528357|11860096|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7521458|NCT02528357|11860097|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521459|NCT02528357|11860098|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7521460|NCT02528357|11860099|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
7521461|NCT02528357|11860100|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
7521462|NCT02528357|11860101|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521463|NCT02528357|11860102|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521464|NCT02528357|11860103|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521465|NCT02528357|11860104|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
7521466|NCT02528357|11860086|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521467|NCT02528357|11860087|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521468|NCT02528357|11860088|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521469|NCT02528357|11860089|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521470|NCT02528357|11860090|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521471|NCT02528357|11860091|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521472|NCT02528357|11860092|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521473|NCT02528357|11860093|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521474|NCT02528357|11860094|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521475|NCT02528357|11860095|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521476|NCT02528357|11860096|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521477|NCT02528357|11860097|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7521478|NCT02528357|11860098|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7521479|NCT02528357|11860099|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521480|NCT02528357|11860100|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521481|NCT02528357|11860101|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521482|NCT02528357|11860102|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521483|NCT02528357|11860103|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521484|NCT02528357|11860104|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521485|NCT02528357|11860086|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521486|NCT02528357|11860087|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521487|NCT02528357|11860088|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521488|NCT02528357|11860089|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521489|NCT02528357|11860090|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521490|NCT02528357|11860091|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521491|NCT02528357|11860092|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521492|NCT02528357|11860093|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521493|NCT02528357|11860094|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521494|NCT02528357|11860095|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521495|NCT02528357|11860096|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521496|NCT02528357|11860097|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521497|NCT02528357|11860098|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521498|NCT02528357|11860099|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521499|NCT02528357|11860100|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521500|NCT02528357|11860101|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521501|NCT02528357|11860102|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
7521502|NCT02528357|11860103|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521740|NCT02531633|11860520|FG000|Part A (52 Weeks)|Other|2
7521503|NCT02528357|11860104|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
7521504|NCT02528357|11860086|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521505|NCT02528357|11860087|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521506|NCT02528357|11860088|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521507|NCT02528357|11860089|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521508|NCT02528357|11860090|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521509|NCT02528357|11860091|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521510|NCT02528357|11860092|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521511|NCT02528357|11860093|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521512|NCT02528357|11860094|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521513|NCT02528357|11860095|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521514|NCT02528357|11860096|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521515|NCT02528357|11860097|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521516|NCT02528357|11860098|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521517|NCT02528357|11860099|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521518|NCT02528357|11860100|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521519|NCT02528357|11860101|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
7521520|NCT02528357|11860102|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
7521521|NCT02528357|11860103|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
7521522|NCT02528357|11860104|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
7521523|NCT02528942|11860175|FG000|Overall Study|Did not meet imaging criteria|9
7521524|NCT02528942|11860175|FG000|Overall Study|Lost to Follow-up|25
7521525|NCT02529137|11860188|FG000|Overall Study|Discontinuation for different reasons|8
7521526|NCT02529488|11860193|FG000|Overall Study|Adverse Event|1
7521527|NCT02529488|11860193|FG000|Overall Study|Death|3
7521528|NCT02529553|11860210|FG000|Overall Study|Progressive Disease|1
7521529|NCT02529553|11860211|FG001|Overall Study|Progressive Disease|0
7521530|NCT02529553|11860212|FG002|Overall Study|Progressive Disease|1
7521531|NCT02529553|11860213|FG003|Overall Study|Progressive Disease|3
7521532|NCT02529553|11860214|FG004|Overall Study|Progressive Disease|2
7521533|NCT02529553|11860215|FG005|Overall Study|Progressive Disease|3
7521534|NCT02529553|11860216|FG006|Overall Study|Progressive Disease|3
7521535|NCT02529553|11860217|FG007|Overall Study|Progressive Disease|5
7521536|NCT02529553|11860218|FG008|Overall Study|Progressive Disease|3
7521537|NCT02529553|11860210|FG000|Overall Study|Physician Decision|0
7521538|NCT02529553|11860211|FG001|Overall Study|Physician Decision|1
7521539|NCT02529553|11860212|FG002|Overall Study|Physician Decision|0
7521540|NCT02529553|11860213|FG003|Overall Study|Physician Decision|0
7521541|NCT02529553|11860214|FG004|Overall Study|Physician Decision|1
7521542|NCT02529553|11860215|FG005|Overall Study|Physician Decision|0
7521543|NCT02529553|11860216|FG006|Overall Study|Physician Decision|0
7521544|NCT02529553|11860217|FG007|Overall Study|Physician Decision|0
7521545|NCT02529553|11860218|FG008|Overall Study|Physician Decision|0
7521546|NCT02529553|11860210|FG000|Overall Study|Withdrawal by Subject|0
7521547|NCT02529553|11860211|FG001|Overall Study|Withdrawal by Subject|0
7521548|NCT02529553|11860212|FG002|Overall Study|Withdrawal by Subject|0
7521549|NCT02529553|11860213|FG003|Overall Study|Withdrawal by Subject|0
7521550|NCT02529553|11860214|FG004|Overall Study|Withdrawal by Subject|0
7521551|NCT02529553|11860215|FG005|Overall Study|Withdrawal by Subject|1
7521552|NCT02529553|11860216|FG006|Overall Study|Withdrawal by Subject|0
7521553|NCT02529553|11860217|FG007|Overall Study|Withdrawal by Subject|1
7521554|NCT02529553|11860218|FG008|Overall Study|Withdrawal by Subject|0
7521555|NCT02529995|11860241|FG000|Part A|Ongoing Study at Data Cut-off|14
7521556|NCT02529995|11860242|FG001|Part A|Ongoing Study at Data Cut-off|16
7521557|NCT02529995|11860241|FG000|Part A|Discontinued Study|1
7521558|NCT02529995|11860242|FG001|Part A|Discontinued Study|0
7521559|NCT02529995|11860241|FG000|Part B|Ongoing Study at Data Cut-off|0
7521560|NCT02529995|11860242|FG001|Part B|Ongoing Study at Data Cut-off|7
7521561|NCT02529995|11860241|FG000|Part B|Discontinued Study|6
7521562|NCT02529995|11860242|FG001|Part B|Discontinued Study|5
7521563|NCT02530125|11860248|FG000|Completed Treatment|Early termination of study|1
7521564|NCT02530125|11860248|FG000|Followed for Survival for 2 Years|Early termination of study|3
7521565|NCT02530242|11860263|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
7521566|NCT02530242|11860264|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
7521567|NCT02530385|11860292|FG000|Overall Study|Withdrawal by Subject|0
7521568|NCT02530385|11860293|FG001|Overall Study|Withdrawal by Subject|1
7521569|NCT02530619|11860383|FG000|Registered for Study|Withdrawal by Subject|2
7521570|NCT02530619|11860383|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
7521571|NCT02530619|11860383|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
7521572|NCT02530619|11860383|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
7521573|NCT02530619|11860383|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
7521575|NCT02530619|11860383|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
7521576|NCT02530619|11860383|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
7521577|NCT02530671|11860389|FG000|Overall Study|Lost to Follow-up|2
7521578|NCT02530671|11860390|FG001|Overall Study|Lost to Follow-up|0
7521579|NCT02530671|11860389|FG000|Overall Study|Withdrawal by Subject|1
7521580|NCT02530671|11860390|FG001|Overall Study|Withdrawal by Subject|0
7521581|NCT02530905|11860398|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7521582|NCT02530905|11860399|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
7521583|NCT02530905|11860400|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
7521584|NCT02530970|11860422|FG000|Overall Study|Adverse Event|8
7521585|NCT02530970|11860422|FG000|Overall Study|Lost to Follow-up|88
7521586|NCT02530970|11860422|FG000|Overall Study|Physician Decision|5
7521587|NCT02530970|11860422|FG000|Overall Study|Withdrawal by Subject|14
7521588|NCT02530970|11860422|FG000|Overall Study|Death|6
7521589|NCT02530970|11860422|FG000|Overall Study|Hospitalization|1
7521590|NCT02530970|11860422|FG000|Overall Study|Insurance|2
7521591|NCT02530970|11860422|FG000|Overall Study|Explant|2
7521592|NCT02530970|11860422|FG000|Overall Study|Change in Provider|5
7521593|NCT02530970|11860422|FG000|Overall Study|Relocation|3
7521594|NCT02531035|11860448|FG000|Overall Study|Death|0
7521595|NCT02531035|11860449|FG001|Overall Study|Death|1
7521596|NCT02531035|11860448|FG000|Overall Study|Protocol Violation|1
7521597|NCT02531035|11860449|FG001|Overall Study|Protocol Violation|1
7521598|NCT02531035|11860448|FG000|Overall Study|Noncompliance with study drug|8
7521599|NCT02531035|11860449|FG001|Overall Study|Noncompliance with study drug|3
7521600|NCT02531035|11860448|FG000|Overall Study|Physician Decision|1
7521601|NCT02531035|11860449|FG001|Overall Study|Physician Decision|0
7521602|NCT02531035|11860448|FG000|Overall Study|Adverse Event|16
7521603|NCT02531035|11860449|FG001|Overall Study|Adverse Event|45
7521604|NCT02531035|11860448|FG000|Overall Study|Other|3
7521605|NCT02531035|11860449|FG001|Overall Study|Other|2
7521606|NCT02531035|11860448|FG000|Overall Study|Withdrawal by Subject|42
7521607|NCT02531035|11860449|FG001|Overall Study|Withdrawal by Subject|32
7521608|NCT02531035|11860448|FG000|Overall Study|Lost to Follow-up|8
7521609|NCT02531035|11860449|FG001|Overall Study|Lost to Follow-up|10
7521610|NCT02531035|11860448|FG000|Overall Study|Randomized, not treated|2
7521611|NCT02531035|11860449|FG001|Overall Study|Randomized, not treated|1
7521612|NCT02531113|11860455|FG000|Induction Period: Week 0 to 12|Adverse Event|4
7521613|NCT02531113|11860455|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
7521614|NCT02531113|11860455|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
7521615|NCT02531113|11860455|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
7521616|NCT02531113|11860455|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
7521617|NCT02531113|11860455|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
7521618|NCT02531113|11860455|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
7521619|NCT02531113|11860455|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
7521620|NCT02531373|11860477|FG000|Overall Study|Lack of Efficacy|0
7521621|NCT02531373|11860478|FG001|Overall Study|Lack of Efficacy|0
7521622|NCT02531373|11860479|FG002|Overall Study|Lack of Efficacy|0
7521623|NCT02531373|11860480|FG003|Overall Study|Lack of Efficacy|0
7521624|NCT02531373|11860481|FG004|Overall Study|Lack of Efficacy|3
7521625|NCT02531373|11860482|FG005|Overall Study|Lack of Efficacy|2
7521626|NCT02531373|11860483|FG006|Overall Study|Lack of Efficacy|4
7521627|NCT02531373|11860484|FG007|Overall Study|Lack of Efficacy|8
7521628|NCT02531373|11860485|FG008|Overall Study|Lack of Efficacy|5
7521629|NCT02531373|11860477|FG000|Overall Study|Lost to Follow-up|0
7521630|NCT02531373|11860478|FG001|Overall Study|Lost to Follow-up|0
7521631|NCT02531373|11860479|FG002|Overall Study|Lost to Follow-up|0
7521632|NCT02531373|11860480|FG003|Overall Study|Lost to Follow-up|0
7521633|NCT02531373|11860481|FG004|Overall Study|Lost to Follow-up|0
7521634|NCT02531373|11860482|FG005|Overall Study|Lost to Follow-up|2
7521635|NCT02531373|11860483|FG006|Overall Study|Lost to Follow-up|2
7521636|NCT02531373|11860484|FG007|Overall Study|Lost to Follow-up|0
7521637|NCT02531373|11860485|FG008|Overall Study|Lost to Follow-up|0
7521638|NCT02531373|11860477|FG000|Overall Study|Physician Decision|0
7521639|NCT02531373|11860478|FG001|Overall Study|Physician Decision|0
7521640|NCT02531373|11860479|FG002|Overall Study|Physician Decision|0
7521641|NCT02531373|11860480|FG003|Overall Study|Physician Decision|0
7224649|NCT00057330|11433949|FG000|Overall Study|Physician Decision|1
7521642|NCT02531373|11860481|FG004|Overall Study|Physician Decision|2
7521643|NCT02531373|11860482|FG005|Overall Study|Physician Decision|1
7521644|NCT02531373|11860483|FG006|Overall Study|Physician Decision|0
7521645|NCT02531373|11860484|FG007|Overall Study|Physician Decision|0
7521646|NCT02531373|11860485|FG008|Overall Study|Physician Decision|0
7521647|NCT02531373|11860477|FG000|Overall Study|Protocol Violation|0
7521648|NCT02531373|11860478|FG001|Overall Study|Protocol Violation|0
7521649|NCT02531373|11860479|FG002|Overall Study|Protocol Violation|0
7521650|NCT02531373|11860480|FG003|Overall Study|Protocol Violation|0
7521651|NCT02531373|11860481|FG004|Overall Study|Protocol Violation|0
7521652|NCT02531373|11860482|FG005|Overall Study|Protocol Violation|1
7521653|NCT02531373|11860483|FG006|Overall Study|Protocol Violation|1
7521654|NCT02531373|11860484|FG007|Overall Study|Protocol Violation|0
7521655|NCT02531373|11860485|FG008|Overall Study|Protocol Violation|1
7521656|NCT02531373|11860477|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7521657|NCT02531373|11860478|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7521658|NCT02531373|11860479|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7521659|NCT02531373|11860480|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7521660|NCT02531373|11860481|FG004|Overall Study|Withdrawal by Parent/Guardian|0
7521661|NCT02531373|11860482|FG005|Overall Study|Withdrawal by Parent/Guardian|3
7521662|NCT02531373|11860483|FG006|Overall Study|Withdrawal by Parent/Guardian|4
7521663|NCT02531373|11860484|FG007|Overall Study|Withdrawal by Parent/Guardian|1
7521664|NCT02531373|11860485|FG008|Overall Study|Withdrawal by Parent/Guardian|3
7521665|NCT02531373|11860477|FG000|Overall Study|Withdrawal by Subject|0
7521666|NCT02531373|11860478|FG001|Overall Study|Withdrawal by Subject|0
7521667|NCT02531373|11860479|FG002|Overall Study|Withdrawal by Subject|0
7521668|NCT02531373|11860480|FG003|Overall Study|Withdrawal by Subject|0
7521669|NCT02531373|11860481|FG004|Overall Study|Withdrawal by Subject|3
7521670|NCT02531373|11860482|FG005|Overall Study|Withdrawal by Subject|0
7521671|NCT02531373|11860483|FG006|Overall Study|Withdrawal by Subject|0
7521672|NCT02531373|11860484|FG007|Overall Study|Withdrawal by Subject|0
7521673|NCT02531373|11860485|FG008|Overall Study|Withdrawal by Subject|0
7521674|NCT02531438|11860508|FG000|Overall Study|Adverse Event|7
7521675|NCT02531438|11860509|FG001|Overall Study|Adverse Event|9
7521676|NCT02531438|11860508|FG000|Overall Study|Lost to Follow-up|0
7521677|NCT02531438|11860509|FG001|Overall Study|Lost to Follow-up|3
7521678|NCT02531438|11860508|FG000|Overall Study|Withdrawal by Subject|7
7521679|NCT02531438|11860509|FG001|Overall Study|Withdrawal by Subject|8
7521680|NCT02531438|11860508|FG000|Overall Study|Physician Decision|0
7521681|NCT02531438|11860509|FG001|Overall Study|Physician Decision|1
7521682|NCT02531438|11860508|FG000|Overall Study|Death|6
7521683|NCT02531438|11860509|FG001|Overall Study|Death|3
7521684|NCT02531438|11860508|FG000|Overall Study|Randomized, but Not Treated|4
7521685|NCT02531438|11860509|FG001|Overall Study|Randomized, but Not Treated|0
7521686|NCT02531438|11860508|FG000|Overall Study|Missed EOT/PTE Visit|5
7521687|NCT02531438|11860509|FG001|Overall Study|Missed EOT/PTE Visit|2
7521688|NCT02531438|11860508|FG000|Overall Study|Randomized with Exclusion Criteria|1
7521689|NCT02531438|11860509|FG001|Overall Study|Randomized with Exclusion Criteria|0
7521690|NCT02531633|11860520|FG000|Part A (52 Weeks)|Sponsor request|24
7521691|NCT02531633|11860521|FG001|Part A (52 Weeks)|Sponsor request|24
7521692|NCT02531633|11860522|FG002|Part A (52 Weeks)|Sponsor request|18
7521693|NCT02531633|11860523|FG003|Part A (52 Weeks)|Sponsor request|18
7521694|NCT02531633|11860524|FG004|Part A (52 Weeks)|Sponsor request|19
7521695|NCT02531633|11860525|FG005|Part A (52 Weeks)|Sponsor request|0
7521696|NCT02531633|11860526|FG006|Part A (52 Weeks)|Sponsor request|0
7521697|NCT02531633|11860527|FG007|Part A (52 Weeks)|Sponsor request|0
7521698|NCT02531633|11860528|FG008|Part A (52 Weeks)|Sponsor request|0
7521699|NCT02531633|11860529|FG009|Part A (52 Weeks)|Sponsor request|0
7521700|NCT02531633|11860520|FG000|Part A (52 Weeks)|Protocol Violation|1
7521701|NCT02531633|11860521|FG001|Part A (52 Weeks)|Protocol Violation|0
7521702|NCT02531633|11860522|FG002|Part A (52 Weeks)|Protocol Violation|0
7521703|NCT02531633|11860523|FG003|Part A (52 Weeks)|Protocol Violation|0
7521704|NCT02531633|11860524|FG004|Part A (52 Weeks)|Protocol Violation|0
7521705|NCT02531633|11860525|FG005|Part A (52 Weeks)|Protocol Violation|0
7521706|NCT02531633|11860526|FG006|Part A (52 Weeks)|Protocol Violation|0
7521707|NCT02531633|11860527|FG007|Part A (52 Weeks)|Protocol Violation|0
7521708|NCT02531633|11860528|FG008|Part A (52 Weeks)|Protocol Violation|0
7521709|NCT02531633|11860529|FG009|Part A (52 Weeks)|Protocol Violation|0
7521710|NCT02531633|11860520|FG000|Part A (52 Weeks)|Lost to Follow-up|0
7521711|NCT02531633|11860521|FG001|Part A (52 Weeks)|Lost to Follow-up|0
7521712|NCT02531633|11860522|FG002|Part A (52 Weeks)|Lost to Follow-up|0
7521713|NCT02531633|11860523|FG003|Part A (52 Weeks)|Lost to Follow-up|0
7521714|NCT02531633|11860524|FG004|Part A (52 Weeks)|Lost to Follow-up|1
7521715|NCT02531633|11860525|FG005|Part A (52 Weeks)|Lost to Follow-up|0
7521716|NCT02531633|11860526|FG006|Part A (52 Weeks)|Lost to Follow-up|0
7521717|NCT02531633|11860527|FG007|Part A (52 Weeks)|Lost to Follow-up|0
7521718|NCT02531633|11860528|FG008|Part A (52 Weeks)|Lost to Follow-up|0
7521719|NCT02531633|11860529|FG009|Part A (52 Weeks)|Lost to Follow-up|0
7521720|NCT02531633|11860520|FG000|Part A (52 Weeks)|Physician Decision|1
7521721|NCT02531633|11860521|FG001|Part A (52 Weeks)|Physician Decision|4
7521722|NCT02531633|11860522|FG002|Part A (52 Weeks)|Physician Decision|3
7521723|NCT02531633|11860523|FG003|Part A (52 Weeks)|Physician Decision|1
7521724|NCT02531633|11860524|FG004|Part A (52 Weeks)|Physician Decision|0
7521725|NCT02531633|11860525|FG005|Part A (52 Weeks)|Physician Decision|0
7521726|NCT02531633|11860526|FG006|Part A (52 Weeks)|Physician Decision|0
7521727|NCT02531633|11860527|FG007|Part A (52 Weeks)|Physician Decision|0
7521728|NCT02531633|11860528|FG008|Part A (52 Weeks)|Physician Decision|0
7521729|NCT02531633|11860529|FG009|Part A (52 Weeks)|Physician Decision|0
7521730|NCT02531633|11860520|FG000|Part A (52 Weeks)|Withdrawal by Subject|6
7521731|NCT02531633|11860521|FG001|Part A (52 Weeks)|Withdrawal by Subject|6
7521732|NCT02531633|11860522|FG002|Part A (52 Weeks)|Withdrawal by Subject|1
7521733|NCT02531633|11860523|FG003|Part A (52 Weeks)|Withdrawal by Subject|3
7521734|NCT02531633|11860524|FG004|Part A (52 Weeks)|Withdrawal by Subject|3
7521735|NCT02531633|11860525|FG005|Part A (52 Weeks)|Withdrawal by Subject|0
7521736|NCT02531633|11860526|FG006|Part A (52 Weeks)|Withdrawal by Subject|0
7521737|NCT02531633|11860527|FG007|Part A (52 Weeks)|Withdrawal by Subject|0
7521738|NCT02531633|11860528|FG008|Part A (52 Weeks)|Withdrawal by Subject|0
7521739|NCT02531633|11860529|FG009|Part A (52 Weeks)|Withdrawal by Subject|0
7521741|NCT02531633|11860521|FG001|Part A (52 Weeks)|Other|0
7521742|NCT02531633|11860522|FG002|Part A (52 Weeks)|Other|0
7521743|NCT02531633|11860523|FG003|Part A (52 Weeks)|Other|0
7521744|NCT02531633|11860524|FG004|Part A (52 Weeks)|Other|0
7521745|NCT02531633|11860525|FG005|Part A (52 Weeks)|Other|0
7521746|NCT02531633|11860526|FG006|Part A (52 Weeks)|Other|0
7521747|NCT02531633|11860527|FG007|Part A (52 Weeks)|Other|0
7521748|NCT02531633|11860528|FG008|Part A (52 Weeks)|Other|0
7521749|NCT02531633|11860529|FG009|Part A (52 Weeks)|Other|0
7521750|NCT02531633|11860520|FG000|Part B (104 Weeks)|Sponsor request|0
7521751|NCT02531633|11860521|FG001|Part B (104 Weeks)|Sponsor request|0
7521752|NCT02531633|11860522|FG002|Part B (104 Weeks)|Sponsor request|0
7521753|NCT02531633|11860523|FG003|Part B (104 Weeks)|Sponsor request|0
7521754|NCT02531633|11860524|FG004|Part B (104 Weeks)|Sponsor request|0
7521755|NCT02531633|11860525|FG005|Part B (104 Weeks)|Sponsor request|8
7521756|NCT02531633|11860526|FG006|Part B (104 Weeks)|Sponsor request|5
7521757|NCT02531633|11860527|FG007|Part B (104 Weeks)|Sponsor request|3
7521758|NCT02531633|11860528|FG008|Part B (104 Weeks)|Sponsor request|5
7521759|NCT02531633|11860529|FG009|Part B (104 Weeks)|Sponsor request|4
7521760|NCT02531633|11860520|FG000|Part B (104 Weeks)|Lost to Follow-up|0
7521761|NCT02531633|11860521|FG001|Part B (104 Weeks)|Lost to Follow-up|0
7521762|NCT02531633|11860522|FG002|Part B (104 Weeks)|Lost to Follow-up|0
7521763|NCT02531633|11860523|FG003|Part B (104 Weeks)|Lost to Follow-up|0
7521764|NCT02531633|11860524|FG004|Part B (104 Weeks)|Lost to Follow-up|0
7521765|NCT02531633|11860525|FG005|Part B (104 Weeks)|Lost to Follow-up|0
7521766|NCT02531633|11860526|FG006|Part B (104 Weeks)|Lost to Follow-up|0
7521767|NCT02531633|11860527|FG007|Part B (104 Weeks)|Lost to Follow-up|1
7521768|NCT02531633|11860528|FG008|Part B (104 Weeks)|Lost to Follow-up|0
7521769|NCT02531633|11860529|FG009|Part B (104 Weeks)|Lost to Follow-up|0
7521770|NCT02531646|11860572|FG000|Overall Study|equip. image processing issue|5
7521771|NCT02531646|11860573|FG001|Overall Study|equip. image processing issue|1
7521772|NCT02531646|11860574|FG002|Overall Study|equip. image processing issue|0
7521773|NCT02531698|11860584|FG000|Overall Study|Adverse Event|2
7521774|NCT02531698|11860585|FG001|Overall Study|Adverse Event|1
7521775|NCT02531698|11860584|FG000|Overall Study|Withdrawal by Subject|6
7521776|NCT02531698|11860585|FG001|Overall Study|Withdrawal by Subject|1
7521777|NCT02531698|11860584|FG000|Overall Study|Protocol Violation|2
7521778|NCT02531698|11860585|FG001|Overall Study|Protocol Violation|0
7521779|NCT02531698|11860584|FG000|Overall Study|Lost to Follow-up|1
7521780|NCT02531698|11860585|FG001|Overall Study|Lost to Follow-up|0
7521781|NCT02531802|11860621|FG000|Received Vaccination 2|Medication interfering with study taken|0
7521782|NCT02531802|11860622|FG001|Received Vaccination 2|Medication interfering with study taken|0
7521783|NCT02531802|11860623|FG002|Received Vaccination 2|Medication interfering with study taken|1
7521784|NCT02531802|11860624|FG003|Received Vaccination 2|Medication interfering with study taken|0
7521785|NCT02531802|11860625|FG004|Received Vaccination 2|Medication interfering with study taken|0
7521786|NCT02531802|11860626|FG005|Received Vaccination 2|Medication interfering with study taken|0
7521787|NCT02531802|11860627|FG006|Received Vaccination 2|Medication interfering with study taken|0
7521788|NCT02531802|11860628|FG007|Received Vaccination 2|Medication interfering with study taken|0
7521789|NCT02531802|11860629|FG008|Received Vaccination 2|Medication interfering with study taken|0
7521790|NCT02531802|11860630|FG009|Received Vaccination 2|Medication interfering with study taken|1
7521791|NCT02531802|11860631|FG010|Received Vaccination 2|Medication interfering with study taken|1
7521792|NCT02531802|11860632|FG011|Received Vaccination 2|Medication interfering with study taken|0
7521793|NCT02531802|11860633|FG012|Received Vaccination 2|Medication interfering with study taken|1
7521794|NCT02531802|11860634|FG013|Received Vaccination 2|Medication interfering with study taken|0
7521795|NCT02531802|11860635|FG014|Received Vaccination 2|Medication interfering with study taken|0
7521796|NCT02531802|11860636|FG015|Received Vaccination 2|Medication interfering with study taken|0
7521797|NCT02531802|11860637|FG016|Received Vaccination 2|Medication interfering with study taken|0
7521798|NCT02531802|11860638|FG017|Received Vaccination 2|Medication interfering with study taken|0
7521799|NCT02531802|11860639|FG018|Received Vaccination 2|Medication interfering with study taken|1
7521800|NCT02531802|11860640|FG019|Received Vaccination 2|Medication interfering with study taken|0
7521801|NCT02531802|11860641|FG020|Received Vaccination 2|Medication interfering with study taken|0
7521802|NCT02531802|11860621|FG000|Received Vaccination 2|Physician Decision|0
7521803|NCT02531802|11860622|FG001|Received Vaccination 2|Physician Decision|0
7521804|NCT02531802|11860623|FG002|Received Vaccination 2|Physician Decision|0
7521805|NCT02531802|11860624|FG003|Received Vaccination 2|Physician Decision|0
7521806|NCT02531802|11860625|FG004|Received Vaccination 2|Physician Decision|0
7521807|NCT02531802|11860626|FG005|Received Vaccination 2|Physician Decision|1
7521808|NCT02531802|11860627|FG006|Received Vaccination 2|Physician Decision|0
7521809|NCT02531802|11860628|FG007|Received Vaccination 2|Physician Decision|0
7521810|NCT02531802|11860629|FG008|Received Vaccination 2|Physician Decision|0
7521811|NCT02531802|11860630|FG009|Received Vaccination 2|Physician Decision|2
7521812|NCT02531802|11860631|FG010|Received Vaccination 2|Physician Decision|0
7521813|NCT02531802|11860632|FG011|Received Vaccination 2|Physician Decision|0
7521814|NCT02531802|11860633|FG012|Received Vaccination 2|Physician Decision|0
7521815|NCT02531802|11860634|FG013|Received Vaccination 2|Physician Decision|1
7521816|NCT02531802|11860635|FG014|Received Vaccination 2|Physician Decision|0
7521817|NCT02531802|11860636|FG015|Received Vaccination 2|Physician Decision|0
7521818|NCT02531802|11860637|FG016|Received Vaccination 2|Physician Decision|0
7521819|NCT02531802|11860638|FG017|Received Vaccination 2|Physician Decision|1
7521820|NCT02531802|11860639|FG018|Received Vaccination 2|Physician Decision|0
7521821|NCT02531802|11860640|FG019|Received Vaccination 2|Physician Decision|0
7521822|NCT02531802|11860641|FG020|Received Vaccination 2|Physician Decision|0
7521823|NCT02531802|11860621|FG000|Received Vaccination 2|Adverse Event|0
7521824|NCT02531802|11860622|FG001|Received Vaccination 2|Adverse Event|0
7521825|NCT02531802|11860623|FG002|Received Vaccination 2|Adverse Event|0
7521826|NCT02531802|11860624|FG003|Received Vaccination 2|Adverse Event|0
7521827|NCT02531802|11860625|FG004|Received Vaccination 2|Adverse Event|0
7521828|NCT02531802|11860626|FG005|Received Vaccination 2|Adverse Event|2
7521829|NCT02531802|11860627|FG006|Received Vaccination 2|Adverse Event|0
7521830|NCT02531802|11860628|FG007|Received Vaccination 2|Adverse Event|0
7521831|NCT02531802|11860629|FG008|Received Vaccination 2|Adverse Event|0
7521832|NCT02531802|11860630|FG009|Received Vaccination 2|Adverse Event|0
7521833|NCT02531802|11860631|FG010|Received Vaccination 2|Adverse Event|0
7521834|NCT02531802|11860632|FG011|Received Vaccination 2|Adverse Event|0
7521835|NCT02531802|11860633|FG012|Received Vaccination 2|Adverse Event|0
7521836|NCT02531802|11860634|FG013|Received Vaccination 2|Adverse Event|0
7521837|NCT02531802|11860635|FG014|Received Vaccination 2|Adverse Event|0
7521838|NCT02531802|11860636|FG015|Received Vaccination 2|Adverse Event|0
7521839|NCT02531802|11860637|FG016|Received Vaccination 2|Adverse Event|0
7521840|NCT02531802|11860638|FG017|Received Vaccination 2|Adverse Event|2
7521841|NCT02531802|11860639|FG018|Received Vaccination 2|Adverse Event|1
7521842|NCT02531802|11860640|FG019|Received Vaccination 2|Adverse Event|0
7521843|NCT02531802|11860641|FG020|Received Vaccination 2|Adverse Event|1
7521844|NCT02531802|11860621|FG000|Received Vaccination 2|Withdrawal by Subject|0
7521845|NCT02531802|11860622|FG001|Received Vaccination 2|Withdrawal by Subject|0
7521846|NCT02531802|11860623|FG002|Received Vaccination 2|Withdrawal by Subject|0
7521847|NCT02531802|11860624|FG003|Received Vaccination 2|Withdrawal by Subject|0
7521848|NCT02531802|11860625|FG004|Received Vaccination 2|Withdrawal by Subject|0
7521849|NCT02531802|11860626|FG005|Received Vaccination 2|Withdrawal by Subject|0
7521850|NCT02531802|11860627|FG006|Received Vaccination 2|Withdrawal by Subject|0
7521851|NCT02531802|11860628|FG007|Received Vaccination 2|Withdrawal by Subject|0
7521852|NCT02531802|11860629|FG008|Received Vaccination 2|Withdrawal by Subject|0
7521853|NCT02531802|11860630|FG009|Received Vaccination 2|Withdrawal by Subject|0
7521854|NCT02531802|11860631|FG010|Received Vaccination 2|Withdrawal by Subject|1
7521855|NCT02531802|11860632|FG011|Received Vaccination 2|Withdrawal by Subject|0
7521856|NCT02531802|11860633|FG012|Received Vaccination 2|Withdrawal by Subject|1
7521857|NCT02531802|11860634|FG013|Received Vaccination 2|Withdrawal by Subject|1
7521858|NCT02531802|11860635|FG014|Received Vaccination 2|Withdrawal by Subject|1
7521859|NCT02531802|11860636|FG015|Received Vaccination 2|Withdrawal by Subject|0
7521860|NCT02531802|11860637|FG016|Received Vaccination 2|Withdrawal by Subject|0
7521861|NCT02531802|11860638|FG017|Received Vaccination 2|Withdrawal by Subject|1
7521862|NCT02531802|11860639|FG018|Received Vaccination 2|Withdrawal by Subject|1
7521863|NCT02531802|11860640|FG019|Received Vaccination 2|Withdrawal by Subject|1
7521864|NCT02531802|11860641|FG020|Received Vaccination 2|Withdrawal by Subject|0
7521865|NCT02532179|11860742|FG000|Overall Study|Lost to Follow-up|1
7224650|NCT00057330|11433950|FG001|Overall Study|Physician Decision|0
7224651|NCT00057330|11433949|FG000|Overall Study|Other|260
7521866|NCT02532179|11860742|FG000|Overall Study|Pregnancy|1
7521867|NCT02532179|11860742|FG000|Overall Study|Subject received depot steroid injection|1
7521868|NCT02532283|11860748|FG000|Overall Study|Adverse Event|0
7521869|NCT02532283|11860749|FG001|Overall Study|Adverse Event|1
7521870|NCT02532283|11860748|FG000|Overall Study|Death|1
7521871|NCT02532283|11860749|FG001|Overall Study|Death|0
7521872|NCT02532283|11860748|FG000|Overall Study|Lost to Follow-up|0
7521873|NCT02532283|11860749|FG001|Overall Study|Lost to Follow-up|1
7521874|NCT02532283|11860748|FG000|Overall Study|Withdrawal by Subject|8
7521875|NCT02532283|11860749|FG001|Overall Study|Withdrawal by Subject|3
7521876|NCT02532374|11860757|FG000|Overall Study|Withdrawal by Subject|1
7521877|NCT02532374|11860757|FG000|Overall Study|Physician Decision|1
7521878|NCT02532465|11860771|FG000|Overall Study|Protocol Violation|1
7521879|NCT02532465|11860772|FG001|Overall Study|Protocol Violation|0
7521880|NCT02532465|11860771|FG000|Overall Study|Lack of Efficacy|0
7521881|NCT02532465|11860772|FG001|Overall Study|Lack of Efficacy|1
7521882|NCT02532517|11860778|FG000|Overall Study|Did not complete 24-Month visit|4
7521883|NCT02532517|11860778|FG000|Overall Study|Failed Angiographic eligibility|1
7521884|NCT02532517|11860778|FG000|Overall Study|Lost to Follow-up|4
7521885|NCT02532517|11860778|FG000|Overall Study|Withdrawal by Subject|4
7521886|NCT02532517|11860778|FG000|Overall Study|Death|4
7521887|NCT02532543|11860786|FG000|Overall Study|Lost to Follow-up|0
7521888|NCT02532543|11860787|FG001|Overall Study|Lost to Follow-up|0
7521889|NCT02532543|11860788|FG002|Overall Study|Lost to Follow-up|1
7521890|NCT02532543|11860789|FG003|Overall Study|Lost to Follow-up|0
7521891|NCT02532647|11860812|FG000|Overall Study|Did not receive trial medication|1
7521892|NCT02532647|11860813|FG001|Overall Study|Did not receive trial medication|0
7521893|NCT02532647|11860814|FG002|Overall Study|Did not receive trial medication|1
7521894|NCT02532764|11860832|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521895|NCT02532764|11860833|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521896|NCT02532764|11860834|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521897|NCT02532764|11860835|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521898|NCT02532764|11860836|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521899|NCT02532764|11860837|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521900|NCT02532764|11860838|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
7521901|NCT02532764|11860839|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7521902|NCT02532764|11860840|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7521903|NCT02532764|11860841|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
7521904|NCT02532855|11860870|FG000|Overall Study|Lost to Follow-up|4
7521905|NCT02532855|11860871|FG001|Overall Study|Lost to Follow-up|3
7521906|NCT02532855|11860870|FG000|Overall Study|Withdrawal by Subject|4
7521907|NCT02532855|11860871|FG001|Overall Study|Withdrawal by Subject|8
7521908|NCT02532972|11860886|FG000|Overall Study|Withdrawal by Subject|1
7521923|NCT02533258|11860936|FG000|Overall Study|Adverse Event|1
7521924|NCT02533258|11860936|FG000|Overall Study|Death|2
7521925|NCT02533258|11860936|FG000|Overall Study|Other|1
7521926|NCT02533258|11860936|FG000|Overall Study|Economic factor|1
7521927|NCT02533258|11860936|FG000|Overall Study|Progression of pleural effusion|1
7521928|NCT02533258|11860936|FG000|Overall Study|Lack of Efficacy|2
7521929|NCT02533375|11860940|FG000|Overall Study|Lack of Efficacy|3
7521930|NCT02533375|11860940|FG000|Overall Study|Adverse Event|2
7521931|NCT02533401|11860944|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
7521932|NCT02533401|11860944|FG000|Overall Study|Death|5
7521933|NCT02533401|11860944|FG000|Overall Study|Insufficient Response/Progressed Disease|1
7521934|NCT02533401|11860944|FG000|Overall Study|Lost to Follow-up|1
7521935|NCT02533401|11860944|FG000|Overall Study|Violation of Selection Criteria|1
7521936|NCT02533453|11860955|FG000|Overall Study|Adverse Event|6
7521937|NCT02533453|11860955|FG000|Overall Study|Protocol Violation|1
7521938|NCT02533453|11860955|FG000|Overall Study|Withdrawal by Subject|2
7521939|NCT02533570|11860980|FG000|Overall Study|Adverse Event|0
7521940|NCT02533570|11860981|FG001|Overall Study|Adverse Event|1
7521941|NCT02533570|11860982|FG002|Overall Study|Adverse Event|1
7521942|NCT02533674|11860998|FG000|Dose Level I|Progressive disease|1
7521943|NCT02533674|11860999|FG001|Dose Level I|Progressive disease|0
7521944|NCT02533674|11861000|FG002|Dose Level I|Progressive disease|0
7521945|NCT02533674|11861001|FG003|Dose Level I|Progressive disease|0
7521946|NCT02533674|11861002|FG004|Dose Level I|Progressive disease|0
7521947|NCT02533674|11861003|FG005|Dose Level I|Progressive disease|0
7521948|NCT02533674|11861004|FG006|Dose Level I|Progressive disease|0
7521949|NCT02533674|11861005|FG007|Dose Level I|Progressive disease|0
7521950|NCT02533674|11860998|FG000|Dose Level I|Withdrawal by Subject|1
7521951|NCT02533674|11860999|FG001|Dose Level I|Withdrawal by Subject|0
7521952|NCT02533674|11861000|FG002|Dose Level I|Withdrawal by Subject|0
7521953|NCT02533674|11861001|FG003|Dose Level I|Withdrawal by Subject|0
7521954|NCT02533674|11861002|FG004|Dose Level I|Withdrawal by Subject|0
7521955|NCT02533674|11861003|FG005|Dose Level I|Withdrawal by Subject|0
7521956|NCT02533674|11861004|FG006|Dose Level I|Withdrawal by Subject|0
7521957|NCT02533674|11861005|FG007|Dose Level I|Withdrawal by Subject|0
7521958|NCT02533674|11860998|FG000|Dose Level I|Physician Decision|1
7521959|NCT02533674|11860999|FG001|Dose Level I|Physician Decision|0
7521960|NCT02533674|11861000|FG002|Dose Level I|Physician Decision|0
7521961|NCT02533674|11861001|FG003|Dose Level I|Physician Decision|0
7521962|NCT02533674|11861002|FG004|Dose Level I|Physician Decision|0
7521963|NCT02533674|11861003|FG005|Dose Level I|Physician Decision|0
7521964|NCT02533674|11861004|FG006|Dose Level I|Physician Decision|0
7521965|NCT02533674|11861005|FG007|Dose Level I|Physician Decision|0
7521966|NCT02533674|11860998|FG000|Dose Level I|Death|1
7521967|NCT02533674|11860999|FG001|Dose Level I|Death|0
7521968|NCT02533674|11861000|FG002|Dose Level I|Death|0
7521969|NCT02533674|11861001|FG003|Dose Level I|Death|0
7521970|NCT02533674|11861002|FG004|Dose Level I|Death|0
7521971|NCT02533674|11861003|FG005|Dose Level I|Death|0
7521972|NCT02533674|11861004|FG006|Dose Level I|Death|0
7521973|NCT02533674|11861005|FG007|Dose Level I|Death|0
7521974|NCT02533674|11860998|FG000|Dose Level I|Never Treated|1
7521975|NCT02533674|11860999|FG001|Dose Level I|Never Treated|0
7521976|NCT02533674|11861000|FG002|Dose Level I|Never Treated|0
7521977|NCT02533674|11861001|FG003|Dose Level I|Never Treated|0
7521978|NCT02533674|11861002|FG004|Dose Level I|Never Treated|0
7521979|NCT02533674|11861003|FG005|Dose Level I|Never Treated|0
7521980|NCT02533674|11861004|FG006|Dose Level I|Never Treated|0
7521981|NCT02533674|11861005|FG007|Dose Level I|Never Treated|0
7521982|NCT02533674|11860998|FG000|Dose Level II|Progressive disease|0
7521983|NCT02533674|11860999|FG001|Dose Level II|Progressive disease|3
7521984|NCT02533674|11861000|FG002|Dose Level II|Progressive disease|0
7521985|NCT02533674|11861001|FG003|Dose Level II|Progressive disease|0
7521986|NCT02533674|11861002|FG004|Dose Level II|Progressive disease|0
7521987|NCT02533674|11861003|FG005|Dose Level II|Progressive disease|0
7521988|NCT02533674|11861004|FG006|Dose Level II|Progressive disease|0
7521989|NCT02533674|11861005|FG007|Dose Level II|Progressive disease|0
7521990|NCT02533674|11860998|FG000|Dose Level II|Withdrawal by Subject|0
7521991|NCT02533674|11860999|FG001|Dose Level II|Withdrawal by Subject|1
7521992|NCT02533674|11861000|FG002|Dose Level II|Withdrawal by Subject|0
7521993|NCT02533674|11861001|FG003|Dose Level II|Withdrawal by Subject|0
7521994|NCT02533674|11861002|FG004|Dose Level II|Withdrawal by Subject|0
7521995|NCT02533674|11861003|FG005|Dose Level II|Withdrawal by Subject|0
7521996|NCT02533674|11861004|FG006|Dose Level II|Withdrawal by Subject|0
7521997|NCT02533674|11861005|FG007|Dose Level II|Withdrawal by Subject|0
7521998|NCT02533674|11860998|FG000|Dose Level II|Treatment-related AE|0
7521999|NCT02533674|11860999|FG001|Dose Level II|Treatment-related AE|1
7522000|NCT02533674|11861000|FG002|Dose Level II|Treatment-related AE|0
7522001|NCT02533674|11861001|FG003|Dose Level II|Treatment-related AE|0
7522002|NCT02533674|11861002|FG004|Dose Level II|Treatment-related AE|0
7522003|NCT02533674|11861003|FG005|Dose Level II|Treatment-related AE|0
7522004|NCT02533674|11861004|FG006|Dose Level II|Treatment-related AE|0
7522005|NCT02533674|11861005|FG007|Dose Level II|Treatment-related AE|0
7522006|NCT02533674|11860998|FG000|Dose Level II|Physician Decision|0
7522007|NCT02533674|11860999|FG001|Dose Level II|Physician Decision|1
7522008|NCT02533674|11861000|FG002|Dose Level II|Physician Decision|0
7522009|NCT02533674|11861001|FG003|Dose Level II|Physician Decision|0
7522010|NCT02533674|11861002|FG004|Dose Level II|Physician Decision|0
7522011|NCT02533674|11861003|FG005|Dose Level II|Physician Decision|0
7522012|NCT02533674|11861004|FG006|Dose Level II|Physician Decision|0
7522013|NCT02533674|11861005|FG007|Dose Level II|Physician Decision|0
7522014|NCT02533674|11860998|FG000|Dose Level II|Non-treatment-related AE|0
7522015|NCT02533674|11860999|FG001|Dose Level II|Non-treatment-related AE|1
7522016|NCT02533674|11861000|FG002|Dose Level II|Non-treatment-related AE|0
7522017|NCT02533674|11861001|FG003|Dose Level II|Non-treatment-related AE|0
7522018|NCT02533674|11861002|FG004|Dose Level II|Non-treatment-related AE|0
7522019|NCT02533674|11861003|FG005|Dose Level II|Non-treatment-related AE|0
7522020|NCT02533674|11861004|FG006|Dose Level II|Non-treatment-related AE|0
7522021|NCT02533674|11861005|FG007|Dose Level II|Non-treatment-related AE|0
7522022|NCT02533674|11860998|FG000|Dose Level III|Progressive disease|0
7522023|NCT02533674|11860999|FG001|Dose Level III|Progressive disease|0
7522024|NCT02533674|11861000|FG002|Dose Level III|Progressive disease|2
7522025|NCT02533674|11861001|FG003|Dose Level III|Progressive disease|0
7522026|NCT02533674|11861002|FG004|Dose Level III|Progressive disease|0
7522027|NCT02533674|11861003|FG005|Dose Level III|Progressive disease|0
7522028|NCT02533674|11861004|FG006|Dose Level III|Progressive disease|0
7522029|NCT02533674|11861005|FG007|Dose Level III|Progressive disease|0
7522030|NCT02533674|11860998|FG000|Dose Level III|Withdrawal by Subject|0
7522031|NCT02533674|11860999|FG001|Dose Level III|Withdrawal by Subject|0
7522032|NCT02533674|11861000|FG002|Dose Level III|Withdrawal by Subject|1
7522033|NCT02533674|11861001|FG003|Dose Level III|Withdrawal by Subject|0
7522034|NCT02533674|11861002|FG004|Dose Level III|Withdrawal by Subject|0
7522035|NCT02533674|11861003|FG005|Dose Level III|Withdrawal by Subject|0
7522036|NCT02533674|11861004|FG006|Dose Level III|Withdrawal by Subject|0
7522037|NCT02533674|11861005|FG007|Dose Level III|Withdrawal by Subject|0
7522038|NCT02533674|11860998|FG000|Dose Level III|Treatment-related AE|0
7522039|NCT02533674|11860999|FG001|Dose Level III|Treatment-related AE|0
7522040|NCT02533674|11861000|FG002|Dose Level III|Treatment-related AE|1
7522041|NCT02533674|11861001|FG003|Dose Level III|Treatment-related AE|0
7522042|NCT02533674|11861002|FG004|Dose Level III|Treatment-related AE|0
7522043|NCT02533674|11861003|FG005|Dose Level III|Treatment-related AE|0
7522044|NCT02533674|11861004|FG006|Dose Level III|Treatment-related AE|0
7522045|NCT02533674|11861005|FG007|Dose Level III|Treatment-related AE|0
7522046|NCT02533674|11860998|FG000|Dose Level IV|Progressive disease|0
7522047|NCT02533674|11860999|FG001|Dose Level IV|Progressive disease|0
7522048|NCT02533674|11861000|FG002|Dose Level IV|Progressive disease|0
7522049|NCT02533674|11861001|FG003|Dose Level IV|Progressive disease|3
7522050|NCT02533674|11861002|FG004|Dose Level IV|Progressive disease|0
7522051|NCT02533674|11861003|FG005|Dose Level IV|Progressive disease|0
7522052|NCT02533674|11861004|FG006|Dose Level IV|Progressive disease|0
7522053|NCT02533674|11861005|FG007|Dose Level IV|Progressive disease|0
7522054|NCT02533674|11860998|FG000|Dose Level IV|Withdrawal by Subject|0
7522055|NCT02533674|11860999|FG001|Dose Level IV|Withdrawal by Subject|0
7522056|NCT02533674|11861000|FG002|Dose Level IV|Withdrawal by Subject|0
7522057|NCT02533674|11861001|FG003|Dose Level IV|Withdrawal by Subject|1
7522058|NCT02533674|11861002|FG004|Dose Level IV|Withdrawal by Subject|0
7522059|NCT02533674|11861003|FG005|Dose Level IV|Withdrawal by Subject|0
7522060|NCT02533674|11861004|FG006|Dose Level IV|Withdrawal by Subject|0
7522061|NCT02533674|11861005|FG007|Dose Level IV|Withdrawal by Subject|0
7522062|NCT02533674|11860998|FG000|Dose Level IV|Physician Decision|0
7522063|NCT02533674|11860999|FG001|Dose Level IV|Physician Decision|0
7522064|NCT02533674|11861000|FG002|Dose Level IV|Physician Decision|0
7522065|NCT02533674|11861001|FG003|Dose Level IV|Physician Decision|1
7522066|NCT02533674|11861002|FG004|Dose Level IV|Physician Decision|0
7522067|NCT02533674|11861003|FG005|Dose Level IV|Physician Decision|0
7522068|NCT02533674|11861004|FG006|Dose Level IV|Physician Decision|0
7522069|NCT02533674|11861005|FG007|Dose Level IV|Physician Decision|0
7522070|NCT02533674|11860998|FG000|Dose Level V|Progressive disease|0
7522071|NCT02533674|11860999|FG001|Dose Level V|Progressive disease|0
7522072|NCT02533674|11861000|FG002|Dose Level V|Progressive disease|0
7522073|NCT02533674|11861001|FG003|Dose Level V|Progressive disease|0
7522074|NCT02533674|11861002|FG004|Dose Level V|Progressive disease|3
7522075|NCT02533674|11861003|FG005|Dose Level V|Progressive disease|0
7522076|NCT02533674|11861004|FG006|Dose Level V|Progressive disease|0
7522077|NCT02533674|11861005|FG007|Dose Level V|Progressive disease|0
7522078|NCT02533674|11860998|FG000|Dose Level V|Withdrawal by Subject|0
7522079|NCT02533674|11860999|FG001|Dose Level V|Withdrawal by Subject|0
7522080|NCT02533674|11861000|FG002|Dose Level V|Withdrawal by Subject|0
7522081|NCT02533674|11861001|FG003|Dose Level V|Withdrawal by Subject|0
7522082|NCT02533674|11861002|FG004|Dose Level V|Withdrawal by Subject|1
7522083|NCT02533674|11861003|FG005|Dose Level V|Withdrawal by Subject|0
7522084|NCT02533674|11861004|FG006|Dose Level V|Withdrawal by Subject|0
7522085|NCT02533674|11861005|FG007|Dose Level V|Withdrawal by Subject|0
7522086|NCT02533674|11860998|FG000|Dose Level V|Physician Decision|0
7522087|NCT02533674|11860999|FG001|Dose Level V|Physician Decision|0
7522088|NCT02533674|11861000|FG002|Dose Level V|Physician Decision|0
7522089|NCT02533674|11861001|FG003|Dose Level V|Physician Decision|0
7522090|NCT02533674|11861002|FG004|Dose Level V|Physician Decision|1
7522091|NCT02533674|11861003|FG005|Dose Level V|Physician Decision|0
7522092|NCT02533674|11861004|FG006|Dose Level V|Physician Decision|0
7522093|NCT02533674|11861005|FG007|Dose Level V|Physician Decision|0
7522094|NCT02533674|11860998|FG000|Dose Level VI|Progressive disease|0
7522095|NCT02533674|11860999|FG001|Dose Level VI|Progressive disease|0
7522096|NCT02533674|11861000|FG002|Dose Level VI|Progressive disease|0
7522097|NCT02533674|11861001|FG003|Dose Level VI|Progressive disease|0
7522098|NCT02533674|11861002|FG004|Dose Level VI|Progressive disease|0
7522099|NCT02533674|11861003|FG005|Dose Level VI|Progressive disease|7
7522100|NCT02533674|11861004|FG006|Dose Level VI|Progressive disease|0
7522101|NCT02533674|11861005|FG007|Dose Level VI|Progressive disease|0
7522102|NCT02533674|11860998|FG000|Dose Level VI|Withdrawal by Subject|0
7522103|NCT02533674|11860999|FG001|Dose Level VI|Withdrawal by Subject|0
7522104|NCT02533674|11861000|FG002|Dose Level VI|Withdrawal by Subject|0
7522105|NCT02533674|11861001|FG003|Dose Level VI|Withdrawal by Subject|0
7522106|NCT02533674|11861002|FG004|Dose Level VI|Withdrawal by Subject|0
7522107|NCT02533674|11861003|FG005|Dose Level VI|Withdrawal by Subject|1
7522108|NCT02533674|11861004|FG006|Dose Level VI|Withdrawal by Subject|0
7522109|NCT02533674|11861005|FG007|Dose Level VI|Withdrawal by Subject|0
7522110|NCT02533674|11860998|FG000|Dose Level VI|Treatment-related AE|0
7522111|NCT02533674|11860999|FG001|Dose Level VI|Treatment-related AE|0
7522112|NCT02533674|11861000|FG002|Dose Level VI|Treatment-related AE|0
7522113|NCT02533674|11861001|FG003|Dose Level VI|Treatment-related AE|0
7522114|NCT02533674|11861002|FG004|Dose Level VI|Treatment-related AE|0
7522115|NCT02533674|11861003|FG005|Dose Level VI|Treatment-related AE|1
7522116|NCT02533674|11861004|FG006|Dose Level VI|Treatment-related AE|0
7522117|NCT02533674|11861005|FG007|Dose Level VI|Treatment-related AE|0
7522118|NCT02533674|11860998|FG000|Dose Level VII|Progressive disease|0
7522119|NCT02533674|11860999|FG001|Dose Level VII|Progressive disease|0
7522120|NCT02533674|11861000|FG002|Dose Level VII|Progressive disease|0
7522121|NCT02533674|11861001|FG003|Dose Level VII|Progressive disease|0
7522122|NCT02533674|11861002|FG004|Dose Level VII|Progressive disease|0
7522123|NCT02533674|11861003|FG005|Dose Level VII|Progressive disease|0
7522124|NCT02533674|11861004|FG006|Dose Level VII|Progressive disease|10
7522125|NCT02533674|11861005|FG007|Dose Level VII|Progressive disease|0
7522126|NCT02533674|11860998|FG000|Dose Level VII|Withdrawal by Subject|0
7522127|NCT02533674|11860999|FG001|Dose Level VII|Withdrawal by Subject|0
7522128|NCT02533674|11861000|FG002|Dose Level VII|Withdrawal by Subject|0
7522129|NCT02533674|11861001|FG003|Dose Level VII|Withdrawal by Subject|0
7522130|NCT02533674|11861002|FG004|Dose Level VII|Withdrawal by Subject|0
7522131|NCT02533674|11861003|FG005|Dose Level VII|Withdrawal by Subject|0
7522132|NCT02533674|11861004|FG006|Dose Level VII|Withdrawal by Subject|3
7522133|NCT02533674|11861005|FG007|Dose Level VII|Withdrawal by Subject|0
7522134|NCT02533674|11860998|FG000|Dose Level VII|Treatment-related AE|0
7522135|NCT02533674|11860999|FG001|Dose Level VII|Treatment-related AE|0
7522136|NCT02533674|11861000|FG002|Dose Level VII|Treatment-related AE|0
7522137|NCT02533674|11861001|FG003|Dose Level VII|Treatment-related AE|0
7522138|NCT02533674|11861002|FG004|Dose Level VII|Treatment-related AE|0
7522139|NCT02533674|11861003|FG005|Dose Level VII|Treatment-related AE|0
7522140|NCT02533674|11861004|FG006|Dose Level VII|Treatment-related AE|1
7522141|NCT02533674|11861005|FG007|Dose Level VII|Treatment-related AE|0
7522142|NCT02533674|11860998|FG000|Dose Level VII|Death|0
7522143|NCT02533674|11860999|FG001|Dose Level VII|Death|0
7522144|NCT02533674|11861000|FG002|Dose Level VII|Death|0
7522145|NCT02533674|11861001|FG003|Dose Level VII|Death|0
7522146|NCT02533674|11861002|FG004|Dose Level VII|Death|0
7522147|NCT02533674|11861003|FG005|Dose Level VII|Death|0
7522148|NCT02533674|11861004|FG006|Dose Level VII|Death|2
7522149|NCT02533674|11861005|FG007|Dose Level VII|Death|0
7522150|NCT02533674|11860998|FG000|Dose Level VIII|Progressive disease|0
7522151|NCT02533674|11860999|FG001|Dose Level VIII|Progressive disease|0
7522152|NCT02533674|11861000|FG002|Dose Level VIII|Progressive disease|0
7522153|NCT02533674|11861001|FG003|Dose Level VIII|Progressive disease|0
7522154|NCT02533674|11861002|FG004|Dose Level VIII|Progressive disease|0
7522155|NCT02533674|11861003|FG005|Dose Level VIII|Progressive disease|0
7522156|NCT02533674|11861004|FG006|Dose Level VIII|Progressive disease|0
7522157|NCT02533674|11861005|FG007|Dose Level VIII|Progressive disease|3
7522158|NCT02533674|11860998|FG000|Dose Level VIII|Withdrawal by Subject|0
7522159|NCT02533674|11860999|FG001|Dose Level VIII|Withdrawal by Subject|0
7522160|NCT02533674|11861000|FG002|Dose Level VIII|Withdrawal by Subject|0
7522161|NCT02533674|11861001|FG003|Dose Level VIII|Withdrawal by Subject|0
7522162|NCT02533674|11861002|FG004|Dose Level VIII|Withdrawal by Subject|0
7522163|NCT02533674|11861003|FG005|Dose Level VIII|Withdrawal by Subject|0
7522164|NCT02533674|11861004|FG006|Dose Level VIII|Withdrawal by Subject|0
7522165|NCT02533674|11861005|FG007|Dose Level VIII|Withdrawal by Subject|1
7522166|NCT02533674|11860998|FG000|Dose Level VIII|Treatment-related AE|0
7522167|NCT02533674|11860999|FG001|Dose Level VIII|Treatment-related AE|0
7522168|NCT02533674|11861000|FG002|Dose Level VIII|Treatment-related AE|0
7522169|NCT02533674|11861001|FG003|Dose Level VIII|Treatment-related AE|0
7522170|NCT02533674|11861002|FG004|Dose Level VIII|Treatment-related AE|0
7522171|NCT02533674|11861003|FG005|Dose Level VIII|Treatment-related AE|0
7522172|NCT02533674|11861004|FG006|Dose Level VIII|Treatment-related AE|0
7522173|NCT02533674|11861005|FG007|Dose Level VIII|Treatment-related AE|1
7522174|NCT02533674|11860998|FG000|Dose Level VIII|Never treated|0
7522175|NCT02533674|11860999|FG001|Dose Level VIII|Never treated|0
7522176|NCT02533674|11861000|FG002|Dose Level VIII|Never treated|0
7522177|NCT02533674|11861001|FG003|Dose Level VIII|Never treated|0
7522178|NCT02533674|11861002|FG004|Dose Level VIII|Never treated|0
7522179|NCT02533674|11861003|FG005|Dose Level VIII|Never treated|0
7522180|NCT02533674|11861004|FG006|Dose Level VIII|Never treated|0
7522181|NCT02533674|11861005|FG007|Dose Level VIII|Never treated|1
7522182|NCT02533999|11861052|FG000|Overall Study|Lost to Follow-up|3
7522183|NCT02533999|11861053|FG001|Overall Study|Lost to Follow-up|5
7522184|NCT02533999|11861052|FG000|Overall Study|Protocol Violation|3
7522185|NCT02533999|11861053|FG001|Overall Study|Protocol Violation|0
7522186|NCT02533999|11861052|FG000|Overall Study|Adverse Event|0
7522187|NCT02533999|11861053|FG001|Overall Study|Adverse Event|1
7522188|NCT02533999|11861052|FG000|Overall Study|Randomized but intervention not received|0
7522189|NCT02533999|11861053|FG001|Overall Study|Randomized but intervention not received|1
7522190|NCT02534324|11861077|FG000|Overall Study|Protocol Violation|4
7522191|NCT02534324|11861078|FG001|Overall Study|Protocol Violation|1
7522192|NCT02534324|11861077|FG000|Overall Study|Lost to Follow-up|20
7522193|NCT02534324|11861078|FG001|Overall Study|Lost to Follow-up|7
7522194|NCT02534324|11861077|FG000|Overall Study|Adverse Event|1
7522195|NCT02534324|11861078|FG001|Overall Study|Adverse Event|0
7522196|NCT02534350|11861086|FG000|Overall Study|Randomized But Not Treated|1
7522197|NCT02534350|11861087|FG001|Overall Study|Randomized But Not Treated|0
7522198|NCT02534350|11861086|FG000|Overall Study|Protocol Violation|1
7522199|NCT02534350|11861087|FG001|Overall Study|Protocol Violation|0
7522200|NCT02534350|11861086|FG000|Overall Study|Withdrew Consent|2
7522201|NCT02534350|11861087|FG001|Overall Study|Withdrew Consent|0
7522202|NCT02534493|11861093|FG000|Overall Study|Lost to Follow-up|1
7522203|NCT02534493|11861093|FG000|Overall Study|Withdrawal by Subject|1
7522204|NCT02534883|11861101|FG000|Overall Study|Early Termination|8
7522205|NCT02534883|11861102|FG001|Overall Study|Early Termination|3
7522206|NCT02534896|11861111|FG000|Overall Study|Adverse Event|2
7522207|NCT02534896|11861112|FG001|Overall Study|Adverse Event|1
7522208|NCT02534896|11861113|FG002|Overall Study|Adverse Event|1
7522209|NCT02534896|11861111|FG000|Overall Study|Insufficient therapeutic response|2
7522210|NCT02534896|11861112|FG001|Overall Study|Insufficient therapeutic response|0
7522211|NCT02534896|11861113|FG002|Overall Study|Insufficient therapeutic response|0
7522212|NCT02534935|11861124|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
7522213|NCT02534935|11861125|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
7522214|NCT02534935|11861126|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
7522215|NCT02534935|11861124|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
7522216|NCT02534935|11861125|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
7522217|NCT02534935|11861126|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
7522218|NCT02534935|11861124|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
7522219|NCT02534935|11861125|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
7522220|NCT02534935|11861126|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
7522221|NCT02534935|11861124|FG000|Stage 1: 24 Months|Lost to Follow-up|0
7522222|NCT02534935|11861125|FG001|Stage 1: 24 Months|Lost to Follow-up|1
7522223|NCT02534935|11861126|FG002|Stage 1: 24 Months|Lost to Follow-up|1
7522224|NCT02534935|11861124|FG000|Stage 1: 24 Months|Adverse Event|0
7522225|NCT02534935|11861125|FG001|Stage 1: 24 Months|Adverse Event|2
7522226|NCT02534935|11861126|FG002|Stage 1: 24 Months|Adverse Event|0
7522227|NCT02534935|11861124|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
7522228|NCT02534935|11861125|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
7522229|NCT02534935|11861126|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
7522230|NCT02534935|11861124|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7522231|NCT02534935|11861125|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
7522232|NCT02534935|11861126|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
7522233|NCT02535000|11861154|FG000|Overall Study|Cancellation of surgery.|1
7522234|NCT02535000|11861155|FG001|Overall Study|Cancellation of surgery.|2
7522235|NCT02535364|11861175|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
7522236|NCT02535364|11861175|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
7522237|NCT02535364|11861175|FG000|Part A Screening Through Leukapheresis|Disease progression|1
7522238|NCT02535364|11861175|FG000|Part B Screening|Study placed on clinical hold by FDA|7
7522239|NCT02535364|11861175|FG000|Part B Screening|Unable to manufacture JCAR015|3
7522240|NCT02535364|11861175|FG000|Part B Screening|Death|2
7522241|NCT02535364|11861175|FG000|Part B Screening|Physician Decision|1
7522242|NCT02535364|11861175|FG000|Part B Screening|Withdrawal by Subject|1
7522243|NCT02535364|11861175|FG000|Part B Screening|Adverse Event|1
7522244|NCT02535364|11861175|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
7522245|NCT02535364|11861175|FG000|Study Treatment|Death|1
7522246|NCT02535364|11861175|FG000|Study Treatment|Study placed on clinical hold by FDA|1
7522247|NCT02535364|11861175|FG000|12-Month Follow-up Period|Disease progression|22
7522248|NCT02535364|11861175|FG000|12-Month Follow-up Period|Death|5
7522249|NCT02535364|11861175|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
7522250|NCT02535364|11861175|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
7522251|NCT02535364|11861175|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
7522252|NCT02535416|11861188|FG000|Overall Study|Family bereavement overseas|1
7522253|NCT02535416|11861189|FG001|Overall Study|Family bereavement overseas|0
7522254|NCT02535416|11861190|FG002|Overall Study|Family bereavement overseas|0
7522255|NCT02535416|11861191|FG003|Overall Study|Family bereavement overseas|0
7522256|NCT02535416|11861192|FG004|Overall Study|Family bereavement overseas|0
7522257|NCT02535416|11861193|FG005|Overall Study|Family bereavement overseas|0
7522258|NCT02535416|11861194|FG006|Overall Study|Family bereavement overseas|0
7522259|NCT02535416|11861195|FG007|Overall Study|Family bereavement overseas|0
7522260|NCT02535416|11861196|FG008|Overall Study|Family bereavement overseas|0
7536975|NCT02727660|11885209|FG001|Overall Study|Protocol Specified Disc. Criteria|5
7536976|NCT02727660|11885210|FG002|Overall Study|Protocol Specified Disc. Criteria|2
7536977|NCT02727660|11885208|FG000|Overall Study|Administrative Reasons|2
7536978|NCT02727660|11885209|FG001|Overall Study|Administrative Reasons|3
7536979|NCT02727660|11885210|FG002|Overall Study|Administrative Reasons|4
7536980|NCT02727777|11885225|FG000|Overall Study|Screen Failure|2
7536981|NCT02727777|11885226|FG001|Overall Study|Screen Failure|0
7536982|NCT02727777|11885227|FG002|Overall Study|Screen Failure|0
7536983|NCT02727777|11885225|FG000|Overall Study|Progressive disease|2
7536984|NCT02727777|11885226|FG001|Overall Study|Progressive disease|0
7536985|NCT02727777|11885227|FG002|Overall Study|Progressive disease|0
7536986|NCT02728089|11885271|FG000|Overall Study|Physician Decision|2
7536987|NCT02728089|11885271|FG000|Overall Study|Withdrawal by Subject|1
7522261|NCT02535715|11861248|FG000|Overall Study|Withdrawal by Subject|0
7522262|NCT02535715|11861249|FG001|Overall Study|Withdrawal by Subject|0
7522263|NCT02535715|11861250|FG002|Overall Study|Withdrawal by Subject|1
7522264|NCT02535741|11861261|FG000|Overall Study|Adverse Event|3
7522265|NCT02535741|11861261|FG000|Overall Study|Withdrawal by Subject|9
7522266|NCT02535741|11861261|FG000|Overall Study|Lost to Follow-up|10
7522267|NCT02535741|11861261|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
7522268|NCT02535741|11861261|FG000|Overall Study|Missing data|6
7522269|NCT02536313|11861326|FG000|Overall Study|Lack of Efficacy|0
7522270|NCT02536313|11861327|FG001|Overall Study|Lack of Efficacy|1
7522271|NCT02536378|11861337|FG000|Overall Study|Physician Decision|0
7522272|NCT02536378|11861338|FG001|Overall Study|Physician Decision|2
7522273|NCT02536378|11861337|FG000|Overall Study|Withdrawal by Subject|0
7522274|NCT02536378|11861338|FG001|Overall Study|Withdrawal by Subject|1
7522275|NCT02536378|11861337|FG000|Overall Study|Death|1
7522276|NCT02536378|11861338|FG001|Overall Study|Death|2
7522277|NCT02536378|11861337|FG000|Overall Study|Patient refused further follow up|6
7522278|NCT02536378|11861338|FG001|Overall Study|Patient refused further follow up|2
7522279|NCT02536404|11861348|FG000|Overall Study|Adverse Event|5
7522280|NCT02536404|11861349|FG001|Overall Study|Adverse Event|0
7522281|NCT02536404|11861348|FG000|Overall Study|Withdrawal by Subject|4
7522282|NCT02536404|11861349|FG001|Overall Study|Withdrawal by Subject|1
7522283|NCT02536404|11861348|FG000|Overall Study|Physician Decision|10
7522284|NCT02536404|11861349|FG001|Overall Study|Physician Decision|0
7522285|NCT02536404|11861348|FG000|Overall Study|Sponsor decision|1
7522286|NCT02536404|11861349|FG001|Overall Study|Sponsor decision|0
7522287|NCT02536508|11861358|FG000|Overall Study|Withdrawal by Subject|18
7522288|NCT02536508|11861359|FG001|Overall Study|Withdrawal by Subject|13
7522289|NCT02536508|11861360|FG002|Overall Study|Withdrawal by Subject|7
7522290|NCT02536508|11861358|FG000|Overall Study|Adverse Event|14
7522291|NCT02536508|11861359|FG001|Overall Study|Adverse Event|13
7522292|NCT02536508|11861360|FG002|Overall Study|Adverse Event|6
7522293|NCT02536508|11861358|FG000|Overall Study|Lost to Follow-up|12
7522294|NCT02536508|11861359|FG001|Overall Study|Lost to Follow-up|4
7522295|NCT02536508|11861360|FG002|Overall Study|Lost to Follow-up|0
7522296|NCT02536508|11861358|FG000|Overall Study|Lack of Efficacy|3
7522297|NCT02536508|11861359|FG001|Overall Study|Lack of Efficacy|5
7522298|NCT02536508|11861360|FG002|Overall Study|Lack of Efficacy|4
7522299|NCT02536508|11861358|FG000|Overall Study|Protocol Discontinuation Criteria|3
7522300|NCT02536508|11861359|FG001|Overall Study|Protocol Discontinuation Criteria|2
7522301|NCT02536508|11861360|FG002|Overall Study|Protocol Discontinuation Criteria|2
7522302|NCT02536508|11861358|FG000|Overall Study|Physician Decision|0
7522303|NCT02536508|11861359|FG001|Overall Study|Physician Decision|4
7522304|NCT02536508|11861360|FG002|Overall Study|Physician Decision|2
7522305|NCT02536508|11861358|FG000|Overall Study|Major Protocol Deviation|2
7522306|NCT02536508|11861359|FG001|Overall Study|Major Protocol Deviation|2
7522307|NCT02536508|11861360|FG002|Overall Study|Major Protocol Deviation|2
7522308|NCT02536508|11861358|FG000|Overall Study|Administrative Reasons|0
7522309|NCT02536508|11861359|FG001|Overall Study|Administrative Reasons|1
7522310|NCT02536508|11861360|FG002|Overall Study|Administrative Reasons|0
7522311|NCT02536664|11861370|FG000|Overall Study|Inadequate completion of documentation|2
7522312|NCT02536664|11861371|FG001|Overall Study|Inadequate completion of documentation|4
7522313|NCT02536664|11861370|FG000|Overall Study|Progression|13
7522314|NCT02536664|11861371|FG001|Overall Study|Progression|18
7522315|NCT02536664|11861370|FG000|Overall Study|Death due to lymphoma|2
7522316|NCT02536664|11861371|FG001|Overall Study|Death due to lymphoma|1
7522317|NCT02536664|11861370|FG000|Overall Study|Death due to other reason|3
7522318|NCT02536664|11861371|FG001|Overall Study|Death due to other reason|2
7522319|NCT02536664|11861370|FG000|Overall Study|Intolerability|8
7522320|NCT02536664|11861371|FG001|Overall Study|Intolerability|6
7522321|NCT02536664|11861370|FG000|Overall Study|Withdrawal by Subject|8
7522322|NCT02536664|11861371|FG001|Overall Study|Withdrawal by Subject|5
7522323|NCT02536664|11861370|FG000|Overall Study|Other|18
7522324|NCT02536664|11861371|FG001|Overall Study|Other|24
7522325|NCT02536664|11861370|FG000|Overall Study|Missing|53
7522326|NCT02536664|11861371|FG001|Overall Study|Missing|20
7522327|NCT02536781|11861379|FG000|Overall Study|Lost to Follow-up|2
7522328|NCT02536781|11861380|FG001|Overall Study|Lost to Follow-up|0
7522329|NCT02536833|11861390|FG000|Overall Study|Discontinued Before Treatment|0
7522330|NCT02536833|11861391|FG001|Overall Study|Discontinued Before Treatment|0
7522331|NCT02536833|11861392|FG002|Overall Study|Discontinued Before Treatment|1
7522332|NCT02536833|11861393|FG003|Overall Study|Discontinued Before Treatment|2
7522333|NCT02536833|11861390|FG000|Overall Study|Adverse Event|1
7522334|NCT02536833|11861391|FG001|Overall Study|Adverse Event|3
7522335|NCT02536833|11861392|FG002|Overall Study|Adverse Event|4
7522336|NCT02536833|11861393|FG003|Overall Study|Adverse Event|1
7522337|NCT02536833|11861390|FG000|Overall Study|Lost to Follow-up|2
7522338|NCT02536833|11861391|FG001|Overall Study|Lost to Follow-up|1
7522339|NCT02536833|11861392|FG002|Overall Study|Lost to Follow-up|2
7522340|NCT02536833|11861393|FG003|Overall Study|Lost to Follow-up|2
7522341|NCT02536833|11861390|FG000|Overall Study|Physician Decision|0
7522342|NCT02536833|11861391|FG001|Overall Study|Physician Decision|0
7522343|NCT02536833|11861392|FG002|Overall Study|Physician Decision|0
7522344|NCT02536833|11861393|FG003|Overall Study|Physician Decision|1
7522345|NCT02536833|11861390|FG000|Overall Study|Site Terminated by Sponsor|2
7522346|NCT02536833|11861391|FG001|Overall Study|Site Terminated by Sponsor|2
7522347|NCT02536833|11861392|FG002|Overall Study|Site Terminated by Sponsor|2
7522348|NCT02536833|11861393|FG003|Overall Study|Site Terminated by Sponsor|2
7522349|NCT02536833|11861390|FG000|Overall Study|Subject Non-Compliance|0
7522350|NCT02536833|11861391|FG001|Overall Study|Subject Non-Compliance|1
7522351|NCT02536833|11861392|FG002|Overall Study|Subject Non-Compliance|1
7522352|NCT02536833|11861393|FG003|Overall Study|Subject Non-Compliance|0
7522353|NCT02536833|11861390|FG000|Overall Study|Withdrawal by Subject|4
7522354|NCT02536833|11861391|FG001|Overall Study|Withdrawal by Subject|3
7522355|NCT02536833|11861392|FG002|Overall Study|Withdrawal by Subject|5
7522356|NCT02536833|11861393|FG003|Overall Study|Withdrawal by Subject|11
7522357|NCT02536846|11861404|FG000|Overall Study|Withdrawal by Subject|1
7522358|NCT02536963|11861409|FG000|Overall Study|Withdrawal by Subject|18
7522359|NCT02536976|11861415|FG000|Overall Study|Physician Decision|0
7522360|NCT02536976|11861416|FG001|Overall Study|Physician Decision|1
7522361|NCT02537015|11861424|FG000|Overall Study|Adverse Event|3
7522362|NCT02537015|11861424|FG000|Overall Study|Withdrawal by Subject|2
7522363|NCT02537015|11861424|FG000|Overall Study|Other Miscellaneous Reasons|1
7522364|NCT02537431|11861428|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
7522365|NCT02537522|11861441|FG000|Phase I - Contralateral|Subject no longer eligible|15
7522366|NCT02537522|11861442|FG001|Phase I - Contralateral|Subject no longer eligible|7
7522367|NCT02537522|11861443|FG002|Phase I - Contralateral|Subject no longer eligible|0
7522368|NCT02537522|11861444|FG003|Phase I - Contralateral|Subject no longer eligible|0
7522369|NCT02537522|11861441|FG000|Phase I - Contralateral|Withdrawal by Subject|0
7522370|NCT02537522|11861442|FG001|Phase I - Contralateral|Withdrawal by Subject|1
7522371|NCT02537522|11861443|FG002|Phase I - Contralateral|Withdrawal by Subject|0
7522372|NCT02537522|11861444|FG003|Phase I - Contralateral|Withdrawal by Subject|0
7522373|NCT02537522|11861441|FG000|Phase I - Contralateral|incorrect randomization|0
7522374|NCT02537522|11861442|FG001|Phase I - Contralateral|incorrect randomization|1
7522375|NCT02537522|11861443|FG002|Phase I - Contralateral|incorrect randomization|0
7522376|NCT02537522|11861444|FG003|Phase I - Contralateral|incorrect randomization|0
7522377|NCT02537522|11861441|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
7522378|NCT02537522|11861442|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
7522379|NCT02537522|11861443|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
7522380|NCT02537522|11861444|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
7522381|NCT02537522|11861441|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
7522382|NCT02537522|11861442|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
7522383|NCT02537522|11861443|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
7522384|NCT02537522|11861444|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
7522385|NCT02537574|11861453|FG000|Overall Study|Adverse Event|1
7522386|NCT02537574|11861454|FG001|Overall Study|Adverse Event|3
7522387|NCT02537574|11861455|FG002|Overall Study|Adverse Event|2
7522388|NCT02537574|11861453|FG000|Overall Study|Lost to Follow-up|40
7522389|NCT02537574|11861454|FG001|Overall Study|Lost to Follow-up|51
7522390|NCT02537574|11861455|FG002|Overall Study|Lost to Follow-up|55
7522391|NCT02537574|11861453|FG000|Overall Study|Noncompliance with study drug|0
7522392|NCT02537574|11861454|FG001|Overall Study|Noncompliance with study drug|1
7522393|NCT02537574|11861455|FG002|Overall Study|Noncompliance with study drug|1
7522394|NCT02537574|11861453|FG000|Overall Study|Physician Decision|2
7522395|NCT02537574|11861454|FG001|Overall Study|Physician Decision|0
7522396|NCT02537574|11861455|FG002|Overall Study|Physician Decision|0
7522397|NCT02537574|11861453|FG000|Overall Study|Protocol Violation|4
7522398|NCT02537574|11861454|FG001|Overall Study|Protocol Violation|2
7522399|NCT02537574|11861455|FG002|Overall Study|Protocol Violation|3
7522400|NCT02537574|11861453|FG000|Overall Study|Withdrawal by Subject|37
7522401|NCT02537574|11861454|FG001|Overall Study|Withdrawal by Subject|27
7522402|NCT02537574|11861455|FG002|Overall Study|Withdrawal by Subject|29
7522403|NCT02537574|11861453|FG000|Overall Study|Lack of Efficacy|14
7522404|NCT02537574|11861454|FG001|Overall Study|Lack of Efficacy|16
7522405|NCT02537574|11861455|FG002|Overall Study|Lack of Efficacy|15
7522406|NCT02537574|11861453|FG000|Overall Study|Duplicate Patient|1
7522407|NCT02537574|11861454|FG001|Overall Study|Duplicate Patient|0
7522408|NCT02537574|11861455|FG002|Overall Study|Duplicate Patient|0
7522409|NCT02537574|11861453|FG000|Overall Study|Patient not Stable|0
7522410|NCT02537574|11861454|FG001|Overall Study|Patient not Stable|1
7522411|NCT02537574|11861455|FG002|Overall Study|Patient not Stable|0
7522412|NCT02537574|11861453|FG000|Overall Study|Incarceration|0
7522413|NCT02537574|11861454|FG001|Overall Study|Incarceration|1
7522414|NCT02537574|11861455|FG002|Overall Study|Incarceration|0
7522415|NCT02537574|11861453|FG000|Overall Study|Failed Naloxone Challenge|0
7522416|NCT02537574|11861454|FG001|Overall Study|Failed Naloxone Challenge|1
7522417|NCT02537574|11861455|FG002|Overall Study|Failed Naloxone Challenge|0
7522418|NCT02537574|11861453|FG000|Overall Study|Transportation Issues|0
7522419|NCT02537574|11861454|FG001|Overall Study|Transportation Issues|0
7522420|NCT02537574|11861455|FG002|Overall Study|Transportation Issues|1
7522421|NCT02537574|11861453|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
7522422|NCT02537574|11861454|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
7522423|NCT02537574|11861455|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
7522424|NCT02537574|11861453|FG000|Overall Study|Noncompliance with Protocol|0
7522425|NCT02537574|11861454|FG001|Overall Study|Noncompliance with Protocol|0
7522426|NCT02537574|11861455|FG002|Overall Study|Noncompliance with Protocol|1
7522427|NCT02538029|11861502|FG000|Overall Study|unable to complete cognitive assessments|1
7522428|NCT02538029|11861503|FG001|Overall Study|unable to complete cognitive assessments|0
7522429|NCT02538029|11861504|FG002|Overall Study|unable to complete cognitive assessments|1
7522430|NCT02538094|11861525|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
7522431|NCT02538094|11861526|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
7522432|NCT02538094|11861525|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
7522433|NCT02538094|11861526|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
7522434|NCT02538107|11861532|FG000|Overall Study|Did not receive any Mircera dose|11
7522435|NCT02538107|11861532|FG000|Overall Study|Missing|5
7522436|NCT02538107|11861532|FG000|Overall Study|Necessity of dialysis|20
7522437|NCT02538107|11861532|FG000|Overall Study|Administration of other ESA|11
7522438|NCT02538107|11861532|FG000|Overall Study|No further treatment necessary|18
7522439|NCT02538107|11861532|FG000|Overall Study|Withdrawal by Subject|17
7522440|NCT02538107|11861532|FG000|Overall Study|Death|4
7522441|NCT02538107|11861532|FG000|Overall Study|Administrative reason|5
7522442|NCT02538107|11861532|FG000|Overall Study|Adverse Event|4
7522443|NCT02538107|11861532|FG000|Overall Study|Surgery|1
7522444|NCT02538107|11861532|FG000|Overall Study|Other|7
7522445|NCT02538107|11861532|FG000|Overall Study|Not recorded|7
7522446|NCT02538341|11861548|FG000|Overall Study|Lost to Follow-up|51
7522447|NCT02538341|11861549|FG001|Overall Study|Lost to Follow-up|46
7522448|NCT02538341|11861548|FG000|Overall Study|Withdrawal by Subject|3
7522449|NCT02538341|11861549|FG001|Overall Study|Withdrawal by Subject|1
7522450|NCT02538341|11861548|FG000|Overall Study|Death|2
7522451|NCT02538341|11861549|FG001|Overall Study|Death|0
7522452|NCT02538471|11861573|FG000|Overall Study|Progression of disease|2
7522453|NCT02538614|11861586|FG000|Overall Study|Progressive Disease|2
7522454|NCT02538900|11861617|FG000|Overall Study|Death|2
7522455|NCT02538900|11861618|FG001|Overall Study|Death|2
7522456|NCT02538900|11861619|FG002|Overall Study|Death|2
7522457|NCT02538900|11861617|FG000|Overall Study|Withdrawal by Subject|18
7522458|NCT02538900|11861618|FG001|Overall Study|Withdrawal by Subject|16
7522459|NCT02538900|11861619|FG002|Overall Study|Withdrawal by Subject|15
7522460|NCT02538965|11861627|FG000|Treatment Period|Other = Death due to disease progression|1
7522461|NCT02538965|11861627|FG000|Treatment Period|Adverse Event|2
7522462|NCT02538965|11861627|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7522463|NCT02538965|11861627|FG000|Treatment Period|Treatment Failure|9
7522464|NCT02538965|11861627|FG000|Treatment Period|Disease Progression|1
7522465|NCT02538965|11861627|FG000|Treatment Period|Physician Decision|2
7522466|NCT02538965|11861627|FG000|Follow-Up Period|Other = Death due to disease progression|13
7522467|NCT02538965|11861627|FG000|Follow-Up Period|Withdrawal by Parent|4
7522468|NCT02539134|11861646|FG000|Overall Study|Lost to Follow-up|1
7522469|NCT02539134|11861647|FG001|Overall Study|Lost to Follow-up|0
7522470|NCT02539134|11861648|FG002|Overall Study|Lost to Follow-up|0
7522471|NCT02539134|11861649|FG003|Overall Study|Lost to Follow-up|0
7522472|NCT02539134|11861650|FG004|Overall Study|Lost to Follow-up|0
7522473|NCT02539134|11861651|FG005|Overall Study|Lost to Follow-up|0
7522474|NCT02539368|11861684|FG000|Overall Study|Death|4
7522475|NCT02539368|11861685|FG001|Overall Study|Death|2
7522476|NCT02539368|11861686|FG002|Overall Study|Death|1
7522477|NCT02539368|11861687|FG003|Overall Study|Death|0
7522478|NCT02539368|11861688|FG004|Overall Study|Death|0
7522479|NCT02539368|11861684|FG000|Overall Study|Withdrawal by Subject|44
7522480|NCT02539368|11861685|FG001|Overall Study|Withdrawal by Subject|35
7522481|NCT02539368|11861686|FG002|Overall Study|Withdrawal by Subject|9
7522482|NCT02539368|11861687|FG003|Overall Study|Withdrawal by Subject|1
7522483|NCT02539368|11861688|FG004|Overall Study|Withdrawal by Subject|3
7522484|NCT02539368|11861684|FG000|Overall Study|Physician Decision|49
7522485|NCT02539368|11861685|FG001|Overall Study|Physician Decision|15
7522486|NCT02539368|11861686|FG002|Overall Study|Physician Decision|7
7522487|NCT02539368|11861687|FG003|Overall Study|Physician Decision|0
7522488|NCT02539368|11861688|FG004|Overall Study|Physician Decision|2
7522489|NCT02539368|11861684|FG000|Overall Study|Lost to Follow-up|96
7522490|NCT02539368|11861685|FG001|Overall Study|Lost to Follow-up|21
7522491|NCT02539368|11861686|FG002|Overall Study|Lost to Follow-up|16
7522492|NCT02539368|11861687|FG003|Overall Study|Lost to Follow-up|4
7522493|NCT02539368|11861688|FG004|Overall Study|Lost to Follow-up|3
7522494|NCT02539368|11861684|FG000|Overall Study|Adverse Event|44
7522495|NCT02539368|11861685|FG001|Overall Study|Adverse Event|5
7522496|NCT02539368|11861686|FG002|Overall Study|Adverse Event|9
7522497|NCT02539368|11861687|FG003|Overall Study|Adverse Event|0
7522498|NCT02539368|11861688|FG004|Overall Study|Adverse Event|3
7522499|NCT02539368|11861684|FG000|Overall Study|Participant Non-compliant|13
7522500|NCT02539368|11861685|FG001|Overall Study|Participant Non-compliant|2
7522501|NCT02539368|11861686|FG002|Overall Study|Participant Non-compliant|1
7522502|NCT02539368|11861687|FG003|Overall Study|Participant Non-compliant|1
7522503|NCT02539368|11861688|FG004|Overall Study|Participant Non-compliant|0
7522504|NCT02539368|11861684|FG000|Overall Study|Other|145
7522505|NCT02539368|11861685|FG001|Overall Study|Other|18
7522506|NCT02539368|11861686|FG002|Overall Study|Other|24
7522507|NCT02539368|11861687|FG003|Overall Study|Other|1
7522508|NCT02539368|11861688|FG004|Overall Study|Other|3
7522509|NCT02539368|11861684|FG000|Overall Study|Missing|10
7522510|NCT02539368|11861685|FG001|Overall Study|Missing|3
7522511|NCT02539368|11861686|FG002|Overall Study|Missing|0
7522512|NCT02539368|11861687|FG003|Overall Study|Missing|0
7522513|NCT02539368|11861688|FG004|Overall Study|Missing|0
7522514|NCT02539797|11861721|FG000|Overall Study|Lost to Follow-up|0
7522515|NCT02539797|11861722|FG001|Overall Study|Lost to Follow-up|1
7522516|NCT02539797|11861723|FG002|Overall Study|Lost to Follow-up|0
7522517|NCT02540083|11861746|FG000|Overall Study|Withdrawal by Subject|16
7522518|NCT02540213|11861767|FG000|Overall Study|Death/adverse event|18
7522519|NCT02540213|11861767|FG000|Overall Study|Administrative reasons|3
7522520|NCT02540213|11861767|FG000|Overall Study|Kidney transplant|3
7522521|NCT02540213|11861767|FG000|Overall Study|Lack of Efficacy|6
7522522|NCT02540213|11861767|FG000|Overall Study|Consent withdrawn|7
7522523|NCT02540213|11861767|FG000|Overall Study|Enrolled but not treated|2
7522524|NCT02540265|11861783|FG000|Overall Study|Lost to Follow-up|0
7522525|NCT02540265|11861784|FG001|Overall Study|Lost to Follow-up|0
7522526|NCT02540265|11861785|FG002|Overall Study|Lost to Follow-up|1
7522527|NCT02540291|11861797|FG000|Overall Study|Death|7
7522528|NCT02540291|11861798|FG001|Overall Study|Death|7
7522529|NCT02540291|11861799|FG002|Overall Study|Death|5
7522530|NCT02540291|11861800|FG003|Overall Study|Death|7
7522531|NCT02540291|11861797|FG000|Overall Study|Lost to Follow-up|0
7522532|NCT02540291|11861798|FG001|Overall Study|Lost to Follow-up|0
7522533|NCT02540291|11861799|FG002|Overall Study|Lost to Follow-up|1
7522534|NCT02540291|11861800|FG003|Overall Study|Lost to Follow-up|0
7522535|NCT02540291|11861797|FG000|Overall Study|Withdrawal Of Consent|0
7522536|NCT02540291|11861798|FG001|Overall Study|Withdrawal Of Consent|1
7522537|NCT02540291|11861799|FG002|Overall Study|Withdrawal Of Consent|0
7522538|NCT02540291|11861800|FG003|Overall Study|Withdrawal Of Consent|0
7522539|NCT02540291|11861797|FG000|Overall Study|Study Terminated By Sponsor|1
7522540|NCT02540291|11861798|FG001|Overall Study|Study Terminated By Sponsor|0
7522541|NCT02540291|11861799|FG002|Overall Study|Study Terminated By Sponsor|0
7522542|NCT02540291|11861800|FG003|Overall Study|Study Terminated By Sponsor|0
7522543|NCT02540291|11861797|FG000|Overall Study|Other|0
7522544|NCT02540291|11861798|FG001|Overall Study|Other|0
7522545|NCT02540291|11861799|FG002|Overall Study|Other|1
7522546|NCT02540291|11861800|FG003|Overall Study|Other|0
7522547|NCT02540356|11861814|FG000|Overall Study|Terminated due to disease progression|1
7522548|NCT02540356|11861815|FG001|Overall Study|Terminated due to disease progression|0
7522549|NCT02540538|11861832|FG000|Overall Study|Pregnancy|0
7522550|NCT02540538|11861833|FG001|Overall Study|Pregnancy|1
7522551|NCT02540538|11861834|FG002|Overall Study|Pregnancy|0
7522552|NCT02540668|11861852|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
7522553|NCT02540668|11861853|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
7522554|NCT02540850|11861872|FG000|Overall Study|Lost to Follow-up|69
7522555|NCT02540850|11861873|FG001|Overall Study|Lost to Follow-up|66
7522556|NCT02540850|11861874|FG002|Overall Study|Lost to Follow-up|34
7522557|NCT02540954|11861884|FG000|Overall Study|Physician Decision|3
7522558|NCT02540954|11861885|FG001|Overall Study|Physician Decision|1
7522559|NCT02540954|11861884|FG000|Overall Study|Withdrawal by Subject|6
7522560|NCT02540954|11861885|FG001|Overall Study|Withdrawal by Subject|5
7522561|NCT02540954|11861884|FG000|Overall Study|Lost to Follow-up|1
7522562|NCT02540954|11861885|FG001|Overall Study|Lost to Follow-up|1
7522563|NCT02540954|11861884|FG000|Overall Study|Adverse Event|4
7522564|NCT02540954|11861885|FG001|Overall Study|Adverse Event|2
7522565|NCT02540954|11861884|FG000|Overall Study|Death|0
7522566|NCT02540954|11861885|FG001|Overall Study|Death|3
7522567|NCT02540954|11861884|FG000|Overall Study|Treatment failure|1
7522568|NCT02540954|11861885|FG001|Overall Study|Treatment failure|0
7522569|NCT02540954|11861884|FG000|Overall Study|Other reason|4
7522570|NCT02540954|11861885|FG001|Overall Study|Other reason|2
7522571|NCT02540993|11861893|FG000|Overall Study|Lost to Follow-up|5
7522572|NCT02540993|11861894|FG001|Overall Study|Lost to Follow-up|3
7522573|NCT02540993|11861893|FG000|Overall Study|Withdrawal by Subject|4
7522574|NCT02540993|11861894|FG001|Overall Study|Withdrawal by Subject|6
7522575|NCT02540993|11861893|FG000|Overall Study|GCP violations|33
7522576|NCT02540993|11861894|FG001|Overall Study|GCP violations|27
7522577|NCT02541604|11861932|FG000|Overall Study|Death|6
7522578|NCT02541604|11861933|FG001|Overall Study|Death|5
7522579|NCT02541604|11861934|FG002|Overall Study|Death|7
7522580|NCT02541604|11861935|FG003|Overall Study|Death|2
7522581|NCT02541604|11861936|FG004|Overall Study|Death|9
7522582|NCT02541604|11861937|FG005|Overall Study|Death|8
7522583|NCT02541604|11861938|FG006|Overall Study|Death|9
7522584|NCT02541604|11861939|FG007|Overall Study|Death|9
7522585|NCT02541604|11861940|FG008|Overall Study|Death|3
7522586|NCT02541604|11861941|FG009|Overall Study|Death|4
7522587|NCT02541604|11861942|FG010|Overall Study|Death|2
7522588|NCT02541604|11861943|FG011|Overall Study|Death|3
7522589|NCT02541604|11861932|FG000|Overall Study|Lost to Follow-up|2
7522590|NCT02541604|11861933|FG001|Overall Study|Lost to Follow-up|0
7522591|NCT02541604|11861934|FG002|Overall Study|Lost to Follow-up|1
7522592|NCT02541604|11861935|FG003|Overall Study|Lost to Follow-up|0
7522593|NCT02541604|11861936|FG004|Overall Study|Lost to Follow-up|0
7522594|NCT02541604|11861937|FG005|Overall Study|Lost to Follow-up|1
7522595|NCT02541604|11861938|FG006|Overall Study|Lost to Follow-up|1
7522596|NCT02541604|11861939|FG007|Overall Study|Lost to Follow-up|0
7522597|NCT02541604|11861940|FG008|Overall Study|Lost to Follow-up|0
7522598|NCT02541604|11861941|FG009|Overall Study|Lost to Follow-up|0
7522599|NCT02541604|11861942|FG010|Overall Study|Lost to Follow-up|0
7522600|NCT02541604|11861943|FG011|Overall Study|Lost to Follow-up|0
7522601|NCT02541604|11861932|FG000|Overall Study|Withdrawal by Subject|2
7522602|NCT02541604|11861933|FG001|Overall Study|Withdrawal by Subject|0
7522603|NCT02541604|11861934|FG002|Overall Study|Withdrawal by Subject|1
7522604|NCT02541604|11861935|FG003|Overall Study|Withdrawal by Subject|0
7522605|NCT02541604|11861936|FG004|Overall Study|Withdrawal by Subject|1
7522606|NCT02541604|11861937|FG005|Overall Study|Withdrawal by Subject|1
7522607|NCT02541604|11861938|FG006|Overall Study|Withdrawal by Subject|0
7522608|NCT02541604|11861939|FG007|Overall Study|Withdrawal by Subject|0
7522609|NCT02541604|11861940|FG008|Overall Study|Withdrawal by Subject|1
7522610|NCT02541604|11861941|FG009|Overall Study|Withdrawal by Subject|0
7522611|NCT02541604|11861942|FG010|Overall Study|Withdrawal by Subject|0
7522612|NCT02541604|11861943|FG011|Overall Study|Withdrawal by Subject|0
7522613|NCT02541604|11861932|FG000|Overall Study|Study Terminated by Sponsor|1
7522614|NCT02541604|11861933|FG001|Overall Study|Study Terminated by Sponsor|4
7522615|NCT02541604|11861934|FG002|Overall Study|Study Terminated by Sponsor|2
7522616|NCT02541604|11861935|FG003|Overall Study|Study Terminated by Sponsor|1
7522617|NCT02541604|11861936|FG004|Overall Study|Study Terminated by Sponsor|0
7522618|NCT02541604|11861937|FG005|Overall Study|Study Terminated by Sponsor|0
7522619|NCT02541604|11861938|FG006|Overall Study|Study Terminated by Sponsor|0
7522620|NCT02541604|11861939|FG007|Overall Study|Study Terminated by Sponsor|0
7522621|NCT02541604|11861940|FG008|Overall Study|Study Terminated by Sponsor|0
7522622|NCT02541604|11861941|FG009|Overall Study|Study Terminated by Sponsor|0
7522623|NCT02541604|11861942|FG010|Overall Study|Study Terminated by Sponsor|0
7522624|NCT02541604|11861943|FG011|Overall Study|Study Terminated by Sponsor|0
7522625|NCT02541604|11861932|FG000|Overall Study|Medical condition may jeopardize safety|0
7522626|NCT02541604|11861933|FG001|Overall Study|Medical condition may jeopardize safety|0
7522627|NCT02541604|11861934|FG002|Overall Study|Medical condition may jeopardize safety|0
7522628|NCT02541604|11861935|FG003|Overall Study|Medical condition may jeopardize safety|0
7522629|NCT02541604|11861936|FG004|Overall Study|Medical condition may jeopardize safety|0
7522630|NCT02541604|11861937|FG005|Overall Study|Medical condition may jeopardize safety|0
7522631|NCT02541604|11861938|FG006|Overall Study|Medical condition may jeopardize safety|0
7522632|NCT02541604|11861939|FG007|Overall Study|Medical condition may jeopardize safety|1
7522633|NCT02541604|11861940|FG008|Overall Study|Medical condition may jeopardize safety|0
7522634|NCT02541604|11861941|FG009|Overall Study|Medical condition may jeopardize safety|0
7522635|NCT02541604|11861942|FG010|Overall Study|Medical condition may jeopardize safety|0
7522636|NCT02541604|11861943|FG011|Overall Study|Medical condition may jeopardize safety|0
7522637|NCT02541669|11861997|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
7522638|NCT02541669|11861998|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
7522639|NCT02541669|11861999|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
7522640|NCT02541669|11862000|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
7522641|NCT02541669|11862001|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
7522642|NCT02541903|11862031|FG000|Overall Study|Death|1
7522643|NCT02542072|11862054|FG000|First Intervention (1 Month)|Adverse Event|1
7522644|NCT02542072|11862055|FG001|First Intervention (1 Month)|Adverse Event|1
7522645|NCT02542072|11862054|FG000|First Intervention (1 Month)|Lost to Follow-up|2
7522646|NCT02542072|11862055|FG001|First Intervention (1 Month)|Lost to Follow-up|0
7522647|NCT02542072|11862054|FG000|First Intervention (1 Month)|Lens discomfort|1
7522648|NCT02542072|11862055|FG001|First Intervention (1 Month)|Lens discomfort|2
7522649|NCT02542072|11862054|FG000|First Intervention (1 Month)|Protocol Violation|1
7522650|NCT02542072|11862055|FG001|First Intervention (1 Month)|Protocol Violation|0
7522651|NCT02542072|11862054|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
7522652|NCT02542072|11862055|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
7522653|NCT02542072|11862054|FG000|Second Intervention (1 Month)|Lens discomfort|1
7522654|NCT02542072|11862055|FG001|Second Intervention (1 Month)|Lens discomfort|0
7522655|NCT02542605|11862130|FG000|Part B: Challenge Phase|Sponsor decision|1
7522656|NCT02542605|11862131|FG001|Part B: Challenge Phase|Sponsor decision|0
7522657|NCT02542605|11862132|FG002|Part B: Challenge Phase|Sponsor decision|0
7522658|NCT02542605|11862130|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
7522659|NCT02542605|11862131|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
7522660|NCT02542605|11862132|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
7522661|NCT02542631|11862143|FG000|Overall Study|Adverse Event|1
7522662|NCT02542631|11862144|FG001|Overall Study|Adverse Event|1
7522663|NCT02542631|11862143|FG000|Overall Study|Sponsor Termination|1
7522664|NCT02542631|11862144|FG001|Overall Study|Sponsor Termination|0
7522665|NCT02542631|11862143|FG000|Overall Study|Withdrawal by Subject|11
7522666|NCT02542631|11862144|FG001|Overall Study|Withdrawal by Subject|16
7522667|NCT02542631|11862143|FG000|Overall Study|Protocol Violation|1
7522668|NCT02542631|11862144|FG001|Overall Study|Protocol Violation|1
7522669|NCT02542631|11862143|FG000|Overall Study|Physician Decision|6
7522670|NCT02542631|11862144|FG001|Overall Study|Physician Decision|4
7522671|NCT02542631|11862143|FG000|Overall Study|Lost to Follow-up|6
7522672|NCT02542631|11862144|FG001|Overall Study|Lost to Follow-up|5
7522673|NCT02542631|11862143|FG000|Overall Study|Death|1
7522674|NCT02542631|11862144|FG001|Overall Study|Death|2
7522675|NCT02542631|11862143|FG000|Overall Study|Other|2
7522676|NCT02542631|11862144|FG001|Overall Study|Other|1
7522677|NCT02542631|11862143|FG000|Overall Study|Used Prohibited Medication|2
7522678|NCT02542631|11862144|FG001|Overall Study|Used Prohibited Medication|1
7522679|NCT02542865|11862159|FG000|Overall Study|Identified as screen failure|1
7522680|NCT02542865|11862160|FG001|Overall Study|Identified as screen failure|0
7522681|NCT02542865|11862159|FG000|Overall Study|Withdrawal by Subject|16
7522682|NCT02542865|11862160|FG001|Overall Study|Withdrawal by Subject|0
7522683|NCT02542943|11862169|FG000|Overall Study|Lost to Follow-up|1
7522684|NCT02542943|11862170|FG001|Overall Study|Lost to Follow-up|0
7522685|NCT02542943|11862171|FG002|Overall Study|Lost to Follow-up|0
7522686|NCT02542943|11862169|FG000|Overall Study|Withdrawal by Subject|0
7522687|NCT02542943|11862170|FG001|Overall Study|Withdrawal by Subject|1
7522688|NCT02542943|11862171|FG002|Overall Study|Withdrawal by Subject|0
7522689|NCT02543203|11862182|FG000|Overall Study|Unpalatable Fragrance|2
7522690|NCT02543203|11862183|FG001|Overall Study|Unpalatable Fragrance|2
7522691|NCT02543203|11862182|FG000|Overall Study|Lost to Follow-up|1
7522692|NCT02543203|11862183|FG001|Overall Study|Lost to Follow-up|0
7522693|NCT02543203|11862182|FG000|Overall Study|Increased Irritability|1
7522694|NCT02543203|11862183|FG001|Overall Study|Increased Irritability|0
7522695|NCT02543203|11862182|FG000|Overall Study|Family|1
7522696|NCT02543203|11862183|FG001|Overall Study|Family|2
7522697|NCT02543203|11862182|FG000|Overall Study|Negative Behavior|1
7522698|NCT02543203|11862183|FG001|Overall Study|Negative Behavior|0
7522699|NCT02543203|11862182|FG000|Overall Study|Withdrawal by Subject|0
7522700|NCT02543203|11862183|FG001|Overall Study|Withdrawal by Subject|1
7522701|NCT02543294|11862197|FG000|Overall Study|Lost to Follow-up|3
7522702|NCT02543294|11862197|FG000|Overall Study|Physician Decision|2
7522703|NCT02543294|11862197|FG000|Overall Study|Withdrawal by Subject|7
7522704|NCT02543346|11862202|FG000|Second Priming Visit|Withdrawal by Subject|0
7522705|NCT02543346|11862203|FG001|Second Priming Visit|Withdrawal by Subject|2
7522706|NCT02543346|11862204|FG002|Second Priming Visit|Withdrawal by Subject|2
7522707|NCT02543346|11862205|FG003|Second Priming Visit|Withdrawal by Subject|2
7522708|NCT02543346|11862202|FG000|Second Priming Visit|Adverse Event|1
7522709|NCT02543346|11862203|FG001|Second Priming Visit|Adverse Event|0
7522710|NCT02543346|11862204|FG002|Second Priming Visit|Adverse Event|0
7522711|NCT02543346|11862205|FG003|Second Priming Visit|Adverse Event|0
7522712|NCT02543528|11862228|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
7522713|NCT02543528|11862229|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
7522714|NCT02543528|11862230|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
7522715|NCT02543528|11862231|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
7522716|NCT02543528|11862232|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
7522717|NCT02543528|11862228|FG000|Adaptation Period|Lens Handling Difficultes|0
7522718|NCT02543528|11862229|FG001|Adaptation Period|Lens Handling Difficultes|0
7522719|NCT02543528|11862230|FG002|Adaptation Period|Lens Handling Difficultes|0
7522720|NCT02543528|11862231|FG003|Adaptation Period|Lens Handling Difficultes|0
7522721|NCT02543528|11862232|FG004|Adaptation Period|Lens Handling Difficultes|8
7522722|NCT02543528|11862228|FG000|Adaptation Period|Lost to Follow-up|0
7522723|NCT02543528|11862229|FG001|Adaptation Period|Lost to Follow-up|0
7522724|NCT02543528|11862230|FG002|Adaptation Period|Lost to Follow-up|0
7522725|NCT02543528|11862231|FG003|Adaptation Period|Lost to Follow-up|0
7522726|NCT02543528|11862232|FG004|Adaptation Period|Lost to Follow-up|14
7522727|NCT02543528|11862228|FG000|Adaptation Period|Adverse Event|0
7522728|NCT02543528|11862229|FG001|Adaptation Period|Adverse Event|0
7522729|NCT02543528|11862230|FG002|Adaptation Period|Adverse Event|0
7522730|NCT02543528|11862231|FG003|Adaptation Period|Adverse Event|0
7522731|NCT02543528|11862232|FG004|Adaptation Period|Adverse Event|2
7522732|NCT02543528|11862228|FG000|Extended Wear Period|Adverse Event|17
7522733|NCT02543528|11862229|FG001|Extended Wear Period|Adverse Event|11
7522734|NCT02543528|11862230|FG002|Extended Wear Period|Adverse Event|16
7522735|NCT02543528|11862231|FG003|Extended Wear Period|Adverse Event|3
7522736|NCT02543528|11862232|FG004|Extended Wear Period|Adverse Event|0
7522737|NCT02543528|11862228|FG000|Extended Wear Period|Missed too many scheduled visits|0
7522738|NCT02543528|11862229|FG001|Extended Wear Period|Missed too many scheduled visits|0
7522739|NCT02543528|11862230|FG002|Extended Wear Period|Missed too many scheduled visits|1
7522740|NCT02543528|11862231|FG003|Extended Wear Period|Missed too many scheduled visits|3
7522741|NCT02543528|11862232|FG004|Extended Wear Period|Missed too many scheduled visits|0
7522742|NCT02543528|11862228|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
7522743|NCT02543528|11862229|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
7522744|NCT02543528|11862230|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
7522745|NCT02543528|11862231|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
7522746|NCT02543528|11862232|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
7522747|NCT02543528|11862228|FG000|Extended Wear Period|Lost to Follow-up|0
7522748|NCT02543528|11862229|FG001|Extended Wear Period|Lost to Follow-up|1
7522749|NCT02543528|11862230|FG002|Extended Wear Period|Lost to Follow-up|2
7522750|NCT02543528|11862231|FG003|Extended Wear Period|Lost to Follow-up|1
7522751|NCT02543528|11862232|FG004|Extended Wear Period|Lost to Follow-up|0
7522752|NCT02543528|11862228|FG000|Extended Wear Period|Withdrawal by Subject|10
7522753|NCT02543528|11862229|FG001|Extended Wear Period|Withdrawal by Subject|9
7522754|NCT02543528|11862230|FG002|Extended Wear Period|Withdrawal by Subject|4
7522755|NCT02543528|11862231|FG003|Extended Wear Period|Withdrawal by Subject|5
7536994|NCT02728206|11885287|FG000|Overall Study|Death|1
7522756|NCT02543528|11862232|FG004|Extended Wear Period|Withdrawal by Subject|0
7522757|NCT02543658|11862257|FG000|Overall Study|Lack of Efficacy|0
7522758|NCT02543658|11862258|FG001|Overall Study|Lack of Efficacy|4
7522759|NCT02543801|11862280|FG000|Overall Study|Protocol Violation|1
7522760|NCT02543801|11862281|FG001|Overall Study|Protocol Violation|2
7522761|NCT02543801|11862282|FG002|Overall Study|Protocol Violation|0
7522762|NCT02543801|11862283|FG003|Overall Study|Protocol Violation|0
7522763|NCT02543892|11862311|FG000|Received Vaccination 2|Withdrawal by Subject|1
7522764|NCT02543892|11862312|FG001|Received Vaccination 2|Withdrawal by Subject|0
7522765|NCT02543892|11862313|FG002|Received Vaccination 2|Withdrawal by Subject|0
7522766|NCT02543892|11862314|FG003|Received Vaccination 2|Withdrawal by Subject|0
7522767|NCT02543892|11862315|FG004|Received Vaccination 2|Withdrawal by Subject|0
7522768|NCT02543892|11862316|FG005|Received Vaccination 2|Withdrawal by Subject|0
7522769|NCT02543892|11862317|FG006|Received Vaccination 2|Withdrawal by Subject|0
7522770|NCT02543892|11862318|FG007|Received Vaccination 2|Withdrawal by Subject|1
7522771|NCT02543892|11862311|FG000|Received Vaccination 2|Physician Decision|0
7522772|NCT02543892|11862312|FG001|Received Vaccination 2|Physician Decision|0
7522773|NCT02543892|11862313|FG002|Received Vaccination 2|Physician Decision|0
7522774|NCT02543892|11862314|FG003|Received Vaccination 2|Physician Decision|0
7522775|NCT02543892|11862315|FG004|Received Vaccination 2|Physician Decision|0
7522776|NCT02543892|11862316|FG005|Received Vaccination 2|Physician Decision|1
7522777|NCT02543892|11862317|FG006|Received Vaccination 2|Physician Decision|0
7522778|NCT02543892|11862318|FG007|Received Vaccination 2|Physician Decision|0
7522779|NCT02543892|11862311|FG000|Received Vaccination 2|Adverse Event|0
7522780|NCT02543892|11862312|FG001|Received Vaccination 2|Adverse Event|1
7522781|NCT02543892|11862313|FG002|Received Vaccination 2|Adverse Event|0
7522782|NCT02543892|11862314|FG003|Received Vaccination 2|Adverse Event|0
7522783|NCT02543892|11862315|FG004|Received Vaccination 2|Adverse Event|0
7522784|NCT02543892|11862316|FG005|Received Vaccination 2|Adverse Event|0
7522785|NCT02543892|11862317|FG006|Received Vaccination 2|Adverse Event|0
7522786|NCT02543892|11862318|FG007|Received Vaccination 2|Adverse Event|0
7522787|NCT02543892|11862311|FG000|Had Immunology Data|Withdrawal by Subject|0
7522788|NCT02543892|11862312|FG001|Had Immunology Data|Withdrawal by Subject|0
7522789|NCT02543892|11862313|FG002|Had Immunology Data|Withdrawal by Subject|0
7522790|NCT02543892|11862314|FG003|Had Immunology Data|Withdrawal by Subject|0
7522791|NCT02543892|11862315|FG004|Had Immunology Data|Withdrawal by Subject|0
7522792|NCT02543892|11862316|FG005|Had Immunology Data|Withdrawal by Subject|0
7522793|NCT02543892|11862317|FG006|Had Immunology Data|Withdrawal by Subject|1
7522794|NCT02543892|11862318|FG007|Had Immunology Data|Withdrawal by Subject|0
7522795|NCT02543918|11862343|FG000|Overall Study|Never treated|0
7522796|NCT02543918|11862344|FG001|Overall Study|Never treated|1
7522797|NCT02543918|11862343|FG000|Overall Study|Lost to Follow-up|1
7522798|NCT02543918|11862344|FG001|Overall Study|Lost to Follow-up|1
7522799|NCT02543918|11862343|FG000|Overall Study|Withdrawal by Subject|1
7522800|NCT02543918|11862344|FG001|Overall Study|Withdrawal by Subject|1
7522801|NCT02543918|11862343|FG000|Overall Study|Adverse Event|1
7522802|NCT02543918|11862344|FG001|Overall Study|Adverse Event|1
7536995|NCT02728830|11885291|FG000|Overall Study|Exclusionary Surgery|9
7536996|NCT02728830|11885291|FG000|Overall Study|Exclusionary Pathology|6
7536997|NCT02728830|11885291|FG000|Overall Study|Physician Decision|3
7536998|NCT02728830|11885291|FG000|Overall Study|Withdrawal by Subject|2
7536999|NCT02728830|11885291|FG000|Overall Study|Lost to Follow-up|1
7537000|NCT02728830|11885291|FG000|Overall Study|Exclusionary Lab Values|1
7537001|NCT02728830|11885291|FG000|Overall Study|Contraindicated Illness|1
7537002|NCT02728830|11885291|FG000|Overall Study|Language Barrier|1
7537003|NCT02728895|11885297|FG000|Overall Study|Other|1
7537004|NCT02728895|11885298|FG001|Overall Study|Other|2
7537005|NCT02728895|11885297|FG000|Overall Study|Withdrawal by Subject|0
7537006|NCT02728895|11885298|FG001|Overall Study|Withdrawal by Subject|3
7537831|NCT02282345|11886959|FG000|Overall Study|Progression|0
7537832|NCT02282345|11886960|FG001|Overall Study|Progression|1
7522803|NCT02544113|11862352|FG000|Overall Study|Death|3
7522804|NCT02544113|11862353|FG001|Overall Study|Death|4
7522805|NCT02544152|11862361|FG000|Overall Study|Adverse Event|0
7522806|NCT02544152|11862362|FG001|Overall Study|Adverse Event|4
7522807|NCT02544152|11862361|FG000|Overall Study|Withdrawal by Subject|0
7522808|NCT02544152|11862362|FG001|Overall Study|Withdrawal by Subject|3
7522809|NCT02544152|11862361|FG000|Overall Study|Other|1
7522810|NCT02544152|11862362|FG001|Overall Study|Other|0
7522811|NCT02544217|11862374|FG000|Overall Study|Withdrawal by Subject|1
7522812|NCT02544217|11862375|FG001|Overall Study|Withdrawal by Subject|1
7522813|NCT02544217|11862376|FG002|Overall Study|Withdrawal by Subject|0
7522814|NCT02544217|11862377|FG003|Overall Study|Withdrawal by Subject|0
7522815|NCT02544217|11862378|FG004|Overall Study|Withdrawal by Subject|0
7522816|NCT02544217|11862379|FG005|Overall Study|Withdrawal by Subject|0
7522817|NCT02544321|11862448|FG000|Overall Study|Withdrawal by Subject|1
7522818|NCT02544321|11862449|FG001|Overall Study|Withdrawal by Subject|2
7522819|NCT02544321|11862448|FG000|Overall Study|Adverse Event|1
7522820|NCT02544321|11862449|FG001|Overall Study|Adverse Event|1
7522821|NCT02544321|11862448|FG000|Overall Study|Protocol Violation|0
7522822|NCT02544321|11862449|FG001|Overall Study|Protocol Violation|1
7522823|NCT02544451|11862467|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
7522824|NCT02544451|11862468|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
7522825|NCT02544451|11862469|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
7522826|NCT02544451|11862470|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
7522827|NCT02544451|11862467|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
7522828|NCT02544451|11862468|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
7522829|NCT02544451|11862469|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
7522830|NCT02544451|11862470|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
7522831|NCT02544451|11862467|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
7522832|NCT02544451|11862468|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7522833|NCT02544451|11862469|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7522834|NCT02544451|11862470|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
7522835|NCT02544451|11862467|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
7522836|NCT02544451|11862468|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
7522837|NCT02544451|11862469|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
7522838|NCT02544451|11862470|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
7522839|NCT02544451|11862467|FG000|Treatment Period 1 (96 Weeks)|Other|4
7522840|NCT02544451|11862468|FG001|Treatment Period 1 (96 Weeks)|Other|4
7522841|NCT02544451|11862469|FG002|Treatment Period 1 (96 Weeks)|Other|0
7522842|NCT02544451|11862470|FG003|Treatment Period 1 (96 Weeks)|Other|0
7522843|NCT02544451|11862467|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7522844|NCT02544451|11862468|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7522845|NCT02544451|11862469|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
7522846|NCT02544451|11862470|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
7522847|NCT02544633|11862497|FG000|Treatment Period|Patient Still on Treatment/Study|0
7522848|NCT02544633|11862498|FG001|Treatment Period|Patient Still on Treatment/Study|1
7522849|NCT02544633|11862499|FG002|Treatment Period|Patient Still on Treatment/Study|1
7522850|NCT02544633|11862500|FG003|Treatment Period|Patient Still on Treatment/Study|0
7522851|NCT02544633|11862497|FG000|Treatment Period|Adverse Event|7
7522852|NCT02544633|11862498|FG001|Treatment Period|Adverse Event|4
7522853|NCT02544633|11862499|FG002|Treatment Period|Adverse Event|0
7522854|NCT02544633|11862500|FG003|Treatment Period|Adverse Event|5
7522855|NCT02544633|11862497|FG000|Treatment Period|Lack of Efficacy|17
7522856|NCT02544633|11862498|FG001|Treatment Period|Lack of Efficacy|11
7522857|NCT02544633|11862499|FG002|Treatment Period|Lack of Efficacy|5
7522858|NCT02544633|11862500|FG003|Treatment Period|Lack of Efficacy|5
7522859|NCT02544633|11862497|FG000|Treatment Period|Global Deterioration of Health|3
7522860|NCT02544633|11862498|FG001|Treatment Period|Global Deterioration of Health|3
7522861|NCT02544633|11862499|FG002|Treatment Period|Global Deterioration of Health|0
7522862|NCT02544633|11862500|FG003|Treatment Period|Global Deterioration of Health|1
7522863|NCT02544633|11862497|FG000|Treatment Period|Withdrawal by Subject|1
7522864|NCT02544633|11862498|FG001|Treatment Period|Withdrawal by Subject|0
7522865|NCT02544633|11862499|FG002|Treatment Period|Withdrawal by Subject|0
7522866|NCT02544633|11862500|FG003|Treatment Period|Withdrawal by Subject|0
7522867|NCT02544633|11862497|FG000|Treatment Period|Lost to Follow-up|0
7522868|NCT02544633|11862498|FG001|Treatment Period|Lost to Follow-up|1
7522869|NCT02544633|11862499|FG002|Treatment Period|Lost to Follow-up|0
7522870|NCT02544633|11862500|FG003|Treatment Period|Lost to Follow-up|0
7522871|NCT02544633|11862497|FG000|Treatment Period|Death|0
7522872|NCT02544633|11862498|FG001|Treatment Period|Death|0
7522873|NCT02544633|11862499|FG002|Treatment Period|Death|1
7522874|NCT02544633|11862500|FG003|Treatment Period|Death|0
7522875|NCT02544633|11862497|FG000|Treatment Period|Non-compliance|0
7522876|NCT02544633|11862498|FG001|Treatment Period|Non-compliance|0
7522877|NCT02544633|11862499|FG002|Treatment Period|Non-compliance|1
7522878|NCT02544633|11862500|FG003|Treatment Period|Non-compliance|0
7522879|NCT02544633|11862497|FG000|Treatment Period|Clinical Disease Progression|0
7522880|NCT02544633|11862498|FG001|Treatment Period|Clinical Disease Progression|0
7522881|NCT02544633|11862499|FG002|Treatment Period|Clinical Disease Progression|0
7522882|NCT02544633|11862500|FG003|Treatment Period|Clinical Disease Progression|1
7522883|NCT02544633|11862497|FG000|Survival Follow-up Period|Death|12
7522884|NCT02544633|11862498|FG001|Survival Follow-up Period|Death|14
7522885|NCT02544633|11862499|FG002|Survival Follow-up Period|Death|3
7522886|NCT02544633|11862500|FG003|Survival Follow-up Period|Death|9
7522887|NCT02544633|11862497|FG000|Survival Follow-up Period|Lost to Follow-up|0
7522888|NCT02544633|11862498|FG001|Survival Follow-up Period|Lost to Follow-up|1
7522889|NCT02544633|11862499|FG002|Survival Follow-up Period|Lost to Follow-up|1
7522890|NCT02544633|11862500|FG003|Survival Follow-up Period|Lost to Follow-up|0
7522891|NCT02544633|11862497|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7522892|NCT02544633|11862498|FG001|Survival Follow-up Period|Withdrawal by Subject|0
7522893|NCT02544633|11862499|FG002|Survival Follow-up Period|Withdrawal by Subject|1
7522894|NCT02544633|11862500|FG003|Survival Follow-up Period|Withdrawal by Subject|0
7522895|NCT02544633|11862497|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
7522896|NCT02544633|11862498|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
7522897|NCT02544633|11862499|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
7522898|NCT02544633|11862500|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
7522914|NCT02545075|11862546|FG000|Randomization|Lost to Follow-up|0
7522915|NCT02545075|11862547|FG001|Randomization|Lost to Follow-up|1
7522916|NCT02545075|11862546|FG000|Randomization|Withdrawal by Subject|0
7522917|NCT02545075|11862547|FG001|Randomization|Withdrawal by Subject|6
7522918|NCT02545075|11862546|FG000|Treatment|Disease progression|71
7522919|NCT02545075|11862547|FG001|Treatment|Disease progression|32
7522920|NCT02545075|11862546|FG000|Treatment|Participant dicontinued study treatment|7
7522921|NCT02545075|11862547|FG001|Treatment|Participant dicontinued study treatment|9
7522922|NCT02545075|11862546|FG000|Treatment|Withdrawal by Subject|1
7522923|NCT02545075|11862547|FG001|Treatment|Withdrawal by Subject|0
7522924|NCT02545075|11862546|FG000|Treatment|Adverse event not related to study drug|1
7522925|NCT02545075|11862547|FG001|Treatment|Adverse event not related to study drug|0
7522926|NCT02545075|11862546|FG000|Treatment|Death|1
7522927|NCT02545075|11862547|FG001|Treatment|Death|0
7522928|NCT02545075|11862546|FG000|Treatment|Participant drug toxicity|1
7522929|NCT02545075|11862547|FG001|Treatment|Participant drug toxicity|0
7522930|NCT02545075|11862546|FG000|Treatment|Completed treatment|40
7522931|NCT02545075|11862547|FG001|Treatment|Completed treatment|12
7522932|NCT02545270|11862560|FG000|Overall Study|technical difficulties|0
7522933|NCT02545270|11862561|FG001|Overall Study|technical difficulties|1
7522934|NCT02545270|11862562|FG002|Overall Study|technical difficulties|0
7522935|NCT02545270|11862560|FG000|Overall Study|Videos being too similar to other|0
7522936|NCT02545270|11862561|FG001|Overall Study|Videos being too similar to other|0
7522937|NCT02545270|11862562|FG002|Overall Study|Videos being too similar to other|2
7522938|NCT02545322|11862571|FG000|Overall Study|Withdrawal by Subject|3
7522939|NCT02545504|11862577|FG000|Overall Study|Death|174
7522940|NCT02545504|11862578|FG001|Overall Study|Death|168
7522941|NCT02545504|11862577|FG000|Overall Study|Unknown reason|30
7522942|NCT02545504|11862578|FG001|Overall Study|Unknown reason|32
7522943|NCT02545504|11862577|FG000|Overall Study|Withdrew consent|9
7522944|NCT02545504|11862578|FG001|Overall Study|Withdrew consent|11
7522945|NCT02545504|11862577|FG000|Overall Study|Investigator's discretion|3
7522946|NCT02545504|11862578|FG001|Overall Study|Investigator's discretion|1
7522947|NCT02545504|11862577|FG000|Overall Study|Lost to Follow-up|2
7522948|NCT02545504|11862578|FG001|Overall Study|Lost to Follow-up|2
7522949|NCT02545543|11862590|FG000|Overall Study|Lost to Follow-up|67
7522950|NCT02545543|11862591|FG001|Overall Study|Lost to Follow-up|25
7522951|NCT02545543|11862590|FG000|Overall Study|Physician Decision|3
7522952|NCT02545543|11862591|FG001|Overall Study|Physician Decision|0
7522953|NCT02545543|11862590|FG000|Overall Study|Withdrawal by Subject|9
7522954|NCT02545543|11862591|FG001|Overall Study|Withdrawal by Subject|8
7522955|NCT02545543|11862590|FG000|Overall Study|Noncomplaince|1
7522956|NCT02545543|11862591|FG001|Overall Study|Noncomplaince|0
7522957|NCT02545543|11862590|FG000|Overall Study|Enrolment of subject at >1 study site|1
7522958|NCT02545543|11862591|FG001|Overall Study|Enrolment of subject at >1 study site|1
7522959|NCT02545933|11862625|FG000|Overall Study|Adverse Event|3
7522960|NCT02545933|11862626|FG001|Overall Study|Adverse Event|0
7522961|NCT02545933|11862627|FG002|Overall Study|Adverse Event|0
7522962|NCT02545933|11862625|FG000|Overall Study|Withdrawal by Subject|2
7522963|NCT02545933|11862626|FG001|Overall Study|Withdrawal by Subject|3
7522964|NCT02545933|11862627|FG002|Overall Study|Withdrawal by Subject|3
7522965|NCT02545933|11862625|FG000|Overall Study|Protocol Violation|1
7522966|NCT02545933|11862626|FG001|Overall Study|Protocol Violation|0
7522967|NCT02545933|11862627|FG002|Overall Study|Protocol Violation|1
7522968|NCT02546193|11862637|FG000|Overall Study|Withdrawal by Subject|2
7522969|NCT02546193|11862638|FG001|Overall Study|Withdrawal by Subject|0
7522970|NCT02546193|11862639|FG002|Overall Study|Withdrawal by Subject|1
7522971|NCT02546193|11862640|FG003|Overall Study|Withdrawal by Subject|0
7522972|NCT02546193|11862637|FG000|Overall Study|Not eligible at time of induction|4
7522973|NCT02546193|11862638|FG001|Overall Study|Not eligible at time of induction|6
7522974|NCT02546193|11862639|FG002|Overall Study|Not eligible at time of induction|1
7522975|NCT02546193|11862640|FG003|Overall Study|Not eligible at time of induction|0
7522976|NCT02546323|11862648|FG000|Overall Study|Withdrawal by Subject|36
7522977|NCT02546323|11862649|FG001|Overall Study|Withdrawal by Subject|33
7522978|NCT02546323|11862648|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
7522979|NCT02546323|11862649|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
7522980|NCT02546323|11862648|FG000|Overall Study|Adverse Event|17
7522981|NCT02546323|11862649|FG001|Overall Study|Adverse Event|11
7522982|NCT02546323|11862648|FG000|Overall Study|Patient Specific Reasons|1
7522983|NCT02546323|11862649|FG001|Overall Study|Patient Specific Reasons|2
7522984|NCT02546323|11862648|FG000|Overall Study|Lost to Follow-up|2
7522985|NCT02546323|11862649|FG001|Overall Study|Lost to Follow-up|3
7522986|NCT02546323|11862648|FG000|Overall Study|Non-compliance with Study Drug|2
7522987|NCT02546323|11862649|FG001|Overall Study|Non-compliance with Study Drug|2
7522988|NCT02546323|11862648|FG000|Overall Study|Met Withdrawal Criteria|2
7522989|NCT02546323|11862649|FG001|Overall Study|Met Withdrawal Criteria|14
7522990|NCT02546362|11862655|FG000|4-week Treatment Period|Lost to Follow-up|1
7522991|NCT02546362|11862655|FG000|4-week Treatment Period|Change in medication|2
7522992|NCT02546362|11862655|FG000|12-week Treatment Period|Withdrawal by Subject|6
7522993|NCT02546362|11862655|FG000|12-week Treatment Period|Lost to Follow-up|2
7522994|NCT02546362|11862655|FG000|12-week Treatment Period|Change in medication|1
7522995|NCT02546544|11862673|FG000|Overall Study|Disease Progression|14
7522996|NCT02546544|11862673|FG000|Overall Study|Adverse Event|1
7522997|NCT02546544|11862673|FG000|Overall Study|Withdrawal by Subject|1
7522998|NCT02546609|11862693|FG000|Overall Study|Withdrawal by Subject|0
7522999|NCT02546609|11862694|FG001|Overall Study|Withdrawal by Subject|1
7523000|NCT02546609|11862695|FG002|Overall Study|Withdrawal by Subject|2
7523001|NCT02546609|11862693|FG000|Overall Study|Adverse Event|0
7523002|NCT02546609|11862694|FG001|Overall Study|Adverse Event|6
7523003|NCT02546609|11862695|FG002|Overall Study|Adverse Event|1
7523004|NCT02546609|11862693|FG000|Overall Study|Protocol Violation|0
7523005|NCT02546609|11862694|FG001|Overall Study|Protocol Violation|1
7523006|NCT02546609|11862695|FG002|Overall Study|Protocol Violation|1
7523007|NCT02546609|11862693|FG000|Overall Study|Lost to Follow-up|2
7523008|NCT02546609|11862694|FG001|Overall Study|Lost to Follow-up|3
7523009|NCT02546609|11862695|FG002|Overall Study|Lost to Follow-up|1
7523010|NCT02546609|11862693|FG000|Overall Study|travel or work schedule restriction|0
7523011|NCT02546609|11862694|FG001|Overall Study|travel or work schedule restriction|0
7523012|NCT02546609|11862695|FG002|Overall Study|travel or work schedule restriction|2
7523013|NCT02546765|11862707|FG000|Overall Study|Withdrawal by Subject|0
7523014|NCT02546765|11862708|FG001|Overall Study|Withdrawal by Subject|1
7523015|NCT02546765|11862709|FG002|Overall Study|Withdrawal by Subject|0
7523016|NCT02546765|11862710|FG003|Overall Study|Withdrawal by Subject|0
7523017|NCT02546856|11862733|FG000|4 Months Evaluation|Death|2
7523018|NCT02546856|11862734|FG001|4 Months Evaluation|Death|3
7523019|NCT02546856|11862733|FG000|4 Months Evaluation|Withdrawal by Subject|2
7523020|NCT02546856|11862734|FG001|4 Months Evaluation|Withdrawal by Subject|3
7523021|NCT02546856|11862733|FG000|4 Months Evaluation|Lost to Follow-up|3
7523022|NCT02546856|11862734|FG001|4 Months Evaluation|Lost to Follow-up|3
7523023|NCT02546856|11862733|FG000|4 Months Evaluation|Physician Decision|3
7523024|NCT02546856|11862734|FG001|4 Months Evaluation|Physician Decision|0
7523025|NCT02546856|11862733|FG000|4 Months Evaluation|Working or living abroad|5
7523026|NCT02546856|11862734|FG001|4 Months Evaluation|Working or living abroad|1
7523027|NCT02546856|11862733|FG000|4 Months Evaluation|reasons not due to titration|4
7523028|NCT02546856|11862734|FG001|4 Months Evaluation|reasons not due to titration|1
7523029|NCT02546856|11862733|FG000|4 Months Evaluation|HF Unit not active in summer|1
7523030|NCT02546856|11862734|FG001|4 Months Evaluation|HF Unit not active in summer|0
7523031|NCT02546856|11862733|FG000|6 Months Evaluation|Death|1
7523032|NCT02546856|11862734|FG001|6 Months Evaluation|Death|1
7523033|NCT02546856|11862733|FG000|6 Months Evaluation|Lost to Follow-up|1
7523034|NCT02546856|11862734|FG001|6 Months Evaluation|Lost to Follow-up|1
7523035|NCT02546856|11862733|FG000|6 Months Evaluation|Working or living abroad|6
7523036|NCT02546856|11862734|FG001|6 Months Evaluation|Working or living abroad|4
7523037|NCT02546856|11862733|FG000|6 Months Evaluation|reasons not due to titration|0
7523038|NCT02546856|11862734|FG001|6 Months Evaluation|reasons not due to titration|1
7523039|NCT02547038|11862763|FG000|Overall Study|Lost to Follow-up|3
7523040|NCT02547038|11862764|FG001|Overall Study|Lost to Follow-up|2
7523041|NCT02547220|11862781|FG000|Overall Study|Withdrawal by Subject|1
7523042|NCT02547220|11862782|FG001|Overall Study|Withdrawal by Subject|0
7523043|NCT02547220|11862781|FG000|Overall Study|Study terminated by sponsor|18
7523044|NCT02547220|11862782|FG001|Overall Study|Study terminated by sponsor|20
7523045|NCT02547233|11862790|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
7523046|NCT02547233|11862791|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
7523047|NCT02547233|11862790|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
7523048|NCT02547233|11862791|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
7523049|NCT02547233|11862790|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
7523050|NCT02547233|11862791|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
7523051|NCT02547233|11862790|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7523052|NCT02547233|11862791|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7523053|NCT02547233|11862790|FG000|12-month Follow-up|Withdrawal by Subject|10
7523054|NCT02547233|11862791|FG001|12-month Follow-up|Withdrawal by Subject|10
7523055|NCT02547233|11862790|FG000|12-month Follow-up|Lost to Follow-up|3
7523056|NCT02547233|11862791|FG001|12-month Follow-up|Lost to Follow-up|3
7523057|NCT02547233|11862790|FG000|12-month Follow-up|Lack of Efficacy|1
7523058|NCT02547233|11862791|FG001|12-month Follow-up|Lack of Efficacy|2
7523059|NCT02547233|11862790|FG000|12-month Follow-up|Protocol Violation|0
7523060|NCT02547233|11862791|FG001|12-month Follow-up|Protocol Violation|1
7523061|NCT02547233|11862790|FG000|12-month Follow-up|Other|0
7523062|NCT02547233|11862791|FG001|12-month Follow-up|Other|1
7523063|NCT02547363|11862801|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7523064|NCT02547363|11862802|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7523065|NCT02547363|11862801|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7523066|NCT02547363|11862802|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
7523067|NCT02547363|11862801|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7523068|NCT02547363|11862802|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
7523069|NCT02547363|11862801|FG000|3-day Treatment and 8-week Follow-up|Other|1
7523070|NCT02547363|11862802|FG001|3-day Treatment and 8-week Follow-up|Other|1
7523071|NCT02547363|11862801|FG000|12-month Follow-up|Withdrawal by Subject|4
7523072|NCT02547363|11862802|FG001|12-month Follow-up|Withdrawal by Subject|3
7523073|NCT02547363|11862801|FG000|12-month Follow-up|Lost to Follow-up|4
7523074|NCT02547363|11862802|FG001|12-month Follow-up|Lost to Follow-up|1
7523075|NCT02547363|11862801|FG000|12-month Follow-up|Lack of Efficacy|1
7523076|NCT02547363|11862802|FG001|12-month Follow-up|Lack of Efficacy|1
7523077|NCT02547363|11862801|FG000|12-month Follow-up|Other|1
7523078|NCT02547363|11862802|FG001|12-month Follow-up|Other|0
7523079|NCT02547428|11862812|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
7523080|NCT02547428|11862813|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
7523081|NCT02547428|11862812|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7523082|NCT02547428|11862813|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
7523083|NCT02547428|11862812|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7523084|NCT02547428|11862813|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
7523085|NCT02547428|11862812|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
7523086|NCT02547428|11862813|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
7523087|NCT02547428|11862812|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
7523088|NCT02547428|11862813|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
7523089|NCT02547428|11862812|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
7523090|NCT02547428|11862813|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
7523091|NCT02547428|11862812|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
7523092|NCT02547428|11862813|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
7523093|NCT02547428|11862812|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
7523094|NCT02547428|11862813|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
7523095|NCT02547454|11862826|FG000|Overall Study|Due to hemodialysis|53
7523096|NCT02547454|11862826|FG000|Overall Study|Due to transplantation|1
7523097|NCT02547454|11862826|FG000|Overall Study|Due to no further need to treat|4
7523098|NCT02547454|11862826|FG000|Overall Study|Death|38
7523099|NCT02547454|11862826|FG000|Overall Study|Lost to Follow-up|26
7523100|NCT02547454|11862826|FG000|Overall Study|Other|39
7523101|NCT02547454|11862826|FG000|Overall Study|No data|11
7523102|NCT02547649|11862842|FG000|Overall Study|Lost to Follow-up|3
7523103|NCT02547649|11862843|FG001|Overall Study|Lost to Follow-up|1
7523104|NCT02547649|11862844|FG002|Overall Study|Lost to Follow-up|1
7523105|NCT02547649|11862842|FG000|Overall Study|Not vaccinated|0
7523106|NCT02547649|11862843|FG001|Overall Study|Not vaccinated|0
7523107|NCT02547649|11862844|FG002|Overall Study|Not vaccinated|1
7523108|NCT02547649|11862842|FG000|Overall Study|Withdrawal by Subject|0
7523109|NCT02547649|11862843|FG001|Overall Study|Withdrawal by Subject|4
7523110|NCT02547649|11862844|FG002|Overall Study|Withdrawal by Subject|2
7523111|NCT02547766|11862857|FG000|Overall Study|Withdrawal by Subject|1
7523112|NCT02547922|11862873|FG000|Overall Study|Withdrawal by Subject|9
7523113|NCT02547922|11862874|FG001|Overall Study|Withdrawal by Subject|6
7523114|NCT02547922|11862875|FG002|Overall Study|Withdrawal by Subject|10
7523115|NCT02547922|11862873|FG000|Overall Study|Adverse Event|3
7523116|NCT02547922|11862874|FG001|Overall Study|Adverse Event|1
7523117|NCT02547922|11862875|FG002|Overall Study|Adverse Event|2
7523118|NCT02547922|11862873|FG000|Overall Study|Lost to Follow-up|1
7523119|NCT02547922|11862874|FG001|Overall Study|Lost to Follow-up|0
7523120|NCT02547922|11862875|FG002|Overall Study|Lost to Follow-up|0
7523121|NCT02547922|11862873|FG000|Overall Study|Lack of Efficacy|5
7523122|NCT02547922|11862874|FG001|Overall Study|Lack of Efficacy|7
7523123|NCT02547922|11862875|FG002|Overall Study|Lack of Efficacy|4
7523124|NCT02547922|11862873|FG000|Overall Study|Death|1
7523125|NCT02547922|11862874|FG001|Overall Study|Death|0
7523126|NCT02547922|11862875|FG002|Overall Study|Death|0
7523127|NCT02547922|11862873|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
7523128|NCT02547922|11862874|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
7523129|NCT02547922|11862875|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
7523130|NCT02547922|11862873|FG000|Overall Study|TECHNICAL PROBLEMS|1
7523131|NCT02547922|11862874|FG001|Overall Study|TECHNICAL PROBLEMS|0
7523132|NCT02547922|11862875|FG002|Overall Study|TECHNICAL PROBLEMS|0
7523133|NCT02547922|11862873|FG000|Overall Study|PROGRESSIVE DISEASE|1
7523134|NCT02547922|11862874|FG001|Overall Study|PROGRESSIVE DISEASE|0
7523135|NCT02547922|11862875|FG002|Overall Study|PROGRESSIVE DISEASE|2
7523136|NCT02547922|11862873|FG000|Overall Study|Physician Decision|2
7523137|NCT02547922|11862874|FG001|Overall Study|Physician Decision|1
7523138|NCT02547922|11862875|FG002|Overall Study|Physician Decision|2
7523139|NCT02547922|11862873|FG000|Overall Study|Patients did not receive IP|1
7523140|NCT02547922|11862874|FG001|Overall Study|Patients did not receive IP|1
7523141|NCT02547922|11862875|FG002|Overall Study|Patients did not receive IP|0
7523142|NCT02547935|11862892|FG000|Overall Study|Other|0
7523143|NCT02547935|11862893|FG001|Overall Study|Other|1
7523144|NCT02547935|11862894|FG002|Overall Study|Other|0
7523145|NCT02547935|11862892|FG000|Overall Study|Withdrawal by Subject|2
7523146|NCT02547935|11862893|FG001|Overall Study|Withdrawal by Subject|3
7523147|NCT02547935|11862894|FG002|Overall Study|Withdrawal by Subject|4
7523148|NCT02547935|11862892|FG000|Overall Study|Screen Failure|2
7523149|NCT02547935|11862893|FG001|Overall Study|Screen Failure|0
7523150|NCT02547935|11862894|FG002|Overall Study|Screen Failure|0
7523151|NCT02547935|11862892|FG000|Overall Study|Physician Decision|0
7523152|NCT02547935|11862893|FG001|Overall Study|Physician Decision|1
7523153|NCT02547935|11862894|FG002|Overall Study|Physician Decision|0
7523154|NCT02547935|11862892|FG000|Overall Study|Lost to Follow-up|0
7523155|NCT02547935|11862893|FG001|Overall Study|Lost to Follow-up|2
7523156|NCT02547935|11862894|FG002|Overall Study|Lost to Follow-up|1
7523157|NCT02547935|11862892|FG000|Overall Study|Death|1
7523158|NCT02547935|11862893|FG001|Overall Study|Death|1
7523159|NCT02547935|11862894|FG002|Overall Study|Death|0
7523160|NCT02547974|11862908|FG000|Overall Study|Withdrawal by Subject|1
7523161|NCT02547974|11862909|FG001|Overall Study|Withdrawal by Subject|0
7523162|NCT02547974|11862910|FG002|Overall Study|Withdrawal by Subject|0
7523163|NCT02547974|11862911|FG003|Overall Study|Withdrawal by Subject|0
7523164|NCT02547987|11862924|FG000|Overall Study|Withdrawal by Subject|1
7523165|NCT02547987|11862924|FG000|Overall Study|Adverse Event|2
7523166|NCT02548078|11862930|FG000|Overall Study|Serious adverse event/Adverse event|1
7523167|NCT02548078|11862931|FG001|Overall Study|Serious adverse event/Adverse event|0
7523168|NCT02548078|11862930|FG000|Overall Study|Moved from study area|3
7523169|NCT02548078|11862931|FG001|Overall Study|Moved from study area|3
7523170|NCT02548078|11862930|FG000|Overall Study|Lost to Follow-up|1
7523171|NCT02548078|11862931|FG001|Overall Study|Lost to Follow-up|3
7523172|NCT02548156|11862944|FG000|Washout Period 1|Lost to Follow-up|0
7523173|NCT02548156|11862945|FG001|Washout Period 1|Lost to Follow-up|0
7523174|NCT02548156|11862946|FG002|Washout Period 1|Lost to Follow-up|0
7523175|NCT02548156|11862947|FG003|Washout Period 1|Lost to Follow-up|0
7523176|NCT02548156|11862948|FG004|Washout Period 1|Lost to Follow-up|1
7523177|NCT02548156|11862949|FG005|Washout Period 1|Lost to Follow-up|0
7523178|NCT02548455|11862990|FG000|Overall Study|Withdrawal by Subject|27
7523179|NCT02548455|11862990|FG000|Overall Study|Death|26
7523180|NCT02548455|11862990|FG000|Overall Study|Lost to Follow-up|14
7523181|NCT02548455|11862990|FG000|Overall Study|Visit not completed|173
7523182|NCT02548585|11863001|FG000|Overall Study|Withdrawal by Subject|0
7523183|NCT02548585|11863002|FG001|Overall Study|Withdrawal by Subject|0
7523184|NCT02548585|11863003|FG002|Overall Study|Withdrawal by Subject|0
7523185|NCT02548585|11863004|FG003|Overall Study|Withdrawal by Subject|0
7523186|NCT02548585|11863005|FG004|Overall Study|Withdrawal by Subject|0
7523187|NCT02548585|11863006|FG005|Overall Study|Withdrawal by Subject|1
7523188|NCT02548585|11863007|FG006|Overall Study|Withdrawal by Subject|0
7523189|NCT02548585|11863001|FG000|Overall Study|Lost to Follow-up|1
7523190|NCT02548585|11863002|FG001|Overall Study|Lost to Follow-up|0
7523191|NCT02548585|11863003|FG002|Overall Study|Lost to Follow-up|0
7523192|NCT02548585|11863004|FG003|Overall Study|Lost to Follow-up|0
7523193|NCT02548585|11863005|FG004|Overall Study|Lost to Follow-up|0
7523194|NCT02548585|11863006|FG005|Overall Study|Lost to Follow-up|0
7523195|NCT02548585|11863007|FG006|Overall Study|Lost to Follow-up|0
7523196|NCT02548585|11863001|FG000|Overall Study|Other|1
7523197|NCT02548585|11863002|FG001|Overall Study|Other|0
7523198|NCT02548585|11863003|FG002|Overall Study|Other|0
7523199|NCT02548585|11863004|FG003|Overall Study|Other|2
7523200|NCT02548585|11863005|FG004|Overall Study|Other|3
7523201|NCT02548585|11863006|FG005|Overall Study|Other|0
7523202|NCT02548585|11863007|FG006|Overall Study|Other|1
7523203|NCT02548585|11863001|FG000|Overall Study|Randomized but not treated|0
7523204|NCT02548585|11863002|FG001|Overall Study|Randomized but not treated|0
7523205|NCT02548585|11863003|FG002|Overall Study|Randomized but not treated|0
7523206|NCT02548585|11863004|FG003|Overall Study|Randomized but not treated|0
7523207|NCT02548585|11863005|FG004|Overall Study|Randomized but not treated|0
7523208|NCT02548585|11863006|FG005|Overall Study|Randomized but not treated|1
7523209|NCT02548585|11863007|FG006|Overall Study|Randomized but not treated|0
7523210|NCT02548650|11863050|FG000|Triple Therapy|Adverse Event|1
7523211|NCT02548650|11863051|FG001|Triple Therapy|Adverse Event|0
7523212|NCT02548650|11863050|FG000|Triple Therapy|Withdrawal by Subject|0
7523213|NCT02548650|11863051|FG001|Triple Therapy|Withdrawal by Subject|4
7523214|NCT02548650|11863050|FG000|Double Therapy|Adverse Event|1
7523215|NCT02548650|11863051|FG001|Double Therapy|Adverse Event|1
7523216|NCT02548650|11863050|FG000|Double Therapy|Withdrawal by Subject|0
7523217|NCT02548650|11863051|FG001|Double Therapy|Withdrawal by Subject|1
7523218|NCT02548962|11863090|FG000|Overall Study|Withdrawal by Subject|1
7523219|NCT02548962|11863091|FG001|Overall Study|Withdrawal by Subject|0
7523220|NCT02549027|11863126|FG000|Washout After Period 4|Withdrawal by Subject|0
7523221|NCT02549027|11863127|FG001|Washout After Period 4|Withdrawal by Subject|1
7523222|NCT02549027|11863128|FG002|Washout After Period 4|Withdrawal by Subject|1
7523223|NCT02549027|11863129|FG003|Washout After Period 4|Withdrawal by Subject|1
7523224|NCT02549027|11863130|FG004|Washout After Period 4|Withdrawal by Subject|0
7523225|NCT02549027|11863131|FG005|Washout After Period 4|Withdrawal by Subject|0
7523226|NCT02549027|11863126|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7523227|NCT02549027|11863127|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7523228|NCT02549027|11863128|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7523229|NCT02549027|11863129|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7523230|NCT02549027|11863130|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
7523231|NCT02549027|11863131|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
7523232|NCT02549196|11863162|FG000|Overall Study|Protocol Violation|0
7523233|NCT02549196|11863163|FG001|Overall Study|Protocol Violation|0
7523234|NCT02549196|11863164|FG002|Overall Study|Protocol Violation|0
7523235|NCT02549196|11863165|FG003|Overall Study|Protocol Violation|1
7523236|NCT02549196|11863162|FG000|Overall Study|Withdrawal by Subject|1
7523237|NCT02549196|11863163|FG001|Overall Study|Withdrawal by Subject|0
7523238|NCT02549196|11863164|FG002|Overall Study|Withdrawal by Subject|1
7523239|NCT02549196|11863165|FG003|Overall Study|Withdrawal by Subject|0
7523240|NCT02549287|11863177|FG000|Overall Study|Lost to Follow-up|65
7523241|NCT02549287|11863178|FG001|Overall Study|Lost to Follow-up|26
7523242|NCT02549287|11863177|FG000|Overall Study|Withdrawal by Subject|15
7523243|NCT02549287|11863178|FG001|Overall Study|Withdrawal by Subject|6
7523244|NCT02549339|11863186|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
7523245|NCT02549339|11863187|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
7523246|NCT02549339|11863186|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
7523247|NCT02549339|11863187|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7523248|NCT02549339|11863186|FG000|3-day Treatment and 8-week Follow-up|Other|1
7523249|NCT02549339|11863187|FG001|3-day Treatment and 8-week Follow-up|Other|0
7523250|NCT02549339|11863186|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
7523251|NCT02549339|11863187|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
7523252|NCT02549339|11863186|FG000|12-month Follow-up|Lack of Efficacy|0
7523253|NCT02549339|11863187|FG001|12-month Follow-up|Lack of Efficacy|2
7523254|NCT02549339|11863186|FG000|12-month Follow-up|Withdrawal by Subject|8
7523255|NCT02549339|11863187|FG001|12-month Follow-up|Withdrawal by Subject|3
7523256|NCT02549339|11863186|FG000|12-month Follow-up|Lost to Follow-up|1
7523257|NCT02549339|11863187|FG001|12-month Follow-up|Lost to Follow-up|3
7523258|NCT02549339|11863186|FG000|12-month Follow-up|Other|0
7523259|NCT02549339|11863187|FG001|12-month Follow-up|Other|3
7523260|NCT02549352|11863197|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
7523261|NCT02549352|11863198|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
7523262|NCT02549352|11863197|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
7523263|NCT02549352|11863198|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
7523264|NCT02549352|11863197|FG000|3-day Treatment and 8-week Follow-up|Other|0
7523265|NCT02549352|11863198|FG001|3-day Treatment and 8-week Follow-up|Other|2
7523266|NCT02549352|11863197|FG000|12-month Follow-up|Withdrawal by Subject|4
7523267|NCT02549352|11863198|FG001|12-month Follow-up|Withdrawal by Subject|5
7523268|NCT02549352|11863197|FG000|12-month Follow-up|Lost to Follow-up|3
7523269|NCT02549352|11863198|FG001|12-month Follow-up|Lost to Follow-up|2
7523270|NCT02549352|11863197|FG000|12-month Follow-up|Death|0
7523271|NCT02549352|11863198|FG001|12-month Follow-up|Death|1
7523272|NCT02549352|11863197|FG000|12-month Follow-up|Protocol Violation|0
7523273|NCT02549352|11863198|FG001|12-month Follow-up|Protocol Violation|1
7523274|NCT02549352|11863197|FG000|12-month Follow-up|Other|1
7523275|NCT02549352|11863198|FG001|12-month Follow-up|Other|3
7523276|NCT02549573|11863228|FG000|Overall Study|Withdrawal by Subject|0
7523277|NCT02549573|11863229|FG001|Overall Study|Withdrawal by Subject|2
7523278|NCT02549573|11863228|FG000|Overall Study|Protocol Violation|0
7523279|NCT02549573|11863229|FG001|Overall Study|Protocol Violation|1
7523280|NCT02549859|11863235|FG000|Long-term 60 Hz DBS|Study Closed|1
7523281|NCT02550106|11863243|FG000|Overall Study|Adverse Event|1
7523282|NCT02550106|11863243|FG000|Overall Study|Lack of Efficacy|3
7523283|NCT02550106|11863243|FG000|Overall Study|Protocol Violation|6
7523284|NCT02550106|11863243|FG000|Overall Study|Withdrawal by Subject|2
7523285|NCT02550795|11863278|FG000|Overall Study|Physician Decision|0
7523286|NCT02550795|11863279|FG001|Overall Study|Physician Decision|1
7523287|NCT02550795|11863280|FG002|Overall Study|Physician Decision|0
7523288|NCT02550938|11863292|FG000|Overall Study|Lost to Follow-up|8
7523289|NCT02550938|11863293|FG001|Overall Study|Lost to Follow-up|7
7523290|NCT02550938|11863294|FG002|Overall Study|Lost to Follow-up|12
7523291|NCT02550938|11863295|FG003|Overall Study|Lost to Follow-up|11
7523292|NCT02551055|11863312|FG000|Overall Study|Death|2
7523293|NCT02551055|11863313|FG001|Overall Study|Death|4
7523294|NCT02551055|11863314|FG002|Overall Study|Death|2
7523295|NCT02551055|11863315|FG003|Overall Study|Death|2
7523296|NCT02551055|11863316|FG004|Overall Study|Death|2
7523297|NCT02551055|11863317|FG005|Overall Study|Death|1
7523298|NCT02551055|11863318|FG006|Overall Study|Death|2
7523299|NCT02551055|11863319|FG007|Overall Study|Death|0
7523300|NCT02551055|11863312|FG000|Overall Study|Study Terminated by Sponsor|1
7523301|NCT02551055|11863313|FG001|Overall Study|Study Terminated by Sponsor|1
7523302|NCT02551055|11863314|FG002|Overall Study|Study Terminated by Sponsor|0
7523303|NCT02551055|11863315|FG003|Overall Study|Study Terminated by Sponsor|2
7523304|NCT02551055|11863316|FG004|Overall Study|Study Terminated by Sponsor|2
7523305|NCT02551055|11863317|FG005|Overall Study|Study Terminated by Sponsor|0
7523306|NCT02551055|11863318|FG006|Overall Study|Study Terminated by Sponsor|0
7523307|NCT02551055|11863319|FG007|Overall Study|Study Terminated by Sponsor|0
7523308|NCT02551055|11863312|FG000|Overall Study|Withdrawal by Subject|1
7523309|NCT02551055|11863313|FG001|Overall Study|Withdrawal by Subject|1
7523310|NCT02551055|11863314|FG002|Overall Study|Withdrawal by Subject|0
7523311|NCT02551055|11863315|FG003|Overall Study|Withdrawal by Subject|1
7523312|NCT02551055|11863316|FG004|Overall Study|Withdrawal by Subject|2
7523313|NCT02551055|11863317|FG005|Overall Study|Withdrawal by Subject|0
7523314|NCT02551055|11863318|FG006|Overall Study|Withdrawal by Subject|0
7523315|NCT02551055|11863319|FG007|Overall Study|Withdrawal by Subject|0
7523316|NCT02551055|11863312|FG000|Overall Study|Reason not specified|0
7523317|NCT02551055|11863313|FG001|Overall Study|Reason not specified|0
7523318|NCT02551055|11863314|FG002|Overall Study|Reason not specified|0
7523319|NCT02551055|11863315|FG003|Overall Study|Reason not specified|0
7523320|NCT02551055|11863316|FG004|Overall Study|Reason not specified|1
7523321|NCT02551055|11863317|FG005|Overall Study|Reason not specified|0
7523322|NCT02551055|11863318|FG006|Overall Study|Reason not specified|1
7523323|NCT02551055|11863319|FG007|Overall Study|Reason not specified|0
7523324|NCT02551159|11863349|FG000|Overall Study|Death|352
7523325|NCT02551159|11863350|FG001|Overall Study|Death|174
7523326|NCT02551159|11863351|FG002|Overall Study|Death|161
7523327|NCT02551159|11863349|FG000|Overall Study|Withdrawal by Subject|8
7523328|NCT02551159|11863350|FG001|Overall Study|Withdrawal by Subject|5
7523329|NCT02551159|11863351|FG002|Overall Study|Withdrawal by Subject|16
7523330|NCT02551159|11863349|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
7523331|NCT02551159|11863350|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
7523332|NCT02551159|11863351|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
7523333|NCT02551666|11863381|FG000|Overall Study|Withdrawal by Subject|1
7523334|NCT02551666|11863382|FG001|Overall Study|Withdrawal by Subject|3
7523335|NCT02551692|11863391|FG000|Overall Study|Lost to Follow-up|0
7523336|NCT02551692|11863392|FG001|Overall Study|Lost to Follow-up|1
7523337|NCT02551692|11863393|FG002|Overall Study|Lost to Follow-up|4
7523338|NCT02551692|11863391|FG000|Overall Study|Withdrawal by Subject|1
7523339|NCT02551692|11863392|FG001|Overall Study|Withdrawal by Subject|0
7523340|NCT02551692|11863393|FG002|Overall Study|Withdrawal by Subject|1
7523341|NCT02551731|11863401|FG000|Overall Study|Withdrawal by Subject|2
7523342|NCT02551874|11863457|FG000|Overall Study|Lost to Follow-up|0
7523343|NCT02551874|11863458|FG001|Overall Study|Lost to Follow-up|2
7523344|NCT02551874|11863457|FG000|Overall Study|Pregnancy|0
7523345|NCT02551874|11863458|FG001|Overall Study|Pregnancy|1
7523346|NCT02551874|11863457|FG000|Overall Study|Reason not reported|10
7523347|NCT02551874|11863458|FG001|Overall Study|Reason not reported|4
7523348|NCT02551874|11863457|FG000|Overall Study|Did not receive randomized treatment|0
7523349|NCT02551874|11863458|FG001|Overall Study|Did not receive randomized treatment|7
7523350|NCT02551874|11863457|FG000|Overall Study|Did not enter long-term study|18
7523351|NCT02551874|11863458|FG001|Overall Study|Did not enter long-term study|25
7523352|NCT02552121|11863485|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
7523353|NCT02552121|11863486|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523354|NCT02552121|11863487|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523355|NCT02552121|11863488|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523356|NCT02552121|11863489|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523357|NCT02552121|11863490|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523358|NCT02552121|11863491|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523359|NCT02552121|11863492|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
7523360|NCT02552121|11863485|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
7523361|NCT02552121|11863486|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523362|NCT02552121|11863487|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523363|NCT02552121|11863488|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523364|NCT02552121|11863489|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523365|NCT02552121|11863490|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523366|NCT02552121|11863491|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523367|NCT02552121|11863492|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
7523368|NCT02552121|11863485|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523369|NCT02552121|11863486|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
7523370|NCT02552121|11863487|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523371|NCT02552121|11863488|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523372|NCT02552121|11863489|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523373|NCT02552121|11863490|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523374|NCT02552121|11863491|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523375|NCT02552121|11863492|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
7523376|NCT02552121|11863485|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523377|NCT02552121|11863486|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
7523378|NCT02552121|11863487|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523379|NCT02552121|11863488|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523380|NCT02552121|11863489|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523381|NCT02552121|11863490|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523382|NCT02552121|11863491|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523383|NCT02552121|11863492|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
7523384|NCT02552121|11863485|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523385|NCT02552121|11863486|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
7523386|NCT02552121|11863487|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523387|NCT02552121|11863488|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523388|NCT02552121|11863489|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523389|NCT02552121|11863490|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523390|NCT02552121|11863491|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523391|NCT02552121|11863492|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
7523392|NCT02552121|11863485|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523393|NCT02552121|11863486|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
7523394|NCT02552121|11863487|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523395|NCT02552121|11863488|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523396|NCT02552121|11863489|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523397|NCT02552121|11863490|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523398|NCT02552121|11863491|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523399|NCT02552121|11863492|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
7523400|NCT02552121|11863485|FG000|Part 2: Cohort Expansion|Patient Choice|0
7523401|NCT02552121|11863486|FG001|Part 2: Cohort Expansion|Patient Choice|0
7523402|NCT02552121|11863487|FG002|Part 2: Cohort Expansion|Patient Choice|1
7523403|NCT02552121|11863488|FG003|Part 2: Cohort Expansion|Patient Choice|0
7523404|NCT02552121|11863489|FG004|Part 2: Cohort Expansion|Patient Choice|0
7523405|NCT02552121|11863490|FG005|Part 2: Cohort Expansion|Patient Choice|0
7523406|NCT02552121|11863491|FG006|Part 2: Cohort Expansion|Patient Choice|1
7523407|NCT02552121|11863492|FG007|Part 2: Cohort Expansion|Patient Choice|0
7523408|NCT02552121|11863485|FG000|Part 2: Cohort Expansion|Disease Progression|0
7523409|NCT02552121|11863486|FG001|Part 2: Cohort Expansion|Disease Progression|0
7523410|NCT02552121|11863487|FG002|Part 2: Cohort Expansion|Disease Progression|3
7523411|NCT02552121|11863488|FG003|Part 2: Cohort Expansion|Disease Progression|2
7523412|NCT02552121|11863489|FG004|Part 2: Cohort Expansion|Disease Progression|1
7523413|NCT02552121|11863490|FG005|Part 2: Cohort Expansion|Disease Progression|4
7523414|NCT02552121|11863491|FG006|Part 2: Cohort Expansion|Disease Progression|0
7523415|NCT02552121|11863492|FG007|Part 2: Cohort Expansion|Disease Progression|3
7523416|NCT02552121|11863485|FG000|Part 2: Cohort Expansion|Adverse Event|0
7523417|NCT02552121|11863486|FG001|Part 2: Cohort Expansion|Adverse Event|0
7523418|NCT02552121|11863487|FG002|Part 2: Cohort Expansion|Adverse Event|6
7523419|NCT02552121|11863488|FG003|Part 2: Cohort Expansion|Adverse Event|1
7523420|NCT02552121|11863489|FG004|Part 2: Cohort Expansion|Adverse Event|0
7523421|NCT02552121|11863490|FG005|Part 2: Cohort Expansion|Adverse Event|0
7523422|NCT02552121|11863491|FG006|Part 2: Cohort Expansion|Adverse Event|0
7523423|NCT02552121|11863492|FG007|Part 2: Cohort Expansion|Adverse Event|0
7523424|NCT02552121|11863485|FG000|Part 2: Cohort Expansion|Death|0
7523425|NCT02552121|11863486|FG001|Part 2: Cohort Expansion|Death|0
7523426|NCT02552121|11863487|FG002|Part 2: Cohort Expansion|Death|1
7523427|NCT02552121|11863488|FG003|Part 2: Cohort Expansion|Death|0
7523428|NCT02552121|11863489|FG004|Part 2: Cohort Expansion|Death|0
7523429|NCT02552121|11863490|FG005|Part 2: Cohort Expansion|Death|0
7523430|NCT02552121|11863491|FG006|Part 2: Cohort Expansion|Death|0
7523431|NCT02552121|11863492|FG007|Part 2: Cohort Expansion|Death|0
7523432|NCT02552147|11863524|FG000|First Intervention (7 Days)|Protocol Violation|1
7523433|NCT02552147|11863525|FG001|First Intervention (7 Days)|Protocol Violation|0
7523434|NCT02552147|11863524|FG000|Second Intervention (7 Days)|Protocol Violation|2
7523435|NCT02552147|11863525|FG001|Second Intervention (7 Days)|Protocol Violation|0
7523436|NCT02552225|11863533|FG000|Overall Study|Withdrawal by Subject|1
7523437|NCT02552225|11863534|FG001|Overall Study|Withdrawal by Subject|0
7523438|NCT02552238|11863540|FG000|Overall Study|Withdrawal by Subject|2
7523439|NCT02552238|11863540|FG000|Overall Study|Adverse Event|2
7523440|NCT02552303|11863555|FG000|Allocation|Withdrawal by Subject|2
7523441|NCT02552303|11863556|FG001|Allocation|Withdrawal by Subject|1
7523442|NCT02552303|11863557|FG002|Allocation|Withdrawal by Subject|1
7523443|NCT02552303|11863558|FG003|Allocation|Withdrawal by Subject|1
7523444|NCT02552303|11863555|FG000|Allocation|ineligible|1
7523445|NCT02552303|11863556|FG001|Allocation|ineligible|1
7523446|NCT02552303|11863557|FG002|Allocation|ineligible|0
7523447|NCT02552303|11863558|FG003|Allocation|ineligible|0
7523448|NCT02552303|11863555|FG000|Follow-Up|Lost to Follow-up|0
7523449|NCT02552303|11863556|FG001|Follow-Up|Lost to Follow-up|0
7523450|NCT02552303|11863557|FG002|Follow-Up|Lost to Follow-up|1
7523451|NCT02552303|11863558|FG003|Follow-Up|Lost to Follow-up|0
7523452|NCT02552303|11863555|FG000|Follow-Up|ineligible|0
7523453|NCT02552303|11863556|FG001|Follow-Up|ineligible|2
7523454|NCT02552303|11863557|FG002|Follow-Up|ineligible|0
7523455|NCT02552303|11863558|FG003|Follow-Up|ineligible|0
7523456|NCT02552316|11863568|FG000|Overall Study|Withdrawal by Subject|1
7523457|NCT02552316|11863568|FG000|Overall Study|Withdrawal due to non-compliance|1
7523458|NCT02552355|11863620|FG000|Overall Study|Adverse Event|0
7523459|NCT02552355|11863621|FG001|Overall Study|Adverse Event|2
7523460|NCT02552355|11863622|FG002|Overall Study|Adverse Event|2
7523461|NCT02552355|11863623|FG003|Overall Study|Adverse Event|0
7523462|NCT02552355|11863620|FG000|Overall Study|Withdrawal by Subject|0
7523463|NCT02552355|11863621|FG001|Overall Study|Withdrawal by Subject|0
7523464|NCT02552355|11863622|FG002|Overall Study|Withdrawal by Subject|0
7523465|NCT02552355|11863623|FG003|Overall Study|Withdrawal by Subject|1
7523466|NCT02552732|11863638|FG000|Overall Study|Lost to Follow-up|2
7523467|NCT02552732|11863638|FG000|Overall Study|Physician Decision|1
7523468|NCT02552732|11863638|FG000|Overall Study|Day 1 SpO2 > 96%|1
7523469|NCT02552732|11863638|FG000|Overall Study|Withdrawal by Subject|6
7523470|NCT02552888|11863654|FG000|Overall Study|Lost to Follow-up|1
7523471|NCT02552888|11863655|FG001|Overall Study|Lost to Follow-up|1
7537009|NCT02729051|11885339|FG000|Overall Study|Adverse Event|21
7537010|NCT02729051|11885340|FG001|Overall Study|Adverse Event|11
7537011|NCT02729051|11885339|FG000|Overall Study|Lack of Efficacy|1
7537012|NCT02729051|11885340|FG001|Overall Study|Lack of Efficacy|1
7537013|NCT02729051|11885339|FG000|Overall Study|Lost to Follow-up|1
7537014|NCT02729051|11885340|FG001|Overall Study|Lost to Follow-up|2
7537015|NCT02729051|11885339|FG000|Overall Study|Physician Decision|1
7537016|NCT02729051|11885340|FG001|Overall Study|Physician Decision|1
7537017|NCT02729051|11885339|FG000|Overall Study|Withdrawal by Subject|6
7537018|NCT02729051|11885340|FG001|Overall Study|Withdrawal by Subject|17
7537019|NCT02729194|11885346|FG000|Overall Study|Withdrawal by Subject|3
7537020|NCT02729545|11885352|FG000|Overall Study|Pregnancy|1
7537021|NCT02729545|11885353|FG001|Overall Study|Pregnancy|1
7537022|NCT02729545|11885352|FG000|Overall Study|Lost to Follow-up|0
7537023|NCT02729545|11885353|FG001|Overall Study|Lost to Follow-up|1
7537024|NCT02729545|11885352|FG000|Overall Study|Withdrawal by Subject|2
7537025|NCT02729545|11885353|FG001|Overall Study|Withdrawal by Subject|3
7537026|NCT02729740|11885359|FG000|Overall Study|Early Termination|130
7537027|NCT02729740|11885359|FG000|Overall Study|Other|1
7537028|NCT02729831|11885367|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
7537029|NCT02729831|11885368|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
7537030|NCT02729831|11885369|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
7537031|NCT02729831|11885370|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
7537032|NCT02729831|11885367|FG000|1 Week Post-visit|Lost to Follow-up|43
7537033|NCT02729831|11885368|FG001|1 Week Post-visit|Lost to Follow-up|40
7537034|NCT02729831|11885369|FG002|1 Week Post-visit|Lost to Follow-up|38
7537035|NCT02729831|11885370|FG003|1 Week Post-visit|Lost to Follow-up|36
7537036|NCT02729831|11885367|FG000|6 Month Follow-up|Lost to Follow-up|54
7537037|NCT02729831|11885368|FG001|6 Month Follow-up|Lost to Follow-up|51
7537038|NCT02729831|11885369|FG002|6 Month Follow-up|Lost to Follow-up|48
7537039|NCT02729831|11885370|FG003|6 Month Follow-up|Lost to Follow-up|42
7537040|NCT02729831|11885367|FG000|6 Month Follow-up|Death|1
7537041|NCT02729831|11885368|FG001|6 Month Follow-up|Death|3
7537042|NCT02729831|11885369|FG002|6 Month Follow-up|Death|0
7537043|NCT02729831|11885370|FG003|6 Month Follow-up|Death|1
7537044|NCT02729896|11885383|FG000|Overall Study|Death|0
7537045|NCT02729896|11885384|FG001|Overall Study|Death|2
7537046|NCT02729896|11885385|FG002|Overall Study|Death|13
7537047|NCT02729896|11885383|FG000|Overall Study|Lost to Follow-up|0
7537048|NCT02729896|11885384|FG001|Overall Study|Lost to Follow-up|2
7537049|NCT02729896|11885385|FG002|Overall Study|Lost to Follow-up|3
7537050|NCT02729896|11885383|FG000|Overall Study|Other|0
7537051|NCT02729896|11885384|FG001|Overall Study|Other|2
7537052|NCT02729896|11885385|FG002|Overall Study|Other|0
7537053|NCT02729896|11885383|FG000|Overall Study|Physician Decision|1
7537054|NCT02729896|11885384|FG001|Overall Study|Physician Decision|2
7537055|NCT02729896|11885385|FG002|Overall Study|Physician Decision|3
7537056|NCT02729896|11885383|FG000|Overall Study|Progressive Disease|0
7537057|NCT02729896|11885384|FG001|Overall Study|Progressive Disease|1
7537058|NCT02729896|11885385|FG002|Overall Study|Progressive Disease|0
7537059|NCT02729896|11885383|FG000|Overall Study|Withdrawal by Subject|1
7537060|NCT02729896|11885384|FG001|Overall Study|Withdrawal by Subject|0
7537061|NCT02729896|11885385|FG002|Overall Study|Withdrawal by Subject|3
7537062|NCT02729909|11885396|FG000|Overall Study|Lost to Follow-up|0
7537063|NCT02729909|11885397|FG001|Overall Study|Lost to Follow-up|1
7537064|NCT02729909|11885396|FG000|Overall Study|Lack of Efficacy|0
7537065|NCT02729909|11885397|FG001|Overall Study|Lack of Efficacy|2
7523472|NCT02552966|11863665|FG000|Overall Study|Lost to Follow-up|2
7523473|NCT02552966|11863665|FG000|Overall Study|Withdrawal by Subject|3
7523474|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
7523475|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
7523476|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
7523477|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
7523478|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
7523479|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
7523480|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Death|1
7523481|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Death|3
7523482|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
7523483|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
7523484|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
7523485|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
7523486|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
7523487|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
7523488|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7523489|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
7523490|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
7523491|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
7523492|NCT02553317|11863675|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
7523493|NCT02553317|11863676|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
7523494|NCT02553330|11863686|FG000|Overall Study|Study Terminated by Sponsor|2
7523495|NCT02553330|11863687|FG001|Overall Study|Study Terminated by Sponsor|13
7523496|NCT02553330|11863688|FG002|Overall Study|Study Terminated by Sponsor|12
7523497|NCT02553330|11863686|FG000|Overall Study|Withdrawal by Subject|3
7523498|NCT02553330|11863687|FG001|Overall Study|Withdrawal by Subject|19
7523499|NCT02553330|11863688|FG002|Overall Study|Withdrawal by Subject|21
7523500|NCT02553330|11863686|FG000|Overall Study|Other|0
7523501|NCT02553330|11863687|FG001|Overall Study|Other|1
7523502|NCT02553330|11863688|FG002|Overall Study|Other|0
7523503|NCT02553330|11863686|FG000|Overall Study|Non compliance to study treatment|0
7523504|NCT02553330|11863687|FG001|Overall Study|Non compliance to study treatment|1
7523505|NCT02553330|11863688|FG002|Overall Study|Non compliance to study treatment|0
7523506|NCT02553330|11863686|FG000|Overall Study|Adverse Event|0
7523507|NCT02553330|11863687|FG001|Overall Study|Adverse Event|1
7523508|NCT02553330|11863688|FG002|Overall Study|Adverse Event|0
7523509|NCT02553330|11863686|FG000|Overall Study|Lost to Follow-up|0
7523510|NCT02553330|11863687|FG001|Overall Study|Lost to Follow-up|4
7523511|NCT02553330|11863688|FG002|Overall Study|Lost to Follow-up|4
7523512|NCT02553421|11863709|FG000|Overall Study|Lost to Follow-up|21
7523513|NCT02553421|11863710|FG001|Overall Study|Lost to Follow-up|1
7523514|NCT02553421|11863709|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
7523515|NCT02553421|11863710|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
7523516|NCT02553421|11863709|FG000|Overall Study|Improper Device Placement|3
7523517|NCT02553421|11863710|FG001|Overall Study|Improper Device Placement|0
7523518|NCT02553499|11863731|FG000|Overall Study|Adverse Event|0
7523519|NCT02553499|11863732|FG001|Overall Study|Adverse Event|0
7523520|NCT02553499|11863733|FG002|Overall Study|Adverse Event|0
7523521|NCT02553499|11863734|FG003|Overall Study|Adverse Event|0
7523522|NCT02553499|11863735|FG004|Overall Study|Adverse Event|0
7523523|NCT02553499|11863736|FG005|Overall Study|Adverse Event|0
7523524|NCT02553499|11863737|FG006|Overall Study|Adverse Event|1
7523525|NCT02553499|11863738|FG007|Overall Study|Adverse Event|1
7523526|NCT02553499|11863739|FG008|Overall Study|Adverse Event|0
7523527|NCT02553499|11863740|FG009|Overall Study|Adverse Event|0
7523528|NCT02553499|11863741|FG010|Overall Study|Adverse Event|0
7523529|NCT02553499|11863742|FG011|Overall Study|Adverse Event|0
7523530|NCT02553499|11863743|FG012|Overall Study|Adverse Event|0
7523531|NCT02553499|11863744|FG013|Overall Study|Adverse Event|1
7523532|NCT02553499|11863731|FG000|Overall Study|Death|0
7523533|NCT02553499|11863732|FG001|Overall Study|Death|1
7523534|NCT02553499|11863733|FG002|Overall Study|Death|1
7523535|NCT02553499|11863734|FG003|Overall Study|Death|0
7523536|NCT02553499|11863735|FG004|Overall Study|Death|1
7523537|NCT02553499|11863736|FG005|Overall Study|Death|2
7523538|NCT02553499|11863737|FG006|Overall Study|Death|0
7523539|NCT02553499|11863738|FG007|Overall Study|Death|0
7523540|NCT02553499|11863739|FG008|Overall Study|Death|0
7523541|NCT02553499|11863740|FG009|Overall Study|Death|0
7523542|NCT02553499|11863741|FG010|Overall Study|Death|1
7523543|NCT02553499|11863742|FG011|Overall Study|Death|0
7523544|NCT02553499|11863743|FG012|Overall Study|Death|0
7523545|NCT02553499|11863744|FG013|Overall Study|Death|0
7523546|NCT02553499|11863731|FG000|Overall Study|Lost to Follow-up|0
7523547|NCT02553499|11863732|FG001|Overall Study|Lost to Follow-up|0
7523548|NCT02553499|11863733|FG002|Overall Study|Lost to Follow-up|0
7523549|NCT02553499|11863734|FG003|Overall Study|Lost to Follow-up|0
7523550|NCT02553499|11863735|FG004|Overall Study|Lost to Follow-up|0
7523551|NCT02553499|11863736|FG005|Overall Study|Lost to Follow-up|0
7523552|NCT02553499|11863737|FG006|Overall Study|Lost to Follow-up|1
7523553|NCT02553499|11863738|FG007|Overall Study|Lost to Follow-up|0
7523554|NCT02553499|11863739|FG008|Overall Study|Lost to Follow-up|0
7523555|NCT02553499|11863740|FG009|Overall Study|Lost to Follow-up|0
7523556|NCT02553499|11863741|FG010|Overall Study|Lost to Follow-up|0
7523557|NCT02553499|11863742|FG011|Overall Study|Lost to Follow-up|0
7523558|NCT02553499|11863743|FG012|Overall Study|Lost to Follow-up|0
7523559|NCT02553499|11863744|FG013|Overall Study|Lost to Follow-up|0
7523560|NCT02553499|11863731|FG000|Overall Study|Physician Decision|0
7523561|NCT02553499|11863732|FG001|Overall Study|Physician Decision|1
7523562|NCT02553499|11863733|FG002|Overall Study|Physician Decision|1
7523563|NCT02553499|11863734|FG003|Overall Study|Physician Decision|0
7523564|NCT02553499|11863735|FG004|Overall Study|Physician Decision|1
7523565|NCT02553499|11863736|FG005|Overall Study|Physician Decision|0
7523566|NCT02553499|11863737|FG006|Overall Study|Physician Decision|0
7523567|NCT02553499|11863738|FG007|Overall Study|Physician Decision|1
7523568|NCT02553499|11863739|FG008|Overall Study|Physician Decision|1
7523569|NCT02553499|11863740|FG009|Overall Study|Physician Decision|2
7523570|NCT02553499|11863741|FG010|Overall Study|Physician Decision|1
7523571|NCT02553499|11863742|FG011|Overall Study|Physician Decision|3
7523572|NCT02553499|11863743|FG012|Overall Study|Physician Decision|1
7523573|NCT02553499|11863744|FG013|Overall Study|Physician Decision|0
7523574|NCT02553499|11863731|FG000|Overall Study|Progressive Disease|0
7523575|NCT02553499|11863732|FG001|Overall Study|Progressive Disease|0
7523576|NCT02553499|11863733|FG002|Overall Study|Progressive Disease|0
7523577|NCT02553499|11863734|FG003|Overall Study|Progressive Disease|2
7523578|NCT02553499|11863735|FG004|Overall Study|Progressive Disease|1
7523579|NCT02553499|11863736|FG005|Overall Study|Progressive Disease|1
7523580|NCT02553499|11863737|FG006|Overall Study|Progressive Disease|1
7523581|NCT02553499|11863738|FG007|Overall Study|Progressive Disease|0
7523582|NCT02553499|11863739|FG008|Overall Study|Progressive Disease|0
7523583|NCT02553499|11863740|FG009|Overall Study|Progressive Disease|1
7523584|NCT02553499|11863741|FG010|Overall Study|Progressive Disease|0
7523585|NCT02553499|11863742|FG011|Overall Study|Progressive Disease|0
7523586|NCT02553499|11863743|FG012|Overall Study|Progressive Disease|2
7523587|NCT02553499|11863744|FG013|Overall Study|Progressive Disease|1
7523588|NCT02553499|11863731|FG000|Overall Study|Study Terminated by Sponsor|0
7523589|NCT02553499|11863732|FG001|Overall Study|Study Terminated by Sponsor|0
7523590|NCT02553499|11863733|FG002|Overall Study|Study Terminated by Sponsor|0
7523591|NCT02553499|11863734|FG003|Overall Study|Study Terminated by Sponsor|0
7523592|NCT02553499|11863735|FG004|Overall Study|Study Terminated by Sponsor|0
7523593|NCT02553499|11863736|FG005|Overall Study|Study Terminated by Sponsor|0
7523594|NCT02553499|11863737|FG006|Overall Study|Study Terminated by Sponsor|0
7523595|NCT02553499|11863738|FG007|Overall Study|Study Terminated by Sponsor|0
7523596|NCT02553499|11863739|FG008|Overall Study|Study Terminated by Sponsor|1
7523597|NCT02553499|11863740|FG009|Overall Study|Study Terminated by Sponsor|0
7523598|NCT02553499|11863741|FG010|Overall Study|Study Terminated by Sponsor|0
7523599|NCT02553499|11863742|FG011|Overall Study|Study Terminated by Sponsor|0
7523600|NCT02553499|11863743|FG012|Overall Study|Study Terminated by Sponsor|0
7523601|NCT02553499|11863744|FG013|Overall Study|Study Terminated by Sponsor|0
7523602|NCT02553499|11863731|FG000|Overall Study|Withdrawal by Subject|2
7523603|NCT02553499|11863732|FG001|Overall Study|Withdrawal by Subject|0
7523604|NCT02553499|11863733|FG002|Overall Study|Withdrawal by Subject|0
7523605|NCT02553499|11863734|FG003|Overall Study|Withdrawal by Subject|0
7523606|NCT02553499|11863735|FG004|Overall Study|Withdrawal by Subject|0
7523607|NCT02553499|11863736|FG005|Overall Study|Withdrawal by Subject|0
7523608|NCT02553499|11863737|FG006|Overall Study|Withdrawal by Subject|0
7523609|NCT02553499|11863738|FG007|Overall Study|Withdrawal by Subject|1
7523610|NCT02553499|11863739|FG008|Overall Study|Withdrawal by Subject|1
7523611|NCT02553499|11863740|FG009|Overall Study|Withdrawal by Subject|0
7523612|NCT02553499|11863741|FG010|Overall Study|Withdrawal by Subject|1
7523613|NCT02553499|11863742|FG011|Overall Study|Withdrawal by Subject|0
7523614|NCT02553499|11863743|FG012|Overall Study|Withdrawal by Subject|0
7523615|NCT02553499|11863744|FG013|Overall Study|Withdrawal by Subject|0
7523616|NCT02553538|11863781|FG000|Overall Study|Could Not Reach by Telephone|133
7523617|NCT02553538|11863782|FG001|Overall Study|Could Not Reach by Telephone|0
7523618|NCT02553538|11863781|FG000|Overall Study|Died or Left Network|54
7523619|NCT02553538|11863782|FG001|Overall Study|Died or Left Network|56
7523620|NCT02553629|11863790|FG000|Overall Study|Logistic reasons|3
7523621|NCT02553629|11863791|FG001|Overall Study|Logistic reasons|6
7523622|NCT02553772|11863808|FG000|Overall Study|Adverse Event|2
7523623|NCT02553772|11863809|FG001|Overall Study|Adverse Event|3
7523624|NCT02553772|11863808|FG000|Overall Study|Lost to Follow-up|2
7523625|NCT02553772|11863809|FG001|Overall Study|Lost to Follow-up|1
7523626|NCT02553772|11863808|FG000|Overall Study|Withdrawal of Consent|1
7523627|NCT02553772|11863809|FG001|Overall Study|Withdrawal of Consent|1
7523628|NCT02553772|11863808|FG000|Overall Study|Lack of Efficacy|1
7523629|NCT02553772|11863809|FG001|Overall Study|Lack of Efficacy|0
7523630|NCT02553772|11863808|FG000|Overall Study|Other Miscellaneous Reasons|0
7523631|NCT02553772|11863809|FG001|Overall Study|Other Miscellaneous Reasons|1
7523632|NCT02553928|11863821|FG000|Overall Study|Adverse Event|2
7523633|NCT02553928|11863822|FG001|Overall Study|Adverse Event|1
7523634|NCT02553928|11863821|FG000|Overall Study|Lost to Follow-up|0
7523635|NCT02553928|11863822|FG001|Overall Study|Lost to Follow-up|1
7523636|NCT02553928|11863821|FG000|Overall Study|Administrative reason(s)|0
7523637|NCT02553928|11863822|FG001|Overall Study|Administrative reason(s)|1
7523638|NCT02554019|11863832|FG000|Overall Study|Withdrawal by Subject|1
7523639|NCT02554019|11863833|FG001|Overall Study|Withdrawal by Subject|0
7523640|NCT02554019|11863834|FG002|Overall Study|Withdrawal by Subject|2
7523641|NCT02554019|11863832|FG000|Overall Study|Adverse Event|1
7523642|NCT02554019|11863833|FG001|Overall Study|Adverse Event|0
7523643|NCT02554019|11863834|FG002|Overall Study|Adverse Event|0
7523644|NCT02554279|11863844|FG000|Overall Study|Adverse Event|2
7523645|NCT02554279|11863845|FG001|Overall Study|Adverse Event|5
7523646|NCT02554279|11863844|FG000|Overall Study|Lost to Follow-up|3
7523647|NCT02554279|11863845|FG001|Overall Study|Lost to Follow-up|2
7523648|NCT02554279|11863844|FG000|Overall Study|Withdrawal by Subject|6
7523649|NCT02554279|11863845|FG001|Overall Study|Withdrawal by Subject|4
7523650|NCT02554279|11863844|FG000|Overall Study|Protocol Violation|2
7523651|NCT02554279|11863845|FG001|Overall Study|Protocol Violation|1
7523652|NCT02554279|11863844|FG000|Overall Study|Other reason|19
7523653|NCT02554279|11863845|FG001|Overall Study|Other reason|6
7523654|NCT02554513|11863868|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
7523655|NCT02554513|11863869|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
7523656|NCT02554656|11863881|FG000|Overall Study|Protocol Violation|3
7523657|NCT02554682|11863895|FG000|Overall Study|Lost to Follow-up|11
7523658|NCT02554682|11863896|FG001|Overall Study|Lost to Follow-up|9
7523659|NCT02554682|11863897|FG002|Overall Study|Lost to Follow-up|4
7523660|NCT02554682|11863898|FG003|Overall Study|Lost to Follow-up|3
7523661|NCT02554682|11863899|FG004|Overall Study|Lost to Follow-up|2
7523662|NCT02554682|11863900|FG005|Overall Study|Lost to Follow-up|1
7523663|NCT02554682|11863901|FG006|Overall Study|Lost to Follow-up|6
7523664|NCT02554682|11863902|FG007|Overall Study|Lost to Follow-up|6
7523665|NCT02554682|11863903|FG008|Overall Study|Lost to Follow-up|2
7523666|NCT02554682|11863904|FG009|Overall Study|Lost to Follow-up|2
7523667|NCT02554682|11863895|FG000|Overall Study|Withdrawal by Subject|2
7523668|NCT02554682|11863896|FG001|Overall Study|Withdrawal by Subject|1
7523669|NCT02554682|11863897|FG002|Overall Study|Withdrawal by Subject|0
7523670|NCT02554682|11863898|FG003|Overall Study|Withdrawal by Subject|0
7523671|NCT02554682|11863899|FG004|Overall Study|Withdrawal by Subject|0
7523672|NCT02554682|11863900|FG005|Overall Study|Withdrawal by Subject|0
7523673|NCT02554682|11863901|FG006|Overall Study|Withdrawal by Subject|0
7523674|NCT02554682|11863902|FG007|Overall Study|Withdrawal by Subject|0
7523675|NCT02554682|11863903|FG008|Overall Study|Withdrawal by Subject|0
7523676|NCT02554682|11863904|FG009|Overall Study|Withdrawal by Subject|0
7523677|NCT02554682|11863895|FG000|Overall Study|Physician Decision|2
7523678|NCT02554682|11863896|FG001|Overall Study|Physician Decision|2
7523679|NCT02554682|11863897|FG002|Overall Study|Physician Decision|0
7523680|NCT02554682|11863898|FG003|Overall Study|Physician Decision|0
7523681|NCT02554682|11863899|FG004|Overall Study|Physician Decision|0
7523682|NCT02554682|11863900|FG005|Overall Study|Physician Decision|0
7523683|NCT02554682|11863901|FG006|Overall Study|Physician Decision|0
7523684|NCT02554682|11863902|FG007|Overall Study|Physician Decision|0
7523685|NCT02554682|11863903|FG008|Overall Study|Physician Decision|0
7523686|NCT02554682|11863904|FG009|Overall Study|Physician Decision|0
7523687|NCT02554721|11863934|FG000|Overall Study|Adverse Event|1
7523688|NCT02554721|11863935|FG001|Overall Study|Adverse Event|0
7523689|NCT02554721|11863936|FG002|Overall Study|Adverse Event|0
7523690|NCT02554721|11863937|FG003|Overall Study|Adverse Event|0
7523691|NCT02554721|11863938|FG004|Overall Study|Adverse Event|1
7523692|NCT02554721|11863934|FG000|Overall Study|Noncompliance|0
7523693|NCT02554721|11863935|FG001|Overall Study|Noncompliance|0
7523694|NCT02554721|11863936|FG002|Overall Study|Noncompliance|0
7523695|NCT02554721|11863937|FG003|Overall Study|Noncompliance|0
7523696|NCT02554721|11863938|FG004|Overall Study|Noncompliance|1
7523697|NCT02554786|11863962|FG000|Overall Study|Subject/guardian decision|29
7523698|NCT02554786|11863963|FG001|Overall Study|Subject/guardian decision|17
7523699|NCT02554786|11863964|FG002|Overall Study|Subject/guardian decision|18
7523700|NCT02554786|11863965|FG003|Overall Study|Subject/guardian decision|30
7523701|NCT02554786|11863966|FG004|Overall Study|Subject/guardian decision|20
7523702|NCT02554786|11863962|FG000|Overall Study|Lost to Follow-up|4
7523703|NCT02554786|11863963|FG001|Overall Study|Lost to Follow-up|3
7523704|NCT02554786|11863964|FG002|Overall Study|Lost to Follow-up|4
7523705|NCT02554786|11863965|FG003|Overall Study|Lost to Follow-up|2
7523706|NCT02554786|11863966|FG004|Overall Study|Lost to Follow-up|2
7523707|NCT02554786|11863962|FG000|Overall Study|Protocol deviation|1
7523708|NCT02554786|11863963|FG001|Overall Study|Protocol deviation|3
7523709|NCT02554786|11863964|FG002|Overall Study|Protocol deviation|3
7523710|NCT02554786|11863965|FG003|Overall Study|Protocol deviation|4
7523711|NCT02554786|11863966|FG004|Overall Study|Protocol deviation|2
7523712|NCT02554786|11863962|FG000|Overall Study|Technical problems|1
7523713|NCT02554786|11863963|FG001|Overall Study|Technical problems|1
7523714|NCT02554786|11863964|FG002|Overall Study|Technical problems|0
7523715|NCT02554786|11863965|FG003|Overall Study|Technical problems|2
7523716|NCT02554786|11863966|FG004|Overall Study|Technical problems|1
7523717|NCT02554786|11863962|FG000|Overall Study|Adverse Event|0
7523718|NCT02554786|11863963|FG001|Overall Study|Adverse Event|0
7523719|NCT02554786|11863964|FG002|Overall Study|Adverse Event|0
7523720|NCT02554786|11863965|FG003|Overall Study|Adverse Event|0
7523721|NCT02554786|11863966|FG004|Overall Study|Adverse Event|2
7523722|NCT02554786|11863962|FG000|Overall Study|Death|0
7523723|NCT02554786|11863963|FG001|Overall Study|Death|0
7523724|NCT02554786|11863964|FG002|Overall Study|Death|0
7523725|NCT02554786|11863965|FG003|Overall Study|Death|1
7523726|NCT02554786|11863966|FG004|Overall Study|Death|0
7523727|NCT02554786|11863962|FG000|Overall Study|Non-compliance with study treatment|0
7523728|NCT02554786|11863963|FG001|Overall Study|Non-compliance with study treatment|1
7523729|NCT02554786|11863964|FG002|Overall Study|Non-compliance with study treatment|1
7523730|NCT02554786|11863965|FG003|Overall Study|Non-compliance with study treatment|0
7523731|NCT02554786|11863966|FG004|Overall Study|Non-compliance with study treatment|1
7523732|NCT02554786|11863962|FG000|Overall Study|Physician Decision|0
7523733|NCT02554786|11863963|FG001|Overall Study|Physician Decision|1
7523734|NCT02554786|11863964|FG002|Overall Study|Physician Decision|4
7523735|NCT02554786|11863965|FG003|Overall Study|Physician Decision|1
7523736|NCT02554786|11863966|FG004|Overall Study|Physician Decision|1
7523737|NCT02554786|11863962|FG000|Overall Study|Pregnancy|0
7523738|NCT02554786|11863963|FG001|Overall Study|Pregnancy|0
7523739|NCT02554786|11863964|FG002|Overall Study|Pregnancy|0
7523740|NCT02554786|11863965|FG003|Overall Study|Pregnancy|1
7523741|NCT02554786|11863966|FG004|Overall Study|Pregnancy|1
7523742|NCT02554877|11863995|FG000|Overall Study|Adverse Event|2
7523743|NCT02554877|11863996|FG001|Overall Study|Adverse Event|0
7523744|NCT02554877|11863997|FG002|Overall Study|Adverse Event|0
7523745|NCT02554877|11863998|FG003|Overall Study|Adverse Event|1
7523746|NCT02554877|11863995|FG000|Overall Study|Lost to Follow-up|1
7523747|NCT02554877|11863996|FG001|Overall Study|Lost to Follow-up|1
7523748|NCT02554877|11863997|FG002|Overall Study|Lost to Follow-up|1
7523749|NCT02554877|11863998|FG003|Overall Study|Lost to Follow-up|2
7523750|NCT02554877|11863995|FG000|Overall Study|Did not meet entrance criteria|0
7523751|NCT02554877|11863996|FG001|Overall Study|Did not meet entrance criteria|0
7523752|NCT02554877|11863997|FG002|Overall Study|Did not meet entrance criteria|1
7523753|NCT02554877|11863998|FG003|Overall Study|Did not meet entrance criteria|0
7523754|NCT02554877|11863995|FG000|Overall Study|No longer met eligibility criteria|1
7523755|NCT02554877|11863996|FG001|Overall Study|No longer met eligibility criteria|0
7523756|NCT02554877|11863997|FG002|Overall Study|No longer met eligibility criteria|1
7523757|NCT02554877|11863998|FG003|Overall Study|No longer met eligibility criteria|1
7523758|NCT02554877|11863995|FG000|Overall Study|Protocol Violation|3
7523759|NCT02554877|11863996|FG001|Overall Study|Protocol Violation|1
7523760|NCT02554877|11863997|FG002|Overall Study|Protocol Violation|1
7523761|NCT02554877|11863998|FG003|Overall Study|Protocol Violation|0
7523762|NCT02554877|11863995|FG000|Overall Study|Other|1
7523763|NCT02554877|11863996|FG001|Overall Study|Other|3
7523764|NCT02554877|11863997|FG002|Overall Study|Other|0
7523765|NCT02554877|11863998|FG003|Overall Study|Other|3
7523766|NCT02554877|11863995|FG000|Overall Study|Insufficient clinical response|4
7523923|NCT02555722|11864129|FG001|Week 2|Withdrawal by Subject|0
7523767|NCT02554877|11863996|FG001|Overall Study|Insufficient clinical response|0
7523768|NCT02554877|11863997|FG002|Overall Study|Insufficient clinical response|0
7523769|NCT02554877|11863998|FG003|Overall Study|Insufficient clinical response|0
7523770|NCT02554877|11863995|FG000|Overall Study|No longer willing to participate|0
7523771|NCT02554877|11863996|FG001|Overall Study|No longer willing to participate|2
7523772|NCT02554877|11863997|FG002|Overall Study|No longer willing to participate|2
7523773|NCT02554877|11863998|FG003|Overall Study|No longer willing to participate|0
7523774|NCT02554890|11864010|FG000|Double-blind|Adverse Event|45
7523775|NCT02554890|11864011|FG001|Double-blind|Adverse Event|51
7523776|NCT02554890|11864010|FG000|Double-blind|Death|6
7523777|NCT02554890|11864011|FG001|Double-blind|Death|4
7523778|NCT02554890|11864010|FG000|Double-blind|Protocol Violation|1
7523779|NCT02554890|11864011|FG001|Double-blind|Protocol Violation|1
7523780|NCT02554890|11864010|FG000|Double-blind|Physician Decision|4
7523781|NCT02554890|11864011|FG001|Double-blind|Physician Decision|3
7523782|NCT02554890|11864010|FG000|Double-blind|Subject/Guardian decision|21
7523783|NCT02554890|11864011|FG001|Double-blind|Subject/Guardian decision|16
7523784|NCT02554890|11864010|FG000|Double-blind|Lost to Follow-up|7
7523785|NCT02554890|11864011|FG001|Double-blind|Lost to Follow-up|5
7523786|NCT02554890|11864010|FG000|Double-blind|Technical problems|1
7523787|NCT02554890|11864011|FG001|Double-blind|Technical problems|0
7523788|NCT02554890|11864010|FG000|Double-blind|Withdrawal by Subject|5
7523789|NCT02554890|11864011|FG001|Double-blind|Withdrawal by Subject|6
7523790|NCT02554890|11864010|FG000|Double-blind|Noncompliance with study treatment|6
7523791|NCT02554890|11864011|FG001|Double-blind|Noncompliance with study treatment|5
7523792|NCT02554890|11864010|FG000|Open-label|Adverse Event|0
7523793|NCT02554890|11864011|FG001|Open-label|Adverse Event|30
7523794|NCT02554890|11864010|FG000|Open-label|Death|0
7523795|NCT02554890|11864011|FG001|Open-label|Death|1
7523796|NCT02554890|11864010|FG000|Open-label|Physician Decision|0
7523797|NCT02554890|11864011|FG001|Open-label|Physician Decision|1
7523798|NCT02554890|11864010|FG000|Open-label|Subject/Guardian decision|0
7523799|NCT02554890|11864011|FG001|Open-label|Subject/Guardian decision|11
7523800|NCT02554890|11864010|FG000|Open-label|Lost to Follow-up|0
7523801|NCT02554890|11864011|FG001|Open-label|Lost to Follow-up|7
7523802|NCT02554890|11864010|FG000|Open-label|Technical problems|0
7523803|NCT02554890|11864011|FG001|Open-label|Technical problems|1
7523804|NCT02554890|11864010|FG000|Open-label|Withdrawal by Subject|0
7523805|NCT02554890|11864011|FG001|Open-label|Withdrawal by Subject|1
7523806|NCT02554903|11864021|FG000|Overall Study|Death|1
7523807|NCT02554903|11864022|FG001|Overall Study|Death|1
7523808|NCT02554903|11864021|FG000|Overall Study|Physician Decision|2
7523809|NCT02554903|11864022|FG001|Overall Study|Physician Decision|2
7523810|NCT02554903|11864021|FG000|Overall Study|Heart Transplant|1
7523811|NCT02554903|11864022|FG001|Overall Study|Heart Transplant|2
7523812|NCT02554929|11864031|FG000|Overall Study|Lost to Follow-up|4
7523813|NCT02554929|11864032|FG001|Overall Study|Lost to Follow-up|4
7523814|NCT02554929|11864031|FG000|Overall Study|Withdrawal by Subject|2
7523815|NCT02554929|11864032|FG001|Overall Study|Withdrawal by Subject|8
7523816|NCT02554981|11864038|FG000|Overall Study|Adverse Event|1
7523817|NCT02554981|11864038|FG000|Overall Study|Administrative Reasons|1
7523818|NCT02554981|11864038|FG000|Overall Study|Other Miscellaneous Reasons|3
7523819|NCT02555215|11864053|FG000|Overall Study|Other|1
7523820|NCT02555215|11864053|FG000|Overall Study|Investigator Decision|2
7523821|NCT02555371|11864083|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
7523822|NCT02555371|11864084|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7523823|NCT02555371|11864085|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7523824|NCT02555371|11864086|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7523825|NCT02555371|11864087|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
7523826|NCT02555371|11864083|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
7523827|NCT02555371|11864084|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7523828|NCT02555371|11864085|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7523829|NCT02555371|11864086|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7523830|NCT02555371|11864087|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
7523831|NCT02555371|11864083|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
7523832|NCT02555371|11864084|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7523833|NCT02555371|11864085|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7523834|NCT02555371|11864086|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7523835|NCT02555371|11864087|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
7523836|NCT02555371|11864083|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
7523837|NCT02555371|11864084|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7523838|NCT02555371|11864085|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7523839|NCT02555371|11864086|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7523840|NCT02555371|11864087|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
7523841|NCT02555371|11864083|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
7523842|NCT02555371|11864084|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7523843|NCT02555371|11864085|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7523844|NCT02555371|11864086|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7523845|NCT02555371|11864087|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
7523846|NCT02555371|11864083|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7523847|NCT02555371|11864084|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
7523848|NCT02555371|11864085|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
7523849|NCT02555371|11864086|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7523850|NCT02555371|11864087|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
7523851|NCT02555371|11864083|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7523852|NCT02555371|11864084|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7523853|NCT02555371|11864085|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
7523854|NCT02555371|11864086|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7523855|NCT02555371|11864087|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
7523856|NCT02555371|11864083|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7523857|NCT02555371|11864084|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
7523858|NCT02555371|11864085|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7523859|NCT02555371|11864086|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7523860|NCT02555371|11864087|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
7523861|NCT02555371|11864083|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
7523862|NCT02555371|11864084|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
7523863|NCT02555371|11864085|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
7523864|NCT02555371|11864086|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
7523865|NCT02555371|11864087|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
7523866|NCT02555371|11864083|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7523867|NCT02555371|11864084|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7523868|NCT02555371|11864085|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7523869|NCT02555371|11864086|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
7523870|NCT02555371|11864087|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
7523871|NCT02555371|11864083|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7523872|NCT02555371|11864084|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7523873|NCT02555371|11864085|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7523874|NCT02555371|11864086|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
7523875|NCT02555371|11864087|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
7523876|NCT02555371|11864083|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7523877|NCT02555371|11864084|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7523878|NCT02555371|11864085|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7523879|NCT02555371|11864086|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
7523880|NCT02555371|11864087|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
7523881|NCT02555371|11864083|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7523882|NCT02555371|11864084|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7523883|NCT02555371|11864085|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7523884|NCT02555371|11864086|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
7523885|NCT02555371|11864087|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
7523886|NCT02555371|11864083|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7523887|NCT02555371|11864084|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7523888|NCT02555371|11864085|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7523889|NCT02555371|11864086|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
7523890|NCT02555371|11864087|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
7523891|NCT02555618|11864102|FG000|Overall Study|Sponsor's Circumstances|1
7523892|NCT02555618|11864103|FG001|Overall Study|Sponsor's Circumstances|0
7523893|NCT02555683|11864116|FG000|Overall Study|Physician Decision|1
7523894|NCT02555683|11864117|FG001|Overall Study|Physician Decision|0
7523895|NCT02555683|11864118|FG002|Overall Study|Physician Decision|2
7523896|NCT02555683|11864116|FG000|Overall Study|Lost to Follow-up|2
7523897|NCT02555683|11864117|FG001|Overall Study|Lost to Follow-up|1
7523898|NCT02555683|11864118|FG002|Overall Study|Lost to Follow-up|2
7523899|NCT02555683|11864116|FG000|Overall Study|Technical Problems|1
7523900|NCT02555683|11864117|FG001|Overall Study|Technical Problems|1
7523901|NCT02555683|11864118|FG002|Overall Study|Technical Problems|0
7523902|NCT02555683|11864116|FG000|Overall Study|Protocol deviation|0
7523903|NCT02555683|11864117|FG001|Overall Study|Protocol deviation|1
7523904|NCT02555683|11864118|FG002|Overall Study|Protocol deviation|0
7523905|NCT02555683|11864116|FG000|Overall Study|Lack of Efficacy|2
7523906|NCT02555683|11864117|FG001|Overall Study|Lack of Efficacy|0
7523907|NCT02555683|11864118|FG002|Overall Study|Lack of Efficacy|0
7523908|NCT02555683|11864116|FG000|Overall Study|Death|0
7523909|NCT02555683|11864117|FG001|Overall Study|Death|1
7523910|NCT02555683|11864118|FG002|Overall Study|Death|2
7523911|NCT02555683|11864116|FG000|Overall Study|Adverse Event|1
7523912|NCT02555683|11864117|FG001|Overall Study|Adverse Event|0
7523913|NCT02555683|11864118|FG002|Overall Study|Adverse Event|1
7523914|NCT02555683|11864116|FG000|Overall Study|Subject/guardian decision|12
7523915|NCT02555683|11864117|FG001|Overall Study|Subject/guardian decision|12
7523916|NCT02555683|11864118|FG002|Overall Study|Subject/guardian decision|22
7523917|NCT02555683|11864116|FG000|Overall Study|Death post Treatment/safety period|0
7523918|NCT02555683|11864117|FG001|Overall Study|Death post Treatment/safety period|1
7523919|NCT02555683|11864118|FG002|Overall Study|Death post Treatment/safety period|0
7523920|NCT02555722|11864128|FG000|Week 2|Adverse Event|0
7523921|NCT02555722|11864129|FG001|Week 2|Adverse Event|1
7523922|NCT02555722|11864128|FG000|Week 2|Withdrawal by Subject|1
7523924|NCT02555722|11864128|FG000|Month 1|Lens Discomfort|1
7523925|NCT02555722|11864129|FG001|Month 1|Lens Discomfort|0
7523926|NCT02555722|11864128|FG000|Month 2|Withdrawal by Subject|3
7523927|NCT02555722|11864129|FG001|Month 2|Withdrawal by Subject|0
7523928|NCT02555722|11864128|FG000|Month 2|Lost to Follow-up|1
7523929|NCT02555722|11864129|FG001|Month 2|Lost to Follow-up|0
7523930|NCT02555878|11864160|FG000|Overall Study|Lost to Follow-up|2
7523931|NCT02555878|11864161|FG001|Overall Study|Lost to Follow-up|3
7523932|NCT02555878|11864160|FG000|Overall Study|Withdrawal by Subject|48
7523933|NCT02555878|11864161|FG001|Overall Study|Withdrawal by Subject|48
7523934|NCT02555878|11864160|FG000|Overall Study|Adverse Event|12
7523935|NCT02555878|11864161|FG001|Overall Study|Adverse Event|8
7523936|NCT02555878|11864160|FG000|Overall Study|Death|74
7523937|NCT02555878|11864161|FG001|Overall Study|Death|59
7523938|NCT02555878|11864160|FG000|Overall Study|Protocol Violation|1
7523939|NCT02555878|11864161|FG001|Overall Study|Protocol Violation|2
7523940|NCT02555878|11864160|FG000|Overall Study|Physician Decision|12
7523941|NCT02555878|11864161|FG001|Overall Study|Physician Decision|13
7523942|NCT02555878|11864160|FG000|Overall Study|Other|17
7523943|NCT02555878|11864161|FG001|Overall Study|Other|17
7523944|NCT02556138|11864186|FG000|Overall Study|Withdrawal by Subject|1
7523945|NCT02556177|11864192|FG000|Overall Study|Subjects did not complete all 4 visits|283
7523946|NCT02556177|11864193|FG001|Overall Study|Subjects did not complete all 4 visits|61
7523947|NCT02556203|11864201|FG000|Overall Study|Withdrawal by Subject|21
7523948|NCT02556203|11864202|FG001|Overall Study|Withdrawal by Subject|21
7523949|NCT02556203|11864201|FG000|Overall Study|Lost to Follow-up|5
7523950|NCT02556203|11864202|FG001|Overall Study|Lost to Follow-up|5
7523951|NCT02556203|11864201|FG000|Overall Study|Adverse Event|1
7523952|NCT02556203|11864202|FG001|Overall Study|Adverse Event|0
7523953|NCT02556255|11864208|FG000|Overall Study|Lost to Follow-up|4
7523954|NCT02556307|11864212|FG000|Overall Study|Premature treatment interruption|11
7523955|NCT02556307|11864212|FG000|Overall Study|Lost to Follow-up|36
7523956|NCT02556307|11864212|FG000|Overall Study|Change to triple therapy|4
7523957|NCT02556307|11864212|FG000|Overall Study|Enrolled but not treated|2
7523958|NCT02556632|11864241|FG000|Overall Study|Lost to Follow-up|1
7523959|NCT02556632|11864242|FG001|Overall Study|Lost to Follow-up|0
7523960|NCT02556632|11864243|FG002|Overall Study|Lost to Follow-up|0
7523961|NCT02556632|11864241|FG000|Overall Study|Disliked Intervention|1
7523962|NCT02556632|11864242|FG001|Overall Study|Disliked Intervention|1
7523963|NCT02556632|11864243|FG002|Overall Study|Disliked Intervention|1
7523964|NCT02556632|11864241|FG000|Overall Study|No Reason|1
7523965|NCT02556632|11864242|FG001|Overall Study|No Reason|0
7523966|NCT02556632|11864243|FG002|Overall Study|No Reason|1
7523967|NCT02556632|11864241|FG000|Overall Study|Personal Issues|0
7523968|NCT02556632|11864242|FG001|Overall Study|Personal Issues|1
7523969|NCT02556632|11864243|FG002|Overall Study|Personal Issues|1
7523970|NCT02556632|11864241|FG000|Overall Study|Changed Mind|0
7523971|NCT02556632|11864242|FG001|Overall Study|Changed Mind|1
7523972|NCT02556632|11864243|FG002|Overall Study|Changed Mind|0
7523973|NCT02556632|11864241|FG000|Overall Study|Withdrew (Unrelated Medical)|1
7523974|NCT02556632|11864242|FG001|Overall Study|Withdrew (Unrelated Medical)|0
7523975|NCT02556632|11864243|FG002|Overall Study|Withdrew (Unrelated Medical)|0
7523976|NCT02556632|11864241|FG000|Overall Study|Unrelated Adverse Event|1
7523977|NCT02556632|11864242|FG001|Overall Study|Unrelated Adverse Event|0
7523978|NCT02556632|11864243|FG002|Overall Study|Unrelated Adverse Event|3
7523979|NCT02556632|11864241|FG000|Overall Study|Related Adverse Event|0
7523980|NCT02556632|11864242|FG001|Overall Study|Related Adverse Event|1
7523981|NCT02556632|11864243|FG002|Overall Study|Related Adverse Event|0
7523982|NCT02556632|11864241|FG000|Overall Study|Possibly Related Adverse Event|0
7523983|NCT02556632|11864242|FG001|Overall Study|Possibly Related Adverse Event|0
7523984|NCT02556632|11864243|FG002|Overall Study|Possibly Related Adverse Event|1
7523985|NCT02556632|11864241|FG000|Overall Study|Did Not Start RT|0
7523986|NCT02556632|11864242|FG001|Overall Study|Did Not Start RT|1
7523987|NCT02556632|11864243|FG002|Overall Study|Did Not Start RT|0
7523988|NCT02556632|11864241|FG000|Overall Study|Ineligible|0
7523989|NCT02556632|11864242|FG001|Overall Study|Ineligible|1
7523990|NCT02556632|11864243|FG002|Overall Study|Ineligible|0
7523991|NCT02556632|11864241|FG000|Overall Study|Disliked Study Procedures|0
7523992|NCT02556632|11864242|FG001|Overall Study|Disliked Study Procedures|0
7523993|NCT02556632|11864243|FG002|Overall Study|Disliked Study Procedures|1
7523994|NCT02556632|11864241|FG000|Overall Study|Treatment or Change Delay|0
7523995|NCT02556632|11864242|FG001|Overall Study|Treatment or Change Delay|0
7523996|NCT02556632|11864243|FG002|Overall Study|Treatment or Change Delay|1
7523997|NCT02556775|11864255|FG000|Overall Study|Withdrawal by Subject|1
7523998|NCT02556775|11864256|FG001|Overall Study|Withdrawal by Subject|0
7523999|NCT02556775|11864257|FG002|Overall Study|Withdrawal by Subject|1
7524000|NCT02556775|11864258|FG003|Overall Study|Withdrawal by Subject|0
7524001|NCT02556775|11864255|FG000|Overall Study|Lost to Follow-up|1
7524002|NCT02556775|11864256|FG001|Overall Study|Lost to Follow-up|0
7524003|NCT02556775|11864257|FG002|Overall Study|Lost to Follow-up|0
7524004|NCT02556775|11864258|FG003|Overall Study|Lost to Follow-up|0
7524005|NCT02556801|11864283|FG000|Overall Study|Lost to Follow-up|1
7524006|NCT02556801|11864284|FG001|Overall Study|Lost to Follow-up|0
7524007|NCT02556801|11864285|FG002|Overall Study|Lost to Follow-up|2
7524008|NCT02556801|11864286|FG003|Overall Study|Lost to Follow-up|0
7524009|NCT02556801|11864283|FG000|Overall Study|Withdrawal by Subject|1
7524010|NCT02556801|11864284|FG001|Overall Study|Withdrawal by Subject|1
7524011|NCT02556801|11864285|FG002|Overall Study|Withdrawal by Subject|1
7524012|NCT02556801|11864286|FG003|Overall Study|Withdrawal by Subject|0
7524013|NCT02556801|11864283|FG000|Overall Study|Protocol Violation|0
7524014|NCT02556801|11864284|FG001|Overall Study|Protocol Violation|3
7524015|NCT02556801|11864285|FG002|Overall Study|Protocol Violation|1
7524016|NCT02556801|11864286|FG003|Overall Study|Protocol Violation|1
7524017|NCT02556801|11864283|FG000|Overall Study|Adverse Event|0
7524018|NCT02556801|11864284|FG001|Overall Study|Adverse Event|2
7524019|NCT02556801|11864285|FG002|Overall Study|Adverse Event|0
7524020|NCT02556801|11864286|FG003|Overall Study|Adverse Event|3
7524021|NCT02556801|11864283|FG000|Overall Study|Pregnancy|0
7524022|NCT02556801|11864284|FG001|Overall Study|Pregnancy|1
7524023|NCT02556801|11864285|FG002|Overall Study|Pregnancy|0
7524024|NCT02556801|11864286|FG003|Overall Study|Pregnancy|0
7524025|NCT02556801|11864283|FG000|Overall Study|Personal reasons patient|0
7524026|NCT02556801|11864284|FG001|Overall Study|Personal reasons patient|0
7524027|NCT02556801|11864285|FG002|Overall Study|Personal reasons patient|0
7524028|NCT02556801|11864286|FG003|Overall Study|Personal reasons patient|1
7524029|NCT02556918|11864298|FG000|Overall Study|Protocol Violation|5
7524030|NCT02556918|11864299|FG001|Overall Study|Protocol Violation|6
7524031|NCT02556918|11864298|FG000|Overall Study|Withdrawal by Subject|4
7524032|NCT02556918|11864299|FG001|Overall Study|Withdrawal by Subject|4
7524033|NCT02557100|11864318|FG000|Single Blind Treatment Period|Lost to Follow-up|0
7524034|NCT02557100|11864319|FG001|Single Blind Treatment Period|Lost to Follow-up|1
7524035|NCT02557100|11864320|FG002|Single Blind Treatment Period|Lost to Follow-up|0
7524036|NCT02557100|11864318|FG000|Single Blind Treatment Period|Death|0
7524037|NCT02557100|11864319|FG001|Single Blind Treatment Period|Death|1
7524038|NCT02557100|11864320|FG002|Single Blind Treatment Period|Death|0
7524039|NCT02557100|11864318|FG000|Single Blind Treatment Period|Request to Discontinue|0
7524040|NCT02557100|11864319|FG001|Single Blind Treatment Period|Request to Discontinue|1
7524041|NCT02557100|11864320|FG002|Single Blind Treatment Period|Request to Discontinue|0
7524042|NCT02557100|11864318|FG000|Single Blind Treatment Period|Adverse Event|0
7524043|NCT02557100|11864319|FG001|Single Blind Treatment Period|Adverse Event|1
7524044|NCT02557100|11864320|FG002|Single Blind Treatment Period|Adverse Event|0
7524045|NCT02557100|11864318|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
7524046|NCT02557100|11864319|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
7524047|NCT02557100|11864320|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
7524048|NCT02557100|11864318|FG000|Cumulative Abatacept Period|Other Reasons|0
7524049|NCT02557100|11864319|FG001|Cumulative Abatacept Period|Other Reasons|0
7524050|NCT02557100|11864320|FG002|Cumulative Abatacept Period|Other Reasons|1
7524051|NCT02557100|11864318|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
7524052|NCT02557100|11864319|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
7524053|NCT02557100|11864320|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
7524054|NCT02557100|11864318|FG000|Cumulative Abatacept Period|Request to Discontinue|0
7524055|NCT02557100|11864319|FG001|Cumulative Abatacept Period|Request to Discontinue|0
7524056|NCT02557100|11864320|FG002|Cumulative Abatacept Period|Request to Discontinue|1
7524057|NCT02557399|11864339|FG000|Overall Study|Adverse Event|6
7524058|NCT02557399|11864340|FG001|Overall Study|Adverse Event|5
7524059|NCT02557399|11864339|FG000|Overall Study|Protocol Violation|0
7524060|NCT02557399|11864340|FG001|Overall Study|Protocol Violation|1
7524061|NCT02557399|11864339|FG000|Overall Study|Protocol-defined stopping criteria|0
7524062|NCT02557399|11864340|FG001|Overall Study|Protocol-defined stopping criteria|1
7524063|NCT02557399|11864339|FG000|Overall Study|Withdrawal by Subject|1
7524064|NCT02557399|11864340|FG001|Overall Study|Withdrawal by Subject|1
7524065|NCT02557516|11864353|FG000|Overall Study|Adverse Event|1
7524066|NCT02557516|11864354|FG001|Overall Study|Adverse Event|0
7524067|NCT02557516|11864355|FG002|Overall Study|Adverse Event|2
7524068|NCT02557516|11864356|FG003|Overall Study|Adverse Event|1
7524069|NCT02557516|11864353|FG000|Overall Study|Disease progression|0
7524070|NCT02557516|11864354|FG001|Overall Study|Disease progression|2
7524071|NCT02557516|11864355|FG002|Overall Study|Disease progression|0
7524072|NCT02557516|11864356|FG003|Overall Study|Disease progression|0
7524073|NCT02557516|11864353|FG000|Overall Study|Physician Decision|0
7524074|NCT02557516|11864354|FG001|Overall Study|Physician Decision|2
7524075|NCT02557516|11864355|FG002|Overall Study|Physician Decision|0
7524076|NCT02557516|11864356|FG003|Overall Study|Physician Decision|0
7524077|NCT02557516|11864353|FG000|Overall Study|Sponsor decision|0
7524078|NCT02557516|11864354|FG001|Overall Study|Sponsor decision|1
7524079|NCT02557516|11864355|FG002|Overall Study|Sponsor decision|2
7524080|NCT02557516|11864356|FG003|Overall Study|Sponsor decision|8
7524081|NCT02557646|11864380|FG000|Overall Study|Adverse Event|40
7524082|NCT02557646|11864380|FG000|Overall Study|Death|1
7524083|NCT02557646|11864380|FG000|Overall Study|Lack of Efficacy|186
7524084|NCT02557646|11864380|FG000|Overall Study|Withdrawal by Subject|18
7524085|NCT02557646|11864380|FG000|Overall Study|Lost to Follow-up|17
7524086|NCT02557646|11864380|FG000|Overall Study|Other|14
7524087|NCT02558231|11864395|FG000|Overall Study|Death|4
7524088|NCT02558231|11864396|FG001|Overall Study|Death|12
7524089|NCT02558231|11864395|FG000|Overall Study|Lost to Follow-up|7
7524090|NCT02558231|11864396|FG001|Overall Study|Lost to Follow-up|4
7524091|NCT02558231|11864395|FG000|Overall Study|Withdrawal by Subject|7
7524092|NCT02558231|11864396|FG001|Overall Study|Withdrawal by Subject|4
7524093|NCT02558231|11864395|FG000|Overall Study|Physician Decision|7
7524094|NCT02558231|11864396|FG001|Overall Study|Physician Decision|5
7524095|NCT02558231|11864395|FG000|Overall Study|Sponsor Decision|0
7524096|NCT02558231|11864396|FG001|Overall Study|Sponsor Decision|1
7524097|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Adverse Event|9
7524098|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Adverse Event|3
7524099|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Death|7
7524100|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Death|7
7524101|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
7524102|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
7524103|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Physician Decision|1
7524104|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Physician Decision|0
7524105|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Protocol Violation|1
7524106|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Protocol Violation|1
7524107|NCT02558296|11864404|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
7524108|NCT02558296|11864405|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
7524109|NCT02558296|11864404|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
7524110|NCT02558296|11864405|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
7524111|NCT02558296|11864404|FG000|Completed the Study|Adverse Event|14
7524112|NCT02558296|11864405|FG001|Completed the Study|Adverse Event|5
7524113|NCT02558296|11864404|FG000|Completed the Study|Death|39
7524114|NCT02558296|11864405|FG001|Completed the Study|Death|25
7524115|NCT02558296|11864404|FG000|Completed the Study|Lost to Follow-up|31
7524116|NCT02558296|11864405|FG001|Completed the Study|Lost to Follow-up|23
7524117|NCT02558296|11864404|FG000|Completed the Study|Physician Decision|6
7524118|NCT02558296|11864405|FG001|Completed the Study|Physician Decision|0
7524119|NCT02558296|11864404|FG000|Completed the Study|Protocol Violation|2
7524120|NCT02558296|11864405|FG001|Completed the Study|Protocol Violation|1
7524121|NCT02558296|11864404|FG000|Completed the Study|Withdrawal by Subject|53
7524122|NCT02558296|11864405|FG001|Completed the Study|Withdrawal by Subject|31
7524123|NCT02558296|11864404|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
7524124|NCT02558296|11864405|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
7524125|NCT02558400|11864427|FG000|Overall Study|Adverse Event|47
7524126|NCT02558400|11864428|FG001|Overall Study|Adverse Event|53
7524127|NCT02558400|11864429|FG002|Overall Study|Adverse Event|4
7524128|NCT02558400|11864427|FG000|Overall Study|Withdrawal by Subject|13
7524129|NCT02558400|11864428|FG001|Overall Study|Withdrawal by Subject|9
7524130|NCT02558400|11864429|FG002|Overall Study|Withdrawal by Subject|8
7524131|NCT02558400|11864427|FG000|Overall Study|Non-Compliant|0
7524132|NCT02558400|11864428|FG001|Overall Study|Non-Compliant|1
7524133|NCT02558400|11864429|FG002|Overall Study|Non-Compliant|3
7524134|NCT02558400|11864427|FG000|Overall Study|Lost to Follow-up|5
7524135|NCT02558400|11864428|FG001|Overall Study|Lost to Follow-up|5
7524136|NCT02558400|11864429|FG002|Overall Study|Lost to Follow-up|4
7524137|NCT02558400|11864427|FG000|Overall Study|Lack of Efficacy|0
7524138|NCT02558400|11864428|FG001|Overall Study|Lack of Efficacy|13
7524139|NCT02558400|11864429|FG002|Overall Study|Lack of Efficacy|1
7524140|NCT02558400|11864427|FG000|Overall Study|Disallowed Concurrent Medication|6
7524141|NCT02558400|11864428|FG001|Overall Study|Disallowed Concurrent Medication|7
7524142|NCT02558400|11864429|FG002|Overall Study|Disallowed Concurrent Medication|5
7524143|NCT02558400|11864427|FG000|Overall Study|Physician Decision|2
7524144|NCT02558400|11864428|FG001|Overall Study|Physician Decision|2
7524145|NCT02558400|11864429|FG002|Overall Study|Physician Decision|0
7524146|NCT02558400|11864427|FG000|Overall Study|Protocol Violation|6
7524147|NCT02558400|11864428|FG001|Overall Study|Protocol Violation|3
7524148|NCT02558400|11864429|FG002|Overall Study|Protocol Violation|8
7524149|NCT02558400|11864427|FG000|Overall Study|Death|0
7524150|NCT02558400|11864428|FG001|Overall Study|Death|1
7524151|NCT02558400|11864429|FG002|Overall Study|Death|0
7524152|NCT02558400|11864427|FG000|Overall Study|Ineligible for the study|0
7524153|NCT02558400|11864428|FG001|Overall Study|Ineligible for the study|2
7524154|NCT02558400|11864429|FG002|Overall Study|Ineligible for the study|0
7524155|NCT02558790|11864440|FG000|Overall Study|Lost to Follow-up|2
7524156|NCT02558790|11864440|FG000|Overall Study|Physician Decision|1
7524157|NCT02558790|11864440|FG000|Overall Study|Withdrawal by Subject|1
7524158|NCT02558790|11864440|FG000|Overall Study|Screen Fail|3
7524159|NCT02558894|11864479|FG000|Overall Study|Death; any cause, entire study duration|28
7524160|NCT02558894|11864480|FG001|Overall Study|Death; any cause, entire study duration|31
7524161|NCT02558894|11864479|FG000|Overall Study|Withdrawal by Subject|2
7524162|NCT02558894|11864480|FG001|Overall Study|Withdrawal by Subject|1
7524163|NCT02558894|11864479|FG000|Overall Study|Closure of Part A|2
7524164|NCT02558894|11864480|FG001|Overall Study|Closure of Part A|1
7524165|NCT02559115|11864486|FG000|Overall Study|Withdrawal by Subject|3
7524166|NCT02559206|11864498|FG000|Overall Study|Adverse Event|0
7524167|NCT02559206|11864499|FG001|Overall Study|Adverse Event|4
7524168|NCT02559206|11864500|FG002|Overall Study|Adverse Event|1
7524169|NCT02559206|11864501|FG003|Overall Study|Adverse Event|5
7524170|NCT02559206|11864502|FG004|Overall Study|Adverse Event|3
7524171|NCT02559206|11864503|FG005|Overall Study|Adverse Event|0
7524172|NCT02559206|11864504|FG006|Overall Study|Adverse Event|1
7524173|NCT02559206|11864505|FG007|Overall Study|Adverse Event|0
7524174|NCT02559206|11864498|FG000|Overall Study|Protocol Violation|1
7524175|NCT02559206|11864499|FG001|Overall Study|Protocol Violation|0
7524176|NCT02559206|11864500|FG002|Overall Study|Protocol Violation|1
7524177|NCT02559206|11864501|FG003|Overall Study|Protocol Violation|0
7524178|NCT02559206|11864502|FG004|Overall Study|Protocol Violation|0
7524179|NCT02559206|11864503|FG005|Overall Study|Protocol Violation|2
7524180|NCT02559206|11864504|FG006|Overall Study|Protocol Violation|0
7524181|NCT02559206|11864505|FG007|Overall Study|Protocol Violation|0
7524182|NCT02559206|11864498|FG000|Overall Study|Withdrawal by Subject|3
7524183|NCT02559206|11864499|FG001|Overall Study|Withdrawal by Subject|3
7524184|NCT02559206|11864500|FG002|Overall Study|Withdrawal by Subject|1
7524185|NCT02559206|11864501|FG003|Overall Study|Withdrawal by Subject|3
7524186|NCT02559206|11864502|FG004|Overall Study|Withdrawal by Subject|5
7524187|NCT02559206|11864503|FG005|Overall Study|Withdrawal by Subject|4
7524188|NCT02559206|11864504|FG006|Overall Study|Withdrawal by Subject|1
7524189|NCT02559206|11864505|FG007|Overall Study|Withdrawal by Subject|2
7524190|NCT02559206|11864498|FG000|Overall Study|Lost to Follow-up|3
7524191|NCT02559206|11864499|FG001|Overall Study|Lost to Follow-up|5
7524192|NCT02559206|11864500|FG002|Overall Study|Lost to Follow-up|3
7524193|NCT02559206|11864501|FG003|Overall Study|Lost to Follow-up|3
7524194|NCT02559206|11864502|FG004|Overall Study|Lost to Follow-up|2
7524195|NCT02559206|11864503|FG005|Overall Study|Lost to Follow-up|5
7524196|NCT02559206|11864504|FG006|Overall Study|Lost to Follow-up|1
7524197|NCT02559206|11864505|FG007|Overall Study|Lost to Follow-up|4
7524198|NCT02559206|11864498|FG000|Overall Study|Lack of Efficacy|1
7524199|NCT02559206|11864499|FG001|Overall Study|Lack of Efficacy|0
7524200|NCT02559206|11864500|FG002|Overall Study|Lack of Efficacy|3
7524201|NCT02559206|11864501|FG003|Overall Study|Lack of Efficacy|2
7524202|NCT02559206|11864502|FG004|Overall Study|Lack of Efficacy|2
7524203|NCT02559206|11864503|FG005|Overall Study|Lack of Efficacy|3
7524204|NCT02559206|11864504|FG006|Overall Study|Lack of Efficacy|3
7524205|NCT02559206|11864505|FG007|Overall Study|Lack of Efficacy|3
7524206|NCT02559206|11864498|FG000|Overall Study|Other Not Specified|0
7524207|NCT02559206|11864499|FG001|Overall Study|Other Not Specified|0
7524208|NCT02559206|11864500|FG002|Overall Study|Other Not Specified|0
7524209|NCT02559206|11864501|FG003|Overall Study|Other Not Specified|1
7524210|NCT02559206|11864502|FG004|Overall Study|Other Not Specified|0
7524211|NCT02559206|11864503|FG005|Overall Study|Other Not Specified|0
7524212|NCT02559206|11864504|FG006|Overall Study|Other Not Specified|0
7524213|NCT02559206|11864505|FG007|Overall Study|Other Not Specified|0
7524214|NCT02559310|11864525|FG000|Overall Study|Death|4
7524215|NCT02559310|11864526|FG001|Overall Study|Death|3
7524216|NCT02559310|11864525|FG000|Overall Study|Lost to Follow-up|5
7524217|NCT02559310|11864526|FG001|Overall Study|Lost to Follow-up|3
7524218|NCT02559310|11864525|FG000|Overall Study|Physician Decision|2
7524219|NCT02559310|11864526|FG001|Overall Study|Physician Decision|1
7524220|NCT02559310|11864525|FG000|Overall Study|Withdrawal by Subject|13
7524221|NCT02559310|11864526|FG001|Overall Study|Withdrawal by Subject|9
7524222|NCT02559310|11864525|FG000|Overall Study|Sponsor Decision|0
7524223|NCT02559310|11864526|FG001|Overall Study|Sponsor Decision|1
7524224|NCT02559310|11864525|FG000|Overall Study|Randomized but not treated|3
7524225|NCT02559310|11864526|FG001|Overall Study|Randomized but not treated|2
7524226|NCT02559414|11864535|FG000|Overall Study|Lost to Follow-up|0
7524227|NCT02559414|11864536|FG001|Overall Study|Lost to Follow-up|1
7524228|NCT02559414|11864537|FG002|Overall Study|Lost to Follow-up|0
7524229|NCT02559414|11864535|FG000|Overall Study|Withdrawal by Subject|1
7524230|NCT02559414|11864536|FG001|Overall Study|Withdrawal by Subject|0
7524231|NCT02559414|11864537|FG002|Overall Study|Withdrawal by Subject|1
7524232|NCT02559414|11864535|FG000|Overall Study|Other|0
7524233|NCT02559414|11864536|FG001|Overall Study|Other|1
7524234|NCT02559414|11864537|FG002|Overall Study|Other|1
7524235|NCT02559505|11864562|FG000|Overall Study|Lost to Follow-up|23
7524236|NCT02559505|11864563|FG001|Overall Study|Lost to Follow-up|20
7524237|NCT02559505|11864562|FG000|Overall Study|Withdrawal by Subject|4
7524238|NCT02559505|11864563|FG001|Overall Study|Withdrawal by Subject|2
7524239|NCT02559570|11864586|FG000|Overall Study|Adverse Event|0
7524240|NCT02559570|11864587|FG001|Overall Study|Adverse Event|2
7524241|NCT02559570|11864588|FG002|Overall Study|Adverse Event|0
7524242|NCT02559570|11864589|FG003|Overall Study|Adverse Event|1
7524243|NCT02559570|11864590|FG004|Overall Study|Adverse Event|0
7524244|NCT02559570|11864586|FG000|Overall Study|Withdrawal of Consent|0
7524245|NCT02559570|11864587|FG001|Overall Study|Withdrawal of Consent|0
7524246|NCT02559570|11864588|FG002|Overall Study|Withdrawal of Consent|1
7524247|NCT02559570|11864589|FG003|Overall Study|Withdrawal of Consent|2
7524248|NCT02559570|11864590|FG004|Overall Study|Withdrawal of Consent|1
7524249|NCT02559570|11864586|FG000|Overall Study|Lost to Follow-up|1
7524250|NCT02559570|11864587|FG001|Overall Study|Lost to Follow-up|0
7524251|NCT02559570|11864588|FG002|Overall Study|Lost to Follow-up|0
7524252|NCT02559570|11864589|FG003|Overall Study|Lost to Follow-up|0
7524253|NCT02559570|11864590|FG004|Overall Study|Lost to Follow-up|0
7524254|NCT02559570|11864586|FG000|Overall Study|Protocol Violation|1
7524255|NCT02559570|11864587|FG001|Overall Study|Protocol Violation|0
7524256|NCT02559570|11864588|FG002|Overall Study|Protocol Violation|0
7524257|NCT02559570|11864589|FG003|Overall Study|Protocol Violation|0
7524258|NCT02559570|11864590|FG004|Overall Study|Protocol Violation|1
7524259|NCT02559570|11864586|FG000|Overall Study|Other Miscellaneous Reasons|0
7524260|NCT02559570|11864587|FG001|Overall Study|Other Miscellaneous Reasons|0
7524261|NCT02559570|11864588|FG002|Overall Study|Other Miscellaneous Reasons|1
7524262|NCT02559570|11864589|FG003|Overall Study|Other Miscellaneous Reasons|0
7524263|NCT02559570|11864590|FG004|Overall Study|Other Miscellaneous Reasons|0
7524264|NCT02559622|11864605|FG000|Overall Study|Progressive disease|0
7524265|NCT02559622|11864606|FG001|Overall Study|Progressive disease|1
7524266|NCT02559622|11864607|FG002|Overall Study|Progressive disease|0
7524267|NCT02559622|11864608|FG003|Overall Study|Progressive disease|0
7524268|NCT02559622|11864605|FG000|Overall Study|Adverse Event|0
7524269|NCT02559622|11864606|FG001|Overall Study|Adverse Event|2
7524270|NCT02559622|11864607|FG002|Overall Study|Adverse Event|2
7524271|NCT02559622|11864608|FG003|Overall Study|Adverse Event|2
7524272|NCT02559622|11864605|FG000|Overall Study|Patient/guardian decision|1
7524273|NCT02559622|11864606|FG001|Overall Study|Patient/guardian decision|2
7524274|NCT02559622|11864607|FG002|Overall Study|Patient/guardian decision|0
7524275|NCT02559622|11864608|FG003|Overall Study|Patient/guardian decision|1
7524279|NCT02559713|11864626|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
7524280|NCT02559817|11864635|FG000|Treatment Period|Adverse Event|1
7524281|NCT02559817|11864636|FG001|Treatment Period|Adverse Event|0
7524282|NCT02559817|11864637|FG002|Treatment Period|Adverse Event|1
7524283|NCT02559817|11864638|FG003|Treatment Period|Adverse Event|0
7524284|NCT02559817|11864639|FG004|Treatment Period|Adverse Event|0
7524285|NCT02559817|11864635|FG000|Treatment Period|Lack of Efficacy|0
7524286|NCT02559817|11864636|FG001|Treatment Period|Lack of Efficacy|1
7524287|NCT02559817|11864637|FG002|Treatment Period|Lack of Efficacy|0
7524288|NCT02559817|11864638|FG003|Treatment Period|Lack of Efficacy|0
7524289|NCT02559817|11864639|FG004|Treatment Period|Lack of Efficacy|0
7524290|NCT02559817|11864635|FG000|Treatment Period|Lost to Follow-up|0
7524291|NCT02559817|11864636|FG001|Treatment Period|Lost to Follow-up|1
7524292|NCT02559817|11864637|FG002|Treatment Period|Lost to Follow-up|0
7524293|NCT02559817|11864638|FG003|Treatment Period|Lost to Follow-up|1
7524294|NCT02559817|11864639|FG004|Treatment Period|Lost to Follow-up|0
7524295|NCT02559817|11864635|FG000|Treatment Period|Non-Compliance With Study Drug|0
7524296|NCT02559817|11864636|FG001|Treatment Period|Non-Compliance With Study Drug|0
7524297|NCT02559817|11864637|FG002|Treatment Period|Non-Compliance With Study Drug|1
7524298|NCT02559817|11864638|FG003|Treatment Period|Non-Compliance With Study Drug|0
7524299|NCT02559817|11864639|FG004|Treatment Period|Non-Compliance With Study Drug|0
7524300|NCT02559817|11864635|FG000|Treatment Period|Protocol Violation|0
7524301|NCT02559817|11864636|FG001|Treatment Period|Protocol Violation|0
7524302|NCT02559817|11864637|FG002|Treatment Period|Protocol Violation|0
7524303|NCT02559817|11864638|FG003|Treatment Period|Protocol Violation|1
7524304|NCT02559817|11864639|FG004|Treatment Period|Protocol Violation|0
7524305|NCT02559895|11864655|FG000|Overall Study|Adverse Event|3
7524306|NCT02559895|11864656|FG001|Overall Study|Adverse Event|3
7524307|NCT02559895|11864657|FG002|Overall Study|Adverse Event|2
7524308|NCT02559895|11864658|FG003|Overall Study|Adverse Event|1
7524309|NCT02559895|11864655|FG000|Overall Study|Lack of Efficacy|2
7524310|NCT02559895|11864656|FG001|Overall Study|Lack of Efficacy|3
7524311|NCT02559895|11864657|FG002|Overall Study|Lack of Efficacy|2
7524312|NCT02559895|11864658|FG003|Overall Study|Lack of Efficacy|8
7524313|NCT02559895|11864655|FG000|Overall Study|Lost to Follow-up|22
7524314|NCT02559895|11864656|FG001|Overall Study|Lost to Follow-up|16
7524315|NCT02559895|11864657|FG002|Overall Study|Lost to Follow-up|12
7524316|NCT02559895|11864658|FG003|Overall Study|Lost to Follow-up|17
7524317|NCT02559895|11864655|FG000|Overall Study|Physician Decision|1
7524318|NCT02559895|11864656|FG001|Overall Study|Physician Decision|1
7524319|NCT02559895|11864657|FG002|Overall Study|Physician Decision|3
7524320|NCT02559895|11864658|FG003|Overall Study|Physician Decision|0
7524321|NCT02559895|11864655|FG000|Overall Study|Withdrawal by Subject|16
7524322|NCT02559895|11864656|FG001|Overall Study|Withdrawal by Subject|9
7524323|NCT02559895|11864657|FG002|Overall Study|Withdrawal by Subject|20
7524324|NCT02559895|11864658|FG003|Overall Study|Withdrawal by Subject|9
7524325|NCT02559895|11864655|FG000|Overall Study|Study Burden|10
7524326|NCT02559895|11864656|FG001|Overall Study|Study Burden|16
7524327|NCT02559895|11864657|FG002|Overall Study|Study Burden|12
7524328|NCT02559895|11864658|FG003|Overall Study|Study Burden|22
7524329|NCT02559895|11864655|FG000|Overall Study|Other|1
7524330|NCT02559895|11864656|FG001|Overall Study|Other|5
7524331|NCT02559895|11864657|FG002|Overall Study|Other|3
7524332|NCT02559895|11864658|FG003|Overall Study|Other|3
7524333|NCT02560012|11864668|FG000|Overall Study|Study Terminated|2
7524334|NCT02560025|11864672|FG000|Overall Study|Ineligible after consent/ registration|3
7524335|NCT02560389|11864709|FG000|Overall Study|Lost to Follow-up|1
7524336|NCT02560389|11864710|FG001|Overall Study|Lost to Follow-up|2
7524337|NCT02560389|11864711|FG002|Overall Study|Lost to Follow-up|2
7524338|NCT02560389|11864709|FG000|Overall Study|Tested positive for illicit substance|0
7524339|NCT02560389|11864710|FG001|Overall Study|Tested positive for illicit substance|1
7524340|NCT02560389|11864711|FG002|Overall Study|Tested positive for illicit substance|0
7524341|NCT02560558|11864730|FG000|Overall Study|Adverse Event|1
7524342|NCT02560558|11864731|FG001|Overall Study|Adverse Event|0
7524343|NCT02560558|11864730|FG000|Overall Study|Death|0
7524344|NCT02560558|11864731|FG001|Overall Study|Death|2
7524345|NCT02560558|11864730|FG000|Overall Study|Lost to Follow-up|0
7524346|NCT02560558|11864731|FG001|Overall Study|Lost to Follow-up|4
7524347|NCT02560558|11864730|FG000|Overall Study|Protocol Violation|3
7524348|NCT02560558|11864731|FG001|Overall Study|Protocol Violation|0
7524349|NCT02560558|11864730|FG000|Overall Study|Withdrawal by Subject|3
7524350|NCT02560558|11864731|FG001|Overall Study|Withdrawal by Subject|0
7524351|NCT02561000|11864790|FG000|Overall Study|Withdrawal by Subject|2
7524352|NCT02561000|11864791|FG001|Overall Study|Withdrawal by Subject|3
7524353|NCT02561000|11864792|FG002|Overall Study|Withdrawal by Subject|0
7524354|NCT02561000|11864790|FG000|Overall Study|Adverse Event|0
7524355|NCT02561000|11864791|FG001|Overall Study|Adverse Event|1
7524356|NCT02561000|11864792|FG002|Overall Study|Adverse Event|0
7524357|NCT02561078|11864802|FG000|Overall Study|Adverse Event|5
7524358|NCT02561078|11864803|FG001|Overall Study|Adverse Event|2
7524359|NCT02561078|11864802|FG000|Overall Study|Death|2
7524360|NCT02561078|11864803|FG001|Overall Study|Death|1
7524361|NCT02561078|11864802|FG000|Overall Study|Lost to Follow-up|2
7524362|NCT02561078|11864803|FG001|Overall Study|Lost to Follow-up|6
7524363|NCT02561078|11864802|FG000|Overall Study|Non-Compliance with Study Drug|6
7524364|NCT02561078|11864803|FG001|Overall Study|Non-Compliance with Study Drug|3
7524365|NCT02561078|11864802|FG000|Overall Study|Physician Decision|2
7524366|NCT02561078|11864803|FG001|Overall Study|Physician Decision|3
7524367|NCT02561078|11864802|FG000|Overall Study|Withdrawal by Subject|13
7524368|NCT02561078|11864803|FG001|Overall Study|Withdrawal by Subject|10
7524369|NCT02561156|11864831|FG000|Part 2|Adverse Event|0
7524370|NCT02561156|11864832|FG001|Part 2|Adverse Event|0
7524371|NCT02561156|11864833|FG002|Part 2|Adverse Event|0
7524372|NCT02561156|11864834|FG003|Part 2|Adverse Event|0
7524373|NCT02561156|11864835|FG004|Part 2|Adverse Event|0
7524374|NCT02561156|11864836|FG005|Part 2|Adverse Event|0
7524375|NCT02561156|11864837|FG006|Part 2|Adverse Event|0
7524376|NCT02561156|11864838|FG007|Part 2|Adverse Event|0
7524377|NCT02561156|11864839|FG008|Part 2|Adverse Event|0
7524378|NCT02561156|11864840|FG009|Part 2|Adverse Event|0
7524379|NCT02561156|11864841|FG010|Part 2|Adverse Event|0
7524380|NCT02561156|11864842|FG011|Part 2|Adverse Event|1
7524381|NCT02561156|11864843|FG012|Part 2|Adverse Event|0
7524382|NCT02561195|11864893|FG000|Vaccination 1 to 3|Adverse Event|4
7524383|NCT02561195|11864894|FG001|Vaccination 1 to 3|Adverse Event|5
7524384|NCT02561195|11864895|FG002|Vaccination 1 to 3|Adverse Event|0
7524385|NCT02561195|11864896|FG003|Vaccination 1 to 3|Adverse Event|3
7524386|NCT02561195|11864897|FG004|Vaccination 1 to 3|Adverse Event|4
7524387|NCT02561195|11864898|FG005|Vaccination 1 to 3|Adverse Event|0
7524388|NCT02561195|11864899|FG006|Vaccination 1 to 3|Adverse Event|0
7524389|NCT02561195|11864900|FG007|Vaccination 1 to 3|Adverse Event|0
7524390|NCT02561195|11864901|FG008|Vaccination 1 to 3|Adverse Event|0
7524391|NCT02561195|11864902|FG009|Vaccination 1 to 3|Adverse Event|0
7524392|NCT02561195|11864903|FG010|Vaccination 1 to 3|Adverse Event|0
7524393|NCT02561195|11864904|FG011|Vaccination 1 to 3|Adverse Event|0
7524394|NCT02561195|11864905|FG012|Vaccination 1 to 3|Adverse Event|0
7524395|NCT02561195|11864906|FG013|Vaccination 1 to 3|Adverse Event|0
7524396|NCT02561195|11864893|FG000|Vaccination 1 to 3|Lost to Follow-up|3
7524397|NCT02561195|11864894|FG001|Vaccination 1 to 3|Lost to Follow-up|4
7524398|NCT02561195|11864895|FG002|Vaccination 1 to 3|Lost to Follow-up|0
7524399|NCT02561195|11864896|FG003|Vaccination 1 to 3|Lost to Follow-up|2
7524400|NCT02561195|11864897|FG004|Vaccination 1 to 3|Lost to Follow-up|3
7524401|NCT02561195|11864898|FG005|Vaccination 1 to 3|Lost to Follow-up|3
7524402|NCT02561195|11864899|FG006|Vaccination 1 to 3|Lost to Follow-up|0
7524403|NCT02561195|11864900|FG007|Vaccination 1 to 3|Lost to Follow-up|0
7524404|NCT02561195|11864901|FG008|Vaccination 1 to 3|Lost to Follow-up|0
7524405|NCT02561195|11864902|FG009|Vaccination 1 to 3|Lost to Follow-up|0
7524406|NCT02561195|11864903|FG010|Vaccination 1 to 3|Lost to Follow-up|0
7524407|NCT02561195|11864904|FG011|Vaccination 1 to 3|Lost to Follow-up|0
7524408|NCT02561195|11864905|FG012|Vaccination 1 to 3|Lost to Follow-up|0
7524409|NCT02561195|11864906|FG013|Vaccination 1 to 3|Lost to Follow-up|0
7524410|NCT02561195|11864893|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524411|NCT02561195|11864894|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
7524412|NCT02561195|11864895|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524413|NCT02561195|11864896|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
7524414|NCT02561195|11864897|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
7524415|NCT02561195|11864898|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
7524416|NCT02561195|11864899|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524417|NCT02561195|11864900|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524418|NCT02561195|11864901|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524419|NCT02561195|11864902|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524420|NCT02561195|11864903|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524421|NCT02561195|11864904|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524422|NCT02561195|11864905|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524423|NCT02561195|11864906|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
7524424|NCT02561195|11864893|FG000|Vaccination 1 to 3|No longer willing to participate|2
7524425|NCT02561195|11864894|FG001|Vaccination 1 to 3|No longer willing to participate|4
7524426|NCT02561195|11864895|FG002|Vaccination 1 to 3|No longer willing to participate|0
7524427|NCT02561195|11864896|FG003|Vaccination 1 to 3|No longer willing to participate|4
7524428|NCT02561195|11864897|FG004|Vaccination 1 to 3|No longer willing to participate|1
7524429|NCT02561195|11864898|FG005|Vaccination 1 to 3|No longer willing to participate|3
7524430|NCT02561195|11864899|FG006|Vaccination 1 to 3|No longer willing to participate|0
7524431|NCT02561195|11864900|FG007|Vaccination 1 to 3|No longer willing to participate|0
7524432|NCT02561195|11864901|FG008|Vaccination 1 to 3|No longer willing to participate|0
7524433|NCT02561195|11864902|FG009|Vaccination 1 to 3|No longer willing to participate|0
7524434|NCT02561195|11864903|FG010|Vaccination 1 to 3|No longer willing to participate|0
7524435|NCT02561195|11864904|FG011|Vaccination 1 to 3|No longer willing to participate|0
7524436|NCT02561195|11864905|FG012|Vaccination 1 to 3|No longer willing to participate|0
7524437|NCT02561195|11864906|FG013|Vaccination 1 to 3|No longer willing to participate|0
7524438|NCT02561195|11864893|FG000|Vaccination 1 to 3|Other|7
7524439|NCT02561195|11864894|FG001|Vaccination 1 to 3|Other|3
7524440|NCT02561195|11864895|FG002|Vaccination 1 to 3|Other|1
7524441|NCT02561195|11864896|FG003|Vaccination 1 to 3|Other|7
7524442|NCT02561195|11864897|FG004|Vaccination 1 to 3|Other|5
7524443|NCT02561195|11864898|FG005|Vaccination 1 to 3|Other|1
7524444|NCT02561195|11864899|FG006|Vaccination 1 to 3|Other|0
7524445|NCT02561195|11864900|FG007|Vaccination 1 to 3|Other|0
7524446|NCT02561195|11864901|FG008|Vaccination 1 to 3|Other|0
7524447|NCT02561195|11864902|FG009|Vaccination 1 to 3|Other|0
7524448|NCT02561195|11864903|FG010|Vaccination 1 to 3|Other|0
7524449|NCT02561195|11864904|FG011|Vaccination 1 to 3|Other|0
7524450|NCT02561195|11864905|FG012|Vaccination 1 to 3|Other|0
7524451|NCT02561195|11864906|FG013|Vaccination 1 to 3|Other|0
7524452|NCT02561195|11864893|FG000|Vaccination 1 to 3|Protocol Violation|1
7524453|NCT02561195|11864894|FG001|Vaccination 1 to 3|Protocol Violation|0
7524454|NCT02561195|11864895|FG002|Vaccination 1 to 3|Protocol Violation|1
7524455|NCT02561195|11864896|FG003|Vaccination 1 to 3|Protocol Violation|2
7524456|NCT02561195|11864897|FG004|Vaccination 1 to 3|Protocol Violation|5
7524457|NCT02561195|11864898|FG005|Vaccination 1 to 3|Protocol Violation|2
7524458|NCT02561195|11864899|FG006|Vaccination 1 to 3|Protocol Violation|0
7524459|NCT02561195|11864900|FG007|Vaccination 1 to 3|Protocol Violation|0
7524460|NCT02561195|11864901|FG008|Vaccination 1 to 3|Protocol Violation|0
7524461|NCT02561195|11864902|FG009|Vaccination 1 to 3|Protocol Violation|0
7524462|NCT02561195|11864903|FG010|Vaccination 1 to 3|Protocol Violation|0
7524463|NCT02561195|11864904|FG011|Vaccination 1 to 3|Protocol Violation|0
7524464|NCT02561195|11864905|FG012|Vaccination 1 to 3|Protocol Violation|0
7524465|NCT02561195|11864906|FG013|Vaccination 1 to 3|Protocol Violation|0
7524466|NCT02561195|11864893|FG000|Vaccination 1 to 3|Death|2
7524467|NCT02561195|11864894|FG001|Vaccination 1 to 3|Death|1
7524468|NCT02561195|11864895|FG002|Vaccination 1 to 3|Death|0
7524469|NCT02561195|11864896|FG003|Vaccination 1 to 3|Death|2
7524470|NCT02561195|11864897|FG004|Vaccination 1 to 3|Death|0
7524471|NCT02561195|11864898|FG005|Vaccination 1 to 3|Death|0
7524472|NCT02561195|11864899|FG006|Vaccination 1 to 3|Death|0
7524473|NCT02561195|11864900|FG007|Vaccination 1 to 3|Death|0
7524474|NCT02561195|11864901|FG008|Vaccination 1 to 3|Death|0
7524475|NCT02561195|11864902|FG009|Vaccination 1 to 3|Death|0
7524476|NCT02561195|11864903|FG010|Vaccination 1 to 3|Death|0
7524477|NCT02561195|11864904|FG011|Vaccination 1 to 3|Death|0
7524478|NCT02561195|11864905|FG012|Vaccination 1 to 3|Death|0
7524479|NCT02561195|11864906|FG013|Vaccination 1 to 3|Death|0
7524480|NCT02561195|11864893|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
7524481|NCT02561195|11864894|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
7524482|NCT02561195|11864895|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
7524483|NCT02561195|11864896|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
7524484|NCT02561195|11864897|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
7524485|NCT02561195|11864898|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
7524486|NCT02561195|11864899|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
7524487|NCT02561195|11864900|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
7524488|NCT02561195|11864901|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
7524489|NCT02561195|11864902|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
7524490|NCT02561195|11864903|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
7524491|NCT02561195|11864904|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
7524492|NCT02561195|11864905|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
7524493|NCT02561195|11864906|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
7524494|NCT02561195|11864893|FG000|Vaccination 1 to 3|Randomized but not treated|1
7524495|NCT02561195|11864894|FG001|Vaccination 1 to 3|Randomized but not treated|0
7524496|NCT02561195|11864895|FG002|Vaccination 1 to 3|Randomized but not treated|0
7524497|NCT02561195|11864896|FG003|Vaccination 1 to 3|Randomized but not treated|0
7524498|NCT02561195|11864897|FG004|Vaccination 1 to 3|Randomized but not treated|0
7524499|NCT02561195|11864898|FG005|Vaccination 1 to 3|Randomized but not treated|0
7524500|NCT02561195|11864899|FG006|Vaccination 1 to 3|Randomized but not treated|0
7524501|NCT02561195|11864900|FG007|Vaccination 1 to 3|Randomized but not treated|0
7524502|NCT02561195|11864901|FG008|Vaccination 1 to 3|Randomized but not treated|0
7524503|NCT02561195|11864902|FG009|Vaccination 1 to 3|Randomized but not treated|0
7524504|NCT02561195|11864903|FG010|Vaccination 1 to 3|Randomized but not treated|0
7524505|NCT02561195|11864904|FG011|Vaccination 1 to 3|Randomized but not treated|0
7524506|NCT02561195|11864905|FG012|Vaccination 1 to 3|Randomized but not treated|0
7524507|NCT02561195|11864906|FG013|Vaccination 1 to 3|Randomized but not treated|0
7524508|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
7524509|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
7524510|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
7524511|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
7524512|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
7524513|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
7524514|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
7524515|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
7524516|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
7524517|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
7524518|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
7524519|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
7524520|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
7524521|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
7524522|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
7524523|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
7524524|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
7524525|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
7524526|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
7524527|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
7524528|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
7524529|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
7524530|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
7524531|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
7524532|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
7524533|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
7524534|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
7524535|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
7524536|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Death|0
7524537|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Death|0
7524538|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Death|0
7524539|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Death|0
7524540|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Death|0
7524541|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Death|0
7524542|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Death|0
7524543|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Death|0
7524544|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Death|0
7524545|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Death|1
7524546|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Death|0
7524547|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Death|0
7524548|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Death|0
7524549|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Death|0
7524550|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524551|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524552|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524553|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524554|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524555|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524556|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7524557|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7524558|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524559|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
7524560|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7524561|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7524562|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
7524563|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
7524564|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524565|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524566|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524567|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524568|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524569|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524570|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524571|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524572|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524573|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524574|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
7524575|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7524576|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7524577|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
7524578|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Other|0
7524579|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Other|0
7524580|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Other|0
7524581|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Other|0
7524582|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Other|0
7524583|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Other|0
7524584|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Other|0
7524585|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Other|0
7524586|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Other|0
7524587|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Other|0
7524588|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Other|2
7524589|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Other|2
7524590|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Other|1
7524591|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Other|0
7524592|NCT02561195|11864893|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
7524593|NCT02561195|11864894|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
7524594|NCT02561195|11864895|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
7524595|NCT02561195|11864896|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
7524596|NCT02561195|11864897|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
7524597|NCT02561195|11864898|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
7524598|NCT02561195|11864899|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
7524599|NCT02561195|11864900|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
7524600|NCT02561195|11864901|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
7524601|NCT02561195|11864902|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
7524602|NCT02561195|11864903|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
7524603|NCT02561195|11864904|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
7524604|NCT02561195|11864905|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
7524605|NCT02561195|11864906|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
7524606|NCT02561247|11864947|FG000|Overall Study|Protocol Violation|1
7524607|NCT02561247|11864947|FG000|Overall Study|Withdrawal by Subject|1
7524608|NCT02561247|11864947|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
7537066|NCT02729909|11885396|FG000|Overall Study|Significant Protocol Deviation|0
7537067|NCT02729909|11885397|FG001|Overall Study|Significant Protocol Deviation|2
7537068|NCT02729909|11885396|FG000|Overall Study|Voluntary Withdrawal|1
7524609|NCT02561273|11864953|FG000|Overall Study|Protocol Violation|1
7524610|NCT02561273|11864954|FG001|Overall Study|Protocol Violation|0
7524611|NCT02561455|11864989|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
7524612|NCT02561455|11864990|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
7524613|NCT02561455|11864991|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
7524614|NCT02561455|11864992|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
7524615|NCT02561455|11864989|FG000|Overall Study|Withdrawal by Subject|1
7524616|NCT02561455|11864990|FG001|Overall Study|Withdrawal by Subject|0
7524617|NCT02561455|11864991|FG002|Overall Study|Withdrawal by Subject|1
7524618|NCT02561455|11864992|FG003|Overall Study|Withdrawal by Subject|0
7524619|NCT02561455|11864989|FG000|Overall Study|Disease Progression|0
7524620|NCT02561455|11864990|FG001|Overall Study|Disease Progression|1
7524621|NCT02561455|11864991|FG002|Overall Study|Disease Progression|0
7524622|NCT02561455|11864992|FG003|Overall Study|Disease Progression|0
7524623|NCT02561572|11865016|FG000|Overall Study|Inadequate time before surgery|2
7524624|NCT02561572|11865017|FG001|Overall Study|Inadequate time before surgery|1
7524625|NCT02561572|11865016|FG000|Overall Study|Protocol Violation|0
7524626|NCT02561572|11865017|FG001|Overall Study|Protocol Violation|1
7524627|NCT02561806|11865045|FG000|Induction Period|Adverse Event|0
7524628|NCT02561806|11865046|FG001|Induction Period|Adverse Event|2
7524629|NCT02561806|11865045|FG000|Induction Period|Lack of Efficacy|1
7524630|NCT02561806|11865046|FG001|Induction Period|Lack of Efficacy|0
7524631|NCT02561806|11865045|FG000|Induction Period|Withdrawal by Subject|0
7524632|NCT02561806|11865046|FG001|Induction Period|Withdrawal by Subject|2
7524633|NCT02561806|11865045|FG000|Induction Period|Site staff became unblinded|1
7524634|NCT02561806|11865046|FG001|Induction Period|Site staff became unblinded|0
7524635|NCT02561806|11865045|FG000|Induction Period|Randomized but not treated|0
7524636|NCT02561806|11865046|FG001|Induction Period|Randomized but not treated|1
7524637|NCT02561806|11865045|FG000|Maintenance Period|Adverse Event|2
7524638|NCT02561806|11865046|FG001|Maintenance Period|Adverse Event|1
7524639|NCT02561806|11865045|FG000|Maintenance Period|Lack of Efficacy|3
7524640|NCT02561806|11865046|FG001|Maintenance Period|Lack of Efficacy|1
7524641|NCT02561806|11865045|FG000|Maintenance Period|Lost to Follow-up|2
7524642|NCT02561806|11865046|FG001|Maintenance Period|Lost to Follow-up|2
7524643|NCT02561806|11865045|FG000|Maintenance Period|Protocol Violation|1
7524644|NCT02561806|11865046|FG001|Maintenance Period|Protocol Violation|0
7524645|NCT02561806|11865045|FG000|Maintenance Period|Withdrawal by Subject|5
7524646|NCT02561806|11865046|FG001|Maintenance Period|Withdrawal by Subject|3
7524647|NCT02561806|11865045|FG000|Maintenance Period|Site staff became unblinded|0
7524648|NCT02561806|11865046|FG001|Maintenance Period|Site staff became unblinded|1
7524649|NCT02561806|11865045|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
7524650|NCT02561806|11865046|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
7524651|NCT02561806|11865045|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
7524652|NCT02561806|11865046|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
7524653|NCT02561832|11865069|FG000|Overall Study|Withdrawal by Subject|1
7524654|NCT02561832|11865070|FG001|Overall Study|Withdrawal by Subject|1
7524655|NCT02561832|11865069|FG000|Overall Study|Adverse Event|3
7524656|NCT02561832|11865070|FG001|Overall Study|Adverse Event|0
7524657|NCT02561832|11865069|FG000|Overall Study|Disease progression|3
7524658|NCT02561832|11865070|FG001|Overall Study|Disease progression|3
7524659|NCT02562482|11865099|FG000|Overall Study|Enrolled, but did not receive product|4
7524660|NCT02562482|11865100|FG001|Overall Study|Enrolled, but did not receive product|0
7524661|NCT02562482|11865099|FG000|Overall Study|Lost to Follow-up|9
7524662|NCT02562482|11865100|FG001|Overall Study|Lost to Follow-up|6
7524663|NCT02562482|11865099|FG000|Overall Study|Moved from area|2
7524664|NCT02562482|11865100|FG001|Overall Study|Moved from area|3
7524665|NCT02562482|11865099|FG000|Overall Study|Withdrawal by Subject|5
7524666|NCT02562482|11865100|FG001|Overall Study|Withdrawal by Subject|3
7524667|NCT02562482|11865099|FG000|Overall Study|Physician Decision|1
7524668|NCT02562482|11865100|FG001|Overall Study|Physician Decision|3
7524669|NCT02562482|11865099|FG000|Overall Study|Illness/Injury unrelated to product|0
7524670|NCT02562482|11865100|FG001|Overall Study|Illness/Injury unrelated to product|1
7524671|NCT02563067|11865165|FG000|Overall Study|Subject/guardian decision|14
7524672|NCT02563067|11865166|FG001|Overall Study|Subject/guardian decision|20
7524673|NCT02563067|11865167|FG002|Overall Study|Subject/guardian decision|16
7524674|NCT02563067|11865165|FG000|Overall Study|Physician Decision|0
7524675|NCT02563067|11865166|FG001|Overall Study|Physician Decision|1
7524676|NCT02563067|11865167|FG002|Overall Study|Physician Decision|3
7524677|NCT02563067|11865165|FG000|Overall Study|Lost to Follow-up|1
7524678|NCT02563067|11865166|FG001|Overall Study|Lost to Follow-up|2
7524679|NCT02563067|11865167|FG002|Overall Study|Lost to Follow-up|0
7524680|NCT02563067|11865165|FG000|Overall Study|Technical problems|0
7524681|NCT02563067|11865166|FG001|Overall Study|Technical problems|1
7524682|NCT02563067|11865167|FG002|Overall Study|Technical problems|0
7524683|NCT02563067|11865165|FG000|Overall Study|Lack of Efficacy|1
7524684|NCT02563067|11865166|FG001|Overall Study|Lack of Efficacy|0
7524685|NCT02563067|11865167|FG002|Overall Study|Lack of Efficacy|0
7524686|NCT02563067|11865165|FG000|Overall Study|Death|0
7524687|NCT02563067|11865166|FG001|Overall Study|Death|1
7524688|NCT02563067|11865167|FG002|Overall Study|Death|1
7524689|NCT02563067|11865165|FG000|Overall Study|Adverse Event|2
7524690|NCT02563067|11865166|FG001|Overall Study|Adverse Event|1
7524691|NCT02563067|11865167|FG002|Overall Study|Adverse Event|0
7524692|NCT02563067|11865165|FG000|Overall Study|Death post Treatment/safety period|1
7524693|NCT02563067|11865166|FG001|Overall Study|Death post Treatment/safety period|0
7524694|NCT02563067|11865167|FG002|Overall Study|Death post Treatment/safety period|0
7524695|NCT02563106|11865195|FG000|Overall Study|Withdrawal by Subject|7
7524696|NCT02563106|11865196|FG001|Overall Study|Withdrawal by Subject|8
7524697|NCT02563106|11865195|FG000|Overall Study|Adverse Event|17
7524698|NCT02563106|11865196|FG001|Overall Study|Adverse Event|15
7524699|NCT02563106|11865195|FG000|Overall Study|Protocol Violation|1
7524700|NCT02563106|11865196|FG001|Overall Study|Protocol Violation|0
7524701|NCT02563106|11865195|FG000|Overall Study|Use of non-permitted concurrent therapy|1
7524702|NCT02563106|11865196|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7524703|NCT02563106|11865195|FG000|Overall Study|Lost to Follow-up|3
7524704|NCT02563106|11865196|FG001|Overall Study|Lost to Follow-up|2
7524705|NCT02563106|11865195|FG000|Overall Study|Physician Decision|3
7524706|NCT02563106|11865196|FG001|Overall Study|Physician Decision|1
7524707|NCT02563106|11865195|FG000|Overall Study|Other reason - not specified|2
7524708|NCT02563106|11865196|FG001|Overall Study|Other reason - not specified|1
7524709|NCT02563548|11865225|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
7524710|NCT02563548|11865226|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7524711|NCT02563548|11865227|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7524712|NCT02563548|11865228|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
7524713|NCT02563548|11865229|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7524714|NCT02563548|11865230|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
7524715|NCT02563548|11865225|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
7524716|NCT02563548|11865226|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7524717|NCT02563548|11865227|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
7524718|NCT02563548|11865228|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7524719|NCT02563548|11865229|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7524720|NCT02563548|11865230|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
7524721|NCT02563548|11865225|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7524722|NCT02563548|11865226|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7524723|NCT02563548|11865227|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
7524724|NCT02563548|11865228|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7524725|NCT02563548|11865229|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7524726|NCT02563548|11865230|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
7524727|NCT02563548|11865225|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7524728|NCT02563548|11865226|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7524729|NCT02563548|11865227|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
7524730|NCT02563548|11865228|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
7524731|NCT02563548|11865229|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7524732|NCT02563548|11865230|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
7524733|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7524734|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7524735|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7524736|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
7524737|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
7524738|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
7524739|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7524740|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7524741|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7524742|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
7524743|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
7524744|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
7524745|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7524746|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7524747|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7524748|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7524749|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
7524750|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
7524751|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7524752|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7524753|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7524754|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
7524755|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
7524756|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
7524757|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7524758|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7524759|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7524760|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7524761|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
7524762|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
7524763|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7524764|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7524765|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7524766|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7524767|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
7524768|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
7524769|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7524770|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7524771|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7524772|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7524773|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
7524774|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
7524775|NCT02563548|11865225|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7524776|NCT02563548|11865226|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7524777|NCT02563548|11865227|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7524778|NCT02563548|11865228|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7524779|NCT02563548|11865229|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
7524780|NCT02563548|11865230|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
7524781|NCT02563561|11865253|FG000|Overall Study|Histology Other than Ta, G1-G2|3
7524782|NCT02563561|11865254|FG001|Overall Study|Histology Other than Ta, G1-G2|6
7524783|NCT02563561|11865255|FG002|Overall Study|Histology Other than Ta, G1-G2|6
7524784|NCT02563561|11865253|FG000|Overall Study|Withdrew of Consent|1
7524785|NCT02563561|11865254|FG001|Overall Study|Withdrew of Consent|1
7524786|NCT02563561|11865255|FG002|Overall Study|Withdrew of Consent|2
7524787|NCT02563561|11865253|FG000|Overall Study|Lost to Follow-up|1
7524788|NCT02563561|11865254|FG001|Overall Study|Lost to Follow-up|1
7524789|NCT02563561|11865255|FG002|Overall Study|Lost to Follow-up|0
7524790|NCT02563561|11865253|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
7524791|NCT02563561|11865254|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
7524792|NCT02563561|11865255|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
7524793|NCT02563561|11865253|FG000|Overall Study|Investigator Decision|3
7524794|NCT02563561|11865254|FG001|Overall Study|Investigator Decision|4
7524795|NCT02563561|11865255|FG002|Overall Study|Investigator Decision|2
7524796|NCT02563561|11865253|FG000|Overall Study|Sponsor Decision|5
7524797|NCT02563561|11865254|FG001|Overall Study|Sponsor Decision|2
7524798|NCT02563561|11865255|FG002|Overall Study|Sponsor Decision|4
7524799|NCT02563561|11865253|FG000|Overall Study|Other|1
7524800|NCT02563561|11865254|FG001|Overall Study|Other|5
7524801|NCT02563561|11865255|FG002|Overall Study|Other|2
7524802|NCT02563899|11865291|FG000|Overall Study|Protocol Violation|1
7524803|NCT02563899|11865292|FG001|Overall Study|Protocol Violation|0
7524804|NCT02563899|11865293|FG002|Overall Study|Protocol Violation|0
7524805|NCT02563899|11865294|FG003|Overall Study|Protocol Violation|0
7524806|NCT02563899|11865291|FG000|Overall Study|Withdrawal by Subject|0
7524807|NCT02563899|11865292|FG001|Overall Study|Withdrawal by Subject|0
7524808|NCT02563899|11865293|FG002|Overall Study|Withdrawal by Subject|1
7524809|NCT02563899|11865294|FG003|Overall Study|Withdrawal by Subject|0
7524810|NCT02564042|11865342|FG000|Overall Study|Adverse Event|4
7524811|NCT02564042|11865343|FG001|Overall Study|Adverse Event|4
7524812|NCT02564042|11865344|FG002|Overall Study|Adverse Event|3
7524813|NCT02564042|11865345|FG003|Overall Study|Adverse Event|0
7524814|NCT02564042|11865346|FG004|Overall Study|Adverse Event|0
7524815|NCT02564042|11865347|FG005|Overall Study|Adverse Event|1
7524816|NCT02564042|11865342|FG000|Overall Study|Lost to Follow-up|1
7524817|NCT02564042|11865343|FG001|Overall Study|Lost to Follow-up|1
7524818|NCT02564042|11865344|FG002|Overall Study|Lost to Follow-up|1
7524819|NCT02564042|11865345|FG003|Overall Study|Lost to Follow-up|0
7524820|NCT02564042|11865346|FG004|Overall Study|Lost to Follow-up|1
7524821|NCT02564042|11865347|FG005|Overall Study|Lost to Follow-up|1
7524822|NCT02564042|11865342|FG000|Overall Study|Physician Decision|1
7524823|NCT02564042|11865343|FG001|Overall Study|Physician Decision|0
7524824|NCT02564042|11865344|FG002|Overall Study|Physician Decision|0
7524825|NCT02564042|11865345|FG003|Overall Study|Physician Decision|1
7524826|NCT02564042|11865346|FG004|Overall Study|Physician Decision|0
7524827|NCT02564042|11865347|FG005|Overall Study|Physician Decision|0
7524828|NCT02564042|11865342|FG000|Overall Study|Withdrawal by Subject|5
7524829|NCT02564042|11865343|FG001|Overall Study|Withdrawal by Subject|3
7524830|NCT02564042|11865344|FG002|Overall Study|Withdrawal by Subject|2
7524831|NCT02564042|11865345|FG003|Overall Study|Withdrawal by Subject|2
7524832|NCT02564042|11865346|FG004|Overall Study|Withdrawal by Subject|10
7524833|NCT02564042|11865347|FG005|Overall Study|Withdrawal by Subject|12
7524834|NCT02564055|11865367|FG000|Overall Study|Adverse Event|1
7524835|NCT02564055|11865368|FG001|Overall Study|Adverse Event|0
7524836|NCT02564055|11865369|FG002|Overall Study|Adverse Event|4
7524837|NCT02564055|11865370|FG003|Overall Study|Adverse Event|1
7524838|NCT02564055|11865371|FG004|Overall Study|Adverse Event|4
7524839|NCT02564055|11865372|FG005|Overall Study|Adverse Event|1
7524840|NCT02564055|11865367|FG000|Overall Study|Protocol Violation|1
7524841|NCT02564055|11865368|FG001|Overall Study|Protocol Violation|0
7524842|NCT02564055|11865369|FG002|Overall Study|Protocol Violation|0
7524843|NCT02564055|11865370|FG003|Overall Study|Protocol Violation|0
7524844|NCT02564055|11865371|FG004|Overall Study|Protocol Violation|0
7524845|NCT02564055|11865372|FG005|Overall Study|Protocol Violation|0
7524846|NCT02564055|11865367|FG000|Overall Study|Reached stopping criteria|0
7524847|NCT02564055|11865368|FG001|Overall Study|Reached stopping criteria|0
7524848|NCT02564055|11865369|FG002|Overall Study|Reached stopping criteria|0
7524849|NCT02564055|11865370|FG003|Overall Study|Reached stopping criteria|0
7524850|NCT02564055|11865371|FG004|Overall Study|Reached stopping criteria|0
7524851|NCT02564055|11865372|FG005|Overall Study|Reached stopping criteria|1
7524852|NCT02564055|11865367|FG000|Overall Study|Lost to Follow-up|0
7524853|NCT02564055|11865368|FG001|Overall Study|Lost to Follow-up|1
7524854|NCT02564055|11865369|FG002|Overall Study|Lost to Follow-up|4
7524855|NCT02564055|11865370|FG003|Overall Study|Lost to Follow-up|2
7524856|NCT02564055|11865371|FG004|Overall Study|Lost to Follow-up|1
7524857|NCT02564055|11865372|FG005|Overall Study|Lost to Follow-up|0
7524858|NCT02564055|11865367|FG000|Overall Study|Physician Decision|0
7524859|NCT02564055|11865368|FG001|Overall Study|Physician Decision|0
7524860|NCT02564055|11865369|FG002|Overall Study|Physician Decision|1
7524861|NCT02564055|11865370|FG003|Overall Study|Physician Decision|0
7524862|NCT02564055|11865371|FG004|Overall Study|Physician Decision|0
7524863|NCT02564055|11865372|FG005|Overall Study|Physician Decision|0
7524864|NCT02564055|11865367|FG000|Overall Study|Withdrawal by Subject|4
7524865|NCT02564055|11865368|FG001|Overall Study|Withdrawal by Subject|4
7524866|NCT02564055|11865369|FG002|Overall Study|Withdrawal by Subject|3
7524867|NCT02564055|11865370|FG003|Overall Study|Withdrawal by Subject|3
7524868|NCT02564055|11865371|FG004|Overall Study|Withdrawal by Subject|10
7524869|NCT02564055|11865372|FG005|Overall Study|Withdrawal by Subject|10
7524870|NCT02564120|11865391|FG000|Overall Study|Did not return release forms|160
7524871|NCT02564120|11865391|FG000|Overall Study|Death|58
7524872|NCT02564120|11865391|FG000|Overall Study|Withdrawal by Subject|204
7524873|NCT02564120|11865391|FG000|Overall Study|Other medical condition|24
7524874|NCT02564198|11865408|FG000|Overall Study|Withdrawal by Subject|2
7524875|NCT02564198|11865409|FG001|Overall Study|Withdrawal by Subject|4
7524876|NCT02564198|11865410|FG002|Overall Study|Withdrawal by Subject|0
7524877|NCT02564198|11865408|FG000|Overall Study|Adverse Event|0
7524878|NCT02564198|11865409|FG001|Overall Study|Adverse Event|1
7524879|NCT02564198|11865410|FG002|Overall Study|Adverse Event|0
7524880|NCT02564211|11865420|FG000|Overall Study|Adverse Event|4
7524881|NCT02564471|11865443|FG000|Overall Study|Adverse Event|1
7524882|NCT02564471|11865444|FG001|Overall Study|Adverse Event|0
7524883|NCT02564471|11865445|FG002|Overall Study|Adverse Event|0
7524884|NCT02564471|11865446|FG003|Overall Study|Adverse Event|0
7524885|NCT02564471|11865443|FG000|Overall Study|Withdrawal by Subject|2
7524886|NCT02564471|11865444|FG001|Overall Study|Withdrawal by Subject|1
7524887|NCT02564471|11865445|FG002|Overall Study|Withdrawal by Subject|3
7524888|NCT02564471|11865446|FG003|Overall Study|Withdrawal by Subject|0
7524889|NCT02564471|11865443|FG000|Overall Study|Lost to Follow-up|0
7524890|NCT02564471|11865444|FG001|Overall Study|Lost to Follow-up|2
7524891|NCT02564471|11865445|FG002|Overall Study|Lost to Follow-up|0
7524892|NCT02564471|11865446|FG003|Overall Study|Lost to Follow-up|0
7524893|NCT02564718|11865467|FG000|Overall Study|Withdrew from treatment|0
7524894|NCT02564718|11865468|FG001|Overall Study|Withdrew from treatment|1
7524895|NCT02564887|11865476|FG000|Overall Study|Lost to Follow-up|6
7524896|NCT02564887|11865477|FG001|Overall Study|Lost to Follow-up|0
7524907|NCT02565147|11865509|FG000|Overall Study|Withdrawal by Subject|5
7524908|NCT02565147|11865510|FG001|Overall Study|Withdrawal by Subject|1
7524909|NCT02565147|11865509|FG000|Overall Study|Lost to Follow-up|0
7524910|NCT02565147|11865510|FG001|Overall Study|Lost to Follow-up|1
7524911|NCT02565147|11865509|FG000|Overall Study|Death|1
7524912|NCT02565147|11865510|FG001|Overall Study|Death|1
7524913|NCT02565186|11865518|FG000|Overall Study|Adverse Event|113
7524914|NCT02565186|11865519|FG001|Overall Study|Adverse Event|148
7524915|NCT02565186|11865518|FG000|Overall Study|Lost to Follow-up|102
7524916|NCT02565186|11865519|FG001|Overall Study|Lost to Follow-up|93
7524917|NCT02565186|11865518|FG000|Overall Study|Non-Compliance|57
7524918|NCT02565186|11865519|FG001|Overall Study|Non-Compliance|55
7524919|NCT02565186|11865518|FG000|Overall Study|Withdrawal by Subject|229
7524920|NCT02565186|11865519|FG001|Overall Study|Withdrawal by Subject|214
7524921|NCT02565186|11865518|FG000|Overall Study|Physician Decision|18
7524922|NCT02565186|11865519|FG001|Overall Study|Physician Decision|16
7524923|NCT02565186|11865518|FG000|Overall Study|Sponsor Request|5
7524924|NCT02565186|11865519|FG001|Overall Study|Sponsor Request|9
7524925|NCT02565186|11865518|FG000|Overall Study|Missing|1
7524926|NCT02565186|11865519|FG001|Overall Study|Missing|0
7524927|NCT02565186|11865518|FG000|Overall Study|Did Not Receive Study Drug|55
7524928|NCT02565186|11865519|FG001|Overall Study|Did Not Receive Study Drug|86
7524929|NCT02565381|11865528|FG000|Overall Study|Lost to Follow-up|1
7524930|NCT02565381|11865529|FG001|Overall Study|Lost to Follow-up|0
7524931|NCT02565381|11865530|FG002|Overall Study|Lost to Follow-up|1
7524932|NCT02565511|11865551|FG000|Overall Study|Study terminated by Sponsor|35
7524933|NCT02565511|11865552|FG001|Overall Study|Study terminated by Sponsor|22
7524934|NCT02565511|11865553|FG002|Overall Study|Study terminated by Sponsor|235
7524935|NCT02565511|11865554|FG003|Overall Study|Study terminated by Sponsor|156
7524936|NCT02565511|11865551|FG000|Overall Study|Withdrawal by Subject|3
7524937|NCT02565511|11865552|FG001|Overall Study|Withdrawal by Subject|0
7524938|NCT02565511|11865553|FG002|Overall Study|Withdrawal by Subject|12
7524939|NCT02565511|11865554|FG003|Overall Study|Withdrawal by Subject|5
7524940|NCT02565511|11865551|FG000|Overall Study|Adverse Event|0
7524941|NCT02565511|11865552|FG001|Overall Study|Adverse Event|0
7524942|NCT02565511|11865553|FG002|Overall Study|Adverse Event|1
7524943|NCT02565511|11865554|FG003|Overall Study|Adverse Event|1
7524944|NCT02565511|11865551|FG000|Overall Study|Lost to Follow-up|4
7524945|NCT02565511|11865552|FG001|Overall Study|Lost to Follow-up|1
7524946|NCT02565511|11865553|FG002|Overall Study|Lost to Follow-up|0
7524947|NCT02565511|11865554|FG003|Overall Study|Lost to Follow-up|1
7524948|NCT02565511|11865551|FG000|Overall Study|Physician Decision|0
7524949|NCT02565511|11865552|FG001|Overall Study|Physician Decision|0
7524950|NCT02565511|11865553|FG002|Overall Study|Physician Decision|0
7524951|NCT02565511|11865554|FG003|Overall Study|Physician Decision|1
7524952|NCT02565511|11865551|FG000|Overall Study|Protocol deviation|0
7524953|NCT02565511|11865552|FG001|Overall Study|Protocol deviation|0
7524954|NCT02565511|11865553|FG002|Overall Study|Protocol deviation|3
7524955|NCT02565511|11865554|FG003|Overall Study|Protocol deviation|0
7524956|NCT02565576|11865566|FG000|Overall Study|abnormal lab value|2
7524957|NCT02565576|11865567|FG001|Overall Study|abnormal lab value|0
7524958|NCT02565576|11865566|FG000|Overall Study|subject / guardian decision|1
7524959|NCT02565576|11865567|FG001|Overall Study|subject / guardian decision|3
7524960|NCT02565576|11865566|FG000|Overall Study|Lost to Follow-up|1
7524961|NCT02565576|11865567|FG001|Overall Study|Lost to Follow-up|0
7524962|NCT02565576|11865566|FG000|Overall Study|Death|0
7524963|NCT02565576|11865567|FG001|Overall Study|Death|2
7524964|NCT02565576|11865566|FG000|Overall Study|Adverse Event|1
7524965|NCT02565576|11865567|FG001|Overall Study|Adverse Event|0
7524966|NCT02565615|11865578|FG000|Overall Study|Death|0
7524967|NCT02565615|11865579|FG001|Overall Study|Death|1
7524968|NCT02565615|11865580|FG002|Overall Study|Death|0
7524969|NCT02565615|11865581|FG003|Overall Study|Death|0
7524970|NCT02565615|11865582|FG004|Overall Study|Death|4
7524971|NCT02565615|11865578|FG000|Overall Study|Not willing to participate in study|2
7524972|NCT02565615|11865579|FG001|Overall Study|Not willing to participate in study|21
7524973|NCT02565615|11865580|FG002|Overall Study|Not willing to participate in study|0
7524974|NCT02565615|11865581|FG003|Overall Study|Not willing to participate in study|1
7524975|NCT02565615|11865582|FG004|Overall Study|Not willing to participate in study|169
7524976|NCT02565615|11865578|FG000|Overall Study|Lost to Follow-up|0
7524977|NCT02565615|11865579|FG001|Overall Study|Lost to Follow-up|4
7524978|NCT02565615|11865580|FG002|Overall Study|Lost to Follow-up|0
7524979|NCT02565615|11865581|FG003|Overall Study|Lost to Follow-up|1
7524980|NCT02565615|11865582|FG004|Overall Study|Lost to Follow-up|765
7524981|NCT02565615|11865578|FG000|Overall Study|Not meeting eligibility criteria|0
7524982|NCT02565615|11865579|FG001|Overall Study|Not meeting eligibility criteria|7
7524983|NCT02565615|11865580|FG002|Overall Study|Not meeting eligibility criteria|0
7524984|NCT02565615|11865581|FG003|Overall Study|Not meeting eligibility criteria|0
7524985|NCT02565615|11865582|FG004|Overall Study|Not meeting eligibility criteria|25
7524986|NCT02565615|11865578|FG000|Overall Study|Reason not defined|0
7524987|NCT02565615|11865579|FG001|Overall Study|Reason not defined|2
7524988|NCT02565615|11865580|FG002|Overall Study|Reason not defined|0
7524989|NCT02565615|11865581|FG003|Overall Study|Reason not defined|1
7524990|NCT02565615|11865582|FG004|Overall Study|Reason not defined|62
7524991|NCT02565615|11865578|FG000|Overall Study|Adverse Event|1
7524992|NCT02565615|11865579|FG001|Overall Study|Adverse Event|1
7524993|NCT02565615|11865580|FG002|Overall Study|Adverse Event|0
7524994|NCT02565615|11865581|FG003|Overall Study|Adverse Event|0
7524995|NCT02565615|11865582|FG004|Overall Study|Adverse Event|9
7524996|NCT02565615|11865578|FG000|Overall Study|Untreated|0
7524997|NCT02565615|11865579|FG001|Overall Study|Untreated|0
7524998|NCT02565615|11865580|FG002|Overall Study|Untreated|0
7524999|NCT02565615|11865581|FG003|Overall Study|Untreated|0
7525000|NCT02565615|11865582|FG004|Overall Study|Untreated|567
7525001|NCT02565706|11865607|FG000|Overall Study|Withdrawal by Subject|5
7525002|NCT02565706|11865608|FG001|Overall Study|Withdrawal by Subject|7
7525003|NCT02565706|11865609|FG002|Overall Study|Withdrawal by Subject|7
7525004|NCT02565706|11865610|FG003|Overall Study|Withdrawal by Subject|11
7525005|NCT02565706|11865607|FG000|Overall Study|Lost to Follow-up|72
7525006|NCT02565706|11865608|FG001|Overall Study|Lost to Follow-up|75
7525007|NCT02565706|11865609|FG002|Overall Study|Lost to Follow-up|82
7525008|NCT02565706|11865610|FG003|Overall Study|Lost to Follow-up|74
7525012|NCT02565810|11865633|FG000|Overall Study|Withdrawal by Subject|1
7525013|NCT02566005|11865658|FG000|Overall Study|vaginal bleeding|0
7525014|NCT02566005|11865659|FG001|Overall Study|vaginal bleeding|1
7525015|NCT02566005|11865658|FG000|Overall Study|received foley|8
7525016|NCT02566005|11865659|FG001|Overall Study|received foley|0
7525017|NCT02566005|11865658|FG000|Overall Study|did not receive foley|0
7525018|NCT02566005|11865659|FG001|Overall Study|did not receive foley|1
7525019|NCT02566005|11865658|FG000|Overall Study|labor after randomization|0
7525020|NCT02566005|11865659|FG001|Overall Study|labor after randomization|4
7525021|NCT02566031|11865667|FG000|Overall Study|Patient/guardian decision|14
7525022|NCT02566031|11865668|FG001|Overall Study|Patient/guardian decision|7
7525023|NCT02566031|11865667|FG000|Overall Study|Protocol deviation|2
7525024|NCT02566031|11865668|FG001|Overall Study|Protocol deviation|3
7525025|NCT02566031|11865667|FG000|Overall Study|Adverse Event|3
7525026|NCT02566031|11865668|FG001|Overall Study|Adverse Event|1
7525027|NCT02566031|11865667|FG000|Overall Study|Lost to Follow-up|1
7525028|NCT02566031|11865668|FG001|Overall Study|Lost to Follow-up|1
7525029|NCT02566109|11865702|FG000|Overall Study|Withdrawal by Subject|1
7525030|NCT02566525|11865753|FG000|Overall Study|Protocol Violation|3
7525031|NCT02566525|11865754|FG001|Overall Study|Protocol Violation|5
7525032|NCT02566577|11865764|FG000|Overall Study|Withdrawal by Subject|1
7525033|NCT02566577|11865765|FG001|Overall Study|Withdrawal by Subject|1
7525034|NCT02566577|11865764|FG000|Overall Study|Equipment failure|1
7525035|NCT02566577|11865765|FG001|Overall Study|Equipment failure|1
7525036|NCT02566577|11865764|FG000|Overall Study|Physical limitation|1
7525037|NCT02566577|11865765|FG001|Overall Study|Physical limitation|0
7525038|NCT02566759|11865799|FG000|All Parts|Withdrawal by Subject|0
7525039|NCT02566759|11865800|FG001|All Parts|Withdrawal by Subject|1
7525040|NCT02566759|11865801|FG002|All Parts|Withdrawal by Subject|0
7525041|NCT02566759|11865802|FG003|All Parts|Withdrawal by Subject|0
7525042|NCT02566759|11865803|FG004|All Parts|Withdrawal by Subject|0
7525043|NCT02566759|11865804|FG005|All Parts|Withdrawal by Subject|0
7525044|NCT02566759|11865805|FG006|All Parts|Withdrawal by Subject|0
7525045|NCT02566759|11865806|FG007|All Parts|Withdrawal by Subject|0
7525046|NCT02566759|11865807|FG008|All Parts|Withdrawal by Subject|0
7525047|NCT02566759|11865808|FG009|All Parts|Withdrawal by Subject|0
7525048|NCT02566759|11865809|FG010|All Parts|Withdrawal by Subject|0
7525049|NCT02566759|11865810|FG011|All Parts|Withdrawal by Subject|0
7525050|NCT02566759|11865811|FG012|All Parts|Withdrawal by Subject|0
7525051|NCT02566759|11865812|FG013|All Parts|Withdrawal by Subject|0
7525052|NCT02566759|11865813|FG014|All Parts|Withdrawal by Subject|0
7525053|NCT02566759|11865814|FG015|All Parts|Withdrawal by Subject|0
7525054|NCT02566759|11865815|FG016|All Parts|Withdrawal by Subject|0
7525055|NCT02566759|11865799|FG000|All Parts|Adverse Event|0
7525056|NCT02566759|11865800|FG001|All Parts|Adverse Event|0
7525057|NCT02566759|11865801|FG002|All Parts|Adverse Event|0
7525058|NCT02566759|11865802|FG003|All Parts|Adverse Event|0
7525059|NCT02566759|11865803|FG004|All Parts|Adverse Event|0
7525060|NCT02566759|11865804|FG005|All Parts|Adverse Event|0
7525061|NCT02566759|11865805|FG006|All Parts|Adverse Event|0
7525062|NCT02566759|11865806|FG007|All Parts|Adverse Event|0
7525063|NCT02566759|11865807|FG008|All Parts|Adverse Event|0
7525064|NCT02566759|11865808|FG009|All Parts|Adverse Event|0
7525065|NCT02566759|11865809|FG010|All Parts|Adverse Event|0
7525066|NCT02566759|11865810|FG011|All Parts|Adverse Event|0
7525067|NCT02566759|11865811|FG012|All Parts|Adverse Event|1
7525068|NCT02566759|11865812|FG013|All Parts|Adverse Event|3
7525069|NCT02566759|11865813|FG014|All Parts|Adverse Event|0
7525070|NCT02566759|11865814|FG015|All Parts|Adverse Event|0
7525071|NCT02566759|11865815|FG016|All Parts|Adverse Event|0
7525072|NCT02566759|11865799|FG000|All Parts|Other|0
7525073|NCT02566759|11865800|FG001|All Parts|Other|0
7525074|NCT02566759|11865801|FG002|All Parts|Other|0
7525075|NCT02566759|11865802|FG003|All Parts|Other|0
7525076|NCT02566759|11865803|FG004|All Parts|Other|0
7525077|NCT02566759|11865804|FG005|All Parts|Other|0
7525078|NCT02566759|11865805|FG006|All Parts|Other|0
7525079|NCT02566759|11865806|FG007|All Parts|Other|0
7525080|NCT02566759|11865807|FG008|All Parts|Other|0
7525081|NCT02566759|11865808|FG009|All Parts|Other|0
7525082|NCT02566759|11865809|FG010|All Parts|Other|0
7525083|NCT02566759|11865810|FG011|All Parts|Other|0
7525084|NCT02566759|11865811|FG012|All Parts|Other|0
7525085|NCT02566759|11865812|FG013|All Parts|Other|2
7525086|NCT02566759|11865813|FG014|All Parts|Other|0
7525087|NCT02566759|11865814|FG015|All Parts|Other|0
7525088|NCT02566759|11865815|FG016|All Parts|Other|0
7525089|NCT02566759|11865799|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525090|NCT02566759|11865800|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525091|NCT02566759|11865801|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525092|NCT02566759|11865802|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525093|NCT02566759|11865803|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525094|NCT02566759|11865804|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525095|NCT02566759|11865805|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525096|NCT02566759|11865806|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525097|NCT02566759|11865807|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525098|NCT02566759|11865808|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525099|NCT02566759|11865809|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525100|NCT02566759|11865810|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525101|NCT02566759|11865811|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525102|NCT02566759|11865812|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525103|NCT02566759|11865813|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525104|NCT02566759|11865814|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
7525105|NCT02566759|11865815|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
7525106|NCT02566785|11865876|FG000|Overall Study|Lost to Follow-up|0
7525107|NCT02566785|11865877|FG001|Overall Study|Lost to Follow-up|2
7525108|NCT02566785|11865876|FG000|Overall Study|Worsening condition|1
7525109|NCT02566785|11865877|FG001|Overall Study|Worsening condition|1
7525110|NCT02566889|11865885|FG000|Overall Study|Withdrawal by Subject|3
7525111|NCT02566889|11865886|FG001|Overall Study|Withdrawal by Subject|1
7525112|NCT02566889|11865885|FG000|Overall Study|Adverse Event|4
7525113|NCT02566889|11865886|FG001|Overall Study|Adverse Event|2
7525114|NCT02566889|11865885|FG000|Overall Study|Other|6
7525115|NCT02566889|11865886|FG001|Overall Study|Other|2
7525116|NCT02566902|11865893|FG000|Overall Study|Protocol Violation|2
7525117|NCT02566902|11865894|FG001|Overall Study|Protocol Violation|1
7525118|NCT02566993|11865902|FG000|Overall Study|Randomized but not treated|5
7525119|NCT02566993|11865903|FG001|Overall Study|Randomized but not treated|16
7525120|NCT02566993|11865902|FG000|Overall Study|Progressive disease|213
7525121|NCT02566993|11865903|FG001|Overall Study|Progressive disease|152
7525122|NCT02566993|11865902|FG000|Overall Study|Withdrawal by Subject|12
7525123|NCT02566993|11865903|FG001|Overall Study|Withdrawal by Subject|28
7525124|NCT02566993|11865902|FG000|Overall Study|Death|17
7525125|NCT02566993|11865903|FG001|Overall Study|Death|23
7525126|NCT02566993|11865902|FG000|Overall Study|Physician Decision|10
7525127|NCT02566993|11865903|FG001|Overall Study|Physician Decision|17
7525128|NCT02566993|11865902|FG000|Overall Study|Study drug-related adverse event|20
7525129|NCT02566993|11865903|FG001|Overall Study|Study drug-related adverse event|41
7525130|NCT02566993|11865902|FG000|Overall Study|Non study drug-related adverse event|9
7525131|NCT02566993|11865903|FG001|Overall Study|Non study drug-related adverse event|9
7525132|NCT02566993|11865902|FG000|Overall Study|Symptomatic deterioration|9
7525133|NCT02566993|11865903|FG001|Overall Study|Symptomatic deterioration|16
7525134|NCT02566993|11865902|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
7525135|NCT02566993|11865903|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
7525136|NCT02566993|11865902|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
7525137|NCT02566993|11865903|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
7525138|NCT02566993|11865902|FG000|Overall Study|Screening failure|2
7525139|NCT02566993|11865903|FG001|Overall Study|Screening failure|0
7525140|NCT02566993|11865902|FG000|Overall Study|Lost to Follow-up|0
7525141|NCT02566993|11865903|FG001|Overall Study|Lost to Follow-up|1
7525142|NCT02566993|11865902|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
7525143|NCT02566993|11865903|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
7525144|NCT02567188|11865911|FG000|Overall Study|Death|10
7525145|NCT02567188|11865911|FG000|Overall Study|Terminated Mircera Treatment|9
7525146|NCT02567188|11865911|FG000|Overall Study|Lost to Follow-up|5
7525147|NCT02567188|11865911|FG000|Overall Study|Adverse Event|1
7525148|NCT02567188|11865911|FG000|Overall Study|Withdrawal by Subject|1
7525149|NCT02567188|11865911|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
7525150|NCT02567188|11865911|FG000|Overall Study|Moved and Changed Clinic|1
7525151|NCT02567188|11865911|FG000|Overall Study|Started Hemodialysis|2
7525152|NCT02567188|11865911|FG000|Overall Study|Protocol Violation|5
7525153|NCT02567227|11865918|FG000|9 Weeks|Adverse Event|5
7525154|NCT02567227|11865919|FG001|9 Weeks|Adverse Event|5
7525155|NCT02567227|11865918|FG000|9 Weeks|Withdrawal by Subject|18
7525156|NCT02567227|11865919|FG001|9 Weeks|Withdrawal by Subject|8
7525157|NCT02567227|11865918|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
7525158|NCT02567227|11865919|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
7525159|NCT02567227|11865918|FG000|6 Month|Death|2
7525160|NCT02567227|11865919|FG001|6 Month|Death|0
7525161|NCT02567227|11865918|FG000|6 Month|Lost to Follow-up|43
7525162|NCT02567227|11865919|FG001|6 Month|Lost to Follow-up|40
7525163|NCT02567227|11865918|FG000|12 Months|Lost to Follow-up|31
7525164|NCT02567227|11865919|FG001|12 Months|Lost to Follow-up|32
7525165|NCT02567227|11865918|FG000|12 Months|Death|0
7525166|NCT02567227|11865919|FG001|12 Months|Death|2
7525167|NCT02567266|11865928|FG000|Overall Study|Withdrawal by Subject|10
7525168|NCT02567266|11865929|FG001|Overall Study|Withdrawal by Subject|7
7525169|NCT02567266|11865930|FG002|Overall Study|Withdrawal by Subject|6
7525170|NCT02567266|11865928|FG000|Overall Study|Lost to Follow-up|13
7525171|NCT02567266|11865929|FG001|Overall Study|Lost to Follow-up|8
7525172|NCT02567266|11865930|FG002|Overall Study|Lost to Follow-up|10
7525173|NCT02567552|11865940|FG000|Overall Study|Adverse Event|0
7525174|NCT02567552|11865941|FG001|Overall Study|Adverse Event|1
7525175|NCT02567656|11865953|FG000|Overall Study|Premature discontinuation due to PD|1
7525176|NCT02567656|11865954|FG001|Overall Study|Premature discontinuation due to PD|1
7525177|NCT02567656|11865955|FG002|Overall Study|Premature discontinuation due to PD|2
7525178|NCT02567656|11865956|FG003|Overall Study|Premature discontinuation due to PD|0
7525179|NCT02567656|11865957|FG004|Overall Study|Premature discontinuation due to PD|0
7525180|NCT02567656|11865958|FG005|Overall Study|Premature discontinuation due to PD|0
7525181|NCT02567708|11865972|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7525182|NCT02567708|11865973|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
7525183|NCT02567708|11865972|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
7525184|NCT02567708|11865973|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
7525185|NCT02567708|11865972|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
7525186|NCT02567708|11865973|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7525187|NCT02567708|11865972|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
7525188|NCT02567708|11865973|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
7525189|NCT02568046|11865989|FG000|Overall Study|Adverse Event|0
7525190|NCT02568046|11865990|FG001|Overall Study|Adverse Event|1
7525191|NCT02568046|11865989|FG000|Overall Study|Death|2
7525192|NCT02568046|11865990|FG001|Overall Study|Death|0
7525193|NCT02568046|11865989|FG000|Overall Study|Progressive Disease|1
7525194|NCT02568046|11865990|FG001|Overall Study|Progressive Disease|0
7525195|NCT02568046|11865989|FG000|Overall Study|Withdrawal by Subject|2
7525196|NCT02568046|11865990|FG001|Overall Study|Withdrawal by Subject|1
7525197|NCT02568046|11865989|FG000|Overall Study|Other Events|0
7525198|NCT02568046|11865990|FG001|Overall Study|Other Events|1
7525199|NCT02568072|11865996|FG000|Overall Study|Unavailable for appointment|23
7525200|NCT02568072|11865996|FG000|Overall Study|Unable to contact|3
7525201|NCT02568072|11865996|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
7525202|NCT02568072|11865996|FG000|Overall Study|Withdrawal by Subject|1
7525203|NCT02568072|11865996|FG000|Overall Study|Sustained injury, marathon not run|24
7525204|NCT02568254|11866001|FG000|Period 2|Adverse Event|0
7525205|NCT02568254|11866002|FG001|Period 2|Adverse Event|0
7525206|NCT02568254|11866003|FG002|Period 2|Adverse Event|1
7525207|NCT02568254|11866004|FG003|Period 2|Adverse Event|0
7525208|NCT02568254|11866005|FG004|Period 2|Adverse Event|0
7525209|NCT02568254|11866006|FG005|Period 2|Adverse Event|0
7525210|NCT02568254|11866001|FG000|Period 3|Unstatisfactory Lens fitting|0
7525211|NCT02568254|11866002|FG001|Period 3|Unstatisfactory Lens fitting|0
7525212|NCT02568254|11866003|FG002|Period 3|Unstatisfactory Lens fitting|0
7525213|NCT02568254|11866004|FG003|Period 3|Unstatisfactory Lens fitting|0
7525214|NCT02568254|11866005|FG004|Period 3|Unstatisfactory Lens fitting|1
7525215|NCT02568254|11866006|FG005|Period 3|Unstatisfactory Lens fitting|0
7525216|NCT02568384|11866018|FG000|Overall Study|Mobile devices incompatible with App|2
7525217|NCT02568397|11866022|FG000|Period 2|Withdrawal by Subject|0
7525218|NCT02568397|11866023|FG001|Period 2|Withdrawal by Subject|1
7525219|NCT02568397|11866022|FG000|Period 2|Physician Decision|0
7525220|NCT02568397|11866023|FG001|Period 2|Physician Decision|1
7525221|NCT02568475|11866040|FG000|Overall Study|Lost to Follow-up|40
7525222|NCT02568475|11866041|FG001|Overall Study|Lost to Follow-up|39
7525223|NCT02568475|11866040|FG000|Overall Study|Withdrawal by Subject|2
7525224|NCT02568475|11866041|FG001|Overall Study|Withdrawal by Subject|0
7525225|NCT02568475|11866040|FG000|Overall Study|Discharged home|4
7525226|NCT02568475|11866041|FG001|Overall Study|Discharged home|4
7525227|NCT02568475|11866040|FG000|Overall Study|Short-term: Discharge location unknown|4
7525228|NCT02568475|11866041|FG001|Overall Study|Short-term: Discharge location unknown|0
7525229|NCT02568475|11866040|FG000|Overall Study|Transferred to another facility|1
7525230|NCT02568475|11866041|FG001|Overall Study|Transferred to another facility|0
7525231|NCT02568683|11866060|FG000|Overall Study|Death|0
7525232|NCT02568683|11866061|FG001|Overall Study|Death|2
7525233|NCT02568683|11866060|FG000|Overall Study|Withdrew Consent|1
7525234|NCT02568683|11866061|FG001|Overall Study|Withdrew Consent|0
7525235|NCT02568683|11866060|FG000|Overall Study|Study Terminated By Sponsor|5
7525236|NCT02568683|11866061|FG001|Overall Study|Study Terminated By Sponsor|2
7525237|NCT02569398|11866089|FG000|Overall Study|Adverse Event|0
7525238|NCT02569398|11866090|FG001|Overall Study|Adverse Event|1
7525239|NCT02569398|11866091|FG002|Overall Study|Adverse Event|6
7525240|NCT02569398|11866089|FG000|Overall Study|Withdrawal by Subject|43
7525241|NCT02569398|11866090|FG001|Overall Study|Withdrawal by Subject|43
7525242|NCT02569398|11866091|FG002|Overall Study|Withdrawal by Subject|30
7525243|NCT02569398|11866089|FG000|Overall Study|Study terminated by sponsor|130
7525244|NCT02569398|11866090|FG001|Overall Study|Study terminated by sponsor|131
7525245|NCT02569398|11866091|FG002|Overall Study|Study terminated by sponsor|134
7525246|NCT02569398|11866089|FG000|Overall Study|Other|12
7525247|NCT02569398|11866090|FG001|Overall Study|Other|14
7525248|NCT02569398|11866091|FG002|Overall Study|Other|13
7525249|NCT02569437|11866110|FG000|Overall Study|Lost to Follow-up|12
7525250|NCT02569437|11866111|FG001|Overall Study|Lost to Follow-up|14
7525251|NCT02569710|11866144|FG000|Overall Study|Adverse Event|1
7525252|NCT02569710|11866145|FG001|Overall Study|Adverse Event|0
7525253|NCT02569710|11866146|FG002|Overall Study|Adverse Event|0
7525254|NCT02569710|11866147|FG003|Overall Study|Adverse Event|0
7525255|NCT02569710|11866148|FG004|Overall Study|Adverse Event|0
7525256|NCT02569710|11866149|FG005|Overall Study|Adverse Event|0
7525257|NCT02569710|11866150|FG006|Overall Study|Adverse Event|0
7525258|NCT02569710|11866151|FG007|Overall Study|Adverse Event|0
7525259|NCT02569710|11866152|FG008|Overall Study|Adverse Event|0
7525260|NCT02569710|11866153|FG009|Overall Study|Adverse Event|0
7525261|NCT02569710|11866144|FG000|Overall Study|Lost to Follow-up|0
7525262|NCT02569710|11866145|FG001|Overall Study|Lost to Follow-up|0
7525263|NCT02569710|11866146|FG002|Overall Study|Lost to Follow-up|0
7525264|NCT02569710|11866147|FG003|Overall Study|Lost to Follow-up|0
7525265|NCT02569710|11866148|FG004|Overall Study|Lost to Follow-up|0
7525266|NCT02569710|11866149|FG005|Overall Study|Lost to Follow-up|0
7525267|NCT02569710|11866150|FG006|Overall Study|Lost to Follow-up|1
7525268|NCT02569710|11866151|FG007|Overall Study|Lost to Follow-up|0
7525269|NCT02569710|11866152|FG008|Overall Study|Lost to Follow-up|1
7525270|NCT02569710|11866153|FG009|Overall Study|Lost to Follow-up|0
7525271|NCT02569710|11866144|FG000|Overall Study|Virologic failure|0
7525272|NCT02569710|11866145|FG001|Overall Study|Virologic failure|0
7525273|NCT02569710|11866146|FG002|Overall Study|Virologic failure|0
7525274|NCT02569710|11866147|FG003|Overall Study|Virologic failure|0
7525275|NCT02569710|11866148|FG004|Overall Study|Virologic failure|1
7525276|NCT02569710|11866149|FG005|Overall Study|Virologic failure|0
7525277|NCT02569710|11866150|FG006|Overall Study|Virologic failure|1
7525278|NCT02569710|11866151|FG007|Overall Study|Virologic failure|0
7525279|NCT02569710|11866152|FG008|Overall Study|Virologic failure|0
7525280|NCT02569710|11866153|FG009|Overall Study|Virologic failure|0
7525281|NCT02569710|11866144|FG000|Overall Study|Withdrawal by Subject|0
7525282|NCT02569710|11866145|FG001|Overall Study|Withdrawal by Subject|0
7525283|NCT02569710|11866146|FG002|Overall Study|Withdrawal by Subject|0
7525284|NCT02569710|11866147|FG003|Overall Study|Withdrawal by Subject|0
7525285|NCT02569710|11866148|FG004|Overall Study|Withdrawal by Subject|0
7525286|NCT02569710|11866149|FG005|Overall Study|Withdrawal by Subject|1
7525287|NCT02569710|11866150|FG006|Overall Study|Withdrawal by Subject|0
7525288|NCT02569710|11866151|FG007|Overall Study|Withdrawal by Subject|0
7525289|NCT02569710|11866152|FG008|Overall Study|Withdrawal by Subject|0
7525290|NCT02569710|11866153|FG009|Overall Study|Withdrawal by Subject|0
7537069|NCT02729909|11885397|FG001|Overall Study|Voluntary Withdrawal|0
7537094|NCT02730195|11885420|FG000|Overall Study|Withdrawal by Subject|1
7537095|NCT02730208|11885426|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7537096|NCT02730208|11885427|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7525346|NCT02570165|11866283|FG003|Overall Study|Lack of Efficacy|0
7537097|NCT02730351|11885450|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
7537098|NCT02730351|11885451|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
7537099|NCT02730351|11885450|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
7537100|NCT02730351|11885451|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
7537101|NCT02730351|11885450|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
7537102|NCT02730351|11885451|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
7537103|NCT02730351|11885450|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
7537104|NCT02730351|11885451|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
7537105|NCT02730351|11885450|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
7537106|NCT02730351|11885451|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
7537107|NCT02730377|11885459|FG000|Overall Study|Other|5
7537108|NCT02730377|11885460|FG001|Overall Study|Other|4
7537109|NCT02730377|11885459|FG000|Overall Study|Death|1
7537110|NCT02730377|11885460|FG001|Overall Study|Death|8
7537111|NCT02730377|11885459|FG000|Overall Study|Inadequate glycaemic control|368
7537112|NCT02730377|11885460|FG001|Overall Study|Inadequate glycaemic control|473
7537113|NCT02730377|11885459|FG000|Overall Study|Adverse Event|79
7537114|NCT02730377|11885460|FG001|Overall Study|Adverse Event|41
7537115|NCT02730377|11885459|FG000|Overall Study|Protocol Violation|23
7537116|NCT02730377|11885460|FG001|Overall Study|Protocol Violation|30
7537117|NCT02730377|11885459|FG000|Overall Study|Lack of Efficacy|4
7537118|NCT02730377|11885460|FG001|Overall Study|Lack of Efficacy|13
7537119|NCT02730377|11885459|FG000|Overall Study|Pregnancy|0
7537120|NCT02730377|11885460|FG001|Overall Study|Pregnancy|1
7537121|NCT02730377|11885459|FG000|Overall Study|Withdrawal by Subject|45
7537122|NCT02730377|11885460|FG001|Overall Study|Withdrawal by Subject|42
7537123|NCT02730377|11885459|FG000|Overall Study|Lost to Follow-up|25
7537124|NCT02730377|11885460|FG001|Overall Study|Lost to Follow-up|21
7537125|NCT02730455|11885474|FG000|Overall Study|Death|5
7537126|NCT02730455|11885475|FG001|Overall Study|Death|6
7525291|NCT02569801|11866192|FG000|Overall Study|Withdrawal by Subject|9
7525292|NCT02569801|11866193|FG001|Overall Study|Withdrawal by Subject|9
7525293|NCT02569801|11866192|FG000|Overall Study|Sponsor Decision|13
7525294|NCT02569801|11866193|FG001|Overall Study|Sponsor Decision|14
7525295|NCT02569801|11866192|FG000|Overall Study|Progressive Disease|2
7525296|NCT02569801|11866193|FG001|Overall Study|Progressive Disease|7
7525297|NCT02569801|11866192|FG000|Overall Study|Lost to Follow-up|0
7525298|NCT02569801|11866193|FG001|Overall Study|Lost to Follow-up|1
7525299|NCT02569801|11866192|FG000|Overall Study|Death|12
7525300|NCT02569801|11866193|FG001|Overall Study|Death|4
7525301|NCT02569853|11866201|FG000|Overall Study|Adverse Event|2
7525302|NCT02569853|11866202|FG001|Overall Study|Adverse Event|0
7525303|NCT02569853|11866201|FG000|Overall Study|Withdrawal by Subject|3
7525304|NCT02569853|11866202|FG001|Overall Study|Withdrawal by Subject|2
7525305|NCT02569853|11866201|FG000|Overall Study|Lost to Follow-up|3
7525306|NCT02569853|11866202|FG001|Overall Study|Lost to Follow-up|3
7525307|NCT02569853|11866201|FG000|Overall Study|Protocol Violation|1
7525308|NCT02569853|11866202|FG001|Overall Study|Protocol Violation|1
7525309|NCT02569853|11866201|FG000|Overall Study|Did not experience migraine attack|10
7525310|NCT02569853|11866202|FG001|Overall Study|Did not experience migraine attack|7
7525311|NCT02569853|11866201|FG000|Overall Study|Physician Decision|1
7525312|NCT02569853|11866202|FG001|Overall Study|Physician Decision|1
7525313|NCT02569996|11866217|FG000|Overall Study|Adverse Event|6
7525314|NCT02569996|11866217|FG000|Overall Study|Physician Decision|3
7525315|NCT02569996|11866217|FG000|Overall Study|Progression of the disease|18
7525316|NCT02569996|11866217|FG000|Overall Study|New anti-lymphoma treatment|1
7525317|NCT02569996|11866217|FG000|Overall Study|Non-compliance|9
7525318|NCT02569996|11866217|FG000|Overall Study|Withdrawal by Subject|5
7525319|NCT02569996|11866217|FG000|Overall Study|Lost to Follow-up|5
7525320|NCT02569996|11866217|FG000|Overall Study|Complete remission|7
7525321|NCT02569996|11866217|FG000|Overall Study|Unknown reason|1
7525322|NCT02570074|11866232|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
7525323|NCT02570074|11866233|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
7525324|NCT02570126|11866253|FG000|Overall Study|Lost to Follow-up|2
7525325|NCT02570126|11866254|FG001|Overall Study|Lost to Follow-up|0
7525326|NCT02570126|11866253|FG000|Overall Study|Unable To Arrange Visit 3|1
7525327|NCT02570126|11866254|FG001|Overall Study|Unable To Arrange Visit 3|0
7525328|NCT02570126|11866253|FG000|Overall Study|Violation Of Procedures GSK|0
7525329|NCT02570126|11866254|FG001|Overall Study|Violation Of Procedures GSK|1
7525330|NCT02570126|11866253|FG000|Overall Study|Protocol Violation|0
7525331|NCT02570126|11866254|FG001|Overall Study|Protocol Violation|1
7525332|NCT02570126|11866253|FG000|Overall Study|Withdrawal by Subject|3
7525333|NCT02570126|11866254|FG001|Overall Study|Withdrawal by Subject|7
7525334|NCT02570152|11866269|FG000|Overall Study|Protocol Violation|2
7525335|NCT02570152|11866269|FG000|Overall Study|Migrated/moved from study area|13
7525336|NCT02570165|11866280|FG000|Overall Study|Adverse Event|1
7525337|NCT02570165|11866281|FG001|Overall Study|Adverse Event|0
7525338|NCT02570165|11866282|FG002|Overall Study|Adverse Event|2
7525339|NCT02570165|11866283|FG003|Overall Study|Adverse Event|0
7525340|NCT02570165|11866284|FG004|Overall Study|Adverse Event|0
7525341|NCT02570165|11866285|FG005|Overall Study|Adverse Event|0
7525342|NCT02570165|11866286|FG006|Overall Study|Adverse Event|0
7525343|NCT02570165|11866280|FG000|Overall Study|Lack of Efficacy|0
7525344|NCT02570165|11866281|FG001|Overall Study|Lack of Efficacy|1
7525345|NCT02570165|11866282|FG002|Overall Study|Lack of Efficacy|0
7525347|NCT02570165|11866284|FG004|Overall Study|Lack of Efficacy|4
7525348|NCT02570165|11866285|FG005|Overall Study|Lack of Efficacy|0
7525349|NCT02570165|11866286|FG006|Overall Study|Lack of Efficacy|0
7525350|NCT02570165|11866280|FG000|Overall Study|Par. Reached Stopping Criteria|1
7525351|NCT02570165|11866281|FG001|Overall Study|Par. Reached Stopping Criteria|1
7525352|NCT02570165|11866282|FG002|Overall Study|Par. Reached Stopping Criteria|0
7525353|NCT02570165|11866283|FG003|Overall Study|Par. Reached Stopping Criteria|2
7525354|NCT02570165|11866284|FG004|Overall Study|Par. Reached Stopping Criteria|1
7525355|NCT02570165|11866285|FG005|Overall Study|Par. Reached Stopping Criteria|1
7525356|NCT02570165|11866286|FG006|Overall Study|Par. Reached Stopping Criteria|0
7525357|NCT02570165|11866280|FG000|Overall Study|Lost to Follow-up|0
7525358|NCT02570165|11866281|FG001|Overall Study|Lost to Follow-up|0
7525359|NCT02570165|11866282|FG002|Overall Study|Lost to Follow-up|1
7525360|NCT02570165|11866283|FG003|Overall Study|Lost to Follow-up|1
7525361|NCT02570165|11866284|FG004|Overall Study|Lost to Follow-up|0
7525362|NCT02570165|11866285|FG005|Overall Study|Lost to Follow-up|0
7525363|NCT02570165|11866286|FG006|Overall Study|Lost to Follow-up|0
7525364|NCT02570165|11866280|FG000|Overall Study|Physician Decision|0
7525365|NCT02570165|11866281|FG001|Overall Study|Physician Decision|1
7525366|NCT02570165|11866282|FG002|Overall Study|Physician Decision|0
7525367|NCT02570165|11866283|FG003|Overall Study|Physician Decision|0
7525368|NCT02570165|11866284|FG004|Overall Study|Physician Decision|0
7525369|NCT02570165|11866285|FG005|Overall Study|Physician Decision|0
7525370|NCT02570165|11866286|FG006|Overall Study|Physician Decision|0
7525371|NCT02570165|11866280|FG000|Overall Study|Withdrawal by Subject|0
7525372|NCT02570165|11866281|FG001|Overall Study|Withdrawal by Subject|0
7525373|NCT02570165|11866282|FG002|Overall Study|Withdrawal by Subject|0
7525374|NCT02570165|11866283|FG003|Overall Study|Withdrawal by Subject|2
7525375|NCT02570165|11866284|FG004|Overall Study|Withdrawal by Subject|1
7525376|NCT02570165|11866285|FG005|Overall Study|Withdrawal by Subject|0
7525377|NCT02570165|11866286|FG006|Overall Study|Withdrawal by Subject|0
7525378|NCT02570165|11866280|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
7525379|NCT02570165|11866281|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
7525380|NCT02570165|11866282|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
7525381|NCT02570165|11866283|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
7525382|NCT02570165|11866284|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
7525383|NCT02570165|11866285|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
7525384|NCT02570165|11866286|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
7525385|NCT02570165|11866280|FG000|Overall Study|Withdrawal Request by GSK|0
7525386|NCT02570165|11866281|FG001|Overall Study|Withdrawal Request by GSK|0
7525387|NCT02570165|11866282|FG002|Overall Study|Withdrawal Request by GSK|2
7525388|NCT02570165|11866283|FG003|Overall Study|Withdrawal Request by GSK|0
7525389|NCT02570165|11866284|FG004|Overall Study|Withdrawal Request by GSK|0
7525390|NCT02570165|11866285|FG005|Overall Study|Withdrawal Request by GSK|0
7525391|NCT02570165|11866286|FG006|Overall Study|Withdrawal Request by GSK|0
7525392|NCT02570711|11866325|FG000|Overall Study|Death|1
7525393|NCT02570711|11866326|FG001|Overall Study|Death|0
7525394|NCT02570711|11866325|FG000|Overall Study|Early Termination of Study by Sponsor|0
7525395|NCT02570711|11866326|FG001|Overall Study|Early Termination of Study by Sponsor|2
7525396|NCT02570750|11866334|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7525397|NCT02570750|11866335|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
7525398|NCT02570750|11866334|FG000|Overall Study|Protocol deviation|4
7525399|NCT02570750|11866335|FG001|Overall Study|Protocol deviation|2
7525400|NCT02570750|11866334|FG000|Overall Study|Withdrawal by Subject|5
7525401|NCT02570750|11866335|FG001|Overall Study|Withdrawal by Subject|0
7525402|NCT02570750|11866334|FG000|Overall Study|Lost to Follow-up|2
7525403|NCT02570750|11866335|FG001|Overall Study|Lost to Follow-up|2
7525404|NCT02570750|11866334|FG000|Overall Study|Adverse Event|2
7525405|NCT02570750|11866335|FG001|Overall Study|Adverse Event|1
7525406|NCT02571049|11866341|FG000|Screening|Did not meet entry criteria|2
7525407|NCT02571049|11866342|FG001|Screening|Did not meet entry criteria|2
7525408|NCT02571049|11866341|FG000|Randomization|No migraine attack|0
7525409|NCT02571049|11866342|FG001|Randomization|No migraine attack|1
7525410|NCT02571049|11866341|FG000|Randomization|Adverse Event|0
7525411|NCT02571049|11866342|FG001|Randomization|Adverse Event|1
7525412|NCT02571075|11866350|FG000|Overall Study|Lost to Follow-up|20
7525413|NCT02571075|11866351|FG001|Overall Study|Lost to Follow-up|24
7525414|NCT02571244|11866381|FG000|Overall Study|Lost to Follow-up|0
7525415|NCT02571244|11866382|FG001|Overall Study|Lost to Follow-up|1
7525416|NCT02571244|11866381|FG000|Overall Study|Unable to reach out post discharge|3
7525417|NCT02571244|11866382|FG001|Overall Study|Unable to reach out post discharge|0
7525418|NCT02571452|11866402|FG000|Overall Study Treatment|Protocol Violation|0
7525419|NCT02571452|11866403|FG001|Overall Study Treatment|Protocol Violation|1
7525420|NCT02571452|11866402|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
7525421|NCT02571452|11866403|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
7525422|NCT02571452|11866402|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
7525423|NCT02571452|11866403|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
7537127|NCT02730455|11885476|FG002|Overall Study|Death|4
7537128|NCT02730455|11885474|FG000|Overall Study|Consent withdrawn|2
7537129|NCT02730455|11885475|FG001|Overall Study|Consent withdrawn|4
7537130|NCT02730455|11885476|FG002|Overall Study|Consent withdrawn|1
7537131|NCT02730455|11885474|FG000|Overall Study|Lost to Follow-up|3
7537132|NCT02730455|11885475|FG001|Overall Study|Lost to Follow-up|1
7537133|NCT02730455|11885476|FG002|Overall Study|Lost to Follow-up|4
7537134|NCT02730455|11885474|FG000|Overall Study|Other|1
7537135|NCT02730455|11885475|FG001|Overall Study|Other|1
7537136|NCT02730455|11885476|FG002|Overall Study|Other|2
7537137|NCT02730455|11885474|FG000|Overall Study|Other|2
7537138|NCT02730455|11885475|FG001|Overall Study|Other|2
7537139|NCT02730455|11885476|FG002|Overall Study|Other|0
7537140|NCT02730598|11885486|FG000|Overall Study|Withdrawal by Subject|3
7537141|NCT02730598|11885487|FG001|Overall Study|Withdrawal by Subject|3
7537142|NCT02730598|11885486|FG000|Overall Study|Protocol Violation|0
7537143|NCT02730598|11885487|FG001|Overall Study|Protocol Violation|1
7537144|NCT02730598|11885486|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
7537145|NCT02730598|11885487|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
7537146|NCT02730728|11885500|FG000|Overall Study|Withdrawal by Subject|0
7537147|NCT02730728|11885501|FG001|Overall Study|Withdrawal by Subject|1
7537148|NCT02730728|11885502|FG002|Overall Study|Withdrawal by Subject|0
7537149|NCT02730728|11885500|FG000|Overall Study|Lack of Efficacy|0
7537150|NCT02730728|11885501|FG001|Overall Study|Lack of Efficacy|1
7537151|NCT02730728|11885502|FG002|Overall Study|Lack of Efficacy|1
7537152|NCT02730819|11885510|FG000|Overall Study|Lost to Follow-up|9
7537153|NCT02730871|11885516|FG000|Overall Study|Adverse Event|6
7537154|NCT02730871|11885517|FG001|Overall Study|Adverse Event|0
7537155|NCT02731131|11885547|FG000|Overall Study|Psychiatric Disorder|0
7537156|NCT02731131|11885548|FG001|Overall Study|Psychiatric Disorder|1
7537157|NCT02731131|11885547|FG000|Overall Study|Refused Therapy|0
7537158|NCT02731131|11885548|FG001|Overall Study|Refused Therapy|1
7537159|NCT02731157|11885554|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
7537160|NCT02731638|11885620|FG000|Overall Study|Lost to Follow-up|6
7525424|NCT02571777|11866419|FG000|Overall Study|Subject/guardian decision|34
7525425|NCT02571777|11866420|FG001|Overall Study|Subject/guardian decision|26
7525426|NCT02571777|11866421|FG002|Overall Study|Subject/guardian decision|26
7525427|NCT02571777|11866422|FG003|Overall Study|Subject/guardian decision|25
7525428|NCT02571777|11866423|FG004|Overall Study|Subject/guardian decision|27
7525429|NCT02571777|11866419|FG000|Overall Study|Protocol Deviation|2
7525430|NCT02571777|11866420|FG001|Overall Study|Protocol Deviation|3
7525431|NCT02571777|11866421|FG002|Overall Study|Protocol Deviation|4
7525432|NCT02571777|11866422|FG003|Overall Study|Protocol Deviation|8
7525433|NCT02571777|11866423|FG004|Overall Study|Protocol Deviation|4
7525434|NCT02571777|11866419|FG000|Overall Study|Death|1
7525435|NCT02571777|11866420|FG001|Overall Study|Death|1
7525436|NCT02571777|11866421|FG002|Overall Study|Death|4
7525437|NCT02571777|11866422|FG003|Overall Study|Death|0
7525438|NCT02571777|11866423|FG004|Overall Study|Death|0
7525439|NCT02571777|11866419|FG000|Overall Study|Lost to Follow-up|1
7525440|NCT02571777|11866420|FG001|Overall Study|Lost to Follow-up|1
7525441|NCT02571777|11866421|FG002|Overall Study|Lost to Follow-up|2
7525442|NCT02571777|11866422|FG003|Overall Study|Lost to Follow-up|0
7525443|NCT02571777|11866423|FG004|Overall Study|Lost to Follow-up|1
7525444|NCT02571777|11866419|FG000|Overall Study|Physician Decision|1
7525445|NCT02571777|11866420|FG001|Overall Study|Physician Decision|7
7525446|NCT02571777|11866421|FG002|Overall Study|Physician Decision|5
7525447|NCT02571777|11866422|FG003|Overall Study|Physician Decision|2
7525448|NCT02571777|11866423|FG004|Overall Study|Physician Decision|4
7525449|NCT02571777|11866419|FG000|Overall Study|Pregnancy|0
7525450|NCT02571777|11866420|FG001|Overall Study|Pregnancy|0
7525451|NCT02571777|11866421|FG002|Overall Study|Pregnancy|0
7525452|NCT02571777|11866422|FG003|Overall Study|Pregnancy|2
7525453|NCT02571777|11866423|FG004|Overall Study|Pregnancy|0
7525454|NCT02571972|11866435|FG000|Overall Study|Protocol Violation|2
7525455|NCT02571972|11866435|FG000|Overall Study|Withdrawal by Subject|2
7525456|NCT02572076|11866439|FG000|Overall Study|Protocol Violation|1
7525457|NCT02572167|11866446|FG000|Overall Study|In follow up|6
7525458|NCT02572167|11866447|FG001|Overall Study|In follow up|48
7525459|NCT02572167|11866448|FG002|Overall Study|In follow up|27
7525460|NCT02572167|11866446|FG000|Overall Study|Withdrawal by Subject|0
7525461|NCT02572167|11866447|FG001|Overall Study|Withdrawal by Subject|3
7525462|NCT02572167|11866448|FG002|Overall Study|Withdrawal by Subject|1
7525463|NCT02572167|11866446|FG000|Overall Study|Lost to Follow-up|0
7525464|NCT02572167|11866447|FG001|Overall Study|Lost to Follow-up|2
7525465|NCT02572167|11866448|FG002|Overall Study|Lost to Follow-up|1
7525466|NCT02572167|11866446|FG000|Overall Study|Death|0
7525467|NCT02572167|11866447|FG001|Overall Study|Death|3
7525468|NCT02572167|11866448|FG002|Overall Study|Death|1
7525469|NCT02572167|11866446|FG000|Overall Study|Did not meet inclusion criteria|0
7525470|NCT02572167|11866447|FG001|Overall Study|Did not meet inclusion criteria|0
7525471|NCT02572167|11866448|FG002|Overall Study|Did not meet inclusion criteria|1
7525472|NCT02572388|11866460|FG000|Overall Study|Withdrawal by Subject|1
7525473|NCT02572388|11866461|FG001|Overall Study|Withdrawal by Subject|1
7525474|NCT02572388|11866462|FG002|Overall Study|Withdrawal by Subject|2
7525475|NCT02572388|11866463|FG003|Overall Study|Withdrawal by Subject|2
7525476|NCT02572401|11866477|FG000|Overall Study|Lost to Follow-up|5
7525477|NCT02572401|11866478|FG001|Overall Study|Lost to Follow-up|8
7525478|NCT02572401|11866479|FG002|Overall Study|Lost to Follow-up|9
7525479|NCT02572401|11866480|FG003|Overall Study|Lost to Follow-up|9
7525480|NCT02572401|11866477|FG000|Overall Study|Death|0
7525481|NCT02572401|11866478|FG001|Overall Study|Death|0
7525482|NCT02572401|11866479|FG002|Overall Study|Death|0
7525483|NCT02572401|11866480|FG003|Overall Study|Death|1
7525484|NCT02572570|11866499|FG000|Overall Study|Study Terminated|27
7525485|NCT02572817|11866529|FG000|Overall Study|Death|6
7525486|NCT02572817|11866530|FG001|Overall Study|Death|3
7525487|NCT02572817|11866529|FG000|Overall Study|Lost to Follow-up|3
7525488|NCT02572817|11866530|FG001|Overall Study|Lost to Follow-up|3
7525489|NCT02573012|11866538|FG000|Overall Study|Adverse Event|5
7525490|NCT02573012|11866539|FG001|Overall Study|Adverse Event|5
7525491|NCT02573012|11866538|FG000|Overall Study|Lack of Efficacy|5
7525492|NCT02573012|11866539|FG001|Overall Study|Lack of Efficacy|4
7525493|NCT02573012|11866538|FG000|Overall Study|Non-compliance|1
7525494|NCT02573012|11866539|FG001|Overall Study|Non-compliance|2
7525495|NCT02573012|11866538|FG000|Overall Study|Withdrawal by Subject|2
7525496|NCT02573012|11866539|FG001|Overall Study|Withdrawal by Subject|2
7525497|NCT02573012|11866538|FG000|Overall Study|Study Ended per Protocol|1
7525498|NCT02573012|11866539|FG001|Overall Study|Study Ended per Protocol|0
7525499|NCT02573012|11866538|FG000|Overall Study|Physician Decision|1
7525500|NCT02573012|11866539|FG001|Overall Study|Physician Decision|2
7525501|NCT02573155|11866547|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
7525502|NCT02573155|11866548|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
7525503|NCT02573155|11866547|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
7525504|NCT02573155|11866548|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
7525505|NCT02573155|11866547|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
7525506|NCT02573155|11866548|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
7525507|NCT02573155|11866547|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
7525508|NCT02573155|11866548|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
7525509|NCT02573155|11866547|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
7525510|NCT02573155|11866548|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
7525511|NCT02573155|11866547|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
7525512|NCT02573155|11866548|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
7525513|NCT02573155|11866547|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
7525514|NCT02573155|11866548|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
7525515|NCT02573155|11866547|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
7525516|NCT02573155|11866548|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
7525517|NCT02573246|11866588|FG000|Overall Study|Lost to Follow-up|2
7525518|NCT02573246|11866589|FG001|Overall Study|Lost to Follow-up|0
7525519|NCT02573246|11866590|FG002|Overall Study|Lost to Follow-up|0
7525520|NCT02573246|11866591|FG003|Overall Study|Lost to Follow-up|0
7525521|NCT02573246|11866592|FG004|Overall Study|Lost to Follow-up|1
7525522|NCT02573246|11866588|FG000|Overall Study|Withdrawal by Subject|0
7525523|NCT02573246|11866589|FG001|Overall Study|Withdrawal by Subject|0
7525524|NCT02573246|11866590|FG002|Overall Study|Withdrawal by Subject|0
7525525|NCT02573246|11866591|FG003|Overall Study|Withdrawal by Subject|0
7525526|NCT02573246|11866592|FG004|Overall Study|Withdrawal by Subject|1
7525527|NCT02573246|11866588|FG000|Overall Study|Physician Decision|1
7525528|NCT02573246|11866589|FG001|Overall Study|Physician Decision|1
7525529|NCT02573246|11866590|FG002|Overall Study|Physician Decision|3
7525530|NCT02573246|11866591|FG003|Overall Study|Physician Decision|2
7525531|NCT02573246|11866592|FG004|Overall Study|Physician Decision|2
7525532|NCT02573311|11866611|FG000|Disposition for Part 1|Withdrawal by Subject|7
7525533|NCT02573311|11866612|FG001|Disposition for Part 1|Withdrawal by Subject|3
7525534|NCT02573311|11866611|FG000|Disposition for Part 2|Physician Decision|25
7525535|NCT02573311|11866612|FG001|Disposition for Part 2|Physician Decision|7
7525536|NCT02573311|11866611|FG000|Disposition for Part 2|Adverse Event|36
7525537|NCT02573311|11866612|FG001|Disposition for Part 2|Adverse Event|5
7525538|NCT02573311|11866611|FG000|Disposition for Part 2|Lost to Follow-up|76
7525539|NCT02573311|11866612|FG001|Disposition for Part 2|Lost to Follow-up|7
7525540|NCT02573311|11866611|FG000|Disposition for Part 2|Withdrawal by Subject|60
7525541|NCT02573311|11866612|FG001|Disposition for Part 2|Withdrawal by Subject|3
7525542|NCT02573311|11866611|FG000|Disposition for Part 2|Investigator decision|0
7525543|NCT02573311|11866612|FG001|Disposition for Part 2|Investigator decision|1
7525544|NCT02573311|11866611|FG000|Disposition for Part 2|Other than specified above|13
7525545|NCT02573311|11866612|FG001|Disposition for Part 2|Other than specified above|3
7525546|NCT02573350|11866620|FG000|Overall Study|Lost to Follow-up|2
7525547|NCT02573350|11866621|FG001|Overall Study|Lost to Follow-up|1
7525548|NCT02573350|11866620|FG000|Overall Study|Adverse Event|3
7525549|NCT02573350|11866621|FG001|Overall Study|Adverse Event|4
7525550|NCT02573350|11866620|FG000|Overall Study|Subject met Withdrawal Criteria|1
7525551|NCT02573350|11866621|FG001|Overall Study|Subject met Withdrawal Criteria|1
7525552|NCT02573350|11866620|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
7525553|NCT02573350|11866621|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
7525554|NCT02573350|11866620|FG000|Overall Study|Subject withdrew consent to participate|6
7525555|NCT02573350|11866621|FG001|Overall Study|Subject withdrew consent to participate|1
7525556|NCT02573350|11866620|FG000|Overall Study|Protocol Deviation|1
7525557|NCT02573350|11866621|FG001|Overall Study|Protocol Deviation|1
7525558|NCT02573467|11866643|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
7525559|NCT02573467|11866644|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
7525560|NCT02573467|11866645|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
7525561|NCT02573467|11866646|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
7525562|NCT02573467|11866643|FG000|Double-blind Treatment Epoch|Adverse Event|1
7525563|NCT02573467|11866644|FG001|Double-blind Treatment Epoch|Adverse Event|0
7525564|NCT02573467|11866645|FG002|Double-blind Treatment Epoch|Adverse Event|1
7525565|NCT02573467|11866646|FG003|Double-blind Treatment Epoch|Adverse Event|0
7525566|NCT02573467|11866643|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
7525567|NCT02573467|11866644|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
7525568|NCT02573467|11866645|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
7525569|NCT02573467|11866646|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
7525570|NCT02573467|11866643|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
7525571|NCT02573467|11866644|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
7525572|NCT02573467|11866645|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
7525573|NCT02573467|11866646|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
7525574|NCT02573467|11866643|FG000|Post-treatment Follow up Epoch|Death|1
7525575|NCT02573467|11866644|FG001|Post-treatment Follow up Epoch|Death|1
7525576|NCT02573467|11866645|FG002|Post-treatment Follow up Epoch|Death|0
7525577|NCT02573467|11866646|FG003|Post-treatment Follow up Epoch|Death|1
7525578|NCT02573467|11866643|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
7525579|NCT02573467|11866644|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
7525580|NCT02573467|11866645|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
7525581|NCT02573467|11866646|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
7525582|NCT02573467|11866643|FG000|Post-treatment Follow up Epoch|Technical problems|0
7525583|NCT02573467|11866644|FG001|Post-treatment Follow up Epoch|Technical problems|0
7525584|NCT02573467|11866645|FG002|Post-treatment Follow up Epoch|Technical problems|1
7525585|NCT02573467|11866646|FG003|Post-treatment Follow up Epoch|Technical problems|0
7525586|NCT02573870|11866668|FG000|Overall Study|Adverse Event|0
7525587|NCT02573870|11866669|FG001|Overall Study|Adverse Event|2
7525588|NCT02573870|11866668|FG000|Overall Study|Lack of Efficacy|0
7525589|NCT02573870|11866669|FG001|Overall Study|Lack of Efficacy|1
7525590|NCT02573870|11866668|FG000|Overall Study|Other: Reached defined stopping criteria|0
7525591|NCT02573870|11866669|FG001|Overall Study|Other: Reached defined stopping criteria|1
7525592|NCT02573870|11866668|FG000|Overall Study|Lost to Follow-up|0
7525593|NCT02573870|11866669|FG001|Overall Study|Lost to Follow-up|1
7525594|NCT02573870|11866668|FG000|Overall Study|Other: Fail to Meet Visit|0
7525595|NCT02573870|11866669|FG001|Overall Study|Other: Fail to Meet Visit|2
7525596|NCT02573883|11866677|FG000|Six Month Follow Up|Lost to Follow-up|1
7525597|NCT02573883|11866678|FG001|Six Month Follow Up|Lost to Follow-up|0
7525598|NCT02573883|11866679|FG002|Six Month Follow Up|Lost to Follow-up|0
7525599|NCT02573883|11866680|FG003|Six Month Follow Up|Lost to Follow-up|0
7525600|NCT02573883|11866677|FG000|One Year Follow Up|Lost to Follow-up|2
7525601|NCT02573883|11866678|FG001|One Year Follow Up|Lost to Follow-up|1
7525602|NCT02573883|11866679|FG002|One Year Follow Up|Lost to Follow-up|0
7525603|NCT02573883|11866680|FG003|One Year Follow Up|Lost to Follow-up|0
7525604|NCT02573948|11866695|FG000|Longitudinal Cohort|Death|9
7525605|NCT02573948|11866695|FG000|Longitudinal Cohort|Lost to Follow-up|22
7525606|NCT02573948|11866695|FG000|Longitudinal Cohort|Incarcerated|25
7525607|NCT02574078|11866715|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7525608|NCT02574078|11866716|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
7525609|NCT02574078|11866717|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
7525610|NCT02574078|11866718|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
7525611|NCT02574078|11866719|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
7525612|NCT02574078|11866720|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
7525613|NCT02574078|11866721|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
7525614|NCT02574078|11866722|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
7525615|NCT02574078|11866723|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
7525616|NCT02574078|11866724|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
7525617|NCT02574078|11866725|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
7525618|NCT02574078|11866726|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
7525619|NCT02574078|11866727|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
7525620|NCT02574078|11866715|FG000|Pre-Treatment Period|Participant withdrew consent|0
7525621|NCT02574078|11866716|FG001|Pre-Treatment Period|Participant withdrew consent|0
7525622|NCT02574078|11866717|FG002|Pre-Treatment Period|Participant withdrew consent|0
7525623|NCT02574078|11866718|FG003|Pre-Treatment Period|Participant withdrew consent|0
7525624|NCT02574078|11866719|FG004|Pre-Treatment Period|Participant withdrew consent|0
7525625|NCT02574078|11866720|FG005|Pre-Treatment Period|Participant withdrew consent|0
7525626|NCT02574078|11866721|FG006|Pre-Treatment Period|Participant withdrew consent|0
7525627|NCT02574078|11866722|FG007|Pre-Treatment Period|Participant withdrew consent|3
7525628|NCT02574078|11866723|FG008|Pre-Treatment Period|Participant withdrew consent|0
7525629|NCT02574078|11866724|FG009|Pre-Treatment Period|Participant withdrew consent|0
7525630|NCT02574078|11866725|FG010|Pre-Treatment Period|Participant withdrew consent|2
7525631|NCT02574078|11866726|FG011|Pre-Treatment Period|Participant withdrew consent|0
7525632|NCT02574078|11866727|FG012|Pre-Treatment Period|Participant withdrew consent|0
7525633|NCT02574078|11866715|FG000|Pre-Treatment Period|Other reasons|0
7525634|NCT02574078|11866716|FG001|Pre-Treatment Period|Other reasons|0
7525635|NCT02574078|11866717|FG002|Pre-Treatment Period|Other reasons|0
7525636|NCT02574078|11866718|FG003|Pre-Treatment Period|Other reasons|0
7525637|NCT02574078|11866719|FG004|Pre-Treatment Period|Other reasons|0
7525638|NCT02574078|11866720|FG005|Pre-Treatment Period|Other reasons|0
7525639|NCT02574078|11866721|FG006|Pre-Treatment Period|Other reasons|2
7525640|NCT02574078|11866722|FG007|Pre-Treatment Period|Other reasons|0
7525641|NCT02574078|11866723|FG008|Pre-Treatment Period|Other reasons|0
7525642|NCT02574078|11866724|FG009|Pre-Treatment Period|Other reasons|0
7525643|NCT02574078|11866725|FG010|Pre-Treatment Period|Other reasons|2
7525644|NCT02574078|11866726|FG011|Pre-Treatment Period|Other reasons|0
7525645|NCT02574078|11866727|FG012|Pre-Treatment Period|Other reasons|0
7525646|NCT02574078|11866715|FG000|Pre-Treatment Period|Poor/non-compliance|0
7525647|NCT02574078|11866716|FG001|Pre-Treatment Period|Poor/non-compliance|0
7525648|NCT02574078|11866717|FG002|Pre-Treatment Period|Poor/non-compliance|0
7525649|NCT02574078|11866718|FG003|Pre-Treatment Period|Poor/non-compliance|0
7525650|NCT02574078|11866719|FG004|Pre-Treatment Period|Poor/non-compliance|0
7525651|NCT02574078|11866720|FG005|Pre-Treatment Period|Poor/non-compliance|0
7525652|NCT02574078|11866721|FG006|Pre-Treatment Period|Poor/non-compliance|0
7525653|NCT02574078|11866722|FG007|Pre-Treatment Period|Poor/non-compliance|0
7525654|NCT02574078|11866723|FG008|Pre-Treatment Period|Poor/non-compliance|0
7525655|NCT02574078|11866724|FG009|Pre-Treatment Period|Poor/non-compliance|0
7525656|NCT02574078|11866725|FG010|Pre-Treatment Period|Poor/non-compliance|0
7525657|NCT02574078|11866726|FG011|Pre-Treatment Period|Poor/non-compliance|1
7525658|NCT02574078|11866727|FG012|Pre-Treatment Period|Poor/non-compliance|0
7525659|NCT02574078|11866715|FG000|Treatment Period|Disease progression|6
7525660|NCT02574078|11866716|FG001|Treatment Period|Disease progression|4
7525661|NCT02574078|11866717|FG002|Treatment Period|Disease progression|7
7525662|NCT02574078|11866718|FG003|Treatment Period|Disease progression|18
7525663|NCT02574078|11866719|FG004|Treatment Period|Disease progression|16
7525664|NCT02574078|11866720|FG005|Treatment Period|Disease progression|26
7525665|NCT02574078|11866721|FG006|Treatment Period|Disease progression|5
7525666|NCT02574078|11866722|FG007|Treatment Period|Disease progression|9
7525667|NCT02574078|11866723|FG008|Treatment Period|Disease progression|8
7525668|NCT02574078|11866724|FG009|Treatment Period|Disease progression|5
7525669|NCT02574078|11866725|FG010|Treatment Period|Disease progression|20
7525670|NCT02574078|11866726|FG011|Treatment Period|Disease progression|29
7525671|NCT02574078|11866727|FG012|Treatment Period|Disease progression|2
7525672|NCT02574078|11866715|FG000|Treatment Period|Study drug toxicity|1
7525673|NCT02574078|11866716|FG001|Treatment Period|Study drug toxicity|1
7525674|NCT02574078|11866717|FG002|Treatment Period|Study drug toxicity|0
7525675|NCT02574078|11866718|FG003|Treatment Period|Study drug toxicity|5
7525676|NCT02574078|11866719|FG004|Treatment Period|Study drug toxicity|3
7525677|NCT02574078|11866720|FG005|Treatment Period|Study drug toxicity|1
7525678|NCT02574078|11866721|FG006|Treatment Period|Study drug toxicity|2
7525679|NCT02574078|11866722|FG007|Treatment Period|Study drug toxicity|0
7525680|NCT02574078|11866723|FG008|Treatment Period|Study drug toxicity|2
7525681|NCT02574078|11866724|FG009|Treatment Period|Study drug toxicity|1
7525682|NCT02574078|11866725|FG010|Treatment Period|Study drug toxicity|16
7525683|NCT02574078|11866726|FG011|Treatment Period|Study drug toxicity|2
7525684|NCT02574078|11866727|FG012|Treatment Period|Study drug toxicity|4
7525685|NCT02574078|11866715|FG000|Treatment Period|Death|2
7525686|NCT02574078|11866716|FG001|Treatment Period|Death|0
7525687|NCT02574078|11866717|FG002|Treatment Period|Death|0
7525688|NCT02574078|11866718|FG003|Treatment Period|Death|0
7525689|NCT02574078|11866719|FG004|Treatment Period|Death|1
7525690|NCT02574078|11866720|FG005|Treatment Period|Death|1
7525691|NCT02574078|11866721|FG006|Treatment Period|Death|1
7525692|NCT02574078|11866722|FG007|Treatment Period|Death|1
7525693|NCT02574078|11866723|FG008|Treatment Period|Death|7
7525694|NCT02574078|11866724|FG009|Treatment Period|Death|1
7525695|NCT02574078|11866725|FG010|Treatment Period|Death|0
7525696|NCT02574078|11866726|FG011|Treatment Period|Death|2
7525697|NCT02574078|11866727|FG012|Treatment Period|Death|1
7525698|NCT02574078|11866715|FG000|Treatment Period|Adverse event unrelated to drug|0
7525699|NCT02574078|11866716|FG001|Treatment Period|Adverse event unrelated to drug|0
7525700|NCT02574078|11866717|FG002|Treatment Period|Adverse event unrelated to drug|1
7525701|NCT02574078|11866718|FG003|Treatment Period|Adverse event unrelated to drug|0
7525702|NCT02574078|11866719|FG004|Treatment Period|Adverse event unrelated to drug|2
7525703|NCT02574078|11866720|FG005|Treatment Period|Adverse event unrelated to drug|3
7525704|NCT02574078|11866721|FG006|Treatment Period|Adverse event unrelated to drug|0
7525705|NCT02574078|11866722|FG007|Treatment Period|Adverse event unrelated to drug|0
7525706|NCT02574078|11866723|FG008|Treatment Period|Adverse event unrelated to drug|1
7525707|NCT02574078|11866724|FG009|Treatment Period|Adverse event unrelated to drug|2
7525708|NCT02574078|11866725|FG010|Treatment Period|Adverse event unrelated to drug|4
7525709|NCT02574078|11866726|FG011|Treatment Period|Adverse event unrelated to drug|1
7525710|NCT02574078|11866727|FG012|Treatment Period|Adverse event unrelated to drug|0
7525711|NCT02574078|11866715|FG000|Treatment Period|Administrative reason by Sponsor|0
7525712|NCT02574078|11866716|FG001|Treatment Period|Administrative reason by Sponsor|1
7525713|NCT02574078|11866717|FG002|Treatment Period|Administrative reason by Sponsor|0
7525714|NCT02574078|11866718|FG003|Treatment Period|Administrative reason by Sponsor|0
7525715|NCT02574078|11866719|FG004|Treatment Period|Administrative reason by Sponsor|0
7525716|NCT02574078|11866720|FG005|Treatment Period|Administrative reason by Sponsor|0
7525717|NCT02574078|11866721|FG006|Treatment Period|Administrative reason by Sponsor|1
7525718|NCT02574078|11866722|FG007|Treatment Period|Administrative reason by Sponsor|0
7525719|NCT02574078|11866723|FG008|Treatment Period|Administrative reason by Sponsor|0
7525720|NCT02574078|11866724|FG009|Treatment Period|Administrative reason by Sponsor|0
7525721|NCT02574078|11866725|FG010|Treatment Period|Administrative reason by Sponsor|0
7525722|NCT02574078|11866726|FG011|Treatment Period|Administrative reason by Sponsor|0
7525723|NCT02574078|11866727|FG012|Treatment Period|Administrative reason by Sponsor|3
7525724|NCT02574078|11866715|FG000|Treatment Period|Other reasons|1
7525725|NCT02574078|11866716|FG001|Treatment Period|Other reasons|0
7525726|NCT02574078|11866717|FG002|Treatment Period|Other reasons|1
7525727|NCT02574078|11866718|FG003|Treatment Period|Other reasons|3
7525728|NCT02574078|11866719|FG004|Treatment Period|Other reasons|3
7525729|NCT02574078|11866720|FG005|Treatment Period|Other reasons|1
7525730|NCT02574078|11866721|FG006|Treatment Period|Other reasons|2
7525731|NCT02574078|11866722|FG007|Treatment Period|Other reasons|1
7525732|NCT02574078|11866723|FG008|Treatment Period|Other reasons|3
7525733|NCT02574078|11866724|FG009|Treatment Period|Other reasons|1
7525734|NCT02574078|11866725|FG010|Treatment Period|Other reasons|1
7525735|NCT02574078|11866726|FG011|Treatment Period|Other reasons|3
7525736|NCT02574078|11866727|FG012|Treatment Period|Other reasons|1
7525737|NCT02574078|11866715|FG000|Treatment Period|Participant request to stop drug|0
7525738|NCT02574078|11866716|FG001|Treatment Period|Participant request to stop drug|0
7525739|NCT02574078|11866717|FG002|Treatment Period|Participant request to stop drug|0
7525740|NCT02574078|11866718|FG003|Treatment Period|Participant request to stop drug|2
7525741|NCT02574078|11866719|FG004|Treatment Period|Participant request to stop drug|4
7525742|NCT02574078|11866720|FG005|Treatment Period|Participant request to stop drug|0
7525743|NCT02574078|11866721|FG006|Treatment Period|Participant request to stop drug|1
7525744|NCT02574078|11866722|FG007|Treatment Period|Participant request to stop drug|0
7525745|NCT02574078|11866723|FG008|Treatment Period|Participant request to stop drug|3
7525746|NCT02574078|11866724|FG009|Treatment Period|Participant request to stop drug|2
7525747|NCT02574078|11866725|FG010|Treatment Period|Participant request to stop drug|2
7525748|NCT02574078|11866726|FG011|Treatment Period|Participant request to stop drug|4
7525749|NCT02574078|11866727|FG012|Treatment Period|Participant request to stop drug|1
7525750|NCT02574078|11866715|FG000|Treatment Period|Participant withdrew consent|0
7525751|NCT02574078|11866716|FG001|Treatment Period|Participant withdrew consent|0
7525752|NCT02574078|11866717|FG002|Treatment Period|Participant withdrew consent|0
7525753|NCT02574078|11866718|FG003|Treatment Period|Participant withdrew consent|0
7525754|NCT02574078|11866719|FG004|Treatment Period|Participant withdrew consent|1
7525755|NCT02574078|11866720|FG005|Treatment Period|Participant withdrew consent|1
7525756|NCT02574078|11866721|FG006|Treatment Period|Participant withdrew consent|0
7525757|NCT02574078|11866722|FG007|Treatment Period|Participant withdrew consent|1
7525758|NCT02574078|11866723|FG008|Treatment Period|Participant withdrew consent|0
7525759|NCT02574078|11866724|FG009|Treatment Period|Participant withdrew consent|2
7525760|NCT02574078|11866725|FG010|Treatment Period|Participant withdrew consent|1
7525761|NCT02574078|11866726|FG011|Treatment Period|Participant withdrew consent|4
7525762|NCT02574078|11866727|FG012|Treatment Period|Participant withdrew consent|1
7525763|NCT02574078|11866715|FG000|Treatment Period|Participant no longer meets criteria|0
7525764|NCT02574078|11866716|FG001|Treatment Period|Participant no longer meets criteria|0
7525765|NCT02574078|11866717|FG002|Treatment Period|Participant no longer meets criteria|0
7525766|NCT02574078|11866718|FG003|Treatment Period|Participant no longer meets criteria|0
7525767|NCT02574078|11866719|FG004|Treatment Period|Participant no longer meets criteria|1
7525768|NCT02574078|11866720|FG005|Treatment Period|Participant no longer meets criteria|0
7525769|NCT02574078|11866721|FG006|Treatment Period|Participant no longer meets criteria|0
7525770|NCT02574078|11866722|FG007|Treatment Period|Participant no longer meets criteria|0
7525771|NCT02574078|11866723|FG008|Treatment Period|Participant no longer meets criteria|0
7525772|NCT02574078|11866724|FG009|Treatment Period|Participant no longer meets criteria|1
7525773|NCT02574078|11866725|FG010|Treatment Period|Participant no longer meets criteria|1
7525774|NCT02574078|11866726|FG011|Treatment Period|Participant no longer meets criteria|1
7525775|NCT02574078|11866727|FG012|Treatment Period|Participant no longer meets criteria|0
7525776|NCT02574078|11866715|FG000|Treatment Period|Lost to Follow-up|0
7525777|NCT02574078|11866716|FG001|Treatment Period|Lost to Follow-up|0
7525778|NCT02574078|11866717|FG002|Treatment Period|Lost to Follow-up|0
7525779|NCT02574078|11866718|FG003|Treatment Period|Lost to Follow-up|0
7525780|NCT02574078|11866719|FG004|Treatment Period|Lost to Follow-up|0
7525781|NCT02574078|11866720|FG005|Treatment Period|Lost to Follow-up|0
7525782|NCT02574078|11866721|FG006|Treatment Period|Lost to Follow-up|0
7525783|NCT02574078|11866722|FG007|Treatment Period|Lost to Follow-up|0
7525784|NCT02574078|11866723|FG008|Treatment Period|Lost to Follow-up|0
7525785|NCT02574078|11866724|FG009|Treatment Period|Lost to Follow-up|1
7525786|NCT02574078|11866725|FG010|Treatment Period|Lost to Follow-up|0
7525787|NCT02574078|11866726|FG011|Treatment Period|Lost to Follow-up|1
7525788|NCT02574078|11866727|FG012|Treatment Period|Lost to Follow-up|0
7525789|NCT02574078|11866715|FG000|Treatment Period|Maximum clinical benefit|0
7525790|NCT02574078|11866716|FG001|Treatment Period|Maximum clinical benefit|0
7525791|NCT02574078|11866717|FG002|Treatment Period|Maximum clinical benefit|0
7525792|NCT02574078|11866718|FG003|Treatment Period|Maximum clinical benefit|0
7525793|NCT02574078|11866719|FG004|Treatment Period|Maximum clinical benefit|0
7525794|NCT02574078|11866720|FG005|Treatment Period|Maximum clinical benefit|0
7525795|NCT02574078|11866721|FG006|Treatment Period|Maximum clinical benefit|0
7525796|NCT02574078|11866722|FG007|Treatment Period|Maximum clinical benefit|0
7525797|NCT02574078|11866723|FG008|Treatment Period|Maximum clinical benefit|0
7525798|NCT02574078|11866724|FG009|Treatment Period|Maximum clinical benefit|1
7525799|NCT02574078|11866725|FG010|Treatment Period|Maximum clinical benefit|0
7525800|NCT02574078|11866726|FG011|Treatment Period|Maximum clinical benefit|0
7525801|NCT02574078|11866727|FG012|Treatment Period|Maximum clinical benefit|0
7525802|NCT02574247|11866761|FG000|Overall Study|Withdrawal by Subject|1
7525803|NCT02574247|11866762|FG001|Overall Study|Withdrawal by Subject|0
7525804|NCT02574247|11866763|FG002|Overall Study|Withdrawal by Subject|0
7525805|NCT02574247|11866761|FG000|Overall Study|Did not meet inclusion criteria|4
7525806|NCT02574247|11866762|FG001|Overall Study|Did not meet inclusion criteria|3
7525807|NCT02574247|11866763|FG002|Overall Study|Did not meet inclusion criteria|5
7525808|NCT02574260|11866773|FG000|Overall Study|Disease Progression|1
7525809|NCT02574312|11866779|FG000|3 Months Follow-up|Withdrawal by Subject|1
7525810|NCT02574312|11866780|FG001|3 Months Follow-up|Withdrawal by Subject|0
7525811|NCT02574520|11866790|FG000|Overall Study|Not dosed|2
7525812|NCT02574520|11866791|FG001|Overall Study|Not dosed|0
7525813|NCT02574520|11866792|FG002|Overall Study|Not dosed|5
7525814|NCT02574520|11866793|FG003|Overall Study|Not dosed|4
7525815|NCT02574520|11866790|FG000|Overall Study|Adverse Event|0
7525816|NCT02574520|11866791|FG001|Overall Study|Adverse Event|0
7525817|NCT02574520|11866792|FG002|Overall Study|Adverse Event|0
7525818|NCT02574520|11866793|FG003|Overall Study|Adverse Event|1
7525819|NCT02574520|11866790|FG000|Overall Study|Withdrawal by Subject|0
7525820|NCT02574520|11866791|FG001|Overall Study|Withdrawal by Subject|0
7525821|NCT02574520|11866792|FG002|Overall Study|Withdrawal by Subject|0
7525822|NCT02574520|11866793|FG003|Overall Study|Withdrawal by Subject|1
7525823|NCT02574520|11866790|FG000|Overall Study|Other|0
7525824|NCT02574520|11866791|FG001|Overall Study|Other|0
7525825|NCT02574520|11866792|FG002|Overall Study|Other|0
7525826|NCT02574520|11866793|FG003|Overall Study|Other|2
7525827|NCT02574637|11866817|FG000|Double-blind Period|Adverse Event|1
7525828|NCT02574637|11866818|FG001|Double-blind Period|Adverse Event|0
7525829|NCT02574637|11866819|FG002|Double-blind Period|Adverse Event|0
7525830|NCT02574637|11866820|FG003|Double-blind Period|Adverse Event|0
7525831|NCT02574637|11866821|FG004|Double-blind Period|Adverse Event|0
7525832|NCT02574637|11866822|FG005|Double-blind Period|Adverse Event|0
7525833|NCT02574637|11866823|FG006|Double-blind Period|Adverse Event|0
7525834|NCT02574637|11866824|FG007|Double-blind Period|Adverse Event|0
7525835|NCT02574637|11866825|FG008|Double-blind Period|Adverse Event|0
7525836|NCT02574637|11866826|FG009|Double-blind Period|Adverse Event|0
7525837|NCT02574637|11866817|FG000|Double-blind Period|Lack of Efficacy|0
7525838|NCT02574637|11866818|FG001|Double-blind Period|Lack of Efficacy|0
7525839|NCT02574637|11866819|FG002|Double-blind Period|Lack of Efficacy|2
7525840|NCT02574637|11866820|FG003|Double-blind Period|Lack of Efficacy|0
7525841|NCT02574637|11866821|FG004|Double-blind Period|Lack of Efficacy|0
7525842|NCT02574637|11866822|FG005|Double-blind Period|Lack of Efficacy|0
7525843|NCT02574637|11866823|FG006|Double-blind Period|Lack of Efficacy|0
7525844|NCT02574637|11866824|FG007|Double-blind Period|Lack of Efficacy|0
7525845|NCT02574637|11866825|FG008|Double-blind Period|Lack of Efficacy|0
7525846|NCT02574637|11866826|FG009|Double-blind Period|Lack of Efficacy|0
7525847|NCT02574637|11866817|FG000|Double-blind Period|Protocol Deviation|1
7525848|NCT02574637|11866818|FG001|Double-blind Period|Protocol Deviation|0
7525849|NCT02574637|11866819|FG002|Double-blind Period|Protocol Deviation|0
7525850|NCT02574637|11866820|FG003|Double-blind Period|Protocol Deviation|0
7525851|NCT02574637|11866821|FG004|Double-blind Period|Protocol Deviation|0
7525852|NCT02574637|11866822|FG005|Double-blind Period|Protocol Deviation|0
7525853|NCT02574637|11866823|FG006|Double-blind Period|Protocol Deviation|0
7525854|NCT02574637|11866824|FG007|Double-blind Period|Protocol Deviation|0
7525855|NCT02574637|11866825|FG008|Double-blind Period|Protocol Deviation|0
7525856|NCT02574637|11866826|FG009|Double-blind Period|Protocol Deviation|0
7525857|NCT02574637|11866817|FG000|Double-blind Period|Non-Compliance With Study Drug|0
7525858|NCT02574637|11866818|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7525859|NCT02574637|11866819|FG002|Double-blind Period|Non-Compliance With Study Drug|0
7525860|NCT02574637|11866820|FG003|Double-blind Period|Non-Compliance With Study Drug|1
7525861|NCT02574637|11866821|FG004|Double-blind Period|Non-Compliance With Study Drug|0
7525862|NCT02574637|11866822|FG005|Double-blind Period|Non-Compliance With Study Drug|0
7525863|NCT02574637|11866823|FG006|Double-blind Period|Non-Compliance With Study Drug|0
7525864|NCT02574637|11866824|FG007|Double-blind Period|Non-Compliance With Study Drug|0
7525865|NCT02574637|11866825|FG008|Double-blind Period|Non-Compliance With Study Drug|0
7525866|NCT02574637|11866826|FG009|Double-blind Period|Non-Compliance With Study Drug|0
7525867|NCT02574637|11866817|FG000|Double-blind Period|Study Terminated By Sponsor|1
7525868|NCT02574637|11866818|FG001|Double-blind Period|Study Terminated By Sponsor|1
7525869|NCT02574637|11866819|FG002|Double-blind Period|Study Terminated By Sponsor|5
7525870|NCT02574637|11866820|FG003|Double-blind Period|Study Terminated By Sponsor|2
7525871|NCT02574637|11866821|FG004|Double-blind Period|Study Terminated By Sponsor|2
7525872|NCT02574637|11866822|FG005|Double-blind Period|Study Terminated By Sponsor|0
7525873|NCT02574637|11866823|FG006|Double-blind Period|Study Terminated By Sponsor|0
7525874|NCT02574637|11866824|FG007|Double-blind Period|Study Terminated By Sponsor|0
7525875|NCT02574637|11866825|FG008|Double-blind Period|Study Terminated By Sponsor|0
7525876|NCT02574637|11866826|FG009|Double-blind Period|Study Terminated By Sponsor|0
7525877|NCT02574637|11866817|FG000|Double-blind Period|Reason Not Specified|0
7525878|NCT02574637|11866818|FG001|Double-blind Period|Reason Not Specified|0
7525879|NCT02574637|11866819|FG002|Double-blind Period|Reason Not Specified|0
7525880|NCT02574637|11866820|FG003|Double-blind Period|Reason Not Specified|1
7525881|NCT02574637|11866821|FG004|Double-blind Period|Reason Not Specified|0
7525882|NCT02574637|11866822|FG005|Double-blind Period|Reason Not Specified|0
7525883|NCT02574637|11866823|FG006|Double-blind Period|Reason Not Specified|0
7525884|NCT02574637|11866824|FG007|Double-blind Period|Reason Not Specified|0
7525885|NCT02574637|11866825|FG008|Double-blind Period|Reason Not Specified|0
7525886|NCT02574637|11866826|FG009|Double-blind Period|Reason Not Specified|0
7525887|NCT02574637|11866817|FG000|Open-label (OL) Period|Adverse Event|0
7525888|NCT02574637|11866818|FG001|Open-label (OL) Period|Adverse Event|0
7525889|NCT02574637|11866819|FG002|Open-label (OL) Period|Adverse Event|0
7525890|NCT02574637|11866820|FG003|Open-label (OL) Period|Adverse Event|0
7525891|NCT02574637|11866821|FG004|Open-label (OL) Period|Adverse Event|0
7525892|NCT02574637|11866822|FG005|Open-label (OL) Period|Adverse Event|0
7525893|NCT02574637|11866823|FG006|Open-label (OL) Period|Adverse Event|0
7525894|NCT02574637|11866824|FG007|Open-label (OL) Period|Adverse Event|0
7525895|NCT02574637|11866825|FG008|Open-label (OL) Period|Adverse Event|1
7525896|NCT02574637|11866826|FG009|Open-label (OL) Period|Adverse Event|0
7525897|NCT02574637|11866817|FG000|Open-label (OL) Period|Withdrawal by Subject|0
7525898|NCT02574637|11866818|FG001|Open-label (OL) Period|Withdrawal by Subject|0
7525899|NCT02574637|11866819|FG002|Open-label (OL) Period|Withdrawal by Subject|0
7525900|NCT02574637|11866820|FG003|Open-label (OL) Period|Withdrawal by Subject|0
7525901|NCT02574637|11866821|FG004|Open-label (OL) Period|Withdrawal by Subject|0
7525902|NCT02574637|11866822|FG005|Open-label (OL) Period|Withdrawal by Subject|1
7525903|NCT02574637|11866823|FG006|Open-label (OL) Period|Withdrawal by Subject|0
7525904|NCT02574637|11866824|FG007|Open-label (OL) Period|Withdrawal by Subject|0
7525905|NCT02574637|11866825|FG008|Open-label (OL) Period|Withdrawal by Subject|0
7525906|NCT02574637|11866826|FG009|Open-label (OL) Period|Withdrawal by Subject|1
7525907|NCT02574637|11866817|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
7525908|NCT02574637|11866818|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
7525909|NCT02574637|11866819|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
7525910|NCT02574637|11866820|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
7525911|NCT02574637|11866821|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
7525912|NCT02574637|11866822|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
7525913|NCT02574637|11866823|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
7525914|NCT02574637|11866824|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
7525915|NCT02574637|11866825|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
7525916|NCT02574637|11866826|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
7525917|NCT02574845|11866857|FG000|Overall Study|Consent withdrawn further participation|0
7525918|NCT02574845|11866858|FG001|Overall Study|Consent withdrawn further participation|0
7525919|NCT02574845|11866859|FG002|Overall Study|Consent withdrawn further participation|0
7525920|NCT02574845|11866860|FG003|Overall Study|Consent withdrawn further participation|0
7525921|NCT02574845|11866861|FG004|Overall Study|Consent withdrawn further participation|1
7525922|NCT02574845|11866862|FG005|Overall Study|Consent withdrawn further participation|0
7525923|NCT02574845|11866857|FG000|Overall Study|Adverse Event|0
7525924|NCT02574845|11866858|FG001|Overall Study|Adverse Event|1
7525925|NCT02574845|11866859|FG002|Overall Study|Adverse Event|0
7525926|NCT02574845|11866860|FG003|Overall Study|Adverse Event|0
7525927|NCT02574845|11866861|FG004|Overall Study|Adverse Event|0
7525928|NCT02574845|11866862|FG005|Overall Study|Adverse Event|1
7525929|NCT02575079|11866882|FG000|Overall Study|Death|3
7525930|NCT02575079|11866883|FG001|Overall Study|Death|0
7525931|NCT02575079|11866882|FG000|Overall Study|Withdrawal by Subject|3
7525932|NCT02575079|11866883|FG001|Overall Study|Withdrawal by Subject|0
7525933|NCT02575807|11866897|FG000|Overall Study|Death|8
7525934|NCT02575807|11866898|FG001|Overall Study|Death|3
7525935|NCT02575807|11866899|FG002|Overall Study|Death|7
7525936|NCT02575807|11866900|FG003|Overall Study|Death|0
7525937|NCT02575807|11866901|FG004|Overall Study|Death|1
7525938|NCT02575807|11866897|FG000|Overall Study|Study terminated by Sponsor|0
7525939|NCT02575807|11866898|FG001|Overall Study|Study terminated by Sponsor|1
7525940|NCT02575807|11866899|FG002|Overall Study|Study terminated by Sponsor|7
7525941|NCT02575807|11866900|FG003|Overall Study|Study terminated by Sponsor|0
7525942|NCT02575807|11866901|FG004|Overall Study|Study terminated by Sponsor|1
7525943|NCT02575807|11866897|FG000|Overall Study|Terminated due to FDA clinical hold|1
7525944|NCT02575807|11866898|FG001|Overall Study|Terminated due to FDA clinical hold|0
7525945|NCT02575807|11866899|FG002|Overall Study|Terminated due to FDA clinical hold|0
7525946|NCT02575807|11866900|FG003|Overall Study|Terminated due to FDA clinical hold|0
7525947|NCT02575807|11866901|FG004|Overall Study|Terminated due to FDA clinical hold|0
7525948|NCT02575807|11866897|FG000|Overall Study|Terminated due to physician decision|0
7525949|NCT02575807|11866898|FG001|Overall Study|Terminated due to physician decision|0
7525950|NCT02575807|11866899|FG002|Overall Study|Terminated due to physician decision|1
7525951|NCT02575807|11866900|FG003|Overall Study|Terminated due to physician decision|0
7525952|NCT02575807|11866901|FG004|Overall Study|Terminated due to physician decision|0
7525953|NCT02575807|11866897|FG000|Overall Study|Subject ineligible - medical implant|0
7525954|NCT02575807|11866898|FG001|Overall Study|Subject ineligible - medical implant|0
7525955|NCT02575807|11866899|FG002|Overall Study|Subject ineligible - medical implant|0
7525956|NCT02575807|11866900|FG003|Overall Study|Subject ineligible - medical implant|1
7525957|NCT02575807|11866901|FG004|Overall Study|Subject ineligible - medical implant|0
7525958|NCT02575807|11866897|FG000|Overall Study|Withdrawal by Subject|0
7525959|NCT02575807|11866898|FG001|Overall Study|Withdrawal by Subject|0
7525960|NCT02575807|11866899|FG002|Overall Study|Withdrawal by Subject|1
7525961|NCT02575807|11866900|FG003|Overall Study|Withdrawal by Subject|1
7525962|NCT02575807|11866901|FG004|Overall Study|Withdrawal by Subject|2
7525963|NCT02575833|11866917|FG000|Overall Study|Withdrawal by Subject|0
7525964|NCT02575833|11866918|FG001|Overall Study|Withdrawal by Subject|1
7525965|NCT02575833|11866917|FG000|Overall Study|Lost to Follow-up|1
7525966|NCT02575833|11866918|FG001|Overall Study|Lost to Follow-up|0
7525967|NCT02575911|11866924|FG000|Overall Study|Lost to Follow-up|1
7525968|NCT02575950|11866936|FG000|Overall Study|Withdrawal by Subject|0
7525969|NCT02575950|11866937|FG001|Overall Study|Withdrawal by Subject|0
7525970|NCT02575950|11866938|FG002|Overall Study|Withdrawal by Subject|0
7525971|NCT02575950|11866939|FG003|Overall Study|Withdrawal by Subject|2
7525972|NCT02575950|11866936|FG000|Overall Study|Lost to Follow-up|0
7525973|NCT02575950|11866937|FG001|Overall Study|Lost to Follow-up|1
7525974|NCT02575950|11866938|FG002|Overall Study|Lost to Follow-up|0
7525975|NCT02575950|11866939|FG003|Overall Study|Lost to Follow-up|3
7525976|NCT02576054|11866951|FG000|Overall Study|Withdrawal by Subject|1
7525977|NCT02576067|11866959|FG000|Overall Study|Death|0
7525978|NCT02576067|11866960|FG001|Overall Study|Death|1
7525979|NCT02576067|11866959|FG000|Overall Study|Lack of Efficacy|1
7525980|NCT02576067|11866960|FG001|Overall Study|Lack of Efficacy|0
7525981|NCT02576067|11866959|FG000|Overall Study|Lost to Follow-up|11
7525982|NCT02576067|11866960|FG001|Overall Study|Lost to Follow-up|0
7525983|NCT02576067|11866959|FG000|Overall Study|Withdrawal by Subject|11
7525984|NCT02576067|11866960|FG001|Overall Study|Withdrawal by Subject|2
7525985|NCT02576067|11866959|FG000|Overall Study|study closure of main CIRT trial)|0
7525986|NCT02576067|11866960|FG001|Overall Study|study closure of main CIRT trial)|8
7525987|NCT02576067|11866959|FG000|Overall Study|not randomized, failed run-in|7
7525988|NCT02576067|11866960|FG001|Overall Study|not randomized, failed run-in|0
7525989|NCT02576067|11866959|FG000|Overall Study|screen failure/ re-enrolled|0
7525990|NCT02576067|11866960|FG001|Overall Study|screen failure/ re-enrolled|25
7525991|NCT02576067|11866959|FG000|Overall Study|Physician Decision|4
7525992|NCT02576067|11866960|FG001|Overall Study|Physician Decision|0
7525993|NCT02576145|11866968|FG000|Overall Study|Adverse Event|1
7525994|NCT02576145|11866969|FG001|Overall Study|Adverse Event|0
7525995|NCT02576145|11866968|FG000|Overall Study|Withdrawal by Subject|1
7525996|NCT02576145|11866969|FG001|Overall Study|Withdrawal by Subject|0
7525997|NCT02576145|11866968|FG000|Overall Study|Acute rejection|1
7525998|NCT02576145|11866969|FG001|Overall Study|Acute rejection|0
7525999|NCT02576145|11866968|FG000|Overall Study|Tetanus Titers Decreased|0
7526000|NCT02576145|11866969|FG001|Overall Study|Tetanus Titers Decreased|1
7526001|NCT02576535|11866984|FG000|Overall Study|Withdrawal by Subject|2
7526002|NCT02576587|11866990|FG000|Baseline|Equipment failure|0
7526003|NCT02576587|11866991|FG001|Baseline|Equipment failure|1
7526004|NCT02576587|11866990|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
7526005|NCT02576587|11866991|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
7526006|NCT02576587|11866990|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
7526007|NCT02576587|11866991|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
7526008|NCT02576587|11866990|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
7526009|NCT02576587|11866991|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
7526010|NCT02576639|11867004|FG000|Overall Study|Withdrawal by Subject|1
7526011|NCT02576639|11867005|FG001|Overall Study|Withdrawal by Subject|2
7526012|NCT02576639|11867006|FG002|Overall Study|Withdrawal by Subject|1
7526013|NCT02576639|11867007|FG003|Overall Study|Withdrawal by Subject|0
7526014|NCT02576639|11867008|FG004|Overall Study|Withdrawal by Subject|1
7526015|NCT02576639|11867004|FG000|Overall Study|Adverse Event|1
7526016|NCT02576639|11867005|FG001|Overall Study|Adverse Event|0
7526017|NCT02576639|11867006|FG002|Overall Study|Adverse Event|1
7526018|NCT02576639|11867007|FG003|Overall Study|Adverse Event|1
7526019|NCT02576639|11867008|FG004|Overall Study|Adverse Event|2
7526020|NCT02576639|11867004|FG000|Overall Study|Physician Decision|0
7526021|NCT02576639|11867005|FG001|Overall Study|Physician Decision|0
7526022|NCT02576639|11867006|FG002|Overall Study|Physician Decision|0
7526023|NCT02576639|11867007|FG003|Overall Study|Physician Decision|0
7526024|NCT02576639|11867008|FG004|Overall Study|Physician Decision|1
7526025|NCT02576652|11867024|FG000|Overall Study|Withdrawal by Subject|2
7526026|NCT02576678|11867031|FG000|Overall Study|Adverse Event|0
7526027|NCT02576678|11867032|FG001|Overall Study|Adverse Event|0
7526028|NCT02576678|11867033|FG002|Overall Study|Adverse Event|2
7526029|NCT02576678|11867031|FG000|Overall Study|Withdrawal by Subject|3
7526030|NCT02576678|11867032|FG001|Overall Study|Withdrawal by Subject|1
7526031|NCT02576678|11867033|FG002|Overall Study|Withdrawal by Subject|2
7526032|NCT02576678|11867031|FG000|Overall Study|Lost to Follow-up|0
7526033|NCT02576678|11867032|FG001|Overall Study|Lost to Follow-up|0
7526034|NCT02576678|11867033|FG002|Overall Study|Lost to Follow-up|1
7526035|NCT02576678|11867031|FG000|Overall Study|Miscellaneous|2
7526036|NCT02576678|11867032|FG001|Overall Study|Miscellaneous|0
7526037|NCT02576678|11867033|FG002|Overall Study|Miscellaneous|0
7526038|NCT02576938|11867054|FG000|Overall Study|Adverse Event|5
7526039|NCT02576938|11867055|FG001|Overall Study|Adverse Event|3
7526040|NCT02576938|11867056|FG002|Overall Study|Adverse Event|6
7526041|NCT02576938|11867054|FG000|Overall Study|Protocol Violation|1
7526042|NCT02576938|11867055|FG001|Overall Study|Protocol Violation|1
7526043|NCT02576938|11867056|FG002|Overall Study|Protocol Violation|1
7526044|NCT02576938|11867054|FG000|Overall Study|Withdrawal by Subject|3
7526045|NCT02576938|11867055|FG001|Overall Study|Withdrawal by Subject|2
7526046|NCT02576938|11867056|FG002|Overall Study|Withdrawal by Subject|4
7526047|NCT02576938|11867054|FG000|Overall Study|Lack of Efficacy|9
7526048|NCT02576938|11867055|FG001|Overall Study|Lack of Efficacy|4
7526049|NCT02576938|11867056|FG002|Overall Study|Lack of Efficacy|0
7526050|NCT02576938|11867054|FG000|Overall Study|Lost to Follow-up|2
7526051|NCT02576938|11867055|FG001|Overall Study|Lost to Follow-up|0
7526052|NCT02576938|11867056|FG002|Overall Study|Lost to Follow-up|1
7526053|NCT02576938|11867054|FG000|Overall Study|Physician Decision|0
7526054|NCT02576938|11867055|FG001|Overall Study|Physician Decision|1
7526055|NCT02576938|11867056|FG002|Overall Study|Physician Decision|0
7526056|NCT02576938|11867054|FG000|Overall Study|Met Exclusion Criteria|0
7526057|NCT02576938|11867055|FG001|Overall Study|Met Exclusion Criteria|1
7526058|NCT02576938|11867056|FG002|Overall Study|Met Exclusion Criteria|0
7526059|NCT02576951|11867070|FG000|Overall Study|Lost to Follow-up|0
7526060|NCT02576951|11867071|FG001|Overall Study|Lost to Follow-up|0
7526061|NCT02576951|11867072|FG002|Overall Study|Lost to Follow-up|2
7526062|NCT02576951|11867073|FG003|Overall Study|Lost to Follow-up|2
7526063|NCT02576951|11867070|FG000|Overall Study|Withdrawal by Subject|1
7526064|NCT02576951|11867071|FG001|Overall Study|Withdrawal by Subject|0
7526065|NCT02576951|11867072|FG002|Overall Study|Withdrawal by Subject|0
7526066|NCT02576951|11867073|FG003|Overall Study|Withdrawal by Subject|2
7526067|NCT02576951|11867070|FG000|Overall Study|Protocol Violation|0
7526068|NCT02576951|11867071|FG001|Overall Study|Protocol Violation|0
7526069|NCT02576951|11867072|FG002|Overall Study|Protocol Violation|0
7526070|NCT02576951|11867073|FG003|Overall Study|Protocol Violation|1
7526071|NCT02576977|11867087|FG000|Overall Study|Adverse Event|13
7526072|NCT02576977|11867088|FG001|Overall Study|Adverse Event|2
7526073|NCT02576977|11867087|FG000|Overall Study|Death|73
7526074|NCT02576977|11867088|FG001|Overall Study|Death|60
7526075|NCT02576977|11867087|FG000|Overall Study|Screen failure|1
7526076|NCT02576977|11867088|FG001|Overall Study|Screen failure|0
7526077|NCT02576977|11867087|FG000|Overall Study|Study Terminated at Selected Sites|27
7526078|NCT02576977|11867088|FG001|Overall Study|Study Terminated at Selected Sites|50
7526079|NCT02576977|11867087|FG000|Overall Study|Withdrawal by Subject|11
7526080|NCT02576977|11867088|FG001|Overall Study|Withdrawal by Subject|11
7526081|NCT02576977|11867087|FG000|Overall Study|Final Disposition Unknown|0
7526082|NCT02576977|11867088|FG001|Overall Study|Final Disposition Unknown|1
7526083|NCT02576977|11867087|FG000|Overall Study|Lost to Follow-up|1
7526084|NCT02576977|11867088|FG001|Overall Study|Lost to Follow-up|0
7526085|NCT02576977|11867087|FG000|Overall Study|Progressive Disease|0
7526086|NCT02576977|11867088|FG001|Overall Study|Progressive Disease|1
7526087|NCT02576990|11867096|FG000|Overall Study|Death|29
7526088|NCT02576990|11867097|FG001|Overall Study|Death|18
7526089|NCT02576990|11867096|FG000|Overall Study|Physician Decision|1
7526090|NCT02576990|11867097|FG001|Overall Study|Physician Decision|0
7526091|NCT02576990|11867096|FG000|Overall Study|Screen failure|2
7526092|NCT02576990|11867097|FG001|Overall Study|Screen failure|0
7526093|NCT02576990|11867096|FG000|Overall Study|Sponsor's decision|24
7526094|NCT02576990|11867097|FG001|Overall Study|Sponsor's decision|4
7526095|NCT02576990|11867096|FG000|Overall Study|Withdrawal by Subject|0
7526096|NCT02576990|11867097|FG001|Overall Study|Withdrawal by Subject|2
7526097|NCT02577003|11867105|FG000|Overall Study|Adverse Event|2
7526098|NCT02577003|11867106|FG001|Overall Study|Adverse Event|4
7526099|NCT02577003|11867105|FG000|Overall Study|Withdrawal by Subject|0
7526100|NCT02577003|11867106|FG001|Overall Study|Withdrawal by Subject|1
7526101|NCT02577016|11867114|FG000|Overall Study|Adverse Event|2
7526102|NCT02577016|11867115|FG001|Overall Study|Adverse Event|1
7526103|NCT02577016|11867114|FG000|Overall Study|Physician Decision|0
7526104|NCT02577016|11867115|FG001|Overall Study|Physician Decision|1
7526105|NCT02577029|11867129|FG000|Overall Study|Adverse Event|1
7526106|NCT02577029|11867130|FG001|Overall Study|Adverse Event|0
7526107|NCT02577029|11867131|FG002|Overall Study|Adverse Event|2
7526108|NCT02577029|11867132|FG003|Overall Study|Adverse Event|0
7526109|NCT02577029|11867133|FG004|Overall Study|Adverse Event|1
7526110|NCT02577029|11867134|FG005|Overall Study|Adverse Event|0
7526111|NCT02577029|11867135|FG006|Overall Study|Adverse Event|0
7526112|NCT02577029|11867136|FG007|Overall Study|Adverse Event|0
7526113|NCT02577029|11867129|FG000|Overall Study|Withdrawal by Subject|0
7526114|NCT02577029|11867130|FG001|Overall Study|Withdrawal by Subject|0
7526115|NCT02577029|11867131|FG002|Overall Study|Withdrawal by Subject|0
7526116|NCT02577029|11867132|FG003|Overall Study|Withdrawal by Subject|0
7526117|NCT02577029|11867133|FG004|Overall Study|Withdrawal by Subject|0
7526118|NCT02577029|11867134|FG005|Overall Study|Withdrawal by Subject|1
7526119|NCT02577029|11867135|FG006|Overall Study|Withdrawal by Subject|0
7526120|NCT02577029|11867136|FG007|Overall Study|Withdrawal by Subject|0
7526121|NCT02577029|11867129|FG000|Overall Study|Sponsor Termination of the Study|9
7526122|NCT02577029|11867130|FG001|Overall Study|Sponsor Termination of the Study|2
7526123|NCT02577029|11867131|FG002|Overall Study|Sponsor Termination of the Study|5
7526124|NCT02577029|11867132|FG003|Overall Study|Sponsor Termination of the Study|12
7526125|NCT02577029|11867133|FG004|Overall Study|Sponsor Termination of the Study|10
7526126|NCT02577029|11867134|FG005|Overall Study|Sponsor Termination of the Study|12
7526127|NCT02577029|11867135|FG006|Overall Study|Sponsor Termination of the Study|12
7526128|NCT02577029|11867136|FG007|Overall Study|Sponsor Termination of the Study|12
7526129|NCT02577107|11867166|FG000|Overall Study|Protocol deviation|0
7526130|NCT02577107|11867167|FG001|Overall Study|Protocol deviation|1
7526131|NCT02577146|11867173|FG000|Overall Study|Lost to Follow-up|8
7526132|NCT02577146|11867173|FG000|Overall Study|Physician Decision|3
7526133|NCT02577146|11867173|FG000|Overall Study|Screen Failure|17
7526134|NCT02577315|11867179|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7526135|NCT02577315|11867180|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7526136|NCT02577718|11867232|FG000|Overall Study|Death|6
7526137|NCT02577718|11867232|FG000|Overall Study|Withdrawal by Subject|2
7526138|NCT02577887|11867247|FG000|Overall Study|Death|93
7526139|NCT02577887|11867247|FG000|Overall Study|Protocol Violation|125
7526140|NCT02577887|11867247|FG000|Overall Study|Withdrawal by Subject|80
7526141|NCT02578186|11867286|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7526142|NCT02578186|11867287|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
7526143|NCT02578186|11867286|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
7526144|NCT02578186|11867287|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
7526145|NCT02578316|11867301|FG000|Extension Phase|Progression of disease|6
7526146|NCT02578706|11867312|FG000|Overall Study|Withdrawal by Subject|1
7526147|NCT02578706|11867313|FG001|Overall Study|Withdrawal by Subject|0
7526148|NCT02578706|11867314|FG002|Overall Study|Withdrawal by Subject|0
7526149|NCT02578706|11867312|FG000|Overall Study|Lost to Follow-up|0
7526150|NCT02578706|11867313|FG001|Overall Study|Lost to Follow-up|4
7526151|NCT02578706|11867314|FG002|Overall Study|Lost to Follow-up|0
7526152|NCT02578706|11867312|FG000|Overall Study|Physician Decision|0
7526153|NCT02578706|11867313|FG001|Overall Study|Physician Decision|1
7526154|NCT02578706|11867314|FG002|Overall Study|Physician Decision|0
7537161|NCT02731638|11885621|FG001|Overall Study|Lost to Follow-up|9
7537162|NCT02731690|11885627|FG000|Overall Study|Adverse Event|1
7537163|NCT02731690|11885627|FG000|Overall Study|Withdrawal by Subject|3
7537164|NCT02731690|11885627|FG000|Overall Study|Discontinuation of Study by Sponsor|26
7537165|NCT02731729|11885633|FG000|Overall Study|Death|2
7537166|NCT02731729|11885634|FG001|Overall Study|Death|2
7537167|NCT02731729|11885633|FG000|Overall Study|Study terminated by Sponsor|6
7537168|NCT02731729|11885634|FG001|Overall Study|Study terminated by Sponsor|6
7537169|NCT02731729|11885633|FG000|Overall Study|Withdrawal by Subject|1
7537170|NCT02731729|11885634|FG001|Overall Study|Withdrawal by Subject|0
7537171|NCT02731742|11885644|FG000|Overall Study|Death|1
7537172|NCT02731742|11885645|FG001|Overall Study|Death|2
7537173|NCT02731742|11885646|FG002|Overall Study|Death|5
7537174|NCT02731742|11885647|FG003|Overall Study|Death|0
7537175|NCT02731742|11885644|FG000|Overall Study|Physician Decision|0
7537176|NCT02731742|11885645|FG001|Overall Study|Physician Decision|0
7537177|NCT02731742|11885646|FG002|Overall Study|Physician Decision|0
7537178|NCT02731742|11885647|FG003|Overall Study|Physician Decision|1
7537179|NCT02731742|11885644|FG000|Overall Study|Study Terminated by Sponsor|2
7537180|NCT02731742|11885645|FG001|Overall Study|Study Terminated by Sponsor|1
7537181|NCT02731742|11885646|FG002|Overall Study|Study Terminated by Sponsor|1
7537182|NCT02731742|11885647|FG003|Overall Study|Study Terminated by Sponsor|1
7537183|NCT02731755|11885657|FG000|First Intervention|Withdrawal by Subject|0
7537184|NCT02731755|11885658|FG001|First Intervention|Withdrawal by Subject|2
7537185|NCT02732015|11885684|FG000|Overall Study|Lost to Follow-up|0
7537186|NCT02732015|11885685|FG001|Overall Study|Lost to Follow-up|1
7537187|NCT02732119|11885696|FG000|Phase I|Adverse Event|1
7537188|NCT02732119|11885697|FG001|Phase I|Adverse Event|3
7537189|NCT02732119|11885698|FG002|Phase I|Adverse Event|1
7537190|NCT02732119|11885699|FG003|Phase I|Adverse Event|0
7537191|NCT02732119|11885700|FG004|Phase I|Adverse Event|0
7537192|NCT02732119|11885696|FG000|Phase I|Progressive disease|7
7537193|NCT02732119|11885697|FG001|Phase I|Progressive disease|3
7537194|NCT02732119|11885698|FG002|Phase I|Progressive disease|2
7537195|NCT02732119|11885699|FG003|Phase I|Progressive disease|0
7537196|NCT02732119|11885700|FG004|Phase I|Progressive disease|0
7537197|NCT02732119|11885696|FG000|Phase I|Protocol deviation|0
7537198|NCT02732119|11885697|FG001|Phase I|Protocol deviation|1
7537199|NCT02732119|11885698|FG002|Phase I|Protocol deviation|0
7537200|NCT02732119|11885699|FG003|Phase I|Protocol deviation|0
7537201|NCT02732119|11885700|FG004|Phase I|Protocol deviation|0
7537202|NCT02732119|11885696|FG000|Phase I|Physician Decision|0
7537203|NCT02732119|11885697|FG001|Phase I|Physician Decision|3
7537204|NCT02732119|11885698|FG002|Phase I|Physician Decision|4
7537205|NCT02732119|11885699|FG003|Phase I|Physician Decision|0
7537206|NCT02732119|11885700|FG004|Phase I|Physician Decision|0
7537207|NCT02732119|11885696|FG000|Phase II|Adverse Event|0
7537208|NCT02732119|11885697|FG001|Phase II|Adverse Event|0
7537209|NCT02732119|11885698|FG002|Phase II|Adverse Event|0
7537210|NCT02732119|11885699|FG003|Phase II|Adverse Event|3
7537211|NCT02732119|11885700|FG004|Phase II|Adverse Event|3
7537212|NCT02732119|11885696|FG000|Phase II|Death|0
7537213|NCT02732119|11885697|FG001|Phase II|Death|0
7537214|NCT02732119|11885698|FG002|Phase II|Death|0
7537215|NCT02732119|11885699|FG003|Phase II|Death|1
7537216|NCT02732119|11885700|FG004|Phase II|Death|0
7537217|NCT02732119|11885696|FG000|Phase II|Progressive dissease|0
7537218|NCT02732119|11885697|FG001|Phase II|Progressive dissease|0
7537219|NCT02732119|11885698|FG002|Phase II|Progressive dissease|0
7537220|NCT02732119|11885699|FG003|Phase II|Progressive dissease|30
7537221|NCT02732119|11885700|FG004|Phase II|Progressive dissease|23
7537222|NCT02732119|11885696|FG000|Phase II|Study terminated by sponsor|0
7537223|NCT02732119|11885697|FG001|Phase II|Study terminated by sponsor|0
7537224|NCT02732119|11885698|FG002|Phase II|Study terminated by sponsor|0
7537225|NCT02732119|11885699|FG003|Phase II|Study terminated by sponsor|2
7537226|NCT02732119|11885700|FG004|Phase II|Study terminated by sponsor|2
7537227|NCT02732119|11885696|FG000|Phase II|Other|0
7537228|NCT02732119|11885697|FG001|Phase II|Other|0
7537229|NCT02732119|11885698|FG002|Phase II|Other|0
7537230|NCT02732119|11885699|FG003|Phase II|Other|2
7537231|NCT02732119|11885700|FG004|Phase II|Other|0
7537232|NCT02732119|11885696|FG000|Phase II|Physician Decision|0
7537233|NCT02732119|11885697|FG001|Phase II|Physician Decision|0
7526155|NCT02578862|11867334|FG000|Overall Study|Withdrawal by Subject|0
7526156|NCT02578862|11867335|FG001|Overall Study|Withdrawal by Subject|1
7526157|NCT02578862|11867334|FG000|Overall Study|Unplanned unilateral procedure|0
7526158|NCT02578862|11867335|FG001|Overall Study|Unplanned unilateral procedure|1
7526159|NCT02578940|11867350|FG000|Overall Study|Screening failure|5
7526160|NCT02578940|11867350|FG000|Overall Study|Lost to Follow-up|1
7526161|NCT02578992|11867358|FG000|Overall Study|equipment not available or malfunction|3
7526162|NCT02578992|11867359|FG001|Overall Study|equipment not available or malfunction|3
7526163|NCT02579382|11867402|FG000|Main Study Phase|Lost to Follow-up|0
7526164|NCT02579382|11867403|FG001|Main Study Phase|Lost to Follow-up|0
7526165|NCT02579382|11867404|FG002|Main Study Phase|Lost to Follow-up|2
7526166|NCT02579382|11867405|FG003|Main Study Phase|Lost to Follow-up|0
7526167|NCT02579382|11867402|FG000|Main Study Phase|Withdrew Consent|0
7526168|NCT02579382|11867403|FG001|Main Study Phase|Withdrew Consent|0
7526169|NCT02579382|11867404|FG002|Main Study Phase|Withdrew Consent|0
7526170|NCT02579382|11867405|FG003|Main Study Phase|Withdrew Consent|2
7526171|NCT02579382|11867402|FG000|Main Study Phase|Lack of Efficacy|0
7526172|NCT02579382|11867403|FG001|Main Study Phase|Lack of Efficacy|0
7526173|NCT02579382|11867404|FG002|Main Study Phase|Lack of Efficacy|0
7526174|NCT02579382|11867405|FG003|Main Study Phase|Lack of Efficacy|1
7526175|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
7526176|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
7526177|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
7526178|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
7526179|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
7526180|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7526181|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
7526182|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
7526183|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
7526184|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7526185|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7526186|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
7526187|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7526188|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
7526189|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7526190|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
7526191|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7526192|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
7526193|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7526194|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
7526195|NCT02579382|11867402|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7526196|NCT02579382|11867403|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
7526197|NCT02579382|11867404|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7526198|NCT02579382|11867405|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
7526199|NCT02579603|11867442|FG000|Overall Study|Not treated|1
7526200|NCT02579603|11867443|FG001|Overall Study|Not treated|0
7526201|NCT02579603|11867442|FG000|Overall Study|Adverse Event|2
7526202|NCT02579603|11867443|FG001|Overall Study|Adverse Event|2
7526203|NCT02579603|11867442|FG000|Overall Study|Other than stated|1
7526204|NCT02579603|11867443|FG001|Overall Study|Other than stated|0
7526205|NCT02579616|11867450|FG000|Overall Study|Participants did not receive treatment|3
7526206|NCT02579629|11867457|FG000|Overall Study|Withdrawal by Subject|0
7526207|NCT02579629|11867458|FG001|Overall Study|Withdrawal by Subject|1
7526208|NCT02579629|11867459|FG002|Overall Study|Withdrawal by Subject|0
7526209|NCT02579629|11867457|FG000|Overall Study|Screen Failure|2
7526210|NCT02579629|11867458|FG001|Overall Study|Screen Failure|0
7526211|NCT02579629|11867459|FG002|Overall Study|Screen Failure|2
7526212|NCT02579759|11867470|FG000|Overall Study|Protocol Violation|2
7526213|NCT02579759|11867471|FG001|Overall Study|Protocol Violation|0
7526214|NCT02579759|11867472|FG002|Overall Study|Protocol Violation|0
7526215|NCT02579759|11867470|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
7526216|NCT02579759|11867471|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
7526217|NCT02579759|11867472|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
7526218|NCT02579759|11867470|FG000|Overall Study|BfArM hold|13
7526219|NCT02579759|11867471|FG001|Overall Study|BfArM hold|12
7526220|NCT02579759|11867472|FG002|Overall Study|BfArM hold|12
7526221|NCT02579759|11867470|FG000|Overall Study|Sponsor stopped Dose 2|0
7526222|NCT02579759|11867471|FG001|Overall Study|Sponsor stopped Dose 2|41
7526223|NCT02579759|11867472|FG002|Overall Study|Sponsor stopped Dose 2|0
7526224|NCT02579759|11867470|FG000|Overall Study|Non compliance|0
7526225|NCT02579759|11867471|FG001|Overall Study|Non compliance|1
7526226|NCT02579759|11867472|FG002|Overall Study|Non compliance|0
7526227|NCT02579759|11867470|FG000|Overall Study|Pregnancy|0
7526228|NCT02579759|11867471|FG001|Overall Study|Pregnancy|1
7526229|NCT02579759|11867472|FG002|Overall Study|Pregnancy|0
7526230|NCT02579759|11867470|FG000|Overall Study|Inclusion/exclusion criteria|0
7526231|NCT02579759|11867471|FG001|Overall Study|Inclusion/exclusion criteria|0
7526232|NCT02579759|11867472|FG002|Overall Study|Inclusion/exclusion criteria|1
7526233|NCT02579759|11867470|FG000|Overall Study|Adverse Event|4
7526234|NCT02579759|11867471|FG001|Overall Study|Adverse Event|3
7526235|NCT02579759|11867472|FG002|Overall Study|Adverse Event|1
7526236|NCT02579759|11867470|FG000|Overall Study|Withdrawal by Subject|3
7526237|NCT02579759|11867471|FG001|Overall Study|Withdrawal by Subject|3
7526238|NCT02579759|11867472|FG002|Overall Study|Withdrawal by Subject|5
7526239|NCT02579759|11867470|FG000|Overall Study|Lost to Follow-up|2
7526240|NCT02579759|11867471|FG001|Overall Study|Lost to Follow-up|2
7526241|NCT02579759|11867472|FG002|Overall Study|Lost to Follow-up|2
7526242|NCT02579772|11867482|FG000|Overall Study|Withdrawal by Subject|0
7526243|NCT02579772|11867483|FG001|Overall Study|Withdrawal by Subject|1
7526244|NCT02579772|11867482|FG000|Overall Study|Usage of additional antioxidants|1
7526245|NCT02579772|11867483|FG001|Overall Study|Usage of additional antioxidants|0
7526246|NCT02579772|11867482|FG000|Overall Study|flu-like illness, orthopedic trauma|1
7526247|NCT02579772|11867483|FG001|Overall Study|flu-like illness, orthopedic trauma|1
7526248|NCT02579863|11867491|FG000|Overall Study|Final Disposition Unknown|2
7526249|NCT02579863|11867492|FG001|Overall Study|Final Disposition Unknown|1
7526250|NCT02579863|11867491|FG000|Overall Study|Adverse Event|18
7526251|NCT02579863|11867492|FG001|Overall Study|Adverse Event|11
7526252|NCT02579863|11867491|FG000|Overall Study|Death|31
7526253|NCT02579863|11867492|FG001|Overall Study|Death|29
7526254|NCT02579863|11867491|FG000|Overall Study|Lost to Follow-up|2
7526255|NCT02579863|11867492|FG001|Overall Study|Lost to Follow-up|1
7526256|NCT02579863|11867491|FG000|Overall Study|Physician Decision|1
7526257|NCT02579863|11867492|FG001|Overall Study|Physician Decision|2
7526258|NCT02579863|11867491|FG000|Overall Study|Screen Failure|0
7526259|NCT02579863|11867492|FG001|Overall Study|Screen Failure|2
7526260|NCT02579863|11867491|FG000|Overall Study|Study Terminated at Selected Sites|82
7526261|NCT02579863|11867492|FG001|Overall Study|Study Terminated at Selected Sites|88
7526262|NCT02579863|11867491|FG000|Overall Study|Withdrawal by Subject|20
7526263|NCT02579863|11867492|FG001|Overall Study|Withdrawal by Subject|20
7526264|NCT02579928|11867518|FG000|Overall Study|Withdrawal by Subject|1
7526265|NCT02579928|11867519|FG001|Overall Study|Withdrawal by Subject|0
7526266|NCT02580240|11867547|FG000|Overall Study|Physician Decision|2
7526267|NCT02580240|11867548|FG001|Overall Study|Physician Decision|0
7526268|NCT02580357|11867561|FG000|Overall Study|Lost to Follow-up|2
7526269|NCT02580357|11867562|FG001|Overall Study|Lost to Follow-up|0
7526270|NCT02580357|11867563|FG002|Overall Study|Lost to Follow-up|0
7526271|NCT02580357|11867561|FG000|Overall Study|Protocol Violation|1
7526272|NCT02580357|11867562|FG001|Overall Study|Protocol Violation|0
7526273|NCT02580357|11867563|FG002|Overall Study|Protocol Violation|0
7526274|NCT02580591|11867575|FG000|Overall Study|Adverse Event|0
7526275|NCT02580591|11867576|FG001|Overall Study|Adverse Event|1
7526276|NCT02580591|11867577|FG002|Overall Study|Adverse Event|2
7526277|NCT02580591|11867578|FG003|Overall Study|Adverse Event|5
7526278|NCT02580591|11867575|FG000|Overall Study|Protocol Violation|3
7526279|NCT02580591|11867576|FG001|Overall Study|Protocol Violation|2
7526280|NCT02580591|11867577|FG002|Overall Study|Protocol Violation|1
7526281|NCT02580591|11867578|FG003|Overall Study|Protocol Violation|1
7526282|NCT02580591|11867575|FG000|Overall Study|Lost to Follow-up|5
7526283|NCT02580591|11867576|FG001|Overall Study|Lost to Follow-up|3
7526284|NCT02580591|11867577|FG002|Overall Study|Lost to Follow-up|3
7526285|NCT02580591|11867578|FG003|Overall Study|Lost to Follow-up|1
7526286|NCT02580591|11867575|FG000|Overall Study|Withdrawal by Subject|6
7526287|NCT02580591|11867576|FG001|Overall Study|Withdrawal by Subject|1
7526288|NCT02580591|11867577|FG002|Overall Study|Withdrawal by Subject|2
7526289|NCT02580591|11867578|FG003|Overall Study|Withdrawal by Subject|3
7526290|NCT02580591|11867575|FG000|Overall Study|Not treated|1
7526291|NCT02580591|11867576|FG001|Overall Study|Not treated|1
7526292|NCT02580591|11867577|FG002|Overall Study|Not treated|0
7526293|NCT02580591|11867578|FG003|Overall Study|Not treated|0
7526294|NCT02580591|11867575|FG000|Overall Study|Other than specified|3
7526295|NCT02580591|11867576|FG001|Overall Study|Other than specified|2
7526296|NCT02580591|11867577|FG002|Overall Study|Other than specified|5
7526297|NCT02580591|11867578|FG003|Overall Study|Other than specified|2
7526298|NCT02580877|11867594|FG000|Overall Study|Withdrawal by Subject|1
7526299|NCT02580877|11867595|FG001|Overall Study|Withdrawal by Subject|3
7526300|NCT02580877|11867594|FG000|Overall Study|Adverse Event|0
7526301|NCT02580877|11867595|FG001|Overall Study|Adverse Event|1
7526302|NCT02581163|11867611|FG000|Overall Study|Failure to return|15
7526303|NCT02581163|11867611|FG000|Overall Study|Insufficient virological response|3
7526304|NCT02581163|11867611|FG000|Overall Study|Withdrew consent|1
7526305|NCT02581163|11867611|FG000|Overall Study|Death|1
7526306|NCT02581163|11867611|FG000|Overall Study|Other, not specified|9
7526307|NCT02581189|11867618|FG000|Overall Study|Failure to return|36
7526308|NCT02581189|11867618|FG000|Overall Study|Withdrew consent|5
7526309|NCT02581189|11867618|FG000|Overall Study|Death|3
7526310|NCT02581189|11867618|FG000|Overall Study|Insufficient virological response|2
7526311|NCT02581189|11867618|FG000|Overall Study|Other, not specified|7
7526312|NCT02581202|11867625|FG000|Overall Study|Lack of Efficacy|2
7526313|NCT02581202|11867625|FG000|Overall Study|Withdrawal by Subject|4
7526314|NCT02581202|11867625|FG000|Overall Study|Lost to Follow-up|5
7526315|NCT02581202|11867625|FG000|Overall Study|Pregnancy|3
7526316|NCT02581345|11867632|FG000|Part 1: up to Week 16|Adverse Event|3
7526317|NCT02581345|11867633|FG001|Part 1: up to Week 16|Adverse Event|8
7526318|NCT02581345|11867634|FG002|Part 1: up to Week 16|Adverse Event|0
7526319|NCT02581345|11867635|FG003|Part 1: up to Week 16|Adverse Event|0
7526320|NCT02581345|11867632|FG000|Part 1: up to Week 16|Physician Decision|2
7526321|NCT02581345|11867633|FG001|Part 1: up to Week 16|Physician Decision|4
7526322|NCT02581345|11867634|FG002|Part 1: up to Week 16|Physician Decision|0
7526323|NCT02581345|11867635|FG003|Part 1: up to Week 16|Physician Decision|0
7526324|NCT02581345|11867632|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
7526325|NCT02581345|11867633|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
7526326|NCT02581345|11867634|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
7526327|NCT02581345|11867635|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
7526328|NCT02581345|11867632|FG000|Part 1: up to Week 16|Lost to Follow-up|2
7526329|NCT02581345|11867633|FG001|Part 1: up to Week 16|Lost to Follow-up|0
7526330|NCT02581345|11867634|FG002|Part 1: up to Week 16|Lost to Follow-up|0
7526331|NCT02581345|11867635|FG003|Part 1: up to Week 16|Lost to Follow-up|0
7526332|NCT02581345|11867632|FG000|Part 1: up to Week 16|Unspecified Reason|3
7526333|NCT02581345|11867633|FG001|Part 1: up to Week 16|Unspecified Reason|3
7526334|NCT02581345|11867634|FG002|Part 1: up to Week 16|Unspecified Reason|0
7526335|NCT02581345|11867635|FG003|Part 1: up to Week 16|Unspecified Reason|0
7526336|NCT02581345|11867632|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
7526337|NCT02581345|11867633|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
7526338|NCT02581345|11867634|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
7526339|NCT02581345|11867635|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
7526340|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
7526341|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
7526342|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
7526343|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
7526344|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
7526345|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
7526346|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
7526347|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
7526348|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
7526349|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
7526350|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
7526351|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
7526352|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
7526353|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
7526354|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
7526355|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
7526356|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
7526357|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7526358|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
7526359|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
7526360|NCT02581345|11867632|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
7526361|NCT02581345|11867633|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
7526362|NCT02581345|11867634|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
7526363|NCT02581345|11867635|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
7526364|NCT02581410|11867663|FG000|Vaccination Phase|Adverse Event|2
7526365|NCT02581410|11867664|FG001|Vaccination Phase|Adverse Event|1
7526366|NCT02581410|11867663|FG000|Vaccination Phase|Withdrawal by Subject|0
7526367|NCT02581410|11867664|FG001|Vaccination Phase|Withdrawal by Subject|1
7526368|NCT02581410|11867663|FG000|Vaccination Phase|Migrated/moved from study area|0
7526369|NCT02581410|11867664|FG001|Vaccination Phase|Migrated/moved from study area|1
7526370|NCT02581410|11867663|FG000|End of Study Phase|Adverse Event|4
7526371|NCT02581410|11867664|FG001|End of Study Phase|Adverse Event|3
7526372|NCT02581410|11867663|FG000|End of Study Phase|Withdrawal by Subject|1
7526373|NCT02581410|11867664|FG001|End of Study Phase|Withdrawal by Subject|2
7526374|NCT02581410|11867663|FG000|End of Study Phase|Migrated/moved from study area|0
7526375|NCT02581410|11867664|FG001|End of Study Phase|Migrated/moved from study area|3
7526376|NCT02581410|11867663|FG000|End of Study Phase|Lost to Follow-up|0
7526377|NCT02581410|11867664|FG001|End of Study Phase|Lost to Follow-up|2
7526378|NCT02581410|11867663|FG000|End of Study Phase|Other-transfer of subject not completed|0
7526379|NCT02581410|11867664|FG001|End of Study Phase|Other-transfer of subject not completed|1
7526380|NCT02581488|11867682|FG000|Overall Study|Adverse Event|6
7526381|NCT02581488|11867683|FG001|Overall Study|Adverse Event|7
7526382|NCT02581488|11867682|FG000|Overall Study|Lost to Follow-up|1
7526383|NCT02581488|11867683|FG001|Overall Study|Lost to Follow-up|0
7526384|NCT02581488|11867682|FG000|Overall Study|Withdrawal by Subject|1
7526385|NCT02581488|11867683|FG001|Overall Study|Withdrawal by Subject|0
7526386|NCT02581488|11867682|FG000|Overall Study|Non-Compliance|1
7526387|NCT02581488|11867683|FG001|Overall Study|Non-Compliance|0
7526388|NCT02581488|11867682|FG000|Overall Study|Protocol Violation|0
7526389|NCT02581488|11867683|FG001|Overall Study|Protocol Violation|4
7526390|NCT02581891|11867711|FG000|Overall Study|Adverse Event|4
7526391|NCT02581891|11867712|FG001|Overall Study|Adverse Event|6
7526392|NCT02581891|11867711|FG000|Overall Study|Death|3
7526393|NCT02581891|11867712|FG001|Overall Study|Death|4
7526394|NCT02581891|11867711|FG000|Overall Study|Lost to Follow-up|1
7526395|NCT02581891|11867712|FG001|Overall Study|Lost to Follow-up|2
7526396|NCT02581891|11867711|FG000|Overall Study|Physician Decision|0
7526397|NCT02581891|11867712|FG001|Overall Study|Physician Decision|1
7526398|NCT02581891|11867711|FG000|Overall Study|Withdrawal by Subject|4
7526399|NCT02581891|11867712|FG001|Overall Study|Withdrawal by Subject|5
7526400|NCT02581891|11867711|FG000|Overall Study|Other Reasons|3
7526401|NCT02581891|11867712|FG001|Overall Study|Other Reasons|1
7526402|NCT02581891|11867711|FG000|Overall Study|Discontinued during followup|1
7526403|NCT02581891|11867712|FG001|Overall Study|Discontinued during followup|0
7526404|NCT02581995|11867719|FG000|Overall Study|Unspecified other|3
7526405|NCT02581995|11867719|FG000|Overall Study|Adverse Event|6
7526406|NCT02581995|11867719|FG000|Overall Study|Lost to Follow-up|5
7526407|NCT02581995|11867719|FG000|Overall Study|Withdrawal by participant|12
7526408|NCT02581995|11867719|FG000|Overall Study|Physician Decision|1
7526409|NCT02581995|11867719|FG000|Overall Study|Death|4
7526410|NCT02582242|11867739|FG000|Overall Study|Adverse Event|4
7526411|NCT02582242|11867740|FG001|Overall Study|Adverse Event|3
7526412|NCT02582242|11867739|FG000|Overall Study|Protocol Violation|3
7526413|NCT02582242|11867740|FG001|Overall Study|Protocol Violation|1
7526414|NCT02582242|11867739|FG000|Overall Study|Lost to Follow-up|0
7526415|NCT02582242|11867740|FG001|Overall Study|Lost to Follow-up|1
7526416|NCT02582242|11867739|FG000|Overall Study|Withdrawal by Subject|11
7526417|NCT02582242|11867740|FG001|Overall Study|Withdrawal by Subject|11
7526418|NCT02582242|11867739|FG000|Overall Study|Unclassified|2
7526419|NCT02582242|11867740|FG001|Overall Study|Unclassified|1
7526420|NCT02582255|11867748|FG000|Overall Study|Protocol Violation|0
7526421|NCT02582255|11867749|FG001|Overall Study|Protocol Violation|3
7526422|NCT02582515|11867758|FG000|Overall Study|Withdrawal by Subject|0
7526423|NCT02582515|11867759|FG001|Overall Study|Withdrawal by Subject|1
7526424|NCT02582632|11867765|FG000|Overall Study|Other|1
7526425|NCT02582658|11867769|FG000|Overall Study|Failure to Return|10
7526426|NCT02582658|11867769|FG000|Overall Study|Insufficient Virological Response|2
7526427|NCT02582658|11867769|FG000|Overall Study|Withdrawn Consent|1
7526428|NCT02582658|11867769|FG000|Overall Study|Death|1
7526429|NCT02582658|11867769|FG000|Overall Study|Not further specified|11
7526430|NCT02582671|11867773|FG000|Overall Study|Failure to return|1
7526431|NCT02582671|11867773|FG000|Overall Study|Other, not specified|1
7526432|NCT02582684|11867778|FG000|Overall Study|Unable to contact subject/parent|4
7526433|NCT02582684|11867778|FG000|Overall Study|Subject not able to get to clinic|10
7526434|NCT02582684|11867778|FG000|Overall Study|Subject withdrew consent|1
7526435|NCT02582684|11867778|FG000|Overall Study|Found to be ineligible after enrollment|2
7526436|NCT02582814|11867784|FG000|Overall Study|Study-specific withdrawal criteria|1
7526437|NCT02582814|11867785|FG001|Overall Study|Study-specific withdrawal criteria|0
7526438|NCT02582814|11867784|FG000|Overall Study|Withdrawal by Subject|4
7526439|NCT02582814|11867785|FG001|Overall Study|Withdrawal by Subject|3
7526440|NCT02582814|11867784|FG000|Overall Study|Adverse Event|4
7526441|NCT02582814|11867785|FG001|Overall Study|Adverse Event|4
7526442|NCT02582866|11867806|FG000|Overall Study|Death|1
7526443|NCT02582866|11867806|FG000|Overall Study|Lack of Efficacy|2
7526444|NCT02582866|11867806|FG000|Overall Study|Lost to Follow-up|2
7526445|NCT02582866|11867806|FG000|Overall Study|Withdrawal by Subject|7
7526446|NCT02582866|11867806|FG000|Overall Study|Investigator decision|5
7526447|NCT02582866|11867806|FG000|Overall Study|Participant wants to get pregnant|1
7526448|NCT02582866|11867806|FG000|Overall Study|Pregnancy|2
7526449|NCT02582866|11867806|FG000|Overall Study|Sponsor decision|1
7526450|NCT02582866|11867806|FG000|Overall Study|Withdrawal due to personal reasons|1
7526451|NCT02582983|11867814|FG000|Overall Study|Death|3
7526452|NCT02582983|11867814|FG000|Overall Study|Withdrawal by Subject|2
7526453|NCT02582983|11867814|FG000|Overall Study|Adverse Event|1
7526454|NCT02583256|11867826|FG000|Overall Study|Withdrawal by Subject|0
7526455|NCT02583256|11867827|FG001|Overall Study|Withdrawal by Subject|1
7526456|NCT02583256|11867828|FG002|Overall Study|Withdrawal by Subject|1
7526457|NCT02583256|11867829|FG003|Overall Study|Withdrawal by Subject|0
7526458|NCT02583256|11867826|FG000|Overall Study|Lost to Follow-up|1
7526459|NCT02583256|11867827|FG001|Overall Study|Lost to Follow-up|1
7526460|NCT02583256|11867828|FG002|Overall Study|Lost to Follow-up|0
7526461|NCT02583256|11867829|FG003|Overall Study|Lost to Follow-up|1
7526462|NCT02583256|11867826|FG000|Overall Study|Administrative/Other|2
7526463|NCT02583256|11867827|FG001|Overall Study|Administrative/Other|0
7526464|NCT02583256|11867828|FG002|Overall Study|Administrative/Other|1
7526465|NCT02583256|11867829|FG003|Overall Study|Administrative/Other|2
7526466|NCT02583399|11867850|FG000|Overall Study|Able to be discharged|3
7526467|NCT02583399|11867850|FG000|Overall Study|Wanted to use a restricted medication|3
7526468|NCT02583425|11867854|FG000|Screening|Did not meet entry criteria|12
7526469|NCT02583425|11867854|FG000|Baseline|Did not meet continued criteria|5
7526470|NCT02583425|11867854|FG000|Treatment Period|Adverse Event|1
7526471|NCT02583477|11867861|FG000|Overall Study|Adverse Event|0
7526472|NCT02583477|11867862|FG001|Overall Study|Adverse Event|2
7526473|NCT02583477|11867861|FG000|Overall Study|Death|1
7526474|NCT02583477|11867862|FG001|Overall Study|Death|16
7526475|NCT02583477|11867861|FG000|Overall Study|Study terminated|2
7526476|NCT02583477|11867862|FG001|Overall Study|Study terminated|2
7526477|NCT02583711|11867872|FG000|Overall Study|Withdrawal by Subject|0
7526478|NCT02583711|11867873|FG001|Overall Study|Withdrawal by Subject|10
7526479|NCT02583711|11867874|FG002|Overall Study|Withdrawal by Subject|0
7526480|NCT02584257|11867888|FG000|Period 1|Withdrawal by Subject|0
7526481|NCT02584257|11867889|FG001|Period 1|Withdrawal by Subject|0
7526482|NCT02584257|11867890|FG002|Period 1|Withdrawal by Subject|0
7526483|NCT02584257|11867891|FG003|Period 1|Withdrawal by Subject|0
7526484|NCT02584257|11867892|FG004|Period 1|Withdrawal by Subject|0
7526485|NCT02584257|11867893|FG005|Period 1|Withdrawal by Subject|0
7526486|NCT02584257|11867894|FG006|Period 1|Withdrawal by Subject|1
7526487|NCT02584257|11867895|FG007|Period 1|Withdrawal by Subject|0
7526488|NCT02584257|11867896|FG008|Period 1|Withdrawal by Subject|0
7526489|NCT02584257|11867888|FG000|Period 2|Physician Decision|1
7526490|NCT02584257|11867889|FG001|Period 2|Physician Decision|0
7526491|NCT02584257|11867890|FG002|Period 2|Physician Decision|0
7526492|NCT02584257|11867891|FG003|Period 2|Physician Decision|0
7526493|NCT02584257|11867892|FG004|Period 2|Physician Decision|0
7526494|NCT02584257|11867893|FG005|Period 2|Physician Decision|0
7526495|NCT02584257|11867894|FG006|Period 2|Physician Decision|0
7526496|NCT02584257|11867895|FG007|Period 2|Physician Decision|0
7526497|NCT02584257|11867896|FG008|Period 2|Physician Decision|0
7526498|NCT02584257|11867888|FG000|Period 2|Adverse Event|0
7526499|NCT02584257|11867889|FG001|Period 2|Adverse Event|1
7526500|NCT02584257|11867890|FG002|Period 2|Adverse Event|0
7526501|NCT02584257|11867891|FG003|Period 2|Adverse Event|0
7526502|NCT02584257|11867892|FG004|Period 2|Adverse Event|0
7526503|NCT02584257|11867893|FG005|Period 2|Adverse Event|0
7526504|NCT02584257|11867894|FG006|Period 2|Adverse Event|0
7526505|NCT02584257|11867895|FG007|Period 2|Adverse Event|0
7526506|NCT02584257|11867896|FG008|Period 2|Adverse Event|0
7526507|NCT02584452|11867910|FG000|Overall Study|Physician Decision|1
7526508|NCT02584452|11867911|FG001|Overall Study|Physician Decision|1
7526509|NCT02584452|11867910|FG000|Overall Study|Lost to Follow-up|1
7526510|NCT02584452|11867911|FG001|Overall Study|Lost to Follow-up|1
7526511|NCT02584504|11867921|FG000|Double-blind Treatment|Participant withdrew consent|0
7526512|NCT02584504|11867922|FG001|Double-blind Treatment|Participant withdrew consent|0
7526513|NCT02584504|11867923|FG002|Double-blind Treatment|Participant withdrew consent|1
7526514|NCT02584504|11867921|FG000|Double-blind Treatment|Adverse Event|0
7526515|NCT02584504|11867922|FG001|Double-blind Treatment|Adverse Event|1
7526516|NCT02584504|11867923|FG002|Double-blind Treatment|Adverse Event|0
7526517|NCT02584504|11867921|FG000|Double-blind Treatment|Family Matter|0
7526518|NCT02584504|11867922|FG001|Double-blind Treatment|Family Matter|1
7526519|NCT02584504|11867923|FG002|Double-blind Treatment|Family Matter|0
7526520|NCT02584504|11867921|FG000|Open-label Treatment|Participant withdrew consent|0
7526521|NCT02584504|11867922|FG001|Open-label Treatment|Participant withdrew consent|0
7526522|NCT02584504|11867923|FG002|Open-label Treatment|Participant withdrew consent|4
7526523|NCT02584504|11867921|FG000|Open-label Treatment|Adverse Event|2
7526524|NCT02584504|11867922|FG001|Open-label Treatment|Adverse Event|2
7526525|NCT02584504|11867923|FG002|Open-label Treatment|Adverse Event|3
7526526|NCT02584504|11867921|FG000|Open-label Treatment|Physician Decision|0
7526527|NCT02584504|11867922|FG001|Open-label Treatment|Physician Decision|1
7526528|NCT02584504|11867923|FG002|Open-label Treatment|Physician Decision|0
7526529|NCT02584504|11867921|FG000|Open-label Treatment|Entered but not treated|0
7526530|NCT02584504|11867922|FG001|Open-label Treatment|Entered but not treated|1
7526531|NCT02584504|11867923|FG002|Open-label Treatment|Entered but not treated|1
7526532|NCT02584660|11867941|FG000|Overall Study|Adverse Event|4
7526533|NCT02584660|11867942|FG001|Overall Study|Adverse Event|0
7526534|NCT02584660|11867941|FG000|Overall Study|Lost to Follow-up|3
7526535|NCT02584660|11867942|FG001|Overall Study|Lost to Follow-up|4
7526536|NCT02584660|11867941|FG000|Overall Study|Protocol Violation|0
7526537|NCT02584660|11867942|FG001|Overall Study|Protocol Violation|1
7526538|NCT02584660|11867941|FG000|Overall Study|Withdrawal by Subject|0
7526539|NCT02584660|11867942|FG001|Overall Study|Withdrawal by Subject|2
7526540|NCT02584660|11867941|FG000|Overall Study|Other|0
7526541|NCT02584660|11867942|FG001|Overall Study|Other|1
7526542|NCT02584855|11867984|FG000|Open-Label Treatment Period|Lack of Efficacy|61
7526543|NCT02584855|11867985|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7526544|NCT02584855|11867986|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7526545|NCT02584855|11867987|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7526546|NCT02584855|11867988|FG004|Open-Label Treatment Period|Lack of Efficacy|0
7526547|NCT02584855|11867989|FG005|Open-Label Treatment Period|Lack of Efficacy|0
7526548|NCT02584855|11867984|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
7526549|NCT02584855|11867985|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7526550|NCT02584855|11867986|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7526551|NCT02584855|11867987|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7526552|NCT02584855|11867988|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
7526553|NCT02584855|11867989|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
7526554|NCT02584855|11867984|FG000|Open-Label Treatment Period|Adverse Event|14
7526555|NCT02584855|11867985|FG001|Open-Label Treatment Period|Adverse Event|0
7526556|NCT02584855|11867986|FG002|Open-Label Treatment Period|Adverse Event|0
7526557|NCT02584855|11867987|FG003|Open-Label Treatment Period|Adverse Event|0
7526558|NCT02584855|11867988|FG004|Open-Label Treatment Period|Adverse Event|0
7526559|NCT02584855|11867989|FG005|Open-Label Treatment Period|Adverse Event|0
7526560|NCT02584855|11867984|FG000|Open-Label Treatment Period|Death|2
7526561|NCT02584855|11867985|FG001|Open-Label Treatment Period|Death|0
7526562|NCT02584855|11867986|FG002|Open-Label Treatment Period|Death|0
7526563|NCT02584855|11867987|FG003|Open-Label Treatment Period|Death|0
7526564|NCT02584855|11867988|FG004|Open-Label Treatment Period|Death|0
7526565|NCT02584855|11867989|FG005|Open-Label Treatment Period|Death|0
7526566|NCT02584855|11867984|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7526567|NCT02584855|11867985|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7526568|NCT02584855|11867986|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7526569|NCT02584855|11867987|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7526570|NCT02584855|11867988|FG004|Open-Label Treatment Period|Lost to Follow-up|0
7526571|NCT02584855|11867989|FG005|Open-Label Treatment Period|Lost to Follow-up|0
7526572|NCT02584855|11867984|FG000|Open-Label Treatment Period|Protocol Violation|1
7526573|NCT02584855|11867985|FG001|Open-Label Treatment Period|Protocol Violation|0
7526574|NCT02584855|11867986|FG002|Open-Label Treatment Period|Protocol Violation|0
7526575|NCT02584855|11867987|FG003|Open-Label Treatment Period|Protocol Violation|0
7526576|NCT02584855|11867988|FG004|Open-Label Treatment Period|Protocol Violation|0
7526577|NCT02584855|11867989|FG005|Open-Label Treatment Period|Protocol Violation|0
7526578|NCT02584855|11867984|FG000|Open-Label Treatment Period|No PI Available|2
7526579|NCT02584855|11867985|FG001|Open-Label Treatment Period|No PI Available|0
7526580|NCT02584855|11867986|FG002|Open-Label Treatment Period|No PI Available|0
7526581|NCT02584855|11867987|FG003|Open-Label Treatment Period|No PI Available|0
7526582|NCT02584855|11867988|FG004|Open-Label Treatment Period|No PI Available|0
7526583|NCT02584855|11867989|FG005|Open-Label Treatment Period|No PI Available|0
7526584|NCT02584855|11867984|FG000|Open-Label Treatment Period|Sponsor Decision|1
7526585|NCT02584855|11867985|FG001|Open-Label Treatment Period|Sponsor Decision|0
7526586|NCT02584855|11867986|FG002|Open-Label Treatment Period|Sponsor Decision|0
7526587|NCT02584855|11867987|FG003|Open-Label Treatment Period|Sponsor Decision|0
7526588|NCT02584855|11867988|FG004|Open-Label Treatment Period|Sponsor Decision|0
7526589|NCT02584855|11867989|FG005|Open-Label Treatment Period|Sponsor Decision|0
7526590|NCT02584855|11867984|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7526591|NCT02584855|11867985|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7526592|NCT02584855|11867986|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
7526593|NCT02584855|11867987|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7526594|NCT02584855|11867988|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7526595|NCT02584855|11867989|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
7526596|NCT02584855|11867984|FG000|Double-Blind Withdrawal Period|Adverse Event|0
7526597|NCT02584855|11867985|FG001|Double-Blind Withdrawal Period|Adverse Event|4
7526598|NCT02584855|11867986|FG002|Double-Blind Withdrawal Period|Adverse Event|0
7526599|NCT02584855|11867987|FG003|Double-Blind Withdrawal Period|Adverse Event|1
7526600|NCT02584855|11867988|FG004|Double-Blind Withdrawal Period|Adverse Event|0
7526601|NCT02584855|11867989|FG005|Double-Blind Withdrawal Period|Adverse Event|0
7526602|NCT02584855|11867984|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
7526603|NCT02584855|11867985|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
7526604|NCT02584855|11867986|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
7526605|NCT02584855|11867987|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
7526606|NCT02584855|11867988|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
7526607|NCT02584855|11867989|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
7526608|NCT02584855|11867984|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7526609|NCT02584855|11867985|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
7526610|NCT02584855|11867986|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7526611|NCT02584855|11867987|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7526612|NCT02584855|11867988|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7526613|NCT02584855|11867989|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
7526614|NCT02584855|11867984|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
7526615|NCT02584855|11867985|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
7526616|NCT02584855|11867986|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
7526617|NCT02584855|11867987|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
7526618|NCT02584855|11867988|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
7526619|NCT02584855|11867989|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
7526620|NCT02584855|11867984|FG000|Post Treatment Follow-up Period|Protocol Violation|0
7526621|NCT02584855|11867985|FG001|Post Treatment Follow-up Period|Protocol Violation|0
7526622|NCT02584855|11867986|FG002|Post Treatment Follow-up Period|Protocol Violation|0
7526623|NCT02584855|11867987|FG003|Post Treatment Follow-up Period|Protocol Violation|0
7526624|NCT02584855|11867988|FG004|Post Treatment Follow-up Period|Protocol Violation|1
7526625|NCT02584855|11867989|FG005|Post Treatment Follow-up Period|Protocol Violation|0
7526626|NCT02584959|11868014|FG000|Period 1|Withdrawn from study|3
7526627|NCT02584959|11868015|FG001|Period 1|Withdrawn from study|4
7526628|NCT02584959|11868016|FG002|Period 1|Withdrawn from study|0
7526629|NCT02584959|11868014|FG000|Period 2|Withdrawn from study|6
7526630|NCT02584959|11868015|FG001|Period 2|Withdrawn from study|1
7526631|NCT02584959|11868016|FG002|Period 2|Withdrawn from study|2
7526632|NCT02585713|11868062|FG000|Overall Study|Withdrew prior to treatment|2
7526633|NCT02585713|11868063|FG001|Overall Study|Withdrew prior to treatment|7
7526634|NCT02585713|11868062|FG000|Overall Study|Other|3
7526635|NCT02585713|11868063|FG001|Overall Study|Other|1
7526636|NCT02585778|11868073|FG000|Overall Study|Adverse Event|17
7526637|NCT02585778|11868074|FG001|Overall Study|Adverse Event|4
7526638|NCT02585778|11868073|FG000|Overall Study|Participant did not wish to continue|9
7526639|NCT02585778|11868074|FG001|Overall Study|Participant did not wish to continue|4
7526640|NCT02585778|11868073|FG000|Overall Study|Poor compliance to study protocol|0
7526641|NCT02585778|11868074|FG001|Overall Study|Poor compliance to study protocol|2
7526642|NCT02585778|11868073|FG000|Overall Study|Death|0
7526643|NCT02585778|11868074|FG001|Overall Study|Death|1
7526644|NCT02585778|11868073|FG000|Overall Study|Randomized but not treated|1
7526645|NCT02585778|11868074|FG001|Overall Study|Randomized but not treated|2
7526646|NCT02585778|11868073|FG000|Overall Study|Other than specified above|6
7526647|NCT02585778|11868074|FG001|Overall Study|Other than specified above|2
7526648|NCT02585830|11868084|FG000|Overall Study|Withdrawal by Subject|3
7526649|NCT02585934|11868111|FG000|Overall Study|Lost to Follow-up|2
7526650|NCT02585934|11868112|FG001|Overall Study|Lost to Follow-up|2
7526651|NCT02585934|11868111|FG000|Overall Study|Protocol Violation|14
7526652|NCT02585934|11868112|FG001|Overall Study|Protocol Violation|11
7526653|NCT02585934|11868111|FG000|Overall Study|Adverse Event|21
7526654|NCT02585934|11868112|FG001|Overall Study|Adverse Event|22
7526655|NCT02585934|11868111|FG000|Overall Study|Physician Decision|3
7526656|NCT02585934|11868112|FG001|Overall Study|Physician Decision|2
7526657|NCT02585934|11868111|FG000|Overall Study|Withdrawal by Subject|7
7526658|NCT02585934|11868112|FG001|Overall Study|Withdrawal by Subject|21
7526659|NCT02585934|11868111|FG000|Overall Study|Lack of Efficacy|2
7526660|NCT02585934|11868112|FG001|Overall Study|Lack of Efficacy|1
7526661|NCT02585934|11868111|FG000|Overall Study|Death|2
7526662|NCT02585934|11868112|FG001|Overall Study|Death|0
7526663|NCT02585934|11868111|FG000|Overall Study|Caregiver Withdrew Consent|7
7526664|NCT02585934|11868112|FG001|Overall Study|Caregiver Withdrew Consent|7
7526665|NCT02585934|11868111|FG000|Overall Study|Sponsor Termination|1
7526666|NCT02585934|11868112|FG001|Overall Study|Sponsor Termination|2
7526667|NCT02585934|11868111|FG000|Overall Study|Another Reason|10
7526668|NCT02585934|11868112|FG001|Overall Study|Another Reason|5
7526669|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Physician Decision|0
7526670|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Physician Decision|1
7526671|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Physician Decision|0
7526672|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
7526673|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
7526674|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
7526675|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
7526676|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
7526677|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
7526678|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Other|4
7526679|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Other|4
7526680|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Other|0
7526681|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
7526682|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
7526683|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
7526684|NCT02585960|11868126|FG000|PK/Safety Assessment Period|Screen Failure|0
7526685|NCT02585960|11868127|FG001|PK/Safety Assessment Period|Screen Failure|0
7526686|NCT02585960|11868128|FG002|PK/Safety Assessment Period|Screen Failure|1
7526687|NCT02585960|11868126|FG000|Prophylactic Treatment Period|Major protocol deviation|0
7526688|NCT02585960|11868127|FG001|Prophylactic Treatment Period|Major protocol deviation|4
7526689|NCT02585960|11868128|FG002|Prophylactic Treatment Period|Major protocol deviation|0
7526690|NCT02585960|11868126|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7526691|NCT02585960|11868127|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
7526692|NCT02585960|11868128|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
7526693|NCT02585999|11868139|FG000|Overall Study|Lost to Follow-up|1
7526694|NCT02585999|11868139|FG000|Overall Study|Protocol Violation|1
7526695|NCT02586012|11868144|FG000|Overall Study|Withdrawal by Subject|1
7526696|NCT02586012|11868145|FG001|Overall Study|Withdrawal by Subject|1
7526697|NCT02586012|11868146|FG002|Overall Study|Withdrawal by Subject|0
7526698|NCT02586012|11868147|FG003|Overall Study|Withdrawal by Subject|1
7526699|NCT02586012|11868148|FG004|Overall Study|Withdrawal by Subject|0
7526700|NCT02586012|11868149|FG005|Overall Study|Withdrawal by Subject|2
7526701|NCT02586012|11868144|FG000|Overall Study|Protocol Violation|0
7526702|NCT02586012|11868145|FG001|Overall Study|Protocol Violation|0
7526703|NCT02586012|11868146|FG002|Overall Study|Protocol Violation|0
7526704|NCT02586012|11868147|FG003|Overall Study|Protocol Violation|0
7526705|NCT02586012|11868148|FG004|Overall Study|Protocol Violation|0
7526706|NCT02586012|11868149|FG005|Overall Study|Protocol Violation|1
7526707|NCT02586012|11868144|FG000|Overall Study|study terminated|0
7526708|NCT02586012|11868145|FG001|Overall Study|study terminated|2
7526709|NCT02586012|11868146|FG002|Overall Study|study terminated|1
7526710|NCT02586012|11868147|FG003|Overall Study|study terminated|1
7526711|NCT02586012|11868148|FG004|Overall Study|study terminated|1
7526712|NCT02586012|11868149|FG005|Overall Study|study terminated|0
7526713|NCT02586064|11868160|FG000|Overall Study|Other Obligations|6
7526714|NCT02586064|11868161|FG001|Overall Study|Other Obligations|6
7526715|NCT02586064|11868160|FG000|Overall Study|Other|3
7526716|NCT02586064|11868161|FG001|Overall Study|Other|7
7526717|NCT02586064|11868160|FG000|Overall Study|Never Started|3
7526718|NCT02586064|11868161|FG001|Overall Study|Never Started|3
7526719|NCT02586064|11868160|FG000|Overall Study|Lost Interest|1
7526720|NCT02586064|11868161|FG001|Overall Study|Lost Interest|4
7526721|NCT02586064|11868160|FG000|Overall Study|Miscellaneous Life Issues|0
7526722|NCT02586064|11868161|FG001|Overall Study|Miscellaneous Life Issues|5
7526723|NCT02586064|11868160|FG000|Overall Study|Infrequent Attendance|2
7526724|NCT02586064|11868161|FG001|Overall Study|Infrequent Attendance|1
7526725|NCT02586064|11868160|FG000|Overall Study|Timed Out|2
7526726|NCT02586064|11868161|FG001|Overall Study|Timed Out|0
7526727|NCT02586064|11868160|FG000|Overall Study|AUD relapse|0
7526728|NCT02586064|11868161|FG001|Overall Study|AUD relapse|2
7526729|NCT02586064|11868160|FG000|Overall Study|Legal Issue|1
7526730|NCT02586064|11868161|FG001|Overall Study|Legal Issue|0
7526731|NCT02586077|11868170|FG000|Overall Study|Withdrawal by Subject|1
7526732|NCT02586077|11868170|FG000|Overall Study|Physician Decision|4
7526733|NCT02586077|11868170|FG000|Overall Study|Lost to Follow-up|3
7526734|NCT02586155|11868177|FG000|Overall Study|Adverse Event|2
7526735|NCT02586155|11868178|FG001|Overall Study|Adverse Event|3
7526736|NCT02586155|11868177|FG000|Overall Study|Withdrawal by Subject|31
7526737|NCT02586155|11868178|FG001|Overall Study|Withdrawal by Subject|24
7526738|NCT02586155|11868177|FG000|Overall Study|Lost to Follow-up|7
7526739|NCT02586155|11868178|FG001|Overall Study|Lost to Follow-up|13
7526740|NCT02586155|11868177|FG000|Overall Study|Death|61
7526741|NCT02586155|11868178|FG001|Overall Study|Death|72
7526742|NCT02586155|11868177|FG000|Overall Study|Other reasons|26
7526743|NCT02586155|11868178|FG001|Overall Study|Other reasons|15
7526744|NCT02586233|11868191|FG000|Overall Study|Randomized but did not receive treatment|0
7526745|NCT02586233|11868192|FG001|Overall Study|Randomized but did not receive treatment|1
7526746|NCT02586233|11868193|FG002|Overall Study|Randomized but did not receive treatment|0
7526747|NCT02586233|11868194|FG003|Overall Study|Randomized but did not receive treatment|0
7526748|NCT02586233|11868195|FG004|Overall Study|Randomized but did not receive treatment|0
7526749|NCT02586233|11868196|FG005|Overall Study|Randomized but did not receive treatment|2
7526750|NCT02586233|11868197|FG006|Overall Study|Randomized but did not receive treatment|2
7526751|NCT02586233|11868191|FG000|Overall Study|Death|0
7526752|NCT02586233|11868192|FG001|Overall Study|Death|1
7526753|NCT02586233|11868193|FG002|Overall Study|Death|0
7526754|NCT02586233|11868194|FG003|Overall Study|Death|0
7526755|NCT02586233|11868195|FG004|Overall Study|Death|2
7526756|NCT02586233|11868196|FG005|Overall Study|Death|0
7526757|NCT02586233|11868197|FG006|Overall Study|Death|0
7526758|NCT02586415|11868219|FG000|Overall Study|Death|13
7526759|NCT02586415|11868220|FG001|Overall Study|Death|23
7526760|NCT02586415|11868219|FG000|Overall Study|Lost to Follow-up|1
7526761|NCT02586415|11868220|FG001|Overall Study|Lost to Follow-up|2
7526762|NCT02586493|11868227|FG000|Overall Study|Adverse Event|4
7526763|NCT02586493|11868227|FG000|Overall Study|Protocol Violation|6
7526764|NCT02586493|11868227|FG000|Overall Study|Lost to Follow-up|1
7526765|NCT02586493|11868227|FG000|Overall Study|Withdrawal by Subject|1
7526766|NCT02586506|11868231|FG000|Overall Study|Protocol Violation|6
7526767|NCT02586506|11868231|FG000|Overall Study|Lost to Follow-up|1
7526768|NCT02586506|11868231|FG000|Overall Study|Other Reason|2
7526769|NCT02586727|11868237|FG000|Overall Study|Lost to Follow-up|1
7526770|NCT02586727|11868238|FG001|Overall Study|Lost to Follow-up|0
7526771|NCT02586805|11868248|FG000|Overall Study|Withdrawal by Subject|3
7526772|NCT02586805|11868249|FG001|Overall Study|Withdrawal by Subject|1
7526773|NCT02586805|11868250|FG002|Overall Study|Withdrawal by Subject|1
7526774|NCT02586805|11868251|FG003|Overall Study|Withdrawal by Subject|2
7526775|NCT02586805|11868248|FG000|Overall Study|Adverse Event|2
7526776|NCT02586805|11868249|FG001|Overall Study|Adverse Event|0
7526777|NCT02586805|11868250|FG002|Overall Study|Adverse Event|1
7526778|NCT02586805|11868251|FG003|Overall Study|Adverse Event|0
7526779|NCT02586805|11868248|FG000|Overall Study|Lost to Follow-up|0
7526780|NCT02586805|11868249|FG001|Overall Study|Lost to Follow-up|0
7526781|NCT02586805|11868250|FG002|Overall Study|Lost to Follow-up|1
7526782|NCT02586805|11868251|FG003|Overall Study|Lost to Follow-up|0
7526783|NCT02586805|11868248|FG000|Overall Study|Physician Decision|1
7526784|NCT02586805|11868249|FG001|Overall Study|Physician Decision|0
7526785|NCT02586805|11868250|FG002|Overall Study|Physician Decision|0
7526786|NCT02586805|11868251|FG003|Overall Study|Physician Decision|0
7526787|NCT02587065|11868285|FG000|Overall Study|Adverse Event|14
7526788|NCT02587065|11868285|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
7526789|NCT02587065|11868285|FG000|Overall Study|Non-adherence to the Protocol|3
7526790|NCT02587065|11868285|FG000|Overall Study|Discontinuation of Study Medication|2
7526791|NCT02587065|11868285|FG000|Overall Study|Reason not Specified|3
7526792|NCT02587143|11868300|FG000|Overall Study|Adverse Event|1
7526793|NCT02587143|11868301|FG001|Overall Study|Adverse Event|0
7537234|NCT02732119|11885698|FG002|Phase II|Physician Decision|0
7537235|NCT02732119|11885699|FG003|Phase II|Physician Decision|8
7537236|NCT02732119|11885700|FG004|Phase II|Physician Decision|5
7537237|NCT02732210|11885751|FG000|Overall Study|Site Closed|0
7537238|NCT02732210|11885752|FG001|Overall Study|Site Closed|11
7537239|NCT02732210|11885751|FG000|Overall Study|Study Ended|13
7537240|NCT02732210|11885752|FG001|Overall Study|Study Ended|13
7537241|NCT02732210|11885751|FG000|Overall Study|Withdrawal by Subject|28
7537242|NCT02732210|11885752|FG001|Overall Study|Withdrawal by Subject|87
7537243|NCT02732210|11885751|FG000|Overall Study|Lost to Follow-up|5
7537244|NCT02732210|11885752|FG001|Overall Study|Lost to Follow-up|57
7537245|NCT02732210|11885751|FG000|Overall Study|Death|4
7537246|NCT02732210|11885752|FG001|Overall Study|Death|15
7537247|NCT02732210|11885751|FG000|Overall Study|Other|35
7537248|NCT02732210|11885752|FG001|Overall Study|Other|103
7537249|NCT02732210|11885751|FG000|Overall Study|Missing|0
7537250|NCT02732210|11885752|FG001|Overall Study|Missing|8
7537251|NCT02732561|11885772|FG000|Overall Study|Lost to Follow-up|1
7537252|NCT02732561|11885773|FG001|Overall Study|Lost to Follow-up|1
7537253|NCT02732561|11885772|FG000|Overall Study|Withdrawal by Subject|1
7537254|NCT02732561|11885773|FG001|Overall Study|Withdrawal by Subject|0
7537255|NCT02732639|11885793|FG000|Overall Study|Lost to Follow-up|1
7537256|NCT02732847|11885799|FG000|Overall Study|some filled early|42
7537257|NCT02732847|11885800|FG001|Overall Study|some filled early|42
7537258|NCT02732912|11885817|FG000|Overall Study|Discharged before night|2
7537259|NCT02732912|11885818|FG001|Overall Study|Discharged before night|6
7537260|NCT02732912|11885817|FG000|Overall Study|Incomplete completion of questionnaire|2
7537261|NCT02732912|11885818|FG001|Overall Study|Incomplete completion of questionnaire|3
7537262|NCT02732912|11885817|FG000|Overall Study|No outcome; discharged or refused|6
7537263|NCT02732912|11885818|FG001|Overall Study|No outcome; discharged or refused|9
7537264|NCT02732938|11885826|FG000|Overall Study|Death|0
7537265|NCT02732938|11885827|FG001|Overall Study|Death|11
7537266|NCT02732938|11885828|FG002|Overall Study|Death|0
7537267|NCT02732938|11885826|FG000|Overall Study|Randomized but did not receive treatment|0
7537268|NCT02732938|11885827|FG001|Overall Study|Randomized but did not receive treatment|1
7537269|NCT02732938|11885828|FG002|Overall Study|Randomized but did not receive treatment|0
7537270|NCT02732938|11885826|FG000|Overall Study|Refused further follow-up|1
7537271|NCT02732938|11885827|FG001|Overall Study|Refused further follow-up|0
7537272|NCT02732938|11885828|FG002|Overall Study|Refused further follow-up|0
7537273|NCT02732938|11885826|FG000|Overall Study|Study terminated by sponsor|3
7537274|NCT02732938|11885827|FG001|Overall Study|Study terminated by sponsor|6
7537275|NCT02732938|11885828|FG002|Overall Study|Study terminated by sponsor|0
7537276|NCT02732951|11885838|FG000|Overall Study|Other than listed|1
7537277|NCT02732951|11885839|FG001|Overall Study|Other than listed|0
7537278|NCT02732951|11885838|FG000|Overall Study|Lost to Follow-up|0
7537279|NCT02732951|11885839|FG001|Overall Study|Lost to Follow-up|1
7537280|NCT02732951|11885838|FG000|Overall Study|Adverse Event|4
7537281|NCT02732951|11885839|FG001|Overall Study|Adverse Event|4
7537282|NCT02732951|11885838|FG000|Overall Study|Protocol Violation|0
7537283|NCT02732951|11885839|FG001|Overall Study|Protocol Violation|1
7537284|NCT02733367|11885845|FG000|Overall Study|Withdrawal by Subject|6
7537285|NCT02733627|11885858|FG000|Overall Study|Adverse Event|0
7537286|NCT02733627|11885859|FG001|Overall Study|Adverse Event|1
7537287|NCT02733627|11885860|FG002|Overall Study|Adverse Event|1
7537288|NCT02733627|11885861|FG003|Overall Study|Adverse Event|0
7537289|NCT02733627|11885858|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7537290|NCT02733627|11885859|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7537291|NCT02733627|11885860|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
7537292|NCT02733627|11885861|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
7537293|NCT02733991|11885894|FG000|Overall Study|Adverse Event|1
7537294|NCT02733991|11885895|FG001|Overall Study|Adverse Event|0
7537295|NCT02733991|11885894|FG000|Overall Study|Withdrawal by Subject|0
7537296|NCT02733991|11885895|FG001|Overall Study|Withdrawal by Subject|5
7537297|NCT02734212|11885921|FG000|Overall Study|Lost to Follow-up|5
7537298|NCT02734212|11885922|FG001|Overall Study|Lost to Follow-up|10
7537299|NCT02734693|11885967|FG000|Overall Study|Adverse Event|1
7537300|NCT02734693|11885968|FG001|Overall Study|Adverse Event|3
7537301|NCT02734693|11885969|FG002|Overall Study|Adverse Event|3
7537302|NCT02734693|11885967|FG000|Overall Study|Lack of Efficacy|1
7537303|NCT02734693|11885968|FG001|Overall Study|Lack of Efficacy|0
7537304|NCT02734693|11885969|FG002|Overall Study|Lack of Efficacy|0
7537305|NCT02734693|11885967|FG000|Overall Study|Lost to Follow-up|2
7537306|NCT02734693|11885968|FG001|Overall Study|Lost to Follow-up|0
7526794|NCT02587221|11868309|FG000|Overall Study|Adverse Event|3
7526795|NCT02587221|11868310|FG001|Overall Study|Adverse Event|3
7526796|NCT02587221|11868309|FG000|Overall Study|Death|33
7526797|NCT02587221|11868310|FG001|Overall Study|Death|34
7526798|NCT02587221|11868309|FG000|Overall Study|Withdrawal by Subject|66
7526799|NCT02587221|11868310|FG001|Overall Study|Withdrawal by Subject|61
7526800|NCT02587221|11868309|FG000|Overall Study|Lost to Follow-up|21
7526801|NCT02587221|11868310|FG001|Overall Study|Lost to Follow-up|19
7526802|NCT02587221|11868309|FG000|Overall Study|Protocol Violation|6
7526803|NCT02587221|11868310|FG001|Overall Study|Protocol Violation|5
7526804|NCT02587221|11868309|FG000|Overall Study|Other Reason or Unspecified|2
7526805|NCT02587221|11868310|FG001|Overall Study|Other Reason or Unspecified|1
7526806|NCT02587234|11868318|FG000|Overall Study|Withdrawal by Subject|1
7526807|NCT02587234|11868319|FG001|Overall Study|Withdrawal by Subject|1
7526808|NCT02587234|11868318|FG000|Overall Study|Lost to Follow-up|0
7526809|NCT02587234|11868319|FG001|Overall Study|Lost to Follow-up|2
7526810|NCT02587819|11868334|FG000|Overall Study|Adverse Event|1
7526811|NCT02587819|11868334|FG000|Overall Study|Lost to Follow-up|1
7526812|NCT02587962|11868344|FG000|Overall Study|Adverse Event|0
7526813|NCT02587962|11868345|FG001|Overall Study|Adverse Event|0
7526814|NCT02587962|11868346|FG002|Overall Study|Adverse Event|1
7526815|NCT02587962|11868347|FG003|Overall Study|Adverse Event|0
7526816|NCT02587962|11868348|FG004|Overall Study|Adverse Event|0
7526817|NCT02587962|11868344|FG000|Overall Study|Withdrawal by Subject|0
7526818|NCT02587962|11868345|FG001|Overall Study|Withdrawal by Subject|0
7526819|NCT02587962|11868346|FG002|Overall Study|Withdrawal by Subject|1
7526820|NCT02587962|11868347|FG003|Overall Study|Withdrawal by Subject|1
7526821|NCT02587962|11868348|FG004|Overall Study|Withdrawal by Subject|4
7526822|NCT02587962|11868344|FG000|Overall Study|Radiological progression|2
7526823|NCT02587962|11868345|FG001|Overall Study|Radiological progression|2
7526824|NCT02587962|11868346|FG002|Overall Study|Radiological progression|2
7526825|NCT02587962|11868347|FG003|Overall Study|Radiological progression|5
7526826|NCT02587962|11868348|FG004|Overall Study|Radiological progression|10
7526827|NCT02587962|11868344|FG000|Overall Study|Clinical progression|0
7526828|NCT02587962|11868345|FG001|Overall Study|Clinical progression|1
7526829|NCT02587962|11868346|FG002|Overall Study|Clinical progression|2
7526830|NCT02587962|11868347|FG003|Overall Study|Clinical progression|0
7526831|NCT02587962|11868348|FG004|Overall Study|Clinical progression|1
7526832|NCT02588092|11868373|FG000|Overall Study|Death|4
7526833|NCT02588092|11868374|FG001|Overall Study|Death|3
7526834|NCT02588092|11868375|FG002|Overall Study|Death|3
7526835|NCT02588092|11868376|FG003|Overall Study|Death|3
7526836|NCT02588092|11868377|FG004|Overall Study|Death|2
7526837|NCT02588092|11868378|FG005|Overall Study|Death|2
7526838|NCT02588092|11868379|FG006|Overall Study|Death|2
7526839|NCT02588092|11868380|FG007|Overall Study|Death|1
7526840|NCT02588092|11868381|FG008|Overall Study|Death|5
7526841|NCT02588092|11868382|FG009|Overall Study|Death|2
7526842|NCT02588092|11868373|FG000|Overall Study|Withdrawal by Subject|0
7526843|NCT02588092|11868374|FG001|Overall Study|Withdrawal by Subject|0
7526844|NCT02588092|11868375|FG002|Overall Study|Withdrawal by Subject|0
7526845|NCT02588092|11868376|FG003|Overall Study|Withdrawal by Subject|0
7526846|NCT02588092|11868377|FG004|Overall Study|Withdrawal by Subject|0
7526847|NCT02588092|11868378|FG005|Overall Study|Withdrawal by Subject|1
7526848|NCT02588092|11868379|FG006|Overall Study|Withdrawal by Subject|1
7526849|NCT02588092|11868380|FG007|Overall Study|Withdrawal by Subject|2
7526850|NCT02588092|11868381|FG008|Overall Study|Withdrawal by Subject|0
7526851|NCT02588092|11868382|FG009|Overall Study|Withdrawal by Subject|0
7526852|NCT02588092|11868373|FG000|Overall Study|Started Another Treatment|0
7526853|NCT02588092|11868374|FG001|Overall Study|Started Another Treatment|0
7526854|NCT02588092|11868375|FG002|Overall Study|Started Another Treatment|0
7526855|NCT02588092|11868376|FG003|Overall Study|Started Another Treatment|0
7526856|NCT02588092|11868377|FG004|Overall Study|Started Another Treatment|1
7526857|NCT02588092|11868378|FG005|Overall Study|Started Another Treatment|0
7526858|NCT02588092|11868379|FG006|Overall Study|Started Another Treatment|0
7526859|NCT02588092|11868380|FG007|Overall Study|Started Another Treatment|1
7526860|NCT02588092|11868381|FG008|Overall Study|Started Another Treatment|0
7526861|NCT02588092|11868382|FG009|Overall Study|Started Another Treatment|0
7526862|NCT02588092|11868373|FG000|Overall Study|Sponsor Decision|0
7526863|NCT02588092|11868374|FG001|Overall Study|Sponsor Decision|0
7526864|NCT02588092|11868375|FG002|Overall Study|Sponsor Decision|0
7526865|NCT02588092|11868376|FG003|Overall Study|Sponsor Decision|0
7526866|NCT02588092|11868377|FG004|Overall Study|Sponsor Decision|0
7526867|NCT02588092|11868378|FG005|Overall Study|Sponsor Decision|0
7526868|NCT02588092|11868379|FG006|Overall Study|Sponsor Decision|0
7526869|NCT02588092|11868380|FG007|Overall Study|Sponsor Decision|0
7526870|NCT02588092|11868381|FG008|Overall Study|Sponsor Decision|1
7526871|NCT02588092|11868382|FG009|Overall Study|Sponsor Decision|1
7537307|NCT02734693|11885969|FG002|Overall Study|Lost to Follow-up|0
7537308|NCT02734693|11885967|FG000|Overall Study|Protocol Violation|1
7537309|NCT02734693|11885968|FG001|Overall Study|Protocol Violation|0
7537310|NCT02734693|11885969|FG002|Overall Study|Protocol Violation|0
7537311|NCT02734693|11885967|FG000|Overall Study|Withdrawal by Subject|1
7537312|NCT02734693|11885968|FG001|Overall Study|Withdrawal by Subject|0
7537313|NCT02734693|11885969|FG002|Overall Study|Withdrawal by Subject|0
7526872|NCT04960228|11868410|FG000|Overall Study|Withdrawal by Subject|216
7526873|NCT04960228|11868411|FG001|Overall Study|Withdrawal by Subject|35
7526874|NCT04960228|11868410|FG000|Overall Study|Failed attention check|69
7526875|NCT04960228|11868411|FG001|Overall Study|Failed attention check|148
7526876|NCT04960228|11868410|FG000|Overall Study|Flagged for response quality by Dynata|3
7526877|NCT04960228|11868411|FG001|Overall Study|Flagged for response quality by Dynata|3
7526878|NCT03922477|11868417|FG000|Overall Study|Death|9
7526879|NCT03922477|11868417|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1
7526880|NCT03922477|11868417|FG000|Overall Study|Physician Decision|1
7526881|NCT03922477|11868417|FG000|Overall Study|Withdrawal by Subject|2
7526882|NCT03688074|11868423|FG000|Overall Study|Adverse Event|0
7526883|NCT03688074|11868424|FG001|Overall Study|Adverse Event|1
7526884|NCT03688074|11868423|FG000|Overall Study|Other|1
7526885|NCT03688074|11868424|FG001|Overall Study|Other|0
7526886|NCT03342001|11868430|FG000|Overall Study|Adverse Event|1
7526887|NCT03342001|11868430|FG000|Overall Study|Lost to Follow-up|1
7526888|NCT02859558|11868448|FG000|Step 1|Not Eligible|0
7526889|NCT02859558|11868449|FG001|Step 1|Not Eligible|0
7526890|NCT02859558|11868450|FG002|Step 1|Not Eligible|0
7526891|NCT02859558|11868451|FG003|Step 1|Not Eligible|0
7526892|NCT02859558|11868452|FG004|Step 1|Not Eligible|3
7526893|NCT02859558|11868448|FG000|Step 1|Lost to Follow-up|1
7526894|NCT02859558|11868449|FG001|Step 1|Lost to Follow-up|3
7526895|NCT02859558|11868450|FG002|Step 1|Lost to Follow-up|3
7526896|NCT02859558|11868451|FG003|Step 1|Lost to Follow-up|0
7526897|NCT02859558|11868452|FG004|Step 1|Lost to Follow-up|0
7526898|NCT02859558|11868448|FG000|Step 1|Did Not Return to Clinic|2
7526899|NCT02859558|11868449|FG001|Step 1|Did Not Return to Clinic|3
7526900|NCT02859558|11868450|FG002|Step 1|Did Not Return to Clinic|4
7526901|NCT02859558|11868451|FG003|Step 1|Did Not Return to Clinic|0
7526902|NCT02859558|11868452|FG004|Step 1|Did Not Return to Clinic|0
7526903|NCT02859558|11868448|FG000|Step 1|Moved|0
7526904|NCT02859558|11868449|FG001|Step 1|Moved|1
7526905|NCT02859558|11868450|FG002|Step 1|Moved|1
7526906|NCT02859558|11868451|FG003|Step 1|Moved|0
7526907|NCT02859558|11868452|FG004|Step 1|Moved|0
7526908|NCT02859558|11868448|FG000|Step 1|Withdrawal By Participant|1
7526909|NCT02859558|11868449|FG001|Step 1|Withdrawal By Participant|2
7526910|NCT02859558|11868450|FG002|Step 1|Withdrawal By Participant|1
7526911|NCT02859558|11868451|FG003|Step 1|Withdrawal By Participant|0
7526912|NCT02859558|11868452|FG004|Step 1|Withdrawal By Participant|0
7526913|NCT02859558|11868448|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
7526914|NCT02859558|11868449|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
7526915|NCT02859558|11868450|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
7526916|NCT02859558|11868451|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0
7526917|NCT02859558|11868452|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0
7526918|NCT02859558|11868448|FG000|Step 1|Incarceration|0
7526919|NCT02859558|11868449|FG001|Step 1|Incarceration|1
7526920|NCT02859558|11868450|FG002|Step 1|Incarceration|0
7526921|NCT02859558|11868451|FG003|Step 1|Incarceration|0
7526922|NCT02859558|11868452|FG004|Step 1|Incarceration|0
7526923|NCT02859558|11868448|FG000|Step 1|Non-Adherence to Study Drug|2
7526924|NCT02859558|11868449|FG001|Step 1|Non-Adherence to Study Drug|0
7526925|NCT02859558|11868450|FG002|Step 1|Non-Adherence to Study Drug|1
7526926|NCT02859558|11868451|FG003|Step 1|Non-Adherence to Study Drug|0
7526927|NCT02859558|11868452|FG004|Step 1|Non-Adherence to Study Drug|0
7526928|NCT02859558|11868448|FG000|Step 1|Non-Adherence to Study Requirements|3
7526929|NCT02859558|11868449|FG001|Step 1|Non-Adherence to Study Requirements|1
7526930|NCT02859558|11868450|FG002|Step 1|Non-Adherence to Study Requirements|0
7526931|NCT02859558|11868451|FG003|Step 1|Non-Adherence to Study Requirements|0
7526932|NCT02859558|11868452|FG004|Step 1|Non-Adherence to Study Requirements|0
7526933|NCT02859558|11868448|FG000|Step 1|Virologic Failure|2
7526934|NCT02859558|11868449|FG001|Step 1|Virologic Failure|1
7526935|NCT02859558|11868450|FG002|Step 1|Virologic Failure|1
7526936|NCT02859558|11868451|FG003|Step 1|Virologic Failure|0
7526937|NCT02859558|11868452|FG004|Step 1|Virologic Failure|0
7526938|NCT02859558|11868448|FG000|Step 2|Active On Study|23
7526939|NCT02859558|11868449|FG001|Step 2|Active On Study|38
7526940|NCT02859558|11868450|FG002|Step 2|Active On Study|20
7526941|NCT02859558|11868451|FG003|Step 2|Active On Study|0
7526942|NCT02859558|11868452|FG004|Step 2|Active On Study|0
7526943|NCT02859558|11868448|FG000|Step 2|Did Not Return to Clinic|2
7526944|NCT02859558|11868449|FG001|Step 2|Did Not Return to Clinic|0
7526945|NCT02859558|11868450|FG002|Step 2|Did Not Return to Clinic|0
7526946|NCT02859558|11868451|FG003|Step 2|Did Not Return to Clinic|0
7526947|NCT02859558|11868452|FG004|Step 2|Did Not Return to Clinic|0
7526948|NCT02859558|11868448|FG000|Step 2|Unexpected Closure of Site|0
7526949|NCT02859558|11868449|FG001|Step 2|Unexpected Closure of Site|1
7526950|NCT02859558|11868450|FG002|Step 2|Unexpected Closure of Site|1
7526951|NCT02859558|11868451|FG003|Step 2|Unexpected Closure of Site|0
7526952|NCT02859558|11868452|FG004|Step 2|Unexpected Closure of Site|0
7526953|NCT02818920|11868462|FG000|Overall Study|Unresectable|4
7526954|NCT02818920|11868462|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
7526955|NCT02818920|11868462|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
7526956|NCT02818920|11868462|FG000|Overall Study|Adverse Event|3
7526957|NCT02818920|11868462|FG000|Overall Study|Developed Other Disease|1
7526958|NCT02818920|11868462|FG000|Overall Study|Refused Further Treatment|1
7526959|NCT02481310|11868469|FG000|Follow up|Still in follow up|0
7526960|NCT02481310|11868470|FG001|Follow up|Still in follow up|3
7526961|NCT02481310|11868471|FG002|Follow up|Still in follow up|0
7537314|NCT02734810|11885979|FG000|Overall Study|Adverse Event|1
7537315|NCT02734810|11885980|FG001|Overall Study|Adverse Event|0
7537316|NCT02734810|11885979|FG000|Overall Study|Lack of Efficacy|1
7537317|NCT02734810|11885980|FG001|Overall Study|Lack of Efficacy|0
7537318|NCT02734862|11886002|FG000|Part A|Death|3
7537319|NCT02734862|11886003|FG001|Part A|Death|4
7537320|NCT02734862|11886004|FG002|Part A|Death|6
7537321|NCT02734862|11886002|FG000|Part A|Lost to Follow-up|2
7537322|NCT02734862|11886003|FG001|Part A|Lost to Follow-up|1
7537323|NCT02734862|11886004|FG002|Part A|Lost to Follow-up|1
7537324|NCT02734862|11886002|FG000|Part A|Withdrawal by Subject|1
7537325|NCT02734862|11886003|FG001|Part A|Withdrawal by Subject|1
7537326|NCT02734862|11886004|FG002|Part A|Withdrawal by Subject|2
7537327|NCT02734862|11886002|FG000|Part A|Physician Decision|2
7537328|NCT02734862|11886003|FG001|Part A|Physician Decision|0
7537329|NCT02734862|11886004|FG002|Part A|Physician Decision|1
7537330|NCT02734862|11886002|FG000|Part A|Adverse Event|2
7537331|NCT02734862|11886003|FG001|Part A|Adverse Event|0
7537332|NCT02734862|11886004|FG002|Part A|Adverse Event|1
7537333|NCT02734862|11886002|FG000|Part A|Noncompliance|1
7537334|NCT02734862|11886003|FG001|Part A|Noncompliance|1
7537335|NCT02734862|11886004|FG002|Part A|Noncompliance|0
7537336|NCT02734862|11886002|FG000|Part A|Other|1
7537337|NCT02734862|11886003|FG001|Part A|Other|1
7537338|NCT02734862|11886004|FG002|Part A|Other|3
7537339|NCT02734862|11886002|FG000|Part B|Death|8
7537340|NCT02734862|11886003|FG001|Part B|Death|3
7537341|NCT02734862|11886004|FG002|Part B|Death|5
7537342|NCT02734862|11886002|FG000|Part B|Lost to Follow-up|2
7537343|NCT02734862|11886003|FG001|Part B|Lost to Follow-up|2
7537344|NCT02734862|11886004|FG002|Part B|Lost to Follow-up|0
7537345|NCT02734862|11886002|FG000|Part B|Withdrawal by Subject|3
7537346|NCT02734862|11886003|FG001|Part B|Withdrawal by Subject|1
7537347|NCT02734862|11886004|FG002|Part B|Withdrawal by Subject|0
7537348|NCT02734862|11886002|FG000|Part B|Other|0
7537349|NCT02734862|11886003|FG001|Part B|Other|1
7537350|NCT02734862|11886004|FG002|Part B|Other|0
7537351|NCT02735096|11886029|FG000|Overall Study|No symptoms in clinic/personal leave|1
7537352|NCT02735200|11886054|FG000|Overall Study|Lost to Follow-up|0
7537353|NCT02735200|11886055|FG001|Overall Study|Lost to Follow-up|5
7537354|NCT02735200|11886054|FG000|Overall Study|Withdrawal by Subject|8
7537355|NCT02735200|11886055|FG001|Overall Study|Withdrawal by Subject|0
7537361|NCT02735577|11886098|FG000|Disulfiram Treatment|Lost to Follow-up|1
7537362|NCT02735577|11886098|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
7537363|NCT02735915|11886115|FG000|Overall Study|Not vaccinated but subject ID assigned|8
7537364|NCT02735915|11886115|FG000|Overall Study|Withdrawal following SAE|2
7537365|NCT02735915|11886115|FG000|Overall Study|Withdrawal by Subject|1
7537366|NCT02735980|11886124|FG000|Overall Study|Adverse Event|0
7537367|NCT02735980|11886125|FG001|Overall Study|Adverse Event|4
7537368|NCT02735980|11886126|FG002|Overall Study|Adverse Event|1
7537369|NCT02735980|11886124|FG000|Overall Study|Death|5
7537370|NCT02735980|11886125|FG001|Overall Study|Death|4
7537371|NCT02735980|11886126|FG002|Overall Study|Death|0
7537372|NCT02735980|11886124|FG000|Overall Study|Physician Decision|3
7537373|NCT02735980|11886125|FG001|Overall Study|Physician Decision|1
7537374|NCT02735980|11886126|FG002|Overall Study|Physician Decision|0
7537375|NCT02735980|11886124|FG000|Overall Study|Screen failure|1
7537376|NCT02735980|11886125|FG001|Overall Study|Screen failure|0
7537377|NCT02735980|11886126|FG002|Overall Study|Screen failure|0
7537378|NCT02735980|11886124|FG000|Overall Study|Withdrawal by Subject|1
7537379|NCT02735980|11886125|FG001|Overall Study|Withdrawal by Subject|2
7537380|NCT02735980|11886126|FG002|Overall Study|Withdrawal by Subject|0
7537381|NCT02736188|11886148|FG000|Overall Study|Discontinuation of Study by Sponsor|134
7537382|NCT02736188|11886148|FG000|Overall Study|Adverse Event|1
7537383|NCT02736188|11886148|FG000|Overall Study|Withdrawal by Subject|1
7537384|NCT02736188|11886148|FG000|Overall Study|Other|6
7537385|NCT02736409|11886158|FG000|Overall Study|Withdrawal by Subject|4
7526962|NCT02343952|11868475|FG000|Study Treatment|Disease Progression|23
7526963|NCT02343952|11868475|FG000|Study Treatment|Death|3
7526964|NCT02343952|11868475|FG000|Study Treatment|Adverse Event|19
7526965|NCT02343952|11868475|FG000|Study Treatment|Withdrawal by Subject|7
7526966|NCT02343952|11868475|FG000|Study Treatment|other complicating Diseases|1
7526967|NCT02343952|11868475|FG000|Follow up|Withdrawal by Subject|3
7526968|NCT02343952|11868475|FG000|Follow up|Death|33
7526969|NCT02343952|11868475|FG000|Follow up|Patient does not meet eligibility for study.|1
7526970|NCT02343952|11868475|FG000|Follow up|Research department closed by the practice.|5
7526971|NCT02343952|11868475|FG000|Follow up|Patient went home to Russia|1
7526972|NCT02343952|11868475|FG000|Follow up|Disease Progression|1
7526973|NCT02343952|11868475|FG000|Follow up|study terminated|1
7526974|NCT02326155|11868481|FG000|Overall Study|Adverse Event|21
7526975|NCT02326155|11868482|FG001|Overall Study|Adverse Event|5
7526976|NCT02326155|11868481|FG000|Overall Study|Death|3
7526977|NCT02326155|11868482|FG001|Overall Study|Death|0
7526978|NCT02326155|11868481|FG000|Overall Study|Lack of Efficacy|49
7526979|NCT02326155|11868482|FG001|Overall Study|Lack of Efficacy|5
7526980|NCT02326155|11868481|FG000|Overall Study|Lost to Follow-up|14
7526981|NCT02326155|11868482|FG001|Overall Study|Lost to Follow-up|3
7526982|NCT02326155|11868481|FG000|Overall Study|Protocol Violation|2
7526983|NCT02326155|11868482|FG001|Overall Study|Protocol Violation|0
7526984|NCT02326155|11868481|FG000|Overall Study|Withdrawal by Subject|34
7526985|NCT02326155|11868482|FG001|Overall Study|Withdrawal by Subject|11
7526986|NCT02326155|11868481|FG000|Overall Study|Disease progression|37
7526987|NCT02326155|11868482|FG001|Overall Study|Disease progression|4
7526988|NCT02326155|11868481|FG000|Overall Study|Study close|188
7526989|NCT02326155|11868482|FG001|Overall Study|Study close|21
7526990|NCT02326155|11868481|FG000|Overall Study|except for study close|46
7526991|NCT02326155|11868482|FG001|Overall Study|except for study close|13
7526992|NCT02304367|11868488|FG000|Overall Study|Lack of Response to Bruosumab|1
7526993|NCT02304367|11868488|FG000|Overall Study|Sponsor Decision|3
7526994|NCT02304367|11868488|FG000|Overall Study|Death|2
7526995|NCT02304367|11868488|FG000|Overall Study|Physician Decision|1
7526996|NCT02304367|11868488|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1
7526997|NCT02588261|11868510|FG000|Overall Study|Study Terminated by Sponsor|157
7526998|NCT02588261|11868511|FG001|Overall Study|Study Terminated by Sponsor|142
7526999|NCT02588261|11868510|FG000|Overall Study|Protocol Deviation|1
7527000|NCT02588261|11868511|FG001|Overall Study|Protocol Deviation|0
7527001|NCT02588261|11868510|FG000|Overall Study|Death|1
7527002|NCT02588261|11868511|FG001|Overall Study|Death|2
7527003|NCT02588261|11868510|FG000|Overall Study|Withdrawal by Subject|12
7527004|NCT02588261|11868511|FG001|Overall Study|Withdrawal by Subject|8
7527005|NCT02588261|11868510|FG000|Overall Study|Noncompliance with Study Drug|0
7527006|NCT02588261|11868511|FG001|Overall Study|Noncompliance with Study Drug|1
7527007|NCT02588261|11868510|FG000|Overall Study|Miscellaneous|5
7527008|NCT02588261|11868511|FG001|Overall Study|Miscellaneous|4
7527009|NCT02588261|11868510|FG000|Overall Study|Progressive Disease|61
7527010|NCT02588261|11868511|FG001|Overall Study|Progressive Disease|82
7527011|NCT02588261|11868510|FG000|Overall Study|Adverse Event|29
7527012|NCT02588261|11868511|FG001|Overall Study|Adverse Event|24
7527013|NCT02588261|11868510|FG000|Overall Study|Lost to Follow-up|1
7527014|NCT02588261|11868511|FG001|Overall Study|Lost to Follow-up|0
7527015|NCT02588339|11868517|FG000|Overall Study|Withdrawal by Subject|1
7527016|NCT02588339|11868517|FG000|Overall Study|GVHD Progression prior to treatment|2
7527017|NCT02588612|11868550|FG000|Overall Study|Physician Decision|1
7527018|NCT02588612|11868550|FG000|Overall Study|Leukapheresis did not yield enough cells|1
7527019|NCT02588612|11868550|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
7527020|NCT02588612|11868550|FG000|Overall Study|Death prior to T-cell infusion|1
7527021|NCT02588664|11868556|FG000|Overall Study|Death|56
7527022|NCT02588664|11868557|FG001|Overall Study|Death|55
7527023|NCT02588664|11868556|FG000|Overall Study|Lost to Follow-up|1305
7527024|NCT02588664|11868557|FG001|Overall Study|Lost to Follow-up|990
7527025|NCT02588833|11868565|FG000|Part 1|Withdrawal by Subject|1
7527026|NCT02588833|11868566|FG001|Part 1|Withdrawal by Subject|0
7527027|NCT02588833|11868565|FG000|Part 2A|Physician Decision|0
7527028|NCT02588833|11868566|FG001|Part 2A|Physician Decision|1
7527029|NCT02588833|11868565|FG000|Part 2A|Withdrawal by Subject|0
7527030|NCT02588833|11868566|FG001|Part 2A|Withdrawal by Subject|1
7527031|NCT02588833|11868565|FG000|Part 2B|Adverse Event|0
7527032|NCT02588833|11868566|FG001|Part 2B|Adverse Event|1
7527033|NCT02588833|11868565|FG000|Part 2C|Adverse Event|0
7527034|NCT02588833|11868566|FG001|Part 2C|Adverse Event|1
7527035|NCT02588833|11868565|FG000|Part 2C|Withdrawal by Subject|0
7527036|NCT02588833|11868566|FG001|Part 2C|Withdrawal by Subject|1
7527037|NCT02588833|11868565|FG000|Part 3 (Safety Follow-up)|Other|0
7527038|NCT02588833|11868566|FG001|Part 3 (Safety Follow-up)|Other|2
7527039|NCT02589405|11868606|FG000|Overall Study|Adverse Event|3
7527040|NCT02589405|11868606|FG000|Overall Study|Withdrawal by Subject|1
7527041|NCT02589626|11868612|FG000|Overall Study|Other than the reason specified|1
7527042|NCT02589626|11868613|FG001|Overall Study|Other than the reason specified|0
7527043|NCT02589626|11868612|FG000|Overall Study|Withdrawal by Subject|1
7527044|NCT02589626|11868613|FG001|Overall Study|Withdrawal by Subject|1
7527045|NCT02589626|11868612|FG000|Overall Study|Adverse Event|1
7527046|NCT02589626|11868613|FG001|Overall Study|Adverse Event|1
7527047|NCT02589639|11868622|FG000|Overall Study|Lost to Follow-up|1
7527048|NCT02589639|11868623|FG001|Overall Study|Lost to Follow-up|0
7527049|NCT02589639|11868624|FG002|Overall Study|Lost to Follow-up|0
7527050|NCT02589639|11868622|FG000|Overall Study|Protocol Violation|1
7527051|NCT02589639|11868623|FG001|Overall Study|Protocol Violation|0
7527052|NCT02589639|11868624|FG002|Overall Study|Protocol Violation|0
7527053|NCT02589639|11868622|FG000|Overall Study|Patient withdrawal, not due to AE|3
7527054|NCT02589639|11868623|FG001|Overall Study|Patient withdrawal, not due to AE|0
7527055|NCT02589639|11868624|FG002|Overall Study|Patient withdrawal, not due to AE|0
7527056|NCT02589639|11868622|FG000|Overall Study|Adverse Event|4
7527057|NCT02589639|11868623|FG001|Overall Study|Adverse Event|5
7527058|NCT02589639|11868624|FG002|Overall Study|Adverse Event|3
7527059|NCT02589639|11868622|FG000|Overall Study|Other reason than specified above|1
7527060|NCT02589639|11868623|FG001|Overall Study|Other reason than specified above|2
7527061|NCT02589639|11868624|FG002|Overall Study|Other reason than specified above|1
7527062|NCT02589639|11868622|FG000|Overall Study|Not Treated|0
7527063|NCT02589639|11868623|FG001|Overall Study|Not Treated|3
7527064|NCT02589639|11868624|FG002|Overall Study|Not Treated|0
7527065|NCT02589665|11868636|FG000|Induction Period|Did not receive drug|0
7527066|NCT02589665|11868637|FG001|Induction Period|Did not receive drug|0
7527067|NCT02589665|11868638|FG002|Induction Period|Did not receive drug|0
7527068|NCT02589665|11868639|FG003|Induction Period|Did not receive drug|1
7527069|NCT02589665|11868640|FG004|Induction Period|Did not receive drug|0
7527070|NCT02589665|11868641|FG005|Induction Period|Did not receive drug|0
7527071|NCT02589665|11868642|FG006|Induction Period|Did not receive drug|0
7527072|NCT02589665|11868643|FG007|Induction Period|Did not receive drug|0
7527073|NCT02589665|11868644|FG008|Induction Period|Did not receive drug|0
7527074|NCT02589665|11868645|FG009|Induction Period|Did not receive drug|0
7527075|NCT02589665|11868636|FG000|Induction Period|Adverse Event|3
7527076|NCT02589665|11868637|FG001|Induction Period|Adverse Event|0
7527077|NCT02589665|11868638|FG002|Induction Period|Adverse Event|2
7527078|NCT02589665|11868639|FG003|Induction Period|Adverse Event|2
7527079|NCT02589665|11868640|FG004|Induction Period|Adverse Event|0
7527080|NCT02589665|11868641|FG005|Induction Period|Adverse Event|0
7527081|NCT02589665|11868642|FG006|Induction Period|Adverse Event|0
7527082|NCT02589665|11868643|FG007|Induction Period|Adverse Event|0
7527083|NCT02589665|11868644|FG008|Induction Period|Adverse Event|0
7527084|NCT02589665|11868645|FG009|Induction Period|Adverse Event|0
7527085|NCT02589665|11868636|FG000|Induction Period|Withdrawal by Subject|0
7527086|NCT02589665|11868637|FG001|Induction Period|Withdrawal by Subject|1
7527087|NCT02589665|11868638|FG002|Induction Period|Withdrawal by Subject|0
7527088|NCT02589665|11868639|FG003|Induction Period|Withdrawal by Subject|1
7527089|NCT02589665|11868640|FG004|Induction Period|Withdrawal by Subject|0
7527090|NCT02589665|11868641|FG005|Induction Period|Withdrawal by Subject|0
7527091|NCT02589665|11868642|FG006|Induction Period|Withdrawal by Subject|0
7527092|NCT02589665|11868643|FG007|Induction Period|Withdrawal by Subject|0
7527093|NCT02589665|11868644|FG008|Induction Period|Withdrawal by Subject|0
7527094|NCT02589665|11868645|FG009|Induction Period|Withdrawal by Subject|0
7527095|NCT02589665|11868636|FG000|Induction Period|Protocol Violation|0
7527096|NCT02589665|11868637|FG001|Induction Period|Protocol Violation|1
7527097|NCT02589665|11868638|FG002|Induction Period|Protocol Violation|0
7527098|NCT02589665|11868639|FG003|Induction Period|Protocol Violation|0
7527099|NCT02589665|11868640|FG004|Induction Period|Protocol Violation|0
7527100|NCT02589665|11868641|FG005|Induction Period|Protocol Violation|0
7527101|NCT02589665|11868642|FG006|Induction Period|Protocol Violation|0
7527102|NCT02589665|11868643|FG007|Induction Period|Protocol Violation|0
7527103|NCT02589665|11868644|FG008|Induction Period|Protocol Violation|0
7527104|NCT02589665|11868645|FG009|Induction Period|Protocol Violation|0
7527105|NCT02589665|11868636|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527106|NCT02589665|11868637|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527107|NCT02589665|11868638|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527108|NCT02589665|11868639|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527109|NCT02589665|11868640|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
7527110|NCT02589665|11868641|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
7527111|NCT02589665|11868642|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
7527112|NCT02589665|11868643|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527113|NCT02589665|11868644|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527114|NCT02589665|11868645|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
7527115|NCT02589665|11868636|FG000|Maintenance Period|Withdrawal by Subject|0
7527116|NCT02589665|11868637|FG001|Maintenance Period|Withdrawal by Subject|0
7527117|NCT02589665|11868638|FG002|Maintenance Period|Withdrawal by Subject|0
7527118|NCT02589665|11868639|FG003|Maintenance Period|Withdrawal by Subject|0
7527119|NCT02589665|11868640|FG004|Maintenance Period|Withdrawal by Subject|4
7527120|NCT02589665|11868641|FG005|Maintenance Period|Withdrawal by Subject|2
7527121|NCT02589665|11868642|FG006|Maintenance Period|Withdrawal by Subject|4
7527122|NCT02589665|11868643|FG007|Maintenance Period|Withdrawal by Subject|0
7527123|NCT02589665|11868644|FG008|Maintenance Period|Withdrawal by Subject|0
7527124|NCT02589665|11868645|FG009|Maintenance Period|Withdrawal by Subject|0
7527125|NCT02589665|11868636|FG000|Maintenance Period|Lack of Efficacy|0
7527126|NCT02589665|11868637|FG001|Maintenance Period|Lack of Efficacy|0
7527127|NCT02589665|11868638|FG002|Maintenance Period|Lack of Efficacy|0
7527128|NCT02589665|11868639|FG003|Maintenance Period|Lack of Efficacy|0
7527129|NCT02589665|11868640|FG004|Maintenance Period|Lack of Efficacy|2
7527130|NCT02589665|11868641|FG005|Maintenance Period|Lack of Efficacy|1
7527131|NCT02589665|11868642|FG006|Maintenance Period|Lack of Efficacy|0
7527132|NCT02589665|11868643|FG007|Maintenance Period|Lack of Efficacy|0
7527133|NCT02589665|11868644|FG008|Maintenance Period|Lack of Efficacy|0
7527134|NCT02589665|11868645|FG009|Maintenance Period|Lack of Efficacy|0
7527135|NCT02589665|11868636|FG000|Maintenance Period|Adverse Event|0
7527136|NCT02589665|11868637|FG001|Maintenance Period|Adverse Event|0
7527137|NCT02589665|11868638|FG002|Maintenance Period|Adverse Event|0
7527138|NCT02589665|11868639|FG003|Maintenance Period|Adverse Event|0
7527139|NCT02589665|11868640|FG004|Maintenance Period|Adverse Event|0
7527140|NCT02589665|11868641|FG005|Maintenance Period|Adverse Event|0
7527141|NCT02589665|11868642|FG006|Maintenance Period|Adverse Event|2
7527142|NCT02589665|11868643|FG007|Maintenance Period|Adverse Event|0
7527143|NCT02589665|11868644|FG008|Maintenance Period|Adverse Event|0
7527144|NCT02589665|11868645|FG009|Maintenance Period|Adverse Event|0
7527145|NCT02589665|11868636|FG000|Maintenance Period|Lost to Follow-up|0
7527146|NCT02589665|11868637|FG001|Maintenance Period|Lost to Follow-up|0
7527147|NCT02589665|11868638|FG002|Maintenance Period|Lost to Follow-up|0
7527148|NCT02589665|11868639|FG003|Maintenance Period|Lost to Follow-up|0
7527149|NCT02589665|11868640|FG004|Maintenance Period|Lost to Follow-up|0
7527150|NCT02589665|11868641|FG005|Maintenance Period|Lost to Follow-up|1
7527151|NCT02589665|11868642|FG006|Maintenance Period|Lost to Follow-up|0
7527152|NCT02589665|11868643|FG007|Maintenance Period|Lost to Follow-up|0
7527153|NCT02589665|11868644|FG008|Maintenance Period|Lost to Follow-up|0
7527154|NCT02589665|11868645|FG009|Maintenance Period|Lost to Follow-up|0
7527155|NCT02589665|11868636|FG000|Maintenance Period|Physician Decision|0
7527156|NCT02589665|11868637|FG001|Maintenance Period|Physician Decision|0
7527157|NCT02589665|11868638|FG002|Maintenance Period|Physician Decision|0
7527158|NCT02589665|11868639|FG003|Maintenance Period|Physician Decision|0
7527159|NCT02589665|11868640|FG004|Maintenance Period|Physician Decision|0
7527160|NCT02589665|11868641|FG005|Maintenance Period|Physician Decision|1
7527161|NCT02589665|11868642|FG006|Maintenance Period|Physician Decision|0
7527162|NCT02589665|11868643|FG007|Maintenance Period|Physician Decision|0
7527163|NCT02589665|11868644|FG008|Maintenance Period|Physician Decision|0
7527164|NCT02589665|11868645|FG009|Maintenance Period|Physician Decision|0
7527165|NCT02589665|11868636|FG000|Maintenance Period|Reason Not Collected|0
7527166|NCT02589665|11868637|FG001|Maintenance Period|Reason Not Collected|0
7527167|NCT02589665|11868638|FG002|Maintenance Period|Reason Not Collected|0
7527168|NCT02589665|11868639|FG003|Maintenance Period|Reason Not Collected|0
7527169|NCT02589665|11868640|FG004|Maintenance Period|Reason Not Collected|0
7527170|NCT02589665|11868641|FG005|Maintenance Period|Reason Not Collected|1
7527171|NCT02589665|11868642|FG006|Maintenance Period|Reason Not Collected|1
7527172|NCT02589665|11868643|FG007|Maintenance Period|Reason Not Collected|0
7527173|NCT02589665|11868644|FG008|Maintenance Period|Reason Not Collected|0
7527174|NCT02589665|11868645|FG009|Maintenance Period|Reason Not Collected|0
7527175|NCT02589665|11868636|FG000|Induction Extension Period|Adverse Event|0
7527176|NCT02589665|11868637|FG001|Induction Extension Period|Adverse Event|0
7527177|NCT02589665|11868638|FG002|Induction Extension Period|Adverse Event|0
7527178|NCT02589665|11868639|FG003|Induction Extension Period|Adverse Event|0
7527179|NCT02589665|11868640|FG004|Induction Extension Period|Adverse Event|0
7527180|NCT02589665|11868641|FG005|Induction Extension Period|Adverse Event|0
7527181|NCT02589665|11868642|FG006|Induction Extension Period|Adverse Event|0
7527182|NCT02589665|11868643|FG007|Induction Extension Period|Adverse Event|0
7527183|NCT02589665|11868644|FG008|Induction Extension Period|Adverse Event|4
7527184|NCT02589665|11868645|FG009|Induction Extension Period|Adverse Event|0
7527185|NCT02589665|11868636|FG000|Induction Extension Period|Lack of Efficacy|0
7527186|NCT02589665|11868637|FG001|Induction Extension Period|Lack of Efficacy|0
7527187|NCT02589665|11868638|FG002|Induction Extension Period|Lack of Efficacy|0
7527188|NCT02589665|11868639|FG003|Induction Extension Period|Lack of Efficacy|0
7527189|NCT02589665|11868640|FG004|Induction Extension Period|Lack of Efficacy|0
7527190|NCT02589665|11868641|FG005|Induction Extension Period|Lack of Efficacy|0
7527191|NCT02589665|11868642|FG006|Induction Extension Period|Lack of Efficacy|0
7527192|NCT02589665|11868643|FG007|Induction Extension Period|Lack of Efficacy|0
7527193|NCT02589665|11868644|FG008|Induction Extension Period|Lack of Efficacy|3
7527194|NCT02589665|11868645|FG009|Induction Extension Period|Lack of Efficacy|0
7527195|NCT02589665|11868636|FG000|Induction Extension Period|Withdrawal by Subject|0
7527196|NCT02589665|11868637|FG001|Induction Extension Period|Withdrawal by Subject|0
7527197|NCT02589665|11868638|FG002|Induction Extension Period|Withdrawal by Subject|0
7527198|NCT02589665|11868639|FG003|Induction Extension Period|Withdrawal by Subject|0
7527199|NCT02589665|11868640|FG004|Induction Extension Period|Withdrawal by Subject|0
7527200|NCT02589665|11868641|FG005|Induction Extension Period|Withdrawal by Subject|0
7527201|NCT02589665|11868642|FG006|Induction Extension Period|Withdrawal by Subject|0
7527202|NCT02589665|11868643|FG007|Induction Extension Period|Withdrawal by Subject|2
7527203|NCT02589665|11868644|FG008|Induction Extension Period|Withdrawal by Subject|3
7527204|NCT02589665|11868645|FG009|Induction Extension Period|Withdrawal by Subject|0
7527205|NCT02589665|11868636|FG000|Induction Extension Period|Physician Decision|0
7527206|NCT02589665|11868637|FG001|Induction Extension Period|Physician Decision|0
7527207|NCT02589665|11868638|FG002|Induction Extension Period|Physician Decision|0
7527208|NCT02589665|11868639|FG003|Induction Extension Period|Physician Decision|0
7527209|NCT02589665|11868640|FG004|Induction Extension Period|Physician Decision|0
7527210|NCT02589665|11868641|FG005|Induction Extension Period|Physician Decision|0
7527211|NCT02589665|11868642|FG006|Induction Extension Period|Physician Decision|0
7527212|NCT02589665|11868643|FG007|Induction Extension Period|Physician Decision|0
7527213|NCT02589665|11868644|FG008|Induction Extension Period|Physician Decision|1
7527214|NCT02589665|11868645|FG009|Induction Extension Period|Physician Decision|0
7527215|NCT02589665|11868636|FG000|Induction Extension Period|Reason Not Collected|0
7527216|NCT02589665|11868637|FG001|Induction Extension Period|Reason Not Collected|0
7527217|NCT02589665|11868638|FG002|Induction Extension Period|Reason Not Collected|0
7527218|NCT02589665|11868639|FG003|Induction Extension Period|Reason Not Collected|0
7527219|NCT02589665|11868640|FG004|Induction Extension Period|Reason Not Collected|0
7527220|NCT02589665|11868641|FG005|Induction Extension Period|Reason Not Collected|0
7527221|NCT02589665|11868642|FG006|Induction Extension Period|Reason Not Collected|0
7527222|NCT02589665|11868643|FG007|Induction Extension Period|Reason Not Collected|0
7527223|NCT02589665|11868644|FG008|Induction Extension Period|Reason Not Collected|1
7527224|NCT02589665|11868645|FG009|Induction Extension Period|Reason Not Collected|0
7527225|NCT02589665|11868636|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527226|NCT02589665|11868637|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527227|NCT02589665|11868638|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527228|NCT02589665|11868639|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527229|NCT02589665|11868640|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527230|NCT02589665|11868641|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527231|NCT02589665|11868642|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527232|NCT02589665|11868643|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527233|NCT02589665|11868644|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
7527234|NCT02589665|11868645|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
7527235|NCT02589665|11868636|FG000|Maintenance Extension Period|Withdrawal by Subject|0
7527236|NCT02589665|11868637|FG001|Maintenance Extension Period|Withdrawal by Subject|0
7527237|NCT02589665|11868638|FG002|Maintenance Extension Period|Withdrawal by Subject|0
7527238|NCT02589665|11868639|FG003|Maintenance Extension Period|Withdrawal by Subject|0
7527239|NCT02589665|11868640|FG004|Maintenance Extension Period|Withdrawal by Subject|0
7527240|NCT02589665|11868641|FG005|Maintenance Extension Period|Withdrawal by Subject|0
7527241|NCT02589665|11868642|FG006|Maintenance Extension Period|Withdrawal by Subject|0
7527242|NCT02589665|11868643|FG007|Maintenance Extension Period|Withdrawal by Subject|0
7527243|NCT02589665|11868644|FG008|Maintenance Extension Period|Withdrawal by Subject|0
7527244|NCT02589665|11868645|FG009|Maintenance Extension Period|Withdrawal by Subject|4
7527245|NCT02589665|11868636|FG000|Maintenance Extension Period|Lack of Efficacy|0
7527246|NCT02589665|11868637|FG001|Maintenance Extension Period|Lack of Efficacy|0
7527247|NCT02589665|11868638|FG002|Maintenance Extension Period|Lack of Efficacy|0
7527248|NCT02589665|11868639|FG003|Maintenance Extension Period|Lack of Efficacy|0
7527249|NCT02589665|11868640|FG004|Maintenance Extension Period|Lack of Efficacy|0
7527250|NCT02589665|11868641|FG005|Maintenance Extension Period|Lack of Efficacy|0
7527251|NCT02589665|11868642|FG006|Maintenance Extension Period|Lack of Efficacy|0
7527252|NCT02589665|11868643|FG007|Maintenance Extension Period|Lack of Efficacy|0
7527253|NCT02589665|11868644|FG008|Maintenance Extension Period|Lack of Efficacy|0
7527254|NCT02589665|11868645|FG009|Maintenance Extension Period|Lack of Efficacy|4
7527255|NCT02589665|11868636|FG000|Maintenance Extension Period|Adverse Event|0
7527256|NCT02589665|11868637|FG001|Maintenance Extension Period|Adverse Event|0
7527257|NCT02589665|11868638|FG002|Maintenance Extension Period|Adverse Event|0
7527258|NCT02589665|11868639|FG003|Maintenance Extension Period|Adverse Event|0
7527259|NCT02589665|11868640|FG004|Maintenance Extension Period|Adverse Event|0
7527260|NCT02589665|11868641|FG005|Maintenance Extension Period|Adverse Event|0
7527261|NCT02589665|11868642|FG006|Maintenance Extension Period|Adverse Event|0
7527262|NCT02589665|11868643|FG007|Maintenance Extension Period|Adverse Event|0
7527263|NCT02589665|11868644|FG008|Maintenance Extension Period|Adverse Event|0
7527264|NCT02589665|11868645|FG009|Maintenance Extension Period|Adverse Event|2
7527265|NCT02589665|11868636|FG000|Maintenance Extension Period|Non-responder|0
7527266|NCT02589665|11868637|FG001|Maintenance Extension Period|Non-responder|0
7527267|NCT02589665|11868638|FG002|Maintenance Extension Period|Non-responder|0
7537386|NCT02736409|11886159|FG001|Overall Study|Withdrawal by Subject|2
7527268|NCT02589665|11868639|FG003|Maintenance Extension Period|Non-responder|0
7527269|NCT02589665|11868640|FG004|Maintenance Extension Period|Non-responder|0
7527270|NCT02589665|11868641|FG005|Maintenance Extension Period|Non-responder|0
7527271|NCT02589665|11868642|FG006|Maintenance Extension Period|Non-responder|0
7527272|NCT02589665|11868643|FG007|Maintenance Extension Period|Non-responder|0
7527273|NCT02589665|11868644|FG008|Maintenance Extension Period|Non-responder|0
7527274|NCT02589665|11868645|FG009|Maintenance Extension Period|Non-responder|1
7527275|NCT02590003|11868698|FG000|Overall Study|Death|1
7527276|NCT02590003|11868699|FG001|Overall Study|Death|2
7527277|NCT02590354|11868705|FG000|Phase 1|Active hepatitis B or C infection|1
7527278|NCT02590354|11868705|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
7527279|NCT02590354|11868705|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
7527280|NCT02590354|11868705|FG000|Phase 1|Subject does not want to participate|20
7527281|NCT02590354|11868705|FG000|Phase 1|Lost to Follow-up|1
7527282|NCT02590354|11868705|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
7527283|NCT02590406|11868712|FG000|Overall Study|Adverse Event|1
7527284|NCT02590406|11868713|FG001|Overall Study|Adverse Event|0
7527285|NCT02590406|11868712|FG000|Overall Study|Saturometer malfunction|0
7527286|NCT02590406|11868713|FG001|Overall Study|Saturometer malfunction|1
7527287|NCT02590432|11868721|FG000|Open-label Treatment Period|Adverse Event|97
7527288|NCT02590432|11868722|FG001|Open-label Treatment Period|Adverse Event|79
7527289|NCT02590432|11868723|FG002|Open-label Treatment Period|Adverse Event|0
7527290|NCT02590432|11868724|FG003|Open-label Treatment Period|Adverse Event|0
7527291|NCT02590432|11868725|FG004|Open-label Treatment Period|Adverse Event|0
7527292|NCT02590432|11868726|FG005|Open-label Treatment Period|Adverse Event|0
7527293|NCT02590432|11868727|FG006|Open-label Treatment Period|Adverse Event|0
7527294|NCT02590432|11868728|FG007|Open-label Treatment Period|Adverse Event|0
7527295|NCT02590432|11868729|FG008|Open-label Treatment Period|Adverse Event|0
7527296|NCT02590432|11868721|FG000|Open-label Treatment Period|Lack of Efficacy|14
7527297|NCT02590432|11868722|FG001|Open-label Treatment Period|Lack of Efficacy|5
7527298|NCT02590432|11868723|FG002|Open-label Treatment Period|Lack of Efficacy|0
7527299|NCT02590432|11868724|FG003|Open-label Treatment Period|Lack of Efficacy|0
7527300|NCT02590432|11868725|FG004|Open-label Treatment Period|Lack of Efficacy|0
7527301|NCT02590432|11868726|FG005|Open-label Treatment Period|Lack of Efficacy|0
7527302|NCT02590432|11868727|FG006|Open-label Treatment Period|Lack of Efficacy|0
7527303|NCT02590432|11868728|FG007|Open-label Treatment Period|Lack of Efficacy|0
7527304|NCT02590432|11868729|FG008|Open-label Treatment Period|Lack of Efficacy|0
7527305|NCT02590432|11868721|FG000|Open-label Treatment Period|Withdrawal of Consent|43
7527306|NCT02590432|11868722|FG001|Open-label Treatment Period|Withdrawal of Consent|28
7527307|NCT02590432|11868723|FG002|Open-label Treatment Period|Withdrawal of Consent|0
7527308|NCT02590432|11868724|FG003|Open-label Treatment Period|Withdrawal of Consent|0
7527309|NCT02590432|11868725|FG004|Open-label Treatment Period|Withdrawal of Consent|0
7527310|NCT02590432|11868726|FG005|Open-label Treatment Period|Withdrawal of Consent|0
7527311|NCT02590432|11868727|FG006|Open-label Treatment Period|Withdrawal of Consent|0
7527312|NCT02590432|11868728|FG007|Open-label Treatment Period|Withdrawal of Consent|0
7527313|NCT02590432|11868729|FG008|Open-label Treatment Period|Withdrawal of Consent|0
7527314|NCT02590432|11868721|FG000|Open-label Treatment Period|Lost to Follow-up|51
7527315|NCT02590432|11868722|FG001|Open-label Treatment Period|Lost to Follow-up|29
7527316|NCT02590432|11868723|FG002|Open-label Treatment Period|Lost to Follow-up|0
7527317|NCT02590432|11868724|FG003|Open-label Treatment Period|Lost to Follow-up|0
7527318|NCT02590432|11868725|FG004|Open-label Treatment Period|Lost to Follow-up|0
7527319|NCT02590432|11868726|FG005|Open-label Treatment Period|Lost to Follow-up|0
7527320|NCT02590432|11868727|FG006|Open-label Treatment Period|Lost to Follow-up|0
7527321|NCT02590432|11868728|FG007|Open-label Treatment Period|Lost to Follow-up|0
7527322|NCT02590432|11868729|FG008|Open-label Treatment Period|Lost to Follow-up|0
7527323|NCT02590432|11868721|FG000|Open-label Treatment Period|Protocol Violation|10
7527324|NCT02590432|11868722|FG001|Open-label Treatment Period|Protocol Violation|4
7527325|NCT02590432|11868723|FG002|Open-label Treatment Period|Protocol Violation|0
7527326|NCT02590432|11868724|FG003|Open-label Treatment Period|Protocol Violation|0
7527327|NCT02590432|11868725|FG004|Open-label Treatment Period|Protocol Violation|0
7527328|NCT02590432|11868726|FG005|Open-label Treatment Period|Protocol Violation|0
7527329|NCT02590432|11868727|FG006|Open-label Treatment Period|Protocol Violation|0
7527330|NCT02590432|11868728|FG007|Open-label Treatment Period|Protocol Violation|0
7527331|NCT02590432|11868729|FG008|Open-label Treatment Period|Protocol Violation|0
7527332|NCT02590432|11868721|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
7527333|NCT02590432|11868722|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
7527334|NCT02590432|11868723|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
7527335|NCT02590432|11868724|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
7527336|NCT02590432|11868725|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
7527337|NCT02590432|11868726|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
7527338|NCT02590432|11868727|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
7527339|NCT02590432|11868728|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
7527340|NCT02590432|11868729|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
7527341|NCT02590432|11868721|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
7527342|NCT02590432|11868722|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
7527343|NCT02590432|11868723|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527344|NCT02590432|11868724|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527345|NCT02590432|11868725|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527346|NCT02590432|11868726|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527347|NCT02590432|11868727|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527348|NCT02590432|11868728|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527349|NCT02590432|11868729|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
7527350|NCT02590432|11868721|FG000|Double-blind Treatment Period|Adverse Event|0
7527351|NCT02590432|11868722|FG001|Double-blind Treatment Period|Adverse Event|0
7527352|NCT02590432|11868723|FG002|Double-blind Treatment Period|Adverse Event|14
7527353|NCT02590432|11868724|FG003|Double-blind Treatment Period|Adverse Event|12
7527354|NCT02590432|11868725|FG004|Double-blind Treatment Period|Adverse Event|6
7527355|NCT02590432|11868726|FG005|Double-blind Treatment Period|Adverse Event|22
7527356|NCT02590432|11868727|FG006|Double-blind Treatment Period|Adverse Event|20
7527357|NCT02590432|11868728|FG007|Double-blind Treatment Period|Adverse Event|0
7527358|NCT02590432|11868729|FG008|Double-blind Treatment Period|Adverse Event|0
7527359|NCT02590432|11868721|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7527360|NCT02590432|11868722|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7527361|NCT02590432|11868723|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7527362|NCT02590432|11868724|FG003|Double-blind Treatment Period|Lack of Efficacy|0
7527363|NCT02590432|11868725|FG004|Double-blind Treatment Period|Lack of Efficacy|0
7527364|NCT02590432|11868726|FG005|Double-blind Treatment Period|Lack of Efficacy|0
7527365|NCT02590432|11868727|FG006|Double-blind Treatment Period|Lack of Efficacy|0
7527366|NCT02590432|11868728|FG007|Double-blind Treatment Period|Lack of Efficacy|0
7527367|NCT02590432|11868729|FG008|Double-blind Treatment Period|Lack of Efficacy|0
7527368|NCT02590432|11868721|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
7527369|NCT02590432|11868722|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
7527370|NCT02590432|11868723|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
7527371|NCT02590432|11868724|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
7527372|NCT02590432|11868725|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
7527373|NCT02590432|11868726|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
7527374|NCT02590432|11868727|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
7527375|NCT02590432|11868728|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
7527376|NCT02590432|11868729|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
7527377|NCT02590432|11868721|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7527378|NCT02590432|11868722|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7527379|NCT02590432|11868723|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7527380|NCT02590432|11868724|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7527381|NCT02590432|11868725|FG004|Double-blind Treatment Period|Lost to Follow-up|0
7527382|NCT02590432|11868726|FG005|Double-blind Treatment Period|Lost to Follow-up|2
7527383|NCT02590432|11868727|FG006|Double-blind Treatment Period|Lost to Follow-up|0
7527384|NCT02590432|11868728|FG007|Double-blind Treatment Period|Lost to Follow-up|0
7527385|NCT02590432|11868729|FG008|Double-blind Treatment Period|Lost to Follow-up|0
7527386|NCT02590432|11868721|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527387|NCT02590432|11868722|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527388|NCT02590432|11868723|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527389|NCT02590432|11868724|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527390|NCT02590432|11868725|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527391|NCT02590432|11868726|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
7527392|NCT02590432|11868727|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527393|NCT02590432|11868728|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527394|NCT02590432|11868729|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
7527395|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527396|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527397|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527398|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527399|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527400|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527401|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
7527402|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
7527403|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
7527404|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527405|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527406|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527407|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527408|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527409|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527410|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527411|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
7527412|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
7527413|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527414|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527415|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527416|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527417|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527418|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527419|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
7527420|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
7527421|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
7527422|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527423|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527424|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527425|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527426|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527427|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527428|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527429|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
7527430|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
7527431|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527432|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527433|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527434|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527435|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527436|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527437|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527438|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
7527439|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
7527440|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527441|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527442|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527443|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527444|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527445|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527446|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527447|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
7527448|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
7527449|NCT02590432|11868721|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527450|NCT02590432|11868722|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527451|NCT02590432|11868723|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527452|NCT02590432|11868724|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527453|NCT02590432|11868725|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527454|NCT02590432|11868726|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527455|NCT02590432|11868727|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527456|NCT02590432|11868728|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
7527457|NCT02590432|11868729|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
7527458|NCT02590562|11868741|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
7527459|NCT02590588|11868751|FG000|Overall Study|Adverse Event|1
7527460|NCT02590939|11868757|FG000|Overall Study|Withdrawal by Subject|3
7527461|NCT02590939|11868758|FG001|Overall Study|Withdrawal by Subject|1
7527462|NCT02590939|11868757|FG000|Overall Study|Failed the nociceptive test|2
7527463|NCT02590939|11868758|FG001|Overall Study|Failed the nociceptive test|1
7527464|NCT02591238|11868772|FG000|Overall Study|Pregnancy|1
7527465|NCT02591238|11868773|FG001|Overall Study|Pregnancy|0
7527466|NCT02591238|11868774|FG002|Overall Study|Pregnancy|0
7527467|NCT02591238|11868775|FG003|Overall Study|Pregnancy|0
7527468|NCT02591238|11868772|FG000|Overall Study|Withdrawal by Subject|0
7527469|NCT02591238|11868773|FG001|Overall Study|Withdrawal by Subject|0
7527470|NCT02591238|11868774|FG002|Overall Study|Withdrawal by Subject|0
7527471|NCT02591238|11868775|FG003|Overall Study|Withdrawal by Subject|1
7527472|NCT02591238|11868772|FG000|Overall Study|influenza|0
7527473|NCT02591238|11868773|FG001|Overall Study|influenza|0
7527474|NCT02591238|11868774|FG002|Overall Study|influenza|0
7527475|NCT02591238|11868775|FG003|Overall Study|influenza|1
7527476|NCT02591238|11868772|FG000|Overall Study|personal circumstances|0
7527477|NCT02591238|11868773|FG001|Overall Study|personal circumstances|0
7527478|NCT02591238|11868774|FG002|Overall Study|personal circumstances|0
7527479|NCT02591238|11868775|FG003|Overall Study|personal circumstances|1
7527480|NCT02591238|11868772|FG000|Overall Study|personal circumstances|0
7527481|NCT02591238|11868773|FG001|Overall Study|personal circumstances|1
7527482|NCT02591238|11868774|FG002|Overall Study|personal circumstances|0
7527483|NCT02591238|11868775|FG003|Overall Study|personal circumstances|0
7527484|NCT02591290|11868785|FG000|Overall Study|Withdrawal by Subject|2
7527485|NCT02592018|11868808|FG000|Overall Study|Adverse Event|1
7527486|NCT02592018|11868808|FG000|Overall Study|Lost to Follow-up|1
7527487|NCT02592434|11868821|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
7527488|NCT02592434|11868822|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
7527489|NCT02592434|11868823|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
7527490|NCT02592434|11868821|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
7527491|NCT02592434|11868822|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7527492|NCT02592434|11868823|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
7527493|NCT02592434|11868821|FG000|Open-Label Phase (18 Weeks)|Other|3
7527494|NCT02592434|11868822|FG001|Open-Label Phase (18 Weeks)|Other|0
7527495|NCT02592434|11868823|FG002|Open-Label Phase (18 Weeks)|Other|0
7527496|NCT02592434|11868821|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
7527497|NCT02592434|11868822|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7527498|NCT02592434|11868823|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
7527499|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
7527500|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
7527501|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
7527502|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
7527503|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
7527504|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
7527505|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Other|0
7527506|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Other|1
7527507|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Other|0
7527508|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7527509|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
7527510|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
7527511|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7527512|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
7527513|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
7527514|NCT02592434|11868821|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7527515|NCT02592434|11868822|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
7527516|NCT02592434|11868823|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
7527517|NCT02592447|11868833|FG000|Overall Study|Lost to Follow-up|1
7527518|NCT02592447|11868834|FG001|Overall Study|Lost to Follow-up|0
7527519|NCT02592447|11868833|FG000|Overall Study|Ineligible after randomization|1
7224652|NCT00057330|11433950|FG001|Overall Study|Other|206
7224653|NCT00057746|11433999|FG000|Overall Study|Withdrawal by Subject|0
7224654|NCT00057746|11434000|FG001|Overall Study|Withdrawal by Subject|0
7224655|NCT00057746|11434001|FG002|Overall Study|Withdrawal by Subject|1
7224656|NCT00057811|11434015|FG000|Overall Study|Lack of Efficacy|1
7224657|NCT00057811|11434016|FG001|Overall Study|Lack of Efficacy|4
7527520|NCT02592447|11868834|FG001|Overall Study|Ineligible after randomization|0
7527521|NCT02592447|11868833|FG000|Overall Study|Withdrawal by Subject|0
7527522|NCT02592447|11868834|FG001|Overall Study|Withdrawal by Subject|1
7527523|NCT02592798|11868881|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
7527524|NCT02592798|11868882|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
7527525|NCT02592798|11868881|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
7527526|NCT02592798|11868882|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
7527527|NCT02592798|11868881|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
7527528|NCT02592798|11868882|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
7527529|NCT02592798|11868881|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
7527530|NCT02592798|11868882|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
7527531|NCT02592798|11868881|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
7527532|NCT02592798|11868882|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
7527533|NCT02592798|11868881|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
7527534|NCT02592798|11868882|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
7527535|NCT02592798|11868881|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
7527536|NCT02592798|11868882|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
7527537|NCT02592798|11868881|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
7537387|NCT02736409|11886160|FG002|Overall Study|Withdrawal by Subject|17
7224658|NCT00057811|11434015|FG000|Overall Study|Physician Decision|1
7527538|NCT02592798|11868882|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
7527539|NCT02592798|11868881|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
7527540|NCT02592798|11868882|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
7527541|NCT02592798|11868881|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
7527542|NCT02592798|11868882|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
7527543|NCT02592798|11868881|FG000|Transition From DB2 to OLE|Other reasons|1
7527544|NCT02592798|11868882|FG001|Transition From DB2 to OLE|Other reasons|0
7527545|NCT02592798|11868881|FG000|Open Label Period (OLE)|Other reasons|0
7527546|NCT02592798|11868882|FG001|Open Label Period (OLE)|Other reasons|2
7527547|NCT02592798|11868881|FG000|Open Label Period (OLE)|Participant request to discontinue|1
7527548|NCT02592798|11868882|FG001|Open Label Period (OLE)|Participant request to discontinue|0
7527549|NCT02592798|11868881|FG000|Open Label Period (OLE)|Lost to Follow-up|0
7527550|NCT02592798|11868882|FG001|Open Label Period (OLE)|Lost to Follow-up|1
7527551|NCT02592798|11868881|FG000|Open Label Period (OLE)|Lack of Efficacy|3
7527552|NCT02592798|11868882|FG001|Open Label Period (OLE)|Lack of Efficacy|5
7527553|NCT02592798|11868881|FG000|Open Label Period (OLE)|Adverse Event|0
7527554|NCT02592798|11868882|FG001|Open Label Period (OLE)|Adverse Event|1
7527555|NCT02592876|11868897|FG000|Overall Study|Withdrawal by Subject|3
7527556|NCT02592876|11868898|FG001|Overall Study|Withdrawal by Subject|3
7527557|NCT02592876|11868897|FG000|Overall Study|Study Termination by Sponsor|32
7527558|NCT02592876|11868898|FG001|Overall Study|Study Termination by Sponsor|27
7527559|NCT02592876|11868897|FG000|Overall Study|Lost to Follow-up|0
7527560|NCT02592876|11868898|FG001|Overall Study|Lost to Follow-up|1
7527561|NCT02592876|11868897|FG000|Overall Study|Death|6
7527562|NCT02592876|11868898|FG001|Overall Study|Death|9
7527563|NCT02593097|11868929|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
7527564|NCT02593097|11868930|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
7527565|NCT02593097|11868929|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7527566|NCT02593097|11868930|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
7527567|NCT02593097|11868929|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
7527568|NCT02593097|11868930|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
7527569|NCT02593097|11868929|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
7527570|NCT02593097|11868930|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
7527571|NCT02593097|11868929|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7527572|NCT02593097|11868930|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7527573|NCT02593149|11868938|FG000|Run-In|Didn't use CVC for at least 21 days|36
7527574|NCT02593149|11868939|FG001|Run-In|Didn't use CVC for at least 21 days|38
7527575|NCT02593149|11868938|FG000|Intervention|Didn't use CVC for at least 21 day|116
7527576|NCT02593149|11868939|FG001|Intervention|Didn't use CVC for at least 21 day|115
7527577|NCT02593305|11868948|FG000|Post 1|Comparison only group. No intervention.|0
7527578|NCT02593305|11868949|FG001|Post 1|Comparison only group. No intervention.|0
7527579|NCT02593305|11868950|FG002|Post 1|Comparison only group. No intervention.|10
7527580|NCT02593318|11868961|FG000|Overall Study|Withdrawal by Subject|1
7527581|NCT02593318|11868962|FG001|Overall Study|Withdrawal by Subject|1
7527582|NCT02593539|11868983|FG000|Overall Study|Adverse Event|1
7527583|NCT02593773|11868995|FG000|Overall Study|Voluntary Withdrawal|3
7527584|NCT02593773|11868995|FG000|Overall Study|Study Terminated by Sponsor|31
7527585|NCT02593773|11868995|FG000|Overall Study|Death|1
7527586|NCT02593825|11869001|FG000|Intervention|Lost to Follow-up|10
7527587|NCT02593825|11869002|FG001|Intervention|Lost to Follow-up|12
7527588|NCT02593864|11869010|FG000|Overall Study|Withdrawal by Subject|3
7527589|NCT02593864|11869010|FG000|Overall Study|Lost to Follow-up|3
7537388|NCT02736409|11886161|FG003|Overall Study|Withdrawal by Subject|3
7537389|NCT02736409|11886158|FG000|Overall Study|Non-Compliance with Study Drug|0
7537390|NCT02736409|11886159|FG001|Overall Study|Non-Compliance with Study Drug|0
7537391|NCT02736409|11886160|FG002|Overall Study|Non-Compliance with Study Drug|0
7537392|NCT02736409|11886161|FG003|Overall Study|Non-Compliance with Study Drug|1
7537393|NCT02736409|11886158|FG000|Overall Study|Adverse Event|0
7537394|NCT02736409|11886159|FG001|Overall Study|Adverse Event|1
7537395|NCT02736409|11886160|FG002|Overall Study|Adverse Event|5
7537396|NCT02736409|11886161|FG003|Overall Study|Adverse Event|4
7537397|NCT02736409|11886158|FG000|Overall Study|Other|0
7537398|NCT02736409|11886159|FG001|Overall Study|Other|0
7537399|NCT02736409|11886160|FG002|Overall Study|Other|1
7537400|NCT02736409|11886161|FG003|Overall Study|Other|1
7537401|NCT02736409|11886158|FG000|Overall Study|Pregnancy|0
7537402|NCT02736409|11886159|FG001|Overall Study|Pregnancy|0
7537403|NCT02736409|11886160|FG002|Overall Study|Pregnancy|1
7537404|NCT02736409|11886161|FG003|Overall Study|Pregnancy|0
7537405|NCT02736409|11886158|FG000|Overall Study|Lost to Follow-up|0
7537406|NCT02736409|11886159|FG001|Overall Study|Lost to Follow-up|0
7537407|NCT02736409|11886160|FG002|Overall Study|Lost to Follow-up|2
7537408|NCT02736409|11886161|FG003|Overall Study|Lost to Follow-up|1
7537409|NCT02736409|11886158|FG000|Overall Study|Physician Decision|0
7537410|NCT02736409|11886159|FG001|Overall Study|Physician Decision|0
7537411|NCT02736409|11886160|FG002|Overall Study|Physician Decision|0
7537412|NCT02736409|11886161|FG003|Overall Study|Physician Decision|2
7537413|NCT02736474|11886174|FG000|Overall Study|Lost to Follow-up|0
7537414|NCT02736474|11886175|FG001|Overall Study|Lost to Follow-up|1
7537415|NCT02736578|11886183|FG000|Overall Study|Adverse Event|1
7537416|NCT02736578|11886184|FG001|Overall Study|Adverse Event|0
7527590|NCT04142242|11869020|FG000|Overall Study|Non-compliance with the protocol|1
7527591|NCT04142242|11869021|FG001|Overall Study|Non-compliance with the protocol|0
7527592|NCT04142242|11869022|FG002|Overall Study|Non-compliance with the protocol|0
7527593|NCT04142242|11869023|FG003|Overall Study|Non-compliance with the protocol|0
7527594|NCT04142242|11869024|FG004|Overall Study|Non-compliance with the protocol|0
7527595|NCT04142242|11869025|FG005|Overall Study|Non-compliance with the protocol|1
7527596|NCT04142242|11869020|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7527597|NCT04142242|11869021|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
7527598|NCT04142242|11869022|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7527599|NCT04142242|11869023|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7527600|NCT04142242|11869024|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7527601|NCT04142242|11869025|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
7527602|NCT04142242|11869020|FG000|Overall Study|Ongoing|0
7527603|NCT04142242|11869021|FG001|Overall Study|Ongoing|0
7527604|NCT04142242|11869022|FG002|Overall Study|Ongoing|31
7527605|NCT04142242|11869023|FG003|Overall Study|Ongoing|39
7527606|NCT04142242|11869024|FG004|Overall Study|Ongoing|0
7527607|NCT04142242|11869025|FG005|Overall Study|Ongoing|0
7527608|NCT03990389|11869046|FG000|Overall Study|Lost to Follow-up|3
7527609|NCT03990389|11869047|FG001|Overall Study|Lost to Follow-up|0
7527610|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43
7527611|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25
7527612|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4
7527613|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35
7527614|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19
7527615|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3
7527616|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16
7527617|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4
7527618|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3
7527619|NCT03939312|11869053|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22
7527620|NCT03939312|11869053|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12
7527621|NCT03939312|11869053|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4
7527622|NCT03934541|11869063|FG000|Overall Study|Study Terminated by Sponsor|0
7527623|NCT03934541|11869064|FG001|Overall Study|Study Terminated by Sponsor|1
7527624|NCT03934541|11869065|FG002|Overall Study|Study Terminated by Sponsor|0
7527625|NCT03934541|11869066|FG003|Overall Study|Study Terminated by Sponsor|0
7527626|NCT03895034|11869076|FG000|Overall Study|Lost to Follow-up|2
7527627|NCT03870477|11869080|FG000|Overall Study|Early Study Termination|1
7527628|NCT03351244|11869087|FG000|Overall Study|Adverse Event|7
7527629|NCT03351244|11869088|FG001|Overall Study|Adverse Event|11
7527630|NCT03351244|11869089|FG002|Overall Study|Adverse Event|12
7527631|NCT03351244|11869087|FG000|Overall Study|Investigator's decision|0
7527632|NCT03351244|11869088|FG001|Overall Study|Investigator's decision|0
7527633|NCT03351244|11869089|FG002|Overall Study|Investigator's decision|2
7527634|NCT03351244|11869087|FG000|Overall Study|System error|0
7527635|NCT03351244|11869088|FG001|Overall Study|System error|0
7527636|NCT03351244|11869089|FG002|Overall Study|System error|2
7527637|NCT03351244|11869087|FG000|Overall Study|COVID-19 restrictions|3
7527638|NCT03351244|11869088|FG001|Overall Study|COVID-19 restrictions|0
7527639|NCT03351244|11869089|FG002|Overall Study|COVID-19 restrictions|1
7527640|NCT03351244|11869087|FG000|Overall Study|Non-compliance|2
7527641|NCT03351244|11869088|FG001|Overall Study|Non-compliance|5
7527642|NCT03351244|11869089|FG002|Overall Study|Non-compliance|0
7527643|NCT03351244|11869087|FG000|Overall Study|Withdrawal by Subject|11
7527644|NCT03351244|11869088|FG001|Overall Study|Withdrawal by Subject|16
7527645|NCT03351244|11869089|FG002|Overall Study|Withdrawal by Subject|13
7527646|NCT03351244|11869087|FG000|Overall Study|Lost to Follow-up|2
7527647|NCT03351244|11869088|FG001|Overall Study|Lost to Follow-up|6
7527648|NCT03351244|11869089|FG002|Overall Study|Lost to Follow-up|4
7527649|NCT03351244|11869087|FG000|Overall Study|Protocol Violation|2
7527650|NCT03351244|11869088|FG001|Overall Study|Protocol Violation|2
7527651|NCT03351244|11869089|FG002|Overall Study|Protocol Violation|0
7527652|NCT02982954|11869121|FG000|Treatment Period|Disease progression|62
7527653|NCT02982954|11869122|FG001|Treatment Period|Disease progression|26
7527654|NCT02982954|11869123|FG002|Treatment Period|Disease progression|12
7527655|NCT02982954|11869124|FG003|Treatment Period|Disease progression|10
7527656|NCT02982954|11869121|FG000|Treatment Period|study drug toxicity|20
7527657|NCT02982954|11869122|FG001|Treatment Period|study drug toxicity|10
7527658|NCT02982954|11869123|FG002|Treatment Period|study drug toxicity|8
7527659|NCT02982954|11869124|FG003|Treatment Period|study drug toxicity|0
7527660|NCT02982954|11869121|FG000|Treatment Period|Death|1
7527661|NCT02982954|11869122|FG001|Treatment Period|Death|3
7527662|NCT02982954|11869123|FG002|Treatment Period|Death|2
7527663|NCT02982954|11869124|FG003|Treatment Period|Death|4
7527664|NCT02982954|11869121|FG000|Treatment Period|Adverse events unrelated to study drug|4
7527665|NCT02982954|11869122|FG001|Treatment Period|Adverse events unrelated to study drug|1
7527666|NCT02982954|11869123|FG002|Treatment Period|Adverse events unrelated to study drug|1
7527667|NCT02982954|11869124|FG003|Treatment Period|Adverse events unrelated to study drug|3
7527668|NCT02982954|11869121|FG000|Treatment Period|participant request to discontinue|2
7527669|NCT02982954|11869122|FG001|Treatment Period|participant request to discontinue|2
7527670|NCT02982954|11869123|FG002|Treatment Period|participant request to discontinue|1
7527671|NCT02982954|11869124|FG003|Treatment Period|participant request to discontinue|2
7527672|NCT02982954|11869121|FG000|Treatment Period|participant withdrew consent|1
7527673|NCT02982954|11869122|FG001|Treatment Period|participant withdrew consent|1
7527674|NCT02982954|11869123|FG002|Treatment Period|participant withdrew consent|0
7527675|NCT02982954|11869124|FG003|Treatment Period|participant withdrew consent|1
7527676|NCT02982954|11869121|FG000|Treatment Period|maximum clinical benefit|1
7527677|NCT02982954|11869122|FG001|Treatment Period|maximum clinical benefit|0
7527678|NCT02982954|11869123|FG002|Treatment Period|maximum clinical benefit|0
7527679|NCT02982954|11869124|FG003|Treatment Period|maximum clinical benefit|0
7527680|NCT02982954|11869121|FG000|Treatment Period|no longer meets study criteria|0
7527681|NCT02982954|11869122|FG001|Treatment Period|no longer meets study criteria|1
7527682|NCT02982954|11869123|FG002|Treatment Period|no longer meets study criteria|0
7527683|NCT02982954|11869124|FG003|Treatment Period|no longer meets study criteria|0
7527684|NCT02982954|11869121|FG000|Treatment Period|Admin reason by sponsor|3
7527685|NCT02982954|11869122|FG001|Treatment Period|Admin reason by sponsor|0
7527686|NCT02982954|11869123|FG002|Treatment Period|Admin reason by sponsor|0
7527687|NCT02982954|11869124|FG003|Treatment Period|Admin reason by sponsor|0
7527688|NCT02982954|11869121|FG000|Treatment Period|other reasons|12
7527689|NCT02982954|11869122|FG001|Treatment Period|other reasons|8
7527690|NCT02982954|11869123|FG002|Treatment Period|other reasons|4
7527691|NCT02982954|11869124|FG003|Treatment Period|other reasons|5
7527692|NCT02982954|11869121|FG000|Continuing in Study|Death|44
7527693|NCT02982954|11869122|FG001|Continuing in Study|Death|27
7527694|NCT02982954|11869123|FG002|Continuing in Study|Death|10
7527695|NCT02982954|11869124|FG003|Continuing in Study|Death|17
7527696|NCT02982954|11869121|FG000|Continuing in Study|participant withdrew consent|9
7527697|NCT02982954|11869122|FG001|Continuing in Study|participant withdrew consent|5
7527698|NCT02982954|11869123|FG002|Continuing in Study|participant withdrew consent|1
7527699|NCT02982954|11869124|FG003|Continuing in Study|participant withdrew consent|1
7527700|NCT02982954|11869121|FG000|Continuing in Study|Lost to Follow-up|1
7527701|NCT02982954|11869122|FG001|Continuing in Study|Lost to Follow-up|0
7527702|NCT02982954|11869123|FG002|Continuing in Study|Lost to Follow-up|0
7527703|NCT02982954|11869124|FG003|Continuing in Study|Lost to Follow-up|0
7527704|NCT02982954|11869121|FG000|Continuing in Study|other reasons|0
7527705|NCT02982954|11869122|FG001|Continuing in Study|other reasons|1
7527706|NCT02982954|11869123|FG002|Continuing in Study|other reasons|0
7527707|NCT02982954|11869124|FG003|Continuing in Study|other reasons|0
7317691|NCT00724126|11546683|FG000|Overall Study|Adverse Event|2
7413161|NCT01423916|11685310|FG002|Overall Study|Physician Decision|1
7413162|NCT01423916|11685308|FG000|Overall Study|Withdrawal by Subject|3
7413163|NCT01423916|11685309|FG001|Overall Study|Withdrawal by Subject|10
7413164|NCT01423916|11685310|FG002|Overall Study|Withdrawal by Subject|3
7413165|NCT01423916|11685308|FG000|Overall Study|Protocol Deviation|1
7413166|NCT01423916|11685309|FG001|Overall Study|Protocol Deviation|0
7413167|NCT01423916|11685310|FG002|Overall Study|Protocol Deviation|0
7413168|NCT01424189|11685348|FG000|Overall Study|Adverse Event|1
7413169|NCT01424189|11685349|FG001|Overall Study|Adverse Event|0
7413170|NCT01424189|11685348|FG000|Overall Study|Lost to Follow-up|4
7413171|NCT01424189|11685349|FG001|Overall Study|Lost to Follow-up|1
7413172|NCT01424189|11685348|FG000|Overall Study|Withdrawal by Subject|4
7413173|NCT01424189|11685349|FG001|Overall Study|Withdrawal by Subject|4
7413174|NCT01424189|11685348|FG000|Overall Study|Subject moved|1
7413175|NCT01424189|11685349|FG001|Overall Study|Subject moved|0
7413176|NCT01424189|11685348|FG000|Overall Study|Death|3
7413177|NCT01424189|11685349|FG001|Overall Study|Death|1
7413178|NCT01424228|11685366|FG000|Overall Study|Withdrawal by Subject|27
7413179|NCT01424228|11685367|FG001|Overall Study|Withdrawal by Subject|11
7413180|NCT01424228|11685366|FG000|Overall Study|Adverse Event|10
7527780|NCT02727699|11869171|FG000|Overall Study|Adverse Event|2
7527781|NCT02727699|11869172|FG001|Overall Study|Adverse Event|0
7527782|NCT02727699|11869171|FG000|Overall Study|Withdrawal by Subject|5
7527783|NCT02727699|11869172|FG001|Overall Study|Withdrawal by Subject|3
7527784|NCT02727699|11869171|FG000|Overall Study|Protocol Violation|0
7527785|NCT02727699|11869172|FG001|Overall Study|Protocol Violation|1
7527786|NCT02727699|11869171|FG000|Overall Study|Physician Decision|0
7527787|NCT02727699|11869172|FG001|Overall Study|Physician Decision|1
7527788|NCT02727699|11869171|FG000|Overall Study|Lost to Follow-up|1
7527789|NCT02727699|11869172|FG001|Overall Study|Lost to Follow-up|0
7527790|NCT02727699|11869171|FG000|Overall Study|Sponsor Decision|1
7527791|NCT02727699|11869172|FG001|Overall Study|Sponsor Decision|0
7527792|NCT02230254|11869192|FG000|Overall Study|Lost to Follow-up|3
7527813|NCT01891396|11869226|FG000|Overall Study|Withdrawal by Subject|4
7527814|NCT01891396|11869227|FG001|Overall Study|Withdrawal by Subject|4
7527815|NCT01891396|11869228|FG002|Overall Study|Withdrawal by Subject|3
7527816|NCT01891396|11869226|FG000|Overall Study|Lost to Follow-up|0
7527817|NCT01891396|11869227|FG001|Overall Study|Lost to Follow-up|1
7527818|NCT01891396|11869228|FG002|Overall Study|Lost to Follow-up|0
7537417|NCT02736721|11886194|FG000|Overall Study|Adverse Event|8
7537418|NCT02736721|11886194|FG000|Overall Study|Lost to Follow-up|3
7537419|NCT02736721|11886194|FG000|Overall Study|Other|5
7537420|NCT02736825|11886200|FG000|Overall Study|Lost to Follow-up|10
7537421|NCT02736825|11886201|FG001|Overall Study|Lost to Follow-up|11
7537422|NCT02736825|11886200|FG000|Overall Study|Early Termination|0
7537423|NCT02736825|11886201|FG001|Overall Study|Early Termination|1
7537424|NCT02736890|11886210|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
7537425|NCT02736890|11886211|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
7537426|NCT02736890|11886210|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
7537427|NCT02736890|11886211|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
7537428|NCT02737358|11886265|FG000|Overall Study|Withdrawal by Subject|7
7537429|NCT02737358|11886266|FG001|Overall Study|Withdrawal by Subject|12
7537430|NCT02737358|11886265|FG000|Overall Study|Lost to Follow-up|2
7537431|NCT02737358|11886266|FG001|Overall Study|Lost to Follow-up|3
7537432|NCT02737501|11886284|FG000|Randomized Phase|Died|41
7537433|NCT02737501|11886285|FG001|Randomized Phase|Died|29
7537434|NCT02737501|11886286|FG002|Randomized Phase|Died|0
7537435|NCT02737501|11886284|FG000|Randomized Phase|Withdrawal by Subject|16
7537436|NCT02737501|11886285|FG001|Randomized Phase|Withdrawal by Subject|6
7537437|NCT02737501|11886286|FG002|Randomized Phase|Withdrawal by Subject|0
7537438|NCT02737501|11886284|FG000|Randomized Phase|Lost to Follow-up|0
7537439|NCT02737501|11886285|FG001|Randomized Phase|Lost to Follow-up|1
7537440|NCT02737501|11886286|FG002|Randomized Phase|Lost to Follow-up|0
7537441|NCT02737501|11886284|FG000|Randomized Phase|Site Terminated by Sponsor|58
7537442|NCT02737501|11886285|FG001|Randomized Phase|Site Terminated by Sponsor|16
7537443|NCT02737501|11886286|FG002|Randomized Phase|Site Terminated by Sponsor|0
7537444|NCT02737501|11886284|FG000|Randomized Phase|Reason not Specified|1
7537445|NCT02737501|11886285|FG001|Randomized Phase|Reason not Specified|1
7537446|NCT02737501|11886286|FG002|Randomized Phase|Reason not Specified|0
7537447|NCT02737501|11886284|FG000|Randomized Phase|Never Treated|1
7537448|NCT02737501|11886285|FG001|Randomized Phase|Never Treated|1
7537449|NCT02737501|11886286|FG002|Randomized Phase|Never Treated|0
7537450|NCT02737501|11886284|FG000|Crossover Phase|Died|0
7537451|NCT02737501|11886285|FG001|Crossover Phase|Died|0
7537452|NCT02737501|11886286|FG002|Crossover Phase|Died|22
7537453|NCT02737501|11886284|FG000|Crossover Phase|Withdrew Consent|0
7537454|NCT02737501|11886285|FG001|Crossover Phase|Withdrew Consent|0
7537455|NCT02737501|11886286|FG002|Crossover Phase|Withdrew Consent|9
7537456|NCT02737501|11886284|FG000|Crossover Phase|Physician Decision|0
7537457|NCT02737501|11886285|FG001|Crossover Phase|Physician Decision|0
7537458|NCT02737501|11886286|FG002|Crossover Phase|Physician Decision|1
7537459|NCT02737501|11886284|FG000|Crossover Phase|Site Terminated by Sponsor|0
7537460|NCT02737501|11886285|FG001|Crossover Phase|Site Terminated by Sponsor|0
7537461|NCT02737501|11886286|FG002|Crossover Phase|Site Terminated by Sponsor|23
7537462|NCT02737592|11886294|FG000|Overall Study|Withdrawal by Subject|1
7527819|NCT01525901|11869244|FG000|Period 2: 12 Weeks|Adverse Event|0
7527820|NCT01525901|11869245|FG001|Period 2: 12 Weeks|Adverse Event|1
7527821|NCT01525901|11869246|FG002|Period 2: 12 Weeks|Adverse Event|0
7527822|NCT01525901|11869247|FG003|Period 2: 12 Weeks|Adverse Event|0
7527823|NCT01354431|11869260|FG000|Pre-Treatment Period|Not reported|1
7527824|NCT01354431|11869261|FG001|Pre-Treatment Period|Not reported|0
7527825|NCT01354431|11869262|FG002|Pre-Treatment Period|Not reported|0
7527826|NCT01354431|11869260|FG000|Treatment Period|Disease Progression|50
7527827|NCT01354431|11869261|FG001|Treatment Period|Disease Progression|40
7527828|NCT01354431|11869262|FG002|Treatment Period|Disease Progression|44
7527829|NCT01354431|11869260|FG000|Treatment Period|Study Drug Toxicity|5
7527830|NCT01354431|11869261|FG001|Treatment Period|Study Drug Toxicity|8
7527831|NCT01354431|11869262|FG002|Treatment Period|Study Drug Toxicity|4
7527832|NCT01354431|11869260|FG000|Treatment Period|Death|0
7527833|NCT01354431|11869261|FG001|Treatment Period|Death|1
7527834|NCT01354431|11869262|FG002|Treatment Period|Death|0
7537463|NCT02737618|11886298|FG000|Overall Study|Withdrawal by Subject|9
7527835|NCT01354431|11869260|FG000|Treatment Period|AE unrelated to study drug|1
7527836|NCT01354431|11869261|FG001|Treatment Period|AE unrelated to study drug|2
7527837|NCT01354431|11869262|FG002|Treatment Period|AE unrelated to study drug|5
7527838|NCT01354431|11869260|FG000|Treatment Period|Participant request to discontinue|2
7527839|NCT01354431|11869261|FG001|Treatment Period|Participant request to discontinue|2
7527840|NCT01354431|11869262|FG002|Treatment Period|Participant request to discontinue|1
7527841|NCT01354431|11869260|FG000|Treatment Period|Participant withdrew consent|0
7527842|NCT01354431|11869261|FG001|Treatment Period|Participant withdrew consent|1
7527843|NCT01354431|11869262|FG002|Treatment Period|Participant withdrew consent|0
7527844|NCT01354431|11869260|FG000|Treatment Period|Participant no longer meeting study criteria|1
7527845|NCT01354431|11869261|FG001|Treatment Period|Participant no longer meeting study criteria|0
7527846|NCT01354431|11869262|FG002|Treatment Period|Participant no longer meeting study criteria|0
7527847|NCT01003691|11869274|FG000|Overall Study|Adverse Event|0
7527848|NCT01003691|11869275|FG001|Overall Study|Adverse Event|0
7527849|NCT01003691|11869276|FG002|Overall Study|Adverse Event|0
7527850|NCT01003691|11869277|FG003|Overall Study|Adverse Event|1
7527851|NCT02594098|11869299|FG000|Overall Study|Lack of Efficacy|17
7527852|NCT02594098|11869300|FG001|Overall Study|Lack of Efficacy|6
7527853|NCT02594098|11869299|FG000|Overall Study|Withdrawal by Subject|1
7527854|NCT02594098|11869300|FG001|Overall Study|Withdrawal by Subject|3
7527855|NCT02594098|11869299|FG000|Overall Study|Terminated participation|6
7527856|NCT02594098|11869300|FG001|Overall Study|Terminated participation|2
7527857|NCT02594098|11869299|FG000|Overall Study|Seek alternative treatment|2
7527858|NCT02594098|11869300|FG001|Overall Study|Seek alternative treatment|1
7527859|NCT02594098|11869299|FG000|Overall Study|Other|0
7527860|NCT02594098|11869300|FG001|Overall Study|Other|1
7527861|NCT02594163|11869319|FG000|Treatment Period|Progressive disease|2
7527862|NCT02594163|11869320|FG001|Treatment Period|Progressive disease|3
7527863|NCT02594163|11869319|FG000|Treatment Period|Adverse Event|1
7527864|NCT02594163|11869320|FG001|Treatment Period|Adverse Event|5
7527865|NCT02594163|11869319|FG000|Treatment Period|Physician Decision|1
7527866|NCT02594163|11869320|FG001|Treatment Period|Physician Decision|3
7527867|NCT02594163|11869319|FG000|Treatment Period|Study termination by sponsor|2
7527868|NCT02594163|11869320|FG001|Treatment Period|Study termination by sponsor|1
7527869|NCT02594163|11869319|FG000|Treatment Period|Other, Non-AE|1
7527870|NCT02594163|11869320|FG001|Treatment Period|Other, Non-AE|0
7527871|NCT02594163|11869319|FG000|Follow-up Period|Withdrawal by Subject|0
7527872|NCT02594163|11869320|FG001|Follow-up Period|Withdrawal by Subject|1
7527873|NCT02594163|11869319|FG000|Follow-up Period|Study Termination by Sponsor|6
7527874|NCT02594163|11869320|FG001|Follow-up Period|Study Termination by Sponsor|4
7527875|NCT02594163|11869319|FG000|Follow-up Period|Lost to Follow-up|1
7527876|NCT02594163|11869320|FG001|Follow-up Period|Lost to Follow-up|0
7527877|NCT02594163|11869319|FG000|Follow-up Period|Death|2
7527878|NCT02594163|11869320|FG001|Follow-up Period|Death|5
7527879|NCT02594163|11869319|FG000|Follow-up Period|Adverse Event|0
7527880|NCT02594163|11869320|FG001|Follow-up Period|Adverse Event|1
7527881|NCT02594163|11869319|FG000|Follow-up Period|Progressive Disease|2
7527882|NCT02594163|11869320|FG001|Follow-up Period|Progressive Disease|0
7527883|NCT02594163|11869319|FG000|Follow-up Period|Physician Decision|0
7527884|NCT02594163|11869320|FG001|Follow-up Period|Physician Decision|1
7527885|NCT02595008|11869356|FG000|Overall Study|Enrolled In Error|1
7527886|NCT02595008|11869357|FG001|Overall Study|Enrolled In Error|0
7527887|NCT02595073|11869365|FG000|Overall Study|Progressive Disease|0
7527888|NCT02595073|11869366|FG001|Overall Study|Progressive Disease|1
7527889|NCT02595073|11869365|FG000|Overall Study|Protocol Violation|2
7527890|NCT02595073|11869366|FG001|Overall Study|Protocol Violation|0
7527891|NCT02595398|11869374|FG000|Overall Study|Non-compliance|1
7527892|NCT02595398|11869375|FG001|Overall Study|Non-compliance|0
7527893|NCT02595398|11869374|FG000|Overall Study|Withdrawal by Subject|2
7527894|NCT02595398|11869375|FG001|Overall Study|Withdrawal by Subject|1
7527895|NCT02595398|11869374|FG000|Overall Study|Lost to Follow-up|1
7527896|NCT02595398|11869375|FG001|Overall Study|Lost to Follow-up|0
7527897|NCT02595437|11869381|FG000|Triferic Via IV|Withdrawal by Subject|1
7527898|NCT02595450|11869393|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
7527899|NCT02595450|11869393|FG000|Overall Study|Enrolled, but not treated|8
7527900|NCT02595502|11869397|FG000|Period 1|Adverse Event|0
7527901|NCT02595502|11869398|FG001|Period 1|Adverse Event|1
7527902|NCT02595502|11869397|FG000|Period 1|Withdrawal by Subject|1
7527903|NCT02595502|11869398|FG001|Period 1|Withdrawal by Subject|0
7527904|NCT02595502|11869397|FG000|Period 1|Lost to Follow-up|0
7527905|NCT02595502|11869398|FG001|Period 1|Lost to Follow-up|1
7527906|NCT02595502|11869397|FG000|Period 2|Adverse Event|1
7527907|NCT02595502|11869398|FG001|Period 2|Adverse Event|1
7527908|NCT02595502|11869397|FG000|Period 2|Received incorrect lens at Period 1|0
7527909|NCT02595502|11869398|FG001|Period 2|Received incorrect lens at Period 1|1
7527910|NCT02595502|11869397|FG000|Period 3|Protocol Violation|0
7527911|NCT02595502|11869398|FG001|Period 3|Protocol Violation|1
7527912|NCT02595502|11869397|FG000|Period 3|Lost to Follow-up|1
7527913|NCT02595502|11869398|FG001|Period 3|Lost to Follow-up|0
7527914|NCT02595502|11869397|FG000|Period 3|Received Incorrect Treatment at period 3|0
7527915|NCT02595502|11869398|FG001|Period 3|Received Incorrect Treatment at period 3|1
7527916|NCT02595528|11869408|FG000|Overall Study|Withdrawal by Subject|1
7527917|NCT02595528|11869409|FG001|Overall Study|Withdrawal by Subject|2
7527918|NCT02595528|11869410|FG002|Overall Study|Withdrawal by Subject|1
7527919|NCT02595528|11869411|FG003|Overall Study|Withdrawal by Subject|3
7527920|NCT02595528|11869408|FG000|Overall Study|Lost to Follow-up|1
7527921|NCT02595528|11869409|FG001|Overall Study|Lost to Follow-up|1
7527922|NCT02595528|11869410|FG002|Overall Study|Lost to Follow-up|0
7527923|NCT02595528|11869411|FG003|Overall Study|Lost to Follow-up|1
7527924|NCT02595723|11869437|FG000|First Washout (21 Days)|Withdrawal by Subject|1
7527925|NCT02595723|11869438|FG001|First Washout (21 Days)|Withdrawal by Subject|0
7527926|NCT02595723|11869439|FG002|First Washout (21 Days)|Withdrawal by Subject|0
7527927|NCT02595723|11869437|FG000|First Washout (21 Days)|Lost to Follow-up|1
7527928|NCT02595723|11869438|FG001|First Washout (21 Days)|Lost to Follow-up|0
7527929|NCT02595723|11869439|FG002|First Washout (21 Days)|Lost to Follow-up|0
7527930|NCT02595749|11869449|FG000|Overall Study|Withdrawal by Subject|12
7527931|NCT02595749|11869450|FG001|Overall Study|Withdrawal by Subject|7
7527932|NCT02595970|11869456|FG000|Overall Study|Withdrawal by Subject|2
7527933|NCT02595970|11869456|FG000|Overall Study|Physician Decision|2
7527934|NCT02595970|11869456|FG000|Overall Study|Protocol Violation|4
7527935|NCT02595970|11869456|FG000|Overall Study|Adverse Event|5
7527936|NCT02595970|11869456|FG000|Overall Study|Lack of Efficacy|7
7527937|NCT02596009|11869465|FG000|Overall Study|Administrative problems|0
7527938|NCT02596009|11869466|FG001|Overall Study|Administrative problems|1
7527939|NCT02596009|11869467|FG002|Overall Study|Administrative problems|0
7527940|NCT02596009|11869468|FG003|Overall Study|Administrative problems|0
7527941|NCT02596009|11869469|FG004|Overall Study|Administrative problems|0
7527942|NCT02596009|11869470|FG005|Overall Study|Administrative problems|0
7527943|NCT02596230|11869490|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
7527944|NCT02596230|11869491|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
7527945|NCT02596230|11869492|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
7527946|NCT02596230|11869493|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
7527947|NCT02596230|11869494|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
7527948|NCT02596230|11869490|FG000|Objective 2, One Year|Lost to Follow-up|0
7527949|NCT02596230|11869491|FG001|Objective 2, One Year|Lost to Follow-up|41
7527950|NCT02596230|11869492|FG002|Objective 2, One Year|Lost to Follow-up|41
7527951|NCT02596230|11869493|FG003|Objective 2, One Year|Lost to Follow-up|32
7527952|NCT02596230|11869494|FG004|Objective 2, One Year|Lost to Follow-up|46
7527953|NCT02596230|11869490|FG000|Objective 2, One Year|Withdrawal by Subject|0
7527954|NCT02596230|11869491|FG001|Objective 2, One Year|Withdrawal by Subject|11
7527955|NCT02596230|11869492|FG002|Objective 2, One Year|Withdrawal by Subject|14
7527956|NCT02596230|11869493|FG003|Objective 2, One Year|Withdrawal by Subject|5
7527957|NCT02596230|11869494|FG004|Objective 2, One Year|Withdrawal by Subject|2
7527958|NCT02596230|11869490|FG000|Objective 2, One Year|Adverse drug reaction|0
7527959|NCT02596230|11869491|FG001|Objective 2, One Year|Adverse drug reaction|1
7527960|NCT02596230|11869492|FG002|Objective 2, One Year|Adverse drug reaction|0
7527961|NCT02596230|11869493|FG003|Objective 2, One Year|Adverse drug reaction|0
7527962|NCT02596230|11869494|FG004|Objective 2, One Year|Adverse drug reaction|0
7527963|NCT02596230|11869490|FG000|Objective 2, One Year|Death|0
7527964|NCT02596230|11869491|FG001|Objective 2, One Year|Death|12
7527965|NCT02596230|11869492|FG002|Objective 2, One Year|Death|41
7527966|NCT02596230|11869493|FG003|Objective 2, One Year|Death|21
7527967|NCT02596230|11869494|FG004|Objective 2, One Year|Death|30
7527968|NCT02596230|11869490|FG000|Objective 2, One Year|Other|0
7527969|NCT02596230|11869491|FG001|Objective 2, One Year|Other|3
7527970|NCT02596230|11869492|FG002|Objective 2, One Year|Other|2
7527971|NCT02596230|11869493|FG003|Objective 2, One Year|Other|0
7527972|NCT02596230|11869494|FG004|Objective 2, One Year|Other|0
7527973|NCT02596620|11869527|FG000|Overall Study|Lost to Follow-up|1
7527974|NCT02596620|11869528|FG001|Overall Study|Lost to Follow-up|1
7527975|NCT02596711|11869537|FG000|Overall Study|Lost to Follow-up|1
7527976|NCT02596711|11869538|FG001|Overall Study|Lost to Follow-up|2
7527977|NCT02596711|11869539|FG002|Overall Study|Lost to Follow-up|3
7527978|NCT02596854|11869557|FG000|Overall Study|Withdrawn|8
7527979|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
7527980|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
7527981|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
7527982|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
7527983|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
7527984|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7527985|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
7527986|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
7527987|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7527988|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7527989|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
7527990|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
7527991|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
7527992|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7527993|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
7527994|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
7527995|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
7527996|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
7527997|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
7527998|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
7527999|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
7528000|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7528001|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
7528002|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
7528003|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
7528004|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7528005|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7528006|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
7528007|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7528008|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
7528009|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
7528010|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
7528011|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
7528012|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
7528013|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
7528014|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
7528015|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7528016|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7528017|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
7528018|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
7528019|NCT02596893|11869570|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
7528020|NCT02596893|11869571|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
7528021|NCT02596893|11869572|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
7528022|NCT02596893|11869573|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
7528023|NCT02596945|11869592|FG000|Overall Study|No documentation of study drug dosing|3
7528024|NCT02596945|11869592|FG000|Overall Study|Other|32
7528025|NCT02596945|11869592|FG000|Overall Study|Change to hemodialysis|15
7528026|NCT02596945|11869592|FG000|Overall Study|Other Erythropoietin stimulating agent|4
7528027|NCT02596945|11869592|FG000|Overall Study|Withdrawal by Subject|1
7528028|NCT02596945|11869592|FG000|Overall Study|Missing|1
7528029|NCT02596958|11869596|FG000|Overall Study|Serious Adverse Drug Reactions|44
7528030|NCT02596958|11869596|FG000|Overall Study|Cancer Progression|441
7528031|NCT02596958|11869596|FG000|Overall Study|Death From Cancer|112
7528032|NCT02596958|11869596|FG000|Overall Study|Death From Other Cause|33
7528033|NCT02596958|11869596|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
7528034|NCT02596958|11869596|FG000|Overall Study|Administrative Reasons/Other|231
7528035|NCT02596958|11869596|FG000|Overall Study|Lost to Follow-up|33
7528036|NCT02596958|11869596|FG000|Overall Study|Missing|32
7528037|NCT02596958|11869596|FG000|Overall Study|Excluded Due to Second Line Treatment|9
7528038|NCT02596971|11869603|FG000|Overall Study|Death|5
7528039|NCT02596971|11869604|FG001|Overall Study|Death|1
7528040|NCT02596971|11869605|FG002|Overall Study|Death|5
7528041|NCT02596971|11869603|FG000|Overall Study|Withdrawal by Subject|5
7528042|NCT02596971|11869604|FG001|Overall Study|Withdrawal by Subject|1
7528043|NCT02596971|11869605|FG002|Overall Study|Withdrawal by Subject|4
7528044|NCT02597049|11869619|FG000|Overall Study|Lost to Follow-up|0
7528045|NCT02597049|11869620|FG001|Overall Study|Lost to Follow-up|3
7528046|NCT02597049|11869621|FG002|Overall Study|Lost to Follow-up|2
7528047|NCT02597049|11869619|FG000|Overall Study|Withdrawal by Subject|2
7528048|NCT02597049|11869620|FG001|Overall Study|Withdrawal by Subject|2
7528049|NCT02597049|11869621|FG002|Overall Study|Withdrawal by Subject|1
7528050|NCT02597049|11869619|FG000|Overall Study|Adverse Event|2
7528051|NCT02597049|11869620|FG001|Overall Study|Adverse Event|0
7528052|NCT02597049|11869621|FG002|Overall Study|Adverse Event|0
7528053|NCT02597049|11869619|FG000|Overall Study|Death|2
7528054|NCT02597049|11869620|FG001|Overall Study|Death|0
7528055|NCT02597049|11869621|FG002|Overall Study|Death|0
7528056|NCT02597049|11869619|FG000|Overall Study|Noncompliant with Study Visits|1
7528057|NCT02597049|11869620|FG001|Overall Study|Noncompliant with Study Visits|0
7528058|NCT02597049|11869621|FG002|Overall Study|Noncompliant with Study Visits|0
7528059|NCT02597452|11869692|FG000|Overall Study|testing incomplete|30
7528060|NCT02597478|11869698|FG000|Overall Study|Withdrawal by Subject|2
7528061|NCT02597478|11869699|FG001|Overall Study|Withdrawal by Subject|0
7528062|NCT02597478|11869698|FG000|Overall Study|Change of opioid dose|1
7528063|NCT02597478|11869699|FG001|Overall Study|Change of opioid dose|0
7528064|NCT02597478|11869698|FG000|Overall Study|Insufficient exertional dyspnea|0
7528065|NCT02597478|11869699|FG001|Overall Study|Insufficient exertional dyspnea|1
7528066|NCT02597712|11869745|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
7528067|NCT02597712|11869746|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
7528068|NCT02597712|11869745|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
7528069|NCT02597712|11869746|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
7528070|NCT02597712|11869745|FG000|Overall Study|Recurrent metastatic prostate cancer|0
7528071|NCT02597712|11869746|FG001|Overall Study|Recurrent metastatic prostate cancer|1
7528072|NCT02597855|11869754|FG000|Overall Study|Lost to Follow-up|2
7528073|NCT02597855|11869755|FG001|Overall Study|Lost to Follow-up|1
7528074|NCT02597920|11869773|FG000|Overall Study|Worsening of other pre-existing disease|0
7528075|NCT02597920|11869774|FG001|Overall Study|Worsening of other pre-existing disease|1
7528076|NCT02597920|11869775|FG002|Overall Study|Worsening of other pre-existing disease|0
7528077|NCT02597920|11869773|FG000|Overall Study|Other adverse event|20
7528078|NCT02597920|11869774|FG001|Overall Study|Other adverse event|30
7528079|NCT02597920|11869775|FG002|Overall Study|Other adverse event|0
7528080|NCT02597920|11869773|FG000|Overall Study|Lost to Follow-up|7
7528081|NCT02597920|11869774|FG001|Overall Study|Lost to Follow-up|9
7528082|NCT02597920|11869775|FG002|Overall Study|Lost to Follow-up|0
7528083|NCT02597920|11869773|FG000|Overall Study|Refuse to continue in the study|3
7528084|NCT02597920|11869774|FG001|Overall Study|Refuse to continue in the study|13
7528085|NCT02597920|11869775|FG002|Overall Study|Refuse to continue in the study|1
7528086|NCT02597920|11869773|FG000|Overall Study|Other than specified|10
7528087|NCT02597920|11869774|FG001|Overall Study|Other than specified|31
7528088|NCT02597920|11869775|FG002|Overall Study|Other than specified|5
7528089|NCT02597920|11869773|FG000|Overall Study|Other|1
7528090|NCT02597920|11869774|FG001|Overall Study|Other|0
7528091|NCT02597920|11869775|FG002|Overall Study|Other|0
7413181|NCT01424228|11685367|FG001|Overall Study|Adverse Event|14
7413182|NCT01424228|11685366|FG000|Overall Study|Sponsor's decision|9
7528092|NCT02597933|11869787|FG000|Overall Study|Withdrawal by Subject|7
7528093|NCT02597933|11869788|FG001|Overall Study|Withdrawal by Subject|5
7528094|NCT02597933|11869787|FG000|Overall Study|Protocol Violation|2
7528095|NCT02597933|11869788|FG001|Overall Study|Protocol Violation|2
7528096|NCT02597933|11869787|FG000|Overall Study|Adverse Event|20
7528097|NCT02597933|11869788|FG001|Overall Study|Adverse Event|28
7528098|NCT02597933|11869787|FG000|Overall Study|Not treated|2
7528099|NCT02597933|11869788|FG001|Overall Study|Not treated|2
7528100|NCT02597933|11869787|FG000|Overall Study|Other than stated above|7
7528101|NCT02597933|11869788|FG001|Overall Study|Other than stated above|14
7528102|NCT02597946|11869794|FG000|Overall Study|Withdrawal by Subject|1
7528103|NCT02597946|11869794|FG000|Overall Study|Progressive disease|16
7528104|NCT02597946|11869794|FG000|Overall Study|Other than above|1
7528105|NCT02598076|11869800|FG000|Overall Study|Lost to Follow-up|2
7528106|NCT02598076|11869801|FG001|Overall Study|Lost to Follow-up|3
7528107|NCT02598128|11869823|FG000|Period A: Days -7 to -1|Adverse Event|1
7528108|NCT02598128|11869824|FG001|Period A: Days -7 to -1|Adverse Event|0
7528109|NCT02598128|11869825|FG002|Period A: Days -7 to -1|Adverse Event|0
7528110|NCT02598128|11869826|FG003|Period A: Days -7 to -1|Adverse Event|0
7528111|NCT02598193|11869838|FG000|Overall Study|Adverse Event|13
7528112|NCT02598193|11869838|FG000|Overall Study|Withdrawal by Subject|1
7528113|NCT02598193|11869838|FG000|Overall Study|Listed in active lung transplant list|1
7528114|NCT02598193|11869838|FG000|Overall Study|Does not want to take Nintedanib|1
7528115|NCT02598297|11869844|FG000|Overall Study|Study terminated by Sponsor|21
7528116|NCT02598297|11869845|FG001|Overall Study|Study terminated by Sponsor|23
7528117|NCT02598297|11869844|FG000|Overall Study|Adverse Event|1
7528118|NCT02598297|11869845|FG001|Overall Study|Adverse Event|1
7528119|NCT02598297|11869844|FG000|Overall Study|Physician Decision|1
7528120|NCT02598297|11869845|FG001|Overall Study|Physician Decision|0
7528121|NCT02598297|11869844|FG000|Overall Study|Subject/guardian decision|1
7528122|NCT02598297|11869845|FG001|Overall Study|Subject/guardian decision|0
7528123|NCT02598297|11869844|FG000|Overall Study|Followed for survival|1
7528124|NCT02598297|11869845|FG001|Overall Study|Followed for survival|0
7528125|NCT02598934|11869853|FG000|Overall Study|Adverse Event|11
7528126|NCT02598934|11869854|FG001|Overall Study|Adverse Event|13
7528127|NCT02598934|11869853|FG000|Overall Study|Failure to Return|3
7528128|NCT02598934|11869854|FG001|Overall Study|Failure to Return|3
7528129|NCT02598934|11869853|FG000|Overall Study|Withdrawal by Subject|2
7528130|NCT02598934|11869854|FG001|Overall Study|Withdrawal by Subject|3
7528131|NCT02598934|11869853|FG000|Overall Study|Administrative|2
7528132|NCT02598934|11869854|FG001|Overall Study|Administrative|1
7528133|NCT02598934|11869853|FG000|Overall Study|Protocol Violation|1
7528134|NCT02598934|11869854|FG001|Overall Study|Protocol Violation|2
7528135|NCT02599129|11869862|FG000|Overall Study|Lack of Efficacy|2
7528136|NCT02599129|11869863|FG001|Overall Study|Lack of Efficacy|2
7528137|NCT02599129|11869862|FG000|Overall Study|Lost to Follow-up|1
7528138|NCT02599129|11869863|FG001|Overall Study|Lost to Follow-up|0
7528139|NCT02599129|11869862|FG000|Overall Study|Withdrawal by Subject|2
7528140|NCT02599129|11869863|FG001|Overall Study|Withdrawal by Subject|1
7528141|NCT02599402|11869875|FG000|Overall Study|Disease progression|153
7528142|NCT02599402|11869875|FG000|Overall Study|Study drug toxicity|201
7528143|NCT02599402|11869875|FG000|Overall Study|Death|26
7528144|NCT02599402|11869875|FG000|Overall Study|Adverse Event unrelated to study drug|23
7528145|NCT02599402|11869875|FG000|Overall Study|Participant request to discontinue study treatment|13
7528146|NCT02599402|11869875|FG000|Overall Study|Participant withdrew consent|5
7528147|NCT02599402|11869875|FG000|Overall Study|Lost to Follow-up|1
7528148|NCT02599402|11869875|FG000|Overall Study|Maximum Clinical Benefit|7
7528149|NCT02599402|11869875|FG000|Overall Study|Poor/non-compliance|1
7528150|NCT02599402|11869875|FG000|Overall Study|Pregnancy|1
7528151|NCT02599402|11869875|FG000|Overall Study|Participant no longer met study criteria|7
7528152|NCT02599402|11869875|FG000|Overall Study|Other Reasons|95
7528153|NCT02599688|11869926|FG000|Overall Study|Lack of Efficacy|1
7528154|NCT02599688|11869926|FG000|Overall Study|Withdrawal by Subject|1
7528155|NCT02599688|11869926|FG000|Overall Study|Termination by Sponsor|2
7528156|NCT02599961|11869938|FG000|Overall Study|Withdrawal by Subject|1
7528157|NCT02599961|11869938|FG000|Overall Study|Subject Non-Compliance|2
7528158|NCT02599961|11869938|FG000|Overall Study|Discontinuation of Study by Sponsor|9
7528159|NCT02599961|11869938|FG000|Overall Study|Other, Not Specified|3
7528160|NCT02600351|11869950|FG000|Overall Study|Lack of Efficacy|3
7528161|NCT02600351|11869951|FG001|Overall Study|Lack of Efficacy|0
7528162|NCT02600351|11869952|FG002|Overall Study|Lack of Efficacy|5
7528163|NCT02600351|11869953|FG003|Overall Study|Lack of Efficacy|2
7528164|NCT02600351|11869950|FG000|Overall Study|Lost to Follow-up|1
7528165|NCT02600351|11869951|FG001|Overall Study|Lost to Follow-up|0
7528166|NCT02600351|11869952|FG002|Overall Study|Lost to Follow-up|0
7528167|NCT02600351|11869953|FG003|Overall Study|Lost to Follow-up|0
7528168|NCT02600351|11869950|FG000|Overall Study|Randomized but Not Treated|1
7528169|NCT02600351|11869951|FG001|Overall Study|Randomized but Not Treated|0
7528170|NCT02600351|11869952|FG002|Overall Study|Randomized but Not Treated|1
7528171|NCT02600351|11869953|FG003|Overall Study|Randomized but Not Treated|3
7528172|NCT02600559|11869981|FG000|Overall Study|Withdrawal by Subject|3
7528173|NCT02600559|11869981|FG000|Overall Study|Lost to Follow-up|20
7528174|NCT02600819|11870019|FG000|GEN Phase|Adverse Event|2
7528175|NCT02600819|11870020|FG001|GEN Phase|Adverse Event|0
7528176|NCT02600819|11870019|FG000|GEN Phase|Death|2
7528177|NCT02600819|11870020|FG001|GEN Phase|Death|0
7528178|NCT02600819|11870019|FG000|GEN Phase|Investigator's Discretion|4
7528179|NCT02600819|11870020|FG001|GEN Phase|Investigator's Discretion|0
7528180|NCT02600819|11870019|FG000|GEN Phase|Non-Compliance with Study Drug|1
7528181|NCT02600819|11870020|FG001|GEN Phase|Non-Compliance with Study Drug|0
7528182|NCT02600819|11870019|FG000|GEN Phase|Withdrew Consent|5
7528183|NCT02600819|11870020|FG001|GEN Phase|Withdrew Consent|0
7528184|NCT02600819|11870019|FG000|GEN Phase|Lost to Follow-up|2
7528185|NCT02600819|11870020|FG001|GEN Phase|Lost to Follow-up|0
7528186|NCT02600845|11870026|FG000|Overall Study|Reason Not Specified|3
7528187|NCT02600845|11870026|FG000|Overall Study|Non-compliance with Study Procedures|10
7528188|NCT02600845|11870026|FG000|Overall Study|Consent Withdrawal|5
7528189|NCT02600871|11870032|FG000|Overall Study|Lost to Follow-up|13
7528190|NCT02600871|11870033|FG001|Overall Study|Lost to Follow-up|10
7528191|NCT02601001|11870043|FG000|Dosing Period 2|Adverse Event|0
7528192|NCT02601001|11870044|FG001|Dosing Period 2|Adverse Event|0
7528193|NCT02601001|11870045|FG002|Dosing Period 2|Adverse Event|0
7528194|NCT02601001|11870046|FG003|Dosing Period 2|Adverse Event|0
7528195|NCT02601001|11870047|FG004|Dosing Period 2|Adverse Event|0
7528196|NCT02601001|11870048|FG005|Dosing Period 2|Adverse Event|0
7528197|NCT02601001|11870049|FG006|Dosing Period 2|Adverse Event|1
7528198|NCT02601027|11870072|FG000|Registration to Surgery|Withdrawal by Subject|20
7528199|NCT02601027|11870073|FG001|Registration to Surgery|Withdrawal by Subject|10
7528200|NCT02601300|11870094|FG000|Induction Phase|Lack of Efficacy|2
7528201|NCT02601300|11870094|FG000|Induction Phase|Protocol Violation|1
7528202|NCT02601300|11870094|FG000|Extension Phase|Withdrawal by Subject|3
7528203|NCT02601300|11870094|FG000|Extension Phase|Adverse Event|4
7528204|NCT02601300|11870094|FG000|Extension Phase|Lack of Efficacy|10
7528205|NCT02601469|11870102|FG000|Overall Study|Enrolled in Error|1
7528206|NCT02601469|11870103|FG001|Overall Study|Enrolled in Error|0
7528207|NCT02601560|11870117|FG000|Overall Study|Other|0
7528208|NCT02601560|11870118|FG001|Overall Study|Other|0
7528209|NCT02601560|11870119|FG002|Overall Study|Other|0
7528210|NCT02601560|11870120|FG003|Overall Study|Other|0
7528211|NCT02601560|11870121|FG004|Overall Study|Other|0
7528212|NCT02601560|11870122|FG005|Overall Study|Other|0
7528213|NCT02601560|11870123|FG006|Overall Study|Other|1
7528214|NCT02601560|11870124|FG007|Overall Study|Other|0
7528215|NCT02601573|11870154|FG000|Overall Study|Lost to Follow-up|0
7528216|NCT02601573|11870155|FG001|Overall Study|Lost to Follow-up|3
7528217|NCT02601573|11870156|FG002|Overall Study|Lost to Follow-up|1
7528218|NCT02601573|11870157|FG003|Overall Study|Lost to Follow-up|0
7528219|NCT02601573|11870158|FG004|Overall Study|Lost to Follow-up|2
7528220|NCT02601573|11870154|FG000|Overall Study|Withdrawal by Subject|0
7528221|NCT02601573|11870155|FG001|Overall Study|Withdrawal by Subject|1
7528222|NCT02601573|11870156|FG002|Overall Study|Withdrawal by Subject|0
7528223|NCT02601573|11870157|FG003|Overall Study|Withdrawal by Subject|1
7528224|NCT02601573|11870158|FG004|Overall Study|Withdrawal by Subject|0
7528225|NCT02601625|11870174|FG000|Overall Study|Lost to Follow-up|0
7528226|NCT02601625|11870175|FG001|Overall Study|Lost to Follow-up|0
7528227|NCT02601625|11870176|FG002|Overall Study|Lost to Follow-up|1
7528228|NCT02601625|11870177|FG003|Overall Study|Lost to Follow-up|1
7528229|NCT02601820|11870201|FG000|Early On-Treatment (T2)|Missing T2 Record|51
7528230|NCT02601820|11870201|FG000|Late On-Treatment (T3)|missing T3 Record|49
7528231|NCT02601820|11870201|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
7528232|NCT02601820|11870201|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
7537464|NCT04865354|11886308|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1
7537465|NCT04865354|11886309|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0
7537466|NCT04865354|11886308|FG000|First Wear Period (8 Days)|Lost to Follow-up|0
7537467|NCT04865354|11886309|FG001|First Wear Period (8 Days)|Lost to Follow-up|1
7537468|NCT04865354|11886308|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1
7537469|NCT04865354|11886309|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0
7537501|NCT04097925|11886360|FG000|Overall Study|Withdrawal by Subject|1
7537502|NCT03994120|11886384|FG000|Overall Study|Lost to Follow-up|3
7537503|NCT03994120|11886385|FG001|Overall Study|Lost to Follow-up|1
7537504|NCT03934216|11886393|FG000|Randomization|Randomized in Error|1
7537505|NCT03934216|11886394|FG001|Randomization|Randomized in Error|1
7537506|NCT03934216|11886393|FG000|Treatment Period|Adverse Event|10
7537507|NCT03934216|11886394|FG001|Treatment Period|Adverse Event|3
7537508|NCT03934216|11886393|FG000|Treatment Period|Withdrawal by Participant|6
7537509|NCT03934216|11886394|FG001|Treatment Period|Withdrawal by Participant|2
7537510|NCT03934216|11886393|FG000|Treatment Period|Other Reasons|2
7537511|NCT03934216|11886394|FG001|Treatment Period|Other Reasons|2
7537512|NCT03907280|11886403|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0
7537513|NCT03907280|11886404|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1
7537514|NCT03907280|11886405|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0
7537515|NCT03745768|11886426|FG000|Overall Study|discontinued study|2
7537516|NCT03745768|11886427|FG001|Overall Study|discontinued study|0
7537517|NCT03694522|11886435|FG000|Overall Study|Ongoing|42
7537518|NCT03694522|11886436|FG001|Overall Study|Ongoing|27
7537519|NCT03694522|11886435|FG000|Overall Study|Withdrawal by Subject|6
7537520|NCT03694522|11886436|FG001|Overall Study|Withdrawal by Subject|10
7537521|NCT03694522|11886435|FG000|Overall Study|Death|28
7537522|NCT03694522|11886436|FG001|Overall Study|Death|40
7537523|NCT03694522|11886435|FG000|Overall Study|Other|1
7537524|NCT03694522|11886436|FG001|Overall Study|Other|1
7537525|NCT03689374|11886444|FG000|Run-in Period (12 Weeks)|Run-in failure|526
7537526|NCT03689374|11886445|FG001|Run-in Period (12 Weeks)|Run-in failure|0
7537527|NCT03689374|11886446|FG002|Run-in Period (12 Weeks)|Run-in failure|0
7537528|NCT03689374|11886444|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0
7537529|NCT03689374|11886445|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10
7537530|NCT03689374|11886446|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38
7537531|NCT03689374|11886444|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0
7537532|NCT03689374|11886445|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3
7537533|NCT03689374|11886446|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4
7537534|NCT03689374|11886444|FG000|Treatment Period (Week 0 to 52)|Death|0
7528233|NCT02602080|11870237|FG000|Overall Study|Protocol Violation|6
7528234|NCT02602080|11870238|FG001|Overall Study|Protocol Violation|1
7528235|NCT02602080|11870239|FG002|Overall Study|Protocol Violation|3
7528236|NCT02603107|11870268|FG000|Randomized Phase|Withdrew consent|8
7528237|NCT02603107|11870269|FG001|Randomized Phase|Withdrew consent|15
7528238|NCT02603107|11870268|FG000|Randomized Phase|Lost to Follow-up|1
7528239|NCT02603107|11870269|FG001|Randomized Phase|Lost to Follow-up|3
7528240|NCT02603107|11870268|FG000|Randomized Phase|Adverse Event|2
7528241|NCT02603107|11870269|FG001|Randomized Phase|Adverse Event|0
7528242|NCT02603107|11870268|FG000|Randomized Phase|Death|1
7528243|NCT02603107|11870269|FG001|Randomized Phase|Death|1
7528244|NCT02603107|11870268|FG000|Randomized Phase|Non-compliance with study drug|1
7528245|NCT02603107|11870269|FG001|Randomized Phase|Non-compliance with study drug|1
7528246|NCT02603107|11870268|FG000|Randomized Phase|Investigator's discretion|0
7528247|NCT02603107|11870269|FG001|Randomized Phase|Investigator's discretion|1
7528248|NCT02603107|11870268|FG000|Randomized Phase|Lack of Efficacy|1
7528249|NCT02603107|11870269|FG001|Randomized Phase|Lack of Efficacy|0
7528250|NCT02603107|11870268|FG000|Randomized Phase|Protocol Violation|1
7528251|NCT02603107|11870269|FG001|Randomized Phase|Protocol Violation|0
7528252|NCT02603107|11870268|FG000|Optional Extension Phase|Lost to Follow-up|3
7528253|NCT02603107|11870269|FG001|Optional Extension Phase|Lost to Follow-up|3
7528254|NCT02603107|11870268|FG000|Optional Extension Phase|Withdrew consent|3
7528255|NCT02603107|11870269|FG001|Optional Extension Phase|Withdrew consent|2
7528256|NCT02603107|11870268|FG000|Optional Extension Phase|Investigator's discretion|2
7528257|NCT02603107|11870269|FG001|Optional Extension Phase|Investigator's discretion|2
7528258|NCT02603107|11870268|FG000|Optional Extension Phase|Pregnancy|0
7528259|NCT02603107|11870269|FG001|Optional Extension Phase|Pregnancy|3
7528260|NCT02603107|11870268|FG000|Optional Extension Phase|Adverse Event|0
7528261|NCT02603107|11870269|FG001|Optional Extension Phase|Adverse Event|2
7528262|NCT02603107|11870268|FG000|Optional Extension Phase|Not treated in extension phase|0
7528263|NCT02603107|11870269|FG001|Optional Extension Phase|Not treated in extension phase|1
7528264|NCT02603107|11870268|FG000|Optional Extension Phase|Protocol Violation|1
7528265|NCT02603107|11870269|FG001|Optional Extension Phase|Protocol Violation|0
7528266|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Withdrew consent|4
7528267|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Withdrew consent|8
7528268|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Adverse Event|3
7528269|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Adverse Event|3
7528270|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
7528271|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
7528272|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Death|2
7528273|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Death|0
7528274|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
7528275|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
7528276|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Pregnancy|1
7528277|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Pregnancy|1
7528278|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
7528279|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
7528280|NCT02603120|11870279|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
7528281|NCT02603120|11870280|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
7413183|NCT01424228|11685367|FG001|Overall Study|Sponsor's decision|12
7413184|NCT01424228|11685366|FG000|Overall Study|Lack of Efficacy|5
7413185|NCT01424228|11685367|FG001|Overall Study|Lack of Efficacy|7
7413186|NCT01424228|11685366|FG000|Overall Study|inclusion/exclusion criteria not met|2
7413187|NCT01424228|11685367|FG001|Overall Study|inclusion/exclusion criteria not met|2
7413188|NCT01424228|11685366|FG000|Overall Study|Non-compliance|2
7413189|NCT01424228|11685367|FG001|Overall Study|Non-compliance|0
7413190|NCT01424228|11685366|FG000|Overall Study|Worsening of symptoms|1
7413191|NCT01424228|11685367|FG001|Overall Study|Worsening of symptoms|0
7413192|NCT01424228|11685366|FG000|Overall Study|Unplanned journey|0
7413193|NCT01424228|11685367|FG001|Overall Study|Unplanned journey|1
7413194|NCT01424306|11685377|FG000|Overall Study|Protocol Violation|0
7413195|NCT01424306|11685378|FG001|Overall Study|Protocol Violation|0
7413196|NCT01424306|11685379|FG002|Overall Study|Protocol Violation|0
7413197|NCT01424306|11685380|FG003|Overall Study|Protocol Violation|0
7413198|NCT01424306|11685381|FG004|Overall Study|Protocol Violation|1
7413199|NCT01424306|11685382|FG005|Overall Study|Protocol Violation|0
7413200|NCT01424397|11685426|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
7413201|NCT01424397|11685427|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
7413202|NCT01424397|11685428|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
7413203|NCT01424397|11685429|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
7413204|NCT01424397|11685430|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
7413205|NCT01424397|11685431|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
7413206|NCT01424397|11685432|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
7413207|NCT01424397|11685433|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
7413208|NCT01424397|11685434|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
7413209|NCT01424397|11685435|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
7413210|NCT01424397|11685436|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
7413211|NCT01424397|11685437|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
7413212|NCT01424501|11685457|FG000|Overall Study|Withdrawal by Subject|1
7413213|NCT01424501|11685458|FG001|Overall Study|Withdrawal by Subject|0
7413214|NCT01424501|11685459|FG002|Overall Study|Withdrawal by Subject|1
7413215|NCT01424501|11685460|FG003|Overall Study|Withdrawal by Subject|0
7413216|NCT01424501|11685461|FG004|Overall Study|Withdrawal by Subject|0
7413217|NCT01424501|11685462|FG005|Overall Study|Withdrawal by Subject|0
7413218|NCT01424501|11685457|FG000|Overall Study|Lost to Follow-up|0
7413219|NCT01424501|11685458|FG001|Overall Study|Lost to Follow-up|1
7528282|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
7528283|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
7528284|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
7413220|NCT01424501|11685459|FG002|Overall Study|Lost to Follow-up|1
7413221|NCT01424501|11685460|FG003|Overall Study|Lost to Follow-up|0
7413222|NCT01424501|11685461|FG004|Overall Study|Lost to Follow-up|0
7413223|NCT01424501|11685462|FG005|Overall Study|Lost to Follow-up|0
7528285|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
7528286|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
7528287|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
7528288|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
7528289|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
7528290|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
7528291|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
7528292|NCT02603120|11870279|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
7528293|NCT02603120|11870280|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
7528294|NCT02603172|11870296|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0
7528295|NCT02603172|11870297|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0
7528296|NCT02603172|11870298|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1
7528297|NCT02603172|11870299|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0
7528298|NCT02603172|11870300|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0
7528299|NCT02603172|11870301|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0
7528300|NCT02603172|11870302|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0
7528301|NCT02603172|11870303|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0
7528302|NCT02603393|11870326|FG000|Overall Study|Patient/guardian decision|32
7528303|NCT02603393|11870327|FG001|Overall Study|Patient/guardian decision|18
7528304|NCT02603393|11870326|FG000|Overall Study|Adverse Event|17
7528305|NCT02603393|11870327|FG001|Overall Study|Adverse Event|15
7528306|NCT02603393|11870326|FG000|Overall Study|Technical problems|4
7528307|NCT02603393|11870327|FG001|Overall Study|Technical problems|7
7528308|NCT02603393|11870326|FG000|Overall Study|Lack of Efficacy|7
7528309|NCT02603393|11870327|FG001|Overall Study|Lack of Efficacy|2
7528310|NCT02603393|11870326|FG000|Overall Study|Death|3
7528311|NCT02603393|11870327|FG001|Overall Study|Death|4
7528312|NCT02603393|11870326|FG000|Overall Study|Physician Decision|3
7528313|NCT02603393|11870327|FG001|Overall Study|Physician Decision|3
7528314|NCT02603393|11870326|FG000|Overall Study|Protocol deviation|2
7528315|NCT02603393|11870327|FG001|Overall Study|Protocol deviation|3
7528316|NCT02603393|11870326|FG000|Overall Study|Lost to Follow-up|1
7528317|NCT02603393|11870327|FG001|Overall Study|Lost to Follow-up|2
7528318|NCT02603393|11870326|FG000|Overall Study|Non-compliance with study treatment|1
7528319|NCT02603393|11870327|FG001|Overall Study|Non-compliance with study treatment|0
7528320|NCT02603393|11870326|FG000|Overall Study|Sponsor decision|1
7528321|NCT02603393|11870327|FG001|Overall Study|Sponsor decision|0
7528322|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7528323|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
7528324|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7528325|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7528326|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7528327|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
7528328|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7528329|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7528330|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
7528331|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
7528332|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
7528333|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
7528334|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
7528335|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7528336|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
7528337|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7528338|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
7528339|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
7528340|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7528341|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7528342|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7528343|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7528344|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
7528345|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
7528346|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7528347|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
7528348|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7528349|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7528350|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7528351|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
7528352|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
7528353|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7528354|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7317692|NCT00724126|11546684|FG001|Overall Study|Adverse Event|0
7317693|NCT00724126|11546683|FG000|Overall Study|Withdrawal by Subject|8
7317694|NCT00724126|11546684|FG001|Overall Study|Withdrawal by Subject|6
7317695|NCT00724126|11546683|FG000|Overall Study|Lost to Follow-up|6
7317696|NCT00724126|11546684|FG001|Overall Study|Lost to Follow-up|6
7317697|NCT00724126|11546683|FG000|Overall Study|Noncompliance|2
7317698|NCT00724126|11546684|FG001|Overall Study|Noncompliance|1
7317699|NCT00724126|11546683|FG000|Overall Study|Subject randomized although ineligible|1
7317700|NCT00724126|11546684|FG001|Overall Study|Subject randomized although ineligible|1
7317701|NCT00724126|11546683|FG000|Overall Study|Subject had to leave vicinity of site|0
7317702|NCT00724126|11546684|FG001|Overall Study|Subject had to leave vicinity of site|1
7317703|NCT00724152|11546695|FG000|Two-arm Study Period|Withdrawal by Subject|3
7317704|NCT00724152|11546696|FG001|Two-arm Study Period|Withdrawal by Subject|2
7317705|NCT00724152|11546697|FG002|Two-arm Study Period|Withdrawal by Subject|0
7317706|NCT00724152|11546695|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7317707|NCT00724152|11546696|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
7317708|NCT00724152|11546697|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
7317709|NCT00724243|11546707|FG000|Overall Study|Lack of Efficacy|10
7317710|NCT00724243|11546707|FG000|Overall Study|Adverse Event|5
7317711|NCT00724373|11546724|FG000|Overall Study|Adverse Event|41
7317712|NCT00724373|11546724|FG000|Overall Study|Lack of Efficacy|82
7317713|NCT00724373|11546724|FG000|Overall Study|Lost to Follow-up|7
7317714|NCT00724373|11546724|FG000|Overall Study|Non-compliance|2
7317715|NCT00724373|11546724|FG000|Overall Study|HCV RNA negative after 4 weeks|9
7317716|NCT00724373|11546724|FG000|Overall Study|Participant moved away|1
7317717|NCT00724373|11546724|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
7317718|NCT00724373|11546724|FG000|Overall Study|Only to have 24 week regimen|1
7317719|NCT00724373|11546724|FG000|Overall Study|Viral Relapse|1
7317720|NCT00724373|11546724|FG000|Overall Study|Acute HCV infection|1
7317721|NCT00724373|11546724|FG000|Overall Study|Drug Relapse|1
7317722|NCT00724373|11546724|FG000|Overall Study|Tolerability|23
7317723|NCT00724451|11546728|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
7317724|NCT00724451|11546728|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
7317725|NCT00724451|11546728|FG000|Overall Study|Not Eligible for Treatment|431
7317726|NCT00724451|11546728|FG000|Overall Study|Participant Refused Treatment|89
7317727|NCT00724451|11546728|FG000|Overall Study|Never Started Treatment|89
7317728|NCT00724451|11546728|FG000|Overall Study|Unknown; No Data Sources Available|9
7317729|NCT00724451|11546728|FG000|Overall Study|Physician Decision|116
7317730|NCT00724451|11546728|FG000|Overall Study|Withdrawal by Subject|45
7317731|NCT00724451|11546728|FG000|Overall Study|Investigator + Participant Decision|13
7317732|NCT00724503|11546739|FG000|Overall Study|Lost to Follow-up|4
7317733|NCT00724503|11546740|FG001|Overall Study|Lost to Follow-up|8
7317734|NCT00724503|11546739|FG000|Overall Study|Withdrawal by Subject|11
7317735|NCT00724503|11546740|FG001|Overall Study|Withdrawal by Subject|23
7317736|NCT00724503|11546739|FG000|Overall Study|Death|190
7317737|NCT00724503|11546740|FG001|Overall Study|Death|182
7317738|NCT00724503|11546739|FG000|Overall Study|Adverse Event|1
7317739|NCT00724503|11546740|FG001|Overall Study|Adverse Event|0
7317740|NCT00724503|11546739|FG000|Overall Study|Not otherwise specified|4
7317741|NCT00724503|11546740|FG001|Overall Study|Not otherwise specified|7
7317742|NCT00724711|11546787|FG000|Overall Study|Adverse Event|7
7317743|NCT00724711|11546788|FG001|Overall Study|Adverse Event|3
7317744|NCT00724711|11546787|FG000|Overall Study|Pregnancy|0
7528355|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7528356|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
7528357|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
7528358|NCT02603419|11870339|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7528359|NCT02603419|11870340|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7528360|NCT02603419|11870341|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7528361|NCT02603419|11870342|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
7528362|NCT02603419|11870343|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7224659|NCT00057811|11434016|FG001|Overall Study|Physician Decision|0
7224660|NCT00057811|11434015|FG000|Overall Study|Withdrawal by Subject|3
7224661|NCT00057811|11434016|FG001|Overall Study|Withdrawal by Subject|4
7224662|NCT00057811|11434015|FG000|Overall Study|Ineligible|4
7224663|NCT00057811|11434016|FG001|Overall Study|Ineligible|2
7224664|NCT00057811|11434015|FG000|Overall Study|Inevaluable|1
7528363|NCT02603419|11870344|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
7528364|NCT02603419|11870339|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7528365|NCT02603419|11870340|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7528366|NCT02603419|11870341|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7528367|NCT02603419|11870342|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7528368|NCT02603419|11870343|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
7528369|NCT02603419|11870344|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
7528370|NCT02603419|11870339|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7528371|NCT02603419|11870340|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7528372|NCT02603419|11870341|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7528373|NCT02603419|11870342|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7528374|NCT02603419|11870343|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
7528375|NCT02603419|11870344|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
7528376|NCT02603419|11870339|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7528377|NCT02603419|11870340|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7528378|NCT02603419|11870341|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7528379|NCT02603419|11870342|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7528380|NCT02603419|11870343|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
7528381|NCT02603419|11870344|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
7528382|NCT02603809|11870369|FG000|Overall Study|Withdrawal by Subject|4
7528383|NCT02603809|11870370|FG001|Overall Study|Withdrawal by Subject|1
7528384|NCT02603809|11870371|FG002|Overall Study|Withdrawal by Subject|2
7528385|NCT02603809|11870372|FG003|Overall Study|Withdrawal by Subject|3
7528386|NCT02603809|11870373|FG004|Overall Study|Withdrawal by Subject|3
7528387|NCT02603809|11870374|FG005|Overall Study|Withdrawal by Subject|4
7528388|NCT02603809|11870369|FG000|Overall Study|Lost to Follow-up|2
7528389|NCT02603809|11870370|FG001|Overall Study|Lost to Follow-up|3
7528390|NCT02603809|11870371|FG002|Overall Study|Lost to Follow-up|1
7528391|NCT02603809|11870372|FG003|Overall Study|Lost to Follow-up|4
7528392|NCT02603809|11870373|FG004|Overall Study|Lost to Follow-up|2
7528393|NCT02603809|11870374|FG005|Overall Study|Lost to Follow-up|2
7528394|NCT02603809|11870369|FG000|Overall Study|Pre-specified discontinuation criteria|3
7528395|NCT02603809|11870370|FG001|Overall Study|Pre-specified discontinuation criteria|3
7528396|NCT02603809|11870371|FG002|Overall Study|Pre-specified discontinuation criteria|2
7528397|NCT02603809|11870372|FG003|Overall Study|Pre-specified discontinuation criteria|2
7528398|NCT02603809|11870373|FG004|Overall Study|Pre-specified discontinuation criteria|3
7528399|NCT02603809|11870374|FG005|Overall Study|Pre-specified discontinuation criteria|1
7528400|NCT02603809|11870369|FG000|Overall Study|Physician Decision|0
7528401|NCT02603809|11870370|FG001|Overall Study|Physician Decision|0
7528402|NCT02603809|11870371|FG002|Overall Study|Physician Decision|0
7528403|NCT02603809|11870372|FG003|Overall Study|Physician Decision|1
7528404|NCT02603809|11870373|FG004|Overall Study|Physician Decision|2
7528405|NCT02603809|11870374|FG005|Overall Study|Physician Decision|1
7528406|NCT02603809|11870369|FG000|Overall Study|Adverse Event|3
7528407|NCT02603809|11870370|FG001|Overall Study|Adverse Event|0
7528408|NCT02603809|11870371|FG002|Overall Study|Adverse Event|2
7528409|NCT02603809|11870372|FG003|Overall Study|Adverse Event|2
7528410|NCT02603809|11870373|FG004|Overall Study|Adverse Event|1
7528411|NCT02603809|11870374|FG005|Overall Study|Adverse Event|1
7528412|NCT02603809|11870369|FG000|Overall Study|Lack of Efficacy|0
7528413|NCT02603809|11870370|FG001|Overall Study|Lack of Efficacy|1
7528414|NCT02603809|11870371|FG002|Overall Study|Lack of Efficacy|0
7528415|NCT02603809|11870372|FG003|Overall Study|Lack of Efficacy|0
7528416|NCT02603809|11870373|FG004|Overall Study|Lack of Efficacy|0
7528417|NCT02603809|11870374|FG005|Overall Study|Lack of Efficacy|1
7528418|NCT02603952|11870399|FG000|Overall Study|Withdrawal by Subject|1
7528419|NCT02603952|11870400|FG001|Overall Study|Withdrawal by Subject|0
7528420|NCT02603952|11870401|FG002|Overall Study|Withdrawal by Subject|0
7528421|NCT02603952|11870402|FG003|Overall Study|Withdrawal by Subject|0
7528422|NCT02603952|11870399|FG000|Overall Study|Received oseltamivir by error|0
7528423|NCT02603952|11870400|FG001|Overall Study|Received oseltamivir by error|0
7528424|NCT02603952|11870401|FG002|Overall Study|Received oseltamivir by error|0
7528425|NCT02603952|11870402|FG003|Overall Study|Received oseltamivir by error|1
7528426|NCT02604017|11870417|FG000|Overall Study|Withdrew Consent|0
7528427|NCT02604017|11870418|FG001|Overall Study|Withdrew Consent|2
7528428|NCT02604017|11870417|FG000|Overall Study|Lost to Follow-up|5
7528429|NCT02604017|11870418|FG001|Overall Study|Lost to Follow-up|6
7528430|NCT02604017|11870417|FG000|Overall Study|Other|1
7528431|NCT02604017|11870418|FG001|Overall Study|Other|0
7528432|NCT02604160|11870426|FG000|Overall Study|Protocol Violation|0
7528433|NCT02604160|11870427|FG001|Overall Study|Protocol Violation|1
7528434|NCT02604160|11870426|FG000|Overall Study|Physician Decision|0
7528435|NCT02604160|11870427|FG001|Overall Study|Physician Decision|1
7528436|NCT02604199|11870452|FG000|Overall Study|Pregnancy|0
7528437|NCT02604199|11870453|FG001|Overall Study|Pregnancy|0
7528438|NCT02604199|11870454|FG002|Overall Study|Pregnancy|0
7528439|NCT02604199|11870455|FG003|Overall Study|Pregnancy|1
7528440|NCT02604199|11870452|FG000|Overall Study|Study terminated by sponsor|0
7528441|NCT02604199|11870453|FG001|Overall Study|Study terminated by sponsor|2
7528442|NCT02604199|11870454|FG002|Overall Study|Study terminated by sponsor|0
7528443|NCT02604199|11870455|FG003|Overall Study|Study terminated by sponsor|2
7528444|NCT02604199|11870452|FG000|Overall Study|Withdrawal by Subject|0
7528445|NCT02604199|11870453|FG001|Overall Study|Withdrawal by Subject|1
7528446|NCT02604199|11870454|FG002|Overall Study|Withdrawal by Subject|0
7528447|NCT02604199|11870455|FG003|Overall Study|Withdrawal by Subject|0
7528448|NCT02604212|11870472|FG000|Overall Study|Study Terminated by Sponsor|2
7528449|NCT02604212|11870473|FG001|Overall Study|Study Terminated by Sponsor|1
7528450|NCT02604212|11870474|FG002|Overall Study|Study Terminated by Sponsor|3
7528451|NCT02604212|11870475|FG003|Overall Study|Study Terminated by Sponsor|3
7528452|NCT02604212|11870472|FG000|Overall Study|Withdrawal by Subject|0
7528453|NCT02604212|11870473|FG001|Overall Study|Withdrawal by Subject|0
7528454|NCT02604212|11870474|FG002|Overall Study|Withdrawal by Subject|1
7528455|NCT02604212|11870475|FG003|Overall Study|Withdrawal by Subject|0
7528456|NCT02604264|11870492|FG000|Intervention|Didn't use CVC for at least 21 days|200
7528457|NCT02604264|11870493|FG001|Intervention|Didn't use CVC for at least 21 days|242
7528458|NCT02604342|11870501|FG000|Overall Study|Death|32
7528459|NCT02604342|11870502|FG001|Overall Study|Death|16
7528460|NCT02604342|11870501|FG000|Overall Study|Progression of disease|1
7528461|NCT02604342|11870502|FG001|Overall Study|Progression of disease|0
7528462|NCT02604342|11870501|FG000|Overall Study|Withdrawal by Subject|5
7528463|NCT02604342|11870502|FG001|Overall Study|Withdrawal by Subject|6
7528464|NCT02604342|11870501|FG000|Overall Study|Other|1
7528465|NCT02604342|11870502|FG001|Overall Study|Other|0
7528466|NCT02604342|11870501|FG000|Overall Study|Study Termination by Sponsor|1
7528467|NCT02604342|11870502|FG001|Overall Study|Study Termination by Sponsor|0
7528468|NCT02604342|11870501|FG000|Overall Study|Lost to Follow-up|1
7528469|NCT02604342|11870502|FG001|Overall Study|Lost to Follow-up|1
7528470|NCT02604342|11870501|FG000|Overall Study|Physician Decision|2
7528471|NCT02604342|11870502|FG001|Overall Study|Physician Decision|0
7528472|NCT02604407|11870511|FG000|Overall Study|Adverse Event|0
7528473|NCT02604407|11870512|FG001|Overall Study|Adverse Event|7
7528474|NCT02604407|11870513|FG002|Overall Study|Adverse Event|5
7528475|NCT02604407|11870511|FG000|Overall Study|Protocol Violation|2
7528476|NCT02604407|11870512|FG001|Overall Study|Protocol Violation|0
7528477|NCT02604407|11870513|FG002|Overall Study|Protocol Violation|0
7528478|NCT02604407|11870511|FG000|Overall Study|Withdrawal by Subject|3
7528479|NCT02604407|11870512|FG001|Overall Study|Withdrawal by Subject|3
7528480|NCT02604407|11870513|FG002|Overall Study|Withdrawal by Subject|5
7528481|NCT02604407|11870511|FG000|Overall Study|Lost to Follow-up|2
7317745|NCT00724711|11546788|FG001|Overall Study|Pregnancy|1
7317746|NCT00724711|11546787|FG000|Overall Study|Lack of Efficacy|0
7317747|NCT00724711|11546788|FG001|Overall Study|Lack of Efficacy|1
7317748|NCT00724711|11546787|FG000|Overall Study|Physician Decision|0
7317749|NCT00724711|11546788|FG001|Overall Study|Physician Decision|3
7317750|NCT00724711|11546787|FG000|Overall Study|Withdrawal by Subject|5
7317751|NCT00724711|11546788|FG001|Overall Study|Withdrawal by Subject|4
7317752|NCT00724711|11546787|FG000|Overall Study|Lost to Follow-up|4
7317753|NCT00724711|11546788|FG001|Overall Study|Lost to Follow-up|5
7317754|NCT00724711|11546787|FG000|Overall Study|Protocol Violation|1
7317755|NCT00724711|11546788|FG001|Overall Study|Protocol Violation|0
7317756|NCT00724815|11546805|FG000|Overall Study|Randomized, not treated|31
7317757|NCT00724815|11546806|FG001|Overall Study|Randomized, not treated|30
7317758|NCT00724815|11546805|FG000|Overall Study|Adverse Event|5
7317759|NCT00724815|11546806|FG001|Overall Study|Adverse Event|3
7317760|NCT00724815|11546805|FG000|Overall Study|Lost to Follow-up|4
7317761|NCT00724815|11546806|FG001|Overall Study|Lost to Follow-up|1
7317762|NCT00724815|11546805|FG000|Overall Study|Other Various|3
7317763|NCT00724815|11546806|FG001|Overall Study|Other Various|5
7317764|NCT00724854|11546814|FG000|Overall Study|Lack of Efficacy|187
7317765|NCT00724854|11546815|FG001|Overall Study|Lack of Efficacy|13
7317766|NCT00724854|11546814|FG000|Overall Study|Lost to Follow-up|87
7317767|NCT00724854|11546815|FG001|Overall Study|Lost to Follow-up|10
7317768|NCT00724854|11546814|FG000|Overall Study|Adverse Event|62
7317769|NCT00724854|11546815|FG001|Overall Study|Adverse Event|4
7317770|NCT00724854|11546814|FG000|Overall Study|Other|42
7317771|NCT00724854|11546815|FG001|Overall Study|Other|3
7317772|NCT00724854|11546814|FG000|Overall Study|Death|11
7317773|NCT00724854|11546815|FG001|Overall Study|Death|0
7317774|NCT00724854|11546814|FG000|Overall Study|Change of treatment|7
7317775|NCT00724854|11546815|FG001|Overall Study|Change of treatment|0
7317776|NCT00724854|11546814|FG000|Overall Study|Withdrawal by Subject|5
7317777|NCT00724854|11546815|FG001|Overall Study|Withdrawal by Subject|0
7317778|NCT00724854|11546814|FG000|Overall Study|Adverse event + lack of efficacy|2
7317779|NCT00724854|11546815|FG001|Overall Study|Adverse event + lack of efficacy|1
7317780|NCT00724867|11546822|FG000|Overall Study|Adverse Event|25
7317781|NCT00724867|11546822|FG000|Overall Study|Lack of Efficacy|14
7317782|NCT00724867|11546822|FG000|Overall Study|Lost to Follow-up|12
7317783|NCT00724867|11546822|FG000|Overall Study|Non-compliance with study drug|6
7317784|NCT00724867|11546822|FG000|Overall Study|Physician Decision|17
7317785|NCT00724867|11546822|FG000|Overall Study|Protocol Violation|1
7317786|NCT00724867|11546822|FG000|Overall Study|Withdrawal by Subject|31
7317787|NCT00724867|11546822|FG000|Overall Study|Sponsor decision to end study|14
7317788|NCT00724867|11546822|FG000|Overall Study|Subject incarcerated|1
7317789|NCT00724867|11546822|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
7317790|NCT00724867|11546822|FG000|Overall Study|Subject moved out of state|1
7317791|NCT00724867|11546822|FG000|Overall Study|Elected to exit due to site closure|2
7317792|NCT00724893|11546831|FG000|Overall Study|Adverse Event|76
7317793|NCT00724893|11546832|FG001|Overall Study|Adverse Event|142
7317794|NCT00724893|11546831|FG000|Overall Study|Withdrawal by Subject|0
7317795|NCT00724893|11546832|FG001|Overall Study|Withdrawal by Subject|1
7317796|NCT00724893|11546831|FG000|Overall Study|Lack of virologic response|94
7317797|NCT00724893|11546832|FG001|Overall Study|Lack of virologic response|202
7317798|NCT00724893|11546831|FG000|Overall Study|Reason not specified|193
7317799|NCT00724893|11546832|FG001|Overall Study|Reason not specified|7
7317800|NCT00724893|11546831|FG000|Overall Study|Patient choice|0
7317801|NCT00724893|11546832|FG001|Overall Study|Patient choice|26
7317802|NCT00724893|11546831|FG000|Overall Study|Geographic reasons|0
7317803|NCT00724893|11546832|FG001|Overall Study|Geographic reasons|11
7317804|NCT00724893|11546831|FG000|Overall Study|Incarceration|0
7317805|NCT00724893|11546832|FG001|Overall Study|Incarceration|9
7317806|NCT00724893|11546831|FG000|Overall Study|Substance abuse|0
7317807|NCT00724893|11546832|FG001|Overall Study|Substance abuse|3
7317808|NCT00724893|11546831|FG000|Overall Study|Financial reasons|0
7317809|NCT00724893|11546832|FG001|Overall Study|Financial reasons|2
7317810|NCT00724893|11546831|FG000|Overall Study|Assigned shorter treatment|0
7317811|NCT00724893|11546832|FG001|Overall Study|Assigned shorter treatment|2
7317812|NCT00724893|11546831|FG000|Overall Study|Lost to Follow-up|0
7317813|NCT00724893|11546832|FG001|Overall Study|Lost to Follow-up|52
7317814|NCT00724893|11546831|FG000|Overall Study|Unknown, missing data|1
7317815|NCT00724893|11546832|FG001|Overall Study|Unknown, missing data|1
7317816|NCT00724932|11546855|FG000|Overall Study|Lost to Follow-up|1
7317817|NCT00724932|11546856|FG001|Overall Study|Lost to Follow-up|0
7317818|NCT00724932|11546855|FG000|Overall Study|Not treated|4
7317819|NCT00724932|11546856|FG001|Overall Study|Not treated|3
7317820|NCT00724945|11546864|FG000|Period 1|non-compliance|1
7317821|NCT00724945|11546865|FG001|Period 1|non-compliance|0
7317822|NCT00724945|11546864|FG000|Period 1|Adverse Event|1
7317823|NCT00724945|11546865|FG001|Period 1|Adverse Event|1
7317824|NCT00724945|11546864|FG000|Period 1|Lost to Follow-up|1
7317825|NCT00724945|11546865|FG001|Period 1|Lost to Follow-up|0
7317826|NCT00724945|11546864|FG000|Period 2|lens comfort issue|3
7317827|NCT00724945|11546865|FG001|Period 2|lens comfort issue|0
7317828|NCT00724945|11546864|FG000|Period 2|lens physiology issue|1
7317829|NCT00724945|11546865|FG001|Period 2|lens physiology issue|0
7317830|NCT00724958|11546871|FG000|Overall Study|Adverse Event|28
7317831|NCT00724958|11546871|FG000|Overall Study|Loss of Response|40
7317832|NCT00724958|11546871|FG000|Overall Study|No Response|18
7528482|NCT02604407|11870512|FG001|Overall Study|Lost to Follow-up|1
7528483|NCT02604407|11870513|FG002|Overall Study|Lost to Follow-up|2
7528484|NCT02604407|11870511|FG000|Overall Study|Lack of Efficacy|1
7528485|NCT02604407|11870512|FG001|Overall Study|Lack of Efficacy|0
7528486|NCT02604407|11870513|FG002|Overall Study|Lack of Efficacy|0
7528487|NCT02604407|11870511|FG000|Overall Study|Other|3
7528488|NCT02604407|11870512|FG001|Overall Study|Other|1
7528489|NCT02604407|11870513|FG002|Overall Study|Other|4
7528490|NCT02604550|11870523|FG000|Overall Study|Lost to Follow-up|7
7528491|NCT02604550|11870524|FG001|Overall Study|Lost to Follow-up|6
7528492|NCT02604550|11870523|FG000|Overall Study|Withdrawal by Subject|0
7528493|NCT02604550|11870524|FG001|Overall Study|Withdrawal by Subject|1
7528494|NCT02604550|11870523|FG000|Overall Study|Incomplete data using paper journal|18
7528495|NCT02604550|11870524|FG001|Overall Study|Incomplete data using paper journal|19
7528496|NCT02604589|11870533|FG000|Overall Study|catheter dislodgement|0
7528497|NCT02604589|11870534|FG001|Overall Study|catheter dislodgement|0
7528498|NCT02604589|11870535|FG002|Overall Study|catheter dislodgement|1
7528499|NCT02605122|11870551|FG000|Overall Study|Withdrawal by Subject|4
7528500|NCT02605122|11870552|FG001|Overall Study|Withdrawal by Subject|1
7528501|NCT02605122|11870551|FG000|Overall Study|Lost to Follow-up|1
7528502|NCT02605122|11870552|FG001|Overall Study|Lost to Follow-up|1
7528503|NCT02605174|11870562|FG000|Overall Study|Adverse Event|0
7528504|NCT02605174|11870563|FG001|Overall Study|Adverse Event|0
7528505|NCT02605174|11870564|FG002|Overall Study|Adverse Event|1
7528506|NCT02605174|11870565|FG003|Overall Study|Adverse Event|0
7528507|NCT02605174|11870566|FG004|Overall Study|Adverse Event|4
7528508|NCT02605174|11870567|FG005|Overall Study|Adverse Event|0
7528509|NCT02605174|11870568|FG006|Overall Study|Adverse Event|0
7528510|NCT02605174|11870562|FG000|Overall Study|Lost to Follow-up|20
7528511|NCT02605174|11870563|FG001|Overall Study|Lost to Follow-up|7
7528512|NCT02605174|11870564|FG002|Overall Study|Lost to Follow-up|27
7528513|NCT02605174|11870565|FG003|Overall Study|Lost to Follow-up|10
7528514|NCT02605174|11870566|FG004|Overall Study|Lost to Follow-up|20
7528515|NCT02605174|11870567|FG005|Overall Study|Lost to Follow-up|10
7528516|NCT02605174|11870568|FG006|Overall Study|Lost to Follow-up|29
7528517|NCT02605174|11870562|FG000|Overall Study|Protocol Violation|10
7528518|NCT02605174|11870563|FG001|Overall Study|Protocol Violation|4
7528519|NCT02605174|11870564|FG002|Overall Study|Protocol Violation|14
7528520|NCT02605174|11870565|FG003|Overall Study|Protocol Violation|6
7528521|NCT02605174|11870566|FG004|Overall Study|Protocol Violation|7
7528522|NCT02605174|11870567|FG005|Overall Study|Protocol Violation|7
7528523|NCT02605174|11870568|FG006|Overall Study|Protocol Violation|12
7528524|NCT02605174|11870562|FG000|Overall Study|Pregnancy|1
7528525|NCT02605174|11870563|FG001|Overall Study|Pregnancy|0
7528526|NCT02605174|11870564|FG002|Overall Study|Pregnancy|0
7528527|NCT02605174|11870565|FG003|Overall Study|Pregnancy|2
7528528|NCT02605174|11870566|FG004|Overall Study|Pregnancy|0
7528529|NCT02605174|11870567|FG005|Overall Study|Pregnancy|0
7528530|NCT02605174|11870568|FG006|Overall Study|Pregnancy|0
7528531|NCT02605174|11870562|FG000|Overall Study|Withdrawal by Subject|9
7528532|NCT02605174|11870563|FG001|Overall Study|Withdrawal by Subject|6
7528533|NCT02605174|11870564|FG002|Overall Study|Withdrawal by Subject|14
7528534|NCT02605174|11870565|FG003|Overall Study|Withdrawal by Subject|11
7528535|NCT02605174|11870566|FG004|Overall Study|Withdrawal by Subject|6
7528536|NCT02605174|11870567|FG005|Overall Study|Withdrawal by Subject|4
7528537|NCT02605174|11870568|FG006|Overall Study|Withdrawal by Subject|15
7528538|NCT02605174|11870562|FG000|Overall Study|Physician Decision|2
7528539|NCT02605174|11870563|FG001|Overall Study|Physician Decision|0
7528540|NCT02605174|11870564|FG002|Overall Study|Physician Decision|0
7528541|NCT02605174|11870565|FG003|Overall Study|Physician Decision|0
7224665|NCT00057811|11434016|FG001|Overall Study|Inevaluable|2
7224666|NCT00057837|11434024|FG000|Overall Study|Progression/relapse|12
7224667|NCT00057837|11434025|FG001|Overall Study|Progression/relapse|14
7224668|NCT00057837|11434024|FG000|Overall Study|Adverse Event|2
7224669|NCT00057837|11434025|FG001|Overall Study|Adverse Event|12
7224670|NCT00057837|11434024|FG000|Overall Study|Death|5
7224671|NCT00057837|11434025|FG001|Overall Study|Death|4
7224672|NCT00057837|11434024|FG000|Overall Study|Withdrawal by Subject|5
7224673|NCT00057837|11434025|FG001|Overall Study|Withdrawal by Subject|3
7224674|NCT00057837|11434024|FG000|Overall Study|Alternative therapy|0
7224675|NCT00057837|11434025|FG001|Overall Study|Alternative therapy|1
7224676|NCT00057837|11434024|FG000|Overall Study|Other complicating disease|2
7224677|NCT00057837|11434025|FG001|Overall Study|Other complicating disease|1
7224678|NCT00057837|11434024|FG000|Overall Study|Physician Decision|1
7528542|NCT02605174|11870566|FG004|Overall Study|Physician Decision|0
7528543|NCT02605174|11870567|FG005|Overall Study|Physician Decision|0
7528544|NCT02605174|11870568|FG006|Overall Study|Physician Decision|3
7528545|NCT02605174|11870562|FG000|Overall Study|Randomization Failure|22
7528546|NCT02605174|11870563|FG001|Overall Study|Randomization Failure|6
7528547|NCT02605174|11870564|FG002|Overall Study|Randomization Failure|20
7528548|NCT02605174|11870565|FG003|Overall Study|Randomization Failure|7
7528549|NCT02605174|11870566|FG004|Overall Study|Randomization Failure|16
7528550|NCT02605174|11870567|FG005|Overall Study|Randomization Failure|11
7528551|NCT02605174|11870568|FG006|Overall Study|Randomization Failure|30
7528552|NCT02605447|11870627|FG000|Overall Study|Death|66
7528553|NCT02605447|11870627|FG000|Overall Study|Physician Decision|1
7528554|NCT02605447|11870627|FG000|Overall Study|Lost to Follow-up|24
7528555|NCT02605447|11870627|FG000|Overall Study|Withdrawal by Subject|10
7528556|NCT02605447|11870627|FG000|Overall Study|Not disclosed|1
7528557|NCT02605642|11870634|FG000|Overall Study|Other|11
7528558|NCT02605642|11870635|FG001|Overall Study|Other|1
7528559|NCT02605642|11870634|FG000|Overall Study|Participant non-compliance|2
7528560|NCT02605642|11870635|FG001|Overall Study|Participant non-compliance|4
7528561|NCT02605642|11870634|FG000|Overall Study|Physician Decision|10
7528562|NCT02605642|11870635|FG001|Overall Study|Physician Decision|0
7528563|NCT02605642|11870634|FG000|Overall Study|Lost to Follow-up|12
7528564|NCT02605642|11870635|FG001|Overall Study|Lost to Follow-up|1
7224679|NCT00057837|11434025|FG001|Overall Study|Physician Decision|0
7224680|NCT00057837|11434024|FG000|Overall Study|Ineligible|3
7224681|NCT00057837|11434025|FG001|Overall Study|Ineligible|3
7224682|NCT00057837|11434024|FG000|Overall Study|Never started treatment|1
7224683|NCT00057837|11434025|FG001|Overall Study|Never started treatment|1
7224684|NCT00057863|11434031|FG000|Overall Study|Death|1
7224685|NCT00057863|11434031|FG000|Overall Study|Withdrawal by Subject|2
7224686|NCT00057876|11434037|FG000|Overall Study|Adverse Event|8
7224687|NCT00057876|11434038|FG001|Overall Study|Adverse Event|8
7224688|NCT00057876|11434037|FG000|Overall Study|Death|2
7224689|NCT00057876|11434038|FG001|Overall Study|Death|1
7528565|NCT02605642|11870634|FG000|Overall Study|Adverse Event|14
7528566|NCT02605642|11870635|FG001|Overall Study|Adverse Event|2
7528567|NCT02605642|11870634|FG000|Overall Study|Withdrawal by Subject|23
7528568|NCT02605642|11870635|FG001|Overall Study|Withdrawal by Subject|2
7528569|NCT02605642|11870634|FG000|Overall Study|Lack of response|24
7224690|NCT00057876|11434037|FG000|Overall Study|Withdrawal by Subject|5
7224691|NCT00057876|11434038|FG001|Overall Study|Withdrawal by Subject|6
7224692|NCT00057876|11434037|FG000|Overall Study|Lack of Efficacy|10
7224693|NCT00057876|11434038|FG001|Overall Study|Lack of Efficacy|8
7224694|NCT00057876|11434037|FG000|Overall Study|Ineligible|1
7224695|NCT00057876|11434038|FG001|Overall Study|Ineligible|2
7224696|NCT00057876|11434037|FG000|Overall Study|other reason|2
7224697|NCT00057876|11434038|FG001|Overall Study|other reason|2
7224698|NCT00057876|11434037|FG000|Overall Study|other complicating disease|1
7224699|NCT00057876|11434038|FG001|Overall Study|other complicating disease|0
7224700|NCT00057941|11434046|FG000|Overall Study|Death|1
7224701|NCT00057941|11434047|FG001|Overall Study|Death|2
7224702|NCT00057941|11434046|FG000|Overall Study|Adverse Event|7
7224703|NCT00057941|11434047|FG001|Overall Study|Adverse Event|9
7224704|NCT00057941|11434046|FG000|Overall Study|Lack of Efficacy|54
7224705|NCT00057941|11434047|FG001|Overall Study|Lack of Efficacy|53
7224706|NCT00057941|11434046|FG000|Overall Study|Withdrawal by Subject|6
7224707|NCT00057941|11434047|FG001|Overall Study|Withdrawal by Subject|1
7224708|NCT00057941|11434046|FG000|Overall Study|still on treatment|3
7224709|NCT00057941|11434047|FG001|Overall Study|still on treatment|1
7224710|NCT00057941|11434046|FG000|Overall Study|insurance, symptomatic deterioration|1
7224711|NCT00057941|11434047|FG001|Overall Study|insurance, symptomatic deterioration|3
7224712|NCT00057941|11434046|FG000|Overall Study|Ineligible|2
7224713|NCT00057941|11434047|FG001|Overall Study|Ineligible|5
7224714|NCT00057954|11434053|FG000|Overall Study|Death|1
7224715|NCT00057954|11434053|FG000|Overall Study|Disease progression|1
7224716|NCT00058058|11434065|FG000|Overall Study|Withdrawal by Subject|4
7224717|NCT00058058|11434065|FG000|Overall Study|Ineligible|20
7224718|NCT00058058|11434065|FG000|Overall Study|Claustrophobic|5
7224719|NCT00058058|11434065|FG000|Overall Study|technical issues|6
7224720|NCT00058058|11434065|FG000|Overall Study|Poor positioning, illness,pain|3
7224721|NCT00058123|11434070|FG000|Overall Study|Wrong histology|9
7224722|NCT00058123|11434070|FG000|Overall Study|Received >3 prior treatments|1
7224723|NCT00058214|11434075|FG000|Overall Study|Adverse Event|1
7224724|NCT00058422|11434100|FG000|Overall Study|Not treated|2
7224725|NCT00058539|11434104|FG000|Overall Study|Disease progression|24
7224726|NCT00058539|11434104|FG000|Overall Study|Adverse Event|3
7224727|NCT00058539|11434104|FG000|Overall Study|Withdrawal by Subject|5
7224728|NCT00058539|11434104|FG000|Overall Study|Physician Decision|9
7224729|NCT00058539|11434104|FG000|Overall Study|Death|1
7224730|NCT00058552|11434110|FG000|Overall Study|Died prior to receiving treatment|4
7224731|NCT00058552|11434111|FG001|Overall Study|Died prior to receiving treatment|2
7224732|NCT00058552|11434110|FG000|Overall Study|Disease progression|52
7224733|NCT00058552|11434111|FG001|Overall Study|Disease progression|44
7224734|NCT00058552|11434110|FG000|Overall Study|Adverse Event|4
7224735|NCT00058552|11434111|FG001|Overall Study|Adverse Event|2
7224736|NCT00058552|11434110|FG000|Overall Study|Withdrawal by Subject|3
7224737|NCT00058552|11434111|FG001|Overall Study|Withdrawal by Subject|5
7224738|NCT00058552|11434110|FG000|Overall Study|Physician Decision|2
7224739|NCT00058552|11434111|FG001|Overall Study|Physician Decision|5
7224740|NCT00058552|11434110|FG000|Overall Study|Clinical disease progression|0
7224741|NCT00058552|11434111|FG001|Overall Study|Clinical disease progression|4
7224742|NCT00058825|11434119|FG000|Overall Study|Relapse|9
7224743|NCT00058825|11434119|FG000|Overall Study|Progressive Disease|5
7224744|NCT00058825|11434119|FG000|Overall Study|Graft Failure|5
7224745|NCT00058825|11434119|FG000|Overall Study|Death|3
7224746|NCT00059202|11434127|FG000|Overall Study|Withdrawal by Subject|5
7224747|NCT00059202|11434128|FG001|Overall Study|Withdrawal by Subject|9
7224748|NCT00059202|11434127|FG000|Overall Study|Protocol Violation|1
7224749|NCT00059202|11434128|FG001|Overall Study|Protocol Violation|3
7224750|NCT00059202|11434127|FG000|Overall Study|drug toxicity|0
7224751|NCT00059202|11434128|FG001|Overall Study|drug toxicity|3
7224752|NCT00059215|11434141|FG000|Overall Study|Adverse Event|5
7224753|NCT00059215|11434142|FG001|Overall Study|Adverse Event|5
7224754|NCT00059215|11434143|FG002|Overall Study|Adverse Event|9
7224755|NCT00059215|11434144|FG003|Overall Study|Adverse Event|9
7224756|NCT00059215|11434141|FG000|Overall Study|Death|0
7413224|NCT01424514|11685477|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7413225|NCT01424514|11685478|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
7413226|NCT01424514|11685477|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
7224757|NCT00059215|11434142|FG001|Overall Study|Death|0
7224758|NCT00059215|11434143|FG002|Overall Study|Death|3
7224759|NCT00059215|11434144|FG003|Overall Study|Death|0
7224760|NCT00059215|11434141|FG000|Overall Study|Lost to Follow-up|1
7224761|NCT00059215|11434142|FG001|Overall Study|Lost to Follow-up|2
7224762|NCT00059215|11434143|FG002|Overall Study|Lost to Follow-up|0
7224763|NCT00059215|11434144|FG003|Overall Study|Lost to Follow-up|0
7224764|NCT00059215|11434141|FG000|Overall Study|Withdrawal by Subject|4
7224765|NCT00059215|11434142|FG001|Overall Study|Withdrawal by Subject|4
7224766|NCT00059215|11434143|FG002|Overall Study|Withdrawal by Subject|1
7224767|NCT00059215|11434144|FG003|Overall Study|Withdrawal by Subject|3
7224768|NCT00059215|11434141|FG000|Overall Study|Protocol Violation|1
7224769|NCT00059215|11434142|FG001|Overall Study|Protocol Violation|0
7224770|NCT00059215|11434143|FG002|Overall Study|Protocol Violation|1
7224771|NCT00059215|11434144|FG003|Overall Study|Protocol Violation|0
7224772|NCT00059215|11434141|FG000|Overall Study|Protocol entry criteria not met|1
7224773|NCT00059215|11434142|FG001|Overall Study|Protocol entry criteria not met|1
7224774|NCT00059215|11434143|FG002|Overall Study|Protocol entry criteria not met|0
7224775|NCT00059215|11434144|FG003|Overall Study|Protocol entry criteria not met|2
7224776|NCT00059215|11434141|FG000|Overall Study|Physician Decision|1
7224777|NCT00059215|11434142|FG001|Overall Study|Physician Decision|2
7224778|NCT00059215|11434143|FG002|Overall Study|Physician Decision|1
7224779|NCT00059215|11434144|FG003|Overall Study|Physician Decision|1
7224780|NCT00059332|11434166|FG000|Overall Study|Withdrawal by Subject|2
7224781|NCT00059332|11434167|FG001|Overall Study|Withdrawal by Subject|1
7224782|NCT00059332|11434166|FG000|Overall Study|Lost to Follow-up|1
7224783|NCT00059332|11434167|FG001|Overall Study|Lost to Follow-up|1
7224784|NCT00059787|11434213|FG000|Overall Study|Adverse Event|13
7224785|NCT00059787|11434213|FG000|Overall Study|disease progression|2
7224786|NCT00059787|11434213|FG000|Overall Study|ineligible|1
7224787|NCT00059787|11434213|FG000|Overall Study|Other|4
7224788|NCT00059839|11434220|FG000|Overall Study|Death|1
7224789|NCT00059839|11434221|FG001|Overall Study|Death|1
7224790|NCT00059839|11434220|FG000|Overall Study|Lack of Efficacy|6
7224791|NCT00059839|11434221|FG001|Overall Study|Lack of Efficacy|5
7224792|NCT00059839|11434220|FG000|Overall Study|Lost to Follow-up|2
7224793|NCT00059839|11434221|FG001|Overall Study|Lost to Follow-up|0
7224794|NCT00059839|11434220|FG000|Overall Study|Physician Decision|1
7224795|NCT00059839|11434221|FG001|Overall Study|Physician Decision|2
7224796|NCT00059839|11434220|FG000|Overall Study|Withdrawal by Subject|1
7224797|NCT00059839|11434221|FG001|Overall Study|Withdrawal by Subject|6
7224798|NCT00059839|11434220|FG000|Overall Study|Ineligible|1
7224799|NCT00059839|11434221|FG001|Overall Study|Ineligible|3
7224800|NCT00060840|11434274|FG000|Overall Study|Change in surgical plan|2
7224801|NCT00060840|11434275|FG001|Overall Study|Change in surgical plan|6
7224802|NCT00060840|11434274|FG000|Overall Study|Death|0
7224803|NCT00060840|11434275|FG001|Overall Study|Death|1
7224804|NCT00060840|11434274|FG000|Overall Study|Withdrawal by Subject|0
7528570|NCT02605642|11870635|FG001|Overall Study|Lack of response|11
7528571|NCT02605837|11870643|FG000|Overall Study|Adverse Event|3
7528572|NCT02605837|11870644|FG001|Overall Study|Adverse Event|1
7528573|NCT02605837|11870643|FG000|Overall Study|Non-Compliance with Study Drug|0
7528574|NCT02605837|11870644|FG001|Overall Study|Non-Compliance with Study Drug|1
7528575|NCT02605837|11870643|FG000|Overall Study|Withdrawal by Subject|8
7528576|NCT02605837|11870644|FG001|Overall Study|Withdrawal by Subject|8
7528577|NCT02605837|11870643|FG000|Overall Study|Physician Decision|0
7528578|NCT02605837|11870644|FG001|Overall Study|Physician Decision|1
7528579|NCT02605928|11870673|FG000|Overall Study|Model tuning phase|28
7528580|NCT02605928|11870673|FG000|Overall Study|Lack of Efficacy|5
7528581|NCT02605954|11870679|FG000|Overall Study|Adverse Event|5
7528582|NCT02605954|11870680|FG001|Overall Study|Adverse Event|1
7528583|NCT02605954|11870679|FG000|Overall Study|Investigator's Discretion|1
7528584|NCT02605954|11870680|FG001|Overall Study|Investigator's Discretion|0
7528585|NCT02605954|11870679|FG000|Overall Study|Non-Compliance with Study Drug|1
7528586|NCT02605954|11870680|FG001|Overall Study|Non-Compliance with Study Drug|0
7528587|NCT02605954|11870679|FG000|Overall Study|Withdrew Consent|2
7528588|NCT02605954|11870680|FG001|Overall Study|Withdrew Consent|2
7528589|NCT02605954|11870679|FG000|Overall Study|Lost to Follow-up|3
7528590|NCT02605954|11870680|FG001|Overall Study|Lost to Follow-up|0
7528591|NCT02605954|11870679|FG000|Overall Study|Randomized but not treated|0
7224805|NCT00060840|11434275|FG001|Overall Study|Withdrawal by Subject|1
7224806|NCT00060840|11434274|FG000|Overall Study|Subinvestigator unavailable|0
7224807|NCT00060840|11434275|FG001|Overall Study|Subinvestigator unavailable|1
7317833|NCT00724958|11546871|FG000|Overall Study|Remission|7
7317834|NCT00724958|11546871|FG000|Overall Study|Other Reason|76
7317835|NCT00724958|11546871|FG000|Overall Study|No documentation for end of therapy|13
7317836|NCT00724971|11546875|FG000|Overall Study|Adverse Event|5
7317837|NCT00724971|11546875|FG000|Overall Study|Withdrawal by Subject|1
7317838|NCT00725010|11546904|FG000|Overall Study|Toxicity|9
7317839|NCT00725010|11546904|FG000|Overall Study|Tumor Progression|7
7317840|NCT00725010|11546904|FG000|Overall Study|Withdrawal by Subject|2
7317841|NCT00725010|11546904|FG000|Overall Study|Death|1
7317842|NCT00725010|11546904|FG000|Overall Study|Lost to Follow-up|1
7317843|NCT00725010|11546904|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
7528592|NCT02605954|11870680|FG001|Overall Study|Randomized but not treated|1
7528593|NCT02606253|11870692|FG000|Overall Study|Adverse Event|2
7528594|NCT02606253|11870693|FG001|Overall Study|Adverse Event|0
7528595|NCT02606253|11870694|FG002|Overall Study|Adverse Event|0
7528596|NCT02606253|11870692|FG000|Overall Study|Protocol Violation|2
7528597|NCT02606253|11870693|FG001|Overall Study|Protocol Violation|1
7528598|NCT02606253|11870694|FG002|Overall Study|Protocol Violation|0
7528599|NCT02606253|11870692|FG000|Overall Study|Physician Decision|1
7528600|NCT02606253|11870693|FG001|Overall Study|Physician Decision|1
7528601|NCT02606253|11870694|FG002|Overall Study|Physician Decision|0
7528602|NCT02606643|11870724|FG000|Overall Study|did not meet inclusion criteria|1
7528603|NCT02606643|11870725|FG001|Overall Study|did not meet inclusion criteria|3
7528604|NCT02606877|11870753|FG000|Overall Study|Adverse Event|3
7528605|NCT02606877|11870754|FG001|Overall Study|Adverse Event|0
7528606|NCT02606877|11870753|FG000|Overall Study|Non-compliance with protocol|0
7528607|NCT02606877|11870754|FG001|Overall Study|Non-compliance with protocol|1
7528608|NCT02606877|11870753|FG000|Overall Study|Other than listed above|1
7528609|NCT02606877|11870754|FG001|Overall Study|Other than listed above|0
7528610|NCT02607228|11870783|FG000|Overall Study|Progressive Disease|4
7528611|NCT02607228|11870784|FG001|Overall Study|Progressive Disease|3
7528612|NCT02607228|11870785|FG002|Overall Study|Progressive Disease|1
7528613|NCT02607228|11870786|FG003|Overall Study|Progressive Disease|5
7528614|NCT02607228|11870787|FG004|Overall Study|Progressive Disease|4
7528615|NCT02607228|11870788|FG005|Overall Study|Progressive Disease|3
7528616|NCT02607228|11870789|FG006|Overall Study|Progressive Disease|1
7528617|NCT02607228|11870783|FG000|Overall Study|Adverse Event|1
7528618|NCT02607228|11870784|FG001|Overall Study|Adverse Event|0
7528619|NCT02607228|11870785|FG002|Overall Study|Adverse Event|1
7528620|NCT02607228|11870786|FG003|Overall Study|Adverse Event|0
7528621|NCT02607228|11870787|FG004|Overall Study|Adverse Event|1
7528622|NCT02607228|11870788|FG005|Overall Study|Adverse Event|1
7528623|NCT02607228|11870789|FG006|Overall Study|Adverse Event|1
7528624|NCT02607228|11870783|FG000|Overall Study|Investigator's Discretion|0
7528625|NCT02607228|11870784|FG001|Overall Study|Investigator's Discretion|0
7528626|NCT02607228|11870785|FG002|Overall Study|Investigator's Discretion|1
7528627|NCT02607228|11870786|FG003|Overall Study|Investigator's Discretion|0
7528628|NCT02607228|11870787|FG004|Overall Study|Investigator's Discretion|0
7528629|NCT02607228|11870788|FG005|Overall Study|Investigator's Discretion|1
7528630|NCT02607228|11870789|FG006|Overall Study|Investigator's Discretion|0
7528631|NCT02607228|11870783|FG000|Overall Study|Withdrew Consent|0
7528632|NCT02607228|11870784|FG001|Overall Study|Withdrew Consent|1
7528633|NCT02607228|11870785|FG002|Overall Study|Withdrew Consent|0
7528634|NCT02607228|11870786|FG003|Overall Study|Withdrew Consent|0
7528635|NCT02607228|11870787|FG004|Overall Study|Withdrew Consent|0
7528636|NCT02607228|11870788|FG005|Overall Study|Withdrew Consent|1
7528637|NCT02607228|11870789|FG006|Overall Study|Withdrew Consent|0
7528638|NCT02607228|11870783|FG000|Overall Study|Study Terminated by Sponsor|0
7528639|NCT02607228|11870784|FG001|Overall Study|Study Terminated by Sponsor|0
7528640|NCT02607228|11870785|FG002|Overall Study|Study Terminated by Sponsor|0
7528641|NCT02607228|11870786|FG003|Overall Study|Study Terminated by Sponsor|1
7528642|NCT02607228|11870787|FG004|Overall Study|Study Terminated by Sponsor|0
7528643|NCT02607228|11870788|FG005|Overall Study|Study Terminated by Sponsor|0
7528644|NCT02607228|11870789|FG006|Overall Study|Study Terminated by Sponsor|0
7528645|NCT02607280|11870827|FG000|Overall Study|Adverse Event|4
7528646|NCT02607280|11870828|FG001|Overall Study|Adverse Event|0
7528647|NCT02607280|11870827|FG000|Overall Study|Decrease in CrCl <15|0
7528648|NCT02607280|11870828|FG001|Overall Study|Decrease in CrCl <15|1
7528649|NCT02607306|11870837|FG000|Overall Study|Adverse Event|8
7528650|NCT02607306|11870838|FG001|Overall Study|Adverse Event|6
7528651|NCT02607306|11870839|FG002|Overall Study|Adverse Event|6
7528652|NCT02607306|11870837|FG000|Overall Study|Unclassified|1
7528653|NCT02607306|11870838|FG001|Overall Study|Unclassified|4
7528654|NCT02607306|11870839|FG002|Overall Study|Unclassified|0
7528655|NCT02607306|11870837|FG000|Overall Study|Withdrawal by Subject|8
7528656|NCT02607306|11870838|FG001|Overall Study|Withdrawal by Subject|10
7528657|NCT02607306|11870839|FG002|Overall Study|Withdrawal by Subject|2
7528658|NCT02607306|11870837|FG000|Overall Study|Lack of Efficacy|0
7528659|NCT02607306|11870838|FG001|Overall Study|Lack of Efficacy|1
7528660|NCT02607306|11870839|FG002|Overall Study|Lack of Efficacy|1
7528661|NCT02607306|11870837|FG000|Overall Study|Protocol Violation|4
7317844|NCT00725010|11546904|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
7528662|NCT02607306|11870838|FG001|Overall Study|Protocol Violation|2
7528663|NCT02607306|11870839|FG002|Overall Study|Protocol Violation|1
7224808|NCT00060840|11434274|FG000|Overall Study|Physician Decision|1
7224809|NCT00060840|11434275|FG001|Overall Study|Physician Decision|0
7224810|NCT00060840|11434274|FG000|Overall Study|Other|1
7224811|NCT00060840|11434275|FG001|Overall Study|Other|0
7224812|NCT00060944|11434283|FG000|Overall Study|Adverse Event|12
7224813|NCT00060944|11434284|FG001|Overall Study|Adverse Event|10
7224814|NCT00060944|11434283|FG000|Overall Study|Death|2
7224815|NCT00060944|11434284|FG001|Overall Study|Death|3
7224816|NCT00060944|11434283|FG000|Overall Study|Withdrawal by Subject|18
7224817|NCT00060944|11434284|FG001|Overall Study|Withdrawal by Subject|5
7224818|NCT00060944|11434283|FG000|Overall Study|Disease Progression|93
7224819|NCT00060944|11434284|FG001|Overall Study|Disease Progression|94
7224820|NCT00060944|11434283|FG000|Overall Study|Lost to Follow-up|1
7224821|NCT00060944|11434284|FG001|Overall Study|Lost to Follow-up|0
7224822|NCT00060944|11434283|FG000|Overall Study|Subject Ineligible To Continue|2
7224823|NCT00060944|11434284|FG001|Overall Study|Subject Ineligible To Continue|1
7224824|NCT00060944|11434283|FG000|Overall Study|Treatment Switch|0
7224825|NCT00060944|11434284|FG001|Overall Study|Treatment Switch|13
7224826|NCT00060944|11434283|FG000|Overall Study|Other|2
7224827|NCT00060944|11434284|FG001|Overall Study|Other|4
7224828|NCT00060944|11434283|FG000|Overall Study|randomized but not treated|6
7224829|NCT00060944|11434284|FG001|Overall Study|randomized but not treated|4
7224830|NCT00061048|11434290|FG000|Overall Study|Adverse Event|2
7224831|NCT00061048|11434290|FG000|Overall Study|disease progression|20
7224832|NCT00061633|11434305|FG000|Overall Study|Adverse Event|1
7224833|NCT00061633|11434306|FG001|Overall Study|Adverse Event|2
7224834|NCT00061633|11434305|FG000|Overall Study|Withdrawal by Subject|2
7224835|NCT00061633|11434306|FG001|Overall Study|Withdrawal by Subject|2
7224836|NCT00061633|11434305|FG000|Overall Study|Lost to Follow-up|1
7224837|NCT00061633|11434306|FG001|Overall Study|Lost to Follow-up|4
7224838|NCT00061633|11434305|FG000|Overall Study|Other|1
7224839|NCT00061633|11434306|FG001|Overall Study|Other|1
7224840|NCT00061633|11434305|FG000|Overall Study|Never received study treatment|0
7224841|NCT00061633|11434306|FG001|Overall Study|Never received study treatment|2
7224842|NCT00061932|11434318|FG000|Overall Study|Withdrawal by Subject|13
7224843|NCT00061932|11434319|FG001|Overall Study|Withdrawal by Subject|4
7224844|NCT00062010|11434326|FG000|Overall Study|Ineligible|3
7224845|NCT00062166|11434330|FG000|Overall Study|Withdrawal by Subject|6
7224846|NCT00062374|11434335|FG000|Overall Study|Not treated|12
7224847|NCT00062439|11434339|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
7224848|NCT00062439|11434339|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
7224849|NCT00062439|11434339|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
7224850|NCT00062439|11434339|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
7224851|NCT00062439|11434339|FG000|Post Chemoradiation Assessment|Death|1
7224852|NCT00062439|11434339|FG000|Post Chemoradiation Assessment|Disease progression|2
7224853|NCT00062439|11434339|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
7224854|NCT00062439|11434339|FG000|Post Chemoradiation Assessment|Physician Decision|1
7224855|NCT00062439|11434339|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
7224856|NCT00062439|11434339|FG000|Surgery|Physician Decision|4
7224857|NCT00062439|11434339|FG000|Surgery|Death|1
7224858|NCT00062439|11434339|FG000|Surgery|Adverse Event|2
7224859|NCT00062439|11434339|FG000|Consolidation Chemotherapy|Adverse Event|2
7224860|NCT00062647|11434350|FG000|Overall Study|Death|2
7224861|NCT00062647|11434351|FG001|Overall Study|Death|2
7224862|NCT00062647|11434350|FG000|Overall Study|Adverse Event|1
7224863|NCT00062647|11434351|FG001|Overall Study|Adverse Event|1
7224864|NCT00062647|11434350|FG000|Overall Study|Withdrawal by Subject|2
7224865|NCT00062647|11434351|FG001|Overall Study|Withdrawal by Subject|1
7224866|NCT00062647|11434350|FG000|Overall Study|Protocol Violation|1
7224867|NCT00062647|11434351|FG001|Overall Study|Protocol Violation|0
7224868|NCT00062647|11434350|FG000|Overall Study|Lost to Follow-up|1
7224869|NCT00062647|11434351|FG001|Overall Study|Lost to Follow-up|2
7224870|NCT00062647|11434350|FG000|Overall Study|Failed continuation criteria|4
7256767|NCT00325468|11468502|FG002|Overall Study|Physician Decision|0
7413227|NCT01424514|11685478|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
7413228|NCT01424566|11685489|FG000|Single-blind Treatment|Adverse Event|71
7413229|NCT01424566|11685490|FG001|Single-blind Treatment|Adverse Event|0
7413230|NCT01424566|11685491|FG002|Single-blind Treatment|Adverse Event|0
7413231|NCT01424566|11685489|FG000|Single-blind Treatment|Withdrawal by Subject|16
7413232|NCT01424566|11685490|FG001|Single-blind Treatment|Withdrawal by Subject|0
7413233|NCT01424566|11685491|FG002|Single-blind Treatment|Withdrawal by Subject|0
7413234|NCT01424566|11685489|FG000|Single-blind Treatment|Withdrawal by Investigator|2
7413235|NCT01424566|11685490|FG001|Single-blind Treatment|Withdrawal by Investigator|0
7413236|NCT01424566|11685491|FG002|Single-blind Treatment|Withdrawal by Investigator|0
7413237|NCT01424566|11685489|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
7413238|NCT01424566|11685490|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7413239|NCT01424566|11685491|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
7413240|NCT01424566|11685489|FG000|Single-blind Treatment|Met Exclusion Criteria|1
7413241|NCT01424566|11685490|FG001|Single-blind Treatment|Met Exclusion Criteria|0
7413242|NCT01424566|11685491|FG002|Single-blind Treatment|Met Exclusion Criteria|0
7413243|NCT01424566|11685489|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
7413244|NCT01424566|11685490|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
7413245|NCT01424566|11685491|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
7413246|NCT01424566|11685489|FG000|Double-blind Treatment|Adverse Event|0
7413247|NCT01424566|11685490|FG001|Double-blind Treatment|Adverse Event|21
7413248|NCT01424566|11685491|FG002|Double-blind Treatment|Adverse Event|13
7413249|NCT01424566|11685489|FG000|Double-blind Treatment|Withdrawal by Subject|0
7413250|NCT01424566|11685490|FG001|Double-blind Treatment|Withdrawal by Subject|2
7413251|NCT01424566|11685491|FG002|Double-blind Treatment|Withdrawal by Subject|0
7413252|NCT01424566|11685489|FG000|Double-blind Treatment|Withdrawal by Investigator|0
7413253|NCT01424566|11685490|FG001|Double-blind Treatment|Withdrawal by Investigator|1
7413254|NCT01424566|11685491|FG002|Double-blind Treatment|Withdrawal by Investigator|1
7413255|NCT01424566|11685489|FG000|Double-blind Treatment|Lack of Efficacy|0
7413256|NCT01424566|11685490|FG001|Double-blind Treatment|Lack of Efficacy|1
7413257|NCT01424566|11685491|FG002|Double-blind Treatment|Lack of Efficacy|1
7413258|NCT01424644|11685500|FG000|Overall Study|Adverse Event|2
7413259|NCT01424644|11685501|FG001|Overall Study|Adverse Event|0
7413260|NCT01424644|11685500|FG000|Overall Study|Withdrawal by Subject|9
7413261|NCT01424644|11685501|FG001|Overall Study|Withdrawal by Subject|12
7528664|NCT02607735|11870859|FG000|Primary Study|Randomized but Never Treated|1
7528665|NCT02607735|11870860|FG001|Primary Study|Randomized but Never Treated|0
7528666|NCT02607735|11870861|FG002|Primary Study|Randomized but Never Treated|0
7528667|NCT02607735|11870859|FG000|Primary Study|Lost to Follow-up|4
7528668|NCT02607735|11870860|FG001|Primary Study|Lost to Follow-up|0
7528669|NCT02607735|11870861|FG002|Primary Study|Lost to Follow-up|0
7528670|NCT02607735|11870859|FG000|Primary Study|Withdrew Consent|2
7528671|NCT02607735|11870860|FG001|Primary Study|Withdrew Consent|0
7528672|NCT02607735|11870861|FG002|Primary Study|Withdrew Consent|0
7528673|NCT02607735|11870859|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
7528674|NCT02607735|11870860|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
7528675|NCT02607735|11870861|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
7528676|NCT02607735|11870859|FG000|Deferred Treatment Substudy|Withdrew Consent|0
7528677|NCT02607735|11870860|FG001|Deferred Treatment Substudy|Withdrew Consent|0
7528678|NCT02607735|11870861|FG002|Deferred Treatment Substudy|Withdrew Consent|1
7528679|NCT02607800|11870871|FG000|Overall Study|Lost to Follow-up|7
7528680|NCT02607800|11870872|FG001|Overall Study|Lost to Follow-up|10
7528681|NCT02607800|11870871|FG000|Overall Study|Withdrew Consent|2
7528682|NCT02607800|11870872|FG001|Overall Study|Withdrew Consent|0
7528683|NCT02607800|11870871|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
7528684|NCT02607800|11870872|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
7413262|NCT01424644|11685500|FG000|Overall Study|Lost to Follow-up|16
7413263|NCT01424644|11685501|FG001|Overall Study|Lost to Follow-up|12
7413264|NCT01424644|11685500|FG000|Overall Study|Protocol Violation|4
7528701|NCT02608099|11870898|FG000|Overall Study|Ablation procedure not initiated|3
7528702|NCT02608099|11870899|FG001|Overall Study|Ablation procedure not initiated|2
7528703|NCT02608450|11870929|FG000|Overall Study|Lost to Follow-up|39
7528704|NCT02608450|11870930|FG001|Overall Study|Lost to Follow-up|32
7528705|NCT02608450|11870929|FG000|Overall Study|Withdrawal by Subject|21
7528706|NCT02608450|11870930|FG001|Overall Study|Withdrawal by Subject|15
7528707|NCT02608450|11870929|FG000|Overall Study|Adverse Event|3
7528708|NCT02608450|11870930|FG001|Overall Study|Adverse Event|6
7528709|NCT02608450|11870929|FG000|Overall Study|Withdrawal by parent|2
7528710|NCT02608450|11870930|FG001|Overall Study|Withdrawal by parent|3
7528711|NCT02608450|11870929|FG000|Overall Study|Lack of Efficacy|0
7528712|NCT02608450|11870930|FG001|Overall Study|Lack of Efficacy|3
7528713|NCT02608450|11870929|FG000|Overall Study|Noncompliance with study drug|0
7528714|NCT02608450|11870930|FG001|Overall Study|Noncompliance with study drug|2
7528715|NCT02608450|11870929|FG000|Overall Study|Physician Decision|0
7528716|NCT02608450|11870930|FG001|Overall Study|Physician Decision|1
7528717|NCT02608450|11870929|FG000|Overall Study|Pregnancy|0
7413265|NCT01424644|11685501|FG001|Overall Study|Protocol Violation|3
7413266|NCT01424644|11685500|FG000|Overall Study|Administrative Reason|1
7413267|NCT01424644|11685501|FG001|Overall Study|Administrative Reason|0
7413268|NCT01424644|11685500|FG000|Overall Study|Unable to Classify|1
7413269|NCT01424644|11685501|FG001|Overall Study|Unable to Classify|0
7413270|NCT01424670|11685509|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
7413271|NCT01424670|11685510|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
7413272|NCT01424670|11685509|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
7413273|NCT01424670|11685510|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
7413274|NCT01424670|11685509|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
7413275|NCT01424670|11685510|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
7413276|NCT01424670|11685509|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
7413277|NCT01424670|11685510|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
7413278|NCT01424670|11685509|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
7413279|NCT01424670|11685510|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
7413280|NCT01424670|11685509|FG000|Continuation Period|Adverse Event|13
7413281|NCT01424670|11685510|FG001|Continuation Period|Adverse Event|5
7413282|NCT01424670|11685509|FG000|Continuation Period|Lost to Follow-up|2
7413283|NCT01424670|11685510|FG001|Continuation Period|Lost to Follow-up|0
7413284|NCT01424670|11685509|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
7413285|NCT01424670|11685510|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
7413286|NCT01424670|11685509|FG000|Continuation Period|Physician Decision|5
7413287|NCT01424670|11685510|FG001|Continuation Period|Physician Decision|4
7413288|NCT01424670|11685509|FG000|Continuation Period|Withdrawal by Subject|13
7413289|NCT01424670|11685510|FG001|Continuation Period|Withdrawal by Subject|4
7413290|NCT01424722|11685518|FG000|Overall Study|Sponsor terminated investigation|2258
7413291|NCT01424813|11685524|FG000|Overall Study|Withdrawal by Subject|3
7413292|NCT01424813|11685525|FG001|Overall Study|Withdrawal by Subject|0
7413293|NCT01424813|11685524|FG000|Overall Study|Protocol Violation|1
7413294|NCT01424813|11685525|FG001|Overall Study|Protocol Violation|0
7413295|NCT01424813|11685524|FG000|Overall Study|Other|1
7413296|NCT01424813|11685525|FG001|Overall Study|Other|2
7413297|NCT01424930|11685533|FG000|Overall Study|Adverse Event|0
7413298|NCT01424930|11685534|FG001|Overall Study|Adverse Event|1
7413299|NCT01424930|11685533|FG000|Overall Study|Death|1
7413300|NCT01424930|11685534|FG001|Overall Study|Death|0
7413301|NCT01424930|11685533|FG000|Overall Study|Progressive Disease|3
7413302|NCT01424930|11685534|FG001|Overall Study|Progressive Disease|6
7413303|NCT01424930|11685533|FG000|Overall Study|Screen Failure|0
7413304|NCT01424930|11685534|FG001|Overall Study|Screen Failure|1
7413305|NCT01424930|11685533|FG000|Overall Study|Reason not specified|0
7413306|NCT01424930|11685534|FG001|Overall Study|Reason not specified|6
7413307|NCT01425190|11685552|FG000|Overall Study|Full dose not consumed.|1
7528718|NCT02608450|11870930|FG001|Overall Study|Pregnancy|1
7528719|NCT02608450|11870929|FG000|Overall Study|Progressive disease|1
7528720|NCT02608450|11870930|FG001|Overall Study|Progressive disease|0
7317845|NCT00725010|11546904|FG000|Overall Study|No further documentation|1
7317846|NCT00725010|11546904|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
7317847|NCT00725075|11546913|FG000|Overall Study|Use of Excluded Medication|0
7317848|NCT00725075|11546914|FG001|Overall Study|Use of Excluded Medication|1
7317849|NCT00725075|11546915|FG002|Overall Study|Use of Excluded Medication|0
7317850|NCT00725075|11546913|FG000|Overall Study|Protocol Violation|0
7317851|NCT00725075|11546914|FG001|Overall Study|Protocol Violation|0
7317852|NCT00725075|11546915|FG002|Overall Study|Protocol Violation|1
7317853|NCT00725075|11546913|FG000|Overall Study|Lost to Follow-up|1
7317854|NCT00725075|11546914|FG001|Overall Study|Lost to Follow-up|0
7317855|NCT00725075|11546915|FG002|Overall Study|Lost to Follow-up|0
7317856|NCT00725075|11546913|FG000|Overall Study|Withdrawal by Subject|4
7317857|NCT00725075|11546914|FG001|Overall Study|Withdrawal by Subject|5
7317858|NCT00725075|11546915|FG002|Overall Study|Withdrawal by Subject|4
7317859|NCT00725075|11546913|FG000|Overall Study|Adverse Event|2
7317860|NCT00725075|11546914|FG001|Overall Study|Adverse Event|1
7317861|NCT00725075|11546915|FG002|Overall Study|Adverse Event|1
7317862|NCT00725075|11546913|FG000|Overall Study|Worsening of Disease|2
7317863|NCT00725075|11546914|FG001|Overall Study|Worsening of Disease|1
7317864|NCT00725075|11546915|FG002|Overall Study|Worsening of Disease|2
7317865|NCT00725075|11546913|FG000|Overall Study|Inclusion/Exclusion Criteria|1
7317866|NCT00725075|11546914|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7317867|NCT00725075|11546915|FG002|Overall Study|Inclusion/Exclusion Criteria|1
7317868|NCT00725075|11546913|FG000|Overall Study|Other|1
7317869|NCT00725075|11546914|FG001|Overall Study|Other|0
7317870|NCT00725075|11546915|FG002|Overall Study|Other|0
7317871|NCT00725101|11546923|FG000|Overall Study|Death|3
7317872|NCT00725101|11546923|FG000|Overall Study|Lost to Follow-up|353
7317873|NCT00725101|11546923|FG000|Overall Study|Protocol Violation|1
7317874|NCT00725101|11546923|FG000|Overall Study|Withdrawal by Subject|127
7317875|NCT00725101|11546923|FG000|Overall Study|not specified/no reason given|11
7317876|NCT00725205|11546934|FG000|Overall Study|Adverse Event|22
7317877|NCT00725205|11546934|FG000|Overall Study|Investigator Discontinued|1
7317878|NCT00725205|11546934|FG000|Overall Study|Non-compliance With Protocol|14
7317879|NCT00725205|11546934|FG000|Overall Study|Other|8
7317880|NCT00725205|11546934|FG000|Overall Study|Protocol Defined Clinical Event|1
7317881|NCT00725205|11546934|FG000|Overall Study|Treatment Failure|41
7317882|NCT00725283|11546947|FG000|Overall Study|Missing Code|3
7317883|NCT00725283|11546947|FG000|Overall Study|Death|5
7317884|NCT00725283|11546947|FG000|Overall Study|Other|6
7317885|NCT00725283|11546947|FG000|Overall Study|Withdrawal by Subject|10
7317886|NCT00725296|11546951|FG000|Overall Study|Adverse Event|11
7317887|NCT00725296|11546951|FG000|Overall Study|Lack of Efficacy|7
7317888|NCT00725296|11546951|FG000|Overall Study|Withdrawal by Subject|3
7317889|NCT00725296|11546951|FG000|Overall Study|Non-Compliance|2
7317890|NCT00725296|11546951|FG000|Overall Study|Lost to Follow-up|1
7528721|NCT02608450|11870929|FG000|Overall Study|Multiple reasons|0
7528722|NCT02608450|11870930|FG001|Overall Study|Multiple reasons|2
7528723|NCT02608476|11870952|FG000|Overall Study|Withdrawal by Subject|30
7528724|NCT02608476|11870953|FG001|Overall Study|Withdrawal by Subject|37
7528725|NCT02608476|11870952|FG000|Overall Study|Lost to Follow-up|24
7528726|NCT02608476|11870953|FG001|Overall Study|Lost to Follow-up|24
7528727|NCT02608476|11870952|FG000|Overall Study|Adverse Event|2
7528728|NCT02608476|11870953|FG001|Overall Study|Adverse Event|8
7528729|NCT02608476|11870952|FG000|Overall Study|Withdrawal by Parent/Guardian|5
7528730|NCT02608476|11870953|FG001|Overall Study|Withdrawal by Parent/Guardian|4
7528731|NCT02608476|11870952|FG000|Overall Study|Noncompliance with treatment|1
7528732|NCT02608476|11870953|FG001|Overall Study|Noncompliance with treatment|5
7528733|NCT02608476|11870952|FG000|Overall Study|Lack of Efficacy|3
7528734|NCT02608476|11870953|FG001|Overall Study|Lack of Efficacy|1
7528735|NCT02608476|11870952|FG000|Overall Study|Other|0
7528736|NCT02608476|11870953|FG001|Overall Study|Other|1
7528737|NCT02608476|11870952|FG000|Overall Study|Physician Decision|1
7528738|NCT02608476|11870953|FG001|Overall Study|Physician Decision|0
7528739|NCT02608476|11870952|FG000|Overall Study|Pregnancy|0
7528740|NCT02608476|11870953|FG001|Overall Study|Pregnancy|1
7528741|NCT02608476|11870952|FG000|Overall Study|Progressive disease|1
7528742|NCT02608476|11870953|FG001|Overall Study|Progressive disease|0
7528743|NCT02608879|11870971|FG000|Overall Study|Lost to Follow-up|1
7528744|NCT02608879|11870972|FG001|Overall Study|Lost to Follow-up|0
7528745|NCT02608879|11870973|FG002|Overall Study|Lost to Follow-up|0
7528746|NCT02608879|11870971|FG000|Overall Study|Did not meet continuation criteria|0
7528747|NCT02608879|11870972|FG001|Overall Study|Did not meet continuation criteria|0
7528748|NCT02608879|11870973|FG002|Overall Study|Did not meet continuation criteria|3
7528749|NCT02608892|11870983|FG000|Overall Study|Lost to Follow-up|1
7528750|NCT02608892|11870984|FG001|Overall Study|Lost to Follow-up|0
7528751|NCT02609178|11871011|FG000|First Crown|Withdrawal by Subject|0
7528752|NCT02609178|11871012|FG001|First Crown|Withdrawal by Subject|0
7528753|NCT02609178|11871013|FG002|First Crown|Withdrawal by Subject|1
7528754|NCT02609178|11871014|FG003|First Crown|Withdrawal by Subject|1
7528755|NCT02609178|11871015|FG004|First Crown|Withdrawal by Subject|0
7528756|NCT02609178|11871016|FG005|First Crown|Withdrawal by Subject|0
7528757|NCT02609399|11871038|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
7528758|NCT02609399|11871039|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
7528759|NCT02609399|11871038|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
7528760|NCT02609399|11871039|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
7528761|NCT02609399|11871038|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
7528762|NCT02609399|11871039|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
7413308|NCT01425190|11685553|FG001|Overall Study|Full dose not consumed.|0
7413309|NCT01425190|11685554|FG002|Overall Study|Full dose not consumed.|0
7413310|NCT01425203|11685564|FG000|Treatment Phase|DC during PR Lead-in Phase|3
7413311|NCT01425203|11685565|FG001|Treatment Phase|DC during PR Lead-in Phase|1
7413312|NCT01425203|11685566|FG002|Treatment Phase|DC during PR Lead-in Phase|0
7413313|NCT01425203|11685564|FG000|Treatment Phase|Failure at futility timepoint|8
7413314|NCT01425203|11685565|FG001|Treatment Phase|Failure at futility timepoint|27
7413315|NCT01425203|11685566|FG002|Treatment Phase|Failure at futility timepoint|0
7413316|NCT01425203|11685564|FG000|Treatment Phase|Other virologic failure criteria|5
7413317|NCT01425203|11685565|FG001|Treatment Phase|Other virologic failure criteria|3
7413318|NCT01425203|11685566|FG002|Treatment Phase|Other virologic failure criteria|0
7413319|NCT01425203|11685564|FG000|Treatment Phase|Unidentified reasons|11
7413320|NCT01425203|11685565|FG001|Treatment Phase|Unidentified reasons|5
7528763|NCT02609607|11871049|FG000|Overall Study|Lost to Follow-up|0
7413321|NCT01425203|11685566|FG002|Treatment Phase|Unidentified reasons|0
7413322|NCT01425203|11685564|FG000|Treatment Phase|Did not receive treatment|0
7413323|NCT01425203|11685565|FG001|Treatment Phase|Did not receive treatment|1
7413324|NCT01425203|11685566|FG002|Treatment Phase|Did not receive treatment|0
7413325|NCT01425203|11685564|FG000|Crossover Phase|Failure at futility timepoint|0
7413326|NCT01425203|11685565|FG001|Crossover Phase|Failure at futility timepoint|0
7413327|NCT01425203|11685566|FG002|Crossover Phase|Failure at futility timepoint|3
7413328|NCT01425203|11685564|FG000|Crossover Phase|Other virologic failure criteria|0
7413329|NCT01425203|11685565|FG001|Crossover Phase|Other virologic failure criteria|0
7413330|NCT01425203|11685566|FG002|Crossover Phase|Other virologic failure criteria|3
7413331|NCT01425268|11685584|FG000|Overall Study|Withdrawal by Subject|2
7528764|NCT02609607|11871050|FG001|Overall Study|Lost to Follow-up|1
7528765|NCT02609633|11871058|FG000|Overall Study|Consent Withdrawn|0
7528766|NCT02609633|11871059|FG001|Overall Study|Consent Withdrawn|1
7528767|NCT02609633|11871058|FG000|Overall Study|Protocol Deviation|1
7528768|NCT02609633|11871059|FG001|Overall Study|Protocol Deviation|0
7528769|NCT02609633|11871058|FG000|Overall Study|Non-Compliant with Study Procedures|2
7528770|NCT02609633|11871059|FG001|Overall Study|Non-Compliant with Study Procedures|0
7528771|NCT02609633|11871058|FG000|Overall Study|Reason not Specified|2
7528772|NCT02609633|11871059|FG001|Overall Study|Reason not Specified|1
7528773|NCT02609659|11871066|FG000|Overall Study|Adverse Event|1
7528774|NCT02609659|11871066|FG000|Overall Study|Lost to Follow-up|6
7528775|NCT02609659|11871066|FG000|Overall Study|Other|1
7528776|NCT02609672|11871072|FG000|Overall Study|Lost to Follow-up|3
7528777|NCT02609672|11871073|FG001|Overall Study|Lost to Follow-up|1
7413332|NCT01425268|11685585|FG001|Overall Study|Withdrawal by Subject|0
7413333|NCT01425268|11685584|FG000|Overall Study|Sponsor Decision|5
7413334|NCT01425268|11685585|FG001|Overall Study|Sponsor Decision|0
7413335|NCT01425268|11685584|FG000|Overall Study|Physician Decision|1
7413336|NCT01425268|11685585|FG001|Overall Study|Physician Decision|0
7413337|NCT01425359|11685604|FG000|Overall Study|Randomized but Not Treated|2
7413338|NCT01425359|11685605|FG001|Overall Study|Randomized but Not Treated|3
7413339|NCT01425359|11685604|FG000|Overall Study|Adverse Event|9
7528778|NCT02609984|11871089|FG000|Overall Study|Death|29
7528779|NCT02609984|11871090|FG001|Overall Study|Death|26
7528780|NCT02609984|11871089|FG000|Overall Study|Participation Discontinued by Sponsor|12
7528781|NCT02609984|11871090|FG001|Overall Study|Participation Discontinued by Sponsor|10
7528782|NCT02609984|11871089|FG000|Overall Study|Lost to Follow-up|1
7528783|NCT02609984|11871090|FG001|Overall Study|Lost to Follow-up|2
7528784|NCT02609984|11871089|FG000|Overall Study|Withdrawal by Subject|0
7528785|NCT02609984|11871090|FG001|Overall Study|Withdrawal by Subject|1
7528786|NCT02609984|11871089|FG000|Overall Study|Disease Progression|2
7528787|NCT02609984|11871090|FG001|Overall Study|Disease Progression|0
7528788|NCT02610140|11871098|FG000|Randomization and Treatment Period|Radiological progression|23
7528789|NCT02610140|11871099|FG001|Randomization and Treatment Period|Radiological progression|15
7528790|NCT02610140|11871098|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
7528791|NCT02610140|11871099|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
7528792|NCT02610140|11871098|FG000|Randomization and Treatment Period|Protocol Violation|1
7413340|NCT01425359|11685605|FG001|Overall Study|Adverse Event|8
7413341|NCT01425359|11685604|FG000|Overall Study|Revascularization|0
7413342|NCT01425359|11685605|FG001|Overall Study|Revascularization|1
7413343|NCT01425359|11685604|FG000|Overall Study|Death|0
7413344|NCT01425359|11685605|FG001|Overall Study|Death|1
7413345|NCT01425359|11685604|FG000|Overall Study|Unsatisfactory Response|1
7413346|NCT01425359|11685605|FG001|Overall Study|Unsatisfactory Response|0
7413347|NCT01425359|11685604|FG000|Overall Study|Protocol Violation|1
7413348|NCT01425359|11685605|FG001|Overall Study|Protocol Violation|2
7413349|NCT01425359|11685604|FG000|Overall Study|Subject Withdrew Consent|1
7413350|NCT01425359|11685605|FG001|Overall Study|Subject Withdrew Consent|2
7413351|NCT01425359|11685604|FG000|Overall Study|Investigator's Discretion|2
7413352|NCT01425359|11685605|FG001|Overall Study|Investigator's Discretion|0
7413353|NCT01425359|11685604|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
7413354|NCT01425359|11685605|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
7413355|NCT01425463|11685614|FG000|Overall Study|Adverse Event|5
7413356|NCT01425463|11685615|FG001|Overall Study|Adverse Event|7
7413357|NCT01425463|11685614|FG000|Overall Study|Lack of Efficacy|1
7413358|NCT01425463|11685615|FG001|Overall Study|Lack of Efficacy|1
7413359|NCT01425463|11685614|FG000|Overall Study|Protocol Violation|2
7413360|NCT01425463|11685615|FG001|Overall Study|Protocol Violation|2
7413361|NCT01425463|11685614|FG000|Overall Study|Lost to Follow-up|5
7413362|NCT01425463|11685615|FG001|Overall Study|Lost to Follow-up|2
7413363|NCT01425463|11685614|FG000|Overall Study|Withdrawal by Subject|7
7413364|NCT01425463|11685615|FG001|Overall Study|Withdrawal by Subject|5
7413365|NCT01425463|11685614|FG000|Overall Study|Unknown Reason|4
7413366|NCT01425463|11685615|FG001|Overall Study|Unknown Reason|7
7413367|NCT01425528|11685623|FG000|Overall Study|Withdrawal by Subject|1
7413368|NCT01425528|11685624|FG001|Overall Study|Withdrawal by Subject|1
7413369|NCT01425281|11685632|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
7413370|NCT01425281|11685633|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
7413371|NCT01425281|11685632|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
7413372|NCT01425281|11685633|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
7413373|NCT01425281|11685632|FG000|At 180-day Clinical Follow-up|Death|0
7413374|NCT01425281|11685633|FG001|At 180-day Clinical Follow-up|Death|1
7413375|NCT01425281|11685632|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7528793|NCT02610140|11871099|FG001|Randomization and Treatment Period|Protocol Violation|0
7413376|NCT01425281|11685633|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
7413377|NCT01425281|11685632|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
7413378|NCT01425281|11685633|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
7413379|NCT01425281|11685632|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
7413380|NCT01425281|11685633|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
7413381|NCT01425281|11685632|FG000|At 2-year Clinical Follow-up|Death|2
7413382|NCT01425281|11685633|FG001|At 2-year Clinical Follow-up|Death|0
7413383|NCT01425281|11685632|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
7413384|NCT01425281|11685633|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
7413385|NCT01425281|11685632|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
7413386|NCT01425281|11685633|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
7413387|NCT01425281|11685632|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7413388|NCT01425281|11685633|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
7413389|NCT01425281|11685632|FG000|At 3-year Clinical Follow-up|Death|2
7413390|NCT01425281|11685633|FG001|At 3-year Clinical Follow-up|Death|3
7413391|NCT01425281|11685632|FG000|At 4-year Clinical Follow-up|Death|7
7413392|NCT01425281|11685633|FG001|At 4-year Clinical Follow-up|Death|3
7413393|NCT01425281|11685632|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
7413394|NCT01425281|11685633|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
7413395|NCT01425281|11685632|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7413396|NCT01425281|11685633|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
7413397|NCT01425281|11685632|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
7413398|NCT01425281|11685633|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
7413399|NCT01425281|11685632|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
7413400|NCT01425281|11685633|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
7413401|NCT01425281|11685632|FG000|At 5-year Clinical Follow-up|Death|2
7413402|NCT01425281|11685633|FG001|At 5-year Clinical Follow-up|Death|0
7413403|NCT01425281|11685632|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
7413404|NCT01425281|11685633|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
7413405|NCT01425281|11685632|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
7413406|NCT01425281|11685633|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
7413407|NCT01425281|11685632|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
7413408|NCT01425281|11685633|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
7413409|NCT01425632|11685643|FG000|Overall Study|Adverse Event|0
7413410|NCT01425632|11685644|FG001|Overall Study|Adverse Event|1
7413411|NCT01425632|11685645|FG002|Overall Study|Adverse Event|1
7413412|NCT01425632|11685643|FG000|Overall Study|Physician Decision|1
7413413|NCT01425632|11685644|FG001|Overall Study|Physician Decision|0
7413414|NCT01425632|11685645|FG002|Overall Study|Physician Decision|0
7528794|NCT02610140|11871098|FG000|Randomization and Treatment Period|Physician Decision|0
7528795|NCT02610140|11871099|FG001|Randomization and Treatment Period|Physician Decision|1
7528796|NCT02610140|11871098|FG000|Randomization and Treatment Period|Lack of Efficacy|1
7528797|NCT02610140|11871099|FG001|Randomization and Treatment Period|Lack of Efficacy|0
7528798|NCT02610140|11871098|FG000|Randomization and Treatment Period|Death|7
7528799|NCT02610140|11871099|FG001|Randomization and Treatment Period|Death|1
7528800|NCT02610140|11871098|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
7528801|NCT02610140|11871099|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
7528802|NCT02610140|11871098|FG000|Randomization and Treatment Period|Adverse Event|44
7528803|NCT02610140|11871099|FG001|Randomization and Treatment Period|Adverse Event|13
7528804|NCT02610140|11871098|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
7528805|NCT02610140|11871099|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
7528806|NCT02610140|11871098|FG000|Randomization and Treatment Period|Ongoing but not completed|9
7528807|NCT02610140|11871099|FG001|Randomization and Treatment Period|Ongoing but not completed|2
7528808|NCT02610140|11871098|FG000|Randomization and Treatment Period|Not treated|3
7528809|NCT02610140|11871099|FG001|Randomization and Treatment Period|Not treated|10
7528810|NCT02610140|11871098|FG000|Safety Follow-up|Other|0
7528811|NCT02610140|11871099|FG001|Safety Follow-up|Other|2
7528812|NCT02610140|11871098|FG000|Safety Follow-up|Lost to Follow-up|1
7528813|NCT02610140|11871099|FG001|Safety Follow-up|Lost to Follow-up|0
7528814|NCT02610140|11871098|FG000|Safety Follow-up|No follow-up|5
7528815|NCT02610140|11871099|FG001|Safety Follow-up|No follow-up|3
7528816|NCT02610140|11871098|FG000|Safety Follow-up|Death|12
7528817|NCT02610140|11871099|FG001|Safety Follow-up|Death|2
7528818|NCT02610140|11871098|FG000|Safety Follow-up|Deterioration of general conditions|15
7528819|NCT02610140|11871099|FG001|Safety Follow-up|Deterioration of general conditions|5
7528820|NCT02610140|11871098|FG000|Safety Follow-up|Withdrawal by Subject|12
7528821|NCT02610140|11871099|FG001|Safety Follow-up|Withdrawal by Subject|12
7528822|NCT02610140|11871098|FG000|Active Follow-up|Progressive disease - radiological|30
7528823|NCT02610140|11871099|FG001|Active Follow-up|Progressive disease - radiological|22
7528824|NCT02610140|11871098|FG000|Active Follow-up|Death|8
7528825|NCT02610140|11871099|FG001|Active Follow-up|Death|1
7528826|NCT02610140|11871098|FG000|Active Follow-up|Withdrawal by Subject|4
7528827|NCT02610140|11871099|FG001|Active Follow-up|Withdrawal by Subject|0
7528828|NCT02610140|11871098|FG000|Active Follow-up|Progressive disease - clinical|1
7528829|NCT02610140|11871099|FG001|Active Follow-up|Progressive disease - clinical|2
7528830|NCT02610140|11871098|FG000|Active Follow-up|Deterioration of general conditions|1
7528831|NCT02610140|11871099|FG001|Active Follow-up|Deterioration of general conditions|0
7528832|NCT02610140|11871098|FG000|Active Follow-up|Ongoing but not completed|4
7528833|NCT02610140|11871099|FG001|Active Follow-up|Ongoing but not completed|1
7528834|NCT02610140|11871098|FG000|Long-term Follow-up|Death|86
7528835|NCT02610140|11871099|FG001|Long-term Follow-up|Death|44
7528836|NCT02610140|11871098|FG000|Long-term Follow-up|Withdrawal by Subject|6
7528837|NCT02610140|11871099|FG001|Long-term Follow-up|Withdrawal by Subject|3
7528838|NCT02610140|11871098|FG000|Long-term Follow-up|Lost to Follow-up|1
7528839|NCT02610140|11871099|FG001|Long-term Follow-up|Lost to Follow-up|2
7528840|NCT02610140|11871098|FG000|Long-term Follow-up|Ongoing but not completed|30
7528841|NCT02610140|11871099|FG001|Long-term Follow-up|Ongoing but not completed|17
7528842|NCT02610192|11871105|FG000|Overall Study|Received other treatment|8
7528843|NCT02610192|11871105|FG000|Overall Study|Physician Decision|1
7528844|NCT02610231|11871109|FG000|Overall Study|Withdrawal by Subject|27
7528845|NCT02610231|11871109|FG000|Overall Study|Adverse Event|20
7256768|NCT00325468|11468503|FG003|Overall Study|Physician Decision|1
7413415|NCT01425632|11685643|FG000|Overall Study|Protocol Violation|0
7413416|NCT01425632|11685644|FG001|Overall Study|Protocol Violation|0
7413417|NCT01425632|11685645|FG002|Overall Study|Protocol Violation|2
7413418|NCT01425632|11685643|FG000|Overall Study|Withdrawal by Subject|0
7413419|NCT01425632|11685644|FG001|Overall Study|Withdrawal by Subject|0
7413420|NCT01425632|11685645|FG002|Overall Study|Withdrawal by Subject|1
7413421|NCT01425723|11685655|FG000|Overall Study|Lack of Efficacy|0
7413422|NCT01425723|11685656|FG001|Overall Study|Lack of Efficacy|1
7528846|NCT02610231|11871109|FG000|Overall Study|Death|5
7528847|NCT02610231|11871109|FG000|Overall Study|Surgery|2
7528848|NCT02610231|11871109|FG000|Overall Study|Physician Decision|1
7528849|NCT02610231|11871109|FG000|Overall Study|Non Compliance|2
7413423|NCT01425723|11685655|FG000|Overall Study|Withdrawal by Subject|1
7413424|NCT01425723|11685656|FG001|Overall Study|Withdrawal by Subject|4
7413425|NCT01425723|11685655|FG000|Overall Study|Lost to Follow-up|0
7413426|NCT01425723|11685656|FG001|Overall Study|Lost to Follow-up|3
7413427|NCT01425723|11685655|FG000|Overall Study|Physician Decision|2
7413428|NCT01425723|11685656|FG001|Overall Study|Physician Decision|0
7413429|NCT01425723|11685655|FG000|Overall Study|Other|1
7413430|NCT01425723|11685656|FG001|Overall Study|Other|10
7413431|NCT01425749|11685673|FG000|Overall Study|progression of melanoma|0
7413432|NCT01425749|11685674|FG001|Overall Study|progression of melanoma|1
7413433|NCT01425801|11685683|FG000|Period 1|Withdrawal by Subject|0
7413434|NCT01425801|11685684|FG001|Period 1|Withdrawal by Subject|0
7413435|NCT01425801|11685685|FG002|Period 1|Withdrawal by Subject|0
7413436|NCT01425801|11685686|FG003|Period 1|Withdrawal by Subject|0
7413437|NCT01425801|11685687|FG004|Period 1|Withdrawal by Subject|1
7413438|NCT01425801|11685688|FG005|Period 1|Withdrawal by Subject|0
7413439|NCT01425801|11685683|FG000|Period 2|Withdrawal by Subject|0
7413440|NCT01425801|11685684|FG001|Period 2|Withdrawal by Subject|0
7413441|NCT01425801|11685685|FG002|Period 2|Withdrawal by Subject|0
7413442|NCT01425801|11685686|FG003|Period 2|Withdrawal by Subject|0
7413443|NCT01425801|11685687|FG004|Period 2|Withdrawal by Subject|1
7413444|NCT01425801|11685688|FG005|Period 2|Withdrawal by Subject|0
7413445|NCT01425801|11685683|FG000|Period 3|Stability criteria not fullfilled|0
7413446|NCT01425801|11685684|FG001|Period 3|Stability criteria not fullfilled|0
7413447|NCT01425801|11685685|FG002|Period 3|Stability criteria not fullfilled|1
7413448|NCT01425801|11685686|FG003|Period 3|Stability criteria not fullfilled|0
7413449|NCT01425801|11685687|FG004|Period 3|Stability criteria not fullfilled|0
7413450|NCT01425801|11685688|FG005|Period 3|Stability criteria not fullfilled|0
7413451|NCT01425801|11685683|FG000|Period 4|Not able to maintain visit schedule|0
7413452|NCT01425801|11685684|FG001|Period 4|Not able to maintain visit schedule|0
7413453|NCT01425801|11685685|FG002|Period 4|Not able to maintain visit schedule|1
7413454|NCT01425801|11685686|FG003|Period 4|Not able to maintain visit schedule|0
7413455|NCT01425801|11685687|FG004|Period 4|Not able to maintain visit schedule|0
7413456|NCT01425801|11685688|FG005|Period 4|Not able to maintain visit schedule|0
7413457|NCT01425814|11685702|FG000|Period 1|Stability criteria not fulfilled|0
7413458|NCT01425814|11685703|FG001|Period 1|Stability criteria not fulfilled|1
7413459|NCT01425814|11685704|FG002|Period 1|Stability criteria not fulfilled|0
7413460|NCT01425814|11685705|FG003|Period 1|Stability criteria not fulfilled|0
7413461|NCT01425814|11685706|FG004|Period 1|Stability criteria not fulfilled|0
7413462|NCT01425814|11685707|FG005|Period 1|Stability criteria not fulfilled|0
7413463|NCT01425814|11685702|FG000|Period 2|Stability criteria not fulfilled|0
7528850|NCT02610231|11871109|FG000|Overall Study|Other|3
7528851|NCT02610725|11871125|FG000|Overall Study|Lost to Follow-up|197
7528852|NCT02610725|11871125|FG000|Overall Study|self-reported contraindication|9
7528853|NCT02610816|11871131|FG000|Phase 1|Withdrawal by Subject|2
7528854|NCT02610816|11871132|FG001|Phase 1|Withdrawal by Subject|6
7528855|NCT02610816|11871133|FG002|Phase 1|Withdrawal by Subject|0
7528856|NCT02610816|11871134|FG003|Phase 1|Withdrawal by Subject|0
7528857|NCT02610816|11871131|FG000|Phase 1|Lost to Follow-up|2
7528858|NCT02610816|11871132|FG001|Phase 1|Lost to Follow-up|1
7528859|NCT02610816|11871133|FG002|Phase 1|Lost to Follow-up|0
7528860|NCT02610816|11871134|FG003|Phase 1|Lost to Follow-up|0
7528861|NCT02610816|11871131|FG000|Phase 1|Physician Decision|0
7528862|NCT02610816|11871132|FG001|Phase 1|Physician Decision|1
7528863|NCT02610816|11871133|FG002|Phase 1|Physician Decision|0
7528864|NCT02610816|11871134|FG003|Phase 1|Physician Decision|0
7528865|NCT02610816|11871131|FG000|Phase 2|Withdrawal by Subject|0
7528866|NCT02610816|11871132|FG001|Phase 2|Withdrawal by Subject|0
7528867|NCT02610816|11871133|FG002|Phase 2|Withdrawal by Subject|9
7528868|NCT02610816|11871134|FG003|Phase 2|Withdrawal by Subject|3
7528869|NCT02610816|11871131|FG000|Phase 2|Lost to Follow-up|0
7413464|NCT01425814|11685703|FG001|Period 2|Stability criteria not fulfilled|1
7413465|NCT01425814|11685704|FG002|Period 2|Stability criteria not fulfilled|0
7413466|NCT01425814|11685705|FG003|Period 2|Stability criteria not fulfilled|0
7413467|NCT01425814|11685706|FG004|Period 2|Stability criteria not fulfilled|0
7528870|NCT02610816|11871132|FG001|Phase 2|Lost to Follow-up|0
7528871|NCT02610816|11871133|FG002|Phase 2|Lost to Follow-up|2
7528872|NCT02610816|11871134|FG003|Phase 2|Lost to Follow-up|0
7528873|NCT02610816|11871131|FG000|Phase 2|Physician Decision|0
7413468|NCT01425814|11685707|FG005|Period 2|Stability criteria not fulfilled|0
7528874|NCT02610816|11871132|FG001|Phase 2|Physician Decision|0
7413469|NCT01425814|11685702|FG000|Period 3|Adverse Event|0
7413470|NCT01425814|11685703|FG001|Period 3|Adverse Event|0
7413471|NCT01425814|11685704|FG002|Period 3|Adverse Event|0
7413472|NCT01425814|11685705|FG003|Period 3|Adverse Event|0
7413473|NCT01425814|11685706|FG004|Period 3|Adverse Event|0
7413474|NCT01425814|11685707|FG005|Period 3|Adverse Event|1
7528875|NCT02610816|11871133|FG002|Phase 2|Physician Decision|0
7528876|NCT02610816|11871134|FG003|Phase 2|Physician Decision|2
7528877|NCT02610816|11871131|FG000|Phase 2|Pregnancy|0
7528878|NCT02610816|11871132|FG001|Phase 2|Pregnancy|0
7528879|NCT02610816|11871133|FG002|Phase 2|Pregnancy|0
7528880|NCT02610816|11871134|FG003|Phase 2|Pregnancy|1
7528881|NCT02610842|11871144|FG000|Overall Study|Lost to Follow-up|5
7528882|NCT02611362|11871200|FG000|Overall Study|Withdrawal by Subject|7
7528883|NCT02611362|11871201|FG001|Overall Study|Withdrawal by Subject|2
7528884|NCT02611362|11871200|FG000|Overall Study|Lost to Follow-up|2
7528885|NCT02611362|11871201|FG001|Overall Study|Lost to Follow-up|4
7528886|NCT02611479|11871208|FG000|Baseline Enrollment|Exited study|13
7413475|NCT01425814|11685702|FG000|Period 4|Adverse Event|1
7413476|NCT01425814|11685703|FG001|Period 4|Adverse Event|0
7413477|NCT01425814|11685704|FG002|Period 4|Adverse Event|1
7413478|NCT01425814|11685705|FG003|Period 4|Adverse Event|0
7413479|NCT01425814|11685706|FG004|Period 4|Adverse Event|0
7413480|NCT01425814|11685707|FG005|Period 4|Adverse Event|0
7413481|NCT01425814|11685702|FG000|Period 5|Stability criteria not fulfilled|0
7413482|NCT01425814|11685703|FG001|Period 5|Stability criteria not fulfilled|0
7528887|NCT02611479|11871208|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
7528888|NCT02611479|11871208|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
7528889|NCT02611479|11871208|FG000|Data Cleaning|No baseline function or pain metrics|2
7528890|NCT02611752|11871214|FG000|Overall Study|Adverse Event|0
7528891|NCT02611752|11871215|FG001|Overall Study|Adverse Event|1
7528892|NCT02611778|11871245|FG000|Overall Study|Withdrawal by Subject|2
7528893|NCT02611778|11871246|FG001|Overall Study|Withdrawal by Subject|8
7528894|NCT02611778|11871245|FG000|Overall Study|Adverse Event|1
7528895|NCT02611778|11871246|FG001|Overall Study|Adverse Event|2
7528896|NCT02611778|11871245|FG000|Overall Study|Death|2
7528897|NCT02611778|11871246|FG001|Overall Study|Death|1
7528898|NCT02611778|11871245|FG000|Overall Study|Protocol Violation|1
7528899|NCT02611778|11871246|FG001|Overall Study|Protocol Violation|0
7528900|NCT02611778|11871245|FG000|Overall Study|Lost to Follow-up|3
7528901|NCT02611778|11871246|FG001|Overall Study|Lost to Follow-up|1
7528902|NCT02611778|11871245|FG000|Overall Study|Need for alternative treatment|1
7528903|NCT02611778|11871246|FG001|Overall Study|Need for alternative treatment|0
7528904|NCT02611778|11871245|FG000|Overall Study|Other Reason|2
7528905|NCT02611778|11871246|FG001|Overall Study|Other Reason|1
7528906|NCT02611882|11871256|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
7528907|NCT02611882|11871257|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7528908|NCT02611882|11871258|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
7528909|NCT02612064|11871267|FG000|Overall Study|Withdrawal by Subject|1
7528910|NCT02612064|11871268|FG001|Overall Study|Withdrawal by Subject|1
7528911|NCT02612064|11871267|FG000|Overall Study|Other|0
7528912|NCT02612064|11871268|FG001|Overall Study|Other|2
7528913|NCT02612077|11871274|FG000|Overall Study|Adverse Event|3
7528914|NCT02612077|11871274|FG000|Overall Study|Withdrawal by Subject|9
7528915|NCT02612077|11871274|FG000|Overall Study|Protocol Violation|28
7528916|NCT02612077|11871274|FG000|Overall Study|Lost to Follow-up|20
7528917|NCT02612077|11871274|FG000|Overall Study|Death|377
7528918|NCT02612077|11871274|FG000|Overall Study|Moved or Changed Medical Team|23
7528919|NCT02612077|11871274|FG000|Overall Study|Enrollment in a Clinical Trial|1
7224871|NCT00062647|11434351|FG001|Overall Study|Failed continuation criteria|2
7224872|NCT00062647|11434350|FG000|Overall Study|Other|4
7413483|NCT01425814|11685704|FG002|Period 5|Stability criteria not fulfilled|1
7413484|NCT01425814|11685705|FG003|Period 5|Stability criteria not fulfilled|0
7413485|NCT01425814|11685706|FG004|Period 5|Stability criteria not fulfilled|0
7413486|NCT01425814|11685707|FG005|Period 5|Stability criteria not fulfilled|1
7413487|NCT01426009|11685735|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
7528920|NCT02612077|11871274|FG000|Overall Study|Disease Progression|3
7528921|NCT02612077|11871274|FG000|Overall Study|Unknown reason|2
7413488|NCT01426009|11685735|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
7413489|NCT01426009|11685735|FG000|Washout 1|Withdrawal by Subject|1
7528922|NCT02612155|11871283|FG000|Overall Study|Death|1
7528923|NCT02612155|11871284|FG001|Overall Study|Death|1
7528924|NCT02612155|11871283|FG000|Overall Study|Lost to Follow-up|2
7528925|NCT02612155|11871284|FG001|Overall Study|Lost to Follow-up|2
7528926|NCT02612428|11871292|FG000|VTL-308|Death|14
7528927|NCT02612428|11871293|FG001|VTL-308|Death|16
7528928|NCT02612428|11871292|FG000|VTL-308|Withdrawal by Subject|0
7528929|NCT02612428|11871293|FG001|VTL-308|Withdrawal by Subject|1
7528930|NCT02612428|11871292|FG000|VTL-308E|Death|9
7528931|NCT02612428|11871293|FG001|VTL-308E|Death|7
7528932|NCT02612428|11871292|FG000|VTL-308E|Lost to Follow-up|2
7528933|NCT02612428|11871293|FG001|VTL-308E|Lost to Follow-up|0
7528934|NCT02612610|11871303|FG000|Overall Study|Withdrawal by Subject|1
7528935|NCT02612610|11871304|FG001|Overall Study|Withdrawal by Subject|1
7528936|NCT02612610|11871305|FG002|Overall Study|Withdrawal by Subject|0
7528937|NCT02612610|11871306|FG003|Overall Study|Withdrawal by Subject|2
7528938|NCT02612610|11871303|FG000|Overall Study|Adverse Event|2
7528939|NCT02612610|11871304|FG001|Overall Study|Adverse Event|2
7528940|NCT02612610|11871305|FG002|Overall Study|Adverse Event|3
7528941|NCT02612610|11871306|FG003|Overall Study|Adverse Event|10
7528942|NCT02612610|11871303|FG000|Overall Study|Lost to Follow-up|0
7528943|NCT02612610|11871304|FG001|Overall Study|Lost to Follow-up|1
7528944|NCT02612610|11871305|FG002|Overall Study|Lost to Follow-up|0
7528945|NCT02612610|11871306|FG003|Overall Study|Lost to Follow-up|0
7528946|NCT02612610|11871303|FG000|Overall Study|Protocol Violation|0
7528947|NCT02612610|11871304|FG001|Overall Study|Protocol Violation|1
7528948|NCT02612610|11871305|FG002|Overall Study|Protocol Violation|1
7528949|NCT02612610|11871306|FG003|Overall Study|Protocol Violation|0
7528950|NCT02612610|11871303|FG000|Overall Study|Lack of Efficacy|1
7528951|NCT02612610|11871304|FG001|Overall Study|Lack of Efficacy|2
7528952|NCT02612610|11871305|FG002|Overall Study|Lack of Efficacy|0
7528953|NCT02612610|11871306|FG003|Overall Study|Lack of Efficacy|1
7528954|NCT02612610|11871303|FG000|Overall Study|Physician Decision|0
7528955|NCT02612610|11871304|FG001|Overall Study|Physician Decision|1
7528956|NCT02612610|11871305|FG002|Overall Study|Physician Decision|0
7528957|NCT02612610|11871306|FG003|Overall Study|Physician Decision|0
7528958|NCT02612610|11871303|FG000|Overall Study|Noncompliance|1
7528959|NCT02612610|11871304|FG001|Overall Study|Noncompliance|0
7528960|NCT02612610|11871305|FG002|Overall Study|Noncompliance|0
7528961|NCT02612610|11871306|FG003|Overall Study|Noncompliance|0
7528962|NCT02612610|11871303|FG000|Overall Study|Cough Improvement|0
7528963|NCT02612610|11871304|FG001|Overall Study|Cough Improvement|0
7528964|NCT02612610|11871305|FG002|Overall Study|Cough Improvement|1
7528965|NCT02612610|11871306|FG003|Overall Study|Cough Improvement|0
7528966|NCT02612623|11871320|FG000|Overall Study|Withdrawal by Subject|0
7528967|NCT02612623|11871321|FG001|Overall Study|Withdrawal by Subject|1
7413490|NCT01426009|11685735|FG000|Washout 1|Personal Reasons|1
7413491|NCT01426009|11685735|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
7413492|NCT01426009|11685735|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
7413493|NCT01426009|11685735|FG000|Washout 2|electrive surgery|1
7413494|NCT01426009|11685735|FG000|Washout 3|personal reasons|1
7528968|NCT02612623|11871322|FG002|Overall Study|Withdrawal by Subject|0
7528969|NCT02612623|11871323|FG003|Overall Study|Withdrawal by Subject|0
7528970|NCT02612623|11871320|FG000|Overall Study|Adverse Event|1
7528971|NCT02612623|11871321|FG001|Overall Study|Adverse Event|0
7528972|NCT02612623|11871322|FG002|Overall Study|Adverse Event|1
7528973|NCT02612623|11871323|FG003|Overall Study|Adverse Event|0
7537535|NCT03689374|11886445|FG001|Treatment Period (Week 0 to 52)|Death|11
7537536|NCT03689374|11886446|FG002|Treatment Period (Week 0 to 52)|Death|1
7537537|NCT03639311|11886454|FG000|Overall Study|Ongoing at the time of analysis|88
7537538|NCT03639311|11886455|FG001|Overall Study|Ongoing at the time of analysis|0
7537539|NCT03639311|11886454|FG000|Overall Study|Lost to Follow-up|1
7537540|NCT03639311|11886455|FG001|Overall Study|Lost to Follow-up|0
7537541|NCT03639311|11886454|FG000|Overall Study|Adverse Event|1
7537542|NCT03639311|11886455|FG001|Overall Study|Adverse Event|0
7413495|NCT01426009|11685735|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
7413496|NCT01426009|11685735|FG000|Washout 4|Lost to Follow-up|1
7413497|NCT01426217|11685757|FG000|Overall Study|lost sample|8
7413498|NCT01426217|11685758|FG001|Overall Study|lost sample|14
7413538|NCT01426347|11685787|FG000|Overall Study|Lost to Follow-up|0
7413539|NCT01426347|11685788|FG001|Overall Study|Lost to Follow-up|3
7413540|NCT01426347|11685787|FG000|Overall Study|Protocol Violation|2
7413541|NCT01426347|11685788|FG001|Overall Study|Protocol Violation|0
7528974|NCT02612727|11871346|FG000|Overall Study|Parent request|4
7528975|NCT02612727|11871347|FG001|Overall Study|Parent request|1
7528976|NCT02612727|11871346|FG000|Overall Study|Needed treatment incompatible with PT|1
7528977|NCT02612727|11871347|FG001|Overall Study|Needed treatment incompatible with PT|1
7528978|NCT02612727|11871346|FG000|Overall Study|Direct hyperbilirubinemia|0
7528979|NCT02612727|11871347|FG001|Overall Study|Direct hyperbilirubinemia|2
7413542|NCT01426347|11685787|FG000|Overall Study|Withdrawal by Subject|5
7413543|NCT01426347|11685788|FG001|Overall Study|Withdrawal by Subject|0
7413544|NCT01426373|11685803|FG000|Overall Study|Adverse Event|6
7413545|NCT01426373|11685803|FG000|Overall Study|Lost to Follow-up|14
7413546|NCT01426373|11685803|FG000|Overall Study|Participant Convenience|10
7413547|NCT01426373|11685803|FG000|Overall Study|Miscellaneous Reasons|4
7413548|NCT01426386|11685815|FG000|Overall Study|Adverse Event|0
7413549|NCT01426386|11685816|FG001|Overall Study|Adverse Event|1
7413550|NCT01426386|11685817|FG002|Overall Study|Adverse Event|0
7413551|NCT01426386|11685818|FG003|Overall Study|Adverse Event|0
7413552|NCT01426386|11685819|FG004|Overall Study|Adverse Event|0
7413553|NCT01426386|11685820|FG005|Overall Study|Adverse Event|0
7413554|NCT01426386|11685815|FG000|Overall Study|Did not attend scheduled visit|1
7413555|NCT01426386|11685816|FG001|Overall Study|Did not attend scheduled visit|4
7466349|NCT01890915|11766149|FG000|Overall Study|Adverse Event|1
7317891|NCT00725296|11546951|FG000|Overall Study|Other|38
7317892|NCT00725322|11546958|FG000|Washout (28 Days)|Withdrawal by Subject|2
7317893|NCT00725322|11546959|FG001|Washout (28 Days)|Withdrawal by Subject|0
7317894|NCT00725322|11546958|FG000|Washout (28 Days)|Protocol Violation|0
7317895|NCT00725322|11546959|FG001|Washout (28 Days)|Protocol Violation|1
7317896|NCT00725452|11546969|FG000|Overall Study|Adverse Event|3
7528980|NCT02612779|11871355|FG000|Overall Study|Administrative reason by sponsor|4
7528981|NCT02612779|11871356|FG001|Overall Study|Administrative reason by sponsor|1
7317897|NCT00725452|11546969|FG000|Overall Study|Lack of Efficacy|2
7317898|NCT00725452|11546969|FG000|Overall Study|Reason not specified|1
7317899|NCT00725452|11546969|FG000|Overall Study|Physician Decision|1
7317900|NCT00725452|11546969|FG000|Overall Study|Withdrawal by Subject|3
7317901|NCT00725452|11546969|FG000|Overall Study|Lost to Follow-up|1
7317902|NCT00725543|11546987|FG000|Overall Study|Adverse Event|10
7317903|NCT00725543|11546987|FG000|Overall Study|Lack of Efficacy|3
7317904|NCT00725543|11546987|FG000|Overall Study|Withdrawal by Subject|10
7317905|NCT00725543|11546987|FG000|Overall Study|Physician Decision|5
7317906|NCT00725543|11546987|FG000|Overall Study|Lost to Follow-up|4
7317907|NCT00725543|11546987|FG000|Overall Study|Non-compliance|2
7528982|NCT02612779|11871355|FG000|Overall Study|No longer meet study criteria|0
7317908|NCT00725543|11546987|FG000|Overall Study|Other|119
7317909|NCT00725608|11546991|FG000|Overall Study|Lost to Follow-up|60
7317910|NCT00725608|11546991|FG000|Overall Study|Adverse Event|14
7317911|NCT00725608|11546991|FG000|Overall Study|Individual reasons|86
7317912|NCT00725608|11546991|FG000|Overall Study|Other|7
7317913|NCT00725621|11546995|FG000|Overall Study|Adverse Event|25
7317914|NCT00725621|11546995|FG000|Overall Study|Lack of Efficacy|46
7317915|NCT00725621|11546995|FG000|Overall Study|Withdrawal by Subject|57
7317916|NCT00725621|11546995|FG000|Overall Study|Physician Decision|19
7317917|NCT00725621|11546995|FG000|Overall Study|Lost to Follow-up|52
7317918|NCT00725621|11546995|FG000|Overall Study|Non-compliance|8
7317919|NCT00725621|11546995|FG000|Overall Study|Continued treatment by other physician|6
7317920|NCT00725621|11546995|FG000|Overall Study|Switched to other study|1
7317921|NCT00725621|11546995|FG000|Overall Study|Switched to other drug|1
7317922|NCT00725621|11546995|FG000|Overall Study|Prepared for elective surgery|1
7528983|NCT02612779|11871356|FG001|Overall Study|No longer meet study criteria|1
7528984|NCT02612779|11871355|FG000|Overall Study|Disease progression|29
7528985|NCT02612779|11871356|FG001|Overall Study|Disease progression|2
7317923|NCT00725621|11546995|FG000|Overall Study|Reason not specified|55
7317924|NCT00725712|11547005|FG000|Overall Study|Withdrawal by Subject|2
7317925|NCT00725712|11547006|FG001|Overall Study|Withdrawal by Subject|1
7317926|NCT00725712|11547005|FG000|Overall Study|Protocol Violation|1
7317927|NCT00725712|11547006|FG001|Overall Study|Protocol Violation|0
7528986|NCT02612779|11871355|FG000|Overall Study|Study drug toxicity|10
7528987|NCT02612779|11871356|FG001|Overall Study|Study drug toxicity|1
7528988|NCT02612779|11871355|FG000|Overall Study|Death|1
7528989|NCT02612779|11871356|FG001|Overall Study|Death|0
7528990|NCT02612779|11871355|FG000|Overall Study|Adverse event unrelated to study drug|5
7528991|NCT02612779|11871356|FG001|Overall Study|Adverse event unrelated to study drug|0
7528992|NCT02612779|11871355|FG000|Overall Study|Participant withdrew consent|4
7528993|NCT02612779|11871356|FG001|Overall Study|Participant withdrew consent|0
7528994|NCT02612779|11871355|FG000|Overall Study|Lost to Follow-up|1
7528995|NCT02612779|11871356|FG001|Overall Study|Lost to Follow-up|0
7528996|NCT02612779|11871355|FG000|Overall Study|Maximum clinical benefit|10
7528997|NCT02612779|11871356|FG001|Overall Study|Maximum clinical benefit|1
7528998|NCT02612779|11871355|FG000|Overall Study|Other reasons|4
7528999|NCT02612779|11871356|FG001|Overall Study|Other reasons|0
7529000|NCT02612909|11871381|FG000|Phase 2|Withdrawal by Subject|2
7317928|NCT00725712|11547005|FG000|Overall Study|Progressive disease|37
7529001|NCT02612909|11871382|FG001|Phase 2|Withdrawal by Subject|5
7529002|NCT02612909|11871383|FG002|Phase 2|Withdrawal by Subject|0
7413556|NCT01426386|11685817|FG002|Overall Study|Did not attend scheduled visit|0
7413557|NCT01426386|11685818|FG003|Overall Study|Did not attend scheduled visit|0
7413558|NCT01426386|11685819|FG004|Overall Study|Did not attend scheduled visit|2
7413559|NCT01426386|11685820|FG005|Overall Study|Did not attend scheduled visit|1
7413560|NCT01426386|11685815|FG000|Overall Study|Poor response|2
7413561|NCT01426386|11685816|FG001|Overall Study|Poor response|1
7413562|NCT01426386|11685817|FG002|Overall Study|Poor response|2
7413563|NCT01426386|11685818|FG003|Overall Study|Poor response|0
7413564|NCT01426386|11685819|FG004|Overall Study|Poor response|1
7529003|NCT02612909|11871384|FG003|Phase 2|Withdrawal by Subject|0
7413565|NCT01426386|11685820|FG005|Overall Study|Poor response|0
7413566|NCT01426386|11685815|FG000|Overall Study|Personal reasons|0
7413567|NCT01426386|11685816|FG001|Overall Study|Personal reasons|0
7413568|NCT01426386|11685817|FG002|Overall Study|Personal reasons|0
7413569|NCT01426386|11685818|FG003|Overall Study|Personal reasons|0
7413570|NCT01426386|11685819|FG004|Overall Study|Personal reasons|1
7413571|NCT01426386|11685820|FG005|Overall Study|Personal reasons|0
7413572|NCT01426412|11685843|FG000|Overall Study|Withdrawal by Subject|1
7413573|NCT01426412|11685844|FG001|Overall Study|Withdrawal by Subject|0
7413574|NCT01426412|11685845|FG002|Overall Study|Withdrawal by Subject|0
7413575|NCT01426412|11685846|FG003|Overall Study|Withdrawal by Subject|0
7413576|NCT01426412|11685847|FG004|Overall Study|Withdrawal by Subject|1
7413577|NCT01426412|11685848|FG005|Overall Study|Withdrawal by Subject|0
7413578|NCT01426412|11685849|FG006|Overall Study|Withdrawal by Subject|0
7413579|NCT01426412|11685850|FG007|Overall Study|Withdrawal by Subject|3
7413580|NCT01426412|11685851|FG008|Overall Study|Withdrawal by Subject|1
7413581|NCT01426425|11685882|FG000|Overall Study|Exited prior to EP study|22
7413582|NCT01426425|11685882|FG000|Overall Study|Inclusion/exclusion criteria not met|151
7413583|NCT01426425|11685882|FG000|Overall Study|Met inclusion/exclusion, not treated|2
7413584|NCT01426438|11685889|FG000|Overall Study|Lost to Follow-up|1
7413585|NCT01426438|11685890|FG001|Overall Study|Lost to Follow-up|3
7413586|NCT01426438|11685889|FG000|Overall Study|Off study Treatment|9
7413587|NCT01426438|11685890|FG001|Overall Study|Off study Treatment|3
7413588|NCT01426438|11685889|FG000|Overall Study|Poor scan quality|3
7413589|NCT01426438|11685890|FG001|Overall Study|Poor scan quality|2
7413590|NCT01426438|11685889|FG000|Overall Study|Missed Scan|2
7413591|NCT01426438|11685890|FG001|Overall Study|Missed Scan|2
7413592|NCT01426789|11685920|FG000|Part 1|Protocol deviation|0
7413593|NCT01426789|11685921|FG001|Part 1|Protocol deviation|1
7413594|NCT01426789|11685922|FG002|Part 1|Protocol deviation|0
7413595|NCT01426789|11685923|FG003|Part 1|Protocol deviation|0
7413596|NCT01426789|11685924|FG004|Part 1|Protocol deviation|0
7413597|NCT01426789|11685925|FG005|Part 1|Protocol deviation|0
7413598|NCT01426789|11685920|FG000|Part 1|Lost to Follow-up|1
7413599|NCT01426789|11685921|FG001|Part 1|Lost to Follow-up|2
7413600|NCT01426789|11685922|FG002|Part 1|Lost to Follow-up|0
7413601|NCT01426789|11685923|FG003|Part 1|Lost to Follow-up|0
7413602|NCT01426789|11685924|FG004|Part 1|Lost to Follow-up|0
7413603|NCT01426789|11685925|FG005|Part 1|Lost to Follow-up|0
7413604|NCT01426789|11685920|FG000|Part 1|Lack of Efficacy|2
7413605|NCT01426789|11685921|FG001|Part 1|Lack of Efficacy|1
7413606|NCT01426789|11685922|FG002|Part 1|Lack of Efficacy|0
7413607|NCT01426789|11685923|FG003|Part 1|Lack of Efficacy|0
7413608|NCT01426789|11685924|FG004|Part 1|Lack of Efficacy|0
7413609|NCT01426789|11685925|FG005|Part 1|Lack of Efficacy|0
7413610|NCT01426789|11685920|FG000|Part 1|Adverse Event|3
7413611|NCT01426789|11685921|FG001|Part 1|Adverse Event|0
7413612|NCT01426789|11685922|FG002|Part 1|Adverse Event|0
7413613|NCT01426789|11685923|FG003|Part 1|Adverse Event|0
7413614|NCT01426789|11685924|FG004|Part 1|Adverse Event|0
7413615|NCT01426789|11685925|FG005|Part 1|Adverse Event|0
7413616|NCT01426789|11685920|FG000|Part 2|Protocol deviation|0
7413617|NCT01426789|11685921|FG001|Part 2|Protocol deviation|0
7413618|NCT01426789|11685922|FG002|Part 2|Protocol deviation|1
7413619|NCT01426789|11685923|FG003|Part 2|Protocol deviation|0
7413620|NCT01426789|11685924|FG004|Part 2|Protocol deviation|0
7413621|NCT01426789|11685925|FG005|Part 2|Protocol deviation|0
7413622|NCT01426789|11685920|FG000|Part 2|Death|0
7413623|NCT01426789|11685921|FG001|Part 2|Death|0
7413624|NCT01426789|11685922|FG002|Part 2|Death|1
7413625|NCT01426789|11685923|FG003|Part 2|Death|0
7413626|NCT01426789|11685924|FG004|Part 2|Death|1
7413627|NCT01426789|11685925|FG005|Part 2|Death|0
7413628|NCT01426789|11685920|FG000|Part 2|Administrative problems|0
7413629|NCT01426789|11685921|FG001|Part 2|Administrative problems|0
7413630|NCT01426789|11685922|FG002|Part 2|Administrative problems|2
7413631|NCT01426789|11685923|FG003|Part 2|Administrative problems|0
7413632|NCT01426789|11685924|FG004|Part 2|Administrative problems|1
7413633|NCT01426789|11685925|FG005|Part 2|Administrative problems|0
7413634|NCT01426789|11685920|FG000|Part 2|Lost to Follow-up|0
7413635|NCT01426789|11685921|FG001|Part 2|Lost to Follow-up|0
7413636|NCT01426789|11685922|FG002|Part 2|Lost to Follow-up|4
7413637|NCT01426789|11685923|FG003|Part 2|Lost to Follow-up|0
7413638|NCT01426789|11685924|FG004|Part 2|Lost to Follow-up|1
7413639|NCT01426789|11685925|FG005|Part 2|Lost to Follow-up|0
7413640|NCT01426789|11685920|FG000|Part 2|Withdrawal by Subject|0
7413641|NCT01426789|11685921|FG001|Part 2|Withdrawal by Subject|0
7413642|NCT01426789|11685922|FG002|Part 2|Withdrawal by Subject|0
7413643|NCT01426789|11685923|FG003|Part 2|Withdrawal by Subject|1
7413644|NCT01426789|11685924|FG004|Part 2|Withdrawal by Subject|2
7413645|NCT01426789|11685925|FG005|Part 2|Withdrawal by Subject|0
7413646|NCT01426789|11685920|FG000|Part 2|Lack of Efficacy|0
7413647|NCT01426789|11685921|FG001|Part 2|Lack of Efficacy|0
7413648|NCT01426789|11685922|FG002|Part 2|Lack of Efficacy|5
7413649|NCT01426789|11685923|FG003|Part 2|Lack of Efficacy|0
7413650|NCT01426789|11685924|FG004|Part 2|Lack of Efficacy|2
7413651|NCT01426789|11685925|FG005|Part 2|Lack of Efficacy|0
7413652|NCT01426789|11685920|FG000|Part 2|Adverse Event|0
7413653|NCT01426789|11685921|FG001|Part 2|Adverse Event|0
7413654|NCT01426789|11685922|FG002|Part 2|Adverse Event|2
7413655|NCT01426789|11685923|FG003|Part 2|Adverse Event|0
7413656|NCT01426789|11685924|FG004|Part 2|Adverse Event|1
7413657|NCT01426789|11685925|FG005|Part 2|Adverse Event|0
7413658|NCT01426854|11685944|FG000|Overall Study|Adverse Event|1
7413659|NCT01426854|11685945|FG001|Overall Study|Adverse Event|5
7317929|NCT00725712|11547006|FG001|Overall Study|Progressive disease|16
7529004|NCT02612909|11871385|FG004|Phase 2|Withdrawal by Subject|0
7529005|NCT02612909|11871381|FG000|Phase 2|Pregnancy|0
7529006|NCT02612909|11871382|FG001|Phase 2|Pregnancy|0
7529007|NCT02612909|11871383|FG002|Phase 2|Pregnancy|1
7529008|NCT02612909|11871384|FG003|Phase 2|Pregnancy|0
7529009|NCT02612909|11871385|FG004|Phase 2|Pregnancy|0
7529010|NCT02612909|11871381|FG000|Phase 3|Withdrawal by Subject|0
7529011|NCT02612909|11871382|FG001|Phase 3|Withdrawal by Subject|0
7529012|NCT02612909|11871383|FG002|Phase 3|Withdrawal by Subject|0
7529013|NCT02612909|11871384|FG003|Phase 3|Withdrawal by Subject|1
7529014|NCT02612909|11871385|FG004|Phase 3|Withdrawal by Subject|0
7529015|NCT02613169|11871410|FG000|Overall Study|Withdrawal by Subject|4
7529016|NCT02613169|11871411|FG001|Overall Study|Withdrawal by Subject|1
7529017|NCT02613169|11871410|FG000|Overall Study|Lost to Follow-up|0
7529018|NCT02613169|11871411|FG001|Overall Study|Lost to Follow-up|5
7529019|NCT02613169|11871410|FG000|Overall Study|HIV|0
7529020|NCT02613169|11871411|FG001|Overall Study|HIV|2
7224873|NCT00062647|11434351|FG001|Overall Study|Other|4
7224874|NCT00062647|11434350|FG000|Overall Study|Never received study treatment|1
7224875|NCT00062647|11434351|FG001|Overall Study|Never received study treatment|1
7224876|NCT00062868|11434398|FG000|Dose Level 1|Death|2
7224877|NCT00062868|11434399|FG001|Dose Level 1|Death|0
7224878|NCT00062868|11434400|FG002|Dose Level 1|Death|0
7224879|NCT00062868|11434401|FG003|Dose Level 1|Death|2
7224880|NCT00062868|11434402|FG004|Dose Level 1|Death|0
7224881|NCT00062868|11434403|FG005|Dose Level 1|Death|0
7224882|NCT00062868|11434404|FG006|Dose Level 1|Death|3
7224883|NCT00062868|11434405|FG007|Dose Level 1|Death|0
7224884|NCT00062868|11434406|FG008|Dose Level 1|Death|0
7224885|NCT00062868|11434407|FG009|Dose Level 1|Death|0
7224886|NCT00062868|11434408|FG010|Dose Level 1|Death|0
7224887|NCT00062868|11434409|FG011|Dose Level 1|Death|0
7224888|NCT00062868|11434410|FG012|Dose Level 1|Death|0
7529021|NCT02613169|11871410|FG000|Overall Study|No TB infection endpoint|14
7529022|NCT02613169|11871411|FG001|Overall Study|No TB infection endpoint|9
7529023|NCT02613182|11871417|FG000|Overall Study|Death|6
7529024|NCT02613182|11871417|FG000|Overall Study|Physician Decision|1
7529025|NCT02613182|11871417|FG000|Overall Study|Study Terminated by Sponsor|21
7529026|NCT02613182|11871417|FG000|Overall Study|Withdrawal by Subject|6
7529027|NCT02613208|11871421|FG000|Overall Study|Withdrawal by Subject|1
7529028|NCT02613208|11871421|FG000|Overall Study|Change of address|2
7529029|NCT02613208|11871421|FG000|Overall Study|Physician Decision|2
7529030|NCT02613208|11871421|FG000|Overall Study|Lost to Follow-up|5
7529031|NCT02613208|11871421|FG000|Overall Study|Death|37
7529032|NCT02613221|11871425|FG000|Overall Study|Lack of efficacy (exacerbation)|50
7529033|NCT02613221|11871425|FG000|Overall Study|Adverse Event|2
7529034|NCT02613221|11871425|FG000|Overall Study|Voluntary Discontinuation|1
7529035|NCT02613221|11871425|FG000|Overall Study|Delayed Treatment|1
7529036|NCT02613221|11871425|FG000|Overall Study|Enrolled but Not Treated|1
7529037|NCT02613364|11871436|FG000|Overall Study|Other|19
7529038|NCT02613364|11871437|FG001|Overall Study|Other|29
7529039|NCT02613364|11871438|FG002|Overall Study|Other|17
7529040|NCT02613364|11871436|FG000|Overall Study|Too time consuming|21
7529041|NCT02613364|11871437|FG001|Overall Study|Too time consuming|26
7529042|NCT02613364|11871438|FG002|Overall Study|Too time consuming|26
7529043|NCT02613364|11871436|FG000|Overall Study|Withdrawal by Subject|13
7529044|NCT02613364|11871437|FG001|Overall Study|Withdrawal by Subject|18
7317930|NCT00725712|11547005|FG000|Overall Study|Clinical progression not based on RECIST|0
7317931|NCT00725712|11547006|FG001|Overall Study|Clinical progression not based on RECIST|3
7317932|NCT00725712|11547005|FG000|Overall Study|Adverse Event|5
7317933|NCT00725712|11547006|FG001|Overall Study|Adverse Event|5
7317934|NCT00725712|11547005|FG000|Overall Study|Death|2
7317935|NCT00725712|11547006|FG001|Overall Study|Death|0
7317936|NCT00725712|11547005|FG000|Overall Study|Other: Death|1
7317937|NCT00725712|11547006|FG001|Overall Study|Other: Death|0
7317938|NCT00725712|11547005|FG000|Overall Study|Hospitalized, unable to continue|0
7317939|NCT00725712|11547006|FG001|Overall Study|Hospitalized, unable to continue|1
7317940|NCT00725725|11547019|FG000|Overall Study|Adverse Event|1
7317941|NCT00725725|11547020|FG001|Overall Study|Adverse Event|3
7317942|NCT00725725|11547021|FG002|Overall Study|Adverse Event|2
7317943|NCT00725725|11547019|FG000|Overall Study|Lost to Follow-up|2
7317944|NCT00725725|11547020|FG001|Overall Study|Lost to Follow-up|0
7317945|NCT00725725|11547021|FG002|Overall Study|Lost to Follow-up|2
7529045|NCT02613364|11871438|FG002|Overall Study|Withdrawal by Subject|17
7224889|NCT00062868|11434411|FG013|Dose Level 1|Death|0
7224890|NCT00062868|11434412|FG014|Dose Level 1|Death|0
7224891|NCT00062868|11434413|FG015|Dose Level 1|Death|0
7529046|NCT02613364|11871436|FG000|Overall Study|Medical|12
7224892|NCT00062868|11434414|FG016|Dose Level 1|Death|0
7224893|NCT00062868|11434415|FG017|Dose Level 1|Death|0
7224894|NCT00062868|11434416|FG018|Dose Level 1|Death|7
7224895|NCT00062868|11434417|FG019|Dose Level 1|Death|0
7224896|NCT00062868|11434418|FG020|Dose Level 1|Death|1
7224897|NCT00062868|11434398|FG000|Dose Level 1|Lost to Follow-up|0
7224898|NCT00062868|11434399|FG001|Dose Level 1|Lost to Follow-up|0
7224899|NCT00062868|11434400|FG002|Dose Level 1|Lost to Follow-up|0
7224900|NCT00062868|11434401|FG003|Dose Level 1|Lost to Follow-up|0
7224901|NCT00062868|11434402|FG004|Dose Level 1|Lost to Follow-up|0
7224902|NCT00062868|11434403|FG005|Dose Level 1|Lost to Follow-up|0
7413660|NCT01426854|11685944|FG000|Overall Study|Subject Decision Unrelated to AE|5
7413661|NCT01426854|11685945|FG001|Overall Study|Subject Decision Unrelated to AE|6
7413662|NCT01426854|11685944|FG000|Overall Study|Lost to Follow-up|3
7413663|NCT01426854|11685945|FG001|Overall Study|Lost to Follow-up|0
7413664|NCT01426854|11685944|FG000|Overall Study|Noncompliance|0
7413665|NCT01426854|11685945|FG001|Overall Study|Noncompliance|1
7413666|NCT01426854|11685944|FG000|Overall Study|Treatment Failure|0
7413667|NCT01426854|11685945|FG001|Overall Study|Treatment Failure|16
7413668|NCT01426854|11685944|FG000|Overall Study|Protocol Deviation|0
7413669|NCT01426854|11685945|FG001|Overall Study|Protocol Deviation|1
7413670|NCT01426854|11685944|FG000|Overall Study|Other|3
7413671|NCT01426854|11685945|FG001|Overall Study|Other|2
7413672|NCT01426958|11685964|FG000|Overall Study|Adverse Event|2
7413673|NCT01427309|11685985|FG000|Overall Study|Lost to Follow-up|130
7413674|NCT01427309|11685986|FG001|Overall Study|Lost to Follow-up|145
7413675|NCT01427309|11685987|FG002|Overall Study|Lost to Follow-up|122
7413676|NCT01427309|11685988|FG003|Overall Study|Lost to Follow-up|135
7413677|NCT01427309|11685985|FG000|Overall Study|Protocol Violation|42
7413678|NCT01427309|11685986|FG001|Overall Study|Protocol Violation|69
7413679|NCT01427309|11685987|FG002|Overall Study|Protocol Violation|125
7413680|NCT01427309|11685988|FG003|Overall Study|Protocol Violation|124
7413681|NCT01427309|11685985|FG000|Overall Study|Adverse Event|0
7413682|NCT01427309|11685986|FG001|Overall Study|Adverse Event|0
7413683|NCT01427309|11685987|FG002|Overall Study|Adverse Event|3
7413684|NCT01427309|11685988|FG003|Overall Study|Adverse Event|1
7413685|NCT01427309|11685985|FG000|Overall Study|Serious adverse event|52
7413686|NCT01427309|11685986|FG001|Overall Study|Serious adverse event|45
7413687|NCT01427309|11685987|FG002|Overall Study|Serious adverse event|50
7413688|NCT01427309|11685988|FG003|Overall Study|Serious adverse event|61
7413689|NCT01427309|11685985|FG000|Overall Study|Withdrawal by Subject|148
7413690|NCT01427309|11685986|FG001|Overall Study|Withdrawal by Subject|148
7413691|NCT01427309|11685987|FG002|Overall Study|Withdrawal by Subject|61
7413692|NCT01427309|11685988|FG003|Overall Study|Withdrawal by Subject|55
7413693|NCT01427608|11686045|FG000|Overall Study|Death|1
7413694|NCT01427608|11686046|FG001|Overall Study|Death|0
7413695|NCT01427608|11686045|FG000|Overall Study|Withdrawal by Subject|7
7413696|NCT01427608|11686046|FG001|Overall Study|Withdrawal by Subject|3
7413697|NCT01427608|11686045|FG000|Overall Study|Relapsed-all cause|13
7413698|NCT01427608|11686046|FG001|Overall Study|Relapsed-all cause|34
7413699|NCT01427608|11686045|FG000|Overall Study|Events not attributed to study meds|0
7413700|NCT01427608|11686046|FG001|Overall Study|Events not attributed to study meds|1
7413701|NCT01427738|11686056|FG000|Overall Study|Death|12
7413702|NCT01427738|11686057|FG001|Overall Study|Death|9
7413703|NCT01427738|11686056|FG000|Overall Study|Severe debilitation, unable to continue|0
7413704|NCT01427738|11686057|FG001|Overall Study|Severe debilitation, unable to continue|1
7413705|NCT01427738|11686056|FG000|Overall Study|Subject unable to get to clinic|5
7413706|NCT01427738|11686057|FG001|Overall Study|Subject unable to get to clinic|2
7413707|NCT01427738|11686056|FG000|Overall Study|Withdrawal by Subject|0
7413708|NCT01427738|11686057|FG001|Overall Study|Withdrawal by Subject|2
7413709|NCT01427738|11686056|FG000|Overall Study|Subject not willing to adhere to reqs|1
7413710|NCT01427738|11686057|FG001|Overall Study|Subject not willing to adhere to reqs|2
7413711|NCT01427738|11686056|FG000|Overall Study|Lost to Follow-up|1
7413712|NCT01427738|11686057|FG001|Overall Study|Lost to Follow-up|5
7413713|NCT01427751|11686065|FG000|Overall Study|Adverse Event|18
7413714|NCT01427751|11686066|FG001|Overall Study|Adverse Event|2
7413715|NCT01427751|11686065|FG000|Overall Study|No further treatment benefit expected|5
7413716|NCT01427751|11686066|FG001|Overall Study|No further treatment benefit expected|1
7413717|NCT01427751|11686065|FG000|Overall Study|Lost to Follow-up|3
7413718|NCT01427751|11686066|FG001|Overall Study|Lost to Follow-up|1
7413719|NCT01427751|11686065|FG000|Overall Study|Withdrawal of consent|2
7224903|NCT00062868|11434404|FG006|Dose Level 1|Lost to Follow-up|0
7224904|NCT00062868|11434405|FG007|Dose Level 1|Lost to Follow-up|0
7413720|NCT01427751|11686066|FG001|Overall Study|Withdrawal of consent|2
7413721|NCT01427751|11686065|FG000|Overall Study|Protocol Violation|6
7413722|NCT01427751|11686066|FG001|Overall Study|Protocol Violation|4
7413723|NCT01427751|11686065|FG000|Overall Study|Death|2
7413724|NCT01427751|11686066|FG001|Overall Study|Death|0
7413725|NCT01427751|11686065|FG000|Overall Study|Other miscellaneous reasons|6
7413726|NCT01427751|11686066|FG001|Overall Study|Other miscellaneous reasons|4
7413727|NCT01427803|11686074|FG000|Overall Study|Lost to Follow-up|32
7224905|NCT00062868|11434406|FG008|Dose Level 1|Lost to Follow-up|0
7529047|NCT02613364|11871437|FG001|Overall Study|Medical|13
7224906|NCT00062868|11434407|FG009|Dose Level 1|Lost to Follow-up|0
7224907|NCT00062868|11434408|FG010|Dose Level 1|Lost to Follow-up|0
7529048|NCT02613364|11871438|FG002|Overall Study|Medical|9
7224908|NCT00062868|11434409|FG011|Dose Level 1|Lost to Follow-up|0
7224909|NCT00062868|11434410|FG012|Dose Level 1|Lost to Follow-up|1
7529049|NCT02613364|11871436|FG000|Overall Study|Disliked Study Procedure|1
7529050|NCT02613364|11871437|FG001|Overall Study|Disliked Study Procedure|1
7529051|NCT02613364|11871438|FG002|Overall Study|Disliked Study Procedure|4
7529052|NCT02613364|11871436|FG000|Overall Study|Disliked Intervention|0
7317946|NCT00725725|11547019|FG000|Overall Study|Withdrawal by Subject|1
7317947|NCT00725725|11547020|FG001|Overall Study|Withdrawal by Subject|0
7317948|NCT00725725|11547021|FG002|Overall Study|Withdrawal by Subject|1
7317949|NCT00725725|11547019|FG000|Overall Study|Protocol Violation|0
7317950|NCT00725725|11547020|FG001|Overall Study|Protocol Violation|1
7317951|NCT00725725|11547021|FG002|Overall Study|Protocol Violation|0
7317952|NCT00725764|11547039|FG000|Overall Study|Withdrawal by Subject|2
7317953|NCT00725764|11547039|FG000|Overall Study|Physician Decision|1
7317954|NCT00725764|11547039|FG000|Overall Study|Progressive Disease|7
7317955|NCT00725764|11547039|FG000|Overall Study|Lost to Follow-up|1
7224910|NCT00062868|11434411|FG013|Dose Level 1|Lost to Follow-up|0
7224911|NCT00062868|11434412|FG014|Dose Level 1|Lost to Follow-up|0
7224912|NCT00062868|11434413|FG015|Dose Level 1|Lost to Follow-up|0
7224913|NCT00062868|11434414|FG016|Dose Level 1|Lost to Follow-up|0
7224914|NCT00062868|11434415|FG017|Dose Level 1|Lost to Follow-up|0
7224915|NCT00062868|11434416|FG018|Dose Level 1|Lost to Follow-up|2
7224916|NCT00062868|11434417|FG019|Dose Level 1|Lost to Follow-up|0
7224917|NCT00062868|11434418|FG020|Dose Level 1|Lost to Follow-up|1
7224918|NCT00062868|11434398|FG000|Dose Level 2|Death|0
7224919|NCT00062868|11434399|FG001|Dose Level 2|Death|3
7224920|NCT00062868|11434400|FG002|Dose Level 2|Death|0
7224921|NCT00062868|11434401|FG003|Dose Level 2|Death|0
7224922|NCT00062868|11434402|FG004|Dose Level 2|Death|2
7224923|NCT00062868|11434403|FG005|Dose Level 2|Death|0
7224924|NCT00062868|11434404|FG006|Dose Level 2|Death|0
7224925|NCT00062868|11434405|FG007|Dose Level 2|Death|0
7224926|NCT00062868|11434406|FG008|Dose Level 2|Death|0
7224927|NCT00062868|11434407|FG009|Dose Level 2|Death|0
7224928|NCT00062868|11434408|FG010|Dose Level 2|Death|1
7224929|NCT00062868|11434409|FG011|Dose Level 2|Death|0
7224930|NCT00062868|11434410|FG012|Dose Level 2|Death|0
7224931|NCT00062868|11434411|FG013|Dose Level 2|Death|0
7224932|NCT00062868|11434412|FG014|Dose Level 2|Death|0
7224933|NCT00062868|11434413|FG015|Dose Level 2|Death|0
7224934|NCT00062868|11434414|FG016|Dose Level 2|Death|2
7224935|NCT00062868|11434415|FG017|Dose Level 2|Death|0
7224936|NCT00062868|11434416|FG018|Dose Level 2|Death|0
7224937|NCT00062868|11434417|FG019|Dose Level 2|Death|0
7224938|NCT00062868|11434418|FG020|Dose Level 2|Death|0
7224939|NCT00062868|11434398|FG000|Dose Level 2|Lost to Follow-up|0
7224940|NCT00062868|11434399|FG001|Dose Level 2|Lost to Follow-up|0
7224941|NCT00062868|11434400|FG002|Dose Level 2|Lost to Follow-up|0
7224942|NCT00062868|11434401|FG003|Dose Level 2|Lost to Follow-up|0
7413728|NCT01427803|11686075|FG001|Overall Study|Lost to Follow-up|26
7413729|NCT01427803|11686074|FG000|Overall Study|Withdrawal by Subject|20
7413730|NCT01427803|11686075|FG001|Overall Study|Withdrawal by Subject|0
7413731|NCT01427803|11686074|FG000|Overall Study|Unable to complete full treatment period|6
7413732|NCT01427803|11686075|FG001|Overall Study|Unable to complete full treatment period|0
7413733|NCT01427803|11686074|FG000|Overall Study|Protocol Violation|1
7413734|NCT01427803|11686075|FG001|Overall Study|Protocol Violation|0
7413735|NCT01427803|11686074|FG000|Overall Study|Physician Decision|3
7413736|NCT01427803|11686075|FG001|Overall Study|Physician Decision|0
7413737|NCT01427803|11686074|FG000|Overall Study|did not take product|1
7413738|NCT01427803|11686075|FG001|Overall Study|did not take product|0
7413739|NCT01427907|11686085|FG000|Overall Study|Withdrawal by Subject|3
7413740|NCT01427907|11686086|FG001|Overall Study|Withdrawal by Subject|4
7413741|NCT01427920|11686094|FG000|Overall Study|Adverse Event|1
7413742|NCT01427920|11686095|FG001|Overall Study|Adverse Event|2
7413743|NCT01427920|11686094|FG000|Overall Study|Lack of Efficacy|1
7413744|NCT01427920|11686095|FG001|Overall Study|Lack of Efficacy|0
7413745|NCT01427920|11686094|FG000|Overall Study|Protocol Violation|1
7413746|NCT01427920|11686095|FG001|Overall Study|Protocol Violation|3
7413747|NCT01427920|11686094|FG000|Overall Study|Withdrawal Criteria|4
7413748|NCT01427920|11686095|FG001|Overall Study|Withdrawal Criteria|4
7413749|NCT01427920|11686094|FG000|Overall Study|Unclassified|2
7413750|NCT01427920|11686095|FG001|Overall Study|Unclassified|8
7413751|NCT01427933|11686103|FG000|Overall Study|Withdrawal by Subject|5
7413752|NCT01427933|11686104|FG001|Overall Study|Withdrawal by Subject|8
7413753|NCT01427933|11686103|FG000|Overall Study|Lost to Follow-up|1
7413754|NCT01427933|11686104|FG001|Overall Study|Lost to Follow-up|5
7413755|NCT01427933|11686103|FG000|Overall Study|Other|1
7413756|NCT01427933|11686104|FG001|Overall Study|Other|0
7413757|NCT01427933|11686103|FG000|Overall Study|Investigator's Decision|1
7413758|NCT01427933|11686104|FG001|Overall Study|Investigator's Decision|0
7224943|NCT00062868|11434402|FG004|Dose Level 2|Lost to Follow-up|0
7224944|NCT00062868|11434403|FG005|Dose Level 2|Lost to Follow-up|0
7224945|NCT00062868|11434404|FG006|Dose Level 2|Lost to Follow-up|0
7224946|NCT00062868|11434405|FG007|Dose Level 2|Lost to Follow-up|0
7224947|NCT00062868|11434406|FG008|Dose Level 2|Lost to Follow-up|0
7224948|NCT00062868|11434407|FG009|Dose Level 2|Lost to Follow-up|0
7224949|NCT00062868|11434408|FG010|Dose Level 2|Lost to Follow-up|0
7224950|NCT00062868|11434409|FG011|Dose Level 2|Lost to Follow-up|0
7224951|NCT00062868|11434410|FG012|Dose Level 2|Lost to Follow-up|0
7224952|NCT00062868|11434411|FG013|Dose Level 2|Lost to Follow-up|1
7224953|NCT00062868|11434412|FG014|Dose Level 2|Lost to Follow-up|0
7224954|NCT00062868|11434413|FG015|Dose Level 2|Lost to Follow-up|0
7224955|NCT00062868|11434414|FG016|Dose Level 2|Lost to Follow-up|1
7224956|NCT00062868|11434415|FG017|Dose Level 2|Lost to Follow-up|0
7224957|NCT00062868|11434416|FG018|Dose Level 2|Lost to Follow-up|0
7224958|NCT00062868|11434417|FG019|Dose Level 2|Lost to Follow-up|0
7413759|NCT01427972|11686123|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
7413760|NCT01427972|11686124|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
7413761|NCT01427972|11686125|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
7413762|NCT01427972|11686126|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
7413763|NCT01427972|11686127|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
7413764|NCT01427972|11686128|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
7413765|NCT01427972|11686129|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
7413766|NCT01427972|11686130|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
7413767|NCT01427972|11686131|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
7413768|NCT01427972|11686132|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
7413769|NCT01427972|11686133|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
7413770|NCT01427972|11686134|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
7413771|NCT01427972|11686123|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413772|NCT01427972|11686124|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413773|NCT01427972|11686125|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413774|NCT01427972|11686126|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413775|NCT01427972|11686127|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413776|NCT01427972|11686128|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
7413777|NCT01427972|11686129|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413778|NCT01427972|11686130|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413779|NCT01427972|11686131|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413780|NCT01427972|11686132|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413781|NCT01427972|11686133|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413782|NCT01427972|11686134|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
7413783|NCT01427972|11686123|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413784|NCT01427972|11686124|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
7413785|NCT01427972|11686125|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413786|NCT01427972|11686126|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413787|NCT01427972|11686127|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413788|NCT01427972|11686128|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413789|NCT01427972|11686129|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413790|NCT01427972|11686130|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413791|NCT01427972|11686131|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413792|NCT01427972|11686132|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413793|NCT01427972|11686133|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413794|NCT01427972|11686134|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
7413795|NCT01428063|11686167|FG000|Overall Study|Lack of Efficacy|8
7413796|NCT01428063|11686168|FG001|Overall Study|Lack of Efficacy|4
7413797|NCT01428063|11686169|FG002|Overall Study|Lack of Efficacy|1
7413798|NCT01428063|11686167|FG000|Overall Study|Adverse Event|2
7413799|NCT01428063|11686168|FG001|Overall Study|Adverse Event|3
7413800|NCT01428063|11686169|FG002|Overall Study|Adverse Event|0
7413801|NCT01428063|11686167|FG000|Overall Study|Lost to Follow-up|0
7529053|NCT02613364|11871437|FG001|Overall Study|Disliked Intervention|3
7529054|NCT02613364|11871438|FG002|Overall Study|Disliked Intervention|3
7529055|NCT02613403|11871450|FG000|Overall Study|Lost to Follow-up|0
7529056|NCT02613403|11871451|FG001|Overall Study|Lost to Follow-up|1
7529057|NCT02613403|11871452|FG002|Overall Study|Lost to Follow-up|0
7529058|NCT02613403|11871453|FG003|Overall Study|Lost to Follow-up|0
7529059|NCT02613403|11871454|FG004|Overall Study|Lost to Follow-up|0
7529060|NCT02613403|11871450|FG000|Overall Study|Withdrawal by Subject|2
7529061|NCT02613403|11871451|FG001|Overall Study|Withdrawal by Subject|0
7529062|NCT02613403|11871452|FG002|Overall Study|Withdrawal by Subject|0
7529063|NCT02613403|11871453|FG003|Overall Study|Withdrawal by Subject|0
7529064|NCT02613403|11871454|FG004|Overall Study|Withdrawal by Subject|0
7529065|NCT02613481|11871464|FG000|Overall Study|Lost to Follow-up|7
7529066|NCT02613481|11871464|FG000|Overall Study|Withdrawal by Subject|2
7529067|NCT02613572|11871471|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
7529068|NCT02613572|11871472|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7529069|NCT02613572|11871473|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
7529070|NCT02613572|11871471|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
7529071|NCT02613572|11871472|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
7529072|NCT02613572|11871473|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
7529073|NCT02613871|11871485|FG000|Overall Study|Death|2
7529074|NCT02613871|11871485|FG000|Overall Study|Withdrew Consent|1
7529075|NCT02613884|11871489|FG000|Overall Study|Death|1
7529076|NCT02613884|11871489|FG000|Overall Study|Lost to Follow-up|1
7529077|NCT02613910|11871508|FG000|Overall Study|Termination of study|1
7529078|NCT02614079|11871512|FG000|Overall Study|Withdrawal by Subject|1
7529079|NCT02614131|11871523|FG000|Overall Study|Withdrawal by Subject|1
7529080|NCT02614131|11871524|FG001|Overall Study|Withdrawal by Subject|0
7529081|NCT02614131|11871525|FG002|Overall Study|Withdrawal by Subject|0
7529082|NCT02614131|11871526|FG003|Overall Study|Withdrawal by Subject|0
7529083|NCT02614131|11871527|FG004|Overall Study|Withdrawal by Subject|0
7529084|NCT02614131|11871528|FG005|Overall Study|Withdrawal by Subject|0
7529085|NCT02614131|11871529|FG006|Overall Study|Withdrawal by Subject|0
7529086|NCT02614131|11871523|FG000|Overall Study|Adverse Event|0
7529087|NCT02614131|11871524|FG001|Overall Study|Adverse Event|0
7529088|NCT02614131|11871525|FG002|Overall Study|Adverse Event|0
7317956|NCT00725764|11547039|FG000|Overall Study|Death|1
7529089|NCT02614131|11871526|FG003|Overall Study|Adverse Event|0
7529090|NCT02614131|11871527|FG004|Overall Study|Adverse Event|0
7529091|NCT02614131|11871528|FG005|Overall Study|Adverse Event|0
7413802|NCT01428063|11686168|FG001|Overall Study|Lost to Follow-up|2
7413803|NCT01428063|11686169|FG002|Overall Study|Lost to Follow-up|0
7413804|NCT01428063|11686167|FG000|Overall Study|No longer meets study criteria|0
7413805|NCT01428063|11686168|FG001|Overall Study|No longer meets study criteria|1
7413806|NCT01428063|11686169|FG002|Overall Study|No longer meets study criteria|0
7413807|NCT01428076|11686190|FG000|Overall Study|Adverse Event|0
7413808|NCT01428076|11686191|FG001|Overall Study|Adverse Event|1
7413809|NCT01428115|11686199|FG000|Overall Study|Lack of Efficacy|3
7413810|NCT01428115|11686199|FG000|Overall Study|Lost to Follow-up|10
7413811|NCT01428115|11686199|FG000|Overall Study|Pregnancy|1
7413812|NCT01428115|11686199|FG000|Overall Study|Protocol Violation|3
7413813|NCT01428115|11686199|FG000|Overall Study|Withdrawal by Subject|4
7413814|NCT01428128|11686204|FG000|Overall Study|Withdrawal by Subject|4
7413815|NCT01428128|11686204|FG000|Overall Study|Screen failure by p53|10
7413816|NCT01428128|11686204|FG000|Overall Study|Received Neulasta in one cycle|2
7413817|NCT01428128|11686204|FG000|Overall Study|Adverse Event|1
7413818|NCT01428193|11686209|FG000|Overall Study|Physician Decision|1
7413819|NCT01428193|11686209|FG000|Overall Study|Elevated screening liver enzymes|1
7413820|NCT01428219|11686213|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
7413821|NCT01428258|11686223|FG000|Intervention 1|Withdrawal by Subject|2
7413822|NCT01428258|11686224|FG001|Intervention 1|Withdrawal by Subject|0
7413823|NCT01428453|11686252|FG000|Overall Study|Adverse Event|2
7413824|NCT01428453|11686253|FG001|Overall Study|Adverse Event|7
7413825|NCT01428453|11686252|FG000|Overall Study|Protocol Violation|1
7413826|NCT01428453|11686253|FG001|Overall Study|Protocol Violation|0
7413827|NCT01428453|11686252|FG000|Overall Study|Lost to Follow-up|0
7413828|NCT01428453|11686253|FG001|Overall Study|Lost to Follow-up|1
7413829|NCT01428453|11686252|FG000|Overall Study|Withdrawal by Subject|3
7413830|NCT01428453|11686253|FG001|Overall Study|Withdrawal by Subject|1
7466350|NCT01890915|11766150|FG001|Overall Study|Adverse Event|0
7466351|NCT01890915|11766149|FG000|Overall Study|Protocol Violation|2
7466352|NCT01890915|11766150|FG001|Overall Study|Protocol Violation|0
7466353|NCT01890915|11766149|FG000|Overall Study|Equipment Malfunction|0
7466354|NCT01890915|11766150|FG001|Overall Study|Equipment Malfunction|1
7466355|NCT01890967|11766171|FG000|Overall Study|Adverse Event|3
7466356|NCT01890967|11766172|FG001|Overall Study|Adverse Event|3
7466357|NCT01890967|11766173|FG002|Overall Study|Adverse Event|3
7466358|NCT01890967|11766174|FG003|Overall Study|Adverse Event|2
7466359|NCT01890967|11766175|FG004|Overall Study|Adverse Event|1
7466360|NCT01890967|11766176|FG005|Overall Study|Adverse Event|7
7466361|NCT01890967|11766171|FG000|Overall Study|Death|1
7466362|NCT01890967|11766172|FG001|Overall Study|Death|0
7466363|NCT01890967|11766173|FG002|Overall Study|Death|0
7466364|NCT01890967|11766174|FG003|Overall Study|Death|0
7529092|NCT02614131|11871529|FG006|Overall Study|Adverse Event|1
7529093|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Adverse Event|10
7529094|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Adverse Event|9
7529095|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Adverse Event|7
7529096|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
7529097|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7529098|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
7529099|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
7529100|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
7529101|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
7529102|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Physician Decision|7
7529103|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Physician Decision|3
7529104|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Physician Decision|2
7529105|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Pregnancy|2
7529106|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Pregnancy|1
7529107|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Pregnancy|3
7413831|NCT01428583|11686261|FG000|Overall Study|Adverse Event|75
7413832|NCT01428583|11686261|FG000|Overall Study|Withdrawal by Subject|51
7413833|NCT01428583|11686261|FG000|Overall Study|Lack of Efficacy|37
7413834|NCT01428583|11686261|FG000|Overall Study|Lost to Follow-up|17
7413835|NCT01428583|11686261|FG000|Overall Study|Death|1
7413836|NCT01428583|11686261|FG000|Overall Study|Pregnancy|1
7413837|NCT01428583|11686261|FG000|Overall Study|Protocol Violation|1
7413838|NCT01428583|11686261|FG000|Overall Study|Physician Decision|12
7413839|NCT01428583|11686261|FG000|Overall Study|Non-compliant|25
7413840|NCT01428583|11686261|FG000|Overall Study|Confirmed positive urine drug test|8
7413841|NCT01428583|11686261|FG000|Overall Study|Sponsor's request|3
7413842|NCT01428583|11686261|FG000|Overall Study|Other|6
7413843|NCT01428661|11686268|FG000|Double-Masked Phase|Protocol Violation|9
7413844|NCT01428661|11686269|FG001|Double-Masked Phase|Protocol Violation|4
7413845|NCT01428661|11686270|FG002|Double-Masked Phase|Protocol Violation|0
7413846|NCT01428661|11686268|FG000|Double-Masked Phase|Adverse Event|13
7413847|NCT01428661|11686269|FG001|Double-Masked Phase|Adverse Event|4
7413848|NCT01428661|11686270|FG002|Double-Masked Phase|Adverse Event|0
7413849|NCT01428661|11686268|FG000|Double-Masked Phase|Lost to Follow-up|14
7413850|NCT01428661|11686269|FG001|Double-Masked Phase|Lost to Follow-up|14
7413851|NCT01428661|11686270|FG002|Double-Masked Phase|Lost to Follow-up|0
7413852|NCT01428661|11686268|FG000|Double-Masked Phase|Withdrawal by Subject|18
7413853|NCT01428661|11686269|FG001|Double-Masked Phase|Withdrawal by Subject|20
7413854|NCT01428661|11686270|FG002|Double-Masked Phase|Withdrawal by Subject|0
7413855|NCT01428661|11686268|FG000|Double-Masked Phase|Lack of Efficacy|2
7537543|NCT03591874|11886491|FG000|Overall Study|Adverse Event|4
7413856|NCT01428661|11686269|FG001|Double-Masked Phase|Lack of Efficacy|1
7413857|NCT01428661|11686270|FG002|Double-Masked Phase|Lack of Efficacy|0
7413858|NCT01428661|11686268|FG000|Double-Masked Phase|*Various|1
7413859|NCT01428661|11686269|FG001|Double-Masked Phase|*Various|6
7224959|NCT00062868|11434418|FG020|Dose Level 2|Lost to Follow-up|0
7224960|NCT00062868|11434398|FG000|Dose Level 3|Death|0
7224961|NCT00062868|11434399|FG001|Dose Level 3|Death|0
7224962|NCT00062868|11434400|FG002|Dose Level 3|Death|0
7224963|NCT00062868|11434401|FG003|Dose Level 3|Death|0
7224964|NCT00062868|11434402|FG004|Dose Level 3|Death|0
7224965|NCT00062868|11434403|FG005|Dose Level 3|Death|0
7224966|NCT00062868|11434404|FG006|Dose Level 3|Death|0
7224967|NCT00062868|11434405|FG007|Dose Level 3|Death|0
7224968|NCT00062868|11434406|FG008|Dose Level 3|Death|0
7224969|NCT00062868|11434407|FG009|Dose Level 3|Death|0
7224970|NCT00062868|11434408|FG010|Dose Level 3|Death|0
7224971|NCT00062868|11434409|FG011|Dose Level 3|Death|1
7224972|NCT00062868|11434410|FG012|Dose Level 3|Death|0
7224973|NCT00062868|11434411|FG013|Dose Level 3|Death|0
7224974|NCT00062868|11434412|FG014|Dose Level 3|Death|0
7224975|NCT00062868|11434413|FG015|Dose Level 3|Death|0
7224976|NCT00062868|11434414|FG016|Dose Level 3|Death|0
7224977|NCT00062868|11434415|FG017|Dose Level 3|Death|1
7224978|NCT00062868|11434416|FG018|Dose Level 3|Death|0
7224979|NCT00062868|11434417|FG019|Dose Level 3|Death|0
7224980|NCT00062868|11434418|FG020|Dose Level 3|Death|0
7224981|NCT00062868|11434398|FG000|Dose Level 3|Lost to Follow-up|0
7224982|NCT00062868|11434399|FG001|Dose Level 3|Lost to Follow-up|0
7224983|NCT00062868|11434400|FG002|Dose Level 3|Lost to Follow-up|0
7224984|NCT00062868|11434401|FG003|Dose Level 3|Lost to Follow-up|0
7224985|NCT00062868|11434402|FG004|Dose Level 3|Lost to Follow-up|0
7224986|NCT00062868|11434403|FG005|Dose Level 3|Lost to Follow-up|0
7224987|NCT00062868|11434404|FG006|Dose Level 3|Lost to Follow-up|0
7224988|NCT00062868|11434405|FG007|Dose Level 3|Lost to Follow-up|0
7224989|NCT00062868|11434406|FG008|Dose Level 3|Lost to Follow-up|0
7224990|NCT00062868|11434407|FG009|Dose Level 3|Lost to Follow-up|0
7224991|NCT00062868|11434408|FG010|Dose Level 3|Lost to Follow-up|0
7224992|NCT00062868|11434409|FG011|Dose Level 3|Lost to Follow-up|0
7224993|NCT00062868|11434410|FG012|Dose Level 3|Lost to Follow-up|0
7224994|NCT00062868|11434411|FG013|Dose Level 3|Lost to Follow-up|0
7224995|NCT00062868|11434412|FG014|Dose Level 3|Lost to Follow-up|1
7224996|NCT00062868|11434413|FG015|Dose Level 3|Lost to Follow-up|0
7224997|NCT00062868|11434414|FG016|Dose Level 3|Lost to Follow-up|0
7224998|NCT00062868|11434415|FG017|Dose Level 3|Lost to Follow-up|0
7224999|NCT00062868|11434416|FG018|Dose Level 3|Lost to Follow-up|0
7225000|NCT00062868|11434417|FG019|Dose Level 3|Lost to Follow-up|0
7225001|NCT00062868|11434418|FG020|Dose Level 3|Lost to Follow-up|0
7225002|NCT00062868|11434398|FG000|Dose Level 3|Withdrew|0
7225003|NCT00062868|11434399|FG001|Dose Level 3|Withdrew|0
7225004|NCT00062868|11434400|FG002|Dose Level 3|Withdrew|2
7225005|NCT00062868|11434401|FG003|Dose Level 3|Withdrew|0
7225006|NCT00062868|11434402|FG004|Dose Level 3|Withdrew|0
7225007|NCT00062868|11434403|FG005|Dose Level 3|Withdrew|0
7225008|NCT00062868|11434404|FG006|Dose Level 3|Withdrew|0
7225009|NCT00062868|11434405|FG007|Dose Level 3|Withdrew|0
7225010|NCT00062868|11434406|FG008|Dose Level 3|Withdrew|0
7225011|NCT00062868|11434407|FG009|Dose Level 3|Withdrew|0
7225012|NCT00062868|11434408|FG010|Dose Level 3|Withdrew|0
7225013|NCT00062868|11434409|FG011|Dose Level 3|Withdrew|0
7225014|NCT00062868|11434410|FG012|Dose Level 3|Withdrew|0
7225015|NCT00062868|11434411|FG013|Dose Level 3|Withdrew|0
7225016|NCT00062868|11434412|FG014|Dose Level 3|Withdrew|0
7225017|NCT00062868|11434413|FG015|Dose Level 3|Withdrew|0
7225018|NCT00062868|11434414|FG016|Dose Level 3|Withdrew|0
7225019|NCT00062868|11434415|FG017|Dose Level 3|Withdrew|0
7225020|NCT00062868|11434416|FG018|Dose Level 3|Withdrew|0
7225021|NCT00062868|11434417|FG019|Dose Level 3|Withdrew|0
7225022|NCT00062868|11434418|FG020|Dose Level 3|Withdrew|0
7225023|NCT00063154|11434462|FG000|Overall Study|Disease progression|27
7225024|NCT00063154|11434462|FG000|Overall Study|Adverse Event|2
7225025|NCT00063154|11434462|FG000|Overall Study|Physician Decision|10
7225026|NCT00063154|11434462|FG000|Overall Study|Death|3
7225027|NCT00063154|11434462|FG000|Overall Study|Reason unspecified|1
7225028|NCT00063154|11434462|FG000|Overall Study|Did not receive treatment|8
7225029|NCT00063258|11434472|FG000|Overall Study|Physician Decision|2
7225030|NCT00063258|11434473|FG001|Overall Study|Physician Decision|0
7225031|NCT00063258|11434472|FG000|Overall Study|Lack of Efficacy|2
7225032|NCT00063258|11434473|FG001|Overall Study|Lack of Efficacy|0
7225033|NCT00063882|11434525|FG000|Overall Study|Protocol Violation|3
7225034|NCT00063882|11434526|FG001|Overall Study|Protocol Violation|3
7225035|NCT00063882|11434525|FG000|Overall Study|Withdrawal by Subject|2
7317957|NCT00725764|11547039|FG000|Overall Study|Participant non compliant with protocol|1
7317958|NCT00725764|11547039|FG000|Overall Study|Decline in performance status|1
7317959|NCT00725842|11547044|FG000|Overall Study|Lost to Follow-up|19
7317960|NCT00725842|11547044|FG000|Overall Study|Death|1
7317961|NCT00725842|11547044|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
7317962|NCT00725842|11547044|FG000|Overall Study|Consent date prior to study start date|5
7317963|NCT00725842|11547044|FG000|Overall Study|Inclusion criterion not met|1
7317964|NCT00725842|11547044|FG000|Overall Study|No Visit 1 data|1
7317965|NCT00725920|11547050|FG000|Overall Study|Lack of Efficacy|3
7317966|NCT00725920|11547051|FG001|Overall Study|Lack of Efficacy|6
7317967|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Death|0
7317968|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Death|0
7317969|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Death|0
7317970|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Death|0
7317971|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Death|1
7317972|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Death|0
7317973|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Death|0
7317974|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Death|0
7317975|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Adverse Event|2
7317976|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Adverse Event|2
7317977|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Adverse Event|2
7317978|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Adverse Event|1
7317979|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Adverse Event|7
7317980|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Adverse Event|3
7317981|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Adverse Event|0
7317982|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Adverse Event|0
7317983|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7317984|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7317985|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7317986|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
7317987|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7317988|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
7317989|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7317990|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
7317991|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Disease progression|3
7317992|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Disease progression|1
7317993|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Disease progression|0
7317994|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Disease progression|0
7317995|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Disease progression|0
7317996|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Disease progression|0
7317997|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Disease progression|0
7529108|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Protocol Violation|2
7529109|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Protocol Violation|2
7529110|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Protocol Violation|2
7529111|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
7529112|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7529113|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
7529114|NCT02614183|11871554|FG000|Double Blind Treatment Phase|Did not receive study drug|1
7529115|NCT02614183|11871555|FG001|Double Blind Treatment Phase|Did not receive study drug|1
7529116|NCT02614183|11871556|FG002|Double Blind Treatment Phase|Did not receive study drug|2
7529117|NCT02614183|11871554|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
7529118|NCT02614183|11871555|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7529119|NCT02614183|11871556|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
7529120|NCT02614183|11871554|FG000|Post Treatment Follow-up Phase|Physician Decision|5
7529121|NCT02614183|11871555|FG001|Post Treatment Follow-up Phase|Physician Decision|1
7529122|NCT02614183|11871556|FG002|Post Treatment Follow-up Phase|Physician Decision|2
7529123|NCT02614183|11871554|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
7529124|NCT02614183|11871555|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
7529125|NCT02614183|11871556|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7529126|NCT02614183|11871554|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
7529127|NCT02614183|11871555|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
7529128|NCT02614183|11871556|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7529129|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Adverse Event|8
7529130|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Adverse Event|5
7529131|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Adverse Event|9
7529132|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Adverse Event|0
7529133|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Adverse Event|0
7529134|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Adverse Event|0
7529135|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
7529136|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
7529137|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
7529138|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
7529139|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
7529140|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
7529141|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
7529142|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
7529143|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
7529144|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
7529145|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
7529146|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
7529147|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Physician Decision|4
7529148|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Physician Decision|0
7529149|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Physician Decision|2
7529150|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Physician Decision|0
7529151|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Physician Decision|0
7529152|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Physician Decision|0
7529153|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Pregnancy|1
7529154|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Pregnancy|2
7529155|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Pregnancy|0
7529156|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Pregnancy|0
7529157|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Pregnancy|0
7529158|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Pregnancy|0
7529159|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Protocol Violation|5
7529160|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Protocol Violation|2
7529161|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Protocol Violation|1
7529162|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Protocol Violation|0
7529163|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Protocol Violation|1
7529164|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Protocol Violation|0
7529165|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
7529166|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
7529167|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
7529168|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
7529169|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
7529170|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
7529171|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
7529172|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
7529173|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
7529174|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
7529175|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
7529176|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
7529177|NCT02614196|11871576|FG000|Double Blind Treatment Phase|Did not receive study drug|2
7529178|NCT02614196|11871577|FG001|Double Blind Treatment Phase|Did not receive study drug|2
7529179|NCT02614196|11871578|FG002|Double Blind Treatment Phase|Did not receive study drug|3
7529180|NCT02614196|11871579|FG003|Double Blind Treatment Phase|Did not receive study drug|0
7529181|NCT02614196|11871580|FG004|Double Blind Treatment Phase|Did not receive study drug|0
7529182|NCT02614196|11871581|FG005|Double Blind Treatment Phase|Did not receive study drug|0
7529183|NCT02614196|11871576|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
7529184|NCT02614196|11871577|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
7529185|NCT02614196|11871578|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
7529186|NCT02614196|11871579|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
7529187|NCT02614196|11871580|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
7529188|NCT02614196|11871581|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
7529189|NCT02614196|11871576|FG000|Post Treatment Follow-up Phase|Pregnancy|2
7529190|NCT02614196|11871577|FG001|Post Treatment Follow-up Phase|Pregnancy|0
7529191|NCT02614196|11871578|FG002|Post Treatment Follow-up Phase|Pregnancy|0
7529192|NCT02614196|11871579|FG003|Post Treatment Follow-up Phase|Pregnancy|0
7529193|NCT02614196|11871580|FG004|Post Treatment Follow-up Phase|Pregnancy|0
7529194|NCT02614196|11871581|FG005|Post Treatment Follow-up Phase|Pregnancy|0
7529195|NCT02614196|11871576|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
7529196|NCT02614196|11871577|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
7529197|NCT02614196|11871578|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
7529198|NCT02614196|11871579|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
7413860|NCT01428661|11686270|FG002|Double-Masked Phase|*Various|0
7413861|NCT01428661|11686268|FG000|Open Label Extension|Protocol Violation|0
7413862|NCT01428661|11686269|FG001|Open Label Extension|Protocol Violation|0
7413863|NCT01428661|11686270|FG002|Open Label Extension|Protocol Violation|9
7413864|NCT01428661|11686268|FG000|Open Label Extension|Adverse Event|0
7413865|NCT01428661|11686269|FG001|Open Label Extension|Adverse Event|0
7413866|NCT01428661|11686270|FG002|Open Label Extension|Adverse Event|15
7413867|NCT01428661|11686268|FG000|Open Label Extension|Lost to Follow-up|0
7413868|NCT01428661|11686269|FG001|Open Label Extension|Lost to Follow-up|0
7413869|NCT01428661|11686270|FG002|Open Label Extension|Lost to Follow-up|38
7413870|NCT01428661|11686268|FG000|Open Label Extension|Withdrawal by Subject|0
7413871|NCT01428661|11686269|FG001|Open Label Extension|Withdrawal by Subject|0
7413872|NCT01428661|11686270|FG002|Open Label Extension|Withdrawal by Subject|49
7413873|NCT01428661|11686268|FG000|Open Label Extension|Lack of Efficacy|0
7413874|NCT01428661|11686269|FG001|Open Label Extension|Lack of Efficacy|0
7413875|NCT01428661|11686270|FG002|Open Label Extension|Lack of Efficacy|24
7413876|NCT01428661|11686268|FG000|Open Label Extension|**Various|0
7413877|NCT01428661|11686269|FG001|Open Label Extension|**Various|0
7413878|NCT01428661|11686270|FG002|Open Label Extension|**Various|185
7413879|NCT01428713|11686278|FG000|Overall Study|Non-compliance|2
7413880|NCT01428713|11686279|FG001|Overall Study|Non-compliance|2
7413881|NCT01428713|11686278|FG000|Overall Study|Withdrawal by Subject|1
7413882|NCT01428713|11686279|FG001|Overall Study|Withdrawal by Subject|1
7413883|NCT01428713|11686278|FG000|Overall Study|Adverse Event|0
7413884|NCT01428713|11686279|FG001|Overall Study|Adverse Event|2
7413885|NCT01428882|11686291|FG000|Overall Study|Lack of Efficacy|2
7413886|NCT01428882|11686292|FG001|Overall Study|Lack of Efficacy|7
7413887|NCT01428882|11686291|FG000|Overall Study|Protocol Violation|4
7413888|NCT01428882|11686292|FG001|Overall Study|Protocol Violation|3
7413889|NCT01429051|11686298|FG000|Titration Phase|Death|1
7413890|NCT01429051|11686298|FG000|Titration Phase|Withdrawal by Subject|7
7413891|NCT01429051|11686298|FG000|Titration Phase|Physician Decision|1
7413892|NCT01429051|11686298|FG000|Titration Phase|Unsuccessful titration at any dose|1
7413893|NCT01429051|11686298|FG000|Titration Phase|Less than 3 BTP episodes per week|2
7413894|NCT01429051|11686298|FG000|Efficacy Phase|Adverse Event|1
7413895|NCT01429051|11686298|FG000|Efficacy Phase|Death|1
7413896|NCT01429051|11686298|FG000|Tolerability Phase|Death|5
7413897|NCT01429051|11686298|FG000|Tolerability Phase|Adverse Event|2
7413898|NCT01429051|11686298|FG000|Tolerability Phase|Withdrawal by Subject|5
7413899|NCT01429051|11686298|FG000|Tolerability Phase|Physician Decision|1
7413900|NCT01429051|11686298|FG000|Tolerability Phase|Other|2
7413901|NCT01429077|11686328|FG000|Overall Study|Lost to Follow-up|0
7413902|NCT01429077|11686329|FG001|Overall Study|Lost to Follow-up|3
7413903|NCT01429285|11686358|FG000|Overall Study|Protocol Violation|9
7413904|NCT01429285|11686359|FG001|Overall Study|Protocol Violation|4
7413905|NCT01429285|11686358|FG000|Overall Study|Missing Data|5
7413906|NCT01429285|11686359|FG001|Overall Study|Missing Data|3
7413907|NCT01429285|11686358|FG000|Overall Study|Erroneously Enrolled Twice|8
7413908|NCT01429285|11686359|FG001|Overall Study|Erroneously Enrolled Twice|2
7413909|NCT01429298|11686367|FG000|Overall Study|Protocol Violation|4
7413910|NCT01429298|11686368|FG001|Overall Study|Protocol Violation|6
7413911|NCT01429441|11686385|FG000|Overall Study|Adverse Event|5
7413912|NCT01429441|11686386|FG001|Overall Study|Adverse Event|1
7413913|NCT01429441|11686385|FG000|Overall Study|Death|0
7413914|NCT01429441|11686386|FG001|Overall Study|Death|2
7413915|NCT01429441|11686385|FG000|Overall Study|Lost to Follow-up|5
7413916|NCT01429441|11686386|FG001|Overall Study|Lost to Follow-up|2
7413917|NCT01429441|11686385|FG000|Overall Study|Physician Decision|1
7413918|NCT01429441|11686386|FG001|Overall Study|Physician Decision|0
7413919|NCT01429441|11686385|FG000|Overall Study|Withdrawal by Subject|27
7413920|NCT01429441|11686386|FG001|Overall Study|Withdrawal by Subject|18
7413921|NCT01429584|11686417|FG000|Overall Study|Withdrawal by Subject|1
7413922|NCT01429584|11686418|FG001|Overall Study|Withdrawal by Subject|0
7529199|NCT02614196|11871580|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
7529200|NCT02614196|11871581|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
7529201|NCT02614196|11871576|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
7529202|NCT02614196|11871577|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7529203|NCT02614196|11871578|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
7529204|NCT02614196|11871579|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
7529205|NCT02614196|11871580|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7529206|NCT02614196|11871581|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
7529207|NCT02614287|11871624|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
7529208|NCT02614287|11871625|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
7529209|NCT02614287|11871624|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
7529210|NCT02614287|11871625|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
7529211|NCT02614287|11871624|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
7529212|NCT02614287|11871625|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
7529213|NCT02614287|11871624|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
7529214|NCT02614287|11871625|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
7529215|NCT02614287|11871624|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
7529216|NCT02614287|11871625|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
7529217|NCT02614287|11871624|FG000|Post Treatment Follow-up Phase|Adverse Event|1
7529218|NCT02614287|11871625|FG001|Post Treatment Follow-up Phase|Adverse Event|0
7529219|NCT02614287|11871624|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
7529220|NCT02614287|11871625|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
7529221|NCT02614287|11871624|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
7529222|NCT02614287|11871625|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
7529223|NCT02614560|11871647|FG000|Overall Study|Death|6
7529224|NCT02614560|11871648|FG001|Overall Study|Death|2
7529225|NCT02614703|11871656|FG000|Overall Study|Withdrawal by Subject|7
7529226|NCT02614703|11871657|FG001|Overall Study|Withdrawal by Subject|1
7529227|NCT02614729|11871665|FG000|Overall Study|Withdrawal by Subject|1
7529228|NCT02614729|11871666|FG001|Overall Study|Withdrawal by Subject|0
7529229|NCT02615145|11871687|FG000|Overall Study|Did Not Start Treatment|0
7529230|NCT02615145|11871688|FG001|Overall Study|Did Not Start Treatment|0
7529231|NCT02615145|11871689|FG002|Overall Study|Did Not Start Treatment|1
7529232|NCT02615145|11871690|FG003|Overall Study|Did Not Start Treatment|1
7529233|NCT02615145|11871687|FG000|Overall Study|Failure to Return|20
7529234|NCT02615145|11871688|FG001|Overall Study|Failure to Return|10
7529235|NCT02615145|11871689|FG002|Overall Study|Failure to Return|7
7529236|NCT02615145|11871690|FG003|Overall Study|Failure to Return|0
7529237|NCT02615145|11871687|FG000|Overall Study|Death|2
7529238|NCT02615145|11871688|FG001|Overall Study|Death|3
7529239|NCT02615145|11871689|FG002|Overall Study|Death|0
7413923|NCT01429584|11686417|FG000|Overall Study|Protocol Violation|0
7413924|NCT01429584|11686418|FG001|Overall Study|Protocol Violation|1
7413925|NCT01429623|11686426|FG000|Overall Study|Death|1
7529240|NCT02615145|11871690|FG003|Overall Study|Death|0
7529241|NCT02615145|11871687|FG000|Overall Study|Other, Not Specified|5
7529242|NCT02615145|11871688|FG001|Overall Study|Other, Not Specified|2
7317998|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Disease progression|0
7317999|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7318000|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7413926|NCT01429623|11686427|FG001|Overall Study|Death|0
7413927|NCT01429623|11686426|FG000|Overall Study|Adverse Event|7
7413928|NCT01429623|11686427|FG001|Overall Study|Adverse Event|14
7413929|NCT01429623|11686426|FG000|Overall Study|Withdrawal by Subject|19
7413930|NCT01429623|11686427|FG001|Overall Study|Withdrawal by Subject|13
7413931|NCT01429623|11686426|FG000|Overall Study|Physician Decision|2
7413932|NCT01429623|11686427|FG001|Overall Study|Physician Decision|3
7413933|NCT01429623|11686426|FG000|Overall Study|Protocol Violation|3
7413934|NCT01429623|11686427|FG001|Overall Study|Protocol Violation|2
7413935|NCT01429623|11686426|FG000|Overall Study|Assorted|1
7413936|NCT01429623|11686427|FG001|Overall Study|Assorted|2
7413937|NCT01429623|11686426|FG000|Overall Study|Conversion to Alzheimer's disease|14
7413938|NCT01429623|11686427|FG001|Overall Study|Conversion to Alzheimer's disease|21
7413939|NCT01429623|11686426|FG000|Overall Study|No post baseline data|4
7413940|NCT01429623|11686427|FG001|Overall Study|No post baseline data|4
7413941|NCT01429792|11686433|FG000|Overall Study|Other Reasons|67
7413942|NCT01429792|11686433|FG000|Overall Study|Unknown Disposition|94
7413943|NCT01429792|11686433|FG000|Overall Study|Negative HCV-RNA at Week 4|1
7413944|NCT01429792|11686433|FG000|Overall Study|Negative HCV-RNA at Week 12|4
7413945|NCT01429792|11686433|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
7529243|NCT02615145|11871689|FG002|Overall Study|Other, Not Specified|0
7529244|NCT02615145|11871690|FG003|Overall Study|Other, Not Specified|0
7529245|NCT02615171|11871731|FG000|Overall Study|Lost to Follow-up|2
7529246|NCT02615171|11871732|FG001|Overall Study|Lost to Follow-up|1
7529247|NCT02615249|11871738|FG000|Overall Study|Withdrawal by Subject|1
7529248|NCT02615470|11871745|FG000|Overall Study|Lost to Follow-up|21
7529249|NCT02615470|11871746|FG001|Overall Study|Lost to Follow-up|32
7529250|NCT02615509|11871752|FG000|Overall Study|Lost to Follow-up|134
7529251|NCT02615509|11871752|FG000|Overall Study|Death|4
7318001|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7318002|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
7318003|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
7318004|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
7318005|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7318006|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
7318007|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7413946|NCT01429792|11686433|FG000|Overall Study|Positive HCV-RNA at Week 24|50
7413947|NCT01429792|11686433|FG000|Overall Study|Withdrawal by Subject|70
7413948|NCT01429792|11686433|FG000|Overall Study|Lost to Follow-up|88
7529252|NCT02615509|11871752|FG000|Overall Study|Withdrawal by Subject|8
7529253|NCT02616029|11871785|FG000|Overall Study|Adverse Event|1
7529254|NCT02616029|11871786|FG001|Overall Study|Adverse Event|0
7529255|NCT02616029|11871785|FG000|Overall Study|Death|0
7529256|NCT02616029|11871786|FG001|Overall Study|Death|1
7529257|NCT02616029|11871785|FG000|Overall Study|Protocol Violation|1
7413949|NCT01430104|11686468|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
7413950|NCT01430130|11686475|FG000|Overall Study|Lost to Follow-up|1
7413951|NCT01430130|11686475|FG000|Overall Study|Infection on Control Side of Incision|1
7413952|NCT01430403|11686523|FG000|Overall Study|Lost to Follow-up|5
7413953|NCT01430403|11686524|FG001|Overall Study|Lost to Follow-up|5
7413954|NCT01430403|11686525|FG002|Overall Study|Lost to Follow-up|3
7413955|NCT01430403|11686523|FG000|Overall Study|Physician Decision|1
7413956|NCT01430403|11686524|FG001|Overall Study|Physician Decision|0
7529258|NCT02616029|11871786|FG001|Overall Study|Protocol Violation|0
7529259|NCT02616029|11871785|FG000|Overall Study|Withdrew Consent|1
7529260|NCT02616029|11871786|FG001|Overall Study|Withdrew Consent|0
7529261|NCT02616029|11871785|FG000|Overall Study|Enrolled and Never Treated|1
7529262|NCT02616029|11871786|FG001|Overall Study|Enrolled and Never Treated|1
7529263|NCT02616380|11871801|FG000|Overall Study|Lost to Follow-up|1
7529264|NCT02616380|11871801|FG000|Overall Study|Other|2
7529265|NCT02616601|11871824|FG000|Overall Study|Withdrawal by Subject|4
7529266|NCT02616601|11871825|FG001|Overall Study|Withdrawal by Subject|4
7529267|NCT02616601|11871826|FG002|Overall Study|Withdrawal by Subject|3
7529268|NCT02616601|11871824|FG000|Overall Study|Adverse Event|2
7529269|NCT02616601|11871825|FG001|Overall Study|Adverse Event|0
7529270|NCT02616601|11871826|FG002|Overall Study|Adverse Event|2
7413957|NCT01430403|11686525|FG002|Overall Study|Physician Decision|0
7413958|NCT01430403|11686523|FG000|Overall Study|Protocol Violation|2
7413959|NCT01430403|11686524|FG001|Overall Study|Protocol Violation|3
7413960|NCT01430403|11686525|FG002|Overall Study|Protocol Violation|2
7529271|NCT02616601|11871824|FG000|Overall Study|Death|1
7529272|NCT02616601|11871825|FG001|Overall Study|Death|0
7318008|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7413961|NCT01430403|11686523|FG000|Overall Study|Withdrawal by Subject|9
7413962|NCT01430403|11686524|FG001|Overall Study|Withdrawal by Subject|1
7413963|NCT01430403|11686525|FG002|Overall Study|Withdrawal by Subject|3
7413964|NCT01430442|11686546|FG000|Overall Study|Subject Withdrew Consent|3
7413965|NCT01430442|11686547|FG001|Overall Study|Subject Withdrew Consent|0
7413966|NCT01430442|11686548|FG002|Overall Study|Subject Withdrew Consent|1
7413967|NCT01430442|11686549|FG003|Overall Study|Subject Withdrew Consent|0
7413968|NCT01430442|11686550|FG004|Overall Study|Subject Withdrew Consent|2
7413969|NCT01430442|11686551|FG005|Overall Study|Subject Withdrew Consent|1
7413970|NCT01430442|11686552|FG006|Overall Study|Subject Withdrew Consent|5
7413971|NCT01430442|11686553|FG007|Overall Study|Subject Withdrew Consent|2
7413972|NCT01430442|11686546|FG000|Overall Study|Lost to Follow-up|2
7413973|NCT01430442|11686547|FG001|Overall Study|Lost to Follow-up|0
7413974|NCT01430442|11686548|FG002|Overall Study|Lost to Follow-up|1
7413975|NCT01430442|11686549|FG003|Overall Study|Lost to Follow-up|2
7318009|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7318010|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
7318011|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
7318012|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
7318013|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7318014|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
7318015|NCT00726232|11547072|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
7318016|NCT00726232|11547073|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
7413976|NCT01430442|11686550|FG004|Overall Study|Lost to Follow-up|2
7225036|NCT00063882|11434526|FG001|Overall Study|Withdrawal by Subject|1
7225037|NCT00063934|11434532|FG000|Overall Study|Ineligible|1
7225038|NCT00063986|11434536|FG000|Overall Study|Withdrawal by Subject|1
7225039|NCT00063986|11434536|FG000|Overall Study|Ineligible|1
7225040|NCT00063986|11434536|FG000|Overall Study|Intra-operatively ineligible|4
7225041|NCT00063999|11434542|FG000|Overall Study|Withdrawal by Subject|1
7225042|NCT00063999|11434543|FG001|Overall Study|Withdrawal by Subject|0
7225043|NCT00063999|11434542|FG000|Overall Study|Ineligible|44
7225044|NCT00063999|11434543|FG001|Overall Study|Ineligible|24
7225045|NCT00064025|11434556|FG000|Overall Study|Ineligible|4
7225046|NCT00064025|11434556|FG000|Overall Study|Inevaluable|3
7225047|NCT00064077|11434579|FG000|Overall Study|Improper prior treatment|1
7225048|NCT00064077|11434580|FG001|Overall Study|Improper prior treatment|0
7225049|NCT00064077|11434581|FG002|Overall Study|Improper prior treatment|0
7225050|NCT00064077|11434582|FG003|Overall Study|Improper prior treatment|0
7225051|NCT00064077|11434579|FG000|Overall Study|Poor risk|2
7225052|NCT00064077|11434580|FG001|Overall Study|Poor risk|0
7225053|NCT00064077|11434581|FG002|Overall Study|Poor risk|1
7225054|NCT00064077|11434582|FG003|Overall Study|Poor risk|1
7225055|NCT00064077|11434579|FG000|Overall Study|Pathology|10
7225056|NCT00064077|11434580|FG001|Overall Study|Pathology|7
7225057|NCT00064077|11434581|FG002|Overall Study|Pathology|3
7225058|NCT00064077|11434582|FG003|Overall Study|Pathology|4
7225059|NCT00064077|11434579|FG000|Overall Study|No surgery|0
7225060|NCT00064077|11434580|FG001|Overall Study|No surgery|0
7225061|NCT00064077|11434581|FG002|Overall Study|No surgery|1
7225062|NCT00064077|11434582|FG003|Overall Study|No surgery|0
7225063|NCT00064077|11434579|FG000|Overall Study|No tumor|0
7225064|NCT00064077|11434580|FG001|Overall Study|No tumor|0
7225065|NCT00064077|11434581|FG002|Overall Study|No tumor|1
7225066|NCT00064077|11434582|FG003|Overall Study|No tumor|0
7225067|NCT00064077|11434579|FG000|Overall Study|Other reasons|2
7225068|NCT00064077|11434580|FG001|Overall Study|Other reasons|2
7225069|NCT00064077|11434581|FG002|Overall Study|Other reasons|1
7225070|NCT00064077|11434582|FG003|Overall Study|Other reasons|2
7225071|NCT00064259|11434592|FG000|Overall Study|Adverse Event|1
7225072|NCT00064259|11434593|FG001|Overall Study|Adverse Event|0
7225073|NCT00064259|11434594|FG002|Overall Study|Adverse Event|0
7225074|NCT00064259|11434595|FG003|Overall Study|Adverse Event|1
7225075|NCT00064298|11434602|FG000|Overall Study|Withdrawal by Subject|2
7225076|NCT00064298|11434603|FG001|Overall Study|Withdrawal by Subject|1
7225077|NCT00064298|11434602|FG000|Overall Study|Lost to Follow-up|2
7225078|NCT00064298|11434603|FG001|Overall Study|Lost to Follow-up|2
7225079|NCT00064298|11434602|FG000|Overall Study|Death|0
7225080|NCT00064298|11434603|FG001|Overall Study|Death|1
7225081|NCT00064298|11434602|FG000|Overall Study|Disease Progression|2
7225082|NCT00064298|11434603|FG001|Overall Study|Disease Progression|1
7225083|NCT00064337|11434609|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
7225084|NCT00064337|11434609|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
7529273|NCT02616601|11871826|FG002|Overall Study|Death|0
7529274|NCT02616601|11871824|FG000|Overall Study|Lost to Follow-up|1
7529275|NCT02616601|11871825|FG001|Overall Study|Lost to Follow-up|0
7529276|NCT02616601|11871826|FG002|Overall Study|Lost to Follow-up|1
7529277|NCT02616601|11871824|FG000|Overall Study|Non-Compliance with Test Article|1
7225085|NCT00064337|11434609|FG000|PBSCC or Induction/PBSCC|Progression|3
7225086|NCT00064337|11434609|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
7225087|NCT00064337|11434609|FG000|PBSCC or Induction/PBSCC|Death|2
7413977|NCT01430442|11686551|FG005|Overall Study|Lost to Follow-up|1
7529278|NCT02616601|11871825|FG001|Overall Study|Non-Compliance with Test Article|0
7225088|NCT00064337|11434609|FG000|Transplant|Adverse Event|9
7225089|NCT00064337|11434609|FG000|Transplant|Not protocol-specified|5
7529279|NCT02616601|11871826|FG002|Overall Study|Non-Compliance with Test Article|1
7225090|NCT00064337|11434609|FG000|Transplant|Death|3
7225091|NCT00064337|11434609|FG000|Transplant|Patient Refusal|2
7225092|NCT00064337|11434609|FG000|Transplant|Progression|2
7225093|NCT00064337|11434609|FG000|Maintenance|Adverse Event|3
7225094|NCT00064337|11434609|FG000|Maintenance|Progression|2
7225095|NCT00064337|11434609|FG000|Maintenance|On treatment at time of analysis|2
7225096|NCT00064337|11434609|FG000|Maintenance|Not protocol-specified|2
7225097|NCT00064337|11434609|FG000|Maintenance|Death|1
7225098|NCT00064350|11434619|FG000|Induction Treatment|Disease Progression|5
7225099|NCT00064350|11434620|FG001|Induction Treatment|Disease Progression|1
7413978|NCT01430442|11686552|FG006|Overall Study|Lost to Follow-up|5
7413979|NCT01430442|11686553|FG007|Overall Study|Lost to Follow-up|1
7413980|NCT01430442|11686546|FG000|Overall Study|Pregnancy|1
7413981|NCT01430442|11686547|FG001|Overall Study|Pregnancy|0
7413982|NCT01430442|11686548|FG002|Overall Study|Pregnancy|0
7413983|NCT01430442|11686549|FG003|Overall Study|Pregnancy|0
7413984|NCT01430442|11686550|FG004|Overall Study|Pregnancy|0
7413985|NCT01430442|11686551|FG005|Overall Study|Pregnancy|1
7413986|NCT01430442|11686552|FG006|Overall Study|Pregnancy|0
7413987|NCT01430442|11686553|FG007|Overall Study|Pregnancy|0
7413988|NCT01430442|11686546|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
7413989|NCT01430442|11686547|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
7413990|NCT01430442|11686548|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
7413991|NCT01430442|11686549|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
7413992|NCT01430442|11686550|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
7413993|NCT01430442|11686551|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
7529280|NCT02616614|11871837|FG000|Overall Study|Withdrawal by Subject|10
7529281|NCT02616614|11871838|FG001|Overall Study|Withdrawal by Subject|5
7529282|NCT02616614|11871839|FG002|Overall Study|Withdrawal by Subject|6
7529283|NCT02616614|11871837|FG000|Overall Study|Physician Decision|2
7529284|NCT02616614|11871838|FG001|Overall Study|Physician Decision|1
7529285|NCT02616614|11871839|FG002|Overall Study|Physician Decision|0
7529286|NCT02616614|11871837|FG000|Overall Study|Adverse Event|1
7529287|NCT02616614|11871838|FG001|Overall Study|Adverse Event|4
7529288|NCT02616614|11871839|FG002|Overall Study|Adverse Event|1
7529289|NCT02616614|11871837|FG000|Overall Study|Protocol Violation|0
7529290|NCT02616614|11871838|FG001|Overall Study|Protocol Violation|3
7529291|NCT02616614|11871839|FG002|Overall Study|Protocol Violation|1
7529292|NCT02616614|11871837|FG000|Overall Study|Prohibited Medication|12
7529293|NCT02616614|11871838|FG001|Overall Study|Prohibited Medication|9
7529294|NCT02616614|11871839|FG002|Overall Study|Prohibited Medication|5
7529295|NCT02616614|11871837|FG000|Overall Study|More than 3 applications missed|6
7529296|NCT02616614|11871838|FG001|Overall Study|More than 3 applications missed|8
7529297|NCT02616614|11871839|FG002|Overall Study|More than 3 applications missed|1
7529298|NCT02616614|11871837|FG000|Overall Study|Lost to Follow-up|31
7529299|NCT02616614|11871838|FG001|Overall Study|Lost to Follow-up|28
7529300|NCT02616614|11871839|FG002|Overall Study|Lost to Follow-up|13
7529301|NCT02616614|11871837|FG000|Overall Study|Pregnancy|2
7529302|NCT02616614|11871838|FG001|Overall Study|Pregnancy|0
7529303|NCT02616614|11871839|FG002|Overall Study|Pregnancy|1
7529304|NCT02616614|11871837|FG000|Overall Study|Other|1
7529305|NCT02616614|11871838|FG001|Overall Study|Other|2
7529306|NCT02616614|11871839|FG002|Overall Study|Other|1
7529307|NCT02616783|11871850|FG000|Overall Study|Randomized but Not Treated|1
7529308|NCT02616783|11871851|FG001|Overall Study|Randomized but Not Treated|0
7529309|NCT02616783|11871850|FG000|Overall Study|Adverse Event|1
7529310|NCT02616783|11871851|FG001|Overall Study|Adverse Event|0
7529311|NCT02616783|11871850|FG000|Overall Study|Death|1
7529312|NCT02616783|11871851|FG001|Overall Study|Death|0
7529313|NCT02616783|11871850|FG000|Overall Study|Non-Compliance with Study Drug|1
7529314|NCT02616783|11871851|FG001|Overall Study|Non-Compliance with Study Drug|0
7529315|NCT02616783|11871850|FG000|Overall Study|Protocol Violation|1
7529316|NCT02616783|11871851|FG001|Overall Study|Protocol Violation|1
7529317|NCT02616783|11871850|FG000|Overall Study|Withdrew Consent|1
7529318|NCT02616783|11871851|FG001|Overall Study|Withdrew Consent|1
7529319|NCT02616900|11871857|FG000|Overall Study|Lack of Efficacy|7
7529320|NCT02616900|11871857|FG000|Overall Study|Lost to Follow-up|2
7529321|NCT02616900|11871857|FG000|Overall Study|Protocol Violation|5
7529322|NCT02616900|11871857|FG000|Overall Study|Withdrawal by Subject|3
7529323|NCT02616900|11871857|FG000|Overall Study|Incomplete data|6
7529324|NCT02617628|11871863|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
7529325|NCT02617628|11871864|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
7529326|NCT02618382|11871952|FG000|Overall Study|Physician Decision|1
7529327|NCT02618382|11871952|FG000|Overall Study|Withdrawal by Subject|1
7529328|NCT02618382|11871952|FG000|Overall Study|Protocol Violation|1
7529329|NCT02618616|11871962|FG000|Overall Study|Lack of Efficacy|4
7529330|NCT02618616|11871963|FG001|Overall Study|Lack of Efficacy|0
7529331|NCT02618616|11871962|FG000|Overall Study|Pregnancy|0
7529332|NCT02618616|11871963|FG001|Overall Study|Pregnancy|1
7529333|NCT02618616|11871962|FG000|Overall Study|Adverse Event|8
7529334|NCT02618616|11871963|FG001|Overall Study|Adverse Event|0
7529335|NCT02618616|11871962|FG000|Overall Study|Failure to comply with dosing/evaluation|1
7529336|NCT02618616|11871963|FG001|Overall Study|Failure to comply with dosing/evaluation|0
7529337|NCT02618616|11871962|FG000|Overall Study|Consent withdrawn by subject|8
7529338|NCT02618616|11871963|FG001|Overall Study|Consent withdrawn by subject|5
7529339|NCT02618616|11871962|FG000|Overall Study|Lost to Follow-up|0
7529340|NCT02618616|11871963|FG001|Overall Study|Lost to Follow-up|1
7529341|NCT02618759|11871996|FG000|Overall Study|Lost to Follow-up|0
7529342|NCT02618759|11871997|FG001|Overall Study|Lost to Follow-up|1
7529343|NCT02618759|11871996|FG000|Overall Study|Withdrawal by Subject|1
7529344|NCT02618759|11871997|FG001|Overall Study|Withdrawal by Subject|0
7529345|NCT02618759|11871996|FG000|Overall Study|Other Reasons|1
7529346|NCT02618759|11871997|FG001|Overall Study|Other Reasons|4
7529347|NCT02618928|11872023|FG000|Overall Study|Failure to Return|28
7529348|NCT02618928|11872023|FG000|Overall Study|Insufficient Virological Response|1
7529349|NCT02618928|11872023|FG000|Overall Study|Withdrawal by Subject|2
7529350|NCT02618928|11872023|FG000|Overall Study|Death|3
7529351|NCT02618928|11872023|FG000|Overall Study|Other|11
7529352|NCT02618928|11872023|FG000|Overall Study|Missing|6
7318017|NCT00726232|11547074|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
7318018|NCT00726232|11547075|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
7318019|NCT00726232|11547076|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
7318020|NCT00726232|11547077|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
7318021|NCT00726232|11547078|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
7318022|NCT00726232|11547079|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
7318023|NCT00726232|11547072|FG000|Expansion Phase|Death|0
7318024|NCT00726232|11547073|FG001|Expansion Phase|Death|0
7318025|NCT00726232|11547074|FG002|Expansion Phase|Death|0
7318026|NCT00726232|11547075|FG003|Expansion Phase|Death|0
7318027|NCT00726232|11547076|FG004|Expansion Phase|Death|0
7318028|NCT00726232|11547077|FG005|Expansion Phase|Death|0
7318029|NCT00726232|11547078|FG006|Expansion Phase|Death|0
7318030|NCT00726232|11547079|FG007|Expansion Phase|Death|1
7318031|NCT00726232|11547072|FG000|Expansion Phase|Adverse Event|0
7318032|NCT00726232|11547073|FG001|Expansion Phase|Adverse Event|0
7318033|NCT00726232|11547074|FG002|Expansion Phase|Adverse Event|0
7318034|NCT00726232|11547075|FG003|Expansion Phase|Adverse Event|0
7318035|NCT00726232|11547076|FG004|Expansion Phase|Adverse Event|0
7318036|NCT00726232|11547077|FG005|Expansion Phase|Adverse Event|0
7318037|NCT00726232|11547078|FG006|Expansion Phase|Adverse Event|6
7318038|NCT00726232|11547079|FG007|Expansion Phase|Adverse Event|11
7318039|NCT00726232|11547072|FG000|Expansion Phase|Withdrawal by Subject|0
7318040|NCT00726232|11547073|FG001|Expansion Phase|Withdrawal by Subject|0
7318041|NCT00726232|11547074|FG002|Expansion Phase|Withdrawal by Subject|0
7318042|NCT00726232|11547075|FG003|Expansion Phase|Withdrawal by Subject|0
7318043|NCT00726232|11547076|FG004|Expansion Phase|Withdrawal by Subject|0
7318044|NCT00726232|11547077|FG005|Expansion Phase|Withdrawal by Subject|0
7318045|NCT00726232|11547078|FG006|Expansion Phase|Withdrawal by Subject|2
7318046|NCT00726232|11547079|FG007|Expansion Phase|Withdrawal by Subject|3
7318047|NCT00726232|11547072|FG000|Expansion Phase|Disease progression|0
7318048|NCT00726232|11547073|FG001|Expansion Phase|Disease progression|0
7318049|NCT00726232|11547074|FG002|Expansion Phase|Disease progression|0
7318050|NCT00726232|11547075|FG003|Expansion Phase|Disease progression|0
7318051|NCT00726232|11547076|FG004|Expansion Phase|Disease progression|0
7318052|NCT00726232|11547077|FG005|Expansion Phase|Disease progression|0
7318053|NCT00726232|11547078|FG006|Expansion Phase|Disease progression|4
7318054|NCT00726232|11547079|FG007|Expansion Phase|Disease progression|0
7318055|NCT00726232|11547072|FG000|Expansion Phase|Termination of the trial by sponsor|0
7318056|NCT00726232|11547073|FG001|Expansion Phase|Termination of the trial by sponsor|0
7318057|NCT00726232|11547074|FG002|Expansion Phase|Termination of the trial by sponsor|0
7318058|NCT00726232|11547075|FG003|Expansion Phase|Termination of the trial by sponsor|0
7318059|NCT00726232|11547076|FG004|Expansion Phase|Termination of the trial by sponsor|0
7318060|NCT00726232|11547077|FG005|Expansion Phase|Termination of the trial by sponsor|0
7529353|NCT02618928|11872023|FG000|Overall Study|Treatment Never Started|7
7529354|NCT02618967|11872038|FG000|Overall Study|Lost to Follow-up|0
7529355|NCT02618967|11872039|FG001|Overall Study|Lost to Follow-up|0
7529356|NCT02618967|11872040|FG002|Overall Study|Lost to Follow-up|1
7529357|NCT02618967|11872041|FG003|Overall Study|Lost to Follow-up|0
7529358|NCT02618967|11872042|FG004|Overall Study|Lost to Follow-up|2
7529359|NCT02618967|11872043|FG005|Overall Study|Lost to Follow-up|0
7529360|NCT02618967|11872044|FG006|Overall Study|Lost to Follow-up|0
7529361|NCT02618967|11872045|FG007|Overall Study|Lost to Follow-up|0
7529362|NCT02618967|11872038|FG000|Overall Study|Withdrawal by Subject|1
7529363|NCT02618967|11872039|FG001|Overall Study|Withdrawal by Subject|0
7529364|NCT02618967|11872040|FG002|Overall Study|Withdrawal by Subject|0
7413994|NCT01430442|11686552|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
7413995|NCT01430442|11686553|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
7413996|NCT01430455|11686571|FG000|Overall Study|Withdrawal by Subject|1
7413997|NCT01430455|11686571|FG000|Overall Study|Switched to follow-up phase|1
7413998|NCT01430468|11686577|FG000|Overall Study|Physician Decision|2
7413999|NCT01430468|11686578|FG001|Overall Study|Physician Decision|1
7414000|NCT01430468|11686577|FG000|Overall Study|Withdrawal by Subject|5
7414001|NCT01430468|11686578|FG001|Overall Study|Withdrawal by Subject|5
7414002|NCT01430559|11686586|FG000|Overall Study|Adverse Event|7
7414003|NCT01430559|11686587|FG001|Overall Study|Adverse Event|3
7414004|NCT01430559|11686586|FG000|Overall Study|Entry criteria not met|1
7414005|NCT01430559|11686587|FG001|Overall Study|Entry criteria not met|1
7414006|NCT01430559|11686586|FG000|Overall Study|Lost to Follow-up|1
7414007|NCT01430559|11686587|FG001|Overall Study|Lost to Follow-up|0
7414008|NCT01430559|11686586|FG000|Overall Study|Medication error|1
7414009|NCT01430559|11686587|FG001|Overall Study|Medication error|0
7414010|NCT01430559|11686586|FG000|Overall Study|Withdrawal by Subject|3
7414011|NCT01430559|11686587|FG001|Overall Study|Withdrawal by Subject|2
7414012|NCT01430559|11686586|FG000|Overall Study|Protocol Violation|1
7414013|NCT01430559|11686587|FG001|Overall Study|Protocol Violation|0
7414014|NCT01430559|11686586|FG000|Overall Study|Other|3
7414015|NCT01430559|11686587|FG001|Overall Study|Other|3
7414016|NCT01430559|11686586|FG000|Overall Study|Randomized, Not Treated|3
7414017|NCT01430559|11686587|FG001|Overall Study|Randomized, Not Treated|3
7414018|NCT01430585|11686598|FG000|Overall Study|Death|1
7414019|NCT01430585|11686598|FG000|Overall Study|Objective Progression or Relapse|3
7414020|NCT01430585|11686598|FG000|Overall Study|Study Terminated by Sponsor|3
7414021|NCT01430585|11686598|FG000|Overall Study|Other|7
7414022|NCT01430611|11686610|FG000|Overall Study|Adverse Event|0
7414023|NCT01430611|11686611|FG001|Overall Study|Adverse Event|1
7414024|NCT01430611|11686610|FG000|Overall Study|Protocol Violation|1
7414025|NCT01430611|11686611|FG001|Overall Study|Protocol Violation|0
7414026|NCT01430611|11686610|FG000|Overall Study|Lost to Follow-up|1
7414027|NCT01430611|11686611|FG001|Overall Study|Lost to Follow-up|0
7414028|NCT01430611|11686610|FG000|Overall Study|Withdrawal by Subject|15
7414029|NCT01430611|11686611|FG001|Overall Study|Withdrawal by Subject|14
7414030|NCT01430624|11686620|FG000|Overall Study|Lost to Follow-up|23
7414031|NCT01430624|11686621|FG001|Overall Study|Lost to Follow-up|29
7414032|NCT01430624|11686622|FG002|Overall Study|Lost to Follow-up|27
7414033|NCT01430624|11686620|FG000|Overall Study|technical or eligibility|5
7414034|NCT01430624|11686621|FG001|Overall Study|technical or eligibility|5
7414035|NCT01430624|11686622|FG002|Overall Study|technical or eligibility|2
7414036|NCT01430754|11686654|FG000|Run-In Phase|Circadian Period Ineligible|24
7414037|NCT01430754|11686655|FG001|Run-In Phase|Circadian Period Ineligible|0
7414038|NCT01430754|11686654|FG000|Run-In Phase|Protocol Violation|6
7414039|NCT01430754|11686655|FG001|Run-In Phase|Protocol Violation|0
7414040|NCT01430754|11686654|FG000|Run-In Phase|Adverse Event|2
7414041|NCT01430754|11686655|FG001|Run-In Phase|Adverse Event|0
7414042|NCT01430754|11686654|FG000|Run-In Phase|Other|2
7414043|NCT01430754|11686655|FG001|Run-In Phase|Other|0
7414044|NCT01430754|11686654|FG000|Run-In Phase|Withdrawal by Subject|2
7414045|NCT01430754|11686655|FG001|Run-In Phase|Withdrawal by Subject|0
7414046|NCT01430754|11686654|FG000|Run-In Phase|Lost to Follow-up|1
7414047|NCT01430754|11686655|FG001|Run-In Phase|Lost to Follow-up|0
7414048|NCT01431079|11686683|FG000|Overall Study|Lost to Follow-up|35
7414049|NCT01431079|11686684|FG001|Overall Study|Lost to Follow-up|39
7414050|NCT01431144|11686729|FG000|Overall Study|Implant mobility and removal|2
7414051|NCT01431144|11686730|FG001|Overall Study|Implant mobility and removal|0
7414052|NCT01431274|11686769|FG000|Overall Study|Adverse Event|51
7414053|NCT01431274|11686770|FG001|Overall Study|Adverse Event|37
7414054|NCT01431274|11686771|FG002|Overall Study|Adverse Event|43
7414055|NCT01431274|11686772|FG003|Overall Study|Adverse Event|30
7414056|NCT01431274|11686773|FG004|Overall Study|Adverse Event|37
7414057|NCT01431274|11686769|FG000|Overall Study|Consent withdrawn not due to AE|29
7414058|NCT01431274|11686770|FG001|Overall Study|Consent withdrawn not due to AE|20
7414059|NCT01431274|11686771|FG002|Overall Study|Consent withdrawn not due to AE|17
7414060|NCT01431274|11686772|FG003|Overall Study|Consent withdrawn not due to AE|20
7414061|NCT01431274|11686773|FG004|Overall Study|Consent withdrawn not due to AE|11
7414062|NCT01431274|11686769|FG000|Overall Study|Non compliant with protocol|5
7414063|NCT01431274|11686770|FG001|Overall Study|Non compliant with protocol|8
7414064|NCT01431274|11686771|FG002|Overall Study|Non compliant with protocol|4
7414065|NCT01431274|11686772|FG003|Overall Study|Non compliant with protocol|4
7414066|NCT01431274|11686773|FG004|Overall Study|Non compliant with protocol|4
7414067|NCT01431274|11686769|FG000|Overall Study|Lost to Follow-up|6
7529365|NCT02618967|11872041|FG003|Overall Study|Withdrawal by Subject|0
7529366|NCT02618967|11872042|FG004|Overall Study|Withdrawal by Subject|0
7529367|NCT02618967|11872043|FG005|Overall Study|Withdrawal by Subject|0
7529368|NCT02618967|11872044|FG006|Overall Study|Withdrawal by Subject|0
7529369|NCT02618967|11872045|FG007|Overall Study|Withdrawal by Subject|0
7529370|NCT02619175|11872065|FG000|Overall Study|Withdrawal by Subject|1
7529371|NCT02619175|11872066|FG001|Overall Study|Withdrawal by Subject|0
7529372|NCT02619175|11872065|FG000|Overall Study|foot pain|1
7529373|NCT02619175|11872066|FG001|Overall Study|foot pain|0
7529374|NCT02619617|11872124|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
7529375|NCT02619617|11872125|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
7529376|NCT02619617|11872124|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
7529377|NCT02619617|11872125|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
7529378|NCT02620020|11872146|FG000|Overall Study|Adverse Event|8
7529379|NCT02620020|11872147|FG001|Overall Study|Adverse Event|4
7529380|NCT02620020|11872148|FG002|Overall Study|Adverse Event|3
7529381|NCT02620020|11872149|FG003|Overall Study|Adverse Event|5
7529382|NCT02620020|11872146|FG000|Overall Study|Lost to Follow-up|4
7529383|NCT02620020|11872147|FG001|Overall Study|Lost to Follow-up|8
7529384|NCT02620020|11872148|FG002|Overall Study|Lost to Follow-up|1
7529385|NCT02620020|11872149|FG003|Overall Study|Lost to Follow-up|4
7529386|NCT02620020|11872146|FG000|Overall Study|Physician Decision|7
7529387|NCT02620020|11872147|FG001|Overall Study|Physician Decision|4
7529388|NCT02620020|11872148|FG002|Overall Study|Physician Decision|3
7529389|NCT02620020|11872149|FG003|Overall Study|Physician Decision|4
7529390|NCT02620020|11872146|FG000|Overall Study|Protocol Violation|5
7529391|NCT02620020|11872147|FG001|Overall Study|Protocol Violation|2
7529392|NCT02620020|11872148|FG002|Overall Study|Protocol Violation|1
7529393|NCT02620020|11872149|FG003|Overall Study|Protocol Violation|1
7529394|NCT02620020|11872146|FG000|Overall Study|Withdrawal by Subject|20
7529395|NCT02620020|11872147|FG001|Overall Study|Withdrawal by Subject|16
7529396|NCT02620020|11872148|FG002|Overall Study|Withdrawal by Subject|17
7529397|NCT02620020|11872149|FG003|Overall Study|Withdrawal by Subject|12
7529398|NCT02620020|11872146|FG000|Overall Study|Death|0
7529399|NCT02620020|11872147|FG001|Overall Study|Death|1
7529400|NCT02620020|11872148|FG002|Overall Study|Death|0
7529401|NCT02620020|11872149|FG003|Overall Study|Death|0
7529402|NCT02620384|11872161|FG000|Overall Study|Adverse Event|2
7529403|NCT02620384|11872162|FG001|Overall Study|Adverse Event|1
7529404|NCT02620384|11872161|FG000|Overall Study|Discharged prior to 2nd dose|2
7529405|NCT02620384|11872162|FG001|Overall Study|Discharged prior to 2nd dose|5
7529406|NCT02620384|11872161|FG000|Overall Study|Drug shortage prevented 2nd dose|0
7529407|NCT02620384|11872162|FG001|Overall Study|Drug shortage prevented 2nd dose|1
7529408|NCT02620787|11872185|FG000|Overall Study|Adverse Event|1
7529409|NCT02620787|11872186|FG001|Overall Study|Adverse Event|0
7529410|NCT02620787|11872185|FG000|Overall Study|Eligibility Criteria Not Met|1
7529411|NCT02620787|11872186|FG001|Overall Study|Eligibility Criteria Not Met|0
7529412|NCT02621034|11872217|FG000|Overall Study|Lost to Follow-up|3
7529413|NCT02621034|11872218|FG001|Overall Study|Lost to Follow-up|2
7529414|NCT02621034|11872219|FG002|Overall Study|Lost to Follow-up|5
7529415|NCT02621047|11872232|FG000|Overall Study|Adverse Event|0
7529416|NCT02621047|11872233|FG001|Overall Study|Adverse Event|0
7529417|NCT02621047|11872234|FG002|Overall Study|Adverse Event|1
7529418|NCT02621073|11872254|FG000|Overall Study|Lost to Follow-up|0
7529419|NCT02621073|11872255|FG001|Overall Study|Lost to Follow-up|1
7529420|NCT02621073|11872254|FG000|Overall Study|Physician Decision|3
7529421|NCT02621073|11872255|FG001|Overall Study|Physician Decision|2
7529422|NCT02621931|11872286|FG000|Overall Study|Death|0
7414068|NCT01431274|11686770|FG001|Overall Study|Lost to Follow-up|7
7414069|NCT01431274|11686771|FG002|Overall Study|Lost to Follow-up|1
7414070|NCT01431274|11686772|FG003|Overall Study|Lost to Follow-up|4
7414071|NCT01431274|11686773|FG004|Overall Study|Lost to Follow-up|0
7414072|NCT01431274|11686769|FG000|Overall Study|Other reason not stated above|6
7414073|NCT01431274|11686770|FG001|Overall Study|Other reason not stated above|5
7414074|NCT01431274|11686771|FG002|Overall Study|Other reason not stated above|7
7414075|NCT01431274|11686772|FG003|Overall Study|Other reason not stated above|2
7414076|NCT01431274|11686773|FG004|Overall Study|Other reason not stated above|4
7414077|NCT01431287|11686790|FG000|Overall Study|not treated|0
7414078|NCT01431287|11686791|FG001|Overall Study|not treated|0
7529423|NCT02621931|11872287|FG001|Overall Study|Death|1
7529424|NCT02621931|11872288|FG002|Overall Study|Death|0
7414079|NCT01431287|11686792|FG002|Overall Study|not treated|1
7529425|NCT02621931|11872286|FG000|Overall Study|Adverse Event|8
7529426|NCT02621931|11872287|FG001|Overall Study|Adverse Event|5
7529427|NCT02621931|11872288|FG002|Overall Study|Adverse Event|7
7529428|NCT02621931|11872286|FG000|Overall Study|Withdrawal by Subject|12
7529429|NCT02621931|11872287|FG001|Overall Study|Withdrawal by Subject|10
7529430|NCT02621931|11872288|FG002|Overall Study|Withdrawal by Subject|11
7529431|NCT02621931|11872286|FG000|Overall Study|Protocol Violation|2
7529432|NCT02621931|11872287|FG001|Overall Study|Protocol Violation|2
7529433|NCT02621931|11872288|FG002|Overall Study|Protocol Violation|2
7529434|NCT02621931|11872286|FG000|Overall Study|Pregnancy|2
7529435|NCT02621931|11872287|FG001|Overall Study|Pregnancy|0
7529436|NCT02621931|11872288|FG002|Overall Study|Pregnancy|0
7529437|NCT02621931|11872286|FG000|Overall Study|Noncompliance to study procedures|0
7529438|NCT02621931|11872287|FG001|Overall Study|Noncompliance to study procedures|1
7529439|NCT02621931|11872288|FG002|Overall Study|Noncompliance to study procedures|2
7529440|NCT02621931|11872286|FG000|Overall Study|Lost to Follow-up|8
7529441|NCT02621931|11872287|FG001|Overall Study|Lost to Follow-up|7
7529442|NCT02621931|11872288|FG002|Overall Study|Lost to Follow-up|10
7529443|NCT02621931|11872286|FG000|Overall Study|Lack of Efficacy|0
7529444|NCT02621931|11872287|FG001|Overall Study|Lack of Efficacy|0
7529445|NCT02621931|11872288|FG002|Overall Study|Lack of Efficacy|1
7529446|NCT02621931|11872286|FG000|Overall Study|Other|1
7529447|NCT02621931|11872287|FG001|Overall Study|Other|1
7529448|NCT02621931|11872288|FG002|Overall Study|Other|3
7529449|NCT02622074|11872313|FG000|Overall Study|Death|4
7529450|NCT02622074|11872314|FG001|Overall Study|Death|0
7529451|NCT02622074|11872315|FG002|Overall Study|Death|0
7529452|NCT02622074|11872316|FG003|Overall Study|Death|1
7529453|NCT02622074|11872317|FG004|Overall Study|Death|1
7529454|NCT02622074|11872318|FG005|Overall Study|Death|0
7529455|NCT02622074|11872313|FG000|Overall Study|Withdrawal by Subject|0
7529456|NCT02622074|11872314|FG001|Overall Study|Withdrawal by Subject|1
7529457|NCT02622074|11872315|FG002|Overall Study|Withdrawal by Subject|0
7529458|NCT02622074|11872316|FG003|Overall Study|Withdrawal by Subject|0
7529459|NCT02622074|11872317|FG004|Overall Study|Withdrawal by Subject|0
7529460|NCT02622074|11872318|FG005|Overall Study|Withdrawal by Subject|0
7529461|NCT02622113|11872334|FG000|Overall Study|Adverse Event|4
7529462|NCT02622113|11872335|FG001|Overall Study|Adverse Event|4
7529463|NCT02622113|11872334|FG000|Overall Study|Physician Decision|0
7529464|NCT02622113|11872335|FG001|Overall Study|Physician Decision|1
7529465|NCT02622113|11872334|FG000|Overall Study|Withdrawal by Subject|0
7529466|NCT02622113|11872335|FG001|Overall Study|Withdrawal by Subject|2
7529467|NCT02622113|11872334|FG000|Overall Study|Stopping Criteria|1
7529468|NCT02622113|11872335|FG001|Overall Study|Stopping Criteria|3
7529469|NCT02622321|11872369|FG000|Overall Study|Withdrawal by Subject|2
7529470|NCT02622321|11872370|FG001|Overall Study|Withdrawal by Subject|0
7529471|NCT02622321|11872371|FG002|Overall Study|Withdrawal by Subject|0
7529472|NCT02622321|11872372|FG003|Overall Study|Withdrawal by Subject|0
7529473|NCT02622321|11872369|FG000|Overall Study|Death|0
7529474|NCT02622321|11872370|FG001|Overall Study|Death|0
7529475|NCT02622321|11872371|FG002|Overall Study|Death|1
7529476|NCT02622321|11872372|FG003|Overall Study|Death|0
7414080|NCT01431287|11686793|FG003|Overall Study|not treated|0
7529477|NCT02622321|11872369|FG000|Overall Study|Physician Decision|1
7529478|NCT02622321|11872370|FG001|Overall Study|Physician Decision|0
7529479|NCT02622321|11872371|FG002|Overall Study|Physician Decision|0
7529480|NCT02622321|11872372|FG003|Overall Study|Physician Decision|0
7529481|NCT02622568|11872398|FG000|Overall Study|Lost to Follow-up|5
7529482|NCT02622568|11872399|FG001|Overall Study|Lost to Follow-up|5
7414081|NCT01431287|11686794|FG004|Overall Study|not treated|0
7414082|NCT01431287|11686790|FG000|Overall Study|Adverse Event|59
7414083|NCT01431287|11686791|FG001|Overall Study|Adverse Event|57
7414084|NCT01431287|11686792|FG002|Overall Study|Adverse Event|53
7414085|NCT01431287|11686793|FG003|Overall Study|Adverse Event|33
7414086|NCT01431287|11686794|FG004|Overall Study|Adverse Event|41
7414087|NCT01431287|11686790|FG000|Overall Study|Non compliant with protocol|6
7529483|NCT02622724|11872407|FG000|Overall Study|Death|51
7529484|NCT02622724|11872408|FG001|Overall Study|Death|53
7529485|NCT02622724|11872407|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
7529486|NCT02622724|11872408|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
7529487|NCT02622724|11872407|FG000|Overall Study|Early termination of study|38
7529488|NCT02622724|11872408|FG001|Overall Study|Early termination of study|43
7529489|NCT02623218|11872425|FG000|Overall Study|Lost to Follow-up|0
7529490|NCT02623218|11872426|FG001|Overall Study|Lost to Follow-up|1
7529491|NCT02623218|11872427|FG002|Overall Study|Lost to Follow-up|0
7529492|NCT02623218|11872428|FG003|Overall Study|Lost to Follow-up|0
7529493|NCT02623218|11872429|FG004|Overall Study|Lost to Follow-up|0
7529494|NCT02623322|11872444|FG000|Overall Study|Lost to Follow-up|2
7529495|NCT02623322|11872445|FG001|Overall Study|Lost to Follow-up|1
7529496|NCT02623322|11872446|FG002|Overall Study|Lost to Follow-up|0
7529497|NCT02623335|11872458|FG000|Overall Study|Death|8
7529498|NCT02623335|11872459|FG001|Overall Study|Death|7
7529499|NCT02623335|11872458|FG000|Overall Study|Lost to Follow-up|15
7529500|NCT02623335|11872459|FG001|Overall Study|Lost to Follow-up|23
7529501|NCT02623335|11872458|FG000|Overall Study|Withdrawal by Subject|2
7529502|NCT02623335|11872459|FG001|Overall Study|Withdrawal by Subject|5
7529503|NCT02623335|11872458|FG000|Overall Study|Protocol Violation|2
7529504|NCT02623335|11872459|FG001|Overall Study|Protocol Violation|1
7529505|NCT02623361|11872476|FG000|Overall Study|Protocol Violation|0
7529506|NCT02623361|11872477|FG001|Overall Study|Protocol Violation|1
7529507|NCT02623361|11872476|FG000|Overall Study|Withdrawal by Subject|0
7529508|NCT02623361|11872477|FG001|Overall Study|Withdrawal by Subject|1
7537544|NCT03591874|11886492|FG001|Overall Study|Adverse Event|0
7537545|NCT03591874|11886491|FG000|Overall Study|Withdrawal by Subject|2
7537546|NCT03591874|11886492|FG001|Overall Study|Withdrawal by Subject|1
7537547|NCT03591874|11886491|FG000|Overall Study|Investigator Withdrawal of Subject|1
7537548|NCT03591874|11886492|FG001|Overall Study|Investigator Withdrawal of Subject|0
7537549|NCT03591874|11886491|FG000|Overall Study|On Study at Time of Study Termination|12
7537550|NCT03591874|11886492|FG001|Overall Study|On Study at Time of Study Termination|6
7537572|NCT03418727|11886543|FG000|Overall Study|Adverse Event|1
7537573|NCT03418727|11886544|FG001|Overall Study|Adverse Event|2
7537574|NCT03418727|11886545|FG002|Overall Study|Adverse Event|0
7537575|NCT03418727|11886543|FG000|Overall Study|Withdrawal by Subject|0
7537576|NCT03418727|11886544|FG001|Overall Study|Withdrawal by Subject|0
7537577|NCT03418727|11886545|FG002|Overall Study|Withdrawal by Subject|2
7537578|NCT03410108|11886553|FG000|Overall Study|Ongoing|41
7414088|NCT01431287|11686791|FG001|Overall Study|Non compliant with protocol|6
7414089|NCT01431287|11686792|FG002|Overall Study|Non compliant with protocol|5
7537579|NCT03410108|11886553|FG000|Overall Study|Adverse Event|4
7537580|NCT03410108|11886553|FG000|Overall Study|Progressive Disease|58
7537581|NCT03410108|11886553|FG000|Overall Study|Withdrawal by Subject|1
7537582|NCT03123185|11886578|FG000|Overall Study|Withdrawal by Subject|0
7537583|NCT03123185|11886579|FG001|Overall Study|Withdrawal by Subject|0
7537584|NCT03123185|11886580|FG002|Overall Study|Withdrawal by Subject|0
7537585|NCT03123185|11886581|FG003|Overall Study|Withdrawal by Subject|0
7537586|NCT03123185|11886582|FG004|Overall Study|Withdrawal by Subject|0
7537587|NCT03123185|11886583|FG005|Overall Study|Withdrawal by Subject|0
7537588|NCT03123185|11886584|FG006|Overall Study|Withdrawal by Subject|0
7529509|NCT02623829|11872494|FG000|Overall Study|Lost to Follow-up|1
7414090|NCT01431287|11686793|FG003|Overall Study|Non compliant with protocol|6
7529510|NCT02623829|11872495|FG001|Overall Study|Lost to Follow-up|1
7529511|NCT02624050|11872512|FG000|Overall Study|Physician Decision|4
7529512|NCT02624050|11872513|FG001|Overall Study|Physician Decision|0
7529513|NCT02624050|11872512|FG000|Overall Study|Protocol Violation|2
7529514|NCT02624050|11872513|FG001|Overall Study|Protocol Violation|0
7529515|NCT02624284|11872531|FG000|Overall Study|Withdrawal by Subject|3
7529516|NCT02624284|11872532|FG001|Overall Study|Withdrawal by Subject|6
7529517|NCT02624284|11872533|FG002|Overall Study|Withdrawal by Subject|3
7529518|NCT02624284|11872531|FG000|Overall Study|Protocol Violation|9
7529519|NCT02624284|11872532|FG001|Overall Study|Protocol Violation|10
7529520|NCT02624284|11872533|FG002|Overall Study|Protocol Violation|7
7529521|NCT02624284|11872531|FG000|Overall Study|Revealed exclusionary condition|2
7529522|NCT02624284|11872532|FG001|Overall Study|Revealed exclusionary condition|2
7529523|NCT02624284|11872533|FG002|Overall Study|Revealed exclusionary condition|0
7225100|NCT00064350|11434621|FG002|Induction Treatment|Disease Progression|110
7225101|NCT00064350|11434619|FG000|Induction Treatment|Adverse Event|0
7225102|NCT00064350|11434620|FG001|Induction Treatment|Adverse Event|2
7225103|NCT00064350|11434621|FG002|Induction Treatment|Adverse Event|49
7225104|NCT00064350|11434619|FG000|Induction Treatment|Death|0
7225105|NCT00064350|11434620|FG001|Induction Treatment|Death|0
7225106|NCT00064350|11434621|FG002|Induction Treatment|Death|9
7225107|NCT00064350|11434619|FG000|Induction Treatment|Withdrawal by Subject|0
7225108|NCT00064350|11434620|FG001|Induction Treatment|Withdrawal by Subject|0
7225109|NCT00064350|11434621|FG002|Induction Treatment|Withdrawal by Subject|21
7225110|NCT00064350|11434619|FG000|Induction Treatment|Ineligible or never started treatment|3
7225111|NCT00064350|11434620|FG001|Induction Treatment|Ineligible or never started treatment|6
7225112|NCT00064350|11434621|FG002|Induction Treatment|Ineligible or never started treatment|34
7225113|NCT00064350|11434619|FG000|Induction Treatment|Other|0
7225114|NCT00064350|11434620|FG001|Induction Treatment|Other|0
7225115|NCT00064350|11434621|FG002|Induction Treatment|Other|13
7225116|NCT00064350|11434619|FG000|Randomization|Adverse Event|8
7225117|NCT00064350|11434620|FG001|Randomization|Adverse Event|3
7225118|NCT00064350|11434621|FG002|Randomization|Adverse Event|0
7225119|NCT00064350|11434619|FG000|Randomization|Death|3
7225120|NCT00064350|11434620|FG001|Randomization|Death|0
7225121|NCT00064350|11434621|FG002|Randomization|Death|0
7225122|NCT00064350|11434619|FG000|Randomization|Withdrawal by Subject|1
7225123|NCT00064350|11434620|FG001|Randomization|Withdrawal by Subject|0
7225124|NCT00064350|11434621|FG002|Randomization|Withdrawal by Subject|0
7225125|NCT00064350|11434619|FG000|Randomization|Ineligible or never started treatment|9
7225126|NCT00064350|11434620|FG001|Randomization|Ineligible or never started treatment|15
7225127|NCT00064350|11434621|FG002|Randomization|Ineligible or never started treatment|0
7225128|NCT00064350|11434619|FG000|Randomization|Other|5
7225129|NCT00064350|11434620|FG001|Randomization|Other|0
7225130|NCT00064350|11434621|FG002|Randomization|Other|0
7529524|NCT02624284|11872531|FG000|Overall Study|Adverse Event|0
7225131|NCT00064350|11434619|FG000|Cross-Over|Adverse Event|0
7529525|NCT02624284|11872532|FG001|Overall Study|Adverse Event|0
7414091|NCT01431287|11686794|FG004|Overall Study|Non compliant with protocol|5
7414092|NCT01431287|11686790|FG000|Overall Study|Lost to Follow-up|0
7414093|NCT01431287|11686791|FG001|Overall Study|Lost to Follow-up|3
7414094|NCT01431287|11686792|FG002|Overall Study|Lost to Follow-up|2
7414095|NCT01431287|11686793|FG003|Overall Study|Lost to Follow-up|3
7414096|NCT01431287|11686794|FG004|Overall Study|Lost to Follow-up|1
7414097|NCT01431287|11686790|FG000|Overall Study|Consent withdrawn not due to AE|29
7414098|NCT01431287|11686791|FG001|Overall Study|Consent withdrawn not due to AE|30
7414099|NCT01431287|11686792|FG002|Overall Study|Consent withdrawn not due to AE|34
7414100|NCT01431287|11686793|FG003|Overall Study|Consent withdrawn not due to AE|19
7414101|NCT01431287|11686794|FG004|Overall Study|Consent withdrawn not due to AE|29
7414102|NCT01431287|11686790|FG000|Overall Study|not stated above|4
7414103|NCT01431287|11686791|FG001|Overall Study|not stated above|2
7414104|NCT01431287|11686792|FG002|Overall Study|not stated above|2
7414105|NCT01431287|11686793|FG003|Overall Study|not stated above|2
7414106|NCT01431287|11686794|FG004|Overall Study|not stated above|1
7414107|NCT01431521|11686856|FG000|Overall Study|Withdrawal by Subject|0
7414108|NCT01431521|11686857|FG001|Overall Study|Withdrawal by Subject|0
7414109|NCT01431521|11686858|FG002|Overall Study|Withdrawal by Subject|1
7414110|NCT01431521|11686859|FG003|Overall Study|Withdrawal by Subject|0
7414111|NCT01431534|11686871|FG000|Treatment Phase|Adverse Event|0
7414112|NCT01431534|11686872|FG001|Treatment Phase|Adverse Event|0
7414113|NCT01431534|11686873|FG002|Treatment Phase|Adverse Event|1
7414114|NCT01431534|11686871|FG000|Treatment Phase|Progressive Disease|4
7414115|NCT01431534|11686872|FG001|Treatment Phase|Progressive Disease|3
7414116|NCT01431534|11686873|FG002|Treatment Phase|Progressive Disease|10
7414117|NCT01431638|11686888|FG000|Overall Study|Adverse Event|1
7414118|NCT01431638|11686889|FG001|Overall Study|Adverse Event|3
7414119|NCT01431638|11686890|FG002|Overall Study|Adverse Event|1
7414120|NCT01431638|11686888|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7414121|NCT01431638|11686889|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7414122|NCT01431638|11686890|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7414123|NCT01431638|11686888|FG000|Overall Study|Participants condition no longer requires study drug|0
7414124|NCT01431638|11686889|FG001|Overall Study|Participants condition no longer requires study drug|1
7414125|NCT01431638|11686890|FG002|Overall Study|Participants condition no longer requires study drug|0
7414126|NCT01431638|11686888|FG000|Overall Study|Participant withdrew consent|14
7414127|NCT01431638|11686889|FG001|Overall Study|Participant withdrew consent|5
7414128|NCT01431638|11686890|FG002|Overall Study|Participant withdrew consent|8
7414129|NCT01431638|11686888|FG000|Overall Study|Lost to Follow-up|7
7414130|NCT01431638|11686889|FG001|Overall Study|Lost to Follow-up|9
7414131|NCT01431638|11686890|FG002|Overall Study|Lost to Follow-up|7
7414132|NCT01431638|11686888|FG000|Overall Study|Administrative problems|1
7414133|NCT01431638|11686889|FG001|Overall Study|Administrative problems|4
7414134|NCT01431638|11686890|FG002|Overall Study|Administrative problems|6
7414135|NCT01431638|11686888|FG000|Overall Study|Death|1
7414136|NCT01431638|11686889|FG001|Overall Study|Death|0
7414137|NCT01431638|11686890|FG002|Overall Study|Death|0
7529526|NCT02624284|11872533|FG002|Overall Study|Adverse Event|1
7529527|NCT02624492|11872548|FG000|Overall Study|Adverse Event|2
7529528|NCT02624492|11872549|FG001|Overall Study|Adverse Event|2
7529529|NCT02624492|11872550|FG002|Overall Study|Adverse Event|2
7529530|NCT02624492|11872548|FG000|Overall Study|Progressive disease|0
7529531|NCT02624492|11872549|FG001|Overall Study|Progressive disease|2
7529532|NCT02624492|11872550|FG002|Overall Study|Progressive disease|3
7529533|NCT02624687|11872560|FG000|Overall Study|Withdrawal by Subject|1
7529534|NCT02624687|11872561|FG001|Overall Study|Withdrawal by Subject|1
7529535|NCT02624687|11872560|FG000|Overall Study|medical leave from work|0
7529536|NCT02624687|11872561|FG001|Overall Study|medical leave from work|1
7529537|NCT02624713|11872580|FG000|Overall Study|Lost to Follow-up|14
7529538|NCT02624713|11872581|FG001|Overall Study|Lost to Follow-up|0
7529539|NCT02624791|11872588|FG000|Overall Study|Withdrawal by Subject|2
7529540|NCT02624791|11872589|FG001|Overall Study|Withdrawal by Subject|0
7529541|NCT02624791|11872590|FG002|Overall Study|Withdrawal by Subject|0
7414138|NCT01431638|11686888|FG000|Overall Study|Protocol deviation|1
7414139|NCT01431638|11686889|FG001|Overall Study|Protocol deviation|1
7414140|NCT01431638|11686890|FG002|Overall Study|Protocol deviation|4
7414141|NCT01431638|11686888|FG000|Overall Study|Participants Did not enter extension study from core study|39
7414142|NCT01431638|11686889|FG001|Overall Study|Participants Did not enter extension study from core study|46
7414143|NCT01431638|11686890|FG002|Overall Study|Participants Did not enter extension study from core study|32
7414144|NCT01431716|11686902|FG000|Overall Study|Withdrawal of consent|1
7414145|NCT01431950|11686948|FG000|Overall Study|Study Site Closed/Terminated|7
7414146|NCT01431950|11686949|FG001|Overall Study|Study Site Closed/Terminated|3
7414147|NCT01431950|11686948|FG000|Overall Study|Withdrawal by Subject|4
7529542|NCT02624791|11872591|FG003|Overall Study|Withdrawal by Subject|0
7529543|NCT02624791|11872592|FG004|Overall Study|Withdrawal by Subject|0
7529544|NCT02624791|11872593|FG005|Overall Study|Withdrawal by Subject|0
7529545|NCT02624986|11872618|FG000|Overall Study|Death|0
7529546|NCT02624986|11872619|FG001|Overall Study|Death|1
7529547|NCT02624986|11872620|FG002|Overall Study|Death|2
7529548|NCT02624986|11872621|FG003|Overall Study|Death|2
7529549|NCT02624986|11872622|FG004|Overall Study|Death|2
7529550|NCT02624986|11872623|FG005|Overall Study|Death|0
7529551|NCT02624986|11872624|FG006|Overall Study|Death|0
7529552|NCT02624986|11872625|FG007|Overall Study|Death|1
7529553|NCT02624986|11872618|FG000|Overall Study|Study Terminated by Sponsor|1
7529554|NCT02624986|11872619|FG001|Overall Study|Study Terminated by Sponsor|1
7529555|NCT02624986|11872620|FG002|Overall Study|Study Terminated by Sponsor|0
7529556|NCT02624986|11872621|FG003|Overall Study|Study Terminated by Sponsor|1
7529557|NCT02624986|11872622|FG004|Overall Study|Study Terminated by Sponsor|2
7529558|NCT02624986|11872623|FG005|Overall Study|Study Terminated by Sponsor|2
7529559|NCT02624986|11872624|FG006|Overall Study|Study Terminated by Sponsor|4
7529560|NCT02624986|11872625|FG007|Overall Study|Study Terminated by Sponsor|3
7529561|NCT02624986|11872618|FG000|Overall Study|Progressive Disease|0
7529562|NCT02624986|11872619|FG001|Overall Study|Progressive Disease|1
7529563|NCT02624986|11872620|FG002|Overall Study|Progressive Disease|0
7529564|NCT02624986|11872621|FG003|Overall Study|Progressive Disease|0
7529565|NCT02624986|11872622|FG004|Overall Study|Progressive Disease|0
7529566|NCT02624986|11872623|FG005|Overall Study|Progressive Disease|0
7529567|NCT02624986|11872624|FG006|Overall Study|Progressive Disease|0
7529568|NCT02624986|11872625|FG007|Overall Study|Progressive Disease|0
7529569|NCT02624986|11872618|FG000|Overall Study|Protocol Violation|1
7529570|NCT02624986|11872619|FG001|Overall Study|Protocol Violation|0
7529571|NCT02624986|11872620|FG002|Overall Study|Protocol Violation|0
7529572|NCT02624986|11872621|FG003|Overall Study|Protocol Violation|0
7529573|NCT02624986|11872622|FG004|Overall Study|Protocol Violation|0
7529574|NCT02624986|11872623|FG005|Overall Study|Protocol Violation|0
7529575|NCT02624986|11872624|FG006|Overall Study|Protocol Violation|0
7529576|NCT02624986|11872625|FG007|Overall Study|Protocol Violation|0
7529577|NCT02624986|11872618|FG000|Overall Study|Withdrawal by Subject|0
7529578|NCT02624986|11872619|FG001|Overall Study|Withdrawal by Subject|0
7529579|NCT02624986|11872620|FG002|Overall Study|Withdrawal by Subject|0
7529580|NCT02624986|11872621|FG003|Overall Study|Withdrawal by Subject|0
7529581|NCT02624986|11872622|FG004|Overall Study|Withdrawal by Subject|0
7529582|NCT02624986|11872623|FG005|Overall Study|Withdrawal by Subject|0
7529583|NCT02624986|11872624|FG006|Overall Study|Withdrawal by Subject|0
7529584|NCT02624986|11872625|FG007|Overall Study|Withdrawal by Subject|1
7529585|NCT02625220|11872681|FG000|Overall Study|Adverse Event|2
7529586|NCT02625220|11872681|FG000|Overall Study|Lost to Follow-up|2
7529587|NCT02625220|11872681|FG000|Overall Study|Protocol Violation|1
7529588|NCT02625220|11872681|FG000|Overall Study|Study discontinued at site|2
7529589|NCT02625233|11872687|FG000|Overall Study|Adverse Event|2
7529590|NCT02625233|11872688|FG001|Overall Study|Adverse Event|0
7529591|NCT02625259|11872699|FG000|First Intervention (Day 1)|Other|0
7529592|NCT02625259|11872700|FG001|First Intervention (Day 1)|Other|0
7529593|NCT02625259|11872701|FG002|First Intervention (Day 1)|Other|1
7529594|NCT02625259|11872702|FG003|First Intervention (Day 1)|Other|0
7529595|NCT02625259|11872703|FG004|First Intervention (Day 1)|Other|0
7529596|NCT02625259|11872699|FG000|First Intervention (Day 1)|Adverse Event|2
7529597|NCT02625259|11872700|FG001|First Intervention (Day 1)|Adverse Event|1
7529598|NCT02625259|11872701|FG002|First Intervention (Day 1)|Adverse Event|0
7529599|NCT02625259|11872702|FG003|First Intervention (Day 1)|Adverse Event|0
7529600|NCT02625259|11872703|FG004|First Intervention (Day 1)|Adverse Event|0
7529601|NCT02625259|11872699|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
7529602|NCT02625259|11872700|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
7529603|NCT02625259|11872701|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
7537589|NCT03123185|11886585|FG007|Overall Study|Withdrawal by Subject|0
7414148|NCT01431950|11686949|FG001|Overall Study|Withdrawal by Subject|3
7414149|NCT01431950|11686948|FG000|Overall Study|Protocol Violation|2
7414150|NCT01431950|11686949|FG001|Overall Study|Protocol Violation|3
7414151|NCT01431950|11686948|FG000|Overall Study|Adverse Event|2
7414152|NCT01431950|11686949|FG001|Overall Study|Adverse Event|2
7414153|NCT01431950|11686948|FG000|Overall Study|Physician Decision|2
7414154|NCT01431950|11686949|FG001|Overall Study|Physician Decision|1
7414155|NCT01431950|11686948|FG000|Overall Study|Lack of Efficacy|2
7414156|NCT01431950|11686949|FG001|Overall Study|Lack of Efficacy|1
7414157|NCT01431950|11686948|FG000|Overall Study|Lost to Follow-up|0
7414158|NCT01431950|11686949|FG001|Overall Study|Lost to Follow-up|1
7414159|NCT01431950|11686948|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
7414160|NCT01431950|11686949|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7414161|NCT01431963|11686955|FG000|Overall Study|Adverse Event|18
7414162|NCT01431963|11686955|FG000|Overall Study|Lack of Efficacy|7
7414163|NCT01431963|11686955|FG000|Overall Study|Protocol Violation|1
7414164|NCT01431963|11686955|FG000|Overall Study|Protocol-defined Stopping Criteria|2
7414165|NCT01431963|11686955|FG000|Overall Study|Physician Decision|4
7414166|NCT01431963|11686955|FG000|Overall Study|Withdrawal by Subject|3
7414167|NCT01431976|11686959|FG000|Overall Study|Adverse Event|6
7414168|NCT01431976|11686959|FG000|Overall Study|Lack of Efficacy|2
7414169|NCT01431976|11686959|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
7414170|NCT01431976|11686959|FG000|Overall Study|Physician Decision|1
7414171|NCT01431976|11686959|FG000|Overall Study|Withdrawal by Subject|1
7414172|NCT01432171|11686985|FG000|Overall Study|Death|1
7529604|NCT02625259|11872702|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
7529605|NCT02625259|11872703|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
7529606|NCT02625623|11872757|FG000|Overall Study|Participants randomized but not treated|9
7529607|NCT02625623|11872758|FG001|Overall Study|Participants randomized but not treated|1
7529608|NCT02625909|11872772|FG000|Overall Study|Death|2
7529609|NCT02625909|11872773|FG001|Overall Study|Death|0
7529610|NCT02625909|11872772|FG000|Overall Study|Lost to Follow-up|3
7529611|NCT02625909|11872773|FG001|Overall Study|Lost to Follow-up|5
7529612|NCT02625909|11872772|FG000|Overall Study|Lack of Efficacy|9
7529613|NCT02625909|11872773|FG001|Overall Study|Lack of Efficacy|2
7529614|NCT02625909|11872772|FG000|Overall Study|Reinfection|3
7529615|NCT02625909|11872773|FG001|Overall Study|Reinfection|2
7529616|NCT02625922|11872781|FG000|Overall Study|Non-availability of IMP|1
7529617|NCT02625922|11872782|FG001|Overall Study|Non-availability of IMP|1
7529618|NCT02625922|11872781|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
7529619|NCT02625922|11872782|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
7529620|NCT02625974|11872793|FG000|Overall Study|Adverse Event|12
7529621|NCT02625974|11872794|FG001|Overall Study|Adverse Event|2
7529622|NCT02625974|11872793|FG000|Overall Study|Withdrawal by Subject|3
7529623|NCT02625974|11872794|FG001|Overall Study|Withdrawal by Subject|1
7414173|NCT01432171|11686986|FG001|Overall Study|Death|2
7414174|NCT01432171|11686985|FG000|Overall Study|Lost to Follow-up|6
7414175|NCT01432171|11686986|FG001|Overall Study|Lost to Follow-up|5
7414176|NCT01432171|11686985|FG000|Overall Study|Withdrawal by Subject|3
7414177|NCT01432171|11686986|FG001|Overall Study|Withdrawal by Subject|1
7529624|NCT02625974|11872793|FG000|Overall Study|positive parasitemia|1
7529625|NCT02625974|11872794|FG001|Overall Study|positive parasitemia|0
7529626|NCT02625974|11872793|FG000|Overall Study|non-compliance with study drug|0
7529627|NCT02625974|11872794|FG001|Overall Study|non-compliance with study drug|2
7529628|NCT02625974|11872793|FG000|Overall Study|Protocol Violation|0
7414178|NCT01432171|11686985|FG000|Overall Study|Noncompliance|2
7529629|NCT02625974|11872794|FG001|Overall Study|Protocol Violation|1
7529630|NCT02626000|11872836|FG000|Overall Study|Decision by Sponsor|1
7529631|NCT02626000|11872836|FG000|Overall Study|Death|29
7529632|NCT02626026|11872847|FG000|Overall Study|Randomized but Never Treated|0
7529633|NCT02626026|11872848|FG001|Overall Study|Randomized but Never Treated|0
7529634|NCT02626026|11872849|FG002|Overall Study|Randomized but Never Treated|0
7529635|NCT02626026|11872850|FG003|Overall Study|Randomized but Never Treated|0
7529636|NCT02626026|11872851|FG004|Overall Study|Randomized but Never Treated|1
7529637|NCT02626026|11872852|FG005|Overall Study|Randomized but Never Treated|0
7529638|NCT02626182|11872893|FG000|Overall Study|Adverse Event|2
7529639|NCT02626182|11872894|FG001|Overall Study|Adverse Event|0
7529640|NCT02626780|11872920|FG000|Overall Study|Withdrawal by Subject|3
7529641|NCT02626819|11872926|FG000|Overall Study|Lost to Follow-up|3
7529642|NCT02626819|11872927|FG001|Overall Study|Lost to Follow-up|2
7529643|NCT02626819|11872926|FG000|Overall Study|Withdrawal by Subject|1
7529644|NCT02626819|11872927|FG001|Overall Study|Withdrawal by Subject|0
7529645|NCT02626819|11872926|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
7529646|NCT02626819|11872927|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
7529647|NCT02627144|11872964|FG000|Overall Study|Serious adverse event|32
7529648|NCT02627144|11872964|FG000|Overall Study|Cancer progression|171
7529649|NCT02627144|11872964|FG000|Overall Study|Death from cancer|20
7529650|NCT02627144|11872964|FG000|Overall Study|Death from other cause|8
7529651|NCT02627144|11872964|FG000|Overall Study|Refusal of treatment / poor cooperation|38
7414179|NCT01432171|11686986|FG001|Overall Study|Noncompliance|3
7414180|NCT01432171|11686985|FG000|Overall Study|Insurance denial trial coverage|1
7414181|NCT01432171|11686986|FG001|Overall Study|Insurance denial trial coverage|0
7414182|NCT01432171|11686985|FG000|Overall Study|Patient moved to palliative care|1
7414183|NCT01432171|11686986|FG001|Overall Study|Patient moved to palliative care|0
7414184|NCT01432262|11687010|FG000|Overall Study|Withdrawal by Subject|2
7414185|NCT01432262|11687011|FG001|Overall Study|Withdrawal by Subject|1
7414186|NCT01432275|11687017|FG000|First BG Meter System (7 Days)|Adverse Event|0
7414187|NCT01432275|11687018|FG001|First BG Meter System (7 Days)|Adverse Event|2
7414188|NCT01432275|11687017|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
7414189|NCT01432275|11687018|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
7414190|NCT01432275|11687017|FG000|Second BG Meter System (7 Days)|Adverse Event|1
7414191|NCT01432275|11687018|FG001|Second BG Meter System (7 Days)|Adverse Event|1
7529652|NCT02627144|11872964|FG000|Overall Study|Administrative reasons|65
7529653|NCT02627144|11872964|FG000|Overall Study|Lost to Follow-up|8
7529654|NCT02627144|11872964|FG000|Overall Study|Enrolled, not treated|6
7529655|NCT02627144|11872964|FG000|Overall Study|Other|17
7529656|NCT02627495|11872968|FG000|Overall Study|Withdrawal by Subject|4
7529657|NCT02627677|11872975|FG000|Overall Study|Adverse event (not progressive disease)|1
7529658|NCT02627677|11872976|FG001|Overall Study|Adverse event (not progressive disease)|4
7529659|NCT02627677|11872977|FG002|Overall Study|Adverse event (not progressive disease)|1
7529660|NCT02627677|11872975|FG000|Overall Study|Progressive disease|1
7529661|NCT02627677|11872976|FG001|Overall Study|Progressive disease|3
7529662|NCT02627677|11872977|FG002|Overall Study|Progressive disease|0
7529663|NCT02627677|11872975|FG000|Overall Study|Lack of Efficacy|1
7529664|NCT02627677|11872976|FG001|Overall Study|Lack of Efficacy|2
7529665|NCT02627677|11872977|FG002|Overall Study|Lack of Efficacy|0
7529666|NCT02627677|11872975|FG000|Overall Study|Lost to Follow-up|0
7529667|NCT02627677|11872976|FG001|Overall Study|Lost to Follow-up|0
7529668|NCT02627677|11872977|FG002|Overall Study|Lost to Follow-up|1
7529669|NCT02627677|11872975|FG000|Overall Study|Pregnancy|0
7529670|NCT02627677|11872976|FG001|Overall Study|Pregnancy|1
7529671|NCT02627677|11872977|FG002|Overall Study|Pregnancy|0
7529672|NCT02627677|11872975|FG000|Overall Study|Study Terminated by Sponsor|5
7529673|NCT02627677|11872976|FG001|Overall Study|Study Terminated by Sponsor|10
7529674|NCT02627677|11872977|FG002|Overall Study|Study Terminated by Sponsor|6
7529675|NCT02627677|11872975|FG000|Overall Study|Physician Decision|0
7529676|NCT02627677|11872976|FG001|Overall Study|Physician Decision|0
7529677|NCT02627677|11872977|FG002|Overall Study|Physician Decision|2
7529678|NCT02627677|11872975|FG000|Overall Study|Withdrawal by Subject|2
7529679|NCT02627677|11872976|FG001|Overall Study|Withdrawal by Subject|1
7529680|NCT02627677|11872977|FG002|Overall Study|Withdrawal by Subject|1
7529681|NCT02627677|11872975|FG000|Overall Study|Reason not Specified|0
7529682|NCT02627677|11872976|FG001|Overall Study|Reason not Specified|0
7529683|NCT02627677|11872977|FG002|Overall Study|Reason not Specified|1
7529684|NCT02627677|11872975|FG000|Overall Study|Randomized but not Treated|1
7529685|NCT02627677|11872976|FG001|Overall Study|Randomized but not Treated|0
7529686|NCT02627677|11872977|FG002|Overall Study|Randomized but not Treated|0
7529687|NCT02628028|11873008|FG000|Dosing Period|Withdrawal by Subject|0
7529688|NCT02628028|11873009|FG001|Dosing Period|Withdrawal by Subject|0
7529689|NCT02628028|11873010|FG002|Dosing Period|Withdrawal by Subject|1
7529690|NCT02628028|11873011|FG003|Dosing Period|Withdrawal by Subject|0
7529691|NCT02628028|11873012|FG004|Dosing Period|Withdrawal by Subject|2
7529692|NCT02628028|11873013|FG005|Dosing Period|Withdrawal by Subject|4
7529693|NCT02628028|11873014|FG006|Dosing Period|Withdrawal by Subject|1
7529694|NCT02628028|11873015|FG007|Dosing Period|Withdrawal by Subject|1
7414192|NCT01432275|11687017|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
7414193|NCT01432275|11687018|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
7414194|NCT01432275|11687017|FG000|Second BG Meter System (7 Days)|Physician Decision|0
7414195|NCT01432275|11687018|FG001|Second BG Meter System (7 Days)|Physician Decision|1
7414196|NCT01432275|11687017|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
7414197|NCT01432275|11687018|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
7414198|NCT01432275|11687017|FG000|ADC With Calculator (10 Days)|Physician Decision|1
7414199|NCT01432275|11687018|FG001|ADC With Calculator (10 Days)|Physician Decision|1
7414200|NCT01432275|11687017|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
7414201|NCT01432275|11687018|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
7414202|NCT01432275|11687017|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
7414203|NCT01432275|11687018|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
7529695|NCT02628028|11873008|FG000|Dosing Period|Adverse Event|0
7529696|NCT02628028|11873009|FG001|Dosing Period|Adverse Event|0
7529697|NCT02628028|11873010|FG002|Dosing Period|Adverse Event|0
7529698|NCT02628028|11873011|FG003|Dosing Period|Adverse Event|0
7529699|NCT02628028|11873012|FG004|Dosing Period|Adverse Event|2
7529700|NCT02628028|11873013|FG005|Dosing Period|Adverse Event|1
7529701|NCT02628028|11873014|FG006|Dosing Period|Adverse Event|3
7529702|NCT02628028|11873015|FG007|Dosing Period|Adverse Event|2
7529703|NCT02628028|11873008|FG000|Dosing Period|Death|0
7529704|NCT02628028|11873009|FG001|Dosing Period|Death|0
7529705|NCT02628028|11873010|FG002|Dosing Period|Death|0
7529706|NCT02628028|11873011|FG003|Dosing Period|Death|0
7529707|NCT02628028|11873012|FG004|Dosing Period|Death|0
7529708|NCT02628028|11873013|FG005|Dosing Period|Death|0
7529709|NCT02628028|11873014|FG006|Dosing Period|Death|0
7529710|NCT02628028|11873015|FG007|Dosing Period|Death|1
7529711|NCT02628028|11873008|FG000|Dosing Period|Lack of Efficacy|0
7529712|NCT02628028|11873009|FG001|Dosing Period|Lack of Efficacy|0
7529713|NCT02628028|11873010|FG002|Dosing Period|Lack of Efficacy|0
7529714|NCT02628028|11873011|FG003|Dosing Period|Lack of Efficacy|0
7529715|NCT02628028|11873012|FG004|Dosing Period|Lack of Efficacy|3
7529716|NCT02628028|11873013|FG005|Dosing Period|Lack of Efficacy|0
7529717|NCT02628028|11873014|FG006|Dosing Period|Lack of Efficacy|1
7529718|NCT02628028|11873015|FG007|Dosing Period|Lack of Efficacy|0
7529719|NCT02628028|11873008|FG000|Dosing Period|Study Terminated by Sponsor|0
7529720|NCT02628028|11873009|FG001|Dosing Period|Study Terminated by Sponsor|0
7529721|NCT02628028|11873010|FG002|Dosing Period|Study Terminated by Sponsor|0
7529722|NCT02628028|11873011|FG003|Dosing Period|Study Terminated by Sponsor|0
7529723|NCT02628028|11873012|FG004|Dosing Period|Study Terminated by Sponsor|7
7529724|NCT02628028|11873013|FG005|Dosing Period|Study Terminated by Sponsor|6
7529725|NCT02628028|11873014|FG006|Dosing Period|Study Terminated by Sponsor|7
7529726|NCT02628028|11873015|FG007|Dosing Period|Study Terminated by Sponsor|7
7529727|NCT02628028|11873008|FG000|Dosing Period|Physician Decision|0
7529728|NCT02628028|11873009|FG001|Dosing Period|Physician Decision|0
7529729|NCT02628028|11873010|FG002|Dosing Period|Physician Decision|0
7529730|NCT02628028|11873011|FG003|Dosing Period|Physician Decision|0
7529731|NCT02628028|11873012|FG004|Dosing Period|Physician Decision|0
7529732|NCT02628028|11873013|FG005|Dosing Period|Physician Decision|1
7529733|NCT02628028|11873014|FG006|Dosing Period|Physician Decision|0
7529734|NCT02628028|11873015|FG007|Dosing Period|Physician Decision|0
7529735|NCT02628028|11873008|FG000|Dosing Period|Site Terminated by Sponsor|0
7529736|NCT02628028|11873009|FG001|Dosing Period|Site Terminated by Sponsor|0
7529737|NCT02628028|11873010|FG002|Dosing Period|Site Terminated by Sponsor|0
7529738|NCT02628028|11873011|FG003|Dosing Period|Site Terminated by Sponsor|0
7529739|NCT02628028|11873012|FG004|Dosing Period|Site Terminated by Sponsor|0
7529740|NCT02628028|11873013|FG005|Dosing Period|Site Terminated by Sponsor|1
7529741|NCT02628028|11873014|FG006|Dosing Period|Site Terminated by Sponsor|1
7529742|NCT02628028|11873015|FG007|Dosing Period|Site Terminated by Sponsor|0
7529743|NCT02628028|11873008|FG000|Dosing Period|Lost to Follow-up|0
7529744|NCT02628028|11873009|FG001|Dosing Period|Lost to Follow-up|0
7529745|NCT02628028|11873010|FG002|Dosing Period|Lost to Follow-up|0
7529746|NCT02628028|11873011|FG003|Dosing Period|Lost to Follow-up|0
7529747|NCT02628028|11873012|FG004|Dosing Period|Lost to Follow-up|0
7529748|NCT02628028|11873013|FG005|Dosing Period|Lost to Follow-up|0
7529749|NCT02628028|11873014|FG006|Dosing Period|Lost to Follow-up|1
7529750|NCT02628028|11873015|FG007|Dosing Period|Lost to Follow-up|0
7529751|NCT02628028|11873008|FG000|Dosing Period|Other|0
7529752|NCT02628028|11873009|FG001|Dosing Period|Other|0
7529753|NCT02628028|11873010|FG002|Dosing Period|Other|0
7529754|NCT02628028|11873011|FG003|Dosing Period|Other|0
7414204|NCT01432327|11687028|FG000|Posttest 3 Months|depression|3
7414205|NCT01432327|11687029|FG001|Posttest 3 Months|depression|0
7414206|NCT01432327|11687030|FG002|Posttest 3 Months|depression|0
7414207|NCT01432327|11687031|FG003|Posttest 3 Months|depression|0
7414208|NCT01432327|11687028|FG000|Posttest 3 Months|Lost to Follow-up|1
7414209|NCT01432327|11687029|FG001|Posttest 3 Months|Lost to Follow-up|0
7414210|NCT01432327|11687030|FG002|Posttest 3 Months|Lost to Follow-up|2
7414211|NCT01432327|11687031|FG003|Posttest 3 Months|Lost to Follow-up|1
7414212|NCT01432327|11687028|FG000|Posttest 3 Months|Allergic reaction|0
7414213|NCT01432327|11687029|FG001|Posttest 3 Months|Allergic reaction|2
7414214|NCT01432327|11687030|FG002|Posttest 3 Months|Allergic reaction|0
7414215|NCT01432327|11687031|FG003|Posttest 3 Months|Allergic reaction|0
7414216|NCT01432327|11687028|FG000|Posttest 6 Months|Lost to Follow-up|0
7414217|NCT01432327|11687029|FG001|Posttest 6 Months|Lost to Follow-up|0
7414218|NCT01432327|11687030|FG002|Posttest 6 Months|Lost to Follow-up|3
7414219|NCT01432327|11687031|FG003|Posttest 6 Months|Lost to Follow-up|2
7414220|NCT01432327|11687028|FG000|Posttest 6 Months|Allergic reaction|0
7414221|NCT01432327|11687029|FG001|Posttest 6 Months|Allergic reaction|0
7414222|NCT01432327|11687030|FG002|Posttest 6 Months|Allergic reaction|1
7414223|NCT01432327|11687031|FG003|Posttest 6 Months|Allergic reaction|0
7529755|NCT02628028|11873012|FG004|Dosing Period|Other|2
7529756|NCT02628028|11873013|FG005|Dosing Period|Other|1
7529757|NCT02628028|11873014|FG006|Dosing Period|Other|2
7529758|NCT02628028|11873015|FG007|Dosing Period|Other|4
7529759|NCT02628028|11873008|FG000|Long-term Extension (LTE) Period|Adverse Event|0
7529760|NCT02628028|11873009|FG001|Long-term Extension (LTE) Period|Adverse Event|0
7529761|NCT02628028|11873010|FG002|Long-term Extension (LTE) Period|Adverse Event|0
7529762|NCT02628028|11873011|FG003|Long-term Extension (LTE) Period|Adverse Event|0
7529763|NCT02628028|11873012|FG004|Long-term Extension (LTE) Period|Adverse Event|0
7529764|NCT02628028|11873013|FG005|Long-term Extension (LTE) Period|Adverse Event|1
7529765|NCT02628028|11873014|FG006|Long-term Extension (LTE) Period|Adverse Event|0
7529766|NCT02628028|11873015|FG007|Long-term Extension (LTE) Period|Adverse Event|3
7529767|NCT02628028|11873008|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529768|NCT02628028|11873009|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529769|NCT02628028|11873010|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529770|NCT02628028|11873011|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529771|NCT02628028|11873012|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529772|NCT02628028|11873013|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
7529773|NCT02628028|11873014|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
7529774|NCT02628028|11873015|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
7529775|NCT02628028|11873008|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7529776|NCT02628028|11873009|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7529777|NCT02628028|11873010|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7529778|NCT02628028|11873011|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7529779|NCT02628028|11873012|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
7529780|NCT02628028|11873013|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
7529781|NCT02628028|11873014|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7529782|NCT02628028|11873015|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
7529783|NCT02628028|11873008|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7529784|NCT02628028|11873009|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7529785|NCT02628028|11873010|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7529786|NCT02628028|11873011|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7529787|NCT02628028|11873012|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
7529788|NCT02628028|11873013|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
7529789|NCT02628028|11873014|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7529790|NCT02628028|11873015|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
7529791|NCT02628028|11873008|FG000|Long-term Extension (LTE) Period|Other|0
7529792|NCT02628028|11873009|FG001|Long-term Extension (LTE) Period|Other|0
7529793|NCT02628028|11873010|FG002|Long-term Extension (LTE) Period|Other|0
7529794|NCT02628028|11873011|FG003|Long-term Extension (LTE) Period|Other|0
7529795|NCT02628028|11873012|FG004|Long-term Extension (LTE) Period|Other|0
7529796|NCT02628028|11873013|FG005|Long-term Extension (LTE) Period|Other|3
7414224|NCT01432327|11687028|FG000|Posttest 6 Months|Withdrawal by Subject|0
7414225|NCT01432327|11687029|FG001|Posttest 6 Months|Withdrawal by Subject|0
7414226|NCT01432327|11687030|FG002|Posttest 6 Months|Withdrawal by Subject|1
7414227|NCT01432327|11687031|FG003|Posttest 6 Months|Withdrawal by Subject|0
7529797|NCT02628028|11873014|FG006|Long-term Extension (LTE) Period|Other|4
7414228|NCT01432327|11687028|FG000|Posttest 1 Year|Measurement have to take place in future|24
7414229|NCT01432327|11687029|FG001|Posttest 1 Year|Measurement have to take place in future|28
7414230|NCT01432327|11687030|FG002|Posttest 1 Year|Measurement have to take place in future|15
7414231|NCT01432327|11687031|FG003|Posttest 1 Year|Measurement have to take place in future|20
7414232|NCT01432327|11687028|FG000|Posttest 1 Year|Lost to Follow-up|0
7414233|NCT01432327|11687029|FG001|Posttest 1 Year|Lost to Follow-up|0
7414234|NCT01432327|11687030|FG002|Posttest 1 Year|Lost to Follow-up|4
7414235|NCT01432327|11687031|FG003|Posttest 1 Year|Lost to Follow-up|2
7529798|NCT02628028|11873015|FG007|Long-term Extension (LTE) Period|Other|3
7529799|NCT02628418|11873065|FG000|Overall Study|Lost to Follow-up|1
7529800|NCT02628418|11873066|FG001|Overall Study|Lost to Follow-up|2
7529801|NCT02628600|11873080|FG000|Overall Study|Death|2
7529802|NCT02628600|11873081|FG001|Overall Study|Death|1
7529803|NCT02628600|11873080|FG000|Overall Study|Adverse Event|3
7529804|NCT02628600|11873081|FG001|Overall Study|Adverse Event|20
7529805|NCT02628600|11873080|FG000|Overall Study|Protocol Violation|0
7414236|NCT01432327|11687028|FG000|Posttest 1 Year|Allergic reaction|0
7414237|NCT01432327|11687029|FG001|Posttest 1 Year|Allergic reaction|0
7414238|NCT01432327|11687030|FG002|Posttest 1 Year|Allergic reaction|1
7414239|NCT01432327|11687031|FG003|Posttest 1 Year|Allergic reaction|1
7414240|NCT01432366|11687041|FG000|Overall Study|Non-Responder|7
7414241|NCT01432366|11687041|FG000|Overall Study|Adverse Event|8
7414242|NCT01432366|11687041|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
7414243|NCT01432366|11687041|FG000|Overall Study|Pregnancy|1
7414244|NCT01432366|11687041|FG000|Overall Study|Lost to Follow-up|13
7414245|NCT01432366|11687041|FG000|Overall Study|Lack of Efficacy|1
7414246|NCT01432366|11687041|FG000|Overall Study|Site Closed|20
7414247|NCT01432366|11687041|FG000|Overall Study|Investigator Forget to Complete Visits|1
7414248|NCT01432366|11687041|FG000|Overall Study|Other|14
7414249|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
7414250|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7414251|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
7414252|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
7414253|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
7414254|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
7414255|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
7414256|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7414257|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
7414258|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
7529806|NCT02628600|11873081|FG001|Overall Study|Protocol Violation|1
7529807|NCT02628600|11873080|FG000|Overall Study|Lack of Efficacy|2
7529808|NCT02628600|11873081|FG001|Overall Study|Lack of Efficacy|0
7529809|NCT02628600|11873080|FG000|Overall Study|Withdrawal by Subject|13
7529810|NCT02628600|11873081|FG001|Overall Study|Withdrawal by Subject|8
7529811|NCT02628600|11873080|FG000|Overall Study|Lost to Follow-up|1
7529812|NCT02628600|11873081|FG001|Overall Study|Lost to Follow-up|0
7529813|NCT02628600|11873080|FG000|Overall Study|Physician Decision|2
7529814|NCT02628600|11873081|FG001|Overall Study|Physician Decision|2
7529815|NCT02628600|11873080|FG000|Overall Study|Other not specified|1
7529816|NCT02628600|11873081|FG001|Overall Study|Other not specified|0
7529817|NCT02628743|11873087|FG000|Overall Study|Other|3
7529818|NCT02628743|11873087|FG000|Overall Study|Withdrawal by Subject|50
7414259|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
7414260|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
7414261|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
7414262|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7414263|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
7414264|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
7529819|NCT02628743|11873087|FG000|Overall Study|Study Terminated by Sponsor|76
7529820|NCT02628743|11873087|FG000|Overall Study|Physician Decision|2
7529821|NCT02628769|11873091|FG000|First Intervention|Adverse Event|1
7529822|NCT02628769|11873092|FG001|First Intervention|Adverse Event|0
7529823|NCT02628769|11873091|FG000|First Intervention|Withdrawal by Subject|0
7529824|NCT02628769|11873092|FG001|First Intervention|Withdrawal by Subject|1
7529825|NCT02628769|11873091|FG000|Second Intervention|Adverse Event|2
7529826|NCT02628769|11873092|FG001|Second Intervention|Adverse Event|0
7529827|NCT02628769|11873091|FG000|Second Intervention|Physician Decision|0
7529828|NCT02628769|11873092|FG001|Second Intervention|Physician Decision|1
7529829|NCT02628873|11873100|FG000|Break (1 Hour)|Withdrawal by Subject|0
7529830|NCT02628873|11873101|FG001|Break (1 Hour)|Withdrawal by Subject|1
7529831|NCT02628873|11873100|FG000|Second Test (1 Hour)|Physician Decision|1
7529832|NCT02628873|11873101|FG001|Second Test (1 Hour)|Physician Decision|0
7529833|NCT02628938|11873110|FG000|Overall Study|Did not attend the follow up recall|2
7529834|NCT02628938|11873111|FG001|Overall Study|Did not attend the follow up recall|2
7529835|NCT02628938|11873112|FG002|Overall Study|Did not attend the follow up recall|1
7529836|NCT02628938|11873110|FG000|Overall Study|Failure to comply with the instructions|3
7529837|NCT02628938|11873111|FG001|Overall Study|Failure to comply with the instructions|0
7529997|NCT02631876|11873384|FG000|Overall Study|Death|96
7529838|NCT02628938|11873112|FG002|Overall Study|Failure to comply with the instructions|3
7529839|NCT02629133|11873135|FG000|Overall Study|Lost to Follow-up|3
7529840|NCT02629133|11873136|FG001|Overall Study|Lost to Follow-up|1
7529841|NCT02629133|11873135|FG000|Overall Study|Withdrawal by Subject|1
7529842|NCT02629133|11873136|FG001|Overall Study|Withdrawal by Subject|1
7529843|NCT02629822|11873151|FG000|Base Study|Lost to Follow-up|2
7529844|NCT02629822|11873151|FG000|Base Study|Non-Compliance With Study Drug|1
7529845|NCT02629822|11873151|FG000|Extension Study|Adverse Event|1
7529846|NCT02629822|11873151|FG000|Extension Study|Lost to Follow-up|1
7529847|NCT02629861|11873159|FG000|Overall Study|Adverse Event|7
7529848|NCT02629861|11873160|FG001|Overall Study|Adverse Event|5
7529849|NCT02629861|11873161|FG002|Overall Study|Adverse Event|4
7529850|NCT02629861|11873159|FG000|Overall Study|Withdrawal by Subject|5
7529851|NCT02629861|11873160|FG001|Overall Study|Withdrawal by Subject|8
7529852|NCT02629861|11873161|FG002|Overall Study|Withdrawal by Subject|13
7529853|NCT02629861|11873159|FG000|Overall Study|Protocol Violation|2
7529854|NCT02629861|11873160|FG001|Overall Study|Protocol Violation|3
7529855|NCT02629861|11873161|FG002|Overall Study|Protocol Violation|7
7529856|NCT02629861|11873159|FG000|Overall Study|Lost to Follow-up|12
7529857|NCT02629861|11873160|FG001|Overall Study|Lost to Follow-up|9
7529858|NCT02629861|11873161|FG002|Overall Study|Lost to Follow-up|4
7529859|NCT02629861|11873159|FG000|Overall Study|Other|1
7529860|NCT02629861|11873160|FG001|Overall Study|Other|1
7529861|NCT02629861|11873161|FG002|Overall Study|Other|0
7529862|NCT02629861|11873159|FG000|Overall Study|Pregnancy|2
7529863|NCT02629861|11873160|FG001|Overall Study|Pregnancy|1
7529864|NCT02629861|11873161|FG002|Overall Study|Pregnancy|0
7529865|NCT02629965|11873169|FG000|Period 1|Adverse Event|1
7529866|NCT02629965|11873170|FG001|Period 1|Adverse Event|0
7529867|NCT02629965|11873169|FG000|Period 1|Unexpected worsening of disease|2
7529868|NCT02629965|11873170|FG001|Period 1|Unexpected worsening of disease|0
7529869|NCT02629965|11873169|FG000|Period 1|Other than listed above|1
7529870|NCT02629965|11873170|FG001|Period 1|Other than listed above|2
7529871|NCT02629965|11873169|FG000|Period 2|Adverse Event|1
7529872|NCT02629965|11873170|FG001|Period 2|Adverse Event|0
7529873|NCT02630186|11873207|FG000|Overall Study|Withdrawal by Subject|1
7529874|NCT02630251|11873215|FG000|Overall Study|Physician Decision|0
7529875|NCT02630251|11873216|FG001|Overall Study|Physician Decision|0
7529876|NCT02630251|11873217|FG002|Overall Study|Physician Decision|1
7529877|NCT02630251|11873218|FG003|Overall Study|Physician Decision|0
7529878|NCT02630563|11873237|FG000|Overall Study|Administrative|1
7529879|NCT02630693|11873244|FG000|Overall Study|No receive treatment|0
7529880|NCT02630693|11873245|FG001|Overall Study|No receive treatment|1
7529881|NCT02630706|11873254|FG000|Overall Study|Adverse Event|2
7529882|NCT02630706|11873255|FG001|Overall Study|Adverse Event|1
7529883|NCT02630706|11873256|FG002|Overall Study|Adverse Event|1
7529884|NCT02630706|11873254|FG000|Overall Study|Lost to Follow-up|0
7529885|NCT02630706|11873255|FG001|Overall Study|Lost to Follow-up|1
7529886|NCT02630706|11873256|FG002|Overall Study|Lost to Follow-up|2
7529887|NCT02630706|11873254|FG000|Overall Study|Physician Decision|1
7529888|NCT02630706|11873255|FG001|Overall Study|Physician Decision|1
7529889|NCT02630706|11873256|FG002|Overall Study|Physician Decision|0
7529890|NCT02630706|11873254|FG000|Overall Study|Pregnancy|0
7529891|NCT02630706|11873255|FG001|Overall Study|Pregnancy|1
7529892|NCT02630706|11873256|FG002|Overall Study|Pregnancy|0
7529893|NCT02630706|11873254|FG000|Overall Study|Withdrawal by Subject|4
7529894|NCT02630706|11873255|FG001|Overall Study|Withdrawal by Subject|5
7529895|NCT02630706|11873256|FG002|Overall Study|Withdrawal by Subject|7
7529896|NCT02630966|11873284|FG000|Overall Study|Adverse Event|1
7529897|NCT02630966|11873285|FG001|Overall Study|Adverse Event|3
7529898|NCT02630966|11873284|FG000|Overall Study|Significant Protocol Deviation|0
7529899|NCT02630966|11873285|FG001|Overall Study|Significant Protocol Deviation|2
7529900|NCT02630966|11873284|FG000|Overall Study|Voluntary Withdrawal|1
7529901|NCT02630966|11873285|FG001|Overall Study|Voluntary Withdrawal|1
7529902|NCT02630966|11873284|FG000|Overall Study|Lack of Efficacy|0
7529903|NCT02630966|11873285|FG001|Overall Study|Lack of Efficacy|2
7529904|NCT02631538|11873317|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
7529905|NCT02631538|11873318|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
7529906|NCT02631538|11873319|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
7529907|NCT02631538|11873320|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
7529908|NCT02631538|11873317|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7529909|NCT02631538|11873318|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
7529910|NCT02631538|11873319|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
7529911|NCT02631538|11873320|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
7529912|NCT02631538|11873317|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7529913|NCT02631538|11873318|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
7529914|NCT02631538|11873319|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7529915|NCT02631538|11873320|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
7529916|NCT02631538|11873317|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
7529917|NCT02631538|11873318|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
7529918|NCT02631538|11873319|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
7529919|NCT02631538|11873320|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
7529920|NCT02631538|11873317|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7529998|NCT02631876|11873385|FG001|Overall Study|Death|50
7529921|NCT02631538|11873318|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7529922|NCT02631538|11873319|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
7529923|NCT02631538|11873320|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
7529924|NCT02631538|11873317|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7529925|NCT02631538|11873318|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7529926|NCT02631538|11873319|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
7529927|NCT02631538|11873320|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
7529928|NCT02631551|11873334|FG000|Overall Study|Adverse Event|1
7529929|NCT02631551|11873335|FG001|Overall Study|Adverse Event|2
7529930|NCT02631551|11873336|FG002|Overall Study|Adverse Event|4
7529931|NCT02631551|11873337|FG003|Overall Study|Adverse Event|0
7529932|NCT02631551|11873334|FG000|Overall Study|Lack of Efficacy|0
7529933|NCT02631551|11873335|FG001|Overall Study|Lack of Efficacy|0
7529934|NCT02631551|11873336|FG002|Overall Study|Lack of Efficacy|1
7529935|NCT02631551|11873337|FG003|Overall Study|Lack of Efficacy|0
7529936|NCT02631551|11873334|FG000|Overall Study|Lost to Follow-up|1
7529937|NCT02631551|11873335|FG001|Overall Study|Lost to Follow-up|2
7529938|NCT02631551|11873336|FG002|Overall Study|Lost to Follow-up|0
7529939|NCT02631551|11873337|FG003|Overall Study|Lost to Follow-up|3
7529940|NCT02631551|11873334|FG000|Overall Study|Withdrawal by Subject|2
7529941|NCT02631551|11873335|FG001|Overall Study|Withdrawal by Subject|2
7414265|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
7414266|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
7529942|NCT02631551|11873336|FG002|Overall Study|Withdrawal by Subject|0
7529943|NCT02631551|11873337|FG003|Overall Study|Withdrawal by Subject|5
7529944|NCT02631551|11873334|FG000|Overall Study|Protocol deviation|3
7529945|NCT02631551|11873335|FG001|Overall Study|Protocol deviation|6
7529946|NCT02631551|11873336|FG002|Overall Study|Protocol deviation|3
7529947|NCT02631551|11873337|FG003|Overall Study|Protocol deviation|0
7529948|NCT02631551|11873334|FG000|Overall Study|Non-compliance with study procedures|0
7529949|NCT02631551|11873335|FG001|Overall Study|Non-compliance with study procedures|0
7529950|NCT02631551|11873336|FG002|Overall Study|Non-compliance with study procedures|1
7529951|NCT02631551|11873337|FG003|Overall Study|Non-compliance with study procedures|1
7529952|NCT02631551|11873334|FG000|Overall Study|Non-compliance with study drug|1
7529953|NCT02631551|11873335|FG001|Overall Study|Non-compliance with study drug|0
7529954|NCT02631551|11873336|FG002|Overall Study|Non-compliance with study drug|0
7529955|NCT02631551|11873337|FG003|Overall Study|Non-compliance with study drug|0
7529956|NCT02631551|11873334|FG000|Overall Study|Other, specific reasons not collected|5
7529957|NCT02631551|11873335|FG001|Overall Study|Other, specific reasons not collected|7
7529958|NCT02631551|11873336|FG002|Overall Study|Other, specific reasons not collected|2
7529959|NCT02631551|11873337|FG003|Overall Study|Other, specific reasons not collected|2
7529960|NCT02631746|11873351|FG000|Overall Study|Lack of Efficacy|3
7529961|NCT02631850|11873368|FG000|Treatment Period|Lost to Follow-up|0
7529962|NCT02631850|11873369|FG001|Treatment Period|Lost to Follow-up|1
7529963|NCT02631850|11873370|FG002|Treatment Period|Lost to Follow-up|0
7529964|NCT02631850|11873371|FG003|Treatment Period|Lost to Follow-up|0
7529965|NCT02631850|11873368|FG000|Treatment Period|Protocol Violation|1
7529966|NCT02631850|11873369|FG001|Treatment Period|Protocol Violation|0
7529967|NCT02631850|11873370|FG002|Treatment Period|Protocol Violation|0
7529968|NCT02631850|11873371|FG003|Treatment Period|Protocol Violation|0
7529969|NCT02631850|11873368|FG000|Treatment Period|Withdrawal by Subject|0
7529970|NCT02631850|11873369|FG001|Treatment Period|Withdrawal by Subject|5
7529971|NCT02631850|11873370|FG002|Treatment Period|Withdrawal by Subject|2
7529972|NCT02631850|11873371|FG003|Treatment Period|Withdrawal by Subject|2
7529973|NCT02631850|11873368|FG000|Treatment Period|Adverse Event|1
7529974|NCT02631850|11873369|FG001|Treatment Period|Adverse Event|0
7529975|NCT02631850|11873370|FG002|Treatment Period|Adverse Event|2
7529976|NCT02631850|11873371|FG003|Treatment Period|Adverse Event|3
7529977|NCT02631850|11873368|FG000|Treatment Period|Family medical issue|1
7529978|NCT02631850|11873369|FG001|Treatment Period|Family medical issue|0
7529979|NCT02631850|11873370|FG002|Treatment Period|Family medical issue|0
7529980|NCT02631850|11873371|FG003|Treatment Period|Family medical issue|0
7529981|NCT02631850|11873368|FG000|6 Month Follow up|Lost to Follow-up|5
7529982|NCT02631850|11873369|FG001|6 Month Follow up|Lost to Follow-up|8
7529983|NCT02631850|11873370|FG002|6 Month Follow up|Lost to Follow-up|3
7529984|NCT02631850|11873371|FG003|6 Month Follow up|Lost to Follow-up|5
7529985|NCT02631850|11873368|FG000|6 Month Follow up|Withdrawal by Subject|1
7529986|NCT02631850|11873369|FG001|6 Month Follow up|Withdrawal by Subject|0
7529987|NCT02631850|11873370|FG002|6 Month Follow up|Withdrawal by Subject|0
7529988|NCT02631850|11873371|FG003|6 Month Follow up|Withdrawal by Subject|2
7529989|NCT02631850|11873368|FG000|6 Month Follow up|Adverse Event|1
7529990|NCT02631850|11873369|FG001|6 Month Follow up|Adverse Event|4
7529991|NCT02631850|11873370|FG002|6 Month Follow up|Adverse Event|1
7529992|NCT02631850|11873371|FG003|6 Month Follow up|Adverse Event|3
7529993|NCT02631850|11873368|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
7529994|NCT02631850|11873369|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7529995|NCT02631850|11873370|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
7529996|NCT02631850|11873371|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
7529999|NCT02631876|11873384|FG000|Overall Study|Investigator's discretion|1
7530000|NCT02631876|11873385|FG001|Overall Study|Investigator's discretion|0
7530001|NCT02631876|11873384|FG000|Overall Study|Lost to Follow-up|2
7530002|NCT02631876|11873385|FG001|Overall Study|Lost to Follow-up|0
7530003|NCT02631876|11873384|FG000|Overall Study|Withdrawal by Subject|16
7530004|NCT02631876|11873385|FG001|Overall Study|Withdrawal by Subject|9
7530005|NCT02631876|11873384|FG000|Overall Study|Other than specified|4
7530006|NCT02631876|11873385|FG001|Overall Study|Other than specified|4
7530007|NCT02632110|11873406|FG000|Overall Study|Withdrawal by Subject|1
7530008|NCT02632110|11873407|FG001|Overall Study|Withdrawal by Subject|1
7530009|NCT02632110|11873408|FG002|Overall Study|Withdrawal by Subject|0
7530010|NCT02632110|11873409|FG003|Overall Study|Withdrawal by Subject|0
7530011|NCT02632110|11873410|FG004|Overall Study|Withdrawal by Subject|1
7530012|NCT02632110|11873411|FG005|Overall Study|Withdrawal by Subject|1
7530013|NCT02632110|11873412|FG006|Overall Study|Withdrawal by Subject|3
7530014|NCT02632110|11873413|FG007|Overall Study|Withdrawal by Subject|3
7530015|NCT02632110|11873414|FG008|Overall Study|Withdrawal by Subject|1
7530016|NCT02632110|11873415|FG009|Overall Study|Withdrawal by Subject|1
7530017|NCT02632552|11873490|FG000|Overall Study|Lost to Follow-up|14
7530018|NCT02632552|11873491|FG001|Overall Study|Lost to Follow-up|8
7530019|NCT02632552|11873490|FG000|Overall Study|Withdrawal by Subject|2
7530020|NCT02632552|11873491|FG001|Overall Study|Withdrawal by Subject|0
7530021|NCT02632552|11873490|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
7530022|NCT02632552|11873491|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
7530023|NCT02632747|11873500|FG000|Wash-out Period|Adverse Event|1
7530024|NCT02632747|11873501|FG001|Wash-out Period|Adverse Event|0
7530025|NCT02632786|11873509|FG000|Overall Study|Adverse Event|2
7530026|NCT02632786|11873510|FG001|Overall Study|Adverse Event|1
7530027|NCT02632786|11873509|FG000|Overall Study|Death|3
7530028|NCT02632786|11873510|FG001|Overall Study|Death|2
7530029|NCT02632786|11873509|FG000|Overall Study|Physician Decision|5
7530030|NCT02632786|11873510|FG001|Overall Study|Physician Decision|4
7530031|NCT02632786|11873509|FG000|Overall Study|Withdrawal by Subject|1
7530032|NCT02632786|11873510|FG001|Overall Study|Withdrawal by Subject|0
7530033|NCT02632838|11873528|FG000|Overall Study|Withdrawal by Subject|3
7530034|NCT02632838|11873529|FG001|Overall Study|Withdrawal by Subject|0
7530035|NCT02632838|11873528|FG000|Overall Study|Lost to Follow-up|0
7530036|NCT02632838|11873529|FG001|Overall Study|Lost to Follow-up|2
7530037|NCT02633020|11873541|FG000|Overall Study|Adverse Event|1
7530038|NCT02633020|11873542|FG001|Overall Study|Adverse Event|0
7530039|NCT02633046|11873548|FG000|Overall Study|Adverse Event|8
7530040|NCT02633046|11873548|FG000|Overall Study|Physician Decision|7
7530041|NCT02633046|11873548|FG000|Overall Study|Withdrawal by Subject|8
7530042|NCT02633046|11873548|FG000|Overall Study|Increased proteinuria|2
7530043|NCT02633046|11873548|FG000|Overall Study|Participant decided not to continue with open label extension|1
7530044|NCT02633046|11873548|FG000|Overall Study|Mutual decision patient and physician|1
7530045|NCT02633215|11873554|FG000|Overall Study|Lost to Follow-up|2
7530046|NCT02633215|11873555|FG001|Overall Study|Lost to Follow-up|3
7530047|NCT02633306|11873561|FG000|Overall Study|Withdrawal by Subject|3
7530048|NCT02633501|11873595|FG000|Overall Study|Adverse Event|0
7530049|NCT02633501|11873596|FG001|Overall Study|Adverse Event|0
7530050|NCT02633501|11873597|FG002|Overall Study|Adverse Event|1
7530051|NCT02633501|11873598|FG003|Overall Study|Adverse Event|0
7530052|NCT02633501|11873599|FG004|Overall Study|Adverse Event|1
7530053|NCT02633501|11873600|FG005|Overall Study|Adverse Event|1
7530054|NCT02633501|11873595|FG000|Overall Study|Withdrawal by Subject|2
7530055|NCT02633501|11873596|FG001|Overall Study|Withdrawal by Subject|1
7530056|NCT02633501|11873597|FG002|Overall Study|Withdrawal by Subject|2
7530057|NCT02633501|11873598|FG003|Overall Study|Withdrawal by Subject|2
7530058|NCT02633501|11873599|FG004|Overall Study|Withdrawal by Subject|1
7387527|NCT01214837|11646075|FG002|Overall Study|Inappropriate Enrolment|2
7530059|NCT02633501|11873600|FG005|Overall Study|Withdrawal by Subject|3
7530060|NCT02633501|11873595|FG000|Overall Study|Various other reasons|0
7530061|NCT02633501|11873596|FG001|Overall Study|Various other reasons|2
7530062|NCT02633501|11873597|FG002|Overall Study|Various other reasons|4
7530063|NCT02633501|11873598|FG003|Overall Study|Various other reasons|1
7530064|NCT02633501|11873599|FG004|Overall Study|Various other reasons|7
7530065|NCT02633501|11873600|FG005|Overall Study|Various other reasons|11
7530066|NCT02633501|11873595|FG000|Overall Study|Lost to Follow-up|0
7530067|NCT02633501|11873596|FG001|Overall Study|Lost to Follow-up|0
7530068|NCT02633501|11873597|FG002|Overall Study|Lost to Follow-up|0
7530069|NCT02633501|11873598|FG003|Overall Study|Lost to Follow-up|1
7530070|NCT02633501|11873599|FG004|Overall Study|Lost to Follow-up|2
7530071|NCT02633501|11873600|FG005|Overall Study|Lost to Follow-up|0
7530072|NCT02633527|11873624|FG000|Overall Study|Failed to meet eligibility|0
7530073|NCT02633527|11873625|FG001|Overall Study|Failed to meet eligibility|1
7530074|NCT02633527|11873626|FG002|Overall Study|Failed to meet eligibility|1
7530075|NCT02633527|11873627|FG003|Overall Study|Failed to meet eligibility|0
7530076|NCT02633527|11873628|FG004|Overall Study|Failed to meet eligibility|1
7530077|NCT02633527|11873624|FG000|Overall Study|Adverse Event|0
7530078|NCT02633527|11873625|FG001|Overall Study|Adverse Event|4
7530079|NCT02633527|11873626|FG002|Overall Study|Adverse Event|3
7530080|NCT02633527|11873627|FG003|Overall Study|Adverse Event|1
7530081|NCT02633527|11873628|FG004|Overall Study|Adverse Event|5
7530082|NCT02633527|11873624|FG000|Overall Study|Lost to Follow-up|1
7530083|NCT02633527|11873625|FG001|Overall Study|Lost to Follow-up|2
7530084|NCT02633527|11873626|FG002|Overall Study|Lost to Follow-up|5
7530085|NCT02633527|11873627|FG003|Overall Study|Lost to Follow-up|5
7530086|NCT02633527|11873628|FG004|Overall Study|Lost to Follow-up|4
7530087|NCT02633527|11873624|FG000|Overall Study|Withdrawal by Subject|0
7530088|NCT02633527|11873625|FG001|Overall Study|Withdrawal by Subject|3
7530089|NCT02633527|11873626|FG002|Overall Study|Withdrawal by Subject|5
7530090|NCT02633527|11873627|FG003|Overall Study|Withdrawal by Subject|4
7530091|NCT02633527|11873628|FG004|Overall Study|Withdrawal by Subject|4
7530092|NCT02633527|11873624|FG000|Overall Study|Protocol Violation|0
7530093|NCT02633527|11873625|FG001|Overall Study|Protocol Violation|1
7530094|NCT02633527|11873626|FG002|Overall Study|Protocol Violation|1
7530095|NCT02633527|11873627|FG003|Overall Study|Protocol Violation|1
7530096|NCT02633527|11873628|FG004|Overall Study|Protocol Violation|1
7530097|NCT02633527|11873624|FG000|Overall Study|Physician Decision|0
7530098|NCT02633527|11873625|FG001|Overall Study|Physician Decision|0
7530099|NCT02633527|11873626|FG002|Overall Study|Physician Decision|0
7530100|NCT02633527|11873627|FG003|Overall Study|Physician Decision|0
7530101|NCT02633527|11873628|FG004|Overall Study|Physician Decision|1
7530102|NCT02633527|11873624|FG000|Overall Study|Administrative reason|1
7530103|NCT02633527|11873625|FG001|Overall Study|Administrative reason|0
7530104|NCT02633527|11873626|FG002|Overall Study|Administrative reason|0
7530105|NCT02633527|11873627|FG003|Overall Study|Administrative reason|1
7530106|NCT02633527|11873628|FG004|Overall Study|Administrative reason|0
7530107|NCT02633527|11873624|FG000|Overall Study|Multiple reasons|1
7530108|NCT02633527|11873625|FG001|Overall Study|Multiple reasons|0
7530109|NCT02633527|11873626|FG002|Overall Study|Multiple reasons|2
7530110|NCT02633527|11873627|FG003|Overall Study|Multiple reasons|2
7530111|NCT02633527|11873628|FG004|Overall Study|Multiple reasons|1
7537590|NCT03123185|11886586|FG008|Overall Study|Withdrawal by Subject|0
7537591|NCT03123185|11886587|FG009|Overall Study|Withdrawal by Subject|0
7537592|NCT03123185|11886588|FG010|Overall Study|Withdrawal by Subject|0
7537593|NCT03123185|11886589|FG011|Overall Study|Withdrawal by Subject|0
7537594|NCT03123185|11886590|FG012|Overall Study|Withdrawal by Subject|1
7537595|NCT03123185|11886591|FG013|Overall Study|Withdrawal by Subject|0
7414267|NCT01432444|11687058|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
7414268|NCT01432444|11687059|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7414269|NCT01432444|11687060|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
7530112|NCT02633787|11873649|FG000|Overall Study|Withdrawal by Subject|1
7530113|NCT02633800|11873655|FG000|Overall Study|Death|3
7530114|NCT02633800|11873656|FG001|Overall Study|Death|3
7530115|NCT02633800|11873655|FG000|Overall Study|Reason not provided|1
7530116|NCT02633800|11873656|FG001|Overall Study|Reason not provided|0
7530117|NCT02633800|11873655|FG000|Overall Study|Radiologic(al) progression|23
7530118|NCT02633800|11873656|FG001|Overall Study|Radiologic(al) progression|23
7530119|NCT02633800|11873655|FG000|Overall Study|Clinical progression|3
7530120|NCT02633800|11873656|FG001|Overall Study|Clinical progression|6
7530121|NCT02633800|11873655|FG000|Overall Study|Study terminated by sponsor|6
7530122|NCT02633800|11873656|FG001|Overall Study|Study terminated by sponsor|5
7530123|NCT02633800|11873655|FG000|Overall Study|Adverse event, non-fatal|7
7530124|NCT02633800|11873656|FG001|Overall Study|Adverse event, non-fatal|2
7530125|NCT02633800|11873655|FG000|Overall Study|Withdrawal by Subject|0
7530126|NCT02633800|11873656|FG001|Overall Study|Withdrawal by Subject|3
7530127|NCT02633800|11873655|FG000|Overall Study|Patient Request|1
7530128|NCT02633800|11873656|FG001|Overall Study|Patient Request|1
7530129|NCT02634151|11873698|FG000|Overall Study|Withdrawal by Subject|1
7530130|NCT02634151|11873699|FG001|Overall Study|Withdrawal by Subject|0
7530131|NCT02634151|11873698|FG000|Overall Study|Non-Compliance|0
7530132|NCT02634151|11873699|FG001|Overall Study|Non-Compliance|1
7530133|NCT02634151|11873698|FG000|Overall Study|Other|0
7530134|NCT02634151|11873699|FG001|Overall Study|Other|1
7530135|NCT02634320|11873714|FG000|Overall Study|Adverse Event|2
7530136|NCT02634320|11873714|FG000|Overall Study|Lost to Follow-up|3
7530137|NCT02634320|11873714|FG000|Overall Study|Moved out of area|2
7530138|NCT02634320|11873714|FG000|Overall Study|Out of window for study visits|1
7530139|NCT02634320|11873714|FG000|Overall Study|Protocol Violation|1
7530140|NCT02634320|11873714|FG000|Overall Study|Withdrawal by Subject|5
7530141|NCT02634320|11873714|FG000|Overall Study|Lack of Efficacy|2
7530152|NCT02634346|11873731|FG000|Overall Study|Withdrawal by Subject|8
7530153|NCT02634346|11873732|FG001|Overall Study|Withdrawal by Subject|9
7530154|NCT02634346|11873733|FG002|Overall Study|Withdrawal by Subject|8
7530155|NCT02634346|11873731|FG000|Overall Study|Adverse Event|2
7530156|NCT02634346|11873732|FG001|Overall Study|Adverse Event|2
7530157|NCT02634346|11873733|FG002|Overall Study|Adverse Event|7
7530158|NCT02634346|11873731|FG000|Overall Study|Lack of Efficacy|1
7414270|NCT01432444|11687058|FG000|Treatment Phase|Lost to Follow-up|0
7530159|NCT02634346|11873732|FG001|Overall Study|Lack of Efficacy|2
7530160|NCT02634346|11873733|FG002|Overall Study|Lack of Efficacy|8
7530161|NCT02634346|11873731|FG000|Overall Study|Lost to Follow-up|1
7530162|NCT02634346|11873732|FG001|Overall Study|Lost to Follow-up|0
7530163|NCT02634346|11873733|FG002|Overall Study|Lost to Follow-up|0
7530164|NCT02634346|11873731|FG000|Overall Study|Protocol Violation|0
7530165|NCT02634346|11873732|FG001|Overall Study|Protocol Violation|1
7530166|NCT02634346|11873733|FG002|Overall Study|Protocol Violation|0
7530167|NCT02634580|11873745|FG000|Double-blind Treatment Period|Subject Request|1
7530168|NCT02634580|11873746|FG001|Double-blind Treatment Period|Subject Request|0
7530169|NCT02634580|11873747|FG002|Double-blind Treatment Period|Subject Request|1
7530170|NCT02634580|11873748|FG003|Double-blind Treatment Period|Subject Request|1
7530171|NCT02634580|11873745|FG000|Open-label Extension Period|Withdrawal by Subject|0
7530172|NCT02634580|11873746|FG001|Open-label Extension Period|Withdrawal by Subject|1
7530173|NCT02634580|11873747|FG002|Open-label Extension Period|Withdrawal by Subject|0
7530174|NCT02634580|11873748|FG003|Open-label Extension Period|Withdrawal by Subject|1
7530175|NCT02634788|11873778|FG000|Overall Study|Adverse Event|0
7530176|NCT02634788|11873779|FG001|Overall Study|Adverse Event|8
7530177|NCT02634788|11873780|FG002|Overall Study|Adverse Event|3
7530178|NCT02634788|11873781|FG003|Overall Study|Adverse Event|1
7530179|NCT02634788|11873778|FG000|Overall Study|Lack of Efficacy|4
7530180|NCT02634788|11873779|FG001|Overall Study|Lack of Efficacy|0
7530181|NCT02634788|11873780|FG002|Overall Study|Lack of Efficacy|1
7530182|NCT02634788|11873781|FG003|Overall Study|Lack of Efficacy|4
7530183|NCT02634788|11873778|FG000|Overall Study|Lost to Follow-up|0
7530184|NCT02634788|11873779|FG001|Overall Study|Lost to Follow-up|1
7530185|NCT02634788|11873780|FG002|Overall Study|Lost to Follow-up|0
7530186|NCT02634788|11873781|FG003|Overall Study|Lost to Follow-up|0
7530187|NCT02634788|11873778|FG000|Overall Study|Withdrawal by Subject|0
7530188|NCT02634788|11873779|FG001|Overall Study|Withdrawal by Subject|1
7530189|NCT02634788|11873780|FG002|Overall Study|Withdrawal by Subject|1
7530190|NCT02634788|11873781|FG003|Overall Study|Withdrawal by Subject|0
7530191|NCT02634801|11873794|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
7530192|NCT02634801|11873795|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
7530193|NCT02634801|11873796|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
7530194|NCT02634801|11873794|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7530195|NCT02634801|11873795|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
7530196|NCT02634801|11873796|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
7530197|NCT02634801|11873794|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
7530198|NCT02634801|11873795|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7530199|NCT02634801|11873796|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
7530200|NCT02634801|11873794|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7530201|NCT02634801|11873795|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
7530202|NCT02634801|11873796|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
7530203|NCT02634801|11873794|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
7530204|NCT02634801|11873795|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
7530205|NCT02634801|11873796|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
7530206|NCT02634801|11873794|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
7530207|NCT02634801|11873795|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
7530208|NCT02634801|11873796|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
7530209|NCT02634801|11873794|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
7530210|NCT02634801|11873795|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7530211|NCT02634801|11873796|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
7530212|NCT02634801|11873794|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7530213|NCT02634801|11873795|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7530214|NCT02634801|11873796|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
7530215|NCT02634801|11873794|FG000|Extension Period (Weeks 24 to 36)|Missing|1
7530216|NCT02634801|11873795|FG001|Extension Period (Weeks 24 to 36)|Missing|0
7530217|NCT02634801|11873796|FG002|Extension Period (Weeks 24 to 36)|Missing|0
7530218|NCT02634801|11873794|FG000|Follow-up Period|Lost to Follow-up|3
7530219|NCT02634801|11873795|FG001|Follow-up Period|Lost to Follow-up|1
7530220|NCT02634801|11873796|FG002|Follow-up Period|Lost to Follow-up|2
7530221|NCT02634801|11873794|FG000|Follow-up Period|Physician Decision|0
7530222|NCT02634801|11873795|FG001|Follow-up Period|Physician Decision|0
7530223|NCT02634801|11873796|FG002|Follow-up Period|Physician Decision|1
7530224|NCT02634801|11873794|FG000|Follow-up Period|Withdrawal by Subject|1
7530225|NCT02634801|11873795|FG001|Follow-up Period|Withdrawal by Subject|2
7530226|NCT02634801|11873796|FG002|Follow-up Period|Withdrawal by Subject|5
7530227|NCT02634801|11873794|FG000|Follow-up Period|Adverse Event|1
7530228|NCT02634801|11873795|FG001|Follow-up Period|Adverse Event|5
7530229|NCT02634801|11873796|FG002|Follow-up Period|Adverse Event|0
7530230|NCT02634983|11873821|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
7530231|NCT02634983|11873822|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
7530232|NCT02635204|11873839|FG000|Overall Study|Adverse Event|1
7530233|NCT02635204|11873840|FG001|Overall Study|Adverse Event|0
7530234|NCT02635204|11873839|FG000|Overall Study|Lost to Follow-up|1
7530235|NCT02635204|11873840|FG001|Overall Study|Lost to Follow-up|1
7530236|NCT02635347|11873848|FG000|Overall Study|Failed screening|20
7530237|NCT02635347|11873849|FG001|Overall Study|Failed screening|7
7530238|NCT02635386|11873861|FG000|Overall Study|Pregnancy|2
7530239|NCT02635386|11873862|FG001|Overall Study|Pregnancy|0
7530240|NCT02635386|11873863|FG002|Overall Study|Pregnancy|0
7530241|NCT02635386|11873864|FG003|Overall Study|Pregnancy|0
7530242|NCT02635386|11873865|FG004|Overall Study|Pregnancy|2
7530243|NCT02635386|11873861|FG000|Overall Study|Withdrawal by Subject|1
7530244|NCT02635386|11873862|FG001|Overall Study|Withdrawal by Subject|1
7530245|NCT02635386|11873863|FG002|Overall Study|Withdrawal by Subject|0
7530246|NCT02635386|11873864|FG003|Overall Study|Withdrawal by Subject|1
7530247|NCT02635386|11873865|FG004|Overall Study|Withdrawal by Subject|0
7530248|NCT02635386|11873861|FG000|Overall Study|Physician Decision|0
7530249|NCT02635386|11873862|FG001|Overall Study|Physician Decision|1
7530250|NCT02635386|11873863|FG002|Overall Study|Physician Decision|0
7530251|NCT02635386|11873864|FG003|Overall Study|Physician Decision|0
7530252|NCT02635386|11873865|FG004|Overall Study|Physician Decision|0
7530253|NCT02635386|11873861|FG000|Overall Study|Moved Out of State|0
7530254|NCT02635386|11873862|FG001|Overall Study|Moved Out of State|1
7530255|NCT02635386|11873863|FG002|Overall Study|Moved Out of State|0
7530256|NCT02635386|11873864|FG003|Overall Study|Moved Out of State|0
7530257|NCT02635386|11873865|FG004|Overall Study|Moved Out of State|0
7530258|NCT02635386|11873861|FG000|Overall Study|Noncompliant|0
7530259|NCT02635386|11873862|FG001|Overall Study|Noncompliant|2
7530260|NCT02635386|11873863|FG002|Overall Study|Noncompliant|1
7530261|NCT02635386|11873864|FG003|Overall Study|Noncompliant|1
7530262|NCT02635386|11873865|FG004|Overall Study|Noncompliant|1
7530263|NCT02635386|11873861|FG000|Overall Study|side effects|0
7530264|NCT02635386|11873862|FG001|Overall Study|side effects|0
7530265|NCT02635386|11873863|FG002|Overall Study|side effects|1
7553209|NCT03011099|11914162|FG000|Overall Study|Withdrawal by Subject|0
7553210|NCT03011099|11914163|FG001|Overall Study|Withdrawal by Subject|2
7553211|NCT03011333|11914178|FG000|Overall Study|Lost to Follow-up|0
7553212|NCT03011333|11914179|FG001|Overall Study|Lost to Follow-up|1
7553213|NCT03011333|11914180|FG002|Overall Study|Lost to Follow-up|0
7553214|NCT03011333|11914181|FG003|Overall Study|Lost to Follow-up|1
7553215|NCT03011333|11914182|FG004|Overall Study|Lost to Follow-up|4
7553216|NCT03011333|11914183|FG005|Overall Study|Lost to Follow-up|4
7553217|NCT03011333|11914184|FG006|Overall Study|Lost to Follow-up|5
7553218|NCT03011840|11914202|FG000|Overall Study|Not received PIL in post PIL phase|0
7553219|NCT03011840|11914203|FG001|Overall Study|Not received PIL in post PIL phase|21
7553220|NCT03011892|11914215|FG000|Double Blind (DB) Period|Adverse Event|0
7553221|NCT03011892|11914216|FG001|Double Blind (DB) Period|Adverse Event|1
7553222|NCT03011892|11914217|FG002|Double Blind (DB) Period|Adverse Event|1
7530266|NCT02635386|11873864|FG003|Overall Study|side effects|4
7553223|NCT03011892|11914218|FG003|Double Blind (DB) Period|Adverse Event|0
7553224|NCT03011892|11914219|FG004|Double Blind (DB) Period|Adverse Event|0
7530267|NCT02635386|11873865|FG004|Overall Study|side effects|6
7530268|NCT02635386|11873861|FG000|Overall Study|needed other major surgery|0
7530269|NCT02635386|11873862|FG001|Overall Study|needed other major surgery|1
7530270|NCT02635386|11873863|FG002|Overall Study|needed other major surgery|0
7530271|NCT02635386|11873864|FG003|Overall Study|needed other major surgery|0
7530272|NCT02635386|11873865|FG004|Overall Study|needed other major surgery|0
7530273|NCT02635386|11873861|FG000|Overall Study|Other medical problems not drug related|0
7318061|NCT00726232|11547078|FG006|Expansion Phase|Termination of the trial by sponsor|10
7318062|NCT00726232|11547079|FG007|Expansion Phase|Termination of the trial by sponsor|16
7318063|NCT00726232|11547072|FG000|Expansion Phase|Per Investigator: lack of response|0
7414271|NCT01432444|11687059|FG001|Treatment Phase|Lost to Follow-up|33
7530274|NCT02635386|11873862|FG001|Overall Study|Other medical problems not drug related|0
7530275|NCT02635386|11873863|FG002|Overall Study|Other medical problems not drug related|0
7530276|NCT02635386|11873864|FG003|Overall Study|Other medical problems not drug related|1
7530277|NCT02635386|11873865|FG004|Overall Study|Other medical problems not drug related|0
7414272|NCT01432444|11687060|FG002|Treatment Phase|Lost to Follow-up|0
7530278|NCT02635646|11873902|FG000|Overall Study|Lost to Follow-up|24
7530279|NCT02635646|11873903|FG001|Overall Study|Lost to Follow-up|25
7530280|NCT02635646|11873902|FG000|Overall Study|Pregnancy|1
7530281|NCT02635646|11873903|FG001|Overall Study|Pregnancy|1
7530282|NCT02635724|11873918|FG000|Overall Study|Withdrawal by Subject|0
7553225|NCT03011892|11914220|FG005|Double Blind (DB) Period|Adverse Event|0
7553226|NCT03011892|11914221|FG006|Double Blind (DB) Period|Adverse Event|0
7553227|NCT03011892|11914222|FG007|Double Blind (DB) Period|Adverse Event|0
7553228|NCT03011892|11914223|FG008|Double Blind (DB) Period|Adverse Event|0
7553229|NCT03011892|11914224|FG009|Double Blind (DB) Period|Adverse Event|0
7553230|NCT03011892|11914225|FG010|Double Blind (DB) Period|Adverse Event|0
7553231|NCT03011892|11914226|FG011|Double Blind (DB) Period|Adverse Event|0
7553232|NCT03011892|11914215|FG000|Double Blind (DB) Period|Lack of Efficacy|1
7553233|NCT03011892|11914216|FG001|Double Blind (DB) Period|Lack of Efficacy|0
7553234|NCT03011892|11914217|FG002|Double Blind (DB) Period|Lack of Efficacy|0
7553235|NCT03011892|11914218|FG003|Double Blind (DB) Period|Lack of Efficacy|0
7553236|NCT03011892|11914219|FG004|Double Blind (DB) Period|Lack of Efficacy|0
7553237|NCT03011892|11914220|FG005|Double Blind (DB) Period|Lack of Efficacy|0
7553238|NCT03011892|11914221|FG006|Double Blind (DB) Period|Lack of Efficacy|0
7553239|NCT03011892|11914222|FG007|Double Blind (DB) Period|Lack of Efficacy|0
7553240|NCT03011892|11914223|FG008|Double Blind (DB) Period|Lack of Efficacy|0
7553241|NCT03011892|11914224|FG009|Double Blind (DB) Period|Lack of Efficacy|0
7553242|NCT03011892|11914225|FG010|Double Blind (DB) Period|Lack of Efficacy|0
7553243|NCT03011892|11914226|FG011|Double Blind (DB) Period|Lack of Efficacy|0
7553244|NCT03011892|11914215|FG000|Double Blind (DB) Period|Lost to Follow-up|0
7553245|NCT03011892|11914216|FG001|Double Blind (DB) Period|Lost to Follow-up|3
7553246|NCT03011892|11914217|FG002|Double Blind (DB) Period|Lost to Follow-up|2
7553247|NCT03011892|11914218|FG003|Double Blind (DB) Period|Lost to Follow-up|5
7553248|NCT03011892|11914219|FG004|Double Blind (DB) Period|Lost to Follow-up|0
7553249|NCT03011892|11914220|FG005|Double Blind (DB) Period|Lost to Follow-up|2
7553250|NCT03011892|11914221|FG006|Double Blind (DB) Period|Lost to Follow-up|0
7553251|NCT03011892|11914222|FG007|Double Blind (DB) Period|Lost to Follow-up|0
7553252|NCT03011892|11914223|FG008|Double Blind (DB) Period|Lost to Follow-up|0
7553253|NCT03011892|11914224|FG009|Double Blind (DB) Period|Lost to Follow-up|0
7553254|NCT03011892|11914225|FG010|Double Blind (DB) Period|Lost to Follow-up|0
7553255|NCT03011892|11914226|FG011|Double Blind (DB) Period|Lost to Follow-up|0
7553256|NCT03011892|11914215|FG000|Double Blind (DB) Period|Other|1
7553257|NCT03011892|11914216|FG001|Double Blind (DB) Period|Other|1
7553258|NCT03011892|11914217|FG002|Double Blind (DB) Period|Other|1
7553259|NCT03011892|11914218|FG003|Double Blind (DB) Period|Other|0
7553260|NCT03011892|11914219|FG004|Double Blind (DB) Period|Other|1
7553261|NCT03011892|11914220|FG005|Double Blind (DB) Period|Other|0
7553262|NCT03011892|11914221|FG006|Double Blind (DB) Period|Other|0
7553263|NCT03011892|11914222|FG007|Double Blind (DB) Period|Other|0
7553264|NCT03011892|11914223|FG008|Double Blind (DB) Period|Other|0
7530283|NCT02635724|11873919|FG001|Overall Study|Withdrawal by Subject|1
7530284|NCT02635724|11873920|FG002|Overall Study|Withdrawal by Subject|0
7530285|NCT02635737|11873928|FG000|Overall Study|Protocol Violation|1
7553265|NCT03011892|11914224|FG009|Double Blind (DB) Period|Other|0
7553266|NCT03011892|11914225|FG010|Double Blind (DB) Period|Other|0
7553267|NCT03011892|11914226|FG011|Double Blind (DB) Period|Other|0
7553268|NCT03011892|11914215|FG000|Double Blind (DB) Period|Physician Decision|1
7553269|NCT03011892|11914216|FG001|Double Blind (DB) Period|Physician Decision|0
7553270|NCT03011892|11914217|FG002|Double Blind (DB) Period|Physician Decision|1
7553271|NCT03011892|11914218|FG003|Double Blind (DB) Period|Physician Decision|0
7553272|NCT03011892|11914219|FG004|Double Blind (DB) Period|Physician Decision|0
7553273|NCT03011892|11914220|FG005|Double Blind (DB) Period|Physician Decision|0
7553274|NCT03011892|11914221|FG006|Double Blind (DB) Period|Physician Decision|0
7553275|NCT03011892|11914222|FG007|Double Blind (DB) Period|Physician Decision|0
7553276|NCT03011892|11914223|FG008|Double Blind (DB) Period|Physician Decision|0
7553277|NCT03011892|11914224|FG009|Double Blind (DB) Period|Physician Decision|0
7553278|NCT03011892|11914225|FG010|Double Blind (DB) Period|Physician Decision|0
7553279|NCT03011892|11914226|FG011|Double Blind (DB) Period|Physician Decision|0
7553280|NCT03011892|11914215|FG000|Double Blind (DB) Period|Pregnancy|0
7553281|NCT03011892|11914216|FG001|Double Blind (DB) Period|Pregnancy|0
7553282|NCT03011892|11914217|FG002|Double Blind (DB) Period|Pregnancy|0
7553283|NCT03011892|11914218|FG003|Double Blind (DB) Period|Pregnancy|0
7553284|NCT03011892|11914219|FG004|Double Blind (DB) Period|Pregnancy|1
7553285|NCT03011892|11914220|FG005|Double Blind (DB) Period|Pregnancy|0
7553286|NCT03011892|11914221|FG006|Double Blind (DB) Period|Pregnancy|0
7553287|NCT03011892|11914222|FG007|Double Blind (DB) Period|Pregnancy|0
7553288|NCT03011892|11914223|FG008|Double Blind (DB) Period|Pregnancy|0
7553289|NCT03011892|11914224|FG009|Double Blind (DB) Period|Pregnancy|0
7553290|NCT03011892|11914225|FG010|Double Blind (DB) Period|Pregnancy|0
7553291|NCT03011892|11914226|FG011|Double Blind (DB) Period|Pregnancy|0
7553292|NCT03011892|11914215|FG000|Double Blind (DB) Period|Protocol Violation|1
7553293|NCT03011892|11914216|FG001|Double Blind (DB) Period|Protocol Violation|0
7553294|NCT03011892|11914217|FG002|Double Blind (DB) Period|Protocol Violation|0
7553295|NCT03011892|11914218|FG003|Double Blind (DB) Period|Protocol Violation|0
7553296|NCT03011892|11914219|FG004|Double Blind (DB) Period|Protocol Violation|0
7553297|NCT03011892|11914220|FG005|Double Blind (DB) Period|Protocol Violation|0
7553298|NCT03011892|11914221|FG006|Double Blind (DB) Period|Protocol Violation|0
7553299|NCT03011892|11914222|FG007|Double Blind (DB) Period|Protocol Violation|0
7553300|NCT03011892|11914223|FG008|Double Blind (DB) Period|Protocol Violation|0
7553301|NCT03011892|11914224|FG009|Double Blind (DB) Period|Protocol Violation|0
7553302|NCT03011892|11914225|FG010|Double Blind (DB) Period|Protocol Violation|0
7553303|NCT03011892|11914226|FG011|Double Blind (DB) Period|Protocol Violation|0
7553304|NCT03011892|11914215|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
7553305|NCT03011892|11914216|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
7553306|NCT03011892|11914217|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
7553307|NCT03011892|11914218|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
7530286|NCT02635984|11873942|FG000|Overall Study|Lost to Follow-up|2
7530287|NCT02635984|11873943|FG001|Overall Study|Lost to Follow-up|4
7530288|NCT02635984|11873942|FG000|Overall Study|Study Arm Closed|1
7530289|NCT02635984|11873943|FG001|Overall Study|Study Arm Closed|0
7530290|NCT02636361|11873955|FG000|Period 4|Physician Decision|0
7530291|NCT02636361|11873956|FG001|Period 4|Physician Decision|0
7530292|NCT02636361|11873957|FG002|Period 4|Physician Decision|0
7530293|NCT02636361|11873958|FG003|Period 4|Physician Decision|1
7530294|NCT02636361|11873959|FG004|Period 4|Physician Decision|0
7530295|NCT02636595|11873973|FG000|Overall Study|Lost to Follow-up|1
7530296|NCT02636595|11873973|FG000|Overall Study|Other|1
7530297|NCT02636608|11873977|FG000|Overall Study|Failure to Return|4
7530298|NCT02636608|11873977|FG000|Overall Study|Insufficient Virological Response|1
7530299|NCT02636608|11873977|FG000|Overall Study|Death|3
7530300|NCT02636608|11873977|FG000|Overall Study|Other|2
7530301|NCT02636608|11873977|FG000|Overall Study|Did Not Receive Treatment|1
7530302|NCT02636699|11873986|FG000|Overall Study|Adverse Event|4
7530303|NCT02636699|11873987|FG001|Overall Study|Adverse Event|0
7387528|NCT01214837|11646073|FG000|Overall Study|Administrative Reason|2
7530304|NCT02636699|11873986|FG000|Overall Study|Lost to Follow-up|3
7530305|NCT02636699|11873987|FG001|Overall Study|Lost to Follow-up|3
7530306|NCT02636699|11873986|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
7553308|NCT03011892|11914219|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
7553309|NCT03011892|11914220|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
7318064|NCT00726232|11547073|FG001|Expansion Phase|Per Investigator: lack of response|0
7318065|NCT00726232|11547074|FG002|Expansion Phase|Per Investigator: lack of response|0
7414273|NCT01432444|11687058|FG000|Treatment Phase|Adverse Event|0
7414274|NCT01432444|11687059|FG001|Treatment Phase|Adverse Event|37
7414275|NCT01432444|11687060|FG002|Treatment Phase|Adverse Event|0
7414276|NCT01432444|11687058|FG000|Treatment Phase|Met Withdrawal Criteria|0
7414277|NCT01432444|11687059|FG001|Treatment Phase|Met Withdrawal Criteria|11
7414278|NCT01432444|11687060|FG002|Treatment Phase|Met Withdrawal Criteria|0
7414279|NCT01432444|11687058|FG000|Treatment Phase|Physician Decision|0
7414280|NCT01432444|11687059|FG001|Treatment Phase|Physician Decision|5
7414281|NCT01432444|11687060|FG002|Treatment Phase|Physician Decision|0
7318066|NCT00726232|11547075|FG003|Expansion Phase|Per Investigator: lack of response|0
7318067|NCT00726232|11547076|FG004|Expansion Phase|Per Investigator: lack of response|0
7318068|NCT00726232|11547077|FG005|Expansion Phase|Per Investigator: lack of response|0
7318069|NCT00726232|11547078|FG006|Expansion Phase|Per Investigator: lack of response|1
7318070|NCT00726232|11547079|FG007|Expansion Phase|Per Investigator: lack of response|7
7318071|NCT00726232|11547072|FG000|Expansion Phase|Unspecified reason|0
7318072|NCT00726232|11547073|FG001|Expansion Phase|Unspecified reason|0
7318073|NCT00726232|11547074|FG002|Expansion Phase|Unspecified reason|0
7318074|NCT00726232|11547075|FG003|Expansion Phase|Unspecified reason|0
7318075|NCT00726232|11547076|FG004|Expansion Phase|Unspecified reason|0
7318076|NCT00726232|11547077|FG005|Expansion Phase|Unspecified reason|0
7318077|NCT00726232|11547078|FG006|Expansion Phase|Unspecified reason|1
7318078|NCT00726232|11547079|FG007|Expansion Phase|Unspecified reason|0
7318079|NCT00726323|11547100|FG000|Overall Study|Withdrawal by Subject|3
7318080|NCT00726323|11547101|FG001|Overall Study|Withdrawal by Subject|1
7318081|NCT00726323|11547100|FG000|Overall Study|Physician Decision|1
7318082|NCT00726323|11547101|FG001|Overall Study|Physician Decision|0
7318083|NCT00726323|11547100|FG000|Overall Study|Progressive disease|23
7318084|NCT00726323|11547101|FG001|Overall Study|Progressive disease|16
7318085|NCT00726323|11547100|FG000|Overall Study|Clinical progression|0
7318086|NCT00726323|11547101|FG001|Overall Study|Clinical progression|3
7318087|NCT00726323|11547100|FG000|Overall Study|Adverse Event|9
7318088|NCT00726323|11547101|FG001|Overall Study|Adverse Event|9
7318089|NCT00726323|11547100|FG000|Overall Study|Death|1
7318090|NCT00726323|11547101|FG001|Overall Study|Death|0
7318091|NCT00726323|11547100|FG000|Overall Study|Participant wished to discontinue|0
7318092|NCT00726323|11547101|FG001|Overall Study|Participant wished to discontinue|1
7318093|NCT00726323|11547100|FG000|Overall Study|Metastatic lesions inferred cyst|0
7318094|NCT00726323|11547101|FG001|Overall Study|Metastatic lesions inferred cyst|1
7318095|NCT00726388|11547111|FG000|Overall Study|Withdrawal by Subject|5
7553310|NCT03011892|11914221|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
7553311|NCT03011892|11914222|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
7553312|NCT03011892|11914223|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
7553313|NCT03011892|11914224|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
7553314|NCT03011892|11914225|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
7553315|NCT03011892|11914226|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
7553316|NCT03011892|11914215|FG000|Double Blind (DB) Period|Randomized but not treated|0
7553317|NCT03011892|11914216|FG001|Double Blind (DB) Period|Randomized but not treated|0
7553318|NCT03011892|11914217|FG002|Double Blind (DB) Period|Randomized but not treated|0
7553319|NCT03011892|11914218|FG003|Double Blind (DB) Period|Randomized but not treated|0
7553320|NCT03011892|11914219|FG004|Double Blind (DB) Period|Randomized but not treated|1
7553321|NCT03011892|11914220|FG005|Double Blind (DB) Period|Randomized but not treated|0
7318096|NCT00726388|11547111|FG000|Overall Study|Adverse Event|3
7318097|NCT00726388|11547111|FG000|Overall Study|Lost to Follow-up|10
7318098|NCT00726388|11547111|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
7318099|NCT00726388|11547111|FG000|Overall Study|Other|5
7318100|NCT00726388|11547111|FG000|Overall Study|Enrolled, Not Treated|79
7318101|NCT00726453|11547124|FG000|Primary Enrollment Group|Death|18
7318102|NCT00726453|11547125|FG001|Primary Enrollment Group|Death|0
7318103|NCT00726453|11547124|FG000|Primary Enrollment Group|Withdrawal by Subject|13
7318104|NCT00726453|11547125|FG001|Primary Enrollment Group|Withdrawal by Subject|0
7414282|NCT01432444|11687058|FG000|Treatment Phase|Withdrawal by Subject|0
7318105|NCT00726453|11547124|FG000|38 mm Length Group|Death|0
7414283|NCT01432444|11687059|FG001|Treatment Phase|Withdrawal by Subject|41
7225132|NCT00064350|11434620|FG001|Cross-Over|Adverse Event|1
7225133|NCT00064350|11434621|FG002|Cross-Over|Adverse Event|0
7553322|NCT03011892|11914221|FG006|Double Blind (DB) Period|Randomized but not treated|0
7225134|NCT00064350|11434619|FG000|Cross-Over|Death|1
7225135|NCT00064350|11434620|FG001|Cross-Over|Death|3
7225136|NCT00064350|11434621|FG002|Cross-Over|Death|0
7225137|NCT00064350|11434619|FG000|Cross-Over|Withdrawal by Subject|2
7414284|NCT01432444|11687060|FG002|Treatment Phase|Withdrawal by Subject|0
7414285|NCT01432444|11687058|FG000|Treatment Phase|Protocol Deviation|0
7414286|NCT01432444|11687059|FG001|Treatment Phase|Protocol Deviation|3
7414287|NCT01432444|11687060|FG002|Treatment Phase|Protocol Deviation|0
7414288|NCT01432444|11687058|FG000|Treatment Phase|Lack of Efficacy|0
7414289|NCT01432444|11687059|FG001|Treatment Phase|Lack of Efficacy|10
7414290|NCT01432444|11687060|FG002|Treatment Phase|Lack of Efficacy|0
7414291|NCT01432444|11687058|FG000|Extension Phase|Lost to Follow-up|0
7414292|NCT01432444|11687059|FG001|Extension Phase|Lost to Follow-up|0
7414293|NCT01432444|11687060|FG002|Extension Phase|Lost to Follow-up|17
7414294|NCT01432444|11687058|FG000|Extension Phase|Adverse Event|0
7414295|NCT01432444|11687059|FG001|Extension Phase|Adverse Event|0
7414296|NCT01432444|11687060|FG002|Extension Phase|Adverse Event|10
7414297|NCT01432444|11687058|FG000|Extension Phase|Sponsor Discontinued Trial|0
7414298|NCT01432444|11687059|FG001|Extension Phase|Sponsor Discontinued Trial|0
7414299|NCT01432444|11687060|FG002|Extension Phase|Sponsor Discontinued Trial|7
7414300|NCT01432444|11687058|FG000|Extension Phase|Met Withdrawal Criteria|0
7414301|NCT01432444|11687059|FG001|Extension Phase|Met Withdrawal Criteria|0
7414302|NCT01432444|11687060|FG002|Extension Phase|Met Withdrawal Criteria|144
7414303|NCT01432444|11687058|FG000|Extension Phase|Physician Decision|0
7414304|NCT01432444|11687059|FG001|Extension Phase|Physician Decision|0
7414305|NCT01432444|11687060|FG002|Extension Phase|Physician Decision|1
7414306|NCT01432444|11687058|FG000|Extension Phase|Withdrawal by Subject|0
7414307|NCT01432444|11687059|FG001|Extension Phase|Withdrawal by Subject|0
7414308|NCT01432444|11687060|FG002|Extension Phase|Withdrawal by Subject|13
7414309|NCT01432457|11687068|FG000|Overall Study|Adverse Event|7
7414310|NCT01432457|11687069|FG001|Overall Study|Adverse Event|10
7414311|NCT01432457|11687070|FG002|Overall Study|Adverse Event|16
7414312|NCT01432457|11687068|FG000|Overall Study|Lack of Efficacy|2
7414313|NCT01432457|11687069|FG001|Overall Study|Lack of Efficacy|1
7414314|NCT01432457|11687070|FG002|Overall Study|Lack of Efficacy|1
7414315|NCT01432457|11687068|FG000|Overall Study|Lost to Follow-up|11
7414316|NCT01432457|11687069|FG001|Overall Study|Lost to Follow-up|15
7414317|NCT01432457|11687070|FG002|Overall Study|Lost to Follow-up|20
7414318|NCT01432457|11687068|FG000|Overall Study|Protocol Violation|3
7414319|NCT01432457|11687069|FG001|Overall Study|Protocol Violation|2
7414320|NCT01432457|11687070|FG002|Overall Study|Protocol Violation|6
7414321|NCT01432457|11687068|FG000|Overall Study|Withdrawal by Subject|6
7414322|NCT01432457|11687069|FG001|Overall Study|Withdrawal by Subject|11
7414323|NCT01432457|11687070|FG002|Overall Study|Withdrawal by Subject|9
7414324|NCT01432457|11687068|FG000|Overall Study|Reasons not defined|2
7414325|NCT01432457|11687069|FG001|Overall Study|Reasons not defined|3
7414326|NCT01432457|11687070|FG002|Overall Study|Reasons not defined|4
7414327|NCT01432457|11687068|FG000|Overall Study|Did not take study drug|6
7414328|NCT01432457|11687069|FG001|Overall Study|Did not take study drug|6
7414329|NCT01432457|11687070|FG002|Overall Study|Did not take study drug|3
7225138|NCT00064350|11434620|FG001|Cross-Over|Withdrawal by Subject|2
7225139|NCT00064350|11434621|FG002|Cross-Over|Withdrawal by Subject|0
7225140|NCT00064350|11434619|FG000|Cross-Over|Ineligible or never started treatment|3
7225141|NCT00064350|11434620|FG001|Cross-Over|Ineligible or never started treatment|6
7225142|NCT00064350|11434621|FG002|Cross-Over|Ineligible or never started treatment|0
7225143|NCT00064350|11434619|FG000|Cross-Over|Other|0
7225144|NCT00064350|11434620|FG001|Cross-Over|Other|2
7225145|NCT00064350|11434621|FG002|Cross-Over|Other|0
7225146|NCT00064662|11434632|FG000|Overall Study|Death|1
7225147|NCT00064662|11434633|FG001|Overall Study|Death|1
7225148|NCT00064662|11434632|FG000|Overall Study|Lost to Follow-up|57
7414330|NCT01432574|11687095|FG000|Overall Study|Moved|2
7414331|NCT01432574|11687095|FG000|Overall Study|Not interested|1
7414332|NCT01432600|11687104|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
7414333|NCT01432600|11687105|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
7414334|NCT01432600|11687106|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
7414335|NCT01432626|11687116|FG000|Overall Study|LV function recovered|2
7414336|NCT01432626|11687116|FG000|Overall Study|Withdrawal by Subject|2
7414337|NCT01432626|11687116|FG000|Overall Study|Only 1 image competed|2
7414338|NCT01432626|11687116|FG000|Overall Study|Imaging agent not available|1
7414339|NCT01432730|11687120|FG000|Period 1|Adverse Event|2
7414340|NCT01432730|11687121|FG001|Period 1|Adverse Event|0
7414341|NCT01432730|11687120|FG000|Period 2|Adverse Event|0
7414342|NCT01432730|11687121|FG001|Period 2|Adverse Event|4
7414343|NCT01432756|11687131|FG000|Overall Study|Lost to Follow-up|1
7414344|NCT01432756|11687132|FG001|Overall Study|Lost to Follow-up|0
7414345|NCT01432756|11687133|FG002|Overall Study|Lost to Follow-up|2
7414346|NCT01432756|11687134|FG003|Overall Study|Lost to Follow-up|1
7414347|NCT01432938|11687152|FG000|First Intervention|Protocol Violation|1
7414348|NCT01432938|11687153|FG001|First Intervention|Protocol Violation|0
7414349|NCT01432938|11687152|FG000|First Intervention|Physician Decision|1
7414350|NCT01432938|11687153|FG001|First Intervention|Physician Decision|0
7414351|NCT01432938|11687152|FG000|Second Intervention|Adverse Event|1
7414352|NCT01432938|11687153|FG001|Second Intervention|Adverse Event|0
7414353|NCT01432951|11687160|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
7414354|NCT01433055|11687175|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
7414355|NCT01433055|11687176|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
7414356|NCT01433055|11687175|FG000|Overall Study|Severely elevated triglycerides at entry|1
7414357|NCT01433055|11687176|FG001|Overall Study|Severely elevated triglycerides at entry|0
7414358|NCT01433159|11687203|FG000|Overall Study|Adverse Event|1
7414359|NCT01433159|11687204|FG001|Overall Study|Adverse Event|0
7225149|NCT00064662|11434633|FG001|Overall Study|Lost to Follow-up|44
7225150|NCT00064662|11434632|FG000|Overall Study|Withdrawal by Subject|14
7225151|NCT00064662|11434633|FG001|Overall Study|Withdrawal by Subject|14
7225152|NCT00064662|11434632|FG000|Overall Study|Administratively withdrawn|2
7225153|NCT00064662|11434633|FG001|Overall Study|Administratively withdrawn|2
7255464|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7414360|NCT01433159|11687203|FG000|Overall Study|Physician Decision|1
7414361|NCT01433159|11687204|FG001|Overall Study|Physician Decision|0
7414362|NCT01433159|11687203|FG000|Overall Study|Protocol Violation|0
7414363|NCT01433159|11687204|FG001|Overall Study|Protocol Violation|1
7414364|NCT01433172|11687213|FG000|Overall Study|Withdrawal by Subject|0
7255465|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
7255466|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
7255467|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
7255468|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Move|0
7553323|NCT03011892|11914222|FG007|Double Blind (DB) Period|Randomized but not treated|0
7553324|NCT03011892|11914223|FG008|Double Blind (DB) Period|Randomized but not treated|0
7553325|NCT03011892|11914224|FG009|Double Blind (DB) Period|Randomized but not treated|0
7553326|NCT03011892|11914225|FG010|Double Blind (DB) Period|Randomized but not treated|0
7553327|NCT03011892|11914226|FG011|Double Blind (DB) Period|Randomized but not treated|0
7553328|NCT03011892|11914215|FG000|Open Label (OL) Period|Lost to Follow-up|0
7553329|NCT03011892|11914216|FG001|Open Label (OL) Period|Lost to Follow-up|0
7553330|NCT03011892|11914217|FG002|Open Label (OL) Period|Lost to Follow-up|0
7553331|NCT03011892|11914218|FG003|Open Label (OL) Period|Lost to Follow-up|0
7553332|NCT03011892|11914219|FG004|Open Label (OL) Period|Lost to Follow-up|0
7553333|NCT03011892|11914220|FG005|Open Label (OL) Period|Lost to Follow-up|0
7553334|NCT03011892|11914221|FG006|Open Label (OL) Period|Lost to Follow-up|4
7553335|NCT03011892|11914222|FG007|Open Label (OL) Period|Lost to Follow-up|2
7553336|NCT03011892|11914223|FG008|Open Label (OL) Period|Lost to Follow-up|1
7553337|NCT03011892|11914224|FG009|Open Label (OL) Period|Lost to Follow-up|0
7553338|NCT03011892|11914225|FG010|Open Label (OL) Period|Lost to Follow-up|1
7553339|NCT03011892|11914226|FG011|Open Label (OL) Period|Lost to Follow-up|1
7553340|NCT03011892|11914215|FG000|Open Label (OL) Period|Withdrawal by Subject|0
7553341|NCT03011892|11914216|FG001|Open Label (OL) Period|Withdrawal by Subject|0
7553342|NCT03011892|11914217|FG002|Open Label (OL) Period|Withdrawal by Subject|0
7553343|NCT03011892|11914218|FG003|Open Label (OL) Period|Withdrawal by Subject|0
7553344|NCT03011892|11914219|FG004|Open Label (OL) Period|Withdrawal by Subject|0
7553345|NCT03011892|11914220|FG005|Open Label (OL) Period|Withdrawal by Subject|0
7553346|NCT03011892|11914221|FG006|Open Label (OL) Period|Withdrawal by Subject|3
7553347|NCT03011892|11914222|FG007|Open Label (OL) Period|Withdrawal by Subject|0
7553348|NCT03011892|11914223|FG008|Open Label (OL) Period|Withdrawal by Subject|1
7553349|NCT03011892|11914224|FG009|Open Label (OL) Period|Withdrawal by Subject|0
7553350|NCT03011892|11914225|FG010|Open Label (OL) Period|Withdrawal by Subject|1
7553351|NCT03011892|11914226|FG011|Open Label (OL) Period|Withdrawal by Subject|2
7553352|NCT03011892|11914215|FG000|Open Label (OL) Period|Reason not specified|0
7553353|NCT03011892|11914216|FG001|Open Label (OL) Period|Reason not specified|0
7553354|NCT03011892|11914217|FG002|Open Label (OL) Period|Reason not specified|0
7553355|NCT03011892|11914218|FG003|Open Label (OL) Period|Reason not specified|0
7553356|NCT03011892|11914219|FG004|Open Label (OL) Period|Reason not specified|0
7553357|NCT03011892|11914220|FG005|Open Label (OL) Period|Reason not specified|0
7553358|NCT03011892|11914221|FG006|Open Label (OL) Period|Reason not specified|0
7553359|NCT03011892|11914222|FG007|Open Label (OL) Period|Reason not specified|1
7553360|NCT03011892|11914223|FG008|Open Label (OL) Period|Reason not specified|0
7553361|NCT03011892|11914224|FG009|Open Label (OL) Period|Reason not specified|0
7553362|NCT03011892|11914225|FG010|Open Label (OL) Period|Reason not specified|0
7553363|NCT03011892|11914226|FG011|Open Label (OL) Period|Reason not specified|0
7553364|NCT03012061|11914256|FG000|Overall Study|Withdrawal by Subject|1
7553365|NCT03012061|11914257|FG001|Overall Study|Withdrawal by Subject|5
7553366|NCT03012061|11914258|FG002|Overall Study|Withdrawal by Subject|4
7553367|NCT03012061|11914256|FG000|Overall Study|Investigator Site Closed|1
7553368|NCT03012061|11914257|FG001|Overall Study|Investigator Site Closed|2
7553369|NCT03012061|11914258|FG002|Overall Study|Investigator Site Closed|0
7553370|NCT03012061|11914256|FG000|Overall Study|Lost to Follow-up|2
7553371|NCT03012061|11914257|FG001|Overall Study|Lost to Follow-up|1
7553372|NCT03012061|11914258|FG002|Overall Study|Lost to Follow-up|0
7553373|NCT03012061|11914256|FG000|Overall Study|Study closed/ Terminated|0
7553374|NCT03012061|11914257|FG001|Overall Study|Study closed/ Terminated|0
7553375|NCT03012061|11914258|FG002|Overall Study|Study closed/ Terminated|1
7553376|NCT03012061|11914256|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
7553377|NCT03012061|11914257|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
7466376|NCT01890967|11766174|FG003|Overall Study|Protocol Violation|2
7553378|NCT03012061|11914258|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
7553379|NCT03012061|11914256|FG000|Overall Study|Protocol Violation|0
7553380|NCT03012061|11914257|FG001|Overall Study|Protocol Violation|0
7553381|NCT03012061|11914258|FG002|Overall Study|Protocol Violation|2
7553382|NCT03012061|11914256|FG000|Overall Study|Lack of Efficacy|0
7553383|NCT03012061|11914257|FG001|Overall Study|Lack of Efficacy|1
7553384|NCT03012061|11914258|FG002|Overall Study|Lack of Efficacy|0
7553385|NCT03012061|11914256|FG000|Overall Study|Adverse Event|2
7553386|NCT03012061|11914257|FG001|Overall Study|Adverse Event|0
7553387|NCT03012061|11914258|FG002|Overall Study|Adverse Event|0
7553388|NCT03012334|11914290|FG000|Period 1|Withdrawal by Subject|0
7553389|NCT03012334|11914291|FG001|Period 1|Withdrawal by Subject|0
7553390|NCT03012334|11914292|FG002|Period 1|Withdrawal by Subject|0
7553391|NCT03012334|11914293|FG003|Period 1|Withdrawal by Subject|0
7553392|NCT03012334|11914294|FG004|Period 1|Withdrawal by Subject|0
7553393|NCT03012334|11914295|FG005|Period 1|Withdrawal by Subject|0
7553394|NCT03012334|11914296|FG006|Period 1|Withdrawal by Subject|0
7553395|NCT03012334|11914297|FG007|Period 1|Withdrawal by Subject|0
7553396|NCT03012334|11914298|FG008|Period 1|Withdrawal by Subject|0
7553397|NCT03012334|11914299|FG009|Period 1|Withdrawal by Subject|1
7553398|NCT03012334|11914290|FG000|Period 2|Withdrawal by Subject|0
7553399|NCT03012334|11914291|FG001|Period 2|Withdrawal by Subject|1
7553400|NCT03012334|11914292|FG002|Period 2|Withdrawal by Subject|0
7553401|NCT03012334|11914293|FG003|Period 2|Withdrawal by Subject|0
7553402|NCT03012334|11914294|FG004|Period 2|Withdrawal by Subject|0
7553403|NCT03012334|11914295|FG005|Period 2|Withdrawal by Subject|0
7553404|NCT03012334|11914296|FG006|Period 2|Withdrawal by Subject|0
7553405|NCT03012334|11914297|FG007|Period 2|Withdrawal by Subject|0
7553406|NCT03012334|11914298|FG008|Period 2|Withdrawal by Subject|0
7553407|NCT03012334|11914299|FG009|Period 2|Withdrawal by Subject|0
7553408|NCT03012334|11914290|FG000|Period 2|Protocol Violation|0
7553409|NCT03012334|11914291|FG001|Period 2|Protocol Violation|0
7553410|NCT03012334|11914292|FG002|Period 2|Protocol Violation|1
7553411|NCT03012334|11914293|FG003|Period 2|Protocol Violation|0
7553412|NCT03012334|11914294|FG004|Period 2|Protocol Violation|0
7553413|NCT03012334|11914295|FG005|Period 2|Protocol Violation|0
7553414|NCT03012334|11914296|FG006|Period 2|Protocol Violation|0
7318106|NCT00726453|11547125|FG001|38 mm Length Group|Death|3
7318107|NCT00726557|11547130|FG000|Overall Study|Screening failure|4
7318108|NCT00726557|11547130|FG000|Overall Study|No end of treatment documentation|37
7553415|NCT03012334|11914297|FG007|Period 2|Protocol Violation|1
7553416|NCT03012334|11914298|FG008|Period 2|Protocol Violation|0
7553417|NCT03012334|11914299|FG009|Period 2|Protocol Violation|0
7553418|NCT03012334|11914290|FG000|Period 4|Non-Compliance|0
7553419|NCT03012334|11914291|FG001|Period 4|Non-Compliance|0
7553420|NCT03012334|11914292|FG002|Period 4|Non-Compliance|0
7553421|NCT03012334|11914293|FG003|Period 4|Non-Compliance|0
7553422|NCT03012334|11914294|FG004|Period 4|Non-Compliance|0
7553423|NCT03012334|11914295|FG005|Period 4|Non-Compliance|0
7553424|NCT03012334|11914296|FG006|Period 4|Non-Compliance|1
7553425|NCT03012334|11914297|FG007|Period 4|Non-Compliance|0
7553426|NCT03012334|11914298|FG008|Period 4|Non-Compliance|0
7553427|NCT03012334|11914299|FG009|Period 4|Non-Compliance|0
7553428|NCT03012334|11914290|FG000|Period 4|Adverse Event|0
7553429|NCT03012334|11914291|FG001|Period 4|Adverse Event|0
7553430|NCT03012334|11914292|FG002|Period 4|Adverse Event|0
7553431|NCT03012334|11914293|FG003|Period 4|Adverse Event|0
7553432|NCT03012334|11914294|FG004|Period 4|Adverse Event|0
7553433|NCT03012334|11914295|FG005|Period 4|Adverse Event|0
7553434|NCT03012334|11914296|FG006|Period 4|Adverse Event|0
7553435|NCT03012334|11914297|FG007|Period 4|Adverse Event|0
7553436|NCT03012334|11914298|FG008|Period 4|Adverse Event|1
7553437|NCT03012334|11914299|FG009|Period 4|Adverse Event|0
7574510|NCT03682120|11957408|FG000|Overall Study|Enrolled but Treatment Not Administered|0
7318109|NCT00726557|11547130|FG000|Overall Study|No follow-up documentation available|55
7318110|NCT00726557|11547130|FG000|Overall Study|Treatment less than 3 months|17
7318111|NCT00726557|11547130|FG000|Overall Study|Inclusion criteria not met|15
7318112|NCT00726609|11547135|FG000|Overall Study|Adverse Event|10
7318113|NCT00726609|11547135|FG000|Overall Study|Withdrawal by Subject|2
7530307|NCT02636699|11873987|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
7530308|NCT02636699|11873986|FG000|Overall Study|Physician Decision|0
7530309|NCT02636699|11873987|FG001|Overall Study|Physician Decision|1
7318114|NCT00726609|11547135|FG000|Overall Study|Lack of Efficacy|25
7318115|NCT00726609|11547135|FG000|Overall Study|Other|16
7318116|NCT00726609|11547135|FG000|Overall Study|Missing|42
7318117|NCT00726609|11547135|FG000|Overall Study|Other|3
7318118|NCT00726622|11547141|FG000|Overall Study|Withdrawal by Subject|16
7318119|NCT00726622|11547142|FG001|Overall Study|Withdrawal by Subject|2
7318120|NCT00726622|11547141|FG000|Overall Study|Physician Decision|0
7530310|NCT02636699|11873986|FG000|Overall Study|Withdrawal by Subject|13
7530311|NCT02636699|11873987|FG001|Overall Study|Withdrawal by Subject|6
7530312|NCT02636699|11873986|FG000|Overall Study|Other|3
7530313|NCT02636699|11873987|FG001|Overall Study|Other|1
7530314|NCT02636725|11873998|FG000|Baseline|Adverse Event|1
7530315|NCT02636725|11873998|FG000|Baseline|Lack of Efficacy|2
7530316|NCT02636868|11874005|FG000|Overall Study|Death|0
7530317|NCT02636868|11874006|FG001|Overall Study|Death|1
7530318|NCT02636868|11874007|FG002|Overall Study|Death|2
7530319|NCT02636907|11874015|FG000|Autoinjector Assessment Period|Adverse Event|2
7574511|NCT03682120|11957409|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7574512|NCT03682120|11957410|FG002|Overall Study|Enrolled but Treatment Not Administered|0
7574513|NCT03682120|11957411|FG003|Overall Study|Enrolled but Treatment Not Administered|0
7574514|NCT03682302|11957427|FG000|Overall Study|Lost to Follow-up|1
7574515|NCT03682302|11957428|FG001|Overall Study|Lost to Follow-up|2
7574516|NCT03682302|11957429|FG002|Overall Study|Lost to Follow-up|0
7574517|NCT03682302|11957430|FG003|Overall Study|Lost to Follow-up|1
7574518|NCT03682302|11957427|FG000|Overall Study|Study drug was not administered|0
7574519|NCT03682302|11957428|FG001|Overall Study|Study drug was not administered|0
7574520|NCT03682302|11957429|FG002|Overall Study|Study drug was not administered|1
7574521|NCT03682302|11957430|FG003|Overall Study|Study drug was not administered|1
7574522|NCT03682705|11957446|FG000|Overall Study|Adverse Event|1
7574523|NCT03682705|11957447|FG001|Overall Study|Adverse Event|1
7574524|NCT03682705|11957448|FG002|Overall Study|Adverse Event|1
7574525|NCT03682705|11957449|FG003|Overall Study|Adverse Event|0
7553438|NCT03012828|11914326|FG000|Overall Study|Lost to Follow-up|1
7553439|NCT03012828|11914327|FG001|Overall Study|Lost to Follow-up|0
7553440|NCT03012828|11914328|FG002|Overall Study|Lost to Follow-up|1
7553441|NCT03012828|11914329|FG003|Overall Study|Lost to Follow-up|0
7553442|NCT03012828|11914330|FG004|Overall Study|Lost to Follow-up|1
7553443|NCT03012828|11914331|FG005|Overall Study|Lost to Follow-up|0
7553444|NCT03012828|11914326|FG000|Overall Study|Withdrawal by Subject|0
7553445|NCT03012828|11914327|FG001|Overall Study|Withdrawal by Subject|0
7553446|NCT03012828|11914328|FG002|Overall Study|Withdrawal by Subject|1
7553447|NCT03012828|11914329|FG003|Overall Study|Withdrawal by Subject|0
7553448|NCT03012828|11914330|FG004|Overall Study|Withdrawal by Subject|0
7414365|NCT01433172|11687214|FG001|Overall Study|Withdrawal by Subject|1
7414366|NCT01433172|11687215|FG002|Overall Study|Withdrawal by Subject|0
7414367|NCT01433172|11687213|FG000|Overall Study|Disease Progression|0
7414368|NCT01433172|11687214|FG001|Overall Study|Disease Progression|0
7414369|NCT01433172|11687215|FG002|Overall Study|Disease Progression|1
7414370|NCT01433172|11687213|FG000|Overall Study|Death|0
7414371|NCT01433172|11687214|FG001|Overall Study|Death|2
7414372|NCT01433172|11687215|FG002|Overall Study|Death|0
7414373|NCT01433250|11687225|FG000|Overall Study|Protocol Violation|0
7414374|NCT01433250|11687226|FG001|Overall Study|Protocol Violation|1
7414375|NCT01433250|11687225|FG000|Overall Study|Withdrawal by Subject|3
7414376|NCT01433250|11687226|FG001|Overall Study|Withdrawal by Subject|2
7414377|NCT01433263|11687234|FG000|Overall Study|Adverse Event|3
7414378|NCT01433263|11687235|FG001|Overall Study|Adverse Event|1
7414379|NCT01433263|11687234|FG000|Overall Study|Death|5
7414380|NCT01433263|11687235|FG001|Overall Study|Death|3
7414381|NCT01433263|11687234|FG000|Overall Study|Lost to Follow-up|0
7414382|NCT01433263|11687235|FG001|Overall Study|Lost to Follow-up|1
7414383|NCT01433263|11687234|FG000|Overall Study|Protocol Deviation|1
7414384|NCT01433263|11687235|FG001|Overall Study|Protocol Deviation|0
7414385|NCT01433263|11687234|FG000|Overall Study|Withdrawal by Subject|10
7414386|NCT01433263|11687235|FG001|Overall Study|Withdrawal by Subject|7
7414387|NCT01433354|11687244|FG000|Overall Study|Adverse Event|6
7414388|NCT01433354|11687244|FG000|Overall Study|Lost to Follow-up|1
7414389|NCT01433354|11687244|FG000|Overall Study|Administrative problems|90
7414390|NCT01433354|11687244|FG000|Overall Study|Protocol Violation|2
7414391|NCT01433354|11687244|FG000|Overall Study|Lack of Efficacy|17
7414392|NCT01433354|11687244|FG000|Overall Study|Subject Withdrew Consent|3
7414393|NCT01433549|11687258|FG000|Phase 2: Second Study Product|Adverse Event|0
7414394|NCT01433549|11687259|FG001|Phase 2: Second Study Product|Adverse Event|1
7414395|NCT01433978|11687292|FG000|Core Study|Adverse Event, Non-Fatal|0
7414396|NCT01433978|11687293|FG001|Core Study|Adverse Event, Non-Fatal|1
7414397|NCT01433978|11687294|FG002|Core Study|Adverse Event, Non-Fatal|0
7414398|NCT01433978|11687292|FG000|Core Study|Lack of Efficacy|5
7414399|NCT01433978|11687293|FG001|Core Study|Lack of Efficacy|1
7414400|NCT01433978|11687294|FG002|Core Study|Lack of Efficacy|0
7414401|NCT01433978|11687292|FG000|Core Study|Study Terminated by Sponsor|6
7414402|NCT01433978|11687293|FG001|Core Study|Study Terminated by Sponsor|9
7414403|NCT01433978|11687294|FG002|Core Study|Study Terminated by Sponsor|0
7414404|NCT01433978|11687292|FG000|Extension Phase|Adverse Event, Non-Fatal|0
7414405|NCT01433978|11687293|FG001|Extension Phase|Adverse Event, Non-Fatal|0
7414406|NCT01433978|11687294|FG002|Extension Phase|Adverse Event, Non-Fatal|1
7414407|NCT01433978|11687292|FG000|Extension Phase|Lack of Efficacy|0
7414408|NCT01433978|11687293|FG001|Extension Phase|Lack of Efficacy|0
7414409|NCT01433978|11687294|FG002|Extension Phase|Lack of Efficacy|1
7414410|NCT01433978|11687292|FG000|Extension Phase|Study Terminated by Sponsor|0
7414411|NCT01433978|11687293|FG001|Extension Phase|Study Terminated by Sponsor|0
7414412|NCT01433978|11687294|FG002|Extension Phase|Study Terminated by Sponsor|4
7466365|NCT01890967|11766175|FG004|Overall Study|Death|0
7466366|NCT01890967|11766176|FG005|Overall Study|Death|0
7466367|NCT01890967|11766171|FG000|Overall Study|Lost to Follow-up|1
7466368|NCT01890967|11766172|FG001|Overall Study|Lost to Follow-up|1
7466369|NCT01890967|11766173|FG002|Overall Study|Lost to Follow-up|1
7466370|NCT01890967|11766174|FG003|Overall Study|Lost to Follow-up|1
7466371|NCT01890967|11766175|FG004|Overall Study|Lost to Follow-up|0
7466372|NCT01890967|11766176|FG005|Overall Study|Lost to Follow-up|1
7466373|NCT01890967|11766171|FG000|Overall Study|Protocol Violation|0
7466374|NCT01890967|11766172|FG001|Overall Study|Protocol Violation|3
7466375|NCT01890967|11766173|FG002|Overall Study|Protocol Violation|3
7466377|NCT01890967|11766175|FG004|Overall Study|Protocol Violation|4
7466378|NCT01890967|11766176|FG005|Overall Study|Protocol Violation|1
7466379|NCT01890967|11766171|FG000|Overall Study|Sponsor Decision|2
7466380|NCT01890967|11766172|FG001|Overall Study|Sponsor Decision|0
7466381|NCT01890967|11766173|FG002|Overall Study|Sponsor Decision|1
7466382|NCT01890967|11766174|FG003|Overall Study|Sponsor Decision|3
7466383|NCT01890967|11766175|FG004|Overall Study|Sponsor Decision|2
7466384|NCT01890967|11766176|FG005|Overall Study|Sponsor Decision|3
7466385|NCT01890967|11766171|FG000|Overall Study|Withdrawal by Subject|3
7466386|NCT01890967|11766172|FG001|Overall Study|Withdrawal by Subject|4
7466387|NCT01890967|11766173|FG002|Overall Study|Withdrawal by Subject|2
7466388|NCT01890967|11766174|FG003|Overall Study|Withdrawal by Subject|3
7553449|NCT03012828|11914331|FG005|Overall Study|Withdrawal by Subject|1
7530320|NCT02636907|11874015|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
7553450|NCT03012828|11914326|FG000|Overall Study|Non-compliance with protocol|0
7318121|NCT00726622|11547142|FG001|Overall Study|Physician Decision|1
7318122|NCT00726622|11547141|FG000|Overall Study|Metastasis|2
7318123|NCT00726622|11547142|FG001|Overall Study|Metastasis|0
7318124|NCT00726661|11547150|FG000|Overall Study|Lost to Follow-up|36
7318125|NCT00726661|11547151|FG001|Overall Study|Lost to Follow-up|11
7318126|NCT00726661|11547150|FG000|Overall Study|Withdrawal by Subject|17
7318127|NCT00726661|11547151|FG001|Overall Study|Withdrawal by Subject|13
7318128|NCT00726661|11547150|FG000|Overall Study|Trial terminated by sponsor|214
7318129|NCT00726661|11547151|FG001|Overall Study|Trial terminated by sponsor|187
7318130|NCT00726661|11547150|FG000|Overall Study|Death|475
7318131|NCT00726661|11547151|FG001|Overall Study|Death|159
7318132|NCT00726661|11547150|FG000|Overall Study|Physician Decision|25
7318133|NCT00726661|11547151|FG001|Overall Study|Physician Decision|13
7318134|NCT00726661|11547150|FG000|Overall Study|Other|47
7318135|NCT00726661|11547151|FG001|Overall Study|Other|35
7318136|NCT00726752|11547178|FG000|Overall Study|Lack of Efficacy|6
7318137|NCT00726882|11547182|FG000|Overall Study|Withdrawal by Subject|5
7318138|NCT00726882|11547182|FG000|Overall Study|Lost to Follow-up|7
7318139|NCT00726882|11547182|FG000|Overall Study|Other|10
7318140|NCT00726895|11547188|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7318141|NCT00726895|11547189|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7318142|NCT00726986|11547196|FG000|Induction Phase|Adverse Event|4
7318143|NCT00726986|11547196|FG000|Induction Phase|Withdrawal by Subject|2
7318144|NCT00726986|11547196|FG000|Induction Phase|Death|2
7318145|NCT00726986|11547196|FG000|Induction Phase|Lack of Efficacy|5
7318146|NCT00726986|11547196|FG000|Induction Phase|Secondary Disease|2
7318147|NCT00726986|11547196|FG000|Maintenance Phase|Adverse Event|1
7318148|NCT00726986|11547196|FG000|Maintenance Phase|Lack of Efficacy|2
7318149|NCT00726999|11547202|FG000|Overall Study|Physician Decision|0
7318150|NCT00726999|11547203|FG001|Overall Study|Physician Decision|1
7318151|NCT00726999|11547202|FG000|Overall Study|Withdrawal by Subject|2
7318152|NCT00726999|11547203|FG001|Overall Study|Withdrawal by Subject|0
7318153|NCT00726999|11547202|FG000|Overall Study|Protocol Violation|1
7318154|NCT00726999|11547203|FG001|Overall Study|Protocol Violation|0
7318155|NCT00727025|11547211|FG000|Overall Study|Physician Decision|23
7318156|NCT00727194|11547228|FG000|Screening Period|Low QMG scores|0
7318157|NCT00727194|11547229|FG001|Screening Period|Low QMG scores|0
7318158|NCT00727194|11547230|FG002|Screening Period|Low QMG scores|6
7318159|NCT00727194|11547228|FG000|Screening Period|Lacked AChR antibodies|0
7318160|NCT00727194|11547229|FG001|Screening Period|Lacked AChR antibodies|0
7318161|NCT00727194|11547230|FG002|Screening Period|Lacked AChR antibodies|5
7318162|NCT00727194|11547228|FG000|Screening Period|Not stable on concomitant MG therapy|0
7318163|NCT00727194|11547229|FG001|Screening Period|Not stable on concomitant MG therapy|0
7318164|NCT00727194|11547230|FG002|Screening Period|Not stable on concomitant MG therapy|2
7318165|NCT00727194|11547228|FG000|Screening Period|Severe infections|0
7318166|NCT00727194|11547229|FG001|Screening Period|Severe infections|0
7318167|NCT00727194|11547230|FG002|Screening Period|Severe infections|2
7318168|NCT00727194|11547228|FG000|Screening Period|History of thymoma|0
7318169|NCT00727194|11547229|FG001|Screening Period|History of thymoma|0
7318170|NCT00727194|11547230|FG002|Screening Period|History of thymoma|1
7318171|NCT00727194|11547228|FG000|Treatment Period 2|Lack of Efficacy|0
7318172|NCT00727194|11547229|FG001|Treatment Period 2|Lack of Efficacy|1
7318173|NCT00727194|11547230|FG002|Treatment Period 2|Lack of Efficacy|0
7318174|NCT00727246|11547257|FG000|Overall Study|could not complete MRI|0
7553451|NCT03012828|11914327|FG001|Overall Study|Non-compliance with protocol|0
7553452|NCT03012828|11914328|FG002|Overall Study|Non-compliance with protocol|0
7553453|NCT03012828|11914329|FG003|Overall Study|Non-compliance with protocol|0
7553454|NCT03012828|11914330|FG004|Overall Study|Non-compliance with protocol|1
7553455|NCT03012828|11914331|FG005|Overall Study|Non-compliance with protocol|0
7318175|NCT00727246|11547258|FG001|Overall Study|could not complete MRI|1
7318176|NCT00727246|11547259|FG002|Overall Study|could not complete MRI|0
7318177|NCT00727246|11547260|FG003|Overall Study|could not complete MRI|1
7318178|NCT00727246|11547257|FG000|Overall Study|incidental finding|0
7318179|NCT00727246|11547258|FG001|Overall Study|incidental finding|0
7318180|NCT00727246|11547259|FG002|Overall Study|incidental finding|0
7318181|NCT00727246|11547260|FG003|Overall Study|incidental finding|1
7318182|NCT00727246|11547257|FG000|Overall Study|withdrawn|0
7318183|NCT00727246|11547258|FG001|Overall Study|withdrawn|0
7318184|NCT00727246|11547259|FG002|Overall Study|withdrawn|1
7318185|NCT00727246|11547260|FG003|Overall Study|withdrawn|0
7318186|NCT00727259|11547270|FG000|Overall Study|Not all questionnaires completed|1055
7318187|NCT00727272|11547275|FG000|Washout Period A|Adverse Event|0
7318188|NCT00727272|11547276|FG001|Washout Period A|Adverse Event|0
7318189|NCT00727272|11547277|FG002|Washout Period A|Adverse Event|1
7530321|NCT02636907|11874015|FG000|Extension Phase|Adverse Event|2
7530322|NCT02636907|11874015|FG000|Extension Phase|Withdrawal by Subject|4
7530323|NCT02636907|11874015|FG000|Extension Phase|Physician Decision|1
7530324|NCT02636907|11874015|FG000|Extension Phase|Lost to Follow-up|2
7530325|NCT02636907|11874015|FG000|Extension Phase|Lack of Efficacy|1
7530326|NCT02637037|11874021|FG000|Overall Study|Positive drug screen at admission|1
7530327|NCT02637037|11874022|FG001|Overall Study|Positive drug screen at admission|0
7553456|NCT03012828|11914326|FG000|Overall Study|Delay to last visit would delay DBL|0
7318190|NCT00727272|11547275|FG000|Washout Period B|Withdrawal by Subject|0
7318191|NCT00727272|11547276|FG001|Washout Period B|Withdrawal by Subject|0
7318192|NCT00727272|11547277|FG002|Washout Period B|Withdrawal by Subject|1
7318193|NCT00727311|11547291|FG000|Overall Study|Did not receive drug|316
7318194|NCT00727311|11547291|FG000|Overall Study|Missing end of therapy data|205
7318195|NCT00727311|11547291|FG000|Overall Study|Adverse Event|58
7318196|NCT00727311|11547291|FG000|Overall Study|Lack of Efficacy|242
7318197|NCT00727311|11547291|FG000|Overall Study|Lost to Follow-up|73
7318198|NCT00727311|11547291|FG000|Overall Study|Withdrawal by Subject|77
7318199|NCT00727311|11547291|FG000|Overall Study|Other|97
7318200|NCT00727311|11547291|FG000|Overall Study|Multiple reasons|39
7318201|NCT00727402|11547317|FG000|Overall Study|Physician Decision|116
7318202|NCT00727415|11547321|FG000|Phase I|Dose Limiting Toxicity|2
7318203|NCT00727441|11547328|FG000|Overall Study|Disease Progression|11
7318204|NCT00727441|11547329|FG001|Overall Study|Disease Progression|14
7318205|NCT00727441|11547330|FG002|Overall Study|Disease Progression|17
7318206|NCT00727441|11547328|FG000|Overall Study|Eligibility|7
7318207|NCT00727441|11547329|FG001|Overall Study|Eligibility|5
7318208|NCT00727441|11547330|FG002|Overall Study|Eligibility|7
7318209|NCT00727441|11547328|FG000|Overall Study|Death|0
7318210|NCT00727441|11547329|FG001|Overall Study|Death|1
7318211|NCT00727441|11547330|FG002|Overall Study|Death|1
7318212|NCT00727441|11547328|FG000|Overall Study|Physician Decision|0
7318213|NCT00727441|11547329|FG001|Overall Study|Physician Decision|1
7318214|NCT00727441|11547330|FG002|Overall Study|Physician Decision|0
7318215|NCT00727441|11547328|FG000|Overall Study|Withdrawal by Subject|0
7318216|NCT00727441|11547329|FG001|Overall Study|Withdrawal by Subject|1
7318217|NCT00727441|11547330|FG002|Overall Study|Withdrawal by Subject|0
7318218|NCT00727506|11547347|FG000|Overall Study|Adverse Event|0
7318219|NCT00727506|11547348|FG001|Overall Study|Adverse Event|0
7318220|NCT00727506|11547349|FG002|Overall Study|Adverse Event|4
7318221|NCT00727506|11547350|FG003|Overall Study|Adverse Event|4
7318222|NCT00727506|11547351|FG004|Overall Study|Adverse Event|1
7318223|NCT00727506|11547352|FG005|Overall Study|Adverse Event|8
7318224|NCT00727506|11547347|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
7318225|NCT00727506|11547348|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7318226|NCT00727506|11547349|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
7318227|NCT00727506|11547350|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7318228|NCT00727506|11547351|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
7318229|NCT00727506|11547352|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
7318230|NCT00727506|11547347|FG000|Overall Study|Progressive disease|4
7318231|NCT00727506|11547348|FG001|Overall Study|Progressive disease|7
7318232|NCT00727506|11547349|FG002|Overall Study|Progressive disease|9
7318233|NCT00727506|11547350|FG003|Overall Study|Progressive disease|28
7318234|NCT00727506|11547351|FG004|Overall Study|Progressive disease|38
7318235|NCT00727506|11547352|FG005|Overall Study|Progressive disease|28
7318236|NCT00727506|11547347|FG000|Overall Study|Refused to continue medication|0
7318237|NCT00727506|11547348|FG001|Overall Study|Refused to continue medication|1
7414413|NCT01433991|11687305|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
7414414|NCT01433991|11687306|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7414415|NCT01433991|11687307|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7414416|NCT01433991|11687308|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
7414417|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
7414418|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
7414419|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
7414420|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
7414421|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7414422|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7414423|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
7414424|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
7414425|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
7414426|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
7414427|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
7414428|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
7414429|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
7414430|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
7414431|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
7414432|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
7414433|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
7414434|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
7318238|NCT00727506|11547349|FG002|Overall Study|Refused to continue medication|2
7318239|NCT00727506|11547350|FG003|Overall Study|Refused to continue medication|3
7318240|NCT00727506|11547351|FG004|Overall Study|Refused to continue medication|1
7318241|NCT00727506|11547352|FG005|Overall Study|Refused to continue medication|2
7318242|NCT00727506|11547347|FG000|Overall Study|Other reason not described above|0
7318243|NCT00727506|11547348|FG001|Overall Study|Other reason not described above|0
7318244|NCT00727506|11547349|FG002|Overall Study|Other reason not described above|1
7318245|NCT00727506|11547350|FG003|Overall Study|Other reason not described above|4
7318246|NCT00727506|11547351|FG004|Overall Study|Other reason not described above|1
7318247|NCT00727506|11547352|FG005|Overall Study|Other reason not described above|1
7318248|NCT00727532|11547372|FG000|Overall Study|Adverse Event|1
7318249|NCT00727532|11547372|FG000|Overall Study|Withdrawal by Subject|1
7318250|NCT00727558|11547378|FG000|Overall Study|Lens issue|0
7318251|NCT00727558|11547379|FG001|Overall Study|Lens issue|1
7318252|NCT00727558|11547378|FG000|Overall Study|Adverse Event|0
7318253|NCT00727558|11547379|FG001|Overall Study|Adverse Event|1
7318254|NCT00727558|11547378|FG000|Overall Study|Subject unable to return for follow-up|1
7318255|NCT00727558|11547379|FG001|Overall Study|Subject unable to return for follow-up|1
7318256|NCT00727558|11547378|FG000|Overall Study|Lost to Follow-up|1
7318257|NCT00727558|11547379|FG001|Overall Study|Lost to Follow-up|0
7318258|NCT00727571|11547389|FG000|Overall Study|Ineligibility determined|1
7318259|NCT00727571|11547390|FG001|Overall Study|Ineligibility determined|1
7318260|NCT00727571|11547391|FG002|Overall Study|Ineligibility determined|1
7318261|NCT00727571|11547392|FG003|Overall Study|Ineligibility determined|0
7318262|NCT00727571|11547389|FG000|Overall Study|Death|0
7318263|NCT00727571|11547390|FG001|Overall Study|Death|19
7553457|NCT03012828|11914327|FG001|Overall Study|Delay to last visit would delay DBL|0
7553458|NCT03012828|11914328|FG002|Overall Study|Delay to last visit would delay DBL|0
7553459|NCT03012828|11914329|FG003|Overall Study|Delay to last visit would delay DBL|0
7553460|NCT03012828|11914330|FG004|Overall Study|Delay to last visit would delay DBL|0
7553461|NCT03012828|11914331|FG005|Overall Study|Delay to last visit would delay DBL|1
7553462|NCT03012841|11914347|FG000|Overall Study|Protocol Violation|0
7553463|NCT03012841|11914348|FG001|Overall Study|Protocol Violation|10
7553464|NCT03012841|11914347|FG000|Overall Study|Lost to Follow-up|6
7553465|NCT03012841|11914348|FG001|Overall Study|Lost to Follow-up|1
7553466|NCT03012841|11914347|FG000|Overall Study|Withdrawal by Subject|6
7553467|NCT03012841|11914348|FG001|Overall Study|Withdrawal by Subject|0
7553468|NCT03012841|11914347|FG000|Overall Study|Unable to complete 12 month visit|6
7553469|NCT03012841|11914348|FG001|Overall Study|Unable to complete 12 month visit|0
7553470|NCT03012841|11914347|FG000|Overall Study|Subject relocation|1
7553471|NCT03012841|11914348|FG001|Overall Study|Subject relocation|0
7553472|NCT03012841|11914347|FG000|Overall Study|Seasonal winter travel|1
7553473|NCT03012841|11914348|FG001|Overall Study|Seasonal winter travel|0
7553474|NCT03012841|11914347|FG000|Overall Study|Physician Decision|0
7553475|NCT03012841|11914348|FG001|Overall Study|Physician Decision|2
7553476|NCT03012841|11914347|FG000|Overall Study|No ablation performed|0
7553477|NCT03012841|11914348|FG001|Overall Study|No ablation performed|2
7553478|NCT03012841|11914347|FG000|Overall Study|Study reached n=165 treated subject cap|0
7553479|NCT03012841|11914348|FG001|Overall Study|Study reached n=165 treated subject cap|5
7553480|NCT03012841|11914347|FG000|Overall Study|Insurance change|0
7553481|NCT03012841|11914348|FG001|Overall Study|Insurance change|1
7553482|NCT03013985|11914355|FG000|Overall Study|Protocol Violation|2
7553483|NCT03013985|11914356|FG001|Overall Study|Protocol Violation|2
7553484|NCT03013985|11914355|FG000|Overall Study|Withdrawal by Subject|14
7553485|NCT03013985|11914356|FG001|Overall Study|Withdrawal by Subject|17
7553486|NCT03014011|11914362|FG000|First Intervention|Withdrawal by Subject|1
7553487|NCT03014011|11914363|FG001|First Intervention|Withdrawal by Subject|0
7553488|NCT03014011|11914362|FG000|Washout|Withdrawal by Subject|1
7553489|NCT03014011|11914363|FG001|Washout|Withdrawal by Subject|0
7553490|NCT03014180|11914369|FG000|Overall Study|Protocol Violation|2
7553491|NCT03014206|11914377|FG000|Overall Study|Registration Violation|12
7553492|NCT03014453|11914381|FG000|Overall Study|Lost to Follow-up|12
7553493|NCT03014453|11914381|FG000|Overall Study|Discontinued GER|3
7553494|NCT03014453|11914381|FG000|Overall Study|Excluded|19
7553495|NCT03014453|11914381|FG000|Overall Study|Refused to take part in|37
7553496|NCT03014479|11914387|FG000|Overall Study|Adverse Event|0
7553497|NCT03014479|11914388|FG001|Overall Study|Adverse Event|1
7553498|NCT03014479|11914387|FG000|Overall Study|Voluntary Withdrawal|0
7553499|NCT03014479|11914388|FG001|Overall Study|Voluntary Withdrawal|2
7553500|NCT03014479|11914387|FG000|Overall Study|Unacceptable Inability of Site Visit|0
7553501|NCT03014479|11914388|FG001|Overall Study|Unacceptable Inability of Site Visit|1
7553502|NCT03014674|11914406|FG000|Overall Study|Withdrawal by Subject|1
7553503|NCT03014674|11914407|FG001|Overall Study|Withdrawal by Subject|0
7553504|NCT03014674|11914408|FG002|Overall Study|Withdrawal by Subject|0
7553505|NCT03015116|11914428|FG000|Overall Study|Lost to Follow-up|3
7553506|NCT03015116|11914429|FG001|Overall Study|Lost to Follow-up|0
7553507|NCT03015116|11914430|FG002|Overall Study|Lost to Follow-up|2
7553508|NCT03015116|11914428|FG000|Overall Study|Withdrawal by Subject|3
7553509|NCT03015116|11914429|FG001|Overall Study|Withdrawal by Subject|1
7553510|NCT03015116|11914430|FG002|Overall Study|Withdrawal by Subject|0
7553511|NCT03015116|11914428|FG000|Overall Study|Subject has New Medical Status|1
7553512|NCT03015116|11914429|FG001|Overall Study|Subject has New Medical Status|0
7553513|NCT03015116|11914430|FG002|Overall Study|Subject has New Medical Status|0
7318264|NCT00727571|11547391|FG002|Overall Study|Death|5
7318265|NCT00727571|11547392|FG003|Overall Study|Death|1
7318266|NCT00727571|11547389|FG000|Overall Study|Physician Decision|0
7553514|NCT03015116|11914428|FG000|Overall Study|Physician Decision|0
7553515|NCT03015116|11914429|FG001|Overall Study|Physician Decision|1
7553516|NCT03015116|11914430|FG002|Overall Study|Physician Decision|0
7318267|NCT00727571|11547390|FG001|Overall Study|Physician Decision|5
7318268|NCT00727571|11547391|FG002|Overall Study|Physician Decision|0
7318269|NCT00727571|11547392|FG003|Overall Study|Physician Decision|0
7318270|NCT00727571|11547389|FG000|Overall Study|Withdrawal by Subject|0
7318271|NCT00727571|11547390|FG001|Overall Study|Withdrawal by Subject|10
7318272|NCT00727571|11547391|FG002|Overall Study|Withdrawal by Subject|11
7318273|NCT00727571|11547392|FG003|Overall Study|Withdrawal by Subject|0
7318274|NCT00727571|11547389|FG000|Overall Study|Subject Non Compliance|0
7318275|NCT00727571|11547390|FG001|Overall Study|Subject Non Compliance|6
7318276|NCT00727571|11547391|FG002|Overall Study|Subject Non Compliance|0
7318277|NCT00727571|11547392|FG003|Overall Study|Subject Non Compliance|4
7318278|NCT00727571|11547389|FG000|Overall Study|Dismissed from nursing home|0
7414435|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
7414436|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
7414437|NCT01433991|11687305|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7414438|NCT01433991|11687306|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7414439|NCT01433991|11687307|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
7414440|NCT01433991|11687308|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
7414441|NCT01434654|11687373|FG000|Overall Study|Withdrawal by Subject|1
7414442|NCT01434654|11687374|FG001|Overall Study|Withdrawal by Subject|0
7414443|NCT01434654|11687373|FG000|Overall Study|Lost to Follow-up|1
7414444|NCT01434654|11687374|FG001|Overall Study|Lost to Follow-up|0
7414445|NCT01434667|11687384|FG000|Overall Study|Lost to Follow-up|5
7414446|NCT01434667|11687385|FG001|Overall Study|Lost to Follow-up|10
7414447|NCT01434680|11687395|FG000|Overall Study|Withdrawal by Subject|1
7414448|NCT01434680|11687396|FG001|Overall Study|Withdrawal by Subject|0
7414449|NCT01434680|11687397|FG002|Overall Study|Withdrawal by Subject|2
7414450|NCT01434680|11687398|FG003|Overall Study|Withdrawal by Subject|0
7414451|NCT01434680|11687395|FG000|Overall Study|Lost to Follow-up|1
7414452|NCT01434680|11687396|FG001|Overall Study|Lost to Follow-up|1
7414453|NCT01434680|11687397|FG002|Overall Study|Lost to Follow-up|0
7414454|NCT01434680|11687398|FG003|Overall Study|Lost to Follow-up|0
7414455|NCT01434680|11687395|FG000|Overall Study|Protocol Violation|1
7414456|NCT01434680|11687396|FG001|Overall Study|Protocol Violation|1
7414457|NCT01434680|11687397|FG002|Overall Study|Protocol Violation|0
7414458|NCT01434680|11687398|FG003|Overall Study|Protocol Violation|0
7414459|NCT01434693|11687412|FG000|Overall Study|Adverse Event|1
7414460|NCT01434693|11687413|FG001|Overall Study|Adverse Event|0
7414461|NCT01434693|11687414|FG002|Overall Study|Adverse Event|0
7414462|NCT01434693|11687415|FG003|Overall Study|Adverse Event|0
7414463|NCT01434693|11687412|FG000|Overall Study|Withdrawal by Subject|1
7414464|NCT01434693|11687413|FG001|Overall Study|Withdrawal by Subject|0
7414465|NCT01434693|11687414|FG002|Overall Study|Withdrawal by Subject|1
7414466|NCT01434693|11687415|FG003|Overall Study|Withdrawal by Subject|1
7414467|NCT01434693|11687412|FG000|Overall Study|Lost to Follow-up|1
7414468|NCT01434693|11687413|FG001|Overall Study|Lost to Follow-up|0
7414469|NCT01434693|11687414|FG002|Overall Study|Lost to Follow-up|0
7414470|NCT01434693|11687415|FG003|Overall Study|Lost to Follow-up|0
7414471|NCT01434810|11687427|FG000|Overall Study|Did not receive treatment|11
7414472|NCT01434810|11687428|FG001|Overall Study|Did not receive treatment|3
7414473|NCT01434810|11687427|FG000|Overall Study|Missing data/received <5hr phototherapy|12
7414474|NCT01434810|11687428|FG001|Overall Study|Missing data/received <5hr phototherapy|7
7414475|NCT01434823|11687436|FG000|Overall Study|Incomplete data in medical record|4
7414476|NCT01434823|11687437|FG001|Overall Study|Incomplete data in medical record|7
7414477|NCT01435018|11687447|FG000|Overall Study|Death|37
7414478|NCT01435018|11687448|FG001|Overall Study|Death|18
7414479|NCT01435018|11687449|FG002|Overall Study|Death|25
7414480|NCT01435018|11687447|FG000|Overall Study|Site is closing|4
7414481|NCT01435018|11687448|FG001|Overall Study|Site is closing|9
7414482|NCT01435018|11687449|FG002|Overall Study|Site is closing|7
7414483|NCT01435018|11687447|FG000|Overall Study|Withdrew consent|0
7553517|NCT03015181|11914447|FG000|Overall Study|Enrolled, but product never administered|1
7553518|NCT03015181|11914448|FG001|Overall Study|Enrolled, but product never administered|0
7553519|NCT03015181|11914449|FG002|Overall Study|Enrolled, but product never administered|0
7553520|NCT03015181|11914450|FG003|Overall Study|Enrolled, but product never administered|0
7553521|NCT03015181|11914451|FG004|Overall Study|Enrolled, but product never administered|0
7553522|NCT03015181|11914452|FG005|Overall Study|Enrolled, but product never administered|0
7414484|NCT01435018|11687448|FG001|Overall Study|Withdrew consent|3
7414485|NCT01435018|11687449|FG002|Overall Study|Withdrew consent|1
7414486|NCT01435018|11687447|FG000|Overall Study|Not willing to adhere to requirements|0
7414487|NCT01435018|11687448|FG001|Overall Study|Not willing to adhere to requirements|2
7414488|NCT01435018|11687449|FG002|Overall Study|Not willing to adhere to requirements|3
7414489|NCT01435018|11687447|FG000|Overall Study|Not able to get to clinic|2
7414490|NCT01435018|11687448|FG001|Overall Study|Not able to get to clinic|0
7414491|NCT01435018|11687449|FG002|Overall Study|Not able to get to clinic|2
7414492|NCT01435018|11687447|FG000|Overall Study|Severe debilitation, unable to continue|0
7414493|NCT01435018|11687448|FG001|Overall Study|Severe debilitation, unable to continue|0
7414494|NCT01435018|11687449|FG002|Overall Study|Severe debilitation, unable to continue|1
7414495|NCT01435018|11687447|FG000|Overall Study|Unable to contact participant/parent|1
7414496|NCT01435018|11687448|FG001|Overall Study|Unable to contact participant/parent|1
7414497|NCT01435018|11687449|FG002|Overall Study|Unable to contact participant/parent|1
7318279|NCT00727571|11547390|FG001|Overall Study|Dismissed from nursing home|9
7318280|NCT00727571|11547391|FG002|Overall Study|Dismissed from nursing home|5
7318281|NCT00727571|11547392|FG003|Overall Study|Dismissed from nursing home|0
7318282|NCT00727571|11547389|FG000|Overall Study|Hospitalization|0
7318283|NCT00727571|11547390|FG001|Overall Study|Hospitalization|1
7318284|NCT00727571|11547391|FG002|Overall Study|Hospitalization|0
7318285|NCT00727571|11547392|FG003|Overall Study|Hospitalization|1
7318286|NCT00727571|11547389|FG000|Overall Study|AE not leading to hospitalization|0
7318287|NCT00727571|11547390|FG001|Overall Study|AE not leading to hospitalization|0
7318288|NCT00727571|11547391|FG002|Overall Study|AE not leading to hospitalization|2
7553523|NCT03015181|11914453|FG006|Overall Study|Enrolled, but product never administered|0
7553524|NCT03015181|11914447|FG000|Overall Study|Withdrawal by Subject|0
7318289|NCT00727571|11547392|FG003|Overall Study|AE not leading to hospitalization|0
7414498|NCT01435018|11687447|FG000|Overall Study|Enrollment Violation|0
7414499|NCT01435018|11687448|FG001|Overall Study|Enrollment Violation|1
7414500|NCT01435018|11687449|FG002|Overall Study|Enrollment Violation|0
7414501|NCT01435018|11687447|FG000|Overall Study|Never started chemotherapy|3
7530328|NCT02637037|11874021|FG000|Overall Study|Withdrawal by Subject|2
7530329|NCT02637037|11874022|FG001|Overall Study|Withdrawal by Subject|1
7530330|NCT02637037|11874021|FG000|Overall Study|Adverse Event|1
7530331|NCT02637037|11874022|FG001|Overall Study|Adverse Event|0
7530332|NCT02637063|11874043|FG000|Overall Study|Lost to Follow-up|3
7530333|NCT02637063|11874044|FG001|Overall Study|Lost to Follow-up|2
7530334|NCT02637063|11874045|FG002|Overall Study|Lost to Follow-up|3
7530335|NCT02637063|11874043|FG000|Overall Study|Withdrawal by Subject|2
7530336|NCT02637063|11874044|FG001|Overall Study|Withdrawal by Subject|2
7530337|NCT02637063|11874045|FG002|Overall Study|Withdrawal by Subject|3
7530338|NCT02637076|11874055|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7530339|NCT02637076|11874056|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
7530340|NCT02637076|11874055|FG000|Overall Study|Withdrawal by Subject|0
7530341|NCT02637076|11874056|FG001|Overall Study|Withdrawal by Subject|4
7530342|NCT02637141|11874065|FG000|Overall Study|Adverse Event|1
7414502|NCT01435018|11687448|FG001|Overall Study|Never started chemotherapy|0
7414503|NCT01435018|11687449|FG002|Overall Study|Never started chemotherapy|1
7414504|NCT01435031|11687459|FG000|ITT at 1 Month|Withdrawal by Subject|1
7414505|NCT01435031|11687459|FG000|ITT at 1 Month|Death|1
7414506|NCT01435031|11687459|FG000|ITT at 1 Month|Lost to Follow-up|4
7414507|NCT01435031|11687459|FG000|ITT at 6 Months|Death|2
7414508|NCT01435031|11687459|FG000|ITT at 6 Months|Lost to Follow-up|3
7414509|NCT01435031|11687459|FG000|ITT at 1 Year|Death|1
7414510|NCT01435031|11687459|FG000|ITT at 1 Year|Withdrawal by Subject|2
7414511|NCT01435031|11687459|FG000|ITT at 1 Year|Lost to Follow-up|6
7414512|NCT01435031|11687459|FG000|ITT at 2 Years|Death|7
7414513|NCT01435031|11687459|FG000|ITT at 2 Years|Withdrawal by Subject|2
7414514|NCT01435031|11687459|FG000|ITT at 2 Years|Lost to Follow-up|4
7414515|NCT01435031|11687459|FG000|ITT at 3 Years|Death|5
7414516|NCT01435031|11687459|FG000|ITT at 3 Years|Withdrawal by Subject|2
7414517|NCT01435031|11687459|FG000|ITT at 3 Years|Lost to Follow-up|4
7414518|NCT01435031|11687459|FG000|ITT at 4 Years|Death|4
7414519|NCT01435031|11687459|FG000|ITT at 4 Years|Withdrawal by Subject|2
7414520|NCT01435031|11687459|FG000|ITT at 4 Years|Lost to Follow-up|1
7414521|NCT01435122|11687463|FG000|Overall Study|Early withdrawal due to toxicity|8
7414522|NCT01435265|11687473|FG000|Overall Study|Lost to Follow-up|0
7414523|NCT01435265|11687474|FG001|Overall Study|Lost to Follow-up|1
7414524|NCT01435356|11687491|FG000|Overall Study|Adverse Event|2
7414525|NCT01435356|11687492|FG001|Overall Study|Adverse Event|0
7414526|NCT01435356|11687491|FG000|Overall Study|Disease progression/recurrence|17
7414527|NCT01435356|11687492|FG001|Overall Study|Disease progression/recurrence|10
7414528|NCT01435356|11687491|FG000|Overall Study|Protocol Violation|0
7414529|NCT01435356|11687492|FG001|Overall Study|Protocol Violation|1
7414530|NCT01435356|11687491|FG000|Overall Study|Study Discontinuation, amendment 4|5
7414531|NCT01435356|11687492|FG001|Overall Study|Study Discontinuation, amendment 4|11
7414532|NCT01435356|11687491|FG000|Overall Study|Withdrawal by Subject|1
7414533|NCT01435356|11687492|FG001|Overall Study|Withdrawal by Subject|1
7414534|NCT01435356|11687491|FG000|Overall Study|Facial palsy|1
7414535|NCT01435356|11687492|FG001|Overall Study|Facial palsy|0
7414536|NCT01435356|11687491|FG000|Overall Study|IC withdrawal due to study cancellation|1
7530343|NCT02637141|11874066|FG001|Overall Study|Adverse Event|1
7530344|NCT02637141|11874067|FG002|Overall Study|Adverse Event|0
7530345|NCT02637141|11874065|FG000|Overall Study|Withdrawal by Subject|1
7530346|NCT02637141|11874066|FG001|Overall Study|Withdrawal by Subject|1
7530347|NCT02637141|11874067|FG002|Overall Study|Withdrawal by Subject|1
7318290|NCT00727571|11547389|FG000|Overall Study|Other|0
7414537|NCT01435356|11687492|FG001|Overall Study|IC withdrawal due to study cancellation|0
7530348|NCT02637232|11874075|FG000|Overall Study|Lost to Follow-up|42
7530349|NCT02637232|11874075|FG000|Overall Study|Adverse Event|11
7553525|NCT03015181|11914448|FG001|Overall Study|Withdrawal by Subject|0
7414538|NCT01435356|11687491|FG000|Overall Study|Physician Decision|1
7414539|NCT01435356|11687492|FG001|Overall Study|Physician Decision|0
7414540|NCT01435356|11687491|FG000|Overall Study|Patient decision|3
7414541|NCT01435356|11687492|FG001|Overall Study|Patient decision|0
7414542|NCT01435356|11687491|FG000|Overall Study|Patient moved to another city|1
7553526|NCT03015181|11914449|FG002|Overall Study|Withdrawal by Subject|0
7553527|NCT03015181|11914450|FG003|Overall Study|Withdrawal by Subject|0
7553528|NCT03015181|11914451|FG004|Overall Study|Withdrawal by Subject|0
7553529|NCT03015181|11914452|FG005|Overall Study|Withdrawal by Subject|1
7553530|NCT03015181|11914453|FG006|Overall Study|Withdrawal by Subject|0
7553531|NCT03015181|11914447|FG000|Overall Study|Physician Decision|0
7553532|NCT03015181|11914448|FG001|Overall Study|Physician Decision|0
7553533|NCT03015181|11914449|FG002|Overall Study|Physician Decision|0
7553534|NCT03015181|11914450|FG003|Overall Study|Physician Decision|0
7553535|NCT03015181|11914451|FG004|Overall Study|Physician Decision|0
7553536|NCT03015181|11914452|FG005|Overall Study|Physician Decision|0
7553537|NCT03015181|11914453|FG006|Overall Study|Physician Decision|1
7553538|NCT03015220|11914493|FG000|Overall Study|Withdrawal by Subject|3
7553539|NCT03015220|11914494|FG001|Overall Study|Withdrawal by Subject|2
7553540|NCT03015220|11914495|FG002|Overall Study|Withdrawal by Subject|2
7553541|NCT03015220|11914496|FG003|Overall Study|Withdrawal by Subject|2
7553542|NCT03015220|11914493|FG000|Overall Study|Lost to Follow-up|0
7553543|NCT03015220|11914494|FG001|Overall Study|Lost to Follow-up|0
7553544|NCT03015220|11914495|FG002|Overall Study|Lost to Follow-up|1
7553545|NCT03015220|11914496|FG003|Overall Study|Lost to Follow-up|0
7553546|NCT03015363|11914506|FG000|Overall Study|Physician Decision|14
7553547|NCT03015363|11914506|FG000|Overall Study|Withdrawal by Subject|3
7553548|NCT03015532|11914518|FG000|Overall Study|Adverse Event|0
7553549|NCT03015532|11914519|FG001|Overall Study|Adverse Event|0
7553550|NCT03015532|11914520|FG002|Overall Study|Adverse Event|0
7553551|NCT03015532|11914521|FG003|Overall Study|Adverse Event|0
7553552|NCT03015532|11914522|FG004|Overall Study|Adverse Event|0
7553553|NCT03015532|11914523|FG005|Overall Study|Adverse Event|2
7553554|NCT03015532|11914524|FG006|Overall Study|Adverse Event|1
7553555|NCT03015532|11914525|FG007|Overall Study|Adverse Event|0
7553556|NCT03015532|11914518|FG000|Overall Study|Withdrawal by Subject|0
7553557|NCT03015532|11914519|FG001|Overall Study|Withdrawal by Subject|0
7553558|NCT03015532|11914520|FG002|Overall Study|Withdrawal by Subject|0
7318291|NCT00727571|11547390|FG001|Overall Study|Other|4
7318292|NCT00727571|11547391|FG002|Overall Study|Other|6
7318293|NCT00727571|11547392|FG003|Overall Study|Other|0
7318294|NCT00727649|11547422|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
7318295|NCT00727649|11547423|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
7318296|NCT00727649|11547422|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
7318297|NCT00727649|11547423|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
7318298|NCT00727649|11547422|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
7318299|NCT00727649|11547423|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
7318300|NCT00727649|11547422|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
7318301|NCT00727649|11547423|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
7318302|NCT00727649|11547422|FG000|Second Intervention (4-weeks)|Death|1
7318303|NCT00727649|11547423|FG001|Second Intervention (4-weeks)|Death|0
7318304|NCT00727649|11547422|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
7318305|NCT00727649|11547423|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
7318306|NCT00727649|11547422|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
7318307|NCT00727649|11547423|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
7318308|NCT00727714|11547431|FG000|Overall Study|Lost to Follow-up|2
7318309|NCT00727844|11547446|FG000|Initial Randomization|Physician Decision|2
7318310|NCT00727844|11547447|FG001|Initial Randomization|Physician Decision|0
7318311|NCT00727844|11547448|FG002|Initial Randomization|Physician Decision|0
7318312|NCT00727844|11547449|FG003|Initial Randomization|Physician Decision|0
7384601|NCT01195662|11641825|FG001|Double Blind Treatment Period|Adverse Event|1
7384602|NCT01195662|11641826|FG002|Double Blind Treatment Period|Adverse Event|2
7384603|NCT01195662|11641824|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
7384604|NCT01195662|11641825|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
7384605|NCT01195662|11641826|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
7384606|NCT01195662|11641824|FG000|Double Blind Treatment Period|Lost to Follow-up|3
7384607|NCT01195662|11641825|FG001|Double Blind Treatment Period|Lost to Follow-up|2
7384608|NCT01195662|11641826|FG002|Double Blind Treatment Period|Lost to Follow-up|3
7384609|NCT01195662|11641824|FG000|Double Blind Treatment Period|Administrative reason|2
7384610|NCT01195662|11641825|FG001|Double Blind Treatment Period|Administrative reason|1
7384611|NCT01195662|11641826|FG002|Double Blind Treatment Period|Administrative reason|1
7384612|NCT01195662|11641824|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
7384613|NCT01195662|11641825|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
7384614|NCT01195662|11641826|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
7384615|NCT01195662|11641824|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
7384616|NCT01195662|11641825|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
7384617|NCT01195662|11641826|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
7384618|NCT01195662|11641824|FG000|Double Blind Treatment Period|Lack of Efficacy|2
7553559|NCT03015532|11914521|FG003|Overall Study|Withdrawal by Subject|0
7553560|NCT03015532|11914522|FG004|Overall Study|Withdrawal by Subject|0
7553561|NCT03015532|11914523|FG005|Overall Study|Withdrawal by Subject|0
7553562|NCT03015532|11914524|FG006|Overall Study|Withdrawal by Subject|1
7553563|NCT03015532|11914525|FG007|Overall Study|Withdrawal by Subject|0
7553564|NCT03016078|11914558|FG000|Overall Study|Protocol Violation|1
7318313|NCT00727909|11547468|FG000|Overall Study|Withdrawal by Subject|5
7318314|NCT00727909|11547469|FG001|Overall Study|Withdrawal by Subject|11
7318315|NCT00727909|11547470|FG002|Overall Study|Withdrawal by Subject|8
7318316|NCT00727909|11547471|FG003|Overall Study|Withdrawal by Subject|5
7318317|NCT00727909|11547468|FG000|Overall Study|Death|0
7318318|NCT00727909|11547469|FG001|Overall Study|Death|0
7318319|NCT00727909|11547470|FG002|Overall Study|Death|1
7318320|NCT00727909|11547471|FG003|Overall Study|Death|0
7318321|NCT00727961|11547475|FG000|Overall Study|Lost to Follow-up|1
7318322|NCT00727961|11547475|FG000|Overall Study|Adverse Event|4
7318323|NCT00727961|11547475|FG000|Overall Study|Patient's refusal|2
7318324|NCT00727961|11547475|FG000|Overall Study|Progression|30
7318325|NCT00728130|11547479|FG000|Overall Study|Withdrawal by Subject|1
7318326|NCT00728130|11547479|FG000|Overall Study|Paperwork not completed in time|1
7318327|NCT00728130|11547479|FG000|Overall Study|Physician Decision|1
7318328|NCT00728182|11547485|FG000|Overall Study|Adverse Event|1
7318329|NCT00728182|11547486|FG001|Overall Study|Adverse Event|0
7318330|NCT00728182|11547485|FG000|Overall Study|Lost to Follow-up|2
7318331|NCT00728182|11547486|FG001|Overall Study|Lost to Follow-up|0
7318332|NCT00728182|11547485|FG000|Overall Study|Death|0
7318333|NCT00728182|11547486|FG001|Overall Study|Death|2
7318334|NCT00728182|11547485|FG000|Overall Study|Protocol Noncompliance|0
7318335|NCT00728182|11547486|FG001|Overall Study|Protocol Noncompliance|1
7318336|NCT00728468|11547498|FG000|Overall Study|Enrolled but not treated|1
7318337|NCT00728468|11547498|FG000|Overall Study|Death|1
7318338|NCT00728468|11547498|FG000|Overall Study|Protocol Violation|4
7318339|NCT00728468|11547498|FG000|Overall Study|Objective progression or relapse|9
7414543|NCT01435356|11687492|FG001|Overall Study|Patient moved to another city|1
7414544|NCT01435382|11687502|FG000|Overall Study|Lost to Follow-up|1
7414545|NCT01435382|11687503|FG001|Overall Study|Lost to Follow-up|0
7414546|NCT01435382|11687504|FG002|Overall Study|Lost to Follow-up|1
7414547|NCT01435382|11687505|FG003|Overall Study|Lost to Follow-up|0
7414548|NCT01435382|11687502|FG000|Overall Study|Withdrawal by Subject|0
7414549|NCT01435382|11687503|FG001|Overall Study|Withdrawal by Subject|2
7414550|NCT01435382|11687504|FG002|Overall Study|Withdrawal by Subject|0
7414551|NCT01435382|11687505|FG003|Overall Study|Withdrawal by Subject|1
7414552|NCT01435460|11687523|FG000|Overall Study|Adverse Event|2
7414553|NCT01435460|11687524|FG001|Overall Study|Adverse Event|1
7414554|NCT01435460|11687523|FG000|Overall Study|Lost to Follow-up|6
7414555|NCT01435460|11687524|FG001|Overall Study|Lost to Follow-up|1
7414556|NCT01435460|11687523|FG000|Overall Study|Withdrawal by Subject|1
7414557|NCT01435460|11687524|FG001|Overall Study|Withdrawal by Subject|3
7414558|NCT01435460|11687523|FG000|Overall Study|Protocol Violation|0
7414559|NCT01435460|11687524|FG001|Overall Study|Protocol Violation|1
7414560|NCT01435460|11687523|FG000|Overall Study|Did not meet eligibility criteria|2
7414561|NCT01435460|11687524|FG001|Overall Study|Did not meet eligibility criteria|0
7414562|NCT01435577|11687541|FG000|Overall Study|Adverse Event|10
7414563|NCT01435577|11687542|FG001|Overall Study|Adverse Event|0
7414564|NCT01435577|11687541|FG000|Overall Study|Lack of Efficacy|7
7414565|NCT01435577|11687542|FG001|Overall Study|Lack of Efficacy|51
7414566|NCT01435577|11687541|FG000|Overall Study|Alternative treatment started|0
7414567|NCT01435577|11687542|FG001|Overall Study|Alternative treatment started|1
7414568|NCT01435616|11687563|FG000|Overall Study|Adverse Event|39
7414569|NCT01435616|11687564|FG001|Overall Study|Adverse Event|21
7414570|NCT01435616|11687563|FG000|Overall Study|Death|7
7414571|NCT01435616|11687564|FG001|Overall Study|Death|2
7414572|NCT01435616|11687563|FG000|Overall Study|Lost to Follow-up|22
7414573|NCT01435616|11687564|FG001|Overall Study|Lost to Follow-up|13
7414574|NCT01435616|11687563|FG000|Overall Study|Protocol Violation|16
7414575|NCT01435616|11687564|FG001|Overall Study|Protocol Violation|13
7414576|NCT01435616|11687563|FG000|Overall Study|Withdrawal by Subject|66
7414577|NCT01435616|11687564|FG001|Overall Study|Withdrawal by Subject|24
7414578|NCT01435616|11687563|FG000|Overall Study|Physician Decision|20
7414579|NCT01435616|11687564|FG001|Overall Study|Physician Decision|7
7414580|NCT01435616|11687563|FG000|Overall Study|Sponsor Decision|1
7414581|NCT01435616|11687564|FG001|Overall Study|Sponsor Decision|0
7414582|NCT01435655|11687572|FG000|Overall Study|Death|2
7414583|NCT01435655|11687572|FG000|Overall Study|Other|1
7414584|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Adverse Event|40
7414585|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7414586|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7414587|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Adverse Event|0
7414588|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Adverse Event|0
7414589|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Adverse Event|0
7414590|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
7414591|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7414592|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7414593|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
7318340|NCT00728468|11547498|FG000|Overall Study|Study terminated by sponsor|1
7318341|NCT00728481|11547504|FG000|Overall Study|Withdrawal by Subject|0
7318342|NCT00728481|11547505|FG001|Overall Study|Withdrawal by Subject|1
7318343|NCT00728481|11547504|FG000|Overall Study|Adverse Event|0
7318344|NCT00728481|11547505|FG001|Overall Study|Adverse Event|1
7318345|NCT00728481|11547504|FG000|Overall Study|Study medication non-compliance|0
7318346|NCT00728481|11547505|FG001|Overall Study|Study medication non-compliance|2
7318347|NCT00728481|11547504|FG000|Overall Study|Incorrectly assigned to opposite arm|1
7318348|NCT00728481|11547505|FG001|Overall Study|Incorrectly assigned to opposite arm|0
7318349|NCT00728494|11547513|FG000|Overall Study|Adverse Event|7
7318350|NCT00728494|11547514|FG001|Overall Study|Adverse Event|0
7318351|NCT00728494|11547513|FG000|Overall Study|Withdrawal by Subject|0
7318352|NCT00728494|11547514|FG001|Overall Study|Withdrawal by Subject|2
7318353|NCT00728494|11547513|FG000|Overall Study|Lack of Efficacy|2
7318354|NCT00728494|11547514|FG001|Overall Study|Lack of Efficacy|4
7318355|NCT00728494|11547513|FG000|Overall Study|No data available|0
7318356|NCT00728494|11547514|FG001|Overall Study|No data available|1
7318357|NCT00728689|11547531|FG000|Washout Period (Days 4 - 10)|Death in family|1
7318358|NCT00728689|11547532|FG001|Washout Period (Days 4 - 10)|Death in family|0
7318359|NCT00728936|11547579|FG000|Overall Study|Withdrawal by Subject|0
7318360|NCT00728936|11547580|FG001|Overall Study|Withdrawal by Subject|0
7318361|NCT00728936|11547581|FG002|Overall Study|Withdrawal by Subject|0
7318362|NCT00728936|11547582|FG003|Overall Study|Withdrawal by Subject|0
7318363|NCT00728936|11547583|FG004|Overall Study|Withdrawal by Subject|0
7318364|NCT00728936|11547584|FG005|Overall Study|Withdrawal by Subject|1
7318365|NCT00728936|11547585|FG006|Overall Study|Withdrawal by Subject|0
7318366|NCT00728949|11547603|FG000|Overall Study|Adverse Event|8
7318367|NCT00728949|11547604|FG001|Overall Study|Adverse Event|0
7318368|NCT00728949|11547603|FG000|Overall Study|Withdrawal by Subject|2
7318369|NCT00728949|11547604|FG001|Overall Study|Withdrawal by Subject|2
7318370|NCT00728949|11547603|FG000|Overall Study|Abnormal Lab Results|0
7318371|NCT00728949|11547604|FG001|Overall Study|Abnormal Lab Results|2
7318372|NCT00728949|11547603|FG000|Overall Study|On treatment at cutoff date|1
7318373|NCT00728949|11547604|FG001|Overall Study|On treatment at cutoff date|0
7318374|NCT00728988|11547612|FG000|Overall Study|Not Treated|2
7318375|NCT00728988|11547613|FG001|Overall Study|Not Treated|2
7318376|NCT00728988|11547612|FG000|Overall Study|Death|1
7318377|NCT00728988|11547613|FG001|Overall Study|Death|1
7318378|NCT00728988|11547612|FG000|Overall Study|Adverse Event|3
7318379|NCT00728988|11547613|FG001|Overall Study|Adverse Event|2
7318380|NCT00728988|11547612|FG000|Overall Study|Other|85
7318381|NCT00728988|11547613|FG001|Overall Study|Other|77
7318382|NCT00728988|11547612|FG000|Overall Study|Withdrawal by Subject|2
7318383|NCT00728988|11547613|FG001|Overall Study|Withdrawal by Subject|6
7318384|NCT00729157|11547637|FG000|Overall Study|Withdrawal by Subject|1
7318385|NCT00729183|11547643|FG000|Overall Study|Adverse Event|11
7318386|NCT00729183|11547644|FG001|Overall Study|Adverse Event|5
7318387|NCT00729183|11547643|FG000|Overall Study|Lack of Efficacy|0
7318388|NCT00729183|11547644|FG001|Overall Study|Lack of Efficacy|1
7318389|NCT00729183|11547643|FG000|Overall Study|Lost to Follow-up|3
7318390|NCT00729183|11547644|FG001|Overall Study|Lost to Follow-up|1
7318391|NCT00729183|11547643|FG000|Overall Study|Physician Decision|1
7318392|NCT00729183|11547644|FG001|Overall Study|Physician Decision|1
7318393|NCT00729183|11547643|FG000|Overall Study|Protocol Violation|1
7318394|NCT00729183|11547644|FG001|Overall Study|Protocol Violation|0
7318395|NCT00729183|11547643|FG000|Overall Study|Withdrawal by Subject|9
7318396|NCT00729183|11547644|FG001|Overall Study|Withdrawal by Subject|7
7318397|NCT00729248|11547650|FG000|Overall Study|Physician Decision|2
7318398|NCT00729326|11547657|FG000|Overall Study|Lost to Follow-up|2
7318399|NCT00729326|11547658|FG001|Overall Study|Lost to Follow-up|0
7318400|NCT00729326|11547657|FG000|Overall Study|Physician Decision|0
7318401|NCT00729326|11547658|FG001|Overall Study|Physician Decision|1
7318402|NCT00729326|11547657|FG000|Overall Study|Protocol Violation|3
7318403|NCT00729326|11547658|FG001|Overall Study|Protocol Violation|2
7318404|NCT00729326|11547657|FG000|Overall Study|Subject Decision|4
7318405|NCT00729326|11547658|FG001|Overall Study|Subject Decision|4
7318406|NCT00729326|11547657|FG000|Overall Study|Sponsor Decision|1
7318407|NCT00729326|11547658|FG001|Overall Study|Sponsor Decision|2
7318408|NCT00729378|11547666|FG000|Baseline|Did not complete study measurements|72
7318409|NCT00729378|11547667|FG001|Baseline|Did not complete study measurements|33
7318410|NCT00729378|11547666|FG000|Baseline|Withdrawal by Subject|66
7318411|NCT00729378|11547667|FG001|Baseline|Withdrawal by Subject|59
7318412|NCT00729378|11547666|FG000|12-months|Lost to Follow-up|100
7318413|NCT00729378|11547667|FG001|12-months|Lost to Follow-up|65
7318414|NCT00729378|11547666|FG000|24-months|Lost to Follow-up|72
7318415|NCT00729378|11547667|FG001|24-months|Lost to Follow-up|51
7318416|NCT00729378|11547666|FG000|36-months|Lost to Follow-up|15
7318417|NCT00729378|11547667|FG001|36-months|Lost to Follow-up|6
7318418|NCT00729469|11547688|FG000|Overall Study|Adverse Event|14
7318419|NCT00729469|11547689|FG001|Overall Study|Adverse Event|25
7318420|NCT00729469|11547688|FG000|Overall Study|Lost to Follow-up|9
7318421|NCT00729469|11547689|FG001|Overall Study|Lost to Follow-up|9
7318422|NCT00729469|11547688|FG000|Overall Study|Protocol Violation|2
7318423|NCT00729469|11547689|FG001|Overall Study|Protocol Violation|1
7318424|NCT00729469|11547688|FG000|Overall Study|Withdrawal by Subject|19
7318425|NCT00729469|11547689|FG001|Overall Study|Withdrawal by Subject|8
7318426|NCT00729469|11547688|FG000|Overall Study|Other-Not mentioned|9
7318427|NCT00729469|11547689|FG001|Overall Study|Other-Not mentioned|4
7318428|NCT00729586|11547714|FG000|Overall Study|Ineligible|0
7318429|NCT00729586|11547715|FG001|Overall Study|Ineligible|1
7318430|NCT00729586|11547714|FG000|Overall Study|never treated|1
7318431|NCT00729586|11547715|FG001|Overall Study|never treated|0
7318432|NCT00729612|11547722|FG000|Overall Study|Non evaluable for response|10
7318433|NCT00729690|11547740|FG000|Overall Study|IT Catheter Malfunction|0
7318434|NCT00729690|11547741|FG001|Overall Study|IT Catheter Malfunction|2
7318435|NCT00729690|11547742|FG002|Overall Study|IT Catheter Malfunction|2
7318436|NCT00729833|11547758|FG000|Overall Study|Death|5
7318437|NCT00729833|11547759|FG001|Overall Study|Death|1
7318438|NCT00729833|11547760|FG002|Overall Study|Death|3
7318439|NCT00729833|11547761|FG003|Overall Study|Death|5
7318440|NCT00729833|11547758|FG000|Overall Study|Study Terminated by Sponsor|0
7318441|NCT00729833|11547759|FG001|Overall Study|Study Terminated by Sponsor|0
7318442|NCT00729833|11547760|FG002|Overall Study|Study Terminated by Sponsor|1
7318443|NCT00729833|11547761|FG003|Overall Study|Study Terminated by Sponsor|0
7318444|NCT00729833|11547758|FG000|Overall Study|Lost to Follow-up|1
7318445|NCT00729833|11547759|FG001|Overall Study|Lost to Follow-up|0
7318446|NCT00729833|11547760|FG002|Overall Study|Lost to Follow-up|0
7318447|NCT00729833|11547761|FG003|Overall Study|Lost to Follow-up|0
7318448|NCT00729833|11547758|FG000|Overall Study|Withdrawal by Subject|3
7318449|NCT00729833|11547759|FG001|Overall Study|Withdrawal by Subject|1
7318450|NCT00729833|11547760|FG002|Overall Study|Withdrawal by Subject|3
7318451|NCT00729833|11547761|FG003|Overall Study|Withdrawal by Subject|0
7318452|NCT00729833|11547758|FG000|Overall Study|Unspecified Reasons|11
7318453|NCT00729833|11547759|FG001|Overall Study|Unspecified Reasons|5
7318454|NCT00729833|11547760|FG002|Overall Study|Unspecified Reasons|5
7318455|NCT00729833|11547761|FG003|Overall Study|Unspecified Reasons|1
7318456|NCT00729859|11547784|FG000|Overall Study|Adverse Event|0
7318457|NCT00729859|11547785|FG001|Overall Study|Adverse Event|1
7318458|NCT00729859|11547786|FG002|Overall Study|Adverse Event|0
7318459|NCT00729859|11547784|FG000|Overall Study|Withdrawal by Subject|0
7318460|NCT00729859|11547785|FG001|Overall Study|Withdrawal by Subject|1
7318461|NCT00729859|11547786|FG002|Overall Study|Withdrawal by Subject|0
7318462|NCT00729937|11547815|FG000|Overall Study|Lost to Follow-up|49
7318463|NCT00729937|11547816|FG001|Overall Study|Lost to Follow-up|58
7318464|NCT00729937|11547817|FG002|Overall Study|Lost to Follow-up|18
7318465|NCT00729937|11547818|FG003|Overall Study|Lost to Follow-up|33
7318466|NCT00729937|11547819|FG004|Overall Study|Lost to Follow-up|18
7318467|NCT00729937|11547820|FG005|Overall Study|Lost to Follow-up|23
7318468|NCT00729937|11547815|FG000|Overall Study|Physician Decision|7
7318469|NCT00729937|11547816|FG001|Overall Study|Physician Decision|16
7318470|NCT00729937|11547817|FG002|Overall Study|Physician Decision|2
7318471|NCT00729937|11547818|FG003|Overall Study|Physician Decision|0
7318472|NCT00729937|11547819|FG004|Overall Study|Physician Decision|5
7318473|NCT00729937|11547820|FG005|Overall Study|Physician Decision|8
7318474|NCT00729937|11547815|FG000|Overall Study|Death|1
7318475|NCT00729937|11547816|FG001|Overall Study|Death|0
7318476|NCT00729937|11547817|FG002|Overall Study|Death|1
7318477|NCT00729937|11547818|FG003|Overall Study|Death|0
7414594|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
7414595|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
7414596|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
7414597|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414598|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414599|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414600|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414601|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414602|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
7414603|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414604|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414605|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414606|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414607|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414608|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
7414609|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414610|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414611|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414612|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7318478|NCT00729937|11547819|FG004|Overall Study|Death|0
7318479|NCT00729937|11547820|FG005|Overall Study|Death|1
7318480|NCT00729937|11547815|FG000|Overall Study|Withdrawal by Subject|3
7318481|NCT00729937|11547816|FG001|Overall Study|Withdrawal by Subject|5
7318482|NCT00729937|11547817|FG002|Overall Study|Withdrawal by Subject|6
7318483|NCT00729937|11547818|FG003|Overall Study|Withdrawal by Subject|0
7318484|NCT00729937|11547819|FG004|Overall Study|Withdrawal by Subject|4
7318485|NCT00729937|11547820|FG005|Overall Study|Withdrawal by Subject|2
7318486|NCT00729937|11547815|FG000|Overall Study|Randomized but not treated|12
7318487|NCT00729937|11547816|FG001|Overall Study|Randomized but not treated|6
7318488|NCT00729937|11547817|FG002|Overall Study|Randomized but not treated|1
7318489|NCT00729937|11547818|FG003|Overall Study|Randomized but not treated|0
7318490|NCT00729937|11547819|FG004|Overall Study|Randomized but not treated|1
7318491|NCT00729937|11547820|FG005|Overall Study|Randomized but not treated|3
7318492|NCT00729937|11547815|FG000|Overall Study|Did not meet eligibility criteria|2
7318493|NCT00729937|11547816|FG001|Overall Study|Did not meet eligibility criteria|1
7318494|NCT00729937|11547817|FG002|Overall Study|Did not meet eligibility criteria|0
7318495|NCT00729937|11547818|FG003|Overall Study|Did not meet eligibility criteria|0
7318496|NCT00729937|11547819|FG004|Overall Study|Did not meet eligibility criteria|0
7318497|NCT00729937|11547820|FG005|Overall Study|Did not meet eligibility criteria|0
7318498|NCT00729937|11547815|FG000|Overall Study|Incarcerated|0
7318499|NCT00729937|11547816|FG001|Overall Study|Incarcerated|2
7318500|NCT00729937|11547817|FG002|Overall Study|Incarcerated|1
7318501|NCT00729937|11547818|FG003|Overall Study|Incarcerated|1
7318502|NCT00729937|11547819|FG004|Overall Study|Incarcerated|0
7318503|NCT00729937|11547820|FG005|Overall Study|Incarcerated|0
7318504|NCT00730015|11547837|FG000|Overall Study|Adverse Event|11
7318505|NCT00730015|11547838|FG001|Overall Study|Adverse Event|10
7318506|NCT00730015|11547839|FG002|Overall Study|Adverse Event|8
7318507|NCT00730015|11547837|FG000|Overall Study|Protocol Violation|2
7318508|NCT00730015|11547838|FG001|Overall Study|Protocol Violation|6
7318509|NCT00730015|11547839|FG002|Overall Study|Protocol Violation|4
7318510|NCT00730015|11547837|FG000|Overall Study|Withdrawal by Subject|12
7318511|NCT00730015|11547838|FG001|Overall Study|Withdrawal by Subject|12
7318512|NCT00730015|11547839|FG002|Overall Study|Withdrawal by Subject|8
7318513|NCT00730015|11547837|FG000|Overall Study|Lost to Follow-up|4
7318514|NCT00730015|11547838|FG001|Overall Study|Lost to Follow-up|10
7318515|NCT00730015|11547839|FG002|Overall Study|Lost to Follow-up|3
7318516|NCT00730015|11547837|FG000|Overall Study|Lack of Efficacy|1
7318517|NCT00730015|11547838|FG001|Overall Study|Lack of Efficacy|2
7318518|NCT00730015|11547839|FG002|Overall Study|Lack of Efficacy|8
7318519|NCT00730015|11547837|FG000|Overall Study|Other Reason|1
7318520|NCT00730015|11547838|FG001|Overall Study|Other Reason|0
7318521|NCT00730015|11547839|FG002|Overall Study|Other Reason|1
7318522|NCT00730028|11547857|FG000|Overall Study|Adverse Event|23
7318523|NCT00730028|11547858|FG001|Overall Study|Adverse Event|26
7318524|NCT00730028|11547859|FG002|Overall Study|Adverse Event|16
7318525|NCT00730028|11547860|FG003|Overall Study|Adverse Event|20
7318526|NCT00730028|11547861|FG004|Overall Study|Adverse Event|43
7318527|NCT00730028|11547857|FG000|Overall Study|Lost to Follow-up|13
7318528|NCT00730028|11547858|FG001|Overall Study|Lost to Follow-up|26
7318529|NCT00730028|11547859|FG002|Overall Study|Lost to Follow-up|22
7318530|NCT00730028|11547860|FG003|Overall Study|Lost to Follow-up|26
7318531|NCT00730028|11547861|FG004|Overall Study|Lost to Follow-up|25
7318532|NCT00730028|11547857|FG000|Overall Study|Protocol Violation|6
7318533|NCT00730028|11547858|FG001|Overall Study|Protocol Violation|1
7318534|NCT00730028|11547859|FG002|Overall Study|Protocol Violation|1
7318535|NCT00730028|11547860|FG003|Overall Study|Protocol Violation|2
7318536|NCT00730028|11547861|FG004|Overall Study|Protocol Violation|0
7318537|NCT00730028|11547857|FG000|Overall Study|Withdrawal by Subject|9
7318538|NCT00730028|11547858|FG001|Overall Study|Withdrawal by Subject|5
7318539|NCT00730028|11547859|FG002|Overall Study|Withdrawal by Subject|4
7318540|NCT00730028|11547860|FG003|Overall Study|Withdrawal by Subject|5
7318541|NCT00730028|11547861|FG004|Overall Study|Withdrawal by Subject|9
7318542|NCT00730028|11547857|FG000|Overall Study|Physician Decision|3
7318543|NCT00730028|11547858|FG001|Overall Study|Physician Decision|3
7318544|NCT00730028|11547859|FG002|Overall Study|Physician Decision|2
7318545|NCT00730028|11547860|FG003|Overall Study|Physician Decision|3
7318546|NCT00730028|11547861|FG004|Overall Study|Physician Decision|2
7318547|NCT00730028|11547857|FG000|Overall Study|Treatment Failure|5
7318548|NCT00730028|11547858|FG001|Overall Study|Treatment Failure|5
7318549|NCT00730028|11547859|FG002|Overall Study|Treatment Failure|0
7318550|NCT00730028|11547860|FG003|Overall Study|Treatment Failure|0
7414613|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414614|NCT01435759|11687581|FG000|Antidepressant Lead-in Phase|Other|119
7414615|NCT01435759|11687582|FG001|Antidepressant Lead-in Phase|Other|0
7414616|NCT01435759|11687583|FG002|Antidepressant Lead-in Phase|Other|0
7414617|NCT01435759|11687584|FG003|Antidepressant Lead-in Phase|Other|0
7414618|NCT01435759|11687585|FG004|Antidepressant Lead-in Phase|Other|0
7414619|NCT01435759|11687586|FG005|Antidepressant Lead-in Phase|Other|0
7414620|NCT01435759|11687581|FG000|Double-blind Phase|Adverse Event|7
7318551|NCT00730028|11547861|FG004|Overall Study|Treatment Failure|1
7318552|NCT00730028|11547857|FG000|Overall Study|Randomization Error|1
7318553|NCT00730028|11547858|FG001|Overall Study|Randomization Error|0
7318554|NCT00730028|11547859|FG002|Overall Study|Randomization Error|0
7318555|NCT00730028|11547860|FG003|Overall Study|Randomization Error|0
7318556|NCT00730028|11547861|FG004|Overall Study|Randomization Error|2
7318557|NCT00730041|11547875|FG000|Overall Study|Lost to Follow-up|0
7318558|NCT00730041|11547876|FG001|Overall Study|Lost to Follow-up|2
7318559|NCT00730158|11547884|FG000|Overall Study|Withdrawal by Subject|1
7318560|NCT00730158|11547885|FG001|Overall Study|Withdrawal by Subject|1
7318561|NCT00730171|11547895|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
7318562|NCT00730171|11547895|FG000|Overall Study|Adverse Event|193
7318563|NCT00730171|11547895|FG000|Overall Study|Protocol Violation|48
7318564|NCT00730171|11547895|FG000|Overall Study|Withdrawal by Subject|202
7318565|NCT00730171|11547895|FG000|Overall Study|Lost to Follow-up|121
7318566|NCT00730171|11547895|FG000|Overall Study|Insufficient Therapeutic Response|141
7318567|NCT00730171|11547895|FG000|Overall Study|Other|61
7318568|NCT00730236|11547903|FG000|Overall Study|Adverse Event|4
7318569|NCT00730236|11547903|FG000|Overall Study|Withdrawal by Subject|1
7553565|NCT03016078|11914558|FG000|Overall Study|Protocol Violation|1
7553566|NCT03016325|11914570|FG000|Treatment Period|Participant withdrew consent|0
7553567|NCT03016325|11914571|FG001|Treatment Period|Participant withdrew consent|1
7553568|NCT03016325|11914572|FG002|Treatment Period|Participant withdrew consent|0
7553569|NCT03016325|11914573|FG003|Treatment Period|Participant withdrew consent|0
7553570|NCT03016325|11914574|FG004|Treatment Period|Participant withdrew consent|0
7553571|NCT03016325|11914575|FG005|Treatment Period|Participant withdrew consent|0
7553572|NCT03016325|11914576|FG006|Treatment Period|Participant withdrew consent|0
7553573|NCT03016325|11914577|FG007|Treatment Period|Participant withdrew consent|0
7553574|NCT03016325|11914570|FG000|Treatment Period|Death|0
7553575|NCT03016325|11914571|FG001|Treatment Period|Death|0
7553576|NCT03016325|11914572|FG002|Treatment Period|Death|0
7553577|NCT03016325|11914573|FG003|Treatment Period|Death|0
7553578|NCT03016325|11914574|FG004|Treatment Period|Death|2
7553579|NCT03016325|11914575|FG005|Treatment Period|Death|0
7553580|NCT03016325|11914576|FG006|Treatment Period|Death|0
7553581|NCT03016325|11914577|FG007|Treatment Period|Death|0
7553582|NCT03016325|11914570|FG000|Treatment Period|Participant refuses assessments|0
7553583|NCT03016325|11914571|FG001|Treatment Period|Participant refuses assessments|0
7553584|NCT03016325|11914572|FG002|Treatment Period|Participant refuses assessments|1
7553585|NCT03016325|11914573|FG003|Treatment Period|Participant refuses assessments|0
7553586|NCT03016325|11914574|FG004|Treatment Period|Participant refuses assessments|0
7553587|NCT03016325|11914575|FG005|Treatment Period|Participant refuses assessments|0
7553588|NCT03016325|11914576|FG006|Treatment Period|Participant refuses assessments|0
7553589|NCT03016325|11914577|FG007|Treatment Period|Participant refuses assessments|0
7553590|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Death|2
7553591|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Death|0
7553592|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Death|5
7553593|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Death|6
7553594|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Death|3
7553595|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Death|0
7553596|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Death|0
7553597|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Death|0
7553598|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
7553599|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
7553600|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
7553601|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
7553602|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
7553603|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
7553604|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
7553605|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
7553606|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
7553607|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
7553608|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
7553609|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
7553610|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
7553611|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
7553612|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
7553613|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
7553614|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Participant refused to visit|0
7553615|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Participant refused to visit|1
7553616|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Participant refused to visit|2
7553617|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Participant refused to visit|0
7553618|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Participant refused to visit|2
7553619|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Participant refused to visit|0
7553620|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Participant refused to visit|0
7553621|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Participant refused to visit|0
7318570|NCT00730236|11547903|FG000|Overall Study|Non-compliance|1
7318571|NCT00730275|11547911|FG000|Overall Study|Withdrawal by Subject|0
7530350|NCT02637232|11874075|FG000|Overall Study|patient 's decision|2
7530351|NCT02637323|11874081|FG000|Overall Study|Lost to Follow-up|2
7530352|NCT02637323|11874082|FG001|Overall Study|Lost to Follow-up|0
7530353|NCT02637323|11874081|FG000|Overall Study|Protocol Violation|0
7530354|NCT02637323|11874082|FG001|Overall Study|Protocol Violation|1
7530355|NCT02637557|11874102|FG000|Overall Study|Adverse Event|3
7530356|NCT02637557|11874103|FG001|Overall Study|Adverse Event|1
7530357|NCT02637557|11874104|FG002|Overall Study|Adverse Event|3
7530358|NCT02637557|11874105|FG003|Overall Study|Adverse Event|3
7553622|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
7553623|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
7553624|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
7553625|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
7414735|NCT01436110|11687672|FG001|Overall Study|Adverse Event|1
7553626|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
7553627|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
7553628|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
7553629|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
7318572|NCT00730275|11547912|FG001|Overall Study|Withdrawal by Subject|0
7530359|NCT02637557|11874102|FG000|Overall Study|Lost to Follow-up|1
7530360|NCT02637557|11874103|FG001|Overall Study|Lost to Follow-up|1
7530361|NCT02637557|11874104|FG002|Overall Study|Lost to Follow-up|0
7530362|NCT02637557|11874105|FG003|Overall Study|Lost to Follow-up|1
7530363|NCT02637557|11874102|FG000|Overall Study|Physician Decision|1
7530364|NCT02637557|11874103|FG001|Overall Study|Physician Decision|0
7530365|NCT02637557|11874104|FG002|Overall Study|Physician Decision|0
7530366|NCT02637557|11874105|FG003|Overall Study|Physician Decision|0
7530367|NCT02637557|11874102|FG000|Overall Study|Protocol Violation|2
7530368|NCT02637557|11874103|FG001|Overall Study|Protocol Violation|0
7530369|NCT02637557|11874104|FG002|Overall Study|Protocol Violation|2
7530370|NCT02637557|11874105|FG003|Overall Study|Protocol Violation|1
7530371|NCT02637557|11874102|FG000|Overall Study|Withdrawal by Subject|1
7530372|NCT02637557|11874103|FG001|Overall Study|Withdrawal by Subject|3
7530373|NCT02637557|11874104|FG002|Overall Study|Withdrawal by Subject|4
7530374|NCT02637557|11874105|FG003|Overall Study|Withdrawal by Subject|2
7530375|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
7530376|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
7530377|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
7530378|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
7530379|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
7530380|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
7530381|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
7530382|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
7318573|NCT00730275|11547913|FG002|Overall Study|Withdrawal by Subject|0
7318574|NCT00730275|11547914|FG003|Overall Study|Withdrawal by Subject|1
7318575|NCT00730327|11547927|FG000|Overall Study|Lost to Follow-up|14
7318576|NCT00730327|11547928|FG001|Overall Study|Lost to Follow-up|16
7318577|NCT00730327|11547927|FG000|Overall Study|Adverse Event|8
7318578|NCT00730327|11547928|FG001|Overall Study|Adverse Event|1
7318579|NCT00730327|11547927|FG000|Overall Study|Withdrawal by Subject|3
7318580|NCT00730327|11547928|FG001|Overall Study|Withdrawal by Subject|13
7318581|NCT00730327|11547927|FG000|Overall Study|Subject withdrew (reason not specified)|2
7318582|NCT00730327|11547928|FG001|Overall Study|Subject withdrew (reason not specified)|7
7318583|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Adverse Event|5
7318584|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Adverse Event|10
7318585|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Adverse Event|4
7318586|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Adverse Event|8
7318587|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Adverse Event|4
7318588|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
7318589|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
7318590|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
7318591|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
7318592|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
7318593|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7318594|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7318595|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
7318596|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
7318597|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
7318598|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
7318599|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
7318600|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
7318601|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
7318602|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
7318603|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
7318604|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
7318605|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
7318606|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
7318607|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
7318608|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
7318609|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
7318610|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
7318611|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
7318612|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
7318613|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
7530383|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
7530384|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
7530385|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
7530386|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
7530387|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
7530388|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
7318614|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7318615|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7318616|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7387529|NCT01214837|11646074|FG001|Overall Study|Administrative Reason|6
7318617|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
7318618|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
7318619|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
7318620|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
7318621|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
7318622|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
7318623|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
7318624|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
7318625|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
7318626|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
7318627|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
7318628|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7318629|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7318630|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
7318631|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7318632|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
7318633|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Misrandomized|0
7318634|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Misrandomized|1
7414621|NCT01435759|11687582|FG001|Double-blind Phase|Adverse Event|0
7414622|NCT01435759|11687583|FG002|Double-blind Phase|Adverse Event|1
7414623|NCT01435759|11687584|FG003|Double-blind Phase|Adverse Event|1
7414624|NCT01435759|11687585|FG004|Double-blind Phase|Adverse Event|1
7414625|NCT01435759|11687586|FG005|Double-blind Phase|Adverse Event|3
7414626|NCT01435759|11687581|FG000|Double-blind Phase|Protocol Violation|2
7414627|NCT01435759|11687582|FG001|Double-blind Phase|Protocol Violation|0
7414628|NCT01435759|11687583|FG002|Double-blind Phase|Protocol Violation|1
7414629|NCT01435759|11687584|FG003|Double-blind Phase|Protocol Violation|2
7414630|NCT01435759|11687585|FG004|Double-blind Phase|Protocol Violation|0
7414631|NCT01435759|11687586|FG005|Double-blind Phase|Protocol Violation|1
7414632|NCT01435759|11687581|FG000|Double-blind Phase|Withdrawal by Subject|17
7414633|NCT01435759|11687582|FG001|Double-blind Phase|Withdrawal by Subject|4
7414634|NCT01435759|11687583|FG002|Double-blind Phase|Withdrawal by Subject|3
7414635|NCT01435759|11687584|FG003|Double-blind Phase|Withdrawal by Subject|4
7414636|NCT01435759|11687585|FG004|Double-blind Phase|Withdrawal by Subject|2
7414637|NCT01435759|11687586|FG005|Double-blind Phase|Withdrawal by Subject|2
7414638|NCT01435759|11687581|FG000|Double-blind Phase|Lost to Follow-up|31
7414639|NCT01435759|11687582|FG001|Double-blind Phase|Lost to Follow-up|1
7414640|NCT01435759|11687583|FG002|Double-blind Phase|Lost to Follow-up|2
7414641|NCT01435759|11687584|FG003|Double-blind Phase|Lost to Follow-up|0
7414642|NCT01435759|11687585|FG004|Double-blind Phase|Lost to Follow-up|3
7414643|NCT01435759|11687586|FG005|Double-blind Phase|Lost to Follow-up|3
7414644|NCT01435759|11687581|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
7414645|NCT01435759|11687582|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7414646|NCT01435759|11687583|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7414647|NCT01435759|11687584|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7414648|NCT01435759|11687585|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
7414649|NCT01435759|11687586|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
7414650|NCT01435759|11687581|FG000|Double-blind Phase|Other|8
7414651|NCT01435759|11687582|FG001|Double-blind Phase|Other|2
7414652|NCT01435759|11687583|FG002|Double-blind Phase|Other|0
7414653|NCT01435759|11687584|FG003|Double-blind Phase|Other|2
7414654|NCT01435759|11687585|FG004|Double-blind Phase|Other|0
7414655|NCT01435759|11687586|FG005|Double-blind Phase|Other|0
7414656|NCT01435772|11687601|FG000|Overall Study|Adverse Event|1
7414657|NCT01435772|11687602|FG001|Overall Study|Adverse Event|0
7414658|NCT01435772|11687603|FG002|Overall Study|Adverse Event|2
7414659|NCT01435772|11687601|FG000|Overall Study|Withdrawal by Subject|0
7414660|NCT01435772|11687602|FG001|Overall Study|Withdrawal by Subject|1
7414661|NCT01435772|11687603|FG002|Overall Study|Withdrawal by Subject|3
7414662|NCT01435772|11687601|FG000|Overall Study|Other - study termination|2
7414663|NCT01435772|11687602|FG001|Overall Study|Other - study termination|2
7414664|NCT01435772|11687603|FG002|Overall Study|Other - study termination|10
7414665|NCT01435798|11687612|FG000|Overall Study|Withdrawal by Subject|1
7414666|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
7414667|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
7414668|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
7414669|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Death|1
7414670|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Death|0
7414671|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Death|0
7414672|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
7414673|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7414674|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
7414675|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
7414676|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7414677|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
7414678|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
7318635|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Misrandomized|0
7318636|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Misrandomized|0
7318637|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Misrandomized|0
7318638|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
7318639|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
7318640|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
7318641|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
7318642|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
7318643|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7318644|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7318645|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7318646|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
7318647|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
7318648|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7318649|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7318650|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
7318651|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7530389|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
7530390|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
7530391|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Incarceration|1
7318652|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
7318653|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Change of location|0
7318654|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Change of location|0
7318655|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Change of location|0
7318656|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Change of location|1
7318657|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Change of location|0
7318658|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Pregnancy|0
7318659|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Pregnancy|1
7318660|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Pregnancy|0
7318661|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Pregnancy|0
7318662|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Pregnancy|0
7318663|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7318664|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7318665|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7318666|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
7318667|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
7318668|NCT00730405|11547943|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
7318669|NCT00730405|11547944|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
7318670|NCT00730405|11547945|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
7318671|NCT00730405|11547946|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
7318672|NCT00730405|11547947|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
7318673|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Adverse Event|2
7318674|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Adverse Event|6
7318675|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Adverse Event|2
7318676|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Adverse Event|3
7318677|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Adverse Event|4
7318678|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
7318679|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
7318680|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
7318681|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
7318682|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
7318683|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
7318684|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
7318685|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
7318686|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
7318687|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
7318688|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Death|0
7318689|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Death|1
7318690|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Death|0
7318691|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Death|1
7318692|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Death|0
7318693|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Change of location|1
7318694|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Change of location|1
7318695|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Change of location|0
7318696|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Change of location|1
7318697|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Change of location|0
7318698|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
7318699|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
7530392|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Incarceration|0
7530393|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
7318700|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
7318701|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
7318702|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
7318703|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7318704|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7318705|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
7318706|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7318707|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
7318708|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7318709|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7318710|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
7318711|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7318712|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
7414679|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7414680|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
7414681|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
7414682|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7414683|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
7414684|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
7414685|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7414686|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
7414687|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
7414688|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7414689|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
7414690|NCT01435928|11687631|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
7414691|NCT01435928|11687632|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
7414692|NCT01435928|11687633|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
7414693|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
7414694|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
7414695|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
7414696|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
7414697|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
7414698|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
7414699|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
7414700|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
7414701|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
7414702|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
7414703|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
7414704|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
7414705|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
7414706|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
7414707|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
7414708|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
7414709|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
7414710|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
7414711|NCT01435928|11687631|FG000|Double Blind Phase - 28 Weeks|Administrative|0
7414712|NCT01435928|11687632|FG001|Double Blind Phase - 28 Weeks|Administrative|5
7414713|NCT01435928|11687633|FG002|Double Blind Phase - 28 Weeks|Administrative|2
7414714|NCT01436071|11687661|FG000|Overall Study|Adverse Event|1
7414715|NCT01436071|11687662|FG001|Overall Study|Adverse Event|0
7414716|NCT01436071|11687661|FG000|Overall Study|Lack of Efficacy|16
7414717|NCT01436071|11687662|FG001|Overall Study|Lack of Efficacy|7
7414718|NCT01436071|11687661|FG000|Overall Study|Protocol Violation|0
7414719|NCT01436071|11687662|FG001|Overall Study|Protocol Violation|1
7414720|NCT01436071|11687661|FG000|Overall Study|Lost to Follow-up|3
7414721|NCT01436071|11687662|FG001|Overall Study|Lost to Follow-up|1
7414722|NCT01436071|11687661|FG000|Overall Study|Physician Decision|1
7414723|NCT01436071|11687662|FG001|Overall Study|Physician Decision|0
7414724|NCT01436071|11687661|FG000|Overall Study|Withdrawal by Subject|2
7414725|NCT01436071|11687662|FG001|Overall Study|Withdrawal by Subject|2
7414726|NCT01436071|11687661|FG000|Overall Study|Did Not Receive Trial Medication|3
7414727|NCT01436071|11687662|FG001|Overall Study|Did Not Receive Trial Medication|3
7414728|NCT01436110|11687671|FG000|Overall Study|Lack of Efficacy|23
7414729|NCT01436110|11687672|FG001|Overall Study|Lack of Efficacy|14
7414730|NCT01436110|11687673|FG002|Overall Study|Lack of Efficacy|9
7414731|NCT01436110|11687671|FG000|Overall Study|Withdrawal by Subject|6
7414732|NCT01436110|11687672|FG001|Overall Study|Withdrawal by Subject|8
7414733|NCT01436110|11687673|FG002|Overall Study|Withdrawal by Subject|4
7414734|NCT01436110|11687671|FG000|Overall Study|Adverse Event|2
7414736|NCT01436110|11687673|FG002|Overall Study|Adverse Event|2
7414737|NCT01436110|11687671|FG000|Overall Study|Physician Decision|3
7414738|NCT01436110|11687672|FG001|Overall Study|Physician Decision|1
7414739|NCT01436110|11687673|FG002|Overall Study|Physician Decision|1
7414740|NCT01436110|11687671|FG000|Overall Study|Lost to Follow-up|1
7318713|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7318714|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7318715|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7318716|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
7318717|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
7318718|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
7318719|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7318720|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7318721|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7318722|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
7318723|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7414741|NCT01436110|11687672|FG001|Overall Study|Lost to Follow-up|1
7553630|NCT03016325|11914570|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553631|NCT03016325|11914571|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553632|NCT03016325|11914572|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
7553633|NCT03016325|11914573|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553634|NCT03016325|11914574|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553635|NCT03016325|11914575|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553636|NCT03016325|11914576|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553637|NCT03016325|11914577|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
7553638|NCT03016325|11914570|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553639|NCT03016325|11914571|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
7553640|NCT03016325|11914572|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553641|NCT03016325|11914573|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553642|NCT03016325|11914574|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553643|NCT03016325|11914575|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553644|NCT03016325|11914576|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553645|NCT03016325|11914577|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
7553646|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Death|3
7553647|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Death|3
7553648|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Death|11
7553649|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Death|12
7553650|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Death|9
7553651|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Death|0
7553652|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Death|0
7553653|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Death|1
7553654|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
7553655|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
7553656|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
7553657|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
7553658|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
7553659|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
7553660|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
7553661|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
7553662|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
7553663|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
7553664|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
7553665|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
7553666|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
7553667|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
7553668|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
7553669|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
7414742|NCT01436110|11687673|FG002|Overall Study|Lost to Follow-up|3
7414743|NCT01436110|11687671|FG000|Overall Study|Protocol Violation|3
7414744|NCT01436110|11687672|FG001|Overall Study|Protocol Violation|1
7414745|NCT01436110|11687673|FG002|Overall Study|Protocol Violation|1
7414746|NCT01436110|11687671|FG000|Overall Study|Did Not Receive Trial Medication|1
7414747|NCT01436110|11687672|FG001|Overall Study|Did Not Receive Trial Medication|0
7414748|NCT01436110|11687673|FG002|Overall Study|Did Not Receive Trial Medication|3
7414749|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Adverse Event|39
7414750|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Adverse Event|0
7414751|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Adverse Event|0
7414752|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
7414753|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
7414754|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
7414755|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
7414756|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414757|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
7414758|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
7414759|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
7318724|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7318725|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7318726|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
7318727|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
7318728|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7318729|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7318730|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
7318731|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7318732|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
7318733|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7318734|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
7318735|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7318736|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7318737|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
7318738|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
7318739|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
7318740|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
7318741|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
7318742|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
7318743|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Non-compliance|1
7318744|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Non-compliance|0
7318745|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Non-compliance|2
7318746|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Non-compliance|0
7318747|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Non-compliance|0
7318748|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Missing|0
7318749|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Missing|0
7318750|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Missing|2
7318751|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Missing|0
7318752|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Missing|0
7318753|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
7318754|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
7318755|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
7318756|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
7414760|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
7414761|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
7414762|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7414763|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
7414764|NCT01436149|11687683|FG000|Antidepressant Lead-in Phase|Other|119
7414765|NCT01436149|11687684|FG001|Antidepressant Lead-in Phase|Other|0
7414766|NCT01436149|11687685|FG002|Antidepressant Lead-in Phase|Other|0
7414767|NCT01436149|11687683|FG000|Randomized Phase|Adverse Event|9
7414768|NCT01436149|11687684|FG001|Randomized Phase|Adverse Event|10
7414769|NCT01436149|11687685|FG002|Randomized Phase|Adverse Event|11
7414770|NCT01436149|11687683|FG000|Randomized Phase|Protocol Violation|4
7414771|NCT01436149|11687684|FG001|Randomized Phase|Protocol Violation|5
7414772|NCT01436149|11687685|FG002|Randomized Phase|Protocol Violation|0
7414773|NCT01436149|11687683|FG000|Randomized Phase|Withdrawal by Subject|16
7414774|NCT01436149|11687684|FG001|Randomized Phase|Withdrawal by Subject|10
7414775|NCT01436149|11687685|FG002|Randomized Phase|Withdrawal by Subject|10
7414776|NCT01436149|11687683|FG000|Randomized Phase|Lost to Follow-up|34
7414777|NCT01436149|11687684|FG001|Randomized Phase|Lost to Follow-up|5
7414778|NCT01436149|11687685|FG002|Randomized Phase|Lost to Follow-up|6
7414779|NCT01436149|11687683|FG000|Randomized Phase|Lack of Efficacy|0
7414780|NCT01436149|11687684|FG001|Randomized Phase|Lack of Efficacy|0
7414781|NCT01436149|11687685|FG002|Randomized Phase|Lack of Efficacy|1
7414782|NCT01436149|11687683|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7414783|NCT01436149|11687684|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7414784|NCT01436149|11687685|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
7414785|NCT01436149|11687683|FG000|Randomized Phase|Other|12
7414786|NCT01436149|11687684|FG001|Randomized Phase|Other|5
7414787|NCT01436149|11687685|FG002|Randomized Phase|Other|11
7414788|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Adverse Event|26
7414789|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Adverse Event|0
7414790|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Adverse Event|0
7414791|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Protocol Violation|24
7414792|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Protocol Violation|0
7414793|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Protocol Violation|0
7414794|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
7414795|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
7414796|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
7414797|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
7414798|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
7414799|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
7466389|NCT01890967|11766175|FG004|Overall Study|Withdrawal by Subject|3
7318757|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
7318758|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7318759|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7318760|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
7318761|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7318762|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
7318763|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Mis-randomized|0
7318764|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Mis-randomized|1
7318765|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Mis-randomized|0
7318766|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Mis-randomized|0
7318767|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Mis-randomized|0
7318768|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
7318769|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
7318770|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
7318771|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
7318772|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
7318773|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7318774|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7318775|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7318776|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
7318777|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
7318778|NCT00730405|11547943|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
7318779|NCT00730405|11547944|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
7318780|NCT00730405|11547945|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
7318781|NCT00730405|11547946|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
7318782|NCT00730405|11547947|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
7318783|NCT00730691|11547982|FG000|Overall Study|Adverse Event|4
7318784|NCT00730691|11547983|FG001|Overall Study|Adverse Event|8
7318785|NCT00730691|11547984|FG002|Overall Study|Adverse Event|11
7318786|NCT00730691|11547985|FG003|Overall Study|Adverse Event|11
7318787|NCT00730691|11547986|FG004|Overall Study|Adverse Event|23
7318788|NCT00730691|11547982|FG000|Overall Study|Lack of Efficacy|4
7318789|NCT00730691|11547983|FG001|Overall Study|Lack of Efficacy|4
7318790|NCT00730691|11547984|FG002|Overall Study|Lack of Efficacy|2
7318791|NCT00730691|11547985|FG003|Overall Study|Lack of Efficacy|1
7318792|NCT00730691|11547986|FG004|Overall Study|Lack of Efficacy|1
7318793|NCT00730691|11547982|FG000|Overall Study|Non-compliance with Study Drug|6
7318794|NCT00730691|11547983|FG001|Overall Study|Non-compliance with Study Drug|1
7318795|NCT00730691|11547984|FG002|Overall Study|Non-compliance with Study Drug|6
7318796|NCT00730691|11547985|FG003|Overall Study|Non-compliance with Study Drug|3
7318797|NCT00730691|11547986|FG004|Overall Study|Non-compliance with Study Drug|3
7318798|NCT00730691|11547982|FG000|Overall Study|Protocol Deviations|3
7318799|NCT00730691|11547983|FG001|Overall Study|Protocol Deviations|5
7318800|NCT00730691|11547984|FG002|Overall Study|Protocol Deviations|3
7318801|NCT00730691|11547985|FG003|Overall Study|Protocol Deviations|7
7318802|NCT00730691|11547986|FG004|Overall Study|Protocol Deviations|5
7318803|NCT00730691|11547982|FG000|Overall Study|Withdrawal of Consent|7
7318804|NCT00730691|11547983|FG001|Overall Study|Withdrawal of Consent|9
7318805|NCT00730691|11547984|FG002|Overall Study|Withdrawal of Consent|3
7318806|NCT00730691|11547985|FG003|Overall Study|Withdrawal of Consent|6
7318807|NCT00730691|11547986|FG004|Overall Study|Withdrawal of Consent|3
7318808|NCT00730691|11547982|FG000|Overall Study|Lost to Follow-up|11
7318809|NCT00730691|11547983|FG001|Overall Study|Lost to Follow-up|8
7318810|NCT00730691|11547984|FG002|Overall Study|Lost to Follow-up|13
7318811|NCT00730691|11547985|FG003|Overall Study|Lost to Follow-up|15
7318812|NCT00730691|11547986|FG004|Overall Study|Lost to Follow-up|13
7318813|NCT00730691|11547982|FG000|Overall Study|Other|1
7318814|NCT00730691|11547983|FG001|Overall Study|Other|1
7318815|NCT00730691|11547984|FG002|Overall Study|Other|1
7318816|NCT00730691|11547985|FG003|Overall Study|Other|2
7318817|NCT00730691|11547986|FG004|Overall Study|Other|2
7318818|NCT00730756|11548004|FG000|Overall Study|Adverse Event|2
7318819|NCT00730756|11548005|FG001|Overall Study|Adverse Event|0
7318820|NCT00730756|11548004|FG000|Overall Study|Lack of Efficacy|1
7318821|NCT00730756|11548005|FG001|Overall Study|Lack of Efficacy|1
7318822|NCT00730756|11548004|FG000|Overall Study|Protocol Deviation|1
7318823|NCT00730756|11548005|FG001|Overall Study|Protocol Deviation|2
7318824|NCT00730756|11548004|FG000|Overall Study|Lost to Follow-up|0
7318825|NCT00730756|11548005|FG001|Overall Study|Lost to Follow-up|1
7318826|NCT00730756|11548004|FG000|Overall Study|Withdrew Consent|0
7318827|NCT00730756|11548005|FG001|Overall Study|Withdrew Consent|1
7318828|NCT00730847|11548011|FG000|Overall Study|Adverse Event|1
7318829|NCT00730847|11548011|FG000|Overall Study|Protocol Violation|2
7318830|NCT00730847|11548011|FG000|Overall Study|Withdrawal by Subject|16
7318831|NCT00730847|11548011|FG000|Overall Study|Lost to Follow-up|67
7318832|NCT00730847|11548011|FG000|Overall Study|Unknown completion status|21
7318833|NCT00730847|11548011|FG000|Overall Study|Other|24
7318834|NCT00730912|11548018|FG000|Overall Study|Discontinued|0
7318835|NCT00730912|11548019|FG001|Overall Study|Discontinued|0
7553670|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
7553671|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
7553672|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
7553673|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
7553674|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
7553675|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
7553676|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
7553677|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
7553678|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
7553679|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
7553680|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
7553681|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
7553682|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
7553683|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
7553684|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
7318836|NCT00730912|11548020|FG002|Overall Study|Discontinued|1
7318837|NCT00730925|11548028|FG000|Overall Study|Progressive Disease|21
7318838|NCT00730925|11548028|FG000|Overall Study|Dose reducing Event|2
7318839|NCT00730925|11548028|FG000|Overall Study|Other Averse Event|7
7318840|NCT00730925|11548028|FG000|Overall Study|Protocol Violation|1
7318841|NCT00730925|11548028|FG000|Overall Study|Withdrawal by Subject|1
7318842|NCT00730925|11548028|FG000|Overall Study|Switch to combination therapy|8
7318843|NCT00730925|11548028|FG000|Overall Study|Other|1
7318844|NCT00731042|11548039|FG000|Second Intervention|Did not meet inclusion criteria|0
7318845|NCT00731042|11548040|FG001|Second Intervention|Did not meet inclusion criteria|2
7318846|NCT00731120|11548065|FG000|Overall Study|Adverse Event|7
7318847|NCT00731120|11548066|FG001|Overall Study|Adverse Event|6
7318848|NCT00731120|11548067|FG002|Overall Study|Adverse Event|8
7318849|NCT00731120|11548065|FG000|Overall Study|Lack of Efficacy|4
7318850|NCT00731120|11548066|FG001|Overall Study|Lack of Efficacy|5
7318851|NCT00731120|11548067|FG002|Overall Study|Lack of Efficacy|4
7318852|NCT00731120|11548065|FG000|Overall Study|Noncompliance with Study Drug|3
7318853|NCT00731120|11548066|FG001|Overall Study|Noncompliance with Study Drug|3
7318854|NCT00731120|11548067|FG002|Overall Study|Noncompliance with Study Drug|1
7318855|NCT00731120|11548065|FG000|Overall Study|Protocol Deviations|1
7318856|NCT00731120|11548066|FG001|Overall Study|Protocol Deviations|6
7318857|NCT00731120|11548067|FG002|Overall Study|Protocol Deviations|1
7318858|NCT00731120|11548065|FG000|Overall Study|Withdrawal of Consent|13
7318859|NCT00731120|11548066|FG001|Overall Study|Withdrawal of Consent|8
7318860|NCT00731120|11548067|FG002|Overall Study|Withdrawal of Consent|4
7318861|NCT00731120|11548065|FG000|Overall Study|Lost to Follow-up|10
7414800|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
7414801|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414802|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
7414803|NCT01436162|11687693|FG000|Single-blind Lead-in Phase|Other|107
7414804|NCT01436162|11687694|FG001|Single-blind Lead-in Phase|Other|0
7414805|NCT01436162|11687695|FG002|Single-blind Lead-in Phase|Other|0
7414806|NCT01436162|11687693|FG000|Randomized Phase|Adverse Event|1
7414807|NCT01436162|11687694|FG001|Randomized Phase|Adverse Event|5
7414808|NCT01436162|11687695|FG002|Randomized Phase|Adverse Event|6
7414809|NCT01436162|11687693|FG000|Randomized Phase|Protocol Violation|4
7414810|NCT01436162|11687694|FG001|Randomized Phase|Protocol Violation|4
7414811|NCT01436162|11687695|FG002|Randomized Phase|Protocol Violation|2
7414812|NCT01436162|11687693|FG000|Randomized Phase|Withdrawal by Subject|16
7414813|NCT01436162|11687694|FG001|Randomized Phase|Withdrawal by Subject|9
7414814|NCT01436162|11687695|FG002|Randomized Phase|Withdrawal by Subject|8
7414815|NCT01436162|11687693|FG000|Randomized Phase|Lost to Follow-up|17
7414816|NCT01436162|11687694|FG001|Randomized Phase|Lost to Follow-up|5
7414817|NCT01436162|11687695|FG002|Randomized Phase|Lost to Follow-up|4
7414818|NCT01436162|11687693|FG000|Randomized Phase|Lack of Efficacy|0
7414819|NCT01436162|11687694|FG001|Randomized Phase|Lack of Efficacy|1
7414820|NCT01436162|11687695|FG002|Randomized Phase|Lack of Efficacy|1
7414821|NCT01436162|11687693|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
7414822|NCT01436162|11687694|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
7414823|NCT01436162|11687695|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
7414824|NCT01436162|11687693|FG000|Randomized Phase|Other|2
7414825|NCT01436162|11687694|FG001|Randomized Phase|Other|5
7414826|NCT01436162|11687695|FG002|Randomized Phase|Other|4
7414827|NCT01436175|11687703|FG000|Overall Study|Adverse Event|111
7414828|NCT01436175|11687703|FG000|Overall Study|Protocol Violation|49
7414829|NCT01436175|11687703|FG000|Overall Study|Withdrawal by Subject|108
7414830|NCT01436175|11687703|FG000|Overall Study|Lost to Follow-up|89
7414831|NCT01436175|11687703|FG000|Overall Study|Lack of Efficacy|24
7414832|NCT01436175|11687703|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
7414833|NCT01436175|11687703|FG000|Overall Study|Other|826
7553685|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
7318862|NCT00731120|11548066|FG001|Overall Study|Lost to Follow-up|15
7318863|NCT00731120|11548067|FG002|Overall Study|Lost to Follow-up|17
7318864|NCT00731120|11548065|FG000|Overall Study|Other|4
7318865|NCT00731120|11548066|FG001|Overall Study|Other|0
7318866|NCT00731120|11548067|FG002|Overall Study|Other|1
7318867|NCT00731133|11548075|FG000|Overall Study|Withdrawal by Subject|10
7318868|NCT00731549|11548100|FG000|Overall Study|Lost to Follow-up|19
7530394|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
7318869|NCT00731549|11548100|FG000|Overall Study|Met withdrawal criteria|24
7318870|NCT00731549|11548100|FG000|Overall Study|Physician Decision|16
7318871|NCT00731549|11548100|FG000|Overall Study|Withdrawal by Subject|89
7318872|NCT00731549|11548100|FG000|Overall Study|Protocol deviation|1
7318873|NCT00731549|11548100|FG000|Overall Study|Adverse Event|31
7318874|NCT00731549|11548100|FG000|Overall Study|Lack of efficacy with AE|37
7318875|NCT00731549|11548100|FG000|Overall Study|Lack of efficacy without AE|6
7318876|NCT00731666|11548136|FG000|Overall Study|Adverse Event|2
7318877|NCT00731666|11548136|FG000|Overall Study|Lost to Follow-up|8
7318878|NCT00731666|11548136|FG000|Overall Study|Withdrawal by Subject|2
7318879|NCT00731679|11548142|FG000|Overall Study|Adverse Event|7
7318880|NCT00731679|11548143|FG001|Overall Study|Adverse Event|8
7318881|NCT00731679|11548142|FG000|Overall Study|Withdrawal by Subject|8
7318882|NCT00731679|11548143|FG001|Overall Study|Withdrawal by Subject|8
7318883|NCT00731679|11548142|FG000|Overall Study|Lost to Follow-up|7
7318884|NCT00731679|11548143|FG001|Overall Study|Lost to Follow-up|8
7318885|NCT00731679|11548142|FG000|Overall Study|Noncompliance|0
7318886|NCT00731679|11548143|FG001|Overall Study|Noncompliance|1
7318887|NCT00731679|11548142|FG000|Overall Study|Pregnancy|0
7318888|NCT00731679|11548143|FG001|Overall Study|Pregnancy|1
7318889|NCT00731692|11548152|FG000|Core Study (36 Months)|Lack of Efficacy|11
7318890|NCT00731692|11548153|FG001|Core Study (36 Months)|Lack of Efficacy|23
7318891|NCT00731692|11548154|FG002|Core Study (36 Months)|Lack of Efficacy|64
7318892|NCT00731692|11548152|FG000|Core Study (36 Months)|Physician Decision|1
7318893|NCT00731692|11548153|FG001|Core Study (36 Months)|Physician Decision|0
7318894|NCT00731692|11548154|FG002|Core Study (36 Months)|Physician Decision|2
7318895|NCT00731692|11548152|FG000|Core Study (36 Months)|Death|2
7318896|NCT00731692|11548153|FG001|Core Study (36 Months)|Death|1
7318897|NCT00731692|11548154|FG002|Core Study (36 Months)|Death|2
7318898|NCT00731692|11548152|FG000|Core Study (36 Months)|Lost to Follow-up|1
7318899|NCT00731692|11548153|FG001|Core Study (36 Months)|Lost to Follow-up|3
7318900|NCT00731692|11548154|FG002|Core Study (36 Months)|Lost to Follow-up|3
7318901|NCT00731692|11548152|FG000|Core Study (36 Months)|Administrative|2
7318902|NCT00731692|11548153|FG001|Core Study (36 Months)|Administrative|2
7318903|NCT00731692|11548154|FG002|Core Study (36 Months)|Administrative|6
7318904|NCT00731692|11548152|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
7318905|NCT00731692|11548153|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
7318906|NCT00731692|11548154|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
7318907|NCT00731692|11548152|FG000|Core Study (36 Months)|Protocol Violation|4
7318908|NCT00731692|11548153|FG001|Core Study (36 Months)|Protocol Violation|5
7318909|NCT00731692|11548154|FG002|Core Study (36 Months)|Protocol Violation|8
7318910|NCT00731692|11548152|FG000|Core Study (36 Months)|Abnormal Lab values|6
7318911|NCT00731692|11548153|FG001|Core Study (36 Months)|Abnormal Lab values|19
7318912|NCT00731692|11548154|FG002|Core Study (36 Months)|Abnormal Lab values|5
7318913|NCT00731692|11548152|FG000|Core Study (36 Months)|Adverse Event|25
7318914|NCT00731692|11548153|FG001|Core Study (36 Months)|Adverse Event|28
7318915|NCT00731692|11548154|FG002|Core Study (36 Months)|Adverse Event|29
7318916|NCT00731692|11548152|FG000|Core Study (36 Months)|Withdrawal by Subject|12
7318917|NCT00731692|11548153|FG001|Core Study (36 Months)|Withdrawal by Subject|32
7318918|NCT00731692|11548154|FG002|Core Study (36 Months)|Withdrawal by Subject|46
7318919|NCT00731692|11548152|FG000|Extension Phase|Admin Problems: Terminated # patients|69
7318920|NCT00731692|11548153|FG001|Extension Phase|Admin Problems: Terminated # patients|189
7318921|NCT00731692|11548154|FG002|Extension Phase|Admin Problems: Terminated # patients|277
7318922|NCT00731692|11548152|FG000|Extension Phase|Abnormal test procedure|0
7318923|NCT00731692|11548153|FG001|Extension Phase|Abnormal test procedure|0
7318924|NCT00731692|11548154|FG002|Extension Phase|Abnormal test procedure|1
7318925|NCT00731692|11548152|FG000|Extension Phase|Abnormal lab values|0
7318926|NCT00731692|11548153|FG001|Extension Phase|Abnormal lab values|0
7318927|NCT00731692|11548154|FG002|Extension Phase|Abnormal lab values|1
7318928|NCT00731692|11548152|FG000|Extension Phase|Lost to Follow-up|0
7318929|NCT00731692|11548153|FG001|Extension Phase|Lost to Follow-up|1
7318930|NCT00731692|11548154|FG002|Extension Phase|Lost to Follow-up|4
7318931|NCT00731692|11548152|FG000|Extension Phase|Withdrawal by Subject|4
7318932|NCT00731692|11548153|FG001|Extension Phase|Withdrawal by Subject|5
7318933|NCT00731692|11548154|FG002|Extension Phase|Withdrawal by Subject|3
7318934|NCT00731692|11548152|FG000|Extension Phase|Adverse Event|1
7530395|NCT02637856|11874137|FG000|Main Study (Baseline to Week 100)|Site Closing|6
7318935|NCT00731692|11548153|FG001|Extension Phase|Adverse Event|1
7318936|NCT00731692|11548154|FG002|Extension Phase|Adverse Event|15
7318937|NCT00731783|11548172|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
7318938|NCT00731783|11548173|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
7318939|NCT00731783|11548172|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
7318940|NCT00731783|11548173|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
7318941|NCT00731783|11548172|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
7318942|NCT00731783|11548173|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
7318943|NCT00731783|11548172|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
7318944|NCT00731783|11548173|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
7318945|NCT00731822|11548181|FG000|Overall Study|Adverse Event|2
7530396|NCT02637856|11874138|FG001|Main Study (Baseline to Week 100)|Site Closing|0
7318946|NCT00731822|11548182|FG001|Overall Study|Adverse Event|1
7318947|NCT00731822|11548181|FG000|Overall Study|Protocol Violation|1
7318948|NCT00731822|11548182|FG001|Overall Study|Protocol Violation|0
7318949|NCT00731822|11548181|FG000|Overall Study|Lost to Follow-up|1
7318950|NCT00731822|11548182|FG001|Overall Study|Lost to Follow-up|0
7318951|NCT00731939|11548197|FG000|Overall Study|Adverse Event|6
7318952|NCT00731939|11548197|FG000|Overall Study|Lost to Follow-up|15
7318953|NCT00731939|11548197|FG000|Overall Study|Not implanted with study device|9
7318954|NCT00731939|11548197|FG000|Overall Study|Withdrawal by Subject|2
7318955|NCT00731939|11548197|FG000|Overall Study|Did not meet enrollment criteria|2
7318956|NCT00732069|11548205|FG000|Washout After First Study Drug|Adverse Event|1
7318957|NCT00732069|11548206|FG001|Washout After First Study Drug|Adverse Event|0
7318958|NCT00732069|11548207|FG002|Washout After First Study Drug|Adverse Event|0
7318959|NCT00732069|11548208|FG003|Washout After First Study Drug|Adverse Event|0
7318960|NCT00732069|11548209|FG004|Washout After First Study Drug|Adverse Event|0
7318961|NCT00732069|11548210|FG005|Washout After First Study Drug|Adverse Event|0
7318962|NCT00732160|11548222|FG000|Overall Study|Adverse Event|1
7318963|NCT00732160|11548223|FG001|Overall Study|Adverse Event|0
7318964|NCT00732160|11548224|FG002|Overall Study|Adverse Event|1
7318965|NCT00732160|11548225|FG003|Overall Study|Adverse Event|1
7318966|NCT00732160|11548222|FG000|Overall Study|scheduling|4
7318967|NCT00732160|11548223|FG001|Overall Study|scheduling|4
7318968|NCT00732160|11548224|FG002|Overall Study|scheduling|2
7318969|NCT00732160|11548225|FG003|Overall Study|scheduling|1
7318970|NCT00732199|11548237|FG000|Overall Study|Withdrawal by Subject|25
7318971|NCT00732199|11548238|FG001|Overall Study|Withdrawal by Subject|18
7318972|NCT00732199|11548237|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
7318973|NCT00732199|11548238|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
7318974|NCT00732238|11548270|FG000|Overall Study|Bacteremia|4
7318975|NCT00732238|11548271|FG001|Overall Study|Bacteremia|1
7318976|NCT00732238|11548270|FG000|Overall Study|Asymptomatic bacteriuria|1
7318977|NCT00732238|11548271|FG001|Overall Study|Asymptomatic bacteriuria|0
7318978|NCT00732251|11548279|FG000|Overall Study|Lost to Follow-up|3
7318979|NCT00732251|11548279|FG000|Overall Study|Withdrawal by Subject|3
7318980|NCT00732251|11548279|FG000|Overall Study|Early Term due to Site Closure|1
7318981|NCT00732303|11548283|FG000|Overall Study|Study Terminated|2
7318982|NCT00732472|11548291|FG000|Overall Study|Adverse Event|0
7318983|NCT00732472|11548292|FG001|Overall Study|Adverse Event|1
7318984|NCT00732472|11548293|FG002|Overall Study|Adverse Event|1
7318985|NCT00732472|11548294|FG003|Overall Study|Adverse Event|1
7318986|NCT00732472|11548291|FG000|Overall Study|Protocol Violation|0
7318987|NCT00732472|11548292|FG001|Overall Study|Protocol Violation|0
7318988|NCT00732472|11548293|FG002|Overall Study|Protocol Violation|0
7318989|NCT00732472|11548294|FG003|Overall Study|Protocol Violation|1
7318990|NCT00732472|11548291|FG000|Overall Study|Withdrawal by Subject|0
7318991|NCT00732472|11548292|FG001|Overall Study|Withdrawal by Subject|2
7318992|NCT00732472|11548293|FG002|Overall Study|Withdrawal by Subject|0
7318993|NCT00732472|11548294|FG003|Overall Study|Withdrawal by Subject|1
7318994|NCT00732498|11548305|FG000|Overall Study|Ineligible|1
7318995|NCT00732498|11548305|FG000|Overall Study|Adverse Event|2
7318996|NCT00732498|11548305|FG000|Overall Study|Physician Decision|3
7318997|NCT00732615|11548311|FG000|Overall Study|Withdrawal by Subject|3
7318998|NCT00732615|11548312|FG001|Overall Study|Withdrawal by Subject|1
7318999|NCT00732615|11548311|FG000|Overall Study|Lost to Follow-up|0
7319000|NCT00732615|11548312|FG001|Overall Study|Lost to Follow-up|1
7319001|NCT00732615|11548311|FG000|Overall Study|Adverse Event|0
7319002|NCT00732615|11548312|FG001|Overall Study|Adverse Event|2
7319003|NCT00732615|11548311|FG000|Overall Study|Physician Decision|3
7319004|NCT00732615|11548312|FG001|Overall Study|Physician Decision|0
7319005|NCT00732615|11548311|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7319006|NCT00732615|11548312|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
7319007|NCT00732641|11548321|FG000|Overall Study|Relapse or Progressive Disease|65
7319008|NCT00732641|11548322|FG001|Overall Study|Relapse or Progressive Disease|101
7319009|NCT00732641|11548321|FG000|Overall Study|Serious Adverse Events|12
7319010|NCT00732641|11548322|FG001|Overall Study|Serious Adverse Events|3
7319011|NCT00732641|11548321|FG000|Overall Study|Physician Decision|6
7319012|NCT00732641|11548322|FG001|Overall Study|Physician Decision|0
7319013|NCT00732641|11548321|FG000|Overall Study|Withdrawal by Subject|4
7319014|NCT00732641|11548322|FG001|Overall Study|Withdrawal by Subject|2
7319015|NCT00732641|11548321|FG000|Overall Study|Unable to Complete|1
7319016|NCT00732641|11548322|FG001|Overall Study|Unable to Complete|1
7319017|NCT00732641|11548321|FG000|Overall Study|Other|18
7319018|NCT00732641|11548322|FG001|Overall Study|Other|5
7319019|NCT00732758|11548343|FG000|Overall Study|Lost to Follow-up|8
7319020|NCT00732758|11548344|FG001|Overall Study|Lost to Follow-up|16
7319021|NCT00732875|11548350|FG000|Overall Study|Adverse Event|16
7319022|NCT00732875|11548350|FG000|Overall Study|Withdrawal by Subject|6
7319023|NCT00732875|11548350|FG000|Overall Study|Lack of Efficacy|13
7319024|NCT00732940|11548365|FG000|Overall Study|Withdrawal by Subject|1
7319025|NCT00732940|11548366|FG001|Overall Study|Withdrawal by Subject|2
7319026|NCT00732940|11548365|FG000|Overall Study|Adverse Event|0
7319027|NCT00732940|11548366|FG001|Overall Study|Adverse Event|1
7319028|NCT00732940|11548365|FG000|Overall Study|Lost to Follow-up|1
7319029|NCT00732940|11548366|FG001|Overall Study|Lost to Follow-up|0
7319030|NCT00732992|11548374|FG000|Overall Study|Adverse Event|1
7319031|NCT00732992|11548375|FG001|Overall Study|Adverse Event|1
7319032|NCT00732992|11548374|FG000|Overall Study|Objective Progression or Relapse|3
7319033|NCT00732992|11548375|FG001|Overall Study|Objective Progression or Relapse|5
7319034|NCT00732992|11548374|FG000|Overall Study|Global Deterioration of Health Status|1
7319035|NCT00732992|11548375|FG001|Overall Study|Global Deterioration of Health Status|0
7553686|NCT03016325|11914570|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
7553687|NCT03016325|11914571|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
7553688|NCT03016325|11914572|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
7553689|NCT03016325|11914573|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
7553690|NCT03016325|11914574|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
7319036|NCT00732992|11548374|FG000|Overall Study|Withdrawal by Subject|1
7319037|NCT00732992|11548375|FG001|Overall Study|Withdrawal by Subject|0
7319038|NCT00733226|11548403|FG000|Overall Study|Withdrawal by Subject|1
7319039|NCT00733226|11548404|FG001|Overall Study|Withdrawal by Subject|0
7319040|NCT00733226|11548403|FG000|Overall Study|Lost to Follow-up|2
7319041|NCT00733226|11548404|FG001|Overall Study|Lost to Follow-up|0
7319042|NCT00733226|11548403|FG000|Overall Study|moved to another place|2
7319043|NCT00733226|11548404|FG001|Overall Study|moved to another place|0
7384619|NCT01195662|11641825|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7384620|NCT01195662|11641826|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7384621|NCT01195662|11641824|FG000|Double Blind Treatment Period|Non-specified|3
7384622|NCT01195662|11641825|FG001|Double Blind Treatment Period|Non-specified|0
7384623|NCT01195662|11641826|FG002|Double Blind Treatment Period|Non-specified|0
7384624|NCT01195662|11641824|FG000|Double Blind Treatment Period|Missing disposition information|0
7384625|NCT01195662|11641825|FG001|Double Blind Treatment Period|Missing disposition information|1
7384626|NCT01195662|11641826|FG002|Double Blind Treatment Period|Missing disposition information|1
7384627|NCT01195662|11641824|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
7384628|NCT01195662|11641825|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
7384629|NCT01195662|11641826|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
7384630|NCT01195662|11641824|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
7384631|NCT01195662|11641825|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7530397|NCT02637856|11874137|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
7530398|NCT02637856|11874138|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
7384632|NCT01195662|11641826|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
7384633|NCT01195675|11641835|FG000|Overall Study|Adverse Event|1
7384634|NCT01195675|11641835|FG000|Overall Study|Withdrawal by Subject|2
7387530|NCT01214837|11646075|FG002|Overall Study|Administrative Reason|4
7387531|NCT01214837|11646073|FG000|Overall Study|Protocol Violation|3
7387532|NCT01214837|11646074|FG001|Overall Study|Protocol Violation|1
7387533|NCT01214837|11646075|FG002|Overall Study|Protocol Violation|5
7387534|NCT01214837|11646073|FG000|Overall Study|Unable to Classify|1
7387535|NCT01214837|11646074|FG001|Overall Study|Unable to Classify|3
7387536|NCT01214837|11646075|FG002|Overall Study|Unable to Classify|0
7387537|NCT01214850|11646087|FG000|Overall Study|Withdrawal by Subject|38
7387538|NCT01214850|11646088|FG001|Overall Study|Withdrawal by Subject|31
7387539|NCT01214850|11646089|FG002|Overall Study|Withdrawal by Subject|28
7387540|NCT01214850|11646087|FG000|Overall Study|Lost to Follow-up|124
7387541|NCT01214850|11646088|FG001|Overall Study|Lost to Follow-up|98
7387542|NCT01214850|11646089|FG002|Overall Study|Lost to Follow-up|123
7387543|NCT01214850|11646087|FG000|Overall Study|Protocol Violation|5
7387544|NCT01214850|11646088|FG001|Overall Study|Protocol Violation|5
7387545|NCT01214850|11646089|FG002|Overall Study|Protocol Violation|6
7387546|NCT01214850|11646087|FG000|Overall Study|Adverse event or death|11
7387547|NCT01214850|11646088|FG001|Overall Study|Adverse event or death|8
7387548|NCT01214850|11646089|FG002|Overall Study|Adverse event or death|3
7387549|NCT01214850|11646087|FG000|Overall Study|Inappropriate enrollment|2
7387550|NCT01214850|11646088|FG001|Overall Study|Inappropriate enrollment|1
7387551|NCT01214850|11646089|FG002|Overall Study|Inappropriate enrollment|0
7387552|NCT01214850|11646087|FG000|Overall Study|Administrative reason|1
7387553|NCT01214850|11646088|FG001|Overall Study|Administrative reason|0
7387554|NCT01214850|11646089|FG002|Overall Study|Administrative reason|0
7387555|NCT01214850|11646087|FG000|Overall Study|Unable to classify|2
7387556|NCT01214850|11646088|FG001|Overall Study|Unable to classify|1
7387557|NCT01214850|11646089|FG002|Overall Study|Unable to classify|1
7387558|NCT01214915|11646100|FG000|Overall Study|Adverse Event|8
7387559|NCT01214915|11646100|FG000|Overall Study|Lack of Efficacy|3
7387560|NCT01215032|11646113|FG000|Overall Study|Adverse Event|3
7387561|NCT01215032|11646113|FG000|Overall Study|Lack of Efficacy|17
7387562|NCT01215097|11646121|FG000|Overall Study|Adverse Event|1
7387563|NCT01215097|11646122|FG001|Overall Study|Adverse Event|3
7387564|NCT01215097|11646121|FG000|Overall Study|Protocol Violation|0
7530399|NCT02637856|11874137|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
7530400|NCT02637856|11874138|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
7530401|NCT02637895|11874146|FG000|Overall Study|Lost to Follow-up|4
7387565|NCT01215097|11646122|FG001|Overall Study|Protocol Violation|2
7530402|NCT02637895|11874147|FG001|Overall Study|Lost to Follow-up|0
7387566|NCT01215097|11646121|FG000|Overall Study|Lost to Follow-up|2
7319044|NCT00733291|11548417|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
7319045|NCT00733291|11548418|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7319046|NCT00733291|11548419|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7319047|NCT00733291|11548420|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
7319048|NCT00733304|11548434|FG000|Overall Study|Adverse Event|3
7319049|NCT00733304|11548435|FG001|Overall Study|Adverse Event|0
7319050|NCT00733304|11548436|FG002|Overall Study|Adverse Event|0
7319051|NCT00733304|11548434|FG000|Overall Study|Lack of Efficacy|0
7319052|NCT00733304|11548435|FG001|Overall Study|Lack of Efficacy|0
7319053|NCT00733304|11548436|FG002|Overall Study|Lack of Efficacy|2
7319054|NCT00733304|11548434|FG000|Overall Study|Lost to Follow-up|0
7319055|NCT00733304|11548435|FG001|Overall Study|Lost to Follow-up|1
7319056|NCT00733304|11548436|FG002|Overall Study|Lost to Follow-up|0
7319057|NCT00733304|11548434|FG000|Overall Study|Physician Decision|3
7319058|NCT00733304|11548435|FG001|Overall Study|Physician Decision|1
7319059|NCT00733304|11548436|FG002|Overall Study|Physician Decision|3
7530403|NCT02637895|11874146|FG000|Overall Study|Protocol Violation|0
7530404|NCT02637895|11874147|FG001|Overall Study|Protocol Violation|1
7530405|NCT02637895|11874146|FG000|Overall Study|Lack of Efficacy|1
7530406|NCT02637895|11874147|FG001|Overall Study|Lack of Efficacy|0
7530407|NCT02637895|11874146|FG000|Overall Study|Withdrawal by Subject|1
7530408|NCT02637895|11874147|FG001|Overall Study|Withdrawal by Subject|1
7530409|NCT02637895|11874146|FG000|Overall Study|Abnormal baseline lab|0
7530410|NCT02637895|11874147|FG001|Overall Study|Abnormal baseline lab|1
7553691|NCT03016325|11914575|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
7553692|NCT03016325|11914576|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
7319060|NCT00733304|11548434|FG000|Overall Study|Withdrawal by Subject|1
7319061|NCT00733304|11548435|FG001|Overall Study|Withdrawal by Subject|1
7319062|NCT00733304|11548436|FG002|Overall Study|Withdrawal by Subject|0
7319063|NCT00733369|11548471|FG000|Overall Study|Lost to Follow-up|2
7319064|NCT00733369|11548472|FG001|Overall Study|Lost to Follow-up|1
7319065|NCT00733369|11548471|FG000|Overall Study|Adverse Event|4
7319066|NCT00733369|11548472|FG001|Overall Study|Adverse Event|4
7319067|NCT00733369|11548471|FG000|Overall Study|Protocol Violation|4
7319068|NCT00733369|11548472|FG001|Overall Study|Protocol Violation|4
7319069|NCT00733408|11548478|FG000|Overall Study|Adverse Event|4
7319070|NCT00733421|11548484|FG000|Overall Study|Withdrawal by Subject|1
7319071|NCT00733421|11548485|FG001|Overall Study|Withdrawal by Subject|1
7319072|NCT00733499|11548493|FG000|Pre-operative|Protocol Violation|0
7319073|NCT00733499|11548494|FG001|Pre-operative|Protocol Violation|1
7319074|NCT00733499|11548493|FG000|3 Months Follow-up|Death|1
7319075|NCT00733499|11548494|FG001|3 Months Follow-up|Death|2
7319076|NCT00733499|11548493|FG000|6 Months Follow-up|Death|0
7319077|NCT00733499|11548494|FG001|6 Months Follow-up|Death|2
7319078|NCT00733499|11548493|FG000|6 Months Follow-up|Adverse Event|0
7319079|NCT00733499|11548494|FG001|6 Months Follow-up|Adverse Event|1
7319080|NCT00733499|11548493|FG000|12 Months Follow-up|Death|2
7319081|NCT00733499|11548494|FG001|12 Months Follow-up|Death|1
7319082|NCT00733499|11548493|FG000|24 Months Follow-up|Death|0
7319083|NCT00733499|11548494|FG001|24 Months Follow-up|Death|1
7319084|NCT00733499|11548493|FG000|5 Year Followup|Adverse Event|2
7319085|NCT00733499|11548494|FG001|5 Year Followup|Adverse Event|2
7319086|NCT00733499|11548493|FG000|5 Year Followup|Non device related AE|0
7319087|NCT00733499|11548494|FG001|5 Year Followup|Non device related AE|1
7319088|NCT00733499|11548493|FG000|5 Year Followup|Revision of Study Implant|0
7319089|NCT00733499|11548494|FG001|5 Year Followup|Revision of Study Implant|1
7319090|NCT00733499|11548493|FG000|5 Year Followup|Lost to Follow-up|2
7319091|NCT00733499|11548494|FG001|5 Year Followup|Lost to Follow-up|0
7319092|NCT00733499|11548493|FG000|5 Year Followup|Death|13
7319093|NCT00733499|11548494|FG001|5 Year Followup|Death|19
7319094|NCT00733499|11548493|FG000|5 Year Followup|missing, unable to locate|0
7319095|NCT00733499|11548494|FG001|5 Year Followup|missing, unable to locate|1
7319096|NCT00733499|11548493|FG000|5 Year Followup|Withdrawal by Subject|4
7319097|NCT00733499|11548494|FG001|5 Year Followup|Withdrawal by Subject|1
7319098|NCT00733499|11548493|FG000|10 Year Followup|Death|9
7319099|NCT00733499|11548494|FG001|10 Year Followup|Death|7
7319100|NCT00733499|11548493|FG000|10 Year Followup|Adverse Event|3
7319101|NCT00733499|11548494|FG001|10 Year Followup|Adverse Event|3
7319102|NCT00733499|11548493|FG000|10 Year Followup|Lost to Follow-up|3
7319103|NCT00733499|11548494|FG001|10 Year Followup|Lost to Follow-up|2
7319104|NCT00733499|11548493|FG000|10 Year Followup|Withdrawal by Subject|5
7319105|NCT00733499|11548494|FG001|10 Year Followup|Withdrawal by Subject|5
7319106|NCT00733499|11548493|FG000|10 Year Followup|missing, unable to locate|0
7319107|NCT00733499|11548494|FG001|10 Year Followup|missing, unable to locate|2
7319108|NCT00733746|11548504|FG000|Overall Study|Ineligible|5
7319109|NCT00733824|11548513|FG000|Phase I|Withdrawal by Subject|1
7319110|NCT00733824|11548514|FG001|Phase I|Withdrawal by Subject|0
7319111|NCT00733824|11548515|FG002|Phase I|Withdrawal by Subject|0
7319112|NCT00733824|11548516|FG003|Phase I|Withdrawal by Subject|0
7319113|NCT00733824|11548517|FG004|Phase I|Withdrawal by Subject|0
7319114|NCT00733902|11548535|FG000|Overall Study|Death|0
7319115|NCT00733902|11548536|FG001|Overall Study|Death|0
7530411|NCT02638012|11874167|FG000|Overall Study|Lost to Follow-up|1
7530412|NCT02638103|11874184|FG000|Overall Study|Adverse Event|13
7319116|NCT00733902|11548537|FG002|Overall Study|Death|0
7319117|NCT00733902|11548538|FG003|Overall Study|Death|1
7319118|NCT00733902|11548535|FG000|Overall Study|Adverse Event|3
7319119|NCT00733902|11548536|FG001|Overall Study|Adverse Event|4
7319120|NCT00733902|11548537|FG002|Overall Study|Adverse Event|7
7319121|NCT00733902|11548538|FG003|Overall Study|Adverse Event|11
7319122|NCT00733902|11548535|FG000|Overall Study|Lack of Efficacy|56
7319123|NCT00733902|11548536|FG001|Overall Study|Lack of Efficacy|21
7319124|NCT00733902|11548537|FG002|Overall Study|Lack of Efficacy|34
7319125|NCT00733902|11548538|FG003|Overall Study|Lack of Efficacy|23
7319126|NCT00733902|11548535|FG000|Overall Study|Protocol Violation|4
7319127|NCT00733902|11548536|FG001|Overall Study|Protocol Violation|6
7319128|NCT00733902|11548537|FG002|Overall Study|Protocol Violation|3
7319129|NCT00733902|11548538|FG003|Overall Study|Protocol Violation|3
7319130|NCT00733902|11548535|FG000|Overall Study|Withdrawal by Subject|10
7319131|NCT00733902|11548536|FG001|Overall Study|Withdrawal by Subject|5
7319132|NCT00733902|11548537|FG002|Overall Study|Withdrawal by Subject|4
7319133|NCT00733902|11548538|FG003|Overall Study|Withdrawal by Subject|16
7319134|NCT00733902|11548535|FG000|Overall Study|Entered extension study|89
7319135|NCT00733902|11548536|FG001|Overall Study|Entered extension study|124
7319136|NCT00733902|11548537|FG002|Overall Study|Entered extension study|111
7319137|NCT00733902|11548538|FG003|Overall Study|Entered extension study|109
7319138|NCT00733902|11548535|FG000|Overall Study|Randomized but not treated|2
7319139|NCT00733902|11548536|FG001|Overall Study|Randomized but not treated|2
7319140|NCT00733902|11548537|FG002|Overall Study|Randomized but not treated|2
7319141|NCT00733902|11548538|FG003|Overall Study|Randomized but not treated|1
7319148|NCT00733980|11548559|FG000|Overall Study|Adverse Event|5
7319149|NCT00733980|11548560|FG001|Overall Study|Adverse Event|2
7319150|NCT00733980|11548559|FG000|Overall Study|Lack of Efficacy|0
7319151|NCT00733980|11548560|FG001|Overall Study|Lack of Efficacy|1
7319152|NCT00733980|11548559|FG000|Overall Study|Protocol Violation|2
7319153|NCT00733980|11548560|FG001|Overall Study|Protocol Violation|1
7319154|NCT00733980|11548559|FG000|Overall Study|Protocol defined stopping criteria reach|1
7319155|NCT00733980|11548560|FG001|Overall Study|Protocol defined stopping criteria reach|1
7319156|NCT00733980|11548559|FG000|Overall Study|Lost to Follow-up|6
7319157|NCT00733980|11548560|FG001|Overall Study|Lost to Follow-up|11
7319158|NCT00733980|11548559|FG000|Overall Study|Physician Decision|2
7319159|NCT00733980|11548560|FG001|Overall Study|Physician Decision|3
7319160|NCT00733980|11548559|FG000|Overall Study|Withdrawal by Subject|6
7530413|NCT02638103|11874185|FG001|Overall Study|Adverse Event|12
7530414|NCT02638103|11874186|FG002|Overall Study|Adverse Event|19
7530415|NCT02638103|11874187|FG003|Overall Study|Adverse Event|12
7530416|NCT02638103|11874184|FG000|Overall Study|Withdrawal by Subject|43
7530417|NCT02638103|11874185|FG001|Overall Study|Withdrawal by Subject|53
7530418|NCT02638103|11874186|FG002|Overall Study|Withdrawal by Subject|30
7319161|NCT00733980|11548560|FG001|Overall Study|Withdrawal by Subject|2
7319162|NCT00734032|11548585|FG000|Overall Study|Adverse Event|0
7319163|NCT00734032|11548586|FG001|Overall Study|Adverse Event|1
7319164|NCT00734032|11548587|FG002|Overall Study|Adverse Event|0
7319165|NCT00734032|11548588|FG003|Overall Study|Adverse Event|0
7319166|NCT00734071|11548600|FG000|Overall Study|Adverse Event|4
7319167|NCT00734071|11548601|FG001|Overall Study|Adverse Event|3
7319168|NCT00734071|11548600|FG000|Overall Study|Lack of Efficacy|3
7319169|NCT00734071|11548601|FG001|Overall Study|Lack of Efficacy|1
7319170|NCT00734071|11548600|FG000|Overall Study|Noncompliance|2
7319171|NCT00734071|11548601|FG001|Overall Study|Noncompliance|2
7319172|NCT00734071|11548600|FG000|Overall Study|Protocol Deviations|3
7319173|NCT00734071|11548601|FG001|Overall Study|Protocol Deviations|4
7414834|NCT01436201|11687708|FG000|Overall Study|Adverse Event|2
7414835|NCT01436201|11687708|FG000|Overall Study|Withdrawal by Subject|1
7414836|NCT01436201|11687708|FG000|Overall Study|Protocol Violation|1
7414837|NCT01436305|11687737|FG000|Overall Study|Death|1
7414838|NCT01436305|11687738|FG001|Overall Study|Death|0
7414839|NCT01436305|11687739|FG002|Overall Study|Death|0
7319174|NCT00734071|11548600|FG000|Overall Study|Voluntary Withdrawal|9
7319175|NCT00734071|11548601|FG001|Overall Study|Voluntary Withdrawal|7
7319176|NCT00734071|11548600|FG000|Overall Study|Lost to Follow-up|16
7319177|NCT00734071|11548601|FG001|Overall Study|Lost to Follow-up|8
7319178|NCT00734071|11548600|FG000|Overall Study|Other|1
7319179|NCT00734071|11548601|FG001|Overall Study|Other|2
7319180|NCT00734097|11548607|FG000|Screening|Protocol Violation|12
7319181|NCT00734097|11548607|FG000|Screening|Withdrawal by Subject|5
7319182|NCT00734097|11548607|FG000|Screening|Lost to Follow-up|2
7319183|NCT00734097|11548607|FG000|Screening|Unconfirmed pregnancy|1
7319184|NCT00734097|11548607|FG000|Open Label|Lost to Follow-up|7
7414840|NCT01436305|11687737|FG000|Overall Study|Lost to Follow-up|0
7414841|NCT01436305|11687738|FG001|Overall Study|Lost to Follow-up|1
7319185|NCT00734097|11548607|FG000|Open Label|Withdrawal by Subject|5
7319186|NCT00734097|11548607|FG000|Open Label|Protocol Violation|4
7319187|NCT00734149|11548611|FG000|Overall Study|Withdrawal by Subject|1
7414842|NCT01436305|11687739|FG002|Overall Study|Lost to Follow-up|0
7319188|NCT00734162|11548621|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7319189|NCT00734162|11548622|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
7319190|NCT00734162|11548623|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
7319191|NCT00734162|11548624|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
7319192|NCT00734162|11548621|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7319193|NCT00734162|11548622|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7319194|NCT00734162|11548623|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
7319195|NCT00734162|11548624|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
7319196|NCT00734162|11548621|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
7319197|NCT00734162|11548622|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7319198|NCT00734162|11548623|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7319199|NCT00734162|11548624|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
7319200|NCT00734162|11548621|FG000|Open-Label Phase|Withdrew Consent|1
7319201|NCT00734162|11548622|FG001|Open-Label Phase|Withdrew Consent|0
7319202|NCT00734162|11548623|FG002|Open-Label Phase|Withdrew Consent|1
7319203|NCT00734162|11548624|FG003|Open-Label Phase|Withdrew Consent|1
7319204|NCT00734162|11548621|FG000|Open-Label Phase|Lost to Follow-up|1
7319205|NCT00734162|11548622|FG001|Open-Label Phase|Lost to Follow-up|2
7319206|NCT00734162|11548623|FG002|Open-Label Phase|Lost to Follow-up|0
7319207|NCT00734162|11548624|FG003|Open-Label Phase|Lost to Follow-up|1
7319208|NCT00734162|11548621|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
7319209|NCT00734162|11548622|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
7319210|NCT00734162|11548623|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
7319211|NCT00734162|11548624|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
7319212|NCT00734214|11548640|FG000|Overall Study|Withdrawal by Subject|3
7319213|NCT00734214|11548641|FG001|Overall Study|Withdrawal by Subject|4
7319214|NCT00734214|11548640|FG000|Overall Study|MD withdrawal|1
7319215|NCT00734214|11548641|FG001|Overall Study|MD withdrawal|0
7319216|NCT00734474|11548702|FG000|Overall Study|Entry Criteria Not Met|0
7319217|NCT00734474|11548703|FG001|Overall Study|Entry Criteria Not Met|0
7319218|NCT00734474|11548704|FG002|Overall Study|Entry Criteria Not Met|5
7319219|NCT00734474|11548705|FG003|Overall Study|Entry Criteria Not Met|0
7319220|NCT00734474|11548706|FG004|Overall Study|Entry Criteria Not Met|3
7319221|NCT00734474|11548707|FG005|Overall Study|Entry Criteria Not Met|1
7319222|NCT00734474|11548708|FG006|Overall Study|Entry Criteria Not Met|0
7319223|NCT00734474|11548709|FG007|Overall Study|Entry Criteria Not Met|1
7319224|NCT00734474|11548710|FG008|Overall Study|Entry Criteria Not Met|1
7319225|NCT00734474|11548702|FG000|Overall Study|Lost to Follow-up|1
7319226|NCT00734474|11548703|FG001|Overall Study|Lost to Follow-up|0
7319227|NCT00734474|11548704|FG002|Overall Study|Lost to Follow-up|13
7319228|NCT00734474|11548705|FG003|Overall Study|Lost to Follow-up|0
7319229|NCT00734474|11548706|FG004|Overall Study|Lost to Follow-up|11
7319230|NCT00734474|11548707|FG005|Overall Study|Lost to Follow-up|1
7319231|NCT00734474|11548708|FG006|Overall Study|Lost to Follow-up|0
7319232|NCT00734474|11548709|FG007|Overall Study|Lost to Follow-up|9
7319233|NCT00734474|11548710|FG008|Overall Study|Lost to Follow-up|4
7319234|NCT00734474|11548702|FG000|Overall Study|Withdrawal by Subject|2
7319235|NCT00734474|11548703|FG001|Overall Study|Withdrawal by Subject|1
7319236|NCT00734474|11548704|FG002|Overall Study|Withdrawal by Subject|18
7319237|NCT00734474|11548705|FG003|Overall Study|Withdrawal by Subject|0
7319238|NCT00734474|11548706|FG004|Overall Study|Withdrawal by Subject|24
7319239|NCT00734474|11548707|FG005|Overall Study|Withdrawal by Subject|2
7319240|NCT00734474|11548708|FG006|Overall Study|Withdrawal by Subject|0
7319241|NCT00734474|11548709|FG007|Overall Study|Withdrawal by Subject|36
7319242|NCT00734474|11548710|FG008|Overall Study|Withdrawal by Subject|21
7319243|NCT00734474|11548702|FG000|Overall Study|Physician Decision|0
7319244|NCT00734474|11548703|FG001|Overall Study|Physician Decision|0
7319245|NCT00734474|11548704|FG002|Overall Study|Physician Decision|4
7319246|NCT00734474|11548705|FG003|Overall Study|Physician Decision|1
7319247|NCT00734474|11548706|FG004|Overall Study|Physician Decision|11
7319248|NCT00734474|11548707|FG005|Overall Study|Physician Decision|0
7319249|NCT00734474|11548708|FG006|Overall Study|Physician Decision|0
7319250|NCT00734474|11548709|FG007|Overall Study|Physician Decision|9
7319251|NCT00734474|11548710|FG008|Overall Study|Physician Decision|9
7319252|NCT00734474|11548702|FG000|Overall Study|Adverse Event|4
7319253|NCT00734474|11548703|FG001|Overall Study|Adverse Event|4
7319254|NCT00734474|11548704|FG002|Overall Study|Adverse Event|63
7319255|NCT00734474|11548705|FG003|Overall Study|Adverse Event|1
7319256|NCT00734474|11548706|FG004|Overall Study|Adverse Event|64
7319257|NCT00734474|11548707|FG005|Overall Study|Adverse Event|0
7319258|NCT00734474|11548708|FG006|Overall Study|Adverse Event|1
7319259|NCT00734474|11548709|FG007|Overall Study|Adverse Event|65
7319260|NCT00734474|11548710|FG008|Overall Study|Adverse Event|39
7319261|NCT00734474|11548702|FG000|Overall Study|Protocol Violation|0
7319262|NCT00734474|11548703|FG001|Overall Study|Protocol Violation|0
7319263|NCT00734474|11548704|FG002|Overall Study|Protocol Violation|4
7319264|NCT00734474|11548705|FG003|Overall Study|Protocol Violation|0
7319265|NCT00734474|11548706|FG004|Overall Study|Protocol Violation|3
7319266|NCT00734474|11548707|FG005|Overall Study|Protocol Violation|0
7319267|NCT00734474|11548708|FG006|Overall Study|Protocol Violation|0
7319268|NCT00734474|11548709|FG007|Overall Study|Protocol Violation|3
7319269|NCT00734474|11548710|FG008|Overall Study|Protocol Violation|1
7319270|NCT00734474|11548702|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
7319271|NCT00734474|11548703|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
7319272|NCT00734474|11548704|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
7319273|NCT00734474|11548705|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
7319274|NCT00734474|11548706|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
7319275|NCT00734474|11548707|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
7319276|NCT00734474|11548708|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
7319277|NCT00734474|11548709|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
7319278|NCT00734474|11548710|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
7319279|NCT00734474|11548702|FG000|Overall Study|Sponsor Decision|0
7319280|NCT00734474|11548703|FG001|Overall Study|Sponsor Decision|0
7319281|NCT00734474|11548704|FG002|Overall Study|Sponsor Decision|0
7319282|NCT00734474|11548705|FG003|Overall Study|Sponsor Decision|0
7319283|NCT00734474|11548706|FG004|Overall Study|Sponsor Decision|2
7319284|NCT00734474|11548707|FG005|Overall Study|Sponsor Decision|0
7319285|NCT00734474|11548708|FG006|Overall Study|Sponsor Decision|0
7319286|NCT00734474|11548709|FG007|Overall Study|Sponsor Decision|0
7319287|NCT00734474|11548710|FG008|Overall Study|Sponsor Decision|0
7319288|NCT00734474|11548702|FG000|Overall Study|Death|0
7319289|NCT00734474|11548703|FG001|Overall Study|Death|0
7319290|NCT00734474|11548704|FG002|Overall Study|Death|1
7319291|NCT00734474|11548705|FG003|Overall Study|Death|0
7319292|NCT00734474|11548706|FG004|Overall Study|Death|0
7319293|NCT00734474|11548707|FG005|Overall Study|Death|0
7319294|NCT00734474|11548708|FG006|Overall Study|Death|0
7319295|NCT00734474|11548709|FG007|Overall Study|Death|2
7319296|NCT00734474|11548710|FG008|Overall Study|Death|1
7319297|NCT00734474|11548702|FG000|Overall Study|Lack of Efficacy|0
7319298|NCT00734474|11548703|FG001|Overall Study|Lack of Efficacy|0
7319299|NCT00734474|11548704|FG002|Overall Study|Lack of Efficacy|4
7319300|NCT00734474|11548705|FG003|Overall Study|Lack of Efficacy|0
7319301|NCT00734474|11548706|FG004|Overall Study|Lack of Efficacy|0
7319302|NCT00734474|11548707|FG005|Overall Study|Lack of Efficacy|0
7319303|NCT00734474|11548708|FG006|Overall Study|Lack of Efficacy|0
7319304|NCT00734474|11548709|FG007|Overall Study|Lack of Efficacy|4
7319305|NCT00734474|11548710|FG008|Overall Study|Lack of Efficacy|6
7319306|NCT00734539|11548742|FG000|Main Study|Death|33
7319307|NCT00734539|11548743|FG001|Main Study|Death|32
7319308|NCT00734539|11548742|FG000|Main Study|Physician Decision|2
7319309|NCT00734539|11548743|FG001|Main Study|Physician Decision|0
7319310|NCT00734539|11548742|FG000|Main Study|Withdrawal by Subject|1
7319311|NCT00734539|11548743|FG001|Main Study|Withdrawal by Subject|3
7319312|NCT00734539|11548742|FG000|Main Study|Enrolled in error; ineligible|1
7319313|NCT00734539|11548743|FG001|Main Study|Enrolled in error; ineligible|0
7319314|NCT00734578|11548755|FG000|Overall Study|Adverse Event|4
7319315|NCT00734578|11548756|FG001|Overall Study|Adverse Event|6
7319316|NCT00734578|11548757|FG002|Overall Study|Adverse Event|1
7319317|NCT00734578|11548755|FG000|Overall Study|Protocol Violation|8
7319318|NCT00734578|11548756|FG001|Overall Study|Protocol Violation|6
7319319|NCT00734578|11548757|FG002|Overall Study|Protocol Violation|3
7319320|NCT00734578|11548755|FG000|Overall Study|Withdrawal by Subject|7
7319321|NCT00734578|11548756|FG001|Overall Study|Withdrawal by Subject|8
7319322|NCT00734578|11548757|FG002|Overall Study|Withdrawal by Subject|11
7319323|NCT00734578|11548755|FG000|Overall Study|Lost to Follow-up|9
7319324|NCT00734578|11548756|FG001|Overall Study|Lost to Follow-up|3
7319325|NCT00734578|11548757|FG002|Overall Study|Lost to Follow-up|5
7319326|NCT00734578|11548755|FG000|Overall Study|Lack of Efficacy|3
7530419|NCT02638103|11874187|FG003|Overall Study|Withdrawal by Subject|61
7530420|NCT02638103|11874184|FG000|Overall Study|Protocol Violation|1
7530421|NCT02638103|11874185|FG001|Overall Study|Protocol Violation|2
7530422|NCT02638103|11874186|FG002|Overall Study|Protocol Violation|1
7530423|NCT02638103|11874187|FG003|Overall Study|Protocol Violation|4
7530424|NCT02638103|11874184|FG000|Overall Study|Pregnancy|2
7530425|NCT02638103|11874185|FG001|Overall Study|Pregnancy|3
7319327|NCT00734578|11548756|FG001|Overall Study|Lack of Efficacy|2
7319328|NCT00734578|11548757|FG002|Overall Study|Lack of Efficacy|5
7319329|NCT00734578|11548755|FG000|Overall Study|Randomized in error|1
7319330|NCT00734578|11548756|FG001|Overall Study|Randomized in error|0
7319331|NCT00734578|11548757|FG002|Overall Study|Randomized in error|0
7319332|NCT00734578|11548755|FG000|Overall Study|Exclusion criteria|1
7319333|NCT00734578|11548756|FG001|Overall Study|Exclusion criteria|0
7319334|NCT00734578|11548757|FG002|Overall Study|Exclusion criteria|0
7319335|NCT00734591|11548767|FG000|Screening for Prospective Period|Site did not participate|1604
7319336|NCT00734591|11548768|FG001|Screening for Prospective Period|Site did not participate|1488
7319337|NCT00734591|11548767|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
7319338|NCT00734591|11548768|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
7319339|NCT00734591|11548767|FG000|Prospective Period|Withdrawal by Subject|11
7530426|NCT02638103|11874186|FG002|Overall Study|Pregnancy|0
7319340|NCT00734591|11548768|FG001|Prospective Period|Withdrawal by Subject|9
7319341|NCT00734591|11548767|FG000|Prospective Period|Lost to Follow-up|37
7319342|NCT00734591|11548768|FG001|Prospective Period|Lost to Follow-up|33
7319343|NCT00734591|11548767|FG000|Prospective Period|Study Terminated|1
7319344|NCT00734591|11548768|FG001|Prospective Period|Study Terminated|0
7530427|NCT02638103|11874187|FG003|Overall Study|Pregnancy|1
7530428|NCT02638103|11874184|FG000|Overall Study|Non-compliance to Study Procedures|2
7414843|NCT01436305|11687737|FG000|Overall Study|Withdrawal by Subject|1
7414844|NCT01436305|11687738|FG001|Overall Study|Withdrawal by Subject|3
7414845|NCT01436305|11687739|FG002|Overall Study|Withdrawal by Subject|0
7414846|NCT01436357|11687749|FG000|Overall Study|Death|5
7414847|NCT01436357|11687750|FG001|Overall Study|Death|1
7414848|NCT01436357|11687749|FG000|Overall Study|Enrolled but not vaccinated|1
7414849|NCT01436357|11687750|FG001|Overall Study|Enrolled but not vaccinated|1
7414850|NCT01436357|11687749|FG000|Overall Study|Incarceration|18
7414851|NCT01436357|11687750|FG001|Overall Study|Incarceration|20
7414852|NCT01436357|11687749|FG000|Overall Study|Lost to Follow-up|67
7414853|NCT01436357|11687750|FG001|Overall Study|Lost to Follow-up|61
7414854|NCT01436357|11687749|FG000|Overall Study|Protocol Violation|1
7414855|NCT01436357|11687750|FG001|Overall Study|Protocol Violation|0
7414856|NCT01436357|11687749|FG000|Overall Study|Withdrawal by Subject|26
7414857|NCT01436357|11687750|FG001|Overall Study|Withdrawal by Subject|38
7414858|NCT01436357|11687749|FG000|Overall Study|Physician Decision|3
7414859|NCT01436357|11687750|FG001|Overall Study|Physician Decision|4
7414860|NCT01436357|11687749|FG000|Overall Study|Moved out of area|1
7414861|NCT01436357|11687750|FG001|Overall Study|Moved out of area|2
7414862|NCT01436357|11687749|FG000|Overall Study|Subject in rehab|0
7414863|NCT01436357|11687750|FG001|Overall Study|Subject in rehab|1
7414864|NCT01436370|11687764|FG000|Overall Study|Lost to Follow-up|0
7414865|NCT01436370|11687765|FG001|Overall Study|Lost to Follow-up|0
7414866|NCT01436370|11687766|FG002|Overall Study|Lost to Follow-up|0
7414867|NCT01436370|11687767|FG003|Overall Study|Lost to Follow-up|0
7414868|NCT01436370|11687768|FG004|Overall Study|Lost to Follow-up|1
7414869|NCT01436370|11687769|FG005|Overall Study|Lost to Follow-up|0
7414870|NCT01436370|11687770|FG006|Overall Study|Lost to Follow-up|0
7414871|NCT01436370|11687771|FG007|Overall Study|Lost to Follow-up|0
7414872|NCT01436500|11687803|FG000|Overall Study|Death|1
7414873|NCT01436500|11687804|FG001|Overall Study|Death|0
7414874|NCT01436500|11687805|FG002|Overall Study|Death|0
7414875|NCT01436500|11687806|FG003|Overall Study|Death|0
7414876|NCT01436500|11687807|FG004|Overall Study|Death|0
7414877|NCT01436500|11687803|FG000|Overall Study|Adverse Event|0
7414878|NCT01436500|11687804|FG001|Overall Study|Adverse Event|2
7414879|NCT01436500|11687805|FG002|Overall Study|Adverse Event|2
7414880|NCT01436500|11687806|FG003|Overall Study|Adverse Event|0
7414881|NCT01436500|11687807|FG004|Overall Study|Adverse Event|1
7414882|NCT01436500|11687803|FG000|Overall Study|Withdrawal by Subject|0
7414883|NCT01436500|11687804|FG001|Overall Study|Withdrawal by Subject|0
7414884|NCT01436500|11687805|FG002|Overall Study|Withdrawal by Subject|2
7414885|NCT01436500|11687806|FG003|Overall Study|Withdrawal by Subject|0
7414886|NCT01436500|11687807|FG004|Overall Study|Withdrawal by Subject|2
7414887|NCT01436500|11687803|FG000|Overall Study|Physician Decision|0
7414888|NCT01436500|11687804|FG001|Overall Study|Physician Decision|0
7414889|NCT01436500|11687805|FG002|Overall Study|Physician Decision|1
7414890|NCT01436500|11687806|FG003|Overall Study|Physician Decision|0
7414891|NCT01436500|11687807|FG004|Overall Study|Physician Decision|0
7414892|NCT01436500|11687803|FG000|Overall Study|liver transplant|1
7414893|NCT01436500|11687804|FG001|Overall Study|liver transplant|0
7414894|NCT01436500|11687805|FG002|Overall Study|liver transplant|0
7414895|NCT01436500|11687806|FG003|Overall Study|liver transplant|0
7414896|NCT01436500|11687807|FG004|Overall Study|liver transplant|0
7414897|NCT01436500|11687803|FG000|Overall Study|initiation of dialysis|0
7414898|NCT01436500|11687804|FG001|Overall Study|initiation of dialysis|0
7414899|NCT01436500|11687805|FG002|Overall Study|initiation of dialysis|0
7414900|NCT01436500|11687806|FG003|Overall Study|initiation of dialysis|0
7414901|NCT01436500|11687807|FG004|Overall Study|initiation of dialysis|1
7414902|NCT01436500|11687803|FG000|Overall Study|discontinued study drug|1
7414903|NCT01436500|11687804|FG001|Overall Study|discontinued study drug|0
7414904|NCT01436500|11687805|FG002|Overall Study|discontinued study drug|0
7414905|NCT01436500|11687806|FG003|Overall Study|discontinued study drug|0
7414906|NCT01436500|11687807|FG004|Overall Study|discontinued study drug|0
7414907|NCT01436500|11687803|FG000|Overall Study|Other|0
7414908|NCT01436500|11687804|FG001|Overall Study|Other|1
7414909|NCT01436500|11687805|FG002|Overall Study|Other|0
7414910|NCT01436500|11687806|FG003|Overall Study|Other|1
7414911|NCT01436500|11687807|FG004|Overall Study|Other|0
7414912|NCT01436643|11687832|FG000|2-week Pre-treatment|Abnormal test result|0
7414913|NCT01436643|11687833|FG001|2-week Pre-treatment|Abnormal test result|0
7414914|NCT01436643|11687834|FG002|2-week Pre-treatment|Abnormal test result|0
7414915|NCT01436643|11687835|FG003|2-week Pre-treatment|Abnormal test result|1
7414916|NCT01436643|11687832|FG000|2-week Pre-treatment|Adverse Event|0
7414917|NCT01436643|11687833|FG001|2-week Pre-treatment|Adverse Event|0
7414918|NCT01436643|11687834|FG002|2-week Pre-treatment|Adverse Event|0
7414919|NCT01436643|11687835|FG003|2-week Pre-treatment|Adverse Event|5
7414920|NCT01436643|11687832|FG000|2-week Pre-treatment|Protocol Violation|0
7414921|NCT01436643|11687833|FG001|2-week Pre-treatment|Protocol Violation|0
7414922|NCT01436643|11687834|FG002|2-week Pre-treatment|Protocol Violation|0
7414923|NCT01436643|11687835|FG003|2-week Pre-treatment|Protocol Violation|4
7414924|NCT01436643|11687832|FG000|Core Phase (16 Weeks)|Adverse Event|0
7414925|NCT01436643|11687833|FG001|Core Phase (16 Weeks)|Adverse Event|3
7414926|NCT01436643|11687834|FG002|Core Phase (16 Weeks)|Adverse Event|1
7414927|NCT01436643|11687835|FG003|Core Phase (16 Weeks)|Adverse Event|0
7414928|NCT01436643|11687832|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
7319345|NCT00734591|11548767|FG000|Prospective Period|Other|2
7319346|NCT00734591|11548768|FG001|Prospective Period|Other|2
7319347|NCT00734604|11548780|FG000|Overall Study|Adverse Event|0
7319348|NCT00734604|11548781|FG001|Overall Study|Adverse Event|2
7319349|NCT00734604|11548782|FG002|Overall Study|Adverse Event|0
7319350|NCT00734604|11548783|FG003|Overall Study|Adverse Event|2
7319351|NCT00734604|11548784|FG004|Overall Study|Adverse Event|1
7319352|NCT00734604|11548785|FG005|Overall Study|Adverse Event|1
7319353|NCT00734604|11548780|FG000|Overall Study|Serious Adverse Event|1
7319354|NCT00734604|11548781|FG001|Overall Study|Serious Adverse Event|0
7319355|NCT00734604|11548782|FG002|Overall Study|Serious Adverse Event|1
7319356|NCT00734604|11548783|FG003|Overall Study|Serious Adverse Event|2
7319357|NCT00734604|11548784|FG004|Overall Study|Serious Adverse Event|0
7319358|NCT00734604|11548785|FG005|Overall Study|Serious Adverse Event|1
7319359|NCT00734604|11548780|FG000|Overall Study|Lost to Follow-up|1
7319360|NCT00734604|11548781|FG001|Overall Study|Lost to Follow-up|2
7319361|NCT00734604|11548782|FG002|Overall Study|Lost to Follow-up|2
7319362|NCT00734604|11548783|FG003|Overall Study|Lost to Follow-up|4
7319363|NCT00734604|11548784|FG004|Overall Study|Lost to Follow-up|2
7319364|NCT00734604|11548785|FG005|Overall Study|Lost to Follow-up|3
7319365|NCT00734604|11548780|FG000|Overall Study|Physician Decision|0
7319366|NCT00734604|11548781|FG001|Overall Study|Physician Decision|1
7319367|NCT00734604|11548782|FG002|Overall Study|Physician Decision|1
7319368|NCT00734604|11548783|FG003|Overall Study|Physician Decision|0
7319369|NCT00734604|11548784|FG004|Overall Study|Physician Decision|0
7319370|NCT00734604|11548785|FG005|Overall Study|Physician Decision|0
7319371|NCT00734604|11548780|FG000|Overall Study|Protocol Violation|0
7319372|NCT00734604|11548781|FG001|Overall Study|Protocol Violation|2
7319373|NCT00734604|11548782|FG002|Overall Study|Protocol Violation|0
7319374|NCT00734604|11548783|FG003|Overall Study|Protocol Violation|0
7319375|NCT00734604|11548784|FG004|Overall Study|Protocol Violation|1
7319376|NCT00734604|11548785|FG005|Overall Study|Protocol Violation|0
7319377|NCT00734604|11548780|FG000|Overall Study|Sponsor Decision|1
7319378|NCT00734604|11548781|FG001|Overall Study|Sponsor Decision|2
7319379|NCT00734604|11548782|FG002|Overall Study|Sponsor Decision|1
7319380|NCT00734604|11548783|FG003|Overall Study|Sponsor Decision|0
7319381|NCT00734604|11548784|FG004|Overall Study|Sponsor Decision|2
7319382|NCT00734604|11548785|FG005|Overall Study|Sponsor Decision|0
7319383|NCT00734604|11548780|FG000|Overall Study|Withdrawal by Subject|0
7319384|NCT00734604|11548781|FG001|Overall Study|Withdrawal by Subject|2
7319385|NCT00734604|11548782|FG002|Overall Study|Withdrawal by Subject|0
7319386|NCT00734604|11548783|FG003|Overall Study|Withdrawal by Subject|1
7319387|NCT00734604|11548784|FG004|Overall Study|Withdrawal by Subject|2
7319388|NCT00734604|11548785|FG005|Overall Study|Withdrawal by Subject|1
7319389|NCT00734604|11548780|FG000|Overall Study|Lack of Efficacy|0
7319390|NCT00734604|11548781|FG001|Overall Study|Lack of Efficacy|1
7319391|NCT00734604|11548782|FG002|Overall Study|Lack of Efficacy|1
7319392|NCT00734604|11548783|FG003|Overall Study|Lack of Efficacy|0
7319393|NCT00734604|11548784|FG004|Overall Study|Lack of Efficacy|0
7319394|NCT00734604|11548785|FG005|Overall Study|Lack of Efficacy|0
7319395|NCT00734617|11548798|FG000|Overall Study|Adverse Event|4
7319396|NCT00734617|11548799|FG001|Overall Study|Adverse Event|7
7319397|NCT00734617|11548798|FG000|Overall Study|Withdrawal by Subject|103
7319398|NCT00734617|11548799|FG001|Overall Study|Withdrawal by Subject|95
7319399|NCT00734630|11548807|FG000|Overall Study|Lack of Efficacy|4
7319400|NCT00734630|11548808|FG001|Overall Study|Lack of Efficacy|4
7319401|NCT00734630|11548807|FG000|Overall Study|Withdrawal by Subject|7
7319402|NCT00734630|11548808|FG001|Overall Study|Withdrawal by Subject|9
7319403|NCT00734630|11548807|FG000|Overall Study|Lost to Follow-up|13
7319404|NCT00734630|11548808|FG001|Overall Study|Lost to Follow-up|7
7319405|NCT00734630|11548807|FG000|Overall Study|Protocol Violation|0
7319406|NCT00734630|11548808|FG001|Overall Study|Protocol Violation|3
7319407|NCT00734630|11548807|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7319408|NCT00734630|11548808|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7319409|NCT00734630|11548807|FG000|Overall Study|Adverse Event|3
7319410|NCT00734630|11548808|FG001|Overall Study|Adverse Event|6
7319411|NCT00734630|11548807|FG000|Overall Study|Randomized in Error|0
7319412|NCT00734630|11548808|FG001|Overall Study|Randomized in Error|1
7319413|NCT00734630|11548807|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
7319414|NCT00734630|11548808|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
7319415|NCT00734630|11548807|FG000|Overall Study|Poor Compliance|1
7319416|NCT00734630|11548808|FG001|Overall Study|Poor Compliance|1
7319417|NCT00734656|11548814|FG000|Lab Session 1|Withdrawal by Subject|2
7319418|NCT00734656|11548815|FG001|Lab Session 1|Withdrawal by Subject|0
7319419|NCT00734656|11548816|FG002|Lab Session 1|Withdrawal by Subject|0
7319420|NCT00734656|11548817|FG003|Lab Session 1|Withdrawal by Subject|0
7319421|NCT00734656|11548814|FG000|Washout 1|Withdrawal by Subject|1
7319422|NCT00734656|11548815|FG001|Washout 1|Withdrawal by Subject|5
7319423|NCT00734656|11548816|FG002|Washout 1|Withdrawal by Subject|2
7319424|NCT00734656|11548817|FG003|Washout 1|Withdrawal by Subject|3
7319425|NCT00734656|11548814|FG000|Lab Session 2|Withdrawal by Subject|1
7319426|NCT00734656|11548815|FG001|Lab Session 2|Withdrawal by Subject|0
7319427|NCT00734656|11548816|FG002|Lab Session 2|Withdrawal by Subject|0
7319428|NCT00734656|11548817|FG003|Lab Session 2|Withdrawal by Subject|1
7319429|NCT00734656|11548814|FG000|Washout 2|Withdrawal by Subject|1
7319430|NCT00734656|11548815|FG001|Washout 2|Withdrawal by Subject|1
7319431|NCT00734656|11548816|FG002|Washout 2|Withdrawal by Subject|1
7319432|NCT00734656|11548817|FG003|Washout 2|Withdrawal by Subject|0
7319433|NCT00734656|11548814|FG000|Washout 3|Withdrawal by Subject|1
7319434|NCT00734656|11548815|FG001|Washout 3|Withdrawal by Subject|0
7319435|NCT00734656|11548816|FG002|Washout 3|Withdrawal by Subject|0
7319436|NCT00734656|11548817|FG003|Washout 3|Withdrawal by Subject|1
7319437|NCT00734656|11548814|FG000|Lab Session 4|Withdrawal by Subject|0
7319438|NCT00734656|11548815|FG001|Lab Session 4|Withdrawal by Subject|0
7319439|NCT00734656|11548816|FG002|Lab Session 4|Withdrawal by Subject|0
7319440|NCT00734656|11548817|FG003|Lab Session 4|Withdrawal by Subject|1
7319441|NCT00734747|11548832|FG000|SRS Procedure|No staples placed|3
7319442|NCT00734747|11548832|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
7319443|NCT00734851|11548845|FG000|Overall Study|Withdrawal by Subject|2
7319444|NCT00734851|11548845|FG000|Overall Study|Lost to Follow-up|1
7319445|NCT00734851|11548845|FG000|Overall Study|Physician Decision|18
7319446|NCT00734929|11548860|FG000|Overall Study|Lost to Follow-up|1
7319447|NCT00734929|11548861|FG001|Overall Study|Lost to Follow-up|2
7319448|NCT00734929|11548860|FG000|Overall Study|No intervention/ screen fail|5
7319449|NCT00734929|11548861|FG001|Overall Study|No intervention/ screen fail|3
7319450|NCT00734994|11548878|FG000|Overall Study|Withdrawal by Subject|1
7319451|NCT00735007|11548883|FG000|Overall Study|Adverse Event|4
7319452|NCT00735007|11548883|FG000|Overall Study|Protocol Violation|1
7319453|NCT00735072|11548889|FG000|Overall Study|interrupted study med during ARV change|1
7319454|NCT00735072|11548890|FG001|Overall Study|interrupted study med during ARV change|0
7319455|NCT00735072|11548889|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
7319456|NCT00735072|11548890|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
7319457|NCT00735371|11548907|FG000|Overall Study|Adverse Event|3
7319458|NCT00735371|11548908|FG001|Overall Study|Adverse Event|3
7319459|NCT00735371|11548909|FG002|Overall Study|Adverse Event|4
7319460|NCT00735371|11548910|FG003|Overall Study|Adverse Event|1
7414929|NCT01436643|11687833|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
7414930|NCT01436643|11687834|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
7414931|NCT01436643|11687835|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
7414932|NCT01436643|11687832|FG000|Core Phase (16 Weeks)|Protocol Violation|1
7414933|NCT01436643|11687833|FG001|Core Phase (16 Weeks)|Protocol Violation|1
7414934|NCT01436643|11687834|FG002|Core Phase (16 Weeks)|Protocol Violation|1
7414935|NCT01436643|11687835|FG003|Core Phase (16 Weeks)|Protocol Violation|0
7414936|NCT01437267|11687876|FG000|Overall Study|Withdrawal by Subject|0
7414937|NCT01437267|11687877|FG001|Overall Study|Withdrawal by Subject|0
7414938|NCT01437267|11687878|FG002|Overall Study|Withdrawal by Subject|0
7414939|NCT01437267|11687879|FG003|Overall Study|Withdrawal by Subject|1
7414940|NCT01437267|11687880|FG004|Overall Study|Withdrawal by Subject|0
7414941|NCT01437267|11687881|FG005|Overall Study|Withdrawal by Subject|0
7414942|NCT01437267|11687876|FG000|Overall Study|Protocol Violation|0
7414943|NCT01437267|11687877|FG001|Overall Study|Protocol Violation|1
7414944|NCT01437267|11687878|FG002|Overall Study|Protocol Violation|0
7414945|NCT01437267|11687879|FG003|Overall Study|Protocol Violation|0
7414946|NCT01437267|11687880|FG004|Overall Study|Protocol Violation|0
7414947|NCT01437267|11687881|FG005|Overall Study|Protocol Violation|0
7414948|NCT01437319|11687895|FG000|Phase I|Lost to Follow-up|2
7414949|NCT01437319|11687896|FG001|Phase I|Lost to Follow-up|0
7414950|NCT01437319|11687897|FG002|Phase I|Lost to Follow-up|0
7414951|NCT01437319|11687895|FG000|Phase I|Protocol Violation|1
7414952|NCT01437319|11687896|FG001|Phase I|Protocol Violation|0
7414953|NCT01437319|11687897|FG002|Phase I|Protocol Violation|0
7414954|NCT01437319|11687895|FG000|Phase I|Study related symptoms/complaints|27
7414955|NCT01437319|11687896|FG001|Phase I|Study related symptoms/complaints|0
7414956|NCT01437319|11687897|FG002|Phase I|Study related symptoms/complaints|0
7414957|NCT01437319|11687895|FG000|Phase I|Withdrawal by Subject|25
7414958|NCT01437319|11687896|FG001|Phase I|Withdrawal by Subject|0
7414959|NCT01437319|11687897|FG002|Phase I|Withdrawal by Subject|0
7414960|NCT01437319|11687895|FG000|Phase II|Withdrawal by Subject|0
7414961|NCT01437319|11687896|FG001|Phase II|Withdrawal by Subject|8
7414962|NCT01437319|11687897|FG002|Phase II|Withdrawal by Subject|16
7414963|NCT01437319|11687895|FG000|Phase II|Lost to Follow-up|0
7414964|NCT01437319|11687896|FG001|Phase II|Lost to Follow-up|7
7414965|NCT01437319|11687897|FG002|Phase II|Lost to Follow-up|2
7414966|NCT01437319|11687895|FG000|Phase II|Study related symptoms/complaints|0
7414967|NCT01437319|11687896|FG001|Phase II|Study related symptoms/complaints|28
7414968|NCT01437319|11687897|FG002|Phase II|Study related symptoms/complaints|19
7414969|NCT01437319|11687895|FG000|Phase II|Protocol Violation|0
7414970|NCT01437319|11687896|FG001|Phase II|Protocol Violation|1
7414971|NCT01437319|11687897|FG002|Phase II|Protocol Violation|0
7414972|NCT01437397|11687911|FG000|Overall Study|Lost to Follow-up|9
7414973|NCT01437397|11687912|FG001|Overall Study|Lost to Follow-up|4
7414974|NCT01437397|11687913|FG002|Overall Study|Lost to Follow-up|2
7414975|NCT01437397|11687914|FG003|Overall Study|Lost to Follow-up|4
7414976|NCT01437397|11687915|FG004|Overall Study|Lost to Follow-up|5
7414977|NCT01437397|11687911|FG000|Overall Study|Withdrawal by Subject|11
7414978|NCT01437397|11687912|FG001|Overall Study|Withdrawal by Subject|12
7414979|NCT01437397|11687913|FG002|Overall Study|Withdrawal by Subject|24
7319461|NCT00735371|11548907|FG000|Overall Study|Protocol Violation|2
7319462|NCT00735371|11548908|FG001|Overall Study|Protocol Violation|2
7319463|NCT00735371|11548909|FG002|Overall Study|Protocol Violation|0
7319464|NCT00735371|11548910|FG003|Overall Study|Protocol Violation|3
7319465|NCT00735371|11548907|FG000|Overall Study|Withdrawal by Subject|0
7319466|NCT00735371|11548908|FG001|Overall Study|Withdrawal by Subject|2
7319467|NCT00735371|11548909|FG002|Overall Study|Withdrawal by Subject|2
7319468|NCT00735371|11548910|FG003|Overall Study|Withdrawal by Subject|0
7319469|NCT00735371|11548907|FG000|Overall Study|Lost to Follow-up|1
7319470|NCT00735371|11548908|FG001|Overall Study|Lost to Follow-up|1
7319471|NCT00735371|11548909|FG002|Overall Study|Lost to Follow-up|3
7319472|NCT00735371|11548910|FG003|Overall Study|Lost to Follow-up|1
7319473|NCT00735371|11548907|FG000|Overall Study|Lack of Efficacy|4
7319474|NCT00735371|11548908|FG001|Overall Study|Lack of Efficacy|2
7319475|NCT00735371|11548909|FG002|Overall Study|Lack of Efficacy|0
7319476|NCT00735371|11548910|FG003|Overall Study|Lack of Efficacy|4
7319477|NCT00735371|11548907|FG000|Overall Study|Sponsor Decision|3
7319478|NCT00735371|11548908|FG001|Overall Study|Sponsor Decision|1
7319479|NCT00735371|11548909|FG002|Overall Study|Sponsor Decision|0
7319480|NCT00735371|11548910|FG003|Overall Study|Sponsor Decision|1
7319481|NCT00735371|11548907|FG000|Overall Study|Protocol Violation|0
7319482|NCT00735371|11548908|FG001|Overall Study|Protocol Violation|1
7319483|NCT00735371|11548909|FG002|Overall Study|Protocol Violation|2
7319484|NCT00735371|11548910|FG003|Overall Study|Protocol Violation|0
7319485|NCT00735371|11548907|FG000|Overall Study|Prior Vyvanse Exposure|1
7319486|NCT00735371|11548908|FG001|Overall Study|Prior Vyvanse Exposure|1
7319487|NCT00735371|11548909|FG002|Overall Study|Prior Vyvanse Exposure|0
7319488|NCT00735371|11548910|FG003|Overall Study|Prior Vyvanse Exposure|0
7319489|NCT00735371|11548907|FG000|Overall Study|Exclusion criteria|1
7319490|NCT00735371|11548908|FG001|Overall Study|Exclusion criteria|0
7319491|NCT00735371|11548909|FG002|Overall Study|Exclusion criteria|0
7319492|NCT00735371|11548910|FG003|Overall Study|Exclusion criteria|0
7319493|NCT00735397|11548920|FG000|Overall Study|Adverse Event|194
7319494|NCT00735397|11548920|FG000|Overall Study|Lost to Follow-up|33
7319495|NCT00735397|11548920|FG000|Overall Study|Participant choice|252
7319496|NCT00735397|11548920|FG000|Overall Study|Inadequate therapeutic effect|202
7319497|NCT00735397|11548920|FG000|Overall Study|Administrative/Other|502
7319498|NCT00735475|11548956|FG000|Overall Study|Adverse Event|0
7319499|NCT00735475|11548957|FG001|Overall Study|Adverse Event|1
7319500|NCT00735475|11548956|FG000|Overall Study|Death|1
7319501|NCT00735475|11548957|FG001|Overall Study|Death|1
7319502|NCT00735475|11548956|FG000|Overall Study|Lost to Follow-up|3
7319503|NCT00735475|11548957|FG001|Overall Study|Lost to Follow-up|3
7319504|NCT00735475|11548956|FG000|Overall Study|Physician Decision|0
7319505|NCT00735475|11548957|FG001|Overall Study|Physician Decision|1
7319506|NCT00735475|11548956|FG000|Overall Study|Withdrawal by Subject|4
7319507|NCT00735475|11548957|FG001|Overall Study|Withdrawal by Subject|5
7319508|NCT00735644|11548972|FG000|Overall Study|Did not receive study vaccine|0
7319509|NCT00735644|11548973|FG001|Overall Study|Did not receive study vaccine|1
7319510|NCT00735644|11548974|FG002|Overall Study|Did not receive study vaccine|0
7319511|NCT00735644|11548975|FG003|Overall Study|Did not receive study vaccine|0
7319512|NCT00735644|11548976|FG004|Overall Study|Did not receive study vaccine|0
7319513|NCT00735644|11548972|FG000|Overall Study|Withdrawal by Subject|0
7319514|NCT00735644|11548973|FG001|Overall Study|Withdrawal by Subject|1
7319515|NCT00735644|11548974|FG002|Overall Study|Withdrawal by Subject|1
7319516|NCT00735644|11548975|FG003|Overall Study|Withdrawal by Subject|1
7319517|NCT00735644|11548976|FG004|Overall Study|Withdrawal by Subject|0
7319518|NCT00735696|11549004|FG000|Overall Study|Withdrawal by Subject|1
7319519|NCT00735696|11549004|FG000|Overall Study|Enrolled but never Treated|1
7319520|NCT00735709|11549012|FG000|Overall Study|Adverse Event|2
7319521|NCT00735709|11549013|FG001|Overall Study|Adverse Event|3
7319522|NCT00735709|11549014|FG002|Overall Study|Adverse Event|1
7319523|NCT00735709|11549015|FG003|Overall Study|Adverse Event|5
7414980|NCT01437397|11687914|FG003|Overall Study|Withdrawal by Subject|11
7414981|NCT01437397|11687915|FG004|Overall Study|Withdrawal by Subject|22
7414982|NCT01437397|11687911|FG000|Overall Study|Protocol Violation|10
7414983|NCT01437397|11687912|FG001|Overall Study|Protocol Violation|12
7414984|NCT01437397|11687913|FG002|Overall Study|Protocol Violation|13
7319524|NCT00735709|11549012|FG000|Overall Study|Lack of Efficacy|8
7319525|NCT00735709|11549013|FG001|Overall Study|Lack of Efficacy|4
7319526|NCT00735709|11549014|FG002|Overall Study|Lack of Efficacy|2
7319527|NCT00735709|11549015|FG003|Overall Study|Lack of Efficacy|3
7319528|NCT00735709|11549012|FG000|Overall Study|Noncompliance|0
7319529|NCT00735709|11549013|FG001|Overall Study|Noncompliance|0
7319530|NCT00735709|11549014|FG002|Overall Study|Noncompliance|1
7319531|NCT00735709|11549015|FG003|Overall Study|Noncompliance|0
7319532|NCT00735709|11549012|FG000|Overall Study|Protocol deviations|1
7319533|NCT00735709|11549013|FG001|Overall Study|Protocol deviations|2
7319534|NCT00735709|11549014|FG002|Overall Study|Protocol deviations|1
7319535|NCT00735709|11549015|FG003|Overall Study|Protocol deviations|1
7319536|NCT00735709|11549012|FG000|Overall Study|Voluntary Withdrawal|1
7319537|NCT00735709|11549013|FG001|Overall Study|Voluntary Withdrawal|3
7319538|NCT00735709|11549014|FG002|Overall Study|Voluntary Withdrawal|5
7319539|NCT00735709|11549015|FG003|Overall Study|Voluntary Withdrawal|7
7319540|NCT00735709|11549012|FG000|Overall Study|Lost to Follow-up|0
7319541|NCT00735709|11549013|FG001|Overall Study|Lost to Follow-up|1
7414985|NCT01437397|11687914|FG003|Overall Study|Protocol Violation|21
7319542|NCT00735709|11549014|FG002|Overall Study|Lost to Follow-up|1
7319543|NCT00735709|11549015|FG003|Overall Study|Lost to Follow-up|1
7319544|NCT00735709|11549012|FG000|Overall Study|Excluded medication|1
7319545|NCT00735709|11549013|FG001|Overall Study|Excluded medication|0
7319546|NCT00735709|11549014|FG002|Overall Study|Excluded medication|0
7319547|NCT00735709|11549015|FG003|Overall Study|Excluded medication|1
7319548|NCT00735878|11549052|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
7319549|NCT00735878|11549053|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
7319550|NCT00735878|11549054|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
7319551|NCT00735904|11549065|FG000|Overall Study|Adverse Event|3
7319552|NCT00735904|11549065|FG000|Overall Study|Death|20
7319553|NCT00735904|11549065|FG000|Overall Study|Protocol Violation|1
7319554|NCT00735904|11549065|FG000|Overall Study|Withdrawal by Subject|1
7319555|NCT00735904|11549065|FG000|Overall Study|Study Terminated by Sponsor|5
7319556|NCT00735904|11549065|FG000|Overall Study|Other|8
7319557|NCT00735943|11549073|FG000|Overall Study|Lost to Follow-up|1
7319558|NCT00735943|11549073|FG000|Overall Study|Adverse Event|1
7319559|NCT00736034|11549081|FG000|Overall Study|Adverse Event|2
7319560|NCT00736099|11549097|FG000|Overall Study|Adverse Event|61
7319561|NCT00736099|11549098|FG001|Overall Study|Adverse Event|18
7319562|NCT00736099|11549097|FG000|Overall Study|Protocol Violation|10
7319563|NCT00736099|11549098|FG001|Overall Study|Protocol Violation|4
7319564|NCT00736099|11549097|FG000|Overall Study|Lost to Follow-up|12
7319565|NCT00736099|11549098|FG001|Overall Study|Lost to Follow-up|5
7319566|NCT00736099|11549097|FG000|Overall Study|Withdrawal by Subject|42
7319567|NCT00736099|11549098|FG001|Overall Study|Withdrawal by Subject|13
7319568|NCT00736099|11549097|FG000|Overall Study|Lack of Efficacy|15
7319569|NCT00736099|11549098|FG001|Overall Study|Lack of Efficacy|8
7319570|NCT00736099|11549097|FG000|Overall Study|Other reason|43
7319571|NCT00736099|11549098|FG001|Overall Study|Other reason|10
7319572|NCT00736190|11549113|FG000|Overall Study|Pregnancy|1
7319573|NCT00736190|11549113|FG000|Overall Study|Withdrawal by Subject|1
7319574|NCT00736190|11549113|FG000|Overall Study|Adverse Event|1
7319575|NCT00736255|11549137|FG000|Overall Study|Adverse Event|1
7319576|NCT00736255|11549138|FG001|Overall Study|Adverse Event|0
7319577|NCT00736255|11549137|FG000|Overall Study|Physician Decision|1
7319578|NCT00736255|11549138|FG001|Overall Study|Physician Decision|0
7319579|NCT00736255|11549137|FG000|Overall Study|Non-compliance|1
7319580|NCT00736255|11549138|FG001|Overall Study|Non-compliance|1
7319581|NCT00736333|11549144|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
7319582|NCT00736333|11549144|FG000|Overall Study|Data Missing|2
7319583|NCT00736333|11549144|FG000|Overall Study|Tumor Progression|75
7319584|NCT00736333|11549144|FG000|Overall Study|Toxicity|6
7319585|NCT00736333|11549144|FG000|Overall Study|Withdrawal by Subject|10
7319586|NCT00736333|11549144|FG000|Overall Study|Death|7
7319587|NCT00736333|11549144|FG000|Overall Study|Other|4
7319588|NCT00736450|11549148|FG000|Overall Study|Not ABC gene eligible|19
7319589|NCT00736450|11549148|FG000|Overall Study|Withdrawal by Subject|5
7319590|NCT00736450|11549148|FG000|Overall Study|Physician Decision|1
7319591|NCT00736476|11549154|FG000|Overall Study|Adverse Event|1
7319592|NCT00736476|11549155|FG001|Overall Study|Adverse Event|0
7319593|NCT00736489|11549167|FG000|Period 1|Lost to Follow-up|1
7319594|NCT00736489|11549168|FG001|Period 1|Lost to Follow-up|0
7319595|NCT00736489|11549169|FG002|Period 1|Lost to Follow-up|0
7319596|NCT00736489|11549170|FG003|Period 1|Lost to Follow-up|0
7319597|NCT00736489|11549171|FG004|Period 1|Lost to Follow-up|0
7319598|NCT00736489|11549172|FG005|Period 1|Lost to Follow-up|0
7319599|NCT00736489|11549167|FG000|Period 1|Withdrawal by Subject|0
7319600|NCT00736489|11549168|FG001|Period 1|Withdrawal by Subject|0
7319601|NCT00736489|11549169|FG002|Period 1|Withdrawal by Subject|0
7319602|NCT00736489|11549170|FG003|Period 1|Withdrawal by Subject|0
7319603|NCT00736489|11549171|FG004|Period 1|Withdrawal by Subject|0
7319604|NCT00736489|11549172|FG005|Period 1|Withdrawal by Subject|1
7319605|NCT00736502|11549186|FG000|Overall Study|Adverse Event|22
7319606|NCT00736502|11549186|FG000|Overall Study|Lack of Efficacy|16
7319607|NCT00736502|11549186|FG000|Overall Study|Lost to Follow-up|27
7319608|NCT00736645|11549214|FG000|Overall Study|Adverse Event|0
7319609|NCT00736645|11549215|FG001|Overall Study|Adverse Event|2
7319610|NCT00736645|11549216|FG002|Overall Study|Adverse Event|0
7319611|NCT00736645|11549217|FG003|Overall Study|Adverse Event|0
7319612|NCT00736723|11549229|FG000|Overall Study|Withdrawal by Subject|4
7319613|NCT00736723|11549230|FG001|Overall Study|Withdrawal by Subject|3
7319614|NCT00736840|11549236|FG000|Overall Study|Lost to Follow-up|13
7319615|NCT00736853|11549240|FG000|Open-Label Period|Physician Decision|2
7319616|NCT00736853|11549241|FG001|Open-Label Period|Physician Decision|0
7319617|NCT00736853|11549242|FG002|Open-Label Period|Physician Decision|0
7319618|NCT00736853|11549240|FG000|Open-Label Period|Adverse Event|31
7319619|NCT00736853|11549241|FG001|Open-Label Period|Adverse Event|0
7319620|NCT00736853|11549242|FG002|Open-Label Period|Adverse Event|0
7319621|NCT00736853|11549240|FG000|Open-Label Period|Withdrawal by Subject|16
7319622|NCT00736853|11549241|FG001|Open-Label Period|Withdrawal by Subject|0
7319623|NCT00736853|11549242|FG002|Open-Label Period|Withdrawal by Subject|0
7319624|NCT00736853|11549240|FG000|Open-Label Period|Started but not treated|42
7319625|NCT00736853|11549241|FG001|Open-Label Period|Started but not treated|0
7319626|NCT00736853|11549242|FG002|Open-Label Period|Started but not treated|0
7319627|NCT00736853|11549240|FG000|Open-Label Period|Failed to meet the transfer criteria|40
7319628|NCT00736853|11549241|FG001|Open-Label Period|Failed to meet the transfer criteria|0
7319629|NCT00736853|11549242|FG002|Open-Label Period|Failed to meet the transfer criteria|0
7319630|NCT00736853|11549240|FG000|Open-Label Period|Unable to attend hospital appointments|1
7319631|NCT00736853|11549241|FG001|Open-Label Period|Unable to attend hospital appointments|0
7319632|NCT00736853|11549242|FG002|Open-Label Period|Unable to attend hospital appointments|0
7414986|NCT01437397|11687915|FG004|Overall Study|Protocol Violation|19
7414987|NCT01437397|11687911|FG000|Overall Study|Lack of Efficacy|5
7414988|NCT01437397|11687912|FG001|Overall Study|Lack of Efficacy|4
7414989|NCT01437397|11687913|FG002|Overall Study|Lack of Efficacy|8
7530429|NCT02638103|11874185|FG001|Overall Study|Non-compliance to Study Procedures|1
7414990|NCT01437397|11687914|FG003|Overall Study|Lack of Efficacy|10
7414991|NCT01437397|11687915|FG004|Overall Study|Lack of Efficacy|20
7414992|NCT01437397|11687911|FG000|Overall Study|Adverse Event|21
7414993|NCT01437397|11687912|FG001|Overall Study|Adverse Event|22
7414994|NCT01437397|11687913|FG002|Overall Study|Adverse Event|16
7414995|NCT01437397|11687914|FG003|Overall Study|Adverse Event|14
7414996|NCT01437397|11687915|FG004|Overall Study|Adverse Event|21
7414997|NCT01437397|11687911|FG000|Overall Study|Site termination/COPD exacerbation/other|10
7414998|NCT01437397|11687912|FG001|Overall Study|Site termination/COPD exacerbation/other|8
7414999|NCT01437397|11687913|FG002|Overall Study|Site termination/COPD exacerbation/other|9
7415000|NCT01437397|11687914|FG003|Overall Study|Site termination/COPD exacerbation/other|9
7415001|NCT01437397|11687915|FG004|Overall Study|Site termination/COPD exacerbation/other|14
7415002|NCT01437540|11687951|FG000|Overall Study|Not listed below|7
7415003|NCT01437540|11687952|FG001|Overall Study|Not listed below|6
7415004|NCT01437540|11687951|FG000|Overall Study|COPD exacerbation|13
7415005|NCT01437540|11687952|FG001|Overall Study|COPD exacerbation|3
7415006|NCT01437540|11687951|FG000|Overall Study|Lost to Follow-up|3
7415007|NCT01437540|11687952|FG001|Overall Study|Lost to Follow-up|5
7415008|NCT01437540|11687951|FG000|Overall Study|Lack of Efficacy|23
7415009|NCT01437540|11687952|FG001|Overall Study|Lack of Efficacy|11
7415010|NCT01437540|11687951|FG000|Overall Study|Protocol Violation|24
7415011|NCT01437540|11687952|FG001|Overall Study|Protocol Violation|12
7415012|NCT01437540|11687951|FG000|Overall Study|Adverse Event|26
7415013|NCT01437540|11687952|FG001|Overall Study|Adverse Event|13
7415014|NCT01437540|11687951|FG000|Overall Study|Withdrawal by Subject|31
7415015|NCT01437540|11687952|FG001|Overall Study|Withdrawal by Subject|15
7415016|NCT01437878|11687974|FG000|Overall Study|Withdrawal by Subject|1
7415017|NCT01437878|11687975|FG001|Overall Study|Withdrawal by Subject|0
7415018|NCT01437943|11687983|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
7415019|NCT01437943|11687984|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
7415020|NCT01437943|11687983|FG000|Overall Study|Subject expressed pregnancy plans|1
7415021|NCT01437943|11687984|FG001|Overall Study|Subject expressed pregnancy plans|0
7415022|NCT01437943|11687983|FG000|Overall Study|Adverse Event|2
7415023|NCT01437943|11687984|FG001|Overall Study|Adverse Event|0
7415024|NCT01437995|11687993|FG000|Overall Study|Lost to Follow-up|11
7415025|NCT01437995|11687994|FG001|Overall Study|Lost to Follow-up|18
7415026|NCT01437995|11687995|FG002|Overall Study|Lost to Follow-up|20
7415027|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
7415028|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
7415029|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
7415030|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
7319633|NCT00736853|11549240|FG000|Double-Blind Period|Lack of Efficacy|0
7319634|NCT00736853|11549241|FG001|Double-Blind Period|Lack of Efficacy|19
7319635|NCT00736853|11549242|FG002|Double-Blind Period|Lack of Efficacy|42
7319636|NCT00736853|11549240|FG000|Double-Blind Period|Adverse Event|0
7319637|NCT00736853|11549241|FG001|Double-Blind Period|Adverse Event|3
7319638|NCT00736853|11549242|FG002|Double-Blind Period|Adverse Event|2
7319639|NCT00736853|11549240|FG000|Double-Blind Period|Withdrawal by Subject|0
7319640|NCT00736853|11549241|FG001|Double-Blind Period|Withdrawal by Subject|1
7319641|NCT00736853|11549242|FG002|Double-Blind Period|Withdrawal by Subject|4
7319642|NCT00736853|11549240|FG000|Double-Blind Period|Ineligible to participate the study|0
7319643|NCT00736853|11549241|FG001|Double-Blind Period|Ineligible to participate the study|1
7319644|NCT00736853|11549242|FG002|Double-Blind Period|Ineligible to participate the study|0
7319645|NCT00736879|11549255|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7319646|NCT00736879|11549256|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7319647|NCT00736879|11549257|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7319648|NCT00736879|11549258|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7319649|NCT00736879|11549255|FG000|Double Blind Treatment Period|Adverse Event|0
7319650|NCT00736879|11549256|FG001|Double Blind Treatment Period|Adverse Event|1
7319651|NCT00736879|11549257|FG002|Double Blind Treatment Period|Adverse Event|1
7319652|NCT00736879|11549258|FG003|Double Blind Treatment Period|Adverse Event|0
7319653|NCT00736879|11549255|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
7319654|NCT00736879|11549256|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
7319655|NCT00736879|11549257|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
7319656|NCT00736879|11549258|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
7319657|NCT00736879|11549255|FG000|Double Blind Treatment Period|Lost to Follow-up|0
7319658|NCT00736879|11549256|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7319659|NCT00736879|11549257|FG002|Double Blind Treatment Period|Lost to Follow-up|2
7319660|NCT00736879|11549258|FG003|Double Blind Treatment Period|Lost to Follow-up|1
7319661|NCT00736879|11549255|FG000|Double Blind Treatment Period|Poor non-compliance|0
7319662|NCT00736879|11549256|FG001|Double Blind Treatment Period|Poor non-compliance|0
7530430|NCT02638103|11874186|FG002|Overall Study|Non-compliance to Study Procedures|1
7319663|NCT00736879|11549257|FG002|Double Blind Treatment Period|Poor non-compliance|1
7319664|NCT00736879|11549258|FG003|Double Blind Treatment Period|Poor non-compliance|1
7319665|NCT00736879|11549255|FG000|Double Blind Treatment Period|No longer met criteria|0
7319666|NCT00736879|11549256|FG001|Double Blind Treatment Period|No longer met criteria|1
7319667|NCT00736879|11549257|FG002|Double Blind Treatment Period|No longer met criteria|0
7319668|NCT00736879|11549258|FG003|Double Blind Treatment Period|No longer met criteria|0
7319669|NCT00736879|11549255|FG000|Double Blind Treatment Period|non-specified|0
7319670|NCT00736879|11549256|FG001|Double Blind Treatment Period|non-specified|1
7319671|NCT00736879|11549257|FG002|Double Blind Treatment Period|non-specified|0
7319672|NCT00736879|11549258|FG003|Double Blind Treatment Period|non-specified|0
7319673|NCT00736879|11549255|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7319674|NCT00736879|11549256|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
7319675|NCT00736879|11549257|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7319676|NCT00736879|11549258|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
7319677|NCT00736879|11549255|FG000|Follow up Period - No Drug Treatment|non-specified|1
7319678|NCT00736879|11549256|FG001|Follow up Period - No Drug Treatment|non-specified|2
7319679|NCT00736879|11549257|FG002|Follow up Period - No Drug Treatment|non-specified|0
7319680|NCT00736879|11549258|FG003|Follow up Period - No Drug Treatment|non-specified|0
7319681|NCT00736944|11549271|FG000|Induction|Death|1
7319682|NCT00736944|11549271|FG000|Definitive Treatment|Physician Decision|1
7319683|NCT00736957|11549278|FG000|Overall Study|Adverse Event|43
7319684|NCT00736957|11549278|FG000|Overall Study|Withdrawal by Subject|49
7319685|NCT00736957|11549278|FG000|Overall Study|violation of eligibility criteria|2
7319686|NCT00736957|11549278|FG000|Overall Study|did not attend hospital appointments|1
7319687|NCT00736957|11549278|FG000|Overall Study|not eligible for Treatment Period I|22
7319688|NCT00736957|11549278|FG000|Overall Study|Physician Decision|5
7319689|NCT00736996|11549285|FG000|Overall Study|Lost to Follow-up|1
7319690|NCT00736996|11549286|FG001|Overall Study|Lost to Follow-up|9
7319691|NCT00736996|11549287|FG002|Overall Study|Lost to Follow-up|2
7319692|NCT00737048|11549298|FG000|Overall Study|Physician Decision|0
7319693|NCT00737048|11549299|FG001|Overall Study|Physician Decision|0
7319694|NCT00737048|11549300|FG002|Overall Study|Physician Decision|1
7319695|NCT00737048|11549298|FG000|Overall Study|Adverse Event|0
7319696|NCT00737048|11549299|FG001|Overall Study|Adverse Event|1
7319697|NCT00737048|11549300|FG002|Overall Study|Adverse Event|0
7319698|NCT00737048|11549298|FG000|Overall Study|Worsening of the symptoms|3
7319699|NCT00737048|11549299|FG001|Overall Study|Worsening of the symptoms|5
7319700|NCT00737048|11549300|FG002|Overall Study|Worsening of the symptoms|3
7319701|NCT00737061|11549308|FG000|Waiting Period|Lost to Follow-up|6
7319702|NCT00737061|11549308|FG000|Waiting Period|Withdrawal by Subject|1
7319703|NCT00737061|11549308|FG000|Waiting Period|Bilateral placement failure|34
7319704|NCT00737061|11549308|FG000|Waiting Period|Deemed patent following HSG|26
7319705|NCT00737061|11549308|FG000|Waiting Period|Alternative contraception failure|3
7319706|NCT00737061|11549308|FG000|Waiting Period|Elected surgical tubal ligation|5
7319707|NCT00737061|11549308|FG000|1 Year Wearing Period|Lost to Follow-up|11
7319708|NCT00737061|11549308|FG000|1 Year Wearing Period|Withdrawal by Subject|2
7319709|NCT00737061|11549308|FG000|1 Year Wearing Period|Discontinued reilance|3
7319710|NCT00737061|11549308|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
7319711|NCT00737100|11549315|FG000|Overall Study|Adverse Event|6
7319712|NCT00737100|11549316|FG001|Overall Study|Adverse Event|5
7319713|NCT00737100|11549317|FG002|Overall Study|Adverse Event|3
7319714|NCT00737100|11549315|FG000|Overall Study|Lost to Follow-up|0
7319715|NCT00737100|11549316|FG001|Overall Study|Lost to Follow-up|1
7319716|NCT00737100|11549317|FG002|Overall Study|Lost to Follow-up|0
7319717|NCT00737100|11549315|FG000|Overall Study|Withdrawal by Subject|0
7319718|NCT00737100|11549316|FG001|Overall Study|Withdrawal by Subject|0
7319719|NCT00737100|11549317|FG002|Overall Study|Withdrawal by Subject|3
7319720|NCT00737100|11549315|FG000|Overall Study|Reason discontinued not explained above|1
7319721|NCT00737100|11549316|FG001|Overall Study|Reason discontinued not explained above|1
7319722|NCT00737100|11549317|FG002|Overall Study|Reason discontinued not explained above|1
7319723|NCT00737438|11549355|FG000|Overall Study|Withdrawal by Subject|2
7319724|NCT00737438|11549355|FG000|Overall Study|Patient ineligible|1
7319725|NCT00737464|11549359|FG000|Overall Study|Adverse Event|1
7319726|NCT00737464|11549359|FG000|Overall Study|Death|6
7319727|NCT00737464|11549359|FG000|Overall Study|Other - Failure to Return|1
7319728|NCT00737464|11549359|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
7319729|NCT00737464|11549359|FG000|Overall Study|Other reasons|4
7319730|NCT00737477|11549363|FG000|Overall Study|Adverse Event|9
7319731|NCT00737477|11549363|FG000|Overall Study|Death|9
7319732|NCT00737477|11549363|FG000|Overall Study|Treatment Refusal|1
7319733|NCT00737477|11549363|FG000|Overall Study|Withdrawal by Subject|1
7553693|NCT03016325|11914577|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
7553694|NCT03016325|11914570|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553695|NCT03016325|11914571|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
7553696|NCT03016325|11914572|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553697|NCT03016325|11914573|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553698|NCT03016325|11914574|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553699|NCT03016325|11914575|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553700|NCT03016325|11914576|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553701|NCT03016325|11914577|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
7553702|NCT03016325|11914570|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7553703|NCT03016325|11914571|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7553704|NCT03016325|11914572|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7553705|NCT03016325|11914573|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7553706|NCT03016325|11914574|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
7553707|NCT03016325|11914575|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
7553708|NCT03016325|11914576|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
7553709|NCT03016325|11914577|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
7553710|NCT03016403|11914602|FG000|Baseline|Death|5
7553711|NCT03016403|11914603|FG001|Baseline|Death|8
7553712|NCT03016403|11914604|FG002|Baseline|Death|1
7553713|NCT03016403|11914605|FG003|Baseline|Death|0
7553714|NCT03016403|11914602|FG000|Baseline|Withdrawal by Subject|2
7553715|NCT03016403|11914603|FG001|Baseline|Withdrawal by Subject|8
7553716|NCT03016403|11914604|FG002|Baseline|Withdrawal by Subject|4
7553717|NCT03016403|11914605|FG003|Baseline|Withdrawal by Subject|10
7553718|NCT03016403|11914602|FG000|Baseline|Lost to Follow-up|9
7553719|NCT03016403|11914603|FG001|Baseline|Lost to Follow-up|11
7553720|NCT03016403|11914604|FG002|Baseline|Lost to Follow-up|6
7553721|NCT03016403|11914605|FG003|Baseline|Lost to Follow-up|24
7415031|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
7415032|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
7415033|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
7415034|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
7415035|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
7415036|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
7415037|NCT01438060|11688014|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
7415038|NCT01438060|11688015|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
7415039|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
7415040|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
7415041|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7415042|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
7415043|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
7415044|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
7415045|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
7415046|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
7415047|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
7415048|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
7415049|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Death|22
7415050|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Death|12
7415051|NCT01438060|11688014|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
7415052|NCT01438060|11688015|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
7415053|NCT01438060|11688014|FG000|On Study Beyond Week 140|Adverse Event|0
7415054|NCT01438060|11688015|FG001|On Study Beyond Week 140|Adverse Event|2
7415055|NCT01438060|11688014|FG000|On Study Beyond Week 140|Lack of Efficacy|0
7415056|NCT01438060|11688015|FG001|On Study Beyond Week 140|Lack of Efficacy|1
7415057|NCT01438060|11688014|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
7415058|NCT01438060|11688015|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
7415059|NCT01438060|11688014|FG000|On Study Beyond Week 140|Death|0
7415060|NCT01438060|11688015|FG001|On Study Beyond Week 140|Death|1
7415061|NCT01438060|11688014|FG000|On Study Beyond Week 140|Other Reason|0
7415062|NCT01438060|11688015|FG001|On Study Beyond Week 140|Other Reason|3
7415063|NCT01438151|11688026|FG000|Overall Study|study terminated|8
7415064|NCT01438177|11688030|FG000|Overall Study|Withdrawal by Subject|1
7415065|NCT01438177|11688030|FG000|Overall Study|Initiation of new therapy|1
7415066|NCT01438294|11688040|FG000|Overall Study|Lost to Follow-up|3
7415067|NCT01438294|11688041|FG001|Overall Study|Lost to Follow-up|7
7415068|NCT01438307|11688049|FG000|Overall Study|Death|1
7415069|NCT01438307|11688050|FG001|Overall Study|Death|1
7415070|NCT01438411|11688056|FG000|Overall Study|Adverse Event|8
7415071|NCT01438411|11688056|FG000|Overall Study|Lost to Follow-up|1
7415072|NCT01438411|11688056|FG000|Overall Study|Lack of Efficacy|1
7415073|NCT01438411|11688056|FG000|Overall Study|Withdrawal by Subject|3
7415074|NCT01438424|11688060|FG000|Overall Study|Continuing treatment|29
7415075|NCT01438424|11688060|FG000|Overall Study|Minimal virologic response|95
7415076|NCT01438424|11688060|FG000|Overall Study|Not identified|55
7415077|NCT01438424|11688060|FG000|Overall Study|Withdrawal by Subject|104
7415078|NCT01438424|11688060|FG000|Overall Study|Progression of chronic hepatitis B|22
7553722|NCT03016403|11914602|FG000|6-week Follow-up|Death|1
7553723|NCT03016403|11914603|FG001|6-week Follow-up|Death|4
7553724|NCT03016403|11914604|FG002|6-week Follow-up|Death|0
7553725|NCT03016403|11914605|FG003|6-week Follow-up|Death|0
7415079|NCT01438424|11688060|FG000|Overall Study|Death|22
7415080|NCT01438424|11688060|FG000|Overall Study|Adverse Event|17
7415081|NCT01438424|11688060|FG000|Overall Study|Lost to Follow-up|17
7415082|NCT01438424|11688060|FG000|Overall Study|Abnormal laboratory test result|14
7415083|NCT01438424|11688060|FG000|Overall Study|Need for drug prohibited by protocol|14
7415084|NCT01438424|11688060|FG000|Overall Study|Pregnancy|7
7415085|NCT01438424|11688060|FG000|Overall Study|No longer met inclusion criteria|1
7415086|NCT01438424|11688060|FG000|Overall Study|Participant noncompliance|20
7415087|NCT01438476|11688076|FG000|Overall Study|Protocol Violation|1
7415088|NCT01438476|11688077|FG001|Overall Study|Protocol Violation|0
7415089|NCT01438476|11688076|FG000|Overall Study|Withdrawal by Subject|1
7415090|NCT01438476|11688077|FG001|Overall Study|Withdrawal by Subject|0
7415091|NCT01438476|11688076|FG000|Overall Study|No Surgery- Disease|8
7415092|NCT01438476|11688077|FG001|Overall Study|No Surgery- Disease|10
7415093|NCT01438476|11688076|FG000|Overall Study|Communication barrier|0
7415094|NCT01438476|11688077|FG001|Overall Study|Communication barrier|1
7415095|NCT01438489|11688086|FG000|Overall Study|Lost to Follow-up|4
7415096|NCT01438489|11688087|FG001|Overall Study|Lost to Follow-up|2
7415097|NCT01438489|11688088|FG002|Overall Study|Lost to Follow-up|2
7415098|NCT01438489|11688086|FG000|Overall Study|Withdrawal by Subject|11
7415099|NCT01438489|11688087|FG001|Overall Study|Withdrawal by Subject|3
7415100|NCT01438489|11688088|FG002|Overall Study|Withdrawal by Subject|8
7415101|NCT01438489|11688086|FG000|Overall Study|Death|0
7415102|NCT01438489|11688087|FG001|Overall Study|Death|0
7415103|NCT01438489|11688088|FG002|Overall Study|Death|1
7415104|NCT01438489|11688086|FG000|Overall Study|Sponsor decision|4
7415105|NCT01438489|11688087|FG001|Overall Study|Sponsor decision|1
7415106|NCT01438489|11688088|FG002|Overall Study|Sponsor decision|4
7415107|NCT01438489|11688086|FG000|Overall Study|Subject choice/Subject moved|2
7415108|NCT01438489|11688087|FG001|Overall Study|Subject choice/Subject moved|1
7415109|NCT01438489|11688088|FG002|Overall Study|Subject choice/Subject moved|1
7415110|NCT01438489|11688086|FG000|Overall Study|Investigator decision|0
7415111|NCT01438489|11688087|FG001|Overall Study|Investigator decision|1
7415112|NCT01438489|11688088|FG002|Overall Study|Investigator decision|0
7415113|NCT01438489|11688086|FG000|Overall Study|AE/SAEs|2
7415114|NCT01438489|11688087|FG001|Overall Study|AE/SAEs|1
7415115|NCT01438489|11688088|FG002|Overall Study|AE/SAEs|1
7415116|NCT01438489|11688086|FG000|Overall Study|Received prohibited medication|1
7415117|NCT01438489|11688087|FG001|Overall Study|Received prohibited medication|0
7415118|NCT01438489|11688088|FG002|Overall Study|Received prohibited medication|0
7415119|NCT01438489|11688086|FG000|Overall Study|Did not complete all 3 follow-up visits|2
7415120|NCT01438489|11688087|FG001|Overall Study|Did not complete all 3 follow-up visits|5
7415121|NCT01438489|11688088|FG002|Overall Study|Did not complete all 3 follow-up visits|2
7415122|NCT01438489|11688086|FG000|Overall Study|Inadequate venous access|0
7415123|NCT01438489|11688087|FG001|Overall Study|Inadequate venous access|2
7415124|NCT01438489|11688088|FG002|Overall Study|Inadequate venous access|0
7415125|NCT01438541|11688098|FG000|Overall Study|Physician Decision|1
7415126|NCT01438541|11688098|FG000|Overall Study|Withdrawal by Subject|1
7415127|NCT01438541|11688098|FG000|Overall Study|discharge from the hospital|5
7415128|NCT01438814|11688110|FG000|Overall Study|Adverse Event|3
7415129|NCT01438814|11688111|FG001|Overall Study|Adverse Event|3
7415130|NCT01438814|11688110|FG000|Overall Study|Protocol Violation|1
7415131|NCT01438814|11688111|FG001|Overall Study|Protocol Violation|2
7415132|NCT01438814|11688110|FG000|Overall Study|Lost to Follow-up|4
7415133|NCT01438814|11688111|FG001|Overall Study|Lost to Follow-up|3
7415134|NCT01438814|11688110|FG000|Overall Study|Withdrawal by Subject|4
7415135|NCT01438814|11688111|FG001|Overall Study|Withdrawal by Subject|2
7415136|NCT01438814|11688110|FG000|Overall Study|Other|2
7415137|NCT01438814|11688111|FG001|Overall Study|Other|4
7415138|NCT01438840|11688119|FG000|Core Study|Adverse Event|0
7415139|NCT01438840|11688120|FG001|Core Study|Adverse Event|3
7415140|NCT01438840|11688121|FG002|Core Study|Adverse Event|0
7415141|NCT01438840|11688119|FG000|Core Study|Lack of Efficacy|15
7415142|NCT01438840|11688120|FG001|Core Study|Lack of Efficacy|7
7415143|NCT01438840|11688121|FG002|Core Study|Lack of Efficacy|0
7415144|NCT01438840|11688119|FG000|Core Study|Withdrawal of consent|1
7415145|NCT01438840|11688120|FG001|Core Study|Withdrawal of consent|0
7415146|NCT01438840|11688121|FG002|Core Study|Withdrawal of consent|0
7415147|NCT01438840|11688119|FG000|Extension Phase|Adverse Event|0
7415148|NCT01438840|11688120|FG001|Extension Phase|Adverse Event|0
7415149|NCT01438840|11688121|FG002|Extension Phase|Adverse Event|3
7415150|NCT01438840|11688119|FG000|Extension Phase|Lost to Follow-up|0
7415151|NCT01438840|11688120|FG001|Extension Phase|Lost to Follow-up|0
7415152|NCT01438840|11688121|FG002|Extension Phase|Lost to Follow-up|1
7415153|NCT01438840|11688119|FG000|Extension Phase|Withdrawal by Subject|0
7415154|NCT01438840|11688120|FG001|Extension Phase|Withdrawal by Subject|0
7415155|NCT01438840|11688121|FG002|Extension Phase|Withdrawal by Subject|3
7415156|NCT01438840|11688119|FG000|Extension Phase|Lack of Efficacy|0
7415157|NCT01438840|11688120|FG001|Extension Phase|Lack of Efficacy|0
7415158|NCT01438840|11688121|FG002|Extension Phase|Lack of Efficacy|2
7415159|NCT01438840|11688119|FG000|Extension Phase|Other|0
7415160|NCT01438840|11688120|FG001|Extension Phase|Other|0
7415161|NCT01438840|11688121|FG002|Extension Phase|Other|1
7415162|NCT01438957|11688133|FG000|Overall Study|Physician Decision|1
7553726|NCT03016403|11914602|FG000|6-week Follow-up|Lost to Follow-up|2
7553727|NCT03016403|11914603|FG001|6-week Follow-up|Lost to Follow-up|7
7553728|NCT03016403|11914604|FG002|6-week Follow-up|Lost to Follow-up|4
7553729|NCT03016403|11914605|FG003|6-week Follow-up|Lost to Follow-up|8
7553730|NCT03016403|11914602|FG000|6-week Follow-up|Withdrawal by Subject|0
7553731|NCT03016403|11914603|FG001|6-week Follow-up|Withdrawal by Subject|2
7553732|NCT03016403|11914604|FG002|6-week Follow-up|Withdrawal by Subject|0
7553733|NCT03016403|11914605|FG003|6-week Follow-up|Withdrawal by Subject|1
7553734|NCT03016403|11914602|FG000|3-month Follow-up and 6-month Follow-up|Death|6
7553735|NCT03016403|11914603|FG001|3-month Follow-up and 6-month Follow-up|Death|4
7553736|NCT03016403|11914604|FG002|3-month Follow-up and 6-month Follow-up|Death|0
7553737|NCT03016403|11914605|FG003|3-month Follow-up and 6-month Follow-up|Death|0
7553738|NCT03016403|11914602|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7553739|NCT03016403|11914603|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
7553740|NCT03016403|11914604|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
7553741|NCT03016403|11914605|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
7553742|NCT03016403|11914602|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7553743|NCT03016403|11914603|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7553744|NCT03016403|11914604|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
7553745|NCT03016403|11914605|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
7553746|NCT03016598|11914619|FG000|Overall Study|Lost to Follow-up|0
7553747|NCT03016598|11914620|FG001|Overall Study|Lost to Follow-up|2
7553748|NCT03017079|11914628|FG000|Overall Study|Physician Decision|1
7319734|NCT00737477|11549363|FG000|Overall Study|Renal Transplantation|10
7319735|NCT00737477|11549363|FG000|Overall Study|Other|4
7319736|NCT00737529|11549367|FG000|Overall Study|Disease Progression|95
7319737|NCT00737529|11549367|FG000|Overall Study|Adverse Event|24
7319738|NCT00737529|11549367|FG000|Overall Study|Withdrawal by Subject|5
7319739|NCT00737529|11549367|FG000|Overall Study|Death|4
7319740|NCT00737529|11549367|FG000|Overall Study|Protocol Violation|1
7319741|NCT00737529|11549367|FG000|Overall Study|Other|4
7319742|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
7319743|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
7319744|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Withdrew Consent|5
7319745|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Withdrew Consent|6
7319746|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
7319747|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
7530431|NCT02638103|11874187|FG003|Overall Study|Non-compliance to Study Procedures|1
7553749|NCT03017079|11914629|FG001|Overall Study|Physician Decision|1
7553750|NCT03017079|11914628|FG000|Overall Study|Death|3
7553751|NCT03017079|11914629|FG001|Overall Study|Death|2
7553752|NCT03017079|11914628|FG000|Overall Study|Lack of Efficacy|2
7553753|NCT03017079|11914629|FG001|Overall Study|Lack of Efficacy|2
7553754|NCT03017079|11914628|FG000|Overall Study|Protocol Violation|0
7553755|NCT03017079|11914629|FG001|Overall Study|Protocol Violation|1
7530432|NCT02638103|11874184|FG000|Overall Study|Lost to Follow-up|26
7530433|NCT02638103|11874185|FG001|Overall Study|Lost to Follow-up|33
7553756|NCT03017235|11914644|FG000|Overall Study|Withdrawal by Subject|4
7553757|NCT03017235|11914645|FG001|Overall Study|Withdrawal by Subject|3
7553758|NCT03017235|11914644|FG000|Overall Study|Lost to Follow-up|2
7553759|NCT03017235|11914645|FG001|Overall Study|Lost to Follow-up|7
7553760|NCT03017235|11914644|FG000|Overall Study|Adverse Event|0
7553761|NCT03017235|11914645|FG001|Overall Study|Adverse Event|1
7553762|NCT03017235|11914644|FG000|Overall Study|Protocol Violation|2
7553763|NCT03017235|11914645|FG001|Overall Study|Protocol Violation|1
7553764|NCT03017235|11914644|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
7553765|NCT03017235|11914645|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
7553766|NCT03017612|11914664|FG000|Overall Study|Adverse Event|2
7553767|NCT03017846|11914668|FG000|Overall Study|Lost to Follow-up|3
7553768|NCT03017846|11914668|FG000|Overall Study|Adverse Event|2
7553769|NCT03018028|11914695|FG000|Overall Study|Withdrawal by Subject|3
7553770|NCT03018028|11914696|FG001|Overall Study|Withdrawal by Subject|0
7553771|NCT03018028|11914697|FG002|Overall Study|Withdrawal by Subject|1
7553772|NCT03018028|11914698|FG003|Overall Study|Withdrawal by Subject|2
7553773|NCT03018028|11914699|FG004|Overall Study|Withdrawal by Subject|0
7553774|NCT03018106|11914713|FG000|Overall Study|Lost to Follow-up|0
7553775|NCT03018106|11914714|FG001|Overall Study|Lost to Follow-up|1
7553776|NCT03018249|11914724|FG000|Overall Study|Withdrawal by Subject|2
7553777|NCT03018249|11914725|FG001|Overall Study|Withdrawal by Subject|2
7553778|NCT03018340|11914733|FG000|Overall Study|Adverse Event|1
7553779|NCT03018340|11914734|FG001|Overall Study|Adverse Event|2
7553780|NCT03018340|11914733|FG000|Overall Study|Withdrawal by Subject|0
7553781|NCT03018340|11914734|FG001|Overall Study|Withdrawal by Subject|8
7553782|NCT03018340|11914733|FG000|Overall Study|Lack of Efficacy|0
7530434|NCT02638103|11874186|FG002|Overall Study|Lost to Follow-up|20
7530435|NCT02638103|11874187|FG003|Overall Study|Lost to Follow-up|37
7530436|NCT02638103|11874184|FG000|Overall Study|Lack of Efficacy|14
7530437|NCT02638103|11874185|FG001|Overall Study|Lack of Efficacy|10
7530438|NCT02638103|11874186|FG002|Overall Study|Lack of Efficacy|12
7530439|NCT02638103|11874187|FG003|Overall Study|Lack of Efficacy|22
7553783|NCT03018340|11914734|FG001|Overall Study|Lack of Efficacy|1
7553784|NCT03018340|11914733|FG000|Overall Study|Non-compliance with study drug/procedure|3
7553785|NCT03018340|11914734|FG001|Overall Study|Non-compliance with study drug/procedure|4
7415163|NCT01438957|11688134|FG001|Overall Study|Physician Decision|1
7415164|NCT01438957|11688135|FG002|Overall Study|Physician Decision|0
7415165|NCT01438957|11688136|FG003|Overall Study|Physician Decision|1
7530440|NCT02638103|11874184|FG000|Overall Study|Other than specified|5
7530441|NCT02638103|11874185|FG001|Overall Study|Other than specified|4
7415166|NCT01438957|11688137|FG004|Overall Study|Physician Decision|0
7415167|NCT01438996|11688152|FG000|Overall Study|Not meeting Inclusion Criteria|4
7415168|NCT01438996|11688153|FG001|Overall Study|Not meeting Inclusion Criteria|1
7225154|NCT00064701|11434642|FG000|One Year Post-transplant|Did not receive study drug|7
7225155|NCT00064701|11434643|FG001|One Year Post-transplant|Did not receive study drug|12
7415169|NCT01438996|11688154|FG002|Overall Study|Not meeting Inclusion Criteria|0
7415170|NCT01439009|11688164|FG000|Overall Study|Physician Decision|5
7415171|NCT01439009|11688165|FG001|Overall Study|Physician Decision|3
7415172|NCT01439009|11688164|FG000|Overall Study|Protocol Violation|2
7415173|NCT01439009|11688165|FG001|Overall Study|Protocol Violation|0
7415174|NCT01439009|11688164|FG000|Overall Study|Deviation of exclusion criteria|1
7415175|NCT01439009|11688165|FG001|Overall Study|Deviation of exclusion criteria|0
7415176|NCT01439074|11688177|FG000|Overall Study|Lost to Follow-up|3
7415177|NCT01439074|11688178|FG001|Overall Study|Lost to Follow-up|4
7415178|NCT01439074|11688177|FG000|Overall Study|Subject shedding|1
7415179|NCT01439074|11688178|FG001|Overall Study|Subject shedding|0
7415180|NCT01439074|11688177|FG000|Overall Study|Withdrawal by Subject|1
7415181|NCT01439074|11688178|FG001|Overall Study|Withdrawal by Subject|5
7415182|NCT01439074|11688177|FG000|Overall Study|Other|4
7415183|NCT01439074|11688178|FG001|Overall Study|Other|4
7415184|NCT01439126|11688190|FG000|Overall Study|Adverse Event|2
7415185|NCT01439126|11688191|FG001|Overall Study|Adverse Event|0
7415186|NCT01439126|11688190|FG000|Overall Study|Withdrawal by Subject|5
7415187|NCT01439126|11688191|FG001|Overall Study|Withdrawal by Subject|21
7415188|NCT01439126|11688190|FG000|Overall Study|Protocol Violation|6
7415189|NCT01439126|11688191|FG001|Overall Study|Protocol Violation|4
7415190|NCT01439126|11688190|FG000|Overall Study|Lost to Follow-up|6
7415191|NCT01439126|11688191|FG001|Overall Study|Lost to Follow-up|3
7415192|NCT01439126|11688190|FG000|Overall Study|Other-Use of prohibited treatment|0
7415193|NCT01439126|11688191|FG001|Overall Study|Other-Use of prohibited treatment|2
7415194|NCT01439126|11688190|FG000|Overall Study|Other-Miscellaneous|12
7415195|NCT01439126|11688191|FG001|Overall Study|Other-Miscellaneous|12
7415196|NCT01439204|11688199|FG000|Overall Study|Withdrawal by Subject|0
7415197|NCT01439204|11688200|FG001|Overall Study|Withdrawal by Subject|1
7415198|NCT01439204|11688199|FG000|Overall Study|Lost to Follow-up|0
7415199|NCT01439204|11688200|FG001|Overall Study|Lost to Follow-up|2
7415200|NCT01439204|11688199|FG000|Overall Study|No longer meets study criteria|1
7415201|NCT01439204|11688200|FG001|Overall Study|No longer meets study criteria|0
7415202|NCT01439204|11688199|FG000|Overall Study|poor/non-compliance|3
7415203|NCT01439204|11688200|FG001|Overall Study|poor/non-compliance|0
7415204|NCT01439282|11688208|FG000|Overall Study|Adverse Event|5
7415205|NCT01439282|11688209|FG001|Overall Study|Adverse Event|0
7415206|NCT01439282|11688208|FG000|Overall Study|Withdrawal by Subject|2
7415207|NCT01439282|11688209|FG001|Overall Study|Withdrawal by Subject|0
7415208|NCT01439282|11688208|FG000|Overall Study|Other|1
7415209|NCT01439282|11688209|FG001|Overall Study|Other|1
7415210|NCT01439360|11688218|FG000|Overall Study|Adverse Event|4
7415211|NCT01439360|11688219|FG001|Overall Study|Adverse Event|16
7415212|NCT01439360|11688218|FG000|Overall Study|Lost to Follow-up|43
7415213|NCT01439360|11688219|FG001|Overall Study|Lost to Follow-up|58
7415214|NCT01439360|11688218|FG000|Overall Study|Others|10
7415215|NCT01439360|11688219|FG001|Overall Study|Others|5
7415216|NCT01439360|11688218|FG000|Overall Study|Protocol Violation|1
7415217|NCT01439360|11688219|FG001|Overall Study|Protocol Violation|0
7415218|NCT01439360|11688218|FG000|Overall Study|Withdrawal by Subject|140
7415219|NCT01439360|11688219|FG001|Overall Study|Withdrawal by Subject|129
7415220|NCT01439373|11688227|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
7415221|NCT01439373|11688228|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
7415222|NCT01439373|11688227|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
7415223|NCT01439373|11688228|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
7415224|NCT01439555|11688238|FG000|Overall Study|Protocol Violation|1
7415225|NCT01439568|11688244|FG000|Overall Study|Lost to Follow-up|1
7415226|NCT01439568|11688245|FG001|Overall Study|Lost to Follow-up|0
7415227|NCT01439568|11688244|FG000|Overall Study|Withdrawal by Subject|2
7415228|NCT01439568|11688245|FG001|Overall Study|Withdrawal by Subject|2
7415229|NCT01439711|11688276|FG000|Overall Study|Ineligible|13
7415230|NCT01439711|11688276|FG000|Overall Study|Cancel|3
7530442|NCT02638103|11874186|FG002|Overall Study|Other than specified|2
7553786|NCT03018340|11914733|FG000|Overall Study|Lost to Follow-up|1
7415231|NCT01439711|11688276|FG000|Overall Study|Progression Prior to Beginning Tx|1
7415232|NCT01439711|11688276|FG000|Overall Study|Adverse Event|5
7415233|NCT01439711|11688276|FG000|Overall Study|Withdrawal by Subject|3
7415234|NCT01439711|11688276|FG000|Overall Study|Progression During Active Tx|3
7415235|NCT01439711|11688276|FG000|Overall Study|Noncompliance|3
7415236|NCT01439711|11688276|FG000|Overall Study|No MRI|9
7553787|NCT03018340|11914734|FG001|Overall Study|Lost to Follow-up|7
7553788|NCT03018340|11914733|FG000|Overall Study|Protocol Violation|3
7553789|NCT03018340|11914734|FG001|Overall Study|Protocol Violation|7
7553790|NCT03018340|11914733|FG000|Overall Study|Not further specified|0
7553791|NCT03018340|11914734|FG001|Overall Study|Not further specified|1
7553792|NCT03018691|11914747|FG000|Overall Study|Adverse Event|1
7553793|NCT03018691|11914748|FG001|Overall Study|Adverse Event|1
7553794|NCT03018691|11914749|FG002|Overall Study|Adverse Event|4
7553795|NCT03018691|11914747|FG000|Overall Study|Lack of Efficacy|0
7553796|NCT03018691|11914748|FG001|Overall Study|Lack of Efficacy|0
7553797|NCT03018691|11914749|FG002|Overall Study|Lack of Efficacy|1
7553798|NCT03018691|11914747|FG000|Overall Study|Withdrawal by Subject|0
7553799|NCT03018691|11914748|FG001|Overall Study|Withdrawal by Subject|0
7553800|NCT03018691|11914749|FG002|Overall Study|Withdrawal by Subject|1
7553801|NCT03018691|11914747|FG000|Overall Study|Withdrawal by parent/guardian|1
7553802|NCT03018691|11914748|FG001|Overall Study|Withdrawal by parent/guardian|0
7553803|NCT03018691|11914749|FG002|Overall Study|Withdrawal by parent/guardian|1
7553804|NCT03018938|11914786|FG000|Overall Study|Death|0
7553805|NCT03018938|11914787|FG001|Overall Study|Death|1
7553806|NCT03018938|11914786|FG000|Overall Study|Lost to Follow-up|21
7553807|NCT03018938|11914787|FG001|Overall Study|Lost to Follow-up|32
7553808|NCT03018938|11914786|FG000|Overall Study|Withdrawal by Subject|38
7553809|NCT03018938|11914787|FG001|Overall Study|Withdrawal by Subject|45
7553810|NCT03018938|11914786|FG000|Overall Study|Physician Decision|3
7553811|NCT03018938|11914787|FG001|Overall Study|Physician Decision|2
7553812|NCT03018938|11914786|FG000|Overall Study|Sponsor Decision|0
7553813|NCT03018938|11914787|FG001|Overall Study|Sponsor Decision|1
7553814|NCT03018938|11914786|FG000|Overall Study|Screen failure-After randomization|4
7553815|NCT03018938|11914787|FG001|Overall Study|Screen failure-After randomization|2
7553816|NCT03018938|11914786|FG000|Overall Study|Not recorded|0
7553817|NCT03018938|11914787|FG001|Overall Study|Not recorded|2
7553818|NCT03019289|11914828|FG000|Overall Study|Adverse Event|1
7553819|NCT03019289|11914829|FG001|Overall Study|Adverse Event|0
7553820|NCT03019289|11914830|FG002|Overall Study|Adverse Event|0
7553821|NCT03019289|11914831|FG003|Overall Study|Adverse Event|0
7553822|NCT03019289|11914832|FG004|Overall Study|Adverse Event|0
7553823|NCT03019289|11914833|FG005|Overall Study|Adverse Event|0
7553824|NCT03019289|11914834|FG006|Overall Study|Adverse Event|0
7553825|NCT03019289|11914835|FG007|Overall Study|Adverse Event|0
7553826|NCT03019289|11914836|FG008|Overall Study|Adverse Event|1
7553827|NCT03019289|11914828|FG000|Overall Study|Other|1
7553828|NCT03019289|11914829|FG001|Overall Study|Other|0
7553829|NCT03019289|11914830|FG002|Overall Study|Other|0
7553830|NCT03019289|11914831|FG003|Overall Study|Other|0
7553831|NCT03019289|11914832|FG004|Overall Study|Other|0
7553832|NCT03019289|11914833|FG005|Overall Study|Other|0
7553833|NCT03019289|11914834|FG006|Overall Study|Other|0
7553834|NCT03019289|11914835|FG007|Overall Study|Other|0
7553835|NCT03019289|11914836|FG008|Overall Study|Other|0
7553836|NCT03019458|11914859|FG000|Overall Study|Death|0
7553837|NCT03019458|11914860|FG001|Overall Study|Death|1
7553838|NCT03019549|11914868|FG000|Washout|DId not meet genotype criteria|11
7553839|NCT03019549|11914868|FG000|Period 2|Adverse Event|2
7553840|NCT03019549|11914868|FG000|Period 2|Physician Decision|2
7553841|NCT03019549|11914868|FG000|Period 2|Withdrawal by Subject|1
7553842|NCT03019627|11914879|FG000|Overall Study|Adverse Event|8
7553843|NCT03019627|11914880|FG001|Overall Study|Adverse Event|0
7553844|NCT03019627|11914879|FG000|Overall Study|Unrelated to adverse event|1
7553845|NCT03019627|11914880|FG001|Overall Study|Unrelated to adverse event|3
7553846|NCT03019627|11914879|FG000|Overall Study|Lost to Follow-up|2
7553847|NCT03019627|11914880|FG001|Overall Study|Lost to Follow-up|1
7553848|NCT03019627|11914879|FG000|Overall Study|not compliance|2
7553849|NCT03019627|11914880|FG001|Overall Study|not compliance|2
7553850|NCT03019627|11914879|FG000|Overall Study|Other|2
7553851|NCT03019627|11914880|FG001|Overall Study|Other|2
7553852|NCT03019965|11914922|FG000|Overall Study|Withdrawal by Subject|1
7553853|NCT03019965|11914923|FG001|Overall Study|Withdrawal by Subject|0
7553854|NCT03019965|11914922|FG000|Overall Study|Protocol Violation|1
7553855|NCT03019965|11914923|FG001|Overall Study|Protocol Violation|3
7553856|NCT03019965|11914922|FG000|Overall Study|viral or fungal infection|3
7553857|NCT03019965|11914923|FG001|Overall Study|viral or fungal infection|4
7553858|NCT03019965|11914922|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
7553859|NCT03019965|11914923|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
7553860|NCT03019965|11914922|FG000|Overall Study|Physician Decision|1
7553861|NCT03019965|11914923|FG001|Overall Study|Physician Decision|1
7553862|NCT03020069|11914935|FG000|Overall Study|Lost to Follow-up|0
7553863|NCT03020069|11914936|FG001|Overall Study|Lost to Follow-up|1
7553864|NCT03020407|11914952|FG000|Overall Study|Withdrawal by Subject|2
7553865|NCT03020407|11914953|FG001|Overall Study|Withdrawal by Subject|1
7553866|NCT03020407|11914952|FG000|Overall Study|Lost to Follow-up|2
7553867|NCT03020407|11914953|FG001|Overall Study|Lost to Follow-up|3
7553868|NCT03020407|11914952|FG000|Overall Study|Protocol Violation|0
7553869|NCT03020407|11914953|FG001|Overall Study|Protocol Violation|1
7553870|NCT03020576|11915009|FG000|Overall Study|Withdrawal by Subject|1
7553871|NCT03020576|11915010|FG001|Overall Study|Withdrawal by Subject|2
7553872|NCT03020615|11915019|FG000|Overall Study|Physician Decision|3
7553873|NCT03020615|11915020|FG001|Overall Study|Physician Decision|1
7553874|NCT03020615|11915021|FG002|Overall Study|Physician Decision|2
7553875|NCT03020615|11915019|FG000|Overall Study|Parent/guardian/patient choice|3
7553876|NCT03020615|11915020|FG001|Overall Study|Parent/guardian/patient choice|0
7553877|NCT03020615|11915021|FG002|Overall Study|Parent/guardian/patient choice|4
7553878|NCT03020615|11915019|FG000|Overall Study|Screen failure|0
7553879|NCT03020615|11915020|FG001|Overall Study|Screen failure|0
7553880|NCT03020615|11915021|FG002|Overall Study|Screen failure|1
7553881|NCT03020615|11915019|FG000|Overall Study|Death|1
7553882|NCT03020615|11915020|FG001|Overall Study|Death|0
7553883|NCT03020615|11915021|FG002|Overall Study|Death|0
7553884|NCT03020615|11915019|FG000|Overall Study|Lost to Follow-up|0
7553885|NCT03020615|11915020|FG001|Overall Study|Lost to Follow-up|1
7553886|NCT03020615|11915021|FG002|Overall Study|Lost to Follow-up|0
7553887|NCT03020641|11915034|FG000|Overall Study|Lost to Follow-up|0
7553888|NCT03020641|11915035|FG001|Overall Study|Lost to Follow-up|1
7553889|NCT03020641|11915034|FG000|Overall Study|Converted to open surgery|2
7553890|NCT03020641|11915035|FG001|Overall Study|Converted to open surgery|1
7553891|NCT03020641|11915034|FG000|Overall Study|for surgery not performed|0
7553892|NCT03020641|11915035|FG001|Overall Study|for surgery not performed|1
7553893|NCT03020745|11915061|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
7553894|NCT03020745|11915062|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
7553895|NCT03020745|11915063|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
7553896|NCT03020745|11915064|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
7553897|NCT03020745|11915065|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
7553898|NCT03020745|11915066|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
7553899|NCT03020745|11915067|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
7553900|NCT03020745|11915068|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
7553901|NCT03020745|11915069|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
7553902|NCT03020745|11915070|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
7553903|NCT03020745|11915061|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553904|NCT03020745|11915062|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553905|NCT03020745|11915063|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553906|NCT03020745|11915064|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553907|NCT03020745|11915065|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553908|NCT03020745|11915066|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553909|NCT03020745|11915067|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553910|NCT03020745|11915068|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
7553911|NCT03020745|11915069|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553912|NCT03020745|11915070|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
7553913|NCT03020745|11915061|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553914|NCT03020745|11915062|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7415237|NCT01439724|11688282|FG000|Overall Study|missing consultation|9
7415238|NCT01439724|11688283|FG001|Overall Study|missing consultation|8
7466390|NCT01890967|11766176|FG005|Overall Study|Withdrawal by Subject|1
7466391|NCT01891357|11766229|FG000|Overall Study|Protocol Violation|3
7466392|NCT01891669|11766243|FG000|Overall Study|Death|0
7466393|NCT01891669|11766244|FG001|Overall Study|Death|0
7466394|NCT01891669|11766245|FG002|Overall Study|Death|0
7466395|NCT01891669|11766246|FG003|Overall Study|Death|0
7466396|NCT01891669|11766247|FG004|Overall Study|Death|0
7466397|NCT01891669|11766248|FG005|Overall Study|Death|0
7466398|NCT01891669|11766249|FG006|Overall Study|Death|0
7466399|NCT01891669|11766250|FG007|Overall Study|Death|1
7466400|NCT01891669|11766251|FG008|Overall Study|Death|0
7466401|NCT01891669|11766252|FG009|Overall Study|Death|1
7466402|NCT01891669|11766243|FG000|Overall Study|Withdrawal by Subject|1
7466403|NCT01891669|11766244|FG001|Overall Study|Withdrawal by Subject|1
7466404|NCT01891669|11766245|FG002|Overall Study|Withdrawal by Subject|0
7466405|NCT01891669|11766246|FG003|Overall Study|Withdrawal by Subject|0
7466406|NCT01891669|11766247|FG004|Overall Study|Withdrawal by Subject|0
7466407|NCT01891669|11766248|FG005|Overall Study|Withdrawal by Subject|0
7553915|NCT03020745|11915063|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553916|NCT03020745|11915064|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553917|NCT03020745|11915065|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553918|NCT03020745|11915066|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7553919|NCT03020745|11915067|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553920|NCT03020745|11915068|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553921|NCT03020745|11915069|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
7553922|NCT03020745|11915070|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
7553923|NCT03020745|11915061|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553924|NCT03020745|11915062|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553925|NCT03020745|11915063|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553926|NCT03020745|11915064|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553927|NCT03020745|11915065|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7466408|NCT01891669|11766249|FG006|Overall Study|Withdrawal by Subject|1
7466409|NCT01891669|11766250|FG007|Overall Study|Withdrawal by Subject|2
7466410|NCT01891669|11766251|FG008|Overall Study|Withdrawal by Subject|1
7466411|NCT01891669|11766252|FG009|Overall Study|Withdrawal by Subject|1
7466412|NCT01891669|11766243|FG000|Overall Study|Other|1
7466413|NCT01891669|11766244|FG001|Overall Study|Other|0
7553928|NCT03020745|11915066|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553929|NCT03020745|11915067|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7319769|NCT00737672|11549392|FG001|Overall Study|Death|22
7553930|NCT03020745|11915068|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553931|NCT03020745|11915069|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
7553932|NCT03020745|11915070|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
7553933|NCT03020888|11915094|FG000|Overall Study|Physician Decision|4
7553934|NCT03020888|11915094|FG000|Overall Study|Withdrawal by Subject|6
7553935|NCT03020888|11915094|FG000|Overall Study|Insurance coverage|2
7553936|NCT03020888|11915094|FG000|Overall Study|Lost to Follow-up|1
7553937|NCT03020966|11915100|FG000|Overall Study|Withdrawal by Subject|2
7553938|NCT03020966|11915101|FG001|Overall Study|Withdrawal by Subject|0
7553939|NCT03020992|11915107|FG000|Overall Study|Adverse Event|5
7553940|NCT03020992|11915107|FG000|Overall Study|Withdrawal by Subject|1
7553941|NCT03021005|11915114|FG000|Overall Study|Lost to Follow-up|39
7553942|NCT03021005|11915115|FG001|Overall Study|Lost to Follow-up|26
7553943|NCT03021018|11915124|FG000|Overall Study|Adverse Event|1
7553944|NCT03021018|11915125|FG001|Overall Study|Adverse Event|0
7553945|NCT03021018|11915126|FG002|Overall Study|Adverse Event|0
7553946|NCT03021018|11915124|FG000|Overall Study|Fall with subsequent nasal fracture|1
7553947|NCT03021018|11915125|FG001|Overall Study|Fall with subsequent nasal fracture|0
7553948|NCT03021018|11915126|FG002|Overall Study|Fall with subsequent nasal fracture|0
7553949|NCT03021187|11915138|FG000|Overall Study|Death|0
7553950|NCT03021187|11915139|FG001|Overall Study|Death|0
7553951|NCT03021187|11915140|FG002|Overall Study|Death|3
7553952|NCT03021187|11915141|FG003|Overall Study|Death|0
7553953|NCT03021187|11915138|FG000|Overall Study|Withdrawal by Subject|0
7553954|NCT03021187|11915139|FG001|Overall Study|Withdrawal by Subject|6
7553955|NCT03021187|11915140|FG002|Overall Study|Withdrawal by Subject|2
7553956|NCT03021187|11915141|FG003|Overall Study|Withdrawal by Subject|5
7553957|NCT03021187|11915138|FG000|Overall Study|Lost to Follow-up|10
7553958|NCT03021187|11915139|FG001|Overall Study|Lost to Follow-up|3
7553959|NCT03021187|11915140|FG002|Overall Study|Lost to Follow-up|1
7553960|NCT03021187|11915141|FG003|Overall Study|Lost to Follow-up|4
7553961|NCT03021265|11915151|FG000|Overall Study|Adverse Event|29
7553962|NCT03021265|11915151|FG000|Overall Study|Lack of Efficacy|3
7553963|NCT03021265|11915151|FG000|Overall Study|Improved|17
7553964|NCT03021265|11915151|FG000|Overall Study|Lost to Follow-up|67
7553965|NCT03021265|11915151|FG000|Overall Study|No reason given|2
7553966|NCT03021265|11915151|FG000|Overall Study|No visit since the first visit|4
7553967|NCT03021304|11915155|FG000|Overall Study|Lack of Efficacy|1
7553968|NCT03021499|11915170|FG000|Overall Study|Adverse Event|1
7553969|NCT03021499|11915171|FG001|Overall Study|Adverse Event|0
7553970|NCT03021499|11915170|FG000|Overall Study|Death|1
7553971|NCT03021499|11915171|FG001|Overall Study|Death|5
7553972|NCT03021499|11915170|FG000|Overall Study|Lack of Efficacy|0
7553973|NCT03021499|11915171|FG001|Overall Study|Lack of Efficacy|1
7415239|NCT01439867|11688309|FG000|Overall Study|Non-compliance|0
7415240|NCT01439867|11688310|FG001|Overall Study|Non-compliance|1
7415241|NCT01439867|11688309|FG000|Overall Study|Withdrawal by Subject|1
7415242|NCT01439867|11688310|FG001|Overall Study|Withdrawal by Subject|2
7415243|NCT01439867|11688309|FG000|Overall Study|Administrative Decision|4
7415244|NCT01439867|11688310|FG001|Overall Study|Administrative Decision|5
7415245|NCT01439867|11688309|FG000|Overall Study|Protocol-specified Criteria|1
7415246|NCT01439867|11688310|FG001|Overall Study|Protocol-specified Criteria|0
7553974|NCT03021499|11915170|FG000|Overall Study|Lost to Follow-up|1
7553975|NCT03021499|11915171|FG001|Overall Study|Lost to Follow-up|3
7553976|NCT03021499|11915170|FG000|Overall Study|Physician Decision|2
7553977|NCT03021499|11915171|FG001|Overall Study|Physician Decision|3
7553978|NCT03021499|11915170|FG000|Overall Study|Pregnancy|1
7553979|NCT03021499|11915171|FG001|Overall Study|Pregnancy|0
7553980|NCT03021499|11915170|FG000|Overall Study|Withdrawal by Subject|7
7553981|NCT03021499|11915171|FG001|Overall Study|Withdrawal by Subject|14
7553982|NCT03021499|11915170|FG000|Overall Study|Prohibited medication required|1
7553983|NCT03021499|11915171|FG001|Overall Study|Prohibited medication required|0
7553984|NCT03021499|11915170|FG000|Overall Study|Protocol non-compliance|1
7553985|NCT03021499|11915171|FG001|Overall Study|Protocol non-compliance|1
7553986|NCT03021499|11915170|FG000|Overall Study|None of the above|0
7553987|NCT03021499|11915171|FG001|Overall Study|None of the above|4
7574526|NCT03682705|11957450|FG004|Overall Study|Adverse Event|1
7319748|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
7319749|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
7319750|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Protocol Violation|2
7319751|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Protocol Violation|3
7319752|NCT00737568|11549373|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
7319753|NCT00737568|11549374|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
7319754|NCT00737568|11549373|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
7319755|NCT00737568|11549374|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
7319756|NCT00737568|11549373|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
7319757|NCT00737568|11549374|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
7319758|NCT00737568|11549373|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
7319759|NCT00737568|11549374|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
7319760|NCT00737633|11549382|FG000|Overall Study|Study terminated by sponsor|44
7319761|NCT00737633|11549383|FG001|Overall Study|Study terminated by sponsor|55
7319762|NCT00737633|11549382|FG000|Overall Study|Lost to Follow-up|0
7319763|NCT00737633|11549383|FG001|Overall Study|Lost to Follow-up|1
7319764|NCT00737633|11549382|FG000|Overall Study|protocol non-compliance|0
7319765|NCT00737633|11549383|FG001|Overall Study|protocol non-compliance|1
7384635|NCT01195831|11641918|FG000|Overall Study|Lost to Follow-up|2
7384636|NCT01195831|11641919|FG001|Overall Study|Lost to Follow-up|4
7384637|NCT01195831|11641918|FG000|Overall Study|Withdrawal by Subject|2
7384638|NCT01195831|11641919|FG001|Overall Study|Withdrawal by Subject|2
7384639|NCT01195831|11641918|FG000|Overall Study|Adverse Event|4
7384640|NCT01195831|11641919|FG001|Overall Study|Adverse Event|2
7384641|NCT01195831|11641918|FG000|Overall Study|Protocol Violation|0
7384642|NCT01195831|11641919|FG001|Overall Study|Protocol Violation|2
7384643|NCT01195844|11641925|FG000|Overall Study|Fecal sample not collected|40
7384644|NCT01195948|11641955|FG000|Overall Study|Lost to Follow-up|0
7384645|NCT01195948|11641956|FG001|Overall Study|Lost to Follow-up|1
7384646|NCT01195948|11641957|FG002|Overall Study|Lost to Follow-up|2
7384647|NCT01196026|11641974|FG000|Overall Study|Withdrawal by Subject|1
7384648|NCT01196026|11641975|FG001|Overall Study|Withdrawal by Subject|4
7384649|NCT01196026|11641976|FG002|Overall Study|Withdrawal by Subject|0
7384650|NCT01196026|11641977|FG003|Overall Study|Withdrawal by Subject|0
7384651|NCT01196026|11641978|FG004|Overall Study|Withdrawal by Subject|0
7384652|NCT01196026|11641979|FG005|Overall Study|Withdrawal by Subject|0
7384653|NCT01196026|11641974|FG000|Overall Study|Lost to Follow-up|0
7384654|NCT01196026|11641975|FG001|Overall Study|Lost to Follow-up|3
7384655|NCT01196026|11641976|FG002|Overall Study|Lost to Follow-up|0
7384656|NCT01196026|11641977|FG003|Overall Study|Lost to Follow-up|0
7384657|NCT01196026|11641978|FG004|Overall Study|Lost to Follow-up|1
7384658|NCT01196026|11641979|FG005|Overall Study|Lost to Follow-up|0
7384659|NCT01196026|11641974|FG000|Overall Study|Other|0
7384660|NCT01196026|11641975|FG001|Overall Study|Other|1
7384661|NCT01196026|11641976|FG002|Overall Study|Other|0
7384662|NCT01196026|11641977|FG003|Overall Study|Other|0
7384663|NCT01196026|11641978|FG004|Overall Study|Other|0
7384664|NCT01196026|11641979|FG005|Overall Study|Other|0
7384665|NCT01196052|11641995|FG000|Overall Study|Adverse Event|9
7384666|NCT01196052|11641995|FG000|Overall Study|Lost to Follow-up|1
7384667|NCT01196052|11641995|FG000|Overall Study|Noncompliance to Protocol Requirements|2
7384668|NCT01196052|11641995|FG000|Overall Study|Reason not Specified|5
7384669|NCT01196052|11641995|FG000|Overall Study|Withdrawal by Subject|6
7384670|NCT01196078|11642001|FG000|Overall Study|Withdrawal by Subject|3
7384671|NCT01196078|11642002|FG001|Overall Study|Withdrawal by Subject|5
7553988|NCT03021499|11915170|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
7553989|NCT03021499|11915171|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
7553990|NCT03021564|11915190|FG000|Overall Study|Death|84
7553991|NCT03021564|11915191|FG001|Overall Study|Death|466
7553992|NCT03021564|11915190|FG000|Overall Study|Lost to Follow-up|0
7553993|NCT03021564|11915191|FG001|Overall Study|Lost to Follow-up|2
7553996|NCT03021668|11915210|FG000|Overall Study|Physician Decision|0
7553997|NCT03021668|11915211|FG001|Overall Study|Physician Decision|1
7553998|NCT03022045|11915232|FG000|Overall Study|Adverse Event|0
7553999|NCT03022045|11915233|FG001|Overall Study|Adverse Event|1
7554000|NCT03022045|11915232|FG000|Overall Study|Withdrawal by Subject|1
7384672|NCT01196078|11642001|FG000|Overall Study|Adverse Event|4
7384673|NCT01196078|11642002|FG001|Overall Study|Adverse Event|4
7384674|NCT01196078|11642001|FG000|Overall Study|Protocol Violation|2
7384675|NCT01196078|11642002|FG001|Overall Study|Protocol Violation|1
7384676|NCT01196078|11642001|FG000|Overall Study|Lack of Efficacy|17
7384677|NCT01196078|11642002|FG001|Overall Study|Lack of Efficacy|23
7384678|NCT01196078|11642001|FG000|Overall Study|Lost to Follow-up|1
7384679|NCT01196078|11642002|FG001|Overall Study|Lost to Follow-up|0
7384680|NCT01196078|11642001|FG000|Overall Study|Death|6
7384681|NCT01196078|11642002|FG001|Overall Study|Death|4
7384682|NCT01196091|11642011|FG000|Overall Study|Adverse Event|22
7384683|NCT01196091|11642012|FG001|Overall Study|Adverse Event|27
7384684|NCT01196091|11642013|FG002|Overall Study|Adverse Event|26
7554001|NCT03022045|11915233|FG001|Overall Study|Withdrawal by Subject|1
7554002|NCT03022084|11915245|FG000|Overall Study|Lost to Follow-up|2
7319766|NCT00737672|11549391|FG000|Overall Study|Graft Abandonment|48
7319767|NCT00737672|11549392|FG001|Overall Study|Graft Abandonment|56
7319768|NCT00737672|11549391|FG000|Overall Study|Death|23
7319770|NCT00737672|11549391|FG000|Overall Study|Withdrawal by Subject|1
7319771|NCT00737672|11549392|FG001|Overall Study|Withdrawal by Subject|2
7319772|NCT00737672|11549391|FG000|Overall Study|Lost to Follow-up|1
7319773|NCT00737672|11549392|FG001|Overall Study|Lost to Follow-up|0
7319774|NCT00737672|11549391|FG000|Overall Study|Miscellaneous|7
7319775|NCT00737672|11549392|FG001|Overall Study|Miscellaneous|1
7319776|NCT00737672|11549391|FG000|Overall Study|Physician Decision|0
7319777|NCT00737672|11549392|FG001|Overall Study|Physician Decision|2
7319778|NCT00737698|11549401|FG000|Overall Study|Withdrawal by Subject|6
7530443|NCT02638103|11874187|FG003|Overall Study|Other than specified|4
7319779|NCT00737698|11549402|FG001|Overall Study|Withdrawal by Subject|5
7319780|NCT00737698|11549403|FG002|Overall Study|Withdrawal by Subject|3
7319781|NCT00737698|11549401|FG000|Overall Study|Death|0
7319782|NCT00737698|11549402|FG001|Overall Study|Death|0
7319783|NCT00737698|11549403|FG002|Overall Study|Death|1
7319784|NCT00737711|11549411|FG000|Overall Study|Adverse Event|2
7319785|NCT00737711|11549411|FG000|Overall Study|Death|8
7319786|NCT00737711|11549411|FG000|Overall Study|Failure to return|4
7319787|NCT00737711|11549411|FG000|Overall Study|Protocol Violation|1
7319788|NCT00737711|11549411|FG000|Overall Study|Withdrawal by Subject|5
7319789|NCT00737711|11549411|FG000|Overall Study|Blood transfusion|6
7319790|NCT00737711|11549411|FG000|Overall Study|Other|5
7319791|NCT00738062|11549461|FG000|Open Label Treatment|Lack of Efficacy|5
7319792|NCT00738062|11549462|FG001|Open Label Treatment|Lack of Efficacy|0
7319793|NCT00738062|11549463|FG002|Open Label Treatment|Lack of Efficacy|0
7319794|NCT00738062|11549461|FG000|Open Label Treatment|Adverse Event|11
7319795|NCT00738062|11549462|FG001|Open Label Treatment|Adverse Event|0
7319796|NCT00738062|11549463|FG002|Open Label Treatment|Adverse Event|0
7319797|NCT00738062|11549461|FG000|Open Label Treatment|Protocol Violation|2
7319798|NCT00738062|11549462|FG001|Open Label Treatment|Protocol Violation|0
7319799|NCT00738062|11549463|FG002|Open Label Treatment|Protocol Violation|0
7319800|NCT00738062|11549461|FG000|Open Label Treatment|Withdrawal by Subject|9
7319801|NCT00738062|11549462|FG001|Open Label Treatment|Withdrawal by Subject|0
7319802|NCT00738062|11549463|FG002|Open Label Treatment|Withdrawal by Subject|0
7319803|NCT00738062|11549461|FG000|Open Label Treatment|Investigator Decision|1
7319804|NCT00738062|11549462|FG001|Open Label Treatment|Investigator Decision|0
7319805|NCT00738062|11549463|FG002|Open Label Treatment|Investigator Decision|0
7319806|NCT00738062|11549461|FG000|Open-Label Extension|Adverse Event|5
7319807|NCT00738062|11549462|FG001|Open-Label Extension|Adverse Event|0
7319808|NCT00738062|11549463|FG002|Open-Label Extension|Adverse Event|0
7319809|NCT00738062|11549461|FG000|Open-Label Extension|Physician Decision|1
7319810|NCT00738062|11549462|FG001|Open-Label Extension|Physician Decision|0
7319811|NCT00738062|11549463|FG002|Open-Label Extension|Physician Decision|0
7319812|NCT00738062|11549461|FG000|Open-Label Extension|Lack of Efficacy|2
7319813|NCT00738062|11549462|FG001|Open-Label Extension|Lack of Efficacy|0
7319814|NCT00738062|11549463|FG002|Open-Label Extension|Lack of Efficacy|0
7319815|NCT00738062|11549461|FG000|Open-Label Extension|Withdrawal by Subject|6
7319816|NCT00738062|11549462|FG001|Open-Label Extension|Withdrawal by Subject|0
7319817|NCT00738062|11549463|FG002|Open-Label Extension|Withdrawal by Subject|0
7319818|NCT00738062|11549461|FG000|Open-Label Extension|Protocol Violation|1
7319819|NCT00738062|11549462|FG001|Open-Label Extension|Protocol Violation|0
7319820|NCT00738062|11549463|FG002|Open-Label Extension|Protocol Violation|0
7319821|NCT00738062|11549461|FG000|Open-Label Extension|Study Terminated|2
7319822|NCT00738062|11549462|FG001|Open-Label Extension|Study Terminated|0
7319823|NCT00738062|11549463|FG002|Open-Label Extension|Study Terminated|0
7319824|NCT00738101|11549472|FG000|Overall Study|Physician Decision|5
7319825|NCT00738101|11549472|FG000|Overall Study|Death|1
7319826|NCT00738101|11549472|FG000|Overall Study|Repeat enrollment|1
7319827|NCT00738283|11549476|FG000|Overall Study|Death|1
7319828|NCT00738283|11549476|FG000|Overall Study|Transfer to another facility|2
7319829|NCT00738283|11549476|FG000|Overall Study|Discharge home prior to end of study|1
7319830|NCT00738374|11549488|FG000|Induction Treatment Phase|Adverse Event|14
7319831|NCT00738374|11549489|FG001|Induction Treatment Phase|Adverse Event|0
7319832|NCT00738374|11549490|FG002|Induction Treatment Phase|Adverse Event|0
7319833|NCT00738374|11549491|FG003|Induction Treatment Phase|Adverse Event|0
7319834|NCT00738374|11549488|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
7319835|NCT00738374|11549489|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
7319836|NCT00738374|11549490|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
7319837|NCT00738374|11549491|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
7319838|NCT00738374|11549488|FG000|Induction Treatment Phase|Physician Decision|2
7319839|NCT00738374|11549489|FG001|Induction Treatment Phase|Physician Decision|0
7319840|NCT00738374|11549490|FG002|Induction Treatment Phase|Physician Decision|0
7319841|NCT00738374|11549491|FG003|Induction Treatment Phase|Physician Decision|0
7319842|NCT00738374|11549488|FG000|Induction Treatment Phase|Protocol Violation|2
7319843|NCT00738374|11549489|FG001|Induction Treatment Phase|Protocol Violation|0
7319844|NCT00738374|11549490|FG002|Induction Treatment Phase|Protocol Violation|0
7319845|NCT00738374|11549491|FG003|Induction Treatment Phase|Protocol Violation|0
7319846|NCT00738374|11549488|FG000|Induction Treatment Phase|Non-compliance|1
7319847|NCT00738374|11549489|FG001|Induction Treatment Phase|Non-compliance|0
7319848|NCT00738374|11549490|FG002|Induction Treatment Phase|Non-compliance|0
7319849|NCT00738374|11549491|FG003|Induction Treatment Phase|Non-compliance|0
7319850|NCT00738374|11549488|FG000|Induction Treatment Phase|Withdrawal by Subject|1
7319851|NCT00738374|11549489|FG001|Induction Treatment Phase|Withdrawal by Subject|0
7319852|NCT00738374|11549490|FG002|Induction Treatment Phase|Withdrawal by Subject|0
7319853|NCT00738374|11549491|FG003|Induction Treatment Phase|Withdrawal by Subject|0
7319854|NCT00738374|11549488|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
7319855|NCT00738374|11549489|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
7319856|NCT00738374|11549490|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
7319857|NCT00738374|11549491|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
7319858|NCT00738374|11549488|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
7319859|NCT00738374|11549489|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
7319860|NCT00738374|11549490|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
7319861|NCT00738374|11549491|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
7319862|NCT00738374|11549488|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7319863|NCT00738374|11549489|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7319864|NCT00738374|11549490|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
7319865|NCT00738374|11549491|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
7319866|NCT00738374|11549488|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
7319867|NCT00738374|11549489|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
7319868|NCT00738374|11549490|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
7319869|NCT00738374|11549491|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
7319870|NCT00738374|11549488|FG000|Maintenance Treatment/Observation Phase|Other|0
7319871|NCT00738374|11549489|FG001|Maintenance Treatment/Observation Phase|Other|1
7319872|NCT00738374|11549490|FG002|Maintenance Treatment/Observation Phase|Other|0
7319873|NCT00738374|11549491|FG003|Maintenance Treatment/Observation Phase|Other|0
7319874|NCT00738400|11549502|FG000|Overall Study|Adverse Event|3
7319875|NCT00738400|11549503|FG001|Overall Study|Adverse Event|1
7319876|NCT00738400|11549502|FG000|Overall Study|Withdrawal by Subject|0
7319877|NCT00738400|11549503|FG001|Overall Study|Withdrawal by Subject|1
7319878|NCT00738400|11549502|FG000|Overall Study|Lack of Efficacy|0
7319879|NCT00738400|11549503|FG001|Overall Study|Lack of Efficacy|1
7319880|NCT00738400|11549502|FG000|Overall Study|Lost to Follow-up|0
7319881|NCT00738400|11549503|FG001|Overall Study|Lost to Follow-up|3
7319882|NCT00738400|11549502|FG000|Overall Study|Protocol Violation|1
7319883|NCT00738400|11549503|FG001|Overall Study|Protocol Violation|0
7319884|NCT00738400|11549502|FG000|Overall Study|Non-compliant with study medication|0
7319885|NCT00738400|11549503|FG001|Overall Study|Non-compliant with study medication|1
7319886|NCT00738530|11549520|FG000|Overall Study|Death|220
7319887|NCT00738530|11549521|FG001|Overall Study|Death|224
7319888|NCT00738530|11549520|FG000|Overall Study|Lost to Follow-up|8
7319889|NCT00738530|11549521|FG001|Overall Study|Lost to Follow-up|6
7319890|NCT00738530|11549520|FG000|Overall Study|Withdrawal by Subject|6
7319891|NCT00738530|11549521|FG001|Overall Study|Withdrawal by Subject|8
7319892|NCT00738673|11549533|FG000|Overall Study|Adverse Event|1
7319893|NCT00738673|11549534|FG001|Overall Study|Adverse Event|0
7319894|NCT00738673|11549533|FG000|Overall Study|Lack of Efficacy|19
7319895|NCT00738673|11549534|FG001|Overall Study|Lack of Efficacy|8
7319896|NCT00738673|11549533|FG000|Overall Study|Protocol Violation|1
7415271|NCT01439945|11688341|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
7415272|NCT01439945|11688342|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
7415273|NCT01439945|11688343|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
7415274|NCT01439945|11688344|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
7415275|NCT01439945|11688341|FG000|Double-Blind Treatment Phase|Ineligible|1
7415276|NCT01439945|11688342|FG001|Double-Blind Treatment Phase|Ineligible|2
7415277|NCT01439945|11688343|FG002|Double-Blind Treatment Phase|Ineligible|0
7554003|NCT03022084|11915246|FG001|Overall Study|Lost to Follow-up|3
7415278|NCT01439945|11688344|FG003|Double-Blind Treatment Phase|Ineligible|1
7415279|NCT01439971|11688360|FG000|Overall Study|Required number in cohort dosed|0
7415280|NCT01439971|11688361|FG001|Overall Study|Required number in cohort dosed|1
7415281|NCT01439971|11688362|FG002|Overall Study|Required number in cohort dosed|2
7415282|NCT01439971|11688363|FG003|Overall Study|Required number in cohort dosed|0
7415283|NCT01439971|11688364|FG004|Overall Study|Required number in cohort dosed|1
7554004|NCT03022370|11915256|FG000|Overall Study|Death|6
7319897|NCT00738673|11549534|FG001|Overall Study|Protocol Violation|2
7319898|NCT00738673|11549533|FG000|Overall Study|Withdrawal by Subject|3
7319899|NCT00738673|11549534|FG001|Overall Study|Withdrawal by Subject|1
7319900|NCT00738699|11549542|FG000|Overall Study|Withdrawal by Subject|5
7319901|NCT00738699|11549543|FG001|Overall Study|Withdrawal by Subject|0
7319902|NCT00738699|11549542|FG000|Overall Study|Lost to Follow-up|1
7319903|NCT00738699|11549543|FG001|Overall Study|Lost to Follow-up|0
7319904|NCT00738699|11549542|FG000|Overall Study|Death|144
7319905|NCT00738699|11549543|FG001|Overall Study|Death|68
7319906|NCT00738699|11549542|FG000|Overall Study|Discontinuation of study by Sponsor|123
7319907|NCT00738699|11549543|FG001|Overall Study|Discontinuation of study by Sponsor|72
7319908|NCT00738699|11549542|FG000|Overall Study|Other|2
7319909|NCT00738699|11549543|FG001|Overall Study|Other|0
7319910|NCT00738881|11549551|FG000|Overall Study|Withdrawal by Subject|0
7319911|NCT00738881|11549552|FG001|Overall Study|Withdrawal by Subject|2
7319912|NCT00738894|11549560|FG000|Overall Study|Lost to Follow-up|23
7319913|NCT00738894|11549561|FG001|Overall Study|Lost to Follow-up|13
7319914|NCT00738894|11549560|FG000|Overall Study|Withdrawal by Subject|10
7319915|NCT00738894|11549561|FG001|Overall Study|Withdrawal by Subject|15
7319916|NCT00738894|11549560|FG000|Overall Study|Physician Decision|4
7319917|NCT00738894|11549561|FG001|Overall Study|Physician Decision|5
7319918|NCT00738894|11549560|FG000|Overall Study|Death|2
7319919|NCT00738894|11549561|FG001|Overall Study|Death|0
7319920|NCT00739102|11549567|FG000|Overall Study|Death|5
7319921|NCT00739102|11549567|FG000|Overall Study|Withdrawal by Subject|10
7319922|NCT00739297|11549571|FG000|First Washout Period of 4-7 Days|Adverse Event|0
7319923|NCT00739297|11549572|FG001|First Washout Period of 4-7 Days|Adverse Event|0
7319924|NCT00739297|11549573|FG002|First Washout Period of 4-7 Days|Adverse Event|0
7319925|NCT00739297|11549574|FG003|First Washout Period of 4-7 Days|Adverse Event|2
7319926|NCT00739297|11549575|FG004|First Washout Period of 4-7 Days|Adverse Event|0
7319927|NCT00739297|11549576|FG005|First Washout Period of 4-7 Days|Adverse Event|0
7319928|NCT00739297|11549577|FG006|First Washout Period of 4-7 Days|Adverse Event|2
7319929|NCT00739297|11549571|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7319930|NCT00739297|11549572|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7319931|NCT00739297|11549573|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7319932|NCT00739297|11549574|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7319933|NCT00739297|11549575|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
7319934|NCT00739297|11549576|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7319935|NCT00739297|11549577|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
7319936|NCT00739310|11549593|FG000|Overall Study|Poor adherance to prescribed therapy|4
7319937|NCT00739310|11549593|FG000|Overall Study|Withdrawal by Subject|1
7319938|NCT00739310|11549593|FG000|Overall Study|Lost to Follow-up|2
7319939|NCT00739596|11549618|FG000|Overall Study|Adverse Event|12
7319940|NCT00739596|11549619|FG001|Overall Study|Adverse Event|6
7319941|NCT00739596|11549618|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
7319942|NCT00739596|11549619|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7319943|NCT00739596|11549618|FG000|Overall Study|Patient Withdrew Consent|8
7319944|NCT00739596|11549619|FG001|Overall Study|Patient Withdrew Consent|8
7319945|NCT00739596|11549618|FG000|Overall Study|Lost to Follow-up|0
7319946|NCT00739596|11549619|FG001|Overall Study|Lost to Follow-up|2
7319947|NCT00739596|11549618|FG000|Overall Study|Protocol Deviation|1
7319948|NCT00739596|11549619|FG001|Overall Study|Protocol Deviation|1
7319949|NCT00739648|11549627|FG000|Overall Study|Adverse Event|3
7319950|NCT00739648|11549628|FG001|Overall Study|Adverse Event|15
7319951|NCT00739648|11549627|FG000|Overall Study|Withdrawal by Subject|13
7319952|NCT00739648|11549628|FG001|Overall Study|Withdrawal by Subject|25
7319953|NCT00739648|11549627|FG000|Overall Study|Lost to Follow-up|4
7319954|NCT00739648|11549628|FG001|Overall Study|Lost to Follow-up|7
7319955|NCT00739648|11549627|FG000|Overall Study|Death|2
7319956|NCT00739648|11549628|FG001|Overall Study|Death|0
7319957|NCT00739648|11549627|FG000|Overall Study|Do not know|4
7319958|NCT00739648|11549628|FG001|Overall Study|Do not know|6
7319959|NCT00739661|11549640|FG000|Overall Study|Adverse Event|2
7319960|NCT00739661|11549641|FG001|Overall Study|Adverse Event|0
7319961|NCT00739661|11549640|FG000|Overall Study|Physician decision to withdraw patient|1
7319962|NCT00739661|11549641|FG001|Overall Study|Physician decision to withdraw patient|0
7319963|NCT00739661|11549640|FG000|Overall Study|Patient decision to withdraw|9
7319964|NCT00739661|11549641|FG001|Overall Study|Patient decision to withdraw|4
7319965|NCT00739661|11549640|FG000|Overall Study|Disease progression, radiographic|33
7319966|NCT00739661|11549641|FG001|Overall Study|Disease progression, radiographic|37
7319967|NCT00739661|11549640|FG000|Overall Study|Reason for discontinuation not available|1
7319968|NCT00739661|11549641|FG001|Overall Study|Reason for discontinuation not available|1
7319969|NCT00739908|11549687|FG000|Overall Study|Adverse Event|5
7319970|NCT00739908|11549688|FG001|Overall Study|Adverse Event|6
7319971|NCT00739908|11549687|FG000|Overall Study|Withdrawal by Subject|4
7319972|NCT00739908|11549688|FG001|Overall Study|Withdrawal by Subject|2
7319973|NCT00739908|11549687|FG000|Overall Study|Lost to Follow-up|14
7319974|NCT00739908|11549688|FG001|Overall Study|Lost to Follow-up|9
7319975|NCT00739908|11549687|FG000|Overall Study|Non-Compliance With Study Procedures|2
7319976|NCT00739908|11549688|FG001|Overall Study|Non-Compliance With Study Procedures|3
7319977|NCT00739908|11549687|FG000|Overall Study|Non-Compliance With Study Medication|0
7319978|NCT00739908|11549688|FG001|Overall Study|Non-Compliance With Study Medication|3
7319979|NCT00739908|11549687|FG000|Overall Study|Lack of Efficacy|0
7319980|NCT00739908|11549688|FG001|Overall Study|Lack of Efficacy|1
7319981|NCT00739908|11549687|FG000|Overall Study|Relocation|0
7319982|NCT00739908|11549688|FG001|Overall Study|Relocation|1
7319983|NCT00739934|11549696|FG000|Voriconazole IV|Adverse Event|6
7319984|NCT00739934|11549696|FG000|Voriconazole Oral|Other|3
7319985|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
7319986|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319987|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319988|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319989|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319990|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319991|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319992|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319993|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
7319994|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
7319995|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7554005|NCT03022370|11915257|FG001|Overall Study|Death|12
7554006|NCT03022370|11915256|FG000|Overall Study|Lost to Follow-up|174
7554007|NCT03022370|11915257|FG001|Overall Study|Lost to Follow-up|109
7319996|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7319997|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7319998|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7319999|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7320000|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7320001|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7320002|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
7320003|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
7320004|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320005|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320006|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320007|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320008|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320009|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320010|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320011|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
7320012|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
7320013|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320014|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320015|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320016|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320017|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320018|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320019|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320020|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
7320021|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
7320022|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320023|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7384685|NCT01196091|11642011|FG000|Overall Study|Death|3
7384686|NCT01196091|11642012|FG001|Overall Study|Death|2
7384687|NCT01196091|11642013|FG002|Overall Study|Death|2
7384688|NCT01196091|11642011|FG000|Overall Study|Entry Criteria Not Met|11
7384689|NCT01196091|11642012|FG001|Overall Study|Entry Criteria Not Met|11
7384690|NCT01196091|11642013|FG002|Overall Study|Entry Criteria Not Met|10
7384691|NCT01196091|11642011|FG000|Overall Study|Lack of Efficacy|15
7415284|NCT01440049|11688376|FG000|Overall Study|Adverse Event|5
7415285|NCT01440101|11688383|FG000|Overall Study|Adverse Event|2
7415286|NCT01440101|11688384|FG001|Overall Study|Adverse Event|0
7415287|NCT01440101|11688385|FG002|Overall Study|Adverse Event|0
7415288|NCT01440101|11688383|FG000|Overall Study|Withdrawal by Subject|0
7530444|NCT02638259|11874227|FG000|Treatment Period 1|Adverse Event|1
7530445|NCT02638259|11874228|FG001|Treatment Period 1|Adverse Event|5
7530446|NCT02638259|11874227|FG000|Treatment Period 1|Death|0
7530447|NCT02638259|11874228|FG001|Treatment Period 1|Death|1
7530448|NCT02638259|11874227|FG000|Treatment Period 1|Lack of Efficacy|0
7554008|NCT03022422|11915298|FG000|Overall Study|3 subjects consented but not vaccinated|0
7530449|NCT02638259|11874228|FG001|Treatment Period 1|Lack of Efficacy|1
7384692|NCT01196091|11642012|FG001|Overall Study|Lack of Efficacy|12
7384693|NCT01196091|11642013|FG002|Overall Study|Lack of Efficacy|17
7384694|NCT01196091|11642011|FG000|Overall Study|Lost to Follow-up|5
7384695|NCT01196091|11642012|FG001|Overall Study|Lost to Follow-up|5
7320024|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320025|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320026|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320027|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320028|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320029|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
7320030|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
7320031|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320032|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320033|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320034|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320035|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320036|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320037|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320038|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
7320039|NCT00739973|11549718|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
7320040|NCT00739973|11549719|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320041|NCT00739973|11549720|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320042|NCT00739973|11549721|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320043|NCT00739973|11549722|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320044|NCT00739973|11549723|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320045|NCT00739973|11549724|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320046|NCT00739973|11549725|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320047|NCT00739973|11549726|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
7320048|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7320049|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7320050|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7320051|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
7320052|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
7320053|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
7320054|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7320055|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
7320056|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
7320057|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320058|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320059|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320060|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320061|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7320062|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320063|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320064|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
7320065|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
7320066|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7320067|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
7320068|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320069|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320070|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320071|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320072|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320073|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320074|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
7320075|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
7320076|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7320077|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
7320078|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
7320079|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7320080|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7320081|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7320082|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
7320083|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
7320084|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320085|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320086|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
7384696|NCT01196091|11642013|FG002|Overall Study|Lost to Follow-up|6
7320087|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320088|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320089|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320090|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320091|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320186|NCT00740792|11549855|FG002|Overall Study|Lack of Efficacy|0
7320092|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
7320093|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7320094|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7320095|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7320096|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7320097|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7320098|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7320099|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
7320100|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
7320101|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
7320102|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7320103|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7384697|NCT01196091|11642011|FG000|Overall Study|Parent/Caregiver Decision|0
7384698|NCT01196091|11642012|FG001|Overall Study|Parent/Caregiver Decision|0
7384699|NCT01196091|11642013|FG002|Overall Study|Parent/Caregiver Decision|1
7384700|NCT01196091|11642011|FG000|Overall Study|Withdrawal by Subject|16
7415289|NCT01440101|11688384|FG001|Overall Study|Withdrawal by Subject|3
7415290|NCT01440101|11688385|FG002|Overall Study|Withdrawal by Subject|1
7415291|NCT01440101|11688383|FG000|Overall Study|Other|0
7415292|NCT01440101|11688384|FG001|Overall Study|Other|1
7415293|NCT01440101|11688385|FG002|Overall Study|Other|0
7415294|NCT01440283|11688394|FG000|Overall Study|Death|3
7415295|NCT01440283|11688394|FG000|Overall Study|Withdrawal by Subject|4
7415296|NCT01440283|11688394|FG000|Overall Study|Physician Decision|3
7415297|NCT01440322|11688406|FG000|Overall Study|Discomfort|2
7415298|NCT01440322|11688407|FG001|Overall Study|Discomfort|0
7415299|NCT01440322|11688406|FG000|Overall Study|Biomicroscopy|1
7415300|NCT01440322|11688407|FG001|Overall Study|Biomicroscopy|0
7415301|NCT01440322|11688406|FG000|Overall Study|Symptoms and Problems|1
7415302|NCT01440322|11688407|FG001|Overall Study|Symptoms and Problems|0
7415303|NCT01440322|11688406|FG000|Overall Study|Unacceptable Subjective Vision|1
7415304|NCT01440322|11688407|FG001|Overall Study|Unacceptable Subjective Vision|0
7415305|NCT01440322|11688406|FG000|Overall Study|Other Product Related|1
7415306|NCT01440322|11688407|FG001|Overall Study|Other Product Related|0
7415307|NCT01440322|11688406|FG000|Overall Study|Unrelated Medical Problem|0
7415308|NCT01440322|11688407|FG001|Overall Study|Unrelated Medical Problem|1
7415309|NCT01440322|11688406|FG000|Overall Study|Other Non-Product Related|1
7415310|NCT01440322|11688407|FG001|Overall Study|Other Non-Product Related|0
7415311|NCT01440374|11688416|FG000|Part 1: Open-label Phase|Adverse Event|5
7415312|NCT01440374|11688417|FG001|Part 1: Open-label Phase|Adverse Event|0
7415313|NCT01440374|11688418|FG002|Part 1: Open-label Phase|Adverse Event|0
7415314|NCT01440374|11688419|FG003|Part 1: Open-label Phase|Adverse Event|0
7415315|NCT01440374|11688416|FG000|Part 1: Open-label Phase|Physician Decision|1
7415316|NCT01440374|11688417|FG001|Part 1: Open-label Phase|Physician Decision|0
7415317|NCT01440374|11688418|FG002|Part 1: Open-label Phase|Physician Decision|0
7415318|NCT01440374|11688419|FG003|Part 1: Open-label Phase|Physician Decision|0
7415319|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Physician Decision|0
7415320|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Physician Decision|8
7415321|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Physician Decision|17
7415322|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Physician Decision|0
7415323|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
7415324|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
7415325|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
7415326|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
7415327|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Protocol Violation|0
7415328|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Protocol Violation|0
7415329|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Protocol Violation|1
7415330|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Protocol Violation|0
7415331|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
7415332|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
7415333|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
7384701|NCT01196091|11642012|FG001|Overall Study|Withdrawal by Subject|19
7384702|NCT01196091|11642013|FG002|Overall Study|Withdrawal by Subject|22
7384703|NCT01196091|11642011|FG000|Overall Study|Physician Decision|3
7384704|NCT01196091|11642012|FG001|Overall Study|Physician Decision|3
7384705|NCT01196091|11642013|FG002|Overall Study|Physician Decision|4
7384706|NCT01196091|11642011|FG000|Overall Study|Protocol Violation|1
7384707|NCT01196091|11642012|FG001|Overall Study|Protocol Violation|3
7384708|NCT01196091|11642013|FG002|Overall Study|Protocol Violation|3
7384709|NCT01196091|11642011|FG000|Overall Study|Sponsor Decision|6
7384710|NCT01196091|11642012|FG001|Overall Study|Sponsor Decision|5
7320104|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
7320105|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7320106|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7320107|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
7320108|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
7320109|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
7320110|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
7320111|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320112|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320113|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320114|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320115|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320116|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320117|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
7320118|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320119|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
7320120|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
7320121|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7320122|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7320123|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7320124|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7320125|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
7320126|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7320127|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
7320128|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
7320129|NCT00739973|11549718|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320130|NCT00739973|11549719|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
7320131|NCT00739973|11549720|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320132|NCT00739973|11549721|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320133|NCT00739973|11549722|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320134|NCT00739973|11549723|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320135|NCT00739973|11549724|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
7320136|NCT00739973|11549725|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320137|NCT00739973|11549726|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
7320138|NCT00740051|11549770|FG000|Overall Study|Lack of Efficacy|2
7320139|NCT00740051|11549771|FG001|Overall Study|Lack of Efficacy|5
7320140|NCT00740051|11549770|FG000|Overall Study|Adverse Event|1
7320141|NCT00740051|11549771|FG001|Overall Study|Adverse Event|4
7320142|NCT00740051|11549770|FG000|Overall Study|Protocol Violation|2
7320143|NCT00740051|11549771|FG001|Overall Study|Protocol Violation|6
7320144|NCT00740051|11549770|FG000|Overall Study|Lost to Follow-up|3
7320145|NCT00740051|11549771|FG001|Overall Study|Lost to Follow-up|8
7320146|NCT00740051|11549770|FG000|Overall Study|Withdrawal by Subject|6
7320147|NCT00740051|11549771|FG001|Overall Study|Withdrawal by Subject|8
7320148|NCT00740051|11549770|FG000|Overall Study|Other reason (not specified)|4
7320149|NCT00740051|11549771|FG001|Overall Study|Other reason (not specified)|1
7320150|NCT00740220|11549796|FG000|Overall Study|screen failures (non-COPD patients)|9
7320151|NCT00740584|11549809|FG000|Overall Study|Withdrawal by Subject|1
7320152|NCT00740636|11549816|FG000|Overall Study|Adverse Event|0
7320153|NCT00740636|11549817|FG001|Overall Study|Adverse Event|2
7320154|NCT00740636|11549816|FG000|Overall Study|Patient Ineligible|0
7320155|NCT00740636|11549817|FG001|Overall Study|Patient Ineligible|1
7320156|NCT00740636|11549816|FG000|Overall Study|Patient Not Treated|0
7320157|NCT00740636|11549817|FG001|Overall Study|Patient Not Treated|1
7320158|NCT00740636|11549816|FG000|Overall Study|Progressive Disease|1
7320159|NCT00740636|11549817|FG001|Overall Study|Progressive Disease|0
7320160|NCT00740636|11549816|FG000|Overall Study|Death|1
7320161|NCT00740636|11549817|FG001|Overall Study|Death|0
7320162|NCT00740714|11549826|FG000|Overall Study|Withdrawal by Subject|17
7320163|NCT00740714|11549827|FG001|Overall Study|Withdrawal by Subject|19
7320164|NCT00740714|11549828|FG002|Overall Study|Withdrawal by Subject|29
7320165|NCT00740779|11549839|FG000|Overall Study|Adverse Event|4
7320166|NCT00740779|11549840|FG001|Overall Study|Adverse Event|6
7320167|NCT00740779|11549841|FG002|Overall Study|Adverse Event|3
7320168|NCT00740779|11549839|FG000|Overall Study|Protocol Violation|1
7320169|NCT00740779|11549840|FG001|Overall Study|Protocol Violation|1
7320170|NCT00740779|11549841|FG002|Overall Study|Protocol Violation|1
7320171|NCT00740779|11549839|FG000|Overall Study|Lack of Efficacy|0
7320172|NCT00740779|11549840|FG001|Overall Study|Lack of Efficacy|0
7320173|NCT00740779|11549841|FG002|Overall Study|Lack of Efficacy|2
7320174|NCT00740779|11549839|FG000|Overall Study|Withdrawal by Subject|2
7320175|NCT00740779|11549840|FG001|Overall Study|Withdrawal by Subject|4
7320176|NCT00740779|11549841|FG002|Overall Study|Withdrawal by Subject|2
7320177|NCT00740779|11549839|FG000|Overall Study|Lost to Follow-up|2
7320178|NCT00740779|11549840|FG001|Overall Study|Lost to Follow-up|3
7320179|NCT00740779|11549841|FG002|Overall Study|Lost to Follow-up|5
7320180|NCT00740792|11549853|FG000|Overall Study|Adverse Event|3
7320181|NCT00740792|11549854|FG001|Overall Study|Adverse Event|1
7320182|NCT00740792|11549855|FG002|Overall Study|Adverse Event|1
7320183|NCT00740792|11549856|FG003|Overall Study|Adverse Event|3
7320184|NCT00740792|11549853|FG000|Overall Study|Lack of Efficacy|1
7320185|NCT00740792|11549854|FG001|Overall Study|Lack of Efficacy|1
7554009|NCT03022422|11915299|FG001|Overall Study|3 subjects consented but not vaccinated|0
7554010|NCT03022422|11915300|FG002|Overall Study|3 subjects consented but not vaccinated|3
7554011|NCT03022422|11915301|FG003|Overall Study|3 subjects consented but not vaccinated|0
7554012|NCT03022422|11915302|FG004|Overall Study|3 subjects consented but not vaccinated|0
7554013|NCT03022422|11915303|FG005|Overall Study|3 subjects consented but not vaccinated|0
7554014|NCT03022630|11915358|FG000|Overall Study|Death|9
7320187|NCT00740792|11549856|FG003|Overall Study|Lack of Efficacy|3
7320188|NCT00740792|11549853|FG000|Overall Study|Lost to Follow-up|2
7320189|NCT00740792|11549854|FG001|Overall Study|Lost to Follow-up|1
7320190|NCT00740792|11549855|FG002|Overall Study|Lost to Follow-up|0
7320191|NCT00740792|11549856|FG003|Overall Study|Lost to Follow-up|0
7320192|NCT00740792|11549853|FG000|Overall Study|Protocol Violation|0
7320193|NCT00740792|11549854|FG001|Overall Study|Protocol Violation|1
7320194|NCT00740792|11549855|FG002|Overall Study|Protocol Violation|0
7320195|NCT00740792|11549856|FG003|Overall Study|Protocol Violation|2
7320196|NCT00740792|11549853|FG000|Overall Study|Withdrawal by Subject|1
7320197|NCT00740792|11549854|FG001|Overall Study|Withdrawal by Subject|1
7320198|NCT00740792|11549855|FG002|Overall Study|Withdrawal by Subject|0
7320199|NCT00740792|11549856|FG003|Overall Study|Withdrawal by Subject|0
7320200|NCT00740792|11549853|FG000|Overall Study|administrative|3
7415334|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
7415335|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Adverse Event|0
7415336|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Adverse Event|7
7415337|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Adverse Event|31
7415338|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Adverse Event|0
7415339|NCT01440374|11688416|FG000|Part 2; Double-blind Phase|Not treated|0
7415340|NCT01440374|11688417|FG001|Part 2; Double-blind Phase|Not treated|0
7415341|NCT01440374|11688418|FG002|Part 2; Double-blind Phase|Not treated|1
7415342|NCT01440374|11688419|FG003|Part 2; Double-blind Phase|Not treated|0
7415343|NCT01440374|11688416|FG000|Part 3: Extension|Withdrawal by Subject|0
7415344|NCT01440374|11688417|FG001|Part 3: Extension|Withdrawal by Subject|0
7415345|NCT01440374|11688418|FG002|Part 3: Extension|Withdrawal by Subject|0
7415346|NCT01440374|11688419|FG003|Part 3: Extension|Withdrawal by Subject|5
7415347|NCT01440374|11688416|FG000|Part 3: Extension|Adverse Event|0
7415348|NCT01440374|11688417|FG001|Part 3: Extension|Adverse Event|0
7415349|NCT01440374|11688418|FG002|Part 3: Extension|Adverse Event|0
7415350|NCT01440374|11688419|FG003|Part 3: Extension|Adverse Event|13
7415351|NCT01440374|11688416|FG000|Part 3: Extension|Physician Decision|0
7415352|NCT01440374|11688417|FG001|Part 3: Extension|Physician Decision|0
7415353|NCT01440374|11688418|FG002|Part 3: Extension|Physician Decision|0
7415354|NCT01440374|11688419|FG003|Part 3: Extension|Physician Decision|14
7415355|NCT01440569|11688459|FG000|Main Study|Enrolled but not treated|1
7415356|NCT01440569|11688460|FG001|Main Study|Enrolled but not treated|0
7415357|NCT01440569|11688459|FG000|Main Study|Adverse Event|9
7415358|NCT01440569|11688460|FG001|Main Study|Adverse Event|0
7415359|NCT01440569|11688459|FG000|Main Study|Pregnancy|1
7415360|NCT01440569|11688460|FG001|Main Study|Pregnancy|0
7415361|NCT01440569|11688459|FG000|Main Study|Investigator's Discretion|1
7415362|NCT01440569|11688460|FG001|Main Study|Investigator's Discretion|1
7415363|NCT01440569|11688459|FG000|Main Study|Withdrew Consent|7
7415364|NCT01440569|11688460|FG001|Main Study|Withdrew Consent|1
7415365|NCT01440569|11688459|FG000|Main Study|Lost to Follow-up|13
7415366|NCT01440569|11688460|FG001|Main Study|Lost to Follow-up|2
7415367|NCT01440569|11688459|FG000|Main Study|Subject Non-Compliance|3
7415368|NCT01440569|11688460|FG001|Main Study|Subject Non-Compliance|0
7415369|NCT01440569|11688459|FG000|Main Study|Protocol Violation|1
7415370|NCT01440569|11688460|FG001|Main Study|Protocol Violation|0
7415371|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Adverse Event|3
7415372|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Adverse Event|0
7415373|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Pregnancy|1
7415374|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Pregnancy|0
7415375|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
7415376|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
7320201|NCT00740792|11549854|FG001|Overall Study|administrative|3
7415377|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
7415378|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
7415379|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Withdrew Consent|11
7415380|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Withdrew Consent|1
7415381|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
7415382|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
7415383|NCT01440569|11688459|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
7554015|NCT03022630|11915359|FG001|Overall Study|Death|7
7320202|NCT00740792|11549855|FG002|Overall Study|administrative|8
7320203|NCT00740792|11549856|FG003|Overall Study|administrative|2
7320204|NCT00740857|11549882|FG000|Overall Study|Withdrawal by Subject|1
7320205|NCT00740857|11549883|FG001|Overall Study|Withdrawal by Subject|0
7320206|NCT00740857|11549884|FG002|Overall Study|Withdrawal by Subject|0
7320207|NCT00740870|11549892|FG000|Overall Study|Not Catheterized|4
7320208|NCT00740870|11549892|FG000|Overall Study|Further testing contraindicated implant|17
7320209|NCT00741013|11549902|FG000|Overall Study|Adverse Event|1
7320210|NCT00741013|11549903|FG001|Overall Study|Adverse Event|0
7320211|NCT00741013|11549904|FG002|Overall Study|Adverse Event|0
7320212|NCT00741013|11549902|FG000|Overall Study|Withdrawal by Subject|0
7320213|NCT00741013|11549903|FG001|Overall Study|Withdrawal by Subject|0
7320214|NCT00741013|11549904|FG002|Overall Study|Withdrawal by Subject|1
7320215|NCT00741013|11549902|FG000|Overall Study|Discovered failed screen after enrolled|0
7320216|NCT00741013|11549903|FG001|Overall Study|Discovered failed screen after enrolled|2
7320217|NCT00741013|11549904|FG002|Overall Study|Discovered failed screen after enrolled|0
7320218|NCT00741039|11549920|FG000|Overall Study|Patient non-compliance|2
7320219|NCT00741039|11549921|FG001|Overall Study|Patient non-compliance|0
7320220|NCT00741091|11549927|FG000|Overall Study|Death|13
7320221|NCT00741091|11549927|FG000|Overall Study|Lost to Follow-up|16
7320222|NCT00741091|11549927|FG000|Overall Study|Withdrawal by Subject|6
7320223|NCT00741091|11549927|FG000|Overall Study|Missed Visit|22
7320224|NCT00741260|11549957|FG000|Overall Study|Disease Progression|3
7415384|NCT01440569|11688460|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
7415385|NCT01440647|11688477|FG000|Overall Study|Death|2
7415386|NCT01440647|11688478|FG001|Overall Study|Death|3
7415387|NCT01440803|11688512|FG000|Overall Study|Met study stopping rule|2
7415388|NCT01440803|11688513|FG001|Overall Study|Met study stopping rule|1
7415389|NCT01440803|11688512|FG000|Overall Study|Lost to Follow-up|0
7415390|NCT01440803|11688513|FG001|Overall Study|Lost to Follow-up|2
7415391|NCT01440803|11688512|FG000|Overall Study|Withdrawal by Subject|0
7415392|NCT01440803|11688513|FG001|Overall Study|Withdrawal by Subject|1
7415393|NCT01440816|11688522|FG000|Overall Study|Disease Progression|0
7415394|NCT01440816|11688523|FG001|Overall Study|Disease Progression|9
7415395|NCT01440816|11688522|FG000|Overall Study|To Be Seen By Local Oncologist|1
7415396|NCT01440816|11688523|FG001|Overall Study|To Be Seen By Local Oncologist|2
7415397|NCT01440881|11688533|FG000|Overall Study|Death|0
7415398|NCT01440881|11688534|FG001|Overall Study|Death|1
7415399|NCT01440946|11688556|FG000|Overall Study|Lost to Follow-up|1
7415400|NCT01440946|11688557|FG001|Overall Study|Lost to Follow-up|1
7415401|NCT01440946|11688556|FG000|Overall Study|Physician Decision|1
7415402|NCT01440946|11688557|FG001|Overall Study|Physician Decision|0
7415403|NCT01440972|11688570|FG000|Overall Study|Withdrawal by Subject|3
7415404|NCT01440972|11688571|FG001|Overall Study|Withdrawal by Subject|2
7415405|NCT01441063|11688581|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
7415406|NCT01441063|11688581|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
7415407|NCT01441102|11688592|FG000|Overall Study|Adverse Event|1
7415408|NCT01441102|11688592|FG000|Overall Study|Withdrawal by Subject|2
7415409|NCT01441180|11688599|FG000|Overall Study|Lost to Follow-up|1
7415410|NCT01441180|11688600|FG001|Overall Study|Lost to Follow-up|1
7415411|NCT01441180|11688601|FG002|Overall Study|Lost to Follow-up|1
7415412|NCT01441180|11688599|FG000|Overall Study|Discontinued|0
7415413|NCT01441180|11688600|FG001|Overall Study|Discontinued|0
7415414|NCT01441180|11688601|FG002|Overall Study|Discontinued|2
7415415|NCT01441414|11688655|FG000|Overall Study|Participant died|9
7415416|NCT01441414|11688655|FG000|Overall Study|Other reasons|3
7415417|NCT01441414|11688655|FG000|Overall Study|Study terminated by sponsor|2
7415418|NCT01441414|11688655|FG000|Overall Study|Subject refused further follow-up|1
7415419|NCT01441440|11688674|FG000|Overall Study|Death|1
7415420|NCT01441440|11688675|FG001|Overall Study|Death|0
7415421|NCT01441440|11688676|FG002|Overall Study|Death|1
7415422|NCT01441440|11688674|FG000|Overall Study|Adverse Event|2
7415423|NCT01441440|11688675|FG001|Overall Study|Adverse Event|9
7415424|NCT01441440|11688676|FG002|Overall Study|Adverse Event|9
7415425|NCT01441440|11688674|FG000|Overall Study|Lost to Follow-up|0
7415426|NCT01441440|11688675|FG001|Overall Study|Lost to Follow-up|2
7415427|NCT01441440|11688676|FG002|Overall Study|Lost to Follow-up|1
7415428|NCT01441440|11688674|FG000|Overall Study|Withdrawal by Subject|11
7415429|NCT01441440|11688675|FG001|Overall Study|Withdrawal by Subject|9
7415430|NCT01441440|11688676|FG002|Overall Study|Withdrawal by Subject|9
7415431|NCT01441440|11688674|FG000|Overall Study|Pregnancy|1
7415432|NCT01441440|11688675|FG001|Overall Study|Pregnancy|0
7415433|NCT01441440|11688676|FG002|Overall Study|Pregnancy|0
7415434|NCT01441440|11688674|FG000|Overall Study|Lack of Efficacy|1
7415435|NCT01441440|11688675|FG001|Overall Study|Lack of Efficacy|0
7415436|NCT01441440|11688676|FG002|Overall Study|Lack of Efficacy|1
7415437|NCT01441440|11688674|FG000|Overall Study|Moving|0
7415438|NCT01441440|11688675|FG001|Overall Study|Moving|1
7415439|NCT01441440|11688676|FG002|Overall Study|Moving|1
7415440|NCT01441440|11688674|FG000|Overall Study|Work-related matter|0
7415441|NCT01441440|11688675|FG001|Overall Study|Work-related matter|1
7415442|NCT01441440|11688676|FG002|Overall Study|Work-related matter|0
7415443|NCT01441440|11688674|FG000|Overall Study|Difficllty in keeping the schedule|1
7415444|NCT01441440|11688675|FG001|Overall Study|Difficllty in keeping the schedule|1
7415445|NCT01441440|11688676|FG002|Overall Study|Difficllty in keeping the schedule|0
7466414|NCT01891669|11766245|FG002|Overall Study|Other|0
7320225|NCT00741260|11549958|FG001|Overall Study|Disease Progression|5
7320226|NCT00741260|11549959|FG002|Overall Study|Disease Progression|3
7320227|NCT00741260|11549960|FG003|Overall Study|Disease Progression|3
7320228|NCT00741260|11549961|FG004|Overall Study|Disease Progression|5
7320229|NCT00741260|11549962|FG005|Overall Study|Disease Progression|37
7320230|NCT00741260|11549963|FG006|Overall Study|Disease Progression|4
7320231|NCT00741260|11549957|FG000|Overall Study|Death|0
7320232|NCT00741260|11549958|FG001|Overall Study|Death|1
7320233|NCT00741260|11549959|FG002|Overall Study|Death|0
7320234|NCT00741260|11549960|FG003|Overall Study|Death|1
7320235|NCT00741260|11549961|FG004|Overall Study|Death|2
7320236|NCT00741260|11549962|FG005|Overall Study|Death|2
7320237|NCT00741260|11549963|FG006|Overall Study|Death|1
7320238|NCT00741260|11549957|FG000|Overall Study|Withdrawal by Subject|0
7320239|NCT00741260|11549958|FG001|Overall Study|Withdrawal by Subject|0
7320240|NCT00741260|11549959|FG002|Overall Study|Withdrawal by Subject|0
7320241|NCT00741260|11549960|FG003|Overall Study|Withdrawal by Subject|0
7320242|NCT00741260|11549961|FG004|Overall Study|Withdrawal by Subject|1
7320243|NCT00741260|11549962|FG005|Overall Study|Withdrawal by Subject|3
7320244|NCT00741260|11549963|FG006|Overall Study|Withdrawal by Subject|1
7320245|NCT00741260|11549957|FG000|Overall Study|Physician Decision|1
7320246|NCT00741260|11549958|FG001|Overall Study|Physician Decision|1
7320247|NCT00741260|11549959|FG002|Overall Study|Physician Decision|0
7320248|NCT00741260|11549960|FG003|Overall Study|Physician Decision|0
7320249|NCT00741260|11549961|FG004|Overall Study|Physician Decision|0
7320250|NCT00741260|11549962|FG005|Overall Study|Physician Decision|0
7320251|NCT00741260|11549963|FG006|Overall Study|Physician Decision|0
7320252|NCT00741260|11549957|FG000|Overall Study|Other|2
7320253|NCT00741260|11549958|FG001|Overall Study|Other|1
7320254|NCT00741260|11549959|FG002|Overall Study|Other|1
7320255|NCT00741260|11549960|FG003|Overall Study|Other|2
7320256|NCT00741260|11549961|FG004|Overall Study|Other|1
7320257|NCT00741260|11549962|FG005|Overall Study|Other|3
7320258|NCT00741260|11549963|FG006|Overall Study|Other|1
7320259|NCT00741286|11549999|FG000|Overall Study|Lost to Follow-up|15
7320260|NCT00741286|11550000|FG001|Overall Study|Lost to Follow-up|10
7320261|NCT00741286|11549999|FG000|Overall Study|Adverse Event|1
7320262|NCT00741286|11550000|FG001|Overall Study|Adverse Event|6
7320263|NCT00741286|11549999|FG000|Overall Study|Protocol Violation|3
7320264|NCT00741286|11550000|FG001|Overall Study|Protocol Violation|2
7320265|NCT00741286|11549999|FG000|Overall Study|Primary Outcome|1
7320266|NCT00741286|11550000|FG001|Overall Study|Primary Outcome|1
7320267|NCT00741338|11550008|FG000|Overall Study|Adverse Event|0
7320268|NCT00741338|11550009|FG001|Overall Study|Adverse Event|1
7320269|NCT00741598|11550051|FG000|Overall Study|Lost to Follow-up|3
7320270|NCT00741598|11550052|FG001|Overall Study|Lost to Follow-up|4
7320271|NCT00741598|11550051|FG000|Overall Study|Lack of Efficacy|1
7320272|NCT00741598|11550052|FG001|Overall Study|Lack of Efficacy|2
7320273|NCT00741598|11550051|FG000|Overall Study|Physician Decision|1
7320274|NCT00741598|11550052|FG001|Overall Study|Physician Decision|1
7320275|NCT00741598|11550051|FG000|Overall Study|Pregnancy|1
7320276|NCT00741598|11550052|FG001|Overall Study|Pregnancy|0
7320277|NCT00741598|11550051|FG000|Overall Study|Withdrawal by Subject|3
7320278|NCT00741598|11550052|FG001|Overall Study|Withdrawal by Subject|2
7320279|NCT00741611|11550062|FG000|Overall Study|Death|0
7320280|NCT00741611|11550063|FG001|Overall Study|Death|0
7320281|NCT00741611|11550064|FG002|Overall Study|Death|1
7320282|NCT00741611|11550062|FG000|Overall Study|Withdrawal by Subject|0
7320283|NCT00741611|11550063|FG001|Overall Study|Withdrawal by Subject|2
7320284|NCT00741611|11550064|FG002|Overall Study|Withdrawal by Subject|2
7320285|NCT00741819|11550073|FG000|Overall Study|Adverse Event|3
7320286|NCT00741819|11550073|FG000|Overall Study|Withdrawal by Subject|3
7320287|NCT00741819|11550073|FG000|Overall Study|Death|1
7320288|NCT00741819|11550073|FG000|Overall Study|Disease progression|1
7320289|NCT00741936|11550090|FG000|Overall Study|Lost to Follow-up|1
7320290|NCT00741936|11550091|FG001|Overall Study|Lost to Follow-up|1
7320291|NCT00741936|11550090|FG000|Overall Study|Adverse Event|3
7320292|NCT00741936|11550091|FG001|Overall Study|Adverse Event|4
7320293|NCT00741936|11550090|FG000|Overall Study|Pregnancy|0
7320294|NCT00741936|11550091|FG001|Overall Study|Pregnancy|1
7320295|NCT00741936|11550090|FG000|Overall Study|Protocol Violation|2
7320296|NCT00741936|11550091|FG001|Overall Study|Protocol Violation|0
7320297|NCT00741936|11550090|FG000|Overall Study|Lack of Efficacy|0
7320298|NCT00741936|11550091|FG001|Overall Study|Lack of Efficacy|2
7320299|NCT00741936|11550090|FG000|Overall Study|Low compliance|3
7320300|NCT00741936|11550091|FG001|Overall Study|Low compliance|0
7320301|NCT00742001|11550100|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
7320302|NCT00742001|11550101|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
7320303|NCT00742001|11550102|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
7320304|NCT00742027|11550113|FG000|Overall Study|Disease Progression|76
7320305|NCT00742027|11550113|FG000|Overall Study|New Cancer Therapy|19
7320306|NCT00742027|11550113|FG000|Overall Study|Withdrawal by Subject|18
7320307|NCT00742027|11550113|FG000|Overall Study|Death|7
7320308|NCT00742027|11550113|FG000|Overall Study|Lost to Follow-up|4
7320309|NCT00742027|11550113|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
7320310|NCT00742027|11550113|FG000|Overall Study|Missing|2
7320311|NCT00742027|11550113|FG000|Overall Study|Administrative Problems|1
7320312|NCT00742079|11550123|FG000|Overall Study|Lost to Follow-up|0
7320313|NCT00742079|11550124|FG001|Overall Study|Lost to Follow-up|1
7320314|NCT00742183|11550141|FG000|Overall Study|Adverse Event|2
7320315|NCT00742183|11550142|FG001|Overall Study|Adverse Event|2
7320316|NCT00742183|11550141|FG000|Overall Study|Death|1
7320317|NCT00742183|11550142|FG001|Overall Study|Death|0
7320318|NCT00742183|11550141|FG000|Overall Study|Physician Decision|0
7320319|NCT00742183|11550142|FG001|Overall Study|Physician Decision|2
7320320|NCT00742183|11550141|FG000|Overall Study|Lost to Follow-up|4
7320321|NCT00742183|11550142|FG001|Overall Study|Lost to Follow-up|4
7320322|NCT00742183|11550141|FG000|Overall Study|Required skin-graft|1
7320323|NCT00742183|11550142|FG001|Overall Study|Required skin-graft|1
7320324|NCT00742183|11550141|FG000|Overall Study|Withdrawal by Subject|1
7320325|NCT00742183|11550142|FG001|Overall Study|Withdrawal by Subject|0
7320326|NCT00742183|11550141|FG000|Overall Study|Lack of Efficacy|0
7320327|NCT00742183|11550142|FG001|Overall Study|Lack of Efficacy|3
7320328|NCT00742209|11550153|FG000|Overall Study|Adverse Event|11
7320329|NCT00742209|11550154|FG001|Overall Study|Adverse Event|4
7320330|NCT00742209|11550155|FG002|Overall Study|Adverse Event|17
7320331|NCT00742209|11550156|FG003|Overall Study|Adverse Event|16
7320332|NCT00742209|11550157|FG004|Overall Study|Adverse Event|13
7320333|NCT00742209|11550153|FG000|Overall Study|Participant Withdrew Consent|8
7320334|NCT00742209|11550154|FG001|Overall Study|Participant Withdrew Consent|4
7320335|NCT00742209|11550155|FG002|Overall Study|Participant Withdrew Consent|14
7415446|NCT01441596|11688717|FG000|Overall Study|Other reason not defined below|0
7415447|NCT01441596|11688718|FG001|Overall Study|Other reason not defined below|2
7415448|NCT01441596|11688719|FG002|Overall Study|Other reason not defined below|1
7415449|NCT01441596|11688717|FG000|Overall Study|Withdrawal by Subject|4
7415450|NCT01441596|11688718|FG001|Overall Study|Withdrawal by Subject|0
7415451|NCT01441596|11688719|FG002|Overall Study|Withdrawal by Subject|2
7415452|NCT01441596|11688717|FG000|Overall Study|Not treated|0
7415453|NCT01441596|11688718|FG001|Overall Study|Not treated|1
7415454|NCT01441596|11688719|FG002|Overall Study|Not treated|1
7415455|NCT01441635|11688737|FG000|Overall Study|Adverse Event|4
7415456|NCT01441635|11688738|FG001|Overall Study|Adverse Event|3
7415457|NCT01441635|11688739|FG002|Overall Study|Adverse Event|1
7415458|NCT01441635|11688740|FG003|Overall Study|Adverse Event|5
7415459|NCT01441635|11688741|FG004|Overall Study|Adverse Event|1
7415460|NCT01441635|11688742|FG005|Overall Study|Adverse Event|2
7415461|NCT01441635|11688743|FG006|Overall Study|Adverse Event|2
7415462|NCT01441635|11688744|FG007|Overall Study|Adverse Event|2
7415463|NCT01441635|11688745|FG008|Overall Study|Adverse Event|1
7415464|NCT01441635|11688746|FG009|Overall Study|Adverse Event|0
7415465|NCT01441635|11688737|FG000|Overall Study|Withdrawal by Subject|1
7415466|NCT01441635|11688738|FG001|Overall Study|Withdrawal by Subject|1
7415467|NCT01441635|11688739|FG002|Overall Study|Withdrawal by Subject|0
7415468|NCT01441635|11688740|FG003|Overall Study|Withdrawal by Subject|1
7415469|NCT01441635|11688741|FG004|Overall Study|Withdrawal by Subject|0
7415470|NCT01441635|11688742|FG005|Overall Study|Withdrawal by Subject|0
7415471|NCT01441635|11688743|FG006|Overall Study|Withdrawal by Subject|2
7415472|NCT01441635|11688744|FG007|Overall Study|Withdrawal by Subject|0
7415473|NCT01441635|11688745|FG008|Overall Study|Withdrawal by Subject|1
7415474|NCT01441635|11688746|FG009|Overall Study|Withdrawal by Subject|1
7415475|NCT01441635|11688737|FG000|Overall Study|Lost to Follow-up|0
7415476|NCT01441635|11688738|FG001|Overall Study|Lost to Follow-up|1
7415477|NCT01441635|11688739|FG002|Overall Study|Lost to Follow-up|1
7415478|NCT01441635|11688740|FG003|Overall Study|Lost to Follow-up|1
7415479|NCT01441635|11688741|FG004|Overall Study|Lost to Follow-up|1
7554016|NCT03022630|11915358|FG000|Overall Study|Withdrawal by Subject|0
7554017|NCT03022630|11915359|FG001|Overall Study|Withdrawal by Subject|5
7554018|NCT03022799|11915383|FG000|Overall Study|Adverse Event|0
7554019|NCT03022799|11915384|FG001|Overall Study|Adverse Event|0
7554020|NCT03022799|11915385|FG002|Overall Study|Adverse Event|0
7554021|NCT03022799|11915386|FG003|Overall Study|Adverse Event|0
7320336|NCT00742209|11550156|FG003|Overall Study|Participant Withdrew Consent|7
7320337|NCT00742209|11550157|FG004|Overall Study|Participant Withdrew Consent|4
7320338|NCT00742209|11550153|FG000|Overall Study|Protocol Violation|6
7320339|NCT00742209|11550154|FG001|Overall Study|Protocol Violation|5
7320340|NCT00742209|11550155|FG002|Overall Study|Protocol Violation|4
7320341|NCT00742209|11550156|FG003|Overall Study|Protocol Violation|5
7320342|NCT00742209|11550157|FG004|Overall Study|Protocol Violation|3
7320343|NCT00742209|11550153|FG000|Overall Study|Lost to Follow-up|3
7320344|NCT00742209|11550154|FG001|Overall Study|Lost to Follow-up|4
7415480|NCT01441635|11688742|FG005|Overall Study|Lost to Follow-up|3
7554022|NCT03022799|11915387|FG004|Overall Study|Adverse Event|0
7320345|NCT00742209|11550155|FG002|Overall Study|Lost to Follow-up|5
7320346|NCT00742209|11550156|FG003|Overall Study|Lost to Follow-up|5
7320347|NCT00742209|11550157|FG004|Overall Study|Lost to Follow-up|3
7320348|NCT00742209|11550153|FG000|Overall Study|Lack of Efficacy|6
7320349|NCT00742209|11550154|FG001|Overall Study|Lack of Efficacy|1
7320350|NCT00742209|11550155|FG002|Overall Study|Lack of Efficacy|1
7320351|NCT00742209|11550156|FG003|Overall Study|Lack of Efficacy|3
7320352|NCT00742209|11550157|FG004|Overall Study|Lack of Efficacy|1
7320353|NCT00742209|11550153|FG000|Overall Study|Investigator Discretion|0
7320354|NCT00742209|11550154|FG001|Overall Study|Investigator Discretion|0
7415481|NCT01441635|11688743|FG006|Overall Study|Lost to Follow-up|1
7554023|NCT03022799|11915388|FG005|Overall Study|Adverse Event|0
7554024|NCT03022799|11915389|FG006|Overall Study|Adverse Event|0
7554025|NCT03022799|11915390|FG007|Overall Study|Adverse Event|0
7554026|NCT03022799|11915391|FG008|Overall Study|Adverse Event|0
7554027|NCT03022799|11915392|FG009|Overall Study|Adverse Event|1
7554028|NCT03022799|11915393|FG010|Overall Study|Adverse Event|1
7554029|NCT03022799|11915394|FG011|Overall Study|Adverse Event|0
7554030|NCT03022799|11915395|FG012|Overall Study|Adverse Event|0
7554031|NCT03022981|11915453|FG000|Overall Study|Adverse Event|0
7554032|NCT03022981|11915454|FG001|Overall Study|Adverse Event|1
7554033|NCT03022981|11915455|FG002|Overall Study|Adverse Event|0
7554034|NCT03022981|11915453|FG000|Overall Study|Investigator's Discretion|0
7554035|NCT03022981|11915454|FG001|Overall Study|Investigator's Discretion|1
7554036|NCT03022981|11915455|FG002|Overall Study|Investigator's Discretion|2
7554037|NCT03022981|11915453|FG000|Overall Study|Lost to Follow-up|6
7554038|NCT03022981|11915454|FG001|Overall Study|Lost to Follow-up|2
7554039|NCT03022981|11915455|FG002|Overall Study|Lost to Follow-up|1
7554040|NCT03022981|11915453|FG000|Overall Study|Non-Compliance With Study Drug|0
7554041|NCT03022981|11915454|FG001|Overall Study|Non-Compliance With Study Drug|0
7554042|NCT03022981|11915455|FG002|Overall Study|Non-Compliance With Study Drug|2
7554043|NCT03022981|11915453|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
7554044|NCT03022981|11915454|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
7554045|NCT03022981|11915455|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
7554046|NCT03023137|11915475|FG000|Overall Study|Multiple pregnancy|2
7554047|NCT03023137|11915476|FG001|Overall Study|Multiple pregnancy|4
7554048|NCT03023137|11915475|FG000|Overall Study|Lost to Follow-up|1
7554049|NCT03023137|11915476|FG001|Overall Study|Lost to Follow-up|1
7554050|NCT03023137|11915475|FG000|Overall Study|Protocol Violation|0
7554051|NCT03023137|11915476|FG001|Overall Study|Protocol Violation|4
7554052|NCT03023137|11915475|FG000|Overall Study|Lost the baby in a car accident|1
7554053|NCT03023137|11915476|FG001|Overall Study|Lost the baby in a car accident|0
7554054|NCT03023397|11915490|FG000|Run-In|Failed screening allergen challenge|1
7554055|NCT03023397|11915491|FG001|Run-In|Failed screening allergen challenge|0
7554056|NCT03023397|11915492|FG002|Run-In|Failed screening allergen challenge|0
7320355|NCT00742209|11550155|FG002|Overall Study|Investigator Discretion|5
7320356|NCT00742209|11550156|FG003|Overall Study|Investigator Discretion|1
7320357|NCT00742209|11550157|FG004|Overall Study|Investigator Discretion|1
7320358|NCT00742235|11550172|FG000|Overall Study|Lost to Follow-up|0
7320359|NCT00742235|11550173|FG001|Overall Study|Lost to Follow-up|31
7320360|NCT00742274|11550181|FG000|Overall Study|Death|1
7320361|NCT00742274|11550182|FG001|Overall Study|Death|0
7320362|NCT00742274|11550181|FG000|Overall Study|Withdrawal by Subject|1
7320363|NCT00742274|11550182|FG001|Overall Study|Withdrawal by Subject|2
7320364|NCT00742274|11550181|FG000|Overall Study|Removed for medical reasons|1
7320365|NCT00742274|11550182|FG001|Overall Study|Removed for medical reasons|1
7320366|NCT00742326|11550199|FG000|Overall Study|Physician Decision|0
7320367|NCT00742326|11550200|FG001|Overall Study|Physician Decision|1
7320368|NCT00742391|11550208|FG000|Overall Study|Adverse Event|2
7320369|NCT00742391|11550209|FG001|Overall Study|Adverse Event|1
7320370|NCT00742391|11550208|FG000|Overall Study|Lost to Follow-up|1
7320371|NCT00742391|11550209|FG001|Overall Study|Lost to Follow-up|0
7320372|NCT00742391|11550208|FG000|Overall Study|Protocol Violation|1
7320373|NCT00742391|11550209|FG001|Overall Study|Protocol Violation|0
7320374|NCT00742417|11550217|FG000|Randomized|Withdrawal by legal representative|0
7320375|NCT00742417|11550218|FG001|Randomized|Withdrawal by legal representative|1
7320376|NCT00742417|11550217|FG000|Randomized|Withdrawal by Subject|1
7320377|NCT00742417|11550218|FG001|Randomized|Withdrawal by Subject|0
7320378|NCT00742417|11550217|FG000|Randomized|Physician Decision|1
7320379|NCT00742417|11550218|FG001|Randomized|Physician Decision|0
7320380|NCT00742417|11550217|FG000|Intensive Period|Withdrawal by Subject|1
7320381|NCT00742417|11550218|FG001|Intensive Period|Withdrawal by Subject|1
7320382|NCT00742417|11550217|FG000|Intensive Period|Adverse Event|2
7320383|NCT00742417|11550218|FG001|Intensive Period|Adverse Event|0
7320384|NCT00742508|11550237|FG000|8-Week Primary Evaluation Period|Adverse Event|2
7320385|NCT00742508|11550238|FG001|8-Week Primary Evaluation Period|Adverse Event|4
7320386|NCT00742508|11550237|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
7320387|NCT00742508|11550238|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
7320388|NCT00742508|11550237|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
7554057|NCT03023397|11915490|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
7554058|NCT03023397|11915491|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7554059|NCT03023397|11915492|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
7554060|NCT03023423|11915504|FG000|Overall Study|Death|5
7554061|NCT03023423|11915505|FG001|Overall Study|Death|12
7554062|NCT03023423|11915506|FG002|Overall Study|Death|20
7554063|NCT03023423|11915504|FG000|Overall Study|Other|0
7320389|NCT00742508|11550238|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
7320390|NCT00742508|11550237|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
7320391|NCT00742508|11550238|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
7384711|NCT01196091|11642013|FG002|Overall Study|Sponsor Decision|4
7554064|NCT03023423|11915505|FG001|Overall Study|Other|2
7554065|NCT03023423|11915506|FG002|Overall Study|Other|2
7320392|NCT00742508|11550237|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
7320393|NCT00742508|11550238|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
7320394|NCT00742560|11550249|FG000|Overall Study|Adverse Event|0
7320395|NCT00742560|11550250|FG001|Overall Study|Adverse Event|0
7320396|NCT00742560|11550251|FG002|Overall Study|Adverse Event|1
7320397|NCT00742560|11550252|FG003|Overall Study|Adverse Event|1
7320398|NCT00742560|11550253|FG004|Overall Study|Adverse Event|1
7320399|NCT00742560|11550249|FG000|Overall Study|Death|0
7320400|NCT00742560|11550250|FG001|Overall Study|Death|2
7320401|NCT00742560|11550251|FG002|Overall Study|Death|0
7320402|NCT00742560|11550252|FG003|Overall Study|Death|2
7320403|NCT00742560|11550253|FG004|Overall Study|Death|3
7320404|NCT00742560|11550249|FG000|Overall Study|Subject's Decision|1
7320405|NCT00742560|11550250|FG001|Overall Study|Subject's Decision|0
7320406|NCT00742560|11550251|FG002|Overall Study|Subject's Decision|2
7320407|NCT00742560|11550252|FG003|Overall Study|Subject's Decision|3
7320408|NCT00742560|11550253|FG004|Overall Study|Subject's Decision|3
7320409|NCT00742560|11550249|FG000|Overall Study|Investigator's Decision|0
7320410|NCT00742560|11550250|FG001|Overall Study|Investigator's Decision|0
7320411|NCT00742560|11550251|FG002|Overall Study|Investigator's Decision|4
7320412|NCT00742560|11550252|FG003|Overall Study|Investigator's Decision|1
7320413|NCT00742560|11550253|FG004|Overall Study|Investigator's Decision|0
7320414|NCT00742560|11550249|FG000|Overall Study|Disease Progression|1
7320415|NCT00742560|11550250|FG001|Overall Study|Disease Progression|0
7320416|NCT00742560|11550251|FG002|Overall Study|Disease Progression|5
7320417|NCT00742560|11550252|FG003|Overall Study|Disease Progression|17
7320418|NCT00742560|11550253|FG004|Overall Study|Disease Progression|16
7415482|NCT01441635|11688744|FG007|Overall Study|Lost to Follow-up|1
7415483|NCT01441635|11688745|FG008|Overall Study|Lost to Follow-up|0
7415484|NCT01441635|11688746|FG009|Overall Study|Lost to Follow-up|1
7415485|NCT01441635|11688737|FG000|Overall Study|Noncompliance|0
7415486|NCT01441635|11688738|FG001|Overall Study|Noncompliance|1
7415487|NCT01441635|11688739|FG002|Overall Study|Noncompliance|0
7415488|NCT01441635|11688740|FG003|Overall Study|Noncompliance|0
7415489|NCT01441635|11688741|FG004|Overall Study|Noncompliance|0
7415490|NCT01441635|11688742|FG005|Overall Study|Noncompliance|0
7415491|NCT01441635|11688743|FG006|Overall Study|Noncompliance|1
7415492|NCT01441635|11688744|FG007|Overall Study|Noncompliance|0
7415493|NCT01441635|11688745|FG008|Overall Study|Noncompliance|0
7415494|NCT01441635|11688746|FG009|Overall Study|Noncompliance|0
7415495|NCT01441635|11688737|FG000|Overall Study|Surgery or Invasive Intervention|0
7415496|NCT01441635|11688738|FG001|Overall Study|Surgery or Invasive Intervention|0
7415497|NCT01441635|11688739|FG002|Overall Study|Surgery or Invasive Intervention|1
7415498|NCT01441635|11688740|FG003|Overall Study|Surgery or Invasive Intervention|0
7415499|NCT01441635|11688741|FG004|Overall Study|Surgery or Invasive Intervention|0
7415500|NCT01441635|11688742|FG005|Overall Study|Surgery or Invasive Intervention|0
7415501|NCT01441635|11688743|FG006|Overall Study|Surgery or Invasive Intervention|0
7415502|NCT01441635|11688744|FG007|Overall Study|Surgery or Invasive Intervention|0
7415503|NCT01441635|11688745|FG008|Overall Study|Surgery or Invasive Intervention|0
7415504|NCT01441635|11688746|FG009|Overall Study|Surgery or Invasive Intervention|0
7415505|NCT01441635|11688737|FG000|Overall Study|Received Exclusionary Medication|1
7415506|NCT01441635|11688738|FG001|Overall Study|Received Exclusionary Medication|0
7415507|NCT01441635|11688739|FG002|Overall Study|Received Exclusionary Medication|0
7415508|NCT01441635|11688740|FG003|Overall Study|Received Exclusionary Medication|0
7415509|NCT01441635|11688741|FG004|Overall Study|Received Exclusionary Medication|0
7415510|NCT01441635|11688742|FG005|Overall Study|Received Exclusionary Medication|0
7415511|NCT01441635|11688743|FG006|Overall Study|Received Exclusionary Medication|0
7415512|NCT01441635|11688744|FG007|Overall Study|Received Exclusionary Medication|0
7415513|NCT01441635|11688745|FG008|Overall Study|Received Exclusionary Medication|0
7415514|NCT01441635|11688746|FG009|Overall Study|Received Exclusionary Medication|0
7415515|NCT01441635|11688737|FG000|Overall Study|Other|0
7415516|NCT01441635|11688738|FG001|Overall Study|Other|0
7415517|NCT01441635|11688739|FG002|Overall Study|Other|0
7415518|NCT01441635|11688740|FG003|Overall Study|Other|0
7415519|NCT01441635|11688741|FG004|Overall Study|Other|0
7415520|NCT01441635|11688742|FG005|Overall Study|Other|0
7415521|NCT01441635|11688743|FG006|Overall Study|Other|0
7415522|NCT01441635|11688744|FG007|Overall Study|Other|1
7415523|NCT01441635|11688745|FG008|Overall Study|Other|0
7415524|NCT01441635|11688746|FG009|Overall Study|Other|0
7415525|NCT01441765|11688770|FG000|Overall Study|Death|1
7415526|NCT01441765|11688771|FG001|Overall Study|Death|0
7415527|NCT01441960|11688790|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
7320419|NCT00742560|11550249|FG000|Overall Study|New Multiple Myeloma Therapy|1
7415528|NCT01441960|11688791|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
7415529|NCT01441960|11688790|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
7415530|NCT01441960|11688791|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
7320420|NCT00742560|11550250|FG001|Overall Study|New Multiple Myeloma Therapy|0
7320421|NCT00742560|11550251|FG002|Overall Study|New Multiple Myeloma Therapy|2
7320422|NCT00742560|11550252|FG003|Overall Study|New Multiple Myeloma Therapy|3
7320423|NCT00742560|11550253|FG004|Overall Study|New Multiple Myeloma Therapy|4
7320424|NCT00742560|11550249|FG000|Overall Study|Other|0
7320425|NCT00742560|11550250|FG001|Overall Study|Other|1
7320426|NCT00742560|11550251|FG002|Overall Study|Other|8
7320427|NCT00742560|11550252|FG003|Overall Study|Other|9
7320428|NCT00742560|11550253|FG004|Overall Study|Other|9
7320429|NCT00742560|11550249|FG000|Overall Study|MIssing|0
7320430|NCT00742560|11550250|FG001|Overall Study|MIssing|0
7320431|NCT00742560|11550251|FG002|Overall Study|MIssing|0
7320432|NCT00742560|11550252|FG003|Overall Study|MIssing|0
7320433|NCT00742560|11550253|FG004|Overall Study|MIssing|1
7320434|NCT00742625|11550293|FG000|Remission Induction|Progression|6
7320435|NCT00742625|11550293|FG000|Remission Induction|Failed induction|8
7320436|NCT00742625|11550293|FG000|Remission Induction|Adverse Event|3
7320437|NCT00742625|11550293|FG000|Remission Induction|Death|10
7320438|NCT00742625|11550293|FG000|Remission Induction|Refusal|5
7320439|NCT00742625|11550293|FG000|Remission Induction|Non protocol treatment|17
7320440|NCT00742625|11550293|FG000|Remission Induction|Other, not specified|5
7320441|NCT00742625|11550293|FG000|Consolidation|Progression|5
7320442|NCT00742625|11550293|FG000|Consolidation|Adverse Event|1
7320443|NCT00742625|11550293|FG000|Consolidation|Death|1
7320444|NCT00742625|11550293|FG000|Consolidation|Refused|1
7320445|NCT00742625|11550293|FG000|Consolidation|Non protocol therapy|13
7320446|NCT00742781|11550300|FG000|Overall Study|Withdrawal by Subject|3
7320447|NCT00742859|11550309|FG000|Overall Study|Adverse Event|5
7320448|NCT00742859|11550310|FG001|Overall Study|Adverse Event|6
7320449|NCT00742859|11550311|FG002|Overall Study|Adverse Event|3
7320450|NCT00742859|11550312|FG003|Overall Study|Adverse Event|1
7320451|NCT00742859|11550309|FG000|Overall Study|Death|1
7415531|NCT01441960|11688790|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
7415532|NCT01441960|11688791|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
7415533|NCT01441973|11688803|FG000|Overall Study|Disease progression|8
7415534|NCT01441973|11688804|FG001|Overall Study|Disease progression|6
7415535|NCT01441973|11688803|FG000|Overall Study|Adverse event unrelated to study drug|3
7415536|NCT01441973|11688804|FG001|Overall Study|Adverse event unrelated to study drug|2
7415537|NCT01441973|11688803|FG000|Overall Study|Participant request to discontinue|1
7415538|NCT01441973|11688804|FG001|Overall Study|Participant request to discontinue|1
7415539|NCT01441973|11688803|FG000|Overall Study|Poor compliance/noncompliance|0
7415540|NCT01441973|11688804|FG001|Overall Study|Poor compliance/noncompliance|1
7415541|NCT01441973|11688803|FG000|Overall Study|Administrative reason by sponsor|3
7415542|NCT01441973|11688804|FG001|Overall Study|Administrative reason by sponsor|5
7415543|NCT01441973|11688803|FG000|Overall Study|Participant withdrew consent|0
7415544|NCT01441973|11688804|FG001|Overall Study|Participant withdrew consent|1
7415545|NCT01442038|11688813|FG000|Overall Study|Death|35
7415546|NCT01442038|11688814|FG001|Overall Study|Death|29
7415547|NCT01442038|11688813|FG000|Overall Study|Investigator-Initiated Early Closure|44
7415548|NCT01442038|11688814|FG001|Overall Study|Investigator-Initiated Early Closure|43
7415549|NCT01442038|11688813|FG000|Overall Study|Participant Withdrew Consent|137
7415550|NCT01442038|11688814|FG001|Overall Study|Participant Withdrew Consent|102
7415551|NCT01442038|11688813|FG000|Overall Study|Lost to Follow-up|37
7415552|NCT01442038|11688814|FG001|Overall Study|Lost to Follow-up|51
7415553|NCT01442038|11688813|FG000|Overall Study|Adverse Event|26
7415554|NCT01442038|11688814|FG001|Overall Study|Adverse Event|15
7415555|NCT01442038|11688813|FG000|Overall Study|Protocol Deviation|9
7415556|NCT01442038|11688814|FG001|Overall Study|Protocol Deviation|20
7415557|NCT01442038|11688813|FG000|Overall Study|Investigator's Discretion|13
7415558|NCT01442038|11688814|FG001|Overall Study|Investigator's Discretion|16
7415559|NCT01442038|11688813|FG000|Overall Study|Study Terminated By Sponsor|2
7415560|NCT01442038|11688814|FG001|Overall Study|Study Terminated By Sponsor|3
7415561|NCT01442064|11688826|FG000|Overall Study|Adverse Event|2
7415562|NCT01442064|11688827|FG001|Overall Study|Adverse Event|2
7415563|NCT01442064|11688828|FG002|Overall Study|Adverse Event|2
7415564|NCT01442064|11688829|FG003|Overall Study|Adverse Event|1
7415565|NCT01442064|11688830|FG004|Overall Study|Adverse Event|2
7415566|NCT01442064|11688831|FG005|Overall Study|Adverse Event|0
7415567|NCT01442064|11688826|FG000|Overall Study|Death|0
7415568|NCT01442064|11688827|FG001|Overall Study|Death|1
7415569|NCT01442064|11688828|FG002|Overall Study|Death|3
7415570|NCT01442064|11688829|FG003|Overall Study|Death|3
7415571|NCT01442064|11688830|FG004|Overall Study|Death|1
7415572|NCT01442064|11688831|FG005|Overall Study|Death|3
7415573|NCT01442064|11688826|FG000|Overall Study|Lost to Follow-up|5
7415574|NCT01442064|11688827|FG001|Overall Study|Lost to Follow-up|5
7415575|NCT01442064|11688828|FG002|Overall Study|Lost to Follow-up|1
7415576|NCT01442064|11688829|FG003|Overall Study|Lost to Follow-up|1
7415577|NCT01442064|11688830|FG004|Overall Study|Lost to Follow-up|3
7415578|NCT01442064|11688831|FG005|Overall Study|Lost to Follow-up|3
7415579|NCT01442064|11688826|FG000|Overall Study|Physician Decision|1
7415580|NCT01442064|11688827|FG001|Overall Study|Physician Decision|1
7415581|NCT01442064|11688828|FG002|Overall Study|Physician Decision|2
7415582|NCT01442064|11688829|FG003|Overall Study|Physician Decision|3
7415583|NCT01442064|11688830|FG004|Overall Study|Physician Decision|3
7320452|NCT00742859|11550310|FG001|Overall Study|Death|0
7320453|NCT00742859|11550311|FG002|Overall Study|Death|0
7320454|NCT00742859|11550312|FG003|Overall Study|Death|1
7320455|NCT00742859|11550309|FG000|Overall Study|Physician Decision|1
7320456|NCT00742859|11550310|FG001|Overall Study|Physician Decision|2
7320457|NCT00742859|11550311|FG002|Overall Study|Physician Decision|0
7554066|NCT03023423|11915504|FG000|Overall Study|Ongoing|2
7554067|NCT03023423|11915505|FG001|Overall Study|Ongoing|32
7554068|NCT03023423|11915506|FG002|Overall Study|Ongoing|24
7574527|NCT03682705|11957451|FG005|Overall Study|Adverse Event|1
7574528|NCT03682705|11957446|FG000|Overall Study|Withdrawal by Subject|1
7574529|NCT03682705|11957447|FG001|Overall Study|Withdrawal by Subject|3
7574530|NCT03682705|11957448|FG002|Overall Study|Withdrawal by Subject|2
7574531|NCT03682705|11957449|FG003|Overall Study|Withdrawal by Subject|4
7574532|NCT03682705|11957450|FG004|Overall Study|Withdrawal by Subject|0
7574533|NCT03682705|11957451|FG005|Overall Study|Withdrawal by Subject|1
7574534|NCT03682705|11957446|FG000|Overall Study|Other, not specified|0
7574535|NCT03682705|11957447|FG001|Overall Study|Other, not specified|0
7574536|NCT03682705|11957448|FG002|Overall Study|Other, not specified|0
7574537|NCT03682705|11957449|FG003|Overall Study|Other, not specified|1
7574538|NCT03682705|11957450|FG004|Overall Study|Other, not specified|2
7574539|NCT03682705|11957451|FG005|Overall Study|Other, not specified|0
7574540|NCT03682705|11957446|FG000|Overall Study|Lost to Follow-up|0
7574541|NCT03682705|11957447|FG001|Overall Study|Lost to Follow-up|0
7574542|NCT03682705|11957448|FG002|Overall Study|Lost to Follow-up|0
7574543|NCT03682705|11957449|FG003|Overall Study|Lost to Follow-up|0
7574544|NCT03682705|11957450|FG004|Overall Study|Lost to Follow-up|3
7574545|NCT03682705|11957451|FG005|Overall Study|Lost to Follow-up|0
7574546|NCT03683576|11957487|FG000|Overall Study|Withdrawal by Subject|2
7574547|NCT03683576|11957488|FG001|Overall Study|Withdrawal by Subject|0
7574548|NCT03683576|11957489|FG002|Overall Study|Withdrawal by Subject|8
7574549|NCT03683576|11957490|FG003|Overall Study|Withdrawal by Subject|3
7574550|NCT03683576|11957487|FG000|Overall Study|Adverse Event|3
7574551|NCT03683576|11957488|FG001|Overall Study|Adverse Event|0
7574552|NCT03683576|11957489|FG002|Overall Study|Adverse Event|0
7574553|NCT03683576|11957490|FG003|Overall Study|Adverse Event|4
7574554|NCT03683576|11957487|FG000|Overall Study|Lack of Efficacy|1
7574555|NCT03683576|11957488|FG001|Overall Study|Lack of Efficacy|0
7574556|NCT03683576|11957489|FG002|Overall Study|Lack of Efficacy|1
7574557|NCT03683576|11957490|FG003|Overall Study|Lack of Efficacy|1
7574558|NCT03683576|11957487|FG000|Overall Study|Lost to Follow-up|0
7574559|NCT03683576|11957488|FG001|Overall Study|Lost to Follow-up|1
7574560|NCT03683576|11957489|FG002|Overall Study|Lost to Follow-up|2
7574561|NCT03683576|11957490|FG003|Overall Study|Lost to Follow-up|0
7574562|NCT03683576|11957487|FG000|Overall Study|Other, Not Specified|0
7574563|NCT03683576|11957488|FG001|Overall Study|Other, Not Specified|2
7574564|NCT03683576|11957489|FG002|Overall Study|Other, Not Specified|0
7574565|NCT03683576|11957490|FG003|Overall Study|Other, Not Specified|0
7574566|NCT03683576|11957487|FG000|Overall Study|Protocol Violation|0
7574567|NCT03683576|11957488|FG001|Overall Study|Protocol Violation|1
7574568|NCT03683576|11957489|FG002|Overall Study|Protocol Violation|1
7574569|NCT03683576|11957490|FG003|Overall Study|Protocol Violation|0
7320458|NCT00742859|11550312|FG003|Overall Study|Physician Decision|0
7320459|NCT00742859|11550309|FG000|Overall Study|Withdrawal by Subject|4
7320460|NCT00742859|11550310|FG001|Overall Study|Withdrawal by Subject|2
7320461|NCT00742859|11550311|FG002|Overall Study|Withdrawal by Subject|4
7320462|NCT00742859|11550312|FG003|Overall Study|Withdrawal by Subject|1
7320463|NCT00742859|11550309|FG000|Overall Study|Endpoint|0
7320464|NCT00742859|11550310|FG001|Overall Study|Endpoint|1
7320465|NCT00742859|11550311|FG002|Overall Study|Endpoint|1
7320466|NCT00742859|11550312|FG003|Overall Study|Endpoint|2
7320467|NCT00742859|11550309|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
7530450|NCT02638259|11874227|FG000|Treatment Period 1|Protocol Violation|0
7530451|NCT02638259|11874228|FG001|Treatment Period 1|Protocol Violation|3
7530452|NCT02638259|11874227|FG000|Treatment Period 1|Withdrawal by Subject|4
7530453|NCT02638259|11874228|FG001|Treatment Period 1|Withdrawal by Subject|6
7530454|NCT02638259|11874227|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
7530455|NCT02638259|11874228|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
7530456|NCT02638259|11874227|FG000|Treatment Period 2|Adverse Event|5
7530457|NCT02638259|11874228|FG001|Treatment Period 2|Adverse Event|4
7530458|NCT02638259|11874227|FG000|Treatment Period 2|Withdrawal by Subject|1
7530459|NCT02638259|11874228|FG001|Treatment Period 2|Withdrawal by Subject|7
7320468|NCT00742859|11550310|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
7320469|NCT00742859|11550311|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
7530460|NCT02638337|11874240|FG000|Overall Study|Adverse Event|6
7530461|NCT02638337|11874241|FG001|Overall Study|Adverse Event|10
7530462|NCT02638337|11874240|FG000|Overall Study|Protocol Violation|3
7530463|NCT02638337|11874241|FG001|Overall Study|Protocol Violation|0
7574570|NCT03683719|11957505|FG000|Overall Study|Lack of Efficacy|1
7574571|NCT03683719|11957506|FG001|Overall Study|Lack of Efficacy|3
7574572|NCT03683719|11957507|FG002|Overall Study|Lack of Efficacy|4
7574573|NCT03683719|11957508|FG003|Overall Study|Lack of Efficacy|0
7574574|NCT03683719|11957509|FG004|Overall Study|Lack of Efficacy|4
7574575|NCT03683719|11957505|FG000|Overall Study|Adverse Event|6
7574576|NCT03683719|11957506|FG001|Overall Study|Adverse Event|6
7574577|NCT03683719|11957507|FG002|Overall Study|Adverse Event|0
7574578|NCT03683719|11957508|FG003|Overall Study|Adverse Event|1
7320470|NCT00742859|11550312|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
7574579|NCT03683719|11957509|FG004|Overall Study|Adverse Event|3
7574580|NCT03683719|11957505|FG000|Overall Study|Withdrawal by Subject|4
7574581|NCT03683719|11957506|FG001|Overall Study|Withdrawal by Subject|4
7530464|NCT02638337|11874240|FG000|Overall Study|Withdrawal by Subject|13
7530465|NCT02638337|11874241|FG001|Overall Study|Withdrawal by Subject|16
7530466|NCT02638337|11874240|FG000|Overall Study|Lost to Follow-up|7
7530467|NCT02638337|11874241|FG001|Overall Study|Lost to Follow-up|7
7530468|NCT02638337|11874240|FG000|Overall Study|Other - Miscellaneous|4
7530469|NCT02638337|11874241|FG001|Overall Study|Other - Miscellaneous|3
7530470|NCT02638493|11874250|FG000|Overall Study|Inability to provide semen samples|2
7530471|NCT02638493|11874251|FG001|Overall Study|Inability to provide semen samples|0
7530472|NCT02638493|11874252|FG002|Overall Study|Inability to provide semen samples|0
7530473|NCT02638623|11874273|FG000|Overall Study|Surgery timing|5
7530474|NCT02638623|11874274|FG001|Overall Study|Surgery timing|6
7530475|NCT02638623|11874273|FG000|Overall Study|Not given intervention|2
7530476|NCT02638623|11874274|FG001|Overall Study|Not given intervention|0
7530477|NCT02638948|11874284|FG000|Overall Study|Withdrawal by Subject|4
7530478|NCT02638948|11874285|FG001|Overall Study|Withdrawal by Subject|5
7530479|NCT02638948|11874286|FG002|Overall Study|Withdrawal by Subject|3
7530480|NCT02638948|11874287|FG003|Overall Study|Withdrawal by Subject|1
7530481|NCT02638948|11874284|FG000|Overall Study|Administrative Reason by Sponsor|0
7530482|NCT02638948|11874285|FG001|Overall Study|Administrative Reason by Sponsor|1
7530483|NCT02638948|11874286|FG002|Overall Study|Administrative Reason by Sponsor|0
7554069|NCT03023722|11915557|FG000|Overall Study|No follow-up assessment|4
7554070|NCT03023826|11915561|FG000|Period 1|Withdrawal by Subject|0
7554071|NCT03023826|11915562|FG001|Period 1|Withdrawal by Subject|0
7554072|NCT03023826|11915563|FG002|Period 1|Withdrawal by Subject|0
7554073|NCT03023826|11915564|FG003|Period 1|Withdrawal by Subject|0
7554074|NCT03023826|11915565|FG004|Period 1|Withdrawal by Subject|1
7530484|NCT02638948|11874287|FG003|Overall Study|Administrative Reason by Sponsor|4
7530485|NCT02638948|11874284|FG000|Overall Study|Adverse Event|0
7530486|NCT02638948|11874285|FG001|Overall Study|Adverse Event|0
7530487|NCT02638948|11874286|FG002|Overall Study|Adverse Event|1
7530488|NCT02638948|11874287|FG003|Overall Study|Adverse Event|1
7530489|NCT02638948|11874284|FG000|Overall Study|Lack of Efficacy|1
7530490|NCT02638948|11874285|FG001|Overall Study|Lack of Efficacy|1
7530491|NCT02638948|11874286|FG002|Overall Study|Lack of Efficacy|0
7530492|NCT02638948|11874287|FG003|Overall Study|Lack of Efficacy|0
7530493|NCT02638948|11874284|FG000|Overall Study|Lost to Follow-up|0
7530494|NCT02638948|11874285|FG001|Overall Study|Lost to Follow-up|0
7530495|NCT02638948|11874286|FG002|Overall Study|Lost to Follow-up|1
7530496|NCT02638948|11874287|FG003|Overall Study|Lost to Follow-up|1
7530497|NCT02638948|11874284|FG000|Overall Study|Poor/Non-Compliance|0
7530498|NCT02638948|11874285|FG001|Overall Study|Poor/Non-Compliance|2
7530499|NCT02638948|11874286|FG002|Overall Study|Poor/Non-Compliance|1
7530500|NCT02638948|11874287|FG003|Overall Study|Poor/Non-Compliance|0
7530501|NCT02638948|11874284|FG000|Overall Study|Participant no longer met study criteria|0
7530502|NCT02638948|11874285|FG001|Overall Study|Participant no longer met study criteria|1
7530503|NCT02638948|11874286|FG002|Overall Study|Participant no longer met study criteria|0
7530504|NCT02638948|11874287|FG003|Overall Study|Participant no longer met study criteria|0
7530505|NCT02638948|11874284|FG000|Overall Study|Other than specified above|4
7530506|NCT02638948|11874285|FG001|Overall Study|Other than specified above|1
7530507|NCT02638948|11874286|FG002|Overall Study|Other than specified above|1
7530508|NCT02638948|11874287|FG003|Overall Study|Other than specified above|1
7530509|NCT02639052|11874309|FG000|Overall Study|Lost to Follow-up|1
7530510|NCT02639182|11874317|FG000|Overall Study|Disease Progression|50
7530511|NCT02639182|11874318|FG001|Overall Study|Disease Progression|49
7530512|NCT02639182|11874317|FG000|Overall Study|Adverse Event|7
7530513|NCT02639182|11874318|FG001|Overall Study|Adverse Event|5
7530514|NCT02639182|11874317|FG000|Overall Study|Physician Decision|3
7530515|NCT02639182|11874318|FG001|Overall Study|Physician Decision|3
7530516|NCT02639182|11874317|FG000|Overall Study|Withdrew Consent|5
7530517|NCT02639182|11874318|FG001|Overall Study|Withdrew Consent|4
7530518|NCT02639182|11874317|FG000|Overall Study|Lost to Follow-up|0
7530519|NCT02639182|11874318|FG001|Overall Study|Lost to Follow-up|1
7530520|NCT02639182|11874317|FG000|Overall Study|Study Closure|1
7530521|NCT02639182|11874318|FG001|Overall Study|Study Closure|2
7530522|NCT02639182|11874317|FG000|Overall Study|Sponsor Ended Study|0
7530523|NCT02639182|11874318|FG001|Overall Study|Sponsor Ended Study|1
7530524|NCT02639182|11874317|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1
7530525|NCT02639182|11874318|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1
7530526|NCT02639247|11874326|FG000|Overall Study|Lost to Follow-up|2
7530527|NCT02639247|11874327|FG001|Overall Study|Lost to Follow-up|1
7530528|NCT02639247|11874326|FG000|Overall Study|Death|2
7530529|NCT02639247|11874327|FG001|Overall Study|Death|0
7530530|NCT02639247|11874326|FG000|Overall Study|Withdrew Consent|0
7530531|NCT02639247|11874327|FG001|Overall Study|Withdrew Consent|1
7530532|NCT02639247|11874326|FG000|Overall Study|Protocol Violation|1
7530533|NCT02639247|11874327|FG001|Overall Study|Protocol Violation|0
7530534|NCT02639338|11874344|FG000|Overall Study|Lost to Follow-up|2
7530535|NCT02639338|11874345|FG001|Overall Study|Lost to Follow-up|2
7530536|NCT02639338|11874344|FG000|Overall Study|Withdrew Consent|1
7530537|NCT02639338|11874345|FG001|Overall Study|Withdrew Consent|2
7530538|NCT02639338|11874344|FG000|Overall Study|Death|1
7530539|NCT02639338|11874345|FG001|Overall Study|Death|0
7530540|NCT02639338|11874344|FG000|Overall Study|Randomized but Not Treated|0
7530541|NCT02639338|11874345|FG001|Overall Study|Randomized but Not Treated|1
7530542|NCT02640053|11874416|FG000|Overall Study|Withdrawal by Subject|2
7530543|NCT02640053|11874417|FG001|Overall Study|Withdrawal by Subject|1
7415584|NCT01442064|11688831|FG005|Overall Study|Physician Decision|1
7415585|NCT01442064|11688826|FG000|Overall Study|Withdrawal by Subject|6
7415586|NCT01442064|11688827|FG001|Overall Study|Withdrawal by Subject|3
7415587|NCT01442064|11688828|FG002|Overall Study|Withdrawal by Subject|2
7530544|NCT02640053|11874416|FG000|Overall Study|Adverse Event|1
7320471|NCT00742859|11550309|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
7320472|NCT00742859|11550310|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
7320473|NCT00742859|11550311|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
7320474|NCT00742859|11550312|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
7320475|NCT00742859|11550309|FG000|Overall Study|Sponsor request patient out of town|0
7415588|NCT01442064|11688829|FG003|Overall Study|Withdrawal by Subject|2
7415589|NCT01442064|11688830|FG004|Overall Study|Withdrawal by Subject|2
7415590|NCT01442064|11688831|FG005|Overall Study|Withdrawal by Subject|1
7415591|NCT01442064|11688826|FG000|Overall Study|Sponsor decision|82
7415592|NCT01442064|11688827|FG001|Overall Study|Sponsor decision|88
7415593|NCT01442064|11688828|FG002|Overall Study|Sponsor decision|92
7415594|NCT01442064|11688829|FG003|Overall Study|Sponsor decision|88
7415595|NCT01442064|11688830|FG004|Overall Study|Sponsor decision|95
7415596|NCT01442064|11688831|FG005|Overall Study|Sponsor decision|87
7415597|NCT01442064|11688826|FG000|Overall Study|Subject non-compliance|0
7415598|NCT01442064|11688827|FG001|Overall Study|Subject non-compliance|0
7415599|NCT01442064|11688828|FG002|Overall Study|Subject non-compliance|0
7415600|NCT01442064|11688829|FG003|Overall Study|Subject non-compliance|0
7415601|NCT01442064|11688830|FG004|Overall Study|Subject non-compliance|0
7415602|NCT01442064|11688831|FG005|Overall Study|Subject non-compliance|2
7415603|NCT01442064|11688826|FG000|Overall Study|Condition mandated other intervention|1
7415604|NCT01442064|11688827|FG001|Overall Study|Condition mandated other intervention|1
7415605|NCT01442064|11688828|FG002|Overall Study|Condition mandated other intervention|2
7415606|NCT01442064|11688829|FG003|Overall Study|Condition mandated other intervention|0
7415607|NCT01442064|11688830|FG004|Overall Study|Condition mandated other intervention|0
7530545|NCT02640053|11874417|FG001|Overall Study|Adverse Event|1
7530546|NCT02640053|11874416|FG000|Overall Study|Alternative Therapy|1
7530547|NCT02640053|11874417|FG001|Overall Study|Alternative Therapy|1
7530548|NCT02640053|11874416|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
7530549|NCT02640053|11874417|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
7530550|NCT02640157|11874426|FG000|Overall Study|Adverse Event|2
7530551|NCT02640157|11874427|FG001|Overall Study|Adverse Event|2
7530552|NCT02640157|11874428|FG002|Overall Study|Adverse Event|1
7530553|NCT02640157|11874426|FG000|Overall Study|Withdrew consent|2
7530554|NCT02640157|11874427|FG001|Overall Study|Withdrew consent|0
7530555|NCT02640157|11874428|FG002|Overall Study|Withdrew consent|2
7530556|NCT02640157|11874426|FG000|Overall Study|Lost to Follow-up|9
7530557|NCT02640157|11874427|FG001|Overall Study|Lost to Follow-up|2
7530558|NCT02640157|11874428|FG002|Overall Study|Lost to Follow-up|7
7530559|NCT02640157|11874426|FG000|Overall Study|Randomized in error; did not receive Tx|0
7554075|NCT03023826|11915566|FG005|Period 1|Withdrawal by Subject|0
7554076|NCT03023878|11915574|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
7554077|NCT03023878|11915574|FG000|Pre-Study Run-In Period|Death|1
7554078|NCT03023878|11915574|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
7320476|NCT00742859|11550310|FG001|Overall Study|Sponsor request patient out of town|0
7320477|NCT00742859|11550311|FG002|Overall Study|Sponsor request patient out of town|1
7320478|NCT00742859|11550312|FG003|Overall Study|Sponsor request patient out of town|1
7320479|NCT00742859|11550309|FG000|Overall Study|Site error|0
7320480|NCT00742859|11550310|FG001|Overall Study|Site error|0
7320481|NCT00742859|11550311|FG002|Overall Study|Site error|1
7320482|NCT00742859|11550312|FG003|Overall Study|Site error|1
7320483|NCT00742885|11550333|FG000|Overall Study|Lost to Follow-up|1
7320484|NCT00742885|11550334|FG001|Overall Study|Lost to Follow-up|0
7320485|NCT00742924|11550347|FG000|Overall Study|Adverse Event|0
7320486|NCT00742924|11550348|FG001|Overall Study|Adverse Event|0
7320487|NCT00742924|11550349|FG002|Overall Study|Adverse Event|1
7320488|NCT00742924|11550350|FG003|Overall Study|Adverse Event|1
7320489|NCT00742924|11550347|FG000|Overall Study|Lack of Efficacy|5
7320490|NCT00742924|11550348|FG001|Overall Study|Lack of Efficacy|1
7320491|NCT00742924|11550349|FG002|Overall Study|Lack of Efficacy|2
7320492|NCT00742924|11550350|FG003|Overall Study|Lack of Efficacy|4
7320493|NCT00742924|11550347|FG000|Overall Study|Physician Decision|0
7320494|NCT00742924|11550348|FG001|Overall Study|Physician Decision|0
7320495|NCT00742924|11550349|FG002|Overall Study|Physician Decision|0
7320496|NCT00742924|11550350|FG003|Overall Study|Physician Decision|1
7320497|NCT00742924|11550347|FG000|Overall Study|Withdrawal by Subject|0
7320498|NCT00742924|11550348|FG001|Overall Study|Withdrawal by Subject|1
7320499|NCT00742924|11550349|FG002|Overall Study|Withdrawal by Subject|1
7320500|NCT00742924|11550350|FG003|Overall Study|Withdrawal by Subject|0
7320501|NCT00743106|11550375|FG000|Overall Study|Met intraoperative exclusion criterion|8
7320502|NCT00743106|11550376|FG001|Overall Study|Met intraoperative exclusion criterion|5
7320503|NCT00743119|11550382|FG000|Overall Study|unreliable|3
7320504|NCT00743119|11550382|FG000|Overall Study|Withdrawal by Subject|1
7320505|NCT00743145|11550394|FG000|Overall Study|Withdrawal by Subject|1
7320506|NCT00743145|11550394|FG000|Overall Study|Adverse Event|2
7320507|NCT00743145|11550394|FG000|Overall Study|Pregnancy|1
7320508|NCT00743249|11550410|FG000|Overall Study|Adverse Event|0
7320509|NCT00743249|11550411|FG001|Overall Study|Adverse Event|4
7320510|NCT00743249|11550410|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
7320511|NCT00743249|11550411|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
7320512|NCT00743249|11550410|FG000|Overall Study|Unsuccessful insertion of stent|2
7320513|NCT00743249|11550411|FG001|Overall Study|Unsuccessful insertion of stent|1
7320514|NCT00743275|11550423|FG000|Overall Study|Protocol Violation|0
7320515|NCT00743275|11550424|FG001|Overall Study|Protocol Violation|1
7320516|NCT00743288|11550430|FG000|Overall Study|Adverse Event|1
7320517|NCT00743288|11550431|FG001|Overall Study|Adverse Event|1
7320518|NCT00743288|11550432|FG002|Overall Study|Adverse Event|2
7320519|NCT00743288|11550433|FG003|Overall Study|Adverse Event|2
7320520|NCT00743288|11550434|FG004|Overall Study|Adverse Event|1
7320521|NCT00743288|11550435|FG005|Overall Study|Adverse Event|1
7320522|NCT00743288|11550436|FG006|Overall Study|Adverse Event|2
7320523|NCT00743288|11550430|FG000|Overall Study|Withdrawal by Subject|0
7320524|NCT00743288|11550431|FG001|Overall Study|Withdrawal by Subject|0
7320525|NCT00743288|11550432|FG002|Overall Study|Withdrawal by Subject|1
7320526|NCT00743288|11550433|FG003|Overall Study|Withdrawal by Subject|0
7320527|NCT00743288|11550434|FG004|Overall Study|Withdrawal by Subject|0
7320528|NCT00743288|11550435|FG005|Overall Study|Withdrawal by Subject|1
7320529|NCT00743288|11550436|FG006|Overall Study|Withdrawal by Subject|1
7320530|NCT00743288|11550430|FG000|Overall Study|Progressive disease (PD)|2
7320531|NCT00743288|11550431|FG001|Overall Study|Progressive disease (PD)|0
7320532|NCT00743288|11550432|FG002|Overall Study|Progressive disease (PD)|1
7320533|NCT00743288|11550433|FG003|Overall Study|Progressive disease (PD)|4
7320534|NCT00743288|11550434|FG004|Overall Study|Progressive disease (PD)|5
7320535|NCT00743288|11550435|FG005|Overall Study|Progressive disease (PD)|3
7320536|NCT00743288|11550436|FG006|Overall Study|Progressive disease (PD)|6
7320537|NCT00743288|11550430|FG000|Overall Study|Worsening of condition (Not PD)|0
7320538|NCT00743288|11550431|FG001|Overall Study|Worsening of condition (Not PD)|2
7320539|NCT00743288|11550432|FG002|Overall Study|Worsening of condition (Not PD)|1
7320540|NCT00743288|11550433|FG003|Overall Study|Worsening of condition (Not PD)|1
7320541|NCT00743288|11550434|FG004|Overall Study|Worsening of condition (Not PD)|0
7320542|NCT00743288|11550435|FG005|Overall Study|Worsening of condition (Not PD)|0
7320543|NCT00743288|11550436|FG006|Overall Study|Worsening of condition (Not PD)|0
7320544|NCT00743340|11550447|FG000|Overall Study|Study medication non-compliance|1
7320545|NCT00743340|11550447|FG000|Overall Study|Lost to Follow-up|1
7320546|NCT00743340|11550447|FG000|Overall Study|Withdrawal from the Study|5
7320547|NCT00743340|11550447|FG000|Overall Study|Protocol Violation|1
7320548|NCT00743340|11550447|FG000|Overall Study|Virologic failure|8
7320549|NCT00743340|11550447|FG000|Overall Study|Pregnancy|1
7320550|NCT00743340|11550447|FG000|Overall Study|Rolled over to other Gilead Study|23
7320551|NCT00743340|11550447|FG000|Overall Study|Participant Relocated|1
7320552|NCT00743366|11550451|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
7320553|NCT00743366|11550452|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
7384712|NCT01196091|11642011|FG000|Overall Study|Excluded Site|5
7384713|NCT01196091|11642012|FG001|Overall Study|Excluded Site|11
7384714|NCT01196091|11642013|FG002|Overall Study|Excluded Site|8
7384715|NCT01196091|11642011|FG000|Overall Study|Randomized, No Study Drug Received|1
7384716|NCT01196091|11642012|FG001|Overall Study|Randomized, No Study Drug Received|0
7384717|NCT01196091|11642013|FG002|Overall Study|Randomized, No Study Drug Received|1
7415608|NCT01442064|11688831|FG005|Overall Study|Condition mandated other intervention|2
7415609|NCT01442103|11688848|FG000|Overall Study|Lost to Follow-up|2
7415610|NCT01442155|11688861|FG000|Overall Study|Complete remission|35
7415611|NCT01442155|11688861|FG000|Overall Study|Recurrence|26
7415612|NCT01442155|11688861|FG000|Overall Study|Adverse Event|2
7415613|NCT01442155|11688861|FG000|Overall Study|Lost to Follow-up|2
7415614|NCT01442181|11688867|FG000|Overall Study|patient refused surgery|1
7415615|NCT01442181|11688868|FG001|Overall Study|patient refused surgery|0
7415616|NCT01442181|11688867|FG000|Overall Study|no insurance for surgery|1
7415617|NCT01442181|11688868|FG001|Overall Study|no insurance for surgery|0
7415618|NCT01442181|11688867|FG000|Overall Study|low ejection factor|0
7415619|NCT01442181|11688868|FG001|Overall Study|low ejection factor|1
7415620|NCT01442181|11688867|FG000|Overall Study|Lost to Follow-up|1
7415621|NCT01442181|11688868|FG001|Overall Study|Lost to Follow-up|1
7415622|NCT01442181|11688867|FG000|Overall Study|patient in an additional study|1
7415623|NCT01442181|11688868|FG001|Overall Study|patient in an additional study|0
7415624|NCT01442181|11688867|FG000|Overall Study|atrial fibrillation not noted|0
7415625|NCT01442181|11688868|FG001|Overall Study|atrial fibrillation not noted|1
7415626|NCT01442376|11688878|FG000|Overall Study|Adverse Event|0
7415627|NCT01442376|11688879|FG001|Overall Study|Adverse Event|3
7415628|NCT01442376|11688880|FG002|Overall Study|Adverse Event|2
7415629|NCT01442376|11688878|FG000|Overall Study|Death|0
7415630|NCT01442376|11688879|FG001|Overall Study|Death|1
7415631|NCT01442376|11688880|FG002|Overall Study|Death|1
7384718|NCT01196104|11642028|FG000|Overall Study|Lost to Follow-up|1
7384719|NCT01196104|11642029|FG001|Overall Study|Lost to Follow-up|0
7415632|NCT01442376|11688878|FG000|Overall Study|Withdrawal of consent|0
7320554|NCT00743431|11550458|FG000|Overall Study|Toxicity|6
7320555|NCT00743431|11550458|FG000|Overall Study|Tumor progression|56
7320556|NCT00743431|11550458|FG000|Overall Study|Withdrawal by Subject|13
7320557|NCT00743431|11550458|FG000|Overall Study|Death|9
7320558|NCT00743431|11550458|FG000|Overall Study|Reason for discontinuation not specified|29
7320559|NCT00743431|11550458|FG000|Overall Study|No documentation available|13
7320560|NCT00743444|11550462|FG000|First Intervention|Catheter placement problems|0
7320561|NCT00743444|11550463|FG001|First Intervention|Catheter placement problems|1
7320562|NCT00743444|11550462|FG000|Washout Period|Adverse Event|0
7320563|NCT00743444|11550463|FG001|Washout Period|Adverse Event|1
7320564|NCT00743483|11550469|FG000|Baseline Period|Physician Decision|1
7320565|NCT00743483|11550469|FG000|Treatment Period|Adverse Event|1
7320566|NCT00743509|11550473|FG000|Overall Study|Withdrawal by Subject|2
7320567|NCT00743652|11550486|FG000|Overall Study|Parent/Legal Guardian Request|3
7320568|NCT00743652|11550487|FG001|Overall Study|Parent/Legal Guardian Request|2
7320569|NCT00743652|11550488|FG002|Overall Study|Parent/Legal Guardian Request|2
7320570|NCT00743652|11550489|FG003|Overall Study|Parent/Legal Guardian Request|2
7320571|NCT00743652|11550490|FG004|Overall Study|Parent/Legal Guardian Request|0
7320572|NCT00743652|11550486|FG000|Overall Study|Adverse Event|3
7320573|NCT00743652|11550487|FG001|Overall Study|Adverse Event|0
7320574|NCT00743652|11550488|FG002|Overall Study|Adverse Event|0
7320575|NCT00743652|11550489|FG003|Overall Study|Adverse Event|0
7320576|NCT00743652|11550490|FG004|Overall Study|Adverse Event|0
7320577|NCT00743652|11550486|FG000|Overall Study|Death|2
7320578|NCT00743652|11550487|FG001|Overall Study|Death|0
7320579|NCT00743652|11550488|FG002|Overall Study|Death|0
7320580|NCT00743652|11550489|FG003|Overall Study|Death|0
7320581|NCT00743652|11550490|FG004|Overall Study|Death|0
7320582|NCT00743652|11550486|FG000|Overall Study|Investigator Request|0
7320583|NCT00743652|11550487|FG001|Overall Study|Investigator Request|0
7320584|NCT00743652|11550488|FG002|Overall Study|Investigator Request|0
7320585|NCT00743652|11550489|FG003|Overall Study|Investigator Request|2
7530560|NCT02640157|11874427|FG001|Overall Study|Randomized in error; did not receive Tx|1
7530561|NCT02640157|11874428|FG002|Overall Study|Randomized in error; did not receive Tx|0
7530562|NCT02640235|11874439|FG000|Overall Study|Withdrawal by Subject|7
7530563|NCT02640235|11874440|FG001|Overall Study|Withdrawal by Subject|6
7530564|NCT02640235|11874439|FG000|Overall Study|Lost to Follow-up|4
7530565|NCT02640235|11874440|FG001|Overall Study|Lost to Follow-up|3
7530566|NCT02640235|11874439|FG000|Overall Study|Death|2
7530567|NCT02640235|11874440|FG001|Overall Study|Death|3
7530568|NCT02640235|11874439|FG000|Overall Study|Other|1
7530569|NCT02640235|11874440|FG001|Overall Study|Other|2
7530570|NCT02640404|11874448|FG000|Overall Study|Protocol Violation|1
7530571|NCT02640404|11874449|FG001|Overall Study|Protocol Violation|0
7530572|NCT02640404|11874448|FG000|Overall Study|Withdrawal by Subject|1
7530573|NCT02640404|11874449|FG001|Overall Study|Withdrawal by Subject|0
7530574|NCT02640482|11874457|FG000|Overall Study|Lost to Follow-up|3
7530575|NCT02640482|11874458|FG001|Overall Study|Lost to Follow-up|0
7530576|NCT02640547|11874464|FG000|Overall Study|Failure to Return|1
7530577|NCT02640547|11874464|FG000|Overall Study|Withdrawal by Subject|1
7530578|NCT02640547|11874464|FG000|Overall Study|Death|6
7530579|NCT02640547|11874464|FG000|Overall Study|Miscellaneous|3
7530580|NCT02640612|11874479|FG000|Overall Study|Adverse Event|6
7530581|NCT02640612|11874480|FG001|Overall Study|Adverse Event|7
7530582|NCT02640612|11874481|FG002|Overall Study|Adverse Event|2
7530583|NCT02640612|11874479|FG000|Overall Study|Death|1
7530584|NCT02640612|11874480|FG001|Overall Study|Death|0
7530585|NCT02640612|11874481|FG002|Overall Study|Death|0
7530586|NCT02640612|11874479|FG000|Overall Study|Withdrawal by Subject|10
7530587|NCT02640612|11874480|FG001|Overall Study|Withdrawal by Subject|3
7530588|NCT02640612|11874481|FG002|Overall Study|Withdrawal by Subject|3
7530589|NCT02640612|11874479|FG000|Overall Study|Lost to Follow-up|4
7530590|NCT02640612|11874480|FG001|Overall Study|Lost to Follow-up|1
7530591|NCT02640612|11874481|FG002|Overall Study|Lost to Follow-up|1
7530592|NCT02640612|11874479|FG000|Overall Study|Protocol Violation|0
7530593|NCT02640612|11874480|FG001|Overall Study|Protocol Violation|2
7320586|NCT00743652|11550490|FG004|Overall Study|Investigator Request|0
7320587|NCT00743652|11550486|FG000|Overall Study|Other|1
7320588|NCT00743652|11550487|FG001|Overall Study|Other|1
7320589|NCT00743652|11550488|FG002|Overall Study|Other|0
7320590|NCT00743652|11550489|FG003|Overall Study|Other|0
7320591|NCT00743652|11550490|FG004|Overall Study|Other|0
7320592|NCT00743652|11550486|FG000|Overall Study|Lost to Follow-up|1
7320593|NCT00743652|11550487|FG001|Overall Study|Lost to Follow-up|0
7320594|NCT00743652|11550488|FG002|Overall Study|Lost to Follow-up|0
7530594|NCT02640612|11874481|FG002|Overall Study|Protocol Violation|0
7530595|NCT02640612|11874479|FG000|Overall Study|Lack of Efficacy|1
7530596|NCT02640612|11874480|FG001|Overall Study|Lack of Efficacy|1
7530597|NCT02640612|11874481|FG002|Overall Study|Lack of Efficacy|0
7530598|NCT02640755|11874500|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
7530599|NCT02640755|11874501|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
7530600|NCT02640755|11874500|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
7530601|NCT02640755|11874501|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
7530602|NCT02640755|11874500|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
7320595|NCT00743652|11550489|FG003|Overall Study|Lost to Follow-up|0
7320596|NCT00743652|11550490|FG004|Overall Study|Lost to Follow-up|0
7320597|NCT00744042|11550532|FG000|Overall Study|Withdrawal by Subject|1
7320598|NCT00744055|11550544|FG000|Overall Study|Withdrawal by Subject|6
7320599|NCT00744055|11550545|FG001|Overall Study|Withdrawal by Subject|9
7320600|NCT00744055|11550544|FG000|Overall Study|Lack of Efficacy|0
7320601|NCT00744055|11550545|FG001|Overall Study|Lack of Efficacy|1
7320602|NCT00744055|11550544|FG000|Overall Study|Physician Decision|0
7320603|NCT00744055|11550545|FG001|Overall Study|Physician Decision|2
7320604|NCT00744055|11550544|FG000|Overall Study|Protocol Violation|1
7320605|NCT00744055|11550545|FG001|Overall Study|Protocol Violation|1
7320606|NCT00744055|11550544|FG000|Overall Study|Lost to Follow-up|0
7320607|NCT00744055|11550545|FG001|Overall Study|Lost to Follow-up|1
7320608|NCT00744237|11550570|FG000|Overall Study|Lack of Efficacy|1
7320609|NCT00744237|11550571|FG001|Overall Study|Lack of Efficacy|1
7320610|NCT00744237|11550572|FG002|Overall Study|Lack of Efficacy|0
7320611|NCT00744237|11550570|FG000|Overall Study|Withdrawal by Subject|9
7320612|NCT00744237|11550571|FG001|Overall Study|Withdrawal by Subject|5
7320613|NCT00744237|11550572|FG002|Overall Study|Withdrawal by Subject|3
7320614|NCT00744237|11550570|FG000|Overall Study|Lost to Follow-up|1
7320615|NCT00744237|11550571|FG001|Overall Study|Lost to Follow-up|1
7320616|NCT00744237|11550572|FG002|Overall Study|Lost to Follow-up|1
7320617|NCT00744237|11550570|FG000|Overall Study|Protocol Violation|3
7320618|NCT00744237|11550571|FG001|Overall Study|Protocol Violation|4
7320619|NCT00744237|11550572|FG002|Overall Study|Protocol Violation|3
7320620|NCT00744237|11550570|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
7320621|NCT00744237|11550571|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
7320622|NCT00744237|11550572|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
7320623|NCT00744237|11550570|FG000|Overall Study|Dosing Error|1
7415633|NCT01442376|11688879|FG001|Overall Study|Withdrawal of consent|0
7415634|NCT01442376|11688880|FG002|Overall Study|Withdrawal of consent|1
7415635|NCT01442376|11688878|FG000|Overall Study|Patients not treated|2
7415636|NCT01442376|11688879|FG001|Overall Study|Patients not treated|3
7415637|NCT01442376|11688880|FG002|Overall Study|Patients not treated|1
7415638|NCT01442376|11688878|FG000|Overall Study|Not eligible for subsequent cycles|1
7415639|NCT01442376|11688879|FG001|Overall Study|Not eligible for subsequent cycles|2
7415640|NCT01442376|11688880|FG002|Overall Study|Not eligible for subsequent cycles|0
7415641|NCT01442493|11688890|FG000|Overall Study|withdrawn from study|3
7415642|NCT01442493|11688891|FG001|Overall Study|withdrawn from study|2
7415643|NCT01442675|11688897|FG000|Overall Study|Protocol Violation|6
7415644|NCT01442675|11688897|FG000|Overall Study|Lost to Follow-up|2
7415645|NCT01442675|11688897|FG000|Overall Study|Withdrawal by Subject|4
7415646|NCT01442688|11688904|FG000|First Intervention|Withdrawal by Subject|1
7415647|NCT01442688|11688905|FG001|First Intervention|Withdrawal by Subject|0
7415648|NCT01442688|11688904|FG000|First Intervention|subject incarcerated|1
7415649|NCT01442688|11688905|FG001|First Intervention|subject incarcerated|0
7415650|NCT01442688|11688904|FG000|Second Intervention|Adverse Event|1
7415651|NCT01442688|11688905|FG001|Second Intervention|Adverse Event|0
7415652|NCT01442714|11688911|FG000|Overall Study|Death|11
7415653|NCT01442714|11688911|FG000|Overall Study|Withdrawal by Subject|1
7415654|NCT01442779|11688917|FG000|Overall Study|Withdrawal by Subject|3
7415655|NCT01442779|11688917|FG000|Overall Study|Death|3
7415656|NCT01442779|11688917|FG000|Overall Study|Non-compliance|1
7415657|NCT01443026|11688932|FG000|Overall Study|Physician Decision|1
7415658|NCT01443026|11688933|FG001|Overall Study|Physician Decision|0
7415659|NCT01443026|11688932|FG000|Overall Study|Death|0
7415660|NCT01443026|11688933|FG001|Overall Study|Death|1
7415661|NCT01443026|11688932|FG000|Overall Study|Withdrawal by Subject|0
7320624|NCT00744237|11550571|FG001|Overall Study|Dosing Error|0
7320625|NCT00744237|11550572|FG002|Overall Study|Dosing Error|1
7320626|NCT00744237|11550570|FG000|Overall Study|Study Drug Error|1
7320627|NCT00744237|11550571|FG001|Overall Study|Study Drug Error|0
7320628|NCT00744237|11550572|FG002|Overall Study|Study Drug Error|0
7320629|NCT00744237|11550570|FG000|Overall Study|Prohibited Concomitant Medication|0
7320630|NCT00744237|11550571|FG001|Overall Study|Prohibited Concomitant Medication|0
7320631|NCT00744237|11550572|FG002|Overall Study|Prohibited Concomitant Medication|1
7320632|NCT00744237|11550570|FG000|Overall Study|Poor Compliance|0
7320633|NCT00744237|11550571|FG001|Overall Study|Poor Compliance|2
7320634|NCT00744237|11550572|FG002|Overall Study|Poor Compliance|0
7320635|NCT00744237|11550570|FG000|Overall Study|Administrative. Site Closed|1
7320636|NCT00744237|11550571|FG001|Overall Study|Administrative. Site Closed|1
7320637|NCT00744237|11550572|FG002|Overall Study|Administrative. Site Closed|1
7320638|NCT00744237|11550570|FG000|Overall Study|Adverse Event|9
7320639|NCT00744237|11550571|FG001|Overall Study|Adverse Event|13
7320640|NCT00744237|11550572|FG002|Overall Study|Adverse Event|5
7320641|NCT00744263|11550582|FG000|Overall Study|Death|3006
7320642|NCT00744263|11550583|FG001|Overall Study|Death|3005
7320643|NCT00744263|11550582|FG000|Overall Study|Lost to Follow-up|2038
7320644|NCT00744263|11550583|FG001|Overall Study|Lost to Follow-up|2135
7415662|NCT01443026|11688933|FG001|Overall Study|Withdrawal by Subject|3
7415663|NCT01443026|11688932|FG000|Overall Study|Lost to Follow-up|2
7415664|NCT01443026|11688933|FG001|Overall Study|Lost to Follow-up|1
7415665|NCT01443078|11688939|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
7415666|NCT01443078|11688939|FG000|Overall Study|Withdrawal by Subject|1
7320645|NCT00744263|11550582|FG000|Overall Study|Withdrawal by Subject|166
7320646|NCT00744263|11550583|FG001|Overall Study|Withdrawal by Subject|150
7320647|NCT00744263|11550582|FG000|Overall Study|Physician Decision|20
7320648|NCT00744263|11550583|FG001|Overall Study|Physician Decision|23
7320649|NCT00744263|11550582|FG000|Overall Study|Protocol Violation|3
7320650|NCT00744263|11550583|FG001|Overall Study|Protocol Violation|5
7320651|NCT00744263|11550582|FG000|Overall Study|Adverse Event|1
7320652|NCT00744263|11550583|FG001|Overall Study|Adverse Event|0
7320653|NCT00744263|11550582|FG000|Overall Study|Other|2
7320654|NCT00744263|11550583|FG001|Overall Study|Other|2
7320655|NCT00744328|11550594|FG000|Overall Study|Lost to Follow-up|2
7320656|NCT00744328|11550595|FG001|Overall Study|Lost to Follow-up|5
7320657|NCT00744328|11550596|FG002|Overall Study|Lost to Follow-up|3
7320658|NCT00744328|11550594|FG000|Overall Study|Withdrawal by Subject|5
7320659|NCT00744328|11550595|FG001|Overall Study|Withdrawal by Subject|3
7320660|NCT00744328|11550596|FG002|Overall Study|Withdrawal by Subject|4
7320661|NCT00744328|11550594|FG000|Overall Study|Found ineligible after randomization|0
7320662|NCT00744328|11550595|FG001|Overall Study|Found ineligible after randomization|0
7320663|NCT00744328|11550596|FG002|Overall Study|Found ineligible after randomization|1
7320664|NCT00744471|11550618|FG000|Overall Study|Randomized but not treated|1
7320665|NCT00744471|11550619|FG001|Overall Study|Randomized but not treated|1
7320666|NCT00744471|11550620|FG002|Overall Study|Randomized but not treated|4
7320667|NCT00744471|11550621|FG003|Overall Study|Randomized but not treated|0
7320668|NCT00744471|11550618|FG000|Overall Study|Death|0
7320669|NCT00744471|11550619|FG001|Overall Study|Death|0
7320670|NCT00744471|11550620|FG002|Overall Study|Death|0
7320671|NCT00744471|11550621|FG003|Overall Study|Death|1
7320672|NCT00744471|11550618|FG000|Overall Study|Adverse Event|6
7320673|NCT00744471|11550619|FG001|Overall Study|Adverse Event|7
7320674|NCT00744471|11550620|FG002|Overall Study|Adverse Event|5
7320675|NCT00744471|11550621|FG003|Overall Study|Adverse Event|9
7320676|NCT00744471|11550618|FG000|Overall Study|Withdrawal by Subject|9
7320677|NCT00744471|11550619|FG001|Overall Study|Withdrawal by Subject|9
7320678|NCT00744471|11550620|FG002|Overall Study|Withdrawal by Subject|15
7320679|NCT00744471|11550621|FG003|Overall Study|Withdrawal by Subject|12
7320680|NCT00744471|11550618|FG000|Overall Study|Protocol Violation|1
7320681|NCT00744471|11550619|FG001|Overall Study|Protocol Violation|4
7320682|NCT00744471|11550620|FG002|Overall Study|Protocol Violation|1
7320683|NCT00744471|11550621|FG003|Overall Study|Protocol Violation|2
7320684|NCT00744471|11550618|FG000|Overall Study|Entered extension study|41
7320685|NCT00744471|11550619|FG001|Overall Study|Entered extension study|84
7320686|NCT00744471|11550620|FG002|Overall Study|Entered extension study|100
7320687|NCT00744471|11550621|FG003|Overall Study|Entered extension study|91
7320688|NCT00744471|11550618|FG000|Overall Study|Other|2
7320689|NCT00744471|11550619|FG001|Overall Study|Other|3
7320690|NCT00744471|11550620|FG002|Overall Study|Other|6
7320691|NCT00744471|11550621|FG003|Overall Study|Other|2
7320692|NCT00744471|11550618|FG000|Overall Study|Lack of Efficacy|83
7320693|NCT00744471|11550619|FG001|Overall Study|Lack of Efficacy|37
7320694|NCT00744471|11550620|FG002|Overall Study|Lack of Efficacy|19
7530603|NCT02640755|11874501|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
7530604|NCT02641080|11874532|FG000|Overall Study|Physician Decision|2
7530605|NCT02641080|11874533|FG001|Overall Study|Physician Decision|0
7530606|NCT02641080|11874532|FG000|Overall Study|Withdrawal by Subject|0
7530607|NCT02641080|11874533|FG001|Overall Study|Withdrawal by Subject|1
7530608|NCT02641080|11874532|FG000|Overall Study|Rehab Center denied use of pumps|0
7530609|NCT02641080|11874533|FG001|Overall Study|Rehab Center denied use of pumps|3
7554079|NCT03023878|11915574|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
7320695|NCT00744471|11550621|FG003|Overall Study|Lack of Efficacy|31
7320696|NCT00744471|11550618|FG000|Overall Study|Lost to Follow-up|0
7320697|NCT00744471|11550619|FG001|Overall Study|Lost to Follow-up|0
7320698|NCT00744471|11550620|FG002|Overall Study|Lost to Follow-up|2
7320699|NCT00744471|11550621|FG003|Overall Study|Lost to Follow-up|0
7320700|NCT00744497|11550633|FG000|Overall Study|Withdrawal by Subject|21
7320701|NCT00744497|11550634|FG001|Overall Study|Withdrawal by Subject|18
7320702|NCT00744497|11550633|FG000|Overall Study|Death|11
7320703|NCT00744497|11550634|FG001|Overall Study|Death|9
7320704|NCT00744497|11550633|FG000|Overall Study|Lost to Follow-up|4
7320705|NCT00744497|11550634|FG001|Overall Study|Lost to Follow-up|2
7320706|NCT00744497|11550633|FG000|Overall Study|Poor compliance/noncompliance|9
7554080|NCT03023878|11915574|FG000|Treatment Period|Disease Progression|1
7320707|NCT00744497|11550634|FG001|Overall Study|Poor compliance/noncompliance|5
7320708|NCT00744497|11550633|FG000|Overall Study|No longer meets study criteria|7
7320709|NCT00744497|11550634|FG001|Overall Study|No longer meets study criteria|3
7320710|NCT00744497|11550633|FG000|Overall Study|Administrative Reason By Sponsor|25
7320711|NCT00744497|11550634|FG001|Overall Study|Administrative Reason By Sponsor|8
7320712|NCT00744497|11550633|FG000|Overall Study|Disease progression|312
7320713|NCT00744497|11550634|FG001|Overall Study|Disease progression|219
7320714|NCT00744497|11550633|FG000|Overall Study|Study drug toxicity|68
7320715|NCT00744497|11550634|FG001|Overall Study|Study drug toxicity|141
7530610|NCT02641080|11874532|FG000|Overall Study|Lost to Follow-up|0
7320716|NCT00744497|11550633|FG000|Overall Study|Adverse event unrelated to study drug|78
7320717|NCT00744497|11550634|FG001|Overall Study|Adverse event unrelated to study drug|122
7530611|NCT02641080|11874533|FG001|Overall Study|Lost to Follow-up|3
7320718|NCT00744497|11550633|FG000|Overall Study|Patient requested to stop study drug|65
7320719|NCT00744497|11550634|FG001|Overall Study|Patient requested to stop study drug|80
7320720|NCT00744497|11550633|FG000|Overall Study|Maximum clinical benefit|141
7320721|NCT00744497|11550634|FG001|Overall Study|Maximum clinical benefit|142
7320722|NCT00744497|11550633|FG000|Overall Study|Not defined|19
7320723|NCT00744497|11550634|FG001|Overall Study|Not defined|13
7320724|NCT00744523|11550642|FG000|30 Days After the Procedure|Insufficient follow-up|0
7320725|NCT00744523|11550643|FG001|30 Days After the Procedure|Insufficient follow-up|5
7320726|NCT00744627|11550653|FG000|Overall Study|Adverse Event|6
7320727|NCT00744627|11550654|FG001|Overall Study|Adverse Event|9
7320728|NCT00744627|11550653|FG000|Overall Study|Lack of Efficacy|7
7320729|NCT00744627|11550654|FG001|Overall Study|Lack of Efficacy|3
7320730|NCT00744627|11550653|FG000|Overall Study|Noncompliance|0
7320731|NCT00744627|11550654|FG001|Overall Study|Noncompliance|1
7320732|NCT00744627|11550653|FG000|Overall Study|Protocol Deviations|0
7320733|NCT00744627|11550654|FG001|Overall Study|Protocol Deviations|2
7320734|NCT00744627|11550653|FG000|Overall Study|Voluntary Withdrawal|9
7320735|NCT00744627|11550654|FG001|Overall Study|Voluntary Withdrawal|6
7320736|NCT00744627|11550653|FG000|Overall Study|Lost to Follow-up|2
7320737|NCT00744627|11550654|FG001|Overall Study|Lost to Follow-up|1
7320738|NCT00744627|11550653|FG000|Overall Study|Other|1
7320739|NCT00744627|11550654|FG001|Overall Study|Other|0
7320740|NCT00744653|11550660|FG000|Overall Study|antineoplastic treatment|11
7320741|NCT00744653|11550660|FG000|Overall Study|Death|1
7320742|NCT00744653|11550660|FG000|Overall Study|Lost to Follow-up|1
7320743|NCT00744653|11550660|FG000|Overall Study|Physician Decision|3
7320744|NCT00744757|11550669|FG000|Overall Study|Objective disease progression|7
7320745|NCT00744757|11550669|FG000|Overall Study|Physician Decision|5
7320746|NCT00744757|11550669|FG000|Overall Study|Withdrawal by Subject|1
7320747|NCT00744757|11550669|FG000|Overall Study|Death|6
7320748|NCT00744757|11550669|FG000|Overall Study|Adverse Event|2
7320749|NCT00744796|11550673|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
7320750|NCT00744861|11550690|FG000|Feasibility Stage 1|Withdrawal by Subject|1
7320751|NCT00744861|11550691|FG001|Feasibility Stage 1|Withdrawal by Subject|1
7320752|NCT00744861|11550692|FG002|Feasibility Stage 1|Withdrawal by Subject|0
7320753|NCT00744861|11550693|FG003|Feasibility Stage 1|Withdrawal by Subject|0
7320754|NCT00744861|11550690|FG000|Feasibility Stage 1|Pregnancy|0
7320755|NCT00744861|11550691|FG001|Feasibility Stage 1|Pregnancy|1
7320756|NCT00744861|11550692|FG002|Feasibility Stage 1|Pregnancy|0
7320757|NCT00744861|11550693|FG003|Feasibility Stage 1|Pregnancy|0
7320758|NCT00744861|11550690|FG000|Pivotal Stage 2|Adverse Event|0
7320759|NCT00744861|11550691|FG001|Pivotal Stage 2|Adverse Event|0
7320760|NCT00744861|11550692|FG002|Pivotal Stage 2|Adverse Event|6
7320761|NCT00744861|11550693|FG003|Pivotal Stage 2|Adverse Event|11
7320762|NCT00744861|11550690|FG000|Pivotal Stage 2|Death|0
7320763|NCT00744861|11550691|FG001|Pivotal Stage 2|Death|0
7320764|NCT00744861|11550692|FG002|Pivotal Stage 2|Death|0
7320765|NCT00744861|11550693|FG003|Pivotal Stage 2|Death|1
7320766|NCT00744861|11550690|FG000|Pivotal Stage 2|Lost to Follow-up|0
7320767|NCT00744861|11550691|FG001|Pivotal Stage 2|Lost to Follow-up|0
7415667|NCT01443078|11688939|FG000|Overall Study|Patient had brain mets|1
7415668|NCT01443130|11688949|FG000|Overall Study|Lost to Follow-up|44
7415669|NCT01443130|11688950|FG001|Overall Study|Lost to Follow-up|42
7415670|NCT01443130|11688951|FG002|Overall Study|Lost to Follow-up|50
7415671|NCT01443130|11688952|FG003|Overall Study|Lost to Follow-up|23
7415672|NCT01443130|11688953|FG004|Overall Study|Lost to Follow-up|25
7415673|NCT01443130|11688954|FG005|Overall Study|Lost to Follow-up|21
7415674|NCT01443130|11688949|FG000|Overall Study|Death|0
7415675|NCT01443130|11688950|FG001|Overall Study|Death|1
7415676|NCT01443130|11688951|FG002|Overall Study|Death|0
7415677|NCT01443130|11688952|FG003|Overall Study|Death|7
7415678|NCT01443130|11688953|FG004|Overall Study|Death|10
7415679|NCT01443130|11688954|FG005|Overall Study|Death|8
7415680|NCT01443130|11688949|FG000|Overall Study|Adverse Event|2
7415681|NCT01443130|11688950|FG001|Overall Study|Adverse Event|1
7415682|NCT01443130|11688951|FG002|Overall Study|Adverse Event|1
7415683|NCT01443130|11688952|FG003|Overall Study|Adverse Event|0
7415684|NCT01443130|11688953|FG004|Overall Study|Adverse Event|0
7415685|NCT01443130|11688954|FG005|Overall Study|Adverse Event|0
7415686|NCT01443130|11688949|FG000|Overall Study|Protocol Violation|2
7415687|NCT01443130|11688950|FG001|Overall Study|Protocol Violation|1
7415688|NCT01443130|11688951|FG002|Overall Study|Protocol Violation|3
7415689|NCT01443130|11688952|FG003|Overall Study|Protocol Violation|2
7415690|NCT01443130|11688953|FG004|Overall Study|Protocol Violation|2
7415691|NCT01443130|11688954|FG005|Overall Study|Protocol Violation|3
7415692|NCT01443130|11688949|FG000|Overall Study|Withdrawal by Subject|15
7415693|NCT01443130|11688950|FG001|Overall Study|Withdrawal by Subject|14
7415694|NCT01443130|11688951|FG002|Overall Study|Withdrawal by Subject|12
7415695|NCT01443130|11688952|FG003|Overall Study|Withdrawal by Subject|7
7320768|NCT00744861|11550692|FG002|Pivotal Stage 2|Lost to Follow-up|13
7320769|NCT00744861|11550693|FG003|Pivotal Stage 2|Lost to Follow-up|14
7320770|NCT00744861|11550690|FG000|Pivotal Stage 2|Physician Decision|0
7320771|NCT00744861|11550691|FG001|Pivotal Stage 2|Physician Decision|0
7415696|NCT01443130|11688953|FG004|Overall Study|Withdrawal by Subject|7
7415697|NCT01443130|11688954|FG005|Overall Study|Withdrawal by Subject|2
7415698|NCT01443130|11688949|FG000|Overall Study|Death of Subject's Infant|5
7320772|NCT00744861|11550692|FG002|Pivotal Stage 2|Physician Decision|3
7320773|NCT00744861|11550693|FG003|Pivotal Stage 2|Physician Decision|1
7320774|NCT00744861|11550690|FG000|Pivotal Stage 2|Protocol Violation|0
7320775|NCT00744861|11550691|FG001|Pivotal Stage 2|Protocol Violation|0
7320776|NCT00744861|11550692|FG002|Pivotal Stage 2|Protocol Violation|0
7320777|NCT00744861|11550693|FG003|Pivotal Stage 2|Protocol Violation|1
7320778|NCT00744861|11550690|FG000|Pivotal Stage 2|Withdrawal by Subject|0
7320779|NCT00744861|11550691|FG001|Pivotal Stage 2|Withdrawal by Subject|0
7320780|NCT00744861|11550692|FG002|Pivotal Stage 2|Withdrawal by Subject|20
7320781|NCT00744861|11550693|FG003|Pivotal Stage 2|Withdrawal by Subject|14
7320782|NCT00744861|11550690|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
7320783|NCT00744861|11550691|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
7320784|NCT00744861|11550692|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
7320785|NCT00744861|11550693|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
7320786|NCT00744874|11550701|FG000|Overall Study|Lost to Follow-up|1
7320787|NCT00744874|11550701|FG000|Overall Study|Withdrawal by Subject|1
7320788|NCT00744874|11550701|FG000|Overall Study|Study Device not available at procedure|1
7320789|NCT00744874|11550701|FG000|Overall Study|Unable to accomodate schedule|1
7320790|NCT00744939|11550716|FG000|Overall Study|Withdrawal by Subject|9
7320791|NCT00744939|11550716|FG000|Overall Study|Protocol Violation|13
7320792|NCT00744939|11550716|FG000|Overall Study|Death|24
7320793|NCT00744939|11550716|FG000|Overall Study|distance|4
7320794|NCT00744939|11550716|FG000|Overall Study|Lost to Follow-up|12
7320795|NCT00744939|11550716|FG000|Overall Study|Medical history exclusionary|1
7320796|NCT00744939|11550716|FG000|Overall Study|Did not receive Magnevist|7
7320797|NCT00744939|11550716|FG000|Overall Study|Failed inclusion/exclusion criteria|19
7320798|NCT00744939|11550716|FG000|Overall Study|coma|1
7320799|NCT00744939|11550716|FG000|Overall Study|incorrect race|1
7320800|NCT00744978|11550739|FG000|Period 1|Lost to Follow-up|1
7320801|NCT00744978|11550740|FG001|Period 1|Lost to Follow-up|0
7320802|NCT00744978|11550739|FG000|Period 1|Withdrawal by Subject|0
7320803|NCT00744978|11550740|FG001|Period 1|Withdrawal by Subject|2
7320804|NCT00744978|11550739|FG000|Period 1|Other|0
7320805|NCT00744978|11550740|FG001|Period 1|Other|2
7320806|NCT00744978|11550739|FG000|Period 1|Adverse Event|4
7320807|NCT00744978|11550740|FG001|Period 1|Adverse Event|0
7320808|NCT00744978|11550739|FG000|Period 1|Randomized but not Treated|1
7320809|NCT00744978|11550740|FG001|Period 1|Randomized but not Treated|1
7320810|NCT00744978|11550739|FG000|Period 2|Adverse Event|0
7320811|NCT00744978|11550740|FG001|Period 2|Adverse Event|1
7320812|NCT00744991|11550746|FG000|Overall Study|Progressive Disease|11
7320813|NCT00744991|11550746|FG000|Overall Study|Withdrawal by Subject|8
7320814|NCT00744991|11550746|FG000|Overall Study|Physician Decision|3
7320815|NCT00744991|11550746|FG000|Overall Study|Adverse Event|2
7320816|NCT00744991|11550746|FG000|Overall Study|Protocol Entry Criteria Unmet|1
7320817|NCT00745095|11550759|FG000|Overall Study|Declined to participate|1
7320818|NCT00745095|11550760|FG001|Overall Study|Declined to participate|0
7320819|NCT00745095|11550761|FG002|Overall Study|Declined to participate|0
7320820|NCT00745095|11550762|FG003|Overall Study|Declined to participate|0
7320821|NCT00745095|11550763|FG004|Overall Study|Declined to participate|92
7320822|NCT00745095|11550764|FG005|Overall Study|Declined to participate|95
7320823|NCT00745095|11550759|FG000|Overall Study|Ineligible due to GFR criteria|0
7320824|NCT00745095|11550760|FG001|Overall Study|Ineligible due to GFR criteria|2
7320825|NCT00745095|11550761|FG002|Overall Study|Ineligible due to GFR criteria|3
7320826|NCT00745095|11550762|FG003|Overall Study|Ineligible due to GFR criteria|3
7320827|NCT00745095|11550763|FG004|Overall Study|Ineligible due to GFR criteria|30
7320828|NCT00745095|11550764|FG005|Overall Study|Ineligible due to GFR criteria|28
7320829|NCT00745121|11550783|FG000|Overall Study|Death|3
7320830|NCT00745121|11550784|FG001|Overall Study|Death|0
7320831|NCT00745121|11550783|FG000|Overall Study|Adverse Event|1
7320832|NCT00745121|11550784|FG001|Overall Study|Adverse Event|0
7320833|NCT00745121|11550783|FG000|Overall Study|Lost to Follow-up|1
7320834|NCT00745121|11550784|FG001|Overall Study|Lost to Follow-up|0
7320835|NCT00745121|11550783|FG000|Overall Study|Withdrawal by Subject|4
7320836|NCT00745121|11550784|FG001|Overall Study|Withdrawal by Subject|2
7320837|NCT00745251|11550792|FG000|Overall Study|Adverse Event|1
7320838|NCT00745251|11550793|FG001|Overall Study|Adverse Event|2
7320839|NCT00745251|11550792|FG000|Overall Study|Withdrawal by Subject|1
7320840|NCT00745251|11550793|FG001|Overall Study|Withdrawal by Subject|1
7320841|NCT00745368|11550808|FG000|Overall Study|Unable to provide sample|3
7320842|NCT00745420|11550812|FG000|Overall Study|Ineligible|1
7320843|NCT00745498|11550819|FG000|Overall Study|Lost to Follow-up|1
7320844|NCT00745498|11550820|FG001|Overall Study|Lost to Follow-up|1
7320845|NCT00745498|11550821|FG002|Overall Study|Lost to Follow-up|3
7320846|NCT00745498|11550819|FG000|Overall Study|Injection of intravitreal silicone oil o|3
7320847|NCT00745498|11550820|FG001|Overall Study|Injection of intravitreal silicone oil o|4
7320848|NCT00745498|11550821|FG002|Overall Study|Injection of intravitreal silicone oil o|4
7320849|NCT00745498|11550819|FG000|Overall Study|Non-PDR related VH|0
7320850|NCT00745498|11550820|FG001|Overall Study|Non-PDR related VH|1
7320851|NCT00745498|11550821|FG002|Overall Study|Non-PDR related VH|1
7320852|NCT00745498|11550819|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
7320853|NCT00745498|11550820|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
7320854|NCT00745498|11550821|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
7530612|NCT02641379|11874571|FG000|Overall Study|Exclusion criterion during screening|1
7530613|NCT02641379|11874572|FG001|Overall Study|Exclusion criterion during screening|0
7530614|NCT02641379|11874573|FG002|Overall Study|Exclusion criterion during screening|0
7530615|NCT02641379|11874574|FG003|Overall Study|Exclusion criterion during screening|1
7530616|NCT02641379|11874575|FG004|Overall Study|Exclusion criterion during screening|2
7320855|NCT00745615|11550833|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
7320856|NCT00745615|11550834|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
7320857|NCT00745615|11550835|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7320858|NCT00745615|11550836|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
7320859|NCT00745615|11550837|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7320860|NCT00745615|11550838|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
7320861|NCT00745615|11550833|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
7320862|NCT00745615|11550834|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
7320863|NCT00745615|11550835|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
7320864|NCT00745615|11550836|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
7320865|NCT00745615|11550837|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
7320866|NCT00745615|11550838|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
7320867|NCT00745615|11550833|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
7320868|NCT00745615|11550834|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
7320869|NCT00745615|11550835|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
7320870|NCT00745615|11550836|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
7320871|NCT00745615|11550837|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
7320872|NCT00745615|11550838|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
7320873|NCT00745615|11550833|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
7320874|NCT00745615|11550834|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
7320875|NCT00745615|11550835|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
7320876|NCT00745615|11550836|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
7320877|NCT00745615|11550837|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
7320878|NCT00745615|11550838|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
7320879|NCT00745615|11550833|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7320880|NCT00745615|11550834|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
7320881|NCT00745615|11550835|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7320882|NCT00745615|11550836|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7415699|NCT01443130|11688950|FG001|Overall Study|Death of Subject's Infant|10
7415700|NCT01443130|11688951|FG002|Overall Study|Death of Subject's Infant|11
7415701|NCT01443130|11688952|FG003|Overall Study|Death of Subject's Infant|0
7415702|NCT01443130|11688953|FG004|Overall Study|Death of Subject's Infant|0
7415703|NCT01443130|11688954|FG005|Overall Study|Death of Subject's Infant|0
7415704|NCT01443364|11688968|FG000|Overall Study|Lack of Efficacy|14
7415705|NCT01443364|11688968|FG000|Overall Study|Lost to Follow-up|3
7415706|NCT01443364|11688968|FG000|Overall Study|Withdrawal by Subject|5
7415707|NCT01443364|11688968|FG000|Overall Study|Other Reason|4
7415708|NCT01443364|11688968|FG000|Overall Study|SAE, non-fatal|6
7415709|NCT01443364|11688968|FG000|Overall Study|AE, non-serious non-fatal|8
7415710|NCT01443364|11688968|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7415711|NCT01443403|11688976|FG000|Overall Study|Adverse Event|1
7415712|NCT01443403|11688977|FG001|Overall Study|Adverse Event|1
7415713|NCT01443403|11688978|FG002|Overall Study|Adverse Event|4
7415714|NCT01443403|11688979|FG003|Overall Study|Adverse Event|5
7415715|NCT01443403|11688976|FG000|Overall Study|Withdrawal by Subject|0
7415716|NCT01443403|11688977|FG001|Overall Study|Withdrawal by Subject|1
7415717|NCT01443403|11688978|FG002|Overall Study|Withdrawal by Subject|2
7415718|NCT01443403|11688979|FG003|Overall Study|Withdrawal by Subject|1
7415719|NCT01443403|11688976|FG000|Overall Study|Lost to Follow-up|0
7415720|NCT01443403|11688977|FG001|Overall Study|Lost to Follow-up|0
7415721|NCT01443403|11688978|FG002|Overall Study|Lost to Follow-up|0
7415722|NCT01443403|11688979|FG003|Overall Study|Lost to Follow-up|1
7415723|NCT01443403|11688976|FG000|Overall Study|Protocol Violation|2
7415724|NCT01443403|11688977|FG001|Overall Study|Protocol Violation|1
7415725|NCT01443403|11688978|FG002|Overall Study|Protocol Violation|1
7415726|NCT01443403|11688979|FG003|Overall Study|Protocol Violation|1
7415727|NCT01443403|11688976|FG000|Overall Study|Use of Prohibited Treatment|2
7415728|NCT01443403|11688977|FG001|Overall Study|Use of Prohibited Treatment|3
7415729|NCT01443403|11688978|FG002|Overall Study|Use of Prohibited Treatment|0
7415730|NCT01443403|11688979|FG003|Overall Study|Use of Prohibited Treatment|0
7415731|NCT01443403|11688976|FG000|Overall Study|Other - Miscellaneous|1
7415732|NCT01443403|11688977|FG001|Overall Study|Other - Miscellaneous|0
7415733|NCT01443403|11688978|FG002|Overall Study|Other - Miscellaneous|0
7415734|NCT01443403|11688979|FG003|Overall Study|Other - Miscellaneous|1
7415735|NCT01443845|11689022|FG000|Overall Study|Protocol Violation|43
7415736|NCT01443845|11689023|FG001|Overall Study|Protocol Violation|45
7415737|NCT01443845|11689022|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
7415738|NCT01443845|11689023|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
7415739|NCT01443845|11689022|FG000|Overall Study|Deterioration in pulmonary function|1
7415740|NCT01443845|11689023|FG001|Overall Study|Deterioration in pulmonary function|4
7415741|NCT01443845|11689022|FG000|Overall Study|Lack of Efficacy|10
7530617|NCT02641379|11874576|FG005|Overall Study|Exclusion criterion during screening|0
7530618|NCT02641379|11874577|FG006|Overall Study|Exclusion criterion during screening|0
7530619|NCT02641379|11874578|FG007|Overall Study|Exclusion criterion during screening|0
7530620|NCT02641379|11874579|FG008|Overall Study|Exclusion criterion during screening|0
7320883|NCT00745615|11550837|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7320884|NCT00745615|11550838|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
7320885|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7320886|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7320887|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7320888|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
7320889|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7320890|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
7320891|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7320892|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7320893|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7320894|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
7320895|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7320896|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
7320897|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7320898|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7320899|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7320900|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
7320901|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
7320902|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
7320903|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7320904|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7320905|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7320906|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
7320907|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
7320908|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
7320909|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7320910|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7320911|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7320912|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
7320913|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
7320914|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
7320915|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7320916|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7320917|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7320918|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
7320919|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
7320920|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
7320921|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7320922|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7320923|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7320924|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7320925|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
7320926|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
7320927|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
7320928|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
7320929|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
7320930|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
7320931|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
7320932|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
7320933|NCT00745615|11550833|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7320934|NCT00745615|11550834|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7320935|NCT00745615|11550835|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7320936|NCT00745615|11550836|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
7320937|NCT00745615|11550837|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
7320938|NCT00745615|11550838|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
7320939|NCT00745823|11550852|FG000|Overall Study|Adverse Event|5
7320940|NCT00745823|11550853|FG001|Overall Study|Adverse Event|3
7320941|NCT00745823|11550852|FG000|Overall Study|Lack of Efficacy|20
7320942|NCT00745823|11550853|FG001|Overall Study|Lack of Efficacy|6
7320943|NCT00745823|11550852|FG000|Overall Study|Lost to Follow-up|10
7320944|NCT00745823|11550853|FG001|Overall Study|Lost to Follow-up|11
7320945|NCT00745823|11550852|FG000|Overall Study|Physician Decision|10
7320946|NCT00745823|11550853|FG001|Overall Study|Physician Decision|5
7320947|NCT00745823|11550852|FG000|Overall Study|Pregnancy|0
7320948|NCT00745823|11550853|FG001|Overall Study|Pregnancy|4
7320949|NCT00745823|11550852|FG000|Overall Study|Withdrawal by Subject|14
7320950|NCT00745823|11550853|FG001|Overall Study|Withdrawal by Subject|8
7320951|NCT00745823|11550852|FG000|Overall Study|Study Terminated by Sponsor|326
7320952|NCT00745823|11550853|FG001|Overall Study|Study Terminated by Sponsor|349
7320953|NCT00745849|11550861|FG000|First Intervention|Withdrawal by Subject|0
7320954|NCT00745849|11550862|FG001|First Intervention|Withdrawal by Subject|1
7320955|NCT00745849|11550861|FG000|First Intervention|Lost to Follow-up|1
7320956|NCT00745849|11550862|FG001|First Intervention|Lost to Follow-up|1
7320957|NCT00745849|11550861|FG000|Second Intervention|Lost to Follow-up|2
7320958|NCT00745849|11550862|FG001|Second Intervention|Lost to Follow-up|1
7320959|NCT00745875|11550870|FG000|Overall Study|Continuing study treatment|4
7320960|NCT00745875|11550871|FG001|Overall Study|Continuing study treatment|4
7320961|NCT00745901|11550879|FG000|Overall Study|Adverse Event|3
7320962|NCT00745901|11550880|FG001|Overall Study|Adverse Event|4
7320963|NCT00745901|11550879|FG000|Overall Study|Protocol Violation|0
7320964|NCT00745901|11550880|FG001|Overall Study|Protocol Violation|1
7320965|NCT00745901|11550879|FG000|Overall Study|Withdrawal by Subject|1
7320966|NCT00745901|11550880|FG001|Overall Study|Withdrawal by Subject|0
7320967|NCT00745901|11550879|FG000|Overall Study|Lost to Follow-up|7
7320968|NCT00745901|11550880|FG001|Overall Study|Lost to Follow-up|4
7320969|NCT00745901|11550879|FG000|Overall Study|Pregnancy|2
7320970|NCT00745901|11550880|FG001|Overall Study|Pregnancy|4
7320971|NCT00745901|11550879|FG000|Overall Study|Lack of compliance|2
7320972|NCT00745901|11550880|FG001|Overall Study|Lack of compliance|2
7320973|NCT00745901|11550879|FG000|Overall Study|Patient's next menses did not start with|1
7320974|NCT00745901|11550880|FG001|Overall Study|Patient's next menses did not start with|0
7320975|NCT00745901|11550879|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
7320976|NCT00745901|11550880|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
7320977|NCT00745901|11550879|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
7320978|NCT00745901|11550880|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
7320979|NCT00745901|11550879|FG000|Overall Study|Patient didn't take any study medication|7
7320980|NCT00745901|11550880|FG001|Overall Study|Patient didn't take any study medication|3
7320981|NCT00746096|11550897|FG000|Overall Study|Adverse Event|1
7530621|NCT02641379|11874580|FG009|Overall Study|Exclusion criterion during screening|0
7530622|NCT02641379|11874581|FG010|Overall Study|Exclusion criterion during screening|0
7530623|NCT02641379|11874571|FG000|Overall Study|Withdrawal of informed consent|0
7320982|NCT00746096|11550898|FG001|Overall Study|Adverse Event|0
7320983|NCT00746096|11550897|FG000|Overall Study|Withdrawal by Subject|5
7320984|NCT00746096|11550898|FG001|Overall Study|Withdrawal by Subject|1
7320985|NCT00746096|11550897|FG000|Overall Study|Lost to Follow-up|2
7320986|NCT00746096|11550898|FG001|Overall Study|Lost to Follow-up|1
7320987|NCT00746096|11550897|FG000|Overall Study|Protocol Violation|1
7320988|NCT00746096|11550898|FG001|Overall Study|Protocol Violation|0
7320989|NCT00746096|11550897|FG000|Overall Study|No study drug treatment|1
7320990|NCT00746096|11550898|FG001|Overall Study|No study drug treatment|1
7320991|NCT00746252|11550924|FG000|Overall Study|weight gain >7.5 %|1
7320992|NCT00746252|11550925|FG001|Overall Study|weight gain >7.5 %|2
7320993|NCT00746330|11550935|FG000|Period 1|Abnormal test procedure result|0
7415742|NCT01443845|11689023|FG001|Overall Study|Lack of Efficacy|5
7415743|NCT01443845|11689022|FG000|Overall Study|Adverse Event|64
7415744|NCT01443845|11689023|FG001|Overall Study|Adverse Event|138
7415745|NCT01443845|11689022|FG000|Overall Study|Withdrawal by Subject|63
7415746|NCT01443845|11689023|FG001|Overall Study|Withdrawal by Subject|67
7415747|NCT01443845|11689022|FG000|Overall Study|Military Conflict - Site Terminated|20
7415748|NCT01443845|11689023|FG001|Overall Study|Military Conflict - Site Terminated|21
7415749|NCT01443845|11689022|FG000|Overall Study|Lost to Follow-up|9
7415750|NCT01443845|11689023|FG001|Overall Study|Lost to Follow-up|13
7415751|NCT01443858|11689032|FG000|Overall Study|Withdrawal by Subject|9
7415752|NCT01443858|11689033|FG001|Overall Study|Withdrawal by Subject|8
7415753|NCT01443858|11689034|FG002|Overall Study|Withdrawal by Subject|5
7415754|NCT01443858|11689032|FG000|Overall Study|Lack of Efficacy|1
7415755|NCT01443858|11689033|FG001|Overall Study|Lack of Efficacy|0
7415756|NCT01443858|11689034|FG002|Overall Study|Lack of Efficacy|0
7415757|NCT01443858|11689032|FG000|Overall Study|Lost to Follow-up|5
7415758|NCT01443858|11689033|FG001|Overall Study|Lost to Follow-up|5
7415759|NCT01443858|11689034|FG002|Overall Study|Lost to Follow-up|2
7415760|NCT01444027|11689045|FG000|Overall Study|Withdrawal by Subject|4
7415761|NCT01444027|11689046|FG001|Overall Study|Withdrawal by Subject|10
7415762|NCT01444027|11689047|FG002|Overall Study|Withdrawal by Subject|24
7415763|NCT01444027|11689045|FG000|Overall Study|Lost to Follow-up|26
7415764|NCT01444027|11689046|FG001|Overall Study|Lost to Follow-up|20
7415765|NCT01444027|11689047|FG002|Overall Study|Lost to Follow-up|14
7415766|NCT01444300|11689071|FG000|Overall Study|Adverse Event|4
7415767|NCT01444300|11689072|FG001|Overall Study|Adverse Event|0
7320994|NCT00746330|11550936|FG001|Period 1|Abnormal test procedure result|0
7320995|NCT00746330|11550937|FG002|Period 1|Abnormal test procedure result|1
7320996|NCT00746330|11550938|FG003|Period 1|Abnormal test procedure result|0
7320997|NCT00746356|11550949|FG000|Overall Study|Withdrawal by Subject|2
7320998|NCT00746356|11550950|FG001|Overall Study|Withdrawal by Subject|3
7320999|NCT00746356|11550949|FG000|Overall Study|Death|7
7321000|NCT00746356|11550950|FG001|Overall Study|Death|3
7321001|NCT00746356|11550949|FG000|Overall Study|Lost to Follow-up|1
7321002|NCT00746356|11550950|FG001|Overall Study|Lost to Follow-up|0
7321003|NCT00746356|11550949|FG000|Overall Study|Removal of Device|0
7321004|NCT00746356|11550950|FG001|Overall Study|Removal of Device|1
7321005|NCT00746356|11550949|FG000|Overall Study|Patient relocated|1
7321006|NCT00746356|11550950|FG001|Overall Study|Patient relocated|0
7321007|NCT00746551|11550995|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
7321008|NCT00746551|11550996|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
7321009|NCT00746551|11550995|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
7321010|NCT00746551|11550996|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
7321011|NCT00746551|11550995|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
7321012|NCT00746551|11550996|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
7321013|NCT00746564|11551002|FG000|Overall Study|Required Pacemaker/ICD Implant|2
7321014|NCT00746733|11551031|FG000|Second Intervention|Adverse Event|1
7321015|NCT00746733|11551032|FG001|Second Intervention|Adverse Event|0
7321016|NCT00746733|11551031|FG000|Third Intervention|Withdrawal by Subject|1
7321017|NCT00746733|11551032|FG001|Third Intervention|Withdrawal by Subject|1
7321018|NCT00746785|11551048|FG000|Overall Study|Lost to Follow-up|29
7321019|NCT00746785|11551049|FG001|Overall Study|Lost to Follow-up|25
7321020|NCT00746785|11551050|FG002|Overall Study|Lost to Follow-up|27
7321021|NCT00746798|11551062|FG000|Overall Study|Protocol Violation|0
7321022|NCT00746798|11551063|FG001|Overall Study|Protocol Violation|1
7321023|NCT00746798|11551064|FG002|Overall Study|Protocol Violation|0
7321024|NCT00746798|11551065|FG003|Overall Study|Protocol Violation|0
7321025|NCT00746798|11551062|FG000|Overall Study|Withdrawal by Subject|0
7321026|NCT00746798|11551063|FG001|Overall Study|Withdrawal by Subject|1
7321027|NCT00746798|11551064|FG002|Overall Study|Withdrawal by Subject|1
7321028|NCT00746798|11551065|FG003|Overall Study|Withdrawal by Subject|0
7321029|NCT00746798|11551062|FG000|Overall Study|Death|0
7321030|NCT00746798|11551063|FG001|Overall Study|Death|0
7321031|NCT00746798|11551064|FG002|Overall Study|Death|2
7321032|NCT00746798|11551065|FG003|Overall Study|Death|0
7321033|NCT00746798|11551062|FG000|Overall Study|Participant unable to return for visit|1
7321034|NCT00746798|11551063|FG001|Overall Study|Participant unable to return for visit|0
7321035|NCT00746798|11551064|FG002|Overall Study|Participant unable to return for visit|0
7321036|NCT00746798|11551065|FG003|Overall Study|Participant unable to return for visit|0
7321037|NCT00746941|11551099|FG000|Overall Study|Death|2
7321038|NCT00746941|11551100|FG001|Overall Study|Death|0
7321039|NCT00746941|11551101|FG002|Overall Study|Death|0
7321040|NCT00746941|11551102|FG003|Overall Study|Death|6
7321041|NCT00746941|11551099|FG000|Overall Study|Physician Decision|0
7321042|NCT00746941|11551100|FG001|Overall Study|Physician Decision|0
7321043|NCT00746941|11551101|FG002|Overall Study|Physician Decision|2
7321044|NCT00746941|11551102|FG003|Overall Study|Physician Decision|0
7321045|NCT00746941|11551099|FG000|Overall Study|Withdrawal by Subject|3
7321046|NCT00746941|11551100|FG001|Overall Study|Withdrawal by Subject|0
7321047|NCT00746941|11551101|FG002|Overall Study|Withdrawal by Subject|0
7321048|NCT00746941|11551102|FG003|Overall Study|Withdrawal by Subject|2
7321049|NCT00746941|11551099|FG000|Overall Study|Other, reason not provided|2
7321050|NCT00746941|11551100|FG001|Overall Study|Other, reason not provided|4
7321051|NCT00746941|11551101|FG002|Overall Study|Other, reason not provided|0
7321052|NCT00746941|11551102|FG003|Overall Study|Other, reason not provided|4
7321053|NCT00746941|11551099|FG000|Overall Study|Adverse Event|0
7321054|NCT00746941|11551100|FG001|Overall Study|Adverse Event|0
7321055|NCT00746941|11551101|FG002|Overall Study|Adverse Event|0
7321056|NCT00746941|11551102|FG003|Overall Study|Adverse Event|1
7321057|NCT00747006|11551122|FG000|Overall Study|Adverse Event|1
7415768|NCT01444378|11689079|FG000|Overall Study|Lost to Follow-up|1
7415769|NCT01444378|11689079|FG000|Overall Study|Withdrawal by Subject|1
7415770|NCT01444378|11689079|FG000|Overall Study|Death|3
7415771|NCT01444378|11689079|FG000|Overall Study|Administrative Closure Of The Study|2
7415772|NCT01444378|11689079|FG000|Overall Study|Missed Visits|10
7415773|NCT01444391|11689086|FG000|Overall Study|Death|1
7415774|NCT01444417|11689092|FG000|Overall Study|Ineligibility Determined|0
7415775|NCT01444417|11689093|FG001|Overall Study|Ineligibility Determined|1
7415776|NCT01444417|11689092|FG000|Overall Study|Withdrawal by Subject|2
7415777|NCT01444417|11689093|FG001|Overall Study|Withdrawal by Subject|0
7415778|NCT01444430|11689101|FG000|Overall Study|Withdrawal by Subject|53
7415779|NCT01444430|11689102|FG001|Overall Study|Withdrawal by Subject|72
7415780|NCT01444430|11689101|FG000|Overall Study|Death|6
7415781|NCT01444430|11689102|FG001|Overall Study|Death|8
7415782|NCT01444430|11689101|FG000|Overall Study|Lost to Follow-up|2
7415783|NCT01444430|11689102|FG001|Overall Study|Lost to Follow-up|0
7415784|NCT01444430|11689101|FG000|Overall Study|CRF termination module not completed.|0
7415785|NCT01444430|11689102|FG001|Overall Study|CRF termination module not completed.|1
7321058|NCT00747006|11551123|FG001|Overall Study|Adverse Event|0
7321059|NCT00747006|11551124|FG002|Overall Study|Adverse Event|0
7321060|NCT00747006|11551122|FG000|Overall Study|Lost to Follow-up|0
7321061|NCT00747006|11551123|FG001|Overall Study|Lost to Follow-up|1
7321062|NCT00747006|11551124|FG002|Overall Study|Lost to Follow-up|0
7321063|NCT00747006|11551122|FG000|Overall Study|Physician Decision|2
7321064|NCT00747006|11551123|FG001|Overall Study|Physician Decision|0
7321065|NCT00747006|11551124|FG002|Overall Study|Physician Decision|1
7321066|NCT00747149|11551137|FG000|Overall Study|Adverse Event|0
7321067|NCT00747149|11551138|FG001|Overall Study|Adverse Event|15
7321068|NCT00747149|11551137|FG000|Overall Study|Lost to Follow-up|0
7321069|NCT00747149|11551138|FG001|Overall Study|Lost to Follow-up|10
7321070|NCT00747149|11551137|FG000|Overall Study|Withdrawal by Subject|0
7530624|NCT02641379|11874572|FG001|Overall Study|Withdrawal of informed consent|1
7530625|NCT02641379|11874573|FG002|Overall Study|Withdrawal of informed consent|0
7530626|NCT02641379|11874574|FG003|Overall Study|Withdrawal of informed consent|0
7321071|NCT00747149|11551138|FG001|Overall Study|Withdrawal by Subject|6
7321072|NCT00747149|11551137|FG000|Overall Study|Did not receive treatment|0
7321073|NCT00747149|11551138|FG001|Overall Study|Did not receive treatment|1
7321074|NCT00747149|11551137|FG000|Overall Study|Incorrect enrollment|0
7321075|NCT00747149|11551138|FG001|Overall Study|Incorrect enrollment|6
7321076|NCT00747149|11551137|FG000|Overall Study|Severe non-compliance to protocol|0
7321077|NCT00747149|11551138|FG001|Overall Study|Severe non-compliance to protocol|1
7321078|NCT00747149|11551137|FG000|Overall Study|Not reported|1
7321079|NCT00747149|11551138|FG001|Overall Study|Not reported|4
7321080|NCT00747227|11551161|FG000|Overall Study|Death|3
7321081|NCT00747227|11551162|FG001|Overall Study|Death|1
7321082|NCT00747227|11551161|FG000|Overall Study|Withdrawal by Subject|1
7321083|NCT00747227|11551162|FG001|Overall Study|Withdrawal by Subject|0
7321084|NCT00747227|11551161|FG000|Overall Study|Lost to Follow-up|1
7321085|NCT00747227|11551162|FG001|Overall Study|Lost to Follow-up|2
7321086|NCT00747227|11551161|FG000|Overall Study|Illness|1
7321087|NCT00747227|11551162|FG001|Overall Study|Illness|1
7321088|NCT00747344|11551170|FG000|Controlled Period|Adverse Event|3
7321089|NCT00747344|11551171|FG001|Controlled Period|Adverse Event|0
7321090|NCT00747344|11551172|FG002|Controlled Period|Adverse Event|0
7321091|NCT00747344|11551173|FG003|Controlled Period|Adverse Event|0
7321092|NCT00747344|11551170|FG000|Controlled Period|Lack of Efficacy|2
7321093|NCT00747344|11551171|FG001|Controlled Period|Lack of Efficacy|1
7321094|NCT00747344|11551172|FG002|Controlled Period|Lack of Efficacy|0
7321095|NCT00747344|11551173|FG003|Controlled Period|Lack of Efficacy|0
7321096|NCT00747344|11551170|FG000|Controlled Period|Other|0
7321097|NCT00747344|11551171|FG001|Controlled Period|Other|3
7321098|NCT00747344|11551172|FG002|Controlled Period|Other|0
7321099|NCT00747344|11551173|FG003|Controlled Period|Other|0
7321100|NCT00747344|11551170|FG000|After Controlled Period|Adverse Event|0
7321101|NCT00747344|11551171|FG001|After Controlled Period|Adverse Event|0
7321102|NCT00747344|11551172|FG002|After Controlled Period|Adverse Event|0
7321103|NCT00747344|11551173|FG003|After Controlled Period|Adverse Event|1
7321104|NCT00747435|11551181|FG000|Overall Study|Lost to Follow-up|2
7321105|NCT00747435|11551181|FG000|Overall Study|Withdrawal by Subject|3
7321106|NCT00747435|11551181|FG000|Overall Study|Still undergoing follow up|1
7321107|NCT00747474|11551185|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321108|NCT00747474|11551186|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321109|NCT00747474|11551187|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321110|NCT00747474|11551188|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321111|NCT00747474|11551189|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321112|NCT00747474|11551190|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321113|NCT00747474|11551191|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321114|NCT00747474|11551192|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
7321115|NCT00747474|11551193|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321116|NCT00747474|11551194|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321117|NCT00747474|11551195|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321118|NCT00747474|11551196|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
7321119|NCT00747565|11551207|FG000|Overall Study|Withdrawal by Subject|10
7321120|NCT00747565|11551208|FG001|Overall Study|Withdrawal by Subject|6
7321121|NCT00747565|11551207|FG000|Overall Study|Lost to Follow-up|4
7321122|NCT00747565|11551208|FG001|Overall Study|Lost to Follow-up|1
7321123|NCT00747617|11551216|FG000|Overall Study|Lost to Follow-up|3
7321124|NCT00747617|11551217|FG001|Overall Study|Lost to Follow-up|1
7321125|NCT00747643|11551225|FG000|Overall Study|Withdrawal by Subject|36
7321126|NCT00747643|11551226|FG001|Overall Study|Withdrawal by Subject|27
7321127|NCT00747812|11551247|FG000|Overall Study|Research Site Staff Relocation|5
7321128|NCT00747812|11551248|FG001|Overall Study|Research Site Staff Relocation|3
7321129|NCT00748033|11551256|FG000|Overall Study|Adverse Event|0
7321130|NCT00748033|11551257|FG001|Overall Study|Adverse Event|1
7321131|NCT00748098|11551280|FG000|First Treatment Intervention Period|Adverse Event|1
7321132|NCT00748098|11551281|FG001|First Treatment Intervention Period|Adverse Event|1
7321133|NCT00748098|11551280|FG000|First Treatment Intervention Period|Protocol Violation|1
7321134|NCT00748098|11551281|FG001|First Treatment Intervention Period|Protocol Violation|0
7321135|NCT00748098|11551280|FG000|First Treatment Intervention Period|Lost to Follow-up|1
7321136|NCT00748098|11551281|FG001|First Treatment Intervention Period|Lost to Follow-up|0
7321137|NCT00748098|11551280|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
7321138|NCT00748098|11551281|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
7321139|NCT00748098|11551280|FG000|First Taper Period|Protocol Violation|1
7321140|NCT00748098|11551281|FG001|First Taper Period|Protocol Violation|0
7321141|NCT00748098|11551280|FG000|First Taper Period|Withdrawal by Subject|2
7321142|NCT00748098|11551281|FG001|First Taper Period|Withdrawal by Subject|0
7321143|NCT00748098|11551280|FG000|First Taper Period|Protocol Stopping Criteria Met|0
7321144|NCT00748098|11551281|FG001|First Taper Period|Protocol Stopping Criteria Met|1
7321145|NCT00748098|11551280|FG000|1-Week Washout Period|Adverse Event|0
7321146|NCT00748098|11551281|FG001|1-Week Washout Period|Adverse Event|1
7321147|NCT00748098|11551280|FG000|1-Week Washout Period|Withdrawal by Subject|2
7321148|NCT00748098|11551281|FG001|1-Week Washout Period|Withdrawal by Subject|0
7321149|NCT00748098|11551280|FG000|Second Treatment Intervention Period|Adverse Event|4
7321150|NCT00748098|11551281|FG001|Second Treatment Intervention Period|Adverse Event|1
7415786|NCT01444456|11689108|FG000|Overall Study|Withdrawal by Subject|21
7415787|NCT01444456|11689108|FG000|Overall Study|Physician Decision|9
7415788|NCT01444456|11689108|FG000|Overall Study|Lost to Follow-up|37
7415789|NCT01444456|11689108|FG000|Overall Study|Death|73
7415790|NCT01444456|11689108|FG000|Overall Study|Ineligibility determined|23
7415791|NCT01444456|11689108|FG000|Overall Study|Other|18
7415792|NCT01444456|11689108|FG000|Overall Study|Not treated|104
7415793|NCT01444651|11689114|FG000|Overall Study|Adverse Event|3
7415794|NCT01444651|11689115|FG001|Overall Study|Adverse Event|2
7415795|NCT01444651|11689114|FG000|Overall Study|Lost to Follow-up|5
7415796|NCT01444651|11689115|FG001|Overall Study|Lost to Follow-up|5
7415797|NCT01444651|11689114|FG000|Overall Study|Non-fasting|2
7415798|NCT01444651|11689115|FG001|Overall Study|Non-fasting|1
7415799|NCT01444651|11689114|FG000|Overall Study|Missing data|1
7415800|NCT01444651|11689115|FG001|Overall Study|Missing data|1
7415801|NCT01444742|11689125|FG000|Overall Study|Death|1
7415802|NCT01444781|11689132|FG000|Overall Study|Lost to Follow-up|0
7415803|NCT01444781|11689133|FG001|Overall Study|Lost to Follow-up|3
7415804|NCT01444781|11689134|FG002|Overall Study|Lost to Follow-up|1
7415805|NCT01444781|11689132|FG000|Overall Study|Withdrawal by Subject|3
7415806|NCT01444781|11689133|FG001|Overall Study|Withdrawal by Subject|1
7415807|NCT01444781|11689134|FG002|Overall Study|Withdrawal by Subject|2
7415808|NCT01444898|11689149|FG000|Overall Study|Withdrawal by Subject|1
7415809|NCT01445080|11689189|FG000|Overall Study|Adverse Event|5
7415810|NCT01445080|11689190|FG001|Overall Study|Adverse Event|3
7415811|NCT01445080|11689191|FG002|Overall Study|Adverse Event|11
7415812|NCT01445080|11689192|FG003|Overall Study|Adverse Event|6
7415813|NCT01445080|11689193|FG004|Overall Study|Adverse Event|2
7415814|NCT01445080|11689194|FG005|Overall Study|Adverse Event|3
7415815|NCT01445080|11689195|FG006|Overall Study|Adverse Event|0
7415816|NCT01445080|11689196|FG007|Overall Study|Adverse Event|3
7415817|NCT01445080|11689197|FG008|Overall Study|Adverse Event|10
7415818|NCT01445080|11689189|FG000|Overall Study|Physician Decision|0
7415819|NCT01445080|11689190|FG001|Overall Study|Physician Decision|0
7415820|NCT01445080|11689191|FG002|Overall Study|Physician Decision|1
7415821|NCT01445080|11689192|FG003|Overall Study|Physician Decision|0
7415822|NCT01445080|11689193|FG004|Overall Study|Physician Decision|0
7415823|NCT01445080|11689194|FG005|Overall Study|Physician Decision|3
7415824|NCT01445080|11689195|FG006|Overall Study|Physician Decision|2
7415825|NCT01445080|11689196|FG007|Overall Study|Physician Decision|2
7415826|NCT01445080|11689197|FG008|Overall Study|Physician Decision|0
7415827|NCT01445080|11689189|FG000|Overall Study|Withdrawal by Subject|1
7415828|NCT01445080|11689190|FG001|Overall Study|Withdrawal by Subject|0
7415829|NCT01445080|11689191|FG002|Overall Study|Withdrawal by Subject|0
7415830|NCT01445080|11689192|FG003|Overall Study|Withdrawal by Subject|1
7415831|NCT01445080|11689193|FG004|Overall Study|Withdrawal by Subject|0
7415832|NCT01445080|11689194|FG005|Overall Study|Withdrawal by Subject|0
7415833|NCT01445080|11689195|FG006|Overall Study|Withdrawal by Subject|0
7415834|NCT01445080|11689196|FG007|Overall Study|Withdrawal by Subject|0
7415835|NCT01445080|11689197|FG008|Overall Study|Withdrawal by Subject|2
7415836|NCT01445080|11689189|FG000|Overall Study|Ineligible/Inevaluable|1
7415837|NCT01445080|11689190|FG001|Overall Study|Ineligible/Inevaluable|2
7321151|NCT00748098|11551280|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
7321152|NCT00748098|11551281|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
7321153|NCT00748098|11551280|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
7321154|NCT00748098|11551281|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
7321155|NCT00748189|11551290|FG000|Overall Study|Death|99
7321156|NCT00748189|11551291|FG001|Overall Study|Death|84
7321157|NCT00748189|11551290|FG000|Overall Study|Withdrawal by Subject|23
7321158|NCT00748189|11551291|FG001|Overall Study|Withdrawal by Subject|29
7321159|NCT00748189|11551290|FG000|Overall Study|Physician Decision|16
7321160|NCT00748189|11551291|FG001|Overall Study|Physician Decision|5
7321161|NCT00748189|11551290|FG000|Overall Study|Lost to Follow-up|8
7321162|NCT00748189|11551291|FG001|Overall Study|Lost to Follow-up|15
7321163|NCT00748189|11551290|FG000|Overall Study|Study terminated by Sponsor|70
7321164|NCT00748189|11551291|FG001|Overall Study|Study terminated by Sponsor|79
7321165|NCT00748215|11551304|FG000|Overall Study|Withdrawal by Subject|7
7321166|NCT00748215|11551305|FG001|Overall Study|Withdrawal by Subject|7
7321167|NCT00748215|11551304|FG000|Overall Study|Treatment change|2
7321168|NCT00748215|11551305|FG001|Overall Study|Treatment change|1
7321169|NCT00748215|11551304|FG000|Overall Study|Change in patient condition|0
7321170|NCT00748215|11551305|FG001|Overall Study|Change in patient condition|3
7321171|NCT00748215|11551304|FG000|Overall Study|Non-compliant|0
7321172|NCT00748215|11551305|FG001|Overall Study|Non-compliant|2
7321173|NCT00748215|11551304|FG000|Overall Study|Adverse Event|0
7321174|NCT00748215|11551305|FG001|Overall Study|Adverse Event|5
7321175|NCT00748241|11551311|FG000|Overall Study|Implant failure|1
7321176|NCT00748241|11551311|FG000|Overall Study|Lost to Follow-up|5
7321177|NCT00748241|11551311|FG000|Overall Study|Death|2
7321178|NCT00748540|11551324|FG000|Overall Study|Physician Decision|1
7321179|NCT00748553|11551330|FG000|Overall Study|Adverse Event|0
7321180|NCT00748553|11551331|FG001|Overall Study|Adverse Event|1
7321181|NCT00748553|11551330|FG000|Overall Study|disease progression|2
7321182|NCT00748553|11551331|FG001|Overall Study|disease progression|0
7321183|NCT00748553|11551330|FG000|Overall Study|noncompliance|1
7321184|NCT00748553|11551331|FG001|Overall Study|noncompliance|0
7321185|NCT00748566|11551336|FG000|Overall Study|Adverse Event|49
7321186|NCT00748566|11551336|FG000|Overall Study|Death|1
7321187|NCT00748566|11551336|FG000|Overall Study|Lack of Efficacy|12
7321188|NCT00748566|11551336|FG000|Overall Study|Lost to Follow-up|1
7321189|NCT00748566|11551336|FG000|Overall Study|Protocol Violation|13
7321190|NCT00748566|11551336|FG000|Overall Study|Withdrawal by Subject|22
7321191|NCT00748566|11551336|FG000|Overall Study|Study terminated by sponsor|5
7321192|NCT00748566|11551336|FG000|Overall Study|Other|9
7321193|NCT00748709|11551350|FG000|Overall Study|Progressive disease|15
7321194|NCT00748709|11551350|FG000|Overall Study|Drug reducing Toxity|2
7321195|NCT00748709|11551350|FG000|Overall Study|Other Adverse Event|1
7321196|NCT00748709|11551350|FG000|Overall Study|Withdrawal by Subject|1
7321197|NCT00748709|11551350|FG000|Overall Study|Other Reasons|1
7321198|NCT00748969|11551380|FG000|Overall Study|Withdrawal by Subject|1
7321199|NCT00748969|11551381|FG001|Overall Study|Withdrawal by Subject|0
7321200|NCT00748969|11551380|FG000|Overall Study|Withdrawal by Subject|0
7321201|NCT00748969|11551381|FG001|Overall Study|Withdrawal by Subject|1
7321202|NCT00749190|11551417|FG000|Overall Study|Adverse Event|0
7321203|NCT00749190|11551418|FG001|Overall Study|Adverse Event|2
7321204|NCT00749190|11551419|FG002|Overall Study|Adverse Event|0
7321205|NCT00749190|11551420|FG003|Overall Study|Adverse Event|4
7321206|NCT00749190|11551421|FG004|Overall Study|Adverse Event|0
7321207|NCT00749190|11551422|FG005|Overall Study|Adverse Event|3
7321208|NCT00749190|11551423|FG006|Overall Study|Adverse Event|0
7321209|NCT00749190|11551417|FG000|Overall Study|Lack of Efficacy|3
7321210|NCT00749190|11551418|FG001|Overall Study|Lack of Efficacy|1
7321211|NCT00749190|11551419|FG002|Overall Study|Lack of Efficacy|1
7321212|NCT00749190|11551420|FG003|Overall Study|Lack of Efficacy|0
7321213|NCT00749190|11551421|FG004|Overall Study|Lack of Efficacy|0
7321214|NCT00749190|11551422|FG005|Overall Study|Lack of Efficacy|1
7321215|NCT00749190|11551423|FG006|Overall Study|Lack of Efficacy|0
7321216|NCT00749190|11551417|FG000|Overall Study|Withdrawal by Subject|2
7321217|NCT00749190|11551418|FG001|Overall Study|Withdrawal by Subject|1
7321218|NCT00749190|11551419|FG002|Overall Study|Withdrawal by Subject|0
7321219|NCT00749190|11551420|FG003|Overall Study|Withdrawal by Subject|0
7321220|NCT00749190|11551421|FG004|Overall Study|Withdrawal by Subject|0
7321221|NCT00749190|11551422|FG005|Overall Study|Withdrawal by Subject|1
7321222|NCT00749190|11551423|FG006|Overall Study|Withdrawal by Subject|0
7321223|NCT00749190|11551417|FG000|Overall Study|Protocol Violation|0
7321224|NCT00749190|11551418|FG001|Overall Study|Protocol Violation|1
7321225|NCT00749190|11551419|FG002|Overall Study|Protocol Violation|0
7321226|NCT00749190|11551420|FG003|Overall Study|Protocol Violation|0
7321227|NCT00749190|11551421|FG004|Overall Study|Protocol Violation|0
7321228|NCT00749190|11551422|FG005|Overall Study|Protocol Violation|0
7321229|NCT00749190|11551423|FG006|Overall Study|Protocol Violation|1
7321230|NCT00749190|11551417|FG000|Overall Study|Other reason not defined above|0
7415838|NCT01445080|11689191|FG002|Overall Study|Ineligible/Inevaluable|0
7415839|NCT01445080|11689192|FG003|Overall Study|Ineligible/Inevaluable|1
7415840|NCT01445080|11689193|FG004|Overall Study|Ineligible/Inevaluable|2
7415841|NCT01445080|11689194|FG005|Overall Study|Ineligible/Inevaluable|3
7415842|NCT01445080|11689195|FG006|Overall Study|Ineligible/Inevaluable|0
7415843|NCT01445080|11689196|FG007|Overall Study|Ineligible/Inevaluable|0
7415844|NCT01445080|11689197|FG008|Overall Study|Ineligible/Inevaluable|6
7415845|NCT01445171|11689232|FG000|Overall Study|Lost to Follow-up|11
7415846|NCT01445171|11689232|FG000|Overall Study|Withdrawal by Subject|16
7415847|NCT01445171|11689232|FG000|Overall Study|Death|51
7415848|NCT01445171|11689232|FG000|Overall Study|Subjects declined to return for followup|9
7415849|NCT01445171|11689232|FG000|Overall Study|Consented but did not receive device|8
7415850|NCT01445301|11689241|FG000|Overall Study|Adverse Event|15
7415851|NCT01445301|11689242|FG001|Overall Study|Adverse Event|25
7415852|NCT01445301|11689243|FG002|Overall Study|Adverse Event|4
7415853|NCT01445301|11689241|FG000|Overall Study|Lack of Efficacy|0
7415854|NCT01445301|11689242|FG001|Overall Study|Lack of Efficacy|1
7415855|NCT01445301|11689243|FG002|Overall Study|Lack of Efficacy|0
7415856|NCT01445301|11689241|FG000|Overall Study|Protocol Violation|1
7415857|NCT01445301|11689242|FG001|Overall Study|Protocol Violation|0
7321231|NCT00749190|11551418|FG001|Overall Study|Other reason not defined above|0
7321232|NCT00749190|11551419|FG002|Overall Study|Other reason not defined above|0
7321233|NCT00749190|11551420|FG003|Overall Study|Other reason not defined above|1
7321234|NCT00749190|11551421|FG004|Overall Study|Other reason not defined above|0
7321235|NCT00749190|11551422|FG005|Overall Study|Other reason not defined above|0
7321236|NCT00749190|11551423|FG006|Overall Study|Other reason not defined above|0
7321237|NCT00749203|11551446|FG000|no Infusion at Week 1|Lost to Follow-up|0
7321238|NCT00749203|11551447|FG001|no Infusion at Week 1|Lost to Follow-up|1
7321239|NCT00749203|11551446|FG000|no Infusion at Week 1|Withdrawal by Subject|0
7321240|NCT00749203|11551447|FG001|no Infusion at Week 1|Withdrawal by Subject|1
7321241|NCT00749203|11551446|FG000|no Infusion at Week 1|delayed-onset sedation|0
7321242|NCT00749203|11551447|FG001|no Infusion at Week 1|delayed-onset sedation|1
7321243|NCT00749203|11551446|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
7321244|NCT00749203|11551447|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
7321245|NCT00749203|11551446|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
7321246|NCT00749203|11551447|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
7321247|NCT00749203|11551446|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
7321248|NCT00749203|11551447|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
7321249|NCT00749398|11551468|FG000|Overall Study|Lack of Efficacy|7
7321250|NCT00749398|11551468|FG000|Overall Study|Adverse Event|4
7321251|NCT00749398|11551468|FG000|Overall Study|Serious adverse event|11
7321252|NCT00749398|11551468|FG000|Overall Study|Withdrawal by Subject|17
7321253|NCT00749398|11551468|FG000|Overall Study|Lost to Follow-up|11
7321254|NCT00749398|11551468|FG000|Overall Study|Reason not specified|2
7321255|NCT00749398|11551468|FG000|Overall Study|Unknown reason|1
7321256|NCT00749411|11551474|FG000|Overall Study|Adverse Event|0
7321257|NCT00749411|11551475|FG001|Overall Study|Adverse Event|2
7321258|NCT00749411|11551474|FG000|Overall Study|Lack of Efficacy|0
7321259|NCT00749411|11551475|FG001|Overall Study|Lack of Efficacy|1
7321260|NCT00749411|11551474|FG000|Overall Study|Protocol Violation|1
7321261|NCT00749411|11551475|FG001|Overall Study|Protocol Violation|1
7321262|NCT00749411|11551474|FG000|Overall Study|Protocol-defined stopping criteria|0
7321263|NCT00749411|11551475|FG001|Overall Study|Protocol-defined stopping criteria|1
7384720|NCT01196104|11642028|FG000|Overall Study|Physician Decision|0
7384721|NCT01196104|11642029|FG001|Overall Study|Physician Decision|1
7384722|NCT01196104|11642028|FG000|Overall Study|Withdrawal by Subject|3
7384723|NCT01196104|11642029|FG001|Overall Study|Withdrawal by Subject|3
7384724|NCT01196104|11642028|FG000|Overall Study|Various|0
7384725|NCT01196104|11642029|FG001|Overall Study|Various|1
7384726|NCT01196416|11642065|FG000|Overall Study|Withdrawal by Subject|2
7384727|NCT01196429|11642071|FG000|Overall Study|Ineligible - inadequate pathology|1
7384728|NCT01196429|11642072|FG001|Overall Study|Ineligible - inadequate pathology|0
7384729|NCT01196429|11642071|FG000|Overall Study|Ineligible - wrong cell type|1
7384730|NCT01196429|11642072|FG001|Overall Study|Ineligible - wrong cell type|0
7384731|NCT01196429|11642071|FG000|Overall Study|Refused - Never Treated|1
7384732|NCT01196429|11642072|FG001|Overall Study|Refused - Never Treated|0
7384733|NCT01196741|11642091|FG000|Overall Study|Disease progression|34
7384734|NCT01196741|11642092|FG001|Overall Study|Disease progression|14
7384735|NCT01196741|11642091|FG000|Overall Study|Adverse Event|10
7384736|NCT01196741|11642092|FG001|Overall Study|Adverse Event|6
7384737|NCT01196741|11642091|FG000|Overall Study|Serious Adverse Event|3
7384738|NCT01196741|11642092|FG001|Overall Study|Serious Adverse Event|1
7384739|NCT01196741|11642091|FG000|Overall Study|Dose limiting Adverse Event|2
7384740|NCT01196741|11642092|FG001|Overall Study|Dose limiting Adverse Event|1
7384741|NCT01196741|11642091|FG000|Overall Study|Withdrawal by Subject|3
7384742|NCT01196741|11642092|FG001|Overall Study|Withdrawal by Subject|0
7384743|NCT01196741|11642091|FG000|Overall Study|Other reason|3
7384744|NCT01196741|11642092|FG001|Overall Study|Other reason|3
7384745|NCT01196741|11642091|FG000|Overall Study|Other|3
7384746|NCT01196741|11642092|FG001|Overall Study|Other|2
7384747|NCT01196741|11642091|FG000|Overall Study|Protocol Violation|2
7384748|NCT01196741|11642092|FG001|Overall Study|Protocol Violation|1
7384749|NCT01196975|11642154|FG000|Overall Study|Adverse Event|2
7384750|NCT01196975|11642155|FG001|Overall Study|Adverse Event|2
7384751|NCT01196975|11642156|FG002|Overall Study|Adverse Event|0
7384752|NCT01196975|11642157|FG003|Overall Study|Adverse Event|0
7384753|NCT01196975|11642158|FG004|Overall Study|Adverse Event|2
7384754|NCT01196975|11642154|FG000|Overall Study|Withdrawal by Subject|2
7384755|NCT01196975|11642155|FG001|Overall Study|Withdrawal by Subject|1
7384756|NCT01196975|11642156|FG002|Overall Study|Withdrawal by Subject|0
7384757|NCT01196975|11642157|FG003|Overall Study|Withdrawal by Subject|1
7384758|NCT01196975|11642158|FG004|Overall Study|Withdrawal by Subject|0
7384759|NCT01196975|11642154|FG000|Overall Study|Lost to Follow-up|11
7384760|NCT01196975|11642155|FG001|Overall Study|Lost to Follow-up|6
7384761|NCT01196975|11642156|FG002|Overall Study|Lost to Follow-up|5
7384762|NCT01196975|11642157|FG003|Overall Study|Lost to Follow-up|5
7384763|NCT01196975|11642158|FG004|Overall Study|Lost to Follow-up|11
7384764|NCT01196988|11642197|FG000|Overall Study|Adverse Event|1
7384765|NCT01196988|11642198|FG001|Overall Study|Adverse Event|2
7384766|NCT01196988|11642199|FG002|Overall Study|Adverse Event|0
7384767|NCT01196988|11642200|FG003|Overall Study|Adverse Event|0
7384768|NCT01196988|11642197|FG000|Overall Study|Withdrawal by Subject|5
7384769|NCT01196988|11642198|FG001|Overall Study|Withdrawal by Subject|1
7384770|NCT01196988|11642199|FG002|Overall Study|Withdrawal by Subject|4
7384771|NCT01196988|11642200|FG003|Overall Study|Withdrawal by Subject|0
7384772|NCT01196988|11642197|FG000|Overall Study|Lost to Follow-up|16
7384773|NCT01196988|11642198|FG001|Overall Study|Lost to Follow-up|29
7384774|NCT01196988|11642199|FG002|Overall Study|Lost to Follow-up|21
7384775|NCT01196988|11642200|FG003|Overall Study|Lost to Follow-up|1
7384776|NCT01196988|11642197|FG000|Overall Study|Other|2
7384777|NCT01196988|11642198|FG001|Overall Study|Other|0
7384778|NCT01196988|11642199|FG002|Overall Study|Other|0
7384779|NCT01196988|11642200|FG003|Overall Study|Other|0
7384780|NCT01197300|11642213|FG000|Overall Study|Lost to Follow-up|0
7384781|NCT01197300|11642214|FG001|Overall Study|Lost to Follow-up|1
7321264|NCT00749463|11551484|FG000|Overall Study|Adverse Event|0
7321265|NCT00749463|11551485|FG001|Overall Study|Adverse Event|4
7321266|NCT00749463|11551486|FG002|Overall Study|Adverse Event|1
7321267|NCT00749463|11551484|FG000|Overall Study|Withdrawal by Subject|1
7321268|NCT00749463|11551485|FG001|Overall Study|Withdrawal by Subject|0
7321269|NCT00749463|11551486|FG002|Overall Study|Withdrawal by Subject|0
7321270|NCT00749580|11551505|FG000|Overall Study|Lost to Follow-up|4
7321271|NCT00749580|11551506|FG001|Overall Study|Lost to Follow-up|8
7321272|NCT00749580|11551505|FG000|Overall Study|Adverse Event|0
7321273|NCT00749580|11551506|FG001|Overall Study|Adverse Event|1
7321274|NCT00749684|11551534|FG000|Overall Study|Death|1
7321275|NCT00749684|11551534|FG000|Overall Study|Adverse Event|27
7321276|NCT00749684|11551534|FG000|Overall Study|Participant's Wish|10
7321277|NCT00749684|11551534|FG000|Overall Study|Not Documented|1
7321278|NCT00749684|11551534|FG000|Overall Study|Progressive Desease|31
7321279|NCT00749684|11551534|FG000|Overall Study|Therapy according to protocol + AE|2
7321280|NCT00749684|11551534|FG000|Overall Study|AE+discontinuation on participants wish|1
7321281|NCT00749684|11551534|FG000|Overall Study|Missing|9
7321282|NCT00749775|11551547|FG000|Overall Study|Protocol Violation|24
7321283|NCT00749775|11551547|FG000|Overall Study|Lost to Follow-up|36
7321284|NCT00749775|11551547|FG000|Overall Study|No visit after first day of treatment|44
7321285|NCT00749775|11551547|FG000|Overall Study|No drug administration|3
7321286|NCT00749892|11551573|FG000|Overall Study|Withdrawal by Subject|3
7321287|NCT00749944|11551590|FG000|Overall Study|Lost to Follow-up|2
7321288|NCT00749944|11551591|FG001|Overall Study|Lost to Follow-up|1
7321289|NCT00749944|11551590|FG000|Overall Study|Other|1
7321290|NCT00749944|11551591|FG001|Overall Study|Other|0
7321291|NCT00749944|11551590|FG000|Overall Study|Withdrawal by Subject|2
7321292|NCT00749944|11551591|FG001|Overall Study|Withdrawal by Subject|0
7321293|NCT00749996|11551610|FG000|Overall Study|Lost to Follow-up|7
7321294|NCT00749996|11551611|FG001|Overall Study|Lost to Follow-up|4
7321295|NCT00749996|11551610|FG000|Overall Study|Withdrawal by Subject|5
7321296|NCT00749996|11551611|FG001|Overall Study|Withdrawal by Subject|4
7321297|NCT00749996|11551610|FG000|Overall Study|Protocol Violation|2
7321298|NCT00749996|11551611|FG001|Overall Study|Protocol Violation|3
7321299|NCT00749996|11551610|FG000|Overall Study|Physician Decision|2
7321300|NCT00749996|11551611|FG001|Overall Study|Physician Decision|0
7321301|NCT00749996|11551610|FG000|Overall Study|Pregnancy|0
7321302|NCT00749996|11551611|FG001|Overall Study|Pregnancy|2
7321303|NCT00749996|11551610|FG000|Overall Study|Adverse Event|1
7321304|NCT00749996|11551611|FG001|Overall Study|Adverse Event|0
7321305|NCT00749996|11551610|FG000|Overall Study|Death|1
7321306|NCT00749996|11551611|FG001|Overall Study|Death|0
7321307|NCT00750061|11551619|FG000|Overall Study|Adverse Event|2
7321308|NCT00750061|11551620|FG001|Overall Study|Adverse Event|0
7321309|NCT00750061|11551619|FG000|Overall Study|Withdrawal by Subject|0
7321310|NCT00750061|11551620|FG001|Overall Study|Withdrawal by Subject|1
7321311|NCT00750061|11551619|FG000|Overall Study|Physician Decision|0
7321312|NCT00750061|11551620|FG001|Overall Study|Physician Decision|1
7321313|NCT00750139|11551630|FG000|Overall Study|Adverse Event|1
7321314|NCT00750139|11551631|FG001|Overall Study|Adverse Event|2
7321315|NCT00750139|11551632|FG002|Overall Study|Adverse Event|0
7321316|NCT00750139|11551633|FG003|Overall Study|Adverse Event|1
7321317|NCT00750139|11551630|FG000|Overall Study|Lost to Follow-up|17
7321318|NCT00750139|11551631|FG001|Overall Study|Lost to Follow-up|12
7321319|NCT00750139|11551632|FG002|Overall Study|Lost to Follow-up|15
7321320|NCT00750139|11551633|FG003|Overall Study|Lost to Follow-up|6
7321321|NCT00750139|11551630|FG000|Overall Study|Withdrawal by Subject|3
7321322|NCT00750139|11551631|FG001|Overall Study|Withdrawal by Subject|2
7321323|NCT00750139|11551632|FG002|Overall Study|Withdrawal by Subject|6
7321324|NCT00750139|11551633|FG003|Overall Study|Withdrawal by Subject|2
7321325|NCT00750139|11551630|FG000|Overall Study|Physician Decision|1
7321326|NCT00750139|11551631|FG001|Overall Study|Physician Decision|1
7321327|NCT00750139|11551632|FG002|Overall Study|Physician Decision|0
7321328|NCT00750139|11551633|FG003|Overall Study|Physician Decision|0
7321329|NCT00750139|11551630|FG000|Overall Study|Non-compliance|1
7321330|NCT00750139|11551631|FG001|Overall Study|Non-compliance|0
7321331|NCT00750139|11551632|FG002|Overall Study|Non-compliance|1
7321332|NCT00750139|11551633|FG003|Overall Study|Non-compliance|3
7321333|NCT00750139|11551630|FG000|Overall Study|Termination by sponsor|4
7321334|NCT00750139|11551631|FG001|Overall Study|Termination by sponsor|0
7321335|NCT00750139|11551632|FG002|Overall Study|Termination by sponsor|0
7321336|NCT00750139|11551633|FG003|Overall Study|Termination by sponsor|1
7321337|NCT00750139|11551630|FG000|Overall Study|Non-specific|62
7321338|NCT00750139|11551631|FG001|Overall Study|Non-specific|42
7321339|NCT00750139|11551632|FG002|Overall Study|Non-specific|79
7321340|NCT00750139|11551633|FG003|Overall Study|Non-specific|33
7321341|NCT00750152|11551647|FG000|Overall Study|Adverse Event|2
7321342|NCT00750152|11551648|FG001|Overall Study|Adverse Event|1
7321343|NCT00750152|11551647|FG000|Overall Study|Lost to Follow-up|8
7321344|NCT00750152|11551648|FG001|Overall Study|Lost to Follow-up|13
7321345|NCT00750152|11551647|FG000|Overall Study|Withdrawal by Subject|3
7321346|NCT00750152|11551648|FG001|Overall Study|Withdrawal by Subject|3
7321347|NCT00750152|11551647|FG000|Overall Study|Physician Decision|1
7321348|NCT00750152|11551648|FG001|Overall Study|Physician Decision|1
7321349|NCT00750152|11551647|FG000|Overall Study|Non-compliance|0
7321350|NCT00750152|11551648|FG001|Overall Study|Non-compliance|1
7321351|NCT00750152|11551647|FG000|Overall Study|Termination by sponsor|1
7321352|NCT00750152|11551648|FG001|Overall Study|Termination by sponsor|0
7321353|NCT00750152|11551647|FG000|Overall Study|Other|7
7321354|NCT00750152|11551648|FG001|Overall Study|Other|8
7321355|NCT00750308|11551698|FG000|First Treatment|Adverse Event|0
7321356|NCT00750308|11551699|FG001|First Treatment|Adverse Event|1
7321357|NCT00750308|11551700|FG002|First Treatment|Adverse Event|0
7321358|NCT00750308|11551701|FG003|First Treatment|Adverse Event|0
7321359|NCT00750308|11551702|FG004|First Treatment|Adverse Event|0
7321360|NCT00750308|11551703|FG005|First Treatment|Adverse Event|0
7321361|NCT00750308|11551704|FG006|First Treatment|Adverse Event|0
7321362|NCT00750308|11551705|FG007|First Treatment|Adverse Event|0
7321363|NCT00750308|11551706|FG008|First Treatment|Adverse Event|0
7321364|NCT00750308|11551707|FG009|First Treatment|Adverse Event|0
7321365|NCT00750308|11551708|FG010|First Treatment|Adverse Event|1
7321366|NCT00750308|11551709|FG011|First Treatment|Adverse Event|1
7321367|NCT00750308|11551698|FG000|First Treatment|Withdrawal by Subject|0
7321368|NCT00750308|11551699|FG001|First Treatment|Withdrawal by Subject|0
7321369|NCT00750308|11551700|FG002|First Treatment|Withdrawal by Subject|0
7321370|NCT00750308|11551701|FG003|First Treatment|Withdrawal by Subject|1
7321371|NCT00750308|11551702|FG004|First Treatment|Withdrawal by Subject|0
7321372|NCT00750308|11551703|FG005|First Treatment|Withdrawal by Subject|0
7321373|NCT00750308|11551704|FG006|First Treatment|Withdrawal by Subject|0
7321374|NCT00750308|11551705|FG007|First Treatment|Withdrawal by Subject|1
7321375|NCT00750308|11551706|FG008|First Treatment|Withdrawal by Subject|0
7321376|NCT00750308|11551707|FG009|First Treatment|Withdrawal by Subject|0
7321377|NCT00750308|11551708|FG010|First Treatment|Withdrawal by Subject|0
7321378|NCT00750308|11551709|FG011|First Treatment|Withdrawal by Subject|0
7321379|NCT00750308|11551698|FG000|Second Treatment|Adverse Event|0
7321380|NCT00750308|11551699|FG001|Second Treatment|Adverse Event|0
7321381|NCT00750308|11551700|FG002|Second Treatment|Adverse Event|0
7321382|NCT00750308|11551701|FG003|Second Treatment|Adverse Event|0
7321383|NCT00750308|11551702|FG004|Second Treatment|Adverse Event|0
7321384|NCT00750308|11551703|FG005|Second Treatment|Adverse Event|1
7321385|NCT00750308|11551704|FG006|Second Treatment|Adverse Event|0
7321386|NCT00750308|11551705|FG007|Second Treatment|Adverse Event|0
7321387|NCT00750308|11551706|FG008|Second Treatment|Adverse Event|1
7321388|NCT00750308|11551707|FG009|Second Treatment|Adverse Event|0
7321389|NCT00750308|11551708|FG010|Second Treatment|Adverse Event|0
7321390|NCT00750308|11551709|FG011|Second Treatment|Adverse Event|0
7321391|NCT00750308|11551698|FG000|Second Treatment|Withdrawal by Subject|0
7321392|NCT00750308|11551699|FG001|Second Treatment|Withdrawal by Subject|0
7321393|NCT00750308|11551700|FG002|Second Treatment|Withdrawal by Subject|0
7321394|NCT00750308|11551701|FG003|Second Treatment|Withdrawal by Subject|0
7321395|NCT00750308|11551702|FG004|Second Treatment|Withdrawal by Subject|1
7530627|NCT02641379|11874575|FG004|Overall Study|Withdrawal of informed consent|0
7530628|NCT02641379|11874576|FG005|Overall Study|Withdrawal of informed consent|0
7530629|NCT02641379|11874577|FG006|Overall Study|Withdrawal of informed consent|0
7530630|NCT02641379|11874578|FG007|Overall Study|Withdrawal of informed consent|1
7530631|NCT02641379|11874579|FG008|Overall Study|Withdrawal of informed consent|0
7530632|NCT02641379|11874580|FG009|Overall Study|Withdrawal of informed consent|0
7530633|NCT02641379|11874581|FG010|Overall Study|Withdrawal of informed consent|0
7530634|NCT02641379|11874571|FG000|Overall Study|Adverse Event|7
7530635|NCT02641379|11874572|FG001|Overall Study|Adverse Event|8
7321396|NCT00750308|11551703|FG005|Second Treatment|Withdrawal by Subject|0
7321397|NCT00750308|11551704|FG006|Second Treatment|Withdrawal by Subject|0
7321398|NCT00750308|11551705|FG007|Second Treatment|Withdrawal by Subject|0
7321399|NCT00750308|11551706|FG008|Second Treatment|Withdrawal by Subject|0
7321400|NCT00750308|11551707|FG009|Second Treatment|Withdrawal by Subject|0
7321401|NCT00750308|11551708|FG010|Second Treatment|Withdrawal by Subject|0
7321402|NCT00750308|11551709|FG011|Second Treatment|Withdrawal by Subject|0
7321403|NCT00750308|11551698|FG000|Third Treatment|Withdrawal by Subject|0
7321404|NCT00750308|11551699|FG001|Third Treatment|Withdrawal by Subject|1
7321405|NCT00750308|11551700|FG002|Third Treatment|Withdrawal by Subject|0
7321406|NCT00750308|11551701|FG003|Third Treatment|Withdrawal by Subject|0
7321407|NCT00750308|11551702|FG004|Third Treatment|Withdrawal by Subject|0
7321408|NCT00750308|11551703|FG005|Third Treatment|Withdrawal by Subject|0
7321409|NCT00750308|11551704|FG006|Third Treatment|Withdrawal by Subject|0
7321410|NCT00750308|11551705|FG007|Third Treatment|Withdrawal by Subject|0
7321411|NCT00750308|11551706|FG008|Third Treatment|Withdrawal by Subject|0
7321412|NCT00750308|11551707|FG009|Third Treatment|Withdrawal by Subject|0
7321413|NCT00750308|11551708|FG010|Third Treatment|Withdrawal by Subject|0
7321414|NCT00750308|11551709|FG011|Third Treatment|Withdrawal by Subject|0
7321415|NCT00750438|11551765|FG000|Overall Study|Protocol Violation|4
7321416|NCT00750438|11551766|FG001|Overall Study|Protocol Violation|1
7321417|NCT00750438|11551765|FG000|Overall Study|Physician Decision|2
7321418|NCT00750438|11551766|FG001|Overall Study|Physician Decision|2
7321419|NCT00750438|11551765|FG000|Overall Study|Withdrawal by Subject|1
7321420|NCT00750438|11551766|FG001|Overall Study|Withdrawal by Subject|1
7321421|NCT00750737|11551774|FG000|Overall Study|Withdrawal by Subject|3
7321422|NCT00750737|11551775|FG001|Overall Study|Withdrawal by Subject|3
7321423|NCT00750867|11551794|FG000|Overall Study|Adverse Event|2
7321424|NCT00750880|11551798|FG000|Overall Study|Adverse Event|76
7321425|NCT00750880|11551798|FG000|Overall Study|Death|4
7321426|NCT00750880|11551798|FG000|Overall Study|Lack of Efficacy|46
7321427|NCT00750880|11551798|FG000|Overall Study|Lost to Follow-up|10
7321428|NCT00750880|11551798|FG000|Overall Study|Protocol Violation|15
7321429|NCT00750880|11551798|FG000|Overall Study|Withdrawal by Subject|33
7321430|NCT00750880|11551798|FG000|Overall Study|Physician Decision|20
7321431|NCT00750880|11551798|FG000|Overall Study|Administrative|11
7321432|NCT00750893|11551803|FG000|Overall Study|Adverse Event|5
7321433|NCT00750893|11551803|FG000|Overall Study|Withdrawal by Subject|10
7321434|NCT00750893|11551803|FG000|Overall Study|Lost to Follow-up|510
7321435|NCT00750893|11551803|FG000|Overall Study|Other|17
7321436|NCT00750919|11551807|FG000|Overall Study|Adverse Event|9
7321437|NCT00750919|11551807|FG000|Overall Study|Withdrawal by Subject|1
7321438|NCT00750919|11551807|FG000|Overall Study|Lack of Efficacy|8
7321439|NCT00750919|11551807|FG000|Overall Study|Could not cooperate, unrelated to trial|4
7321440|NCT00750919|11551807|FG000|Overall Study|Other|36
7321441|NCT00751023|11551813|FG000|Overall Study|Lost to Follow-up|11
7321442|NCT00751023|11551814|FG001|Overall Study|Lost to Follow-up|7
7321443|NCT00751036|11551822|FG000|Overall Study|Disease Progression|28
7321444|NCT00751036|11551823|FG001|Overall Study|Disease Progression|29
7321445|NCT00751036|11551822|FG000|Overall Study|Adverse Event|6
7321446|NCT00751036|11551823|FG001|Overall Study|Adverse Event|4
7321447|NCT00751036|11551822|FG000|Overall Study|Administrative Problems|3
7321448|NCT00751036|11551823|FG001|Overall Study|Administrative Problems|4
7321449|NCT00751036|11551822|FG000|Overall Study|Withdrawal by Subject|5
7321450|NCT00751036|11551823|FG001|Overall Study|Withdrawal by Subject|2
7321451|NCT00751036|11551822|FG000|Overall Study|Death|3
7321452|NCT00751036|11551823|FG001|Overall Study|Death|3
7321453|NCT00751036|11551822|FG000|Overall Study|Lost to Follow-up|0
7321454|NCT00751036|11551823|FG001|Overall Study|Lost to Follow-up|1
7321455|NCT00751036|11551822|FG000|Overall Study|Protocol Violation|1
7321456|NCT00751036|11551823|FG001|Overall Study|Protocol Violation|0
7321457|NCT00751036|11551822|FG000|Overall Study|Missing end of Treatment Page|2
7321458|NCT00751036|11551823|FG001|Overall Study|Missing end of Treatment Page|3
7321459|NCT00751101|11551831|FG000|Overall Study|Withdrawal by Subject|1
7321460|NCT00751101|11551832|FG001|Overall Study|Withdrawal by Subject|0
7321461|NCT00751101|11551831|FG000|Overall Study|No HFS / Never Started Patch/|0
7321462|NCT00751101|11551832|FG001|Overall Study|No HFS / Never Started Patch/|4
7321463|NCT00751101|11551831|FG000|Overall Study|Never began capecitabine|1
7321464|NCT00751101|11551832|FG001|Overall Study|Never began capecitabine|0
7321465|NCT00751101|11551831|FG000|Overall Study|Physician Decision|0
7321466|NCT00751101|11551832|FG001|Overall Study|Physician Decision|1
7321467|NCT00751114|11551844|FG000|Overall Study|Adverse Event|2
7321468|NCT00751114|11551845|FG001|Overall Study|Adverse Event|4
7321469|NCT00751114|11551844|FG000|Overall Study|Protocol Violation|8
7321470|NCT00751114|11551845|FG001|Overall Study|Protocol Violation|9
7321471|NCT00751114|11551844|FG000|Overall Study|Withdrawal by Subject|9
7321472|NCT00751114|11551845|FG001|Overall Study|Withdrawal by Subject|4
7321473|NCT00751114|11551844|FG000|Overall Study|Lost to Follow-up|4
7321474|NCT00751114|11551845|FG001|Overall Study|Lost to Follow-up|7
7321475|NCT00751114|11551844|FG000|Overall Study|Lack of Efficacy|0
7321476|NCT00751114|11551845|FG001|Overall Study|Lack of Efficacy|7
7321477|NCT00751114|11551844|FG000|Overall Study|Not Treated|13
7321478|NCT00751114|11551845|FG001|Overall Study|Not Treated|1
7321479|NCT00751114|11551844|FG000|Overall Study|Out of country for 2 months|1
7321480|NCT00751114|11551845|FG001|Overall Study|Out of country for 2 months|0
7321481|NCT00751114|11551844|FG000|Overall Study|Move to another city|1
7321482|NCT00751114|11551845|FG001|Overall Study|Move to another city|0
7321483|NCT00751140|11551851|FG000|Overall Study|benign angioma excluded from analysis|1
7321484|NCT00751296|11551869|FG000|Overall Study|Adverse Event|2
7530636|NCT02641379|11874573|FG002|Overall Study|Adverse Event|2
7530637|NCT02641379|11874574|FG003|Overall Study|Adverse Event|2
7530638|NCT02641379|11874575|FG004|Overall Study|Adverse Event|5
7530639|NCT02641379|11874576|FG005|Overall Study|Adverse Event|1
7530640|NCT02641379|11874577|FG006|Overall Study|Adverse Event|5
7530641|NCT02641379|11874578|FG007|Overall Study|Adverse Event|0
7530642|NCT02641379|11874579|FG008|Overall Study|Adverse Event|1
7530643|NCT02641379|11874580|FG009|Overall Study|Adverse Event|1
7530644|NCT02641379|11874581|FG010|Overall Study|Adverse Event|5
7530645|NCT02641379|11874571|FG000|Overall Study|Lack of Efficacy|0
7530646|NCT02641379|11874572|FG001|Overall Study|Lack of Efficacy|0
7530647|NCT02641379|11874573|FG002|Overall Study|Lack of Efficacy|2
7530648|NCT02641379|11874574|FG003|Overall Study|Lack of Efficacy|0
7554081|NCT03023878|11915574|FG000|Treatment Period|Withdrawal by Subject|1
7554082|NCT03023878|11915574|FG000|Treatment Period|Adverse Event|1
7554083|NCT03023878|11915574|FG000|Long Term Follow-Up Period|Death|2
7554084|NCT03024606|11915593|FG000|Overall Study|Withdrawal by Subject|9
7321485|NCT00751348|11551875|FG000|Overall Study|Withdrawal by Subject|5
7321486|NCT00751348|11551876|FG001|Overall Study|Withdrawal by Subject|2
7321487|NCT00751348|11551875|FG000|Overall Study|Migration from study area|1
7321488|NCT00751348|11551876|FG001|Overall Study|Migration from study area|0
7321489|NCT00751400|11551882|FG000|Overall Study|Lost to Follow-up|10
7321490|NCT00751621|11551895|FG000|Overall Study|Adverse Event|1
7530649|NCT02641379|11874575|FG004|Overall Study|Lack of Efficacy|0
7530650|NCT02641379|11874576|FG005|Overall Study|Lack of Efficacy|2
7554085|NCT03024606|11915594|FG001|Overall Study|Withdrawal by Subject|10
7554086|NCT03024970|11915600|FG000|First Intervention|Adverse Event|1
7554087|NCT03024970|11915601|FG001|First Intervention|Adverse Event|0
7554088|NCT03024970|11915600|FG000|Second Intervention|Lost to Follow-up|1
7321491|NCT00751621|11551895|FG000|Overall Study|Withdrawal by Subject|1
7321492|NCT00751621|11551895|FG000|Overall Study|Subject moved to another country|1
7321493|NCT00751621|11551895|FG000|Overall Study|Poor adherence to asthma treatment|1
7321494|NCT00751790|11551915|FG000|Overall Study|Lost to Follow-up|1
7321495|NCT00751790|11551915|FG000|Overall Study|Death|3
7321496|NCT00751790|11551915|FG000|Overall Study|Withdrawal by Subject|1
7321497|NCT00751881|11551922|FG000|Core Treatment Period|Not treated|1
7321498|NCT00751881|11551923|FG001|Core Treatment Period|Not treated|1
7415858|NCT01445301|11689243|FG002|Overall Study|Protocol Violation|0
7415859|NCT01445301|11689241|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
7415860|NCT01445301|11689242|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
7415861|NCT01445301|11689243|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
7415862|NCT01445301|11689241|FG000|Overall Study|Physician Decision|0
7415863|NCT01445301|11689242|FG001|Overall Study|Physician Decision|2
7415864|NCT01445301|11689243|FG002|Overall Study|Physician Decision|0
7415865|NCT01445301|11689241|FG000|Overall Study|Withdrawal by Subject|5
7415866|NCT01445301|11689242|FG001|Overall Study|Withdrawal by Subject|6
7415867|NCT01445301|11689243|FG002|Overall Study|Withdrawal by Subject|4
7415868|NCT01445535|11689255|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
7415869|NCT01445535|11689256|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
7415870|NCT01445535|11689257|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
7415871|NCT01445535|11689258|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
7415872|NCT01445535|11689255|FG000|Overall Study|Disease progression|1
7415873|NCT01445535|11689256|FG001|Overall Study|Disease progression|0
7415874|NCT01445535|11689257|FG002|Overall Study|Disease progression|1
7415875|NCT01445535|11689258|FG003|Overall Study|Disease progression|0
7415876|NCT01445535|11689255|FG000|Overall Study|PI discretion|0
7415877|NCT01445535|11689256|FG001|Overall Study|PI discretion|0
7554089|NCT03024970|11915601|FG001|Second Intervention|Lost to Follow-up|0
7554090|NCT03025217|11915607|FG000|Overall Study|Pregnancy|1
7554091|NCT03025217|11915607|FG000|Overall Study|Lost to Follow-up|1
7554092|NCT03025217|11915607|FG000|Overall Study|Not eligible, poor English|2
7554093|NCT03026075|11915620|FG000|Overall Study|Physician Decision|1
7554094|NCT03026088|11915624|FG000|Overall Study|Study termination|20
7554095|NCT03026166|11915630|FG000|Overall Study|Death|22
7554096|NCT03026166|11915631|FG001|Overall Study|Death|7
7554097|NCT03026166|11915630|FG000|Overall Study|Physician Decision|2
7554098|NCT03026166|11915631|FG001|Overall Study|Physician Decision|0
7554099|NCT03026166|11915630|FG000|Overall Study|Withdrawal by Subject|1
7554100|NCT03026166|11915631|FG001|Overall Study|Withdrawal by Subject|2
7554101|NCT03026166|11915630|FG000|Overall Study|Lost to Follow-up|1
7554102|NCT03026166|11915631|FG001|Overall Study|Lost to Follow-up|0
7554103|NCT03026166|11915630|FG000|Overall Study|Study Terminated by Sponsor|3
7554104|NCT03026166|11915631|FG001|Overall Study|Study Terminated by Sponsor|3
7554105|NCT03026166|11915630|FG000|Overall Study|Other|1
7554106|NCT03026166|11915631|FG001|Overall Study|Other|0
7554107|NCT03026257|11915643|FG000|Overall Study|Adverse Event|3
7554108|NCT03026257|11915644|FG001|Overall Study|Adverse Event|0
7530651|NCT02641379|11874577|FG006|Overall Study|Lack of Efficacy|0
7415878|NCT01445535|11689257|FG002|Overall Study|PI discretion|0
7415879|NCT01445535|11689258|FG003|Overall Study|PI discretion|1
7415880|NCT01445548|11689269|FG000|Overall Study|Adverse Event|1
7415881|NCT01445613|11689273|FG000|30-day Follow-up|Withdrawal by Subject|6
7415882|NCT01445613|11689273|FG000|30-day Follow-up|Physician Decision|3
7415883|NCT01445613|11689273|FG000|30-day Follow-up|Missed visit|23
7415884|NCT01445613|11689273|FG000|30-day Follow-up|Death|3
7415885|NCT01445613|11689273|FG000|1-year Follow-up|Withdrawal by Subject|12
7415886|NCT01445613|11689273|FG000|1-year Follow-up|Missed visit|29
7415887|NCT01445613|11689273|FG000|1-year Follow-up|Lost to Follow-up|2
7554109|NCT03026257|11915645|FG002|Overall Study|Adverse Event|0
7554110|NCT03026257|11915646|FG003|Overall Study|Adverse Event|0
7554111|NCT03026257|11915647|FG004|Overall Study|Adverse Event|0
7554112|NCT03026257|11915648|FG005|Overall Study|Adverse Event|0
7554113|NCT03026257|11915643|FG000|Overall Study|Lost to Follow-up|1
7321499|NCT00751881|11551924|FG002|Core Treatment Period|Not treated|2
7530652|NCT02641379|11874578|FG007|Overall Study|Lack of Efficacy|5
7530653|NCT02641379|11874579|FG008|Overall Study|Lack of Efficacy|0
7530654|NCT02641379|11874580|FG009|Overall Study|Lack of Efficacy|0
7530655|NCT02641379|11874581|FG010|Overall Study|Lack of Efficacy|0
7530656|NCT02641379|11874571|FG000|Overall Study|Participant unable to attend study visit|4
7530657|NCT02641379|11874572|FG001|Overall Study|Participant unable to attend study visit|10
7530658|NCT02641379|11874573|FG002|Overall Study|Participant unable to attend study visit|1
7530659|NCT02641379|11874574|FG003|Overall Study|Participant unable to attend study visit|2
7554114|NCT03026257|11915644|FG001|Overall Study|Lost to Follow-up|0
7554115|NCT03026257|11915645|FG002|Overall Study|Lost to Follow-up|0
7554116|NCT03026257|11915646|FG003|Overall Study|Lost to Follow-up|0
7554117|NCT03026257|11915647|FG004|Overall Study|Lost to Follow-up|0
7554118|NCT03026257|11915648|FG005|Overall Study|Lost to Follow-up|0
7415888|NCT01445613|11689273|FG000|1-year Follow-up|Death|30
7554119|NCT03026257|11915643|FG000|Overall Study|Protocol Violation|1
7554120|NCT03026257|11915644|FG001|Overall Study|Protocol Violation|0
7554121|NCT03026257|11915645|FG002|Overall Study|Protocol Violation|0
7554122|NCT03026257|11915646|FG003|Overall Study|Protocol Violation|1
7554123|NCT03026257|11915647|FG004|Overall Study|Protocol Violation|1
7321500|NCT00751881|11551922|FG000|Core Treatment Period|Adverse Event|26
7321501|NCT00751881|11551923|FG001|Core Treatment Period|Adverse Event|54
7530660|NCT02641379|11874575|FG004|Overall Study|Participant unable to attend study visit|5
7530661|NCT02641379|11874576|FG005|Overall Study|Participant unable to attend study visit|1
7530662|NCT02641379|11874577|FG006|Overall Study|Participant unable to attend study visit|1
7530663|NCT02641379|11874578|FG007|Overall Study|Participant unable to attend study visit|1
7530664|NCT02641379|11874579|FG008|Overall Study|Participant unable to attend study visit|0
7530665|NCT02641379|11874580|FG009|Overall Study|Participant unable to attend study visit|2
7530666|NCT02641379|11874581|FG010|Overall Study|Participant unable to attend study visit|0
7530667|NCT02641379|11874571|FG000|Overall Study|Participant's compliance|0
7530668|NCT02641379|11874572|FG001|Overall Study|Participant's compliance|1
7530669|NCT02641379|11874573|FG002|Overall Study|Participant's compliance|0
7530670|NCT02641379|11874574|FG003|Overall Study|Participant's compliance|1
7530671|NCT02641379|11874575|FG004|Overall Study|Participant's compliance|0
7530672|NCT02641379|11874576|FG005|Overall Study|Participant's compliance|2
7530673|NCT02641379|11874577|FG006|Overall Study|Participant's compliance|0
7530674|NCT02641379|11874578|FG007|Overall Study|Participant's compliance|0
7530675|NCT02641379|11874579|FG008|Overall Study|Participant's compliance|1
7530676|NCT02641379|11874580|FG009|Overall Study|Participant's compliance|1
7530677|NCT02641379|11874581|FG010|Overall Study|Participant's compliance|1
7530678|NCT02641379|11874571|FG000|Overall Study|Participant cannot be reached|4
7530679|NCT02641379|11874572|FG001|Overall Study|Participant cannot be reached|4
7530680|NCT02641379|11874573|FG002|Overall Study|Participant cannot be reached|0
7530681|NCT02641379|11874574|FG003|Overall Study|Participant cannot be reached|8
7554124|NCT03026257|11915648|FG005|Overall Study|Protocol Violation|0
7321502|NCT00751881|11551924|FG002|Core Treatment Period|Adverse Event|58
7321503|NCT00751881|11551922|FG000|Core Treatment Period|Lack of Efficacy|37
7321504|NCT00751881|11551923|FG001|Core Treatment Period|Lack of Efficacy|30
7321505|NCT00751881|11551924|FG002|Core Treatment Period|Lack of Efficacy|20
7321506|NCT00751881|11551922|FG000|Core Treatment Period|Poor compliance to protocol|15
7321507|NCT00751881|11551923|FG001|Core Treatment Period|Poor compliance to protocol|3
7321508|NCT00751881|11551924|FG002|Core Treatment Period|Poor compliance to protocol|4
7321509|NCT00751881|11551922|FG000|Core Treatment Period|Lost to Follow-up|6
7321510|NCT00751881|11551923|FG001|Core Treatment Period|Lost to Follow-up|4
7321511|NCT00751881|11551924|FG002|Core Treatment Period|Lost to Follow-up|3
7321512|NCT00751881|11551922|FG000|Core Treatment Period|Other: protocol deviation|3
7321513|NCT00751881|11551923|FG001|Core Treatment Period|Other: protocol deviation|3
7321514|NCT00751881|11551924|FG002|Core Treatment Period|Other: protocol deviation|7
7321515|NCT00751881|11551922|FG000|Core Treatment Period|Other: wish to parent|5
7321516|NCT00751881|11551923|FG001|Core Treatment Period|Other: wish to parent|7
7321517|NCT00751881|11551924|FG002|Core Treatment Period|Other: wish to parent|4
7321518|NCT00751881|11551922|FG000|Core Treatment Period|Other: personal/family constraints|6
7321519|NCT00751881|11551923|FG001|Core Treatment Period|Other: personal/family constraints|7
7321520|NCT00751881|11551924|FG002|Core Treatment Period|Other: personal/family constraints|10
7321521|NCT00751881|11551922|FG000|Core Treatment Period|Other: MS treatment change|6
7321522|NCT00751881|11551923|FG001|Core Treatment Period|Other: MS treatment change|4
7321523|NCT00751881|11551924|FG002|Core Treatment Period|Other: MS treatment change|4
7321524|NCT00751881|11551922|FG000|Core Treatment Period|Other: tolerability complaints|2
7321525|NCT00751881|11551923|FG001|Core Treatment Period|Other: tolerability complaints|0
7321526|NCT00751881|11551924|FG002|Core Treatment Period|Other: tolerability complaints|0
7321527|NCT00751881|11551922|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
7321528|NCT00751881|11551923|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
7321529|NCT00751881|11551924|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
7321530|NCT00751881|11551922|FG000|Extension Study Period|Adverse Event|18
7321531|NCT00751881|11551923|FG001|Extension Study Period|Adverse Event|20
7321532|NCT00751881|11551924|FG002|Extension Study Period|Adverse Event|21
7321533|NCT00751881|11551922|FG000|Extension Study Period|Lack of Efficacy|14
7321534|NCT00751881|11551923|FG001|Extension Study Period|Lack of Efficacy|10
7321535|NCT00751881|11551924|FG002|Extension Study Period|Lack of Efficacy|20
7321536|NCT00751881|11551922|FG000|Extension Study Period|Lost to Follow-up|4
7321537|NCT00751881|11551923|FG001|Extension Study Period|Lost to Follow-up|9
7415889|NCT01445613|11689273|FG000|1-year Follow-up|Physician Decision|2
7415890|NCT01445613|11689273|FG000|1-year Follow-up|Received a non-study stent|2
7415891|NCT01445652|11689289|FG000|Overall Study|Not comfortable in lenses|5
7415892|NCT01445652|11689290|FG001|Overall Study|Not comfortable in lenses|0
7415893|NCT01445652|11689289|FG000|Overall Study|Failed to attend scheduled visit|2
7415894|NCT01445652|11689290|FG001|Overall Study|Failed to attend scheduled visit|3
7415895|NCT01445652|11689289|FG000|Overall Study|Failed teach session|2
7415896|NCT01445652|11689290|FG001|Overall Study|Failed teach session|0
7415897|NCT01445652|11689289|FG000|Overall Study|Adverse Event|1
7415898|NCT01445652|11689290|FG001|Overall Study|Adverse Event|0
7415899|NCT01445678|11689298|FG000|Overall Study|Adverse Event|12
7415900|NCT01445678|11689299|FG001|Overall Study|Adverse Event|8
7321538|NCT00751881|11551924|FG002|Extension Study Period|Lost to Follow-up|6
7321539|NCT00751881|11551922|FG000|Extension Study Period|Poor Compliance to Protocol|3
7321540|NCT00751881|11551923|FG001|Extension Study Period|Poor Compliance to Protocol|2
7321541|NCT00751881|11551924|FG002|Extension Study Period|Poor Compliance to Protocol|1
7321542|NCT00751881|11551922|FG000|Extension Study Period|Other than specified above|26
7321543|NCT00751881|11551923|FG001|Extension Study Period|Other than specified above|30
7321544|NCT00751881|11551924|FG002|Extension Study Period|Other than specified above|18
7321545|NCT00751998|11551946|FG000|Overall Study|Lost to Follow-up|7
7321546|NCT00751998|11551946|FG000|Overall Study|Death|11
7321547|NCT00751998|11551946|FG000|Overall Study|Withdrawal by Subject|2
7321548|NCT00752089|11551950|FG000|Overall Study|Adverse Event|1
7321549|NCT00752089|11551950|FG000|Overall Study|Protocol Deviation|2
7321550|NCT00752089|11551950|FG000|Overall Study|Could not attend visit 9|1
7554125|NCT03026257|11915643|FG000|Overall Study|Withdrawal by Subject|1
7321551|NCT00752089|11551950|FG000|Overall Study|Not capable of wearing partial denture|1
7321552|NCT00752089|11551950|FG000|Overall Study|Cannot continue the study|1
7321553|NCT00752128|11551970|FG000|Overall Study|Withdrawal by Subject|4
7321554|NCT00752206|11551977|FG000|Overall Study|Disease progression|8
7321555|NCT00752206|11551978|FG001|Overall Study|Disease progression|11
7415901|NCT01445678|11689298|FG000|Overall Study|Lack of Efficacy|0
7415902|NCT01445678|11689299|FG001|Overall Study|Lack of Efficacy|2
7415903|NCT01445678|11689298|FG000|Overall Study|Lost to Follow-up|8
7415904|NCT01445678|11689299|FG001|Overall Study|Lost to Follow-up|5
7415905|NCT01445678|11689298|FG000|Overall Study|Protocol Violation|1
7415906|NCT01445678|11689299|FG001|Overall Study|Protocol Violation|1
7415907|NCT01445678|11689298|FG000|Overall Study|Withdrawal by Subject|9
7415908|NCT01445678|11689299|FG001|Overall Study|Withdrawal by Subject|5
7415909|NCT01445730|11689305|FG000|Overall Study|Adverse Event|1
7415910|NCT01445730|11689305|FG000|Overall Study|For the advice of a dentist|1
7415911|NCT01445730|11689305|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
7415912|NCT01445769|11689309|FG000|Overall Study|Consent Withdrawn|2
7415913|NCT01445769|11689309|FG000|Overall Study|Disease Progression|1
7415914|NCT01445769|11689309|FG000|Overall Study|Lost to Follow-up|5
7415915|NCT01445847|11689326|FG000|Overall Study|Protocol Violation|13
7415916|NCT01445847|11689327|FG001|Overall Study|Protocol Violation|14
7554126|NCT03026257|11915644|FG001|Overall Study|Withdrawal by Subject|1
7554127|NCT03026257|11915645|FG002|Overall Study|Withdrawal by Subject|0
7554128|NCT03026257|11915646|FG003|Overall Study|Withdrawal by Subject|0
7554129|NCT03026257|11915647|FG004|Overall Study|Withdrawal by Subject|0
7554130|NCT03026257|11915648|FG005|Overall Study|Withdrawal by Subject|0
7554131|NCT03026283|11915662|FG000|CCTA Diagnosis|CCTA not performed as planned|9
7554132|NCT03026283|11915663|FG001|CCTA Diagnosis|CCTA not performed as planned|0
7554133|NCT03026283|11915664|FG002|CCTA Diagnosis|CCTA not performed as planned|0
7554134|NCT03026283|11915665|FG003|CCTA Diagnosis|CCTA not performed as planned|0
7554135|NCT03026283|11915666|FG004|CCTA Diagnosis|CCTA not performed as planned|0
7554136|NCT03026283|11915667|FG005|CCTA Diagnosis|CCTA not performed as planned|0
7554137|NCT03026283|11915668|FG006|CCTA Diagnosis|CCTA not performed as planned|0
7554138|NCT03026283|11915669|FG007|CCTA Diagnosis|CCTA not performed as planned|0
7554139|NCT03026283|11915662|FG000|CCTA Diagnosis|Withdrawal by Subject|5
7554140|NCT03026283|11915663|FG001|CCTA Diagnosis|Withdrawal by Subject|0
7554141|NCT03026283|11915664|FG002|CCTA Diagnosis|Withdrawal by Subject|0
7554142|NCT03026283|11915665|FG003|CCTA Diagnosis|Withdrawal by Subject|0
7554143|NCT03026283|11915666|FG004|CCTA Diagnosis|Withdrawal by Subject|0
7554144|NCT03026283|11915667|FG005|CCTA Diagnosis|Withdrawal by Subject|0
7554145|NCT03026283|11915668|FG006|CCTA Diagnosis|Withdrawal by Subject|0
7554146|NCT03026283|11915669|FG007|CCTA Diagnosis|Withdrawal by Subject|0
7554147|NCT03026283|11915662|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554148|NCT03026283|11915663|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
7554149|NCT03026283|11915664|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554150|NCT03026283|11915665|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554151|NCT03026283|11915666|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554152|NCT03026283|11915667|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554153|NCT03026283|11915668|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7554154|NCT03026283|11915669|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
7321556|NCT00752206|11551977|FG000|Overall Study|Pregnancy|1
7321557|NCT00752206|11551978|FG001|Overall Study|Pregnancy|0
7321558|NCT00752219|11551986|FG000|Overall Study|Clinical failure|0
7321559|NCT00752219|11551987|FG001|Overall Study|Clinical failure|1
7321560|NCT00752219|11551986|FG000|Overall Study|Adverse Event|5
7321561|NCT00752219|11551987|FG001|Overall Study|Adverse Event|3
7321562|NCT00752219|11551986|FG000|Overall Study|Protocol deviation|1
7321563|NCT00752219|11551987|FG001|Overall Study|Protocol deviation|0
7321564|NCT00752219|11551986|FG000|Overall Study|Lost to Follow-up|1
7321565|NCT00752219|11551987|FG001|Overall Study|Lost to Follow-up|2
7321566|NCT00752219|11551986|FG000|Overall Study|Randomized but not treated|1
7415917|NCT01445847|11689326|FG000|Overall Study|Missed Data|1
7415918|NCT01445847|11689327|FG001|Overall Study|Missed Data|0
7415919|NCT01445886|11689337|FG000|Overall Study|Lost to Follow-up|2
7415920|NCT01445886|11689337|FG000|Overall Study|Protocol Violation|3
7554155|NCT03026283|11915662|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554156|NCT03026283|11915663|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554157|NCT03026283|11915664|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
7554158|NCT03026283|11915665|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554159|NCT03026283|11915666|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554160|NCT03026283|11915667|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554161|NCT03026283|11915668|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554162|NCT03026283|11915669|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
7554163|NCT03026283|11915662|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7321567|NCT00752219|11551987|FG001|Overall Study|Randomized but not treated|0
7321568|NCT00752219|11551986|FG000|Overall Study|Other|3
7321569|NCT00752219|11551987|FG001|Overall Study|Other|0
7321570|NCT00752232|11552000|FG000|Overall Study|Protocol Violation|0
7321571|NCT00752232|11552001|FG001|Overall Study|Protocol Violation|0
7321572|NCT00752232|11552002|FG002|Overall Study|Protocol Violation|0
7321573|NCT00752232|11552003|FG003|Overall Study|Protocol Violation|0
7321574|NCT00752232|11552004|FG004|Overall Study|Protocol Violation|0
7321575|NCT00752232|11552005|FG005|Overall Study|Protocol Violation|1
7321576|NCT00752232|11552006|FG006|Overall Study|Protocol Violation|0
7321577|NCT00752232|11552000|FG000|Overall Study|Caregiver request|2
7321578|NCT00752232|11552001|FG001|Overall Study|Caregiver request|0
7321579|NCT00752232|11552002|FG002|Overall Study|Caregiver request|0
7321580|NCT00752232|11552003|FG003|Overall Study|Caregiver request|0
7321581|NCT00752232|11552004|FG004|Overall Study|Caregiver request|1
7321582|NCT00752232|11552005|FG005|Overall Study|Caregiver request|0
7321583|NCT00752232|11552006|FG006|Overall Study|Caregiver request|0
7321584|NCT00752232|11552000|FG000|Overall Study|Investigator request|0
7321585|NCT00752232|11552001|FG001|Overall Study|Investigator request|0
7321586|NCT00752232|11552002|FG002|Overall Study|Investigator request|0
7321587|NCT00752232|11552003|FG003|Overall Study|Investigator request|0
7321588|NCT00752232|11552004|FG004|Overall Study|Investigator request|1
7321589|NCT00752232|11552005|FG005|Overall Study|Investigator request|0
7321590|NCT00752232|11552006|FG006|Overall Study|Investigator request|0
7321591|NCT00752232|11552000|FG000|Overall Study|Subject request|0
7321592|NCT00752232|11552001|FG001|Overall Study|Subject request|0
7321593|NCT00752232|11552002|FG002|Overall Study|Subject request|1
7321594|NCT00752232|11552003|FG003|Overall Study|Subject request|0
7321595|NCT00752232|11552004|FG004|Overall Study|Subject request|0
7321596|NCT00752232|11552005|FG005|Overall Study|Subject request|0
7321597|NCT00752232|11552006|FG006|Overall Study|Subject request|0
7321598|NCT00752232|11552000|FG000|Overall Study|Group home admission|0
7321599|NCT00752232|11552001|FG001|Overall Study|Group home admission|0
7321600|NCT00752232|11552002|FG002|Overall Study|Group home admission|0
7321601|NCT00752232|11552003|FG003|Overall Study|Group home admission|1
7321602|NCT00752232|11552004|FG004|Overall Study|Group home admission|0
7321603|NCT00752232|11552005|FG005|Overall Study|Group home admission|0
7321604|NCT00752232|11552006|FG006|Overall Study|Group home admission|0
7321605|NCT00752232|11552000|FG000|Overall Study|Caregiver could not attend the subject|0
7321606|NCT00752232|11552001|FG001|Overall Study|Caregiver could not attend the subject|0
7321607|NCT00752232|11552002|FG002|Overall Study|Caregiver could not attend the subject|0
7321608|NCT00752232|11552003|FG003|Overall Study|Caregiver could not attend the subject|0
7321609|NCT00752232|11552004|FG004|Overall Study|Caregiver could not attend the subject|1
7321610|NCT00752232|11552005|FG005|Overall Study|Caregiver could not attend the subject|0
7321611|NCT00752232|11552006|FG006|Overall Study|Caregiver could not attend the subject|0
7321612|NCT00752557|11552026|FG000|Overall Study|Withdrawal by Subject|4
7321613|NCT00752557|11552027|FG001|Overall Study|Withdrawal by Subject|3
7321614|NCT00752557|11552028|FG002|Overall Study|Withdrawal by Subject|3
7321615|NCT00752557|11552026|FG000|Overall Study|Unspecified resaons|0
7321616|NCT00752557|11552027|FG001|Overall Study|Unspecified resaons|2
7321617|NCT00752557|11552028|FG002|Overall Study|Unspecified resaons|2
7321618|NCT00752557|11552026|FG000|Overall Study|Lost to Follow-up|1
7321619|NCT00752557|11552027|FG001|Overall Study|Lost to Follow-up|0
7321620|NCT00752557|11552028|FG002|Overall Study|Lost to Follow-up|1
7321621|NCT00752609|11552040|FG000|Overall Study|Adverse Event|2
7321622|NCT00752609|11552041|FG001|Overall Study|Adverse Event|2
7530682|NCT02641379|11874575|FG004|Overall Study|Participant cannot be reached|2
7530683|NCT02641379|11874576|FG005|Overall Study|Participant cannot be reached|1
7530684|NCT02641379|11874577|FG006|Overall Study|Participant cannot be reached|0
7530685|NCT02641379|11874578|FG007|Overall Study|Participant cannot be reached|1
7530686|NCT02641379|11874579|FG008|Overall Study|Participant cannot be reached|0
7530687|NCT02641379|11874580|FG009|Overall Study|Participant cannot be reached|2
7530688|NCT02641379|11874581|FG010|Overall Study|Participant cannot be reached|1
7530689|NCT02641379|11874571|FG000|Overall Study|PCR positive at Week 24|15
7530690|NCT02641379|11874572|FG001|Overall Study|PCR positive at Week 24|21
7530691|NCT02641379|11874573|FG002|Overall Study|PCR positive at Week 24|62
7530692|NCT02641379|11874574|FG003|Overall Study|PCR positive at Week 24|0
7530693|NCT02641379|11874575|FG004|Overall Study|PCR positive at Week 24|0
7530694|NCT02641379|11874576|FG005|Overall Study|PCR positive at Week 24|6
7574582|NCT03683719|11957507|FG002|Overall Study|Withdrawal by Subject|3
7321623|NCT00752609|11552040|FG000|Overall Study|Withdrawal by Subject|3
7321624|NCT00752609|11552041|FG001|Overall Study|Withdrawal by Subject|0
7321625|NCT00752609|11552040|FG000|Overall Study|Physician Decision|1
7321626|NCT00752609|11552041|FG001|Overall Study|Physician Decision|0
7321627|NCT00752609|11552040|FG000|Overall Study|Death|1
7321628|NCT00752609|11552041|FG001|Overall Study|Death|0
7321629|NCT00752609|11552040|FG000|Overall Study|Met exclusion criteria|1
7321630|NCT00752609|11552041|FG001|Overall Study|Met exclusion criteria|0
7530695|NCT02641379|11874577|FG006|Overall Study|PCR positive at Week 24|3
7530696|NCT02641379|11874578|FG007|Overall Study|PCR positive at Week 24|8
7321631|NCT00752609|11552040|FG000|Overall Study|Received Aranesp in error|1
7321632|NCT00752609|11552041|FG001|Overall Study|Received Aranesp in error|0
7321633|NCT00752622|11552050|FG000|Induction Phase|Adverse Event|3
7321634|NCT00752622|11552050|FG000|Induction Phase|Other|3
7321635|NCT00752622|11552050|FG000|Induction Phase|Non-responder|14
7321636|NCT00752622|11552050|FG000|Induction Phase|Withdrawal by Subject|1
7321637|NCT00752622|11552050|FG000|Induction Phase|Premature study termination|14
7321638|NCT00752622|11552050|FG000|Observational Phase|Premature Study Termination|36
7321639|NCT00752622|11552050|FG000|Observational Phase|Non-responder|2
7321640|NCT00752622|11552050|FG000|Observational Phase|Withdrawal by Subject|2
7321641|NCT00752622|11552050|FG000|Observational Phase|Adverse Event|1
7321642|NCT00752622|11552050|FG000|Observational Phase|Other|2
7321643|NCT00752622|11552050|FG000|Interventional Phase|Non-responder|2
7321644|NCT00752622|11552050|FG000|Interventional Phase|Physician Decision|1
7321645|NCT00752622|11552050|FG000|Interventional Phase|Premature Study Termination|5
7321646|NCT00752726|11552057|FG000|Overall Study|Lost to Follow-up|2
7321647|NCT00752726|11552058|FG001|Overall Study|Lost to Follow-up|1
7321648|NCT00752726|11552057|FG000|Overall Study|Adverse Event|3
7321649|NCT00752726|11552058|FG001|Overall Study|Adverse Event|0
7321650|NCT00752726|11552057|FG000|Overall Study|Withdrawal by Subject|5
7321651|NCT00752726|11552058|FG001|Overall Study|Withdrawal by Subject|10
7321652|NCT00752726|11552057|FG000|Overall Study|Other Reason|1
7321653|NCT00752726|11552058|FG001|Overall Study|Other Reason|2
7321654|NCT00752791|11552064|FG000|Overall Study|Adverse Event|7
7321655|NCT00752791|11552064|FG000|Overall Study|Withdrawal by Subject|1
7321656|NCT00752791|11552064|FG000|Overall Study|Physician Decision|1
7321657|NCT00752791|11552064|FG000|Overall Study|Death|1
7321658|NCT00752791|11552064|FG000|Overall Study|Renal transplant|3
7321659|NCT00752791|11552064|FG000|Overall Study|Switched to hemodialysis|2
7321660|NCT00752791|11552064|FG000|Overall Study|Protocol deviation|1
7321661|NCT00752856|11552070|FG000|Overall Study|randomized but did not do viral kinetics|0
7321662|NCT00752856|11552071|FG001|Overall Study|randomized but did not do viral kinetics|1
7321663|NCT00752895|11552079|FG000|Overall Study|Withdrawal by Subject|8
7321664|NCT00752895|11552080|FG001|Overall Study|Withdrawal by Subject|3
7321665|NCT00753012|11552103|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
7321666|NCT00753012|11552104|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
7321667|NCT00753012|11552103|FG000|Overall Study|Adverse Event|2
7321668|NCT00753012|11552104|FG001|Overall Study|Adverse Event|0
7321669|NCT00753012|11552103|FG000|Overall Study|Withdrawal by Subject|0
7321670|NCT00753012|11552104|FG001|Overall Study|Withdrawal by Subject|1
7321671|NCT00753012|11552103|FG000|Overall Study|Lost to Follow-up|4
7321672|NCT00753012|11552104|FG001|Overall Study|Lost to Follow-up|0
7321673|NCT00753012|11552103|FG000|Overall Study|Confounded endpoint data|1
7321674|NCT00753012|11552104|FG001|Overall Study|Confounded endpoint data|0
7321675|NCT00753272|11552130|FG000|Overall Study|Adverse Event|878
7321676|NCT00753272|11552131|FG001|Overall Study|Adverse Event|869
7321677|NCT00753272|11552130|FG000|Overall Study|Protocol Violation|28
7321678|NCT00753272|11552131|FG001|Overall Study|Protocol Violation|46
7321679|NCT00753272|11552130|FG000|Overall Study|Withdrawal by Subject|2481
7321680|NCT00753272|11552131|FG001|Overall Study|Withdrawal by Subject|2407
7321681|NCT00753272|11552130|FG000|Overall Study|Lost to Follow-up|491
7321682|NCT00753272|11552131|FG001|Overall Study|Lost to Follow-up|497
7321683|NCT00753272|11552130|FG000|Overall Study|Other|1104
7321684|NCT00753272|11552131|FG001|Overall Study|Other|1088
7321685|NCT00753415|11552168|FG000|Part A|Disease progression|1
7321686|NCT00753415|11552169|FG001|Part A|Disease progression|0
7415921|NCT01445951|11689346|FG000|Overall Study|Adverse Event|16
7321687|NCT00753415|11552170|FG002|Part A|Disease progression|1
7321688|NCT00753415|11552171|FG003|Part A|Disease progression|2
7321689|NCT00753415|11552172|FG004|Part A|Disease progression|0
7321690|NCT00753415|11552173|FG005|Part A|Disease progression|0
7321691|NCT00753415|11552174|FG006|Part A|Disease progression|0
7321692|NCT00753415|11552175|FG007|Part A|Disease progression|0
7321693|NCT00753415|11552176|FG008|Part A|Disease progression|0
7321694|NCT00753415|11552177|FG009|Part A|Disease progression|0
7321695|NCT00753415|11552168|FG000|Part A|Withdrawal by Subject|0
7321696|NCT00753415|11552169|FG001|Part A|Withdrawal by Subject|0
7321697|NCT00753415|11552170|FG002|Part A|Withdrawal by Subject|1
7321698|NCT00753415|11552171|FG003|Part A|Withdrawal by Subject|0
7321699|NCT00753415|11552172|FG004|Part A|Withdrawal by Subject|0
7321700|NCT00753415|11552173|FG005|Part A|Withdrawal by Subject|0
7321701|NCT00753415|11552174|FG006|Part A|Withdrawal by Subject|0
7321702|NCT00753415|11552175|FG007|Part A|Withdrawal by Subject|0
7321703|NCT00753415|11552176|FG008|Part A|Withdrawal by Subject|0
7415922|NCT01445951|11689347|FG001|Overall Study|Adverse Event|9
7415923|NCT01445951|11689348|FG002|Overall Study|Adverse Event|0
7321704|NCT00753415|11552177|FG009|Part A|Withdrawal by Subject|0
7321705|NCT00753415|11552168|FG000|Part B|Lost to Follow-up|0
7321706|NCT00753415|11552169|FG001|Part B|Lost to Follow-up|0
7321707|NCT00753415|11552170|FG002|Part B|Lost to Follow-up|0
7321708|NCT00753415|11552171|FG003|Part B|Lost to Follow-up|0
7321709|NCT00753415|11552172|FG004|Part B|Lost to Follow-up|0
7321710|NCT00753415|11552173|FG005|Part B|Lost to Follow-up|0
7415924|NCT01445951|11689346|FG000|Overall Study|Protocol Violation|2
7415925|NCT01445951|11689347|FG001|Overall Study|Protocol Violation|2
7415926|NCT01445951|11689348|FG002|Overall Study|Protocol Violation|2
7415927|NCT01445951|11689346|FG000|Overall Study|Withdrawal by Subject|21
7415928|NCT01445951|11689347|FG001|Overall Study|Withdrawal by Subject|16
7415929|NCT01445951|11689348|FG002|Overall Study|Withdrawal by Subject|8
7415930|NCT01445951|11689346|FG000|Overall Study|Physician Decision|3
7415931|NCT01445951|11689347|FG001|Overall Study|Physician Decision|1
7415932|NCT01445951|11689348|FG002|Overall Study|Physician Decision|0
7415933|NCT01445951|11689346|FG000|Overall Study|Lost to Follow-up|1
7415934|NCT01445951|11689347|FG001|Overall Study|Lost to Follow-up|2
7415935|NCT01445951|11689348|FG002|Overall Study|Lost to Follow-up|4
7415936|NCT01445951|11689346|FG000|Overall Study|Pregnancy|0
7415937|NCT01445951|11689347|FG001|Overall Study|Pregnancy|1
7415938|NCT01445951|11689348|FG002|Overall Study|Pregnancy|4
7415939|NCT01445951|11689346|FG000|Overall Study|Death|0
7415940|NCT01445951|11689347|FG001|Overall Study|Death|0
7415941|NCT01445951|11689348|FG002|Overall Study|Death|1
7415942|NCT01445951|11689346|FG000|Overall Study|Non-compliance with study drug|1
7415943|NCT01445951|11689347|FG001|Overall Study|Non-compliance with study drug|2
7415944|NCT01445951|11689348|FG002|Overall Study|Non-compliance with study drug|0
7415945|NCT01445951|11689346|FG000|Overall Study|Non-compliance with protocol|0
7415946|NCT01445951|11689347|FG001|Overall Study|Non-compliance with protocol|1
7415947|NCT01445951|11689348|FG002|Overall Study|Non-compliance with protocol|0
7415948|NCT01445951|11689346|FG000|Overall Study|Sponsor decision - subject travel|0
7415949|NCT01445951|11689347|FG001|Overall Study|Sponsor decision - subject travel|1
7415950|NCT01445951|11689348|FG002|Overall Study|Sponsor decision - subject travel|0
7415951|NCT01445951|11689346|FG000|Overall Study|Cough|0
7415952|NCT01445951|11689347|FG001|Overall Study|Cough|1
7415953|NCT01445951|11689348|FG002|Overall Study|Cough|0
7415954|NCT01446003|11689356|FG000|Period 1|Protocol Violation|2
7415955|NCT01446003|11689357|FG001|Period 1|Protocol Violation|0
7415956|NCT01446003|11689356|FG000|Period 2|Adverse Event|1
7415957|NCT01446003|11689357|FG001|Period 2|Adverse Event|0
7415958|NCT01446042|11689366|FG000|Overall Study|Withdrawal by Subject|12
7415959|NCT01446042|11689367|FG001|Overall Study|Withdrawal by Subject|2
7415960|NCT01446042|11689368|FG002|Overall Study|Withdrawal by Subject|4
7530697|NCT02641379|11874579|FG008|Overall Study|PCR positive at Week 24|0
7530698|NCT02641379|11874580|FG009|Overall Study|PCR positive at Week 24|1
7530699|NCT02641379|11874581|FG010|Overall Study|PCR positive at Week 24|0
7530700|NCT02641379|11874571|FG000|Overall Study|PCR positive at follow up 2|1
7530701|NCT02641379|11874572|FG001|Overall Study|PCR positive at follow up 2|0
7530702|NCT02641379|11874573|FG002|Overall Study|PCR positive at follow up 2|0
7530703|NCT02641379|11874574|FG003|Overall Study|PCR positive at follow up 2|0
7530704|NCT02641379|11874575|FG004|Overall Study|PCR positive at follow up 2|0
7530705|NCT02641379|11874576|FG005|Overall Study|PCR positive at follow up 2|0
7530706|NCT02641379|11874577|FG006|Overall Study|PCR positive at follow up 2|0
7530707|NCT02641379|11874578|FG007|Overall Study|PCR positive at follow up 2|0
7530708|NCT02641379|11874579|FG008|Overall Study|PCR positive at follow up 2|0
7530709|NCT02641379|11874580|FG009|Overall Study|PCR positive at follow up 2|0
7530710|NCT02641379|11874581|FG010|Overall Study|PCR positive at follow up 2|0
7530711|NCT02641379|11874571|FG000|Overall Study|Participant showed relapse|1
7530712|NCT02641379|11874572|FG001|Overall Study|Participant showed relapse|0
7530713|NCT02641379|11874573|FG002|Overall Study|Participant showed relapse|0
7530714|NCT02641379|11874574|FG003|Overall Study|Participant showed relapse|0
7530715|NCT02641379|11874575|FG004|Overall Study|Participant showed relapse|0
7530716|NCT02641379|11874576|FG005|Overall Study|Participant showed relapse|0
7530717|NCT02641379|11874577|FG006|Overall Study|Participant showed relapse|1
7530718|NCT02641379|11874578|FG007|Overall Study|Participant showed relapse|0
7530719|NCT02641379|11874579|FG008|Overall Study|Participant showed relapse|0
7554164|NCT03026283|11915663|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7554165|NCT03026283|11915664|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7554166|NCT03026283|11915665|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
7554167|NCT03026283|11915666|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
7554168|NCT03026283|11915667|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7321711|NCT00753415|11552174|FG006|Part B|Lost to Follow-up|0
7321712|NCT00753415|11552175|FG007|Part B|Lost to Follow-up|1
7321713|NCT00753415|11552176|FG008|Part B|Lost to Follow-up|1
7321714|NCT00753415|11552177|FG009|Part B|Lost to Follow-up|0
7321715|NCT00753415|11552168|FG000|Part B|Disease progression|0
7321716|NCT00753415|11552169|FG001|Part B|Disease progression|0
7321717|NCT00753415|11552170|FG002|Part B|Disease progression|0
7321718|NCT00753415|11552171|FG003|Part B|Disease progression|0
7321719|NCT00753415|11552172|FG004|Part B|Disease progression|0
7415961|NCT01446042|11689366|FG000|Overall Study|Adverse Event|1
7321720|NCT00753415|11552173|FG005|Part B|Disease progression|0
7530720|NCT02641379|11874580|FG009|Overall Study|Participant showed relapse|0
7321721|NCT00753415|11552174|FG006|Part B|Disease progression|0
7321722|NCT00753415|11552175|FG007|Part B|Disease progression|0
7321723|NCT00753415|11552176|FG008|Part B|Disease progression|2
7321724|NCT00753415|11552177|FG009|Part B|Disease progression|1
7321725|NCT00753454|11552201|FG000|Overall Study|Adverse Event|4
7321726|NCT00753454|11552201|FG000|Overall Study|Lack of Efficacy|1
7321727|NCT00753454|11552201|FG000|Overall Study|Lost to Follow-up|3
7321728|NCT00753454|11552201|FG000|Overall Study|Withdrawal by Subject|5
7321729|NCT00753454|11552201|FG000|Overall Study|Investigator Decision|1
7321730|NCT00753506|11552207|FG000|Overall Study|Withdrawal by Subject|4
7321731|NCT00753506|11552208|FG001|Overall Study|Withdrawal by Subject|1
7321732|NCT00753506|11552207|FG000|Overall Study|Lost to Follow-up|2
7321733|NCT00753506|11552208|FG001|Overall Study|Lost to Follow-up|0
7321734|NCT00753506|11552207|FG000|Overall Study|Other reason|1
7321735|NCT00753506|11552208|FG001|Overall Study|Other reason|1
7321736|NCT00753519|11552216|FG000|Overall Study|Withdrawal by Subject|0
7321737|NCT00753519|11552217|FG001|Overall Study|Withdrawal by Subject|2
7321738|NCT00753623|11552227|FG000|Phase I (14 Days)|Withdrawal by Subject|1
7321739|NCT00753623|11552228|FG001|Phase I (14 Days)|Withdrawal by Subject|1
7321740|NCT00753623|11552227|FG000|Phase I (14 Days)|Physician Decision|1
7321741|NCT00753623|11552228|FG001|Phase I (14 Days)|Physician Decision|2
7321742|NCT00753623|11552227|FG000|Phase I (14 Days)|Adverse Event|0
7321743|NCT00753623|11552228|FG001|Phase I (14 Days)|Adverse Event|1
7321744|NCT00753623|11552227|FG000|Washout (7 Days)|Physician Decision|1
7321745|NCT00753623|11552228|FG001|Washout (7 Days)|Physician Decision|0
7321746|NCT00753623|11552227|FG000|Phase II (14 Days)|Physician Decision|0
7321747|NCT00753623|11552228|FG001|Phase II (14 Days)|Physician Decision|1
7321748|NCT00753649|11552240|FG000|Overall Study|Migrated/moved from study area|1
7321749|NCT00753649|11552241|FG001|Overall Study|Migrated/moved from study area|0
7321750|NCT00753649|11552240|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
7321751|NCT00753649|11552241|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
7321752|NCT00753649|11552240|FG000|Overall Study|Lost to follow-up-complete vaccination|1
7321753|NCT00753649|11552241|FG001|Overall Study|Lost to follow-up-complete vaccination|0
7415962|NCT01446042|11689367|FG001|Overall Study|Adverse Event|0
7415963|NCT01446042|11689368|FG002|Overall Study|Adverse Event|4
7530721|NCT02641379|11874581|FG010|Overall Study|Participant showed relapse|0
7530722|NCT02641379|11874571|FG000|Overall Study|Participant stopped study/treatment|1
7530723|NCT02641379|11874572|FG001|Overall Study|Participant stopped study/treatment|3
7530724|NCT02641379|11874573|FG002|Overall Study|Participant stopped study/treatment|1
7530725|NCT02641379|11874574|FG003|Overall Study|Participant stopped study/treatment|0
7530726|NCT02641379|11874575|FG004|Overall Study|Participant stopped study/treatment|0
7530727|NCT02641379|11874576|FG005|Overall Study|Participant stopped study/treatment|1
7530728|NCT02641379|11874577|FG006|Overall Study|Participant stopped study/treatment|2
7530729|NCT02641379|11874578|FG007|Overall Study|Participant stopped study/treatment|0
7530730|NCT02641379|11874579|FG008|Overall Study|Participant stopped study/treatment|1
7530731|NCT02641379|11874580|FG009|Overall Study|Participant stopped study/treatment|0
7530732|NCT02641379|11874581|FG010|Overall Study|Participant stopped study/treatment|0
7415964|NCT01446042|11689366|FG000|Overall Study|Lost to Follow-up|5
7415965|NCT01446042|11689367|FG001|Overall Study|Lost to Follow-up|0
7415966|NCT01446042|11689368|FG002|Overall Study|Lost to Follow-up|0
7415967|NCT01446042|11689366|FG000|Overall Study|Other reasons|2
7415968|NCT01446042|11689367|FG001|Overall Study|Other reasons|1
7415969|NCT01446042|11689368|FG002|Overall Study|Other reasons|1
7415970|NCT01446159|11689380|FG000|Overall Study|Withdrawal by Subject|1
7415971|NCT01446159|11689381|FG001|Overall Study|Withdrawal by Subject|0
7415972|NCT01446159|11689382|FG002|Overall Study|Withdrawal by Subject|14
7415973|NCT01446159|11689383|FG003|Overall Study|Withdrawal by Subject|11
7415974|NCT01446159|11689380|FG000|Overall Study|Lost to Follow-up|0
7415975|NCT01446159|11689381|FG001|Overall Study|Lost to Follow-up|0
7415976|NCT01446159|11689382|FG002|Overall Study|Lost to Follow-up|1
7415977|NCT01446159|11689383|FG003|Overall Study|Lost to Follow-up|2
7415978|NCT01446159|11689380|FG000|Overall Study|Death|2
7415979|NCT01446159|11689381|FG001|Overall Study|Death|3
7415980|NCT01446159|11689382|FG002|Overall Study|Death|43
7415981|NCT01446159|11689383|FG003|Overall Study|Death|36
7415982|NCT01446159|11689380|FG000|Overall Study|Other|0
7415983|NCT01446159|11689381|FG001|Overall Study|Other|0
7415984|NCT01446159|11689382|FG002|Overall Study|Other|13
7415985|NCT01446159|11689383|FG003|Overall Study|Other|13
7466415|NCT01891669|11766246|FG003|Overall Study|Other|0
7466416|NCT01891669|11766247|FG004|Overall Study|Other|0
7466417|NCT01891669|11766248|FG005|Overall Study|Other|0
7466418|NCT01891669|11766249|FG006|Overall Study|Other|0
7466419|NCT01891669|11766250|FG007|Overall Study|Other|1
7466420|NCT01891669|11766251|FG008|Overall Study|Other|0
7530733|NCT02641379|11874571|FG000|Overall Study|Therapy stopped due to misunderstanding|1
7530734|NCT02641379|11874572|FG001|Overall Study|Therapy stopped due to misunderstanding|0
7321754|NCT00753649|11552240|FG000|Overall Study|Protocol Violation|2
7466421|NCT01891669|11766252|FG009|Overall Study|Other|0
7466422|NCT01891721|11766286|FG000|Overall Study|Lost to Follow-up|10
7466423|NCT01891721|11766287|FG001|Overall Study|Lost to Follow-up|5
7466424|NCT01891721|11766288|FG002|Overall Study|Lost to Follow-up|1
7466425|NCT01891864|11766309|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7321755|NCT00753649|11552241|FG001|Overall Study|Protocol Violation|0
7321756|NCT00753675|11552250|FG000|Overall Study|other reason|11
7321757|NCT00753675|11552251|FG001|Overall Study|other reason|12
7321758|NCT00753675|11552252|FG002|Overall Study|other reason|13
7321759|NCT00753675|11552250|FG000|Overall Study|Death|1
7321760|NCT00753675|11552251|FG001|Overall Study|Death|2
7321761|NCT00753675|11552252|FG002|Overall Study|Death|4
7321762|NCT00753675|11552250|FG000|Overall Study|Adverse Event|11
7321763|NCT00753675|11552251|FG001|Overall Study|Adverse Event|9
7321764|NCT00753675|11552252|FG002|Overall Study|Adverse Event|4
7321765|NCT00753675|11552250|FG000|Overall Study|Objective progression of disease|35
7321766|NCT00753675|11552251|FG001|Overall Study|Objective progression of disease|35
7321767|NCT00753675|11552252|FG002|Overall Study|Objective progression of disease|35
7321768|NCT00753675|11552250|FG000|Overall Study|Withdrawal by Subject|0
7321769|NCT00753675|11552251|FG001|Overall Study|Withdrawal by Subject|1
7321770|NCT00753675|11552252|FG002|Overall Study|Withdrawal by Subject|0
7321771|NCT00753675|11552250|FG000|Overall Study|Lost to Follow-up|1
7321772|NCT00753675|11552251|FG001|Overall Study|Lost to Follow-up|0
7321773|NCT00753675|11552252|FG002|Overall Study|Lost to Follow-up|0
7321774|NCT00753688|11552262|FG000|Overall Study|Death|102
7321775|NCT00753688|11552263|FG001|Overall Study|Death|203
7321776|NCT00753688|11552262|FG000|Overall Study|Missing|4
7321777|NCT00753688|11552263|FG001|Overall Study|Missing|9
7321778|NCT00753688|11552262|FG000|Overall Study|Participant Withdrew Consent|2
7321779|NCT00753688|11552263|FG001|Overall Study|Participant Withdrew Consent|2
7321780|NCT00753688|11552262|FG000|Overall Study|Ongoing - in Follow-up|15
7321781|NCT00753688|11552263|FG001|Overall Study|Ongoing - in Follow-up|31
7321782|NCT00753688|11552262|FG000|Overall Study|Adverse Event|0
7321783|NCT00753688|11552263|FG001|Overall Study|Adverse Event|1
7321784|NCT00753714|11552271|FG000|Overall Study|Lack of Efficacy|21
7321785|NCT00753714|11552272|FG001|Overall Study|Lack of Efficacy|34
7321786|NCT00753714|11552271|FG000|Overall Study|Adverse Event|26
7321787|NCT00753714|11552272|FG001|Overall Study|Adverse Event|18
7321788|NCT00753714|11552271|FG000|Overall Study|Protocol Violation|1
7321789|NCT00753714|11552272|FG001|Overall Study|Protocol Violation|0
7321790|NCT00753714|11552271|FG000|Overall Study|Lost to Follow-up|0
7321791|NCT00753714|11552272|FG001|Overall Study|Lost to Follow-up|1
7321792|NCT00753714|11552271|FG000|Overall Study|Withdrawal by Subject|2
7321793|NCT00753714|11552272|FG001|Overall Study|Withdrawal by Subject|1
7321794|NCT00753714|11552271|FG000|Overall Study|Death|3
7321795|NCT00753714|11552272|FG001|Overall Study|Death|3
7321796|NCT00753714|11552271|FG000|Overall Study|Other|7
7321797|NCT00753714|11552272|FG001|Overall Study|Other|5
7321798|NCT00753766|11552283|FG000|Overall Study|Physician Decision|1
7321799|NCT00753766|11552284|FG001|Overall Study|Physician Decision|0
7321800|NCT00753896|11552291|FG000|Overall Study|Adverse Event|4
7321801|NCT00753896|11552291|FG000|Overall Study|Death|1
7321802|NCT00753896|11552291|FG000|Overall Study|Lost to Follow-up|2
7321803|NCT00753896|11552291|FG000|Overall Study|Protocol Violation|1
7321804|NCT00753896|11552291|FG000|Overall Study|Withdrawal by Subject|4
7321805|NCT00753896|11552291|FG000|Overall Study|Entry Criteria Not Met|4
7554169|NCT03026283|11915668|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7554170|NCT03026283|11915669|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
7554171|NCT03026283|11915662|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7554172|NCT03026283|11915663|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7554173|NCT03026283|11915664|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7554174|NCT03026283|11915665|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
7554175|NCT03026283|11915666|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7554176|NCT03026283|11915667|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
7554177|NCT03026283|11915668|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7321806|NCT00753922|11552299|FG000|Overall Study|Lost to Follow-up|155
7321807|NCT00753922|11552300|FG001|Overall Study|Lost to Follow-up|24
7321808|NCT00753922|11552301|FG002|Overall Study|Lost to Follow-up|28
7321809|NCT00753922|11552302|FG003|Overall Study|Lost to Follow-up|5
7321810|NCT00753922|11552299|FG000|Overall Study|Withdrawal by Subject|9
7321811|NCT00753922|11552300|FG001|Overall Study|Withdrawal by Subject|11
7321812|NCT00753922|11552301|FG002|Overall Study|Withdrawal by Subject|4
7321813|NCT00753922|11552302|FG003|Overall Study|Withdrawal by Subject|2
7321814|NCT00753922|11552299|FG000|Overall Study|Patient Non-compliance|55
7321815|NCT00753922|11552300|FG001|Overall Study|Patient Non-compliance|22
7321816|NCT00753922|11552301|FG002|Overall Study|Patient Non-compliance|14
7415986|NCT01446237|11689395|FG000|Overall Study|Adverse Event|1
7415987|NCT01446237|11689395|FG000|Overall Study|Lost to Follow-up|2
7321817|NCT00753922|11552302|FG003|Overall Study|Patient Non-compliance|11
7321818|NCT00753922|11552299|FG000|Overall Study|Patients Not Completing Visit|11
7321819|NCT00753922|11552300|FG001|Overall Study|Patients Not Completing Visit|0
7554178|NCT03026283|11915669|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
7554179|NCT03026283|11915662|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7321820|NCT00753922|11552301|FG002|Overall Study|Patients Not Completing Visit|1
7321821|NCT00753922|11552302|FG003|Overall Study|Patients Not Completing Visit|0
7321822|NCT00753922|11552299|FG000|Overall Study|Death|2
7321823|NCT00753922|11552300|FG001|Overall Study|Death|23
7321824|NCT00753922|11552301|FG002|Overall Study|Death|2
7321825|NCT00753922|11552302|FG003|Overall Study|Death|1
7321826|NCT00753922|11552299|FG000|Overall Study|Discontinuation Due to Explantation|14
7530735|NCT02641379|11874573|FG002|Overall Study|Therapy stopped due to misunderstanding|0
7530736|NCT02641379|11874574|FG003|Overall Study|Therapy stopped due to misunderstanding|0
7530737|NCT02641379|11874575|FG004|Overall Study|Therapy stopped due to misunderstanding|0
7530738|NCT02641379|11874576|FG005|Overall Study|Therapy stopped due to misunderstanding|0
7530739|NCT02641379|11874577|FG006|Overall Study|Therapy stopped due to misunderstanding|0
7530740|NCT02641379|11874578|FG007|Overall Study|Therapy stopped due to misunderstanding|0
7530741|NCT02641379|11874579|FG008|Overall Study|Therapy stopped due to misunderstanding|0
7530742|NCT02641379|11874580|FG009|Overall Study|Therapy stopped due to misunderstanding|0
7530743|NCT02641379|11874581|FG010|Overall Study|Therapy stopped due to misunderstanding|0
7530744|NCT02641379|11874571|FG000|Overall Study|Financial problems|0
7530745|NCT02641379|11874572|FG001|Overall Study|Financial problems|1
7530746|NCT02641379|11874573|FG002|Overall Study|Financial problems|0
7530747|NCT02641379|11874574|FG003|Overall Study|Financial problems|0
7530748|NCT02641379|11874575|FG004|Overall Study|Financial problems|0
7530749|NCT02641379|11874576|FG005|Overall Study|Financial problems|0
7530750|NCT02641379|11874577|FG006|Overall Study|Financial problems|0
7530751|NCT02641379|11874578|FG007|Overall Study|Financial problems|0
7530752|NCT02641379|11874579|FG008|Overall Study|Financial problems|0
7530753|NCT02641379|11874580|FG009|Overall Study|Financial problems|0
7530754|NCT02641379|11874581|FG010|Overall Study|Financial problems|0
7530755|NCT02641379|11874571|FG000|Overall Study|PCR positive at Week 68|0
7530756|NCT02641379|11874572|FG001|Overall Study|PCR positive at Week 68|1
7530757|NCT02641379|11874573|FG002|Overall Study|PCR positive at Week 68|0
7530758|NCT02641379|11874574|FG003|Overall Study|PCR positive at Week 68|0
7530759|NCT02641379|11874575|FG004|Overall Study|PCR positive at Week 68|0
7530760|NCT02641379|11874576|FG005|Overall Study|PCR positive at Week 68|0
7530761|NCT02641379|11874577|FG006|Overall Study|PCR positive at Week 68|0
7530762|NCT02641379|11874578|FG007|Overall Study|PCR positive at Week 68|0
7530763|NCT02641379|11874579|FG008|Overall Study|PCR positive at Week 68|0
7530764|NCT02641379|11874580|FG009|Overall Study|PCR positive at Week 68|0
7530765|NCT02641379|11874581|FG010|Overall Study|PCR positive at Week 68|0
7530766|NCT02641379|11874571|FG000|Overall Study|PCR positive at Week 48|0
7530767|NCT02641379|11874572|FG001|Overall Study|PCR positive at Week 48|1
7530768|NCT02641379|11874573|FG002|Overall Study|PCR positive at Week 48|0
7530769|NCT02641379|11874574|FG003|Overall Study|PCR positive at Week 48|0
7530770|NCT02641379|11874575|FG004|Overall Study|PCR positive at Week 48|0
7530771|NCT02641379|11874576|FG005|Overall Study|PCR positive at Week 48|0
7530772|NCT02641379|11874577|FG006|Overall Study|PCR positive at Week 48|0
7530773|NCT02641379|11874578|FG007|Overall Study|PCR positive at Week 48|0
7530774|NCT02641379|11874579|FG008|Overall Study|PCR positive at Week 48|0
7530775|NCT02641379|11874580|FG009|Overall Study|PCR positive at Week 48|0
7530776|NCT02641379|11874581|FG010|Overall Study|PCR positive at Week 48|0
7530777|NCT02641379|11874571|FG000|Overall Study|PCR not performed at Week 12|0
7530778|NCT02641379|11874572|FG001|Overall Study|PCR not performed at Week 12|0
7530779|NCT02641379|11874573|FG002|Overall Study|PCR not performed at Week 12|1
7530780|NCT02641379|11874574|FG003|Overall Study|PCR not performed at Week 12|0
7530781|NCT02641379|11874575|FG004|Overall Study|PCR not performed at Week 12|0
7530782|NCT02641379|11874576|FG005|Overall Study|PCR not performed at Week 12|0
7530783|NCT02641379|11874577|FG006|Overall Study|PCR not performed at Week 12|0
7530784|NCT02641379|11874578|FG007|Overall Study|PCR not performed at Week 12|0
7530785|NCT02641379|11874579|FG008|Overall Study|PCR not performed at Week 12|0
7530786|NCT02641379|11874580|FG009|Overall Study|PCR not performed at Week 12|0
7530787|NCT02641379|11874581|FG010|Overall Study|PCR not performed at Week 12|0
7530788|NCT02641379|11874571|FG000|Overall Study|No PCR at baseline|0
7530789|NCT02641379|11874572|FG001|Overall Study|No PCR at baseline|0
7530790|NCT02641379|11874573|FG002|Overall Study|No PCR at baseline|1
7530791|NCT02641379|11874574|FG003|Overall Study|No PCR at baseline|0
7530792|NCT02641379|11874575|FG004|Overall Study|No PCR at baseline|0
7530793|NCT02641379|11874576|FG005|Overall Study|No PCR at baseline|0
7530794|NCT02641379|11874577|FG006|Overall Study|No PCR at baseline|0
7530795|NCT02641379|11874578|FG007|Overall Study|No PCR at baseline|0
7530796|NCT02641379|11874579|FG008|Overall Study|No PCR at baseline|0
7530797|NCT02641379|11874580|FG009|Overall Study|No PCR at baseline|0
7530798|NCT02641379|11874581|FG010|Overall Study|No PCR at baseline|0
7530799|NCT02641379|11874571|FG000|Overall Study|PCR positive at Week 28|0
7554180|NCT03026283|11915663|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7554181|NCT03026283|11915664|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7554182|NCT03026283|11915665|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
7554183|NCT03026283|11915666|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7554184|NCT03026283|11915667|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
7554185|NCT03026283|11915668|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7554186|NCT03026283|11915669|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
7554187|NCT03026283|11915662|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7554188|NCT03026283|11915663|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7530800|NCT02641379|11874572|FG001|Overall Study|PCR positive at Week 28|0
7321827|NCT00753922|11552300|FG001|Overall Study|Discontinuation Due to Explantation|14
7530801|NCT02641379|11874573|FG002|Overall Study|PCR positive at Week 28|1
7530802|NCT02641379|11874574|FG003|Overall Study|PCR positive at Week 28|0
7530803|NCT02641379|11874575|FG004|Overall Study|PCR positive at Week 28|0
7530804|NCT02641379|11874576|FG005|Overall Study|PCR positive at Week 28|0
7530805|NCT02641379|11874577|FG006|Overall Study|PCR positive at Week 28|0
7530806|NCT02641379|11874578|FG007|Overall Study|PCR positive at Week 28|0
7530807|NCT02641379|11874579|FG008|Overall Study|PCR positive at Week 28|0
7530808|NCT02641379|11874580|FG009|Overall Study|PCR positive at Week 28|0
7530809|NCT02641379|11874581|FG010|Overall Study|PCR positive at Week 28|0
7530810|NCT02641379|11874571|FG000|Overall Study|PCR sample for Week 4 not drawn|0
7530811|NCT02641379|11874572|FG001|Overall Study|PCR sample for Week 4 not drawn|0
7530812|NCT02641379|11874573|FG002|Overall Study|PCR sample for Week 4 not drawn|0
7530813|NCT02641379|11874574|FG003|Overall Study|PCR sample for Week 4 not drawn|1
7530814|NCT02641379|11874575|FG004|Overall Study|PCR sample for Week 4 not drawn|0
7530815|NCT02641379|11874576|FG005|Overall Study|PCR sample for Week 4 not drawn|0
7530816|NCT02641379|11874577|FG006|Overall Study|PCR sample for Week 4 not drawn|0
7530817|NCT02641379|11874578|FG007|Overall Study|PCR sample for Week 4 not drawn|0
7530818|NCT02641379|11874579|FG008|Overall Study|PCR sample for Week 4 not drawn|0
7530819|NCT02641379|11874580|FG009|Overall Study|PCR sample for Week 4 not drawn|0
7530820|NCT02641379|11874581|FG010|Overall Study|PCR sample for Week 4 not drawn|0
7530821|NCT02641379|11874571|FG000|Overall Study|Inclusion criteria not fulfilled|0
7530822|NCT02641379|11874572|FG001|Overall Study|Inclusion criteria not fulfilled|0
7530823|NCT02641379|11874573|FG002|Overall Study|Inclusion criteria not fulfilled|0
7530824|NCT02641379|11874574|FG003|Overall Study|Inclusion criteria not fulfilled|1
7530825|NCT02641379|11874575|FG004|Overall Study|Inclusion criteria not fulfilled|0
7530826|NCT02641379|11874576|FG005|Overall Study|Inclusion criteria not fulfilled|0
7530827|NCT02641379|11874577|FG006|Overall Study|Inclusion criteria not fulfilled|0
7530828|NCT02641379|11874578|FG007|Overall Study|Inclusion criteria not fulfilled|0
7530829|NCT02641379|11874579|FG008|Overall Study|Inclusion criteria not fulfilled|0
7530830|NCT02641379|11874580|FG009|Overall Study|Inclusion criteria not fulfilled|0
7530831|NCT02641379|11874581|FG010|Overall Study|Inclusion criteria not fulfilled|0
7530832|NCT02641379|11874571|FG000|Overall Study|Baseline viral load unavailable|0
7530833|NCT02641379|11874572|FG001|Overall Study|Baseline viral load unavailable|0
7530834|NCT02641379|11874573|FG002|Overall Study|Baseline viral load unavailable|0
7530835|NCT02641379|11874574|FG003|Overall Study|Baseline viral load unavailable|1
7530836|NCT02641379|11874575|FG004|Overall Study|Baseline viral load unavailable|0
7530837|NCT02641379|11874576|FG005|Overall Study|Baseline viral load unavailable|0
7530838|NCT02641379|11874577|FG006|Overall Study|Baseline viral load unavailable|0
7530839|NCT02641379|11874578|FG007|Overall Study|Baseline viral load unavailable|0
7530840|NCT02641379|11874579|FG008|Overall Study|Baseline viral load unavailable|0
7530841|NCT02641379|11874580|FG009|Overall Study|Baseline viral load unavailable|0
7530842|NCT02641379|11874581|FG010|Overall Study|Baseline viral load unavailable|0
7530843|NCT02641379|11874571|FG000|Overall Study|Blood could not be drawn|0
7530844|NCT02641379|11874572|FG001|Overall Study|Blood could not be drawn|0
7530845|NCT02641379|11874573|FG002|Overall Study|Blood could not be drawn|0
7530846|NCT02641379|11874574|FG003|Overall Study|Blood could not be drawn|0
7530847|NCT02641379|11874575|FG004|Overall Study|Blood could not be drawn|1
7554189|NCT03026283|11915664|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7321828|NCT00753922|11552301|FG002|Overall Study|Discontinuation Due to Explantation|14
7321829|NCT00753922|11552302|FG003|Overall Study|Discontinuation Due to Explantation|4
7321830|NCT00754065|11552336|FG000|Overall Study|Never received treatment|12
7321831|NCT00754065|11552337|FG001|Overall Study|Never received treatment|2
7321832|NCT00754065|11552336|FG000|Overall Study|Adverse Event|19
7321833|NCT00754065|11552337|FG001|Overall Study|Adverse Event|25
7321834|NCT00754065|11552336|FG000|Overall Study|Lost to Follow-up|7
7321835|NCT00754065|11552337|FG001|Overall Study|Lost to Follow-up|11
7321836|NCT00754065|11552336|FG000|Overall Study|Protocol Violation|12
7321837|NCT00754065|11552337|FG001|Overall Study|Protocol Violation|10
7321838|NCT00754065|11552336|FG000|Overall Study|Withdrawal by Subject|4
7321839|NCT00754065|11552337|FG001|Overall Study|Withdrawal by Subject|5
7321840|NCT00754065|11552336|FG000|Overall Study|Pregnancy|6
7321841|NCT00754065|11552337|FG001|Overall Study|Pregnancy|0
7321842|NCT00754065|11552336|FG000|Overall Study|Reason not specified or unknown, etc.|21
7321843|NCT00754065|11552337|FG001|Overall Study|Reason not specified or unknown, etc.|27
7321844|NCT00754234|11552390|FG000|Overall Study|Withdrawal by Subject|3
7321845|NCT00754325|11552409|FG000|Initial Treatment|Continuing Active Treatment|4
7321846|NCT00754325|11552410|FG001|Initial Treatment|Continuing Active Treatment|5
7321847|NCT00754325|11552409|FG000|Initial Treatment|Adverse Event|7
7321848|NCT00754325|11552410|FG001|Initial Treatment|Adverse Event|6
7554190|NCT03026283|11915665|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
7554191|NCT03026283|11915666|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7554192|NCT03026283|11915667|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7554193|NCT03026283|11915668|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7554194|NCT03026283|11915669|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
7321849|NCT00754325|11552409|FG000|Initial Treatment|Withdrawal by Subject|2
7321850|NCT00754325|11552410|FG001|Initial Treatment|Withdrawal by Subject|2
7321851|NCT00754325|11552409|FG000|Initial Treatment|Physician Decision|2
7574583|NCT03683719|11957508|FG003|Overall Study|Withdrawal by Subject|5
7321852|NCT00754325|11552410|FG001|Initial Treatment|Physician Decision|0
7321853|NCT00754325|11552409|FG000|Initial Treatment|Sponsor Request|0
7321854|NCT00754325|11552410|FG001|Initial Treatment|Sponsor Request|1
7321855|NCT00754325|11552409|FG000|Initial Treatment|Disease Progression|35
7321856|NCT00754325|11552410|FG001|Initial Treatment|Disease Progression|35
7321857|NCT00754338|11552421|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7321858|NCT00754338|11552422|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7321859|NCT00754338|11552423|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
7321860|NCT00754338|11552424|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
7321861|NCT00754338|11552421|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7321862|NCT00754338|11552422|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7321863|NCT00754338|11552423|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
7321864|NCT00754338|11552424|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
7321865|NCT00754390|11552447|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
7321866|NCT00754390|11552447|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
7321867|NCT00754390|11552447|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
7321868|NCT00754390|11552447|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
7321869|NCT00754442|11552456|FG000|Overall Study|Withdrawal by Subject|5
7321870|NCT00754442|11552457|FG001|Overall Study|Withdrawal by Subject|3
7321871|NCT00754559|11552498|FG000|Overall Study|Adverse Event|15
7321872|NCT00754559|11552498|FG000|Overall Study|Protocol Violation|11
7321873|NCT00754559|11552498|FG000|Overall Study|Lack of Efficacy|10
7321874|NCT00754559|11552498|FG000|Overall Study|Lost to Follow-up|2
7321875|NCT00754559|11552498|FG000|Overall Study|Administrative reason|1
7415988|NCT01446237|11689395|FG000|Overall Study|Withdrawal by Subject|7
7415989|NCT01446289|11689403|FG000|Overall Study|Withdrawal by Subject|1
7415990|NCT01446289|11689404|FG001|Overall Study|Withdrawal by Subject|0
7415991|NCT01446289|11689405|FG002|Overall Study|Withdrawal by Subject|1
7415992|NCT01446289|11689406|FG003|Overall Study|Withdrawal by Subject|0
7415993|NCT01446419|11689420|FG000|Overall Study|Death|1
7415994|NCT01446419|11689421|FG001|Overall Study|Death|0
7415995|NCT01446419|11689420|FG000|Overall Study|Withdrawal by Subject|1
7415996|NCT01446419|11689421|FG001|Overall Study|Withdrawal by Subject|1
7415997|NCT01446419|11689420|FG000|Overall Study|Terminated per protocol|3
7530848|NCT02641379|11874576|FG005|Overall Study|Blood could not be drawn|0
7530849|NCT02641379|11874577|FG006|Overall Study|Blood could not be drawn|0
7530850|NCT02641379|11874578|FG007|Overall Study|Blood could not be drawn|0
7554195|NCT03026283|11915662|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7415998|NCT01446419|11689421|FG001|Overall Study|Terminated per protocol|0
7415999|NCT01446809|11689453|FG000|Overall Study|Adverse Event|0
7416000|NCT01446809|11689454|FG001|Overall Study|Adverse Event|0
7416001|NCT01446809|11689455|FG002|Overall Study|Adverse Event|1
7416002|NCT01446809|11689453|FG000|Overall Study|Failure to complete study procedures|0
7416003|NCT01446809|11689454|FG001|Overall Study|Failure to complete study procedures|0
7416004|NCT01446809|11689455|FG002|Overall Study|Failure to complete study procedures|1
7416005|NCT01446874|11689467|FG000|Overall Study|Not eligible|1
7416006|NCT01446874|11689468|FG001|Overall Study|Not eligible|0
7416007|NCT01446874|11689469|FG002|Overall Study|Not eligible|0
7416008|NCT01446874|11689467|FG000|Overall Study|No surgery/No qualifying surgery|1
7416009|NCT01446874|11689468|FG001|Overall Study|No surgery/No qualifying surgery|0
7416010|NCT01446874|11689469|FG002|Overall Study|No surgery/No qualifying surgery|12
7416011|NCT01446874|11689467|FG000|Overall Study|Non-compliance|0
7416012|NCT01446874|11689468|FG001|Overall Study|Non-compliance|4
7416013|NCT01446874|11689469|FG002|Overall Study|Non-compliance|0
7416014|NCT01446874|11689467|FG000|Overall Study|Antibiotics for pre-op infection|0
7416015|NCT01446874|11689468|FG001|Overall Study|Antibiotics for pre-op infection|0
7416016|NCT01446874|11689469|FG002|Overall Study|Antibiotics for pre-op infection|2
7416017|NCT01446874|11689467|FG000|Overall Study|Withdrawal by Subject|0
7416018|NCT01446874|11689468|FG001|Overall Study|Withdrawal by Subject|0
7554196|NCT03026283|11915663|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7554197|NCT03026283|11915664|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7554198|NCT03026283|11915665|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7554199|NCT03026283|11915666|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
7554200|NCT03026283|11915667|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
7554201|NCT03026283|11915668|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7574584|NCT03683719|11957509|FG004|Overall Study|Withdrawal by Subject|5
7416019|NCT01446874|11689469|FG002|Overall Study|Withdrawal by Subject|4
7416020|NCT01446913|11689480|FG000|Overall Study|Significant illness|1
7416021|NCT01446913|11689481|FG001|Overall Study|Significant illness|1
7416022|NCT01446913|11689482|FG002|Overall Study|Significant illness|1
7530851|NCT02641379|11874579|FG008|Overall Study|Blood could not be drawn|0
7416023|NCT01446913|11689480|FG000|Overall Study|Withdrawal by Subject|5
7416024|NCT01446913|11689481|FG001|Overall Study|Withdrawal by Subject|3
7530852|NCT02641379|11874580|FG009|Overall Study|Blood could not be drawn|0
7416025|NCT01446913|11689482|FG002|Overall Study|Withdrawal by Subject|5
7530853|NCT02641379|11874581|FG010|Overall Study|Blood could not be drawn|0
7530854|NCT02641379|11874571|FG000|Overall Study|Protocol Violation|0
7530855|NCT02641379|11874572|FG001|Overall Study|Protocol Violation|0
7321876|NCT00754559|11552498|FG000|Overall Study|Other|5
7321877|NCT00754559|11552498|FG000|Overall Study|Withdrawal by Subject|3
7416026|NCT01446913|11689480|FG000|Overall Study|Physician Decision|0
7416027|NCT01446913|11689481|FG001|Overall Study|Physician Decision|0
7416028|NCT01446913|11689482|FG002|Overall Study|Physician Decision|2
7416029|NCT01446913|11689480|FG000|Overall Study|Lost to Follow-up|3
7416030|NCT01446913|11689481|FG001|Overall Study|Lost to Follow-up|5
7416031|NCT01446913|11689482|FG002|Overall Study|Lost to Follow-up|3
7416032|NCT01446965|11689498|FG000|Randominization|One site was dismissed due to IRB irregularity|30
7416033|NCT01446965|11689499|FG001|Randominization|One site was dismissed due to IRB irregularity|16
7416034|NCT01446965|11689498|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
7416035|NCT01446965|11689499|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
7416036|NCT01447407|11689568|FG000|Overall Study|Withdrawal by Subject|2
7416037|NCT01447407|11689569|FG001|Overall Study|Withdrawal by Subject|0
7416038|NCT01447407|11689570|FG002|Overall Study|Withdrawal by Subject|0
7416039|NCT01447407|11689571|FG003|Overall Study|Withdrawal by Subject|1
7416040|NCT01447407|11689568|FG000|Overall Study|Physician Decision|0
7416041|NCT01447407|11689569|FG001|Overall Study|Physician Decision|0
7416042|NCT01447407|11689570|FG002|Overall Study|Physician Decision|1
7416043|NCT01447407|11689571|FG003|Overall Study|Physician Decision|1
7416044|NCT01447420|11689584|FG000|Overall Study|Adverse Event|2
7416045|NCT01447420|11689585|FG001|Overall Study|Adverse Event|4
7416046|NCT01447420|11689586|FG002|Overall Study|Adverse Event|2
7416047|NCT01447420|11689584|FG000|Overall Study|Protocol Violation|3
7416048|NCT01447420|11689585|FG001|Overall Study|Protocol Violation|3
7416049|NCT01447420|11689586|FG002|Overall Study|Protocol Violation|0
7416050|NCT01447420|11689584|FG000|Overall Study|Withdrawal by Subject|4
7416051|NCT01447420|11689585|FG001|Overall Study|Withdrawal by Subject|1
7416052|NCT01447420|11689586|FG002|Overall Study|Withdrawal by Subject|0
7416053|NCT01447420|11689584|FG000|Overall Study|Lack of Efficacy|1
7416054|NCT01447420|11689585|FG001|Overall Study|Lack of Efficacy|19
7416055|NCT01447420|11689586|FG002|Overall Study|Lack of Efficacy|8
7416056|NCT01447433|11689595|FG000|Overall Study|Lost to Follow-up|0
7416057|NCT01447433|11689596|FG001|Overall Study|Lost to Follow-up|2
7416058|NCT01447433|11689595|FG000|Overall Study|Withdrawal by Subject|3
7416059|NCT01447433|11689596|FG001|Overall Study|Withdrawal by Subject|3
7416060|NCT01447433|11689595|FG000|Overall Study|Protocol Violation|1
7416061|NCT01447433|11689596|FG001|Overall Study|Protocol Violation|1
7416062|NCT01447446|11689608|FG000|Overall Study|Death|6
7416063|NCT01447446|11689609|FG001|Overall Study|Death|3
7416064|NCT01447446|11689610|FG002|Overall Study|Death|2
7416065|NCT01447446|11689611|FG003|Overall Study|Death|1
7416066|NCT01447446|11689612|FG004|Overall Study|Death|7
7416067|NCT01447446|11689613|FG005|Overall Study|Death|0
7416068|NCT01447446|11689608|FG000|Overall Study|Adverse Event|3
7416069|NCT01447446|11689609|FG001|Overall Study|Adverse Event|0
7416070|NCT01447446|11689610|FG002|Overall Study|Adverse Event|1
7416071|NCT01447446|11689611|FG003|Overall Study|Adverse Event|0
7416072|NCT01447446|11689612|FG004|Overall Study|Adverse Event|2
7416073|NCT01447446|11689613|FG005|Overall Study|Adverse Event|0
7416074|NCT01447446|11689608|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
7416075|NCT01447446|11689609|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
7416076|NCT01447446|11689610|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
7416077|NCT01447446|11689611|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
7416078|NCT01447446|11689612|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
7416079|NCT01447446|11689613|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
7416080|NCT01447446|11689608|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
7416081|NCT01447446|11689609|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
7416082|NCT01447446|11689610|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
7416083|NCT01447446|11689611|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
7416084|NCT01447446|11689612|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
7416085|NCT01447446|11689613|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
7416086|NCT01447446|11689608|FG000|Overall Study|Administrative/Other|34
7416087|NCT01447446|11689609|FG001|Overall Study|Administrative/Other|9
7416088|NCT01447446|11689610|FG002|Overall Study|Administrative/Other|10
7416089|NCT01447446|11689611|FG003|Overall Study|Administrative/Other|2
7416090|NCT01447446|11689612|FG004|Overall Study|Administrative/Other|33
7416091|NCT01447446|11689613|FG005|Overall Study|Administrative/Other|4
7416092|NCT01447446|11689608|FG000|Overall Study|SVR12 Assessment|13
7416093|NCT01447446|11689609|FG001|Overall Study|SVR12 Assessment|1
7416094|NCT01447446|11689610|FG002|Overall Study|SVR12 Assessment|2
7554202|NCT03026283|11915669|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
7554203|NCT03026530|11915684|FG000|Overall Study|Lost to Follow-up|19
7554204|NCT03026530|11915685|FG001|Overall Study|Lost to Follow-up|24
7416095|NCT01447446|11689611|FG003|Overall Study|SVR12 Assessment|1
7416096|NCT01447446|11689612|FG004|Overall Study|SVR12 Assessment|5
7416097|NCT01447446|11689613|FG005|Overall Study|SVR12 Assessment|5
7416098|NCT01447446|11689608|FG000|Overall Study|New Treatment Started|8
7416099|NCT01447446|11689609|FG001|Overall Study|New Treatment Started|2
7416100|NCT01447446|11689610|FG002|Overall Study|New Treatment Started|1
7416101|NCT01447446|11689611|FG003|Overall Study|New Treatment Started|0
7416102|NCT01447446|11689612|FG004|Overall Study|New Treatment Started|2
7416103|NCT01447446|11689613|FG005|Overall Study|New Treatment Started|0
7321878|NCT00754572|11552505|FG000|Overall Study|Adverse Event|19
7321879|NCT00754572|11552505|FG000|Overall Study|Other|39
7321880|NCT00754572|11552505|FG000|Overall Study|Protocol Violation|3
7530856|NCT02641379|11874573|FG002|Overall Study|Protocol Violation|0
7530857|NCT02641379|11874574|FG003|Overall Study|Protocol Violation|0
7321881|NCT00754572|11552505|FG000|Overall Study|Withdrawal by Subject|3
7321882|NCT00754572|11552505|FG000|Overall Study|Lack of Efficacy|2
7321883|NCT00754572|11552505|FG000|Overall Study|Death|1
7321884|NCT00754572|11552505|FG000|Overall Study|Administrative Reason|3
7321885|NCT00754572|11552505|FG000|Overall Study|Lost to Follow-up|1
7384782|NCT01197300|11642213|FG000|Overall Study|Protocol Violation|0
7384783|NCT01197300|11642214|FG001|Overall Study|Protocol Violation|1
7384784|NCT01197378|11642231|FG000|Overall Study|Adverse Event|3
7384785|NCT01197378|11642231|FG000|Overall Study|Withdrawal by Subject|1
7384786|NCT01197378|11642231|FG000|Overall Study|Physician Decision|1
7384787|NCT01197378|11642231|FG000|Overall Study|Other|2
7530858|NCT02641379|11874575|FG004|Overall Study|Protocol Violation|2
7384788|NCT01197417|11642237|FG000|Overall Study|Physician Decision|3
7384789|NCT01197417|11642238|FG001|Overall Study|Physician Decision|2
7384790|NCT01197417|11642237|FG000|Overall Study|Withdrawal by Subject|2
7384791|NCT01197417|11642238|FG001|Overall Study|Withdrawal by Subject|4
7384792|NCT01197417|11642237|FG000|Overall Study|Site miscommunication|0
7384793|NCT01197417|11642238|FG001|Overall Study|Site miscommunication|1
7384794|NCT01197417|11642237|FG000|Overall Study|Subject transferred to intensive care|0
7530886|NCT02641379|11874581|FG010|Overall Study|Lost to Follow-up|0
7384795|NCT01197417|11642238|FG001|Overall Study|Subject transferred to intensive care|1
7384796|NCT01197417|11642237|FG000|Overall Study|Not consented in time to receive drug|0
7384797|NCT01197417|11642238|FG001|Overall Study|Not consented in time to receive drug|1
7384798|NCT01197417|11642237|FG000|Overall Study|Hypotension|1
7384799|NCT01197417|11642238|FG001|Overall Study|Hypotension|2
7384800|NCT01197417|11642237|FG000|Overall Study|Found to be ineligible|2
7384801|NCT01197417|11642238|FG001|Overall Study|Found to be ineligible|5
7384802|NCT01197417|11642237|FG000|Overall Study|No 25-hour magnesium level|0
7384803|NCT01197417|11642238|FG001|Overall Study|No 25-hour magnesium level|2
7384804|NCT01197508|11642266|FG000|Overall Study|Withdrawal by Subject|8
7384805|NCT01197508|11642267|FG001|Overall Study|Withdrawal by Subject|7
7384806|NCT01197508|11642268|FG002|Overall Study|Withdrawal by Subject|15
7384807|NCT01197508|11642269|FG003|Overall Study|Withdrawal by Subject|4
7384808|NCT01197508|11642266|FG000|Overall Study|Eligiblity criteria not fulfilled|0
7384809|NCT01197508|11642267|FG001|Overall Study|Eligiblity criteria not fulfilled|0
7384810|NCT01197508|11642268|FG002|Overall Study|Eligiblity criteria not fulfilled|2
7384811|NCT01197508|11642269|FG003|Overall Study|Eligiblity criteria not fulfilled|0
7384812|NCT01197508|11642266|FG000|Overall Study|Adverse Event|10
7384813|NCT01197508|11642267|FG001|Overall Study|Adverse Event|13
7384814|NCT01197508|11642268|FG002|Overall Study|Adverse Event|23
7384815|NCT01197508|11642269|FG003|Overall Study|Adverse Event|3
7384816|NCT01197508|11642266|FG000|Overall Study|Severe non-compliance to protocol|0
7384817|NCT01197508|11642267|FG001|Overall Study|Severe non-compliance to protocol|3
7384818|NCT01197508|11642268|FG002|Overall Study|Severe non-compliance to protocol|1
7384819|NCT01197508|11642269|FG003|Overall Study|Severe non-compliance to protocol|3
7384820|NCT01197508|11642266|FG000|Overall Study|Condition under investigation worsened|1
7384821|NCT01197508|11642267|FG001|Overall Study|Condition under investigation worsened|1
7384822|NCT01197508|11642268|FG002|Overall Study|Condition under investigation worsened|1
7530859|NCT02641379|11874576|FG005|Overall Study|Protocol Violation|0
7554205|NCT03026530|11915684|FG000|Overall Study|Protocol Violation|2
7554206|NCT03026530|11915685|FG001|Overall Study|Protocol Violation|5
7384823|NCT01197508|11642269|FG003|Overall Study|Condition under investigation worsened|1
7384824|NCT01197508|11642266|FG000|Overall Study|Lack of Efficacy|1
7384825|NCT01197508|11642267|FG001|Overall Study|Lack of Efficacy|2
7384826|NCT01197508|11642268|FG002|Overall Study|Lack of Efficacy|2
7384827|NCT01197508|11642269|FG003|Overall Study|Lack of Efficacy|1
7530860|NCT02641379|11874577|FG006|Overall Study|Protocol Violation|0
7530861|NCT02641379|11874578|FG007|Overall Study|Protocol Violation|0
7530862|NCT02641379|11874579|FG008|Overall Study|Protocol Violation|1
7530863|NCT02641379|11874580|FG009|Overall Study|Protocol Violation|0
7530864|NCT02641379|11874581|FG010|Overall Study|Protocol Violation|0
7530865|NCT02641379|11874571|FG000|Overall Study|Participation in sili rescue study|0
7530866|NCT02641379|11874572|FG001|Overall Study|Participation in sili rescue study|0
7530867|NCT02641379|11874573|FG002|Overall Study|Participation in sili rescue study|0
7530868|NCT02641379|11874574|FG003|Overall Study|Participation in sili rescue study|0
7530869|NCT02641379|11874575|FG004|Overall Study|Participation in sili rescue study|0
7530870|NCT02641379|11874576|FG005|Overall Study|Participation in sili rescue study|1
7530871|NCT02641379|11874577|FG006|Overall Study|Participation in sili rescue study|0
7530872|NCT02641379|11874578|FG007|Overall Study|Participation in sili rescue study|0
7530873|NCT02641379|11874579|FG008|Overall Study|Participation in sili rescue study|0
7530874|NCT02641379|11874580|FG009|Overall Study|Participation in sili rescue study|0
7530875|NCT02641379|11874581|FG010|Overall Study|Participation in sili rescue study|0
7530876|NCT02641379|11874571|FG000|Overall Study|Lost to Follow-up|0
7530877|NCT02641379|11874572|FG001|Overall Study|Lost to Follow-up|0
7530878|NCT02641379|11874573|FG002|Overall Study|Lost to Follow-up|0
7530879|NCT02641379|11874574|FG003|Overall Study|Lost to Follow-up|0
7530880|NCT02641379|11874575|FG004|Overall Study|Lost to Follow-up|0
7321886|NCT00754624|11552509|FG000|Overall Study|Adverse Event|16
7321887|NCT00754624|11552509|FG000|Overall Study|Death|1
7321888|NCT00754624|11552509|FG000|Overall Study|Physician Decision|8
7321889|NCT00754624|11552509|FG000|Overall Study|Protocol Violation|1
7321890|NCT00754624|11552509|FG000|Overall Study|Withdrawal by Subject|28
7321891|NCT00754624|11552509|FG000|Overall Study|Various|12
7321892|NCT00754624|11552509|FG000|Overall Study|Lost to Follow-up|3
7321893|NCT00754650|11552513|FG000|Overall Study|Disease Progression|2
7321894|NCT00754741|11552520|FG000|Overall Study|Died or disenrolled|57
7321895|NCT00754741|11552521|FG001|Overall Study|Died or disenrolled|69
7321896|NCT00754741|11552522|FG002|Overall Study|Died or disenrolled|54
7321897|NCT00754936|11552552|FG000|Overall Study|Lost to Follow-up|3
7321898|NCT00754936|11552552|FG000|Overall Study|Physician Decision|1
7554207|NCT03027466|11915722|FG000|Overall Study|Opting out of the app|1869
7554208|NCT03027466|11915723|FG001|Overall Study|Opting out of the app|1819
7554209|NCT03027466|11915724|FG002|Overall Study|Opting out of the app|1743
7554210|NCT03027466|11915725|FG003|Overall Study|Opting out of the app|1821
7554211|NCT03027557|11915738|FG000|Overall Study|Adverse Event|1
7554212|NCT03027557|11915739|FG001|Overall Study|Adverse Event|0
7554213|NCT03027557|11915740|FG002|Overall Study|Adverse Event|0
7530881|NCT02641379|11874576|FG005|Overall Study|Lost to Follow-up|0
7530882|NCT02641379|11874577|FG006|Overall Study|Lost to Follow-up|0
7530883|NCT02641379|11874578|FG007|Overall Study|Lost to Follow-up|0
7530884|NCT02641379|11874579|FG008|Overall Study|Lost to Follow-up|1
7530885|NCT02641379|11874580|FG009|Overall Study|Lost to Follow-up|0
7554214|NCT03028012|11915760|FG000|Overall Study|Lost to Follow-up|2
7554215|NCT03028012|11915761|FG001|Overall Study|Lost to Follow-up|3
7321899|NCT00754936|11552552|FG000|Overall Study|Withdrawal by Subject|2
7321900|NCT00754936|11552552|FG000|Overall Study|Side Effects|3
7321901|NCT00754936|11552552|FG000|Overall Study|Inter-current medical events|3
7321902|NCT00755079|11552567|FG000|Overall Study|Lost to Follow-up|1
7321903|NCT00755079|11552568|FG001|Overall Study|Lost to Follow-up|3
7321904|NCT00755079|11552567|FG000|Overall Study|Adverse Event|0
7530887|NCT02641379|11874571|FG000|Overall Study|Source data not found|0
7554216|NCT03028012|11915762|FG002|Overall Study|Lost to Follow-up|3
7554217|NCT03028129|11915795|FG000|Overall Study|Adverse Event|13
7554218|NCT03028129|11915796|FG001|Overall Study|Adverse Event|2
7554219|NCT03028129|11915795|FG000|Overall Study|Lost to Follow-up|50
7554220|NCT03028129|11915796|FG001|Overall Study|Lost to Follow-up|38
7554221|NCT03028129|11915795|FG000|Overall Study|Physician Decision|0
7554222|NCT03028129|11915796|FG001|Overall Study|Physician Decision|1
7554223|NCT03028129|11915795|FG000|Overall Study|Protocol Violation|1
7554224|NCT03028129|11915796|FG001|Overall Study|Protocol Violation|1
7554225|NCT03028129|11915795|FG000|Overall Study|Withdrawal by Subject|62
7554226|NCT03028129|11915796|FG001|Overall Study|Withdrawal by Subject|45
7554227|NCT03028142|11915802|FG000|Overall Study|Adverse Event|1
7554228|NCT03028142|11915803|FG001|Overall Study|Adverse Event|1
7554229|NCT03028142|11915804|FG002|Overall Study|Adverse Event|0
7554230|NCT03028142|11915805|FG003|Overall Study|Adverse Event|0
7554231|NCT03028142|11915806|FG004|Overall Study|Adverse Event|0
7554232|NCT03028142|11915807|FG005|Overall Study|Adverse Event|1
7554233|NCT03028142|11915802|FG000|Overall Study|Withdrawal by Subject|0
7554234|NCT03028142|11915803|FG001|Overall Study|Withdrawal by Subject|0
7554235|NCT03028142|11915804|FG002|Overall Study|Withdrawal by Subject|0
7554236|NCT03028142|11915805|FG003|Overall Study|Withdrawal by Subject|0
7554237|NCT03028142|11915806|FG004|Overall Study|Withdrawal by Subject|1
7554238|NCT03028142|11915807|FG005|Overall Study|Withdrawal by Subject|0
7554239|NCT03028415|11915840|FG000|Overall Study|Lost to Follow-up|6
7554240|NCT03028415|11915841|FG001|Overall Study|Lost to Follow-up|3
7554241|NCT03028415|11915840|FG000|Overall Study|Withdrawal by Subject|1
7554242|NCT03028415|11915841|FG001|Overall Study|Withdrawal by Subject|0
7554243|NCT03028415|11915840|FG000|Overall Study|Discontinued due to COVID-19|1
7554244|NCT03028415|11915841|FG001|Overall Study|Discontinued due to COVID-19|0
7554245|NCT03028870|11915881|FG000|Overall Study|Adverse Event|7
7554246|NCT03028870|11915882|FG001|Overall Study|Adverse Event|4
7554247|NCT03028870|11915883|FG002|Overall Study|Adverse Event|3
7554248|NCT03028870|11915884|FG003|Overall Study|Adverse Event|3
7554249|NCT03028870|11915881|FG000|Overall Study|Withdrawal by Subject|1
7554250|NCT03028870|11915882|FG001|Overall Study|Withdrawal by Subject|1
7554251|NCT03028870|11915883|FG002|Overall Study|Withdrawal by Subject|1
7554252|NCT03028870|11915884|FG003|Overall Study|Withdrawal by Subject|2
7554253|NCT03028870|11915881|FG000|Overall Study|Lost to Follow-up|1
7554254|NCT03028870|11915882|FG001|Overall Study|Lost to Follow-up|0
7554255|NCT03028870|11915883|FG002|Overall Study|Lost to Follow-up|0
7554256|NCT03028870|11915884|FG003|Overall Study|Lost to Follow-up|0
7554257|NCT03028870|11915881|FG000|Overall Study|Lack of Efficacy|3
7554258|NCT03028870|11915882|FG001|Overall Study|Lack of Efficacy|0
7554259|NCT03028870|11915883|FG002|Overall Study|Lack of Efficacy|0
7530888|NCT02641379|11874572|FG001|Overall Study|Source data not found|0
7530889|NCT02641379|11874573|FG002|Overall Study|Source data not found|0
7554260|NCT03028870|11915884|FG003|Overall Study|Lack of Efficacy|0
7554261|NCT03028870|11915881|FG000|Overall Study|Administrative|5
7554262|NCT03028870|11915882|FG001|Overall Study|Administrative|5
7321905|NCT00755079|11552568|FG001|Overall Study|Adverse Event|1
7530890|NCT02641379|11874574|FG003|Overall Study|Source data not found|0
7321906|NCT00755079|11552567|FG000|Overall Study|Withdrawal by Subject|0
7321907|NCT00755079|11552568|FG001|Overall Study|Withdrawal by Subject|2
7321908|NCT00755105|11552577|FG000|Overall Study|Withdrawal by Subject|9
7321909|NCT00755105|11552578|FG001|Overall Study|Withdrawal by Subject|11
7321910|NCT00755105|11552579|FG002|Overall Study|Withdrawal by Subject|4
7321911|NCT00755183|11552598|FG000|Overall Study|Adverse Event|5
7321912|NCT00755183|11552599|FG001|Overall Study|Adverse Event|2
7321913|NCT00755183|11552598|FG000|Overall Study|Protocol Violation|0
7321914|NCT00755183|11552599|FG001|Overall Study|Protocol Violation|1
7321915|NCT00755183|11552598|FG000|Overall Study|Withdrawal by Subject|0
7321916|NCT00755183|11552599|FG001|Overall Study|Withdrawal by Subject|2
7321917|NCT00755183|11552598|FG000|Overall Study|Administrative|2
7321918|NCT00755183|11552599|FG001|Overall Study|Administrative|1
7321919|NCT00755196|11552607|FG000|Overall Study|Lost to Follow-up|1
7321920|NCT00755196|11552607|FG000|Overall Study|Lack of Efficiency|1
7321921|NCT00755222|11552614|FG000|Overall Study|Withdrawal by Subject|4
7321922|NCT00755222|11552615|FG001|Overall Study|Withdrawal by Subject|2
7321923|NCT00755222|11552614|FG000|Overall Study|Adverse Event|2
7321924|NCT00755222|11552615|FG001|Overall Study|Adverse Event|0
7321925|NCT00755222|11552614|FG000|Overall Study|Protocol Violation|2
7416104|NCT01447446|11689608|FG000|Overall Study|Reason not Specified|1
7416105|NCT01447446|11689609|FG001|Overall Study|Reason not Specified|1
7416106|NCT01447446|11689610|FG002|Overall Study|Reason not Specified|1
7416107|NCT01447446|11689611|FG003|Overall Study|Reason not Specified|1
7416108|NCT01447446|11689612|FG004|Overall Study|Reason not Specified|1
7416109|NCT01447446|11689613|FG005|Overall Study|Reason not Specified|0
7416110|NCT01447576|11689654|FG000|Overall Study|Lost to Follow-up|52
7416111|NCT01447576|11689654|FG000|Overall Study|Adverse Event|127
7416112|NCT01447576|11689654|FG000|Overall Study|Participant met withdrawal criteria|40
7416113|NCT01447576|11689654|FG000|Overall Study|Withdrawal by Subject|100
7416114|NCT01447576|11689654|FG000|Overall Study|Protocol deviation|83
7416115|NCT01447576|11689654|FG000|Overall Study|Lack of Efficacy|68
7416116|NCT01447576|11689654|FG000|Overall Study|Physician Decision|6
7416117|NCT01447719|11689671|FG000|Overall Study|Image acquisition failure|2
7416118|NCT01447719|11689671|FG000|Overall Study|Invalid image or not imaged|3
7416119|NCT01447719|11689671|FG000|Overall Study|Subject still living at end of study|79
7416120|NCT01447719|11689671|FG000|Overall Study|Withdrawal by Subject|2
7416121|NCT01447719|11689671|FG000|Overall Study|Family withdrew autopsy consent|7
7416122|NCT01447927|11689712|FG000|Overall Study|Adverse Event|4
7416123|NCT01447927|11689713|FG001|Overall Study|Adverse Event|3
7416124|NCT01447927|11689712|FG000|Overall Study|Withdrawal by Subject|1
7416125|NCT01447927|11689713|FG001|Overall Study|Withdrawal by Subject|0
7416126|NCT01448044|11689721|FG000|Treatment Period|Adverse Event|4
7416127|NCT01448044|11689722|FG001|Treatment Period|Adverse Event|3
7416128|NCT01448044|11689721|FG000|Treatment Period|Lack of Efficacy|5
7416129|NCT01448044|11689722|FG001|Treatment Period|Lack of Efficacy|12
7416130|NCT01448044|11689721|FG000|Treatment Period|Subject requested discontinue study drug|1
7416131|NCT01448044|11689722|FG001|Treatment Period|Subject requested discontinue study drug|0
7416132|NCT01448044|11689721|FG000|Treatment Period|Completed 24 weeks treatment period only|8
7416133|NCT01448044|11689722|FG001|Treatment Period|Completed 24 weeks treatment period only|0
7416134|NCT01448044|11689721|FG000|Treatment Period|Participant does not meet study criteria|1
7416135|NCT01448044|11689722|FG001|Treatment Period|Participant does not meet study criteria|0
7416136|NCT01448044|11689721|FG000|Treatment Period|Lost to Follow-up|2
7416137|NCT01448044|11689722|FG001|Treatment Period|Lost to Follow-up|1
7416138|NCT01448044|11689721|FG000|Treatment Period|Other reason|2
7416139|NCT01448044|11689722|FG001|Treatment Period|Other reason|0
7416140|NCT01448044|11689721|FG000|Follow Up Period|Withdrawal by Subject|1
7416141|NCT01448044|11689722|FG001|Follow Up Period|Withdrawal by Subject|1
7416142|NCT01448044|11689721|FG000|Follow Up Period|Lost to Follow-up|6
7416143|NCT01448044|11689722|FG001|Follow Up Period|Lost to Follow-up|2
7416144|NCT01448044|11689721|FG000|Follow Up Period|Other|5
7416145|NCT01448044|11689722|FG001|Follow Up Period|Other|11
7416146|NCT01448057|11689730|FG000|Overall Study|Protocol Violation|3
7416147|NCT01448057|11689731|FG001|Overall Study|Protocol Violation|2
7416148|NCT01448057|11689730|FG000|Overall Study|Lost to Follow-up|3
7416149|NCT01448057|11689731|FG001|Overall Study|Lost to Follow-up|0
7416150|NCT01448057|11689730|FG000|Overall Study|Adverse Event|0
7416151|NCT01448057|11689731|FG001|Overall Study|Adverse Event|2
7416152|NCT01448057|11689730|FG000|Overall Study|Withdrawal by Subject|2
7416153|NCT01448057|11689731|FG001|Overall Study|Withdrawal by Subject|0
7416154|NCT01448213|11689739|FG000|Overall Study|Lost to Follow-up|12
7416155|NCT01448213|11689740|FG001|Overall Study|Lost to Follow-up|10
7416156|NCT01448213|11689739|FG000|Overall Study|Adverse Event|4
7321926|NCT00755222|11552615|FG001|Overall Study|Protocol Violation|0
7416157|NCT01448213|11689740|FG001|Overall Study|Adverse Event|10
7416158|NCT01448213|11689739|FG000|Overall Study|Protocol Violation|1
7416159|NCT01448213|11689740|FG001|Overall Study|Protocol Violation|2
7416160|NCT01448616|11689785|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
7416161|NCT01448616|11689786|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
7416162|NCT01448616|11689787|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
7416163|NCT01448616|11689788|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
7416164|NCT01448616|11689785|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
7321927|NCT00755326|11552641|FG000|Overall Study|Lost to Follow-up|2
7321928|NCT00755326|11552642|FG001|Overall Study|Lost to Follow-up|3
7321929|NCT00755417|11552652|FG000|Overall Study|Adverse Event|28
7321930|NCT00755417|11552653|FG001|Overall Study|Adverse Event|20
7321931|NCT00755417|11552654|FG002|Overall Study|Adverse Event|7
7321932|NCT00755417|11552652|FG000|Overall Study|Lack of Efficacy|8
7321933|NCT00755417|11552653|FG001|Overall Study|Lack of Efficacy|4
7321934|NCT00755417|11552654|FG002|Overall Study|Lack of Efficacy|9
7321935|NCT00755417|11552652|FG000|Overall Study|Protocol Violation|2
7321936|NCT00755417|11552653|FG001|Overall Study|Protocol Violation|1
7321937|NCT00755417|11552654|FG002|Overall Study|Protocol Violation|1
7321938|NCT00755417|11552652|FG000|Overall Study|Lost to Follow-up|3
7321939|NCT00755417|11552653|FG001|Overall Study|Lost to Follow-up|0
7321940|NCT00755417|11552654|FG002|Overall Study|Lost to Follow-up|1
7321941|NCT00755417|11552652|FG000|Overall Study|Withdrawal by Subject|12
7321942|NCT00755417|11552653|FG001|Overall Study|Withdrawal by Subject|12
7321943|NCT00755417|11552654|FG002|Overall Study|Withdrawal by Subject|12
7321944|NCT00755417|11552652|FG000|Overall Study|Not specified or missing data|9
7321945|NCT00755417|11552653|FG001|Overall Study|Not specified or missing data|18
7321946|NCT00755417|11552654|FG002|Overall Study|Not specified or missing data|12
7321947|NCT00755716|11552665|FG000|Overall Study|Adverse Event|1
7321948|NCT00755716|11552666|FG001|Overall Study|Adverse Event|4
7321949|NCT00755716|11552667|FG002|Overall Study|Adverse Event|1
7321950|NCT00755716|11552665|FG000|Overall Study|Lack of Efficacy|2
7321951|NCT00755716|11552666|FG001|Overall Study|Lack of Efficacy|0
7321952|NCT00755716|11552667|FG002|Overall Study|Lack of Efficacy|0
7321953|NCT00755716|11552665|FG000|Overall Study|Lost to Follow-up|5
7321954|NCT00755716|11552666|FG001|Overall Study|Lost to Follow-up|3
7321955|NCT00755716|11552667|FG002|Overall Study|Lost to Follow-up|1
7321956|NCT00755716|11552665|FG000|Overall Study|work schedule issues|0
7321957|NCT00755716|11552666|FG001|Overall Study|work schedule issues|1
7321958|NCT00755716|11552667|FG002|Overall Study|work schedule issues|1
7321959|NCT00755807|11552690|FG000|Acute Phase|Adverse Event|16
7321960|NCT00755807|11552691|FG001|Acute Phase|Adverse Event|5
7321961|NCT00755807|11552690|FG000|Acute Phase|Protocol Violation|1
7321962|NCT00755807|11552691|FG001|Acute Phase|Protocol Violation|3
7321963|NCT00755807|11552690|FG000|Acute Phase|Withdrawal by Subject|1
7321964|NCT00755807|11552691|FG001|Acute Phase|Withdrawal by Subject|2
7321965|NCT00755807|11552690|FG000|Acute Phase|Lack of Efficacy|0
7554263|NCT03028870|11915883|FG002|Overall Study|Administrative|12
7554264|NCT03028870|11915884|FG003|Overall Study|Administrative|4
7554265|NCT03029143|11915938|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
7554266|NCT03029143|11915939|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7554267|NCT03029143|11915940|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
7554268|NCT03029143|11915938|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
7554269|NCT03029143|11915939|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7554270|NCT03029143|11915940|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
7554271|NCT03029143|11915938|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
7554272|NCT03029143|11915939|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7554273|NCT03029143|11915940|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
7554274|NCT03029143|11915938|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
7554275|NCT03029143|11915939|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7554276|NCT03029143|11915940|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
7554277|NCT03029143|11915938|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
7554278|NCT03029143|11915939|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7554279|NCT03029143|11915940|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
7554280|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
7554281|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
7554282|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
7554283|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
7554284|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
7554285|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
7554286|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
7554287|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
7554288|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
7554289|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
7554290|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
7554291|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
7554292|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
7554293|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
7554294|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
7554295|NCT03029143|11915938|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
7574585|NCT03683719|11957505|FG000|Overall Study|Lost to Follow-up|1
7321966|NCT00755807|11552691|FG001|Acute Phase|Lack of Efficacy|1
7321967|NCT00755807|11552690|FG000|Acute Phase|Physician Decision|0
7321968|NCT00755807|11552691|FG001|Acute Phase|Physician Decision|1
7321969|NCT00755807|11552690|FG000|Open-label Extension Phase|Adverse Event|7
7321970|NCT00755807|11552691|FG001|Open-label Extension Phase|Adverse Event|7
7321971|NCT00755807|11552690|FG000|Open-label Extension Phase|Protocol Violation|5
7321972|NCT00755807|11552691|FG001|Open-label Extension Phase|Protocol Violation|2
7321973|NCT00755807|11552690|FG000|Open-label Extension Phase|Lack of Efficacy|3
7321974|NCT00755807|11552691|FG001|Open-label Extension Phase|Lack of Efficacy|3
7321975|NCT00755807|11552690|FG000|Open-label Extension Phase|Withdrawal by Subject|1
7416165|NCT01448616|11689786|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7416166|NCT01448616|11689787|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7416167|NCT01448616|11689788|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
7416168|NCT01448616|11689785|FG000|Study Drug (Treatment Phase)|Adverse Event|0
7416169|NCT01448616|11689786|FG001|Study Drug (Treatment Phase)|Adverse Event|1
7416170|NCT01448616|11689787|FG002|Study Drug (Treatment Phase)|Adverse Event|1
7416171|NCT01448616|11689788|FG003|Study Drug (Treatment Phase)|Adverse Event|0
7416172|NCT01448616|11689785|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
7416173|NCT01448616|11689786|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
7416174|NCT01448616|11689787|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
7416175|NCT01448616|11689788|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
7416176|NCT01448616|11689785|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
7416177|NCT01448616|11689786|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
7416178|NCT01448616|11689787|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7416179|NCT01448616|11689788|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
7416180|NCT01448707|11689803|FG000|Overall Study|Adverse Event|3
7416181|NCT01448707|11689804|FG001|Overall Study|Adverse Event|1
7416182|NCT01448707|11689803|FG000|Overall Study|Lost to Follow-up|2
7416183|NCT01448707|11689804|FG001|Overall Study|Lost to Follow-up|6
7416184|NCT01448707|11689803|FG000|Overall Study|Withdrawal by Subject|6
7416185|NCT01448707|11689804|FG001|Overall Study|Withdrawal by Subject|7
7416186|NCT01448707|11689803|FG000|Overall Study|Other|7
7416187|NCT01448707|11689804|FG001|Overall Study|Other|4
7416188|NCT01448824|11689818|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416189|NCT01448824|11689819|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416190|NCT01448824|11689820|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416191|NCT01448824|11689821|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416192|NCT01448824|11689822|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416193|NCT01448824|11689823|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416194|NCT01448824|11689824|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
7416195|NCT01448824|11689825|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
7416196|NCT01448824|11689818|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7416197|NCT01448824|11689819|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7416198|NCT01448824|11689820|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7416199|NCT01448824|11689821|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7416200|NCT01448824|11689822|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
7416201|NCT01448824|11689823|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
7416202|NCT01448824|11689824|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7416203|NCT01448824|11689825|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
7416204|NCT01448824|11689818|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416205|NCT01448824|11689819|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416206|NCT01448824|11689820|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416207|NCT01448824|11689821|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416208|NCT01448824|11689822|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416209|NCT01448824|11689823|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
7416210|NCT01448824|11689824|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416211|NCT01448824|11689825|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
7416212|NCT01448824|11689818|FG000|Part 1: Washout Period|Lost to Follow-up|1
7416213|NCT01448824|11689819|FG001|Part 1: Washout Period|Lost to Follow-up|0
7416214|NCT01448824|11689820|FG002|Part 1: Washout Period|Lost to Follow-up|0
7416215|NCT01448824|11689821|FG003|Part 1: Washout Period|Lost to Follow-up|0
7416216|NCT01448824|11689822|FG004|Part 1: Washout Period|Lost to Follow-up|0
7416217|NCT01448824|11689823|FG005|Part 1: Washout Period|Lost to Follow-up|0
7416218|NCT01448824|11689824|FG006|Part 1: Washout Period|Lost to Follow-up|0
7416219|NCT01448824|11689825|FG007|Part 1: Washout Period|Lost to Follow-up|0
7416220|NCT01448824|11689818|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416221|NCT01448824|11689819|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416222|NCT01448824|11689820|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416223|NCT01448824|11689821|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416224|NCT01448824|11689822|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416225|NCT01448824|11689823|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416226|NCT01448824|11689824|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
7416227|NCT01448824|11689825|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
7416228|NCT01448824|11689818|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416229|NCT01448824|11689819|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416230|NCT01448824|11689820|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7468728|NCT01914393|11769700|FG000|Overall Study|Lack of Efficacy|11
7321976|NCT00755807|11552691|FG001|Open-label Extension Phase|Withdrawal by Subject|3
7321977|NCT00755807|11552690|FG000|Open-label Extension Phase|Lost to Follow-up|2
7321978|NCT00755807|11552691|FG001|Open-label Extension Phase|Lost to Follow-up|0
7321979|NCT00755807|11552690|FG000|Open-label Extension Phase|Sponsor Decision|0
7321980|NCT00755807|11552691|FG001|Open-label Extension Phase|Sponsor Decision|1
7321981|NCT00755846|11552707|FG000|Overall Study|Adverse Event|0
7321982|NCT00755846|11552708|FG001|Overall Study|Adverse Event|0
7321983|NCT00755846|11552709|FG002|Overall Study|Adverse Event|0
7321984|NCT00755846|11552710|FG003|Overall Study|Adverse Event|1
7321985|NCT00755846|11552711|FG004|Overall Study|Adverse Event|3
7321986|NCT00755846|11552712|FG005|Overall Study|Adverse Event|2
7321987|NCT00755846|11552707|FG000|Overall Study|Protocol Violation|1
7321988|NCT00755846|11552708|FG001|Overall Study|Protocol Violation|1
7321989|NCT00755846|11552709|FG002|Overall Study|Protocol Violation|1
7321990|NCT00755846|11552710|FG003|Overall Study|Protocol Violation|1
7321991|NCT00755846|11552711|FG004|Overall Study|Protocol Violation|1
7321992|NCT00755846|11552712|FG005|Overall Study|Protocol Violation|1
7321993|NCT00755846|11552707|FG000|Overall Study|Lost to Follow-up|0
7321994|NCT00755846|11552708|FG001|Overall Study|Lost to Follow-up|2
7321995|NCT00755846|11552709|FG002|Overall Study|Lost to Follow-up|1
7530891|NCT02641379|11874575|FG004|Overall Study|Source data not found|0
7530892|NCT02641379|11874576|FG005|Overall Study|Source data not found|1
7530893|NCT02641379|11874577|FG006|Overall Study|Source data not found|0
7530894|NCT02641379|11874578|FG007|Overall Study|Source data not found|0
7530895|NCT02641379|11874579|FG008|Overall Study|Source data not found|0
7530896|NCT02641379|11874580|FG009|Overall Study|Source data not found|0
7530897|NCT02641379|11874581|FG010|Overall Study|Source data not found|0
7530898|NCT02641379|11874571|FG000|Overall Study|Participant showed weight reduction|0
7530899|NCT02641379|11874572|FG001|Overall Study|Participant showed weight reduction|0
7530900|NCT02641379|11874573|FG002|Overall Study|Participant showed weight reduction|0
7554296|NCT03029143|11915939|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
7554297|NCT03029143|11915940|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
7554298|NCT03029208|11915951|FG000|Overall Study|Withdrawal by Subject|2
7554299|NCT03029208|11915952|FG001|Overall Study|Withdrawal by Subject|3
7554300|NCT03029208|11915951|FG000|Overall Study|Lost to Follow-up|0
7554301|NCT03029208|11915952|FG001|Overall Study|Lost to Follow-up|1
7554302|NCT03029247|11915969|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
7554303|NCT03029247|11915970|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
7554304|NCT03029247|11915969|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7554305|NCT03029247|11915970|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
7554306|NCT03029247|11915969|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
7554307|NCT03029247|11915970|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
7554308|NCT03029247|11915969|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7554309|NCT03029247|11915970|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
7554310|NCT03029585|11915978|FG000|Overall Study|Death|1
7554311|NCT03029585|11915979|FG001|Overall Study|Death|1
7554312|NCT03029585|11915978|FG000|Overall Study|Withdrawal by Subject|1
7554313|NCT03029585|11915979|FG001|Overall Study|Withdrawal by Subject|0
7554314|NCT03029624|11915985|FG000|Overall Study|Adverse Event|1
7554315|NCT03029624|11915985|FG000|Overall Study|Withdrawal by Subject|1
7554316|NCT03029624|11915985|FG000|Overall Study|Lack of Efficacy|1
7554317|NCT03029624|11915985|FG000|Overall Study|MRI need|2
7554318|NCT03029650|11915991|FG000|Washout (1 Week)|Withdrawal by Subject|1
7554319|NCT03029650|11915992|FG001|Washout (1 Week)|Withdrawal by Subject|1
7554320|NCT03029650|11915991|FG000|Washout (1 Week)|Physician Decision|0
7554321|NCT03029650|11915992|FG001|Washout (1 Week)|Physician Decision|1
7554322|NCT03029819|11916013|FG000|Overall Study|Lost to Follow-up|3
7554323|NCT03029819|11916014|FG001|Overall Study|Lost to Follow-up|5
7554324|NCT03029819|11916013|FG000|Overall Study|Removed due to disruptive behavior|0
7554325|NCT03029819|11916014|FG001|Overall Study|Removed due to disruptive behavior|1
7554326|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Protocol deviation|8
7554327|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Protocol deviation|0
7554328|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Protocol deviation|0
7554329|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Other|1
7554330|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Other|0
7554331|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Other|0
7554332|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Physician Decision|3
7554333|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Physician Decision|0
7554334|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Physician Decision|0
7554335|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
7554336|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
7554337|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
7554338|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
7554339|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7321996|NCT00755846|11552710|FG003|Overall Study|Lost to Follow-up|0
7321997|NCT00755846|11552711|FG004|Overall Study|Lost to Follow-up|4
7530901|NCT02641379|11874574|FG003|Overall Study|Participant showed weight reduction|0
7530902|NCT02641379|11874575|FG004|Overall Study|Participant showed weight reduction|0
7321998|NCT00755846|11552712|FG005|Overall Study|Lost to Follow-up|2
7321999|NCT00755846|11552707|FG000|Overall Study|Withdrawal by Subject|2
7322000|NCT00755846|11552708|FG001|Overall Study|Withdrawal by Subject|3
7322001|NCT00755846|11552709|FG002|Overall Study|Withdrawal by Subject|5
7322002|NCT00755846|11552710|FG003|Overall Study|Withdrawal by Subject|2
7322003|NCT00755846|11552711|FG004|Overall Study|Withdrawal by Subject|0
7322004|NCT00755846|11552712|FG005|Overall Study|Withdrawal by Subject|1
7322005|NCT00755846|11552707|FG000|Overall Study|Hyperglycemic Rescue|21
7322006|NCT00755846|11552708|FG001|Overall Study|Hyperglycemic Rescue|7
7322007|NCT00755846|11552709|FG002|Overall Study|Hyperglycemic Rescue|5
7322008|NCT00755846|11552710|FG003|Overall Study|Hyperglycemic Rescue|8
7322009|NCT00755846|11552711|FG004|Overall Study|Hyperglycemic Rescue|8
7322010|NCT00755846|11552712|FG005|Overall Study|Hyperglycemic Rescue|7
7322011|NCT00755846|11552707|FG000|Overall Study|Physician Decision|1
7322012|NCT00755846|11552708|FG001|Overall Study|Physician Decision|3
7322013|NCT00755846|11552709|FG002|Overall Study|Physician Decision|0
7322014|NCT00755846|11552710|FG003|Overall Study|Physician Decision|1
7322015|NCT00755846|11552711|FG004|Overall Study|Physician Decision|0
7322016|NCT00755846|11552712|FG005|Overall Study|Physician Decision|1
7322017|NCT00755846|11552707|FG000|Overall Study|Administrative Error|0
7322018|NCT00755846|11552708|FG001|Overall Study|Administrative Error|1
7322019|NCT00755846|11552709|FG002|Overall Study|Administrative Error|0
7322020|NCT00755846|11552710|FG003|Overall Study|Administrative Error|0
7322021|NCT00755846|11552711|FG004|Overall Study|Administrative Error|0
7322022|NCT00755846|11552712|FG005|Overall Study|Administrative Error|0
7322023|NCT00755846|11552707|FG000|Overall Study|Participant Non-compliance|0
7322024|NCT00755846|11552708|FG001|Overall Study|Participant Non-compliance|0
7322025|NCT00755846|11552709|FG002|Overall Study|Participant Non-compliance|0
7322026|NCT00755846|11552710|FG003|Overall Study|Participant Non-compliance|0
7530903|NCT02641379|11874576|FG005|Overall Study|Participant showed weight reduction|0
7530904|NCT02641379|11874577|FG006|Overall Study|Participant showed weight reduction|0
7530905|NCT02641379|11874578|FG007|Overall Study|Participant showed weight reduction|1
7530906|NCT02641379|11874579|FG008|Overall Study|Participant showed weight reduction|0
7530907|NCT02641379|11874580|FG009|Overall Study|Participant showed weight reduction|0
7530908|NCT02641379|11874581|FG010|Overall Study|Participant showed weight reduction|0
7530909|NCT02641379|11874571|FG000|Overall Study|Non-response Week 12|0
7530910|NCT02641379|11874572|FG001|Overall Study|Non-response Week 12|0
7530911|NCT02641379|11874573|FG002|Overall Study|Non-response Week 12|0
7530912|NCT02641379|11874574|FG003|Overall Study|Non-response Week 12|0
7554340|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
7530913|NCT02641379|11874575|FG004|Overall Study|Non-response Week 12|0
7530914|NCT02641379|11874576|FG005|Overall Study|Non-response Week 12|0
7530915|NCT02641379|11874577|FG006|Overall Study|Non-response Week 12|0
7530916|NCT02641379|11874578|FG007|Overall Study|Non-response Week 12|1
7530917|NCT02641379|11874579|FG008|Overall Study|Non-response Week 12|0
7530918|NCT02641379|11874580|FG009|Overall Study|Non-response Week 12|0
7530919|NCT02641379|11874581|FG010|Overall Study|Non-response Week 12|0
7530920|NCT02641379|11874571|FG000|Overall Study|No 2 Log drop at Week 12|0
7530921|NCT02641379|11874572|FG001|Overall Study|No 2 Log drop at Week 12|0
7530922|NCT02641379|11874573|FG002|Overall Study|No 2 Log drop at Week 12|0
7530923|NCT02641379|11874574|FG003|Overall Study|No 2 Log drop at Week 12|0
7530924|NCT02641379|11874575|FG004|Overall Study|No 2 Log drop at Week 12|0
7530925|NCT02641379|11874576|FG005|Overall Study|No 2 Log drop at Week 12|0
7530926|NCT02641379|11874577|FG006|Overall Study|No 2 Log drop at Week 12|0
7530927|NCT02641379|11874578|FG007|Overall Study|No 2 Log drop at Week 12|0
7530928|NCT02641379|11874579|FG008|Overall Study|No 2 Log drop at Week 12|0
7530929|NCT02641379|11874580|FG009|Overall Study|No 2 Log drop at Week 12|0
7530930|NCT02641379|11874581|FG010|Overall Study|No 2 Log drop at Week 12|1
7530931|NCT02641379|11874571|FG000|Overall Study|Negative PCR result|0
7530932|NCT02641379|11874572|FG001|Overall Study|Negative PCR result|0
7530933|NCT02641379|11874573|FG002|Overall Study|Negative PCR result|0
7530934|NCT02641379|11874574|FG003|Overall Study|Negative PCR result|0
7530935|NCT02641379|11874575|FG004|Overall Study|Negative PCR result|0
7530936|NCT02641379|11874576|FG005|Overall Study|Negative PCR result|0
7530937|NCT02641379|11874577|FG006|Overall Study|Negative PCR result|0
7530938|NCT02641379|11874578|FG007|Overall Study|Negative PCR result|0
7530939|NCT02641379|11874579|FG008|Overall Study|Negative PCR result|0
7530940|NCT02641379|11874580|FG009|Overall Study|Negative PCR result|1
7530941|NCT02641379|11874581|FG010|Overall Study|Negative PCR result|0
7530942|NCT02641379|11874571|FG000|Overall Study|Participant's PCR high|0
7322027|NCT00755846|11552711|FG004|Overall Study|Participant Non-compliance|1
7322028|NCT00755846|11552712|FG005|Overall Study|Participant Non-compliance|0
7530943|NCT02641379|11874572|FG001|Overall Study|Participant's PCR high|0
7530944|NCT02641379|11874573|FG002|Overall Study|Participant's PCR high|0
7530945|NCT02641379|11874574|FG003|Overall Study|Participant's PCR high|0
7530946|NCT02641379|11874575|FG004|Overall Study|Participant's PCR high|0
7530947|NCT02641379|11874576|FG005|Overall Study|Participant's PCR high|0
7530948|NCT02641379|11874577|FG006|Overall Study|Participant's PCR high|0
7530949|NCT02641379|11874578|FG007|Overall Study|Participant's PCR high|1
7530950|NCT02641379|11874579|FG008|Overall Study|Participant's PCR high|0
7322029|NCT00755937|11552735|FG000|Recruitment|Unknown if infliximab received|164
7322030|NCT00755937|11552735|FG000|Observational Follow-up|Lost to Follow-up|148
7322031|NCT00756002|11552741|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
7322032|NCT00756002|11552742|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
7322033|NCT00756002|11552741|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7322034|NCT00756002|11552742|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7322035|NCT00756002|11552741|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
7322036|NCT00756002|11552742|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
7322037|NCT00756002|11552741|FG000|Double-Blind Treatment Period|Protocol Violation|6
7322038|NCT00756002|11552742|FG001|Double-Blind Treatment Period|Protocol Violation|5
7322039|NCT00756002|11552741|FG000|Double-Blind Treatment Period|Other|2
7322040|NCT00756002|11552742|FG001|Double-Blind Treatment Period|Other|2
7322041|NCT00756275|11552780|FG000|Overall Study|Lost to Follow-up|25
7322042|NCT00756275|11552781|FG001|Overall Study|Lost to Follow-up|21
7322043|NCT00756275|11552780|FG000|Overall Study|Withdrawal by Subject|4
7322044|NCT00756275|11552781|FG001|Overall Study|Withdrawal by Subject|7
7416231|NCT01448824|11689821|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416232|NCT01448824|11689822|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416233|NCT01448824|11689823|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416234|NCT01448824|11689824|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
7416235|NCT01448824|11689825|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
7416236|NCT01448824|11689818|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416237|NCT01448824|11689819|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416238|NCT01448824|11689820|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416239|NCT01448824|11689821|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416240|NCT01448824|11689822|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416241|NCT01448824|11689823|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416242|NCT01448824|11689824|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
7416243|NCT01448824|11689825|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
7416244|NCT01448824|11689818|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7416245|NCT01448824|11689819|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7416246|NCT01448824|11689820|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7416247|NCT01448824|11689821|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7416248|NCT01448824|11689822|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7554341|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Adverse Event|18
7554342|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Adverse Event|0
7554343|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Adverse Event|0
7554344|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
7554345|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
7554346|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
7554347|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Sponsor decision|2
7554348|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Sponsor decision|0
7554349|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Sponsor decision|0
7554350|NCT03030599|11916032|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
7554351|NCT03030599|11916033|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
7554352|NCT03030599|11916034|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
7554353|NCT03030599|11916032|FG000|Stable Dose|Protocol deviation|3
7554354|NCT03030599|11916033|FG001|Stable Dose|Protocol deviation|0
7554355|NCT03030599|11916034|FG002|Stable Dose|Protocol deviation|0
7554356|NCT03030599|11916032|FG000|Stable Dose|Adverse Event|1
7554357|NCT03030599|11916033|FG001|Stable Dose|Adverse Event|0
7554358|NCT03030599|11916034|FG002|Stable Dose|Adverse Event|0
7554359|NCT03030599|11916032|FG000|Stable Dose|Lost to Follow-up|1
7554360|NCT03030599|11916033|FG001|Stable Dose|Lost to Follow-up|0
7554361|NCT03030599|11916034|FG002|Stable Dose|Lost to Follow-up|0
7554362|NCT03030599|11916032|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7554363|NCT03030599|11916033|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
7554364|NCT03030599|11916034|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
7554365|NCT03030599|11916032|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
7554366|NCT03030599|11916033|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
7554367|NCT03030599|11916034|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
7554368|NCT03030599|11916032|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
7554369|NCT03030599|11916033|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
7554370|NCT03030599|11916034|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
7554371|NCT03030599|11916032|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7554372|NCT03030599|11916033|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
7554373|NCT03030599|11916034|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
7554374|NCT03030599|11916032|FG000|Open-label Extension|Adverse Event|3
7554375|NCT03030599|11916033|FG001|Open-label Extension|Adverse Event|0
7554376|NCT03030599|11916034|FG002|Open-label Extension|Adverse Event|0
7554377|NCT03030599|11916032|FG000|Open-label Extension|Lost to Follow-up|2
7554378|NCT03030599|11916033|FG001|Open-label Extension|Lost to Follow-up|0
7554379|NCT03030599|11916034|FG002|Open-label Extension|Lost to Follow-up|0
7322045|NCT00756314|11552789|FG000|Overall Study|Lost to Follow-up|2
7322046|NCT00756314|11552790|FG001|Overall Study|Lost to Follow-up|59
7322047|NCT00756444|11552798|FG000|Overall Study|Adverse Event|1
7322048|NCT00756444|11552799|FG001|Overall Study|Adverse Event|1
7322049|NCT00756444|11552798|FG000|Overall Study|Withdrawal by Subject|6
7322050|NCT00756444|11552799|FG001|Overall Study|Withdrawal by Subject|8
7322051|NCT00756444|11552798|FG000|Overall Study|Lost to Follow-up|0
7322052|NCT00756444|11552799|FG001|Overall Study|Lost to Follow-up|1
7322053|NCT00756444|11552798|FG000|Overall Study|Death|5
7322054|NCT00756444|11552799|FG001|Overall Study|Death|4
7322055|NCT00756444|11552798|FG000|Overall Study|Disease Progression|2
7322056|NCT00756444|11552799|FG001|Overall Study|Disease Progression|7
7322057|NCT00756444|11552798|FG000|Overall Study|Ineligibility Determined|1
7322058|NCT00756444|11552799|FG001|Overall Study|Ineligibility Determined|0
7322059|NCT00756457|11552808|FG000|Overall Study|Lost to Follow-up|1
7322060|NCT00756457|11552809|FG001|Overall Study|Lost to Follow-up|2
7322061|NCT00756470|11552831|FG000|Overall Study|Withdrawal by Subject|1
7322062|NCT00756470|11552831|FG000|Overall Study|Adverse Event|4
7322063|NCT00756652|11552878|FG000|Original Phase|Withdrawal by Subject|864
7322064|NCT00756652|11552879|FG001|Original Phase|Withdrawal by Subject|23
7322065|NCT00756652|11552878|FG000|Original Phase|Lost to Follow-up|601
7322066|NCT00756652|11552879|FG001|Original Phase|Lost to Follow-up|0
7322067|NCT00756652|11552878|FG000|Original Phase|Other Discontinuation|797
7322068|NCT00756652|11552879|FG001|Original Phase|Other Discontinuation|5
7554380|NCT03030599|11916032|FG000|Open-label Extension|Lack of Efficacy|1
7554381|NCT03030599|11916033|FG001|Open-label Extension|Lack of Efficacy|0
7554382|NCT03030599|11916034|FG002|Open-label Extension|Lack of Efficacy|0
7554383|NCT03030599|11916032|FG000|Open-label Extension|Other Reason|1
7554384|NCT03030599|11916033|FG001|Open-label Extension|Other Reason|0
7554385|NCT03030599|11916034|FG002|Open-label Extension|Other Reason|0
7554386|NCT03030989|11916077|FG000|Overall Study|Fever|2
7554387|NCT03030989|11916078|FG001|Overall Study|Fever|2
7554388|NCT03030989|11916077|FG000|Overall Study|Rash|2
7554389|NCT03030989|11916078|FG001|Overall Study|Rash|1
7554390|NCT03030989|11916077|FG000|Overall Study|Fatigue/Overwhelmed|1
7554391|NCT03030989|11916078|FG001|Overall Study|Fatigue/Overwhelmed|5
7554392|NCT03030989|11916077|FG000|Overall Study|Positive Blood Cultures|2
7554393|NCT03030989|11916078|FG001|Overall Study|Positive Blood Cultures|1
7554394|NCT03030989|11916077|FG000|Overall Study|Line Removed|0
7554395|NCT03030989|11916078|FG001|Overall Study|Line Removed|2
7554396|NCT03030989|11916077|FG000|Overall Study|No longer interested|5
7554397|NCT03030989|11916078|FG001|Overall Study|No longer interested|3
7554398|NCT03031431|11916084|FG000|Overall Study|Infant removed by maternal request|1
7554399|NCT03031496|11916088|FG000|Period 1|Adverse Event|2
7554400|NCT03031496|11916089|FG001|Period 1|Adverse Event|0
7554401|NCT03031496|11916088|FG000|Period 1|Withdrawal by Subject|0
7554402|NCT03031496|11916089|FG001|Period 1|Withdrawal by Subject|2
7554403|NCT03031678|11916095|FG000|Overall Study|Study closed prior to completion|1
7554404|NCT03031899|11916112|FG000|Overall Study|Protocol Violation|1
7554405|NCT03031899|11916112|FG000|Overall Study|lesion disappeared after stopping habit|1
7554406|NCT03031938|11916122|FG000|Overall Study|Death|1
7554407|NCT03031938|11916123|FG001|Overall Study|Death|0
7554408|NCT03032380|11916140|FG000|Overall Study|Adverse Event|0
7554409|NCT03032380|11916141|FG001|Overall Study|Adverse Event|1
7554410|NCT03032380|11916140|FG000|Overall Study|Lack of Efficacy|1
7554411|NCT03032380|11916141|FG001|Overall Study|Lack of Efficacy|0
7554412|NCT03032380|11916140|FG000|Overall Study|Withdrawal by Subject|2
7554413|NCT03032380|11916141|FG001|Overall Study|Withdrawal by Subject|3
7554414|NCT03032380|11916140|FG000|Overall Study|Recovery|0
7554415|NCT03032380|11916141|FG001|Overall Study|Recovery|1
7554416|NCT03032380|11916140|FG000|Overall Study|Death|39
7554417|NCT03032380|11916141|FG001|Overall Study|Death|34
7554418|NCT03032380|11916140|FG000|Overall Study|Other - Miscellaneous|0
7554419|NCT03032380|11916141|FG001|Overall Study|Other - Miscellaneous|1
7554420|NCT03032523|11916158|FG000|Overall Study|Withdrawal by Subject|2
7554421|NCT03032523|11916159|FG001|Overall Study|Withdrawal by Subject|2
7554422|NCT03032523|11916158|FG000|Overall Study|Physician Decision|1
7554423|NCT03032523|11916159|FG001|Overall Study|Physician Decision|0
7554424|NCT03033394|11916199|FG000|Completed Pharmacokinetic Analysis|Missing data|1
7554425|NCT03033394|11916199|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
7554426|NCT03033394|11916199|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
7554427|NCT03033394|11916199|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
7554428|NCT03033394|11916199|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
7322069|NCT00756652|11552878|FG000|Original Phase|Participant Noncompliance|18622
7322070|NCT00756652|11552879|FG001|Original Phase|Participant Noncompliance|424
7322071|NCT00756652|11552878|FG000|Original Phase|Unknown Discontinuation Reason|2
7322072|NCT00756652|11552879|FG001|Original Phase|Unknown Discontinuation Reason|0
7322073|NCT00756652|11552878|FG000|Original Phase|Participants without data|3259
7554429|NCT03033745|11916220|FG000|Overall Study|Protocol Violation|0
7554430|NCT03033745|11916221|FG001|Overall Study|Protocol Violation|0
7554431|NCT03033745|11916222|FG002|Overall Study|Protocol Violation|1
7554432|NCT03033745|11916220|FG000|Overall Study|Adverse Event|1
7554433|NCT03033745|11916221|FG001|Overall Study|Adverse Event|0
7554434|NCT03033745|11916222|FG002|Overall Study|Adverse Event|1
7322074|NCT00756652|11552879|FG001|Original Phase|Participants without data|466
7322075|NCT00756652|11552878|FG000|Original Phase|Death|168
7322076|NCT00756652|11552879|FG001|Original Phase|Death|1
7322077|NCT00756652|11552878|FG000|Original Phase|Not due for F/U at Phase One closure|11076
7322078|NCT00756652|11552879|FG001|Original Phase|Not due for F/U at Phase One closure|2
7322079|NCT00756652|11552878|FG000|Re-Op Phase|Withdrawal by Subject|62
7322080|NCT00756652|11552879|FG001|Re-Op Phase|Withdrawal by Subject|0
7322081|NCT00756652|11552878|FG000|Re-Op Phase|Death|6
7322082|NCT00756652|11552879|FG001|Re-Op Phase|Death|0
7322083|NCT00756652|11552878|FG000|Re-Op Phase|Lost to Follow-up|340
7322084|NCT00756652|11552879|FG001|Re-Op Phase|Lost to Follow-up|0
7322085|NCT00756652|11552878|FG000|Re-Op Phase|Site Closed|2454
7322086|NCT00756652|11552879|FG001|Re-Op Phase|Site Closed|0
7322087|NCT00756652|11552878|FG000|Re-Op Phase|Withdrawn after explant|14
7322088|NCT00756652|11552879|FG001|Re-Op Phase|Withdrawn after explant|0
7322089|NCT00756717|11552888|FG000|Overall Study|Withdrawal by Subject|2
7322090|NCT00756730|11552894|FG000|Overall Study|discontinued due to rash prior to week 4|0
7322091|NCT00756730|11552895|FG001|Overall Study|discontinued due to rash prior to week 4|1
7322092|NCT00756730|11552894|FG000|Overall Study|persistent low-level viremmia|0
7322093|NCT00756730|11552895|FG001|Overall Study|persistent low-level viremmia|1
7322094|NCT00756886|11552903|FG000|Overall Study|Lost to Follow-up|1
7322095|NCT00756886|11552904|FG001|Overall Study|Lost to Follow-up|0
7322096|NCT00756886|11552903|FG000|Overall Study|Adverse Event|0
7416249|NCT01448824|11689823|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7554435|NCT03033745|11916220|FG000|Overall Study|Withdrawal by Subject|0
7554436|NCT03033745|11916221|FG001|Overall Study|Withdrawal by Subject|1
7554437|NCT03033745|11916222|FG002|Overall Study|Withdrawal by Subject|0
7554438|NCT03033784|11916239|FG000|Overall Study|Anxiety related to MRI scanner|0
7554439|NCT03033784|11916240|FG001|Overall Study|Anxiety related to MRI scanner|1
7554440|NCT03033784|11916241|FG002|Overall Study|Anxiety related to MRI scanner|0
7554441|NCT03033784|11916242|FG003|Overall Study|Anxiety related to MRI scanner|0
7554442|NCT03033784|11916243|FG004|Overall Study|Anxiety related to MRI scanner|0
7554443|NCT03033784|11916244|FG005|Overall Study|Anxiety related to MRI scanner|0
7554444|NCT03033784|11916245|FG006|Overall Study|Anxiety related to MRI scanner|0
7554445|NCT03033784|11916246|FG007|Overall Study|Anxiety related to MRI scanner|0
7554446|NCT03033784|11916247|FG008|Overall Study|Anxiety related to MRI scanner|0
7554447|NCT03033784|11916248|FG009|Overall Study|Anxiety related to MRI scanner|0
7554448|NCT03033784|11916249|FG010|Overall Study|Anxiety related to MRI scanner|0
7554449|NCT03033784|11916250|FG011|Overall Study|Anxiety related to MRI scanner|0
7554450|NCT03033784|11916251|FG012|Overall Study|Anxiety related to MRI scanner|0
7554451|NCT03033784|11916239|FG000|Overall Study|Withdrawal by Subject|0
7554452|NCT03033784|11916240|FG001|Overall Study|Withdrawal by Subject|0
7554453|NCT03033784|11916241|FG002|Overall Study|Withdrawal by Subject|0
7554454|NCT03033784|11916242|FG003|Overall Study|Withdrawal by Subject|0
7554455|NCT03033784|11916243|FG004|Overall Study|Withdrawal by Subject|0
7554456|NCT03033784|11916244|FG005|Overall Study|Withdrawal by Subject|0
7554457|NCT03033784|11916245|FG006|Overall Study|Withdrawal by Subject|0
7554458|NCT03033784|11916246|FG007|Overall Study|Withdrawal by Subject|0
7554459|NCT03033784|11916247|FG008|Overall Study|Withdrawal by Subject|0
7554460|NCT03033784|11916248|FG009|Overall Study|Withdrawal by Subject|0
7554461|NCT03033784|11916249|FG010|Overall Study|Withdrawal by Subject|0
7554462|NCT03033784|11916250|FG011|Overall Study|Withdrawal by Subject|0
7554463|NCT03033784|11916251|FG012|Overall Study|Withdrawal by Subject|2
7554464|NCT03034044|11916262|FG000|Overall Study|Enrolled, but not received Xyntha|1
7322097|NCT00756886|11552904|FG001|Overall Study|Adverse Event|3
7322098|NCT00756886|11552903|FG000|Overall Study|Lack of Efficacy|1
7322099|NCT00756886|11552904|FG001|Overall Study|Lack of Efficacy|0
7322100|NCT00756886|11552903|FG000|Overall Study|Ineligible|9
7322101|NCT00756886|11552904|FG001|Overall Study|Ineligible|4
7322102|NCT00757003|11552928|FG000|Overall Study|Death|33
7322103|NCT00757003|11552928|FG000|Overall Study|Lost to Follow-up|9
7322104|NCT00757003|11552928|FG000|Overall Study|Withdrawal by Subject|4
7322105|NCT00757003|11552928|FG000|Overall Study|Surgically explanted|2
7322106|NCT00757003|11552928|FG000|Overall Study|Not implanted|1
7322107|NCT00757172|11552933|FG000|Overall Study|Withdrawal by Subject|4
7322108|NCT00757172|11552933|FG000|Overall Study|Physician Decision|3
7322109|NCT00757172|11552933|FG000|Overall Study|Progression|4
7322110|NCT00757237|11552939|FG000|Overall Study|Lost to Follow-up|0
7322111|NCT00757237|11552940|FG001|Overall Study|Lost to Follow-up|1
7322112|NCT00757237|11552939|FG000|Overall Study|Protocol Violation|0
7322113|NCT00757237|11552940|FG001|Overall Study|Protocol Violation|2
7322114|NCT00757237|11552939|FG000|Overall Study|Physician Decision|2
7322115|NCT00757237|11552940|FG001|Overall Study|Physician Decision|3
7322116|NCT00757237|11552939|FG000|Overall Study|Withdrawal by Subject|8
7322117|NCT00757237|11552940|FG001|Overall Study|Withdrawal by Subject|12
7554465|NCT03034057|11916266|FG000|Overall Study|Withdrawal by Subject|10
7554466|NCT03034057|11916266|FG000|Overall Study|Protocol Violation|1
7554467|NCT03034057|11916266|FG000|Overall Study|Not defined|2
7554468|NCT03034057|11916266|FG000|Overall Study|Lost to Follow-up|19
7554469|NCT03034057|11916266|FG000|Overall Study|Adverse Event|22
7554470|NCT03034057|11916266|FG000|Overall Study|Medication error without associated AE|1
7554471|NCT03034135|11916270|FG000|Overall Study|Withdrawal by Subject|2
7530951|NCT02641379|11874580|FG009|Overall Study|Participant's PCR high|0
7554472|NCT03034460|11916276|FG000|Overall Study|Adverse Event|0
7322118|NCT00757237|11552939|FG000|Overall Study|Safety or Tolerability|3
7322119|NCT00757237|11552940|FG001|Overall Study|Safety or Tolerability|5
7322120|NCT00757237|11552939|FG000|Overall Study|Other|0
7322121|NCT00757237|11552940|FG001|Overall Study|Other|2
7322122|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
7322123|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
7322124|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
7322125|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
7322126|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
7322127|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
7322128|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Death|1
7322129|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Death|0
7322130|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
7322131|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
7322132|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
7322133|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
7322134|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
7322135|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
7322136|NCT00757588|11552954|FG000|Period 1: Short-term (24-week) Phase|Other|0
7322137|NCT00757588|11552955|FG001|Period 1: Short-term (24-week) Phase|Other|1
7322138|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
7322139|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
7322140|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
7322141|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
7322142|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
7322143|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
7322144|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7322145|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
7554473|NCT03034460|11916277|FG001|Overall Study|Adverse Event|1
7554474|NCT03034460|11916276|FG000|Overall Study|Withdrawal by Subject|2
7554475|NCT03034460|11916277|FG001|Overall Study|Withdrawal by Subject|2
7554476|NCT03034460|11916276|FG000|Overall Study|Personal Reasons|1
7554477|NCT03034460|11916277|FG001|Overall Study|Personal Reasons|0
7554478|NCT03034577|11916289|FG000|Overall Study|Withdrawal by Subject|6
7554479|NCT03034577|11916290|FG001|Overall Study|Withdrawal by Subject|9
7554480|NCT03034577|11916289|FG000|Overall Study|Lost to Follow-up|25
7554481|NCT03034577|11916290|FG001|Overall Study|Lost to Follow-up|26
7554482|NCT03034772|11916300|FG000|Overall Study|Adverse Event|0
7554483|NCT03034772|11916301|FG001|Overall Study|Adverse Event|1
7554484|NCT03034772|11916300|FG000|Overall Study|Withdrawal by Subject|0
7554485|NCT03034772|11916301|FG001|Overall Study|Withdrawal by Subject|1
7554486|NCT03034915|11916310|FG000|Overall Study|Adverse Event|29
7554487|NCT03034915|11916311|FG001|Overall Study|Adverse Event|32
7554488|NCT03034915|11916312|FG002|Overall Study|Adverse Event|22
7554489|NCT03034915|11916310|FG000|Overall Study|Lost to Follow-up|5
7554490|NCT03034915|11916311|FG001|Overall Study|Lost to Follow-up|13
7554491|NCT03034915|11916312|FG002|Overall Study|Lost to Follow-up|3
7554492|NCT03034915|11916310|FG000|Overall Study|Withdrawal by Subject|29
7554493|NCT03034915|11916311|FG001|Overall Study|Withdrawal by Subject|46
7554494|NCT03034915|11916312|FG002|Overall Study|Withdrawal by Subject|41
7554495|NCT03034915|11916310|FG000|Overall Study|Protocol Deviation|2
7554496|NCT03034915|11916311|FG001|Overall Study|Protocol Deviation|14
7554497|NCT03034915|11916312|FG002|Overall Study|Protocol Deviation|7
7554498|NCT03034915|11916310|FG000|Overall Study|Lack of Efficacy|8
7554499|NCT03034915|11916311|FG001|Overall Study|Lack of Efficacy|16
7554500|NCT03034915|11916312|FG002|Overall Study|Lack of Efficacy|18
7554501|NCT03034915|11916310|FG000|Overall Study|Site closed|2
7554502|NCT03034915|11916311|FG001|Overall Study|Site closed|2
7554503|NCT03034915|11916312|FG002|Overall Study|Site closed|4
7554504|NCT03034915|11916310|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
7554505|NCT03034915|11916311|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
7554506|NCT03034915|11916312|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
7554507|NCT03034915|11916310|FG000|Overall Study|Physician Decision|1
7554508|NCT03034915|11916311|FG001|Overall Study|Physician Decision|5
7554509|NCT03034915|11916312|FG002|Overall Study|Physician Decision|2
7554510|NCT03034954|11916334|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
7554511|NCT03034954|11916335|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
7322146|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
7387567|NCT01215097|11646122|FG001|Overall Study|Lost to Follow-up|0
7530952|NCT02641379|11874581|FG010|Overall Study|Participant's PCR high|0
7530953|NCT02641379|11874571|FG000|Overall Study|Participant treated after Week 24|0
7530954|NCT02641379|11874572|FG001|Overall Study|Participant treated after Week 24|0
7530955|NCT02641379|11874573|FG002|Overall Study|Participant treated after Week 24|0
7530956|NCT02641379|11874574|FG003|Overall Study|Participant treated after Week 24|0
7530957|NCT02641379|11874575|FG004|Overall Study|Participant treated after Week 24|0
7530958|NCT02641379|11874576|FG005|Overall Study|Participant treated after Week 24|0
7322147|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
7322148|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
7322149|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
7322150|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
7322151|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
7322152|NCT00757588|11552954|FG000|Period 2: Long-term (52-week) Phase|Other|1
7322153|NCT00757588|11552955|FG001|Period 2: Long-term (52-week) Phase|Other|0
7322154|NCT00757705|11553015|FG000|Overall Study|Adverse Event|19
7322155|NCT00757705|11553015|FG000|Overall Study|Lost to Follow-up|16
7322156|NCT00757705|11553015|FG000|Overall Study|Withdrawal by Subject|25
7322157|NCT00757705|11553015|FG000|Overall Study|Insufficient Response|26
7322158|NCT00757705|11553015|FG000|Overall Study|Ineligible to continue|8
7322159|NCT00757705|11553015|FG000|Overall Study|Non-compliant|9
7322160|NCT00757705|11553015|FG000|Overall Study|Other|18
7322161|NCT00757783|11553021|FG000|Overall Study|Adverse Event|0
7322162|NCT00757783|11553022|FG001|Overall Study|Adverse Event|2
7322163|NCT00757783|11553021|FG000|Overall Study|Lost to Follow-up|1
7322164|NCT00757783|11553022|FG001|Overall Study|Lost to Follow-up|1
7322165|NCT00757783|11553021|FG000|Overall Study|Protocol Violation|1
7322166|NCT00757783|11553022|FG001|Overall Study|Protocol Violation|0
7322167|NCT00757783|11553021|FG000|Overall Study|Withdrawal by Subject|2
7322168|NCT00757783|11553022|FG001|Overall Study|Withdrawal by Subject|1
7322169|NCT00757783|11553021|FG000|Overall Study|Other|1
7322170|NCT00757783|11553022|FG001|Overall Study|Other|2
7322171|NCT00757848|11553042|FG000|Overall Study|Voluntary discontinuation|1
7322172|NCT00757848|11553043|FG001|Overall Study|Voluntary discontinuation|0
7322173|NCT00757848|11553042|FG000|Overall Study|Adverse Event|1
7322174|NCT00757848|11553043|FG001|Overall Study|Adverse Event|2
7322175|NCT00757848|11553042|FG000|Overall Study|Incorrect enrolment|1
7322176|NCT00757848|11553043|FG001|Overall Study|Incorrect enrolment|0
7322177|NCT00758043|11553053|FG000|Overall Study|Adverse Event|1
7322178|NCT00758043|11553054|FG001|Overall Study|Adverse Event|20
7322179|NCT00758043|11553055|FG002|Overall Study|Adverse Event|12
7322180|NCT00758043|11553056|FG003|Overall Study|Adverse Event|62
7322181|NCT00758043|11553053|FG000|Overall Study|Lack of Efficacy|0
7322182|NCT00758043|11553054|FG001|Overall Study|Lack of Efficacy|6
7322183|NCT00758043|11553055|FG002|Overall Study|Lack of Efficacy|18
7322184|NCT00758043|11553056|FG003|Overall Study|Lack of Efficacy|12
7322185|NCT00758043|11553053|FG000|Overall Study|Refused Further Treatment|0
7322186|NCT00758043|11553054|FG001|Overall Study|Refused Further Treatment|11
7322187|NCT00758043|11553055|FG002|Overall Study|Refused Further Treatment|5
7322188|NCT00758043|11553056|FG003|Overall Study|Refused Further Treatment|8
7322189|NCT00758043|11553053|FG000|Overall Study|Lost to Follow-up|0
7322190|NCT00758043|11553054|FG001|Overall Study|Lost to Follow-up|2
7322191|NCT00758043|11553055|FG002|Overall Study|Lost to Follow-up|2
7322192|NCT00758043|11553056|FG003|Overall Study|Lost to Follow-up|5
7322193|NCT00758043|11553053|FG000|Overall Study|Withdrawal by Subject|0
7322194|NCT00758043|11553054|FG001|Overall Study|Withdrawal by Subject|1
7322195|NCT00758043|11553055|FG002|Overall Study|Withdrawal by Subject|1
7322196|NCT00758043|11553056|FG003|Overall Study|Withdrawal by Subject|4
7322197|NCT00758043|11553053|FG000|Overall Study|Required Prohibited Medication|0
7322198|NCT00758043|11553054|FG001|Overall Study|Required Prohibited Medication|0
7322199|NCT00758043|11553055|FG002|Overall Study|Required Prohibited Medication|1
7322200|NCT00758043|11553056|FG003|Overall Study|Required Prohibited Medication|3
7322201|NCT00758043|11553053|FG000|Overall Study|Non-Compliant With study Drug|0
7322202|NCT00758043|11553054|FG001|Overall Study|Non-Compliant With study Drug|0
7322203|NCT00758043|11553055|FG002|Overall Study|Non-Compliant With study Drug|0
7322204|NCT00758043|11553056|FG003|Overall Study|Non-Compliant With study Drug|1
7322205|NCT00758043|11553053|FG000|Overall Study|Other Reasons|0
7322206|NCT00758043|11553054|FG001|Overall Study|Other Reasons|1
7322207|NCT00758043|11553055|FG002|Overall Study|Other Reasons|0
7322208|NCT00758043|11553056|FG003|Overall Study|Other Reasons|5
7322209|NCT00758069|11553075|FG000|Overall Study|Lack of Efficacy|0
7322210|NCT00758069|11553076|FG001|Overall Study|Lack of Efficacy|0
7322211|NCT00758069|11553077|FG002|Overall Study|Lack of Efficacy|1
7322212|NCT00758069|11553075|FG000|Overall Study|Incorrect Study Drug|1
7322213|NCT00758069|11553076|FG001|Overall Study|Incorrect Study Drug|0
7322214|NCT00758069|11553077|FG002|Overall Study|Incorrect Study Drug|0
7322215|NCT00758160|11553085|FG000|Overall Study|No Longer Requires Study Medication|4
7322216|NCT00758160|11553085|FG000|Overall Study|Administration Problems|3
7322217|NCT00758160|11553085|FG000|Overall Study|Adverse Event|15
7322218|NCT00758160|11553085|FG000|Overall Study|Lack of Efficacy|10
7322219|NCT00758160|11553085|FG000|Overall Study|Lost to Follow-up|14
7322220|NCT00758160|11553085|FG000|Overall Study|Protocol Violation|12
7322221|NCT00758160|11553085|FG000|Overall Study|Withdrawal by Subject|8
7322222|NCT00758264|11553096|FG000|Active Phase|Withdrawal by Subject|0
7322223|NCT00758264|11553097|FG001|Active Phase|Withdrawal by Subject|0
7322224|NCT00758264|11553098|FG002|Active Phase|Withdrawal by Subject|1
7322225|NCT00758264|11553096|FG000|Active Phase|Lost to Follow-up|1
7322226|NCT00758264|11553097|FG001|Active Phase|Lost to Follow-up|0
7322227|NCT00758264|11553098|FG002|Active Phase|Lost to Follow-up|0
7322228|NCT00758264|11553096|FG000|Active Phase|Other|0
7322229|NCT00758264|11553097|FG001|Active Phase|Other|0
7322230|NCT00758264|11553098|FG002|Active Phase|Other|4
7322231|NCT00758394|11553119|FG000|2nd Intervention Order|Lost to Follow-up|0
7322232|NCT00758394|11553120|FG001|2nd Intervention Order|Lost to Follow-up|1
7322233|NCT00758394|11553121|FG002|2nd Intervention Order|Lost to Follow-up|0
7322234|NCT00758394|11553122|FG003|2nd Intervention Order|Lost to Follow-up|0
7322235|NCT00758394|11553119|FG000|3rd Intervention|Lost to Follow-up|1
7322236|NCT00758394|11553120|FG001|3rd Intervention|Lost to Follow-up|0
7322237|NCT00758394|11553121|FG002|3rd Intervention|Lost to Follow-up|0
7322238|NCT00758394|11553122|FG003|3rd Intervention|Lost to Follow-up|1
7322239|NCT00758459|11553143|FG000|Overall Study|Adverse Event|3
7322240|NCT00758459|11553144|FG001|Overall Study|Adverse Event|2
7322241|NCT00758459|11553143|FG000|Overall Study|Protocol Violation|0
7322242|NCT00758459|11553144|FG001|Overall Study|Protocol Violation|1
7322243|NCT00758459|11553143|FG000|Overall Study|Withdrawal by Subject|0
7554512|NCT03034967|11916347|FG000|Overall Study|Withdrawal by Subject|9
7554513|NCT03034967|11916348|FG001|Overall Study|Withdrawal by Subject|2
7554514|NCT03034967|11916349|FG002|Overall Study|Withdrawal by Subject|6
7554515|NCT03034967|11916350|FG003|Overall Study|Withdrawal by Subject|6
7554516|NCT03034967|11916351|FG004|Overall Study|Withdrawal by Subject|9
7554517|NCT03034967|11916352|FG005|Overall Study|Withdrawal by Subject|2
7554518|NCT03034967|11916347|FG000|Overall Study|Physician Decision|1
7554519|NCT03034967|11916348|FG001|Overall Study|Physician Decision|0
7554520|NCT03034967|11916349|FG002|Overall Study|Physician Decision|1
7554521|NCT03034967|11916350|FG003|Overall Study|Physician Decision|1
7554522|NCT03034967|11916351|FG004|Overall Study|Physician Decision|1
7554523|NCT03034967|11916352|FG005|Overall Study|Physician Decision|0
7554524|NCT03034967|11916347|FG000|Overall Study|Lost to Follow-up|0
7554525|NCT03034967|11916348|FG001|Overall Study|Lost to Follow-up|0
7554526|NCT03034967|11916349|FG002|Overall Study|Lost to Follow-up|0
7554527|NCT03034967|11916350|FG003|Overall Study|Lost to Follow-up|1
7554528|NCT03034967|11916351|FG004|Overall Study|Lost to Follow-up|0
7554529|NCT03034967|11916352|FG005|Overall Study|Lost to Follow-up|2
7554530|NCT03034967|11916347|FG000|Overall Study|Liver function test abnormality|0
7554531|NCT03034967|11916348|FG001|Overall Study|Liver function test abnormality|0
7554532|NCT03034967|11916349|FG002|Overall Study|Liver function test abnormality|1
7554533|NCT03034967|11916350|FG003|Overall Study|Liver function test abnormality|0
7554534|NCT03034967|11916351|FG004|Overall Study|Liver function test abnormality|0
7554535|NCT03034967|11916352|FG005|Overall Study|Liver function test abnormality|0
7554536|NCT03034967|11916347|FG000|Overall Study|Protocol Violation|1
7554537|NCT03034967|11916348|FG001|Overall Study|Protocol Violation|0
7554538|NCT03034967|11916349|FG002|Overall Study|Protocol Violation|0
7554539|NCT03034967|11916350|FG003|Overall Study|Protocol Violation|0
7554540|NCT03034967|11916351|FG004|Overall Study|Protocol Violation|0
7554541|NCT03034967|11916352|FG005|Overall Study|Protocol Violation|2
7554542|NCT03034967|11916347|FG000|Overall Study|Lack of Efficacy|0
7554543|NCT03034967|11916348|FG001|Overall Study|Lack of Efficacy|1
7554544|NCT03034967|11916349|FG002|Overall Study|Lack of Efficacy|2
7554545|NCT03034967|11916350|FG003|Overall Study|Lack of Efficacy|1
7554546|NCT03034967|11916351|FG004|Overall Study|Lack of Efficacy|1
7554547|NCT03034967|11916352|FG005|Overall Study|Lack of Efficacy|0
7554548|NCT03034967|11916347|FG000|Overall Study|Adverse Event, non-fatal|3
7554549|NCT03034967|11916348|FG001|Overall Study|Adverse Event, non-fatal|1
7554550|NCT03034967|11916349|FG002|Overall Study|Adverse Event, non-fatal|2
7554551|NCT03034967|11916350|FG003|Overall Study|Adverse Event, non-fatal|0
7554552|NCT03034967|11916351|FG004|Overall Study|Adverse Event, non-fatal|2
7554553|NCT03034967|11916352|FG005|Overall Study|Adverse Event, non-fatal|8
7554554|NCT03034967|11916347|FG000|Overall Study|Adverse Event, Serious Fatal|0
7554555|NCT03034967|11916348|FG001|Overall Study|Adverse Event, Serious Fatal|1
7554556|NCT03034967|11916349|FG002|Overall Study|Adverse Event, Serious Fatal|1
7554557|NCT03034967|11916350|FG003|Overall Study|Adverse Event, Serious Fatal|2
7554558|NCT03034967|11916351|FG004|Overall Study|Adverse Event, Serious Fatal|1
7554559|NCT03034967|11916352|FG005|Overall Study|Adverse Event, Serious Fatal|1
7554560|NCT03035032|11916371|FG000|Overall Study|Adverse Event|2
7554561|NCT03035032|11916371|FG000|Overall Study|Death|9
7554562|NCT03035032|11916371|FG000|Overall Study|Lost to Follow-up|1
7554563|NCT03035032|11916371|FG000|Overall Study|Progressive Disease|22
7554564|NCT03035032|11916371|FG000|Overall Study|Protocol Violation|2
7554565|NCT03035032|11916371|FG000|Overall Study|Withdrawal by Subject|2
7554566|NCT03035032|11916371|FG000|Overall Study|Physician Decision|5
7554567|NCT03035864|11916435|FG000|Treatment Period|Adverse Event|1
7554568|NCT03035864|11916436|FG001|Treatment Period|Adverse Event|0
7554569|NCT03035864|11916435|FG000|Treatment Period|Other|3
7554570|NCT03035864|11916436|FG001|Treatment Period|Other|1
7554571|NCT03035864|11916435|FG000|Follow-up Period|Adverse Event|1
7554572|NCT03035864|11916436|FG001|Follow-up Period|Adverse Event|0
7554573|NCT03035864|11916435|FG000|Follow-up Period|Lost to Follow-up|6
7554574|NCT03035864|11916436|FG001|Follow-up Period|Lost to Follow-up|2
7554575|NCT03035864|11916435|FG000|Follow-up Period|Physician Decision|1
7322244|NCT00758459|11553144|FG001|Overall Study|Withdrawal by Subject|1
7322245|NCT00758485|11553152|FG000|Overall Study|Lost to Follow-up|0
7322246|NCT00758485|11553153|FG001|Overall Study|Lost to Follow-up|1
7322247|NCT00758485|11553152|FG000|Overall Study|Not Treated|1
7322248|NCT00758485|11553153|FG001|Overall Study|Not Treated|2
7554576|NCT03035864|11916436|FG001|Follow-up Period|Physician Decision|0
7322249|NCT00758498|11553163|FG000|Overall Study|Adverse Event|2
7322250|NCT00758498|11553164|FG001|Overall Study|Adverse Event|2
7322251|NCT00758498|11553165|FG002|Overall Study|Adverse Event|3
7322252|NCT00758498|11553163|FG000|Overall Study|Subject legally detained out of state|1
7322253|NCT00758498|11553164|FG001|Overall Study|Subject legally detained out of state|0
7322254|NCT00758498|11553165|FG002|Overall Study|Subject legally detained out of state|0
7322255|NCT00758498|11553163|FG000|Overall Study|Withdrawal by Subject|0
7322256|NCT00758498|11553164|FG001|Overall Study|Withdrawal by Subject|0
7322257|NCT00758498|11553165|FG002|Overall Study|Withdrawal by Subject|1
7322258|NCT00758498|11553163|FG000|Overall Study|Noncompliance to study procedures|0
7322259|NCT00758498|11553164|FG001|Overall Study|Noncompliance to study procedures|0
7322260|NCT00758498|11553165|FG002|Overall Study|Noncompliance to study procedures|1
7322261|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7322262|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
7322263|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
7530959|NCT02641379|11874577|FG006|Overall Study|Participant treated after Week 24|0
7530960|NCT02641379|11874578|FG007|Overall Study|Participant treated after Week 24|0
7530961|NCT02641379|11874579|FG008|Overall Study|Participant treated after Week 24|1
7530962|NCT02641379|11874580|FG009|Overall Study|Participant treated after Week 24|0
7530963|NCT02641379|11874581|FG010|Overall Study|Participant treated after Week 24|0
7530964|NCT02641379|11874571|FG000|Overall Study|Missing PCR result at Week 8|0
7530965|NCT02641379|11874572|FG001|Overall Study|Missing PCR result at Week 8|0
7530966|NCT02641379|11874573|FG002|Overall Study|Missing PCR result at Week 8|0
7530967|NCT02641379|11874574|FG003|Overall Study|Missing PCR result at Week 8|0
7554577|NCT03035864|11916435|FG000|Follow-up Period|Other|3
7554578|NCT03035864|11916436|FG001|Follow-up Period|Other|2
7554579|NCT03035916|11916445|FG000|Overall Study|Puncture failed|0
7322264|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322265|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
7322266|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
7322267|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322268|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322269|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322270|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322271|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322272|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322273|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322274|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322275|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322276|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322277|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
7322278|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7322279|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7554580|NCT03035916|11916446|FG001|Overall Study|Puncture failed|2
7554581|NCT03035916|11916447|FG002|Overall Study|Puncture failed|0
7554582|NCT03035942|11916463|FG000|Overall Study|Adverse Event|8
7554583|NCT03035942|11916464|FG001|Overall Study|Adverse Event|4
7554584|NCT03035942|11916465|FG002|Overall Study|Adverse Event|5
7554585|NCT03036072|11916486|FG000|Overall Study|Death|0
7554586|NCT03036072|11916487|FG001|Overall Study|Death|1
7554587|NCT03036072|11916486|FG000|Overall Study|Withdrawal by Subject|0
7554588|NCT03036072|11916487|FG001|Overall Study|Withdrawal by Subject|1
7554589|NCT03036072|11916486|FG000|Overall Study|Physician Decision|0
7554590|NCT03036072|11916487|FG001|Overall Study|Physician Decision|1
7554591|NCT03036124|11916495|FG000|Overall Study|Lost to Follow-up|0
7554592|NCT03036124|11916496|FG001|Overall Study|Lost to Follow-up|2
7554593|NCT03036124|11916495|FG000|Overall Study|Withdrawal by Subject|5
7554594|NCT03036124|11916496|FG001|Overall Study|Withdrawal by Subject|4
7554595|NCT03036150|11916504|FG000|Overall Study|Withdrawal by Subject|8
7554596|NCT03036150|11916505|FG001|Overall Study|Withdrawal by Subject|3
7554597|NCT03036150|11916504|FG000|Overall Study|Lost to Follow-up|2
7554598|NCT03036150|11916505|FG001|Overall Study|Lost to Follow-up|2
7554599|NCT03036813|11916601|FG000|Overall Study|Adverse Event|6
7554600|NCT03036813|11916602|FG001|Overall Study|Adverse Event|11
7554601|NCT03036813|11916603|FG002|Overall Study|Adverse Event|6
7554602|NCT03036813|11916601|FG000|Overall Study|Withdrawal by Subject|12
7554603|NCT03036813|11916602|FG001|Overall Study|Withdrawal by Subject|6
7554604|NCT03036813|11916603|FG002|Overall Study|Withdrawal by Subject|10
7322280|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
7322281|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7322282|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
7322283|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
7322284|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322285|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322286|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322287|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7554605|NCT03036813|11916601|FG000|Overall Study|Lost to Follow-up|1
7554606|NCT03036813|11916602|FG001|Overall Study|Lost to Follow-up|1
7322288|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322289|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322290|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322291|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322292|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322293|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322294|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
7322295|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
7322296|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
7322297|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
7322298|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
7322299|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
7554607|NCT03036813|11916603|FG002|Overall Study|Lost to Follow-up|0
7554608|NCT03036813|11916601|FG000|Overall Study|Physician Decision|2
7554609|NCT03036813|11916602|FG001|Overall Study|Physician Decision|1
7554610|NCT03036813|11916603|FG002|Overall Study|Physician Decision|1
7554611|NCT03036813|11916601|FG000|Overall Study|Non-Compliance|1
7554612|NCT03036813|11916602|FG001|Overall Study|Non-Compliance|5
7554613|NCT03036813|11916603|FG002|Overall Study|Non-Compliance|3
7554614|NCT03036813|11916601|FG000|Overall Study|Pregnancy|0
7554615|NCT03036813|11916602|FG001|Overall Study|Pregnancy|0
7554616|NCT03036813|11916603|FG002|Overall Study|Pregnancy|1
7554617|NCT03036813|11916601|FG000|Overall Study|Other|0
7554618|NCT03036813|11916602|FG001|Overall Study|Other|3
7554619|NCT03036813|11916603|FG002|Overall Study|Other|5
7554620|NCT03036839|11916617|FG000|Overall Study|Adverse Event|0
7554621|NCT03036839|11916618|FG001|Overall Study|Adverse Event|0
7554622|NCT03036839|11916619|FG002|Overall Study|Adverse Event|1
7554623|NCT03036839|11916617|FG000|Overall Study|Death|3
7554624|NCT03036839|11916618|FG001|Overall Study|Death|0
7554625|NCT03036839|11916619|FG002|Overall Study|Death|3
7554626|NCT03036839|11916617|FG000|Overall Study|Withdrew Consent|0
7554627|NCT03036839|11916618|FG001|Overall Study|Withdrew Consent|0
7554628|NCT03036839|11916619|FG002|Overall Study|Withdrew Consent|1
7554629|NCT03036852|11916633|FG000|Overall Study|Death|2
7554630|NCT03036852|11916633|FG000|Overall Study|Lack of Efficacy|2
7554631|NCT03036852|11916633|FG000|Overall Study|Adverse Event|1
7554632|NCT03036852|11916633|FG000|Overall Study|Lost to Follow-up|1
7574586|NCT03683719|11957506|FG001|Overall Study|Lost to Follow-up|0
7574587|NCT03683719|11957507|FG002|Overall Study|Lost to Follow-up|0
7574588|NCT03683719|11957508|FG003|Overall Study|Lost to Follow-up|1
7574589|NCT03683719|11957509|FG004|Overall Study|Lost to Follow-up|1
7574590|NCT03683719|11957505|FG000|Overall Study|Other personal reasons|0
7574591|NCT03683719|11957506|FG001|Overall Study|Other personal reasons|0
7574592|NCT03683719|11957507|FG002|Overall Study|Other personal reasons|1
7574593|NCT03683719|11957508|FG003|Overall Study|Other personal reasons|0
7574594|NCT03683719|11957509|FG004|Overall Study|Other personal reasons|1
7574595|NCT03683758|11957523|FG000|Overall Study|Non-study commitment conflict|1
7574596|NCT03683758|11957524|FG001|Overall Study|Non-study commitment conflict|3
7574597|NCT03683758|11957523|FG000|Overall Study|Illness preventing participation|1
7574598|NCT03683758|11957524|FG001|Overall Study|Illness preventing participation|0
7574599|NCT03683758|11957523|FG000|Overall Study|Adverse Event|1
7574600|NCT03683758|11957524|FG001|Overall Study|Adverse Event|0
7574601|NCT03684044|11957538|FG000|Overall Study|Adverse Event|3
7574602|NCT03684044|11957539|FG001|Overall Study|Adverse Event|0
7574603|NCT03684044|11957538|FG000|Overall Study|Death|4
7574604|NCT03684044|11957539|FG001|Overall Study|Death|7
7574605|NCT03684044|11957538|FG000|Overall Study|Lost to Follow-up|3
7574606|NCT03684044|11957539|FG001|Overall Study|Lost to Follow-up|2
7574607|NCT03684044|11957538|FG000|Overall Study|Patient Not Available|0
7574608|NCT03684044|11957539|FG001|Overall Study|Patient Not Available|2
7574609|NCT03684044|11957538|FG000|Overall Study|Physician Decision|1
7574610|NCT03684044|11957539|FG001|Overall Study|Physician Decision|0
7574611|NCT03684044|11957538|FG000|Overall Study|Withdrawal by Subject|11
7574612|NCT03684044|11957539|FG001|Overall Study|Withdrawal by Subject|9
7575470|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
7575471|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7575472|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7575473|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
7575474|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
7575475|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
7575476|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
7575477|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
7322300|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
7322301|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
7322302|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
7322303|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
7575478|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
7575479|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7575480|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7575481|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
7575482|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
7322304|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
7322305|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
7322306|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
7322307|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
7322308|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
7322309|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
7322310|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
7322311|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
7322312|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322313|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7322314|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7322315|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322316|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
7322317|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
7322318|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322319|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322320|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322321|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322322|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322323|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322324|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322325|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322326|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322327|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322328|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
7322329|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322330|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322331|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
7322332|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
7322333|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
7416250|NCT01448824|11689824|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
7416251|NCT01448824|11689825|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
7416252|NCT01448850|11689855|FG000|Overall Study|Death|3
7416253|NCT01448850|11689856|FG001|Overall Study|Death|6
7416254|NCT01448850|11689855|FG000|Overall Study|Withdrawal by Subject|13
7416255|NCT01448850|11689856|FG001|Overall Study|Withdrawal by Subject|21
7416256|NCT01448850|11689855|FG000|Overall Study|Lost to Follow-up|3
7416257|NCT01448850|11689856|FG001|Overall Study|Lost to Follow-up|1
7416258|NCT01448850|11689855|FG000|Overall Study|Other|15
7416259|NCT01448850|11689856|FG001|Overall Study|Other|12
7416260|NCT01449006|11689865|FG000|Overall Study|Lost to Follow-up|1
7416261|NCT01449006|11689866|FG001|Overall Study|Lost to Follow-up|0
7554633|NCT03037307|11916681|FG000|Period 1|Did Not Meet Study Criteria|0
7554634|NCT03037307|11916682|FG001|Period 1|Did Not Meet Study Criteria|0
7554635|NCT03037307|11916683|FG002|Period 1|Did Not Meet Study Criteria|0
7554636|NCT03037307|11916684|FG003|Period 1|Did Not Meet Study Criteria|1
7554637|NCT03037307|11916685|FG004|Period 1|Did Not Meet Study Criteria|0
7554638|NCT03037307|11916686|FG005|Period 1|Did Not Meet Study Criteria|0
7554639|NCT03037489|11916697|FG000|Overall Study|Adverse Event|4
7554640|NCT03037489|11916698|FG001|Overall Study|Adverse Event|0
7554641|NCT03037489|11916697|FG000|Overall Study|Withdrawal by Subject|3
7554642|NCT03037489|11916698|FG001|Overall Study|Withdrawal by Subject|0
7554643|NCT03037580|11916715|FG000|Overall Study|Withdrawal by Subject|3
7554644|NCT03037580|11916716|FG001|Overall Study|Withdrawal by Subject|0
7554645|NCT03037580|11916715|FG000|Overall Study|Adverse Event|1
7554646|NCT03037580|11916716|FG001|Overall Study|Adverse Event|0
7554647|NCT03037580|11916715|FG000|Overall Study|Study Terminated by Sponsor|12
7554648|NCT03037580|11916716|FG001|Overall Study|Study Terminated by Sponsor|15
7554649|NCT03037580|11916715|FG000|Overall Study|Death|0
7554650|NCT03037580|11916716|FG001|Overall Study|Death|1
7554651|NCT03037619|11916724|FG000|Overall Study|Lost to Follow-up|0
7554652|NCT03037619|11916725|FG001|Overall Study|Lost to Follow-up|1
7554653|NCT03038113|11916765|FG000|Overall Study|Withdrawal by Subject|0
7554654|NCT03038113|11916766|FG001|Overall Study|Withdrawal by Subject|0
7554655|NCT03038113|11916767|FG002|Overall Study|Withdrawal by Subject|1
7554656|NCT03038113|11916768|FG003|Overall Study|Withdrawal by Subject|0
7554657|NCT03038113|11916769|FG004|Overall Study|Withdrawal by Subject|0
7554658|NCT03038113|11916770|FG005|Overall Study|Withdrawal by Subject|0
7554659|NCT03038113|11916771|FG006|Overall Study|Withdrawal by Subject|0
7554660|NCT03038113|11916772|FG007|Overall Study|Withdrawal by Subject|0
7554661|NCT03038113|11916773|FG008|Overall Study|Withdrawal by Subject|0
7554662|NCT03038113|11916774|FG009|Overall Study|Withdrawal by Subject|0
7416262|NCT01449006|11689865|FG000|Overall Study|Withdrawal by Subject|1
7416263|NCT01449006|11689866|FG001|Overall Study|Withdrawal by Subject|0
7554663|NCT03038113|11916775|FG010|Overall Study|Withdrawal by Subject|0
7416264|NCT01449006|11689865|FG000|Overall Study|Protocol Violation|1
7554664|NCT03038113|11916776|FG011|Overall Study|Withdrawal by Subject|0
7554665|NCT03038113|11916777|FG012|Overall Study|Withdrawal by Subject|0
7554666|NCT03038113|11916778|FG013|Overall Study|Withdrawal by Subject|1
7554667|NCT03038113|11916765|FG000|Overall Study|Lost to Follow-up|0
7322334|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322335|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322336|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322337|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322338|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322339|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322340|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322341|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322342|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322343|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322344|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322345|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
7322346|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322347|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322348|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322349|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322350|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
7322351|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322352|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322353|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322354|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322355|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322356|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322357|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322358|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322359|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322360|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322361|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322362|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
7322363|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322364|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
7322365|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322366|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322367|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322368|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322369|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322370|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322371|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322372|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322373|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322374|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322375|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322376|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322377|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322378|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322379|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
7322380|NCT00758524|11553179|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322381|NCT00758524|11553180|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
7322382|NCT00758524|11553181|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322383|NCT00758524|11553182|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322384|NCT00758524|11553183|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322385|NCT00758524|11553184|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322386|NCT00758524|11553185|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322387|NCT00758524|11553186|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322388|NCT00758524|11553187|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322389|NCT00758524|11553188|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322390|NCT00758524|11553189|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322391|NCT00758524|11553190|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322392|NCT00758524|11553191|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322393|NCT00758524|11553192|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322394|NCT00758524|11553193|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322395|NCT00758524|11553194|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322396|NCT00758524|11553195|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
7322397|NCT00758524|11553179|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322398|NCT00758524|11553180|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322399|NCT00758524|11553181|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322400|NCT00758524|11553182|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322401|NCT00758524|11553183|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322402|NCT00758524|11553184|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322403|NCT00758524|11553185|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322404|NCT00758524|11553186|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322405|NCT00758524|11553187|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
7322406|NCT00758524|11553188|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322407|NCT00758524|11553189|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322408|NCT00758524|11553190|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322409|NCT00758524|11553191|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322410|NCT00758524|11553192|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322411|NCT00758524|11553193|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322412|NCT00758524|11553194|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322413|NCT00758524|11553195|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
7322414|NCT00758524|11553179|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322415|NCT00758524|11553180|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322416|NCT00758524|11553181|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322417|NCT00758524|11553182|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322418|NCT00758524|11553183|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322419|NCT00758524|11553184|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322420|NCT00758524|11553185|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
7322421|NCT00758524|11553186|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322422|NCT00758524|11553187|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322423|NCT00758524|11553188|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322424|NCT00758524|11553189|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322425|NCT00758524|11553190|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7554719|NCT03039192|11916939|FG000|Overall Study|Withdrawal by Subject|6
7322426|NCT00758524|11553191|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322427|NCT00758524|11553192|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322428|NCT00758524|11553193|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322429|NCT00758524|11553194|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322430|NCT00758524|11553195|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
7322431|NCT00758589|11553250|FG000|Overall Study|Adverse Event|3
7322432|NCT00758589|11553251|FG001|Overall Study|Adverse Event|2
7322433|NCT00758589|11553252|FG002|Overall Study|Adverse Event|5
7322434|NCT00758589|11553253|FG003|Overall Study|Adverse Event|4
7322435|NCT00758589|11553250|FG000|Overall Study|Withdrawal by Subject|0
7322436|NCT00758589|11553251|FG001|Overall Study|Withdrawal by Subject|1
7322437|NCT00758589|11553252|FG002|Overall Study|Withdrawal by Subject|1
7322438|NCT00758589|11553253|FG003|Overall Study|Withdrawal by Subject|1
7322439|NCT00758589|11553250|FG000|Overall Study|Palm stopped to work|0
7322440|NCT00758589|11553251|FG001|Overall Study|Palm stopped to work|0
7322441|NCT00758589|11553252|FG002|Overall Study|Palm stopped to work|0
7322442|NCT00758589|11553253|FG003|Overall Study|Palm stopped to work|1
7322443|NCT00758602|11553265|FG000|Overall Study|Adverse Event|11
7322444|NCT00758602|11553266|FG001|Overall Study|Adverse Event|10
7322445|NCT00758602|11553265|FG000|Overall Study|Lost to Follow-up|4
7322446|NCT00758602|11553266|FG001|Overall Study|Lost to Follow-up|3
7322447|NCT00758602|11553265|FG000|Overall Study|Withdrawal by Subject|1
7322448|NCT00758602|11553266|FG001|Overall Study|Withdrawal by Subject|3
7322449|NCT00758602|11553265|FG000|Overall Study|Protocol Violation|0
7322450|NCT00758602|11553266|FG001|Overall Study|Protocol Violation|2
7322451|NCT00758602|11553265|FG000|Overall Study|Death|0
7554668|NCT03038113|11916766|FG001|Overall Study|Lost to Follow-up|0
7554669|NCT03038113|11916767|FG002|Overall Study|Lost to Follow-up|0
7554670|NCT03038113|11916768|FG003|Overall Study|Lost to Follow-up|0
7554671|NCT03038113|11916769|FG004|Overall Study|Lost to Follow-up|0
7554672|NCT03038113|11916770|FG005|Overall Study|Lost to Follow-up|0
7554673|NCT03038113|11916771|FG006|Overall Study|Lost to Follow-up|1
7554674|NCT03038113|11916772|FG007|Overall Study|Lost to Follow-up|0
7554675|NCT03038113|11916773|FG008|Overall Study|Lost to Follow-up|0
7554676|NCT03038113|11916774|FG009|Overall Study|Lost to Follow-up|0
7554677|NCT03038113|11916775|FG010|Overall Study|Lost to Follow-up|0
7554678|NCT03038113|11916776|FG011|Overall Study|Lost to Follow-up|0
7554679|NCT03038113|11916777|FG012|Overall Study|Lost to Follow-up|0
7554680|NCT03038113|11916778|FG013|Overall Study|Lost to Follow-up|0
7554681|NCT03038126|11916827|FG000|Overall Study|Death|1
7554682|NCT03038126|11916828|FG001|Overall Study|Death|1
7554683|NCT03038126|11916827|FG000|Overall Study|Withdrawal by Subject|5
7554684|NCT03038126|11916828|FG001|Overall Study|Withdrawal by Subject|0
7322452|NCT00758602|11553266|FG001|Overall Study|Death|1
7322453|NCT00758602|11553265|FG000|Overall Study|Reason not specified|3
7322454|NCT00758602|11553266|FG001|Overall Study|Reason not specified|3
7322455|NCT00758680|11553283|FG000|Overall Study|Adverse Event|0
7322456|NCT00758680|11553284|FG001|Overall Study|Adverse Event|0
7554685|NCT03038126|11916827|FG000|Overall Study|Lost to Follow-up|0
7554686|NCT03038126|11916828|FG001|Overall Study|Lost to Follow-up|1
7554687|NCT03038126|11916827|FG000|Overall Study|Long Term Hospitalization|2
7554688|NCT03038126|11916828|FG001|Overall Study|Long Term Hospitalization|0
7322457|NCT00758680|11553285|FG002|Overall Study|Adverse Event|0
7322458|NCT00758680|11553286|FG003|Overall Study|Adverse Event|0
7322459|NCT00758680|11553287|FG004|Overall Study|Adverse Event|0
7554689|NCT03038126|11916827|FG000|Overall Study|Too Ill to Participate|1
7554690|NCT03038126|11916828|FG001|Overall Study|Too Ill to Participate|2
7554691|NCT03038620|11916859|FG000|Overall Study|Lost to Follow-up|18
7554692|NCT03038620|11916860|FG001|Overall Study|Lost to Follow-up|23
7554693|NCT03038620|11916859|FG000|Overall Study|Withdrawal by Subject|0
7554694|NCT03038620|11916860|FG001|Overall Study|Withdrawal by Subject|15
7554695|NCT03038620|11916859|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
7554696|NCT03038620|11916860|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
7554697|NCT03038880|11916888|FG000|Overall Study|Death|1
7554698|NCT03038880|11916889|FG001|Overall Study|Death|2
7554699|NCT03038880|11916890|FG002|Overall Study|Death|0
7554700|NCT03038880|11916888|FG000|Overall Study|Physician Decision|2
7554701|NCT03038880|11916889|FG001|Overall Study|Physician Decision|1
7554702|NCT03038880|11916890|FG002|Overall Study|Physician Decision|0
7554703|NCT03039023|11916903|FG000|Overall Study|Withdrawal by Subject|1
7554704|NCT03039023|11916904|FG001|Overall Study|Withdrawal by Subject|0
7554705|NCT03039023|11916905|FG002|Overall Study|Withdrawal by Subject|1
7554706|NCT03039023|11916906|FG003|Overall Study|Withdrawal by Subject|1
7554707|NCT03039023|11916907|FG004|Overall Study|Withdrawal by Subject|0
7554708|NCT03039023|11916903|FG000|Overall Study|Physician Decision|0
7554709|NCT03039023|11916904|FG001|Overall Study|Physician Decision|0
7554710|NCT03039023|11916905|FG002|Overall Study|Physician Decision|0
7554711|NCT03039023|11916906|FG003|Overall Study|Physician Decision|1
7554712|NCT03039023|11916907|FG004|Overall Study|Physician Decision|0
7554713|NCT03039192|11916939|FG000|Overall Study|Lost to Follow-up|4
7554714|NCT03039192|11916940|FG001|Overall Study|Lost to Follow-up|4
7554715|NCT03039192|11916939|FG000|Overall Study|Adverse event, serious fatal|0
7554716|NCT03039192|11916940|FG001|Overall Study|Adverse event, serious fatal|1
7554717|NCT03039192|11916939|FG000|Overall Study|Adverse event, non-fatal|0
7554718|NCT03039192|11916940|FG001|Overall Study|Adverse event, non-fatal|2
7554720|NCT03039192|11916940|FG001|Overall Study|Withdrawal by Subject|9
7554721|NCT03039192|11916939|FG000|Overall Study|Discontinued from treatment phase|19
7554722|NCT03039192|11916940|FG001|Overall Study|Discontinued from treatment phase|12
7554723|NCT03039192|11916939|FG000|Overall Study|Other|3
7554724|NCT03039192|11916940|FG001|Overall Study|Other|2
7554725|NCT03039283|11916946|FG000|Overall Study|Protocol Violation|2
7554726|NCT03039569|11916961|FG000|Overall Study|Lost to Follow-up|5
7554727|NCT03039569|11916962|FG001|Overall Study|Lost to Follow-up|4
7554728|NCT03039621|11916971|FG000|Overall Study|Violation of inclusion criteria|3
7554729|NCT03039621|11916972|FG001|Overall Study|Violation of inclusion criteria|2
7554730|NCT03039621|11916971|FG000|Overall Study|Non-compliance with protocol requirement|4
7554731|NCT03039621|11916972|FG001|Overall Study|Non-compliance with protocol requirement|5
7554732|NCT03039621|11916971|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
7554733|NCT03039621|11916972|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
7554734|NCT03039621|11916971|FG000|Overall Study|Violation of non-inclusion criteria|1
7554735|NCT03039621|11916972|FG001|Overall Study|Violation of non-inclusion criteria|2
7554736|NCT03039686|11916981|FG000|Double-blind Period|Administrative Reason by Sponsor|24
7554737|NCT03039686|11916982|FG001|Double-blind Period|Administrative Reason by Sponsor|25
7554738|NCT03039686|11916983|FG002|Double-blind Period|Administrative Reason by Sponsor|21
7554739|NCT03039686|11916981|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
7554740|NCT03039686|11916982|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
7554741|NCT03039686|11916983|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
7554742|NCT03039686|11916981|FG000|Double-blind Period|Withdrawal by Subject|2
7554743|NCT03039686|11916982|FG001|Double-blind Period|Withdrawal by Subject|2
7554744|NCT03039686|11916983|FG002|Double-blind Period|Withdrawal by Subject|1
7554745|NCT03039686|11916981|FG000|Double-blind Period|Death|0
7554746|NCT03039686|11916982|FG001|Double-blind Period|Death|0
7554747|NCT03039686|11916983|FG002|Double-blind Period|Death|1
7554748|NCT03039686|11916981|FG000|Open Label Period|Administrative Reason by Sponsor|0
7554749|NCT03039686|11916982|FG001|Open Label Period|Administrative Reason by Sponsor|34
7554750|NCT03039686|11916983|FG002|Open Label Period|Administrative Reason by Sponsor|41
7554751|NCT03039686|11916981|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
7554752|NCT03039686|11916982|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
7554753|NCT03039686|11916983|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
7554754|NCT03039686|11916981|FG000|Open Label Period|Withdrawal by Subject|0
7554755|NCT03039686|11916982|FG001|Open Label Period|Withdrawal by Subject|3
7554756|NCT03039686|11916983|FG002|Open Label Period|Withdrawal by Subject|1
7554757|NCT03039699|11917003|FG000|Overall Study|Incorrect inclusion|5
7322460|NCT00758680|11553288|FG005|Overall Study|Adverse Event|0
7416265|NCT01449006|11689866|FG001|Overall Study|Protocol Violation|0
7554758|NCT03039699|11917004|FG001|Overall Study|Incorrect inclusion|4
7554759|NCT03039699|11917003|FG000|Overall Study|Lack of data to assess study endpoint|5
7554760|NCT03039699|11917004|FG001|Overall Study|Lack of data to assess study endpoint|3
7322461|NCT00758680|11553289|FG006|Overall Study|Adverse Event|0
7554761|NCT03039699|11917003|FG000|Overall Study|Bacterial infection|12
7322462|NCT00758680|11553290|FG007|Overall Study|Adverse Event|1
7322463|NCT00758680|11553291|FG008|Overall Study|Adverse Event|0
7322464|NCT00758680|11553292|FG009|Overall Study|Adverse Event|1
7322465|NCT00758680|11553283|FG000|Overall Study|Laboratory Adverse Event|0
7322466|NCT00758680|11553284|FG001|Overall Study|Laboratory Adverse Event|0
7322467|NCT00758680|11553285|FG002|Overall Study|Laboratory Adverse Event|0
7322468|NCT00758680|11553286|FG003|Overall Study|Laboratory Adverse Event|0
7322469|NCT00758680|11553287|FG004|Overall Study|Laboratory Adverse Event|0
7322470|NCT00758680|11553288|FG005|Overall Study|Laboratory Adverse Event|0
7322471|NCT00758680|11553289|FG006|Overall Study|Laboratory Adverse Event|0
7322472|NCT00758680|11553290|FG007|Overall Study|Laboratory Adverse Event|0
7322473|NCT00758680|11553291|FG008|Overall Study|Laboratory Adverse Event|1
7322474|NCT00758680|11553292|FG009|Overall Study|Laboratory Adverse Event|0
7322475|NCT00758680|11553283|FG000|Overall Study|Withdrawal by Subject|0
7322476|NCT00758680|11553284|FG001|Overall Study|Withdrawal by Subject|0
7322477|NCT00758680|11553285|FG002|Overall Study|Withdrawal by Subject|0
7322478|NCT00758680|11553286|FG003|Overall Study|Withdrawal by Subject|0
7322479|NCT00758680|11553287|FG004|Overall Study|Withdrawal by Subject|0
7322480|NCT00758680|11553288|FG005|Overall Study|Withdrawal by Subject|0
7322481|NCT00758680|11553289|FG006|Overall Study|Withdrawal by Subject|1
7322482|NCT00758680|11553290|FG007|Overall Study|Withdrawal by Subject|0
7322483|NCT00758680|11553291|FG008|Overall Study|Withdrawal by Subject|1
7322484|NCT00758680|11553292|FG009|Overall Study|Withdrawal by Subject|0
7554762|NCT03039699|11917004|FG001|Overall Study|Bacterial infection|28
7554763|NCT03039738|11917012|FG000|Overall Study|Incomplete data sets|54
7554764|NCT03039738|11917013|FG001|Overall Study|Incomplete data sets|0
7554765|NCT03040024|11917035|FG000|Overall Study|Adverse Event|0
7554766|NCT03040024|11917036|FG001|Overall Study|Adverse Event|1
7554767|NCT03040024|11917037|FG002|Overall Study|Adverse Event|0
7554768|NCT03040024|11917035|FG000|Overall Study|Death|0
7554769|NCT03040024|11917036|FG001|Overall Study|Death|1
7554770|NCT03040024|11917037|FG002|Overall Study|Death|0
7554771|NCT03040024|11917035|FG000|Overall Study|Physician Decision|0
7554772|NCT03040024|11917036|FG001|Overall Study|Physician Decision|0
7554773|NCT03040024|11917037|FG002|Overall Study|Physician Decision|1
7554774|NCT03040336|11917056|FG000|Overall Study|Death|1
7554775|NCT03040336|11917057|FG001|Overall Study|Death|0
7554776|NCT03040336|11917056|FG000|Overall Study|Withdrawal by Subject|2
7554777|NCT03040336|11917057|FG001|Overall Study|Withdrawal by Subject|3
7554778|NCT03040674|11917114|FG000|Overall Study|Lost to Follow-up|225
7554779|NCT03040674|11917114|FG000|Overall Study|Death|23
7554780|NCT03040687|11917122|FG000|Overall Study|Withdrawal by Subject|1
7554781|NCT03040687|11917123|FG001|Overall Study|Withdrawal by Subject|0
7554782|NCT03040687|11917124|FG002|Overall Study|Withdrawal by Subject|0
7554783|NCT03040713|11917132|FG000|Overall Study|Positive amyloid scan|3
7554784|NCT03040986|11917142|FG000|Overall Study|Hospice|1
7554785|NCT03040986|11917143|FG001|Overall Study|Hospice|0
7554786|NCT03040986|11917142|FG000|Overall Study|Adverse Event|2
7554787|NCT03040986|11917143|FG001|Overall Study|Adverse Event|1
7554788|NCT03040986|11917142|FG000|Overall Study|Disease progression on study|3
7554789|NCT03040986|11917143|FG001|Overall Study|Disease progression on study|1
7554790|NCT03041025|11917154|FG000|Overall Study|Adverse Event|0
7554791|NCT03041025|11917155|FG001|Overall Study|Adverse Event|0
7554792|NCT03041025|11917156|FG002|Overall Study|Adverse Event|1
7554793|NCT03041025|11917154|FG000|Overall Study|Lost to Follow-up|1
7554794|NCT03041025|11917155|FG001|Overall Study|Lost to Follow-up|0
7554795|NCT03041025|11917156|FG002|Overall Study|Lost to Follow-up|0
7554796|NCT03041025|11917154|FG000|Overall Study|Withdrawal by Subject|0
7554797|NCT03041025|11917155|FG001|Overall Study|Withdrawal by Subject|0
7554798|NCT03041025|11917156|FG002|Overall Study|Withdrawal by Subject|1
7554799|NCT03041038|11917169|FG000|Overall Study|Withdrawal by Subject|4
7554800|NCT03041038|11917170|FG001|Overall Study|Withdrawal by Subject|0
7554801|NCT03041038|11917169|FG000|Overall Study|Lost to Follow-up|1
7554802|NCT03041038|11917170|FG001|Overall Study|Lost to Follow-up|1
7554803|NCT03041038|11917169|FG000|Overall Study|Protocol Violation|1
7554804|NCT03041038|11917170|FG001|Overall Study|Protocol Violation|1
7554805|NCT03041090|11917180|FG000|Overall Study|technical error|0
7554806|NCT03041090|11917181|FG001|Overall Study|technical error|3
7554807|NCT03041116|11917189|FG000|Double-blind|Death|0
7554808|NCT03041116|11917190|FG001|Double-blind|Death|2
7554809|NCT03041116|11917189|FG000|Double-blind|Withdrawal by Subject|0
7554810|NCT03041116|11917190|FG001|Double-blind|Withdrawal by Subject|4
7554811|NCT03041116|11917189|FG000|Open-label|Death|1
7554812|NCT03041116|11917190|FG001|Open-label|Death|0
7554813|NCT03041116|11917189|FG000|Open-label|Termination of the study by Sponsor|39
7554814|NCT03041116|11917190|FG001|Open-label|Termination of the study by Sponsor|37
7322485|NCT00758706|11553317|FG000|Overall Study|Adverse Event|4
7322486|NCT00758706|11553318|FG001|Overall Study|Adverse Event|4
7322487|NCT00758771|11553376|FG000|Overall Study|Withdrawal by Subject|1
7322488|NCT00758771|11553377|FG001|Overall Study|Withdrawal by Subject|1
7322489|NCT00758771|11553376|FG000|Overall Study|Did not meet eligibility criteria|2
7322490|NCT00758771|11553377|FG001|Overall Study|Did not meet eligibility criteria|4
7554815|NCT03041116|11917189|FG000|Open-label|Withdrawal by Subject|1
7554816|NCT03041116|11917190|FG001|Open-label|Withdrawal by Subject|0
7554817|NCT03041792|11917226|FG000|Overall Study|Adverse Event|4
7554818|NCT03041792|11917227|FG001|Overall Study|Adverse Event|0
7322491|NCT00759031|11553410|FG000|First Intervention (1 Day)|Physician Decision|1
7322492|NCT00759031|11553411|FG001|First Intervention (1 Day)|Physician Decision|0
7322493|NCT00759031|11553410|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7322494|NCT00759031|11553411|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7322495|NCT00759031|11553410|FG000|First Intervention (1 Day)|Screening failure|1
7322496|NCT00759031|11553411|FG001|First Intervention (1 Day)|Screening failure|0
7322497|NCT00759109|11553423|FG000|Overall Study|Adverse Event|17
7322498|NCT00759109|11553424|FG001|Overall Study|Adverse Event|12
7322499|NCT00759109|11553423|FG000|Overall Study|Inability to comply|1
7322500|NCT00759109|11553424|FG001|Overall Study|Inability to comply|1
7322501|NCT00759109|11553423|FG000|Overall Study|Withdrawal by Subject|9
7322502|NCT00759109|11553424|FG001|Overall Study|Withdrawal by Subject|5
7322503|NCT00759109|11553423|FG000|Overall Study|Death|4
7322504|NCT00759109|11553424|FG001|Overall Study|Death|3
7322505|NCT00759109|11553423|FG000|Overall Study|Lost to Follow-up|4
7322506|NCT00759109|11553424|FG001|Overall Study|Lost to Follow-up|6
7322507|NCT00759109|11553423|FG000|Overall Study|Started new therapy|2
7322508|NCT00759109|11553424|FG001|Overall Study|Started new therapy|6
7322509|NCT00759109|11553423|FG000|Overall Study|HCV RNA negative|1
7322510|NCT00759109|11553424|FG001|Overall Study|HCV RNA negative|0
7322511|NCT00759109|11553423|FG000|Overall Study|Participant moved to a different city|0
7322512|NCT00759109|11553424|FG001|Overall Study|Participant moved to a different city|1
7322513|NCT00759109|11553423|FG000|Overall Study|Participant had a liver transplant|0
7322514|NCT00759109|11553424|FG001|Overall Study|Participant had a liver transplant|1
7416266|NCT01449279|11689880|FG000|Overall Study|Lack of Efficacy|5
7416267|NCT01449279|11689880|FG000|Overall Study|Toxicity|2
7416268|NCT01449370|11689913|FG000|Overall Study|Disease Progression|5
7416269|NCT01449370|11689914|FG001|Overall Study|Disease Progression|4
7416270|NCT01449370|11689915|FG002|Overall Study|Disease Progression|8
7416271|NCT01449370|11689916|FG003|Overall Study|Disease Progression|3
7416272|NCT01449370|11689917|FG004|Overall Study|Disease Progression|3
7416273|NCT01449370|11689918|FG005|Overall Study|Disease Progression|3
7416274|NCT01449370|11689919|FG006|Overall Study|Disease Progression|3
7416275|NCT01449370|11689920|FG007|Overall Study|Disease Progression|2
7416276|NCT01449370|11689921|FG008|Overall Study|Disease Progression|9
7416277|NCT01449370|11689922|FG009|Overall Study|Disease Progression|1
7416278|NCT01449370|11689923|FG010|Overall Study|Disease Progression|3
7416279|NCT01449370|11689924|FG011|Overall Study|Disease Progression|3
7416280|NCT01449370|11689925|FG012|Overall Study|Disease Progression|2
7416281|NCT01449370|11689926|FG013|Overall Study|Disease Progression|8
7416282|NCT01449370|11689927|FG014|Overall Study|Disease Progression|3
7416283|NCT01449370|11689928|FG015|Overall Study|Disease Progression|1
7416284|NCT01449370|11689929|FG016|Overall Study|Disease Progression|4
7416285|NCT01449370|11689930|FG017|Overall Study|Disease Progression|3
7554819|NCT03041792|11917226|FG000|Overall Study|Death in the family|0
7554820|NCT03041792|11917227|FG001|Overall Study|Death in the family|2
7554821|NCT03041792|11917226|FG000|Overall Study|Randomized but not treated|0
7554822|NCT03041792|11917227|FG001|Overall Study|Randomized but not treated|1
7554823|NCT03042312|11917278|FG000|Overall Study|Administrative Reason|1
7554824|NCT03042312|11917279|FG001|Overall Study|Administrative Reason|1
7554825|NCT03042312|11917278|FG000|Overall Study|Adverse Event|0
7554826|NCT03042312|11917279|FG001|Overall Study|Adverse Event|1
7554827|NCT03042312|11917278|FG000|Overall Study|Lost to Follow-up|1
7554828|NCT03042312|11917279|FG001|Overall Study|Lost to Follow-up|3
7554829|NCT03042312|11917278|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
7554830|NCT03042312|11917279|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
7322515|NCT00759109|11553423|FG000|Overall Study|Lost during study|1
7322516|NCT00759109|11553424|FG001|Overall Study|Lost during study|0
7322517|NCT00759148|11553432|FG000|Overall Study|Adverse Event|1
7322518|NCT00759148|11553433|FG001|Overall Study|Adverse Event|6
7322519|NCT00759148|11553432|FG000|Overall Study|Withdrawal by Subject|3
7322520|NCT00759148|11553433|FG001|Overall Study|Withdrawal by Subject|7
7322521|NCT00759148|11553432|FG000|Overall Study|Lost to Follow-up|3
7322522|NCT00759148|11553433|FG001|Overall Study|Lost to Follow-up|9
7322523|NCT00759148|11553432|FG000|Overall Study|Treatment Failure|6
7322524|NCT00759148|11553433|FG001|Overall Study|Treatment Failure|10
7322525|NCT00759148|11553432|FG000|Overall Study|Reason not given|1
7322526|NCT00759148|11553433|FG001|Overall Study|Reason not given|0
7322527|NCT00759174|11553448|FG000|Overall Study|Other|0
7322528|NCT00759174|11553449|FG001|Overall Study|Other|2
7322529|NCT00759356|11553489|FG000|Overall Study|Adverse Event|0
7322530|NCT00759356|11553490|FG001|Overall Study|Adverse Event|1
7416286|NCT01449370|11689931|FG018|Overall Study|Disease Progression|1
7416287|NCT01449370|11689932|FG019|Overall Study|Disease Progression|2
7416288|NCT01449370|11689933|FG020|Overall Study|Disease Progression|5
7416289|NCT01449370|11689934|FG021|Overall Study|Disease Progression|2
7416290|NCT01449370|11689935|FG022|Overall Study|Disease Progression|3
7416291|NCT01449370|11689936|FG023|Overall Study|Disease Progression|7
7554831|NCT03042312|11917278|FG000|Overall Study|Withdrawal by Subject|4
7554832|NCT03042312|11917279|FG001|Overall Study|Withdrawal by Subject|5
7554833|NCT03042559|11917287|FG000|Overall Study|drop out|1
7322531|NCT00759356|11553489|FG000|Overall Study|Withdrawal by Subject|0
7322532|NCT00759356|11553490|FG001|Overall Study|Withdrawal by Subject|2
7416292|NCT01449370|11689937|FG024|Overall Study|Disease Progression|3
7322533|NCT00759356|11553489|FG000|Overall Study|Subject was unable to return|1
7322534|NCT00759356|11553490|FG001|Overall Study|Subject was unable to return|0
7416293|NCT01449370|11689913|FG000|Overall Study|Adverse Event|1
7416294|NCT01449370|11689914|FG001|Overall Study|Adverse Event|2
7416295|NCT01449370|11689915|FG002|Overall Study|Adverse Event|0
7554834|NCT03042559|11917288|FG001|Overall Study|drop out|1
7554835|NCT03042767|11917305|FG000|Overall Study|Lost to Follow-up|1
7554836|NCT03042767|11917306|FG001|Overall Study|Lost to Follow-up|2
7554837|NCT03042910|11917312|FG000|Overall Study|Adverse Event|1
7554838|NCT03042910|11917312|FG000|Overall Study|Disease Progression|2
7554839|NCT03042910|11917312|FG000|Overall Study|Withdrawal by Subject|3
7554840|NCT03042910|11917312|FG000|Overall Study|Enrolled but not treated|1
7554841|NCT03043365|11917345|FG000|Weeks 0 to Week 8|Adverse Event|1
7554842|NCT03043365|11917346|FG001|Weeks 0 to Week 8|Adverse Event|3
7554843|NCT03043365|11917345|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
7554844|NCT03043365|11917346|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
7554845|NCT03043365|11917345|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
7554846|NCT03043365|11917346|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
7554847|NCT03043560|11917365|FG000|Overall Study|Discontinued Intervention|1
7554848|NCT03043560|11917366|FG001|Overall Study|Discontinued Intervention|2
7554849|NCT03043560|11917365|FG000|Overall Study|Lost to Follow-up|0
7554850|NCT03043560|11917366|FG001|Overall Study|Lost to Follow-up|1
7554851|NCT03043651|11917372|FG000|Overall Study|Death|1
7554852|NCT03043651|11917372|FG000|Overall Study|Progressive Disease|2
7554853|NCT03043651|11917372|FG000|Overall Study|Adverse Event|2
7554854|NCT03043651|11917372|FG000|Overall Study|Withdrawal by Subject|4
7554855|NCT03043651|11917372|FG000|Overall Study|Study Terminated by Sponsor|39
7554856|NCT03044106|11917407|FG000|Washout (1 Week)|Withdrawal by Subject|0
7554857|NCT03044106|11917408|FG001|Washout (1 Week)|Withdrawal by Subject|2
7554858|NCT03044197|11917423|FG000|Overall Study|Withdrawal by Subject|3
7554859|NCT03044197|11917424|FG001|Overall Study|Withdrawal by Subject|1
7554860|NCT03044249|11917432|FG000|Overall Study|Adverse Event|4
7554861|NCT03044249|11917433|FG001|Overall Study|Adverse Event|9
7554862|NCT03044249|11917432|FG000|Overall Study|Lost to Follow-up|1
7554863|NCT03044249|11917433|FG001|Overall Study|Lost to Follow-up|0
7554864|NCT03044249|11917432|FG000|Overall Study|Non-compliance with Study Drug|1
7554865|NCT03044249|11917433|FG001|Overall Study|Non-compliance with Study Drug|0
7554866|NCT03044249|11917432|FG000|Overall Study|Study Terminated by Sponsor|2
7554867|NCT03044249|11917433|FG001|Overall Study|Study Terminated by Sponsor|0
7554868|NCT03044249|11917432|FG000|Overall Study|Withdrawal by Subject|2
7554869|NCT03044249|11917433|FG001|Overall Study|Withdrawal by Subject|5
7554870|NCT03044353|11917447|FG000|Overall Study|Adverse Event|0
7554871|NCT03044353|11917448|FG001|Overall Study|Adverse Event|1
7554872|NCT03044353|11917449|FG002|Overall Study|Adverse Event|0
7554873|NCT03044431|11917460|FG000|Overall Study|Lost to Follow-up|59
7554874|NCT03044574|11917466|FG000|Overall Study|Lost to Follow-up|37
7554875|NCT03044574|11917467|FG001|Overall Study|Lost to Follow-up|45
7554876|NCT03044730|11917482|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
7554877|NCT03044730|11917482|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
7554878|NCT03044730|11917482|FG000|3 Cycles of Pembro + Capecitab|Death|1
7554879|NCT03044730|11917482|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
7554880|NCT03044730|11917482|FG000|Cycles 4 and Beyond|Progressive Disease|9
7554881|NCT03044730|11917482|FG000|Cycles 4 and Beyond|Adverse Event|1
7554882|NCT03044730|11917482|FG000|On Follow-up for 2 Years|Still in follow-up|7
7554883|NCT03044730|11917482|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
7554884|NCT03044730|11917482|FG000|On Follow-up for 2 Years|Death|17
7554885|NCT03044886|11917490|FG000|Overall Study|Lost to Follow-up|15
7554886|NCT03044886|11917491|FG001|Overall Study|Lost to Follow-up|10
7554887|NCT03044886|11917492|FG002|Overall Study|Lost to Follow-up|12
7554888|NCT03045081|11917502|FG000|Overall Study|Withdrawal by Subject|6
7554889|NCT03045081|11917503|FG001|Overall Study|Withdrawal by Subject|11
7554890|NCT03045302|11917509|FG000|Overall Study|Pre-treatment adverse event|1
7554891|NCT03045328|11917513|FG000|Overall Study|Withdrawal by Subject|2
7554892|NCT03045887|11917551|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
7554893|NCT03045887|11917552|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7322535|NCT00759395|11553498|FG000|Overall Study|Adverse Event|1
7416296|NCT01449370|11689916|FG003|Overall Study|Adverse Event|1
7416297|NCT01449370|11689917|FG004|Overall Study|Adverse Event|0
7416298|NCT01449370|11689918|FG005|Overall Study|Adverse Event|0
7554894|NCT03045887|11917553|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554895|NCT03045887|11917554|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554896|NCT03045887|11917555|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554897|NCT03045887|11917556|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554898|NCT03045887|11917557|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554899|NCT03045887|11917558|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554900|NCT03045887|11917559|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554901|NCT03045887|11917560|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
7554902|NCT03045887|11917551|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554903|NCT03045887|11917552|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554904|NCT03045887|11917553|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7322536|NCT00759395|11553499|FG001|Overall Study|Adverse Event|0
7322537|NCT00759395|11553498|FG000|Overall Study|Withdrawal by Subject|1
7322538|NCT00759395|11553499|FG001|Overall Study|Withdrawal by Subject|0
7554905|NCT03045887|11917554|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
7554906|NCT03045887|11917555|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554907|NCT03045887|11917556|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554908|NCT03045887|11917557|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554909|NCT03045887|11917558|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554910|NCT03045887|11917559|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554911|NCT03045887|11917560|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
7554912|NCT03045887|11917551|FG000|Part A, Period 2 (1 Day)|Adverse Event|1
7554913|NCT03045887|11917552|FG001|Part A, Period 2 (1 Day)|Adverse Event|0
7554914|NCT03045887|11917553|FG002|Part A, Period 2 (1 Day)|Adverse Event|0
7554915|NCT03045887|11917554|FG003|Part A, Period 2 (1 Day)|Adverse Event|0
7554916|NCT03045887|11917555|FG004|Part A, Period 2 (1 Day)|Adverse Event|0
7554917|NCT03045887|11917556|FG005|Part A, Period 2 (1 Day)|Adverse Event|0
7554918|NCT03045887|11917557|FG006|Part A, Period 2 (1 Day)|Adverse Event|0
7554919|NCT03045887|11917558|FG007|Part A, Period 2 (1 Day)|Adverse Event|0
7554920|NCT03045887|11917559|FG008|Part A, Period 2 (1 Day)|Adverse Event|0
7554921|NCT03045887|11917560|FG009|Part A, Period 2 (1 Day)|Adverse Event|0
7554922|NCT03045887|11917551|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554923|NCT03045887|11917552|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554924|NCT03045887|11917553|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7554925|NCT03045887|11917554|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
7554926|NCT03045887|11917555|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554927|NCT03045887|11917556|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554928|NCT03045887|11917557|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554929|NCT03045887|11917558|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554930|NCT03045887|11917559|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554931|NCT03045887|11917560|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
7554932|NCT03045887|11917551|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554933|NCT03045887|11917552|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554934|NCT03045887|11917553|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554935|NCT03045887|11917554|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
7554936|NCT03045887|11917555|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554937|NCT03045887|11917556|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554938|NCT03045887|11917557|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554939|NCT03045887|11917558|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554940|NCT03045887|11917559|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554941|NCT03045887|11917560|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
7554942|NCT03046056|11917594|FG000|Overall Study|Non-responder at Week 10|6
7554943|NCT03046056|11917595|FG001|Overall Study|Non-responder at Week 10|6
7554944|NCT03046056|11917596|FG002|Overall Study|Non-responder at Week 10|4
7554945|NCT03046056|11917594|FG000|Overall Study|Protocol-specified Disease Worsening|3
7554946|NCT03046056|11917595|FG001|Overall Study|Protocol-specified Disease Worsening|3
7554947|NCT03046056|11917596|FG002|Overall Study|Protocol-specified Disease Worsening|1
7554948|NCT03046056|11917594|FG000|Overall Study|Adverse Event|1
7554949|NCT03046056|11917595|FG001|Overall Study|Adverse Event|5
7554950|NCT03046056|11917596|FG002|Overall Study|Adverse Event|0
7554951|NCT03046056|11917594|FG000|Overall Study|Non-compliance With Study Drug|0
7554952|NCT03046056|11917595|FG001|Overall Study|Non-compliance With Study Drug|0
7554953|NCT03046056|11917596|FG002|Overall Study|Non-compliance With Study Drug|2
7554954|NCT03046056|11917594|FG000|Overall Study|Protocol Violation|1
7554955|NCT03046056|11917595|FG001|Overall Study|Protocol Violation|1
7554956|NCT03046056|11917596|FG002|Overall Study|Protocol Violation|0
7554957|NCT03046056|11917594|FG000|Overall Study|Investigator's Discretion|0
7554958|NCT03046056|11917595|FG001|Overall Study|Investigator's Discretion|1
7554959|NCT03046056|11917596|FG002|Overall Study|Investigator's Discretion|0
7554960|NCT03046056|11917594|FG000|Overall Study|Withdrew Consent|1
7554961|NCT03046056|11917595|FG001|Overall Study|Withdrew Consent|0
7554962|NCT03046056|11917596|FG002|Overall Study|Withdrew Consent|0
7554963|NCT03046446|11917622|FG000|Overall Study|Lack of Efficacy|7
7554964|NCT03046446|11917622|FG000|Overall Study|Adverse Event|6
7554965|NCT03046446|11917622|FG000|Overall Study|Lost to Follow-up|3
7554966|NCT03046446|11917622|FG000|Overall Study|Withdrawal by Subject|14
7554967|NCT03046446|11917622|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
7554968|NCT03046446|11917622|FG000|Overall Study|Disease Progression (see caveats)|25
7554969|NCT03046446|11917622|FG000|Overall Study|Non OA related knee surgery|1
7554970|NCT03047551|11917685|FG000|Overall Study|Did not receive TAS|1
7554971|NCT03047551|11917686|FG001|Overall Study|Did not receive TAS|0
7554972|NCT03047551|11917685|FG000|Overall Study|Physician Decision|1
7322539|NCT00759395|11553498|FG000|Overall Study|Lack of Efficacy|0
7554973|NCT03047551|11917686|FG001|Overall Study|Physician Decision|0
7554974|NCT03047551|11917685|FG000|Overall Study|Withdrawal by Subject|0
7554975|NCT03047551|11917686|FG001|Overall Study|Withdrawal by Subject|1
7554976|NCT03047551|11917685|FG000|Overall Study|Probe malfunction|0
7554977|NCT03047551|11917686|FG001|Overall Study|Probe malfunction|1
7322540|NCT00759395|11553499|FG001|Overall Study|Lack of Efficacy|2
7322541|NCT00759564|11553542|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
7322542|NCT00759564|11553543|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
7322543|NCT00759564|11553544|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
7322544|NCT00759564|11553545|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
7530968|NCT02641379|11874575|FG004|Overall Study|Missing PCR result at Week 8|0
7530969|NCT02641379|11874576|FG005|Overall Study|Missing PCR result at Week 8|0
7554978|NCT03047551|11917685|FG000|Overall Study|Ineligible|0
7554979|NCT03047551|11917686|FG001|Overall Study|Ineligible|1
7554980|NCT03047720|11917694|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
7554981|NCT03047720|11917695|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
7554982|NCT03047980|11917701|FG000|Overall Study|Adverse Event|1
7554983|NCT03048058|11917711|FG000|Overall Study|Lost to Follow-up|4
7554984|NCT03048058|11917712|FG001|Overall Study|Lost to Follow-up|0
7554985|NCT03048058|11917711|FG000|Overall Study|Withdrawal by Subject|0
7554986|NCT03048058|11917712|FG001|Overall Study|Withdrawal by Subject|4
7554987|NCT03048500|11917731|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
7554988|NCT03048500|11917731|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
7554989|NCT03048500|11917731|FG000|Reached 1st Response/Continued Treatment|Death|1
7554990|NCT03048500|11917731|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
7554991|NCT03048500|11917731|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
7554992|NCT03048500|11917731|FG000|Follow up for 3 Years|Currently in Follow-up|4
7554993|NCT03048500|11917731|FG000|Follow up for 3 Years|Death|12
7554994|NCT03048747|11917735|FG000|Overall Study|Adverse Event|2
7554995|NCT03048747|11917735|FG000|Overall Study|Participant Met Withdrawal Criteria|2
7554996|NCT03048747|11917735|FG000|Overall Study|Physician Decision|1
7574613|NCT03684642|11957557|FG000|Overall Study|Adverse Event|6
7574614|NCT03684642|11957558|FG001|Overall Study|Adverse Event|15
7574615|NCT03684642|11957559|FG002|Overall Study|Adverse Event|11
7574616|NCT03684642|11957557|FG000|Overall Study|Withdrawal by Subject|35
7574617|NCT03684642|11957558|FG001|Overall Study|Withdrawal by Subject|53
7574618|NCT03684642|11957559|FG002|Overall Study|Withdrawal by Subject|23
7574619|NCT03684642|11957557|FG000|Overall Study|Lack of Efficacy|0
7574620|NCT03684642|11957558|FG001|Overall Study|Lack of Efficacy|0
7574621|NCT03684642|11957559|FG002|Overall Study|Lack of Efficacy|1
7530970|NCT02641379|11874577|FG006|Overall Study|Missing PCR result at Week 8|0
7530971|NCT02641379|11874578|FG007|Overall Study|Missing PCR result at Week 8|0
7530972|NCT02641379|11874579|FG008|Overall Study|Missing PCR result at Week 8|0
7530973|NCT02641379|11874580|FG009|Overall Study|Missing PCR result at Week 8|1
7530974|NCT02641379|11874581|FG010|Overall Study|Missing PCR result at Week 8|0
7530975|NCT02641379|11874571|FG000|Overall Study|PCR positive|0
7530976|NCT02641379|11874572|FG001|Overall Study|PCR positive|0
7530977|NCT02641379|11874573|FG002|Overall Study|PCR positive|0
7530978|NCT02641379|11874574|FG003|Overall Study|PCR positive|0
7530979|NCT02641379|11874575|FG004|Overall Study|PCR positive|0
7530980|NCT02641379|11874576|FG005|Overall Study|PCR positive|0
7574622|NCT03684642|11957557|FG000|Overall Study|Poor compliance to protocol|0
7574623|NCT03684642|11957558|FG001|Overall Study|Poor compliance to protocol|4
7574624|NCT03684642|11957559|FG002|Overall Study|Poor compliance to protocol|1
7574625|NCT03684642|11957557|FG000|Overall Study|Other than specified|62
7574626|NCT03684642|11957558|FG001|Overall Study|Other than specified|60
7574627|NCT03684642|11957559|FG002|Overall Study|Other than specified|67
7574628|NCT03684642|11957557|FG000|Overall Study|Randomized and not treated|0
7574629|NCT03684642|11957558|FG001|Overall Study|Randomized and not treated|0
7574630|NCT03684642|11957559|FG002|Overall Study|Randomized and not treated|1
7574631|NCT03684642|11957557|FG000|Overall Study|Missing completion status but alive at last contact|0
7574632|NCT03684642|11957558|FG001|Overall Study|Missing completion status but alive at last contact|1
7574633|NCT03684642|11957559|FG002|Overall Study|Missing completion status but alive at last contact|2
7574634|NCT03684928|11957567|FG000|First Intervention|Lost to Follow-up|0
7574635|NCT03684928|11957568|FG001|First Intervention|Lost to Follow-up|1
7574636|NCT03684928|11957567|FG000|First Intervention|Withdrawal by Subject|0
7574637|NCT03684928|11957568|FG001|First Intervention|Withdrawal by Subject|2
7574638|NCT03684928|11957567|FG000|Second Intervention|Soft Tissue Injury|1
7574639|NCT03684928|11957568|FG001|Second Intervention|Soft Tissue Injury|0
7574640|NCT03685344|11957578|FG000|Overall Study|Withdrawal by Subject|1
7574641|NCT03685344|11957579|FG001|Overall Study|Withdrawal by Subject|1
7574642|NCT03685344|11957580|FG002|Overall Study|Withdrawal by Subject|2
7574643|NCT03685344|11957581|FG003|Overall Study|Withdrawal by Subject|0
7574644|NCT03685344|11957578|FG000|Overall Study|Physician Decision|1
7574645|NCT03685344|11957579|FG001|Overall Study|Physician Decision|1
7574646|NCT03685344|11957580|FG002|Overall Study|Physician Decision|5
7574647|NCT03685344|11957581|FG003|Overall Study|Physician Decision|0
7574648|NCT03685344|11957578|FG000|Overall Study|Death|1
7574649|NCT03685344|11957579|FG001|Overall Study|Death|1
7574650|NCT03685344|11957580|FG002|Overall Study|Death|0
7574651|NCT03685344|11957581|FG003|Overall Study|Death|0
7574652|NCT03685643|11957602|FG000|Overall Study|Lost to Follow-up|14
7574653|NCT03685643|11957603|FG001|Overall Study|Lost to Follow-up|22
7322545|NCT00759564|11553546|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
7530981|NCT02641379|11874577|FG006|Overall Study|PCR positive|1
7322546|NCT00759681|11553597|FG000|Overall Study|Death|2
7322547|NCT00759681|11553598|FG001|Overall Study|Death|5
7322548|NCT00759681|11553597|FG000|Overall Study|Lost to Follow-up|8
7322549|NCT00759681|11553598|FG001|Overall Study|Lost to Follow-up|5
7322550|NCT00759759|11553611|FG000|Overall Study|didn't return for period 2|1
7322551|NCT00759759|11553612|FG001|Overall Study|didn't return for period 2|0
7322552|NCT00759759|11553611|FG000|Overall Study|Didn't receive drug in period 2|1
7322553|NCT00759759|11553612|FG001|Overall Study|Didn't receive drug in period 2|0
7322554|NCT00759759|11553611|FG000|Overall Study|Withdrawal by Subject|2
7322555|NCT00759759|11553612|FG001|Overall Study|Withdrawal by Subject|1
7530982|NCT02641379|11874578|FG007|Overall Study|PCR positive|0
7554997|NCT03049280|11917749|FG000|Overall Study|Physician Decision|1
7554998|NCT03049488|11917761|FG000|Overall Study|Lost to Follow-up|1
7554999|NCT03049488|11917762|FG001|Overall Study|Lost to Follow-up|1
7555000|NCT03049488|11917763|FG002|Overall Study|Lost to Follow-up|0
7555001|NCT03049488|11917764|FG003|Overall Study|Lost to Follow-up|0
7555002|NCT03049488|11917765|FG004|Overall Study|Lost to Follow-up|0
7555003|NCT03049488|11917766|FG005|Overall Study|Lost to Follow-up|0
7555004|NCT03049488|11917761|FG000|Overall Study|Moved from Area|1
7555005|NCT03049488|11917762|FG001|Overall Study|Moved from Area|0
7555006|NCT03049488|11917763|FG002|Overall Study|Moved from Area|0
7555007|NCT03049488|11917764|FG003|Overall Study|Moved from Area|1
7555008|NCT03049488|11917765|FG004|Overall Study|Moved from Area|1
7555009|NCT03049488|11917766|FG005|Overall Study|Moved from Area|0
7555010|NCT03049488|11917761|FG000|Overall Study|Physician Decision|0
7555011|NCT03049488|11917762|FG001|Overall Study|Physician Decision|1
7555012|NCT03049488|11917763|FG002|Overall Study|Physician Decision|0
7530983|NCT02641379|11874579|FG008|Overall Study|PCR positive|0
7555013|NCT03049488|11917764|FG003|Overall Study|Physician Decision|0
7555014|NCT03049488|11917765|FG004|Overall Study|Physician Decision|0
7555015|NCT03049488|11917766|FG005|Overall Study|Physician Decision|0
7555016|NCT03049488|11917761|FG000|Overall Study|Withdrawal by Subject|0
7555017|NCT03049488|11917762|FG001|Overall Study|Withdrawal by Subject|0
7555018|NCT03049488|11917763|FG002|Overall Study|Withdrawal by Subject|0
7555019|NCT03049488|11917764|FG003|Overall Study|Withdrawal by Subject|1
7555020|NCT03049488|11917765|FG004|Overall Study|Withdrawal by Subject|1
7555021|NCT03049488|11917766|FG005|Overall Study|Withdrawal by Subject|0
7555022|NCT03049748|11917792|FG000|Overall Study|Lost to Follow-up|1
7555023|NCT03049748|11917793|FG001|Overall Study|Lost to Follow-up|0
7555024|NCT03049748|11917792|FG000|Overall Study|Death|3
7555025|NCT03049748|11917793|FG001|Overall Study|Death|0
7555026|NCT03049748|11917792|FG000|Overall Study|Withdrawal by Subject|0
7555027|NCT03049748|11917793|FG001|Overall Study|Withdrawal by Subject|3
7555028|NCT03049748|11917792|FG000|Overall Study|Protocol Violation|0
7555029|NCT03049748|11917793|FG001|Overall Study|Protocol Violation|2
7555030|NCT03049748|11917792|FG000|Overall Study|Moved out of state (relocation)|0
7555031|NCT03049748|11917793|FG001|Overall Study|Moved out of state (relocation)|1
7555032|NCT03049852|11917802|FG000|Overall Study|Lost to Follow-up|0
7555033|NCT03049852|11917803|FG001|Overall Study|Lost to Follow-up|1
7555034|NCT03049852|11917804|FG002|Overall Study|Lost to Follow-up|0
7555035|NCT03050307|11917889|FG000|Overall Study|Adverse Event|4
7555036|NCT03050307|11917890|FG001|Overall Study|Adverse Event|2
7555037|NCT03050307|11917889|FG000|Overall Study|Significant Protocol Deviation|0
7555038|NCT03050307|11917890|FG001|Overall Study|Significant Protocol Deviation|1
7555039|NCT03050307|11917889|FG000|Overall Study|Lost to Follow-up|0
7555040|NCT03050307|11917890|FG001|Overall Study|Lost to Follow-up|1
7555041|NCT03050307|11917889|FG000|Overall Study|Voluntary Withdrawal|3
7555042|NCT03050307|11917890|FG001|Overall Study|Voluntary Withdrawal|4
7555043|NCT03050307|11917889|FG000|Overall Study|Reason not Specified|1
7555044|NCT03050307|11917890|FG001|Overall Study|Reason not Specified|1
7555045|NCT03050359|11917909|FG000|Overall Study|Randomized But Not Treated|2
7555046|NCT03050359|11917910|FG001|Overall Study|Randomized But Not Treated|0
7555047|NCT03050359|11917909|FG000|Overall Study|Pretreatment Event/Adverse Event|5
7555048|NCT03050359|11917910|FG001|Overall Study|Pretreatment Event/Adverse Event|10
7555049|NCT03050359|11917909|FG000|Overall Study|Significant Protocol Deviation|2
7555050|NCT03050359|11917910|FG001|Overall Study|Significant Protocol Deviation|3
7555051|NCT03050359|11917909|FG000|Overall Study|Lost to Follow-up|2
7555052|NCT03050359|11917910|FG001|Overall Study|Lost to Follow-up|1
7555053|NCT03050359|11917909|FG000|Overall Study|Voluntary Withdrawal|4
7555054|NCT03050359|11917910|FG001|Overall Study|Voluntary Withdrawal|6
7555055|NCT03050359|11917909|FG000|Overall Study|Pregnancy|1
7555056|NCT03050359|11917910|FG001|Overall Study|Pregnancy|0
7555057|NCT03050359|11917909|FG000|Overall Study|Reason Not Specified|1
7555058|NCT03050359|11917910|FG001|Overall Study|Reason Not Specified|0
7555059|NCT03050372|11917918|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
7555060|NCT03050372|11917919|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
7384828|NCT01197508|11642266|FG000|Overall Study|Study-specific withdrawal criteria|0
7384829|NCT01197508|11642267|FG001|Overall Study|Study-specific withdrawal criteria|0
7384830|NCT01197508|11642268|FG002|Overall Study|Study-specific withdrawal criteria|1
7555061|NCT03050372|11917918|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
7555062|NCT03050372|11917919|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
7384831|NCT01197508|11642269|FG003|Overall Study|Study-specific withdrawal criteria|2
7555063|NCT03050450|11917929|FG000|Overall Study|Physician Decision|1
7322556|NCT00759785|11553629|FG000|Overall Study|Participant sample not evaluable|11
7322557|NCT00759785|11553630|FG001|Overall Study|Participant sample not evaluable|2
7322558|NCT00759785|11553629|FG000|Overall Study|Participant sample lost|0
7322559|NCT00759785|11553630|FG001|Overall Study|Participant sample lost|1
7322560|NCT00759785|11553629|FG000|Overall Study|Protocol Violation|1
7555064|NCT03050450|11917930|FG001|Overall Study|Physician Decision|0
7555065|NCT03050450|11917931|FG002|Overall Study|Physician Decision|0
7555066|NCT03050450|11917932|FG003|Overall Study|Physician Decision|0
7555067|NCT03050450|11917933|FG004|Overall Study|Physician Decision|0
7555068|NCT03050801|11918014|FG000|Experiment 1|Lost to Follow-up|0
7555069|NCT03050801|11918015|FG001|Experiment 1|Lost to Follow-up|1
7555070|NCT03050801|11918016|FG002|Experiment 1|Lost to Follow-up|0
7555071|NCT03050801|11918017|FG003|Experiment 1|Lost to Follow-up|0
7555072|NCT03050801|11918018|FG004|Experiment 1|Lost to Follow-up|0
7555073|NCT03050801|11918019|FG005|Experiment 1|Lost to Follow-up|0
7555074|NCT03050801|11918014|FG000|Experiment 1|Physician Decision|0
7555075|NCT03050801|11918015|FG001|Experiment 1|Physician Decision|3
7555076|NCT03050801|11918016|FG002|Experiment 1|Physician Decision|0
7555077|NCT03050801|11918017|FG003|Experiment 1|Physician Decision|0
7555078|NCT03050801|11918018|FG004|Experiment 1|Physician Decision|0
7555079|NCT03050801|11918019|FG005|Experiment 1|Physician Decision|0
7555080|NCT03050801|11918014|FG000|Experiment 1|Change of experimental design|0
7555081|NCT03050801|11918015|FG001|Experiment 1|Change of experimental design|3
7555082|NCT03050801|11918016|FG002|Experiment 1|Change of experimental design|0
7555083|NCT03050801|11918017|FG003|Experiment 1|Change of experimental design|0
7555084|NCT03050801|11918018|FG004|Experiment 1|Change of experimental design|0
7555085|NCT03050801|11918019|FG005|Experiment 1|Change of experimental design|0
7555086|NCT03050801|11918014|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
7555087|NCT03050801|11918015|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
7555088|NCT03050801|11918016|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
7555089|NCT03050801|11918017|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
7555090|NCT03050801|11918018|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
7555091|NCT03050801|11918019|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
7555092|NCT03050801|11918014|FG000|Experiment 2|Lost to Follow-up|0
7555093|NCT03050801|11918015|FG001|Experiment 2|Lost to Follow-up|0
7555094|NCT03050801|11918016|FG002|Experiment 2|Lost to Follow-up|0
7555095|NCT03050801|11918017|FG003|Experiment 2|Lost to Follow-up|1
7555096|NCT03050801|11918018|FG004|Experiment 2|Lost to Follow-up|1
7555097|NCT03050801|11918019|FG005|Experiment 2|Lost to Follow-up|0
7555098|NCT03050801|11918014|FG000|Experiment 2|Physician Decision|0
7555099|NCT03050801|11918015|FG001|Experiment 2|Physician Decision|0
7555100|NCT03050801|11918016|FG002|Experiment 2|Physician Decision|0
7555101|NCT03050801|11918017|FG003|Experiment 2|Physician Decision|0
7555102|NCT03050801|11918018|FG004|Experiment 2|Physician Decision|1
7555103|NCT03050801|11918019|FG005|Experiment 2|Physician Decision|0
7555104|NCT03050801|11918014|FG000|Experiment 2|Pregnancy|0
7555105|NCT03050801|11918015|FG001|Experiment 2|Pregnancy|0
7555106|NCT03050801|11918016|FG002|Experiment 2|Pregnancy|0
7555107|NCT03050801|11918017|FG003|Experiment 2|Pregnancy|0
7555108|NCT03050801|11918018|FG004|Experiment 2|Pregnancy|1
7555109|NCT03050801|11918019|FG005|Experiment 2|Pregnancy|0
7322561|NCT00759785|11553630|FG001|Overall Study|Protocol Violation|0
7322562|NCT00759785|11553629|FG000|Overall Study|Physician Decision|0
7322563|NCT00759785|11553630|FG001|Overall Study|Physician Decision|1
7322564|NCT00759785|11553629|FG000|Overall Study|Withdrawal by Subject|0
7322565|NCT00759785|11553630|FG001|Overall Study|Withdrawal by Subject|1
7322566|NCT00759863|11553651|FG000|Overall Study|Death, moved, or lost contact|20
7322567|NCT00759863|11553652|FG001|Overall Study|Death, moved, or lost contact|18
7322568|NCT00759876|11553658|FG000|Overall Study|Sponsor terminated study early|36
7322569|NCT00759902|11553664|FG000|Overall Study|Adverse Event|0
7322570|NCT00759902|11553665|FG001|Overall Study|Adverse Event|1
7322571|NCT00759915|11553673|FG000|Overall Study|Withdrawal by Subject|1
7322572|NCT00759915|11553674|FG001|Overall Study|Withdrawal by Subject|0
7322573|NCT00759915|11553673|FG000|Overall Study|Adverse Event|0
7322574|NCT00759915|11553674|FG001|Overall Study|Adverse Event|1
7322575|NCT00759941|11553682|FG000|Overall Study|Use of medication|1
7322576|NCT00759941|11553683|FG001|Overall Study|Use of medication|0
7322577|NCT00759941|11553682|FG000|Overall Study|Adverse Event|1
7322578|NCT00759941|11553683|FG001|Overall Study|Adverse Event|0
7322579|NCT00759941|11553682|FG000|Overall Study|Exited in error by site|1
7322580|NCT00759941|11553683|FG001|Overall Study|Exited in error by site|1
7322581|NCT00759954|11553691|FG000|Overall Study|Personal reason|1
7322582|NCT00759954|11553692|FG001|Overall Study|Personal reason|0
7322583|NCT00759954|11553691|FG000|Overall Study|Adverse Event|1
7322584|NCT00759954|11553692|FG001|Overall Study|Adverse Event|2
7322585|NCT00760084|11553729|FG000|Overall Study|Physician Decision|5
7322586|NCT00760084|11553729|FG000|Overall Study|Withdrawal by Subject|2
7322587|NCT00760084|11553729|FG000|Overall Study|Progressive Disease|3
7322588|NCT00760214|11553736|FG000|Overall Study|Adverse Event|8
7322589|NCT00760214|11553737|FG001|Overall Study|Adverse Event|9
7322590|NCT00760214|11553738|FG002|Overall Study|Adverse Event|12
7322591|NCT00760214|11553736|FG000|Overall Study|Protocol Violation|3
7322592|NCT00760214|11553737|FG001|Overall Study|Protocol Violation|0
7322593|NCT00760214|11553738|FG002|Overall Study|Protocol Violation|3
7555110|NCT03050801|11918014|FG000|Experiment 2|Withdrawal by Subject|0
7555111|NCT03050801|11918015|FG001|Experiment 2|Withdrawal by Subject|0
7555112|NCT03050801|11918016|FG002|Experiment 2|Withdrawal by Subject|0
7555113|NCT03050801|11918017|FG003|Experiment 2|Withdrawal by Subject|1
7555114|NCT03050801|11918018|FG004|Experiment 2|Withdrawal by Subject|0
7555115|NCT03050801|11918019|FG005|Experiment 2|Withdrawal by Subject|0
7555116|NCT03050801|11918014|FG000|Experiment 2|Poor data quality|0
7555117|NCT03050801|11918015|FG001|Experiment 2|Poor data quality|0
7555118|NCT03050801|11918016|FG002|Experiment 2|Poor data quality|0
7555119|NCT03050801|11918017|FG003|Experiment 2|Poor data quality|4
7555120|NCT03050801|11918018|FG004|Experiment 2|Poor data quality|1
7555121|NCT03050801|11918019|FG005|Experiment 2|Poor data quality|0
7555122|NCT03050801|11918014|FG000|Experiment 2|Discomfort during stimulation|0
7555123|NCT03050801|11918015|FG001|Experiment 2|Discomfort during stimulation|0
7555124|NCT03050801|11918016|FG002|Experiment 2|Discomfort during stimulation|0
7555125|NCT03050801|11918017|FG003|Experiment 2|Discomfort during stimulation|0
7555126|NCT03050801|11918018|FG004|Experiment 2|Discomfort during stimulation|0
7555127|NCT03050801|11918019|FG005|Experiment 2|Discomfort during stimulation|2
7555128|NCT03051100|11918047|FG000|Overall Study|Withdrawal by Subject|1
7555129|NCT03051100|11918048|FG001|Overall Study|Withdrawal by Subject|0
7555130|NCT03051165|11918054|FG000|Overall Study|Withdrawal by Subject|1
7555131|NCT03051165|11918054|FG000|Overall Study|Early termination of study|12
7555132|NCT03051607|11918072|FG000|Overall Study|Adverse Event|66
7555133|NCT03051620|11918076|FG000|Overall Study|Lost to Follow-up|6
7555134|NCT03051620|11918076|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
7555135|NCT03052322|11918116|FG000|Overall Study|Other un-specified|1
7555136|NCT03052322|11918117|FG001|Overall Study|Other un-specified|2
7555137|NCT03052322|11918116|FG000|Overall Study|Withdrawal by Subject|10
7555138|NCT03052322|11918117|FG001|Overall Study|Withdrawal by Subject|9
7555139|NCT03052322|11918116|FG000|Overall Study|Death|0
7555140|NCT03052322|11918117|FG001|Overall Study|Death|2
7555141|NCT03052322|11918116|FG000|Overall Study|Lack of Efficacy|1
7555142|NCT03052322|11918117|FG001|Overall Study|Lack of Efficacy|2
7555143|NCT03052322|11918116|FG000|Overall Study|Protocol Violation|1
7555144|NCT03052322|11918117|FG001|Overall Study|Protocol Violation|0
7555145|NCT03052322|11918116|FG000|Overall Study|Lost to Follow-up|2
7555146|NCT03052322|11918117|FG001|Overall Study|Lost to Follow-up|4
7555147|NCT03052322|11918116|FG000|Overall Study|Adverse Event|6
7555148|NCT03052322|11918117|FG001|Overall Study|Adverse Event|13
7555149|NCT03052426|11918126|FG000|Overall Study|Withdrawal by Subject|0
7555150|NCT03052426|11918127|FG001|Overall Study|Withdrawal by Subject|1
7555151|NCT03052426|11918128|FG002|Overall Study|Withdrawal by Subject|0
7555152|NCT03052426|11918126|FG000|Overall Study|Lost to Follow-up|2
7555153|NCT03052426|11918127|FG001|Overall Study|Lost to Follow-up|0
7555154|NCT03052426|11918128|FG002|Overall Study|Lost to Follow-up|1
7555155|NCT03052517|11918144|FG000|Overall Study|Study Terminated By Sponsor|928
7555156|NCT03052517|11918145|FG001|Overall Study|Study Terminated By Sponsor|938
7555157|NCT03052517|11918146|FG002|Overall Study|Study Terminated By Sponsor|296
7530984|NCT02641379|11874580|FG009|Overall Study|PCR positive|0
7530985|NCT02641379|11874581|FG010|Overall Study|PCR positive|0
7555158|NCT03052517|11918144|FG000|Overall Study|Subject/Guardian Decision|50
7555159|NCT03052517|11918145|FG001|Overall Study|Subject/Guardian Decision|45
7530986|NCT02641392|11874613|FG000|Overall Study|Lost to Follow-up|0
7530987|NCT02641392|11874614|FG001|Overall Study|Lost to Follow-up|0
7530988|NCT02641392|11874615|FG002|Overall Study|Lost to Follow-up|2
7530989|NCT02641392|11874613|FG000|Overall Study|Withdrawal by Subject|0
7530990|NCT02641392|11874614|FG001|Overall Study|Withdrawal by Subject|0
7530991|NCT02641392|11874615|FG002|Overall Study|Withdrawal by Subject|17
7530992|NCT02641392|11874613|FG000|Overall Study|Adverse Event|0
7530993|NCT02641392|11874614|FG001|Overall Study|Adverse Event|1
7530994|NCT02641392|11874615|FG002|Overall Study|Adverse Event|25
7530995|NCT02641392|11874613|FG000|Overall Study|Study Terminated by Sponsor|4
7530996|NCT02641392|11874614|FG001|Overall Study|Study Terminated by Sponsor|12
7530997|NCT02641392|11874615|FG002|Overall Study|Study Terminated by Sponsor|144
7530998|NCT02641392|11874613|FG000|Overall Study|Lack of Efficacy|0
7530999|NCT02641392|11874614|FG001|Overall Study|Lack of Efficacy|0
7531000|NCT02641392|11874615|FG002|Overall Study|Lack of Efficacy|101
7555160|NCT03052517|11918146|FG002|Overall Study|Subject/Guardian Decision|22
7555161|NCT03052517|11918144|FG000|Overall Study|Lack of Efficacy|23
7555162|NCT03052517|11918145|FG001|Overall Study|Lack of Efficacy|14
7555163|NCT03052517|11918146|FG002|Overall Study|Lack of Efficacy|7
7416299|NCT01449370|11689919|FG006|Overall Study|Adverse Event|0
7555164|NCT03052517|11918144|FG000|Overall Study|Adverse Event|6
7555165|NCT03052517|11918145|FG001|Overall Study|Adverse Event|5
7555166|NCT03052517|11918146|FG002|Overall Study|Adverse Event|0
7555167|NCT03052517|11918144|FG000|Overall Study|Physician Decision|4
7555168|NCT03052517|11918145|FG001|Overall Study|Physician Decision|5
7555169|NCT03052517|11918146|FG002|Overall Study|Physician Decision|1
7555170|NCT03052517|11918144|FG000|Overall Study|Death|3
7531001|NCT02641392|11874613|FG000|Overall Study|Miscellaneous|0
7531002|NCT02641392|11874614|FG001|Overall Study|Miscellaneous|0
7531003|NCT02641392|11874615|FG002|Overall Study|Miscellaneous|3
7555171|NCT03052517|11918145|FG001|Overall Study|Death|0
7555172|NCT03052517|11918146|FG002|Overall Study|Death|1
7322594|NCT00760214|11553736|FG000|Overall Study|Lost to Follow-up|0
7322595|NCT00760214|11553737|FG001|Overall Study|Lost to Follow-up|0
7322596|NCT00760214|11553738|FG002|Overall Study|Lost to Follow-up|1
7322597|NCT00760214|11553736|FG000|Overall Study|Withdrawal by Subject|12
7322598|NCT00760214|11553737|FG001|Overall Study|Withdrawal by Subject|14
7322599|NCT00760214|11553738|FG002|Overall Study|Withdrawal by Subject|13
7322600|NCT00760214|11553736|FG000|Overall Study|Lack of Efficacy|3
7322601|NCT00760214|11553737|FG001|Overall Study|Lack of Efficacy|2
7416300|NCT01449370|11689920|FG007|Overall Study|Adverse Event|0
7416301|NCT01449370|11689921|FG008|Overall Study|Adverse Event|1
7416302|NCT01449370|11689922|FG009|Overall Study|Adverse Event|1
7416303|NCT01449370|11689923|FG010|Overall Study|Adverse Event|0
7416304|NCT01449370|11689924|FG011|Overall Study|Adverse Event|0
7416305|NCT01449370|11689925|FG012|Overall Study|Adverse Event|0
7416306|NCT01449370|11689926|FG013|Overall Study|Adverse Event|2
7416307|NCT01449370|11689927|FG014|Overall Study|Adverse Event|0
7416308|NCT01449370|11689928|FG015|Overall Study|Adverse Event|1
7416309|NCT01449370|11689929|FG016|Overall Study|Adverse Event|0
7416310|NCT01449370|11689930|FG017|Overall Study|Adverse Event|0
7416311|NCT01449370|11689931|FG018|Overall Study|Adverse Event|1
7416312|NCT01449370|11689932|FG019|Overall Study|Adverse Event|1
7416313|NCT01449370|11689933|FG020|Overall Study|Adverse Event|0
7416314|NCT01449370|11689934|FG021|Overall Study|Adverse Event|1
7416315|NCT01449370|11689935|FG022|Overall Study|Adverse Event|0
7416316|NCT01449370|11689936|FG023|Overall Study|Adverse Event|1
7416317|NCT01449370|11689937|FG024|Overall Study|Adverse Event|3
7416318|NCT01449370|11689913|FG000|Overall Study|Participant Decision|0
7416319|NCT01449370|11689914|FG001|Overall Study|Participant Decision|0
7416320|NCT01449370|11689915|FG002|Overall Study|Participant Decision|0
7416321|NCT01449370|11689916|FG003|Overall Study|Participant Decision|0
7416322|NCT01449370|11689917|FG004|Overall Study|Participant Decision|0
7416323|NCT01449370|11689918|FG005|Overall Study|Participant Decision|0
7416324|NCT01449370|11689919|FG006|Overall Study|Participant Decision|0
7416325|NCT01449370|11689920|FG007|Overall Study|Participant Decision|1
7416326|NCT01449370|11689921|FG008|Overall Study|Participant Decision|1
7416327|NCT01449370|11689922|FG009|Overall Study|Participant Decision|0
7416328|NCT01449370|11689923|FG010|Overall Study|Participant Decision|0
7416329|NCT01449370|11689924|FG011|Overall Study|Participant Decision|0
7416330|NCT01449370|11689925|FG012|Overall Study|Participant Decision|1
7416331|NCT01449370|11689926|FG013|Overall Study|Participant Decision|1
7416332|NCT01449370|11689927|FG014|Overall Study|Participant Decision|0
7416333|NCT01449370|11689928|FG015|Overall Study|Participant Decision|1
7416334|NCT01449370|11689929|FG016|Overall Study|Participant Decision|3
7416335|NCT01449370|11689930|FG017|Overall Study|Participant Decision|0
7416336|NCT01449370|11689931|FG018|Overall Study|Participant Decision|1
7416337|NCT01449370|11689932|FG019|Overall Study|Participant Decision|0
7416338|NCT01449370|11689933|FG020|Overall Study|Participant Decision|0
7416339|NCT01449370|11689934|FG021|Overall Study|Participant Decision|1
7416340|NCT01449370|11689935|FG022|Overall Study|Participant Decision|0
7416341|NCT01449370|11689936|FG023|Overall Study|Participant Decision|0
7416342|NCT01449370|11689937|FG024|Overall Study|Participant Decision|1
7416343|NCT01449370|11689913|FG000|Overall Study|Lost to Follow-up|0
7416344|NCT01449370|11689914|FG001|Overall Study|Lost to Follow-up|0
7416345|NCT01449370|11689915|FG002|Overall Study|Lost to Follow-up|0
7416346|NCT01449370|11689916|FG003|Overall Study|Lost to Follow-up|0
7416347|NCT01449370|11689917|FG004|Overall Study|Lost to Follow-up|0
7416348|NCT01449370|11689918|FG005|Overall Study|Lost to Follow-up|0
7416349|NCT01449370|11689919|FG006|Overall Study|Lost to Follow-up|0
7416350|NCT01449370|11689920|FG007|Overall Study|Lost to Follow-up|0
7416351|NCT01449370|11689921|FG008|Overall Study|Lost to Follow-up|0
7416352|NCT01449370|11689922|FG009|Overall Study|Lost to Follow-up|0
7416353|NCT01449370|11689923|FG010|Overall Study|Lost to Follow-up|0
7416354|NCT01449370|11689924|FG011|Overall Study|Lost to Follow-up|0
7555173|NCT03052517|11918144|FG000|Overall Study|Lost to Follow-up|2
7555174|NCT03052517|11918145|FG001|Overall Study|Lost to Follow-up|4
7555175|NCT03052517|11918146|FG002|Overall Study|Lost to Follow-up|0
7555176|NCT03052517|11918144|FG000|Overall Study|Pregnancy|1
7555177|NCT03052517|11918145|FG001|Overall Study|Pregnancy|0
7555178|NCT03052517|11918146|FG002|Overall Study|Pregnancy|1
7555179|NCT03052517|11918144|FG000|Overall Study|Non-Compliance With Study Treatment|0
7555180|NCT03052517|11918145|FG001|Overall Study|Non-Compliance With Study Treatment|2
7555181|NCT03052517|11918146|FG002|Overall Study|Non-Compliance With Study Treatment|0
7555182|NCT03052517|11918144|FG000|Overall Study|Technical Problems|0
7416355|NCT01449370|11689925|FG012|Overall Study|Lost to Follow-up|0
7322602|NCT00760214|11553738|FG002|Overall Study|Lack of Efficacy|4
7416356|NCT01449370|11689926|FG013|Overall Study|Lost to Follow-up|0
7416357|NCT01449370|11689927|FG014|Overall Study|Lost to Follow-up|0
7416358|NCT01449370|11689928|FG015|Overall Study|Lost to Follow-up|0
7416359|NCT01449370|11689929|FG016|Overall Study|Lost to Follow-up|0
7416360|NCT01449370|11689930|FG017|Overall Study|Lost to Follow-up|0
7416361|NCT01449370|11689931|FG018|Overall Study|Lost to Follow-up|0
7555183|NCT03052517|11918145|FG001|Overall Study|Technical Problems|1
7416362|NCT01449370|11689932|FG019|Overall Study|Lost to Follow-up|0
7416363|NCT01449370|11689933|FG020|Overall Study|Lost to Follow-up|1
7555184|NCT03052517|11918146|FG002|Overall Study|Technical Problems|0
7322603|NCT00760214|11553736|FG000|Overall Study|Pregnancy|0
7322604|NCT00760214|11553737|FG001|Overall Study|Pregnancy|0
7322605|NCT00760214|11553738|FG002|Overall Study|Pregnancy|1
7322606|NCT00760214|11553736|FG000|Overall Study|Physician Decision|1
7322607|NCT00760214|11553737|FG001|Overall Study|Physician Decision|1
7322608|NCT00760214|11553738|FG002|Overall Study|Physician Decision|1
7322609|NCT00760214|11553736|FG000|Overall Study|Other|3
7322610|NCT00760214|11553737|FG001|Overall Study|Other|4
7322611|NCT00760214|11553738|FG002|Overall Study|Other|6
7322612|NCT00760266|11553748|FG000|Overall Study|Adverse Event|13
7322613|NCT00760266|11553749|FG001|Overall Study|Adverse Event|7
7322614|NCT00760266|11553748|FG000|Overall Study|Abnormal laboratory value(s)|1
7322615|NCT00760266|11553749|FG001|Overall Study|Abnormal laboratory value(s)|0
7322616|NCT00760266|11553748|FG000|Overall Study|Abnormal test procedure result(s)|1
7322617|NCT00760266|11553749|FG001|Overall Study|Abnormal test procedure result(s)|0
7322618|NCT00760266|11553748|FG000|Overall Study|Lack of Efficacy|2
7322619|NCT00760266|11553749|FG001|Overall Study|Lack of Efficacy|2
7322620|NCT00760266|11553748|FG000|Overall Study|Protocol deviation|2
7322621|NCT00760266|11553749|FG001|Overall Study|Protocol deviation|4
7322622|NCT00760266|11553748|FG000|Overall Study|Patient withdrew consent|3
7322623|NCT00760266|11553749|FG001|Overall Study|Patient withdrew consent|3
7322624|NCT00760266|11553748|FG000|Overall Study|Lost to Follow-up|2
7322625|NCT00760266|11553749|FG001|Overall Study|Lost to Follow-up|1
7322626|NCT00760266|11553748|FG000|Overall Study|Administrative Problems|0
7322627|NCT00760266|11553749|FG001|Overall Study|Administrative Problems|1
7322628|NCT00760383|11553757|FG000|Overall Study|moved away; withdrew; medical reasons|5
7322629|NCT00760383|11553758|FG001|Overall Study|moved away; withdrew; medical reasons|7
7322630|NCT00760474|11553773|FG000|Period 1 (P1)|Discontinued then re-entered|1
7555185|NCT03052725|11918160|FG000|Overall Study|Adverse Event|2
7555186|NCT03052725|11918161|FG001|Overall Study|Adverse Event|0
7555187|NCT03052725|11918160|FG000|Overall Study|Withdrawal by Subject|3
7555188|NCT03052725|11918161|FG001|Overall Study|Withdrawal by Subject|4
7555189|NCT03052725|11918160|FG000|Overall Study|Pregnancy|0
7555190|NCT03052725|11918161|FG001|Overall Study|Pregnancy|1
7555191|NCT03052725|11918160|FG000|Overall Study|Site closure|0
7555192|NCT03052725|11918161|FG001|Overall Study|Site closure|1
7555193|NCT03052725|11918160|FG000|Overall Study|Study terminated by sponsor|143
7555194|NCT03052725|11918161|FG001|Overall Study|Study terminated by sponsor|144
7322631|NCT00760474|11553774|FG001|Period 1 (P1)|Discontinued then re-entered|1
7322632|NCT00760474|11553773|FG000|Placebo Washout Period|Other|0
7322633|NCT00760474|11553774|FG001|Placebo Washout Period|Other|1
7322634|NCT00760474|11553773|FG000|Period 2 (P2)|Lost to Follow-up|1
7322635|NCT00760474|11553774|FG001|Period 2 (P2)|Lost to Follow-up|0
7322636|NCT00760474|11553773|FG000|Period 2 (P2)|Adverse Event|0
7322637|NCT00760474|11553774|FG001|Period 2 (P2)|Adverse Event|1
7555195|NCT03052751|11918168|FG000|Dosing Period 1|Adverse Event|0
7555196|NCT03052751|11918169|FG001|Dosing Period 1|Adverse Event|1
7555197|NCT03052751|11918170|FG002|Dosing Period 1|Adverse Event|0
7555198|NCT03052751|11918171|FG003|Dosing Period 1|Adverse Event|0
7555199|NCT03052751|11918172|FG004|Dosing Period 1|Adverse Event|0
7555200|NCT03052751|11918173|FG005|Dosing Period 1|Adverse Event|0
7322638|NCT00760487|11553781|FG000|Overall Study|Unilateral implantation|3
7322639|NCT00760513|11553787|FG000|Overall Study|Withdrawal by Subject|5
7322640|NCT00760513|11553788|FG001|Overall Study|Withdrawal by Subject|7
7322641|NCT00760552|11553814|FG000|Overall Study|Death|2
7322642|NCT00760552|11553815|FG001|Overall Study|Death|0
7322643|NCT00760552|11553814|FG000|Overall Study|Lost to Follow-up|11
7322644|NCT00760552|11553815|FG001|Overall Study|Lost to Follow-up|10
7322645|NCT00760617|11553846|FG000|Overall Study|Adverse Event|5
7322646|NCT00760617|11553847|FG001|Overall Study|Adverse Event|2
7322647|NCT00760617|11553848|FG002|Overall Study|Adverse Event|0
7322648|NCT00760617|11553846|FG000|Overall Study|Lost to Follow-up|0
7322649|NCT00760617|11553847|FG001|Overall Study|Lost to Follow-up|0
7322650|NCT00760617|11553848|FG002|Overall Study|Lost to Follow-up|5
7322651|NCT00760669|11553856|FG000|Overall Study|Not assessed for overall improvement|18
7322652|NCT00760669|11553856|FG000|Overall Study|Participants missing efficacy assessment|6
7322653|NCT00760669|11553856|FG000|Overall Study|Participants with overlapping cases|1
7555201|NCT03052751|11918168|FG000|Dosing Period 2|Adverse Event|0
7322654|NCT00760669|11553856|FG000|Overall Study|Took drug before entering in contract|5
7322655|NCT00760747|11553862|FG000|Study Period II|Adverse Event|3
7322656|NCT00760747|11553863|FG001|Study Period II|Adverse Event|4
7322657|NCT00760747|11553862|FG000|Study Period II|Lack of Efficacy|0
7322658|NCT00760747|11553863|FG001|Study Period II|Lack of Efficacy|6
7322659|NCT00760747|11553862|FG000|Study Period II|Parent/Caregiver Decision|3
7322660|NCT00760747|11553863|FG001|Study Period II|Parent/Caregiver Decision|0
7322661|NCT00760747|11553862|FG000|Study Period II|Protocol Violation|6
7322662|NCT00760747|11553863|FG001|Study Period II|Protocol Violation|3
7322663|NCT00760747|11553862|FG000|Study Period II|Withdrawal by Subject|1
7555202|NCT03052751|11918169|FG001|Dosing Period 2|Adverse Event|0
7555203|NCT03052751|11918170|FG002|Dosing Period 2|Adverse Event|3
7322664|NCT00760747|11553863|FG001|Study Period II|Withdrawal by Subject|0
7555204|NCT03052751|11918171|FG003|Dosing Period 2|Adverse Event|0
7555205|NCT03052751|11918172|FG004|Dosing Period 2|Adverse Event|0
7555206|NCT03052751|11918173|FG005|Dosing Period 2|Adverse Event|0
7555207|NCT03052751|11918168|FG000|Observation Period|Adverse Event|0
7322665|NCT00760747|11553862|FG000|Study Period II|No drug administered|0
7322666|NCT00760747|11553863|FG001|Study Period II|No drug administered|1
7322667|NCT00760747|11553862|FG000|Study Period III|Adverse Event|1
7322668|NCT00760747|11553863|FG001|Study Period III|Adverse Event|0
7322669|NCT00760747|11553862|FG000|Study Period III|Lack of Efficacy|1
7322670|NCT00760747|11553863|FG001|Study Period III|Lack of Efficacy|0
7322671|NCT00760747|11553862|FG000|Study Period III|Parent/Caregiver Decision|0
7322672|NCT00760747|11553863|FG001|Study Period III|Parent/Caregiver Decision|1
7322673|NCT00760747|11553862|FG000|Study Period III|Protocol Violation|1
7322674|NCT00760747|11553863|FG001|Study Period III|Protocol Violation|1
7322675|NCT00760747|11553862|FG000|Study Period III|Physician Decision|0
7322676|NCT00760747|11553863|FG001|Study Period III|Physician Decision|1
7322677|NCT00760838|11553871|FG000|Overall Study|Adverse Event|1
7322678|NCT00760838|11553872|FG001|Overall Study|Adverse Event|1
7322679|NCT00760838|11553871|FG000|Overall Study|Lack of Efficacy|1
7322680|NCT00760838|11553872|FG001|Overall Study|Lack of Efficacy|0
7322681|NCT00760838|11553871|FG000|Overall Study|Lost to Follow-up|2
7322682|NCT00760838|11553872|FG001|Overall Study|Lost to Follow-up|0
7322683|NCT00760838|11553871|FG000|Overall Study|Withdrawal by Subject|1
7322684|NCT00760838|11553872|FG001|Overall Study|Withdrawal by Subject|1
7322685|NCT00760877|11553880|FG000|Overall Study|Protocol Violation|1
7322686|NCT00760877|11553881|FG001|Overall Study|Protocol Violation|0
7322687|NCT00760877|11553880|FG000|Overall Study|Non-compliance with protocol treatment|2
7322688|NCT00760877|11553881|FG001|Overall Study|Non-compliance with protocol treatment|1
7322689|NCT00760877|11553880|FG000|Overall Study|Pregnancy|1
7322690|NCT00760877|11553881|FG001|Overall Study|Pregnancy|4
7322691|NCT00760877|11553880|FG000|Overall Study|Death|2
7322692|NCT00760877|11553881|FG001|Overall Study|Death|1
7322693|NCT00760877|11553880|FG000|Overall Study|Withdrawal by Subject|7
7322694|NCT00760877|11553881|FG001|Overall Study|Withdrawal by Subject|3
7322695|NCT00760877|11553880|FG000|Overall Study|Adverse Event|19
7322696|NCT00760877|11553881|FG001|Overall Study|Adverse Event|12
7322697|NCT00760877|11553880|FG000|Overall Study|Participant diagnosed with AML|0
7322698|NCT00760877|11553881|FG001|Overall Study|Participant diagnosed with AML|1
7322699|NCT00760877|11553880|FG000|Overall Study|Participant not eligible to cross-over|0
7322700|NCT00760877|11553881|FG001|Overall Study|Participant not eligible to cross-over|1
7322701|NCT00760877|11553880|FG000|Overall Study|Physician Decision|1
7322702|NCT00760877|11553881|FG001|Overall Study|Physician Decision|2
7322703|NCT00760877|11553880|FG000|Overall Study|Participants transferred to AMN107A2408|11
7322704|NCT00760877|11553881|FG001|Overall Study|Participants transferred to AMN107A2408|1
7322705|NCT00760877|11553880|FG000|Overall Study|Treatment failure|1
7322706|NCT00760877|11553881|FG001|Overall Study|Treatment failure|0
7322707|NCT00760929|11553892|FG000|Overall Study|Adverse Event|2
7322708|NCT00760929|11553893|FG001|Overall Study|Adverse Event|0
7322709|NCT00760929|11553894|FG002|Overall Study|Adverse Event|6
7322710|NCT00760929|11553895|FG003|Overall Study|Adverse Event|10
7322711|NCT00760929|11553892|FG000|Overall Study|Lack of Efficacy|0
7322712|NCT00760929|11553893|FG001|Overall Study|Lack of Efficacy|2
7322713|NCT00760929|11553894|FG002|Overall Study|Lack of Efficacy|1
7322714|NCT00760929|11553895|FG003|Overall Study|Lack of Efficacy|0
7322715|NCT00760929|11553892|FG000|Overall Study|Withdrawal by Subject|1
7322716|NCT00760929|11553893|FG001|Overall Study|Withdrawal by Subject|0
7322717|NCT00760929|11553894|FG002|Overall Study|Withdrawal by Subject|9
7322718|NCT00760929|11553895|FG003|Overall Study|Withdrawal by Subject|1
7322719|NCT00760929|11553892|FG000|Overall Study|Lost to Follow-up|0
7322720|NCT00760929|11553893|FG001|Overall Study|Lost to Follow-up|0
7322721|NCT00760929|11553894|FG002|Overall Study|Lost to Follow-up|1
7322722|NCT00760929|11553895|FG003|Overall Study|Lost to Follow-up|0
7322723|NCT00760929|11553892|FG000|Overall Study|Progression of Disease|21
7322724|NCT00760929|11553893|FG001|Overall Study|Progression of Disease|26
7322725|NCT00760929|11553894|FG002|Overall Study|Progression of Disease|38
7322726|NCT00760929|11553895|FG003|Overall Study|Progression of Disease|42
7322727|NCT00760929|11553892|FG000|Overall Study|Other|2
7322728|NCT00760929|11553893|FG001|Overall Study|Other|0
7322729|NCT00760929|11553894|FG002|Overall Study|Other|2
7322730|NCT00760929|11553895|FG003|Overall Study|Other|1
7322731|NCT00760929|11553892|FG000|Overall Study|Death|0
7322732|NCT00760929|11553893|FG001|Overall Study|Death|0
7322733|NCT00760929|11553894|FG002|Overall Study|Death|1
7322734|NCT00760929|11553895|FG003|Overall Study|Death|0
7322735|NCT00760929|11553892|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7322736|NCT00760929|11553893|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7322737|NCT00760929|11553894|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7322738|NCT00760929|11553895|FG003|Overall Study|Violation of Selection Criteria at Entry|1
7322739|NCT00760994|11553907|FG000|Overall Study|Lost to Follow-up|4
7322740|NCT00760994|11553908|FG001|Overall Study|Lost to Follow-up|4
7322741|NCT00760994|11553909|FG002|Overall Study|Lost to Follow-up|3
7322742|NCT00761150|11553963|FG000|Open-label Period|Adverse Event|36
7322743|NCT00761150|11553964|FG001|Open-label Period|Adverse Event|0
7322744|NCT00761150|11553965|FG002|Open-label Period|Adverse Event|0
7322745|NCT00761150|11553963|FG000|Open-label Period|Did not meet DB randomization criteria|11
7322746|NCT00761150|11553964|FG001|Open-label Period|Did not meet DB randomization criteria|0
7322747|NCT00761150|11553965|FG002|Open-label Period|Did not meet DB randomization criteria|0
7322748|NCT00761150|11553963|FG000|Open-label Period|Lost to Follow-up|7
7322749|NCT00761150|11553964|FG001|Open-label Period|Lost to Follow-up|0
7322750|NCT00761150|11553965|FG002|Open-label Period|Lost to Follow-up|0
7322751|NCT00761150|11553963|FG000|Open-label Period|Lack of Efficacy|4
7322752|NCT00761150|11553964|FG001|Open-label Period|Lack of Efficacy|0
7322753|NCT00761150|11553965|FG002|Open-label Period|Lack of Efficacy|0
7322754|NCT00761150|11553963|FG000|Open-label Period|Withdrawal by Subject|5
7322755|NCT00761150|11553964|FG001|Open-label Period|Withdrawal by Subject|0
7322756|NCT00761150|11553965|FG002|Open-label Period|Withdrawal by Subject|0
7416364|NCT01449370|11689934|FG021|Overall Study|Lost to Follow-up|0
7416365|NCT01449370|11689935|FG022|Overall Study|Lost to Follow-up|0
7416366|NCT01449370|11689936|FG023|Overall Study|Lost to Follow-up|0
7416367|NCT01449370|11689937|FG024|Overall Study|Lost to Follow-up|0
7416368|NCT01449370|11689913|FG000|Overall Study|Other|0
7416369|NCT01449370|11689914|FG001|Overall Study|Other|0
7416370|NCT01449370|11689915|FG002|Overall Study|Other|0
7416371|NCT01449370|11689916|FG003|Overall Study|Other|0
7416372|NCT01449370|11689917|FG004|Overall Study|Other|0
7416373|NCT01449370|11689918|FG005|Overall Study|Other|0
7416374|NCT01449370|11689919|FG006|Overall Study|Other|0
7416375|NCT01449370|11689920|FG007|Overall Study|Other|0
7416376|NCT01449370|11689921|FG008|Overall Study|Other|1
7416377|NCT01449370|11689922|FG009|Overall Study|Other|1
7416378|NCT01449370|11689923|FG010|Overall Study|Other|0
7416379|NCT01449370|11689924|FG011|Overall Study|Other|0
7416380|NCT01449370|11689925|FG012|Overall Study|Other|0
7416381|NCT01449370|11689926|FG013|Overall Study|Other|0
7416382|NCT01449370|11689927|FG014|Overall Study|Other|0
7416383|NCT01449370|11689928|FG015|Overall Study|Other|0
7416384|NCT01449370|11689929|FG016|Overall Study|Other|0
7416385|NCT01449370|11689930|FG017|Overall Study|Other|0
7416386|NCT01449370|11689931|FG018|Overall Study|Other|0
7416387|NCT01449370|11689932|FG019|Overall Study|Other|0
7416388|NCT01449370|11689933|FG020|Overall Study|Other|0
7416389|NCT01449370|11689934|FG021|Overall Study|Other|0
7416390|NCT01449370|11689935|FG022|Overall Study|Other|1
7416391|NCT01449370|11689936|FG023|Overall Study|Other|1
7416392|NCT01449370|11689937|FG024|Overall Study|Other|0
7416393|NCT01449370|11689913|FG000|Overall Study|Medication Prohibited by Protocol|0
7416394|NCT01449370|11689914|FG001|Overall Study|Medication Prohibited by Protocol|0
7416395|NCT01449370|11689915|FG002|Overall Study|Medication Prohibited by Protocol|0
7416396|NCT01449370|11689916|FG003|Overall Study|Medication Prohibited by Protocol|0
7416397|NCT01449370|11689917|FG004|Overall Study|Medication Prohibited by Protocol|0
7416398|NCT01449370|11689918|FG005|Overall Study|Medication Prohibited by Protocol|0
7416399|NCT01449370|11689919|FG006|Overall Study|Medication Prohibited by Protocol|0
7416400|NCT01449370|11689920|FG007|Overall Study|Medication Prohibited by Protocol|0
7416401|NCT01449370|11689921|FG008|Overall Study|Medication Prohibited by Protocol|0
7416402|NCT01449370|11689922|FG009|Overall Study|Medication Prohibited by Protocol|0
7416403|NCT01449370|11689923|FG010|Overall Study|Medication Prohibited by Protocol|0
7416404|NCT01449370|11689924|FG011|Overall Study|Medication Prohibited by Protocol|0
7416405|NCT01449370|11689925|FG012|Overall Study|Medication Prohibited by Protocol|0
7416406|NCT01449370|11689926|FG013|Overall Study|Medication Prohibited by Protocol|0
7416407|NCT01449370|11689927|FG014|Overall Study|Medication Prohibited by Protocol|0
7416408|NCT01449370|11689928|FG015|Overall Study|Medication Prohibited by Protocol|0
7416409|NCT01449370|11689929|FG016|Overall Study|Medication Prohibited by Protocol|0
7416410|NCT01449370|11689930|FG017|Overall Study|Medication Prohibited by Protocol|0
7416411|NCT01449370|11689931|FG018|Overall Study|Medication Prohibited by Protocol|0
7416412|NCT01449370|11689932|FG019|Overall Study|Medication Prohibited by Protocol|0
7416413|NCT01449370|11689933|FG020|Overall Study|Medication Prohibited by Protocol|0
7416414|NCT01449370|11689934|FG021|Overall Study|Medication Prohibited by Protocol|0
7416415|NCT01449370|11689935|FG022|Overall Study|Medication Prohibited by Protocol|0
7416416|NCT01449370|11689936|FG023|Overall Study|Medication Prohibited by Protocol|1
7416417|NCT01449370|11689937|FG024|Overall Study|Medication Prohibited by Protocol|0
7416418|NCT01449370|11689913|FG000|Overall Study|Death|0
7416419|NCT01449370|11689914|FG001|Overall Study|Death|0
7416420|NCT01449370|11689915|FG002|Overall Study|Death|0
7416421|NCT01449370|11689916|FG003|Overall Study|Death|0
7416422|NCT01449370|11689917|FG004|Overall Study|Death|0
7416423|NCT01449370|11689918|FG005|Overall Study|Death|0
7416424|NCT01449370|11689919|FG006|Overall Study|Death|0
7416425|NCT01449370|11689920|FG007|Overall Study|Death|0
7416426|NCT01449370|11689921|FG008|Overall Study|Death|0
7416427|NCT01449370|11689922|FG009|Overall Study|Death|0
7416428|NCT01449370|11689923|FG010|Overall Study|Death|0
7416429|NCT01449370|11689924|FG011|Overall Study|Death|0
7416430|NCT01449370|11689925|FG012|Overall Study|Death|0
7416431|NCT01449370|11689926|FG013|Overall Study|Death|0
7416432|NCT01449370|11689927|FG014|Overall Study|Death|0
7416433|NCT01449370|11689928|FG015|Overall Study|Death|0
7322757|NCT00761150|11553963|FG000|Open-label Period|Noncompliance|2
7416434|NCT01449370|11689929|FG016|Overall Study|Death|0
7416435|NCT01449370|11689930|FG017|Overall Study|Death|0
7416436|NCT01449370|11689931|FG018|Overall Study|Death|0
7416437|NCT01449370|11689932|FG019|Overall Study|Death|0
7416438|NCT01449370|11689933|FG020|Overall Study|Death|0
7416439|NCT01449370|11689934|FG021|Overall Study|Death|0
7416440|NCT01449370|11689935|FG022|Overall Study|Death|0
7322758|NCT00761150|11553964|FG001|Open-label Period|Noncompliance|0
7322759|NCT00761150|11553965|FG002|Open-label Period|Noncompliance|0
7322760|NCT00761150|11553963|FG000|Open-label Period|Other|5
7322761|NCT00761150|11553964|FG001|Open-label Period|Other|0
7322762|NCT00761150|11553965|FG002|Open-label Period|Other|0
7416441|NCT01449370|11689936|FG023|Overall Study|Death|0
7416442|NCT01449370|11689937|FG024|Overall Study|Death|1
7416443|NCT01449461|11690016|FG000|Overall Study|Adverse Event|0
7416444|NCT01449461|11690017|FG001|Overall Study|Adverse Event|3
7416445|NCT01449461|11690018|FG002|Overall Study|Adverse Event|2
7416446|NCT01449461|11690019|FG003|Overall Study|Adverse Event|3
7416447|NCT01449461|11690020|FG004|Overall Study|Adverse Event|4
7416448|NCT01449461|11690021|FG005|Overall Study|Adverse Event|4
7416449|NCT01449461|11690016|FG000|Overall Study|Death|0
7416450|NCT01449461|11690017|FG001|Overall Study|Death|2
7416451|NCT01449461|11690018|FG002|Overall Study|Death|0
7416452|NCT01449461|11690019|FG003|Overall Study|Death|0
7416453|NCT01449461|11690020|FG004|Overall Study|Death|7
7416454|NCT01449461|11690021|FG005|Overall Study|Death|1
7416455|NCT01449461|11690016|FG000|Overall Study|Physician Decision|0
7416456|NCT01449461|11690017|FG001|Overall Study|Physician Decision|1
7416457|NCT01449461|11690018|FG002|Overall Study|Physician Decision|0
7416458|NCT01449461|11690019|FG003|Overall Study|Physician Decision|4
7416459|NCT01449461|11690020|FG004|Overall Study|Physician Decision|1
7416460|NCT01449461|11690021|FG005|Overall Study|Physician Decision|0
7416461|NCT01449461|11690016|FG000|Overall Study|Documented Progressive Disease|4
7416462|NCT01449461|11690017|FG001|Overall Study|Documented Progressive Disease|7
7416463|NCT01449461|11690018|FG002|Overall Study|Documented Progressive Disease|14
7416464|NCT01449461|11690019|FG003|Overall Study|Documented Progressive Disease|15
7416465|NCT01449461|11690020|FG004|Overall Study|Documented Progressive Disease|24
7416466|NCT01449461|11690021|FG005|Overall Study|Documented Progressive Disease|5
7416467|NCT01449461|11690016|FG000|Overall Study|Clinical Progressive Disease|2
7416468|NCT01449461|11690017|FG001|Overall Study|Clinical Progressive Disease|2
7416469|NCT01449461|11690018|FG002|Overall Study|Clinical Progressive Disease|0
7416470|NCT01449461|11690019|FG003|Overall Study|Clinical Progressive Disease|3
7416471|NCT01449461|11690020|FG004|Overall Study|Clinical Progressive Disease|4
7416472|NCT01449461|11690021|FG005|Overall Study|Clinical Progressive Disease|2
7416473|NCT01449461|11690016|FG000|Overall Study|Protocol Violation|0
7416474|NCT01449461|11690017|FG001|Overall Study|Protocol Violation|0
7416475|NCT01449461|11690018|FG002|Overall Study|Protocol Violation|0
7416476|NCT01449461|11690019|FG003|Overall Study|Protocol Violation|1
7416477|NCT01449461|11690020|FG004|Overall Study|Protocol Violation|0
7416478|NCT01449461|11690021|FG005|Overall Study|Protocol Violation|0
7416479|NCT01449461|11690016|FG000|Overall Study|Site Terminated by Sponsor|0
7416480|NCT01449461|11690017|FG001|Overall Study|Site Terminated by Sponsor|1
7416481|NCT01449461|11690018|FG002|Overall Study|Site Terminated by Sponsor|2
7416482|NCT01449461|11690019|FG003|Overall Study|Site Terminated by Sponsor|3
7416483|NCT01449461|11690020|FG004|Overall Study|Site Terminated by Sponsor|4
7416484|NCT01449461|11690021|FG005|Overall Study|Site Terminated by Sponsor|1
7416485|NCT01449461|11690016|FG000|Overall Study|Withdrawal by Subject|0
7416486|NCT01449461|11690017|FG001|Overall Study|Withdrawal by Subject|1
7416487|NCT01449461|11690018|FG002|Overall Study|Withdrawal by Subject|0
7416488|NCT01449461|11690019|FG003|Overall Study|Withdrawal by Subject|0
7416489|NCT01449461|11690020|FG004|Overall Study|Withdrawal by Subject|2
7416490|NCT01449461|11690021|FG005|Overall Study|Withdrawal by Subject|1
7416491|NCT01449461|11690016|FG000|Overall Study|Reason not Specified|0
7416492|NCT01449461|11690017|FG001|Overall Study|Reason not Specified|1
7416493|NCT01449461|11690018|FG002|Overall Study|Reason not Specified|0
7416494|NCT01449461|11690019|FG003|Overall Study|Reason not Specified|3
7416495|NCT01449461|11690020|FG004|Overall Study|Reason not Specified|2
7416496|NCT01449461|11690021|FG005|Overall Study|Reason not Specified|1
7416497|NCT01449526|11690055|FG000|Overall Study|Lost to Follow-up|1
7555208|NCT03052751|11918169|FG001|Observation Period|Adverse Event|0
7531004|NCT02641392|11874613|FG000|Overall Study|Death|0
7531005|NCT02641392|11874614|FG001|Overall Study|Death|0
7531006|NCT02641392|11874615|FG002|Overall Study|Death|1
7531007|NCT02641587|11874647|FG000|Confinement Period|Adverse Event|1
7531008|NCT02641587|11874648|FG001|Confinement Period|Adverse Event|0
7531009|NCT02641587|11874647|FG000|Confinement Period|Withdrawal by Subject|2
7555209|NCT03052751|11918170|FG002|Observation Period|Adverse Event|0
7555210|NCT03052751|11918171|FG003|Observation Period|Adverse Event|0
7555211|NCT03052751|11918172|FG004|Observation Period|Adverse Event|1
7555212|NCT03052751|11918173|FG005|Observation Period|Adverse Event|0
7322763|NCT00761150|11553963|FG000|Double-blind Period|Lack of Efficacy|0
7416498|NCT01449526|11690056|FG001|Overall Study|Lost to Follow-up|2
7416499|NCT01449526|11690055|FG000|Overall Study|Withdrawal by Subject|1
7416500|NCT01449526|11690056|FG001|Overall Study|Withdrawal by Subject|1
7416501|NCT01449526|11690055|FG000|Overall Study|Symptoms/complaints|0
7416502|NCT01449526|11690056|FG001|Overall Study|Symptoms/complaints|1
7416503|NCT01449526|11690055|FG000|Overall Study|Lack of Motivation|0
7416504|NCT01449526|11690056|FG001|Overall Study|Lack of Motivation|1
7416505|NCT01449526|11690055|FG000|Overall Study|Cannot maintain visits|0
7416506|NCT01449526|11690056|FG001|Overall Study|Cannot maintain visits|1
7531010|NCT02641587|11874648|FG001|Confinement Period|Withdrawal by Subject|1
7555213|NCT03052764|11918185|FG000|Double-Blind Treatment Period|Adverse Event|2
7555214|NCT03052764|11918186|FG001|Double-Blind Treatment Period|Adverse Event|0
7555215|NCT03052764|11918185|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
7555216|NCT03052764|11918186|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
7555217|NCT03052764|11918185|FG000|Double-Blind Treatment Period|Protocol Violation|2
7555218|NCT03052764|11918186|FG001|Double-Blind Treatment Period|Protocol Violation|1
7555219|NCT03052764|11918185|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
7531011|NCT02641587|11874647|FG000|Ambulatory Period|Withdrawal by Subject|1
7531012|NCT02641587|11874648|FG001|Ambulatory Period|Withdrawal by Subject|0
7555220|NCT03052764|11918186|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7555221|NCT03052764|11918185|FG000|Double-Blind Treatment Period|Reason not Specified|2
7555222|NCT03052764|11918186|FG001|Double-Blind Treatment Period|Reason not Specified|1
7555223|NCT03052816|11918196|FG000|Overall Study|Withdrawal by Subject|1
7555224|NCT03052816|11918197|FG001|Overall Study|Withdrawal by Subject|0
7555225|NCT03052816|11918196|FG000|Overall Study|Desired opioids|2
7555226|NCT03052816|11918197|FG001|Overall Study|Desired opioids|0
7555227|NCT03052959|11918207|FG000|Overall Study|Lost to Follow-up|4
7555228|NCT03052959|11918208|FG001|Overall Study|Lost to Follow-up|5
7555229|NCT03053050|11918228|FG000|Randomized Phase|Study Terminated by Sponsor|259
7555230|NCT03053050|11918229|FG001|Randomized Phase|Study Terminated by Sponsor|260
7322764|NCT00761150|11553964|FG001|Double-blind Period|Lack of Efficacy|2
7322765|NCT00761150|11553965|FG002|Double-blind Period|Lack of Efficacy|19
7322766|NCT00761150|11553963|FG000|Double-blind Period|Adverse Event|0
7322767|NCT00761150|11553964|FG001|Double-blind Period|Adverse Event|3
7322768|NCT00761150|11553965|FG002|Double-blind Period|Adverse Event|3
7322769|NCT00761150|11553963|FG000|Double-blind Period|Withdrawal by Subject|0
7322770|NCT00761150|11553964|FG001|Double-blind Period|Withdrawal by Subject|3
7322771|NCT00761150|11553965|FG002|Double-blind Period|Withdrawal by Subject|2
7322772|NCT00761150|11553963|FG000|Double-blind Period|Lost to Follow-up|0
7322773|NCT00761150|11553964|FG001|Double-blind Period|Lost to Follow-up|2
7322774|NCT00761150|11553965|FG002|Double-blind Period|Lost to Follow-up|1
7322775|NCT00761150|11553963|FG000|Double-blind Period|Did not meet DB randomization criteria|0
7322776|NCT00761150|11553964|FG001|Double-blind Period|Did not meet DB randomization criteria|0
7322777|NCT00761150|11553965|FG002|Double-blind Period|Did not meet DB randomization criteria|1
7322778|NCT00761150|11553963|FG000|Double-blind Period|Noncompliance|0
7322779|NCT00761150|11553964|FG001|Double-blind Period|Noncompliance|1
7322780|NCT00761150|11553965|FG002|Double-blind Period|Noncompliance|0
7322781|NCT00761150|11553963|FG000|Double-blind Period|Other|0
7322782|NCT00761150|11553964|FG001|Double-blind Period|Other|3
7322783|NCT00761150|11553965|FG002|Double-blind Period|Other|3
7322784|NCT00761189|11553972|FG000|Overall Study|Adverse Event|42
7322785|NCT00761189|11553972|FG000|Overall Study|Lack of Efficacy|45
7322786|NCT00761189|11553972|FG000|Overall Study|Lost to Follow-up|36
7322787|NCT00761189|11553972|FG000|Overall Study|Withdrawal by Subject|49
7322788|NCT00761189|11553972|FG000|Overall Study|Other|13
7322789|NCT00761215|11553988|FG000|Overall Study|Randomized but didn't receive drug|1
7322790|NCT00761215|11553989|FG001|Overall Study|Randomized but didn't receive drug|1
7322791|NCT00761215|11553990|FG002|Overall Study|Randomized but didn't receive drug|2
7322792|NCT00761215|11553988|FG000|Overall Study|Lost to Follow-up|6
7322793|NCT00761215|11553989|FG001|Overall Study|Lost to Follow-up|3
7322794|NCT00761215|11553990|FG002|Overall Study|Lost to Follow-up|6
7322795|NCT00761215|11553988|FG000|Overall Study|Withdrawal by Subject|1
7322796|NCT00761215|11553989|FG001|Overall Study|Withdrawal by Subject|0
7322797|NCT00761215|11553990|FG002|Overall Study|Withdrawal by Subject|0
7322798|NCT00761215|11553988|FG000|Overall Study|Bacteremia|1
7322799|NCT00761215|11553989|FG001|Overall Study|Bacteremia|0
7322800|NCT00761215|11553990|FG002|Overall Study|Bacteremia|0
7322801|NCT00761267|11554004|FG000|Overall Study|Death|1
7322802|NCT00761267|11554005|FG001|Overall Study|Death|2
7322803|NCT00761267|11554006|FG002|Overall Study|Death|5
7322804|NCT00761267|11554004|FG000|Overall Study|Lost to Follow-up|0
7322805|NCT00761267|11554005|FG001|Overall Study|Lost to Follow-up|0
7322806|NCT00761267|11554006|FG002|Overall Study|Lost to Follow-up|1
7322807|NCT00761267|11554004|FG000|Overall Study|Randomized but not treated|1
7322808|NCT00761267|11554005|FG001|Overall Study|Randomized but not treated|1
7322809|NCT00761267|11554006|FG002|Overall Study|Randomized but not treated|0
7322810|NCT00761267|11554004|FG000|Overall Study|Withdrawal by Subject|0
7322811|NCT00761267|11554005|FG001|Overall Study|Withdrawal by Subject|1
7322812|NCT00761267|11554006|FG002|Overall Study|Withdrawal by Subject|0
7322813|NCT00761280|11554027|FG000|Randomization to First Dose|Withdrawal by Subject|0
7322814|NCT00761280|11554028|FG001|Randomization to First Dose|Withdrawal by Subject|2
7322815|NCT00761280|11554027|FG000|Randomization to First Dose|Sponsor decision|1
7531013|NCT02641730|11874674|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7531014|NCT02641730|11874675|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7531015|NCT02641730|11874676|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7531016|NCT02641730|11874677|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7531017|NCT02641730|11874678|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
7531018|NCT02641730|11874674|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
7531019|NCT02641730|11874675|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
7531020|NCT02641730|11874676|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
7537598|NCT02949219|11886703|FG000|Overall Study|Withdrawal by Subject|1
7322816|NCT00761280|11554028|FG001|Randomization to First Dose|Sponsor decision|0
7322817|NCT00761280|11554027|FG000|Randomization to First Dose|Other|1
7322818|NCT00761280|11554028|FG001|Randomization to First Dose|Other|0
7322819|NCT00761280|11554027|FG000|First Dose to End of Study|End of trial|5
7322820|NCT00761280|11554028|FG001|First Dose to End of Study|End of trial|5
7322821|NCT00761280|11554027|FG000|First Dose to End of Study|Progressive disease|5
7322822|NCT00761280|11554028|FG001|First Dose to End of Study|Progressive disease|3
7322823|NCT00761280|11554027|FG000|First Dose to End of Study|Sponsor decision|1
7322824|NCT00761280|11554028|FG001|First Dose to End of Study|Sponsor decision|2
7322825|NCT00761280|11554027|FG000|First Dose to End of Study|Death|1
7322826|NCT00761280|11554028|FG001|First Dose to End of Study|Death|0
7322827|NCT00761280|11554027|FG000|First Dose to End of Study|Lost to Follow-up|0
7322828|NCT00761280|11554028|FG001|First Dose to End of Study|Lost to Follow-up|1
7322829|NCT00761306|11554034|FG000|Overall Study|Adverse Event|5
7322830|NCT00761306|11554034|FG000|Overall Study|Lack of Efficacy|4
7322831|NCT00761306|11554034|FG000|Overall Study|Protocol Violation|2
7322832|NCT00761306|11554034|FG000|Overall Study|Withdrawal of Consent|3
7322833|NCT00761306|11554034|FG000|Overall Study|Lost to Follow-up|1
7322834|NCT00761306|11554034|FG000|Overall Study|Administrative or Other Reasons|5
7322835|NCT00761319|11554040|FG000|Overall Study|Protocol Violation|21
7322836|NCT00761319|11554041|FG001|Overall Study|Protocol Violation|14
7322837|NCT00761319|11554040|FG000|Overall Study|Adverse Event|11
7322838|NCT00761319|11554041|FG001|Overall Study|Adverse Event|7
7322839|NCT00761319|11554040|FG000|Overall Study|Withdrawal by Subject|8
7322840|NCT00761319|11554041|FG001|Overall Study|Withdrawal by Subject|7
7322841|NCT00761319|11554040|FG000|Overall Study|Noncompliance|4
7322842|NCT00761319|11554041|FG001|Overall Study|Noncompliance|3
7322843|NCT00761319|11554040|FG000|Overall Study|Lost to Follow-up|1
7322844|NCT00761319|11554041|FG001|Overall Study|Lost to Follow-up|1
7322845|NCT00761319|11554040|FG000|Overall Study|Nonspecified|2
7322846|NCT00761319|11554041|FG001|Overall Study|Nonspecified|2
7322847|NCT00761319|11554040|FG000|Overall Study|Missing|1
7322848|NCT00761319|11554041|FG001|Overall Study|Missing|0
7322849|NCT00761462|11554053|FG000|Treatment|Subjects never received study medication|23
7322850|NCT00761462|11554054|FG001|Treatment|Subjects never received study medication|12
7322851|NCT00761462|11554053|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
7322852|NCT00761462|11554054|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
7322853|NCT00761462|11554053|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
7322854|NCT00761462|11554054|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
7322855|NCT00761462|11554053|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
7322856|NCT00761462|11554054|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
7322857|NCT00761514|11554060|FG000|Overall Study|Adverse Event|1
7322858|NCT00761514|11554060|FG000|Overall Study|Withdrawal by Subject|2
7322859|NCT00761514|11554060|FG000|Overall Study|Lost to Follow-up|1
7322860|NCT00761514|11554060|FG000|Overall Study|Health insurance didn't cover study drug|1
7322861|NCT00761514|11554060|FG000|Overall Study|Problem complying with study visit|1
7322862|NCT00761514|11554060|FG000|Overall Study|Unable to pay for medications|1
7322863|NCT00761579|11554064|FG000|Overall Study|Adverse Event|10
7322864|NCT00761579|11554064|FG000|Overall Study|Death|2
7322865|NCT00761579|11554064|FG000|Overall Study|Lack of Efficacy|21
7322866|NCT00761579|11554064|FG000|Overall Study|Lost to Follow-up|16
7322867|NCT00761579|11554064|FG000|Overall Study|Pregnancy|1
7322868|NCT00761579|11554064|FG000|Overall Study|Withdrawal by Subject|34
7322869|NCT00761579|11554064|FG000|Overall Study|Lack of compliance|2
7322870|NCT00761579|11554064|FG000|Overall Study|Protocol deviation|1
7322871|NCT00761579|11554064|FG000|Overall Study|Drug overdose|1
7322872|NCT00761579|11554064|FG000|Overall Study|Aggravation of depression|1
7322873|NCT00761579|11554064|FG000|Overall Study|Aggravation of symptoms by changing drug|1
7322874|NCT00761579|11554064|FG000|Overall Study|Lost survey form|1
7322875|NCT00761579|11554064|FG000|Overall Study|Intake of prohibited concomitant drug|1
7322876|NCT00761605|11554079|FG000|Overall Study|Adverse Event|26
7322877|NCT00761605|11554079|FG000|Overall Study|Death|2
7322878|NCT00761605|11554079|FG000|Overall Study|Lack of Efficacy|26
7322879|NCT00761605|11554079|FG000|Overall Study|Lost to Follow-up|29
7322880|NCT00761605|11554079|FG000|Overall Study|Withdrawal by Subject|37
7322881|NCT00761605|11554079|FG000|Overall Study|Other|21
7322882|NCT00761631|11554091|FG000|Overall Study|Parent/legal guardian request|8
7322883|NCT00761631|11554092|FG001|Overall Study|Parent/legal guardian request|3
7322884|NCT00761631|11554093|FG002|Overall Study|Parent/legal guardian request|8
7322885|NCT00761631|11554094|FG003|Overall Study|Parent/legal guardian request|0
7322886|NCT00761631|11554095|FG004|Overall Study|Parent/legal guardian request|5
7322887|NCT00761631|11554096|FG005|Overall Study|Parent/legal guardian request|0
7322888|NCT00761631|11554091|FG000|Overall Study|Lost to Follow-up|2
7322889|NCT00761631|11554092|FG001|Overall Study|Lost to Follow-up|4
7322890|NCT00761631|11554093|FG002|Overall Study|Lost to Follow-up|7
7322891|NCT00761631|11554094|FG003|Overall Study|Lost to Follow-up|1
7322892|NCT00761631|11554095|FG004|Overall Study|Lost to Follow-up|6
7322893|NCT00761631|11554096|FG005|Overall Study|Lost to Follow-up|1
7322894|NCT00761631|11554091|FG000|Overall Study|Protocol Violation|2
7322895|NCT00761631|11554092|FG001|Overall Study|Protocol Violation|0
7322896|NCT00761631|11554093|FG002|Overall Study|Protocol Violation|0
7322897|NCT00761631|11554094|FG003|Overall Study|Protocol Violation|1
7322898|NCT00761631|11554095|FG004|Overall Study|Protocol Violation|5
7322899|NCT00761631|11554096|FG005|Overall Study|Protocol Violation|1
7322900|NCT00761631|11554091|FG000|Overall Study|Randomized, not treated|1
7322901|NCT00761631|11554092|FG001|Overall Study|Randomized, not treated|0
7322902|NCT00761631|11554093|FG002|Overall Study|Randomized, not treated|0
7322903|NCT00761631|11554094|FG003|Overall Study|Randomized, not treated|0
7322904|NCT00761631|11554095|FG004|Overall Study|Randomized, not treated|0
7322905|NCT00761631|11554096|FG005|Overall Study|Randomized, not treated|0
7322906|NCT00761631|11554091|FG000|Overall Study|Failed to return|1
7322907|NCT00761631|11554092|FG001|Overall Study|Failed to return|0
7322908|NCT00761631|11554093|FG002|Overall Study|Failed to return|1
7322909|NCT00761631|11554094|FG003|Overall Study|Failed to return|1
7322910|NCT00761631|11554095|FG004|Overall Study|Failed to return|5
7322911|NCT00761631|11554096|FG005|Overall Study|Failed to return|2
7322912|NCT00761631|11554091|FG000|Overall Study|Physician Decision|1
7322913|NCT00761631|11554092|FG001|Overall Study|Physician Decision|0
7322914|NCT00761631|11554093|FG002|Overall Study|Physician Decision|0
7322915|NCT00761631|11554094|FG003|Overall Study|Physician Decision|0
7322916|NCT00761631|11554095|FG004|Overall Study|Physician Decision|0
7322917|NCT00761631|11554096|FG005|Overall Study|Physician Decision|0
7322918|NCT00761631|11554091|FG000|Overall Study|Other|0
7322919|NCT00761631|11554092|FG001|Overall Study|Other|0
7322920|NCT00761631|11554093|FG002|Overall Study|Other|0
7322921|NCT00761631|11554094|FG003|Overall Study|Other|0
7416507|NCT01449539|11690062|FG000|Overall Study|Withdrawal by Subject|3
7416508|NCT01449539|11690062|FG000|Overall Study|Toxicity not study related|1
7416509|NCT01449630|11690075|FG000|Period 1|Physician Decision|1
7416510|NCT01449630|11690076|FG001|Period 1|Physician Decision|0
7416511|NCT01449630|11690077|FG002|Period 1|Physician Decision|0
7416512|NCT01449630|11690078|FG003|Period 1|Physician Decision|1
7416513|NCT01449630|11690079|FG004|Period 1|Physician Decision|0
7416514|NCT01449630|11690080|FG005|Period 1|Physician Decision|0
7416515|NCT01449630|11690081|FG006|Period 1|Physician Decision|0
7416516|NCT01449630|11690082|FG007|Period 1|Physician Decision|0
7416517|NCT01449630|11690083|FG008|Period 1|Physician Decision|0
7416518|NCT01449630|11690075|FG000|Period 1|Sponsor Decision|0
7416519|NCT01449630|11690076|FG001|Period 1|Sponsor Decision|0
7416520|NCT01449630|11690077|FG002|Period 1|Sponsor Decision|0
7416521|NCT01449630|11690078|FG003|Period 1|Sponsor Decision|0
7416522|NCT01449630|11690079|FG004|Period 1|Sponsor Decision|0
7416523|NCT01449630|11690080|FG005|Period 1|Sponsor Decision|1
7416524|NCT01449630|11690081|FG006|Period 1|Sponsor Decision|0
7416525|NCT01449630|11690082|FG007|Period 1|Sponsor Decision|0
7416526|NCT01449630|11690083|FG008|Period 1|Sponsor Decision|0
7416527|NCT01449630|11690075|FG000|Period 2|Sponsor Decision|0
7416528|NCT01449630|11690076|FG001|Period 2|Sponsor Decision|0
7416529|NCT01449630|11690077|FG002|Period 2|Sponsor Decision|0
7416530|NCT01449630|11690078|FG003|Period 2|Sponsor Decision|0
7416531|NCT01449630|11690079|FG004|Period 2|Sponsor Decision|0
7416532|NCT01449630|11690080|FG005|Period 2|Sponsor Decision|0
7416533|NCT01449630|11690081|FG006|Period 2|Sponsor Decision|1
7416534|NCT01449630|11690082|FG007|Period 2|Sponsor Decision|0
7416535|NCT01449630|11690083|FG008|Period 2|Sponsor Decision|0
7416536|NCT01449682|11690107|FG000|Overall Study|Death|0
7416537|NCT01449682|11690108|FG001|Overall Study|Death|1
7416538|NCT01449682|11690107|FG000|Overall Study|Adverse Event|1
7416539|NCT01449682|11690108|FG001|Overall Study|Adverse Event|0
7416540|NCT01449708|11690116|FG000|Overall Study|Protocol Violation|0
7416541|NCT01449708|11690117|FG001|Overall Study|Protocol Violation|1
7416542|NCT01449708|11690116|FG000|Overall Study|surgical complication|1
7416543|NCT01449708|11690117|FG001|Overall Study|surgical complication|2
7416544|NCT01449708|11690116|FG000|Overall Study|respiratory failure|1
7416545|NCT01449708|11690117|FG001|Overall Study|respiratory failure|0
7416546|NCT01449721|11690128|FG000|Overall Study|Physician Decision|0
7416547|NCT01449721|11690129|FG001|Overall Study|Physician Decision|1
7416548|NCT01449721|11690128|FG000|Overall Study|Physician Decision|0
7416549|NCT01449721|11690129|FG001|Overall Study|Physician Decision|1
7416550|NCT01449812|11690151|FG000|Overall Study|Migrated/moved from study area|1
7416551|NCT01449812|11690152|FG001|Overall Study|Migrated/moved from study area|0
7416552|NCT01449812|11690153|FG002|Overall Study|Migrated/moved from study area|0
7416553|NCT01449812|11690151|FG000|Overall Study|Withdrawal by Subject|0
7322922|NCT00761631|11554095|FG004|Overall Study|Other|1
7322923|NCT00761631|11554096|FG005|Overall Study|Other|1
7322924|NCT00761657|11554128|FG000|Part 1 (up to Day 57)|Adverse Event|0
7322925|NCT00761657|11554129|FG001|Part 1 (up to Day 57)|Adverse Event|0
7322926|NCT00761657|11554130|FG002|Part 1 (up to Day 57)|Adverse Event|0
7322927|NCT00761657|11554131|FG003|Part 1 (up to Day 57)|Adverse Event|1
7416554|NCT01449812|11690152|FG001|Overall Study|Withdrawal by Subject|0
7416555|NCT01449812|11690153|FG002|Overall Study|Withdrawal by Subject|1
7416556|NCT01449812|11690151|FG000|Overall Study|Lost to Follow-up|1
7416557|NCT01449812|11690152|FG001|Overall Study|Lost to Follow-up|0
7322928|NCT00761657|11554132|FG004|Part 1 (up to Day 57)|Adverse Event|0
7322929|NCT00761657|11554133|FG005|Part 1 (up to Day 57)|Adverse Event|0
7322930|NCT00761657|11554134|FG006|Part 1 (up to Day 57)|Adverse Event|0
7416558|NCT01449812|11690153|FG002|Overall Study|Lost to Follow-up|0
7416559|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Adverse Event|5
7416560|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Adverse Event|13
7416561|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Adverse Event|0
7322931|NCT00761657|11554135|FG007|Part 1 (up to Day 57)|Adverse Event|0
7322932|NCT00761657|11554136|FG008|Part 1 (up to Day 57)|Adverse Event|0
7322933|NCT00761657|11554128|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322934|NCT00761657|11554129|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322935|NCT00761657|11554130|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
7322936|NCT00761657|11554131|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
7322937|NCT00761657|11554132|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322938|NCT00761657|11554133|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322939|NCT00761657|11554134|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322940|NCT00761657|11554135|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322941|NCT00761657|11554136|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
7322942|NCT00761657|11554128|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
7322943|NCT00761657|11554129|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
7322944|NCT00761657|11554130|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
7322945|NCT00761657|11554131|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
7322946|NCT00761657|11554132|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
7322947|NCT00761657|11554133|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
7322948|NCT00761657|11554134|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
7322949|NCT00761657|11554135|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
7322950|NCT00761657|11554136|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
7322951|NCT00761657|11554128|FG000|Part 2 (up to Day 114)|Adverse Event|0
7322952|NCT00761657|11554129|FG001|Part 2 (up to Day 114)|Adverse Event|0
7322953|NCT00761657|11554130|FG002|Part 2 (up to Day 114)|Adverse Event|0
7322954|NCT00761657|11554131|FG003|Part 2 (up to Day 114)|Adverse Event|0
7322955|NCT00761657|11554132|FG004|Part 2 (up to Day 114)|Adverse Event|0
7322956|NCT00761657|11554133|FG005|Part 2 (up to Day 114)|Adverse Event|0
7322957|NCT00761657|11554134|FG006|Part 2 (up to Day 114)|Adverse Event|0
7322958|NCT00761657|11554135|FG007|Part 2 (up to Day 114)|Adverse Event|0
7322959|NCT00761657|11554136|FG008|Part 2 (up to Day 114)|Adverse Event|1
7322960|NCT00761735|11554166|FG000|Overall Study|Lost to Follow-up|6
7322961|NCT00761735|11554166|FG000|Overall Study|Withdrawal by Subject|6
7322962|NCT00761735|11554166|FG000|Overall Study|Non-compliance with protocol|1
7322963|NCT00761735|11554166|FG000|Overall Study|Administrative|1
7322964|NCT00761748|11554174|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
7322965|NCT00761748|11554175|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
7322966|NCT00761748|11554174|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
7322967|NCT00761748|11554175|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
7322968|NCT00761761|11554183|FG000|Overall Study|Lost to Follow-up|3
7322969|NCT00761761|11554184|FG001|Overall Study|Lost to Follow-up|1
7322970|NCT00761761|11554183|FG000|Overall Study|Withdrawal by Subject|3
7322971|NCT00761761|11554184|FG001|Overall Study|Withdrawal by Subject|0
7322972|NCT00761774|11554192|FG000|Overall Study|Adverse Event|17
7322973|NCT00761774|11554192|FG000|Overall Study|Lack of Efficacy|37
7322974|NCT00761774|11554192|FG000|Overall Study|Lost to Follow-up|2
7322975|NCT00761774|11554192|FG000|Overall Study|Withdrawal by Subject|9
7322976|NCT00761774|11554192|FG000|Overall Study|Non-compliance|4
7322977|NCT00761774|11554192|FG000|Overall Study|End of study|2
7322978|NCT00761774|11554192|FG000|Overall Study|Reclassification of seizures|1
7322979|NCT00761774|11554192|FG000|Overall Study|Medical decision to read SUSAR reports|1
7322980|NCT00761774|11554192|FG000|Overall Study|Sponsor decision|1
7322981|NCT00761774|11554192|FG000|Overall Study|Investigator clinical judgement|1
7322982|NCT00761774|11554192|FG000|Overall Study|Patient moved out of study area|1
7322983|NCT00761774|11554192|FG000|Overall Study|Coordinator leaving site|1
7322984|NCT00761774|11554192|FG000|Overall Study|Subject IP non-compliance|1
7322985|NCT00761774|11554192|FG000|Overall Study|IP stopped by hospital physician|1
7322986|NCT00761865|11554209|FG000|Overall Study|Lost to Follow-up|8
7322987|NCT00761865|11554210|FG001|Overall Study|Lost to Follow-up|7
7322988|NCT00761891|11554216|FG000|Overall Study|Withdrawal by Subject|10
7322989|NCT00761956|11554236|FG000|Overall Study|Lost to Follow-up|6
7322990|NCT00761956|11554237|FG001|Overall Study|Lost to Follow-up|11
7322991|NCT00761956|11554236|FG000|Overall Study|Withdrawal by Subject|3
7322992|NCT00761956|11554237|FG001|Overall Study|Withdrawal by Subject|8
7322993|NCT00761956|11554236|FG000|Overall Study|Death|0
7322994|NCT00761956|11554237|FG001|Overall Study|Death|1
7322995|NCT00761956|11554236|FG000|Overall Study|Adverse Event|26
7322996|NCT00761956|11554237|FG001|Overall Study|Adverse Event|34
7322997|NCT00761969|11554245|FG000|Overall Study|Death|112
7322998|NCT00761969|11554246|FG001|Overall Study|Death|47
7322999|NCT00761969|11554245|FG000|Overall Study|Lost to Follow-up|88
7323000|NCT00761969|11554246|FG001|Overall Study|Lost to Follow-up|93
7323001|NCT00762034|11554263|FG000|Induction Period|Protocol Violation|1
7323002|NCT00762034|11554264|FG001|Induction Period|Protocol Violation|2
7323003|NCT00762034|11554263|FG000|Induction Period|Entry Criterion Not Met|12
7323004|NCT00762034|11554264|FG001|Induction Period|Entry Criterion Not Met|11
7323005|NCT00762034|11554263|FG000|Induction Period|Adverse Event|27
7323006|NCT00762034|11554264|FG001|Induction Period|Adverse Event|38
7323007|NCT00762034|11554263|FG000|Induction Period|Lost to Follow-up|1
7323008|NCT00762034|11554264|FG001|Induction Period|Lost to Follow-up|1
7323009|NCT00762034|11554263|FG000|Induction Period|Progressive Disease|73
7323010|NCT00762034|11554264|FG001|Induction Period|Progressive Disease|55
7323011|NCT00762034|11554263|FG000|Induction Period|Physician Decision|21
7323012|NCT00762034|11554264|FG001|Induction Period|Physician Decision|20
7323013|NCT00762034|11554263|FG000|Induction Period|Withdrawal by Subject|15
7323014|NCT00762034|11554264|FG001|Induction Period|Withdrawal by Subject|19
7323015|NCT00762034|11554263|FG000|Induction Period|Deaths Not Due to Study Disease|19
7323016|NCT00762034|11554264|FG001|Induction Period|Deaths Not Due to Study Disease|14
7323017|NCT00762034|11554263|FG000|Induction Period|Deaths Due to Study Disease|9
7323018|NCT00762034|11554264|FG001|Induction Period|Deaths Due to Study Disease|9
7323019|NCT00762034|11554263|FG000|Maintenance Period|Protocol Violation|1
7323020|NCT00762034|11554264|FG001|Maintenance Period|Protocol Violation|3
7323021|NCT00762034|11554263|FG000|Maintenance Period|Entry Criterion Not Met|0
7323022|NCT00762034|11554264|FG001|Maintenance Period|Entry Criterion Not Met|2
7323023|NCT00762034|11554263|FG000|Maintenance Period|Adverse Event|42
7323024|NCT00762034|11554264|FG001|Maintenance Period|Adverse Event|26
7323025|NCT00762034|11554263|FG000|Maintenance Period|Progressive Disease|186
7323026|NCT00762034|11554264|FG001|Maintenance Period|Progressive Disease|224
7323027|NCT00762034|11554263|FG000|Maintenance Period|Physician Decision|25
7323028|NCT00762034|11554264|FG001|Maintenance Period|Physician Decision|20
7323029|NCT00762034|11554263|FG000|Maintenance Period|Withdrawal by Subject|34
7323030|NCT00762034|11554264|FG001|Maintenance Period|Withdrawal by Subject|14
7323031|NCT00762034|11554263|FG000|Maintenance Period|Death not due to study disease|2
7323032|NCT00762034|11554264|FG001|Maintenance Period|Death not due to study disease|5
7323033|NCT00762034|11554263|FG000|Maintenance Period|Death due to study disease|3
7323034|NCT00762034|11554264|FG001|Maintenance Period|Death due to study disease|3
7323035|NCT00762034|11554263|FG000|Maintenance Period|Other|1
7323036|NCT00762034|11554264|FG001|Maintenance Period|Other|1
7323037|NCT00762073|11554282|FG000|Overall Study|Lack of Efficacy|1
7323038|NCT00762073|11554283|FG001|Overall Study|Lack of Efficacy|1
7323039|NCT00762073|11554284|FG002|Overall Study|Lack of Efficacy|0
7323040|NCT00762073|11554285|FG003|Overall Study|Lack of Efficacy|0
7323041|NCT00762073|11554282|FG000|Overall Study|Adverse Event|1
7555231|NCT03053050|11918230|FG002|Randomized Phase|Study Terminated by Sponsor|128
7555232|NCT03053050|11918231|FG003|Randomized Phase|Study Terminated by Sponsor|0
7555233|NCT03053050|11918228|FG000|Randomized Phase|Withdrew Consent|16
7555234|NCT03053050|11918229|FG001|Randomized Phase|Withdrew Consent|8
7555235|NCT03053050|11918230|FG002|Randomized Phase|Withdrew Consent|9
7555236|NCT03053050|11918231|FG003|Randomized Phase|Withdrew Consent|0
7555237|NCT03053050|11918228|FG000|Randomized Phase|Investigator's Discretion|6
7555238|NCT03053050|11918229|FG001|Randomized Phase|Investigator's Discretion|6
7555239|NCT03053050|11918230|FG002|Randomized Phase|Investigator's Discretion|3
7555240|NCT03053050|11918231|FG003|Randomized Phase|Investigator's Discretion|0
7323042|NCT00762073|11554283|FG001|Overall Study|Adverse Event|0
7323043|NCT00762073|11554284|FG002|Overall Study|Adverse Event|1
7323044|NCT00762073|11554285|FG003|Overall Study|Adverse Event|1
7323045|NCT00762073|11554282|FG000|Overall Study|Significant Subject Noncompliance|0
7323046|NCT00762073|11554283|FG001|Overall Study|Significant Subject Noncompliance|1
7323047|NCT00762073|11554284|FG002|Overall Study|Significant Subject Noncompliance|0
7323048|NCT00762073|11554285|FG003|Overall Study|Significant Subject Noncompliance|1
7323049|NCT00762073|11554282|FG000|Overall Study|Withdrawal by Subject|1
7323050|NCT00762073|11554283|FG001|Overall Study|Withdrawal by Subject|2
7323051|NCT00762073|11554284|FG002|Overall Study|Withdrawal by Subject|1
7323052|NCT00762073|11554285|FG003|Overall Study|Withdrawal by Subject|1
7323053|NCT00762073|11554282|FG000|Overall Study|Not on treatment for >/= 77 days|1
7323054|NCT00762073|11554283|FG001|Overall Study|Not on treatment for >/= 77 days|0
7323055|NCT00762073|11554284|FG002|Overall Study|Not on treatment for >/= 77 days|0
7323056|NCT00762073|11554285|FG003|Overall Study|Not on treatment for >/= 77 days|0
7323057|NCT00762086|11554304|FG000|Overall Study|Adverse Event|2
7323058|NCT00762086|11554305|FG001|Overall Study|Adverse Event|0
7323059|NCT00762086|11554304|FG000|Overall Study|Lost to Follow-up|0
7323060|NCT00762086|11554305|FG001|Overall Study|Lost to Follow-up|2
7323061|NCT00762086|11554304|FG000|Overall Study|Non compliance|1
7323062|NCT00762086|11554305|FG001|Overall Study|Non compliance|0
7323063|NCT00762086|11554304|FG000|Overall Study|Withdrawal by Subject|2
7323064|NCT00762086|11554305|FG001|Overall Study|Withdrawal by Subject|2
7323065|NCT00762086|11554304|FG000|Overall Study|Ineligible to participate in the study|1
7323066|NCT00762086|11554305|FG001|Overall Study|Ineligible to participate in the study|0
7323067|NCT00762164|11554313|FG000|Overall Study|Lost to Follow-up|1
7323068|NCT00762164|11554314|FG001|Overall Study|Lost to Follow-up|1
7323069|NCT00762164|11554313|FG000|Overall Study|Discontinued medication|2
7323070|NCT00762164|11554314|FG001|Overall Study|Discontinued medication|0
7323071|NCT00762164|11554313|FG000|Overall Study|Withdrawal by Subject|0
7323072|NCT00762164|11554314|FG001|Overall Study|Withdrawal by Subject|1
7323073|NCT00762229|11554342|FG000|Overall Study|Lost to Follow-up|1
7323074|NCT00762229|11554343|FG001|Overall Study|Lost to Follow-up|1
7323075|NCT00762229|11554342|FG000|Overall Study|did not recveive intervention|0
7323076|NCT00762229|11554343|FG001|Overall Study|did not recveive intervention|1
7323077|NCT00762268|11554351|FG000|Overall Study|Withdrawal by Subject|3
7323078|NCT00762268|11554352|FG001|Overall Study|Withdrawal by Subject|3
7323079|NCT00762359|11554397|FG000|Overall Study|Adverse Event|20
7323080|NCT00762359|11554398|FG001|Overall Study|Adverse Event|23
7323081|NCT00762359|11554397|FG000|Overall Study|Protocol Violation|21
7323082|NCT00762359|11554398|FG001|Overall Study|Protocol Violation|13
7323083|NCT00762359|11554397|FG000|Overall Study|Withdrawal by Subject|13
7323084|NCT00762359|11554398|FG001|Overall Study|Withdrawal by Subject|10
7416562|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
7416563|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
7416564|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
7416565|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Protocol Violation|5
7416566|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Protocol Violation|6
7416567|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Protocol Violation|0
7416568|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
7416569|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7416570|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
7416571|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
7416572|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
7416573|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
7416574|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
7416575|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
7416576|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
7416577|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Physician Decision|2
7416578|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Physician Decision|3
7416579|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Physician Decision|0
7416580|NCT01449929|11690167|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
7416581|NCT01449929|11690168|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
7416582|NCT01449929|11690169|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
7416583|NCT01449929|11690167|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
7416584|NCT01449929|11690168|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
7416585|NCT01449929|11690169|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
7416586|NCT01449929|11690167|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7416587|NCT01449929|11690168|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
7416588|NCT01449929|11690169|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
7416589|NCT01449929|11690167|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7416590|NCT01449929|11690168|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
7416591|NCT01449929|11690169|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
7416592|NCT01449955|11690181|FG000|Overall Study|Withdrawal by Subject|1
7416593|NCT01449955|11690182|FG001|Overall Study|Withdrawal by Subject|2
7416594|NCT01450007|11690198|FG000|Overall Study|Late exclusion before treatment|2
7416595|NCT01450007|11690199|FG001|Overall Study|Late exclusion before treatment|3
7416596|NCT01450007|11690200|FG002|Overall Study|Late exclusion before treatment|2
7416597|NCT01450007|11690198|FG000|Overall Study|Protocol Violation|0
7416598|NCT01450007|11690199|FG001|Overall Study|Protocol Violation|1
7416599|NCT01450007|11690200|FG002|Overall Study|Protocol Violation|1
7416600|NCT01450007|11690198|FG000|Overall Study|Adverse Event|0
7416601|NCT01450007|11690199|FG001|Overall Study|Adverse Event|1
7416602|NCT01450007|11690200|FG002|Overall Study|Adverse Event|0
7416603|NCT01450098|11690210|FG000|Period 3|Protocol Violation|0
7416604|NCT01450098|11690211|FG001|Period 3|Protocol Violation|1
7416605|NCT01450098|11690210|FG000|Period 3|Withdrawal by Subject|0
7416606|NCT01450098|11690211|FG001|Period 3|Withdrawal by Subject|2
7416607|NCT01450137|11690226|FG000|Up to Week 12|Adverse Event|2
7416608|NCT01450137|11690227|FG001|Up to Week 12|Adverse Event|1
7416609|NCT01450137|11690226|FG000|Up to Week 12|Withdrawal by Subject|0
7416610|NCT01450137|11690227|FG001|Up to Week 12|Withdrawal by Subject|2
7416611|NCT01450137|11690226|FG000|Week 12 to Study End|Death|0
7416612|NCT01450137|11690227|FG001|Week 12 to Study End|Death|1
7416613|NCT01450137|11690226|FG000|Week 12 to Study End|Withdrawal by Subject|0
7416614|NCT01450137|11690227|FG001|Week 12 to Study End|Withdrawal by Subject|1
7416615|NCT01450540|11690272|FG000|Overall Study|Withdrawal by Subject|19
7416616|NCT01450540|11690273|FG001|Overall Study|Withdrawal by Subject|13
7416617|NCT01450540|11690272|FG000|Overall Study|protocol deviation|3
7416618|NCT01450540|11690273|FG001|Overall Study|protocol deviation|23
7416623|NCT01450683|11690290|FG000|Overall Study|Adverse Event|2
7416624|NCT01450696|11690296|FG000|Overall Study|Never Treated|1
7416625|NCT01450696|11690297|FG001|Overall Study|Never Treated|1
7416626|NCT01450696|11690296|FG000|Overall Study|Death|77
7416627|NCT01450696|11690297|FG001|Overall Study|Death|84
7416628|NCT01450696|11690296|FG000|Overall Study|Lost to Follow-up|3
7416629|NCT01450696|11690297|FG001|Overall Study|Lost to Follow-up|3
7416630|NCT01450696|11690296|FG000|Overall Study|Non-Compliance|1
7416631|NCT01450696|11690297|FG001|Overall Study|Non-Compliance|0
7416632|NCT01450696|11690296|FG000|Overall Study|Withdrawal by Subject|13
7416633|NCT01450696|11690297|FG001|Overall Study|Withdrawal by Subject|2
7416634|NCT01450696|11690296|FG000|Overall Study|Study Terminated by Sponsor|53
7416635|NCT01450696|11690297|FG001|Overall Study|Study Terminated by Sponsor|58
7416636|NCT01450761|11690305|FG000|Randomization|Subject no longer meets study criteria|1
7468729|NCT01914393|11769701|FG001|Overall Study|Lack of Efficacy|16
7323085|NCT00762359|11554397|FG000|Overall Study|Lack of Efficacy|0
7323086|NCT00762359|11554398|FG001|Overall Study|Lack of Efficacy|4
7323087|NCT00762359|11554397|FG000|Overall Study|Institution closed|2
7323088|NCT00762359|11554398|FG001|Overall Study|Institution closed|3
7323089|NCT00762359|11554397|FG000|Overall Study|Physician Decision|2
7323090|NCT00762359|11554398|FG001|Overall Study|Physician Decision|3
7323091|NCT00762359|11554397|FG000|Overall Study|Removal|0
7323092|NCT00762359|11554398|FG001|Overall Study|Removal|1
7323093|NCT00762359|11554397|FG000|Overall Study|Withdrew consent|1
7323094|NCT00762359|11554398|FG001|Overall Study|Withdrew consent|0
7323095|NCT00762372|11554407|FG000|Overall Study|Adverse Event|1
7323096|NCT00762372|11554408|FG001|Overall Study|Adverse Event|0
7323097|NCT00762372|11554409|FG002|Overall Study|Adverse Event|0
7323098|NCT00762385|11554423|FG000|First Intervention|Lens Issue|1
7323099|NCT00762385|11554424|FG001|First Intervention|Lens Issue|1
7323100|NCT00762385|11554423|FG000|First Intervention|Lost to Follow-up|0
7323101|NCT00762385|11554424|FG001|First Intervention|Lost to Follow-up|2
7323102|NCT00762385|11554423|FG000|First Intervention|Ineligible|1
7323103|NCT00762385|11554424|FG001|First Intervention|Ineligible|0
7323104|NCT00762385|11554423|FG000|First Intervention|Protocol Violation|0
7323105|NCT00762385|11554424|FG001|First Intervention|Protocol Violation|1
7323106|NCT00762385|11554423|FG000|Second Intervention|Protocol Violation|3
7323107|NCT00762385|11554424|FG001|Second Intervention|Protocol Violation|3
7323108|NCT00762411|11554435|FG000|Initial Treatment|Death|7
7323109|NCT00762411|11554436|FG001|Initial Treatment|Death|6
7323110|NCT00762411|11554435|FG000|Initial Treatment|Adverse Event|132
7323111|NCT00762411|11554436|FG001|Initial Treatment|Adverse Event|40
7323112|NCT00762411|11554435|FG000|Initial Treatment|Protocol Violation|4
7323113|NCT00762411|11554436|FG001|Initial Treatment|Protocol Violation|1
7323114|NCT00762411|11554435|FG000|Initial Treatment|Withdrawal by Subject|65
7323115|NCT00762411|11554436|FG001|Initial Treatment|Withdrawal by Subject|52
7323116|NCT00762411|11554435|FG000|Initial Treatment|Physician Decision|1
7323117|NCT00762411|11554436|FG001|Initial Treatment|Physician Decision|0
7323118|NCT00762411|11554435|FG000|Initial Treatment|Sponsor Decision|293
7323119|NCT00762411|11554436|FG001|Initial Treatment|Sponsor Decision|401
7323120|NCT00762411|11554435|FG000|Initial Treatment|Lost to Follow-up|5
7323121|NCT00762411|11554436|FG001|Initial Treatment|Lost to Follow-up|0
7323122|NCT00762411|11554435|FG000|Initial Treatment|Caregiver Decision|21
7323123|NCT00762411|11554436|FG001|Initial Treatment|Caregiver Decision|16
7323124|NCT00762411|11554435|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
7323125|NCT00762411|11554436|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
7323126|NCT00762411|11554435|FG000|Initial Treatment|Entry Criteria Exclusion|0
7323127|NCT00762411|11554436|FG001|Initial Treatment|Entry Criteria Exclusion|1
7323128|NCT00762411|11554435|FG000|Delayed Start|Adverse Event|0
7323129|NCT00762411|11554436|FG001|Delayed Start|Adverse Event|4
7323130|NCT00762411|11554435|FG000|Delayed Start|Protocol Violation|0
7323131|NCT00762411|11554436|FG001|Delayed Start|Protocol Violation|1
7323132|NCT00762411|11554435|FG000|Delayed Start|Sponsor Decision|16
7323133|NCT00762411|11554436|FG001|Delayed Start|Sponsor Decision|20
7323134|NCT00762411|11554435|FG000|Delayed Start|Caregiver Decision|1
7323135|NCT00762411|11554436|FG001|Delayed Start|Caregiver Decision|1
7323136|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|Death|1
7323137|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|Death|8
7323138|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
7323139|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
7323140|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
7323141|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
7323142|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
7323143|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7323144|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7323145|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
7323146|NCT00762411|11554435|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
7323147|NCT00762411|11554436|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
7323148|NCT00762463|11554470|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7323149|NCT00762463|11554471|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
7323150|NCT00762463|11554472|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7323151|NCT00762463|11554473|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
7323152|NCT00762463|11554470|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
7323153|NCT00762463|11554471|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
7323154|NCT00762463|11554472|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7323155|NCT00762463|11554473|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
7323156|NCT00762463|11554470|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
7323157|NCT00762463|11554471|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
7323158|NCT00762463|11554472|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7323159|NCT00762463|11554473|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
7323160|NCT00762463|11554470|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
7323161|NCT00762463|11554471|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
7323162|NCT00762463|11554472|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7384832|NCT01197508|11642266|FG000|Overall Study|Lost to Follow-up|1
7323163|NCT00762463|11554473|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
7323164|NCT00762463|11554470|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7323165|NCT00762463|11554471|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7323166|NCT00762463|11554472|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
7323167|NCT00762463|11554473|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
7323168|NCT00762463|11554470|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7323169|NCT00762463|11554471|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7323170|NCT00762463|11554472|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
7323171|NCT00762463|11554473|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
7323172|NCT00762463|11554470|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
7323173|NCT00762463|11554471|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7323174|NCT00762463|11554472|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
7323175|NCT00762463|11554473|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
7323176|NCT00762463|11554470|FG000|Extension Phase (Week 6 to Week 12)|Other|0
7416637|NCT01450761|11690306|FG001|Randomization|Subject no longer meets study criteria|2
7416638|NCT01450761|11690305|FG000|Randomization|Withdrawal by Subject|2
7416639|NCT01450761|11690306|FG001|Randomization|Withdrawal by Subject|0
7416640|NCT01450761|11690305|FG000|Randomization|Disease progression|0
7416641|NCT01450761|11690306|FG001|Randomization|Disease progression|2
7416642|NCT01450761|11690305|FG000|Randomization|Adverse Event unrelated to study drug|1
7416643|NCT01450761|11690306|FG001|Randomization|Adverse Event unrelated to study drug|0
7416644|NCT01450761|11690305|FG000|Randomization|Other|0
7416645|NCT01450761|11690306|FG001|Randomization|Other|1
7416646|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Disease progression|33
7416647|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Disease progression|32
7416648|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
7416649|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
7416650|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
7416651|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
7416652|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Study drug toxicity|6
7416653|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Study drug toxicity|10
7531021|NCT02641730|11874677|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
7555241|NCT03053050|11918228|FG000|Randomized Phase|Lost to Follow-up|5
7555242|NCT03053050|11918229|FG001|Randomized Phase|Lost to Follow-up|1
7555243|NCT03053050|11918230|FG002|Randomized Phase|Lost to Follow-up|1
7555244|NCT03053050|11918231|FG003|Randomized Phase|Lost to Follow-up|0
7555245|NCT03053050|11918228|FG000|Randomized Phase|Adverse Event|0
7555246|NCT03053050|11918229|FG001|Randomized Phase|Adverse Event|1
7555247|NCT03053050|11918230|FG002|Randomized Phase|Adverse Event|0
7555248|NCT03053050|11918231|FG003|Randomized Phase|Adverse Event|0
7555249|NCT03053050|11918228|FG000|Randomized Phase|Randomized but Never Treated|2
7416654|NCT01450761|11690305|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
7531022|NCT02641730|11874678|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
7531023|NCT02641730|11874674|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7531024|NCT02641730|11874675|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7531025|NCT02641730|11874676|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7531026|NCT02641730|11874677|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
7531027|NCT02641730|11874678|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
7531028|NCT02641730|11874674|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
7531029|NCT02641730|11874675|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
7531030|NCT02641730|11874676|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
7531031|NCT02641730|11874677|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
7531032|NCT02641730|11874678|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
7531033|NCT02641730|11874674|FG000|After Controlled Period (Week 16 - 52)|Other|0
7531034|NCT02641730|11874675|FG001|After Controlled Period (Week 16 - 52)|Other|1
7416655|NCT01450761|11690306|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
7416656|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Death|3
7416657|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Death|3
7416658|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Other|2
7416659|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Other|2
7416660|NCT01450761|11690305|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
7416661|NCT01450761|11690306|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
7416662|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Disease progression|318
7416663|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Disease progression|415
7416664|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
7416665|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
7416666|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
7416667|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
7416668|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
7416669|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
7416670|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
7555250|NCT03053050|11918229|FG001|Randomized Phase|Randomized but Never Treated|2
7323177|NCT00762463|11554471|FG001|Extension Phase (Week 6 to Week 12)|Other|0
7323178|NCT00762463|11554472|FG002|Extension Phase (Week 6 to Week 12)|Other|0
7323179|NCT00762463|11554473|FG003|Extension Phase (Week 6 to Week 12)|Other|1
7323180|NCT00762476|11554488|FG000|Overall Study|Adverse Event|7
7323181|NCT00762476|11554489|FG001|Overall Study|Adverse Event|1
7323182|NCT00762476|11554488|FG000|Overall Study|Lost to Follow-up|2
7323183|NCT00762476|11554489|FG001|Overall Study|Lost to Follow-up|0
7323184|NCT00762476|11554488|FG000|Overall Study|Protocol Violation|5
7323185|NCT00762476|11554489|FG001|Overall Study|Protocol Violation|6
7323186|NCT00762476|11554488|FG000|Overall Study|Physician Decision|2
7323187|NCT00762476|11554489|FG001|Overall Study|Physician Decision|14
7323188|NCT00762476|11554488|FG000|Overall Study|Withdrawal by Subject|6
7323189|NCT00762476|11554489|FG001|Overall Study|Withdrawal by Subject|12
7323190|NCT00762476|11554488|FG000|Overall Study|antibiotic use|0
7323191|NCT00762476|11554489|FG001|Overall Study|antibiotic use|1
7323192|NCT00762476|11554488|FG000|Overall Study|non-compliance with study visits|0
7416671|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
7416672|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Death|5
7416673|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Death|6
7416674|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
7416675|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
7416676|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
7416677|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
7416678|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
7416679|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
7416680|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
7416681|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
7416682|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Not reported|2
7416683|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Not reported|2
7416684|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
7416685|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
7416686|NCT01450761|11690305|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
7416687|NCT01450761|11690306|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
7416688|NCT01450800|11690323|FG000|Overall Study|Protocol Violation|1
7416689|NCT01450800|11690324|FG001|Overall Study|Protocol Violation|3
7416690|NCT01450813|11690336|FG000|Overall Study|Physician Decision|1
7416691|NCT01450813|11690337|FG001|Overall Study|Physician Decision|1
7416692|NCT01450813|11690338|FG002|Overall Study|Physician Decision|0
7416693|NCT01450813|11690339|FG003|Overall Study|Physician Decision|3
7416694|NCT01450943|11690363|FG000|Overall Study|Screen failure, loss to follow-up|2
7416695|NCT01450943|11690364|FG001|Overall Study|Screen failure, loss to follow-up|7
7416696|NCT01450943|11690365|FG002|Overall Study|Screen failure, loss to follow-up|6
7416697|NCT01451164|11690381|FG000|Overall Study|Adverse Event|19
7416698|NCT01451164|11690382|FG001|Overall Study|Adverse Event|12
7416699|NCT01451164|11690383|FG002|Overall Study|Adverse Event|18
7416700|NCT01451164|11690384|FG003|Overall Study|Adverse Event|21
7416701|NCT01451164|11690381|FG000|Overall Study|Withdrawal Criteria|1
7416702|NCT01451164|11690382|FG001|Overall Study|Withdrawal Criteria|1
7416703|NCT01451164|11690383|FG002|Overall Study|Withdrawal Criteria|1
7416704|NCT01451164|11690384|FG003|Overall Study|Withdrawal Criteria|1
7416705|NCT01451164|11690381|FG000|Overall Study|Physician Decision|2
7416706|NCT01451164|11690382|FG001|Overall Study|Physician Decision|0
7416707|NCT01451164|11690383|FG002|Overall Study|Physician Decision|1
7416708|NCT01451164|11690384|FG003|Overall Study|Physician Decision|0
7416709|NCT01451164|11690381|FG000|Overall Study|Withdrawal by Subject|14
7416710|NCT01451164|11690382|FG001|Overall Study|Withdrawal by Subject|11
7416711|NCT01451164|11690383|FG002|Overall Study|Withdrawal by Subject|16
7416712|NCT01451164|11690384|FG003|Overall Study|Withdrawal by Subject|17
7416713|NCT01451164|11690381|FG000|Overall Study|Protocol Violation|0
7416714|NCT01451164|11690382|FG001|Overall Study|Protocol Violation|1
7416715|NCT01451164|11690383|FG002|Overall Study|Protocol Violation|0
7416716|NCT01451164|11690384|FG003|Overall Study|Protocol Violation|0
7416717|NCT01451164|11690381|FG000|Overall Study|Lack of Efficacy|7
7416718|NCT01451164|11690382|FG001|Overall Study|Lack of Efficacy|9
7416719|NCT01451164|11690383|FG002|Overall Study|Lack of Efficacy|9
7416720|NCT01451164|11690384|FG003|Overall Study|Lack of Efficacy|7
7416721|NCT01451203|11690396|FG000|Double-blind Treatment Period|Did not receive treatment|1
7416722|NCT01451203|11690397|FG001|Double-blind Treatment Period|Did not receive treatment|2
7323193|NCT00762476|11554489|FG001|Overall Study|non-compliance with study visits|2
7323194|NCT00762476|11554488|FG000|Overall Study|Seasonal allergies|1
7323195|NCT00762476|11554489|FG001|Overall Study|Seasonal allergies|0
7323196|NCT00762502|11554499|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
7323197|NCT00762502|11554500|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
7323198|NCT00762502|11554501|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
7323199|NCT00762502|11554499|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
7323200|NCT00762502|11554500|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
7323201|NCT00762502|11554501|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
7323202|NCT00762502|11554499|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
7323203|NCT00762502|11554500|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
7323204|NCT00762502|11554501|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
7323205|NCT00762606|11554527|FG000|Overall Study|Lost to Follow-up|18
7323206|NCT00762606|11554528|FG001|Overall Study|Lost to Follow-up|13
7323207|NCT00762762|11554565|FG000|Overall Study|Did not report for appointments|8
7323208|NCT00762762|11554566|FG001|Overall Study|Did not report for appointments|10
7323209|NCT00762788|11554578|FG000|Overall Study|Lost to Follow-up|26
7323210|NCT00762788|11554579|FG001|Overall Study|Lost to Follow-up|37
7323211|NCT00762788|11554580|FG002|Overall Study|Lost to Follow-up|21
7323212|NCT00762788|11554581|FG003|Overall Study|Lost to Follow-up|26
7323213|NCT00762788|11554582|FG004|Overall Study|Lost to Follow-up|13
7323214|NCT00762788|11554583|FG005|Overall Study|Lost to Follow-up|21
7323215|NCT00762892|11554608|FG000|Overall Study|Lost to Follow-up|2
7323216|NCT00762892|11554609|FG001|Overall Study|Lost to Follow-up|5
7323217|NCT00762892|11554608|FG000|Overall Study|Withdrawal by Subject|0
7323218|NCT00762892|11554609|FG001|Overall Study|Withdrawal by Subject|1
7323219|NCT00762892|11554608|FG000|Overall Study|Death|1
7323220|NCT00762892|11554609|FG001|Overall Study|Death|0
7323221|NCT00762892|11554608|FG000|Overall Study|Pregnancy|1
7323222|NCT00762892|11554609|FG001|Overall Study|Pregnancy|0
7323223|NCT00762892|11554608|FG000|Overall Study|Incarceration|1
7323224|NCT00762892|11554609|FG001|Overall Study|Incarceration|0
7323225|NCT00762970|11554622|FG000|Overall Study|Withdrawal by Subject|7
7323226|NCT00762970|11554623|FG001|Overall Study|Withdrawal by Subject|4
7323227|NCT00762970|11554624|FG002|Overall Study|Withdrawal by Subject|0
7531035|NCT02641730|11874676|FG002|After Controlled Period (Week 16 - 52)|Other|1
7323228|NCT00762970|11554622|FG000|Overall Study|Protocol Violation|3
7323229|NCT00762970|11554623|FG001|Overall Study|Protocol Violation|1
7323230|NCT00762970|11554624|FG002|Overall Study|Protocol Violation|1
7323231|NCT00762970|11554622|FG000|Overall Study|Lost to Follow-up|1
7323232|NCT00762970|11554623|FG001|Overall Study|Lost to Follow-up|2
7323233|NCT00762970|11554624|FG002|Overall Study|Lost to Follow-up|0
7323234|NCT00762970|11554622|FG000|Overall Study|Difficulty of handling lens|1
7323235|NCT00762970|11554623|FG001|Overall Study|Difficulty of handling lens|2
7323236|NCT00762970|11554624|FG002|Overall Study|Difficulty of handling lens|0
7323237|NCT00762996|11554632|FG000|Period One|Protocol Violation|0
7323238|NCT00762996|11554633|FG001|Period One|Protocol Violation|0
7323239|NCT00762996|11554634|FG002|Period One|Protocol Violation|1
7323240|NCT00762996|11554635|FG003|Period One|Protocol Violation|0
7323241|NCT00762996|11554632|FG000|Period One|ineligible|0
7323242|NCT00762996|11554633|FG001|Period One|ineligible|0
7323243|NCT00762996|11554634|FG002|Period One|ineligible|1
7323244|NCT00762996|11554635|FG003|Period One|ineligible|1
7323245|NCT00762996|11554632|FG000|Period One|Adverse Event|0
7323246|NCT00762996|11554633|FG001|Period One|Adverse Event|0
7323247|NCT00762996|11554634|FG002|Period One|Adverse Event|1
7323248|NCT00762996|11554635|FG003|Period One|Adverse Event|0
7323249|NCT00762996|11554632|FG000|Period One|Withdrawal by Subject|0
7323250|NCT00762996|11554633|FG001|Period One|Withdrawal by Subject|0
7323251|NCT00762996|11554634|FG002|Period One|Withdrawal by Subject|1
7323252|NCT00762996|11554635|FG003|Period One|Withdrawal by Subject|0
7323253|NCT00763035|11554643|FG000|First Intervention|Did not meeting inclusion/exclusion|1
7323254|NCT00763035|11554644|FG001|First Intervention|Did not meeting inclusion/exclusion|0
7323255|NCT00763035|11554643|FG000|First Intervention|Adverse Event|0
7323256|NCT00763035|11554644|FG001|First Intervention|Adverse Event|1
7323257|NCT00763035|11554643|FG000|Second Intervention|Adverse Event|1
7323258|NCT00763035|11554644|FG001|Second Intervention|Adverse Event|0
7323259|NCT00763035|11554643|FG000|Second Intervention|Physician Decision|2
7323260|NCT00763035|11554644|FG001|Second Intervention|Physician Decision|0
7323261|NCT00763139|11554668|FG000|Overall Study|Adverse Event|4
7323262|NCT00763139|11554669|FG001|Overall Study|Adverse Event|2
7323263|NCT00763139|11554668|FG000|Overall Study|Withdrawal by Subject|0
7323264|NCT00763139|11554669|FG001|Overall Study|Withdrawal by Subject|1
7323265|NCT00763139|11554668|FG000|Overall Study|med change not allowed by protocol|1
7323266|NCT00763139|11554669|FG001|Overall Study|med change not allowed by protocol|0
7323267|NCT00763256|11554694|FG000|Overall Study|Didn't return for appointments|7
7323268|NCT00763256|11554695|FG001|Overall Study|Didn't return for appointments|10
7323269|NCT00763269|11554703|FG000|Overall Study|Lost to Follow-up|12
7323270|NCT00763269|11554704|FG001|Overall Study|Lost to Follow-up|13
7384833|NCT01197508|11642267|FG001|Overall Study|Lost to Follow-up|1
7384834|NCT01197508|11642268|FG002|Overall Study|Lost to Follow-up|2
7384835|NCT01197508|11642269|FG003|Overall Study|Lost to Follow-up|0
7384836|NCT01197508|11642266|FG000|Overall Study|Other|2
7384837|NCT01197508|11642267|FG001|Overall Study|Other|3
7384838|NCT01197508|11642268|FG002|Overall Study|Other|2
7384839|NCT01197508|11642269|FG003|Overall Study|Other|2
7384840|NCT01197521|11642282|FG000|Overall Study|Not reported|24
7384841|NCT01197521|11642283|FG001|Overall Study|Not reported|25
7384842|NCT01197521|11642284|FG002|Overall Study|Not reported|21
7384843|NCT01197521|11642282|FG000|Overall Study|Enrolment in long term extension|42
7384844|NCT01197521|11642283|FG001|Overall Study|Enrolment in long term extension|36
7384845|NCT01197521|11642284|FG002|Overall Study|Enrolment in long term extension|87
7384846|NCT01197521|11642282|FG000|Overall Study|Severe non-compliance to protocol|1
7384847|NCT01197521|11642283|FG001|Overall Study|Severe non-compliance to protocol|3
7384848|NCT01197521|11642284|FG002|Overall Study|Severe non-compliance to protocol|3
7387568|NCT01215097|11646121|FG000|Overall Study|Withdrawal by Subject|6
7531036|NCT02641730|11874677|FG003|After Controlled Period (Week 16 - 52)|Other|0
7531037|NCT02641730|11874678|FG004|After Controlled Period (Week 16 - 52)|Other|1
7555251|NCT03053050|11918230|FG002|Randomized Phase|Randomized but Never Treated|2
7323271|NCT00763282|11554712|FG000|Overall Study|Withdrawal by Subject|6
7323272|NCT00763282|11554713|FG001|Overall Study|Withdrawal by Subject|5
7323273|NCT00763282|11554712|FG000|Overall Study|Death|4
7416723|NCT01451203|11690396|FG000|Double-blind Treatment Period|Consent Withdrawn|3
7416724|NCT01451203|11690397|FG001|Double-blind Treatment Period|Consent Withdrawn|2
7416725|NCT01451203|11690396|FG000|Double-blind Treatment Period|Lack of Efficacy|71
7416726|NCT01451203|11690397|FG001|Double-blind Treatment Period|Lack of Efficacy|36
7416727|NCT01451203|11690396|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
7416728|NCT01451203|11690397|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
7416729|NCT01451203|11690396|FG000|Double-blind Treatment Period|Adverse Event|6
7416730|NCT01451203|11690397|FG001|Double-blind Treatment Period|Adverse Event|9
7416731|NCT01451203|11690396|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
7416732|NCT01451203|11690397|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
7416733|NCT01451203|11690396|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
7416734|NCT01451203|11690397|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
7416735|NCT01451203|11690396|FG000|Double-blind Treatment Period|Investigator decision|2
7416736|NCT01451203|11690397|FG001|Double-blind Treatment Period|Investigator decision|0
7416737|NCT01451203|11690396|FG000|Post-treatment Period|Consent withdrawn|2
7416738|NCT01451203|11690397|FG001|Post-treatment Period|Consent withdrawn|4
7416739|NCT01451203|11690396|FG000|Post-treatment Period|Lack of Efficacy|12
7416740|NCT01451203|11690397|FG001|Post-treatment Period|Lack of Efficacy|28
7416741|NCT01451203|11690396|FG000|Post-treatment Period|Adverse Event|0
7416742|NCT01451203|11690397|FG001|Post-treatment Period|Adverse Event|1
7416743|NCT01451203|11690396|FG000|Post-treatment Period|Investigator decision|0
7416744|NCT01451203|11690397|FG001|Post-treatment Period|Investigator decision|1
7416745|NCT01451398|11690413|FG000|Overall Study|Adverse Event|7
7416746|NCT01451398|11690414|FG001|Overall Study|Adverse Event|9
7416747|NCT01451398|11690413|FG000|Overall Study|Protocol Violation|1
7416748|NCT01451398|11690414|FG001|Overall Study|Protocol Violation|2
7416749|NCT01451398|11690413|FG000|Overall Study|Physician Decision|1
7416750|NCT01451398|11690414|FG001|Overall Study|Physician Decision|1
7416751|NCT01451398|11690413|FG000|Overall Study|Withdrawal by Subject|10
7416752|NCT01451398|11690414|FG001|Overall Study|Withdrawal by Subject|14
7416753|NCT01451398|11690413|FG000|Overall Study|Lost to Follow-up|6
7416754|NCT01451398|11690414|FG001|Overall Study|Lost to Follow-up|4
7416755|NCT01451398|11690413|FG000|Overall Study|Non-compliance with study drug|1
7416756|NCT01451398|11690414|FG001|Overall Study|Non-compliance with study drug|3
7416757|NCT01451398|11690413|FG000|Overall Study|Non-compliance with protocol|1
7416758|NCT01451398|11690414|FG001|Overall Study|Non-compliance with protocol|1
7416759|NCT01451398|11690413|FG000|Overall Study|Moved out of country|0
7416760|NCT01451398|11690414|FG001|Overall Study|Moved out of country|1
7416825|NCT01451437|11690468|FG008|Overall Study|Withdrawal by Subject|0
7416761|NCT01451398|11690413|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
7416762|NCT01451398|11690414|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
7416763|NCT01451398|11690413|FG000|Overall Study|Lack of Efficacy|0
7416764|NCT01451398|11690414|FG001|Overall Study|Lack of Efficacy|1
7416765|NCT01451424|11690433|FG000|Overall Study|Withdrawal by Subject|1
7416766|NCT01451424|11690434|FG001|Overall Study|Withdrawal by Subject|1
7416767|NCT01451424|11690435|FG002|Overall Study|Withdrawal by Subject|0
7416768|NCT01451424|11690436|FG003|Overall Study|Withdrawal by Subject|2
7416769|NCT01451424|11690433|FG000|Overall Study|Lost to Follow-up|0
7416770|NCT01451424|11690434|FG001|Overall Study|Lost to Follow-up|1
7416771|NCT01451424|11690435|FG002|Overall Study|Lost to Follow-up|0
7416772|NCT01451424|11690436|FG003|Overall Study|Lost to Follow-up|1
7416773|NCT01451424|11690433|FG000|Overall Study|Physician Decision|0
7416774|NCT01451424|11690434|FG001|Overall Study|Physician Decision|0
7416775|NCT01451424|11690435|FG002|Overall Study|Physician Decision|1
7416776|NCT01451424|11690436|FG003|Overall Study|Physician Decision|1
7416777|NCT01451424|11690433|FG000|Overall Study|Adverse Event|0
7416778|NCT01451424|11690434|FG001|Overall Study|Adverse Event|0
7416779|NCT01451424|11690435|FG002|Overall Study|Adverse Event|0
7416780|NCT01451424|11690436|FG003|Overall Study|Adverse Event|1
7416781|NCT01451437|11690460|FG000|Overall Study|Adverse Event|0
7416782|NCT01451437|11690461|FG001|Overall Study|Adverse Event|0
7416783|NCT01451437|11690462|FG002|Overall Study|Adverse Event|0
7416784|NCT01451437|11690463|FG003|Overall Study|Adverse Event|0
7323274|NCT00763282|11554713|FG001|Overall Study|Death|3
7323275|NCT00763282|11554712|FG000|Overall Study|Lost to Follow-up|22
7323276|NCT00763282|11554713|FG001|Overall Study|Lost to Follow-up|26
7323277|NCT00763321|11554724|FG000|Open-label Period|Adverse Event|24
7323278|NCT00763321|11554725|FG001|Open-label Period|Adverse Event|0
7323279|NCT00763321|11554726|FG002|Open-label Period|Adverse Event|0
7323280|NCT00763321|11554724|FG000|Open-label Period|Lost to Follow-up|14
7323281|NCT00763321|11554725|FG001|Open-label Period|Lost to Follow-up|0
7323282|NCT00763321|11554726|FG002|Open-label Period|Lost to Follow-up|0
7323283|NCT00763321|11554724|FG000|Open-label Period|Withdrawal by Subject|7
7416785|NCT01451437|11690464|FG004|Overall Study|Adverse Event|0
7416786|NCT01451437|11690465|FG005|Overall Study|Adverse Event|1
7323284|NCT00763321|11554725|FG001|Open-label Period|Withdrawal by Subject|0
7323285|NCT00763321|11554726|FG002|Open-label Period|Withdrawal by Subject|0
7323286|NCT00763321|11554724|FG000|Open-label Period|Subject noncompliant|7
7323287|NCT00763321|11554725|FG001|Open-label Period|Subject noncompliant|0
7323288|NCT00763321|11554726|FG002|Open-label Period|Subject noncompliant|0
7323289|NCT00763321|11554724|FG000|Open-label Period|Did not meet DB randomization criteria|5
7323290|NCT00763321|11554725|FG001|Open-label Period|Did not meet DB randomization criteria|0
7323291|NCT00763321|11554726|FG002|Open-label Period|Did not meet DB randomization criteria|0
7323292|NCT00763321|11554724|FG000|Open-label Period|Lack of Efficacy|2
7323293|NCT00763321|11554725|FG001|Open-label Period|Lack of Efficacy|0
7323294|NCT00763321|11554726|FG002|Open-label Period|Lack of Efficacy|0
7416787|NCT01451437|11690466|FG006|Overall Study|Adverse Event|1
7416788|NCT01451437|11690467|FG007|Overall Study|Adverse Event|2
7416789|NCT01451437|11690468|FG008|Overall Study|Adverse Event|1
7416790|NCT01451437|11690460|FG000|Overall Study|Physician Decision|1
7416791|NCT01451437|11690461|FG001|Overall Study|Physician Decision|1
7416792|NCT01451437|11690462|FG002|Overall Study|Physician Decision|2
7416793|NCT01451437|11690463|FG003|Overall Study|Physician Decision|0
7416794|NCT01451437|11690464|FG004|Overall Study|Physician Decision|0
7416795|NCT01451437|11690465|FG005|Overall Study|Physician Decision|0
7416796|NCT01451437|11690466|FG006|Overall Study|Physician Decision|0
7416797|NCT01451437|11690467|FG007|Overall Study|Physician Decision|0
7416798|NCT01451437|11690468|FG008|Overall Study|Physician Decision|0
7416799|NCT01451437|11690460|FG000|Overall Study|Disease Progression|0
7416800|NCT01451437|11690461|FG001|Overall Study|Disease Progression|0
7416801|NCT01451437|11690462|FG002|Overall Study|Disease Progression|1
7416802|NCT01451437|11690463|FG003|Overall Study|Disease Progression|1
7416803|NCT01451437|11690464|FG004|Overall Study|Disease Progression|3
7416804|NCT01451437|11690465|FG005|Overall Study|Disease Progression|2
7416805|NCT01451437|11690466|FG006|Overall Study|Disease Progression|3
7416806|NCT01451437|11690467|FG007|Overall Study|Disease Progression|1
7416807|NCT01451437|11690468|FG008|Overall Study|Disease Progression|3
7416808|NCT01451437|11690460|FG000|Overall Study|Protocol Violation|0
7416809|NCT01451437|11690461|FG001|Overall Study|Protocol Violation|0
7416810|NCT01451437|11690462|FG002|Overall Study|Protocol Violation|0
7416811|NCT01451437|11690463|FG003|Overall Study|Protocol Violation|0
7416812|NCT01451437|11690464|FG004|Overall Study|Protocol Violation|0
7416813|NCT01451437|11690465|FG005|Overall Study|Protocol Violation|0
7416814|NCT01451437|11690466|FG006|Overall Study|Protocol Violation|1
7416815|NCT01451437|11690467|FG007|Overall Study|Protocol Violation|0
7416816|NCT01451437|11690468|FG008|Overall Study|Protocol Violation|0
7416817|NCT01451437|11690460|FG000|Overall Study|Withdrawal by Subject|0
7416818|NCT01451437|11690461|FG001|Overall Study|Withdrawal by Subject|0
7416819|NCT01451437|11690462|FG002|Overall Study|Withdrawal by Subject|0
7416820|NCT01451437|11690463|FG003|Overall Study|Withdrawal by Subject|0
7416821|NCT01451437|11690464|FG004|Overall Study|Withdrawal by Subject|1
7416822|NCT01451437|11690465|FG005|Overall Study|Withdrawal by Subject|0
7416823|NCT01451437|11690466|FG006|Overall Study|Withdrawal by Subject|1
7416824|NCT01451437|11690467|FG007|Overall Study|Withdrawal by Subject|0
7416826|NCT01451541|11690509|FG000|Overall Study|Adverse Event|4
7416827|NCT01451541|11690510|FG001|Overall Study|Adverse Event|3
7416828|NCT01451541|11690511|FG002|Overall Study|Adverse Event|6
7416829|NCT01451541|11690509|FG000|Overall Study|Lack of Efficacy|2
7416830|NCT01451541|11690510|FG001|Overall Study|Lack of Efficacy|0
7416831|NCT01451541|11690511|FG002|Overall Study|Lack of Efficacy|0
7416832|NCT01451541|11690509|FG000|Overall Study|Lost to Follow-up|4
7416833|NCT01451541|11690510|FG001|Overall Study|Lost to Follow-up|4
7416834|NCT01451541|11690511|FG002|Overall Study|Lost to Follow-up|7
7416835|NCT01451541|11690509|FG000|Overall Study|Withdrawal by Subject|15
7416836|NCT01451541|11690510|FG001|Overall Study|Withdrawal by Subject|8
7416837|NCT01451541|11690511|FG002|Overall Study|Withdrawal by Subject|6
7416838|NCT01451541|11690509|FG000|Overall Study|randomization error, noncompliance|11
7416839|NCT01451541|11690510|FG001|Overall Study|randomization error, noncompliance|10
7416840|NCT01451541|11690511|FG002|Overall Study|randomization error, noncompliance|8
7416841|NCT01451554|11690523|FG000|Overall Study|Withdrawal by Subject|14
7416842|NCT01451554|11690524|FG001|Overall Study|Withdrawal by Subject|9
7323295|NCT00763321|11554724|FG000|Open-label Period|Other|4
7323296|NCT00763321|11554725|FG001|Open-label Period|Other|0
7323297|NCT00763321|11554726|FG002|Open-label Period|Other|0
7323298|NCT00763321|11554724|FG000|Double-blind Period|Lack of Efficacy|0
7416843|NCT01451606|11690532|FG000|Overall Study|Withdrawal by Subject|4
7416844|NCT01451606|11690533|FG001|Overall Study|Withdrawal by Subject|3
7416845|NCT01451645|11690577|FG000|Overall Study|Protocol Violation|1
7416846|NCT01451645|11690578|FG001|Overall Study|Protocol Violation|0
7416847|NCT01451645|11690577|FG000|Overall Study|Adverse Event|0
7416848|NCT01451645|11690578|FG001|Overall Study|Adverse Event|3
7416849|NCT01451645|11690577|FG000|Overall Study|Withdrawal by Subject|4
7416850|NCT01451645|11690578|FG001|Overall Study|Withdrawal by Subject|2
7416851|NCT01451645|11690577|FG000|Overall Study|Lost to Follow-up|4
7416852|NCT01451645|11690578|FG001|Overall Study|Lost to Follow-up|3
7416853|NCT01451749|11690586|FG000|Overall Study|Protocol Violation|14
7416854|NCT01451749|11690587|FG001|Overall Study|Protocol Violation|7
7416855|NCT01451749|11690586|FG000|Overall Study|Lost to Follow-up|15
7416856|NCT01451749|11690587|FG001|Overall Study|Lost to Follow-up|5
7323299|NCT00763321|11554725|FG001|Double-blind Period|Lack of Efficacy|9
7323300|NCT00763321|11554726|FG002|Double-blind Period|Lack of Efficacy|17
7323301|NCT00763321|11554724|FG000|Double-blind Period|Adverse Event|0
7323302|NCT00763321|11554725|FG001|Double-blind Period|Adverse Event|4
7323303|NCT00763321|11554726|FG002|Double-blind Period|Adverse Event|4
7323304|NCT00763321|11554724|FG000|Double-blind Period|Lost to Follow-up|0
7323305|NCT00763321|11554725|FG001|Double-blind Period|Lost to Follow-up|4
7323306|NCT00763321|11554726|FG002|Double-blind Period|Lost to Follow-up|2
7323307|NCT00763321|11554724|FG000|Double-blind Period|Withdrawal by Subject|0
7323308|NCT00763321|11554725|FG001|Double-blind Period|Withdrawal by Subject|2
7323309|NCT00763321|11554726|FG002|Double-blind Period|Withdrawal by Subject|3
7323310|NCT00763321|11554724|FG000|Double-blind Period|Other|0
7323311|NCT00763321|11554725|FG001|Double-blind Period|Other|2
7323312|NCT00763321|11554726|FG002|Double-blind Period|Other|3
7323313|NCT00763386|11554748|FG000|Overall Study|Adverse Event|43
7323314|NCT00763386|11554749|FG001|Overall Study|Adverse Event|33
7323315|NCT00763386|11554748|FG000|Overall Study|Death|1
7323316|NCT00763386|11554749|FG001|Overall Study|Death|2
7323317|NCT00763386|11554748|FG000|Overall Study|Lost to Follow-up|3
7323318|NCT00763386|11554749|FG001|Overall Study|Lost to Follow-up|3
7323319|NCT00763386|11554748|FG000|Overall Study|Withdrawal by Subject|0
7323320|NCT00763386|11554749|FG001|Overall Study|Withdrawal by Subject|1
7323321|NCT00763386|11554748|FG000|Overall Study|CRF missing|0
7323322|NCT00763386|11554749|FG001|Overall Study|CRF missing|1
7323323|NCT00763386|11554748|FG000|Overall Study|Study Prosthesis Removed|1
7323324|NCT00763386|11554749|FG001|Overall Study|Study Prosthesis Removed|0
7323325|NCT00763451|11554768|FG000|Overall Study|Adverse Event|4
7323326|NCT00763451|11554769|FG001|Overall Study|Adverse Event|6
7323327|NCT00763451|11554770|FG002|Overall Study|Adverse Event|19
7323328|NCT00763451|11554771|FG003|Overall Study|Adverse Event|14
7323329|NCT00763451|11554768|FG000|Overall Study|Lack of Efficacy|1
7323330|NCT00763451|11554769|FG001|Overall Study|Lack of Efficacy|4
7323331|NCT00763451|11554770|FG002|Overall Study|Lack of Efficacy|3
7323332|NCT00763451|11554771|FG003|Overall Study|Lack of Efficacy|2
7323333|NCT00763451|11554768|FG000|Overall Study|Withdrawal by Subject|1
7323334|NCT00763451|11554769|FG001|Overall Study|Withdrawal by Subject|6
7323335|NCT00763451|11554770|FG002|Overall Study|Withdrawal by Subject|9
7323336|NCT00763451|11554771|FG003|Overall Study|Withdrawal by Subject|7
7323337|NCT00763451|11554768|FG000|Overall Study|Protocol Violation|0
7323338|NCT00763451|11554769|FG001|Overall Study|Protocol Violation|0
7323339|NCT00763451|11554770|FG002|Overall Study|Protocol Violation|1
7323340|NCT00763451|11554771|FG003|Overall Study|Protocol Violation|0
7323341|NCT00763451|11554768|FG000|Overall Study|Poor Compliance to Protocol|1
7323342|NCT00763451|11554769|FG001|Overall Study|Poor Compliance to Protocol|1
7323343|NCT00763451|11554770|FG002|Overall Study|Poor Compliance to Protocol|2
7323344|NCT00763451|11554771|FG003|Overall Study|Poor Compliance to Protocol|2
7323345|NCT00763451|11554768|FG000|Overall Study|Familial and Personal Reasons|5
7323346|NCT00763451|11554769|FG001|Overall Study|Familial and Personal Reasons|3
7323347|NCT00763451|11554770|FG002|Overall Study|Familial and Personal Reasons|5
7323348|NCT00763451|11554771|FG003|Overall Study|Familial and Personal Reasons|4
7323349|NCT00763451|11554768|FG000|Overall Study|Randomized but not Treated|1
7323350|NCT00763451|11554769|FG001|Overall Study|Randomized but not Treated|1
7323351|NCT00763451|11554770|FG002|Overall Study|Randomized but not Treated|0
7323352|NCT00763451|11554771|FG003|Overall Study|Randomized but not Treated|0
7323353|NCT00763451|11554768|FG000|Overall Study|Study Site Reason|0
7323354|NCT00763451|11554769|FG001|Overall Study|Study Site Reason|1
7323355|NCT00763451|11554770|FG002|Overall Study|Study Site Reason|1
7323356|NCT00763451|11554771|FG003|Overall Study|Study Site Reason|1
7323357|NCT00763698|11554786|FG000|Overall Study|Unsuccessful Implant|5
7323358|NCT00763698|11554786|FG000|Overall Study|Death|4
7323359|NCT00763698|11554786|FG000|Overall Study|Withdrawal by Subject|1
7323360|NCT00763815|11554797|FG000|Overall Study|Adverse Event|14
7323361|NCT00763815|11554798|FG001|Overall Study|Adverse Event|29
7323362|NCT00763815|11554797|FG000|Overall Study|Lack of Efficacy|10
7323363|NCT00763815|11554798|FG001|Overall Study|Lack of Efficacy|11
7323364|NCT00763815|11554797|FG000|Overall Study|Poor Compliance to Protocol|6
7323365|NCT00763815|11554798|FG001|Overall Study|Poor Compliance to Protocol|6
7323366|NCT00763815|11554797|FG000|Overall Study|Lost to Follow-up|2
7323367|NCT00763815|11554798|FG001|Overall Study|Lost to Follow-up|4
7323368|NCT00763815|11554797|FG000|Overall Study|Early Termination|1
7323369|NCT00763815|11554798|FG001|Overall Study|Early Termination|0
7323370|NCT00763815|11554797|FG000|Overall Study|Familial and Personal Reasons|9
7323371|NCT00763815|11554798|FG001|Overall Study|Familial and Personal Reasons|16
7323372|NCT00763815|11554797|FG000|Overall Study|Physician Decision|1
7323373|NCT00763815|11554798|FG001|Overall Study|Physician Decision|0
7323374|NCT00763815|11554797|FG000|Overall Study|Withdrawal by Subject|7
7323375|NCT00763815|11554798|FG001|Overall Study|Withdrawal by Subject|12
7323376|NCT00763815|11554797|FG000|Overall Study|Protocol Violation|2
7323377|NCT00763815|11554798|FG001|Overall Study|Protocol Violation|5
7323378|NCT00763815|11554797|FG000|Overall Study|Sponsor's Decision|0
7323379|NCT00763815|11554798|FG001|Overall Study|Sponsor's Decision|1
7323380|NCT00763958|11554819|FG000|Overall Study|did not meet final criteria|4
7323381|NCT00763958|11554820|FG001|Overall Study|did not meet final criteria|4
7323382|NCT00763958|11554819|FG000|Overall Study|Lost to Follow-up|10
7323383|NCT00763958|11554820|FG001|Overall Study|Lost to Follow-up|2
7323384|NCT00763958|11554819|FG000|Overall Study|Believed they were receiving placebo|0
7323385|NCT00763958|11554820|FG001|Overall Study|Believed they were receiving placebo|5
7323386|NCT00763971|11554830|FG000|Overall Study|Adverse Event|5
7323387|NCT00763971|11554831|FG001|Overall Study|Adverse Event|2
7323388|NCT00763971|11554832|FG002|Overall Study|Adverse Event|4
7323389|NCT00763971|11554830|FG000|Overall Study|Protocol Violation|3
7323390|NCT00763971|11554831|FG001|Overall Study|Protocol Violation|3
7323391|NCT00763971|11554832|FG002|Overall Study|Protocol Violation|2
7323392|NCT00763971|11554830|FG000|Overall Study|Withdrawal by Subject|4
7323393|NCT00763971|11554831|FG001|Overall Study|Withdrawal by Subject|5
7323394|NCT00763971|11554832|FG002|Overall Study|Withdrawal by Subject|5
7323395|NCT00763971|11554830|FG000|Overall Study|Lost to Follow-up|0
7323396|NCT00763971|11554831|FG001|Overall Study|Lost to Follow-up|1
7323397|NCT00763971|11554832|FG002|Overall Study|Lost to Follow-up|0
7323398|NCT00763971|11554830|FG000|Overall Study|Lack of Efficacy|11
7323399|NCT00763971|11554831|FG001|Overall Study|Lack of Efficacy|22
7323400|NCT00763971|11554832|FG002|Overall Study|Lack of Efficacy|54
7323401|NCT00763971|11554830|FG000|Overall Study|Unable to swallow capsule|2
7323402|NCT00763971|11554831|FG001|Overall Study|Unable to swallow capsule|1
7323403|NCT00763971|11554832|FG002|Overall Study|Unable to swallow capsule|1
7323404|NCT00763971|11554830|FG000|Overall Study|Personal reason|3
7323405|NCT00763971|11554831|FG001|Overall Study|Personal reason|0
7323406|NCT00763971|11554832|FG002|Overall Study|Personal reason|0
7323407|NCT00763971|11554830|FG000|Overall Study|Exclusion criteria met|1
7323408|NCT00763971|11554831|FG001|Overall Study|Exclusion criteria met|0
7323409|NCT00763971|11554832|FG002|Overall Study|Exclusion criteria met|0
7323410|NCT00763971|11554830|FG000|Overall Study|Sponsor decision|1
7323411|NCT00763971|11554831|FG001|Overall Study|Sponsor decision|0
7323412|NCT00763971|11554832|FG002|Overall Study|Sponsor decision|0
7323413|NCT00763971|11554830|FG000|Overall Study|Due to holiday season|2
7323414|NCT00763971|11554831|FG001|Overall Study|Due to holiday season|0
7323415|NCT00763971|11554832|FG002|Overall Study|Due to holiday season|1
7323416|NCT00763971|11554830|FG000|Overall Study|Randomization error|0
7323417|NCT00763971|11554831|FG001|Overall Study|Randomization error|0
7323418|NCT00763971|11554832|FG002|Overall Study|Randomization error|1
7323419|NCT00763971|11554830|FG000|Overall Study|Medical monitor decision|0
7323420|NCT00763971|11554831|FG001|Overall Study|Medical monitor decision|0
7323421|NCT00763971|11554832|FG002|Overall Study|Medical monitor decision|1
7416857|NCT01451749|11690586|FG000|Overall Study|Meet the exclusion criteria,and|1
7416858|NCT01451749|11690587|FG001|Overall Study|Meet the exclusion criteria,and|1
7416859|NCT01451749|11690586|FG000|Overall Study|Adverse Event|2
7416860|NCT01451749|11690587|FG001|Overall Study|Adverse Event|0
7416861|NCT01451749|11690586|FG000|Overall Study|Withdrawal by Subject|0
7416862|NCT01451749|11690587|FG001|Overall Study|Withdrawal by Subject|1
7416863|NCT01451762|11690598|FG000|Overall Study|Lost to Follow-up|3
7416864|NCT01451762|11690599|FG001|Overall Study|Lost to Follow-up|6
7416865|NCT01451762|11690600|FG002|Overall Study|Lost to Follow-up|6
7416866|NCT01451814|11690623|FG000|Overall Study|Withdrawal by Subject|1
7416867|NCT01451814|11690624|FG001|Overall Study|Withdrawal by Subject|1
7416868|NCT01451814|11690623|FG000|Overall Study|Lost to Follow-up|5
7416869|NCT01451814|11690624|FG001|Overall Study|Lost to Follow-up|4
7416870|NCT01451827|11690634|FG000|Overall Study|Adverse Event|2
7416871|NCT01451827|11690635|FG001|Overall Study|Adverse Event|0
7416872|NCT01451827|11690636|FG002|Overall Study|Adverse Event|1
7416873|NCT01451827|11690637|FG003|Overall Study|Adverse Event|1
7416874|NCT01451827|11690634|FG000|Overall Study|Protocol deviation|1
7416875|NCT01451827|11690635|FG001|Overall Study|Protocol deviation|0
7416876|NCT01451827|11690636|FG002|Overall Study|Protocol deviation|0
7416877|NCT01451827|11690637|FG003|Overall Study|Protocol deviation|0
7416878|NCT01451827|11690634|FG000|Overall Study|Lost to Follow-up|0
7416879|NCT01451827|11690635|FG001|Overall Study|Lost to Follow-up|3
7416880|NCT01451827|11690636|FG002|Overall Study|Lost to Follow-up|0
7416881|NCT01451827|11690637|FG003|Overall Study|Lost to Follow-up|2
7416882|NCT01451827|11690634|FG000|Overall Study|Participant met withdrawal criteria|0
7416883|NCT01451827|11690635|FG001|Overall Study|Participant met withdrawal criteria|2
7416884|NCT01451827|11690636|FG002|Overall Study|Participant met withdrawal criteria|0
7323422|NCT00763971|11554830|FG000|Overall Study|Moved to another country|0
7323423|NCT00763971|11554831|FG001|Overall Study|Moved to another country|1
7323424|NCT00763971|11554832|FG002|Overall Study|Moved to another country|0
7323425|NCT00763971|11554830|FG000|Overall Study|Subject wanted dose reduction|0
7323426|NCT00763971|11554831|FG001|Overall Study|Subject wanted dose reduction|1
7323427|NCT00763971|11554832|FG002|Overall Study|Subject wanted dose reduction|0
7323428|NCT00763971|11554830|FG000|Overall Study|Lack of availability|0
7323429|NCT00763971|11554831|FG001|Overall Study|Lack of availability|1
7323430|NCT00763971|11554832|FG002|Overall Study|Lack of availability|0
7323431|NCT00763971|11554830|FG000|Overall Study|Performed final visit on phone|0
7416885|NCT01451827|11690637|FG003|Overall Study|Participant met withdrawal criteria|0
7416886|NCT01451827|11690634|FG000|Overall Study|Withdrawal by Subject|0
7416887|NCT01451827|11690635|FG001|Overall Study|Withdrawal by Subject|0
7416888|NCT01451827|11690636|FG002|Overall Study|Withdrawal by Subject|1
7416889|NCT01451827|11690637|FG003|Overall Study|Withdrawal by Subject|1
7416890|NCT01451931|11690650|FG000|Overall Study|Lost to Follow-up|17
7323432|NCT00763971|11554831|FG001|Overall Study|Performed final visit on phone|1
7323433|NCT00763971|11554832|FG002|Overall Study|Performed final visit on phone|0
7323434|NCT00763971|11554830|FG000|Overall Study|Participation in 489-326 required|1
7323435|NCT00763971|11554831|FG001|Overall Study|Participation in 489-326 required|0
7323436|NCT00763971|11554832|FG002|Overall Study|Participation in 489-326 required|0
7323437|NCT00764322|11554846|FG000|Overall Study|Withdrawal by Subject|11
7323438|NCT00764322|11554846|FG000|Overall Study|No CYP2D6 genotyping|9
7323439|NCT00764361|11554865|FG000|Overall Study|Withdrawal by Subject|2
7323440|NCT00764361|11554866|FG001|Overall Study|Withdrawal by Subject|3
7323441|NCT00764361|11554865|FG000|Overall Study|Adverse Event|0
7323442|NCT00764361|11554866|FG001|Overall Study|Adverse Event|1
7323443|NCT00764465|11554878|FG000|Overall Study|Adverse Event|2
7323444|NCT00764465|11554879|FG001|Overall Study|Adverse Event|0
7323445|NCT00764465|11554880|FG002|Overall Study|Adverse Event|0
7323446|NCT00764465|11554881|FG003|Overall Study|Adverse Event|1
7323447|NCT00764465|11554882|FG004|Overall Study|Adverse Event|1
7323448|NCT00764465|11554883|FG005|Overall Study|Adverse Event|1
7323449|NCT00764465|11554878|FG000|Overall Study|Withdrawal by Subject|0
7323450|NCT00764465|11554879|FG001|Overall Study|Withdrawal by Subject|1
7323451|NCT00764465|11554880|FG002|Overall Study|Withdrawal by Subject|1
7323452|NCT00764465|11554881|FG003|Overall Study|Withdrawal by Subject|0
7323453|NCT00764465|11554882|FG004|Overall Study|Withdrawal by Subject|0
7323454|NCT00764465|11554883|FG005|Overall Study|Withdrawal by Subject|0
7323455|NCT00764491|11554902|FG000|Overall Study|Lost to Follow-up|35
7323456|NCT00764491|11554903|FG001|Overall Study|Lost to Follow-up|17
7323457|NCT00764504|11554912|FG000|Overall Study|Death|12
7323458|NCT00764504|11554913|FG001|Overall Study|Death|6
7323459|NCT00764504|11554914|FG002|Overall Study|Death|13
7323460|NCT00764504|11554912|FG000|Overall Study|Revision of Device|12
7323461|NCT00764504|11554913|FG001|Overall Study|Revision of Device|23
7323462|NCT00764504|11554914|FG002|Overall Study|Revision of Device|14
7323463|NCT00764504|11554912|FG000|Overall Study|Physician Decision|1
7323464|NCT00764504|11554913|FG001|Overall Study|Physician Decision|0
7323465|NCT00764504|11554914|FG002|Overall Study|Physician Decision|0
7323466|NCT00764504|11554912|FG000|Overall Study|Withdrawal by Subject|1
7323467|NCT00764504|11554913|FG001|Overall Study|Withdrawal by Subject|7
7323468|NCT00764504|11554914|FG002|Overall Study|Withdrawal by Subject|4
7323469|NCT00764504|11554912|FG000|Overall Study|Lost to Follow-up|40
7323470|NCT00764504|11554913|FG001|Overall Study|Lost to Follow-up|34
7323471|NCT00764504|11554914|FG002|Overall Study|Lost to Follow-up|72
7323472|NCT00764517|11554924|FG000|Overall Study|Adverse Event|9
7323473|NCT00764517|11554925|FG001|Overall Study|Adverse Event|3
7323474|NCT00764517|11554924|FG000|Overall Study|Death|3
7323475|NCT00764517|11554925|FG001|Overall Study|Death|11
7323476|NCT00764517|11554924|FG000|Overall Study|Physician Decision|3
7323477|NCT00764517|11554925|FG001|Overall Study|Physician Decision|0
7323478|NCT00764660|11554933|FG000|Overall Study|Adverse Event|6
7323479|NCT00764660|11554934|FG001|Overall Study|Adverse Event|3
7323480|NCT00764660|11554933|FG000|Overall Study|Lost to Follow-up|3
7323481|NCT00764660|11554934|FG001|Overall Study|Lost to Follow-up|4
7323482|NCT00764660|11554933|FG000|Overall Study|Withdrawal by Subject|7
7531038|NCT02641730|11874674|FG000|Observational Period (Week 60 - Week 84)|Other|0
7531039|NCT02641730|11874675|FG001|Observational Period (Week 60 - Week 84)|Other|0
7531040|NCT02641730|11874676|FG002|Observational Period (Week 60 - Week 84)|Other|0
7531041|NCT02641730|11874677|FG003|Observational Period (Week 60 - Week 84)|Other|0
7531042|NCT02641730|11874678|FG004|Observational Period (Week 60 - Week 84)|Other|1
7531043|NCT02642159|11874717|FG000|Overall Study|Randomized but not treated|1
7531044|NCT02642159|11874718|FG001|Overall Study|Randomized but not treated|0
7531045|NCT02642159|11874717|FG000|Overall Study|Adverse Event|10
7531046|NCT02642159|11874718|FG001|Overall Study|Adverse Event|4
7531047|NCT02642159|11874717|FG000|Overall Study|Withdrawal by Subject|9
7531048|NCT02642159|11874718|FG001|Overall Study|Withdrawal by Subject|1
7531049|NCT02642159|11874717|FG000|Overall Study|Poor compliance to study protocol|1
7531050|NCT02642159|11874718|FG001|Overall Study|Poor compliance to study protocol|0
7531051|NCT02642159|11874717|FG000|Overall Study|Other than specified above|10
7531052|NCT02642159|11874718|FG001|Overall Study|Other than specified above|3
7531053|NCT02642432|11874743|FG000|Overall Study|Adverse Event|2
7531054|NCT02642432|11874743|FG000|Overall Study|Withdrew Consent|1
7531055|NCT02642432|11874743|FG000|Overall Study|Lost to Follow-up|2
7531056|NCT02642432|11874743|FG000|Overall Study|Other|3
7537599|NCT02921763|11886707|FG000|Overall Study|Adverse Event|4
7537600|NCT02921763|11886707|FG000|Overall Study|Lost to Follow-up|4
7537601|NCT02921763|11886707|FG000|Overall Study|Lack of Efficacy|3
7537602|NCT02921763|11886707|FG000|Overall Study|Protocol Violation|2
7537603|NCT02921763|11886707|FG000|Overall Study|Withdrawal by Subject|2
7537604|NCT02921763|11886707|FG000|Overall Study|Physician Decision|1
7537605|NCT02921763|11886707|FG000|Overall Study|No data obtained|2
7537612|NCT02836236|11886741|FG000|Overall Study|Randomized but Never Treated|1
7537613|NCT02836236|11886742|FG001|Overall Study|Randomized but Never Treated|0
7323483|NCT00764660|11554934|FG001|Overall Study|Withdrawal by Subject|3
7323484|NCT00764660|11554933|FG000|Overall Study|Noncompliance With Protocol|5
7323485|NCT00764660|11554934|FG001|Overall Study|Noncompliance With Protocol|1
7323486|NCT00764660|11554933|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7323487|NCT00764660|11554934|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
7323488|NCT00764673|11554940|FG000|Overall Study|Death|1
7323489|NCT00764673|11554940|FG000|Overall Study|Lost to Follow-up|3
7323490|NCT00764673|11554940|FG000|Overall Study|Withdrawal by Subject|6
7323491|NCT00764673|11554940|FG000|Overall Study|Revision of Device|2
7323492|NCT00764751|11554963|FG000|Overall Study|Adverse Event|1
7323493|NCT00764751|11554964|FG001|Overall Study|Adverse Event|1
7323494|NCT00764751|11554963|FG000|Overall Study|Psoriasis flare up on the scalp|1
7323495|NCT00764751|11554964|FG001|Overall Study|Psoriasis flare up on the scalp|0
7323496|NCT00764790|11554978|FG000|Overall Study|Protocol Violation|0
7323497|NCT00764790|11554979|FG001|Overall Study|Protocol Violation|0
7323498|NCT00764790|11554980|FG002|Overall Study|Protocol Violation|1
7323499|NCT00764790|11554978|FG000|Overall Study|Withdrawal by Subject|10
7323500|NCT00764790|11554979|FG001|Overall Study|Withdrawal by Subject|12
7323501|NCT00764790|11554980|FG002|Overall Study|Withdrawal by Subject|6
7323502|NCT00764790|11554978|FG000|Overall Study|Lost to Follow-up|28
7323503|NCT00764790|11554979|FG001|Overall Study|Lost to Follow-up|29
7323504|NCT00764790|11554980|FG002|Overall Study|Lost to Follow-up|23
7323505|NCT00764868|11554988|FG000|Overall Study|Adverse Event|18
7323506|NCT00764868|11554988|FG000|Overall Study|Withdrawal by Subject|31
7323507|NCT00764868|11554988|FG000|Overall Study|Non-compliance|16
7323508|NCT00764868|11554988|FG000|Overall Study|Lost to Follow-up|25
7323509|NCT00764868|11554988|FG000|Overall Study|Lack of Efficacy|5
7323510|NCT00764868|11554988|FG000|Overall Study|Subject moved|7
7323511|NCT00764868|11554988|FG000|Overall Study|Pregnancy|3
7323512|NCT00764868|11554988|FG000|Overall Study|Prohibited medication|1
7323513|NCT00764868|11554988|FG000|Overall Study|Out of town|1
7323514|NCT00764868|11554988|FG000|Overall Study|Misuse and compliance of study drug|1
7323515|NCT00764868|11554988|FG000|Overall Study|Subject sent to boarding school|1
7323516|NCT00764868|11554988|FG000|Overall Study|Met an exclusion criteria|1
7323517|NCT00764868|11554988|FG000|Overall Study|Positive drug screen|2
7323518|NCT00764868|11554988|FG000|Overall Study|Sponsor requested withdrawal|1
7323519|NCT00764881|11554994|FG000|Overall Study|Adverse Event|5
7323520|NCT00764881|11554995|FG001|Overall Study|Adverse Event|1
7323521|NCT00764881|11554994|FG000|Overall Study|Withdrawal by Subject|1
7323522|NCT00764881|11554995|FG001|Overall Study|Withdrawal by Subject|3
7323523|NCT00764881|11554994|FG000|Overall Study|Protocol Violation|2
7323524|NCT00764881|11554995|FG001|Overall Study|Protocol Violation|2
7323525|NCT00764881|11554994|FG000|Overall Study|Lost to Follow-up|2
7323526|NCT00764881|11554995|FG001|Overall Study|Lost to Follow-up|0
7323527|NCT00764881|11554994|FG000|Overall Study|Noncompliant|1
7323528|NCT00764881|11554995|FG001|Overall Study|Noncompliant|0
7323529|NCT00764881|11554994|FG000|Overall Study|Accidentally discontinued study drug|1
7323530|NCT00764881|11554995|FG001|Overall Study|Accidentally discontinued study drug|0
7323531|NCT00764881|11554994|FG000|Overall Study|Wished to become pregnant|1
7323532|NCT00764881|11554995|FG001|Overall Study|Wished to become pregnant|0
7323533|NCT00764881|11554994|FG000|Overall Study|Carcinoma detected|1
7323534|NCT00764881|11554995|FG001|Overall Study|Carcinoma detected|0
7323535|NCT00764881|11554994|FG000|Overall Study|Possibly noncompliant (study drug)|0
7323536|NCT00764881|11554995|FG001|Overall Study|Possibly noncompliant (study drug)|2
7323537|NCT00764881|11554994|FG000|Overall Study|no treatment or no observation|2
7323538|NCT00764881|11554995|FG001|Overall Study|no treatment or no observation|2
7416891|NCT01451931|11690651|FG001|Overall Study|Lost to Follow-up|36
7416892|NCT01451931|11690652|FG002|Overall Study|Lost to Follow-up|21
7416893|NCT01451931|11690650|FG000|Overall Study|Withdrawal by Subject|16
7416894|NCT01451931|11690651|FG001|Overall Study|Withdrawal by Subject|22
7416895|NCT01451931|11690652|FG002|Overall Study|Withdrawal by Subject|22
7416896|NCT01452347|11690727|FG000|Overall Study|Adverse Event|2
7323539|NCT00764946|11555004|FG000|Overall Study|Lack of Efficacy|1
7416897|NCT01452347|11690728|FG001|Overall Study|Adverse Event|1
7416898|NCT01452347|11690727|FG000|Overall Study|Non compliance protocol|2
7416899|NCT01452347|11690728|FG001|Overall Study|Non compliance protocol|0
7416900|NCT01452347|11690727|FG000|Overall Study|Lost to Follow-up|2
7416901|NCT01452347|11690728|FG001|Overall Study|Lost to Follow-up|0
7416902|NCT01452347|11690727|FG000|Overall Study|Withdrawal by Subject|3
7416903|NCT01452347|11690728|FG001|Overall Study|Withdrawal by Subject|3
7416904|NCT01452347|11690727|FG000|Overall Study|Not treated|6
7416905|NCT01452347|11690728|FG001|Overall Study|Not treated|3
7416906|NCT01452347|11690727|FG000|Overall Study|Other reason not defined above|2
7416907|NCT01452347|11690728|FG001|Overall Study|Other reason not defined above|0
7416908|NCT01452412|11690738|FG000|Overall Study|Withdrawal by Subject|15
7416909|NCT01452412|11690739|FG001|Overall Study|Withdrawal by Subject|11
7323540|NCT00764946|11555005|FG001|Overall Study|Lack of Efficacy|0
7323541|NCT00764946|11555006|FG002|Overall Study|Lack of Efficacy|0
7323542|NCT00764946|11555004|FG000|Overall Study|Lost to Follow-up|3
7323543|NCT00764946|11555005|FG001|Overall Study|Lost to Follow-up|4
7416910|NCT01452412|11690738|FG000|Overall Study|Adverse Event|4
7416911|NCT01452412|11690739|FG001|Overall Study|Adverse Event|3
7416912|NCT01452412|11690738|FG000|Overall Study|Lost to Follow-up|5
7416913|NCT01452412|11690739|FG001|Overall Study|Lost to Follow-up|3
7555252|NCT03053050|11918231|FG003|Randomized Phase|Randomized but Never Treated|0
7555253|NCT03053050|11918228|FG000|Randomized Phase|Entered the Open-Label Phase|36
7555254|NCT03053050|11918229|FG001|Randomized Phase|Entered the Open-Label Phase|45
7555255|NCT03053050|11918230|FG002|Randomized Phase|Entered the Open-Label Phase|18
7555256|NCT03053050|11918231|FG003|Randomized Phase|Entered the Open-Label Phase|0
7555257|NCT03053050|11918228|FG000|Open-label Phase|Study Terminated by Sponsor|0
7555258|NCT03053050|11918229|FG001|Open-label Phase|Study Terminated by Sponsor|0
7555259|NCT03053050|11918230|FG002|Open-label Phase|Study Terminated by Sponsor|0
7555260|NCT03053050|11918231|FG003|Open-label Phase|Study Terminated by Sponsor|89
7555261|NCT03053050|11918228|FG000|Open-label Phase|Withdrew Consent|0
7555262|NCT03053050|11918229|FG001|Open-label Phase|Withdrew Consent|0
7555263|NCT03053050|11918230|FG002|Open-label Phase|Withdrew Consent|0
7555264|NCT03053050|11918231|FG003|Open-label Phase|Withdrew Consent|6
7555265|NCT03053050|11918228|FG000|Open-label Phase|Investigator's Discretion|0
7555266|NCT03053050|11918229|FG001|Open-label Phase|Investigator's Discretion|0
7555267|NCT03053050|11918230|FG002|Open-label Phase|Investigator's Discretion|0
7555268|NCT03053050|11918231|FG003|Open-label Phase|Investigator's Discretion|4
7555269|NCT03053063|11918243|FG000|Randomized Phase|Study Terminated by Sponsor|326
7555270|NCT03053063|11918244|FG001|Randomized Phase|Study Terminated by Sponsor|317
7555271|NCT03053063|11918245|FG002|Randomized Phase|Study Terminated by Sponsor|161
7555272|NCT03053063|11918246|FG003|Randomized Phase|Study Terminated by Sponsor|0
7555273|NCT03053063|11918243|FG000|Randomized Phase|Withdrew consent|8
7323544|NCT00764946|11555006|FG002|Overall Study|Lost to Follow-up|0
7323545|NCT00764946|11555004|FG000|Overall Study|Physician Decision|2
7323546|NCT00764946|11555005|FG001|Overall Study|Physician Decision|4
7323547|NCT00764946|11555006|FG002|Overall Study|Physician Decision|0
7323548|NCT00764946|11555004|FG000|Overall Study|Adverse Event|3
7323549|NCT00764946|11555005|FG001|Overall Study|Adverse Event|2
7323550|NCT00764946|11555006|FG002|Overall Study|Adverse Event|1
7323551|NCT00764946|11555004|FG000|Overall Study|Withdrawal by Subject|3
7323552|NCT00764946|11555005|FG001|Overall Study|Withdrawal by Subject|6
7323553|NCT00764946|11555006|FG002|Overall Study|Withdrawal by Subject|2
7323554|NCT00764946|11555004|FG000|Overall Study|Never Treated|1
7323555|NCT00764946|11555005|FG001|Overall Study|Never Treated|1
7323556|NCT00764946|11555006|FG002|Overall Study|Never Treated|1
7323557|NCT00765037|11555020|FG000|Overall Study|Lost to Follow-up|5
7323558|NCT00765037|11555020|FG000|Overall Study|Adverse Event|1
7323559|NCT00765063|11555024|FG000|Overall Study|Lack of Efficacy|5
7323560|NCT00765063|11555024|FG000|Overall Study|Withdrawal by Subject|1
7323561|NCT00765063|11555024|FG000|Overall Study|Other|16
7323562|NCT00765063|11555024|FG000|Overall Study|Protocol Violation|6
7323563|NCT00765063|11555024|FG000|Overall Study|Adverse Event|4
7323564|NCT00765076|11555031|FG000|Overall Study|Adverse Event|1
7323565|NCT00765076|11555032|FG001|Overall Study|Adverse Event|0
7323566|NCT00765076|11555033|FG002|Overall Study|Adverse Event|0
7323567|NCT00765076|11555031|FG000|Overall Study|Withdrawal by Subject|0
7323568|NCT00765076|11555032|FG001|Overall Study|Withdrawal by Subject|0
7323569|NCT00765076|11555033|FG002|Overall Study|Withdrawal by Subject|1
7323570|NCT00765102|11555041|FG000|Overall Study|Progressive disease|18
7323571|NCT00765102|11555041|FG000|Overall Study|Adverse Event|6
7323572|NCT00765102|11555041|FG000|Overall Study|Physician Decision|4
7323573|NCT00765102|11555041|FG000|Overall Study|Withdrawal by Subject|2
7323574|NCT00765102|11555041|FG000|Overall Study|Protocol Violation|1
7323575|NCT00765245|11555081|FG000|Overall Study|disease progression|3
7323576|NCT00765245|11555082|FG001|Overall Study|disease progression|2
7323577|NCT00765245|11555081|FG000|Overall Study|Withdrawal by Subject|3
7323578|NCT00765245|11555082|FG001|Overall Study|Withdrawal by Subject|0
7323579|NCT00765245|11555081|FG000|Overall Study|Adverse Event|5
7323580|NCT00765245|11555082|FG001|Overall Study|Adverse Event|0
7323581|NCT00765245|11555081|FG000|Overall Study|Physician Decision|1
7323582|NCT00765245|11555082|FG001|Overall Study|Physician Decision|0
7323583|NCT00765245|11555081|FG000|Overall Study|Death|1
7323584|NCT00765245|11555082|FG001|Overall Study|Death|0
7323585|NCT00765336|11555090|FG000|Overall Study|Protocol Violation|4
7323586|NCT00765336|11555091|FG001|Overall Study|Protocol Violation|2
7323587|NCT00765336|11555090|FG000|Overall Study|Withdrawal by Subject|6
7323588|NCT00765336|11555091|FG001|Overall Study|Withdrawal by Subject|4
7323589|NCT00765336|11555090|FG000|Overall Study|Lost to Follow-up|7
7323590|NCT00765336|11555091|FG001|Overall Study|Lost to Follow-up|9
7323591|NCT00765336|11555090|FG000|Overall Study|Adverse Event|2
7555274|NCT03053063|11918244|FG001|Randomized Phase|Withdrew consent|11
7555275|NCT03053063|11918245|FG002|Randomized Phase|Withdrew consent|5
7555276|NCT03053063|11918246|FG003|Randomized Phase|Withdrew consent|0
7574654|NCT03686033|11957622|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
7323592|NCT00765336|11555091|FG001|Overall Study|Adverse Event|1
7323593|NCT00765362|11555097|FG000|Overall Study|Death|9
7323594|NCT00765362|11555097|FG000|Overall Study|Adverse Event|2
7323595|NCT00765362|11555097|FG000|Overall Study|Protocol Violation|18
7323596|NCT00765362|11555097|FG000|Overall Study|Withdrawal by Subject|13
7323597|NCT00765362|11555097|FG000|Overall Study|Lost to Follow-up|95
7323598|NCT00765388|11555107|FG000|Period 1|Lack of Efficacy|1
7323599|NCT00765388|11555108|FG001|Period 1|Lack of Efficacy|2
7323600|NCT00765388|11555107|FG000|Period 1|Lost to Follow-up|0
7323601|NCT00765388|11555108|FG001|Period 1|Lost to Follow-up|1
7323602|NCT00765388|11555107|FG000|Period 1|Herpes Zoster|0
7323603|NCT00765388|11555108|FG001|Period 1|Herpes Zoster|1
7323604|NCT00765388|11555107|FG000|Period 1|Hip operation|0
7323605|NCT00765388|11555108|FG001|Period 1|Hip operation|1
7323606|NCT00765674|11555145|FG000|Overall Study|Adverse Event|7
7323607|NCT00765674|11555146|FG001|Overall Study|Adverse Event|2
7323608|NCT00765674|11555147|FG002|Overall Study|Adverse Event|8
7323609|NCT00765674|11555148|FG003|Overall Study|Adverse Event|11
7323610|NCT00765674|11555145|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7323611|NCT00765674|11555146|FG001|Overall Study|Abnormal Laboratory Value(s)|0
7323612|NCT00765674|11555147|FG002|Overall Study|Abnormal Laboratory Value(s)|1
7323613|NCT00765674|11555148|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7323614|NCT00765674|11555145|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7323615|NCT00765674|11555146|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
7323616|NCT00765674|11555147|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
7323617|NCT00765674|11555148|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
7323618|NCT00765674|11555145|FG000|Overall Study|Lack of Efficacy|2
7323619|NCT00765674|11555146|FG001|Overall Study|Lack of Efficacy|3
7323620|NCT00765674|11555147|FG002|Overall Study|Lack of Efficacy|1
7323621|NCT00765674|11555148|FG003|Overall Study|Lack of Efficacy|2
7323622|NCT00765674|11555145|FG000|Overall Study|Protocol Violation|2
7323623|NCT00765674|11555146|FG001|Overall Study|Protocol Violation|0
7323624|NCT00765674|11555147|FG002|Overall Study|Protocol Violation|1
7323625|NCT00765674|11555148|FG003|Overall Study|Protocol Violation|0
7323626|NCT00765674|11555145|FG000|Overall Study|Withdrawal by Subject|5
7323627|NCT00765674|11555146|FG001|Overall Study|Withdrawal by Subject|7
7323628|NCT00765674|11555147|FG002|Overall Study|Withdrawal by Subject|3
7323629|NCT00765674|11555148|FG003|Overall Study|Withdrawal by Subject|8
7323630|NCT00765674|11555145|FG000|Overall Study|Lost to Follow-up|4
7323631|NCT00765674|11555146|FG001|Overall Study|Lost to Follow-up|6
7323632|NCT00765674|11555147|FG002|Overall Study|Lost to Follow-up|2
7323633|NCT00765674|11555148|FG003|Overall Study|Lost to Follow-up|1
7323634|NCT00765674|11555145|FG000|Overall Study|Randomized in Error - No Study Drug|0
7323635|NCT00765674|11555146|FG001|Overall Study|Randomized in Error - No Study Drug|1
7323636|NCT00765674|11555147|FG002|Overall Study|Randomized in Error - No Study Drug|0
7323637|NCT00765674|11555148|FG003|Overall Study|Randomized in Error - No Study Drug|1
7323638|NCT00765726|11555158|FG000|Overall Study|Withdrawal by Subject|1
7323639|NCT00765726|11555158|FG000|Overall Study|Discontinuation of study by sponsor|8
7323640|NCT00765817|11555164|FG000|Overall Study|Adverse Event|13
7323641|NCT00765817|11555165|FG001|Overall Study|Adverse Event|1
7531057|NCT02642614|11874764|FG000|Overall Study|Adverse Event|1
7531058|NCT02642614|11874765|FG001|Overall Study|Adverse Event|1
7531059|NCT02642614|11874766|FG002|Overall Study|Adverse Event|2
7531060|NCT02642614|11874767|FG003|Overall Study|Adverse Event|2
7555277|NCT03053063|11918243|FG000|Randomized Phase|Investigator's Discretion|8
7555278|NCT03053063|11918244|FG001|Randomized Phase|Investigator's Discretion|6
7555279|NCT03053063|11918245|FG002|Randomized Phase|Investigator's Discretion|2
7555280|NCT03053063|11918246|FG003|Randomized Phase|Investigator's Discretion|0
7555281|NCT03053063|11918243|FG000|Randomized Phase|Lost to Follow-up|3
7555282|NCT03053063|11918244|FG001|Randomized Phase|Lost to Follow-up|5
7555283|NCT03053063|11918245|FG002|Randomized Phase|Lost to Follow-up|1
7555284|NCT03053063|11918246|FG003|Randomized Phase|Lost to Follow-up|0
7555285|NCT03053063|11918243|FG000|Randomized Phase|Adverse Event|0
7555286|NCT03053063|11918244|FG001|Randomized Phase|Adverse Event|1
7555287|NCT03053063|11918245|FG002|Randomized Phase|Adverse Event|0
7555288|NCT03053063|11918246|FG003|Randomized Phase|Adverse Event|0
7555289|NCT03053063|11918243|FG000|Randomized Phase|Randomized but Never Treated|1
7555290|NCT03053063|11918244|FG001|Randomized Phase|Randomized but Never Treated|3
7555291|NCT03053063|11918245|FG002|Randomized Phase|Randomized but Never Treated|2
7555292|NCT03053063|11918246|FG003|Randomized Phase|Randomized but Never Treated|0
7555293|NCT03053063|11918243|FG000|Randomized Phase|Entered the Open-Label Phase|9
7555294|NCT03053063|11918244|FG001|Randomized Phase|Entered the Open-Label Phase|11
7555295|NCT03053063|11918245|FG002|Randomized Phase|Entered the Open-Label Phase|3
7555296|NCT03053063|11918246|FG003|Randomized Phase|Entered the Open-Label Phase|0
7555297|NCT03053063|11918243|FG000|Open-Label Phase|Study Terminated by Sponsor|0
7555298|NCT03053063|11918244|FG001|Open-Label Phase|Study Terminated by Sponsor|0
7555299|NCT03053063|11918245|FG002|Open-Label Phase|Study Terminated by Sponsor|0
7555300|NCT03053063|11918246|FG003|Open-Label Phase|Study Terminated by Sponsor|19
7555301|NCT03053063|11918243|FG000|Open-Label Phase|Death|0
7555302|NCT03053063|11918244|FG001|Open-Label Phase|Death|0
7555303|NCT03053063|11918245|FG002|Open-Label Phase|Death|0
7323642|NCT00765817|11555164|FG000|Overall Study|Death|0
7531061|NCT02642614|11874764|FG000|Overall Study|Lost to Follow-up|1
7531062|NCT02642614|11874765|FG001|Overall Study|Lost to Follow-up|0
7531063|NCT02642614|11874766|FG002|Overall Study|Lost to Follow-up|0
7531064|NCT02642614|11874767|FG003|Overall Study|Lost to Follow-up|0
7531065|NCT02642614|11874764|FG000|Overall Study|Withdrawal by Subject|1
7531066|NCT02642614|11874765|FG001|Overall Study|Withdrawal by Subject|1
7323643|NCT00765817|11555165|FG001|Overall Study|Death|1
7323644|NCT00765817|11555164|FG000|Overall Study|Entry criteria not met|2
7323645|NCT00765817|11555165|FG001|Overall Study|Entry criteria not met|2
7323646|NCT00765817|11555164|FG000|Overall Study|Loss of glucose control|0
7531067|NCT02642614|11874766|FG002|Overall Study|Withdrawal by Subject|0
7531068|NCT02642614|11874767|FG003|Overall Study|Withdrawal by Subject|0
7531069|NCT02642653|11874787|FG000|Overall Study|Adverse Event|2
7531070|NCT02642653|11874788|FG001|Overall Study|Adverse Event|0
7531071|NCT02642679|11874794|FG000|Overall Study|Withdrawal by Subject|1
7531072|NCT02642679|11874794|FG000|Overall Study|Physician Decision|1
7531073|NCT02642679|11874794|FG000|Overall Study|Physician Decision|1
7531074|NCT02643082|11874828|FG000|Period 1|Adverse Event|1
7531075|NCT02643082|11874829|FG001|Period 1|Adverse Event|0
7531076|NCT02643251|11874856|FG000|Overall Study|Adverse Event|3
7531077|NCT02643251|11874857|FG001|Overall Study|Adverse Event|1
7531078|NCT02643251|11874856|FG000|Overall Study|Withdrawal by Subject|2
7531079|NCT02643251|11874857|FG001|Overall Study|Withdrawal by Subject|0
7531080|NCT02643251|11874856|FG000|Overall Study|Lost to Follow-up|4
7531081|NCT02643251|11874857|FG001|Overall Study|Lost to Follow-up|1
7531082|NCT02643251|11874856|FG000|Overall Study|Protocol Violation|1
7531083|NCT02643251|11874857|FG001|Overall Study|Protocol Violation|0
7531084|NCT02643251|11874856|FG000|Overall Study|PI Decision to terminate patient|1
7531085|NCT02643251|11874857|FG001|Overall Study|PI Decision to terminate patient|0
7531086|NCT02643355|11874865|FG000|Overall Study|Withdrawal by Subject|1
7531087|NCT02643355|11874866|FG001|Overall Study|Withdrawal by Subject|3
7531088|NCT02643355|11874865|FG000|Overall Study|Protocol Violation|0
7531089|NCT02643355|11874866|FG001|Overall Study|Protocol Violation|2
7531090|NCT02643394|11874874|FG000|Overall Study|Protocol Violation|4
7531091|NCT02643394|11874875|FG001|Overall Study|Protocol Violation|5
7531092|NCT02643472|11874893|FG000|Overall Study|Death|2
7531093|NCT02643472|11874894|FG001|Overall Study|Death|5
7531094|NCT02643472|11874893|FG000|Overall Study|Withdrawal by Subject|3
7531095|NCT02643472|11874894|FG001|Overall Study|Withdrawal by Subject|2
7531096|NCT02643472|11874893|FG000|Overall Study|Protocol Violation|0
7531097|NCT02643472|11874894|FG001|Overall Study|Protocol Violation|1
7531098|NCT02643472|11874893|FG000|Overall Study|Lost to Follow-up|22
7531099|NCT02643472|11874894|FG001|Overall Study|Lost to Follow-up|26
7531100|NCT02643628|11874914|FG000|Overall Study|Lost to Follow-up|1
7531101|NCT02643628|11874915|FG001|Overall Study|Lost to Follow-up|4
7531102|NCT02643628|11874914|FG000|Overall Study|Withdrawal by Subject|0
7531103|NCT02643628|11874915|FG001|Overall Study|Withdrawal by Subject|1
7531104|NCT02643628|11874914|FG000|Overall Study|Relocated out of state|0
7531105|NCT02643628|11874915|FG001|Overall Study|Relocated out of state|1
7531106|NCT02643693|11874923|FG000|Overall Study|Physician Decision|0
7531107|NCT02643693|11874924|FG001|Overall Study|Physician Decision|1
7531108|NCT02643693|11874925|FG002|Overall Study|Physician Decision|0
7531109|NCT02643693|11874926|FG003|Overall Study|Physician Decision|0
7531110|NCT02643693|11874927|FG004|Overall Study|Physician Decision|0
7531111|NCT02643693|11874928|FG005|Overall Study|Physician Decision|0
7531112|NCT02643693|11874923|FG000|Overall Study|Withdrawal by Subject|0
7531113|NCT02643693|11874924|FG001|Overall Study|Withdrawal by Subject|1
7531114|NCT02643693|11874925|FG002|Overall Study|Withdrawal by Subject|0
7531115|NCT02643693|11874926|FG003|Overall Study|Withdrawal by Subject|0
7531116|NCT02643693|11874927|FG004|Overall Study|Withdrawal by Subject|0
7531117|NCT02643693|11874928|FG005|Overall Study|Withdrawal by Subject|0
7531118|NCT02643693|11874923|FG000|Overall Study|Protocol Adherence Issues|2
7531119|NCT02643693|11874924|FG001|Overall Study|Protocol Adherence Issues|0
7531120|NCT02643693|11874925|FG002|Overall Study|Protocol Adherence Issues|1
7531121|NCT02643693|11874926|FG003|Overall Study|Protocol Adherence Issues|0
7531122|NCT02643693|11874927|FG004|Overall Study|Protocol Adherence Issues|0
7531123|NCT02643693|11874928|FG005|Overall Study|Protocol Adherence Issues|1
7531124|NCT02644096|11874965|FG000|Overall Study|Withdrawal by Subject|28
7531125|NCT02644096|11874966|FG001|Overall Study|Withdrawal by Subject|25
7531126|NCT02644109|11874974|FG000|Overall Study|Adverse Event|0
7531127|NCT02644109|11874975|FG001|Overall Study|Adverse Event|4
7531128|NCT02644122|11874981|FG000|Overall Study|Withdrawal by Subject|1
7531129|NCT02644343|11875003|FG000|Overall Study|Withdrawal by Subject|1
7531130|NCT02644356|11875007|FG000|Overall Study|Withdrawal by Subject|2
7531131|NCT02644668|11875014|FG000|Overall Study|Adverse Event|2
7531132|NCT02644668|11875015|FG001|Overall Study|Adverse Event|0
7531133|NCT02644668|11875016|FG002|Overall Study|Adverse Event|1
7531134|NCT02644668|11875014|FG000|Overall Study|Protocol Violation|0
7531135|NCT02644668|11875015|FG001|Overall Study|Protocol Violation|0
7531136|NCT02644668|11875016|FG002|Overall Study|Protocol Violation|1
7531137|NCT02644668|11875014|FG000|Overall Study|Withdrawal by Subject|0
7531138|NCT02644668|11875015|FG001|Overall Study|Withdrawal by Subject|0
7531139|NCT02644668|11875016|FG002|Overall Study|Withdrawal by Subject|1
7531140|NCT02645409|11875084|FG000|Overall Study|Withdrawal by Subject|3
7531141|NCT02645409|11875085|FG001|Overall Study|Withdrawal by Subject|0
7531142|NCT02645409|11875084|FG000|Overall Study|Physician Decision|1
7531143|NCT02645409|11875085|FG001|Overall Study|Physician Decision|0
7531144|NCT02646124|11875106|FG000|Overall Study|Lost to Follow-up|0
7531145|NCT02646124|11875107|FG001|Overall Study|Lost to Follow-up|2
7531146|NCT02646332|11875115|FG000|Overall Study|Lost to Follow-up|0
7531147|NCT02646332|11875116|FG001|Overall Study|Lost to Follow-up|3
7531148|NCT02646423|11875133|FG000|Overall Study|Adverse Event|5
7531149|NCT02646423|11875134|FG001|Overall Study|Adverse Event|7
7531150|NCT02646423|11875133|FG000|Overall Study|Ineligible|2
7531151|NCT02646423|11875134|FG001|Overall Study|Ineligible|1
7531152|NCT02646566|11875152|FG000|Overall Study|Lost to Follow-up|5
7531153|NCT02646566|11875153|FG001|Overall Study|Lost to Follow-up|4
7531154|NCT02646566|11875154|FG002|Overall Study|Lost to Follow-up|5
7531155|NCT02646566|11875152|FG000|Overall Study|Treatment failure|1
7531156|NCT02646566|11875153|FG001|Overall Study|Treatment failure|0
7531157|NCT02646566|11875154|FG002|Overall Study|Treatment failure|0
7531158|NCT02646618|11875164|FG000|Overall Study|Lost to Follow-up|10
7531159|NCT02646618|11875165|FG001|Overall Study|Lost to Follow-up|14
7531160|NCT02646891|11875209|FG000|Overall Study|Adverse Event|0
7531161|NCT02646891|11875210|FG001|Overall Study|Adverse Event|1
7531162|NCT02646891|11875211|FG002|Overall Study|Adverse Event|0
7531163|NCT02646891|11875212|FG003|Overall Study|Adverse Event|0
7531164|NCT02646891|11875213|FG004|Overall Study|Adverse Event|0
7531165|NCT02646891|11875214|FG005|Overall Study|Adverse Event|0
7531166|NCT02646891|11875215|FG006|Overall Study|Adverse Event|0
7531167|NCT02646891|11875216|FG007|Overall Study|Adverse Event|0
7323647|NCT00765817|11555165|FG001|Overall Study|Loss of glucose control|2
7323648|NCT00765817|11555164|FG000|Overall Study|Lost to Follow-up|1
7323649|NCT00765817|11555165|FG001|Overall Study|Lost to Follow-up|3
7323650|NCT00765817|11555164|FG000|Overall Study|Physician Decision|2
7323651|NCT00765817|11555165|FG001|Overall Study|Physician Decision|1
7323652|NCT00765817|11555164|FG000|Overall Study|Protocol Violation|1
7323653|NCT00765817|11555165|FG001|Overall Study|Protocol Violation|1
7323654|NCT00765817|11555164|FG000|Overall Study|Subject decision|7
7323655|NCT00765817|11555165|FG001|Overall Study|Subject decision|11
7323656|NCT00765843|11555174|FG000|Overall Study|Lost to Follow-up|1
7323657|NCT00765843|11555175|FG001|Overall Study|Lost to Follow-up|3
7323658|NCT00765843|11555176|FG002|Overall Study|Lost to Follow-up|2
7323659|NCT00765843|11555174|FG000|Overall Study|did not return to receive intervention|0
7323660|NCT00765843|11555175|FG001|Overall Study|did not return to receive intervention|1
7323661|NCT00765843|11555176|FG002|Overall Study|did not return to receive intervention|0
7323662|NCT00765843|11555174|FG000|Overall Study|Adverse Event|0
7416914|NCT01452412|11690738|FG000|Overall Study|Death|1
7416915|NCT01452412|11690739|FG001|Overall Study|Death|0
7416916|NCT01452412|11690738|FG000|Overall Study|Initiated dialysis|1
7416917|NCT01452412|11690739|FG001|Overall Study|Initiated dialysis|0
7416918|NCT01452412|11690738|FG000|Overall Study|Other|2
7416919|NCT01452412|11690739|FG001|Overall Study|Other|0
7466426|NCT01891864|11766310|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
7466427|NCT01891864|11766311|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7466428|NCT01891864|11766312|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7466429|NCT01891864|11766313|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7466430|NCT01891864|11766314|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
7466431|NCT01891864|11766309|FG000|Treatment Period 1|Physician Decision|0
7466432|NCT01891864|11766310|FG001|Treatment Period 1|Physician Decision|1
7466433|NCT01891864|11766311|FG002|Treatment Period 1|Physician Decision|0
7466434|NCT01891864|11766312|FG003|Treatment Period 1|Physician Decision|0
7466435|NCT01891864|11766313|FG004|Treatment Period 1|Physician Decision|0
7466436|NCT01891864|11766314|FG005|Treatment Period 1|Physician Decision|0
7466437|NCT01891864|11766309|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
7466438|NCT01891864|11766310|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
7466439|NCT01891864|11766311|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
7466440|NCT01891864|11766312|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
7466441|NCT01891864|11766313|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
7466442|NCT01891864|11766314|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
7466443|NCT01891864|11766309|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7466444|NCT01891864|11766310|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
7466445|NCT01891864|11766311|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7466446|NCT01891864|11766312|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7466447|NCT01891864|11766313|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7466448|NCT01891864|11766314|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
7466449|NCT01891864|11766309|FG000|Treatment Period 1|Withdrawal by Subject|2
7466450|NCT01891864|11766310|FG001|Treatment Period 1|Withdrawal by Subject|5
7466451|NCT01891864|11766311|FG002|Treatment Period 1|Withdrawal by Subject|0
7466452|NCT01891864|11766312|FG003|Treatment Period 1|Withdrawal by Subject|0
7466453|NCT01891864|11766313|FG004|Treatment Period 1|Withdrawal by Subject|0
7466454|NCT01891864|11766314|FG005|Treatment Period 1|Withdrawal by Subject|0
7466455|NCT01891864|11766309|FG000|Treatment Period 1|Lost to Follow-up|1
7466456|NCT01891864|11766310|FG001|Treatment Period 1|Lost to Follow-up|0
7466457|NCT01891864|11766311|FG002|Treatment Period 1|Lost to Follow-up|0
7466458|NCT01891864|11766312|FG003|Treatment Period 1|Lost to Follow-up|0
7466459|NCT01891864|11766313|FG004|Treatment Period 1|Lost to Follow-up|0
7466460|NCT01891864|11766314|FG005|Treatment Period 1|Lost to Follow-up|0
7466461|NCT01891864|11766309|FG000|Treatment Period 2|Protocol Violation|0
7466462|NCT01891864|11766310|FG001|Treatment Period 2|Protocol Violation|0
7466463|NCT01891864|11766311|FG002|Treatment Period 2|Protocol Violation|0
7531168|NCT02646891|11875217|FG008|Overall Study|Adverse Event|0
7531169|NCT02646891|11875218|FG009|Overall Study|Adverse Event|0
7531170|NCT02646891|11875209|FG000|Overall Study|Lost to Follow-up|0
7531171|NCT02646891|11875210|FG001|Overall Study|Lost to Follow-up|0
7531172|NCT02646891|11875211|FG002|Overall Study|Lost to Follow-up|0
7323663|NCT00765843|11555175|FG001|Overall Study|Adverse Event|0
7323664|NCT00765843|11555176|FG002|Overall Study|Adverse Event|1
7323665|NCT00765882|11555194|FG000|Overall Study|Adverse Event|10
7323666|NCT00765882|11555195|FG001|Overall Study|Adverse Event|21
7323667|NCT00765882|11555196|FG002|Overall Study|Adverse Event|20
7323668|NCT00765882|11555194|FG000|Overall Study|Lack of Efficacy|4
7323669|NCT00765882|11555195|FG001|Overall Study|Lack of Efficacy|0
7323670|NCT00765882|11555196|FG002|Overall Study|Lack of Efficacy|1
7323671|NCT00765882|11555194|FG000|Overall Study|Protocol Violation|4
7323672|NCT00765882|11555195|FG001|Overall Study|Protocol Violation|3
7323673|NCT00765882|11555196|FG002|Overall Study|Protocol Violation|1
7323674|NCT00765882|11555194|FG000|Overall Study|Withdrawal by Subject|2
7323675|NCT00765882|11555195|FG001|Overall Study|Withdrawal by Subject|6
7323676|NCT00765882|11555196|FG002|Overall Study|Withdrawal by Subject|6
7323677|NCT00765882|11555194|FG000|Overall Study|Lost to Follow-up|1
7323678|NCT00765882|11555195|FG001|Overall Study|Lost to Follow-up|9
7323679|NCT00765882|11555196|FG002|Overall Study|Lost to Follow-up|6
7323680|NCT00765882|11555194|FG000|Overall Study|Other Reason|3
7323681|NCT00765882|11555195|FG001|Overall Study|Other Reason|1
7323682|NCT00765882|11555196|FG002|Overall Study|Other Reason|2
7323683|NCT00765999|11555219|FG000|Overall Study|Adverse Event|203
7323684|NCT00765999|11555219|FG000|Overall Study|Insufficient Therapeutic Response|100
7323685|NCT00765999|11555219|FG000|Overall Study|Protocol Violation|95
7323686|NCT00765999|11555219|FG000|Overall Study|Consent Withdrawn|202
7323687|NCT00765999|11555219|FG000|Overall Study|Lost to Follow-up|131
7323688|NCT00765999|11555219|FG000|Overall Study|Study Terminated by Sponsor|2
7323689|NCT00765999|11555219|FG000|Overall Study|Other Miscellaneous Reasons|51
7323690|NCT00766038|11555227|FG000|Overall Study|Lost to Follow-up|15
7323691|NCT00766038|11555228|FG001|Overall Study|Lost to Follow-up|14
7323692|NCT00766051|11555238|FG000|Overall Study|Withdrawal by Subject|2
7323693|NCT00766051|11555239|FG001|Overall Study|Withdrawal by Subject|0
7531173|NCT02646891|11875212|FG003|Overall Study|Lost to Follow-up|0
7531174|NCT02646891|11875213|FG004|Overall Study|Lost to Follow-up|0
7531175|NCT02646891|11875214|FG005|Overall Study|Lost to Follow-up|0
7531176|NCT02646891|11875215|FG006|Overall Study|Lost to Follow-up|2
7531177|NCT02646891|11875216|FG007|Overall Study|Lost to Follow-up|2
7323694|NCT00766090|11555249|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323695|NCT00766090|11555250|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323696|NCT00766090|11555251|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323697|NCT00766090|11555252|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323698|NCT00766090|11555253|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323699|NCT00766090|11555254|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323700|NCT00766090|11555255|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323701|NCT00766090|11555256|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323702|NCT00766090|11555257|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7323703|NCT00766090|11555258|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323704|NCT00766090|11555259|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323705|NCT00766090|11555260|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7323706|NCT00766090|11555249|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
7323707|NCT00766090|11555250|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323708|NCT00766090|11555251|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323709|NCT00766090|11555252|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323710|NCT00766090|11555253|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323711|NCT00766090|11555254|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323712|NCT00766090|11555255|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323713|NCT00766090|11555256|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323714|NCT00766090|11555257|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323715|NCT00766090|11555258|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323716|NCT00766090|11555259|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323717|NCT00766090|11555260|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
7323718|NCT00766090|11555249|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7323719|NCT00766090|11555250|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323720|NCT00766090|11555251|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323721|NCT00766090|11555252|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7323722|NCT00766090|11555253|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323723|NCT00766090|11555254|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323724|NCT00766090|11555255|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323725|NCT00766090|11555256|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323726|NCT00766090|11555257|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323727|NCT00766090|11555258|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323728|NCT00766090|11555259|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323729|NCT00766090|11555260|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7323730|NCT00766090|11555249|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
7323731|NCT00766090|11555250|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
7323732|NCT00766090|11555251|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
7323733|NCT00766090|11555252|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
7323734|NCT00766090|11555253|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
7323735|NCT00766090|11555254|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
7531178|NCT02646891|11875217|FG008|Overall Study|Lost to Follow-up|2
7531179|NCT02646891|11875218|FG009|Overall Study|Lost to Follow-up|2
7323736|NCT00766090|11555255|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
7323737|NCT00766090|11555256|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
7323738|NCT00766090|11555257|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
7323739|NCT00766090|11555258|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
7323740|NCT00766090|11555259|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
7323741|NCT00766090|11555260|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
7323742|NCT00766090|11555249|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323743|NCT00766090|11555250|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323744|NCT00766090|11555251|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323745|NCT00766090|11555252|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323746|NCT00766090|11555253|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
7323747|NCT00766090|11555254|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323748|NCT00766090|11555255|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323749|NCT00766090|11555256|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323750|NCT00766090|11555257|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323751|NCT00766090|11555258|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323752|NCT00766090|11555259|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7416920|NCT01452529|11690752|FG000|Run-in Period|Adverse Event|96
7416921|NCT01452529|11690753|FG001|Run-in Period|Adverse Event|0
7416922|NCT01452529|11690754|FG002|Run-in Period|Adverse Event|0
7416923|NCT01452529|11690752|FG000|Run-in Period|Withdrawal by Subject|49
7416924|NCT01452529|11690753|FG001|Run-in Period|Withdrawal by Subject|0
7416925|NCT01452529|11690754|FG002|Run-in Period|Withdrawal by Subject|0
7416926|NCT01452529|11690752|FG000|Run-in Period|Lost to Follow-up|19
7416927|NCT01452529|11690753|FG001|Run-in Period|Lost to Follow-up|0
7416928|NCT01452529|11690754|FG002|Run-in Period|Lost to Follow-up|0
7416929|NCT01452529|11690752|FG000|Run-in Period|Lack of Efficacy|46
7416930|NCT01452529|11690753|FG001|Run-in Period|Lack of Efficacy|0
7416931|NCT01452529|11690754|FG002|Run-in Period|Lack of Efficacy|0
7416932|NCT01452529|11690752|FG000|Run-in Period|Confirmed or suspected diversion|23
7416933|NCT01452529|11690753|FG001|Run-in Period|Confirmed or suspected diversion|0
7416934|NCT01452529|11690754|FG002|Run-in Period|Confirmed or suspected diversion|0
7416935|NCT01452529|11690752|FG000|Run-in Period|Administrative|21
7416936|NCT01452529|11690753|FG001|Run-in Period|Administrative|0
7416937|NCT01452529|11690754|FG002|Run-in Period|Administrative|0
7416938|NCT01452529|11690752|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
7416939|NCT01452529|11690753|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
7416940|NCT01452529|11690754|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
7416941|NCT01452529|11690752|FG000|Double-blind (DB) Period|Adverse Event|0
7531180|NCT02646891|11875209|FG000|Overall Study|Protocol Violation|0
7531181|NCT02646891|11875210|FG001|Overall Study|Protocol Violation|0
7531182|NCT02646891|11875211|FG002|Overall Study|Protocol Violation|0
7531183|NCT02646891|11875212|FG003|Overall Study|Protocol Violation|0
7531184|NCT02646891|11875213|FG004|Overall Study|Protocol Violation|0
7531185|NCT02646891|11875214|FG005|Overall Study|Protocol Violation|0
7531186|NCT02646891|11875215|FG006|Overall Study|Protocol Violation|1
7531187|NCT02646891|11875216|FG007|Overall Study|Protocol Violation|1
7531188|NCT02646891|11875217|FG008|Overall Study|Protocol Violation|0
7531189|NCT02646891|11875218|FG009|Overall Study|Protocol Violation|0
7531190|NCT02646891|11875209|FG000|Overall Study|Withdrawal by Subject|2
7531191|NCT02646891|11875210|FG001|Overall Study|Withdrawal by Subject|0
7531192|NCT02646891|11875211|FG002|Overall Study|Withdrawal by Subject|1
7531193|NCT02646891|11875212|FG003|Overall Study|Withdrawal by Subject|0
7531194|NCT02646891|11875213|FG004|Overall Study|Withdrawal by Subject|0
7531195|NCT02646891|11875214|FG005|Overall Study|Withdrawal by Subject|0
7531196|NCT02646891|11875215|FG006|Overall Study|Withdrawal by Subject|5
7531197|NCT02646891|11875216|FG007|Overall Study|Withdrawal by Subject|9
7531198|NCT02646891|11875217|FG008|Overall Study|Withdrawal by Subject|7
7531199|NCT02646891|11875218|FG009|Overall Study|Withdrawal by Subject|3
7531200|NCT02646891|11875209|FG000|Overall Study|Death|0
7531201|NCT02646891|11875210|FG001|Overall Study|Death|0
7323753|NCT00766090|11555260|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7323754|NCT00766090|11555249|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323755|NCT00766090|11555250|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323756|NCT00766090|11555251|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
7323757|NCT00766090|11555252|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323758|NCT00766090|11555253|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323759|NCT00766090|11555254|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323760|NCT00766090|11555255|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323761|NCT00766090|11555256|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323762|NCT00766090|11555257|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323763|NCT00766090|11555258|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323764|NCT00766090|11555259|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7323765|NCT00766090|11555260|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
7416942|NCT01452529|11690753|FG001|Double-blind (DB) Period|Adverse Event|18
7531202|NCT02646891|11875211|FG002|Overall Study|Death|0
7531203|NCT02646891|11875212|FG003|Overall Study|Death|0
7531204|NCT02646891|11875213|FG004|Overall Study|Death|0
7531205|NCT02646891|11875214|FG005|Overall Study|Death|0
7531206|NCT02646891|11875215|FG006|Overall Study|Death|1
7323766|NCT00766090|11555249|FG000|Washout Period 2 (14 Days)|Physician Decision|0
7323767|NCT00766090|11555250|FG001|Washout Period 2 (14 Days)|Physician Decision|0
7323768|NCT00766090|11555251|FG002|Washout Period 2 (14 Days)|Physician Decision|1
7323769|NCT00766090|11555252|FG003|Washout Period 2 (14 Days)|Physician Decision|0
7323770|NCT00766090|11555253|FG004|Washout Period 2 (14 Days)|Physician Decision|0
7323771|NCT00766090|11555254|FG005|Washout Period 2 (14 Days)|Physician Decision|0
7323772|NCT00766090|11555255|FG006|Washout Period 2 (14 Days)|Physician Decision|0
7323773|NCT00766090|11555256|FG007|Washout Period 2 (14 Days)|Physician Decision|0
7323774|NCT00766090|11555257|FG008|Washout Period 2 (14 Days)|Physician Decision|0
7323775|NCT00766090|11555258|FG009|Washout Period 2 (14 Days)|Physician Decision|0
7323776|NCT00766090|11555259|FG010|Washout Period 2 (14 Days)|Physician Decision|0
7323777|NCT00766090|11555260|FG011|Washout Period 2 (14 Days)|Physician Decision|0
7323778|NCT00766090|11555249|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
7323779|NCT00766090|11555250|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
7323780|NCT00766090|11555251|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
7323781|NCT00766090|11555252|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
7323782|NCT00766090|11555253|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
7323783|NCT00766090|11555254|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
7323784|NCT00766090|11555255|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
7323785|NCT00766090|11555256|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
7323786|NCT00766090|11555257|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
7323787|NCT00766090|11555258|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
7323788|NCT00766090|11555259|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
7323789|NCT00766090|11555260|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
7323790|NCT00766090|11555249|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323791|NCT00766090|11555250|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7323792|NCT00766090|11555251|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323793|NCT00766090|11555252|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7323794|NCT00766090|11555253|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323795|NCT00766090|11555254|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323796|NCT00766090|11555255|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323797|NCT00766090|11555256|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323798|NCT00766090|11555257|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323799|NCT00766090|11555258|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323800|NCT00766090|11555259|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
7323801|NCT00766090|11555260|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
7323802|NCT00766090|11555249|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323803|NCT00766090|11555250|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323804|NCT00766090|11555251|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323805|NCT00766090|11555252|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323806|NCT00766090|11555253|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
7323807|NCT00766090|11555254|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323808|NCT00766090|11555255|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323809|NCT00766090|11555256|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323810|NCT00766090|11555257|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323811|NCT00766090|11555258|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323812|NCT00766090|11555259|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323813|NCT00766090|11555260|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
7323814|NCT00766142|11555281|FG000|Overall Study|Protocol Violation|4
7323815|NCT00766363|11555289|FG000|Overall Study|Withdrawal by Subject|1
7323816|NCT00766363|11555290|FG001|Overall Study|Withdrawal by Subject|0
7323817|NCT00766363|11555291|FG002|Overall Study|Withdrawal by Subject|0
7323818|NCT00766363|11555292|FG003|Overall Study|Withdrawal by Subject|0
7323819|NCT00766363|11555289|FG000|Overall Study|Adverse Event Prior to Randomization|0
7323820|NCT00766363|11555290|FG001|Overall Study|Adverse Event Prior to Randomization|1
7323821|NCT00766363|11555291|FG002|Overall Study|Adverse Event Prior to Randomization|0
7323822|NCT00766363|11555292|FG003|Overall Study|Adverse Event Prior to Randomization|0
7323823|NCT00766376|11555303|FG000|Overall Study|Withdrawal by Subject|27
7323824|NCT00766415|11555309|FG000|Overall Study|Withdrawal by Subject|0
7323825|NCT00766415|11555310|FG001|Overall Study|Withdrawal by Subject|1
7323826|NCT00766467|11555318|FG000|Overall Study|Withdrawal by Subject|7
7323827|NCT00766467|11555319|FG001|Overall Study|Withdrawal by Subject|2
7323828|NCT00766467|11555318|FG000|Overall Study|Adverse Event|1
7323829|NCT00766467|11555319|FG001|Overall Study|Adverse Event|1
7323830|NCT00766467|11555318|FG000|Overall Study|Protocol Violation|2
7323831|NCT00766467|11555319|FG001|Overall Study|Protocol Violation|4
7323832|NCT00766467|11555318|FG000|Overall Study|Tumor Progression on Study|0
7323833|NCT00766467|11555319|FG001|Overall Study|Tumor Progression on Study|1
7323834|NCT00766467|11555318|FG000|Overall Study|Physician Decision|1
7323835|NCT00766467|11555319|FG001|Overall Study|Physician Decision|0
7323836|NCT00766493|11555325|FG000|30 Days Post-Procedure|Discontinued|7
7323837|NCT00766493|11555325|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
7323838|NCT00766493|11555325|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
7323839|NCT00766506|11555331|FG000|Overall Study|Use rescue medication after 3 hours|3
7323840|NCT00766506|11555332|FG001|Overall Study|Use rescue medication after 3 hours|0
7323841|NCT00766506|11555331|FG000|Overall Study|Other|2
7323842|NCT00766506|11555332|FG001|Overall Study|Other|2
7323843|NCT00766532|11555338|FG000|Overall Study|Protocol Violation|2
7323844|NCT00766597|11555342|FG000|Overall Study|Unexpected closure of study|4
7323845|NCT00766597|11555342|FG000|Overall Study|Without CCR5-tropic virus|5
7323846|NCT00766675|11555352|FG000|Overall Study|Adverse Event|16
7323847|NCT00766675|11555352|FG000|Overall Study|Lost to Follow-up|2
7323848|NCT00766675|11555352|FG000|Overall Study|Withdrawal by Subject|11
7323849|NCT00766675|11555352|FG000|Overall Study|Protocol Violation|8
7323850|NCT00766675|11555352|FG000|Overall Study|Participant took prohibited medication|1
7323851|NCT00766675|11555352|FG000|Overall Study|Receive other anti-neoplastic treatment|1
7323852|NCT00766675|11555352|FG000|Overall Study|Insufficient therapy|1
7323853|NCT00766831|11555372|FG000|Overall Study|Withdrawal by Subject|4
7323854|NCT00766831|11555372|FG000|Overall Study|Lost to Follow-up|3
7323855|NCT00766831|11555372|FG000|Overall Study|Adverse Event|20
7323856|NCT00766831|11555372|FG000|Overall Study|Protocol Violation|15
7323857|NCT00766831|11555372|FG000|Overall Study|Physician Decision|5
7323858|NCT00766831|11555372|FG000|Overall Study|Withdrawal of consent|26
7323859|NCT00766831|11555372|FG000|Overall Study|Non cooperation by participants|14
7323860|NCT00766831|11555372|FG000|Overall Study|Other|28
7323861|NCT00767000|11555381|FG000|54-week Study|Adverse Event|4
7323862|NCT00767000|11555382|FG001|54-week Study|Adverse Event|6
7323863|NCT00767000|11555383|FG002|54-week Study|Adverse Event|6
7323864|NCT00767000|11555384|FG003|54-week Study|Adverse Event|8
7323865|NCT00767000|11555385|FG004|54-week Study|Adverse Event|4
7323866|NCT00767000|11555381|FG000|54-week Study|Creaninine/creatinine clearance|2
7323867|NCT00767000|11555382|FG001|54-week Study|Creaninine/creatinine clearance|1
7323868|NCT00767000|11555383|FG002|54-week Study|Creaninine/creatinine clearance|2
7323869|NCT00767000|11555384|FG003|54-week Study|Creaninine/creatinine clearance|2
7323870|NCT00767000|11555385|FG004|54-week Study|Creaninine/creatinine clearance|4
7323871|NCT00767000|11555381|FG000|54-week Study|Hyperglycemia|0
7323872|NCT00767000|11555382|FG001|54-week Study|Hyperglycemia|0
7323873|NCT00767000|11555383|FG002|54-week Study|Hyperglycemia|1
7323874|NCT00767000|11555384|FG003|54-week Study|Hyperglycemia|0
7323875|NCT00767000|11555385|FG004|54-week Study|Hyperglycemia|1
7323876|NCT00767000|11555381|FG000|54-week Study|Hypoglycemia|0
7323877|NCT00767000|11555382|FG001|54-week Study|Hypoglycemia|1
7323878|NCT00767000|11555383|FG002|54-week Study|Hypoglycemia|0
7323879|NCT00767000|11555384|FG003|54-week Study|Hypoglycemia|0
7323880|NCT00767000|11555385|FG004|54-week Study|Hypoglycemia|0
7323881|NCT00767000|11555381|FG000|54-week Study|Interruption of study medication|0
7323882|NCT00767000|11555382|FG001|54-week Study|Interruption of study medication|0
7323883|NCT00767000|11555383|FG002|54-week Study|Interruption of study medication|1
7323884|NCT00767000|11555384|FG003|54-week Study|Interruption of study medication|0
7323885|NCT00767000|11555385|FG004|54-week Study|Interruption of study medication|0
7323886|NCT00767000|11555381|FG000|54-week Study|Lack of Efficacy|2
7323887|NCT00767000|11555382|FG001|54-week Study|Lack of Efficacy|0
7323888|NCT00767000|11555383|FG002|54-week Study|Lack of Efficacy|1
7323889|NCT00767000|11555384|FG003|54-week Study|Lack of Efficacy|0
7323890|NCT00767000|11555385|FG004|54-week Study|Lack of Efficacy|5
7323891|NCT00767000|11555381|FG000|54-week Study|Lost to Follow-up|4
7323892|NCT00767000|11555382|FG001|54-week Study|Lost to Follow-up|0
7323893|NCT00767000|11555383|FG002|54-week Study|Lost to Follow-up|1
7323894|NCT00767000|11555384|FG003|54-week Study|Lost to Follow-up|4
7323895|NCT00767000|11555385|FG004|54-week Study|Lost to Follow-up|2
7323896|NCT00767000|11555381|FG000|54-week Study|Physician Decision|4
7323897|NCT00767000|11555382|FG001|54-week Study|Physician Decision|0
7531207|NCT02646891|11875216|FG007|Overall Study|Death|1
7531208|NCT02646891|11875217|FG008|Overall Study|Death|1
7531209|NCT02646891|11875218|FG009|Overall Study|Death|0
7531210|NCT02647281|11875284|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531211|NCT02647281|11875285|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531212|NCT02647281|11875286|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531213|NCT02647281|11875287|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531214|NCT02647281|11875288|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531215|NCT02647281|11875289|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531216|NCT02647281|11875290|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531217|NCT02647281|11875291|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
7531218|NCT02647281|11875292|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
7531219|NCT02647320|11875326|FG000|Overall Study|Adverse Event|0
7323898|NCT00767000|11555383|FG002|54-week Study|Physician Decision|1
7323899|NCT00767000|11555384|FG003|54-week Study|Physician Decision|1
7416943|NCT01452529|11690754|FG002|Double-blind (DB) Period|Adverse Event|11
7416944|NCT01452529|11690752|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
7416945|NCT01452529|11690753|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
7416946|NCT01452529|11690754|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
7416947|NCT01452529|11690752|FG000|Double-blind (DB) Period|Lost to Follow-up|0
7416948|NCT01452529|11690753|FG001|Double-blind (DB) Period|Lost to Follow-up|5
7323900|NCT00767000|11555385|FG004|54-week Study|Physician Decision|1
7323901|NCT00767000|11555381|FG000|54-week Study|Progressive disease|0
7323902|NCT00767000|11555382|FG001|54-week Study|Progressive disease|0
7323903|NCT00767000|11555383|FG002|54-week Study|Progressive disease|1
7323904|NCT00767000|11555384|FG003|54-week Study|Progressive disease|0
7323905|NCT00767000|11555385|FG004|54-week Study|Progressive disease|0
7323906|NCT00767000|11555381|FG000|54-week Study|Protocol Violation|0
7323907|NCT00767000|11555382|FG001|54-week Study|Protocol Violation|0
7323908|NCT00767000|11555383|FG002|54-week Study|Protocol Violation|1
7323909|NCT00767000|11555384|FG003|54-week Study|Protocol Violation|2
7323910|NCT00767000|11555385|FG004|54-week Study|Protocol Violation|0
7323911|NCT00767000|11555381|FG000|54-week Study|Withdrawal by Subject|2
7323912|NCT00767000|11555382|FG001|54-week Study|Withdrawal by Subject|3
7323913|NCT00767000|11555383|FG002|54-week Study|Withdrawal by Subject|5
7323914|NCT00767000|11555384|FG003|54-week Study|Withdrawal by Subject|11
7323915|NCT00767000|11555385|FG004|54-week Study|Withdrawal by Subject|13
7323916|NCT00767000|11555381|FG000|54-week Study|Study terminated by sponsor|90
7323917|NCT00767000|11555382|FG001|54-week Study|Study terminated by sponsor|102
7323918|NCT00767000|11555383|FG002|54-week Study|Study terminated by sponsor|89
7323919|NCT00767000|11555384|FG003|54-week Study|Study terminated by sponsor|196
7323920|NCT00767000|11555385|FG004|54-week Study|Study terminated by sponsor|194
7323921|NCT00767000|11555381|FG000|54-week Study|Reason not reported|0
7323922|NCT00767000|11555382|FG001|54-week Study|Reason not reported|0
7323923|NCT00767000|11555383|FG002|54-week Study|Reason not reported|0
7323924|NCT00767000|11555384|FG003|54-week Study|Reason not reported|1
7323925|NCT00767000|11555385|FG004|54-week Study|Reason not reported|0
7323926|NCT00767000|11555381|FG000|Optional 104-week Extension|Study terminated by sponsor|7
7323927|NCT00767000|11555382|FG001|Optional 104-week Extension|Study terminated by sponsor|3
7323928|NCT00767000|11555383|FG002|Optional 104-week Extension|Study terminated by sponsor|7
7323929|NCT00767000|11555384|FG003|Optional 104-week Extension|Study terminated by sponsor|2
7323930|NCT00767000|11555385|FG004|Optional 104-week Extension|Study terminated by sponsor|4
7323931|NCT00767039|11555399|FG000|Overall Study|Death|5
7323932|NCT00767039|11555400|FG001|Overall Study|Death|2
7323933|NCT00767104|11555408|FG000|Overall Study|Lost to Follow-up|1
7323934|NCT00767104|11555409|FG001|Overall Study|Lost to Follow-up|2
7323935|NCT00767325|11555417|FG000|Overall Study|Lack of Efficacy|2
7323936|NCT00767325|11555417|FG000|Overall Study|Adverse Event|7
7323937|NCT00767325|11555417|FG000|Overall Study|Lost to Follow-up|3
7323938|NCT00767325|11555417|FG000|Overall Study|No longer met study criteria|2
7323939|NCT00767325|11555417|FG000|Overall Study|Missed visit due to family reasons|1
7323940|NCT00767455|11555447|FG000|Overall Study|Investigator error|19
7323941|NCT00767520|11555479|FG000|Overall Study|Participants still on treatment|11
7323942|NCT00767520|11555480|FG001|Overall Study|Participants still on treatment|15
7323943|NCT00767520|11555479|FG000|Overall Study|Randomized in error and Never treated|0
7323944|NCT00767520|11555480|FG001|Overall Study|Randomized in error and Never treated|2
7323945|NCT00767676|11555501|FG000|Overall Study|Investigator error|54
7323946|NCT00767806|11555528|FG000|Overall Study|Adverse Event|30
7323947|NCT00767806|11555529|FG001|Overall Study|Adverse Event|11
7323948|NCT00767806|11555528|FG000|Overall Study|Withdrawal by Subject|8
7323949|NCT00767806|11555529|FG001|Overall Study|Withdrawal by Subject|13
7323950|NCT00767806|11555528|FG000|Overall Study|Protocol Violation|6
7323951|NCT00767806|11555529|FG001|Overall Study|Protocol Violation|5
7323952|NCT00767806|11555528|FG000|Overall Study|Lack of Efficacy|1
7323953|NCT00767806|11555529|FG001|Overall Study|Lack of Efficacy|9
7323954|NCT00767806|11555528|FG000|Overall Study|Physician Decision|4
7323955|NCT00767806|11555529|FG001|Overall Study|Physician Decision|3
7323956|NCT00767806|11555528|FG000|Overall Study|Lost to Follow-up|1
7323957|NCT00767806|11555529|FG001|Overall Study|Lost to Follow-up|4
7323958|NCT00767806|11555528|FG000|Overall Study|Entry Criteria Not Met|1
7323959|NCT00767806|11555529|FG001|Overall Study|Entry Criteria Not Met|1
7323960|NCT00767806|11555528|FG000|Overall Study|Sponsor Decision|0
7323961|NCT00767806|11555529|FG001|Overall Study|Sponsor Decision|1
7323962|NCT00767819|11555538|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7323963|NCT00767819|11555539|FG001|Overall Study|Unsatisfactory therapeutic effect|14
7323964|NCT00767819|11555540|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7323965|NCT00767819|11555538|FG000|Overall Study|Withdrawal by Subject|1
7323966|NCT00767819|11555539|FG001|Overall Study|Withdrawal by Subject|1
7323967|NCT00767819|11555540|FG002|Overall Study|Withdrawal by Subject|0
7323968|NCT00767819|11555538|FG000|Overall Study|Administrative problems|0
7323969|NCT00767819|11555539|FG001|Overall Study|Administrative problems|1
7323970|NCT00767819|11555540|FG002|Overall Study|Administrative problems|0
7323971|NCT00767819|11555538|FG000|Overall Study|Death|2
7323972|NCT00767819|11555539|FG001|Overall Study|Death|3
7323973|NCT00767819|11555540|FG002|Overall Study|Death|0
7323974|NCT00767819|11555538|FG000|Overall Study|Adverse Event|2
7323975|NCT00767819|11555539|FG001|Overall Study|Adverse Event|0
7323976|NCT00767819|11555540|FG002|Overall Study|Adverse Event|0
7323977|NCT00767819|11555538|FG000|Overall Study|Abnormal lab values|1
7323978|NCT00767819|11555539|FG001|Overall Study|Abnormal lab values|0
7531220|NCT02647320|11875327|FG001|Overall Study|Adverse Event|1
7531221|NCT02647320|11875328|FG002|Overall Study|Adverse Event|3
7531222|NCT02647320|11875329|FG003|Overall Study|Adverse Event|2
7323979|NCT00767819|11555540|FG002|Overall Study|Abnormal lab values|0
7323980|NCT00767819|11555538|FG000|Overall Study|Lost to Follow-up|1
7323981|NCT00767819|11555539|FG001|Overall Study|Lost to Follow-up|0
7323982|NCT00767819|11555540|FG002|Overall Study|Lost to Follow-up|0
7323983|NCT00768053|11555548|FG000|Overall Study|Adverse Event|10
7323984|NCT00768053|11555548|FG000|Overall Study|Lost to Follow-up|1
7323985|NCT00768066|11555555|FG000|Overall Study|Did not receive study product injection.|3
7323986|NCT00768066|11555556|FG001|Overall Study|Did not receive study product injection.|3
7323987|NCT00768066|11555557|FG002|Overall Study|Did not receive study product injection.|0
7323988|NCT00768079|11555568|FG000|Overall Study|Lost to Follow-up|2
7323989|NCT00768079|11555569|FG001|Overall Study|Lost to Follow-up|0
7323990|NCT00768079|11555570|FG002|Overall Study|Lost to Follow-up|4
7323991|NCT00768079|11555568|FG000|Overall Study|Participant incarcerated|0
7323992|NCT00768079|11555569|FG001|Overall Study|Participant incarcerated|1
7323993|NCT00768079|11555570|FG002|Overall Study|Participant incarcerated|0
7323994|NCT00768144|11555584|FG000|Overall Study|Adverse Event|13
7323995|NCT00768144|11555584|FG000|Overall Study|Progressive Disease|21
7323996|NCT00768144|11555584|FG000|Overall Study|Patient or MD Decision to End Treatment|1
7323997|NCT00768144|11555584|FG000|Overall Study|Pt Withdrew Consent|1
7323998|NCT00768222|11555590|FG000|Overall Study|Lost to Follow-up|1
7323999|NCT00768222|11555591|FG001|Overall Study|Lost to Follow-up|1
7324000|NCT00768222|11555590|FG000|Overall Study|Withdrawal by Subject|3
7324001|NCT00768222|11555591|FG001|Overall Study|Withdrawal by Subject|1
7324002|NCT00768222|11555590|FG000|Overall Study|Protocol Violation|0
7324003|NCT00768222|11555591|FG001|Overall Study|Protocol Violation|2
7324004|NCT00768300|11555636|FG000|Overall Study|Randomized but not treated|1
7324005|NCT00768300|11555637|FG001|Overall Study|Randomized but not treated|1
7324006|NCT00768300|11555636|FG000|Overall Study|Adverse Event|10
7324007|NCT00768300|11555637|FG001|Overall Study|Adverse Event|2
7324008|NCT00768300|11555636|FG000|Overall Study|Protocol Violation|6
7324009|NCT00768300|11555637|FG001|Overall Study|Protocol Violation|1
7324010|NCT00768300|11555636|FG000|Overall Study|Withdrawal by Subject|13
7324011|NCT00768300|11555637|FG001|Overall Study|Withdrawal by Subject|7
7324012|NCT00768300|11555636|FG000|Overall Study|Physician Decision|2
7324013|NCT00768300|11555637|FG001|Overall Study|Physician Decision|3
7324014|NCT00768300|11555636|FG000|Overall Study|Study discontinued by Sponsor|271
7324015|NCT00768300|11555637|FG001|Overall Study|Study discontinued by Sponsor|140
7324016|NCT00768300|11555636|FG000|Overall Study|Death|21
7324017|NCT00768300|11555637|FG001|Overall Study|Death|5
7531223|NCT02647320|11875330|FG004|Overall Study|Adverse Event|1
7531224|NCT02647320|11875326|FG000|Overall Study|Protocol Violation|0
7531225|NCT02647320|11875327|FG001|Overall Study|Protocol Violation|0
7531226|NCT02647320|11875328|FG002|Overall Study|Protocol Violation|3
7531227|NCT02647320|11875329|FG003|Overall Study|Protocol Violation|0
7531228|NCT02647320|11875330|FG004|Overall Study|Protocol Violation|0
7531229|NCT02647320|11875326|FG000|Overall Study|Withdrawal by Subject|7
7531230|NCT02647320|11875327|FG001|Overall Study|Withdrawal by Subject|4
7531231|NCT02647320|11875328|FG002|Overall Study|Withdrawal by Subject|2
7324018|NCT00768300|11555636|FG000|Overall Study|Subject moved to pursue lung transplant|1
7324019|NCT00768300|11555637|FG001|Overall Study|Subject moved to pursue lung transplant|1
7324020|NCT00768300|11555636|FG000|Overall Study|Screen failure following randomization|1
7324021|NCT00768300|11555637|FG001|Overall Study|Screen failure following randomization|0
7324022|NCT00768300|11555636|FG000|Overall Study|Received lung transplant|1
7324023|NCT00768300|11555637|FG001|Overall Study|Received lung transplant|1
7324024|NCT00768300|11555636|FG000|Overall Study|Lost to Follow-up|0
7324025|NCT00768300|11555637|FG001|Overall Study|Lost to Follow-up|1
7324026|NCT00768300|11555636|FG000|Overall Study|Began prohibited concomitant medication|0
7324027|NCT00768300|11555637|FG001|Overall Study|Began prohibited concomitant medication|1
7324028|NCT00768300|11555636|FG000|Overall Study|Treated but never dosed with Study drug|1
7324029|NCT00768300|11555637|FG001|Overall Study|Treated but never dosed with Study drug|0
7324030|NCT00768300|11555636|FG000|Overall Study|Missing data|1
7324031|NCT00768300|11555637|FG001|Overall Study|Missing data|0
7324032|NCT00768430|11555645|FG000|7 Day Endpoint|Withdrawal by Subject|2
7324033|NCT00768430|11555646|FG001|7 Day Endpoint|Withdrawal by Subject|3
7324034|NCT00768469|11555654|FG000|Overall Study|Adverse Event|0
7324035|NCT00768469|11555655|FG001|Overall Study|Adverse Event|2
7324036|NCT00768469|11555654|FG000|Overall Study|Disease Progression|3
7324037|NCT00768469|11555655|FG001|Overall Study|Disease Progression|4
7324038|NCT00768469|11555654|FG000|Overall Study|Withdrawal by Subject|0
7324039|NCT00768469|11555655|FG001|Overall Study|Withdrawal by Subject|1
7324040|NCT00768560|11555675|FG000|Intervention Set 1|Adverse Event|0
7324041|NCT00768560|11555676|FG001|Intervention Set 1|Adverse Event|1
7324042|NCT00768560|11555677|FG002|Intervention Set 1|Adverse Event|0
7324043|NCT00768560|11555678|FG003|Intervention Set 1|Adverse Event|0
7324044|NCT00768560|11555679|FG004|Intervention Set 1|Adverse Event|0
7324045|NCT00768560|11555680|FG005|Intervention Set 1|Adverse Event|0
7384849|NCT01197521|11642282|FG000|Overall Study|Lack of therapeutic response|2
7384850|NCT01197521|11642283|FG001|Overall Study|Lack of therapeutic response|3
7384851|NCT01197521|11642284|FG002|Overall Study|Lack of therapeutic response|4
7384852|NCT01197521|11642282|FG000|Overall Study|Dev. of study specific discont. criteria|6
7384853|NCT01197521|11642283|FG001|Overall Study|Dev. of study specific discont. criteria|16
7384854|NCT01197521|11642284|FG002|Overall Study|Dev. of study specific discont. criteria|2
7384855|NCT01197521|11642282|FG000|Overall Study|Lost to Follow-up|3
7384856|NCT01197521|11642283|FG001|Overall Study|Lost to Follow-up|2
7384857|NCT01197521|11642284|FG002|Overall Study|Lost to Follow-up|2
7384858|NCT01197521|11642282|FG000|Overall Study|Adverse Event|25
7384859|NCT01197521|11642283|FG001|Overall Study|Adverse Event|28
7384860|NCT01197521|11642284|FG002|Overall Study|Adverse Event|24
7555304|NCT03053063|11918246|FG003|Open-Label Phase|Death|2
7555305|NCT03053063|11918243|FG000|Open-Label Phase|Investigator's discretion|0
7555306|NCT03053063|11918244|FG001|Open-Label Phase|Investigator's discretion|0
7555307|NCT03053063|11918245|FG002|Open-Label Phase|Investigator's discretion|0
7555308|NCT03053063|11918246|FG003|Open-Label Phase|Investigator's discretion|2
7555309|NCT03053180|11918255|FG000|Overall Study|Failure to Return|1
7555310|NCT03053271|11918259|FG000|Overall Study|Did not meet randomization criteria|3
7555311|NCT03053271|11918259|FG000|Overall Study|Withdrawal by Subject|1
7555312|NCT03053427|11918275|FG000|Overall Study|Adverse Event|4
7555313|NCT03053427|11918276|FG001|Overall Study|Adverse Event|4
7555314|NCT03053427|11918275|FG000|Overall Study|Lack of Efficacy|1
7555315|NCT03053427|11918276|FG001|Overall Study|Lack of Efficacy|3
7324046|NCT00768651|11555701|FG000|Overall Study|Withdrawal by Subject|1
7324047|NCT00768664|11555706|FG000|Overall Study|Death|57
7324048|NCT00768664|11555706|FG000|Overall Study|Lost to Follow-up|2
7324049|NCT00768664|11555706|FG000|Overall Study|Other|9
7324050|NCT00768664|11555706|FG000|Overall Study|Participant refused|1
7324051|NCT00768755|11555726|FG000|Phase 1|Death|6
7324052|NCT00768755|11555727|FG001|Phase 1|Death|0
7416949|NCT01452529|11690754|FG002|Double-blind (DB) Period|Lost to Follow-up|3
7416950|NCT01452529|11690752|FG000|Double-blind (DB) Period|Lack of Efficacy|0
7416951|NCT01452529|11690753|FG001|Double-blind (DB) Period|Lack of Efficacy|16
7416952|NCT01452529|11690754|FG002|Double-blind (DB) Period|Lack of Efficacy|44
7416953|NCT01452529|11690752|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
7416954|NCT01452529|11690753|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
7416955|NCT01452529|11690754|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
7416956|NCT01452529|11690752|FG000|Double-blind (DB) Period|Administrative|0
7416957|NCT01452529|11690753|FG001|Double-blind (DB) Period|Administrative|11
7416958|NCT01452529|11690754|FG002|Double-blind (DB) Period|Administrative|7
7416959|NCT01452789|11690763|FG000|Overall Study|Withdrawal by Subject|3
7416960|NCT01452789|11690764|FG001|Overall Study|Withdrawal by Subject|2
7555316|NCT03053427|11918275|FG000|Overall Study|Lost to Follow-up|2
7555317|NCT03053427|11918276|FG001|Overall Study|Lost to Follow-up|2
7555318|NCT03053427|11918275|FG000|Overall Study|Worsening of the target disease|0
7324053|NCT00768755|11555728|FG002|Phase 1|Death|0
7324054|NCT00768755|11555729|FG003|Phase 1|Death|0
7324055|NCT00768755|11555726|FG000|Phase 1|Other|4
7324056|NCT00768755|11555727|FG001|Phase 1|Other|0
7324057|NCT00768755|11555728|FG002|Phase 1|Other|0
7324058|NCT00768755|11555729|FG003|Phase 1|Other|0
7324059|NCT00768755|11555726|FG000|Phase 2|Death|0
7324060|NCT00768755|11555727|FG001|Phase 2|Death|37
7324061|NCT00768755|11555728|FG002|Phase 2|Death|48
7324062|NCT00768755|11555729|FG003|Phase 2|Death|31
7324063|NCT00768755|11555726|FG000|Phase 2|Protocol Violation|0
7324064|NCT00768755|11555727|FG001|Phase 2|Protocol Violation|2
7324065|NCT00768755|11555728|FG002|Phase 2|Protocol Violation|0
7324066|NCT00768755|11555729|FG003|Phase 2|Protocol Violation|1
7324067|NCT00768755|11555726|FG000|Phase 2|Lost to Follow-up|0
7324068|NCT00768755|11555727|FG001|Phase 2|Lost to Follow-up|1
7324069|NCT00768755|11555728|FG002|Phase 2|Lost to Follow-up|1
7324070|NCT00768755|11555729|FG003|Phase 2|Lost to Follow-up|4
7324071|NCT00768755|11555726|FG000|Phase 2|Withdrawal by Subject|0
7324072|NCT00768755|11555727|FG001|Phase 2|Withdrawal by Subject|1
7324073|NCT00768755|11555728|FG002|Phase 2|Withdrawal by Subject|0
7324074|NCT00768755|11555729|FG003|Phase 2|Withdrawal by Subject|1
7324075|NCT00768755|11555726|FG000|Phase 2|Other|0
7324076|NCT00768755|11555727|FG001|Phase 2|Other|1
7324077|NCT00768755|11555728|FG002|Phase 2|Other|2
7324078|NCT00768755|11555729|FG003|Phase 2|Other|4
7324079|NCT00768755|11555726|FG000|Phase 2|Study Terminated by Sponsor|0
7324080|NCT00768755|11555727|FG001|Phase 2|Study Terminated by Sponsor|13
7324081|NCT00768755|11555728|FG002|Phase 2|Study Terminated by Sponsor|7
7324082|NCT00768755|11555729|FG003|Phase 2|Study Terminated by Sponsor|14
7324083|NCT00768755|11555726|FG000|Phase 2|Randomized but not treated|0
7324084|NCT00768755|11555727|FG001|Phase 2|Randomized but not treated|0
7324085|NCT00768755|11555728|FG002|Phase 2|Randomized but not treated|0
7324086|NCT00768755|11555729|FG003|Phase 2|Randomized but not treated|2
7324087|NCT00768898|11555738|FG000|Overall Study|Unrelated injury|1
7324088|NCT00768898|11555738|FG000|Overall Study|Headache|1
7324089|NCT00768989|11555749|FG000|Prior to Week 24|Withdrawal by Subject|1
7324090|NCT00768989|11555750|FG001|Prior to Week 24|Withdrawal by Subject|0
7324091|NCT00768989|11555749|FG000|Prior to Week 24|Adverse Event|3
7531232|NCT02647320|11875329|FG003|Overall Study|Withdrawal by Subject|2
7324092|NCT00768989|11555750|FG001|Prior to Week 24|Adverse Event|0
7324093|NCT00768989|11555749|FG000|Prior to Week 24|Lost to Follow-up|0
7324094|NCT00768989|11555750|FG001|Prior to Week 24|Lost to Follow-up|1
7324095|NCT00768989|11555749|FG000|Prior to Week 24|Protocol Violation|0
7324096|NCT00768989|11555750|FG001|Prior to Week 24|Protocol Violation|2
7324097|NCT00768989|11555749|FG000|Week 24 to Prior to Week 36|Adverse Event|1
7324098|NCT00768989|11555750|FG001|Week 24 to Prior to Week 36|Adverse Event|0
7324099|NCT00768989|11555749|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
7324100|NCT00768989|11555750|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
7324101|NCT00768989|11555749|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
7324102|NCT00768989|11555750|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
7324103|NCT00768989|11555749|FG000|On or After Week 36|Lack of Efficacy|1
7324104|NCT00768989|11555750|FG001|On or After Week 36|Lack of Efficacy|0
7324105|NCT00768989|11555749|FG000|On or After Week 36|Adverse Event|0
7324106|NCT00768989|11555750|FG001|On or After Week 36|Adverse Event|1
7324107|NCT00768989|11555749|FG000|On or After Week 36|Lost to Follow-up|1
7324108|NCT00768989|11555750|FG001|On or After Week 36|Lost to Follow-up|0
7324109|NCT00768989|11555749|FG000|On or After Week 36|Poor Compliance|1
7324110|NCT00768989|11555750|FG001|On or After Week 36|Poor Compliance|0
7324111|NCT00768989|11555749|FG000|On or After Week 36|Protocol Violation|1
7324112|NCT00768989|11555750|FG001|On or After Week 36|Protocol Violation|0
7324113|NCT00768989|11555749|FG000|On or After Week 36|Did not attend termination visit|2
7324114|NCT00768989|11555750|FG001|On or After Week 36|Did not attend termination visit|0
7324115|NCT00768989|11555749|FG000|On or After Week 36|Sponsor Termination|45
7324116|NCT00768989|11555750|FG001|On or After Week 36|Sponsor Termination|26
7324117|NCT00769067|11555769|FG000|Overall Study|Death|89
7324118|NCT00769067|11555770|FG001|Overall Study|Death|86
7324119|NCT00769067|11555769|FG000|Overall Study|Lost to Follow-up|3
7324120|NCT00769067|11555770|FG001|Overall Study|Lost to Follow-up|1
7324121|NCT00769067|11555769|FG000|Overall Study|Study terminated by sponsor|1
7324122|NCT00769067|11555770|FG001|Overall Study|Study terminated by sponsor|3
7324123|NCT00769067|11555769|FG000|Overall Study|Other|1
7324124|NCT00769067|11555770|FG001|Overall Study|Other|3
7324125|NCT00769067|11555769|FG000|Overall Study|Withdrawal by Subject|0
7324126|NCT00769067|11555770|FG001|Overall Study|Withdrawal by Subject|1
7324127|NCT00769119|11555779|FG000|Overall Study|Voluntary discontinuation|0
7324128|NCT00769119|11555780|FG001|Overall Study|Voluntary discontinuation|2
7324129|NCT00769119|11555779|FG000|Overall Study|Adverse Event|1
7324130|NCT00769119|11555780|FG001|Overall Study|Adverse Event|1
7324131|NCT00769119|11555779|FG000|Overall Study|Disallowed medication|1
7324132|NCT00769119|11555780|FG001|Overall Study|Disallowed medication|0
7324133|NCT00769132|11555786|FG000|Period 1|Adverse Event|1
7324134|NCT00769132|11555787|FG001|Period 1|Adverse Event|0
7324135|NCT00769132|11555788|FG002|Period 1|Adverse Event|0
7324136|NCT00769132|11555789|FG003|Period 1|Adverse Event|1
7324137|NCT00769132|11555786|FG000|Period 2|Withdrawal by Subject|0
7324138|NCT00769132|11555787|FG001|Period 2|Withdrawal by Subject|0
7324139|NCT00769132|11555788|FG002|Period 2|Withdrawal by Subject|0
7324140|NCT00769132|11555789|FG003|Period 2|Withdrawal by Subject|1
7324141|NCT00769132|11555786|FG000|Period 3|Withdrawal by Subject|1
7324142|NCT00769132|11555787|FG001|Period 3|Withdrawal by Subject|0
7324143|NCT00769132|11555788|FG002|Period 3|Withdrawal by Subject|0
7324144|NCT00769132|11555789|FG003|Period 3|Withdrawal by Subject|0
7324145|NCT00769132|11555786|FG000|Period 4|Withdrawal by Subject|0
7324146|NCT00769132|11555787|FG001|Period 4|Withdrawal by Subject|1
7324147|NCT00769132|11555788|FG002|Period 4|Withdrawal by Subject|0
7324148|NCT00769132|11555789|FG003|Period 4|Withdrawal by Subject|0
7324149|NCT00769184|11555799|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
7324150|NCT00769184|11555800|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
7324151|NCT00769184|11555799|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
7324152|NCT00769184|11555800|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
7324153|NCT00769184|11555799|FG000|No Treatment (6 Weeks)|Adverse Event|1
7324154|NCT00769184|11555800|FG001|No Treatment (6 Weeks)|Adverse Event|1
7324155|NCT00769483|11555827|FG000|Overall Study|Withdrawal by Subject|0
7324156|NCT00769483|11555828|FG001|Overall Study|Withdrawal by Subject|1
7324157|NCT00769483|11555829|FG002|Overall Study|Withdrawal by Subject|0
7324158|NCT00769483|11555830|FG003|Overall Study|Withdrawal by Subject|0
7324159|NCT00769483|11555831|FG004|Overall Study|Withdrawal by Subject|1
7324160|NCT00769483|11555832|FG005|Overall Study|Withdrawal by Subject|0
7324161|NCT00769561|11555850|FG000|Overall Study|Withdrawal by Subject|2
7324162|NCT00769561|11555851|FG001|Overall Study|Withdrawal by Subject|2
7324163|NCT00769561|11555850|FG000|Overall Study|Lost to Follow-up|1
7324164|NCT00769561|11555851|FG001|Overall Study|Lost to Follow-up|3
7324165|NCT00769704|11555871|FG000|Overall Study|Lost to Follow-up|3
7324166|NCT00769704|11555872|FG001|Overall Study|Lost to Follow-up|2
7324167|NCT00769704|11555871|FG000|Overall Study|Death|95
7324168|NCT00769704|11555872|FG001|Overall Study|Death|190
7324169|NCT00769704|11555871|FG000|Overall Study|Withdrawal by Subject|12
7324170|NCT00769704|11555872|FG001|Overall Study|Withdrawal by Subject|5
7324171|NCT00769704|11555871|FG000|Overall Study|Other|1
7324172|NCT00769704|11555872|FG001|Overall Study|Other|2
7324173|NCT00769860|11555885|FG000|Overall Study|Withdrawal by Subject|2
7324174|NCT00769860|11555886|FG001|Overall Study|Withdrawal by Subject|0
7324175|NCT00770029|11555911|FG000|Overall Study|Lost to Follow-up|2
7324176|NCT00770029|11555912|FG001|Overall Study|Lost to Follow-up|0
7324177|NCT00770029|11555911|FG000|Overall Study|Withdrawal by Subject|3
7324178|NCT00770029|11555912|FG001|Overall Study|Withdrawal by Subject|3
7324179|NCT00770029|11555911|FG000|Overall Study|Adverse Event|1
7324180|NCT00770029|11555912|FG001|Overall Study|Adverse Event|0
7324181|NCT00770120|11555918|FG000|Overall Study|Progression|31
7416994|NCT01453023|11690782|FG000|Treatment Period (TP) 1|Protocol Violation|1
7416995|NCT01453023|11690783|FG001|Treatment Period (TP) 1|Protocol Violation|0
7416996|NCT01453023|11690782|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
7416997|NCT01453023|11690783|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
7416998|NCT01453023|11690782|FG000|Treatment Period 2|Protocol Violation|0
7416999|NCT01453023|11690783|FG001|Treatment Period 2|Protocol Violation|1
7417000|NCT01453036|11690792|FG000|Overall Study|Lost to Follow-up|26
7417001|NCT01453036|11690793|FG001|Overall Study|Lost to Follow-up|115
7417002|NCT01453036|11690794|FG002|Overall Study|Lost to Follow-up|31
7417003|NCT01453049|11690804|FG000|Overall Study|Protocol Violation|2
7417004|NCT01453049|11690805|FG001|Overall Study|Protocol Violation|5
7417005|NCT01453049|11690804|FG000|Overall Study|Lost to Follow-up|2
7417006|NCT01453049|11690805|FG001|Overall Study|Lost to Follow-up|1
7417007|NCT01453049|11690804|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
7417008|NCT01453049|11690805|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
7417009|NCT01453049|11690804|FG000|Overall Study|Withdrawal by Subject|1
7417010|NCT01453049|11690805|FG001|Overall Study|Withdrawal by Subject|0
7417011|NCT01453049|11690804|FG000|Overall Study|Randomized in Error|1
7417012|NCT01453049|11690805|FG001|Overall Study|Randomized in Error|0
7417013|NCT01453153|11690823|FG000|Overall Study|Physician Decision|0
7417014|NCT01453153|11690824|FG001|Overall Study|Physician Decision|0
7417015|NCT01453153|11690825|FG002|Overall Study|Physician Decision|1
7417016|NCT01453153|11690823|FG000|Overall Study|Progressive Disease|3
7417017|NCT01453153|11690824|FG001|Overall Study|Progressive Disease|2
7417018|NCT01453153|11690825|FG002|Overall Study|Progressive Disease|16
7417019|NCT01453153|11690823|FG000|Overall Study|Withdrawal by Subject|0
7417020|NCT01453153|11690824|FG001|Overall Study|Withdrawal by Subject|1
7417021|NCT01453153|11690825|FG002|Overall Study|Withdrawal by Subject|2
7417022|NCT01453153|11690823|FG000|Overall Study|Adverse Event|1
7417023|NCT01453153|11690824|FG001|Overall Study|Adverse Event|1
7417024|NCT01453153|11690825|FG002|Overall Study|Adverse Event|1
7417025|NCT01453205|11690853|FG000|Overall Study|Lost to Follow-up|3
7417026|NCT01453205|11690854|FG001|Overall Study|Lost to Follow-up|0
7417027|NCT01453205|11690855|FG002|Overall Study|Lost to Follow-up|1
7417028|NCT01453205|11690853|FG000|Overall Study|Withdrawal by Subject|8
7417029|NCT01453205|11690854|FG001|Overall Study|Withdrawal by Subject|3
7417030|NCT01453205|11690855|FG002|Overall Study|Withdrawal by Subject|0
7417031|NCT01453205|11690853|FG000|Overall Study|Death|24
7417032|NCT01453205|11690854|FG001|Overall Study|Death|22
7417033|NCT01453205|11690855|FG002|Overall Study|Death|18
7417034|NCT01453205|11690853|FG000|Overall Study|Other|45
7417035|NCT01453205|11690854|FG001|Overall Study|Other|27
7417036|NCT01453205|11690855|FG002|Overall Study|Other|35
7417037|NCT01453296|11690866|FG000|Treatment Period 1|Adverse Event|0
7417038|NCT01453296|11690867|FG001|Treatment Period 1|Adverse Event|1
7417039|NCT01453296|11690866|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
7417040|NCT01453296|11690867|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
7417041|NCT01453296|11690866|FG000|Treatment Period 2|Adverse Event|1
7417042|NCT01453296|11690867|FG001|Treatment Period 2|Adverse Event|0
7417043|NCT01453296|11690866|FG000|Treatment Period 2|Withdrawal by Subject|1
7417044|NCT01453296|11690867|FG001|Treatment Period 2|Withdrawal by Subject|0
7417045|NCT01453348|11690876|FG000|Overall Study|Death|0
7417046|NCT01453348|11690877|FG001|Overall Study|Death|0
7324182|NCT00770120|11555918|FG000|Overall Study|Adverse Event|11
7417047|NCT01453348|11690878|FG002|Overall Study|Death|1
7324183|NCT00770120|11555918|FG000|Overall Study|Not Protocol Specified|11
7324184|NCT00770120|11555918|FG000|Overall Study|Death|3
7324185|NCT00770120|11555918|FG000|Overall Study|Withdrawal by Subject|2
7324186|NCT00770120|11555918|FG000|Overall Study|Ineligible|1
7324187|NCT00770120|11555918|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
7324188|NCT00770120|11555918|FG000|Overall Study|Reason under Review|1
7324189|NCT00770146|11555942|FG000|Treatment Period|Withdrawal by Subject|6
7324190|NCT00770146|11555943|FG001|Treatment Period|Withdrawal by Subject|13
7324191|NCT00770146|11555942|FG000|Treatment Period|Adverse Event|2
7324192|NCT00770146|11555943|FG001|Treatment Period|Adverse Event|26
7324193|NCT00770146|11555942|FG000|Treatment Period|Other|1
7324194|NCT00770146|11555943|FG001|Treatment Period|Other|5
7324195|NCT00770146|11555942|FG000|Treatment Period|Protocol non-compliance|0
7324196|NCT00770146|11555943|FG001|Treatment Period|Protocol non-compliance|1
7324197|NCT00770146|11555942|FG000|Follow-up Period|Withdrawal by Subject|7
7324198|NCT00770146|11555943|FG001|Follow-up Period|Withdrawal by Subject|13
7324199|NCT00770146|11555942|FG000|Follow-up Period|Adverse Event|0
7324200|NCT00770146|11555943|FG001|Follow-up Period|Adverse Event|2
7324201|NCT00770146|11555942|FG000|Follow-up Period|Other|4
7324202|NCT00770146|11555943|FG001|Follow-up Period|Other|5
7324203|NCT00770211|11555951|FG000|Overall Study|Lost to Follow-up|1
7324204|NCT00770211|11555952|FG001|Overall Study|Lost to Follow-up|0
7324205|NCT00770211|11555951|FG000|Overall Study|Withdrawal by Subject|0
7324206|NCT00770211|11555952|FG001|Overall Study|Withdrawal by Subject|2
7324207|NCT00770224|11555958|FG000|Step 1: Induction|Adverse Event|3
7324208|NCT00770224|11555959|FG001|Step 1: Induction|Adverse Event|0
7324209|NCT00770224|11555958|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
7324210|NCT00770224|11555959|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
7324211|NCT00770224|11555958|FG000|Step 1: Induction|Other reason not protocol specified|2
7324212|NCT00770224|11555959|FG001|Step 1: Induction|Other reason not protocol specified|0
7324213|NCT00770224|11555958|FG000|Step 1: Induction|Ineligible|2
7324214|NCT00770224|11555959|FG001|Step 1: Induction|Ineligible|0
7324215|NCT00770224|11555958|FG000|Step 1: Induction|No protocol treatment given|1
7324216|NCT00770224|11555959|FG001|Step 1: Induction|No protocol treatment given|0
7324217|NCT00770224|11555958|FG000|Step 2: Maintenance|Adverse Event|0
7324218|NCT00770224|11555959|FG001|Step 2: Maintenance|Adverse Event|10
7324219|NCT00770224|11555958|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
7324220|NCT00770224|11555959|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
7324221|NCT00770224|11555958|FG000|Step 2: Maintenance|Progression/relapse|0
7324222|NCT00770224|11555959|FG001|Step 2: Maintenance|Progression/relapse|1
7324223|NCT00770224|11555958|FG000|Step 2: Maintenance|Death|0
7324224|NCT00770224|11555959|FG001|Step 2: Maintenance|Death|2
7324225|NCT00770224|11555958|FG000|Step 2: Maintenance|Other reason not protocol specified|0
7324226|NCT00770224|11555959|FG001|Step 2: Maintenance|Other reason not protocol specified|7
7324227|NCT00770224|11555958|FG000|Step 2: Maintenance|Ineligible|0
7324228|NCT00770224|11555959|FG001|Step 2: Maintenance|Ineligible|2
7324229|NCT00770289|11555966|FG000|Overall Study|Other|6
7324230|NCT00770315|11555979|FG000|Overall Study|Adverse Event|11
7324231|NCT00770315|11555980|FG001|Overall Study|Adverse Event|17
7324232|NCT00770315|11555981|FG002|Overall Study|Adverse Event|16
7417048|NCT01453348|11690876|FG000|Overall Study|Withdrawal by Subject|0
7417049|NCT01453348|11690877|FG001|Overall Study|Withdrawal by Subject|1
7417050|NCT01453348|11690878|FG002|Overall Study|Withdrawal by Subject|0
7417051|NCT01453348|11690876|FG000|Overall Study|Protocol Violation|1
7417052|NCT01453348|11690877|FG001|Overall Study|Protocol Violation|0
7417053|NCT01453348|11690878|FG002|Overall Study|Protocol Violation|0
7417054|NCT01453361|11690889|FG000|Overall Study|Disease Progression|6
7417055|NCT01453361|11690889|FG000|Overall Study|Screen-Failures|10
7417056|NCT01453374|11690893|FG000|Overall Study|Adverse Event|7
7417057|NCT01453374|11690893|FG000|Overall Study|Lack of Efficacy|1
7417058|NCT01453374|11690893|FG000|Overall Study|Lost to Follow-up|3
7417059|NCT01453374|11690893|FG000|Overall Study|Withdrawal by Subject|5
7417060|NCT01453374|11690893|FG000|Overall Study|Incarcerated|2
7417061|NCT01453439|11690931|FG000|Treatment Phase|Withdrawal by Subject|13
7531233|NCT02647320|11875330|FG004|Overall Study|Withdrawal by Subject|7
7417062|NCT01453439|11690932|FG001|Treatment Phase|Withdrawal by Subject|10
7417063|NCT01453439|11690931|FG000|Treatment Phase|Suicidal Ideation|2
7417064|NCT01453439|11690932|FG001|Treatment Phase|Suicidal Ideation|0
7417065|NCT01453439|11690931|FG000|Treatment Phase|Need for higher level of care|1
7417066|NCT01453439|11690932|FG001|Treatment Phase|Need for higher level of care|1
7417067|NCT01453439|11690931|FG000|Treatment Phase|Therapist conflict of interest|1
7417068|NCT01453439|11690932|FG001|Treatment Phase|Therapist conflict of interest|0
7417069|NCT01453439|11690931|FG000|Follow-up|Withdrawal by Subject|0
7417070|NCT01453439|11690932|FG001|Follow-up|Withdrawal by Subject|1
7417071|NCT01453439|11690931|FG000|Follow-up|Lost to Follow-up|5
7417072|NCT01453439|11690932|FG001|Follow-up|Lost to Follow-up|10
7417073|NCT01453595|11690954|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
7417074|NCT01453595|11690955|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
7417075|NCT01453595|11690956|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
7324233|NCT00770315|11555982|FG003|Overall Study|Adverse Event|6
7324234|NCT00770315|11555979|FG000|Overall Study|Lost to Follow-up|9
7324235|NCT00770315|11555980|FG001|Overall Study|Lost to Follow-up|5
7417076|NCT01453725|11690964|FG000|Overall Study|Adverse Event|3
7324236|NCT00770315|11555981|FG002|Overall Study|Lost to Follow-up|10
7324237|NCT00770315|11555982|FG003|Overall Study|Lost to Follow-up|3
7324238|NCT00770315|11555979|FG000|Overall Study|Withdrawal by Subject|13
7324239|NCT00770315|11555980|FG001|Overall Study|Withdrawal by Subject|17
7324240|NCT00770315|11555981|FG002|Overall Study|Withdrawal by Subject|24
7324241|NCT00770315|11555982|FG003|Overall Study|Withdrawal by Subject|20
7324242|NCT00770315|11555979|FG000|Overall Study|Noncompliance with Protocol|7
7324243|NCT00770315|11555980|FG001|Overall Study|Noncompliance with Protocol|4
7324244|NCT00770315|11555981|FG002|Overall Study|Noncompliance with Protocol|7
7324245|NCT00770315|11555982|FG003|Overall Study|Noncompliance with Protocol|9
7324246|NCT00770328|11555994|FG000|Overall Study|Adverse Event|11
7324247|NCT00770328|11555995|FG001|Overall Study|Adverse Event|2
7324248|NCT00770328|11555994|FG000|Overall Study|Lost to Follow-up|2
7324249|NCT00770328|11555995|FG001|Overall Study|Lost to Follow-up|2
7324250|NCT00770341|11556004|FG000|Overall Study|Did not meet eligibility criteria|1
7324251|NCT00770341|11556005|FG001|Overall Study|Did not meet eligibility criteria|0
7324252|NCT00770341|11556006|FG002|Overall Study|Did not meet eligibility criteria|0
7324253|NCT00770341|11556004|FG000|Overall Study|Withdrawal by Subject|0
7324254|NCT00770341|11556005|FG001|Overall Study|Withdrawal by Subject|1
7324255|NCT00770341|11556006|FG002|Overall Study|Withdrawal by Subject|0
7324256|NCT00770341|11556004|FG000|Overall Study|Clinical Adverse Event|3
7324257|NCT00770341|11556005|FG001|Overall Study|Clinical Adverse Event|1
7324258|NCT00770341|11556006|FG002|Overall Study|Clinical Adverse Event|2
7324259|NCT00770341|11556004|FG000|Overall Study|Laboratory adverse event|3
7324260|NCT00770341|11556005|FG001|Overall Study|Laboratory adverse event|3
7324261|NCT00770341|11556006|FG002|Overall Study|Laboratory adverse event|0
7324262|NCT00770341|11556004|FG000|Overall Study|Lack of Efficacy|3
7324263|NCT00770341|11556005|FG001|Overall Study|Lack of Efficacy|0
7324264|NCT00770341|11556006|FG002|Overall Study|Lack of Efficacy|1
7324265|NCT00770341|11556004|FG000|Overall Study|Other|1
7324266|NCT00770341|11556005|FG001|Overall Study|Other|0
7324267|NCT00770341|11556006|FG002|Overall Study|Other|0
7324268|NCT00770341|11556004|FG000|Overall Study|Not treated|1
7324269|NCT00770341|11556005|FG001|Overall Study|Not treated|0
7324270|NCT00770341|11556006|FG002|Overall Study|Not treated|0
7324271|NCT00770367|11556017|FG000|First Intervention|Withdrawal by Subject|0
7324272|NCT00770367|11556018|FG001|First Intervention|Withdrawal by Subject|2
7324273|NCT00770367|11556017|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
7324274|NCT00770367|11556018|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
7324275|NCT00770367|11556017|FG000|Second Intervention|Lost to Follow-up|2
7324276|NCT00770367|11556018|FG001|Second Intervention|Lost to Follow-up|0
7324277|NCT00770432|11556028|FG000|Overall Study|Other|4
7324278|NCT00770432|11556029|FG001|Overall Study|Other|6
7324279|NCT00770432|11556028|FG000|Overall Study|Non-compliance|0
7324280|NCT00770432|11556029|FG001|Overall Study|Non-compliance|1
7324281|NCT00770484|11556037|FG000|Overall Study|Withdrawal by Subject|1
7324282|NCT00770484|11556038|FG001|Overall Study|Withdrawal by Subject|0
7324283|NCT00770510|11556044|FG000|Overall Study|Lost to Follow-up|2
7324284|NCT00770510|11556044|FG000|Overall Study|Pregnancy|1
7324285|NCT00770510|11556044|FG000|Overall Study|Withdrawal by Subject|2
7324286|NCT00770562|11556058|FG000|Overall Study|Did not take treatment|1
7324287|NCT00770562|11556059|FG001|Overall Study|Did not take treatment|1
7324288|NCT00770588|11556068|FG000|Overall Study|Adverse Event|9
7324289|NCT00770588|11556069|FG001|Overall Study|Adverse Event|2
7324290|NCT00770588|11556068|FG000|Overall Study|Death caused by progression of disease|70
7324291|NCT00770588|11556069|FG001|Overall Study|Death caused by progression of disease|91
7324292|NCT00770588|11556068|FG000|Overall Study|Lost to Follow-up|1
7324293|NCT00770588|11556069|FG001|Overall Study|Lost to Follow-up|1
7324294|NCT00770588|11556068|FG000|Overall Study|Withdrawal by Subject|1
7324295|NCT00770588|11556069|FG001|Overall Study|Withdrawal by Subject|1
7324296|NCT00770601|11556076|FG000|Overall Study|Withdrawal by Subject|1
7324297|NCT00770653|11556082|FG000|Overall Study|Adverse Event|13
7324298|NCT00770653|11556083|FG001|Overall Study|Adverse Event|5
7324299|NCT00770653|11556082|FG000|Overall Study|Protocol Violation|8
7324300|NCT00770653|11556083|FG001|Overall Study|Protocol Violation|6
7324301|NCT00770653|11556082|FG000|Overall Study|Withdrawal by Subject|4
7324302|NCT00770653|11556083|FG001|Overall Study|Withdrawal by Subject|7
7324303|NCT00770653|11556082|FG000|Overall Study|Lack of Compliance|1
7324304|NCT00770653|11556083|FG001|Overall Study|Lack of Compliance|4
7324305|NCT00770653|11556082|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
7324306|NCT00770653|11556083|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
7324307|NCT00770653|11556082|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
7324308|NCT00770653|11556083|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
7324309|NCT00770653|11556082|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
7324310|NCT00770653|11556083|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
7324311|NCT00770653|11556082|FG000|Overall Study|Lost to Follow-up|1
7324312|NCT00770653|11556083|FG001|Overall Study|Lost to Follow-up|2
7324313|NCT00770653|11556082|FG000|Overall Study|Physician Decision|1
7324314|NCT00770653|11556083|FG001|Overall Study|Physician Decision|0
7324315|NCT00770679|11556089|FG000|Overall Study|Lost to Follow-up|3
7324316|NCT00770679|11556089|FG000|Overall Study|Follow-up LDL measurement not collected|3
7324317|NCT00770692|11556097|FG000|Overall Study|Withdrawal by Subject|7
7324318|NCT00770692|11556098|FG001|Overall Study|Withdrawal by Subject|9
7324319|NCT00770692|11556099|FG002|Overall Study|Withdrawal by Subject|9
7324320|NCT00770692|11556100|FG003|Overall Study|Withdrawal by Subject|6
7324321|NCT00770692|11556097|FG000|Overall Study|Adverse Event|3
7324322|NCT00770692|11556098|FG001|Overall Study|Adverse Event|0
7324323|NCT00770692|11556099|FG002|Overall Study|Adverse Event|4
7324324|NCT00770692|11556100|FG003|Overall Study|Adverse Event|4
7324325|NCT00770692|11556097|FG000|Overall Study|Investigator judgment|2
7324326|NCT00770692|11556098|FG001|Overall Study|Investigator judgment|0
7324327|NCT00770692|11556099|FG002|Overall Study|Investigator judgment|1
7324328|NCT00770692|11556100|FG003|Overall Study|Investigator judgment|1
7324329|NCT00770770|11556116|FG000|Overall Study|Lost to Follow-up|1
7324330|NCT00770770|11556117|FG001|Overall Study|Lost to Follow-up|0
7324331|NCT00770770|11556116|FG000|Overall Study|Withdrawal by Subject|1
7555319|NCT03053427|11918276|FG001|Overall Study|Worsening of the target disease|1
7324332|NCT00770770|11556117|FG001|Overall Study|Withdrawal by Subject|0
7324333|NCT00770770|11556116|FG000|Overall Study|Death|0
7324334|NCT00770770|11556117|FG001|Overall Study|Death|1
7324335|NCT00770770|11556116|FG000|Overall Study|Study Terminated|8
7324336|NCT00770770|11556117|FG001|Overall Study|Study Terminated|0
7324337|NCT00770913|11556144|FG000|Overall Study|Adverse Event|1
7324338|NCT00770913|11556145|FG001|Overall Study|Adverse Event|3
7324339|NCT00770913|11556146|FG002|Overall Study|Adverse Event|6
7324340|NCT00770913|11556144|FG000|Overall Study|Refusal to continue participation|6
7324341|NCT00770913|11556145|FG001|Overall Study|Refusal to continue participation|4
7324342|NCT00770913|11556146|FG002|Overall Study|Refusal to continue participation|5
7324343|NCT00770913|11556144|FG000|Overall Study|Physician Decision|0
7324344|NCT00770913|11556145|FG001|Overall Study|Physician Decision|1
7324345|NCT00770913|11556146|FG002|Overall Study|Physician Decision|1
7324346|NCT00770913|11556144|FG000|Overall Study|Protocol Violation|3
7324347|NCT00770913|11556145|FG001|Overall Study|Protocol Violation|0
7324348|NCT00770913|11556146|FG002|Overall Study|Protocol Violation|1
7324349|NCT00770913|11556144|FG000|Overall Study|Incorrect drug was allocated|1
7324350|NCT00770913|11556145|FG001|Overall Study|Incorrect drug was allocated|0
7324351|NCT00770913|11556146|FG002|Overall Study|Incorrect drug was allocated|0
7324352|NCT00770991|11556156|FG000|Overall Study|Physician Decision|2
7324353|NCT00770991|11556157|FG001|Overall Study|Physician Decision|0
7324354|NCT00770991|11556156|FG000|Overall Study|Withdrawal by Subject|1
7324355|NCT00770991|11556157|FG001|Overall Study|Withdrawal by Subject|0
7324356|NCT00770991|11556156|FG000|Overall Study|Adverse Event|1
7324357|NCT00770991|11556157|FG001|Overall Study|Adverse Event|5
7324358|NCT00770991|11556156|FG000|Overall Study|Pregnancy|1
7324359|NCT00770991|11556157|FG001|Overall Study|Pregnancy|0
7417077|NCT01453725|11690965|FG001|Overall Study|Adverse Event|3
7417078|NCT01453725|11690964|FG000|Overall Study|Lost to Follow-up|4
7417079|NCT01453725|11690965|FG001|Overall Study|Lost to Follow-up|0
7417080|NCT01453725|11690964|FG000|Overall Study|Non-compliance With Protocol|1
7417081|NCT01453725|11690965|FG001|Overall Study|Non-compliance With Protocol|2
7417082|NCT01453725|11690964|FG000|Overall Study|Protocol Violation|1
7417083|NCT01453725|11690965|FG001|Overall Study|Protocol Violation|0
7417084|NCT01453725|11690964|FG000|Overall Study|Withdrawal by Subject|2
7417085|NCT01453725|11690965|FG001|Overall Study|Withdrawal by Subject|3
7417086|NCT01453725|11690964|FG000|Overall Study|Pregnancy Wish|0
7417087|NCT01453725|11690965|FG001|Overall Study|Pregnancy Wish|2
7417088|NCT01453725|11690964|FG000|Overall Study|Pregnancy|1
7417089|NCT01453725|11690965|FG001|Overall Study|Pregnancy|0
7417090|NCT01453725|11690964|FG000|Overall Study|Physician Decision|1
7417091|NCT01453725|11690965|FG001|Overall Study|Physician Decision|1
7417092|NCT01453855|11690975|FG000|Overall Study|Adverse Event|3
7417093|NCT01453855|11690976|FG001|Overall Study|Adverse Event|4
7417094|NCT01453855|11690975|FG000|Overall Study|Lost to Follow-up|2
7417095|NCT01453855|11690976|FG001|Overall Study|Lost to Follow-up|1
7417096|NCT01453855|11690975|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
7417097|NCT01453855|11690976|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
7417098|NCT01453855|11690975|FG000|Overall Study|Noncompliance|1
7417099|NCT01453855|11690976|FG001|Overall Study|Noncompliance|0
7417100|NCT01453855|11690975|FG000|Overall Study|Inadequate Control of IOP|1
7417101|NCT01453855|11690976|FG001|Overall Study|Inadequate Control of IOP|5
7417102|NCT01453855|11690975|FG000|Overall Study|Other|0
7417103|NCT01453855|11690976|FG001|Overall Study|Other|1
7417104|NCT01453998|11690994|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
7417105|NCT01453998|11690995|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
7417106|NCT01453998|11690996|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
7417107|NCT01454063|11691009|FG000|Randomized|Adverse Event|1
7417108|NCT01454063|11691010|FG001|Randomized|Adverse Event|1
7417109|NCT01454063|11691009|FG000|Randomized|Protocol Violation|0
7417110|NCT01454063|11691010|FG001|Randomized|Protocol Violation|1
7417111|NCT01454076|11691021|FG000|Overall Study|Other|2
7555320|NCT03053427|11918275|FG000|Overall Study|Protocol Deviation|3
7555321|NCT03053427|11918276|FG001|Overall Study|Protocol Deviation|3
7324360|NCT00771030|11556175|FG000|Overall Study|Adverse Event|0
7417112|NCT01454076|11691022|FG001|Overall Study|Other|0
7417113|NCT01454076|11691023|FG002|Overall Study|Other|0
7324361|NCT00771030|11556176|FG001|Overall Study|Adverse Event|1
7324362|NCT00771030|11556177|FG002|Overall Study|Adverse Event|0
7324363|NCT00771030|11556178|FG003|Overall Study|Adverse Event|0
7417114|NCT01454076|11691024|FG003|Overall Study|Other|1
7324364|NCT00771030|11556179|FG004|Overall Study|Adverse Event|0
7324365|NCT00771030|11556180|FG005|Overall Study|Adverse Event|0
7324366|NCT00771030|11556181|FG006|Overall Study|Adverse Event|0
7324367|NCT00771472|11556246|FG000|Overall Study|Physician Decision|2
7324368|NCT00771472|11556247|FG001|Overall Study|Physician Decision|3
7324369|NCT00771472|11556246|FG000|Overall Study|Progressive Disease|3
7324370|NCT00771472|11556247|FG001|Overall Study|Progressive Disease|1
7324371|NCT00771472|11556246|FG000|Overall Study|Protocol Violation|1
7324372|NCT00771472|11556247|FG001|Overall Study|Protocol Violation|0
7324373|NCT00771615|11556318|FG000|Overall Study|Withdrawal by Subject|0
7324374|NCT00771615|11556319|FG001|Overall Study|Withdrawal by Subject|1
7324375|NCT00771615|11556320|FG002|Overall Study|Withdrawal by Subject|0
7324376|NCT00771615|11556321|FG003|Overall Study|Withdrawal by Subject|0
7324377|NCT00771615|11556322|FG004|Overall Study|Withdrawal by Subject|0
7324378|NCT00771615|11556323|FG005|Overall Study|Withdrawal by Subject|0
7324379|NCT00771615|11556324|FG006|Overall Study|Withdrawal by Subject|0
7324380|NCT00771615|11556325|FG007|Overall Study|Withdrawal by Subject|1
7324381|NCT00771615|11556326|FG008|Overall Study|Withdrawal by Subject|0
7324382|NCT00771615|11556318|FG000|Overall Study|Lost to Follow-up|1
7324383|NCT00771615|11556319|FG001|Overall Study|Lost to Follow-up|1
7324384|NCT00771615|11556320|FG002|Overall Study|Lost to Follow-up|1
7324385|NCT00771615|11556321|FG003|Overall Study|Lost to Follow-up|1
7324386|NCT00771615|11556322|FG004|Overall Study|Lost to Follow-up|0
7324387|NCT00771615|11556323|FG005|Overall Study|Lost to Follow-up|1
7324388|NCT00771615|11556324|FG006|Overall Study|Lost to Follow-up|1
7324389|NCT00771615|11556325|FG007|Overall Study|Lost to Follow-up|0
7324390|NCT00771615|11556326|FG008|Overall Study|Lost to Follow-up|0
7324391|NCT00771667|11556359|FG000|Induction Phase|Adverse Event|5
7324392|NCT00771667|11556360|FG001|Induction Phase|Adverse Event|2
7324393|NCT00771667|11556361|FG002|Induction Phase|Adverse Event|4
7324394|NCT00771667|11556362|FG003|Induction Phase|Adverse Event|1
7324395|NCT00771667|11556363|FG004|Induction Phase|Adverse Event|0
7324396|NCT00771667|11556364|FG005|Induction Phase|Adverse Event|0
7324397|NCT00771667|11556365|FG006|Induction Phase|Adverse Event|0
7324398|NCT00771667|11556366|FG007|Induction Phase|Adverse Event|0
7324399|NCT00771667|11556367|FG008|Induction Phase|Adverse Event|0
7324400|NCT00771667|11556368|FG009|Induction Phase|Adverse Event|0
7324401|NCT00771667|11556359|FG000|Induction Phase|Lack of Efficacy|9
7324402|NCT00771667|11556360|FG001|Induction Phase|Lack of Efficacy|2
7324403|NCT00771667|11556361|FG002|Induction Phase|Lack of Efficacy|4
7324404|NCT00771667|11556362|FG003|Induction Phase|Lack of Efficacy|3
7324405|NCT00771667|11556363|FG004|Induction Phase|Lack of Efficacy|0
7324406|NCT00771667|11556364|FG005|Induction Phase|Lack of Efficacy|0
7324407|NCT00771667|11556365|FG006|Induction Phase|Lack of Efficacy|0
7324408|NCT00771667|11556366|FG007|Induction Phase|Lack of Efficacy|0
7324409|NCT00771667|11556367|FG008|Induction Phase|Lack of Efficacy|0
7324410|NCT00771667|11556368|FG009|Induction Phase|Lack of Efficacy|0
7324411|NCT00771667|11556359|FG000|Induction Phase|Lost to Follow-up|1
7324412|NCT00771667|11556360|FG001|Induction Phase|Lost to Follow-up|0
7324413|NCT00771667|11556361|FG002|Induction Phase|Lost to Follow-up|1
7324414|NCT00771667|11556362|FG003|Induction Phase|Lost to Follow-up|0
7324415|NCT00771667|11556363|FG004|Induction Phase|Lost to Follow-up|0
7324416|NCT00771667|11556364|FG005|Induction Phase|Lost to Follow-up|0
7324417|NCT00771667|11556365|FG006|Induction Phase|Lost to Follow-up|0
7324418|NCT00771667|11556366|FG007|Induction Phase|Lost to Follow-up|0
7324419|NCT00771667|11556367|FG008|Induction Phase|Lost to Follow-up|0
7324420|NCT00771667|11556368|FG009|Induction Phase|Lost to Follow-up|0
7324421|NCT00771667|11556359|FG000|Induction Phase|Other|4
7324422|NCT00771667|11556360|FG001|Induction Phase|Other|6
7324423|NCT00771667|11556361|FG002|Induction Phase|Other|3
7324424|NCT00771667|11556362|FG003|Induction Phase|Other|4
7324425|NCT00771667|11556363|FG004|Induction Phase|Other|0
7324426|NCT00771667|11556364|FG005|Induction Phase|Other|0
7324427|NCT00771667|11556365|FG006|Induction Phase|Other|0
7324428|NCT00771667|11556366|FG007|Induction Phase|Other|0
7324429|NCT00771667|11556367|FG008|Induction Phase|Other|0
7324430|NCT00771667|11556368|FG009|Induction Phase|Other|0
7324431|NCT00771667|11556359|FG000|Maintenance Phase|Adverse Event|0
7324432|NCT00771667|11556360|FG001|Maintenance Phase|Adverse Event|0
7324433|NCT00771667|11556361|FG002|Maintenance Phase|Adverse Event|0
7324434|NCT00771667|11556362|FG003|Maintenance Phase|Adverse Event|0
7324435|NCT00771667|11556363|FG004|Maintenance Phase|Adverse Event|1
7324436|NCT00771667|11556364|FG005|Maintenance Phase|Adverse Event|3
7324437|NCT00771667|11556365|FG006|Maintenance Phase|Adverse Event|5
7324438|NCT00771667|11556366|FG007|Maintenance Phase|Adverse Event|1
7324439|NCT00771667|11556367|FG008|Maintenance Phase|Adverse Event|8
7324440|NCT00771667|11556368|FG009|Maintenance Phase|Adverse Event|7
7324441|NCT00771667|11556359|FG000|Maintenance Phase|Lack of Efficacy|0
7324442|NCT00771667|11556360|FG001|Maintenance Phase|Lack of Efficacy|0
7324443|NCT00771667|11556361|FG002|Maintenance Phase|Lack of Efficacy|0
7324444|NCT00771667|11556362|FG003|Maintenance Phase|Lack of Efficacy|0
7324445|NCT00771667|11556363|FG004|Maintenance Phase|Lack of Efficacy|1
7324446|NCT00771667|11556364|FG005|Maintenance Phase|Lack of Efficacy|3
7324447|NCT00771667|11556365|FG006|Maintenance Phase|Lack of Efficacy|3
7324448|NCT00771667|11556366|FG007|Maintenance Phase|Lack of Efficacy|2
7324449|NCT00771667|11556367|FG008|Maintenance Phase|Lack of Efficacy|11
7324450|NCT00771667|11556368|FG009|Maintenance Phase|Lack of Efficacy|7
7324451|NCT00771667|11556359|FG000|Maintenance Phase|Other|0
7324452|NCT00771667|11556360|FG001|Maintenance Phase|Other|0
7324453|NCT00771667|11556361|FG002|Maintenance Phase|Other|0
7324454|NCT00771667|11556362|FG003|Maintenance Phase|Other|0
7324455|NCT00771667|11556363|FG004|Maintenance Phase|Other|0
7324456|NCT00771667|11556364|FG005|Maintenance Phase|Other|1
7324457|NCT00771667|11556365|FG006|Maintenance Phase|Other|2
7324458|NCT00771667|11556366|FG007|Maintenance Phase|Other|2
7324459|NCT00771667|11556367|FG008|Maintenance Phase|Other|3
7324460|NCT00771667|11556368|FG009|Maintenance Phase|Other|3
7324461|NCT00771758|11556398|FG000|Overall Study|Adverse Event|2
7324462|NCT00771758|11556399|FG001|Overall Study|Adverse Event|8
7324463|NCT00771758|11556400|FG002|Overall Study|Adverse Event|1
7324464|NCT00771758|11556398|FG000|Overall Study|Lack of Efficacy|0
7324465|NCT00771758|11556399|FG001|Overall Study|Lack of Efficacy|2
7324466|NCT00771758|11556400|FG002|Overall Study|Lack of Efficacy|1
7324467|NCT00771758|11556398|FG000|Overall Study|Lost to Follow-up|1
7324468|NCT00771758|11556399|FG001|Overall Study|Lost to Follow-up|0
7324469|NCT00771758|11556400|FG002|Overall Study|Lost to Follow-up|0
7324470|NCT00771758|11556398|FG000|Overall Study|Protocol Violation|1
7324471|NCT00771758|11556399|FG001|Overall Study|Protocol Violation|0
7324472|NCT00771758|11556400|FG002|Overall Study|Protocol Violation|0
7324473|NCT00771758|11556398|FG000|Overall Study|Withdrawal by Subject|1
7324474|NCT00771758|11556399|FG001|Overall Study|Withdrawal by Subject|0
7324475|NCT00771758|11556400|FG002|Overall Study|Withdrawal by Subject|0
7324476|NCT00771758|11556398|FG000|Overall Study|Other|3
7324477|NCT00771758|11556399|FG001|Overall Study|Other|2
7324478|NCT00771758|11556400|FG002|Overall Study|Other|0
7324479|NCT00771810|11556428|FG000|Overall Study|Adverse Event|3
7324480|NCT00771810|11556429|FG001|Overall Study|Adverse Event|0
7324481|NCT00771810|11556430|FG002|Overall Study|Adverse Event|2
7324482|NCT00771810|11556428|FG000|Overall Study|Lost to Follow-up|0
7324483|NCT00771810|11556429|FG001|Overall Study|Lost to Follow-up|0
7324484|NCT00771810|11556430|FG002|Overall Study|Lost to Follow-up|1
7324485|NCT00771810|11556428|FG000|Overall Study|Physician Decision|1
7324486|NCT00771810|11556429|FG001|Overall Study|Physician Decision|2
7324487|NCT00771810|11556430|FG002|Overall Study|Physician Decision|2
7324488|NCT00771810|11556428|FG000|Overall Study|Protocol Violation|0
7324489|NCT00771810|11556429|FG001|Overall Study|Protocol Violation|1
7324490|NCT00771810|11556430|FG002|Overall Study|Protocol Violation|1
7324491|NCT00771810|11556428|FG000|Overall Study|Withdrawal by Subject|1
7324492|NCT00771810|11556429|FG001|Overall Study|Withdrawal by Subject|2
7324493|NCT00771810|11556430|FG002|Overall Study|Withdrawal by Subject|0
7324494|NCT00771810|11556428|FG000|Overall Study|Other|0
7324495|NCT00771810|11556429|FG001|Overall Study|Other|0
7324496|NCT00771810|11556430|FG002|Overall Study|Other|1
7324497|NCT00771849|11556441|FG000|Overall Study|Lost to Follow-up|1
7324498|NCT00771849|11556442|FG001|Overall Study|Lost to Follow-up|2
7531234|NCT02647320|11875326|FG000|Overall Study|Persistent hyperglycemia|0
7324499|NCT00771849|11556441|FG000|Overall Study|Withdrawal by Subject|1
7324500|NCT00771849|11556442|FG001|Overall Study|Withdrawal by Subject|1
7324501|NCT00771849|11556441|FG000|Overall Study|Not vaccinated|0
7324502|NCT00771849|11556442|FG001|Overall Study|Not vaccinated|1
7324503|NCT00771901|11556464|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
7324504|NCT00771901|11556465|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
7324505|NCT00771901|11556466|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
7324506|NCT00771914|11556478|FG000|Overall Study|Physician Decision|0
7324507|NCT00771914|11556479|FG001|Overall Study|Physician Decision|0
7324508|NCT00771914|11556480|FG002|Overall Study|Physician Decision|0
7324509|NCT00771914|11556481|FG003|Overall Study|Physician Decision|1
7324510|NCT00771914|11556478|FG000|Overall Study|Lost to Follow-up|0
7324511|NCT00771914|11556479|FG001|Overall Study|Lost to Follow-up|0
7324512|NCT00771914|11556480|FG002|Overall Study|Lost to Follow-up|0
7324513|NCT00771914|11556481|FG003|Overall Study|Lost to Follow-up|1
7324514|NCT00771927|11556493|FG000|Overall Study|Adverse Event|100
7324515|NCT00771927|11556494|FG001|Overall Study|Adverse Event|105
7324516|NCT00771927|11556493|FG000|Overall Study|Lack of Efficacy|70
7324517|NCT00771927|11556494|FG001|Overall Study|Lack of Efficacy|42
7324518|NCT00771927|11556493|FG000|Overall Study|Lost to Follow-up|46
7324519|NCT00771927|11556494|FG001|Overall Study|Lost to Follow-up|46
7324520|NCT00771927|11556493|FG000|Overall Study|Withdrawal by Subject|16
7324521|NCT00771927|11556494|FG001|Overall Study|Withdrawal by Subject|17
7531235|NCT02647320|11875327|FG001|Overall Study|Persistent hyperglycemia|1
7324522|NCT00771927|11556493|FG000|Overall Study|Other reason|23
7324523|NCT00771927|11556494|FG001|Overall Study|Other reason|27
7324524|NCT00771953|11556502|FG000|Overall Study|Adverse Event|5
7324525|NCT00771953|11556503|FG001|Overall Study|Adverse Event|3
7324526|NCT00771953|11556502|FG000|Overall Study|Death|2
7324527|NCT00771953|11556503|FG001|Overall Study|Death|2
7324528|NCT00771953|11556502|FG000|Overall Study|Progression before active Tx|1
7324529|NCT00771953|11556503|FG001|Overall Study|Progression before active Tx|2
7324530|NCT00771953|11556502|FG000|Overall Study|Sponsor decision|1
7324531|NCT00771953|11556503|FG001|Overall Study|Sponsor decision|0
7324532|NCT00771953|11556502|FG000|Overall Study|Other complicating disease|1
7324533|NCT00771953|11556503|FG001|Overall Study|Other complicating disease|0
7324534|NCT00771953|11556502|FG000|Overall Study|Withdrawal by Subject|0
7324535|NCT00771953|11556503|FG001|Overall Study|Withdrawal by Subject|3
7324536|NCT00772005|11556515|FG000|Overall Study|Adverse Event|9
7324537|NCT00772005|11556516|FG001|Overall Study|Adverse Event|14
7324538|NCT00772005|11556517|FG002|Overall Study|Adverse Event|10
7324539|NCT00772005|11556518|FG003|Overall Study|Adverse Event|13
7324540|NCT00772005|11556515|FG000|Overall Study|Lack of Efficacy|0
7324541|NCT00772005|11556516|FG001|Overall Study|Lack of Efficacy|1
7324542|NCT00772005|11556517|FG002|Overall Study|Lack of Efficacy|0
7324543|NCT00772005|11556518|FG003|Overall Study|Lack of Efficacy|0
7324544|NCT00772005|11556515|FG000|Overall Study|Withdrawal by Subject|3
7324545|NCT00772005|11556516|FG001|Overall Study|Withdrawal by Subject|7
7324546|NCT00772005|11556517|FG002|Overall Study|Withdrawal by Subject|10
7324547|NCT00772005|11556518|FG003|Overall Study|Withdrawal by Subject|2
7324548|NCT00772005|11556515|FG000|Overall Study|Protocol Violation|2
7324549|NCT00772005|11556516|FG001|Overall Study|Protocol Violation|4
7324550|NCT00772005|11556517|FG002|Overall Study|Protocol Violation|1
7324551|NCT00772005|11556518|FG003|Overall Study|Protocol Violation|6
7324552|NCT00772005|11556515|FG000|Overall Study|Lost to Follow-up|7
7324553|NCT00772005|11556516|FG001|Overall Study|Lost to Follow-up|3
7324554|NCT00772005|11556517|FG002|Overall Study|Lost to Follow-up|6
7324555|NCT00772005|11556518|FG003|Overall Study|Lost to Follow-up|3
7324556|NCT00772005|11556515|FG000|Overall Study|Non-compliance with study procedures|1
7324557|NCT00772005|11556516|FG001|Overall Study|Non-compliance with study procedures|1
7324558|NCT00772005|11556517|FG002|Overall Study|Non-compliance with study procedures|0
7324559|NCT00772005|11556518|FG003|Overall Study|Non-compliance with study procedures|1
7324560|NCT00772005|11556515|FG000|Overall Study|Non-compliance with drug administration|3
7324561|NCT00772005|11556516|FG001|Overall Study|Non-compliance with drug administration|0
7324562|NCT00772005|11556517|FG002|Overall Study|Non-compliance with drug administration|1
7324563|NCT00772005|11556518|FG003|Overall Study|Non-compliance with drug administration|1
7324564|NCT00772031|11556530|FG000|Overall Study|Early termination of trial|12
7324565|NCT00772031|11556531|FG001|Overall Study|Early termination of trial|10
7324566|NCT00772031|11556530|FG000|Overall Study|Lost to Follow-up|20
7324567|NCT00772031|11556531|FG001|Overall Study|Lost to Follow-up|33
7324568|NCT00772070|11556545|FG000|Overall Study|Lost to Follow-up|0
7324569|NCT00772070|11556546|FG001|Overall Study|Lost to Follow-up|8
7324570|NCT00772070|11556545|FG000|Overall Study|Withdrawal by Subject|0
7324571|NCT00772070|11556546|FG001|Overall Study|Withdrawal by Subject|2
7324572|NCT00772070|11556545|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
7324573|NCT00772070|11556546|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
7324574|NCT00772109|11556556|FG000|Overall Study|Serious adverse event|1
7324575|NCT00772109|11556557|FG001|Overall Study|Serious adverse event|0
7324576|NCT00772109|11556558|FG002|Overall Study|Serious adverse event|1
7324577|NCT00772109|11556559|FG003|Overall Study|Serious adverse event|0
7324578|NCT00772109|11556556|FG000|Overall Study|Protocol Violation|5
7324579|NCT00772109|11556557|FG001|Overall Study|Protocol Violation|8
7324580|NCT00772109|11556558|FG002|Overall Study|Protocol Violation|7
7324581|NCT00772109|11556559|FG003|Overall Study|Protocol Violation|6
7324582|NCT00772109|11556556|FG000|Overall Study|Lost to Follow-up|7
7324583|NCT00772109|11556557|FG001|Overall Study|Lost to Follow-up|3
7324584|NCT00772109|11556558|FG002|Overall Study|Lost to Follow-up|5
7324585|NCT00772109|11556559|FG003|Overall Study|Lost to Follow-up|9
7324586|NCT00772109|11556556|FG000|Overall Study|Withdrawal by Subject|8
7324587|NCT00772109|11556557|FG001|Overall Study|Withdrawal by Subject|8
7324588|NCT00772109|11556558|FG002|Overall Study|Withdrawal by Subject|6
7324589|NCT00772109|11556559|FG003|Overall Study|Withdrawal by Subject|16
7324590|NCT00772148|11556571|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
7324591|NCT00772148|11556572|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
7324592|NCT00772148|11556571|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
7324593|NCT00772148|11556572|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
7324594|NCT00772148|11556571|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
7324595|NCT00772148|11556572|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
7324596|NCT00772148|11556571|FG000|Maintenance Phase (Week 52)|Death|2
7324597|NCT00772148|11556572|FG001|Maintenance Phase (Week 52)|Death|2
7324598|NCT00772148|11556571|FG000|Maintenance Phase (Week 52)|Adverse Event|1
7324599|NCT00772148|11556572|FG001|Maintenance Phase (Week 52)|Adverse Event|0
7324600|NCT00772148|11556571|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
7324601|NCT00772148|11556572|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
7324602|NCT00772148|11556571|FG000|Maintenance Phase (Week 52)|Administrative/other|1
7324603|NCT00772148|11556572|FG001|Maintenance Phase (Week 52)|Administrative/other|2
7324604|NCT00772330|11556582|FG000|Overall Study|Lost to Follow-up|3
7324605|NCT00772369|11556589|FG000|Overall Study|Did not return record release form|1
7324606|NCT00772382|11556593|FG000|Overall Study|Adverse Event|19
7324607|NCT00772382|11556593|FG000|Overall Study|Death|6
7324608|NCT00772382|11556593|FG000|Overall Study|Lack of Efficacy|4
7324609|NCT00772382|11556593|FG000|Overall Study|Physician Decision|5
7324610|NCT00772382|11556593|FG000|Overall Study|Protocol Violation|1
7324611|NCT00772382|11556593|FG000|Overall Study|Withdrawal by Subject|10
7324612|NCT00772382|11556593|FG000|Overall Study|Other Reasons|10
7324613|NCT00772447|11556599|FG000|Overall Study|Withdrawal by Subject|9
7324614|NCT00772447|11556600|FG001|Overall Study|Withdrawal by Subject|5
7324615|NCT00772447|11556599|FG000|Overall Study|Physician Decision|4
7324616|NCT00772447|11556600|FG001|Overall Study|Physician Decision|8
7324617|NCT00772447|11556599|FG000|Overall Study|Lost to Follow-up|2
7324618|NCT00772447|11556600|FG001|Overall Study|Lost to Follow-up|4
7324619|NCT00772447|11556599|FG000|Overall Study|incorrect enrolment|3
7324620|NCT00772447|11556600|FG001|Overall Study|incorrect enrolment|4
7531236|NCT02647320|11875328|FG002|Overall Study|Persistent hyperglycemia|1
7324621|NCT00772447|11556599|FG000|Overall Study|Protocol Violation|0
7324622|NCT00772447|11556600|FG001|Overall Study|Protocol Violation|1
7324623|NCT00772447|11556599|FG000|Overall Study|all others|2
7324624|NCT00772447|11556600|FG001|Overall Study|all others|2
7324625|NCT00772538|11556609|FG000|Overall Study|Adverse Event|6
7324626|NCT00772538|11556610|FG001|Overall Study|Adverse Event|6
7324627|NCT00772538|11556609|FG000|Overall Study|Protocol Violation|3
7324628|NCT00772538|11556610|FG001|Overall Study|Protocol Violation|3
7324629|NCT00772538|11556609|FG000|Overall Study|Lost to Follow-up|1
7324630|NCT00772538|11556610|FG001|Overall Study|Lost to Follow-up|1
7324631|NCT00772538|11556609|FG000|Overall Study|Withdrawal by Subject|3
7324632|NCT00772538|11556610|FG001|Overall Study|Withdrawal by Subject|8
7324633|NCT00772538|11556609|FG000|Overall Study|Lack of Efficacy|0
7324634|NCT00772538|11556610|FG001|Overall Study|Lack of Efficacy|1
7324635|NCT00772538|11556609|FG000|Overall Study|Other|7
7324636|NCT00772538|11556610|FG001|Overall Study|Other|7
7324637|NCT00772577|11556618|FG000|Overall Study|Adverse Event|6
7324638|NCT00772577|11556619|FG001|Overall Study|Adverse Event|3
7324639|NCT00772577|11556618|FG000|Overall Study|Abnormal laboratory values|0
7324640|NCT00772577|11556619|FG001|Overall Study|Abnormal laboratory values|1
7324641|NCT00772577|11556618|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7324642|NCT00772577|11556619|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7324643|NCT00772577|11556618|FG000|Overall Study|Patient withdrew consent|8
7324644|NCT00772577|11556619|FG001|Overall Study|Patient withdrew consent|5
7324645|NCT00772577|11556618|FG000|Overall Study|Lost to Follow-up|4
7324646|NCT00772577|11556619|FG001|Overall Study|Lost to Follow-up|3
7324647|NCT00772577|11556618|FG000|Overall Study|Administrative problems|2
7324648|NCT00772577|11556619|FG001|Overall Study|Administrative problems|1
7324649|NCT00772577|11556618|FG000|Overall Study|Protocol Deviation|3
7324650|NCT00772577|11556619|FG001|Overall Study|Protocol Deviation|2
7324651|NCT00772603|11556645|FG000|Overall Study|Withdrawal by Subject|11
7324652|NCT00772603|11556646|FG001|Overall Study|Withdrawal by Subject|10
7324653|NCT00772603|11556647|FG002|Overall Study|Withdrawal by Subject|6
7324654|NCT00772603|11556645|FG000|Overall Study|Adverse Event|37
7324655|NCT00772603|11556646|FG001|Overall Study|Adverse Event|18
7324656|NCT00772603|11556647|FG002|Overall Study|Adverse Event|10
7324657|NCT00772603|11556645|FG000|Overall Study|Subject Non-compliance|1
7324658|NCT00772603|11556646|FG001|Overall Study|Subject Non-compliance|6
7324659|NCT00772603|11556647|FG002|Overall Study|Subject Non-compliance|4
7324660|NCT00772603|11556645|FG000|Overall Study|Protocol Violation|0
7324661|NCT00772603|11556646|FG001|Overall Study|Protocol Violation|1
7324662|NCT00772603|11556647|FG002|Overall Study|Protocol Violation|1
7324663|NCT00772603|11556645|FG000|Overall Study|Lost to Follow-up|1
7324664|NCT00772603|11556646|FG001|Overall Study|Lost to Follow-up|5
7324665|NCT00772603|11556647|FG002|Overall Study|Lost to Follow-up|2
7324666|NCT00772603|11556645|FG000|Overall Study|Physician Decision|0
7324667|NCT00772603|11556646|FG001|Overall Study|Physician Decision|0
7324668|NCT00772603|11556647|FG002|Overall Study|Physician Decision|1
7324669|NCT00772603|11556645|FG000|Overall Study|Other|2
7324670|NCT00772603|11556646|FG001|Overall Study|Other|0
7324671|NCT00772603|11556647|FG002|Overall Study|Other|2
7324672|NCT00772629|11556660|FG000|Overall Study|Subject was not vaccinated|1
7324673|NCT00772629|11556661|FG001|Overall Study|Subject was not vaccinated|0
7324674|NCT00772668|11556667|FG000|Overall Study|Physician Decision|3
7324675|NCT00772707|11556672|FG000|Overall Study|Withdrawn|3
7324676|NCT00772889|11556684|FG000|Overall Study|Adverse Event|7
7324677|NCT00772889|11556685|FG001|Overall Study|Adverse Event|4
7324678|NCT00772889|11556686|FG002|Overall Study|Adverse Event|0
7324679|NCT00772889|11556684|FG000|Overall Study|Withdrawal by Subject|9
7324680|NCT00772889|11556685|FG001|Overall Study|Withdrawal by Subject|8
7324681|NCT00772889|11556686|FG002|Overall Study|Withdrawal by Subject|9
7324682|NCT00772889|11556684|FG000|Overall Study|Lost to Follow-up|6
7324683|NCT00772889|11556685|FG001|Overall Study|Lost to Follow-up|6
7531237|NCT02647320|11875329|FG003|Overall Study|Persistent hyperglycemia|1
7324684|NCT00772889|11556686|FG002|Overall Study|Lost to Follow-up|7
7324685|NCT00772928|11556700|FG000|Overall Study|Lost to Follow-up|9
7324686|NCT00772928|11556701|FG001|Overall Study|Lost to Follow-up|6
7324687|NCT00772928|11556700|FG000|Overall Study|Protocol Violation|10
7324688|NCT00772928|11556701|FG001|Overall Study|Protocol Violation|12
7324689|NCT00772928|11556700|FG000|Overall Study|Withdrawal by Subject|25
7324690|NCT00772928|11556701|FG001|Overall Study|Withdrawal by Subject|22
7324691|NCT00772928|11556700|FG000|Overall Study|Did not receive vaccine|0
7324692|NCT00772928|11556701|FG001|Overall Study|Did not receive vaccine|1
7324693|NCT00772941|11556707|FG000|Overall Study|CRFs not available|195
7531238|NCT02647320|11875330|FG004|Overall Study|Persistent hyperglycemia|1
7324694|NCT00772941|11556707|FG000|Overall Study|Study not completed|16
7324695|NCT00772941|11556707|FG000|Overall Study|Missed Visits|374
7324696|NCT00772941|11556707|FG000|Overall Study|Poor Compliance|7
7324697|NCT00772941|11556707|FG000|Overall Study|GPSP Violation|90
7324698|NCT00772954|11556737|FG000|Overall Study|Adverse Event|0
7324699|NCT00772954|11556738|FG001|Overall Study|Adverse Event|0
7324700|NCT00772954|11556739|FG002|Overall Study|Adverse Event|1
7324701|NCT00772967|11556747|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
7324702|NCT00772967|11556748|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
7324703|NCT00772967|11556749|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
7324704|NCT00772967|11556750|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
7324705|NCT00772967|11556751|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
7324706|NCT00772967|11556752|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
7324707|NCT00772967|11556747|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
7324708|NCT00772967|11556748|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
7324709|NCT00772967|11556749|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
7324710|NCT00772967|11556750|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
7324711|NCT00772967|11556751|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
7324712|NCT00772967|11556752|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
7324713|NCT00772967|11556747|FG000|Crossover Treatment 3|Adverse Event|0
7324714|NCT00772967|11556748|FG001|Crossover Treatment 3|Adverse Event|0
7324715|NCT00772967|11556749|FG002|Crossover Treatment 3|Adverse Event|0
7324716|NCT00772967|11556750|FG003|Crossover Treatment 3|Adverse Event|0
7324717|NCT00772967|11556751|FG004|Crossover Treatment 3|Adverse Event|1
7324718|NCT00772967|11556752|FG005|Crossover Treatment 3|Adverse Event|0
7324719|NCT00773097|11556760|FG000|Overall Study|Withdrawal by Subject|1
7324720|NCT00773097|11556760|FG000|Overall Study|Physician Decision|6
7324721|NCT00773136|11556764|FG000|Overall Study|Physician Decision|2
7324722|NCT00773175|11556771|FG000|Overall Study|Adverse Event|2
7324723|NCT00773175|11556772|FG001|Overall Study|Adverse Event|0
7324724|NCT00773175|11556771|FG000|Overall Study|Consent Withdrawn|0
7324725|NCT00773175|11556772|FG001|Overall Study|Consent Withdrawn|2
7324726|NCT00773253|11556785|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
7324727|NCT00773253|11556786|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
7324728|NCT00773279|11556794|FG000|Period 1|Adverse Event|2
7324729|NCT00773279|11556795|FG001|Period 1|Adverse Event|1
7324730|NCT00773279|11556794|FG000|Period 1|Lack of Efficacy|0
7324731|NCT00773279|11556795|FG001|Period 1|Lack of Efficacy|2
7324732|NCT00773279|11556794|FG000|Period 1|Unclassified|5
7324733|NCT00773279|11556795|FG001|Period 1|Unclassified|1
7324734|NCT00773279|11556794|FG000|Period 2|Adverse Event|0
7324735|NCT00773279|11556795|FG001|Period 2|Adverse Event|1
7324736|NCT00773279|11556794|FG000|Period 2|Lack of Efficacy|1
7324737|NCT00773279|11556795|FG001|Period 2|Lack of Efficacy|0
7324738|NCT00773279|11556794|FG000|Period 2|Protocol Violation|0
7417115|NCT01454076|11691025|FG004|Overall Study|Other|2
7417116|NCT01454076|11691021|FG000|Overall Study|Withdrawal by Subject|3
7417117|NCT01454076|11691022|FG001|Overall Study|Withdrawal by Subject|4
7417118|NCT01454076|11691023|FG002|Overall Study|Withdrawal by Subject|2
7417119|NCT01454076|11691024|FG003|Overall Study|Withdrawal by Subject|1
7417120|NCT01454076|11691025|FG004|Overall Study|Withdrawal by Subject|2
7417121|NCT01454076|11691021|FG000|Overall Study|Adverse Event|8
7417122|NCT01454076|11691022|FG001|Overall Study|Adverse Event|2
7417123|NCT01454076|11691023|FG002|Overall Study|Adverse Event|7
7417124|NCT01454076|11691024|FG003|Overall Study|Adverse Event|0
7417125|NCT01454076|11691025|FG004|Overall Study|Adverse Event|2
7417126|NCT01454102|11691062|FG000|Overall Study|Continuing in the treatment period|0
7417127|NCT01454102|11691063|FG001|Overall Study|Continuing in the treatment period|0
7417128|NCT01454102|11691064|FG002|Overall Study|Continuing in the treatment period|0
7417129|NCT01454102|11691065|FG003|Overall Study|Continuing in the treatment period|0
7417130|NCT01454102|11691066|FG004|Overall Study|Continuing in the treatment period|3
7417131|NCT01454102|11691067|FG005|Overall Study|Continuing in the treatment period|3
7417132|NCT01454102|11691068|FG006|Overall Study|Continuing in the treatment period|2
7417133|NCT01454102|11691069|FG007|Overall Study|Continuing in the treatment period|0
7417134|NCT01454102|11691070|FG008|Overall Study|Continuing in the treatment period|1
7417135|NCT01454102|11691071|FG009|Overall Study|Continuing in the treatment period|0
7417136|NCT01454102|11691072|FG010|Overall Study|Continuing in the treatment period|0
7417137|NCT01454102|11691073|FG011|Overall Study|Continuing in the treatment period|4
7417138|NCT01454102|11691074|FG012|Overall Study|Continuing in the treatment period|7
7417139|NCT01454102|11691075|FG013|Overall Study|Continuing in the treatment period|4
7417140|NCT01454102|11691076|FG014|Overall Study|Continuing in the treatment period|3
7417141|NCT01454102|11691077|FG015|Overall Study|Continuing in the treatment period|1
7417142|NCT01454284|11691120|FG000|Overall Study|Adverse Event|20
7417143|NCT01454284|11691121|FG001|Overall Study|Adverse Event|7
7417144|NCT01454284|11691120|FG000|Overall Study|Death|0
7417145|NCT01454284|11691121|FG001|Overall Study|Death|3
7417146|NCT01454284|11691120|FG000|Overall Study|Lost to Follow-up|13
7417147|NCT01454284|11691121|FG001|Overall Study|Lost to Follow-up|8
7417148|NCT01454284|11691120|FG000|Overall Study|Protocol Violation|9
7417149|NCT01454284|11691121|FG001|Overall Study|Protocol Violation|6
7417150|NCT01454284|11691120|FG000|Overall Study|Withdrawal by Subject|58
7417151|NCT01454284|11691121|FG001|Overall Study|Withdrawal by Subject|36
7417152|NCT01454284|11691120|FG000|Overall Study|Physician Decision|16
7417153|NCT01454284|11691121|FG001|Overall Study|Physician Decision|11
7417154|NCT01454284|11691120|FG000|Overall Study|Sponsor Decision|0
7417155|NCT01454284|11691121|FG001|Overall Study|Sponsor Decision|2
7417156|NCT01454401|11691138|FG000|Overall Study|Death|1
7417157|NCT01454401|11691138|FG000|Overall Study|hospitalised|1
7417158|NCT01454401|11691138|FG000|Overall Study|osteomyelitis|2
7417159|NCT01454401|11691138|FG000|Overall Study|non-adherence|1
7324739|NCT00773279|11556795|FG001|Period 2|Protocol Violation|3
7324740|NCT00773279|11556794|FG000|Period 2|Unclassified|2
7324741|NCT00773279|11556795|FG001|Period 2|Unclassified|2
7531239|NCT02647320|11875326|FG000|Overall Study|Study terminated by sponsor|1
7531240|NCT02647320|11875327|FG001|Overall Study|Study terminated by sponsor|1
7324742|NCT00773292|11556802|FG000|Treatment 48 Weeks|Adverse Event|1
7324743|NCT00773292|11556802|FG000|Treatment 48 Weeks|Lack of Efficacy|1
7324744|NCT00773383|11556815|FG000|Overall Study|Adverse Event|4
7324745|NCT00773383|11556815|FG000|Overall Study|Death|1
7324746|NCT00773383|11556815|FG000|Overall Study|Progression of Disease|23
7324747|NCT00773383|11556815|FG000|Overall Study|Other|2
7324748|NCT00773383|11556815|FG000|Overall Study|No study dose received|1
7384861|NCT01197534|11642298|FG000|Overall Study|Not reported|16
7384862|NCT01197534|11642299|FG001|Overall Study|Not reported|10
7384863|NCT01197534|11642300|FG002|Overall Study|Not reported|16
7384864|NCT01197534|11642298|FG000|Overall Study|Enrolment in long term extension|57
7384865|NCT01197534|11642299|FG001|Overall Study|Enrolment in long term extension|66
7384866|NCT01197534|11642300|FG002|Overall Study|Enrolment in long term extension|119
7384867|NCT01197534|11642298|FG000|Overall Study|Severe non-compliance to protocol|3
7384868|NCT01197534|11642299|FG001|Overall Study|Severe non-compliance to protocol|4
7384869|NCT01197534|11642300|FG002|Overall Study|Severe non-compliance to protocol|1
7384870|NCT01197534|11642298|FG000|Overall Study|Lack of therapeutic response|9
7384871|NCT01197534|11642299|FG001|Overall Study|Lack of therapeutic response|4
7384872|NCT01197534|11642300|FG002|Overall Study|Lack of therapeutic response|9
7384873|NCT01197534|11642298|FG000|Overall Study|Dev. of study specific discont. criteria|13
7384874|NCT01197534|11642299|FG001|Overall Study|Dev. of study specific discont. criteria|6
7384875|NCT01197534|11642300|FG002|Overall Study|Dev. of study specific discont. criteria|2
7384876|NCT01197534|11642298|FG000|Overall Study|Lost to Follow-up|1
7384877|NCT01197534|11642299|FG001|Overall Study|Lost to Follow-up|4
7384878|NCT01197534|11642300|FG002|Overall Study|Lost to Follow-up|2
7384879|NCT01197534|11642298|FG000|Overall Study|Adverse Event|35
7384880|NCT01197534|11642299|FG001|Overall Study|Adverse Event|36
7384881|NCT01197534|11642300|FG002|Overall Study|Adverse Event|24
7384882|NCT01197560|11642317|FG000|Overall Study|Adverse Event|6
7384883|NCT01197560|11642318|FG001|Overall Study|Adverse Event|8
7384884|NCT01197560|11642317|FG000|Overall Study|Death|3
7384885|NCT01197560|11642318|FG001|Overall Study|Death|5
7384886|NCT01197560|11642317|FG000|Overall Study|Withdrawal by Subject|1
7384887|NCT01197560|11642318|FG001|Overall Study|Withdrawal by Subject|1
7384888|NCT01197560|11642317|FG000|Overall Study|Disease progression|40
7384889|NCT01197560|11642318|FG001|Overall Study|Disease progression|35
7384890|NCT01197560|11642317|FG000|Overall Study|Miscellaneous|4
7384891|NCT01197560|11642318|FG001|Overall Study|Miscellaneous|3
7384892|NCT01197560|11642317|FG000|Overall Study|Missing|0
7384893|NCT01197560|11642318|FG001|Overall Study|Missing|1
7384894|NCT01197755|11642352|FG000|Overall Study|Adverse Event|8
7384895|NCT01197755|11642353|FG001|Overall Study|Adverse Event|10
7384896|NCT01197755|11642354|FG002|Overall Study|Adverse Event|10
7384897|NCT01197755|11642352|FG000|Overall Study|Study-specific discontinuation criteria|2
7384898|NCT01197755|11642353|FG001|Overall Study|Study-specific discontinuation criteria|1
7384899|NCT01197755|11642354|FG002|Overall Study|Study-specific discontinuation criteria|0
7384900|NCT01197755|11642352|FG000|Overall Study|Entered the long-term extension study|18
7384901|NCT01197755|11642353|FG001|Overall Study|Entered the long-term extension study|21
7384902|NCT01197755|11642354|FG002|Overall Study|Entered the long-term extension study|35
7384903|NCT01197755|11642352|FG000|Overall Study|Lack of therapeutic response|0
7384904|NCT01197755|11642353|FG001|Overall Study|Lack of therapeutic response|7
7384905|NCT01197755|11642354|FG002|Overall Study|Lack of therapeutic response|4
7384906|NCT01197755|11642352|FG000|Overall Study|Severe non-compliance to the protocol|2
7384907|NCT01197755|11642353|FG001|Overall Study|Severe non-compliance to the protocol|1
7384908|NCT01197755|11642354|FG002|Overall Study|Severe non-compliance to the protocol|2
7384909|NCT01197755|11642352|FG000|Overall Study|Withdrawal by Subject|1
7384910|NCT01197755|11642353|FG001|Overall Study|Withdrawal by Subject|0
7384911|NCT01197755|11642354|FG002|Overall Study|Withdrawal by Subject|0
7384912|NCT01197755|11642352|FG000|Overall Study|Lost to Follow-up|0
7384913|NCT01197755|11642353|FG001|Overall Study|Lost to Follow-up|0
7384914|NCT01197755|11642354|FG002|Overall Study|Lost to Follow-up|1
7384915|NCT01197755|11642352|FG000|Overall Study|eg, change in circumstances|7
7384916|NCT01197755|11642353|FG001|Overall Study|eg, change in circumstances|3
7384917|NCT01197755|11642354|FG002|Overall Study|eg, change in circumstances|2
7384918|NCT01197794|11642371|FG000|Overall Study|Adverse Event|3
7384919|NCT01197794|11642372|FG001|Overall Study|Adverse Event|2
7384920|NCT01197794|11642373|FG002|Overall Study|Adverse Event|4
7384921|NCT01197794|11642374|FG003|Overall Study|Adverse Event|4
7384922|NCT01197794|11642375|FG004|Overall Study|Adverse Event|4
7384923|NCT01197794|11642376|FG005|Overall Study|Adverse Event|2
7384924|NCT01197794|11642377|FG006|Overall Study|Adverse Event|3
7384925|NCT01197794|11642371|FG000|Overall Study|Protocol Violation|0
7417160|NCT01454531|11691167|FG000|Overall Study|Adverse Event|14
7531241|NCT02647320|11875328|FG002|Overall Study|Study terminated by sponsor|1
7384926|NCT01197794|11642372|FG001|Overall Study|Protocol Violation|0
7384927|NCT01197794|11642373|FG002|Overall Study|Protocol Violation|0
7384928|NCT01197794|11642374|FG003|Overall Study|Protocol Violation|0
7324749|NCT00773461|11556838|FG000|Overall Study|Adverse Event|1
7324750|NCT00773461|11556839|FG001|Overall Study|Adverse Event|3
7324751|NCT00773461|11556838|FG000|Overall Study|Withdrawal by Subject|4
7324752|NCT00773461|11556839|FG001|Overall Study|Withdrawal by Subject|1
7324753|NCT00773513|11556852|FG000|Overall Study|Renal Transplant|254
7324754|NCT00773513|11556853|FG001|Overall Study|Renal Transplant|263
7324755|NCT00773513|11556852|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
7324756|NCT00773513|11556853|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
7324757|NCT00773513|11556852|FG000|Overall Study|Withdrew Consent|68
7324758|NCT00773513|11556853|FG001|Overall Study|Withdrew Consent|69
7324759|NCT00773513|11556852|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
7324760|NCT00773513|11556853|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
7324761|NCT00773513|11556852|FG000|Overall Study|Failure to Return|22
7324762|NCT00773513|11556853|FG001|Overall Study|Failure to Return|8
7324763|NCT00773513|11556852|FG000|Overall Study|Insufficient Therapeutic Response|1
7324764|NCT00773513|11556853|FG001|Overall Study|Insufficient Therapeutic Response|18
7324765|NCT00773513|11556852|FG000|Overall Study|Reason Not Specified|159
7324766|NCT00773513|11556853|FG001|Overall Study|Reason Not Specified|126
7324767|NCT00773513|11556852|FG000|Overall Study|Death|531
7324768|NCT00773513|11556853|FG001|Overall Study|Death|545
7324769|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
7324770|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
7324771|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
7324772|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
7324773|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7324774|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
7324775|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
7324776|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
7324777|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7324778|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
7324779|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7324780|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
7324781|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7324782|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
7324783|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
7324784|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
7324785|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7324786|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
7324787|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
7324788|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
7324789|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
7324790|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
7324791|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
7324792|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
7324793|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
7324794|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7324795|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7324796|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
7324797|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7324798|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
7324799|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
7324800|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
7324801|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
7324802|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7324803|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7324804|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
7324805|NCT00773734|11556867|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
7324806|NCT00773734|11556868|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
7324807|NCT00773734|11556869|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
7324808|NCT00773734|11556870|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
7324809|NCT00773734|11556871|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
7324810|NCT00773734|11556872|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
7324811|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7324812|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
7324813|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7324814|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
7324815|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
7324816|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
7324817|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7324818|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7324819|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
7324820|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
7324821|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7324822|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
7324823|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7324824|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7324825|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
7324826|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7324827|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
7324828|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
7324829|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7324830|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7324831|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
7324832|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7324833|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7324834|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
7324835|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7324836|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7324837|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7324838|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7324839|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
7324840|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
7324841|NCT00773734|11556867|FG000|Core: Active Treatment Phase Week 16-24|Other|0
7324842|NCT00773734|11556868|FG001|Core: Active Treatment Phase Week 16-24|Other|1
7324843|NCT00773734|11556869|FG002|Core: Active Treatment Phase Week 16-24|Other|0
7324844|NCT00773734|11556870|FG003|Core: Active Treatment Phase Week 16-24|Other|0
7324845|NCT00773734|11556871|FG004|Core: Active Treatment Phase Week 16-24|Other|0
7324846|NCT00773734|11556872|FG005|Core: Active Treatment Phase Week 16-24|Other|0
7324847|NCT00773734|11556867|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
7324848|NCT00773734|11556868|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
7324849|NCT00773734|11556869|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
7324850|NCT00773734|11556870|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
7324851|NCT00773734|11556871|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
7324852|NCT00773734|11556872|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
7324853|NCT00773734|11556867|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
7324854|NCT00773734|11556868|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
7324855|NCT00773734|11556869|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
7324856|NCT00773734|11556870|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
7324857|NCT00773734|11556871|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
7324858|NCT00773734|11556872|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
7324859|NCT00773734|11556867|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
7324860|NCT00773734|11556868|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7324861|NCT00773734|11556869|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
7324862|NCT00773734|11556870|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7324863|NCT00773734|11556871|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
7324864|NCT00773734|11556872|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
7324865|NCT00773734|11556867|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7324866|NCT00773734|11556868|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
7324867|NCT00773734|11556869|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
7324868|NCT00773734|11556870|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
7324869|NCT00773734|11556871|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
7324870|NCT00773734|11556872|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
7324871|NCT00773734|11556867|FG000|Extension: Active Treatment Week 24-52|Other|0
7324872|NCT00773734|11556868|FG001|Extension: Active Treatment Week 24-52|Other|0
7324873|NCT00773734|11556869|FG002|Extension: Active Treatment Week 24-52|Other|1
7324874|NCT00773734|11556870|FG003|Extension: Active Treatment Week 24-52|Other|2
7324875|NCT00773734|11556871|FG004|Extension: Active Treatment Week 24-52|Other|0
7324876|NCT00773734|11556872|FG005|Extension: Active Treatment Week 24-52|Other|1
7324877|NCT00773734|11556867|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
7324878|NCT00773734|11556868|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
7324879|NCT00773734|11556869|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
7324880|NCT00773734|11556870|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
7324881|NCT00773734|11556871|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
7324882|NCT00773734|11556872|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
7324883|NCT00773734|11556867|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7324884|NCT00773734|11556868|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7324885|NCT00773734|11556869|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
7324886|NCT00773734|11556870|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
7324887|NCT00773734|11556871|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7324888|NCT00773734|11556872|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
7324889|NCT00773734|11556867|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7324890|NCT00773734|11556868|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7324891|NCT00773734|11556869|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
7324892|NCT00773734|11556870|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
7324893|NCT00773734|11556871|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7324894|NCT00773734|11556872|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
7324895|NCT00773734|11556867|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7324896|NCT00773734|11556868|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7324897|NCT00773734|11556869|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7324898|NCT00773734|11556870|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
7324899|NCT00773734|11556871|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7324900|NCT00773734|11556872|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
7324901|NCT00773747|11556931|FG000|Overall Study|Lack of Efficacy|112
7324902|NCT00773747|11556932|FG001|Overall Study|Lack of Efficacy|144
7324903|NCT00773747|11556931|FG000|Overall Study|Physician Decision|26
7324904|NCT00773747|11556932|FG001|Overall Study|Physician Decision|18
7324905|NCT00773747|11556931|FG000|Overall Study|Lost to Follow-up|0
7324906|NCT00773747|11556932|FG001|Overall Study|Lost to Follow-up|1
7324907|NCT00773747|11556931|FG000|Overall Study|Protocol Violation|2
7324908|NCT00773747|11556932|FG001|Overall Study|Protocol Violation|2
7324909|NCT00773747|11556931|FG000|Overall Study|Withdrawal by Subject|89
7324910|NCT00773747|11556932|FG001|Overall Study|Withdrawal by Subject|61
7324911|NCT00773747|11556931|FG000|Overall Study|Adverse Event|61
7324912|NCT00773747|11556932|FG001|Overall Study|Adverse Event|62
7324913|NCT00773747|11556931|FG000|Overall Study|Death|5
7324914|NCT00773747|11556932|FG001|Overall Study|Death|8
7324915|NCT00773747|11556931|FG000|Overall Study|Not Treated|2
7324916|NCT00773747|11556932|FG001|Overall Study|Not Treated|0
7324917|NCT00773838|11556946|FG000|Overall Study|Adverse Event|29
7324918|NCT00773838|11556946|FG000|Overall Study|Lost to Follow-up|1
7324919|NCT00773838|11556946|FG000|Overall Study|Physician Decision|8
7324920|NCT00773838|11556946|FG000|Overall Study|Progressive Disease|82
7324921|NCT00773838|11556946|FG000|Overall Study|Protocol Violation|2
7417161|NCT01454531|11691167|FG000|Overall Study|Withdrawal by Subject|5
7417162|NCT01454531|11691167|FG000|Overall Study|Lost to Follow-up|1
7417163|NCT01454531|11691167|FG000|Overall Study|Physician Decision|1
7417164|NCT01454531|11691167|FG000|Overall Study|Delay in IMP administration|1
7417165|NCT01454531|11691167|FG000|Overall Study|Other|1
7417166|NCT01454570|11691171|FG000|Overall Study|Withdrawal by Subject|2
7417167|NCT01454570|11691171|FG000|Overall Study|Screen Failure|7
7417168|NCT01454583|11691178|FG000|1st Year|Lost to Follow-up|1057
7417169|NCT01454583|11691179|FG001|1st Year|Lost to Follow-up|318
7417170|NCT01454583|11691180|FG002|1st Year|Lost to Follow-up|180
7417171|NCT01454583|11691178|FG000|2nd Year|Lost to Follow-up|3965
7417172|NCT01454583|11691179|FG001|2nd Year|Lost to Follow-up|1049
7417173|NCT01454583|11691180|FG002|2nd Year|Lost to Follow-up|737
7531242|NCT02647320|11875329|FG003|Overall Study|Study terminated by sponsor|1
7417174|NCT01454583|11691178|FG000|3rd Year|Lost to Follow-up|1959
7417175|NCT01454583|11691179|FG001|3rd Year|Lost to Follow-up|512
7417176|NCT01454583|11691180|FG002|3rd Year|Lost to Follow-up|297
7417177|NCT01454596|11691200|FG000|Overall Study|Death|0
7417178|NCT01454596|11691201|FG001|Overall Study|Death|0
7417179|NCT01454596|11691202|FG002|Overall Study|Death|0
7417180|NCT01454596|11691203|FG003|Overall Study|Death|0
7417181|NCT01454596|11691204|FG004|Overall Study|Death|0
7417182|NCT01454596|11691205|FG005|Overall Study|Death|0
7417183|NCT01454596|11691206|FG006|Overall Study|Death|0
7417184|NCT01454596|11691207|FG007|Overall Study|Death|0
7417185|NCT01454596|11691208|FG008|Overall Study|Death|0
7417186|NCT01454596|11691209|FG009|Overall Study|Death|1
7417187|NCT01454596|11691210|FG010|Overall Study|Death|1
7417188|NCT01454596|11691211|FG011|Overall Study|Death|0
7417189|NCT01454726|11691239|FG000|Overall Study|Withdrawal by Subject|0
7417190|NCT01454726|11691240|FG001|Overall Study|Withdrawal by Subject|1
7417191|NCT01454739|11691248|FG000|Overall Study|Protocol Violation|2
7417192|NCT01454739|11691249|FG001|Overall Study|Protocol Violation|3
7417193|NCT01454739|11691248|FG000|Overall Study|Withdrawal by Subject|2
7417194|NCT01454739|11691249|FG001|Overall Study|Withdrawal by Subject|6
7417195|NCT01454739|11691248|FG000|Overall Study|Other|3
7417196|NCT01454739|11691249|FG001|Overall Study|Other|5
7417197|NCT01454739|11691248|FG000|Overall Study|Physician Decision|0
7417198|NCT01454739|11691249|FG001|Overall Study|Physician Decision|5
7417199|NCT01454739|11691248|FG000|Overall Study|Lost to Follow-up|0
7417200|NCT01454739|11691249|FG001|Overall Study|Lost to Follow-up|1
7417201|NCT01454739|11691248|FG000|Overall Study|Adverse Event|0
7417202|NCT01454739|11691249|FG001|Overall Study|Adverse Event|1
7531243|NCT02647320|11875330|FG004|Overall Study|Study terminated by sponsor|2
7324922|NCT00773838|11556946|FG000|Overall Study|Withdrawal by Subject|21
7324923|NCT00773968|11556954|FG000|Overall Study|Adverse Event|2
7324924|NCT00773968|11556954|FG000|Overall Study|Death|1
7324925|NCT00773968|11556954|FG000|Overall Study|Failure to Return|2
7324926|NCT00773968|11556954|FG000|Overall Study|Lack of Efficacy|3
7324927|NCT00773968|11556954|FG000|Overall Study|Protocol Violation|1
7417203|NCT01454778|11691262|FG000|Overall Study|Lost to Follow-up|2
7417204|NCT01454778|11691262|FG000|Overall Study|Death|1
7324928|NCT00773968|11556954|FG000|Overall Study|Withdrawal by Subject|11
7417205|NCT01454830|11691279|FG000|Overall Study|Withdrawal by Subject|4
7324929|NCT00773968|11556954|FG000|Overall Study|Screen Failure|17
7417206|NCT01454830|11691280|FG001|Overall Study|Withdrawal by Subject|4
7324930|NCT00773968|11556954|FG000|Overall Study|Other|8
7324931|NCT00774046|11556958|FG000|Screening|Not eligible|56
7324932|NCT00774046|11556958|FG000|Enrollment|Desired other therapy/refused|28
7324933|NCT00774046|11556958|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
7324934|NCT00774397|11557008|FG000|Overall Study|Adverse Event|1
7324935|NCT00774397|11557009|FG001|Overall Study|Adverse Event|3
7324936|NCT00774397|11557010|FG002|Overall Study|Adverse Event|16
7324937|NCT00774397|11557011|FG003|Overall Study|Adverse Event|8
7324938|NCT00774397|11557012|FG004|Overall Study|Adverse Event|8
7324939|NCT00774397|11557013|FG005|Overall Study|Adverse Event|3
7324940|NCT00774397|11557014|FG006|Overall Study|Adverse Event|16
7324941|NCT00774397|11557008|FG000|Overall Study|Lack of Efficacy|11
7324942|NCT00774397|11557009|FG001|Overall Study|Lack of Efficacy|4
7324943|NCT00774397|11557010|FG002|Overall Study|Lack of Efficacy|5
7324944|NCT00774397|11557011|FG003|Overall Study|Lack of Efficacy|3
7324945|NCT00774397|11557012|FG004|Overall Study|Lack of Efficacy|27
7324946|NCT00774397|11557013|FG005|Overall Study|Lack of Efficacy|15
7324947|NCT00774397|11557014|FG006|Overall Study|Lack of Efficacy|9
7324948|NCT00774397|11557008|FG000|Overall Study|Protocol Violation|0
7324949|NCT00774397|11557009|FG001|Overall Study|Protocol Violation|1
7324950|NCT00774397|11557010|FG002|Overall Study|Protocol Violation|3
7324951|NCT00774397|11557011|FG003|Overall Study|Protocol Violation|1
7324952|NCT00774397|11557012|FG004|Overall Study|Protocol Violation|2
7324953|NCT00774397|11557013|FG005|Overall Study|Protocol Violation|1
7324954|NCT00774397|11557014|FG006|Overall Study|Protocol Violation|0
7324955|NCT00774397|11557008|FG000|Overall Study|Lost to Follow-up|0
7324956|NCT00774397|11557009|FG001|Overall Study|Lost to Follow-up|1
7324957|NCT00774397|11557010|FG002|Overall Study|Lost to Follow-up|1
7324958|NCT00774397|11557011|FG003|Overall Study|Lost to Follow-up|1
7324959|NCT00774397|11557012|FG004|Overall Study|Lost to Follow-up|0
7324960|NCT00774397|11557013|FG005|Overall Study|Lost to Follow-up|1
7324961|NCT00774397|11557014|FG006|Overall Study|Lost to Follow-up|0
7324962|NCT00774397|11557008|FG000|Overall Study|Refused to continue trial medication|1
7324963|NCT00774397|11557009|FG001|Overall Study|Refused to continue trial medication|3
7324964|NCT00774397|11557010|FG002|Overall Study|Refused to continue trial medication|2
7324965|NCT00774397|11557011|FG003|Overall Study|Refused to continue trial medication|2
7324966|NCT00774397|11557012|FG004|Overall Study|Refused to continue trial medication|6
7324967|NCT00774397|11557013|FG005|Overall Study|Refused to continue trial medication|2
7324968|NCT00774397|11557014|FG006|Overall Study|Refused to continue trial medication|3
7324969|NCT00774397|11557008|FG000|Overall Study|Not treated|0
7324970|NCT00774397|11557009|FG001|Overall Study|Not treated|0
7324971|NCT00774397|11557010|FG002|Overall Study|Not treated|0
7324972|NCT00774397|11557011|FG003|Overall Study|Not treated|0
7324973|NCT00774397|11557012|FG004|Overall Study|Not treated|1
7324974|NCT00774397|11557013|FG005|Overall Study|Not treated|0
7324975|NCT00774397|11557014|FG006|Overall Study|Not treated|1
7324976|NCT00774397|11557008|FG000|Overall Study|Other than those stated above|1
7324977|NCT00774397|11557009|FG001|Overall Study|Other than those stated above|1
7324978|NCT00774397|11557010|FG002|Overall Study|Other than those stated above|3
7324979|NCT00774397|11557011|FG003|Overall Study|Other than those stated above|2
7324980|NCT00774397|11557012|FG004|Overall Study|Other than those stated above|2
7324981|NCT00774397|11557013|FG005|Overall Study|Other than those stated above|0
7324982|NCT00774397|11557014|FG006|Overall Study|Other than those stated above|1
7324983|NCT00774566|11557039|FG000|Overall Study|Protocol Violation|18
7324984|NCT00774566|11557040|FG001|Overall Study|Protocol Violation|15
7324985|NCT00774748|11557055|FG000|Overall Study|Lost to Follow-up|3
7324986|NCT00774787|11557063|FG000|Overall Study|Lost to Follow-up|1
7324987|NCT00774800|11557067|FG000|Intervention 4|Withdrawal by Subject|1
7324988|NCT00774852|11557079|FG000|Overall Study|Adverse Event|9
7324989|NCT00774852|11557080|FG001|Overall Study|Adverse Event|6
7324990|NCT00774852|11557079|FG000|Overall Study|Death|2
7324991|NCT00774852|11557080|FG001|Overall Study|Death|1
7324992|NCT00774852|11557079|FG000|Overall Study|Lack of Efficacy|3
7324993|NCT00774852|11557080|FG001|Overall Study|Lack of Efficacy|7
7324994|NCT00774852|11557079|FG000|Overall Study|Lost to Follow-up|9
7324995|NCT00774852|11557080|FG001|Overall Study|Lost to Follow-up|5
7324996|NCT00774852|11557079|FG000|Overall Study|Physician Decision|2
7324997|NCT00774852|11557080|FG001|Overall Study|Physician Decision|6
7324998|NCT00774852|11557079|FG000|Overall Study|Pregnancy|1
7324999|NCT00774852|11557080|FG001|Overall Study|Pregnancy|2
7325000|NCT00774852|11557079|FG000|Overall Study|Withdrawal by Subject|2
7325001|NCT00774852|11557080|FG001|Overall Study|Withdrawal by Subject|2
7325002|NCT00774852|11557079|FG000|Overall Study|Non-responder|15
7325003|NCT00774852|11557080|FG001|Overall Study|Non-responder|11
7325004|NCT00774852|11557079|FG000|Overall Study|Subject non-compliance|0
7325005|NCT00774852|11557080|FG001|Overall Study|Subject non-compliance|1
7325006|NCT00774852|11557079|FG000|Overall Study|Protocol Violation|1
7325007|NCT00774852|11557080|FG001|Overall Study|Protocol Violation|0
7325008|NCT00774852|11557079|FG000|Overall Study|Subject received prohibited medication|1
7325009|NCT00774852|11557080|FG001|Overall Study|Subject received prohibited medication|0
7325010|NCT00774930|11557098|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
7325011|NCT00774930|11557099|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
7325012|NCT00774930|11557098|FG000|DB Phase|Adverse Event|1
7325013|NCT00774930|11557099|FG001|DB Phase|Adverse Event|2
7325014|NCT00774930|11557098|FG000|DB Phase|Subject Decision|1
7325015|NCT00774930|11557099|FG001|DB Phase|Subject Decision|5
7325016|NCT00774930|11557098|FG000|DB Phase|Sponsor Decision|0
7325017|NCT00774930|11557099|FG001|DB Phase|Sponsor Decision|1
7325018|NCT00774930|11557098|FG000|DB Phase|Disease Progression|1
7325019|NCT00774930|11557099|FG001|DB Phase|Disease Progression|1
7325020|NCT00774930|11557098|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
7325021|NCT00774930|11557099|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
7325022|NCT00774930|11557098|FG000|IOL Phase|Adverse Event|1
7325023|NCT00774930|11557099|FG001|IOL Phase|Adverse Event|1
7325024|NCT00774930|11557098|FG000|IOL Phase|Subject Decision|4
7325025|NCT00774930|11557099|FG001|IOL Phase|Subject Decision|3
7325026|NCT00774930|11557098|FG000|IOL Phase|Physician Decision|3
7325027|NCT00774930|11557099|FG001|IOL Phase|Physician Decision|2
7325028|NCT00774930|11557098|FG000|IOL Phase|Sponsor Decision|1
7325029|NCT00774930|11557099|FG001|IOL Phase|Sponsor Decision|0
7325030|NCT00774930|11557098|FG000|IOL Phase|Disease Progression|2
7325031|NCT00774930|11557099|FG001|IOL Phase|Disease Progression|1
7325032|NCT00774930|11557098|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
7325033|NCT00774930|11557099|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
7325034|NCT00774930|11557098|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
7325035|NCT00774930|11557099|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
7325036|NCT00774930|11557098|FG000|IOL Phase|Other|1
7325037|NCT00774930|11557099|FG001|IOL Phase|Other|0
7325038|NCT00774930|11557098|FG000|IOL Phase|Brain radiation|0
7325039|NCT00774930|11557099|FG001|IOL Phase|Brain radiation|1
7325040|NCT00774930|11557098|FG000|LTOLE Phase|Adverse Event|7
7325041|NCT00774930|11557099|FG001|LTOLE Phase|Adverse Event|3
7325042|NCT00774930|11557098|FG000|LTOLE Phase|Subject decision|0
7325043|NCT00774930|11557099|FG001|LTOLE Phase|Subject decision|5
7325044|NCT00774930|11557098|FG000|LTOLE Phase|Physician Decision|4
7325045|NCT00774930|11557099|FG001|LTOLE Phase|Physician Decision|1
7325046|NCT00774930|11557098|FG000|LTOLE Phase|Sponsor decision|2
7325047|NCT00774930|11557099|FG001|LTOLE Phase|Sponsor decision|1
7325048|NCT00774930|11557098|FG000|LTOLE Phase|Disease Progression|2
7325049|NCT00774930|11557099|FG001|LTOLE Phase|Disease Progression|5
7325050|NCT00774930|11557098|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
7325051|NCT00774930|11557099|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
7325052|NCT00774930|11557098|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
7325053|NCT00774930|11557099|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
7325054|NCT00774995|11557111|FG000|Overall Study|Protocol Violation|0
7325055|NCT00774995|11557112|FG001|Overall Study|Protocol Violation|0
7325056|NCT00774995|11557113|FG002|Overall Study|Protocol Violation|1
7325057|NCT00774995|11557114|FG003|Overall Study|Protocol Violation|0
7325058|NCT00775021|11557124|FG000|First Intervention|Lost to Follow-up|1
7325059|NCT00775021|11557125|FG001|First Intervention|Lost to Follow-up|0
7325060|NCT00775021|11557124|FG000|Second Intervention|Adverse Event|0
7325061|NCT00775021|11557125|FG001|Second Intervention|Adverse Event|1
7325062|NCT00775138|11557135|FG000|Overall Study|Withdrawal by Subject|0
7325063|NCT00775138|11557136|FG001|Overall Study|Withdrawal by Subject|0
7325064|NCT00775138|11557137|FG002|Overall Study|Withdrawal by Subject|2
7417207|NCT01454830|11691279|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
7417208|NCT01454830|11691280|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
7417209|NCT01454830|11691279|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
7417210|NCT01454830|11691280|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
7417211|NCT01454830|11691279|FG000|Overall Study|Post-allocation Exclude-other treatment|6
7417212|NCT01454830|11691280|FG001|Overall Study|Post-allocation Exclude-other treatment|7
7417213|NCT01454830|11691279|FG000|Overall Study|Withdrawal - no polysomnography|3
7325065|NCT00775138|11557138|FG003|Overall Study|Withdrawal by Subject|2
7325066|NCT00775138|11557135|FG000|Overall Study|Adverse Event|0
7325067|NCT00775138|11557136|FG001|Overall Study|Adverse Event|0
7325068|NCT00775138|11557137|FG002|Overall Study|Adverse Event|1
7325069|NCT00775138|11557138|FG003|Overall Study|Adverse Event|0
7325070|NCT00775203|11557152|FG000|Overall Study|Adverse Event|25
7325071|NCT00775203|11557153|FG001|Overall Study|Adverse Event|6
7325072|NCT00775203|11557152|FG000|Overall Study|Lack of Efficacy|8
7325073|NCT00775203|11557153|FG001|Overall Study|Lack of Efficacy|9
7325074|NCT00775203|11557152|FG000|Overall Study|Withdrawal by Subject|11
7325075|NCT00775203|11557153|FG001|Overall Study|Withdrawal by Subject|9
7325076|NCT00775203|11557152|FG000|Overall Study|Lost to Follow-up|11
7325077|NCT00775203|11557153|FG001|Overall Study|Lost to Follow-up|15
7325078|NCT00775203|11557152|FG000|Overall Study|Administrative reason|2
7325079|NCT00775203|11557153|FG001|Overall Study|Administrative reason|0
7325080|NCT00775203|11557152|FG000|Overall Study|Noncompliance|4
7325081|NCT00775203|11557153|FG001|Overall Study|Noncompliance|2
7325082|NCT00775203|11557152|FG000|Overall Study|Protocol Violation|0
7325083|NCT00775203|11557153|FG001|Overall Study|Protocol Violation|1
7325084|NCT00775203|11557152|FG000|Overall Study|Entered other study|1
7325085|NCT00775203|11557153|FG001|Overall Study|Entered other study|0
7325086|NCT00775203|11557152|FG000|Overall Study|Physician Decision|0
7325087|NCT00775203|11557153|FG001|Overall Study|Physician Decision|1
7325088|NCT00775268|11557170|FG000|Baseline|Drug not synthesize dose|1
7325089|NCT00775268|11557171|FG001|Baseline|Drug not synthesize dose|0
7325090|NCT00775268|11557170|FG000|Baseline|Not treated-ineligible per CT|0
7325091|NCT00775268|11557171|FG001|Baseline|Not treated-ineligible per CT|1
7417214|NCT01454830|11691280|FG001|Overall Study|Withdrawal - no polysomnography|2
7325092|NCT00775268|11557170|FG000|After 2 Cycles|Participant refused to be scanned further|1
7325093|NCT00775268|11557171|FG001|After 2 Cycles|Participant refused to be scanned further|0
7325094|NCT00775268|11557170|FG000|After Completion|Participant missed scan appointment|1
7325095|NCT00775268|11557171|FG001|After Completion|Participant missed scan appointment|0
7325096|NCT00775437|11557196|FG000|Overall Study|Loss of efficacy|2
7325097|NCT00775437|11557196|FG000|Overall Study|Withdrawal by Subject|3
7325098|NCT00775437|11557196|FG000|Overall Study|Lost to Follow-up|1
7325099|NCT00775450|11557205|FG000|Overall Study|Serious Adverse Event|2
7325100|NCT00775450|11557206|FG001|Overall Study|Serious Adverse Event|0
7325101|NCT00775450|11557207|FG002|Overall Study|Serious Adverse Event|0
7325102|NCT00775450|11557208|FG003|Overall Study|Serious Adverse Event|0
7325103|NCT00775450|11557209|FG004|Overall Study|Serious Adverse Event|0
7325104|NCT00775450|11557205|FG000|Overall Study|Protocol Violation|0
7325105|NCT00775450|11557206|FG001|Overall Study|Protocol Violation|0
7325106|NCT00775450|11557207|FG002|Overall Study|Protocol Violation|0
7325107|NCT00775450|11557208|FG003|Overall Study|Protocol Violation|0
7325108|NCT00775450|11557209|FG004|Overall Study|Protocol Violation|1
7325109|NCT00775450|11557205|FG000|Overall Study|Withdrawal by Subject|1
7325110|NCT00775450|11557206|FG001|Overall Study|Withdrawal by Subject|0
7325111|NCT00775450|11557207|FG002|Overall Study|Withdrawal by Subject|0
7325112|NCT00775450|11557208|FG003|Overall Study|Withdrawal by Subject|0
7325113|NCT00775450|11557209|FG004|Overall Study|Withdrawal by Subject|1
7325114|NCT00775463|11557223|FG000|Overall Study|Withdrawal by Subject|0
7325115|NCT00775463|11557224|FG001|Overall Study|Withdrawal by Subject|1
7417215|NCT01454934|11691288|FG000|Overall Study|Clinical progression|28
7417216|NCT01454934|11691289|FG001|Overall Study|Clinical progression|25
7417217|NCT01454934|11691288|FG000|Overall Study|Other|6
7417218|NCT01454934|11691289|FG001|Overall Study|Other|17
7417219|NCT01454934|11691288|FG000|Overall Study|Adverse Event|28
7417220|NCT01454934|11691289|FG001|Overall Study|Adverse Event|24
7417221|NCT01454934|11691288|FG000|Overall Study|Withdrawn consent|2
7417222|NCT01454934|11691289|FG001|Overall Study|Withdrawn consent|5
7417223|NCT01454934|11691288|FG000|Overall Study|Withdrawal by Subject|11
7417224|NCT01454934|11691289|FG001|Overall Study|Withdrawal by Subject|15
7417225|NCT01454934|11691288|FG000|Overall Study|Disease progression|194
7417226|NCT01454934|11691289|FG001|Overall Study|Disease progression|181
7417227|NCT01454934|11691288|FG000|Overall Study|Lost to Follow-up|0
7417228|NCT01454934|11691289|FG001|Overall Study|Lost to Follow-up|1
7417229|NCT01454934|11691288|FG000|Overall Study|Not treated|1
7417230|NCT01454934|11691289|FG001|Overall Study|Not treated|2
7417231|NCT01455012|11691330|FG000|Overall Study|Adverse Event|0
7417232|NCT01455012|11691331|FG001|Overall Study|Adverse Event|2
7417233|NCT01455012|11691330|FG000|Overall Study|Lack of Efficacy|6
7417234|NCT01455012|11691331|FG001|Overall Study|Lack of Efficacy|1
7417235|NCT01455012|11691330|FG000|Overall Study|Withdrawal by Subject|3
7417236|NCT01455012|11691331|FG001|Overall Study|Withdrawal by Subject|1
7417237|NCT01455012|11691330|FG000|Overall Study|Unknown reason|2
7417238|NCT01455012|11691331|FG001|Overall Study|Unknown reason|0
7417239|NCT01455194|11691348|FG000|Overall Study|Screen Failure|20
7417240|NCT01455194|11691349|FG001|Overall Study|Screen Failure|0
7417241|NCT01455194|11691350|FG002|Overall Study|Screen Failure|0
7417242|NCT01455194|11691351|FG003|Overall Study|Screen Failure|0
7417243|NCT01455194|11691348|FG000|Overall Study|Randomisation Failure|90
7417244|NCT01455194|11691349|FG001|Overall Study|Randomisation Failure|0
7417245|NCT01455194|11691350|FG002|Overall Study|Randomisation Failure|0
7417246|NCT01455194|11691351|FG003|Overall Study|Randomisation Failure|0
7417247|NCT01455194|11691348|FG000|Overall Study|Deterioration in asthma|12
7417248|NCT01455194|11691349|FG001|Overall Study|Deterioration in asthma|6
7417249|NCT01455194|11691350|FG002|Overall Study|Deterioration in asthma|14
7417250|NCT01455194|11691351|FG003|Overall Study|Deterioration in asthma|9
7417251|NCT01455194|11691348|FG000|Overall Study|Adverse Event|1
7417252|NCT01455194|11691349|FG001|Overall Study|Adverse Event|1
7417253|NCT01455194|11691350|FG002|Overall Study|Adverse Event|1
7417254|NCT01455194|11691351|FG003|Overall Study|Adverse Event|3
7417255|NCT01455194|11691348|FG000|Overall Study|Withdrawal by Subject|21
7417256|NCT01455194|11691349|FG001|Overall Study|Withdrawal by Subject|16
7417257|NCT01455194|11691350|FG002|Overall Study|Withdrawal by Subject|12
7417258|NCT01455194|11691351|FG003|Overall Study|Withdrawal by Subject|9
7417259|NCT01455194|11691348|FG000|Overall Study|Lost to Follow-up|2
7417260|NCT01455194|11691349|FG001|Overall Study|Lost to Follow-up|0
7417261|NCT01455194|11691350|FG002|Overall Study|Lost to Follow-up|1
7417262|NCT01455194|11691351|FG003|Overall Study|Lost to Follow-up|1
7417263|NCT01455194|11691348|FG000|Overall Study|Pregnancy|0
7417264|NCT01455194|11691349|FG001|Overall Study|Pregnancy|1
7325116|NCT00775463|11557223|FG000|Overall Study|Adverse Event|7
7325117|NCT00775463|11557224|FG001|Overall Study|Adverse Event|9
7325118|NCT00775463|11557223|FG000|Overall Study|Protocol Violation|2
7325119|NCT00775463|11557224|FG001|Overall Study|Protocol Violation|2
7417265|NCT01455194|11691350|FG002|Overall Study|Pregnancy|1
7417266|NCT01455194|11691351|FG003|Overall Study|Pregnancy|0
7417267|NCT01455194|11691348|FG000|Overall Study|Discontinuation criterion fulfilled|3
7417268|NCT01455194|11691349|FG001|Overall Study|Discontinuation criterion fulfilled|2
7417269|NCT01455194|11691350|FG002|Overall Study|Discontinuation criterion fulfilled|0
7417270|NCT01455194|11691351|FG003|Overall Study|Discontinuation criterion fulfilled|2
7325120|NCT00775463|11557223|FG000|Overall Study|Lost to Follow-up|1
7325121|NCT00775463|11557224|FG001|Overall Study|Lost to Follow-up|0
7325122|NCT00775463|11557223|FG000|Overall Study|Lack of Efficacy|1
7325123|NCT00775463|11557224|FG001|Overall Study|Lack of Efficacy|1
7325124|NCT00775528|11557237|FG000|Overall Study|Protocol Violation|1
7325125|NCT00775593|11557241|FG000|Overall Study|Unmet eligibility criteria|6
7325126|NCT00775593|11557241|FG000|Overall Study|Death|1
7325127|NCT00775606|11557247|FG000|Overall Study|Study sponsor terminated funding|3
7325128|NCT00775606|11557248|FG001|Overall Study|Study sponsor terminated funding|0
7325129|NCT00775983|11557309|FG000|Overall Study|Protocol Violation|1
7325130|NCT00775983|11557310|FG001|Overall Study|Protocol Violation|2
7325131|NCT00776009|11557322|FG000|Period 1: First Intervention|Withdrawal by Subject|0
7325132|NCT00776009|11557323|FG001|Period 1: First Intervention|Withdrawal by Subject|0
7325133|NCT00776009|11557324|FG002|Period 1: First Intervention|Withdrawal by Subject|1
7325134|NCT00776009|11557325|FG003|Period 1: First Intervention|Withdrawal by Subject|0
7325135|NCT00776009|11557326|FG004|Period 1: First Intervention|Withdrawal by Subject|1
7325136|NCT00776009|11557327|FG005|Period 1: First Intervention|Withdrawal by Subject|0
7325137|NCT00776009|11557322|FG000|Period 1: First Intervention|Protocol Violation|0
7325138|NCT00776009|11557323|FG001|Period 1: First Intervention|Protocol Violation|1
7325139|NCT00776009|11557324|FG002|Period 1: First Intervention|Protocol Violation|0
7325140|NCT00776009|11557325|FG003|Period 1: First Intervention|Protocol Violation|0
7325141|NCT00776009|11557326|FG004|Period 1: First Intervention|Protocol Violation|1
7417271|NCT01455194|11691348|FG000|Overall Study|Miscellaneous|4
7417272|NCT01455194|11691349|FG001|Overall Study|Miscellaneous|5
7417273|NCT01455194|11691350|FG002|Overall Study|Miscellaneous|1
7417274|NCT01455194|11691351|FG003|Overall Study|Miscellaneous|4
7417275|NCT01455220|11691364|FG000|Overall Study|screen fail|30
7417276|NCT01455415|11691373|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
7417277|NCT01455415|11691374|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
7417278|NCT01455415|11691373|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
7417279|NCT01455415|11691374|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
7417280|NCT01455415|11691373|FG000|Period 1|Drug Error not Associated to AE|0
7417281|NCT01455415|11691374|FG001|Period 1|Drug Error not Associated to AE|1
7417282|NCT01455415|11691373|FG000|Period 1|AE Not Related to Study Drug|2
7417283|NCT01455415|11691374|FG001|Period 1|AE Not Related to Study Drug|6
7417284|NCT01455415|11691373|FG000|Period 1|Withdrawal by Subject|4
7417285|NCT01455415|11691374|FG001|Period 1|Withdrawal by Subject|5
7417286|NCT01455415|11691373|FG000|Period 1|Unspecified Reason|1
7417287|NCT01455415|11691374|FG001|Period 1|Unspecified Reason|1
7417288|NCT01455415|11691373|FG000|Period 1|Protocol Violation|0
7417289|NCT01455415|11691374|FG001|Period 1|Protocol Violation|2
7417290|NCT01455415|11691373|FG000|Washout|AE Related to Study Drug|2
7417291|NCT01455415|11691374|FG001|Washout|AE Related to Study Drug|0
7417292|NCT01455415|11691373|FG000|Washout|Lost to Follow-up|1
7417293|NCT01455415|11691374|FG001|Washout|Lost to Follow-up|0
7417294|NCT01455415|11691373|FG000|Washout|Drug Error not Associated to AE|2
7417295|NCT01455415|11691374|FG001|Washout|Drug Error not Associated to AE|1
7417296|NCT01455415|11691373|FG000|Washout|AE Not Related to Study Drug|2
7417297|NCT01455415|11691374|FG001|Washout|AE Not Related to Study Drug|3
7417298|NCT01455415|11691373|FG000|Washout|Unspecified Reason|1
7417299|NCT01455415|11691374|FG001|Washout|Unspecified Reason|2
7417300|NCT01455415|11691373|FG000|Washout|Protocol Violation|0
7417301|NCT01455415|11691374|FG001|Washout|Protocol Violation|1
7417302|NCT01455415|11691373|FG000|Period 2|AE Related to Study Drug|1
7417303|NCT01455415|11691374|FG001|Period 2|AE Related to Study Drug|2
7417304|NCT01455415|11691373|FG000|Period 2|Lost to Follow-up|2
7417305|NCT01455415|11691374|FG001|Period 2|Lost to Follow-up|1
7417306|NCT01455415|11691373|FG000|Period 2|AE Not Related to Study Drug|2
7417307|NCT01455415|11691374|FG001|Period 2|AE Not Related to Study Drug|1
7417308|NCT01455415|11691373|FG000|Period 2|Lack of Efficacy|2
7417309|NCT01455415|11691374|FG001|Period 2|Lack of Efficacy|0
7417310|NCT01455415|11691373|FG000|Period 2|Withdrawal by Subject|2
7417311|NCT01455415|11691374|FG001|Period 2|Withdrawal by Subject|3
7417312|NCT01455415|11691373|FG000|Period 2|Unspecified Reason|2
7417313|NCT01455415|11691374|FG001|Period 2|Unspecified Reason|3
7417314|NCT01455415|11691373|FG000|Period 2|Protocol Violation|2
7417315|NCT01455415|11691374|FG001|Period 2|Protocol Violation|0
7417316|NCT01455415|11691373|FG000|Follow-up|AE Related to Study Drug|0
7417317|NCT01455415|11691374|FG001|Follow-up|AE Related to Study Drug|1
7325142|NCT00776009|11557327|FG005|Period 1: First Intervention|Protocol Violation|0
7325143|NCT00776009|11557322|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
7417318|NCT01455415|11691373|FG000|Follow-up|Lack of Efficacy|0
7417319|NCT01455415|11691374|FG001|Follow-up|Lack of Efficacy|1
7417320|NCT01455415|11691373|FG000|Follow-up|Withdrawal by Subject|2
7417321|NCT01455415|11691374|FG001|Follow-up|Withdrawal by Subject|0
7417322|NCT01455415|11691373|FG000|Follow-up|Unspecified Reason|1
7417323|NCT01455415|11691374|FG001|Follow-up|Unspecified Reason|0
7417324|NCT01455428|11691382|FG000|Overall Study|Protocol Violation|2
7417325|NCT01455428|11691383|FG001|Overall Study|Protocol Violation|1
7417326|NCT01455428|11691382|FG000|Overall Study|Adverse Event|6
7417327|NCT01455428|11691383|FG001|Overall Study|Adverse Event|2
7417328|NCT01455428|11691382|FG000|Overall Study|Lost to Follow-up|1
7417329|NCT01455428|11691383|FG001|Overall Study|Lost to Follow-up|1
7325144|NCT00776009|11557323|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
7325145|NCT00776009|11557324|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
7325146|NCT00776009|11557325|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
7325147|NCT00776009|11557326|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
7325148|NCT00776009|11557327|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
7325149|NCT00776009|11557322|FG000|Period 2: Second Intervention|Protocol Violation|1
7325150|NCT00776009|11557323|FG001|Period 2: Second Intervention|Protocol Violation|0
7325151|NCT00776009|11557324|FG002|Period 2: Second Intervention|Protocol Violation|1
7325152|NCT00776009|11557325|FG003|Period 2: Second Intervention|Protocol Violation|0
7325153|NCT00776009|11557326|FG004|Period 2: Second Intervention|Protocol Violation|0
7325154|NCT00776009|11557327|FG005|Period 2: Second Intervention|Protocol Violation|0
7325155|NCT00776009|11557322|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
7325156|NCT00776009|11557323|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
7325157|NCT00776009|11557324|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
7325158|NCT00776009|11557325|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
7325159|NCT00776009|11557326|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
7325160|NCT00776009|11557327|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
7325161|NCT00776230|11557338|FG000|Overall Study|Lost to Follow-up|2
7325162|NCT00776230|11557339|FG001|Overall Study|Lost to Follow-up|1
7325163|NCT00776230|11557340|FG002|Overall Study|Lost to Follow-up|5
7325164|NCT00776230|11557338|FG000|Overall Study|Not vaccinated at Day 0|1
7325165|NCT00776230|11557339|FG001|Overall Study|Not vaccinated at Day 0|0
7325166|NCT00776230|11557340|FG002|Overall Study|Not vaccinated at Day 0|0
7325167|NCT00776230|11557338|FG000|Overall Study|Withdrawal by Subject|0
7325168|NCT00776230|11557339|FG001|Overall Study|Withdrawal by Subject|1
7325169|NCT00776230|11557340|FG002|Overall Study|Withdrawal by Subject|0
7325170|NCT00776230|11557338|FG000|Overall Study|Subject missed Visit 4|0
7325171|NCT00776230|11557339|FG001|Overall Study|Subject missed Visit 4|1
7325172|NCT00776230|11557340|FG002|Overall Study|Subject missed Visit 4|0
7325173|NCT00776659|11557363|FG000|Overall Study|Lost to Follow-up|15
7325174|NCT00776659|11557363|FG000|Overall Study|Withdrawal by Subject|10
7325175|NCT00776659|11557363|FG000|Overall Study|Study Terminated by Sponsor|1
7325176|NCT00776789|11557369|FG000|Overall Study|Consent refusal|2
7325177|NCT00776789|11557370|FG001|Overall Study|Consent refusal|2
7325178|NCT00776789|11557369|FG000|Overall Study|Poor quality video|1
7325179|NCT00776789|11557370|FG001|Overall Study|Poor quality video|1
7325180|NCT00776919|11557382|FG000|Overall Study|Withdrawal by Subject|16
7325181|NCT00776919|11557383|FG001|Overall Study|Withdrawal by Subject|14
7325182|NCT00776919|11557384|FG002|Overall Study|Withdrawal by Subject|15
7325183|NCT00776919|11557385|FG003|Overall Study|Withdrawal by Subject|26
7325184|NCT00776919|11557382|FG000|Overall Study|Lost to Follow-up|8
7325185|NCT00776919|11557383|FG001|Overall Study|Lost to Follow-up|12
7325186|NCT00776919|11557384|FG002|Overall Study|Lost to Follow-up|11
7325187|NCT00776919|11557385|FG003|Overall Study|Lost to Follow-up|8
7325188|NCT00776919|11557382|FG000|Overall Study|Adverse Event|1
7325189|NCT00776919|11557383|FG001|Overall Study|Adverse Event|0
7325190|NCT00776919|11557384|FG002|Overall Study|Adverse Event|2
7325191|NCT00776919|11557385|FG003|Overall Study|Adverse Event|2
7325192|NCT00776919|11557382|FG000|Overall Study|Protocol Violation|1
7325193|NCT00776919|11557383|FG001|Overall Study|Protocol Violation|2
7325194|NCT00776919|11557384|FG002|Overall Study|Protocol Violation|0
7325195|NCT00776919|11557385|FG003|Overall Study|Protocol Violation|1
7325196|NCT00776919|11557382|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
7325197|NCT00776919|11557383|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
7325198|NCT00776919|11557384|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
7325199|NCT00776919|11557385|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
7325200|NCT00776984|11557397|FG000|Overall Study|Adverse Event|8
7325201|NCT00776984|11557398|FG001|Overall Study|Adverse Event|2
7325202|NCT00776984|11557397|FG000|Overall Study|Protocol Violation|4
7325203|NCT00776984|11557398|FG001|Overall Study|Protocol Violation|2
7325204|NCT00776984|11557397|FG000|Overall Study|Lost to Follow-up|2
7325205|NCT00776984|11557398|FG001|Overall Study|Lost to Follow-up|0
7325206|NCT00776984|11557397|FG000|Overall Study|Withdrawal by Subject|12
7325207|NCT00776984|11557398|FG001|Overall Study|Withdrawal by Subject|7
7325208|NCT00776984|11557397|FG000|Overall Study|Lack of Efficacy|0
7325209|NCT00776984|11557398|FG001|Overall Study|Lack of Efficacy|1
7325210|NCT00776984|11557397|FG000|Overall Study|Other|5
7325211|NCT00776984|11557398|FG001|Overall Study|Other|9
7325212|NCT00776997|11557404|FG000|Overall Study|Adverse Event|2
7325213|NCT00777023|11557411|FG000|Overall Study|Adverse Event|15
7325214|NCT00777023|11557412|FG001|Overall Study|Adverse Event|21
7325215|NCT00777023|11557413|FG002|Overall Study|Adverse Event|8
7325216|NCT00777023|11557411|FG000|Overall Study|Lack of Efficacy|1
7325217|NCT00777023|11557412|FG001|Overall Study|Lack of Efficacy|0
7325218|NCT00777023|11557413|FG002|Overall Study|Lack of Efficacy|14
7325219|NCT00777023|11557411|FG000|Overall Study|Protocol Violation|2
7325220|NCT00777023|11557412|FG001|Overall Study|Protocol Violation|1
7325221|NCT00777023|11557413|FG002|Overall Study|Protocol Violation|1
7325222|NCT00777023|11557411|FG000|Overall Study|Lost to Follow-up|2
7325223|NCT00777023|11557412|FG001|Overall Study|Lost to Follow-up|3
7325224|NCT00777023|11557413|FG002|Overall Study|Lost to Follow-up|3
7325225|NCT00777023|11557411|FG000|Overall Study|Death|0
7325226|NCT00777023|11557412|FG001|Overall Study|Death|1
7325227|NCT00777023|11557413|FG002|Overall Study|Death|0
7325228|NCT00777023|11557411|FG000|Overall Study|Withdrawal by Subject|7
7325229|NCT00777023|11557412|FG001|Overall Study|Withdrawal by Subject|7
7325230|NCT00777023|11557413|FG002|Overall Study|Withdrawal by Subject|8
7325231|NCT00777023|11557411|FG000|Overall Study|Missing data|1
7325232|NCT00777023|11557412|FG001|Overall Study|Missing data|1
7325233|NCT00777023|11557413|FG002|Overall Study|Missing data|0
7325234|NCT00777023|11557411|FG000|Overall Study|Reasons not specified|4
7325235|NCT00777023|11557412|FG001|Overall Study|Reasons not specified|4
7325236|NCT00777023|11557413|FG002|Overall Study|Reasons not specified|2
7325237|NCT00777023|11557411|FG000|Overall Study|Last dose date unknown|3
7325238|NCT00777023|11557412|FG001|Overall Study|Last dose date unknown|3
7325239|NCT00777023|11557413|FG002|Overall Study|Last dose date unknown|1
7325240|NCT00777049|11557423|FG000|Overall Study|Withdrawal by Subject|1
7325241|NCT00777049|11557424|FG001|Overall Study|Withdrawal by Subject|0
7325242|NCT00777049|11557423|FG000|Overall Study|No treatment (elevated liver enzymes)|0
7325243|NCT00777049|11557424|FG001|Overall Study|No treatment (elevated liver enzymes)|1
7325244|NCT00777088|11557439|FG000|Overall Study|PED Treatment not attempted|1
7325245|NCT00777101|11557446|FG000|Overall Study|Death|48
7325246|NCT00777101|11557447|FG001|Overall Study|Death|43
7325247|NCT00777101|11557446|FG000|Overall Study|Withdrawal by Subject|11
7325248|NCT00777101|11557447|FG001|Overall Study|Withdrawal by Subject|6
7325249|NCT00777101|11557446|FG000|Overall Study|Lost to Follow-up|2
7325250|NCT00777101|11557447|FG001|Overall Study|Lost to Follow-up|1
7325251|NCT00777101|11557446|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7325252|NCT00777101|11557447|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7325253|NCT00777101|11557446|FG000|Overall Study|Failed to Return|0
7325254|NCT00777101|11557447|FG001|Overall Study|Failed to Return|1
7325255|NCT00777153|11557457|FG000|Overall Study|Lost to Follow-up|1
7325256|NCT00777153|11557458|FG001|Overall Study|Lost to Follow-up|1
7325257|NCT00777153|11557459|FG002|Overall Study|Lost to Follow-up|0
7325258|NCT00777153|11557457|FG000|Overall Study|Death|85
7325259|NCT00777153|11557458|FG001|Overall Study|Death|73
7325260|NCT00777153|11557459|FG002|Overall Study|Death|33
7325261|NCT00777153|11557457|FG000|Overall Study|Withdrawal by Subject|3
7325262|NCT00777153|11557458|FG001|Overall Study|Withdrawal by Subject|4
7325263|NCT00777153|11557459|FG002|Overall Study|Withdrawal by Subject|3
7325264|NCT00777153|11557457|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7325265|NCT00777153|11557458|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
7325266|NCT00777153|11557459|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
7325267|NCT00777205|11557482|FG000|Overall Study|Lost to Follow-up|25
7325268|NCT00777205|11557483|FG001|Overall Study|Lost to Follow-up|9
7325269|NCT00777205|11557482|FG000|Overall Study|Withdrawal by Subject|6
7325270|NCT00777205|11557483|FG001|Overall Study|Withdrawal by Subject|4
7325271|NCT00777205|11557482|FG000|Overall Study|Death|0
7325272|NCT00777205|11557483|FG001|Overall Study|Death|2
7325273|NCT00777205|11557482|FG000|Overall Study|Protocol Violation|0
7325274|NCT00777205|11557483|FG001|Overall Study|Protocol Violation|56
7325275|NCT00777257|11557494|FG000|Overall Study|Adverse Event|3
7325276|NCT00777257|11557495|FG001|Overall Study|Adverse Event|1
7325277|NCT00777257|11557496|FG002|Overall Study|Adverse Event|0
7325278|NCT00777257|11557494|FG000|Overall Study|Lost to Follow-up|3
7325279|NCT00777257|11557495|FG001|Overall Study|Lost to Follow-up|3
7325280|NCT00777257|11557496|FG002|Overall Study|Lost to Follow-up|2
7325281|NCT00777257|11557494|FG000|Overall Study|Protocol Violation|2
7325282|NCT00777257|11557495|FG001|Overall Study|Protocol Violation|2
7325283|NCT00777257|11557496|FG002|Overall Study|Protocol Violation|2
7325284|NCT00777257|11557494|FG000|Overall Study|Withdrawal by Subject|3
7325285|NCT00777257|11557495|FG001|Overall Study|Withdrawal by Subject|6
7325286|NCT00777257|11557496|FG002|Overall Study|Withdrawal by Subject|5
7325287|NCT00777296|11557508|FG000|Overall Study|Adverse Event|0
7325288|NCT00777296|11557509|FG001|Overall Study|Adverse Event|1
7325289|NCT00777296|11557510|FG002|Overall Study|Adverse Event|0
7325290|NCT00777296|11557511|FG003|Overall Study|Adverse Event|1
7325291|NCT00777296|11557508|FG000|Overall Study|Withdrawal by Subject|1
7325292|NCT00777296|11557509|FG001|Overall Study|Withdrawal by Subject|0
7325293|NCT00777296|11557510|FG002|Overall Study|Withdrawal by Subject|0
7325294|NCT00777296|11557511|FG003|Overall Study|Withdrawal by Subject|0
7325295|NCT00777296|11557508|FG000|Overall Study|CRF form not completed|0
7325296|NCT00777296|11557509|FG001|Overall Study|CRF form not completed|0
7325297|NCT00777296|11557510|FG002|Overall Study|CRF form not completed|2
7325298|NCT00777296|11557511|FG003|Overall Study|CRF form not completed|0
7325299|NCT00777556|11557542|FG000|Overall Study|Inappropriate self-selection|34
7325300|NCT00777556|11557542|FG000|Overall Study|Dispensed but did not use product|12
7325301|NCT00777556|11557542|FG000|Overall Study|Did not complete all 3 follow-up visits|20
7325302|NCT00777608|11557548|FG000|Overall Study|Lost to Follow-up|1
7325303|NCT00777608|11557549|FG001|Overall Study|Lost to Follow-up|1
7325304|NCT00777608|11557548|FG000|Overall Study|Withdrawal by Subject|1
7325305|NCT00777608|11557549|FG001|Overall Study|Withdrawal by Subject|3
7325306|NCT00777608|11557548|FG000|Overall Study|Protocol Violation|1
7325307|NCT00777608|11557549|FG001|Overall Study|Protocol Violation|0
7325308|NCT00777608|11557548|FG000|Overall Study|Investigator Decision|1
7325309|NCT00777608|11557549|FG001|Overall Study|Investigator Decision|2
7325310|NCT00777803|11557590|FG000|Overall Study|Lost to Follow-up|12
7325311|NCT00777803|11557591|FG001|Overall Study|Lost to Follow-up|5
7325312|NCT00777803|11557590|FG000|Overall Study|Adverse Event|1
7325313|NCT00777803|11557591|FG001|Overall Study|Adverse Event|0
7325314|NCT00777803|11557590|FG000|Overall Study|Non-compliance|2
7325315|NCT00777803|11557591|FG001|Overall Study|Non-compliance|2
7325316|NCT00777829|11557597|FG000|Overall Study|Withdrawal by Subject|0
7325317|NCT00777829|11557598|FG001|Overall Study|Withdrawal by Subject|2
7325318|NCT00777920|11557612|FG000|Overall Study|Adverse Event|39
7325319|NCT00777920|11557612|FG000|Overall Study|Withdrawal of Consent|4
7325320|NCT00777920|11557612|FG000|Overall Study|Lost to Follow-up|1
7325321|NCT00777920|11557612|FG000|Overall Study|Investigator's discretion|1
7531244|NCT02647320|11875326|FG000|Overall Study|Reason not provided|0
7531245|NCT02647320|11875327|FG001|Overall Study|Reason not provided|0
7325322|NCT00777920|11557612|FG000|Overall Study|Clinical status did not improve|1
7325323|NCT00777920|11557612|FG000|Overall Study|Other, not specified|4
7325324|NCT00777946|11557619|FG000|Overall Study|Adverse Event|11
7325325|NCT00777946|11557620|FG001|Overall Study|Adverse Event|1
7325326|NCT00777946|11557621|FG002|Overall Study|Adverse Event|3
7325327|NCT00777946|11557619|FG000|Overall Study|Lack of Efficacy|0
7325328|NCT00777946|11557620|FG001|Overall Study|Lack of Efficacy|0
7325329|NCT00777946|11557621|FG002|Overall Study|Lack of Efficacy|9
7325330|NCT00777946|11557619|FG000|Overall Study|Condition no longer required study drug|1
7325331|NCT00777946|11557620|FG001|Overall Study|Condition no longer required study drug|0
7325332|NCT00777946|11557621|FG002|Overall Study|Condition no longer required study drug|0
7325333|NCT00777946|11557619|FG000|Overall Study|Patient withdrew consent|3
7325334|NCT00777946|11557620|FG001|Overall Study|Patient withdrew consent|2
7325335|NCT00777946|11557621|FG002|Overall Study|Patient withdrew consent|3
7325336|NCT00777946|11557619|FG000|Overall Study|Lost to Follow-up|3
7325337|NCT00777946|11557620|FG001|Overall Study|Lost to Follow-up|1
7325338|NCT00777946|11557621|FG002|Overall Study|Lost to Follow-up|0
7325339|NCT00777946|11557619|FG000|Overall Study|Protocol deviation|2
7325340|NCT00777946|11557620|FG001|Overall Study|Protocol deviation|1
7325341|NCT00777946|11557621|FG002|Overall Study|Protocol deviation|1
7325342|NCT00777946|11557619|FG000|Overall Study|Randomized in error|1
7325343|NCT00777946|11557620|FG001|Overall Study|Randomized in error|1
7325344|NCT00777946|11557621|FG002|Overall Study|Randomized in error|0
7325345|NCT00778102|11557631|FG000|Overall Study|Adverse Event|8
7325346|NCT00778102|11557632|FG001|Overall Study|Adverse Event|5
7325347|NCT00778102|11557631|FG000|Overall Study|Death|1
7325348|NCT00778102|11557632|FG001|Overall Study|Death|1
7325349|NCT00778102|11557631|FG000|Overall Study|Lost to Follow-up|1
7325350|NCT00778102|11557632|FG001|Overall Study|Lost to Follow-up|0
7325351|NCT00778102|11557631|FG000|Overall Study|Violation of Selection Criteria|1
7325352|NCT00778102|11557632|FG001|Overall Study|Violation of Selection Criteria|1
7325353|NCT00778102|11557631|FG000|Overall Study|Protocol Violation|0
7325354|NCT00778102|11557632|FG001|Overall Study|Protocol Violation|1
7325355|NCT00778102|11557631|FG000|Overall Study|Refused Treatment|2
7325356|NCT00778102|11557632|FG001|Overall Study|Refused Treatment|3
7325357|NCT00778102|11557631|FG000|Overall Study|Withdrawal by Subject|1
7325358|NCT00778102|11557632|FG001|Overall Study|Withdrawal by Subject|1
7325359|NCT00778102|11557631|FG000|Overall Study|Administrative Reason|7
7325360|NCT00778102|11557632|FG001|Overall Study|Administrative Reason|10
7325361|NCT00778258|11557660|FG000|Overall Study|Adverse Event|1
7325362|NCT00778258|11557661|FG001|Overall Study|Adverse Event|0
7325363|NCT00778258|11557662|FG002|Overall Study|Adverse Event|0
7325364|NCT00778258|11557663|FG003|Overall Study|Adverse Event|0
7325365|NCT00778258|11557664|FG004|Overall Study|Adverse Event|0
7325366|NCT00778258|11557665|FG005|Overall Study|Adverse Event|1
7325367|NCT00778258|11557666|FG006|Overall Study|Adverse Event|0
7325368|NCT00778258|11557667|FG007|Overall Study|Adverse Event|0
7325369|NCT00778258|11557668|FG008|Overall Study|Adverse Event|0
7325370|NCT00778258|11557660|FG000|Overall Study|Lost to Follow-up|0
7325371|NCT00778258|11557661|FG001|Overall Study|Lost to Follow-up|0
7325372|NCT00778258|11557662|FG002|Overall Study|Lost to Follow-up|2
7325373|NCT00778258|11557663|FG003|Overall Study|Lost to Follow-up|0
7325374|NCT00778258|11557664|FG004|Overall Study|Lost to Follow-up|0
7325375|NCT00778258|11557665|FG005|Overall Study|Lost to Follow-up|3
7325376|NCT00778258|11557666|FG006|Overall Study|Lost to Follow-up|2
7325377|NCT00778258|11557667|FG007|Overall Study|Lost to Follow-up|2
7325378|NCT00778258|11557668|FG008|Overall Study|Lost to Follow-up|0
7325379|NCT00778258|11557660|FG000|Overall Study|Withdrawal by Subject|6
7325380|NCT00778258|11557661|FG001|Overall Study|Withdrawal by Subject|2
7325381|NCT00778258|11557662|FG002|Overall Study|Withdrawal by Subject|8
7325382|NCT00778258|11557663|FG003|Overall Study|Withdrawal by Subject|2
7325383|NCT00778258|11557664|FG004|Overall Study|Withdrawal by Subject|0
7325384|NCT00778258|11557665|FG005|Overall Study|Withdrawal by Subject|6
7325385|NCT00778258|11557666|FG006|Overall Study|Withdrawal by Subject|12
7325386|NCT00778258|11557667|FG007|Overall Study|Withdrawal by Subject|12
7325387|NCT00778258|11557668|FG008|Overall Study|Withdrawal by Subject|4
7325388|NCT00778258|11557660|FG000|Overall Study|New Contraindication|0
7325389|NCT00778258|11557661|FG001|Overall Study|New Contraindication|0
7325390|NCT00778258|11557662|FG002|Overall Study|New Contraindication|0
7325391|NCT00778258|11557663|FG003|Overall Study|New Contraindication|0
7531246|NCT02647320|11875328|FG002|Overall Study|Reason not provided|1
7325392|NCT00778258|11557664|FG004|Overall Study|New Contraindication|0
7325393|NCT00778258|11557665|FG005|Overall Study|New Contraindication|0
7325394|NCT00778258|11557666|FG006|Overall Study|New Contraindication|0
7325395|NCT00778258|11557667|FG007|Overall Study|New Contraindication|1
7325396|NCT00778258|11557668|FG008|Overall Study|New Contraindication|0
7325397|NCT00778258|11557660|FG000|Overall Study|Non-compliance|0
7325398|NCT00778258|11557661|FG001|Overall Study|Non-compliance|0
7325399|NCT00778258|11557662|FG002|Overall Study|Non-compliance|0
7325400|NCT00778258|11557663|FG003|Overall Study|Non-compliance|1
7325401|NCT00778258|11557664|FG004|Overall Study|Non-compliance|0
7325402|NCT00778258|11557665|FG005|Overall Study|Non-compliance|0
7325403|NCT00778258|11557666|FG006|Overall Study|Non-compliance|0
7417330|NCT01455428|11691382|FG000|Overall Study|Withdrawal by Subject|2
7531247|NCT02647320|11875329|FG003|Overall Study|Reason not provided|0
7531248|NCT02647320|11875330|FG004|Overall Study|Reason not provided|2
7531249|NCT02647320|11875326|FG000|Overall Study|Lost to Follow-up|1
7531250|NCT02647320|11875327|FG001|Overall Study|Lost to Follow-up|1
7531251|NCT02647320|11875328|FG002|Overall Study|Lost to Follow-up|0
7531252|NCT02647320|11875329|FG003|Overall Study|Lost to Follow-up|0
7531253|NCT02647320|11875330|FG004|Overall Study|Lost to Follow-up|0
7531254|NCT02647320|11875326|FG000|Overall Study|Develop anemia|1
7531255|NCT02647320|11875327|FG001|Overall Study|Develop anemia|0
7531256|NCT02647320|11875328|FG002|Overall Study|Develop anemia|0
7531257|NCT02647320|11875329|FG003|Overall Study|Develop anemia|0
7531258|NCT02647320|11875330|FG004|Overall Study|Develop anemia|0
7531259|NCT02647320|11875326|FG000|Overall Study|Lack of Efficacy|0
7531260|NCT02647320|11875327|FG001|Overall Study|Lack of Efficacy|0
7531261|NCT02647320|11875328|FG002|Overall Study|Lack of Efficacy|0
7531262|NCT02647320|11875329|FG003|Overall Study|Lack of Efficacy|1
7531263|NCT02647320|11875330|FG004|Overall Study|Lack of Efficacy|0
7531264|NCT02647320|11875326|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
7531265|NCT02647320|11875327|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
7531266|NCT02647320|11875328|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
7531267|NCT02647320|11875329|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
7531268|NCT02647320|11875330|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
7531269|NCT02647645|11875350|FG000|Overall Study|Lost to Follow-up|2
7531270|NCT02647645|11875351|FG001|Overall Study|Lost to Follow-up|1
7555322|NCT03053427|11918275|FG000|Overall Study|Withdrawal by Subject|3
7555323|NCT03053427|11918276|FG001|Overall Study|Withdrawal by Subject|2
7555324|NCT03053427|11918275|FG000|Overall Study|Miscellaneous|0
7555325|NCT03053427|11918276|FG001|Overall Study|Miscellaneous|1
7555326|NCT03053492|11918284|FG000|Overall Study|Adverse Event|1
7555327|NCT03053492|11918285|FG001|Overall Study|Adverse Event|1
7555328|NCT03053492|11918284|FG000|Overall Study|Withdrawal by Subject|7
7555329|NCT03053492|11918285|FG001|Overall Study|Withdrawal by Subject|5
7555330|NCT03054064|11918302|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
7555331|NCT03054064|11918302|FG000|Overall Study|Investigator Decision|2
7555332|NCT03054064|11918302|FG000|Overall Study|Bladder Issue|1
7555333|NCT03054064|11918302|FG000|Overall Study|High Blood Pressure|1
7555334|NCT03054064|11918302|FG000|Overall Study|Change in Status|1
7555335|NCT03054337|11918334|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
7555336|NCT03054337|11918335|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
7531271|NCT02647658|11875359|FG000|Overall Study|Consent refusal|15
7531272|NCT02647658|11875360|FG001|Overall Study|Consent refusal|24
7531273|NCT02647788|11875368|FG000|Overall Study|Lost to Follow-up|13
7531274|NCT02647788|11875369|FG001|Overall Study|Lost to Follow-up|11
7531275|NCT02647788|11875368|FG000|Overall Study|Did not want opiate|0
7531276|NCT02647788|11875369|FG001|Overall Study|Did not want opiate|1
7531277|NCT02647788|11875368|FG000|Overall Study|Withdrawal by Subject|1
7531278|NCT02647788|11875369|FG001|Overall Study|Withdrawal by Subject|0
7531279|NCT02647788|11875368|FG000|Overall Study|Felt itchy with assigned medication|1
7531280|NCT02647788|11875369|FG001|Overall Study|Felt itchy with assigned medication|0
7531281|NCT02647788|11875368|FG000|Overall Study|Felt nauseous with assigned medication|1
7531282|NCT02647788|11875369|FG001|Overall Study|Felt nauseous with assigned medication|1
7531283|NCT02647866|11875380|FG000|Overall Study|Adverse Event|0
7555337|NCT03054337|11918336|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
7555338|NCT03054337|11918337|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
7574655|NCT03686033|11957623|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
7325404|NCT00778258|11557667|FG007|Overall Study|Non-compliance|0
7325405|NCT00778258|11557668|FG008|Overall Study|Non-compliance|0
7325406|NCT00778258|11557660|FG000|Overall Study|Other|0
7417331|NCT01455428|11691383|FG001|Overall Study|Withdrawal by Subject|5
7417332|NCT01455428|11691382|FG000|Overall Study|Did not meet entrance criteria|0
7417333|NCT01455428|11691383|FG001|Overall Study|Did not meet entrance criteria|2
7417334|NCT01455428|11691382|FG000|Overall Study|Insufficient clinical response|0
7417335|NCT01455428|11691383|FG001|Overall Study|Insufficient clinical response|2
7417336|NCT01455428|11691382|FG000|Overall Study|Did not receive treatment|1
7417337|NCT01455428|11691383|FG001|Overall Study|Did not receive treatment|1
7417338|NCT01455428|11691382|FG000|Overall Study|Other|2
7417339|NCT01455428|11691383|FG001|Overall Study|Other|4
7417340|NCT01456039|11691426|FG000|Phase 1 (First Step)|Disease Progression|1
7417341|NCT01456039|11691427|FG001|Phase 1 (First Step)|Disease Progression|1
7531284|NCT02647866|11875381|FG001|Overall Study|Adverse Event|0
7531285|NCT02647866|11875382|FG002|Overall Study|Adverse Event|2
7531286|NCT02647866|11875383|FG003|Overall Study|Adverse Event|2
7531287|NCT02647866|11875384|FG004|Overall Study|Adverse Event|1
7531288|NCT02647866|11875380|FG000|Overall Study|Disease Worsening|3
7531289|NCT02647866|11875381|FG001|Overall Study|Disease Worsening|1
7531290|NCT02647866|11875382|FG002|Overall Study|Disease Worsening|0
7531291|NCT02647866|11875383|FG003|Overall Study|Disease Worsening|0
7531292|NCT02647866|11875384|FG004|Overall Study|Disease Worsening|1
7531293|NCT02647866|11875380|FG000|Overall Study|Withdrawal by Subject|1
7531294|NCT02647866|11875381|FG001|Overall Study|Withdrawal by Subject|1
7531295|NCT02647866|11875382|FG002|Overall Study|Withdrawal by Subject|2
7531296|NCT02647866|11875383|FG003|Overall Study|Withdrawal by Subject|4
7531297|NCT02647866|11875384|FG004|Overall Study|Withdrawal by Subject|4
7531298|NCT02647866|11875380|FG000|Overall Study|Physician Decision|0
7531299|NCT02647866|11875381|FG001|Overall Study|Physician Decision|1
7531300|NCT02647866|11875382|FG002|Overall Study|Physician Decision|1
7531301|NCT02647866|11875383|FG003|Overall Study|Physician Decision|0
7531302|NCT02647866|11875384|FG004|Overall Study|Physician Decision|2
7531303|NCT02647866|11875380|FG000|Overall Study|Death|0
7531304|NCT02647866|11875381|FG001|Overall Study|Death|1
7531305|NCT02647866|11875382|FG002|Overall Study|Death|0
7531306|NCT02647866|11875383|FG003|Overall Study|Death|0
7531307|NCT02647866|11875384|FG004|Overall Study|Death|0
7531308|NCT02647866|11875380|FG000|Overall Study|Subject moved to different country|1
7531309|NCT02647866|11875381|FG001|Overall Study|Subject moved to different country|0
7531310|NCT02647866|11875382|FG002|Overall Study|Subject moved to different country|0
7531311|NCT02647866|11875383|FG003|Overall Study|Subject moved to different country|0
7531312|NCT02647866|11875384|FG004|Overall Study|Subject moved to different country|0
7531313|NCT02647905|11875404|FG000|Overall Study|Lost to Follow-up|1
7531314|NCT02647905|11875404|FG000|Overall Study|Withdrawal by Subject|2
7555339|NCT03054337|11918338|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
7555340|NCT03054337|11918339|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
7555341|NCT03054350|11918372|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7555342|NCT03054350|11918373|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7555343|NCT03054350|11918374|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
7555344|NCT03054350|11918375|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
7555345|NCT03054350|11918376|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
7555346|NCT03054350|11918377|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
7555347|NCT03054350|11918372|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7555348|NCT03054350|11918373|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7555349|NCT03054350|11918374|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
7555350|NCT03054350|11918375|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7555351|NCT03054350|11918376|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7555352|NCT03054350|11918377|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
7555353|NCT03054350|11918372|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7555354|NCT03054350|11918373|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7555355|NCT03054350|11918374|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7555356|NCT03054350|11918375|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
7555357|NCT03054350|11918376|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7574656|NCT03686033|11957624|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
7531315|NCT02647944|11875410|FG000|Overall Study|Withdrawal by Subject|0
7531316|NCT02647944|11875411|FG001|Overall Study|Withdrawal by Subject|3
7531317|NCT02647944|11875410|FG000|Overall Study|Adverse Event|2
7531318|NCT02647944|11875411|FG001|Overall Study|Adverse Event|0
7531319|NCT02648204|11875434|FG000|Overall Study|Withdrawal by Subject|12
7531320|NCT02648204|11875435|FG001|Overall Study|Withdrawal by Subject|8
7531321|NCT02648204|11875436|FG002|Overall Study|Withdrawal by Subject|2
7531322|NCT02648204|11875437|FG003|Overall Study|Withdrawal by Subject|6
7531323|NCT02648204|11875434|FG000|Overall Study|Lost to Follow-up|5
7325407|NCT00778258|11557661|FG001|Overall Study|Other|0
7325408|NCT00778258|11557662|FG002|Overall Study|Other|0
7531324|NCT02648204|11875435|FG001|Overall Study|Lost to Follow-up|8
7531325|NCT02648204|11875436|FG002|Overall Study|Lost to Follow-up|4
7531326|NCT02648204|11875437|FG003|Overall Study|Lost to Follow-up|6
7531327|NCT02648204|11875434|FG000|Overall Study|Missing follow-up information|4
7531328|NCT02648204|11875435|FG001|Overall Study|Missing follow-up information|4
7531329|NCT02648204|11875436|FG002|Overall Study|Missing follow-up information|4
7531330|NCT02648204|11875437|FG003|Overall Study|Missing follow-up information|2
7531331|NCT02648204|11875434|FG000|Overall Study|Death|1
7531332|NCT02648204|11875435|FG001|Overall Study|Death|1
7531333|NCT02648204|11875436|FG002|Overall Study|Death|2
7325409|NCT00778258|11557663|FG003|Overall Study|Other|0
7531334|NCT02648204|11875437|FG003|Overall Study|Death|2
7531335|NCT02648204|11875434|FG000|Overall Study|Adverse Event|0
7531336|NCT02648204|11875435|FG001|Overall Study|Adverse Event|0
7325410|NCT00778258|11557664|FG004|Overall Study|Other|0
7531337|NCT02648204|11875436|FG002|Overall Study|Adverse Event|1
7531338|NCT02648204|11875437|FG003|Overall Study|Adverse Event|0
7325411|NCT00778258|11557665|FG005|Overall Study|Other|0
7325412|NCT00778258|11557666|FG006|Overall Study|Other|1
7325413|NCT00778258|11557667|FG007|Overall Study|Other|0
7325414|NCT00778258|11557668|FG008|Overall Study|Other|0
7325415|NCT00778336|11557709|FG000|Index Procedure-Discharge|Death|6
7325416|NCT00778336|11557710|FG001|Index Procedure-Discharge|Death|3
7325417|NCT00778336|11557711|FG002|Index Procedure-Discharge|Death|2
7325418|NCT00778336|11557712|FG003|Index Procedure-Discharge|Death|0
7325419|NCT00778336|11557709|FG000|3 Month Follow Up|Lost to Follow-up|15
7325420|NCT00778336|11557710|FG001|3 Month Follow Up|Lost to Follow-up|20
7325421|NCT00778336|11557711|FG002|3 Month Follow Up|Lost to Follow-up|3
7325422|NCT00778336|11557712|FG003|3 Month Follow Up|Lost to Follow-up|0
7325423|NCT00778336|11557709|FG000|3 Month Follow Up|Death|8
7325424|NCT00778336|11557710|FG001|3 Month Follow Up|Death|3
7325425|NCT00778336|11557711|FG002|3 Month Follow Up|Death|2
7325426|NCT00778336|11557712|FG003|3 Month Follow Up|Death|0
7325427|NCT00778375|11557722|FG000|Overall Study|Ineligible|3
7325428|NCT00778622|11557731|FG000|Overall Study|Adverse Event|5
7325429|NCT00778622|11557732|FG001|Overall Study|Adverse Event|4
7325430|NCT00778622|11557733|FG002|Overall Study|Adverse Event|7
7325431|NCT00778622|11557731|FG000|Overall Study|Withdrawal by Subject|4
7325432|NCT00778622|11557732|FG001|Overall Study|Withdrawal by Subject|5
7325433|NCT00778622|11557733|FG002|Overall Study|Withdrawal by Subject|5
7325434|NCT00778622|11557731|FG000|Overall Study|Lost to Follow-up|3
7325435|NCT00778622|11557732|FG001|Overall Study|Lost to Follow-up|3
7325436|NCT00778622|11557733|FG002|Overall Study|Lost to Follow-up|2
7325437|NCT00778622|11557731|FG000|Overall Study|Protocol Violation|0
7325438|NCT00778622|11557732|FG001|Overall Study|Protocol Violation|3
7325439|NCT00778622|11557733|FG002|Overall Study|Protocol Violation|0
7325440|NCT00778622|11557731|FG000|Overall Study|Lack of Efficacy|2
7325441|NCT00778622|11557732|FG001|Overall Study|Lack of Efficacy|0
7325442|NCT00778622|11557733|FG002|Overall Study|Lack of Efficacy|0
7325443|NCT00778622|11557731|FG000|Overall Study|immigration|1
7325444|NCT00778622|11557732|FG001|Overall Study|immigration|0
7325445|NCT00778622|11557733|FG002|Overall Study|immigration|0
7325446|NCT00778622|11557731|FG000|Overall Study|Other|1
7325447|NCT00778622|11557732|FG001|Overall Study|Other|0
7325448|NCT00778622|11557733|FG002|Overall Study|Other|1
7325449|NCT00778817|11557754|FG000|Overall Study|Adverse Event|2
7325450|NCT00778817|11557754|FG000|Overall Study|Withdrawal by Subject|2
7531339|NCT02648217|11875449|FG000|Overall Study|Adverse Event|0
7531340|NCT02648217|11875450|FG001|Overall Study|Adverse Event|1
7531341|NCT02648217|11875449|FG000|Overall Study|Lost to Follow-up|1
7531342|NCT02648217|11875450|FG001|Overall Study|Lost to Follow-up|1
7531343|NCT02648217|11875449|FG000|Overall Study|Withdrawal by Subject|4
7531344|NCT02648217|11875450|FG001|Overall Study|Withdrawal by Subject|3
7531345|NCT02648217|11875449|FG000|Overall Study|Unclassified|5
7531346|NCT02648217|11875450|FG001|Overall Study|Unclassified|0
7531347|NCT02648438|11875463|FG000|Overall Study|Eligibility criteria not fulfilled|0
7531348|NCT02648438|11875464|FG001|Overall Study|Eligibility criteria not fulfilled|2
7531349|NCT02648438|11875465|FG002|Overall Study|Eligibility criteria not fulfilled|0
7531350|NCT02648438|11875463|FG000|Overall Study|Protocol Violation|2
7531351|NCT02648438|11875464|FG001|Overall Study|Protocol Violation|0
7531352|NCT02648438|11875465|FG002|Overall Study|Protocol Violation|0
7531353|NCT02648438|11875463|FG000|Overall Study|Withdrawal by Subject|1
7531354|NCT02648438|11875464|FG001|Overall Study|Withdrawal by Subject|1
7531355|NCT02648438|11875465|FG002|Overall Study|Withdrawal by Subject|0
7531356|NCT02648932|11875496|FG000|Overall Study|No transplant|3
7531357|NCT02648932|11875497|FG001|Overall Study|No transplant|1
7531358|NCT02649218|11875550|FG000|Overall Study|Adverse Event|8
7531359|NCT02649218|11875550|FG000|Overall Study|Lack of Efficacy|8
7531360|NCT02649218|11875550|FG000|Overall Study|Pregnancy|3
7531361|NCT02649218|11875550|FG000|Overall Study|Protocol Violation|3
7531362|NCT02649218|11875550|FG000|Overall Study|Physician Decision|1
7531363|NCT02649218|11875550|FG000|Overall Study|Withdrawal by Subject|2
7531364|NCT02649231|11875559|FG000|Overall Study|Adverse Event|0
7531365|NCT02649231|11875560|FG001|Overall Study|Adverse Event|0
7531366|NCT02649231|11875561|FG002|Overall Study|Adverse Event|0
7555358|NCT03054350|11918377|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
7531367|NCT02649231|11875562|FG003|Overall Study|Adverse Event|1
7531368|NCT02649231|11875559|FG000|Overall Study|Lost to Follow-up|2
7574657|NCT03686033|11957625|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
7325451|NCT00778830|11557760|FG000|Overall Study|Ongoing at data cut-off|0
7325452|NCT00778830|11557761|FG001|Overall Study|Ongoing at data cut-off|1
7325453|NCT00778895|11557774|FG000|Active Phase|Adverse Event|3
7325454|NCT00778895|11557775|FG001|Active Phase|Adverse Event|1
7325455|NCT00778895|11557776|FG002|Active Phase|Adverse Event|0
7325456|NCT00778895|11557774|FG000|Active Phase|Withdrawal by Subject|1
7325457|NCT00778895|11557775|FG001|Active Phase|Withdrawal by Subject|4
7325458|NCT00778895|11557776|FG002|Active Phase|Withdrawal by Subject|0
7325459|NCT00778895|11557774|FG000|Active Phase|Lost to Follow-up|1
7325460|NCT00778895|11557775|FG001|Active Phase|Lost to Follow-up|1
7325461|NCT00778895|11557776|FG002|Active Phase|Lost to Follow-up|0
7531369|NCT02649231|11875560|FG001|Overall Study|Lost to Follow-up|1
7531370|NCT02649231|11875561|FG002|Overall Study|Lost to Follow-up|1
7531371|NCT02649231|11875562|FG003|Overall Study|Lost to Follow-up|0
7531372|NCT02649231|11875559|FG000|Overall Study|Withdrawal by Subject|0
7531373|NCT02649231|11875560|FG001|Overall Study|Withdrawal by Subject|1
7531374|NCT02649231|11875561|FG002|Overall Study|Withdrawal by Subject|0
7531375|NCT02649231|11875562|FG003|Overall Study|Withdrawal by Subject|1
7531376|NCT02649231|11875559|FG000|Overall Study|Protocol Violation|2
7531377|NCT02649231|11875560|FG001|Overall Study|Protocol Violation|1
7531378|NCT02649231|11875561|FG002|Overall Study|Protocol Violation|1
7531379|NCT02649231|11875562|FG003|Overall Study|Protocol Violation|0
7325462|NCT00778895|11557774|FG000|Active Phase|Other|2
7325463|NCT00778895|11557775|FG001|Active Phase|Other|0
7325464|NCT00778895|11557776|FG002|Active Phase|Other|0
7325465|NCT00778895|11557774|FG000|ESFU Phase|Adverse Event|2
7325466|NCT00778895|11557775|FG001|ESFU Phase|Adverse Event|1
7325467|NCT00778895|11557776|FG002|ESFU Phase|Adverse Event|0
7325468|NCT00778895|11557774|FG000|ESFU Phase|Withdrawal by Subject|1
7325469|NCT00778895|11557775|FG001|ESFU Phase|Withdrawal by Subject|4
7325470|NCT00778895|11557776|FG002|ESFU Phase|Withdrawal by Subject|0
7325471|NCT00778895|11557774|FG000|ESFU Phase|Lost to Follow-up|6
7325472|NCT00778895|11557775|FG001|ESFU Phase|Lost to Follow-up|7
7325473|NCT00778895|11557776|FG002|ESFU Phase|Lost to Follow-up|2
7325474|NCT00778895|11557774|FG000|ESFU Phase|Other|2
7325475|NCT00778895|11557775|FG001|ESFU Phase|Other|0
7325476|NCT00778895|11557776|FG002|ESFU Phase|Other|0
7325477|NCT00778921|11557788|FG000|Overall Study|Adverse Event|9
7325478|NCT00778921|11557789|FG001|Overall Study|Adverse Event|10
7325479|NCT00778921|11557790|FG002|Overall Study|Adverse Event|14
7325480|NCT00778921|11557788|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7325481|NCT00778921|11557789|FG001|Overall Study|Abnormal Laboratory Value(s)|0
7325482|NCT00778921|11557790|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7325483|NCT00778921|11557788|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
7325484|NCT00778921|11557789|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7325485|NCT00778921|11557790|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
7325486|NCT00778921|11557788|FG000|Overall Study|Unsatisfactory therapeutic response|1
7325487|NCT00778921|11557789|FG001|Overall Study|Unsatisfactory therapeutic response|1
7325488|NCT00778921|11557790|FG002|Overall Study|Unsatisfactory therapeutic response|1
7325489|NCT00778921|11557788|FG000|Overall Study|Patient No Longer Requires Study Drug|0
7325490|NCT00778921|11557789|FG001|Overall Study|Patient No Longer Requires Study Drug|1
7325491|NCT00778921|11557790|FG002|Overall Study|Patient No Longer Requires Study Drug|0
7325492|NCT00778921|11557788|FG000|Overall Study|Patient withdrew request|3
7325493|NCT00778921|11557789|FG001|Overall Study|Patient withdrew request|1
7325494|NCT00778921|11557790|FG002|Overall Study|Patient withdrew request|6
7325495|NCT00778921|11557788|FG000|Overall Study|Lost to Follow-up|0
7325496|NCT00778921|11557789|FG001|Overall Study|Lost to Follow-up|2
7325497|NCT00778921|11557790|FG002|Overall Study|Lost to Follow-up|1
7325498|NCT00778921|11557788|FG000|Overall Study|Administrative Problems|1
7325499|NCT00778921|11557789|FG001|Overall Study|Administrative Problems|2
7325500|NCT00778921|11557790|FG002|Overall Study|Administrative Problems|0
7325501|NCT00778921|11557788|FG000|Overall Study|Protocol Violation|3
7325502|NCT00778921|11557789|FG001|Overall Study|Protocol Violation|0
7325503|NCT00778921|11557790|FG002|Overall Study|Protocol Violation|2
7325504|NCT00778921|11557788|FG000|Overall Study|Not treated|0
7325505|NCT00778921|11557789|FG001|Overall Study|Not treated|2
7325506|NCT00778921|11557790|FG002|Overall Study|Not treated|2
7325507|NCT00779025|11557798|FG000|Overall Study|Withdrawal by Subject|1
7325508|NCT00779142|11557811|FG000|Overall Study|Screen Failures|3
7325509|NCT00779246|11557827|FG000|Overall Study|Missing sufficient data for analysis|33
7325510|NCT00779246|11557828|FG001|Overall Study|Missing sufficient data for analysis|53
7325511|NCT00779259|11557834|FG000|Quinine Alone|Adverse Event|2
7555359|NCT03054350|11918372|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
7555360|NCT03054350|11918373|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
7555361|NCT03054350|11918374|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
7555362|NCT03054350|11918375|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
7555363|NCT03054350|11918376|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
7531380|NCT02649634|11875635|FG000|Overall Study|Withdrawal by Subject|3
7531381|NCT02649634|11875636|FG001|Overall Study|Withdrawal by Subject|5
7531382|NCT02649634|11875635|FG000|Overall Study|Lost to Follow-up|0
7531383|NCT02649634|11875636|FG001|Overall Study|Lost to Follow-up|1
7531384|NCT02649894|11875650|FG000|Overall Study|Adverse Event|1
7325518|NCT00779402|11557888|FG000|Treatment Phase 1|Disease Progression|1
7325519|NCT00779402|11557889|FG001|Treatment Phase 1|Disease Progression|0
7325520|NCT00779402|11557888|FG000|Treatment Phase 1|Adverse Event|2
7325521|NCT00779402|11557889|FG001|Treatment Phase 1|Adverse Event|0
7325522|NCT00779402|11557888|FG000|Treatment Phase 1|Protocol Violation|1
7325523|NCT00779402|11557889|FG001|Treatment Phase 1|Protocol Violation|0
7325524|NCT00779402|11557888|FG000|Treatment Phase 1|Patient Refused to Continue|17
7325525|NCT00779402|11557889|FG001|Treatment Phase 1|Patient Refused to Continue|2
7325526|NCT00779402|11557888|FG000|Treatment Phase 1|Lost to Follow-up|0
7325527|NCT00779402|11557889|FG001|Treatment Phase 1|Lost to Follow-up|1
7325528|NCT00779402|11557888|FG000|Treatment Phase 1|Death|0
7325529|NCT00779402|11557889|FG001|Treatment Phase 1|Death|1
7325530|NCT00779402|11557888|FG000|Treatment Phase 1|Intercurrent Illness|1
7531385|NCT02649894|11875651|FG001|Overall Study|Adverse Event|0
7325531|NCT00779402|11557889|FG001|Treatment Phase 1|Intercurrent Illness|1
7325532|NCT00779402|11557888|FG000|Treatment Phase 1|Withdrawal by Subject|1
7325533|NCT00779402|11557889|FG001|Treatment Phase 1|Withdrawal by Subject|0
7325534|NCT00779402|11557888|FG000|Treatment Phase 1|Other|4
7325535|NCT00779402|11557889|FG001|Treatment Phase 1|Other|2
7325536|NCT00779402|11557888|FG000|Treatment Phase 1|Closure of Study|3
7325537|NCT00779402|11557889|FG001|Treatment Phase 1|Closure of Study|2
7325538|NCT00779402|11557888|FG000|Treatment Phase 1|Completed Protocol Visits|3
7325539|NCT00779402|11557889|FG001|Treatment Phase 1|Completed Protocol Visits|6
7325540|NCT00779402|11557888|FG000|Surveillance Phase|Protocol Violation|0
7325541|NCT00779402|11557889|FG001|Surveillance Phase|Protocol Violation|1
7325542|NCT00779402|11557888|FG000|Surveillance Phase|Patient refused to continue|22
7531386|NCT02649894|11875650|FG000|Overall Study|Physician Decision|0
7531387|NCT02649894|11875651|FG001|Overall Study|Physician Decision|1
7531388|NCT02649894|11875650|FG000|Overall Study|Withdrawal by Subject|5
7531389|NCT02649894|11875651|FG001|Overall Study|Withdrawal by Subject|2
7531390|NCT02649894|11875650|FG000|Overall Study|Lost to Follow-up|2
7531391|NCT02649894|11875651|FG001|Overall Study|Lost to Follow-up|1
7531392|NCT02649894|11875650|FG000|Overall Study|Death|30
7531393|NCT02649894|11875651|FG001|Overall Study|Death|7
7531394|NCT02649894|11875650|FG000|Overall Study|Other, not specified|6
7531395|NCT02649894|11875651|FG001|Overall Study|Other, not specified|0
7531396|NCT02650128|11875657|FG000|Overall Study|Death|2
7531397|NCT02650466|11875694|FG000|Overall Study|Physician Decision|1
7555364|NCT03054350|11918377|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
7555365|NCT03054428|11918411|FG000|Overall Study|Physician Decision|0
7555366|NCT03054428|11918412|FG001|Overall Study|Physician Decision|1
7555367|NCT03054428|11918413|FG002|Overall Study|Physician Decision|1
7555368|NCT03054428|11918411|FG000|Overall Study|Lack of Efficacy|3
7555369|NCT03054428|11918412|FG001|Overall Study|Lack of Efficacy|1
7555370|NCT03054428|11918413|FG002|Overall Study|Lack of Efficacy|0
7555371|NCT03054428|11918411|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
7555372|NCT03054428|11918412|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
7555373|NCT03054428|11918413|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
7555374|NCT03054428|11918411|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
7555375|NCT03054428|11918412|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7555376|NCT03054428|11918413|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
7555377|NCT03054428|11918411|FG000|Overall Study|Transitioned to OLE study|76
7555378|NCT03054428|11918412|FG001|Overall Study|Transitioned to OLE study|76
7555379|NCT03054428|11918413|FG002|Overall Study|Transitioned to OLE study|73
7555380|NCT03054428|11918411|FG000|Overall Study|Withdrawal by Subject|3
7555381|NCT03054428|11918412|FG001|Overall Study|Withdrawal by Subject|2
7555382|NCT03054428|11918413|FG002|Overall Study|Withdrawal by Subject|3
7555383|NCT03054428|11918411|FG000|Overall Study|Lost to Follow-up|0
7555384|NCT03054428|11918412|FG001|Overall Study|Lost to Follow-up|0
7555385|NCT03054428|11918413|FG002|Overall Study|Lost to Follow-up|1
7555386|NCT03054870|11918508|FG000|Day of Ventilation Imaging|Protocol Violation|4
7555387|NCT03054870|11918508|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
7555388|NCT03055195|11918560|FG000|Overall Study|Lack of Efficacy|1
7555389|NCT03055195|11918561|FG001|Overall Study|Lack of Efficacy|0
7325543|NCT00779402|11557889|FG001|Surveillance Phase|Patient refused to continue|14
7325544|NCT00779402|11557888|FG000|Surveillance Phase|Lost to Follow-up|2
7325545|NCT00779402|11557889|FG001|Surveillance Phase|Lost to Follow-up|1
7325546|NCT00779402|11557888|FG000|Surveillance Phase|Death|0
7325547|NCT00779402|11557889|FG001|Surveillance Phase|Death|1
7531398|NCT02650466|11875694|FG000|Overall Study|Withdrawal by Subject|5
7531399|NCT02650466|11875694|FG000|Overall Study|Lost to Follow-up|1
7325548|NCT00779402|11557888|FG000|Surveillance Phase|Intercurrent Illness|2
7325549|NCT00779402|11557889|FG001|Surveillance Phase|Intercurrent Illness|0
7325550|NCT00779402|11557888|FG000|Surveillance Phase|Other|5
7325551|NCT00779402|11557889|FG001|Surveillance Phase|Other|5
7325552|NCT00779402|11557888|FG000|Surveillance Phase|Withdrawal by Subject|4
7325553|NCT00779402|11557889|FG001|Surveillance Phase|Withdrawal by Subject|1
7325554|NCT00779402|11557888|FG000|Surveillance Phase|Closure of study|5
7325555|NCT00779402|11557889|FG001|Surveillance Phase|Closure of study|6
7325556|NCT00779402|11557888|FG000|Surveillance Phase|Completed Protocol Visits|3
7325557|NCT00779402|11557889|FG001|Surveillance Phase|Completed Protocol Visits|2
7325558|NCT00779402|11557888|FG000|Long-term Follow-up|Patient refused to continue|2
7325559|NCT00779402|11557889|FG001|Long-term Follow-up|Patient refused to continue|0
7325560|NCT00779402|11557888|FG000|Long-term Follow-up|Other|5
7325561|NCT00779402|11557889|FG001|Long-term Follow-up|Other|0
7325562|NCT00779402|11557888|FG000|Long-term Follow-up|Closure of Study|8
7325563|NCT00779402|11557889|FG001|Long-term Follow-up|Closure of Study|4
7531400|NCT02650895|11875715|FG000|Overall Study|Withdrawal by Subject|0
7531401|NCT02650895|11875716|FG001|Overall Study|Withdrawal by Subject|1
7531402|NCT02650895|11875717|FG002|Overall Study|Withdrawal by Subject|0
7325564|NCT00779402|11557888|FG000|Long-term Follow-up|Completed Protocol Visits|6
7325565|NCT00779402|11557889|FG001|Long-term Follow-up|Completed Protocol Visits|2
7531403|NCT02650895|11875718|FG003|Overall Study|Withdrawal by Subject|0
7531404|NCT02650895|11875719|FG004|Overall Study|Withdrawal by Subject|0
7555390|NCT03055195|11918560|FG000|Overall Study|Withdrawal by Subject|6
7555391|NCT03055195|11918561|FG001|Overall Study|Withdrawal by Subject|7
7325566|NCT00779467|11557899|FG000|Overall Study|Lack of Efficacy|11
7325567|NCT00779467|11557900|FG001|Overall Study|Lack of Efficacy|2
7325568|NCT00779467|11557901|FG002|Overall Study|Lack of Efficacy|6
7325569|NCT00779467|11557902|FG003|Overall Study|Lack of Efficacy|11
7325570|NCT00779467|11557899|FG000|Overall Study|failed inclusion criteria|3
7325571|NCT00779467|11557900|FG001|Overall Study|failed inclusion criteria|3
7325572|NCT00779467|11557901|FG002|Overall Study|failed inclusion criteria|1
7325573|NCT00779467|11557902|FG003|Overall Study|failed inclusion criteria|2
7325574|NCT00779467|11557899|FG000|Overall Study|missing data|1
7325575|NCT00779467|11557900|FG001|Overall Study|missing data|0
7325576|NCT00779467|11557901|FG002|Overall Study|missing data|1
7325577|NCT00779467|11557902|FG003|Overall Study|missing data|4
7325578|NCT00779467|11557899|FG000|Overall Study|technical issue|0
7325579|NCT00779467|11557900|FG001|Overall Study|technical issue|0
7325580|NCT00779467|11557901|FG002|Overall Study|technical issue|2
7325581|NCT00779467|11557902|FG003|Overall Study|technical issue|1
7325582|NCT00779467|11557899|FG000|Overall Study|unavailable research staff|0
7325583|NCT00779467|11557900|FG001|Overall Study|unavailable research staff|0
7325584|NCT00779467|11557901|FG002|Overall Study|unavailable research staff|0
7325585|NCT00779467|11557902|FG003|Overall Study|unavailable research staff|1
7325586|NCT00779506|11557912|FG000|Overall Study|Screening Failed|2
7325587|NCT00779506|11557912|FG000|Overall Study|Adverse Event|4
7325588|NCT00779506|11557912|FG000|Overall Study|Lack of Efficacy|11
7325589|NCT00779506|11557912|FG000|Overall Study|Protocol Violation|5
7325590|NCT00779506|11557912|FG000|Overall Study|Withdrawal by Subject|6
7325591|NCT00779506|11557912|FG000|Overall Study|Lost to Follow-up|1
7325592|NCT00779584|11557934|FG000|Overall Study|Protocol Violation|0
7325593|NCT00779584|11557935|FG001|Overall Study|Protocol Violation|0
7325594|NCT00779584|11557936|FG002|Overall Study|Protocol Violation|0
7325595|NCT00779584|11557937|FG003|Overall Study|Protocol Violation|0
7325596|NCT00779584|11557938|FG004|Overall Study|Protocol Violation|0
7325597|NCT00779584|11557939|FG005|Overall Study|Protocol Violation|1
7325598|NCT00779584|11557940|FG006|Overall Study|Protocol Violation|0
7417342|NCT01456039|11691428|FG002|Phase 1 (First Step)|Disease Progression|0
7417343|NCT01456039|11691426|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
7417344|NCT01456039|11691427|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
7417345|NCT01456039|11691428|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
7417346|NCT01456039|11691426|FG000|Phase 1 (First Step)|Adverse Event|0
7417347|NCT01456039|11691427|FG001|Phase 1 (First Step)|Adverse Event|3
7417348|NCT01456039|11691428|FG002|Phase 1 (First Step)|Adverse Event|0
7417349|NCT01456039|11691426|FG000|Phase 1 (First Step)|Other|0
7417350|NCT01456039|11691427|FG001|Phase 1 (First Step)|Other|1
7417351|NCT01456039|11691428|FG002|Phase 1 (First Step)|Other|0
7417352|NCT01456039|11691426|FG000|Phase 2 (Second Step)|Disease Progression|0
7417353|NCT01456039|11691427|FG001|Phase 2 (Second Step)|Disease Progression|0
7417354|NCT01456039|11691428|FG002|Phase 2 (Second Step)|Disease Progression|17
7417355|NCT01456039|11691426|FG000|Phase 2 (Second Step)|Adverse Event|0
7417356|NCT01456039|11691427|FG001|Phase 2 (Second Step)|Adverse Event|0
7417357|NCT01456039|11691428|FG002|Phase 2 (Second Step)|Adverse Event|10
7417358|NCT01456039|11691426|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
7417359|NCT01456039|11691427|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
7417360|NCT01456039|11691428|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
7417361|NCT01456039|11691426|FG000|Phase 2 (Second Step)|Protocol Violation|0
7417362|NCT01456039|11691427|FG001|Phase 2 (Second Step)|Protocol Violation|0
7417363|NCT01456039|11691428|FG002|Phase 2 (Second Step)|Protocol Violation|1
7417364|NCT01456039|11691426|FG000|Phase 2 (Second Step)|Other|0
7417365|NCT01456039|11691427|FG001|Phase 2 (Second Step)|Other|0
7417366|NCT01456039|11691428|FG002|Phase 2 (Second Step)|Other|1
7417367|NCT01456052|11691447|FG000|Overall Study|Adverse Event|1
7417368|NCT01456052|11691448|FG001|Overall Study|Adverse Event|1
7417369|NCT01456052|11691449|FG002|Overall Study|Adverse Event|2
7417370|NCT01456052|11691447|FG000|Overall Study|Consent withdrawn|0
7417371|NCT01456052|11691448|FG001|Overall Study|Consent withdrawn|2
7417372|NCT01456052|11691449|FG002|Overall Study|Consent withdrawn|1
7417373|NCT01456052|11691447|FG000|Overall Study|Protocol Violation|0
7417374|NCT01456052|11691448|FG001|Overall Study|Protocol Violation|1
7417375|NCT01456052|11691449|FG002|Overall Study|Protocol Violation|0
7417376|NCT01456052|11691447|FG000|Overall Study|Physician Decision|1
7417377|NCT01456052|11691448|FG001|Overall Study|Physician Decision|0
7417378|NCT01456052|11691449|FG002|Overall Study|Physician Decision|1
7417379|NCT01456052|11691447|FG000|Overall Study|Treatment Failure|0
7417380|NCT01456052|11691448|FG001|Overall Study|Treatment Failure|1
7417381|NCT01456052|11691449|FG002|Overall Study|Treatment Failure|1
7417382|NCT01456130|11691458|FG000|Overall Study|Adverse Event|4
7417383|NCT01456130|11691458|FG000|Overall Study|Voluntary Withdrawal|1
7417384|NCT01456130|11691458|FG000|Overall Study|Lack of Efficacy|4
7325599|NCT00779584|11557941|FG007|Overall Study|Protocol Violation|0
7325600|NCT00779584|11557942|FG008|Overall Study|Protocol Violation|0
7325601|NCT00779584|11557934|FG000|Overall Study|Withdrawal by Subject|1
7417385|NCT01456130|11691458|FG000|Overall Study|Other|1
7417386|NCT01456169|11691469|FG000|Overall Study|Adverse Event|1
7417387|NCT01456169|11691470|FG001|Overall Study|Adverse Event|2
7417388|NCT01456169|11691471|FG002|Overall Study|Adverse Event|7
7417389|NCT01456169|11691469|FG000|Overall Study|Major Protocol Deviation|3
7417390|NCT01456169|11691470|FG001|Overall Study|Major Protocol Deviation|2
7417391|NCT01456169|11691471|FG002|Overall Study|Major Protocol Deviation|3
7417392|NCT01456169|11691469|FG000|Overall Study|Voluntary Withdrawal|3
7325602|NCT00779584|11557935|FG001|Overall Study|Withdrawal by Subject|1
7325603|NCT00779584|11557936|FG002|Overall Study|Withdrawal by Subject|2
7325604|NCT00779584|11557937|FG003|Overall Study|Withdrawal by Subject|0
7325605|NCT00779584|11557938|FG004|Overall Study|Withdrawal by Subject|0
7325606|NCT00779584|11557939|FG005|Overall Study|Withdrawal by Subject|2
7325607|NCT00779584|11557940|FG006|Overall Study|Withdrawal by Subject|1
7325608|NCT00779584|11557941|FG007|Overall Study|Withdrawal by Subject|0
7325609|NCT00779584|11557942|FG008|Overall Study|Withdrawal by Subject|0
7325610|NCT00779584|11557934|FG000|Overall Study|Lost to Follow-up|0
7325611|NCT00779584|11557935|FG001|Overall Study|Lost to Follow-up|0
7325612|NCT00779584|11557936|FG002|Overall Study|Lost to Follow-up|0
7325613|NCT00779584|11557937|FG003|Overall Study|Lost to Follow-up|0
7325614|NCT00779584|11557938|FG004|Overall Study|Lost to Follow-up|1
7325615|NCT00779584|11557939|FG005|Overall Study|Lost to Follow-up|0
7325616|NCT00779584|11557940|FG006|Overall Study|Lost to Follow-up|0
7325617|NCT00779584|11557941|FG007|Overall Study|Lost to Follow-up|0
7325618|NCT00779584|11557942|FG008|Overall Study|Lost to Follow-up|0
7325619|NCT00779584|11557934|FG000|Overall Study|Progression of Disease|0
7325620|NCT00779584|11557935|FG001|Overall Study|Progression of Disease|1
7325621|NCT00779584|11557936|FG002|Overall Study|Progression of Disease|2
7325622|NCT00779584|11557937|FG003|Overall Study|Progression of Disease|6
7325623|NCT00779584|11557938|FG004|Overall Study|Progression of Disease|5
7325624|NCT00779584|11557939|FG005|Overall Study|Progression of Disease|1
7325625|NCT00779584|11557940|FG006|Overall Study|Progression of Disease|4
7325626|NCT00779584|11557941|FG007|Overall Study|Progression of Disease|2
7325627|NCT00779584|11557942|FG008|Overall Study|Progression of Disease|1
7325628|NCT00779584|11557934|FG000|Overall Study|Adverse Event|1
7325629|NCT00779584|11557935|FG001|Overall Study|Adverse Event|0
7325630|NCT00779584|11557936|FG002|Overall Study|Adverse Event|2
7555392|NCT03055195|11918560|FG000|Overall Study|Study Terminated by Sponsor|2
7555393|NCT03055195|11918561|FG001|Overall Study|Study Terminated by Sponsor|6
7555394|NCT03055195|11918560|FG000|Overall Study|Protocol Violation|2
7325631|NCT00779584|11557937|FG003|Overall Study|Adverse Event|0
7325632|NCT00779584|11557938|FG004|Overall Study|Adverse Event|0
7325633|NCT00779584|11557939|FG005|Overall Study|Adverse Event|0
7325634|NCT00779584|11557940|FG006|Overall Study|Adverse Event|2
7325635|NCT00779584|11557941|FG007|Overall Study|Adverse Event|1
7325636|NCT00779584|11557942|FG008|Overall Study|Adverse Event|1
7325637|NCT00779584|11557934|FG000|Overall Study|Symptomatic Deterioration|1
7325638|NCT00779584|11557935|FG001|Overall Study|Symptomatic Deterioration|1
7325639|NCT00779584|11557936|FG002|Overall Study|Symptomatic Deterioration|1
7325640|NCT00779584|11557937|FG003|Overall Study|Symptomatic Deterioration|0
7325641|NCT00779584|11557938|FG004|Overall Study|Symptomatic Deterioration|0
7325642|NCT00779584|11557939|FG005|Overall Study|Symptomatic Deterioration|1
7325643|NCT00779584|11557940|FG006|Overall Study|Symptomatic Deterioration|1
7325644|NCT00779584|11557941|FG007|Overall Study|Symptomatic Deterioration|0
7325645|NCT00779584|11557942|FG008|Overall Study|Symptomatic Deterioration|0
7325646|NCT00779584|11557934|FG000|Overall Study|Ongoing in Study|0
7325647|NCT00779584|11557935|FG001|Overall Study|Ongoing in Study|0
7325648|NCT00779584|11557936|FG002|Overall Study|Ongoing in Study|0
7325649|NCT00779584|11557937|FG003|Overall Study|Ongoing in Study|0
7325650|NCT00779584|11557938|FG004|Overall Study|Ongoing in Study|1
7325651|NCT00779584|11557939|FG005|Overall Study|Ongoing in Study|1
7325652|NCT00779584|11557940|FG006|Overall Study|Ongoing in Study|0
7325653|NCT00779584|11557941|FG007|Overall Study|Ongoing in Study|0
7325654|NCT00779584|11557942|FG008|Overall Study|Ongoing in Study|0
7325655|NCT00779675|11557962|FG000|Treatment Period|Adverse Event|87
7325656|NCT00779675|11557962|FG000|Treatment Period|Treatment Failure|80
7325657|NCT00779675|11557962|FG000|Treatment Period|Transferred to Another Study|38
7325658|NCT00779675|11557962|FG000|Treatment Period|Lost to Follow-up|23
7325659|NCT00779675|11557962|FG000|Treatment Period|Withdrawal by Subject|46
7325660|NCT00779675|11557962|FG000|Treatment Period|Protocol Violation|54
7325661|NCT00779675|11557962|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
7325662|NCT00779675|11557962|FG000|Treatment Period|Administrative|3
7325663|NCT00779675|11557962|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
7325664|NCT00779675|11557962|FG000|Extended Treatment Period|Protocol Violation|13
7325665|NCT00779675|11557962|FG000|Extended Treatment Period|Adverse Event|6
7325666|NCT00779675|11557962|FG000|Extended Treatment Period|Treatment Failure|11
7325667|NCT00779675|11557962|FG000|Extended Treatment Period|Protocol defined clinical event|1
7325668|NCT00779675|11557962|FG000|Extended Treatment Period|Lost to Follow-up|6
7384929|NCT01197794|11642375|FG004|Overall Study|Protocol Violation|2
7384930|NCT01197794|11642376|FG005|Overall Study|Protocol Violation|0
7384931|NCT01197794|11642377|FG006|Overall Study|Protocol Violation|1
7384932|NCT01197794|11642371|FG000|Overall Study|Development of study withdrawal criteria|3
7384933|NCT01197794|11642372|FG001|Overall Study|Development of study withdrawal criteria|0
7417393|NCT01456169|11691470|FG001|Overall Study|Voluntary Withdrawal|0
7384934|NCT01197794|11642373|FG002|Overall Study|Development of study withdrawal criteria|0
7384935|NCT01197794|11642374|FG003|Overall Study|Development of study withdrawal criteria|1
7384936|NCT01197794|11642375|FG004|Overall Study|Development of study withdrawal criteria|0
7384937|NCT01197794|11642376|FG005|Overall Study|Development of study withdrawal criteria|0
7384938|NCT01197794|11642377|FG006|Overall Study|Development of study withdrawal criteria|1
7417394|NCT01456169|11691471|FG002|Overall Study|Voluntary Withdrawal|2
7325669|NCT00779766|11557976|FG000|Month 24|Serious Adverse Event|2
7325670|NCT00779766|11557977|FG001|Month 24|Serious Adverse Event|3
7325671|NCT00779766|11557976|FG000|Month 24|Adverse Event|3
7531405|NCT02650895|11875720|FG005|Overall Study|Withdrawal by Subject|0
7325672|NCT00779766|11557977|FG001|Month 24|Adverse Event|3
7325673|NCT00779766|11557976|FG000|Month 24|Protocol Violation|3
7325674|NCT00779766|11557977|FG001|Month 24|Protocol Violation|1
7325675|NCT00779766|11557976|FG000|Month 24|Withdrawal by Subject|159
7325676|NCT00779766|11557977|FG001|Month 24|Withdrawal by Subject|127
7325677|NCT00779766|11557976|FG000|Month 24|Migrated/moved from study area|138
7325678|NCT00779766|11557977|FG001|Month 24|Migrated/moved from study area|162
7325679|NCT00779766|11557976|FG000|Month 24|Lost to Follow-up|9
7325680|NCT00779766|11557977|FG001|Month 24|Lost to Follow-up|9
7325681|NCT00779766|11557976|FG000|Month 24|Other|18
7325682|NCT00779766|11557977|FG001|Month 24|Other|27
7325683|NCT00779766|11557976|FG000|Month 48|Withdrawal by Subject|68
7325684|NCT00779766|11557977|FG001|Month 48|Withdrawal by Subject|63
7325685|NCT00779766|11557976|FG000|Month 48|Migrated/moved from study area|76
7325686|NCT00779766|11557977|FG001|Month 48|Migrated/moved from study area|75
7325687|NCT00779766|11557976|FG000|Month 48|Lost to Follow-up|29
7325688|NCT00779766|11557977|FG001|Month 48|Lost to Follow-up|30
7325689|NCT00779766|11557976|FG000|Month 48|Other|1
7325690|NCT00779766|11557977|FG001|Month 48|Other|0
7325691|NCT00779766|11557976|FG000|Month 72|Withdrawal by Subject|55
7325692|NCT00779766|11557977|FG001|Month 72|Withdrawal by Subject|71
7325693|NCT00779766|11557976|FG000|Month 72|Migrated/moved from study area|124
7325694|NCT00779766|11557977|FG001|Month 72|Migrated/moved from study area|109
7417395|NCT01456169|11691469|FG000|Overall Study|Lack of Efficacy|2
7417396|NCT01456169|11691470|FG001|Overall Study|Lack of Efficacy|0
7417397|NCT01456169|11691471|FG002|Overall Study|Lack of Efficacy|0
7417398|NCT01456169|11691469|FG000|Overall Study|Other|1
7417399|NCT01456169|11691470|FG001|Overall Study|Other|1
7417400|NCT01456169|11691471|FG002|Overall Study|Other|0
7417401|NCT01456195|11691483|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7417402|NCT01456195|11691484|FG001|Overall Study|Pretreatment Event/Adverse Event|4
7417403|NCT01456195|11691485|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7417404|NCT01456195|11691483|FG000|Overall Study|Lost to Follow-up|3
7417405|NCT01456195|11691484|FG001|Overall Study|Lost to Follow-up|1
7417406|NCT01456195|11691485|FG002|Overall Study|Lost to Follow-up|3
7417407|NCT01456195|11691483|FG000|Overall Study|Voluntary Withdrawal|5
7417408|NCT01456195|11691484|FG001|Overall Study|Voluntary Withdrawal|3
7417409|NCT01456195|11691485|FG002|Overall Study|Voluntary Withdrawal|7
7417410|NCT01456195|11691483|FG000|Overall Study|Lack of Efficacy|0
7417411|NCT01456195|11691484|FG001|Overall Study|Lack of Efficacy|1
7417412|NCT01456195|11691485|FG002|Overall Study|Lack of Efficacy|0
7417413|NCT01456195|11691483|FG000|Overall Study|Other Reasons|2
7417414|NCT01456195|11691484|FG001|Overall Study|Other Reasons|1
7417415|NCT01456195|11691485|FG002|Overall Study|Other Reasons|3
7417416|NCT01456221|11691495|FG000|Overall Study|Withdrawal by Subject|56
7417417|NCT01456221|11691496|FG001|Overall Study|Withdrawal by Subject|49
7417418|NCT01456221|11691495|FG000|Overall Study|Lost to Follow-up|1
7417419|NCT01456221|11691496|FG001|Overall Study|Lost to Follow-up|4
7417420|NCT01456221|11691495|FG000|Overall Study|Received medication|3
7417421|NCT01456221|11691496|FG001|Overall Study|Received medication|2
7417422|NCT01456221|11691495|FG000|Overall Study|Incomplete data|4
7417423|NCT01456221|11691496|FG001|Overall Study|Incomplete data|2
7417424|NCT01456780|11691527|FG000|Overall Study|Lost to Follow-up|3
7417425|NCT01456780|11691528|FG001|Overall Study|Lost to Follow-up|3
7417426|NCT01456780|11691529|FG002|Overall Study|Lost to Follow-up|0
7417427|NCT01456897|11691539|FG000|Overall Study|Adverse Event|19
7417428|NCT01456897|11691540|FG001|Overall Study|Adverse Event|22
7417429|NCT01456897|11691539|FG000|Overall Study|Protocol Violation|3
7417430|NCT01456897|11691540|FG001|Overall Study|Protocol Violation|4
7417431|NCT01456897|11691539|FG000|Overall Study|Physician Decision|5
7417432|NCT01456897|11691540|FG001|Overall Study|Physician Decision|3
7417433|NCT01456897|11691539|FG000|Overall Study|Withdrawal by Subject|44
7325695|NCT00779766|11557976|FG000|Month 72|Lost to Follow-up|6
7325696|NCT00779766|11557977|FG001|Month 72|Lost to Follow-up|8
7325697|NCT00779766|11557976|FG000|Month 72|Other|0
7325698|NCT00779766|11557977|FG001|Month 72|Other|1
7325699|NCT00779779|11557984|FG000|Overall Study|Adverse Event|1
7325700|NCT00779779|11557984|FG000|Overall Study|Protocol Violation|14
7325701|NCT00779779|11557984|FG000|Overall Study|Withdrawal by Subject|4
7325702|NCT00779779|11557984|FG000|Overall Study|Lost to Follow-up|5
7325703|NCT00779857|11557988|FG000|Overall Study|Death|1
7325704|NCT00779857|11557988|FG000|Overall Study|Withdrawal by Subject|3
7417434|NCT01456897|11691540|FG001|Overall Study|Withdrawal by Subject|17
7417435|NCT01456897|11691539|FG000|Overall Study|Lack of Efficacy|4
7417436|NCT01456897|11691540|FG001|Overall Study|Lack of Efficacy|11
7417437|NCT01456936|11691550|FG000|Overall Study|Other reason|41
7417438|NCT01456936|11691551|FG001|Overall Study|Other reason|30
7325705|NCT00779857|11557988|FG000|Overall Study|Missed Visit|2
7325706|NCT00779909|11558009|FG000|Overall Study|Lost to Follow-up|1
7417439|NCT01456936|11691552|FG002|Overall Study|Other reason|36
7325707|NCT00779909|11558010|FG001|Overall Study|Lost to Follow-up|0
7325708|NCT00779909|11558011|FG002|Overall Study|Lost to Follow-up|0
7325709|NCT00779909|11558012|FG003|Overall Study|Lost to Follow-up|1
7325710|NCT00779909|11558009|FG000|Overall Study|Withdrawal by Subject|0
7325711|NCT00779909|11558010|FG001|Overall Study|Withdrawal by Subject|1
7325712|NCT00779909|11558011|FG002|Overall Study|Withdrawal by Subject|0
7325713|NCT00779909|11558012|FG003|Overall Study|Withdrawal by Subject|0
7325714|NCT00780143|11558038|FG000|Overall Study|Progressive disease|1
7325715|NCT00780143|11558038|FG000|Overall Study|Toxicity|1
7325716|NCT00780143|11558038|FG000|Overall Study|Adverse Event|1
7325717|NCT00780273|11558055|FG000|Overall Study|Death|1
7325718|NCT00780273|11558055|FG000|Overall Study|Lost to Follow-up|1
7325719|NCT00780416|11558075|FG000|Overall Study|Physician Decision|3
7325720|NCT00780416|11558076|FG001|Overall Study|Physician Decision|3
7325721|NCT00780416|11558075|FG000|Overall Study|Protocol Violation|1
7325722|NCT00780416|11558076|FG001|Overall Study|Protocol Violation|0
7325723|NCT00780416|11558075|FG000|Overall Study|Withdrawal by Subject|8
7325724|NCT00780416|11558076|FG001|Overall Study|Withdrawal by Subject|6
7325725|NCT00780559|11558097|FG000|Overall Study|Lost to Follow-up|2
7325726|NCT00780559|11558098|FG001|Overall Study|Lost to Follow-up|7
7325727|NCT00780559|11558097|FG000|Overall Study|Death|1
7325728|NCT00780559|11558098|FG001|Overall Study|Death|0
7325729|NCT00780910|11558157|FG000|Overall Study|Adverse Event|2
7325730|NCT00780975|11558170|FG000|Overall Study|Progressive disease|3
7325731|NCT00780975|11558170|FG000|Overall Study|Toxicity|5
7325732|NCT00781274|11558183|FG000|Overall Study|Withdrawal by Subject|2
7325733|NCT00781326|11558187|FG000|Phase I|Adverse Event|1
7325734|NCT00781326|11558187|FG000|Phase I|Withdrawal by Subject|1
7325735|NCT00781326|11558187|FG000|Phase I|Physician Decision|2
7325736|NCT00781365|11558193|FG000|Overall Study|Withdrawal by Subject|13
7325737|NCT00781365|11558194|FG001|Overall Study|Withdrawal by Subject|8
7325738|NCT00781365|11558193|FG000|Overall Study|Did Not Attend Visit|20
7325739|NCT00781365|11558194|FG001|Overall Study|Did Not Attend Visit|28
7325740|NCT00781365|11558193|FG000|Overall Study|Language barrier|1
7325741|NCT00781365|11558194|FG001|Overall Study|Language barrier|0
7325742|NCT00781391|11558203|FG000|Overall Study|never received study drug|24
7325743|NCT00781391|11558204|FG001|Overall Study|never received study drug|23
7325744|NCT00781391|11558205|FG002|Overall Study|never received study drug|32
7325745|NCT00781391|11558203|FG000|Overall Study|Protocol Violation|19
7325746|NCT00781391|11558204|FG001|Overall Study|Protocol Violation|17
7325747|NCT00781391|11558205|FG002|Overall Study|Protocol Violation|20
7325748|NCT00781391|11558203|FG000|Overall Study|Death|789
7325749|NCT00781391|11558204|FG001|Overall Study|Death|730
7325750|NCT00781391|11558205|FG002|Overall Study|Death|706
7325751|NCT00781391|11558203|FG000|Overall Study|Withdrawal by Subject|47
7555395|NCT03055195|11918561|FG001|Overall Study|Protocol Violation|1
7555396|NCT03055195|11918560|FG000|Overall Study|Physician Decision|1
7555397|NCT03055195|11918561|FG001|Overall Study|Physician Decision|0
7555398|NCT03055221|11918567|FG000|Overall Study|Adverse Event|2
7555399|NCT03055221|11918567|FG000|Overall Study|Withdrawal by Subject|4
7555400|NCT03055221|11918567|FG000|Overall Study|Death|6
7555401|NCT03055221|11918567|FG000|Overall Study|Physician Decision|1
7555402|NCT03055221|11918567|FG000|Overall Study|Study terminated by Sponsor|3
7555403|NCT03055260|11918573|FG000|Overall Study|Withdrawal by Subject|1
7555404|NCT03055260|11918574|FG001|Overall Study|Withdrawal by Subject|0
7555405|NCT03055338|11918583|FG000|Overall Study|Lost to Follow-up|9
7555406|NCT03055338|11918584|FG001|Overall Study|Lost to Follow-up|2
7555407|NCT03055338|11918585|FG002|Overall Study|Lost to Follow-up|3
7555408|NCT03055338|11918583|FG000|Overall Study|No Post-treatment Protocol Contact|0
7555409|NCT03055338|11918584|FG001|Overall Study|No Post-treatment Protocol Contact|1
7555410|NCT03055338|11918585|FG002|Overall Study|No Post-treatment Protocol Contact|0
7555411|NCT03055338|11918583|FG000|Overall Study|Physician Decision|0
7555412|NCT03055338|11918584|FG001|Overall Study|Physician Decision|0
7555413|NCT03055338|11918585|FG002|Overall Study|Physician Decision|2
7555414|NCT03055338|11918583|FG000|Overall Study|Withdrawal by Subject|9
7555415|NCT03055338|11918584|FG001|Overall Study|Withdrawal by Subject|8
7555416|NCT03055338|11918585|FG002|Overall Study|Withdrawal by Subject|7
7555417|NCT03055494|11918595|FG000|Overall Study|Lost to Follow-up|6
7555418|NCT03055494|11918596|FG001|Overall Study|Lost to Follow-up|0
7555419|NCT03055494|11918595|FG000|Overall Study|Physician Decision|2
7555420|NCT03055494|11918596|FG001|Overall Study|Physician Decision|0
7555421|NCT03055494|11918595|FG000|Overall Study|Withdrawal by Subject|1
7555422|NCT03055494|11918596|FG001|Overall Study|Withdrawal by Subject|0
7555423|NCT03055494|11918595|FG000|Overall Study|Adverse Event|0
7555424|NCT03055494|11918596|FG001|Overall Study|Adverse Event|1
7555425|NCT03055494|11918595|FG000|Overall Study|Non-compliance with study treatment|1
7555426|NCT03055494|11918596|FG001|Overall Study|Non-compliance with study treatment|0
7555427|NCT03055624|11918603|FG000|Overall Study|Study closed|9
7555428|NCT03055806|11918615|FG000|Overall Study|Adverse Event|0
7555429|NCT03055806|11918616|FG001|Overall Study|Adverse Event|0
7555430|NCT03055806|11918617|FG002|Overall Study|Adverse Event|1
7555431|NCT03055806|11918618|FG003|Overall Study|Adverse Event|1
7325752|NCT00781391|11558204|FG001|Overall Study|Withdrawal by Subject|37
7325753|NCT00781391|11558205|FG002|Overall Study|Withdrawal by Subject|25
7325754|NCT00781391|11558203|FG000|Overall Study|Lost to Follow-up|0
7325755|NCT00781391|11558204|FG001|Overall Study|Lost to Follow-up|0
7325756|NCT00781391|11558205|FG002|Overall Study|Lost to Follow-up|1
7325757|NCT00781456|11558215|FG000|Overall Study|Adverse Event|3
7325758|NCT00781456|11558216|FG001|Overall Study|Adverse Event|3
7325759|NCT00781456|11558215|FG000|Overall Study|Withdrawal by Subject|3
7325760|NCT00781456|11558216|FG001|Overall Study|Withdrawal by Subject|5
7325761|NCT00781456|11558215|FG000|Overall Study|Protocol Violation|4
7325762|NCT00781456|11558216|FG001|Overall Study|Protocol Violation|1
7325763|NCT00781456|11558215|FG000|Overall Study|Noncompliance With Protocol|1
7325764|NCT00781456|11558216|FG001|Overall Study|Noncompliance With Protocol|1
7325765|NCT00781456|11558215|FG000|Overall Study|Lost to Follow-up|10
7325766|NCT00781456|11558216|FG001|Overall Study|Lost to Follow-up|5
7325767|NCT00781456|11558215|FG000|Overall Study|Other Reason, Unknown|0
7325768|NCT00781456|11558216|FG001|Overall Study|Other Reason, Unknown|1
7325769|NCT00781599|11558235|FG000|Overall Study|Lost to Follow-up|7
7325770|NCT00781599|11558236|FG001|Overall Study|Lost to Follow-up|4
7325771|NCT00781768|11558244|FG000|Overall Study|Not transplanted.|0
7325772|NCT00781768|11558245|FG001|Overall Study|Not transplanted.|2
7325773|NCT00781859|11558253|FG000|Overall Study|Adverse Event|2
7325774|NCT00781859|11558254|FG001|Overall Study|Adverse Event|2
7325775|NCT00781859|11558253|FG000|Overall Study|Withdrawal by Subject|8
7325776|NCT00781859|11558254|FG001|Overall Study|Withdrawal by Subject|4
7325777|NCT00781859|11558253|FG000|Overall Study|Lost to Follow-up|6
7325778|NCT00781859|11558254|FG001|Overall Study|Lost to Follow-up|3
7325779|NCT00781859|11558253|FG000|Overall Study|Death|3
7325780|NCT00781859|11558254|FG001|Overall Study|Death|0
7325781|NCT00781885|11558260|FG000|Overall Study|Physician Decision|1
7325782|NCT00781911|11558275|FG000|Overall Study|Adverse Event|4
7325783|NCT00781911|11558276|FG001|Overall Study|Adverse Event|4
7325784|NCT00781911|11558275|FG000|Overall Study|Withdrawal by Subject|1
7325785|NCT00781911|11558276|FG001|Overall Study|Withdrawal by Subject|2
7325786|NCT00781911|11558275|FG000|Overall Study|Physician Decision|0
7325787|NCT00781911|11558276|FG001|Overall Study|Physician Decision|2
7325788|NCT00781911|11558275|FG000|Overall Study|Sponsor Decision|1
7325789|NCT00781911|11558276|FG001|Overall Study|Sponsor Decision|0
7325790|NCT00781937|11558286|FG000|Main Trial Period Through Week 56|Adverse Event|18
7325791|NCT00781937|11558287|FG001|Main Trial Period Through Week 56|Adverse Event|18
7325792|NCT00781937|11558286|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
7325793|NCT00781937|11558287|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
7325794|NCT00781937|11558286|FG000|Main Trial Period Through Week 56|Protocol Violation|8
7325795|NCT00781937|11558287|FG001|Main Trial Period Through Week 56|Protocol Violation|5
7325796|NCT00781937|11558286|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
7325797|NCT00781937|11558287|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
7325798|NCT00781937|11558286|FG000|Main Trial Period Through Week 56|Unclassified|10
7325799|NCT00781937|11558287|FG001|Main Trial Period Through Week 56|Unclassified|15
7325800|NCT00781937|11558286|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
7325801|NCT00781937|11558287|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
7325802|NCT00781937|11558286|FG000|Follow up Period (Week 56-68)|Unclassified|5
7325803|NCT00781937|11558287|FG001|Follow up Period (Week 56-68)|Unclassified|4
7325804|NCT00781963|11558305|FG000|Overall Study|Death|3
7325805|NCT00781963|11558306|FG001|Overall Study|Death|0
7325806|NCT00781963|11558305|FG000|Overall Study|Lost to Follow-up|2
7325807|NCT00781963|11558306|FG001|Overall Study|Lost to Follow-up|1
7325808|NCT00781963|11558305|FG000|Overall Study|Withdrawal by Subject|3
7325809|NCT00781963|11558306|FG001|Overall Study|Withdrawal by Subject|1
7325810|NCT00781963|11558305|FG000|Overall Study|Refused follow-up|9
7325811|NCT00781963|11558306|FG001|Overall Study|Refused follow-up|0
7325812|NCT00782067|11558312|FG000|Overall Study|Adverse Event|35
7325813|NCT00782067|11558312|FG000|Overall Study|Subject withdrew consent|11
7325814|NCT00782067|11558312|FG000|Overall Study|Lost to Follow-up|2
7325815|NCT00782067|11558312|FG000|Overall Study|Administrative problems|14
7325816|NCT00782067|11558312|FG000|Overall Study|Death|9
7325817|NCT00782067|11558312|FG000|Overall Study|Disease progression|43
7325818|NCT00782067|11558312|FG000|Overall Study|Protocol deviation|2
7325819|NCT00782171|11558318|FG000|Overall Study|Lost to Follow-up|2
7325820|NCT00782171|11558319|FG001|Overall Study|Lost to Follow-up|2
7325821|NCT00782171|11558318|FG000|Overall Study|Withdrawal by Subject|2
7325822|NCT00782171|11558319|FG001|Overall Study|Withdrawal by Subject|1
7325823|NCT00782171|11558318|FG000|Overall Study|complications|3
7325824|NCT00782171|11558319|FG001|Overall Study|complications|1
7325825|NCT00782171|11558318|FG000|Overall Study|others|7
7325826|NCT00782171|11558319|FG001|Overall Study|others|9
7325827|NCT00782171|11558318|FG000|Overall Study|not eligible|8
7325828|NCT00782171|11558319|FG001|Overall Study|not eligible|6
7325829|NCT00782210|11558328|FG000|Overall Study|Adverse Event|21
7325830|NCT00782210|11558329|FG001|Overall Study|Adverse Event|17
7325831|NCT00782210|11558330|FG002|Overall Study|Adverse Event|16
7325832|NCT00782210|11558328|FG000|Overall Study|Lost to Follow-up|2
7325833|NCT00782210|11558329|FG001|Overall Study|Lost to Follow-up|1
7325834|NCT00782210|11558330|FG002|Overall Study|Lost to Follow-up|2
7325835|NCT00782210|11558328|FG000|Overall Study|Withdrawal by Subject|11
7325836|NCT00782210|11558329|FG001|Overall Study|Withdrawal by Subject|8
7325837|NCT00782210|11558330|FG002|Overall Study|Withdrawal by Subject|11
7325838|NCT00782210|11558328|FG000|Overall Study|Non compliance with protocol|0
7325839|NCT00782210|11558329|FG001|Overall Study|Non compliance with protocol|3
7325840|NCT00782210|11558330|FG002|Overall Study|Non compliance with protocol|2
7325841|NCT00782210|11558328|FG000|Overall Study|Lack of Efficacy|13
7325842|NCT00782210|11558329|FG001|Overall Study|Lack of Efficacy|4
7325843|NCT00782210|11558330|FG002|Overall Study|Lack of Efficacy|1
7325844|NCT00782210|11558328|FG000|Overall Study|Other reason not described above|3
7325845|NCT00782210|11558329|FG001|Overall Study|Other reason not described above|2
7325846|NCT00782210|11558330|FG002|Overall Study|Other reason not described above|3
7325847|NCT00782275|11558347|FG000|Overall Study|Adverse Event|11
7325848|NCT00782275|11558347|FG000|Overall Study|Withdrawal by Subject|1
7325849|NCT00782275|11558347|FG000|Overall Study|Progressive Disease|21
7325850|NCT00782275|11558347|FG000|Overall Study|Physician Decision|4
7325851|NCT00782275|11558347|FG000|Overall Study|Not started treatment|1
7325852|NCT00782275|11558347|FG000|Overall Study|Other|3
7325853|NCT00782340|11558354|FG000|Open Label Titration|Adverse Event|12
7325854|NCT00782340|11558355|FG001|Open Label Titration|Adverse Event|0
7325855|NCT00782340|11558356|FG002|Open Label Titration|Adverse Event|0
7325856|NCT00782340|11558354|FG000|Open Label Titration|Treatment failure|50
7325857|NCT00782340|11558355|FG001|Open Label Titration|Treatment failure|0
7325858|NCT00782340|11558356|FG002|Open Label Titration|Treatment failure|0
7325859|NCT00782340|11558354|FG000|Open Label Titration|Protocol Violation|5
7325860|NCT00782340|11558355|FG001|Open Label Titration|Protocol Violation|0
7325861|NCT00782340|11558356|FG002|Open Label Titration|Protocol Violation|0
7325862|NCT00782340|11558354|FG000|Open Label Titration|Withdrawal by Subject|5
7325863|NCT00782340|11558355|FG001|Open Label Titration|Withdrawal by Subject|0
7325864|NCT00782340|11558356|FG002|Open Label Titration|Withdrawal by Subject|0
7325865|NCT00782340|11558354|FG000|Open Label Titration|Enrollment capped|16
7325866|NCT00782340|11558355|FG001|Open Label Titration|Enrollment capped|0
7325867|NCT00782340|11558356|FG002|Open Label Titration|Enrollment capped|0
7325868|NCT00782340|11558354|FG000|Open Label Titration|Did not meet responder criteria|2
7325869|NCT00782340|11558355|FG001|Open Label Titration|Did not meet responder criteria|0
7325870|NCT00782340|11558356|FG002|Open Label Titration|Did not meet responder criteria|0
7325871|NCT00782340|11558354|FG000|Open Label Titration|Lost to Follow-up|5
7325872|NCT00782340|11558355|FG001|Open Label Titration|Lost to Follow-up|0
7325873|NCT00782340|11558356|FG002|Open Label Titration|Lost to Follow-up|0
7325874|NCT00782340|11558354|FG000|Open Label Titration|Randomized in error|6
7325875|NCT00782340|11558355|FG001|Open Label Titration|Randomized in error|0
7325876|NCT00782340|11558356|FG002|Open Label Titration|Randomized in error|0
7325877|NCT00782418|11558367|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
7325878|NCT00782418|11558368|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325879|NCT00782418|11558369|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325880|NCT00782418|11558370|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325881|NCT00782418|11558371|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325882|NCT00782418|11558372|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325883|NCT00782418|11558373|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
7325884|NCT00782418|11558367|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7325885|NCT00782418|11558368|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7325886|NCT00782418|11558369|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7325887|NCT00782418|11558370|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7325888|NCT00782418|11558371|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7531410|NCT02651116|11875755|FG000|Overall Study|Adverse Event|0
7531411|NCT02651116|11875756|FG001|Overall Study|Adverse Event|1
7531412|NCT02651116|11875755|FG000|Overall Study|No Longer Willing To Participate In Study|1
7531413|NCT02651116|11875756|FG001|Overall Study|No Longer Willing To Participate In Study|0
7531414|NCT02651155|11875764|FG000|Overall Study|Pretreatment Event/Adverse Event|1
7531415|NCT02651155|11875765|FG001|Overall Study|Pretreatment Event/Adverse Event|2
7531416|NCT02651155|11875764|FG000|Overall Study|Voluntary Withdrawal|5
7531417|NCT02651155|11875765|FG001|Overall Study|Voluntary Withdrawal|0
7531418|NCT02651194|11875771|FG000|Overall Study|Lost to Follow-up|3
7531419|NCT02651194|11875771|FG000|Overall Study|Other|2
7325889|NCT00782418|11558372|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
7325890|NCT00782418|11558373|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
7325891|NCT00782496|11558389|FG000|Overall Study|Lost to Follow-up|14
7325892|NCT00782496|11558390|FG001|Overall Study|Lost to Follow-up|15
7325893|NCT00782509|11558400|FG000|Overall Study|Adverse Event|20
7325894|NCT00782509|11558401|FG001|Overall Study|Adverse Event|10
7325895|NCT00782509|11558402|FG002|Overall Study|Adverse Event|20
7325896|NCT00782509|11558400|FG000|Overall Study|Lost to Follow-up|1
7325897|NCT00782509|11558401|FG001|Overall Study|Lost to Follow-up|2
7325898|NCT00782509|11558402|FG002|Overall Study|Lost to Follow-up|3
7325899|NCT00782509|11558400|FG000|Overall Study|Withdrawal by Subject|3
7325900|NCT00782509|11558401|FG001|Overall Study|Withdrawal by Subject|5
7325901|NCT00782509|11558402|FG002|Overall Study|Withdrawal by Subject|8
7325902|NCT00782509|11558400|FG000|Overall Study|Non compliance with protocol|2
7325903|NCT00782509|11558401|FG001|Overall Study|Non compliance with protocol|0
7531420|NCT02651220|11875778|FG000|Overall Study|Adverse Event|1
7325904|NCT00782509|11558402|FG002|Overall Study|Non compliance with protocol|0
7387569|NCT01215097|11646122|FG001|Overall Study|Withdrawal by Subject|3
7531421|NCT02651220|11875779|FG001|Overall Study|Adverse Event|5
7325905|NCT00782509|11558400|FG000|Overall Study|Other reasons not stated above|5
7325906|NCT00782509|11558401|FG001|Overall Study|Other reasons not stated above|2
7325907|NCT00782509|11558402|FG002|Overall Study|Other reasons not stated above|3
7325908|NCT00782509|11558400|FG000|Overall Study|Lack of Efficacy|10
7325909|NCT00782509|11558401|FG001|Overall Study|Lack of Efficacy|5
7325910|NCT00782509|11558402|FG002|Overall Study|Lack of Efficacy|2
7325911|NCT00782626|11558417|FG000|Overall Study|Adverse Event|1
7325912|NCT00782626|11558417|FG000|Overall Study|Progressive Disease|5
7325913|NCT00782626|11558417|FG000|Overall Study|Other Complicating Disease|1
7325914|NCT00782717|11558434|FG000|Overall Study|Adverse Event|2
7325915|NCT00782717|11558435|FG001|Overall Study|Adverse Event|5
7325916|NCT00782717|11558434|FG000|Overall Study|Patient decision unrelated to AE|6
7325917|NCT00782717|11558435|FG001|Overall Study|Patient decision unrelated to AE|3
7325918|NCT00782717|11558434|FG000|Overall Study|Noncompliance|2
7325919|NCT00782717|11558435|FG001|Overall Study|Noncompliance|1
7325920|NCT00782717|11558434|FG000|Overall Study|Treatment failure|3
7325921|NCT00782717|11558435|FG001|Overall Study|Treatment failure|14
7325922|NCT00782717|11558434|FG000|Overall Study|Enrollment close prior to surgery|1
7325923|NCT00782717|11558435|FG001|Overall Study|Enrollment close prior to surgery|0
7325924|NCT00782717|11558434|FG000|Overall Study|Did not meet entrance criteria|1
7325925|NCT00782717|11558435|FG001|Overall Study|Did not meet entrance criteria|3
7325926|NCT00782717|11558434|FG000|Overall Study|Exited in error|0
7325927|NCT00782717|11558435|FG001|Overall Study|Exited in error|2
7325928|NCT00782795|11558447|FG000|Overall Study|Withdrawal by Subject|1
7325929|NCT00782795|11558448|FG001|Overall Study|Withdrawal by Subject|2
7325930|NCT00782834|11558478|FG000|Treatment Phase|fibrous tumor not GIST|1
7325931|NCT00783094|11558485|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
7325932|NCT00783094|11558486|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
7325933|NCT00783094|11558487|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
7325934|NCT00783094|11558485|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
7325935|NCT00783094|11558486|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
7325936|NCT00783094|11558487|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
7325937|NCT00783094|11558485|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
7325938|NCT00783094|11558486|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
7325939|NCT00783094|11558487|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
7325940|NCT00783094|11558485|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
7325941|NCT00783094|11558486|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
7325942|NCT00783094|11558487|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
7325943|NCT00783094|11558485|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7325944|NCT00783094|11558486|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
7325945|NCT00783094|11558487|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
7325946|NCT00783094|11558485|FG000|Open-Label Extension Period|Adverse Event|12
7325947|NCT00783094|11558486|FG001|Open-Label Extension Period|Adverse Event|7
7325948|NCT00783094|11558487|FG002|Open-Label Extension Period|Adverse Event|16
7325949|NCT00783094|11558485|FG000|Open-Label Extension Period|Death|0
7325950|NCT00783094|11558486|FG001|Open-Label Extension Period|Death|0
7325951|NCT00783094|11558487|FG002|Open-Label Extension Period|Death|1
7325952|NCT00783094|11558485|FG000|Open-Label Extension Period|Protocol Violation|4
7325953|NCT00783094|11558486|FG001|Open-Label Extension Period|Protocol Violation|5
7325954|NCT00783094|11558487|FG002|Open-Label Extension Period|Protocol Violation|7
7325955|NCT00783094|11558485|FG000|Open-Label Extension Period|Withdrawal by Subject|1
7325956|NCT00783094|11558486|FG001|Open-Label Extension Period|Withdrawal by Subject|1
7325957|NCT00783094|11558487|FG002|Open-Label Extension Period|Withdrawal by Subject|3
7325958|NCT00783094|11558485|FG000|Open-Label Extension Period|Physician Decision|4
7325959|NCT00783094|11558486|FG001|Open-Label Extension Period|Physician Decision|2
7325960|NCT00783094|11558487|FG002|Open-Label Extension Period|Physician Decision|3
7325961|NCT00783094|11558485|FG000|Open-Label Extension Period|Lack of Efficacy|1
7325962|NCT00783094|11558486|FG001|Open-Label Extension Period|Lack of Efficacy|4
7325963|NCT00783094|11558487|FG002|Open-Label Extension Period|Lack of Efficacy|0
7325964|NCT00783198|11558501|FG000|Overall Study|Adverse Event|15
7325965|NCT00783198|11558502|FG001|Overall Study|Adverse Event|19
7325966|NCT00783198|11558503|FG002|Overall Study|Adverse Event|3
7325967|NCT00783198|11558501|FG000|Overall Study|Lost to Follow-up|11
7325968|NCT00783198|11558502|FG001|Overall Study|Lost to Follow-up|1
7325969|NCT00783198|11558503|FG002|Overall Study|Lost to Follow-up|7
7325970|NCT00783198|11558501|FG000|Overall Study|Withdrawal by Subject|22
7325971|NCT00783198|11558502|FG001|Overall Study|Withdrawal by Subject|14
7325972|NCT00783198|11558503|FG002|Overall Study|Withdrawal by Subject|20
7325973|NCT00783198|11558501|FG000|Overall Study|Noncompliance with protocol|7
7325974|NCT00783198|11558502|FG001|Overall Study|Noncompliance with protocol|7
7325975|NCT00783198|11558503|FG002|Overall Study|Noncompliance with protocol|10
7325976|NCT00783198|11558501|FG000|Overall Study|Did not meet protocol eligibility|0
7325977|NCT00783198|11558502|FG001|Overall Study|Did not meet protocol eligibility|1
7325978|NCT00783198|11558503|FG002|Overall Study|Did not meet protocol eligibility|0
7325979|NCT00783198|11558501|FG000|Overall Study|Administrative|2
7325980|NCT00783198|11558502|FG001|Overall Study|Administrative|1
7325981|NCT00783198|11558503|FG002|Overall Study|Administrative|2
7417440|NCT01456936|11691553|FG003|Overall Study|Other reason|33
7325982|NCT00783289|11558515|FG000|Overall Study|Protocol Violation|0
7325983|NCT00783289|11558516|FG001|Overall Study|Protocol Violation|1
7325984|NCT00783289|11558517|FG002|Overall Study|Protocol Violation|0
7325985|NCT00783289|11558518|FG003|Overall Study|Protocol Violation|0
7325986|NCT00783302|11558531|FG000|Overall Study|Lost to Follow-up|17
7325987|NCT00783302|11558531|FG000|Overall Study|Technical Problems|11
7325988|NCT00783302|11558531|FG000|Overall Study|Protocol Violation|3
7325989|NCT00783302|11558531|FG000|Overall Study|Physician Decision|1
7325990|NCT00783302|11558531|FG000|Overall Study|Withdrawal by Subject|3
7325991|NCT00783432|11558551|FG000|Overall Study|Adverse Event|22
7325992|NCT00783432|11558552|FG001|Overall Study|Adverse Event|17
7325993|NCT00783432|11558551|FG000|Overall Study|Lack of Efficacy|20
7325994|NCT00783432|11558552|FG001|Overall Study|Lack of Efficacy|21
7325995|NCT00783432|11558551|FG000|Overall Study|Lost to Follow-up|11
7325996|NCT00783432|11558552|FG001|Overall Study|Lost to Follow-up|6
7325997|NCT00783432|11558551|FG000|Overall Study|Withdrawal by Subject|23
7325998|NCT00783432|11558552|FG001|Overall Study|Withdrawal by Subject|20
7325999|NCT00783432|11558551|FG000|Overall Study|subject moved|3
7326000|NCT00783432|11558552|FG001|Overall Study|subject moved|5
7326001|NCT00783432|11558551|FG000|Overall Study|Protocol Violation|6
7326002|NCT00783432|11558552|FG001|Overall Study|Protocol Violation|9
7417441|NCT01456936|11691550|FG000|Overall Study|No longer meets eligibility criteria|4
7417442|NCT01456936|11691551|FG001|Overall Study|No longer meets eligibility criteria|8
7417443|NCT01456936|11691552|FG002|Overall Study|No longer meets eligibility criteria|6
7417444|NCT01456936|11691553|FG003|Overall Study|No longer meets eligibility criteria|5
7417445|NCT01456936|11691550|FG000|Overall Study|Protocol Violation|4
7417446|NCT01456936|11691551|FG001|Overall Study|Protocol Violation|2
7417447|NCT01456936|11691552|FG002|Overall Study|Protocol Violation|5
7417448|NCT01456936|11691553|FG003|Overall Study|Protocol Violation|5
7417449|NCT01456936|11691550|FG000|Overall Study|Pregnancy|1
7417450|NCT01456936|11691551|FG001|Overall Study|Pregnancy|0
7417451|NCT01456936|11691552|FG002|Overall Study|Pregnancy|0
7417452|NCT01456936|11691553|FG003|Overall Study|Pregnancy|1
7417453|NCT01456936|11691550|FG000|Overall Study|Insufficient clinical response|4
7417454|NCT01456936|11691551|FG001|Overall Study|Insufficient clinical response|4
7417455|NCT01456936|11691552|FG002|Overall Study|Insufficient clinical response|14
7417456|NCT01456936|11691553|FG003|Overall Study|Insufficient clinical response|13
7417457|NCT01456936|11691550|FG000|Overall Study|No longer willing to participate|195
7417458|NCT01456936|11691551|FG001|Overall Study|No longer willing to participate|218
7417459|NCT01456936|11691552|FG002|Overall Study|No longer willing to participate|224
7417460|NCT01456936|11691553|FG003|Overall Study|No longer willing to participate|248
7417461|NCT01456936|11691550|FG000|Overall Study|Lost to Follow-up|135
7417462|NCT01456936|11691551|FG001|Overall Study|Lost to Follow-up|126
7417463|NCT01456936|11691552|FG002|Overall Study|Lost to Follow-up|144
7417464|NCT01456936|11691553|FG003|Overall Study|Lost to Follow-up|127
7417465|NCT01456936|11691550|FG000|Overall Study|Medication error|0
7417466|NCT01456936|11691551|FG001|Overall Study|Medication error|1
7417467|NCT01456936|11691552|FG002|Overall Study|Medication error|0
7417468|NCT01456936|11691553|FG003|Overall Study|Medication error|1
7417469|NCT01456936|11691550|FG000|Overall Study|Adverse event (study drug)|25
7417470|NCT01456936|11691551|FG001|Overall Study|Adverse event (study drug)|21
7417471|NCT01456936|11691552|FG002|Overall Study|Adverse event (study drug)|26
7417472|NCT01456936|11691553|FG003|Overall Study|Adverse event (study drug)|17
7417473|NCT01456936|11691550|FG000|Overall Study|Adverse event (study drug unrelated)|9
7417474|NCT01456936|11691551|FG001|Overall Study|Adverse event (study drug unrelated)|7
7326065|NCT00783692|11558584|FG006|Maintenance Phase|Lack of Efficacy|177
7417475|NCT01456936|11691552|FG002|Overall Study|Adverse event (study drug unrelated)|9
7417476|NCT01456936|11691553|FG003|Overall Study|Adverse event (study drug unrelated)|9
7417477|NCT01456936|11691550|FG000|Overall Study|Death|0
7417478|NCT01456936|11691551|FG001|Overall Study|Death|3
7417479|NCT01456936|11691552|FG002|Overall Study|Death|1
7417480|NCT01456936|11691553|FG003|Overall Study|Death|3
7417481|NCT01456936|11691550|FG000|Overall Study|Randomized but not treated|21
7417482|NCT01456936|11691551|FG001|Overall Study|Randomized but not treated|28
7417483|NCT01456936|11691552|FG002|Overall Study|Randomized but not treated|16
7417484|NCT01456936|11691553|FG003|Overall Study|Randomized but not treated|21
7417485|NCT01456949|11691563|FG000|Enrollment|PI death- incomplete data|6
7417486|NCT01456949|11691563|FG000|Enrollment|Death|1
7417487|NCT01456949|11691563|FG000|Enrollment|I/E criteria not met prior to procedure|13
7417488|NCT01456949|11691563|FG000|Enrollment|Physician Decision|10
7417489|NCT01456949|11691563|FG000|Enrollment|Withdrawal by Subject|7
7417490|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Death|5
7417491|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
7417492|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
7417493|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
7326003|NCT00783692|11558578|FG000|Induction Phase|Adverse Event|7
7326004|NCT00783692|11558579|FG001|Induction Phase|Adverse Event|9
7326005|NCT00783692|11558580|FG002|Induction Phase|Adverse Event|24
7326006|NCT00783692|11558581|FG003|Induction Phase|Adverse Event|0
7326007|NCT00783692|11558582|FG004|Induction Phase|Adverse Event|0
7417494|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
7417495|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
7466464|NCT01891864|11766312|FG003|Treatment Period 2|Protocol Violation|1
7326008|NCT00783692|11558583|FG005|Induction Phase|Adverse Event|0
7326009|NCT00783692|11558584|FG006|Induction Phase|Adverse Event|0
7326010|NCT00783692|11558578|FG000|Induction Phase|Protocol Violation|0
7326011|NCT00783692|11558579|FG001|Induction Phase|Protocol Violation|0
7326012|NCT00783692|11558580|FG002|Induction Phase|Protocol Violation|1
7326013|NCT00783692|11558581|FG003|Induction Phase|Protocol Violation|0
7326014|NCT00783692|11558582|FG004|Induction Phase|Protocol Violation|0
7326015|NCT00783692|11558583|FG005|Induction Phase|Protocol Violation|0
7326016|NCT00783692|11558584|FG006|Induction Phase|Protocol Violation|0
7326017|NCT00783692|11558578|FG000|Induction Phase|Lack of Efficacy|1
7326018|NCT00783692|11558579|FG001|Induction Phase|Lack of Efficacy|3
7326019|NCT00783692|11558580|FG002|Induction Phase|Lack of Efficacy|28
7326020|NCT00783692|11558581|FG003|Induction Phase|Lack of Efficacy|0
7326021|NCT00783692|11558582|FG004|Induction Phase|Lack of Efficacy|0
7326022|NCT00783692|11558583|FG005|Induction Phase|Lack of Efficacy|0
7326023|NCT00783692|11558584|FG006|Induction Phase|Lack of Efficacy|0
7326024|NCT00783692|11558578|FG000|Induction Phase|Withdrawal by Subject|3
7326025|NCT00783692|11558579|FG001|Induction Phase|Withdrawal by Subject|9
7326026|NCT00783692|11558580|FG002|Induction Phase|Withdrawal by Subject|16
7326027|NCT00783692|11558581|FG003|Induction Phase|Withdrawal by Subject|0
7326028|NCT00783692|11558582|FG004|Induction Phase|Withdrawal by Subject|0
7326029|NCT00783692|11558583|FG005|Induction Phase|Withdrawal by Subject|0
7326030|NCT00783692|11558584|FG006|Induction Phase|Withdrawal by Subject|0
7326031|NCT00783692|11558578|FG000|Induction Phase|Lost to Follow-up|0
7326032|NCT00783692|11558579|FG001|Induction Phase|Lost to Follow-up|0
7326033|NCT00783692|11558580|FG002|Induction Phase|Lost to Follow-up|3
7326034|NCT00783692|11558581|FG003|Induction Phase|Lost to Follow-up|0
7326035|NCT00783692|11558582|FG004|Induction Phase|Lost to Follow-up|0
7326036|NCT00783692|11558583|FG005|Induction Phase|Lost to Follow-up|0
7326037|NCT00783692|11558584|FG006|Induction Phase|Lost to Follow-up|0
7326038|NCT00783692|11558578|FG000|Induction Phase|Other|0
7326039|NCT00783692|11558579|FG001|Induction Phase|Other|0
7326040|NCT00783692|11558580|FG002|Induction Phase|Other|2
7326041|NCT00783692|11558581|FG003|Induction Phase|Other|0
7326042|NCT00783692|11558582|FG004|Induction Phase|Other|0
7326043|NCT00783692|11558583|FG005|Induction Phase|Other|0
7326044|NCT00783692|11558584|FG006|Induction Phase|Other|0
7326045|NCT00783692|11558578|FG000|Maintenance Phase|Adverse Event|7
7326046|NCT00783692|11558579|FG001|Maintenance Phase|Adverse Event|0
7326047|NCT00783692|11558580|FG002|Maintenance Phase|Adverse Event|0
7326048|NCT00783692|11558581|FG003|Maintenance Phase|Adverse Event|15
7326049|NCT00783692|11558582|FG004|Maintenance Phase|Adverse Event|12
7326050|NCT00783692|11558583|FG005|Maintenance Phase|Adverse Event|9
7326051|NCT00783692|11558584|FG006|Maintenance Phase|Adverse Event|38
7326052|NCT00783692|11558578|FG000|Maintenance Phase|Protocol Violation|0
7326053|NCT00783692|11558579|FG001|Maintenance Phase|Protocol Violation|0
7326054|NCT00783692|11558580|FG002|Maintenance Phase|Protocol Violation|0
7326055|NCT00783692|11558581|FG003|Maintenance Phase|Protocol Violation|1
7326056|NCT00783692|11558582|FG004|Maintenance Phase|Protocol Violation|2
7326057|NCT00783692|11558583|FG005|Maintenance Phase|Protocol Violation|3
7326058|NCT00783692|11558584|FG006|Maintenance Phase|Protocol Violation|4
7326059|NCT00783692|11558578|FG000|Maintenance Phase|Lack of Efficacy|79
7326060|NCT00783692|11558579|FG001|Maintenance Phase|Lack of Efficacy|0
7326061|NCT00783692|11558580|FG002|Maintenance Phase|Lack of Efficacy|0
7326062|NCT00783692|11558581|FG003|Maintenance Phase|Lack of Efficacy|64
7326063|NCT00783692|11558582|FG004|Maintenance Phase|Lack of Efficacy|58
7326064|NCT00783692|11558583|FG005|Maintenance Phase|Lack of Efficacy|48
7326066|NCT00783692|11558578|FG000|Maintenance Phase|Withdrawal by Subject|7
7326067|NCT00783692|11558579|FG001|Maintenance Phase|Withdrawal by Subject|0
7326068|NCT00783692|11558580|FG002|Maintenance Phase|Withdrawal by Subject|0
7326069|NCT00783692|11558581|FG003|Maintenance Phase|Withdrawal by Subject|7
7326070|NCT00783692|11558582|FG004|Maintenance Phase|Withdrawal by Subject|6
7326071|NCT00783692|11558583|FG005|Maintenance Phase|Withdrawal by Subject|9
7326072|NCT00783692|11558584|FG006|Maintenance Phase|Withdrawal by Subject|24
7326073|NCT00783692|11558578|FG000|Maintenance Phase|Lost to Follow-up|2
7326074|NCT00783692|11558579|FG001|Maintenance Phase|Lost to Follow-up|0
7326075|NCT00783692|11558580|FG002|Maintenance Phase|Lost to Follow-up|0
7326076|NCT00783692|11558581|FG003|Maintenance Phase|Lost to Follow-up|1
7326077|NCT00783692|11558582|FG004|Maintenance Phase|Lost to Follow-up|3
7326078|NCT00783692|11558583|FG005|Maintenance Phase|Lost to Follow-up|2
7326079|NCT00783692|11558584|FG006|Maintenance Phase|Lost to Follow-up|5
7326080|NCT00783692|11558578|FG000|Maintenance Phase|Other|0
7326081|NCT00783692|11558579|FG001|Maintenance Phase|Other|0
7326082|NCT00783692|11558580|FG002|Maintenance Phase|Other|0
7326083|NCT00783692|11558581|FG003|Maintenance Phase|Other|1
7326084|NCT00783692|11558582|FG004|Maintenance Phase|Other|0
7326085|NCT00783692|11558583|FG005|Maintenance Phase|Other|1
7326086|NCT00783692|11558584|FG006|Maintenance Phase|Other|1
7326087|NCT00783705|11558599|FG000|Overall Study|Adverse Event|2
7326088|NCT00783705|11558600|FG001|Overall Study|Adverse Event|0
7326089|NCT00783705|11558599|FG000|Overall Study|Withdrawal by Subject|3
7326090|NCT00783705|11558600|FG001|Overall Study|Withdrawal by Subject|2
7326091|NCT00783705|11558599|FG000|Overall Study|Lost to Follow-up|1
7326092|NCT00783705|11558600|FG001|Overall Study|Lost to Follow-up|3
7326093|NCT00783718|11558609|FG000|Induction Phase|Adverse Event|4
7326094|NCT00783718|11558610|FG001|Induction Phase|Adverse Event|0
7326095|NCT00783718|11558611|FG002|Induction Phase|Adverse Event|7
7326096|NCT00783718|11558612|FG003|Induction Phase|Adverse Event|0
7326097|NCT00783718|11558613|FG004|Induction Phase|Adverse Event|0
7326098|NCT00783718|11558614|FG005|Induction Phase|Adverse Event|0
7326099|NCT00783718|11558615|FG006|Induction Phase|Adverse Event|0
7326100|NCT00783718|11558609|FG000|Induction Phase|Protocol Violation|1
7326101|NCT00783718|11558610|FG001|Induction Phase|Protocol Violation|1
7326102|NCT00783718|11558611|FG002|Induction Phase|Protocol Violation|6
7326103|NCT00783718|11558612|FG003|Induction Phase|Protocol Violation|0
7326104|NCT00783718|11558613|FG004|Induction Phase|Protocol Violation|0
7326105|NCT00783718|11558614|FG005|Induction Phase|Protocol Violation|0
7326106|NCT00783718|11558615|FG006|Induction Phase|Protocol Violation|0
7326107|NCT00783718|11558609|FG000|Induction Phase|Lack of Efficacy|5
7326108|NCT00783718|11558610|FG001|Induction Phase|Lack of Efficacy|2
7326109|NCT00783718|11558611|FG002|Induction Phase|Lack of Efficacy|14
7326110|NCT00783718|11558612|FG003|Induction Phase|Lack of Efficacy|0
7326111|NCT00783718|11558613|FG004|Induction Phase|Lack of Efficacy|0
7326112|NCT00783718|11558614|FG005|Induction Phase|Lack of Efficacy|0
7326113|NCT00783718|11558615|FG006|Induction Phase|Lack of Efficacy|0
7326114|NCT00783718|11558609|FG000|Induction Phase|Withdrawal by Subject|3
7326115|NCT00783718|11558610|FG001|Induction Phase|Withdrawal by Subject|4
7326116|NCT00783718|11558611|FG002|Induction Phase|Withdrawal by Subject|8
7326117|NCT00783718|11558612|FG003|Induction Phase|Withdrawal by Subject|0
7326118|NCT00783718|11558613|FG004|Induction Phase|Withdrawal by Subject|0
7326119|NCT00783718|11558614|FG005|Induction Phase|Withdrawal by Subject|0
7326120|NCT00783718|11558615|FG006|Induction Phase|Withdrawal by Subject|0
7326121|NCT00783718|11558609|FG000|Induction Phase|Lost to Follow-up|1
7326122|NCT00783718|11558610|FG001|Induction Phase|Lost to Follow-up|0
7326123|NCT00783718|11558611|FG002|Induction Phase|Lost to Follow-up|1
7326124|NCT00783718|11558612|FG003|Induction Phase|Lost to Follow-up|0
7326125|NCT00783718|11558613|FG004|Induction Phase|Lost to Follow-up|0
7326126|NCT00783718|11558614|FG005|Induction Phase|Lost to Follow-up|0
7326127|NCT00783718|11558615|FG006|Induction Phase|Lost to Follow-up|0
7326128|NCT00783718|11558609|FG000|Maintenance Phase|Adverse Event|12
7326129|NCT00783718|11558610|FG001|Maintenance Phase|Adverse Event|0
7326130|NCT00783718|11558611|FG002|Maintenance Phase|Adverse Event|0
7326131|NCT00783718|11558612|FG003|Maintenance Phase|Adverse Event|15
7326132|NCT00783718|11558613|FG004|Maintenance Phase|Adverse Event|7
7326133|NCT00783718|11558614|FG005|Maintenance Phase|Adverse Event|6
7326134|NCT00783718|11558615|FG006|Maintenance Phase|Adverse Event|16
7326135|NCT00783718|11558609|FG000|Maintenance Phase|Protocol Violation|1
7326136|NCT00783718|11558610|FG001|Maintenance Phase|Protocol Violation|0
7326137|NCT00783718|11558611|FG002|Maintenance Phase|Protocol Violation|0
7326138|NCT00783718|11558612|FG003|Maintenance Phase|Protocol Violation|0
7326139|NCT00783718|11558613|FG004|Maintenance Phase|Protocol Violation|0
7326140|NCT00783718|11558614|FG005|Maintenance Phase|Protocol Violation|0
7326141|NCT00783718|11558615|FG006|Maintenance Phase|Protocol Violation|2
7326142|NCT00783718|11558609|FG000|Maintenance Phase|Lack of Efficacy|83
7326143|NCT00783718|11558610|FG001|Maintenance Phase|Lack of Efficacy|0
7326144|NCT00783718|11558611|FG002|Maintenance Phase|Lack of Efficacy|0
7326145|NCT00783718|11558612|FG003|Maintenance Phase|Lack of Efficacy|61
7326146|NCT00783718|11558613|FG004|Maintenance Phase|Lack of Efficacy|31
7326147|NCT00783718|11558614|FG005|Maintenance Phase|Lack of Efficacy|33
7326148|NCT00783718|11558615|FG006|Maintenance Phase|Lack of Efficacy|155
7326149|NCT00783718|11558609|FG000|Maintenance Phase|Withdrawal by Subject|6
7326150|NCT00783718|11558610|FG001|Maintenance Phase|Withdrawal by Subject|0
7326151|NCT00783718|11558611|FG002|Maintenance Phase|Withdrawal by Subject|0
7326152|NCT00783718|11558612|FG003|Maintenance Phase|Withdrawal by Subject|2
7326153|NCT00783718|11558613|FG004|Maintenance Phase|Withdrawal by Subject|5
7326154|NCT00783718|11558614|FG005|Maintenance Phase|Withdrawal by Subject|2
7326155|NCT00783718|11558615|FG006|Maintenance Phase|Withdrawal by Subject|20
7326156|NCT00783718|11558609|FG000|Maintenance Phase|Lost to Follow-up|3
7326157|NCT00783718|11558610|FG001|Maintenance Phase|Lost to Follow-up|0
7326158|NCT00783718|11558611|FG002|Maintenance Phase|Lost to Follow-up|0
7326159|NCT00783718|11558612|FG003|Maintenance Phase|Lost to Follow-up|0
7326160|NCT00783718|11558613|FG004|Maintenance Phase|Lost to Follow-up|2
7326161|NCT00783718|11558614|FG005|Maintenance Phase|Lost to Follow-up|0
7326162|NCT00783718|11558615|FG006|Maintenance Phase|Lost to Follow-up|2
7326163|NCT00783796|11558625|FG000|Overall Study|Did not receive any stent|4
7326164|NCT00783796|11558625|FG000|Overall Study|Received non-XIENCE V stent|1
7326165|NCT00783796|11558625|FG000|Overall Study|Received commercial XIENCE V stent|1
7326166|NCT00783835|11558631|FG000|Overall Study|Adverse Event|3
7326167|NCT00783835|11558631|FG000|Overall Study|Medical Criteria|1
7326168|NCT00783835|11558631|FG000|Overall Study|Withdrawal by Subject|2
7417496|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
7417497|NCT01456949|11691563|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
7417498|NCT01456962|11691569|FG000|Overall Study|Lost to Follow-up|2
7417499|NCT01456962|11691570|FG001|Overall Study|Lost to Follow-up|1
7417500|NCT01457014|11691576|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
7417501|NCT01457014|11691577|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
7326169|NCT00783835|11558631|FG000|Overall Study|Lost to Follow-up|1
7326170|NCT00783835|11558631|FG000|Overall Study|Participant not Adherent|3
7326171|NCT00784134|11558676|FG000|Overall Study|Lost to Follow-up|3
7326172|NCT00784134|11558677|FG001|Overall Study|Lost to Follow-up|6
7326173|NCT00784147|11558685|FG000|Overall Study|Lost to Follow-up|2
7326174|NCT00784147|11558686|FG001|Overall Study|Lost to Follow-up|4
7326175|NCT00784147|11558685|FG000|Overall Study|Withdrawal by Subject|1
7326176|NCT00784147|11558686|FG001|Overall Study|Withdrawal by Subject|3
7326177|NCT00784147|11558685|FG000|Overall Study|Physician Decision|2
7326178|NCT00784147|11558686|FG001|Overall Study|Physician Decision|1
7326179|NCT00784147|11558685|FG000|Overall Study|Protocol Violation|1
7326180|NCT00784147|11558686|FG001|Overall Study|Protocol Violation|1
7326181|NCT00784147|11558685|FG000|Overall Study|Death|2
7326182|NCT00784147|11558686|FG001|Overall Study|Death|0
7326183|NCT00784238|11558713|FG000|Overall Study|Adverse Event|14
7326184|NCT00784238|11558713|FG000|Overall Study|Death|2
7326185|NCT00784238|11558713|FG000|Overall Study|Lack of Efficacy|33
7326186|NCT00784238|11558713|FG000|Overall Study|Lost to Follow-up|29
7326187|NCT00784238|11558713|FG000|Overall Study|Pregnancy|1
7326188|NCT00784238|11558713|FG000|Overall Study|Withdrawal by Subject|26
7326189|NCT00784238|11558713|FG000|Overall Study|Other|14
7326190|NCT00784277|11558724|FG000|IR Treatment|Adverse Event|4
7326191|NCT00784277|11558725|FG001|IR Treatment|Adverse Event|8
7326192|NCT00784277|11558726|FG002|IR Treatment|Adverse Event|19
7326193|NCT00784277|11558727|FG003|IR Treatment|Adverse Event|35
7417502|NCT01457014|11691578|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
7417503|NCT01457014|11691579|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
7417504|NCT01457014|11691576|FG000|First Night|Withdrawal by Subject|3
7417505|NCT01457014|11691577|FG001|First Night|Withdrawal by Subject|0
7417506|NCT01457014|11691578|FG002|First Night|Withdrawal by Subject|0
7417507|NCT01457014|11691579|FG003|First Night|Withdrawal by Subject|0
7417508|NCT01457118|11691591|FG000|Overall Study|Adverse Event|1
7417509|NCT01457118|11691592|FG001|Overall Study|Adverse Event|0
7417510|NCT01457118|11691593|FG002|Overall Study|Adverse Event|0
7417511|NCT01457118|11691594|FG003|Overall Study|Adverse Event|1
7417512|NCT01457118|11691591|FG000|Overall Study|Clinical Progression|0
7417513|NCT01457118|11691592|FG001|Overall Study|Clinical Progression|1
7417514|NCT01457118|11691593|FG002|Overall Study|Clinical Progression|0
7417515|NCT01457118|11691594|FG003|Overall Study|Clinical Progression|1
7417516|NCT01457118|11691591|FG000|Overall Study|Physician Decision|2
7417517|NCT01457118|11691592|FG001|Overall Study|Physician Decision|0
7417518|NCT01457118|11691593|FG002|Overall Study|Physician Decision|0
7417519|NCT01457118|11691594|FG003|Overall Study|Physician Decision|0
7417520|NCT01457118|11691591|FG000|Overall Study|Progressive Disease by RECIST|12
7417521|NCT01457118|11691592|FG001|Overall Study|Progressive Disease by RECIST|3
7417522|NCT01457118|11691593|FG002|Overall Study|Progressive Disease by RECIST|1
7417523|NCT01457118|11691594|FG003|Overall Study|Progressive Disease by RECIST|0
7417524|NCT01457118|11691591|FG000|Overall Study|Withdrawal by Subject|5
7417525|NCT01457118|11691592|FG001|Overall Study|Withdrawal by Subject|0
7417526|NCT01457118|11691593|FG002|Overall Study|Withdrawal by Subject|0
7417527|NCT01457118|11691594|FG003|Overall Study|Withdrawal by Subject|0
7417528|NCT01457339|11691612|FG000|Period 3 (100 mg)|Adverse Event|0
7417529|NCT01457339|11691613|FG001|Period 3 (100 mg)|Adverse Event|1
7417530|NCT01457339|11691612|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
7417531|NCT01457339|11691613|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
7417532|NCT01457339|11691612|FG000|Period 6 (250 mg)|Family Emergency|1
7417533|NCT01457339|11691613|FG001|Period 6 (250 mg)|Family Emergency|0
7417534|NCT01457339|11691612|FG000|Period 6 (250 mg)|Personal appointment|0
7417535|NCT01457339|11691613|FG001|Period 6 (250 mg)|Personal appointment|1
7417536|NCT01457352|11691638|FG000|Period 1|Adverse Event|2
7326194|NCT00784277|11558728|FG004|IR Treatment|Adverse Event|0
7326195|NCT00784277|11558729|FG005|IR Treatment|Adverse Event|0
7326196|NCT00784277|11558730|FG006|IR Treatment|Adverse Event|0
7326197|NCT00784277|11558724|FG000|IR Treatment|Lack of Efficacy|4
7326198|NCT00784277|11558725|FG001|IR Treatment|Lack of Efficacy|4
7326199|NCT00784277|11558726|FG002|IR Treatment|Lack of Efficacy|1
7326200|NCT00784277|11558727|FG003|IR Treatment|Lack of Efficacy|0
7326201|NCT00784277|11558728|FG004|IR Treatment|Lack of Efficacy|0
7326202|NCT00784277|11558729|FG005|IR Treatment|Lack of Efficacy|0
7326203|NCT00784277|11558730|FG006|IR Treatment|Lack of Efficacy|0
7326204|NCT00784277|11558724|FG000|IR Treatment|Lost to Follow-up|1
7417537|NCT01457352|11691639|FG001|Period 1|Adverse Event|0
7417538|NCT01457352|11691638|FG000|Period 1|Withdrawal by Subject|2
7417539|NCT01457352|11691639|FG001|Period 1|Withdrawal by Subject|0
7417540|NCT01457352|11691638|FG000|Period 1|Physician Decision|2
7417541|NCT01457352|11691639|FG001|Period 1|Physician Decision|0
7417542|NCT01457352|11691638|FG000|Period 1|MS related disease progression|1
7417543|NCT01457352|11691639|FG001|Period 1|MS related disease progression|0
7417544|NCT01457352|11691638|FG000|Period 1|Withdrawn|1
7417545|NCT01457352|11691639|FG001|Period 1|Withdrawn|0
7417546|NCT01457352|11691638|FG000|Period 1|withdrew per sponsor|1
7417547|NCT01457352|11691639|FG001|Period 1|withdrew per sponsor|0
7417548|NCT01457352|11691638|FG000|Period 1|Protocol Violation|4
7417549|NCT01457352|11691639|FG001|Period 1|Protocol Violation|0
7417550|NCT01457352|11691638|FG000|Period 1|Did not meet eligibility criteria|3
7466465|NCT01891864|11766313|FG004|Treatment Period 2|Protocol Violation|0
7326205|NCT00784277|11558725|FG001|IR Treatment|Lost to Follow-up|0
7326206|NCT00784277|11558726|FG002|IR Treatment|Lost to Follow-up|1
7326207|NCT00784277|11558727|FG003|IR Treatment|Lost to Follow-up|0
7326208|NCT00784277|11558728|FG004|IR Treatment|Lost to Follow-up|0
7326209|NCT00784277|11558729|FG005|IR Treatment|Lost to Follow-up|0
7326210|NCT00784277|11558730|FG006|IR Treatment|Lost to Follow-up|0
7326211|NCT00784277|11558724|FG000|IR Treatment|Withdrawal by Subject|5
7326212|NCT00784277|11558725|FG001|IR Treatment|Withdrawal by Subject|1
7326213|NCT00784277|11558726|FG002|IR Treatment|Withdrawal by Subject|4
7326214|NCT00784277|11558727|FG003|IR Treatment|Withdrawal by Subject|6
7326215|NCT00784277|11558728|FG004|IR Treatment|Withdrawal by Subject|0
7326216|NCT00784277|11558729|FG005|IR Treatment|Withdrawal by Subject|0
7326217|NCT00784277|11558730|FG006|IR Treatment|Withdrawal by Subject|0
7417551|NCT01457352|11691639|FG001|Period 1|Did not meet eligibility criteria|0
7417552|NCT01457352|11691638|FG000|Period 2|Withdrawal by Subject|23
7417553|NCT01457352|11691639|FG001|Period 2|Withdrawal by Subject|0
7417554|NCT01457352|11691638|FG000|Period 2|Adverse Event|22
7417555|NCT01457352|11691639|FG001|Period 2|Adverse Event|0
7417556|NCT01457352|11691638|FG000|Period 2|no analysis|10
7417557|NCT01457352|11691639|FG001|Period 2|no analysis|0
7417558|NCT01457352|11691638|FG000|Period 2|Lack of Efficacy|8
7417559|NCT01457352|11691639|FG001|Period 2|Lack of Efficacy|0
7417560|NCT01457352|11691638|FG000|Period 2|Protocol Violation|4
7417561|NCT01457352|11691639|FG001|Period 2|Protocol Violation|0
7417562|NCT01457352|11691638|FG000|Period 2|Sponsor's withdrawal|7
7417563|NCT01457352|11691639|FG001|Period 2|Sponsor's withdrawal|0
7417564|NCT01457352|11691638|FG000|Period 2|Lost to Follow-up|1
7417565|NCT01457352|11691639|FG001|Period 2|Lost to Follow-up|0
7417566|NCT01457352|11691638|FG000|Period 2|dose change|1
7417567|NCT01457352|11691639|FG001|Period 2|dose change|0
7417568|NCT01457352|11691638|FG000|Period 2|Physician Decision|1
7417569|NCT01457352|11691639|FG001|Period 2|Physician Decision|0
7417570|NCT01457352|11691638|FG000|Period 2|Did not meet eligibility criteria|3
7417571|NCT01457352|11691639|FG001|Period 2|Did not meet eligibility criteria|0
7417572|NCT01457352|11691638|FG000|Period 3|Adverse Event|1
7417573|NCT01457352|11691639|FG001|Period 3|Adverse Event|1
7417574|NCT01457352|11691638|FG000|Period 3|Withdrawal by Subject|0
7417575|NCT01457352|11691639|FG001|Period 3|Withdrawal by Subject|2
7417576|NCT01457352|11691638|FG000|Period 3|incorrect treatment|0
7417577|NCT01457352|11691639|FG001|Period 3|incorrect treatment|1
7417578|NCT01457352|11691638|FG000|Period 3|Sponsor's withdrawal|0
7417579|NCT01457352|11691639|FG001|Period 3|Sponsor's withdrawal|1
7417580|NCT01457703|11691693|FG000|Overall Study|Screen Failure|5
7417581|NCT01457703|11691694|FG001|Overall Study|Screen Failure|7
7417582|NCT01457703|11691693|FG000|Overall Study|Withdrawal by Subject|1
7417583|NCT01457703|11691694|FG001|Overall Study|Withdrawal by Subject|4
7417584|NCT01457846|11691704|FG000|Overall Study|Death before treatment|1
7417585|NCT01457846|11691705|FG001|Overall Study|Death before treatment|2
7417586|NCT01457846|11691704|FG000|Overall Study|Did not receive treatment|0
7417587|NCT01457846|11691705|FG001|Overall Study|Did not receive treatment|1
7417588|NCT01457846|11691704|FG000|Overall Study|Death|27
7417589|NCT01457846|11691705|FG001|Overall Study|Death|16
7417590|NCT01457846|11691704|FG000|Overall Study|Unclassified reason for not completed|11
7417591|NCT01457846|11691705|FG001|Overall Study|Unclassified reason for not completed|10
7417592|NCT01457846|11691704|FG000|Overall Study|Withdrawal by Subject|1
7417593|NCT01457846|11691705|FG001|Overall Study|Withdrawal by Subject|1
7417594|NCT01457846|11691704|FG000|Overall Study|Lost to Follow-up|1
7417595|NCT01457846|11691705|FG001|Overall Study|Lost to Follow-up|0
7417596|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
7417597|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
7417598|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
7417599|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
7417600|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
7417601|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
7417602|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
7417603|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
7417604|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
7417605|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
7417606|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
7417607|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7417608|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7417609|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7417610|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
7417611|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7417612|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7417613|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
7417614|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7417615|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
7417616|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7326218|NCT00784277|11558724|FG000|IR Treatment|Resolution Of Pain|0
7417617|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7417618|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
7555432|NCT03055806|11918615|FG000|Overall Study|Lost to Follow-up|0
7555433|NCT03055806|11918616|FG001|Overall Study|Lost to Follow-up|3
7555434|NCT03055806|11918617|FG002|Overall Study|Lost to Follow-up|6
7555435|NCT03055806|11918618|FG003|Overall Study|Lost to Follow-up|7
7555436|NCT03055806|11918615|FG000|Overall Study|Physician Decision|1
7555437|NCT03055806|11918616|FG001|Overall Study|Physician Decision|0
7555438|NCT03055806|11918617|FG002|Overall Study|Physician Decision|0
7555439|NCT03055806|11918618|FG003|Overall Study|Physician Decision|1
7555440|NCT03055806|11918615|FG000|Overall Study|Protocol Violation|1
7555441|NCT03055806|11918616|FG001|Overall Study|Protocol Violation|0
7555442|NCT03055806|11918617|FG002|Overall Study|Protocol Violation|0
7555443|NCT03055806|11918618|FG003|Overall Study|Protocol Violation|0
7555444|NCT03055806|11918615|FG000|Overall Study|Withdrawal of consent to continue drug|1
7555445|NCT03055806|11918616|FG001|Overall Study|Withdrawal of consent to continue drug|1
7555446|NCT03055806|11918617|FG002|Overall Study|Withdrawal of consent to continue drug|2
7555447|NCT03055806|11918618|FG003|Overall Study|Withdrawal of consent to continue drug|0
7555448|NCT03055806|11918615|FG000|Overall Study|Withdrawal of consent to continue study|2
7555449|NCT03055806|11918616|FG001|Overall Study|Withdrawal of consent to continue study|3
7555450|NCT03055806|11918617|FG002|Overall Study|Withdrawal of consent to continue study|4
7555451|NCT03055806|11918618|FG003|Overall Study|Withdrawal of consent to continue study|6
7555452|NCT03055806|11918615|FG000|Overall Study|Partner not willing to try intercourse|1
7555453|NCT03055806|11918616|FG001|Overall Study|Partner not willing to try intercourse|0
7555454|NCT03055806|11918617|FG002|Overall Study|Partner not willing to try intercourse|0
7555455|NCT03055806|11918618|FG003|Overall Study|Partner not willing to try intercourse|0
7555456|NCT03055832|11918630|FG000|Week 2|Withdrawal by Subject|1
7555457|NCT03055832|11918631|FG001|Week 2|Withdrawal by Subject|0
7555458|NCT03055936|11918659|FG000|Overall Study|Adverse Event|0
7555459|NCT03055936|11918660|FG001|Overall Study|Adverse Event|1
7555460|NCT03055936|11918661|FG002|Overall Study|Adverse Event|1
7555461|NCT03055936|11918662|FG003|Overall Study|Adverse Event|1
7555462|NCT03055936|11918659|FG000|Overall Study|Personal reason|2
7555463|NCT03055936|11918660|FG001|Overall Study|Personal reason|0
7555464|NCT03055936|11918661|FG002|Overall Study|Personal reason|1
7555465|NCT03055936|11918662|FG003|Overall Study|Personal reason|0
7555466|NCT03055988|11918696|FG000|Period 1|Adverse Event|0
7555467|NCT03055988|11918697|FG001|Period 1|Adverse Event|1
7555468|NCT03055988|11918696|FG000|Period 1|Lost to Follow-up|1
7555469|NCT03055988|11918697|FG001|Period 1|Lost to Follow-up|0
7555470|NCT03055988|11918696|FG000|Period 1|Withdrawal by Subject|0
7555471|NCT03055988|11918697|FG001|Period 1|Withdrawal by Subject|4
7555472|NCT03055988|11918696|FG000|Period 2|Adverse Event|0
7555473|NCT03055988|11918697|FG001|Period 2|Adverse Event|1
7555474|NCT03055988|11918696|FG000|Period 2|Other than listed|1
7555475|NCT03055988|11918697|FG001|Period 2|Other than listed|1
7326219|NCT00784277|11558725|FG001|IR Treatment|Resolution Of Pain|1
7326220|NCT00784277|11558726|FG002|IR Treatment|Resolution Of Pain|0
7326221|NCT00784277|11558727|FG003|IR Treatment|Resolution Of Pain|0
7326222|NCT00784277|11558728|FG004|IR Treatment|Resolution Of Pain|0
7326223|NCT00784277|11558729|FG005|IR Treatment|Resolution Of Pain|0
7326224|NCT00784277|11558730|FG006|IR Treatment|Resolution Of Pain|0
7326225|NCT00784277|11558724|FG000|IR Treatment|Other|2
7326226|NCT00784277|11558725|FG001|IR Treatment|Other|3
7326227|NCT00784277|11558726|FG002|IR Treatment|Other|3
7326228|NCT00784277|11558727|FG003|IR Treatment|Other|2
7326229|NCT00784277|11558728|FG004|IR Treatment|Other|0
7326230|NCT00784277|11558729|FG005|IR Treatment|Other|0
7326231|NCT00784277|11558730|FG006|IR Treatment|Other|0
7326232|NCT00784277|11558724|FG000|ER Treatment|Adverse Event|0
7326233|NCT00784277|11558725|FG001|ER Treatment|Adverse Event|0
7326234|NCT00784277|11558726|FG002|ER Treatment|Adverse Event|0
7326235|NCT00784277|11558727|FG003|ER Treatment|Adverse Event|0
7326236|NCT00784277|11558728|FG004|ER Treatment|Adverse Event|1
7326237|NCT00784277|11558729|FG005|ER Treatment|Adverse Event|7
7326238|NCT00784277|11558730|FG006|ER Treatment|Adverse Event|7
7326239|NCT00784277|11558724|FG000|ER Treatment|Lack of Efficacy|0
7326240|NCT00784277|11558725|FG001|ER Treatment|Lack of Efficacy|0
7326241|NCT00784277|11558726|FG002|ER Treatment|Lack of Efficacy|0
7417619|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7555482|NCT03056300|11918716|FG000|Overall Study|Surgical reason per study protocol|3
7555483|NCT03056352|11918720|FG000|Overall Study|Lost to Follow-up|1
7555484|NCT03056573|11918742|FG000|Overall Study|Death|2
7555485|NCT03056573|11918743|FG001|Overall Study|Death|4
7555486|NCT03056573|11918742|FG000|Overall Study|Withdrawal by Subject|2
7555487|NCT03056573|11918743|FG001|Overall Study|Withdrawal by Subject|0
7555488|NCT03056573|11918742|FG000|Overall Study|Lost to Follow-up|1
7555489|NCT03056573|11918743|FG001|Overall Study|Lost to Follow-up|1
7555490|NCT03056690|11918751|FG000|Overall Study|Adverse Event|3
7326242|NCT00784277|11558727|FG003|ER Treatment|Lack of Efficacy|0
7555491|NCT03056690|11918752|FG001|Overall Study|Adverse Event|2
7326243|NCT00784277|11558728|FG004|ER Treatment|Lack of Efficacy|3
7326244|NCT00784277|11558729|FG005|ER Treatment|Lack of Efficacy|4
7531422|NCT02651220|11875780|FG002|Overall Study|Adverse Event|1
7531423|NCT02651220|11875778|FG000|Overall Study|Lost to Follow-up|8
7531424|NCT02651220|11875779|FG001|Overall Study|Lost to Follow-up|14
7326245|NCT00784277|11558730|FG006|ER Treatment|Lack of Efficacy|0
7326246|NCT00784277|11558724|FG000|ER Treatment|Lost to Follow-up|0
7326247|NCT00784277|11558725|FG001|ER Treatment|Lost to Follow-up|0
7326248|NCT00784277|11558726|FG002|ER Treatment|Lost to Follow-up|0
7326249|NCT00784277|11558727|FG003|ER Treatment|Lost to Follow-up|0
7326250|NCT00784277|11558728|FG004|ER Treatment|Lost to Follow-up|0
7326251|NCT00784277|11558729|FG005|ER Treatment|Lost to Follow-up|2
7326252|NCT00784277|11558730|FG006|ER Treatment|Lost to Follow-up|0
7326253|NCT00784277|11558724|FG000|ER Treatment|Withdrawal by Subject|0
7326254|NCT00784277|11558725|FG001|ER Treatment|Withdrawal by Subject|0
7326255|NCT00784277|11558726|FG002|ER Treatment|Withdrawal by Subject|0
7326256|NCT00784277|11558727|FG003|ER Treatment|Withdrawal by Subject|0
7326257|NCT00784277|11558728|FG004|ER Treatment|Withdrawal by Subject|2
7326258|NCT00784277|11558729|FG005|ER Treatment|Withdrawal by Subject|5
7326259|NCT00784277|11558730|FG006|ER Treatment|Withdrawal by Subject|3
7326260|NCT00784277|11558724|FG000|ER Treatment|Study Medication Non-Compliant|0
7326261|NCT00784277|11558725|FG001|ER Treatment|Study Medication Non-Compliant|0
7326262|NCT00784277|11558726|FG002|ER Treatment|Study Medication Non-Compliant|0
7326263|NCT00784277|11558727|FG003|ER Treatment|Study Medication Non-Compliant|0
7326264|NCT00784277|11558728|FG004|ER Treatment|Study Medication Non-Compliant|2
7326265|NCT00784277|11558729|FG005|ER Treatment|Study Medication Non-Compliant|3
7326266|NCT00784277|11558730|FG006|ER Treatment|Study Medication Non-Compliant|3
7326267|NCT00784277|11558724|FG000|ER Treatment|Other|0
7326268|NCT00784277|11558725|FG001|ER Treatment|Other|0
7326269|NCT00784277|11558726|FG002|ER Treatment|Other|0
7326270|NCT00784277|11558727|FG003|ER Treatment|Other|0
7326271|NCT00784277|11558728|FG004|ER Treatment|Other|1
7326272|NCT00784277|11558729|FG005|ER Treatment|Other|3
7326273|NCT00784277|11558730|FG006|ER Treatment|Other|2
7326274|NCT00784368|11558756|FG000|Overall Study|Physician Decision|0
7326275|NCT00784368|11558757|FG001|Overall Study|Physician Decision|0
7417620|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
7417621|NCT01457924|11691720|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7417622|NCT01457924|11691721|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
7417623|NCT01457924|11691722|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7417624|NCT01457924|11691723|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
7417625|NCT01457924|11691724|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
7417626|NCT01457924|11691720|FG000|FUP (Weeks 24-48)|Adverse Event|0
7417627|NCT01457924|11691721|FG001|FUP (Weeks 24-48)|Adverse Event|0
7417628|NCT01457924|11691722|FG002|FUP (Weeks 24-48)|Adverse Event|1
7417629|NCT01457924|11691723|FG003|FUP (Weeks 24-48)|Adverse Event|0
7531425|NCT02651220|11875780|FG002|Overall Study|Lost to Follow-up|14
7531426|NCT02651220|11875778|FG000|Overall Study|Non-Compliance with Study Drug|4
7531427|NCT02651220|11875779|FG001|Overall Study|Non-Compliance with Study Drug|0
7531428|NCT02651220|11875780|FG002|Overall Study|Non-Compliance with Study Drug|1
7531429|NCT02651220|11875778|FG000|Overall Study|Pregnancy|1
7531430|NCT02651220|11875779|FG001|Overall Study|Pregnancy|0
7531431|NCT02651220|11875780|FG002|Overall Study|Pregnancy|1
7531432|NCT02651220|11875778|FG000|Overall Study|Protocol Violation|0
7417630|NCT01457924|11691724|FG004|FUP (Weeks 24-48)|Adverse Event|0
7417631|NCT01457924|11691720|FG000|FUP (Weeks 24-48)|Physician Decision|1
7417632|NCT01457924|11691721|FG001|FUP (Weeks 24-48)|Physician Decision|0
7417633|NCT01457924|11691722|FG002|FUP (Weeks 24-48)|Physician Decision|1
7417634|NCT01457924|11691723|FG003|FUP (Weeks 24-48)|Physician Decision|0
7417635|NCT01457924|11691724|FG004|FUP (Weeks 24-48)|Physician Decision|0
7417636|NCT01457924|11691720|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
7417637|NCT01457924|11691721|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
7417638|NCT01457924|11691722|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
7417639|NCT01457924|11691723|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
7417640|NCT01457924|11691724|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
7417641|NCT01457924|11691720|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
7417642|NCT01457924|11691721|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
7417643|NCT01457924|11691722|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
7417644|NCT01457924|11691723|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
7417645|NCT01457924|11691724|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
7417646|NCT01457924|11691720|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7417647|NCT01457924|11691721|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7417648|NCT01457924|11691722|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
7417649|NCT01457924|11691723|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7417650|NCT01457924|11691724|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
7531433|NCT02651220|11875779|FG001|Overall Study|Protocol Violation|0
7326276|NCT00784368|11558758|FG002|Overall Study|Physician Decision|6
7531434|NCT02651220|11875780|FG002|Overall Study|Protocol Violation|1
7326277|NCT00784368|11558756|FG000|Overall Study|Lack of Efficacy|2
7326278|NCT00784368|11558757|FG001|Overall Study|Lack of Efficacy|0
7326279|NCT00784368|11558758|FG002|Overall Study|Lack of Efficacy|1
7326280|NCT00784368|11558756|FG000|Overall Study|Adverse Event|6
7326281|NCT00784368|11558757|FG001|Overall Study|Adverse Event|9
7326282|NCT00784368|11558758|FG002|Overall Study|Adverse Event|2
7326283|NCT00784368|11558756|FG000|Overall Study|Diagnosis of fever|0
7326284|NCT00784368|11558757|FG001|Overall Study|Diagnosis of fever|0
7326285|NCT00784368|11558758|FG002|Overall Study|Diagnosis of fever|1
7326286|NCT00784368|11558756|FG000|Overall Study|Worsening of complications|0
7326287|NCT00784368|11558757|FG001|Overall Study|Worsening of complications|0
7326288|NCT00784368|11558758|FG002|Overall Study|Worsening of complications|1
7326289|NCT00784368|11558756|FG000|Overall Study|Worsening of symptoms|0
7326290|NCT00784368|11558757|FG001|Overall Study|Worsening of symptoms|1
7326291|NCT00784368|11558758|FG002|Overall Study|Worsening of symptoms|0
7326292|NCT00784368|11558756|FG000|Overall Study|Withdrawal of informed consent|0
7326293|NCT00784368|11558757|FG001|Overall Study|Withdrawal of informed consent|1
7326294|NCT00784368|11558758|FG002|Overall Study|Withdrawal of informed consent|0
7326295|NCT00784459|11558771|FG000|Overall Study|Adverse Event|0
7326296|NCT00784459|11558772|FG001|Overall Study|Adverse Event|2
7531435|NCT02651220|11875778|FG000|Overall Study|Withdrawal by Subject|5
7531436|NCT02651220|11875779|FG001|Overall Study|Withdrawal by Subject|6
7326297|NCT00784550|11558784|FG000|Overall Study|Adverse Event|12
7326298|NCT00784550|11558785|FG001|Overall Study|Adverse Event|10
7326299|NCT00784550|11558784|FG000|Overall Study|Lack of Efficacy|0
7326300|NCT00784550|11558785|FG001|Overall Study|Lack of Efficacy|1
7326301|NCT00784550|11558784|FG000|Overall Study|Protocol Violation|10
7326302|NCT00784550|11558785|FG001|Overall Study|Protocol Violation|10
7326303|NCT00784550|11558784|FG000|Overall Study|Lost to Follow-up|8
7326304|NCT00784550|11558785|FG001|Overall Study|Lost to Follow-up|5
7326305|NCT00784550|11558784|FG000|Overall Study|Physician Decision|2
7326306|NCT00784550|11558785|FG001|Overall Study|Physician Decision|3
7531437|NCT02651220|11875780|FG002|Overall Study|Withdrawal by Subject|8
7531438|NCT02651220|11875778|FG000|Overall Study|Miscellaneous|4
7531439|NCT02651220|11875779|FG001|Overall Study|Miscellaneous|1
7531440|NCT02651220|11875780|FG002|Overall Study|Miscellaneous|2
7531441|NCT02651220|11875778|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7531442|NCT02651220|11875779|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7326307|NCT00784550|11558784|FG000|Overall Study|Withdrawal by Subject|4
7326308|NCT00784550|11558785|FG001|Overall Study|Withdrawal by Subject|13
7326309|NCT00784563|11558794|FG000|Years 1 & 2|Withdrawal by Subject|3
7326310|NCT00784563|11558795|FG001|Years 1 & 2|Withdrawal by Subject|2
7326311|NCT00784563|11558796|FG002|Years 1 & 2|Withdrawal by Subject|0
7326312|NCT00784563|11558794|FG000|Years 1 & 2|Adverse Event|0
7326313|NCT00784563|11558795|FG001|Years 1 & 2|Adverse Event|3
7326314|NCT00784563|11558796|FG002|Years 1 & 2|Adverse Event|0
7326315|NCT00784563|11558794|FG000|Year 3|Withdrawal by Subject|0
7326316|NCT00784563|11558795|FG001|Year 3|Withdrawal by Subject|0
7326317|NCT00784563|11558796|FG002|Year 3|Withdrawal by Subject|2
7326318|NCT00784563|11558794|FG000|Year 3|Adverse Event|0
7326319|NCT00784563|11558795|FG001|Year 3|Adverse Event|0
7326320|NCT00784563|11558796|FG002|Year 3|Adverse Event|1
7326321|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
7326322|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
7326323|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
7326324|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
7326325|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7326326|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
7326327|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
7326328|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7326329|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
7326330|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
7326331|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7326332|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
7326333|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
7326334|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
7326335|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
7326336|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
7326337|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7326338|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
7326339|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
7326340|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7326341|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
7326342|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
7326343|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7326344|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
7326345|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
7326346|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7326347|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
7326348|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
7531443|NCT02651220|11875780|FG002|Overall Study|Withdrawal by Parent/Guardian|1
7326349|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7326350|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
7326351|NCT00784654|11558815|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
7326352|NCT00784654|11558816|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7326353|NCT00784654|11558817|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
7326354|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
7326355|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
7326356|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
7326357|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
7326358|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
7326359|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
7326360|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7326361|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
7326362|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
7326363|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Protocol Violation|0
7326364|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Protocol Violation|2
7326365|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Protocol Violation|1
7326366|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Adverse Event|0
7326367|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Adverse Event|1
7326368|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Adverse Event|1
7326369|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Did not complete a visit|0
7326370|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Did not complete a visit|1
7326371|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Did not complete a visit|0
7326372|NCT00784654|11558815|FG000|Randomized Withdrawal Period|Family reasons|0
7326373|NCT00784654|11558816|FG001|Randomized Withdrawal Period|Family reasons|0
7326374|NCT00784654|11558817|FG002|Randomized Withdrawal Period|Family reasons|1
7326375|NCT00784693|11558830|FG000|Overall Study|Lost to Follow-up|0
7326376|NCT00784693|11558831|FG001|Overall Study|Lost to Follow-up|1
7326377|NCT00784693|11558830|FG000|Overall Study|Lack of Efficacy|1
7326378|NCT00784693|11558831|FG001|Overall Study|Lack of Efficacy|1
7326379|NCT00784693|11558830|FG000|Overall Study|Withdrawal by Subject|0
7326380|NCT00784693|11558831|FG001|Overall Study|Withdrawal by Subject|4
7326381|NCT00784693|11558830|FG000|Overall Study|Randomized but not Treated|1
7326382|NCT00784693|11558831|FG001|Overall Study|Randomized but not Treated|0
7326383|NCT00784693|11558830|FG000|Overall Study|Other|1
7326384|NCT00784693|11558831|FG001|Overall Study|Other|0
7326385|NCT00784719|11558844|FG000|Overall Study|Adverse Event|0
7326386|NCT00784719|11558845|FG001|Overall Study|Adverse Event|2
7326387|NCT00784719|11558846|FG002|Overall Study|Adverse Event|0
7326388|NCT00784719|11558847|FG003|Overall Study|Adverse Event|0
7326389|NCT00784719|11558848|FG004|Overall Study|Adverse Event|1
7326390|NCT00784719|11558849|FG005|Overall Study|Adverse Event|1
7326391|NCT00784719|11558850|FG006|Overall Study|Adverse Event|1
7326392|NCT00784719|11558844|FG000|Overall Study|Lost to Follow-up|0
7326393|NCT00784719|11558845|FG001|Overall Study|Lost to Follow-up|0
7326394|NCT00784719|11558846|FG002|Overall Study|Lost to Follow-up|0
7326395|NCT00784719|11558847|FG003|Overall Study|Lost to Follow-up|0
7326396|NCT00784719|11558848|FG004|Overall Study|Lost to Follow-up|1
7326397|NCT00784719|11558849|FG005|Overall Study|Lost to Follow-up|1
7326398|NCT00784719|11558850|FG006|Overall Study|Lost to Follow-up|0
7326399|NCT00784719|11558844|FG000|Overall Study|Other|2
7326400|NCT00784719|11558845|FG001|Overall Study|Other|1
7326401|NCT00784719|11558846|FG002|Overall Study|Other|1
7326402|NCT00784719|11558847|FG003|Overall Study|Other|0
7326403|NCT00784719|11558848|FG004|Overall Study|Other|2
7326404|NCT00784719|11558849|FG005|Overall Study|Other|1
7326405|NCT00784719|11558850|FG006|Overall Study|Other|3
7326406|NCT00784719|11558844|FG000|Overall Study|Withdrawal by Subject|1
7326407|NCT00784719|11558845|FG001|Overall Study|Withdrawal by Subject|0
7326408|NCT00784719|11558846|FG002|Overall Study|Withdrawal by Subject|0
7326409|NCT00784719|11558847|FG003|Overall Study|Withdrawal by Subject|0
7326410|NCT00784719|11558848|FG004|Overall Study|Withdrawal by Subject|2
7326411|NCT00784719|11558849|FG005|Overall Study|Withdrawal by Subject|0
7326412|NCT00784719|11558850|FG006|Overall Study|Withdrawal by Subject|1
7326413|NCT00784758|11558868|FG000|Overall Study|Withdrawal by Subject|3
7326414|NCT00784758|11558869|FG001|Overall Study|Withdrawal by Subject|0
7326415|NCT00784758|11558868|FG000|Overall Study|Adverse Event|1
7326416|NCT00784758|11558869|FG001|Overall Study|Adverse Event|0
7326417|NCT00784784|11558879|FG000|Overall Study|Withdrawal by Subject|2
7326418|NCT00784784|11558880|FG001|Overall Study|Withdrawal by Subject|2
7326419|NCT00784810|11558888|FG000|Overall Study|Adverse Event|32
7326420|NCT00784810|11558889|FG001|Overall Study|Adverse Event|20
7326421|NCT00784810|11558888|FG000|Overall Study|Lack of Efficacy|14
7326422|NCT00784810|11558889|FG001|Overall Study|Lack of Efficacy|11
7326423|NCT00784810|11558888|FG000|Overall Study|Withdrawal by Subject|11
7326424|NCT00784810|11558889|FG001|Overall Study|Withdrawal by Subject|9
7326425|NCT00784810|11558888|FG000|Overall Study|Administrative|5
7326426|NCT00784810|11558889|FG001|Overall Study|Administrative|8
7326427|NCT00784810|11558888|FG000|Overall Study|Lost to Follow-up|1
7326428|NCT00784810|11558889|FG001|Overall Study|Lost to Follow-up|1
7326429|NCT00784836|11558895|FG000|Overall Study|Early Study Termination|3
7326430|NCT00784875|11558907|FG000|Period A - Baseline|Entry Criteria Not Met|0
7326431|NCT00784875|11558908|FG001|Period A - Baseline|Entry Criteria Not Met|0
7326432|NCT00784875|11558909|FG002|Period A - Baseline|Entry Criteria Not Met|0
7326433|NCT00784875|11558910|FG003|Period A - Baseline|Entry Criteria Not Met|5
7326434|NCT00784875|11558907|FG000|Period A - Baseline|Adverse Event|0
7326435|NCT00784875|11558908|FG001|Period A - Baseline|Adverse Event|0
7326436|NCT00784875|11558909|FG002|Period A - Baseline|Adverse Event|0
7326437|NCT00784875|11558910|FG003|Period A - Baseline|Adverse Event|8
7326438|NCT00784875|11558907|FG000|Period A - Baseline|Protocol Violation|0
7326439|NCT00784875|11558908|FG001|Period A - Baseline|Protocol Violation|0
7326440|NCT00784875|11558909|FG002|Period A - Baseline|Protocol Violation|0
7326441|NCT00784875|11558910|FG003|Period A - Baseline|Protocol Violation|25
7326442|NCT00784875|11558907|FG000|Period A - Baseline|Withdrawal by Subject|0
7326443|NCT00784875|11558908|FG001|Period A - Baseline|Withdrawal by Subject|0
7326444|NCT00784875|11558909|FG002|Period A - Baseline|Withdrawal by Subject|0
7326445|NCT00784875|11558910|FG003|Period A - Baseline|Withdrawal by Subject|27
7326446|NCT00784875|11558907|FG000|Period A - Baseline|Physician Decision|0
7326447|NCT00784875|11558908|FG001|Period A - Baseline|Physician Decision|0
7326448|NCT00784875|11558909|FG002|Period A - Baseline|Physician Decision|0
7326449|NCT00784875|11558910|FG003|Period A - Baseline|Physician Decision|2
7326450|NCT00784875|11558907|FG000|Period A - Baseline|Sponsor Decision|0
7326451|NCT00784875|11558908|FG001|Period A - Baseline|Sponsor Decision|0
7326452|NCT00784875|11558909|FG002|Period A - Baseline|Sponsor Decision|0
7326453|NCT00784875|11558910|FG003|Period A - Baseline|Sponsor Decision|113
7326454|NCT00784875|11558907|FG000|Period A - Baseline|Lost to Follow-up|0
7326455|NCT00784875|11558908|FG001|Period A - Baseline|Lost to Follow-up|0
7326456|NCT00784875|11558909|FG002|Period A - Baseline|Lost to Follow-up|0
7326457|NCT00784875|11558910|FG003|Period A - Baseline|Lost to Follow-up|2
7326458|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7326459|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
7326460|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
7326461|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
7326462|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Adverse Event|0
7326463|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Adverse Event|3
7326464|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Adverse Event|2
7326465|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Adverse Event|1
7326466|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
7326467|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
7326468|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
7326469|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
7326470|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
7326471|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
7326472|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
7326473|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
7326474|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
7326475|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7326476|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
7326477|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
7326478|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Physician Decision|0
7326479|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Physician Decision|0
7326480|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Physician Decision|1
7326481|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Physician Decision|0
7326482|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
7326483|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
7326484|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
7326485|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
7326486|NCT00784875|11558907|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
7326487|NCT00784875|11558908|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
7326488|NCT00784875|11558909|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
7326489|NCT00784875|11558910|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
7326490|NCT00784875|11558907|FG000|Period C|Adverse Event|1
7326491|NCT00784875|11558908|FG001|Period C|Adverse Event|0
7326492|NCT00784875|11558909|FG002|Period C|Adverse Event|4
7326493|NCT00784875|11558910|FG003|Period C|Adverse Event|2
7326494|NCT00784875|11558907|FG000|Period C|Protocol Violation|0
7326495|NCT00784875|11558908|FG001|Period C|Protocol Violation|0
7326496|NCT00784875|11558909|FG002|Period C|Protocol Violation|1
7326497|NCT00784875|11558910|FG003|Period C|Protocol Violation|2
7326498|NCT00784875|11558907|FG000|Period C|Lack of Efficacy|0
7326499|NCT00784875|11558908|FG001|Period C|Lack of Efficacy|0
7326500|NCT00784875|11558909|FG002|Period C|Lack of Efficacy|1
7326501|NCT00784875|11558910|FG003|Period C|Lack of Efficacy|0
7326502|NCT00784875|11558907|FG000|Period C|Withdrawal by Subject|1
7326503|NCT00784875|11558908|FG001|Period C|Withdrawal by Subject|1
7326504|NCT00784875|11558909|FG002|Period C|Withdrawal by Subject|2
7326505|NCT00784875|11558910|FG003|Period C|Withdrawal by Subject|0
7326506|NCT00784875|11558907|FG000|Period C|Physician Decision|0
7326507|NCT00784875|11558908|FG001|Period C|Physician Decision|0
7326508|NCT00784875|11558909|FG002|Period C|Physician Decision|1
7326509|NCT00784875|11558910|FG003|Period C|Physician Decision|1
7326510|NCT00784875|11558907|FG000|Period C|Sponsor Decision|5
7326511|NCT00784875|11558908|FG001|Period C|Sponsor Decision|5
7326512|NCT00784875|11558909|FG002|Period C|Sponsor Decision|4
7326513|NCT00784875|11558910|FG003|Period C|Sponsor Decision|2
7326514|NCT00784875|11558907|FG000|Period D|Adverse Event|0
7326515|NCT00784875|11558908|FG001|Period D|Adverse Event|2
7326516|NCT00784875|11558909|FG002|Period D|Adverse Event|2
7326517|NCT00784875|11558910|FG003|Period D|Adverse Event|0
7326518|NCT00784875|11558907|FG000|Period D|Protocol Violation|1
7326519|NCT00784875|11558908|FG001|Period D|Protocol Violation|0
7326520|NCT00784875|11558909|FG002|Period D|Protocol Violation|0
7326521|NCT00784875|11558910|FG003|Period D|Protocol Violation|0
7326522|NCT00784875|11558907|FG000|Period D|Withdrawal by Subject|2
7326523|NCT00784875|11558908|FG001|Period D|Withdrawal by Subject|0
7326524|NCT00784875|11558909|FG002|Period D|Withdrawal by Subject|2
7326525|NCT00784875|11558910|FG003|Period D|Withdrawal by Subject|0
7326526|NCT00784875|11558907|FG000|Period D|Physician Decision|0
7326527|NCT00784875|11558908|FG001|Period D|Physician Decision|1
7326528|NCT00784875|11558909|FG002|Period D|Physician Decision|0
7326529|NCT00784875|11558910|FG003|Period D|Physician Decision|0
7326530|NCT00784875|11558907|FG000|Period D|Sponsor Decision|1
7326531|NCT00784875|11558908|FG001|Period D|Sponsor Decision|1
7326532|NCT00784875|11558909|FG002|Period D|Sponsor Decision|1
7326533|NCT00784875|11558910|FG003|Period D|Sponsor Decision|0
7326534|NCT00784875|11558907|FG000|Period D|Lost to Follow-up|1
7326535|NCT00784875|11558908|FG001|Period D|Lost to Follow-up|0
7326536|NCT00784875|11558909|FG002|Period D|Lost to Follow-up|1
7326537|NCT00784875|11558910|FG003|Period D|Lost to Follow-up|1
7326538|NCT00784927|11558933|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
7326539|NCT00784927|11558933|FG000|Overall Study|Protocol Violation|1
7326540|NCT00784927|11558933|FG000|Overall Study|Ineligible|1
7326541|NCT00784979|11558938|FG000|Overall Study|incomplete data|6
7326542|NCT00785044|11558942|FG000|Overall Study|Dosed at non-participating sites|152
7326543|NCT00785044|11558942|FG000|Overall Study|Death|77
7326544|NCT00785044|11558942|FG000|Overall Study|Lost to Follow-up|266
7326545|NCT00785044|11558942|FG000|Overall Study|Withdrawal by Subject|1
7326546|NCT00785213|11558947|FG000|Quinine Sulfate Alone|Adverse Event|4
7326547|NCT00785213|11558947|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
7326548|NCT00785486|11558954|FG000|Midazolam Alone|Withdrawal by Subject|1
7326549|NCT00785512|11558977|FG000|Overall Study|Inclusion/Exclusion not meet|0
7326550|NCT00785512|11558978|FG001|Overall Study|Inclusion/Exclusion not meet|0
7326551|NCT00785512|11558977|FG000|Overall Study|Adverse Event|0
7326552|NCT00785512|11558978|FG001|Overall Study|Adverse Event|0
7326553|NCT00785512|11558977|FG000|Overall Study|Lack of Efficacy|0
7326554|NCT00785512|11558978|FG001|Overall Study|Lack of Efficacy|2
7326555|NCT00785512|11558977|FG000|Overall Study|Withdrawal by Subject|0
7326556|NCT00785512|11558978|FG001|Overall Study|Withdrawal by Subject|1
7326557|NCT00785512|11558977|FG000|Overall Study|Lost to Follow-up|3
7326558|NCT00785512|11558978|FG001|Overall Study|Lost to Follow-up|0
7326559|NCT00785512|11558977|FG000|Overall Study|Precedure Refused|0
7326560|NCT00785512|11558978|FG001|Overall Study|Precedure Refused|0
7326561|NCT00785512|11558977|FG000|Overall Study|IVRS Programing Error|0
7326562|NCT00785512|11558978|FG001|Overall Study|IVRS Programing Error|0
7326563|NCT00785512|11558977|FG000|Overall Study|Physician Decision|0
7326564|NCT00785512|11558978|FG001|Overall Study|Physician Decision|0
7326565|NCT00785512|11558977|FG000|Overall Study|Lack of compliance|0
7326566|NCT00785512|11558978|FG001|Overall Study|Lack of compliance|1
7326567|NCT00785538|11558989|FG000|Treatment Period|Adverse Event|1
7326568|NCT00785538|11558990|FG001|Treatment Period|Adverse Event|2
7326569|NCT00785538|11558991|FG002|Treatment Period|Adverse Event|2
7326570|NCT00785538|11558992|FG003|Treatment Period|Adverse Event|0
7326571|NCT00785538|11558989|FG000|Treatment Period|Withdrawal by Subject|0
7417651|NCT01457924|11691720|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7417652|NCT01457924|11691721|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
7417653|NCT01457924|11691722|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
7417654|NCT01457924|11691723|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
7417655|NCT01457924|11691724|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
7417656|NCT01457924|11691720|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7417657|NCT01457924|11691721|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
7417658|NCT01457924|11691722|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7417659|NCT01457924|11691723|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
7417660|NCT01457924|11691724|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
7417661|NCT01457950|11691738|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
7417662|NCT01457950|11691739|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
7417663|NCT01457950|11691740|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
7417664|NCT01457950|11691741|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
7417665|NCT01457950|11691738|FG000|Double-Blind Phase|Protocol Violation|2
7417666|NCT01457950|11691739|FG001|Double-Blind Phase|Protocol Violation|1
7417667|NCT01457950|11691740|FG002|Double-Blind Phase|Protocol Violation|0
7417668|NCT01457950|11691741|FG003|Double-Blind Phase|Protocol Violation|0
7326572|NCT00785538|11558990|FG001|Treatment Period|Withdrawal by Subject|0
7326573|NCT00785538|11558991|FG002|Treatment Period|Withdrawal by Subject|0
7326574|NCT00785538|11558992|FG003|Treatment Period|Withdrawal by Subject|1
7326575|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Adverse Event|5
7326576|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Adverse Event|7
7326577|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Adverse Event|14
7326578|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Adverse Event|10
7326579|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Adverse Event|17
7326580|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
7326581|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
7326582|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
7326583|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
7326584|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
7326585|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
7326586|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
7326587|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
7326588|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
7326589|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
7326590|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Physician Decision|1
7326591|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Physician Decision|0
7326592|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Physician Decision|0
7326593|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Physician Decision|0
7326594|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Physician Decision|0
7326595|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
7326596|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
7326597|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
7326598|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
7326599|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
7326600|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7326601|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7326602|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7326603|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7326604|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
7326605|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7326606|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7326607|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7326608|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
7326609|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
7326610|NCT00785577|11559008|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
7326611|NCT00785577|11559009|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
7326612|NCT00785577|11559010|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
7326613|NCT00785577|11559011|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
7326614|NCT00785577|11559012|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
7326615|NCT00785577|11559008|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7326616|NCT00785577|11559009|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7326617|NCT00785577|11559010|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7326618|NCT00785577|11559011|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
7326619|NCT00785577|11559012|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
7326620|NCT00785577|11559008|FG000|Study Period 3: 1-Week Washout Phase|Death|0
7326621|NCT00785577|11559009|FG001|Study Period 3: 1-Week Washout Phase|Death|0
7326622|NCT00785577|11559010|FG002|Study Period 3: 1-Week Washout Phase|Death|0
7326623|NCT00785577|11559011|FG003|Study Period 3: 1-Week Washout Phase|Death|0
7326624|NCT00785577|11559012|FG004|Study Period 3: 1-Week Washout Phase|Death|1
7326625|NCT00785629|11559038|FG000|Overall Study|Adverse Event|2
7326626|NCT00785629|11559039|FG001|Overall Study|Adverse Event|1
7326627|NCT00785629|11559040|FG002|Overall Study|Adverse Event|1
7326628|NCT00785629|11559041|FG003|Overall Study|Adverse Event|5
7326629|NCT00785629|11559038|FG000|Overall Study|Protocol Violation|1
7326630|NCT00785629|11559039|FG001|Overall Study|Protocol Violation|2
7326631|NCT00785629|11559040|FG002|Overall Study|Protocol Violation|4
7326632|NCT00785629|11559041|FG003|Overall Study|Protocol Violation|5
7326633|NCT00785629|11559038|FG000|Overall Study|administrative decision|5
7326634|NCT00785629|11559039|FG001|Overall Study|administrative decision|1
7326635|NCT00785629|11559040|FG002|Overall Study|administrative decision|3
7326636|NCT00785629|11559041|FG003|Overall Study|administrative decision|4
7326637|NCT00785629|11559038|FG000|Overall Study|Withdrawal by Subject|0
7326638|NCT00785629|11559039|FG001|Overall Study|Withdrawal by Subject|1
7326639|NCT00785629|11559040|FG002|Overall Study|Withdrawal by Subject|2
7326640|NCT00785629|11559041|FG003|Overall Study|Withdrawal by Subject|2
7417669|NCT01457950|11691738|FG000|Double-Blind Phase|Withdrawal by Subject|6
7384939|NCT01197794|11642371|FG000|Overall Study|Eligibility criteria not fulfilled|5
7384940|NCT01197794|11642372|FG001|Overall Study|Eligibility criteria not fulfilled|8
7384941|NCT01197794|11642373|FG002|Overall Study|Eligibility criteria not fulfilled|2
7384942|NCT01197794|11642374|FG003|Overall Study|Eligibility criteria not fulfilled|5
7384943|NCT01197794|11642375|FG004|Overall Study|Eligibility criteria not fulfilled|5
7384944|NCT01197794|11642376|FG005|Overall Study|Eligibility criteria not fulfilled|9
7384945|NCT01197794|11642377|FG006|Overall Study|Eligibility criteria not fulfilled|6
7384946|NCT01197794|11642371|FG000|Overall Study|Withdrawal by Subject|3
7326641|NCT00785707|11559049|FG000|Overall Study|Lost to Follow-up|7
7326642|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
7326643|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
7326644|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Adverse Event|31
7326645|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Adverse Event|21
7326646|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
7326647|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
7326648|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
7326649|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
7326650|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
7326651|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
7326652|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
7326653|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
7326654|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Administrative problems|3
7326655|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Administrative problems|3
7326656|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Death|5
7326657|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Death|8
7326658|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Disease progression|139
7326659|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Disease progression|119
7326660|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Protocol deviation|5
7326661|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Protocol deviation|6
7326662|NCT00785785|11559059|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
7326663|NCT00785785|11559060|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
7326664|NCT00785785|11559059|FG000|Optional Extension Phase|Adverse Event|4
7326665|NCT00785785|11559060|FG001|Optional Extension Phase|Adverse Event|5
7326666|NCT00785785|11559059|FG000|Optional Extension Phase|Withdrawal by Subject|6
7326667|NCT00785785|11559060|FG001|Optional Extension Phase|Withdrawal by Subject|6
7326668|NCT00785785|11559059|FG000|Optional Extension Phase|Lost to Follow-up|1
7326669|NCT00785785|11559060|FG001|Optional Extension Phase|Lost to Follow-up|0
7326670|NCT00785785|11559059|FG000|Optional Extension Phase|Administrative problems|2
7326671|NCT00785785|11559060|FG001|Optional Extension Phase|Administrative problems|0
7326672|NCT00785785|11559059|FG000|Optional Extension Phase|Death|1
7326673|NCT00785785|11559060|FG001|Optional Extension Phase|Death|5
7326674|NCT00785785|11559059|FG000|Optional Extension Phase|Disease progression|22
7326675|NCT00785785|11559060|FG001|Optional Extension Phase|Disease progression|70
7326676|NCT00785785|11559059|FG000|Optional Extension Phase|Protocol deviation|0
7326677|NCT00785785|11559060|FG001|Optional Extension Phase|Protocol deviation|2
7326678|NCT00785785|11559059|FG000|Optional Extension Phase|Study terminated by sponsor|3
7326679|NCT00785785|11559060|FG001|Optional Extension Phase|Study terminated by sponsor|37
7326680|NCT00785928|11559075|FG000|Treatment Phase|Adverse Event|1
7326681|NCT00785928|11559076|FG001|Treatment Phase|Adverse Event|1
7326682|NCT00785928|11559077|FG002|Treatment Phase|Adverse Event|2
7326683|NCT00785928|11559078|FG003|Treatment Phase|Adverse Event|0
7326684|NCT00785928|11559079|FG004|Treatment Phase|Adverse Event|0
7326685|NCT00785928|11559080|FG005|Treatment Phase|Adverse Event|0
7326686|NCT00785928|11559081|FG006|Treatment Phase|Adverse Event|2
7326687|NCT00785928|11559075|FG000|Treatment Phase|Inadequate Response|0
7326688|NCT00785928|11559076|FG001|Treatment Phase|Inadequate Response|1
7326689|NCT00785928|11559077|FG002|Treatment Phase|Inadequate Response|0
7326690|NCT00785928|11559078|FG003|Treatment Phase|Inadequate Response|0
7326691|NCT00785928|11559079|FG004|Treatment Phase|Inadequate Response|0
7326692|NCT00785928|11559080|FG005|Treatment Phase|Inadequate Response|0
7326693|NCT00785928|11559081|FG006|Treatment Phase|Inadequate Response|0
7326694|NCT00785928|11559075|FG000|Treatment Phase|Lack of Efficacy|0
7326695|NCT00785928|11559076|FG001|Treatment Phase|Lack of Efficacy|1
7326696|NCT00785928|11559077|FG002|Treatment Phase|Lack of Efficacy|1
7326697|NCT00785928|11559078|FG003|Treatment Phase|Lack of Efficacy|0
7326698|NCT00785928|11559079|FG004|Treatment Phase|Lack of Efficacy|0
7326699|NCT00785928|11559080|FG005|Treatment Phase|Lack of Efficacy|0
7326700|NCT00785928|11559081|FG006|Treatment Phase|Lack of Efficacy|0
7326701|NCT00785928|11559075|FG000|Treatment Phase|Physician Decision|0
7326702|NCT00785928|11559076|FG001|Treatment Phase|Physician Decision|0
7326703|NCT00785928|11559077|FG002|Treatment Phase|Physician Decision|0
7326704|NCT00785928|11559078|FG003|Treatment Phase|Physician Decision|0
7326705|NCT00785928|11559079|FG004|Treatment Phase|Physician Decision|1
7326706|NCT00785928|11559080|FG005|Treatment Phase|Physician Decision|0
7326707|NCT00785928|11559081|FG006|Treatment Phase|Physician Decision|0
7531444|NCT02651467|11875829|FG000|Overall Study|Withdrawal by Subject|0
7531445|NCT02651467|11875830|FG001|Overall Study|Withdrawal by Subject|0
7326708|NCT00785928|11559075|FG000|Treatment Phase|Sponsor Decision|1
7326709|NCT00785928|11559076|FG001|Treatment Phase|Sponsor Decision|0
7326710|NCT00785928|11559077|FG002|Treatment Phase|Sponsor Decision|0
7326711|NCT00785928|11559078|FG003|Treatment Phase|Sponsor Decision|0
7326712|NCT00785928|11559079|FG004|Treatment Phase|Sponsor Decision|0
7326713|NCT00785928|11559080|FG005|Treatment Phase|Sponsor Decision|0
7326714|NCT00785928|11559081|FG006|Treatment Phase|Sponsor Decision|1
7326715|NCT00785928|11559075|FG000|Treatment Phase|Withdrawal by Subject|1
7326716|NCT00785928|11559076|FG001|Treatment Phase|Withdrawal by Subject|2
7326717|NCT00785928|11559077|FG002|Treatment Phase|Withdrawal by Subject|0
7531446|NCT02651467|11875831|FG002|Overall Study|Withdrawal by Subject|2
7531447|NCT02651467|11875829|FG000|Overall Study|Other (Not specified)|1
7531448|NCT02651467|11875830|FG001|Overall Study|Other (Not specified)|0
7531449|NCT02651467|11875831|FG002|Overall Study|Other (Not specified)|2
7537614|NCT02836236|11886741|FG000|Overall Study|Withdrew Consent|2
7537615|NCT02836236|11886742|FG001|Overall Study|Withdrew Consent|0
7537616|NCT02836236|11886741|FG000|Overall Study|Adverse Event|0
7537617|NCT02836236|11886742|FG001|Overall Study|Adverse Event|1
7537618|NCT02836236|11886741|FG000|Overall Study|Investigator's Discretion|1
7555492|NCT03056690|11918751|FG000|Overall Study|Lack of Efficacy|1
7555493|NCT03056690|11918752|FG001|Overall Study|Lack of Efficacy|2
7326718|NCT00785928|11559078|FG003|Treatment Phase|Withdrawal by Subject|0
7326719|NCT00785928|11559079|FG004|Treatment Phase|Withdrawal by Subject|1
7326720|NCT00785928|11559080|FG005|Treatment Phase|Withdrawal by Subject|0
7326721|NCT00785928|11559081|FG006|Treatment Phase|Withdrawal by Subject|0
7326722|NCT00785980|11559119|FG000|7 Day Washout Period|Protocol Violation|3
7326723|NCT00786032|11559137|FG000|Overall Study|Death|4
7326724|NCT00786032|11559137|FG000|Overall Study|Withdrawal by Subject|14
7326725|NCT00786032|11559137|FG000|Overall Study|Did not complete in the timeframe|6
7326726|NCT00786188|11559145|FG000|Overall Study|Adverse Event|3
7326727|NCT00786188|11559146|FG001|Overall Study|Adverse Event|1
7326728|NCT00786188|11559145|FG000|Overall Study|Withdrawal by Subject|2
7326729|NCT00786188|11559146|FG001|Overall Study|Withdrawal by Subject|0
7326730|NCT00786409|11559154|FG000|Overall Study|Withdrawal by Subject|2
7326731|NCT00786409|11559154|FG000|Overall Study|Adverse Event|2
7326732|NCT00786409|11559154|FG000|Overall Study|Pregnancy|2
7326733|NCT00786409|11559154|FG000|Overall Study|Lost to Follow-up|1
7326734|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Death|2
7326735|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
7326736|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
7326737|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Physician Decision|1
7326738|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
7326739|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
7326740|NCT00786422|11559158|FG000|Rivaroxaban Treatment|Adverse Event|2
7326741|NCT00786422|11559158|FG000|Follow-up Period|Death|1
7326742|NCT00786422|11559158|FG000|Follow-up Period|End-of-study done up to 4 days early|2
7326743|NCT00786474|11559166|FG000|Overall Study|Death|5
7326744|NCT00786474|11559167|FG001|Overall Study|Death|4
7326745|NCT00786474|11559166|FG000|Overall Study|Withdrawal by Subject|23
7326746|NCT00786474|11559167|FG001|Overall Study|Withdrawal by Subject|31
7326747|NCT00786474|11559166|FG000|Overall Study|Lost to Follow-up|3
7326748|NCT00786474|11559167|FG001|Overall Study|Lost to Follow-up|3
7326749|NCT00786474|11559166|FG000|Overall Study|Physician Decision|2
7326750|NCT00786474|11559167|FG001|Overall Study|Physician Decision|1
7326751|NCT00786474|11559166|FG000|Overall Study|Other|4
7326752|NCT00786474|11559167|FG001|Overall Study|Other|4
7326753|NCT00786565|11559190|FG000|Enrollment Prior to Surgery|Site Closed|3
7326754|NCT00786565|11559190|FG000|Enrollment Prior to Surgery|Protocol Violation|3
7326755|NCT00786565|11559190|FG000|Post Surgery|Abnormal macular pucker|1
7326756|NCT00786565|11559190|FG000|Post Surgery|Adapt AO implanted posterior side up|1
7326757|NCT00786799|11559207|FG000|Overall Study|Lost to Follow-up|1
7326758|NCT00786799|11559208|FG001|Overall Study|Lost to Follow-up|1
7326759|NCT00786838|11559228|FG000|Overall Study|Physician Decision|4
7326760|NCT00786838|11559228|FG000|Overall Study|Death|4
7326761|NCT00786838|11559228|FG000|Overall Study|Adverse Event|6
7326762|NCT00786838|11559228|FG000|Overall Study|Progressive disease|31
7326763|NCT00786838|11559228|FG000|Overall Study|Withdrawal by Subject|4
7326764|NCT00786864|11559239|FG000|Overall Study|Lost to Follow-up|0
7326765|NCT00786864|11559240|FG001|Overall Study|Lost to Follow-up|1
7326766|NCT00786864|11559239|FG000|Overall Study|Sustained serious back injury|1
7326767|NCT00786864|11559240|FG001|Overall Study|Sustained serious back injury|0
7326768|NCT00787137|11559287|FG000|Overall Study|Study Termination|0
7326769|NCT00787137|11559288|FG001|Overall Study|Study Termination|0
7326770|NCT00787137|11559289|FG002|Overall Study|Study Termination|1
7326771|NCT00787150|11559300|FG000|Overall Study|Adverse Event|4
7326772|NCT00787150|11559301|FG001|Overall Study|Adverse Event|4
7326773|NCT00787150|11559302|FG002|Overall Study|Adverse Event|4
7326774|NCT00787150|11559300|FG000|Overall Study|Physician Decision|1
7326775|NCT00787150|11559301|FG001|Overall Study|Physician Decision|2
7326776|NCT00787150|11559302|FG002|Overall Study|Physician Decision|1
7326777|NCT00787150|11559300|FG000|Overall Study|Withdrawal by Subject|2
7326778|NCT00787150|11559301|FG001|Overall Study|Withdrawal by Subject|1
7326779|NCT00787150|11559302|FG002|Overall Study|Withdrawal by Subject|0
7326780|NCT00787150|11559300|FG000|Overall Study|Dosing incorrect study durg|2
7326781|NCT00787150|11559301|FG001|Overall Study|Dosing incorrect study durg|0
7326782|NCT00787150|11559302|FG002|Overall Study|Dosing incorrect study durg|0
7326783|NCT00787189|11559314|FG000|Overall Study|Lost to Follow-up|2
7326784|NCT00787189|11559315|FG001|Overall Study|Lost to Follow-up|2
7326785|NCT00787202|11559326|FG000|Overall Study|Adverse Event|3
7326786|NCT00787202|11559327|FG001|Overall Study|Adverse Event|2
7326787|NCT00787202|11559328|FG002|Overall Study|Adverse Event|0
7326788|NCT00787202|11559329|FG003|Overall Study|Adverse Event|0
7537619|NCT02836236|11886742|FG001|Overall Study|Investigator's Discretion|0
7537620|NCT02836236|11886741|FG000|Overall Study|Still on Study|101
7537621|NCT02836236|11886742|FG001|Overall Study|Still on Study|49
7326789|NCT00787202|11559330|FG004|Overall Study|Adverse Event|2
7326790|NCT00787202|11559326|FG000|Overall Study|Lack of Efficacy|5
7326791|NCT00787202|11559327|FG001|Overall Study|Lack of Efficacy|6
7326792|NCT00787202|11559328|FG002|Overall Study|Lack of Efficacy|5
7326793|NCT00787202|11559329|FG003|Overall Study|Lack of Efficacy|2
7326794|NCT00787202|11559330|FG004|Overall Study|Lack of Efficacy|1
7326795|NCT00787202|11559326|FG000|Overall Study|Lost to Follow-up|1
7326796|NCT00787202|11559327|FG001|Overall Study|Lost to Follow-up|0
7326797|NCT00787202|11559328|FG002|Overall Study|Lost to Follow-up|0
7326798|NCT00787202|11559329|FG003|Overall Study|Lost to Follow-up|0
7326799|NCT00787202|11559330|FG004|Overall Study|Lost to Follow-up|0
7326800|NCT00787202|11559326|FG000|Overall Study|Withdrawal by Subject|2
7326801|NCT00787202|11559327|FG001|Overall Study|Withdrawal by Subject|2
7326802|NCT00787202|11559328|FG002|Overall Study|Withdrawal by Subject|2
7326803|NCT00787202|11559329|FG003|Overall Study|Withdrawal by Subject|0
7326804|NCT00787202|11559330|FG004|Overall Study|Withdrawal by Subject|0
7326805|NCT00787202|11559326|FG000|Overall Study|Protocol Violation|2
7326806|NCT00787202|11559327|FG001|Overall Study|Protocol Violation|1
7326807|NCT00787202|11559328|FG002|Overall Study|Protocol Violation|0
7417670|NCT01457950|11691739|FG001|Double-Blind Phase|Withdrawal by Subject|2
7417671|NCT01457950|11691740|FG002|Double-Blind Phase|Withdrawal by Subject|0
7417672|NCT01457950|11691741|FG003|Double-Blind Phase|Withdrawal by Subject|0
7417673|NCT01457950|11691738|FG000|Open-Label Phase|Adverse Event|0
7417674|NCT01457950|11691739|FG001|Open-Label Phase|Adverse Event|0
7417675|NCT01457950|11691740|FG002|Open-Label Phase|Adverse Event|0
7417676|NCT01457950|11691741|FG003|Open-Label Phase|Adverse Event|1
7417677|NCT01457950|11691738|FG000|Open-Label Phase|Protocol Violation|0
7417678|NCT01457950|11691739|FG001|Open-Label Phase|Protocol Violation|0
7417679|NCT01457950|11691740|FG002|Open-Label Phase|Protocol Violation|0
7417680|NCT01457950|11691741|FG003|Open-Label Phase|Protocol Violation|1
7417681|NCT01457950|11691738|FG000|Open-Label Phase|Withdrawal by Subject|0
7417682|NCT01457950|11691739|FG001|Open-Label Phase|Withdrawal by Subject|0
7417683|NCT01457950|11691740|FG002|Open-Label Phase|Withdrawal by Subject|2
7417684|NCT01457950|11691741|FG003|Open-Label Phase|Withdrawal by Subject|0
7417685|NCT01458106|11691754|FG000|Overall Study|Withdrawal by Subject|2
7417686|NCT01458106|11691755|FG001|Overall Study|Withdrawal by Subject|0
7417687|NCT01458106|11691754|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
7417688|NCT01458106|11691755|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
7417689|NCT01458106|11691754|FG000|Overall Study|Withdrawn Per Protocol|0
7417690|NCT01458106|11691755|FG001|Overall Study|Withdrawn Per Protocol|1
7417691|NCT01458119|11691764|FG000|Overall Study|Physician Decision|4
7417692|NCT01458119|11691764|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
7417693|NCT01458119|11691764|FG000|Overall Study|Pregnancy|1
7417694|NCT01458119|11691764|FG000|Overall Study|Death|2
7417695|NCT01458119|11691764|FG000|Overall Study|Adverse Event|1
7417696|NCT01458119|11691764|FG000|Overall Study|Consent Withdrawn by Participant|8
7417697|NCT01458119|11691764|FG000|Overall Study|Non-compliance With Study Drug|3
7417698|NCT01458132|11691771|FG000|Overall Study|Other|15
7417699|NCT01458132|11691772|FG001|Overall Study|Other|3
7417700|NCT01458171|11691778|FG000|Overall Study|Adverse Event|1
7417701|NCT01458210|11691784|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
7417702|NCT01458210|11691784|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
7417703|NCT01458210|11691784|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
7417704|NCT01458210|11691784|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
7417705|NCT01458249|11691793|FG000|Overall Study|Not treated|1
7417706|NCT01458249|11691793|FG000|Overall Study|Adverse Event|4
7417707|NCT01458249|11691793|FG000|Overall Study|Other|2
7417708|NCT01458249|11691793|FG000|Overall Study|Ongoing|1
7417709|NCT01458275|11691801|FG000|Overall Study|Adverse Event|3
7417710|NCT01458275|11691802|FG001|Overall Study|Adverse Event|4
7417711|NCT01458275|11691803|FG002|Overall Study|Adverse Event|1
7417712|NCT01458275|11691801|FG000|Overall Study|Lost to Follow-up|3
7417713|NCT01458275|11691802|FG001|Overall Study|Lost to Follow-up|2
7417714|NCT01458275|11691803|FG002|Overall Study|Lost to Follow-up|5
7417715|NCT01458275|11691801|FG000|Overall Study|Protocol Violation|5
7417716|NCT01458275|11691802|FG001|Overall Study|Protocol Violation|5
7417717|NCT01458275|11691803|FG002|Overall Study|Protocol Violation|2
7417718|NCT01458275|11691801|FG000|Overall Study|Withdrawal by Subject|3
7417719|NCT01458275|11691802|FG001|Overall Study|Withdrawal by Subject|2
7417720|NCT01458275|11691803|FG002|Overall Study|Withdrawal by Subject|1
7326808|NCT00787202|11559329|FG003|Overall Study|Protocol Violation|0
7326809|NCT00787202|11559330|FG004|Overall Study|Protocol Violation|1
7326810|NCT00787202|11559326|FG000|Overall Study|Randomized, not treated|1
7326811|NCT00787202|11559327|FG001|Overall Study|Randomized, not treated|0
7326812|NCT00787202|11559328|FG002|Overall Study|Randomized, not treated|0
7326813|NCT00787202|11559329|FG003|Overall Study|Randomized, not treated|0
7326814|NCT00787202|11559330|FG004|Overall Study|Randomized, not treated|0
7326815|NCT00787254|11559361|FG000|Overall Study|Adverse Event|24
7326816|NCT00787254|11559362|FG001|Overall Study|Adverse Event|23
7326817|NCT00787254|11559361|FG000|Overall Study|Protocol Violation|26
7326818|NCT00787254|11559362|FG001|Overall Study|Protocol Violation|23
7326819|NCT00787254|11559361|FG000|Overall Study|Withdrawal by Subject|16
7531450|NCT02651688|11875864|FG000|Overall Study|Non-compliance|0
7555494|NCT03056690|11918751|FG000|Overall Study|Lost to Follow-up|3
7326820|NCT00787254|11559362|FG001|Overall Study|Withdrawal by Subject|11
7326821|NCT00787254|11559361|FG000|Overall Study|Lack of Efficacy|4
7326822|NCT00787254|11559362|FG001|Overall Study|Lack of Efficacy|15
7326823|NCT00787254|11559361|FG000|Overall Study|NSAIDs discontinuation|1
7326824|NCT00787254|11559362|FG001|Overall Study|NSAIDs discontinuation|2
7326825|NCT00787254|11559361|FG000|Overall Study|Institution closed|1
7326826|NCT00787254|11559362|FG001|Overall Study|Institution closed|0
7326827|NCT00787254|11559361|FG000|Overall Study|Physician Decision|4
7326828|NCT00787254|11559362|FG001|Overall Study|Physician Decision|8
7555495|NCT03056690|11918752|FG001|Overall Study|Lost to Follow-up|2
7555496|NCT03056690|11918751|FG000|Overall Study|Protocol Violation|2
7555497|NCT03056690|11918752|FG001|Overall Study|Protocol Violation|2
7555498|NCT03056690|11918751|FG000|Overall Study|Withdrawal by Subject|3
7555499|NCT03056690|11918752|FG001|Overall Study|Withdrawal by Subject|6
7555500|NCT03056690|11918751|FG000|Overall Study|Non-compliance with Study Drug|1
7555501|NCT03056690|11918752|FG001|Overall Study|Non-compliance with Study Drug|0
7555502|NCT03056690|11918751|FG000|Overall Study|Miscellaneous|1
7555503|NCT03056690|11918752|FG001|Overall Study|Miscellaneous|2
7555504|NCT03057496|11918775|FG000|Overall Study|Withdrawal by Subject|8
7555505|NCT03057496|11918775|FG000|Overall Study|Lost to Follow-up|5
7555506|NCT03057496|11918775|FG000|Overall Study|Did not use device during home trial|3
7555507|NCT03057496|11918775|FG000|Overall Study|Device failure|2
7555508|NCT03057977|11918792|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
7555509|NCT03057977|11918793|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
7555510|NCT03057977|11918792|FG000|Discontinuation From Treatment|Lost to Follow-up|11
7555511|NCT03057977|11918793|FG001|Discontinuation From Treatment|Lost to Follow-up|17
7555512|NCT03057977|11918792|FG000|Discontinuation From Treatment|Protocol Violation|6
7555513|NCT03057977|11918793|FG001|Discontinuation From Treatment|Protocol Violation|5
7555514|NCT03057977|11918792|FG000|Discontinuation From Treatment|Not treated|4
7555515|NCT03057977|11918793|FG001|Discontinuation From Treatment|Not treated|0
7555516|NCT03057977|11918792|FG000|Discontinuation From Treatment|Adverse Event|343
7555517|NCT03057977|11918793|FG001|Discontinuation From Treatment|Adverse Event|337
7555518|NCT03057977|11918792|FG000|Discontinuation From Treatment|Reason Unknown|0
7555519|NCT03057977|11918793|FG001|Discontinuation From Treatment|Reason Unknown|1
7555520|NCT03057977|11918792|FG000|Discontinuation From Treatment|Personal Reasons|1
7555521|NCT03057977|11918793|FG001|Discontinuation From Treatment|Personal Reasons|1
7555522|NCT03057977|11918792|FG000|Discontinuation From Treatment|Unblinded medication|1
7555523|NCT03057977|11918793|FG001|Discontinuation From Treatment|Unblinded medication|0
7555524|NCT03057977|11918792|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7555525|NCT03057977|11918793|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
7555526|NCT03057977|11918792|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
7555527|NCT03057977|11918793|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
7555528|NCT03057977|11918792|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
7555529|NCT03057977|11918793|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
7326829|NCT00787267|11559368|FG000|Overall Study|Screen failure/Ineligible|10
7326830|NCT00787267|11559368|FG000|Overall Study|No Reason Provided|1
7326831|NCT00787267|11559368|FG000|Overall Study|Withdrawal by Subject|1
7326832|NCT00787319|11559372|FG000|Overall Study|Lost to Follow-up|2
7326833|NCT00787319|11559372|FG000|Overall Study|Withdrawal by Subject|15
7531451|NCT02651688|11875865|FG001|Overall Study|Non-compliance|0
7531452|NCT02651688|11875866|FG002|Overall Study|Non-compliance|1
7531453|NCT02651688|11875864|FG000|Overall Study|Principal Investigator (PI) decision|0
7531454|NCT02651688|11875865|FG001|Overall Study|Principal Investigator (PI) decision|2
7531455|NCT02651688|11875866|FG002|Overall Study|Principal Investigator (PI) decision|0
7531456|NCT02651688|11875864|FG000|Overall Study|Lost to Follow-up|1
7531457|NCT02651688|11875865|FG001|Overall Study|Lost to Follow-up|3
7531458|NCT02651688|11875866|FG002|Overall Study|Lost to Follow-up|0
7531459|NCT02651688|11875864|FG000|Overall Study|Withdrawal by Subject|1
7531460|NCT02651688|11875865|FG001|Overall Study|Withdrawal by Subject|0
7531461|NCT02651688|11875866|FG002|Overall Study|Withdrawal by Subject|2
7531462|NCT02651922|11875874|FG000|Overall Study|due to exclusion criteria|2
7531463|NCT02651987|11875880|FG000|Overall Study|Adverse Event|2
7531464|NCT02651987|11875881|FG001|Overall Study|Adverse Event|2
7531465|NCT02651987|11875880|FG000|Overall Study|Consent Withdrawn|2
7531466|NCT02651987|11875881|FG001|Overall Study|Consent Withdrawn|0
7531467|NCT02651987|11875880|FG000|Overall Study|Local PD|0
7531468|NCT02651987|11875881|FG001|Overall Study|Local PD|2
7531469|NCT02651987|11875880|FG000|Overall Study|Investigator Decision|1
7531470|NCT02651987|11875881|FG001|Overall Study|Investigator Decision|1
7531471|NCT02652156|11875893|FG000|Overall Study|Physician Decision|1
7326834|NCT00787319|11559372|FG000|Overall Study|Adverse Event|3
7326835|NCT00787319|11559372|FG000|Overall Study|Objective progression or relapse|30
7326836|NCT00787319|11559372|FG000|Overall Study|Lack of Efficacy|1
7326837|NCT00787319|11559372|FG000|Overall Study|Budget exhausted/exceeded|1
7326838|NCT00787319|11559372|FG000|Overall Study|Unresponsiveness to visit invitation|1
7417731|NCT01458392|11691843|FG000|Overall Study|Death|2
7417732|NCT01458392|11691844|FG001|Overall Study|Death|11
7417733|NCT01458392|11691845|FG002|Overall Study|Death|22
7417734|NCT01458392|11691843|FG000|Overall Study|At the discretion of the sponsor|0
7417735|NCT01458392|11691844|FG001|Overall Study|At the discretion of the sponsor|2
7417736|NCT01458392|11691845|FG002|Overall Study|At the discretion of the sponsor|7
7417737|NCT01458392|11691843|FG000|Overall Study|Patient unwilling to comply with protoco|0
7417738|NCT01458392|11691844|FG001|Overall Study|Patient unwilling to comply with protoco|0
7417739|NCT01458392|11691845|FG002|Overall Study|Patient unwilling to comply with protoco|2
7417740|NCT01458522|11691876|FG000|Overall Study|Withdrawal by Subject|2
7417741|NCT01458522|11691877|FG001|Overall Study|Withdrawal by Subject|2
7417742|NCT01458522|11691876|FG000|Overall Study|Physician Decision|1
7417743|NCT01458522|11691877|FG001|Overall Study|Physician Decision|9
7417744|NCT01458535|11691895|FG000|Overall Study|Other|0
7417745|NCT01458535|11691896|FG001|Overall Study|Other|0
7417746|NCT01458535|11691897|FG002|Overall Study|Other|0
7417747|NCT01458535|11691898|FG003|Overall Study|Other|0
7417748|NCT01458535|11691899|FG004|Overall Study|Other|1
7417749|NCT01458535|11691900|FG005|Overall Study|Other|1
7417750|NCT01458535|11691895|FG000|Overall Study|Withdrawal by Subject|0
7417751|NCT01458535|11691896|FG001|Overall Study|Withdrawal by Subject|0
7417752|NCT01458535|11691897|FG002|Overall Study|Withdrawal by Subject|2
7417753|NCT01458535|11691898|FG003|Overall Study|Withdrawal by Subject|0
7417754|NCT01458535|11691899|FG004|Overall Study|Withdrawal by Subject|1
7417755|NCT01458535|11691900|FG005|Overall Study|Withdrawal by Subject|1
7417756|NCT01458535|11691895|FG000|Overall Study|Lost to Follow-up|0
7417757|NCT01458535|11691896|FG001|Overall Study|Lost to Follow-up|2
7417758|NCT01458535|11691897|FG002|Overall Study|Lost to Follow-up|0
7417759|NCT01458535|11691898|FG003|Overall Study|Lost to Follow-up|3
7417760|NCT01458535|11691899|FG004|Overall Study|Lost to Follow-up|2
7417761|NCT01458535|11691900|FG005|Overall Study|Lost to Follow-up|2
7417762|NCT01458535|11691895|FG000|Overall Study|Adverse Event|0
7417763|NCT01458535|11691896|FG001|Overall Study|Adverse Event|0
7417764|NCT01458535|11691897|FG002|Overall Study|Adverse Event|0
7417765|NCT01458535|11691898|FG003|Overall Study|Adverse Event|1
7417766|NCT01458535|11691899|FG004|Overall Study|Adverse Event|0
7417767|NCT01458535|11691900|FG005|Overall Study|Adverse Event|0
7417768|NCT01458574|11691956|FG000|Overall Study|Adverse Event|5
7417769|NCT01458574|11691957|FG001|Overall Study|Adverse Event|9
7417770|NCT01458574|11691958|FG002|Overall Study|Adverse Event|7
7417771|NCT01458574|11691956|FG000|Overall Study|Lack of Efficacy|70
7417772|NCT01458574|11691957|FG001|Overall Study|Lack of Efficacy|53
7417773|NCT01458574|11691958|FG002|Overall Study|Lack of Efficacy|132
7417774|NCT01458574|11691956|FG000|Overall Study|Lost to Follow-up|3
7417775|NCT01458574|11691957|FG001|Overall Study|Lost to Follow-up|2
7417776|NCT01458574|11691958|FG002|Overall Study|Lost to Follow-up|1
7417777|NCT01458574|11691956|FG000|Overall Study|Pregnancy|1
7417778|NCT01458574|11691957|FG001|Overall Study|Pregnancy|1
7417779|NCT01458574|11691958|FG002|Overall Study|Pregnancy|0
7417780|NCT01458574|11691956|FG000|Overall Study|Protocol Violation|0
7417781|NCT01458574|11691957|FG001|Overall Study|Protocol Violation|1
7531472|NCT02652156|11875894|FG001|Overall Study|Physician Decision|0
7326839|NCT00787319|11559372|FG000|Overall Study|No health insurance reimbursement|2
7326840|NCT00787319|11559372|FG000|Overall Study|Stabilized disease findings|3
7326841|NCT00787319|11559372|FG000|Overall Study|Inactive disease|5
7326842|NCT00787527|11559385|FG000|Overall Study|Toxicity|3
7326843|NCT00787566|11559396|FG000|Overall Study|AE related to chemotherapy|0
7326844|NCT00787566|11559397|FG001|Overall Study|AE related to chemotherapy|1
7326845|NCT00787566|11559398|FG002|Overall Study|AE related to chemotherapy|0
7326846|NCT00787605|11559408|FG000|Overall Study|Administrative Problems|3
7326847|NCT00787605|11559409|FG001|Overall Study|Administrative Problems|0
7326848|NCT00787605|11559408|FG000|Overall Study|Adverse Event|14
7326849|NCT00787605|11559409|FG001|Overall Study|Adverse Event|25
7326850|NCT00787605|11559408|FG000|Overall Study|Lost to Follow-up|3
7326851|NCT00787605|11559409|FG001|Overall Study|Lost to Follow-up|6
7326852|NCT00787605|11559408|FG000|Overall Study|Protocol Violation|7
7326853|NCT00787605|11559409|FG001|Overall Study|Protocol Violation|3
7326854|NCT00787605|11559408|FG000|Overall Study|Withdrawal by Subject|6
7326855|NCT00787605|11559409|FG001|Overall Study|Withdrawal by Subject|13
7326856|NCT00787605|11559408|FG000|Overall Study|Lack of Efficacy|13
7417782|NCT01458574|11691958|FG002|Overall Study|Protocol Violation|0
7417783|NCT01458574|11691956|FG000|Overall Study|Withdrawal by Subject|6
7417784|NCT01458574|11691957|FG001|Overall Study|Withdrawal by Subject|3
7417785|NCT01458574|11691958|FG002|Overall Study|Withdrawal by Subject|5
7417786|NCT01458574|11691956|FG000|Overall Study|Other|2
7417787|NCT01458574|11691957|FG001|Overall Study|Other|1
7417788|NCT01458574|11691958|FG002|Overall Study|Other|0
7531473|NCT02652156|11875895|FG002|Overall Study|Physician Decision|0
7555530|NCT03057977|11918792|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
7555531|NCT03057977|11918793|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
7555532|NCT03057977|11918792|FG000|Discontinuation From Treatment|Unable to continue treatment|4
7555533|NCT03057977|11918793|FG001|Discontinuation From Treatment|Unable to continue treatment|1
7555534|NCT03057977|11918792|FG000|Discontinuation From Treatment|Not attending study visit|3
7555535|NCT03057977|11918793|FG001|Discontinuation From Treatment|Not attending study visit|10
7555536|NCT03057977|11918792|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
7555537|NCT03057977|11918793|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
7555538|NCT03057977|11918792|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
7555539|NCT03057977|11918793|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
7555540|NCT03057977|11918792|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7555541|NCT03057977|11918793|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
7555542|NCT03057977|11918792|FG000|Discontinuation From Trial|Limited follow-up agreed|2
7555543|NCT03057977|11918793|FG001|Discontinuation From Trial|Limited follow-up agreed|2
7555544|NCT03057977|11918792|FG000|Discontinuation From Trial|Withdrawal by Subject|9
7555545|NCT03057977|11918793|FG001|Discontinuation From Trial|Withdrawal by Subject|11
7555546|NCT03058679|11918801|FG000|Baseline to Week 6|Lost to Follow-up|3
7555547|NCT03058679|11918802|FG001|Baseline to Week 6|Lost to Follow-up|2
7555548|NCT03058679|11918801|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
7555549|NCT03058679|11918802|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
7555550|NCT03058679|11918801|FG000|Baseline to Week 6|Adverse Event|6
7555551|NCT03058679|11918802|FG001|Baseline to Week 6|Adverse Event|6
7555552|NCT03058679|11918801|FG000|Baseline to Week 6|Withdrawal by Subject|4
7555553|NCT03058679|11918802|FG001|Baseline to Week 6|Withdrawal by Subject|3
7555554|NCT03058679|11918801|FG000|Baseline to Week 6|Difficulty following the diet|0
7555555|NCT03058679|11918802|FG001|Baseline to Week 6|Difficulty following the diet|2
7555556|NCT03058679|11918801|FG000|Baseline to Week 6|Physician Decision|1
7555557|NCT03058679|11918802|FG001|Baseline to Week 6|Physician Decision|0
7555558|NCT03058679|11918801|FG000|Week 6 to Week 12|Change in medication|5
7326857|NCT00787605|11559409|FG001|Overall Study|Lack of Efficacy|9
7326858|NCT00787644|11559417|FG000|Overall Study|Lost to Follow-up|1
7326859|NCT00787644|11559418|FG001|Overall Study|Lost to Follow-up|1
7326860|NCT00787644|11559417|FG000|Overall Study|Withdrawal by Subject|1
7326861|NCT00787644|11559418|FG001|Overall Study|Withdrawal by Subject|1
7326862|NCT00787787|11559435|FG000|Overall Study|Lack of Efficacy|4
7326863|NCT00787787|11559435|FG000|Overall Study|Adverse Event|3
7326864|NCT00787800|11559441|FG000|Overall Study|Withdrawal by Subject|3
7326865|NCT00787800|11559442|FG001|Overall Study|Withdrawal by Subject|5
7326866|NCT00787800|11559441|FG000|Overall Study|Death|0
7326867|NCT00787800|11559442|FG001|Overall Study|Death|2
7326868|NCT00787839|11559449|FG000|Overall Study|Failure to have the OGTT was most common|404
7326869|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
7326870|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
7326871|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7326872|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
7326873|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
7326874|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
7326875|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
7326876|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
7326877|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
7326878|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
7326879|NCT00787891|11559481|FG000|Short-term Double-blind Phase (Part 1)|Other|0
7326880|NCT00787891|11559482|FG001|Short-term Double-blind Phase (Part 1)|Other|2
7326881|NCT00787891|11559481|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
7326882|NCT00787891|11559482|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
7326883|NCT00787891|11559481|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7326884|NCT00787891|11559482|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
7326885|NCT00787891|11559481|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
7326886|NCT00787891|11559482|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
7326887|NCT00787891|11559481|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
7326888|NCT00787891|11559482|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
7326889|NCT00787930|11559499|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
7326890|NCT00788073|11559528|FG000|STX209 Then Placebo|Adverse Event|1
7326891|NCT00788073|11559529|FG001|STX209 Then Placebo|Adverse Event|0
7326892|NCT00788073|11559528|FG000|STX209 Then Placebo|Lost to Follow-up|0
7326893|NCT00788073|11559529|FG001|STX209 Then Placebo|Lost to Follow-up|1
7326894|NCT00788073|11559528|FG000|STX209 Then Placebo|Withdrawal by Subject|0
7326895|NCT00788073|11559529|FG001|STX209 Then Placebo|Withdrawal by Subject|1
7326896|NCT00788073|11559528|FG000|STX209 Then Placebo|unable to return due to travel|0
7326897|NCT00788073|11559529|FG001|STX209 Then Placebo|unable to return due to travel|1
7326898|NCT00788073|11559528|FG000|Placebo Then STX209|Adverse Event|2
7326899|NCT00788073|11559529|FG001|Placebo Then STX209|Adverse Event|0
7326900|NCT00788073|11559528|FG000|Placebo Then STX209|Protocol Violation|0
7326901|NCT00788073|11559529|FG001|Placebo Then STX209|Protocol Violation|1
7326902|NCT00788372|11559542|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
7326903|NCT00788372|11559542|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
7326904|NCT00788372|11559542|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
7326905|NCT00788372|11559542|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
7326906|NCT00788372|11559542|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
7326907|NCT00788372|11559542|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
7326908|NCT00788372|11559542|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
7326909|NCT00788593|11559546|FG000|Placebo Run-in Phase|Adverse Event|2
7326910|NCT00788593|11559547|FG001|Placebo Run-in Phase|Adverse Event|0
7326911|NCT00788593|11559548|FG002|Placebo Run-in Phase|Adverse Event|0
7326912|NCT00788593|11559546|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
7326913|NCT00788593|11559547|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
7326914|NCT00788593|11559548|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
7326915|NCT00788593|11559546|FG000|Placebo Run-in Phase|Protocol Violation|2
7326916|NCT00788593|11559547|FG001|Placebo Run-in Phase|Protocol Violation|0
7326917|NCT00788593|11559548|FG002|Placebo Run-in Phase|Protocol Violation|0
7326918|NCT00788593|11559546|FG000|First Intervention Period|Adverse Event|0
7326919|NCT00788593|11559547|FG001|First Intervention Period|Adverse Event|1
7326920|NCT00788593|11559548|FG002|First Intervention Period|Adverse Event|0
7326921|NCT00788593|11559546|FG000|Second Intervention Period|Lost to Follow-up|0
7326922|NCT00788593|11559547|FG001|Second Intervention Period|Lost to Follow-up|1
7326923|NCT00788593|11559548|FG002|Second Intervention Period|Lost to Follow-up|0
7326924|NCT00788593|11559546|FG000|Second Intervention Period|Other|0
7326925|NCT00788593|11559547|FG001|Second Intervention Period|Other|0
7326926|NCT00788593|11559548|FG002|Second Intervention Period|Other|1
7326927|NCT00788697|11559558|FG000|Overall Study|No study drug administered|12
7326928|NCT00788697|11559558|FG000|Overall Study|Training Patients|74
7326929|NCT00788697|11559558|FG000|Overall Study|no truth standard procedure available|5
7326930|NCT00788697|11559558|FG000|Overall Study|Technically inadequate truth standard|1
7326931|NCT00788697|11559558|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
7326932|NCT00788775|11559572|FG000|Overall Study|Progressive Disease|8
7326933|NCT00788775|11559573|FG001|Overall Study|Progressive Disease|6
7326934|NCT00788775|11559572|FG000|Overall Study|Withdrawal by Subject|0
7326935|NCT00788775|11559573|FG001|Overall Study|Withdrawal by Subject|2
7326936|NCT00788775|11559572|FG000|Overall Study|Patient Non-Compliance|1
7326937|NCT00788775|11559573|FG001|Overall Study|Patient Non-Compliance|0
7326938|NCT00788775|11559572|FG000|Overall Study|Patient's measurable disease resected.|1
7326939|NCT00788775|11559573|FG001|Overall Study|Patient's measurable disease resected.|0
7326940|NCT00788827|11559579|FG000|Overall Study|Lack of Efficacy|2
7326941|NCT00788957|11559598|FG000|Part 1|Death|8
7326942|NCT00788957|11559599|FG001|Part 1|Death|0
7326943|NCT00788957|11559600|FG002|Part 1|Death|0
7326944|NCT00788957|11559601|FG003|Part 1|Death|0
7326945|NCT00788957|11559602|FG004|Part 1|Death|0
7326946|NCT00788957|11559603|FG005|Part 1|Death|0
7326947|NCT00788957|11559598|FG000|Part 1|Lost to Follow-up|1
7326948|NCT00788957|11559599|FG001|Part 1|Lost to Follow-up|0
7326949|NCT00788957|11559600|FG002|Part 1|Lost to Follow-up|0
7326950|NCT00788957|11559601|FG003|Part 1|Lost to Follow-up|0
7326951|NCT00788957|11559602|FG004|Part 1|Lost to Follow-up|0
7326952|NCT00788957|11559603|FG005|Part 1|Lost to Follow-up|0
7326953|NCT00788957|11559598|FG000|Part 2|Withdrawal by Subject|0
7326954|NCT00788957|11559599|FG001|Part 2|Withdrawal by Subject|9
7326955|NCT00788957|11559600|FG002|Part 2|Withdrawal by Subject|5
7326956|NCT00788957|11559601|FG003|Part 2|Withdrawal by Subject|3
7326957|NCT00788957|11559602|FG004|Part 2|Withdrawal by Subject|0
7326958|NCT00788957|11559603|FG005|Part 2|Withdrawal by Subject|0
7326959|NCT00788957|11559598|FG000|Part 2|Death|0
7326960|NCT00788957|11559599|FG001|Part 2|Death|32
7326961|NCT00788957|11559600|FG002|Part 2|Death|35
7326962|NCT00788957|11559601|FG003|Part 2|Death|37
7326963|NCT00788957|11559602|FG004|Part 2|Death|0
7326964|NCT00788957|11559603|FG005|Part 2|Death|0
7326965|NCT00788957|11559598|FG000|Part 2|Lost to Follow-up|0
7326966|NCT00788957|11559599|FG001|Part 2|Lost to Follow-up|0
7326967|NCT00788957|11559600|FG002|Part 2|Lost to Follow-up|3
7326968|NCT00788957|11559601|FG003|Part 2|Lost to Follow-up|0
7326969|NCT00788957|11559602|FG004|Part 2|Lost to Follow-up|0
7326970|NCT00788957|11559603|FG005|Part 2|Lost to Follow-up|0
7326971|NCT00788957|11559598|FG000|Part 2|On-study at time of data cut-off|0
7326972|NCT00788957|11559599|FG001|Part 2|On-study at time of data cut-off|1
7326973|NCT00788957|11559600|FG002|Part 2|On-study at time of data cut-off|1
7326974|NCT00788957|11559601|FG003|Part 2|On-study at time of data cut-off|1
7326975|NCT00788957|11559602|FG004|Part 2|On-study at time of data cut-off|0
7326976|NCT00788957|11559603|FG005|Part 2|On-study at time of data cut-off|0
7326977|NCT00788957|11559598|FG000|Part 3|Withdrawal by Subject|0
7326978|NCT00788957|11559599|FG001|Part 3|Withdrawal by Subject|0
7326979|NCT00788957|11559600|FG002|Part 3|Withdrawal by Subject|0
7326980|NCT00788957|11559601|FG003|Part 3|Withdrawal by Subject|0
7326981|NCT00788957|11559602|FG004|Part 3|Withdrawal by Subject|0
7326982|NCT00788957|11559603|FG005|Part 3|Withdrawal by Subject|2
7326983|NCT00788957|11559598|FG000|Part 3|Death|0
7326984|NCT00788957|11559599|FG001|Part 3|Death|0
7326985|NCT00788957|11559600|FG002|Part 3|Death|0
7326986|NCT00788957|11559601|FG003|Part 3|Death|0
7326987|NCT00788957|11559602|FG004|Part 3|Death|8
7326988|NCT00788957|11559603|FG005|Part 3|Death|9
7326989|NCT00788957|11559598|FG000|Part 3|On-study at time of data cut-off|0
7326990|NCT00788957|11559599|FG001|Part 3|On-study at time of data cut-off|0
7326991|NCT00788957|11559600|FG002|Part 3|On-study at time of data cut-off|0
7326992|NCT00788957|11559601|FG003|Part 3|On-study at time of data cut-off|0
7326993|NCT00788957|11559602|FG004|Part 3|On-study at time of data cut-off|1
7326994|NCT00788957|11559603|FG005|Part 3|On-study at time of data cut-off|0
7326995|NCT00789035|11559625|FG000|Overall Study|Adverse Event|0
7326996|NCT00789035|11559626|FG001|Overall Study|Adverse Event|2
7326997|NCT00789035|11559627|FG002|Overall Study|Adverse Event|0
7326998|NCT00789035|11559628|FG003|Overall Study|Adverse Event|1
7326999|NCT00789035|11559629|FG004|Overall Study|Adverse Event|3
7327000|NCT00789035|11559625|FG000|Overall Study|Lack of Efficacy|3
7327001|NCT00789035|11559626|FG001|Overall Study|Lack of Efficacy|0
7327002|NCT00789035|11559627|FG002|Overall Study|Lack of Efficacy|0
7327003|NCT00789035|11559628|FG003|Overall Study|Lack of Efficacy|0
7327004|NCT00789035|11559629|FG004|Overall Study|Lack of Efficacy|2
7327005|NCT00789035|11559625|FG000|Overall Study|Protocol Violation|1
7327006|NCT00789035|11559626|FG001|Overall Study|Protocol Violation|0
7327007|NCT00789035|11559627|FG002|Overall Study|Protocol Violation|0
7327008|NCT00789035|11559628|FG003|Overall Study|Protocol Violation|0
7327009|NCT00789035|11559629|FG004|Overall Study|Protocol Violation|0
7327010|NCT00789035|11559625|FG000|Overall Study|Withdrawal by Subject|0
7327011|NCT00789035|11559626|FG001|Overall Study|Withdrawal by Subject|2
7327012|NCT00789035|11559627|FG002|Overall Study|Withdrawal by Subject|0
7327013|NCT00789035|11559628|FG003|Overall Study|Withdrawal by Subject|0
7327014|NCT00789035|11559629|FG004|Overall Study|Withdrawal by Subject|0
7327015|NCT00789035|11559625|FG000|Overall Study|Other reason not defined above|2
7327016|NCT00789035|11559626|FG001|Overall Study|Other reason not defined above|3
7327017|NCT00789035|11559627|FG002|Overall Study|Other reason not defined above|1
7327018|NCT00789035|11559628|FG003|Overall Study|Other reason not defined above|0
7327019|NCT00789035|11559629|FG004|Overall Study|Other reason not defined above|1
7327020|NCT00789191|11559663|FG000|Overall Study|Adverse Event|2
7327021|NCT00789191|11559664|FG001|Overall Study|Adverse Event|4
7327022|NCT00789191|11559663|FG000|Overall Study|Lack of Efficacy|0
7327023|NCT00789191|11559664|FG001|Overall Study|Lack of Efficacy|5
7327024|NCT00789191|11559663|FG000|Overall Study|Protocol Violation|5
7327025|NCT00789191|11559664|FG001|Overall Study|Protocol Violation|3
7327026|NCT00789191|11559663|FG000|Overall Study|Withdrawal Criteria|2
7327027|NCT00789191|11559664|FG001|Overall Study|Withdrawal Criteria|4
7417789|NCT01458574|11691956|FG000|Overall Study|Randomized but not treated|0
7417790|NCT01458574|11691957|FG001|Overall Study|Randomized but not treated|1
7555559|NCT03058679|11918802|FG001|Week 6 to Week 12|Change in medication|7
7417791|NCT01458574|11691958|FG002|Overall Study|Randomized but not treated|0
7417792|NCT01458587|11691968|FG000|Overall Study|Withdrawal by Subject|1
7417793|NCT01458587|11691969|FG001|Overall Study|Withdrawal by Subject|0
7417794|NCT01458639|11691977|FG000|Overall Study|Physician Decision|4
7417795|NCT01458639|11691977|FG000|Overall Study|Equipment issue|1
7417796|NCT01458639|11691977|FG000|Overall Study|Inability to obtain subject blood sample|1
7466466|NCT01891864|11766314|FG005|Treatment Period 2|Protocol Violation|0
7466467|NCT01891864|11766309|FG000|Treatment Period 2|Physician Decision|0
7466468|NCT01891864|11766310|FG001|Treatment Period 2|Physician Decision|0
7466469|NCT01891864|11766311|FG002|Treatment Period 2|Physician Decision|1
7466470|NCT01891864|11766312|FG003|Treatment Period 2|Physician Decision|0
7466471|NCT01891864|11766313|FG004|Treatment Period 2|Physician Decision|0
7466472|NCT01891864|11766314|FG005|Treatment Period 2|Physician Decision|0
7466473|NCT01891864|11766309|FG000|Treatment Period 2|Site Termination|0
7466474|NCT01891864|11766310|FG001|Treatment Period 2|Site Termination|0
7466475|NCT01891864|11766311|FG002|Treatment Period 2|Site Termination|1
7466476|NCT01891864|11766312|FG003|Treatment Period 2|Site Termination|2
7466477|NCT01891864|11766313|FG004|Treatment Period 2|Site Termination|0
7466478|NCT01891864|11766314|FG005|Treatment Period 2|Site Termination|0
7555560|NCT03058679|11918801|FG000|Week 6 to Week 12|Adverse Event|4
7555561|NCT03058679|11918802|FG001|Week 6 to Week 12|Adverse Event|3
7327028|NCT00789191|11559663|FG000|Overall Study|Unclassified|5
7327029|NCT00789191|11559664|FG001|Overall Study|Unclassified|3
7327030|NCT00789321|11559684|FG000|Overall Study|Adverse Event|0
7327031|NCT00789321|11559685|FG001|Overall Study|Adverse Event|1
7327032|NCT00789360|11559693|FG000|Overall Study|Protocol Violation|3
7327033|NCT00789360|11559694|FG001|Overall Study|Protocol Violation|1
7327034|NCT00789373|11559701|FG000|Induction|Adverse Event|64
7327035|NCT00789373|11559702|FG001|Induction|Adverse Event|0
7327036|NCT00789373|11559703|FG002|Induction|Adverse Event|0
7327037|NCT00789373|11559701|FG000|Induction|Death Due to study disease|24
7327038|NCT00789373|11559702|FG001|Induction|Death Due to study disease|0
7327039|NCT00789373|11559703|FG002|Induction|Death Due to study disease|0
7327040|NCT00789373|11559701|FG000|Induction|Death due to adverse event|19
7327041|NCT00789373|11559702|FG001|Induction|Death due to adverse event|0
7327042|NCT00789373|11559703|FG002|Induction|Death due to adverse event|0
7327043|NCT00789373|11559701|FG000|Induction|Death due to toxicity|11
7327044|NCT00789373|11559702|FG001|Induction|Death due to toxicity|0
7327045|NCT00789373|11559703|FG002|Induction|Death due to toxicity|0
7327046|NCT00789373|11559701|FG000|Induction|Death due to procedure|1
7327047|NCT00789373|11559702|FG001|Induction|Death due to procedure|0
7327048|NCT00789373|11559703|FG002|Induction|Death due to procedure|0
7327049|NCT00789373|11559701|FG000|Induction|Investigator decision|7
7327050|NCT00789373|11559702|FG001|Induction|Investigator decision|0
7327051|NCT00789373|11559703|FG002|Induction|Investigator decision|0
7327052|NCT00789373|11559701|FG000|Induction|Protocol entry criteria not met|9
7327053|NCT00789373|11559702|FG001|Induction|Protocol entry criteria not met|0
7327054|NCT00789373|11559703|FG002|Induction|Protocol entry criteria not met|0
7327055|NCT00789373|11559701|FG000|Induction|Lost to Follow-up|6
7327056|NCT00789373|11559702|FG001|Induction|Lost to Follow-up|0
7327057|NCT00789373|11559703|FG002|Induction|Lost to Follow-up|0
7327058|NCT00789373|11559701|FG000|Induction|Protocol Violation|1
7327059|NCT00789373|11559702|FG001|Induction|Protocol Violation|0
7327060|NCT00789373|11559703|FG002|Induction|Protocol Violation|0
7327061|NCT00789373|11559701|FG000|Induction|Progressive Disease|220
7327062|NCT00789373|11559702|FG001|Induction|Progressive Disease|0
7327063|NCT00789373|11559703|FG002|Induction|Progressive Disease|0
7327064|NCT00789373|11559701|FG000|Induction|Withdrawal by Subject|37
7327065|NCT00789373|11559702|FG001|Induction|Withdrawal by Subject|0
7327066|NCT00789373|11559703|FG002|Induction|Withdrawal by Subject|0
7327067|NCT00789373|11559701|FG000|Maintenance|Adverse Event|0
7327068|NCT00789373|11559702|FG001|Maintenance|Adverse Event|65
7327069|NCT00789373|11559703|FG002|Maintenance|Adverse Event|12
7327070|NCT00789373|11559701|FG000|Maintenance|Death due to study disease|0
7327071|NCT00789373|11559702|FG001|Maintenance|Death due to study disease|3
7327072|NCT00789373|11559703|FG002|Maintenance|Death due to study disease|1
7327073|NCT00789373|11559701|FG000|Maintenance|Death due to adverse event|0
7327074|NCT00789373|11559702|FG001|Maintenance|Death due to adverse event|4
7327075|NCT00789373|11559703|FG002|Maintenance|Death due to adverse event|1
7327076|NCT00789373|11559701|FG000|Maintenance|Death due to toxicity|0
7327077|NCT00789373|11559702|FG001|Maintenance|Death due to toxicity|1
7327078|NCT00789373|11559703|FG002|Maintenance|Death due to toxicity|2
7327079|NCT00789373|11559701|FG000|Maintenance|Investigator Decision|0
7327080|NCT00789373|11559702|FG001|Maintenance|Investigator Decision|4
7327081|NCT00789373|11559703|FG002|Maintenance|Investigator Decision|2
7327082|NCT00789373|11559701|FG000|Maintenance|Protocol entry criteria not met|0
7327083|NCT00789373|11559702|FG001|Maintenance|Protocol entry criteria not met|2
7327084|NCT00789373|11559703|FG002|Maintenance|Protocol entry criteria not met|0
7327085|NCT00789373|11559701|FG000|Maintenance|Lost to Follow-up|0
7327086|NCT00789373|11559702|FG001|Maintenance|Lost to Follow-up|2
7327087|NCT00789373|11559703|FG002|Maintenance|Lost to Follow-up|0
7327088|NCT00789373|11559701|FG000|Maintenance|Progressive Disease|0
7327089|NCT00789373|11559702|FG001|Maintenance|Progressive Disease|253
7327090|NCT00789373|11559703|FG002|Maintenance|Progressive Disease|152
7327091|NCT00789373|11559701|FG000|Maintenance|Withdrawal by Subject|0
7327092|NCT00789373|11559702|FG001|Maintenance|Withdrawal by Subject|21
7327093|NCT00789373|11559703|FG002|Maintenance|Withdrawal by Subject|8
7327094|NCT00789373|11559701|FG000|Maintenance|Sponsor Decision|0
7327095|NCT00789373|11559702|FG001|Maintenance|Sponsor Decision|0
7327096|NCT00789373|11559703|FG002|Maintenance|Sponsor Decision|2
7327097|NCT00789373|11559701|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
7327098|NCT00789373|11559702|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
7327099|NCT00789373|11559703|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
7327100|NCT00789477|11559732|FG000|Overall Study|Withdrawal by Subject|2
7327101|NCT00789477|11559733|FG001|Overall Study|Withdrawal by Subject|1
7327102|NCT00789477|11559734|FG002|Overall Study|Withdrawal by Subject|3
7327103|NCT00789477|11559735|FG003|Overall Study|Withdrawal by Subject|2
7327104|NCT00789477|11559736|FG004|Overall Study|Withdrawal by Subject|3
7327105|NCT00789477|11559732|FG000|Overall Study|Protocol Violation|1
7327106|NCT00789477|11559733|FG001|Overall Study|Protocol Violation|0
7327107|NCT00789477|11559734|FG002|Overall Study|Protocol Violation|0
7327108|NCT00789477|11559735|FG003|Overall Study|Protocol Violation|1
7327109|NCT00789477|11559736|FG004|Overall Study|Protocol Violation|0
7327110|NCT00789477|11559732|FG000|Overall Study|Adverse Event|3
7327111|NCT00789477|11559733|FG001|Overall Study|Adverse Event|3
7327112|NCT00789477|11559734|FG002|Overall Study|Adverse Event|1
7327113|NCT00789477|11559735|FG003|Overall Study|Adverse Event|0
7327114|NCT00789477|11559736|FG004|Overall Study|Adverse Event|0
7327115|NCT00789477|11559732|FG000|Overall Study|Death|1
7327116|NCT00789477|11559733|FG001|Overall Study|Death|1
7327117|NCT00789477|11559734|FG002|Overall Study|Death|2
7327118|NCT00789477|11559735|FG003|Overall Study|Death|2
7327119|NCT00789477|11559736|FG004|Overall Study|Death|0
7327120|NCT00789477|11559732|FG000|Overall Study|Lost to Follow-up|0
7327121|NCT00789477|11559733|FG001|Overall Study|Lost to Follow-up|1
7327122|NCT00789477|11559734|FG002|Overall Study|Lost to Follow-up|4
7327123|NCT00789477|11559735|FG003|Overall Study|Lost to Follow-up|2
7327124|NCT00789477|11559736|FG004|Overall Study|Lost to Follow-up|4
7327125|NCT00789477|11559732|FG000|Overall Study|Lack of Efficacy|2
7327126|NCT00789477|11559733|FG001|Overall Study|Lack of Efficacy|0
7327127|NCT00789477|11559734|FG002|Overall Study|Lack of Efficacy|0
7327128|NCT00789477|11559735|FG003|Overall Study|Lack of Efficacy|0
7327129|NCT00789477|11559736|FG004|Overall Study|Lack of Efficacy|0
7327130|NCT00789477|11559732|FG000|Overall Study|Other|2
7327131|NCT00789477|11559733|FG001|Overall Study|Other|0
7327132|NCT00789477|11559734|FG002|Overall Study|Other|1
7327133|NCT00789477|11559735|FG003|Overall Study|Other|3
7327134|NCT00789477|11559736|FG004|Overall Study|Other|0
7327135|NCT00789529|11559752|FG000|Overall Study|Withdrawal by Subject|0
7327136|NCT00789529|11559753|FG001|Overall Study|Withdrawal by Subject|1
7327137|NCT00789529|11559752|FG000|Overall Study|Other Reason|1
7327138|NCT00789529|11559753|FG001|Overall Study|Other Reason|0
7327139|NCT00789555|11559762|FG000|Overall Study|Protocol Amendment|78
7327140|NCT00789555|11559763|FG001|Overall Study|Protocol Amendment|76
7327141|NCT00789555|11559764|FG002|Overall Study|Protocol Amendment|80
7327142|NCT00789555|11559762|FG000|Overall Study|Adverse Event|17
7327143|NCT00789555|11559763|FG001|Overall Study|Adverse Event|7
7327144|NCT00789555|11559764|FG002|Overall Study|Adverse Event|10
7327145|NCT00789555|11559762|FG000|Overall Study|Lost to Follow-up|9
7327146|NCT00789555|11559763|FG001|Overall Study|Lost to Follow-up|10
7327147|NCT00789555|11559764|FG002|Overall Study|Lost to Follow-up|18
7555562|NCT03058679|11918801|FG000|Week 6 to Week 12|Withdrawal by Subject|9
7555563|NCT03058679|11918802|FG001|Week 6 to Week 12|Withdrawal by Subject|4
7555564|NCT03058679|11918801|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
7555565|NCT03058679|11918802|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
7555566|NCT03058692|11918810|FG000|Overall Study|Lost to Follow-up|2
7555567|NCT03058692|11918811|FG001|Overall Study|Lost to Follow-up|1
7555568|NCT03058692|11918810|FG000|Overall Study|Withdrawal by Subject|1
7555569|NCT03058692|11918811|FG001|Overall Study|Withdrawal by Subject|1
7555570|NCT03058991|11918821|FG000|Overall Study|Lost to Follow-up|17
7555571|NCT03058991|11918822|FG001|Overall Study|Lost to Follow-up|12
7327148|NCT00789555|11559762|FG000|Overall Study|Patient decision unnrelated to adv event|38
7327149|NCT00789555|11559763|FG001|Overall Study|Patient decision unnrelated to adv event|29
7327150|NCT00789555|11559764|FG002|Overall Study|Patient decision unnrelated to adv event|26
7327151|NCT00789555|11559762|FG000|Overall Study|Treatment failure|11
7327152|NCT00789555|11559763|FG001|Overall Study|Treatment failure|8
7327153|NCT00789555|11559764|FG002|Overall Study|Treatment failure|12
7417797|NCT01458951|11691984|FG000|Overall Study|Other|1
7417798|NCT01458951|11691985|FG001|Overall Study|Other|0
7417799|NCT01458951|11691986|FG002|Overall Study|Other|0
7417800|NCT01458951|11691984|FG000|Overall Study|Protocol Violation|5
7417801|NCT01458951|11691985|FG001|Overall Study|Protocol Violation|1
7417802|NCT01458951|11691986|FG002|Overall Study|Protocol Violation|0
7417803|NCT01458951|11691984|FG000|Overall Study|Withdrawal by Subject|2
7417804|NCT01458951|11691985|FG001|Overall Study|Withdrawal by Subject|0
7417805|NCT01458951|11691986|FG002|Overall Study|Withdrawal by Subject|2
7417806|NCT01458951|11691984|FG000|Overall Study|Adverse Event|7
7417807|NCT01458951|11691985|FG001|Overall Study|Adverse Event|0
7417808|NCT01458951|11691986|FG002|Overall Study|Adverse Event|2
7417809|NCT01458951|11691984|FG000|Overall Study|Insufficient Clinical Response|17
7417810|NCT01458951|11691985|FG001|Overall Study|Insufficient Clinical Response|0
7417811|NCT01458951|11691986|FG002|Overall Study|Insufficient Clinical Response|11
7417812|NCT01459016|11692004|FG000|Overall Study|Withdrawal by Subject|11
7417813|NCT01459016|11692004|FG000|Overall Study|Amendment Discontinuation Criteria|4
7417814|NCT01459068|11692010|FG000|Overall Study|Withdrawal by Subject|8
7417815|NCT01459068|11692011|FG001|Overall Study|Withdrawal by Subject|18
7417816|NCT01459068|11692010|FG000|Overall Study|Lost to Follow-up|31
7417817|NCT01459068|11692011|FG001|Overall Study|Lost to Follow-up|15
7417818|NCT01459068|11692010|FG000|Overall Study|Death|0
7417819|NCT01459068|11692011|FG001|Overall Study|Death|1
7417820|NCT01459614|11692036|FG000|Overall Study|Adverse Event|1
7417821|NCT01459614|11692037|FG001|Overall Study|Adverse Event|0
7417822|NCT01459718|11692127|FG000|Overall Study|Physician Decision|1
7417823|NCT01459718|11692127|FG000|Overall Study|Lost to Follow-up|1
7417824|NCT01459718|11692127|FG000|Overall Study|Adverse Event|1
7417825|NCT01459783|11692133|FG000|Baseline to 6 Months|Death|1
7417826|NCT01459783|11692134|FG001|Baseline to 6 Months|Death|0
7417827|NCT01459783|11692133|FG000|Baseline to 6 Months|Withdrawal by Subject|12
7417828|NCT01459783|11692134|FG001|Baseline to 6 Months|Withdrawal by Subject|6
7417829|NCT01459783|11692133|FG000|Baseline to 6 Months|Lost to Follow-up|19
7417830|NCT01459783|11692134|FG001|Baseline to 6 Months|Lost to Follow-up|14
7417831|NCT01459783|11692133|FG000|6 Months to 12 Months|Death|0
7417832|NCT01459783|11692134|FG001|6 Months to 12 Months|Death|1
7417833|NCT01459783|11692133|FG000|6 Months to 12 Months|Withdrawal by Subject|6
7417834|NCT01459783|11692134|FG001|6 Months to 12 Months|Withdrawal by Subject|5
7417835|NCT01459783|11692133|FG000|6 Months to 12 Months|Lost to Follow-up|2
7417836|NCT01459783|11692134|FG001|6 Months to 12 Months|Lost to Follow-up|7
7417837|NCT01459783|11692133|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
7417838|NCT01459783|11692134|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
7417839|NCT01459796|11692142|FG000|Overall Study|Non compliance with protocol|2
7555572|NCT03058991|11918823|FG002|Overall Study|Lost to Follow-up|12
7555573|NCT03058991|11918821|FG000|Overall Study|Withdrawal by Subject|1
7555574|NCT03058991|11918822|FG001|Overall Study|Withdrawal by Subject|0
7327154|NCT00789555|11559762|FG000|Overall Study|Protocol Violation|6
7327155|NCT00789555|11559763|FG001|Overall Study|Protocol Violation|9
7327156|NCT00789555|11559764|FG002|Overall Study|Protocol Violation|13
7327157|NCT00789581|11559774|FG000|AC Therapy|Adverse Event|2
7417840|NCT01459796|11692143|FG001|Overall Study|Non compliance with protocol|4
7417841|NCT01459796|11692142|FG000|Overall Study|Adverse Event|5
7327158|NCT00789581|11559775|FG001|AC Therapy|Adverse Event|3
7327159|NCT00789581|11559774|FG000|AC Therapy|Withdrawal by Subject|4
7327160|NCT00789581|11559775|FG001|AC Therapy|Withdrawal by Subject|7
7327161|NCT00789581|11559774|FG000|AC Therapy|Disease recurrence|3
7327162|NCT00789581|11559775|FG001|AC Therapy|Disease recurrence|1
7327163|NCT00789581|11559774|FG000|AC Therapy|Intercurrent Illness|1
7327164|NCT00789581|11559775|FG001|AC Therapy|Intercurrent Illness|0
7327165|NCT00789581|11559774|FG000|AC Therapy|Never Treated|1
7327166|NCT00789581|11559775|FG001|AC Therapy|Never Treated|4
7327167|NCT00789581|11559774|FG000|AC Therapy|Other|0
7327168|NCT00789581|11559775|FG001|AC Therapy|Other|2
7327169|NCT00789581|11559774|FG000|Adjuvant Therapy|Never treated|2
7327170|NCT00789581|11559775|FG001|Adjuvant Therapy|Never treated|2
7327171|NCT00789581|11559774|FG000|Adjuvant Therapy|Adverse Event|20
7327172|NCT00789581|11559775|FG001|Adjuvant Therapy|Adverse Event|44
7327173|NCT00789581|11559774|FG000|Adjuvant Therapy|Withdrawal by Subject|14
7327174|NCT00789581|11559775|FG001|Adjuvant Therapy|Withdrawal by Subject|5
7327175|NCT00789581|11559774|FG000|Adjuvant Therapy|Disease recurrence|2
7327176|NCT00789581|11559775|FG001|Adjuvant Therapy|Disease recurrence|1
7327177|NCT00789581|11559774|FG000|Adjuvant Therapy|Intercurrent Illness|1
7327178|NCT00789581|11559775|FG001|Adjuvant Therapy|Intercurrent Illness|3
7327179|NCT00789581|11559774|FG000|Adjuvant Therapy|Protocol Violation|1
7327180|NCT00789581|11559775|FG001|Adjuvant Therapy|Protocol Violation|1
7327181|NCT00789581|11559774|FG000|Adjuvant Therapy|Other|0
7555575|NCT03058991|11918823|FG002|Overall Study|Withdrawal by Subject|0
7555576|NCT03060447|11918846|FG000|Overall Study|Withdrawal by Subject|2
7555577|NCT03060447|11918847|FG001|Overall Study|Withdrawal by Subject|0
7555578|NCT03060512|11918865|FG000|Overall Study|Adverse Event|4
7555579|NCT03060512|11918866|FG001|Overall Study|Adverse Event|6
7555580|NCT03060512|11918865|FG000|Overall Study|Lost to Follow-up|1
7555581|NCT03060512|11918866|FG001|Overall Study|Lost to Follow-up|1
7555582|NCT03060512|11918865|FG000|Overall Study|Withdrawal by Subject|1
7555583|NCT03060512|11918866|FG001|Overall Study|Withdrawal by Subject|0
7555584|NCT03060512|11918865|FG000|Overall Study|Non-compliance with study medication|1
7555585|NCT03060512|11918866|FG001|Overall Study|Non-compliance with study medication|2
7555586|NCT03060551|11918877|FG000|Overall Study|Withdrawal by Subject|1
7555587|NCT03060551|11918877|FG000|Overall Study|Adverse Event|1
7555588|NCT03061097|11918892|FG000|Overall Study|Withdrawal by Subject|0
7555589|NCT03061097|11918893|FG001|Overall Study|Withdrawal by Subject|3
7555590|NCT03061175|11918901|FG000|Baseline|Participant was deemed ineligible|1
7555591|NCT03061175|11918902|FG001|Baseline|Participant was deemed ineligible|0
7555592|NCT03061175|11918901|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
7555593|NCT03061175|11918902|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
7555594|NCT03061175|11918901|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
7555595|NCT03061175|11918902|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
7555596|NCT03061175|11918901|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
7555597|NCT03061175|11918902|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
7574658|NCT03686033|11957626|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
7574659|NCT03686033|11957627|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
7574660|NCT03686176|11957644|FG000|Overall Study|Procedure cancelled|1
7574661|NCT03686176|11957645|FG001|Overall Study|Procedure cancelled|0
7574662|NCT03686176|11957646|FG002|Overall Study|Procedure cancelled|0
7574663|NCT03686176|11957644|FG000|Overall Study|VR Malfunction|1
7574664|NCT03686176|11957645|FG001|Overall Study|VR Malfunction|0
7574665|NCT03686176|11957646|FG002|Overall Study|VR Malfunction|0
7574666|NCT03687125|11957656|FG000|Overall Study|Progressive Disease|2
7574667|NCT03687125|11957657|FG001|Overall Study|Progressive Disease|1
7574668|NCT03687125|11957656|FG000|Overall Study|Protocol Violation|1
7574669|NCT03687125|11957657|FG001|Overall Study|Protocol Violation|0
7574670|NCT03687372|11957667|FG000|Overall Study|Lost to Follow-up|12
7574671|NCT03687372|11957668|FG001|Overall Study|Lost to Follow-up|21
7574672|NCT03687372|11957667|FG000|Overall Study|Withdrawal by Subject|4
7574673|NCT03687372|11957668|FG001|Overall Study|Withdrawal by Subject|17
7574674|NCT03687372|11957667|FG000|Overall Study|Investigator Decision|1
7574675|NCT03687372|11957668|FG001|Overall Study|Investigator Decision|1
7327182|NCT00789581|11559775|FG001|Adjuvant Therapy|Other|1
7327183|NCT00789698|11559799|FG000|Overall Study|Lack of Efficacy|10
7327184|NCT00789698|11559800|FG001|Overall Study|Lack of Efficacy|4
7327185|NCT00789698|11559801|FG002|Overall Study|Lack of Efficacy|5
7327186|NCT00789698|11559802|FG003|Overall Study|Lack of Efficacy|18
7327187|NCT00789698|11559799|FG000|Overall Study|Adverse Event|5
7327188|NCT00789698|11559800|FG001|Overall Study|Adverse Event|5
7327189|NCT00789698|11559801|FG002|Overall Study|Adverse Event|3
7574678|NCT03687827|11957738|FG000|Treatment Period 1|Death|0
7327190|NCT00789698|11559802|FG003|Overall Study|Adverse Event|4
7574679|NCT03687827|11957739|FG001|Treatment Period 1|Death|1
7574680|NCT03687827|11957738|FG000|Treatment Period 1|Lost to Follow-up|2
7574681|NCT03687827|11957739|FG001|Treatment Period 1|Lost to Follow-up|2
7574682|NCT03687827|11957738|FG000|Treatment Period 1|Physician Decision|5
7327191|NCT00789698|11559799|FG000|Overall Study|Lost to Follow-up|5
7327192|NCT00789698|11559800|FG001|Overall Study|Lost to Follow-up|5
7574683|NCT03687827|11957739|FG001|Treatment Period 1|Physician Decision|2
7327193|NCT00789698|11559801|FG002|Overall Study|Lost to Follow-up|2
7327194|NCT00789698|11559802|FG003|Overall Study|Lost to Follow-up|9
7327195|NCT00789698|11559799|FG000|Overall Study|Protocol Violation|6
7327196|NCT00789698|11559800|FG001|Overall Study|Protocol Violation|1
7327197|NCT00789698|11559801|FG002|Overall Study|Protocol Violation|2
7327198|NCT00789698|11559802|FG003|Overall Study|Protocol Violation|1
7327199|NCT00789698|11559799|FG000|Overall Study|Withdrawal by Subject|14
7417842|NCT01459796|11692143|FG001|Overall Study|Adverse Event|5
7417843|NCT01459796|11692142|FG000|Overall Study|Withdrawal by Subject|6
7417844|NCT01459796|11692143|FG001|Overall Study|Withdrawal by Subject|3
7417845|NCT01459796|11692142|FG000|Overall Study|Lost to Follow-up|5
7417846|NCT01459796|11692143|FG001|Overall Study|Lost to Follow-up|4
7417847|NCT01459796|11692142|FG000|Overall Study|Reason unspecified|1
7417848|NCT01459796|11692143|FG001|Overall Study|Reason unspecified|2
7417849|NCT01459796|11692142|FG000|Overall Study|Decision by the sponsor|75
7417850|NCT01459796|11692143|FG001|Overall Study|Decision by the sponsor|108
7417851|NCT01459913|11692153|FG000|Overall Study|Adverse Event|0
7417852|NCT01459913|11692154|FG001|Overall Study|Adverse Event|0
7417853|NCT01459913|11692155|FG002|Overall Study|Adverse Event|0
7417854|NCT01459913|11692156|FG003|Overall Study|Adverse Event|3
7417855|NCT01459913|11692153|FG000|Overall Study|Withdrawal by Subject|4
7417856|NCT01459913|11692154|FG001|Overall Study|Withdrawal by Subject|0
7417857|NCT01459913|11692155|FG002|Overall Study|Withdrawal by Subject|0
7417858|NCT01459913|11692156|FG003|Overall Study|Withdrawal by Subject|5
7417859|NCT01459913|11692153|FG000|Overall Study|Lost to Follow-up|7
7417860|NCT01459913|11692154|FG001|Overall Study|Lost to Follow-up|4
7417861|NCT01459913|11692155|FG002|Overall Study|Lost to Follow-up|1
7417862|NCT01459913|11692156|FG003|Overall Study|Lost to Follow-up|8
7417863|NCT01459913|11692153|FG000|Overall Study|Death|0
7417864|NCT01459913|11692154|FG001|Overall Study|Death|0
7417865|NCT01459913|11692155|FG002|Overall Study|Death|0
7417866|NCT01459913|11692156|FG003|Overall Study|Death|1
7417867|NCT01459913|11692153|FG000|Overall Study|Non- Compliance|0
7417868|NCT01459913|11692154|FG001|Overall Study|Non- Compliance|0
7417869|NCT01459913|11692155|FG002|Overall Study|Non- Compliance|0
7417870|NCT01459913|11692156|FG003|Overall Study|Non- Compliance|3
7417871|NCT01459913|11692153|FG000|Overall Study|Physician Decision|0
7417872|NCT01459913|11692154|FG001|Overall Study|Physician Decision|1
7417873|NCT01459913|11692155|FG002|Overall Study|Physician Decision|0
7417874|NCT01459913|11692156|FG003|Overall Study|Physician Decision|0
7417875|NCT01459913|11692153|FG000|Overall Study|Study Terminated by Sponsor|30
7417876|NCT01459913|11692154|FG001|Overall Study|Study Terminated by Sponsor|15
7417877|NCT01459913|11692155|FG002|Overall Study|Study Terminated by Sponsor|9
7417878|NCT01459913|11692156|FG003|Overall Study|Study Terminated by Sponsor|11
7417879|NCT01459913|11692153|FG000|Overall Study|Other|0
7417880|NCT01459913|11692154|FG001|Overall Study|Other|0
7417881|NCT01459913|11692155|FG002|Overall Study|Other|3
7417882|NCT01459913|11692156|FG003|Overall Study|Other|1
7417883|NCT01459913|11692153|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
7417884|NCT01459913|11692154|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
7417885|NCT01459913|11692155|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
7417886|NCT01459913|11692156|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
7417887|NCT01460290|11692173|FG000|Overall Study|Adverse Event|3
7417888|NCT01460290|11692173|FG000|Overall Study|Elevated liver function|1
7417889|NCT01460342|11692189|FG000|Overall Study|Adverse Event|5
7417890|NCT01460342|11692190|FG001|Overall Study|Adverse Event|4
7417891|NCT01460342|11692189|FG000|Overall Study|Lost to Follow-up|1
7417892|NCT01460342|11692190|FG001|Overall Study|Lost to Follow-up|2
7417893|NCT01460342|11692189|FG000|Overall Study|Protocol Violation|0
7417894|NCT01460342|11692190|FG001|Overall Study|Protocol Violation|1
7417895|NCT01460342|11692189|FG000|Overall Study|Withdrawal by Subject|3
7417896|NCT01460342|11692190|FG001|Overall Study|Withdrawal by Subject|4
7417897|NCT01460342|11692189|FG000|Overall Study|Physician Decision|1
7417898|NCT01460342|11692190|FG001|Overall Study|Physician Decision|3
7417899|NCT01460342|11692189|FG000|Overall Study|Lack of Efficacy|1
7574684|NCT03687827|11957738|FG000|Treatment Period 1|Withdrawal by Subject|7
7417900|NCT01460342|11692190|FG001|Overall Study|Lack of Efficacy|0
7417901|NCT01460368|11692198|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7417902|NCT01460368|11692199|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7417903|NCT01460368|11692200|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7327268|NCT00789880|11559919|FG002|Overall Study|Adverse Event|0
7417904|NCT01460368|11692201|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7417905|NCT01460368|11692202|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
7417906|NCT01460368|11692203|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7417907|NCT01460368|11692204|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
7417908|NCT01460368|11692198|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7417909|NCT01460368|11692199|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7417910|NCT01460368|11692200|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7417911|NCT01460368|11692201|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7417912|NCT01460368|11692202|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7466479|NCT01891864|11766309|FG000|Treatment Period 2|Lack of Efficacy|0
7327200|NCT00789698|11559800|FG001|Overall Study|Withdrawal by Subject|15
7327201|NCT00789698|11559801|FG002|Overall Study|Withdrawal by Subject|12
7327202|NCT00789698|11559802|FG003|Overall Study|Withdrawal by Subject|19
7327203|NCT00789698|11559799|FG000|Overall Study|Administrative|0
7327204|NCT00789698|11559800|FG001|Overall Study|Administrative|3
7327205|NCT00789698|11559801|FG002|Overall Study|Administrative|3
7327206|NCT00789698|11559802|FG003|Overall Study|Administrative|1
7327207|NCT00789737|11559822|FG000|Overall Study|Withdrawal by Subject|13
7327208|NCT00789737|11559823|FG001|Overall Study|Withdrawal by Subject|22
7327209|NCT00789737|11559822|FG000|Overall Study|Lost to Follow-up|10
7327210|NCT00789737|11559823|FG001|Overall Study|Lost to Follow-up|14
7327211|NCT00789737|11559822|FG000|Overall Study|Adverse Event|8
7327212|NCT00789737|11559823|FG001|Overall Study|Adverse Event|8
7327213|NCT00789737|11559822|FG000|Overall Study|Protocol Violation|3
7327214|NCT00789737|11559823|FG001|Overall Study|Protocol Violation|0
7327215|NCT00789737|11559822|FG000|Overall Study|Lack of Efficacy|3
7327216|NCT00789737|11559823|FG001|Overall Study|Lack of Efficacy|0
7327217|NCT00789737|11559822|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
7327218|NCT00789737|11559823|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
7327219|NCT00789737|11559822|FG000|Overall Study|Other|11
7327220|NCT00789737|11559823|FG001|Overall Study|Other|7
7327221|NCT00789815|11559865|FG000|Overall Study|Protocol Violation|6
7327222|NCT00789815|11559866|FG001|Overall Study|Protocol Violation|1
7327223|NCT00789815|11559865|FG000|Overall Study|Intubation due to massive bleeding|1
7327224|NCT00789815|11559866|FG001|Overall Study|Intubation due to massive bleeding|0
7327225|NCT00789828|11559874|FG000|Core Period (48 Weeks)|Administrative problems|0
7327226|NCT00789828|11559875|FG001|Core Period (48 Weeks)|Administrative problems|1
7327227|NCT00789828|11559874|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
7327228|NCT00789828|11559875|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
7327229|NCT00789828|11559874|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
7327230|NCT00789828|11559875|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
7327231|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
7327232|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
7327233|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
7327234|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
7327235|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
7327236|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
7327237|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
7327238|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
7327239|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Death|1
7327240|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Death|0
7327241|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|Disease progression|1
7327242|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|Disease progression|0
7327243|NCT00789828|11559874|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
7327244|NCT00789828|11559875|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
7327245|NCT00789854|11559887|FG000|Overall Study|Adverse Event|28
7327246|NCT00789854|11559888|FG001|Overall Study|Adverse Event|23
7327247|NCT00789854|11559889|FG002|Overall Study|Adverse Event|18
7327248|NCT00789854|11559887|FG000|Overall Study|Lost to Follow-up|1
7327249|NCT00789854|11559888|FG001|Overall Study|Lost to Follow-up|1
7327250|NCT00789854|11559889|FG002|Overall Study|Lost to Follow-up|4
7327251|NCT00789854|11559887|FG000|Overall Study|Withdrawal by Subject|9
7327252|NCT00789854|11559888|FG001|Overall Study|Withdrawal by Subject|6
7327253|NCT00789854|11559889|FG002|Overall Study|Withdrawal by Subject|17
7327254|NCT00789854|11559887|FG000|Overall Study|Eligibility criteria not fulfilled|2
7327255|NCT00789854|11559888|FG001|Overall Study|Eligibility criteria not fulfilled|5
7327256|NCT00789854|11559889|FG002|Overall Study|Eligibility criteria not fulfilled|1
7327257|NCT00789854|11559887|FG000|Overall Study|Severe non-compliance to the protocol|3
7327258|NCT00789854|11559888|FG001|Overall Study|Severe non-compliance to the protocol|0
7327259|NCT00789854|11559889|FG002|Overall Study|Severe non-compliance to the protocol|0
7327260|NCT00789854|11559887|FG000|Overall Study|Safety reasons|0
7327261|NCT00789854|11559888|FG001|Overall Study|Safety reasons|0
7327262|NCT00789854|11559889|FG002|Overall Study|Safety reasons|2
7327263|NCT00789854|11559887|FG000|Overall Study|Other|6
7327264|NCT00789854|11559888|FG001|Overall Study|Other|0
7327265|NCT00789854|11559889|FG002|Overall Study|Other|5
7327266|NCT00789880|11559917|FG000|Overall Study|Adverse Event|0
7327267|NCT00789880|11559918|FG001|Overall Study|Adverse Event|0
7327269|NCT00789880|11559920|FG003|Overall Study|Adverse Event|0
7327270|NCT00789880|11559921|FG004|Overall Study|Adverse Event|1
7327271|NCT00789880|11559922|FG005|Overall Study|Adverse Event|0
7327272|NCT00789880|11559917|FG000|Overall Study|Protocol Violation|0
7327273|NCT00789880|11559918|FG001|Overall Study|Protocol Violation|1
7327274|NCT00789880|11559919|FG002|Overall Study|Protocol Violation|0
7327275|NCT00789880|11559920|FG003|Overall Study|Protocol Violation|1
7327276|NCT00789880|11559921|FG004|Overall Study|Protocol Violation|0
7327277|NCT00789880|11559922|FG005|Overall Study|Protocol Violation|0
7327278|NCT00789880|11559917|FG000|Overall Study|Withdrawal by Subject|1
7327279|NCT00789880|11559918|FG001|Overall Study|Withdrawal by Subject|0
7327280|NCT00789880|11559919|FG002|Overall Study|Withdrawal by Subject|0
7327281|NCT00789880|11559920|FG003|Overall Study|Withdrawal by Subject|0
7327282|NCT00789880|11559921|FG004|Overall Study|Withdrawal by Subject|2
7327283|NCT00789880|11559922|FG005|Overall Study|Withdrawal by Subject|0
7327284|NCT00789958|11559936|FG000|Overall Study|Adverse Event|3
7327285|NCT00789958|11559936|FG000|Overall Study|Withdrawal by Subject|4
7327286|NCT00789958|11559936|FG000|Overall Study|Progression|3
7327287|NCT00789958|11559936|FG000|Overall Study|not protocol specified|1
7327288|NCT00789958|11559936|FG000|Overall Study|Not eligible/not analyzable|26
7327289|NCT00790023|11559954|FG000|Overall Study|Adverse Event|2
7327290|NCT00790023|11559955|FG001|Overall Study|Adverse Event|1
7327291|NCT00790023|11559956|FG002|Overall Study|Adverse Event|4
7327292|NCT00790023|11559954|FG000|Overall Study|Protocol Violation|2
7327293|NCT00790023|11559955|FG001|Overall Study|Protocol Violation|4
7327294|NCT00790023|11559956|FG002|Overall Study|Protocol Violation|2
7327295|NCT00790023|11559954|FG000|Overall Study|Withdrawal by Subject|2
7327296|NCT00790023|11559955|FG001|Overall Study|Withdrawal by Subject|0
7327297|NCT00790023|11559956|FG002|Overall Study|Withdrawal by Subject|6
7327298|NCT00790023|11559954|FG000|Overall Study|Lost to Follow-up|0
7327299|NCT00790023|11559955|FG001|Overall Study|Lost to Follow-up|0
7327300|NCT00790023|11559956|FG002|Overall Study|Lost to Follow-up|1
7327301|NCT00790023|11559954|FG000|Overall Study|Other|5
7327302|NCT00790023|11559955|FG001|Overall Study|Other|5
7327303|NCT00790023|11559956|FG002|Overall Study|Other|8
7327304|NCT00790036|11559967|FG000|Overall Study|Abnormal lab values|3
7327305|NCT00790036|11559968|FG001|Overall Study|Abnormal lab values|2
7327306|NCT00790036|11559967|FG000|Overall Study|Administrative problems|5
7327307|NCT00790036|11559968|FG001|Overall Study|Administrative problems|9
7327308|NCT00790036|11559967|FG000|Overall Study|Adverse Event|113
7327309|NCT00790036|11559968|FG001|Overall Study|Adverse Event|44
7327310|NCT00790036|11559967|FG000|Overall Study|Death|1
7327311|NCT00790036|11559968|FG001|Overall Study|Death|0
7327312|NCT00790036|11559967|FG000|Overall Study|Disease progression|24
7327313|NCT00790036|11559968|FG001|Overall Study|Disease progression|48
7327314|NCT00790036|11559967|FG000|Overall Study|Lost to Follow-up|1
7417913|NCT01460368|11692203|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
7417914|NCT01460368|11692204|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
7417915|NCT01460368|11692198|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417916|NCT01460368|11692199|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
7417917|NCT01460368|11692200|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417918|NCT01460368|11692201|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417919|NCT01460368|11692202|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417920|NCT01460368|11692203|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417921|NCT01460368|11692204|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
7417922|NCT01460368|11692198|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
7417923|NCT01460368|11692199|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
7555598|NCT03061188|11918912|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
7555599|NCT03061188|11918913|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
7555600|NCT03061188|11918914|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
7417924|NCT01460368|11692200|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
7417925|NCT01460368|11692201|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
7417926|NCT01460368|11692202|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
7417927|NCT01460368|11692203|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
7417928|NCT01460368|11692204|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
7417929|NCT01460368|11692198|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7417930|NCT01460368|11692199|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7417931|NCT01460368|11692200|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7417932|NCT01460368|11692201|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7417933|NCT01460368|11692202|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7417934|NCT01460368|11692203|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
7417935|NCT01460368|11692204|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
7417936|NCT01460381|11692215|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
7417937|NCT01460381|11692216|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
7417938|NCT01460407|11692224|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
7417939|NCT01460407|11692225|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
7417940|NCT01460446|11692234|FG000|Overall Study|Non-compliance|2
7417941|NCT01460446|11692235|FG001|Overall Study|Non-compliance|9
7417942|NCT01460446|11692234|FG000|Overall Study|Consent Withdrawn|0
7417943|NCT01460446|11692235|FG001|Overall Study|Consent Withdrawn|4
7417944|NCT01460446|11692234|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
7417945|NCT01460446|11692235|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
7417946|NCT01460446|11692234|FG000|Overall Study|Surgery/Illness|1
7417947|NCT01460446|11692235|FG001|Overall Study|Surgery/Illness|1
7417948|NCT01460446|11692234|FG000|Overall Study|Pregnancy|1
7555601|NCT03061188|11918915|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
7327315|NCT00790036|11559968|FG001|Overall Study|Lost to Follow-up|2
7327316|NCT00790036|11559967|FG000|Overall Study|Protocol Violation|10
7327317|NCT00790036|11559968|FG001|Overall Study|Protocol Violation|2
7417949|NCT01460446|11692235|FG001|Overall Study|Pregnancy|0
7555602|NCT03061188|11918912|FG000|On Follow-up for 3 Years|Death|0
7555603|NCT03061188|11918913|FG001|On Follow-up for 3 Years|Death|3
7327318|NCT00790036|11559967|FG000|Overall Study|Withdrawal by Subject|18
7327319|NCT00790036|11559968|FG001|Overall Study|Withdrawal by Subject|7
7327320|NCT00790036|11559967|FG000|Overall Study|Subject/guardian decision|20
7327321|NCT00790036|11559968|FG001|Overall Study|Subject/guardian decision|7
7327322|NCT00790088|11559997|FG000|Overall Study|Protocol Violation|11
7327323|NCT00790088|11559997|FG000|Overall Study|Withdrawal by Subject|17
7327324|NCT00790088|11559997|FG000|Overall Study|Lost to Follow-up|7
7327325|NCT00790088|11559997|FG000|Overall Study|Physician Decision|4
7327326|NCT00790205|11560022|FG000|Overall Study|Lost to Follow-up|61
7327327|NCT00790205|11560023|FG001|Overall Study|Lost to Follow-up|71
7327328|NCT00790205|11560022|FG000|Overall Study|Withdrawal by Subject|299
7327329|NCT00790205|11560023|FG001|Overall Study|Withdrawal by Subject|363
7327330|NCT00790296|11560044|FG000|Overall Study|Did not meet study eligibility criteria|1
7327331|NCT00790296|11560045|FG001|Overall Study|Did not meet study eligibility criteria|1
7327332|NCT00790296|11560044|FG000|Overall Study|Adverse Event|0
7327333|NCT00790296|11560045|FG001|Overall Study|Adverse Event|1
7327334|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
7327335|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
7327336|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Progressive disease|0
7327337|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Progressive disease|9
7327338|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Adverse Event|2
7327339|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Adverse Event|4
7327340|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
7327341|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
7327342|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
7327343|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
7327344|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Administrative problems|1
7327345|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Administrative problems|0
7327346|NCT00790400|11560062|FG000|Double-blind Period (Core Phase)|Death|1
7327347|NCT00790400|11560063|FG001|Double-blind Period (Core Phase)|Death|0
7327348|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
7327349|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
7327350|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
7327351|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
7327352|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
7327353|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
7327354|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
7327355|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
7327356|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
7417950|NCT01460446|11692234|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
7417951|NCT01460446|11692235|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
7417952|NCT01460628|11692242|FG000|Overall Study|Adverse Event|3
7417953|NCT01460628|11692242|FG000|Overall Study|Withdrawal by Subject|2
7417954|NCT01460719|11692246|FG000|Overall Study|Adverse Event|1
7417955|NCT01460719|11692246|FG000|Overall Study|Withdrawal by Subject|1
7417956|NCT01460901|11692260|FG000|Overall Study|Withdrawal by Subject|2
7417957|NCT01461005|11692279|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
7417958|NCT01461044|11692286|FG000|Overall Study|Death|58
7417959|NCT01461044|11692287|FG001|Overall Study|Death|35
7417960|NCT01461044|11692286|FG000|Overall Study|Lost to Follow-up|12
7417961|NCT01461044|11692287|FG001|Overall Study|Lost to Follow-up|5
7417962|NCT01461057|11692298|FG000|Overall Study|Death|10
7417963|NCT01461057|11692299|FG001|Overall Study|Death|9
7417964|NCT01461057|11692298|FG000|Overall Study|Withdrawal by Subject|2
7417965|NCT01461057|11692299|FG001|Overall Study|Withdrawal by Subject|3
7417966|NCT01461057|11692298|FG000|Overall Study|Physician Decision|0
7417967|NCT01461057|11692299|FG001|Overall Study|Physician Decision|2
7417968|NCT01461057|11692298|FG000|Overall Study|Adverse Event|0
7417969|NCT01461057|11692299|FG001|Overall Study|Adverse Event|1
7417970|NCT01461057|11692298|FG000|Overall Study|Progression of Disease|1
7417971|NCT01461057|11692299|FG001|Overall Study|Progression of Disease|0
7417972|NCT01461057|11692298|FG000|Overall Study|Study Terminated by Sponsor|2
7417973|NCT01461057|11692299|FG001|Overall Study|Study Terminated by Sponsor|0
7417974|NCT01461096|11692307|FG000|Overall Study|Death|3
7417975|NCT01461096|11692308|FG001|Overall Study|Death|6
7417976|NCT01461096|11692307|FG000|Overall Study|Severe debilitation, unable to continue|1
7417977|NCT01461096|11692308|FG001|Overall Study|Severe debilitation, unable to continue|1
7417978|NCT01461096|11692307|FG000|Overall Study|Subj not able to get to clinic|15
7417979|NCT01461096|11692308|FG001|Overall Study|Subj not able to get to clinic|13
7417980|NCT01461096|11692307|FG000|Overall Study|Site is closing|27
7417981|NCT01461096|11692308|FG001|Overall Study|Site is closing|30
7417982|NCT01461096|11692307|FG000|Overall Study|Withdrawal by Subject|5
7417983|NCT01461096|11692308|FG001|Overall Study|Withdrawal by Subject|3
7417984|NCT01461096|11692307|FG000|Overall Study|Subj not willing to adhere to reqs|3
7417985|NCT01461096|11692308|FG001|Overall Study|Subj not willing to adhere to reqs|4
7417986|NCT01461096|11692307|FG000|Overall Study|Lost to Follow-up|8
7417987|NCT01461096|11692308|FG001|Overall Study|Lost to Follow-up|4
7417988|NCT01461369|11692318|FG000|Overall Study|Lack of Efficacy|2
7417989|NCT01461369|11692319|FG001|Overall Study|Lack of Efficacy|0
7417990|NCT01461369|11692320|FG002|Overall Study|Lack of Efficacy|6
7555604|NCT03061188|11918914|FG002|On Follow-up for 3 Years|Death|5
7555605|NCT03061188|11918915|FG003|On Follow-up for 3 Years|Death|2
7555606|NCT03061188|11918912|FG000|On Follow-up for 3 Years|Still in follow-up|0
7555607|NCT03061188|11918913|FG001|On Follow-up for 3 Years|Still in follow-up|0
7555608|NCT03061188|11918914|FG002|On Follow-up for 3 Years|Still in follow-up|0
7555609|NCT03061188|11918915|FG003|On Follow-up for 3 Years|Still in follow-up|3
7327357|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
7327358|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Death|1
7327359|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Death|0
7327360|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Disease progression|5
7327361|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Disease progression|0
7327362|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
7327363|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
7327364|NCT00790400|11560062|FG000|Everolimus Period (Core or Extension)|New treatment|2
7327365|NCT00790400|11560063|FG001|Everolimus Period (Core or Extension)|New treatment|0
7327366|NCT00790556|11560072|FG000|Treatment Period 1|Physician Decision|1
7327367|NCT00790556|11560073|FG001|Treatment Period 1|Physician Decision|0
7327368|NCT00790556|11560072|FG000|Treatment Period 1|Withdrawal by Subject|1
7327369|NCT00790556|11560073|FG001|Treatment Period 1|Withdrawal by Subject|0
7327370|NCT00790569|11560082|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7327371|NCT00790569|11560083|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
7327372|NCT00790569|11560084|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
7327373|NCT00790569|11560082|FG000|End of Treatment (6 Month Interview)|Death|0
7327374|NCT00790569|11560083|FG001|End of Treatment (6 Month Interview)|Death|2
7327375|NCT00790569|11560084|FG002|End of Treatment (6 Month Interview)|Death|1
7327376|NCT00790569|11560082|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
7327377|NCT00790569|11560083|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
7327378|NCT00790569|11560084|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
7327379|NCT00790569|11560082|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
7327380|NCT00790569|11560083|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
7327381|NCT00790569|11560084|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
7327382|NCT00790569|11560082|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
7327383|NCT00790569|11560083|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
7327384|NCT00790569|11560084|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
7327385|NCT00790569|11560082|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
7327386|NCT00790569|11560083|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
7327387|NCT00790569|11560084|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
7327388|NCT00790582|11560094|FG000|Overall Study|Death|14
7327389|NCT00790582|11560095|FG001|Overall Study|Death|32
7327390|NCT00790582|11560094|FG000|Overall Study|Physician Decision|7
7327391|NCT00790582|11560095|FG001|Overall Study|Physician Decision|1
7327392|NCT00790582|11560094|FG000|Overall Study|Lost to Follow-up|3
7327393|NCT00790582|11560095|FG001|Overall Study|Lost to Follow-up|3
7327394|NCT00790582|11560094|FG000|Overall Study|Withdrawal by Subject|7
7327395|NCT00790582|11560095|FG001|Overall Study|Withdrawal by Subject|51
7327396|NCT00790647|11560103|FG000|Overall Study|Adverse Event|1
7327397|NCT00790751|11560150|FG000|Overall Study|Protocol non-compliance|16
7327398|NCT00790751|11560151|FG001|Overall Study|Protocol non-compliance|16
7327399|NCT00790751|11560152|FG002|Overall Study|Protocol non-compliance|10
7327400|NCT00790751|11560153|FG003|Overall Study|Protocol non-compliance|11
7327401|NCT00790751|11560150|FG000|Overall Study|Lost to Follow-up|4
7327402|NCT00790751|11560151|FG001|Overall Study|Lost to Follow-up|9
7327403|NCT00790751|11560152|FG002|Overall Study|Lost to Follow-up|4
7327404|NCT00790751|11560153|FG003|Overall Study|Lost to Follow-up|5
7327405|NCT00790751|11560150|FG000|Overall Study|Adverse Event|5
7327406|NCT00790751|11560151|FG001|Overall Study|Adverse Event|3
7555610|NCT03061214|11918933|FG000|Overall Study|Withdrawal by Subject|21
7555611|NCT03061214|11918934|FG001|Overall Study|Withdrawal by Subject|26
7555612|NCT03061214|11918935|FG002|Overall Study|Withdrawal by Subject|9
7555613|NCT03061214|11918933|FG000|Overall Study|Lost to Follow-up|3
7327407|NCT00790751|11560152|FG002|Overall Study|Adverse Event|5
7327408|NCT00790751|11560153|FG003|Overall Study|Adverse Event|4
7327409|NCT00790751|11560150|FG000|Overall Study|Requirement for restricted medication|0
7327410|NCT00790751|11560151|FG001|Overall Study|Requirement for restricted medication|2
7327411|NCT00790751|11560152|FG002|Overall Study|Requirement for restricted medication|0
7327412|NCT00790751|11560153|FG003|Overall Study|Requirement for restricted medication|0
7327413|NCT00790751|11560150|FG000|Overall Study|Death|0
7327414|NCT00790751|11560151|FG001|Overall Study|Death|0
7327415|NCT00790751|11560152|FG002|Overall Study|Death|1
7327416|NCT00790751|11560153|FG003|Overall Study|Death|0
7327417|NCT00790751|11560150|FG000|Overall Study|Physician Decision|0
7327418|NCT00790751|11560151|FG001|Overall Study|Physician Decision|0
7327419|NCT00790751|11560152|FG002|Overall Study|Physician Decision|0
7327420|NCT00790751|11560153|FG003|Overall Study|Physician Decision|1
7384947|NCT01197794|11642372|FG001|Overall Study|Withdrawal by Subject|3
7384948|NCT01197794|11642373|FG002|Overall Study|Withdrawal by Subject|4
7384949|NCT01197794|11642374|FG003|Overall Study|Withdrawal by Subject|1
7555614|NCT03061214|11918934|FG001|Overall Study|Lost to Follow-up|1
7555615|NCT03061214|11918935|FG002|Overall Study|Lost to Follow-up|1
7555616|NCT03061214|11918933|FG000|Overall Study|Death|1
7555617|NCT03061214|11918934|FG001|Overall Study|Death|1
7555618|NCT03061214|11918935|FG002|Overall Study|Death|0
7327421|NCT00790790|11560166|FG000|Study Period 2: Therapy Phase|Adverse Event|3
7327422|NCT00790790|11560167|FG001|Study Period 2: Therapy Phase|Adverse Event|16
7327423|NCT00790790|11560168|FG002|Study Period 2: Therapy Phase|Adverse Event|16
7327424|NCT00790790|11560166|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
7327425|NCT00790790|11560167|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
7327426|NCT00790790|11560168|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
7327427|NCT00790790|11560166|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
7327428|NCT00790790|11560167|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
7327429|NCT00790790|11560168|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
7327430|NCT00790790|11560166|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
7327431|NCT00790790|11560167|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
7327432|NCT00790790|11560168|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
7327433|NCT00790790|11560166|FG000|Study Period 2: Therapy Phase|Physician Decision|0
7327434|NCT00790790|11560167|FG001|Study Period 2: Therapy Phase|Physician Decision|1
7327435|NCT00790790|11560168|FG002|Study Period 2: Therapy Phase|Physician Decision|0
7327436|NCT00790842|11560184|FG000|Dose Level 1|Adverse Event|1
7327437|NCT00790842|11560185|FG001|Dose Level 1|Adverse Event|0
7327438|NCT00790842|11560186|FG002|Dose Level 1|Adverse Event|0
7327439|NCT00790842|11560187|FG003|Dose Level 1|Adverse Event|2
7327440|NCT00790842|11560188|FG004|Dose Level 1|Adverse Event|0
7327441|NCT00790842|11560189|FG005|Dose Level 1|Adverse Event|0
7327442|NCT00790842|11560190|FG006|Dose Level 1|Adverse Event|0
7327443|NCT00790842|11560191|FG007|Dose Level 1|Adverse Event|1
7327444|NCT00790842|11560192|FG008|Dose Level 1|Adverse Event|0
7327445|NCT00790842|11560193|FG009|Dose Level 1|Adverse Event|0
7327446|NCT00790842|11560194|FG010|Dose Level 1|Adverse Event|0
7327447|NCT00790842|11560184|FG000|Dose Level 1|Physician Decision|1
7327448|NCT00790842|11560185|FG001|Dose Level 1|Physician Decision|0
7327449|NCT00790842|11560186|FG002|Dose Level 1|Physician Decision|0
7327450|NCT00790842|11560187|FG003|Dose Level 1|Physician Decision|0
7327451|NCT00790842|11560188|FG004|Dose Level 1|Physician Decision|0
7327452|NCT00790842|11560189|FG005|Dose Level 1|Physician Decision|0
7327453|NCT00790842|11560190|FG006|Dose Level 1|Physician Decision|0
7327454|NCT00790842|11560191|FG007|Dose Level 1|Physician Decision|1
7327455|NCT00790842|11560192|FG008|Dose Level 1|Physician Decision|0
7327456|NCT00790842|11560193|FG009|Dose Level 1|Physician Decision|0
7327457|NCT00790842|11560194|FG010|Dose Level 1|Physician Decision|0
7327458|NCT00790842|11560184|FG000|Dose Level 1|Withdrawal by Subject|1
7327459|NCT00790842|11560185|FG001|Dose Level 1|Withdrawal by Subject|0
7327460|NCT00790842|11560186|FG002|Dose Level 1|Withdrawal by Subject|0
7327461|NCT00790842|11560187|FG003|Dose Level 1|Withdrawal by Subject|0
7555619|NCT03061331|11918945|FG000|Washout Period (8 Weeks)|Adverse Event|2
7555620|NCT03061331|11918946|FG001|Washout Period (8 Weeks)|Adverse Event|1
7555621|NCT03062891|11919007|FG000|Overall Study|Withdrawal by Subject|2
7555622|NCT03062891|11919008|FG001|Overall Study|Withdrawal by Subject|0
7555623|NCT03062891|11919007|FG000|Overall Study|Lost to Follow-up|50
7531478|NCT02652442|11875965|FG000|Centrifugation - Distance|Lost to Follow-up|1
7531479|NCT02652624|11875983|FG000|Randomized Phase|Pregnancy|3
7531480|NCT02652624|11875984|FG001|Randomized Phase|Pregnancy|1
7531481|NCT02652624|11875983|FG000|Randomized Phase|Investigator's Discretion|0
7555624|NCT03062891|11919008|FG001|Overall Study|Lost to Follow-up|38
7327462|NCT00790842|11560188|FG004|Dose Level 1|Withdrawal by Subject|0
7327463|NCT00790842|11560189|FG005|Dose Level 1|Withdrawal by Subject|0
7327464|NCT00790842|11560190|FG006|Dose Level 1|Withdrawal by Subject|0
7327465|NCT00790842|11560191|FG007|Dose Level 1|Withdrawal by Subject|0
7327466|NCT00790842|11560192|FG008|Dose Level 1|Withdrawal by Subject|0
7327467|NCT00790842|11560193|FG009|Dose Level 1|Withdrawal by Subject|0
7327468|NCT00790842|11560194|FG010|Dose Level 1|Withdrawal by Subject|0
7327469|NCT00790842|11560184|FG000|Dose Level 2|Death|0
7327470|NCT00790842|11560185|FG001|Dose Level 2|Death|1
7327471|NCT00790842|11560186|FG002|Dose Level 2|Death|0
7327472|NCT00790842|11560187|FG003|Dose Level 2|Death|0
7327473|NCT00790842|11560188|FG004|Dose Level 2|Death|1
7327474|NCT00790842|11560189|FG005|Dose Level 2|Death|0
7327475|NCT00790842|11560190|FG006|Dose Level 2|Death|0
7327476|NCT00790842|11560191|FG007|Dose Level 2|Death|0
7327477|NCT00790842|11560192|FG008|Dose Level 2|Death|0
7327478|NCT00790842|11560193|FG009|Dose Level 2|Death|0
7327479|NCT00790842|11560194|FG010|Dose Level 2|Death|0
7327480|NCT00790842|11560184|FG000|Dose Level 2|Physician Decision|0
7327481|NCT00790842|11560185|FG001|Dose Level 2|Physician Decision|1
7327482|NCT00790842|11560186|FG002|Dose Level 2|Physician Decision|0
7327483|NCT00790842|11560187|FG003|Dose Level 2|Physician Decision|0
7327484|NCT00790842|11560188|FG004|Dose Level 2|Physician Decision|0
7417991|NCT01461369|11692318|FG000|Overall Study|Lost to Follow-up|0
7417992|NCT01461369|11692319|FG001|Overall Study|Lost to Follow-up|0
7555625|NCT03063086|11919035|FG000|Overall Study|technical problems|1
7555626|NCT03063086|11919036|FG001|Overall Study|technical problems|0
7327485|NCT00790842|11560189|FG005|Dose Level 2|Physician Decision|0
7327486|NCT00790842|11560190|FG006|Dose Level 2|Physician Decision|0
7417993|NCT01461369|11692320|FG002|Overall Study|Lost to Follow-up|3
7555627|NCT03063086|11919037|FG002|Overall Study|technical problems|0
7327487|NCT00790842|11560191|FG007|Dose Level 2|Physician Decision|0
7327488|NCT00790842|11560192|FG008|Dose Level 2|Physician Decision|0
7327489|NCT00790842|11560193|FG009|Dose Level 2|Physician Decision|0
7327490|NCT00790842|11560194|FG010|Dose Level 2|Physician Decision|0
7327491|NCT00790842|11560184|FG000|Dose Level 2|Withdrawal by Subject|0
7327492|NCT00790842|11560185|FG001|Dose Level 2|Withdrawal by Subject|1
7327493|NCT00790842|11560186|FG002|Dose Level 2|Withdrawal by Subject|0
7327494|NCT00790842|11560187|FG003|Dose Level 2|Withdrawal by Subject|0
7327495|NCT00790842|11560188|FG004|Dose Level 2|Withdrawal by Subject|0
7327496|NCT00790842|11560189|FG005|Dose Level 2|Withdrawal by Subject|0
7327497|NCT00790842|11560190|FG006|Dose Level 2|Withdrawal by Subject|0
7327498|NCT00790842|11560191|FG007|Dose Level 2|Withdrawal by Subject|0
7327499|NCT00790842|11560192|FG008|Dose Level 2|Withdrawal by Subject|0
7327500|NCT00790842|11560193|FG009|Dose Level 2|Withdrawal by Subject|0
7327501|NCT00790842|11560194|FG010|Dose Level 2|Withdrawal by Subject|0
7327502|NCT00790842|11560184|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327503|NCT00790842|11560185|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327504|NCT00790842|11560186|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327505|NCT00790842|11560187|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327506|NCT00790842|11560188|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327507|NCT00790842|11560189|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327508|NCT00790842|11560190|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327509|NCT00790842|11560191|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327510|NCT00790842|11560192|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
7327511|NCT00790842|11560193|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327512|NCT00790842|11560194|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
7327513|NCT00790842|11560184|FG000|Dose Level 3|Adverse Event|0
7327514|NCT00790842|11560185|FG001|Dose Level 3|Adverse Event|0
7327515|NCT00790842|11560186|FG002|Dose Level 3|Adverse Event|1
7327516|NCT00790842|11560187|FG003|Dose Level 3|Adverse Event|0
7327517|NCT00790842|11560188|FG004|Dose Level 3|Adverse Event|0
7327518|NCT00790842|11560189|FG005|Dose Level 3|Adverse Event|0
7327519|NCT00790842|11560190|FG006|Dose Level 3|Adverse Event|0
7327520|NCT00790842|11560191|FG007|Dose Level 3|Adverse Event|0
7327521|NCT00790842|11560192|FG008|Dose Level 3|Adverse Event|0
7327522|NCT00790842|11560193|FG009|Dose Level 3|Adverse Event|0
7327523|NCT00790842|11560194|FG010|Dose Level 3|Adverse Event|0
7327524|NCT00790842|11560184|FG000|Dose Level 3|Withdrawal by Subject|0
7327525|NCT00790842|11560185|FG001|Dose Level 3|Withdrawal by Subject|0
7327526|NCT00790842|11560186|FG002|Dose Level 3|Withdrawal by Subject|3
7327527|NCT00790842|11560187|FG003|Dose Level 3|Withdrawal by Subject|0
7327528|NCT00790842|11560188|FG004|Dose Level 3|Withdrawal by Subject|0
7327529|NCT00790842|11560189|FG005|Dose Level 3|Withdrawal by Subject|0
7327530|NCT00790842|11560190|FG006|Dose Level 3|Withdrawal by Subject|0
7327531|NCT00790842|11560191|FG007|Dose Level 3|Withdrawal by Subject|0
7327532|NCT00790842|11560192|FG008|Dose Level 3|Withdrawal by Subject|0
7327533|NCT00790842|11560193|FG009|Dose Level 3|Withdrawal by Subject|2
7327534|NCT00790842|11560194|FG010|Dose Level 3|Withdrawal by Subject|0
7327535|NCT00790842|11560184|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327536|NCT00790842|11560185|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327537|NCT00790842|11560186|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327538|NCT00790842|11560187|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327539|NCT00790842|11560188|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327540|NCT00790842|11560189|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
7327541|NCT00790842|11560190|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327542|NCT00790842|11560191|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327543|NCT00790842|11560192|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327544|NCT00790842|11560193|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327545|NCT00790842|11560194|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
7327546|NCT00790842|11560184|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327547|NCT00790842|11560185|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327548|NCT00790842|11560186|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
7327549|NCT00790842|11560187|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327550|NCT00790842|11560188|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327551|NCT00790842|11560189|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327552|NCT00790842|11560190|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327553|NCT00790842|11560191|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327554|NCT00790842|11560192|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327555|NCT00790842|11560193|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327556|NCT00790842|11560194|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
7327557|NCT00790842|11560184|FG000|Dose Level 4|Adverse Event|0
7327558|NCT00790842|11560185|FG001|Dose Level 4|Adverse Event|0
7327559|NCT00790842|11560186|FG002|Dose Level 4|Adverse Event|0
7327560|NCT00790842|11560187|FG003|Dose Level 4|Adverse Event|0
7327561|NCT00790842|11560188|FG004|Dose Level 4|Adverse Event|0
7327562|NCT00790842|11560189|FG005|Dose Level 4|Adverse Event|0
7327563|NCT00790842|11560190|FG006|Dose Level 4|Adverse Event|1
7327564|NCT00790842|11560191|FG007|Dose Level 4|Adverse Event|0
7327565|NCT00790842|11560192|FG008|Dose Level 4|Adverse Event|0
7327566|NCT00790842|11560193|FG009|Dose Level 4|Adverse Event|0
7327567|NCT00790842|11560194|FG010|Dose Level 4|Adverse Event|0
7327568|NCT00790842|11560184|FG000|Dose Level 4|Physician Decision|0
7327569|NCT00790842|11560185|FG001|Dose Level 4|Physician Decision|0
7327570|NCT00790842|11560186|FG002|Dose Level 4|Physician Decision|0
7327571|NCT00790842|11560187|FG003|Dose Level 4|Physician Decision|0
7327572|NCT00790842|11560188|FG004|Dose Level 4|Physician Decision|0
7327573|NCT00790842|11560189|FG005|Dose Level 4|Physician Decision|0
7327574|NCT00790842|11560190|FG006|Dose Level 4|Physician Decision|1
7327575|NCT00790842|11560191|FG007|Dose Level 4|Physician Decision|0
7327576|NCT00790842|11560192|FG008|Dose Level 4|Physician Decision|0
7327577|NCT00790842|11560193|FG009|Dose Level 4|Physician Decision|0
7327578|NCT00790842|11560194|FG010|Dose Level 4|Physician Decision|1
7327579|NCT00790842|11560184|FG000|Dose Level 4|Withdrawal by Subject|0
7327580|NCT00790842|11560185|FG001|Dose Level 4|Withdrawal by Subject|0
7327581|NCT00790842|11560186|FG002|Dose Level 4|Withdrawal by Subject|0
7327582|NCT00790842|11560187|FG003|Dose Level 4|Withdrawal by Subject|0
7327583|NCT00790842|11560188|FG004|Dose Level 4|Withdrawal by Subject|0
7327584|NCT00790842|11560189|FG005|Dose Level 4|Withdrawal by Subject|0
7327585|NCT00790842|11560190|FG006|Dose Level 4|Withdrawal by Subject|0
7327586|NCT00790842|11560191|FG007|Dose Level 4|Withdrawal by Subject|0
7327587|NCT00790842|11560192|FG008|Dose Level 4|Withdrawal by Subject|0
7327588|NCT00790842|11560193|FG009|Dose Level 4|Withdrawal by Subject|0
7327589|NCT00790842|11560194|FG010|Dose Level 4|Withdrawal by Subject|1
7327590|NCT00790842|11560184|FG000|Expansion Cohort|Adverse Event|0
7327591|NCT00790842|11560185|FG001|Expansion Cohort|Adverse Event|0
7327592|NCT00790842|11560186|FG002|Expansion Cohort|Adverse Event|0
7327593|NCT00790842|11560187|FG003|Expansion Cohort|Adverse Event|0
7327594|NCT00790842|11560188|FG004|Expansion Cohort|Adverse Event|0
7327595|NCT00790842|11560189|FG005|Expansion Cohort|Adverse Event|0
7327596|NCT00790842|11560190|FG006|Expansion Cohort|Adverse Event|1
7327597|NCT00790842|11560191|FG007|Expansion Cohort|Adverse Event|0
7327598|NCT00790842|11560192|FG008|Expansion Cohort|Adverse Event|0
7327599|NCT00790842|11560193|FG009|Expansion Cohort|Adverse Event|0
7327600|NCT00790842|11560194|FG010|Expansion Cohort|Adverse Event|0
7327601|NCT00790842|11560184|FG000|Expansion Cohort|Death|0
7327602|NCT00790842|11560185|FG001|Expansion Cohort|Death|0
7327603|NCT00790842|11560186|FG002|Expansion Cohort|Death|2
7327604|NCT00790842|11560187|FG003|Expansion Cohort|Death|0
7327605|NCT00790842|11560188|FG004|Expansion Cohort|Death|0
7327606|NCT00790842|11560189|FG005|Expansion Cohort|Death|0
7327607|NCT00790842|11560190|FG006|Expansion Cohort|Death|0
7327608|NCT00790842|11560191|FG007|Expansion Cohort|Death|0
7327609|NCT00790842|11560192|FG008|Expansion Cohort|Death|0
7327610|NCT00790842|11560193|FG009|Expansion Cohort|Death|0
7327611|NCT00790842|11560194|FG010|Expansion Cohort|Death|0
7327612|NCT00790842|11560184|FG000|Expansion Cohort|Physician Decision|0
7327613|NCT00790842|11560185|FG001|Expansion Cohort|Physician Decision|0
7327614|NCT00790842|11560186|FG002|Expansion Cohort|Physician Decision|1
7327615|NCT00790842|11560187|FG003|Expansion Cohort|Physician Decision|0
7327616|NCT00790842|11560188|FG004|Expansion Cohort|Physician Decision|0
7327617|NCT00790842|11560189|FG005|Expansion Cohort|Physician Decision|0
7327618|NCT00790842|11560190|FG006|Expansion Cohort|Physician Decision|0
7327619|NCT00790842|11560191|FG007|Expansion Cohort|Physician Decision|0
7327620|NCT00790842|11560192|FG008|Expansion Cohort|Physician Decision|0
7327621|NCT00790842|11560193|FG009|Expansion Cohort|Physician Decision|0
7327622|NCT00790842|11560194|FG010|Expansion Cohort|Physician Decision|0
7327623|NCT00790842|11560184|FG000|Expansion Cohort|Withdrawal by Subject|0
7327624|NCT00790842|11560185|FG001|Expansion Cohort|Withdrawal by Subject|0
7327625|NCT00790842|11560186|FG002|Expansion Cohort|Withdrawal by Subject|3
7417994|NCT01461369|11692318|FG000|Overall Study|Adverse Event|9
7417995|NCT01461369|11692319|FG001|Overall Study|Adverse Event|12
7417996|NCT01461369|11692320|FG002|Overall Study|Adverse Event|4
7417997|NCT01461369|11692318|FG000|Overall Study|Protocol Violation|1
7417998|NCT01461369|11692319|FG001|Overall Study|Protocol Violation|2
7417999|NCT01461369|11692320|FG002|Overall Study|Protocol Violation|2
7418000|NCT01461369|11692318|FG000|Overall Study|Withdrawal by Subject|1
7418001|NCT01461369|11692319|FG001|Overall Study|Withdrawal by Subject|3
7418002|NCT01461369|11692320|FG002|Overall Study|Withdrawal by Subject|2
7418003|NCT01461538|11692351|FG000|Overall Study|Death|15
7418004|NCT01461538|11692352|FG001|Overall Study|Death|6
7327626|NCT00790842|11560187|FG003|Expansion Cohort|Withdrawal by Subject|0
7327627|NCT00790842|11560188|FG004|Expansion Cohort|Withdrawal by Subject|0
7327628|NCT00790842|11560189|FG005|Expansion Cohort|Withdrawal by Subject|0
7327629|NCT00790842|11560190|FG006|Expansion Cohort|Withdrawal by Subject|0
7327630|NCT00790842|11560191|FG007|Expansion Cohort|Withdrawal by Subject|0
7327631|NCT00790842|11560192|FG008|Expansion Cohort|Withdrawal by Subject|0
7327632|NCT00790842|11560193|FG009|Expansion Cohort|Withdrawal by Subject|0
7327633|NCT00790842|11560194|FG010|Expansion Cohort|Withdrawal by Subject|0
7327634|NCT00790842|11560184|FG000|Expansion Cohort|Study Closure|0
7418005|NCT01461538|11692353|FG002|Overall Study|Death|2
7327635|NCT00790842|11560185|FG001|Expansion Cohort|Study Closure|0
7327636|NCT00790842|11560186|FG002|Expansion Cohort|Study Closure|1
7327637|NCT00790842|11560187|FG003|Expansion Cohort|Study Closure|0
7418006|NCT01461538|11692351|FG000|Overall Study|Study Stopped by Sponsor|2
7418007|NCT01461538|11692352|FG001|Overall Study|Study Stopped by Sponsor|1
7418008|NCT01461538|11692353|FG002|Overall Study|Study Stopped by Sponsor|0
7418009|NCT01461538|11692351|FG000|Overall Study|Withdrawal by Subject|1
7418010|NCT01461538|11692352|FG001|Overall Study|Withdrawal by Subject|1
7418011|NCT01461538|11692353|FG002|Overall Study|Withdrawal by Subject|0
7418012|NCT01461551|11692366|FG000|Overall Study|Physician Decision|2
7418013|NCT01461551|11692367|FG001|Overall Study|Physician Decision|1
7418014|NCT01461551|11692368|FG002|Overall Study|Physician Decision|2
7418015|NCT01461707|11692392|FG000|Overall Study|Withdrawal by Subject|1
7418016|NCT01461707|11692393|FG001|Overall Study|Withdrawal by Subject|0
7418017|NCT01461811|11692410|FG000|Overall Study|Adverse Event|2
7418018|NCT01461811|11692411|FG001|Overall Study|Adverse Event|1
7418019|NCT01461811|11692410|FG000|Overall Study|Subject decision unrelated to an AE|1
7418020|NCT01461811|11692411|FG001|Overall Study|Subject decision unrelated to an AE|1
7418021|NCT01461811|11692410|FG000|Overall Study|Noncompliance|1
7418022|NCT01461811|11692411|FG001|Overall Study|Noncompliance|1
7418023|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Adverse Event|76
7418024|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Adverse Event|0
7418025|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Adverse Event|0
7418026|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Death|3
7418027|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Death|0
7418028|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Death|0
7418029|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
7418030|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
7418031|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
7418032|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Physician Decision|9
7418033|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Physician Decision|0
7418034|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Physician Decision|0
7418035|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
7418036|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
7418037|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
7418038|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Disease progression|45
7418039|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Disease progression|0
7418040|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Disease progression|0
7418041|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
7418042|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
7418043|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
7418044|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
7418045|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7418046|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
7418047|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Not responding to treatment|11
7418048|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Not responding to treatment|0
7418049|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Not responding to treatment|0
7418050|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
7418051|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
7418052|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
7418053|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
7418054|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7418055|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
7418056|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Sponsor decision|1
7418057|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Sponsor decision|0
7418058|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Sponsor decision|0
7418059|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Protocol deviation|2
7418060|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Protocol deviation|0
7418061|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Protocol deviation|0
7418062|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
7418063|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7418064|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
7418065|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
7418066|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7418067|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
7418068|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Promotor request|1
7418069|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Promotor request|0
7418070|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Promotor request|0
7418071|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
7418072|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7418073|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
7418074|NCT01461928|11692441|FG000|Induction (up to 8 Months)|Medical advisor request|1
7418075|NCT01461928|11692442|FG001|Induction (up to 8 Months)|Medical advisor request|0
7418076|NCT01461928|11692443|FG002|Induction (up to 8 Months)|Medical advisor request|0
7418077|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Death|3
7418078|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Death|0
7418079|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Death|0
7418080|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
7327638|NCT00790842|11560188|FG004|Expansion Cohort|Study Closure|0
7327639|NCT00790842|11560189|FG005|Expansion Cohort|Study Closure|0
7327640|NCT00790842|11560190|FG006|Expansion Cohort|Study Closure|0
7327641|NCT00790842|11560191|FG007|Expansion Cohort|Study Closure|0
7327642|NCT00790842|11560192|FG008|Expansion Cohort|Study Closure|0
7327643|NCT00790842|11560193|FG009|Expansion Cohort|Study Closure|0
7327644|NCT00790842|11560194|FG010|Expansion Cohort|Study Closure|0
7327645|NCT00790868|11560249|FG000|Overall Study|Withdrawal by Subject|4
7327646|NCT00790868|11560250|FG001|Overall Study|Withdrawal by Subject|5
7327647|NCT00790868|11560249|FG000|Overall Study|Lost to Follow-up|2
7327648|NCT00790868|11560250|FG001|Overall Study|Lost to Follow-up|12
7327649|NCT00790907|11560261|FG000|Overall Study|Adverse Event|9
7327650|NCT00790907|11560262|FG001|Overall Study|Adverse Event|7
7327651|NCT00790907|11560263|FG002|Overall Study|Adverse Event|6
7327652|NCT00790907|11560261|FG000|Overall Study|Physician Decision|304
7327653|NCT00790907|11560262|FG001|Overall Study|Physician Decision|271
7327654|NCT00790907|11560263|FG002|Overall Study|Physician Decision|255
7327655|NCT00790907|11560261|FG000|Overall Study|Withdrawal by Subject|1
7327656|NCT00790907|11560262|FG001|Overall Study|Withdrawal by Subject|7
7327657|NCT00790907|11560263|FG002|Overall Study|Withdrawal by Subject|5
7327658|NCT00790907|11560261|FG000|Overall Study|Bleeding Event|11
7327659|NCT00790907|11560262|FG001|Overall Study|Bleeding Event|16
7327660|NCT00790907|11560263|FG002|Overall Study|Bleeding Event|21
7327661|NCT00790907|11560261|FG000|Overall Study|Required Protocol-prohibited Therapy|17
7327662|NCT00790907|11560262|FG001|Overall Study|Required Protocol-prohibited Therapy|5
7327663|NCT00790907|11560263|FG002|Overall Study|Required Protocol-prohibited Therapy|7
7327664|NCT00790907|11560261|FG000|Overall Study|Qualifying Condition Not Present|29
7327665|NCT00790907|11560262|FG001|Overall Study|Qualifying Condition Not Present|14
7327666|NCT00790907|11560263|FG002|Overall Study|Qualifying Condition Not Present|16
7327667|NCT00790907|11560261|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
7327668|NCT00790907|11560262|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
7327669|NCT00790907|11560263|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
7327670|NCT00790907|11560261|FG000|Overall Study|Did Not Receive Study Drug|10
7327671|NCT00790907|11560262|FG001|Overall Study|Did Not Receive Study Drug|0
7327672|NCT00790907|11560263|FG002|Overall Study|Did Not Receive Study Drug|0
7327673|NCT00791128|11560292|FG000|Overall Study|Adverse Event|4
7327674|NCT00791128|11560292|FG000|Overall Study|Device migration|2
7327675|NCT00791128|11560292|FG000|Overall Study|non-compliance by subject|2
7327676|NCT00791128|11560292|FG000|Overall Study|abdominal tumor, unrelated to device|1
7384950|NCT01197794|11642375|FG004|Overall Study|Withdrawal by Subject|1
7384951|NCT01197794|11642376|FG005|Overall Study|Withdrawal by Subject|5
7384952|NCT01197794|11642377|FG006|Overall Study|Withdrawal by Subject|6
7384953|NCT01197794|11642371|FG000|Overall Study|Lost to Follow-up|1
7384954|NCT01197794|11642372|FG001|Overall Study|Lost to Follow-up|1
7384955|NCT01197794|11642373|FG002|Overall Study|Lost to Follow-up|0
7384956|NCT01197794|11642374|FG003|Overall Study|Lost to Follow-up|1
7384957|NCT01197794|11642375|FG004|Overall Study|Lost to Follow-up|0
7384958|NCT01197794|11642376|FG005|Overall Study|Lost to Follow-up|1
7384959|NCT01197794|11642377|FG006|Overall Study|Lost to Follow-up|0
7384960|NCT01197794|11642371|FG000|Overall Study|Other|1
7384961|NCT01197794|11642372|FG001|Overall Study|Other|1
7384962|NCT01197794|11642373|FG002|Overall Study|Other|3
7384963|NCT01197794|11642374|FG003|Overall Study|Other|0
7384964|NCT01197794|11642375|FG004|Overall Study|Other|2
7384965|NCT01197794|11642376|FG005|Overall Study|Other|2
7384966|NCT01197794|11642377|FG006|Overall Study|Other|4
7384967|NCT01197911|11642419|FG000|Overall Study|Adverse Event|0
7384968|NCT01197911|11642420|FG001|Overall Study|Adverse Event|0
7384969|NCT01197911|11642421|FG002|Overall Study|Adverse Event|1
7384970|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
7384971|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7384972|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
7384973|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
7384974|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
7384975|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
7384976|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
7384977|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
7384978|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
7384979|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
7384980|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7384981|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
7384982|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7384983|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
7384984|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
7384985|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
7384986|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
7384987|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
7384988|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
7418081|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
7418082|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
7418083|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
7418084|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
7418085|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
7418086|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Diseases progression|91
7418087|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Diseases progression|0
7418088|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Diseases progression|0
7418089|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Adverse Event|70
7418090|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Adverse Event|0
7418091|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Adverse Event|0
7418092|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Physician Decision|9
7418093|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Physician Decision|0
7418094|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Physician Decision|0
7418095|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
7418096|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
7418097|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
7418098|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
7418099|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7418100|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
7418101|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
7418102|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
7418103|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
7418104|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Not compliant|1
7418105|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Not compliant|0
7418106|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Not compliant|0
7418107|NCT01461928|11692441|FG000|Maintenance I (24 Months)|Did not meet criteria|5
7418108|NCT01461928|11692442|FG001|Maintenance I (24 Months)|Did not meet criteria|0
7418109|NCT01461928|11692443|FG002|Maintenance I (24 Months)|Did not meet criteria|0
7418110|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Adverse Event|0
7418111|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Adverse Event|2
7418112|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Adverse Event|0
7418113|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Death|0
7418114|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Death|10
7418115|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Death|8
7418116|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Physician Decision|0
7418117|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Physician Decision|0
7418118|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Physician Decision|4
7418119|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
7418120|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
7418121|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
7418122|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Moved to another town|0
7418123|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Moved to another town|1
7418124|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Moved to another town|0
7531482|NCT02652624|11875984|FG001|Randomized Phase|Investigator's Discretion|2
7531483|NCT02652624|11875983|FG000|Randomized Phase|Death|0
7531484|NCT02652624|11875984|FG001|Randomized Phase|Death|1
7531485|NCT02652624|11875983|FG000|Randomized Phase|Lost to Follow-up|0
7531486|NCT02652624|11875984|FG001|Randomized Phase|Lost to Follow-up|1
7531487|NCT02652624|11875983|FG000|Extension Phase|Lost to Follow-up|3
7531488|NCT02652624|11875984|FG001|Extension Phase|Lost to Follow-up|1
7418125|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Disease progression|0
7418126|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Disease progression|0
7418127|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Disease progression|3
7418128|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
7418129|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
7418130|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
7418131|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
7418132|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
7418133|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
7418134|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
7418135|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
7418136|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
7418137|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
7418138|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
7418139|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
7418140|NCT01461928|11692441|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
7418141|NCT01461928|11692442|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
7418142|NCT01461928|11692443|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
7418143|NCT01461980|11692457|FG000|Overall Study|Other|9
7418144|NCT01461980|11692458|FG001|Overall Study|Other|8
7418145|NCT01461980|11692459|FG002|Overall Study|Other|6
7418146|NCT01461980|11692457|FG000|Overall Study|Medication error|7
7531489|NCT02652624|11875983|FG000|Extension Phase|Pregnancy|1
7531490|NCT02652624|11875984|FG001|Extension Phase|Pregnancy|1
7418147|NCT01461980|11692458|FG001|Overall Study|Medication error|5
7418148|NCT01461980|11692459|FG002|Overall Study|Medication error|6
7418149|NCT01461980|11692457|FG000|Overall Study|Adverse Event|12
7418150|NCT01461980|11692458|FG001|Overall Study|Adverse Event|5
7418151|NCT01461980|11692459|FG002|Overall Study|Adverse Event|6
7418152|NCT01461980|11692457|FG000|Overall Study|Protocol Violation|12
7418153|NCT01461980|11692458|FG001|Overall Study|Protocol Violation|19
7418154|NCT01461980|11692459|FG002|Overall Study|Protocol Violation|16
7418155|NCT01461980|11692457|FG000|Overall Study|No longer meets eligibility criteria|18
7418156|NCT01461980|11692458|FG001|Overall Study|No longer meets eligibility criteria|9
7418157|NCT01461980|11692459|FG002|Overall Study|No longer meets eligibility criteria|19
7418158|NCT01461980|11692457|FG000|Overall Study|Lost to Follow-up|52
7418159|NCT01461980|11692458|FG001|Overall Study|Lost to Follow-up|53
7418160|NCT01461980|11692459|FG002|Overall Study|Lost to Follow-up|51
7418161|NCT01461980|11692457|FG000|Overall Study|No longer willing to participate|52
7418162|NCT01461980|11692458|FG001|Overall Study|No longer willing to participate|38
7418163|NCT01461980|11692459|FG002|Overall Study|No longer willing to participate|54
7418164|NCT01461980|11692457|FG000|Overall Study|Randomized but not vaccinated|4
7418165|NCT01461980|11692458|FG001|Overall Study|Randomized but not vaccinated|8
7418166|NCT01461980|11692459|FG002|Overall Study|Randomized but not vaccinated|7
7418167|NCT01461993|11692471|FG000|Overall Study|Withdrawal by Subject|60
7418168|NCT01461993|11692472|FG001|Overall Study|Withdrawal by Subject|53
7418169|NCT01461993|11692473|FG002|Overall Study|Withdrawal by Subject|16
7418170|NCT01461993|11692471|FG000|Overall Study|Lost to Follow-up|44
7418171|NCT01461993|11692472|FG001|Overall Study|Lost to Follow-up|48
7418172|NCT01461993|11692473|FG002|Overall Study|Lost to Follow-up|22
7418173|NCT01461993|11692471|FG000|Overall Study|Protocol Violation|10
7418174|NCT01461993|11692472|FG001|Overall Study|Protocol Violation|9
7418175|NCT01461993|11692473|FG002|Overall Study|Protocol Violation|7
7418176|NCT01461993|11692471|FG000|Overall Study|Adverse Event|9
7418177|NCT01461993|11692472|FG001|Overall Study|Adverse Event|11
7418178|NCT01461993|11692473|FG002|Overall Study|Adverse Event|3
7418179|NCT01461993|11692471|FG000|Overall Study|No longer met eligibility criteria|13
7418180|NCT01461993|11692472|FG001|Overall Study|No longer met eligibility criteria|18
7418181|NCT01461993|11692473|FG002|Overall Study|No longer met eligibility criteria|10
7418182|NCT01461993|11692471|FG000|Overall Study|Did not meet entrance criteria|2
7418183|NCT01461993|11692472|FG001|Overall Study|Did not meet entrance criteria|3
7418184|NCT01461993|11692473|FG002|Overall Study|Did not meet entrance criteria|0
7418185|NCT01461993|11692471|FG000|Overall Study|Other|13
7418186|NCT01461993|11692472|FG001|Overall Study|Other|15
7418187|NCT01461993|11692473|FG002|Overall Study|Other|6
7418188|NCT01462045|11692485|FG000|Overall Study|Family matter|0
7418189|NCT01462045|11692486|FG001|Overall Study|Family matter|1
7418190|NCT01462045|11692487|FG002|Overall Study|Family matter|0
7418191|NCT01462084|11692495|FG000|Overall Study|Withdrawal by Subject|1
7418192|NCT01462084|11692496|FG001|Overall Study|Withdrawal by Subject|0
7418193|NCT01462084|11692495|FG000|Overall Study|Protocol Violation|1
7418194|NCT01462084|11692496|FG001|Overall Study|Protocol Violation|1
7418195|NCT01462110|11692505|FG000|Overall Study|Adverse Event|1
7418196|NCT01462110|11692506|FG001|Overall Study|Adverse Event|0
7418197|NCT01462162|11692512|FG000|Overall Study|Adverse Event|5
7418198|NCT01462162|11692512|FG000|Overall Study|Lack of Efficacy|4
7418199|NCT01462162|11692512|FG000|Overall Study|Abnormal laboratory parameters|1
7418200|NCT01462162|11692512|FG000|Overall Study|Other|2
7418201|NCT01462227|11692519|FG000|Second Assignment|Lost to Follow-up|1
7418202|NCT01462227|11692520|FG001|Second Assignment|Lost to Follow-up|0
7418203|NCT01462227|11692521|FG002|Second Assignment|Lost to Follow-up|0
7418204|NCT01462227|11692522|FG003|Second Assignment|Lost to Follow-up|0
7418205|NCT01462227|11692519|FG000|Second Assignment|Protocol Violation|0
7418206|NCT01462227|11692520|FG001|Second Assignment|Protocol Violation|1
7418207|NCT01462227|11692521|FG002|Second Assignment|Protocol Violation|1
7418208|NCT01462227|11692522|FG003|Second Assignment|Protocol Violation|0
7418209|NCT01462266|11692536|FG000|Overall Study|Adverse Event|7
7418210|NCT01462266|11692537|FG001|Overall Study|Adverse Event|6
7418211|NCT01462266|11692536|FG000|Overall Study|Death|2
7418212|NCT01462266|11692537|FG001|Overall Study|Death|1
7418213|NCT01462266|11692536|FG000|Overall Study|Lack of Efficacy|0
7418214|NCT01462266|11692537|FG001|Overall Study|Lack of Efficacy|2
7418215|NCT01462266|11692536|FG000|Overall Study|Lost to Follow-up|4
7418216|NCT01462266|11692537|FG001|Overall Study|Lost to Follow-up|3
7418217|NCT01462266|11692536|FG000|Overall Study|Non-compliance with study drug|3
7418218|NCT01462266|11692537|FG001|Overall Study|Non-compliance with study drug|0
7418219|NCT01462266|11692536|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
7418220|NCT01462266|11692537|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
7418221|NCT01462266|11692536|FG000|Overall Study|Physician Decision|2
7418222|NCT01462266|11692537|FG001|Overall Study|Physician Decision|5
7418223|NCT01462266|11692536|FG000|Overall Study|Protocol Violation|1
7418224|NCT01462266|11692537|FG001|Overall Study|Protocol Violation|3
7418225|NCT01462266|11692536|FG000|Overall Study|Withdrawal by Subject|7
7418226|NCT01462266|11692537|FG001|Overall Study|Withdrawal by Subject|2
7418227|NCT01462266|11692536|FG000|Overall Study|Screen failure|1
7418228|NCT01462266|11692537|FG001|Overall Study|Screen failure|1
7418229|NCT01462318|11692574|FG000|Main Study / TP-DI Study|Other|2
7418230|NCT01462318|11692575|FG001|Main Study / TP-DI Study|Other|0
7418231|NCT01462318|11692576|FG002|Main Study / TP-DI Study|Other|0
7418232|NCT01462318|11692574|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
7555628|NCT03063086|11919038|FG003|Overall Study|technical problems|0
7555629|NCT03063086|11919039|FG004|Overall Study|technical problems|0
7555630|NCT03063086|11919040|FG005|Overall Study|technical problems|0
7555631|NCT03063086|11919035|FG000|Overall Study|Adverse Event|1
7555632|NCT03063086|11919036|FG001|Overall Study|Adverse Event|1
7555633|NCT03063086|11919037|FG002|Overall Study|Adverse Event|1
7555634|NCT03063086|11919038|FG003|Overall Study|Adverse Event|1
7555635|NCT03063086|11919039|FG004|Overall Study|Adverse Event|0
7555636|NCT03063086|11919040|FG005|Overall Study|Adverse Event|0
7555637|NCT03063086|11919035|FG000|Overall Study|subject/guardian decision|1
7555638|NCT03063086|11919036|FG001|Overall Study|subject/guardian decision|0
7555639|NCT03063086|11919037|FG002|Overall Study|subject/guardian decision|0
7555640|NCT03063086|11919038|FG003|Overall Study|subject/guardian decision|0
7555641|NCT03063086|11919039|FG004|Overall Study|subject/guardian decision|0
7418233|NCT01462318|11692575|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
7418234|NCT01462318|11692576|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
7555642|NCT03063086|11919040|FG005|Overall Study|subject/guardian decision|0
7555643|NCT03063086|11919035|FG000|Overall Study|Non-compliance with study treatment|0
7555644|NCT03063086|11919036|FG001|Overall Study|Non-compliance with study treatment|0
7555645|NCT03063086|11919037|FG002|Overall Study|Non-compliance with study treatment|0
7418235|NCT01462318|11692574|FG000|Main Study / TP-DI Study|Adverse Event|4
7418236|NCT01462318|11692575|FG001|Main Study / TP-DI Study|Adverse Event|0
7418237|NCT01462318|11692576|FG002|Main Study / TP-DI Study|Adverse Event|0
7418238|NCT01462318|11692574|FG000|Extension Phase|Lost to Follow-up|0
7418239|NCT01462318|11692575|FG001|Extension Phase|Lost to Follow-up|0
7418240|NCT01462318|11692576|FG002|Extension Phase|Lost to Follow-up|1
7418241|NCT01462318|11692574|FG000|Extension Phase|Other|0
7418242|NCT01462318|11692575|FG001|Extension Phase|Other|0
7418243|NCT01462318|11692576|FG002|Extension Phase|Other|1
7418244|NCT01462318|11692574|FG000|Extension Phase|Disease Progression|0
7418245|NCT01462318|11692575|FG001|Extension Phase|Disease Progression|0
7418246|NCT01462318|11692576|FG002|Extension Phase|Disease Progression|1
7418247|NCT01462318|11692574|FG000|Extension Phase|Withdrawal by Subject|0
7418248|NCT01462318|11692575|FG001|Extension Phase|Withdrawal by Subject|0
7418249|NCT01462318|11692576|FG002|Extension Phase|Withdrawal by Subject|15
7418250|NCT01462318|11692574|FG000|Extension Phase|Investigator Decision|0
7418251|NCT01462318|11692575|FG001|Extension Phase|Investigator Decision|0
7418252|NCT01462318|11692576|FG002|Extension Phase|Investigator Decision|5
7418253|NCT01462318|11692574|FG000|Extension Phase|Adverse Event|0
7418254|NCT01462318|11692575|FG001|Extension Phase|Adverse Event|0
7418255|NCT01462318|11692576|FG002|Extension Phase|Adverse Event|22
7418256|NCT01462344|11692583|FG000|Overall Study|Withdrawal by Subject|245
7418257|NCT01462344|11692584|FG001|Overall Study|Withdrawal by Subject|226
7418258|NCT01462344|11692583|FG000|Overall Study|Adverse Event|24
7418259|NCT01462344|11692584|FG001|Overall Study|Adverse Event|23
7418260|NCT01462344|11692583|FG000|Overall Study|Asthma Exacerbation|34
7418261|NCT01462344|11692584|FG001|Overall Study|Asthma Exacerbation|35
7418262|NCT01462344|11692583|FG000|Overall Study|Lack of Efficacy|5
7418263|NCT01462344|11692584|FG001|Overall Study|Lack of Efficacy|6
7418264|NCT01462344|11692583|FG000|Overall Study|Protocol Violation|68
7418265|NCT01462344|11692584|FG001|Overall Study|Protocol Violation|53
7418266|NCT01462344|11692583|FG000|Overall Study|Lost to Follow-up|7
7418267|NCT01462344|11692584|FG001|Overall Study|Lost to Follow-up|7
7418268|NCT01462357|11692593|FG000|Overall Study|Death|0
7418269|NCT01462357|11692594|FG001|Overall Study|Death|0
7418270|NCT01462357|11692595|FG002|Overall Study|Death|1
7418271|NCT01462357|11692593|FG000|Overall Study|Withdrawal by Subject|3
7418272|NCT01462357|11692594|FG001|Overall Study|Withdrawal by Subject|11
7418273|NCT01462357|11692595|FG002|Overall Study|Withdrawal by Subject|3
7418274|NCT01462357|11692593|FG000|Overall Study|Migrated/moved from study area|2
7418275|NCT01462357|11692594|FG001|Overall Study|Migrated/moved from study area|3
7418276|NCT01462357|11692595|FG002|Overall Study|Migrated/moved from study area|1
7418277|NCT01462357|11692593|FG000|Overall Study|Lost to Follow-up|3
7418278|NCT01462357|11692594|FG001|Overall Study|Lost to Follow-up|5
7418279|NCT01462357|11692595|FG002|Overall Study|Lost to Follow-up|7
7555646|NCT03063086|11919038|FG003|Overall Study|Non-compliance with study treatment|1
7555647|NCT03063086|11919039|FG004|Overall Study|Non-compliance with study treatment|0
7418280|NCT01462435|11692607|FG000|Overall Study|Lack of Efficacy|1
7418281|NCT01462435|11692608|FG001|Overall Study|Lack of Efficacy|0
7418282|NCT01462435|11692609|FG002|Overall Study|Lack of Efficacy|0
7555648|NCT03063086|11919040|FG005|Overall Study|Non-compliance with study treatment|1
7418283|NCT01462435|11692610|FG003|Overall Study|Lack of Efficacy|3
7418284|NCT01462435|11692607|FG000|Overall Study|Physician Decision|0
7418285|NCT01462435|11692608|FG001|Overall Study|Physician Decision|0
7418286|NCT01462435|11692609|FG002|Overall Study|Physician Decision|1
7418287|NCT01462435|11692610|FG003|Overall Study|Physician Decision|0
7418288|NCT01462435|11692607|FG000|Overall Study|Withdrawal by Subject|0
7418289|NCT01462435|11692608|FG001|Overall Study|Withdrawal by Subject|0
7418290|NCT01462435|11692609|FG002|Overall Study|Withdrawal by Subject|0
7418291|NCT01462435|11692610|FG003|Overall Study|Withdrawal by Subject|1
7418292|NCT01462435|11692607|FG000|Overall Study|Lost to Follow-up|0
7418293|NCT01462435|11692608|FG001|Overall Study|Lost to Follow-up|0
7418294|NCT01462435|11692609|FG002|Overall Study|Lost to Follow-up|0
7418295|NCT01462435|11692610|FG003|Overall Study|Lost to Follow-up|1
7418296|NCT01462695|11692626|FG000|Overall Study|Adverse Event|1
7418297|NCT01462695|11692627|FG001|Overall Study|Adverse Event|1
7418298|NCT01462695|11692626|FG000|Overall Study|Death|2
7418299|NCT01462695|11692627|FG001|Overall Study|Death|0
7418300|NCT01462695|11692626|FG000|Overall Study|Lack of Efficacy|6
7418301|NCT01462695|11692627|FG001|Overall Study|Lack of Efficacy|12
7418302|NCT01462695|11692626|FG000|Overall Study|Physician Decision|5
7418303|NCT01462695|11692627|FG001|Overall Study|Physician Decision|0
7418304|NCT01462695|11692626|FG000|Overall Study|Withdrawal by Subject|2
7418305|NCT01462695|11692627|FG001|Overall Study|Withdrawal by Subject|0
7418306|NCT01462695|11692626|FG000|Overall Study|Inevaluable (did not receive study drug)|1
7418307|NCT01462695|11692627|FG001|Overall Study|Inevaluable (did not receive study drug)|0
7418308|NCT01462929|11692654|FG000|Overall Study|Adverse Event|3
7418309|NCT01462929|11692655|FG001|Overall Study|Adverse Event|3
7418310|NCT01462929|11692656|FG002|Overall Study|Adverse Event|4
7418311|NCT01462929|11692654|FG000|Overall Study|Withdrawal by Subject|2
7418312|NCT01462929|11692655|FG001|Overall Study|Withdrawal by Subject|1
7418313|NCT01462929|11692656|FG002|Overall Study|Withdrawal by Subject|0
7418314|NCT01462929|11692654|FG000|Overall Study|Lack of Efficacy|0
7418315|NCT01462929|11692655|FG001|Overall Study|Lack of Efficacy|0
7418316|NCT01462929|11692656|FG002|Overall Study|Lack of Efficacy|1
7418317|NCT01462942|11692669|FG000|Overall Study|Adverse Event|7
7418318|NCT01462942|11692670|FG001|Overall Study|Adverse Event|12
7418319|NCT01462942|11692671|FG002|Overall Study|Adverse Event|10
7418320|NCT01462942|11692672|FG003|Overall Study|Adverse Event|11
7418321|NCT01462942|11692673|FG004|Overall Study|Adverse Event|11
7418322|NCT01462942|11692669|FG000|Overall Study|Other, including COPD exacerbation|3
7418323|NCT01462942|11692670|FG001|Overall Study|Other, including COPD exacerbation|5
7418324|NCT01462942|11692671|FG002|Overall Study|Other, including COPD exacerbation|2
7418325|NCT01462942|11692672|FG003|Overall Study|Other, including COPD exacerbation|8
7418326|NCT01462942|11692673|FG004|Overall Study|Other, including COPD exacerbation|5
7418327|NCT01462942|11692669|FG000|Overall Study|Withdrawal by Subject|14
7418328|NCT01462942|11692670|FG001|Overall Study|Withdrawal by Subject|10
7418329|NCT01462942|11692671|FG002|Overall Study|Withdrawal by Subject|14
7418330|NCT01462942|11692672|FG003|Overall Study|Withdrawal by Subject|16
7418331|NCT01462942|11692673|FG004|Overall Study|Withdrawal by Subject|19
7418332|NCT01462942|11692669|FG000|Overall Study|Lack of Efficacy|6
7418333|NCT01462942|11692670|FG001|Overall Study|Lack of Efficacy|0
7418334|NCT01462942|11692671|FG002|Overall Study|Lack of Efficacy|4
7418335|NCT01462942|11692672|FG003|Overall Study|Lack of Efficacy|5
7418336|NCT01462942|11692673|FG004|Overall Study|Lack of Efficacy|3
7418337|NCT01462942|11692669|FG000|Overall Study|Lost to Follow-up|0
7418338|NCT01462942|11692670|FG001|Overall Study|Lost to Follow-up|1
7418339|NCT01462942|11692671|FG002|Overall Study|Lost to Follow-up|1
7418340|NCT01462942|11692672|FG003|Overall Study|Lost to Follow-up|1
7418341|NCT01462942|11692673|FG004|Overall Study|Lost to Follow-up|1
7418342|NCT01462942|11692669|FG000|Overall Study|Protocol Violation|4
7418343|NCT01462942|11692670|FG001|Overall Study|Protocol Violation|6
7418344|NCT01462942|11692671|FG002|Overall Study|Protocol Violation|9
7418345|NCT01462942|11692672|FG003|Overall Study|Protocol Violation|9
7418346|NCT01462942|11692673|FG004|Overall Study|Protocol Violation|6
7418347|NCT01463007|11692685|FG000|Overall Study|Physician Decision|1
7418348|NCT01463033|11692692|FG000|Overall Study|Lost to Follow-up|4
7418349|NCT01463033|11692693|FG001|Overall Study|Lost to Follow-up|4
7418350|NCT01463033|11692692|FG000|Overall Study|Death|3
7418351|NCT01463033|11692693|FG001|Overall Study|Death|2
7418352|NCT01463098|11692714|FG000|Part A (11 Days)|Participant Choice|2
7418353|NCT01463098|11692715|FG001|Part A (11 Days)|Participant Choice|0
7418354|NCT01463098|11692716|FG002|Part A (11 Days)|Participant Choice|0
7418355|NCT01463098|11692717|FG003|Part A (11 Days)|Participant Choice|0
7418356|NCT01463098|11692718|FG004|Part A (11 Days)|Participant Choice|0
7418357|NCT01463098|11692719|FG005|Part A (11 Days)|Participant Choice|0
7418358|NCT01463098|11692720|FG006|Part A (11 Days)|Participant Choice|0
7418359|NCT01463098|11692721|FG007|Part A (11 Days)|Participant Choice|0
7418360|NCT01463098|11692722|FG008|Part A (11 Days)|Participant Choice|1
7418361|NCT01463098|11692723|FG009|Part A (11 Days)|Participant Choice|0
7418362|NCT01463098|11692724|FG010|Part A (11 Days)|Participant Choice|0
7418363|NCT01463098|11692725|FG011|Part A (11 Days)|Participant Choice|0
7418364|NCT01463098|11692726|FG012|Part A (11 Days)|Participant Choice|0
7418365|NCT01463098|11692727|FG013|Part A (11 Days)|Participant Choice|0
7418366|NCT01463098|11692714|FG000|Part A (11 Days)|Lost to Follow-up|0
7418367|NCT01463098|11692715|FG001|Part A (11 Days)|Lost to Follow-up|0
7418368|NCT01463098|11692716|FG002|Part A (11 Days)|Lost to Follow-up|0
7418369|NCT01463098|11692717|FG003|Part A (11 Days)|Lost to Follow-up|0
7418370|NCT01463098|11692718|FG004|Part A (11 Days)|Lost to Follow-up|1
7418371|NCT01463098|11692719|FG005|Part A (11 Days)|Lost to Follow-up|0
7418372|NCT01463098|11692720|FG006|Part A (11 Days)|Lost to Follow-up|0
7418373|NCT01463098|11692721|FG007|Part A (11 Days)|Lost to Follow-up|0
7418374|NCT01463098|11692722|FG008|Part A (11 Days)|Lost to Follow-up|0
7418375|NCT01463098|11692723|FG009|Part A (11 Days)|Lost to Follow-up|0
7418376|NCT01463098|11692724|FG010|Part A (11 Days)|Lost to Follow-up|0
7418377|NCT01463098|11692725|FG011|Part A (11 Days)|Lost to Follow-up|0
7418378|NCT01463098|11692726|FG012|Part A (11 Days)|Lost to Follow-up|0
7418379|NCT01463098|11692727|FG013|Part A (11 Days)|Lost to Follow-up|0
7418380|NCT01463098|11692714|FG000|Part B (11 Days)|Participant Choice|0
7418381|NCT01463098|11692715|FG001|Part B (11 Days)|Participant Choice|0
7418382|NCT01463098|11692716|FG002|Part B (11 Days)|Participant Choice|0
7418383|NCT01463098|11692717|FG003|Part B (11 Days)|Participant Choice|0
7418384|NCT01463098|11692718|FG004|Part B (11 Days)|Participant Choice|0
7418385|NCT01463098|11692719|FG005|Part B (11 Days)|Participant Choice|0
7418386|NCT01463098|11692720|FG006|Part B (11 Days)|Participant Choice|0
7418387|NCT01463098|11692721|FG007|Part B (11 Days)|Participant Choice|0
7418388|NCT01463098|11692722|FG008|Part B (11 Days)|Participant Choice|0
7418389|NCT01463098|11692723|FG009|Part B (11 Days)|Participant Choice|0
7418390|NCT01463098|11692724|FG010|Part B (11 Days)|Participant Choice|0
7418391|NCT01463098|11692725|FG011|Part B (11 Days)|Participant Choice|1
7418392|NCT01463098|11692726|FG012|Part B (11 Days)|Participant Choice|0
7418393|NCT01463098|11692727|FG013|Part B (11 Days)|Participant Choice|0
7418394|NCT01463111|11692776|FG000|Overall Study|Withdrawal by Subject|2
7418395|NCT01463111|11692776|FG000|Overall Study|Lost to Follow-up|5
7418396|NCT01463111|11692776|FG000|Overall Study|Physician Decision|2
7418397|NCT01463306|11692809|FG000|Overall Study|Adverse Event|6
7418398|NCT01463306|11692810|FG001|Overall Study|Adverse Event|9
7418399|NCT01463306|11692811|FG002|Overall Study|Adverse Event|3
7418400|NCT01463306|11692809|FG000|Overall Study|Death|3
7418401|NCT01463306|11692810|FG001|Overall Study|Death|3
7531491|NCT02652624|11875983|FG000|Extension Phase|Adverse Event|0
7531492|NCT02652624|11875984|FG001|Extension Phase|Adverse Event|1
7531493|NCT02652624|11875983|FG000|Extension Phase|Withdrew Consent|0
7418402|NCT01463306|11692811|FG002|Overall Study|Death|0
7418403|NCT01463306|11692809|FG000|Overall Study|Lack of Efficacy|22
7418404|NCT01463306|11692810|FG001|Overall Study|Lack of Efficacy|16
7418405|NCT01463306|11692811|FG002|Overall Study|Lack of Efficacy|1
7418406|NCT01463306|11692809|FG000|Overall Study|Lost to Follow-up|5
7418407|NCT01463306|11692810|FG001|Overall Study|Lost to Follow-up|2
7418408|NCT01463306|11692811|FG002|Overall Study|Lost to Follow-up|0
7418409|NCT01463306|11692809|FG000|Overall Study|Protocol Violation|4
7418410|NCT01463306|11692810|FG001|Overall Study|Protocol Violation|0
7418411|NCT01463306|11692811|FG002|Overall Study|Protocol Violation|0
7418412|NCT01463306|11692809|FG000|Overall Study|Withdrawal by Subject|19
7418413|NCT01463306|11692810|FG001|Overall Study|Withdrawal by Subject|9
7418414|NCT01463306|11692811|FG002|Overall Study|Withdrawal by Subject|1
7418415|NCT01463306|11692809|FG000|Overall Study|Other|26
7418416|NCT01463306|11692810|FG001|Overall Study|Other|13
7418417|NCT01463306|11692811|FG002|Overall Study|Other|0
7418418|NCT01463306|11692809|FG000|Overall Study|Approval expiry at site|1
7418419|NCT01463306|11692810|FG001|Overall Study|Approval expiry at site|0
7418420|NCT01463306|11692811|FG002|Overall Study|Approval expiry at site|0
7418421|NCT01463527|11692836|FG000|Overall Study|Protocol Violation|1
7418422|NCT01463527|11692837|FG001|Overall Study|Protocol Violation|1
7418423|NCT01463527|11692836|FG000|Overall Study|Crying >20% of sedation|5
7418424|NCT01463527|11692837|FG001|Overall Study|Crying >20% of sedation|6
7418425|NCT01463631|11692847|FG000|Overall Study|Withdrawal by Subject|0
7418426|NCT01463631|11692848|FG001|Overall Study|Withdrawal by Subject|0
7418427|NCT01463631|11692849|FG002|Overall Study|Withdrawal by Subject|0
7418428|NCT01463631|11692850|FG003|Overall Study|Withdrawal by Subject|1
7418429|NCT01463631|11692847|FG000|Overall Study|Death|0
7418430|NCT01463631|11692848|FG001|Overall Study|Death|0
7418431|NCT01463631|11692849|FG002|Overall Study|Death|1
7418432|NCT01463631|11692850|FG003|Overall Study|Death|0
7418433|NCT01463631|11692847|FG000|Overall Study|Progressive Disease|0
7418434|NCT01463631|11692848|FG001|Overall Study|Progressive Disease|0
7418435|NCT01463631|11692849|FG002|Overall Study|Progressive Disease|0
7418436|NCT01463631|11692850|FG003|Overall Study|Progressive Disease|5
7418437|NCT01463683|11692865|FG000|Overall Study|Adverse Event|2
7418438|NCT01463683|11692866|FG001|Overall Study|Adverse Event|0
7418439|NCT01463683|11692867|FG002|Overall Study|Adverse Event|0
7418440|NCT01463683|11692865|FG000|Overall Study|Lost to Follow-up|10
7418441|NCT01463683|11692866|FG001|Overall Study|Lost to Follow-up|9
7418442|NCT01463683|11692867|FG002|Overall Study|Lost to Follow-up|7
7418443|NCT01463683|11692865|FG000|Overall Study|Physician Decision|0
7418444|NCT01463683|11692866|FG001|Overall Study|Physician Decision|3
7418445|NCT01463683|11692867|FG002|Overall Study|Physician Decision|1
7418446|NCT01463683|11692865|FG000|Overall Study|Pregnancy|2
7418447|NCT01463683|11692866|FG001|Overall Study|Pregnancy|2
7418448|NCT01463683|11692867|FG002|Overall Study|Pregnancy|1
7418449|NCT01463683|11692865|FG000|Overall Study|Withdrawal by Subject|5
7418450|NCT01463683|11692866|FG001|Overall Study|Withdrawal by Subject|17
7418451|NCT01463683|11692867|FG002|Overall Study|Withdrawal by Subject|2
7418452|NCT01463696|11692883|FG000|Overall Study|Adverse Event|0
7418453|NCT01463696|11692884|FG001|Overall Study|Adverse Event|1
7418454|NCT01463696|11692885|FG002|Overall Study|Adverse Event|0
7418455|NCT01463696|11692886|FG003|Overall Study|Adverse Event|2
7418456|NCT01463696|11692887|FG004|Overall Study|Adverse Event|0
7418457|NCT01463696|11692888|FG005|Overall Study|Adverse Event|1
7418458|NCT01463696|11692889|FG006|Overall Study|Adverse Event|3
7531494|NCT02652624|11875984|FG001|Extension Phase|Withdrew Consent|1
7418459|NCT01463696|11692890|FG007|Overall Study|Adverse Event|2
7418460|NCT01463696|11692883|FG000|Overall Study|Lost to Follow-up|0
7418461|NCT01463696|11692884|FG001|Overall Study|Lost to Follow-up|0
7418462|NCT01463696|11692885|FG002|Overall Study|Lost to Follow-up|1
7418463|NCT01463696|11692886|FG003|Overall Study|Lost to Follow-up|0
7418464|NCT01463696|11692887|FG004|Overall Study|Lost to Follow-up|0
7418465|NCT01463696|11692888|FG005|Overall Study|Lost to Follow-up|0
7418466|NCT01463696|11692889|FG006|Overall Study|Lost to Follow-up|0
7418467|NCT01463696|11692890|FG007|Overall Study|Lost to Follow-up|0
7418468|NCT01463696|11692883|FG000|Overall Study|Progressive Disease|0
7418469|NCT01463696|11692884|FG001|Overall Study|Progressive Disease|1
7418470|NCT01463696|11692885|FG002|Overall Study|Progressive Disease|0
7418471|NCT01463696|11692886|FG003|Overall Study|Progressive Disease|1
7418472|NCT01463696|11692887|FG004|Overall Study|Progressive Disease|0
7418473|NCT01463696|11692888|FG005|Overall Study|Progressive Disease|1
7418474|NCT01463696|11692889|FG006|Overall Study|Progressive Disease|4
7418475|NCT01463696|11692890|FG007|Overall Study|Progressive Disease|2
7418476|NCT01463696|11692883|FG000|Overall Study|Withdrawal by Subject|0
7418477|NCT01463696|11692884|FG001|Overall Study|Withdrawal by Subject|0
7418478|NCT01463696|11692885|FG002|Overall Study|Withdrawal by Subject|0
7418479|NCT01463696|11692886|FG003|Overall Study|Withdrawal by Subject|1
7418480|NCT01463696|11692887|FG004|Overall Study|Withdrawal by Subject|1
7418481|NCT01463696|11692888|FG005|Overall Study|Withdrawal by Subject|1
7418482|NCT01463696|11692889|FG006|Overall Study|Withdrawal by Subject|2
7418483|NCT01463696|11692890|FG007|Overall Study|Withdrawal by Subject|0
7418484|NCT01463696|11692883|FG000|Overall Study|Not Treated|0
7418485|NCT01463696|11692884|FG001|Overall Study|Not Treated|0
7418486|NCT01463696|11692885|FG002|Overall Study|Not Treated|0
7418487|NCT01463696|11692886|FG003|Overall Study|Not Treated|0
7418488|NCT01463696|11692887|FG004|Overall Study|Not Treated|0
7418489|NCT01463696|11692888|FG005|Overall Study|Not Treated|0
7418490|NCT01463696|11692889|FG006|Overall Study|Not Treated|1
7418491|NCT01463696|11692890|FG007|Overall Study|Not Treated|0
7418492|NCT01463878|11692910|FG000|Overall Study|no longer met criteria for tube feed|2
7418493|NCT01463878|11692911|FG001|Overall Study|no longer met criteria for tube feed|2
7418494|NCT01463982|11692921|FG000|Overall Study|Withdrawal by Subject|0
7418495|NCT01463982|11692922|FG001|Overall Study|Withdrawal by Subject|1
7418496|NCT01463982|11692923|FG002|Overall Study|Withdrawal by Subject|1
7418497|NCT01463982|11692924|FG003|Overall Study|Withdrawal by Subject|0
7418498|NCT01463982|11692921|FG000|Overall Study|Treatment delay over 5 week|0
7418499|NCT01463982|11692922|FG001|Overall Study|Treatment delay over 5 week|0
7418500|NCT01463982|11692923|FG002|Overall Study|Treatment delay over 5 week|1
7418501|NCT01463982|11692924|FG003|Overall Study|Treatment delay over 5 week|0
7418502|NCT01464021|11692934|FG000|Overall Study|Withdrawal by Subject|13
7418503|NCT01464021|11692934|FG000|Overall Study|Lost to Follow-up|1
7418504|NCT01464021|11692934|FG000|Overall Study|Lack of Efficacy|1
7418505|NCT01464021|11692934|FG000|Overall Study|various|11
7418506|NCT01464255|11692958|FG000|Overall Study|unresolve corneal staining|0
7418507|NCT01464255|11692959|FG001|Overall Study|unresolve corneal staining|1
7418508|NCT01464307|11692968|FG000|Main Period|Death|0
7418509|NCT01464307|11692969|FG001|Main Period|Death|1
7418510|NCT01464307|11692968|FG000|Main Period|Adverse Event|6
7418511|NCT01464307|11692969|FG001|Main Period|Adverse Event|1
7418512|NCT01464307|11692968|FG000|Main Period|Lack of Efficacy|2
7418513|NCT01464307|11692969|FG001|Main Period|Lack of Efficacy|0
7418514|NCT01464307|11692968|FG000|Main Period|Withdrawal by Subject|5
7418515|NCT01464307|11692969|FG001|Main Period|Withdrawal by Subject|2
7418516|NCT01464307|11692968|FG000|Main Period|Predefined discontinuation criteria|2
7418517|NCT01464307|11692969|FG001|Main Period|Predefined discontinuation criteria|1
7418518|NCT01464307|11692968|FG000|Open-Label Extension Period|Adverse Event|15
7418519|NCT01464307|11692969|FG001|Open-Label Extension Period|Adverse Event|0
7418520|NCT01464307|11692968|FG000|Open-Label Extension Period|Withdrawal by Subject|14
7418521|NCT01464307|11692969|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7418522|NCT01464307|11692968|FG000|Open-Label Extension Period|Lack of Efficacy|5
7418523|NCT01464307|11692969|FG001|Open-Label Extension Period|Lack of Efficacy|0
7418524|NCT01464307|11692968|FG000|Open-Label Extension Period|Death|1
7418525|NCT01464307|11692969|FG001|Open-Label Extension Period|Death|0
7418526|NCT01464307|11692968|FG000|Open-Label Extension Period|Lost to Follow-up|1
7418527|NCT01464307|11692969|FG001|Open-Label Extension Period|Lost to Follow-up|0
7555649|NCT03063086|11919035|FG000|Overall Study|Physician Decision|0
7555650|NCT03063086|11919036|FG001|Overall Study|Physician Decision|0
7555651|NCT03063086|11919037|FG002|Overall Study|Physician Decision|0
7418528|NCT01464307|11692968|FG000|Open-Label Extension Period|Non-compliance|9
7418529|NCT01464307|11692969|FG001|Open-Label Extension Period|Non-compliance|0
7418530|NCT01464307|11692968|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
7418531|NCT01464307|11692969|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
7418532|NCT01464333|11692976|FG000|Overall Study|Adverse Event|34
7418533|NCT01464333|11692976|FG000|Overall Study|Lack of Efficacy|72
7418534|NCT01464333|11692976|FG000|Overall Study|Withdrawal by Subject|11
7418535|NCT01464333|11692976|FG000|Overall Study|Other|4
7418536|NCT01464333|11692976|FG000|Overall Study|No Hospital Visit|42
7418537|NCT01464346|11692980|FG000|Overall Study|Withdrawal by Subject|0
7418538|NCT01464346|11692981|FG001|Overall Study|Withdrawal by Subject|0
7555652|NCT03063086|11919038|FG003|Overall Study|Physician Decision|1
7555653|NCT03063086|11919039|FG004|Overall Study|Physician Decision|0
7418539|NCT01464346|11692982|FG002|Overall Study|Withdrawal by Subject|1
7418540|NCT01464424|11692994|FG000|Period 1, First 6 Weeks|Adverse Event|0
7418541|NCT01464424|11692995|FG001|Period 1, First 6 Weeks|Adverse Event|1
7418542|NCT01464619|11693003|FG000|Overall Study|Lost to Follow-up|3
7418543|NCT01464619|11693004|FG001|Overall Study|Lost to Follow-up|4
7418544|NCT01464788|11693035|FG000|Overall Study|Lost to Follow-up|0
7418545|NCT01464788|11693036|FG001|Overall Study|Lost to Follow-up|1
7418546|NCT01464788|11693037|FG002|Overall Study|Lost to Follow-up|0
7418547|NCT01464788|11693035|FG000|Overall Study|Patient had hemorrhage after tPA started|0
7418548|NCT01464788|11693036|FG001|Overall Study|Patient had hemorrhage after tPA started|1
7418549|NCT01464788|11693037|FG002|Overall Study|Patient had hemorrhage after tPA started|0
7418550|NCT01464827|11693061|FG000|Overall Study|Adverse Event|0
7418551|NCT01464827|11693062|FG001|Overall Study|Adverse Event|0
7418552|NCT01464827|11693063|FG002|Overall Study|Adverse Event|0
7418553|NCT01464827|11693064|FG003|Overall Study|Adverse Event|0
7418554|NCT01464827|11693065|FG004|Overall Study|Adverse Event|0
7418555|NCT01464827|11693066|FG005|Overall Study|Adverse Event|0
7418556|NCT01464827|11693067|FG006|Overall Study|Adverse Event|0
7418557|NCT01464827|11693068|FG007|Overall Study|Adverse Event|0
7418558|NCT01464827|11693069|FG008|Overall Study|Adverse Event|0
7418559|NCT01464827|11693070|FG009|Overall Study|Adverse Event|0
7418560|NCT01464827|11693071|FG010|Overall Study|Adverse Event|0
7418561|NCT01464827|11693072|FG011|Overall Study|Adverse Event|0
7418562|NCT01464827|11693073|FG012|Overall Study|Adverse Event|1
7418563|NCT01464827|11693074|FG013|Overall Study|Adverse Event|0
7418564|NCT01464827|11693061|FG000|Overall Study|Withdrawal by Subject|1
7418565|NCT01464827|11693062|FG001|Overall Study|Withdrawal by Subject|0
7418566|NCT01464827|11693063|FG002|Overall Study|Withdrawal by Subject|0
7418567|NCT01464827|11693064|FG003|Overall Study|Withdrawal by Subject|0
7418568|NCT01464827|11693065|FG004|Overall Study|Withdrawal by Subject|1
7418569|NCT01464827|11693066|FG005|Overall Study|Withdrawal by Subject|0
7418570|NCT01464827|11693067|FG006|Overall Study|Withdrawal by Subject|0
7418571|NCT01464827|11693068|FG007|Overall Study|Withdrawal by Subject|1
7418572|NCT01464827|11693069|FG008|Overall Study|Withdrawal by Subject|0
7418573|NCT01464827|11693070|FG009|Overall Study|Withdrawal by Subject|0
7418574|NCT01464827|11693071|FG010|Overall Study|Withdrawal by Subject|0
7418575|NCT01464827|11693072|FG011|Overall Study|Withdrawal by Subject|0
7418576|NCT01464827|11693073|FG012|Overall Study|Withdrawal by Subject|0
7418577|NCT01464827|11693074|FG013|Overall Study|Withdrawal by Subject|0
7418578|NCT01464827|11693061|FG000|Overall Study|Lost to Follow-up|0
7418579|NCT01464827|11693062|FG001|Overall Study|Lost to Follow-up|2
7418580|NCT01464827|11693063|FG002|Overall Study|Lost to Follow-up|0
7418581|NCT01464827|11693064|FG003|Overall Study|Lost to Follow-up|2
7418582|NCT01464827|11693065|FG004|Overall Study|Lost to Follow-up|3
7418583|NCT01464827|11693066|FG005|Overall Study|Lost to Follow-up|1
7418584|NCT01464827|11693067|FG006|Overall Study|Lost to Follow-up|2
7418585|NCT01464827|11693068|FG007|Overall Study|Lost to Follow-up|2
7418586|NCT01464827|11693069|FG008|Overall Study|Lost to Follow-up|0
7418587|NCT01464827|11693070|FG009|Overall Study|Lost to Follow-up|0
7418588|NCT01464827|11693071|FG010|Overall Study|Lost to Follow-up|0
7418589|NCT01464827|11693072|FG011|Overall Study|Lost to Follow-up|1
7418590|NCT01464827|11693073|FG012|Overall Study|Lost to Follow-up|0
7418591|NCT01464827|11693074|FG013|Overall Study|Lost to Follow-up|1
7418592|NCT01464827|11693061|FG000|Overall Study|Other|2
7418593|NCT01464827|11693062|FG001|Overall Study|Other|3
7418594|NCT01464827|11693063|FG002|Overall Study|Other|0
7418595|NCT01464827|11693064|FG003|Overall Study|Other|2
7418596|NCT01464827|11693065|FG004|Overall Study|Other|3
7418597|NCT01464827|11693066|FG005|Overall Study|Other|0
7418598|NCT01464827|11693067|FG006|Overall Study|Other|1
7418599|NCT01464827|11693068|FG007|Overall Study|Other|0
7531498|NCT02653170|11876021|FG000|Overall Study|Withdrawal by Subject|3
7531499|NCT02653170|11876022|FG001|Overall Study|Withdrawal by Subject|8
7531500|NCT02653170|11876023|FG002|Overall Study|Withdrawal by Subject|3
7531501|NCT02653170|11876021|FG000|Overall Study|withdrawn by study team|2
7531502|NCT02653170|11876022|FG001|Overall Study|withdrawn by study team|4
7531503|NCT02653170|11876023|FG002|Overall Study|withdrawn by study team|5
7418600|NCT01464827|11693069|FG008|Overall Study|Other|3
7531504|NCT02653170|11876021|FG000|Overall Study|Lost to Follow-up|12
7418601|NCT01464827|11693070|FG009|Overall Study|Other|1
7418602|NCT01464827|11693071|FG010|Overall Study|Other|2
7418603|NCT01464827|11693072|FG011|Overall Study|Other|0
7418604|NCT01464827|11693073|FG012|Overall Study|Other|1
7418605|NCT01464827|11693074|FG013|Overall Study|Other|0
7418606|NCT01464827|11693061|FG000|Overall Study|Not Treated|0
7418607|NCT01464827|11693062|FG001|Overall Study|Not Treated|2
7418608|NCT01464827|11693063|FG002|Overall Study|Not Treated|0
7418609|NCT01464827|11693064|FG003|Overall Study|Not Treated|0
7418610|NCT01464827|11693065|FG004|Overall Study|Not Treated|1
7418611|NCT01464827|11693066|FG005|Overall Study|Not Treated|0
7418612|NCT01464827|11693067|FG006|Overall Study|Not Treated|1
7418613|NCT01464827|11693068|FG007|Overall Study|Not Treated|0
7418614|NCT01464827|11693069|FG008|Overall Study|Not Treated|0
7531505|NCT02653170|11876022|FG001|Overall Study|Lost to Follow-up|4
7418615|NCT01464827|11693070|FG009|Overall Study|Not Treated|2
7418616|NCT01464827|11693071|FG010|Overall Study|Not Treated|0
7418617|NCT01464827|11693072|FG011|Overall Study|Not Treated|1
7418618|NCT01464827|11693073|FG012|Overall Study|Not Treated|0
7418619|NCT01464827|11693074|FG013|Overall Study|Not Treated|2
7418620|NCT01464879|11693128|FG000|Overall Study|Physician Decision|1
7418621|NCT01464879|11693128|FG000|Overall Study|Non-compliance|1
7418622|NCT01464931|11693140|FG000|Overall Study|Withdrawal by Subject|1
7418623|NCT01464931|11693141|FG001|Overall Study|Withdrawal by Subject|0
7466480|NCT01891864|11766310|FG001|Treatment Period 2|Lack of Efficacy|0
7466481|NCT01891864|11766311|FG002|Treatment Period 2|Lack of Efficacy|1
7466482|NCT01891864|11766312|FG003|Treatment Period 2|Lack of Efficacy|0
7466483|NCT01891864|11766313|FG004|Treatment Period 2|Lack of Efficacy|1
7466484|NCT01891864|11766314|FG005|Treatment Period 2|Lack of Efficacy|0
7466485|NCT01891864|11766309|FG000|Treatment Period 2|Adverse Event|0
7466486|NCT01891864|11766310|FG001|Treatment Period 2|Adverse Event|0
7466487|NCT01891864|11766311|FG002|Treatment Period 2|Adverse Event|1
7466488|NCT01891864|11766312|FG003|Treatment Period 2|Adverse Event|2
7466489|NCT01891864|11766313|FG004|Treatment Period 2|Adverse Event|0
7466490|NCT01891864|11766314|FG005|Treatment Period 2|Adverse Event|4
7466491|NCT01891864|11766309|FG000|Treatment Period 2|Termination of Site|0
7466492|NCT01891864|11766310|FG001|Treatment Period 2|Termination of Site|0
7466493|NCT01891864|11766311|FG002|Treatment Period 2|Termination of Site|0
7466494|NCT01891864|11766312|FG003|Treatment Period 2|Termination of Site|0
7466495|NCT01891864|11766313|FG004|Treatment Period 2|Termination of Site|2
7466496|NCT01891864|11766314|FG005|Treatment Period 2|Termination of Site|0
7466497|NCT01891864|11766309|FG000|Treatment Period 2|Withdrawal by Subject|0
7466498|NCT01891864|11766310|FG001|Treatment Period 2|Withdrawal by Subject|0
7466499|NCT01891864|11766311|FG002|Treatment Period 2|Withdrawal by Subject|3
7466500|NCT01891864|11766312|FG003|Treatment Period 2|Withdrawal by Subject|4
7466501|NCT01891864|11766313|FG004|Treatment Period 2|Withdrawal by Subject|1
7466502|NCT01891864|11766314|FG005|Treatment Period 2|Withdrawal by Subject|1
7466503|NCT01891864|11766309|FG000|Extension Period|Lack of Efficacy|0
7466504|NCT01891864|11766310|FG001|Extension Period|Lack of Efficacy|0
7466505|NCT01891864|11766311|FG002|Extension Period|Lack of Efficacy|0
7466506|NCT01891864|11766312|FG003|Extension Period|Lack of Efficacy|1
7466507|NCT01891864|11766313|FG004|Extension Period|Lack of Efficacy|1
7466508|NCT01891864|11766314|FG005|Extension Period|Lack of Efficacy|0
7466509|NCT01891864|11766309|FG000|Extension Period|Pregnancy|0
7466510|NCT01891864|11766310|FG001|Extension Period|Pregnancy|0
7466511|NCT01891864|11766311|FG002|Extension Period|Pregnancy|1
7466512|NCT01891864|11766312|FG003|Extension Period|Pregnancy|0
7466513|NCT01891864|11766313|FG004|Extension Period|Pregnancy|0
7466514|NCT01891864|11766314|FG005|Extension Period|Pregnancy|0
7466515|NCT01891864|11766309|FG000|Extension Period|Adverse Event|0
7466516|NCT01891864|11766310|FG001|Extension Period|Adverse Event|0
7466517|NCT01891864|11766311|FG002|Extension Period|Adverse Event|4
7466518|NCT01891864|11766312|FG003|Extension Period|Adverse Event|2
7466519|NCT01891864|11766313|FG004|Extension Period|Adverse Event|2
7466520|NCT01891864|11766314|FG005|Extension Period|Adverse Event|0
7466521|NCT01891864|11766309|FG000|Extension Period|Withdrawal by Subject|0
7466522|NCT01891864|11766310|FG001|Extension Period|Withdrawal by Subject|0
7466523|NCT01891864|11766311|FG002|Extension Period|Withdrawal by Subject|1
7466524|NCT01891864|11766312|FG003|Extension Period|Withdrawal by Subject|2
7466525|NCT01891864|11766313|FG004|Extension Period|Withdrawal by Subject|4
7466526|NCT01891864|11766314|FG005|Extension Period|Withdrawal by Subject|0
7466527|NCT01891864|11766309|FG000|Extension Period|Lost to Follow-up|0
7466528|NCT01891864|11766310|FG001|Extension Period|Lost to Follow-up|0
7466529|NCT01891864|11766311|FG002|Extension Period|Lost to Follow-up|2
7466530|NCT01891864|11766312|FG003|Extension Period|Lost to Follow-up|0
7466531|NCT01891864|11766313|FG004|Extension Period|Lost to Follow-up|0
7466532|NCT01891864|11766314|FG005|Extension Period|Lost to Follow-up|0
7466533|NCT01891890|11766329|FG000|Overall Study|Lost to Follow-up|0
7466534|NCT01891890|11766330|FG001|Overall Study|Lost to Follow-up|0
7466535|NCT01891890|11766331|FG002|Overall Study|Lost to Follow-up|1
7466536|NCT01891890|11766329|FG000|Overall Study|Study ended before endpoint reached|7
7466537|NCT01891890|11766330|FG001|Overall Study|Study ended before endpoint reached|3
7466538|NCT01891890|11766331|FG002|Overall Study|Study ended before endpoint reached|6
7466539|NCT01892020|11766352|FG000|Period 1|Adverse Event|1
7466540|NCT01892020|11766353|FG001|Period 1|Adverse Event|1
7555654|NCT03063086|11919040|FG005|Overall Study|Physician Decision|0
7555655|NCT03064438|11919104|FG000|Overall Study|Lost to Follow-up|1
7466541|NCT01892020|11766352|FG000|Period 1|Protocol Violation|2
7466542|NCT01892020|11766353|FG001|Period 1|Protocol Violation|4
7466543|NCT01892020|11766352|FG000|Period 1|Unclassified|0
7466544|NCT01892020|11766353|FG001|Period 1|Unclassified|1
7466545|NCT01892020|11766352|FG000|Period 2|Protocol Violation|1
7466546|NCT01892020|11766353|FG001|Period 2|Protocol Violation|0
7466547|NCT01892163|11766361|FG000|Overall Study|Death|1
7466548|NCT01892163|11766362|FG001|Overall Study|Death|1
7466549|NCT01892163|11766361|FG000|Overall Study|Lost to Follow-up|1
7555656|NCT03064438|11919105|FG001|Overall Study|Lost to Follow-up|0
7466550|NCT01892163|11766362|FG001|Overall Study|Lost to Follow-up|0
7466551|NCT01892189|11766377|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7466552|NCT01892189|11766378|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7466553|NCT01892189|11766379|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7418624|NCT01465022|11693163|FG000|Overall Study|Lost to Follow-up|15
7418625|NCT01465022|11693164|FG001|Overall Study|Lost to Follow-up|14
7418626|NCT01465022|11693165|FG002|Overall Study|Lost to Follow-up|0
7418627|NCT01465022|11693163|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
7418628|NCT01465022|11693164|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
7418629|NCT01465022|11693165|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
7418630|NCT01465022|11693163|FG000|Overall Study|Not Randomized|0
7418631|NCT01465022|11693164|FG001|Overall Study|Not Randomized|0
7418632|NCT01465022|11693165|FG002|Overall Study|Not Randomized|70
7418633|NCT01465178|11693186|FG000|Overall Study|Withdrawal by Subject|1
7418634|NCT01465178|11693187|FG001|Overall Study|Withdrawal by Subject|0
7418635|NCT01465191|11693196|FG000|Overall Study|Protocol Violation|6
7418636|NCT01465191|11693197|FG001|Overall Study|Protocol Violation|3
7418637|NCT01465191|11693198|FG002|Overall Study|Protocol Violation|3
7418638|NCT01465191|11693196|FG000|Overall Study|Lost to Follow-up|3
7418639|NCT01465191|11693197|FG001|Overall Study|Lost to Follow-up|6
7418640|NCT01465191|11693198|FG002|Overall Study|Lost to Follow-up|4
7418641|NCT01465347|11693209|FG000|Overall Study|Withdrawal by Subject|1
7418642|NCT01465347|11693210|FG001|Overall Study|Withdrawal by Subject|1
7418643|NCT01465347|11693209|FG000|Overall Study|Physician Decision|0
7418644|NCT01465347|11693210|FG001|Overall Study|Physician Decision|1
7418645|NCT01465347|11693209|FG000|Overall Study|Admitted to hospice|0
7418646|NCT01465347|11693210|FG001|Overall Study|Admitted to hospice|1
7418647|NCT01465386|11693219|FG000|Overall Study|Lack of Efficacy|3
7418648|NCT01465386|11693219|FG000|Overall Study|Adverse Event|1
7418649|NCT01465464|11693242|FG000|Overall Study|Adverse Event|96
7418650|NCT01465464|11693243|FG001|Overall Study|Adverse Event|49
7418651|NCT01465464|11693242|FG000|Overall Study|Lack of Efficacy|139
7418652|NCT01465464|11693243|FG001|Overall Study|Lack of Efficacy|190
7418653|NCT01465464|11693242|FG000|Overall Study|Physician Decision|13
7418654|NCT01465464|11693243|FG001|Overall Study|Physician Decision|5
7418655|NCT01465464|11693242|FG000|Overall Study|Protocol Violation|1
7418656|NCT01465464|11693243|FG001|Overall Study|Protocol Violation|1
7418657|NCT01465464|11693242|FG000|Overall Study|Withdrawal by Subject|46
7418658|NCT01465464|11693243|FG001|Overall Study|Withdrawal by Subject|30
7418659|NCT01465464|11693242|FG000|Overall Study|Other|9
7418660|NCT01465464|11693243|FG001|Overall Study|Other|3
7418661|NCT01465464|11693242|FG000|Overall Study|Ongoing treatment at cutoff date|140
7418662|NCT01465464|11693243|FG001|Overall Study|Ongoing treatment at cutoff date|166
7418663|NCT01465659|11693253|FG000|Completed 1 Cycle of Treatment|Death|0
7418664|NCT01465659|11693254|FG001|Completed 1 Cycle of Treatment|Death|1
7418665|NCT01465659|11693255|FG002|Completed 1 Cycle of Treatment|Death|0
7418666|NCT01465659|11693256|FG003|Completed 1 Cycle of Treatment|Death|0
7418667|NCT01465659|11693253|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
7418668|NCT01465659|11693254|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
7418669|NCT01465659|11693255|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
7418670|NCT01465659|11693256|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
7418671|NCT01465659|11693253|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7418672|NCT01465659|11693254|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
7418673|NCT01465659|11693255|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7418674|NCT01465659|11693256|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
7418675|NCT01465659|11693253|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7418676|NCT01465659|11693254|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7418677|NCT01465659|11693255|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
7418678|NCT01465659|11693256|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
7418679|NCT01465659|11693253|FG000|Completed Follow for 1 Year|Death|6
7418680|NCT01465659|11693254|FG001|Completed Follow for 1 Year|Death|3
7418681|NCT01465659|11693255|FG002|Completed Follow for 1 Year|Death|2
7418682|NCT01465659|11693256|FG003|Completed Follow for 1 Year|Death|4
7418683|NCT01465763|11693272|FG000|Overall Study|Withdrawal by Subject|4
7418684|NCT01465763|11693273|FG001|Overall Study|Withdrawal by Subject|0
7418685|NCT01465763|11693274|FG002|Overall Study|Withdrawal by Subject|1
7418686|NCT01465763|11693272|FG000|Overall Study|Insufficient Clinical Response|11
7418687|NCT01465763|11693273|FG001|Overall Study|Insufficient Clinical Response|0
7418688|NCT01465763|11693274|FG002|Overall Study|Insufficient Clinical Response|1
7418689|NCT01465763|11693272|FG000|Overall Study|Adverse Event|9
7418690|NCT01465763|11693273|FG001|Overall Study|Adverse Event|0
7418691|NCT01465763|11693274|FG002|Overall Study|Adverse Event|1
7418692|NCT01465763|11693272|FG000|Overall Study|Other|2
7418693|NCT01465763|11693273|FG001|Overall Study|Other|0
7418694|NCT01465763|11693274|FG002|Overall Study|Other|0
7418695|NCT01465763|11693272|FG000|Overall Study|Protocol Violation|4
7418696|NCT01465763|11693273|FG001|Overall Study|Protocol Violation|1
7418697|NCT01465763|11693274|FG002|Overall Study|Protocol Violation|1
7418698|NCT01465763|11693272|FG000|Overall Study|Death|1
7418699|NCT01465763|11693273|FG001|Overall Study|Death|0
7418700|NCT01465763|11693274|FG002|Overall Study|Death|0
7418701|NCT01465802|11693286|FG000|Overall Study|Study terminated by sponsor|1
7418702|NCT01465802|11693287|FG001|Overall Study|Study terminated by sponsor|0
7418703|NCT01465802|11693288|FG002|Overall Study|Study terminated by sponsor|0
7418704|NCT01465802|11693289|FG003|Overall Study|Study terminated by sponsor|1
7418705|NCT01465802|11693290|FG004|Overall Study|Study terminated by sponsor|7
7418706|NCT01465802|11693286|FG000|Overall Study|Withdrawal by Subject|7
7418707|NCT01465802|11693287|FG001|Overall Study|Withdrawal by Subject|7
7418708|NCT01465802|11693288|FG002|Overall Study|Withdrawal by Subject|0
7418709|NCT01465802|11693289|FG003|Overall Study|Withdrawal by Subject|8
7418710|NCT01465802|11693290|FG004|Overall Study|Withdrawal by Subject|1
7418711|NCT01465802|11693286|FG000|Overall Study|Lost to Follow-up|1
7418712|NCT01465802|11693287|FG001|Overall Study|Lost to Follow-up|1
7418713|NCT01465802|11693288|FG002|Overall Study|Lost to Follow-up|0
7418714|NCT01465802|11693289|FG003|Overall Study|Lost to Follow-up|0
7418715|NCT01465802|11693290|FG004|Overall Study|Lost to Follow-up|0
7418716|NCT01465802|11693286|FG000|Overall Study|Reason not specified|9
7555657|NCT03064438|11919104|FG000|Overall Study|Withdrawal by Subject|0
7555658|NCT03064438|11919105|FG001|Overall Study|Withdrawal by Subject|1
7555659|NCT03064451|11919111|FG000|Overall Study|Lost to Follow-up|1
7555660|NCT03064451|11919111|FG000|Overall Study|Mapping Failure|4
7555661|NCT03064451|11919111|FG000|Overall Study|Exited prior to procedure|8
7555662|NCT03064451|11919111|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
7555663|NCT03064841|11919115|FG000|Overall Study|Inclusion/exclusion criteria violation|4
7555664|NCT03064841|11919115|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
7555665|NCT03064841|11919115|FG000|Overall Study|Screen failure|2
7555666|NCT03065023|11919123|FG000|Overall Study|Progressive Disease|0
7555667|NCT03065023|11919124|FG001|Overall Study|Progressive Disease|1
7555668|NCT03065023|11919125|FG002|Overall Study|Progressive Disease|0
7555669|NCT03065023|11919126|FG003|Overall Study|Progressive Disease|0
7555670|NCT03065023|11919127|FG004|Overall Study|Progressive Disease|0
7555671|NCT03065023|11919123|FG000|Overall Study|Death|2
7555672|NCT03065023|11919124|FG001|Overall Study|Death|0
7555673|NCT03065023|11919125|FG002|Overall Study|Death|1
7555674|NCT03065023|11919126|FG003|Overall Study|Death|1
7555675|NCT03065023|11919127|FG004|Overall Study|Death|0
7555676|NCT03065023|11919123|FG000|Overall Study|Lost to Follow-up|0
7555677|NCT03065023|11919124|FG001|Overall Study|Lost to Follow-up|1
7555678|NCT03065023|11919125|FG002|Overall Study|Lost to Follow-up|0
7555679|NCT03065023|11919126|FG003|Overall Study|Lost to Follow-up|0
7555680|NCT03065023|11919127|FG004|Overall Study|Lost to Follow-up|0
7555681|NCT03065023|11919123|FG000|Overall Study|Participant Decision|0
7555682|NCT03065023|11919124|FG001|Overall Study|Participant Decision|0
7555683|NCT03065023|11919125|FG002|Overall Study|Participant Decision|0
7555684|NCT03065023|11919126|FG003|Overall Study|Participant Decision|1
7555685|NCT03065023|11919127|FG004|Overall Study|Participant Decision|0
7555686|NCT03065023|11919123|FG000|Overall Study|Withdrawal by Subject|0
7555687|NCT03065023|11919124|FG001|Overall Study|Withdrawal by Subject|0
7555688|NCT03065023|11919125|FG002|Overall Study|Withdrawal by Subject|0
7555689|NCT03065023|11919126|FG003|Overall Study|Withdrawal by Subject|1
7555690|NCT03065023|11919127|FG004|Overall Study|Withdrawal by Subject|0
7555691|NCT03065400|11919164|FG000|Overall Study|Adverse Event|1
7555692|NCT03065400|11919164|FG000|Overall Study|Physician Decision|3
7555693|NCT03065400|11919164|FG000|Overall Study|Withdrawal by Subject|1
7555694|NCT03065400|11919164|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
7555695|NCT03065530|11919172|FG000|Overall Study|Lack of Efficacy|1
7555696|NCT03065530|11919173|FG001|Overall Study|Lack of Efficacy|1
7555697|NCT03065530|11919174|FG002|Overall Study|Lack of Efficacy|0
7555698|NCT03065530|11919175|FG003|Overall Study|Lack of Efficacy|1
7555699|NCT03065530|11919172|FG000|Overall Study|Protocol Violation|1
7555700|NCT03065530|11919173|FG001|Overall Study|Protocol Violation|0
7555701|NCT03065530|11919174|FG002|Overall Study|Protocol Violation|1
7555702|NCT03065530|11919175|FG003|Overall Study|Protocol Violation|1
7555703|NCT03066193|11919206|FG000|Overall Study|Withdrawal by Subject|1
7555704|NCT03066609|11919213|FG000|INDUCTION|Pregnancy|0
7555705|NCT03066609|11919214|FG001|INDUCTION|Pregnancy|0
7555706|NCT03066609|11919215|FG002|INDUCTION|Pregnancy|1
7555707|NCT03066609|11919216|FG003|INDUCTION|Pregnancy|0
7555708|NCT03066609|11919213|FG000|INDUCTION|Lack of Efficacy|0
7555709|NCT03066609|11919214|FG001|INDUCTION|Lack of Efficacy|0
7555710|NCT03066609|11919215|FG002|INDUCTION|Lack of Efficacy|1
7555711|NCT03066609|11919216|FG003|INDUCTION|Lack of Efficacy|0
7555712|NCT03066609|11919213|FG000|INDUCTION|Adverse Event|2
7555713|NCT03066609|11919214|FG001|INDUCTION|Adverse Event|2
7555714|NCT03066609|11919215|FG002|INDUCTION|Adverse Event|0
7555715|NCT03066609|11919216|FG003|INDUCTION|Adverse Event|0
7555716|NCT03066609|11919213|FG000|MAINTENANCE|Adverse Event|0
7555717|NCT03066609|11919214|FG001|MAINTENANCE|Adverse Event|0
7555718|NCT03066609|11919215|FG002|MAINTENANCE|Adverse Event|0
7555719|NCT03066609|11919216|FG003|MAINTENANCE|Adverse Event|1
7555720|NCT03066609|11919213|FG000|MAINTENANCE|Withdrawal by Subject|4
7555721|NCT03066609|11919214|FG001|MAINTENANCE|Withdrawal by Subject|2
7555722|NCT03066609|11919215|FG002|MAINTENANCE|Withdrawal by Subject|1
7555723|NCT03066609|11919216|FG003|MAINTENANCE|Withdrawal by Subject|1
7555724|NCT03066609|11919213|FG000|MAINTENANCE|Lost to Follow-up|0
7555725|NCT03066609|11919214|FG001|MAINTENANCE|Lost to Follow-up|1
7555726|NCT03066609|11919215|FG002|MAINTENANCE|Lost to Follow-up|1
7418717|NCT01465802|11693287|FG001|Overall Study|Reason not specified|4
7418718|NCT01465802|11693288|FG002|Overall Study|Reason not specified|0
7418719|NCT01465802|11693289|FG003|Overall Study|Reason not specified|10
7555727|NCT03066609|11919216|FG003|MAINTENANCE|Lost to Follow-up|0
7555728|NCT03066609|11919213|FG000|MAINTENANCE|Pregnancy|1
7555729|NCT03066609|11919214|FG001|MAINTENANCE|Pregnancy|0
7555730|NCT03066609|11919215|FG002|MAINTENANCE|Pregnancy|0
7555731|NCT03066609|11919216|FG003|MAINTENANCE|Pregnancy|0
7555732|NCT03066609|11919213|FG000|MAINTENANCE|Lack of Efficacy|2
7555733|NCT03066609|11919214|FG001|MAINTENANCE|Lack of Efficacy|1
7555734|NCT03066609|11919215|FG002|MAINTENANCE|Lack of Efficacy|0
7555735|NCT03066609|11919216|FG003|MAINTENANCE|Lack of Efficacy|1
7418720|NCT01465802|11693290|FG004|Overall Study|Reason not specified|2
7418721|NCT01465802|11693286|FG000|Overall Study|Death|15
7418722|NCT01465802|11693287|FG001|Overall Study|Death|12
7418723|NCT01465802|11693288|FG002|Overall Study|Death|0
7418724|NCT01465802|11693289|FG003|Overall Study|Death|10
7418725|NCT01465802|11693290|FG004|Overall Study|Death|2
7418726|NCT01465958|11693308|FG000|Run-in Phase|Protocol Violation|1
7418727|NCT01465958|11693309|FG001|Run-in Phase|Protocol Violation|0
7418728|NCT01465958|11693308|FG000|Subcutaneous (SC) Phase|Adverse Event|0
7418729|NCT01465958|11693309|FG001|Subcutaneous (SC) Phase|Adverse Event|1
7418730|NCT01465997|11693318|FG000|Overall Study|Adverse Event|12
7418731|NCT01465997|11693319|FG001|Overall Study|Adverse Event|22
7418732|NCT01465997|11693318|FG000|Overall Study|Lack of Efficacy|13
7418733|NCT01465997|11693319|FG001|Overall Study|Lack of Efficacy|1
7418734|NCT01465997|11693318|FG000|Overall Study|Protocol Violation|1
7418735|NCT01465997|11693319|FG001|Overall Study|Protocol Violation|4
7418736|NCT01465997|11693318|FG000|Overall Study|Lost to Follow-up|6
7418737|NCT01465997|11693319|FG001|Overall Study|Lost to Follow-up|9
7418738|NCT01465997|11693318|FG000|Overall Study|Withdrawal by Subject|32
7418739|NCT01465997|11693319|FG001|Overall Study|Withdrawal by Subject|35
7418740|NCT01465997|11693318|FG000|Overall Study|investigator's decision|1
7418741|NCT01465997|11693319|FG001|Overall Study|investigator's decision|1
7418742|NCT01465997|11693318|FG000|Overall Study|Death|0
7418743|NCT01465997|11693319|FG001|Overall Study|Death|1
7418744|NCT01465997|11693318|FG000|Overall Study|sponsor's decision|1
7418745|NCT01465997|11693319|FG001|Overall Study|sponsor's decision|1
7418746|NCT01465997|11693318|FG000|Overall Study|subject withdrew consent|1
7418747|NCT01465997|11693319|FG001|Overall Study|subject withdrew consent|0
7418748|NCT01465997|11693318|FG000|Overall Study|local lab unblinded site|1
7418749|NCT01465997|11693319|FG001|Overall Study|local lab unblinded site|0
7418750|NCT01465997|11693318|FG000|Overall Study|withdrew before follow-up|0
7418751|NCT01465997|11693319|FG001|Overall Study|withdrew before follow-up|13
7418752|NCT01465997|11693318|FG000|Overall Study|decision by site staff|0
7418753|NCT01465997|11693319|FG001|Overall Study|decision by site staff|1
7418754|NCT01465997|11693318|FG000|Overall Study|subject left participation SP0993|0
7418755|NCT01465997|11693319|FG001|Overall Study|subject left participation SP0993|1
7418756|NCT01466062|11693327|FG000|Overall Study|Adverse Event|1
7418757|NCT01466062|11693327|FG000|Overall Study|Withdrawal by Subject|1
7555736|NCT03066609|11919213|FG000|OVERALL STUDY|Adverse Event|2
7555737|NCT03066609|11919214|FG001|OVERALL STUDY|Adverse Event|2
7555738|NCT03066609|11919215|FG002|OVERALL STUDY|Adverse Event|0
7555739|NCT03066609|11919216|FG003|OVERALL STUDY|Adverse Event|1
7555740|NCT03066609|11919213|FG000|OVERALL STUDY|Withdrawal by Subject|4
7555741|NCT03066609|11919214|FG001|OVERALL STUDY|Withdrawal by Subject|2
7555742|NCT03066609|11919215|FG002|OVERALL STUDY|Withdrawal by Subject|1
7555743|NCT03066609|11919216|FG003|OVERALL STUDY|Withdrawal by Subject|2
7555744|NCT03066609|11919213|FG000|OVERALL STUDY|Lost to Follow-up|1
7555745|NCT03066609|11919214|FG001|OVERALL STUDY|Lost to Follow-up|1
7555746|NCT03066609|11919215|FG002|OVERALL STUDY|Lost to Follow-up|1
7555747|NCT03066609|11919216|FG003|OVERALL STUDY|Lost to Follow-up|1
7555748|NCT03066609|11919213|FG000|OVERALL STUDY|Pregnancy|1
7555749|NCT03066609|11919214|FG001|OVERALL STUDY|Pregnancy|0
7555750|NCT03066609|11919215|FG002|OVERALL STUDY|Pregnancy|1
7555751|NCT03066609|11919216|FG003|OVERALL STUDY|Pregnancy|0
7555752|NCT03066609|11919213|FG000|OVERALL STUDY|Lack of Efficacy|2
7555753|NCT03066609|11919214|FG001|OVERALL STUDY|Lack of Efficacy|1
7555754|NCT03066609|11919215|FG002|OVERALL STUDY|Lack of Efficacy|1
7555755|NCT03066609|11919216|FG003|OVERALL STUDY|Lack of Efficacy|1
7555756|NCT03066609|11919213|FG000|OVERALL STUDY|discontinued follow up|0
7555757|NCT03066609|11919214|FG001|OVERALL STUDY|discontinued follow up|2
7555758|NCT03066609|11919215|FG002|OVERALL STUDY|discontinued follow up|0
7555759|NCT03066609|11919216|FG003|OVERALL STUDY|discontinued follow up|0
7555760|NCT03066778|11919229|FG000|Overall Study|Death|167
7555761|NCT03066778|11919230|FG001|Overall Study|Death|183
7555762|NCT03066778|11919229|FG000|Overall Study|Withdrawal by Subject|4
7555763|NCT03066778|11919230|FG001|Overall Study|Withdrawal by Subject|5
7555764|NCT03066778|11919229|FG000|Overall Study|Ongoing in Study|57
7418758|NCT01466153|11693347|FG000|Overall Study|Disease Progression|2
7418759|NCT01466153|11693348|FG001|Overall Study|Disease Progression|2
7418760|NCT01466153|11693349|FG002|Overall Study|Disease Progression|0
7418761|NCT01466153|11693347|FG000|Overall Study|Adverse Event|14
7418762|NCT01466153|11693348|FG001|Overall Study|Adverse Event|13
7418763|NCT01466153|11693349|FG002|Overall Study|Adverse Event|17
7418764|NCT01466153|11693347|FG000|Overall Study|Withdrawal of Consent|2
7418765|NCT01466153|11693348|FG001|Overall Study|Withdrawal of Consent|0
7418766|NCT01466153|11693349|FG002|Overall Study|Withdrawal of Consent|0
7555765|NCT03066778|11919230|FG001|Overall Study|Ongoing in Study|37
7418767|NCT01466153|11693347|FG000|Overall Study|Investigator Discretion|3
7555766|NCT03066804|11919238|FG000|Overall Study|Physician Decision|0
7555767|NCT03066804|11919239|FG001|Overall Study|Physician Decision|4
7418768|NCT01466153|11693348|FG001|Overall Study|Investigator Discretion|2
7418769|NCT01466153|11693349|FG002|Overall Study|Investigator Discretion|2
7418770|NCT01466153|11693347|FG000|Overall Study|Randomized-Not Treated|2
7418771|NCT01466153|11693348|FG001|Overall Study|Randomized-Not Treated|3
7418772|NCT01466153|11693349|FG002|Overall Study|Randomized-Not Treated|4
7418773|NCT01466153|11693347|FG000|Overall Study|Other-Unspecified|6
7418774|NCT01466153|11693348|FG001|Overall Study|Other-Unspecified|4
7418775|NCT01466153|11693349|FG002|Overall Study|Other-Unspecified|2
7418776|NCT01466166|11693359|FG000|Overall Study|Death|1
7418777|NCT01466166|11693359|FG000|Overall Study|Lost to Follow-up|7
7418778|NCT01466166|11693359|FG000|Overall Study|Infusion Reaction (IR)|27
7418779|NCT01466166|11693359|FG000|Overall Study|Adverse Event (Other than IR)|11
7418780|NCT01466166|11693359|FG000|Overall Study|Elevated Serum Uric Acid|78
7418781|NCT01466166|11693359|FG000|Overall Study|Withdrawal by Subject|13
7418782|NCT01466166|11693359|FG000|Overall Study|Sponsor Decision|4
7418783|NCT01466166|11693359|FG000|Overall Study|Protocol Violation/Noncompliance|2
7418784|NCT01466166|11693359|FG000|Overall Study|Other|20
7418785|NCT01466179|11693363|FG000|Overall Study|Ongoing in core study|2
7418786|NCT01466179|11693363|FG000|Overall Study|Physician Decision|46
7418787|NCT01466179|11693363|FG000|Overall Study|Progressive disease|43
7418788|NCT01466179|11693363|FG000|Overall Study|Adverse Event|32
7418789|NCT01466179|11693363|FG000|Overall Study|Disease relapse|23
7418790|NCT01466179|11693363|FG000|Overall Study|Lack of Efficacy|14
7418791|NCT01466179|11693363|FG000|Overall Study|Death|7
7418792|NCT01466179|11693363|FG000|Overall Study|Withdrawal by Subject|7
7418793|NCT01466179|11693363|FG000|Overall Study|Protocol Violation|2
7418794|NCT01466179|11693363|FG000|Overall Study|Other|3
7418795|NCT01466192|11693370|FG000|Overall Study|Physician Decision|1
7418796|NCT01466192|11693370|FG000|Overall Study|Withdrawal by Subject|3
7418797|NCT01466270|11693376|FG000|Overall Study|Withdrawal by Subject|4
7418798|NCT01466270|11693377|FG001|Overall Study|Withdrawal by Subject|1
7418799|NCT01466270|11693376|FG000|Overall Study|Physician Decision|1
7418800|NCT01466270|11693377|FG001|Overall Study|Physician Decision|0
7418801|NCT01466270|11693376|FG000|Overall Study|Lost to Follow-up|1
7418802|NCT01466270|11693377|FG001|Overall Study|Lost to Follow-up|3
7418803|NCT01466270|11693376|FG000|Overall Study|Progression|1
7418804|NCT01466270|11693377|FG001|Overall Study|Progression|0
7418805|NCT01466270|11693376|FG000|Overall Study|Toxicity|4
7418806|NCT01466270|11693377|FG001|Overall Study|Toxicity|1
7418807|NCT01466270|11693376|FG000|Overall Study|Multiple|1
7418808|NCT01466270|11693377|FG001|Overall Study|Multiple|1
7418809|NCT01466348|11693385|FG000|Period I - First Intervention|Withdrawal by Subject|0
7418810|NCT01466348|11693386|FG001|Period I - First Intervention|Withdrawal by Subject|1
7418811|NCT01466387|11693422|FG000|Overall Study|Adverse Event|0
7418812|NCT01466387|11693423|FG001|Overall Study|Adverse Event|0
7418813|NCT01466387|11693424|FG002|Overall Study|Adverse Event|1
7418814|NCT01466387|11693425|FG003|Overall Study|Adverse Event|1
7418815|NCT01466387|11693426|FG004|Overall Study|Adverse Event|0
7418816|NCT01466387|11693427|FG005|Overall Study|Adverse Event|0
7418817|NCT01466387|11693422|FG000|Overall Study|Lost to Follow-up|0
7418818|NCT01466387|11693423|FG001|Overall Study|Lost to Follow-up|0
7418819|NCT01466387|11693424|FG002|Overall Study|Lost to Follow-up|0
7418820|NCT01466387|11693425|FG003|Overall Study|Lost to Follow-up|0
7418821|NCT01466387|11693426|FG004|Overall Study|Lost to Follow-up|0
7418822|NCT01466387|11693427|FG005|Overall Study|Lost to Follow-up|1
7418823|NCT01466387|11693422|FG000|Overall Study|Protocol Violation|1
7418824|NCT01466387|11693423|FG001|Overall Study|Protocol Violation|0
7418825|NCT01466387|11693424|FG002|Overall Study|Protocol Violation|0
7418826|NCT01466387|11693425|FG003|Overall Study|Protocol Violation|1
7418827|NCT01466387|11693426|FG004|Overall Study|Protocol Violation|0
7418828|NCT01466387|11693427|FG005|Overall Study|Protocol Violation|0
7418829|NCT01466491|11693454|FG000|Overall Study|Protocol Violation|0
7418830|NCT01466491|11693455|FG001|Overall Study|Protocol Violation|3
7418831|NCT01466491|11693456|FG002|Overall Study|Protocol Violation|2
7418832|NCT01466491|11693457|FG003|Overall Study|Protocol Violation|0
7418833|NCT01466491|11693454|FG000|Overall Study|Missing Data|0
7418834|NCT01466491|11693455|FG001|Overall Study|Missing Data|0
7418835|NCT01466491|11693456|FG002|Overall Study|Missing Data|1
7418836|NCT01466491|11693457|FG003|Overall Study|Missing Data|0
7418837|NCT01466595|11693469|FG000|Overall Study|Withdrawal by Subject|0
7418838|NCT01466595|11693470|FG001|Overall Study|Withdrawal by Subject|1
7418839|NCT01466660|11693478|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
7418840|NCT01466660|11693479|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
7418841|NCT01466660|11693478|FG000|Overall Study|Worsening of underlying cancer disease|5
7418842|NCT01466660|11693479|FG001|Overall Study|Worsening of underlying cancer disease|2
7418843|NCT01466660|11693478|FG000|Overall Study|Other adverse event|19
7418844|NCT01466660|11693479|FG001|Overall Study|Other adverse event|18
7418845|NCT01466660|11693478|FG000|Overall Study|Protocol Violation|2
7418846|NCT01466660|11693479|FG001|Overall Study|Protocol Violation|1
7418847|NCT01466660|11693478|FG000|Overall Study|Refused continuation of trial medication|4
7418932|NCT01467479|11693631|FG002|Overall Study|Study Terminated by Sponsor|3
7418848|NCT01466660|11693479|FG001|Overall Study|Refused continuation of trial medication|3
7418849|NCT01466660|11693478|FG000|Overall Study|Other reason not defined above|10
7418850|NCT01466660|11693479|FG001|Overall Study|Other reason not defined above|8
7418851|NCT01466673|11693487|FG000|Overall Study|Non-compliance with study treatment|2
7418852|NCT01466673|11693488|FG001|Overall Study|Non-compliance with study treatment|0
7418853|NCT01466673|11693487|FG000|Overall Study|Lost to Follow-up|3
7418854|NCT01466673|11693488|FG001|Overall Study|Lost to Follow-up|5
7418855|NCT01466673|11693487|FG000|Overall Study|Adverse Event|2
7418856|NCT01466673|11693488|FG001|Overall Study|Adverse Event|1
7418857|NCT01466790|11693522|FG000|Overall Study|Adverse Event|1
7418858|NCT01466790|11693523|FG001|Overall Study|Adverse Event|0
7418859|NCT01466790|11693524|FG002|Overall Study|Adverse Event|0
7418860|NCT01466790|11693525|FG003|Overall Study|Adverse Event|0
7418861|NCT01466790|11693526|FG004|Overall Study|Adverse Event|2
7418862|NCT01466790|11693527|FG005|Overall Study|Adverse Event|0
7418863|NCT01466790|11693528|FG006|Overall Study|Adverse Event|0
7418864|NCT01466790|11693529|FG007|Overall Study|Adverse Event|0
7418865|NCT01466790|11693522|FG000|Overall Study|Lost to Follow-up|2
7418866|NCT01466790|11693523|FG001|Overall Study|Lost to Follow-up|0
7418867|NCT01466790|11693524|FG002|Overall Study|Lost to Follow-up|0
7418868|NCT01466790|11693525|FG003|Overall Study|Lost to Follow-up|0
7418869|NCT01466790|11693526|FG004|Overall Study|Lost to Follow-up|0
7418870|NCT01466790|11693527|FG005|Overall Study|Lost to Follow-up|0
7418871|NCT01466790|11693528|FG006|Overall Study|Lost to Follow-up|0
7418872|NCT01466790|11693529|FG007|Overall Study|Lost to Follow-up|0
7418873|NCT01466790|11693522|FG000|Overall Study|Withdrawal by Subject|1
7418874|NCT01466790|11693523|FG001|Overall Study|Withdrawal by Subject|1
7418875|NCT01466790|11693524|FG002|Overall Study|Withdrawal by Subject|0
7418876|NCT01466790|11693525|FG003|Overall Study|Withdrawal by Subject|0
7418877|NCT01466790|11693526|FG004|Overall Study|Withdrawal by Subject|1
7418878|NCT01466790|11693527|FG005|Overall Study|Withdrawal by Subject|0
7418879|NCT01466790|11693528|FG006|Overall Study|Withdrawal by Subject|1
7418880|NCT01466790|11693529|FG007|Overall Study|Withdrawal by Subject|1
7418881|NCT01466881|11693543|FG000|Overall Study|Ineligible|5
7418882|NCT01466881|11693543|FG000|Overall Study|Adverse Event|6
7418883|NCT01466881|11693543|FG000|Overall Study|Progression/relapse|20
7418884|NCT01466881|11693543|FG000|Overall Study|Death|4
7418885|NCT01466881|11693543|FG000|Overall Study|Other reason not protocol specified|5
7418886|NCT01467076|11693586|FG000|Overall Study|Lost to Follow-up|1
7418887|NCT01467076|11693587|FG001|Overall Study|Lost to Follow-up|0
7418888|NCT01467076|11693588|FG002|Overall Study|Lost to Follow-up|0
7418889|NCT01467271|11693596|FG000|Overall Study|Death|84
7418890|NCT01467271|11693596|FG000|Overall Study|Lost to Follow-up|83
7418891|NCT01467271|11693596|FG000|Overall Study|Retraction of patient's consent|21
7418892|NCT01467271|11693596|FG000|Overall Study|Other reason|14
7418893|NCT01467427|11693602|FG000|Overall Study|Withdrawal by Subject|1
7418894|NCT01467427|11693603|FG001|Overall Study|Withdrawal by Subject|0
7418895|NCT01467427|11693602|FG000|Overall Study|Entered extension phase|11
7418896|NCT01467427|11693603|FG001|Overall Study|Entered extension phase|11
7418897|NCT01467427|11693602|FG000|Overall Study|Not continuing in extension phase|0
7418898|NCT01467427|11693603|FG001|Overall Study|Not continuing in extension phase|2
7418915|NCT01467479|11693629|FG000|Overall Study|No Study Medication|1
7418916|NCT01467479|11693630|FG001|Overall Study|No Study Medication|0
7418917|NCT01467479|11693631|FG002|Overall Study|No Study Medication|2
7418918|NCT01467479|11693629|FG000|Overall Study|Adverse Event|1
7418919|NCT01467479|11693630|FG001|Overall Study|Adverse Event|2
7418920|NCT01467479|11693631|FG002|Overall Study|Adverse Event|0
7418921|NCT01467479|11693629|FG000|Overall Study|Death|0
7418922|NCT01467479|11693630|FG001|Overall Study|Death|0
7418923|NCT01467479|11693631|FG002|Overall Study|Death|1
7418924|NCT01467479|11693629|FG000|Overall Study|Lost to Follow-up|2
7418925|NCT01467479|11693630|FG001|Overall Study|Lost to Follow-up|5
7418926|NCT01467479|11693631|FG002|Overall Study|Lost to Follow-up|3
7418927|NCT01467479|11693629|FG000|Overall Study|Withdrawal of Consent|3
7418928|NCT01467479|11693630|FG001|Overall Study|Withdrawal of Consent|7
7418929|NCT01467479|11693631|FG002|Overall Study|Withdrawal of Consent|7
7418930|NCT01467479|11693629|FG000|Overall Study|Study Terminated by Sponsor|1
7418931|NCT01467479|11693630|FG001|Overall Study|Study Terminated by Sponsor|3
7418933|NCT01467479|11693629|FG000|Overall Study|Other|1
7418934|NCT01467479|11693630|FG001|Overall Study|Other|0
7418935|NCT01467479|11693631|FG002|Overall Study|Other|0
7418936|NCT01467492|11693642|FG000|Overall Study|Withdrawal by Subject|6
7418937|NCT01467492|11693643|FG001|Overall Study|Withdrawal by Subject|4
7418938|NCT01467492|11693642|FG000|Overall Study|Study Terminated by Sponsor|6
7418939|NCT01467492|11693643|FG001|Overall Study|Study Terminated by Sponsor|4
7418940|NCT01467492|11693642|FG000|Overall Study|Adverse Event|4
7418941|NCT01467492|11693643|FG001|Overall Study|Adverse Event|3
7418942|NCT01467492|11693642|FG000|Overall Study|Lost to Follow-up|3
7418943|NCT01467492|11693643|FG001|Overall Study|Lost to Follow-up|2
7418944|NCT01467492|11693642|FG000|Overall Study|Undefined|2
7418945|NCT01467492|11693643|FG001|Overall Study|Undefined|0
7418946|NCT01467492|11693642|FG000|Overall Study|Enrolled But Not Treated|1
7418947|NCT01467492|11693643|FG001|Overall Study|Enrolled But Not Treated|0
7418948|NCT01467505|11693652|FG000|Overall Study|Adverse Event|1
7418949|NCT01467505|11693653|FG001|Overall Study|Adverse Event|0
7418950|NCT01467505|11693652|FG000|Overall Study|Withdrawal by Subject|4
7418951|NCT01467505|11693653|FG001|Overall Study|Withdrawal by Subject|0
7418952|NCT01467505|11693652|FG000|Overall Study|Study Terminated by Sponsor|28
7418953|NCT01467505|11693653|FG001|Overall Study|Study Terminated by Sponsor|3
7418954|NCT01467570|11693670|FG000|Overall Study|Lost to Follow-up|8
7418955|NCT01467570|11693671|FG001|Overall Study|Lost to Follow-up|9
7418956|NCT01467583|11693682|FG000|Overall Study|Death|1
7418957|NCT01467583|11693683|FG001|Overall Study|Death|1
7418958|NCT01467583|11693684|FG002|Overall Study|Death|0
7418959|NCT01467583|11693682|FG000|Overall Study|Withdrawal by Subject|1
7418960|NCT01467583|11693683|FG001|Overall Study|Withdrawal by Subject|0
7418961|NCT01467583|11693684|FG002|Overall Study|Withdrawal by Subject|0
7418962|NCT01467583|11693682|FG000|Overall Study|Protocol Violation|0
7418963|NCT01467583|11693683|FG001|Overall Study|Protocol Violation|0
7418964|NCT01467583|11693684|FG002|Overall Study|Protocol Violation|2
7418965|NCT01467661|11693695|FG000|Overall Study|Adverse Event|16
7418966|NCT01467661|11693695|FG000|Overall Study|Withdrawal by Subject|1
7555768|NCT03066804|11919238|FG000|Overall Study|Death|23
7555769|NCT03066804|11919239|FG001|Overall Study|Death|17
7555770|NCT03066804|11919238|FG000|Overall Study|Withdrawal by Subject|19
7555771|NCT03066804|11919239|FG001|Overall Study|Withdrawal by Subject|25
7555772|NCT03066804|11919238|FG000|Overall Study|Lost to Follow-up|2
7555773|NCT03066804|11919239|FG001|Overall Study|Lost to Follow-up|0
7555774|NCT03066804|11919238|FG000|Overall Study|Adverse Event|2
7555775|NCT03066804|11919239|FG001|Overall Study|Adverse Event|3
7555776|NCT03066804|11919238|FG000|Overall Study|Technical problems|5
7555777|NCT03066804|11919239|FG001|Overall Study|Technical problems|1
7555778|NCT03066830|11919248|FG000|Overall Study|At the Participant's own Request|16
7555779|NCT03066830|11919249|FG001|Overall Study|At the Participant's own Request|17
7555780|NCT03066830|11919248|FG000|Overall Study|Other|3
7555781|NCT03066830|11919249|FG001|Overall Study|Other|0
7555782|NCT03066830|11919248|FG000|Overall Study|Poor Compliance to Protocol|1
7555783|NCT03066830|11919249|FG001|Overall Study|Poor Compliance to Protocol|0
7555784|NCT03066830|11919248|FG000|Overall Study|Adverse Event|2
7555785|NCT03066830|11919249|FG001|Overall Study|Adverse Event|2
7555786|NCT03066830|11919248|FG000|Overall Study|Lost to Follow-up|11
7555787|NCT03066830|11919249|FG001|Overall Study|Lost to Follow-up|3
7555788|NCT03066999|11919263|FG000|Overall Study|abnormal urethraBladder neck contracture|0
7555789|NCT03066999|11919264|FG001|Overall Study|abnormal urethraBladder neck contracture|2
7555790|NCT03067311|11919273|FG000|Overall Study|Lost to Follow-up|1
7555791|NCT03067311|11919274|FG001|Overall Study|Lost to Follow-up|1
7555792|NCT03067311|11919273|FG000|Overall Study|Moved away|1
7555793|NCT03067311|11919274|FG001|Overall Study|Moved away|1
7555794|NCT03067441|11919282|FG000|Overall Study|Withdrawal by Subject|16
7555795|NCT03067441|11919283|FG001|Overall Study|Withdrawal by Subject|34
7555796|NCT03067441|11919282|FG000|Overall Study|Lost to Follow-up|7
7555797|NCT03067441|11919283|FG001|Overall Study|Lost to Follow-up|5
7555798|NCT03067441|11919282|FG000|Overall Study|Adverse Event|7
7555799|NCT03067441|11919283|FG001|Overall Study|Adverse Event|14
7555800|NCT03067441|11919282|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
7555801|NCT03067441|11919283|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
7555802|NCT03067441|11919282|FG000|Overall Study|Physician Decision|1
7555803|NCT03067441|11919283|FG001|Overall Study|Physician Decision|3
7555804|NCT03067441|11919282|FG000|Overall Study|Other|1
7555805|NCT03067441|11919283|FG001|Overall Study|Other|1
7555806|NCT03067987|11919302|FG000|Overall Study|Lost to Follow-up|7
7555807|NCT03067987|11919303|FG001|Overall Study|Lost to Follow-up|10
7555808|NCT03067987|11919302|FG000|Overall Study|Protocol Violation|1
7418967|NCT01467661|11693695|FG000|Overall Study|Lack of Efficacy|3
7418968|NCT01467661|11693695|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
7418969|NCT01467700|11693705|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7418970|NCT01467700|11693706|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7418971|NCT01467700|11693707|FG002|Overall Study|Pretreatment Event or Adverse Event|2
7418972|NCT01467700|11693708|FG003|Overall Study|Pretreatment Event or Adverse Event|3
7555809|NCT03067987|11919303|FG001|Overall Study|Protocol Violation|2
7555810|NCT03067987|11919302|FG000|Overall Study|Withdrawal by Subject|2
7555811|NCT03067987|11919303|FG001|Overall Study|Withdrawal by Subject|1
7555812|NCT03068455|11919325|FG000|Pre-treatment Period|Disease progression|0
7555813|NCT03068455|11919326|FG001|Pre-treatment Period|Disease progression|1
7555814|NCT03068455|11919325|FG000|Pre-treatment Period|Participant withdrew consent|1
7418973|NCT01467700|11693705|FG000|Overall Study|Major Protocol Deviation|3
7418974|NCT01467700|11693706|FG001|Overall Study|Major Protocol Deviation|3
7555815|NCT03068455|11919326|FG001|Pre-treatment Period|Participant withdrew consent|1
7418975|NCT01467700|11693707|FG002|Overall Study|Major Protocol Deviation|2
7418976|NCT01467700|11693708|FG003|Overall Study|Major Protocol Deviation|3
7418977|NCT01467700|11693705|FG000|Overall Study|Lost to Follow-up|6
7418978|NCT01467700|11693706|FG001|Overall Study|Lost to Follow-up|5
7418979|NCT01467700|11693707|FG002|Overall Study|Lost to Follow-up|2
7418980|NCT01467700|11693708|FG003|Overall Study|Lost to Follow-up|3
7418981|NCT01467700|11693705|FG000|Overall Study|Voluntary Withdrawal|5
7418982|NCT01467700|11693706|FG001|Overall Study|Voluntary Withdrawal|7
7418983|NCT01467700|11693707|FG002|Overall Study|Voluntary Withdrawal|6
7418984|NCT01467700|11693708|FG003|Overall Study|Voluntary Withdrawal|2
7418985|NCT01467700|11693705|FG000|Overall Study|Study Termination|6
7418986|NCT01467700|11693706|FG001|Overall Study|Study Termination|5
7418987|NCT01467700|11693707|FG002|Overall Study|Study Termination|10
7418988|NCT01467700|11693708|FG003|Overall Study|Study Termination|7
7418989|NCT01467700|11693705|FG000|Overall Study|Pregnancy|0
7418990|NCT01467700|11693706|FG001|Overall Study|Pregnancy|1
7418991|NCT01467700|11693707|FG002|Overall Study|Pregnancy|1
7418992|NCT01467700|11693708|FG003|Overall Study|Pregnancy|0
7418993|NCT01467700|11693705|FG000|Overall Study|Lack of Efficacy|2
7418994|NCT01467700|11693706|FG001|Overall Study|Lack of Efficacy|0
7418995|NCT01467700|11693707|FG002|Overall Study|Lack of Efficacy|2
7418996|NCT01467700|11693708|FG003|Overall Study|Lack of Efficacy|1
7418997|NCT01467700|11693705|FG000|Overall Study|Reason not Specified|1
7418998|NCT01467700|11693706|FG001|Overall Study|Reason not Specified|3
7418999|NCT01467700|11693707|FG002|Overall Study|Reason not Specified|2
7419000|NCT01467700|11693708|FG003|Overall Study|Reason not Specified|8
7419001|NCT01467713|11693722|FG000|Overall Study|Pretreatment Event or Adverse Event|9
7419002|NCT01467713|11693723|FG001|Overall Study|Pretreatment Event or Adverse Event|4
7419003|NCT01467713|11693724|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7419004|NCT01467713|11693725|FG003|Overall Study|Pretreatment Event or Adverse Event|5
7419005|NCT01467713|11693722|FG000|Overall Study|Major Protocol Deviation|2
7419006|NCT01467713|11693723|FG001|Overall Study|Major Protocol Deviation|4
7419007|NCT01467713|11693724|FG002|Overall Study|Major Protocol Deviation|4
7419008|NCT01467713|11693725|FG003|Overall Study|Major Protocol Deviation|1
7419009|NCT01467713|11693722|FG000|Overall Study|Lost to Follow-up|9
7419010|NCT01467713|11693723|FG001|Overall Study|Lost to Follow-up|12
7419011|NCT01467713|11693724|FG002|Overall Study|Lost to Follow-up|6
7419012|NCT01467713|11693725|FG003|Overall Study|Lost to Follow-up|9
7419013|NCT01467713|11693722|FG000|Overall Study|Voluntary Withdrawal|18
7419014|NCT01467713|11693723|FG001|Overall Study|Voluntary Withdrawal|14
7419015|NCT01467713|11693724|FG002|Overall Study|Voluntary Withdrawal|21
7419016|NCT01467713|11693725|FG003|Overall Study|Voluntary Withdrawal|20
7419017|NCT01467713|11693722|FG000|Overall Study|Study Termination|23
7419018|NCT01467713|11693723|FG001|Overall Study|Study Termination|33
7419019|NCT01467713|11693724|FG002|Overall Study|Study Termination|28
7419020|NCT01467713|11693725|FG003|Overall Study|Study Termination|29
7419021|NCT01467713|11693722|FG000|Overall Study|Pregnancy|0
7419022|NCT01467713|11693723|FG001|Overall Study|Pregnancy|1
7419023|NCT01467713|11693724|FG002|Overall Study|Pregnancy|1
7419024|NCT01467713|11693725|FG003|Overall Study|Pregnancy|3
7419025|NCT01467713|11693722|FG000|Overall Study|Relapse|35
7419026|NCT01467713|11693723|FG001|Overall Study|Relapse|25
7419027|NCT01467713|11693724|FG002|Overall Study|Relapse|28
7419028|NCT01467713|11693725|FG003|Overall Study|Relapse|35
7419029|NCT01467713|11693722|FG000|Overall Study|Reason not Specified|6
7419030|NCT01467713|11693723|FG001|Overall Study|Reason not Specified|11
7419031|NCT01467713|11693724|FG002|Overall Study|Reason not Specified|8
7419032|NCT01467713|11693725|FG003|Overall Study|Reason not Specified|7
7419033|NCT01467960|11693769|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
7419034|NCT01467960|11693770|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
7419035|NCT01467960|11693771|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
7419036|NCT01467960|11693772|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
7419037|NCT01467960|11693773|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
7419038|NCT01467960|11693774|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
7419039|NCT01468077|11693808|FG000|Overall Study|Adverse Event|2
7419040|NCT01468077|11693809|FG001|Overall Study|Adverse Event|2
7419041|NCT01468077|11693808|FG000|Overall Study|Lack of Efficacy|1
7419042|NCT01468077|11693809|FG001|Overall Study|Lack of Efficacy|1
7419043|NCT01468077|11693808|FG000|Overall Study|Physician Decision|1
7419044|NCT01468077|11693809|FG001|Overall Study|Physician Decision|0
7419045|NCT01468181|11693820|FG000|Overall Study|Adverse Event|8
7419046|NCT01468181|11693821|FG001|Overall Study|Adverse Event|1
7419047|NCT01468181|11693822|FG002|Overall Study|Adverse Event|6
7419048|NCT01468181|11693823|FG003|Overall Study|Adverse Event|2
7419049|NCT01468181|11693824|FG004|Overall Study|Adverse Event|2
7419050|NCT01468181|11693820|FG000|Overall Study|Protocol Violation|2
7419051|NCT01468181|11693821|FG001|Overall Study|Protocol Violation|0
7419052|NCT01468181|11693822|FG002|Overall Study|Protocol Violation|1
7419053|NCT01468181|11693823|FG003|Overall Study|Protocol Violation|0
7419054|NCT01468181|11693824|FG004|Overall Study|Protocol Violation|1
7419055|NCT01468181|11693820|FG000|Overall Study|Physician Decision|0
7419056|NCT01468181|11693821|FG001|Overall Study|Physician Decision|0
7419057|NCT01468181|11693822|FG002|Overall Study|Physician Decision|0
7419058|NCT01468181|11693823|FG003|Overall Study|Physician Decision|1
7419059|NCT01468181|11693824|FG004|Overall Study|Physician Decision|1
7419060|NCT01468181|11693820|FG000|Overall Study|Lost to Follow-up|0
7419061|NCT01468181|11693821|FG001|Overall Study|Lost to Follow-up|0
7419062|NCT01468181|11693822|FG002|Overall Study|Lost to Follow-up|1
7419063|NCT01468181|11693823|FG003|Overall Study|Lost to Follow-up|0
7419064|NCT01468181|11693824|FG004|Overall Study|Lost to Follow-up|1
7531506|NCT02653170|11876023|FG002|Overall Study|Lost to Follow-up|10
7555816|NCT03068455|11919325|FG000|Pre-treatment Period|Poor/non-compliance|0
7555817|NCT03068455|11919326|FG001|Pre-treatment Period|Poor/non-compliance|1
7555818|NCT03068455|11919325|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
7555819|NCT03068455|11919326|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
7555820|NCT03068455|11919325|FG000|Pre-treatment Period|Not reported|2
7555821|NCT03068455|11919326|FG001|Pre-treatment Period|Not reported|1
7555822|NCT03068455|11919325|FG000|Treatment Period|Disease progression|166
7555823|NCT03068455|11919326|FG001|Treatment Period|Disease progression|208
7555824|NCT03068455|11919325|FG000|Treatment Period|Study drug toxicity|317
7419065|NCT01468181|11693820|FG000|Overall Study|Withdrawal by Subject|0
7419066|NCT01468181|11693821|FG001|Overall Study|Withdrawal by Subject|1
7419067|NCT01468181|11693822|FG002|Overall Study|Withdrawal by Subject|0
7419068|NCT01468181|11693823|FG003|Overall Study|Withdrawal by Subject|0
7419069|NCT01468181|11693824|FG004|Overall Study|Withdrawal by Subject|0
7419070|NCT01468207|11693838|FG000|Treatment Period 1|Adverse Event|1
7419071|NCT01468207|11693839|FG001|Treatment Period 1|Adverse Event|0
7419072|NCT01468207|11693840|FG002|Treatment Period 1|Adverse Event|0
7419073|NCT01468207|11693841|FG003|Treatment Period 1|Adverse Event|0
7419074|NCT01468207|11693842|FG004|Treatment Period 1|Adverse Event|0
7419075|NCT01468207|11693843|FG005|Treatment Period 1|Adverse Event|0
7419076|NCT01468207|11693838|FG000|Treatment Period 1|Protocol Violation|1
7419077|NCT01468207|11693839|FG001|Treatment Period 1|Protocol Violation|1
7419078|NCT01468207|11693840|FG002|Treatment Period 1|Protocol Violation|0
7419079|NCT01468207|11693841|FG003|Treatment Period 1|Protocol Violation|0
7419080|NCT01468207|11693842|FG004|Treatment Period 1|Protocol Violation|0
7419081|NCT01468207|11693843|FG005|Treatment Period 1|Protocol Violation|0
7419082|NCT01468207|11693838|FG000|Treatment Period 1|Withdrawal by Subject|5
7419083|NCT01468207|11693839|FG001|Treatment Period 1|Withdrawal by Subject|4
7419084|NCT01468207|11693840|FG002|Treatment Period 1|Withdrawal by Subject|0
7419085|NCT01468207|11693841|FG003|Treatment Period 1|Withdrawal by Subject|0
7555825|NCT03068455|11919326|FG001|Treatment Period|Study drug toxicity|104
7555826|NCT03068455|11919325|FG000|Treatment Period|Adverse Event unrelated to study drug|15
7555827|NCT03068455|11919326|FG001|Treatment Period|Adverse Event unrelated to study drug|7
7419086|NCT01468207|11693842|FG004|Treatment Period 1|Withdrawal by Subject|0
7419087|NCT01468207|11693843|FG005|Treatment Period 1|Withdrawal by Subject|0
7419088|NCT01468207|11693838|FG000|Treatment Period 1|Lost to Follow-up|2
7555828|NCT03068455|11919325|FG000|Treatment Period|Participant request to stop therapy|33
7555829|NCT03068455|11919326|FG001|Treatment Period|Participant request to stop therapy|20
7419089|NCT01468207|11693839|FG001|Treatment Period 1|Lost to Follow-up|1
7419090|NCT01468207|11693840|FG002|Treatment Period 1|Lost to Follow-up|0
7419091|NCT01468207|11693841|FG003|Treatment Period 1|Lost to Follow-up|0
7419092|NCT01468207|11693842|FG004|Treatment Period 1|Lost to Follow-up|0
7419093|NCT01468207|11693843|FG005|Treatment Period 1|Lost to Follow-up|0
7419094|NCT01468207|11693838|FG000|Treatment Period 1|Other|0
7419095|NCT01468207|11693839|FG001|Treatment Period 1|Other|2
7419096|NCT01468207|11693840|FG002|Treatment Period 1|Other|0
7419097|NCT01468207|11693841|FG003|Treatment Period 1|Other|0
7419098|NCT01468207|11693842|FG004|Treatment Period 1|Other|0
7419099|NCT01468207|11693843|FG005|Treatment Period 1|Other|0
7419100|NCT01468207|11693838|FG000|Treatment Period 2|Adverse Event|0
7419101|NCT01468207|11693839|FG001|Treatment Period 2|Adverse Event|0
7419102|NCT01468207|11693840|FG002|Treatment Period 2|Adverse Event|6
7419103|NCT01468207|11693841|FG003|Treatment Period 2|Adverse Event|1
7419104|NCT01468207|11693842|FG004|Treatment Period 2|Adverse Event|2
7419105|NCT01468207|11693843|FG005|Treatment Period 2|Adverse Event|1
7419106|NCT01468207|11693838|FG000|Treatment Period 2|Lack of Efficacy|0
7419107|NCT01468207|11693839|FG001|Treatment Period 2|Lack of Efficacy|0
7419108|NCT01468207|11693840|FG002|Treatment Period 2|Lack of Efficacy|1
7531507|NCT02653300|11876040|FG000|Overall Study|Withdrawal by Subject|2
7531508|NCT02653326|11876046|FG000|Overall Study|Lost to Follow-up|10
7531509|NCT02653326|11876047|FG001|Overall Study|Lost to Follow-up|7
7531510|NCT02653625|11876141|FG000|Overall Study|Adverse Event|1
7531511|NCT02653625|11876141|FG000|Overall Study|Non-compliance with Study Drug|1
7531512|NCT02653625|11876141|FG000|Overall Study|Protocol Violation|1
7531513|NCT02653625|11876141|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
7531514|NCT02653664|11876148|FG000|Post-Treatment|Withdrawal by Subject|6
7531515|NCT02653664|11876149|FG001|Post-Treatment|Withdrawal by Subject|5
7531516|NCT02653664|11876150|FG002|Post-Treatment|Withdrawal by Subject|7
7531517|NCT02653664|11876148|FG000|Post-Treatment|Lost to Follow-up|8
7531518|NCT02653664|11876149|FG001|Post-Treatment|Lost to Follow-up|1
7531519|NCT02653664|11876150|FG002|Post-Treatment|Lost to Follow-up|7
7531520|NCT02653664|11876148|FG000|3 Month Follow-Up|Withdrawal by Subject|9
7531521|NCT02653664|11876149|FG001|3 Month Follow-Up|Withdrawal by Subject|5
7531522|NCT02653664|11876150|FG002|3 Month Follow-Up|Withdrawal by Subject|9
7531523|NCT02653664|11876148|FG000|3 Month Follow-Up|Lost to Follow-up|9
7531524|NCT02653664|11876149|FG001|3 Month Follow-Up|Lost to Follow-up|8
7419109|NCT01468207|11693841|FG003|Treatment Period 2|Lack of Efficacy|1
7419110|NCT01468207|11693842|FG004|Treatment Period 2|Lack of Efficacy|0
7419111|NCT01468207|11693843|FG005|Treatment Period 2|Lack of Efficacy|2
7419112|NCT01468207|11693838|FG000|Treatment Period 2|Withdrawal by Subject|0
7419113|NCT01468207|11693839|FG001|Treatment Period 2|Withdrawal by Subject|0
7419114|NCT01468207|11693840|FG002|Treatment Period 2|Withdrawal by Subject|5
7419115|NCT01468207|11693841|FG003|Treatment Period 2|Withdrawal by Subject|0
7419116|NCT01468207|11693842|FG004|Treatment Period 2|Withdrawal by Subject|0
7419117|NCT01468207|11693843|FG005|Treatment Period 2|Withdrawal by Subject|2
7419118|NCT01468207|11693838|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
7419119|NCT01468207|11693839|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
7419120|NCT01468207|11693840|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
7419121|NCT01468207|11693841|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
7419122|NCT01468207|11693842|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
7419123|NCT01468207|11693843|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
7419124|NCT01468207|11693838|FG000|Treatment Period 2|Lost to Follow-up|0
7419125|NCT01468207|11693839|FG001|Treatment Period 2|Lost to Follow-up|0
7419126|NCT01468207|11693840|FG002|Treatment Period 2|Lost to Follow-up|5
7419127|NCT01468207|11693841|FG003|Treatment Period 2|Lost to Follow-up|1
7419128|NCT01468207|11693842|FG004|Treatment Period 2|Lost to Follow-up|0
7419129|NCT01468207|11693843|FG005|Treatment Period 2|Lost to Follow-up|0
7419130|NCT01468207|11693838|FG000|Treatment Period 2|Other|0
7419131|NCT01468207|11693839|FG001|Treatment Period 2|Other|0
7419132|NCT01468207|11693840|FG002|Treatment Period 2|Other|5
7419133|NCT01468207|11693841|FG003|Treatment Period 2|Other|1
7419134|NCT01468207|11693842|FG004|Treatment Period 2|Other|1
7419135|NCT01468207|11693843|FG005|Treatment Period 2|Other|2
7419136|NCT01468233|11693863|FG000|Treatment Period 1|Adverse Event|5
7419137|NCT01468233|11693864|FG001|Treatment Period 1|Adverse Event|3
7419138|NCT01468233|11693865|FG002|Treatment Period 1|Adverse Event|0
7419139|NCT01468233|11693866|FG003|Treatment Period 1|Adverse Event|0
7531525|NCT02653664|11876150|FG002|3 Month Follow-Up|Lost to Follow-up|16
7555830|NCT03068455|11919325|FG000|Treatment Period|Participant withdrew consent|5
7555831|NCT03068455|11919326|FG001|Treatment Period|Participant withdrew consent|10
7555832|NCT03068455|11919325|FG000|Treatment Period|Poor/non-compliance|3
7555833|NCT03068455|11919326|FG001|Treatment Period|Poor/non-compliance|0
7555834|NCT03068455|11919325|FG000|Treatment Period|Participant no longer meets study criteria|1
7555835|NCT03068455|11919326|FG001|Treatment Period|Participant no longer meets study criteria|3
7555836|NCT03068455|11919325|FG000|Treatment Period|Other reasons|12
7555837|NCT03068455|11919326|FG001|Treatment Period|Other reasons|4
7555838|NCT03068468|11919334|FG000|Placebo-Controlled Period|Randomized but not Treated|1
7555839|NCT03068468|11919335|FG001|Placebo-Controlled Period|Randomized but not Treated|3
7555840|NCT03068468|11919336|FG002|Placebo-Controlled Period|Randomized but not Treated|0
7555841|NCT03068468|11919337|FG003|Placebo-Controlled Period|Randomized but not Treated|0
7555842|NCT03068468|11919334|FG000|Placebo-Controlled Period|Lack of Efficacy|0
7555843|NCT03068468|11919335|FG001|Placebo-Controlled Period|Lack of Efficacy|1
7555844|NCT03068468|11919336|FG002|Placebo-Controlled Period|Lack of Efficacy|0
7555845|NCT03068468|11919337|FG003|Placebo-Controlled Period|Lack of Efficacy|0
7555846|NCT03068468|11919334|FG000|Placebo-Controlled Period|Adverse Event|16
7555847|NCT03068468|11919335|FG001|Placebo-Controlled Period|Adverse Event|21
7555848|NCT03068468|11919336|FG002|Placebo-Controlled Period|Adverse Event|0
7555849|NCT03068468|11919337|FG003|Placebo-Controlled Period|Adverse Event|0
7555850|NCT03068468|11919334|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
7555851|NCT03068468|11919335|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
7555852|NCT03068468|11919336|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
7555853|NCT03068468|11919337|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
7555854|NCT03068468|11919334|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
7555855|NCT03068468|11919335|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
7555856|NCT03068468|11919336|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7555857|NCT03068468|11919337|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
7555858|NCT03068468|11919334|FG000|Placebo-Controlled Period|Reason Not Specified|1
7555859|NCT03068468|11919335|FG001|Placebo-Controlled Period|Reason Not Specified|6
7555860|NCT03068468|11919336|FG002|Placebo-Controlled Period|Reason Not Specified|0
7555861|NCT03068468|11919337|FG003|Placebo-Controlled Period|Reason Not Specified|0
7555862|NCT03068468|11919334|FG000|Placebo-Controlled Period|Death|0
7555863|NCT03068468|11919335|FG001|Placebo-Controlled Period|Death|1
7555864|NCT03068468|11919336|FG002|Placebo-Controlled Period|Death|0
7555865|NCT03068468|11919337|FG003|Placebo-Controlled Period|Death|0
7555866|NCT03068468|11919334|FG000|Open-Label Extension Period|Lack of Efficacy|0
7555867|NCT03068468|11919335|FG001|Open-Label Extension Period|Lack of Efficacy|0
7555868|NCT03068468|11919336|FG002|Open-Label Extension Period|Lack of Efficacy|1
7555869|NCT03068468|11919337|FG003|Open-Label Extension Period|Lack of Efficacy|2
7555870|NCT03068468|11919334|FG000|Open-Label Extension Period|Adverse Event|0
7419140|NCT01468233|11693867|FG004|Treatment Period 1|Adverse Event|0
7419141|NCT01468233|11693868|FG005|Treatment Period 1|Adverse Event|0
7419142|NCT01468233|11693863|FG000|Treatment Period 1|Withdrawal by Subject|3
7419143|NCT01468233|11693864|FG001|Treatment Period 1|Withdrawal by Subject|4
7419144|NCT01468233|11693865|FG002|Treatment Period 1|Withdrawal by Subject|0
7419145|NCT01468233|11693866|FG003|Treatment Period 1|Withdrawal by Subject|0
7419146|NCT01468233|11693867|FG004|Treatment Period 1|Withdrawal by Subject|0
7419147|NCT01468233|11693868|FG005|Treatment Period 1|Withdrawal by Subject|0
7419148|NCT01468233|11693863|FG000|Treatment Period 1|Lost to Follow-up|3
7419149|NCT01468233|11693864|FG001|Treatment Period 1|Lost to Follow-up|0
7419150|NCT01468233|11693865|FG002|Treatment Period 1|Lost to Follow-up|0
7419151|NCT01468233|11693866|FG003|Treatment Period 1|Lost to Follow-up|0
7419152|NCT01468233|11693867|FG004|Treatment Period 1|Lost to Follow-up|0
7419153|NCT01468233|11693868|FG005|Treatment Period 1|Lost to Follow-up|0
7419154|NCT01468233|11693863|FG000|Treatment Period 1|Other|1
7419155|NCT01468233|11693864|FG001|Treatment Period 1|Other|1
7419156|NCT01468233|11693865|FG002|Treatment Period 1|Other|0
7419157|NCT01468233|11693866|FG003|Treatment Period 1|Other|0
7419158|NCT01468233|11693867|FG004|Treatment Period 1|Other|0
7419159|NCT01468233|11693868|FG005|Treatment Period 1|Other|0
7419160|NCT01468233|11693863|FG000|Treatment Period 2|Adverse Event|0
7419161|NCT01468233|11693864|FG001|Treatment Period 2|Adverse Event|0
7419162|NCT01468233|11693865|FG002|Treatment Period 2|Adverse Event|3
7419163|NCT01468233|11693866|FG003|Treatment Period 2|Adverse Event|0
7419164|NCT01468233|11693867|FG004|Treatment Period 2|Adverse Event|2
7419165|NCT01468233|11693868|FG005|Treatment Period 2|Adverse Event|1
7419166|NCT01468233|11693863|FG000|Treatment Period 2|Lack of Efficacy|0
7419167|NCT01468233|11693864|FG001|Treatment Period 2|Lack of Efficacy|0
7419168|NCT01468233|11693865|FG002|Treatment Period 2|Lack of Efficacy|9
7419169|NCT01468233|11693866|FG003|Treatment Period 2|Lack of Efficacy|2
7419170|NCT01468233|11693867|FG004|Treatment Period 2|Lack of Efficacy|0
7419171|NCT01468233|11693868|FG005|Treatment Period 2|Lack of Efficacy|1
7419172|NCT01468233|11693863|FG000|Treatment Period 2|Withdrawal by Subject|0
7531526|NCT02653664|11876148|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7531527|NCT02653664|11876149|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7531528|NCT02653664|11876150|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7531529|NCT02653664|11876148|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
7531530|NCT02653664|11876149|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7531531|NCT02653664|11876150|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
7531532|NCT02653664|11876148|FG000|6 Month Follow-Up|Withdrawal by Subject|13
7531533|NCT02653664|11876149|FG001|6 Month Follow-Up|Withdrawal by Subject|7
7531534|NCT02653664|11876150|FG002|6 Month Follow-Up|Withdrawal by Subject|14
7531535|NCT02653664|11876148|FG000|6 Month Follow-Up|Lost to Follow-up|10
7531536|NCT02653664|11876149|FG001|6 Month Follow-Up|Lost to Follow-up|11
7531537|NCT02653664|11876150|FG002|6 Month Follow-Up|Lost to Follow-up|9
7531538|NCT02653664|11876148|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7531539|NCT02653664|11876149|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
7531540|NCT02653664|11876150|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
7531541|NCT02653664|11876148|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
7531542|NCT02653664|11876149|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
7531543|NCT02653664|11876150|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
7531544|NCT02654002|11876193|FG000|Overall Study|Adverse Event|0
7531545|NCT02654002|11876194|FG001|Overall Study|Adverse Event|0
7531546|NCT02654002|11876195|FG002|Overall Study|Adverse Event|0
7531547|NCT02654002|11876196|FG003|Overall Study|Adverse Event|0
7531548|NCT02654002|11876197|FG004|Overall Study|Adverse Event|0
7531549|NCT02654002|11876198|FG005|Overall Study|Adverse Event|0
7555871|NCT03068468|11919335|FG001|Open-Label Extension Period|Adverse Event|0
7555872|NCT03068468|11919336|FG002|Open-Label Extension Period|Adverse Event|13
7555873|NCT03068468|11919337|FG003|Open-Label Extension Period|Adverse Event|17
7555874|NCT03068468|11919334|FG000|Open-Label Extension Period|Withdrawal by Subject|0
7555875|NCT03068468|11919335|FG001|Open-Label Extension Period|Withdrawal by Subject|0
7531550|NCT02654002|11876199|FG006|Overall Study|Adverse Event|1
7555876|NCT03068468|11919336|FG002|Open-Label Extension Period|Withdrawal by Subject|7
7555877|NCT03068468|11919337|FG003|Open-Label Extension Period|Withdrawal by Subject|20
7555878|NCT03068468|11919334|FG000|Open-Label Extension Period|Death|0
7555879|NCT03068468|11919335|FG001|Open-Label Extension Period|Death|0
7555880|NCT03068468|11919336|FG002|Open-Label Extension Period|Death|0
7555881|NCT03068468|11919337|FG003|Open-Label Extension Period|Death|1
7555882|NCT03068468|11919334|FG000|Open-Label Extension Period|Lost to Follow-up|0
7555883|NCT03068468|11919335|FG001|Open-Label Extension Period|Lost to Follow-up|0
7555884|NCT03068468|11919336|FG002|Open-Label Extension Period|Lost to Follow-up|1
7555885|NCT03068468|11919337|FG003|Open-Label Extension Period|Lost to Follow-up|0
7555886|NCT03068468|11919334|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7555887|NCT03068468|11919335|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7555888|NCT03068468|11919336|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
7419173|NCT01468233|11693864|FG001|Treatment Period 2|Withdrawal by Subject|0
7531551|NCT02654002|11876200|FG007|Overall Study|Adverse Event|0
7531552|NCT02654002|11876201|FG008|Overall Study|Adverse Event|0
7419174|NCT01468233|11693865|FG002|Treatment Period 2|Withdrawal by Subject|9
7419175|NCT01468233|11693866|FG003|Treatment Period 2|Withdrawal by Subject|1
7419176|NCT01468233|11693867|FG004|Treatment Period 2|Withdrawal by Subject|1
7531553|NCT02654002|11876193|FG000|Overall Study|Withdrew Consent|0
7531554|NCT02654002|11876194|FG001|Overall Study|Withdrew Consent|0
7419177|NCT01468233|11693868|FG005|Treatment Period 2|Withdrawal by Subject|1
7419178|NCT01468233|11693863|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
7419179|NCT01468233|11693864|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
7419180|NCT01468233|11693865|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
7555889|NCT03068468|11919337|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
7419181|NCT01468233|11693866|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
7419182|NCT01468233|11693867|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
7419183|NCT01468233|11693868|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
7419184|NCT01468233|11693863|FG000|Treatment Period 2|Lost to Follow-up|0
7419185|NCT01468233|11693864|FG001|Treatment Period 2|Lost to Follow-up|0
7419186|NCT01468233|11693865|FG002|Treatment Period 2|Lost to Follow-up|3
7419187|NCT01468233|11693866|FG003|Treatment Period 2|Lost to Follow-up|0
7419188|NCT01468233|11693867|FG004|Treatment Period 2|Lost to Follow-up|2
7419189|NCT01468233|11693868|FG005|Treatment Period 2|Lost to Follow-up|0
7419190|NCT01468233|11693863|FG000|Treatment Period 2|Other|0
7419191|NCT01468233|11693864|FG001|Treatment Period 2|Other|0
7419192|NCT01468233|11693865|FG002|Treatment Period 2|Other|3
7419193|NCT01468233|11693866|FG003|Treatment Period 2|Other|0
7419194|NCT01468233|11693867|FG004|Treatment Period 2|Other|1
7419195|NCT01468233|11693868|FG005|Treatment Period 2|Other|0
7419196|NCT01468311|11693886|FG000|Overall Study|mobilization failure|1
7419197|NCT01468311|11693886|FG000|Overall Study|Withdrawal by Subject|1
7419198|NCT01468454|11693911|FG000|Overall Study|Did not have surgery after PET|9
7419199|NCT01468597|11693932|FG000|Overall Study|Found ineligible|17
7419200|NCT01468597|11693932|FG000|Overall Study|concomitant valves|12
7419201|NCT01468597|11693932|FG000|Overall Study|off-pump CABG|1
7419202|NCT01468597|11693932|FG000|Overall Study|no platelet function data|5
7419203|NCT01468701|11693962|FG000|Overall Study|Not eligible|91
7419204|NCT01468701|11693963|FG001|Overall Study|Not eligible|140
7419205|NCT01468701|11693964|FG002|Overall Study|Not eligible|29
7419206|NCT01468701|11693965|FG003|Overall Study|Not eligible|12
7419207|NCT01468701|11693966|FG004|Overall Study|Not eligible|22
7419208|NCT01468701|11693967|FG005|Overall Study|Not eligible|2
7419209|NCT01468701|11693968|FG006|Overall Study|Not eligible|39
7419210|NCT01468701|11693969|FG007|Overall Study|Not eligible|1
7419211|NCT01468701|11693970|FG008|Overall Study|Not eligible|40
7419212|NCT01468701|11693971|FG009|Overall Study|Not eligible|126
7419213|NCT01468701|11693972|FG010|Overall Study|Not eligible|39
7419214|NCT01468701|11693973|FG011|Overall Study|Not eligible|33
7419215|NCT01468701|11693974|FG012|Overall Study|Not eligible|1
7419216|NCT01468701|11693975|FG013|Overall Study|Not eligible|19
7419217|NCT01468701|11693976|FG014|Overall Study|Not eligible|1
7419218|NCT01468701|11693977|FG015|Overall Study|Not eligible|32
7419219|NCT01468701|11693978|FG016|Overall Study|Not eligible|0
7419220|NCT01468701|11693962|FG000|Overall Study|Lost to Follow-up|306
7419221|NCT01468701|11693963|FG001|Overall Study|Lost to Follow-up|0
7419222|NCT01468701|11693964|FG002|Overall Study|Lost to Follow-up|0
7419223|NCT01468701|11693965|FG003|Overall Study|Lost to Follow-up|0
7419224|NCT01468701|11693966|FG004|Overall Study|Lost to Follow-up|0
7419225|NCT01468701|11693967|FG005|Overall Study|Lost to Follow-up|0
7419226|NCT01468701|11693968|FG006|Overall Study|Lost to Follow-up|0
7419227|NCT01468701|11693969|FG007|Overall Study|Lost to Follow-up|0
7419228|NCT01468701|11693970|FG008|Overall Study|Lost to Follow-up|215
7419229|NCT01468701|11693971|FG009|Overall Study|Lost to Follow-up|309
7419230|NCT01468701|11693972|FG010|Overall Study|Lost to Follow-up|224
7419231|NCT01468701|11693973|FG011|Overall Study|Lost to Follow-up|212
7419232|NCT01468701|11693974|FG012|Overall Study|Lost to Follow-up|11
7419233|NCT01468701|11693975|FG013|Overall Study|Lost to Follow-up|164
7419234|NCT01468701|11693976|FG014|Overall Study|Lost to Follow-up|17
7419235|NCT01468701|11693977|FG015|Overall Study|Lost to Follow-up|127
7419236|NCT01468701|11693978|FG016|Overall Study|Lost to Follow-up|1
7419237|NCT01468701|11693962|FG000|Overall Study|Withdrawal by Subject|165
7419238|NCT01468701|11693963|FG001|Overall Study|Withdrawal by Subject|0
7419239|NCT01468701|11693964|FG002|Overall Study|Withdrawal by Subject|0
7419240|NCT01468701|11693965|FG003|Overall Study|Withdrawal by Subject|0
7419241|NCT01468701|11693966|FG004|Overall Study|Withdrawal by Subject|0
7419242|NCT01468701|11693967|FG005|Overall Study|Withdrawal by Subject|0
7419243|NCT01468701|11693968|FG006|Overall Study|Withdrawal by Subject|0
7419244|NCT01468701|11693969|FG007|Overall Study|Withdrawal by Subject|0
7419245|NCT01468701|11693970|FG008|Overall Study|Withdrawal by Subject|83
7419246|NCT01468701|11693971|FG009|Overall Study|Withdrawal by Subject|88
7419247|NCT01468701|11693972|FG010|Overall Study|Withdrawal by Subject|100
7419248|NCT01468701|11693973|FG011|Overall Study|Withdrawal by Subject|114
7419249|NCT01468701|11693974|FG012|Overall Study|Withdrawal by Subject|9
7419250|NCT01468701|11693975|FG013|Overall Study|Withdrawal by Subject|47
7419251|NCT01468701|11693976|FG014|Overall Study|Withdrawal by Subject|6
7419252|NCT01468701|11693977|FG015|Overall Study|Withdrawal by Subject|31
7419253|NCT01468701|11693978|FG016|Overall Study|Withdrawal by Subject|0
7419254|NCT01468701|11693962|FG000|Overall Study|Other reasons than listed|437
7419255|NCT01468701|11693963|FG001|Overall Study|Other reasons than listed|0
7419256|NCT01468701|11693964|FG002|Overall Study|Other reasons than listed|0
7419257|NCT01468701|11693965|FG003|Overall Study|Other reasons than listed|0
7419258|NCT01468701|11693966|FG004|Overall Study|Other reasons than listed|0
7419259|NCT01468701|11693967|FG005|Overall Study|Other reasons than listed|0
7419260|NCT01468701|11693968|FG006|Overall Study|Other reasons than listed|0
7419261|NCT01468701|11693969|FG007|Overall Study|Other reasons than listed|0
7419262|NCT01468701|11693970|FG008|Overall Study|Other reasons than listed|318
7419263|NCT01468701|11693971|FG009|Overall Study|Other reasons than listed|658
7419264|NCT01468701|11693972|FG010|Overall Study|Other reasons than listed|433
7419265|NCT01468701|11693973|FG011|Overall Study|Other reasons than listed|504
7419266|NCT01468701|11693974|FG012|Overall Study|Other reasons than listed|28
7419267|NCT01468701|11693975|FG013|Overall Study|Other reasons than listed|239
7419268|NCT01468701|11693976|FG014|Overall Study|Other reasons than listed|39
7419269|NCT01468701|11693977|FG015|Overall Study|Other reasons than listed|172
7419270|NCT01468701|11693978|FG016|Overall Study|Other reasons than listed|0
7419271|NCT01468701|11693962|FG000|Overall Study|No end of study case report form|0
7419272|NCT01468701|11693963|FG001|Overall Study|No end of study case report form|0
7419273|NCT01468701|11693964|FG002|Overall Study|No end of study case report form|0
7419274|NCT01468701|11693965|FG003|Overall Study|No end of study case report form|0
7419275|NCT01468701|11693966|FG004|Overall Study|No end of study case report form|0
7555890|NCT03068468|11919334|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
7555891|NCT03068468|11919335|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
7555892|NCT03068468|11919336|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
7555893|NCT03068468|11919337|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
7555894|NCT03068468|11919334|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7555895|NCT03068468|11919335|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7555896|NCT03068468|11919336|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
7555897|NCT03068468|11919337|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
7555898|NCT03068468|11919334|FG000|Open-Label Extension Period|Reason not Specified|0
7555899|NCT03068468|11919335|FG001|Open-Label Extension Period|Reason not Specified|0
7555900|NCT03068468|11919336|FG002|Open-Label Extension Period|Reason not Specified|1
7555901|NCT03068468|11919337|FG003|Open-Label Extension Period|Reason not Specified|4
7555902|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
7555903|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
7555904|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
7555905|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
7555906|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Death|2
7555907|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Death|2
7555908|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Death|0
7555909|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Death|0
7555910|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Disease progression|1
7555911|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Disease progression|2
7555912|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Disease progression|0
7555913|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Disease progression|0
7555914|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
7555915|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7555916|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7555917|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
7555918|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
7555919|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
7555920|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7555921|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
7555922|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
7555923|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7555924|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7555925|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
7555926|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7555927|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
7555928|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7555929|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
7555930|NCT03068754|11919356|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
7555931|NCT03068754|11919357|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
7555932|NCT03068754|11919358|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7555933|NCT03068754|11919359|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
7555934|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Adverse Event|0
7555935|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Adverse Event|0
7555936|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Adverse Event|0
7555937|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Adverse Event|1
7555938|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Death|0
7555939|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Death|0
7555940|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Death|0
7555941|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Death|1
7555942|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Disease progression|0
7555943|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Disease progression|0
7419276|NCT01468701|11693967|FG005|Overall Study|No end of study case report form|0
7419277|NCT01468701|11693968|FG006|Overall Study|No end of study case report form|0
7531555|NCT02654002|11876195|FG002|Overall Study|Withdrew Consent|0
7531556|NCT02654002|11876196|FG003|Overall Study|Withdrew Consent|0
7419278|NCT01468701|11693969|FG007|Overall Study|No end of study case report form|0
7419279|NCT01468701|11693970|FG008|Overall Study|No end of study case report form|4
7419280|NCT01468701|11693971|FG009|Overall Study|No end of study case report form|1
7419281|NCT01468701|11693972|FG010|Overall Study|No end of study case report form|2
7419282|NCT01468701|11693973|FG011|Overall Study|No end of study case report form|3
7419283|NCT01468701|11693974|FG012|Overall Study|No end of study case report form|0
7419284|NCT01468701|11693975|FG013|Overall Study|No end of study case report form|1
7419285|NCT01468701|11693976|FG014|Overall Study|No end of study case report form|0
7419286|NCT01468701|11693977|FG015|Overall Study|No end of study case report form|0
7419287|NCT01468701|11693978|FG016|Overall Study|No end of study case report form|0
7419288|NCT01468701|11693962|FG000|Overall Study|Not being followed up|0
7419289|NCT01468701|11693963|FG001|Overall Study|Not being followed up|4963
7419290|NCT01468701|11693964|FG002|Overall Study|Not being followed up|1755
7419291|NCT01468701|11693965|FG003|Overall Study|Not being followed up|703
7419292|NCT01468701|11693966|FG004|Overall Study|Not being followed up|1714
7419293|NCT01468701|11693967|FG005|Overall Study|Not being followed up|126
7419294|NCT01468701|11693968|FG006|Overall Study|Not being followed up|1170
7419295|NCT01468701|11693969|FG007|Overall Study|Not being followed up|4
7419296|NCT01468701|11693970|FG008|Overall Study|Not being followed up|0
7531557|NCT02654002|11876197|FG004|Overall Study|Withdrew Consent|0
7555944|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Disease progression|3
7555945|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Disease progression|1
7555946|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7555947|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7555948|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
7555949|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
7555950|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7555951|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7555952|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
7555953|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
7555954|NCT03068754|11919356|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7555955|NCT03068754|11919357|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
7555956|NCT03068754|11919358|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
7555957|NCT03068754|11919359|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
7555958|NCT03068767|11919371|FG000|Overall Study|Lost to Follow-up|7
7555959|NCT03068767|11919372|FG001|Overall Study|Lost to Follow-up|3
7555960|NCT03068767|11919371|FG000|Overall Study|Protocol Violation|3
7555961|NCT03068767|11919372|FG001|Overall Study|Protocol Violation|0
7555962|NCT03069313|11919412|FG000|Overall Study|Adverse Event|5
7555965|NCT03069365|11919425|FG000|Overall Study|Adverse Event|1
7555966|NCT03069482|11919431|FG000|Overall Study|Lost to Follow-up|0
7555967|NCT03069482|11919432|FG001|Overall Study|Lost to Follow-up|1
7555968|NCT03069482|11919431|FG000|Overall Study|Physician Decision|1
7555969|NCT03069482|11919432|FG001|Overall Study|Physician Decision|0
7555970|NCT03069716|11919452|FG000|Run-in Period (2 Weeks)|Adverse Event|1
7555971|NCT03069716|11919453|FG001|Run-in Period (2 Weeks)|Adverse Event|0
7555972|NCT03069716|11919454|FG002|Run-in Period (2 Weeks)|Adverse Event|0
7555973|NCT03069716|11919452|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
7555974|NCT03069716|11919453|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
7555975|NCT03069716|11919454|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
7555976|NCT03069716|11919452|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
7555977|NCT03069716|11919453|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7555978|NCT03069716|11919454|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
7555979|NCT03069716|11919452|FG000|Randomized Treatment|Withdrawal by Subject|0
7555980|NCT03069716|11919453|FG001|Randomized Treatment|Withdrawal by Subject|2
7555981|NCT03069716|11919454|FG002|Randomized Treatment|Withdrawal by Subject|0
7555982|NCT03069989|11919463|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
7555983|NCT03069989|11919464|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
7555984|NCT03070171|11919473|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
7555985|NCT03070171|11919474|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
7555986|NCT03070171|11919473|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
7555987|NCT03070171|11919474|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
7555988|NCT03070431|11919480|FG000|Overall Study|Withdrawal by Subject|2
7555989|NCT03070431|11919480|FG000|Overall Study|Lost to Follow-up|2
7555990|NCT03070483|11919516|FG000|Overall Study|Lost to Follow-up|2
7555991|NCT03070782|11919544|FG000|Overall Study|Adverse Event|3
7555992|NCT03070782|11919545|FG001|Overall Study|Adverse Event|0
7555993|NCT03070782|11919546|FG002|Overall Study|Adverse Event|3
7555994|NCT03070782|11919547|FG003|Overall Study|Adverse Event|1
7419297|NCT01468701|11693971|FG009|Overall Study|Not being followed up|0
7419298|NCT01468701|11693972|FG010|Overall Study|Not being followed up|0
7419299|NCT01468701|11693973|FG011|Overall Study|Not being followed up|0
7531558|NCT02654002|11876198|FG005|Overall Study|Withdrew Consent|1
7419300|NCT01468701|11693974|FG012|Overall Study|Not being followed up|0
7419301|NCT01468701|11693975|FG013|Overall Study|Not being followed up|0
7419302|NCT01468701|11693976|FG014|Overall Study|Not being followed up|0
7419303|NCT01468701|11693977|FG015|Overall Study|Not being followed up|0
7419304|NCT01468701|11693978|FG016|Overall Study|Not being followed up|0
7419305|NCT01468818|11693991|FG000|Overall Study|Death during treatment|2
7419306|NCT01468844|11693997|FG000|Overall Study|Adverse Event|1
7419307|NCT01468844|11693998|FG001|Overall Study|Adverse Event|0
7419308|NCT01468844|11693997|FG000|Overall Study|Withdrawal by Subject|1
7419309|NCT01468844|11693998|FG001|Overall Study|Withdrawal by Subject|0
7419310|NCT01468909|11694009|FG000|Overall Study|Never Treated|2
7419311|NCT01468909|11694010|FG001|Overall Study|Never Treated|2
7419312|NCT01468987|11694022|FG000|Overall Study|Adverse Event|12
7419313|NCT01468987|11694023|FG001|Overall Study|Adverse Event|9
7419314|NCT01468987|11694022|FG000|Overall Study|Death|4
7419315|NCT01468987|11694023|FG001|Overall Study|Death|1
7419316|NCT01468987|11694022|FG000|Overall Study|Lost to Follow-up|10
7419317|NCT01468987|11694023|FG001|Overall Study|Lost to Follow-up|5
7419318|NCT01468987|11694022|FG000|Overall Study|Protocol Violation|8
7419319|NCT01468987|11694023|FG001|Overall Study|Protocol Violation|2
7419320|NCT01468987|11694022|FG000|Overall Study|Withdrawal by Subject|28
7419321|NCT01468987|11694023|FG001|Overall Study|Withdrawal by Subject|28
7419322|NCT01468987|11694022|FG000|Overall Study|Physician Decision|8
7419323|NCT01468987|11694023|FG001|Overall Study|Physician Decision|15
7419324|NCT01468987|11694022|FG000|Overall Study|Sponsor Decision|1
7419325|NCT01468987|11694023|FG001|Overall Study|Sponsor Decision|0
7419326|NCT01469000|11694033|FG000|Overall Study|Withdrawal by Subject|16
7419327|NCT01469000|11694034|FG001|Overall Study|Withdrawal by Subject|3
7419328|NCT01469000|11694033|FG000|Overall Study|Sponsor Decision|4
7419329|NCT01469000|11694034|FG001|Overall Study|Sponsor Decision|1
7419330|NCT01469013|11694045|FG000|Part A (Treatment Period)|Adverse Event|1
7419331|NCT01469013|11694046|FG001|Part A (Treatment Period)|Adverse Event|0
7419332|NCT01469013|11694047|FG002|Part A (Treatment Period)|Adverse Event|0
7419333|NCT01469013|11694048|FG003|Part A (Treatment Period)|Adverse Event|0
7419334|NCT01469013|11694049|FG004|Part A (Treatment Period)|Adverse Event|1
7419335|NCT01469013|11694050|FG005|Part A (Treatment Period)|Adverse Event|0
7419336|NCT01469013|11694051|FG006|Part A (Treatment Period)|Adverse Event|0
7419337|NCT01469013|11694052|FG007|Part A (Treatment Period)|Adverse Event|0
7419338|NCT01469013|11694053|FG008|Part A (Treatment Period)|Adverse Event|0
7419339|NCT01469013|11694054|FG009|Part A (Treatment Period)|Adverse Event|0
7419340|NCT01469013|11694055|FG010|Part A (Treatment Period)|Adverse Event|0
7419341|NCT01469013|11694056|FG011|Part A (Treatment Period)|Adverse Event|0
7419342|NCT01469013|11694057|FG012|Part A (Treatment Period)|Adverse Event|0
7419343|NCT01469013|11694045|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
7419344|NCT01469013|11694046|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
7419345|NCT01469013|11694047|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
7419346|NCT01469013|11694048|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
7419347|NCT01469013|11694049|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
7419348|NCT01469013|11694050|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
7419349|NCT01469013|11694051|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
7419350|NCT01469013|11694052|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
7419351|NCT01469013|11694053|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
7419352|NCT01469013|11694054|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
7419353|NCT01469013|11694055|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
7419354|NCT01469013|11694056|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
7419355|NCT01469013|11694057|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
7419356|NCT01469013|11694045|FG000|Part B (Extension Period)|Adverse Event|0
7419357|NCT01469013|11694046|FG001|Part B (Extension Period)|Adverse Event|0
7419358|NCT01469013|11694047|FG002|Part B (Extension Period)|Adverse Event|0
7419359|NCT01469013|11694048|FG003|Part B (Extension Period)|Adverse Event|0
7419360|NCT01469013|11694049|FG004|Part B (Extension Period)|Adverse Event|0
7419361|NCT01469013|11694050|FG005|Part B (Extension Period)|Adverse Event|2
7419362|NCT01469013|11694051|FG006|Part B (Extension Period)|Adverse Event|5
7419363|NCT01469013|11694052|FG007|Part B (Extension Period)|Adverse Event|5
7419364|NCT01469013|11694053|FG008|Part B (Extension Period)|Adverse Event|3
7419365|NCT01469013|11694054|FG009|Part B (Extension Period)|Adverse Event|3
7419366|NCT01469013|11694055|FG010|Part B (Extension Period)|Adverse Event|1
7419367|NCT01469013|11694056|FG011|Part B (Extension Period)|Adverse Event|6
7419368|NCT01469013|11694057|FG012|Part B (Extension Period)|Adverse Event|3
7419369|NCT01469013|11694045|FG000|Part B (Extension Period)|Withdrawal by Subject|0
7531559|NCT02654002|11876199|FG006|Overall Study|Withdrew Consent|0
7531560|NCT02654002|11876200|FG007|Overall Study|Withdrew Consent|1
7531561|NCT02654002|11876201|FG008|Overall Study|Withdrew Consent|0
7531562|NCT02654054|11876239|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7531563|NCT02654054|11876240|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7531564|NCT02654054|11876241|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7531565|NCT02654054|11876239|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7419370|NCT01469013|11694046|FG001|Part B (Extension Period)|Withdrawal by Subject|0
7419371|NCT01469013|11694047|FG002|Part B (Extension Period)|Withdrawal by Subject|0
7419372|NCT01469013|11694048|FG003|Part B (Extension Period)|Withdrawal by Subject|0
7466554|NCT01892189|11766380|FG003|Washout Period 1 (7 Days)|Adverse Event|0
7531566|NCT02654054|11876240|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7531567|NCT02654054|11876241|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7419373|NCT01469013|11694049|FG004|Part B (Extension Period)|Withdrawal by Subject|0
7419374|NCT01469013|11694050|FG005|Part B (Extension Period)|Withdrawal by Subject|0
7419375|NCT01469013|11694051|FG006|Part B (Extension Period)|Withdrawal by Subject|0
7419376|NCT01469013|11694052|FG007|Part B (Extension Period)|Withdrawal by Subject|0
7419377|NCT01469013|11694053|FG008|Part B (Extension Period)|Withdrawal by Subject|1
7419378|NCT01469013|11694054|FG009|Part B (Extension Period)|Withdrawal by Subject|0
7419379|NCT01469013|11694055|FG010|Part B (Extension Period)|Withdrawal by Subject|1
7419380|NCT01469013|11694056|FG011|Part B (Extension Period)|Withdrawal by Subject|0
7419381|NCT01469013|11694057|FG012|Part B (Extension Period)|Withdrawal by Subject|3
7419382|NCT01469052|11694103|FG000|Overall Study|Adverse Event|2
7419383|NCT01469052|11694104|FG001|Overall Study|Adverse Event|3
7419384|NCT01469052|11694105|FG002|Overall Study|Adverse Event|0
7419385|NCT01469052|11694106|FG003|Overall Study|Adverse Event|2
7419386|NCT01469052|11694107|FG004|Overall Study|Adverse Event|0
7419387|NCT01469052|11694108|FG005|Overall Study|Adverse Event|1
7419388|NCT01469052|11694103|FG000|Overall Study|Progressive disease|3
7419389|NCT01469052|11694104|FG001|Overall Study|Progressive disease|0
7419390|NCT01469052|11694105|FG002|Overall Study|Progressive disease|5
7419391|NCT01469052|11694106|FG003|Overall Study|Progressive disease|3
7419392|NCT01469052|11694107|FG004|Overall Study|Progressive disease|7
7419393|NCT01469052|11694108|FG005|Overall Study|Progressive disease|2
7419394|NCT01469052|11694103|FG000|Overall Study|Lack of Efficacy|0
7419395|NCT01469052|11694104|FG001|Overall Study|Lack of Efficacy|0
7419396|NCT01469052|11694105|FG002|Overall Study|Lack of Efficacy|0
7419397|NCT01469052|11694106|FG003|Overall Study|Lack of Efficacy|0
7419398|NCT01469052|11694107|FG004|Overall Study|Lack of Efficacy|0
7419399|NCT01469052|11694108|FG005|Overall Study|Lack of Efficacy|2
7419400|NCT01469052|11694103|FG000|Overall Study|Moved to rollover protocol|1
7419401|NCT01469052|11694104|FG001|Overall Study|Moved to rollover protocol|0
7419402|NCT01469052|11694105|FG002|Overall Study|Moved to rollover protocol|1
7419403|NCT01469052|11694106|FG003|Overall Study|Moved to rollover protocol|0
7419404|NCT01469052|11694107|FG004|Overall Study|Moved to rollover protocol|0
7419405|NCT01469052|11694108|FG005|Overall Study|Moved to rollover protocol|1
7419406|NCT01469052|11694103|FG000|Overall Study|Other|0
7419407|NCT01469052|11694104|FG001|Overall Study|Other|1
7419408|NCT01469052|11694105|FG002|Overall Study|Other|0
7419409|NCT01469052|11694106|FG003|Overall Study|Other|0
7419410|NCT01469052|11694107|FG004|Overall Study|Other|1
7419411|NCT01469052|11694108|FG005|Overall Study|Other|0
7419412|NCT01469065|11694125|FG000|Overall Study|Lack of Efficacy|0
7419413|NCT01469065|11694126|FG001|Overall Study|Lack of Efficacy|0
7419414|NCT01469065|11694127|FG002|Overall Study|Lack of Efficacy|0
7419415|NCT01469065|11694128|FG003|Overall Study|Lack of Efficacy|0
7419416|NCT01469065|11694129|FG004|Overall Study|Lack of Efficacy|1
7419417|NCT01469065|11694125|FG000|Overall Study|Other|0
7419418|NCT01469065|11694126|FG001|Overall Study|Other|1
7419419|NCT01469065|11694127|FG002|Overall Study|Other|0
7419420|NCT01469065|11694128|FG003|Overall Study|Other|0
7531568|NCT02654054|11876239|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7531569|NCT02654054|11876240|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7531570|NCT02654054|11876241|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
7531571|NCT02654054|11876239|FG000|Post-Treatment Follow-Up Period|Other|1
7531572|NCT02654054|11876240|FG001|Post-Treatment Follow-Up Period|Other|0
7531573|NCT02654054|11876241|FG002|Post-Treatment Follow-Up Period|Other|4
7531574|NCT02654054|11876239|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7531575|NCT02654054|11876240|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7531576|NCT02654054|11876241|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
7531577|NCT02654145|11876250|FG000|Overall Study|Lack of Efficacy|1
7531578|NCT02654145|11876250|FG000|Overall Study|Protocol Violation|1
7531579|NCT02654145|11876250|FG000|Overall Study|Withdrawal by Subject|5
7531580|NCT02654717|11876284|FG000|Overall Study|Adverse Event|2
7531581|NCT02654717|11876285|FG001|Overall Study|Adverse Event|2
7531582|NCT02654717|11876284|FG000|Overall Study|Protocol Violation|1
7531583|NCT02654717|11876285|FG001|Overall Study|Protocol Violation|2
7531584|NCT02654717|11876284|FG000|Overall Study|Withdrawal by Subject|0
7531585|NCT02654717|11876285|FG001|Overall Study|Withdrawal by Subject|1
7531586|NCT02654717|11876284|FG000|Overall Study|Non-permitted medication|3
7531587|NCT02654717|11876285|FG001|Overall Study|Non-permitted medication|0
7419421|NCT01469065|11694129|FG004|Overall Study|Other|0
7419422|NCT01469182|11694147|FG000|Overall Study|Adverse Event|21
7419423|NCT01469182|11694148|FG001|Overall Study|Adverse Event|3
7419424|NCT01469182|11694147|FG000|Overall Study|Lost to Follow-up|3
7531588|NCT02654977|11876342|FG000|Overall Study|Death|1
7531589|NCT02654977|11876342|FG000|Overall Study|Lost to Follow-up|1
7531590|NCT02654977|11876342|FG000|Overall Study|Adverse Event|1
7531591|NCT02654977|11876342|FG000|Overall Study|Withdrawal by Subject|1
7419425|NCT01469182|11694148|FG001|Overall Study|Lost to Follow-up|0
7419426|NCT01469182|11694147|FG000|Overall Study|Withdrawal by Subject|4
7419427|NCT01469182|11694148|FG001|Overall Study|Withdrawal by Subject|1
7419428|NCT01469182|11694147|FG000|Overall Study|Protocol Violation|4
7419429|NCT01469182|11694148|FG001|Overall Study|Protocol Violation|2
7419430|NCT01469182|11694147|FG000|Overall Study|Did not meet Protocol Eligibility|3
7531592|NCT02654977|11876342|FG000|Overall Study|Lack of Efficacy|3
7531593|NCT02655224|11876348|FG000|Overall Study|Adverse Event|1
7531594|NCT02655224|11876349|FG001|Overall Study|Adverse Event|1
7531595|NCT02655237|11876357|FG000|Overall Study|Adverse Event|10
7531596|NCT02655237|11876358|FG001|Overall Study|Adverse Event|7
7531597|NCT02655237|11876357|FG000|Overall Study|Protocol Deviation|2
7531598|NCT02655237|11876358|FG001|Overall Study|Protocol Deviation|0
7531599|NCT02655237|11876357|FG000|Overall Study|Withdrawal by Participant|1
7327677|NCT00791258|11560309|FG000|Overall Study|Adverse Event|87
7419431|NCT01469182|11694148|FG001|Overall Study|Did not meet Protocol Eligibility|0
7419432|NCT01469221|11694156|FG000|Double Blind Phase|Protocol Violation|1
7419433|NCT01469221|11694157|FG001|Double Blind Phase|Protocol Violation|0
7419434|NCT01469221|11694158|FG002|Double Blind Phase|Protocol Violation|0
7419435|NCT01469221|11694156|FG000|Double Blind Phase|Physician Decision|1
7419436|NCT01469221|11694157|FG001|Double Blind Phase|Physician Decision|1
7419437|NCT01469221|11694158|FG002|Double Blind Phase|Physician Decision|0
7419438|NCT01469221|11694156|FG000|Double Blind Phase|Sponsor Terminate Study|12
7419439|NCT01469221|11694157|FG001|Double Blind Phase|Sponsor Terminate Study|16
7419440|NCT01469221|11694158|FG002|Double Blind Phase|Sponsor Terminate Study|0
7419441|NCT01469364|11694178|FG000|Overall Study|Adverse Event|1
7419442|NCT01469364|11694178|FG000|Overall Study|Withdrawal by Subject|1
7419443|NCT01469377|11694185|FG000|Overall Study|Protocol Deviation|7
7419444|NCT01469377|11694186|FG001|Overall Study|Protocol Deviation|10
7419445|NCT01469377|11694187|FG002|Overall Study|Protocol Deviation|10
7419446|NCT01469377|11694185|FG000|Overall Study|Lost to Follow-up|3
7327678|NCT00791258|11560309|FG000|Overall Study|Lost to Follow-up|18
7327679|NCT00791258|11560309|FG000|Overall Study|Protocol Violation|109
7327680|NCT00791258|11560309|FG000|Overall Study|Withdrawal by Subject|40
7327681|NCT00791258|11560309|FG000|Overall Study|Did not take medication for >3 days|1
7327682|NCT00791258|11560309|FG000|Overall Study|subject left area|2
7327683|NCT00791258|11560309|FG000|Overall Study|non-compliance|3
7327684|NCT00791258|11560309|FG000|Overall Study|Subject incarcerated|1
7327685|NCT00791258|11560309|FG000|Overall Study|Subject required restricted medication|1
7327686|NCT00791258|11560309|FG000|Overall Study|Lack of Efficacy|1
7327687|NCT00791388|11560327|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7327688|NCT00791388|11560328|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
7327689|NCT00791388|11560329|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7327690|NCT00791388|11560330|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7327691|NCT00791388|11560331|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
7327692|NCT00791388|11560327|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
7327693|NCT00791388|11560328|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7327694|NCT00791388|11560329|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7327695|NCT00791388|11560330|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7327696|NCT00791388|11560331|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
7327697|NCT00791388|11560327|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
7327698|NCT00791388|11560328|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
7327699|NCT00791388|11560329|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
7327700|NCT00791388|11560330|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
7327701|NCT00791388|11560331|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
7327702|NCT00791479|11560349|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
7327703|NCT00791479|11560350|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
7327704|NCT00791479|11560351|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
7327705|NCT00791479|11560352|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
7327706|NCT00791479|11560353|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
7327707|NCT00791479|11560354|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
7327708|NCT00791479|11560349|FG000|Overall Study|Adverse Event|0
7327709|NCT00791479|11560350|FG001|Overall Study|Adverse Event|1
7327710|NCT00791479|11560351|FG002|Overall Study|Adverse Event|0
7327711|NCT00791479|11560352|FG003|Overall Study|Adverse Event|2
7327712|NCT00791479|11560353|FG004|Overall Study|Adverse Event|0
7327713|NCT00791479|11560354|FG005|Overall Study|Adverse Event|1
7327714|NCT00791479|11560349|FG000|Overall Study|Lost to Follow-up|0
7327715|NCT00791479|11560350|FG001|Overall Study|Lost to Follow-up|1
7327716|NCT00791479|11560351|FG002|Overall Study|Lost to Follow-up|0
7327717|NCT00791479|11560352|FG003|Overall Study|Lost to Follow-up|0
7327718|NCT00791479|11560353|FG004|Overall Study|Lost to Follow-up|0
7327719|NCT00791479|11560354|FG005|Overall Study|Lost to Follow-up|1
7327720|NCT00791479|11560349|FG000|Overall Study|Protocol Violation|2
7327721|NCT00791479|11560350|FG001|Overall Study|Protocol Violation|1
7327722|NCT00791479|11560351|FG002|Overall Study|Protocol Violation|0
7327723|NCT00791479|11560352|FG003|Overall Study|Protocol Violation|1
7327724|NCT00791479|11560353|FG004|Overall Study|Protocol Violation|0
7327725|NCT00791479|11560354|FG005|Overall Study|Protocol Violation|0
7327726|NCT00791479|11560349|FG000|Overall Study|Withdrawal by Subject|0
7327727|NCT00791479|11560350|FG001|Overall Study|Withdrawal by Subject|0
7327728|NCT00791479|11560351|FG002|Overall Study|Withdrawal by Subject|0
7327729|NCT00791479|11560352|FG003|Overall Study|Withdrawal by Subject|1
7327730|NCT00791479|11560353|FG004|Overall Study|Withdrawal by Subject|0
7531600|NCT02655237|11876358|FG001|Overall Study|Withdrawal by Participant|2
7419447|NCT01469377|11694186|FG001|Overall Study|Lost to Follow-up|2
7419448|NCT01469377|11694187|FG002|Overall Study|Lost to Follow-up|5
7419449|NCT01469377|11694185|FG000|Overall Study|Withdrawal of Consent|12
7419450|NCT01469377|11694186|FG001|Overall Study|Withdrawal of Consent|14
7419451|NCT01469377|11694187|FG002|Overall Study|Withdrawal of Consent|15
7419452|NCT01469377|11694185|FG000|Overall Study|Adverse Event|8
7419453|NCT01469377|11694186|FG001|Overall Study|Adverse Event|18
7419454|NCT01469377|11694187|FG002|Overall Study|Adverse Event|36
7419455|NCT01469377|11694185|FG000|Overall Study|Insufficient Therapeutic Response|3
7419456|NCT01469377|11694186|FG001|Overall Study|Insufficient Therapeutic Response|4
7419457|NCT01469377|11694187|FG002|Overall Study|Insufficient Therapeutic Response|0
7419458|NCT01469377|11694185|FG000|Overall Study|Other Miscellaneous Reasons|2
7419459|NCT01469377|11694186|FG001|Overall Study|Other Miscellaneous Reasons|0
7419460|NCT01469377|11694187|FG002|Overall Study|Other Miscellaneous Reasons|0
7419461|NCT01469546|11694195|FG000|Received 5 mg Dose|Adverse Event|13
7419462|NCT01469546|11694195|FG000|Received 5 mg Dose|Death|2
7419463|NCT01469546|11694195|FG000|Received 5 mg Dose|Protocol Violation|2
7419464|NCT01469546|11694195|FG000|Received 5 mg Dose|Progressive Disease|3
7419465|NCT01469546|11694195|FG000|Received 5 mg Dose|Physician Decision|3
7419466|NCT01469637|11694212|FG000|First Intervention|Unacceptable behavior|0
7419467|NCT01469637|11694213|FG001|First Intervention|Unacceptable behavior|1
7419468|NCT01469637|11694212|FG000|Second Intervention|Incarcerated|1
7419469|NCT01469637|11694213|FG001|Second Intervention|Incarcerated|0
7419470|NCT01469819|11694227|FG000|Overall Study|Withdrawal by Subject|1
7419471|NCT01469819|11694227|FG000|Overall Study|Did not meet inclusionary criteria|2
7419472|NCT01469819|11694227|FG000|Overall Study|Could not swallow SmartPill|2
7419473|NCT01469819|11694227|FG000|Overall Study|Technical malfunction of SmartPill data|3
7419474|NCT01470001|11694239|FG000|Overall Study|Lost to Follow-up|1
7419475|NCT01470001|11694240|FG001|Overall Study|Lost to Follow-up|1
7555995|NCT03070782|11919548|FG004|Overall Study|Adverse Event|6
7555996|NCT03070782|11919549|FG005|Overall Study|Adverse Event|2
7555997|NCT03070782|11919544|FG000|Overall Study|Withdrawal by Subject|2
7555998|NCT03070782|11919545|FG001|Overall Study|Withdrawal by Subject|1
7555999|NCT03070782|11919546|FG002|Overall Study|Withdrawal by Subject|1
7556000|NCT03070782|11919547|FG003|Overall Study|Withdrawal by Subject|0
7556001|NCT03070782|11919548|FG004|Overall Study|Withdrawal by Subject|4
7556002|NCT03070782|11919549|FG005|Overall Study|Withdrawal by Subject|3
7556003|NCT03070782|11919544|FG000|Overall Study|Reason Not Specified|2
7556004|NCT03070782|11919545|FG001|Overall Study|Reason Not Specified|0
7556005|NCT03070782|11919546|FG002|Overall Study|Reason Not Specified|0
7556006|NCT03070782|11919547|FG003|Overall Study|Reason Not Specified|1
7556007|NCT03070782|11919548|FG004|Overall Study|Reason Not Specified|2
7556008|NCT03070782|11919549|FG005|Overall Study|Reason Not Specified|1
7556009|NCT03070782|11919544|FG000|Overall Study|Ineligibility|0
7556010|NCT03070782|11919545|FG001|Overall Study|Ineligibility|0
7556011|NCT03070782|11919546|FG002|Overall Study|Ineligibility|0
7556012|NCT03070782|11919547|FG003|Overall Study|Ineligibility|1
7556013|NCT03070782|11919548|FG004|Overall Study|Ineligibility|0
7556014|NCT03070782|11919549|FG005|Overall Study|Ineligibility|1
7556015|NCT03070782|11919544|FG000|Overall Study|Pregnancy|0
7556016|NCT03070782|11919545|FG001|Overall Study|Pregnancy|0
7556017|NCT03070782|11919546|FG002|Overall Study|Pregnancy|0
7556018|NCT03070782|11919547|FG003|Overall Study|Pregnancy|1
7556019|NCT03070782|11919548|FG004|Overall Study|Pregnancy|0
7556020|NCT03070782|11919549|FG005|Overall Study|Pregnancy|0
7556021|NCT03070782|11919544|FG000|Overall Study|Investigator Judgement|0
7556022|NCT03070782|11919545|FG001|Overall Study|Investigator Judgement|0
7556023|NCT03070782|11919546|FG002|Overall Study|Investigator Judgement|0
7556024|NCT03070782|11919547|FG003|Overall Study|Investigator Judgement|1
7556025|NCT03070782|11919548|FG004|Overall Study|Investigator Judgement|0
7556026|NCT03070782|11919549|FG005|Overall Study|Investigator Judgement|0
7556027|NCT03070964|11919563|FG000|Overall Study|Progressive disease|8
7556028|NCT03070964|11919563|FG000|Overall Study|Treatment-unrelated adverse event|2
7556029|NCT03070964|11919563|FG000|Overall Study|Never treated|1
7556030|NCT03070964|11919563|FG000|Overall Study|Physician Decision|1
7556031|NCT03070964|11919563|FG000|Overall Study|Withdrawal by Subject|1
7556032|NCT03070964|11919563|FG000|Overall Study|Adverse Event|1
7556033|NCT03071094|11919569|FG000|Overall Study|Death|1
7556034|NCT03071094|11919570|FG001|Overall Study|Death|1
7556035|NCT03071094|11919569|FG000|Overall Study|Adverse Event|1
7556036|NCT03071094|11919570|FG001|Overall Study|Adverse Event|0
7556037|NCT03071263|11919578|FG000|Overall Study|Adverse Event|1
7556038|NCT03071263|11919579|FG001|Overall Study|Adverse Event|3
7556039|NCT03071263|11919578|FG000|Overall Study|Withdrawal by Subject|1
7556040|NCT03071263|11919579|FG001|Overall Study|Withdrawal by Subject|3
7419476|NCT01470001|11694239|FG000|Overall Study|Physician Decision|2
7419477|NCT01470001|11694240|FG001|Overall Study|Physician Decision|0
7556041|NCT03071263|11919578|FG000|Overall Study|Physician Decision|1
7556042|NCT03071263|11919579|FG001|Overall Study|Physician Decision|0
7556043|NCT03071263|11919578|FG000|Overall Study|Participant moved to another city|0
7556044|NCT03071263|11919579|FG001|Overall Study|Participant moved to another city|1
7556045|NCT03071276|11919585|FG000|Overall Study|Adverse Event|1
7556046|NCT03071276|11919585|FG000|Overall Study|Lack of Efficacy|14
7556047|NCT03072160|11919599|FG000|Overall Study|Adverse Event|3
7556048|NCT03072160|11919600|FG001|Overall Study|Adverse Event|1
7419478|NCT01470001|11694239|FG000|Overall Study|Withdrawal by Subject|2
7419479|NCT01470001|11694240|FG001|Overall Study|Withdrawal by Subject|1
7419480|NCT01470144|11694281|FG000|Overall Study|Adverse Event|2
7419481|NCT01470144|11694281|FG000|Overall Study|Death|1
7419482|NCT01470144|11694281|FG000|Overall Study|Lung transplant|6
7419483|NCT01470144|11694281|FG000|Overall Study|Patient's and investigator's decision|1
7419484|NCT01470248|11694310|FG000|Overall Study|Withdrawal by Subject|1
7419485|NCT01470417|11694316|FG000|Overall Study|Disease progression|0
7419486|NCT01470417|11694317|FG001|Overall Study|Disease progression|2
7419487|NCT01470469|11694325|FG000|Overall Study|Withdrawal by Subject|4
7419488|NCT01470469|11694326|FG001|Overall Study|Withdrawal by Subject|6
7419489|NCT01470469|11694325|FG000|Overall Study|Lack of Efficacy|1
7419490|NCT01470469|11694326|FG001|Overall Study|Lack of Efficacy|7
7419491|NCT01470469|11694325|FG000|Overall Study|Adverse Event|0
7419492|NCT01470469|11694326|FG001|Overall Study|Adverse Event|7
7419493|NCT01470469|11694325|FG000|Overall Study|Lost to Follow-up|2
7419494|NCT01470469|11694326|FG001|Overall Study|Lost to Follow-up|2
7419495|NCT01470469|11694325|FG000|Overall Study|Protocol Violation|1
7419496|NCT01470469|11694326|FG001|Overall Study|Protocol Violation|1
7419497|NCT01470469|11694325|FG000|Overall Study|Other|2
7556049|NCT03072160|11919599|FG000|Overall Study|Refused further treatment|6
7556050|NCT03072160|11919600|FG001|Overall Study|Refused further treatment|1
7556051|NCT03072160|11919599|FG000|Overall Study|Physician Decision|1
7556052|NCT03072160|11919600|FG001|Overall Study|Physician Decision|0
7556053|NCT03072160|11919599|FG000|Overall Study|Disease progression on study|1
7556054|NCT03072160|11919600|FG001|Overall Study|Disease progression on study|1
7556055|NCT03072160|11919599|FG000|Overall Study|No contact|0
7556056|NCT03072160|11919600|FG001|Overall Study|No contact|1
7556057|NCT03072719|11919657|FG000|Overall Study|Adverse Event|1
7556058|NCT03072719|11919658|FG001|Overall Study|Adverse Event|1
7556059|NCT03072875|11919673|FG000|Overall Study|Lost to Follow-up|1
7556060|NCT03073005|11919686|FG000|Overall Study|Death|6
7556061|NCT03073005|11919687|FG001|Overall Study|Death|0
7556062|NCT03073005|11919688|FG002|Overall Study|Death|7
7556063|NCT03073005|11919689|FG003|Overall Study|Death|0
7556064|NCT03073005|11919686|FG000|Overall Study|caregiver withdrew bc of pt death|0
7556065|NCT03073005|11919687|FG001|Overall Study|caregiver withdrew bc of pt death|6
7556066|NCT03073005|11919688|FG002|Overall Study|caregiver withdrew bc of pt death|0
7556067|NCT03073005|11919689|FG003|Overall Study|caregiver withdrew bc of pt death|7
7556068|NCT03073005|11919686|FG000|Overall Study|Lost to Follow-up|2
7556069|NCT03073005|11919687|FG001|Overall Study|Lost to Follow-up|2
7556070|NCT03073005|11919688|FG002|Overall Study|Lost to Follow-up|1
7556071|NCT03073005|11919689|FG003|Overall Study|Lost to Follow-up|2
7556072|NCT03073005|11919686|FG000|Overall Study|Withdrawal by Subject|0
7556073|NCT03073005|11919687|FG001|Overall Study|Withdrawal by Subject|4
7556074|NCT03073005|11919688|FG002|Overall Study|Withdrawal by Subject|4
7556075|NCT03073005|11919689|FG003|Overall Study|Withdrawal by Subject|4
7556076|NCT03073109|11919704|FG000|Overall Study|Adverse Event|0
7556077|NCT03073109|11919705|FG001|Overall Study|Adverse Event|1
7556078|NCT03073109|11919704|FG000|Overall Study|Other|2
7556079|NCT03073109|11919705|FG001|Overall Study|Other|0
7556080|NCT03073109|11919704|FG000|Overall Study|Lost to Follow-up|8
7556081|NCT03073109|11919705|FG001|Overall Study|Lost to Follow-up|1
7556082|NCT03073200|11919740|FG000|Double Blind Treatment Period|Protocol Violation|1
7556083|NCT03073200|11919741|FG001|Double Blind Treatment Period|Protocol Violation|0
7556084|NCT03073200|11919742|FG002|Double Blind Treatment Period|Protocol Violation|0
7556085|NCT03073200|11919743|FG003|Double Blind Treatment Period|Protocol Violation|0
7556086|NCT03073200|11919744|FG004|Double Blind Treatment Period|Protocol Violation|0
7556087|NCT03073200|11919745|FG005|Double Blind Treatment Period|Protocol Violation|0
7556088|NCT03073200|11919746|FG006|Double Blind Treatment Period|Protocol Violation|0
7556089|NCT03073200|11919747|FG007|Double Blind Treatment Period|Protocol Violation|0
7556090|NCT03073200|11919748|FG008|Double Blind Treatment Period|Protocol Violation|0
7556091|NCT03073200|11919749|FG009|Double Blind Treatment Period|Protocol Violation|0
7556092|NCT03073200|11919750|FG010|Double Blind Treatment Period|Protocol Violation|0
7556093|NCT03073200|11919751|FG011|Double Blind Treatment Period|Protocol Violation|0
7556094|NCT03073200|11919752|FG012|Double Blind Treatment Period|Protocol Violation|0
7556095|NCT03073200|11919753|FG013|Double Blind Treatment Period|Protocol Violation|0
7556096|NCT03073200|11919754|FG014|Double Blind Treatment Period|Protocol Violation|0
7556097|NCT03073200|11919740|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556098|NCT03073200|11919741|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
7556099|NCT03073200|11919742|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556100|NCT03073200|11919743|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556101|NCT03073200|11919744|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556102|NCT03073200|11919745|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556103|NCT03073200|11919746|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556104|NCT03073200|11919747|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556105|NCT03073200|11919748|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7419498|NCT01470469|11694326|FG001|Overall Study|Other|1
7466555|NCT01892189|11766381|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7466556|NCT01892189|11766382|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7574685|NCT03687827|11957739|FG001|Treatment Period 1|Withdrawal by Subject|3
7419499|NCT01470599|11694334|FG000|Overall Study|Did not meet entrance criteria|1
7419500|NCT01470599|11694335|FG001|Overall Study|Did not meet entrance criteria|0
7419501|NCT01470599|11694334|FG000|Overall Study|Lost to Follow-up|2
7419502|NCT01470599|11694335|FG001|Overall Study|Lost to Follow-up|1
7556106|NCT03073200|11919749|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556107|NCT03073200|11919750|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556108|NCT03073200|11919751|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556109|NCT03073200|11919752|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556110|NCT03073200|11919753|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556111|NCT03073200|11919754|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
7556112|NCT03073200|11919740|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
7556113|NCT03073200|11919741|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7556114|NCT03073200|11919742|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
7556115|NCT03073200|11919743|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
7556116|NCT03073200|11919744|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7556117|NCT03073200|11919745|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
7556118|NCT03073200|11919746|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
7556119|NCT03073200|11919747|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
7556120|NCT03073200|11919748|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
7556121|NCT03073200|11919749|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
7556122|NCT03073200|11919750|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
7556123|NCT03073200|11919751|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
7556124|NCT03073200|11919752|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
7556125|NCT03073200|11919753|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
7556126|NCT03073200|11919754|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
7556127|NCT03073200|11919740|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
7556128|NCT03073200|11919741|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
7556129|NCT03073200|11919742|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
7556130|NCT03073200|11919743|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
7556131|NCT03073200|11919744|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
7556132|NCT03073200|11919745|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
7556133|NCT03073200|11919746|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
7556134|NCT03073200|11919747|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
7556135|NCT03073200|11919748|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
7556136|NCT03073200|11919749|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
7556137|NCT03073200|11919750|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
7556138|NCT03073200|11919751|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
7556139|NCT03073200|11919752|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
7556140|NCT03073200|11919753|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
7556141|NCT03073200|11919754|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
7556142|NCT03073200|11919740|FG000|Open-Label Maintenance Period|Participant moved to another city|0
7556143|NCT03073200|11919741|FG001|Open-Label Maintenance Period|Participant moved to another city|0
7556144|NCT03073200|11919742|FG002|Open-Label Maintenance Period|Participant moved to another city|0
7556145|NCT03073200|11919743|FG003|Open-Label Maintenance Period|Participant moved to another city|1
7556146|NCT03073200|11919744|FG004|Open-Label Maintenance Period|Participant moved to another city|0
7556147|NCT03073200|11919745|FG005|Open-Label Maintenance Period|Participant moved to another city|0
7556148|NCT03073200|11919746|FG006|Open-Label Maintenance Period|Participant moved to another city|0
7556149|NCT03073200|11919747|FG007|Open-Label Maintenance Period|Participant moved to another city|0
7556150|NCT03073200|11919748|FG008|Open-Label Maintenance Period|Participant moved to another city|0
7556151|NCT03073200|11919749|FG009|Open-Label Maintenance Period|Participant moved to another city|0
7556152|NCT03073200|11919750|FG010|Open-Label Maintenance Period|Participant moved to another city|0
7556153|NCT03073200|11919751|FG011|Open-Label Maintenance Period|Participant moved to another city|0
7556154|NCT03073200|11919752|FG012|Open-Label Maintenance Period|Participant moved to another city|0
7556155|NCT03073200|11919753|FG013|Open-Label Maintenance Period|Participant moved to another city|0
7556156|NCT03073200|11919754|FG014|Open-Label Maintenance Period|Participant moved to another city|0
7556157|NCT03073200|11919740|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
7556158|NCT03073200|11919741|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
7556159|NCT03073200|11919742|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
7556160|NCT03073200|11919743|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
7556161|NCT03073200|11919744|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
7556162|NCT03073200|11919745|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
7556163|NCT03073200|11919746|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
7556164|NCT03073200|11919747|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
7556165|NCT03073200|11919748|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
7556166|NCT03073200|11919749|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
7556167|NCT03073200|11919750|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
7556168|NCT03073200|11919751|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
7556169|NCT03073200|11919752|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
7556170|NCT03073200|11919753|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
7556171|NCT03073200|11919754|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
7556172|NCT03073200|11919740|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
7419503|NCT01470599|11694334|FG000|Overall Study|Withdrawal by Subject|3
7419504|NCT01470599|11694335|FG001|Overall Study|Withdrawal by Subject|4
7419505|NCT01470599|11694334|FG000|Overall Study|Other|1
7419506|NCT01470599|11694335|FG001|Overall Study|Other|0
7556173|NCT03073200|11919741|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
7556174|NCT03073200|11919742|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
7556175|NCT03073200|11919743|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
7556176|NCT03073200|11919744|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
7556177|NCT03073200|11919745|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
7556178|NCT03073200|11919746|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
7556179|NCT03073200|11919747|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
7556180|NCT03073200|11919748|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
7556181|NCT03073200|11919749|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
7556182|NCT03073200|11919750|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
7556183|NCT03073200|11919751|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
7556184|NCT03073200|11919752|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
7556185|NCT03073200|11919753|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
7556186|NCT03073200|11919754|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
7556187|NCT03073200|11919740|FG000|Extension Period|Lost to Follow-up|0
7556188|NCT03073200|11919741|FG001|Extension Period|Lost to Follow-up|0
7556189|NCT03073200|11919742|FG002|Extension Period|Lost to Follow-up|0
7556190|NCT03073200|11919743|FG003|Extension Period|Lost to Follow-up|0
7556191|NCT03073200|11919744|FG004|Extension Period|Lost to Follow-up|0
7556192|NCT03073200|11919745|FG005|Extension Period|Lost to Follow-up|0
7556193|NCT03073200|11919746|FG006|Extension Period|Lost to Follow-up|1
7556194|NCT03073200|11919747|FG007|Extension Period|Lost to Follow-up|1
7556195|NCT03073200|11919748|FG008|Extension Period|Lost to Follow-up|0
7556196|NCT03073200|11919749|FG009|Extension Period|Lost to Follow-up|0
7556197|NCT03073200|11919750|FG010|Extension Period|Lost to Follow-up|0
7556198|NCT03073200|11919751|FG011|Extension Period|Lost to Follow-up|0
7556199|NCT03073200|11919752|FG012|Extension Period|Lost to Follow-up|0
7556200|NCT03073200|11919753|FG013|Extension Period|Lost to Follow-up|0
7556201|NCT03073200|11919754|FG014|Extension Period|Lost to Follow-up|0
7556202|NCT03073200|11919740|FG000|Extension Period|Sponsor Decision|0
7556203|NCT03073200|11919741|FG001|Extension Period|Sponsor Decision|0
7556204|NCT03073200|11919742|FG002|Extension Period|Sponsor Decision|0
7556205|NCT03073200|11919743|FG003|Extension Period|Sponsor Decision|0
7556206|NCT03073200|11919744|FG004|Extension Period|Sponsor Decision|0
7556207|NCT03073200|11919745|FG005|Extension Period|Sponsor Decision|0
7556208|NCT03073200|11919746|FG006|Extension Period|Sponsor Decision|0
7556209|NCT03073200|11919747|FG007|Extension Period|Sponsor Decision|0
7556210|NCT03073200|11919748|FG008|Extension Period|Sponsor Decision|1
7556211|NCT03073200|11919749|FG009|Extension Period|Sponsor Decision|0
7556212|NCT03073200|11919750|FG010|Extension Period|Sponsor Decision|0
7556213|NCT03073200|11919751|FG011|Extension Period|Sponsor Decision|0
7556214|NCT03073200|11919752|FG012|Extension Period|Sponsor Decision|0
7556215|NCT03073200|11919753|FG013|Extension Period|Sponsor Decision|0
7556216|NCT03073200|11919754|FG014|Extension Period|Sponsor Decision|0
7556217|NCT03073200|11919740|FG000|Extension Period|Withdrawal by Parent/Guardian|0
7556218|NCT03073200|11919741|FG001|Extension Period|Withdrawal by Parent/Guardian|0
7556219|NCT03073200|11919742|FG002|Extension Period|Withdrawal by Parent/Guardian|0
7556220|NCT03073200|11919743|FG003|Extension Period|Withdrawal by Parent/Guardian|0
7556221|NCT03073200|11919744|FG004|Extension Period|Withdrawal by Parent/Guardian|0
7556222|NCT03073200|11919745|FG005|Extension Period|Withdrawal by Parent/Guardian|0
7556223|NCT03073200|11919746|FG006|Extension Period|Withdrawal by Parent/Guardian|1
7556224|NCT03073200|11919747|FG007|Extension Period|Withdrawal by Parent/Guardian|3
7556225|NCT03073200|11919748|FG008|Extension Period|Withdrawal by Parent/Guardian|1
7556226|NCT03073200|11919749|FG009|Extension Period|Withdrawal by Parent/Guardian|0
7556227|NCT03073200|11919750|FG010|Extension Period|Withdrawal by Parent/Guardian|0
7556228|NCT03073200|11919751|FG011|Extension Period|Withdrawal by Parent/Guardian|0
7556229|NCT03073200|11919752|FG012|Extension Period|Withdrawal by Parent/Guardian|0
7556230|NCT03073200|11919753|FG013|Extension Period|Withdrawal by Parent/Guardian|0
7556231|NCT03073200|11919754|FG014|Extension Period|Withdrawal by Parent/Guardian|0
7556232|NCT03073200|11919740|FG000|Extension Period|Withdrawal by Subject|0
7556233|NCT03073200|11919741|FG001|Extension Period|Withdrawal by Subject|0
7556234|NCT03073200|11919742|FG002|Extension Period|Withdrawal by Subject|0
7556235|NCT03073200|11919743|FG003|Extension Period|Withdrawal by Subject|0
7556236|NCT03073200|11919744|FG004|Extension Period|Withdrawal by Subject|0
7556237|NCT03073200|11919745|FG005|Extension Period|Withdrawal by Subject|0
7556238|NCT03073200|11919746|FG006|Extension Period|Withdrawal by Subject|1
7556239|NCT03073200|11919747|FG007|Extension Period|Withdrawal by Subject|2
7556240|NCT03073200|11919748|FG008|Extension Period|Withdrawal by Subject|0
7556241|NCT03073200|11919749|FG009|Extension Period|Withdrawal by Subject|0
7556242|NCT03073200|11919750|FG010|Extension Period|Withdrawal by Subject|0
7556243|NCT03073200|11919751|FG011|Extension Period|Withdrawal by Subject|0
7556244|NCT03073200|11919752|FG012|Extension Period|Withdrawal by Subject|0
7556245|NCT03073200|11919753|FG013|Extension Period|Withdrawal by Subject|0
7556246|NCT03073200|11919754|FG014|Extension Period|Withdrawal by Subject|0
7419507|NCT01470599|11694334|FG000|Overall Study|Protocol Violation|3
7419508|NCT01470599|11694335|FG001|Overall Study|Protocol Violation|1
7419509|NCT01470599|11694334|FG000|Overall Study|Adverse event related to study drug|2
7419510|NCT01470599|11694335|FG001|Overall Study|Adverse event related to study drug|5
7419511|NCT01470599|11694334|FG000|Overall Study|Insufficient clinical response|6
7419512|NCT01470599|11694335|FG001|Overall Study|Insufficient clinical response|27
7419513|NCT01470599|11694334|FG000|Overall Study|Adverse event not related to study drug|1
7419514|NCT01470599|11694335|FG001|Overall Study|Adverse event not related to study drug|5
7419515|NCT01470612|11694343|FG000|Overall Study|Adverse Event|20
7419516|NCT01470612|11694344|FG001|Overall Study|Adverse Event|80
7419517|NCT01470612|11694343|FG000|Overall Study|Death|0
7419518|NCT01470612|11694344|FG001|Overall Study|Death|1
7419519|NCT01470612|11694343|FG000|Overall Study|Lack of Efficacy|20
7419520|NCT01470612|11694344|FG001|Overall Study|Lack of Efficacy|326
7556247|NCT03073200|11919740|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7556248|NCT03073200|11919741|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7556249|NCT03073200|11919742|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
7556250|NCT03073200|11919743|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7556251|NCT03073200|11919744|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7556252|NCT03073200|11919745|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
7556253|NCT03073200|11919746|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
7556254|NCT03073200|11919747|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
7556255|NCT03073200|11919748|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
7556256|NCT03073200|11919749|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
7556257|NCT03073200|11919750|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
7556258|NCT03073200|11919751|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
7556259|NCT03073200|11919752|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
7556260|NCT03073200|11919753|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
7556261|NCT03073200|11919754|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
7556262|NCT03073200|11919740|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556263|NCT03073200|11919741|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556264|NCT03073200|11919742|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556265|NCT03073200|11919743|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556266|NCT03073200|11919744|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556267|NCT03073200|11919745|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556268|NCT03073200|11919746|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556269|NCT03073200|11919747|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556270|NCT03073200|11919748|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556271|NCT03073200|11919749|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556272|NCT03073200|11919750|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556273|NCT03073200|11919751|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
7556274|NCT03073200|11919752|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556275|NCT03073200|11919753|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556276|NCT03073200|11919754|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
7556277|NCT03073200|11919740|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7556278|NCT03073200|11919741|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7556279|NCT03073200|11919742|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7556280|NCT03073200|11919743|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7556281|NCT03073200|11919744|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
7556282|NCT03073200|11919745|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
7556283|NCT03073200|11919746|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
7556284|NCT03073200|11919747|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
7556285|NCT03073200|11919748|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
7556286|NCT03073200|11919749|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
7556287|NCT03073200|11919750|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
7556288|NCT03073200|11919751|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
7556289|NCT03073200|11919752|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
7556290|NCT03073200|11919753|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
7556291|NCT03073200|11919754|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
7556292|NCT03073200|11919740|FG000|Randomized Withdrawal Period|Adverse Event|0
7556293|NCT03073200|11919741|FG001|Randomized Withdrawal Period|Adverse Event|0
7556294|NCT03073200|11919742|FG002|Randomized Withdrawal Period|Adverse Event|0
7556295|NCT03073200|11919743|FG003|Randomized Withdrawal Period|Adverse Event|0
7556296|NCT03073200|11919744|FG004|Randomized Withdrawal Period|Adverse Event|0
7556297|NCT03073200|11919745|FG005|Randomized Withdrawal Period|Adverse Event|0
7556298|NCT03073200|11919746|FG006|Randomized Withdrawal Period|Adverse Event|0
7556299|NCT03073200|11919747|FG007|Randomized Withdrawal Period|Adverse Event|0
7556300|NCT03073200|11919748|FG008|Randomized Withdrawal Period|Adverse Event|0
7556301|NCT03073200|11919749|FG009|Randomized Withdrawal Period|Adverse Event|0
7556302|NCT03073200|11919750|FG010|Randomized Withdrawal Period|Adverse Event|1
7419521|NCT01470612|11694343|FG000|Overall Study|Lost to Follow-up|2
7419522|NCT01470612|11694344|FG001|Overall Study|Lost to Follow-up|5
7419523|NCT01470612|11694343|FG000|Overall Study|Did not meet entrance criteria|0
7419524|NCT01470612|11694344|FG001|Overall Study|Did not meet entrance criteria|1
7419525|NCT01470612|11694343|FG000|Overall Study|Pregnancy|2
7419526|NCT01470612|11694344|FG001|Overall Study|Pregnancy|10
7419527|NCT01470612|11694343|FG000|Overall Study|Protocol Violation|2
7419528|NCT01470612|11694344|FG001|Overall Study|Protocol Violation|7
7419529|NCT01470612|11694343|FG000|Overall Study|Withdrawal by Subject|24
7419530|NCT01470612|11694344|FG001|Overall Study|Withdrawal by Subject|79
7419531|NCT01470612|11694343|FG000|Overall Study|Other|14
7419532|NCT01470612|11694344|FG001|Overall Study|Other|156
7419533|NCT01470989|11694380|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
7419534|NCT01470989|11694381|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
7419535|NCT01470989|11694380|FG000|Overall Study|Adverse Event|2
7419536|NCT01470989|11694381|FG001|Overall Study|Adverse Event|5
7419537|NCT01470989|11694380|FG000|Overall Study|Abnormal laboratory value|1
7419538|NCT01470989|11694381|FG001|Overall Study|Abnormal laboratory value|1
7419539|NCT01470989|11694380|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7419540|NCT01470989|11694381|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7419541|NCT01470989|11694380|FG000|Overall Study|Withdrawal by Subject|19
7419542|NCT01470989|11694381|FG001|Overall Study|Withdrawal by Subject|17
7419543|NCT01470989|11694380|FG000|Overall Study|Lost to Follow-up|18
7419544|NCT01470989|11694381|FG001|Overall Study|Lost to Follow-up|13
7419545|NCT01470989|11694380|FG000|Overall Study|Administrative problems|2
7419546|NCT01470989|11694381|FG001|Overall Study|Administrative problems|4
7419547|NCT01470989|11694380|FG000|Overall Study|Death|2
7419548|NCT01470989|11694381|FG001|Overall Study|Death|2
7419549|NCT01470989|11694380|FG000|Overall Study|Protocol deviation|1
7419550|NCT01470989|11694381|FG001|Overall Study|Protocol deviation|2
7419551|NCT01471015|11694392|FG000|Overall Study|Death|0
7419552|NCT01471015|11694393|FG001|Overall Study|Death|1
7419553|NCT01471015|11694394|FG002|Overall Study|Death|1
7419554|NCT01471028|11694404|FG000|VTI-208|Adverse Event|39
7419555|NCT01471028|11694405|FG001|VTI-208|Adverse Event|41
7419556|NCT01471028|11694404|FG000|VTI-208|Withdrawal by Subject|0
7419557|NCT01471028|11694405|FG001|VTI-208|Withdrawal by Subject|2
7419558|NCT01471028|11694404|FG000|VTI-208|Lost to Follow-up|1
7419559|NCT01471028|11694405|FG001|VTI-208|Lost to Follow-up|1
7419560|NCT01471028|11694404|FG000|VTI-208E|Death|7
7419561|NCT01471028|11694405|FG001|VTI-208E|Death|10
7419562|NCT01471028|11694404|FG000|VTI-208E|Withdrawal by Subject|1
7419563|NCT01471028|11694405|FG001|VTI-208E|Withdrawal by Subject|0
7419564|NCT01471028|11694404|FG000|VTI-208E|Lost to Follow-up|0
7419565|NCT01471028|11694405|FG001|VTI-208E|Lost to Follow-up|2
7419566|NCT01471054|11694420|FG000|Overall Study|Study terminated prematurely|4
7419567|NCT01471054|11694421|FG001|Overall Study|Study terminated prematurely|0
7419568|NCT01471093|11694439|FG000|Overall Study|Adverse Event|1
7419569|NCT01471093|11694440|FG001|Overall Study|Adverse Event|0
7419570|NCT01471093|11694441|FG002|Overall Study|Adverse Event|0
7419571|NCT01471093|11694442|FG003|Overall Study|Adverse Event|0
7419572|NCT01471171|11694448|FG000|Treatment Period 1|Adverse Event|4
7419573|NCT01471171|11694449|FG001|Treatment Period 1|Adverse Event|1
7419574|NCT01471171|11694448|FG000|Treatment Period 2|Adverse Event|1
7556303|NCT03073200|11919751|FG011|Randomized Withdrawal Period|Adverse Event|0
7556304|NCT03073200|11919752|FG012|Randomized Withdrawal Period|Adverse Event|0
7556305|NCT03073200|11919753|FG013|Randomized Withdrawal Period|Adverse Event|0
7556306|NCT03073200|11919754|FG014|Randomized Withdrawal Period|Adverse Event|0
7556307|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7556308|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7556309|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
7556310|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
7556311|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
7556312|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
7556313|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
7556314|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
7556315|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
7556316|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
7556317|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
7556318|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
7556319|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
7419575|NCT01471171|11694449|FG001|Treatment Period 2|Adverse Event|0
7419576|NCT01471197|11694457|FG000|Overall Study|Disease Progression|4
7419577|NCT01471197|11694458|FG001|Overall Study|Disease Progression|2
7419578|NCT01471197|11694457|FG000|Overall Study|Death|1
7419579|NCT01471197|11694458|FG001|Overall Study|Death|0
7419580|NCT01471197|11694457|FG000|Overall Study|Study Drug Toxicity|1
7419581|NCT01471197|11694458|FG001|Overall Study|Study Drug Toxicity|0
7419582|NCT01471353|11694464|FG000|Overall Study|remain on study|3
7419583|NCT01471379|11694471|FG000|Overall Study|Adverse Event|1
7419584|NCT01471379|11694472|FG001|Overall Study|Adverse Event|0
7419585|NCT01471379|11694473|FG002|Overall Study|Adverse Event|0
7419586|NCT01471379|11694471|FG000|Overall Study|Study terminated|0
7419587|NCT01471379|11694472|FG001|Overall Study|Study terminated|1
7419588|NCT01471379|11694473|FG002|Overall Study|Study terminated|0
7556320|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
7556321|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
7556322|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556323|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556324|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556325|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556326|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7419593|NCT01471574|11694505|FG000|Treatment Period|Lack of Efficacy|12
7419594|NCT01471574|11694506|FG001|Treatment Period|Lack of Efficacy|4
7556327|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556328|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556329|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556330|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556331|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556332|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556333|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556334|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556335|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7556336|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7556337|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556338|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556339|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556340|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556341|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556342|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556343|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556344|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556345|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556346|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556347|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556348|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556349|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556350|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
7556351|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
7556352|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7556353|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7556354|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7556355|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7556356|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7556357|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7556358|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7556359|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7556360|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7556361|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7556362|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7556363|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7556364|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7556365|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7556366|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
7556367|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556368|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556369|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556370|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556371|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556372|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556373|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556374|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556375|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556376|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556377|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556378|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556379|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556380|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
7556381|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
7556382|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556383|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7419595|NCT01471574|11694507|FG002|Treatment Period|Lack of Efficacy|14
7419596|NCT01471574|11694508|FG003|Treatment Period|Lack of Efficacy|1
7419597|NCT01471574|11694505|FG000|Treatment Period|Adverse Event|7
7419598|NCT01471574|11694506|FG001|Treatment Period|Adverse Event|3
7419599|NCT01471574|11694507|FG002|Treatment Period|Adverse Event|6
7419600|NCT01471574|11694508|FG003|Treatment Period|Adverse Event|1
7556384|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556385|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556386|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556387|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556388|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556389|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556390|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556391|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556392|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556393|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556394|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556395|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
7556396|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
7556397|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556398|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556399|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7327731|NCT00791479|11560354|FG005|Overall Study|Withdrawal by Subject|1
7327732|NCT00791492|11560377|FG000|Overall Study|Withdrawal by Subject|1
7556400|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556401|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556402|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556403|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556404|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556405|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556406|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556407|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556408|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556409|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556410|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
7556411|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7556412|NCT03073200|11919740|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556413|NCT03073200|11919741|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556414|NCT03073200|11919742|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556415|NCT03073200|11919743|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556416|NCT03073200|11919744|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556417|NCT03073200|11919745|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556418|NCT03073200|11919746|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556419|NCT03073200|11919747|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556420|NCT03073200|11919748|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556421|NCT03073200|11919749|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556422|NCT03073200|11919750|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556423|NCT03073200|11919751|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556424|NCT03073200|11919752|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556425|NCT03073200|11919753|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
7556426|NCT03073200|11919754|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
7556427|NCT03073213|11919779|FG000|Multiple Dose Period|Protocol Violation|0
7556428|NCT03073213|11919780|FG001|Multiple Dose Period|Protocol Violation|0
7556429|NCT03073213|11919781|FG002|Multiple Dose Period|Protocol Violation|1
7556430|NCT03073798|11919809|FG000|Overall Study|Adverse Event|1
7327733|NCT00791492|11560378|FG001|Overall Study|Withdrawal by Subject|2
7327734|NCT00791492|11560377|FG000|Overall Study|Liver transplantation|5
7327735|NCT00791492|11560378|FG001|Overall Study|Liver transplantation|1
7327736|NCT00791518|11560384|FG000|Overall Study|Protocol Violation|93
7327737|NCT00791557|11560403|FG000|Overall Study|Adverse Event|1
7327738|NCT00791648|11560409|FG000|Overall Study|Physician Decision|0
7327739|NCT00791648|11560410|FG001|Overall Study|Physician Decision|1
7327740|NCT00791648|11560409|FG000|Overall Study|Withdrawal by Subject|0
7327741|NCT00791648|11560410|FG001|Overall Study|Withdrawal by Subject|1
7327742|NCT00791661|11560419|FG000|7 Day Wash-out|Adverse Event|0
7327743|NCT00791661|11560420|FG001|7 Day Wash-out|Adverse Event|0
7327744|NCT00791661|11560421|FG002|7 Day Wash-out|Adverse Event|1
7327745|NCT00791661|11560419|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7327746|NCT00791661|11560420|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
7327747|NCT00791661|11560421|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
7327748|NCT00791700|11560449|FG000|Overall Study|Insufficient clinical response|1
7327749|NCT00791700|11560450|FG001|Overall Study|Insufficient clinical response|4
7327750|NCT00791700|11560451|FG002|Overall Study|Insufficient clinical response|1
7419601|NCT01471574|11694505|FG000|Treatment Period|Withdrawal by Subject|5
7419602|NCT01471574|11694506|FG001|Treatment Period|Withdrawal by Subject|1
7327751|NCT00791700|11560452|FG003|Overall Study|Insufficient clinical response|8
7327752|NCT00791700|11560449|FG000|Overall Study|No longer willing to participate|1
7327753|NCT00791700|11560450|FG001|Overall Study|No longer willing to participate|1
7327754|NCT00791700|11560451|FG002|Overall Study|No longer willing to participate|0
7556431|NCT03073798|11919809|FG000|Overall Study|Withdrawal by Subject|1
7556432|NCT03074162|11919834|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
7556433|NCT03074162|11919835|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
7556434|NCT03074162|11919836|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
7556435|NCT03074162|11919837|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
7556436|NCT03074162|11919838|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
7556437|NCT03074162|11919839|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
7556438|NCT03074162|11919834|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
7556439|NCT03074162|11919835|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
7556440|NCT03074162|11919836|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
7556441|NCT03074162|11919837|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
7556442|NCT03074162|11919838|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
7556443|NCT03074162|11919839|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
7556444|NCT03074162|11919834|FG000|Period 3|Withdrawal by Subject|1
7556445|NCT03074162|11919835|FG001|Period 3|Withdrawal by Subject|0
7556446|NCT03074162|11919836|FG002|Period 3|Withdrawal by Subject|0
7556447|NCT03074162|11919837|FG003|Period 3|Withdrawal by Subject|0
7556448|NCT03074162|11919838|FG004|Period 3|Withdrawal by Subject|1
7556449|NCT03074162|11919839|FG005|Period 3|Withdrawal by Subject|0
7556450|NCT03074331|11919847|FG000|Overall Study|Enrolled but Not Treated|1
7556451|NCT03074331|11919847|FG000|Overall Study|Lost to Follow-up|5
7556452|NCT03074331|11919847|FG000|Overall Study|Withdrew Consent|1
7556453|NCT03074500|11919863|FG000|Overall Study|Lost to Follow-up|1
7556454|NCT03074500|11919864|FG001|Overall Study|Lost to Follow-up|0
7556455|NCT03074500|11919865|FG002|Overall Study|Lost to Follow-up|0
7556456|NCT03074500|11919863|FG000|Overall Study|Lack of Efficacy|0
7556457|NCT03074500|11919864|FG001|Overall Study|Lack of Efficacy|1
7556458|NCT03074500|11919865|FG002|Overall Study|Lack of Efficacy|0
7556459|NCT03074500|11919863|FG000|Overall Study|Adverse Event|0
7556460|NCT03074500|11919864|FG001|Overall Study|Adverse Event|0
7556461|NCT03074500|11919865|FG002|Overall Study|Adverse Event|1
7556462|NCT03075163|11919904|FG000|Overall Study|not eligible for treatment limb|138
7556463|NCT03075163|11919905|FG001|Overall Study|not eligible for treatment limb|138
7556464|NCT03075267|11919914|FG000|Overall Study|Protocol Violation|1
7556465|NCT03075267|11919915|FG001|Overall Study|Protocol Violation|0
7556466|NCT03075267|11919916|FG002|Overall Study|Protocol Violation|0
7556467|NCT03075410|11919933|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
7556468|NCT03075410|11919934|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
7556469|NCT03075410|11919935|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
7556470|NCT03075410|11919936|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
7556471|NCT03075410|11919937|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
7556472|NCT03075410|11919938|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
7556473|NCT03075410|11919939|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
7556474|NCT03075410|11919940|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
7556475|NCT03075410|11919941|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
7556476|NCT03075410|11919933|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
7556477|NCT03075410|11919934|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556478|NCT03075410|11919935|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556479|NCT03075410|11919936|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556480|NCT03075410|11919937|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556481|NCT03075410|11919938|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556482|NCT03075410|11919939|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556483|NCT03075410|11919940|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7556484|NCT03075410|11919941|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
7574686|NCT03687827|11957738|FG000|Treatment Period 2|Physician Decision|4
7574687|NCT03687827|11957739|FG001|Treatment Period 2|Physician Decision|1
7574688|NCT03687827|11957738|FG000|Treatment Period 2|Withdrawal by Subject|1
7574689|NCT03687827|11957739|FG001|Treatment Period 2|Withdrawal by Subject|2
7574690|NCT03687970|11957747|FG000|Overall Study|visit scheduling conflicts|2
7574691|NCT03687970|11957748|FG001|Overall Study|visit scheduling conflicts|0
7574692|NCT03688620|11957774|FG000|Overall Study|Other|0
7574693|NCT03688620|11957775|FG001|Overall Study|Other|0
7574694|NCT03688620|11957776|FG002|Overall Study|Other|1
7574695|NCT03688620|11957774|FG000|Overall Study|Unwilling to attend the scheduled visit|0
7574696|NCT03688620|11957775|FG001|Overall Study|Unwilling to attend the scheduled visit|1
7574697|NCT03688620|11957776|FG002|Overall Study|Unwilling to attend the scheduled visit|0
7574698|NCT03688620|11957774|FG000|Overall Study|Lost to Follow-up|16
7574699|NCT03688620|11957775|FG001|Overall Study|Lost to Follow-up|0
7574700|NCT03688620|11957776|FG002|Overall Study|Lost to Follow-up|1
7574701|NCT03688620|11957774|FG000|Overall Study|Withdrawal by Subject|0
7574702|NCT03688620|11957775|FG001|Overall Study|Withdrawal by Subject|0
7419603|NCT01471574|11694507|FG002|Treatment Period|Withdrawal by Subject|1
7419604|NCT01471574|11694508|FG003|Treatment Period|Withdrawal by Subject|0
7556485|NCT03075501|11919971|FG000|Overall Study|Scheduling difficulties|15
7556486|NCT03075501|11919972|FG001|Overall Study|Scheduling difficulties|9
7556487|NCT03075644|11919985|FG000|Overall Study|Withdrawal by Subject|1
7556488|NCT03075644|11919986|FG001|Overall Study|Withdrawal by Subject|1
7556489|NCT03075761|11919995|FG000|Overall Study|Lost to Follow-up|1
7556490|NCT03075761|11919996|FG001|Overall Study|Lost to Follow-up|6
7556491|NCT03075839|11920007|FG000|Overall Study|Lost to Follow-up|4
7556492|NCT03075878|11920011|FG000|Overall Study|Physician Decision|1
7556493|NCT03075891|11920017|FG000|Overall Study|Withdrawal by Subject|3
7556494|NCT03075891|11920018|FG001|Overall Study|Withdrawal by Subject|6
7556495|NCT03075891|11920017|FG000|Overall Study|Lost to Follow-up|1
7556496|NCT03075891|11920018|FG001|Overall Study|Lost to Follow-up|0
7556497|NCT03075891|11920017|FG000|Overall Study|Pregnancy|3
7556498|NCT03075891|11920018|FG001|Overall Study|Pregnancy|1
7556499|NCT03075891|11920017|FG000|Overall Study|visits not performed (no time)|1
7556500|NCT03075891|11920018|FG001|Overall Study|visits not performed (no time)|0
7556501|NCT03075891|11920017|FG000|Overall Study|Drug abuse relapse issue|0
7556502|NCT03075891|11920018|FG001|Overall Study|Drug abuse relapse issue|1
7556503|NCT03075891|11920017|FG000|Overall Study|Participant requiring study withdrawal|0
7556504|NCT03075891|11920018|FG001|Overall Study|Participant requiring study withdrawal|1
7556505|NCT03075891|11920017|FG000|Overall Study|Adverse event, non-fatal|1
7556506|NCT03075891|11920018|FG001|Overall Study|Adverse event, non-fatal|4
7556507|NCT03075904|11920026|FG000|Overall Study|Physician Decision|3
7556508|NCT03075904|11920026|FG000|Overall Study|Need for Medication not Permitted|1
7556509|NCT03076190|11920032|FG000|Overall Study|Lost to Follow-up|9
7556510|NCT03076190|11920033|FG001|Overall Study|Lost to Follow-up|34
7556511|NCT03076190|11920032|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
7556512|NCT03076190|11920033|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
7556513|NCT03076515|11920059|FG000|Overall Study|DMC decision based on interim analysis|25
7556514|NCT03076515|11920060|FG001|Overall Study|DMC decision based on interim analysis|29
7556515|NCT03076970|11920066|FG000|Washout Period 2|Adverse Event|0
7556516|NCT03076970|11920067|FG001|Washout Period 2|Adverse Event|0
7556517|NCT03076970|11920068|FG002|Washout Period 2|Adverse Event|0
7556518|NCT03076970|11920069|FG003|Washout Period 2|Adverse Event|0
7556519|NCT03076970|11920070|FG004|Washout Period 2|Adverse Event|1
7556520|NCT03076970|11920071|FG005|Washout Period 2|Adverse Event|0
7556521|NCT03076970|11920066|FG000|Period 3|Withdrawal by Subject|0
7556522|NCT03076970|11920067|FG001|Period 3|Withdrawal by Subject|0
7556523|NCT03076970|11920068|FG002|Period 3|Withdrawal by Subject|0
7556524|NCT03076970|11920069|FG003|Period 3|Withdrawal by Subject|0
7556525|NCT03076970|11920070|FG004|Period 3|Withdrawal by Subject|0
7556526|NCT03076970|11920071|FG005|Period 3|Withdrawal by Subject|1
7556527|NCT03076970|11920066|FG000|Period 3|Failure to meet I/E criteria|0
7556528|NCT03076970|11920067|FG001|Period 3|Failure to meet I/E criteria|0
7556529|NCT03076970|11920068|FG002|Period 3|Failure to meet I/E criteria|0
7556530|NCT03076970|11920069|FG003|Period 3|Failure to meet I/E criteria|0
7556531|NCT03076970|11920070|FG004|Period 3|Failure to meet I/E criteria|1
7556532|NCT03076970|11920071|FG005|Period 3|Failure to meet I/E criteria|0
7556533|NCT03076996|11920091|FG000|Overall Study|Withdrawal by Subject|2
7556534|NCT03076996|11920091|FG000|Overall Study|Lost to Follow-up|3
7556535|NCT03076996|11920091|FG000|Overall Study|Literacy precluded participation|1
7556536|NCT03077607|11920122|FG000|Period 1 (15 Days)|Adverse Event|1
7556537|NCT03077607|11920123|FG001|Period 1 (15 Days)|Adverse Event|0
7556538|NCT03077607|11920122|FG000|Period 1 (15 Days)|Death|1
7556539|NCT03077607|11920123|FG001|Period 1 (15 Days)|Death|0
7556540|NCT03077607|11920122|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
7556541|NCT03077607|11920123|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
7556542|NCT03077607|11920122|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7556543|NCT03077607|11920123|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
7556544|NCT03077646|11920143|FG000|Overall Study|Lost to Follow-up|29
7556545|NCT03077646|11920144|FG001|Overall Study|Lost to Follow-up|30
7556546|NCT03077646|11920145|FG002|Overall Study|Lost to Follow-up|31
7556547|NCT03077659|11920156|FG000|Overall Study|Withdrawal by Subject|0
7556548|NCT03077659|11920157|FG001|Overall Study|Withdrawal by Subject|0
7556549|NCT03077659|11920158|FG002|Overall Study|Withdrawal by Subject|1
7556550|NCT03077711|11920171|FG000|Overall Study|Lost to Follow-up|2
7556551|NCT03077711|11920172|FG001|Overall Study|Lost to Follow-up|2
7556552|NCT03077711|11920171|FG000|Overall Study|noncompliant taking medication|2
7556553|NCT03077711|11920172|FG001|Overall Study|noncompliant taking medication|0
7556554|NCT03077724|11920182|FG000|Overall Study|Lost to Follow-up|5
7556555|NCT03077724|11920183|FG001|Overall Study|Lost to Follow-up|1
7556556|NCT03077724|11920182|FG000|Overall Study|Withdrawal by Subject|3
7556557|NCT03077724|11920183|FG001|Overall Study|Withdrawal by Subject|1
7556558|NCT03077919|11920201|FG000|Overall Study|Lost to Follow-up|4
7556559|NCT03077919|11920202|FG001|Overall Study|Lost to Follow-up|1
7419605|NCT01471574|11694505|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
7419606|NCT01471574|11694506|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
7419607|NCT01471574|11694507|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
7419608|NCT01471574|11694508|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
7419609|NCT01471574|11694505|FG000|Treatment Period|Lost to Follow-up|1
7419610|NCT01471574|11694506|FG001|Treatment Period|Lost to Follow-up|2
7419611|NCT01471574|11694507|FG002|Treatment Period|Lost to Follow-up|2
7419612|NCT01471574|11694508|FG003|Treatment Period|Lost to Follow-up|0
7419613|NCT01471574|11694505|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
7419614|NCT01471574|11694506|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
7419615|NCT01471574|11694507|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
7419616|NCT01471574|11694508|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
7419617|NCT01471574|11694505|FG000|Treatment Period|Other|1
7419618|NCT01471574|11694506|FG001|Treatment Period|Other|0
7419619|NCT01471574|11694507|FG002|Treatment Period|Other|0
7419620|NCT01471574|11694508|FG003|Treatment Period|Other|0
7419621|NCT01471574|11694505|FG000|Follow-up Period|Withdrawal by Subject|3
7419622|NCT01471574|11694506|FG001|Follow-up Period|Withdrawal by Subject|0
7419623|NCT01471574|11694507|FG002|Follow-up Period|Withdrawal by Subject|3
7419624|NCT01471574|11694508|FG003|Follow-up Period|Withdrawal by Subject|1
7419625|NCT01471574|11694505|FG000|Follow-up Period|Lost to Follow-up|4
7419626|NCT01471574|11694506|FG001|Follow-up Period|Lost to Follow-up|1
7419627|NCT01471574|11694507|FG002|Follow-up Period|Lost to Follow-up|3
7419628|NCT01471574|11694508|FG003|Follow-up Period|Lost to Follow-up|2
7419629|NCT01471574|11694505|FG000|Follow-up Period|Death|0
7419630|NCT01471574|11694506|FG001|Follow-up Period|Death|0
7419631|NCT01471574|11694507|FG002|Follow-up Period|Death|1
7419632|NCT01471574|11694508|FG003|Follow-up Period|Death|0
7419633|NCT01471574|11694505|FG000|Follow-up Period|Follow-up no longer required|0
7419634|NCT01471574|11694506|FG001|Follow-up Period|Follow-up no longer required|1
7419635|NCT01471574|11694507|FG002|Follow-up Period|Follow-up no longer required|0
7419636|NCT01471574|11694508|FG003|Follow-up Period|Follow-up no longer required|0
7419637|NCT01471691|11694534|FG000|Overall Study|Lack of Efficacy|0
7419638|NCT01471691|11694535|FG001|Overall Study|Lack of Efficacy|1
7419639|NCT01471782|11694547|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
7419640|NCT01471782|11694548|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
7419641|NCT01471782|11694549|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
7419642|NCT01471782|11694550|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
7419643|NCT01471782|11694551|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
7419644|NCT01471782|11694552|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
7419645|NCT01471782|11694547|FG000|Overall Study|Lack of Efficacy|1
7419646|NCT01471782|11694548|FG001|Overall Study|Lack of Efficacy|2
7419647|NCT01471782|11694549|FG002|Overall Study|Lack of Efficacy|1
7419648|NCT01471782|11694550|FG003|Overall Study|Lack of Efficacy|1
7419649|NCT01471782|11694551|FG004|Overall Study|Lack of Efficacy|5
7419650|NCT01471782|11694552|FG005|Overall Study|Lack of Efficacy|18
7419651|NCT01471782|11694547|FG000|Overall Study|Adverse Event|1
7419652|NCT01471782|11694548|FG001|Overall Study|Adverse Event|1
7419653|NCT01471782|11694549|FG002|Overall Study|Adverse Event|2
7419654|NCT01471782|11694550|FG003|Overall Study|Adverse Event|2
7419655|NCT01471782|11694551|FG004|Overall Study|Adverse Event|3
7419656|NCT01471782|11694552|FG005|Overall Study|Adverse Event|1
7419657|NCT01471782|11694547|FG000|Overall Study|Other|0
7419658|NCT01471782|11694548|FG001|Overall Study|Other|0
7419659|NCT01471782|11694549|FG002|Overall Study|Other|1
7419660|NCT01471782|11694550|FG003|Overall Study|Other|1
7419661|NCT01471782|11694551|FG004|Overall Study|Other|6
7419662|NCT01471782|11694552|FG005|Overall Study|Other|5
7419663|NCT01471782|11694547|FG000|Overall Study|Change of Chemotherapy|1
7419664|NCT01471782|11694548|FG001|Overall Study|Change of Chemotherapy|1
7419665|NCT01471782|11694549|FG002|Overall Study|Change of Chemotherapy|0
7419666|NCT01471782|11694550|FG003|Overall Study|Change of Chemotherapy|0
7419667|NCT01471782|11694551|FG004|Overall Study|Change of Chemotherapy|1
7419668|NCT01471782|11694552|FG005|Overall Study|Change of Chemotherapy|4
7419669|NCT01471782|11694547|FG000|Overall Study|Disease Relapse|0
7556560|NCT03078556|11920259|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
7556561|NCT03078556|11920260|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
7556562|NCT03078556|11920261|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
7556563|NCT03078556|11920262|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
7419670|NCT01471782|11694548|FG001|Overall Study|Disease Relapse|0
7419671|NCT01471782|11694549|FG002|Overall Study|Disease Relapse|0
7419672|NCT01471782|11694550|FG003|Overall Study|Disease Relapse|1
7419673|NCT01471782|11694551|FG004|Overall Study|Disease Relapse|2
7419674|NCT01471782|11694552|FG005|Overall Study|Disease Relapse|1
7419675|NCT01471782|11694547|FG000|Overall Study|Physician Decision|0
7419676|NCT01471782|11694548|FG001|Overall Study|Physician Decision|0
7419677|NCT01471782|11694549|FG002|Overall Study|Physician Decision|0
7419678|NCT01471782|11694550|FG003|Overall Study|Physician Decision|0
7419679|NCT01471782|11694551|FG004|Overall Study|Physician Decision|3
7419680|NCT01471782|11694552|FG005|Overall Study|Physician Decision|8
7419681|NCT01471782|11694547|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7419682|NCT01471782|11694548|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7574703|NCT03688620|11957776|FG002|Overall Study|Withdrawal by Subject|6
7419683|NCT01471782|11694549|FG002|Overall Study|Withdrawal by Parent/Guardian|0
7419684|NCT01471782|11694550|FG003|Overall Study|Withdrawal by Parent/Guardian|0
7419685|NCT01471782|11694551|FG004|Overall Study|Withdrawal by Parent/Guardian|1
7419686|NCT01471782|11694552|FG005|Overall Study|Withdrawal by Parent/Guardian|0
7419687|NCT01471782|11694547|FG000|Overall Study|Death|0
7419688|NCT01471782|11694548|FG001|Overall Study|Death|0
7419689|NCT01471782|11694549|FG002|Overall Study|Death|0
7556564|NCT03078556|11920259|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
7556565|NCT03078556|11920260|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
7556566|NCT03078556|11920261|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
7556567|NCT03078556|11920262|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
7556568|NCT03078556|11920259|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7556569|NCT03078556|11920260|FG001|Washout Period 1 (7 Days)|Adverse Event|1
7556570|NCT03078556|11920261|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7556571|NCT03078556|11920262|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7556572|NCT03078556|11920259|FG000|Washout Period 1 (7 Days)|Physician Decision|0
7556573|NCT03078556|11920260|FG001|Washout Period 1 (7 Days)|Physician Decision|1
7556574|NCT03078556|11920261|FG002|Washout Period 1 (7 Days)|Physician Decision|0
7556575|NCT03078556|11920262|FG003|Washout Period 1 (7 Days)|Physician Decision|0
7556578|NCT03078751|11920320|FG000|Overall Study|Adverse Event|4
7556579|NCT03078751|11920321|FG001|Overall Study|Adverse Event|0
7556580|NCT03078751|11920320|FG000|Overall Study|Physician Decision|1
7556581|NCT03078751|11920321|FG001|Overall Study|Physician Decision|0
7556582|NCT03078751|11920320|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
7556583|NCT03078751|11920321|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
7556584|NCT03078751|11920320|FG000|Overall Study|Subject/guardian decision|8
7556585|NCT03078751|11920321|FG001|Overall Study|Subject/guardian decision|1
7556586|NCT03078751|11920320|FG000|Overall Study|Untreated|0
7556587|NCT03078751|11920321|FG001|Overall Study|Untreated|4
7556588|NCT03078816|11920327|FG000|Overall Study|Withdrawal by Subject|1
7556589|NCT03078907|11920333|FG000|Overall Study|Adverse Event|2
7556590|NCT03078907|11920334|FG001|Overall Study|Adverse Event|0
7556591|NCT03078907|11920333|FG000|Overall Study|Other|1
7556592|NCT03078907|11920334|FG001|Overall Study|Other|0
7556593|NCT03078907|11920333|FG000|Overall Study|Protocol Violation|0
7556594|NCT03078907|11920334|FG001|Overall Study|Protocol Violation|1
7556595|NCT03080454|11920379|FG000|Baseline|Adverse Event|2
7556596|NCT03080454|11920379|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
7556597|NCT03080454|11920379|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
7556598|NCT03080493|11920388|FG000|Overall Study|Did not provide NRS pain results|1
7556599|NCT03080493|11920389|FG001|Overall Study|Did not provide NRS pain results|0
7556600|NCT03080493|11920388|FG000|Overall Study|Adverse Event|0
7556601|NCT03080493|11920389|FG001|Overall Study|Adverse Event|1
7556602|NCT03080493|11920388|FG000|Overall Study|Randomization error (parity group)|0
7556603|NCT03080493|11920389|FG001|Overall Study|Randomization error (parity group)|1
7556604|NCT03080961|11920395|FG000|Overall Study|Withdrawal by Subject|3
7556605|NCT03081884|11920413|FG000|Overall Study|deferred prostate cancer treatment|1
7556606|NCT03081884|11920413|FG000|Overall Study|metastasis managed with systemic therapy|3
7556607|NCT03082261|11920427|FG000|Overall Study|Death|4
7556608|NCT03082261|11920427|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
7556609|NCT03082261|11920427|FG000|Overall Study|Insurance denial|1
7556610|NCT03082261|11920427|FG000|Overall Study|Peripheral lead added|1
7556611|NCT03082261|11920427|FG000|Overall Study|Withdrawal by Subject|40
7556612|NCT03082261|11920427|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
7556613|NCT03082261|11920427|FG000|Overall Study|Subject implanted with device other than study device|1
7556614|NCT03082261|11920427|FG000|Overall Study|Lost to Follow-up|14
7556615|NCT03082261|11920427|FG000|Overall Study|Subject moved to a different state|1
7556616|NCT03082261|11920427|FG000|Overall Study|Subject non-compliance|2
7556617|NCT03082261|11920427|FG000|Overall Study|Subject participation terminated by investigator|9
7556618|NCT03082261|11920427|FG000|Overall Study|Subject participation terminated by sponsor|4
7556619|NCT03082261|11920427|FG000|Overall Study|System explant|19
7556620|NCT03082261|11920427|FG000|Overall Study|Unable to place lead(s)|2
7556621|NCT03082261|11920427|FG000|Overall Study|Unsuccessful trial evaluation period|19
7556622|NCT03082599|11920464|FG000|Overall Study|Lost to Follow-up|1
7556623|NCT03082599|11920465|FG001|Overall Study|Lost to Follow-up|0
7556624|NCT03083132|11920482|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
7556625|NCT03083132|11920483|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
7556626|NCT03083132|11920482|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
7556627|NCT03083132|11920483|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
7419690|NCT01471782|11694550|FG003|Overall Study|Death|0
7556628|NCT03083132|11920482|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
7556629|NCT03083132|11920483|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
7556630|NCT03083470|11920503|FG000|Overall Study|Lost to Follow-up|0
7556631|NCT03083470|11920504|FG001|Overall Study|Lost to Follow-up|0
7556632|NCT03083470|11920505|FG002|Overall Study|Lost to Follow-up|0
7556633|NCT03083470|11920506|FG003|Overall Study|Lost to Follow-up|0
7419691|NCT01471782|11694551|FG004|Overall Study|Death|0
7419692|NCT01471782|11694552|FG005|Overall Study|Death|1
7419693|NCT01472185|11694579|FG000|Overall Study|Randomized but Not Treated|0
7419694|NCT01472185|11694580|FG001|Overall Study|Randomized but Not Treated|1
7419695|NCT01472185|11694579|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
7419696|NCT01472185|11694580|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
7419697|NCT01472185|11694579|FG000|Overall Study|Hyperglycemia|5
7419698|NCT01472185|11694580|FG001|Overall Study|Hyperglycemia|2
7419699|NCT01472185|11694579|FG000|Overall Study|Investigator's Discretion|3
7419700|NCT01472185|11694580|FG001|Overall Study|Investigator's Discretion|1
7419701|NCT01472185|11694579|FG000|Overall Study|Lost to Follow-up|4
7419702|NCT01472185|11694580|FG001|Overall Study|Lost to Follow-up|1
7419703|NCT01472185|11694579|FG000|Overall Study|Protocol Violation|5
7419704|NCT01472185|11694580|FG001|Overall Study|Protocol Violation|1
7556634|NCT03083470|11920507|FG004|Overall Study|Lost to Follow-up|1
7556635|NCT03083470|11920503|FG000|Overall Study|Withdrawal by Subject|0
7556636|NCT03083470|11920504|FG001|Overall Study|Withdrawal by Subject|0
7556637|NCT03083470|11920505|FG002|Overall Study|Withdrawal by Subject|0
7419705|NCT01472185|11694579|FG000|Overall Study|Subject Noncompliance|8
7419706|NCT01472185|11694580|FG001|Overall Study|Subject Noncompliance|15
7556638|NCT03083470|11920506|FG003|Overall Study|Withdrawal by Subject|0
7556639|NCT03083470|11920507|FG004|Overall Study|Withdrawal by Subject|1
7556640|NCT03083483|11920522|FG000|Overall Study|Adverse Event|1
7556641|NCT03083483|11920523|FG001|Overall Study|Adverse Event|1
7556642|NCT03083483|11920524|FG002|Overall Study|Adverse Event|1
7556643|NCT03083483|11920522|FG000|Overall Study|Lost to Follow-up|2
7556644|NCT03083483|11920523|FG001|Overall Study|Lost to Follow-up|1
7556645|NCT03083483|11920524|FG002|Overall Study|Lost to Follow-up|1
7556646|NCT03083483|11920522|FG000|Overall Study|technological issues|1
7556647|NCT03083483|11920523|FG001|Overall Study|technological issues|0
7556648|NCT03083483|11920524|FG002|Overall Study|technological issues|1
7556649|NCT03083639|11920534|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
7556650|NCT03083639|11920535|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
7556651|NCT03083639|11920534|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
7556652|NCT03083639|11920535|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
7556653|NCT03083847|11920560|FG000|Main|Physician Decision|0
7556654|NCT03083847|11920561|FG001|Main|Physician Decision|0
7556655|NCT03083847|11920562|FG002|Main|Physician Decision|0
7556656|NCT03083847|11920563|FG003|Main|Physician Decision|0
7556657|NCT03083847|11920564|FG004|Main|Physician Decision|0
7556658|NCT03083847|11920565|FG005|Main|Physician Decision|1
7556659|NCT03083847|11920566|FG006|Main|Physician Decision|0
7556660|NCT03083847|11920567|FG007|Main|Physician Decision|0
7556661|NCT03083847|11920568|FG008|Main|Physician Decision|0
7556662|NCT03083847|11920569|FG009|Main|Physician Decision|0
7556663|NCT03083847|11920560|FG000|Main|Pregnancy|0
7556664|NCT03083847|11920561|FG001|Main|Pregnancy|0
7556665|NCT03083847|11920562|FG002|Main|Pregnancy|0
7556666|NCT03083847|11920563|FG003|Main|Pregnancy|0
7556667|NCT03083847|11920564|FG004|Main|Pregnancy|0
7556668|NCT03083847|11920565|FG005|Main|Pregnancy|0
7556669|NCT03083847|11920566|FG006|Main|Pregnancy|0
7556670|NCT03083847|11920567|FG007|Main|Pregnancy|1
7556671|NCT03083847|11920568|FG008|Main|Pregnancy|0
7556672|NCT03083847|11920569|FG009|Main|Pregnancy|0
7556673|NCT03083847|11920560|FG000|Main|Adverse Event|0
7556674|NCT03083847|11920561|FG001|Main|Adverse Event|0
7556675|NCT03083847|11920562|FG002|Main|Adverse Event|0
7556676|NCT03083847|11920563|FG003|Main|Adverse Event|0
7556677|NCT03083847|11920564|FG004|Main|Adverse Event|0
7556678|NCT03083847|11920565|FG005|Main|Adverse Event|0
7556679|NCT03083847|11920566|FG006|Main|Adverse Event|0
7556680|NCT03083847|11920567|FG007|Main|Adverse Event|2
7556681|NCT03083847|11920568|FG008|Main|Adverse Event|0
7556682|NCT03083847|11920569|FG009|Main|Adverse Event|0
7556683|NCT03083847|11920560|FG000|Main|Withdrawal by Subject|0
7556684|NCT03083847|11920561|FG001|Main|Withdrawal by Subject|0
7556685|NCT03083847|11920562|FG002|Main|Withdrawal by Subject|0
7556686|NCT03083847|11920563|FG003|Main|Withdrawal by Subject|0
7556687|NCT03083847|11920564|FG004|Main|Withdrawal by Subject|0
7556688|NCT03083847|11920565|FG005|Main|Withdrawal by Subject|0
7556689|NCT03083847|11920566|FG006|Main|Withdrawal by Subject|1
7327755|NCT00791700|11560452|FG003|Overall Study|No longer willing to participate|8
7556690|NCT03083847|11920567|FG007|Main|Withdrawal by Subject|1
7556691|NCT03083847|11920568|FG008|Main|Withdrawal by Subject|0
7327756|NCT00791700|11560449|FG000|Overall Study|Non-compliance with study treatment|0
7327757|NCT00791700|11560450|FG001|Overall Study|Non-compliance with study treatment|2
7327758|NCT00791700|11560451|FG002|Overall Study|Non-compliance with study treatment|0
7327759|NCT00791700|11560452|FG003|Overall Study|Non-compliance with study treatment|4
7327760|NCT00791700|11560449|FG000|Overall Study|Withdrawn due to pregnancy|0
7327761|NCT00791700|11560450|FG001|Overall Study|Withdrawn due to pregnancy|0
7327762|NCT00791700|11560451|FG002|Overall Study|Withdrawn due to pregnancy|0
7327763|NCT00791700|11560452|FG003|Overall Study|Withdrawn due to pregnancy|1
7327764|NCT00791700|11560449|FG000|Overall Study|Other|0
7419707|NCT01472185|11694579|FG000|Overall Study|Subject Withdrew Consent|6
7419708|NCT01472185|11694580|FG001|Overall Study|Subject Withdrew Consent|3
7556692|NCT03083847|11920569|FG009|Main|Withdrawal by Subject|0
7556693|NCT03083990|11920599|FG000|Overall Study|Adverse Event|1
7419709|NCT01472289|11694586|FG000|Overall Study|Death|2
7419710|NCT01472341|11694590|FG000|Overall Study|Started insulin therapy|55
7419711|NCT01472341|11694590|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
7419712|NCT01472341|11694590|FG000|Overall Study|Withdrawal by Subject|39
7419713|NCT01472341|11694590|FG000|Overall Study|Lost to Follow-up|52
7419714|NCT01472341|11694590|FG000|Overall Study|Laboratory parameters unavailable|25
7419715|NCT01472341|11694590|FG000|Overall Study|Death|9
7419716|NCT01472380|11694594|FG000|Efavirenz Alone|Withdrawal by Subject|1
7419717|NCT01472380|11694594|FG000|1 Day Period Between Dosing|Protocol Violation|1
7419718|NCT01472757|11694645|FG000|Overall Study|Withdrawal by Subject|1
7419719|NCT01472757|11694646|FG001|Overall Study|Withdrawal by Subject|2
7419720|NCT01472757|11694647|FG002|Overall Study|Withdrawal by Subject|2
7419721|NCT01472757|11694648|FG003|Overall Study|Withdrawal by Subject|0
7419722|NCT01472757|11694645|FG000|Overall Study|Asthma exacerbation|4
7556694|NCT03083990|11920600|FG001|Overall Study|Adverse Event|0
7556695|NCT03084302|11920606|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
7556696|NCT03084302|11920606|FG000|Overall Study|No valid objective monitor data|6
7327765|NCT00791700|11560450|FG001|Overall Study|Other|1
7327766|NCT00791700|11560451|FG002|Overall Study|Other|0
7556697|NCT03084315|11920613|FG000|Overall Study|Lost to Follow-up|8
7556698|NCT03084315|11920614|FG001|Overall Study|Lost to Follow-up|7
7556699|NCT03084315|11920613|FG000|Overall Study|Withdrawal by Subject|2
7556700|NCT03084315|11920614|FG001|Overall Study|Withdrawal by Subject|2
7556701|NCT03084796|11920626|FG000|Overall Study|Adverse Event|4
7556702|NCT03084796|11920627|FG001|Overall Study|Adverse Event|5
7556703|NCT03084796|11920628|FG002|Overall Study|Adverse Event|6
7556704|NCT03084796|11920629|FG003|Overall Study|Adverse Event|2
7556705|NCT03084796|11920630|FG004|Overall Study|Adverse Event|3
7556706|NCT03084796|11920631|FG005|Overall Study|Adverse Event|5
7556707|NCT03084796|11920626|FG000|Overall Study|Withdrawal by Subject|3
7556708|NCT03084796|11920627|FG001|Overall Study|Withdrawal by Subject|5
7556709|NCT03084796|11920628|FG002|Overall Study|Withdrawal by Subject|2
7556710|NCT03084796|11920629|FG003|Overall Study|Withdrawal by Subject|1
7556711|NCT03084796|11920630|FG004|Overall Study|Withdrawal by Subject|3
7556712|NCT03084796|11920631|FG005|Overall Study|Withdrawal by Subject|0
7556713|NCT03084796|11920626|FG000|Overall Study|Protocol Violation|0
7556714|NCT03084796|11920627|FG001|Overall Study|Protocol Violation|0
7556715|NCT03084796|11920628|FG002|Overall Study|Protocol Violation|1
7556716|NCT03084796|11920629|FG003|Overall Study|Protocol Violation|0
7556717|NCT03084796|11920630|FG004|Overall Study|Protocol Violation|1
7556718|NCT03084796|11920631|FG005|Overall Study|Protocol Violation|1
7556719|NCT03084796|11920626|FG000|Overall Study|Lack of Efficacy|0
7556720|NCT03084796|11920627|FG001|Overall Study|Lack of Efficacy|0
7556721|NCT03084796|11920628|FG002|Overall Study|Lack of Efficacy|1
7556722|NCT03084796|11920629|FG003|Overall Study|Lack of Efficacy|0
7556723|NCT03084796|11920630|FG004|Overall Study|Lack of Efficacy|1
7556724|NCT03084796|11920631|FG005|Overall Study|Lack of Efficacy|0
7556725|NCT03084796|11920626|FG000|Overall Study|Lost to Follow-up|0
7556726|NCT03084796|11920627|FG001|Overall Study|Lost to Follow-up|0
7556727|NCT03084796|11920628|FG002|Overall Study|Lost to Follow-up|1
7556728|NCT03084796|11920629|FG003|Overall Study|Lost to Follow-up|1
7556729|NCT03084796|11920630|FG004|Overall Study|Lost to Follow-up|3
7556730|NCT03084796|11920631|FG005|Overall Study|Lost to Follow-up|1
7556731|NCT03084796|11920626|FG000|Overall Study|Randomization error|0
7556732|NCT03084796|11920627|FG001|Overall Study|Randomization error|0
7556733|NCT03084796|11920628|FG002|Overall Study|Randomization error|1
7556734|NCT03084796|11920629|FG003|Overall Study|Randomization error|0
7556735|NCT03084796|11920630|FG004|Overall Study|Randomization error|0
7556736|NCT03084796|11920631|FG005|Overall Study|Randomization error|0
7556737|NCT03085017|11920647|FG000|Overall Study|Death|0
7556738|NCT03085017|11920648|FG001|Overall Study|Death|3
7556739|NCT03085238|11920654|FG000|Overall Study|Adverse Event|2
7556740|NCT03085238|11920654|FG000|Overall Study|Death|2
7556741|NCT03085758|11920670|FG000|Overall Study|Death|26
7556742|NCT03085758|11920671|FG001|Overall Study|Death|24
7556743|NCT03085758|11920672|FG002|Overall Study|Death|53
7556744|NCT03085758|11920670|FG000|Overall Study|Lost to Follow-up|1
7556745|NCT03085758|11920671|FG001|Overall Study|Lost to Follow-up|1
7556746|NCT03085758|11920672|FG002|Overall Study|Lost to Follow-up|1
7556747|NCT03085758|11920670|FG000|Overall Study|Withdrawal by Subject|2
7556748|NCT03085758|11920671|FG001|Overall Study|Withdrawal by Subject|2
7556749|NCT03085758|11920672|FG002|Overall Study|Withdrawal by Subject|1
7556750|NCT03085758|11920670|FG000|Overall Study|Refusal to recall it up to day 90|0
7327767|NCT00791700|11560452|FG003|Overall Study|Other|1
7327768|NCT00791700|11560449|FG000|Overall Study|Death|0
7327769|NCT00791700|11560450|FG001|Overall Study|Death|0
7327770|NCT00791700|11560451|FG002|Overall Study|Death|0
7327771|NCT00791700|11560452|FG003|Overall Study|Death|1
7327772|NCT00791700|11560449|FG000|Overall Study|Lost to Follow-up|4
7327773|NCT00791700|11560450|FG001|Overall Study|Lost to Follow-up|3
7327774|NCT00791700|11560451|FG002|Overall Study|Lost to Follow-up|4
7327775|NCT00791700|11560452|FG003|Overall Study|Lost to Follow-up|6
7556751|NCT03085758|11920671|FG001|Overall Study|Refusal to recall it up to day 90|0
7556752|NCT03085758|11920672|FG002|Overall Study|Refusal to recall it up to day 90|1
7556753|NCT03085758|11920670|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
7556754|NCT03085758|11920671|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
7419723|NCT01472757|11694646|FG001|Overall Study|Asthma exacerbation|1
7419724|NCT01472757|11694647|FG002|Overall Study|Asthma exacerbation|2
7419725|NCT01472757|11694648|FG003|Overall Study|Asthma exacerbation|1
7419726|NCT01472757|11694645|FG000|Overall Study|Treatment period withdrawal criteria met|21
7419727|NCT01472757|11694646|FG001|Overall Study|Treatment period withdrawal criteria met|8
7419728|NCT01472757|11694647|FG002|Overall Study|Treatment period withdrawal criteria met|9
7419729|NCT01472757|11694648|FG003|Overall Study|Treatment period withdrawal criteria met|12
7419730|NCT01472757|11694645|FG000|Overall Study|Protocol Violation|3
7419731|NCT01472757|11694646|FG001|Overall Study|Protocol Violation|2
7419732|NCT01472757|11694647|FG002|Overall Study|Protocol Violation|4
7419733|NCT01472757|11694648|FG003|Overall Study|Protocol Violation|4
7556755|NCT03085758|11920672|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
7556756|NCT03085797|11920686|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
7556757|NCT03085797|11920687|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
7556758|NCT03085797|11920686|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
7556759|NCT03085797|11920687|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
7556760|NCT03085797|11920686|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
7556761|NCT03085797|11920687|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
7556804|NCT03085927|11920742|FG000|Overall Study|Withdrawal by Subject|1
7556805|NCT03085927|11920743|FG001|Overall Study|Withdrawal by Subject|4
7556806|NCT03085927|11920742|FG000|Overall Study|Lost to Follow-up|3
7556807|NCT03085927|11920743|FG001|Overall Study|Lost to Follow-up|1
7556808|NCT03085927|11920742|FG000|Overall Study|Death|1
7556809|NCT03085927|11920743|FG001|Overall Study|Death|0
7556810|NCT03085927|11920742|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
7556811|NCT03085927|11920743|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
7556812|NCT03085927|11920742|FG000|Overall Study|Dyad Became Ineligible|0
7556813|NCT03085927|11920743|FG001|Overall Study|Dyad Became Ineligible|1
7556814|NCT03086018|11920751|FG000|Final Testing for End of Trial|Adverse Event|1
7556815|NCT03086018|11920751|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
7419734|NCT01472757|11694645|FG000|Overall Study|Other reasons|1
7419735|NCT01472757|11694646|FG001|Overall Study|Other reasons|0
7419736|NCT01472757|11694647|FG002|Overall Study|Other reasons|2
7556816|NCT03086057|11920761|FG000|Stage 1: PrEP Uptake|Incarcerated|3
7556817|NCT03086057|11920762|FG001|Stage 1: PrEP Uptake|Incarcerated|1
7556818|NCT03086057|11920763|FG002|Stage 1: PrEP Uptake|Incarcerated|0
7556819|NCT03086057|11920764|FG003|Stage 1: PrEP Uptake|Incarcerated|0
7556820|NCT03086057|11920761|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
7556821|NCT03086057|11920762|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
7419737|NCT01472757|11694648|FG003|Overall Study|Other reasons|2
7419738|NCT01472835|11694669|FG000|Overall Study|Lost to Follow-up|2
7419739|NCT01472835|11694670|FG001|Overall Study|Lost to Follow-up|0
7419740|NCT01472939|11694687|FG000|Overall Study|Adverse Event|3
7419741|NCT01472939|11694688|FG001|Overall Study|Adverse Event|7
7419742|NCT01472939|11694689|FG002|Overall Study|Adverse Event|7
7556822|NCT03086057|11920763|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7556823|NCT03086057|11920764|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
7556824|NCT03086057|11920761|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
7556825|NCT03086057|11920762|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
7556826|NCT03086057|11920763|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
7556827|NCT03086057|11920764|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
7556828|NCT03086057|11920761|FG000|Stage 1: PrEP Uptake|Death|1
7556829|NCT03086057|11920762|FG001|Stage 1: PrEP Uptake|Death|0
7556830|NCT03086057|11920763|FG002|Stage 1: PrEP Uptake|Death|0
7556831|NCT03086057|11920764|FG003|Stage 1: PrEP Uptake|Death|0
7556832|NCT03086057|11920761|FG000|Stage 2: PrEP Adherence|Incarcerated|0
7556833|NCT03086057|11920762|FG001|Stage 2: PrEP Adherence|Incarcerated|0
7556834|NCT03086057|11920763|FG002|Stage 2: PrEP Adherence|Incarcerated|2
7556835|NCT03086057|11920764|FG003|Stage 2: PrEP Adherence|Incarcerated|0
7556836|NCT03086057|11920761|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7556837|NCT03086057|11920762|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7556838|NCT03086057|11920763|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
7556839|NCT03086057|11920764|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
7556840|NCT03086057|11920761|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
7556841|NCT03086057|11920762|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
7556842|NCT03086057|11920763|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
7556843|NCT03086057|11920764|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
7556844|NCT03086135|11920774|FG000|Overall Study|Adverse Event|1
7556845|NCT03086135|11920774|FG000|Overall Study|Lost to Follow-up|2
7556846|NCT03086330|11920796|FG000|Overall Study|Withdrawal by Subject|3
7556847|NCT03086330|11920797|FG001|Overall Study|Withdrawal by Subject|2
7556848|NCT03086330|11920796|FG000|Overall Study|Lost to Follow-up|1
7556849|NCT03086330|11920797|FG001|Overall Study|Lost to Follow-up|2
7556862|NCT03086447|11920827|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7556863|NCT03086447|11920828|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7556864|NCT03086447|11920827|FG000|Overall Study|Lost Lens|2
7556865|NCT03086447|11920828|FG001|Overall Study|Lost Lens|5
7556866|NCT03086447|11920827|FG000|Overall Study|Product quality complaint|0
7556867|NCT03086447|11920828|FG001|Overall Study|Product quality complaint|1
7556868|NCT03086447|11920827|FG000|Overall Study|Lens Damage|1
7556869|NCT03086447|11920828|FG001|Overall Study|Lens Damage|6
7556870|NCT03086447|11920827|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7556871|NCT03086447|11920828|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7556872|NCT03086447|11920827|FG000|Overall Study|Test Article No Longer Available|1
7556873|NCT03086447|11920828|FG001|Overall Study|Test Article No Longer Available|0
7556874|NCT03086447|11920827|FG000|Overall Study|Protocol Violation|2
7556875|NCT03086447|11920828|FG001|Overall Study|Protocol Violation|4
7556876|NCT03086447|11920827|FG000|Overall Study|Lost to Follow-up|0
7556877|NCT03086447|11920828|FG001|Overall Study|Lost to Follow-up|1
7556878|NCT03086447|11920827|FG000|Overall Study|Adverse Event|3
7556879|NCT03086447|11920828|FG001|Overall Study|Adverse Event|0
7556880|NCT03086447|11920827|FG000|Overall Study|Lens Discomfort|2
7556881|NCT03086447|11920828|FG001|Overall Study|Lens Discomfort|1
7556882|NCT03086460|11920834|FG000|Study Participants|Lost to Follow-up|2
7556883|NCT03086460|11920834|FG000|Study Participants|Protocol Violation|1
7556884|NCT03086460|11920834|FG000|Study Participants|Withdrawal by Subject|6
7556885|NCT03086460|11920834|FG000|Treatment A|Lost to Follow-up|1
7556886|NCT03086460|11920834|FG000|Treatment A|Protocol Violation|1
7556887|NCT03086460|11920834|FG000|Treatment A|Withdrawal by Subject|2
7556888|NCT03086460|11920834|FG000|Treatment C|Withdrawal by Subject|2
7556889|NCT03086460|11920834|FG000|Treatment E|Lost to Follow-up|1
7556890|NCT03086460|11920834|FG000|Treatment E|Withdrawal by Subject|3
7556891|NCT03086551|11920851|FG000|First Intervention|Failure to meet inclusion criterion|1
7556892|NCT03086551|11920852|FG001|First Intervention|Failure to meet inclusion criterion|0
7556893|NCT03086551|11920851|FG000|First Intervention|Lost to Follow-up|0
7556894|NCT03086551|11920852|FG001|First Intervention|Lost to Follow-up|1
7556895|NCT03086551|11920851|FG000|Washout|Lost to Follow-up|1
7556896|NCT03086551|11920852|FG001|Washout|Lost to Follow-up|2
7556897|NCT03086551|11920851|FG000|Washout|Withdrawal by Subject|2
7419743|NCT01472939|11694690|FG003|Overall Study|Adverse Event|14
7419744|NCT01472939|11694687|FG000|Overall Study|Lack of Efficacy|1
7419745|NCT01472939|11694688|FG001|Overall Study|Lack of Efficacy|0
7419746|NCT01472939|11694689|FG002|Overall Study|Lack of Efficacy|0
7419747|NCT01472939|11694690|FG003|Overall Study|Lack of Efficacy|1
7419748|NCT01472939|11694687|FG000|Overall Study|Lost to Follow-up|3
7419749|NCT01472939|11694688|FG001|Overall Study|Lost to Follow-up|0
7419750|NCT01472939|11694689|FG002|Overall Study|Lost to Follow-up|2
7419751|NCT01472939|11694690|FG003|Overall Study|Lost to Follow-up|0
7419752|NCT01472939|11694687|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
7419753|NCT01472939|11694688|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
7419754|NCT01472939|11694689|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
7419755|NCT01472939|11694690|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
7419756|NCT01472939|11694687|FG000|Overall Study|Prohibited Medication|0
7419757|NCT01472939|11694688|FG001|Overall Study|Prohibited Medication|1
7419758|NCT01472939|11694689|FG002|Overall Study|Prohibited Medication|0
7419759|NCT01472939|11694690|FG003|Overall Study|Prohibited Medication|0
7419760|NCT01472939|11694687|FG000|Overall Study|Withdrawal By PI|1
7419761|NCT01472939|11694688|FG001|Overall Study|Withdrawal By PI|0
7419762|NCT01472939|11694689|FG002|Overall Study|Withdrawal By PI|0
7419763|NCT01472939|11694690|FG003|Overall Study|Withdrawal By PI|0
7419764|NCT01472939|11694687|FG000|Overall Study|Protocol Violation|3
7419765|NCT01472939|11694688|FG001|Overall Study|Protocol Violation|3
7419766|NCT01472939|11694689|FG002|Overall Study|Protocol Violation|0
7419767|NCT01472939|11694690|FG003|Overall Study|Protocol Violation|1
7419768|NCT01472939|11694687|FG000|Overall Study|Withdrawal by Subject|9
7419769|NCT01472939|11694688|FG001|Overall Study|Withdrawal by Subject|3
7419770|NCT01472939|11694689|FG002|Overall Study|Withdrawal by Subject|1
7419771|NCT01472939|11694690|FG003|Overall Study|Withdrawal by Subject|4
7419772|NCT01472965|11694705|FG000|Overall Study|Withdrawal by Subject|1
7419773|NCT01472965|11694706|FG001|Overall Study|Withdrawal by Subject|0
7419774|NCT01473355|11694718|FG000|Overall Study|Protocol Violation|2
7419775|NCT01473355|11694718|FG000|Overall Study|Adverse Event|2
7419776|NCT01473355|11694718|FG000|Overall Study|Lost to Follow-up|2
7419777|NCT01473381|11694759|FG000|Overall Study|Adverse Event|8
7419778|NCT01473381|11694760|FG001|Overall Study|Adverse Event|20
7419779|NCT01473381|11694761|FG002|Overall Study|Adverse Event|25
7419780|NCT01473381|11694762|FG003|Overall Study|Adverse Event|17
7419781|NCT01473381|11694759|FG000|Overall Study|Insufficient Therapeutic Response|10
7419782|NCT01473381|11694760|FG001|Overall Study|Insufficient Therapeutic Response|1
7419783|NCT01473381|11694761|FG002|Overall Study|Insufficient Therapeutic Response|2
7419784|NCT01473381|11694762|FG003|Overall Study|Insufficient Therapeutic Response|3
7419785|NCT01473381|11694759|FG000|Overall Study|Protocol Violation|17
7419786|NCT01473381|11694760|FG001|Overall Study|Protocol Violation|23
7419787|NCT01473381|11694761|FG002|Overall Study|Protocol Violation|19
7419788|NCT01473381|11694762|FG003|Overall Study|Protocol Violation|17
7419789|NCT01473381|11694759|FG000|Overall Study|Withdrawal of Consent|20
7419790|NCT01473381|11694760|FG001|Overall Study|Withdrawal of Consent|21
7419791|NCT01473381|11694761|FG002|Overall Study|Withdrawal of Consent|20
7419792|NCT01473381|11694762|FG003|Overall Study|Withdrawal of Consent|26
7419793|NCT01473381|11694759|FG000|Overall Study|Lost to Follow-up|25
7419794|NCT01473381|11694760|FG001|Overall Study|Lost to Follow-up|28
7419795|NCT01473381|11694761|FG002|Overall Study|Lost to Follow-up|35
7419796|NCT01473381|11694762|FG003|Overall Study|Lost to Follow-up|23
7419797|NCT01473381|11694759|FG000|Overall Study|Other Reasons|0
7419798|NCT01473381|11694760|FG001|Overall Study|Other Reasons|0
7419799|NCT01473381|11694761|FG002|Overall Study|Other Reasons|1
7419800|NCT01473381|11694762|FG003|Overall Study|Other Reasons|3
7419801|NCT01473394|11694775|FG000|Overall Study|Adverse Event|13
7419802|NCT01473394|11694776|FG001|Overall Study|Adverse Event|16
7419803|NCT01473394|11694775|FG000|Overall Study|Insufficient Therapeutic Response|4
7419804|NCT01473394|11694776|FG001|Overall Study|Insufficient Therapeutic Response|1
7419805|NCT01473394|11694775|FG000|Overall Study|Protocol Violation|7
7419806|NCT01473394|11694776|FG001|Overall Study|Protocol Violation|5
7419807|NCT01473394|11694775|FG000|Overall Study|Withdrew Consent|12
7419808|NCT01473394|11694776|FG001|Overall Study|Withdrew Consent|10
7419809|NCT01473394|11694775|FG000|Overall Study|Lost to Follow-up|9
7419810|NCT01473394|11694776|FG001|Overall Study|Lost to Follow-up|11
7419811|NCT01473407|11694784|FG000|Overall Study|Physician Decision|1
7419812|NCT01473407|11694785|FG001|Overall Study|Physician Decision|4
7419813|NCT01473407|11694784|FG000|Overall Study|Lost to Follow-up|10
7419814|NCT01473407|11694785|FG001|Overall Study|Lost to Follow-up|4
7419815|NCT01473407|11694784|FG000|Overall Study|Adverse Event|8
7419816|NCT01473407|11694785|FG001|Overall Study|Adverse Event|8
7419817|NCT01473407|11694784|FG000|Overall Study|Randomization Error|3
7419818|NCT01473407|11694785|FG001|Overall Study|Randomization Error|1
7419819|NCT01473407|11694784|FG000|Overall Study|Withdrawal by Subject|4
7419820|NCT01473407|11694785|FG001|Overall Study|Withdrawal by Subject|7
7419821|NCT01473407|11694784|FG000|Overall Study|Kidney Transplant|7
7419822|NCT01473407|11694785|FG001|Overall Study|Kidney Transplant|6
7419823|NCT01473407|11694784|FG000|Overall Study|Vacation/Travel|1
7419824|NCT01473407|11694785|FG001|Overall Study|Vacation/Travel|1
7419825|NCT01473407|11694784|FG000|Overall Study|Elevated Hemoglobin|1
7419826|NCT01473407|11694785|FG001|Overall Study|Elevated Hemoglobin|0
7419827|NCT01473407|11694784|FG000|Overall Study|Patient Received Aranesp|1
7419828|NCT01473407|11694785|FG001|Overall Study|Patient Received Aranesp|0
7419829|NCT01473407|11694784|FG000|Overall Study|Patient Lost Green Card Status|1
7419830|NCT01473407|11694785|FG001|Overall Study|Patient Lost Green Card Status|0
7419831|NCT01473407|11694784|FG000|Overall Study|Temperature Excursion|2
7419832|NCT01473407|11694785|FG001|Overall Study|Temperature Excursion|3
7419833|NCT01473407|11694784|FG000|Overall Study|Transfer to Another Facility/Unit|4
7419834|NCT01473407|11694785|FG001|Overall Study|Transfer to Another Facility/Unit|3
7419835|NCT01473407|11694784|FG000|Overall Study|Sponsor's Decision|10
7419836|NCT01473407|11694785|FG001|Overall Study|Sponsor's Decision|10
7556898|NCT03086551|11920852|FG001|Washout|Withdrawal by Subject|1
7556899|NCT03087513|11920878|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
7556900|NCT03087643|11920902|FG000|Overall Study|Withdrawal by Subject|2
7419837|NCT01473407|11694784|FG000|Overall Study|Site Closure|1
7419838|NCT01473407|11694785|FG001|Overall Study|Site Closure|0
7419839|NCT01473420|11694793|FG000|Titration Period (18 Weeks)|Adverse Event|4
7419840|NCT01473420|11694794|FG001|Titration Period (18 Weeks)|Adverse Event|6
7419841|NCT01473420|11694793|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
7419842|NCT01473420|11694794|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
7419843|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
7419844|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
7419845|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
7419846|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
7531601|NCT02655237|11876357|FG000|Overall Study|Lack of Efficacy|0
7419847|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
7419848|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
7419849|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
7419850|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
7419851|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
7419852|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
7419853|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
7419854|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
7419855|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Site closure|3
7419856|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Site closure|1
7419857|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
7419858|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
7419859|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
7419860|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
7419861|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
7419862|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
7419863|NCT01473420|11694793|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
7419864|NCT01473420|11694794|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
7419865|NCT01473524|11694809|FG000|DB Phase|Adverse Event|4
7419866|NCT01473524|11694810|FG001|DB Phase|Adverse Event|8
7419867|NCT01473524|11694811|FG002|DB Phase|Adverse Event|2
7419868|NCT01473524|11694812|FG003|DB Phase|Adverse Event|0
7419869|NCT01473524|11694813|FG004|DB Phase|Adverse Event|0
7419870|NCT01473524|11694814|FG005|DB Phase|Adverse Event|0
7419871|NCT01473524|11694809|FG000|DB Phase|Death|1
7419872|NCT01473524|11694810|FG001|DB Phase|Death|0
7419873|NCT01473524|11694811|FG002|DB Phase|Death|0
7419874|NCT01473524|11694812|FG003|DB Phase|Death|0
7419875|NCT01473524|11694813|FG004|DB Phase|Death|0
7419876|NCT01473524|11694814|FG005|DB Phase|Death|0
7419877|NCT01473524|11694809|FG000|DB Phase|Withdrawal by Subject|2
7419878|NCT01473524|11694810|FG001|DB Phase|Withdrawal by Subject|1
7419879|NCT01473524|11694811|FG002|DB Phase|Withdrawal by Subject|1
7419880|NCT01473524|11694812|FG003|DB Phase|Withdrawal by Subject|0
7419881|NCT01473524|11694813|FG004|DB Phase|Withdrawal by Subject|0
7419882|NCT01473524|11694814|FG005|DB Phase|Withdrawal by Subject|0
7419883|NCT01473524|11694809|FG000|LTSE Phase|Withdrawal by Subject|0
7419884|NCT01473524|11694810|FG001|LTSE Phase|Withdrawal by Subject|0
7419885|NCT01473524|11694811|FG002|LTSE Phase|Withdrawal by Subject|0
7419886|NCT01473524|11694812|FG003|LTSE Phase|Withdrawal by Subject|3
7419887|NCT01473524|11694813|FG004|LTSE Phase|Withdrawal by Subject|3
7419888|NCT01473524|11694814|FG005|LTSE Phase|Withdrawal by Subject|6
7419889|NCT01473524|11694809|FG000|LTSE Phase|Death|0
7419890|NCT01473524|11694810|FG001|LTSE Phase|Death|0
7419891|NCT01473524|11694811|FG002|LTSE Phase|Death|0
7419892|NCT01473524|11694812|FG003|LTSE Phase|Death|0
7419893|NCT01473524|11694813|FG004|LTSE Phase|Death|1
7419894|NCT01473524|11694814|FG005|LTSE Phase|Death|0
7419895|NCT01473524|11694809|FG000|LTSE Phase|Adverse Event of Pruritus|0
7419896|NCT01473524|11694810|FG001|LTSE Phase|Adverse Event of Pruritus|0
7419897|NCT01473524|11694811|FG002|LTSE Phase|Adverse Event of Pruritus|0
7419898|NCT01473524|11694812|FG003|LTSE Phase|Adverse Event of Pruritus|1
7419899|NCT01473524|11694813|FG004|LTSE Phase|Adverse Event of Pruritus|5
7419900|NCT01473524|11694814|FG005|LTSE Phase|Adverse Event of Pruritus|2
7531602|NCT02655237|11876358|FG001|Overall Study|Lack of Efficacy|1
7556901|NCT03087643|11920903|FG001|Overall Study|Withdrawal by Subject|4
7419901|NCT01473524|11694809|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7419902|NCT01473524|11694810|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7556902|NCT03087643|11920902|FG000|Overall Study|Death|2
7419903|NCT01473524|11694811|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
7419904|NCT01473524|11694812|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
7556903|NCT03087643|11920903|FG001|Overall Study|Death|2
7419905|NCT01473524|11694813|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
7419906|NCT01473524|11694814|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
7419907|NCT01473524|11694809|FG000|LTSE Phase|Lost to Follow-up|0
7419908|NCT01473524|11694810|FG001|LTSE Phase|Lost to Follow-up|0
7419909|NCT01473524|11694811|FG002|LTSE Phase|Lost to Follow-up|0
7419910|NCT01473524|11694812|FG003|LTSE Phase|Lost to Follow-up|1
7419911|NCT01473524|11694813|FG004|LTSE Phase|Lost to Follow-up|3
7419912|NCT01473524|11694814|FG005|LTSE Phase|Lost to Follow-up|2
7419913|NCT01473524|11694809|FG000|LTSE Phase|Principal Investigator Decision|0
7419914|NCT01473524|11694810|FG001|LTSE Phase|Principal Investigator Decision|0
7419915|NCT01473524|11694811|FG002|LTSE Phase|Principal Investigator Decision|0
7419916|NCT01473524|11694812|FG003|LTSE Phase|Principal Investigator Decision|1
7419917|NCT01473524|11694813|FG004|LTSE Phase|Principal Investigator Decision|1
7419918|NCT01473524|11694814|FG005|LTSE Phase|Principal Investigator Decision|3
7419919|NCT01473524|11694809|FG000|LTSE Phase|Liver Transplantation|0
7419920|NCT01473524|11694810|FG001|LTSE Phase|Liver Transplantation|0
7419921|NCT01473524|11694811|FG002|LTSE Phase|Liver Transplantation|0
7419922|NCT01473524|11694812|FG003|LTSE Phase|Liver Transplantation|0
7419923|NCT01473524|11694813|FG004|LTSE Phase|Liver Transplantation|0
7419924|NCT01473524|11694814|FG005|LTSE Phase|Liver Transplantation|1
7419925|NCT01473524|11694809|FG000|LTSE Phase|Pregnancy|0
7419926|NCT01473524|11694810|FG001|LTSE Phase|Pregnancy|0
7419927|NCT01473524|11694811|FG002|LTSE Phase|Pregnancy|0
7419928|NCT01473524|11694812|FG003|LTSE Phase|Pregnancy|1
7419929|NCT01473524|11694813|FG004|LTSE Phase|Pregnancy|0
7419930|NCT01473524|11694814|FG005|LTSE Phase|Pregnancy|0
7419931|NCT01473524|11694809|FG000|LTSE Phase|Protocol Violation|0
7419932|NCT01473524|11694810|FG001|LTSE Phase|Protocol Violation|0
7419933|NCT01473524|11694811|FG002|LTSE Phase|Protocol Violation|0
7419934|NCT01473524|11694812|FG003|LTSE Phase|Protocol Violation|0
7419935|NCT01473524|11694813|FG004|LTSE Phase|Protocol Violation|0
7419936|NCT01473524|11694814|FG005|LTSE Phase|Protocol Violation|1
7419937|NCT01473563|11694836|FG000|Overall Study|Lost to FU post tx discontinuation|1
7419938|NCT01473589|11694842|FG000|Overall Study|Adverse Event|1
7419939|NCT01473589|11694843|FG001|Overall Study|Adverse Event|1
7419940|NCT01473589|11694842|FG000|Overall Study|Death|2
7419941|NCT01473589|11694843|FG001|Overall Study|Death|0
7419942|NCT01473589|11694842|FG000|Overall Study|Lost to Follow-up|2
7419943|NCT01473589|11694843|FG001|Overall Study|Lost to Follow-up|2
7419944|NCT01473589|11694842|FG000|Overall Study|Protocol Violation|1
7419945|NCT01473589|11694843|FG001|Overall Study|Protocol Violation|0
7419946|NCT01473589|11694842|FG000|Overall Study|Withdrawal by Subject|5
7419947|NCT01473589|11694843|FG001|Overall Study|Withdrawal by Subject|11
7419948|NCT01473589|11694842|FG000|Overall Study|Physician Decision|0
7419949|NCT01473589|11694843|FG001|Overall Study|Physician Decision|1
7419950|NCT01473589|11694842|FG000|Overall Study|Entry criteria not met|0
7419951|NCT01473589|11694843|FG001|Overall Study|Entry criteria not met|1
7419952|NCT01473602|11694853|FG000|Overall Study|Adverse Event|1
7419953|NCT01473602|11694854|FG001|Overall Study|Adverse Event|2
7419954|NCT01473602|11694853|FG000|Overall Study|Death|0
7419955|NCT01473602|11694854|FG001|Overall Study|Death|1
7419956|NCT01473602|11694853|FG000|Overall Study|Lost to Follow-up|1
7419957|NCT01473602|11694854|FG001|Overall Study|Lost to Follow-up|1
7419958|NCT01473602|11694853|FG000|Overall Study|Withdrawal by Subject|5
7419959|NCT01473602|11694854|FG001|Overall Study|Withdrawal by Subject|4
7419960|NCT01473602|11694853|FG000|Overall Study|Physician Decision|1
7419961|NCT01473602|11694854|FG001|Overall Study|Physician Decision|0
7419962|NCT01473758|11694873|FG000|Cycle 1|Adverse Event|10
7419963|NCT01473758|11694874|FG001|Cycle 1|Adverse Event|2
7419964|NCT01473758|11694875|FG002|Cycle 1|Adverse Event|0
7419965|NCT01473758|11694876|FG003|Cycle 1|Adverse Event|0
7419966|NCT01473758|11694873|FG000|Cycle 1|Withdrawal by Subject|1
7419967|NCT01473758|11694874|FG001|Cycle 1|Withdrawal by Subject|1
7419968|NCT01473758|11694875|FG002|Cycle 1|Withdrawal by Subject|0
7419969|NCT01473758|11694876|FG003|Cycle 1|Withdrawal by Subject|0
7419970|NCT01473758|11694873|FG000|Cycle 2|Adverse Event|0
7419971|NCT01473758|11694874|FG001|Cycle 2|Adverse Event|0
7419972|NCT01473758|11694875|FG002|Cycle 2|Adverse Event|5
7419973|NCT01473758|11694876|FG003|Cycle 2|Adverse Event|0
7419974|NCT01473836|11694884|FG000|Overall Study|Adverse Event|4
7419975|NCT01473836|11694884|FG000|Overall Study|Lack of Efficacy|1
7419976|NCT01473836|11694884|FG000|Overall Study|Does not meet entrance criteria|1
7419977|NCT01473940|11694892|FG000|Induction Therapy|Death|0
7531603|NCT02655237|11876357|FG000|Overall Study|Recovery Leading to Surgery|2
7531604|NCT02655237|11876358|FG001|Overall Study|Recovery Leading to Surgery|1
7531605|NCT02655237|11876357|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
7531606|NCT02655237|11876358|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
7419978|NCT01473940|11694893|FG001|Induction Therapy|Death|0
7419979|NCT01473940|11694894|FG002|Induction Therapy|Death|1
7419980|NCT01473940|11694895|FG003|Induction Therapy|Death|1
7419981|NCT01473940|11694892|FG000|Induction Therapy|Progressive Disease|0
7419982|NCT01473940|11694893|FG001|Induction Therapy|Progressive Disease|1
7419983|NCT01473940|11694894|FG002|Induction Therapy|Progressive Disease|1
7419984|NCT01473940|11694895|FG003|Induction Therapy|Progressive Disease|0
7419985|NCT01473940|11694892|FG000|Maintenance Therapy|Progressive Disease|1
7419986|NCT01473940|11694893|FG001|Maintenance Therapy|Progressive Disease|2
7419987|NCT01473940|11694894|FG002|Maintenance Therapy|Progressive Disease|1
7419988|NCT01473940|11694895|FG003|Maintenance Therapy|Progressive Disease|4
7419989|NCT01473953|11694913|FG000|Overall Study|Other|1
7419990|NCT01473953|11694914|FG001|Overall Study|Other|0
7419991|NCT01473953|11694915|FG002|Overall Study|Other|0
7419992|NCT01473953|11694916|FG003|Overall Study|Other|0
7419993|NCT01473953|11694917|FG004|Overall Study|Other|0
7419994|NCT01474018|11694943|FG000|Overall Study|Lost to Follow-up|0
7419995|NCT01474018|11694944|FG001|Overall Study|Lost to Follow-up|1
7419996|NCT01474018|11694943|FG000|Overall Study|Withdrawal by Subject|0
7419997|NCT01474018|11694944|FG001|Overall Study|Withdrawal by Subject|2
7419998|NCT01474239|11695002|FG000|Overall Study|Disease Progression|37
7419999|NCT01474239|11695003|FG001|Overall Study|Disease Progression|25
7420000|NCT01474239|11695002|FG000|Overall Study|Adverse Event|12
7420001|NCT01474239|11695003|FG001|Overall Study|Adverse Event|3
7420002|NCT01474239|11695002|FG000|Overall Study|Withdrawal by Subject|1
7420003|NCT01474239|11695003|FG001|Overall Study|Withdrawal by Subject|2
7420004|NCT01474239|11695002|FG000|Overall Study|Death|1
7420005|NCT01474239|11695003|FG001|Overall Study|Death|1
7420006|NCT01474239|11695002|FG000|Overall Study|Clinical Disease Progression|7
7420007|NCT01474239|11695003|FG001|Overall Study|Clinical Disease Progression|1
7420008|NCT01474239|11695002|FG000|Overall Study|Withdrawal for Economic Reason|1
7420009|NCT01474239|11695003|FG001|Overall Study|Withdrawal for Economic Reason|0
7420010|NCT01474291|11695011|FG000|Overall Study|Not Evaluable for Efficacy|26
7420011|NCT01474291|11695011|FG000|Overall Study|Lack of Treatment Efficacy|88
7420012|NCT01474291|11695011|FG000|Overall Study|Adverse Event|53
7420013|NCT01474291|11695011|FG000|Overall Study|Lost to Follow-up|29
7420014|NCT01474291|11695011|FG000|Overall Study|Patient No Longer Wanted to Participate|12
7420015|NCT01474291|11695011|FG000|Overall Study|No Reason Reported|10
7420016|NCT01474291|11695011|FG000|Overall Study|Death|2
7420017|NCT01474317|11695018|FG000|Overall Study|Adverse Event|1
7420018|NCT01474317|11695018|FG000|Overall Study|Subject ineligible for study|1
7420019|NCT01474434|11695026|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7420020|NCT01474434|11695027|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
7420021|NCT01474434|11695028|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7420022|NCT01474434|11695029|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
7420023|NCT01474434|11695026|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7420024|NCT01474434|11695027|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7420025|NCT01474434|11695028|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
7420026|NCT01474434|11695029|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
7420027|NCT01474434|11695026|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
7420028|NCT01474434|11695027|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7420029|NCT01474434|11695028|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7420030|NCT01474434|11695029|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
7531607|NCT02655237|11876357|FG000|Overall Study|Randomized but Not Treated|1
7531608|NCT02655237|11876358|FG001|Overall Study|Randomized but Not Treated|0
7531609|NCT02655419|11876375|FG000|Overall Study|Enrolled but not treated|1
7531610|NCT02655419|11876376|FG001|Overall Study|Enrolled but not treated|5
7531611|NCT02655419|11876375|FG000|Overall Study|Withdrawal by Subject|4
7420031|NCT01474486|11695043|FG000|Overall Study|Death|2
7420032|NCT01474486|11695043|FG000|Overall Study|Withdrawal by Subject|4
7420033|NCT01474486|11695043|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
7420034|NCT01474512|11695054|FG000|Induction Period|Adverse Event|6
7420035|NCT01474512|11695055|FG001|Induction Period|Adverse Event|10
7420036|NCT01474512|11695056|FG002|Induction Period|Adverse Event|10
7420037|NCT01474512|11695057|FG003|Induction Period|Adverse Event|0
7420038|NCT01474512|11695058|FG004|Induction Period|Adverse Event|0
7420039|NCT01474512|11695059|FG005|Induction Period|Adverse Event|0
7420040|NCT01474512|11695060|FG006|Induction Period|Adverse Event|0
7420041|NCT01474512|11695061|FG007|Induction Period|Adverse Event|0
7420042|NCT01474512|11695062|FG008|Induction Period|Adverse Event|0
7420043|NCT01474512|11695063|FG009|Induction Period|Adverse Event|0
7420044|NCT01474512|11695064|FG010|Induction Period|Adverse Event|0
7420045|NCT01474512|11695065|FG011|Induction Period|Adverse Event|0
7556904|NCT03087786|11920911|FG000|Overall Study|Withdrawal by Subject|2
7556905|NCT03087786|11920912|FG001|Overall Study|Withdrawal by Subject|0
7556906|NCT03087851|11920921|FG000|Overall Study|Withdraw on medical grounds|0
7556907|NCT03087851|11920922|FG001|Overall Study|Withdraw on medical grounds|1
7556908|NCT03087851|11920923|FG002|Overall Study|Withdraw on medical grounds|2
7556909|NCT03088917|11920970|FG000|Overall Study|In care/cured elsewhere|15
7556910|NCT03088917|11920970|FG000|Overall Study|Refuse re-evaluation|13
7556911|NCT03088917|11920970|FG000|Overall Study|Contact not established|13
7556912|NCT03088917|11920970|FG000|Overall Study|Severe comorbidity/short life expectancy|5
7556913|NCT03088917|11920970|FG000|Overall Study|Moved outside study region|50
7556914|NCT03089047|11920978|FG000|Overall Study|Lost to Follow-up|1
7556915|NCT03089047|11920979|FG001|Overall Study|Lost to Follow-up|0
7556916|NCT03089216|11920989|FG000|Overall Study|Adverse Event|0
7420046|NCT01474512|11695066|FG012|Induction Period|Adverse Event|0
7420047|NCT01474512|11695067|FG013|Induction Period|Adverse Event|0
7420048|NCT01474512|11695068|FG014|Induction Period|Adverse Event|0
7531612|NCT02655419|11876376|FG001|Overall Study|Withdrawal by Subject|1
7420049|NCT01474512|11695069|FG015|Induction Period|Adverse Event|0
7420050|NCT01474512|11695070|FG016|Induction Period|Adverse Event|0
7420051|NCT01474512|11695071|FG017|Induction Period|Adverse Event|0
7420052|NCT01474512|11695054|FG000|Induction Period|Lack of Efficacy|7
7420053|NCT01474512|11695055|FG001|Induction Period|Lack of Efficacy|1
7420054|NCT01474512|11695056|FG002|Induction Period|Lack of Efficacy|0
7420055|NCT01474512|11695057|FG003|Induction Period|Lack of Efficacy|0
7420056|NCT01474512|11695058|FG004|Induction Period|Lack of Efficacy|0
7420057|NCT01474512|11695059|FG005|Induction Period|Lack of Efficacy|0
7420058|NCT01474512|11695060|FG006|Induction Period|Lack of Efficacy|0
7420059|NCT01474512|11695061|FG007|Induction Period|Lack of Efficacy|0
7420060|NCT01474512|11695062|FG008|Induction Period|Lack of Efficacy|0
7420061|NCT01474512|11695063|FG009|Induction Period|Lack of Efficacy|0
7420062|NCT01474512|11695064|FG010|Induction Period|Lack of Efficacy|0
7420063|NCT01474512|11695065|FG011|Induction Period|Lack of Efficacy|0
7420064|NCT01474512|11695066|FG012|Induction Period|Lack of Efficacy|0
7420065|NCT01474512|11695067|FG013|Induction Period|Lack of Efficacy|0
7420066|NCT01474512|11695068|FG014|Induction Period|Lack of Efficacy|0
7420067|NCT01474512|11695069|FG015|Induction Period|Lack of Efficacy|0
7420068|NCT01474512|11695070|FG016|Induction Period|Lack of Efficacy|0
7420069|NCT01474512|11695071|FG017|Induction Period|Lack of Efficacy|0
7420070|NCT01474512|11695054|FG000|Induction Period|Withdrawal by Subject|6
7420071|NCT01474512|11695055|FG001|Induction Period|Withdrawal by Subject|6
7420072|NCT01474512|11695056|FG002|Induction Period|Withdrawal by Subject|5
7420073|NCT01474512|11695057|FG003|Induction Period|Withdrawal by Subject|0
7420074|NCT01474512|11695058|FG004|Induction Period|Withdrawal by Subject|0
7420075|NCT01474512|11695059|FG005|Induction Period|Withdrawal by Subject|0
7420076|NCT01474512|11695060|FG006|Induction Period|Withdrawal by Subject|0
7420077|NCT01474512|11695061|FG007|Induction Period|Withdrawal by Subject|0
7420078|NCT01474512|11695062|FG008|Induction Period|Withdrawal by Subject|0
7420079|NCT01474512|11695063|FG009|Induction Period|Withdrawal by Subject|0
7420080|NCT01474512|11695064|FG010|Induction Period|Withdrawal by Subject|0
7420081|NCT01474512|11695065|FG011|Induction Period|Withdrawal by Subject|0
7420082|NCT01474512|11695066|FG012|Induction Period|Withdrawal by Subject|0
7420083|NCT01474512|11695067|FG013|Induction Period|Withdrawal by Subject|0
7420084|NCT01474512|11695068|FG014|Induction Period|Withdrawal by Subject|0
7420085|NCT01474512|11695069|FG015|Induction Period|Withdrawal by Subject|0
7420086|NCT01474512|11695070|FG016|Induction Period|Withdrawal by Subject|0
7420087|NCT01474512|11695071|FG017|Induction Period|Withdrawal by Subject|0
7420088|NCT01474512|11695054|FG000|Induction Period|Protocol Violation|3
7420089|NCT01474512|11695055|FG001|Induction Period|Protocol Violation|6
7420090|NCT01474512|11695056|FG002|Induction Period|Protocol Violation|0
7420091|NCT01474512|11695057|FG003|Induction Period|Protocol Violation|0
7420092|NCT01474512|11695058|FG004|Induction Period|Protocol Violation|0
7420093|NCT01474512|11695059|FG005|Induction Period|Protocol Violation|0
7420094|NCT01474512|11695060|FG006|Induction Period|Protocol Violation|0
7420095|NCT01474512|11695061|FG007|Induction Period|Protocol Violation|0
7420096|NCT01474512|11695062|FG008|Induction Period|Protocol Violation|0
7420097|NCT01474512|11695063|FG009|Induction Period|Protocol Violation|0
7420098|NCT01474512|11695064|FG010|Induction Period|Protocol Violation|0
7420099|NCT01474512|11695065|FG011|Induction Period|Protocol Violation|0
7420100|NCT01474512|11695066|FG012|Induction Period|Protocol Violation|0
7420101|NCT01474512|11695067|FG013|Induction Period|Protocol Violation|0
7420102|NCT01474512|11695068|FG014|Induction Period|Protocol Violation|0
7420103|NCT01474512|11695069|FG015|Induction Period|Protocol Violation|0
7420104|NCT01474512|11695070|FG016|Induction Period|Protocol Violation|0
7420105|NCT01474512|11695071|FG017|Induction Period|Protocol Violation|0
7420106|NCT01474512|11695054|FG000|Induction Period|Sponsor Decision|1
7420107|NCT01474512|11695055|FG001|Induction Period|Sponsor Decision|1
7420108|NCT01474512|11695056|FG002|Induction Period|Sponsor Decision|1
7420109|NCT01474512|11695057|FG003|Induction Period|Sponsor Decision|0
7420110|NCT01474512|11695058|FG004|Induction Period|Sponsor Decision|0
7420111|NCT01474512|11695059|FG005|Induction Period|Sponsor Decision|0
7420112|NCT01474512|11695060|FG006|Induction Period|Sponsor Decision|0
7420113|NCT01474512|11695061|FG007|Induction Period|Sponsor Decision|0
7420114|NCT01474512|11695062|FG008|Induction Period|Sponsor Decision|0
7420115|NCT01474512|11695063|FG009|Induction Period|Sponsor Decision|0
7420116|NCT01474512|11695064|FG010|Induction Period|Sponsor Decision|0
7420117|NCT01474512|11695065|FG011|Induction Period|Sponsor Decision|0
7420118|NCT01474512|11695066|FG012|Induction Period|Sponsor Decision|0
7420119|NCT01474512|11695067|FG013|Induction Period|Sponsor Decision|0
7420120|NCT01474512|11695068|FG014|Induction Period|Sponsor Decision|0
7420121|NCT01474512|11695069|FG015|Induction Period|Sponsor Decision|0
7420122|NCT01474512|11695070|FG016|Induction Period|Sponsor Decision|0
7420123|NCT01474512|11695071|FG017|Induction Period|Sponsor Decision|0
7420124|NCT01474512|11695054|FG000|Induction Period|Lost to Follow-up|1
7420125|NCT01474512|11695055|FG001|Induction Period|Lost to Follow-up|0
7420126|NCT01474512|11695056|FG002|Induction Period|Lost to Follow-up|2
7420127|NCT01474512|11695057|FG003|Induction Period|Lost to Follow-up|0
7420128|NCT01474512|11695058|FG004|Induction Period|Lost to Follow-up|0
7420129|NCT01474512|11695059|FG005|Induction Period|Lost to Follow-up|0
7420130|NCT01474512|11695060|FG006|Induction Period|Lost to Follow-up|0
7420131|NCT01474512|11695061|FG007|Induction Period|Lost to Follow-up|0
7420132|NCT01474512|11695062|FG008|Induction Period|Lost to Follow-up|0
7420133|NCT01474512|11695063|FG009|Induction Period|Lost to Follow-up|0
7420134|NCT01474512|11695064|FG010|Induction Period|Lost to Follow-up|0
7420135|NCT01474512|11695065|FG011|Induction Period|Lost to Follow-up|0
7420136|NCT01474512|11695066|FG012|Induction Period|Lost to Follow-up|0
7420137|NCT01474512|11695067|FG013|Induction Period|Lost to Follow-up|0
7420138|NCT01474512|11695068|FG014|Induction Period|Lost to Follow-up|0
7420139|NCT01474512|11695069|FG015|Induction Period|Lost to Follow-up|0
7420140|NCT01474512|11695070|FG016|Induction Period|Lost to Follow-up|0
7420141|NCT01474512|11695071|FG017|Induction Period|Lost to Follow-up|0
7420142|NCT01474512|11695054|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
7420143|NCT01474512|11695055|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
7420144|NCT01474512|11695056|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
7420145|NCT01474512|11695057|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
7420146|NCT01474512|11695058|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
7420147|NCT01474512|11695059|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
7420148|NCT01474512|11695060|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
7420149|NCT01474512|11695061|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
7420150|NCT01474512|11695062|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
7420151|NCT01474512|11695063|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
7420152|NCT01474512|11695064|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
7420153|NCT01474512|11695065|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
7420154|NCT01474512|11695066|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
7420155|NCT01474512|11695067|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
7420156|NCT01474512|11695068|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
7420157|NCT01474512|11695069|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
7420158|NCT01474512|11695070|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
7420159|NCT01474512|11695071|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
7420160|NCT01474512|11695054|FG000|Maintenance Period|Adverse Event|0
7420161|NCT01474512|11695055|FG001|Maintenance Period|Adverse Event|0
7420162|NCT01474512|11695056|FG002|Maintenance Period|Adverse Event|0
7420163|NCT01474512|11695057|FG003|Maintenance Period|Adverse Event|4
7420164|NCT01474512|11695058|FG004|Maintenance Period|Adverse Event|2
7420165|NCT01474512|11695059|FG005|Maintenance Period|Adverse Event|7
7420166|NCT01474512|11695060|FG006|Maintenance Period|Adverse Event|0
7420167|NCT01474512|11695061|FG007|Maintenance Period|Adverse Event|19
7420168|NCT01474512|11695062|FG008|Maintenance Period|Adverse Event|1
7420169|NCT01474512|11695063|FG009|Maintenance Period|Adverse Event|3
7420170|NCT01474512|11695064|FG010|Maintenance Period|Adverse Event|0
7420171|NCT01474512|11695065|FG011|Maintenance Period|Adverse Event|0
7420172|NCT01474512|11695066|FG012|Maintenance Period|Adverse Event|0
7420173|NCT01474512|11695067|FG013|Maintenance Period|Adverse Event|0
7420174|NCT01474512|11695068|FG014|Maintenance Period|Adverse Event|0
7420175|NCT01474512|11695069|FG015|Maintenance Period|Adverse Event|0
7420176|NCT01474512|11695070|FG016|Maintenance Period|Adverse Event|0
7420177|NCT01474512|11695071|FG017|Maintenance Period|Adverse Event|0
7531613|NCT02655419|11876375|FG000|Overall Study|Other|0
7531614|NCT02655419|11876376|FG001|Overall Study|Other|1
7531615|NCT02655666|11876414|FG000|Overall Study|Sponsor stopped this clinical research.|12
7531616|NCT02655679|11876423|FG000|Overall Study|Adverse Event|0
7531617|NCT02655679|11876424|FG001|Overall Study|Adverse Event|1
7531618|NCT02655679|11876425|FG002|Overall Study|Adverse Event|0
7531619|NCT02655679|11876426|FG003|Overall Study|Adverse Event|0
7531620|NCT02655679|11876427|FG004|Overall Study|Adverse Event|0
7420178|NCT01474512|11695054|FG000|Maintenance Period|Withdrawal by Subject|0
7420179|NCT01474512|11695055|FG001|Maintenance Period|Withdrawal by Subject|0
7420180|NCT01474512|11695056|FG002|Maintenance Period|Withdrawal by Subject|0
7420181|NCT01474512|11695057|FG003|Maintenance Period|Withdrawal by Subject|6
7420182|NCT01474512|11695058|FG004|Maintenance Period|Withdrawal by Subject|2
7420183|NCT01474512|11695059|FG005|Maintenance Period|Withdrawal by Subject|3
7420184|NCT01474512|11695060|FG006|Maintenance Period|Withdrawal by Subject|1
7420185|NCT01474512|11695061|FG007|Maintenance Period|Withdrawal by Subject|6
7420186|NCT01474512|11695062|FG008|Maintenance Period|Withdrawal by Subject|3
7420187|NCT01474512|11695063|FG009|Maintenance Period|Withdrawal by Subject|1
7420188|NCT01474512|11695064|FG010|Maintenance Period|Withdrawal by Subject|0
7420189|NCT01474512|11695065|FG011|Maintenance Period|Withdrawal by Subject|0
7420190|NCT01474512|11695066|FG012|Maintenance Period|Withdrawal by Subject|0
7420191|NCT01474512|11695067|FG013|Maintenance Period|Withdrawal by Subject|0
7420192|NCT01474512|11695068|FG014|Maintenance Period|Withdrawal by Subject|0
7420193|NCT01474512|11695069|FG015|Maintenance Period|Withdrawal by Subject|0
7420194|NCT01474512|11695070|FG016|Maintenance Period|Withdrawal by Subject|0
7420195|NCT01474512|11695071|FG017|Maintenance Period|Withdrawal by Subject|0
7420196|NCT01474512|11695054|FG000|Maintenance Period|Lost to Follow-up|0
7420197|NCT01474512|11695055|FG001|Maintenance Period|Lost to Follow-up|0
7420198|NCT01474512|11695056|FG002|Maintenance Period|Lost to Follow-up|0
7420199|NCT01474512|11695057|FG003|Maintenance Period|Lost to Follow-up|3
7420200|NCT01474512|11695058|FG004|Maintenance Period|Lost to Follow-up|3
7420201|NCT01474512|11695059|FG005|Maintenance Period|Lost to Follow-up|0
7420202|NCT01474512|11695060|FG006|Maintenance Period|Lost to Follow-up|0
7531621|NCT02655679|11876423|FG000|Overall Study|Withdrawal by Subject|1
7420203|NCT01474512|11695061|FG007|Maintenance Period|Lost to Follow-up|2
7420204|NCT01474512|11695062|FG008|Maintenance Period|Lost to Follow-up|1
7420205|NCT01474512|11695063|FG009|Maintenance Period|Lost to Follow-up|1
7531622|NCT02655679|11876424|FG001|Overall Study|Withdrawal by Subject|1
7420206|NCT01474512|11695064|FG010|Maintenance Period|Lost to Follow-up|0
7420207|NCT01474512|11695065|FG011|Maintenance Period|Lost to Follow-up|0
7420208|NCT01474512|11695066|FG012|Maintenance Period|Lost to Follow-up|0
7420209|NCT01474512|11695067|FG013|Maintenance Period|Lost to Follow-up|0
7420210|NCT01474512|11695068|FG014|Maintenance Period|Lost to Follow-up|0
7420211|NCT01474512|11695069|FG015|Maintenance Period|Lost to Follow-up|0
7420212|NCT01474512|11695070|FG016|Maintenance Period|Lost to Follow-up|0
7420213|NCT01474512|11695071|FG017|Maintenance Period|Lost to Follow-up|0
7420214|NCT01474512|11695054|FG000|Maintenance Period|Death|0
7420215|NCT01474512|11695055|FG001|Maintenance Period|Death|0
7420216|NCT01474512|11695056|FG002|Maintenance Period|Death|0
7420217|NCT01474512|11695057|FG003|Maintenance Period|Death|0
7420218|NCT01474512|11695058|FG004|Maintenance Period|Death|0
7420219|NCT01474512|11695059|FG005|Maintenance Period|Death|2
7420220|NCT01474512|11695060|FG006|Maintenance Period|Death|0
7420221|NCT01474512|11695061|FG007|Maintenance Period|Death|0
7420222|NCT01474512|11695062|FG008|Maintenance Period|Death|0
7420223|NCT01474512|11695063|FG009|Maintenance Period|Death|0
7420224|NCT01474512|11695064|FG010|Maintenance Period|Death|0
7420225|NCT01474512|11695065|FG011|Maintenance Period|Death|0
7420226|NCT01474512|11695066|FG012|Maintenance Period|Death|0
7420227|NCT01474512|11695067|FG013|Maintenance Period|Death|0
7420228|NCT01474512|11695068|FG014|Maintenance Period|Death|0
7420229|NCT01474512|11695069|FG015|Maintenance Period|Death|0
7420230|NCT01474512|11695070|FG016|Maintenance Period|Death|0
7420231|NCT01474512|11695071|FG017|Maintenance Period|Death|0
7420232|NCT01474512|11695054|FG000|Maintenance Period|Physician Decision|0
7420233|NCT01474512|11695055|FG001|Maintenance Period|Physician Decision|0
7420234|NCT01474512|11695056|FG002|Maintenance Period|Physician Decision|0
7420235|NCT01474512|11695057|FG003|Maintenance Period|Physician Decision|0
7420236|NCT01474512|11695058|FG004|Maintenance Period|Physician Decision|0
7420237|NCT01474512|11695059|FG005|Maintenance Period|Physician Decision|1
7420238|NCT01474512|11695060|FG006|Maintenance Period|Physician Decision|0
7420239|NCT01474512|11695061|FG007|Maintenance Period|Physician Decision|2
7420240|NCT01474512|11695062|FG008|Maintenance Period|Physician Decision|0
7420241|NCT01474512|11695063|FG009|Maintenance Period|Physician Decision|0
7420242|NCT01474512|11695064|FG010|Maintenance Period|Physician Decision|0
7420243|NCT01474512|11695065|FG011|Maintenance Period|Physician Decision|0
7420244|NCT01474512|11695066|FG012|Maintenance Period|Physician Decision|0
7420245|NCT01474512|11695067|FG013|Maintenance Period|Physician Decision|0
7420246|NCT01474512|11695068|FG014|Maintenance Period|Physician Decision|0
7420247|NCT01474512|11695069|FG015|Maintenance Period|Physician Decision|0
7420248|NCT01474512|11695070|FG016|Maintenance Period|Physician Decision|0
7420249|NCT01474512|11695071|FG017|Maintenance Period|Physician Decision|0
7420250|NCT01474512|11695054|FG000|Maintenance Period|Clinical Relapse|0
7420251|NCT01474512|11695055|FG001|Maintenance Period|Clinical Relapse|0
7420252|NCT01474512|11695056|FG002|Maintenance Period|Clinical Relapse|0
7420253|NCT01474512|11695057|FG003|Maintenance Period|Clinical Relapse|1
7420254|NCT01474512|11695058|FG004|Maintenance Period|Clinical Relapse|0
7420255|NCT01474512|11695059|FG005|Maintenance Period|Clinical Relapse|0
7420256|NCT01474512|11695060|FG006|Maintenance Period|Clinical Relapse|0
7420257|NCT01474512|11695061|FG007|Maintenance Period|Clinical Relapse|0
7420258|NCT01474512|11695062|FG008|Maintenance Period|Clinical Relapse|0
7420259|NCT01474512|11695063|FG009|Maintenance Period|Clinical Relapse|0
7420260|NCT01474512|11695064|FG010|Maintenance Period|Clinical Relapse|0
7420261|NCT01474512|11695065|FG011|Maintenance Period|Clinical Relapse|0
7420262|NCT01474512|11695066|FG012|Maintenance Period|Clinical Relapse|0
7420263|NCT01474512|11695067|FG013|Maintenance Period|Clinical Relapse|0
7420264|NCT01474512|11695068|FG014|Maintenance Period|Clinical Relapse|0
7420265|NCT01474512|11695069|FG015|Maintenance Period|Clinical Relapse|0
7420266|NCT01474512|11695070|FG016|Maintenance Period|Clinical Relapse|0
7420267|NCT01474512|11695071|FG017|Maintenance Period|Clinical Relapse|0
7420268|NCT01474512|11695054|FG000|Maintenance Period|Lack of Efficacy|0
7420269|NCT01474512|11695055|FG001|Maintenance Period|Lack of Efficacy|0
7420270|NCT01474512|11695056|FG002|Maintenance Period|Lack of Efficacy|0
7420271|NCT01474512|11695057|FG003|Maintenance Period|Lack of Efficacy|1
7420272|NCT01474512|11695058|FG004|Maintenance Period|Lack of Efficacy|0
7420273|NCT01474512|11695059|FG005|Maintenance Period|Lack of Efficacy|0
7420274|NCT01474512|11695060|FG006|Maintenance Period|Lack of Efficacy|0
7420275|NCT01474512|11695061|FG007|Maintenance Period|Lack of Efficacy|11
7420276|NCT01474512|11695062|FG008|Maintenance Period|Lack of Efficacy|11
7420277|NCT01474512|11695063|FG009|Maintenance Period|Lack of Efficacy|12
7420278|NCT01474512|11695064|FG010|Maintenance Period|Lack of Efficacy|0
7420279|NCT01474512|11695065|FG011|Maintenance Period|Lack of Efficacy|0
7420280|NCT01474512|11695066|FG012|Maintenance Period|Lack of Efficacy|0
7420281|NCT01474512|11695067|FG013|Maintenance Period|Lack of Efficacy|0
7420282|NCT01474512|11695068|FG014|Maintenance Period|Lack of Efficacy|0
7420283|NCT01474512|11695069|FG015|Maintenance Period|Lack of Efficacy|0
7420284|NCT01474512|11695070|FG016|Maintenance Period|Lack of Efficacy|0
7420285|NCT01474512|11695071|FG017|Maintenance Period|Lack of Efficacy|0
7420286|NCT01474512|11695054|FG000|Maintenance Period|Protocol Violation|0
7420287|NCT01474512|11695055|FG001|Maintenance Period|Protocol Violation|0
7420288|NCT01474512|11695056|FG002|Maintenance Period|Protocol Violation|0
7420289|NCT01474512|11695057|FG003|Maintenance Period|Protocol Violation|1
7531623|NCT02655679|11876425|FG002|Overall Study|Withdrawal by Subject|0
7531624|NCT02655679|11876426|FG003|Overall Study|Withdrawal by Subject|3
7420290|NCT01474512|11695058|FG004|Maintenance Period|Protocol Violation|0
7420291|NCT01474512|11695059|FG005|Maintenance Period|Protocol Violation|0
7420292|NCT01474512|11695060|FG006|Maintenance Period|Protocol Violation|0
7420293|NCT01474512|11695061|FG007|Maintenance Period|Protocol Violation|1
7420294|NCT01474512|11695062|FG008|Maintenance Period|Protocol Violation|0
7420295|NCT01474512|11695063|FG009|Maintenance Period|Protocol Violation|1
7420296|NCT01474512|11695064|FG010|Maintenance Period|Protocol Violation|0
7420297|NCT01474512|11695065|FG011|Maintenance Period|Protocol Violation|0
7420298|NCT01474512|11695066|FG012|Maintenance Period|Protocol Violation|0
7420299|NCT01474512|11695067|FG013|Maintenance Period|Protocol Violation|0
7420300|NCT01474512|11695068|FG014|Maintenance Period|Protocol Violation|0
7420301|NCT01474512|11695069|FG015|Maintenance Period|Protocol Violation|0
7420302|NCT01474512|11695070|FG016|Maintenance Period|Protocol Violation|0
7420303|NCT01474512|11695071|FG017|Maintenance Period|Protocol Violation|0
7420304|NCT01474512|11695054|FG000|Maintenance Period|Treated but Discontinued in Induction|0
7420305|NCT01474512|11695055|FG001|Maintenance Period|Treated but Discontinued in Induction|0
7420306|NCT01474512|11695056|FG002|Maintenance Period|Treated but Discontinued in Induction|0
7420307|NCT01474512|11695057|FG003|Maintenance Period|Treated but Discontinued in Induction|0
7420308|NCT01474512|11695058|FG004|Maintenance Period|Treated but Discontinued in Induction|1
7420309|NCT01474512|11695059|FG005|Maintenance Period|Treated but Discontinued in Induction|0
7420310|NCT01474512|11695060|FG006|Maintenance Period|Treated but Discontinued in Induction|0
7420311|NCT01474512|11695061|FG007|Maintenance Period|Treated but Discontinued in Induction|0
7420312|NCT01474512|11695062|FG008|Maintenance Period|Treated but Discontinued in Induction|0
7420313|NCT01474512|11695063|FG009|Maintenance Period|Treated but Discontinued in Induction|0
7420314|NCT01474512|11695064|FG010|Maintenance Period|Treated but Discontinued in Induction|0
7420315|NCT01474512|11695065|FG011|Maintenance Period|Treated but Discontinued in Induction|0
7420316|NCT01474512|11695066|FG012|Maintenance Period|Treated but Discontinued in Induction|0
7420317|NCT01474512|11695067|FG013|Maintenance Period|Treated but Discontinued in Induction|0
7420318|NCT01474512|11695068|FG014|Maintenance Period|Treated but Discontinued in Induction|0
7420319|NCT01474512|11695069|FG015|Maintenance Period|Treated but Discontinued in Induction|0
7420320|NCT01474512|11695070|FG016|Maintenance Period|Treated but Discontinued in Induction|0
7420321|NCT01474512|11695071|FG017|Maintenance Period|Treated but Discontinued in Induction|0
7420322|NCT01474512|11695054|FG000|Long-Term Extension Period|Withdrawal by Subject|0
7420323|NCT01474512|11695055|FG001|Long-Term Extension Period|Withdrawal by Subject|0
7420324|NCT01474512|11695056|FG002|Long-Term Extension Period|Withdrawal by Subject|0
7420325|NCT01474512|11695057|FG003|Long-Term Extension Period|Withdrawal by Subject|0
7420326|NCT01474512|11695058|FG004|Long-Term Extension Period|Withdrawal by Subject|0
7420327|NCT01474512|11695059|FG005|Long-Term Extension Period|Withdrawal by Subject|0
7420328|NCT01474512|11695060|FG006|Long-Term Extension Period|Withdrawal by Subject|0
7420329|NCT01474512|11695061|FG007|Long-Term Extension Period|Withdrawal by Subject|0
7420330|NCT01474512|11695062|FG008|Long-Term Extension Period|Withdrawal by Subject|0
7420331|NCT01474512|11695063|FG009|Long-Term Extension Period|Withdrawal by Subject|0
7420332|NCT01474512|11695064|FG010|Long-Term Extension Period|Withdrawal by Subject|0
7420333|NCT01474512|11695065|FG011|Long-Term Extension Period|Withdrawal by Subject|3
7420334|NCT01474512|11695066|FG012|Long-Term Extension Period|Withdrawal by Subject|61
7420335|NCT01474512|11695067|FG013|Long-Term Extension Period|Withdrawal by Subject|61
7420336|NCT01474512|11695068|FG014|Long-Term Extension Period|Withdrawal by Subject|0
7420337|NCT01474512|11695069|FG015|Long-Term Extension Period|Withdrawal by Subject|0
7420338|NCT01474512|11695070|FG016|Long-Term Extension Period|Withdrawal by Subject|0
7420339|NCT01474512|11695071|FG017|Long-Term Extension Period|Withdrawal by Subject|0
7420340|NCT01474512|11695054|FG000|Long-Term Extension Period|Adverse Event|0
7420341|NCT01474512|11695055|FG001|Long-Term Extension Period|Adverse Event|0
7420342|NCT01474512|11695056|FG002|Long-Term Extension Period|Adverse Event|0
7420343|NCT01474512|11695057|FG003|Long-Term Extension Period|Adverse Event|0
7420344|NCT01474512|11695058|FG004|Long-Term Extension Period|Adverse Event|0
7420345|NCT01474512|11695059|FG005|Long-Term Extension Period|Adverse Event|0
7420346|NCT01474512|11695060|FG006|Long-Term Extension Period|Adverse Event|0
7420347|NCT01474512|11695061|FG007|Long-Term Extension Period|Adverse Event|0
7420348|NCT01474512|11695062|FG008|Long-Term Extension Period|Adverse Event|0
7420349|NCT01474512|11695063|FG009|Long-Term Extension Period|Adverse Event|0
7420350|NCT01474512|11695064|FG010|Long-Term Extension Period|Adverse Event|0
7420351|NCT01474512|11695065|FG011|Long-Term Extension Period|Adverse Event|1
7420352|NCT01474512|11695066|FG012|Long-Term Extension Period|Adverse Event|57
7420353|NCT01474512|11695067|FG013|Long-Term Extension Period|Adverse Event|58
7420354|NCT01474512|11695068|FG014|Long-Term Extension Period|Adverse Event|0
7420355|NCT01474512|11695069|FG015|Long-Term Extension Period|Adverse Event|0
7420356|NCT01474512|11695070|FG016|Long-Term Extension Period|Adverse Event|0
7420357|NCT01474512|11695071|FG017|Long-Term Extension Period|Adverse Event|0
7420358|NCT01474512|11695054|FG000|Long-Term Extension Period|Lost to Follow-up|0
7420359|NCT01474512|11695055|FG001|Long-Term Extension Period|Lost to Follow-up|0
7420360|NCT01474512|11695056|FG002|Long-Term Extension Period|Lost to Follow-up|0
7420361|NCT01474512|11695057|FG003|Long-Term Extension Period|Lost to Follow-up|0
7420362|NCT01474512|11695058|FG004|Long-Term Extension Period|Lost to Follow-up|0
7531625|NCT02655679|11876427|FG004|Overall Study|Withdrawal by Subject|1
7420363|NCT01474512|11695059|FG005|Long-Term Extension Period|Lost to Follow-up|0
7420364|NCT01474512|11695060|FG006|Long-Term Extension Period|Lost to Follow-up|0
7420365|NCT01474512|11695061|FG007|Long-Term Extension Period|Lost to Follow-up|0
7420366|NCT01474512|11695062|FG008|Long-Term Extension Period|Lost to Follow-up|0
7420367|NCT01474512|11695063|FG009|Long-Term Extension Period|Lost to Follow-up|0
7420368|NCT01474512|11695064|FG010|Long-Term Extension Period|Lost to Follow-up|0
7420369|NCT01474512|11695065|FG011|Long-Term Extension Period|Lost to Follow-up|0
7420370|NCT01474512|11695066|FG012|Long-Term Extension Period|Lost to Follow-up|25
7420371|NCT01474512|11695067|FG013|Long-Term Extension Period|Lost to Follow-up|25
7420372|NCT01474512|11695068|FG014|Long-Term Extension Period|Lost to Follow-up|0
7420373|NCT01474512|11695069|FG015|Long-Term Extension Period|Lost to Follow-up|0
7420374|NCT01474512|11695070|FG016|Long-Term Extension Period|Lost to Follow-up|0
7420375|NCT01474512|11695071|FG017|Long-Term Extension Period|Lost to Follow-up|0
7420376|NCT01474512|11695054|FG000|Long-Term Extension Period|Lack of Efficacy|0
7420377|NCT01474512|11695055|FG001|Long-Term Extension Period|Lack of Efficacy|0
7420378|NCT01474512|11695056|FG002|Long-Term Extension Period|Lack of Efficacy|0
7420379|NCT01474512|11695057|FG003|Long-Term Extension Period|Lack of Efficacy|0
7420380|NCT01474512|11695058|FG004|Long-Term Extension Period|Lack of Efficacy|0
7420381|NCT01474512|11695059|FG005|Long-Term Extension Period|Lack of Efficacy|0
7420382|NCT01474512|11695060|FG006|Long-Term Extension Period|Lack of Efficacy|0
7420383|NCT01474512|11695061|FG007|Long-Term Extension Period|Lack of Efficacy|0
7420384|NCT01474512|11695062|FG008|Long-Term Extension Period|Lack of Efficacy|0
7420385|NCT01474512|11695063|FG009|Long-Term Extension Period|Lack of Efficacy|0
7420386|NCT01474512|11695064|FG010|Long-Term Extension Period|Lack of Efficacy|0
7420387|NCT01474512|11695065|FG011|Long-Term Extension Period|Lack of Efficacy|1
7420388|NCT01474512|11695066|FG012|Long-Term Extension Period|Lack of Efficacy|24
7420389|NCT01474512|11695067|FG013|Long-Term Extension Period|Lack of Efficacy|25
7420390|NCT01474512|11695068|FG014|Long-Term Extension Period|Lack of Efficacy|0
7420391|NCT01474512|11695069|FG015|Long-Term Extension Period|Lack of Efficacy|0
7420392|NCT01474512|11695070|FG016|Long-Term Extension Period|Lack of Efficacy|0
7420393|NCT01474512|11695071|FG017|Long-Term Extension Period|Lack of Efficacy|0
7420394|NCT01474512|11695054|FG000|Long-Term Extension Period|Physician Decision|0
7420395|NCT01474512|11695055|FG001|Long-Term Extension Period|Physician Decision|0
7420396|NCT01474512|11695056|FG002|Long-Term Extension Period|Physician Decision|0
7420397|NCT01474512|11695057|FG003|Long-Term Extension Period|Physician Decision|0
7420398|NCT01474512|11695058|FG004|Long-Term Extension Period|Physician Decision|0
7420399|NCT01474512|11695059|FG005|Long-Term Extension Period|Physician Decision|0
7420400|NCT01474512|11695060|FG006|Long-Term Extension Period|Physician Decision|0
7420401|NCT01474512|11695061|FG007|Long-Term Extension Period|Physician Decision|0
7420402|NCT01474512|11695062|FG008|Long-Term Extension Period|Physician Decision|0
7420403|NCT01474512|11695063|FG009|Long-Term Extension Period|Physician Decision|0
7420404|NCT01474512|11695064|FG010|Long-Term Extension Period|Physician Decision|0
7420405|NCT01474512|11695065|FG011|Long-Term Extension Period|Physician Decision|0
7420406|NCT01474512|11695066|FG012|Long-Term Extension Period|Physician Decision|21
7420407|NCT01474512|11695067|FG013|Long-Term Extension Period|Physician Decision|21
7420408|NCT01474512|11695068|FG014|Long-Term Extension Period|Physician Decision|0
7420409|NCT01474512|11695069|FG015|Long-Term Extension Period|Physician Decision|0
7420410|NCT01474512|11695070|FG016|Long-Term Extension Period|Physician Decision|0
7420411|NCT01474512|11695071|FG017|Long-Term Extension Period|Physician Decision|0
7420412|NCT01474512|11695054|FG000|Long-Term Extension Period|Clinical Relapse|0
7420413|NCT01474512|11695055|FG001|Long-Term Extension Period|Clinical Relapse|0
7420414|NCT01474512|11695056|FG002|Long-Term Extension Period|Clinical Relapse|0
7420415|NCT01474512|11695057|FG003|Long-Term Extension Period|Clinical Relapse|0
7420416|NCT01474512|11695058|FG004|Long-Term Extension Period|Clinical Relapse|0
7420417|NCT01474512|11695059|FG005|Long-Term Extension Period|Clinical Relapse|0
7420418|NCT01474512|11695060|FG006|Long-Term Extension Period|Clinical Relapse|0
7420419|NCT01474512|11695061|FG007|Long-Term Extension Period|Clinical Relapse|0
7420420|NCT01474512|11695062|FG008|Long-Term Extension Period|Clinical Relapse|0
7420421|NCT01474512|11695063|FG009|Long-Term Extension Period|Clinical Relapse|0
7420422|NCT01474512|11695064|FG010|Long-Term Extension Period|Clinical Relapse|0
7420423|NCT01474512|11695065|FG011|Long-Term Extension Period|Clinical Relapse|0
7420424|NCT01474512|11695066|FG012|Long-Term Extension Period|Clinical Relapse|9
7420425|NCT01474512|11695067|FG013|Long-Term Extension Period|Clinical Relapse|9
7420426|NCT01474512|11695068|FG014|Long-Term Extension Period|Clinical Relapse|0
7420427|NCT01474512|11695069|FG015|Long-Term Extension Period|Clinical Relapse|0
7420428|NCT01474512|11695070|FG016|Long-Term Extension Period|Clinical Relapse|0
7420429|NCT01474512|11695071|FG017|Long-Term Extension Period|Clinical Relapse|0
7420430|NCT01474512|11695054|FG000|Long-Term Extension Period|Death|0
7420431|NCT01474512|11695055|FG001|Long-Term Extension Period|Death|0
7420432|NCT01474512|11695056|FG002|Long-Term Extension Period|Death|0
7420433|NCT01474512|11695057|FG003|Long-Term Extension Period|Death|0
7420434|NCT01474512|11695058|FG004|Long-Term Extension Period|Death|0
7420435|NCT01474512|11695059|FG005|Long-Term Extension Period|Death|0
7420436|NCT01474512|11695060|FG006|Long-Term Extension Period|Death|0
7420437|NCT01474512|11695061|FG007|Long-Term Extension Period|Death|0
7420438|NCT01474512|11695062|FG008|Long-Term Extension Period|Death|0
7420439|NCT01474512|11695063|FG009|Long-Term Extension Period|Death|0
7420440|NCT01474512|11695064|FG010|Long-Term Extension Period|Death|0
7420441|NCT01474512|11695065|FG011|Long-Term Extension Period|Death|0
7420442|NCT01474512|11695066|FG012|Long-Term Extension Period|Death|9
7420443|NCT01474512|11695067|FG013|Long-Term Extension Period|Death|9
7420444|NCT01474512|11695068|FG014|Long-Term Extension Period|Death|0
7420445|NCT01474512|11695069|FG015|Long-Term Extension Period|Death|0
7420446|NCT01474512|11695070|FG016|Long-Term Extension Period|Death|0
7420447|NCT01474512|11695071|FG017|Long-Term Extension Period|Death|0
7420448|NCT01474512|11695054|FG000|Long-Term Extension Period|Sponsor Decision|0
7420449|NCT01474512|11695055|FG001|Long-Term Extension Period|Sponsor Decision|0
7420450|NCT01474512|11695056|FG002|Long-Term Extension Period|Sponsor Decision|0
7420451|NCT01474512|11695057|FG003|Long-Term Extension Period|Sponsor Decision|0
7420452|NCT01474512|11695058|FG004|Long-Term Extension Period|Sponsor Decision|0
7420453|NCT01474512|11695059|FG005|Long-Term Extension Period|Sponsor Decision|0
7420454|NCT01474512|11695060|FG006|Long-Term Extension Period|Sponsor Decision|0
7420455|NCT01474512|11695061|FG007|Long-Term Extension Period|Sponsor Decision|0
7420456|NCT01474512|11695062|FG008|Long-Term Extension Period|Sponsor Decision|0
7420457|NCT01474512|11695063|FG009|Long-Term Extension Period|Sponsor Decision|0
7420458|NCT01474512|11695064|FG010|Long-Term Extension Period|Sponsor Decision|0
7420459|NCT01474512|11695065|FG011|Long-Term Extension Period|Sponsor Decision|0
7420460|NCT01474512|11695066|FG012|Long-Term Extension Period|Sponsor Decision|6
7420461|NCT01474512|11695067|FG013|Long-Term Extension Period|Sponsor Decision|6
7420462|NCT01474512|11695068|FG014|Long-Term Extension Period|Sponsor Decision|0
7420463|NCT01474512|11695069|FG015|Long-Term Extension Period|Sponsor Decision|0
7420464|NCT01474512|11695070|FG016|Long-Term Extension Period|Sponsor Decision|0
7420465|NCT01474512|11695071|FG017|Long-Term Extension Period|Sponsor Decision|0
7420466|NCT01474512|11695054|FG000|Long-Term Extension Period|Protocol Violation|0
7420467|NCT01474512|11695055|FG001|Long-Term Extension Period|Protocol Violation|0
7420468|NCT01474512|11695056|FG002|Long-Term Extension Period|Protocol Violation|0
7420469|NCT01474512|11695057|FG003|Long-Term Extension Period|Protocol Violation|0
7420470|NCT01474512|11695058|FG004|Long-Term Extension Period|Protocol Violation|0
7420471|NCT01474512|11695059|FG005|Long-Term Extension Period|Protocol Violation|0
7420472|NCT01474512|11695060|FG006|Long-Term Extension Period|Protocol Violation|0
7420473|NCT01474512|11695061|FG007|Long-Term Extension Period|Protocol Violation|0
7420474|NCT01474512|11695062|FG008|Long-Term Extension Period|Protocol Violation|0
7420475|NCT01474512|11695063|FG009|Long-Term Extension Period|Protocol Violation|0
7420476|NCT01474512|11695064|FG010|Long-Term Extension Period|Protocol Violation|0
7420477|NCT01474512|11695065|FG011|Long-Term Extension Period|Protocol Violation|0
7420478|NCT01474512|11695066|FG012|Long-Term Extension Period|Protocol Violation|5
7420479|NCT01474512|11695067|FG013|Long-Term Extension Period|Protocol Violation|5
7420480|NCT01474512|11695068|FG014|Long-Term Extension Period|Protocol Violation|0
7420481|NCT01474512|11695069|FG015|Long-Term Extension Period|Protocol Violation|0
7420482|NCT01474512|11695070|FG016|Long-Term Extension Period|Protocol Violation|0
7420483|NCT01474512|11695071|FG017|Long-Term Extension Period|Protocol Violation|0
7420484|NCT01474512|11695054|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
7420485|NCT01474512|11695055|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
7420486|NCT01474512|11695056|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
7420487|NCT01474512|11695057|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
7420488|NCT01474512|11695058|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
7420489|NCT01474512|11695059|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
7420490|NCT01474512|11695060|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
7420491|NCT01474512|11695061|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
7420492|NCT01474512|11695062|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
7420493|NCT01474512|11695063|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
7420494|NCT01474512|11695064|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
7420495|NCT01474512|11695065|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
7420496|NCT01474512|11695066|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
7420497|NCT01474512|11695067|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
7420498|NCT01474512|11695068|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
7420499|NCT01474512|11695069|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
7420500|NCT01474512|11695070|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
7420501|NCT01474512|11695071|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
7420502|NCT01474512|11695054|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
7420503|NCT01474512|11695055|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
7420504|NCT01474512|11695056|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
7420505|NCT01474512|11695057|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
7420506|NCT01474512|11695058|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
7420507|NCT01474512|11695059|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
7420508|NCT01474512|11695060|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
7420509|NCT01474512|11695061|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
7420510|NCT01474512|11695062|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
7420511|NCT01474512|11695063|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
7420512|NCT01474512|11695064|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
7420513|NCT01474512|11695065|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
7420514|NCT01474512|11695066|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
7420515|NCT01474512|11695067|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
7420516|NCT01474512|11695068|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
7420517|NCT01474512|11695069|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
7420518|NCT01474512|11695070|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
7420519|NCT01474512|11695071|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
7420520|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Adverse Event|0
7420521|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Adverse Event|0
7420522|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Adverse Event|0
7420523|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Adverse Event|0
7420524|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Adverse Event|0
7420525|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Adverse Event|0
7420526|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Adverse Event|0
7420527|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Adverse Event|0
7420528|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Adverse Event|0
7420529|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Adverse Event|0
7420530|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Adverse Event|0
7420531|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Adverse Event|0
7420532|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Adverse Event|0
7420533|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Adverse Event|0
7420534|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Adverse Event|8
7420535|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Adverse Event|2
7420536|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Adverse Event|58
7420537|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Adverse Event|11
7420538|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420539|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420540|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420541|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420542|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420543|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420544|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420545|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420546|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420547|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420548|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420549|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420550|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420551|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
7420552|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
7420553|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
7420554|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
7420555|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
7420556|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
7420557|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
7420558|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
7420559|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
7420560|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
7420561|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
7420562|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
7420563|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
7420564|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
7420565|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
7420566|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
7420567|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
7420568|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
7420569|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
7420570|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
7420571|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
7420572|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
7420573|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
7420574|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
7420575|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
7420576|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
7420577|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
7420578|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
7420579|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
7420580|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
7420581|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
7420582|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
7420583|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
7420584|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
7420585|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
7420586|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
7420587|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
7420588|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
7420589|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
7420590|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
7420591|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
7420592|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Physician Decision|0
7420593|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Physician Decision|0
7420594|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Physician Decision|0
7420595|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Physician Decision|0
7420596|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Physician Decision|0
7556917|NCT03089216|11920990|FG001|Overall Study|Adverse Event|0
7556918|NCT03089216|11920991|FG002|Overall Study|Adverse Event|0
7556919|NCT03089216|11920992|FG003|Overall Study|Adverse Event|1
7556920|NCT03089580|11921006|FG000|Overall Study|Lost to Follow-up|2
7556921|NCT03089697|11921014|FG000|Overall Study|Adverse Event|1
7556922|NCT03089697|11921015|FG001|Overall Study|Adverse Event|2
7556923|NCT03089697|11921014|FG000|Overall Study|Withdrawal by Subject|1
7556924|NCT03089697|11921015|FG001|Overall Study|Withdrawal by Subject|0
7556925|NCT03089944|11921035|FG000|Overall Study|Lost to Follow-up|8
7556926|NCT03089944|11921035|FG000|Overall Study|Withdrew Consent|2
7556927|NCT03089944|11921035|FG000|Overall Study|Adverse Event|1
7556928|NCT03089944|11921035|FG000|Overall Study|Other|1
7556929|NCT03090100|11921041|FG000|Overall Study|Adverse Event|9
7556930|NCT03090100|11921042|FG001|Overall Study|Adverse Event|11
7556931|NCT03090100|11921041|FG000|Overall Study|Pregnancy|1
7556932|NCT03090100|11921042|FG001|Overall Study|Pregnancy|1
7556933|NCT03090100|11921041|FG000|Overall Study|Lack of Efficacy|2
7556934|NCT03090100|11921042|FG001|Overall Study|Lack of Efficacy|7
7556935|NCT03090100|11921041|FG000|Overall Study|Lost to Follow-up|2
7556936|NCT03090100|11921042|FG001|Overall Study|Lost to Follow-up|2
7556937|NCT03090100|11921041|FG000|Overall Study|Withdrawal by Subject|7
7556938|NCT03090100|11921042|FG001|Overall Study|Withdrawal by Subject|19
7556939|NCT03090100|11921041|FG000|Overall Study|Protocol Violation|2
7556940|NCT03090100|11921042|FG001|Overall Study|Protocol Violation|6
7556941|NCT03090100|11921041|FG000|Overall Study|Non-compliance|2
7556942|NCT03090100|11921042|FG001|Overall Study|Non-compliance|0
7556943|NCT03090100|11921041|FG000|Overall Study|Other|2
7556944|NCT03090100|11921042|FG001|Overall Study|Other|2
7574704|NCT03688711|11957792|FG000|Overall Study|Withdrawal by Subject|0
7574705|NCT03688711|11957793|FG001|Overall Study|Withdrawal by Subject|1
7574706|NCT03688880|11957801|FG000|Overall Study|Withdrawal by Subject|0
7574707|NCT03688880|11957802|FG001|Overall Study|Withdrawal by Subject|2
7574708|NCT03688880|11957801|FG000|Overall Study|Use of non-permitted concurrent therapy|0
7574709|NCT03688880|11957802|FG001|Overall Study|Use of non-permitted concurrent therapy|2
7574710|NCT03688880|11957801|FG000|Overall Study|Lost to Follow-up|4
7574711|NCT03688880|11957802|FG001|Overall Study|Lost to Follow-up|7
7574712|NCT03688880|11957801|FG000|Overall Study|Adverse Event|0
7574713|NCT03688880|11957802|FG001|Overall Study|Adverse Event|2
7574714|NCT03688880|11957801|FG000|Overall Study|Device deficiencies|0
7574715|NCT03688880|11957802|FG001|Overall Study|Device deficiencies|2
7574716|NCT03688880|11957801|FG000|Overall Study|Other|10
7574717|NCT03688880|11957802|FG001|Overall Study|Other|16
7574718|NCT03689452|11957810|FG000|Overall Study|Lost to Follow-up|1
7574719|NCT03689452|11957811|FG001|Overall Study|Lost to Follow-up|1
7574720|NCT03691779|11957838|FG000|Part B (24 Weeks)|Adverse Event|0
7574721|NCT03691779|11957839|FG001|Part B (24 Weeks)|Adverse Event|1
7574722|NCT03691779|11957838|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
7574723|NCT03691779|11957839|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
7574724|NCT03691831|11957848|FG000|Overall Study|Lost to Follow-up|16
7574725|NCT03691831|11957849|FG001|Overall Study|Lost to Follow-up|12
7574726|NCT03691831|11957848|FG000|Overall Study|Withdrawal by Subject|9
7574727|NCT03691831|11957849|FG001|Overall Study|Withdrawal by Subject|17
7574728|NCT03691831|11957848|FG000|Overall Study|Investigator Decision|2
7574729|NCT03691831|11957849|FG001|Overall Study|Investigator Decision|2
7574730|NCT03691948|11957876|FG000|Overall Study|Lost to Follow-up|1
7574731|NCT03691948|11957877|FG001|Overall Study|Lost to Follow-up|3
7574732|NCT03692676|11957888|FG000|Overall Study|exclude patients with prior use|4424
7574733|NCT03692676|11957889|FG001|Overall Study|exclude patients with prior use|24726
7574734|NCT03692676|11957890|FG002|Overall Study|exclude patients with prior use|0
7574735|NCT03692676|11957891|FG003|Overall Study|exclude patients with prior use|0
7420597|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Physician Decision|0
7574736|NCT03692676|11957888|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
7574737|NCT03692676|11957889|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
7574738|NCT03692676|11957890|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7574739|NCT03692676|11957891|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
7574740|NCT03692676|11957888|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
7574741|NCT03692676|11957889|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
7574742|NCT03692676|11957890|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
7574743|NCT03692676|11957891|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
7574744|NCT03692676|11957888|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
7574745|NCT03692676|11957889|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
7420598|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Physician Decision|0
7556945|NCT03091348|11921077|FG000|Overall Study|Lost to Follow-up|2
7556946|NCT03091348|11921078|FG001|Overall Study|Lost to Follow-up|1
7556947|NCT03091400|11921091|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
7556948|NCT03091400|11921092|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
7556949|NCT03091439|11921100|FG000|Overall Study|Study Terminated by the Sponsor|1
7556950|NCT03091439|11921101|FG001|Overall Study|Study Terminated by the Sponsor|0
7556951|NCT03091738|11921126|FG000|Overall Study|Adverse Event|1
7556952|NCT03091738|11921126|FG000|Overall Study|Lost to Follow-up|1
7556953|NCT03091777|11921137|FG000|Overall Study|Pregnancy|2
7556954|NCT03091777|11921138|FG001|Overall Study|Pregnancy|1
7556955|NCT03091777|11921139|FG002|Overall Study|Pregnancy|0
7556956|NCT03091777|11921137|FG000|Overall Study|Adverse Event|2
7556957|NCT03091777|11921138|FG001|Overall Study|Adverse Event|1
7556958|NCT03091777|11921139|FG002|Overall Study|Adverse Event|4
7556959|NCT03091777|11921137|FG000|Overall Study|Withdrawal by Subject|4
7556960|NCT03091777|11921138|FG001|Overall Study|Withdrawal by Subject|2
7556961|NCT03091777|11921139|FG002|Overall Study|Withdrawal by Subject|6
7556962|NCT03091777|11921137|FG000|Overall Study|Protocol Violation|2
7556963|NCT03091777|11921138|FG001|Overall Study|Protocol Violation|1
7556964|NCT03091777|11921139|FG002|Overall Study|Protocol Violation|1
7556965|NCT03091777|11921137|FG000|Overall Study|Lost to Follow-up|12
7556966|NCT03091777|11921138|FG001|Overall Study|Lost to Follow-up|14
7556967|NCT03091777|11921139|FG002|Overall Study|Lost to Follow-up|7
7556968|NCT03091777|11921137|FG000|Overall Study|Lack of Efficacy|0
7556969|NCT03091777|11921138|FG001|Overall Study|Lack of Efficacy|0
7556970|NCT03091777|11921139|FG002|Overall Study|Lack of Efficacy|5
7556971|NCT03091777|11921137|FG000|Overall Study|Noncompliance with study drug|2
7556972|NCT03091777|11921138|FG001|Overall Study|Noncompliance with study drug|3
7556973|NCT03091777|11921139|FG002|Overall Study|Noncompliance with study drug|1
7556974|NCT03091777|11921137|FG000|Overall Study|Physician Decision|1
7556975|NCT03091777|11921138|FG001|Overall Study|Physician Decision|0
7556976|NCT03091777|11921139|FG002|Overall Study|Physician Decision|1
7556977|NCT03091777|11921137|FG000|Overall Study|Abnormal Laboratory Value|7
7556978|NCT03091777|11921138|FG001|Overall Study|Abnormal Laboratory Value|11
7556979|NCT03091777|11921139|FG002|Overall Study|Abnormal Laboratory Value|12
7556980|NCT03091920|11921150|FG000|Overall Study|Adverse Event|0
7556981|NCT03091920|11921151|FG001|Overall Study|Adverse Event|1
7556982|NCT03091920|11921152|FG002|Overall Study|Adverse Event|0
7556983|NCT03092375|11921183|FG000|Overall Study|Lack of Efficacy|0
7556984|NCT03092375|11921184|FG001|Overall Study|Lack of Efficacy|1
7556985|NCT03092375|11921185|FG002|Overall Study|Lack of Efficacy|1
7556986|NCT03092375|11921186|FG003|Overall Study|Lack of Efficacy|0
7556987|NCT03092479|11921205|FG000|Overall Study|Lost to Follow-up|3
7556988|NCT03092479|11921206|FG001|Overall Study|Lost to Follow-up|2
7556989|NCT03092479|11921205|FG000|Overall Study|Withdrawal by Subject|4
7556990|NCT03092479|11921206|FG001|Overall Study|Withdrawal by Subject|0
7556991|NCT03092726|11921214|FG000|Overall Study|Adverse Event|3
7556992|NCT03092726|11921215|FG001|Overall Study|Adverse Event|10
7556993|NCT03092726|11921214|FG000|Overall Study|Lack of Efficacy|0
7556994|NCT03092726|11921215|FG001|Overall Study|Lack of Efficacy|1
7556995|NCT03092726|11921214|FG000|Overall Study|Lost to Follow-up|1
7556996|NCT03092726|11921215|FG001|Overall Study|Lost to Follow-up|0
7556997|NCT03092726|11921214|FG000|Overall Study|Withdrawal by Subject|5
7556998|NCT03092726|11921215|FG001|Overall Study|Withdrawal by Subject|3
7556999|NCT03092752|11921221|FG000|Overall Study|Aged <40 years|14209
7557000|NCT03092752|11921221|FG000|Overall Study|At least one claim with T2DM|61299
7557001|NCT03092752|11921221|FG000|Overall Study|Having no claim of study drugs|29282
7557002|NCT03092752|11921221|FG000|Overall Study|Average hospital visit interval >92 days|10779
7557003|NCT03092752|11921221|FG000|Overall Study|<6 month history|245900
7557004|NCT03092791|11921250|FG000|Overall Study|Lost to Follow-up|0
7557005|NCT03092791|11921251|FG001|Overall Study|Lost to Follow-up|0
7557006|NCT03092791|11921252|FG002|Overall Study|Lost to Follow-up|0
7557007|NCT03092791|11921253|FG003|Overall Study|Lost to Follow-up|0
7557008|NCT03092791|11921254|FG004|Overall Study|Lost to Follow-up|0
7557009|NCT03092791|11921255|FG005|Overall Study|Lost to Follow-up|0
7557010|NCT03092791|11921256|FG006|Overall Study|Lost to Follow-up|1
7557011|NCT03092791|11921257|FG007|Overall Study|Lost to Follow-up|0
7557012|NCT03092791|11921250|FG000|Overall Study|Withdrawal of Consent|0
7557013|NCT03092791|11921251|FG001|Overall Study|Withdrawal of Consent|0
7557014|NCT03092791|11921252|FG002|Overall Study|Withdrawal of Consent|0
7557015|NCT03092791|11921253|FG003|Overall Study|Withdrawal of Consent|0
7557016|NCT03092791|11921254|FG004|Overall Study|Withdrawal of Consent|4
7557017|NCT03092791|11921255|FG005|Overall Study|Withdrawal of Consent|12
7557018|NCT03092791|11921256|FG006|Overall Study|Withdrawal of Consent|6
7557019|NCT03092791|11921257|FG007|Overall Study|Withdrawal of Consent|4
7557020|NCT03092791|11921250|FG000|Overall Study|Study Termination|0
7557021|NCT03092791|11921251|FG001|Overall Study|Study Termination|0
7557022|NCT03092791|11921252|FG002|Overall Study|Study Termination|0
7557023|NCT03092791|11921253|FG003|Overall Study|Study Termination|0
7557024|NCT03092791|11921254|FG004|Overall Study|Study Termination|55
7557025|NCT03092791|11921255|FG005|Overall Study|Study Termination|46
7557026|NCT03092791|11921256|FG006|Overall Study|Study Termination|53
7557027|NCT03092791|11921257|FG007|Overall Study|Study Termination|55
7557028|NCT03092791|11921250|FG000|Overall Study|Death|0
7557029|NCT03092791|11921251|FG001|Overall Study|Death|0
7531626|NCT02655679|11876423|FG000|Overall Study|Inability to Comply with the Protocol|1
7531627|NCT02655679|11876424|FG001|Overall Study|Inability to Comply with the Protocol|0
7531628|NCT02655679|11876425|FG002|Overall Study|Inability to Comply with the Protocol|0
7531629|NCT02655679|11876426|FG003|Overall Study|Inability to Comply with the Protocol|0
7531630|NCT02655679|11876427|FG004|Overall Study|Inability to Comply with the Protocol|0
7531631|NCT02655679|11876423|FG000|Overall Study|Lost to Follow-up|0
7531632|NCT02655679|11876424|FG001|Overall Study|Lost to Follow-up|1
7531633|NCT02655679|11876425|FG002|Overall Study|Lost to Follow-up|1
7531634|NCT02655679|11876426|FG003|Overall Study|Lost to Follow-up|1
7557030|NCT03092791|11921252|FG002|Overall Study|Death|0
7557031|NCT03092791|11921253|FG003|Overall Study|Death|0
7557032|NCT03092791|11921254|FG004|Overall Study|Death|0
7557033|NCT03092791|11921255|FG005|Overall Study|Death|1
7557034|NCT03092791|11921256|FG006|Overall Study|Death|0
7557035|NCT03092791|11921257|FG007|Overall Study|Death|1
7557036|NCT03092791|11921250|FG000|Overall Study|Reason Not Specified|0
7557037|NCT03092791|11921251|FG001|Overall Study|Reason Not Specified|0
7420599|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Physician Decision|0
7420600|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Physician Decision|0
7420601|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Physician Decision|0
7531635|NCT02655679|11876427|FG004|Overall Study|Lost to Follow-up|0
7531636|NCT02655679|11876423|FG000|Overall Study|Other Miscellaneous Reasons|1
7531637|NCT02655679|11876424|FG001|Overall Study|Other Miscellaneous Reasons|0
7531638|NCT02655679|11876425|FG002|Overall Study|Other Miscellaneous Reasons|0
7531639|NCT02655679|11876426|FG003|Overall Study|Other Miscellaneous Reasons|0
7531640|NCT02655679|11876427|FG004|Overall Study|Other Miscellaneous Reasons|0
7531641|NCT02655887|11876440|FG000|Overall Study|Lost to Follow-up|3
7531642|NCT02655887|11876440|FG000|Overall Study|Death|4
7531643|NCT02655887|11876440|FG000|Overall Study|Withdrawal by Subject|3
7531644|NCT02655887|11876440|FG000|Overall Study|Missed 12-month follow-up visit|4
7531645|NCT02656173|11876462|FG000|Overall Study|Deviation from the Eligible Criteria|3
7531646|NCT02656173|11876463|FG001|Overall Study|Deviation from the Eligible Criteria|2
7531647|NCT02656173|11876462|FG000|Overall Study|Adverse Event|7
7531648|NCT02656173|11876463|FG001|Overall Study|Adverse Event|5
7531649|NCT02656173|11876462|FG000|Overall Study|Withdrawal by Subject|1
7531650|NCT02656173|11876463|FG001|Overall Study|Withdrawal by Subject|3
7531651|NCT02656173|11876462|FG000|Overall Study|Protocol Violation|0
7531652|NCT02656173|11876463|FG001|Overall Study|Protocol Violation|1
7531653|NCT02656173|11876462|FG000|Overall Study|Miscellaneous|2
7531654|NCT02656173|11876463|FG001|Overall Study|Miscellaneous|0
7531655|NCT02656329|11876473|FG000|Overall Study|Lost to Follow-up|2
7531656|NCT02656329|11876474|FG001|Overall Study|Lost to Follow-up|3
7531657|NCT02656329|11876473|FG000|Overall Study|Withdrawal by Subject|7
7531658|NCT02656329|11876474|FG001|Overall Study|Withdrawal by Subject|6
7531659|NCT02656329|11876473|FG000|Overall Study|Study termination by Sponsor|150
7531660|NCT02656329|11876474|FG001|Overall Study|Study termination by Sponsor|142
7531661|NCT02656329|11876473|FG000|Overall Study|Other than specified above|5
7531662|NCT02656329|11876474|FG001|Overall Study|Other than specified above|6
7531663|NCT02656680|11876521|FG000|Overall Study|Lost to Follow-up|0
7531664|NCT02656680|11876522|FG001|Overall Study|Lost to Follow-up|1
7531665|NCT02656693|11876533|FG000|Overall Study|Pregnancy|1
7420602|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Physician Decision|0
7420603|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Physician Decision|0
7420604|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Physician Decision|0
7420605|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Physician Decision|0
7420606|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Physician Decision|0
7420607|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Physician Decision|0
7420608|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Physician Decision|4
7420609|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Physician Decision|5
7420610|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
7420611|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
7420612|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
7420613|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
7420614|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
7420615|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
7420616|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
7420617|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
7420618|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
7420619|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
7420620|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
7420621|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
7420622|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
7557038|NCT03092791|11921252|FG002|Overall Study|Reason Not Specified|0
7420623|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
7420624|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
7420625|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
7531666|NCT02656693|11876534|FG001|Overall Study|Pregnancy|1
7531667|NCT02656693|11876535|FG002|Overall Study|Pregnancy|1
7531668|NCT02656693|11876533|FG000|Overall Study|Bariatric surgery|0
7531669|NCT02656693|11876534|FG001|Overall Study|Bariatric surgery|1
7531670|NCT02656693|11876535|FG002|Overall Study|Bariatric surgery|2
7531671|NCT02657031|11876560|FG000|Overall Study|Adverse Event|1
7420626|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
7420627|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
7420628|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Protocol Violation|0
7420629|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Protocol Violation|0
7420630|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Protocol Violation|0
7420631|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Protocol Violation|0
7420632|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Protocol Violation|0
7420633|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Protocol Violation|0
7420634|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Protocol Violation|0
7420635|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Protocol Violation|0
7420636|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Protocol Violation|0
7420637|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Protocol Violation|0
7420638|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Protocol Violation|0
7420639|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Protocol Violation|0
7420640|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Protocol Violation|0
7420641|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Protocol Violation|0
7420642|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Protocol Violation|2
7420643|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Protocol Violation|2
7420644|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Protocol Violation|4
7420645|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Protocol Violation|0
7420646|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
7420647|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
7420648|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
7420649|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
7420650|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
7420651|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
7420652|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
7420653|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
7420654|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
7420655|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
7420656|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
7420657|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
7420658|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
7420659|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
7420660|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
7420661|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
7420662|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
7420663|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
7420664|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420665|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420666|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420667|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420668|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420669|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420670|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420671|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420672|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420673|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420674|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420675|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420676|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420677|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420678|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7420679|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420680|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
7420681|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
7420682|NCT01474512|11695054|FG000|Post-Treatment Follow-Up|Death|0
7420683|NCT01474512|11695055|FG001|Post-Treatment Follow-Up|Death|0
7420684|NCT01474512|11695056|FG002|Post-Treatment Follow-Up|Death|0
7420685|NCT01474512|11695057|FG003|Post-Treatment Follow-Up|Death|0
7420686|NCT01474512|11695058|FG004|Post-Treatment Follow-Up|Death|0
7420687|NCT01474512|11695059|FG005|Post-Treatment Follow-Up|Death|0
7420688|NCT01474512|11695060|FG006|Post-Treatment Follow-Up|Death|0
7420689|NCT01474512|11695061|FG007|Post-Treatment Follow-Up|Death|0
7420690|NCT01474512|11695062|FG008|Post-Treatment Follow-Up|Death|0
7420691|NCT01474512|11695063|FG009|Post-Treatment Follow-Up|Death|0
7420692|NCT01474512|11695064|FG010|Post-Treatment Follow-Up|Death|0
7420693|NCT01474512|11695065|FG011|Post-Treatment Follow-Up|Death|0
7420694|NCT01474512|11695066|FG012|Post-Treatment Follow-Up|Death|0
7420695|NCT01474512|11695067|FG013|Post-Treatment Follow-Up|Death|0
7420696|NCT01474512|11695068|FG014|Post-Treatment Follow-Up|Death|0
7420697|NCT01474512|11695069|FG015|Post-Treatment Follow-Up|Death|0
7420698|NCT01474512|11695070|FG016|Post-Treatment Follow-Up|Death|1
7420699|NCT01474512|11695071|FG017|Post-Treatment Follow-Up|Death|0
7420700|NCT01474538|11695103|FG000|Treatment Period 1|Death|1
7420701|NCT01474538|11695104|FG001|Treatment Period 1|Death|0
7420702|NCT01474538|11695103|FG000|Treatment Period 1|Physician Decision|1
7420703|NCT01474538|11695104|FG001|Treatment Period 1|Physician Decision|0
7420704|NCT01474538|11695103|FG000|Treatment Period 1|Withdrawal by Subject|1
7420705|NCT01474538|11695104|FG001|Treatment Period 1|Withdrawal by Subject|3
7420706|NCT01474538|11695103|FG000|Treatment Period 1|Protocol Violation|0
7420707|NCT01474538|11695104|FG001|Treatment Period 1|Protocol Violation|1
7420708|NCT01474538|11695103|FG000|Treatment Period 2|Death|1
7420709|NCT01474538|11695104|FG001|Treatment Period 2|Death|0
7420710|NCT01474538|11695103|FG000|Treatment Period 2|Adverse Event|1
7420711|NCT01474538|11695104|FG001|Treatment Period 2|Adverse Event|1
7420712|NCT01474538|11695103|FG000|Treatment Period 2|Withdrawal by Subject|2
7420713|NCT01474538|11695104|FG001|Treatment Period 2|Withdrawal by Subject|0
7420714|NCT01474538|11695103|FG000|Treatment Period 2|Sponsor decision|1
7420715|NCT01474538|11695104|FG001|Treatment Period 2|Sponsor decision|0
7420716|NCT01474538|11695103|FG000|Treatment Period 2|Physician Decision|0
7420717|NCT01474538|11695104|FG001|Treatment Period 2|Physician Decision|1
7420718|NCT01474538|11695103|FG000|Treatment Period 2|Protocol Violation|1
7420719|NCT01474538|11695104|FG001|Treatment Period 2|Protocol Violation|0
7420720|NCT01474551|11695110|FG000|Overall Study|Death|1
7420721|NCT01474681|11695125|FG000|Overall Study|Death|0
7420722|NCT01474681|11695126|FG001|Overall Study|Death|3
7420723|NCT01474681|11695127|FG002|Overall Study|Death|2
7420724|NCT01474681|11695128|FG003|Overall Study|Death|6
7420725|NCT01474746|11695144|FG000|Overall Study|Lost to Follow-up|1
7420726|NCT01474746|11695145|FG001|Overall Study|Lost to Follow-up|1
7420727|NCT01474746|11695144|FG000|Overall Study|Withdrawal by Subject|2
7420728|NCT01474746|11695145|FG001|Overall Study|Withdrawal by Subject|1
7420729|NCT01474772|11695153|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
7420730|NCT01474772|11695154|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
7420731|NCT01474772|11695153|FG000|Period 1|AE not Related to Study Drug|1
7420732|NCT01474772|11695154|FG001|Period 1|AE not Related to Study Drug|0
7420733|NCT01474772|11695153|FG000|Period 1|Withdrawal by Subject|3
7420734|NCT01474772|11695154|FG001|Period 1|Withdrawal by Subject|1
7420735|NCT01474772|11695153|FG000|Period 1|Lost to Follow-up|1
7420736|NCT01474772|11695154|FG001|Period 1|Lost to Follow-up|0
7420737|NCT01474772|11695153|FG000|Period 1|Reason not Specified|1
7420738|NCT01474772|11695154|FG001|Period 1|Reason not Specified|1
7420739|NCT01474772|11695153|FG000|Washout|AE not Related to Study Drug|2
7420740|NCT01474772|11695154|FG001|Washout|AE not Related to Study Drug|0
7420741|NCT01474772|11695153|FG000|Washout|Withdrawal by Subject|1
7420742|NCT01474772|11695154|FG001|Washout|Withdrawal by Subject|0
7420743|NCT01474772|11695153|FG000|Washout|Lost to Follow-up|0
7420744|NCT01474772|11695154|FG001|Washout|Lost to Follow-up|1
7420745|NCT01474772|11695153|FG000|Washout|Reason not Specified|0
7420746|NCT01474772|11695154|FG001|Washout|Reason not Specified|1
7420747|NCT01474772|11695153|FG000|Period 2|Death|0
7420748|NCT01474772|11695154|FG001|Period 2|Death|1
7420749|NCT01474772|11695153|FG000|Period 2|AE Related to Study Drug|0
7420750|NCT01474772|11695154|FG001|Period 2|AE Related to Study Drug|1
7420751|NCT01474772|11695153|FG000|Period 2|AE not Related to Study Drug|4
7420752|NCT01474772|11695154|FG001|Period 2|AE not Related to Study Drug|1
7420753|NCT01474772|11695153|FG000|Period 2|Lack of Efficacy|1
7420754|NCT01474772|11695154|FG001|Period 2|Lack of Efficacy|0
7420755|NCT01474772|11695153|FG000|Period 2|Withdrawal by Subject|3
7420756|NCT01474772|11695154|FG001|Period 2|Withdrawal by Subject|4
7420757|NCT01474772|11695153|FG000|Period 2|Lost to Follow-up|1
7420758|NCT01474772|11695154|FG001|Period 2|Lost to Follow-up|1
7420759|NCT01474772|11695153|FG000|Period 2|Reason not Specified|0
7420760|NCT01474772|11695154|FG001|Period 2|Reason not Specified|2
7420761|NCT01474772|11695153|FG000|Follow-up|AE not Related to Study Drug|0
7420762|NCT01474772|11695154|FG001|Follow-up|AE not Related to Study Drug|1
7420763|NCT01474876|11695176|FG000|Overall Study|Adverse Event|11
7420764|NCT01474876|11695177|FG001|Overall Study|Adverse Event|5
7420765|NCT01474876|11695178|FG002|Overall Study|Adverse Event|0
7420766|NCT01474876|11695176|FG000|Overall Study|Serious Adverse Event|2
7420767|NCT01474876|11695177|FG001|Overall Study|Serious Adverse Event|3
7420768|NCT01474876|11695178|FG002|Overall Study|Serious Adverse Event|0
7420769|NCT01474876|11695176|FG000|Overall Study|Lost to Follow-up|5
7420770|NCT01474876|11695177|FG001|Overall Study|Lost to Follow-up|4
7420771|NCT01474876|11695178|FG002|Overall Study|Lost to Follow-up|0
7420772|NCT01474876|11695176|FG000|Overall Study|Investigator's decision|28
7420773|NCT01474876|11695177|FG001|Overall Study|Investigator's decision|6
7420774|NCT01474876|11695178|FG002|Overall Study|Investigator's decision|0
7420775|NCT01474876|11695176|FG000|Overall Study|Patient's request|19
7420776|NCT01474876|11695177|FG001|Overall Study|Patient's request|5
7420777|NCT01474876|11695178|FG002|Overall Study|Patient's request|0
7420778|NCT01474876|11695176|FG000|Overall Study|Investigator's decision and pt request|1
7420779|NCT01474876|11695177|FG001|Overall Study|Investigator's decision and pt request|0
7420780|NCT01474876|11695178|FG002|Overall Study|Investigator's decision and pt request|0
7420781|NCT01474993|11695196|FG000|Overall Study|Lost to Follow-up|1
7420782|NCT01474993|11695197|FG001|Overall Study|Lost to Follow-up|2
7420783|NCT01474993|11695196|FG000|Overall Study|Adverse Event|0
7420784|NCT01474993|11695197|FG001|Overall Study|Adverse Event|1
7420785|NCT01475071|11695205|FG000|Overall Study|Physician Decision|1
7420786|NCT01475071|11695205|FG000|Overall Study|Withdrawal by Subject|6
7420787|NCT01475071|11695205|FG000|Overall Study|Lost to Follow-up|1
7420788|NCT01475097|11695213|FG000|Overall Study|Protocol Violation|1
7420789|NCT01475097|11695214|FG001|Overall Study|Protocol Violation|1
7420790|NCT01475136|11695224|FG000|Overall Study|Sponsor Decision|0
7420791|NCT01475136|11695225|FG001|Overall Study|Sponsor Decision|1
7420792|NCT01475136|11695226|FG002|Overall Study|Sponsor Decision|0
7420793|NCT01475136|11695227|FG003|Overall Study|Sponsor Decision|0
7420794|NCT01475136|11695224|FG000|Overall Study|Entry Criteria Not Met|0
7420795|NCT01475136|11695225|FG001|Overall Study|Entry Criteria Not Met|2
7420796|NCT01475136|11695226|FG002|Overall Study|Entry Criteria Not Met|3
7420797|NCT01475136|11695227|FG003|Overall Study|Entry Criteria Not Met|1
7420798|NCT01475136|11695224|FG000|Overall Study|Withdrawal by Subject|0
7420799|NCT01475136|11695225|FG001|Overall Study|Withdrawal by Subject|0
7420800|NCT01475136|11695226|FG002|Overall Study|Withdrawal by Subject|0
7420801|NCT01475136|11695227|FG003|Overall Study|Withdrawal by Subject|2
7420802|NCT01475136|11695224|FG000|Overall Study|Adverse Event|1
7420803|NCT01475136|11695225|FG001|Overall Study|Adverse Event|0
7420804|NCT01475136|11695226|FG002|Overall Study|Adverse Event|0
7420805|NCT01475136|11695227|FG003|Overall Study|Adverse Event|1
7420806|NCT01475136|11695224|FG000|Overall Study|Death|0
7420807|NCT01475136|11695225|FG001|Overall Study|Death|0
7420808|NCT01475136|11695226|FG002|Overall Study|Death|0
7420809|NCT01475136|11695227|FG003|Overall Study|Death|1
7420810|NCT01475162|11695237|FG000|Overall Study|Physician Decision|1
7420811|NCT01475162|11695237|FG000|Overall Study|Death|10
7420812|NCT01475162|11695237|FG000|Overall Study|Study closed for safety|3
7420813|NCT01475214|11695249|FG000|Overall Study|Lost to Follow-up|1
7420814|NCT01475214|11695250|FG001|Overall Study|Lost to Follow-up|0
7420815|NCT01475214|11695251|FG002|Overall Study|Lost to Follow-up|1
7420816|NCT01475214|11695249|FG000|Overall Study|Physician Decision|2
7420817|NCT01475214|11695250|FG001|Overall Study|Physician Decision|0
7420818|NCT01475214|11695251|FG002|Overall Study|Physician Decision|0
7420819|NCT01475214|11695249|FG000|Overall Study|Withdrawal by Subject|2
7420820|NCT01475214|11695250|FG001|Overall Study|Withdrawal by Subject|4
7420821|NCT01475214|11695251|FG002|Overall Study|Withdrawal by Subject|1
7420822|NCT01475253|11695263|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
7420823|NCT01475253|11695264|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
7420824|NCT01475253|11695265|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
7420825|NCT01475253|11695266|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
7420826|NCT01475253|11695263|FG000|Randomized, Blinded Study|Lost to Follow-up|1
7420827|NCT01475253|11695264|FG001|Randomized, Blinded Study|Lost to Follow-up|0
7420828|NCT01475253|11695265|FG002|Randomized, Blinded Study|Lost to Follow-up|0
7420829|NCT01475253|11695266|FG003|Randomized, Blinded Study|Lost to Follow-up|0
7420830|NCT01475331|11695286|FG000|Overall Study|Osteophyte obstruction of the proximal|1
7420831|NCT01475331|11695287|FG001|Overall Study|Osteophyte obstruction of the proximal|0
7420832|NCT01475331|11695286|FG000|Overall Study|excessive main duct communication|1
7420833|NCT01475331|11695287|FG001|Overall Study|excessive main duct communication|1
7531672|NCT02657031|11876561|FG001|Overall Study|Adverse Event|2
7531673|NCT02657369|11876583|FG000|Overall Study|Death|27
7531674|NCT02657369|11876583|FG000|Overall Study|Study terminated by sponsor|7
7531675|NCT02657408|11876589|FG000|Overall Study|Adverse Event|3
7531676|NCT02657408|11876590|FG001|Overall Study|Adverse Event|7
7531677|NCT02657889|11876621|FG000|Overall Study|Death|5
7420834|NCT01475331|11695286|FG000|Overall Study|Loss of needle positioning due pt. cough|1
7420835|NCT01475331|11695287|FG001|Overall Study|Loss of needle positioning due pt. cough|0
7420836|NCT01475331|11695286|FG000|Overall Study|Sign of malignancy during the procedure|2
7420837|NCT01475331|11695287|FG001|Overall Study|Sign of malignancy during the procedure|0
7420838|NCT01475331|11695286|FG000|Overall Study|cyst found to be prohibitively small|0
7420839|NCT01475331|11695287|FG001|Overall Study|cyst found to be prohibitively small|1
7420840|NCT01475370|11695296|FG000|Overall Study|Exacerbation of primary disease|2
7420841|NCT01475370|11695297|FG001|Overall Study|Exacerbation of primary disease|2
7420842|NCT01475370|11695298|FG002|Overall Study|Exacerbation of primary disease|2
7420843|NCT01475370|11695296|FG000|Overall Study|Study drug administration difficult|0
7420844|NCT01475370|11695297|FG001|Overall Study|Study drug administration difficult|1
7420845|NCT01475370|11695298|FG002|Overall Study|Study drug administration difficult|1
7420846|NCT01475370|11695296|FG000|Overall Study|Other than specified|1
7420847|NCT01475370|11695297|FG001|Overall Study|Other than specified|0
7420848|NCT01475370|11695298|FG002|Overall Study|Other than specified|0
7420849|NCT01475461|11695312|FG000|Run-in Period|Not meet eligibility criteria|16
7420850|NCT01475461|11695313|FG001|Run-in Period|Not meet eligibility criteria|0
7420851|NCT01475461|11695314|FG002|Run-in Period|Not meet eligibility criteria|0
7420852|NCT01475461|11695315|FG003|Run-in Period|Not meet eligibility criteria|0
7420853|NCT01475461|11695316|FG004|Run-in Period|Not meet eligibility criteria|0
7420854|NCT01475461|11695317|FG005|Run-in Period|Not meet eligibility criteria|0
7420855|NCT01475461|11695318|FG006|Run-in Period|Not meet eligibility criteria|0
7531678|NCT02657889|11876622|FG001|Overall Study|Death|2
7420856|NCT01475461|11695312|FG000|Run-in Period|Lost to Follow-up|7
7420857|NCT01475461|11695313|FG001|Run-in Period|Lost to Follow-up|0
7420858|NCT01475461|11695314|FG002|Run-in Period|Lost to Follow-up|0
7420859|NCT01475461|11695315|FG003|Run-in Period|Lost to Follow-up|0
7420860|NCT01475461|11695316|FG004|Run-in Period|Lost to Follow-up|0
7420861|NCT01475461|11695317|FG005|Run-in Period|Lost to Follow-up|0
7420862|NCT01475461|11695318|FG006|Run-in Period|Lost to Follow-up|0
7531679|NCT02657889|11876623|FG002|Overall Study|Death|20
7420863|NCT01475461|11695312|FG000|Run-in Period|Withdrawal by Subject|11
7420864|NCT01475461|11695313|FG001|Run-in Period|Withdrawal by Subject|0
7420865|NCT01475461|11695314|FG002|Run-in Period|Withdrawal by Subject|0
7420866|NCT01475461|11695315|FG003|Run-in Period|Withdrawal by Subject|0
7420867|NCT01475461|11695316|FG004|Run-in Period|Withdrawal by Subject|0
7420868|NCT01475461|11695317|FG005|Run-in Period|Withdrawal by Subject|0
7420869|NCT01475461|11695318|FG006|Run-in Period|Withdrawal by Subject|0
7420870|NCT01475461|11695312|FG000|Run-in Period|Other|3
7420871|NCT01475461|11695313|FG001|Run-in Period|Other|0
7420872|NCT01475461|11695314|FG002|Run-in Period|Other|0
7420873|NCT01475461|11695315|FG003|Run-in Period|Other|0
7420874|NCT01475461|11695316|FG004|Run-in Period|Other|0
7420875|NCT01475461|11695317|FG005|Run-in Period|Other|0
7557039|NCT03092791|11921253|FG003|Overall Study|Reason Not Specified|0
7557040|NCT03092791|11921254|FG004|Overall Study|Reason Not Specified|1
7557041|NCT03092791|11921255|FG005|Overall Study|Reason Not Specified|1
7557042|NCT03092791|11921256|FG006|Overall Study|Reason Not Specified|0
7420876|NCT01475461|11695318|FG006|Run-in Period|Other|0
7420877|NCT01475461|11695312|FG000|Run-in Period|Protocol Violation|4
7420878|NCT01475461|11695313|FG001|Run-in Period|Protocol Violation|0
7420879|NCT01475461|11695314|FG002|Run-in Period|Protocol Violation|0
7420880|NCT01475461|11695315|FG003|Run-in Period|Protocol Violation|0
7420881|NCT01475461|11695316|FG004|Run-in Period|Protocol Violation|0
7420882|NCT01475461|11695317|FG005|Run-in Period|Protocol Violation|0
7420883|NCT01475461|11695318|FG006|Run-in Period|Protocol Violation|0
7420884|NCT01475461|11695312|FG000|Treatment Period|Death|0
7420885|NCT01475461|11695313|FG001|Treatment Period|Death|0
7420886|NCT01475461|11695314|FG002|Treatment Period|Death|0
7420887|NCT01475461|11695315|FG003|Treatment Period|Death|1
7420888|NCT01475461|11695316|FG004|Treatment Period|Death|0
7420889|NCT01475461|11695317|FG005|Treatment Period|Death|0
7420890|NCT01475461|11695318|FG006|Treatment Period|Death|0
7420891|NCT01475461|11695312|FG000|Treatment Period|Lost to Follow-up|0
7420892|NCT01475461|11695313|FG001|Treatment Period|Lost to Follow-up|3
7420893|NCT01475461|11695314|FG002|Treatment Period|Lost to Follow-up|2
7420894|NCT01475461|11695315|FG003|Treatment Period|Lost to Follow-up|3
7420895|NCT01475461|11695316|FG004|Treatment Period|Lost to Follow-up|1
7420896|NCT01475461|11695317|FG005|Treatment Period|Lost to Follow-up|2
7420897|NCT01475461|11695318|FG006|Treatment Period|Lost to Follow-up|1
7420898|NCT01475461|11695312|FG000|Treatment Period|Withdrawal by Subject|0
7420899|NCT01475461|11695313|FG001|Treatment Period|Withdrawal by Subject|2
7420900|NCT01475461|11695314|FG002|Treatment Period|Withdrawal by Subject|2
7420901|NCT01475461|11695315|FG003|Treatment Period|Withdrawal by Subject|0
7420902|NCT01475461|11695316|FG004|Treatment Period|Withdrawal by Subject|2
7420903|NCT01475461|11695317|FG005|Treatment Period|Withdrawal by Subject|2
7420904|NCT01475461|11695318|FG006|Treatment Period|Withdrawal by Subject|0
7420905|NCT01475461|11695312|FG000|Treatment Period|Other|0
7420906|NCT01475461|11695313|FG001|Treatment Period|Other|1
7420907|NCT01475461|11695314|FG002|Treatment Period|Other|0
7420908|NCT01475461|11695315|FG003|Treatment Period|Other|0
7420909|NCT01475461|11695316|FG004|Treatment Period|Other|0
7420910|NCT01475461|11695317|FG005|Treatment Period|Other|0
7420911|NCT01475461|11695318|FG006|Treatment Period|Other|0
7420912|NCT01475461|11695312|FG000|Treatment Period|Protocol Violation|0
7420913|NCT01475461|11695313|FG001|Treatment Period|Protocol Violation|1
7420914|NCT01475461|11695314|FG002|Treatment Period|Protocol Violation|0
7420915|NCT01475461|11695315|FG003|Treatment Period|Protocol Violation|0
7420916|NCT01475461|11695316|FG004|Treatment Period|Protocol Violation|0
7420917|NCT01475461|11695317|FG005|Treatment Period|Protocol Violation|0
7420918|NCT01475461|11695318|FG006|Treatment Period|Protocol Violation|1
7420919|NCT01475461|11695312|FG000|Treatment Period|Lack of Efficacy|0
7420920|NCT01475461|11695313|FG001|Treatment Period|Lack of Efficacy|2
7420921|NCT01475461|11695314|FG002|Treatment Period|Lack of Efficacy|0
7420922|NCT01475461|11695315|FG003|Treatment Period|Lack of Efficacy|2
7420923|NCT01475461|11695316|FG004|Treatment Period|Lack of Efficacy|1
7420924|NCT01475461|11695317|FG005|Treatment Period|Lack of Efficacy|1
7420925|NCT01475461|11695318|FG006|Treatment Period|Lack of Efficacy|0
7420926|NCT01475461|11695312|FG000|Treatment Period|Medication Error|0
7420927|NCT01475461|11695313|FG001|Treatment Period|Medication Error|0
7420928|NCT01475461|11695314|FG002|Treatment Period|Medication Error|0
7420929|NCT01475461|11695315|FG003|Treatment Period|Medication Error|1
7557043|NCT03092791|11921257|FG007|Overall Study|Reason Not Specified|0
7557044|NCT03093181|11921317|FG000|Overall Study|Withdrawal by Subject|2
7420930|NCT01475461|11695316|FG004|Treatment Period|Medication Error|0
7420931|NCT01475461|11695317|FG005|Treatment Period|Medication Error|0
7420932|NCT01475461|11695318|FG006|Treatment Period|Medication Error|0
7420933|NCT01475461|11695312|FG000|Treatment Period|Adverse Event|0
7420934|NCT01475461|11695313|FG001|Treatment Period|Adverse Event|0
7420935|NCT01475461|11695314|FG002|Treatment Period|Adverse Event|0
7420936|NCT01475461|11695315|FG003|Treatment Period|Adverse Event|1
7420937|NCT01475461|11695316|FG004|Treatment Period|Adverse Event|0
7420938|NCT01475461|11695317|FG005|Treatment Period|Adverse Event|0
7420939|NCT01475461|11695318|FG006|Treatment Period|Adverse Event|0
7420940|NCT01475474|11695351|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
7420941|NCT01475474|11695351|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
7420942|NCT01475487|11695358|FG000|Overall Study|had to leave early for personal reasons|2
7420943|NCT01475487|11695359|FG001|Overall Study|had to leave early for personal reasons|1
7420944|NCT01475721|11695387|FG000|Overall Study|Death|3
7420945|NCT01475721|11695388|FG001|Overall Study|Death|6
7420946|NCT01475721|11695387|FG000|Overall Study|Withdrawal by Subject|8
7420947|NCT01475721|11695388|FG001|Overall Study|Withdrawal by Subject|8
7420948|NCT01475734|11695396|FG000|Overall Study|Withdrawal by Subject|1
7420949|NCT01475734|11695397|FG001|Overall Study|Withdrawal by Subject|0
7420950|NCT01475734|11695396|FG000|Overall Study|Protocol Violation|1
7420951|NCT01475734|11695397|FG001|Overall Study|Protocol Violation|0
7420952|NCT01475734|11695396|FG000|Overall Study|Physician Decision|0
7420953|NCT01475734|11695397|FG001|Overall Study|Physician Decision|1
7420954|NCT01475825|11695407|FG000|Overall Study|Adverse Event|41
7420955|NCT01475825|11695408|FG001|Overall Study|Adverse Event|15
7420956|NCT01475825|11695409|FG002|Overall Study|Adverse Event|27
7420957|NCT01475825|11695410|FG003|Overall Study|Adverse Event|11
7420958|NCT01475825|11695407|FG000|Overall Study|Death|1
7420959|NCT01475825|11695408|FG001|Overall Study|Death|0
7420960|NCT01475825|11695409|FG002|Overall Study|Death|1
7420961|NCT01475825|11695410|FG003|Overall Study|Death|0
7420962|NCT01475825|11695407|FG000|Overall Study|Lack of Efficacy|0
7420963|NCT01475825|11695408|FG001|Overall Study|Lack of Efficacy|0
7420964|NCT01475825|11695409|FG002|Overall Study|Lack of Efficacy|1
7420965|NCT01475825|11695410|FG003|Overall Study|Lack of Efficacy|0
7420966|NCT01475825|11695407|FG000|Overall Study|Lost to Follow-up|0
7420967|NCT01475825|11695408|FG001|Overall Study|Lost to Follow-up|0
7420968|NCT01475825|11695409|FG002|Overall Study|Lost to Follow-up|3
7557045|NCT03093181|11921318|FG001|Overall Study|Withdrawal by Subject|1
7557046|NCT03093181|11921319|FG002|Overall Study|Withdrawal by Subject|2
7557047|NCT03093181|11921317|FG000|Overall Study|Other (Not specified)|1
7557048|NCT03093181|11921318|FG001|Overall Study|Other (Not specified)|0
7557049|NCT03093181|11921319|FG002|Overall Study|Other (Not specified)|0
7557050|NCT03093181|11921317|FG000|Overall Study|Adverse Event|0
7557051|NCT03093181|11921318|FG001|Overall Study|Adverse Event|1
7557052|NCT03093181|11921319|FG002|Overall Study|Adverse Event|0
7557053|NCT03093181|11921317|FG000|Overall Study|Other (Protocol violation)|0
7557054|NCT03093181|11921318|FG001|Overall Study|Other (Protocol violation)|0
7557055|NCT03093181|11921319|FG002|Overall Study|Other (Protocol violation)|1
7557056|NCT03093324|11921342|FG000|Overall Study|Adverse Event|4
7557057|NCT03093324|11921343|FG001|Overall Study|Adverse Event|15
7557058|NCT03093324|11921342|FG000|Overall Study|Lost to Follow-up|1
7557059|NCT03093324|11921343|FG001|Overall Study|Lost to Follow-up|0
7557060|NCT03093324|11921342|FG000|Overall Study|Protocol Deviation|2
7557061|NCT03093324|11921343|FG001|Overall Study|Protocol Deviation|2
7557062|NCT03093324|11921342|FG000|Overall Study|Withdrawal by Subject|2
7557063|NCT03093324|11921343|FG001|Overall Study|Withdrawal by Subject|2
7557064|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
7557065|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
7557066|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
7557067|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
7557068|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7557069|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
7557070|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
7557071|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
7557072|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
7557073|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7557074|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
7420969|NCT01475825|11695410|FG003|Overall Study|Lost to Follow-up|1
7420970|NCT01475825|11695407|FG000|Overall Study|Non-compliance with Study Drug|1
7420971|NCT01475825|11695408|FG001|Overall Study|Non-compliance with Study Drug|2
7420972|NCT01475825|11695409|FG002|Overall Study|Non-compliance with Study Drug|4
7420973|NCT01475825|11695410|FG003|Overall Study|Non-compliance with Study Drug|0
7420974|NCT01475825|11695407|FG000|Overall Study|Other: Not available|0
7420975|NCT01475825|11695408|FG001|Overall Study|Other: Not available|0
7420976|NCT01475825|11695409|FG002|Overall Study|Other: Not available|2
7420977|NCT01475825|11695410|FG003|Overall Study|Other: Not available|0
7420978|NCT01475825|11695407|FG000|Overall Study|Protocol Violation|1
7557075|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
7557076|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
7557077|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
7557078|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
7420979|NCT01475825|11695408|FG001|Overall Study|Protocol Violation|0
7420980|NCT01475825|11695409|FG002|Overall Study|Protocol Violation|0
7420981|NCT01475825|11695410|FG003|Overall Study|Protocol Violation|0
7420982|NCT01475825|11695407|FG000|Overall Study|Physician Decision|0
7420983|NCT01475825|11695408|FG001|Overall Study|Physician Decision|1
7420984|NCT01475825|11695409|FG002|Overall Study|Physician Decision|0
7420985|NCT01475825|11695410|FG003|Overall Study|Physician Decision|0
7420986|NCT01475825|11695407|FG000|Overall Study|Withdrawal by Subject|8
7420987|NCT01475825|11695408|FG001|Overall Study|Withdrawal by Subject|3
7420988|NCT01475825|11695409|FG002|Overall Study|Withdrawal by Subject|11
7420989|NCT01475825|11695410|FG003|Overall Study|Withdrawal by Subject|7
7420990|NCT01475825|11695407|FG000|Overall Study|Did not enter OLC|15
7420991|NCT01475825|11695408|FG001|Overall Study|Did not enter OLC|11
7420992|NCT01475825|11695409|FG002|Overall Study|Did not enter OLC|15
7420993|NCT01475825|11695410|FG003|Overall Study|Did not enter OLC|11
7420994|NCT01475838|11695422|FG000|Randomized Phase|Randomized but Not Treated|0
7420995|NCT01475838|11695423|FG001|Randomized Phase|Randomized but Not Treated|5
7420996|NCT01475838|11695422|FG000|Randomized Phase|Adverse Event|6
7420997|NCT01475838|11695423|FG001|Randomized Phase|Adverse Event|1
7420998|NCT01475838|11695422|FG000|Randomized Phase|Pregnancy|0
7420999|NCT01475838|11695423|FG001|Randomized Phase|Pregnancy|1
7421000|NCT01475838|11695422|FG000|Randomized Phase|Investigators Discretion|1
7421001|NCT01475838|11695423|FG001|Randomized Phase|Investigators Discretion|2
7421002|NCT01475838|11695422|FG000|Randomized Phase|Withdrew Consent|10
7421003|NCT01475838|11695423|FG001|Randomized Phase|Withdrew Consent|14
7421004|NCT01475838|11695422|FG000|Randomized Phase|Lost to Follow-up|3
7421005|NCT01475838|11695423|FG001|Randomized Phase|Lost to Follow-up|4
7421006|NCT01475838|11695422|FG000|Randomized Phase|Participant Noncompliance|1
7421007|NCT01475838|11695423|FG001|Randomized Phase|Participant Noncompliance|5
7421008|NCT01475838|11695422|FG000|Randomized Phase|Protocol Violation|9
7421009|NCT01475838|11695423|FG001|Randomized Phase|Protocol Violation|4
7421010|NCT01475838|11695422|FG000|Extension Phase|Participant Noncompliance|1
7421011|NCT01475838|11695423|FG001|Extension Phase|Participant Noncompliance|0
7421012|NCT01475851|11695432|FG000|Overall Study|Protocol defined stopping criteria|1
7421013|NCT01475851|11695433|FG001|Overall Study|Protocol defined stopping criteria|0
7421014|NCT01476475|11695517|FG000|Overall Study|Adverse Event|6
7421015|NCT01476475|11695518|FG001|Overall Study|Adverse Event|0
7421016|NCT01476475|11695517|FG000|Overall Study|Poor compliance to protocol|1
7421017|NCT01476475|11695518|FG001|Overall Study|Poor compliance to protocol|1
7421018|NCT01476475|11695517|FG000|Overall Study|Other reasons|4
7421019|NCT01476475|11695518|FG001|Overall Study|Other reasons|2
7466557|NCT01892189|11766383|FG006|Washout Period 1 (7 Days)|Adverse Event|0
7466558|NCT01892189|11766384|FG007|Washout Period 1 (7 Days)|Adverse Event|0
7466559|NCT01892189|11766385|FG008|Washout Period 1 (7 Days)|Adverse Event|1
7466560|NCT01892189|11766377|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7466561|NCT01892189|11766378|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7466562|NCT01892189|11766379|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
7466563|NCT01892189|11766380|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7466564|NCT01892189|11766381|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7466565|NCT01892189|11766382|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7466566|NCT01892189|11766383|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7466567|NCT01892189|11766384|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7466568|NCT01892189|11766385|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7466569|NCT01892189|11766377|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466570|NCT01892189|11766378|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466571|NCT01892189|11766379|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466572|NCT01892189|11766380|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466573|NCT01892189|11766381|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466574|NCT01892189|11766382|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
7466575|NCT01892189|11766383|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466576|NCT01892189|11766384|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466577|NCT01892189|11766385|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
7466578|NCT01892293|11766409|FG000|Overall Study|Apheresed but not treated|4
7466579|NCT01892345|11766424|FG000|Overall Study|Adverse Event|0
7466580|NCT01892345|11766425|FG001|Overall Study|Adverse Event|2
7466581|NCT01892345|11766424|FG000|Overall Study|Death|1
7466582|NCT01892345|11766425|FG001|Overall Study|Death|0
7466583|NCT01892345|11766424|FG000|Overall Study|Lost to Follow-up|3
7466584|NCT01892345|11766425|FG001|Overall Study|Lost to Follow-up|0
7466585|NCT01892345|11766424|FG000|Overall Study|Withdrawal by Subject|12
7466586|NCT01892345|11766425|FG001|Overall Study|Withdrawal by Subject|1
7466587|NCT01892436|11766435|FG000|Overall Study|Withdrawal by Subject|8
7466588|NCT01892436|11766436|FG001|Overall Study|Withdrawal by Subject|15
7466589|NCT01892436|11766437|FG002|Overall Study|Withdrawal by Subject|4
7466590|NCT01892436|11766438|FG003|Overall Study|Withdrawal by Subject|4
7466591|NCT01892436|11766435|FG000|Overall Study|Death|1
7466592|NCT01892436|11766436|FG001|Overall Study|Death|1
7466593|NCT01892436|11766437|FG002|Overall Study|Death|0
7466594|NCT01892436|11766438|FG003|Overall Study|Death|0
7466595|NCT01892436|11766435|FG000|Overall Study|Physician Decision|2
7466596|NCT01892436|11766436|FG001|Overall Study|Physician Decision|1
7466597|NCT01892436|11766437|FG002|Overall Study|Physician Decision|0
7466598|NCT01892436|11766438|FG003|Overall Study|Physician Decision|1
7466599|NCT01892436|11766435|FG000|Overall Study|Pregnancy|0
7466600|NCT01892436|11766436|FG001|Overall Study|Pregnancy|2
7466601|NCT01892436|11766437|FG002|Overall Study|Pregnancy|1
7466602|NCT01892436|11766438|FG003|Overall Study|Pregnancy|0
7466603|NCT01892436|11766435|FG000|Overall Study|Technical problems|2
7466604|NCT01892436|11766436|FG001|Overall Study|Technical problems|1
7466605|NCT01892436|11766437|FG002|Overall Study|Technical problems|1
7466606|NCT01892436|11766438|FG003|Overall Study|Technical problems|1
7466607|NCT01892436|11766435|FG000|Overall Study|Lack of Efficacy|1
7421020|NCT01476644|11695525|FG000|Overall Study|Death|5
7421021|NCT01476644|11695525|FG000|Overall Study|moved to another state|2
7421022|NCT01476644|11695525|FG000|Overall Study|Lost to Follow-up|19
7421023|NCT01476644|11695525|FG000|Overall Study|Withdrawal by Subject|13
7421024|NCT01476696|11695530|FG000|Overall Study|Sponsor decision|2
7421025|NCT01476696|11695531|FG001|Overall Study|Sponsor decision|1
7421026|NCT01476696|11695532|FG002|Overall Study|Sponsor decision|0
7421027|NCT01476696|11695530|FG000|Overall Study|Withdrawal by Subject|1
7421028|NCT01476696|11695531|FG001|Overall Study|Withdrawal by Subject|0
7421029|NCT01476696|11695532|FG002|Overall Study|Withdrawal by Subject|0
7421030|NCT01476722|11695545|FG000|Overall Study|Adverse Event|1
7421031|NCT01477333|11695571|FG000|Overall Study|Adverse Event|1
7421032|NCT01477333|11695571|FG000|Overall Study|Withdrawal by Subject|1
7421033|NCT01477333|11695571|FG000|Overall Study|Clinical Deterioration|1
7421034|NCT01477749|11695645|FG000|Overall Study|Physician Decision|4
7421035|NCT01477853|11695669|FG000|Phase A|Adverse Event|1
7421036|NCT01477853|11695670|FG001|Phase A|Adverse Event|2
7421037|NCT01477853|11695671|FG002|Phase A|Adverse Event|2
7421038|NCT01477853|11695669|FG000|Phase A|Lost to Follow-up|4
7421039|NCT01477853|11695670|FG001|Phase A|Lost to Follow-up|3
7421040|NCT01477853|11695671|FG002|Phase A|Lost to Follow-up|2
7421041|NCT01477853|11695669|FG000|Phase A|Physician Decision|1
7421042|NCT01477853|11695670|FG001|Phase A|Physician Decision|0
7421043|NCT01477853|11695671|FG002|Phase A|Physician Decision|1
7421044|NCT01477853|11695669|FG000|Phase A|Study terminated by sponsor|37
7421045|NCT01477853|11695670|FG001|Phase A|Study terminated by sponsor|40
7421046|NCT01477853|11695671|FG002|Phase A|Study terminated by sponsor|39
7421047|NCT01477853|11695669|FG000|Phase B|Lost to Follow-up|0
7421048|NCT01477853|11695670|FG001|Phase B|Lost to Follow-up|1
7421049|NCT01477853|11695671|FG002|Phase B|Lost to Follow-up|0
7421050|NCT01477853|11695669|FG000|Phase B|Study terminated by sponsor|12
7421051|NCT01477853|11695670|FG001|Phase B|Study terminated by sponsor|10
7421052|NCT01477853|11695671|FG002|Phase B|Study terminated by sponsor|11
7421053|NCT01477892|11695681|FG000|Overall Study|Withdrawal by Subject|0
7421054|NCT01477892|11695682|FG001|Overall Study|Withdrawal by Subject|2
7421055|NCT01478048|11695699|FG000|Overall Study|Disease Progression|52
7421056|NCT01478048|11695700|FG001|Overall Study|Disease Progression|35
7421057|NCT01478048|11695699|FG000|Overall Study|study drug toxicity|11
7421058|NCT01478048|11695700|FG001|Overall Study|study drug toxicity|14
7421059|NCT01478048|11695699|FG000|Overall Study|Adverse Event|2
7421060|NCT01478048|11695700|FG001|Overall Study|Adverse Event|11
7421061|NCT01478048|11695699|FG000|Overall Study|subject request to discontinue treatment|3
7421062|NCT01478048|11695700|FG001|Overall Study|subject request to discontinue treatment|5
7421063|NCT01478048|11695699|FG000|Overall Study|Withdrawal by Subject|2
7421064|NCT01478048|11695700|FG001|Overall Study|Withdrawal by Subject|5
7421065|NCT01478048|11695699|FG000|Overall Study|non-specified|6
7421066|NCT01478048|11695700|FG001|Overall Study|non-specified|4
7421067|NCT01478048|11695699|FG000|Overall Study|poor/non-compliance|0
7421068|NCT01478048|11695700|FG001|Overall Study|poor/non-compliance|1
7421069|NCT01478048|11695699|FG000|Overall Study|no longer meets study criteria|1
7421070|NCT01478048|11695700|FG001|Overall Study|no longer meets study criteria|0
7421071|NCT01478087|11695706|FG000|Overall Study|due to sponsor closing study|1
7421072|NCT01478321|11695721|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
7421073|NCT01478321|11695721|FG000|Concurrent Therapy (5 Weeks)|Death|2
7421074|NCT01478321|11695721|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
7421075|NCT01478321|11695721|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
7421076|NCT01478321|11695721|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
7421077|NCT01478321|11695721|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
7421078|NCT01478321|11695721|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
7421079|NCT01478321|11695721|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
7421080|NCT01478347|11695725|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
7421081|NCT01478347|11695725|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
7421082|NCT01478347|11695725|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
7421083|NCT01478360|11695731|FG000|Overall Study|Lost to Follow-up|1
7421084|NCT01478360|11695732|FG001|Overall Study|Lost to Follow-up|0
7421085|NCT01478360|11695731|FG000|Overall Study|Adverse Event|0
7421086|NCT01478360|11695732|FG001|Overall Study|Adverse Event|1
7421087|NCT01478360|11695731|FG000|Overall Study|Administrative problems|1
7421088|NCT01478360|11695732|FG001|Overall Study|Administrative problems|2
7421089|NCT01478373|11695738|FG000|Treatment Phase|Protocol Violation|1
7421090|NCT01478373|11695738|FG000|Survival Phase|Adverse Event|8
7421091|NCT01478373|11695738|FG000|Survival Phase|Protocol Violation|1
7421092|NCT01478373|11695738|FG000|Survival Phase|crossover to another study|2
7421093|NCT01478373|11695738|FG000|Survival Phase|Progressive Disease|27
7421094|NCT01478594|11695765|FG000|Overall Study|Randomized but Never Received Study Drug|0
7421095|NCT01478594|11695766|FG001|Overall Study|Randomized but Never Received Study Drug|1
7421096|NCT01478594|11695765|FG000|Overall Study|Death|45
7421097|NCT01478594|11695766|FG001|Overall Study|Death|18
7421098|NCT01478594|11695765|FG000|Overall Study|Lost to Follow-up|3
7421099|NCT01478594|11695766|FG001|Overall Study|Lost to Follow-up|1
7421100|NCT01478594|11695765|FG000|Overall Study|Withdrawal by Subject|9
7421101|NCT01478594|11695766|FG001|Overall Study|Withdrawal by Subject|3
7421102|NCT01478594|11695765|FG000|Overall Study|Study Closed by Sponsor|8
7421103|NCT01478594|11695766|FG001|Overall Study|Study Closed by Sponsor|5
7421104|NCT01478620|11695825|FG000|Overall Study|Lost to Follow-up|6
7421105|NCT01478828|11695829|FG000|Overall Study|Adverse Event|1
7421106|NCT01478958|11695841|FG000|Overall Study|Withdrawal by Subject|1
7421107|NCT01478958|11695842|FG001|Overall Study|Withdrawal by Subject|1
7421108|NCT01478958|11695843|FG002|Overall Study|Withdrawal by Subject|1
7421109|NCT01478958|11695841|FG000|Overall Study|Weight loss|1
7421110|NCT01478958|11695842|FG001|Overall Study|Weight loss|0
7421111|NCT01478958|11695843|FG002|Overall Study|Weight loss|0
7421112|NCT01478958|11695841|FG000|Overall Study|Re-located|0
7421113|NCT01478958|11695842|FG001|Overall Study|Re-located|1
7421114|NCT01478958|11695843|FG002|Overall Study|Re-located|0
7421115|NCT01478958|11695841|FG000|Overall Study|Unable to comply|0
7421116|NCT01478958|11695842|FG001|Overall Study|Unable to comply|0
7421117|NCT01478958|11695843|FG002|Overall Study|Unable to comply|2
7421118|NCT01478971|11695851|FG000|Standard of Care Period|Adverse Event|1
7421119|NCT01478971|11695851|FG000|Standard of Care Period|Withdrawal by Subject|3
7421120|NCT01478971|11695851|FG000|Standard of Care Period|Death|8
7421121|NCT01478971|11695851|FG000|Standard of Care Period|Lost to Follow-up|9
7421122|NCT01478971|11695851|FG000|Standard of Care Period|Other|4
7421123|NCT01478971|11695851|FG000|Peginesatide Treatment Period|Adverse Event|1
7421124|NCT01478971|11695851|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
7421125|NCT01478971|11695851|FG000|Peginesatide Treatment Period|Death|4
7421126|NCT01478971|11695851|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
7421127|NCT01478971|11695851|FG000|Peginesatide Treatment Period|Other|4
7421128|NCT01479374|11695887|FG000|Overall Study|Adverse Event|2
7421129|NCT01479374|11695888|FG001|Overall Study|Adverse Event|1
7421130|NCT01479374|11695889|FG002|Overall Study|Adverse Event|0
7421131|NCT01479374|11695887|FG000|Overall Study|Lost to Follow-up|1
7421132|NCT01479374|11695888|FG001|Overall Study|Lost to Follow-up|2
7421133|NCT01479374|11695889|FG002|Overall Study|Lost to Follow-up|0
7421134|NCT01479374|11695887|FG000|Overall Study|Decision Unrelated to Adverse Event|0
7421135|NCT01479374|11695888|FG001|Overall Study|Decision Unrelated to Adverse Event|1
7421136|NCT01479374|11695889|FG002|Overall Study|Decision Unrelated to Adverse Event|0
7421137|NCT01479374|11695887|FG000|Overall Study|Other|0
7421138|NCT01479374|11695888|FG001|Overall Study|Other|4
7421139|NCT01479374|11695889|FG002|Overall Study|Other|5
7421140|NCT01479439|11695909|FG000|Overall Study|Adverse Event|1
7421141|NCT01479439|11695910|FG001|Overall Study|Adverse Event|0
7421142|NCT01479439|11695911|FG002|Overall Study|Adverse Event|0
7421143|NCT01479439|11695909|FG000|Overall Study|Lost to Follow-up|0
7421144|NCT01479439|11695910|FG001|Overall Study|Lost to Follow-up|1
7421145|NCT01479439|11695911|FG002|Overall Study|Lost to Follow-up|0
7421146|NCT01479439|11695909|FG000|Overall Study|Protocol Violation|0
7421147|NCT01479439|11695910|FG001|Overall Study|Protocol Violation|0
7421148|NCT01479439|11695911|FG002|Overall Study|Protocol Violation|2
7421149|NCT01479465|11695926|FG000|Overall Study|Disease Progression|9
7421150|NCT01479465|11695927|FG001|Overall Study|Disease Progression|61
7421151|NCT01479465|11695928|FG002|Overall Study|Disease Progression|65
7421152|NCT01479465|11695929|FG003|Overall Study|Disease Progression|70
7421153|NCT01479465|11695926|FG000|Overall Study|Study Discontinued by Sponsor|0
7421154|NCT01479465|11695927|FG001|Overall Study|Study Discontinued by Sponsor|7
7421155|NCT01479465|11695928|FG002|Overall Study|Study Discontinued by Sponsor|5
7421156|NCT01479465|11695929|FG003|Overall Study|Study Discontinued by Sponsor|3
7421157|NCT01479465|11695926|FG000|Overall Study|Adverse Event|0
7421158|NCT01479465|11695927|FG001|Overall Study|Adverse Event|3
7421159|NCT01479465|11695928|FG002|Overall Study|Adverse Event|6
7421160|NCT01479465|11695929|FG003|Overall Study|Adverse Event|4
7421161|NCT01479465|11695926|FG000|Overall Study|Investigator Discretion|1
7421162|NCT01479465|11695927|FG001|Overall Study|Investigator Discretion|4
7421163|NCT01479465|11695928|FG002|Overall Study|Investigator Discretion|2
7421164|NCT01479465|11695929|FG003|Overall Study|Investigator Discretion|4
7421165|NCT01479465|11695926|FG000|Overall Study|Subject Request|1
7421166|NCT01479465|11695927|FG001|Overall Study|Subject Request|3
7421167|NCT01479465|11695928|FG002|Overall Study|Subject Request|4
7421168|NCT01479465|11695929|FG003|Overall Study|Subject Request|2
7421169|NCT01479465|11695926|FG000|Overall Study|Subject Withdrew Consent|0
7421170|NCT01479465|11695927|FG001|Overall Study|Subject Withdrew Consent|5
7421171|NCT01479465|11695928|FG002|Overall Study|Subject Withdrew Consent|2
7421172|NCT01479465|11695929|FG003|Overall Study|Subject Withdrew Consent|1
7421173|NCT01479465|11695926|FG000|Overall Study|Protocol Violation|0
7421174|NCT01479465|11695927|FG001|Overall Study|Protocol Violation|1
7421175|NCT01479465|11695928|FG002|Overall Study|Protocol Violation|1
7421176|NCT01479465|11695929|FG003|Overall Study|Protocol Violation|0
7421177|NCT01479465|11695926|FG000|Overall Study|Death|0
7421178|NCT01479465|11695927|FG001|Overall Study|Death|0
7421179|NCT01479465|11695928|FG002|Overall Study|Death|0
7421180|NCT01479465|11695929|FG003|Overall Study|Death|1
7421181|NCT01479465|11695926|FG000|Overall Study|Lost to Follow-up|0
7421182|NCT01479465|11695927|FG001|Overall Study|Lost to Follow-up|0
7421183|NCT01479465|11695928|FG002|Overall Study|Lost to Follow-up|1
7421184|NCT01479465|11695929|FG003|Overall Study|Lost to Follow-up|0
7421185|NCT01479530|11695963|FG000|Overall Study|Adverse Event|5
7421186|NCT01479530|11695964|FG001|Overall Study|Adverse Event|6
7421187|NCT01479530|11695963|FG000|Overall Study|Lack of Efficacy|0
7421188|NCT01479530|11695964|FG001|Overall Study|Lack of Efficacy|1
7421189|NCT01479530|11695963|FG000|Overall Study|Protocol Violation|2
7421190|NCT01479530|11695964|FG001|Overall Study|Protocol Violation|3
7421191|NCT01479530|11695963|FG000|Overall Study|Withdrawal of Consent|3
7421192|NCT01479530|11695964|FG001|Overall Study|Withdrawal of Consent|2
7421193|NCT01479595|11695993|FG000|Overall Study|Protocol deviation|0
7421194|NCT01479595|11695994|FG001|Overall Study|Protocol deviation|1
7421195|NCT01479595|11695993|FG000|Overall Study|Adverse Event|2
7421196|NCT01479595|11695994|FG001|Overall Study|Adverse Event|1
7421197|NCT01479621|11696006|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
7421198|NCT01479621|11696007|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421199|NCT01479621|11696008|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421200|NCT01479621|11696009|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421201|NCT01479621|11696010|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421202|NCT01479621|11696011|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421203|NCT01479621|11696012|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7421204|NCT01479621|11696006|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
7421205|NCT01479621|11696007|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421206|NCT01479621|11696008|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421207|NCT01479621|11696009|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421208|NCT01479621|11696010|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421209|NCT01479621|11696011|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421210|NCT01479621|11696012|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7421211|NCT01479621|11696006|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
7421212|NCT01479621|11696007|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421213|NCT01479621|11696008|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421214|NCT01479621|11696009|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421215|NCT01479621|11696010|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421216|NCT01479621|11696011|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421217|NCT01479621|11696012|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7421218|NCT01479621|11696006|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
7421219|NCT01479621|11696007|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421220|NCT01479621|11696008|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421221|NCT01479621|11696009|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421222|NCT01479621|11696010|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421223|NCT01479621|11696011|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421224|NCT01479621|11696012|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7421225|NCT01479621|11696006|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7421226|NCT01479621|11696007|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7421227|NCT01479621|11696008|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7421228|NCT01479621|11696009|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7421229|NCT01479621|11696010|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7421230|NCT01479621|11696011|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7421231|NCT01479621|11696012|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7421232|NCT01479621|11696006|FG000|Treatment Period|Adverse Event|0
7421233|NCT01479621|11696007|FG001|Treatment Period|Adverse Event|0
7421234|NCT01479621|11696008|FG002|Treatment Period|Adverse Event|0
7421235|NCT01479621|11696009|FG003|Treatment Period|Adverse Event|0
7421236|NCT01479621|11696010|FG004|Treatment Period|Adverse Event|1
7421237|NCT01479621|11696011|FG005|Treatment Period|Adverse Event|2
7421238|NCT01479621|11696012|FG006|Treatment Period|Adverse Event|2
7421239|NCT01479621|11696006|FG000|Treatment Period|Withdrawal by Subject|0
7421240|NCT01479621|11696007|FG001|Treatment Period|Withdrawal by Subject|4
7421241|NCT01479621|11696008|FG002|Treatment Period|Withdrawal by Subject|2
7421242|NCT01479621|11696009|FG003|Treatment Period|Withdrawal by Subject|2
7421243|NCT01479621|11696010|FG004|Treatment Period|Withdrawal by Subject|5
7557079|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7557080|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
7557081|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
7557082|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
7557083|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
7557084|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
7557085|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
7557086|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
7557087|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
7557088|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
7557089|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
7557090|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
7421244|NCT01479621|11696011|FG005|Treatment Period|Withdrawal by Subject|5
7421245|NCT01479621|11696012|FG006|Treatment Period|Withdrawal by Subject|1
7421246|NCT01479621|11696006|FG000|Treatment Period|Physician Decision|0
7421247|NCT01479621|11696007|FG001|Treatment Period|Physician Decision|0
7421248|NCT01479621|11696008|FG002|Treatment Period|Physician Decision|0
7421249|NCT01479621|11696009|FG003|Treatment Period|Physician Decision|0
7421250|NCT01479621|11696010|FG004|Treatment Period|Physician Decision|1
7421251|NCT01479621|11696011|FG005|Treatment Period|Physician Decision|1
7421252|NCT01479621|11696012|FG006|Treatment Period|Physician Decision|0
7421253|NCT01479621|11696006|FG000|Treatment Period|Non-compliance to study drug|0
7421254|NCT01479621|11696007|FG001|Treatment Period|Non-compliance to study drug|1
7421255|NCT01479621|11696008|FG002|Treatment Period|Non-compliance to study drug|0
7421256|NCT01479621|11696009|FG003|Treatment Period|Non-compliance to study drug|0
7421257|NCT01479621|11696010|FG004|Treatment Period|Non-compliance to study drug|0
7421258|NCT01479621|11696011|FG005|Treatment Period|Non-compliance to study drug|0
7421259|NCT01479621|11696012|FG006|Treatment Period|Non-compliance to study drug|1
7421260|NCT01479621|11696006|FG000|Treatment Period|Protocol Violation|0
7421261|NCT01479621|11696007|FG001|Treatment Period|Protocol Violation|9
7421262|NCT01479621|11696008|FG002|Treatment Period|Protocol Violation|6
7421263|NCT01479621|11696009|FG003|Treatment Period|Protocol Violation|5
7421264|NCT01479621|11696010|FG004|Treatment Period|Protocol Violation|2
7421265|NCT01479621|11696011|FG005|Treatment Period|Protocol Violation|10
7421266|NCT01479621|11696012|FG006|Treatment Period|Protocol Violation|6
7421267|NCT01479621|11696006|FG000|Treatment Period|Pregnancy|0
7421268|NCT01479621|11696007|FG001|Treatment Period|Pregnancy|0
7421269|NCT01479621|11696008|FG002|Treatment Period|Pregnancy|2
7421270|NCT01479621|11696009|FG003|Treatment Period|Pregnancy|0
7421271|NCT01479621|11696010|FG004|Treatment Period|Pregnancy|0
7421272|NCT01479621|11696011|FG005|Treatment Period|Pregnancy|0
7421273|NCT01479621|11696012|FG006|Treatment Period|Pregnancy|0
7421274|NCT01479621|11696006|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
7421275|NCT01479621|11696007|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
7421276|NCT01479621|11696008|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
7421277|NCT01479621|11696009|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
7421278|NCT01479621|11696010|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
7421279|NCT01479621|11696011|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
7421280|NCT01479621|11696012|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
7421281|NCT01479621|11696006|FG000|Treatment Period|Lost to Follow-up|0
7421282|NCT01479621|11696007|FG001|Treatment Period|Lost to Follow-up|0
7421283|NCT01479621|11696008|FG002|Treatment Period|Lost to Follow-up|1
7421284|NCT01479621|11696009|FG003|Treatment Period|Lost to Follow-up|0
7421285|NCT01479621|11696010|FG004|Treatment Period|Lost to Follow-up|2
7421286|NCT01479621|11696011|FG005|Treatment Period|Lost to Follow-up|2
7421287|NCT01479621|11696012|FG006|Treatment Period|Lost to Follow-up|1
7421288|NCT01479621|11696006|FG000|Treatment Period|Met stopping criteria|0
7421289|NCT01479621|11696007|FG001|Treatment Period|Met stopping criteria|8
7421290|NCT01479621|11696008|FG002|Treatment Period|Met stopping criteria|7
7421291|NCT01479621|11696009|FG003|Treatment Period|Met stopping criteria|4
7421292|NCT01479621|11696010|FG004|Treatment Period|Met stopping criteria|9
7421293|NCT01479621|11696011|FG005|Treatment Period|Met stopping criteria|20
7421294|NCT01479621|11696012|FG006|Treatment Period|Met stopping criteria|6
7421295|NCT01479764|11696037|FG000|Randomized|Adverse Event|1
7421296|NCT01479764|11696038|FG001|Randomized|Adverse Event|1
7421297|NCT01479764|11696037|FG000|Randomized|Withdrawal by Subject|1
7421298|NCT01479764|11696038|FG001|Randomized|Withdrawal by Subject|0
7421299|NCT01479764|11696037|FG000|Treated|Lost to Follow-up|0
7421300|NCT01479764|11696038|FG001|Treated|Lost to Follow-up|2
7421301|NCT01479777|11696044|FG000|Overall Study|Physician Decision|2
7421302|NCT01479868|11696048|FG000|Overall Study|Adverse Event|1
7421303|NCT01479868|11696048|FG000|Overall Study|Lost to Follow-up|4
7421304|NCT01479868|11696048|FG000|Overall Study|Protocol Violation|1
7421305|NCT01479868|11696048|FG000|Overall Study|Withdrawal by Subject|1
7421306|NCT01479868|11696048|FG000|Overall Study|Sponsor's Decision|1
7421307|NCT01479868|11696048|FG000|Overall Study|Initiation of new HCV Therapy|1
7421308|NCT01479985|11696054|FG000|Overall Study|Tablet malfunction, no data saved|1
7421309|NCT01479985|11696055|FG001|Overall Study|Tablet malfunction, no data saved|1
7421310|NCT01479985|11696054|FG000|Overall Study|No decisional conflict scale responses|0
7421311|NCT01479985|11696055|FG001|Overall Study|No decisional conflict scale responses|2
7421312|NCT01479985|11696054|FG000|Overall Study|No post-visit survey|5
7421313|NCT01479985|11696055|FG001|Overall Study|No post-visit survey|3
7421314|NCT01480076|11696063|FG000|Overall Study|Run-in Failure|52
7421315|NCT01480076|11696063|FG000|Overall Study|Adverse Event|39
7421316|NCT01480076|11696063|FG000|Overall Study|Death|2
7421317|NCT01480076|11696063|FG000|Overall Study|Disease Progression|5
7421318|NCT01480076|11696063|FG000|Overall Study|Non-compliance With Study Protocol|15
7421319|NCT01480076|11696063|FG000|Overall Study|Withdrawal by Subject|105
7421320|NCT01480076|11696063|FG000|Overall Study|Lost to Follow-up|7
7421321|NCT01480076|11696063|FG000|Overall Study|Investigator Decision|13
7421322|NCT01480076|11696063|FG000|Overall Study|Other|52
7421323|NCT01480258|11696116|FG000|Infant Series|Protocol Violation|2
7421324|NCT01480258|11696117|FG001|Infant Series|Protocol Violation|0
7421325|NCT01480258|11696116|FG000|Infant Series|Physician Decision|0
7421326|NCT01480258|11696117|FG001|Infant Series|Physician Decision|1
7421327|NCT01480258|11696116|FG000|Infant Series|Not Vaccinated|3
7421328|NCT01480258|11696117|FG001|Infant Series|Not Vaccinated|0
7421329|NCT01480258|11696116|FG000|Infant Series|Adverse Event|1
7421330|NCT01480258|11696117|FG001|Infant Series|Adverse Event|1
7421331|NCT01480258|11696116|FG000|Infant Series|Withdrawal by Subject|1
7421332|NCT01480258|11696117|FG001|Infant Series|Withdrawal by Subject|6
7421333|NCT01480258|11696116|FG000|Interim Period|Lost to Follow-up|0
7421334|NCT01480258|11696117|FG001|Interim Period|Lost to Follow-up|2
7421335|NCT01480258|11696116|FG000|Interim Period|Physician Decision|1
7421336|NCT01480258|11696117|FG001|Interim Period|Physician Decision|0
7421337|NCT01480258|11696116|FG000|Interim Period|Protocol Violation|0
7421338|NCT01480258|11696117|FG001|Interim Period|Protocol Violation|1
7421339|NCT01480258|11696116|FG000|Interim Period|Withdrawal by Subject|9
7421340|NCT01480258|11696117|FG001|Interim Period|Withdrawal by Subject|6
7421341|NCT01480284|11696125|FG000|Overall Study|Withdrawal by Subject|2
7421342|NCT01480284|11696126|FG001|Overall Study|Withdrawal by Subject|0
7421343|NCT01480284|11696125|FG000|Overall Study|Adverse Event|1
7421344|NCT01480284|11696126|FG001|Overall Study|Adverse Event|0
7421345|NCT01480284|11696125|FG000|Overall Study|Study closed/terminated|3
7421346|NCT01480284|11696126|FG001|Overall Study|Study closed/terminated|0
7421347|NCT01480284|11696125|FG000|Overall Study|Lost to Follow-up|1
7421348|NCT01480284|11696126|FG001|Overall Study|Lost to Follow-up|0
7421349|NCT01480284|11696125|FG000|Overall Study|Physician Decision|1
7421350|NCT01480284|11696126|FG001|Overall Study|Physician Decision|0
7421351|NCT01480596|11696138|FG000|Overall Study|Adverse Event|3
7421352|NCT01480596|11696139|FG001|Overall Study|Adverse Event|0
7421353|NCT01480596|11696138|FG000|Overall Study|MG exacerbation or change in medication|2
7421354|NCT01480596|11696139|FG001|Overall Study|MG exacerbation or change in medication|2
7421355|NCT01480674|11696145|FG000|Overall Study|Death|23
7421356|NCT01480674|11696145|FG000|Overall Study|Lost to Follow-up|2
7421357|NCT01480674|11696145|FG000|Overall Study|visit not done|10
7421358|NCT01481116|11696156|FG000|Overall Study|Adverse Event|26
7421359|NCT01481116|11696157|FG001|Overall Study|Adverse Event|26
7421360|NCT01481116|11696158|FG002|Overall Study|Adverse Event|42
7421361|NCT01481116|11696156|FG000|Overall Study|Major Protocol Deviation|3
7421362|NCT01481116|11696157|FG001|Overall Study|Major Protocol Deviation|7
7421363|NCT01481116|11696158|FG002|Overall Study|Major Protocol Deviation|1
7421364|NCT01481116|11696156|FG000|Overall Study|Lost to Follow-up|8
7421365|NCT01481116|11696157|FG001|Overall Study|Lost to Follow-up|12
7421366|NCT01481116|11696158|FG002|Overall Study|Lost to Follow-up|11
7421367|NCT01481116|11696156|FG000|Overall Study|Withdrawal by Subject|37
7421368|NCT01481116|11696157|FG001|Overall Study|Withdrawal by Subject|33
7421369|NCT01481116|11696158|FG002|Overall Study|Withdrawal by Subject|37
7421370|NCT01481116|11696156|FG000|Overall Study|Study Termination|730
7421371|NCT01481116|11696157|FG001|Overall Study|Study Termination|729
7421372|NCT01481116|11696158|FG002|Overall Study|Study Termination|713
7421373|NCT01481116|11696156|FG000|Overall Study|Pregnancy|0
7421374|NCT01481116|11696157|FG001|Overall Study|Pregnancy|0
7421375|NCT01481116|11696158|FG002|Overall Study|Pregnancy|1
7421376|NCT01481116|11696156|FG000|Overall Study|Lack of Efficacy|3
7421377|NCT01481116|11696157|FG001|Overall Study|Lack of Efficacy|3
7421378|NCT01481116|11696158|FG002|Overall Study|Lack of Efficacy|1
7421379|NCT01481116|11696156|FG000|Overall Study|Contraindications|1
7421380|NCT01481116|11696157|FG001|Overall Study|Contraindications|1
7421381|NCT01481116|11696158|FG002|Overall Study|Contraindications|0
7421382|NCT01481116|11696156|FG000|Overall Study|Other|1
7421383|NCT01481116|11696157|FG001|Overall Study|Other|1
7421384|NCT01481116|11696158|FG002|Overall Study|Other|0
7421385|NCT01481116|11696156|FG000|Overall Study|Participant Started Taking Glipizide|1
7421386|NCT01481116|11696157|FG001|Overall Study|Participant Started Taking Glipizide|0
7421387|NCT01481116|11696158|FG002|Overall Study|Participant Started Taking Glipizide|0
7421388|NCT01481116|11696156|FG000|Overall Study|Participant Moved Out of Area|2
7421389|NCT01481116|11696157|FG001|Overall Study|Participant Moved Out of Area|0
7421390|NCT01481116|11696158|FG002|Overall Study|Participant Moved Out of Area|1
7421391|NCT01481116|11696156|FG000|Overall Study|Participant Moved Out of Country|1
7421392|NCT01481116|11696157|FG001|Overall Study|Participant Moved Out of Country|0
7421393|NCT01481116|11696158|FG002|Overall Study|Participant Moved Out of Country|1
7421394|NCT01481116|11696156|FG000|Overall Study|Investigator Decision|3
7421395|NCT01481116|11696157|FG001|Overall Study|Investigator Decision|2
7421396|NCT01481116|11696158|FG002|Overall Study|Investigator Decision|1
7421397|NCT01481116|11696156|FG000|Overall Study|Sponsor Decision|0
7421398|NCT01481116|11696157|FG001|Overall Study|Sponsor Decision|1
7421399|NCT01481116|11696158|FG002|Overall Study|Sponsor Decision|3
7421400|NCT01481116|11696156|FG000|Overall Study|Non-Compliant With Study Drug|0
7421401|NCT01481116|11696157|FG001|Overall Study|Non-Compliant With Study Drug|1
7421402|NCT01481116|11696158|FG002|Overall Study|Non-Compliant With Study Drug|1
7421403|NCT01481116|11696156|FG000|Overall Study|Investigator's Discretion|2
7421404|NCT01481116|11696157|FG001|Overall Study|Investigator's Discretion|0
7421405|NCT01481116|11696158|FG002|Overall Study|Investigator's Discretion|0
7421406|NCT01481116|11696156|FG000|Overall Study|Death|2
7421407|NCT01481116|11696157|FG001|Overall Study|Death|1
7421408|NCT01481116|11696158|FG002|Overall Study|Death|0
7421409|NCT01481116|11696156|FG000|Overall Study|Hypoglycemic Event|4
7421410|NCT01481116|11696157|FG001|Overall Study|Hypoglycemic Event|0
7421411|NCT01481116|11696158|FG002|Overall Study|Hypoglycemic Event|0
7421412|NCT01481324|11696173|FG000|Overall Study|Missing Data|0
7421413|NCT01481324|11696174|FG001|Overall Study|Missing Data|2
7421414|NCT01481324|11696175|FG002|Overall Study|Missing Data|2
7421415|NCT01481779|11696218|FG000|Overall Study|Adverse Event|23
7421416|NCT01481779|11696219|FG001|Overall Study|Adverse Event|5
7421417|NCT01481779|11696218|FG000|Overall Study|Lost to Follow-up|3
7421418|NCT01481779|11696219|FG001|Overall Study|Lost to Follow-up|2
7421419|NCT01481779|11696218|FG000|Overall Study|Protocol Violation|2
7421420|NCT01481779|11696219|FG001|Overall Study|Protocol Violation|3
7421421|NCT01481779|11696218|FG000|Overall Study|Withdrawal by Subject|26
7421422|NCT01481779|11696219|FG001|Overall Study|Withdrawal by Subject|13
7421423|NCT01481779|11696218|FG000|Overall Study|Physician Decision|13
7421424|NCT01481779|11696219|FG001|Overall Study|Physician Decision|4
7421425|NCT01481779|11696218|FG000|Overall Study|Sponsor Decision|3
7421426|NCT01481779|11696219|FG001|Overall Study|Sponsor Decision|1
7421427|NCT01481896|11696225|FG000|Overall Study|Lost to Follow-up|12
7421428|NCT01482065|11696241|FG000|Overall Study|Withdrawal by Subject|0
7421429|NCT01482065|11696242|FG001|Overall Study|Withdrawal by Subject|1
7421430|NCT01482169|11696257|FG000|Overall Study|Physician Decision|2
7421431|NCT01482221|11696267|FG000|Overall Study|Lack of Efficacy|1
7421432|NCT01482221|11696268|FG001|Overall Study|Lack of Efficacy|0
7421433|NCT01482221|11696269|FG002|Overall Study|Lack of Efficacy|1
7421434|NCT01482221|11696267|FG000|Overall Study|Lost to Follow-up|3
7421435|NCT01482221|11696268|FG001|Overall Study|Lost to Follow-up|2
7421436|NCT01482221|11696269|FG002|Overall Study|Lost to Follow-up|1
7421437|NCT01482221|11696267|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
7421438|NCT01482221|11696268|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
7421439|NCT01482221|11696269|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7421440|NCT01482221|11696267|FG000|Overall Study|Condition under Investigation Worsened|3
7421441|NCT01482221|11696268|FG001|Overall Study|Condition under Investigation Worsened|2
7421442|NCT01482221|11696269|FG002|Overall Study|Condition under Investigation Worsened|4
7421443|NCT01482221|11696267|FG000|Overall Study|Severe Non-Compliance to Protocol|1
7421444|NCT01482221|11696268|FG001|Overall Study|Severe Non-Compliance to Protocol|0
7421445|NCT01482221|11696269|FG002|Overall Study|Severe Non-Compliance to Protocol|1
7421446|NCT01482221|11696267|FG000|Overall Study|Adverse Event|1
7421447|NCT01482221|11696268|FG001|Overall Study|Adverse Event|7
7421448|NCT01482221|11696269|FG002|Overall Study|Adverse Event|3
7421449|NCT01482221|11696267|FG000|Overall Study|Withdrawal by Subject|10
7421450|NCT01482221|11696268|FG001|Overall Study|Withdrawal by Subject|7
7421451|NCT01482221|11696269|FG002|Overall Study|Withdrawal by Subject|12
7421452|NCT01482221|11696267|FG000|Overall Study|Incorrect randomization|0
7421453|NCT01482221|11696268|FG001|Overall Study|Incorrect randomization|1
7421454|NCT01482221|11696269|FG002|Overall Study|Incorrect randomization|0
7421455|NCT01482221|11696267|FG000|Overall Study|Physician Decision|0
7421456|NCT01482221|11696268|FG001|Overall Study|Physician Decision|1
7421457|NCT01482221|11696269|FG002|Overall Study|Physician Decision|0
7421458|NCT01482312|11696277|FG000|Period 1, 90 Minutes of Wear|Other|1
7421459|NCT01482312|11696278|FG001|Period 1, 90 Minutes of Wear|Other|0
7421460|NCT01482312|11696279|FG002|Period 1, 90 Minutes of Wear|Other|0
7421461|NCT01482312|11696277|FG000|Period 2, 90 Minutes of Wear|Other|1
7421462|NCT01482312|11696278|FG001|Period 2, 90 Minutes of Wear|Other|0
7421463|NCT01482312|11696279|FG002|Period 2, 90 Minutes of Wear|Other|0
7421464|NCT01482429|11696299|FG000|Care Usual|Protocol Violation|0
7421465|NCT01482429|11696300|FG001|Care Usual|Protocol Violation|172
7421466|NCT01482429|11696299|FG000|Care Usual|Lost to Follow-up|0
7421467|NCT01482429|11696300|FG001|Care Usual|Lost to Follow-up|1
7421468|NCT01482429|11696299|FG000|Protocol|Protocol Violation|275
7421469|NCT01482429|11696300|FG001|Protocol|Protocol Violation|0
7421470|NCT01482767|11696374|FG000|Overall Study|Death|1
7421471|NCT01482767|11696375|FG001|Overall Study|Death|1
7421472|NCT01482767|11696374|FG000|Overall Study|Withdrawal by Subject|7
7421473|NCT01482767|11696375|FG001|Overall Study|Withdrawal by Subject|5
7421474|NCT01482767|11696374|FG000|Overall Study|Lost to Follow-up|12
7421475|NCT01482767|11696375|FG001|Overall Study|Lost to Follow-up|6
7421476|NCT01482767|11696374|FG000|Overall Study|Adverse Event|0
7421477|NCT01482767|11696375|FG001|Overall Study|Adverse Event|3
7421478|NCT01482767|11696374|FG000|Overall Study|Site closure|22
7421479|NCT01482767|11696375|FG001|Overall Study|Site closure|14
7421480|NCT01482767|11696374|FG000|Overall Study|Non-adherence to study requirements|4
7421481|NCT01482767|11696375|FG001|Overall Study|Non-adherence to study requirements|7
7421482|NCT01482767|11696374|FG000|Overall Study|Alternate HCV treatment|7
7421483|NCT01482767|11696375|FG001|Overall Study|Alternate HCV treatment|8
7421484|NCT01482767|11696374|FG000|Overall Study|Ineligible|0
7421485|NCT01482767|11696375|FG001|Overall Study|Ineligible|5
7421486|NCT01482767|11696374|FG000|Overall Study|Nurse error|1
7421487|NCT01482767|11696375|FG001|Overall Study|Nurse error|0
7421488|NCT01482819|11696381|FG000|Overall Study|Lost to Follow-up|2
7421489|NCT01482884|11696391|FG000|Overall Study|Medical decision due to lack of efficacy|0
7421490|NCT01482884|11696392|FG001|Overall Study|Medical decision due to lack of efficacy|1
7421491|NCT01482884|11696391|FG000|Overall Study|Protocol Violation|1
7421492|NCT01482884|11696392|FG001|Overall Study|Protocol Violation|0
7421493|NCT01482884|11696391|FG000|Overall Study|Lost to Follow-up|2
7421494|NCT01482884|11696392|FG001|Overall Study|Lost to Follow-up|2
7421495|NCT01482884|11696391|FG000|Overall Study|Lack of Efficacy|0
7421496|NCT01482884|11696392|FG001|Overall Study|Lack of Efficacy|1
7421497|NCT01482884|11696391|FG000|Overall Study|Adverse Event|2
7421498|NCT01482884|11696392|FG001|Overall Study|Adverse Event|1
7421499|NCT01482884|11696391|FG000|Overall Study|Withdrawal by Subject|8
7421500|NCT01482884|11696392|FG001|Overall Study|Withdrawal by Subject|13
7421501|NCT01482910|11696400|FG000|Overall Study|Adverse Event|6
7421502|NCT01482910|11696401|FG001|Overall Study|Adverse Event|5
7421503|NCT01482910|11696400|FG000|Overall Study|Lost to Follow-up|0
7421504|NCT01482910|11696401|FG001|Overall Study|Lost to Follow-up|1
7421505|NCT01482910|11696400|FG000|Overall Study|Protocol Violation|1
7421506|NCT01482910|11696401|FG001|Overall Study|Protocol Violation|1
7421507|NCT01482910|11696400|FG000|Overall Study|Withdrawal by Subject|7
7421508|NCT01482910|11696401|FG001|Overall Study|Withdrawal by Subject|2
7421509|NCT01482910|11696400|FG000|Overall Study|Death|1
7421510|NCT01482910|11696401|FG001|Overall Study|Death|0
7421511|NCT01482962|11696411|FG000|Overall Study|Progressive Disease|65
7421512|NCT01482962|11696412|FG001|Overall Study|Progressive Disease|53
7421513|NCT01482962|11696411|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
7421514|NCT01482962|11696412|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
7421515|NCT01482962|11696411|FG000|Overall Study|Adverse Event|18
7421516|NCT01482962|11696412|FG001|Overall Study|Adverse Event|22
7421517|NCT01482962|11696411|FG000|Overall Study|Withdrawal by Participant|8
7421518|NCT01482962|11696412|FG001|Overall Study|Withdrawal by Participant|13
7421519|NCT01482962|11696411|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
7421520|NCT01482962|11696412|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
7421521|NCT01482962|11696411|FG000|Overall Study|Other Reason|1
7421522|NCT01482962|11696412|FG001|Overall Study|Other Reason|5
7421523|NCT01482962|11696411|FG000|Overall Study|Study Terminated by Sponsor|5
7421524|NCT01482962|11696412|FG001|Overall Study|Study Terminated by Sponsor|2
7421525|NCT01482962|11696411|FG000|Overall Study|Did not Receive Study Drug|1
7421526|NCT01482962|11696412|FG001|Overall Study|Did not Receive Study Drug|6
7421527|NCT01483118|11696422|FG000|Overall Study|Lost to Follow-up|12
7421528|NCT01483118|11696423|FG001|Overall Study|Lost to Follow-up|16
7421529|NCT01483144|11696434|FG000|Overall Study|Adverse Event|9
7421530|NCT01483144|11696435|FG001|Overall Study|Adverse Event|4
7421531|NCT01483144|11696436|FG002|Overall Study|Adverse Event|6
7421532|NCT01483144|11696434|FG000|Overall Study|Withdrawal by Subject|0
7421533|NCT01483144|11696435|FG001|Overall Study|Withdrawal by Subject|2
7421534|NCT01483144|11696436|FG002|Overall Study|Withdrawal by Subject|5
7421535|NCT01483144|11696434|FG000|Overall Study|Physician Decision|1
7421536|NCT01483144|11696435|FG001|Overall Study|Physician Decision|0
7421537|NCT01483144|11696436|FG002|Overall Study|Physician Decision|0
7421538|NCT01483144|11696434|FG000|Overall Study|Lost to Follow-up|2
7421539|NCT01483144|11696435|FG001|Overall Study|Lost to Follow-up|4
7421540|NCT01483144|11696436|FG002|Overall Study|Lost to Follow-up|1
7421541|NCT01483144|11696434|FG000|Overall Study|Protocol Violation|3
7421542|NCT01483144|11696435|FG001|Overall Study|Protocol Violation|3
7421543|NCT01483144|11696436|FG002|Overall Study|Protocol Violation|3
7421544|NCT01483183|11696454|FG000|Overall Study|Physician Decision|0
7421545|NCT01483183|11696455|FG001|Overall Study|Physician Decision|0
7421546|NCT01483183|11696456|FG002|Overall Study|Physician Decision|0
7421547|NCT01483183|11696457|FG003|Overall Study|Physician Decision|0
7421548|NCT01483183|11696458|FG004|Overall Study|Physician Decision|0
7421549|NCT01483183|11696459|FG005|Overall Study|Physician Decision|0
7421550|NCT01483183|11696460|FG006|Overall Study|Physician Decision|2
7421551|NCT01483183|11696461|FG007|Overall Study|Physician Decision|0
7421552|NCT01483183|11696462|FG008|Overall Study|Physician Decision|0
7421553|NCT01483183|11696463|FG009|Overall Study|Physician Decision|0
7421554|NCT01483183|11696454|FG000|Overall Study|Withdrawal by Subject|0
7421555|NCT01483183|11696455|FG001|Overall Study|Withdrawal by Subject|0
7421556|NCT01483183|11696456|FG002|Overall Study|Withdrawal by Subject|0
7421557|NCT01483183|11696457|FG003|Overall Study|Withdrawal by Subject|0
7421558|NCT01483183|11696458|FG004|Overall Study|Withdrawal by Subject|0
7421559|NCT01483183|11696459|FG005|Overall Study|Withdrawal by Subject|0
7421560|NCT01483183|11696460|FG006|Overall Study|Withdrawal by Subject|0
7421561|NCT01483183|11696461|FG007|Overall Study|Withdrawal by Subject|0
7421562|NCT01483183|11696462|FG008|Overall Study|Withdrawal by Subject|0
7421563|NCT01483183|11696463|FG009|Overall Study|Withdrawal by Subject|1
7421564|NCT01483599|11696518|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
7421565|NCT01483599|11696519|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421566|NCT01483599|11696520|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421567|NCT01483599|11696521|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7421568|NCT01483599|11696522|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
7421569|NCT01483599|11696523|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
7421570|NCT01483599|11696524|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
7421571|NCT01483599|11696525|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421572|NCT01483599|11696526|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421573|NCT01483599|11696527|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421574|NCT01483599|11696528|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421575|NCT01483599|11696529|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421576|NCT01483599|11696530|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421577|NCT01483599|11696531|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
7421578|NCT01483599|11696518|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421579|NCT01483599|11696519|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7421580|NCT01483599|11696520|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421581|NCT01483599|11696521|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7421582|NCT01483599|11696522|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421583|NCT01483599|11696523|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421584|NCT01483599|11696524|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
7421585|NCT01483599|11696525|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421586|NCT01483599|11696526|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421587|NCT01483599|11696527|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421588|NCT01483599|11696528|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421589|NCT01483599|11696529|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421590|NCT01483599|11696530|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421591|NCT01483599|11696531|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
7421592|NCT01483599|11696518|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
7421593|NCT01483599|11696519|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421594|NCT01483599|11696520|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421595|NCT01483599|11696521|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421596|NCT01483599|11696522|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421597|NCT01483599|11696523|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421598|NCT01483599|11696524|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421599|NCT01483599|11696525|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421600|NCT01483599|11696526|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421601|NCT01483599|11696527|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421602|NCT01483599|11696528|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421603|NCT01483599|11696529|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421604|NCT01483599|11696530|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421605|NCT01483599|11696531|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
7421606|NCT01483599|11696518|FG000|Controlled Period (CP) (up to Week 16)|Other|0
7421607|NCT01483599|11696519|FG001|Controlled Period (CP) (up to Week 16)|Other|2
7421608|NCT01483599|11696520|FG002|Controlled Period (CP) (up to Week 16)|Other|0
7421609|NCT01483599|11696521|FG003|Controlled Period (CP) (up to Week 16)|Other|1
7421610|NCT01483599|11696522|FG004|Controlled Period (CP) (up to Week 16)|Other|1
7421611|NCT01483599|11696523|FG005|Controlled Period (CP) (up to Week 16)|Other|0
7421612|NCT01483599|11696524|FG006|Controlled Period (CP) (up to Week 16)|Other|0
7421613|NCT01483599|11696525|FG007|Controlled Period (CP) (up to Week 16)|Other|0
7421614|NCT01483599|11696526|FG008|Controlled Period (CP) (up to Week 16)|Other|0
7421615|NCT01483599|11696527|FG009|Controlled Period (CP) (up to Week 16)|Other|0
7421616|NCT01483599|11696528|FG010|Controlled Period (CP) (up to Week 16)|Other|0
7421617|NCT01483599|11696529|FG011|Controlled Period (CP) (up to Week 16)|Other|0
7421618|NCT01483599|11696530|FG012|Controlled Period (CP) (up to Week 16)|Other|0
7421619|NCT01483599|11696531|FG013|Controlled Period (CP) (up to Week 16)|Other|0
7421620|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Death|0
7421621|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Death|0
7421622|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Death|0
7421623|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Death|0
7421624|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Death|0
7421625|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Death|0
7421626|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Death|0
7421627|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Death|0
7421628|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Death|1
7421629|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Death|0
7421630|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Death|0
7421631|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Death|0
7421632|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Death|0
7421633|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Death|0
7421634|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421635|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421636|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421637|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421638|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421639|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421640|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421641|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7421642|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7421643|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421644|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421645|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
7421646|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7466608|NCT01892436|11766436|FG001|Overall Study|Lack of Efficacy|2
7421647|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
7421648|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421649|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421650|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421651|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421652|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421653|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421654|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421655|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421656|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7421657|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421658|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421659|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7421660|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
7421661|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
7421662|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7557091|NCT03093415|11921352|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
7557092|NCT03093415|11921353|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
7557093|NCT03093415|11921354|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
7557094|NCT03093415|11921352|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
7557095|NCT03093415|11921353|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
7557096|NCT03093415|11921354|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
7557097|NCT03093454|11921364|FG000|Overall Study|Withdrawal by Subject|1
7557098|NCT03093454|11921365|FG001|Overall Study|Withdrawal by Subject|1
7557099|NCT03093454|11921364|FG000|Overall Study|Scheduling conflict|3
7557100|NCT03093454|11921365|FG001|Overall Study|Scheduling conflict|1
7557101|NCT03093454|11921364|FG000|Overall Study|Physician Decision|2
7557102|NCT03093454|11921365|FG001|Overall Study|Physician Decision|1
7557103|NCT03093870|11921383|FG000|Overall Study|Withdrawal by Subject|2
7557104|NCT03093870|11921384|FG001|Overall Study|Withdrawal by Subject|6
7557105|NCT03093870|11921385|FG002|Overall Study|Withdrawal by Subject|5
7557106|NCT03093870|11921383|FG000|Overall Study|Death|1
7557107|NCT03093870|11921384|FG001|Overall Study|Death|35
7557108|NCT03093870|11921385|FG002|Overall Study|Death|35
7557109|NCT03093870|11921383|FG000|Overall Study|Radiographic disease progression|10
7557110|NCT03093870|11921384|FG001|Overall Study|Radiographic disease progression|0
7557111|NCT03093870|11921385|FG002|Overall Study|Radiographic disease progression|0
7557112|NCT03093870|11921383|FG000|Overall Study|Clinical disease progression|1
7557113|NCT03093870|11921384|FG001|Overall Study|Clinical disease progression|0
7557114|NCT03093870|11921385|FG002|Overall Study|Clinical disease progression|0
7557115|NCT03093870|11921383|FG000|Overall Study|Physician Decision|2
7557116|NCT03093870|11921384|FG001|Overall Study|Physician Decision|0
7557117|NCT03093870|11921385|FG002|Overall Study|Physician Decision|0
7557118|NCT03093870|11921383|FG000|Overall Study|Adverse Event|7
7557119|NCT03093870|11921384|FG001|Overall Study|Adverse Event|0
7557120|NCT03093870|11921385|FG002|Overall Study|Adverse Event|0
7557121|NCT03093870|11921383|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
7557122|NCT03093870|11921384|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7557123|NCT03093870|11921385|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
7557124|NCT03093870|11921383|FG000|Overall Study|Lost to Follow-up|0
7557125|NCT03093870|11921384|FG001|Overall Study|Lost to Follow-up|0
7557126|NCT03093870|11921385|FG002|Overall Study|Lost to Follow-up|1
7557127|NCT03094195|11921396|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
7557128|NCT03094195|11921397|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
7557129|NCT03094195|11921398|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
7557130|NCT03094195|11921399|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7557131|NCT03094195|11921400|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7557132|NCT03094195|11921401|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7557133|NCT03094195|11921402|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7557134|NCT03094195|11921403|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7557135|NCT03094195|11921396|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
7557136|NCT03094195|11921397|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
7557137|NCT03094195|11921398|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
7557138|NCT03094195|11921399|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7557139|NCT03094195|11921400|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7557140|NCT03094195|11921401|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
7557141|NCT03094195|11921402|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
7557142|NCT03094195|11921403|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
7421663|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7557143|NCT03094195|11921396|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
7557144|NCT03094195|11921397|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
7421664|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421665|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421666|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421667|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421668|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421669|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421670|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7421671|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421672|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
7421673|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421674|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
7421675|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
7421676|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421677|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421678|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421679|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421680|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421681|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421682|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421683|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421684|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
7421685|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421686|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421687|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
7421688|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
7421689|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
7421690|NCT01483599|11696518|FG000|After Controlled Period(Week 16-Week 40)|Other|0
7421691|NCT01483599|11696519|FG001|After Controlled Period(Week 16-Week 40)|Other|0
7421692|NCT01483599|11696520|FG002|After Controlled Period(Week 16-Week 40)|Other|0
7421693|NCT01483599|11696521|FG003|After Controlled Period(Week 16-Week 40)|Other|0
7421694|NCT01483599|11696522|FG004|After Controlled Period(Week 16-Week 40)|Other|0
7421695|NCT01483599|11696523|FG005|After Controlled Period(Week 16-Week 40)|Other|0
7421696|NCT01483599|11696524|FG006|After Controlled Period(Week 16-Week 40)|Other|0
7421697|NCT01483599|11696525|FG007|After Controlled Period(Week 16-Week 40)|Other|1
7421698|NCT01483599|11696526|FG008|After Controlled Period(Week 16-Week 40)|Other|0
7421699|NCT01483599|11696527|FG009|After Controlled Period(Week 16-Week 40)|Other|4
7421700|NCT01483599|11696528|FG010|After Controlled Period(Week 16-Week 40)|Other|0
7421701|NCT01483599|11696529|FG011|After Controlled Period(Week 16-Week 40)|Other|0
7421702|NCT01483599|11696530|FG012|After Controlled Period(Week 16-Week 40)|Other|1
7421703|NCT01483599|11696531|FG013|After Controlled Period(Week 16-Week 40)|Other|0
7421704|NCT01483625|11696562|FG000|Overall Study|Adverse Event|1
7421705|NCT01483625|11696563|FG001|Overall Study|Adverse Event|1
7421706|NCT01483625|11696562|FG000|Overall Study|Refused to continue medication|2
7421707|NCT01483625|11696563|FG001|Overall Study|Refused to continue medication|1
7421708|NCT01483625|11696562|FG000|Overall Study|Due to other reason|1
7421709|NCT01483625|11696563|FG001|Overall Study|Due to other reason|0
7421710|NCT01483651|11696569|FG000|Overall Study|Withdrawal by Subject|0
7421711|NCT01483651|11696570|FG001|Overall Study|Withdrawal by Subject|1
7421712|NCT01483651|11696571|FG002|Overall Study|Withdrawal by Subject|1
7421713|NCT01483651|11696572|FG003|Overall Study|Withdrawal by Subject|0
7421714|NCT01483651|11696573|FG004|Overall Study|Withdrawal by Subject|0
7421715|NCT01483651|11696574|FG005|Overall Study|Withdrawal by Subject|1
7421716|NCT01483690|11696584|FG000|Overall Study|Adverse Event|1
7421717|NCT01483690|11696585|FG001|Overall Study|Adverse Event|2
7421718|NCT01483690|11696584|FG000|Overall Study|clinical deterioration|1
7421719|NCT01483690|11696585|FG001|Overall Study|clinical deterioration|0
7421720|NCT01483690|11696584|FG000|Overall Study|Physician Decision|0
7421721|NCT01483690|11696585|FG001|Overall Study|Physician Decision|2
7421722|NCT01483690|11696584|FG000|Overall Study|exclusionary procedure|0
7421723|NCT01483690|11696585|FG001|Overall Study|exclusionary procedure|1
7421724|NCT01483924|11696605|FG000|Overall Study|Withdrawal by Subject|2
7421725|NCT01483924|11696606|FG001|Overall Study|Withdrawal by Subject|0
7421726|NCT01483924|11696607|FG002|Overall Study|Withdrawal by Subject|0
7421727|NCT01483924|11696608|FG003|Overall Study|Withdrawal by Subject|1
7421728|NCT01483924|11696609|FG004|Overall Study|Withdrawal by Subject|1
7421729|NCT01483924|11696605|FG000|Overall Study|Adverse Event|0
7421730|NCT01483924|11696606|FG001|Overall Study|Adverse Event|0
7421731|NCT01483924|11696607|FG002|Overall Study|Adverse Event|1
7421732|NCT01483924|11696608|FG003|Overall Study|Adverse Event|1
7421733|NCT01483924|11696609|FG004|Overall Study|Adverse Event|0
7421734|NCT01483924|11696605|FG000|Overall Study|Non-compliance|0
7421735|NCT01483924|11696606|FG001|Overall Study|Non-compliance|0
7421736|NCT01483924|11696607|FG002|Overall Study|Non-compliance|0
7421737|NCT01483924|11696608|FG003|Overall Study|Non-compliance|1
7421738|NCT01483924|11696609|FG004|Overall Study|Non-compliance|1
7421739|NCT01483924|11696605|FG000|Overall Study|Sponsor concern over ECG result|0
7421740|NCT01483924|11696606|FG001|Overall Study|Sponsor concern over ECG result|0
7421741|NCT01483924|11696607|FG002|Overall Study|Sponsor concern over ECG result|0
7421742|NCT01483924|11696608|FG003|Overall Study|Sponsor concern over ECG result|1
7421743|NCT01483924|11696609|FG004|Overall Study|Sponsor concern over ECG result|0
7421744|NCT01483937|11696632|FG000|Overall Study|Withdrawal by Subject|4
7421745|NCT01483937|11696633|FG001|Overall Study|Withdrawal by Subject|3
7421746|NCT01484028|11696664|FG000|Period 1|Lost to Follow-up|0
7421747|NCT01484028|11696665|FG001|Period 1|Lost to Follow-up|1
7421748|NCT01484028|11696666|FG002|Period 1|Lost to Follow-up|0
7421749|NCT01484028|11696667|FG003|Period 1|Lost to Follow-up|0
7421750|NCT01484028|11696664|FG000|Period 1|Non-Compliance to Protocol|0
7421751|NCT01484028|11696665|FG001|Period 1|Non-Compliance to Protocol|1
7421752|NCT01484028|11696666|FG002|Period 1|Non-Compliance to Protocol|0
7421753|NCT01484028|11696667|FG003|Period 1|Non-Compliance to Protocol|1
7421754|NCT01484028|11696664|FG000|Period 1|Lens Discomfort|0
7421755|NCT01484028|11696665|FG001|Period 1|Lens Discomfort|1
7421756|NCT01484028|11696666|FG002|Period 1|Lens Discomfort|0
7421757|NCT01484028|11696667|FG003|Period 1|Lens Discomfort|0
7421758|NCT01484054|11696679|FG000|Period 1|Withdrawal by Subject|0
7421759|NCT01484054|11696680|FG001|Period 1|Withdrawal by Subject|1
7421760|NCT01484132|11696687|FG000|Overall Study|Lost to Follow-up|8
7421761|NCT01484132|11696687|FG000|Overall Study|Difficulty with time commitment|2
7421762|NCT01484132|11696687|FG000|Overall Study|Ineligible|1
7421763|NCT01484132|11696687|FG000|Overall Study|No pre-treatment urine sample collected|1
7421764|NCT01484132|11696687|FG000|Overall Study|No post-treatment urine sample collected|10
7421765|NCT01484197|11696691|FG000|Treatment Period 1|Adverse Event|1
7421766|NCT01484197|11696692|FG001|Treatment Period 1|Adverse Event|0
7421767|NCT01484197|11696693|FG002|Treatment Period 1|Adverse Event|0
7421768|NCT01484197|11696694|FG003|Treatment Period 1|Adverse Event|0
7421769|NCT01484197|11696691|FG000|Treatment Period 2|Subject withdrew consent|0
7421770|NCT01484197|11696692|FG001|Treatment Period 2|Subject withdrew consent|0
7421771|NCT01484197|11696693|FG002|Treatment Period 2|Subject withdrew consent|0
7421772|NCT01484197|11696694|FG003|Treatment Period 2|Subject withdrew consent|1
7421773|NCT01484275|11696706|FG000|Overall Study|Study terminated by sponsor|28
7421774|NCT01484275|11696707|FG001|Overall Study|Study terminated by sponsor|32
7421775|NCT01484275|11696706|FG000|Overall Study|Other|10
7421776|NCT01484275|11696707|FG001|Overall Study|Other|0
7421777|NCT01484275|11696706|FG000|Overall Study|Death|3
7421778|NCT01484275|11696707|FG001|Overall Study|Death|4
7421779|NCT01484275|11696706|FG000|Overall Study|Withdrawal by Subject|1
7421780|NCT01484275|11696707|FG001|Overall Study|Withdrawal by Subject|5
7421781|NCT01484275|11696706|FG000|Overall Study|Lost to Follow-up|1
7421782|NCT01484275|11696707|FG001|Overall Study|Lost to Follow-up|1
7466609|NCT01892436|11766437|FG002|Overall Study|Lack of Efficacy|2
7466610|NCT01892436|11766438|FG003|Overall Study|Lack of Efficacy|2
7466611|NCT01892436|11766435|FG000|Overall Study|Lost to Follow-up|1
7466612|NCT01892436|11766436|FG001|Overall Study|Lost to Follow-up|1
7466613|NCT01892436|11766437|FG002|Overall Study|Lost to Follow-up|1
7466614|NCT01892436|11766438|FG003|Overall Study|Lost to Follow-up|3
7466615|NCT01892436|11766435|FG000|Overall Study|non-compliance with treatment|1
7466616|NCT01892436|11766436|FG001|Overall Study|non-compliance with treatment|0
7466617|NCT01892436|11766437|FG002|Overall Study|non-compliance with treatment|0
7466618|NCT01892436|11766438|FG003|Overall Study|non-compliance with treatment|0
7466619|NCT01892436|11766435|FG000|Overall Study|Adverse Event|7
7466620|NCT01892436|11766436|FG001|Overall Study|Adverse Event|6
7466621|NCT01892436|11766437|FG002|Overall Study|Adverse Event|2
7466622|NCT01892436|11766438|FG003|Overall Study|Adverse Event|3
7466623|NCT01892501|11766448|FG000|Overall Study|Protocol Violation|2
7466624|NCT01892501|11766448|FG000|Overall Study|Puncture not carried out|9
7466625|NCT01892501|11766448|FG000|Overall Study|Radiological monitoring not carried out|5
7466626|NCT01892501|11766448|FG000|Overall Study|Non-contributory histological result|12
7466627|NCT01892540|11766455|FG000|Overall Study|Did not complete PET/MRI|0
7557145|NCT03094195|11921398|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
7557146|NCT03094195|11921399|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7557147|NCT03094195|11921400|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7557148|NCT03094195|11921401|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
7557149|NCT03094195|11921402|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
7557150|NCT03094195|11921403|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
7557151|NCT03094195|11921396|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557152|NCT03094195|11921397|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7557153|NCT03094195|11921398|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
7466628|NCT01892540|11766456|FG001|Overall Study|Did not complete PET/MRI|0
7466629|NCT01892540|11766457|FG002|Overall Study|Did not complete PET/MRI|2
7466630|NCT01892540|11766455|FG000|Overall Study|Did not fit in scanner|0
7466631|NCT01892540|11766456|FG001|Overall Study|Did not fit in scanner|0
7466632|NCT01892540|11766457|FG002|Overall Study|Did not fit in scanner|1
7466635|NCT01893203|11766498|FG000|Overall Study|Withdrawal by Subject|1
7466636|NCT01893281|11766502|FG000|Overall Study|Adverse Event|1
7466637|NCT01893281|11766502|FG000|Overall Study|Protocol Violation|1
7421783|NCT01484431|11696729|FG000|Period 1: High Dose|Physician Decision|0
7421784|NCT01484431|11696730|FG001|Period 1: High Dose|Physician Decision|1
7421785|NCT01484431|11696731|FG002|Period 1: High Dose|Physician Decision|0
7421786|NCT01484431|11696729|FG000|Period 2|Death|0
7421787|NCT01484431|11696730|FG001|Period 2|Death|1
7421788|NCT01484431|11696731|FG002|Period 2|Death|1
7421789|NCT01484431|11696729|FG000|Period 2|Physician Decision|0
7421790|NCT01484431|11696730|FG001|Period 2|Physician Decision|0
7421791|NCT01484431|11696731|FG002|Period 2|Physician Decision|1
7421792|NCT01484431|11696729|FG000|Period 2|Non-Compliance with Study Drug|1
7421793|NCT01484431|11696730|FG001|Period 2|Non-Compliance with Study Drug|0
7421794|NCT01484431|11696731|FG002|Period 2|Non-Compliance with Study Drug|0
7421795|NCT01484496|11696746|FG000|Period 1|Protocol Violation|3
7421796|NCT01484496|11696747|FG001|Period 1|Protocol Violation|4
7421797|NCT01484496|11696748|FG002|Period 1|Protocol Violation|0
7421798|NCT01484496|11696749|FG003|Period 1|Protocol Violation|0
7421799|NCT01484496|11696746|FG000|Period 1|Physician Decision|5
7421800|NCT01484496|11696747|FG001|Period 1|Physician Decision|1
7421801|NCT01484496|11696748|FG002|Period 1|Physician Decision|0
7421802|NCT01484496|11696749|FG003|Period 1|Physician Decision|0
7421803|NCT01484496|11696746|FG000|Period 1|Lack of Efficacy|10
7421804|NCT01484496|11696747|FG001|Period 1|Lack of Efficacy|15
7421805|NCT01484496|11696748|FG002|Period 1|Lack of Efficacy|0
7421806|NCT01484496|11696749|FG003|Period 1|Lack of Efficacy|0
7421807|NCT01484496|11696746|FG000|Period 1|Adverse Event|25
7421808|NCT01484496|11696747|FG001|Period 1|Adverse Event|40
7421809|NCT01484496|11696748|FG002|Period 1|Adverse Event|0
7421810|NCT01484496|11696749|FG003|Period 1|Adverse Event|0
7421811|NCT01484496|11696746|FG000|Period 1|Withdrawal by Subject|15
7421812|NCT01484496|11696747|FG001|Period 1|Withdrawal by Subject|12
7421813|NCT01484496|11696748|FG002|Period 1|Withdrawal by Subject|0
7421814|NCT01484496|11696749|FG003|Period 1|Withdrawal by Subject|0
7421815|NCT01484496|11696746|FG000|Period 1|Lost to Follow-up|2
7421816|NCT01484496|11696747|FG001|Period 1|Lost to Follow-up|6
7421817|NCT01484496|11696748|FG002|Period 1|Lost to Follow-up|0
7421818|NCT01484496|11696749|FG003|Period 1|Lost to Follow-up|0
7421819|NCT01484496|11696746|FG000|Period 1|Positive Pregnancy|1
7421820|NCT01484496|11696747|FG001|Period 1|Positive Pregnancy|6
7421821|NCT01484496|11696748|FG002|Period 1|Positive Pregnancy|0
7421822|NCT01484496|11696749|FG003|Period 1|Positive Pregnancy|0
7421823|NCT01484496|11696746|FG000|Period 1|Treatment Failure|3
7421824|NCT01484496|11696747|FG001|Period 1|Treatment Failure|6
7421825|NCT01484496|11696748|FG002|Period 1|Treatment Failure|0
7531680|NCT02657889|11876624|FG003|Overall Study|Death|34
7531681|NCT02657889|11876621|FG000|Overall Study|Lost to Follow-up|2
7531682|NCT02657889|11876622|FG001|Overall Study|Lost to Follow-up|0
7531683|NCT02657889|11876623|FG002|Overall Study|Lost to Follow-up|1
7421826|NCT01484496|11696749|FG003|Period 1|Treatment Failure|0
7421827|NCT01484496|11696746|FG000|Period 1|Lack of Compliance|2
7421828|NCT01484496|11696747|FG001|Period 1|Lack of Compliance|1
7421829|NCT01484496|11696748|FG002|Period 1|Lack of Compliance|0
7421830|NCT01484496|11696749|FG003|Period 1|Lack of Compliance|0
7421831|NCT01484496|11696746|FG000|Period 1|Unable to Visit Site|0
7421832|NCT01484496|11696747|FG001|Period 1|Unable to Visit Site|2
7421833|NCT01484496|11696748|FG002|Period 1|Unable to Visit Site|0
7421834|NCT01484496|11696749|FG003|Period 1|Unable to Visit Site|0
7421835|NCT01484496|11696746|FG000|Period 2|Lack of Efficacy|0
7421836|NCT01484496|11696747|FG001|Period 2|Lack of Efficacy|0
7421837|NCT01484496|11696748|FG002|Period 2|Lack of Efficacy|1
7421838|NCT01484496|11696749|FG003|Period 2|Lack of Efficacy|3
7421839|NCT01484496|11696746|FG000|Period 2|Adverse Event|0
7421840|NCT01484496|11696747|FG001|Period 2|Adverse Event|0
7421841|NCT01484496|11696748|FG002|Period 2|Adverse Event|5
7421842|NCT01484496|11696749|FG003|Period 2|Adverse Event|13
7421843|NCT01484496|11696746|FG000|Period 2|Other|0
7421844|NCT01484496|11696747|FG001|Period 2|Other|0
7421845|NCT01484496|11696748|FG002|Period 2|Other|9
7421846|NCT01484496|11696749|FG003|Period 2|Other|6
7421847|NCT01484561|11696759|FG000|Overall Study|Lack of Efficacy|3
7421848|NCT01484561|11696760|FG001|Overall Study|Lack of Efficacy|1
7421849|NCT01484561|11696759|FG000|Overall Study|Lost to Follow-up|1
7421850|NCT01484561|11696760|FG001|Overall Study|Lost to Follow-up|0
7421851|NCT01484561|11696759|FG000|Overall Study|Withdrawal by Subject|3
7531684|NCT02657889|11876624|FG003|Overall Study|Lost to Follow-up|2
7421852|NCT01484561|11696760|FG001|Overall Study|Withdrawal by Subject|0
7421853|NCT01484561|11696759|FG000|Overall Study|Other|1
7421854|NCT01484561|11696760|FG001|Overall Study|Other|1
7421855|NCT01484561|11696759|FG000|Overall Study|Adverse Event|1
7421856|NCT01484561|11696760|FG001|Overall Study|Adverse Event|4
7421857|NCT01484834|11696783|FG000|Overall Study|Lost to Follow-up|5
7421858|NCT01484834|11696784|FG001|Overall Study|Lost to Follow-up|8
7421859|NCT01484834|11696785|FG002|Overall Study|Lost to Follow-up|1
7421860|NCT01484834|11696786|FG003|Overall Study|Lost to Follow-up|4
7421861|NCT01484873|11696796|FG000|Overall Study|Withdrawal by Subject|2
7421862|NCT01484912|11696803|FG000|Overall Study|Withdrawal by Subject|1
7421863|NCT01484912|11696804|FG001|Overall Study|Withdrawal by Subject|0
7421864|NCT01484912|11696803|FG000|Overall Study|Physician Decision|0
7421865|NCT01484912|11696804|FG001|Overall Study|Physician Decision|1
7421866|NCT01484938|11696810|FG000|Overall Study|Adverse Event|2
7421867|NCT01484938|11696810|FG000|Overall Study|Lost to Follow-up|1
7531685|NCT02657889|11876621|FG000|Overall Study|Withdrawal by Subject|0
7421868|NCT01484938|11696810|FG000|Overall Study|Noncompliance|1
7421869|NCT01484951|11696814|FG000|Overall Study|Adverse Event|3
7421870|NCT01484951|11696814|FG000|Overall Study|Personal Reasons|1
7421871|NCT01484951|11696814|FG000|Overall Study|Non-Compliance|1
7421872|NCT01484977|11696818|FG000|Overall Study|Adverse Event|8
7421873|NCT01484977|11696818|FG000|Overall Study|Lack of Efficacy|4
7421874|NCT01484977|11696818|FG000|Overall Study|Protocol Violation|6
7421875|NCT01484977|11696818|FG000|Overall Study|Lost to Follow-up|1
7531686|NCT02657889|11876622|FG001|Overall Study|Withdrawal by Subject|0
7531687|NCT02657889|11876623|FG002|Overall Study|Withdrawal by Subject|8
7557154|NCT03094195|11921399|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557155|NCT03094195|11921400|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557156|NCT03094195|11921401|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557157|NCT03094195|11921402|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557158|NCT03094195|11921403|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7557159|NCT03094611|11921427|FG000|Overall Study|Lack of Efficacy|1
7557160|NCT03094611|11921427|FG000|Overall Study|Stem Cell Transplant|1
7557161|NCT03095027|11921450|FG000|Period 2, Second Week of Wear|Adverse Event|1
7557162|NCT03095027|11921451|FG001|Period 2, Second Week of Wear|Adverse Event|0
7557165|NCT03095508|11921472|FG000|Overall Study|Adverse Event|0
7557166|NCT03095508|11921473|FG001|Overall Study|Adverse Event|1
7557167|NCT03095521|11921481|FG000|Overall Study|Withdrawal by Subject|0
7557168|NCT03095521|11921482|FG001|Overall Study|Withdrawal by Subject|1
7557169|NCT03095521|11921481|FG000|Overall Study|Lost to Follow-up|0
7557170|NCT03095521|11921482|FG001|Overall Study|Lost to Follow-up|1
7557171|NCT03095599|11921490|FG000|Overall Study|Withdrawal by Subject|1
7421876|NCT01484977|11696818|FG000|Overall Study|Withdrawal by Subject|4
7421877|NCT01484977|11696818|FG000|Overall Study|Subject Protocol Non-compliant|1
7421878|NCT01484977|11696818|FG000|Overall Study|Moving Overseas|1
7421879|NCT01484977|11696818|FG000|Overall Study|Low White Blood Cell Count|1
7421880|NCT01484977|11696818|FG000|Overall Study|Lack of Compliance|1
7421881|NCT01485094|11696829|FG000|Overall Study|Adverse Event|1
7421882|NCT01485094|11696830|FG001|Overall Study|Adverse Event|1
7421883|NCT01485094|11696831|FG002|Overall Study|Adverse Event|1
7421884|NCT01485094|11696829|FG000|Overall Study|Lost to Follow-up|1
7421885|NCT01485094|11696830|FG001|Overall Study|Lost to Follow-up|0
7421886|NCT01485094|11696831|FG002|Overall Study|Lost to Follow-up|0
7421887|NCT01485094|11696829|FG000|Overall Study|Withdrawal by Subject|1
7421888|NCT01485094|11696830|FG001|Overall Study|Withdrawal by Subject|1
7421889|NCT01485094|11696831|FG002|Overall Study|Withdrawal by Subject|0
7421890|NCT01485120|11696839|FG000|Overall Study|Withdrawal by Subject|2
7421891|NCT01485172|11696850|FG000|Overall Study|Adverse Event|2
7421892|NCT01485172|11696851|FG001|Overall Study|Adverse Event|1
7421893|NCT01485172|11696852|FG002|Overall Study|Adverse Event|2
7421894|NCT01485172|11696853|FG003|Overall Study|Adverse Event|2
7421895|NCT01485172|11696854|FG004|Overall Study|Adverse Event|1
7421896|NCT01485172|11696855|FG005|Overall Study|Adverse Event|2
7421897|NCT01485172|11696850|FG000|Overall Study|Lack of Efficacy|2
7421898|NCT01485172|11696851|FG001|Overall Study|Lack of Efficacy|0
7421899|NCT01485172|11696852|FG002|Overall Study|Lack of Efficacy|0
7421900|NCT01485172|11696853|FG003|Overall Study|Lack of Efficacy|0
7421901|NCT01485172|11696854|FG004|Overall Study|Lack of Efficacy|0
7421902|NCT01485172|11696855|FG005|Overall Study|Lack of Efficacy|0
7421903|NCT01485172|11696850|FG000|Overall Study|Protocol Violation|0
7421904|NCT01485172|11696851|FG001|Overall Study|Protocol Violation|0
7421905|NCT01485172|11696852|FG002|Overall Study|Protocol Violation|4
7421906|NCT01485172|11696853|FG003|Overall Study|Protocol Violation|5
7421907|NCT01485172|11696854|FG004|Overall Study|Protocol Violation|1
7421908|NCT01485172|11696855|FG005|Overall Study|Protocol Violation|0
7421909|NCT01485172|11696850|FG000|Overall Study|Protocol defined stopping criteria|1
7421910|NCT01485172|11696851|FG001|Overall Study|Protocol defined stopping criteria|0
7421911|NCT01485172|11696852|FG002|Overall Study|Protocol defined stopping criteria|0
7421912|NCT01485172|11696853|FG003|Overall Study|Protocol defined stopping criteria|0
7421913|NCT01485172|11696854|FG004|Overall Study|Protocol defined stopping criteria|1
7421914|NCT01485172|11696855|FG005|Overall Study|Protocol defined stopping criteria|0
7421915|NCT01485172|11696850|FG000|Overall Study|Lost to Follow-up|0
7421916|NCT01485172|11696851|FG001|Overall Study|Lost to Follow-up|0
7421917|NCT01485172|11696852|FG002|Overall Study|Lost to Follow-up|1
7421918|NCT01485172|11696853|FG003|Overall Study|Lost to Follow-up|0
7421919|NCT01485172|11696854|FG004|Overall Study|Lost to Follow-up|0
7421920|NCT01485172|11696855|FG005|Overall Study|Lost to Follow-up|1
7421921|NCT01485172|11696850|FG000|Overall Study|Physician Decision|0
7421922|NCT01485172|11696851|FG001|Overall Study|Physician Decision|0
7421923|NCT01485172|11696852|FG002|Overall Study|Physician Decision|0
7421924|NCT01485172|11696853|FG003|Overall Study|Physician Decision|0
7421925|NCT01485172|11696854|FG004|Overall Study|Physician Decision|1
7421926|NCT01485172|11696855|FG005|Overall Study|Physician Decision|0
7421927|NCT01485172|11696850|FG000|Overall Study|Withdrawal by Subject|2
7421928|NCT01485172|11696851|FG001|Overall Study|Withdrawal by Subject|0
7421929|NCT01485172|11696852|FG002|Overall Study|Withdrawal by Subject|0
7421930|NCT01485172|11696853|FG003|Overall Study|Withdrawal by Subject|1
7421931|NCT01485172|11696854|FG004|Overall Study|Withdrawal by Subject|1
7421932|NCT01485172|11696855|FG005|Overall Study|Withdrawal by Subject|1
7421933|NCT01485354|11696869|FG000|Overall Study|Withdrawal by Subject|5
7421934|NCT01485536|11696885|FG000|Overall Study|Withdrawal by Subject|3
7557172|NCT03095599|11921491|FG001|Overall Study|Withdrawal by Subject|0
7557173|NCT03095599|11921490|FG000|Overall Study|Lost to Follow-up|1
7557174|NCT03095599|11921491|FG001|Overall Study|Lost to Follow-up|0
7557175|NCT03095599|11921490|FG000|Overall Study|Withdrawal prior to vaccination|1
7557176|NCT03095599|11921491|FG001|Overall Study|Withdrawal prior to vaccination|0
7557177|NCT03095651|11921536|FG000|Overall Study|Lost to Follow-up|1
7557178|NCT03095651|11921537|FG001|Overall Study|Lost to Follow-up|1
7557179|NCT03095651|11921538|FG002|Overall Study|Lost to Follow-up|0
7557180|NCT03095651|11921539|FG003|Overall Study|Lost to Follow-up|1
7557181|NCT03095651|11921540|FG004|Overall Study|Lost to Follow-up|0
7557182|NCT03095651|11921541|FG005|Overall Study|Lost to Follow-up|0
7557183|NCT03095651|11921542|FG006|Overall Study|Lost to Follow-up|0
7557184|NCT03095651|11921543|FG007|Overall Study|Lost to Follow-up|0
7421935|NCT01485536|11696885|FG000|Overall Study|Adverse Event|1
7421964|NCT01485627|11696929|FG000|Overall Study|Patient withdrew|6
7421965|NCT01485627|11696930|FG001|Overall Study|Patient withdrew|5
7421966|NCT01485627|11696929|FG000|Overall Study|Patient died|3
7421967|NCT01485627|11696930|FG001|Overall Study|Patient died|1
7421968|NCT01485627|11696929|FG000|Overall Study|Patient lost to followup|0
7421969|NCT01485627|11696930|FG001|Overall Study|Patient lost to followup|1
7421970|NCT01485627|11696929|FG000|Overall Study|Caregiver withdrew|3
7421971|NCT01485627|11696930|FG001|Overall Study|Caregiver withdrew|3
7421972|NCT01485627|11696929|FG000|Overall Study|Caregiver lost to follow up|11
7421973|NCT01485627|11696930|FG001|Overall Study|Caregiver lost to follow up|12
7421974|NCT01485627|11696929|FG000|Overall Study|Caregiver died|1
7421975|NCT01485627|11696930|FG001|Overall Study|Caregiver died|0
7421976|NCT01485627|11696929|FG000|Overall Study|caregiver was not bereaved|42
7421977|NCT01485627|11696930|FG001|Overall Study|caregiver was not bereaved|35
7421978|NCT01485640|11696940|FG000|Overall Study|Adverse Event|10
7421979|NCT01485640|11696940|FG000|Overall Study|Lack of Efficacy|2
7421980|NCT01485640|11696940|FG000|Overall Study|Protocol Violation|1
7421981|NCT01485640|11696940|FG000|Overall Study|Withdrawal by Subject|14
7421982|NCT01485640|11696940|FG000|Overall Study|Terminated by Sponsor|95
7421983|NCT01485796|11696955|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
7421984|NCT01485796|11696955|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
7421985|NCT01485796|11696955|FG000|Period 2: Epoch 2|Adverse Event|3
7421986|NCT01485796|11696955|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
7421987|NCT01485796|11696955|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
7421988|NCT01485796|11696955|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
7421989|NCT01485796|11696955|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
7421990|NCT01485796|11696955|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
7421991|NCT01485887|11696963|FG000|Overall Study|Withdrawal by Subject|2
7421992|NCT01485887|11696963|FG000|Overall Study|Adverse Event|8
7421993|NCT01485887|11696963|FG000|Overall Study|Deterioration of primary disease|1
7421994|NCT01485887|11696963|FG000|Overall Study|Primary disease markedly improved|1
7421995|NCT01485991|11696969|FG000|Overall Study|Adverse Event|0
7421996|NCT01485991|11696970|FG001|Overall Study|Adverse Event|4
7421997|NCT01485991|11696969|FG000|Overall Study|Lost to Follow-up|13
7557185|NCT03095651|11921536|FG000|Overall Study|Withdrawal by Subject|0
7557186|NCT03095651|11921537|FG001|Overall Study|Withdrawal by Subject|0
7421998|NCT01485991|11696970|FG001|Overall Study|Lost to Follow-up|10
7421999|NCT01485991|11696969|FG000|Overall Study|Withdrawal by Subject|13
7422000|NCT01485991|11696970|FG001|Overall Study|Withdrawal by Subject|20
7422001|NCT01485991|11696969|FG000|Overall Study|randomized but not treated|6
7422002|NCT01485991|11696970|FG001|Overall Study|randomized but not treated|2
7422003|NCT01486199|11696982|FG000|Two Year Period Between Study Days|Physician Decision|1
7422004|NCT01486199|11696983|FG001|Two Year Period Between Study Days|Physician Decision|0
7422005|NCT01486238|11696991|FG000|Overall Study|Death|0
7422006|NCT01486238|11696992|FG001|Overall Study|Death|2
7422007|NCT01486238|11696991|FG000|Overall Study|Withdrawal by Subject|2
7422008|NCT01486238|11696992|FG001|Overall Study|Withdrawal by Subject|1
7422009|NCT01486238|11696991|FG000|Overall Study|Lost to Follow-up|0
7422010|NCT01486238|11696992|FG001|Overall Study|Lost to Follow-up|3
7422011|NCT01486316|11697001|FG000|Overall Study|Device explanted with/without re-implant|3
7422012|NCT01486316|11697002|FG001|Overall Study|Device explanted with/without re-implant|2
7422013|NCT01486316|11697003|FG002|Overall Study|Device explanted with/without re-implant|0
7422014|NCT01486316|11697004|FG003|Overall Study|Device explanted with/without re-implant|2
7422015|NCT01486316|11697001|FG000|Overall Study|Not meeting eligibility criteria|0
7422016|NCT01486316|11697002|FG001|Overall Study|Not meeting eligibility criteria|0
7422017|NCT01486316|11697003|FG002|Overall Study|Not meeting eligibility criteria|1
7422018|NCT01486316|11697004|FG003|Overall Study|Not meeting eligibility criteria|0
7422019|NCT01486316|11697001|FG000|Overall Study|Withdrawal by Subject|1
7422020|NCT01486316|11697002|FG001|Overall Study|Withdrawal by Subject|0
7422021|NCT01486316|11697003|FG002|Overall Study|Withdrawal by Subject|3
7422022|NCT01486316|11697004|FG003|Overall Study|Withdrawal by Subject|0
7422023|NCT01486316|11697001|FG000|Overall Study|Physician Decision|0
7422024|NCT01486316|11697002|FG001|Overall Study|Physician Decision|0
7422025|NCT01486316|11697003|FG002|Overall Study|Physician Decision|1
7422026|NCT01486316|11697004|FG003|Overall Study|Physician Decision|0
7422027|NCT01486316|11697001|FG000|Overall Study|Death|0
7422028|NCT01486316|11697002|FG001|Overall Study|Death|1
7422029|NCT01486316|11697003|FG002|Overall Study|Death|0
7422030|NCT01486316|11697004|FG003|Overall Study|Death|0
7422031|NCT01486446|11697015|FG000|Overall Study|Adverse Event|1
7422032|NCT01486446|11697016|FG001|Overall Study|Adverse Event|0
7422033|NCT01486758|11697041|FG000|Overall Study|Lost to Follow-up|0
7422034|NCT01486758|11697042|FG001|Overall Study|Lost to Follow-up|1
7422035|NCT01486784|11697055|FG000|Overall Study|Withdrawal by Subject|0
7422036|NCT01486784|11697056|FG001|Overall Study|Withdrawal by Subject|0
7422037|NCT01486784|11697057|FG002|Overall Study|Withdrawal by Subject|1
7422038|NCT01486784|11697058|FG003|Overall Study|Withdrawal by Subject|0
7422039|NCT01486784|11697059|FG004|Overall Study|Withdrawal by Subject|1
7422040|NCT01486784|11697060|FG005|Overall Study|Withdrawal by Subject|2
7422041|NCT01486784|11697055|FG000|Overall Study|Subject did not meet entry criteria|0
7422042|NCT01486784|11697056|FG001|Overall Study|Subject did not meet entry criteria|0
7422043|NCT01486784|11697057|FG002|Overall Study|Subject did not meet entry criteria|0
7422044|NCT01486784|11697058|FG003|Overall Study|Subject did not meet entry criteria|0
7422045|NCT01486784|11697059|FG004|Overall Study|Subject did not meet entry criteria|1
7422046|NCT01486784|11697060|FG005|Overall Study|Subject did not meet entry criteria|0
7422047|NCT01486784|11697055|FG000|Overall Study|Death|0
7422048|NCT01486784|11697056|FG001|Overall Study|Death|0
7422049|NCT01486784|11697057|FG002|Overall Study|Death|0
7422050|NCT01486784|11697058|FG003|Overall Study|Death|0
7422051|NCT01486784|11697059|FG004|Overall Study|Death|0
7422052|NCT01486784|11697060|FG005|Overall Study|Death|1
7422053|NCT01486927|11697078|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
7422054|NCT01486927|11697078|FG000|Overall Study|Physician Decision|1
7422055|NCT01486927|11697078|FG000|Overall Study|50 Exposure days not reached|2
7422056|NCT01486927|11697078|FG000|Overall Study|Withdrawal by Subject|8
7422057|NCT01486927|11697078|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
7422058|NCT01486966|11697091|FG000|Overall Study|Adverse Event|0
7422059|NCT01486966|11697092|FG001|Overall Study|Adverse Event|1
7422060|NCT01486966|11697091|FG000|Overall Study|Withdrawal by Subject|0
7422061|NCT01486966|11697092|FG001|Overall Study|Withdrawal by Subject|1
7422062|NCT01487161|11697102|FG000|Overall Study|Adverse Event|1
7422063|NCT01487161|11697103|FG001|Overall Study|Adverse Event|0
7422064|NCT01487161|11697104|FG002|Overall Study|Adverse Event|0
7422065|NCT01487161|11697105|FG003|Overall Study|Adverse Event|0
7422066|NCT01487161|11697102|FG000|Overall Study|Withdrawal by Subject|1
7422067|NCT01487161|11697103|FG001|Overall Study|Withdrawal by Subject|1
7422068|NCT01487161|11697104|FG002|Overall Study|Withdrawal by Subject|1
7422069|NCT01487161|11697105|FG003|Overall Study|Withdrawal by Subject|2
7422070|NCT01487161|11697102|FG000|Overall Study|missing data|0
7422071|NCT01487161|11697103|FG001|Overall Study|missing data|1
7422072|NCT01487161|11697104|FG002|Overall Study|missing data|0
7422073|NCT01487161|11697105|FG003|Overall Study|missing data|0
7422074|NCT01487200|11697124|FG000|Overall Study|Withdrawal by Subject|0
7422075|NCT01487200|11697125|FG001|Overall Study|Withdrawal by Subject|1
7422076|NCT01487200|11697126|FG002|Overall Study|Withdrawal by Subject|0
7422077|NCT01487200|11697127|FG003|Overall Study|Withdrawal by Subject|0
7422078|NCT01487265|11697138|FG000|Overall Study|Adverse Event|8
7422079|NCT01487265|11697138|FG000|Overall Study|Withdrawal by Subject|5
7422080|NCT01487265|11697138|FG000|Overall Study|Disease Progression|21
7422081|NCT01487265|11697138|FG000|Overall Study|Death|2
7422082|NCT01487265|11697138|FG000|Overall Study|Still on Treatment|1
7422083|NCT01487525|11697144|FG000|Overall Study|Withdrawal by Subject|0
7422084|NCT01487525|11697145|FG001|Overall Study|Withdrawal by Subject|1
7422085|NCT01487577|11697151|FG000|Overall Study|Became ineligible after signing consent|1
7422086|NCT01487863|11697168|FG000|Overall Study|Death|19
7422087|NCT01487863|11697169|FG001|Overall Study|Death|19
7422088|NCT01488071|11697197|FG000|Overall Study|Adverse Event|15
7422089|NCT01488071|11697198|FG001|Overall Study|Adverse Event|23
7422090|NCT01488071|11697197|FG000|Overall Study|Lack of Efficacy|11
7422091|NCT01488071|11697198|FG001|Overall Study|Lack of Efficacy|17
7422092|NCT01488071|11697197|FG000|Overall Study|Non-compliance with study drug|2
7422093|NCT01488071|11697198|FG001|Overall Study|Non-compliance with study drug|0
7422094|NCT01488071|11697197|FG000|Overall Study|Protocol Violation|5
7422095|NCT01488071|11697198|FG001|Overall Study|Protocol Violation|7
7422096|NCT01488071|11697197|FG000|Overall Study|Withdrawal of Consent|14
7422097|NCT01488071|11697198|FG001|Overall Study|Withdrawal of Consent|12
7422098|NCT01488071|11697197|FG000|Overall Study|Lost to Follow-up|1
7422099|NCT01488071|11697198|FG001|Overall Study|Lost to Follow-up|0
7422100|NCT01488071|11697197|FG000|Overall Study|Administrative or Other Reason(s)|5
7422101|NCT01488071|11697198|FG001|Overall Study|Administrative or Other Reason(s)|4
7422102|NCT01488097|11697204|FG000|Overall Study|Lost to Follow-up|1
7422103|NCT01488370|11697236|FG000|Overall Study|Protocol Violation|0
7422104|NCT01488370|11697237|FG001|Overall Study|Protocol Violation|1
7422105|NCT01488370|11697238|FG002|Overall Study|Protocol Violation|1
7422106|NCT01488448|11697257|FG000|Overall Study|Withdrawal by Subject|3
7422107|NCT01488448|11697258|FG001|Overall Study|Withdrawal by Subject|1
7422108|NCT01488448|11697257|FG000|Overall Study|Adverse Event|9
7422109|NCT01488448|11697258|FG001|Overall Study|Adverse Event|4
7422110|NCT01488448|11697257|FG000|Overall Study|Physician Decision|4
7422111|NCT01488448|11697258|FG001|Overall Study|Physician Decision|9
7422112|NCT01488448|11697257|FG000|Overall Study|Protocol Violation|4
7422113|NCT01488448|11697258|FG001|Overall Study|Protocol Violation|3
7422114|NCT01488487|11697266|FG000|Overall Study|Adverse Event|6
7422115|NCT01488487|11697266|FG000|Overall Study|Death|1
7422116|NCT01488487|11697266|FG000|Overall Study|Withdrawal by Subject|2
7422117|NCT01488578|11697270|FG000|Overall Study|Protocol Violation|1836
7422118|NCT01488994|11697322|FG000|Overall Study|Withdrawal by Subject|0
7422119|NCT01488994|11697323|FG001|Overall Study|Withdrawal by Subject|1
7422120|NCT01489020|11697340|FG000|Overall Study|Withdrawal by Subject|1
7422121|NCT01489020|11697341|FG001|Overall Study|Withdrawal by Subject|0
7422122|NCT01489020|11697342|FG002|Overall Study|Withdrawal by Subject|0
7422123|NCT01489020|11697343|FG003|Overall Study|Withdrawal by Subject|0
7422124|NCT01489020|11697344|FG004|Overall Study|Withdrawal by Subject|0
7422125|NCT01489020|11697345|FG005|Overall Study|Withdrawal by Subject|0
7422126|NCT01489020|11697340|FG000|Overall Study|Adverse Event|0
7422127|NCT01489020|11697341|FG001|Overall Study|Adverse Event|0
7422128|NCT01489020|11697342|FG002|Overall Study|Adverse Event|3
7422129|NCT01489020|11697343|FG003|Overall Study|Adverse Event|0
7422130|NCT01489020|11697344|FG004|Overall Study|Adverse Event|3
7422131|NCT01489020|11697345|FG005|Overall Study|Adverse Event|0
7422132|NCT01489020|11697340|FG000|Overall Study|Concomitant disease|0
7422133|NCT01489020|11697341|FG001|Overall Study|Concomitant disease|0
7422134|NCT01489020|11697342|FG002|Overall Study|Concomitant disease|0
7422135|NCT01489020|11697343|FG003|Overall Study|Concomitant disease|0
7422136|NCT01489020|11697344|FG004|Overall Study|Concomitant disease|3
7422137|NCT01489020|11697345|FG005|Overall Study|Concomitant disease|0
7422138|NCT01489111|11697365|FG000|Overall Study|Withdrawal criterion|1
7422139|NCT01489189|11697371|FG000|Overall Study|Withdrawal by Subject|20
7422140|NCT01489189|11697372|FG001|Overall Study|Withdrawal by Subject|23
7422141|NCT01489189|11697371|FG000|Overall Study|Death|10
7422142|NCT01489189|11697372|FG001|Overall Study|Death|8
7422143|NCT01489189|11697371|FG000|Overall Study|Missed Visit|1
7422144|NCT01489189|11697372|FG001|Overall Study|Missed Visit|4
7422145|NCT01489254|11697382|FG000|Double-blind Part|Adverse Event|7
7422146|NCT01489254|11697383|FG001|Double-blind Part|Adverse Event|2
7422147|NCT01489254|11697384|FG002|Double-blind Part|Adverse Event|2
7422148|NCT01489254|11697385|FG003|Double-blind Part|Adverse Event|0
7422149|NCT01489254|11697382|FG000|Double-blind Part|Pregnancy|1
7422150|NCT01489254|11697383|FG001|Double-blind Part|Pregnancy|3
7422151|NCT01489254|11697384|FG002|Double-blind Part|Pregnancy|0
7422152|NCT01489254|11697385|FG003|Double-blind Part|Pregnancy|0
7422153|NCT01489254|11697382|FG000|Double-blind Part|Withdrawal by Subject|12
7422154|NCT01489254|11697383|FG001|Double-blind Part|Withdrawal by Subject|20
7422155|NCT01489254|11697384|FG002|Double-blind Part|Withdrawal by Subject|1
7422156|NCT01489254|11697385|FG003|Double-blind Part|Withdrawal by Subject|0
7422157|NCT01489254|11697382|FG000|Double-blind Part|Lost to Follow-up|1
7422158|NCT01489254|11697383|FG001|Double-blind Part|Lost to Follow-up|2
7422159|NCT01489254|11697384|FG002|Double-blind Part|Lost to Follow-up|0
7422160|NCT01489254|11697385|FG003|Double-blind Part|Lost to Follow-up|0
7422161|NCT01489254|11697382|FG000|Double-blind Part|Other reasons for not completing study|4
7422162|NCT01489254|11697383|FG001|Double-blind Part|Other reasons for not completing study|6
7422163|NCT01489254|11697384|FG002|Double-blind Part|Other reasons for not completing study|0
7466638|NCT01893281|11766502|FG000|Overall Study|Withdrawal by Subject|1
7422164|NCT01489254|11697385|FG003|Double-blind Part|Other reasons for not completing study|0
7422165|NCT01489254|11697382|FG000|Open-label Extension Part|Adverse Event|0
7422166|NCT01489254|11697383|FG001|Open-label Extension Part|Adverse Event|0
7422167|NCT01489254|11697384|FG002|Open-label Extension Part|Adverse Event|0
7422168|NCT01489254|11697385|FG003|Open-label Extension Part|Adverse Event|10
7422169|NCT01489254|11697382|FG000|Open-label Extension Part|Pregnancy|0
7422170|NCT01489254|11697383|FG001|Open-label Extension Part|Pregnancy|0
7422171|NCT01489254|11697384|FG002|Open-label Extension Part|Pregnancy|0
7422172|NCT01489254|11697385|FG003|Open-label Extension Part|Pregnancy|3
7557187|NCT03095651|11921538|FG002|Overall Study|Withdrawal by Subject|0
7557188|NCT03095651|11921539|FG003|Overall Study|Withdrawal by Subject|0
7422173|NCT01489254|11697382|FG000|Open-label Extension Part|Withdrawal by Subject|0
7422174|NCT01489254|11697383|FG001|Open-label Extension Part|Withdrawal by Subject|0
7422175|NCT01489254|11697384|FG002|Open-label Extension Part|Withdrawal by Subject|0
7422176|NCT01489254|11697385|FG003|Open-label Extension Part|Withdrawal by Subject|30
7422177|NCT01489254|11697382|FG000|Open-label Extension Part|Protocol Violation|0
7422178|NCT01489254|11697383|FG001|Open-label Extension Part|Protocol Violation|0
7422179|NCT01489254|11697384|FG002|Open-label Extension Part|Protocol Violation|0
7422180|NCT01489254|11697385|FG003|Open-label Extension Part|Protocol Violation|1
7422181|NCT01489254|11697382|FG000|Open-label Extension Part|Lost to Follow-up|0
7422182|NCT01489254|11697383|FG001|Open-label Extension Part|Lost to Follow-up|0
7422183|NCT01489254|11697384|FG002|Open-label Extension Part|Lost to Follow-up|0
7557189|NCT03095651|11921540|FG004|Overall Study|Withdrawal by Subject|0
7422184|NCT01489254|11697385|FG003|Open-label Extension Part|Lost to Follow-up|9
7422185|NCT01489254|11697382|FG000|Open-label Extension Part|Other reasons for not completing study|0
7531688|NCT02657889|11876624|FG003|Overall Study|Withdrawal by Subject|0
7422186|NCT01489254|11697383|FG001|Open-label Extension Part|Other reasons for not completing study|0
7422187|NCT01489254|11697384|FG002|Open-label Extension Part|Other reasons for not completing study|0
7422188|NCT01489254|11697385|FG003|Open-label Extension Part|Other reasons for not completing study|5
7422189|NCT01489358|11697397|FG000|Overall Study|Lost to Follow-up|0
7422190|NCT01489358|11697398|FG001|Overall Study|Lost to Follow-up|0
7422191|NCT01489358|11697399|FG002|Overall Study|Lost to Follow-up|2
7422192|NCT01489527|11697409|FG000|Overall Study|Pregnancy|9
7422193|NCT01489527|11697410|FG001|Overall Study|Pregnancy|14
7422194|NCT01489527|11697409|FG000|Overall Study|Participant moved|6
7422195|NCT01489527|11697410|FG001|Overall Study|Participant moved|7
7422196|NCT01489527|11697409|FG000|Overall Study|Withdrawal by Subject|0
7422197|NCT01489527|11697410|FG001|Overall Study|Withdrawal by Subject|4
7422198|NCT01489527|11697409|FG000|Overall Study|Lost to Follow-up|5
7422199|NCT01489527|11697410|FG001|Overall Study|Lost to Follow-up|1
7422200|NCT01489527|11697409|FG000|Overall Study|Procedures|1
7422201|NCT01489527|11697410|FG001|Overall Study|Procedures|0
7422202|NCT01489527|11697409|FG000|Overall Study|Not compliant|1
7422203|NCT01489527|11697410|FG001|Overall Study|Not compliant|0
7422204|NCT01489891|11697478|FG000|Overall Study|Endoscopy failure|1
7422205|NCT01489891|11697479|FG001|Overall Study|Endoscopy failure|0
7422206|NCT01489956|11697487|FG000|Overall Study|Lost to Follow-up|1
7422207|NCT01489956|11697488|FG001|Overall Study|Lost to Follow-up|0
7422208|NCT01489956|11697489|FG002|Overall Study|Lost to Follow-up|0
7422209|NCT01489956|11697487|FG000|Overall Study|Withdrawal by Subject|0
7422210|NCT01489956|11697488|FG001|Overall Study|Withdrawal by Subject|0
7422211|NCT01489956|11697489|FG002|Overall Study|Withdrawal by Subject|1
7422212|NCT01490060|11697512|FG000|Cycle 1|Change of Treatment|0
7422213|NCT01490060|11697513|FG001|Cycle 1|Change of Treatment|1
7422214|NCT01490060|11697514|FG002|Cycle 1|Change of Treatment|1
7422215|NCT01490060|11697515|FG003|Cycle 1|Change of Treatment|1
7422216|NCT01490060|11697512|FG000|Cycle 1|Insurance Denied|0
7422217|NCT01490060|11697513|FG001|Cycle 1|Insurance Denied|0
7422218|NCT01490060|11697514|FG002|Cycle 1|Insurance Denied|2
7422219|NCT01490060|11697515|FG003|Cycle 1|Insurance Denied|0
7422220|NCT01490060|11697512|FG000|Cycle 1|Withdrawal by Subject|0
7422221|NCT01490060|11697513|FG001|Cycle 1|Withdrawal by Subject|0
7422222|NCT01490060|11697514|FG002|Cycle 1|Withdrawal by Subject|0
7422223|NCT01490060|11697515|FG003|Cycle 1|Withdrawal by Subject|1
7422224|NCT01490060|11697512|FG000|Cycle 1|Treatment at Another Facility|0
7422225|NCT01490060|11697513|FG001|Cycle 1|Treatment at Another Facility|0
7531689|NCT02657889|11876621|FG000|Overall Study|Ongoing in Study|0
7531690|NCT02657889|11876622|FG001|Overall Study|Ongoing in Study|5
7531691|NCT02657889|11876623|FG002|Overall Study|Ongoing in Study|24
7531692|NCT02657889|11876624|FG003|Overall Study|Ongoing in Study|19
7531693|NCT02658019|11876655|FG000|Overall Study|Adverse Event|1
7531694|NCT02658084|11876661|FG000|Overall Study|Withdrawal by Subject|1
7422226|NCT01490060|11697514|FG002|Cycle 1|Treatment at Another Facility|0
7422227|NCT01490060|11697515|FG003|Cycle 1|Treatment at Another Facility|1
7422228|NCT01490060|11697512|FG000|Cycle 2|Change of Treatment|1
7422229|NCT01490060|11697513|FG001|Cycle 2|Change of Treatment|1
7422230|NCT01490060|11697514|FG002|Cycle 2|Change of Treatment|0
7557190|NCT03095651|11921541|FG005|Overall Study|Withdrawal by Subject|1
7422231|NCT01490060|11697515|FG003|Cycle 2|Change of Treatment|0
7422232|NCT01490060|11697512|FG000|Cycle 2|Non-Compliance|0
7422233|NCT01490060|11697513|FG001|Cycle 2|Non-Compliance|0
7422234|NCT01490060|11697514|FG002|Cycle 2|Non-Compliance|1
7422235|NCT01490060|11697515|FG003|Cycle 2|Non-Compliance|0
7422236|NCT01490060|11697512|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
7422237|NCT01490060|11697513|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
7422238|NCT01490060|11697514|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
7422239|NCT01490060|11697515|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
7422240|NCT01490086|11697537|FG000|Overall Study|Consent withdrawn|4
7422241|NCT01490086|11697538|FG001|Overall Study|Consent withdrawn|4
7422242|NCT01490086|11697539|FG002|Overall Study|Consent withdrawn|3
7422243|NCT01490086|11697540|FG003|Overall Study|Consent withdrawn|0
7422244|NCT01490086|11697541|FG004|Overall Study|Consent withdrawn|1
7422245|NCT01490086|11697537|FG000|Overall Study|Non-compliance|0
7422246|NCT01490086|11697538|FG001|Overall Study|Non-compliance|1
7422247|NCT01490086|11697539|FG002|Overall Study|Non-compliance|0
7422248|NCT01490086|11697540|FG003|Overall Study|Non-compliance|0
7422249|NCT01490086|11697541|FG004|Overall Study|Non-compliance|0
7422250|NCT01490086|11697537|FG000|Overall Study|Abnormal laboratory findings|1
7422251|NCT01490086|11697538|FG001|Overall Study|Abnormal laboratory findings|0
7422252|NCT01490086|11697539|FG002|Overall Study|Abnormal laboratory findings|0
7422253|NCT01490086|11697540|FG003|Overall Study|Abnormal laboratory findings|0
7422254|NCT01490086|11697541|FG004|Overall Study|Abnormal laboratory findings|0
7422255|NCT01490086|11697537|FG000|Overall Study|Lost to Follow-up|0
7422256|NCT01490086|11697538|FG001|Overall Study|Lost to Follow-up|0
7422257|NCT01490086|11697539|FG002|Overall Study|Lost to Follow-up|0
7422258|NCT01490086|11697540|FG003|Overall Study|Lost to Follow-up|0
7422259|NCT01490086|11697541|FG004|Overall Study|Lost to Follow-up|1
7422260|NCT01490086|11697537|FG000|Overall Study|Physician Decision|3
7422261|NCT01490086|11697538|FG001|Overall Study|Physician Decision|4
7422262|NCT01490086|11697539|FG002|Overall Study|Physician Decision|2
7422263|NCT01490086|11697540|FG003|Overall Study|Physician Decision|3
7422264|NCT01490086|11697541|FG004|Overall Study|Physician Decision|1
7422265|NCT01490086|11697537|FG000|Overall Study|Adverse Event|0
7422266|NCT01490086|11697538|FG001|Overall Study|Adverse Event|0
7422267|NCT01490086|11697539|FG002|Overall Study|Adverse Event|1
7422268|NCT01490086|11697540|FG003|Overall Study|Adverse Event|2
7422269|NCT01490086|11697541|FG004|Overall Study|Adverse Event|0
7422270|NCT01490086|11697537|FG000|Overall Study|Lack of Efficacy|0
7422271|NCT01490086|11697538|FG001|Overall Study|Lack of Efficacy|3
7422272|NCT01490086|11697539|FG002|Overall Study|Lack of Efficacy|1
7422273|NCT01490086|11697540|FG003|Overall Study|Lack of Efficacy|0
7422274|NCT01490086|11697541|FG004|Overall Study|Lack of Efficacy|8
7422275|NCT01490086|11697537|FG000|Overall Study|Worsening of symptoms|0
7422276|NCT01490086|11697538|FG001|Overall Study|Worsening of symptoms|1
7422277|NCT01490086|11697539|FG002|Overall Study|Worsening of symptoms|0
7422278|NCT01490086|11697540|FG003|Overall Study|Worsening of symptoms|1
7422279|NCT01490086|11697541|FG004|Overall Study|Worsening of symptoms|0
7422280|NCT01490086|11697537|FG000|Overall Study|Subject uncontrollable and abusive|0
7422281|NCT01490086|11697538|FG001|Overall Study|Subject uncontrollable and abusive|1
7557191|NCT03095651|11921542|FG006|Overall Study|Withdrawal by Subject|0
7557192|NCT03095651|11921543|FG007|Overall Study|Withdrawal by Subject|0
7557193|NCT03096314|11921571|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
7531695|NCT02658084|11876662|FG001|Overall Study|Withdrawal by Subject|0
7531696|NCT02658084|11876661|FG000|Overall Study|Study Termination|1
7531697|NCT02658084|11876662|FG001|Overall Study|Study Termination|0
7531698|NCT02658149|11876669|FG000|Overall Study|Physician Decision|1
7531699|NCT02658149|11876670|FG001|Overall Study|Physician Decision|0
7422282|NCT01490086|11697539|FG002|Overall Study|Subject uncontrollable and abusive|0
7422283|NCT01490086|11697540|FG003|Overall Study|Subject uncontrollable and abusive|0
7422284|NCT01490086|11697541|FG004|Overall Study|Subject uncontrollable and abusive|0
7422285|NCT01490086|11697537|FG000|Overall Study|Subject left hospital|0
7422286|NCT01490086|11697538|FG001|Overall Study|Subject left hospital|1
7422287|NCT01490086|11697539|FG002|Overall Study|Subject left hospital|0
7422288|NCT01490086|11697540|FG003|Overall Study|Subject left hospital|1
7422289|NCT01490086|11697541|FG004|Overall Study|Subject left hospital|0
7422290|NCT01490125|11697553|FG000|Period I|Adverse Event|4
7422291|NCT01490125|11697554|FG001|Period I|Adverse Event|1
7422292|NCT01490125|11697555|FG002|Period I|Adverse Event|1
7422293|NCT01490125|11697556|FG003|Period I|Adverse Event|3
7422294|NCT01490125|11697557|FG004|Period I|Adverse Event|2
7422295|NCT01490125|11697558|FG005|Period I|Adverse Event|4
7422296|NCT01490125|11697553|FG000|Period I|Protocol Violation|1
7422297|NCT01490125|11697554|FG001|Period I|Protocol Violation|1
7531700|NCT02658175|11876679|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
7531701|NCT02658175|11876680|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7422298|NCT01490125|11697555|FG002|Period I|Protocol Violation|1
7422299|NCT01490125|11697556|FG003|Period I|Protocol Violation|1
7422300|NCT01490125|11697557|FG004|Period I|Protocol Violation|0
7422301|NCT01490125|11697558|FG005|Period I|Protocol Violation|0
7422302|NCT01490125|11697553|FG000|Period I|Withdrawal by Subject|1
7422303|NCT01490125|11697554|FG001|Period I|Withdrawal by Subject|3
7422304|NCT01490125|11697555|FG002|Period I|Withdrawal by Subject|2
7422305|NCT01490125|11697556|FG003|Period I|Withdrawal by Subject|1
7422306|NCT01490125|11697557|FG004|Period I|Withdrawal by Subject|2
7422307|NCT01490125|11697558|FG005|Period I|Withdrawal by Subject|1
7422308|NCT01490125|11697553|FG000|Period II|Adverse Event|2
7422309|NCT01490125|11697554|FG001|Period II|Adverse Event|3
7422310|NCT01490125|11697555|FG002|Period II|Adverse Event|2
7557194|NCT03096314|11921572|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
7557195|NCT03096483|11921599|FG000|Overall Study|Withdrawal by site|1
7557196|NCT03096847|11921627|FG000|Overall Study|Other|2
7557197|NCT03096847|11921628|FG001|Overall Study|Other|1
7557198|NCT03096847|11921629|FG002|Overall Study|Other|2
7557199|NCT03096847|11921627|FG000|Overall Study|Lost to Follow-up|1
7557200|NCT03096847|11921628|FG001|Overall Study|Lost to Follow-up|0
7557201|NCT03096847|11921629|FG002|Overall Study|Lost to Follow-up|1
7557202|NCT03096847|11921627|FG000|Overall Study|Death|6
7557203|NCT03096847|11921628|FG001|Overall Study|Death|0
7557204|NCT03096847|11921629|FG002|Overall Study|Death|2
7422311|NCT01490125|11697556|FG003|Period II|Adverse Event|2
7422312|NCT01490125|11697557|FG004|Period II|Adverse Event|4
7422313|NCT01490125|11697558|FG005|Period II|Adverse Event|2
7422314|NCT01490125|11697553|FG000|Period II|Protocol Violation|0
7422315|NCT01490125|11697554|FG001|Period II|Protocol Violation|0
7422316|NCT01490125|11697555|FG002|Period II|Protocol Violation|1
7422317|NCT01490125|11697556|FG003|Period II|Protocol Violation|1
7422318|NCT01490125|11697557|FG004|Period II|Protocol Violation|0
7422319|NCT01490125|11697558|FG005|Period II|Protocol Violation|0
7422320|NCT01490125|11697553|FG000|Period II|Lost to Follow-up|0
7422321|NCT01490125|11697554|FG001|Period II|Lost to Follow-up|1
7422322|NCT01490125|11697555|FG002|Period II|Lost to Follow-up|0
7422323|NCT01490125|11697556|FG003|Period II|Lost to Follow-up|0
7422324|NCT01490125|11697557|FG004|Period II|Lost to Follow-up|0
7422325|NCT01490125|11697558|FG005|Period II|Lost to Follow-up|0
7422326|NCT01490125|11697553|FG000|Period II|Withdrawal by Subject|1
7422327|NCT01490125|11697554|FG001|Period II|Withdrawal by Subject|0
7422328|NCT01490125|11697555|FG002|Period II|Withdrawal by Subject|0
7422329|NCT01490125|11697556|FG003|Period II|Withdrawal by Subject|0
7422330|NCT01490125|11697557|FG004|Period II|Withdrawal by Subject|0
7422331|NCT01490125|11697558|FG005|Period II|Withdrawal by Subject|0
7422332|NCT01490125|11697553|FG000|Period III|Adverse Event|3
7422333|NCT01490125|11697554|FG001|Period III|Adverse Event|1
7422334|NCT01490125|11697555|FG002|Period III|Adverse Event|0
7422335|NCT01490125|11697556|FG003|Period III|Adverse Event|1
7422336|NCT01490125|11697557|FG004|Period III|Adverse Event|0
7422337|NCT01490125|11697558|FG005|Period III|Adverse Event|0
7422338|NCT01490125|11697553|FG000|Period III|Death|0
7422339|NCT01490125|11697554|FG001|Period III|Death|0
7422340|NCT01490125|11697555|FG002|Period III|Death|0
7422341|NCT01490125|11697556|FG003|Period III|Death|1
7422342|NCT01490125|11697557|FG004|Period III|Death|0
7422343|NCT01490125|11697558|FG005|Period III|Death|0
7422344|NCT01490125|11697553|FG000|Period III|Lack of Efficacy|0
7422345|NCT01490125|11697554|FG001|Period III|Lack of Efficacy|0
7422346|NCT01490125|11697555|FG002|Period III|Lack of Efficacy|0
7422347|NCT01490125|11697556|FG003|Period III|Lack of Efficacy|0
7422348|NCT01490125|11697557|FG004|Period III|Lack of Efficacy|1
7422349|NCT01490125|11697558|FG005|Period III|Lack of Efficacy|0
7422350|NCT01490294|11697576|FG000|Overall Study|Prematurely discontinuation|4
7422351|NCT01490294|11697577|FG001|Overall Study|Prematurely discontinuation|0
7422352|NCT01490294|11697578|FG002|Overall Study|Prematurely discontinuation|1
7422353|NCT01490294|11697579|FG003|Overall Study|Prematurely discontinuation|1
7422354|NCT01490294|11697576|FG000|Overall Study|Adverse Event|1
7422355|NCT01490294|11697577|FG001|Overall Study|Adverse Event|0
7422356|NCT01490294|11697578|FG002|Overall Study|Adverse Event|0
7422357|NCT01490294|11697579|FG003|Overall Study|Adverse Event|0
7422358|NCT01490450|11697603|FG000|Period 1|Lack of Efficacy|2
7422359|NCT01490450|11697604|FG001|Period 1|Lack of Efficacy|0
7422360|NCT01490450|11697605|FG002|Period 1|Lack of Efficacy|3
7422361|NCT01490450|11697606|FG003|Period 1|Lack of Efficacy|0
7422362|NCT01490450|11697603|FG000|Period 1|Adverse Event|0
7422363|NCT01490450|11697604|FG001|Period 1|Adverse Event|0
7422364|NCT01490450|11697605|FG002|Period 1|Adverse Event|0
7422365|NCT01490450|11697606|FG003|Period 1|Adverse Event|5
7422366|NCT01490450|11697603|FG000|Period 1|Request to discontinue treatment|1
7422367|NCT01490450|11697604|FG001|Period 1|Request to discontinue treatment|0
7422368|NCT01490450|11697605|FG002|Period 1|Request to discontinue treatment|0
7422369|NCT01490450|11697606|FG003|Period 1|Request to discontinue treatment|0
7422370|NCT01490450|11697603|FG000|Period 1|Withdrawal by Subject|0
7422371|NCT01490450|11697604|FG001|Period 1|Withdrawal by Subject|0
7422372|NCT01490450|11697605|FG002|Period 1|Withdrawal by Subject|0
7422373|NCT01490450|11697606|FG003|Period 1|Withdrawal by Subject|3
7557205|NCT03096847|11921627|FG000|Overall Study|Protocol Violation|3
7557206|NCT03096847|11921628|FG001|Overall Study|Protocol Violation|0
7557207|NCT03096847|11921629|FG002|Overall Study|Protocol Violation|6
7422374|NCT01490450|11697603|FG000|Period 1|No longer met study criteria|0
7422375|NCT01490450|11697604|FG001|Period 1|No longer met study criteria|1
7422376|NCT01490450|11697605|FG002|Period 1|No longer met study criteria|1
7422377|NCT01490450|11697606|FG003|Period 1|No longer met study criteria|0
7422378|NCT01490450|11697603|FG000|Period 2|Lack of Efficacy|0
7422379|NCT01490450|11697604|FG001|Period 2|Lack of Efficacy|0
7422380|NCT01490450|11697605|FG002|Period 2|Lack of Efficacy|0
7422381|NCT01490450|11697606|FG003|Period 2|Lack of Efficacy|1
7422382|NCT01490450|11697603|FG000|Period 2|Adverse Event|1
7422383|NCT01490450|11697604|FG001|Period 2|Adverse Event|1
7422384|NCT01490450|11697605|FG002|Period 2|Adverse Event|0
7422385|NCT01490450|11697606|FG003|Period 2|Adverse Event|1
7422386|NCT01490450|11697603|FG000|Period 2|Withdrawal by Subject|1
7557208|NCT03096847|11921627|FG000|Overall Study|Physician Decision|12
7422387|NCT01490450|11697604|FG001|Period 2|Withdrawal by Subject|0
7422388|NCT01490450|11697605|FG002|Period 2|Withdrawal by Subject|0
7422389|NCT01490450|11697606|FG003|Period 2|Withdrawal by Subject|0
7422390|NCT01490450|11697603|FG000|Period 2|Lost to Follow-up|0
7422391|NCT01490450|11697604|FG001|Period 2|Lost to Follow-up|0
7422392|NCT01490450|11697605|FG002|Period 2|Lost to Follow-up|0
7422393|NCT01490450|11697606|FG003|Period 2|Lost to Follow-up|2
7422394|NCT01490580|11697621|FG000|Overall Study|Parents withdrew consent|0
7422395|NCT01490580|11697622|FG001|Overall Study|Parents withdrew consent|2
7422396|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Adverse Event|0
7422397|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Adverse Event|0
7422398|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Adverse Event|2
7422399|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Adverse Event|4
7422400|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Adverse Event|4
7422401|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Adverse Event|0
7422402|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Adverse Event|0
7422403|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Adverse Event|0
7422404|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Adverse Event|0
7422405|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Adverse Event|0
7422406|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Adverse Event|0
7422407|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Adverse Event|0
7422408|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Adverse Event|0
7422409|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Adverse Event|0
7422410|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Adverse Event|0
7422411|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Adverse Event|0
7422412|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Adverse Event|0
7422413|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Adverse Event|0
7422414|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Adverse Event|0
7422415|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Adverse Event|0
7422416|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
7422417|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
7422418|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
7422419|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
7422420|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
7422421|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
7422422|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
7422423|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
7422424|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
7422425|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
7422426|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
7422427|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
7422428|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
7422429|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
7422430|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
7422431|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
7422432|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
7422433|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
7422434|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
7422435|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
7422436|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
7422437|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
7422438|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
7422439|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
7422440|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
7422441|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
7422442|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
7422443|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
7422444|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
7422445|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
7422446|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
7422447|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
7422448|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
7422449|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
7422450|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
7422451|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
7422452|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
7422453|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
7422454|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
7422455|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
7422456|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Physician Decision|0
7422457|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Physician Decision|1
7422458|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Physician Decision|0
7422459|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Physician Decision|1
7422460|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Physician Decision|0
7422461|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Physician Decision|0
7422462|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Physician Decision|0
7557209|NCT03096847|11921628|FG001|Overall Study|Physician Decision|2
7557210|NCT03096847|11921629|FG002|Overall Study|Physician Decision|8
7557211|NCT03096847|11921627|FG000|Overall Study|Withdrawal by Subject|24
7557212|NCT03096847|11921628|FG001|Overall Study|Withdrawal by Subject|1
7557213|NCT03096847|11921629|FG002|Overall Study|Withdrawal by Subject|12
7557214|NCT03096847|11921627|FG000|Overall Study|Adverse Event|72
7557215|NCT03096847|11921628|FG001|Overall Study|Adverse Event|6
7557216|NCT03096847|11921629|FG002|Overall Study|Adverse Event|28
7557217|NCT03096847|11921627|FG000|Overall Study|Progressive disease|97
7422463|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Physician Decision|0
7422464|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Physician Decision|0
7422465|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Physician Decision|0
7422466|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Physician Decision|0
7422467|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Physician Decision|0
7422468|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Physician Decision|0
7422469|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Physician Decision|0
7422470|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Physician Decision|0
7422471|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Physician Decision|0
7422472|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Physician Decision|0
7422473|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Physician Decision|0
7422474|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Physician Decision|0
7422475|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Physician Decision|0
7422476|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
7422477|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
7422478|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
7422479|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
7422480|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
7531702|NCT02658175|11876681|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
7531703|NCT02658175|11876679|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
7422481|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
7422482|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
7422483|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
7422484|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
7422485|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
7422486|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
7422487|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
7422488|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
7422489|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
7422490|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
7422491|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
7422492|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
7422493|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
7422494|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
7422495|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
7422496|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
7422497|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
7422498|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422499|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
7422500|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
7422501|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422502|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422503|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422504|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422505|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422506|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422507|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422508|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422509|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422510|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422511|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422512|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422513|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422514|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422515|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
7422516|NCT01490632|11697637|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422517|NCT01490632|11697638|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422518|NCT01490632|11697639|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7531704|NCT02658175|11876680|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
7531705|NCT02658175|11876681|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
7557218|NCT03096847|11921628|FG001|Overall Study|Progressive disease|10
7422519|NCT01490632|11697640|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422520|NCT01490632|11697641|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
7422521|NCT01490632|11697642|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422522|NCT01490632|11697643|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422523|NCT01490632|11697644|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422524|NCT01490632|11697645|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422525|NCT01490632|11697646|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422526|NCT01490632|11697647|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422527|NCT01490632|11697648|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422528|NCT01490632|11697649|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422529|NCT01490632|11697650|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422530|NCT01490632|11697651|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422531|NCT01490632|11697652|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422532|NCT01490632|11697653|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422533|NCT01490632|11697654|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422534|NCT01490632|11697655|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422535|NCT01490632|11697656|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
7422536|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
7422537|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
7422538|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
7422539|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
7422540|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
7422541|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
7422542|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
7422543|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
7422544|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
7422545|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
7422546|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
7422547|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
7422548|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
7422549|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
7422550|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
7422551|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
7422552|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
7422553|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
7422554|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
7422555|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
7422556|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422557|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422558|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422559|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422560|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422561|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422562|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7422563|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422564|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7422565|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
7422566|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
7422567|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422568|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422569|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422570|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422571|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422572|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422573|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422574|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422575|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
7422576|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422577|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422578|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422579|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422580|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422581|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422582|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
7422583|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422584|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422585|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
7422586|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422587|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422588|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422589|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422590|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422591|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422592|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422593|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422594|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422595|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
7422596|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
7422597|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
7422598|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
7422599|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
7422600|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
7422601|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
7422602|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
7422603|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
7422604|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
7422605|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
7422606|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
7422607|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
7422608|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
7422609|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
7422610|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
7422611|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
7422612|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
7422613|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
7422614|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
7422615|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
7422616|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422617|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422618|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422619|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422620|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422621|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
7557219|NCT03096847|11921629|FG002|Overall Study|Progressive disease|78
7557220|NCT03096847|11921627|FG000|Overall Study|Non-compliance with study medication|1
7557221|NCT03096847|11921628|FG001|Overall Study|Non-compliance with study medication|0
7557222|NCT03096847|11921629|FG002|Overall Study|Non-compliance with study medication|0
7557223|NCT03096847|11921627|FG000|Overall Study|New therapy for study indication|1
7557224|NCT03096847|11921628|FG001|Overall Study|New therapy for study indication|0
7422622|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422623|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422624|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422625|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422626|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422627|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422628|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422629|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422630|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422631|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422632|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422633|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422634|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422635|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
7422636|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422637|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422638|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422639|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422640|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422641|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422642|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7422643|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422644|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7422645|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422646|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
7422647|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
7422648|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422649|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422650|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422651|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422652|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422653|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422654|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422655|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
7422656|NCT01490632|11697637|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422657|NCT01490632|11697638|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422658|NCT01490632|11697639|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422659|NCT01490632|11697640|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422660|NCT01490632|11697641|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422661|NCT01490632|11697642|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
7422662|NCT01490632|11697643|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7422663|NCT01490632|11697644|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
7422664|NCT01490632|11697645|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
7422665|NCT01490632|11697646|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
7422666|NCT01490632|11697647|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
7327776|NCT00791700|11560449|FG000|Overall Study|Adverse Event|0
7327777|NCT00791700|11560450|FG001|Overall Study|Adverse Event|0
7327778|NCT00791700|11560451|FG002|Overall Study|Adverse Event|1
7327779|NCT00791700|11560452|FG003|Overall Study|Adverse Event|1
7327780|NCT00791765|11560475|FG000|Weeks 1 to 12|Adverse Event|0
7327781|NCT00791765|11560476|FG001|Weeks 1 to 12|Adverse Event|1
7327782|NCT00791765|11560475|FG000|Weeks 1 to 12|Lost to Follow-up|1
7327783|NCT00791765|11560476|FG001|Weeks 1 to 12|Lost to Follow-up|0
7327784|NCT00791765|11560475|FG000|Weeks 1 to 12|Withdrawal by Subject|3
7327785|NCT00791765|11560476|FG001|Weeks 1 to 12|Withdrawal by Subject|0
7327786|NCT00791765|11560475|FG000|Weeks 1 to 12|Physician Decision|1
7327787|NCT00791765|11560476|FG001|Weeks 1 to 12|Physician Decision|0
7327788|NCT00791765|11560475|FG000|Weeks 1 to 12|Disease progression|3
7327789|NCT00791765|11560476|FG001|Weeks 1 to 12|Disease progression|0
7327790|NCT00791765|11560475|FG000|Weeks 1 to 12|Ineligibility determined|0
7327791|NCT00791765|11560476|FG001|Weeks 1 to 12|Ineligibility determined|3
7327792|NCT00791765|11560475|FG000|Weeks 13 to 24|Protocol deviation|2
7327793|NCT00791765|11560476|FG001|Weeks 13 to 24|Protocol deviation|0
7327794|NCT00791765|11560475|FG000|Weeks 13 to 24|Adverse Event|0
7327795|NCT00791765|11560476|FG001|Weeks 13 to 24|Adverse Event|3
7327796|NCT00791765|11560475|FG000|Weeks 13 to 24|Withdrawal by Subject|2
7327797|NCT00791765|11560476|FG001|Weeks 13 to 24|Withdrawal by Subject|1
7327798|NCT00791765|11560475|FG000|Weeks 13 to 24|Disease progression|0
7327799|NCT00791765|11560476|FG001|Weeks 13 to 24|Disease progression|1
7327800|NCT00791765|11560475|FG000|Weeks 13 to 24|Lost to Follow-up|1
7327801|NCT00791765|11560476|FG001|Weeks 13 to 24|Lost to Follow-up|2
7327802|NCT00791765|11560475|FG000|Weeks 13 to 24|Other|0
7327803|NCT00791765|11560476|FG001|Weeks 13 to 24|Other|1
7327804|NCT00791778|11560484|FG000|Double-blind Treatment|Adverse Event|49
7327805|NCT00791778|11560485|FG001|Double-blind Treatment|Adverse Event|9
7327806|NCT00791778|11560484|FG000|Double-blind Treatment|Physician Decision|6
7327807|NCT00791778|11560485|FG001|Double-blind Treatment|Physician Decision|26
7327808|NCT00791778|11560484|FG000|Double-blind Treatment|Protocol Violation|0
7327809|NCT00791778|11560485|FG001|Double-blind Treatment|Protocol Violation|4
7327810|NCT00791778|11560484|FG000|Double-blind Treatment|Withdrawal by Subject|20
7327811|NCT00791778|11560485|FG001|Double-blind Treatment|Withdrawal by Subject|9
7327812|NCT00791778|11560484|FG000|Double-blind Treatment|Non-compliant with study medication|2
7422667|NCT01490632|11697648|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
7422668|NCT01490632|11697649|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422669|NCT01490632|11697650|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422670|NCT01490632|11697651|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422671|NCT01490632|11697652|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422672|NCT01490632|11697653|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422673|NCT01490632|11697654|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422674|NCT01490632|11697655|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422675|NCT01490632|11697656|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
7422676|NCT01490632|11697637|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
7422677|NCT01490632|11697638|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
7422678|NCT01490632|11697639|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
7422679|NCT01490632|11697640|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
7422680|NCT01490632|11697641|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
7422681|NCT01490632|11697642|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
7422682|NCT01490632|11697643|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
7422683|NCT01490632|11697644|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
7422684|NCT01490632|11697645|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
7327813|NCT00791778|11560485|FG001|Double-blind Treatment|Non-compliant with study medication|0
7422685|NCT01490632|11697646|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
7422686|NCT01490632|11697647|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
7422687|NCT01490632|11697648|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
7422688|NCT01490632|11697649|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
7422689|NCT01490632|11697650|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
7422690|NCT01490632|11697651|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
7422691|NCT01490632|11697652|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
7422692|NCT01490632|11697653|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
7422693|NCT01490632|11697654|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
7422694|NCT01490632|11697655|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
7422695|NCT01490632|11697656|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
7422696|NCT01490632|11697637|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422697|NCT01490632|11697638|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422698|NCT01490632|11697639|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422699|NCT01490632|11697640|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422700|NCT01490632|11697641|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422701|NCT01490632|11697642|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422702|NCT01490632|11697643|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422703|NCT01490632|11697644|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422704|NCT01490632|11697645|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422705|NCT01490632|11697646|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422706|NCT01490632|11697647|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422707|NCT01490632|11697648|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422708|NCT01490632|11697649|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422709|NCT01490632|11697650|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
7422710|NCT01490632|11697651|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422711|NCT01490632|11697652|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422712|NCT01490632|11697653|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422713|NCT01490632|11697654|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422714|NCT01490632|11697655|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422715|NCT01490632|11697656|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
7422716|NCT01490632|11697637|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422717|NCT01490632|11697638|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422718|NCT01490632|11697639|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422719|NCT01490632|11697640|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422720|NCT01490632|11697641|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422721|NCT01490632|11697642|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422722|NCT01490632|11697643|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7531706|NCT02658175|11876679|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
7531707|NCT02658175|11876680|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
7531708|NCT02658175|11876681|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
7531709|NCT02658175|11876679|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
7557225|NCT03096847|11921629|FG002|Overall Study|New therapy for study indication|1
7557226|NCT03097029|11921656|FG000|Overall Study|Withdrawal by Subject|1
7557227|NCT03097133|11921662|FG000|Overall Study|Lost to Follow-up|3
7557228|NCT03097133|11921663|FG001|Overall Study|Lost to Follow-up|2
7557229|NCT03097133|11921662|FG000|Overall Study|Withdrawal by Subject|2
7557230|NCT03097133|11921663|FG001|Overall Study|Withdrawal by Subject|5
7422723|NCT01490632|11697644|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422724|NCT01490632|11697645|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422725|NCT01490632|11697646|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422726|NCT01490632|11697647|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422727|NCT01490632|11697648|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422728|NCT01490632|11697649|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422729|NCT01490632|11697650|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422730|NCT01490632|11697651|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
7422731|NCT01490632|11697652|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
7422732|NCT01490632|11697653|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7531710|NCT02658175|11876680|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7531711|NCT02658175|11876681|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
7531712|NCT02658175|11876679|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
7531713|NCT02658175|11876680|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
7531714|NCT02658175|11876681|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
7531715|NCT02658175|11876679|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
7531716|NCT02658175|11876680|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7557231|NCT03097133|11921662|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
7557232|NCT03097133|11921663|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
7557233|NCT03097133|11921662|FG000|Overall Study|Other|3
7422733|NCT01490632|11697654|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422734|NCT01490632|11697655|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422735|NCT01490632|11697656|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
7422736|NCT01490632|11697637|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422737|NCT01490632|11697638|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422738|NCT01490632|11697639|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422739|NCT01490632|11697640|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422740|NCT01490632|11697641|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422741|NCT01490632|11697642|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422742|NCT01490632|11697643|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422743|NCT01490632|11697644|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422744|NCT01490632|11697645|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422745|NCT01490632|11697646|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422746|NCT01490632|11697647|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422747|NCT01490632|11697648|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422748|NCT01490632|11697649|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
7422749|NCT01490632|11697650|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
7422750|NCT01490632|11697651|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
7422751|NCT01490632|11697652|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
7422752|NCT01490632|11697653|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422753|NCT01490632|11697654|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422754|NCT01490632|11697655|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422755|NCT01490632|11697656|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
7422756|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Adverse Event|0
7422757|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Adverse Event|0
7422758|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Adverse Event|0
7422759|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Adverse Event|0
7422760|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Adverse Event|0
7422761|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Adverse Event|0
7422762|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Adverse Event|0
7422763|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Adverse Event|0
7422764|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Adverse Event|0
7422765|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Adverse Event|0
7422766|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Adverse Event|0
7422767|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Adverse Event|0
7422768|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Adverse Event|0
7422769|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Adverse Event|0
7422770|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Adverse Event|0
7422771|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Adverse Event|0
7422772|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Adverse Event|0
7422773|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Adverse Event|1
7422774|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Adverse Event|1
7422775|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Adverse Event|3
7422776|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Death|0
7422777|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Death|0
7422778|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Death|0
7422779|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Death|0
7422780|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Death|0
7422781|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Death|0
7422782|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Death|0
7422783|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Death|0
7422784|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Death|0
7422785|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Death|0
7422786|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Death|0
7422787|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Death|0
7422788|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Death|0
7422789|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Death|0
7422790|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Death|0
7422791|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Death|0
7422792|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Death|0
7422793|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Death|0
7422794|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Death|1
7422795|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Death|0
7422796|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
7422797|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
7422798|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
7422799|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
7422800|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
7422801|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
7422802|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
7422803|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
7422804|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
7422805|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
7422806|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
7422807|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
7422808|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
7422809|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
7422810|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
7422811|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
7422812|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
7422813|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
7422814|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
7422815|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
7422816|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
7422817|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
7422818|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
7422819|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
7422820|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
7422821|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
7422822|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
7422823|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
7422824|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
7422825|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
7422826|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
7422827|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
7422828|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
7422829|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
7422830|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
7422831|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
7422832|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
7422833|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
7422834|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
7422835|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
7422836|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Physician Decision|0
7422837|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Physician Decision|0
7422838|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Physician Decision|0
7422839|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Physician Decision|0
7422840|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Physician Decision|0
7422841|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Physician Decision|0
7422842|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Physician Decision|0
7422843|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Physician Decision|0
7422844|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Physician Decision|0
7422845|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Physician Decision|0
7422846|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Physician Decision|0
7422847|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Physician Decision|0
7422848|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Physician Decision|0
7423007|NCT01492088|11698025|FG002|Overall Study|Withdrawal by Patient|0
7422849|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Physician Decision|0
7422850|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Physician Decision|0
7422851|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Physician Decision|0
7422852|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Physician Decision|0
7422853|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Physician Decision|0
7422854|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Physician Decision|1
7422855|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Physician Decision|1
7422856|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Protocol Violation|0
7422857|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Protocol Violation|0
7422858|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Protocol Violation|0
7422859|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Protocol Violation|0
7422860|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Protocol Violation|0
7422861|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Protocol Violation|0
7422862|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Protocol Violation|0
7422863|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Protocol Violation|0
7422864|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Protocol Violation|0
7422865|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Protocol Violation|0
7422866|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Protocol Violation|0
7422867|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Protocol Violation|0
7422868|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Protocol Violation|0
7422869|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Protocol Violation|0
7422870|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Protocol Violation|0
7422871|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Protocol Violation|0
7422872|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Protocol Violation|0
7422873|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Protocol Violation|0
7531717|NCT02658175|11876681|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
7422874|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Protocol Violation|1
7422875|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Protocol Violation|0
7422876|NCT01490632|11697637|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422877|NCT01490632|11697638|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422878|NCT01490632|11697639|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422879|NCT01490632|11697640|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422880|NCT01490632|11697641|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422881|NCT01490632|11697642|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422882|NCT01490632|11697643|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422883|NCT01490632|11697644|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422884|NCT01490632|11697645|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422885|NCT01490632|11697646|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422886|NCT01490632|11697647|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422887|NCT01490632|11697648|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422888|NCT01490632|11697649|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422889|NCT01490632|11697650|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422890|NCT01490632|11697651|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422891|NCT01490632|11697652|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422892|NCT01490632|11697653|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
7422893|NCT01490632|11697654|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
7422894|NCT01490632|11697655|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
7422895|NCT01490632|11697656|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
7422896|NCT01490697|11697705|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
7422897|NCT01490697|11697706|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
7422898|NCT01490814|11697731|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
7422899|NCT01490814|11697732|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
7422900|NCT01490814|11697731|FG000|Overall Study|Physician Decision|1
7422901|NCT01490814|11697732|FG001|Overall Study|Physician Decision|0
7422902|NCT01490814|11697731|FG000|Overall Study|Withdrawal by Subject|0
7422903|NCT01490814|11697732|FG001|Overall Study|Withdrawal by Subject|5
7422904|NCT01490840|11697740|FG000|Phase 1|Lost to Follow-up|1
7422905|NCT01490840|11697741|FG001|Phase 1|Lost to Follow-up|0
7422906|NCT01490840|11697740|FG000|Phase 1|Adverse Event|2
7422907|NCT01490840|11697741|FG001|Phase 1|Adverse Event|1
7422908|NCT01490840|11697740|FG000|Phase 1|Withdrawal by Subject|6
7422909|NCT01490840|11697741|FG001|Phase 1|Withdrawal by Subject|5
7422910|NCT01490840|11697740|FG000|Phase 1|Visit 6a omitted|1
7422911|NCT01490840|11697741|FG001|Phase 1|Visit 6a omitted|0
7422912|NCT01490840|11697740|FG000|Phase 2|Withdrawal by Subject|4
7422913|NCT01490840|11697741|FG001|Phase 2|Withdrawal by Subject|3
7422914|NCT01490840|11697740|FG000|Phase 2|Permanent interruption of fingolimod|0
7422915|NCT01490840|11697741|FG001|Phase 2|Permanent interruption of fingolimod|1
7422916|NCT01490840|11697740|FG000|Phase 2|Lost to Follow-up|1
7422917|NCT01490840|11697741|FG001|Phase 2|Lost to Follow-up|1
7422918|NCT01490840|11697740|FG000|Phase 2|Adverse Event|1
7422919|NCT01490840|11697741|FG001|Phase 2|Adverse Event|1
7422920|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
7422921|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
7422922|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
7422923|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
7422924|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
7422925|NCT01490866|11697747|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
7422926|NCT01490866|11697747|FG000|Axitinib Maintenance Therapy|Disease Progression|30
7422927|NCT01490866|11697747|FG000|Axitinib Maintenance Therapy|Adverse Event|12
7422928|NCT01490866|11697747|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
7422929|NCT01490866|11697747|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
7422930|NCT01490866|11697747|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
7422931|NCT01490918|11697761|FG000|Overall Study|Lost to Follow-up|2
7422932|NCT01490918|11697762|FG001|Overall Study|Lost to Follow-up|1
7422933|NCT01490918|11697763|FG002|Overall Study|Lost to Follow-up|0
7422934|NCT01490918|11697761|FG000|Overall Study|Withdrawal by Subject|7
7422935|NCT01490918|11697762|FG001|Overall Study|Withdrawal by Subject|8
7422936|NCT01490918|11697763|FG002|Overall Study|Withdrawal by Subject|3
7422937|NCT01490918|11697761|FG000|Overall Study|Adverse Event|0
7422938|NCT01490918|11697762|FG001|Overall Study|Adverse Event|0
7422939|NCT01490918|11697763|FG002|Overall Study|Adverse Event|1
7422940|NCT01490918|11697761|FG000|Overall Study|other cause|4
7422941|NCT01490918|11697762|FG001|Overall Study|other cause|5
7422942|NCT01490918|11697763|FG002|Overall Study|other cause|8
7422943|NCT01491035|11697800|FG000|Overall Study|Lost to Follow-up|0
7422944|NCT01491035|11697801|FG001|Overall Study|Lost to Follow-up|0
7422945|NCT01491035|11697802|FG002|Overall Study|Lost to Follow-up|0
7422946|NCT01491035|11697803|FG003|Overall Study|Lost to Follow-up|0
7422947|NCT01491035|11697804|FG004|Overall Study|Lost to Follow-up|1
7422948|NCT01491035|11697805|FG005|Overall Study|Lost to Follow-up|0
7422949|NCT01491035|11697806|FG006|Overall Study|Lost to Follow-up|0
7422950|NCT01491035|11697807|FG007|Overall Study|Lost to Follow-up|0
7422951|NCT01491178|11697848|FG000|Overall Study|Adverse Event|1016
7422952|NCT01491178|11697848|FG000|Overall Study|Improvement of NVAF|210
7422953|NCT01491178|11697848|FG000|Overall Study|To conduct invasive treatment|59
7422954|NCT01491178|11697848|FG000|Overall Study|Lost to follow-up (unknown reason)|287
7422955|NCT01491178|11697848|FG000|Overall Study|Lost to follow-up (changing hospital)|545
7422956|NCT01491178|11697848|FG000|Overall Study|To take a contraindication|20
7422957|NCT01491178|11697848|FG000|Overall Study|Other than specified above|657
7422958|NCT01491607|11697865|FG000|Overall Study|Lost to Follow-up|7
7422959|NCT01491607|11697865|FG000|Overall Study|Withdrawal by Subject|3
7466639|NCT01893346|11766510|FG000|Overall Study|Lost to Follow-up|0
7466640|NCT01893346|11766511|FG001|Overall Study|Lost to Follow-up|1
7466641|NCT01893346|11766512|FG002|Overall Study|Lost to Follow-up|0
7422960|NCT01491672|11697938|FG000|Overall Study|Lost to Follow-up|0
7422961|NCT01491672|11697939|FG001|Overall Study|Lost to Follow-up|4
7422962|NCT01491672|11697940|FG002|Overall Study|Lost to Follow-up|1
7422963|NCT01491672|11697938|FG000|Overall Study|Withdrawal by Subject|6
7422964|NCT01491672|11697939|FG001|Overall Study|Withdrawal by Subject|7
7422965|NCT01491672|11697940|FG002|Overall Study|Withdrawal by Subject|0
7422966|NCT01491672|11697938|FG000|Overall Study|Adverse Event|8
7422967|NCT01491672|11697939|FG001|Overall Study|Adverse Event|10
7422968|NCT01491672|11697940|FG002|Overall Study|Adverse Event|4
7422969|NCT01491672|11697938|FG000|Overall Study|Disease progression|42
7422970|NCT01491672|11697939|FG001|Overall Study|Disease progression|34
7422971|NCT01491672|11697940|FG002|Overall Study|Disease progression|6
7422972|NCT01491672|11697938|FG000|Overall Study|Protocol deviation|0
7422973|NCT01491672|11697939|FG001|Overall Study|Protocol deviation|1
7422974|NCT01491672|11697940|FG002|Overall Study|Protocol deviation|0
7422975|NCT01491672|11697938|FG000|Overall Study|Death|0
7422976|NCT01491672|11697939|FG001|Overall Study|Death|4
7422977|NCT01491672|11697940|FG002|Overall Study|Death|0
7422978|NCT01491737|11697952|FG000|Overall Study|Withdrawal by Subject|20
7422979|NCT01491737|11697953|FG001|Overall Study|Withdrawal by Subject|17
7422980|NCT01491737|11697952|FG000|Overall Study|Lost to Follow-up|2
7422981|NCT01491737|11697953|FG001|Overall Study|Lost to Follow-up|10
7422982|NCT01491737|11697952|FG000|Overall Study|Death|63
7422983|NCT01491737|11697953|FG001|Overall Study|Death|57
7422984|NCT01491737|11697952|FG000|Overall Study|Study Termination by Sponsor|36
7422985|NCT01491737|11697953|FG001|Overall Study|Study Termination by Sponsor|36
7422986|NCT01491737|11697952|FG000|Overall Study|Reason Not Specified|8
7422987|NCT01491737|11697953|FG001|Overall Study|Reason Not Specified|9
7422988|NCT01491802|11697959|FG000|Overall Study|Adverse Event|1
7422989|NCT01491802|11697960|FG001|Overall Study|Adverse Event|1
7422990|NCT01491802|11697959|FG000|Overall Study|Withdrawal by Subject|0
7422991|NCT01491802|11697960|FG001|Overall Study|Withdrawal by Subject|1
7422992|NCT01491841|11697967|FG000|Overall Study|Screen Failure|10
7422993|NCT01491841|11697967|FG000|Overall Study|Withdrawal by Subject|1
7422994|NCT01491854|11697979|FG000|Overall Study|mainly due to premature termination|93
7422995|NCT01491854|11697979|FG000|Overall Study|Death|1
7422996|NCT01491854|11697979|FG000|Overall Study|Withdrawal by Subject|3
7422997|NCT01491854|11697979|FG000|Overall Study|Lost to Follow-up|33
7422998|NCT01491919|11697986|FG000|Overall Study|Insufficient PK sampling|1
7422999|NCT01491919|11697987|FG001|Overall Study|Insufficient PK sampling|2
7423000|NCT01491919|11697988|FG002|Overall Study|Insufficient PK sampling|1
7423001|NCT01491945|11697998|FG000|Overall Study|Death|30
7423002|NCT01491945|11697998|FG000|Overall Study|Withdrwan/LTF|16
7423003|NCT01491945|11697998|FG000|Overall Study|Conversion|4
7423004|NCT01491945|11697998|FG000|Overall Study|Missed Visit|1
7423005|NCT01492088|11698023|FG000|Overall Study|Withdrawal by Patient|0
7423006|NCT01492088|11698024|FG001|Overall Study|Withdrawal by Patient|2
7423008|NCT01492088|11698023|FG000|Overall Study|Death|1
7423009|NCT01492088|11698024|FG001|Overall Study|Death|6
7423010|NCT01492088|11698025|FG002|Overall Study|Death|2
7423011|NCT01492088|11698023|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
7423012|NCT01492088|11698024|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
7423013|NCT01492088|11698025|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
7423014|NCT01492088|11698023|FG000|Overall Study|Alive at Last Follow-up|0
7423015|NCT01492088|11698024|FG001|Overall Study|Alive at Last Follow-up|6
7423016|NCT01492088|11698025|FG002|Overall Study|Alive at Last Follow-up|11
7423017|NCT01492101|11698038|FG000|Overall Study|Death|323
7423018|NCT01492101|11698039|FG001|Overall Study|Death|322
7423019|NCT01492101|11698038|FG000|Overall Study|Withdrawal by Subject|14
7423020|NCT01492101|11698039|FG001|Overall Study|Withdrawal by Subject|18
7423021|NCT01492101|11698038|FG000|Overall Study|Lost to Follow-up|0
7423022|NCT01492101|11698039|FG001|Overall Study|Lost to Follow-up|2
7423023|NCT01492400|11698056|FG000|Overall Study|Miscellaneous Reasons|2
7423024|NCT01492400|11698057|FG001|Overall Study|Miscellaneous Reasons|3
7423025|NCT01492400|11698056|FG000|Overall Study|Personal Reasons|0
7423026|NCT01492400|11698057|FG001|Overall Study|Personal Reasons|5
7423027|NCT01492400|11698056|FG000|Overall Study|Lost to Follow-up|3
7423028|NCT01492400|11698057|FG001|Overall Study|Lost to Follow-up|1
7423029|NCT01492400|11698056|FG000|Overall Study|Pregnancy|0
7423030|NCT01492400|11698057|FG001|Overall Study|Pregnancy|1
7423031|NCT01492400|11698056|FG000|Overall Study|Lack of Efficacy|1
7423032|NCT01492400|11698057|FG001|Overall Study|Lack of Efficacy|1
7423033|NCT01492400|11698056|FG000|Overall Study|Adverse Event|10
7423034|NCT01492400|11698057|FG001|Overall Study|Adverse Event|5
7423035|NCT01492426|11698065|FG000|Treatment|Death|0
7423036|NCT01492426|11698066|FG001|Treatment|Death|1
7423037|NCT01492426|11698065|FG000|Treatment|Other|1
7423038|NCT01492426|11698066|FG001|Treatment|Other|0
7423039|NCT01492426|11698065|FG000|Treatment|Adverse Event|25
7423040|NCT01492426|11698066|FG001|Treatment|Adverse Event|25
7423041|NCT01492426|11698065|FG000|Treatment|Lack of Efficacy|38
7423042|NCT01492426|11698066|FG001|Treatment|Lack of Efficacy|5
7423043|NCT01492426|11698065|FG000|Treatment|Participant withdrew consent|1
7423044|NCT01492426|11698066|FG001|Treatment|Participant withdrew consent|2
7423045|NCT01492426|11698065|FG000|Treatment|Poor compliance/noncompliance|1
7423046|NCT01492426|11698066|FG001|Treatment|Poor compliance/noncompliance|0
7423047|NCT01492426|11698065|FG000|Treatment|Subject requested discontinue study drug|7
7423048|NCT01492426|11698066|FG001|Treatment|Subject requested discontinue study drug|3
7423049|NCT01492426|11698065|FG000|Treatment|Lost to Follow-up|9
7423050|NCT01492426|11698066|FG001|Treatment|Lost to Follow-up|4
7423051|NCT01492426|11698065|FG000|Treatment|Participant does not meet study criteria|1
7423052|NCT01492426|11698066|FG001|Treatment|Participant does not meet study criteria|0
7423053|NCT01492426|11698065|FG000|Follow-Up|Protocol Requires no Follow-Up|2
7423054|NCT01492426|11698066|FG001|Follow-Up|Protocol Requires no Follow-Up|1
7423055|NCT01492426|11698065|FG000|Follow-Up|Death|1
7423056|NCT01492426|11698066|FG001|Follow-Up|Death|0
7423057|NCT01492426|11698065|FG000|Follow-Up|Other|4
7423058|NCT01492426|11698066|FG001|Follow-Up|Other|2
7423059|NCT01492426|11698065|FG000|Follow-Up|Participant Withdrew Consent|6
7423060|NCT01492426|11698066|FG001|Follow-Up|Participant Withdrew Consent|1
7423061|NCT01492426|11698065|FG000|Follow-Up|Lost to Follow-up|12
7423062|NCT01492426|11698066|FG001|Follow-Up|Lost to Follow-up|6
7423063|NCT01492439|11698078|FG000|Overall Study|Withdrew from RTE|4
7423064|NCT01492439|11698079|FG001|Overall Study|Withdrew from RTE|9
7423065|NCT01492686|11698117|FG000|Double-blind Phase|Adverse Event|0
7423066|NCT01492686|11698118|FG001|Double-blind Phase|Adverse Event|2
7423067|NCT01492686|11698117|FG000|Double-blind Phase|Physician Decision|0
7423068|NCT01492686|11698118|FG001|Double-blind Phase|Physician Decision|1
7423069|NCT01492686|11698117|FG000|Double-blind Phase|Withdrawal by Subject|0
7423070|NCT01492686|11698118|FG001|Double-blind Phase|Withdrawal by Subject|2
7423071|NCT01492686|11698117|FG000|Double-blind Phase|Due to a discontinuation criterion|2
7423072|NCT01492686|11698118|FG001|Double-blind Phase|Due to a discontinuation criterion|3
7423073|NCT01492686|11698117|FG000|Open-label Phase|Adverse Event|1
7423074|NCT01492686|11698118|FG001|Open-label Phase|Adverse Event|2
7423075|NCT01492686|11698117|FG000|Open-label Phase|Physician Decision|1
7423076|NCT01492686|11698118|FG001|Open-label Phase|Physician Decision|0
7423077|NCT01492686|11698117|FG000|Open-label Phase|Withdrawal by Subject|6
7423078|NCT01492686|11698118|FG001|Open-label Phase|Withdrawal by Subject|7
7423079|NCT01492686|11698117|FG000|Open-label Phase|Due to a discontinuation criterion|4
7423080|NCT01492686|11698118|FG001|Open-label Phase|Due to a discontinuation criterion|9
7423081|NCT01493089|11698146|FG000|Overall Study|Protocol Violation|2
7423082|NCT01493089|11698147|FG001|Overall Study|Protocol Violation|2
7423083|NCT01493089|11698146|FG000|Overall Study|Withdrawal by Subject|1
7423084|NCT01493089|11698147|FG001|Overall Study|Withdrawal by Subject|0
7423085|NCT01493089|11698146|FG000|Overall Study|Physician Decision|0
7423086|NCT01493089|11698147|FG001|Overall Study|Physician Decision|1
7423087|NCT01493284|11698168|FG000|Overall Study|Death|29
7423088|NCT01493284|11698168|FG000|Overall Study|Withdrawal by Subject|32
7423089|NCT01493414|11698172|FG000|Overall Study|Adverse Event|405
7423090|NCT01493414|11698172|FG000|Overall Study|Disease progression|204
7423091|NCT01493414|11698172|FG000|Overall Study|Death|101
7423092|NCT01493414|11698172|FG000|Overall Study|Physician Decision|93
7423093|NCT01493414|11698172|FG000|Overall Study|Withdrawal by Subject|79
7423094|NCT01493414|11698172|FG000|Overall Study|Protocol deviation|27
7423095|NCT01493414|11698172|FG000|Overall Study|Administrative problems|25
7423096|NCT01493414|11698172|FG000|Overall Study|Lost to Follow-up|16
7423097|NCT01493427|11698180|FG000|Overall Study|Adverse Event|10
7423098|NCT01493427|11698180|FG000|Overall Study|Personal Reasons|4
7423099|NCT01493427|11698180|FG000|Overall Study|Lost to Follow-up|2
7423100|NCT01493427|11698180|FG000|Overall Study|Inability to Follow Instructions|2
7423101|NCT01493427|11698180|FG000|Overall Study|Other|2
7423102|NCT01493531|11698187|FG000|Overall Study|Adverse Event|4
7423103|NCT01493531|11698188|FG001|Overall Study|Adverse Event|12
7423104|NCT01493531|11698189|FG002|Overall Study|Adverse Event|9
7423105|NCT01493531|11698187|FG000|Overall Study|Gout flare|3
7423106|NCT01493531|11698188|FG001|Overall Study|Gout flare|0
7423107|NCT01493531|11698189|FG002|Overall Study|Gout flare|2
7423108|NCT01493531|11698187|FG000|Overall Study|Protocol Violation|8
7423109|NCT01493531|11698188|FG001|Overall Study|Protocol Violation|15
7423110|NCT01493531|11698189|FG002|Overall Study|Protocol Violation|12
7423111|NCT01493531|11698187|FG000|Overall Study|Sponsor terminated study|5
7423112|NCT01493531|11698188|FG001|Overall Study|Sponsor terminated study|2
7423113|NCT01493531|11698189|FG002|Overall Study|Sponsor terminated study|3
7423114|NCT01493531|11698187|FG000|Overall Study|Lost to Follow-up|5
7423115|NCT01493531|11698188|FG001|Overall Study|Lost to Follow-up|7
7423116|NCT01493531|11698189|FG002|Overall Study|Lost to Follow-up|11
7423117|NCT01493531|11698187|FG000|Overall Study|Withdrawal by Subject|16
7423118|NCT01493531|11698188|FG001|Overall Study|Withdrawal by Subject|13
7423119|NCT01493531|11698189|FG002|Overall Study|Withdrawal by Subject|11
7423120|NCT01493531|11698187|FG000|Overall Study|Death|0
7423121|NCT01493531|11698188|FG001|Overall Study|Death|1
7423122|NCT01493531|11698189|FG002|Overall Study|Death|0
7423123|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7423124|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
7423125|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
7423126|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7423127|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
7423128|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
7423129|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Other adverse event|0
7423130|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Other adverse event|0
7423131|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Other adverse event|54
7423132|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Protocol Violation|0
7423133|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Protocol Violation|0
7423134|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Protocol Violation|1
7423135|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
7423136|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
7423137|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
7423138|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
7423139|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
7423140|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
7423141|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Early termination|0
7423142|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Early termination|0
7423143|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Early termination|34
7423144|NCT01493557|11698200|FG000|Not Randomized to Management Strategies|Other than stated above|0
7423145|NCT01493557|11698201|FG001|Not Randomized to Management Strategies|Other than stated above|0
7423146|NCT01493557|11698202|FG002|Not Randomized to Management Strategies|Other than stated above|21
7423147|NCT01493557|11698200|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
7423148|NCT01493557|11698201|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
7423149|NCT01493557|11698202|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
7423150|NCT01493557|11698200|FG000|Randomized to Management Strategies|Other adverse event|8
7423151|NCT01493557|11698201|FG001|Randomized to Management Strategies|Other adverse event|5
7423152|NCT01493557|11698202|FG002|Randomized to Management Strategies|Other adverse event|0
7423153|NCT01493557|11698200|FG000|Randomized to Management Strategies|Protocol Violation|3
7423154|NCT01493557|11698201|FG001|Randomized to Management Strategies|Protocol Violation|0
7423155|NCT01493557|11698202|FG002|Randomized to Management Strategies|Protocol Violation|0
7423156|NCT01493557|11698200|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
7423157|NCT01493557|11698201|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
7423158|NCT01493557|11698202|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
7423159|NCT01493557|11698200|FG000|Randomized to Management Strategies|Other than stated above|1
7423160|NCT01493557|11698201|FG001|Randomized to Management Strategies|Other than stated above|3
7423161|NCT01493557|11698202|FG002|Randomized to Management Strategies|Other than stated above|0
7423162|NCT01493557|11698200|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
7423163|NCT01493557|11698201|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
7423164|NCT01493557|11698202|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
7423165|NCT01493557|11698200|FG000|Adding the Second Strategy|Other adverse event|1
7423166|NCT01493557|11698201|FG001|Adding the Second Strategy|Other adverse event|2
7423167|NCT01493557|11698202|FG002|Adding the Second Strategy|Other adverse event|0
7423168|NCT01493557|11698200|FG000|Adding the Second Strategy|Withdrawal by Subject|0
7423169|NCT01493557|11698201|FG001|Adding the Second Strategy|Withdrawal by Subject|1
7423170|NCT01493557|11698202|FG002|Adding the Second Strategy|Withdrawal by Subject|0
7423171|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
7423172|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7423173|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7423174|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7423175|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
7423176|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7423177|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
7423178|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
7423179|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
7423180|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
7423181|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
7423182|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7423183|NCT01493687|11698238|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7423184|NCT01493687|11698239|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
7423185|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
7423186|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
7423187|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
7423188|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7423189|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7423190|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
7423191|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
7423192|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
7423193|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
7423194|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
7423195|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
7423196|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7423197|NCT01493687|11698238|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
7423198|NCT01493687|11698239|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
7423199|NCT01493687|11698238|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
7423200|NCT01493687|11698239|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
7423201|NCT01493778|11698251|FG000|Overall Study|Withdrawal by Subject|8
7423202|NCT01493960|11698278|FG000|Overall Study|Adverse Event|0
7423203|NCT01493960|11698279|FG001|Overall Study|Adverse Event|1
7423204|NCT01493960|11698278|FG000|Overall Study|Lack of Efficacy|15
7423205|NCT01493960|11698279|FG001|Overall Study|Lack of Efficacy|9
7423206|NCT01493960|11698278|FG000|Overall Study|Protocol Violation|3
7423207|NCT01493960|11698279|FG001|Overall Study|Protocol Violation|0
7423208|NCT01493960|11698278|FG000|Overall Study|Withdrawal by Subject|10
7423209|NCT01493960|11698279|FG001|Overall Study|Withdrawal by Subject|4
7423210|NCT01493960|11698278|FG000|Overall Study|Non-specified|4
7423211|NCT01493960|11698279|FG001|Overall Study|Non-specified|4
7423212|NCT01494038|11698287|FG000|Overall Study|Protocol Violation|1
7423213|NCT01494038|11698288|FG001|Overall Study|Protocol Violation|1
7423214|NCT01494038|11698287|FG000|Overall Study|Lost to Follow-up|18
7423215|NCT01494038|11698288|FG001|Overall Study|Lost to Follow-up|20
7423216|NCT01494038|11698287|FG000|Overall Study|Withdrawal by Subject|44
7423217|NCT01494038|11698288|FG001|Overall Study|Withdrawal by Subject|34
7423218|NCT01494038|11698287|FG000|Overall Study|Not able to get to clinic|21
7423219|NCT01494038|11698288|FG001|Overall Study|Not able to get to clinic|15
7423220|NCT01494038|11698287|FG000|Overall Study|Not willing to adhere to reqs|2
7423221|NCT01494038|11698288|FG001|Overall Study|Not willing to adhere to reqs|9
7423222|NCT01494038|11698287|FG000|Overall Study|Death|2
7423223|NCT01494038|11698288|FG001|Overall Study|Death|4
7327814|NCT00791778|11560484|FG000|Follow-up|Withdrawal by Subject|3
7327815|NCT00791778|11560485|FG001|Follow-up|Withdrawal by Subject|0
7327816|NCT00791778|11560484|FG000|Follow-up|Lost to Follow-up|2
7327817|NCT00791778|11560485|FG001|Follow-up|Lost to Follow-up|1
7423224|NCT01494298|11698320|FG000|Overall Study|Protocol Violation|2
7423225|NCT01494298|11698321|FG001|Overall Study|Protocol Violation|8
7423226|NCT01494350|11698329|FG000|Overall Study|Worsening of lesion|1
7423227|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
7423228|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
7423229|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
7423230|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
7423231|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
7423232|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
7423233|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
7423234|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
7423235|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7423236|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
7423237|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Other|1
7423238|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Other|1
7423239|NCT01494467|11698335|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
7423240|NCT01494467|11698336|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
7423241|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
7423242|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
7423243|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
7423244|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
7423245|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
7423246|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
7423247|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
7423248|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
7423249|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
7423250|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
7423251|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
7423252|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
7423253|NCT01494467|11698335|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
7423254|NCT01494467|11698336|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
7423255|NCT01494506|11698351|FG000|Overall Study|Lack of Efficacy|77
7423256|NCT01494506|11698352|FG001|Overall Study|Lack of Efficacy|83
7423257|NCT01494506|11698353|FG002|Overall Study|Lack of Efficacy|57
7423258|NCT01494506|11698351|FG000|Overall Study|Adverse Event|17
7423259|NCT01494506|11698352|FG001|Overall Study|Adverse Event|10
7423260|NCT01494506|11698353|FG002|Overall Study|Adverse Event|11
7423261|NCT01494506|11698351|FG000|Overall Study|Death|9
7423262|NCT01494506|11698352|FG001|Overall Study|Death|5
7423263|NCT01494506|11698353|FG002|Overall Study|Death|2
7423264|NCT01494506|11698351|FG000|Overall Study|Physician Decision|7
7423265|NCT01494506|11698352|FG001|Overall Study|Physician Decision|5
7423266|NCT01494506|11698353|FG002|Overall Study|Physician Decision|4
7423267|NCT01494506|11698351|FG000|Overall Study|Withdrawal by Subject|17
7423268|NCT01494506|11698352|FG001|Overall Study|Withdrawal by Subject|20
7423269|NCT01494506|11698353|FG002|Overall Study|Withdrawal by Subject|14
7423270|NCT01494506|11698351|FG000|Overall Study|Clinical Deterioration|21
7423271|NCT01494506|11698352|FG001|Overall Study|Clinical Deterioration|17
7423272|NCT01494506|11698353|FG002|Overall Study|Clinical Deterioration|13
7423273|NCT01494506|11698351|FG000|Overall Study|Sponsor Decision|0
7423274|NCT01494506|11698352|FG001|Overall Study|Sponsor Decision|0
7423275|NCT01494506|11698353|FG002|Overall Study|Sponsor Decision|1
7423276|NCT01494506|11698351|FG000|Overall Study|Other|0
7423277|NCT01494506|11698352|FG001|Overall Study|Other|3
7423278|NCT01494506|11698353|FG002|Overall Study|Other|1
7423279|NCT01494532|11698369|FG000|Overall Study|Adverse Event|4
7423280|NCT01494532|11698370|FG001|Overall Study|Adverse Event|1
7423281|NCT01494532|11698371|FG002|Overall Study|Adverse Event|8
7423282|NCT01494532|11698372|FG003|Overall Study|Adverse Event|6
7423283|NCT01494532|11698373|FG004|Overall Study|Adverse Event|5
7423284|NCT01494532|11698374|FG005|Overall Study|Adverse Event|0
7423285|NCT01494532|11698369|FG000|Overall Study|Lack of Efficacy|0
7423286|NCT01494532|11698370|FG001|Overall Study|Lack of Efficacy|0
7423287|NCT01494532|11698371|FG002|Overall Study|Lack of Efficacy|0
7423288|NCT01494532|11698372|FG003|Overall Study|Lack of Efficacy|0
7423289|NCT01494532|11698373|FG004|Overall Study|Lack of Efficacy|2
7423290|NCT01494532|11698374|FG005|Overall Study|Lack of Efficacy|0
7423291|NCT01494532|11698369|FG000|Overall Study|Protocol deviation|2
7423292|NCT01494532|11698370|FG001|Overall Study|Protocol deviation|1
7423293|NCT01494532|11698371|FG002|Overall Study|Protocol deviation|3
7423294|NCT01494532|11698372|FG003|Overall Study|Protocol deviation|2
7423295|NCT01494532|11698373|FG004|Overall Study|Protocol deviation|3
7423296|NCT01494532|11698374|FG005|Overall Study|Protocol deviation|0
7423297|NCT01494532|11698369|FG000|Overall Study|Protocol-defined stopping criteria|0
7423298|NCT01494532|11698370|FG001|Overall Study|Protocol-defined stopping criteria|0
7423299|NCT01494532|11698371|FG002|Overall Study|Protocol-defined stopping criteria|1
7423300|NCT01494532|11698372|FG003|Overall Study|Protocol-defined stopping criteria|0
7423301|NCT01494532|11698373|FG004|Overall Study|Protocol-defined stopping criteria|0
7423302|NCT01494532|11698374|FG005|Overall Study|Protocol-defined stopping criteria|0
7423303|NCT01494532|11698369|FG000|Overall Study|Lost to Follow-up|1
7423304|NCT01494532|11698370|FG001|Overall Study|Lost to Follow-up|0
7423305|NCT01494532|11698371|FG002|Overall Study|Lost to Follow-up|0
7423306|NCT01494532|11698372|FG003|Overall Study|Lost to Follow-up|2
7423307|NCT01494532|11698373|FG004|Overall Study|Lost to Follow-up|0
7423308|NCT01494532|11698374|FG005|Overall Study|Lost to Follow-up|0
7423309|NCT01494532|11698369|FG000|Overall Study|Physician Decision|0
7423310|NCT01494532|11698370|FG001|Overall Study|Physician Decision|1
7423311|NCT01494532|11698371|FG002|Overall Study|Physician Decision|1
7423312|NCT01494532|11698372|FG003|Overall Study|Physician Decision|2
7423313|NCT01494532|11698373|FG004|Overall Study|Physician Decision|0
7423314|NCT01494532|11698374|FG005|Overall Study|Physician Decision|0
7423315|NCT01494532|11698369|FG000|Overall Study|Withdrawal by Subject|3
7423316|NCT01494532|11698370|FG001|Overall Study|Withdrawal by Subject|1
7423317|NCT01494532|11698371|FG002|Overall Study|Withdrawal by Subject|4
7423318|NCT01494532|11698372|FG003|Overall Study|Withdrawal by Subject|3
7423319|NCT01494532|11698373|FG004|Overall Study|Withdrawal by Subject|2
7423320|NCT01494532|11698374|FG005|Overall Study|Withdrawal by Subject|0
7423321|NCT01494584|11698396|FG000|Overall Study|Study Closed/Terminated|1
7423322|NCT01494610|11698419|FG000|Period 1|Withdrawal by Subject|1
7423323|NCT01494610|11698420|FG001|Period 1|Withdrawal by Subject|1
7423324|NCT01494610|11698419|FG000|Period 3|Adverse Event|1
7423325|NCT01494610|11698420|FG001|Period 3|Adverse Event|0
7423326|NCT01494610|11698419|FG000|Period 3|Withdrawal by Subject|1
7423327|NCT01494610|11698420|FG001|Period 3|Withdrawal by Subject|0
7423328|NCT01494610|11698419|FG000|Period 4|Protocol Violation|1
7423329|NCT01494610|11698420|FG001|Period 4|Protocol Violation|0
7423330|NCT01494649|11698434|FG000|Overall Study|Lost to Follow-up|0
7423331|NCT01494649|11698435|FG001|Overall Study|Lost to Follow-up|1
7423332|NCT01494818|11698454|FG000|Overall Study|Relocation|1
7423333|NCT01494818|11698455|FG001|Overall Study|Relocation|2
7423334|NCT01494818|11698454|FG000|Overall Study|Lost to Follow-up|1
7557234|NCT03097133|11921663|FG001|Overall Study|Other|2
7557235|NCT03097133|11921662|FG000|Overall Study|Adverse Event|1
7557236|NCT03097133|11921663|FG001|Overall Study|Adverse Event|0
7557237|NCT03097289|11921669|FG000|Overall Study|Adverse Event|1
7423335|NCT01494818|11698455|FG001|Overall Study|Lost to Follow-up|0
7423336|NCT01494922|11698461|FG000|Overall Study|Adverse Event|1
7423337|NCT01494987|11698467|FG000|Overall Study|Adverse Event|6
7423338|NCT01494987|11698468|FG001|Overall Study|Adverse Event|5
7423339|NCT01494987|11698467|FG000|Overall Study|Hyperglycemia|6
7423340|NCT01494987|11698468|FG001|Overall Study|Hyperglycemia|4
7423341|NCT01494987|11698467|FG000|Overall Study|Investigator's Discretion|1
7423342|NCT01494987|11698468|FG001|Overall Study|Investigator's Discretion|2
7423343|NCT01494987|11698467|FG000|Overall Study|Lost to Follow-up|1
7423344|NCT01494987|11698468|FG001|Overall Study|Lost to Follow-up|1
7423345|NCT01494987|11698467|FG000|Overall Study|Protocol Violation|3
7423346|NCT01494987|11698468|FG001|Overall Study|Protocol Violation|3
7423347|NCT01494987|11698467|FG000|Overall Study|Subject Non-Compliance|9
7423348|NCT01494987|11698468|FG001|Overall Study|Subject Non-Compliance|10
7423349|NCT01494987|11698467|FG000|Overall Study|Subject Withdrew Consent|2
7423350|NCT01494987|11698468|FG001|Overall Study|Subject Withdrew Consent|3
7423351|NCT01495000|11698476|FG000|Overall Study|Lost to Follow-up|2
7423352|NCT01495000|11698477|FG001|Overall Study|Lost to Follow-up|2
7423353|NCT01495000|11698476|FG000|Overall Study|Protocol Violation|1
7557238|NCT03097289|11921669|FG000|Overall Study|Equipment failure|2
7327818|NCT00791921|11560510|FG000|Overall Study|Protocol planed|24
7327819|NCT00791921|11560511|FG001|Overall Study|Protocol planed|88
7327820|NCT00791921|11560510|FG000|Overall Study|Withdrawal by Subject|1
7327821|NCT00791921|11560511|FG001|Overall Study|Withdrawal by Subject|2
7327822|NCT00791921|11560510|FG000|Overall Study|Adverse Event|8
7327823|NCT00791921|11560511|FG001|Overall Study|Adverse Event|2
7327824|NCT00791921|11560510|FG000|Overall Study|Lack of Efficacy|0
7327825|NCT00791921|11560511|FG001|Overall Study|Lack of Efficacy|2
7327826|NCT00791921|11560510|FG000|Overall Study|Lack of study drug administration|1
7327827|NCT00791921|11560511|FG001|Overall Study|Lack of study drug administration|1
7327828|NCT00791921|11560510|FG000|Overall Study|Reason other than those above|0
7327829|NCT00791921|11560511|FG001|Overall Study|Reason other than those above|1
7327830|NCT00791934|11560517|FG000|Overall Study|Withdrawal by Subject|2
7327831|NCT00791934|11560517|FG000|Overall Study|Did not consent for extended follow-up|13
7327832|NCT00791999|11560534|FG000|Overall Study|Protocol planed withdrawal|14
7327833|NCT00791999|11560535|FG001|Overall Study|Protocol planed withdrawal|11
7327834|NCT00791999|11560536|FG002|Overall Study|Protocol planed withdrawal|11
7327835|NCT00791999|11560537|FG003|Overall Study|Protocol planed withdrawal|45
7327836|NCT00791999|11560534|FG000|Overall Study|Withdrawal by Subject|0
7327837|NCT00791999|11560535|FG001|Overall Study|Withdrawal by Subject|1
7327838|NCT00791999|11560536|FG002|Overall Study|Withdrawal by Subject|0
7327839|NCT00791999|11560537|FG003|Overall Study|Withdrawal by Subject|2
7327840|NCT00791999|11560534|FG000|Overall Study|Protocol Violation|3
7327841|NCT00791999|11560535|FG001|Overall Study|Protocol Violation|0
7327842|NCT00791999|11560536|FG002|Overall Study|Protocol Violation|1
7327843|NCT00791999|11560537|FG003|Overall Study|Protocol Violation|0
7327844|NCT00791999|11560534|FG000|Overall Study|Adverse Event|3
7327845|NCT00791999|11560535|FG001|Overall Study|Adverse Event|3
7327846|NCT00791999|11560536|FG002|Overall Study|Adverse Event|7
7327847|NCT00791999|11560537|FG003|Overall Study|Adverse Event|3
7327848|NCT00791999|11560534|FG000|Overall Study|Lack of Efficacy|0
7327849|NCT00791999|11560535|FG001|Overall Study|Lack of Efficacy|1
7327850|NCT00791999|11560536|FG002|Overall Study|Lack of Efficacy|0
7327851|NCT00791999|11560537|FG003|Overall Study|Lack of Efficacy|2
7327852|NCT00791999|11560534|FG000|Overall Study|Reason other than those above|1
7327853|NCT00791999|11560535|FG001|Overall Study|Reason other than those above|0
7327854|NCT00791999|11560536|FG002|Overall Study|Reason other than those above|1
7327855|NCT00791999|11560537|FG003|Overall Study|Reason other than those above|0
7327856|NCT00792103|11560551|FG000|Overall Study|Enrolled, not treated|15
7327857|NCT00792103|11560551|FG000|Overall Study|Lost to Follow-up|17
7327858|NCT00792103|11560551|FG000|Overall Study|Adverse Event|25
7327859|NCT00792103|11560551|FG000|Overall Study|Withdrawal by Subject|52
7327860|NCT00792103|11560551|FG000|Overall Study|Protocol Violation|10
7327861|NCT00792103|11560551|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
7327862|NCT00792298|11560559|FG000|Treatment Period 1|Adverse Event|0
7327863|NCT00792298|11560560|FG001|Treatment Period 1|Adverse Event|1
7327864|NCT00792298|11560561|FG002|Treatment Period 1|Adverse Event|0
7327865|NCT00792298|11560562|FG003|Treatment Period 1|Adverse Event|1
7327866|NCT00792298|11560563|FG004|Treatment Period 1|Adverse Event|0
7327867|NCT00792298|11560564|FG005|Treatment Period 1|Adverse Event|1
7327868|NCT00792298|11560565|FG006|Treatment Period 1|Adverse Event|1
7327869|NCT00792298|11560566|FG007|Treatment Period 1|Adverse Event|0
7327870|NCT00792298|11560559|FG000|Treatment Period 1|Lack of Efficacy|0
7327871|NCT00792298|11560560|FG001|Treatment Period 1|Lack of Efficacy|0
7327872|NCT00792298|11560561|FG002|Treatment Period 1|Lack of Efficacy|1
7327873|NCT00792298|11560562|FG003|Treatment Period 1|Lack of Efficacy|0
7327874|NCT00792298|11560563|FG004|Treatment Period 1|Lack of Efficacy|0
7327875|NCT00792298|11560564|FG005|Treatment Period 1|Lack of Efficacy|0
7327876|NCT00792298|11560565|FG006|Treatment Period 1|Lack of Efficacy|0
7327877|NCT00792298|11560566|FG007|Treatment Period 1|Lack of Efficacy|0
7327878|NCT00792298|11560559|FG000|Treatment Period 1|Withdrawal by Subject|1
7327879|NCT00792298|11560560|FG001|Treatment Period 1|Withdrawal by Subject|0
7327880|NCT00792298|11560561|FG002|Treatment Period 1|Withdrawal by Subject|1
7327881|NCT00792298|11560562|FG003|Treatment Period 1|Withdrawal by Subject|2
7327882|NCT00792298|11560563|FG004|Treatment Period 1|Withdrawal by Subject|0
7327883|NCT00792298|11560564|FG005|Treatment Period 1|Withdrawal by Subject|2
7327884|NCT00792298|11560565|FG006|Treatment Period 1|Withdrawal by Subject|1
7327885|NCT00792298|11560566|FG007|Treatment Period 1|Withdrawal by Subject|0
7327886|NCT00792298|11560559|FG000|Treatment Period 1|Lost to Follow-up|0
7327887|NCT00792298|11560560|FG001|Treatment Period 1|Lost to Follow-up|0
7327888|NCT00792298|11560561|FG002|Treatment Period 1|Lost to Follow-up|0
7327889|NCT00792298|11560562|FG003|Treatment Period 1|Lost to Follow-up|0
7327890|NCT00792298|11560563|FG004|Treatment Period 1|Lost to Follow-up|0
7327891|NCT00792298|11560564|FG005|Treatment Period 1|Lost to Follow-up|0
7327892|NCT00792298|11560565|FG006|Treatment Period 1|Lost to Follow-up|1
7423354|NCT01495000|11698477|FG001|Overall Study|Protocol Violation|0
7423355|NCT01495000|11698476|FG000|Overall Study|Withdrawal by Subject|10
7423356|NCT01495000|11698477|FG001|Overall Study|Withdrawal by Subject|10
7423357|NCT01495702|11698533|FG000|Randomized Phase|Randomized But Not Treated|1
7423358|NCT01495702|11698534|FG001|Randomized Phase|Randomized But Not Treated|4
7423359|NCT01495702|11698533|FG000|Randomized Phase|Adverse Event|2
7423360|NCT01495702|11698534|FG001|Randomized Phase|Adverse Event|2
7423361|NCT01495702|11698533|FG000|Randomized Phase|Death|1
7327893|NCT00792298|11560566|FG007|Treatment Period 1|Lost to Follow-up|0
7327894|NCT00792298|11560559|FG000|Treatment Period 1|Physician Decision|0
7327895|NCT00792298|11560560|FG001|Treatment Period 1|Physician Decision|0
7327896|NCT00792298|11560561|FG002|Treatment Period 1|Physician Decision|0
7327897|NCT00792298|11560562|FG003|Treatment Period 1|Physician Decision|1
7327898|NCT00792298|11560563|FG004|Treatment Period 1|Physician Decision|0
7327899|NCT00792298|11560564|FG005|Treatment Period 1|Physician Decision|0
7327900|NCT00792298|11560565|FG006|Treatment Period 1|Physician Decision|1
7327901|NCT00792298|11560566|FG007|Treatment Period 1|Physician Decision|0
7327902|NCT00792298|11560559|FG000|Treatment Period 1|Protocol Violation|0
7327903|NCT00792298|11560560|FG001|Treatment Period 1|Protocol Violation|0
7327904|NCT00792298|11560561|FG002|Treatment Period 1|Protocol Violation|0
7327905|NCT00792298|11560562|FG003|Treatment Period 1|Protocol Violation|0
7327906|NCT00792298|11560563|FG004|Treatment Period 1|Protocol Violation|0
7327907|NCT00792298|11560564|FG005|Treatment Period 1|Protocol Violation|0
7327908|NCT00792298|11560565|FG006|Treatment Period 1|Protocol Violation|0
7327909|NCT00792298|11560566|FG007|Treatment Period 1|Protocol Violation|1
7327910|NCT00792298|11560559|FG000|Washout|Adverse Event|0
7327911|NCT00792298|11560560|FG001|Washout|Adverse Event|0
7327912|NCT00792298|11560561|FG002|Washout|Adverse Event|0
7327913|NCT00792298|11560562|FG003|Washout|Adverse Event|0
7327914|NCT00792298|11560563|FG004|Washout|Adverse Event|0
7327915|NCT00792298|11560564|FG005|Washout|Adverse Event|1
7557239|NCT03097289|11921669|FG000|Overall Study|Collected platelet product unusable|3
7557240|NCT03097315|11921674|FG000|Overall Study|Withdrawal by Subject|1
7557241|NCT03097588|11921708|FG000|Overall Study|Adverse Event|1
7557242|NCT03097614|11921712|FG000|Overall Study|Adverse Event|3
7557243|NCT03097861|11921737|FG000|Overall Study|Adverse Event|3
7327916|NCT00792298|11560565|FG006|Washout|Adverse Event|0
7327917|NCT00792298|11560566|FG007|Washout|Adverse Event|0
7327918|NCT00792298|11560559|FG000|Washout|Withdrawal by Subject|0
7327919|NCT00792298|11560560|FG001|Washout|Withdrawal by Subject|0
7327920|NCT00792298|11560561|FG002|Washout|Withdrawal by Subject|1
7327921|NCT00792298|11560562|FG003|Washout|Withdrawal by Subject|0
7327922|NCT00792298|11560563|FG004|Washout|Withdrawal by Subject|0
7327923|NCT00792298|11560564|FG005|Washout|Withdrawal by Subject|1
7327924|NCT00792298|11560565|FG006|Washout|Withdrawal by Subject|0
7327925|NCT00792298|11560566|FG007|Washout|Withdrawal by Subject|0
7327926|NCT00792298|11560559|FG000|Treatment Period 2|Lack of Efficacy|0
7327927|NCT00792298|11560560|FG001|Treatment Period 2|Lack of Efficacy|0
7327928|NCT00792298|11560561|FG002|Treatment Period 2|Lack of Efficacy|0
7327929|NCT00792298|11560562|FG003|Treatment Period 2|Lack of Efficacy|0
7327930|NCT00792298|11560563|FG004|Treatment Period 2|Lack of Efficacy|1
7327931|NCT00792298|11560564|FG005|Treatment Period 2|Lack of Efficacy|0
7327932|NCT00792298|11560565|FG006|Treatment Period 2|Lack of Efficacy|0
7327933|NCT00792298|11560566|FG007|Treatment Period 2|Lack of Efficacy|0
7327934|NCT00792298|11560559|FG000|Treatment Period 2|Physician Decision|0
7327935|NCT00792298|11560560|FG001|Treatment Period 2|Physician Decision|0
7327936|NCT00792298|11560561|FG002|Treatment Period 2|Physician Decision|0
7327937|NCT00792298|11560562|FG003|Treatment Period 2|Physician Decision|0
7327938|NCT00792298|11560563|FG004|Treatment Period 2|Physician Decision|0
7327939|NCT00792298|11560564|FG005|Treatment Period 2|Physician Decision|0
7327940|NCT00792298|11560565|FG006|Treatment Period 2|Physician Decision|1
7327941|NCT00792298|11560566|FG007|Treatment Period 2|Physician Decision|0
7327942|NCT00792298|11560559|FG000|Treatment Period 2|Pregnancy|0
7327943|NCT00792298|11560560|FG001|Treatment Period 2|Pregnancy|0
7327944|NCT00792298|11560561|FG002|Treatment Period 2|Pregnancy|1
7327945|NCT00792298|11560562|FG003|Treatment Period 2|Pregnancy|0
7327946|NCT00792298|11560563|FG004|Treatment Period 2|Pregnancy|0
7327947|NCT00792298|11560564|FG005|Treatment Period 2|Pregnancy|0
7327948|NCT00792298|11560565|FG006|Treatment Period 2|Pregnancy|0
7327949|NCT00792298|11560566|FG007|Treatment Period 2|Pregnancy|0
7327950|NCT00792298|11560559|FG000|Treatment Period 2|Withdrawal by Subject|1
7327951|NCT00792298|11560560|FG001|Treatment Period 2|Withdrawal by Subject|1
7327952|NCT00792298|11560561|FG002|Treatment Period 2|Withdrawal by Subject|0
7327953|NCT00792298|11560562|FG003|Treatment Period 2|Withdrawal by Subject|2
7327954|NCT00792298|11560563|FG004|Treatment Period 2|Withdrawal by Subject|1
7327955|NCT00792298|11560564|FG005|Treatment Period 2|Withdrawal by Subject|0
7327956|NCT00792298|11560565|FG006|Treatment Period 2|Withdrawal by Subject|0
7557244|NCT03097861|11921738|FG001|Overall Study|Adverse Event|8
7327957|NCT00792298|11560566|FG007|Treatment Period 2|Withdrawal by Subject|2
7327958|NCT00792467|11560592|FG000|Overall Study|progression of disease|17
7327959|NCT00792467|11560592|FG000|Overall Study|Adverse Event|1
7327960|NCT00792467|11560592|FG000|Overall Study|patient request|1
7327961|NCT00792467|11560592|FG000|Overall Study|Lost to Follow-up|1
7327962|NCT00792467|11560592|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
7327963|NCT00792467|11560592|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
7327964|NCT00792571|11560597|FG000|Overall Study|Death|1
7327965|NCT00792571|11560597|FG000|Overall Study|Adverse Event|4
7327966|NCT00792571|11560597|FG000|Overall Study|Withdrawal by Subject|1
7327967|NCT00792571|11560597|FG000|Overall Study|Other|4
7327968|NCT00792623|11560605|FG000|Overall Study|Adverse Event|2
7557245|NCT03097861|11921739|FG002|Overall Study|Adverse Event|4
7557246|NCT03097861|11921737|FG000|Overall Study|Investigator Decision|0
7327969|NCT00792623|11560605|FG000|Overall Study|Withdrawal by Subject|5
7327970|NCT00792636|11560613|FG000|Overall Study|Protocol Violation|17
7327971|NCT00792636|11560614|FG001|Overall Study|Protocol Violation|23
7327972|NCT00792636|11560615|FG002|Overall Study|Protocol Violation|20
7327973|NCT00792636|11560613|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
7327974|NCT00792636|11560614|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
7327975|NCT00792636|11560615|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
7327976|NCT00792636|11560613|FG000|Overall Study|Lost to Follow-up|13
7327977|NCT00792636|11560614|FG001|Overall Study|Lost to Follow-up|19
7327978|NCT00792636|11560615|FG002|Overall Study|Lost to Follow-up|14
7327979|NCT00792636|11560613|FG000|Overall Study|Withdrew Consent|10
7327980|NCT00792636|11560614|FG001|Overall Study|Withdrew Consent|13
7327981|NCT00792636|11560615|FG002|Overall Study|Withdrew Consent|9
7327982|NCT00792636|11560613|FG000|Overall Study|Lack of Efficacy|3
7327983|NCT00792636|11560614|FG001|Overall Study|Lack of Efficacy|4
7423362|NCT01495702|11698534|FG001|Randomized Phase|Death|0
7423363|NCT01495702|11698533|FG000|Randomized Phase|Lack of Efficacy|2
7423364|NCT01495702|11698534|FG001|Randomized Phase|Lack of Efficacy|0
7423365|NCT01495702|11698533|FG000|Randomized Phase|Investigators Discretion|2
7423366|NCT01495702|11698534|FG001|Randomized Phase|Investigators Discretion|0
7423367|NCT01495702|11698533|FG000|Randomized Phase|Withdrew Consent|10
7423368|NCT01495702|11698534|FG001|Randomized Phase|Withdrew Consent|18
7423369|NCT01495702|11698533|FG000|Randomized Phase|Lost to Follow-up|4
7423370|NCT01495702|11698534|FG001|Randomized Phase|Lost to Follow-up|3
7423371|NCT01495702|11698533|FG000|Randomized Phase|Participant Noncompliance|1
7423372|NCT01495702|11698534|FG001|Randomized Phase|Participant Noncompliance|0
7423373|NCT01495702|11698533|FG000|Randomized Phase|Protocol Violation|3
7423374|NCT01495702|11698534|FG001|Randomized Phase|Protocol Violation|1
7423375|NCT01495793|11698541|FG000|Overall Study|Lost to Follow-up|1
7423376|NCT01495793|11698541|FG000|Overall Study|Violation of inclusion criteria|1
7423377|NCT01495975|11698580|FG000|Overall Study|Lost to Follow-up|1
7423378|NCT01495975|11698581|FG001|Overall Study|Lost to Follow-up|0
7423379|NCT01496066|11698589|FG000|Overall Study|Lost to Follow-up|8
7423380|NCT01496066|11698590|FG001|Overall Study|Lost to Follow-up|5
7423381|NCT01496066|11698589|FG000|Overall Study|Explant|3
7423382|NCT01496066|11698590|FG001|Overall Study|Explant|0
7423383|NCT01496066|11698589|FG000|Overall Study|Death|1
7423384|NCT01496066|11698590|FG001|Overall Study|Death|4
7531718|NCT02658175|11876679|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
7423385|NCT01496183|11698618|FG000|Overall Study|Physician Decision|3
7423386|NCT01496183|11698619|FG001|Overall Study|Physician Decision|1
7423387|NCT01496183|11698618|FG000|Overall Study|Withdrawal by Subject|0
7423388|NCT01496183|11698619|FG001|Overall Study|Withdrawal by Subject|1
7423389|NCT01496274|11698632|FG000|Overall Study|Protocol Violation|0
7423390|NCT01496274|11698633|FG001|Overall Study|Protocol Violation|1
7423391|NCT01496274|11698632|FG000|Overall Study|Adverse Event|1
7423392|NCT01496274|11698633|FG001|Overall Study|Adverse Event|1
7423393|NCT01496274|11698632|FG000|Overall Study|Withdrawal by Subject|2
7423394|NCT01496274|11698633|FG001|Overall Study|Withdrawal by Subject|0
7423395|NCT01496274|11698632|FG000|Overall Study|Lost to Follow-up|0
7423396|NCT01496274|11698633|FG001|Overall Study|Lost to Follow-up|3
7423397|NCT01496287|11698654|FG000|Overall Study|Lost to Follow-up|1
7423398|NCT01496287|11698654|FG000|Overall Study|Incomplete anesthesia|5
7423399|NCT01496365|11698693|FG000|Overall Study|Adverse Event|2
7423400|NCT01496365|11698694|FG001|Overall Study|Adverse Event|3
7423401|NCT01496365|11698695|FG002|Overall Study|Adverse Event|3
7423402|NCT01496365|11698696|FG003|Overall Study|Adverse Event|2
7423403|NCT01496365|11698697|FG004|Overall Study|Adverse Event|5
7423404|NCT01496365|11698698|FG005|Overall Study|Adverse Event|6
7423405|NCT01496365|11698699|FG006|Overall Study|Adverse Event|4
7423406|NCT01496365|11698693|FG000|Overall Study|Withdrawal by Subject|6
7423407|NCT01496365|11698694|FG001|Overall Study|Withdrawal by Subject|6
7423408|NCT01496365|11698695|FG002|Overall Study|Withdrawal by Subject|0
7423409|NCT01496365|11698696|FG003|Overall Study|Withdrawal by Subject|1
7423410|NCT01496365|11698697|FG004|Overall Study|Withdrawal by Subject|3
7423411|NCT01496365|11698698|FG005|Overall Study|Withdrawal by Subject|2
7423412|NCT01496365|11698699|FG006|Overall Study|Withdrawal by Subject|1
7423413|NCT01496365|11698693|FG000|Overall Study|Protocol Violation|2
7423414|NCT01496365|11698694|FG001|Overall Study|Protocol Violation|1
7423415|NCT01496365|11698695|FG002|Overall Study|Protocol Violation|1
7423416|NCT01496365|11698696|FG003|Overall Study|Protocol Violation|0
7423417|NCT01496365|11698697|FG004|Overall Study|Protocol Violation|0
7423418|NCT01496365|11698698|FG005|Overall Study|Protocol Violation|1
7423419|NCT01496365|11698699|FG006|Overall Study|Protocol Violation|0
7327984|NCT00792636|11560615|FG002|Overall Study|Lack of Efficacy|13
7327985|NCT00792636|11560613|FG000|Overall Study|Adverse Event|4
7327986|NCT00792636|11560614|FG001|Overall Study|Adverse Event|2
7327987|NCT00792636|11560615|FG002|Overall Study|Adverse Event|3
7423420|NCT01496365|11698693|FG000|Overall Study|Lack of Efficacy|1
7423421|NCT01496365|11698694|FG001|Overall Study|Lack of Efficacy|0
7423422|NCT01496365|11698695|FG002|Overall Study|Lack of Efficacy|0
7423423|NCT01496365|11698696|FG003|Overall Study|Lack of Efficacy|0
7423424|NCT01496365|11698697|FG004|Overall Study|Lack of Efficacy|0
7423425|NCT01496365|11698698|FG005|Overall Study|Lack of Efficacy|1
7423426|NCT01496365|11698699|FG006|Overall Study|Lack of Efficacy|0
7531719|NCT02658175|11876680|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
7531720|NCT02658175|11876681|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
7531721|NCT02658175|11876679|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
7327988|NCT00792636|11560613|FG000|Overall Study|Investigator Discretion|2
7327989|NCT00792636|11560614|FG001|Overall Study|Investigator Discretion|0
7327990|NCT00792636|11560615|FG002|Overall Study|Investigator Discretion|2
7327991|NCT00792701|11560640|FG000|Overall Study|Adverse Event|0
7327992|NCT00792701|11560641|FG001|Overall Study|Adverse Event|22
7327993|NCT00792701|11560640|FG000|Overall Study|Ineligible|1
7327994|NCT00792701|11560641|FG001|Overall Study|Ineligible|3
7327995|NCT00792701|11560640|FG000|Overall Study|Withdrawal by Subject|1
7327996|NCT00792701|11560641|FG001|Overall Study|Withdrawal by Subject|19
7327997|NCT00792701|11560640|FG000|Overall Study|Not protocol specified|17
7327998|NCT00792701|11560641|FG001|Overall Study|Not protocol specified|0
7327999|NCT00792805|11560652|FG000|Overall Study|Adverse Event|12
7328000|NCT00792805|11560653|FG001|Overall Study|Adverse Event|10
7328001|NCT00792805|11560654|FG002|Overall Study|Adverse Event|10
7328002|NCT00792805|11560652|FG000|Overall Study|Subject withdrew consent|5
7328003|NCT00792805|11560653|FG001|Overall Study|Subject withdrew consent|6
7328004|NCT00792805|11560654|FG002|Overall Study|Subject withdrew consent|5
7328005|NCT00792805|11560652|FG000|Overall Study|Administrative problems|2
7328006|NCT00792805|11560653|FG001|Overall Study|Administrative problems|0
7328007|NCT00792805|11560654|FG002|Overall Study|Administrative problems|4
7328008|NCT00792805|11560652|FG000|Overall Study|Abnormal test procedure result(s)|1
7328009|NCT00792805|11560653|FG001|Overall Study|Abnormal test procedure result(s)|2
7328010|NCT00792805|11560654|FG002|Overall Study|Abnormal test procedure result(s)|0
7328011|NCT00792805|11560652|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7328012|NCT00792805|11560653|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7328013|NCT00792805|11560654|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7328014|NCT00792805|11560652|FG000|Overall Study|Lost to Follow-up|1
7328015|NCT00792805|11560653|FG001|Overall Study|Lost to Follow-up|1
7328016|NCT00792805|11560654|FG002|Overall Study|Lost to Follow-up|6
7328017|NCT00792805|11560652|FG000|Overall Study|Abnormal laboratory value(s)|0
7328018|NCT00792805|11560653|FG001|Overall Study|Abnormal laboratory value(s)|0
7328019|NCT00792805|11560654|FG002|Overall Study|Abnormal laboratory value(s)|1
7328020|NCT00792805|11560652|FG000|Overall Study|Protocol deviation|0
7423427|NCT01496365|11698693|FG000|Overall Study|Lost to Follow-up|0
7423428|NCT01496365|11698694|FG001|Overall Study|Lost to Follow-up|1
7423429|NCT01496365|11698695|FG002|Overall Study|Lost to Follow-up|0
7423430|NCT01496365|11698696|FG003|Overall Study|Lost to Follow-up|0
7423431|NCT01496365|11698697|FG004|Overall Study|Lost to Follow-up|2
7423432|NCT01496365|11698698|FG005|Overall Study|Lost to Follow-up|0
7423433|NCT01496365|11698699|FG006|Overall Study|Lost to Follow-up|0
7423434|NCT01496365|11698693|FG000|Overall Study|Other|4
7423435|NCT01496365|11698694|FG001|Overall Study|Other|4
7423436|NCT01496365|11698695|FG002|Overall Study|Other|2
7423437|NCT01496365|11698696|FG003|Overall Study|Other|1
7423438|NCT01496365|11698697|FG004|Overall Study|Other|3
7423439|NCT01496365|11698698|FG005|Overall Study|Other|0
7423440|NCT01496365|11698699|FG006|Overall Study|Other|1
7423441|NCT01496430|11698718|FG000|Overall Study|Adverse Event|0
7423442|NCT01496430|11698719|FG001|Overall Study|Adverse Event|0
7423443|NCT01496430|11698720|FG002|Overall Study|Adverse Event|1
7423444|NCT01496430|11698718|FG000|Overall Study|Major Protocol Deviation|0
7423445|NCT01496430|11698719|FG001|Overall Study|Major Protocol Deviation|0
7423446|NCT01496430|11698720|FG002|Overall Study|Major Protocol Deviation|1
7423447|NCT01496430|11698718|FG000|Overall Study|Lost to Follow-up|2
7423448|NCT01496430|11698719|FG001|Overall Study|Lost to Follow-up|3
7423449|NCT01496430|11698720|FG002|Overall Study|Lost to Follow-up|1
7423450|NCT01496430|11698718|FG000|Overall Study|Voluntary Withdrawal|2
7423451|NCT01496430|11698719|FG001|Overall Study|Voluntary Withdrawal|1
7423452|NCT01496430|11698720|FG002|Overall Study|Voluntary Withdrawal|6
7423453|NCT01496430|11698718|FG000|Overall Study|Principal Investigator Discretion|0
7423454|NCT01496430|11698719|FG001|Overall Study|Principal Investigator Discretion|1
7423455|NCT01496430|11698720|FG002|Overall Study|Principal Investigator Discretion|1
7423456|NCT01496430|11698718|FG000|Overall Study|Other|2
7423457|NCT01496430|11698719|FG001|Overall Study|Other|0
7423458|NCT01496430|11698720|FG002|Overall Study|Other|0
7423459|NCT01496456|11698728|FG000|Overall Study|Protocol Violation|1
7423460|NCT01496456|11698728|FG000|Overall Study|Lost to Follow-up|7
7423461|NCT01496469|11698737|FG000|Overall Study|Adverse Event|1
7423462|NCT01496469|11698738|FG001|Overall Study|Adverse Event|0
7423463|NCT01496469|11698737|FG000|Overall Study|Protocol Violation|2
7423464|NCT01496469|11698738|FG001|Overall Study|Protocol Violation|0
7423465|NCT01496469|11698737|FG000|Overall Study|Lost to Follow-up|1
7423466|NCT01496469|11698738|FG001|Overall Study|Lost to Follow-up|1
7423467|NCT01496469|11698737|FG000|Overall Study|Withdrawal by Subject|4
7423468|NCT01496469|11698738|FG001|Overall Study|Withdrawal by Subject|4
7423469|NCT01496469|11698737|FG000|Overall Study|BP exceeds protocol limits|1
7423470|NCT01496469|11698738|FG001|Overall Study|BP exceeds protocol limits|2
7423471|NCT01496469|11698737|FG000|Overall Study|Other|1
7423472|NCT01496469|11698738|FG001|Overall Study|Other|1
7423473|NCT01496612|11698744|FG000|1st Intervention|Adverse Event|1
7328021|NCT00792805|11560653|FG001|Overall Study|Protocol deviation|1
7328022|NCT00792805|11560654|FG002|Overall Study|Protocol deviation|1
7328023|NCT00792909|11560665|FG000|Overall Study|Withdrawal by Subject|0
7328024|NCT00792909|11560666|FG001|Overall Study|Withdrawal by Subject|1
7328025|NCT00792909|11560667|FG002|Overall Study|Withdrawal by Subject|0
7328026|NCT00792935|11560699|FG000|Overall Study|Adverse Event|2
7328027|NCT00792935|11560700|FG001|Overall Study|Adverse Event|1
7328028|NCT00792935|11560699|FG000|Overall Study|Lost to Follow-up|0
7423474|NCT01496612|11698745|FG001|1st Intervention|Adverse Event|0
7423475|NCT01496612|11698744|FG000|1st Intervention|Withdrawal by Subject|1
7423476|NCT01496612|11698745|FG001|1st Intervention|Withdrawal by Subject|0
7423477|NCT01496807|11698753|FG000|Overall Study|Progressive Disease|21
7423478|NCT01496807|11698753|FG000|Overall Study|Participant preference/toxicity|8
7423479|NCT01496807|11698753|FG000|Overall Study|Change in diagnosis|1
7423480|NCT01496846|11698763|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7423481|NCT01496846|11698764|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
7423482|NCT01496846|11698765|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7423483|NCT01496846|11698766|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7423484|NCT01496846|11698767|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7423485|NCT01496846|11698768|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
7423486|NCT01496885|11698779|FG000|Overall Study|Lost to Follow-up|13
7423487|NCT01496885|11698779|FG000|Overall Study|Withdrawal by Subject|7
7423488|NCT01496885|11698779|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
7423489|NCT01496885|11698779|FG000|Overall Study|Death|1
7423490|NCT01497067|11698783|FG000|Overall Study|Lost to Follow-up|56
7423491|NCT01497067|11698783|FG000|Overall Study|Adverse Event|3
7423492|NCT01497067|11698783|FG000|Overall Study|Patient decision unrel to Adverse Event|10
7423493|NCT01497067|11698783|FG000|Overall Study|Other|13
7423494|NCT01497197|11698790|FG000|Overall Study|Lost to Follow-up|1
7423495|NCT01497197|11698791|FG001|Overall Study|Lost to Follow-up|0
7423496|NCT01497197|11698790|FG000|Overall Study|Protocol Violation|0
7423497|NCT01497197|11698791|FG001|Overall Study|Protocol Violation|2
7423498|NCT01497197|11698790|FG000|Overall Study|Withdrawal by Subject|2
7423499|NCT01497197|11698791|FG001|Overall Study|Withdrawal by Subject|1
7423500|NCT01497197|11698790|FG000|Overall Study|Excessive/lack of response to treatment|1
7423501|NCT01497197|11698791|FG001|Overall Study|Excessive/lack of response to treatment|0
7423502|NCT01497197|11698790|FG000|Overall Study|Risk of OHSS|1
7423503|NCT01497197|11698791|FG001|Overall Study|Risk of OHSS|0
7423504|NCT01497197|11698790|FG000|Overall Study|No oocytes retrieved|3
7423505|NCT01497197|11698791|FG001|Overall Study|No oocytes retrieved|2
7423506|NCT01497197|11698790|FG000|Overall Study|No fertilisation|6
7423507|NCT01497197|11698791|FG001|Overall Study|No fertilisation|5
7423508|NCT01497197|11698790|FG000|Overall Study|Intention to freeze all embryos|0
7423509|NCT01497197|11698791|FG001|Overall Study|Intention to freeze all embryos|1
7423510|NCT01497197|11698790|FG000|Overall Study|All embryos discarded|0
7423511|NCT01497197|11698791|FG001|Overall Study|All embryos discarded|3
7423512|NCT01497197|11698790|FG000|Overall Study|Other|3
7423513|NCT01497197|11698791|FG001|Overall Study|Other|1
7423514|NCT01497262|11698797|FG000|Overall Study|Abnormal Lab Values|4
7423515|NCT01497262|11698797|FG000|Overall Study|Abnormal Test Procedure Result|1
7423516|NCT01497262|11698797|FG000|Overall Study|Physician Decision|1
7423517|NCT01497262|11698797|FG000|Overall Study|Withdrawal by Subject|2
7423518|NCT01497262|11698797|FG000|Overall Study|Adverse Event|2
7423519|NCT01497262|11698797|FG000|Overall Study|Protocol Violation|1
7423520|NCT01497275|11698801|FG000|Overall Study|Death|1
7423521|NCT01497275|11698801|FG000|Overall Study|Adverse Event|1
7423522|NCT01497366|11698807|FG000|Overall Study|Virologic failure|2
7423523|NCT01497366|11698808|FG001|Overall Study|Virologic failure|50
7423524|NCT01497366|11698807|FG000|Overall Study|Lost to Follow-up|11
7423525|NCT01497366|11698808|FG001|Overall Study|Lost to Follow-up|10
7423526|NCT01497366|11698807|FG000|Overall Study|Withdrawal by Subject|6
7423527|NCT01497366|11698808|FG001|Overall Study|Withdrawal by Subject|6
7423528|NCT01497366|11698807|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
7423529|NCT01497366|11698808|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
7423530|NCT01497366|11698807|FG000|Overall Study|Other|5
7423531|NCT01497366|11698808|FG001|Overall Study|Other|0
7423532|NCT01497366|11698807|FG000|Overall Study|Death|1
7423533|NCT01497366|11698808|FG001|Overall Study|Death|1
7423534|NCT01497366|11698807|FG000|Overall Study|Randomized but not treated|7
7423535|NCT01497366|11698808|FG001|Overall Study|Randomized but not treated|21
7423536|NCT01497899|11698861|FG000|Double-Blind Phase|Randomized but not Treated|1
7423537|NCT01497899|11698862|FG001|Double-Blind Phase|Randomized but not Treated|0
7423538|NCT01497899|11698863|FG002|Double-Blind Phase|Randomized but not Treated|0
7423539|NCT01497899|11698864|FG003|Double-Blind Phase|Randomized but not Treated|0
7423540|NCT01497899|11698861|FG000|Double-Blind Phase|Adverse Event|1
7423541|NCT01497899|11698862|FG001|Double-Blind Phase|Adverse Event|0
7423542|NCT01497899|11698863|FG002|Double-Blind Phase|Adverse Event|0
7423543|NCT01497899|11698864|FG003|Double-Blind Phase|Adverse Event|0
7423544|NCT01497899|11698861|FG000|Double-Blind Phase|Lack of Efficacy|0
7423545|NCT01497899|11698862|FG001|Double-Blind Phase|Lack of Efficacy|1
7423546|NCT01497899|11698863|FG002|Double-Blind Phase|Lack of Efficacy|0
7423547|NCT01497899|11698864|FG003|Double-Blind Phase|Lack of Efficacy|0
7423548|NCT01497899|11698861|FG000|Double-Blind Phase|Investigator's Discretion|1
7423549|NCT01497899|11698862|FG001|Double-Blind Phase|Investigator's Discretion|0
7423550|NCT01497899|11698863|FG002|Double-Blind Phase|Investigator's Discretion|0
7423551|NCT01497899|11698864|FG003|Double-Blind Phase|Investigator's Discretion|0
7423552|NCT01497899|11698861|FG000|Double-Blind Phase|Withdrew Consent|0
7423553|NCT01497899|11698862|FG001|Double-Blind Phase|Withdrew Consent|1
7423554|NCT01497899|11698863|FG002|Double-Blind Phase|Withdrew Consent|0
7423555|NCT01497899|11698864|FG003|Double-Blind Phase|Withdrew Consent|0
7423556|NCT01497899|11698861|FG000|Double-Blind Phase|Lost to Follow-up|3
7423557|NCT01497899|11698862|FG001|Double-Blind Phase|Lost to Follow-up|2
7423558|NCT01497899|11698863|FG002|Double-Blind Phase|Lost to Follow-up|0
7423559|NCT01497899|11698864|FG003|Double-Blind Phase|Lost to Follow-up|0
7423560|NCT01497899|11698861|FG000|Double-Blind Phase|Subject Non-Compliance|0
7423561|NCT01497899|11698862|FG001|Double-Blind Phase|Subject Non-Compliance|1
7423562|NCT01497899|11698863|FG002|Double-Blind Phase|Subject Non-Compliance|0
7423563|NCT01497899|11698864|FG003|Double-Blind Phase|Subject Non-Compliance|0
7423564|NCT01497899|11698861|FG000|Open-Label Extension Phase|Adverse Event|1
7423565|NCT01497899|11698862|FG001|Open-Label Extension Phase|Adverse Event|0
7423566|NCT01497899|11698863|FG002|Open-Label Extension Phase|Adverse Event|0
7423567|NCT01497899|11698864|FG003|Open-Label Extension Phase|Adverse Event|0
7423568|NCT01497899|11698861|FG000|Open-Label Extension Phase|Death|1
7423569|NCT01497899|11698862|FG001|Open-Label Extension Phase|Death|0
7423570|NCT01497899|11698863|FG002|Open-Label Extension Phase|Death|0
7423571|NCT01497899|11698864|FG003|Open-Label Extension Phase|Death|0
7423572|NCT01497899|11698861|FG000|Open-Label Extension Phase|Withdrew Consent|8
7423573|NCT01497899|11698862|FG001|Open-Label Extension Phase|Withdrew Consent|3
7423574|NCT01497899|11698863|FG002|Open-Label Extension Phase|Withdrew Consent|2
7423575|NCT01497899|11698864|FG003|Open-Label Extension Phase|Withdrew Consent|0
7423576|NCT01497899|11698861|FG000|Open-Label Extension Phase|Pregnancy|0
7423577|NCT01497899|11698862|FG001|Open-Label Extension Phase|Pregnancy|1
7423578|NCT01497899|11698863|FG002|Open-Label Extension Phase|Pregnancy|1
7423579|NCT01497899|11698864|FG003|Open-Label Extension Phase|Pregnancy|0
7423580|NCT01497899|11698861|FG000|Open-Label Extension Phase|Protocol Violation|0
7423581|NCT01497899|11698862|FG001|Open-Label Extension Phase|Protocol Violation|0
7423582|NCT01497899|11698863|FG002|Open-Label Extension Phase|Protocol Violation|1
7423583|NCT01497899|11698864|FG003|Open-Label Extension Phase|Protocol Violation|0
7423584|NCT01497899|11698861|FG000|Open-Label Extension Phase|Lost to Follow-up|9
7423585|NCT01497899|11698862|FG001|Open-Label Extension Phase|Lost to Follow-up|3
7423586|NCT01497899|11698863|FG002|Open-Label Extension Phase|Lost to Follow-up|5
7423587|NCT01497899|11698864|FG003|Open-Label Extension Phase|Lost to Follow-up|5
7423588|NCT01497938|11698873|FG000|Overall Study|Adverse Event|0
7423589|NCT01497938|11698874|FG001|Overall Study|Adverse Event|1
7423590|NCT01497938|11698873|FG000|Overall Study|Physician Decision|0
7423591|NCT01497938|11698874|FG001|Overall Study|Physician Decision|1
7423592|NCT01497938|11698873|FG000|Overall Study|Withdrawal by Subject|4
7423593|NCT01497938|11698874|FG001|Overall Study|Withdrawal by Subject|0
7423594|NCT01497938|11698873|FG000|Overall Study|Device Violation|1
7423595|NCT01497938|11698874|FG001|Overall Study|Device Violation|0
7423596|NCT01498068|11698882|FG000|Overall Study|Withdrawal by Subject|1
7423597|NCT01498068|11698883|FG001|Overall Study|Withdrawal by Subject|1
7423598|NCT01498120|11698889|FG000|Overall Study|Lost to Follow-up|1
7423599|NCT01498120|11698889|FG000|Overall Study|Withdrawal by Subject|5
7423600|NCT01498120|11698889|FG000|Overall Study|AE, non-serious non-fatal|3
7423601|NCT01498120|11698889|FG000|Overall Study|Other|4
7423602|NCT01498185|11698898|FG000|Overall Study|Adverse Event|0
7423603|NCT01498185|11698899|FG001|Overall Study|Adverse Event|0
7423604|NCT01498185|11698900|FG002|Overall Study|Adverse Event|0
7423605|NCT01498185|11698901|FG003|Overall Study|Adverse Event|1
7423606|NCT01498185|11698902|FG004|Overall Study|Adverse Event|0
7423607|NCT01498185|11698898|FG000|Overall Study|Withdrawal by Subject|1
7423608|NCT01498185|11698899|FG001|Overall Study|Withdrawal by Subject|1
7423609|NCT01498185|11698900|FG002|Overall Study|Withdrawal by Subject|0
7423610|NCT01498185|11698901|FG003|Overall Study|Withdrawal by Subject|2
7423611|NCT01498185|11698902|FG004|Overall Study|Withdrawal by Subject|1
7531722|NCT02658175|11876680|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
7423612|NCT01498185|11698898|FG000|Overall Study|No longer met criteria, etc|0
7423613|NCT01498185|11698899|FG001|Overall Study|No longer met criteria, etc|0
7423614|NCT01498185|11698900|FG002|Overall Study|No longer met criteria, etc|0
7423615|NCT01498185|11698901|FG003|Overall Study|No longer met criteria, etc|0
7423616|NCT01498185|11698902|FG004|Overall Study|No longer met criteria, etc|2
7423617|NCT01498289|11698920|FG000|Overall Study|Adverse Event|16
7423618|NCT01498289|11698921|FG001|Overall Study|Adverse Event|18
7423619|NCT01498289|11698920|FG000|Overall Study|Death|6
7423620|NCT01498289|11698921|FG001|Overall Study|Death|8
7423621|NCT01498289|11698920|FG000|Overall Study|Withdrawal unrelated to AE|16
7423622|NCT01498289|11698921|FG001|Overall Study|Withdrawal unrelated to AE|16
7423623|NCT01498289|11698920|FG000|Overall Study|Progression/relapse|53
7423624|NCT01498289|11698921|FG001|Overall Study|Progression/relapse|59
7423625|NCT01498289|11698920|FG000|Overall Study|Not protocol specified|7
7423626|NCT01498289|11698921|FG001|Overall Study|Not protocol specified|2
7423627|NCT01498289|11698920|FG000|Overall Study|Reason under review|0
7423628|NCT01498289|11698921|FG001|Overall Study|Reason under review|1
7423629|NCT01498445|11698954|FG000|Overall Study|Lack of Efficacy|0
7423630|NCT01498445|11698955|FG001|Overall Study|Lack of Efficacy|0
7423631|NCT01498445|11698956|FG002|Overall Study|Lack of Efficacy|1
7423632|NCT01498445|11698957|FG003|Overall Study|Lack of Efficacy|2
7423633|NCT01498445|11698958|FG004|Overall Study|Lack of Efficacy|0
7423634|NCT01498445|11698959|FG005|Overall Study|Lack of Efficacy|0
7423635|NCT01498445|11698954|FG000|Overall Study|Screen Failure|0
7423636|NCT01498445|11698955|FG001|Overall Study|Screen Failure|0
7423637|NCT01498445|11698956|FG002|Overall Study|Screen Failure|0
7423638|NCT01498445|11698957|FG003|Overall Study|Screen Failure|0
7423639|NCT01498445|11698958|FG004|Overall Study|Screen Failure|1
7423640|NCT01498445|11698959|FG005|Overall Study|Screen Failure|1
7423641|NCT01498575|11698984|FG000|Overall Sample|Withdrawal by Subject|60
7423642|NCT01498575|11698985|FG001|Overall Sample|Withdrawal by Subject|14
7423643|NCT01498575|11698984|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
7423644|NCT01498575|11698985|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
7423645|NCT01498575|11698984|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
7423646|NCT01498575|11698985|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
7466642|NCT01893346|11766513|FG003|Overall Study|Lost to Follow-up|0
7466643|NCT01893346|11766510|FG000|Overall Study|Protocol Violation|1
7557247|NCT03097861|11921738|FG001|Overall Study|Investigator Decision|1
7557248|NCT03097861|11921739|FG002|Overall Study|Investigator Decision|0
7557249|NCT03097861|11921737|FG000|Overall Study|Lost to Follow-up|0
7557250|NCT03097861|11921738|FG001|Overall Study|Lost to Follow-up|7
7557251|NCT03097861|11921739|FG002|Overall Study|Lost to Follow-up|1
7557252|NCT03097861|11921737|FG000|Overall Study|Withdrawal by Subject|1
7557253|NCT03097861|11921738|FG001|Overall Study|Withdrawal by Subject|5
7466644|NCT01893346|11766511|FG001|Overall Study|Protocol Violation|0
7466645|NCT01893346|11766512|FG002|Overall Study|Protocol Violation|0
7466646|NCT01893346|11766513|FG003|Overall Study|Protocol Violation|0
7531723|NCT02658175|11876681|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
7531724|NCT02658175|11876679|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7531725|NCT02658175|11876680|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
7531726|NCT02658175|11876681|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
7531727|NCT02658175|11876679|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
7531728|NCT02658175|11876680|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7531729|NCT02658175|11876681|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
7531730|NCT02658448|11876698|FG000|Overall Study|Lost to Follow-up|1
7466647|NCT01893346|11766510|FG000|Overall Study|Withdrawal by Subject|2
7466648|NCT01893346|11766511|FG001|Overall Study|Withdrawal by Subject|0
7466649|NCT01893346|11766512|FG002|Overall Study|Withdrawal by Subject|0
7466650|NCT01893346|11766513|FG003|Overall Study|Withdrawal by Subject|0
7466651|NCT01893411|11766535|FG000|Overall Study|Protocol Violation|1
7466652|NCT01893411|11766536|FG001|Overall Study|Protocol Violation|0
7466653|NCT01893411|11766537|FG002|Overall Study|Protocol Violation|0
7466654|NCT01893411|11766535|FG000|Overall Study|Physician Decision|1
7466655|NCT01893411|11766536|FG001|Overall Study|Physician Decision|1
7466656|NCT01893411|11766537|FG002|Overall Study|Physician Decision|2
7466657|NCT01893411|11766535|FG000|Overall Study|Lack of Efficacy|2
7466658|NCT01893411|11766536|FG001|Overall Study|Lack of Efficacy|1
7466659|NCT01893411|11766537|FG002|Overall Study|Lack of Efficacy|0
7531731|NCT02658487|11876717|FG000|Overall Study|Death|2
7531732|NCT02658487|11876717|FG000|Overall Study|Disease progression|10
7531733|NCT02658487|11876717|FG000|Overall Study|Alternative therapy|1
7531734|NCT02658487|11876717|FG000|Overall Study|Adverse Event|1
7531735|NCT02658487|11876717|FG000|Overall Study|Treatment Failure, circulating blasts|1
7531736|NCT02658487|11876717|FG000|Overall Study|Refractory AML|1
7531737|NCT02658630|11876722|FG000|Overall Study|Withdrawal by Subject|4
7531738|NCT02658734|11876726|FG000|Overall Study|Adverse Event|2
7531739|NCT02658734|11876726|FG000|Overall Study|Death|4
7531740|NCT02658734|11876726|FG000|Overall Study|Lost to Follow-up|7
7531741|NCT02658734|11876726|FG000|Overall Study|Withdrawal of Consent|16
7531742|NCT02658734|11876726|FG000|Overall Study|Disease Progression|28
7531743|NCT02659098|11876748|FG000|Overall Study|Withdrawal by Subject|7
7531744|NCT02659150|11876752|FG000|Subject Enrollment|Physician Decision|3
7531745|NCT02659150|11876752|FG000|Subject Enrollment|Withdrawal by Subject|2
7466660|NCT01893411|11766535|FG000|Overall Study|Other|3
7466661|NCT01893411|11766536|FG001|Overall Study|Other|1
7466662|NCT01893411|11766537|FG002|Overall Study|Other|3
7466663|NCT01893411|11766535|FG000|Overall Study|Adverse Event|1
7466664|NCT01893411|11766536|FG001|Overall Study|Adverse Event|0
7466665|NCT01893411|11766537|FG002|Overall Study|Adverse Event|0
7466666|NCT01893411|11766535|FG000|Overall Study|Withdrawal by Subject|7
7466667|NCT01893411|11766536|FG001|Overall Study|Withdrawal by Subject|4
7531746|NCT02659150|11876752|FG000|Baseline Imaging|Withdrawal by Subject|1
7531747|NCT02659150|11876752|FG000|Baseline Imaging|Physician Decision|1
7531748|NCT02659150|11876752|FG000|Study Drug Dosing|Adverse Event|1
7557254|NCT03097861|11921739|FG002|Overall Study|Withdrawal by Subject|3
7466668|NCT01893411|11766537|FG002|Overall Study|Withdrawal by Subject|3
7531749|NCT02659540|11876768|FG000|Overall Study|Adverse Event|3
7531750|NCT02659540|11876769|FG001|Overall Study|Adverse Event|2
7531751|NCT02659540|11876768|FG000|Overall Study|Death|1
7531752|NCT02659540|11876769|FG001|Overall Study|Death|0
7531753|NCT02659540|11876768|FG000|Overall Study|Progressive disease|2
7531754|NCT02659540|11876769|FG001|Overall Study|Progressive disease|6
7531755|NCT02659631|11876785|FG000|Overall Study|Lost to Follow-up|0
7531756|NCT02659631|11876786|FG001|Overall Study|Lost to Follow-up|0
7531757|NCT02659631|11876787|FG002|Overall Study|Lost to Follow-up|2
7531758|NCT02659631|11876788|FG003|Overall Study|Lost to Follow-up|0
7531759|NCT02659631|11876789|FG004|Overall Study|Lost to Follow-up|0
7423647|NCT01498640|11699004|FG000|Overall Study|Lost to Follow-up|1
7423648|NCT01498640|11699004|FG000|Overall Study|Death|1
7423649|NCT01498640|11699004|FG000|Overall Study|Other|3
7423650|NCT01498653|11699014|FG000|Overall Study|Adverse Event|2
7423651|NCT01498653|11699015|FG001|Overall Study|Adverse Event|2
7423652|NCT01498653|11699014|FG000|Overall Study|Lack of Efficacy|12
7423653|NCT01498653|11699015|FG001|Overall Study|Lack of Efficacy|26
7423654|NCT01498653|11699014|FG000|Overall Study|Protocol Violation|0
7423655|NCT01498653|11699015|FG001|Overall Study|Protocol Violation|4
7423656|NCT01498653|11699014|FG000|Overall Study|Lost to Follow-up|1
7423657|NCT01498653|11699015|FG001|Overall Study|Lost to Follow-up|0
7423658|NCT01498653|11699014|FG000|Overall Study|Physician Decision|2
7423659|NCT01498653|11699015|FG001|Overall Study|Physician Decision|0
7423660|NCT01498653|11699014|FG000|Overall Study|Withdrawal by Subject|2
7423661|NCT01498653|11699015|FG001|Overall Study|Withdrawal by Subject|3
7423662|NCT01498679|11699023|FG000|Overall Study|Adverse Event|1
7423663|NCT01498679|11699024|FG001|Overall Study|Adverse Event|4
7423664|NCT01498679|11699023|FG000|Overall Study|Lack of Efficacy|72
7423665|NCT01498679|11699024|FG001|Overall Study|Lack of Efficacy|12
7423666|NCT01498679|11699023|FG000|Overall Study|Protocol Violation|4
7423667|NCT01498679|11699024|FG001|Overall Study|Protocol Violation|0
7423668|NCT01498679|11699023|FG000|Overall Study|Physician Decision|0
7423669|NCT01498679|11699024|FG001|Overall Study|Physician Decision|2
7423670|NCT01498679|11699023|FG000|Overall Study|Withdrawal by Subject|12
7423671|NCT01498679|11699024|FG001|Overall Study|Withdrawal by Subject|4
7423672|NCT01498692|11699030|FG000|Overall Study|Death|4
7423673|NCT01498692|11699030|FG000|Overall Study|Withdrawal by Subject|1
7423674|NCT01498692|11699030|FG000|Overall Study|Missed 12-month visit|3
7423675|NCT01498822|11699045|FG000|Overall Study|Protocol Violation|8
7423676|NCT01498822|11699046|FG001|Overall Study|Protocol Violation|4
7423677|NCT01498822|11699045|FG000|Overall Study|Other Reason|5
7423678|NCT01498822|11699046|FG001|Overall Study|Other Reason|2
7423679|NCT01498822|11699045|FG000|Overall Study|Lack of Efficacy|7
7423680|NCT01498822|11699046|FG001|Overall Study|Lack of Efficacy|2
7423681|NCT01498822|11699045|FG000|Overall Study|AE, non-serious non-fatal|8
7423682|NCT01498822|11699046|FG001|Overall Study|AE, non-serious non-fatal|17
7423683|NCT01498822|11699045|FG000|Overall Study|SAE, non-fatal|2
7423684|NCT01498822|11699046|FG001|Overall Study|SAE, non-fatal|2
7531760|NCT02659631|11876790|FG005|Overall Study|Lost to Follow-up|1
7531761|NCT02659631|11876791|FG006|Overall Study|Lost to Follow-up|0
7531762|NCT02659631|11876792|FG007|Overall Study|Lost to Follow-up|0
7531763|NCT02659631|11876793|FG008|Overall Study|Lost to Follow-up|0
7531764|NCT02659631|11876794|FG009|Overall Study|Lost to Follow-up|0
7531765|NCT02659631|11876785|FG000|Overall Study|Withdrawal prior to treatment|0
7531766|NCT02659631|11876786|FG001|Overall Study|Withdrawal prior to treatment|0
7531767|NCT02659631|11876787|FG002|Overall Study|Withdrawal prior to treatment|0
7531768|NCT02659631|11876788|FG003|Overall Study|Withdrawal prior to treatment|0
7531769|NCT02659631|11876789|FG004|Overall Study|Withdrawal prior to treatment|1
7531770|NCT02659631|11876790|FG005|Overall Study|Withdrawal prior to treatment|0
7531771|NCT02659631|11876791|FG006|Overall Study|Withdrawal prior to treatment|0
7531772|NCT02659631|11876792|FG007|Overall Study|Withdrawal prior to treatment|0
7531773|NCT02659631|11876793|FG008|Overall Study|Withdrawal prior to treatment|0
7531774|NCT02659631|11876794|FG009|Overall Study|Withdrawal prior to treatment|0
7531775|NCT02659631|11876785|FG000|Overall Study|Participant refused further follow-up|0
7531776|NCT02659631|11876786|FG001|Overall Study|Participant refused further follow-up|0
7531777|NCT02659631|11876787|FG002|Overall Study|Participant refused further follow-up|0
7531778|NCT02659631|11876788|FG003|Overall Study|Participant refused further follow-up|1
7531779|NCT02659631|11876789|FG004|Overall Study|Participant refused further follow-up|0
7423685|NCT01498822|11699045|FG000|Overall Study|Adverse Event, serious fatal|1
7423686|NCT01498822|11699046|FG001|Overall Study|Adverse Event, serious fatal|1
7423687|NCT01498822|11699045|FG000|Overall Study|Withdrawal by Subject|15
7423688|NCT01498822|11699046|FG001|Overall Study|Withdrawal by Subject|25
7531780|NCT02659631|11876790|FG005|Overall Study|Participant refused further follow-up|0
7531781|NCT02659631|11876791|FG006|Overall Study|Participant refused further follow-up|0
7531782|NCT02659631|11876792|FG007|Overall Study|Participant refused further follow-up|0
7423689|NCT01498822|11699045|FG000|Overall Study|Lost to Follow-up|8
7423690|NCT01498822|11699046|FG001|Overall Study|Lost to Follow-up|3
7423691|NCT01498887|11699056|FG000|Overall Study|Administrative problems|1
7531783|NCT02659631|11876793|FG008|Overall Study|Participant refused further follow-up|1
7531784|NCT02659631|11876794|FG009|Overall Study|Participant refused further follow-up|0
7423692|NCT01498887|11699057|FG001|Overall Study|Administrative problems|0
7423693|NCT01498887|11699056|FG000|Overall Study|Lost to Follow-up|1
7531785|NCT02659631|11876785|FG000|Overall Study|Death (follow-up phase)|1
7531786|NCT02659631|11876786|FG001|Overall Study|Death (follow-up phase)|2
7531787|NCT02659631|11876787|FG002|Overall Study|Death (follow-up phase)|1
7531788|NCT02659631|11876788|FG003|Overall Study|Death (follow-up phase)|1
7531789|NCT02659631|11876789|FG004|Overall Study|Death (follow-up phase)|3
7531790|NCT02659631|11876790|FG005|Overall Study|Death (follow-up phase)|2
7531791|NCT02659631|11876791|FG006|Overall Study|Death (follow-up phase)|0
7531792|NCT02659631|11876792|FG007|Overall Study|Death (follow-up phase)|3
7531793|NCT02659631|11876793|FG008|Overall Study|Death (follow-up phase)|1
7423694|NCT01498887|11699057|FG001|Overall Study|Lost to Follow-up|1
7423695|NCT01498887|11699056|FG000|Overall Study|Withdrawal by Subject|1
7423696|NCT01498887|11699057|FG001|Overall Study|Withdrawal by Subject|0
7423697|NCT01498887|11699056|FG000|Overall Study|Protocol Violation|1
7423698|NCT01498887|11699057|FG001|Overall Study|Protocol Violation|3
7423699|NCT01498887|11699056|FG000|Overall Study|Lack of Efficacy|5
7423700|NCT01498887|11699057|FG001|Overall Study|Lack of Efficacy|3
7423701|NCT01498887|11699056|FG000|Overall Study|Abnormal result from test procedure|1
7423702|NCT01498887|11699057|FG001|Overall Study|Abnormal result from test procedure|1
7423703|NCT01498887|11699056|FG000|Overall Study|Abnormal laboratory value|2
7423704|NCT01498887|11699057|FG001|Overall Study|Abnormal laboratory value|2
7423705|NCT01498887|11699056|FG000|Overall Study|Adverse Event|4
7423706|NCT01498887|11699057|FG001|Overall Study|Adverse Event|1
7423707|NCT01498952|11699066|FG000|Overall Study|Death|2
7423708|NCT01498952|11699067|FG001|Overall Study|Death|2
7423709|NCT01498952|11699068|FG002|Overall Study|Death|0
7423710|NCT01498952|11699069|FG003|Overall Study|Death|0
7423711|NCT01498952|11699070|FG004|Overall Study|Death|0
7423712|NCT01499043|11699089|FG000|Overall Study|Progressive disease (radiographic)|2
7423713|NCT01499043|11699089|FG000|Overall Study|Progressive disease (clinical)|1
7423714|NCT01499043|11699089|FG000|Overall Study|Withdrawal by Subject|2
7423715|NCT01499043|11699089|FG000|Overall Study|Adverse Event|1
7423716|NCT01499134|11699100|FG000|Overall Study|Withdrawal by Subject|0
7423717|NCT01499134|11699101|FG001|Overall Study|Withdrawal by Subject|1
7423718|NCT01499199|11699125|FG000|Overall Study|Adverse Event|1
7423719|NCT01499199|11699125|FG000|Overall Study|Lack of Efficacy|1
7423720|NCT01499277|11699131|FG000|Overall Study|Adverse Event|3
7423721|NCT01499277|11699132|FG001|Overall Study|Adverse Event|6
7423722|NCT01499277|11699131|FG000|Overall Study|Death|3
7423723|NCT01499277|11699132|FG001|Overall Study|Death|2
7423724|NCT01499277|11699131|FG000|Overall Study|Lost to Follow-up|15
7423725|NCT01499277|11699132|FG001|Overall Study|Lost to Follow-up|8
7423726|NCT01499277|11699131|FG000|Overall Study|Protocol Violation|2
7423727|NCT01499277|11699132|FG001|Overall Study|Protocol Violation|3
7423728|NCT01499277|11699131|FG000|Overall Study|Withdrawal by Subject|16
7423729|NCT01499277|11699132|FG001|Overall Study|Withdrawal by Subject|6
7423730|NCT01499277|11699131|FG000|Overall Study|Lack of therapeutic response and other|8
7423731|NCT01499277|11699132|FG001|Overall Study|Lack of therapeutic response and other|7
7423732|NCT01499290|11699140|FG000|Overall Study|Withdrawal by Subject|22
7423733|NCT01499290|11699141|FG001|Overall Study|Withdrawal by Subject|15
7423734|NCT01499290|11699140|FG000|Overall Study|Not specified in study report|11
7423735|NCT01499290|11699141|FG001|Overall Study|Not specified in study report|5
7423736|NCT01499290|11699140|FG000|Overall Study|Condition improved/subject recovered|1
7423737|NCT01499290|11699141|FG001|Overall Study|Condition improved/subject recovered|0
7423738|NCT01499290|11699140|FG000|Overall Study|Lack of Efficacy|7
7423739|NCT01499290|11699141|FG001|Overall Study|Lack of Efficacy|8
7423740|NCT01499290|11699140|FG000|Overall Study|Adverse Event|14
7423741|NCT01499290|11699141|FG001|Overall Study|Adverse Event|7
7423742|NCT01499303|11699168|FG000|Overall Study|Ongoing|2
7423743|NCT01499303|11699169|FG001|Overall Study|Ongoing|1
7423744|NCT01499303|11699168|FG000|Overall Study|Withdrawal by Subject|0
7423745|NCT01499303|11699169|FG001|Overall Study|Withdrawal by Subject|1
7423746|NCT01499303|11699168|FG000|Overall Study|Adverse Event|1
7423747|NCT01499303|11699169|FG001|Overall Study|Adverse Event|4
7423748|NCT01499303|11699168|FG000|Overall Study|Other|0
7423749|NCT01499303|11699169|FG001|Overall Study|Other|1
7423750|NCT01499355|11699175|FG000|Run-In Period|Study Termination|15
7423751|NCT01499355|11699176|FG001|Run-In Period|Study Termination|0
7423752|NCT01499355|11699177|FG002|Run-In Period|Study Termination|0
7423753|NCT01499355|11699178|FG003|Run-In Period|Study Termination|0
7423754|NCT01499355|11699175|FG000|Run-In Period|Other|3
7423755|NCT01499355|11699176|FG001|Run-In Period|Other|0
7423756|NCT01499355|11699177|FG002|Run-In Period|Other|0
7423757|NCT01499355|11699178|FG003|Run-In Period|Other|0
7423758|NCT01499355|11699175|FG000|Run-In Period|Death|2
7423759|NCT01499355|11699176|FG001|Run-In Period|Death|0
7423760|NCT01499355|11699177|FG002|Run-In Period|Death|0
7423761|NCT01499355|11699178|FG003|Run-In Period|Death|0
7531794|NCT02659631|11876794|FG009|Overall Study|Death (follow-up phase)|0
7531795|NCT02659631|11876785|FG000|Overall Study|Death (treatment phase)|0
7423762|NCT01499355|11699175|FG000|Run-In Period|Investigator Decision|2
7423763|NCT01499355|11699176|FG001|Run-In Period|Investigator Decision|0
7531796|NCT02659631|11876786|FG001|Overall Study|Death (treatment phase)|0
7423764|NCT01499355|11699177|FG002|Run-In Period|Investigator Decision|0
7423765|NCT01499355|11699178|FG003|Run-In Period|Investigator Decision|0
7423766|NCT01499355|11699175|FG000|Run-In Period|Consent Withdrawn|1
7423767|NCT01499355|11699176|FG001|Run-In Period|Consent Withdrawn|0
7423768|NCT01499355|11699177|FG002|Run-In Period|Consent Withdrawn|0
7423769|NCT01499355|11699178|FG003|Run-In Period|Consent Withdrawn|0
7423770|NCT01499355|11699175|FG000|Run-In Period|Adverse Event|8
7423771|NCT01499355|11699176|FG001|Run-In Period|Adverse Event|0
7423772|NCT01499355|11699177|FG002|Run-In Period|Adverse Event|0
7423773|NCT01499355|11699178|FG003|Run-In Period|Adverse Event|0
7423774|NCT01499355|11699175|FG000|Double-Blind Period|Adverse Event|0
7423775|NCT01499355|11699176|FG001|Double-Blind Period|Adverse Event|2
7423776|NCT01499355|11699177|FG002|Double-Blind Period|Adverse Event|3
7423777|NCT01499355|11699178|FG003|Double-Blind Period|Adverse Event|2
7423778|NCT01499355|11699175|FG000|Double-Blind Period|Study Termination|0
7423779|NCT01499355|11699176|FG001|Double-Blind Period|Study Termination|18
7423780|NCT01499355|11699177|FG002|Double-Blind Period|Study Termination|16
7423781|NCT01499355|11699178|FG003|Double-Blind Period|Study Termination|14
7423782|NCT01499355|11699175|FG000|Double-Blind Period|Other|0
7423783|NCT01499355|11699176|FG001|Double-Blind Period|Other|1
7423784|NCT01499355|11699177|FG002|Double-Blind Period|Other|2
7423785|NCT01499355|11699178|FG003|Double-Blind Period|Other|2
7423786|NCT01499355|11699175|FG000|Double-Blind Period|Death|0
7423787|NCT01499355|11699176|FG001|Double-Blind Period|Death|1
7423788|NCT01499355|11699177|FG002|Double-Blind Period|Death|0
7423789|NCT01499355|11699178|FG003|Double-Blind Period|Death|0
7423790|NCT01499355|11699175|FG000|Double-Blind Period|Investigator Decision|0
7423791|NCT01499355|11699176|FG001|Double-Blind Period|Investigator Decision|0
7423792|NCT01499355|11699177|FG002|Double-Blind Period|Investigator Decision|3
7423793|NCT01499355|11699178|FG003|Double-Blind Period|Investigator Decision|3
7423794|NCT01499355|11699175|FG000|Double-Blind Period|Consent Withdrawn|0
7423795|NCT01499355|11699176|FG001|Double-Blind Period|Consent Withdrawn|0
7423796|NCT01499355|11699177|FG002|Double-Blind Period|Consent Withdrawn|1
7423797|NCT01499355|11699178|FG003|Double-Blind Period|Consent Withdrawn|2
7423798|NCT01499355|11699175|FG000|Double-Blind Period|Lost to Follow-up|0
7423799|NCT01499355|11699176|FG001|Double-Blind Period|Lost to Follow-up|1
7423800|NCT01499355|11699177|FG002|Double-Blind Period|Lost to Follow-up|0
7423801|NCT01499355|11699178|FG003|Double-Blind Period|Lost to Follow-up|0
7423802|NCT01499368|11699191|FG000|Overall Study|Did not meet I/E criteria|8
7423803|NCT01499368|11699192|FG001|Overall Study|Did not meet I/E criteria|4
7423804|NCT01499368|11699193|FG002|Overall Study|Did not meet I/E criteria|4
7423805|NCT01499368|11699191|FG000|Overall Study|Prohibited Concomitant medication|1
7423806|NCT01499368|11699192|FG001|Overall Study|Prohibited Concomitant medication|1
7423807|NCT01499368|11699193|FG002|Overall Study|Prohibited Concomitant medication|0
7423808|NCT01499368|11699191|FG000|Overall Study|Withdrawal by Subject|11
7423809|NCT01499368|11699192|FG001|Overall Study|Withdrawal by Subject|10
7423810|NCT01499368|11699193|FG002|Overall Study|Withdrawal by Subject|8
7423811|NCT01499368|11699191|FG000|Overall Study|Lost to Follow-up|3
7531797|NCT02659631|11876787|FG002|Overall Study|Death (treatment phase)|0
7531798|NCT02659631|11876788|FG003|Overall Study|Death (treatment phase)|0
7531799|NCT02659631|11876789|FG004|Overall Study|Death (treatment phase)|1
7531800|NCT02659631|11876790|FG005|Overall Study|Death (treatment phase)|0
7531801|NCT02659631|11876791|FG006|Overall Study|Death (treatment phase)|1
7531802|NCT02659631|11876792|FG007|Overall Study|Death (treatment phase)|0
7531803|NCT02659631|11876793|FG008|Overall Study|Death (treatment phase)|0
7531804|NCT02659631|11876794|FG009|Overall Study|Death (treatment phase)|0
7531805|NCT02659943|11876836|FG000|Overall Study|Switched to alternative treatment|1
7423812|NCT01499368|11699192|FG001|Overall Study|Lost to Follow-up|2
7423813|NCT01499368|11699193|FG002|Overall Study|Lost to Follow-up|5
7423814|NCT01499368|11699191|FG000|Overall Study|Adverse Event|4
7423815|NCT01499368|11699192|FG001|Overall Study|Adverse Event|0
7423816|NCT01499368|11699193|FG002|Overall Study|Adverse Event|2
7423817|NCT01499368|11699191|FG000|Overall Study|Physician Decision|0
7423818|NCT01499368|11699192|FG001|Overall Study|Physician Decision|1
7423819|NCT01499368|11699193|FG002|Overall Study|Physician Decision|0
7423820|NCT01499368|11699191|FG000|Overall Study|Deviation from visit window|0
7423821|NCT01499368|11699192|FG001|Overall Study|Deviation from visit window|0
7423822|NCT01499368|11699193|FG002|Overall Study|Deviation from visit window|1
7423823|NCT01499368|11699191|FG000|Overall Study|Error of Prescriptions|0
7423824|NCT01499368|11699192|FG001|Overall Study|Error of Prescriptions|0
7423825|NCT01499368|11699193|FG002|Overall Study|Error of Prescriptions|1
7423826|NCT01499511|11699210|FG000|Overall Study|Death|1
7423827|NCT01499511|11699211|FG001|Overall Study|Death|0
7531806|NCT02659943|11876837|FG001|Overall Study|Switched to alternative treatment|1
7531807|NCT02659943|11876838|FG002|Overall Study|Switched to alternative treatment|0
7423828|NCT01499576|11699218|FG000|Overall Study|Physician Decision|12
7423829|NCT01499576|11699218|FG000|Overall Study|Withdrawal by Subject|9
7423830|NCT01499667|11699236|FG000|Overall Study|administrative problems|4
7423831|NCT01499667|11699237|FG001|Overall Study|administrative problems|5
7423832|NCT01499667|11699238|FG002|Overall Study|administrative problems|5
7423833|NCT01499667|11699236|FG000|Overall Study|Protocol Violation|1
7423834|NCT01499667|11699237|FG001|Overall Study|Protocol Violation|3
7423835|NCT01499667|11699238|FG002|Overall Study|Protocol Violation|2
7423836|NCT01499667|11699236|FG000|Overall Study|Adverse Event|0
7423837|NCT01499667|11699237|FG001|Overall Study|Adverse Event|2
7423838|NCT01499667|11699238|FG002|Overall Study|Adverse Event|2
7423839|NCT01499667|11699236|FG000|Overall Study|Withdrawal by Subject|2
7423840|NCT01499667|11699237|FG001|Overall Study|Withdrawal by Subject|1
7423841|NCT01499667|11699238|FG002|Overall Study|Withdrawal by Subject|1
7423842|NCT01499667|11699236|FG000|Overall Study|Lack of Efficacy|2
7423843|NCT01499667|11699237|FG001|Overall Study|Lack of Efficacy|0
7423844|NCT01499667|11699238|FG002|Overall Study|Lack of Efficacy|0
7423845|NCT01499810|11699246|FG000|Overall Study|Lost to Follow-up|10
7423846|NCT01499810|11699246|FG000|Overall Study|Protocol Violation|1
7423847|NCT01499810|11699246|FG000|Overall Study|Withdrawal by Subject|1
7423848|NCT01499849|11699253|FG000|Overall Study|Adverse Event|28
7423849|NCT01499849|11699254|FG001|Overall Study|Adverse Event|32
7423850|NCT01499849|11699253|FG000|Overall Study|Chemo completed or Change in Therapy|70
7423851|NCT01499849|11699254|FG001|Overall Study|Chemo completed or Change in Therapy|67
7423852|NCT01499849|11699253|FG000|Overall Study|Withdrawal by Subject|43
7423853|NCT01499849|11699254|FG001|Overall Study|Withdrawal by Subject|43
7423854|NCT01499849|11699253|FG000|Overall Study|Death|5
7423855|NCT01499849|11699254|FG001|Overall Study|Death|7
7423856|NCT01499849|11699253|FG000|Overall Study|Disease Progression|11
7423857|NCT01499849|11699254|FG001|Overall Study|Disease Progression|10
7423858|NCT01499849|11699253|FG000|Overall Study|Protocol Violation|11
7423859|NCT01499849|11699254|FG001|Overall Study|Protocol Violation|11
7423860|NCT01499849|11699253|FG000|Overall Study|Physician Decision|20
7423861|NCT01499849|11699254|FG001|Overall Study|Physician Decision|19
7423862|NCT01499849|11699253|FG000|Overall Study|Lack of Efficacy|3
7423863|NCT01499849|11699254|FG001|Overall Study|Lack of Efficacy|4
7423864|NCT01499849|11699253|FG000|Overall Study|Lost to Follow-up|6
7423865|NCT01499849|11699254|FG001|Overall Study|Lost to Follow-up|3
7423866|NCT01499849|11699253|FG000|Overall Study|Other Reasons|27
7423867|NCT01499849|11699254|FG001|Overall Study|Other Reasons|30
7423868|NCT01499940|11699278|FG000|Overall Study|Study was withdrawn before completion.|9
7423869|NCT01500031|11699282|FG000|Overall Study|Death|1
7423870|NCT01500031|11699282|FG000|Overall Study|Withdrawal by Subject|4
7423871|NCT01500057|11699288|FG000|Overall Study|Lost to Follow-up|6
7423872|NCT01500057|11699289|FG001|Overall Study|Lost to Follow-up|4
7423873|NCT01500083|11699297|FG000|Overall Study|Adverse Event|4
7423874|NCT01500083|11699298|FG001|Overall Study|Adverse Event|17
7423875|NCT01500083|11699297|FG000|Overall Study|Death|0
7423876|NCT01500083|11699298|FG001|Overall Study|Death|2
7423877|NCT01500083|11699297|FG000|Overall Study|Lost to Follow-up|1
7423878|NCT01500083|11699298|FG001|Overall Study|Lost to Follow-up|0
7423879|NCT01500083|11699297|FG000|Overall Study|Withdrawal of Consent|0
7423880|NCT01500083|11699298|FG001|Overall Study|Withdrawal of Consent|1
7423881|NCT01500083|11699297|FG000|Overall Study|Disease Progression|2
7423882|NCT01500083|11699298|FG001|Overall Study|Disease Progression|10
7423883|NCT01500083|11699297|FG000|Overall Study|Investigator Discretion|3
7423884|NCT01500083|11699298|FG001|Overall Study|Investigator Discretion|8
7423885|NCT01500083|11699297|FG000|Overall Study|Other Reasons|2
7423886|NCT01500083|11699298|FG001|Overall Study|Other Reasons|5
7423887|NCT01500096|11699308|FG000|Overall Study|Lost to Follow-up|1
7423888|NCT01500096|11699309|FG001|Overall Study|Lost to Follow-up|0
7423889|NCT01500096|11699310|FG002|Overall Study|Lost to Follow-up|0
7423890|NCT01500096|11699311|FG003|Overall Study|Lost to Follow-up|2
7423891|NCT01500135|11699323|FG000|Overall Study|Withdrawal of Consent|4
7423892|NCT01500135|11699324|FG001|Overall Study|Withdrawal of Consent|0
7423893|NCT01500135|11699323|FG000|Overall Study|Lost to Follow-up|6
7423894|NCT01500135|11699324|FG001|Overall Study|Lost to Follow-up|4
7423895|NCT01500135|11699323|FG000|Overall Study|Fatal Adverse Event (AE)|5
7423896|NCT01500135|11699324|FG001|Overall Study|Fatal Adverse Event (AE)|5
7423897|NCT01500135|11699323|FG000|Overall Study|Principal Investigator (PI) Discretion|1
7423898|NCT01500135|11699324|FG001|Overall Study|Principal Investigator (PI) Discretion|0
7423899|NCT01500135|11699323|FG000|Overall Study|Patient Missed Scheduled Appointments|0
7423900|NCT01500135|11699324|FG001|Overall Study|Patient Missed Scheduled Appointments|1
7423901|NCT01500135|11699323|FG000|Overall Study|Participant was a Safety Concern|1
7423902|NCT01500135|11699324|FG001|Overall Study|Participant was a Safety Concern|0
7423903|NCT01500135|11699323|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
7423904|NCT01500135|11699324|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
7423905|NCT01500187|11699332|FG000|Overall Study|Lost to Follow-up|6
7423906|NCT01500187|11699333|FG001|Overall Study|Lost to Follow-up|0
7423907|NCT01500200|11699342|FG000|Stage 1|Adverse Event|1
7423908|NCT01500200|11699343|FG001|Stage 1|Adverse Event|4
7423909|NCT01500200|11699344|FG002|Stage 1|Adverse Event|5
7423910|NCT01500200|11699345|FG003|Stage 1|Adverse Event|0
7423911|NCT01500200|11699346|FG004|Stage 1|Adverse Event|0
7423912|NCT01500200|11699347|FG005|Stage 1|Adverse Event|0
7423913|NCT01500200|11699342|FG000|Stage 1|Lost to Follow-up|2
7423914|NCT01500200|11699343|FG001|Stage 1|Lost to Follow-up|2
7423915|NCT01500200|11699344|FG002|Stage 1|Lost to Follow-up|1
7423916|NCT01500200|11699345|FG003|Stage 1|Lost to Follow-up|0
7423917|NCT01500200|11699346|FG004|Stage 1|Lost to Follow-up|0
7423918|NCT01500200|11699347|FG005|Stage 1|Lost to Follow-up|0
7423919|NCT01500200|11699342|FG000|Stage 1|Withdrawal by Subject|3
7423920|NCT01500200|11699343|FG001|Stage 1|Withdrawal by Subject|0
7423921|NCT01500200|11699344|FG002|Stage 1|Withdrawal by Subject|0
7423922|NCT01500200|11699345|FG003|Stage 1|Withdrawal by Subject|0
7423923|NCT01500200|11699346|FG004|Stage 1|Withdrawal by Subject|0
7423924|NCT01500200|11699347|FG005|Stage 1|Withdrawal by Subject|0
7423925|NCT01500200|11699342|FG000|Stage 1|Noncompliance with Study Drug|1
7423926|NCT01500200|11699343|FG001|Stage 1|Noncompliance with Study Drug|0
7423927|NCT01500200|11699344|FG002|Stage 1|Noncompliance with Study Drug|0
7423928|NCT01500200|11699345|FG003|Stage 1|Noncompliance with Study Drug|0
7423929|NCT01500200|11699346|FG004|Stage 1|Noncompliance with Study Drug|0
7423930|NCT01500200|11699347|FG005|Stage 1|Noncompliance with Study Drug|0
7423931|NCT01500200|11699342|FG000|Stage 1|Physician Decision|1
7423932|NCT01500200|11699343|FG001|Stage 1|Physician Decision|0
7531808|NCT02659943|11876839|FG003|Overall Study|Switched to alternative treatment|2
7531809|NCT02659943|11876840|FG004|Overall Study|Switched to alternative treatment|1
7531810|NCT02659943|11876841|FG005|Overall Study|Switched to alternative treatment|0
7531811|NCT02659943|11876842|FG006|Overall Study|Switched to alternative treatment|1
7531812|NCT02659943|11876836|FG000|Overall Study|Disease progression on study|0
7531813|NCT02659943|11876837|FG001|Overall Study|Disease progression on study|1
7531814|NCT02659943|11876838|FG002|Overall Study|Disease progression on study|1
7531815|NCT02659943|11876839|FG003|Overall Study|Disease progression on study|1
7531816|NCT02659943|11876840|FG004|Overall Study|Disease progression on study|1
7531817|NCT02659943|11876841|FG005|Overall Study|Disease progression on study|4
7531818|NCT02659943|11876842|FG006|Overall Study|Disease progression on study|0
7531819|NCT02659943|11876836|FG000|Overall Study|Patient's condition per principal investigator|0
7531820|NCT02659943|11876837|FG001|Overall Study|Patient's condition per principal investigator|0
7531821|NCT02659943|11876838|FG002|Overall Study|Patient's condition per principal investigator|0
7531822|NCT02659943|11876839|FG003|Overall Study|Patient's condition per principal investigator|0
7531823|NCT02659943|11876840|FG004|Overall Study|Patient's condition per principal investigator|0
7531824|NCT02659943|11876841|FG005|Overall Study|Patient's condition per principal investigator|1
7531825|NCT02659943|11876842|FG006|Overall Study|Patient's condition per principal investigator|0
7531826|NCT02659943|11876836|FG000|Overall Study|Ineligible|0
7531827|NCT02659943|11876837|FG001|Overall Study|Ineligible|0
7423933|NCT01500200|11699344|FG002|Stage 1|Physician Decision|0
7423934|NCT01500200|11699345|FG003|Stage 1|Physician Decision|0
7423935|NCT01500200|11699346|FG004|Stage 1|Physician Decision|0
7423936|NCT01500200|11699347|FG005|Stage 1|Physician Decision|0
7423937|NCT01500200|11699342|FG000|Stage 2|Adverse Event|0
7423938|NCT01500200|11699343|FG001|Stage 2|Adverse Event|0
7423939|NCT01500200|11699344|FG002|Stage 2|Adverse Event|0
7423940|NCT01500200|11699345|FG003|Stage 2|Adverse Event|0
7423941|NCT01500200|11699346|FG004|Stage 2|Adverse Event|5
7423942|NCT01500200|11699347|FG005|Stage 2|Adverse Event|4
7423943|NCT01500213|11699363|FG000|Overall Study|Adverse Event|35
7423944|NCT01500213|11699364|FG001|Overall Study|Adverse Event|35
7423945|NCT01500213|11699363|FG000|Overall Study|Chemo Completed or Change in Therapy|84
7423946|NCT01500213|11699364|FG001|Overall Study|Chemo Completed or Change in Therapy|81
7423947|NCT01500213|11699363|FG000|Overall Study|Withdrawal by Subject|28
7423948|NCT01500213|11699364|FG001|Overall Study|Withdrawal by Subject|37
7423949|NCT01500213|11699363|FG000|Overall Study|Death|7
7423950|NCT01500213|11699364|FG001|Overall Study|Death|3
7423951|NCT01500213|11699363|FG000|Overall Study|Disease Progression|13
7423952|NCT01500213|11699364|FG001|Overall Study|Disease Progression|21
7423953|NCT01500213|11699363|FG000|Overall Study|Protocol Violation|19
7423954|NCT01500213|11699364|FG001|Overall Study|Protocol Violation|19
7423955|NCT01500213|11699363|FG000|Overall Study|Physician Decision|12
7423956|NCT01500213|11699364|FG001|Overall Study|Physician Decision|10
7423957|NCT01500213|11699363|FG000|Overall Study|Lack of Efficacy|9
7423958|NCT01500213|11699364|FG001|Overall Study|Lack of Efficacy|7
7423959|NCT01500213|11699363|FG000|Overall Study|Lost to Follow-up|3
7423960|NCT01500213|11699364|FG001|Overall Study|Lost to Follow-up|6
7423961|NCT01500213|11699363|FG000|Overall Study|Other Reasons|7
7423962|NCT01500213|11699364|FG001|Overall Study|Other Reasons|5
7423963|NCT01500226|11699372|FG000|Overall Study|Adverse Event|31
7423964|NCT01500226|11699373|FG001|Overall Study|Adverse Event|38
7423965|NCT01500226|11699372|FG000|Overall Study|Chemo Completed or Change in Therapy|235
7423966|NCT01500226|11699373|FG001|Overall Study|Chemo Completed or Change in Therapy|237
7423967|NCT01500226|11699372|FG000|Overall Study|Withdrawal by Subject|93
7423968|NCT01500226|11699373|FG001|Overall Study|Withdrawal by Subject|96
7423969|NCT01500226|11699372|FG000|Overall Study|Death|12
7423970|NCT01500226|11699373|FG001|Overall Study|Death|4
7423971|NCT01500226|11699372|FG000|Overall Study|Disease Progression|16
7423972|NCT01500226|11699373|FG001|Overall Study|Disease Progression|14
7531828|NCT02659943|11876838|FG002|Overall Study|Ineligible|0
7531829|NCT02659943|11876839|FG003|Overall Study|Ineligible|0
7531830|NCT02659943|11876840|FG004|Overall Study|Ineligible|0
7423973|NCT01500226|11699372|FG000|Overall Study|Protocol Violation|53
7423974|NCT01500226|11699373|FG001|Overall Study|Protocol Violation|39
7423975|NCT01500226|11699372|FG000|Overall Study|Physician Decision|17
7423976|NCT01500226|11699373|FG001|Overall Study|Physician Decision|15
7423977|NCT01500226|11699372|FG000|Overall Study|Lack of Efficacy|14
7423978|NCT01500226|11699373|FG001|Overall Study|Lack of Efficacy|30
7423979|NCT01500226|11699372|FG000|Overall Study|Lost to Follow-up|9
7423980|NCT01500226|11699373|FG001|Overall Study|Lost to Follow-up|5
7423981|NCT01500226|11699372|FG000|Overall Study|Other Reasons|19
7423982|NCT01500226|11699373|FG001|Overall Study|Other Reasons|16
7423983|NCT01500252|11699381|FG000|Overall Study|Death|4
7423984|NCT01500252|11699382|FG001|Overall Study|Death|2
7423985|NCT01500252|11699381|FG000|Overall Study|Lost to Follow-up|5
7423986|NCT01500252|11699382|FG001|Overall Study|Lost to Follow-up|4
7423987|NCT01500278|11699391|FG000|Week 0 - Week 12|Lack of Efficacy|0
7423988|NCT01500278|11699392|FG001|Week 0 - Week 12|Lack of Efficacy|1
7423989|NCT01500278|11699391|FG000|Week 0 - Week 12|Protocol Violation|10
7423990|NCT01500278|11699392|FG001|Week 0 - Week 12|Protocol Violation|16
7423991|NCT01500278|11699391|FG000|Week 0 - Week 12|Lost to Follow-up|1
7423992|NCT01500278|11699392|FG001|Week 0 - Week 12|Lost to Follow-up|1
7423993|NCT01500278|11699391|FG000|Week 0 - Week 12|Withdrawal by Subject|7
7423994|NCT01500278|11699392|FG001|Week 0 - Week 12|Withdrawal by Subject|2
7423995|NCT01500278|11699391|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
7423996|NCT01500278|11699392|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
7423997|NCT01500278|11699391|FG000|Week 0 - Week 12|Patient decision|1
7423998|NCT01500278|11699392|FG001|Week 0 - Week 12|Patient decision|0
7423999|NCT01500278|11699391|FG000|Week 0 - Week 12|Exclusion criteria not met|1
7424000|NCT01500278|11699392|FG001|Week 0 - Week 12|Exclusion criteria not met|0
7424001|NCT01500278|11699391|FG000|Week 0 - Week 12|Investigator decision|1
7424002|NCT01500278|11699392|FG001|Week 0 - Week 12|Investigator decision|0
7424003|NCT01500278|11699391|FG000|Week 0 - Week 12|Prior history of serious disease|1
7424004|NCT01500278|11699392|FG001|Week 0 - Week 12|Prior history of serious disease|0
7424005|NCT01500278|11699391|FG000|Week 0 - Week 12|Sponsor decision|1
7424006|NCT01500278|11699392|FG001|Week 0 - Week 12|Sponsor decision|0
7424007|NCT01500278|11699391|FG000|Week 0 - Week 12|Personal reason|0
7424008|NCT01500278|11699392|FG001|Week 0 - Week 12|Personal reason|1
7424009|NCT01500278|11699391|FG000|Week 0 - Week 12|Other serious disease|0
7424010|NCT01500278|11699392|FG001|Week 0 - Week 12|Other serious disease|1
7424011|NCT01500278|11699391|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
7424012|NCT01500278|11699392|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
7424013|NCT01500278|11699391|FG000|Week 13 - Week 104|Lack of Efficacy|11
7424014|NCT01500278|11699392|FG001|Week 13 - Week 104|Lack of Efficacy|12
7424015|NCT01500278|11699391|FG000|Week 13 - Week 104|Protocol Violation|6
7424016|NCT01500278|11699392|FG001|Week 13 - Week 104|Protocol Violation|6
7424017|NCT01500278|11699391|FG000|Week 13 - Week 104|Lost to Follow-up|6
7424018|NCT01500278|11699392|FG001|Week 13 - Week 104|Lost to Follow-up|5
7424019|NCT01500278|11699391|FG000|Week 13 - Week 104|Withdrawal by Subject|22
7424020|NCT01500278|11699392|FG001|Week 13 - Week 104|Withdrawal by Subject|13
7424021|NCT01500278|11699391|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
7531831|NCT02659943|11876841|FG005|Overall Study|Ineligible|0
7531832|NCT02659943|11876842|FG006|Overall Study|Ineligible|1
7531833|NCT02659943|11876836|FG000|Overall Study|No longer meets eligibility|0
7531834|NCT02659943|11876837|FG001|Overall Study|No longer meets eligibility|0
7531835|NCT02659943|11876838|FG002|Overall Study|No longer meets eligibility|0
7531836|NCT02659943|11876839|FG003|Overall Study|No longer meets eligibility|0
7531837|NCT02659943|11876840|FG004|Overall Study|No longer meets eligibility|0
7531838|NCT02659943|11876841|FG005|Overall Study|No longer meets eligibility|0
7531839|NCT02659943|11876842|FG006|Overall Study|No longer meets eligibility|1
7531840|NCT02659943|11876836|FG000|Overall Study|No treatment, per protocol|0
7531841|NCT02659943|11876837|FG001|Overall Study|No treatment, per protocol|0
7531842|NCT02659943|11876838|FG002|Overall Study|No treatment, per protocol|0
7531843|NCT02659943|11876839|FG003|Overall Study|No treatment, per protocol|0
7531844|NCT02659943|11876840|FG004|Overall Study|No treatment, per protocol|0
7531845|NCT02659943|11876841|FG005|Overall Study|No treatment, per protocol|0
7531846|NCT02659943|11876842|FG006|Overall Study|No treatment, per protocol|3
7424022|NCT01500278|11699392|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
7531868|NCT02660229|11876885|FG000|Overall Study|Adverse Event|2
7424023|NCT01500278|11699391|FG000|Week 13 - Week 104|Non/bad compliance|7
7424024|NCT01500278|11699392|FG001|Week 13 - Week 104|Non/bad compliance|5
7531869|NCT02660229|11876886|FG001|Overall Study|Adverse Event|0
7531870|NCT02660229|11876885|FG000|Overall Study|Withdrawal by Subject|0
7424025|NCT01500278|11699391|FG000|Week 13 - Week 104|Recurrent infections|1
7424026|NCT01500278|11699392|FG001|Week 13 - Week 104|Recurrent infections|0
7424027|NCT01500278|11699391|FG000|Week 13 - Week 104|False positive test|1
7424028|NCT01500278|11699392|FG001|Week 13 - Week 104|False positive test|2
7424029|NCT01500278|11699391|FG000|Week 13 - Week 104|Sponsor request|4
7424030|NCT01500278|11699392|FG001|Week 13 - Week 104|Sponsor request|0
7424031|NCT01500278|11699391|FG000|Week 13 - Week 104|Withdrawn in error|1
7424032|NCT01500278|11699392|FG001|Week 13 - Week 104|Withdrawn in error|0
7424033|NCT01500278|11699391|FG000|Week 13 - Week 104|Exclusion criteria not met|1
7424034|NCT01500278|11699392|FG001|Week 13 - Week 104|Exclusion criteria not met|0
7424035|NCT01500278|11699391|FG000|Week 13 - Week 104|Protocol deviation|1
7424036|NCT01500278|11699392|FG001|Week 13 - Week 104|Protocol deviation|0
7424037|NCT01500278|11699391|FG000|Week 13 - Week 104|Principal investigator retiring|1
7424038|NCT01500278|11699392|FG001|Week 13 - Week 104|Principal investigator retiring|0
7424039|NCT01500278|11699391|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
7424040|NCT01500278|11699392|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
7424041|NCT01500278|11699391|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
7424042|NCT01500278|11699392|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
7424043|NCT01500278|11699391|FG000|Week 13 - Week 104|Relocation|0
7424044|NCT01500278|11699392|FG001|Week 13 - Week 104|Relocation|1
7424045|NCT01500278|11699391|FG000|Week 13 - Week 104|Sponsor decision|0
7424046|NCT01500278|11699392|FG001|Week 13 - Week 104|Sponsor decision|2
7424047|NCT01500278|11699391|FG000|Week 13 - Week 104|Medical monitor decision|0
7424048|NCT01500278|11699392|FG001|Week 13 - Week 104|Medical monitor decision|2
7424049|NCT01500278|11699391|FG000|Week 13 - Week 104|Personal reason|0
7424050|NCT01500278|11699392|FG001|Week 13 - Week 104|Personal reason|1
7424051|NCT01500278|11699391|FG000|Week 13 - Week 104|Not completed|0
7424052|NCT01500278|11699392|FG001|Week 13 - Week 104|Not completed|1
7424053|NCT01500278|11699391|FG000|Week 13 - Week 104|Death|2
7424054|NCT01500278|11699392|FG001|Week 13 - Week 104|Death|4
7424055|NCT01500278|11699391|FG000|Week 13 - Week 104|Adverse Event|54
7424056|NCT01500278|11699392|FG001|Week 13 - Week 104|Adverse Event|54
7424057|NCT01500317|11699403|FG000|Overall Study|Withdrawal by Subject|3
7424058|NCT01500317|11699404|FG001|Overall Study|Withdrawal by Subject|2
7424059|NCT01500317|11699405|FG002|Overall Study|Withdrawal by Subject|0
7424060|NCT01500382|11699417|FG000|Washout Period|Study site went out of business|0
7424061|NCT01500382|11699418|FG001|Washout Period|Study site went out of business|0
7424062|NCT01500382|11699419|FG002|Washout Period|Study site went out of business|1
7424063|NCT01500382|11699420|FG003|Washout Period|Study site went out of business|0
7424064|NCT01500434|11699430|FG000|Overall Study|Death|1
7424065|NCT01500434|11699430|FG000|Overall Study|Withdrawal by Subject|1
7424066|NCT01500434|11699430|FG000|Overall Study|Missed 12-month follow-up|5
7424067|NCT01500629|11699445|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
7424068|NCT01500629|11699446|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
7424069|NCT01500694|11699461|FG000|Overall Study|Adverse Event|4
7424070|NCT01500694|11699462|FG001|Overall Study|Adverse Event|3
7424071|NCT01500694|11699461|FG000|Overall Study|Protocol Violation|0
7424072|NCT01500694|11699462|FG001|Overall Study|Protocol Violation|1
7424073|NCT01500694|11699461|FG000|Overall Study|Withdrawal by Subject|23
7424074|NCT01500694|11699462|FG001|Overall Study|Withdrawal by Subject|14
7424075|NCT01500694|11699461|FG000|Overall Study|Lost to Follow-up|2
7424076|NCT01500694|11699462|FG001|Overall Study|Lost to Follow-up|3
7424077|NCT01500694|11699461|FG000|Overall Study|Lack of Efficacy|14
7424078|NCT01500694|11699462|FG001|Overall Study|Lack of Efficacy|5
7424079|NCT01500694|11699461|FG000|Overall Study|Other|9
7424080|NCT01500694|11699462|FG001|Overall Study|Other|3
7424081|NCT01500720|11699470|FG000|Overall Study|Randomized But Not Treated|1
7424082|NCT01500720|11699471|FG001|Overall Study|Randomized But Not Treated|1
7424083|NCT01500720|11699470|FG000|Overall Study|Other|4
7424084|NCT01500720|11699471|FG001|Overall Study|Other|8
7424085|NCT01501110|11699506|FG000|Overall Study|Death|0
7424086|NCT01501110|11699507|FG001|Overall Study|Death|1
7424087|NCT01502033|11699529|FG000|Overall Study|1 participant had scalp discomfort|1
7424088|NCT01502033|11699529|FG000|Overall Study|1 participant had worsening depression|1
7424089|NCT01502033|11699529|FG000|Overall Study|1 participant went back to school|1
7424090|NCT01502072|11699538|FG000|Overall Study|Withdrawal by Subject|1
7424091|NCT01502072|11699539|FG001|Overall Study|Withdrawal by Subject|0
7424092|NCT01502072|11699540|FG002|Overall Study|Withdrawal by Subject|0
7424093|NCT01502072|11699538|FG000|Overall Study|Death|0
7424094|NCT01502072|11699539|FG001|Overall Study|Death|1
7424095|NCT01502072|11699540|FG002|Overall Study|Death|0
7424096|NCT01502228|11699548|FG000|Overall Study|Death|1
7424097|NCT01502293|11699555|FG000|Overall Study|Progressive Disease|20
7424098|NCT01502293|11699556|FG001|Overall Study|Progressive Disease|12
7424099|NCT01502293|11699557|FG002|Overall Study|Progressive Disease|2
7424100|NCT01502293|11699555|FG000|Overall Study|Withdrawal by Subject|3
7424101|NCT01502293|11699556|FG001|Overall Study|Withdrawal by Subject|3
7424102|NCT01502293|11699557|FG002|Overall Study|Withdrawal by Subject|1
7424103|NCT01502293|11699555|FG000|Overall Study|Adverse Event|0
7424104|NCT01502293|11699556|FG001|Overall Study|Adverse Event|2
7424105|NCT01502293|11699557|FG002|Overall Study|Adverse Event|0
7424106|NCT01502293|11699555|FG000|Overall Study|Reason Not Specified|2
7424107|NCT01502293|11699556|FG001|Overall Study|Reason Not Specified|0
7424108|NCT01502293|11699557|FG002|Overall Study|Reason Not Specified|0
7424109|NCT01502293|11699555|FG000|Overall Study|Physician Decision|0
7424110|NCT01502293|11699556|FG001|Overall Study|Physician Decision|0
7424111|NCT01502293|11699557|FG002|Overall Study|Physician Decision|1
7424112|NCT01502410|11699594|FG000|Overall Study|Adverse Event|1
7424113|NCT01502410|11699595|FG001|Overall Study|Adverse Event|2
7424114|NCT01502410|11699596|FG002|Overall Study|Adverse Event|0
7424115|NCT01502410|11699597|FG003|Overall Study|Adverse Event|0
7424116|NCT01502410|11699594|FG000|Overall Study|Lack of Efficacy|7
7424117|NCT01502410|11699595|FG001|Overall Study|Lack of Efficacy|7
7424118|NCT01502410|11699596|FG002|Overall Study|Lack of Efficacy|0
7424119|NCT01502410|11699597|FG003|Overall Study|Lack of Efficacy|0
7424120|NCT01502410|11699594|FG000|Overall Study|Physician Decision|0
7424121|NCT01502410|11699595|FG001|Overall Study|Physician Decision|1
7424122|NCT01502410|11699596|FG002|Overall Study|Physician Decision|0
7424123|NCT01502410|11699597|FG003|Overall Study|Physician Decision|0
7424124|NCT01502410|11699594|FG000|Overall Study|Withdrawal by Subject|2
7424125|NCT01502410|11699595|FG001|Overall Study|Withdrawal by Subject|0
7424126|NCT01502410|11699596|FG002|Overall Study|Withdrawal by Subject|0
7424127|NCT01502410|11699597|FG003|Overall Study|Withdrawal by Subject|0
7424128|NCT01502423|11699608|FG000|Overall Study|Withdrawal by Subject|0
7424129|NCT01502423|11699609|FG001|Overall Study|Withdrawal by Subject|1
7424130|NCT01502631|11699617|FG000|Overall Study|Adverse Event|5
7424131|NCT01502631|11699618|FG001|Overall Study|Adverse Event|8
7424132|NCT01502631|11699617|FG000|Overall Study|Lost to Follow-up|2
7424133|NCT01502631|11699618|FG001|Overall Study|Lost to Follow-up|2
7424134|NCT01502631|11699617|FG000|Overall Study|Participant withdrew consent|2
7424135|NCT01502631|11699618|FG001|Overall Study|Participant withdrew consent|4
7424136|NCT01502631|11699617|FG000|Overall Study|Participant non-compliant|1
7424137|NCT01502631|11699618|FG001|Overall Study|Participant non-compliant|0
7424138|NCT01502631|11699617|FG000|Overall Study|Investigator's decision|0
7424139|NCT01502631|11699618|FG001|Overall Study|Investigator's decision|1
7424140|NCT01502631|11699617|FG000|Overall Study|Other|10
7424141|NCT01502631|11699618|FG001|Overall Study|Other|5
7424142|NCT01502644|11699627|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
7424143|NCT01502644|11699628|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7424144|NCT01502644|11699629|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7424145|NCT01502644|11699630|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
7424146|NCT01502644|11699627|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
7424147|NCT01502644|11699628|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7424148|NCT01502644|11699629|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7424149|NCT01502644|11699630|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
7424150|NCT01502644|11699627|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
7424151|NCT01502644|11699628|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7424152|NCT01502644|11699629|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7424153|NCT01502644|11699630|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
7424154|NCT01502644|11699627|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
7424155|NCT01502644|11699628|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
7424156|NCT01502644|11699629|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
7424157|NCT01502644|11699630|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
7424158|NCT01502644|11699627|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7424159|NCT01502644|11699628|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
7424160|NCT01502644|11699629|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7424161|NCT01502644|11699630|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
7424162|NCT01502709|11699640|FG000|Overall Study|Lost to Follow-up|4
7424163|NCT01502709|11699641|FG001|Overall Study|Lost to Follow-up|0
7424164|NCT01502956|11699682|FG000|Overall Study|Death|0
7424165|NCT01502956|11699683|FG001|Overall Study|Death|2
7424166|NCT01502956|11699682|FG000|Overall Study|Lost to Follow-up|14
7424167|NCT01502956|11699683|FG001|Overall Study|Lost to Follow-up|11
7424168|NCT01502956|11699682|FG000|Overall Study|Physician Decision|2
7424169|NCT01502956|11699683|FG001|Overall Study|Physician Decision|3
7424170|NCT01502956|11699682|FG000|Overall Study|Withdrawal by Subject|8
7424171|NCT01502956|11699683|FG001|Overall Study|Withdrawal by Subject|10
7424172|NCT01503021|11699691|FG000|Overall Study|Adverse Event|7
7424173|NCT01503021|11699692|FG001|Overall Study|Adverse Event|6
7424174|NCT01503021|11699691|FG000|Overall Study|Death|0
7424175|NCT01503021|11699692|FG001|Overall Study|Death|2
7424176|NCT01503021|11699691|FG000|Overall Study|Lost to Follow-up|2
7424177|NCT01503021|11699692|FG001|Overall Study|Lost to Follow-up|0
7424178|NCT01503021|11699691|FG000|Overall Study|Physician Decision|3
7424179|NCT01503021|11699692|FG001|Overall Study|Physician Decision|0
7424180|NCT01503021|11699691|FG000|Overall Study|Protocol Violation|1
7424181|NCT01503021|11699692|FG001|Overall Study|Protocol Violation|3
7424182|NCT01503021|11699691|FG000|Overall Study|Withdrawal by Subject|9
7424183|NCT01503021|11699692|FG001|Overall Study|Withdrawal by Subject|8
7424184|NCT01503021|11699691|FG000|Overall Study|Moved, received transplant, etc.|5
7424185|NCT01503021|11699692|FG001|Overall Study|Moved, received transplant, etc.|7
7424186|NCT01503164|11699705|FG000|Overall Study|Withdrawal by Subject|2
7424187|NCT01503164|11699706|FG001|Overall Study|Withdrawal by Subject|1
7424188|NCT01503229|11699712|FG000|Overall Study|Withdrew consent|1
7424189|NCT01504204|11699748|FG000|Overall Study|Lost to Follow-up|1
7424190|NCT01504204|11699749|FG001|Overall Study|Lost to Follow-up|1
7424191|NCT01504412|11699760|FG000|Overall Study|Adverse Event|1
7424192|NCT01504412|11699761|FG001|Overall Study|Adverse Event|8
7424193|NCT01504412|11699762|FG002|Overall Study|Adverse Event|1
7424194|NCT01504412|11699763|FG003|Overall Study|Adverse Event|7
7424195|NCT01504412|11699764|FG004|Overall Study|Adverse Event|10
7424196|NCT01504412|11699760|FG000|Overall Study|Withdrawal by Subject|2
7424197|NCT01504412|11699761|FG001|Overall Study|Withdrawal by Subject|1
7424198|NCT01504412|11699762|FG002|Overall Study|Withdrawal by Subject|1
7424199|NCT01504412|11699763|FG003|Overall Study|Withdrawal by Subject|5
7424200|NCT01504412|11699764|FG004|Overall Study|Withdrawal by Subject|1
7424201|NCT01504412|11699760|FG000|Overall Study|Other|2
7424202|NCT01504412|11699761|FG001|Overall Study|Other|1
7424203|NCT01504412|11699762|FG002|Overall Study|Other|1
7424204|NCT01504412|11699763|FG003|Overall Study|Other|6
7424205|NCT01504412|11699764|FG004|Overall Study|Other|1
7424206|NCT01504412|11699760|FG000|Overall Study|Lost to Follow-up|0
7424207|NCT01504412|11699761|FG001|Overall Study|Lost to Follow-up|2
7424208|NCT01504412|11699762|FG002|Overall Study|Lost to Follow-up|0
7424209|NCT01504412|11699763|FG003|Overall Study|Lost to Follow-up|0
7424210|NCT01504412|11699764|FG004|Overall Study|Lost to Follow-up|0
7424211|NCT01504412|11699760|FG000|Overall Study|Lack of Efficacy|0
7424212|NCT01504412|11699761|FG001|Overall Study|Lack of Efficacy|0
7424213|NCT01504412|11699762|FG002|Overall Study|Lack of Efficacy|1
7424214|NCT01504412|11699763|FG003|Overall Study|Lack of Efficacy|0
7424215|NCT01504412|11699764|FG004|Overall Study|Lack of Efficacy|1
7424216|NCT01504412|11699760|FG000|Overall Study|Death|0
7424217|NCT01504412|11699761|FG001|Overall Study|Death|0
7424218|NCT01504412|11699762|FG002|Overall Study|Death|0
7424219|NCT01504412|11699763|FG003|Overall Study|Death|1
7424220|NCT01504412|11699764|FG004|Overall Study|Death|0
7424221|NCT01504841|11699798|FG000|Overall Study|Withdrawal by Subject|1
7424222|NCT01504841|11699799|FG001|Overall Study|Withdrawal by Subject|1
7424223|NCT01504841|11699800|FG002|Overall Study|Withdrawal by Subject|0
7424224|NCT01504867|11699818|FG000|Overall Study|Inclusion criteria not met|2
7424225|NCT01504867|11699819|FG001|Overall Study|Inclusion criteria not met|2
7424226|NCT01504867|11699818|FG000|Overall Study|Consent revoked|5
7424227|NCT01504867|11699819|FG001|Overall Study|Consent revoked|1
7424228|NCT01504971|11699838|FG000|Overall Study|Physician Decision|13
7424229|NCT01505010|11699852|FG000|Overall Study|Protocol Violation|0
7424230|NCT01505010|11699853|FG001|Overall Study|Protocol Violation|1
7424231|NCT01505010|11699852|FG000|Overall Study|Lost to Follow-up|0
7424232|NCT01505010|11699853|FG001|Overall Study|Lost to Follow-up|1
7424233|NCT01505114|11699863|FG000|Overall Study|Withdrawal by Subject|5
7424234|NCT01505114|11699864|FG001|Overall Study|Withdrawal by Subject|4
7531871|NCT02660229|11876886|FG001|Overall Study|Withdrawal by Subject|1
7531872|NCT02660242|11876892|FG000|Glucose Tabs|Lost to Follow-up|1
7424235|NCT01505114|11699865|FG002|Overall Study|Withdrawal by Subject|4
7424236|NCT01505114|11699866|FG003|Overall Study|Withdrawal by Subject|7
7424237|NCT01505114|11699863|FG000|Overall Study|Death|1
7424238|NCT01505114|11699864|FG001|Overall Study|Death|0
7424239|NCT01505114|11699865|FG002|Overall Study|Death|0
7424240|NCT01505114|11699866|FG003|Overall Study|Death|1
7424241|NCT01505114|11699863|FG000|Overall Study|unable to adhere to visit schedule|3
7424242|NCT01505114|11699864|FG001|Overall Study|unable to adhere to visit schedule|2
7424243|NCT01505114|11699865|FG002|Overall Study|unable to adhere to visit schedule|3
7424244|NCT01505114|11699866|FG003|Overall Study|unable to adhere to visit schedule|3
7424245|NCT01505114|11699863|FG000|Overall Study|Lost to Follow-up|11
7424246|NCT01505114|11699864|FG001|Overall Study|Lost to Follow-up|5
7424247|NCT01505114|11699865|FG002|Overall Study|Lost to Follow-up|8
7424248|NCT01505114|11699866|FG003|Overall Study|Lost to Follow-up|7
7424249|NCT01505114|11699863|FG000|Overall Study|relocated|4
7424250|NCT01505114|11699864|FG001|Overall Study|relocated|2
7424251|NCT01505114|11699865|FG002|Overall Study|relocated|2
7424252|NCT01505114|11699866|FG003|Overall Study|relocated|3
7424253|NCT01505114|11699863|FG000|Overall Study|inadvertent enrollment due to peanut all|0
7424254|NCT01505114|11699864|FG001|Overall Study|inadvertent enrollment due to peanut all|0
7424255|NCT01505114|11699865|FG002|Overall Study|inadvertent enrollment due to peanut all|0
7424256|NCT01505114|11699866|FG003|Overall Study|inadvertent enrollment due to peanut all|1
7424257|NCT01505114|11699863|FG000|Overall Study|staff safety concerns|0
7424258|NCT01505114|11699864|FG001|Overall Study|staff safety concerns|0
7424259|NCT01505114|11699865|FG002|Overall Study|staff safety concerns|0
7424260|NCT01505114|11699866|FG003|Overall Study|staff safety concerns|1
7424261|NCT01505114|11699863|FG000|Overall Study|investigator decision|1
7424262|NCT01505114|11699864|FG001|Overall Study|investigator decision|0
7424263|NCT01505114|11699865|FG002|Overall Study|investigator decision|1
7424264|NCT01505114|11699866|FG003|Overall Study|investigator decision|0
7424265|NCT01505374|11699900|FG000|Overall Study|Lost to Follow-up|1
7424266|NCT01505374|11699901|FG001|Overall Study|Lost to Follow-up|0
7424267|NCT01505387|11699910|FG000|Overall Study|Protocol Violation|1
7424268|NCT01505387|11699911|FG001|Overall Study|Protocol Violation|0
7424269|NCT01505387|11699910|FG000|Overall Study|Withdrawal by Subject|1
7424270|NCT01505387|11699911|FG001|Overall Study|Withdrawal by Subject|1
7424271|NCT01505491|11699920|FG000|Overall Study|Other reason not listed|1
7424272|NCT01505491|11699921|FG001|Overall Study|Other reason not listed|0
7424273|NCT01505491|11699922|FG002|Overall Study|Other reason not listed|0
7424274|NCT01505491|11699920|FG000|Overall Study|Withdrawal by Subject|1
7424275|NCT01505491|11699921|FG001|Overall Study|Withdrawal by Subject|1
7424276|NCT01505491|11699922|FG002|Overall Study|Withdrawal by Subject|4
7424277|NCT01505491|11699920|FG000|Overall Study|Lost to Follow-up|0
7424278|NCT01505491|11699921|FG001|Overall Study|Lost to Follow-up|0
7424279|NCT01505491|11699922|FG002|Overall Study|Lost to Follow-up|1
7424280|NCT01505530|11699933|FG000|Overall Study|Progressive Disease|19
7424281|NCT01505530|11699934|FG001|Overall Study|Progressive Disease|17
7424282|NCT01505530|11699935|FG002|Overall Study|Progressive Disease|18
7531873|NCT02660242|11876892|FG000|Glucagon Injection|Lost to Follow-up|1
7424283|NCT01505530|11699933|FG000|Overall Study|Adverse Event|1
7424284|NCT01505530|11699934|FG001|Overall Study|Adverse Event|1
7424285|NCT01505530|11699935|FG002|Overall Study|Adverse Event|0
7424286|NCT01505530|11699933|FG000|Overall Study|Withdrawal by Subject|7
7424287|NCT01505530|11699934|FG001|Overall Study|Withdrawal by Subject|8
7424288|NCT01505530|11699935|FG002|Overall Study|Withdrawal by Subject|6
7424289|NCT01505530|11699933|FG000|Overall Study|Physician Decision|6
7424290|NCT01505530|11699934|FG001|Overall Study|Physician Decision|2
7424291|NCT01505530|11699935|FG002|Overall Study|Physician Decision|5
7424292|NCT01505530|11699933|FG000|Overall Study|Sponsor Decision|1
7424293|NCT01505530|11699934|FG001|Overall Study|Sponsor Decision|8
7424294|NCT01505530|11699935|FG002|Overall Study|Sponsor Decision|7
7424295|NCT01505530|11699933|FG000|Overall Study|Death|7
7424296|NCT01505530|11699934|FG001|Overall Study|Death|6
7424297|NCT01505530|11699935|FG002|Overall Study|Death|5
7424298|NCT01505530|11699933|FG000|Overall Study|entry criteria not met|0
7424299|NCT01505530|11699934|FG001|Overall Study|entry criteria not met|1
7424300|NCT01505530|11699935|FG002|Overall Study|entry criteria not met|0
7424301|NCT01505634|11699946|FG000|Overall Study|Withdrawal by Subject|2
7424302|NCT01505634|11699947|FG001|Overall Study|Withdrawal by Subject|5
7424303|NCT01505634|11699948|FG002|Overall Study|Withdrawal by Subject|1
7424304|NCT01505634|11699946|FG000|Overall Study|Physician Decision|1
7424305|NCT01505634|11699947|FG001|Overall Study|Physician Decision|1
7424306|NCT01505634|11699948|FG002|Overall Study|Physician Decision|0
7424307|NCT01505634|11699946|FG000|Overall Study|Adverse Event|1
7424308|NCT01505634|11699947|FG001|Overall Study|Adverse Event|0
7424309|NCT01505634|11699948|FG002|Overall Study|Adverse Event|0
7424310|NCT01505634|11699946|FG000|Overall Study|Insufficient supply of drug at site|1
7424311|NCT01505634|11699947|FG001|Overall Study|Insufficient supply of drug at site|0
7424312|NCT01505634|11699948|FG002|Overall Study|Insufficient supply of drug at site|0
7424313|NCT01505634|11699946|FG000|Overall Study|Protocol Violation|2
7424314|NCT01505634|11699947|FG001|Overall Study|Protocol Violation|0
7424315|NCT01505634|11699948|FG002|Overall Study|Protocol Violation|0
7424316|NCT01505634|11699946|FG000|Overall Study|Lost to Follow-up|1
7424317|NCT01505634|11699947|FG001|Overall Study|Lost to Follow-up|4
7424318|NCT01505634|11699948|FG002|Overall Study|Lost to Follow-up|4
7424319|NCT01505634|11699946|FG000|Overall Study|Death|1
7424320|NCT01505634|11699947|FG001|Overall Study|Death|0
7424321|NCT01505634|11699948|FG002|Overall Study|Death|0
7424322|NCT01505634|11699946|FG000|Overall Study|In a conflict zone|0
7424323|NCT01505634|11699947|FG001|Overall Study|In a conflict zone|0
7424324|NCT01505634|11699948|FG002|Overall Study|In a conflict zone|1
7424325|NCT01505647|11699958|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
7424326|NCT01505647|11699959|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
7424327|NCT01505647|11699958|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
7424328|NCT01505647|11699959|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
7424329|NCT01505647|11699958|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
7424330|NCT01505647|11699959|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
7424331|NCT01505647|11699958|FG000|Day 43 Through Day 182 Follow-up|Death|0
7424332|NCT01505647|11699959|FG001|Day 43 Through Day 182 Follow-up|Death|1
7424333|NCT01505647|11699958|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
7424334|NCT01505647|11699959|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
7424335|NCT01505868|11699989|FG000|Overall Study|Withdrawal by Subject|1
7424336|NCT01505868|11699990|FG001|Overall Study|Withdrawal by Subject|0
7424337|NCT01505868|11699991|FG002|Overall Study|Withdrawal by Subject|0
7424338|NCT01505868|11699992|FG003|Overall Study|Withdrawal by Subject|0
7424339|NCT01505868|11699993|FG004|Overall Study|Withdrawal by Subject|0
7424340|NCT01505881|11700007|FG000|Overall Study|Adverse Event|0
7424341|NCT01505881|11700008|FG001|Overall Study|Adverse Event|1
7424342|NCT01505881|11700007|FG000|Overall Study|Lost to Follow-up|2
7424343|NCT01505881|11700008|FG001|Overall Study|Lost to Follow-up|0
7424344|NCT01505881|11700007|FG000|Overall Study|Withdrawal by Subject|2
7424345|NCT01505881|11700008|FG001|Overall Study|Withdrawal by Subject|0
7424346|NCT01506193|11700027|FG000|Overall Study|Protocol Violation|1
7424347|NCT01506193|11700028|FG001|Overall Study|Protocol Violation|0
7424348|NCT01506193|11700029|FG002|Overall Study|Protocol Violation|1
7424349|NCT01506193|11700027|FG000|Overall Study|Migrated/moved from study area|0
7424350|NCT01506193|11700028|FG001|Overall Study|Migrated/moved from study area|0
7424351|NCT01506193|11700029|FG002|Overall Study|Migrated/moved from study area|1
7424352|NCT01506193|11700027|FG000|Overall Study|Adverse event, non-fatal|0
7424353|NCT01506193|11700028|FG001|Overall Study|Adverse event, non-fatal|0
7424354|NCT01506193|11700029|FG002|Overall Study|Adverse event, non-fatal|1
7424355|NCT01506193|11700027|FG000|Overall Study|Withdrawal by Subject|5
7424356|NCT01506193|11700028|FG001|Overall Study|Withdrawal by Subject|1
7424357|NCT01506193|11700029|FG002|Overall Study|Withdrawal by Subject|8
7424358|NCT01506193|11700027|FG000|Overall Study|Lost to Follow-up|8
7424359|NCT01506193|11700028|FG001|Overall Study|Lost to Follow-up|3
7424360|NCT01506193|11700029|FG002|Overall Study|Lost to Follow-up|3
7424361|NCT01506271|11700041|FG000|Overall Study|Progressive disease|0
7424362|NCT01506271|11700042|FG001|Overall Study|Progressive disease|1
7424363|NCT01506271|11700043|FG002|Overall Study|Progressive disease|0
7424364|NCT01506271|11700041|FG000|Overall Study|Protocol Violation|3
7424365|NCT01506271|11700042|FG001|Overall Study|Protocol Violation|1
7424366|NCT01506271|11700043|FG002|Overall Study|Protocol Violation|0
7424367|NCT01506271|11700041|FG000|Overall Study|Death|0
7424368|NCT01506271|11700042|FG001|Overall Study|Death|1
7424369|NCT01506271|11700043|FG002|Overall Study|Death|0
7424370|NCT01506271|11700041|FG000|Overall Study|Adverse Event|0
7424371|NCT01506271|11700042|FG001|Overall Study|Adverse Event|2
7424372|NCT01506271|11700043|FG002|Overall Study|Adverse Event|0
7424373|NCT01506271|11700041|FG000|Overall Study|Insufficient supply of study drug|1
7424374|NCT01506271|11700042|FG001|Overall Study|Insufficient supply of study drug|0
7424375|NCT01506271|11700043|FG002|Overall Study|Insufficient supply of study drug|0
7424376|NCT01506271|11700041|FG000|Overall Study|Withdrawal by Subject|0
7424377|NCT01506271|11700042|FG001|Overall Study|Withdrawal by Subject|1
7424378|NCT01506271|11700043|FG002|Overall Study|Withdrawal by Subject|1
7424379|NCT01506271|11700041|FG000|Overall Study|Lost to Follow-up|0
7424380|NCT01506271|11700042|FG001|Overall Study|Lost to Follow-up|1
7424381|NCT01506271|11700043|FG002|Overall Study|Lost to Follow-up|2
7424382|NCT01506323|11700053|FG000|Overall Study|Lost to Follow-up|5
7424383|NCT01506323|11700054|FG001|Overall Study|Lost to Follow-up|4
7424384|NCT01506323|11700053|FG000|Overall Study|Withdrawal by Subject|4
7424385|NCT01506323|11700054|FG001|Overall Study|Withdrawal by Subject|4
7424386|NCT01506323|11700053|FG000|Overall Study|Lack of Efficacy|1
7424387|NCT01506323|11700054|FG001|Overall Study|Lack of Efficacy|3
7424388|NCT01506323|11700053|FG000|Overall Study|Moved out of area|5
7424389|NCT01506323|11700054|FG001|Overall Study|Moved out of area|2
7424390|NCT01506323|11700053|FG000|Overall Study|Schedule or Transportation conflict|8
7424391|NCT01506323|11700054|FG001|Overall Study|Schedule or Transportation conflict|0
7424392|NCT01506323|11700053|FG000|Overall Study|Started another treatment|1
7424393|NCT01506323|11700054|FG001|Overall Study|Started another treatment|0
7557255|NCT03097861|11921737|FG000|Overall Study|Reason not provided|3
7557256|NCT03097861|11921738|FG001|Overall Study|Reason not provided|1
7557257|NCT03097861|11921739|FG002|Overall Study|Reason not provided|1
7557258|NCT03098030|11921753|FG000|Overall Study|Death|10
7557259|NCT03098030|11921754|FG001|Overall Study|Death|156
7557260|NCT03098030|11921755|FG002|Overall Study|Death|156
7557261|NCT03098030|11921756|FG003|Overall Study|Death|82
7466669|NCT01893411|11766535|FG000|Overall Study|Lost to Follow-up|2
7466670|NCT01893411|11766536|FG001|Overall Study|Lost to Follow-up|0
7466671|NCT01893411|11766537|FG002|Overall Study|Lost to Follow-up|1
7466672|NCT01893827|11766566|FG000|Overall Study|Lost to Follow-up|19
7466673|NCT01893827|11766567|FG001|Overall Study|Lost to Follow-up|26
7466674|NCT01893905|11766584|FG000|Overall Study|Withdrawal by Subject|1
7466675|NCT01893905|11766585|FG001|Overall Study|Withdrawal by Subject|0
7466676|NCT01893905|11766584|FG000|Overall Study|Adverse Event|9
7466677|NCT01893905|11766585|FG001|Overall Study|Adverse Event|3
7466678|NCT01893905|11766584|FG000|Overall Study|Lack of Efficacy|5
7466679|NCT01893905|11766585|FG001|Overall Study|Lack of Efficacy|7
7466680|NCT01893905|11766584|FG000|Overall Study|Lost to Follow-up|1
7466681|NCT01893905|11766585|FG001|Overall Study|Lost to Follow-up|0
7466682|NCT01893905|11766584|FG000|Overall Study|Protocol Violation|6
7466683|NCT01893905|11766585|FG001|Overall Study|Protocol Violation|1
7466684|NCT01893905|11766584|FG000|Overall Study|Lack of adherence to treatment|2
7466685|NCT01893905|11766585|FG001|Overall Study|Lack of adherence to treatment|0
7466686|NCT01893905|11766584|FG000|Overall Study|Other reason|1
7466687|NCT01893905|11766585|FG001|Overall Study|Other reason|3
7466688|NCT01894022|11766602|FG000|Overall Study|Death|1
7466689|NCT01894022|11766603|FG001|Overall Study|Death|0
7466690|NCT01894022|11766602|FG000|Overall Study|Adverse Event, non-fatal|1
7466691|NCT01894022|11766603|FG001|Overall Study|Adverse Event, non-fatal|0
7466692|NCT01894022|11766602|FG000|Overall Study|Study Closed/terminated|7
7466693|NCT01894022|11766603|FG001|Overall Study|Study Closed/terminated|10
7466694|NCT01894100|11766621|FG000|Overall Study|Lost to Follow-up|0
7466695|NCT01894100|11766622|FG001|Overall Study|Lost to Follow-up|1
7466696|NCT01894100|11766621|FG000|Overall Study|Withdrawal by Subject|3
7466697|NCT01894100|11766622|FG001|Overall Study|Withdrawal by Subject|0
7466698|NCT01894152|11766628|FG000|Overall Study|No DMR and no Stent thrombosis|151
7466699|NCT01894230|11766643|FG000|Overall Study|Lost to Follow-up|2
7466700|NCT01894230|11766644|FG001|Overall Study|Lost to Follow-up|2
7466701|NCT01894230|11766643|FG000|Overall Study|Withdrawal by Subject|4
7466702|NCT01894230|11766644|FG001|Overall Study|Withdrawal by Subject|4
7466703|NCT01894230|11766643|FG000|Overall Study|Non-adherent|0
7466704|NCT01894230|11766644|FG001|Overall Study|Non-adherent|1
7466705|NCT01894230|11766643|FG000|Overall Study|Death|1
7557262|NCT03098030|11921753|FG000|Overall Study|Withdrawal by Subject|0
7557263|NCT03098030|11921754|FG001|Overall Study|Withdrawal by Subject|7
7424394|NCT01506453|11700071|FG000|Overall Study|Withdrawal prior to treatment|0
7424395|NCT01506453|11700072|FG001|Overall Study|Withdrawal prior to treatment|2
7424396|NCT01506479|11700081|FG000|Overall Study|Lost to Follow-up|1
7424397|NCT01506479|11700082|FG001|Overall Study|Lost to Follow-up|2
7424398|NCT01506479|11700083|FG002|Overall Study|Lost to Follow-up|2
7424399|NCT01506479|11700081|FG000|Overall Study|Withdrawal by Subject|1
7424400|NCT01506479|11700082|FG001|Overall Study|Withdrawal by Subject|2
7424401|NCT01506479|11700083|FG002|Overall Study|Withdrawal by Subject|1
7424402|NCT01506479|11700081|FG000|Overall Study|Missing assessment|1
7424403|NCT01506479|11700082|FG001|Overall Study|Missing assessment|0
7424404|NCT01506479|11700083|FG002|Overall Study|Missing assessment|0
7424405|NCT01506479|11700081|FG000|Overall Study|Adverse Event|0
7424406|NCT01506479|11700082|FG001|Overall Study|Adverse Event|1
7424407|NCT01506479|11700083|FG002|Overall Study|Adverse Event|0
7424408|NCT01506596|11700093|FG000|Overall Study|ineligible pathology|1
7424409|NCT01506609|11700103|FG000|Overall Study|Adverse Event Related to Progression|0
7424410|NCT01506609|11700104|FG001|Overall Study|Adverse Event Related to Progression|0
7424411|NCT01506609|11700105|FG002|Overall Study|Adverse Event Related to Progression|0
7424412|NCT01506609|11700106|FG003|Overall Study|Adverse Event Related to Progression|3
7424413|NCT01506609|11700107|FG004|Overall Study|Adverse Event Related to Progression|7
7424414|NCT01506609|11700108|FG005|Overall Study|Adverse Event Related to Progression|3
7424415|NCT01506609|11700103|FG000|Overall Study|Adverse Event Not Related to Progression|0
7424416|NCT01506609|11700104|FG001|Overall Study|Adverse Event Not Related to Progression|1
7424417|NCT01506609|11700105|FG002|Overall Study|Adverse Event Not Related to Progression|0
7424418|NCT01506609|11700106|FG003|Overall Study|Adverse Event Not Related to Progression|6
7424419|NCT01506609|11700107|FG004|Overall Study|Adverse Event Not Related to Progression|10
7424420|NCT01506609|11700108|FG005|Overall Study|Adverse Event Not Related to Progression|5
7424421|NCT01506609|11700103|FG000|Overall Study|Withdrawal by Subject|0
7424422|NCT01506609|11700104|FG001|Overall Study|Withdrawal by Subject|0
7424423|NCT01506609|11700105|FG002|Overall Study|Withdrawal by Subject|0
7424424|NCT01506609|11700106|FG003|Overall Study|Withdrawal by Subject|9
7424425|NCT01506609|11700107|FG004|Overall Study|Withdrawal by Subject|7
7424426|NCT01506609|11700108|FG005|Overall Study|Withdrawal by Subject|7
7424427|NCT01506609|11700103|FG000|Overall Study|Lost to Follow-up|0
7424428|NCT01506609|11700104|FG001|Overall Study|Lost to Follow-up|0
7424429|NCT01506609|11700105|FG002|Overall Study|Lost to Follow-up|0
7424430|NCT01506609|11700106|FG003|Overall Study|Lost to Follow-up|1
7424431|NCT01506609|11700107|FG004|Overall Study|Lost to Follow-up|2
7424432|NCT01506609|11700108|FG005|Overall Study|Lost to Follow-up|0
7424433|NCT01506609|11700103|FG000|Overall Study|Sponsor Discontinued Study|0
7424434|NCT01506609|11700104|FG001|Overall Study|Sponsor Discontinued Study|0
7424435|NCT01506609|11700105|FG002|Overall Study|Sponsor Discontinued Study|0
7424436|NCT01506609|11700106|FG003|Overall Study|Sponsor Discontinued Study|2
7424437|NCT01506609|11700107|FG004|Overall Study|Sponsor Discontinued Study|2
7424438|NCT01506609|11700108|FG005|Overall Study|Sponsor Discontinued Study|0
7424439|NCT01506609|11700103|FG000|Overall Study|Progressive Disease per Protocol|1
7424440|NCT01506609|11700104|FG001|Overall Study|Progressive Disease per Protocol|0
7424441|NCT01506609|11700105|FG002|Overall Study|Progressive Disease per Protocol|0
7424442|NCT01506609|11700106|FG003|Overall Study|Progressive Disease per Protocol|64
7424443|NCT01506609|11700107|FG004|Overall Study|Progressive Disease per Protocol|57
7424444|NCT01506609|11700108|FG005|Overall Study|Progressive Disease per Protocol|74
7424445|NCT01506609|11700103|FG000|Overall Study|Other, Not Specified|0
7424446|NCT01506609|11700104|FG001|Overall Study|Other, Not Specified|0
7424447|NCT01506609|11700105|FG002|Overall Study|Other, Not Specified|0
7424448|NCT01506609|11700106|FG003|Overall Study|Other, Not Specified|10
7424449|NCT01506609|11700107|FG004|Overall Study|Other, Not Specified|7
7424450|NCT01506609|11700108|FG005|Overall Study|Other, Not Specified|3
7424451|NCT01506609|11700103|FG000|Overall Study|Missing / Unknown Reason|1
7424452|NCT01506609|11700104|FG001|Overall Study|Missing / Unknown Reason|0
7424453|NCT01506609|11700105|FG002|Overall Study|Missing / Unknown Reason|1
7424454|NCT01506609|11700106|FG003|Overall Study|Missing / Unknown Reason|4
7424455|NCT01506609|11700107|FG004|Overall Study|Missing / Unknown Reason|4
7424456|NCT01506609|11700108|FG005|Overall Study|Missing / Unknown Reason|2
7424457|NCT01506726|11700121|FG000|Overall Study|Adverse Event|1
7424458|NCT01506726|11700122|FG001|Overall Study|Adverse Event|2
7424459|NCT01506882|11700130|FG000|Overall Study|Lack of Efficacy|4
7424460|NCT01506882|11700131|FG001|Overall Study|Lack of Efficacy|3
7424461|NCT01506882|11700130|FG000|Overall Study|Lost to Follow-up|1
7424462|NCT01506882|11700131|FG001|Overall Study|Lost to Follow-up|0
7424463|NCT01506882|11700130|FG000|Overall Study|Withdrawal by Subject|9
7424464|NCT01506882|11700131|FG001|Overall Study|Withdrawal by Subject|3
7424465|NCT01506882|11700130|FG000|Overall Study|SAE, non-fatal|2
7424466|NCT01506882|11700131|FG001|Overall Study|SAE, non-fatal|0
7424467|NCT01506882|11700130|FG000|Overall Study|AE, non-serious non-fatal|3
7424468|NCT01506882|11700131|FG001|Overall Study|AE, non-serious non-fatal|1
7424469|NCT01506882|11700130|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7424470|NCT01506882|11700131|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7424471|NCT01506882|11700130|FG000|Overall Study|Other Reason|2
7424472|NCT01506882|11700131|FG001|Overall Study|Other Reason|0
7424473|NCT01506908|11700141|FG000|Overall Study|Adverse Event|1
7424474|NCT01506908|11700142|FG001|Overall Study|Adverse Event|0
7424475|NCT01506947|11700150|FG000|Overall Study|Lost to Follow-up|7
7424476|NCT01506947|11700150|FG000|Overall Study|Adverse Event|5
7424477|NCT01506947|11700150|FG000|Overall Study|Death|1
7424478|NCT01506947|11700150|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
7424479|NCT01506960|11700156|FG000|Overall Study|Did not meet angiographic criteria|47
7424480|NCT01507051|11700166|FG000|Overall Study|Withdrawal by Subject|1
7424481|NCT01507051|11700167|FG001|Overall Study|Withdrawal by Subject|3
7424482|NCT01507051|11700168|FG002|Overall Study|Withdrawal by Subject|1
7424483|NCT01507051|11700169|FG003|Overall Study|Withdrawal by Subject|6
7424484|NCT01507051|11700166|FG000|Overall Study|Physician Decision|0
7424485|NCT01507051|11700167|FG001|Overall Study|Physician Decision|0
7424486|NCT01507051|11700168|FG002|Overall Study|Physician Decision|0
7424487|NCT01507051|11700169|FG003|Overall Study|Physician Decision|1
7424488|NCT01507051|11700166|FG000|Overall Study|Adverse Event|1
7424489|NCT01507051|11700167|FG001|Overall Study|Adverse Event|0
7424490|NCT01507051|11700168|FG002|Overall Study|Adverse Event|0
7424491|NCT01507051|11700169|FG003|Overall Study|Adverse Event|0
7424492|NCT01507090|11700179|FG000|Overall Study|incomplete dataset|18
7424493|NCT01507246|11700227|FG000|Overall Study|Required different surgical procedures|2
7424494|NCT01507246|11700228|FG001|Overall Study|Required different surgical procedures|1
7424495|NCT01507298|11700239|FG000|Overall Study|Protocol Violation|0
7424496|NCT01507298|11700240|FG001|Overall Study|Protocol Violation|6
7424497|NCT01507662|11700262|FG000|Overall Study|Death|26
7424498|NCT01507662|11700263|FG001|Overall Study|Death|18
7424499|NCT01507662|11700262|FG000|Overall Study|Withdrawal by Subject|290
7424500|NCT01507662|11700263|FG001|Overall Study|Withdrawal by Subject|287
7424501|NCT01507662|11700262|FG000|Overall Study|Lost to Follow-up|498
7424502|NCT01507662|11700263|FG001|Overall Study|Lost to Follow-up|523
7424503|NCT01507662|11700262|FG000|Overall Study|Proxy interview done|2
7424504|NCT01507662|11700263|FG001|Overall Study|Proxy interview done|3
7424505|NCT01507831|11700291|FG000|Overall Study|Randomized but not treated|0
7424506|NCT01507831|11700292|FG001|Overall Study|Randomized but not treated|3
7424507|NCT01507831|11700291|FG000|Overall Study|Adverse Event|48
7424508|NCT01507831|11700292|FG001|Overall Study|Adverse Event|113
7424509|NCT01507831|11700291|FG000|Overall Study|Death|6
7424510|NCT01507831|11700292|FG001|Overall Study|Death|2
7424511|NCT01507831|11700291|FG000|Overall Study|Poor compliance to protocol|38
7424512|NCT01507831|11700292|FG001|Overall Study|Poor compliance to protocol|60
7424513|NCT01507831|11700291|FG000|Overall Study|Physician Decision|0
7424514|NCT01507831|11700292|FG001|Overall Study|Physician Decision|4
7424515|NCT01507831|11700291|FG000|Overall Study|Participant moved|5
7424516|NCT01507831|11700292|FG001|Overall Study|Participant moved|19
7424517|NCT01507831|11700291|FG000|Overall Study|Consent withdrawn by participant|34
7424518|NCT01507831|11700292|FG001|Overall Study|Consent withdrawn by participant|72
7424519|NCT01507831|11700291|FG000|Overall Study|Related to study drug administration|5
7424520|NCT01507831|11700292|FG001|Overall Study|Related to study drug administration|14
7424521|NCT01507831|11700291|FG000|Overall Study|Last visit outside protocol visit window|51
7424522|NCT01507831|11700292|FG001|Overall Study|Last visit outside protocol visit window|143
7424523|NCT01507831|11700291|FG000|Overall Study|Selection criteria finally not met|0
7424524|NCT01507831|11700292|FG001|Overall Study|Selection criteria finally not met|1
7424525|NCT01507831|11700291|FG000|Overall Study|Site closure|0
7424526|NCT01507831|11700292|FG001|Overall Study|Site closure|3
7424527|NCT01507831|11700291|FG000|Overall Study|Potential lost to follow-up|3
7424528|NCT01507831|11700292|FG001|Overall Study|Potential lost to follow-up|0
7424529|NCT01507831|11700291|FG000|Overall Study|Other|3
7424530|NCT01507831|11700292|FG001|Overall Study|Other|6
7424531|NCT01507896|11700298|FG000|Overall Study|Withdrawal by Subject|1
7424532|NCT01507896|11700298|FG000|Overall Study|The surgery was denied by the sponsor.|1
7424533|NCT01508130|11700365|FG000|Overall Study|Adverse Event|81
7424534|NCT01508130|11700366|FG001|Overall Study|Adverse Event|28
7424535|NCT01508130|11700365|FG000|Overall Study|Death|3
7424536|NCT01508130|11700366|FG001|Overall Study|Death|1
7424537|NCT01508130|11700365|FG000|Overall Study|Protocol Violation|2
7424538|NCT01508130|11700366|FG001|Overall Study|Protocol Violation|0
7424539|NCT01508130|11700365|FG000|Overall Study|Lost to Follow-up|25
7424540|NCT01508130|11700366|FG001|Overall Study|Lost to Follow-up|2
7424541|NCT01508130|11700365|FG000|Overall Study|Withdrawal by Subject|3
7424542|NCT01508130|11700366|FG001|Overall Study|Withdrawal by Subject|3
7424543|NCT01508130|11700365|FG000|Overall Study|Subject's substantial non-compliance|25
7424544|NCT01508130|11700366|FG001|Overall Study|Subject's substantial non-compliance|9
7424545|NCT01508130|11700365|FG000|Overall Study|Insufficient therapeutic response|74
7424546|NCT01508130|11700366|FG001|Overall Study|Insufficient therapeutic response|23
7424547|NCT01508130|11700365|FG000|Overall Study|Administrative|14
7424548|NCT01508130|11700366|FG001|Overall Study|Administrative|3
7424549|NCT01508169|11700376|FG000|Overall Study|Adverse Event|1
7424550|NCT01508169|11700377|FG001|Overall Study|Adverse Event|0
7424551|NCT01508169|11700376|FG000|Overall Study|Withdrawal by Subject|1
7424552|NCT01508169|11700377|FG001|Overall Study|Withdrawal by Subject|0
7424553|NCT01508169|11700376|FG000|Overall Study|Lost to Follow-up|1
7424554|NCT01508169|11700377|FG001|Overall Study|Lost to Follow-up|2
7424555|NCT01508325|11700391|FG000|Overall Study|Withdrawal by Subject|8
7424556|NCT01508325|11700392|FG001|Overall Study|Withdrawal by Subject|9
7424557|NCT01508325|11700391|FG000|Overall Study|Protocol Violation|0
7424558|NCT01508325|11700392|FG001|Overall Study|Protocol Violation|3
7424559|NCT01508325|11700391|FG000|Overall Study|Physician Decision|2
7424560|NCT01508325|11700392|FG001|Overall Study|Physician Decision|1
7424561|NCT01508325|11700391|FG000|Overall Study|Adverse Event|1
7424562|NCT01508325|11700392|FG001|Overall Study|Adverse Event|0
7424563|NCT01508325|11700391|FG000|Overall Study|Lost to Follow-up|5
7424564|NCT01508325|11700392|FG001|Overall Study|Lost to Follow-up|6
7424565|NCT01508325|11700391|FG000|Overall Study|Other|2
7424566|NCT01508325|11700392|FG001|Overall Study|Other|2
7424567|NCT01508650|11700404|FG000|Overall Study|Lost to Follow-up|0
7424568|NCT01508650|11700405|FG001|Overall Study|Lost to Follow-up|3
7424569|NCT01508676|11700413|FG000|Phase I (2 Weeks)|Medication Exclusion|1
7424570|NCT01508676|11700414|FG001|Phase I (2 Weeks)|Medication Exclusion|1
7424571|NCT01508676|11700413|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
7424572|NCT01508676|11700414|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
7424573|NCT01508676|11700413|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
7424574|NCT01508676|11700414|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
7424575|NCT01508676|11700413|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
7424576|NCT01508676|11700414|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
7424577|NCT01508676|11700413|FG000|Phase II (2 Weeks)|Medication Exclusion|1
7424578|NCT01508676|11700414|FG001|Phase II (2 Weeks)|Medication Exclusion|0
7424579|NCT01508702|11700423|FG000|Overall Study|Adverse Event|7
7424580|NCT01508702|11700424|FG001|Overall Study|Adverse Event|3
7424581|NCT01508702|11700423|FG000|Overall Study|Gout flare|2
7424582|NCT01508702|11700424|FG001|Overall Study|Gout flare|0
7424583|NCT01508702|11700423|FG000|Overall Study|Protocol Violation|2
7424584|NCT01508702|11700424|FG001|Overall Study|Protocol Violation|1
7424585|NCT01508702|11700423|FG000|Overall Study|Lost to Follow-up|1
7424586|NCT01508702|11700424|FG001|Overall Study|Lost to Follow-up|2
7424587|NCT01508702|11700423|FG000|Overall Study|Withdrawal by Subject|11
7424588|NCT01508702|11700424|FG001|Overall Study|Withdrawal by Subject|7
7424589|NCT01508910|11700442|FG000|Treatment|Death|2
7424590|NCT01508910|11700443|FG001|Treatment|Death|3
7424591|NCT01508910|11700444|FG002|Treatment|Death|2
7424592|NCT01508910|11700445|FG003|Treatment|Death|0
7424593|NCT01508910|11700442|FG000|Treatment|Lost to Follow-up|0
7424594|NCT01508910|11700443|FG001|Treatment|Lost to Follow-up|0
7424595|NCT01508910|11700444|FG002|Treatment|Lost to Follow-up|2
7424596|NCT01508910|11700445|FG003|Treatment|Lost to Follow-up|1
7424597|NCT01508910|11700442|FG000|Treatment|Withdrawal by Subject|0
7424598|NCT01508910|11700443|FG001|Treatment|Withdrawal by Subject|1
7424599|NCT01508910|11700444|FG002|Treatment|Withdrawal by Subject|6
7424600|NCT01508910|11700445|FG003|Treatment|Withdrawal by Subject|1
7424601|NCT01508910|11700442|FG000|Treatment|Sponsor Decision|0
7424602|NCT01508910|11700443|FG001|Treatment|Sponsor Decision|0
7424603|NCT01508910|11700444|FG002|Treatment|Sponsor Decision|0
7424604|NCT01508910|11700445|FG003|Treatment|Sponsor Decision|1
7424605|NCT01508936|11700459|FG000|Overall Study|Adverse Event|11
7424606|NCT01508936|11700460|FG001|Overall Study|Adverse Event|32
7424607|NCT01508936|11700459|FG000|Overall Study|Lack of Efficacy|0
7424608|NCT01508936|11700460|FG001|Overall Study|Lack of Efficacy|1
7424609|NCT01508936|11700459|FG000|Overall Study|Withdrawal by Subject|4
7424610|NCT01508936|11700460|FG001|Overall Study|Withdrawal by Subject|18
7424611|NCT01508936|11700459|FG000|Overall Study|Protocol Violation|2
7424612|NCT01508936|11700460|FG001|Overall Study|Protocol Violation|3
7424613|NCT01508936|11700459|FG000|Overall Study|Lost to Follow-up|2
7424614|NCT01508936|11700460|FG001|Overall Study|Lost to Follow-up|9
7424615|NCT01508936|11700459|FG000|Overall Study|Other|0
7424616|NCT01508936|11700460|FG001|Overall Study|Other|5
7424617|NCT01508936|11700459|FG000|Overall Study|Data from 2 sites deemed invalid|4
7424618|NCT01508936|11700460|FG001|Overall Study|Data from 2 sites deemed invalid|11
7424619|NCT01509079|11700488|FG000|Overall Study|Lack of Efficacy|0
7424620|NCT01509079|11700489|FG001|Overall Study|Lack of Efficacy|2
7424621|NCT01509079|11700488|FG000|Overall Study|started an excluded medication|0
7424622|NCT01509079|11700489|FG001|Overall Study|started an excluded medication|1
7424623|NCT01509547|11700521|FG000|Overall Study|Lost to Follow-up|24
7424624|NCT01509547|11700522|FG001|Overall Study|Lost to Follow-up|14
7424625|NCT01509547|11700521|FG000|Overall Study|Withdrawal by Subject|11
7424626|NCT01509547|11700522|FG001|Overall Study|Withdrawal by Subject|24
7424627|NCT01509547|11700521|FG000|Overall Study|Physician Decision|0
7424628|NCT01509547|11700522|FG001|Overall Study|Physician Decision|1
7424629|NCT01509664|11700577|FG000|Overall Study|Lost to Follow-up|15
7424630|NCT01509664|11700578|FG001|Overall Study|Lost to Follow-up|21
7424631|NCT01509846|11700607|FG000|Received Vaccination 2|Withdrawal by Subject|0
7424632|NCT01509846|11700608|FG001|Received Vaccination 2|Withdrawal by Subject|0
7424633|NCT01509846|11700609|FG002|Received Vaccination 2|Withdrawal by Subject|1
7424634|NCT01509846|11700610|FG003|Received Vaccination 2|Withdrawal by Subject|0
7424635|NCT01509846|11700611|FG004|Received Vaccination 2|Withdrawal by Subject|0
7557264|NCT03098030|11921755|FG002|Overall Study|Withdrawal by Subject|8
7557265|NCT03098030|11921756|FG003|Overall Study|Withdrawal by Subject|2
7557266|NCT03098030|11921753|FG000|Overall Study|Lost to Follow-up|0
7557267|NCT03098030|11921754|FG001|Overall Study|Lost to Follow-up|0
7557268|NCT03098030|11921755|FG002|Overall Study|Lost to Follow-up|2
7557269|NCT03098030|11921756|FG003|Overall Study|Lost to Follow-up|1
7557270|NCT03098433|11921789|FG000|Overall Study|Withdrawal by Subject|10
7557271|NCT03098550|11921797|FG000|Overall Study|Disease Progression|30
7424636|NCT01509846|11700607|FG000|Received Vaccination 2|Illness|0
7424637|NCT01509846|11700608|FG001|Received Vaccination 2|Illness|0
7424638|NCT01509846|11700609|FG002|Received Vaccination 2|Illness|0
7424639|NCT01509846|11700610|FG003|Received Vaccination 2|Illness|0
7424640|NCT01509846|11700611|FG004|Received Vaccination 2|Illness|1
7424641|NCT01509846|11700607|FG000|Received Vaccination 2|Not vaccinated per protocol|5
7424642|NCT01509846|11700608|FG001|Received Vaccination 2|Not vaccinated per protocol|0
7424643|NCT01509846|11700609|FG002|Received Vaccination 2|Not vaccinated per protocol|0
7424644|NCT01509846|11700610|FG003|Received Vaccination 2|Not vaccinated per protocol|0
7424645|NCT01509846|11700611|FG004|Received Vaccination 2|Not vaccinated per protocol|2
7424646|NCT01509846|11700607|FG000|Received Vaccination 3|Withdrawal by Subject|0
7424647|NCT01509846|11700608|FG001|Received Vaccination 3|Withdrawal by Subject|1
7424648|NCT01509846|11700609|FG002|Received Vaccination 3|Withdrawal by Subject|0
7424649|NCT01509846|11700610|FG003|Received Vaccination 3|Withdrawal by Subject|0
7424650|NCT01509846|11700611|FG004|Received Vaccination 3|Withdrawal by Subject|0
7424651|NCT01509846|11700607|FG000|Received Vaccination 3|Pregnancy|0
7531895|NCT02660489|11876920|FG000|Overall Study|Lost to Follow-up|1
7531896|NCT02660489|11876921|FG001|Overall Study|Lost to Follow-up|1
7531897|NCT02660489|11876920|FG000|Overall Study|Adverse Event|1
7531898|NCT02660489|11876921|FG001|Overall Study|Adverse Event|3
7531899|NCT02660489|11876920|FG000|Overall Study|no rhinovirus infection|4
7424652|NCT01509846|11700608|FG001|Received Vaccination 3|Pregnancy|0
7424653|NCT01509846|11700609|FG002|Received Vaccination 3|Pregnancy|0
7424654|NCT01509846|11700610|FG003|Received Vaccination 3|Pregnancy|1
7424655|NCT01509846|11700611|FG004|Received Vaccination 3|Pregnancy|0
7424656|NCT01509846|11700607|FG000|Received Vaccination 3|Lost to Follow-up|0
7424657|NCT01509846|11700608|FG001|Received Vaccination 3|Lost to Follow-up|0
7424658|NCT01509846|11700609|FG002|Received Vaccination 3|Lost to Follow-up|1
7424659|NCT01509846|11700610|FG003|Received Vaccination 3|Lost to Follow-up|0
7424660|NCT01509846|11700611|FG004|Received Vaccination 3|Lost to Follow-up|0
7424661|NCT01510028|11700655|FG000|Overall Study|Lack of Efficacy|1
7424662|NCT01510028|11700656|FG001|Overall Study|Lack of Efficacy|0
7424663|NCT01510028|11700657|FG002|Overall Study|Lack of Efficacy|0
7424664|NCT01510028|11700658|FG003|Overall Study|Lack of Efficacy|0
7424665|NCT01510145|11700670|FG000|Overall Study|Adverse Event|6
7424666|NCT01510145|11700670|FG000|Overall Study|Lost to Follow-up|5
7424667|NCT01510145|11700670|FG000|Overall Study|Withdrawal by Subject|6
7424668|NCT01510145|11700670|FG000|Overall Study|Relative reported subject withdrew|1
7424669|NCT01510158|11700677|FG000|Overall Study|Adverse Event|7
7424670|NCT01510158|11700678|FG001|Overall Study|Adverse Event|8
7424671|NCT01510158|11700679|FG002|Overall Study|Adverse Event|5
7424672|NCT01510158|11700677|FG000|Overall Study|Gout flare|1
7424673|NCT01510158|11700678|FG001|Overall Study|Gout flare|0
7424674|NCT01510158|11700679|FG002|Overall Study|Gout flare|0
7424675|NCT01510158|11700677|FG000|Overall Study|Protocol Violation|17
7424676|NCT01510158|11700678|FG001|Overall Study|Protocol Violation|16
7424677|NCT01510158|11700679|FG002|Overall Study|Protocol Violation|24
7424678|NCT01510158|11700677|FG000|Overall Study|Sponsor terminated study.|2
7424679|NCT01510158|11700678|FG001|Overall Study|Sponsor terminated study.|0
7424680|NCT01510158|11700679|FG002|Overall Study|Sponsor terminated study.|2
7424681|NCT01510158|11700677|FG000|Overall Study|Lost to Follow-up|13
7424682|NCT01510158|11700678|FG001|Overall Study|Lost to Follow-up|16
7424683|NCT01510158|11700679|FG002|Overall Study|Lost to Follow-up|9
7424684|NCT01510158|11700677|FG000|Overall Study|Withdrawal by Subject|10
7424685|NCT01510158|11700678|FG001|Overall Study|Withdrawal by Subject|13
7531900|NCT02660489|11876921|FG001|Overall Study|no rhinovirus infection|4
7531901|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7531902|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
7531903|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7557272|NCT03098550|11921798|FG001|Overall Study|Disease Progression|19
7557273|NCT03098550|11921799|FG002|Overall Study|Disease Progression|41
7531904|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7531905|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
7557274|NCT03098550|11921797|FG000|Overall Study|Study Drug Toxicity|2
7424686|NCT01510158|11700679|FG002|Overall Study|Withdrawal by Subject|10
7424687|NCT01510158|11700677|FG000|Overall Study|Death|1
7424688|NCT01510158|11700678|FG001|Overall Study|Death|0
7424689|NCT01510158|11700679|FG002|Overall Study|Death|0
7424690|NCT01510717|11700745|FG000|Overall Study|Adverse Event|1
7424691|NCT01510717|11700746|FG001|Overall Study|Adverse Event|2
7424692|NCT01510717|11700745|FG000|Overall Study|Death|1
7424693|NCT01510717|11700746|FG001|Overall Study|Death|0
7424694|NCT01510717|11700745|FG000|Overall Study|Lost to Follow-up|0
7424695|NCT01510717|11700746|FG001|Overall Study|Lost to Follow-up|1
7424696|NCT01510717|11700745|FG000|Overall Study|Withdrawal by Subject|0
7424697|NCT01510717|11700746|FG001|Overall Study|Withdrawal by Subject|2
7424698|NCT01510769|11700756|FG000|Overall Study|Adverse Event|7
7424699|NCT01510769|11700757|FG001|Overall Study|Adverse Event|6
7424700|NCT01510769|11700758|FG002|Overall Study|Adverse Event|4
7424701|NCT01510769|11700756|FG000|Overall Study|Gout Flare|0
7424702|NCT01510769|11700757|FG001|Overall Study|Gout Flare|3
7424703|NCT01510769|11700758|FG002|Overall Study|Gout Flare|1
7424704|NCT01510769|11700756|FG000|Overall Study|Protocol Violation|11
7424705|NCT01510769|11700757|FG001|Overall Study|Protocol Violation|10
7424706|NCT01510769|11700758|FG002|Overall Study|Protocol Violation|9
7424707|NCT01510769|11700756|FG000|Overall Study|Lost to Follow-up|5
7424708|NCT01510769|11700757|FG001|Overall Study|Lost to Follow-up|1
7424709|NCT01510769|11700758|FG002|Overall Study|Lost to Follow-up|5
7424710|NCT01510769|11700756|FG000|Overall Study|Withdrawal by Subject|3
7424711|NCT01510769|11700757|FG001|Overall Study|Withdrawal by Subject|4
7424712|NCT01510769|11700758|FG002|Overall Study|Withdrawal by Subject|3
7424713|NCT01510769|11700756|FG000|Overall Study|Death|1
7424714|NCT01510769|11700757|FG001|Overall Study|Death|1
7424715|NCT01510769|11700758|FG002|Overall Study|Death|0
7424716|NCT01510912|11700773|FG000|Overall Study|Adverse Event|99
7424717|NCT01510912|11700773|FG000|Overall Study|Lack of Efficacy|12
7424718|NCT01510912|11700773|FG000|Overall Study|Non-compliance with trial drug|23
7424719|NCT01510912|11700773|FG000|Overall Study|Withdrawal by Subject|49
7424720|NCT01510912|11700773|FG000|Overall Study|Physician Decision|1
7424721|NCT01510912|11700773|FG000|Overall Study|Protocol Violation|27
7424722|NCT01510912|11700773|FG000|Overall Study|Lost to Follow-up|26
7424723|NCT01510912|11700773|FG000|Overall Study|Other, including joint replacement|5
7424724|NCT01511055|11700787|FG000|Overall Study|Withdrawal by Subject|6
7424725|NCT01511107|11700797|FG000|Overall Study|Ineligible|3
7424726|NCT01511107|11700798|FG001|Overall Study|Ineligible|2
7424727|NCT01511107|11700797|FG000|Overall Study|Lost to Follow-up|10
7424728|NCT01511107|11700798|FG001|Overall Study|Lost to Follow-up|19
7424729|NCT01511107|11700797|FG000|Overall Study|Withdrawal by Subject|9
7424730|NCT01511107|11700798|FG001|Overall Study|Withdrawal by Subject|20
7424731|NCT01511250|11700814|FG000|Overall Study|Withdrawal of Consent|1
7424732|NCT01511250|11700815|FG001|Overall Study|Withdrawal of Consent|0
7424733|NCT01511250|11700816|FG002|Overall Study|Withdrawal of Consent|0
7424734|NCT01511250|11700817|FG003|Overall Study|Withdrawal of Consent|0
7424735|NCT01511250|11700818|FG004|Overall Study|Withdrawal of Consent|0
7424736|NCT01511250|11700819|FG005|Overall Study|Withdrawal of Consent|0
7424737|NCT01511250|11700820|FG006|Overall Study|Withdrawal of Consent|0
7424738|NCT01511250|11700821|FG007|Overall Study|Withdrawal of Consent|1
7424739|NCT01511250|11700822|FG008|Overall Study|Withdrawal of Consent|1
7424740|NCT01511250|11700823|FG009|Overall Study|Withdrawal of Consent|0
7424741|NCT01511250|11700814|FG000|Overall Study|Sponsor/Investigator Decision|1
7424742|NCT01511250|11700815|FG001|Overall Study|Sponsor/Investigator Decision|0
7424743|NCT01511250|11700816|FG002|Overall Study|Sponsor/Investigator Decision|0
7424744|NCT01511250|11700817|FG003|Overall Study|Sponsor/Investigator Decision|0
7424745|NCT01511250|11700818|FG004|Overall Study|Sponsor/Investigator Decision|0
7424746|NCT01511250|11700819|FG005|Overall Study|Sponsor/Investigator Decision|0
7424747|NCT01511250|11700820|FG006|Overall Study|Sponsor/Investigator Decision|0
7424748|NCT01511250|11700821|FG007|Overall Study|Sponsor/Investigator Decision|0
7424749|NCT01511250|11700822|FG008|Overall Study|Sponsor/Investigator Decision|0
7424750|NCT01511250|11700823|FG009|Overall Study|Sponsor/Investigator Decision|0
7424751|NCT01511250|11700814|FG000|Overall Study|Lost to Follow-up|7
7424752|NCT01511250|11700815|FG001|Overall Study|Lost to Follow-up|3
7424753|NCT01511250|11700816|FG002|Overall Study|Lost to Follow-up|3
7424754|NCT01511250|11700817|FG003|Overall Study|Lost to Follow-up|3
7424755|NCT01511250|11700818|FG004|Overall Study|Lost to Follow-up|0
7424756|NCT01511250|11700819|FG005|Overall Study|Lost to Follow-up|0
7424757|NCT01511250|11700820|FG006|Overall Study|Lost to Follow-up|2
7424758|NCT01511250|11700821|FG007|Overall Study|Lost to Follow-up|3
7424759|NCT01511250|11700822|FG008|Overall Study|Lost to Follow-up|13
7424760|NCT01511250|11700823|FG009|Overall Study|Lost to Follow-up|5
7424761|NCT01511250|11700814|FG000|Overall Study|Protocol Violation|0
7424762|NCT01511250|11700815|FG001|Overall Study|Protocol Violation|2
7424763|NCT01511250|11700816|FG002|Overall Study|Protocol Violation|1
7424764|NCT01511250|11700817|FG003|Overall Study|Protocol Violation|0
7424765|NCT01511250|11700818|FG004|Overall Study|Protocol Violation|0
7424766|NCT01511250|11700819|FG005|Overall Study|Protocol Violation|0
7424767|NCT01511250|11700820|FG006|Overall Study|Protocol Violation|0
7424768|NCT01511250|11700821|FG007|Overall Study|Protocol Violation|0
7424769|NCT01511250|11700822|FG008|Overall Study|Protocol Violation|0
7424770|NCT01511250|11700823|FG009|Overall Study|Protocol Violation|0
7424771|NCT01511419|11700851|FG000|Dose 2|Physician Decision|1
7328029|NCT00792935|11560700|FG001|Overall Study|Lost to Follow-up|1
7328030|NCT00792935|11560699|FG000|Overall Study|Protocol Violation|2
7328031|NCT00792935|11560700|FG001|Overall Study|Protocol Violation|0
7328032|NCT00792935|11560699|FG000|Overall Study|Withdrawal by Subject|0
7328033|NCT00792935|11560700|FG001|Overall Study|Withdrawal by Subject|1
7328034|NCT00793104|11560706|FG000|Overall Study|Lost to Follow-up|1
7328035|NCT00793182|11560712|FG000|Overall Study|Adverse Event|0
7328036|NCT00793182|11560713|FG001|Overall Study|Adverse Event|1
7328037|NCT00793325|11560719|FG000|Overall Study|Protocol Violation|18
7328038|NCT00793325|11560719|FG000|Overall Study|Lost to Follow-up|1
7328039|NCT00793403|11560742|FG000|Overall Study|Other|73
7328040|NCT00793546|11560758|FG000|Overall Study|Death|3
7328041|NCT00793546|11560759|FG001|Overall Study|Death|0
7328042|NCT00793546|11560758|FG000|Overall Study|Lost to Follow-up|1
7328043|NCT00793546|11560759|FG001|Overall Study|Lost to Follow-up|0
7328044|NCT00793546|11560758|FG000|Overall Study|Withdrawal by Subject|1
7328045|NCT00793546|11560759|FG001|Overall Study|Withdrawal by Subject|1
7328046|NCT00793546|11560758|FG000|Overall Study|Study Terminated by Sponsor|8
7328047|NCT00793546|11560759|FG001|Overall Study|Study Terminated by Sponsor|27
7328048|NCT00793546|11560758|FG000|Overall Study|Other|1
7328049|NCT00793546|11560759|FG001|Overall Study|Other|0
7328050|NCT00793585|11560773|FG000|Overall Study|Adverse Event|1
7328051|NCT00793585|11560774|FG001|Overall Study|Adverse Event|1
7328052|NCT00793585|11560773|FG000|Overall Study|Protocol Violation|1
7328053|NCT00793585|11560774|FG001|Overall Study|Protocol Violation|2
7328054|NCT00793598|11560785|FG000|Overall Study|Patient Request|0
7424772|NCT01511419|11700852|FG001|Dose 2|Physician Decision|0
7424773|NCT01511445|11700884|FG000|Overall Study|Lost to Follow-up|3
7424774|NCT01511445|11700885|FG001|Overall Study|Lost to Follow-up|1
7424775|NCT01511445|11700884|FG000|Overall Study|Protocol Violation|1
7424776|NCT01511445|11700885|FG001|Overall Study|Protocol Violation|3
7424777|NCT01511445|11700884|FG000|Overall Study|Protocol Violation|1
7424778|NCT01511445|11700885|FG001|Overall Study|Protocol Violation|0
7424779|NCT01511536|11700894|FG000|Phase 1|Other|0
7424780|NCT01511536|11700895|FG001|Phase 1|Other|1
7424781|NCT01511536|11700896|FG002|Phase 1|Other|0
7424782|NCT01511536|11700894|FG000|Phase 2|Other|0
7424783|NCT01511536|11700895|FG001|Phase 2|Other|0
7424784|NCT01511536|11700896|FG002|Phase 2|Other|9
7424785|NCT01511939|11700933|FG000|Overall Study|Withdrawal by Subject|2
7424786|NCT01511939|11700934|FG001|Overall Study|Withdrawal by Subject|1
7424787|NCT01511939|11700935|FG002|Overall Study|Withdrawal by Subject|0
7424788|NCT01512108|11700956|FG000|Overall Study|Adverse Event|9
7424789|NCT01512108|11700957|FG001|Overall Study|Adverse Event|4
7424790|NCT01512108|11700956|FG000|Overall Study|Protocol Violation|1
7424791|NCT01512108|11700957|FG001|Overall Study|Protocol Violation|2
7424792|NCT01512108|11700956|FG000|Overall Study|Withdrawal Criteria|1
7424793|NCT01512108|11700957|FG001|Overall Study|Withdrawal Criteria|0
7424794|NCT01512108|11700956|FG000|Overall Study|Unclassified|11
7424795|NCT01512108|11700957|FG001|Overall Study|Unclassified|3
7424796|NCT01512160|11700967|FG000|Overall Study|Lost to Follow-up|1
7424797|NCT01512160|11700968|FG001|Overall Study|Lost to Follow-up|0
7424798|NCT01512160|11700969|FG002|Overall Study|Lost to Follow-up|0
7424799|NCT01512160|11700970|FG003|Overall Study|Lost to Follow-up|0
7424800|NCT01512160|11700967|FG000|Overall Study|Withdrawal by Subject|1
7424801|NCT01512160|11700968|FG001|Overall Study|Withdrawal by Subject|0
7424802|NCT01512160|11700969|FG002|Overall Study|Withdrawal by Subject|0
7424803|NCT01512160|11700970|FG003|Overall Study|Withdrawal by Subject|1
7424804|NCT01512264|11701006|FG000|Overall Study|Lost to Follow-up|0
7424805|NCT01512264|11701007|FG001|Overall Study|Lost to Follow-up|0
7424806|NCT01512264|11701008|FG002|Overall Study|Lost to Follow-up|0
7424807|NCT01512264|11701009|FG003|Overall Study|Lost to Follow-up|1
7424808|NCT01512368|11701019|FG000|Overall Study|Protocol Violation|3
7424809|NCT01512693|11701043|FG000|Overall Study|Withdrawal by Subject|0
7424810|NCT01512693|11701044|FG001|Overall Study|Withdrawal by Subject|1
7424811|NCT01512745|11701052|FG000|Overall Study|Adverse Event|22
7424812|NCT01512745|11701053|FG001|Overall Study|Adverse Event|3
7424813|NCT01512745|11701052|FG000|Overall Study|Death|9
7328055|NCT00793598|11560786|FG001|Overall Study|Patient Request|1
7328056|NCT00793598|11560787|FG002|Overall Study|Patient Request|0
7328057|NCT00793598|11560788|FG003|Overall Study|Patient Request|0
7328058|NCT00793598|11560789|FG004|Overall Study|Patient Request|0
7328059|NCT00793598|11560790|FG005|Overall Study|Patient Request|0
7424814|NCT01512745|11701053|FG001|Overall Study|Death|13
7424815|NCT01512745|11701052|FG000|Overall Study|Withdrawal by Subject|2
7424816|NCT01512745|11701053|FG001|Overall Study|Withdrawal by Subject|2
7424817|NCT01512745|11701052|FG000|Overall Study|Lost to Follow-up|4
7424818|NCT01512745|11701053|FG001|Overall Study|Lost to Follow-up|0
7424819|NCT01512745|11701052|FG000|Overall Study|Lack of Efficacy|2
7328060|NCT00793598|11560791|FG006|Overall Study|Patient Request|0
7424820|NCT01512745|11701053|FG001|Overall Study|Lack of Efficacy|2
7424821|NCT01512745|11701052|FG000|Overall Study|Protocol Violation|1
7424822|NCT01512745|11701053|FG001|Overall Study|Protocol Violation|0
7424823|NCT01512979|11701095|FG000|Overall Study|Adverse Event|2
7328061|NCT00793598|11560792|FG007|Overall Study|Patient Request|0
7328062|NCT00793598|11560785|FG000|Overall Study|Protocol Violation|0
7424824|NCT01512979|11701096|FG001|Overall Study|Adverse Event|2
7424825|NCT01512979|11701095|FG000|Overall Study|Protocol Violation|1
7424826|NCT01512979|11701096|FG001|Overall Study|Protocol Violation|4
7424827|NCT01512979|11701095|FG000|Overall Study|Lost to Follow-up|2
7424828|NCT01512979|11701096|FG001|Overall Study|Lost to Follow-up|5
7424829|NCT01512979|11701095|FG000|Overall Study|Withdrawal by Subject|1
7424830|NCT01512979|11701096|FG001|Overall Study|Withdrawal by Subject|2
7424831|NCT01512979|11701095|FG000|Overall Study|Reason other than stated above|13
7424832|NCT01512979|11701096|FG001|Overall Study|Reason other than stated above|9
7424833|NCT01513148|11701113|FG000|Overall Study|Protocol Violation|2
7424834|NCT01513148|11701114|FG001|Overall Study|Protocol Violation|2
7424835|NCT01513239|11701163|FG000|Period 1: Main Phase|Adverse Event|1
7424836|NCT01513239|11701164|FG001|Period 1: Main Phase|Adverse Event|1
7424837|NCT01513239|11701165|FG002|Period 1: Main Phase|Adverse Event|2
7424838|NCT01513239|11701166|FG003|Period 1: Main Phase|Adverse Event|0
7424839|NCT01513239|11701167|FG004|Period 1: Main Phase|Adverse Event|0
7424840|NCT01513239|11701168|FG005|Period 1: Main Phase|Adverse Event|0
7424841|NCT01513239|11701163|FG000|Period 1: Main Phase|Death|29
7424842|NCT01513239|11701164|FG001|Period 1: Main Phase|Death|22
7424843|NCT01513239|11701165|FG002|Period 1: Main Phase|Death|32
7424844|NCT01513239|11701166|FG003|Period 1: Main Phase|Death|0
7424845|NCT01513239|11701167|FG004|Period 1: Main Phase|Death|0
7424846|NCT01513239|11701168|FG005|Period 1: Main Phase|Death|0
7424847|NCT01513239|11701163|FG000|Period 1: Main Phase|Lost to Follow-up|11
7424848|NCT01513239|11701164|FG001|Period 1: Main Phase|Lost to Follow-up|10
7424849|NCT01513239|11701165|FG002|Period 1: Main Phase|Lost to Follow-up|6
7424850|NCT01513239|11701166|FG003|Period 1: Main Phase|Lost to Follow-up|0
7424851|NCT01513239|11701167|FG004|Period 1: Main Phase|Lost to Follow-up|0
7424852|NCT01513239|11701168|FG005|Period 1: Main Phase|Lost to Follow-up|0
7424853|NCT01513239|11701163|FG000|Period 1: Main Phase|Physician Decision|4
7424854|NCT01513239|11701164|FG001|Period 1: Main Phase|Physician Decision|4
7424855|NCT01513239|11701165|FG002|Period 1: Main Phase|Physician Decision|4
7531906|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
7531907|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
7531908|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7531909|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7531910|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
7531911|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
7531912|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7328063|NCT00793598|11560786|FG001|Overall Study|Protocol Violation|0
7328064|NCT00793598|11560787|FG002|Overall Study|Protocol Violation|0
7328065|NCT00793598|11560788|FG003|Overall Study|Protocol Violation|0
7328066|NCT00793598|11560789|FG004|Overall Study|Protocol Violation|0
7531913|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7531914|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7531915|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
7531916|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7531917|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
7531918|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7531919|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7424856|NCT01513239|11701166|FG003|Period 1: Main Phase|Physician Decision|0
7424857|NCT01513239|11701167|FG004|Period 1: Main Phase|Physician Decision|0
7424858|NCT01513239|11701168|FG005|Period 1: Main Phase|Physician Decision|0
7424859|NCT01513239|11701163|FG000|Period 1: Main Phase|Protocol Violation|2
7424860|NCT01513239|11701164|FG001|Period 1: Main Phase|Protocol Violation|2
7424861|NCT01513239|11701165|FG002|Period 1: Main Phase|Protocol Violation|2
7424862|NCT01513239|11701166|FG003|Period 1: Main Phase|Protocol Violation|0
7424863|NCT01513239|11701167|FG004|Period 1: Main Phase|Protocol Violation|0
7424864|NCT01513239|11701168|FG005|Period 1: Main Phase|Protocol Violation|0
7424865|NCT01513239|11701163|FG000|Period 1: Main Phase|Technical Problems|1
7424866|NCT01513239|11701164|FG001|Period 1: Main Phase|Technical Problems|2
7424867|NCT01513239|11701165|FG002|Period 1: Main Phase|Technical Problems|0
7424868|NCT01513239|11701166|FG003|Period 1: Main Phase|Technical Problems|0
7424869|NCT01513239|11701167|FG004|Period 1: Main Phase|Technical Problems|0
7424870|NCT01513239|11701168|FG005|Period 1: Main Phase|Technical Problems|0
7424871|NCT01513239|11701163|FG000|Period 1: Main Phase|Withdrawal by Subject|27
7424872|NCT01513239|11701164|FG001|Period 1: Main Phase|Withdrawal by Subject|29
7424873|NCT01513239|11701165|FG002|Period 1: Main Phase|Withdrawal by Subject|42
7424874|NCT01513239|11701166|FG003|Period 1: Main Phase|Withdrawal by Subject|0
7424875|NCT01513239|11701167|FG004|Period 1: Main Phase|Withdrawal by Subject|0
7424876|NCT01513239|11701168|FG005|Period 1: Main Phase|Withdrawal by Subject|0
7424877|NCT01513239|11701163|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7424878|NCT01513239|11701164|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7424879|NCT01513239|11701165|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
7424880|NCT01513239|11701166|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
7531920|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
7531921|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
7328067|NCT00793598|11560790|FG005|Overall Study|Protocol Violation|0
7424881|NCT01513239|11701167|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
7424882|NCT01513239|11701168|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
7424883|NCT01513239|11701163|FG000|Period 2: 9 Month Extension Phase|Death|0
7424884|NCT01513239|11701164|FG001|Period 2: 9 Month Extension Phase|Death|0
7424885|NCT01513239|11701165|FG002|Period 2: 9 Month Extension Phase|Death|0
7424886|NCT01513239|11701166|FG003|Period 2: 9 Month Extension Phase|Death|2
7424887|NCT01513239|11701167|FG004|Period 2: 9 Month Extension Phase|Death|5
7424888|NCT01513239|11701168|FG005|Period 2: 9 Month Extension Phase|Death|2
7424889|NCT01513239|11701163|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7424890|NCT01513239|11701164|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7424891|NCT01513239|11701165|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7424892|NCT01513239|11701166|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
7424893|NCT01513239|11701167|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
7424894|NCT01513239|11701168|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
7424895|NCT01513239|11701163|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
7424896|NCT01513239|11701164|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
7424897|NCT01513239|11701165|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
7424898|NCT01513239|11701166|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
7424899|NCT01513239|11701167|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
7424900|NCT01513239|11701168|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
7424901|NCT01513239|11701163|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
7424902|NCT01513239|11701164|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
7424903|NCT01513239|11701165|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
7424904|NCT01513239|11701166|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
7424905|NCT01513239|11701167|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
7424906|NCT01513239|11701168|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
7424907|NCT01513291|11701182|FG000|Treatment Period|Adverse Event|8
7424908|NCT01513291|11701183|FG001|Treatment Period|Adverse Event|4
7424909|NCT01513291|11701184|FG002|Treatment Period|Adverse Event|0
7424910|NCT01513291|11701185|FG003|Treatment Period|Adverse Event|0
7424911|NCT01513291|11701186|FG004|Treatment Period|Adverse Event|0
7424912|NCT01513291|11701182|FG000|Treatment Period|Lack of Efficacy|3
7424913|NCT01513291|11701183|FG001|Treatment Period|Lack of Efficacy|0
7424914|NCT01513291|11701184|FG002|Treatment Period|Lack of Efficacy|0
7424915|NCT01513291|11701185|FG003|Treatment Period|Lack of Efficacy|0
7424916|NCT01513291|11701186|FG004|Treatment Period|Lack of Efficacy|0
7424917|NCT01513291|11701182|FG000|Treatment Period|Lost to Follow-up|2
7424918|NCT01513291|11701183|FG001|Treatment Period|Lost to Follow-up|3
7424919|NCT01513291|11701184|FG002|Treatment Period|Lost to Follow-up|0
7424920|NCT01513291|11701185|FG003|Treatment Period|Lost to Follow-up|0
7424921|NCT01513291|11701186|FG004|Treatment Period|Lost to Follow-up|0
7424922|NCT01513291|11701182|FG000|Treatment Period|Physician Decision|1
7424923|NCT01513291|11701183|FG001|Treatment Period|Physician Decision|0
7557275|NCT03098550|11921798|FG001|Overall Study|Study Drug Toxicity|1
7557276|NCT03098550|11921799|FG002|Overall Study|Study Drug Toxicity|0
7557277|NCT03098550|11921797|FG000|Overall Study|Death|1
7557278|NCT03098550|11921798|FG001|Overall Study|Death|0
7557279|NCT03098550|11921799|FG002|Overall Study|Death|0
7557280|NCT03098550|11921797|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
7557281|NCT03098550|11921798|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
7557282|NCT03098550|11921799|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
7557283|NCT03098550|11921797|FG000|Overall Study|Administrative reason by sponsor|0
7557284|NCT03098550|11921798|FG001|Overall Study|Administrative reason by sponsor|0
7557285|NCT03098550|11921799|FG002|Overall Study|Administrative reason by sponsor|1
7557286|NCT03098550|11921797|FG000|Overall Study|Other reasons|2
7557287|NCT03098550|11921798|FG001|Overall Study|Other reasons|0
7557288|NCT03098550|11921799|FG002|Overall Study|Other reasons|0
7557289|NCT03098979|11921844|FG000|Overall Study|Adverse Event|1
7557290|NCT03098979|11921845|FG001|Overall Study|Adverse Event|0
7557291|NCT03098979|11921846|FG002|Overall Study|Adverse Event|1
7557292|NCT03098979|11921847|FG003|Overall Study|Adverse Event|4
7557293|NCT03098979|11921848|FG004|Overall Study|Adverse Event|6
7557294|NCT03098979|11921849|FG005|Overall Study|Adverse Event|1
7557295|NCT03098979|11921844|FG000|Overall Study|Withdrawal by Subject|2
7557296|NCT03098979|11921845|FG001|Overall Study|Withdrawal by Subject|1
7557297|NCT03098979|11921846|FG002|Overall Study|Withdrawal by Subject|1
7557298|NCT03098979|11921847|FG003|Overall Study|Withdrawal by Subject|1
7557299|NCT03098979|11921848|FG004|Overall Study|Withdrawal by Subject|2
7557300|NCT03098979|11921849|FG005|Overall Study|Withdrawal by Subject|1
7424924|NCT01513291|11701184|FG002|Treatment Period|Physician Decision|0
7424925|NCT01513291|11701185|FG003|Treatment Period|Physician Decision|0
7424926|NCT01513291|11701186|FG004|Treatment Period|Physician Decision|0
7424927|NCT01513291|11701182|FG000|Treatment Period|Protocol Violation|1
7424928|NCT01513291|11701183|FG001|Treatment Period|Protocol Violation|2
7557301|NCT03098979|11921844|FG000|Overall Study|Death|1
7557302|NCT03098979|11921845|FG001|Overall Study|Death|0
7557303|NCT03098979|11921846|FG002|Overall Study|Death|2
7557304|NCT03098979|11921847|FG003|Overall Study|Death|0
7557305|NCT03098979|11921848|FG004|Overall Study|Death|1
7557306|NCT03098979|11921849|FG005|Overall Study|Death|0
7557307|NCT03098979|11921844|FG000|Overall Study|Physician Decision|2
7557308|NCT03098979|11921845|FG001|Overall Study|Physician Decision|1
7557309|NCT03098979|11921846|FG002|Overall Study|Physician Decision|0
7557310|NCT03098979|11921847|FG003|Overall Study|Physician Decision|0
7424929|NCT01513291|11701184|FG002|Treatment Period|Protocol Violation|0
7424930|NCT01513291|11701185|FG003|Treatment Period|Protocol Violation|0
7424931|NCT01513291|11701186|FG004|Treatment Period|Protocol Violation|0
7424932|NCT01513291|11701182|FG000|Treatment Period|Withdrawal by Subject|8
7424933|NCT01513291|11701183|FG001|Treatment Period|Withdrawal by Subject|5
7424934|NCT01513291|11701184|FG002|Treatment Period|Withdrawal by Subject|0
7424935|NCT01513291|11701185|FG003|Treatment Period|Withdrawal by Subject|0
7424936|NCT01513291|11701186|FG004|Treatment Period|Withdrawal by Subject|0
7424937|NCT01513291|11701182|FG000|Treatment Period|Randomized not treated|0
7424938|NCT01513291|11701183|FG001|Treatment Period|Randomized not treated|2
7424939|NCT01513291|11701184|FG002|Treatment Period|Randomized not treated|0
7424940|NCT01513291|11701185|FG003|Treatment Period|Randomized not treated|0
7424941|NCT01513291|11701186|FG004|Treatment Period|Randomized not treated|0
7424942|NCT01513291|11701182|FG000|Run-out Period|Lost to Follow-up|0
7424943|NCT01513291|11701183|FG001|Run-out Period|Lost to Follow-up|0
7424944|NCT01513291|11701184|FG002|Run-out Period|Lost to Follow-up|0
7424945|NCT01513291|11701185|FG003|Run-out Period|Lost to Follow-up|1
7424946|NCT01513291|11701186|FG004|Run-out Period|Lost to Follow-up|0
7424947|NCT01513291|11701182|FG000|Run-out Period|Withdrawal by Subject|0
7424948|NCT01513291|11701183|FG001|Run-out Period|Withdrawal by Subject|0
7424949|NCT01513291|11701184|FG002|Run-out Period|Withdrawal by Subject|0
7424950|NCT01513291|11701185|FG003|Run-out Period|Withdrawal by Subject|1
7424951|NCT01513291|11701186|FG004|Run-out Period|Withdrawal by Subject|0
7424952|NCT01513317|11701200|FG000|Overall Study|Withdrawal by Subject|15
7424953|NCT01513317|11701201|FG001|Overall Study|Withdrawal by Subject|4
7424954|NCT01513317|11701200|FG000|Overall Study|Death|1
7424955|NCT01513317|11701201|FG001|Overall Study|Death|1
7424956|NCT01513317|11701200|FG000|Overall Study|Study terminated by sponsor|18
7424957|NCT01513317|11701201|FG001|Overall Study|Study terminated by sponsor|18
7424958|NCT01513317|11701200|FG000|Overall Study|Other|0
7424959|NCT01513317|11701201|FG001|Overall Study|Other|1
7424960|NCT01513330|11701207|FG000|SenSura Mio First,|Adverse Event|2
7424961|NCT01513330|11701208|FG001|SenSura Mio First,|Adverse Event|0
7424962|NCT01513330|11701207|FG000|SenSura Mio First,|Lack of Efficacy|0
7424963|NCT01513330|11701208|FG001|SenSura Mio First,|Lack of Efficacy|1
7424964|NCT01513330|11701207|FG000|SenSura Mio First,|Withdrawal by Subject|1
7424965|NCT01513330|11701208|FG001|SenSura Mio First,|Withdrawal by Subject|1
7424966|NCT01513330|11701207|FG000|SenSura Mio First,|Other|1
7424967|NCT01513330|11701208|FG001|SenSura Mio First,|Other|0
7424968|NCT01513330|11701207|FG000|Standard Care First,|Lack of Efficacy|2
7424969|NCT01513330|11701208|FG001|Standard Care First,|Lack of Efficacy|2
7424970|NCT01513330|11701207|FG000|Standard Care First,|Withdrawal by Subject|1
7424971|NCT01513330|11701208|FG001|Standard Care First,|Withdrawal by Subject|2
7424972|NCT01513330|11701207|FG000|Standard Care First,|Other|1
7424973|NCT01513330|11701208|FG001|Standard Care First,|Other|0
7466706|NCT01894230|11766644|FG001|Overall Study|Death|0
7466707|NCT01894243|11766653|FG000|Overall Study|Adverse Event|0
7466708|NCT01894243|11766654|FG001|Overall Study|Adverse Event|1
7466709|NCT01894243|11766655|FG002|Overall Study|Adverse Event|2
7466710|NCT01894243|11766653|FG000|Overall Study|Death|0
7466711|NCT01894243|11766654|FG001|Overall Study|Death|0
7466712|NCT01894243|11766655|FG002|Overall Study|Death|3
7466713|NCT01894243|11766653|FG000|Overall Study|Lack of Efficacy|3
7466714|NCT01894243|11766654|FG001|Overall Study|Lack of Efficacy|3
7466715|NCT01894243|11766655|FG002|Overall Study|Lack of Efficacy|1
7466716|NCT01894243|11766653|FG000|Overall Study|Condition under investigation worsened|8
7466717|NCT01894243|11766654|FG001|Overall Study|Condition under investigation worsened|6
7466718|NCT01894243|11766655|FG002|Overall Study|Condition under investigation worsened|2
7466719|NCT01894243|11766653|FG000|Overall Study|Subject decision|1
7466720|NCT01894243|11766654|FG001|Overall Study|Subject decision|0
7466721|NCT01894243|11766655|FG002|Overall Study|Subject decision|0
7466722|NCT01894243|11766653|FG000|Overall Study|Other|1
7466723|NCT01894243|11766654|FG001|Overall Study|Other|0
7466724|NCT01894243|11766655|FG002|Overall Study|Other|0
7466725|NCT01894256|11766673|FG000|Part A|Adverse Event|0
7466726|NCT01894256|11766674|FG001|Part A|Adverse Event|1
7466727|NCT01894256|11766675|FG002|Part A|Adverse Event|0
7466728|NCT01894256|11766673|FG000|Part B|Death|0
7466729|NCT01894256|11766674|FG001|Part B|Death|1
7466730|NCT01894256|11766675|FG002|Part B|Death|1
7466731|NCT01894256|11766673|FG000|Part B|Withdrawal by Subject|0
7466732|NCT01894256|11766674|FG001|Part B|Withdrawal by Subject|1
7466733|NCT01894256|11766675|FG002|Part B|Withdrawal by Subject|0
7466734|NCT01894256|11766673|FG000|Part B|Lack of Efficacy|15
7466735|NCT01894256|11766674|FG001|Part B|Lack of Efficacy|12
7466736|NCT01894256|11766675|FG002|Part B|Lack of Efficacy|13
7466737|NCT01894477|11766688|FG000|Overall Study|Protocol Violation|0
7466738|NCT01894477|11766689|FG001|Overall Study|Protocol Violation|1
7466739|NCT01894477|11766688|FG000|Overall Study|protocol changed due SC changed to cord|0
7466740|NCT01894477|11766689|FG001|Overall Study|protocol changed due SC changed to cord|1
7466741|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Other|0
7466742|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Other|1
7466743|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Other|1
7466744|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Other|0
7466745|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
7424974|NCT01513460|11701226|FG000|Overall Study|Death|0
7424975|NCT01513460|11701227|FG001|Overall Study|Death|0
7424976|NCT01513460|11701228|FG002|Overall Study|Death|1
7424977|NCT01513460|11701226|FG000|Overall Study|Lost to Follow-up|0
7424978|NCT01513460|11701227|FG001|Overall Study|Lost to Follow-up|0
7424979|NCT01513460|11701228|FG002|Overall Study|Lost to Follow-up|2
7424980|NCT01513460|11701226|FG000|Overall Study|Abnormal laboratory value|1
7424981|NCT01513460|11701227|FG001|Overall Study|Abnormal laboratory value|0
7424982|NCT01513460|11701228|FG002|Overall Study|Abnormal laboratory value|1
7424983|NCT01513460|11701226|FG000|Overall Study|Lack of Efficacy|1
7424984|NCT01513460|11701227|FG001|Overall Study|Lack of Efficacy|2
7424985|NCT01513460|11701228|FG002|Overall Study|Lack of Efficacy|5
7531922|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
7531923|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7531924|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7531925|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
7531926|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
7424986|NCT01513460|11701226|FG000|Overall Study|Protocol deviations|3
7424987|NCT01513460|11701227|FG001|Overall Study|Protocol deviations|4
7424988|NCT01513460|11701228|FG002|Overall Study|Protocol deviations|3
7424989|NCT01513460|11701226|FG000|Overall Study|Withdrawal by Subject|7
7424990|NCT01513460|11701227|FG001|Overall Study|Withdrawal by Subject|8
7424991|NCT01513460|11701228|FG002|Overall Study|Withdrawal by Subject|21
7424992|NCT01513460|11701226|FG000|Overall Study|Adverse Event|16
7424993|NCT01513460|11701227|FG001|Overall Study|Adverse Event|18
7424994|NCT01513460|11701228|FG002|Overall Study|Adverse Event|23
7424995|NCT01513460|11701226|FG000|Overall Study|Abnormal test procedure|1
7424996|NCT01513460|11701227|FG001|Overall Study|Abnormal test procedure|0
7424997|NCT01513460|11701228|FG002|Overall Study|Abnormal test procedure|0
7424998|NCT01513473|11701240|FG000|Main Trial (26 Weeks)|Adverse Event|0
7424999|NCT01513473|11701241|FG001|Main Trial (26 Weeks)|Adverse Event|2
7425000|NCT01513473|11701240|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
7425001|NCT01513473|11701241|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
7425002|NCT01513473|11701240|FG000|Main Trial (26 Weeks)|Unclassified|0
7425003|NCT01513473|11701241|FG001|Main Trial (26 Weeks)|Unclassified|2
7425004|NCT01513473|11701240|FG000|Extension Trial (26 Weeks)|Adverse Event|0
7425005|NCT01513473|11701241|FG001|Extension Trial (26 Weeks)|Adverse Event|1
7425006|NCT01513473|11701240|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
7425007|NCT01513473|11701241|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
7425008|NCT01513551|11701254|FG000|Overall Study|Death|0
7425009|NCT01513551|11701255|FG001|Overall Study|Death|1
7425010|NCT01513551|11701256|FG002|Overall Study|Death|0
7425011|NCT01513551|11701254|FG000|Overall Study|Lost to Follow-up|3
7425012|NCT01513551|11701255|FG001|Overall Study|Lost to Follow-up|5
7425013|NCT01513551|11701256|FG002|Overall Study|Lost to Follow-up|2
7425014|NCT01513551|11701254|FG000|Overall Study|Withdrawal by Subject|1
7425015|NCT01513551|11701255|FG001|Overall Study|Withdrawal by Subject|0
7425016|NCT01513551|11701256|FG002|Overall Study|Withdrawal by Subject|2
7425017|NCT01513551|11701254|FG000|Overall Study|Randomized but not vaccinated|0
7425018|NCT01513551|11701255|FG001|Overall Study|Randomized but not vaccinated|0
7425019|NCT01513551|11701256|FG002|Overall Study|Randomized but not vaccinated|1
7425020|NCT01513590|11701266|FG000|Overall Study|Adverse Event|2
7425021|NCT01513590|11701267|FG001|Overall Study|Adverse Event|3
7425022|NCT01513590|11701266|FG000|Overall Study|Withdrawal Criteria|3
7425023|NCT01513590|11701267|FG001|Overall Study|Withdrawal Criteria|0
7425024|NCT01513590|11701266|FG000|Overall Study|Unclassified|5
7425025|NCT01513590|11701267|FG001|Overall Study|Unclassified|10
7425026|NCT01513759|11701273|FG000|Overall Study|Protocol Violation|4
7425027|NCT01513759|11701273|FG000|Overall Study|Death during catheter placement|1
7425028|NCT01513967|11701298|FG000|Overall Study|Pregnancy|0
7425029|NCT01513967|11701299|FG001|Overall Study|Pregnancy|0
7425030|NCT01513967|11701300|FG002|Overall Study|Pregnancy|0
7425031|NCT01513967|11701301|FG003|Overall Study|Pregnancy|0
7425032|NCT01513967|11701302|FG004|Overall Study|Pregnancy|0
7425033|NCT01513967|11701303|FG005|Overall Study|Pregnancy|0
7425034|NCT01513967|11701304|FG006|Overall Study|Pregnancy|1
7425035|NCT01513967|11701305|FG007|Overall Study|Pregnancy|0
7425036|NCT01513967|11701298|FG000|Overall Study|missed a study visit|0
7425037|NCT01513967|11701299|FG001|Overall Study|missed a study visit|0
7425038|NCT01513967|11701300|FG002|Overall Study|missed a study visit|0
7425039|NCT01513967|11701301|FG003|Overall Study|missed a study visit|0
7425040|NCT01513967|11701302|FG004|Overall Study|missed a study visit|0
7425041|NCT01513967|11701303|FG005|Overall Study|missed a study visit|0
7425042|NCT01513967|11701304|FG006|Overall Study|missed a study visit|1
7425043|NCT01513967|11701305|FG007|Overall Study|missed a study visit|0
7425044|NCT01513967|11701298|FG000|Overall Study|excluded due to positive drug screen|0
7425045|NCT01513967|11701299|FG001|Overall Study|excluded due to positive drug screen|0
7425046|NCT01513967|11701300|FG002|Overall Study|excluded due to positive drug screen|0
7425047|NCT01513967|11701301|FG003|Overall Study|excluded due to positive drug screen|0
7425048|NCT01513967|11701302|FG004|Overall Study|excluded due to positive drug screen|0
7425049|NCT01513967|11701303|FG005|Overall Study|excluded due to positive drug screen|0
7468730|NCT01914393|11769702|FG002|Overall Study|Lack of Efficacy|5
7425050|NCT01513967|11701304|FG006|Overall Study|excluded due to positive drug screen|0
7425051|NCT01513967|11701305|FG007|Overall Study|excluded due to positive drug screen|2
7425052|NCT01513967|11701298|FG000|Overall Study|Physician Decision|0
7425053|NCT01513967|11701299|FG001|Overall Study|Physician Decision|0
7425054|NCT01513967|11701300|FG002|Overall Study|Physician Decision|0
7425055|NCT01513967|11701301|FG003|Overall Study|Physician Decision|0
7425056|NCT01513967|11701302|FG004|Overall Study|Physician Decision|0
7425057|NCT01513967|11701303|FG005|Overall Study|Physician Decision|1
7425058|NCT01513967|11701304|FG006|Overall Study|Physician Decision|0
7425059|NCT01513967|11701305|FG007|Overall Study|Physician Decision|0
7425060|NCT01514136|11701325|FG000|Test Period 1; Test A|Protocol Violation|1
7425061|NCT01514136|11701326|FG001|Test Period 1; Test A|Protocol Violation|0
7425062|NCT01514136|11701327|FG002|Test Period 1; Test A|Protocol Violation|0
7425063|NCT01514136|11701328|FG003|Test Period 1; Test A|Protocol Violation|0
7425064|NCT01514136|11701329|FG004|Test Period 1; Test A|Protocol Violation|0
7425065|NCT01514136|11701330|FG005|Test Period 1; Test A|Protocol Violation|0
7425066|NCT01514136|11701331|FG006|Test Period 1; Test A|Protocol Violation|0
7425067|NCT01514136|11701332|FG007|Test Period 1; Test A|Protocol Violation|0
7425068|NCT01514136|11701325|FG000|Test Period 1; Test A|Break from study holiday|2
7425069|NCT01514136|11701326|FG001|Test Period 1; Test A|Break from study holiday|0
7425070|NCT01514136|11701327|FG002|Test Period 1; Test A|Break from study holiday|0
7425071|NCT01514136|11701328|FG003|Test Period 1; Test A|Break from study holiday|0
7425072|NCT01514136|11701329|FG004|Test Period 1; Test A|Break from study holiday|0
7425073|NCT01514136|11701330|FG005|Test Period 1; Test A|Break from study holiday|0
7425074|NCT01514136|11701331|FG006|Test Period 1; Test A|Break from study holiday|0
7425075|NCT01514136|11701332|FG007|Test Period 1; Test A|Break from study holiday|0
7425076|NCT01514136|11701325|FG000|Test Period 1; Test B|Withdrawal by Subject|0
7425077|NCT01514136|11701326|FG001|Test Period 1; Test B|Withdrawal by Subject|1
7425078|NCT01514136|11701327|FG002|Test Period 1; Test B|Withdrawal by Subject|0
7425079|NCT01514136|11701328|FG003|Test Period 1; Test B|Withdrawal by Subject|0
7425080|NCT01514136|11701329|FG004|Test Period 1; Test B|Withdrawal by Subject|0
7425081|NCT01514136|11701330|FG005|Test Period 1; Test B|Withdrawal by Subject|0
7425082|NCT01514136|11701331|FG006|Test Period 1; Test B|Withdrawal by Subject|0
7425083|NCT01514136|11701332|FG007|Test Period 1; Test B|Withdrawal by Subject|0
7425084|NCT01514136|11701325|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
7425085|NCT01514136|11701326|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
7425086|NCT01514136|11701327|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
7425087|NCT01514136|11701328|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
7425088|NCT01514136|11701329|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
7425089|NCT01514136|11701330|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
7425090|NCT01514136|11701331|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
7425091|NCT01514136|11701332|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
7425092|NCT01514136|11701325|FG000|Test Period 2; Test A*|Adverse Event|0
7425093|NCT01514136|11701326|FG001|Test Period 2; Test A*|Adverse Event|0
7425094|NCT01514136|11701327|FG002|Test Period 2; Test A*|Adverse Event|0
7425095|NCT01514136|11701328|FG003|Test Period 2; Test A*|Adverse Event|0
7425096|NCT01514136|11701329|FG004|Test Period 2; Test A*|Adverse Event|1
7425097|NCT01514136|11701330|FG005|Test Period 2; Test A*|Adverse Event|0
7425098|NCT01514136|11701331|FG006|Test Period 2; Test A*|Adverse Event|0
7425099|NCT01514136|11701332|FG007|Test Period 2; Test A*|Adverse Event|0
7425100|NCT01514136|11701325|FG000|Test Period 2; Test A*|Holiday|0
7425101|NCT01514136|11701326|FG001|Test Period 2; Test A*|Holiday|0
7425102|NCT01514136|11701327|FG002|Test Period 2; Test A*|Holiday|0
7425103|NCT01514136|11701328|FG003|Test Period 2; Test A*|Holiday|0
7425104|NCT01514136|11701329|FG004|Test Period 2; Test A*|Holiday|1
7425105|NCT01514136|11701330|FG005|Test Period 2; Test A*|Holiday|0
7425106|NCT01514136|11701331|FG006|Test Period 2; Test A*|Holiday|0
7425107|NCT01514136|11701332|FG007|Test Period 2; Test A*|Holiday|0
7425108|NCT01514136|11701325|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
7425109|NCT01514136|11701326|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
7425110|NCT01514136|11701327|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
7425111|NCT01514136|11701328|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
7425112|NCT01514136|11701329|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
7425113|NCT01514136|11701330|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
7425114|NCT01514136|11701331|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
7425115|NCT01514136|11701332|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
7425116|NCT01514136|11701325|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
7425117|NCT01514136|11701326|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
7425118|NCT01514136|11701327|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
7425119|NCT01514136|11701328|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
7425120|NCT01514136|11701329|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
7425121|NCT01514136|11701330|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
7425122|NCT01514136|11701331|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
7425123|NCT01514136|11701332|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
7425124|NCT01514136|11701325|FG000|Test Period 2; Test C*|holiday|0
7425125|NCT01514136|11701326|FG001|Test Period 2; Test C*|holiday|0
7425126|NCT01514136|11701327|FG002|Test Period 2; Test C*|holiday|0
7425127|NCT01514136|11701328|FG003|Test Period 2; Test C*|holiday|0
7425128|NCT01514136|11701329|FG004|Test Period 2; Test C*|holiday|0
7425129|NCT01514136|11701330|FG005|Test Period 2; Test C*|holiday|0
7425130|NCT01514136|11701331|FG006|Test Period 2; Test C*|holiday|1
7425131|NCT01514136|11701332|FG007|Test Period 2; Test C*|holiday|0
7425132|NCT01514136|11701325|FG000|Test Period 2; Test C*|Protocol Violation|0
7425133|NCT01514136|11701326|FG001|Test Period 2; Test C*|Protocol Violation|0
7425134|NCT01514136|11701327|FG002|Test Period 2; Test C*|Protocol Violation|0
7425135|NCT01514136|11701328|FG003|Test Period 2; Test C*|Protocol Violation|0
7425136|NCT01514136|11701329|FG004|Test Period 2; Test C*|Protocol Violation|0
7425137|NCT01514136|11701330|FG005|Test Period 2; Test C*|Protocol Violation|0
7425138|NCT01514136|11701331|FG006|Test Period 2; Test C*|Protocol Violation|1
7425139|NCT01514136|11701332|FG007|Test Period 2; Test C*|Protocol Violation|0
7425140|NCT01514201|11701387|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
7425141|NCT01514201|11701388|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425142|NCT01514201|11701389|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425143|NCT01514201|11701390|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425144|NCT01514201|11701387|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7425145|NCT01514201|11701388|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7425146|NCT01514201|11701389|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
7425147|NCT01514201|11701390|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
7425148|NCT01514201|11701387|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7425149|NCT01514201|11701388|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
7425150|NCT01514201|11701389|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
7425151|NCT01514201|11701390|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7425152|NCT01514201|11701387|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7425153|NCT01514201|11701388|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
7425154|NCT01514201|11701389|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7425155|NCT01514201|11701390|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7425156|NCT01514201|11701387|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7425157|NCT01514201|11701388|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7425158|NCT01514201|11701389|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
7425159|NCT01514201|11701390|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
7425160|NCT01514201|11701387|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7425161|NCT01514201|11701388|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7425162|NCT01514201|11701389|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
7425163|NCT01514201|11701390|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
7425164|NCT01514201|11701387|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
7425165|NCT01514201|11701388|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
7425166|NCT01514201|11701389|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
7425167|NCT01514201|11701390|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
7425168|NCT01514201|11701387|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425169|NCT01514201|11701388|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425170|NCT01514201|11701389|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
7425171|NCT01514201|11701390|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
7425172|NCT01514201|11701387|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7425173|NCT01514201|11701388|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7425174|NCT01514201|11701389|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
7425175|NCT01514201|11701390|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
7425176|NCT01514201|11701387|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7425177|NCT01514201|11701388|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7425178|NCT01514201|11701389|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
7425179|NCT01514201|11701390|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
7425180|NCT01514201|11701387|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7425181|NCT01514201|11701388|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7425182|NCT01514201|11701389|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
7425183|NCT01514201|11701390|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
7425184|NCT01514201|11701387|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7425185|NCT01514201|11701388|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7425186|NCT01514201|11701389|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
7425187|NCT01514201|11701390|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
7425188|NCT01514240|11701412|FG000|Overall Study|Adverse Event|4
7425189|NCT01514240|11701413|FG001|Overall Study|Adverse Event|4
7425190|NCT01514240|11701412|FG000|Overall Study|Subject Decision|2
7425191|NCT01514240|11701413|FG001|Overall Study|Subject Decision|7
7425192|NCT01514357|11701442|FG000|Overall Study|Screen failure|2
7425193|NCT01514357|11701443|FG001|Overall Study|Screen failure|0
7425194|NCT01514357|11701442|FG000|Overall Study|Withdrawal by Subject|2
7425195|NCT01514357|11701443|FG001|Overall Study|Withdrawal by Subject|0
7425196|NCT01514370|11701451|FG000|Overall Study|Protocol Violation|2
7425197|NCT01514370|11701452|FG001|Overall Study|Protocol Violation|3
7425198|NCT01514370|11701451|FG000|Overall Study|Lost to Follow-up|0
7425199|NCT01514370|11701452|FG001|Overall Study|Lost to Follow-up|2
7425200|NCT01514370|11701451|FG000|Overall Study|Withdrawal by Subject|2
7425201|NCT01514370|11701452|FG001|Overall Study|Withdrawal by Subject|1
7425202|NCT01514370|11701451|FG000|Overall Study|Adverse Event|1
7425203|NCT01514370|11701452|FG001|Overall Study|Adverse Event|3
7425204|NCT01514370|11701451|FG000|Overall Study|Other|6
7425205|NCT01514370|11701452|FG001|Overall Study|Other|7
7425206|NCT01514422|11701469|FG000|Overall Study|Lost to Follow-up|1
7425207|NCT01514448|11701475|FG000|Overall Study|Death|7
7425208|NCT01514448|11701476|FG001|Overall Study|Death|8
7425209|NCT01514448|11701475|FG000|Overall Study|Withdrawal by Subject|2
7425210|NCT01514448|11701476|FG001|Overall Study|Withdrawal by Subject|0
7425211|NCT01514448|11701475|FG000|Overall Study|Lost to Follow-up|2
7425212|NCT01514448|11701476|FG001|Overall Study|Lost to Follow-up|0
7425213|NCT01514448|11701475|FG000|Overall Study|New Cancer Therapy|1
7425214|NCT01514448|11701476|FG001|Overall Study|New Cancer Therapy|0
7425215|NCT01514461|11701486|FG000|Overall Study|Adverse Event|2
7425216|NCT01514461|11701487|FG001|Overall Study|Adverse Event|1
7425217|NCT01514461|11701488|FG002|Overall Study|Adverse Event|3
7425218|NCT01514461|11701486|FG000|Overall Study|Physician Decision|1
7425219|NCT01514461|11701487|FG001|Overall Study|Physician Decision|1
7425220|NCT01514461|11701488|FG002|Overall Study|Physician Decision|0
7425221|NCT01514461|11701486|FG000|Overall Study|Patient/guardian decision|1
7425222|NCT01514461|11701487|FG001|Overall Study|Patient/guardian decision|1
7425223|NCT01514461|11701488|FG002|Overall Study|Patient/guardian decision|1
7425224|NCT01514461|11701486|FG000|Overall Study|Death|1
7425225|NCT01514461|11701487|FG001|Overall Study|Death|0
7425226|NCT01514461|11701488|FG002|Overall Study|Death|0
7425227|NCT01514760|11701516|FG000|Overall Study|Lost to Follow-up|2
7425228|NCT01514864|11701531|FG000|Overall Study|Disease progression|7
7425229|NCT01514864|11701532|FG001|Overall Study|Disease progression|5
7425230|NCT01514864|11701531|FG000|Overall Study|Study drug toxicity|2
7425231|NCT01514864|11701532|FG001|Overall Study|Study drug toxicity|0
7425232|NCT01515189|11701579|FG000|Induction|Disease Progression|109
7425233|NCT01515189|11701580|FG001|Induction|Disease Progression|155
7425234|NCT01515189|11701579|FG000|Induction|Study drug toxicity|86
7425235|NCT01515189|11701580|FG001|Induction|Study drug toxicity|36
7425236|NCT01515189|11701579|FG000|Induction|Death|24
7425237|NCT01515189|11701580|FG001|Induction|Death|17
7425238|NCT01515189|11701579|FG000|Induction|Adverse Event|14
7425239|NCT01515189|11701580|FG001|Induction|Adverse Event|9
7425240|NCT01515189|11701579|FG000|Induction|Withdrawal by Subject|3
7425241|NCT01515189|11701580|FG001|Induction|Withdrawal by Subject|9
7425242|NCT01515189|11701579|FG000|Induction|No longer meets study criteria|0
7425243|NCT01515189|11701580|FG001|Induction|No longer meets study criteria|2
7425244|NCT01515189|11701579|FG000|Induction|Lost to Follow-up|1
7425245|NCT01515189|11701580|FG001|Induction|Lost to Follow-up|0
7425246|NCT01515189|11701579|FG000|Induction|Other|0
7425247|NCT01515189|11701580|FG001|Induction|Other|4
7425248|NCT01515189|11701579|FG000|First Re-Induction Phase|Disease progression|6
7425249|NCT01515189|11701580|FG001|First Re-Induction Phase|Disease progression|14
7425250|NCT01515189|11701579|FG000|First Re-Induction Phase|Study drug toxicity|5
7425251|NCT01515189|11701580|FG001|First Re-Induction Phase|Study drug toxicity|0
7425252|NCT01515189|11701579|FG000|First Re-Induction Phase|Withdrawal by Subject|1
7425253|NCT01515189|11701580|FG001|First Re-Induction Phase|Withdrawal by Subject|1
7425254|NCT01515189|11701579|FG000|First Re-Induction Phase|No longer meets study criteria|1
7425255|NCT01515189|11701580|FG001|First Re-Induction Phase|No longer meets study criteria|0
7425256|NCT01515189|11701579|FG000|First Re-Induction Phase|Other|1
7425257|NCT01515189|11701580|FG001|First Re-Induction Phase|Other|0
7425258|NCT01515319|11701596|FG000|Overall Study|Withdrawal by Subject|0
7425259|NCT01515319|11701597|FG001|Overall Study|Withdrawal by Subject|0
7425260|NCT01515319|11701598|FG002|Overall Study|Withdrawal by Subject|0
7425261|NCT01515319|11701599|FG003|Overall Study|Withdrawal by Subject|0
7425262|NCT01515319|11701600|FG004|Overall Study|Withdrawal by Subject|0
7425263|NCT01515319|11701601|FG005|Overall Study|Withdrawal by Subject|0
7425264|NCT01515319|11701602|FG006|Overall Study|Withdrawal by Subject|1
7425265|NCT01515319|11701603|FG007|Overall Study|Withdrawal by Subject|0
7425266|NCT01515319|11701604|FG008|Overall Study|Withdrawal by Subject|0
7425267|NCT01515319|11701605|FG009|Overall Study|Withdrawal by Subject|0
7425268|NCT01515319|11701596|FG000|Overall Study|Adverse Event|0
7425269|NCT01515319|11701597|FG001|Overall Study|Adverse Event|0
7425270|NCT01515319|11701598|FG002|Overall Study|Adverse Event|0
7425271|NCT01515319|11701599|FG003|Overall Study|Adverse Event|0
7425272|NCT01515319|11701600|FG004|Overall Study|Adverse Event|0
7425273|NCT01515319|11701601|FG005|Overall Study|Adverse Event|0
7425274|NCT01515319|11701602|FG006|Overall Study|Adverse Event|0
7425275|NCT01515319|11701603|FG007|Overall Study|Adverse Event|0
7425276|NCT01515319|11701604|FG008|Overall Study|Adverse Event|3
7425277|NCT01515319|11701605|FG009|Overall Study|Adverse Event|0
7425278|NCT01515319|11701596|FG000|Overall Study|Protocol Violation|0
7425279|NCT01515319|11701597|FG001|Overall Study|Protocol Violation|0
7425280|NCT01515319|11701598|FG002|Overall Study|Protocol Violation|0
7425281|NCT01515319|11701599|FG003|Overall Study|Protocol Violation|0
7425282|NCT01515319|11701600|FG004|Overall Study|Protocol Violation|0
7425283|NCT01515319|11701601|FG005|Overall Study|Protocol Violation|0
7425284|NCT01515319|11701602|FG006|Overall Study|Protocol Violation|0
7425285|NCT01515319|11701603|FG007|Overall Study|Protocol Violation|0
7425286|NCT01515319|11701604|FG008|Overall Study|Protocol Violation|2
7425287|NCT01515319|11701605|FG009|Overall Study|Protocol Violation|0
7425288|NCT01515423|11701645|FG000|Open Label Phase|Adverse Event|57
7425289|NCT01515423|11701646|FG001|Open Label Phase|Adverse Event|0
7425290|NCT01515423|11701647|FG002|Open Label Phase|Adverse Event|0
7425291|NCT01515423|11701645|FG000|Open Label Phase|Death|2
7425292|NCT01515423|11701646|FG001|Open Label Phase|Death|0
7425293|NCT01515423|11701647|FG002|Open Label Phase|Death|0
7425294|NCT01515423|11701645|FG000|Open Label Phase|Lack of Efficacy|117
7425295|NCT01515423|11701646|FG001|Open Label Phase|Lack of Efficacy|0
7425296|NCT01515423|11701647|FG002|Open Label Phase|Lack of Efficacy|0
7425297|NCT01515423|11701645|FG000|Open Label Phase|Lost to Follow-up|21
7425298|NCT01515423|11701646|FG001|Open Label Phase|Lost to Follow-up|0
7425299|NCT01515423|11701647|FG002|Open Label Phase|Lost to Follow-up|0
7425300|NCT01515423|11701645|FG000|Open Label Phase|Withdrawal by Subject|118
7425301|NCT01515423|11701646|FG001|Open Label Phase|Withdrawal by Subject|0
7425302|NCT01515423|11701647|FG002|Open Label Phase|Withdrawal by Subject|0
7425303|NCT01515423|11701645|FG000|Open Label Phase|excluded from DB Phase|70
7425304|NCT01515423|11701646|FG001|Open Label Phase|excluded from DB Phase|0
7425305|NCT01515423|11701647|FG002|Open Label Phase|excluded from DB Phase|0
7425306|NCT01515423|11701645|FG000|Open Label Phase|Other|28
7425307|NCT01515423|11701646|FG001|Open Label Phase|Other|0
7425308|NCT01515423|11701647|FG002|Open Label Phase|Other|0
7425309|NCT01515423|11701645|FG000|DOUBLE BLIND|Adverse Event|0
7425310|NCT01515423|11701646|FG001|DOUBLE BLIND|Adverse Event|15
7425311|NCT01515423|11701647|FG002|DOUBLE BLIND|Adverse Event|13
7425312|NCT01515423|11701645|FG000|DOUBLE BLIND|Death|0
7425313|NCT01515423|11701646|FG001|DOUBLE BLIND|Death|1
7425314|NCT01515423|11701647|FG002|DOUBLE BLIND|Death|2
7425315|NCT01515423|11701645|FG000|DOUBLE BLIND|Lost to Follow-up|0
7425316|NCT01515423|11701646|FG001|DOUBLE BLIND|Lost to Follow-up|7
7425317|NCT01515423|11701647|FG002|DOUBLE BLIND|Lost to Follow-up|12
7425318|NCT01515423|11701645|FG000|DOUBLE BLIND|Pregnancy|0
7425319|NCT01515423|11701646|FG001|DOUBLE BLIND|Pregnancy|2
7425320|NCT01515423|11701647|FG002|DOUBLE BLIND|Pregnancy|0
7425321|NCT01515423|11701645|FG000|DOUBLE BLIND|Withdrawal by Subject|0
7425322|NCT01515423|11701646|FG001|DOUBLE BLIND|Withdrawal by Subject|50
7425323|NCT01515423|11701647|FG002|DOUBLE BLIND|Withdrawal by Subject|53
7425324|NCT01515423|11701645|FG000|DOUBLE BLIND|Other|0
7425325|NCT01515423|11701646|FG001|DOUBLE BLIND|Other|6
7425326|NCT01515423|11701647|FG002|DOUBLE BLIND|Other|12
7425327|NCT01515423|11701645|FG000|DOUBLE BLIND|Blind broken by investigator|0
7425328|NCT01515423|11701646|FG001|DOUBLE BLIND|Blind broken by investigator|1
7425329|NCT01515423|11701647|FG002|DOUBLE BLIND|Blind broken by investigator|0
7425330|NCT01515475|11701658|FG000|Overall Study|Lost to Follow-up|20
7425331|NCT01515475|11701659|FG001|Overall Study|Lost to Follow-up|15
7425332|NCT01515475|11701660|FG002|Overall Study|Lost to Follow-up|12
7425333|NCT01515475|11701661|FG003|Overall Study|Lost to Follow-up|12
7425334|NCT01515865|11701717|FG000|Part A (Open-label)|Other|3
7425335|NCT01515865|11701718|FG001|Part A (Open-label)|Other|0
7425336|NCT01515865|11701719|FG002|Part A (Open-label)|Other|0
7425337|NCT01515865|11701717|FG000|Part B (Open-label)|Withdrawal by Subject|1
7425338|NCT01515865|11701718|FG001|Part B (Open-label)|Withdrawal by Subject|0
7425339|NCT01515865|11701719|FG002|Part B (Open-label)|Withdrawal by Subject|0
7425340|NCT01515865|11701717|FG000|Part B (Open-label)|Other|1
7425341|NCT01515865|11701718|FG001|Part B (Open-label)|Other|0
7425342|NCT01515865|11701719|FG002|Part B (Open-label)|Other|0
7425343|NCT01516008|11701763|FG000|Overall Study|Adverse Event|0
7425344|NCT01516008|11701764|FG001|Overall Study|Adverse Event|2
7425345|NCT01516008|11701765|FG002|Overall Study|Adverse Event|7
7425346|NCT01516008|11701763|FG000|Overall Study|Lack of Efficacy|44
7425347|NCT01516008|11701764|FG001|Overall Study|Lack of Efficacy|14
7425348|NCT01516008|11701765|FG002|Overall Study|Lack of Efficacy|10
7425349|NCT01516008|11701763|FG000|Overall Study|Protocol Violation|1
7425350|NCT01516008|11701764|FG001|Overall Study|Protocol Violation|0
7425351|NCT01516008|11701765|FG002|Overall Study|Protocol Violation|0
7425352|NCT01516008|11701763|FG000|Overall Study|Reason not specified|0
7425353|NCT01516008|11701764|FG001|Overall Study|Reason not specified|0
7425354|NCT01516008|11701765|FG002|Overall Study|Reason not specified|1
7425355|NCT01516437|11701795|FG000|Overall Study|Reason not specified|0
7425356|NCT01516437|11701796|FG001|Overall Study|Reason not specified|0
7425357|NCT01516437|11701797|FG002|Overall Study|Reason not specified|1
7425358|NCT01516437|11701798|FG003|Overall Study|Reason not specified|1
7425359|NCT01516736|11701834|FG000|Overall Study|Withdrawal by Subject|10
7425360|NCT01516736|11701835|FG001|Overall Study|Withdrawal by Subject|4
7425361|NCT01516736|11701834|FG000|Overall Study|Adverse Event|4
7425362|NCT01516736|11701835|FG001|Overall Study|Adverse Event|5
7425363|NCT01516736|11701834|FG000|Overall Study|Death|3
7425364|NCT01516736|11701835|FG001|Overall Study|Death|1
7425365|NCT01516736|11701834|FG000|Overall Study|Physician Decision|2
7425366|NCT01516736|11701835|FG001|Overall Study|Physician Decision|1
7425367|NCT01516736|11701834|FG000|Overall Study|Lack of Efficacy|1
7425368|NCT01516736|11701835|FG001|Overall Study|Lack of Efficacy|0
7425369|NCT01516736|11701834|FG000|Overall Study|Protocol Violation|0
7425370|NCT01516736|11701835|FG001|Overall Study|Protocol Violation|1
7425371|NCT01516736|11701834|FG000|Overall Study|Other (not specified)|0
7425372|NCT01516736|11701835|FG001|Overall Study|Other (not specified)|1
7425373|NCT01516749|11701841|FG000|Active Therapy|Lost to Follow-up|1
7425374|NCT01516749|11701841|FG000|Follow-up Off Therapy|Lost to Follow-up|1
7425383|NCT01516892|11701854|FG000|Overall Study|Adverse Event|25
7425384|NCT01516892|11701854|FG000|Overall Study|Lack of Efficacy|35
7425385|NCT01516892|11701854|FG000|Overall Study|Pregnancy|5
7425386|NCT01516892|11701854|FG000|Overall Study|Lost to Follow-up|82
7425387|NCT01516892|11701854|FG000|Overall Study|Subject Withdrew Consent|92
7425388|NCT01516892|11701854|FG000|Overall Study|Protocol Violation|60
7425389|NCT01516892|11701854|FG000|Overall Study|Other Miscellaneous Reasons|43
7425390|NCT01516892|11701854|FG000|Overall Study|Missing|1
7425391|NCT01516970|11701875|FG000|Overall Study|Lost to Follow-up|7
7425392|NCT01516970|11701876|FG001|Overall Study|Lost to Follow-up|8
7425393|NCT01516970|11701875|FG000|Overall Study|Adverse Event|1
7425394|NCT01516970|11701876|FG001|Overall Study|Adverse Event|5
7425395|NCT01516970|11701875|FG000|Overall Study|Withdrawal by Subject|1
7425396|NCT01516970|11701876|FG001|Overall Study|Withdrawal by Subject|1
7425397|NCT01516970|11701875|FG000|Overall Study|Other|9
7425398|NCT01516970|11701876|FG001|Overall Study|Other|7
7425399|NCT01517178|11701891|FG000|Period 1|Adverse Event|1
7425400|NCT01517178|11701892|FG001|Period 1|Adverse Event|2
7425401|NCT01517178|11701891|FG000|Period 1|Lack of Efficacy|0
7425402|NCT01517178|11701892|FG001|Period 1|Lack of Efficacy|1
7425403|NCT01517178|11701891|FG000|Period 1|E.g. study termination|3
7425404|NCT01517178|11701892|FG001|Period 1|E.g. study termination|1
7425405|NCT01517178|11701891|FG000|Period 1|Withdrawal by Subject|0
7425406|NCT01517178|11701892|FG001|Period 1|Withdrawal by Subject|1
7425407|NCT01517178|11701891|FG000|Period 2|Adverse Event|1
7425408|NCT01517178|11701892|FG001|Period 2|Adverse Event|0
7425409|NCT01517178|11701891|FG000|Period 2|Withdrawal by Subject|3
7425410|NCT01517178|11701892|FG001|Period 2|Withdrawal by Subject|0
7425411|NCT01517178|11701891|FG000|Period 2|E.g. study termination|2
7425412|NCT01517178|11701892|FG001|Period 2|E.g. study termination|2
7425413|NCT01517282|11701902|FG000|Overall Study|Consent withdrawn|0
7425414|NCT01517282|11701903|FG001|Overall Study|Consent withdrawn|1
7425415|NCT01517282|11701904|FG002|Overall Study|Consent withdrawn|1
7425416|NCT01517282|11701905|FG003|Overall Study|Consent withdrawn|1
7425417|NCT01517282|11701902|FG000|Overall Study|Physician Decision|1
7425418|NCT01517282|11701903|FG001|Overall Study|Physician Decision|0
7425419|NCT01517282|11701904|FG002|Overall Study|Physician Decision|0
7425420|NCT01517282|11701905|FG003|Overall Study|Physician Decision|0
7425421|NCT01517295|11701917|FG000|Overall Study|Physician Decision|1
7425422|NCT01517295|11701918|FG001|Overall Study|Physician Decision|0
7425423|NCT01517373|11701929|FG000|Run-in Period|Death|1
7557311|NCT03098979|11921848|FG004|Overall Study|Physician Decision|0
7557312|NCT03098979|11921849|FG005|Overall Study|Physician Decision|0
7557313|NCT03098979|11921844|FG000|Overall Study|Non-compliance|0
7557314|NCT03098979|11921845|FG001|Overall Study|Non-compliance|0
7557315|NCT03098979|11921846|FG002|Overall Study|Non-compliance|0
7557316|NCT03098979|11921847|FG003|Overall Study|Non-compliance|0
7557317|NCT03098979|11921848|FG004|Overall Study|Non-compliance|0
7557318|NCT03098979|11921849|FG005|Overall Study|Non-compliance|1
7557319|NCT03098979|11921844|FG000|Overall Study|Protocol Violation|0
7557320|NCT03098979|11921845|FG001|Overall Study|Protocol Violation|0
7557321|NCT03098979|11921846|FG002|Overall Study|Protocol Violation|0
7557322|NCT03098979|11921847|FG003|Overall Study|Protocol Violation|0
7557323|NCT03098979|11921848|FG004|Overall Study|Protocol Violation|0
7557324|NCT03098979|11921849|FG005|Overall Study|Protocol Violation|1
7557325|NCT03099096|11921863|FG000|Overall Study|Adverse Event|1
7425424|NCT01517373|11701930|FG001|Run-in Period|Death|0
7425425|NCT01517373|11701931|FG002|Run-in Period|Death|0
7425426|NCT01517373|11701932|FG003|Run-in Period|Death|0
7425427|NCT01517373|11701933|FG004|Run-in Period|Death|0
7425428|NCT01517373|11701934|FG005|Run-in Period|Death|0
7425429|NCT01517373|11701929|FG000|Run-in Period|Adverse Event|5
7425430|NCT01517373|11701930|FG001|Run-in Period|Adverse Event|0
7425431|NCT01517373|11701931|FG002|Run-in Period|Adverse Event|0
7425432|NCT01517373|11701932|FG003|Run-in Period|Adverse Event|0
7425433|NCT01517373|11701933|FG004|Run-in Period|Adverse Event|0
7425434|NCT01517373|11701934|FG005|Run-in Period|Adverse Event|0
7425435|NCT01517373|11701929|FG000|Run-in Period|Did not meet eligibility criteria|34
7425436|NCT01517373|11701930|FG001|Run-in Period|Did not meet eligibility criteria|0
7425437|NCT01517373|11701931|FG002|Run-in Period|Did not meet eligibility criteria|0
7425438|NCT01517373|11701932|FG003|Run-in Period|Did not meet eligibility criteria|0
7425439|NCT01517373|11701933|FG004|Run-in Period|Did not meet eligibility criteria|0
7425440|NCT01517373|11701934|FG005|Run-in Period|Did not meet eligibility criteria|0
7425441|NCT01517373|11701929|FG000|Run-in Period|Lost to Follow-up|1
7425442|NCT01517373|11701930|FG001|Run-in Period|Lost to Follow-up|0
7557326|NCT03099096|11921863|FG000|Overall Study|Physician Decision|1
7557327|NCT03099161|11921870|FG000|Overall Study|Adverse Event|0
7557328|NCT03099161|11921871|FG001|Overall Study|Adverse Event|0
7557329|NCT03099161|11921872|FG002|Overall Study|Adverse Event|2
7557330|NCT03099161|11921870|FG000|Overall Study|Physician Decision|2
7425443|NCT01517373|11701931|FG002|Run-in Period|Lost to Follow-up|0
7425444|NCT01517373|11701932|FG003|Run-in Period|Lost to Follow-up|0
7425445|NCT01517373|11701933|FG004|Run-in Period|Lost to Follow-up|0
7425446|NCT01517373|11701934|FG005|Run-in Period|Lost to Follow-up|0
7425447|NCT01517373|11701929|FG000|Run-in Period|Withdrawal by Subject|12
7425448|NCT01517373|11701930|FG001|Run-in Period|Withdrawal by Subject|0
7425449|NCT01517373|11701931|FG002|Run-in Period|Withdrawal by Subject|0
7425450|NCT01517373|11701932|FG003|Run-in Period|Withdrawal by Subject|0
7425451|NCT01517373|11701933|FG004|Run-in Period|Withdrawal by Subject|0
7425452|NCT01517373|11701934|FG005|Run-in Period|Withdrawal by Subject|0
7425453|NCT01517373|11701929|FG000|Run-in Period|Sponsor Decision|3
7425454|NCT01517373|11701930|FG001|Run-in Period|Sponsor Decision|0
7425455|NCT01517373|11701931|FG002|Run-in Period|Sponsor Decision|0
7425456|NCT01517373|11701932|FG003|Run-in Period|Sponsor Decision|0
7425457|NCT01517373|11701933|FG004|Run-in Period|Sponsor Decision|0
7425458|NCT01517373|11701934|FG005|Run-in Period|Sponsor Decision|0
7425459|NCT01517373|11701929|FG000|Run-in Period|Other|1
7425460|NCT01517373|11701930|FG001|Run-in Period|Other|0
7425461|NCT01517373|11701931|FG002|Run-in Period|Other|0
7425462|NCT01517373|11701932|FG003|Run-in Period|Other|0
7425463|NCT01517373|11701933|FG004|Run-in Period|Other|0
7425464|NCT01517373|11701934|FG005|Run-in Period|Other|0
7425465|NCT01517373|11701929|FG000|Treatment Period|Adverse Event|0
7425466|NCT01517373|11701930|FG001|Treatment Period|Adverse Event|0
7425467|NCT01517373|11701931|FG002|Treatment Period|Adverse Event|0
7425468|NCT01517373|11701932|FG003|Treatment Period|Adverse Event|0
7425469|NCT01517373|11701933|FG004|Treatment Period|Adverse Event|0
7425470|NCT01517373|11701934|FG005|Treatment Period|Adverse Event|2
7425471|NCT01517373|11701929|FG000|Treatment Period|Lost to Follow-up|0
7425472|NCT01517373|11701930|FG001|Treatment Period|Lost to Follow-up|0
7425473|NCT01517373|11701931|FG002|Treatment Period|Lost to Follow-up|1
7425474|NCT01517373|11701932|FG003|Treatment Period|Lost to Follow-up|1
7425475|NCT01517373|11701933|FG004|Treatment Period|Lost to Follow-up|0
7425476|NCT01517373|11701934|FG005|Treatment Period|Lost to Follow-up|0
7425477|NCT01517373|11701929|FG000|Treatment Period|Withdrawal by Subject|0
7425478|NCT01517373|11701930|FG001|Treatment Period|Withdrawal by Subject|3
7425479|NCT01517373|11701931|FG002|Treatment Period|Withdrawal by Subject|2
7425480|NCT01517373|11701932|FG003|Treatment Period|Withdrawal by Subject|2
7425481|NCT01517373|11701933|FG004|Treatment Period|Withdrawal by Subject|2
7425482|NCT01517373|11701934|FG005|Treatment Period|Withdrawal by Subject|3
7425483|NCT01517373|11701929|FG000|Treatment Period|Other|0
7425484|NCT01517373|11701930|FG001|Treatment Period|Other|0
7425485|NCT01517373|11701931|FG002|Treatment Period|Other|0
7425486|NCT01517373|11701932|FG003|Treatment Period|Other|0
7425487|NCT01517373|11701933|FG004|Treatment Period|Other|1
7425488|NCT01517373|11701934|FG005|Treatment Period|Other|0
7425489|NCT01517373|11701929|FG000|Treatment Period|Protocol Violation|0
7425490|NCT01517373|11701930|FG001|Treatment Period|Protocol Violation|0
7425491|NCT01517373|11701931|FG002|Treatment Period|Protocol Violation|0
7425492|NCT01517373|11701932|FG003|Treatment Period|Protocol Violation|0
7425493|NCT01517373|11701933|FG004|Treatment Period|Protocol Violation|1
7425494|NCT01517373|11701934|FG005|Treatment Period|Protocol Violation|0
7425495|NCT01517373|11701929|FG000|Treatment Period|Lack of Efficacy|0
7425496|NCT01517373|11701930|FG001|Treatment Period|Lack of Efficacy|1
7425497|NCT01517373|11701931|FG002|Treatment Period|Lack of Efficacy|1
7425498|NCT01517373|11701932|FG003|Treatment Period|Lack of Efficacy|3
7425499|NCT01517373|11701933|FG004|Treatment Period|Lack of Efficacy|2
7425500|NCT01517373|11701934|FG005|Treatment Period|Lack of Efficacy|0
7425501|NCT01517373|11701929|FG000|Treatment Period|Medication error without AEs|0
7425502|NCT01517373|11701930|FG001|Treatment Period|Medication error without AEs|0
7425503|NCT01517373|11701931|FG002|Treatment Period|Medication error without AEs|2
7425504|NCT01517373|11701932|FG003|Treatment Period|Medication error without AEs|1
7425505|NCT01517373|11701933|FG004|Treatment Period|Medication error without AEs|0
7425506|NCT01517373|11701934|FG005|Treatment Period|Medication error without AEs|2
7425507|NCT01517412|11701949|FG000|Overall Study|Adverse Event|10
7425508|NCT01517412|11701950|FG001|Overall Study|Adverse Event|11
7557331|NCT03099161|11921871|FG001|Overall Study|Physician Decision|0
7557332|NCT03099161|11921872|FG002|Overall Study|Physician Decision|0
7425509|NCT01517412|11701949|FG000|Overall Study|Lack of Efficacy|10
7425510|NCT01517412|11701950|FG001|Overall Study|Lack of Efficacy|5
7425511|NCT01517412|11701949|FG000|Overall Study|Poor compliance to protocol|8
7425512|NCT01517412|11701950|FG001|Overall Study|Poor compliance to protocol|3
7425513|NCT01517412|11701949|FG000|Overall Study|Other than specified above|8
7425514|NCT01517412|11701950|FG001|Overall Study|Other than specified above|5
7425515|NCT01517750|11701964|FG000|Overall Study|Lost to Follow-up|1
7425516|NCT01517750|11701965|FG001|Overall Study|Lost to Follow-up|2
7425517|NCT01517750|11701966|FG002|Overall Study|Lost to Follow-up|4
7425518|NCT01517750|11701967|FG003|Overall Study|Lost to Follow-up|1
7425519|NCT01517867|11701983|FG000|Overall Study|never started treatment|29
7425520|NCT01517867|11701984|FG001|Overall Study|never started treatment|32
7425521|NCT01517867|11701983|FG000|Overall Study|Withdrawal by Subject|34
7425522|NCT01517867|11701984|FG001|Overall Study|Withdrawal by Subject|30
7425523|NCT01517867|11701983|FG000|Overall Study|Still in treatment at study end|0
7425524|NCT01517867|11701984|FG001|Overall Study|Still in treatment at study end|3
7425525|NCT01517893|11701992|FG000|Overall Study|Withdrawal by Subject|3
7425526|NCT01517893|11701993|FG001|Overall Study|Withdrawal by Subject|0
7425527|NCT01517984|11702002|FG000|Overall Study|Lost to Follow-up|0
7425528|NCT01517984|11702003|FG001|Overall Study|Lost to Follow-up|1
7425529|NCT01517984|11702004|FG002|Overall Study|Lost to Follow-up|0
7425530|NCT01517984|11702005|FG003|Overall Study|Lost to Follow-up|0
7425531|NCT01517984|11702002|FG000|Overall Study|Withdrawal by Subject|1
7425532|NCT01517984|11702003|FG001|Overall Study|Withdrawal by Subject|8
7425533|NCT01517984|11702004|FG002|Overall Study|Withdrawal by Subject|4
7425534|NCT01517984|11702005|FG003|Overall Study|Withdrawal by Subject|1
7557333|NCT03099161|11921870|FG000|Overall Study|Progressive Disease|1
7557334|NCT03099161|11921871|FG001|Overall Study|Progressive Disease|4
7557335|NCT03099161|11921872|FG002|Overall Study|Progressive Disease|1
7557336|NCT03099187|11921882|FG000|Double-blind Treatment|Adverse Event|19
7557337|NCT03099187|11921883|FG001|Double-blind Treatment|Adverse Event|1
7425535|NCT01517984|11702002|FG000|Overall Study|Screen Failure|4
7425536|NCT01517984|11702003|FG001|Overall Study|Screen Failure|0
7425537|NCT01517984|11702004|FG002|Overall Study|Screen Failure|0
7425538|NCT01517984|11702005|FG003|Overall Study|Screen Failure|0
7425539|NCT01517984|11702002|FG000|Overall Study|Ineligible for randomization|0
7425540|NCT01517984|11702003|FG001|Overall Study|Ineligible for randomization|14
7425541|NCT01517984|11702004|FG002|Overall Study|Ineligible for randomization|0
7425542|NCT01517984|11702005|FG003|Overall Study|Ineligible for randomization|0
7425543|NCT01518153|11702012|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
7425544|NCT01518153|11702013|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7425545|NCT01518153|11702014|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
7425546|NCT01518153|11702012|FG000|Stem Cell Transplant|Death|2
7425547|NCT01518153|11702013|FG001|Stem Cell Transplant|Death|0
7425548|NCT01518153|11702014|FG002|Stem Cell Transplant|Death|0
7425549|NCT01518153|11702012|FG000|Stem Cell Transplant|Secondary graft failure|1
7425550|NCT01518153|11702013|FG001|Stem Cell Transplant|Secondary graft failure|0
7425551|NCT01518153|11702014|FG002|Stem Cell Transplant|Secondary graft failure|0
7425552|NCT01518153|11702012|FG000|Stem Cell Transplant|Adverse Event|1
7425553|NCT01518153|11702013|FG001|Stem Cell Transplant|Adverse Event|0
7425554|NCT01518153|11702014|FG002|Stem Cell Transplant|Adverse Event|0
7425555|NCT01518153|11702012|FG000|Donor Lymphocyte Infusion|Death|0
7425556|NCT01518153|11702013|FG001|Donor Lymphocyte Infusion|Death|2
7425557|NCT01518153|11702014|FG002|Donor Lymphocyte Infusion|Death|1
7425558|NCT01518192|11702025|FG000|Overall Study|Lost to Follow-up|29
7425559|NCT01518192|11702026|FG001|Overall Study|Lost to Follow-up|26
7531927|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
7531928|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7531929|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7531930|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
7531931|NCT02660580|11876929|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
7531932|NCT02660580|11876930|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
7531933|NCT02660580|11876931|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7531934|NCT02660580|11876932|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7531935|NCT02660580|11876933|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
7531936|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7531937|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7531938|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
7531939|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
7531940|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
7531941|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7425560|NCT01518192|11702027|FG002|Overall Study|Lost to Follow-up|35
7425561|NCT01518244|11702041|FG000|Overall Study|Adverse Event|3
7425562|NCT01518257|11702047|FG000|Overall Study|Lost to Follow-up|1
7425563|NCT01518257|11702048|FG001|Overall Study|Lost to Follow-up|0
7425564|NCT01518257|11702047|FG000|Overall Study|Other Miscellaneous Reason|1
7425565|NCT01518257|11702048|FG001|Overall Study|Other Miscellaneous Reason|0
7425566|NCT01518309|11702058|FG000|Overall Study|Adverse Event|6
7425567|NCT01518309|11702058|FG000|Overall Study|Death|6
7425568|NCT01518309|11702058|FG000|Overall Study|Lack of Efficacy|7
7425569|NCT01518309|11702058|FG000|Overall Study|Withdrawal by Subject|6
7531942|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7531943|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7531944|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
7425570|NCT01518309|11702058|FG000|Overall Study|Physician Decision|3
7531945|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
7557338|NCT03099187|11921884|FG002|Double-blind Treatment|Adverse Event|0
7425571|NCT01518309|11702058|FG000|Overall Study|Sponsor Decision|2
7425572|NCT01518309|11702058|FG000|Overall Study|Not in Predefined Categories|9
7425573|NCT01518322|11702062|FG000|Overall Study|FeNO measurement was missing|13
7425574|NCT01518374|11702071|FG000|Overall Study|Withdrawal by Subject|2
7425575|NCT01518374|11702071|FG000|Overall Study|Protocol Violation|3
7425576|NCT01518374|11702071|FG000|Overall Study|Lost to Follow-up|2
7425577|NCT01518699|11702085|FG000|Period 2|Protocol Violation|1
7425578|NCT01518699|11702086|FG001|Period 2|Protocol Violation|1
7425579|NCT01518699|11702087|FG002|Period 2|Protocol Violation|0
7425580|NCT01518699|11702088|FG003|Period 2|Protocol Violation|0
7425581|NCT01518699|11702089|FG004|Period 2|Protocol Violation|0
7425582|NCT01518699|11702090|FG005|Period 2|Protocol Violation|0
7425583|NCT01518699|11702085|FG000|Period 2|Lost to Follow-up|0
7425584|NCT01518699|11702086|FG001|Period 2|Lost to Follow-up|1
7425585|NCT01518699|11702087|FG002|Period 2|Lost to Follow-up|0
7425586|NCT01518699|11702088|FG003|Period 2|Lost to Follow-up|0
7425587|NCT01518699|11702089|FG004|Period 2|Lost to Follow-up|0
7425588|NCT01518699|11702090|FG005|Period 2|Lost to Follow-up|0
7425589|NCT01518699|11702085|FG000|Period 2|Adverse Event|1
7425590|NCT01518699|11702086|FG001|Period 2|Adverse Event|0
7557339|NCT03099187|11921885|FG003|Double-blind Treatment|Adverse Event|0
7557340|NCT03099187|11921882|FG000|Double-blind Treatment|Death|1
7557341|NCT03099187|11921883|FG001|Double-blind Treatment|Death|3
7557342|NCT03099187|11921884|FG002|Double-blind Treatment|Death|0
7557343|NCT03099187|11921885|FG003|Double-blind Treatment|Death|0
7557344|NCT03099187|11921882|FG000|Double-blind Treatment|Lack of Efficacy|1
7557345|NCT03099187|11921883|FG001|Double-blind Treatment|Lack of Efficacy|0
7557346|NCT03099187|11921884|FG002|Double-blind Treatment|Lack of Efficacy|0
7557347|NCT03099187|11921885|FG003|Double-blind Treatment|Lack of Efficacy|0
7557348|NCT03099187|11921882|FG000|Double-blind Treatment|Physician Decision|2
7557349|NCT03099187|11921883|FG001|Double-blind Treatment|Physician Decision|1
7557350|NCT03099187|11921884|FG002|Double-blind Treatment|Physician Decision|0
7557351|NCT03099187|11921885|FG003|Double-blind Treatment|Physician Decision|0
7557352|NCT03099187|11921882|FG000|Double-blind Treatment|Withdrawal by Subject|9
7557353|NCT03099187|11921883|FG001|Double-blind Treatment|Withdrawal by Subject|4
7557354|NCT03099187|11921884|FG002|Double-blind Treatment|Withdrawal by Subject|0
7557355|NCT03099187|11921885|FG003|Double-blind Treatment|Withdrawal by Subject|0
7557356|NCT03099187|11921882|FG000|Double-blind Treatment|Lung transplantation|0
7425591|NCT01518699|11702087|FG002|Period 2|Adverse Event|0
7425592|NCT01518699|11702088|FG003|Period 2|Adverse Event|0
7425593|NCT01518699|11702089|FG004|Period 2|Adverse Event|0
7425594|NCT01518699|11702090|FG005|Period 2|Adverse Event|0
7425595|NCT01518946|11702107|FG000|Open-label Phase|Other|4
7557357|NCT03099187|11921883|FG001|Double-blind Treatment|Lung transplantation|1
7557358|NCT03099187|11921884|FG002|Double-blind Treatment|Lung transplantation|0
7557359|NCT03099187|11921885|FG003|Double-blind Treatment|Lung transplantation|0
7557360|NCT03099187|11921882|FG000|Double-blind Treatment|Non-compliance with study drug|0
7425596|NCT01518946|11702108|FG001|Open-label Phase|Other|0
7425597|NCT01518946|11702109|FG002|Open-label Phase|Other|0
7425598|NCT01518946|11702107|FG000|Randomized Phase (First Intervention)|Other|0
7425599|NCT01518946|11702108|FG001|Randomized Phase (First Intervention)|Other|1
7425600|NCT01518946|11702109|FG002|Randomized Phase (First Intervention)|Other|0
7425601|NCT01518972|11702118|FG000|Overall Study|Lost to Follow-up|2
7425602|NCT01518972|11702119|FG001|Overall Study|Lost to Follow-up|1
7425603|NCT01518972|11702118|FG000|Overall Study|Withdrawal by Subject|1
7425604|NCT01518972|11702119|FG001|Overall Study|Withdrawal by Subject|0
7425605|NCT01518972|11702118|FG000|Overall Study|Moved from area|1
7425606|NCT01518972|11702119|FG001|Overall Study|Moved from area|0
7425607|NCT01518972|11702118|FG000|Overall Study|Transportation problems|1
7425608|NCT01518972|11702119|FG001|Overall Study|Transportation problems|0
7425609|NCT01518972|11702118|FG000|Overall Study|Exclusionary medical condition|1
7425610|NCT01518972|11702119|FG001|Overall Study|Exclusionary medical condition|0
7328068|NCT00793598|11560791|FG006|Overall Study|Protocol Violation|0
7328069|NCT00793598|11560792|FG007|Overall Study|Protocol Violation|1
7328070|NCT00793598|11560785|FG000|Overall Study|Subject not dosed|0
7328071|NCT00793598|11560786|FG001|Overall Study|Subject not dosed|0
7328072|NCT00793598|11560787|FG002|Overall Study|Subject not dosed|0
7328073|NCT00793598|11560788|FG003|Overall Study|Subject not dosed|0
7328074|NCT00793598|11560789|FG004|Overall Study|Subject not dosed|0
7328075|NCT00793598|11560790|FG005|Overall Study|Subject not dosed|1
7328076|NCT00793598|11560791|FG006|Overall Study|Subject not dosed|0
7328077|NCT00793598|11560792|FG007|Overall Study|Subject not dosed|0
7425611|NCT01518972|11702118|FG000|Overall Study|Missed safety visits|0
7425612|NCT01518972|11702119|FG001|Overall Study|Missed safety visits|1
7425613|NCT01518972|11702118|FG000|Overall Study|Exclusionary medication|0
7425614|NCT01518972|11702119|FG001|Overall Study|Exclusionary medication|1
7425615|NCT01518972|11702118|FG000|Overall Study|Declined medication starting on day 12|0
7425616|NCT01518972|11702119|FG001|Overall Study|Declined medication starting on day 12|1
7425617|NCT01519089|11702136|FG000|Overall Study|Adverse Event|4
7425618|NCT01519089|11702137|FG001|Overall Study|Adverse Event|4
7425619|NCT01519089|11702136|FG000|Overall Study|Lack of Efficacy|0
7425620|NCT01519089|11702137|FG001|Overall Study|Lack of Efficacy|2
7425621|NCT01519089|11702136|FG000|Overall Study|Lost to Follow-up|1
7425622|NCT01519089|11702137|FG001|Overall Study|Lost to Follow-up|0
7425623|NCT01519089|11702136|FG000|Overall Study|Withdrawal by Subject|0
7425624|NCT01519089|11702137|FG001|Overall Study|Withdrawal by Subject|2
7425625|NCT01519089|11702136|FG000|Overall Study|Other|2
7425626|NCT01519089|11702137|FG001|Overall Study|Other|6
7425627|NCT01519089|11702136|FG000|Overall Study|Not received study drug|0
7425628|NCT01519089|11702137|FG001|Overall Study|Not received study drug|1
7425629|NCT01519167|11702147|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
7425630|NCT01519167|11702148|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
7425631|NCT01519167|11702147|FG000|Overall Study|Adverse Event|0
7425632|NCT01519167|11702148|FG001|Overall Study|Adverse Event|1
7425633|NCT01519167|11702147|FG000|Overall Study|Lack of Efficacy|0
7425634|NCT01519167|11702148|FG001|Overall Study|Lack of Efficacy|1
7425635|NCT01519167|11702147|FG000|Overall Study|Medical condition changes&deep sedation|0
7425636|NCT01519167|11702148|FG001|Overall Study|Medical condition changes&deep sedation|2
7425637|NCT01519167|11702147|FG000|Overall Study|Physician Decision|0
7425638|NCT01519167|11702148|FG001|Overall Study|Physician Decision|1
7425639|NCT01519206|11702154|FG000|Overall Study|Lost to Follow-up|3
7425640|NCT01519206|11702154|FG000|Overall Study|Missed Visit|2
7425641|NCT01519245|11702167|FG000|Overall Study|Met exclusion criteria, not analysed|1
7425642|NCT01519245|11702168|FG001|Overall Study|Met exclusion criteria, not analysed|2
7425643|NCT01519323|11702208|FG000|Overall Study|Death|3
7425644|NCT01519323|11702209|FG001|Overall Study|Death|2
7425645|NCT01519323|11702208|FG000|Overall Study|Study terminated by sponsor|0
7425646|NCT01519323|11702209|FG001|Overall Study|Study terminated by sponsor|1
7425647|NCT01519427|11702230|FG000|Overall Study|disease progression|2
7425648|NCT01519518|11702254|FG000|Overall Study|Consent not available|7
7425649|NCT01519518|11702255|FG001|Overall Study|Consent not available|10
7425650|NCT01519635|11702272|FG000|Overall Study|Withdrawal by Subject|0
7425651|NCT01519635|11702273|FG001|Overall Study|Withdrawal by Subject|1
7425652|NCT01519635|11702272|FG000|Overall Study|No possibility to put a catheter|1
7425653|NCT01519635|11702273|FG001|Overall Study|No possibility to put a catheter|2
7466746|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7328078|NCT00793624|11560827|FG000|Overall Study|Adverse Event|18
7328079|NCT00793624|11560828|FG001|Overall Study|Adverse Event|16
7328080|NCT00793624|11560829|FG002|Overall Study|Adverse Event|15
7466747|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466748|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
7466749|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7466750|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
7466751|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7466752|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
7466753|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
7466754|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
7425654|NCT01519661|11702288|FG000|Overall Study|Protocol deviation|6
7425655|NCT01519661|11702288|FG000|Overall Study|Lost to Follow-up|3
7425656|NCT01519661|11702288|FG000|Overall Study|Withdrawal by Subject|17
7425657|NCT01519661|11702288|FG000|Overall Study|Lack of Efficacy|6
7425658|NCT01519661|11702288|FG000|Overall Study|Adverse Event|29
7425659|NCT01519674|11702296|FG000|Overall Study|Adverse Event|3
7425660|NCT01519674|11702297|FG001|Overall Study|Adverse Event|3
7425661|NCT01519674|11702298|FG002|Overall Study|Adverse Event|0
7425662|NCT01519674|11702296|FG000|Overall Study|Lack of Efficacy|1
7425663|NCT01519674|11702297|FG001|Overall Study|Lack of Efficacy|1
7425664|NCT01519674|11702298|FG002|Overall Study|Lack of Efficacy|1
7425665|NCT01519674|11702296|FG000|Overall Study|Protocol Violation|0
7425666|NCT01519674|11702297|FG001|Overall Study|Protocol Violation|3
7425667|NCT01519674|11702298|FG002|Overall Study|Protocol Violation|1
7425668|NCT01519674|11702296|FG000|Overall Study|Withdrawal Criteria|7
7425669|NCT01519674|11702297|FG001|Overall Study|Withdrawal Criteria|2
7425670|NCT01519674|11702298|FG002|Overall Study|Withdrawal Criteria|7
7425671|NCT01519674|11702296|FG000|Overall Study|Unsclassified|10
7425672|NCT01519674|11702297|FG001|Overall Study|Unsclassified|4
7425673|NCT01519674|11702298|FG002|Overall Study|Unsclassified|3
7425674|NCT01519700|11702310|FG000|Overall Study|Death|1
7425675|NCT01519700|11702311|FG001|Overall Study|Death|0
7425676|NCT01519700|11702312|FG002|Overall Study|Death|0
7425677|NCT01519700|11702313|FG003|Overall Study|Death|0
7425678|NCT01519700|11702310|FG000|Overall Study|Lost to Follow-up|0
7425679|NCT01519700|11702311|FG001|Overall Study|Lost to Follow-up|0
7425680|NCT01519700|11702312|FG002|Overall Study|Lost to Follow-up|1
7425681|NCT01519700|11702313|FG003|Overall Study|Lost to Follow-up|1
7425682|NCT01519700|11702310|FG000|Overall Study|Physician Decision|1
7425683|NCT01519700|11702311|FG001|Overall Study|Physician Decision|1
7425684|NCT01519700|11702312|FG002|Overall Study|Physician Decision|3
7425685|NCT01519700|11702313|FG003|Overall Study|Physician Decision|0
7425686|NCT01519700|11702310|FG000|Overall Study|Withdrawal by Subject|5
7425687|NCT01519700|11702311|FG001|Overall Study|Withdrawal by Subject|3
7425688|NCT01519700|11702312|FG002|Overall Study|Withdrawal by Subject|3
7425689|NCT01519700|11702313|FG003|Overall Study|Withdrawal by Subject|2
7425690|NCT01519700|11702310|FG000|Overall Study|Other Reason|2
7425691|NCT01519700|11702311|FG001|Overall Study|Other Reason|2
7425692|NCT01519700|11702312|FG002|Overall Study|Other Reason|0
7425693|NCT01519700|11702313|FG003|Overall Study|Other Reason|4
7425694|NCT01519765|11702344|FG000|Overall Study|Adverse Event|0
7425695|NCT01519765|11702345|FG001|Overall Study|Adverse Event|1
7425696|NCT01519765|11702344|FG000|Overall Study|Lack of Efficacy|2
7425697|NCT01519765|11702345|FG001|Overall Study|Lack of Efficacy|0
7425698|NCT01519765|11702344|FG000|Overall Study|Protocol Violation|1
7425699|NCT01519765|11702345|FG001|Overall Study|Protocol Violation|0
7425700|NCT01519765|11702344|FG000|Overall Study|Withdrawal by Subject|0
7425701|NCT01519765|11702345|FG001|Overall Study|Withdrawal by Subject|1
7425702|NCT01519778|11702352|FG000|Overall Study|Withdrawal by Subject|3
7425703|NCT01519778|11702352|FG000|Overall Study|Lost to Follow-up|10
7425704|NCT01519778|11702352|FG000|Overall Study|Physician Decision|1
7425705|NCT01519791|11702358|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
7425706|NCT01519791|11702359|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
7425707|NCT01519791|11702358|FG000|Overall Study|Protocol Violation|6
7425708|NCT01519791|11702359|FG001|Overall Study|Protocol Violation|19
7425709|NCT01519791|11702358|FG000|Overall Study|Other Reason|87
7425710|NCT01519791|11702359|FG001|Overall Study|Other Reason|222
7531946|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7531947|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
7531948|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
7531949|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7531950|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
7531951|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7531952|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
7531953|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
7531954|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
7531955|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
7425711|NCT01519791|11702358|FG000|Overall Study|subjects randomized in error|2
7425712|NCT01519791|11702359|FG001|Overall Study|subjects randomized in error|0
7425713|NCT01519791|11702358|FG000|Overall Study|Lack of Efficacy|16
7425714|NCT01519791|11702359|FG001|Overall Study|Lack of Efficacy|20
7425715|NCT01519791|11702358|FG000|Overall Study|SAE, non-fatal|6
7425716|NCT01519791|11702359|FG001|Overall Study|SAE, non-fatal|22
7425717|NCT01519791|11702358|FG000|Overall Study|AE, serious fatal|0
7425718|NCT01519791|11702359|FG001|Overall Study|AE, serious fatal|1
7425719|NCT01519791|11702358|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
7425720|NCT01519791|11702359|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
7425721|NCT01519791|11702358|FG000|Overall Study|AE, non-serious non-fatal|12
7425722|NCT01519791|11702359|FG001|Overall Study|AE, non-serious non-fatal|31
7425723|NCT01519791|11702358|FG000|Overall Study|Withdrawal by Subject|15
7425724|NCT01519791|11702359|FG001|Overall Study|Withdrawal by Subject|37
7425725|NCT01519791|11702358|FG000|Overall Study|Lost to Follow-up|6
7425726|NCT01519791|11702359|FG001|Overall Study|Lost to Follow-up|14
7425727|NCT01519817|11702367|FG000|Overall Study|Withdrawal by Subject|1
7425728|NCT01519817|11702368|FG001|Overall Study|Withdrawal by Subject|0
7425729|NCT01519817|11702369|FG002|Overall Study|Withdrawal by Subject|0
7425730|NCT01519817|11702370|FG003|Overall Study|Withdrawal by Subject|0
7425731|NCT01519817|11702367|FG000|Overall Study|Off study due to infection|0
7425732|NCT01519817|11702368|FG001|Overall Study|Off study due to infection|0
7425733|NCT01519817|11702369|FG002|Overall Study|Off study due to infection|0
7425734|NCT01519817|11702370|FG003|Overall Study|Off study due to infection|1
7425735|NCT01519869|11702380|FG000|Overall Study|Lost to Follow-up|1
7425736|NCT01519921|11702395|FG000|Overall Study|Adverse Event|10
7425737|NCT01519921|11702396|FG001|Overall Study|Adverse Event|9
7425738|NCT01519921|11702395|FG000|Overall Study|Lack of Efficacy|4
7425739|NCT01519921|11702396|FG001|Overall Study|Lack of Efficacy|3
7425740|NCT01519921|11702395|FG000|Overall Study|Withdrawal by Subject|3
7425741|NCT01519921|11702396|FG001|Overall Study|Withdrawal by Subject|0
7425742|NCT01519921|11702395|FG000|Overall Study|Lost to Follow-up|2
7425743|NCT01519921|11702396|FG001|Overall Study|Lost to Follow-up|1
7425744|NCT01519921|11702395|FG000|Overall Study|Treatment refusal|2
7425745|NCT01519921|11702396|FG001|Overall Study|Treatment refusal|1
7425746|NCT01519921|11702395|FG000|Overall Study|High alanine aminotransferase (ALT)|0
7425747|NCT01519921|11702396|FG001|Overall Study|High alanine aminotransferase (ALT)|1
7425748|NCT01519934|11702402|FG000|Overall Study|Lost to Follow-up|3
7425749|NCT01519947|11702410|FG000|Overall Study|Death|0
7425750|NCT01519947|11702411|FG001|Overall Study|Death|0
7425751|NCT01519947|11702412|FG002|Overall Study|Death|0
7425752|NCT01519947|11702413|FG003|Overall Study|Death|1
7425753|NCT01519947|11702410|FG000|Overall Study|Protocol Violation|0
7425754|NCT01519947|11702411|FG001|Overall Study|Protocol Violation|0
7425755|NCT01519947|11702412|FG002|Overall Study|Protocol Violation|2
7425756|NCT01519947|11702413|FG003|Overall Study|Protocol Violation|1
7425757|NCT01519947|11702410|FG000|Overall Study|Peritoneal Dialysis Needed|0
7425758|NCT01519947|11702411|FG001|Overall Study|Peritoneal Dialysis Needed|1
7425759|NCT01519947|11702412|FG002|Overall Study|Peritoneal Dialysis Needed|0
7425760|NCT01519947|11702413|FG003|Overall Study|Peritoneal Dialysis Needed|0
7425761|NCT01519947|11702410|FG000|Overall Study|Development of Anemia|0
7425762|NCT01519947|11702411|FG001|Overall Study|Development of Anemia|1
7425763|NCT01519947|11702412|FG002|Overall Study|Development of Anemia|0
7425764|NCT01519947|11702413|FG003|Overall Study|Development of Anemia|1
7425765|NCT01519947|11702410|FG000|Overall Study|Blood Transfusion|0
7425766|NCT01519947|11702411|FG001|Overall Study|Blood Transfusion|1
7425767|NCT01519947|11702412|FG002|Overall Study|Blood Transfusion|1
7425768|NCT01519947|11702413|FG003|Overall Study|Blood Transfusion|0
7425769|NCT01519947|11702410|FG000|Overall Study|Withdrawal by Subject|0
7425770|NCT01519947|11702411|FG001|Overall Study|Withdrawal by Subject|1
7425771|NCT01519947|11702412|FG002|Overall Study|Withdrawal by Subject|0
7425772|NCT01519947|11702413|FG003|Overall Study|Withdrawal by Subject|1
7425773|NCT01519947|11702410|FG000|Overall Study|Lost to Follow-up|0
7425774|NCT01519947|11702411|FG001|Overall Study|Lost to Follow-up|0
7425775|NCT01519947|11702412|FG002|Overall Study|Lost to Follow-up|3
7425776|NCT01519947|11702413|FG003|Overall Study|Lost to Follow-up|2
7425777|NCT01519947|11702410|FG000|Overall Study|Poor Response|1
7425778|NCT01519947|11702411|FG001|Overall Study|Poor Response|0
7425779|NCT01519947|11702412|FG002|Overall Study|Poor Response|0
7425780|NCT01519947|11702413|FG003|Overall Study|Poor Response|1
7425781|NCT01519947|11702410|FG000|Overall Study|Adverse Event|1
7425782|NCT01519947|11702411|FG001|Overall Study|Adverse Event|0
7425783|NCT01519947|11702412|FG002|Overall Study|Adverse Event|1
7425784|NCT01519947|11702413|FG003|Overall Study|Adverse Event|1
7425785|NCT01520324|11702436|FG000|Overall Study|Subject discontinued (moderate illness)|1
7328081|NCT00793624|11560830|FG003|Overall Study|Adverse Event|20
7328082|NCT00793624|11560827|FG000|Overall Study|Lost to Follow-up|2
7328083|NCT00793624|11560828|FG001|Overall Study|Lost to Follow-up|2
7328084|NCT00793624|11560829|FG002|Overall Study|Lost to Follow-up|4
7328085|NCT00793624|11560830|FG003|Overall Study|Lost to Follow-up|0
7328086|NCT00793624|11560827|FG000|Overall Study|Withdrawal by Subject|20
7328087|NCT00793624|11560828|FG001|Overall Study|Withdrawal by Subject|9
7328088|NCT00793624|11560829|FG002|Overall Study|Withdrawal by Subject|11
7328089|NCT00793624|11560830|FG003|Overall Study|Withdrawal by Subject|14
7328090|NCT00793624|11560827|FG000|Overall Study|Lack of Efficacy|9
7425786|NCT01520363|11702442|FG000|Overall Study|Withdrawal by Subject|2
7425787|NCT01520363|11702443|FG001|Overall Study|Withdrawal by Subject|0
7425788|NCT01520402|11702473|FG000|Overall Study|Withdrawal by Subject|2
7425789|NCT01520402|11702473|FG000|Overall Study|Physician Decision|3
7425790|NCT01520506|11702504|FG000|Overall Study|Missed Visit|4
7425791|NCT01520506|11702504|FG000|Overall Study|Lost to Follow-up|1
7425792|NCT01520506|11702504|FG000|Overall Study|Withdrawal by Subject|1
7425793|NCT01520870|11702580|FG000|Overall Study|Withdrawal by Subject|2
7425794|NCT01520909|11702586|FG000|Part 1 (Randomized Period)|Adverse Event|1
7425795|NCT01520909|11702587|FG001|Part 1 (Randomized Period)|Adverse Event|2
7425796|NCT01520909|11702588|FG002|Part 1 (Randomized Period)|Adverse Event|0
7425797|NCT01520909|11702586|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7425798|NCT01520909|11702587|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
7425799|NCT01520909|11702588|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
7425800|NCT01520909|11702586|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7328091|NCT00793624|11560828|FG001|Overall Study|Lack of Efficacy|2
7328092|NCT00793624|11560829|FG002|Overall Study|Lack of Efficacy|1
7328093|NCT00793624|11560830|FG003|Overall Study|Lack of Efficacy|3
7328094|NCT00793624|11560827|FG000|Overall Study|Non compliance with protocol|2
7328095|NCT00793624|11560828|FG001|Overall Study|Non compliance with protocol|3
7328096|NCT00793624|11560829|FG002|Overall Study|Non compliance with protocol|2
7328097|NCT00793624|11560830|FG003|Overall Study|Non compliance with protocol|3
7328098|NCT00793624|11560827|FG000|Overall Study|Other reason not described above|6
7328099|NCT00793624|11560828|FG001|Overall Study|Other reason not described above|4
7328100|NCT00793624|11560829|FG002|Overall Study|Other reason not described above|6
7328101|NCT00793624|11560830|FG003|Overall Study|Other reason not described above|3
7425801|NCT01520909|11702587|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
7425802|NCT01520909|11702588|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
7425803|NCT01520909|11702586|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7425804|NCT01520909|11702587|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
7425805|NCT01520909|11702588|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
7425806|NCT01520922|11702610|FG000|Treatment Phase|Physician Decision|2
7425807|NCT01520922|11702611|FG001|Treatment Phase|Physician Decision|1
7425808|NCT01520922|11702610|FG000|Treatment Phase|Progression|0
7328102|NCT00793780|11560861|FG000|Overall Study|Withdrawal by Subject|2
7328103|NCT00793780|11560862|FG001|Overall Study|Withdrawal by Subject|1
7328104|NCT00793793|11560880|FG000|Overall Study|Adverse Event|0
7328105|NCT00793793|11560881|FG001|Overall Study|Adverse Event|0
7328106|NCT00793793|11560882|FG002|Overall Study|Adverse Event|1
7328107|NCT00793793|11560883|FG003|Overall Study|Adverse Event|1
7328108|NCT00793793|11560884|FG004|Overall Study|Adverse Event|0
7328109|NCT00793793|11560885|FG005|Overall Study|Adverse Event|1
7328110|NCT00793793|11560886|FG006|Overall Study|Adverse Event|2
7328111|NCT00793793|11560887|FG007|Overall Study|Adverse Event|0
7328112|NCT00793793|11560888|FG008|Overall Study|Adverse Event|0
7328113|NCT00793793|11560889|FG009|Overall Study|Adverse Event|0
7328114|NCT00793793|11560890|FG010|Overall Study|Adverse Event|0
7328115|NCT00793793|11560891|FG011|Overall Study|Adverse Event|2
7328116|NCT00793793|11560880|FG000|Overall Study|Protocol Violation|0
7328117|NCT00793793|11560881|FG001|Overall Study|Protocol Violation|0
7328118|NCT00793793|11560882|FG002|Overall Study|Protocol Violation|0
7328119|NCT00793793|11560883|FG003|Overall Study|Protocol Violation|1
7328120|NCT00793793|11560884|FG004|Overall Study|Protocol Violation|0
7328121|NCT00793793|11560885|FG005|Overall Study|Protocol Violation|0
7328122|NCT00793793|11560886|FG006|Overall Study|Protocol Violation|0
7328123|NCT00793793|11560887|FG007|Overall Study|Protocol Violation|0
7328124|NCT00793793|11560888|FG008|Overall Study|Protocol Violation|0
7328125|NCT00793793|11560889|FG009|Overall Study|Protocol Violation|0
7328126|NCT00793793|11560890|FG010|Overall Study|Protocol Violation|0
7328127|NCT00793793|11560891|FG011|Overall Study|Protocol Violation|0
7328128|NCT00793793|11560880|FG000|Overall Study|Lost to Follow-up|0
7328129|NCT00793793|11560881|FG001|Overall Study|Lost to Follow-up|0
7328130|NCT00793793|11560882|FG002|Overall Study|Lost to Follow-up|1
7328131|NCT00793793|11560883|FG003|Overall Study|Lost to Follow-up|0
7328132|NCT00793793|11560884|FG004|Overall Study|Lost to Follow-up|0
7328133|NCT00793793|11560885|FG005|Overall Study|Lost to Follow-up|0
7328134|NCT00793793|11560886|FG006|Overall Study|Lost to Follow-up|0
7328135|NCT00793793|11560887|FG007|Overall Study|Lost to Follow-up|0
7328136|NCT00793793|11560888|FG008|Overall Study|Lost to Follow-up|1
7328137|NCT00793793|11560889|FG009|Overall Study|Lost to Follow-up|3
7328138|NCT00793793|11560890|FG010|Overall Study|Lost to Follow-up|1
7328139|NCT00793793|11560891|FG011|Overall Study|Lost to Follow-up|0
7328140|NCT00793793|11560880|FG000|Overall Study|Withdrawal by Subject|0
7328141|NCT00793793|11560881|FG001|Overall Study|Withdrawal by Subject|0
7328142|NCT00793793|11560882|FG002|Overall Study|Withdrawal by Subject|0
7328143|NCT00793793|11560883|FG003|Overall Study|Withdrawal by Subject|0
7328144|NCT00793793|11560884|FG004|Overall Study|Withdrawal by Subject|1
7328145|NCT00793793|11560885|FG005|Overall Study|Withdrawal by Subject|0
7328146|NCT00793793|11560886|FG006|Overall Study|Withdrawal by Subject|0
7328147|NCT00793793|11560887|FG007|Overall Study|Withdrawal by Subject|0
7328148|NCT00793793|11560888|FG008|Overall Study|Withdrawal by Subject|1
7328149|NCT00793793|11560889|FG009|Overall Study|Withdrawal by Subject|0
7328150|NCT00793793|11560890|FG010|Overall Study|Withdrawal by Subject|0
7328151|NCT00793793|11560891|FG011|Overall Study|Withdrawal by Subject|0
7328152|NCT00793793|11560880|FG000|Overall Study|reason not specified|0
7328153|NCT00793793|11560881|FG001|Overall Study|reason not specified|1
7328154|NCT00793793|11560882|FG002|Overall Study|reason not specified|0
7328155|NCT00793793|11560883|FG003|Overall Study|reason not specified|1
7328156|NCT00793793|11560884|FG004|Overall Study|reason not specified|1
7328157|NCT00793793|11560885|FG005|Overall Study|reason not specified|1
7328158|NCT00793793|11560886|FG006|Overall Study|reason not specified|2
7328159|NCT00793793|11560887|FG007|Overall Study|reason not specified|0
7328160|NCT00793793|11560888|FG008|Overall Study|reason not specified|7
7328161|NCT00793793|11560889|FG009|Overall Study|reason not specified|6
7425809|NCT01520922|11702611|FG001|Treatment Phase|Progression|2
7425810|NCT01520922|11702610|FG000|Treatment Phase|Adverse Event|3
7425811|NCT01520922|11702611|FG001|Treatment Phase|Adverse Event|5
7425812|NCT01520922|11702610|FG000|Follow up|Lost to Follow-up|0
7425813|NCT01520922|11702611|FG001|Follow up|Lost to Follow-up|1
7425814|NCT01520922|11702610|FG000|Survival Follow-up|Withdrawal by Subject|1
7425815|NCT01520922|11702611|FG001|Survival Follow-up|Withdrawal by Subject|0
7425816|NCT01520987|11702625|FG000|Overall Study|Withdrawal by Subject|1
7425817|NCT01520987|11702626|FG001|Overall Study|Withdrawal by Subject|0
7425818|NCT01520987|11702627|FG002|Overall Study|Withdrawal by Subject|0
7425819|NCT01520987|11702628|FG003|Overall Study|Withdrawal by Subject|0
7425820|NCT01520987|11702629|FG004|Overall Study|Withdrawal by Subject|0
7425821|NCT01520987|11702630|FG005|Overall Study|Withdrawal by Subject|1
7425822|NCT01520987|11702631|FG006|Overall Study|Withdrawal by Subject|0
7425823|NCT01520987|11702632|FG007|Overall Study|Withdrawal by Subject|0
7425824|NCT01521117|11702657|FG000|First Intervention (6 Weeks)|Adverse Event|5
7425825|NCT01521117|11702658|FG001|First Intervention (6 Weeks)|Adverse Event|1
7425826|NCT01521117|11702657|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
7425827|NCT01521117|11702658|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
7425828|NCT01521117|11702657|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7425829|NCT01521117|11702658|FG001|Second Intervention (6 Weeks)|Adverse Event|3
7425830|NCT01521364|11702673|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
7425831|NCT01521364|11702673|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
7425832|NCT01521494|11702689|FG000|Overall Study|Adverse Event|1
7425833|NCT01521494|11702690|FG001|Overall Study|Adverse Event|2
7425834|NCT01521494|11702691|FG002|Overall Study|Adverse Event|9
7425835|NCT01521494|11702692|FG003|Overall Study|Adverse Event|6
7425836|NCT01521494|11702693|FG004|Overall Study|Adverse Event|2
7425837|NCT01521494|11702689|FG000|Overall Study|Lack of Efficacy|0
7425838|NCT01521494|11702690|FG001|Overall Study|Lack of Efficacy|0
7425839|NCT01521494|11702691|FG002|Overall Study|Lack of Efficacy|0
7425840|NCT01521494|11702692|FG003|Overall Study|Lack of Efficacy|0
7425841|NCT01521494|11702693|FG004|Overall Study|Lack of Efficacy|2
7425842|NCT01521494|11702689|FG000|Overall Study|Withdrawal by Subject|1
7425843|NCT01521494|11702690|FG001|Overall Study|Withdrawal by Subject|1
7425844|NCT01521494|11702691|FG002|Overall Study|Withdrawal by Subject|0
7425845|NCT01521494|11702692|FG003|Overall Study|Withdrawal by Subject|2
7425846|NCT01521494|11702693|FG004|Overall Study|Withdrawal by Subject|0
7425847|NCT01521494|11702689|FG000|Overall Study|Decrease in serum phosphate|0
7425848|NCT01521494|11702690|FG001|Overall Study|Decrease in serum phosphate|2
7425849|NCT01521494|11702691|FG002|Overall Study|Decrease in serum phosphate|3
7425850|NCT01521494|11702692|FG003|Overall Study|Decrease in serum phosphate|12
7425851|NCT01521494|11702693|FG004|Overall Study|Decrease in serum phosphate|0
7425852|NCT01521494|11702689|FG000|Overall Study|Decrease in serum calcium|0
7425853|NCT01521494|11702690|FG001|Overall Study|Decrease in serum calcium|0
7425854|NCT01521494|11702691|FG002|Overall Study|Decrease in serum calcium|0
7425855|NCT01521494|11702692|FG003|Overall Study|Decrease in serum calcium|1
7425856|NCT01521494|11702693|FG004|Overall Study|Decrease in serum calcium|1
7425857|NCT01521494|11702689|FG000|Overall Study|Physician Decision|0
7425858|NCT01521494|11702690|FG001|Overall Study|Physician Decision|0
7425859|NCT01521494|11702691|FG002|Overall Study|Physician Decision|0
7425860|NCT01521494|11702692|FG003|Overall Study|Physician Decision|0
7425861|NCT01521494|11702693|FG004|Overall Study|Physician Decision|2
7425862|NCT01521507|11702707|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
7425863|NCT01521507|11702708|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
7425864|NCT01521507|11702707|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
7425865|NCT01521507|11702708|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
7425866|NCT01521507|11702707|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
7425867|NCT01521507|11702708|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
7425868|NCT01521507|11702707|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
7425869|NCT01521507|11702708|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
7425870|NCT01521507|11702707|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
7425871|NCT01521507|11702708|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
7425872|NCT01521507|11702707|FG000|Stage 2: Observational Design|Physician Decision|1
7425873|NCT01521507|11702708|FG001|Stage 2: Observational Design|Physician Decision|0
7425874|NCT01521559|11702732|FG000|Overall Study|Adverse Event|0
7425875|NCT01521559|11702733|FG001|Overall Study|Adverse Event|4
7425876|NCT01521559|11702732|FG000|Overall Study|Death|1
7425877|NCT01521559|11702733|FG001|Overall Study|Death|0
7425878|NCT01521559|11702732|FG000|Overall Study|Withdrawal by Subject|9
7425879|NCT01521559|11702733|FG001|Overall Study|Withdrawal by Subject|11
7425880|NCT01521559|11702732|FG000|Overall Study|Lost to Follow-up|3
7425881|NCT01521559|11702733|FG001|Overall Study|Lost to Follow-up|1
7425882|NCT01521559|11702732|FG000|Overall Study|Protocol Violation|1
7425883|NCT01521559|11702733|FG001|Overall Study|Protocol Violation|0
7425884|NCT01521559|11702732|FG000|Overall Study|Other|1
7425885|NCT01521559|11702733|FG001|Overall Study|Other|2
7425886|NCT01521884|11702769|FG000|Overall Study|Non Responders|10
7425887|NCT01521884|11702769|FG000|Overall Study|Adverse Event|5
7425888|NCT01521884|11702769|FG000|Overall Study|Pregnancy|1
7425889|NCT01521884|11702769|FG000|Overall Study|Withdrawal by Subject|1
7425890|NCT01521884|11702769|FG000|Overall Study|Physician Decision|2
7425891|NCT01521884|11702769|FG000|Overall Study|Protocol Violation|3
7425892|NCT01521884|11702769|FG000|Overall Study|Participant non-eligible|1
7425893|NCT01521884|11702769|FG000|Overall Study|Lost to Follow-up|4
7425894|NCT01521897|11702773|FG000|Overall Study|Protocol Violation|18
7425895|NCT01521897|11702773|FG000|Overall Study|Lost to Follow-up|5
7425896|NCT01521923|11702781|FG000|Overall Study|AE, serious fatal|1
7531956|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7531957|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
7531958|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
7531959|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7531960|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
7531961|NCT02660580|11876929|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7531962|NCT02660580|11876930|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7531963|NCT02660580|11876931|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
7531964|NCT02660580|11876932|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7531965|NCT02660580|11876933|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
7425897|NCT01521923|11702782|FG001|Overall Study|AE, serious fatal|0
7425898|NCT01521923|11702783|FG002|Overall Study|AE, serious fatal|0
7425899|NCT01521923|11702784|FG003|Overall Study|AE, serious fatal|0
7425900|NCT01521923|11702781|FG000|Overall Study|SAE, non-fatal|0
7425901|NCT01521923|11702782|FG001|Overall Study|SAE, non-fatal|2
7425902|NCT01521923|11702783|FG002|Overall Study|SAE, non-fatal|2
7425903|NCT01521923|11702784|FG003|Overall Study|SAE, non-fatal|0
7425904|NCT01521923|11702781|FG000|Overall Study|AE, non-serious, non-fatal|1
7425905|NCT01521923|11702782|FG001|Overall Study|AE, non-serious, non-fatal|3
7425906|NCT01521923|11702783|FG002|Overall Study|AE, non-serious, non-fatal|6
7425907|NCT01521923|11702784|FG003|Overall Study|AE, non-serious, non-fatal|2
7425908|NCT01521923|11702781|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7425909|NCT01521923|11702782|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7425910|NCT01521923|11702783|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
7425911|NCT01521923|11702784|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
7425912|NCT01521923|11702781|FG000|Overall Study|Lack of Efficacy|1
7425913|NCT01521923|11702782|FG001|Overall Study|Lack of Efficacy|1
7425914|NCT01521923|11702783|FG002|Overall Study|Lack of Efficacy|0
7425915|NCT01521923|11702784|FG003|Overall Study|Lack of Efficacy|0
7425916|NCT01521923|11702781|FG000|Overall Study|Protocol Violation|0
7425917|NCT01521923|11702782|FG001|Overall Study|Protocol Violation|0
7425918|NCT01521923|11702783|FG002|Overall Study|Protocol Violation|1
7425919|NCT01521923|11702784|FG003|Overall Study|Protocol Violation|0
7425920|NCT01521923|11702781|FG000|Overall Study|Lost to Follow-up|1
7425921|NCT01521923|11702782|FG001|Overall Study|Lost to Follow-up|0
7425922|NCT01521923|11702783|FG002|Overall Study|Lost to Follow-up|2
7425923|NCT01521923|11702784|FG003|Overall Study|Lost to Follow-up|1
7425924|NCT01521923|11702781|FG000|Overall Study|Withdrawal by Subject|1
7425925|NCT01521923|11702782|FG001|Overall Study|Withdrawal by Subject|1
7425926|NCT01521923|11702783|FG002|Overall Study|Withdrawal by Subject|1
7425927|NCT01521923|11702784|FG003|Overall Study|Withdrawal by Subject|2
7425928|NCT01521923|11702781|FG000|Overall Study|Other|2
7425929|NCT01521923|11702782|FG001|Overall Study|Other|1
7425930|NCT01521923|11702783|FG002|Overall Study|Other|3
7425931|NCT01521923|11702784|FG003|Overall Study|Other|6
7425932|NCT01521923|11702781|FG000|Overall Study|AE, captured in Period 1|0
7425933|NCT01521923|11702782|FG001|Overall Study|AE, captured in Period 1|1
7425934|NCT01521923|11702783|FG002|Overall Study|AE, captured in Period 1|0
7425935|NCT01521923|11702784|FG003|Overall Study|AE, captured in Period 1|1
7425936|NCT01522235|11702812|FG000|Overall Study|Physician Decision|1
7425937|NCT01522235|11702813|FG001|Overall Study|Physician Decision|1
7425938|NCT01522248|11702825|FG000|Overall Study|Lost to Follow-up|1
7425939|NCT01522248|11702826|FG001|Overall Study|Lost to Follow-up|0
7425940|NCT01522404|11702853|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
7425941|NCT01522404|11702854|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
7425942|NCT01522404|11702853|FG000|First Intervention (up to Week 29)|Adverse Event|1
7425943|NCT01522404|11702854|FG001|First Intervention (up to Week 29)|Adverse Event|0
7425944|NCT01522404|11702853|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
7425945|NCT01522404|11702854|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
7425946|NCT01522443|11702883|FG000|Overall Study|No longer receiving clinical benefit|36
7425947|NCT01522443|11702884|FG001|Overall Study|No longer receiving clinical benefit|28
7425948|NCT01522443|11702883|FG000|Overall Study|Adverse Event|10
7425949|NCT01522443|11702884|FG001|Overall Study|Adverse Event|15
7425950|NCT01522443|11702883|FG000|Overall Study|Withdrawal by Subject|5
7425951|NCT01522443|11702884|FG001|Overall Study|Withdrawal by Subject|8
7425952|NCT01522443|11702883|FG000|Overall Study|No study treatment given|1
7425953|NCT01522443|11702884|FG001|Overall Study|No study treatment given|1
7425954|NCT01522443|11702883|FG000|Overall Study|Other|1
7425955|NCT01522443|11702884|FG001|Overall Study|Other|3
7425961|NCT01522651|11702906|FG000|Overall Study|Adverse Event|3
7425962|NCT01522651|11702907|FG001|Overall Study|Adverse Event|4
7425963|NCT01522651|11702908|FG002|Overall Study|Adverse Event|4
7425964|NCT01522651|11702909|FG003|Overall Study|Adverse Event|5
7425965|NCT01522651|11702910|FG004|Overall Study|Adverse Event|4
7425966|NCT01522651|11702906|FG000|Overall Study|Cardioversion|1
7425967|NCT01522651|11702907|FG001|Overall Study|Cardioversion|0
7425968|NCT01522651|11702908|FG002|Overall Study|Cardioversion|0
7425969|NCT01522651|11702909|FG003|Overall Study|Cardioversion|0
7425970|NCT01522651|11702910|FG004|Overall Study|Cardioversion|0
7425971|NCT01522651|11702906|FG000|Overall Study|Device Malfunction|0
7425972|NCT01522651|11702907|FG001|Overall Study|Device Malfunction|1
7425973|NCT01522651|11702908|FG002|Overall Study|Device Malfunction|0
7425974|NCT01522651|11702909|FG003|Overall Study|Device Malfunction|0
7425975|NCT01522651|11702910|FG004|Overall Study|Device Malfunction|0
7425976|NCT01522651|11702906|FG000|Overall Study|Investigator's Discretion|0
7425977|NCT01522651|11702907|FG001|Overall Study|Investigator's Discretion|1
7425978|NCT01522651|11702908|FG002|Overall Study|Investigator's Discretion|0
7425979|NCT01522651|11702909|FG003|Overall Study|Investigator's Discretion|0
7425980|NCT01522651|11702910|FG004|Overall Study|Investigator's Discretion|0
7425981|NCT01522651|11702906|FG000|Overall Study|Protocol Violation|3
7425982|NCT01522651|11702907|FG001|Overall Study|Protocol Violation|0
7425983|NCT01522651|11702908|FG002|Overall Study|Protocol Violation|0
7425984|NCT01522651|11702909|FG003|Overall Study|Protocol Violation|0
7425985|NCT01522651|11702910|FG004|Overall Study|Protocol Violation|0
7425986|NCT01522651|11702906|FG000|Overall Study|Reason Not Specified|0
7425987|NCT01522651|11702907|FG001|Overall Study|Reason Not Specified|0
7425988|NCT01522651|11702908|FG002|Overall Study|Reason Not Specified|0
7425989|NCT01522651|11702909|FG003|Overall Study|Reason Not Specified|1
7425990|NCT01522651|11702910|FG004|Overall Study|Reason Not Specified|0
7425991|NCT01522651|11702906|FG000|Overall Study|Participant Non-Compliance|1
7425992|NCT01522651|11702907|FG001|Overall Study|Participant Non-Compliance|0
7425993|NCT01522651|11702908|FG002|Overall Study|Participant Non-Compliance|0
7531966|NCT02660944|11876984|FG000|Overall Study|Adverse Event|3
7531967|NCT02660944|11876985|FG001|Overall Study|Adverse Event|4
7425994|NCT01522651|11702909|FG003|Overall Study|Participant Non-Compliance|0
7425995|NCT01522651|11702910|FG004|Overall Study|Participant Non-Compliance|0
7425996|NCT01522651|11702906|FG000|Overall Study|Withdrew Consent|1
7425997|NCT01522651|11702907|FG001|Overall Study|Withdrew Consent|1
7425998|NCT01522651|11702908|FG002|Overall Study|Withdrew Consent|0
7425999|NCT01522651|11702909|FG003|Overall Study|Withdrew Consent|1
7426000|NCT01522651|11702910|FG004|Overall Study|Withdrew Consent|1
7426001|NCT01522651|11702906|FG000|Overall Study|Randomized but Never Treated|0
7426002|NCT01522651|11702907|FG001|Overall Study|Randomized but Never Treated|1
7426003|NCT01522651|11702908|FG002|Overall Study|Randomized but Never Treated|0
7426004|NCT01522651|11702909|FG003|Overall Study|Randomized but Never Treated|1
7426005|NCT01522651|11702910|FG004|Overall Study|Randomized but Never Treated|1
7531968|NCT02660944|11876984|FG000|Overall Study|Physician Decision|3
7328162|NCT00793793|11560890|FG010|Overall Study|reason not specified|2
7328163|NCT00793793|11560891|FG011|Overall Study|reason not specified|4
7328164|NCT00793819|11560939|FG000|Overall Study|Adverse Event|8
7328165|NCT00793819|11560940|FG001|Overall Study|Adverse Event|4
7328166|NCT00793819|11560939|FG000|Overall Study|Lack of Efficacy|1
7328167|NCT00793819|11560940|FG001|Overall Study|Lack of Efficacy|1
7328168|NCT00793819|11560939|FG000|Overall Study|Withdrawal by Subject|4
7328169|NCT00793819|11560940|FG001|Overall Study|Withdrawal by Subject|3
7328170|NCT00793819|11560939|FG000|Overall Study|Lost to Follow-up|1
7328171|NCT00793819|11560940|FG001|Overall Study|Lost to Follow-up|1
7328172|NCT00793871|11560946|FG000|Overall Study|Death|50
7328173|NCT00793871|11560946|FG000|Overall Study|Lost to Follow-up|3
7328174|NCT00793871|11560946|FG000|Overall Study|Study terminated by the Sponsor|7
7328175|NCT00793910|11560952|FG000|Overall Study|discarded study pills|0
7328176|NCT00793910|11560953|FG001|Overall Study|discarded study pills|1
7328177|NCT00793910|11560952|FG000|Overall Study|did not pick up medications|1
7328178|NCT00793910|11560953|FG001|Overall Study|did not pick up medications|1
7328179|NCT00793910|11560952|FG000|Overall Study|ineligible based on entry criteria|2
7426006|NCT01522950|11702952|FG000|Overall Study|Withdrawal by Subject|3
7426007|NCT01522950|11702953|FG001|Overall Study|Withdrawal by Subject|2
7426008|NCT01522950|11702954|FG002|Overall Study|Withdrawal by Subject|1
7426009|NCT01522950|11702952|FG000|Overall Study|Adverse Event|3
7426010|NCT01522950|11702953|FG001|Overall Study|Adverse Event|1
7426011|NCT01522950|11702954|FG002|Overall Study|Adverse Event|1
7426012|NCT01522950|11702952|FG000|Overall Study|Protocol Violation|0
7426013|NCT01522950|11702953|FG001|Overall Study|Protocol Violation|0
7426014|NCT01522950|11702954|FG002|Overall Study|Protocol Violation|2
7426015|NCT01522950|11702952|FG000|Overall Study|Death|0
7426016|NCT01522950|11702953|FG001|Overall Study|Death|1
7557361|NCT03099187|11921883|FG001|Double-blind Treatment|Non-compliance with study drug|2
7557362|NCT03099187|11921884|FG002|Double-blind Treatment|Non-compliance with study drug|0
7557363|NCT03099187|11921885|FG003|Double-blind Treatment|Non-compliance with study drug|0
7557364|NCT03099187|11921882|FG000|Double-blind Treatment|Disease progression|0
7557365|NCT03099187|11921883|FG001|Double-blind Treatment|Disease progression|1
7557366|NCT03099187|11921884|FG002|Double-blind Treatment|Disease progression|0
7557367|NCT03099187|11921885|FG003|Double-blind Treatment|Disease progression|0
7557368|NCT03099187|11921882|FG000|Double-blind Treatment|Randomization error|0
7557369|NCT03099187|11921883|FG001|Double-blind Treatment|Randomization error|2
7557370|NCT03099187|11921884|FG002|Double-blind Treatment|Randomization error|0
7557371|NCT03099187|11921885|FG003|Double-blind Treatment|Randomization error|0
7557372|NCT03099187|11921882|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
7557373|NCT03099187|11921883|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
7557374|NCT03099187|11921884|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
7557375|NCT03099187|11921885|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
7557376|NCT03099187|11921882|FG000|12-month Safety Follow-up|Adverse Event|0
7557377|NCT03099187|11921883|FG001|12-month Safety Follow-up|Adverse Event|0
7557378|NCT03099187|11921884|FG002|12-month Safety Follow-up|Adverse Event|5
7557379|NCT03099187|11921885|FG003|12-month Safety Follow-up|Adverse Event|12
7557380|NCT03099187|11921882|FG000|12-month Safety Follow-up|Death|0
7557381|NCT03099187|11921883|FG001|12-month Safety Follow-up|Death|0
7557382|NCT03099187|11921884|FG002|12-month Safety Follow-up|Death|7
7557383|NCT03099187|11921885|FG003|12-month Safety Follow-up|Death|9
7557384|NCT03099187|11921882|FG000|12-month Safety Follow-up|Lung transplantation|0
7557385|NCT03099187|11921883|FG001|12-month Safety Follow-up|Lung transplantation|0
7557386|NCT03099187|11921884|FG002|12-month Safety Follow-up|Lung transplantation|2
7557387|NCT03099187|11921885|FG003|12-month Safety Follow-up|Lung transplantation|1
7557388|NCT03099187|11921882|FG000|12-month Safety Follow-up|Lost to Follow-up|0
7557389|NCT03099187|11921883|FG001|12-month Safety Follow-up|Lost to Follow-up|0
7557390|NCT03099187|11921884|FG002|12-month Safety Follow-up|Lost to Follow-up|1
7557391|NCT03099187|11921885|FG003|12-month Safety Follow-up|Lost to Follow-up|0
7557392|NCT03099187|11921882|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
7557393|NCT03099187|11921883|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
7557394|NCT03099187|11921884|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
7557395|NCT03099187|11921885|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
7557396|NCT03099187|11921882|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
7557397|NCT03099187|11921883|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
7557398|NCT03099187|11921884|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
7557399|NCT03099187|11921885|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
7557400|NCT03099187|11921882|FG000|12-month Safety Follow-up|Due to hospitalization|0
7557401|NCT03099187|11921883|FG001|12-month Safety Follow-up|Due to hospitalization|0
7557402|NCT03099187|11921884|FG002|12-month Safety Follow-up|Due to hospitalization|0
7557403|NCT03099187|11921885|FG003|12-month Safety Follow-up|Due to hospitalization|1
7557404|NCT03099538|11921905|FG000|Overall Study|Lack of Efficacy|3
7557405|NCT03099694|11921918|FG000|Overall Study|Withdrawal by Subject|11
7557406|NCT03099694|11921919|FG001|Overall Study|Withdrawal by Subject|13
7557407|NCT03099694|11921918|FG000|Overall Study|Lost to Follow-up|9
7557408|NCT03099694|11921919|FG001|Overall Study|Lost to Follow-up|5
7557409|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557410|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557411|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
7557412|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
7557413|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
7557414|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557415|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
7557416|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
7557417|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
7557418|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557419|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557420|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557421|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
7557422|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7557423|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7557424|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
7557425|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7557426|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7557427|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7557428|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
7557429|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
7557430|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
7557431|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7557432|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7557433|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7557434|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
7557435|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557436|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7557437|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7557438|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557439|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557440|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7557441|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
7557442|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557443|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557444|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557445|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557446|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557447|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
7557448|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557449|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7557450|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7557451|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557452|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557453|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557454|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7557455|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557456|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
7557457|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557458|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557459|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557460|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
7557461|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557462|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557463|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557464|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7557465|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557466|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557467|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557468|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
7557469|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557470|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557471|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557472|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557473|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
7557474|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557475|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557476|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557477|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7557478|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557479|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557480|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
7557481|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557482|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557483|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557484|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557485|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557486|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
7557487|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
7557488|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
7557489|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
7557490|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
7557491|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
7557492|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
7557493|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
7557494|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
7557495|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
7557496|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
7557497|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
7557498|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
7557499|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
7557500|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
7557501|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557502|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557503|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557504|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557505|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557506|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557507|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557508|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557509|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557510|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557511|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7557512|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
7328180|NCT00793910|11560953|FG001|Overall Study|ineligible based on entry criteria|3
7328181|NCT00793910|11560952|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
7328182|NCT00793910|11560953|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
7328183|NCT00793910|11560952|FG000|Overall Study|Withdrawal by Subject|0
7328184|NCT00793910|11560953|FG001|Overall Study|Withdrawal by Subject|1
7557513|NCT03100058|11921935|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557514|NCT03100058|11921936|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557515|NCT03100058|11921937|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557516|NCT03100058|11921938|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557517|NCT03100058|11921939|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557518|NCT03100058|11921940|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557519|NCT03100058|11921941|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
7557520|NCT03100058|11921942|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557521|NCT03100058|11921943|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557522|NCT03100058|11921944|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557523|NCT03100058|11921945|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557524|NCT03100058|11921946|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557525|NCT03100058|11921947|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
7557526|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557527|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557528|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557529|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557530|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557531|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557532|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557533|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557534|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557535|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
7557536|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
7557537|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
7557538|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
7557539|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557540|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557541|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557542|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557543|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557544|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557545|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557546|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557547|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557548|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557549|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
7557550|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
7557551|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
7557552|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557553|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557554|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557555|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557556|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557557|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557558|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557559|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557560|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557561|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
7557562|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
7557563|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
7557564|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
7557565|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7328185|NCT00794040|11560961|FG000|Overall Study|Withdrawal by Subject|3
7328186|NCT00794040|11560962|FG001|Overall Study|Withdrawal by Subject|4
7557566|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557567|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557568|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7328187|NCT00794040|11560961|FG000|Overall Study|Physician Decision|0
7328188|NCT00794040|11560962|FG001|Overall Study|Physician Decision|1
7328189|NCT00794118|11560968|FG000|Overall Study|Lost to Follow-up|16
7328190|NCT00794118|11560968|FG000|Overall Study|Withdrawal by Subject|9
7328191|NCT00794118|11560968|FG000|Overall Study|Changed hospital center|2
7328192|NCT00794157|11560984|FG000|Overall Study|Adverse Event|4
7328193|NCT00794157|11560985|FG001|Overall Study|Adverse Event|1
7328194|NCT00794157|11560986|FG002|Overall Study|Adverse Event|8
7328195|NCT00794157|11560984|FG000|Overall Study|Subject withdrew consent|2
7328196|NCT00794157|11560985|FG001|Overall Study|Subject withdrew consent|0
7328197|NCT00794157|11560986|FG002|Overall Study|Subject withdrew consent|3
7328198|NCT00794157|11560984|FG000|Overall Study|Lost to Follow-up|2
7328199|NCT00794157|11560985|FG001|Overall Study|Lost to Follow-up|0
7328200|NCT00794157|11560986|FG002|Overall Study|Lost to Follow-up|1
7328201|NCT00794157|11560984|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7328202|NCT00794157|11560985|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7328203|NCT00794157|11560986|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7328204|NCT00794157|11560984|FG000|Overall Study|Administrative problems|1
7328205|NCT00794157|11560985|FG001|Overall Study|Administrative problems|7
7328206|NCT00794157|11560986|FG002|Overall Study|Administrative problems|4
7328207|NCT00794157|11560984|FG000|Overall Study|Abnormal test procedure result(s)|0
7328208|NCT00794157|11560985|FG001|Overall Study|Abnormal test procedure result(s)|1
7328209|NCT00794157|11560986|FG002|Overall Study|Abnormal test procedure result(s)|0
7328210|NCT00794157|11560984|FG000|Overall Study|Protocol deviation|0
7328211|NCT00794157|11560985|FG001|Overall Study|Protocol deviation|1
7328212|NCT00794157|11560986|FG002|Overall Study|Protocol deviation|1
7328213|NCT00794196|11561005|FG000|Overall Study|Lost to Follow-up|5
7328214|NCT00794196|11561006|FG001|Overall Study|Lost to Follow-up|23
7328215|NCT00794339|11561025|FG000|Overall Study|Withdrawal by Subject|3
7426017|NCT01522950|11702954|FG002|Overall Study|Death|1
7426018|NCT01522950|11702952|FG000|Overall Study|Study Medication Sensitivity|0
7426019|NCT01522950|11702953|FG001|Overall Study|Study Medication Sensitivity|1
7426020|NCT01522950|11702954|FG002|Overall Study|Study Medication Sensitivity|0
7426021|NCT01523275|11702979|FG000|Overall Study|Lost to Follow-up|1
7426022|NCT01523275|11702980|FG001|Overall Study|Lost to Follow-up|2
7426023|NCT01523275|11702979|FG000|Overall Study|Withdrawal by Subject|1
7426024|NCT01523275|11702980|FG001|Overall Study|Withdrawal by Subject|0
7426025|NCT01523301|11702988|FG000|Overall Study|Adverse Event|25
7426026|NCT01523301|11702989|FG001|Overall Study|Adverse Event|16
7426027|NCT01523301|11702988|FG000|Overall Study|Lack of Efficacy|0
7426028|NCT01523301|11702989|FG001|Overall Study|Lack of Efficacy|2
7426029|NCT01523301|11702988|FG000|Overall Study|Protocol Violation|3
7426030|NCT01523301|11702989|FG001|Overall Study|Protocol Violation|4
7426031|NCT01523301|11702988|FG000|Overall Study|Lost to Follow-up|1
7426032|NCT01523301|11702989|FG001|Overall Study|Lost to Follow-up|0
7426033|NCT01523301|11702988|FG000|Overall Study|Withdrawal by Subject|6
7426034|NCT01523301|11702989|FG001|Overall Study|Withdrawal by Subject|8
7426035|NCT01523301|11702988|FG000|Overall Study|Other Reason|0
7426036|NCT01523301|11702989|FG001|Overall Study|Other Reason|2
7426037|NCT01523366|11702997|FG000|Treatment Period 1|Withdrawal by Subject|1
7426038|NCT01523366|11702998|FG001|Treatment Period 1|Withdrawal by Subject|0
7426039|NCT01523366|11702997|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
7426040|NCT01523366|11702998|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
7426041|NCT01523392|11703008|FG000|Treatment Period 1|Withdrawal by Subject|2
7426042|NCT01523392|11703009|FG001|Treatment Period 1|Withdrawal by Subject|0
7426043|NCT01523392|11703008|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
7426044|NCT01523392|11703009|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
7426045|NCT01523392|11703008|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
7426046|NCT01523392|11703009|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
7426047|NCT01523457|11703019|FG000|Overall Study|Withdrawal by Subject|7
7426048|NCT01523457|11703020|FG001|Overall Study|Withdrawal by Subject|2
7426049|NCT01523587|11703049|FG000|Overall Study|Other than listed|5
7426050|NCT01523587|11703050|FG001|Overall Study|Other than listed|5
7426051|NCT01523587|11703049|FG000|Overall Study|Worsening of underlying cancer disease|19
7426052|NCT01523587|11703050|FG001|Overall Study|Worsening of underlying cancer disease|34
7426053|NCT01523587|11703049|FG000|Overall Study|Adverse Event|68
7426054|NCT01523587|11703050|FG001|Overall Study|Adverse Event|52
7426055|NCT01523587|11703049|FG000|Overall Study|Protocol Violation|5
7426056|NCT01523587|11703050|FG001|Overall Study|Protocol Violation|3
7426057|NCT01523587|11703049|FG000|Overall Study|Lost to Follow-up|2
7426058|NCT01523587|11703050|FG001|Overall Study|Lost to Follow-up|2
7426059|NCT01523587|11703049|FG000|Overall Study|Withdrawal by Subject|28
7328216|NCT00794339|11561025|FG000|Overall Study|Ineligible|4
7426060|NCT01523587|11703050|FG001|Overall Study|Withdrawal by Subject|20
7426061|NCT01523587|11703049|FG000|Overall Study|Withdrew due to Progressive disease|265
7426062|NCT01523587|11703050|FG001|Overall Study|Withdrew due to Progressive disease|279
7426063|NCT01523587|11703049|FG000|Overall Study|Randomised but bot treated|6
7426064|NCT01523587|11703050|FG001|Overall Study|Randomised but bot treated|2
7426065|NCT01523743|11703079|FG000|Period 1|Adverse Event|1
7426066|NCT01523743|11703080|FG001|Period 1|Adverse Event|0
7426067|NCT01523743|11703079|FG000|Period 1|Withdrawal by Subject|6
7426068|NCT01523743|11703080|FG001|Period 1|Withdrawal by Subject|2
7426069|NCT01523743|11703079|FG000|Period 1|Lost to Follow-up|1
7426070|NCT01523743|11703080|FG001|Period 1|Lost to Follow-up|0
7426071|NCT01523743|11703079|FG000|Period 1|Lack of Efficacy|1
7426072|NCT01523743|11703080|FG001|Period 1|Lack of Efficacy|0
7426073|NCT01523743|11703079|FG000|Period 1|Felt unable to empty bladder|1
7426074|NCT01523743|11703080|FG001|Period 1|Felt unable to empty bladder|0
7426075|NCT01523743|11703079|FG000|Period 2|Withdrawal by Subject|0
7426076|NCT01523743|11703080|FG001|Period 2|Withdrawal by Subject|2
7426077|NCT01523743|11703079|FG000|Period 2|Adverse Event|1
7426078|NCT01523743|11703080|FG001|Period 2|Adverse Event|0
7426079|NCT01523756|11703086|FG000|Baseline Period|Adverse Event|0
7426080|NCT01523756|11703087|FG001|Baseline Period|Adverse Event|1
7426081|NCT01523756|11703086|FG000|Test Period 1|Adverse Event|1
7426082|NCT01523756|11703087|FG001|Test Period 1|Adverse Event|0
7426083|NCT01523756|11703086|FG000|Test Period 2|Withdrawal by Subject|0
7426084|NCT01523756|11703087|FG001|Test Period 2|Withdrawal by Subject|1
7426085|NCT01523873|11703152|FG000|Overall Study|Protocol Violation|422
7426086|NCT01523886|11703160|FG000|Overall Study|surgery cancelled|0
7426087|NCT01523886|11703161|FG001|Overall Study|surgery cancelled|1
7426088|NCT01524133|11703197|FG000|Treatment Phase|Withdrawal by Subject|13
7426089|NCT01524133|11703198|FG001|Treatment Phase|Withdrawal by Subject|28
7426090|NCT01524133|11703199|FG002|Treatment Phase|Withdrawal by Subject|31
7426091|NCT01524133|11703197|FG000|Treatment Phase|Physician Decision|6
7426092|NCT01524133|11703198|FG001|Treatment Phase|Physician Decision|3
7426093|NCT01524133|11703199|FG002|Treatment Phase|Physician Decision|3
7426094|NCT01524133|11703197|FG000|Treatment Phase|Lost to Follow-up|0
7426095|NCT01524133|11703198|FG001|Treatment Phase|Lost to Follow-up|1
7426096|NCT01524133|11703199|FG002|Treatment Phase|Lost to Follow-up|2
7426097|NCT01524133|11703197|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
7426098|NCT01524133|11703198|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
7426099|NCT01524133|11703199|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
7426100|NCT01524133|11703197|FG000|Overall Study 52 Weeks|Physician Decision|1
7426101|NCT01524133|11703198|FG001|Overall Study 52 Weeks|Physician Decision|0
7426102|NCT01524133|11703199|FG002|Overall Study 52 Weeks|Physician Decision|2
7426103|NCT01524133|11703197|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
7426104|NCT01524133|11703198|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
7426105|NCT01524133|11703199|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
7426106|NCT01524198|11703209|FG000|Overall Study|Protocol Violation|8
7426107|NCT01524198|11703210|FG001|Overall Study|Protocol Violation|6
7426108|NCT01524198|11703209|FG000|Overall Study|Withdrawal by Subject|15
7426109|NCT01524198|11703210|FG001|Overall Study|Withdrawal by Subject|10
7426110|NCT01524224|11703224|FG000|Overall Study|Progressive Disease|1
7426111|NCT01524224|11703225|FG001|Overall Study|Progressive Disease|0
7426112|NCT01524224|11703226|FG002|Overall Study|Progressive Disease|2
7426113|NCT01524224|11703227|FG003|Overall Study|Progressive Disease|1
7426114|NCT01524224|11703228|FG004|Overall Study|Progressive Disease|2
7426115|NCT01524224|11703229|FG005|Overall Study|Progressive Disease|1
7426116|NCT01524224|11703230|FG006|Overall Study|Progressive Disease|1
7426117|NCT01524224|11703231|FG007|Overall Study|Progressive Disease|5
7426118|NCT01524224|11703224|FG000|Overall Study|Withdrawal by Subject|2
7426119|NCT01524224|11703225|FG001|Overall Study|Withdrawal by Subject|0
7426120|NCT01524224|11703226|FG002|Overall Study|Withdrawal by Subject|0
7426121|NCT01524224|11703227|FG003|Overall Study|Withdrawal by Subject|0
7426122|NCT01524224|11703228|FG004|Overall Study|Withdrawal by Subject|0
7426123|NCT01524224|11703229|FG005|Overall Study|Withdrawal by Subject|0
7426124|NCT01524224|11703230|FG006|Overall Study|Withdrawal by Subject|2
7426125|NCT01524224|11703231|FG007|Overall Study|Withdrawal by Subject|0
7426126|NCT01524224|11703224|FG000|Overall Study|Adverse Event|0
7426127|NCT01524224|11703225|FG001|Overall Study|Adverse Event|1
7426128|NCT01524224|11703226|FG002|Overall Study|Adverse Event|0
7426129|NCT01524224|11703227|FG003|Overall Study|Adverse Event|0
7426130|NCT01524224|11703228|FG004|Overall Study|Adverse Event|0
7426131|NCT01524224|11703229|FG005|Overall Study|Adverse Event|1
7426132|NCT01524224|11703230|FG006|Overall Study|Adverse Event|0
7426133|NCT01524224|11703231|FG007|Overall Study|Adverse Event|0
7426134|NCT01524224|11703224|FG000|Overall Study|Physician Decision|0
7426135|NCT01524224|11703225|FG001|Overall Study|Physician Decision|0
7426136|NCT01524224|11703226|FG002|Overall Study|Physician Decision|0
7426137|NCT01524224|11703227|FG003|Overall Study|Physician Decision|1
7426138|NCT01524224|11703228|FG004|Overall Study|Physician Decision|1
7426139|NCT01524224|11703229|FG005|Overall Study|Physician Decision|0
7426140|NCT01524224|11703230|FG006|Overall Study|Physician Decision|0
7426141|NCT01524224|11703231|FG007|Overall Study|Physician Decision|1
7426142|NCT01524224|11703224|FG000|Overall Study|Sponsor Decision|0
7426143|NCT01524224|11703225|FG001|Overall Study|Sponsor Decision|0
7426144|NCT01524224|11703226|FG002|Overall Study|Sponsor Decision|0
7426145|NCT01524224|11703227|FG003|Overall Study|Sponsor Decision|0
7426146|NCT01524224|11703228|FG004|Overall Study|Sponsor Decision|1
7426147|NCT01524224|11703229|FG005|Overall Study|Sponsor Decision|0
7426148|NCT01524224|11703230|FG006|Overall Study|Sponsor Decision|0
7426149|NCT01524224|11703231|FG007|Overall Study|Sponsor Decision|0
7426150|NCT01524289|11703251|FG000|Overall Study|Lost to Follow-up|0
7426151|NCT01524289|11703252|FG001|Overall Study|Lost to Follow-up|1
7426152|NCT01524289|11703251|FG000|Overall Study|Physician Decision|1
7426153|NCT01524289|11703252|FG001|Overall Study|Physician Decision|0
7426154|NCT01524289|11703251|FG000|Overall Study|Protocol Violation|5
7426155|NCT01524289|11703252|FG001|Overall Study|Protocol Violation|1
7426156|NCT01524289|11703251|FG000|Overall Study|Withdrawal by Subject|11
7426157|NCT01524289|11703252|FG001|Overall Study|Withdrawal by Subject|7
7426158|NCT01524289|11703251|FG000|Overall Study|Adverse Event|12
7426159|NCT01524289|11703252|FG001|Overall Study|Adverse Event|5
7426160|NCT01524289|11703251|FG000|Overall Study|Did not take study medication|1
7426161|NCT01524289|11703252|FG001|Overall Study|Did not take study medication|0
7426162|NCT01524627|11703275|FG000|Overall Study|Physician Decision|0
7426163|NCT01524627|11703276|FG001|Overall Study|Physician Decision|1
7426164|NCT01524627|11703275|FG000|Overall Study|Lost to Follow-up|1
7426165|NCT01524627|11703276|FG001|Overall Study|Lost to Follow-up|1
7426166|NCT01524679|11703284|FG000|Overall Study|Lost to Follow-up|1
7426167|NCT01524679|11703285|FG001|Overall Study|Lost to Follow-up|4
7426168|NCT01524679|11703284|FG000|Overall Study|Withdrawal by Subject|4
7426169|NCT01524679|11703285|FG001|Overall Study|Withdrawal by Subject|4
7426170|NCT01524679|11703284|FG000|Overall Study|Adverse Event|9
7426171|NCT01524679|11703285|FG001|Overall Study|Adverse Event|0
7426172|NCT01524679|11703284|FG000|Overall Study|Protocol Violation|1
7426173|NCT01524679|11703285|FG001|Overall Study|Protocol Violation|0
7426174|NCT01524679|11703284|FG000|Overall Study|Lack of Efficacy|2
7426175|NCT01524679|11703285|FG001|Overall Study|Lack of Efficacy|0
7426176|NCT01524679|11703284|FG000|Overall Study|e.g.wish for children, relocation|6
7426177|NCT01524679|11703285|FG001|Overall Study|e.g.wish for children, relocation|1
7426178|NCT01524692|11703291|FG000|Overall Study|Withdrawal by Subject|3
7426179|NCT01524770|11703296|FG000|First Intervention|Withdrawal by Subject|1
7426180|NCT01524770|11703297|FG001|First Intervention|Withdrawal by Subject|0
7426181|NCT01524770|11703296|FG000|First Intervention|Adverse Event|1
7426182|NCT01524770|11703297|FG001|First Intervention|Adverse Event|1
7426183|NCT01524770|11703296|FG000|First Intervention|Protocol Violation|1
7426184|NCT01524770|11703297|FG001|First Intervention|Protocol Violation|0
7426185|NCT01524783|11703305|FG000|Blinded Period|Adverse Event|64
7426186|NCT01524783|11703306|FG001|Blinded Period|Adverse Event|7
7426187|NCT01524783|11703307|FG002|Blinded Period|Adverse Event|0
7426188|NCT01524783|11703305|FG000|Blinded Period|Disease Progression|89
7426189|NCT01524783|11703306|FG001|Blinded Period|Disease Progression|75
7426190|NCT01524783|11703307|FG002|Blinded Period|Disease Progression|0
7426191|NCT01524783|11703305|FG000|Blinded Period|Withdrawal by Subject|19
7426192|NCT01524783|11703306|FG001|Blinded Period|Withdrawal by Subject|6
7426193|NCT01524783|11703307|FG002|Blinded Period|Withdrawal by Subject|0
7531969|NCT02660944|11876985|FG001|Overall Study|Physician Decision|1
7426194|NCT01524783|11703305|FG000|Blinded Period|Protocol deviation|2
7426195|NCT01524783|11703306|FG001|Blinded Period|Protocol deviation|1
7531970|NCT02660944|11876984|FG000|Overall Study|Withdrawal by Subject|5
7531971|NCT02660944|11876985|FG001|Overall Study|Withdrawal by Subject|3
7557569|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557570|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7531972|NCT02660944|11876984|FG000|Overall Study|Lost to Follow-up|4
7531973|NCT02660944|11876985|FG001|Overall Study|Lost to Follow-up|1
7426196|NCT01524783|11703307|FG002|Blinded Period|Protocol deviation|0
7426197|NCT01524783|11703305|FG000|Blinded Period|Death|5
7426198|NCT01524783|11703306|FG001|Blinded Period|Death|2
7426199|NCT01524783|11703307|FG002|Blinded Period|Death|0
7426200|NCT01524783|11703305|FG000|Open-label Period|Disease progression|13
7426201|NCT01524783|11703306|FG001|Open-label Period|Disease progression|0
7426202|NCT01524783|11703307|FG002|Open-label Period|Disease progression|2
7426203|NCT01524783|11703305|FG000|Open-label Period|Administrative problems|5
7426204|NCT01524783|11703306|FG001|Open-label Period|Administrative problems|0
7426205|NCT01524783|11703307|FG002|Open-label Period|Administrative problems|2
7426206|NCT01524783|11703305|FG000|Open-label Period|Adverse Event|5
7426207|NCT01524783|11703306|FG001|Open-label Period|Adverse Event|0
7426208|NCT01524783|11703307|FG002|Open-label Period|Adverse Event|1
7426209|NCT01524783|11703305|FG000|Open-label Period|Withdrawal by Subject|2
7426210|NCT01524783|11703306|FG001|Open-label Period|Withdrawal by Subject|0
7426211|NCT01524783|11703307|FG002|Open-label Period|Withdrawal by Subject|1
7426212|NCT01524783|11703305|FG000|Open-label Period|Protocol deviation|1
7426213|NCT01524783|11703306|FG001|Open-label Period|Protocol deviation|0
7426214|NCT01524783|11703307|FG002|Open-label Period|Protocol deviation|0
7426215|NCT01524796|11703319|FG000|Overall Study|Adverse Event|13
7426216|NCT01524796|11703319|FG000|Overall Study|Lack of Efficacy|3
7426217|NCT01524796|11703319|FG000|Overall Study|Lost to Follow-up|1
7531974|NCT02660944|11876984|FG000|Overall Study|Subject schedule|0
7531975|NCT02660944|11876985|FG001|Overall Study|Subject schedule|1
7531976|NCT02660944|11876984|FG000|Overall Study|Exclusion criteria met|2
7426218|NCT01524796|11703319|FG000|Overall Study|The price|1
7426219|NCT01524796|11703319|FG000|Overall Study|Withdrawal by Subject|4
7426220|NCT01524796|11703319|FG000|Overall Study|Move|1
7426221|NCT01524796|11703319|FG000|Overall Study|Deterioration of pains|1
7426222|NCT01524796|11703319|FG000|Overall Study|Gall stone surgery|1
7426223|NCT01524796|11703319|FG000|Overall Study|Nervous about confidentiality|1
7426224|NCT01524796|11703319|FG000|Overall Study|Switch to carbamazapine|1
7426225|NCT01524796|11703319|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
7426226|NCT01524887|11703326|FG000|Overall Study|Withdrawal by Subject|6
7531977|NCT02660944|11876985|FG001|Overall Study|Exclusion criteria met|0
7531978|NCT02660983|11876993|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
7426227|NCT01524887|11703327|FG001|Overall Study|Withdrawal by Subject|2
7426228|NCT01524887|11703328|FG002|Overall Study|Withdrawal by Subject|3
7426229|NCT01524887|11703326|FG000|Overall Study|Adverse Event|5
7426230|NCT01524887|11703327|FG001|Overall Study|Adverse Event|1
7426231|NCT01524887|11703328|FG002|Overall Study|Adverse Event|1
7426232|NCT01524887|11703326|FG000|Overall Study|Protocol Violation|0
7426233|NCT01524887|11703327|FG001|Overall Study|Protocol Violation|0
7426234|NCT01524887|11703328|FG002|Overall Study|Protocol Violation|1
7426235|NCT01524887|11703326|FG000|Overall Study|Study termination|73
7426236|NCT01524887|11703327|FG001|Overall Study|Study termination|87
7426237|NCT01524887|11703328|FG002|Overall Study|Study termination|79
7426238|NCT01524887|11703326|FG000|Overall Study|Withdrawal by Caregiver|0
7426239|NCT01524887|11703327|FG001|Overall Study|Withdrawal by Caregiver|0
7426240|NCT01524887|11703328|FG002|Overall Study|Withdrawal by Caregiver|2
7426241|NCT01524887|11703326|FG000|Overall Study|Use of prohibited medication|1
7426242|NCT01524887|11703327|FG001|Overall Study|Use of prohibited medication|0
7426243|NCT01524887|11703328|FG002|Overall Study|Use of prohibited medication|0
7426244|NCT01524900|11703341|FG000|Overall Study|Lost to Follow-up|3
7426245|NCT01524900|11703342|FG001|Overall Study|Lost to Follow-up|12
7426246|NCT01524900|11703343|FG002|Overall Study|Lost to Follow-up|1
7426247|NCT01524900|11703344|FG003|Overall Study|Lost to Follow-up|0
7426248|NCT01524900|11703345|FG004|Overall Study|Lost to Follow-up|0
7426249|NCT01524900|11703341|FG000|Overall Study|Other reason than stated above|1
7426250|NCT01524900|11703342|FG001|Overall Study|Other reason than stated above|1
7426251|NCT01524900|11703343|FG002|Overall Study|Other reason than stated above|0
7426252|NCT01524900|11703344|FG003|Overall Study|Other reason than stated above|0
7426253|NCT01524900|11703345|FG004|Overall Study|Other reason than stated above|0
7426254|NCT01524900|11703341|FG000|Overall Study|No reason documented|2
7426255|NCT01524900|11703342|FG001|Overall Study|No reason documented|1
7426256|NCT01524900|11703343|FG002|Overall Study|No reason documented|0
7426257|NCT01524900|11703344|FG003|Overall Study|No reason documented|1
7426258|NCT01524900|11703345|FG004|Overall Study|No reason documented|0
7426259|NCT01524913|11703361|FG000|Overall Study|Lost to Follow-up|4
7426260|NCT01524913|11703362|FG001|Overall Study|Lost to Follow-up|0
7426261|NCT01524913|11703363|FG002|Overall Study|Lost to Follow-up|0
7426262|NCT01524978|11703382|FG000|Overall Study|Other|16
7426263|NCT01524978|11703383|FG001|Overall Study|Other|2
7426264|NCT01524978|11703384|FG002|Overall Study|Other|1
7426265|NCT01524978|11703385|FG003|Overall Study|Other|2
7557571|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557572|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557573|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557574|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557575|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
7557576|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557577|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
7557578|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557579|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557580|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557581|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557582|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557583|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557584|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557585|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557586|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557587|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557588|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557589|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
7557590|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
7557591|NCT03100058|11921935|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557592|NCT03100058|11921936|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557593|NCT03100058|11921937|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557594|NCT03100058|11921938|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557595|NCT03100058|11921939|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557596|NCT03100058|11921940|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557597|NCT03100058|11921941|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557598|NCT03100058|11921942|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557599|NCT03100058|11921943|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557600|NCT03100058|11921944|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
7426266|NCT01524978|11703386|FG004|Overall Study|Other|1
7426267|NCT01524978|11703387|FG005|Overall Study|Other|3
7426268|NCT01524978|11703388|FG006|Overall Study|Other|17
7557601|NCT03100058|11921945|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7426269|NCT01524978|11703389|FG007|Overall Study|Other|1
7426270|NCT01524978|11703390|FG008|Overall Study|Other|2
7426271|NCT01524978|11703391|FG009|Overall Study|Other|2
7426272|NCT01524978|11703392|FG010|Overall Study|Other|5
7426273|NCT01524978|11703382|FG000|Overall Study|Withdrawal by Subject|12
7426274|NCT01524978|11703383|FG001|Overall Study|Withdrawal by Subject|0
7426275|NCT01524978|11703384|FG002|Overall Study|Withdrawal by Subject|1
7426276|NCT01524978|11703385|FG003|Overall Study|Withdrawal by Subject|1
7426277|NCT01524978|11703386|FG004|Overall Study|Withdrawal by Subject|3
7426278|NCT01524978|11703387|FG005|Overall Study|Withdrawal by Subject|1
7426279|NCT01524978|11703388|FG006|Overall Study|Withdrawal by Subject|6
7426280|NCT01524978|11703389|FG007|Overall Study|Withdrawal by Subject|2
7426281|NCT01524978|11703390|FG008|Overall Study|Withdrawal by Subject|4
7426282|NCT01524978|11703391|FG009|Overall Study|Withdrawal by Subject|0
7426283|NCT01524978|11703392|FG010|Overall Study|Withdrawal by Subject|5
7426284|NCT01524978|11703382|FG000|Overall Study|Lost to Follow-up|0
7426285|NCT01524978|11703383|FG001|Overall Study|Lost to Follow-up|0
7426286|NCT01524978|11703384|FG002|Overall Study|Lost to Follow-up|3
7426287|NCT01524978|11703385|FG003|Overall Study|Lost to Follow-up|0
7426288|NCT01524978|11703386|FG004|Overall Study|Lost to Follow-up|1
7426289|NCT01524978|11703387|FG005|Overall Study|Lost to Follow-up|1
7426290|NCT01524978|11703388|FG006|Overall Study|Lost to Follow-up|2
7426291|NCT01524978|11703389|FG007|Overall Study|Lost to Follow-up|0
7426292|NCT01524978|11703390|FG008|Overall Study|Lost to Follow-up|1
7426293|NCT01524978|11703391|FG009|Overall Study|Lost to Follow-up|1
7426294|NCT01524978|11703392|FG010|Overall Study|Lost to Follow-up|1
7426295|NCT01524978|11703382|FG000|Overall Study|Death|34
7426296|NCT01524978|11703383|FG001|Overall Study|Death|2
7426297|NCT01524978|11703384|FG002|Overall Study|Death|5
7426298|NCT01524978|11703385|FG003|Overall Study|Death|24
7426299|NCT01524978|11703386|FG004|Overall Study|Death|4
7426300|NCT01524978|11703387|FG005|Overall Study|Death|4
7426301|NCT01524978|11703388|FG006|Overall Study|Death|1
7426302|NCT01524978|11703389|FG007|Overall Study|Death|9
7426303|NCT01524978|11703390|FG008|Overall Study|Death|5
7426304|NCT01524978|11703391|FG009|Overall Study|Death|6
7426305|NCT01524978|11703392|FG010|Overall Study|Death|17
7557602|NCT03100058|11921946|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557603|NCT03100058|11921947|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
7557604|NCT03100344|11921994|FG000|Overall Study|Adverse Event|0
7557605|NCT03100344|11921995|FG001|Overall Study|Adverse Event|3
7557606|NCT03100344|11921996|FG002|Overall Study|Adverse Event|2
7426312|NCT01525082|11703411|FG000|Overall Study|Death|1
7426313|NCT01525225|11703427|FG000|Enrollment|No longer met study criteria|1
7426314|NCT01525225|11703427|FG000|Enrollment|Other|1
7426315|NCT01525238|11703434|FG000|Overall Study|Withdrawal by Subject|1
7426316|NCT01525238|11703435|FG001|Overall Study|Withdrawal by Subject|0
7426317|NCT01525238|11703436|FG002|Overall Study|Withdrawal by Subject|0
7466755|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
7466756|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
7466757|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
7466758|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
7466759|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
7466760|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
7466761|NCT01894516|11766704|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7466762|NCT01894516|11766705|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
7466763|NCT01894516|11766706|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
7466764|NCT01894516|11766707|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
7466765|NCT01894516|11766704|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
7466766|NCT01894516|11766705|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
7466767|NCT01894516|11766706|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
7466768|NCT01894516|11766707|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
7466769|NCT01894516|11766704|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466770|NCT01894516|11766705|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466771|NCT01894516|11766706|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
7466772|NCT01894516|11766707|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
7466773|NCT01894568|11766727|FG000|Overall Study|Adverse Event|2
7466774|NCT01894568|11766728|FG001|Overall Study|Adverse Event|3
7466775|NCT01894568|11766727|FG000|Overall Study|Protocol required discontinuation|2
7466776|NCT01894568|11766728|FG001|Overall Study|Protocol required discontinuation|1
7466777|NCT01894568|11766727|FG000|Overall Study|Withdrawal by Subject|5
7466778|NCT01894568|11766728|FG001|Overall Study|Withdrawal by Subject|5
7466779|NCT01894568|11766727|FG000|Overall Study|Physician Decision|1
7466780|NCT01894568|11766728|FG001|Overall Study|Physician Decision|0
7466781|NCT01894568|11766727|FG000|Overall Study|Lost to Follow-up|0
7466782|NCT01894568|11766728|FG001|Overall Study|Lost to Follow-up|1
7466783|NCT01894581|11766737|FG000|Overall Study|Withdrawal by Subject|2
7466784|NCT01894581|11766738|FG001|Overall Study|Withdrawal by Subject|3
7466785|NCT01894581|11766737|FG000|Overall Study|Screen Failure|3
7466786|NCT01894581|11766738|FG001|Overall Study|Screen Failure|4
7466787|NCT01894607|11766744|FG000|Overall Study|Ineligible|1
7466788|NCT01894620|11766750|FG000|Overall Study|Withdrawal by Subject|0
7466789|NCT01894620|11766751|FG001|Overall Study|Withdrawal by Subject|1
7466790|NCT01894776|11766764|FG000|Overall Study|Withdrawal by Subject|1
7466791|NCT01894841|11766770|FG000|Overall Study|Withdrawal by Subject|9
7466792|NCT01894841|11766771|FG001|Overall Study|Withdrawal by Subject|4
7466793|NCT01894841|11766770|FG000|Overall Study|Withdrawn by investigator|2
7426318|NCT01525407|11703446|FG000|Overall Study|Change in recipient treatment plan|2
7426319|NCT01525407|11703447|FG001|Overall Study|Change in recipient treatment plan|2
7531979|NCT02660983|11876994|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
7531980|NCT02660983|11876993|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
7557607|NCT03100344|11921997|FG003|Overall Study|Adverse Event|3
7557608|NCT03100344|11921994|FG000|Overall Study|Lack of Efficacy|2
7426320|NCT01525407|11703446|FG000|Overall Study|Withdrawal by Subject|0
7426321|NCT01525407|11703447|FG001|Overall Study|Withdrawal by Subject|1
7426322|NCT01525407|11703446|FG000|Overall Study|Transplant was delayed|0
7426323|NCT01525407|11703447|FG001|Overall Study|Transplant was delayed|1
7426324|NCT01525407|11703446|FG000|Overall Study|Delay in Transplant|1
7426325|NCT01525407|11703447|FG001|Overall Study|Delay in Transplant|0
7557609|NCT03100344|11921995|FG001|Overall Study|Lack of Efficacy|0
7557610|NCT03100344|11921996|FG002|Overall Study|Lack of Efficacy|0
7557611|NCT03100344|11921997|FG003|Overall Study|Lack of Efficacy|0
7557612|NCT03100344|11921994|FG000|Overall Study|Protocol Violation|1
7557613|NCT03100344|11921995|FG001|Overall Study|Protocol Violation|0
7557614|NCT03100344|11921996|FG002|Overall Study|Protocol Violation|0
7426326|NCT01525550|11703464|FG000|Overall Study|Lost to Follow-up|8
7426327|NCT01525550|11703465|FG001|Overall Study|Lost to Follow-up|2
7426328|NCT01525550|11703464|FG000|Overall Study|Death|19
7426329|NCT01525550|11703465|FG001|Overall Study|Death|28
7426330|NCT01525550|11703464|FG000|Overall Study|Other|0
7426331|NCT01525550|11703465|FG001|Overall Study|Other|4
7426332|NCT01525550|11703464|FG000|Overall Study|Sponsor's Decision|30
7426333|NCT01525550|11703465|FG001|Overall Study|Sponsor's Decision|11
7426334|NCT01525550|11703464|FG000|Overall Study|Withdrawal by Subject|4
7426335|NCT01525550|11703465|FG001|Overall Study|Withdrawal by Subject|0
7426336|NCT01525589|11703478|FG000|Overall Study|Non-treatment-related AE|1
7426337|NCT01525589|11703479|FG001|Overall Study|Non-treatment-related AE|0
7426338|NCT01525589|11703480|FG002|Overall Study|Non-treatment-related AE|0
7426339|NCT01525589|11703478|FG000|Overall Study|Progressive disease|48
7426340|NCT01525589|11703479|FG001|Overall Study|Progressive disease|15
7426341|NCT01525589|11703480|FG002|Overall Study|Progressive disease|29
7426342|NCT01525589|11703478|FG000|Overall Study|Never treated|2
7426343|NCT01525589|11703479|FG001|Overall Study|Never treated|0
7426344|NCT01525589|11703480|FG002|Overall Study|Never treated|0
7426345|NCT01525589|11703478|FG000|Overall Study|Physician Decision|4
7426346|NCT01525589|11703479|FG001|Overall Study|Physician Decision|2
7531981|NCT02660983|11876994|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
7531982|NCT02660983|11876993|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
7557615|NCT03100344|11921997|FG003|Overall Study|Protocol Violation|0
7557616|NCT03100344|11921994|FG000|Overall Study|Withdrawal by Subject|10
7557617|NCT03100344|11921995|FG001|Overall Study|Withdrawal by Subject|7
7557618|NCT03100344|11921996|FG002|Overall Study|Withdrawal by Subject|4
7557619|NCT03100344|11921997|FG003|Overall Study|Withdrawal by Subject|8
7557620|NCT03100344|11921994|FG000|Overall Study|Lost to Follow-up|1
7557621|NCT03100344|11921995|FG001|Overall Study|Lost to Follow-up|1
7557622|NCT03100344|11921996|FG002|Overall Study|Lost to Follow-up|1
7557623|NCT03100344|11921997|FG003|Overall Study|Lost to Follow-up|1
7557624|NCT03100825|11922012|FG000|Overall Study|Participant/Guardian Decision|7
7557625|NCT03100825|11922012|FG000|Overall Study|Physician Decision|1
7557626|NCT03100838|11922016|FG000|Overall Study|Adverse Event|1
7557627|NCT03100838|11922017|FG001|Overall Study|Adverse Event|0
7557628|NCT03100838|11922018|FG002|Overall Study|Adverse Event|0
7557629|NCT03100838|11922019|FG003|Overall Study|Adverse Event|0
7557630|NCT03100838|11922016|FG000|Overall Study|Physician Decision|1
7557631|NCT03100838|11922017|FG001|Overall Study|Physician Decision|1
7557632|NCT03100838|11922018|FG002|Overall Study|Physician Decision|1
7557633|NCT03100838|11922019|FG003|Overall Study|Physician Decision|1
7557634|NCT03100838|11922016|FG000|Overall Study|Pregnancy|0
7557635|NCT03100838|11922017|FG001|Overall Study|Pregnancy|1
7557636|NCT03100838|11922018|FG002|Overall Study|Pregnancy|0
7557637|NCT03100838|11922019|FG003|Overall Study|Pregnancy|0
7557638|NCT03100838|11922016|FG000|Overall Study|Lost to Follow-up|0
7557639|NCT03100838|11922017|FG001|Overall Study|Lost to Follow-up|0
7557640|NCT03100838|11922018|FG002|Overall Study|Lost to Follow-up|1
7557641|NCT03100838|11922019|FG003|Overall Study|Lost to Follow-up|0
7557642|NCT03100942|11922037|FG000|Randomized Treatment Period|Withdrew Consent|4
7557643|NCT03100942|11922038|FG001|Randomized Treatment Period|Withdrew Consent|5
7557644|NCT03100942|11922039|FG002|Randomized Treatment Period|Withdrew Consent|3
7557645|NCT03100942|11922040|FG003|Randomized Treatment Period|Withdrew Consent|3
7557646|NCT03100942|11922041|FG004|Randomized Treatment Period|Withdrew Consent|0
7557647|NCT03100942|11922042|FG005|Randomized Treatment Period|Withdrew Consent|0
7557648|NCT03100942|11922043|FG006|Randomized Treatment Period|Withdrew Consent|0
7426347|NCT01525589|11703480|FG002|Overall Study|Physician Decision|2
7426348|NCT01525589|11703478|FG000|Overall Study|Death|0
7426349|NCT01525589|11703479|FG001|Overall Study|Death|0
7426350|NCT01525589|11703480|FG002|Overall Study|Death|2
7426351|NCT01525589|11703478|FG000|Overall Study|Treatment-related AE|1
7426352|NCT01525589|11703479|FG001|Overall Study|Treatment-related AE|1
7426353|NCT01525589|11703480|FG002|Overall Study|Treatment-related AE|2
7557649|NCT03100942|11922037|FG000|Randomized Treatment Period|Adverse Event|5
7557650|NCT03100942|11922038|FG001|Randomized Treatment Period|Adverse Event|2
7557651|NCT03100942|11922039|FG002|Randomized Treatment Period|Adverse Event|1
7426354|NCT01525589|11703478|FG000|Overall Study|Other reasons|0
7426355|NCT01525589|11703479|FG001|Overall Study|Other reasons|1
7426356|NCT01525589|11703480|FG002|Overall Study|Other reasons|0
7426357|NCT01525589|11703478|FG000|Overall Study|Withdrawal by Subject|0
7426358|NCT01525589|11703479|FG001|Overall Study|Withdrawal by Subject|1
7426359|NCT01525589|11703480|FG002|Overall Study|Withdrawal by Subject|0
7426360|NCT01525602|11703496|FG000|Overall Study|Adverse Event|1
7426361|NCT01525602|11703497|FG001|Overall Study|Adverse Event|0
7426362|NCT01525602|11703498|FG002|Overall Study|Adverse Event|1
7426363|NCT01525602|11703499|FG003|Overall Study|Adverse Event|1
7426364|NCT01525602|11703500|FG004|Overall Study|Adverse Event|3
7426365|NCT01525602|11703501|FG005|Overall Study|Adverse Event|3
7426366|NCT01525602|11703502|FG006|Overall Study|Adverse Event|0
7426367|NCT01525602|11703503|FG007|Overall Study|Adverse Event|1
7426368|NCT01525602|11703496|FG000|Overall Study|Disease progression|6
7426369|NCT01525602|11703497|FG001|Overall Study|Disease progression|3
7426370|NCT01525602|11703498|FG002|Overall Study|Disease progression|2
7426371|NCT01525602|11703499|FG003|Overall Study|Disease progression|5
7426372|NCT01525602|11703500|FG004|Overall Study|Disease progression|22
7426373|NCT01525602|11703501|FG005|Overall Study|Disease progression|2
7426374|NCT01525602|11703502|FG006|Overall Study|Disease progression|3
7426375|NCT01525602|11703503|FG007|Overall Study|Disease progression|3
7426376|NCT01525602|11703496|FG000|Overall Study|Clinical progression|2
7426377|NCT01525602|11703497|FG001|Overall Study|Clinical progression|0
7426378|NCT01525602|11703498|FG002|Overall Study|Clinical progression|0
7426379|NCT01525602|11703499|FG003|Overall Study|Clinical progression|0
7426380|NCT01525602|11703500|FG004|Overall Study|Clinical progression|0
7426381|NCT01525602|11703501|FG005|Overall Study|Clinical progression|0
7426382|NCT01525602|11703502|FG006|Overall Study|Clinical progression|1
7426383|NCT01525602|11703503|FG007|Overall Study|Clinical progression|1
7426384|NCT01525602|11703496|FG000|Overall Study|Non-compliance|0
7426385|NCT01525602|11703497|FG001|Overall Study|Non-compliance|0
7426386|NCT01525602|11703498|FG002|Overall Study|Non-compliance|0
7426387|NCT01525602|11703499|FG003|Overall Study|Non-compliance|0
7426388|NCT01525602|11703500|FG004|Overall Study|Non-compliance|1
7426389|NCT01525602|11703501|FG005|Overall Study|Non-compliance|0
7426390|NCT01525602|11703502|FG006|Overall Study|Non-compliance|0
7426391|NCT01525602|11703503|FG007|Overall Study|Non-compliance|0
7426392|NCT01525602|11703496|FG000|Overall Study|Withdrawal by Subject|0
7426393|NCT01525602|11703497|FG001|Overall Study|Withdrawal by Subject|0
7426394|NCT01525602|11703498|FG002|Overall Study|Withdrawal by Subject|0
7426395|NCT01525602|11703499|FG003|Overall Study|Withdrawal by Subject|0
7426396|NCT01525602|11703500|FG004|Overall Study|Withdrawal by Subject|3
7426397|NCT01525602|11703501|FG005|Overall Study|Withdrawal by Subject|1
7426398|NCT01525602|11703502|FG006|Overall Study|Withdrawal by Subject|0
7426399|NCT01525602|11703503|FG007|Overall Study|Withdrawal by Subject|1
7426400|NCT01525602|11703496|FG000|Overall Study|Physician Decision|0
7426401|NCT01525602|11703497|FG001|Overall Study|Physician Decision|0
7426402|NCT01525602|11703498|FG002|Overall Study|Physician Decision|0
7426403|NCT01525602|11703499|FG003|Overall Study|Physician Decision|0
7426404|NCT01525602|11703500|FG004|Overall Study|Physician Decision|3
7426405|NCT01525602|11703501|FG005|Overall Study|Physician Decision|0
7426406|NCT01525602|11703502|FG006|Overall Study|Physician Decision|1
7426407|NCT01525602|11703503|FG007|Overall Study|Physician Decision|0
7426408|NCT01525602|11703496|FG000|Overall Study|Death|0
7426409|NCT01525602|11703497|FG001|Overall Study|Death|0
7426410|NCT01525602|11703498|FG002|Overall Study|Death|0
7426411|NCT01525602|11703499|FG003|Overall Study|Death|0
7426412|NCT01525602|11703500|FG004|Overall Study|Death|1
7426413|NCT01525602|11703501|FG005|Overall Study|Death|1
7426414|NCT01525602|11703502|FG006|Overall Study|Death|0
7426415|NCT01525602|11703503|FG007|Overall Study|Death|0
7426416|NCT01525602|11703496|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
7426417|NCT01525602|11703497|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
7426418|NCT01525602|11703498|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
7426419|NCT01525602|11703499|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
7426420|NCT01525602|11703500|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
7426421|NCT01525602|11703501|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
7426422|NCT01525602|11703502|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
7426423|NCT01525602|11703503|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
7426424|NCT01525615|11703531|FG000|Overall Study|Adverse Event|11
7426425|NCT01525615|11703532|FG001|Overall Study|Adverse Event|7
7426426|NCT01525615|11703533|FG002|Overall Study|Adverse Event|5
7426427|NCT01525615|11703531|FG000|Overall Study|Lost to Follow-up|1
7426428|NCT01525615|11703532|FG001|Overall Study|Lost to Follow-up|0
7426429|NCT01525615|11703533|FG002|Overall Study|Lost to Follow-up|0
7426430|NCT01525615|11703531|FG000|Overall Study|Withdrawal by Subject|1
7426431|NCT01525615|11703532|FG001|Overall Study|Withdrawal by Subject|0
7426432|NCT01525615|11703533|FG002|Overall Study|Withdrawal by Subject|0
7426433|NCT01525615|11703531|FG000|Overall Study|Other reason not described above|1
7426434|NCT01525615|11703532|FG001|Overall Study|Other reason not described above|0
7426435|NCT01525615|11703533|FG002|Overall Study|Other reason not described above|1
7426436|NCT01525628|11703546|FG000|Overall Study|Adverse Event|1
7426437|NCT01525628|11703547|FG001|Overall Study|Adverse Event|1
7426438|NCT01525628|11703548|FG002|Overall Study|Adverse Event|2
7426439|NCT01525628|11703549|FG003|Overall Study|Adverse Event|0
7426440|NCT01525628|11703550|FG004|Overall Study|Adverse Event|1
7426441|NCT01525628|11703546|FG000|Overall Study|Lack of Efficacy|0
7426442|NCT01525628|11703547|FG001|Overall Study|Lack of Efficacy|2
7426443|NCT01525628|11703548|FG002|Overall Study|Lack of Efficacy|2
7426444|NCT01525628|11703549|FG003|Overall Study|Lack of Efficacy|1
7426445|NCT01525628|11703550|FG004|Overall Study|Lack of Efficacy|2
7557652|NCT03100942|11922040|FG003|Randomized Treatment Period|Adverse Event|0
7557653|NCT03100942|11922041|FG004|Randomized Treatment Period|Adverse Event|0
7557654|NCT03100942|11922042|FG005|Randomized Treatment Period|Adverse Event|0
7557655|NCT03100942|11922043|FG006|Randomized Treatment Period|Adverse Event|0
7557656|NCT03100942|11922037|FG000|Randomized Treatment Period|Investigator's Discretion|2
7557657|NCT03100942|11922038|FG001|Randomized Treatment Period|Investigator's Discretion|1
7557658|NCT03100942|11922039|FG002|Randomized Treatment Period|Investigator's Discretion|0
7328217|NCT00794339|11561025|FG000|Overall Study|Tx prior to ATSM|3
7328218|NCT00794339|11561025|FG000|Overall Study|ATSM imaging not complete or inadequate|3
7328219|NCT00794339|11561025|FG000|Overall Study|Tx not per protocol|1
7328220|NCT00794365|11561046|FG000|Overall Study|Lost to Follow-up|38
7328221|NCT00794365|11561046|FG000|Overall Study|Other|17
7328222|NCT00794365|11561046|FG000|Overall Study|Poor Compliance|11
7328223|NCT00794365|11561046|FG000|Overall Study|Adverse Event|10
7328224|NCT00794365|11561046|FG000|Overall Study|Lack of Efficacy|3
7328225|NCT00794417|11561054|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7328226|NCT00794417|11561055|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7328227|NCT00794417|11561056|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
7328228|NCT00794417|11561057|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
7328229|NCT00794417|11561054|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7328230|NCT00794417|11561055|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
7328231|NCT00794417|11561056|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
7328232|NCT00794417|11561057|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
7328233|NCT00794417|11561054|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
7328234|NCT00794417|11561055|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
7328235|NCT00794417|11561056|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
7328236|NCT00794417|11561057|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
7328237|NCT00794417|11561054|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7328238|NCT00794417|11561055|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7328239|NCT00794417|11561056|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
7328240|NCT00794417|11561057|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
7328241|NCT00794417|11561054|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7328242|NCT00794417|11561055|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7328243|NCT00794417|11561056|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
7328244|NCT00794417|11561057|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
7328245|NCT00794417|11561054|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7328246|NCT00794417|11561055|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7328247|NCT00794417|11561056|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
7328248|NCT00794417|11561057|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
7328249|NCT00794573|11561101|FG000|Overall Study|Death|3
7328250|NCT00794573|11561102|FG001|Overall Study|Death|0
7328251|NCT00794573|11561101|FG000|Overall Study|Withdrawal by Subject|9
7328252|NCT00794573|11561102|FG001|Overall Study|Withdrawal by Subject|12
7328253|NCT00794573|11561101|FG000|Overall Study|Lost to Follow-up|26
7328254|NCT00794573|11561102|FG001|Overall Study|Lost to Follow-up|33
7328255|NCT00794664|11561110|FG000|Treatment Period|Withdrawal by Subject|0
7328256|NCT00794664|11561111|FG001|Treatment Period|Withdrawal by Subject|2
7328257|NCT00794664|11561110|FG000|Treatment Period|Protocol non-compliance|0
7328258|NCT00794664|11561111|FG001|Treatment Period|Protocol non-compliance|1
7328259|NCT00794664|11561110|FG000|Treatment Period|Other|0
7328260|NCT00794664|11561111|FG001|Treatment Period|Other|1
7328261|NCT00794664|11561110|FG000|Treatment Period|Adverse Event|1
7328262|NCT00794664|11561111|FG001|Treatment Period|Adverse Event|8
7328263|NCT00794664|11561110|FG000|Follow-up Period|Other|1
7328264|NCT00794664|11561111|FG001|Follow-up Period|Other|2
7328265|NCT00794664|11561110|FG000|Follow-up Period|Withdrawal by Subject|0
7328266|NCT00794664|11561111|FG001|Follow-up Period|Withdrawal by Subject|2
7328267|NCT00794664|11561110|FG000|Follow-up Period|Protocol non-compliance|0
7328268|NCT00794664|11561111|FG001|Follow-up Period|Protocol non-compliance|1
7328269|NCT00794820|11561117|FG000|Overall Study|Adverse Event|11
7328270|NCT00794820|11561117|FG000|Overall Study|Secondary Malignancies|2
7328271|NCT00794820|11561117|FG000|Overall Study|Resistant Disease|2
7328272|NCT00794820|11561117|FG000|Overall Study|Ineligible/Screen Failure|1
7328273|NCT00794950|11561121|FG000|BCG Induction|Withdrawal by Subject|2
7328274|NCT00794950|11561121|FG000|BCG Induction|ineligible|3
7328275|NCT00794950|11561121|FG000|BCG Induction|noncompliant w. BCG|1
7328276|NCT00794950|11561121|FG000|BCG Induction|Adverse Event|1
7328277|NCT00794950|11561121|FG000|Beginning Sunitinib Treatment|cystectomy|5
7426446|NCT01525628|11703546|FG000|Overall Study|Protocol Violation|0
7426447|NCT01525628|11703547|FG001|Overall Study|Protocol Violation|0
7328278|NCT00794950|11561121|FG000|Beginning Sunitinib Treatment|Physician Decision|5
7328279|NCT00794950|11561121|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
7328280|NCT00794950|11561121|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
7328281|NCT00794963|11561128|FG000|Overall Study|Withdrawal by Subject|1
7328282|NCT00794963|11561129|FG001|Overall Study|Withdrawal by Subject|4
7328283|NCT00795132|11561144|FG000|Overall Study|Death|1
7328284|NCT00795132|11561144|FG000|Overall Study|Relapse|2
7328285|NCT00795184|11561191|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
7328286|NCT00795184|11561192|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
7426448|NCT01525628|11703548|FG002|Overall Study|Protocol Violation|1
7426449|NCT01525628|11703549|FG003|Overall Study|Protocol Violation|0
7426450|NCT01525628|11703550|FG004|Overall Study|Protocol Violation|0
7557659|NCT03100942|11922040|FG003|Randomized Treatment Period|Investigator's Discretion|0
7557660|NCT03100942|11922041|FG004|Randomized Treatment Period|Investigator's Discretion|0
7557661|NCT03100942|11922042|FG005|Randomized Treatment Period|Investigator's Discretion|0
7426451|NCT01525628|11703546|FG000|Overall Study|Lost to Follow-up|1
7426452|NCT01525628|11703547|FG001|Overall Study|Lost to Follow-up|1
7426453|NCT01525628|11703548|FG002|Overall Study|Lost to Follow-up|0
7426454|NCT01525628|11703549|FG003|Overall Study|Lost to Follow-up|0
7426455|NCT01525628|11703550|FG004|Overall Study|Lost to Follow-up|0
7426456|NCT01525628|11703546|FG000|Overall Study|Withdrawal by Subject|0
7426457|NCT01525628|11703547|FG001|Overall Study|Withdrawal by Subject|1
7426458|NCT01525628|11703548|FG002|Overall Study|Withdrawal by Subject|0
7426459|NCT01525628|11703549|FG003|Overall Study|Withdrawal by Subject|0
7426460|NCT01525628|11703550|FG004|Overall Study|Withdrawal by Subject|0
7426461|NCT01525628|11703546|FG000|Overall Study|Other reason not defined above|0
7426462|NCT01525628|11703547|FG001|Overall Study|Other reason not defined above|0
7426463|NCT01525628|11703548|FG002|Overall Study|Other reason not defined above|0
7426464|NCT01525628|11703549|FG003|Overall Study|Other reason not defined above|3
7426465|NCT01525628|11703550|FG004|Overall Study|Other reason not defined above|0
7426466|NCT01525641|11703564|FG000|Overall Study|Case report form not collected|25
7426467|NCT01525641|11703564|FG000|Overall Study|No visit since the first visit|16
7426468|NCT01525641|11703564|FG000|Overall Study|Adverse Event|73
7426469|NCT01525641|11703564|FG000|Overall Study|Lack of Efficacy|24
7426470|NCT01525641|11703564|FG000|Overall Study|Improvement|5
7426471|NCT01525641|11703564|FG000|Overall Study|Lost to follow-up (relocation)|1
7426472|NCT01525641|11703564|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
7426473|NCT01525641|11703564|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
7426474|NCT01525641|11703564|FG000|Overall Study|Other than stated above|7
7426475|NCT01525849|11703585|FG000|Overall Study|Lost to Follow-up|3
7426476|NCT01525849|11703586|FG001|Overall Study|Lost to Follow-up|2
7426477|NCT01525849|11703585|FG000|Overall Study|Withdrawal by Subject|1
7426478|NCT01525849|11703586|FG001|Overall Study|Withdrawal by Subject|9
7426479|NCT01525849|11703585|FG000|Overall Study|Unrelated medical issue (not treated)|1
7426480|NCT01525849|11703586|FG001|Overall Study|Unrelated medical issue (not treated)|2
7426481|NCT01525849|11703585|FG000|Overall Study|Anatomic exclusion criteria identified|0
7426482|NCT01525849|11703586|FG001|Overall Study|Anatomic exclusion criteria identified|3
7426483|NCT01525875|11703598|FG000|Placebo-controlled Period|Withdrawal by Subject|1
7426484|NCT01525875|11703599|FG001|Placebo-controlled Period|Withdrawal by Subject|2
7426485|NCT01525875|11703598|FG000|Open-label Period|Lost to Follow-up|0
7426486|NCT01525875|11703599|FG001|Open-label Period|Lost to Follow-up|2
7426487|NCT01526057|11703608|FG000|Overall Study|Withdrawal by Subject|3
7426488|NCT01526057|11703609|FG001|Overall Study|Withdrawal by Subject|2
7426489|NCT01526057|11703610|FG002|Overall Study|Withdrawal by Subject|2
7426490|NCT01526057|11703608|FG000|Overall Study|Adverse Event|3
7426491|NCT01526057|11703609|FG001|Overall Study|Adverse Event|1
7557662|NCT03100942|11922043|FG006|Randomized Treatment Period|Investigator's Discretion|0
7557663|NCT03100942|11922037|FG000|Randomized Treatment Period|Protocol Violation|0
7557664|NCT03100942|11922038|FG001|Randomized Treatment Period|Protocol Violation|1
7557665|NCT03100942|11922039|FG002|Randomized Treatment Period|Protocol Violation|1
7557666|NCT03100942|11922040|FG003|Randomized Treatment Period|Protocol Violation|1
7557667|NCT03100942|11922041|FG004|Randomized Treatment Period|Protocol Violation|0
7557668|NCT03100942|11922042|FG005|Randomized Treatment Period|Protocol Violation|0
7557669|NCT03100942|11922043|FG006|Randomized Treatment Period|Protocol Violation|0
7557670|NCT03100942|11922037|FG000|Randomized Treatment Period|Lost to Follow-up|0
7557671|NCT03100942|11922038|FG001|Randomized Treatment Period|Lost to Follow-up|0
7557672|NCT03100942|11922039|FG002|Randomized Treatment Period|Lost to Follow-up|1
7557673|NCT03100942|11922040|FG003|Randomized Treatment Period|Lost to Follow-up|0
7557674|NCT03100942|11922041|FG004|Randomized Treatment Period|Lost to Follow-up|0
7557675|NCT03100942|11922042|FG005|Randomized Treatment Period|Lost to Follow-up|0
7557676|NCT03100942|11922043|FG006|Randomized Treatment Period|Lost to Follow-up|0
7557677|NCT03100942|11922037|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7328287|NCT00795509|11561254|FG000|Overall Study|Protocol Violation|31
7426492|NCT01526057|11703610|FG002|Overall Study|Adverse Event|1
7426493|NCT01526057|11703608|FG000|Overall Study|Death|1
7426494|NCT01526057|11703609|FG001|Overall Study|Death|0
7426495|NCT01526057|11703610|FG002|Overall Study|Death|0
7328288|NCT00795535|11561258|FG000|Overall Study|incomplete data and technical problems|20
7328289|NCT00795600|11561264|FG000|Overall Study|Adverse Event|1
7426496|NCT01526057|11703608|FG000|Overall Study|Lost to Follow-up|1
7426497|NCT01526057|11703609|FG001|Overall Study|Lost to Follow-up|0
7426498|NCT01526057|11703610|FG002|Overall Study|Lost to Follow-up|1
7426499|NCT01526057|11703608|FG000|Overall Study|Other|1
7426500|NCT01526057|11703609|FG001|Overall Study|Other|0
7426501|NCT01526057|11703610|FG002|Overall Study|Other|1
7426502|NCT01526057|11703608|FG000|Overall Study|Protocol Violation|0
7426503|NCT01526057|11703609|FG001|Overall Study|Protocol Violation|0
7426504|NCT01526057|11703610|FG002|Overall Study|Protocol Violation|1
7426505|NCT01526148|11703620|FG000|Overall Study|Adverse Event|6
7426506|NCT01526148|11703621|FG001|Overall Study|Adverse Event|5
7426507|NCT01526148|11703620|FG000|Overall Study|Lost to Follow-up|3
7426508|NCT01526148|11703621|FG001|Overall Study|Lost to Follow-up|6
7426509|NCT01526148|11703620|FG000|Overall Study|Withdrawal by Subject|2
7426510|NCT01526148|11703621|FG001|Overall Study|Withdrawal by Subject|0
7426511|NCT01526148|11703620|FG000|Overall Study|Unstable Medical Condition|1
7426512|NCT01526148|11703621|FG001|Overall Study|Unstable Medical Condition|0
7426513|NCT01526148|11703620|FG000|Overall Study|Unable to discontinue concomitant med|1
7426514|NCT01526148|11703621|FG001|Overall Study|Unable to discontinue concomitant med|0
7426515|NCT01526148|11703620|FG000|Overall Study|Moved out of state|1
7426516|NCT01526148|11703621|FG001|Overall Study|Moved out of state|0
7426517|NCT01526148|11703620|FG000|Overall Study|Incarcerated|0
7426518|NCT01526148|11703621|FG001|Overall Study|Incarcerated|2
7426519|NCT01526551|11703679|FG000|Overall Study|Lack of returned parental consent form|424
7426520|NCT01526733|11703704|FG000|Phase 1|Protocol Violation|1
7426521|NCT01526733|11703705|FG001|Phase 1|Protocol Violation|0
7426522|NCT01526733|11703704|FG000|Phase 1|Withdrawal by Subject|1
7426523|NCT01526733|11703705|FG001|Phase 1|Withdrawal by Subject|1
7426524|NCT01526785|11703712|FG000|Overall Study|Study Terminated by Sponsor|8
7426525|NCT01526785|11703712|FG000|Overall Study|Death|2
7426526|NCT01526785|11703712|FG000|Overall Study|Physician Decision|1
7426527|NCT01526785|11703712|FG000|Overall Study|Withdrawal by Subject|2
7426528|NCT01526889|11703718|FG000|Treatment Period|Adverse Event|2
7426529|NCT01526889|11703719|FG001|Treatment Period|Adverse Event|0
7426587|NCT01527006|11703802|FG001|Core Study|Adverse Event|2
7426530|NCT01526889|11703718|FG000|Treatment Extension Period|Administrative problems|1
7426531|NCT01526889|11703719|FG001|Treatment Extension Period|Administrative problems|0
7426532|NCT01526928|11703738|FG000|Overall Study|Progressive Disease|35
7426533|NCT01526928|11703739|FG001|Overall Study|Progressive Disease|17
7426534|NCT01526928|11703740|FG002|Overall Study|Progressive Disease|150
7531983|NCT02660983|11876994|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
7426535|NCT01526928|11703741|FG003|Overall Study|Progressive Disease|182
7426536|NCT01526928|11703742|FG004|Overall Study|Progressive Disease|76
7426537|NCT01526928|11703743|FG005|Overall Study|Progressive Disease|4
7426538|NCT01526928|11703738|FG000|Overall Study|Adverse Event|2
7426539|NCT01526928|11703739|FG001|Overall Study|Adverse Event|1
7426540|NCT01526928|11703740|FG002|Overall Study|Adverse Event|29
7426541|NCT01526928|11703741|FG003|Overall Study|Adverse Event|40
7531984|NCT02660983|11876993|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7531985|NCT02660983|11876994|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
7531986|NCT02660983|11876993|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
7531987|NCT02660983|11876994|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
7557678|NCT03100942|11922038|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7426542|NCT01526928|11703742|FG004|Overall Study|Adverse Event|13
7426543|NCT01526928|11703743|FG005|Overall Study|Adverse Event|2
7426544|NCT01526928|11703738|FG000|Overall Study|Death|0
7426545|NCT01526928|11703739|FG001|Overall Study|Death|0
7426546|NCT01526928|11703740|FG002|Overall Study|Death|3
7426547|NCT01526928|11703741|FG003|Overall Study|Death|0
7426548|NCT01526928|11703742|FG004|Overall Study|Death|0
7426549|NCT01526928|11703743|FG005|Overall Study|Death|0
7426550|NCT01526928|11703738|FG000|Overall Study|Withdrawal by Subject|1
7531988|NCT02660983|11876993|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
7557679|NCT03100942|11922039|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7557680|NCT03100942|11922040|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
7557681|NCT03100942|11922041|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7557682|NCT03100942|11922042|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7557683|NCT03100942|11922043|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
7426551|NCT01526928|11703739|FG001|Overall Study|Withdrawal by Subject|0
7426552|NCT01526928|11703740|FG002|Overall Study|Withdrawal by Subject|13
7426553|NCT01526928|11703741|FG003|Overall Study|Withdrawal by Subject|11
7426554|NCT01526928|11703742|FG004|Overall Study|Withdrawal by Subject|3
7426555|NCT01526928|11703743|FG005|Overall Study|Withdrawal by Subject|0
7426556|NCT01526928|11703738|FG000|Overall Study|Physician Decision|0
7426557|NCT01526928|11703739|FG001|Overall Study|Physician Decision|0
7426558|NCT01526928|11703740|FG002|Overall Study|Physician Decision|2
7426559|NCT01526928|11703741|FG003|Overall Study|Physician Decision|5
7426560|NCT01526928|11703742|FG004|Overall Study|Physician Decision|0
7426561|NCT01526928|11703743|FG005|Overall Study|Physician Decision|0
7426562|NCT01526928|11703738|FG000|Overall Study|Other Reason|0
7426563|NCT01526928|11703739|FG001|Overall Study|Other Reason|1
7426564|NCT01526928|11703740|FG002|Overall Study|Other Reason|11
7426565|NCT01526928|11703741|FG003|Overall Study|Other Reason|4
7426566|NCT01526928|11703742|FG004|Overall Study|Other Reason|1
7426567|NCT01526928|11703743|FG005|Overall Study|Other Reason|0
7426568|NCT01526928|11703738|FG000|Overall Study|Lost to Follow-up|0
7426569|NCT01526928|11703739|FG001|Overall Study|Lost to Follow-up|0
7426570|NCT01526928|11703740|FG002|Overall Study|Lost to Follow-up|0
7426571|NCT01526928|11703741|FG003|Overall Study|Lost to Follow-up|1
7426572|NCT01526928|11703742|FG004|Overall Study|Lost to Follow-up|0
7426573|NCT01526928|11703743|FG005|Overall Study|Lost to Follow-up|0
7426574|NCT01526928|11703738|FG000|Overall Study|Protocol Deviation|0
7426575|NCT01526928|11703739|FG001|Overall Study|Protocol Deviation|0
7426576|NCT01526928|11703740|FG002|Overall Study|Protocol Deviation|0
7426577|NCT01526928|11703741|FG003|Overall Study|Protocol Deviation|2
7426578|NCT01526928|11703742|FG004|Overall Study|Protocol Deviation|0
7328290|NCT00795600|11561265|FG001|Overall Study|Adverse Event|1
7328291|NCT00795600|11561264|FG000|Overall Study|Protocol Violation|1
7426579|NCT01526928|11703743|FG005|Overall Study|Protocol Deviation|0
7426580|NCT01526928|11703738|FG000|Overall Study|Missing|0
7426581|NCT01526928|11703739|FG001|Overall Study|Missing|0
7328292|NCT00795600|11561265|FG001|Overall Study|Protocol Violation|2
7328293|NCT00795600|11561264|FG000|Overall Study|Withdrawal by Subject|1
7328294|NCT00795600|11561265|FG001|Overall Study|Withdrawal by Subject|0
7328295|NCT00795600|11561264|FG000|Overall Study|Unclassified|1
7328296|NCT00795600|11561265|FG001|Overall Study|Unclassified|1
7328297|NCT00795639|11561273|FG000|Overall Study|Death|1
7328298|NCT00795639|11561274|FG001|Overall Study|Death|6
7328299|NCT00795639|11561273|FG000|Overall Study|Withdrawal by Subject|1
7328300|NCT00795639|11561274|FG001|Overall Study|Withdrawal by Subject|3
7328301|NCT00795639|11561273|FG000|Overall Study|Pregnancy|1
7328302|NCT00795639|11561274|FG001|Overall Study|Pregnancy|0
7328303|NCT00795639|11561273|FG000|Overall Study|Adverse Event|5
7328304|NCT00795639|11561274|FG001|Overall Study|Adverse Event|2
7426582|NCT01526928|11703740|FG002|Overall Study|Missing|1
7426583|NCT01526928|11703741|FG003|Overall Study|Missing|0
7426584|NCT01526928|11703742|FG004|Overall Study|Missing|2
7426585|NCT01526928|11703743|FG005|Overall Study|Missing|0
7426586|NCT01527006|11703801|FG000|Core Study|Adverse Event|0
7426588|NCT01527006|11703801|FG000|Core Study|Lost to Follow-up|0
7426589|NCT01527006|11703802|FG001|Core Study|Lost to Follow-up|1
7426590|NCT01527006|11703801|FG000|Core Study|Subject Choice|1
7426591|NCT01527006|11703802|FG001|Core Study|Subject Choice|0
7426592|NCT01527006|11703801|FG000|Core Study|Inadequate Therapeutic Effect|1
7426593|NCT01527006|11703802|FG001|Core Study|Inadequate Therapeutic Effect|0
7426594|NCT01527006|11703801|FG000|Core Study|Withdrawal by Subject|0
7426595|NCT01527006|11703802|FG001|Core Study|Withdrawal by Subject|1
7426596|NCT01527006|11703801|FG000|Core Study|Other|0
7426597|NCT01527006|11703802|FG001|Core Study|Other|2
7426598|NCT01527006|11703801|FG000|Extension Phase|Adverse Event|4
7426599|NCT01527006|11703802|FG001|Extension Phase|Adverse Event|2
7426600|NCT01527006|11703801|FG000|Extension Phase|Lost to Follow-up|0
7426601|NCT01527006|11703802|FG001|Extension Phase|Lost to Follow-up|1
7426602|NCT01527006|11703801|FG000|Extension Phase|Subject Choice|1
7426603|NCT01527006|11703802|FG001|Extension Phase|Subject Choice|1
7426604|NCT01527006|11703801|FG000|Extension Phase|Inadequate therapeutic effect|1
7426605|NCT01527006|11703802|FG001|Extension Phase|Inadequate therapeutic effect|1
7426606|NCT01527006|11703801|FG000|Extension Phase|Other|0
7426607|NCT01527006|11703802|FG001|Extension Phase|Other|3
7426608|NCT01527110|11703827|FG000|Overall Study|Adverse Event|1
7426609|NCT01527357|11703842|FG000|Overall Study|Death|8
7426610|NCT01527357|11703843|FG001|Overall Study|Death|2
7426611|NCT01527357|11703842|FG000|Overall Study|Lost to Follow-up|6
7426612|NCT01527357|11703843|FG001|Overall Study|Lost to Follow-up|4
7426613|NCT01527357|11703842|FG000|Overall Study|Withdrew Consent|1
7426614|NCT01527357|11703843|FG001|Overall Study|Withdrew Consent|1
7426615|NCT01527357|11703842|FG000|Overall Study|Non-compliance|0
7426616|NCT01527357|11703843|FG001|Overall Study|Non-compliance|1
7426617|NCT01527357|11703842|FG000|Overall Study|No Day 29 Visit|0
7426618|NCT01527357|11703843|FG001|Overall Study|No Day 29 Visit|1
7426619|NCT01527357|11703842|FG000|Overall Study|Did Not Receive Treatment|2
7426620|NCT01527357|11703843|FG001|Overall Study|Did Not Receive Treatment|0
7328305|NCT00795639|11561273|FG000|Overall Study|Other|0
7328306|NCT00795639|11561274|FG001|Overall Study|Other|2
7426621|NCT01527370|11703849|FG000|Overall Study|Withdrawal by Subject|4
7426622|NCT01527370|11703849|FG000|Overall Study|Physician Decision|1
7426623|NCT01527370|11703849|FG000|Overall Study|Death|1
7426624|NCT01527383|11703855|FG000|Overall Study|Adverse Event|5
7426625|NCT01527383|11703856|FG001|Overall Study|Adverse Event|0
7426626|NCT01527383|11703855|FG000|Overall Study|Lost to Follow-up|3
7426627|NCT01527383|11703856|FG001|Overall Study|Lost to Follow-up|0
7426628|NCT01527383|11703855|FG000|Overall Study|Physician Decision|2
7426629|NCT01527383|11703856|FG001|Overall Study|Physician Decision|0
7426630|NCT01527383|11703855|FG000|Overall Study|Pregnancy|1
7426631|NCT01527383|11703856|FG001|Overall Study|Pregnancy|0
7426632|NCT01527383|11703855|FG000|Overall Study|Protocol Violation|1
7426633|NCT01527383|11703856|FG001|Overall Study|Protocol Violation|0
7426634|NCT01527383|11703855|FG000|Overall Study|Screen failure|1
7426635|NCT01527383|11703856|FG001|Overall Study|Screen failure|0
7426636|NCT01527383|11703855|FG000|Overall Study|Participant moved|0
7426637|NCT01527383|11703856|FG001|Overall Study|Participant moved|1
7531989|NCT02660983|11876994|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
7531990|NCT02660983|11876993|FG000|Open Label Extension Phase (24 Weeks)|Other|0
7557684|NCT03100942|11922037|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
7557685|NCT03100942|11922038|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
7557686|NCT03100942|11922039|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
7328307|NCT00795639|11561273|FG000|Overall Study|Terminated by sponsor|13
7328308|NCT00795639|11561274|FG001|Overall Study|Terminated by sponsor|12
7328309|NCT00795639|11561273|FG000|Overall Study|Randomized and not treated|0
7328310|NCT00795639|11561274|FG001|Overall Study|Randomized and not treated|1
7328311|NCT00795704|11561282|FG000|Overall Study|Withdrawal by Subject|3
7328312|NCT00795704|11561283|FG001|Overall Study|Withdrawal by Subject|2
7328313|NCT00795704|11561282|FG000|Overall Study|Adverse Event|1
7328314|NCT00795704|11561283|FG001|Overall Study|Adverse Event|1
7557687|NCT03100942|11922040|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
7557688|NCT03100942|11922041|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
7557689|NCT03100942|11922042|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
7557690|NCT03100942|11922043|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
7557691|NCT03101020|11922067|FG000|Overall Study|Lack of time to participate|1
7557692|NCT03101020|11922068|FG001|Overall Study|Lack of time to participate|0
7557693|NCT03101020|11922067|FG000|Overall Study|Ran over by a car|0
7557694|NCT03101020|11922068|FG001|Overall Study|Ran over by a car|1
7557695|NCT03101020|11922067|FG000|Overall Study|Withdrawal by Subject|0
7557696|NCT03101020|11922068|FG001|Overall Study|Withdrawal by Subject|2
7557697|NCT03101150|11922098|FG000|Overall Study|Lost to Follow-up|2
7557698|NCT03101150|11922099|FG001|Overall Study|Lost to Follow-up|4
7557699|NCT03101150|11922098|FG000|Overall Study|Miscarriage|3
7557700|NCT03101150|11922099|FG001|Overall Study|Miscarriage|6
7557701|NCT03101241|11922107|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
7557702|NCT03101241|11922108|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
7557703|NCT03101241|11922107|FG000|Overall Study|Participant withdrew consent|3
7557704|NCT03101241|11922108|FG001|Overall Study|Participant withdrew consent|1
7557705|NCT03101241|11922107|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
7426661|NCT01527500|11703881|FG001|Part B|Adverse Event|0
7557706|NCT03101241|11922108|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
7557707|NCT03101241|11922107|FG000|Overall Study|Lost to Follow-up|2
7557708|NCT03101241|11922108|FG001|Overall Study|Lost to Follow-up|0
7328315|NCT00795717|11561291|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
7328316|NCT00795717|11561292|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
7328317|NCT00795717|11561291|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7328318|NCT00795717|11561292|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
7328319|NCT00795717|11561291|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
7328320|NCT00795717|11561292|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
7557709|NCT03101241|11922107|FG000|Overall Study|Lack of Efficacy|0
7557710|NCT03101241|11922108|FG001|Overall Study|Lack of Efficacy|1
7557711|NCT03101241|11922107|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
7557712|NCT03101241|11922108|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
7557713|NCT03101267|11922117|FG000|Primary Study Period|Withdrawal by Subject|1
7557714|NCT03101267|11922118|FG001|Primary Study Period|Withdrawal by Subject|2
7557715|NCT03101267|11922119|FG002|Primary Study Period|Withdrawal by Subject|3
7557716|NCT03101267|11922117|FG000|Primary Study Period|Miscellaneous|2
7557717|NCT03101267|11922118|FG001|Primary Study Period|Miscellaneous|0
7557718|NCT03101267|11922119|FG002|Primary Study Period|Miscellaneous|0
7557719|NCT03101293|11922129|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
7557720|NCT03101293|11922130|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
7557721|NCT03101358|11922140|FG000|Overall Study|Non-compliance with study schedule|1
7557722|NCT03101358|11922141|FG001|Overall Study|Non-compliance with study schedule|0
7557723|NCT03101358|11922142|FG002|Overall Study|Non-compliance with study schedule|0
7557724|NCT03101358|11922143|FG003|Overall Study|Non-compliance with study schedule|1
7557725|NCT03101358|11922140|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7557726|NCT03101358|11922141|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7426638|NCT01527383|11703855|FG000|Overall Study|Withdrawal by Subject|2
7426639|NCT01527383|11703856|FG001|Overall Study|Withdrawal by Subject|3
7426640|NCT01527487|11703864|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
7426641|NCT01527487|11703865|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
7426642|NCT01527487|11703864|FG000|Overall Study|Disease Progression|4
7426643|NCT01527487|11703865|FG001|Overall Study|Disease Progression|1
7426644|NCT01527487|11703864|FG000|Overall Study|Adverse Event|1
7531991|NCT02660983|11876994|FG001|Open Label Extension Phase (24 Weeks)|Other|1
7531992|NCT02661061|11877003|FG000|Overall Study|Lack of Efficacy|1
7531993|NCT02661061|11877004|FG001|Overall Study|Lack of Efficacy|1
7531994|NCT02661061|11877003|FG000|Overall Study|Withdrawal by Subject|1
7531995|NCT02661061|11877004|FG001|Overall Study|Withdrawal by Subject|1
7531996|NCT02661178|11877034|FG000|Part 1|Protocol Violation|1
7531997|NCT02661178|11877035|FG001|Part 1|Protocol Violation|0
7531998|NCT02661178|11877036|FG002|Part 1|Protocol Violation|0
7531999|NCT02661178|11877037|FG003|Part 1|Protocol Violation|0
7532000|NCT02661178|11877038|FG004|Part 1|Protocol Violation|0
7532001|NCT02661178|11877039|FG005|Part 1|Protocol Violation|0
7328321|NCT00795717|11561291|FG000|Phase II|too busy|0
7328322|NCT00795717|11561292|FG001|Phase II|too busy|1
7328323|NCT00795821|11561305|FG000|Acute Treatment Phase|Adverse Event|23
7328324|NCT00795821|11561306|FG001|Acute Treatment Phase|Adverse Event|4
7328325|NCT00795821|11561305|FG000|Acute Treatment Phase|Death|1
7328326|NCT00795821|11561306|FG001|Acute Treatment Phase|Death|0
7328327|NCT00795821|11561305|FG000|Acute Treatment Phase|Lack of Efficacy|5
7328328|NCT00795821|11561306|FG001|Acute Treatment Phase|Lack of Efficacy|2
7328329|NCT00795821|11561305|FG000|Acute Treatment Phase|Lost to Follow-up|9
7328330|NCT00795821|11561306|FG001|Acute Treatment Phase|Lost to Follow-up|12
7328331|NCT00795821|11561305|FG000|Acute Treatment Phase|Physician Decision|1
7328332|NCT00795821|11561306|FG001|Acute Treatment Phase|Physician Decision|1
7328333|NCT00795821|11561305|FG000|Acute Treatment Phase|Protocol Violation|1
7328334|NCT00795821|11561306|FG001|Acute Treatment Phase|Protocol Violation|2
7328335|NCT00795821|11561305|FG000|Acute Treatment Phase|Withdrawal by Subject|16
7328336|NCT00795821|11561306|FG001|Acute Treatment Phase|Withdrawal by Subject|10
7328337|NCT00795821|11561305|FG000|Long-term Extension Phase|Adverse Event|25
7328338|NCT00795821|11561306|FG001|Long-term Extension Phase|Adverse Event|32
7328339|NCT00795821|11561305|FG000|Long-term Extension Phase|Lack of Efficacy|16
7328340|NCT00795821|11561306|FG001|Long-term Extension Phase|Lack of Efficacy|12
7328341|NCT00795821|11561305|FG000|Long-term Extension Phase|Lost to Follow-up|20
7426645|NCT01527487|11703865|FG001|Overall Study|Adverse Event|1
7426646|NCT01527487|11703864|FG000|Overall Study|Death|0
7426647|NCT01527487|11703865|FG001|Overall Study|Death|1
7426648|NCT01527500|11703880|FG000|Part A|Administrative|11
7426649|NCT01527500|11703881|FG001|Part A|Administrative|7
7426650|NCT01527500|11703880|FG000|Part A|Adverse Event|4
7426651|NCT01527500|11703881|FG001|Part A|Adverse Event|2
7426652|NCT01527500|11703880|FG000|Part A|Death|4
7426653|NCT01527500|11703881|FG001|Part A|Death|1
7426654|NCT01527500|11703880|FG000|Part A|Lost to Follow-up|0
7426655|NCT01527500|11703881|FG001|Part A|Lost to Follow-up|1
7426656|NCT01527500|11703880|FG000|Part A|Protocol Deviation|9
7426657|NCT01527500|11703881|FG001|Part A|Protocol Deviation|2
7426658|NCT01527500|11703880|FG000|Part A|Withdrawal by Subject|2
7426659|NCT01527500|11703881|FG001|Part A|Withdrawal by Subject|0
7426660|NCT01527500|11703880|FG000|Part B|Adverse Event|1
7426662|NCT01527682|11703908|FG000|Overall Study|Protocol Violation|8
7426663|NCT01528033|11703914|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
7426664|NCT01528033|11703915|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
7426665|NCT01528033|11703914|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7426666|NCT01528033|11703915|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
7426667|NCT01528033|11703914|FG000|Primary Endpoint Assessment ITT|Death|2
7426668|NCT01528033|11703915|FG001|Primary Endpoint Assessment ITT|Death|2
7426669|NCT01528033|11703914|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
7426670|NCT01528033|11703915|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
7557727|NCT03101358|11922142|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
7557728|NCT03101358|11922143|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
7557729|NCT03101358|11922140|FG000|Overall Study|Physician Decision|1
7557730|NCT03101358|11922141|FG001|Overall Study|Physician Decision|0
7557731|NCT03101358|11922142|FG002|Overall Study|Physician Decision|0
7557732|NCT03101358|11922143|FG003|Overall Study|Physician Decision|3
7557733|NCT03101358|11922140|FG000|Overall Study|Adverse Event|0
7557734|NCT03101358|11922141|FG001|Overall Study|Adverse Event|0
7557735|NCT03101358|11922142|FG002|Overall Study|Adverse Event|1
7557736|NCT03101358|11922143|FG003|Overall Study|Adverse Event|0
7557737|NCT03101358|11922140|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7557738|NCT03101358|11922141|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7557739|NCT03101358|11922142|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
7557740|NCT03101358|11922143|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
7328342|NCT00795821|11561306|FG001|Long-term Extension Phase|Lost to Follow-up|16
7426671|NCT01528033|11703914|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
7426672|NCT01528033|11703915|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
7426673|NCT01528033|11703914|FG000|Follow Up|No data available|46
7328343|NCT00795821|11561305|FG000|Long-term Extension Phase|Physician Decision|1
7328344|NCT00795821|11561306|FG001|Long-term Extension Phase|Physician Decision|2
7328345|NCT00795821|11561305|FG000|Long-term Extension Phase|Protocol Violation|3
7328346|NCT00795821|11561306|FG001|Long-term Extension Phase|Protocol Violation|5
7328347|NCT00795821|11561305|FG000|Long-term Extension Phase|Withdrawal by Subject|25
7328348|NCT00795821|11561306|FG001|Long-term Extension Phase|Withdrawal by Subject|25
7328349|NCT00795821|11561305|FG000|Taper Phase|Adverse Event|2
7328350|NCT00795821|11561306|FG001|Taper Phase|Adverse Event|0
7426674|NCT01528033|11703915|FG001|Follow Up|No data available|44
7426675|NCT01528072|11703921|FG000|Overall Study|Withdrawal by Subject|5
7426676|NCT01528072|11703921|FG000|Overall Study|Physician Decision|1
7426677|NCT01528072|11703921|FG000|Overall Study|Determined not eligible by AEAC|1
7426678|NCT01528072|11703921|FG000|Overall Study|Missed Visit|2
7426679|NCT01528072|11703921|FG000|Overall Study|Lost to Follow-up|5
7426680|NCT01528072|11703921|FG000|Overall Study|Explanted|2
7426681|NCT01528072|11703921|FG000|Overall Study|Site Closure|4
7426682|NCT01528072|11703921|FG000|Overall Study|Death|2
7426683|NCT01528072|11703921|FG000|Overall Study|Early Termination of Study|52
7426684|NCT01528215|11703966|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
7426685|NCT01528215|11703967|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
7426686|NCT01528215|11703966|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7426687|NCT01528215|11703967|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
7426688|NCT01528215|11703966|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
7426689|NCT01528215|11703967|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
7426690|NCT01528215|11703966|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
7426691|NCT01528215|11703967|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
7426692|NCT01528254|11703984|FG000|Overall Study|Administrative problems|96
7426693|NCT01528254|11703985|FG001|Overall Study|Administrative problems|94
7426694|NCT01528254|11703984|FG000|Overall Study|Adverse Event|28
7426695|NCT01528254|11703985|FG001|Overall Study|Adverse Event|44
7426696|NCT01528254|11703984|FG000|Overall Study|Lost to Follow-up|17
7426697|NCT01528254|11703985|FG001|Overall Study|Lost to Follow-up|24
7426698|NCT01528254|11703984|FG000|Overall Study|Death|13
7426699|NCT01528254|11703985|FG001|Overall Study|Death|9
7426700|NCT01528254|11703984|FG000|Overall Study|Protocol deviation|9
7426701|NCT01528254|11703985|FG001|Overall Study|Protocol deviation|19
7426702|NCT01528254|11703984|FG000|Overall Study|New therapy for study indication|8
7426703|NCT01528254|11703985|FG001|Overall Study|New therapy for study indication|6
7426704|NCT01528254|11703984|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7426705|NCT01528254|11703985|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7426706|NCT01528254|11703984|FG000|Overall Study|Withdrawal by Subject|5
7426707|NCT01528254|11703985|FG001|Overall Study|Withdrawal by Subject|4
7426708|NCT01528254|11703984|FG000|Overall Study|Abnormal laboratory value(s)|3
7426709|NCT01528254|11703985|FG001|Overall Study|Abnormal laboratory value(s)|7
7426710|NCT01528254|11703984|FG000|Overall Study|Abnormal test procedure result(s)|1
7426711|NCT01528254|11703985|FG001|Overall Study|Abnormal test procedure result(s)|0
7426712|NCT01528254|11703984|FG000|Overall Study|No longer requires study drug|1
7557741|NCT03101358|11922140|FG000|Overall Study|Lost to Follow-up|1
7557742|NCT03101358|11922141|FG001|Overall Study|Lost to Follow-up|0
7557743|NCT03101358|11922142|FG002|Overall Study|Lost to Follow-up|0
7557744|NCT03101358|11922143|FG003|Overall Study|Lost to Follow-up|1
7557745|NCT03101371|11922156|FG000|Overall Study|Physician Decision|0
7557746|NCT03101371|11922157|FG001|Overall Study|Physician Decision|1
7557747|NCT03101371|11922156|FG000|Overall Study|Lost to Follow-up|1
7557748|NCT03101371|11922157|FG001|Overall Study|Lost to Follow-up|4
7557749|NCT03101371|11922156|FG000|Overall Study|Did not meet eligibility criteria|2
7557750|NCT03101371|11922157|FG001|Overall Study|Did not meet eligibility criteria|1
7557751|NCT03101462|11922165|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
7557752|NCT03101462|11922166|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
7557753|NCT03101514|11922172|FG000|Overall Study|Withdrawal by Subject|4
7557754|NCT03101514|11922172|FG000|Overall Study|Protocol Violation|2
7557755|NCT03101514|11922172|FG000|Overall Study|patient's information was incomplete|1
7557756|NCT03101592|11922179|FG000|Overall Study|participant files could not be located|111
7557757|NCT03101592|11922180|FG001|Overall Study|participant files could not be located|170
7557758|NCT03101592|11922181|FG002|Overall Study|participant files could not be located|118
7574746|NCT03692676|11957890|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
7574747|NCT03692676|11957891|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
7574748|NCT03692676|11957888|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
7574749|NCT03692676|11957889|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
7574750|NCT03692676|11957890|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
7574751|NCT03692676|11957891|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
7574752|NCT03692676|11957888|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
7574753|NCT03692676|11957889|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
7574754|NCT03692676|11957890|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
7574755|NCT03692676|11957891|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
7574756|NCT03692676|11957888|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
7574757|NCT03692676|11957889|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
7574758|NCT03692676|11957890|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
7574759|NCT03692676|11957891|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
7574760|NCT03692676|11957888|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7574761|NCT03692676|11957889|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
7574762|NCT03692676|11957890|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
7574763|NCT03692676|11957891|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
7575483|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
7426713|NCT01528254|11703985|FG001|Overall Study|No longer requires study drug|1
7426714|NCT01528345|11704007|FG000|Overall Study|Adverse Event|10
7426715|NCT01528345|11704008|FG001|Overall Study|Adverse Event|1
7426716|NCT01528345|11704007|FG000|Overall Study|Death|1
7426717|NCT01528345|11704008|FG001|Overall Study|Death|1
7426718|NCT01528345|11704007|FG000|Overall Study|Non-compliance with study treatment|1
7426719|NCT01528345|11704008|FG001|Overall Study|Non-compliance with study treatment|0
7426720|NCT01528345|11704007|FG000|Overall Study|Progressive Disease|26
7426721|NCT01528345|11704008|FG001|Overall Study|Progressive Disease|40
7426722|NCT01528345|11704007|FG000|Overall Study|Study Terminated by Sponsor|4
7426723|NCT01528345|11704008|FG001|Overall Study|Study Terminated by Sponsor|8
7426724|NCT01528345|11704007|FG000|Overall Study|Subject/Guardian Decision|5
7426725|NCT01528345|11704008|FG001|Overall Study|Subject/Guardian Decision|0
7426726|NCT01528605|11704024|FG000|Overall Study|Lost to Follow-up|1
7426727|NCT01528605|11704025|FG001|Overall Study|Lost to Follow-up|0
7426728|NCT01528605|11704026|FG002|Overall Study|Lost to Follow-up|1
7426729|NCT01528605|11704027|FG003|Overall Study|Lost to Follow-up|1
7426730|NCT01528605|11704028|FG004|Overall Study|Lost to Follow-up|0
7426731|NCT01528605|11704029|FG005|Overall Study|Lost to Follow-up|0
7426732|NCT01528605|11704024|FG000|Overall Study|Death|1
7426733|NCT01528605|11704025|FG001|Overall Study|Death|0
7426734|NCT01528605|11704026|FG002|Overall Study|Death|0
7426735|NCT01528605|11704027|FG003|Overall Study|Death|0
7426736|NCT01528605|11704028|FG004|Overall Study|Death|0
7426737|NCT01528605|11704029|FG005|Overall Study|Death|0
7426738|NCT01528709|11704045|FG000|Overall Study|Death|2
7532002|NCT02661178|11877040|FG006|Part 1|Protocol Violation|0
7532003|NCT02661178|11877041|FG007|Part 1|Protocol Violation|0
7426739|NCT01528709|11704046|FG001|Overall Study|Death|0
7426740|NCT01528709|11704045|FG000|Overall Study|Withdrawal by Subject|10
7426741|NCT01528709|11704046|FG001|Overall Study|Withdrawal by Subject|15
7426742|NCT01528709|11704045|FG000|Overall Study|allergy|1
7426743|NCT01528709|11704046|FG001|Overall Study|allergy|0
7426744|NCT01528735|11704054|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7426745|NCT01528735|11704055|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
7426746|NCT01528735|11704054|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
7426747|NCT01528735|11704055|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
7426748|NCT01528787|11704067|FG000|Overall Study|Withdrawal by Subject|0
7426749|NCT01528787|11704068|FG001|Overall Study|Withdrawal by Subject|0
7426750|NCT01528787|11704069|FG002|Overall Study|Withdrawal by Subject|0
7426751|NCT01528787|11704070|FG003|Overall Study|Withdrawal by Subject|1
7426752|NCT01528787|11704067|FG000|Overall Study|Family Emergency|0
7426753|NCT01528787|11704068|FG001|Overall Study|Family Emergency|0
7426754|NCT01528787|11704069|FG002|Overall Study|Family Emergency|1
7426755|NCT01528787|11704070|FG003|Overall Study|Family Emergency|0
7426756|NCT01528969|11704099|FG000|Overall Study|absent from the school at baseline|2
7426757|NCT01528969|11704100|FG001|Overall Study|absent from the school at baseline|0
7426758|NCT01529034|11704106|FG000|Overall Study|Discontinued prior to study treatment|14
7426759|NCT01529034|11704106|FG000|Overall Study|Site closure|62
7426760|NCT01529034|11704106|FG000|Overall Study|Study termination|29
7426761|NCT01529034|11704106|FG000|Overall Study|Withdrawal by Subject|25
7426762|NCT01529034|11704106|FG000|Overall Study|No treated SCs within protocol window|13
7426763|NCT01529034|11704106|FG000|Overall Study|Noncompliance|8
7426764|NCT01529034|11704106|FG000|Overall Study|Caregiver no longer available|7
7426765|NCT01529034|11704106|FG000|Overall Study|Adverse Event|4
7426766|NCT01529034|11704106|FG000|Overall Study|Protocol Violation|4
7426767|NCT01529034|11704106|FG000|Overall Study|Lack of Efficacy|4
7426768|NCT01529034|11704106|FG000|Overall Study|Investigator no longer available|2
7426769|NCT01529034|11704106|FG000|Overall Study|Study drug not available|2
7426770|NCT01529112|11704123|FG000|Overall Study|Adverse Event|2
7426771|NCT01529112|11704124|FG001|Overall Study|Adverse Event|0
7426772|NCT01529112|11704123|FG000|Overall Study|Death|59
7426773|NCT01529112|11704124|FG001|Overall Study|Death|38
7426774|NCT01529112|11704123|FG000|Overall Study|Protocol Violation|1
7426775|NCT01529112|11704124|FG001|Overall Study|Protocol Violation|0
7426776|NCT01529112|11704123|FG000|Overall Study|Withdrawal by Subject|7
7532004|NCT02661178|11877042|FG008|Part 1|Protocol Violation|0
7557759|NCT03102710|11922226|FG000|Overall Study|Dental metal affected MRI scan quality|1
7557760|NCT03102710|11922227|FG001|Overall Study|Dental metal affected MRI scan quality|0
7426777|NCT01529112|11704124|FG001|Overall Study|Withdrawal by Subject|3
7426778|NCT01529268|11704136|FG000|Overall Study|Lost to Follow-up|9
7426779|NCT01529268|11704137|FG001|Overall Study|Lost to Follow-up|3
7426780|NCT01529268|11704136|FG000|Overall Study|Moved|3
7426781|NCT01529268|11704137|FG001|Overall Study|Moved|0
7426782|NCT01529346|11704148|FG000|Overall Study|Lost to Follow-up|2
7426783|NCT01529346|11704149|FG001|Overall Study|Lost to Follow-up|0
7426784|NCT01529346|11704150|FG002|Overall Study|Lost to Follow-up|1
7426785|NCT01529346|11704151|FG003|Overall Study|Lost to Follow-up|0
7426786|NCT01529346|11704152|FG004|Overall Study|Lost to Follow-up|0
7532005|NCT02661178|11877043|FG009|Part 1|Protocol Violation|0
7532006|NCT02661178|11877044|FG010|Part 1|Protocol Violation|0
7532007|NCT02661178|11877045|FG011|Part 1|Protocol Violation|0
7532008|NCT02661178|11877046|FG012|Part 1|Protocol Violation|0
7532009|NCT02661178|11877047|FG013|Part 1|Protocol Violation|0
7532010|NCT02661178|11877048|FG014|Part 1|Protocol Violation|0
7532011|NCT02661217|11877100|FG000|Overall Study|Physician Decision|12
7532012|NCT02661217|11877101|FG001|Overall Study|Physician Decision|15
7532013|NCT02661217|11877100|FG000|Overall Study|Lost to Follow-up|1
7532014|NCT02661217|11877101|FG001|Overall Study|Lost to Follow-up|4
7532015|NCT02661217|11877100|FG000|Overall Study|Protocol Deviation|0
7532016|NCT02661217|11877101|FG001|Overall Study|Protocol Deviation|4
7426787|NCT01529346|11704148|FG000|Overall Study|Other|0
7426788|NCT01529346|11704149|FG001|Overall Study|Other|1
7426789|NCT01529346|11704150|FG002|Overall Study|Other|1
7532017|NCT02661217|11877100|FG000|Overall Study|Non-compliance with study treatment|5
7532018|NCT02661217|11877101|FG001|Overall Study|Non-compliance with study treatment|5
7532019|NCT02661217|11877100|FG000|Overall Study|Death|21
7532020|NCT02661217|11877101|FG001|Overall Study|Death|15
7532021|NCT02661217|11877100|FG000|Overall Study|Adverse Event|10
7532022|NCT02661217|11877101|FG001|Overall Study|Adverse Event|8
7532023|NCT02661217|11877100|FG000|Overall Study|Withdrawal by Subject|15
7426790|NCT01529346|11704151|FG003|Overall Study|Other|0
7426791|NCT01529346|11704152|FG004|Overall Study|Other|0
7426792|NCT01529385|11704167|FG000|Overall Study|Lost to Follow-up|2
7426793|NCT01529385|11704168|FG001|Overall Study|Lost to Follow-up|1
7426794|NCT01529515|11704205|FG000|TRANSITION PHASE|Adverse Event|16
7426795|NCT01529515|11704206|FG001|TRANSITION PHASE|Adverse Event|0
7426796|NCT01529515|11704207|FG002|TRANSITION PHASE|Adverse Event|0
7328351|NCT00795821|11561305|FG000|Taper Phase|Lost to Follow-up|1
7328352|NCT00795821|11561306|FG001|Taper Phase|Lost to Follow-up|0
7328353|NCT00795821|11561305|FG000|Taper Phase|Physician Decision|2
7328354|NCT00795821|11561306|FG001|Taper Phase|Physician Decision|0
7328355|NCT00795821|11561305|FG000|Taper Phase|Withdrawal by Subject|4
7328356|NCT00795821|11561306|FG001|Taper Phase|Withdrawal by Subject|0
7328357|NCT00795886|11561322|FG000|Overall Study|Death|10
7328358|NCT00795951|11561327|FG000|Overall Study|Lost to Follow-up|1
7426797|NCT01529515|11704208|FG003|TRANSITION PHASE|Adverse Event|0
7426798|NCT01529515|11704205|FG000|TRANSITION PHASE|Death|1
7426799|NCT01529515|11704206|FG001|TRANSITION PHASE|Death|0
7426800|NCT01529515|11704207|FG002|TRANSITION PHASE|Death|0
7426801|NCT01529515|11704208|FG003|TRANSITION PHASE|Death|0
7426802|NCT01529515|11704205|FG000|TRANSITION PHASE|Lack of Efficacy|19
7426803|NCT01529515|11704206|FG001|TRANSITION PHASE|Lack of Efficacy|0
7426804|NCT01529515|11704207|FG002|TRANSITION PHASE|Lack of Efficacy|0
7426805|NCT01529515|11704208|FG003|TRANSITION PHASE|Lack of Efficacy|0
7426806|NCT01529515|11704205|FG000|TRANSITION PHASE|Lost to Follow-up|19
7426807|NCT01529515|11704206|FG001|TRANSITION PHASE|Lost to Follow-up|0
7426808|NCT01529515|11704207|FG002|TRANSITION PHASE|Lost to Follow-up|0
7426809|NCT01529515|11704208|FG003|TRANSITION PHASE|Lost to Follow-up|0
7426810|NCT01529515|11704205|FG000|TRANSITION PHASE|Protocol Violation|4
7426811|NCT01529515|11704206|FG001|TRANSITION PHASE|Protocol Violation|0
7426812|NCT01529515|11704207|FG002|TRANSITION PHASE|Protocol Violation|0
7426813|NCT01529515|11704208|FG003|TRANSITION PHASE|Protocol Violation|0
7426814|NCT01529515|11704205|FG000|TRANSITION PHASE|Withdrawal by Subject|51
7426815|NCT01529515|11704206|FG001|TRANSITION PHASE|Withdrawal by Subject|0
7426816|NCT01529515|11704207|FG002|TRANSITION PHASE|Withdrawal by Subject|0
7426817|NCT01529515|11704208|FG003|TRANSITION PHASE|Withdrawal by Subject|0
7426818|NCT01529515|11704205|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
7426819|NCT01529515|11704206|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7426820|NCT01529515|11704207|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7426821|NCT01529515|11704208|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
7426822|NCT01529515|11704205|FG000|TRANSITION PHASE|Other|9
7426823|NCT01529515|11704206|FG001|TRANSITION PHASE|Other|0
7426824|NCT01529515|11704207|FG002|TRANSITION PHASE|Other|0
7426825|NCT01529515|11704208|FG003|TRANSITION PHASE|Other|0
7426826|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Adverse Event|0
7426827|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Adverse Event|10
7426828|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Adverse Event|0
7532024|NCT02661217|11877101|FG001|Overall Study|Withdrawal by Subject|19
7532025|NCT02661217|11877100|FG000|Overall Study|Did not enter follow-up epoch|7
7532026|NCT02661217|11877101|FG001|Overall Study|Did not enter follow-up epoch|10
7532027|NCT02661217|11877100|FG000|Overall Study|Death - no study drug received|1
7532028|NCT02661217|11877101|FG001|Overall Study|Death - no study drug received|2
7532029|NCT02661217|11877100|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
7532030|NCT02661217|11877101|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
7532031|NCT02661490|11877119|FG000|Overall Study|Lost to Follow-up|0
7532032|NCT02661490|11877120|FG001|Overall Study|Lost to Follow-up|1
7532033|NCT02661490|11877121|FG002|Overall Study|Lost to Follow-up|0
7532034|NCT02661490|11877122|FG003|Overall Study|Lost to Follow-up|0
7532035|NCT02661490|11877123|FG004|Overall Study|Lost to Follow-up|2
7328359|NCT00795951|11561327|FG000|Overall Study|Withdrawal by Subject|1
7426829|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Adverse Event|0
7426830|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
7532036|NCT02661490|11877119|FG000|Overall Study|Withdrawal by Subject|2
7328360|NCT00796003|11561334|FG000|Overall Study|Disease Progression|2
7426831|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
7426832|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
7426833|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
7426834|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
7426835|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
7426836|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
7426837|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
7328361|NCT00796003|11561335|FG001|Overall Study|Disease Progression|13
7532037|NCT02661490|11877120|FG001|Overall Study|Withdrawal by Subject|0
7328362|NCT00796003|11561334|FG000|Overall Study|Adverse Event|1
7328363|NCT00796003|11561335|FG001|Overall Study|Adverse Event|7
7328364|NCT00796003|11561334|FG000|Overall Study|Specified organ function not met|0
7328365|NCT00796003|11561335|FG001|Overall Study|Specified organ function not met|1
7328366|NCT00796003|11561334|FG000|Overall Study|Physician Decision|0
7328367|NCT00796003|11561335|FG001|Overall Study|Physician Decision|4
7328368|NCT00796003|11561334|FG000|Overall Study|Withdrawal by Subject|0
7328369|NCT00796003|11561335|FG001|Overall Study|Withdrawal by Subject|1
7328370|NCT00796003|11561334|FG000|Overall Study|Other|0
7328371|NCT00796003|11561335|FG001|Overall Study|Other|1
7328372|NCT00796003|11561334|FG000|Overall Study|Participants Not treated|0
7328373|NCT00796003|11561335|FG001|Overall Study|Participants Not treated|2
7384989|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7384990|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
7384991|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
7384992|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7384993|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
7384994|NCT01198002|11642433|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
7384995|NCT01198002|11642434|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
7384996|NCT01198002|11642435|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
7384997|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
7384998|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
7384999|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
7385000|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
7385001|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7385002|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
7385003|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
7385004|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7385005|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
7385006|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7385007|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
7385008|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
7385009|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7385010|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
7385011|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
7385012|NCT01198002|11642433|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
7385013|NCT01198002|11642434|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
7385014|NCT01198002|11642435|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
7385015|NCT01198028|11642465|FG000|Overall Study|Adverse Event|5
7385016|NCT01198028|11642465|FG000|Overall Study|Death|3
7385017|NCT01198028|11642465|FG000|Overall Study|Physician Decision|2
7385018|NCT01198132|11642471|FG000|Overall Study|Withdrawal by Subject|4
7385019|NCT01198132|11642472|FG001|Overall Study|Withdrawal by Subject|5
7385020|NCT01198132|11642471|FG000|Overall Study|Physician Decision|5
7385021|NCT01198132|11642472|FG001|Overall Study|Physician Decision|4
7385022|NCT01198132|11642471|FG000|Overall Study|Other Unspecified|3
7385023|NCT01198132|11642472|FG001|Overall Study|Other Unspecified|6
7385024|NCT01198132|11642471|FG000|Overall Study|Lack of Efficacy|2
7385025|NCT01198132|11642472|FG001|Overall Study|Lack of Efficacy|3
7385026|NCT01198132|11642471|FG000|Overall Study|Sign/symptoms of underlying disease|2
7385027|NCT01198132|11642472|FG001|Overall Study|Sign/symptoms of underlying disease|1
7385028|NCT01198132|11642471|FG000|Overall Study|Abnormal/clinically significant biologic|1
7385029|NCT01198132|11642472|FG001|Overall Study|Abnormal/clinically significant biologic|1
7385030|NCT01198132|11642471|FG000|Overall Study|Adverse Event|0
7385031|NCT01198132|11642472|FG001|Overall Study|Adverse Event|1
7385032|NCT01198132|11642471|FG000|Overall Study|Protocol Violation|1
7385033|NCT01198132|11642472|FG001|Overall Study|Protocol Violation|0
7385034|NCT01198145|11642482|FG000|Overall Study|Withdrawal by Subject|1
7385035|NCT01198145|11642483|FG001|Overall Study|Withdrawal by Subject|1
7385036|NCT01198275|11642501|FG000|Overall Study|Adverse Event|2
7385037|NCT01198275|11642502|FG001|Overall Study|Adverse Event|3
7385038|NCT01198275|11642501|FG000|Overall Study|spontaneous return to sinus rhythm|4
7385039|NCT01198275|11642502|FG001|Overall Study|spontaneous return to sinus rhythm|2
7385040|NCT01198470|11642540|FG000|Overall Study|Adverse Event|2
7385041|NCT01198509|11642550|FG000|Overall Study|Withdrawal by Subject|1
7385042|NCT01198509|11642551|FG001|Overall Study|Withdrawal by Subject|0
7385043|NCT01198509|11642552|FG002|Overall Study|Withdrawal by Subject|0
7385044|NCT01198509|11642553|FG003|Overall Study|Withdrawal by Subject|0
7385045|NCT01198509|11642554|FG004|Overall Study|Withdrawal by Subject|0
7385046|NCT01198509|11642555|FG005|Overall Study|Withdrawal by Subject|0
7385047|NCT01198574|11642571|FG000|Overall Study|Resigned from schools|4
7385048|NCT01198574|11642572|FG001|Overall Study|Resigned from schools|1
7385049|NCT01198574|11642573|FG002|Overall Study|Resigned from schools|1
7385050|NCT01198574|11642574|FG003|Overall Study|Resigned from schools|4
7385051|NCT01198587|11642588|FG000|Overall Study|Lost to Follow-up|8
7385052|NCT01198587|11642589|FG001|Overall Study|Lost to Follow-up|0
7385053|NCT01198587|11642590|FG002|Overall Study|Lost to Follow-up|9
7426838|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Protocol Violation|0
7426839|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Protocol Violation|12
7426840|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Protocol Violation|0
7426841|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Protocol Violation|0
7426842|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
7426843|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
7426844|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
7426845|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
7426846|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
7426847|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
7426848|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
7426849|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
7426850|NCT01529515|11704205|FG000|MAINTENANCE PHASE|Other|0
7426851|NCT01529515|11704206|FG001|MAINTENANCE PHASE|Other|10
7426852|NCT01529515|11704207|FG002|MAINTENANCE PHASE|Other|0
7426853|NCT01529515|11704208|FG003|MAINTENANCE PHASE|Other|0
7426854|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Adverse Event|0
7426855|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Adverse Event|0
7426856|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Adverse Event|1
7426857|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Adverse Event|0
7532038|NCT02661490|11877121|FG002|Overall Study|Withdrawal by Subject|2
7532039|NCT02661490|11877122|FG003|Overall Study|Withdrawal by Subject|0
7532040|NCT02661490|11877123|FG004|Overall Study|Withdrawal by Subject|0
7532041|NCT02661490|11877119|FG000|Overall Study|Death|1
7532042|NCT02661490|11877120|FG001|Overall Study|Death|1
7532043|NCT02661490|11877121|FG002|Overall Study|Death|0
7532044|NCT02661490|11877122|FG003|Overall Study|Death|1
7532045|NCT02661490|11877123|FG004|Overall Study|Death|0
7532046|NCT02661490|11877119|FG000|Overall Study|Reason not Specified|0
7532047|NCT02661490|11877120|FG001|Overall Study|Reason not Specified|0
7426858|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
7426859|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
7426860|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
7426861|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
7426862|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Pregnancy|0
7426863|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Pregnancy|0
7426864|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Pregnancy|1
7426865|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Pregnancy|0
7426866|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7426867|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
7426868|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
7426869|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
7426870|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
7426871|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
7426872|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
7426873|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
7426874|NCT01529515|11704205|FG000|DOUBLE BLIND PHASE|Other|0
7426875|NCT01529515|11704206|FG001|DOUBLE BLIND PHASE|Other|0
7426876|NCT01529515|11704207|FG002|DOUBLE BLIND PHASE|Other|9
7426877|NCT01529515|11704208|FG003|DOUBLE BLIND PHASE|Other|2
7426878|NCT01529606|11704217|FG000|Overall Study|Lost to Follow-up|21
7426879|NCT01529606|11704218|FG001|Overall Study|Lost to Follow-up|18
7426880|NCT01529632|11704226|FG000|Overall Study|Administrative problem|2
7426881|NCT01529632|11704227|FG001|Overall Study|Administrative problem|1
7426882|NCT01529632|11704226|FG000|Overall Study|Protocol Violation|0
7426883|NCT01529632|11704227|FG001|Overall Study|Protocol Violation|1
7426884|NCT01529632|11704226|FG000|Overall Study|Adverse Event|1
7426885|NCT01529632|11704227|FG001|Overall Study|Adverse Event|1
7426886|NCT01529645|11704243|FG000|Overall Study|Lost to Follow-up|0
7426887|NCT01529645|11704244|FG001|Overall Study|Lost to Follow-up|1
7426888|NCT01529645|11704245|FG002|Overall Study|Lost to Follow-up|1
7426889|NCT01529645|11704246|FG003|Overall Study|Lost to Follow-up|1
7426890|NCT01529645|11704247|FG004|Overall Study|Lost to Follow-up|1
7426891|NCT01529645|11704248|FG005|Overall Study|Lost to Follow-up|0
7426892|NCT01529645|11704249|FG006|Overall Study|Lost to Follow-up|2
7426893|NCT01529645|11704250|FG007|Overall Study|Lost to Follow-up|0
7426894|NCT01529645|11704251|FG008|Overall Study|Lost to Follow-up|1
7426895|NCT01529645|11704252|FG009|Overall Study|Lost to Follow-up|0
7426896|NCT01529645|11704243|FG000|Overall Study|SAE - Premature contractions|0
7426897|NCT01529645|11704244|FG001|Overall Study|SAE - Premature contractions|0
7426898|NCT01529645|11704245|FG002|Overall Study|SAE - Premature contractions|1
7426899|NCT01529645|11704246|FG003|Overall Study|SAE - Premature contractions|0
7532048|NCT02661490|11877121|FG002|Overall Study|Reason not Specified|0
7426900|NCT01529645|11704247|FG004|Overall Study|SAE - Premature contractions|0
7532049|NCT02661490|11877122|FG003|Overall Study|Reason not Specified|0
7532050|NCT02661490|11877123|FG004|Overall Study|Reason not Specified|1
7532051|NCT02661594|11877139|FG000|Overall Study|Protocol Violation|1
7426901|NCT01529645|11704248|FG005|Overall Study|SAE - Premature contractions|0
7426902|NCT01529645|11704249|FG006|Overall Study|SAE - Premature contractions|0
7426903|NCT01529645|11704250|FG007|Overall Study|SAE - Premature contractions|0
7426904|NCT01529645|11704251|FG008|Overall Study|SAE - Premature contractions|0
7426905|NCT01529645|11704252|FG009|Overall Study|SAE - Premature contractions|0
7426906|NCT01529645|11704243|FG000|Overall Study|Withdrawal by Subject|2
7426907|NCT01529645|11704244|FG001|Overall Study|Withdrawal by Subject|0
7426908|NCT01529645|11704245|FG002|Overall Study|Withdrawal by Subject|0
7426909|NCT01529645|11704246|FG003|Overall Study|Withdrawal by Subject|1
7426910|NCT01529645|11704247|FG004|Overall Study|Withdrawal by Subject|1
7426911|NCT01529645|11704248|FG005|Overall Study|Withdrawal by Subject|1
7426912|NCT01529645|11704249|FG006|Overall Study|Withdrawal by Subject|0
7426913|NCT01529645|11704250|FG007|Overall Study|Withdrawal by Subject|0
7426914|NCT01529645|11704251|FG008|Overall Study|Withdrawal by Subject|0
7426915|NCT01529645|11704252|FG009|Overall Study|Withdrawal by Subject|0
7328374|NCT00796120|11561346|FG000|Overall Study|Death|3
7328375|NCT00796120|11561347|FG001|Overall Study|Death|0
7328376|NCT00796120|11561346|FG000|Overall Study|Adverse Event|11
7328377|NCT00796120|11561347|FG001|Overall Study|Adverse Event|6
7328378|NCT00796120|11561346|FG000|Overall Study|Progressive disease|22
7328379|NCT00796120|11561347|FG001|Overall Study|Progressive disease|13
7328380|NCT00796120|11561346|FG000|Overall Study|Participant refusal|3
7328381|NCT00796120|11561347|FG001|Overall Study|Participant refusal|4
7328382|NCT00796120|11561346|FG000|Overall Study|Other|6
7328383|NCT00796120|11561347|FG001|Overall Study|Other|17
7328384|NCT00796120|11561346|FG000|Overall Study|Physician Decision|16
7328385|NCT00796120|11561347|FG001|Overall Study|Physician Decision|17
7328386|NCT00796120|11561346|FG000|Overall Study|Randomized but not treated|0
7426916|NCT01529749|11704286|FG000|Overall Study|Lost to Follow-up|0
7557761|NCT03102710|11922228|FG002|Overall Study|Dental metal affected MRI scan quality|0
7557762|NCT03102710|11922226|FG000|Overall Study|Technical issues during final MRI scan|0
7426917|NCT01529749|11704287|FG001|Overall Study|Lost to Follow-up|1
7426918|NCT01529749|11704288|FG002|Overall Study|Lost to Follow-up|1
7426919|NCT01529749|11704289|FG003|Overall Study|Lost to Follow-up|0
7426920|NCT01529749|11704286|FG000|Overall Study|Physician Decision|0
7426921|NCT01529749|11704287|FG001|Overall Study|Physician Decision|0
7426922|NCT01529749|11704288|FG002|Overall Study|Physician Decision|0
7426923|NCT01529749|11704289|FG003|Overall Study|Physician Decision|1
7532052|NCT02661594|11877140|FG001|Overall Study|Protocol Violation|0
7532053|NCT02661594|11877141|FG002|Overall Study|Protocol Violation|1
7532054|NCT02661594|11877142|FG003|Overall Study|Protocol Violation|0
7532055|NCT02661815|11877160|FG000|Overall Study|Withdrawal by Subject|1
7532056|NCT02661815|11877161|FG001|Overall Study|Withdrawal by Subject|0
7532057|NCT02661815|11877162|FG002|Overall Study|Withdrawal by Subject|0
7532058|NCT02661815|11877163|FG003|Overall Study|Withdrawal by Subject|0
7532059|NCT02662556|11877220|FG000|Overall Study|Adverse Event|4
7532060|NCT02662556|11877220|FG000|Overall Study|Lack of Efficacy|4
7532061|NCT02662569|11877229|FG000|Overall Study|Withdrawal by Subject|6
7532062|NCT02662569|11877230|FG001|Overall Study|Withdrawal by Subject|1
7532063|NCT02662569|11877231|FG002|Overall Study|Withdrawal by Subject|6
7532064|NCT02662569|11877232|FG003|Overall Study|Withdrawal by Subject|4
7532065|NCT02662569|11877229|FG000|Overall Study|Lost to Follow-up|1
7532066|NCT02662569|11877230|FG001|Overall Study|Lost to Follow-up|0
7532067|NCT02662569|11877231|FG002|Overall Study|Lost to Follow-up|0
7532068|NCT02662569|11877232|FG003|Overall Study|Lost to Follow-up|0
7532069|NCT02662582|11877244|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
7532070|NCT02662582|11877245|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
7532071|NCT02662582|11877244|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
7532072|NCT02662582|11877245|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
7532073|NCT02662582|11877244|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
7426924|NCT01529749|11704286|FG000|Overall Study|Withdrawal by Subject|0
7426925|NCT01529749|11704287|FG001|Overall Study|Withdrawal by Subject|1
7426926|NCT01529749|11704288|FG002|Overall Study|Withdrawal by Subject|1
7426927|NCT01529749|11704289|FG003|Overall Study|Withdrawal by Subject|0
7426928|NCT01529749|11704286|FG000|Overall Study|Protocol Violation|0
7426929|NCT01529749|11704287|FG001|Overall Study|Protocol Violation|0
7426930|NCT01529749|11704288|FG002|Overall Study|Protocol Violation|0
7426931|NCT01529749|11704289|FG003|Overall Study|Protocol Violation|1
7426932|NCT01530256|11704334|FG000|Overall Study|Death|2
7426933|NCT01530334|11704338|FG000|Overall Study|Adverse Event|3
7426934|NCT01530334|11704338|FG000|Overall Study|unknown reason|1
7532074|NCT02662582|11877245|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
7532075|NCT02662582|11877244|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7532076|NCT02662582|11877245|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7532077|NCT02662764|11877256|FG000|Overall Study|Adverse Event|6
7557763|NCT03102710|11922227|FG001|Overall Study|Technical issues during final MRI scan|1
7328387|NCT00796120|11561347|FG001|Overall Study|Randomized but not treated|3
7426935|NCT01530334|11704338|FG000|Overall Study|Progressive disease|47
7426936|NCT01530464|11704369|FG000|Washout (24h)|Withdrawal by Subject|1
7426937|NCT01530464|11704370|FG001|Washout (24h)|Withdrawal by Subject|0
7426938|NCT01530464|11704369|FG000|Washout (24h)|Withdrawal by Subject|0
7532078|NCT02662764|11877256|FG000|Overall Study|Lack of Efficacy|8
7532079|NCT02662764|11877256|FG000|Overall Study|Protocol Violation|1
7532080|NCT02662764|11877256|FG000|Overall Study|Withdrawal by Subject|5
7328388|NCT00796224|11561355|FG000|Overall Study|Adverse Event|1
7328389|NCT00796224|11561356|FG001|Overall Study|Adverse Event|0
7426939|NCT01530464|11704370|FG001|Washout (24h)|Withdrawal by Subject|1
7426940|NCT01531153|11704395|FG000|Overall Study|Withdrawal by Subject|10
7532081|NCT02662764|11877256|FG000|Overall Study|Device failure|4
7532082|NCT02662764|11877256|FG000|Overall Study|Patient changed treatment|1
7426941|NCT01531153|11704396|FG001|Overall Study|Withdrawal by Subject|9
7426942|NCT01531153|11704397|FG002|Overall Study|Withdrawal by Subject|15
7426943|NCT01531205|11704408|FG000|Overall Study|Did not proceed to surgery|1
7426944|NCT01531673|11704445|FG000|Overall Study|Non-Compliance|0
7426945|NCT01531673|11704446|FG001|Overall Study|Non-Compliance|0
7426946|NCT01531673|11704447|FG002|Overall Study|Non-Compliance|0
7426947|NCT01531673|11704448|FG003|Overall Study|Non-Compliance|0
7426948|NCT01531673|11704449|FG004|Overall Study|Non-Compliance|0
7426949|NCT01531673|11704450|FG005|Overall Study|Non-Compliance|1
7426950|NCT01531673|11704451|FG006|Overall Study|Non-Compliance|0
7426951|NCT01531673|11704452|FG007|Overall Study|Non-Compliance|0
7426952|NCT01531673|11704453|FG008|Overall Study|Non-Compliance|0
7426953|NCT01531673|11704454|FG009|Overall Study|Non-Compliance|0
7426954|NCT01531673|11704455|FG010|Overall Study|Non-Compliance|0
7426955|NCT01531673|11704456|FG011|Overall Study|Non-Compliance|0
7426956|NCT01531673|11704457|FG012|Overall Study|Non-Compliance|0
7426957|NCT01531673|11704445|FG000|Overall Study|Adverse Event|0
7426958|NCT01531673|11704446|FG001|Overall Study|Adverse Event|1
7426959|NCT01531673|11704447|FG002|Overall Study|Adverse Event|0
7557764|NCT03102710|11922228|FG002|Overall Study|Technical issues during final MRI scan|0
7557765|NCT03102710|11922226|FG000|Overall Study|Nausea during MRI scan|0
7557766|NCT03102710|11922227|FG001|Overall Study|Nausea during MRI scan|1
7557767|NCT03102710|11922228|FG002|Overall Study|Nausea during MRI scan|0
7557768|NCT03102710|11922226|FG000|Overall Study|Subject unable to attend final session|0
7557769|NCT03102710|11922227|FG001|Overall Study|Subject unable to attend final session|1
7557770|NCT03102710|11922228|FG002|Overall Study|Subject unable to attend final session|0
7557771|NCT03102762|11922247|FG000|Overall Study|Lost to Follow-up|1
7557772|NCT03102762|11922248|FG001|Overall Study|Lost to Follow-up|0
7557773|NCT03102918|11922270|FG000|Overall Study|Protocol Violation|1
7557774|NCT03102918|11922271|FG001|Overall Study|Protocol Violation|0
7557775|NCT03103100|11922284|FG000|Overall Study|Adverse Event|1
7557776|NCT03103100|11922285|FG001|Overall Study|Adverse Event|0
7557777|NCT03103100|11922286|FG002|Overall Study|Adverse Event|0
7426960|NCT01531673|11704448|FG003|Overall Study|Adverse Event|0
7426961|NCT01531673|11704449|FG004|Overall Study|Adverse Event|0
7426962|NCT01531673|11704450|FG005|Overall Study|Adverse Event|0
7426963|NCT01531673|11704451|FG006|Overall Study|Adverse Event|0
7426964|NCT01531673|11704452|FG007|Overall Study|Adverse Event|0
7426965|NCT01531673|11704453|FG008|Overall Study|Adverse Event|0
7426966|NCT01531673|11704454|FG009|Overall Study|Adverse Event|0
7426967|NCT01531673|11704455|FG010|Overall Study|Adverse Event|0
7426968|NCT01531673|11704456|FG011|Overall Study|Adverse Event|0
7426969|NCT01531673|11704457|FG012|Overall Study|Adverse Event|0
7426970|NCT01531673|11704445|FG000|Overall Study|Lost to Follow-up|0
7426971|NCT01531673|11704446|FG001|Overall Study|Lost to Follow-up|0
7426972|NCT01531673|11704447|FG002|Overall Study|Lost to Follow-up|0
7426973|NCT01531673|11704448|FG003|Overall Study|Lost to Follow-up|0
7426974|NCT01531673|11704449|FG004|Overall Study|Lost to Follow-up|1
7426975|NCT01531673|11704450|FG005|Overall Study|Lost to Follow-up|0
7426976|NCT01531673|11704451|FG006|Overall Study|Lost to Follow-up|0
7426977|NCT01531673|11704452|FG007|Overall Study|Lost to Follow-up|0
7426978|NCT01531673|11704453|FG008|Overall Study|Lost to Follow-up|0
7426979|NCT01531673|11704454|FG009|Overall Study|Lost to Follow-up|0
7426980|NCT01531673|11704455|FG010|Overall Study|Lost to Follow-up|0
7426981|NCT01531673|11704456|FG011|Overall Study|Lost to Follow-up|0
7426982|NCT01531673|11704457|FG012|Overall Study|Lost to Follow-up|0
7426983|NCT01531673|11704445|FG000|Overall Study|Other|0
7426984|NCT01531673|11704446|FG001|Overall Study|Other|0
7426985|NCT01531673|11704447|FG002|Overall Study|Other|0
7426986|NCT01531673|11704448|FG003|Overall Study|Other|1
7426987|NCT01531673|11704449|FG004|Overall Study|Other|0
7426988|NCT01531673|11704450|FG005|Overall Study|Other|0
7426989|NCT01531673|11704451|FG006|Overall Study|Other|0
7426990|NCT01531673|11704452|FG007|Overall Study|Other|0
7426991|NCT01531673|11704453|FG008|Overall Study|Other|0
7426992|NCT01531673|11704454|FG009|Overall Study|Other|1
7426993|NCT01531673|11704455|FG010|Overall Study|Other|0
7426994|NCT01531673|11704456|FG011|Overall Study|Other|0
7426995|NCT01531673|11704457|FG012|Overall Study|Other|0
7426996|NCT01531725|11704509|FG000|Overall Study|Protocol Violation|5
7426997|NCT01531894|11704531|FG000|Overall Study|Physician Decision|8
7426998|NCT01531894|11704531|FG000|Overall Study|Death|1
7426999|NCT01531998|11704544|FG000|Overall Study|Withdrawal by Subject|3
7427000|NCT01532388|11704598|FG000|3-month Follow-up|Lost to Follow-up|68
7427001|NCT01532388|11704599|FG001|3-month Follow-up|Lost to Follow-up|68
7427002|NCT01532388|11704598|FG000|6-month Follow-up|Lost to Follow-up|74
7427003|NCT01532388|11704599|FG001|6-month Follow-up|Lost to Follow-up|66
7427004|NCT01532388|11704598|FG000|12-month Follow-up|Lost to Follow-up|69
7427005|NCT01532388|11704599|FG001|12-month Follow-up|Lost to Follow-up|67
7427006|NCT01532414|11704608|FG000|Overall Study|Lost to Follow-up|3
7427007|NCT01532414|11704609|FG001|Overall Study|Lost to Follow-up|0
7427008|NCT01532414|11704610|FG002|Overall Study|Lost to Follow-up|1
7427009|NCT01532414|11704608|FG000|Overall Study|Withdrawal by Subject|3
7427010|NCT01532414|11704609|FG001|Overall Study|Withdrawal by Subject|0
7427011|NCT01532414|11704610|FG002|Overall Study|Withdrawal by Subject|0
7557778|NCT03103100|11922284|FG000|Overall Study|Physician Decision|1
7557779|NCT03103100|11922285|FG001|Overall Study|Physician Decision|0
7427012|NCT01532414|11704608|FG000|Overall Study|No V6 semen sample|0
7427013|NCT01532414|11704609|FG001|Overall Study|No V6 semen sample|1
7427014|NCT01532414|11704610|FG002|Overall Study|No V6 semen sample|0
7427015|NCT01532414|11704608|FG000|Overall Study|Adverse Event|0
7427016|NCT01532414|11704609|FG001|Overall Study|Adverse Event|1
7427017|NCT01532414|11704610|FG002|Overall Study|Adverse Event|1
7427018|NCT01532414|11704608|FG000|Overall Study|Unable to complete 24 hour PK|0
7427019|NCT01532414|11704609|FG001|Overall Study|Unable to complete 24 hour PK|0
7427020|NCT01532414|11704610|FG002|Overall Study|Unable to complete 24 hour PK|1
7427021|NCT01532414|11704608|FG000|Overall Study|Withdrawn by sponsor|1
7427022|NCT01532414|11704609|FG001|Overall Study|Withdrawn by sponsor|0
7427023|NCT01532414|11704610|FG002|Overall Study|Withdrawn by sponsor|0
7427024|NCT01532570|11704631|FG000|Overall Study|Lack of Efficacy|1
7427025|NCT01532570|11704632|FG001|Overall Study|Lack of Efficacy|0
7427026|NCT01532570|11704633|FG002|Overall Study|Lack of Efficacy|0
7427027|NCT01532570|11704634|FG003|Overall Study|Lack of Efficacy|0
7427028|NCT01532570|11704631|FG000|Overall Study|Withdrawal by Subject|0
7427029|NCT01532570|11704632|FG001|Overall Study|Withdrawal by Subject|1
7427030|NCT01532570|11704633|FG002|Overall Study|Withdrawal by Subject|0
7427031|NCT01532570|11704634|FG003|Overall Study|Withdrawal by Subject|0
7427032|NCT01532648|11704653|FG000|Overall Study|Lost to Follow-up|3
7427033|NCT01532648|11704654|FG001|Overall Study|Lost to Follow-up|4
7427034|NCT01532648|11704653|FG000|Overall Study|Lack of Efficacy|4
7427035|NCT01532648|11704654|FG001|Overall Study|Lack of Efficacy|1
7427036|NCT01532648|11704653|FG000|Overall Study|Protocol Violation|1
7427037|NCT01532648|11704654|FG001|Overall Study|Protocol Violation|1
7427038|NCT01532648|11704653|FG000|Overall Study|Adverse Event|12
7427039|NCT01532648|11704654|FG001|Overall Study|Adverse Event|9
7427040|NCT01532648|11704653|FG000|Overall Study|Withdrawal by Subject|16
7427041|NCT01532648|11704654|FG001|Overall Study|Withdrawal by Subject|2
7427042|NCT01532687|11704662|FG000|Overall Study|Death|2
7427043|NCT01532687|11704663|FG001|Overall Study|Death|0
7427044|NCT01532687|11704662|FG000|Overall Study|Adverse Event|6
7427045|NCT01532687|11704663|FG001|Overall Study|Adverse Event|1
7427046|NCT01532687|11704662|FG000|Overall Study|Withdrawal by Subject|1
7427047|NCT01532687|11704663|FG001|Overall Study|Withdrawal by Subject|0
7427048|NCT01532687|11704662|FG000|Overall Study|Physician Decision|2
7427049|NCT01532687|11704663|FG001|Overall Study|Physician Decision|1
7427050|NCT01532687|11704662|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
7427051|NCT01532687|11704663|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
7466794|NCT01894841|11766771|FG001|Overall Study|Withdrawn by investigator|2
7466795|NCT01894841|11766770|FG000|Overall Study|Lost to Follow-up|7
7466796|NCT01894841|11766771|FG001|Overall Study|Lost to Follow-up|3
7466797|NCT01894919|11766815|FG000|Overall Study|Withdrawal by Subject|1
7466798|NCT01894919|11766816|FG001|Overall Study|Withdrawal by Subject|0
7466799|NCT01894919|11766817|FG002|Overall Study|Withdrawal by Subject|0
7466800|NCT01894919|11766818|FG003|Overall Study|Withdrawal by Subject|0
7466801|NCT01894919|11766819|FG004|Overall Study|Withdrawal by Subject|1
7466802|NCT01894919|11766820|FG005|Overall Study|Withdrawal by Subject|0
7466803|NCT01894919|11766821|FG006|Overall Study|Withdrawal by Subject|0
7466804|NCT01894919|11766822|FG007|Overall Study|Withdrawal by Subject|0
7466805|NCT01894919|11766823|FG008|Overall Study|Withdrawal by Subject|0
7466806|NCT01894919|11766824|FG009|Overall Study|Withdrawal by Subject|1
7466807|NCT01894919|11766825|FG010|Overall Study|Withdrawal by Subject|1
7466808|NCT01894919|11766826|FG011|Overall Study|Withdrawal by Subject|0
7466809|NCT01894919|11766827|FG012|Overall Study|Withdrawal by Subject|0
7466810|NCT01894919|11766815|FG000|Overall Study|Adverse Event|0
7466811|NCT01894919|11766816|FG001|Overall Study|Adverse Event|0
7466812|NCT01894919|11766817|FG002|Overall Study|Adverse Event|0
7466813|NCT01894919|11766818|FG003|Overall Study|Adverse Event|0
7466814|NCT01894919|11766819|FG004|Overall Study|Adverse Event|0
7466815|NCT01894919|11766820|FG005|Overall Study|Adverse Event|0
7466816|NCT01894919|11766821|FG006|Overall Study|Adverse Event|0
7466817|NCT01894919|11766822|FG007|Overall Study|Adverse Event|0
7466818|NCT01894919|11766823|FG008|Overall Study|Adverse Event|0
7466819|NCT01894919|11766824|FG009|Overall Study|Adverse Event|0
7466820|NCT01894919|11766825|FG010|Overall Study|Adverse Event|1
7466821|NCT01894919|11766826|FG011|Overall Study|Adverse Event|0
7466822|NCT01894919|11766827|FG012|Overall Study|Adverse Event|0
7466823|NCT01894919|11766815|FG000|Overall Study|Other-Unspecified|1
7466824|NCT01894919|11766816|FG001|Overall Study|Other-Unspecified|0
7466825|NCT01894919|11766817|FG002|Overall Study|Other-Unspecified|0
7466826|NCT01894919|11766818|FG003|Overall Study|Other-Unspecified|0
7466827|NCT01894919|11766819|FG004|Overall Study|Other-Unspecified|0
7466828|NCT01894919|11766820|FG005|Overall Study|Other-Unspecified|0
7466829|NCT01894919|11766821|FG006|Overall Study|Other-Unspecified|0
7466830|NCT01894919|11766822|FG007|Overall Study|Other-Unspecified|0
7466831|NCT01894919|11766823|FG008|Overall Study|Other-Unspecified|0
7466832|NCT01894919|11766824|FG009|Overall Study|Other-Unspecified|0
7466833|NCT01894919|11766825|FG010|Overall Study|Other-Unspecified|0
7466834|NCT01894919|11766826|FG011|Overall Study|Other-Unspecified|0
7466835|NCT01894919|11766827|FG012|Overall Study|Other-Unspecified|0
7466836|NCT01894919|11766815|FG000|Overall Study|Lost to Follow-up|0
7466837|NCT01894919|11766816|FG001|Overall Study|Lost to Follow-up|0
7466838|NCT01894919|11766817|FG002|Overall Study|Lost to Follow-up|0
7427052|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
7427053|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
7427054|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
7427055|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
7427056|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
7427057|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
7427058|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
7427059|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
7427060|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7427061|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
7427062|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
7427063|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
7427064|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
7427065|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
7427066|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
7427067|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
7427068|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
7427069|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
7427070|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
7427071|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
7427072|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
7427073|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
7427074|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
7427075|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
7427076|NCT01532869|11704685|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
7427077|NCT01532869|11704686|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
7427078|NCT01532869|11704685|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
7427079|NCT01532869|11704686|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
7427080|NCT01532869|11704685|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
7427081|NCT01532869|11704686|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
7427082|NCT01532869|11704685|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7427083|NCT01532869|11704686|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
7427084|NCT01532869|11704685|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7427085|NCT01532869|11704686|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
7427086|NCT01532908|11704699|FG000|Overall Study|Not Transplanted|1
7427087|NCT01532908|11704700|FG001|Overall Study|Not Transplanted|0
7427088|NCT01532921|11704706|FG000|Overall Study|Death|3
7427089|NCT01532921|11704706|FG000|Overall Study|Withdrawal by Subject|2
7427090|NCT01532921|11704706|FG000|Overall Study|Lost to Follow-up|3
7427091|NCT01532921|11704706|FG000|Overall Study|Physician Decision|7
7427092|NCT01532921|11704706|FG000|Overall Study|Device was explanted during procedure|1
7427093|NCT01532934|11704716|FG000|Overall Study|Lost to Follow-up|11
7427094|NCT01532934|11704717|FG001|Overall Study|Lost to Follow-up|11
7427095|NCT01532934|11704716|FG000|Overall Study|In controlled environment|3
7557780|NCT03103100|11922286|FG002|Overall Study|Physician Decision|2
7557781|NCT03103503|11922327|FG000|Overall Study|Death|64
7557782|NCT03103503|11922327|FG000|Overall Study|Physician Decision|57
7557783|NCT03103503|11922327|FG000|Overall Study|Withdrawal by Subject|10
7557784|NCT03103503|11922327|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
7557785|NCT03103503|11922327|FG000|Overall Study|Lost to Follow-up|3
7557786|NCT03103503|11922327|FG000|Overall Study|Study Closure|757
7557787|NCT03103763|11922334|FG000|Overall Study|Death|15
7557788|NCT03103763|11922335|FG001|Overall Study|Death|5
7557789|NCT03103763|11922336|FG002|Overall Study|Death|5
7557790|NCT03103763|11922334|FG000|Overall Study|Withdrawal by Subject|0
7557791|NCT03103763|11922335|FG001|Overall Study|Withdrawal by Subject|3
7557792|NCT03103763|11922336|FG002|Overall Study|Withdrawal by Subject|2
7557793|NCT03103906|11922346|FG000|Overall Study|Adverse Event|2
7557794|NCT03103906|11922347|FG001|Overall Study|Adverse Event|3
7557795|NCT03103906|11922346|FG000|Overall Study|Other|2
7557796|NCT03103906|11922347|FG001|Overall Study|Other|0
7557797|NCT03103919|11922355|FG000|Overall Study|Adverse Event|2
7557798|NCT03103919|11922356|FG001|Overall Study|Adverse Event|2
7557799|NCT03104816|11922416|FG000|Overall Study|Lack of Efficacy|0
7557800|NCT03104816|11922417|FG001|Overall Study|Lack of Efficacy|2
7557801|NCT03104816|11922418|FG002|Overall Study|Lack of Efficacy|0
7557802|NCT03104816|11922416|FG000|Overall Study|Protocol Violation|2
7557803|NCT03104816|11922417|FG001|Overall Study|Protocol Violation|0
7557804|NCT03104816|11922418|FG002|Overall Study|Protocol Violation|2
7557805|NCT03105297|11922435|FG000|Baseline Phase (Day 1)|Other|21
7557806|NCT03105297|11922435|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
7557807|NCT03105297|11922435|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
7557808|NCT03105362|11922446|FG000|Overall Study|Withdrawal by Subject|1
7557809|NCT03105362|11922446|FG000|Overall Study|Lost to Follow-up|1
7557810|NCT03106077|11922470|FG000|Overall Study|Screen Failure|94
7557811|NCT03106077|11922471|FG001|Overall Study|Screen Failure|0
7557812|NCT03106753|11922492|FG000|Overall Study|Withdrawal by Subject|0
7427096|NCT01532934|11704717|FG001|Overall Study|In controlled environment|2
7427097|NCT01532986|11704769|FG000|Overall Study|Death|9
7427098|NCT01532986|11704770|FG001|Overall Study|Death|9
7427099|NCT01532986|11704769|FG000|Overall Study|Withdrawal by Subject|7
7427100|NCT01532986|11704770|FG001|Overall Study|Withdrawal by Subject|10
7427101|NCT01532986|11704769|FG000|Overall Study|Physician Decision|7
7427102|NCT01532986|11704770|FG001|Overall Study|Physician Decision|5
7427103|NCT01532999|11704779|FG000|Overall Study|Lost to Follow-up|14
7427104|NCT01532999|11704780|FG001|Overall Study|Lost to Follow-up|8
7427105|NCT01532999|11704779|FG000|Overall Study|Physician Decision|1
7427106|NCT01532999|11704780|FG001|Overall Study|Physician Decision|2
7427107|NCT01532999|11704779|FG000|Overall Study|Withdrawal by Subject|5
7427108|NCT01532999|11704780|FG001|Overall Study|Withdrawal by Subject|0
7427109|NCT01532999|11704779|FG000|Overall Study|Relocated|2
7427110|NCT01532999|11704780|FG001|Overall Study|Relocated|0
7427111|NCT01532999|11704779|FG000|Overall Study|should not have been randomized|1
7427112|NCT01532999|11704780|FG001|Overall Study|should not have been randomized|0
7427113|NCT01532999|11704779|FG000|Overall Study|substantial noncompliance|2
7427114|NCT01532999|11704780|FG001|Overall Study|substantial noncompliance|0
7427115|NCT01532999|11704779|FG000|Overall Study|no show for week 9 assessments|6
7427116|NCT01532999|11704780|FG001|Overall Study|no show for week 9 assessments|4
7427117|NCT01532999|11704779|FG000|Overall Study|Adverse Event|0
7427118|NCT01532999|11704780|FG001|Overall Study|Adverse Event|1
7427119|NCT01532999|11704779|FG000|Overall Study|incarcerated|0
7427120|NCT01532999|11704780|FG001|Overall Study|incarcerated|1
7427121|NCT01532999|11704779|FG000|Overall Study|New job|0
7427122|NCT01532999|11704780|FG001|Overall Study|New job|2
7427123|NCT01533181|11704831|FG000|Overall Study|Disease progression pre-active treatment|0
7427124|NCT01533181|11704832|FG001|Overall Study|Disease progression pre-active treatment|1
7427125|NCT01533181|11704831|FG000|Overall Study|Patient withdrawal pre-active treatment|1
7427126|NCT01533181|11704832|FG001|Overall Study|Patient withdrawal pre-active treatment|0
7427127|NCT01533246|11704847|FG000|Overall Study|Adverse Event|1
7427128|NCT01533246|11704847|FG000|Overall Study|Withdrawal by Subject|1
7427129|NCT01533428|11704857|FG000|Overall Study|Adverse Event|0
7427130|NCT01533428|11704858|FG001|Overall Study|Adverse Event|1
7427131|NCT01533428|11704857|FG000|Overall Study|Lost to Follow-up|2
7427132|NCT01533428|11704858|FG001|Overall Study|Lost to Follow-up|1
7427133|NCT01533428|11704857|FG000|Overall Study|Withdrawal by Subject|7
7427134|NCT01533428|11704858|FG001|Overall Study|Withdrawal by Subject|6
7427135|NCT01533493|11704866|FG000|Overall Study|Adverse Event|2
7427136|NCT01533493|11704867|FG001|Overall Study|Adverse Event|1
7427137|NCT01533493|11704866|FG000|Overall Study|Withdrawal by Subject|1
7427138|NCT01533493|11704867|FG001|Overall Study|Withdrawal by Subject|2
7427139|NCT01533493|11704866|FG000|Overall Study|Lost to Follow-up|2
7427140|NCT01533493|11704867|FG001|Overall Study|Lost to Follow-up|0
7427141|NCT01533688|11704885|FG000|Overall Study|Withdrawal by Subject|5
7427142|NCT01533688|11704886|FG001|Overall Study|Withdrawal by Subject|4
7427143|NCT01533688|11704887|FG002|Overall Study|Withdrawal by Subject|3
7427144|NCT01533688|11704885|FG000|Overall Study|Medically unstable|1
7427145|NCT01533688|11704886|FG001|Overall Study|Medically unstable|3
7427146|NCT01533688|11704887|FG002|Overall Study|Medically unstable|3
7427147|NCT01533688|11704885|FG000|Overall Study|Had colonoscopy at outside hospital|2
7427148|NCT01533688|11704886|FG001|Overall Study|Had colonoscopy at outside hospital|3
7427149|NCT01533688|11704887|FG002|Overall Study|Had colonoscopy at outside hospital|2
7427150|NCT01533922|11704897|FG000|Overall Study|Adverse Event|5
7427151|NCT01533922|11704898|FG001|Overall Study|Adverse Event|8
7427152|NCT01533922|11704899|FG002|Overall Study|Adverse Event|6
7427153|NCT01533922|11704900|FG003|Overall Study|Adverse Event|3
7427154|NCT01533922|11704901|FG004|Overall Study|Adverse Event|4
7427155|NCT01533922|11704897|FG000|Overall Study|Lack of Efficacy|0
7427156|NCT01533922|11704898|FG001|Overall Study|Lack of Efficacy|0
7427157|NCT01533922|11704899|FG002|Overall Study|Lack of Efficacy|1
7427158|NCT01533922|11704900|FG003|Overall Study|Lack of Efficacy|0
7427159|NCT01533922|11704901|FG004|Overall Study|Lack of Efficacy|0
7427160|NCT01533922|11704897|FG000|Overall Study|Protocol Violation|0
7427161|NCT01533922|11704898|FG001|Overall Study|Protocol Violation|3
7427162|NCT01533922|11704899|FG002|Overall Study|Protocol Violation|0
7427163|NCT01533922|11704900|FG003|Overall Study|Protocol Violation|0
7427164|NCT01533922|11704901|FG004|Overall Study|Protocol Violation|1
7427165|NCT01533922|11704897|FG000|Overall Study|Withdrawal by Subject|3
7427166|NCT01533922|11704898|FG001|Overall Study|Withdrawal by Subject|1
7427167|NCT01533922|11704899|FG002|Overall Study|Withdrawal by Subject|2
7427168|NCT01533922|11704900|FG003|Overall Study|Withdrawal by Subject|2
7427169|NCT01533922|11704901|FG004|Overall Study|Withdrawal by Subject|1
7427170|NCT01533922|11704897|FG000|Overall Study|Other reason not defined above|2
7427171|NCT01533922|11704898|FG001|Overall Study|Other reason not defined above|0
7427172|NCT01533922|11704899|FG002|Overall Study|Other reason not defined above|1
7427173|NCT01533922|11704900|FG003|Overall Study|Other reason not defined above|0
7427174|NCT01533922|11704901|FG004|Overall Study|Other reason not defined above|0
7427175|NCT01533935|11704913|FG000|Overall Study|Adverse Event|5
7427176|NCT01533935|11704914|FG001|Overall Study|Adverse Event|7
7427177|NCT01533935|11704915|FG002|Overall Study|Adverse Event|1
7427178|NCT01533935|11704916|FG003|Overall Study|Adverse Event|5
7427179|NCT01533935|11704917|FG004|Overall Study|Adverse Event|3
7427180|NCT01533935|11704913|FG000|Overall Study|Protocol Violation|0
7427181|NCT01533935|11704914|FG001|Overall Study|Protocol Violation|2
7427182|NCT01533935|11704915|FG002|Overall Study|Protocol Violation|0
7427183|NCT01533935|11704916|FG003|Overall Study|Protocol Violation|0
7427184|NCT01533935|11704917|FG004|Overall Study|Protocol Violation|0
7427185|NCT01533935|11704913|FG000|Overall Study|Lost to Follow-up|0
7427186|NCT01533935|11704914|FG001|Overall Study|Lost to Follow-up|0
7427187|NCT01533935|11704915|FG002|Overall Study|Lost to Follow-up|1
7427188|NCT01533935|11704916|FG003|Overall Study|Lost to Follow-up|0
7427189|NCT01533935|11704917|FG004|Overall Study|Lost to Follow-up|0
7427190|NCT01533935|11704913|FG000|Overall Study|Withdrawal by Subject|0
7427191|NCT01533935|11704914|FG001|Overall Study|Withdrawal by Subject|4
7427192|NCT01533935|11704915|FG002|Overall Study|Withdrawal by Subject|5
7427193|NCT01533935|11704916|FG003|Overall Study|Withdrawal by Subject|2
7427194|NCT01533935|11704917|FG004|Overall Study|Withdrawal by Subject|4
7427195|NCT01533935|11704913|FG000|Overall Study|Other reason not defined above|1
7427196|NCT01533935|11704914|FG001|Overall Study|Other reason not defined above|0
7427197|NCT01533935|11704915|FG002|Overall Study|Other reason not defined above|1
7427198|NCT01533935|11704916|FG003|Overall Study|Other reason not defined above|0
7557813|NCT03106753|11922493|FG001|Overall Study|Withdrawal by Subject|1
7557814|NCT03107026|11922517|FG000|Overall Study|Adverse Event|2
7557815|NCT03107026|11922518|FG001|Overall Study|Adverse Event|14
7557816|NCT03107026|11922519|FG002|Overall Study|Adverse Event|23
7557817|NCT03107026|11922517|FG000|Overall Study|Lost to Follow-up|12
7557818|NCT03107026|11922518|FG001|Overall Study|Lost to Follow-up|12
7557819|NCT03107026|11922519|FG002|Overall Study|Lost to Follow-up|13
7557820|NCT03107026|11922517|FG000|Overall Study|Protocol Violation|1
7557821|NCT03107026|11922518|FG001|Overall Study|Protocol Violation|2
7557822|NCT03107026|11922519|FG002|Overall Study|Protocol Violation|0
7557823|NCT03107026|11922517|FG000|Overall Study|Pregnancy|1
7557824|NCT03107026|11922518|FG001|Overall Study|Pregnancy|0
7557825|NCT03107026|11922519|FG002|Overall Study|Pregnancy|0
7557826|NCT03107026|11922517|FG000|Overall Study|Withdrawal by Subject|13
7557827|NCT03107026|11922518|FG001|Overall Study|Withdrawal by Subject|5
7557828|NCT03107026|11922519|FG002|Overall Study|Withdrawal by Subject|17
7557829|NCT03107026|11922517|FG000|Overall Study|non compliance with study visits|1
7557830|NCT03107026|11922518|FG001|Overall Study|non compliance with study visits|2
7557831|NCT03107026|11922519|FG002|Overall Study|non compliance with study visits|0
7557832|NCT03107026|11922517|FG000|Overall Study|non-compliance with study drug|2
7557833|NCT03107026|11922518|FG001|Overall Study|non-compliance with study drug|2
7557834|NCT03107026|11922519|FG002|Overall Study|non-compliance with study drug|3
7557835|NCT03107026|11922517|FG000|Overall Study|Physician Decision|0
7557836|NCT03107026|11922518|FG001|Overall Study|Physician Decision|1
7557837|NCT03107026|11922519|FG002|Overall Study|Physician Decision|0
7557838|NCT03107052|11922530|FG000|Overall Study|Adverse Event|6
7557839|NCT03107052|11922531|FG001|Overall Study|Adverse Event|1
7557840|NCT03107052|11922532|FG002|Overall Study|Adverse Event|2
7557841|NCT03107052|11922530|FG000|Overall Study|Withdrawal by Subject|9
7557842|NCT03107052|11922531|FG001|Overall Study|Withdrawal by Subject|5
7557843|NCT03107052|11922532|FG002|Overall Study|Withdrawal by Subject|8
7557844|NCT03107052|11922530|FG000|Overall Study|Protocol Violation|6
7557845|NCT03107052|11922531|FG001|Overall Study|Protocol Violation|0
7557846|NCT03107052|11922532|FG002|Overall Study|Protocol Violation|3
7557847|NCT03107052|11922530|FG000|Overall Study|Lost to Follow-up|4
7557848|NCT03107052|11922531|FG001|Overall Study|Lost to Follow-up|0
7557849|NCT03107052|11922532|FG002|Overall Study|Lost to Follow-up|1
7557850|NCT03107052|11922530|FG000|Overall Study|Lack of Efficacy|23
7557851|NCT03107052|11922531|FG001|Overall Study|Lack of Efficacy|7
7557852|NCT03107052|11922532|FG002|Overall Study|Lack of Efficacy|4
7557853|NCT03107052|11922530|FG000|Overall Study|Other than specified|4
7557854|NCT03107052|11922531|FG001|Overall Study|Other than specified|2
7557855|NCT03107052|11922532|FG002|Overall Study|Other than specified|0
7557856|NCT03107052|11922530|FG000|Overall Study|Study terminated due to futility|67
7557857|NCT03107052|11922531|FG001|Overall Study|Study terminated due to futility|31
7557858|NCT03107052|11922532|FG002|Overall Study|Study terminated due to futility|23
7557859|NCT03107091|11922540|FG000|Overall Study|Physician Decision|1
7557860|NCT03107377|11922547|FG000|Overall Study|Adverse Event|3
7557861|NCT03107377|11922548|FG001|Overall Study|Adverse Event|3
7557862|NCT03107377|11922547|FG000|Overall Study|Protocol Violation|9
7557863|NCT03107377|11922548|FG001|Overall Study|Protocol Violation|12
7427199|NCT01533935|11704917|FG004|Overall Study|Other reason not defined above|1
7427200|NCT01534078|11704955|FG000|Overall Study|Death|1
7427201|NCT01534078|11704955|FG000|Overall Study|Withdrawal by Subject|1
7557864|NCT03107377|11922547|FG000|Overall Study|Physician Decision|3
7557865|NCT03107377|11922548|FG001|Overall Study|Physician Decision|6
7557866|NCT03107377|11922547|FG000|Overall Study|Pregnancy|7
7557867|NCT03107377|11922548|FG001|Overall Study|Pregnancy|7
7557868|NCT03107377|11922547|FG000|Overall Study|Withdrawal by Subject|16
7557869|NCT03107377|11922548|FG001|Overall Study|Withdrawal by Subject|22
7557870|NCT03107377|11922547|FG000|Overall Study|Lost to Follow-up|37
7557871|NCT03107377|11922548|FG001|Overall Study|Lost to Follow-up|34
7427202|NCT01534182|11704961|FG000|Overall Study|Administrative problems|1
7427203|NCT01534182|11704962|FG001|Overall Study|Administrative problems|0
7427204|NCT01534182|11704961|FG000|Overall Study|Withdrawal by Subject|4
7427205|NCT01534182|11704962|FG001|Overall Study|Withdrawal by Subject|7
7427206|NCT01534182|11704961|FG000|Overall Study|Adverse Event|7
7427207|NCT01534182|11704962|FG001|Overall Study|Adverse Event|3
7427208|NCT01534195|11704971|FG000|Overall Study|Withdrawal by Subject|1
7427209|NCT01534195|11704972|FG001|Overall Study|Withdrawal by Subject|1
7427210|NCT01534208|11704980|FG000|Overall Study|Lost to Follow-up|19
7427211|NCT01534208|11704981|FG001|Overall Study|Lost to Follow-up|14
7427212|NCT01534208|11704980|FG000|Overall Study|Withdrawal by Subject|6
7427213|NCT01534208|11704981|FG001|Overall Study|Withdrawal by Subject|20
7427214|NCT01534208|11704980|FG000|Overall Study|Adverse Event|15
7427215|NCT01534208|11704981|FG001|Overall Study|Adverse Event|8
7427216|NCT01534208|11704980|FG000|Overall Study|Physician Decision|2
7427217|NCT01534208|11704981|FG001|Overall Study|Physician Decision|0
7427218|NCT01534208|11704980|FG000|Overall Study|Lack of Efficacy|0
7427219|NCT01534208|11704981|FG001|Overall Study|Lack of Efficacy|3
7427220|NCT01534208|11704980|FG000|Overall Study|Protocol Violation|2
7427221|NCT01534208|11704981|FG001|Overall Study|Protocol Violation|2
7427222|NCT01534208|11704980|FG000|Overall Study|Sponsor decision|4
7427223|NCT01534208|11704981|FG001|Overall Study|Sponsor decision|1
7427224|NCT01534208|11704980|FG000|Overall Study|Subject relocation|2
7427225|NCT01534208|11704981|FG001|Overall Study|Subject relocation|0
7427226|NCT01534208|11704980|FG000|Overall Study|Lab assessment|2
7427227|NCT01534208|11704981|FG001|Overall Study|Lab assessment|1
7427228|NCT01534208|11704980|FG000|Overall Study|Eligibility error|3
7427229|NCT01534208|11704981|FG001|Overall Study|Eligibility error|0
7427230|NCT01534208|11704980|FG000|Overall Study|PCP decision|1
7427231|NCT01534208|11704981|FG001|Overall Study|PCP decision|0
7427232|NCT01534208|11704980|FG000|Overall Study|Needed prohibited meds|1
7427233|NCT01534208|11704981|FG001|Overall Study|Needed prohibited meds|0
7427234|NCT01534260|11704989|FG000|Overall Study|Adverse Event|1
7427235|NCT01534260|11704990|FG001|Overall Study|Adverse Event|8
7427236|NCT01534260|11704989|FG000|Overall Study|Death|2
7427237|NCT01534260|11704990|FG001|Overall Study|Death|0
7427238|NCT01534260|11704989|FG000|Overall Study|Lack of Efficacy|1
7427239|NCT01534260|11704990|FG001|Overall Study|Lack of Efficacy|1
7427240|NCT01534260|11704989|FG000|Overall Study|Withdrawal by Subject|1
7427241|NCT01534260|11704990|FG001|Overall Study|Withdrawal by Subject|3
7427242|NCT01534260|11704989|FG000|Overall Study|Disease Progression|8
7427243|NCT01534260|11704990|FG001|Overall Study|Disease Progression|6
7427244|NCT01534260|11704989|FG000|Overall Study|Physician Decision|3
7427245|NCT01534260|11704990|FG001|Overall Study|Physician Decision|1
7427246|NCT01534260|11704989|FG000|Overall Study|No treatment, per protocol|0
7427247|NCT01534260|11704990|FG001|Overall Study|No treatment, per protocol|1
7427248|NCT01534273|11705000|FG000|Period 1|Physician Decision|0
7427249|NCT01534273|11705001|FG001|Period 1|Physician Decision|0
7427250|NCT01534273|11705002|FG002|Period 1|Physician Decision|0
7427251|NCT01534273|11705003|FG003|Period 1|Physician Decision|1
7427252|NCT01534273|11705004|FG004|Period 1|Physician Decision|0
7427253|NCT01534273|11705005|FG005|Period 1|Physician Decision|0
7427254|NCT01534273|11705006|FG006|Period 1|Physician Decision|0
7427255|NCT01534351|11705030|FG000|Overall Study|Study Terminated Early|1
7427256|NCT01534351|11705031|FG001|Overall Study|Study Terminated Early|0
7427257|NCT01534351|11705032|FG002|Overall Study|Study Terminated Early|0
7427258|NCT01534520|11705061|FG000|Overall Study|Adverse Event|0
7427259|NCT01534520|11705062|FG001|Overall Study|Adverse Event|1
7427260|NCT01534533|11705076|FG000|Overall Study|Lost to Follow-up|3
7427261|NCT01534533|11705077|FG001|Overall Study|Lost to Follow-up|0
7427262|NCT01534533|11705078|FG002|Overall Study|Lost to Follow-up|4
7427263|NCT01534533|11705079|FG003|Overall Study|Lost to Follow-up|3
7427264|NCT01534533|11705076|FG000|Overall Study|Withdrawal by Subject|5
7557872|NCT03107377|11922547|FG000|Overall Study|Other reason not specified|16
7557873|NCT03107377|11922548|FG001|Overall Study|Other reason not specified|15
7557874|NCT03107715|11922556|FG000|Overall Study|did not deliver at the home hospital|4
7557875|NCT03107715|11922557|FG001|Overall Study|did not deliver at the home hospital|6
7557876|NCT03107715|11922556|FG000|Overall Study|infant stillborn|0
7557877|NCT03107715|11922557|FG001|Overall Study|infant stillborn|1
7557878|NCT03107793|11922572|FG000|Induction Period (16 Weeks)|Adverse Event|5
7557879|NCT03107793|11922573|FG001|Induction Period (16 Weeks)|Adverse Event|0
7557880|NCT03107793|11922574|FG002|Induction Period (16 Weeks)|Adverse Event|0
7557881|NCT03107793|11922572|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
7427265|NCT01534533|11705077|FG001|Overall Study|Withdrawal by Subject|3
7427266|NCT01534533|11705078|FG002|Overall Study|Withdrawal by Subject|4
7557882|NCT03107793|11922573|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
7427267|NCT01534533|11705079|FG003|Overall Study|Withdrawal by Subject|1
7427268|NCT01534637|11705091|FG000|Overall Study|Physician Decision|3
7427269|NCT01534637|11705091|FG000|Overall Study|Lack of Efficacy|3
7427270|NCT01534637|11705091|FG000|Overall Study|Withdrawal by Subject|1
7427271|NCT01534637|11705091|FG000|Overall Study|Adverse Event|1
7427272|NCT01534637|11705091|FG000|Overall Study|Liver Mets before treatment|1
7427273|NCT01534663|11705097|FG000|Overall Study|Lost to Follow-up|0
7427274|NCT01534663|11705098|FG001|Overall Study|Lost to Follow-up|2
7427275|NCT01534663|11705097|FG000|Overall Study|Adverse Event|2
7427276|NCT01534663|11705098|FG001|Overall Study|Adverse Event|1
7427277|NCT01534962|11705128|FG000|Overall Study|Randomized but did not start treatment|2
7427278|NCT01534962|11705129|FG001|Overall Study|Randomized but did not start treatment|0
7427279|NCT01534962|11705130|FG002|Overall Study|Randomized but did not start treatment|0
7427280|NCT01534962|11705131|FG003|Overall Study|Randomized but did not start treatment|1
7427281|NCT01534962|11705128|FG000|Overall Study|Discontinued at AF recurrence|35
7427282|NCT01534962|11705129|FG001|Overall Study|Discontinued at AF recurrence|26
7427283|NCT01534962|11705130|FG002|Overall Study|Discontinued at AF recurrence|24
7427284|NCT01534962|11705131|FG003|Overall Study|Discontinued at AF recurrence|31
7427285|NCT01535040|11705184|FG000|Overall Study|Physician Decision|0
7427286|NCT01535040|11705185|FG001|Overall Study|Physician Decision|1
7427287|NCT01535040|11705184|FG000|Overall Study|Withdrawal by Subject|13
7427288|NCT01535040|11705185|FG001|Overall Study|Withdrawal by Subject|10
7427289|NCT01535040|11705184|FG000|Overall Study|Never Started|9
7427290|NCT01535040|11705185|FG001|Overall Study|Never Started|4
7427291|NCT01535040|11705184|FG000|Overall Study|Toxicity|7
7427292|NCT01535040|11705185|FG001|Overall Study|Toxicity|5
7427293|NCT01535040|11705184|FG000|Overall Study|Multiple Reasons|1
7427294|NCT01535040|11705185|FG001|Overall Study|Multiple Reasons|1
7532083|NCT02662764|11877256|FG000|Overall Study|Patient discharged prior to 24 hrs|5
7532084|NCT02663128|11877267|FG000|Period 2|Physician Decision|0
7532085|NCT02663128|11877268|FG001|Period 2|Physician Decision|0
7532086|NCT02663128|11877269|FG002|Period 2|Physician Decision|0
7427297|NCT01535222|11705210|FG000|Overall Study|Inclusion/exclusion|0
7427298|NCT01535222|11705211|FG001|Overall Study|Inclusion/exclusion|0
7427299|NCT01535222|11705212|FG002|Overall Study|Inclusion/exclusion|1
7427300|NCT01535222|11705213|FG003|Overall Study|Inclusion/exclusion|0
7427301|NCT01535222|11705214|FG004|Overall Study|Inclusion/exclusion|0
7427302|NCT01535222|11705215|FG005|Overall Study|Inclusion/exclusion|0
7427303|NCT01535235|11705231|FG000|Overall Study|Adverse Event|1
7427304|NCT01535235|11705232|FG001|Overall Study|Adverse Event|0
7427305|NCT01535261|11705238|FG000|Overall Study|Physician Decision|8
7427306|NCT01535261|11705238|FG000|Overall Study|Protocol Violation|3
7427307|NCT01535261|11705238|FG000|Overall Study|Death|5
7427308|NCT01535261|11705238|FG000|Overall Study|Lost to Follow-up|8
7427309|NCT01535261|11705238|FG000|Overall Study|Withdrawal by Subject|14
7427310|NCT01535261|11705238|FG000|Overall Study|Adverse Event|12
7427311|NCT01535287|11705244|FG000|Overall Study|drug not prepared in time|5
7427312|NCT01535287|11705245|FG001|Overall Study|drug not prepared in time|6
7427313|NCT01535443|11705278|FG000|Overall Study|Physician Decision|3
7427314|NCT01535560|11705285|FG000|Overall Study|Adverse Event|12
7427315|NCT01535560|11705286|FG001|Overall Study|Adverse Event|7
7427316|NCT01535560|11705285|FG000|Overall Study|Lost to Follow-up|1
7427317|NCT01535560|11705286|FG001|Overall Study|Lost to Follow-up|3
7427318|NCT01535560|11705285|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
7427319|NCT01535560|11705286|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
7427320|NCT01535560|11705285|FG000|Overall Study|Treatment Failure|21
7427321|NCT01535560|11705286|FG001|Overall Study|Treatment Failure|83
7427322|NCT01535560|11705285|FG000|Overall Study|Other|0
7427323|NCT01535560|11705286|FG001|Overall Study|Other|1
7427324|NCT01535560|11705285|FG000|Overall Study|Randomized in Error|0
7427325|NCT01535560|11705286|FG001|Overall Study|Randomized in Error|1
7427326|NCT01535599|11705307|FG000|Overall Study|Adverse Event|6
7427327|NCT01535599|11705308|FG001|Overall Study|Adverse Event|15
7427328|NCT01535599|11705307|FG000|Overall Study|Lost to Follow-up|3
7427329|NCT01535599|11705308|FG001|Overall Study|Lost to Follow-up|4
7427330|NCT01535599|11705307|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
7427331|NCT01535599|11705308|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
7427332|NCT01535599|11705307|FG000|Overall Study|Treatment Failure|33
7427333|NCT01535599|11705308|FG001|Overall Study|Treatment Failure|66
7427334|NCT01535599|11705307|FG000|Overall Study|BL Culture + for Group A Strep|0
7427335|NCT01535599|11705308|FG001|Overall Study|BL Culture + for Group A Strep|1
7427336|NCT01535599|11705307|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
7427337|NCT01535599|11705308|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
7427338|NCT01535599|11705307|FG000|Overall Study|Randomized in Error|2
7427339|NCT01535599|11705308|FG001|Overall Study|Randomized in Error|4
7427340|NCT01535599|11705307|FG000|Overall Study|Did not use product|1
7427341|NCT01535599|11705308|FG001|Overall Study|Did not use product|0
7532087|NCT02663128|11877270|FG003|Period 2|Physician Decision|0
7427342|NCT01535599|11705307|FG000|Overall Study|Other|1
7427343|NCT01535599|11705308|FG001|Overall Study|Other|0
7427344|NCT01535599|11705307|FG000|Overall Study|Stopped medication|0
7427345|NCT01535599|11705308|FG001|Overall Study|Stopped medication|1
7427346|NCT01535599|11705307|FG000|Overall Study|Noncompliance|0
7427347|NCT01535599|11705308|FG001|Overall Study|Noncompliance|1
7427348|NCT01535638|11705314|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
7427349|NCT01535638|11705315|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
7532088|NCT02663128|11877271|FG004|Period 2|Physician Decision|1
7427350|NCT01535638|11705316|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
7427351|NCT01535638|11705317|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
7427352|NCT01535638|11705318|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
7427353|NCT01535638|11705319|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
7427354|NCT01535638|11705314|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
7532089|NCT02663128|11877272|FG005|Period 2|Physician Decision|0
7427355|NCT01535638|11705315|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
7427356|NCT01535638|11705316|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
7427357|NCT01535638|11705317|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
7427358|NCT01535638|11705318|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
7427359|NCT01535638|11705319|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
7427360|NCT01535729|11705336|FG000|Overall Study|Withdrawal by Subject|2
7427361|NCT01535729|11705336|FG000|Overall Study|Disease progression|230
7427362|NCT01535729|11705336|FG000|Overall Study|Discontinued treatment|25
7427363|NCT01535729|11705336|FG000|Overall Study|Lost to Follow-up|8
7427364|NCT01535729|11705336|FG000|Overall Study|Death|52
7427365|NCT01535729|11705336|FG000|Overall Study|Other|19
7427366|NCT01535729|11705336|FG000|Overall Study|Did not sign informed consent|1
7427367|NCT01535729|11705336|FG000|Overall Study|No previous chemotherapy|33
7427368|NCT01535729|11705336|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
7427369|NCT01535729|11705336|FG000|Overall Study|Protocol Violation|11
7427370|NCT01535729|11705336|FG000|Overall Study|Screening failure|1
7427371|NCT01535729|11705336|FG000|Overall Study|Not treated|9
7427372|NCT01535729|11705336|FG000|Overall Study|No participant record available|5
7427373|NCT01536067|11705384|FG000|Overall Study|Disease Progression|1
7427374|NCT01536093|11705390|FG000|Overall Study|Death|1
7427375|NCT01536093|11705391|FG001|Overall Study|Death|2
7427376|NCT01536093|11705390|FG000|Overall Study|absence of maternal colostrum|2
7427377|NCT01536093|11705391|FG001|Overall Study|absence of maternal colostrum|0
7427378|NCT01536093|11705390|FG000|Overall Study|Withdrawal by Subject|0
7427379|NCT01536093|11705391|FG001|Overall Study|Withdrawal by Subject|1
7427380|NCT01536119|11705399|FG000|Overall Study|Lost to Follow-up|17
7427381|NCT01536119|11705400|FG001|Overall Study|Lost to Follow-up|14
7427382|NCT01536145|11705406|FG000|Overall Study|Progressive disease|3
7427383|NCT01536145|11705407|FG001|Overall Study|Progressive disease|4
7427384|NCT01536145|11705408|FG002|Overall Study|Progressive disease|1
7427385|NCT01536145|11705409|FG003|Overall Study|Progressive disease|2
7427386|NCT01536145|11705410|FG004|Overall Study|Progressive disease|1
7427387|NCT01536145|11705411|FG005|Overall Study|Progressive disease|2
7427388|NCT01536145|11705412|FG006|Overall Study|Progressive disease|1
7427389|NCT01536145|11705413|FG007|Overall Study|Progressive disease|2
7427390|NCT01536145|11705414|FG008|Overall Study|Progressive disease|1
7427391|NCT01536145|11705415|FG009|Overall Study|Progressive disease|3
7427392|NCT01536145|11705416|FG010|Overall Study|Progressive disease|3
7427393|NCT01536145|11705406|FG000|Overall Study|Withdrawal by Subject|0
7427394|NCT01536145|11705407|FG001|Overall Study|Withdrawal by Subject|0
7427395|NCT01536145|11705408|FG002|Overall Study|Withdrawal by Subject|1
7427396|NCT01536145|11705409|FG003|Overall Study|Withdrawal by Subject|0
7427397|NCT01536145|11705410|FG004|Overall Study|Withdrawal by Subject|0
7427398|NCT01536145|11705411|FG005|Overall Study|Withdrawal by Subject|1
7427399|NCT01536145|11705412|FG006|Overall Study|Withdrawal by Subject|0
7427400|NCT01536145|11705413|FG007|Overall Study|Withdrawal by Subject|0
7427401|NCT01536145|11705414|FG008|Overall Study|Withdrawal by Subject|2
7427402|NCT01536145|11705415|FG009|Overall Study|Withdrawal by Subject|0
7427403|NCT01536145|11705416|FG010|Overall Study|Withdrawal by Subject|2
7427404|NCT01536145|11705406|FG000|Overall Study|Other|0
7427405|NCT01536145|11705407|FG001|Overall Study|Other|0
7427406|NCT01536145|11705408|FG002|Overall Study|Other|0
7427407|NCT01536145|11705409|FG003|Overall Study|Other|0
7427408|NCT01536145|11705410|FG004|Overall Study|Other|1
7427409|NCT01536145|11705411|FG005|Overall Study|Other|0
7427410|NCT01536145|11705412|FG006|Overall Study|Other|0
7427411|NCT01536145|11705413|FG007|Overall Study|Other|0
7427412|NCT01536145|11705414|FG008|Overall Study|Other|0
7427413|NCT01536145|11705415|FG009|Overall Study|Other|3
7427414|NCT01536145|11705416|FG010|Overall Study|Other|2
7427415|NCT01536145|11705406|FG000|Overall Study|Death|0
7427416|NCT01536145|11705407|FG001|Overall Study|Death|0
7532090|NCT02663453|11877287|FG000|Overall Study|Death|4
7532091|NCT02663453|11877288|FG001|Overall Study|Death|4
7532092|NCT02663453|11877287|FG000|Overall Study|Withdrawal by Subject|1
7532093|NCT02663453|11877288|FG001|Overall Study|Withdrawal by Subject|0
7532094|NCT02663674|11877296|FG000|Overall Study|Lost to Follow-up|5
7532095|NCT02663674|11877297|FG001|Overall Study|Lost to Follow-up|4
7532096|NCT02663674|11877296|FG000|Overall Study|Withdrawal by Subject|1
7532097|NCT02663674|11877297|FG001|Overall Study|Withdrawal by Subject|4
7532098|NCT02663674|11877296|FG000|Overall Study|Physician Decision|1
7532099|NCT02663674|11877297|FG001|Overall Study|Physician Decision|1
7532100|NCT02663674|11877296|FG000|Overall Study|Other Event (Health Related)|0
7532101|NCT02663674|11877297|FG001|Overall Study|Other Event (Health Related)|1
7427417|NCT01536145|11705408|FG002|Overall Study|Death|0
7427418|NCT01536145|11705409|FG003|Overall Study|Death|0
7427419|NCT01536145|11705410|FG004|Overall Study|Death|0
7427420|NCT01536145|11705411|FG005|Overall Study|Death|0
7427421|NCT01536145|11705412|FG006|Overall Study|Death|1
7427422|NCT01536145|11705413|FG007|Overall Study|Death|0
7427423|NCT01536145|11705414|FG008|Overall Study|Death|0
7427424|NCT01536145|11705415|FG009|Overall Study|Death|0
7427425|NCT01536145|11705416|FG010|Overall Study|Death|0
7427426|NCT01536145|11705406|FG000|Overall Study|Adverse Event|0
7532102|NCT02663687|11877308|FG000|Overall Study|Adverse Event|1
7532103|NCT02663687|11877309|FG001|Overall Study|Adverse Event|0
7532104|NCT02663687|11877310|FG002|Overall Study|Adverse Event|0
7427427|NCT01536145|11705407|FG001|Overall Study|Adverse Event|0
7427428|NCT01536145|11705408|FG002|Overall Study|Adverse Event|0
7427429|NCT01536145|11705409|FG003|Overall Study|Adverse Event|0
7427430|NCT01536145|11705410|FG004|Overall Study|Adverse Event|0
7427431|NCT01536145|11705411|FG005|Overall Study|Adverse Event|0
7427432|NCT01536145|11705412|FG006|Overall Study|Adverse Event|0
7427433|NCT01536145|11705413|FG007|Overall Study|Adverse Event|2
7427434|NCT01536145|11705414|FG008|Overall Study|Adverse Event|0
7427435|NCT01536145|11705415|FG009|Overall Study|Adverse Event|0
7427436|NCT01536145|11705416|FG010|Overall Study|Adverse Event|3
7427437|NCT01536171|11705447|FG000|Overall Study|Withdrawal by Subject|1
7427438|NCT01536262|11705473|FG000|Overall Study|Adverse Event|6
7427439|NCT01536262|11705474|FG001|Overall Study|Adverse Event|1
7427440|NCT01536262|11705475|FG002|Overall Study|Adverse Event|2
7427441|NCT01536262|11705473|FG000|Overall Study|Withdrawal by Subject|1
7427442|NCT01536262|11705474|FG001|Overall Study|Withdrawal by Subject|1
7427443|NCT01536262|11705475|FG002|Overall Study|Withdrawal by Subject|0
7427444|NCT01536262|11705473|FG000|Overall Study|Other than stated above|1
7427445|NCT01536262|11705474|FG001|Overall Study|Other than stated above|0
7427446|NCT01536262|11705475|FG002|Overall Study|Other than stated above|0
7427447|NCT01536379|11705495|FG000|Overall Study|Adverse Event|1
7427448|NCT01536379|11705496|FG001|Overall Study|Adverse Event|2
7427449|NCT01536379|11705495|FG000|Overall Study|Withdrawal by Subject|1
7427450|NCT01536379|11705496|FG001|Overall Study|Withdrawal by Subject|1
7427451|NCT01536392|11705504|FG000|Overall Study|Adverse Event|2
7427452|NCT01536392|11705505|FG001|Overall Study|Adverse Event|2
7427453|NCT01536392|11705504|FG000|Overall Study|Physician Decision|2
7427454|NCT01536392|11705505|FG001|Overall Study|Physician Decision|3
7427455|NCT01536392|11705504|FG000|Overall Study|Withdrawal by Subject|3
7427456|NCT01536392|11705505|FG001|Overall Study|Withdrawal by Subject|6
7427457|NCT01536392|11705504|FG000|Overall Study|Non Compliance|3
7427458|NCT01536392|11705505|FG001|Overall Study|Non Compliance|4
7427459|NCT01536392|11705504|FG000|Overall Study|Completed therapy early|3
7427460|NCT01536392|11705505|FG001|Overall Study|Completed therapy early|0
7427461|NCT01536405|11705513|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
7427462|NCT01536405|11705514|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
7427463|NCT01536405|11705513|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
7328390|NCT00796224|11561355|FG000|Overall Study|Protocol Violation|0
7328391|NCT00796224|11561356|FG001|Overall Study|Protocol Violation|1
7328392|NCT00796315|11561374|FG000|Overall Study|Protocol Violation|0
7328393|NCT00796315|11561375|FG001|Overall Study|Protocol Violation|1
7328394|NCT00796315|11561376|FG002|Overall Study|Protocol Violation|0
7328395|NCT00796328|11561387|FG000|Overall Study|experienced hypotension requiring tx|6
7328396|NCT00796367|11561394|FG000|Overall Study|Adverse Event|6
7328397|NCT00796367|11561395|FG001|Overall Study|Adverse Event|4
7328398|NCT00796367|11561396|FG002|Overall Study|Adverse Event|7
7328399|NCT00796367|11561394|FG000|Overall Study|Lost to Follow-up|5
7328400|NCT00796367|11561395|FG001|Overall Study|Lost to Follow-up|4
7328401|NCT00796367|11561396|FG002|Overall Study|Lost to Follow-up|21
7328402|NCT00796367|11561394|FG000|Overall Study|Withdrawal by Subject|9
7328403|NCT00796367|11561395|FG001|Overall Study|Withdrawal by Subject|11
7328404|NCT00796367|11561396|FG002|Overall Study|Withdrawal by Subject|12
7328405|NCT00796367|11561394|FG000|Overall Study|Lack of Efficacy|2
7328406|NCT00796367|11561395|FG001|Overall Study|Lack of Efficacy|1
7328407|NCT00796367|11561396|FG002|Overall Study|Lack of Efficacy|0
7328408|NCT00796367|11561394|FG000|Overall Study|non compliance|3
7328409|NCT00796367|11561395|FG001|Overall Study|non compliance|1
7328410|NCT00796367|11561396|FG002|Overall Study|non compliance|1
7328411|NCT00796367|11561394|FG000|Overall Study|Pregnancy|1
7328412|NCT00796367|11561395|FG001|Overall Study|Pregnancy|0
7328413|NCT00796367|11561396|FG002|Overall Study|Pregnancy|1
7328414|NCT00796367|11561394|FG000|Overall Study|Requirement for restricted medication|2
7328415|NCT00796367|11561395|FG001|Overall Study|Requirement for restricted medication|0
7328416|NCT00796367|11561396|FG002|Overall Study|Requirement for restricted medication|2
7328417|NCT00796367|11561394|FG000|Overall Study|other|2
7328418|NCT00796367|11561395|FG001|Overall Study|other|4
7328419|NCT00796367|11561396|FG002|Overall Study|other|3
7328420|NCT00796419|11561406|FG000|Overall Study|Death|0
7328421|NCT00796419|11561407|FG001|Overall Study|Death|1
7328422|NCT00796445|11561415|FG000|Overall Study|Protocol Violation|5
7328423|NCT00796445|11561416|FG001|Overall Study|Protocol Violation|3
7328424|NCT00796445|11561415|FG000|Overall Study|Adverse event, serious fatal|10
7328425|NCT00796445|11561416|FG001|Overall Study|Adverse event, serious fatal|5
7328426|NCT00796445|11561415|FG000|Overall Study|Adverse event, non-fatal|4
7328427|NCT00796445|11561416|FG001|Overall Study|Adverse event, non-fatal|0
7427464|NCT01536405|11705514|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
7427465|NCT01536405|11705513|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
7427466|NCT01536405|11705514|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
7427467|NCT01536405|11705513|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
7427468|NCT01536405|11705514|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
7427469|NCT01536405|11705513|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7427470|NCT01536405|11705514|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
7466839|NCT01894919|11766818|FG003|Overall Study|Lost to Follow-up|0
7427471|NCT01536405|11705513|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
7427472|NCT01536405|11705514|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
7427473|NCT01536405|11705513|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7427474|NCT01536405|11705514|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
7427475|NCT01536405|11705513|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
7427476|NCT01536405|11705514|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
7427477|NCT01536405|11705513|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
7427478|NCT01536405|11705514|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
7427479|NCT01536405|11705513|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
7427480|NCT01536405|11705514|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
7427481|NCT01536405|11705513|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
7427482|NCT01536405|11705514|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
7427483|NCT01536405|11705513|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
7427484|NCT01536405|11705514|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
7427485|NCT01536405|11705513|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7427486|NCT01536405|11705514|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
7427487|NCT01536418|11705522|FG000|Overall Study|Protocol Violation|2
7427488|NCT01536418|11705523|FG001|Overall Study|Protocol Violation|3
7427489|NCT01536418|11705522|FG000|Overall Study|Physician Decision|1
7427490|NCT01536418|11705523|FG001|Overall Study|Physician Decision|3
7427491|NCT01536418|11705522|FG000|Overall Study|Study closed/terminated|41
7427492|NCT01536418|11705523|FG001|Overall Study|Study closed/terminated|37
7427493|NCT01536418|11705522|FG000|Overall Study|Lack of Efficacy|10
7427494|NCT01536418|11705523|FG001|Overall Study|Lack of Efficacy|16
7427495|NCT01536418|11705522|FG000|Overall Study|Adverse Event|9
7427496|NCT01536418|11705523|FG001|Overall Study|Adverse Event|4
7427497|NCT01536418|11705522|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
7427498|NCT01536418|11705523|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
7427499|NCT01536418|11705522|FG000|Overall Study|Withdrawal by Subject|5
7427500|NCT01536418|11705523|FG001|Overall Study|Withdrawal by Subject|3
7427501|NCT01536535|11705543|FG000|Overall Study|Withdrawal by Subject|10
7427502|NCT01536535|11705544|FG001|Overall Study|Withdrawal by Subject|5
7427503|NCT01536535|11705543|FG000|Overall Study|Lost to Follow-up|4
7427504|NCT01536535|11705544|FG001|Overall Study|Lost to Follow-up|6
7427505|NCT01536535|11705543|FG000|Overall Study|Physician Decision|1
7427506|NCT01536535|11705544|FG001|Overall Study|Physician Decision|1
7532105|NCT02663687|11877311|FG003|Overall Study|Adverse Event|0
7532106|NCT02663687|11877312|FG004|Overall Study|Adverse Event|0
7532107|NCT02663687|11877308|FG000|Overall Study|Other|1
7532108|NCT02663687|11877309|FG001|Overall Study|Other|0
7532109|NCT02663687|11877310|FG002|Overall Study|Other|1
7532110|NCT02663687|11877311|FG003|Overall Study|Other|0
7532111|NCT02663687|11877312|FG004|Overall Study|Other|0
7532112|NCT02663817|11877337|FG000|Overall Study|Screen failure|2
7532113|NCT02663882|11877345|FG000|Overall Study|Lost to Follow-up|4
7427507|NCT01536535|11705543|FG000|Overall Study|Participant moved|0
7427508|NCT01536535|11705544|FG001|Overall Study|Participant moved|1
7427509|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
7427510|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
7427511|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
7427512|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
7427513|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Death|2
7427514|NCT01536561|11705551|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
7427515|NCT01536574|11705560|FG000|Overall Study|Adverse Event|4
7427516|NCT01536574|11705561|FG001|Overall Study|Adverse Event|5
7427517|NCT01536574|11705560|FG000|Overall Study|Withdrawal by Subject|1
7427518|NCT01536574|11705561|FG001|Overall Study|Withdrawal by Subject|2
7427519|NCT01536574|11705560|FG000|Overall Study|Lack of Efficacy|1
7427520|NCT01536574|11705561|FG001|Overall Study|Lack of Efficacy|0
7427521|NCT01536587|11705567|FG000|Overall Study|Adverse Event|2
7427522|NCT01536704|11705571|FG000|Washout Period 1|Withdrawal by Subject|1
7427523|NCT01536704|11705572|FG001|Washout Period 1|Withdrawal by Subject|2
7427524|NCT01536704|11705573|FG002|Washout Period 1|Withdrawal by Subject|0
7427525|NCT01536704|11705574|FG003|Washout Period 1|Withdrawal by Subject|0
7427526|NCT01536704|11705571|FG000|Washout Period 2|Adverse Event|1
7427527|NCT01536704|11705572|FG001|Washout Period 2|Adverse Event|0
7532114|NCT02663882|11877346|FG001|Overall Study|Lost to Follow-up|2
7532115|NCT02663895|11877352|FG000|Overall Study|Adverse Event|3
7427528|NCT01536704|11705573|FG002|Washout Period 2|Adverse Event|0
7427529|NCT01536704|11705574|FG003|Washout Period 2|Adverse Event|0
7427530|NCT01536704|11705571|FG000|Washout Period 2|Withdrawal by Subject|0
7427531|NCT01536704|11705572|FG001|Washout Period 2|Withdrawal by Subject|0
7427532|NCT01536704|11705573|FG002|Washout Period 2|Withdrawal by Subject|0
7427533|NCT01536704|11705574|FG003|Washout Period 2|Withdrawal by Subject|1
7427534|NCT01536704|11705571|FG000|Period 3|Adverse Event|0
7427535|NCT01536704|11705572|FG001|Period 3|Adverse Event|0
7427536|NCT01536704|11705573|FG002|Period 3|Adverse Event|0
7427537|NCT01536704|11705574|FG003|Period 3|Adverse Event|1
7532116|NCT02663895|11877352|FG000|Overall Study|Physician Decision|2
7532117|NCT02663895|11877352|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
7532118|NCT02663895|11877352|FG000|Overall Study|Withdrawal by Subject|1
7427538|NCT01536704|11705571|FG000|Washout Period 3|Adverse Event|0
7427539|NCT01536704|11705572|FG001|Washout Period 3|Adverse Event|0
7427540|NCT01536704|11705573|FG002|Washout Period 3|Adverse Event|1
7427541|NCT01536704|11705574|FG003|Washout Period 3|Adverse Event|0
7427542|NCT01536795|11705590|FG000|Overall Study|Lost to Follow-up|0
7427543|NCT01536795|11705591|FG001|Overall Study|Lost to Follow-up|2
7427544|NCT01536795|11705590|FG000|Overall Study|Lack of Efficacy|1
7427545|NCT01536795|11705591|FG001|Overall Study|Lack of Efficacy|0
7427546|NCT01536860|11705597|FG000|Washout Period (3 Days)|Lost to Follow-up|1
7427547|NCT01536860|11705598|FG001|Washout Period (3 Days)|Lost to Follow-up|0
7427548|NCT01536860|11705599|FG002|Washout Period (3 Days)|Lost to Follow-up|0
7427549|NCT01536951|11705639|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427550|NCT01536951|11705640|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427551|NCT01536951|11705641|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
7427552|NCT01536951|11705642|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
7557883|NCT03107793|11922574|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7557884|NCT03107793|11922572|FG000|Induction Period (16 Weeks)|Physician Decision|1
7557885|NCT03107793|11922573|FG001|Induction Period (16 Weeks)|Physician Decision|0
7557886|NCT03107793|11922574|FG002|Induction Period (16 Weeks)|Physician Decision|0
7557887|NCT03107793|11922572|FG000|Induction Period (16 Weeks)|Progressive Disease|1
7557888|NCT03107793|11922573|FG001|Induction Period (16 Weeks)|Progressive Disease|0
7557889|NCT03107793|11922574|FG002|Induction Period (16 Weeks)|Progressive Disease|0
7557890|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
7557891|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
7557892|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
7557893|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Death|0
7557894|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Death|2
7557895|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Death|0
7557896|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
7427553|NCT01536951|11705643|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427554|NCT01536951|11705644|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427555|NCT01536951|11705645|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427556|NCT01536951|11705646|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427557|NCT01536951|11705647|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
7427558|NCT01536951|11705639|FG000|Second Intervention and Washout Period 2|Adverse Event|0
7427559|NCT01536951|11705640|FG001|Second Intervention and Washout Period 2|Adverse Event|0
7427560|NCT01536951|11705641|FG002|Second Intervention and Washout Period 2|Adverse Event|0
7427561|NCT01536951|11705642|FG003|Second Intervention and Washout Period 2|Adverse Event|0
7427562|NCT01536951|11705643|FG004|Second Intervention and Washout Period 2|Adverse Event|0
7427563|NCT01536951|11705644|FG005|Second Intervention and Washout Period 2|Adverse Event|0
7427564|NCT01536951|11705645|FG006|Second Intervention and Washout Period 2|Adverse Event|0
7427565|NCT01536951|11705646|FG007|Second Intervention and Washout Period 2|Adverse Event|1
7427566|NCT01536951|11705647|FG008|Second Intervention and Washout Period 2|Adverse Event|0
7427567|NCT01537042|11705676|FG000|Overall Study|Adverse Event|0
7427568|NCT01537042|11705677|FG001|Overall Study|Adverse Event|2
7427569|NCT01537042|11705676|FG000|Overall Study|Lack of Efficacy|0
7427570|NCT01537042|11705677|FG001|Overall Study|Lack of Efficacy|1
7427571|NCT01537042|11705676|FG000|Overall Study|Protocol Violation|0
7427572|NCT01537042|11705677|FG001|Overall Study|Protocol Violation|1
7427573|NCT01537042|11705676|FG000|Overall Study|Other|0
7427574|NCT01537042|11705677|FG001|Overall Study|Other|1
7427575|NCT01537068|11705689|FG000|Overall Study|Lost to Follow-up|2
7427576|NCT01537068|11705690|FG001|Overall Study|Lost to Follow-up|1
7427577|NCT01537068|11705689|FG000|Overall Study|Adverse Event|0
7427578|NCT01537068|11705690|FG001|Overall Study|Adverse Event|1
7427579|NCT01537068|11705689|FG000|Overall Study|Withdrawal by Subject|1
7427580|NCT01537068|11705690|FG001|Overall Study|Withdrawal by Subject|1
7427581|NCT01537068|11705689|FG000|Overall Study|Lack of Efficacy|1
7427582|NCT01537068|11705690|FG001|Overall Study|Lack of Efficacy|0
7427583|NCT01537081|11705699|FG000|Overall Study|Adverse Event|5
7427584|NCT01537081|11705700|FG001|Overall Study|Adverse Event|2
7427585|NCT01537081|11705701|FG002|Overall Study|Adverse Event|2
7427586|NCT01537081|11705699|FG000|Overall Study|Lack of Efficacy|2
7427587|NCT01537081|11705700|FG001|Overall Study|Lack of Efficacy|1
7427588|NCT01537081|11705701|FG002|Overall Study|Lack of Efficacy|0
7427589|NCT01537081|11705699|FG000|Overall Study|Lost to Follow-up|17
7427590|NCT01537081|11705700|FG001|Overall Study|Lost to Follow-up|15
7427591|NCT01537081|11705701|FG002|Overall Study|Lost to Follow-up|9
7427592|NCT01537081|11705699|FG000|Overall Study|Protocol Violation|3
7557897|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
7557898|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
7557899|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7557900|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
7427593|NCT01537081|11705700|FG001|Overall Study|Protocol Violation|2
7557901|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
7557902|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
7427594|NCT01537081|11705701|FG002|Overall Study|Protocol Violation|2
7427595|NCT01537081|11705699|FG000|Overall Study|Withdrawal by Subject|6
7427596|NCT01537081|11705700|FG001|Overall Study|Withdrawal by Subject|11
7427597|NCT01537081|11705701|FG002|Overall Study|Withdrawal by Subject|3
7427598|NCT01537081|11705699|FG000|Overall Study|Physician Decision|5
7427599|NCT01537081|11705700|FG001|Overall Study|Physician Decision|6
7427600|NCT01537081|11705701|FG002|Overall Study|Physician Decision|0
7427601|NCT01537081|11705699|FG000|Overall Study|Sponsor decision|0
7427602|NCT01537081|11705700|FG001|Overall Study|Sponsor decision|1
7427603|NCT01537081|11705701|FG002|Overall Study|Sponsor decision|0
7427604|NCT01537081|11705699|FG000|Overall Study|Assigned but never dosed|1
7427605|NCT01537081|11705700|FG001|Overall Study|Assigned but never dosed|0
7427606|NCT01537081|11705701|FG002|Overall Study|Assigned but never dosed|0
7427607|NCT01537120|11705710|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
7427608|NCT01537120|11705710|FG000|3 Weeks Placebo|Withdrawal by Subject|1
7427609|NCT01537133|11705720|FG000|Overall Study|Withdrawal by Subject|2
7427610|NCT01537133|11705721|FG001|Overall Study|Withdrawal by Subject|0
7427611|NCT01537133|11705722|FG002|Overall Study|Withdrawal by Subject|0
7427612|NCT01537133|11705723|FG003|Overall Study|Withdrawal by Subject|0
7427613|NCT01537133|11705720|FG000|Overall Study|Lost to Follow-up|1
7427614|NCT01537133|11705721|FG001|Overall Study|Lost to Follow-up|0
7427615|NCT01537133|11705722|FG002|Overall Study|Lost to Follow-up|0
7427616|NCT01537133|11705723|FG003|Overall Study|Lost to Follow-up|0
7427617|NCT01537198|11705750|FG000|Overall Study|RSV infection|2
7427618|NCT01537198|11705750|FG000|Overall Study|Adverse Event|4
7427619|NCT01537198|11705750|FG000|Overall Study|No Further Visits to the Clinic|37
7427620|NCT01537198|11705750|FG000|Overall Study|Other|111
7427621|NCT01537211|11705756|FG000|Overall Study|Lost to Follow-up|0
7427622|NCT01537211|11705757|FG001|Overall Study|Lost to Follow-up|1
7466840|NCT01894919|11766819|FG004|Overall Study|Lost to Follow-up|2
7466841|NCT01894919|11766820|FG005|Overall Study|Lost to Follow-up|0
7466842|NCT01894919|11766821|FG006|Overall Study|Lost to Follow-up|0
7466843|NCT01894919|11766822|FG007|Overall Study|Lost to Follow-up|0
7466844|NCT01894919|11766823|FG008|Overall Study|Lost to Follow-up|0
7466845|NCT01894919|11766824|FG009|Overall Study|Lost to Follow-up|0
7466846|NCT01894919|11766825|FG010|Overall Study|Lost to Follow-up|0
7466847|NCT01894919|11766826|FG011|Overall Study|Lost to Follow-up|0
7466848|NCT01894919|11766827|FG012|Overall Study|Lost to Follow-up|0
7466849|NCT01894984|11766871|FG000|Overall Study|Other|314
7466850|NCT01894984|11766872|FG001|Overall Study|Other|175
7466851|NCT01895101|11766898|FG000|Overall Study|OPCAB procedure|1
7466852|NCT01895101|11766899|FG001|Overall Study|OPCAB procedure|1
7466853|NCT01895101|11766900|FG002|Overall Study|OPCAB procedure|3
7466854|NCT01895101|11766898|FG000|Overall Study|Withdrawal by Subject|0
7466855|NCT01895101|11766899|FG001|Overall Study|Withdrawal by Subject|1
7466856|NCT01895101|11766900|FG002|Overall Study|Withdrawal by Subject|2
7466857|NCT01895101|11766898|FG000|Overall Study|another study, enrolled in other study|0
7466858|NCT01895101|11766899|FG001|Overall Study|another study, enrolled in other study|1
7466859|NCT01895101|11766900|FG002|Overall Study|another study, enrolled in other study|0
7466860|NCT01895101|11766898|FG000|Overall Study|Death|0
7466861|NCT01895101|11766899|FG001|Overall Study|Death|1
7466862|NCT01895101|11766900|FG002|Overall Study|Death|0
7466863|NCT01895101|11766898|FG000|Overall Study|coagulation disorder|0
7466864|NCT01895101|11766899|FG001|Overall Study|coagulation disorder|1
7466865|NCT01895101|11766900|FG002|Overall Study|coagulation disorder|0
7466866|NCT01895270|11766920|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
7466867|NCT01895270|11766921|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
7466868|NCT01895270|11766920|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
7466869|NCT01895270|11766921|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
7466870|NCT01895270|11766920|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
7466871|NCT01895270|11766921|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
7466872|NCT01895270|11766920|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
7466873|NCT01895270|11766921|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
7466874|NCT01895270|11766920|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
7466875|NCT01895270|11766921|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
7466876|NCT01895270|11766920|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
7466877|NCT01895270|11766921|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
7466878|NCT01895270|11766920|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
7466879|NCT01895270|11766921|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
7466880|NCT01895309|11766929|FG000|Overall Study|Adverse Event|13
7466881|NCT01895309|11766930|FG001|Overall Study|Adverse Event|17
7466882|NCT01895309|11766929|FG000|Overall Study|Protocol Violation|1
7466883|NCT01895309|11766930|FG001|Overall Study|Protocol Violation|0
7466884|NCT01895309|11766929|FG000|Overall Study|Lack of Efficacy|1
7466885|NCT01895309|11766930|FG001|Overall Study|Lack of Efficacy|3
7466886|NCT01895309|11766929|FG000|Overall Study|Lost to Follow-up|1
7466887|NCT01895309|11766930|FG001|Overall Study|Lost to Follow-up|3
7466888|NCT01895309|11766929|FG000|Overall Study|Physician Decision|15
7466889|NCT01895309|11766930|FG001|Overall Study|Physician Decision|10
7466890|NCT01895309|11766929|FG000|Overall Study|Withdrawal by Subject|9
7466891|NCT01895309|11766930|FG001|Overall Study|Withdrawal by Subject|18
7466892|NCT01895322|11766940|FG000|Overall Study|Adverse Event|1
7427623|NCT01537393|11705795|FG000|Overall Study|Exclude prior to study|32
7427624|NCT01537393|11705796|FG001|Overall Study|Exclude prior to study|44
7427625|NCT01537393|11705795|FG000|Overall Study|Death|20
7427626|NCT01537393|11705796|FG001|Overall Study|Death|32
7427627|NCT01537393|11705795|FG000|Overall Study|Withdrawal by Subject|18
7427628|NCT01537393|11705796|FG001|Overall Study|Withdrawal by Subject|17
7427629|NCT01537393|11705795|FG000|Overall Study|Lost to Follow-up|53
7427630|NCT01537393|11705796|FG001|Overall Study|Lost to Follow-up|48
7427631|NCT01537393|11705795|FG000|Overall Study|Failure - Regrafted|28
7427632|NCT01537393|11705796|FG001|Overall Study|Failure - Regrafted|43
7427633|NCT01537393|11705795|FG000|Overall Study|Failure - Not regrafted|2
7427634|NCT01537393|11705796|FG001|Overall Study|Failure - Not regrafted|6
7427635|NCT01537393|11705795|FG000|Overall Study|Censored (severe event unrelated to PT)|1
7427636|NCT01537393|11705796|FG001|Overall Study|Censored (severe event unrelated to PT)|1
7427637|NCT01537432|11705813|FG000|Overall Study|Lost to Follow-up|3
7557903|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
7557904|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
7557905|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
7557906|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
7557907|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
7557908|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
7557909|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
7557910|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
7557911|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
7557912|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
7557913|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
7557914|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
7557915|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
7557916|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
7557917|NCT03107793|11922572|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7557918|NCT03107793|11922573|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
7557919|NCT03107793|11922574|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
7557920|NCT03108027|11922581|FG000|Period 1|Subject/Guardian Decision|0
7557921|NCT03108027|11922582|FG001|Period 1|Subject/Guardian Decision|0
7557922|NCT03108027|11922583|FG002|Period 1|Subject/Guardian Decision|0
7557923|NCT03108027|11922584|FG003|Period 1|Subject/Guardian Decision|2
7557924|NCT03108027|11922585|FG004|Period 1|Subject/Guardian Decision|0
7557925|NCT03108027|11922586|FG005|Period 1|Subject/Guardian Decision|0
7557926|NCT03108027|11922581|FG000|Period 3|Adverse Event|0
7557927|NCT03108027|11922582|FG001|Period 3|Adverse Event|1
7557928|NCT03108027|11922583|FG002|Period 3|Adverse Event|0
7557929|NCT03108027|11922584|FG003|Period 3|Adverse Event|0
7557930|NCT03108027|11922585|FG004|Period 3|Adverse Event|0
7557931|NCT03108027|11922586|FG005|Period 3|Adverse Event|0
7557932|NCT03108157|11922596|FG000|Overall Study|Protocol Violation|15
7557933|NCT03108157|11922597|FG001|Overall Study|Protocol Violation|4
7557934|NCT03108521|11922632|FG000|Overall Study|Lost to Follow-up|3
7557935|NCT03108521|11922633|FG001|Overall Study|Lost to Follow-up|0
7557936|NCT03108521|11922632|FG000|Overall Study|Lack of Efficacy|2
7557937|NCT03108521|11922633|FG001|Overall Study|Lack of Efficacy|0
7557938|NCT03108521|11922632|FG000|Overall Study|Physician Decision|4
7557939|NCT03108521|11922633|FG001|Overall Study|Physician Decision|0
7557940|NCT03108521|11922632|FG000|Overall Study|Adverse Event|3
7557941|NCT03108521|11922633|FG001|Overall Study|Adverse Event|0
7557942|NCT03109184|11922680|FG000|Overall Study|Lost to Follow-up|6
7557943|NCT03109184|11922681|FG001|Overall Study|Lost to Follow-up|6
7557944|NCT03109184|11922680|FG000|Overall Study|Withdrawal by Subject|1
7557945|NCT03109184|11922681|FG001|Overall Study|Withdrawal by Subject|1
7557946|NCT03110029|11922711|FG000|Overall Study|Withdrawal by Subject|1
7557947|NCT03110029|11922712|FG001|Overall Study|Withdrawal by Subject|1
7557948|NCT03110185|11922720|FG000|Overall Study|Death|0
7557949|NCT03110185|11922721|FG001|Overall Study|Death|1
7557950|NCT03110185|11922720|FG000|Overall Study|Withdrawal by Subject|2
7557951|NCT03110185|11922721|FG001|Overall Study|Withdrawal by Subject|7
7557952|NCT03110185|11922720|FG000|Overall Study|Time Constraints|0
7557953|NCT03110185|11922721|FG001|Overall Study|Time Constraints|6
7557954|NCT03110185|11922720|FG000|Overall Study|Conflict with care|5
7557955|NCT03110185|11922721|FG001|Overall Study|Conflict with care|12
7557956|NCT03110185|11922720|FG000|Overall Study|Protocol Violation|1
7557957|NCT03110185|11922721|FG001|Overall Study|Protocol Violation|4
7557958|NCT03110185|11922720|FG000|Overall Study|MRI Incompatible|2
7557959|NCT03110185|11922721|FG001|Overall Study|MRI Incompatible|0
7557960|NCT03110185|11922720|FG000|Overall Study|Patient Refusal|0
7557961|NCT03110185|11922721|FG001|Overall Study|Patient Refusal|1
7557962|NCT03110562|11922752|FG000|Overall Study|Withdrawal by Subject|37
7557963|NCT03110562|11922753|FG001|Overall Study|Withdrawal by Subject|35
7557964|NCT03110562|11922752|FG000|Overall Study|Death|47
7557965|NCT03110562|11922753|FG001|Overall Study|Death|61
7557966|NCT03110562|11922752|FG000|Overall Study|Lost to Follow-up|7
7427638|NCT01537432|11705814|FG001|Overall Study|Lost to Follow-up|1
7557967|NCT03110562|11922753|FG001|Overall Study|Lost to Follow-up|6
7557968|NCT03110562|11922752|FG000|Overall Study|Other|2
7557969|NCT03110562|11922753|FG001|Overall Study|Other|1
7557970|NCT03110562|11922752|FG000|Overall Study|Randomized but never treated|0
7557971|NCT03110562|11922753|FG001|Overall Study|Randomized but never treated|3
7557972|NCT03110562|11922752|FG000|Overall Study|Ongoing|102
7557973|NCT03110562|11922753|FG001|Overall Study|Ongoing|101
7557974|NCT03110770|11922780|FG000|Overall Study|Death|1
7557975|NCT03110770|11922781|FG001|Overall Study|Death|0
7557976|NCT03110770|11922782|FG002|Overall Study|Death|0
7557977|NCT03110770|11922783|FG003|Overall Study|Death|1
7557978|NCT03110770|11922784|FG004|Overall Study|Death|0
7557979|NCT03110770|11922780|FG000|Overall Study|Enrolled but did not receive product|0
7557980|NCT03110770|11922781|FG001|Overall Study|Enrolled but did not receive product|0
7557981|NCT03110770|11922782|FG002|Overall Study|Enrolled but did not receive product|0
7557982|NCT03110770|11922783|FG003|Overall Study|Enrolled but did not receive product|8
7557983|NCT03110770|11922784|FG004|Overall Study|Enrolled but did not receive product|7
7557984|NCT03110770|11922780|FG000|Overall Study|Lost to Follow-up|0
7557985|NCT03110770|11922781|FG001|Overall Study|Lost to Follow-up|0
7557986|NCT03110770|11922782|FG002|Overall Study|Lost to Follow-up|0
7557987|NCT03110770|11922783|FG003|Overall Study|Lost to Follow-up|53
7557988|NCT03110770|11922784|FG004|Overall Study|Lost to Follow-up|45
7557989|NCT03110770|11922780|FG000|Overall Study|Investigator Decision|0
7557990|NCT03110770|11922781|FG001|Overall Study|Investigator Decision|0
7557991|NCT03110770|11922782|FG002|Overall Study|Investigator Decision|0
7557992|NCT03110770|11922783|FG003|Overall Study|Investigator Decision|5
7557993|NCT03110770|11922784|FG004|Overall Study|Investigator Decision|3
7557994|NCT03110770|11922780|FG000|Overall Study|Withdrawal by Subject|0
7427639|NCT01537432|11705813|FG000|Overall Study|Withdrawal by Subject|0
7427640|NCT01537432|11705814|FG001|Overall Study|Withdrawal by Subject|1
7427641|NCT01537432|11705813|FG000|Overall Study|Administrative problems|1
7427642|NCT01537432|11705814|FG001|Overall Study|Administrative problems|0
7427643|NCT01537432|11705813|FG000|Overall Study|Adverse Event|1
7427644|NCT01537432|11705814|FG001|Overall Study|Adverse Event|0
7427645|NCT01537432|11705813|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7427646|NCT01537432|11705814|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7427647|NCT01537549|11705820|FG000|Overall Study|Lost to Follow-up|1
7427648|NCT01537549|11705820|FG000|Overall Study|Withdrawal by Subject|2
7427649|NCT01537783|11705855|FG000|Overall Study|Lost to Follow-up|11
7427650|NCT01537783|11705856|FG001|Overall Study|Lost to Follow-up|2
7427651|NCT01537887|11705875|FG000|Period 1|Physician Decision|0
7427652|NCT01537887|11705876|FG001|Period 1|Physician Decision|0
7427653|NCT01537887|11705877|FG002|Period 1|Physician Decision|0
7427654|NCT01537887|11705878|FG003|Period 1|Physician Decision|0
7427655|NCT01537887|11705879|FG004|Period 1|Physician Decision|1
7427656|NCT01537887|11705880|FG005|Period 1|Physician Decision|1
7427657|NCT01537887|11705875|FG000|Period 1|Did not receive treatment|0
7427658|NCT01537887|11705876|FG001|Period 1|Did not receive treatment|0
7427659|NCT01537887|11705877|FG002|Period 1|Did not receive treatment|1
7427660|NCT01537887|11705878|FG003|Period 1|Did not receive treatment|0
7427661|NCT01537887|11705879|FG004|Period 1|Did not receive treatment|0
7427662|NCT01537887|11705880|FG005|Period 1|Did not receive treatment|0
7427663|NCT01537887|11705875|FG000|Period 2|Withdrawal by Subject|0
7427664|NCT01537887|11705876|FG001|Period 2|Withdrawal by Subject|1
7427665|NCT01537887|11705877|FG002|Period 2|Withdrawal by Subject|0
7427666|NCT01537887|11705878|FG003|Period 2|Withdrawal by Subject|0
7427667|NCT01537887|11705879|FG004|Period 2|Withdrawal by Subject|0
7427668|NCT01537887|11705880|FG005|Period 2|Withdrawal by Subject|0
7427669|NCT01537887|11705875|FG000|Period 3|Adverse Event|0
7427670|NCT01537887|11705876|FG001|Period 3|Adverse Event|0
7427671|NCT01537887|11705877|FG002|Period 3|Adverse Event|1
7427672|NCT01537887|11705878|FG003|Period 3|Adverse Event|0
7427673|NCT01537887|11705879|FG004|Period 3|Adverse Event|0
7427674|NCT01537887|11705880|FG005|Period 3|Adverse Event|0
7427675|NCT01537887|11705875|FG000|Period 3|Withdrawal by Subject|0
7427676|NCT01537887|11705876|FG001|Period 3|Withdrawal by Subject|1
7557995|NCT03110770|11922781|FG001|Overall Study|Withdrawal by Subject|0
7557996|NCT03110770|11922782|FG002|Overall Study|Withdrawal by Subject|0
7557997|NCT03110770|11922783|FG003|Overall Study|Withdrawal by Subject|24
7557998|NCT03110770|11922784|FG004|Overall Study|Withdrawal by Subject|24
7557999|NCT03110770|11922780|FG000|Overall Study|Moved from area|5
7558000|NCT03110770|11922781|FG001|Overall Study|Moved from area|0
7558001|NCT03110770|11922782|FG002|Overall Study|Moved from area|2
7558002|NCT03110770|11922783|FG003|Overall Study|Moved from area|42
7558003|NCT03110770|11922784|FG004|Overall Study|Moved from area|43
7558004|NCT03110770|11922780|FG000|Overall Study|Illness/Injury unrelated to product|0
7558005|NCT03110770|11922781|FG001|Overall Study|Illness/Injury unrelated to product|0
7558006|NCT03110770|11922782|FG002|Overall Study|Illness/Injury unrelated to product|0
7558007|NCT03110770|11922783|FG003|Overall Study|Illness/Injury unrelated to product|0
7558008|NCT03110770|11922784|FG004|Overall Study|Illness/Injury unrelated to product|1
7558009|NCT03111108|11922800|FG000|Overall Study|Death|0
7558010|NCT03111108|11922801|FG001|Overall Study|Death|1
7558011|NCT03111108|11922800|FG000|Overall Study|Withdrawal by Subject|1
7427677|NCT01537887|11705877|FG002|Period 3|Withdrawal by Subject|0
7427678|NCT01537887|11705878|FG003|Period 3|Withdrawal by Subject|0
7427679|NCT01537887|11705879|FG004|Period 3|Withdrawal by Subject|0
7427680|NCT01537887|11705880|FG005|Period 3|Withdrawal by Subject|0
7427681|NCT01538199|11705908|FG000|Overall Study|Lost to Follow-up|1
7427682|NCT01538199|11705909|FG001|Overall Study|Lost to Follow-up|2
7427683|NCT01538199|11705910|FG002|Overall Study|Lost to Follow-up|1
7427684|NCT01538199|11705911|FG003|Overall Study|Lost to Follow-up|0
7427685|NCT01538199|11705908|FG000|Overall Study|participant did not have time|1
7427686|NCT01538199|11705909|FG001|Overall Study|participant did not have time|0
7558012|NCT03111108|11922801|FG001|Overall Study|Withdrawal by Subject|0
7558013|NCT03113916|11922912|FG000|Overall Study|Withdrawal by Subject|9
7558014|NCT03113916|11922913|FG001|Overall Study|Withdrawal by Subject|7
7558015|NCT03113916|11922912|FG000|Overall Study|Pregnancy|1
7558016|NCT03113916|11922913|FG001|Overall Study|Pregnancy|3
7427687|NCT01538199|11705910|FG002|Overall Study|participant did not have time|0
7427688|NCT01538199|11705911|FG003|Overall Study|participant did not have time|2
7427689|NCT01538199|11705908|FG000|Overall Study|Lack of Efficacy|0
7427690|NCT01538199|11705909|FG001|Overall Study|Lack of Efficacy|1
7427691|NCT01538199|11705910|FG002|Overall Study|Lack of Efficacy|0
7427692|NCT01538199|11705911|FG003|Overall Study|Lack of Efficacy|0
7427693|NCT01538472|11705928|FG000|Overall Study|Disease Progression|3
7427694|NCT01538472|11705928|FG000|Overall Study|Death|1
7427695|NCT01538628|11705943|FG000|Overall Study|Withdrawal by Subject|1
7427696|NCT01538628|11705944|FG001|Overall Study|Withdrawal by Subject|1
7427697|NCT01538628|11705943|FG000|Overall Study|Lost to Follow-up|0
7427698|NCT01538628|11705944|FG001|Overall Study|Lost to Follow-up|1
7427699|NCT01538719|11705953|FG000|Overall Study|Lost to Follow-up|2
7427700|NCT01538719|11705954|FG001|Overall Study|Lost to Follow-up|0
7427701|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
7427702|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7427703|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
7427704|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Adverse Event|14
7427705|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Adverse Event|0
7427706|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Adverse Event|0
7558017|NCT03113916|11922912|FG000|Overall Study|Lost to Follow-up|1
7558018|NCT03113916|11922913|FG001|Overall Study|Lost to Follow-up|2
7558019|NCT03114488|11922933|FG000|Time Period 2|Withdrawal by Subject|1
7558020|NCT03114488|11922934|FG001|Time Period 2|Withdrawal by Subject|3
7558021|NCT03114657|11922946|FG000|Overall Study|Adverse Event|9
7558022|NCT03114657|11922947|FG001|Overall Study|Adverse Event|6
7558023|NCT03114657|11922946|FG000|Overall Study|Death|4
7558024|NCT03114657|11922947|FG001|Overall Study|Death|0
7558025|NCT03114657|11922946|FG000|Overall Study|Multiple Reasons|1
7558026|NCT03114657|11922947|FG001|Overall Study|Multiple Reasons|2
7558027|NCT03114657|11922946|FG000|Overall Study|Physician Decision|2
7558028|NCT03114657|11922947|FG001|Overall Study|Physician Decision|2
7558029|NCT03114657|11922946|FG000|Overall Study|Study Terminated By Sponsor|355
7558030|NCT03114657|11922947|FG001|Overall Study|Study Terminated By Sponsor|374
7558031|NCT03114657|11922946|FG000|Overall Study|Symptomatic Deterioration|0
7558032|NCT03114657|11922947|FG001|Overall Study|Symptomatic Deterioration|1
7558033|NCT03114657|11922946|FG000|Overall Study|Withdrawal by Subject|28
7558034|NCT03114657|11922947|FG001|Overall Study|Withdrawal by Subject|22
7558035|NCT03114969|11922967|FG000|Overall Study|Lost to Follow-up|0
7558036|NCT03114969|11922968|FG001|Overall Study|Lost to Follow-up|0
7558037|NCT03114969|11922969|FG002|Overall Study|Lost to Follow-up|3
7558038|NCT03114969|11922970|FG003|Overall Study|Lost to Follow-up|2
7558039|NCT03114969|11922971|FG004|Overall Study|Lost to Follow-up|0
7558040|NCT03114969|11922972|FG005|Overall Study|Lost to Follow-up|0
7558041|NCT03114969|11922973|FG006|Overall Study|Lost to Follow-up|0
7558042|NCT03114969|11922974|FG007|Overall Study|Lost to Follow-up|0
7558043|NCT03114969|11922975|FG008|Overall Study|Lost to Follow-up|0
7558044|NCT03114969|11922967|FG000|Overall Study|Adverse Event|0
7558045|NCT03114969|11922968|FG001|Overall Study|Adverse Event|0
7558046|NCT03114969|11922969|FG002|Overall Study|Adverse Event|1
7558047|NCT03114969|11922970|FG003|Overall Study|Adverse Event|0
7558048|NCT03114969|11922971|FG004|Overall Study|Adverse Event|0
7558049|NCT03114969|11922972|FG005|Overall Study|Adverse Event|1
7558050|NCT03114969|11922973|FG006|Overall Study|Adverse Event|1
7558051|NCT03114969|11922974|FG007|Overall Study|Adverse Event|0
7558052|NCT03114969|11922975|FG008|Overall Study|Adverse Event|2
7558053|NCT03115112|11923017|FG000|Overall Study|Adverse Event|5
7558054|NCT03115112|11923018|FG001|Overall Study|Adverse Event|1
7558055|NCT03115112|11923017|FG000|Overall Study|Withdrawal by Subject|4
7558056|NCT03115112|11923018|FG001|Overall Study|Withdrawal by Subject|2
7558057|NCT03115112|11923017|FG000|Overall Study|Lost to Follow-up|0
7558058|NCT03115112|11923018|FG001|Overall Study|Lost to Follow-up|1
7558059|NCT03115112|11923017|FG000|Overall Study|Death|1
7558060|NCT03115112|11923018|FG001|Overall Study|Death|0
7558061|NCT03115112|11923017|FG000|Overall Study|Pregnancy|1
7558062|NCT03115112|11923018|FG001|Overall Study|Pregnancy|0
7558063|NCT03115112|11923017|FG000|Overall Study|Site closure|1
7558064|NCT03115112|11923018|FG001|Overall Study|Site closure|1
7558065|NCT03115476|11923042|FG000|LP0084-1369|Death|1
7558066|NCT03115476|11923043|FG001|LP0084-1369|Death|0
7558067|NCT03115476|11923044|FG002|LP0084-1369|Death|2
7558068|NCT03115476|11923042|FG000|LP0084-1369|Trial terminated by Sponsor|190
7558069|NCT03115476|11923043|FG001|LP0084-1369|Trial terminated by Sponsor|210
7558070|NCT03115476|11923044|FG002|LP0084-1369|Trial terminated by Sponsor|160
7558071|NCT03116152|11923076|FG000|Overall Study|Disease Progression|49
7558072|NCT03116152|11923077|FG001|Overall Study|Disease Progression|47
7558073|NCT03116152|11923076|FG000|Overall Study|Death|5
7558074|NCT03116152|11923077|FG001|Overall Study|Death|2
7558075|NCT03116152|11923076|FG000|Overall Study|Adverse Event|21
7558076|NCT03116152|11923077|FG001|Overall Study|Adverse Event|7
7558077|NCT03116152|11923076|FG000|Overall Study|Protocol Violation|2
7558078|NCT03116152|11923077|FG001|Overall Study|Protocol Violation|2
7558079|NCT03116152|11923076|FG000|Overall Study|Withdrawal by Subject|0
7427707|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Death|6
7427708|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Death|0
7427709|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Death|0
7558080|NCT03116152|11923077|FG001|Overall Study|Withdrawal by Subject|1
7558081|NCT03116152|11923076|FG000|Overall Study|Physician Decision|3
7427710|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
7427711|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
7427712|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
7427713|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Physician Decision|14
7427714|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Physician Decision|0
7427715|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Physician Decision|0
7427716|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
7427717|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
7427718|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
7427719|NCT01539083|11705983|FG000|Before Randomization (VCD Induction)|Other|5
7427720|NCT01539083|11705984|FG001|Before Randomization (VCD Induction)|Other|0
7427721|NCT01539083|11705985|FG002|Before Randomization (VCD Induction)|Other|0
7427722|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Physician Decision|0
7427723|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Physician Decision|0
7427724|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Physician Decision|1
7427725|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Other|0
7427726|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Other|1
7427727|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Other|1
7427728|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Adverse Event|0
7427729|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Adverse Event|1
7427730|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Adverse Event|1
7427731|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
7427732|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
7558082|NCT03116152|11923077|FG001|Overall Study|Physician Decision|2
7558083|NCT03116152|11923076|FG000|Overall Study|other|11
7558084|NCT03116152|11923077|FG001|Overall Study|other|34
7558085|NCT03116698|11923096|FG000|Overall Study|Adverse Event|1
7558086|NCT03116698|11923097|FG001|Overall Study|Adverse Event|1
7558087|NCT03116698|11923098|FG002|Overall Study|Adverse Event|1
7558088|NCT03116698|11923099|FG003|Overall Study|Adverse Event|0
7558089|NCT03116698|11923096|FG000|Overall Study|Withdrawal by Subject|1
7558090|NCT03116698|11923097|FG001|Overall Study|Withdrawal by Subject|4
7558091|NCT03116698|11923098|FG002|Overall Study|Withdrawal by Subject|5
7558092|NCT03116698|11923099|FG003|Overall Study|Withdrawal by Subject|2
7558093|NCT03116698|11923096|FG000|Overall Study|Lost to Follow-up|2
7558094|NCT03116698|11923097|FG001|Overall Study|Lost to Follow-up|0
7558095|NCT03116698|11923098|FG002|Overall Study|Lost to Follow-up|0
7558096|NCT03116698|11923099|FG003|Overall Study|Lost to Follow-up|0
7558097|NCT03116698|11923096|FG000|Overall Study|Physician Decision|1
7558098|NCT03116698|11923097|FG001|Overall Study|Physician Decision|1
7558099|NCT03116698|11923098|FG002|Overall Study|Physician Decision|0
7558100|NCT03116698|11923099|FG003|Overall Study|Physician Decision|0
7558101|NCT03116698|11923096|FG000|Overall Study|Protocol Violation|1
7558102|NCT03116698|11923097|FG001|Overall Study|Protocol Violation|0
7558103|NCT03116698|11923098|FG002|Overall Study|Protocol Violation|0
7558104|NCT03116698|11923099|FG003|Overall Study|Protocol Violation|0
7558105|NCT03116698|11923096|FG000|Overall Study|Death|0
7558106|NCT03116698|11923097|FG001|Overall Study|Death|0
7558107|NCT03116698|11923098|FG002|Overall Study|Death|2
7558108|NCT03116698|11923099|FG003|Overall Study|Death|0
7558109|NCT03116828|11923111|FG000|Overall Study|Adverse Event|1
7558110|NCT03116828|11923112|FG001|Overall Study|Adverse Event|10
7558111|NCT03116828|11923111|FG000|Overall Study|Withdrawal by Subject|4
7558112|NCT03116828|11923112|FG001|Overall Study|Withdrawal by Subject|8
7558113|NCT03116828|11923111|FG000|Overall Study|OTHER|3
7558114|NCT03116828|11923112|FG001|Overall Study|OTHER|3
7558115|NCT03117361|11923142|FG000|Overall Study|Progressive disease|5
7558116|NCT03117361|11923142|FG000|Overall Study|Death|1
7558117|NCT03117361|11923142|FG000|Overall Study|Physician Decision|2
7558118|NCT03117361|11923142|FG000|Overall Study|On study treatment at the end of study|1
7558119|NCT03117361|11923142|FG000|Overall Study|Treatment-related adverse event|1
7558120|NCT03117738|11923183|FG000|Overall Study|Withdrawal by Subject|3
7558121|NCT03117738|11923184|FG001|Overall Study|Withdrawal by Subject|1
7558122|NCT03117738|11923183|FG000|Overall Study|Lost to Follow-up|1
7558123|NCT03117738|11923184|FG001|Overall Study|Lost to Follow-up|4
7558124|NCT03118297|11923192|FG000|Overall Study|Lost to Follow-up|0
7558125|NCT03118297|11923193|FG001|Overall Study|Lost to Follow-up|2
7558126|NCT03118518|11923205|FG000|Overall Study|Early Exit after treatment|2
7558127|NCT03118518|11923206|FG001|Overall Study|Early Exit after treatment|8
7558128|NCT03118518|11923205|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
7558129|NCT03118518|11923206|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
7558130|NCT03118739|11923223|FG000|Overall Study|Physician Decision|0
7558131|NCT03118739|11923224|FG001|Overall Study|Physician Decision|1
7558132|NCT03118739|11923223|FG000|Overall Study|Withdrawal by Subject|5
7558133|NCT03118739|11923224|FG001|Overall Study|Withdrawal by Subject|3
7558134|NCT03118739|11923223|FG000|Overall Study|Lost to Follow-up|2
7558135|NCT03118739|11923224|FG001|Overall Study|Lost to Follow-up|0
7558136|NCT03118765|11923235|FG000|Overall Study|Withdrawal by Subject|0
7558137|NCT03118765|11923236|FG001|Overall Study|Withdrawal by Subject|0
7558138|NCT03118765|11923237|FG002|Overall Study|Withdrawal by Subject|1
7427733|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
7427734|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
7427735|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
7427736|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
7427737|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Progressive Disease|0
7427738|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Progressive Disease|6
7427739|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Progressive Disease|3
7427740|NCT01539083|11705983|FG000|After Randomization (TP and VTP)|Death|0
7427741|NCT01539083|11705984|FG001|After Randomization (TP and VTP)|Death|6
7427742|NCT01539083|11705985|FG002|After Randomization (TP and VTP)|Death|11
7427743|NCT01539239|11706003|FG000|Overall Study|Death|5
7427744|NCT01539239|11706004|FG001|Overall Study|Death|5
7427745|NCT01539239|11706003|FG000|Overall Study|Lost to Follow-up|7
7427746|NCT01539239|11706004|FG001|Overall Study|Lost to Follow-up|12
7427747|NCT01539291|11706013|FG000|Study GS-US-312-0116|Adverse Event|9
7427748|NCT01539291|11706014|FG001|Study GS-US-312-0116|Adverse Event|0
7427749|NCT01539291|11706015|FG002|Study GS-US-312-0116|Adverse Event|0
7427750|NCT01539291|11706016|FG003|Study GS-US-312-0116|Adverse Event|0
7427751|NCT01539291|11706013|FG000|Study GS-US-312-0116|Physician Decision|1
7427752|NCT01539291|11706014|FG001|Study GS-US-312-0116|Physician Decision|0
7427753|NCT01539291|11706015|FG002|Study GS-US-312-0116|Physician Decision|0
7427754|NCT01539291|11706016|FG003|Study GS-US-312-0116|Physician Decision|0
7427755|NCT01539291|11706013|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
7427756|NCT01539291|11706014|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
7427757|NCT01539291|11706015|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
7427758|NCT01539291|11706016|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
7427759|NCT01539291|11706013|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
7427760|NCT01539291|11706014|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
7427761|NCT01539291|11706015|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
7427762|NCT01539291|11706016|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
7558139|NCT03118765|11923238|FG003|Overall Study|Withdrawal by Subject|0
7558140|NCT03118765|11923239|FG004|Overall Study|Withdrawal by Subject|0
7558141|NCT03118765|11923235|FG000|Overall Study|Adverse Event|1
7558142|NCT03118765|11923236|FG001|Overall Study|Adverse Event|1
7558143|NCT03118765|11923237|FG002|Overall Study|Adverse Event|1
7558144|NCT03118765|11923238|FG003|Overall Study|Adverse Event|1
7558145|NCT03118765|11923239|FG004|Overall Study|Adverse Event|1
7558146|NCT03118765|11923235|FG000|Overall Study|Non compliance with Study Procedures|0
7558147|NCT03118765|11923236|FG001|Overall Study|Non compliance with Study Procedures|0
7558148|NCT03118765|11923237|FG002|Overall Study|Non compliance with Study Procedures|0
7558149|NCT03118765|11923238|FG003|Overall Study|Non compliance with Study Procedures|1
7558150|NCT03118765|11923239|FG004|Overall Study|Non compliance with Study Procedures|0
7558151|NCT03118765|11923235|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7558152|NCT03118765|11923236|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7558153|NCT03118765|11923237|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
7558154|NCT03118765|11923238|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7558155|NCT03118765|11923239|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
7558156|NCT03118765|11923235|FG000|Overall Study|COPD Exacerbation|1
7558157|NCT03118765|11923236|FG001|Overall Study|COPD Exacerbation|0
7558158|NCT03118765|11923237|FG002|Overall Study|COPD Exacerbation|0
7558159|NCT03118765|11923238|FG003|Overall Study|COPD Exacerbation|1
7558160|NCT03118765|11923239|FG004|Overall Study|COPD Exacerbation|0
7558161|NCT03118765|11923235|FG000|Overall Study|Lost to Follow-up|1
7558162|NCT03118765|11923236|FG001|Overall Study|Lost to Follow-up|0
7558163|NCT03118765|11923237|FG002|Overall Study|Lost to Follow-up|1
7558164|NCT03118765|11923238|FG003|Overall Study|Lost to Follow-up|0
7558165|NCT03118765|11923239|FG004|Overall Study|Lost to Follow-up|0
7558166|NCT03118765|11923235|FG000|Overall Study|Sponsor Decision|1
7558167|NCT03118765|11923236|FG001|Overall Study|Sponsor Decision|0
7558168|NCT03118765|11923237|FG002|Overall Study|Sponsor Decision|1
7558169|NCT03118765|11923238|FG003|Overall Study|Sponsor Decision|0
7558170|NCT03118765|11923239|FG004|Overall Study|Sponsor Decision|1
7574764|NCT03692676|11957888|FG000|Overall Study|exclude patients with prior use of same substances and device|0
7574765|NCT03692676|11957889|FG001|Overall Study|exclude patients with prior use of same substances and device|0
7574766|NCT03692676|11957890|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
7574767|NCT03692676|11957891|FG003|Overall Study|exclude patients with prior use of same substances and device|0
7574768|NCT03692676|11957888|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7574769|NCT03692676|11957889|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
7574770|NCT03692676|11957890|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
7574771|NCT03692676|11957891|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
7574772|NCT03692676|11957888|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7574773|NCT03692676|11957889|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7427763|NCT01539291|11706013|FG000|Study GS-US-312-0116|Other|1
7427764|NCT01539291|11706014|FG001|Study GS-US-312-0116|Other|0
7427765|NCT01539291|11706015|FG002|Study GS-US-312-0116|Other|0
7427766|NCT01539291|11706016|FG003|Study GS-US-312-0116|Other|0
7427767|NCT01539291|11706013|FG000|Study GS-US-312-0117|Adverse Event|22
7427768|NCT01539291|11706014|FG001|Study GS-US-312-0117|Adverse Event|1
7427769|NCT01539291|11706015|FG002|Study GS-US-312-0117|Adverse Event|9
7427770|NCT01539291|11706016|FG003|Study GS-US-312-0117|Adverse Event|12
7427771|NCT01539291|11706013|FG000|Study GS-US-312-0117|Physician Decision|9
7427772|NCT01539291|11706014|FG001|Study GS-US-312-0117|Physician Decision|0
7427773|NCT01539291|11706015|FG002|Study GS-US-312-0117|Physician Decision|6
7427774|NCT01539291|11706016|FG003|Study GS-US-312-0117|Physician Decision|4
7427775|NCT01539291|11706013|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
7427776|NCT01539291|11706014|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
7427777|NCT01539291|11706015|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
7427778|NCT01539291|11706016|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
7427779|NCT01539291|11706013|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
7427780|NCT01539291|11706014|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
7427781|NCT01539291|11706015|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
7427782|NCT01539291|11706016|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
7427783|NCT01539291|11706013|FG000|Study GS-US-312-0117|Other|2
7427784|NCT01539291|11706014|FG001|Study GS-US-312-0117|Other|1
7427785|NCT01539291|11706015|FG002|Study GS-US-312-0117|Other|1
7427786|NCT01539291|11706016|FG003|Study GS-US-312-0117|Other|1
7427787|NCT01539317|11706035|FG000|Overall Study|Screening Error. Deleted from analysis.|1
7427788|NCT01539317|11706036|FG001|Overall Study|Screening Error. Deleted from analysis.|0
7427789|NCT01539512|11706047|FG000|Overall Study|Adverse Event|9
7427790|NCT01539512|11706048|FG001|Overall Study|Adverse Event|7
7427791|NCT01539512|11706047|FG000|Overall Study|Physician Decision|1
7427792|NCT01539512|11706048|FG001|Overall Study|Physician Decision|1
7427793|NCT01539512|11706047|FG000|Overall Study|Withdrawal by Subject|12
7427794|NCT01539512|11706048|FG001|Overall Study|Withdrawal by Subject|5
7427795|NCT01539512|11706047|FG000|Overall Study|Richter's Transformation|1
7427796|NCT01539512|11706048|FG001|Overall Study|Richter's Transformation|0
7558171|NCT03118934|11923259|FG000|Overall Study|Adverse Event|0
7558172|NCT03118934|11923260|FG001|Overall Study|Adverse Event|0
7558173|NCT03118934|11923261|FG002|Overall Study|Adverse Event|0
7558174|NCT03118934|11923262|FG003|Overall Study|Adverse Event|0
7558175|NCT03118934|11923263|FG004|Overall Study|Adverse Event|0
7558176|NCT03118934|11923264|FG005|Overall Study|Adverse Event|1
7558177|NCT03118934|11923259|FG000|Overall Study|Physician Decision|0
7558178|NCT03118934|11923260|FG001|Overall Study|Physician Decision|0
7558179|NCT03118934|11923261|FG002|Overall Study|Physician Decision|0
7558180|NCT03118934|11923262|FG003|Overall Study|Physician Decision|0
7558181|NCT03118934|11923263|FG004|Overall Study|Physician Decision|0
7558182|NCT03118934|11923264|FG005|Overall Study|Physician Decision|1
7558183|NCT03118934|11923259|FG000|Overall Study|Discontinued prior to exposure|0
7558184|NCT03118934|11923260|FG001|Overall Study|Discontinued prior to exposure|1
7558185|NCT03118934|11923261|FG002|Overall Study|Discontinued prior to exposure|1
7558186|NCT03118934|11923262|FG003|Overall Study|Discontinued prior to exposure|1
7558187|NCT03118934|11923263|FG004|Overall Study|Discontinued prior to exposure|2
7558188|NCT03118934|11923264|FG005|Overall Study|Discontinued prior to exposure|0
7558189|NCT03118947|11923274|FG000|Overall Study|Adverse Event|7
7558190|NCT03118947|11923274|FG000|Overall Study|Death|3
7558191|NCT03118947|11923274|FG000|Overall Study|Lack of Efficacy|4
7558192|NCT03118947|11923274|FG000|Overall Study|Non-compliance with study drug|1
7558193|NCT03118947|11923274|FG000|Overall Study|Protocol Violation|2
7558194|NCT03118947|11923274|FG000|Overall Study|Withdrawal by Subject|3
7558195|NCT03118947|11923274|FG000|Overall Study|Withdrawal by caregiver|3
7558196|NCT03118947|11923274|FG000|Overall Study|Change in patient's living situation|4
7558197|NCT03118947|11923274|FG000|Overall Study|Lost to Follow-up|2
7558198|NCT03119610|11923324|FG000|Overall Study|Adverse Event|1
7558199|NCT03119610|11923325|FG001|Overall Study|Adverse Event|0
7558200|NCT03119610|11923324|FG000|Overall Study|Lost to Follow-up|0
7558201|NCT03119610|11923325|FG001|Overall Study|Lost to Follow-up|1
7558202|NCT03119688|11923356|FG000|Overall Study|Adverse Event|4
7558203|NCT03119701|11923375|FG000|6-day Dosing|Death|4
7558204|NCT03119701|11923376|FG001|6-day Dosing|Death|1
7558205|NCT03119701|11923375|FG000|6-day Dosing|Adverse Event|3
7558206|NCT03119701|11923376|FG001|6-day Dosing|Adverse Event|0
7558207|NCT03119701|11923375|FG000|6-day Dosing|Physician Decision|0
7558208|NCT03119701|11923376|FG001|6-day Dosing|Physician Decision|1
7558209|NCT03119701|11923375|FG000|6-day Dosing|Withdrawal by Subject|0
7558210|NCT03119701|11923376|FG001|6-day Dosing|Withdrawal by Subject|1
7427797|NCT01539525|11706057|FG000|Overall Study|Lost to Follow-up|19
7558211|NCT03119701|11923375|FG000|Mid-term (Final) Follow-up at D90|Death|3
7558212|NCT03119701|11923376|FG001|Mid-term (Final) Follow-up at D90|Death|1
7558213|NCT03120013|11923398|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
7558214|NCT03120013|11923399|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
7558215|NCT03120351|11923407|FG000|Overall Study|Physician Decision|1
7558216|NCT03120351|11923408|FG001|Overall Study|Physician Decision|1
7558217|NCT03120520|11923418|FG000|Overall Study|Lost to Follow-up|1
7427798|NCT01539525|11706058|FG001|Overall Study|Lost to Follow-up|12
7558218|NCT03120520|11923419|FG001|Overall Study|Lost to Follow-up|1
7558219|NCT03120520|11923420|FG002|Overall Study|Lost to Follow-up|1
7558220|NCT03120520|11923421|FG003|Overall Study|Lost to Follow-up|1
7427799|NCT01539525|11706059|FG002|Overall Study|Lost to Follow-up|11
7427800|NCT01539525|11706057|FG000|Overall Study|Withdrawal by Subject|0
7427801|NCT01539525|11706058|FG001|Overall Study|Withdrawal by Subject|3
7427802|NCT01539525|11706059|FG002|Overall Study|Withdrawal by Subject|2
7427803|NCT01539525|11706057|FG000|Overall Study|Protocol Violation|1
7427804|NCT01539525|11706058|FG001|Overall Study|Protocol Violation|1
7427805|NCT01539525|11706059|FG002|Overall Study|Protocol Violation|4
7427806|NCT01539538|11706072|FG000|Overall Study|Adverse Event|13
7427807|NCT01539538|11706073|FG001|Overall Study|Adverse Event|18
7427808|NCT01539538|11706072|FG000|Overall Study|Lack of Efficacy|13
7427809|NCT01539538|11706073|FG001|Overall Study|Lack of Efficacy|16
7427810|NCT01539538|11706072|FG000|Overall Study|Withdrawal by Subject|2
7427811|NCT01539538|11706073|FG001|Overall Study|Withdrawal by Subject|3
7427812|NCT01539538|11706072|FG000|Overall Study|PCA no longer required or PCA problem|3
7427813|NCT01539538|11706073|FG001|Overall Study|PCA no longer required or PCA problem|7
7427814|NCT01539642|11706081|FG000|Overall Study|Lack of Efficacy|20
7427815|NCT01539642|11706082|FG001|Overall Study|Lack of Efficacy|18
7427816|NCT01539642|11706081|FG000|Overall Study|Patient ready for early discharge|8
7427817|NCT01539642|11706082|FG001|Overall Study|Patient ready for early discharge|7
7427818|NCT01539642|11706081|FG000|Overall Study|Adverse Event|6
7427819|NCT01539642|11706082|FG001|Overall Study|Adverse Event|4
7427820|NCT01539642|11706081|FG000|Overall Study|Withdrawal by Subject|2
7427821|NCT01539642|11706082|FG001|Overall Study|Withdrawal by Subject|2
7427822|NCT01539759|11706097|FG000|Overall Study|Lost to Follow-up|6
7427823|NCT01539759|11706098|FG001|Overall Study|Lost to Follow-up|8
7427824|NCT01539837|11706107|FG000|Overall Study|reduce neutrophil level|0
7427825|NCT01539837|11706108|FG001|Overall Study|reduce neutrophil level|1
7558221|NCT03120520|11923418|FG000|Overall Study|Withdrawal by Subject|3
7558222|NCT03120520|11923419|FG001|Overall Study|Withdrawal by Subject|2
7558223|NCT03120520|11923420|FG002|Overall Study|Withdrawal by Subject|3
7532119|NCT02664272|11877366|FG000|Overall Study|Fluoroscopic images not made available|2
7532120|NCT02664415|11877385|FG000|Overall Study|Adverse Event|1
7532121|NCT02664415|11877386|FG001|Overall Study|Adverse Event|0
7532122|NCT02665052|11877448|FG000|Overall Study|Lost to Follow-up|1
7558224|NCT03120520|11923421|FG003|Overall Study|Withdrawal by Subject|2
7558225|NCT03120520|11923418|FG000|Overall Study|Other|0
7427826|NCT01539837|11706109|FG002|Overall Study|reduce neutrophil level|1
7427827|NCT01539837|11706107|FG000|Overall Study|bad compliance|0
7427828|NCT01539837|11706108|FG001|Overall Study|bad compliance|0
7427829|NCT01539837|11706109|FG002|Overall Study|bad compliance|1
7427830|NCT01540474|11706205|FG000|Vaccination Period|Lost to Follow-up|0
7427831|NCT01540474|11706206|FG001|Vaccination Period|Lost to Follow-up|1
7427832|NCT01540474|11706207|FG002|Vaccination Period|Lost to Follow-up|0
7558226|NCT03120520|11923419|FG001|Overall Study|Other|1
7558227|NCT03120520|11923420|FG002|Overall Study|Other|0
7558228|NCT03120520|11923421|FG003|Overall Study|Other|0
7558229|NCT03121950|11923481|FG000|Overall Study|Withdrawal by Subject|11
7558230|NCT03121950|11923482|FG001|Overall Study|Withdrawal by Subject|2
7558231|NCT03122145|11923492|FG000|Overall Study|Concurrent respiratory disease|3
7558232|NCT03122145|11923493|FG001|Overall Study|Concurrent respiratory disease|0
7558233|NCT03122171|11923499|FG000|Overall Study|Withdrawal by Subject|1
7558234|NCT03122184|11923505|FG000|Overall Study|Lost to Follow-up|4
7558235|NCT03122184|11923506|FG001|Overall Study|Lost to Follow-up|6
7558236|NCT03122184|11923505|FG000|Overall Study|Withdrawal by Subject|3
7558237|NCT03122184|11923506|FG001|Overall Study|Withdrawal by Subject|0
7558238|NCT03122184|11923505|FG000|Overall Study|Terminated due to cognitive problem|1
7558239|NCT03122184|11923506|FG001|Overall Study|Terminated due to cognitive problem|0
7558240|NCT03122223|11923516|FG000|Overall Study|Withdrawal by Subject|2
7558241|NCT03122223|11923517|FG001|Overall Study|Withdrawal by Subject|2
7558242|NCT03122223|11923518|FG002|Overall Study|Withdrawal by Subject|1
7558243|NCT03122223|11923519|FG003|Overall Study|Withdrawal by Subject|0
7558244|NCT03122223|11923516|FG000|Overall Study|Lost to Follow-up|0
7558245|NCT03122223|11923517|FG001|Overall Study|Lost to Follow-up|2
7558246|NCT03122223|11923518|FG002|Overall Study|Lost to Follow-up|2
7558247|NCT03122223|11923519|FG003|Overall Study|Lost to Follow-up|0
7558248|NCT03122223|11923516|FG000|Overall Study|Participant unable to adhere|1
7558249|NCT03122223|11923517|FG001|Overall Study|Participant unable to adhere|1
7558250|NCT03122223|11923518|FG002|Overall Study|Participant unable to adhere|1
7427833|NCT01540474|11706208|FG003|Vaccination Period|Lost to Follow-up|0
7427834|NCT01540487|11706221|FG000|Overall Study|Protocol Violation|1
7427835|NCT01540487|11706222|FG001|Overall Study|Protocol Violation|0
7427836|NCT01540565|11706236|FG000|Overall Study|Ineligible|2
7427837|NCT01540838|11706306|FG000|Overall Study|Open nasogastric tube|9
7427838|NCT01540838|11706307|FG001|Overall Study|Open nasogastric tube|7
7532123|NCT02665052|11877449|FG001|Overall Study|Lost to Follow-up|0
7532124|NCT02665052|11877450|FG002|Overall Study|Lost to Follow-up|0
7532125|NCT02665052|11877451|FG003|Overall Study|Lost to Follow-up|0
7532126|NCT02665052|11877448|FG000|Overall Study|Withdrawal by Subject|1
7532127|NCT02665052|11877449|FG001|Overall Study|Withdrawal by Subject|1
7532128|NCT02665052|11877450|FG002|Overall Study|Withdrawal by Subject|0
7532129|NCT02665052|11877451|FG003|Overall Study|Withdrawal by Subject|5
7532130|NCT02665052|11877448|FG000|Overall Study|Adverse Event|1
7532131|NCT02665052|11877449|FG001|Overall Study|Adverse Event|1
7427839|NCT01540838|11706306|FG000|Overall Study|Treatment doses missing|8
7427840|NCT01540838|11706307|FG001|Overall Study|Treatment doses missing|12
7427841|NCT01540838|11706306|FG000|Overall Study|Additional antibiotic treatment|1
7427842|NCT01540838|11706307|FG001|Overall Study|Additional antibiotic treatment|2
7427843|NCT01540838|11706306|FG000|Overall Study|Died before treatment initiation|1
7427844|NCT01540838|11706307|FG001|Overall Study|Died before treatment initiation|1
7427845|NCT01540838|11706306|FG000|Overall Study|Not BM. Other treatment|3
7427846|NCT01540838|11706307|FG001|Overall Study|Not BM. Other treatment|1
7427847|NCT01540851|11706315|FG000|Overall Study|Lost to Follow-up|14
7427848|NCT01540851|11706316|FG001|Overall Study|Lost to Follow-up|15
7427849|NCT01540851|11706315|FG000|Overall Study|Withdrawal by Subject|7
7427850|NCT01540851|11706316|FG001|Overall Study|Withdrawal by Subject|3
7427851|NCT01540981|11706326|FG000|Overall Study|Withdrawal by Subject|1
7427852|NCT01540981|11706327|FG001|Overall Study|Withdrawal by Subject|0
7427853|NCT01541215|11706335|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
7427854|NCT01541215|11706336|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
7427855|NCT01541215|11706335|FG000|Treatment Period (52 Weeks)|Non-compliance|4
7427856|NCT01541215|11706336|FG001|Treatment Period (52 Weeks)|Non-compliance|4
7427857|NCT01541215|11706335|FG000|Treatment Period (52 Weeks)|Adverse Event|0
7427858|NCT01541215|11706336|FG001|Treatment Period (52 Weeks)|Adverse Event|1
7427859|NCT01541215|11706335|FG000|Treatment Period (52 Weeks)|Unclassified|0
7427860|NCT01541215|11706336|FG001|Treatment Period (52 Weeks)|Unclassified|3
7427861|NCT01541215|11706335|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
7427862|NCT01541215|11706336|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
7427863|NCT01541215|11706335|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
7427864|NCT01541215|11706336|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
7558251|NCT03122223|11923519|FG003|Overall Study|Participant unable to adhere|0
7427865|NCT01541254|11706346|FG000|Overall Study|Withdrawal by Subject|1
7427866|NCT01541254|11706346|FG000|Overall Study|excluded - metal allergy|1
7427867|NCT01541254|11706346|FG000|Overall Study|enrolled after study closed|1
7558252|NCT03122457|11923529|FG000|Overall Study|Withdrawal by Subject|6
7558253|NCT03122535|11923533|FG000|Overall Study|Lost to Follow-up|68
7558254|NCT03122535|11923534|FG001|Overall Study|Lost to Follow-up|68
7558255|NCT03122535|11923533|FG000|Overall Study|Physician Decision|3
7558256|NCT03122535|11923534|FG001|Overall Study|Physician Decision|3
7558257|NCT03122535|11923533|FG000|Overall Study|Withdrawal by Subject|2
7558258|NCT03122535|11923534|FG001|Overall Study|Withdrawal by Subject|2
7558259|NCT03122548|11923540|FG000|Overall Study|Death|2
7558260|NCT03122548|11923540|FG000|Overall Study|Progression - subject went into hospice|1
7558261|NCT03122548|11923540|FG000|Overall Study|Study Terminated by Sponsor|2
7558262|NCT03122860|11923563|FG000|Overall Study|Discontinued Before Treatment|1
7558263|NCT03122860|11923564|FG001|Overall Study|Discontinued Before Treatment|1
7558264|NCT03122860|11923565|FG002|Overall Study|Discontinued Before Treatment|2
7558265|NCT03122860|11923566|FG003|Overall Study|Discontinued Before Treatment|0
7558266|NCT03122860|11923567|FG004|Overall Study|Discontinued Before Treatment|1
7558267|NCT03122860|11923568|FG005|Overall Study|Discontinued Before Treatment|0
7558268|NCT03122860|11923563|FG000|Overall Study|Adverse Event|1
7558269|NCT03122860|11923564|FG001|Overall Study|Adverse Event|0
7558270|NCT03122860|11923565|FG002|Overall Study|Adverse Event|1
7558271|NCT03122860|11923566|FG003|Overall Study|Adverse Event|1
7558272|NCT03122860|11923567|FG004|Overall Study|Adverse Event|0
7558273|NCT03122860|11923568|FG005|Overall Study|Adverse Event|0
7558274|NCT03122860|11923563|FG000|Overall Study|Lost to Follow-up|5
7558275|NCT03122860|11923564|FG001|Overall Study|Lost to Follow-up|2
7558276|NCT03122860|11923565|FG002|Overall Study|Lost to Follow-up|3
7558277|NCT03122860|11923566|FG003|Overall Study|Lost to Follow-up|3
7558278|NCT03122860|11923567|FG004|Overall Study|Lost to Follow-up|5
7558279|NCT03122860|11923568|FG005|Overall Study|Lost to Follow-up|4
7558280|NCT03122860|11923563|FG000|Overall Study|Subject Non-Compliance|0
7558281|NCT03122860|11923564|FG001|Overall Study|Subject Non-Compliance|0
7558282|NCT03122860|11923565|FG002|Overall Study|Subject Non-Compliance|1
7558283|NCT03122860|11923566|FG003|Overall Study|Subject Non-Compliance|0
7558284|NCT03122860|11923567|FG004|Overall Study|Subject Non-Compliance|0
7558285|NCT03122860|11923568|FG005|Overall Study|Subject Non-Compliance|0
7558286|NCT03122860|11923563|FG000|Overall Study|Withdrawal by Subject|3
7558287|NCT03122860|11923564|FG001|Overall Study|Withdrawal by Subject|2
7558288|NCT03122860|11923565|FG002|Overall Study|Withdrawal by Subject|5
7558289|NCT03122860|11923566|FG003|Overall Study|Withdrawal by Subject|7
7558290|NCT03122860|11923567|FG004|Overall Study|Withdrawal by Subject|9
7558291|NCT03122860|11923568|FG005|Overall Study|Withdrawal by Subject|8
7558292|NCT03123120|11923599|FG000|Overall Study|Lost to Follow-up|0
7558293|NCT03123120|11923600|FG001|Overall Study|Lost to Follow-up|1
7558294|NCT03123120|11923599|FG000|Overall Study|Withdrawal by Subject|0
7558295|NCT03123120|11923600|FG001|Overall Study|Withdrawal by Subject|1
7558296|NCT03123354|11923615|FG000|Overall Study|Physician Decision|6
7558297|NCT03123471|11923621|FG000|Placebo-controlled Phase|Adverse Event|3
7427868|NCT01541254|11706346|FG000|Overall Study|GI bleed prior to procedure|1
7427869|NCT01541254|11706346|FG000|Overall Study|stent not required|1
7427870|NCT01541254|11706346|FG000|Overall Study|alternate stent used|1
7558298|NCT03123471|11923622|FG001|Placebo-controlled Phase|Adverse Event|8
7558299|NCT03123471|11923621|FG000|Placebo-controlled Phase|Lack of Efficacy|3
7558300|NCT03123471|11923622|FG001|Placebo-controlled Phase|Lack of Efficacy|4
7558301|NCT03123471|11923621|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
7558302|NCT03123471|11923622|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
7558303|NCT03123471|11923621|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
7558304|NCT03123471|11923622|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
7558305|NCT03123471|11923621|FG000|Placebo-controlled Phase|Lost to Follow-up|1
7558306|NCT03123471|11923622|FG001|Placebo-controlled Phase|Lost to Follow-up|3
7558307|NCT03123471|11923621|FG000|Placebo-controlled Phase|Protocol Deviation|2
7558308|NCT03123471|11923622|FG001|Placebo-controlled Phase|Protocol Deviation|1
7558309|NCT03123471|11923621|FG000|Placebo-controlled Phase|Miscellaneous|0
7558310|NCT03123471|11923622|FG001|Placebo-controlled Phase|Miscellaneous|1
7558311|NCT03123471|11923621|FG000|Apremilast Extension Phase|Lost to Follow-up|2
7558312|NCT03123471|11923622|FG001|Apremilast Extension Phase|Lost to Follow-up|5
7558313|NCT03123471|11923621|FG000|Apremilast Extension Phase|Adverse Event|1
7558314|NCT03123471|11923622|FG001|Apremilast Extension Phase|Adverse Event|5
7558315|NCT03123471|11923621|FG000|Apremilast Extension Phase|Lack of Efficacy|2
7558316|NCT03123471|11923622|FG001|Apremilast Extension Phase|Lack of Efficacy|8
7558317|NCT03123471|11923621|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
7558318|NCT03123471|11923622|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
7558319|NCT03123588|11923636|FG000|Overall Study|Study Terminated by Sponsor|2
7558320|NCT03123588|11923637|FG001|Overall Study|Study Terminated by Sponsor|5
7558321|NCT03123588|11923636|FG000|Overall Study|Withdrawal by Subject|1
7558322|NCT03123588|11923637|FG001|Overall Study|Withdrawal by Subject|0
7558323|NCT03123588|11923636|FG000|Overall Study|Adverse Event|1
7558324|NCT03123588|11923637|FG001|Overall Study|Adverse Event|0
7558325|NCT03123588|11923636|FG000|Overall Study|Physician Decision|2
7558326|NCT03123588|11923637|FG001|Overall Study|Physician Decision|1
7558327|NCT03123861|11923661|FG000|Overall Study|Protocol Violation|1
7558328|NCT03123861|11923662|FG001|Overall Study|Protocol Violation|1
7558329|NCT03123861|11923661|FG000|Overall Study|Withdrawal by Subject|2
7558330|NCT03123861|11923662|FG001|Overall Study|Withdrawal by Subject|2
7558331|NCT03123939|11923681|FG000|Overall Study|Lack of Efficacy|6
7558332|NCT03123939|11923681|FG000|Overall Study|Death|5
7558333|NCT03123939|11923681|FG000|Overall Study|Physician Decision|2
7558334|NCT03123939|11923681|FG000|Overall Study|Subject/guardian decision|2
7558335|NCT03123939|11923681|FG000|Overall Study|Lost to Follow-up|1
7558336|NCT03123939|11923681|FG000|Overall Study|New therapy for study indication|1
7558337|NCT03123939|11923681|FG000|Overall Study|Protocol deviation|1
7558338|NCT03123939|11923681|FG000|Overall Study|Progressive disease|18
7558339|NCT03123939|11923681|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
7558340|NCT03123939|11923681|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
7558341|NCT03124108|11923694|FG000|Overall Study|Adverse Event|0
7558342|NCT03124108|11923695|FG001|Overall Study|Adverse Event|1
7558343|NCT03124108|11923696|FG002|Overall Study|Adverse Event|0
7558344|NCT03124199|11923717|FG000|Overall Study|Lost to Follow-up|4
7558345|NCT03124381|11923747|FG000|Overall Study|Lost to Follow-up|1
7558346|NCT03124381|11923748|FG001|Overall Study|Lost to Follow-up|1
7558347|NCT03124381|11923747|FG000|Overall Study|Withdrawal by Subject|6
7558348|NCT03124381|11923748|FG001|Overall Study|Withdrawal by Subject|3
7558349|NCT03124381|11923747|FG000|Overall Study|Protocol Violation|0
7558350|NCT03124381|11923748|FG001|Overall Study|Protocol Violation|1
7558351|NCT03124381|11923747|FG000|Overall Study|Adverse Event|1
7558352|NCT03124381|11923748|FG001|Overall Study|Adverse Event|1
7558353|NCT03124381|11923747|FG000|Overall Study|Non-Compliance with Study Treatment|1
7558354|NCT03124381|11923748|FG001|Overall Study|Non-Compliance with Study Treatment|0
7558355|NCT03124407|11923758|FG000|Overall Study|Lost to Follow-up|1
7558356|NCT03124407|11923759|FG001|Overall Study|Lost to Follow-up|0
7558357|NCT03124407|11923760|FG002|Overall Study|Lost to Follow-up|0
7558358|NCT03124407|11923761|FG003|Overall Study|Lost to Follow-up|0
7558359|NCT03124407|11923758|FG000|Overall Study|Adverse Event|0
7558360|NCT03124407|11923759|FG001|Overall Study|Adverse Event|0
7558361|NCT03124407|11923760|FG002|Overall Study|Adverse Event|1
7558362|NCT03124407|11923761|FG003|Overall Study|Adverse Event|0
7427871|NCT01541371|11706355|FG000|Overall Study|Withdrawal by Subject|14
7427872|NCT01541371|11706355|FG000|Overall Study|Lost to Follow-up|21
7427873|NCT01541371|11706355|FG000|Overall Study|Adverse Event|15
7427874|NCT01541371|11706355|FG000|Overall Study|Lack of Efficacy|12
7427875|NCT01541371|11706355|FG000|Overall Study|Protocol Violation|6
7427876|NCT01541371|11706355|FG000|Overall Study|Study medication non-compliance|3
7427877|NCT01541371|11706355|FG000|Overall Study|Other|6
7427878|NCT01541644|11706385|FG000|Overall Study|Withdrawal by Subject|3
7427879|NCT01541748|11706398|FG000|Overall Study|Lost to Follow-up|17
7427880|NCT01541748|11706398|FG000|Overall Study|Moved out of state|1
7427881|NCT01541748|11706398|FG000|Overall Study|Withdrawal by Subject|7
7427882|NCT01541748|11706398|FG000|Overall Study|Screen failure|5
7427883|NCT01541748|11706398|FG000|Overall Study|Did not receive study device|1
7427884|NCT01541826|11706414|FG000|Overall Study|Lost to Follow-up|2
7427885|NCT01541826|11706415|FG001|Overall Study|Lost to Follow-up|3
7427886|NCT01541826|11706416|FG002|Overall Study|Lost to Follow-up|0
7427887|NCT01541826|11706414|FG000|Overall Study|Withdrawal by Subject|2
7427888|NCT01541826|11706415|FG001|Overall Study|Withdrawal by Subject|0
7427889|NCT01541826|11706416|FG002|Overall Study|Withdrawal by Subject|0
7427890|NCT01541865|11706424|FG000|Overall Study|Lost to Follow-up|11
7427891|NCT01541865|11706424|FG000|Overall Study|Withdrawal by Subject|9
7427892|NCT01541865|11706424|FG000|Overall Study|Adverse Event|1
7427893|NCT01541865|11706424|FG000|Overall Study|Protocol Violation|1
7427894|NCT01541917|11706442|FG000|Overall Study|Lost to Follow-up|2
7427895|NCT01541917|11706443|FG001|Overall Study|Lost to Follow-up|2
7427896|NCT01541917|11706442|FG000|Overall Study|Withdrawal by Subject|13
7427897|NCT01541917|11706443|FG001|Overall Study|Withdrawal by Subject|7
7427898|NCT01541930|11706452|FG000|Overall Study|Withdrawal by Subject|1
7427899|NCT01541969|11706469|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
7427900|NCT01541969|11706470|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
7427901|NCT01541969|11706469|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7427902|NCT01541969|11706470|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
7427903|NCT01541969|11706469|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
7427904|NCT01541969|11706470|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
7558419|NCT03125200|11923893|FG003|Overall Study|Clinical Progression|1
7558399|NCT03124537|11923801|FG000|Overall Study|Lost to Follow-up|3
7558400|NCT03124537|11923802|FG001|Overall Study|Lost to Follow-up|5
7558401|NCT03124537|11923801|FG000|Overall Study|App Crash, Incomplete Data|7
7558402|NCT03124537|11923802|FG001|Overall Study|App Crash, Incomplete Data|8
7558403|NCT03124563|11923814|FG000|Overall Study|Lost to Follow-up|1
7558404|NCT03124563|11923815|FG001|Overall Study|Lost to Follow-up|1
7558405|NCT03124563|11923814|FG000|Overall Study|Withdrawal by Subject|1
7558406|NCT03124563|11923815|FG001|Overall Study|Withdrawal by Subject|1
7558407|NCT03124784|11923837|FG000|Overall Study|Adverse Event|1
7558408|NCT03124784|11923837|FG000|Overall Study|Computer/Equip Malfunction|1
7558409|NCT03125200|11923890|FG000|Overall Study|Study Termination|0
7558410|NCT03125200|11923891|FG001|Overall Study|Study Termination|0
7558411|NCT03125200|11923892|FG002|Overall Study|Study Termination|0
7427905|NCT01541969|11706469|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
7427906|NCT01541969|11706470|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
7427907|NCT01541969|11706469|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
7427908|NCT01541969|11706470|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
7558412|NCT03125200|11923893|FG003|Overall Study|Study Termination|1
7558413|NCT03125200|11923894|FG004|Overall Study|Study Termination|1
7427909|NCT01541969|11706469|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7427910|NCT01541969|11706470|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
7427911|NCT01541969|11706469|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
7427912|NCT01541969|11706470|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
7427913|NCT01541969|11706469|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7427914|NCT01541969|11706470|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
7427915|NCT01541969|11706469|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
7427916|NCT01541969|11706470|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
7427917|NCT01541969|11706469|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
7427918|NCT01541969|11706470|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
7427919|NCT01542034|11706481|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
7427920|NCT01542034|11706482|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
7427921|NCT01542034|11706481|FG000|Overall Study|Administrative decision|0
7427922|NCT01542034|11706482|FG001|Overall Study|Administrative decision|3
7427923|NCT01542034|11706481|FG000|Overall Study|Subject Noncompliance|1
7427924|NCT01542034|11706482|FG001|Overall Study|Subject Noncompliance|0
7427925|NCT01542034|11706481|FG000|Overall Study|Adverse Event|2
7427926|NCT01542034|11706482|FG001|Overall Study|Adverse Event|2
7427927|NCT01542034|11706481|FG000|Overall Study|Lost to Follow-up|7
7427928|NCT01542034|11706482|FG001|Overall Study|Lost to Follow-up|6
7427929|NCT01542528|11706546|FG000|Overall Study|Lost to Follow-up|2
7427930|NCT01542528|11706547|FG001|Overall Study|Lost to Follow-up|1
7427931|NCT01542528|11706546|FG000|Overall Study|Physician Decision|1
7427932|NCT01542528|11706547|FG001|Overall Study|Physician Decision|0
7427933|NCT01542528|11706546|FG000|Overall Study|Withdrawal by Subject|9
7427934|NCT01542528|11706547|FG001|Overall Study|Withdrawal by Subject|6
7427935|NCT01542632|11706568|FG000|Overall Study|Withdrawal of Consent|0
7427936|NCT01542632|11706569|FG001|Overall Study|Withdrawal of Consent|0
7427937|NCT01542632|11706570|FG002|Overall Study|Withdrawal of Consent|0
7427938|NCT01542632|11706571|FG003|Overall Study|Withdrawal of Consent|2
7427939|NCT01542632|11706572|FG004|Overall Study|Withdrawal of Consent|3
7427940|NCT01542632|11706573|FG005|Overall Study|Withdrawal of Consent|0
7427941|NCT01542632|11706568|FG000|Overall Study|Adverse Event|0
7558414|NCT03125200|11923895|FG005|Overall Study|Study Termination|2
7558415|NCT03125200|11923896|FG006|Overall Study|Study Termination|1
7558416|NCT03125200|11923890|FG000|Overall Study|Clinical Progression|0
7558417|NCT03125200|11923891|FG001|Overall Study|Clinical Progression|0
7558418|NCT03125200|11923892|FG002|Overall Study|Clinical Progression|0
7558420|NCT03125200|11923894|FG004|Overall Study|Clinical Progression|0
7558421|NCT03125200|11923895|FG005|Overall Study|Clinical Progression|1
7558422|NCT03125200|11923896|FG006|Overall Study|Clinical Progression|0
7558423|NCT03125200|11923890|FG000|Overall Study|Progressive Disease|2
7558424|NCT03125200|11923891|FG001|Overall Study|Progressive Disease|1
7558425|NCT03125200|11923892|FG002|Overall Study|Progressive Disease|2
7558426|NCT03125200|11923893|FG003|Overall Study|Progressive Disease|1
7558427|NCT03125200|11923894|FG004|Overall Study|Progressive Disease|2
7558428|NCT03125200|11923895|FG005|Overall Study|Progressive Disease|0
7558429|NCT03125200|11923896|FG006|Overall Study|Progressive Disease|1
7558430|NCT03125200|11923890|FG000|Overall Study|Lack of Efficacy|0
7558431|NCT03125200|11923891|FG001|Overall Study|Lack of Efficacy|0
7558432|NCT03125200|11923892|FG002|Overall Study|Lack of Efficacy|0
7558433|NCT03125200|11923893|FG003|Overall Study|Lack of Efficacy|1
7558434|NCT03125200|11923894|FG004|Overall Study|Lack of Efficacy|0
7558435|NCT03125200|11923895|FG005|Overall Study|Lack of Efficacy|0
7558436|NCT03125200|11923896|FG006|Overall Study|Lack of Efficacy|0
7558437|NCT03125200|11923890|FG000|Overall Study|Toxicity|0
7558438|NCT03125200|11923891|FG001|Overall Study|Toxicity|0
7558439|NCT03125200|11923892|FG002|Overall Study|Toxicity|0
7558440|NCT03125200|11923893|FG003|Overall Study|Toxicity|1
7558441|NCT03125200|11923894|FG004|Overall Study|Toxicity|0
7558442|NCT03125200|11923895|FG005|Overall Study|Toxicity|0
7558443|NCT03125200|11923896|FG006|Overall Study|Toxicity|0
7558444|NCT03125200|11923890|FG000|Overall Study|Consent Withdrawn by Subject|0
7558445|NCT03125200|11923891|FG001|Overall Study|Consent Withdrawn by Subject|1
7558446|NCT03125200|11923892|FG002|Overall Study|Consent Withdrawn by Subject|0
7558447|NCT03125200|11923893|FG003|Overall Study|Consent Withdrawn by Subject|0
7558448|NCT03125200|11923894|FG004|Overall Study|Consent Withdrawn by Subject|1
7558449|NCT03125200|11923895|FG005|Overall Study|Consent Withdrawn by Subject|0
7558450|NCT03125200|11923896|FG006|Overall Study|Consent Withdrawn by Subject|1
7558451|NCT03125395|11923919|FG000|Overall Study|Adverse Event|2
7558452|NCT03125395|11923919|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7558453|NCT03125395|11923919|FG000|Overall Study|Physician Decision|2
7558454|NCT03125395|11923919|FG000|Overall Study|Commercial drug is available|5
7558455|NCT03125629|11923923|FG000|Overall Study|Withdrawal by Subject|2
7558456|NCT03125629|11923923|FG000|Overall Study|Equipment malfunction|1
7427942|NCT01542632|11706569|FG001|Overall Study|Adverse Event|0
7558457|NCT03125915|11923939|FG000|1 Month Follow up|Lost to Follow-up|3
7558458|NCT03125915|11923940|FG001|1 Month Follow up|Lost to Follow-up|3
7427943|NCT01542632|11706570|FG002|Overall Study|Adverse Event|1
7427944|NCT01542632|11706571|FG003|Overall Study|Adverse Event|0
7427945|NCT01542632|11706572|FG004|Overall Study|Adverse Event|0
7558459|NCT03125915|11923941|FG002|1 Month Follow up|Lost to Follow-up|2
7558460|NCT03125915|11923942|FG003|1 Month Follow up|Lost to Follow-up|3
7558461|NCT03125915|11923939|FG000|3 Month Follow-up|Lost to Follow-up|6
7427946|NCT01542632|11706573|FG005|Overall Study|Adverse Event|0
7427947|NCT01542632|11706568|FG000|Overall Study|Lost to Follow-up|0
7427948|NCT01542632|11706569|FG001|Overall Study|Lost to Follow-up|1
7427949|NCT01542632|11706570|FG002|Overall Study|Lost to Follow-up|0
7427950|NCT01542632|11706571|FG003|Overall Study|Lost to Follow-up|0
7427951|NCT01542632|11706572|FG004|Overall Study|Lost to Follow-up|0
7427952|NCT01542632|11706573|FG005|Overall Study|Lost to Follow-up|0
7427953|NCT01542632|11706568|FG000|Overall Study|Sponsor/Investigator Decision|0
7427954|NCT01542632|11706569|FG001|Overall Study|Sponsor/Investigator Decision|0
7427955|NCT01542632|11706570|FG002|Overall Study|Sponsor/Investigator Decision|0
7427956|NCT01542632|11706571|FG003|Overall Study|Sponsor/Investigator Decision|0
7427957|NCT01542632|11706572|FG004|Overall Study|Sponsor/Investigator Decision|1
7427958|NCT01542632|11706573|FG005|Overall Study|Sponsor/Investigator Decision|0
7427959|NCT01542788|11706611|FG000|Overall Study|Randomized but Not Treated|2
7427960|NCT01542788|11706612|FG001|Overall Study|Randomized but Not Treated|0
7427961|NCT01542788|11706611|FG000|Overall Study|Lack of Efficacy|41
7427962|NCT01542788|11706612|FG001|Overall Study|Lack of Efficacy|71
7427963|NCT01542788|11706611|FG000|Overall Study|Lost to Follow-up|5
7427964|NCT01542788|11706612|FG001|Overall Study|Lost to Follow-up|0
7427965|NCT01542788|11706611|FG000|Overall Study|Death|3
7427966|NCT01542788|11706612|FG001|Overall Study|Death|0
7427967|NCT01542788|11706611|FG000|Overall Study|Protocol Violation|2
7558462|NCT03125915|11923940|FG001|3 Month Follow-up|Lost to Follow-up|4
7558463|NCT03125915|11923941|FG002|3 Month Follow-up|Lost to Follow-up|4
7558464|NCT03125915|11923942|FG003|3 Month Follow-up|Lost to Follow-up|2
7558465|NCT03125915|11923939|FG000|6 Month Follow-up|Lost to Follow-up|7
7558466|NCT03125915|11923940|FG001|6 Month Follow-up|Lost to Follow-up|3
7558467|NCT03125915|11923941|FG002|6 Month Follow-up|Lost to Follow-up|6
7558468|NCT03125915|11923942|FG003|6 Month Follow-up|Lost to Follow-up|3
7558469|NCT03125941|11923954|FG000|Overall Study|did not receive intervention|1
7558470|NCT03125941|11923955|FG001|Overall Study|did not receive intervention|2
7558471|NCT03126227|11923963|FG000|Overall Study|Adverse Event|43
7558472|NCT03126227|11923964|FG001|Overall Study|Adverse Event|4
7558473|NCT03126227|11923963|FG000|Overall Study|Death|0
7558474|NCT03126227|11923964|FG001|Overall Study|Death|1
7558475|NCT03126227|11923963|FG000|Overall Study|Lost to Follow-up|0
7558476|NCT03126227|11923964|FG001|Overall Study|Lost to Follow-up|1
7558477|NCT03126227|11923963|FG000|Overall Study|Physician Decision|2
7558478|NCT03126227|11923964|FG001|Overall Study|Physician Decision|0
7558479|NCT03126227|11923963|FG000|Overall Study|Protocol Violation|1
7558480|NCT03126227|11923964|FG001|Overall Study|Protocol Violation|0
7558481|NCT03126227|11923963|FG000|Overall Study|Withdrawal by Subject|19
7558482|NCT03126227|11923964|FG001|Overall Study|Withdrawal by Subject|3
7558483|NCT03126227|11923963|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
7558484|NCT03126227|11923964|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
7558485|NCT03126227|11923963|FG000|Overall Study|Lack of dosing compliance|2
7558486|NCT03126227|11923964|FG001|Overall Study|Lack of dosing compliance|0
7558487|NCT03126227|11923963|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
7558488|NCT03126227|11923964|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
7558489|NCT03126227|11923963|FG000|Overall Study|Scheduling conflict|1
7558490|NCT03126227|11923964|FG001|Overall Study|Scheduling conflict|0
7558491|NCT03126344|11923973|FG000|Overall Study|Lost to Follow-up|0
7558492|NCT03126344|11923974|FG001|Overall Study|Lost to Follow-up|0
7558493|NCT03126344|11923975|FG002|Overall Study|Lost to Follow-up|5
7558494|NCT03126786|11924024|FG000|Overall Study|Adverse Event|3
7558495|NCT03126786|11924025|FG001|Overall Study|Adverse Event|0
7558496|NCT03126786|11924024|FG000|Overall Study|Lost to Follow-up|0
7558497|NCT03126786|11924025|FG001|Overall Study|Lost to Follow-up|1
7558498|NCT03126786|11924024|FG000|Overall Study|Withdrawal by Subject|3
7558499|NCT03126786|11924025|FG001|Overall Study|Withdrawal by Subject|1
7558502|NCT03127644|11924077|FG000|Overall Study|Study-specific withdrawal criteria|0
7558503|NCT03127644|11924078|FG001|Overall Study|Study-specific withdrawal criteria|0
7558504|NCT03127644|11924079|FG002|Overall Study|Study-specific withdrawal criteria|2
7558505|NCT03128099|11924117|FG000|Overall Study|High dose task was too long|0
7558506|NCT03128099|11924118|FG001|Overall Study|High dose task was too long|4
7558507|NCT03128099|11924119|FG002|Overall Study|High dose task was too long|0
7427968|NCT01542788|11706612|FG001|Overall Study|Protocol Violation|0
7427969|NCT01542788|11706611|FG000|Overall Study|Physician Decision|1
7427970|NCT01542788|11706612|FG001|Overall Study|Physician Decision|0
7558508|NCT03128099|11924117|FG000|Overall Study|Participant got a full time job.|1
7558509|NCT03128099|11924118|FG001|Overall Study|Participant got a full time job.|0
7558510|NCT03128099|11924119|FG002|Overall Study|Participant got a full time job.|0
7558511|NCT03128099|11924117|FG000|Overall Study|Became homeless and lost contact|1
7558512|NCT03128099|11924118|FG001|Overall Study|Became homeless and lost contact|0
7558513|NCT03128099|11924119|FG002|Overall Study|Became homeless and lost contact|0
7558514|NCT03128099|11924117|FG000|Overall Study|Did not complete all the assessments|0
7427971|NCT01542788|11706611|FG000|Overall Study|Withdrawal by Subject|1
7427972|NCT01542788|11706612|FG001|Overall Study|Withdrawal by Subject|0
7427973|NCT01543087|11706654|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
7532132|NCT02665052|11877450|FG002|Overall Study|Adverse Event|0
7532133|NCT02665052|11877451|FG003|Overall Study|Adverse Event|0
7532134|NCT02665286|11877495|FG000|Overall Study|Lost to Follow-up|3
7532135|NCT02665286|11877496|FG001|Overall Study|Lost to Follow-up|2
7532136|NCT02665286|11877497|FG002|Overall Study|Lost to Follow-up|1
7558515|NCT03128099|11924118|FG001|Overall Study|Did not complete all the assessments|0
7558516|NCT03128099|11924119|FG002|Overall Study|Did not complete all the assessments|1
7558517|NCT03128307|11924125|FG000|Overall Study|Lost to Follow-up|29
7558518|NCT03128307|11924125|FG000|Overall Study|Withdrawal by Subject|5
7558519|NCT03128723|11924133|FG000|Overall Study|Withdrawal by Subject|2
7558520|NCT03128892|11924137|FG000|Overall Study|Withdrawal by Subject|2
7558521|NCT03128892|11924137|FG000|Overall Study|Physician Decision|1
7574774|NCT03692676|11957890|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
7574775|NCT03692676|11957891|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
7574776|NCT03692676|11957888|FG000|Overall Study|Other|0
7574777|NCT03692676|11957889|FG001|Overall Study|Other|805
7574778|NCT03692676|11957890|FG002|Overall Study|Other|758
7574779|NCT03692676|11957891|FG003|Overall Study|Other|277
7574780|NCT03692676|11957888|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7574781|NCT03692676|11957889|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7574782|NCT03692676|11957890|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
7574783|NCT03692676|11957891|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
7574784|NCT03693625|11957903|FG000|Overall Study|Adverse Event|2
7574785|NCT03693625|11957904|FG001|Overall Study|Adverse Event|0
7532137|NCT02665455|11877514|FG000|Overall Study|Withdrawal by Subject|6
7532138|NCT02665455|11877514|FG000|Overall Study|Lost to Follow-up|1
7574786|NCT03693625|11957903|FG000|Overall Study|Study Terminated By Sponsor|20
7574787|NCT03693625|11957904|FG001|Overall Study|Study Terminated By Sponsor|7
7574788|NCT03693625|11957903|FG000|Overall Study|Withdrawal by Subject|1
7574789|NCT03693625|11957904|FG001|Overall Study|Withdrawal by Subject|1
7574790|NCT03693950|11957927|FG000|Overall Study|Withdrawal by Subject|1
7574791|NCT03693950|11957928|FG001|Overall Study|Withdrawal by Subject|0
7574792|NCT03693989|11957936|FG000|Overall Study|Protocol Violation|3
7574793|NCT03693989|11957937|FG001|Overall Study|Protocol Violation|4
7574794|NCT03694197|11957943|FG000|Overall Study|Adverse Event|9
7558532|NCT03131167|11924210|FG007|Overall Study|Other (Unspecified)|0
7574795|NCT03694197|11957943|FG000|Overall Study|Protocol became inconvenient to participate|1
7574796|NCT03694197|11957943|FG000|Overall Study|Physician Decision|4
7574797|NCT03694197|11957943|FG000|Overall Study|Study terminated by sponsor|1350
7574798|NCT03694197|11957943|FG000|Overall Study|Participant moved|5
7574799|NCT03694197|11957943|FG000|Overall Study|Participant withdrew consent|10
7574800|NCT03694197|11957943|FG000|Overall Study|Related to IMP administration|1
7574801|NCT03694197|11957943|FG000|Overall Study|Not disclosed|5
7574802|NCT03694210|11957947|FG000|Overall Study|Death|1
7574803|NCT03694210|11957947|FG000|Overall Study|Screen Failure|7
7574804|NCT03694548|11957955|FG000|Part A Survey|Protocol Violation|3
7574805|NCT03694548|11957956|FG001|Part A Survey|Protocol Violation|3
7574806|NCT03694548|11957957|FG002|Part A Survey|Protocol Violation|0
7574807|NCT03694548|11957955|FG000|Part B Yoga Program|Protocol Violation|0
7574808|NCT03694548|11957956|FG001|Part B Yoga Program|Protocol Violation|0
7574809|NCT03694548|11957957|FG002|Part B Yoga Program|Protocol Violation|3
7574810|NCT03694548|11957955|FG000|Part B Yoga Program|Did not attend intervention|0
7574811|NCT03694548|11957956|FG001|Part B Yoga Program|Did not attend intervention|0
7574812|NCT03694548|11957957|FG002|Part B Yoga Program|Did not attend intervention|8
7574813|NCT03694925|11957983|FG000|Overall Study|Inadequate laboratory testing|0
7532139|NCT02665455|11877514|FG000|Overall Study|Adverse Event|1
7532140|NCT02665455|11877514|FG000|Overall Study|Protocol Violation|1
7532141|NCT02665689|11877529|FG000|Overall Study|Adverse Event|1
7532142|NCT02665689|11877530|FG001|Overall Study|Adverse Event|0
7532143|NCT02665689|11877529|FG000|Overall Study|Trial termination|1
7532144|NCT02665689|11877530|FG001|Overall Study|Trial termination|1
7532145|NCT02665689|11877529|FG000|Overall Study|Lost to Follow-up|0
7532146|NCT02665689|11877530|FG001|Overall Study|Lost to Follow-up|1
7574814|NCT03694925|11957984|FG001|Overall Study|Inadequate laboratory testing|3
7574815|NCT03694925|11957985|FG002|Overall Study|Inadequate laboratory testing|0
7574816|NCT03695094|11957997|FG000|Overall Study|Adverse Event|1
7574817|NCT03695094|11957998|FG001|Overall Study|Adverse Event|1
7574818|NCT03695094|11957997|FG000|Overall Study|Withdrawal by Subject|1
7574819|NCT03695094|11957998|FG001|Overall Study|Withdrawal by Subject|0
7574820|NCT03695367|11958008|FG000|Overall Study|Missed the Day 28 visit.|1
7574821|NCT03695367|11958009|FG001|Overall Study|Missed the Day 28 visit.|0
7574822|NCT03695367|11958008|FG000|Overall Study|Lost to Follow-up|0
7427974|NCT01543087|11706655|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
7427975|NCT01543087|11706656|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
7427976|NCT01543087|11706657|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
7427977|NCT01543087|11706658|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
7427978|NCT01543087|11706659|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
7532147|NCT02666222|11877562|FG000|Overall Study|Death|2
7532148|NCT02666664|11877602|FG000|Overall Study|Physician Decision|0
7532149|NCT02666664|11877603|FG001|Overall Study|Physician Decision|1
7532150|NCT02666664|11877602|FG000|Overall Study|Protocol Violation|0
7532151|NCT02666664|11877603|FG001|Overall Study|Protocol Violation|2
7532152|NCT02666664|11877602|FG000|Overall Study|Other|0
7532153|NCT02666664|11877603|FG001|Overall Study|Other|1
7532154|NCT02666664|11877602|FG000|Overall Study|Adverse Event|12
7532155|NCT02666664|11877603|FG001|Overall Study|Adverse Event|37
7532156|NCT02666664|11877602|FG000|Overall Study|Withdrawal by participant|23
7532157|NCT02666664|11877603|FG001|Overall Study|Withdrawal by participant|40
7532158|NCT02666664|11877602|FG000|Overall Study|Sponsor decision|0
7558522|NCT03130257|11924167|FG000|Overall Study|Withdrawal by Subject|1
7558523|NCT03130257|11924168|FG001|Overall Study|Withdrawal by Subject|0
7558524|NCT03130257|11924169|FG002|Overall Study|Withdrawal by Subject|2
7427979|NCT01543087|11706654|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
7427980|NCT01543087|11706655|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
7427981|NCT01543087|11706656|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
7427982|NCT01543087|11706657|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
7427983|NCT01543087|11706658|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
7427984|NCT01543087|11706659|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
7427985|NCT01543087|11706654|FG000|Stage 1 (48 Months)|No longer willing to participate|5
7427986|NCT01543087|11706655|FG001|Stage 1 (48 Months)|No longer willing to participate|3
7427987|NCT01543087|11706656|FG002|Stage 1 (48 Months)|No longer willing to participate|18
7427988|NCT01543087|11706657|FG003|Stage 1 (48 Months)|No longer willing to participate|6
7427989|NCT01543087|11706658|FG004|Stage 1 (48 Months)|No longer willing to participate|3
7427990|NCT01543087|11706659|FG005|Stage 1 (48 Months)|No longer willing to participate|0
7427991|NCT01543087|11706654|FG000|Stage 1 (48 Months)|Other than specified|5
7427992|NCT01543087|11706655|FG001|Stage 1 (48 Months)|Other than specified|0
7427993|NCT01543087|11706656|FG002|Stage 1 (48 Months)|Other than specified|9
7427994|NCT01543087|11706657|FG003|Stage 1 (48 Months)|Other than specified|0
7427995|NCT01543087|11706658|FG004|Stage 1 (48 Months)|Other than specified|0
7427996|NCT01543087|11706659|FG005|Stage 1 (48 Months)|Other than specified|0
7427997|NCT01543087|11706654|FG000|Stage 1 (48 Months)|Protocol Violation|0
7558525|NCT03131167|11924203|FG000|Overall Study|Other (Unspecified)|0
7558526|NCT03131167|11924204|FG001|Overall Study|Other (Unspecified)|0
7558527|NCT03131167|11924205|FG002|Overall Study|Other (Unspecified)|0
7558528|NCT03131167|11924206|FG003|Overall Study|Other (Unspecified)|0
7558529|NCT03131167|11924207|FG004|Overall Study|Other (Unspecified)|0
7558530|NCT03131167|11924208|FG005|Overall Study|Other (Unspecified)|1
7558531|NCT03131167|11924209|FG006|Overall Study|Other (Unspecified)|0
7558533|NCT03131167|11924211|FG008|Overall Study|Other (Unspecified)|0
7558534|NCT03131167|11924212|FG009|Overall Study|Other (Unspecified)|0
7558535|NCT03131167|11924213|FG010|Overall Study|Other (Unspecified)|0
7558536|NCT03131167|11924214|FG011|Overall Study|Other (Unspecified)|0
7558537|NCT03131167|11924215|FG012|Overall Study|Other (Unspecified)|0
7558538|NCT03131453|11924268|FG000|Overall Study|Study terminated by Sponsor|424
7558539|NCT03131453|11924269|FG001|Overall Study|Study terminated by Sponsor|222
7558540|NCT03131453|11924270|FG002|Overall Study|Study terminated by Sponsor|438
7558541|NCT03131453|11924268|FG000|Overall Study|Withdrawal by Subject|18
7558542|NCT03131453|11924269|FG001|Overall Study|Withdrawal by Subject|7
7558543|NCT03131453|11924270|FG002|Overall Study|Withdrawal by Subject|13
7558544|NCT03131453|11924268|FG000|Overall Study|Adverse Event|10
7558545|NCT03131453|11924269|FG001|Overall Study|Adverse Event|3
7558546|NCT03131453|11924270|FG002|Overall Study|Adverse Event|3
7558547|NCT03131453|11924268|FG000|Overall Study|Lost to Follow-up|1
7558548|NCT03131453|11924269|FG001|Overall Study|Lost to Follow-up|0
7558549|NCT03131453|11924270|FG002|Overall Study|Lost to Follow-up|1
7558550|NCT03131453|11924268|FG000|Overall Study|Physician Decision|1
7558551|NCT03131453|11924269|FG001|Overall Study|Physician Decision|0
7558552|NCT03131453|11924270|FG002|Overall Study|Physician Decision|1
7558553|NCT03131453|11924268|FG000|Overall Study|Non-compliance with study treatment|1
7558554|NCT03131453|11924269|FG001|Overall Study|Non-compliance with study treatment|0
7558555|NCT03131453|11924270|FG002|Overall Study|Non-compliance with study treatment|0
7558556|NCT03131453|11924268|FG000|Overall Study|Technical problems|1
7558557|NCT03131453|11924269|FG001|Overall Study|Technical problems|0
7558558|NCT03131453|11924270|FG002|Overall Study|Technical problems|0
7558559|NCT03131453|11924268|FG000|Overall Study|Protocol deviation|0
7558560|NCT03131453|11924269|FG001|Overall Study|Protocol deviation|1
7427998|NCT01543087|11706655|FG001|Stage 1 (48 Months)|Protocol Violation|3
7427999|NCT01543087|11706656|FG002|Stage 1 (48 Months)|Protocol Violation|0
7428000|NCT01543087|11706657|FG003|Stage 1 (48 Months)|Protocol Violation|0
7532159|NCT02666664|11877603|FG001|Overall Study|Sponsor decision|1
7558561|NCT03131453|11924270|FG002|Overall Study|Protocol deviation|0
7558562|NCT03131479|11924283|FG000|Overall Study|Adverse Event|0
7558563|NCT03131479|11924284|FG001|Overall Study|Adverse Event|0
7558564|NCT03131479|11924285|FG002|Overall Study|Adverse Event|1
7532160|NCT02666664|11877602|FG000|Overall Study|Lost to Follow-up|1
7532161|NCT02666664|11877603|FG001|Overall Study|Lost to Follow-up|2
7532162|NCT02667236|11877661|FG000|Overall Study|Adverse Event|1
7532163|NCT02667236|11877662|FG001|Overall Study|Adverse Event|1
7558565|NCT03131479|11924286|FG003|Overall Study|Adverse Event|1
7558566|NCT03131479|11924287|FG004|Overall Study|Adverse Event|0
7558567|NCT03131479|11924283|FG000|Overall Study|Subject/Guardian Decision|0
7558568|NCT03131479|11924284|FG001|Overall Study|Subject/Guardian Decision|0
7428001|NCT01543087|11706658|FG004|Stage 1 (48 Months)|Protocol Violation|0
7428002|NCT01543087|11706659|FG005|Stage 1 (48 Months)|Protocol Violation|0
7428003|NCT01543087|11706654|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7428004|NCT01543087|11706655|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
7428005|NCT01543087|11706656|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7428006|NCT01543087|11706657|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7428007|NCT01543087|11706658|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
7428008|NCT01543087|11706659|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
7428009|NCT01543087|11706654|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
7428010|NCT01543087|11706655|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
7428011|NCT01543087|11706656|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
7532164|NCT02667236|11877661|FG000|Overall Study|Withdrawal by Subject|2
7532165|NCT02667236|11877662|FG001|Overall Study|Withdrawal by Subject|0
7532166|NCT02667275|11877670|FG000|Overall Study|Protocol Violation|11
7558569|NCT03131479|11924285|FG002|Overall Study|Subject/Guardian Decision|0
7558570|NCT03131479|11924286|FG003|Overall Study|Subject/Guardian Decision|1
7558571|NCT03131479|11924287|FG004|Overall Study|Subject/Guardian Decision|0
7558572|NCT03131570|11924301|FG000|Overall Study|Adverse Event|1
7558573|NCT03131570|11924302|FG001|Overall Study|Adverse Event|0
7558574|NCT03131596|11924310|FG000|Overall Study|Protocol Violation|3
7558575|NCT03131596|11924311|FG001|Overall Study|Protocol Violation|3
7558576|NCT03131596|11924310|FG000|Overall Study|Lost to Follow-up|3
7558577|NCT03131596|11924311|FG001|Overall Study|Lost to Follow-up|0
7558578|NCT03131648|11924319|FG000|Initial Treatment Period|Not dosed|2
7558579|NCT03131648|11924320|FG001|Initial Treatment Period|Not dosed|2
7558580|NCT03131648|11924321|FG002|Initial Treatment Period|Not dosed|0
7558581|NCT03131648|11924322|FG003|Initial Treatment Period|Not dosed|0
7558582|NCT03131648|11924323|FG004|Initial Treatment Period|Not dosed|0
7558583|NCT03131648|11924324|FG005|Initial Treatment Period|Not dosed|0
7558584|NCT03131648|11924325|FG006|Initial Treatment Period|Not dosed|0
7558585|NCT03131648|11924326|FG007|Initial Treatment Period|Not dosed|0
7558586|NCT03131648|11924319|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
7558587|NCT03131648|11924320|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
7558588|NCT03131648|11924321|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7558589|NCT03131648|11924322|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7558590|NCT03131648|11924323|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7558591|NCT03131648|11924324|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7558592|NCT03131648|11924325|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7558593|NCT03131648|11924326|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
7558594|NCT03131648|11924319|FG000|Open-label Treatment|Discontinued IMP|0
7558595|NCT03131648|11924320|FG001|Open-label Treatment|Discontinued IMP|0
7558596|NCT03131648|11924321|FG002|Open-label Treatment|Discontinued IMP|0
7558597|NCT03131648|11924322|FG003|Open-label Treatment|Discontinued IMP|0
7558598|NCT03131648|11924323|FG004|Open-label Treatment|Discontinued IMP|0
7558599|NCT03131648|11924324|FG005|Open-label Treatment|Discontinued IMP|0
7558600|NCT03131648|11924325|FG006|Open-label Treatment|Discontinued IMP|112
7558601|NCT03131648|11924326|FG007|Open-label Treatment|Discontinued IMP|0
7558602|NCT03131648|11924319|FG000|Open-label Treatment|Completed Week 50|0
7558603|NCT03131648|11924320|FG001|Open-label Treatment|Completed Week 50|0
7558604|NCT03131648|11924321|FG002|Open-label Treatment|Completed Week 50|0
7558605|NCT03131648|11924322|FG003|Open-label Treatment|Completed Week 50|0
7558606|NCT03131648|11924323|FG004|Open-label Treatment|Completed Week 50|0
7558607|NCT03131648|11924324|FG005|Open-label Treatment|Completed Week 50|0
7558608|NCT03131648|11924325|FG006|Open-label Treatment|Completed Week 50|6
7558609|NCT03131648|11924326|FG007|Open-label Treatment|Completed Week 50|0
7558610|NCT03131648|11924319|FG000|Maintenance Treatment Period|Not dosed|0
7558611|NCT03131648|11924320|FG001|Maintenance Treatment Period|Not dosed|0
7532167|NCT02667275|11877671|FG001|Overall Study|Protocol Violation|7
7428012|NCT01543087|11706657|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
7428013|NCT01543087|11706658|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
7428014|NCT01543087|11706659|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
7428015|NCT01543152|11706700|FG000|Overall Study|Withdrawal by Subject|0
7428016|NCT01543152|11706701|FG001|Overall Study|Withdrawal by Subject|2
7428017|NCT01543152|11706702|FG002|Overall Study|Withdrawal by Subject|0
7428018|NCT01543152|11706703|FG003|Overall Study|Withdrawal by Subject|0
7428019|NCT01543152|11706704|FG004|Overall Study|Withdrawal by Subject|0
7428020|NCT01543204|11706728|FG000|Overall Study|Non-compliance|1
7428021|NCT01543204|11706728|FG000|Overall Study|Adverse Event|1
7532168|NCT02667275|11877670|FG000|Overall Study|Lost to Follow-up|0
7532169|NCT02667275|11877671|FG001|Overall Study|Lost to Follow-up|2
7532170|NCT02667275|11877670|FG000|Overall Study|Withdrawal by Subject|0
7532171|NCT02667275|11877671|FG001|Overall Study|Withdrawal by Subject|5
7532172|NCT02667275|11877670|FG000|Overall Study|Discontinued early without completing|0
7532173|NCT02667275|11877671|FG001|Overall Study|Discontinued early without completing|1
7532174|NCT02667288|11877677|FG000|Overall Study|Protocol Violation|5
7532175|NCT02667288|11877677|FG000|Overall Study|Lost to Follow-up|3
7532176|NCT02667288|11877677|FG000|Overall Study|Withdrawal by Subject|5
7532177|NCT02667301|11877681|FG000|Overall Study|Adverse Event|1
7428022|NCT01543204|11706728|FG000|Overall Study|Withdrawal by Subject|4
7428023|NCT01543204|11706728|FG000|Overall Study|Requirement for Alternative Therapy|1
7428024|NCT01543204|11706728|FG000|Overall Study|Lost to Follow-up|1
7428025|NCT01543490|11706738|FG000|Overall Study|Adverse Event|4
7428026|NCT01543490|11706739|FG001|Overall Study|Adverse Event|0
7428027|NCT01543490|11706738|FG000|Overall Study|Physician Decision|1
7428028|NCT01543490|11706739|FG001|Overall Study|Physician Decision|0
7428029|NCT01543490|11706738|FG000|Overall Study|Lack of Efficacy|3
7428030|NCT01543490|11706739|FG001|Overall Study|Lack of Efficacy|3
7428031|NCT01543490|11706738|FG000|Overall Study|Lost to Follow-up|5
7428032|NCT01543490|11706739|FG001|Overall Study|Lost to Follow-up|0
7428033|NCT01543490|11706738|FG000|Overall Study|Withdrawal by Subject|2
7428034|NCT01543490|11706739|FG001|Overall Study|Withdrawal by Subject|0
7428035|NCT01543490|11706738|FG000|Overall Study|Other-Various Administrative Reasons|1
7428036|NCT01543490|11706739|FG001|Overall Study|Other-Various Administrative Reasons|2
7428037|NCT01543503|11706747|FG000|Overall Study|Lost to Follow-up|32
7428038|NCT01543503|11706748|FG001|Overall Study|Lost to Follow-up|36
7428039|NCT01543503|11706747|FG000|Overall Study|Adverse Event|9
7428040|NCT01543503|11706748|FG001|Overall Study|Adverse Event|13
7428041|NCT01543503|11706747|FG000|Overall Study|Lack of Efficacy|4
7428042|NCT01543503|11706748|FG001|Overall Study|Lack of Efficacy|16
7428043|NCT01543503|11706747|FG000|Overall Study|Participant withdrew informed consent|8
7428044|NCT01543503|11706748|FG001|Overall Study|Participant withdrew informed consent|10
7428045|NCT01543503|11706747|FG000|Overall Study|Change of jobs|0
7428046|NCT01543503|11706748|FG001|Overall Study|Change of jobs|1
7428047|NCT01543503|11706747|FG000|Overall Study|Intolerance to the biologic treatment|0
7428048|NCT01543503|11706748|FG001|Overall Study|Intolerance to the biologic treatment|1
7428049|NCT01543503|11706747|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
7428050|NCT01543503|11706748|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
7428051|NCT01543503|11706747|FG000|Overall Study|Participant did not complete last visit|0
7428052|NCT01543503|11706748|FG001|Overall Study|Participant did not complete last visit|2
7428053|NCT01543503|11706747|FG000|Overall Study|Refused to continue treatment|7
7428054|NCT01543503|11706748|FG001|Overall Study|Refused to continue treatment|0
7428055|NCT01543503|11706747|FG000|Overall Study|Incorrect medication received|1
7428056|NCT01543503|11706748|FG001|Overall Study|Incorrect medication received|0
7428057|NCT01543503|11706747|FG000|Overall Study|Participant moved to another city|2
7428058|NCT01543503|11706748|FG001|Overall Study|Participant moved to another city|0
7428059|NCT01543503|11706747|FG000|Overall Study|Participant will not return for visits|0
7428060|NCT01543503|11706748|FG001|Overall Study|Participant will not return for visits|2
7428061|NCT01543503|11706747|FG000|Overall Study|Participant transferred to another city|1
7428062|NCT01543503|11706748|FG001|Overall Study|Participant transferred to another city|0
7428063|NCT01543503|11706747|FG000|Overall Study|Participant moved to Scotland|1
7428064|NCT01543503|11706748|FG001|Overall Study|Participant moved to Scotland|0
7428065|NCT01543503|11706747|FG000|Overall Study|Participant decision to stop treatment|1
7428066|NCT01543503|11706748|FG001|Overall Study|Participant decision to stop treatment|0
7428067|NCT01543503|11706747|FG000|Overall Study|Investigator did not wish to participate|1
7428068|NCT01543503|11706748|FG001|Overall Study|Investigator did not wish to participate|1
7428069|NCT01543503|11706747|FG000|Overall Study|Participant recruited after closing date|0
7428070|NCT01543503|11706748|FG001|Overall Study|Participant recruited after closing date|1
7428071|NCT01543503|11706747|FG000|Overall Study|Site stopped participation|5
7428072|NCT01543503|11706748|FG001|Overall Study|Site stopped participation|1
7428073|NCT01543503|11706747|FG000|Overall Study|Participant did not attend a visit|1
7428074|NCT01543503|11706748|FG001|Overall Study|Participant did not attend a visit|0
7428075|NCT01543503|11706747|FG000|Overall Study|Moved to other rheumatologic site|0
7428076|NCT01543503|11706748|FG001|Overall Study|Moved to other rheumatologic site|1
7428077|NCT01543503|11706747|FG000|Overall Study|Participant consented to another study|0
7428078|NCT01543503|11706748|FG001|Overall Study|Participant consented to another study|2
7428079|NCT01543503|11706747|FG000|Overall Study|Participant went to United States|1
7428080|NCT01543503|11706748|FG001|Overall Study|Participant went to United States|0
7428081|NCT01543503|11706747|FG000|Overall Study|Screen failure|1
7428082|NCT01543503|11706748|FG001|Overall Study|Screen failure|0
7428083|NCT01543685|11706774|FG000|Overall Study|Lack of Efficacy|1
7428084|NCT01543685|11706775|FG001|Overall Study|Lack of Efficacy|2
7428085|NCT01543685|11706776|FG002|Overall Study|Lack of Efficacy|2
7428086|NCT01543685|11706777|FG003|Overall Study|Lack of Efficacy|0
7428087|NCT01543685|11706778|FG004|Overall Study|Lack of Efficacy|2
7428088|NCT01543685|11706774|FG000|Overall Study|Adverse Event|2
7428089|NCT01543685|11706775|FG001|Overall Study|Adverse Event|1
7428090|NCT01543685|11706776|FG002|Overall Study|Adverse Event|0
7428091|NCT01543685|11706777|FG003|Overall Study|Adverse Event|0
7428092|NCT01543685|11706778|FG004|Overall Study|Adverse Event|2
7428093|NCT01543776|11706792|FG000|Overall Study|Withdrawal by Subject|2
7428094|NCT01543776|11706793|FG001|Overall Study|Withdrawal by Subject|2
7428095|NCT01543828|11706801|FG000|Treatment 2|Lost to Follow-up|1
7428096|NCT01543828|11706802|FG001|Treatment 2|Lost to Follow-up|0
7428097|NCT01543958|11706810|FG000|Overall Study|Loss to follow-up|3
7428098|NCT01543958|11706810|FG000|Overall Study|ART initiation|1
7428099|NCT01544114|11706840|FG000|Overall Study|Withdrawal by Subject|0
7428100|NCT01544114|11706841|FG001|Overall Study|Withdrawal by Subject|0
7428101|NCT01544114|11706842|FG002|Overall Study|Withdrawal by Subject|3
7428102|NCT01544114|11706840|FG000|Overall Study|Lost to Follow-up|0
7428103|NCT01544114|11706841|FG001|Overall Study|Lost to Follow-up|2
7428104|NCT01544114|11706842|FG002|Overall Study|Lost to Follow-up|0
7428105|NCT01544114|11706840|FG000|Overall Study|Adverse Event|1
7428106|NCT01544114|11706841|FG001|Overall Study|Adverse Event|1
7428107|NCT01544114|11706842|FG002|Overall Study|Adverse Event|2
7428108|NCT01544114|11706840|FG000|Overall Study|Protocol Violation|0
7428109|NCT01544114|11706841|FG001|Overall Study|Protocol Violation|1
7428110|NCT01544114|11706842|FG002|Overall Study|Protocol Violation|0
7428111|NCT01544153|11706856|FG000|Overall Study|Under 18|0
7428112|NCT01544153|11706857|FG001|Overall Study|Under 18|1
7428113|NCT01544153|11706858|FG002|Overall Study|Under 18|0
7428114|NCT01544153|11706859|FG003|Overall Study|Under 18|0
7428115|NCT01544153|11706856|FG000|Overall Study|Non-smoker|0
7428116|NCT01544153|11706857|FG001|Overall Study|Non-smoker|0
7428117|NCT01544153|11706858|FG002|Overall Study|Non-smoker|1
7428118|NCT01544153|11706859|FG003|Overall Study|Non-smoker|0
7428119|NCT01544179|11706878|FG000|Overall Study|Death|50
7428120|NCT01544179|11706879|FG001|Overall Study|Death|37
7428121|NCT01544179|11706878|FG000|Overall Study|Lost to Follow-up|0
7428122|NCT01544179|11706879|FG001|Overall Study|Lost to Follow-up|1
7428123|NCT01544179|11706878|FG000|Overall Study|Adverse Event|0
7428124|NCT01544179|11706879|FG001|Overall Study|Adverse Event|1
7428125|NCT01544179|11706878|FG000|Overall Study|Withdrawal by Subject|12
7428126|NCT01544179|11706879|FG001|Overall Study|Withdrawal by Subject|7
7428127|NCT01544179|11706878|FG000|Overall Study|Eligibility criteria not fulfilled|1
7428128|NCT01544179|11706879|FG001|Overall Study|Eligibility criteria not fulfilled|0
7428129|NCT01544309|11706887|FG000|Overall Study|Withdrawal by Subject|12
7428130|NCT01544309|11706888|FG001|Overall Study|Withdrawal by Subject|7
7428131|NCT01544309|11706887|FG000|Overall Study|Protocol Violation|2
7428132|NCT01544309|11706888|FG001|Overall Study|Protocol Violation|1
7428133|NCT01544309|11706887|FG000|Overall Study|Physician Decision|4
7428134|NCT01544309|11706888|FG001|Overall Study|Physician Decision|1
7428135|NCT01544309|11706887|FG000|Overall Study|Not performed pre-dose examination|1
7428136|NCT01544309|11706888|FG001|Overall Study|Not performed pre-dose examination|2
7428137|NCT01544309|11706887|FG000|Overall Study|Administered prohibit prior medication|1
7428138|NCT01544309|11706888|FG001|Overall Study|Administered prohibit prior medication|0
7428139|NCT01544348|11706904|FG000|Overall Study|Lost to Follow-up|1
7428140|NCT01544348|11706905|FG001|Overall Study|Lost to Follow-up|0
7428141|NCT01544348|11706906|FG002|Overall Study|Lost to Follow-up|0
7428142|NCT01544348|11706907|FG003|Overall Study|Lost to Follow-up|0
7428143|NCT01544348|11706908|FG004|Overall Study|Lost to Follow-up|0
7428144|NCT01544348|11706909|FG005|Overall Study|Lost to Follow-up|0
7428145|NCT01544348|11706910|FG006|Overall Study|Lost to Follow-up|1
7428146|NCT01544348|11706911|FG007|Overall Study|Lost to Follow-up|0
7428147|NCT01544348|11706904|FG000|Overall Study|Withdrawal by Subject|1
7428148|NCT01544348|11706905|FG001|Overall Study|Withdrawal by Subject|0
7428149|NCT01544348|11706906|FG002|Overall Study|Withdrawal by Subject|0
7428150|NCT01544348|11706907|FG003|Overall Study|Withdrawal by Subject|0
7428151|NCT01544348|11706908|FG004|Overall Study|Withdrawal by Subject|1
7428152|NCT01544348|11706909|FG005|Overall Study|Withdrawal by Subject|2
7428153|NCT01544348|11706910|FG006|Overall Study|Withdrawal by Subject|1
7428154|NCT01544348|11706911|FG007|Overall Study|Withdrawal by Subject|0
7428155|NCT01544348|11706904|FG000|Overall Study|Physician Decision|0
7428156|NCT01544348|11706905|FG001|Overall Study|Physician Decision|0
7428157|NCT01544348|11706906|FG002|Overall Study|Physician Decision|0
7428158|NCT01544348|11706907|FG003|Overall Study|Physician Decision|0
7428159|NCT01544348|11706908|FG004|Overall Study|Physician Decision|0
7428160|NCT01544348|11706909|FG005|Overall Study|Physician Decision|1
7428161|NCT01544348|11706910|FG006|Overall Study|Physician Decision|0
7428162|NCT01544348|11706911|FG007|Overall Study|Physician Decision|0
7466893|NCT01895322|11766940|FG000|Overall Study|Withdrawal by Subject|2
7466894|NCT01895322|11766940|FG000|Overall Study|Protocol Violation|10
7466895|NCT01895335|11766945|FG000|Overall Study|Adverse Event|106
7466896|NCT01895335|11766945|FG000|Overall Study|Lack of Efficacy|53
7466897|NCT01895335|11766945|FG000|Overall Study|Poor Compliance to Protocol|11
7466898|NCT01895335|11766945|FG000|Overall Study|Included But Not treated|1
7466899|NCT01895335|11766945|FG000|Overall Study|Other than Specified Above|44
7466900|NCT01895361|11766952|FG000|Overall Study|Adverse Event|1
7466901|NCT01895361|11766953|FG001|Overall Study|Adverse Event|1
7466902|NCT01895361|11766954|FG002|Overall Study|Adverse Event|3
7466903|NCT01895361|11766952|FG000|Overall Study|Death|2
7466904|NCT01895361|11766953|FG001|Overall Study|Death|1
7466905|NCT01895361|11766954|FG002|Overall Study|Death|2
7466906|NCT01895361|11766952|FG000|Overall Study|Lost to Follow-up|4
7466907|NCT01895361|11766953|FG001|Overall Study|Lost to Follow-up|4
7466908|NCT01895361|11766954|FG002|Overall Study|Lost to Follow-up|6
7466909|NCT01895361|11766952|FG000|Overall Study|Non-compliance with study|1
7466910|NCT01895361|11766953|FG001|Overall Study|Non-compliance with study|3
7466911|NCT01895361|11766954|FG002|Overall Study|Non-compliance with study|1
7466912|NCT01895361|11766952|FG000|Overall Study|Physician Decision|2
7466913|NCT01895361|11766953|FG001|Overall Study|Physician Decision|2
7466914|NCT01895361|11766954|FG002|Overall Study|Physician Decision|2
7466915|NCT01895361|11766952|FG000|Overall Study|Withdrawal by Subject|7
7466916|NCT01895361|11766953|FG001|Overall Study|Withdrawal by Subject|6
7328428|NCT00796445|11561415|FG000|Overall Study|Disease progression/recurrence|537
7328429|NCT00796445|11561416|FG001|Overall Study|Disease progression/recurrence|268
7328430|NCT00796445|11561415|FG000|Overall Study|Other|10
7328431|NCT00796445|11561416|FG001|Overall Study|Other|7
7328432|NCT00796445|11561415|FG000|Overall Study|Withdrawal by Subject|18
7328433|NCT00796445|11561416|FG001|Overall Study|Withdrawal by Subject|9
7328434|NCT00796445|11561415|FG000|Overall Study|Invalid Informed Consent Form|1
7328435|NCT00796445|11561416|FG001|Overall Study|Invalid Informed Consent Form|0
7328436|NCT00796549|11561430|FG000|Overall Study|Adverse Event|11
7328437|NCT00796549|11561430|FG000|Overall Study|not entered|149
7328438|NCT00796549|11561430|FG000|Overall Study|Other|2
7328439|NCT00796549|11561430|FG000|Overall Study|Progressive disease|56
7328440|NCT00796562|11561436|FG000|Overall Study|Death|49
7328441|NCT00796614|11561444|FG000|Overall Study|Adverse Event|1
7328442|NCT00796614|11561445|FG001|Overall Study|Adverse Event|2
7328443|NCT00796614|11561446|FG002|Overall Study|Adverse Event|0
7328444|NCT00796614|11561447|FG003|Overall Study|Adverse Event|0
7328445|NCT00796614|11561444|FG000|Overall Study|Protocol Violation|0
7328446|NCT00796614|11561445|FG001|Overall Study|Protocol Violation|0
7328447|NCT00796614|11561446|FG002|Overall Study|Protocol Violation|2
7328448|NCT00796614|11561447|FG003|Overall Study|Protocol Violation|0
7328449|NCT00796614|11561444|FG000|Overall Study|Lost to Follow-up|2
7328450|NCT00796614|11561445|FG001|Overall Study|Lost to Follow-up|2
7328451|NCT00796614|11561446|FG002|Overall Study|Lost to Follow-up|1
7328452|NCT00796614|11561447|FG003|Overall Study|Lost to Follow-up|0
7328453|NCT00796614|11561444|FG000|Overall Study|Withdrawal by Subject|1
7328454|NCT00796614|11561445|FG001|Overall Study|Withdrawal by Subject|0
7328455|NCT00796614|11561446|FG002|Overall Study|Withdrawal by Subject|0
7428163|NCT01544478|11706957|FG000|Overall Study|Adverse Event|1
7428164|NCT01544478|11706957|FG000|Overall Study|Death|1
7428165|NCT01544478|11706957|FG000|Overall Study|Lost to Follow-up|48
7428166|NCT01544478|11706957|FG000|Overall Study|Physician Decision|15
7428167|NCT01544478|11706957|FG000|Overall Study|Pregnancy|1
7428168|NCT01544478|11706957|FG000|Overall Study|Withdrawal by Subject|52
7428169|NCT01544491|11706963|FG000|Overall Study|Withdrawal by Subject|3
7428170|NCT01544491|11706964|FG001|Overall Study|Withdrawal by Subject|2
7428171|NCT01544491|11706963|FG000|Overall Study|Lost to Follow-up|0
7428172|NCT01544491|11706964|FG001|Overall Study|Lost to Follow-up|1
7428173|NCT01544491|11706963|FG000|Overall Study|administrative problems|2
7428174|NCT01544491|11706964|FG001|Overall Study|administrative problems|0
7428175|NCT01544582|11706973|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
7428176|NCT01544582|11706974|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
7428245|NCT01544595|11706997|FG002|Status at Week 68|Adverse Event|1
7428177|NCT01544582|11706975|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
7428178|NCT01544582|11706976|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
7428179|NCT01544582|11706973|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
7428180|NCT01544582|11706974|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
7428181|NCT01544582|11706975|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
7428182|NCT01544582|11706976|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
7428183|NCT01544582|11706973|FG000|Analysis Population|Participant Refuses to Continue Study|0
7428184|NCT01544582|11706974|FG001|Analysis Population|Participant Refuses to Continue Study|15
7428185|NCT01544582|11706975|FG002|Analysis Population|Participant Refuses to Continue Study|17
7428186|NCT01544582|11706976|FG003|Analysis Population|Participant Refuses to Continue Study|4
7428187|NCT01544582|11706973|FG000|Analysis Population|Physician Decision|0
7428188|NCT01544582|11706974|FG001|Analysis Population|Physician Decision|13
7428189|NCT01544582|11706975|FG002|Analysis Population|Physician Decision|10
7428190|NCT01544582|11706976|FG003|Analysis Population|Physician Decision|9
7428191|NCT01544582|11706973|FG000|Analysis Population|Safety Reason|0
7428192|NCT01544582|11706974|FG001|Analysis Population|Safety Reason|33
7428193|NCT01544582|11706975|FG002|Analysis Population|Safety Reason|31
7428194|NCT01544582|11706976|FG003|Analysis Population|Safety Reason|8
7428195|NCT01544582|11706973|FG000|Analysis Population|Effectiveness Reason|0
7428196|NCT01544582|11706974|FG001|Analysis Population|Effectiveness Reason|48
7428197|NCT01544582|11706975|FG002|Analysis Population|Effectiveness Reason|29
7428198|NCT01544582|11706976|FG003|Analysis Population|Effectiveness Reason|12
7428199|NCT01544582|11706973|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
7428200|NCT01544582|11706974|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
7428201|NCT01544582|11706975|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
7428202|NCT01544582|11706976|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
7428203|NCT01544582|11706973|FG000|Analysis Population|Lost to Follow-up|0
7428204|NCT01544582|11706974|FG001|Analysis Population|Lost to Follow-up|6
7428205|NCT01544582|11706975|FG002|Analysis Population|Lost to Follow-up|6
7428206|NCT01544582|11706976|FG003|Analysis Population|Lost to Follow-up|5
7428207|NCT01544582|11706973|FG000|Analysis Population|Bad Tolerance to Treatment|0
7428208|NCT01544582|11706974|FG001|Analysis Population|Bad Tolerance to Treatment|0
7428209|NCT01544582|11706975|FG002|Analysis Population|Bad Tolerance to Treatment|2
7428210|NCT01544582|11706976|FG003|Analysis Population|Bad Tolerance to Treatment|0
7428211|NCT01544582|11706973|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
7428212|NCT01544582|11706974|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
7428213|NCT01544582|11706975|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
7428214|NCT01544582|11706976|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
7428215|NCT01544582|11706973|FG000|Analysis Population|Intolerance|0
7428216|NCT01544582|11706974|FG001|Analysis Population|Intolerance|1
7428217|NCT01544582|11706975|FG002|Analysis Population|Intolerance|0
7428218|NCT01544582|11706976|FG003|Analysis Population|Intolerance|0
7428219|NCT01544582|11706973|FG000|Analysis Population|Liver Transplantation|0
7428220|NCT01544582|11706974|FG001|Analysis Population|Liver Transplantation|0
7428221|NCT01544582|11706975|FG002|Analysis Population|Liver Transplantation|1
7428222|NCT01544582|11706976|FG003|Analysis Population|Liver Transplantation|0
7428223|NCT01544582|11706973|FG000|Analysis Population|No Social Insurance|0
7428224|NCT01544582|11706974|FG001|Analysis Population|No Social Insurance|0
7428225|NCT01544582|11706975|FG002|Analysis Population|No Social Insurance|1
7428226|NCT01544582|11706976|FG003|Analysis Population|No Social Insurance|0
7428227|NCT01544582|11706973|FG000|Analysis Population|Poor Adherence|0
7428228|NCT01544582|11706974|FG001|Analysis Population|Poor Adherence|0
7428229|NCT01544582|11706975|FG002|Analysis Population|Poor Adherence|1
7428230|NCT01544582|11706976|FG003|Analysis Population|Poor Adherence|0
7428231|NCT01544582|11706973|FG000|Analysis Population|Poor Participant Compliance|0
7428232|NCT01544582|11706974|FG001|Analysis Population|Poor Participant Compliance|1
7428233|NCT01544582|11706975|FG002|Analysis Population|Poor Participant Compliance|0
7428234|NCT01544582|11706976|FG003|Analysis Population|Poor Participant Compliance|0
7428235|NCT01544582|11706973|FG000|Analysis Population|Programmed Surgery|0
7428236|NCT01544582|11706974|FG001|Analysis Population|Programmed Surgery|1
7428237|NCT01544582|11706975|FG002|Analysis Population|Programmed Surgery|0
7428238|NCT01544582|11706976|FG003|Analysis Population|Programmed Surgery|0
7428239|NCT01544582|11706973|FG000|Analysis Population|Participant in Jail|0
7328456|NCT00796614|11561447|FG003|Overall Study|Withdrawal by Subject|1
7328457|NCT00796614|11561444|FG000|Overall Study|Other than stated|1
7328458|NCT00796614|11561445|FG001|Overall Study|Other than stated|0
7328459|NCT00796614|11561446|FG002|Overall Study|Other than stated|0
7328460|NCT00796614|11561447|FG003|Overall Study|Other than stated|0
7328461|NCT00796653|11561470|FG000|Overall Study|Adverse Event|19
7328462|NCT00796653|11561471|FG001|Overall Study|Adverse Event|16
7328463|NCT00796653|11561472|FG002|Overall Study|Adverse Event|16
7328464|NCT00796653|11561473|FG003|Overall Study|Adverse Event|16
7328465|NCT00796653|11561470|FG000|Overall Study|Lost to Follow-up|2
7328466|NCT00796653|11561471|FG001|Overall Study|Lost to Follow-up|1
7428240|NCT01544582|11706974|FG001|Analysis Population|Participant in Jail|0
7428241|NCT01544582|11706975|FG002|Analysis Population|Participant in Jail|1
7428242|NCT01544582|11706976|FG003|Analysis Population|Participant in Jail|0
7428243|NCT01544595|11706995|FG000|Status at Week 68|Adverse Event|3
7428244|NCT01544595|11706996|FG001|Status at Week 68|Adverse Event|2
7428246|NCT01544595|11706998|FG003|Status at Week 68|Adverse Event|0
7428247|NCT01544595|11706999|FG004|Status at Week 68|Adverse Event|0
7428248|NCT01544595|11707000|FG005|Status at Week 68|Adverse Event|0
7428249|NCT01544595|11706995|FG000|Status at Week 68|Lack of Efficacy|1
7428250|NCT01544595|11706996|FG001|Status at Week 68|Lack of Efficacy|0
7428251|NCT01544595|11706997|FG002|Status at Week 68|Lack of Efficacy|0
7428252|NCT01544595|11706998|FG003|Status at Week 68|Lack of Efficacy|0
7428253|NCT01544595|11706999|FG004|Status at Week 68|Lack of Efficacy|0
7428254|NCT01544595|11707000|FG005|Status at Week 68|Lack of Efficacy|0
7428255|NCT01544595|11706995|FG000|Status at Week 68|Lost to Follow-up|1
7558612|NCT03131648|11924321|FG002|Maintenance Treatment Period|Not dosed|3
7558613|NCT03131648|11924322|FG003|Maintenance Treatment Period|Not dosed|2
7558614|NCT03131648|11924323|FG004|Maintenance Treatment Period|Not dosed|1
7558615|NCT03131648|11924324|FG005|Maintenance Treatment Period|Not dosed|0
7558616|NCT03131648|11924325|FG006|Maintenance Treatment Period|Not dosed|0
7558617|NCT03131648|11924326|FG007|Maintenance Treatment Period|Not dosed|0
7558618|NCT03131648|11924319|FG000|Maintenance Treatment Period|Discontinued IMP|0
7558619|NCT03131648|11924320|FG001|Maintenance Treatment Period|Discontinued IMP|0
7428256|NCT01544595|11706996|FG001|Status at Week 68|Lost to Follow-up|1
7428257|NCT01544595|11706997|FG002|Status at Week 68|Lost to Follow-up|0
7428258|NCT01544595|11706998|FG003|Status at Week 68|Lost to Follow-up|0
7428259|NCT01544595|11706999|FG004|Status at Week 68|Lost to Follow-up|0
7428260|NCT01544595|11707000|FG005|Status at Week 68|Lost to Follow-up|0
7428261|NCT01544595|11706995|FG000|Status at Week 68|Non-compliance with study treatment|1
7428262|NCT01544595|11706996|FG001|Status at Week 68|Non-compliance with study treatment|0
7428263|NCT01544595|11706997|FG002|Status at Week 68|Non-compliance with study treatment|0
7428264|NCT01544595|11706998|FG003|Status at Week 68|Non-compliance with study treatment|1
7428265|NCT01544595|11706999|FG004|Status at Week 68|Non-compliance with study treatment|0
7428266|NCT01544595|11707000|FG005|Status at Week 68|Non-compliance with study treatment|0
7428267|NCT01544595|11706995|FG000|Status at Week 68|Protocol Violation|2
7428268|NCT01544595|11706996|FG001|Status at Week 68|Protocol Violation|0
7428269|NCT01544595|11706997|FG002|Status at Week 68|Protocol Violation|1
7328467|NCT00796653|11561472|FG002|Overall Study|Lost to Follow-up|2
7428270|NCT01544595|11706998|FG003|Status at Week 68|Protocol Violation|1
7428271|NCT01544595|11706999|FG004|Status at Week 68|Protocol Violation|0
7328468|NCT00796653|11561473|FG003|Overall Study|Lost to Follow-up|3
7328469|NCT00796653|11561470|FG000|Overall Study|Withdrawal by Subject|16
7428272|NCT01544595|11707000|FG005|Status at Week 68|Protocol Violation|0
7428273|NCT01544595|11706995|FG000|Status at Week 68|Technical problems|1
7428274|NCT01544595|11706996|FG001|Status at Week 68|Technical problems|0
7428275|NCT01544595|11706997|FG002|Status at Week 68|Technical problems|0
7428276|NCT01544595|11706998|FG003|Status at Week 68|Technical problems|1
7428277|NCT01544595|11706999|FG004|Status at Week 68|Technical problems|0
7428278|NCT01544595|11707000|FG005|Status at Week 68|Technical problems|0
7428279|NCT01544595|11706995|FG000|Status at Week 68|Withdrawal by Subject|0
7428280|NCT01544595|11706996|FG001|Status at Week 68|Withdrawal by Subject|1
7428281|NCT01544595|11706997|FG002|Status at Week 68|Withdrawal by Subject|1
7428282|NCT01544595|11706998|FG003|Status at Week 68|Withdrawal by Subject|2
7428283|NCT01544595|11706999|FG004|Status at Week 68|Withdrawal by Subject|0
7428284|NCT01544595|11707000|FG005|Status at Week 68|Withdrawal by Subject|0
7428285|NCT01544595|11706995|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
7428286|NCT01544595|11706996|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
7428287|NCT01544595|11706997|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
7428288|NCT01544595|11706998|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
7428289|NCT01544595|11706999|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
7428290|NCT01544595|11707000|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
7428291|NCT01544595|11706995|FG000|Status at Week 156|Withdrawal by Subject|9
7428292|NCT01544595|11706996|FG001|Status at Week 156|Withdrawal by Subject|10
7428293|NCT01544595|11706997|FG002|Status at Week 156|Withdrawal by Subject|4
7428294|NCT01544595|11706998|FG003|Status at Week 156|Withdrawal by Subject|9
7428295|NCT01544595|11706999|FG004|Status at Week 156|Withdrawal by Subject|20
7428296|NCT01544595|11707000|FG005|Status at Week 156|Withdrawal by Subject|6
7428297|NCT01544595|11706995|FG000|Status at Week 156|Adverse Event|9
7428298|NCT01544595|11706996|FG001|Status at Week 156|Adverse Event|11
7428299|NCT01544595|11706997|FG002|Status at Week 156|Adverse Event|1
7428300|NCT01544595|11706998|FG003|Status at Week 156|Adverse Event|3
7428301|NCT01544595|11706999|FG004|Status at Week 156|Adverse Event|4
7428302|NCT01544595|11707000|FG005|Status at Week 156|Adverse Event|2
7428303|NCT01544595|11706995|FG000|Status at Week 156|Lost to Follow-up|4
7428304|NCT01544595|11706996|FG001|Status at Week 156|Lost to Follow-up|4
7428305|NCT01544595|11706997|FG002|Status at Week 156|Lost to Follow-up|0
7428306|NCT01544595|11706998|FG003|Status at Week 156|Lost to Follow-up|1
7428307|NCT01544595|11706999|FG004|Status at Week 156|Lost to Follow-up|4
7428308|NCT01544595|11707000|FG005|Status at Week 156|Lost to Follow-up|1
7428309|NCT01544595|11706995|FG000|Status at Week 156|Non-compliance with study treatement|0
7428310|NCT01544595|11706996|FG001|Status at Week 156|Non-compliance with study treatement|1
7428311|NCT01544595|11706997|FG002|Status at Week 156|Non-compliance with study treatement|0
7428312|NCT01544595|11706998|FG003|Status at Week 156|Non-compliance with study treatement|1
7428313|NCT01544595|11706999|FG004|Status at Week 156|Non-compliance with study treatement|0
7428314|NCT01544595|11707000|FG005|Status at Week 156|Non-compliance with study treatement|1
7428315|NCT01544595|11706995|FG000|Status at Week 156|Physician Decision|0
7428316|NCT01544595|11706996|FG001|Status at Week 156|Physician Decision|3
7428317|NCT01544595|11706997|FG002|Status at Week 156|Physician Decision|1
7428318|NCT01544595|11706998|FG003|Status at Week 156|Physician Decision|0
7428319|NCT01544595|11706999|FG004|Status at Week 156|Physician Decision|0
7428320|NCT01544595|11707000|FG005|Status at Week 156|Physician Decision|0
7428321|NCT01544595|11706995|FG000|Status at Week 156|Pregnancy|2
7428322|NCT01544595|11706996|FG001|Status at Week 156|Pregnancy|3
7428323|NCT01544595|11706997|FG002|Status at Week 156|Pregnancy|0
7428324|NCT01544595|11706998|FG003|Status at Week 156|Pregnancy|0
7428325|NCT01544595|11706999|FG004|Status at Week 156|Pregnancy|0
7428326|NCT01544595|11707000|FG005|Status at Week 156|Pregnancy|0
7428327|NCT01544595|11706995|FG000|Status at Week 156|Protocol Violation|3
7428328|NCT01544595|11706996|FG001|Status at Week 156|Protocol Violation|1
7428329|NCT01544595|11706997|FG002|Status at Week 156|Protocol Violation|2
7428330|NCT01544595|11706998|FG003|Status at Week 156|Protocol Violation|2
7428331|NCT01544595|11706999|FG004|Status at Week 156|Protocol Violation|0
7428332|NCT01544595|11707000|FG005|Status at Week 156|Protocol Violation|0
7428333|NCT01544595|11706995|FG000|Status at Week 156|Technical problems|3
7428334|NCT01544595|11706996|FG001|Status at Week 156|Technical problems|1
7428335|NCT01544595|11706997|FG002|Status at Week 156|Technical problems|0
7428336|NCT01544595|11706998|FG003|Status at Week 156|Technical problems|1
7428337|NCT01544595|11706999|FG004|Status at Week 156|Technical problems|0
7428338|NCT01544595|11707000|FG005|Status at Week 156|Technical problems|0
7428339|NCT01544595|11706995|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
7428340|NCT01544595|11706996|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
7532178|NCT02667301|11877681|FG000|Overall Study|Lack of Efficacy|1
7532179|NCT02667457|11877693|FG000|Overall Study|Withdrawal by Subject|1
7532180|NCT02667457|11877694|FG001|Overall Study|Withdrawal by Subject|0
7532181|NCT02667457|11877693|FG000|Overall Study|Other Reason|0
7532182|NCT02667457|11877694|FG001|Overall Study|Other Reason|2
7532183|NCT02667626|11877703|FG000|Overall Study|Withdrawal by Subject|0
7532184|NCT02667626|11877704|FG001|Overall Study|Withdrawal by Subject|1
7532185|NCT02667912|11877727|FG000|Overall Study|Death|3
7428341|NCT01544595|11706997|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
7428342|NCT01544595|11706998|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
7428343|NCT01544595|11706999|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
7428344|NCT01544595|11707000|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
7428345|NCT01544595|11706995|FG000|Status at Week 156|Lack of Efficacy|1
7428346|NCT01544595|11706996|FG001|Status at Week 156|Lack of Efficacy|0
7428347|NCT01544595|11706997|FG002|Status at Week 156|Lack of Efficacy|1
7428348|NCT01544595|11706998|FG003|Status at Week 156|Lack of Efficacy|4
7428349|NCT01544595|11706999|FG004|Status at Week 156|Lack of Efficacy|10
7428350|NCT01544595|11707000|FG005|Status at Week 156|Lack of Efficacy|5
7428351|NCT01544920|11707020|FG000|Overall Study|Adverse Event|0
7428352|NCT01544920|11707021|FG001|Overall Study|Adverse Event|3
7428353|NCT01544920|11707020|FG000|Overall Study|Death|0
7428354|NCT01544920|11707021|FG001|Overall Study|Death|1
7428355|NCT01544920|11707020|FG000|Overall Study|Lost to Follow-up|11
7428356|NCT01544920|11707021|FG001|Overall Study|Lost to Follow-up|12
7428357|NCT01544920|11707020|FG000|Overall Study|Protocol Violation|0
7428358|NCT01544920|11707021|FG001|Overall Study|Protocol Violation|2
7428359|NCT01544920|11707020|FG000|Overall Study|Physician Decision|4
7428360|NCT01544920|11707021|FG001|Overall Study|Physician Decision|1
7428361|NCT01544920|11707020|FG000|Overall Study|Withdrawal by Subject|4
7428362|NCT01544920|11707021|FG001|Overall Study|Withdrawal by Subject|4
7428363|NCT01545076|11707038|FG000|IgPro10 Restabilization Period|Adverse Event|4
7428364|NCT01545076|11707039|FG001|IgPro10 Restabilization Period|Adverse Event|0
7428365|NCT01545076|11707040|FG002|IgPro10 Restabilization Period|Adverse Event|0
7428366|NCT01545076|11707041|FG003|IgPro10 Restabilization Period|Adverse Event|0
7428367|NCT01545076|11707042|FG004|IgPro10 Restabilization Period|Adverse Event|0
7428368|NCT01545076|11707038|FG000|IgPro10 Restabilization Period|Physician Decision|2
7428369|NCT01545076|11707039|FG001|IgPro10 Restabilization Period|Physician Decision|0
7428370|NCT01545076|11707040|FG002|IgPro10 Restabilization Period|Physician Decision|0
7428371|NCT01545076|11707041|FG003|IgPro10 Restabilization Period|Physician Decision|0
7428372|NCT01545076|11707042|FG004|IgPro10 Restabilization Period|Physician Decision|0
7428373|NCT01545076|11707038|FG000|IgPro10 Restabilization Period|Protocol Violation|1
7428374|NCT01545076|11707039|FG001|IgPro10 Restabilization Period|Protocol Violation|0
7428375|NCT01545076|11707040|FG002|IgPro10 Restabilization Period|Protocol Violation|0
7428376|NCT01545076|11707041|FG003|IgPro10 Restabilization Period|Protocol Violation|0
7428377|NCT01545076|11707042|FG004|IgPro10 Restabilization Period|Protocol Violation|0
7428378|NCT01545076|11707038|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
7428379|NCT01545076|11707039|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7428380|NCT01545076|11707040|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7428381|NCT01545076|11707041|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7428382|NCT01545076|11707042|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
7428383|NCT01545076|11707038|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
7428384|NCT01545076|11707039|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
7428385|NCT01545076|11707040|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
7532186|NCT02667912|11877728|FG001|Overall Study|Death|1
7428386|NCT01545076|11707041|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
7428387|NCT01545076|11707042|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
7428388|NCT01545076|11707038|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7428389|NCT01545076|11707039|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7428390|NCT01545076|11707040|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7428391|NCT01545076|11707041|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
7428392|NCT01545076|11707042|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
7428393|NCT01545076|11707038|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7428394|NCT01545076|11707039|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
7428395|NCT01545076|11707040|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
7428396|NCT01545076|11707041|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
7428397|NCT01545076|11707042|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
7428398|NCT01545076|11707038|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7428399|NCT01545076|11707039|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7428400|NCT01545076|11707040|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
7428401|NCT01545076|11707041|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7428402|NCT01545076|11707042|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
7428403|NCT01545076|11707038|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7428404|NCT01545076|11707039|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
7428405|NCT01545076|11707040|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
7428406|NCT01545076|11707041|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
7428407|NCT01545076|11707042|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
7428408|NCT01545375|11707104|FG000|Overall Study|Adverse Event|2
7428409|NCT01545375|11707105|FG001|Overall Study|Adverse Event|1
7428410|NCT01545375|11707104|FG000|Overall Study|Lost to Follow-up|34
7428411|NCT01545375|11707105|FG001|Overall Study|Lost to Follow-up|31
7428412|NCT01545375|11707104|FG000|Overall Study|Protocol Violation|3
7428413|NCT01545375|11707105|FG001|Overall Study|Protocol Violation|3
7428414|NCT01545375|11707104|FG000|Overall Study|Withdrawal by Subject|58
7428415|NCT01545375|11707105|FG001|Overall Study|Withdrawal by Subject|55
7428416|NCT01545388|11707114|FG000|Overall Study|Adverse Event|2
7532187|NCT02667912|11877727|FG000|Overall Study|Withdrawal by Subject|1
7428417|NCT01545388|11707115|FG001|Overall Study|Adverse Event|4
7428418|NCT01545388|11707116|FG002|Overall Study|Adverse Event|1
7428419|NCT01545388|11707114|FG000|Overall Study|Lack of Efficacy|3
7428420|NCT01545388|11707115|FG001|Overall Study|Lack of Efficacy|2
7428421|NCT01545388|11707116|FG002|Overall Study|Lack of Efficacy|5
7428422|NCT01545388|11707114|FG000|Overall Study|Participant moved or relocated|1
7428423|NCT01545388|11707115|FG001|Overall Study|Participant moved or relocated|0
7428424|NCT01545388|11707116|FG002|Overall Study|Participant moved or relocated|0
7428425|NCT01545388|11707114|FG000|Overall Study|Withdrawal by Subject|1
7428426|NCT01545388|11707115|FG001|Overall Study|Withdrawal by Subject|4
7428427|NCT01545388|11707116|FG002|Overall Study|Withdrawal by Subject|2
7428428|NCT01545388|11707114|FG000|Overall Study|Other|1
7428429|NCT01545388|11707115|FG001|Overall Study|Other|1
7428430|NCT01545388|11707116|FG002|Overall Study|Other|0
7428431|NCT01545817|11707220|FG000|Pazopanib|Disease progression|51
7428432|NCT01545817|11707221|FG001|Pazopanib|Disease progression|0
7428433|NCT01545817|11707220|FG000|Pazopanib|Adverse Event|19
7428434|NCT01545817|11707221|FG001|Pazopanib|Adverse Event|0
7428435|NCT01545817|11707220|FG000|Pazopanib|Other reason|4
7428436|NCT01545817|11707221|FG001|Pazopanib|Other reason|0
7428437|NCT01545817|11707220|FG000|Everolimus|Other reason|0
7428438|NCT01545817|11707221|FG001|Everolimus|Other reason|7
7428439|NCT01545817|11707220|FG000|Everolimus|Disease progression|0
7428440|NCT01545817|11707221|FG001|Everolimus|Disease progression|25
7428441|NCT01545817|11707220|FG000|Everolimus|Adverse Event|0
7428442|NCT01545817|11707221|FG001|Everolimus|Adverse Event|6
7428443|NCT01545934|11707247|FG000|Overall Study|Withdrawal by Subject|4
7428444|NCT01545934|11707248|FG001|Overall Study|Withdrawal by Subject|3
7428445|NCT01545934|11707247|FG000|Overall Study|Lost to Follow-up|1
7428446|NCT01545934|11707248|FG001|Overall Study|Lost to Follow-up|0
7428447|NCT01546038|11707261|FG000|Overall Study|Death|15
7428448|NCT01546038|11707262|FG001|Overall Study|Death|6
7428449|NCT01546038|11707263|FG002|Overall Study|Death|4
7428450|NCT01546038|11707264|FG003|Overall Study|Death|2
7428451|NCT01546038|11707265|FG004|Overall Study|Death|9
7428452|NCT01546038|11707266|FG005|Overall Study|Death|3
7428453|NCT01546038|11707267|FG006|Overall Study|Death|46
7428454|NCT01546038|11707268|FG007|Overall Study|Death|76
7428455|NCT01546038|11707269|FG008|Overall Study|Death|39
7428456|NCT01546038|11707261|FG000|Overall Study|Lost to Follow-up|0
7428457|NCT01546038|11707262|FG001|Overall Study|Lost to Follow-up|0
7428458|NCT01546038|11707263|FG002|Overall Study|Lost to Follow-up|0
7428459|NCT01546038|11707264|FG003|Overall Study|Lost to Follow-up|0
7428460|NCT01546038|11707265|FG004|Overall Study|Lost to Follow-up|1
7428461|NCT01546038|11707266|FG005|Overall Study|Lost to Follow-up|0
7428462|NCT01546038|11707267|FG006|Overall Study|Lost to Follow-up|2
7428463|NCT01546038|11707268|FG007|Overall Study|Lost to Follow-up|1
7428464|NCT01546038|11707269|FG008|Overall Study|Lost to Follow-up|0
7428465|NCT01546038|11707261|FG000|Overall Study|Withdrawal by Subject|1
7428466|NCT01546038|11707262|FG001|Overall Study|Withdrawal by Subject|0
7428467|NCT01546038|11707263|FG002|Overall Study|Withdrawal by Subject|0
7428468|NCT01546038|11707264|FG003|Overall Study|Withdrawal by Subject|1
7428469|NCT01546038|11707265|FG004|Overall Study|Withdrawal by Subject|0
7428470|NCT01546038|11707266|FG005|Overall Study|Withdrawal by Subject|1
7428471|NCT01546038|11707267|FG006|Overall Study|Withdrawal by Subject|3
7428472|NCT01546038|11707268|FG007|Overall Study|Withdrawal by Subject|3
7428473|NCT01546038|11707269|FG008|Overall Study|Withdrawal by Subject|1
7428474|NCT01546038|11707261|FG000|Overall Study|: Randomized, not treated|0
7428475|NCT01546038|11707262|FG001|Overall Study|: Randomized, not treated|0
7428476|NCT01546038|11707263|FG002|Overall Study|: Randomized, not treated|0
7428477|NCT01546038|11707264|FG003|Overall Study|: Randomized, not treated|0
7428478|NCT01546038|11707265|FG004|Overall Study|: Randomized, not treated|0
7428479|NCT01546038|11707266|FG005|Overall Study|: Randomized, not treated|0
7428480|NCT01546038|11707267|FG006|Overall Study|: Randomized, not treated|2
7428481|NCT01546038|11707268|FG007|Overall Study|: Randomized, not treated|4
7428482|NCT01546038|11707269|FG008|Overall Study|: Randomized, not treated|3
7428483|NCT01546142|11707321|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
7428484|NCT01546142|11707322|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
7428485|NCT01546142|11707321|FG000|Overall Study|Subject Noncompliance|1
7428486|NCT01546142|11707322|FG001|Overall Study|Subject Noncompliance|1
7428487|NCT01546142|11707321|FG000|Overall Study|Adverse Event|6
7428488|NCT01546142|11707322|FG001|Overall Study|Adverse Event|3
7428489|NCT01546142|11707321|FG000|Overall Study|Lost to Follow-up|20
7428490|NCT01546142|11707322|FG001|Overall Study|Lost to Follow-up|15
7428491|NCT01546142|11707321|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
7428492|NCT01546142|11707322|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
7428493|NCT01546142|11707321|FG000|Overall Study|Subject Randomized but Not Treated|1
7428494|NCT01546142|11707322|FG001|Overall Study|Subject Randomized but Not Treated|0
7428495|NCT01546155|11707328|FG000|Overall Study|could not tolerate long scan duration|3
7428496|NCT01546168|11707334|FG000|Overall Study|Lost to Follow-up|1
7428497|NCT01546168|11707335|FG001|Overall Study|Lost to Follow-up|0
7428498|NCT01546168|11707334|FG000|Overall Study|Withdrawal by Subject|1
7428499|NCT01546168|11707335|FG001|Overall Study|Withdrawal by Subject|0
7428500|NCT01546168|11707334|FG000|Overall Study|ineligible after signing consent|2
7428501|NCT01546168|11707335|FG001|Overall Study|ineligible after signing consent|0
7428502|NCT01546519|11707375|FG000|Overall Study|Adverse Event|0
7428503|NCT01546519|11707376|FG001|Overall Study|Adverse Event|0
7428504|NCT01546519|11707377|FG002|Overall Study|Adverse Event|1
7428505|NCT01546519|11707378|FG003|Overall Study|Adverse Event|1
7428506|NCT01546519|11707375|FG000|Overall Study|Death|0
7428507|NCT01546519|11707376|FG001|Overall Study|Death|1
7428508|NCT01546519|11707377|FG002|Overall Study|Death|3
7428509|NCT01546519|11707378|FG003|Overall Study|Death|1
7428510|NCT01546519|11707375|FG000|Overall Study|related to disease progression|2
7428511|NCT01546519|11707376|FG001|Overall Study|related to disease progression|2
7428512|NCT01546519|11707377|FG002|Overall Study|related to disease progression|2
7428513|NCT01546519|11707378|FG003|Overall Study|related to disease progression|1
7428514|NCT01546519|11707375|FG000|Overall Study|Physician Decision|6
7428515|NCT01546519|11707376|FG001|Overall Study|Physician Decision|5
7428516|NCT01546519|11707377|FG002|Overall Study|Physician Decision|2
7428517|NCT01546519|11707378|FG003|Overall Study|Physician Decision|3
7428518|NCT01546519|11707375|FG000|Overall Study|Withdrawal by Subject|1
7428519|NCT01546519|11707376|FG001|Overall Study|Withdrawal by Subject|0
7428520|NCT01546519|11707377|FG002|Overall Study|Withdrawal by Subject|0
7428521|NCT01546519|11707378|FG003|Overall Study|Withdrawal by Subject|0
7428522|NCT01546623|11707394|FG000|Overall Study|Adverse Event|2
7428523|NCT01546623|11707395|FG001|Overall Study|Adverse Event|3
7428524|NCT01546623|11707394|FG000|Overall Study|Major Protocol Deviation|1
7428525|NCT01546623|11707395|FG001|Overall Study|Major Protocol Deviation|1
7428526|NCT01546623|11707394|FG000|Overall Study|High Prostate specific antigen|2
7428527|NCT01546623|11707395|FG001|Overall Study|High Prostate specific antigen|1
7428528|NCT01546623|11707394|FG000|Overall Study|Did Not Receive Study Drug|1
7428529|NCT01546623|11707395|FG001|Overall Study|Did Not Receive Study Drug|1
7428530|NCT01546649|11707412|FG000|Overall Study|Adverse Event|4
7428531|NCT01546649|11707413|FG001|Overall Study|Adverse Event|5
7428532|NCT01546649|11707412|FG000|Overall Study|Protocol Violation|1
7428533|NCT01546649|11707413|FG001|Overall Study|Protocol Violation|0
7428534|NCT01546649|11707412|FG000|Overall Study|Lack of Efficacy|1
7428535|NCT01546649|11707413|FG001|Overall Study|Lack of Efficacy|0
7428536|NCT01546649|11707412|FG000|Overall Study|Recurrence|1
7428537|NCT01546649|11707413|FG001|Overall Study|Recurrence|1
7428538|NCT01546649|11707412|FG000|Overall Study|Discovery of secondary cancer|0
7428539|NCT01546649|11707413|FG001|Overall Study|Discovery of secondary cancer|1
7428540|NCT01546649|11707412|FG000|Overall Study|Withdrawal by Subject|1
7428541|NCT01546649|11707413|FG001|Overall Study|Withdrawal by Subject|2
7428542|NCT01546688|11707430|FG000|Overall Study|Adverse Event|0
7428543|NCT01546688|11707431|FG001|Overall Study|Adverse Event|4
7428544|NCT01546688|11707430|FG000|Overall Study|Withdrawal by Subject|2
7428545|NCT01546688|11707431|FG001|Overall Study|Withdrawal by Subject|1
7428546|NCT01546688|11707430|FG000|Overall Study|Lack of Efficacy|1
7428547|NCT01546688|11707431|FG001|Overall Study|Lack of Efficacy|0
7428548|NCT01546857|11707439|FG000|Overall Study|Withdrawal by Subject|2
7428549|NCT01546857|11707440|FG001|Overall Study|Withdrawal by Subject|3
7428550|NCT01546922|11707447|FG000|First Period of 10 Weeks|Protocol Violation|3
7428551|NCT01546922|11707448|FG001|First Period of 10 Weeks|Protocol Violation|1
7428552|NCT01546922|11707447|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
7428553|NCT01546922|11707448|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
7428554|NCT01546922|11707447|FG000|First Period of 10 Weeks|Investigator's judgment|1
7428555|NCT01546922|11707448|FG001|First Period of 10 Weeks|Investigator's judgment|0
7428556|NCT01546922|11707447|FG000|Second Period of 10 Weeks|Protocol Violation|3
7428557|NCT01546922|11707448|FG001|Second Period of 10 Weeks|Protocol Violation|1
7428558|NCT01546922|11707447|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
7428559|NCT01546922|11707448|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
7428560|NCT01547130|11707465|FG000|Overall Study|Lost to Follow-up|9
7428561|NCT01547130|11707466|FG001|Overall Study|Lost to Follow-up|5
7428562|NCT01547286|11707489|FG000|Overall Study|Did not meet all eligibility criteria|1
7428563|NCT01547286|11707489|FG000|Overall Study|Physician Decision|1
7428564|NCT01547299|11707496|FG000|Overall Study|Withdrawal by Subject|2
7428565|NCT01547299|11707497|FG001|Overall Study|Withdrawal by Subject|2
7428566|NCT01547390|11707505|FG000|Overall Study|Withdrawal by Subject|10
7428567|NCT01547390|11707506|FG001|Overall Study|Withdrawal by Subject|7
7428568|NCT01547390|11707505|FG000|Overall Study|termination of pregnancy|0
7428569|NCT01547390|11707506|FG001|Overall Study|termination of pregnancy|1
7428570|NCT01547390|11707505|FG000|Overall Study|Lost to Follow-up|0
7428571|NCT01547390|11707506|FG001|Overall Study|Lost to Follow-up|2
7428572|NCT01547390|11707505|FG000|Overall Study|Adverse Event|3
7428573|NCT01547390|11707506|FG001|Overall Study|Adverse Event|0
7428574|NCT01547598|11707514|FG000|Overall Study|Withdrew consent|1
7428575|NCT01547598|11707515|FG001|Overall Study|Withdrew consent|1
7428576|NCT01547598|11707514|FG000|Overall Study|Lost to Follow-up|1
7428577|NCT01547598|11707515|FG001|Overall Study|Lost to Follow-up|1
7428578|NCT01547598|11707514|FG000|Overall Study|Adverse Event|1
7428579|NCT01547598|11707515|FG001|Overall Study|Adverse Event|1
7428580|NCT01547598|11707514|FG000|Overall Study|Protocol Violation|1
7428581|NCT01547598|11707515|FG001|Overall Study|Protocol Violation|1
7428582|NCT01547598|11707514|FG000|Overall Study|Other Miscellaneous Reasons|2
7428583|NCT01547598|11707515|FG001|Overall Study|Other Miscellaneous Reasons|1
7428584|NCT01547780|11707540|FG000|Baseline PET Scan|Physician Decision|1
7428585|NCT01547780|11707541|FG001|Baseline PET Scan|Physician Decision|0
7428586|NCT01547780|11707542|FG002|Baseline PET Scan|Physician Decision|1
7428587|NCT01547780|11707543|FG003|Baseline PET Scan|Physician Decision|0
7428588|NCT01547780|11707540|FG000|Baseline PET Scan|Withdrawal by Subject|2
7428589|NCT01547780|11707541|FG001|Baseline PET Scan|Withdrawal by Subject|0
7428590|NCT01547780|11707542|FG002|Baseline PET Scan|Withdrawal by Subject|1
7428591|NCT01547780|11707543|FG003|Baseline PET Scan|Withdrawal by Subject|0
7428592|NCT01548287|11707571|FG000|Screening|No reason provided|0
7428593|NCT01548287|11707572|FG001|Screening|No reason provided|0
7428594|NCT01548287|11707573|FG002|Screening|No reason provided|0
7428595|NCT01548287|11707574|FG003|Screening|No reason provided|0
7428596|NCT01548287|11707575|FG004|Screening|No reason provided|9
7428597|NCT01548287|11707571|FG000|Screening|Did not meet eligibility criteria|0
7428598|NCT01548287|11707572|FG001|Screening|Did not meet eligibility criteria|0
7428599|NCT01548287|11707573|FG002|Screening|Did not meet eligibility criteria|0
7428600|NCT01548287|11707574|FG003|Screening|Did not meet eligibility criteria|0
7428601|NCT01548287|11707575|FG004|Screening|Did not meet eligibility criteria|74
7428602|NCT01548287|11707571|FG000|Randomized Period|Did not meet inclusion criteria|0
7428603|NCT01548287|11707572|FG001|Randomized Period|Did not meet inclusion criteria|0
7428604|NCT01548287|11707573|FG002|Randomized Period|Did not meet inclusion criteria|2
7428605|NCT01548287|11707574|FG003|Randomized Period|Did not meet inclusion criteria|0
7428606|NCT01548287|11707575|FG004|Randomized Period|Did not meet inclusion criteria|0
7428607|NCT01548287|11707571|FG000|Randomized Period|Adverse Event|0
7428608|NCT01548287|11707572|FG001|Randomized Period|Adverse Event|2
7428609|NCT01548287|11707573|FG002|Randomized Period|Adverse Event|5
7428610|NCT01548287|11707574|FG003|Randomized Period|Adverse Event|0
7428611|NCT01548287|11707575|FG004|Randomized Period|Adverse Event|0
7428612|NCT01548404|11707596|FG000|Overall Study|Adverse Event|3
7428613|NCT01548404|11707597|FG001|Overall Study|Adverse Event|1
7428614|NCT01548404|11707596|FG000|Overall Study|Physician Decision|2
7428615|NCT01548404|11707597|FG001|Overall Study|Physician Decision|1
7428616|NCT01548404|11707596|FG000|Overall Study|Inadequate response to study treatment|23
7428617|NCT01548404|11707597|FG001|Overall Study|Inadequate response to study treatment|7
7428618|NCT01548404|11707596|FG000|Overall Study|Lost to Follow-up|2
7428619|NCT01548404|11707597|FG001|Overall Study|Lost to Follow-up|0
7428620|NCT01548404|11707596|FG000|Overall Study|Withdrawal by Subject|0
7428621|NCT01548404|11707597|FG001|Overall Study|Withdrawal by Subject|3
7428622|NCT01548404|11707596|FG000|Overall Study|Other than specified above|0
7428623|NCT01548404|11707597|FG001|Overall Study|Other than specified above|2
7428624|NCT01548417|11707606|FG000|Overall Study|Withdrawal by Subject|0
7428625|NCT01548417|11707607|FG001|Overall Study|Withdrawal by Subject|2
7428626|NCT01548573|11707613|FG000|Overall Study|Death|3
7428627|NCT01548573|11707613|FG000|Overall Study|Withdrawal by Subject|2
7428628|NCT01548599|11707620|FG000|Overall Study|Lost to Follow-up|0
7428629|NCT01548599|11707621|FG001|Overall Study|Lost to Follow-up|1
7428630|NCT01548599|11707620|FG000|Overall Study|Withdrawal by Subject|4
7428631|NCT01548599|11707621|FG001|Overall Study|Withdrawal by Subject|0
7428632|NCT01548599|11707620|FG000|Overall Study|Death|2
7428633|NCT01548599|11707621|FG001|Overall Study|Death|1
7428634|NCT01548638|11707630|FG000|Overall Study|Protocol Violation|3
7428635|NCT01548638|11707630|FG000|Overall Study|Withdrawal by Subject|1
7428636|NCT01548768|11707670|FG000|Overall Study|Withdrawal by Subject|0
7428637|NCT01548768|11707671|FG001|Overall Study|Withdrawal by Subject|2
7428638|NCT01548768|11707672|FG002|Overall Study|Withdrawal by Subject|1
7428639|NCT01548768|11707673|FG003|Overall Study|Withdrawal by Subject|0
7428640|NCT01548768|11707670|FG000|Overall Study|Physician Decision|1
7428641|NCT01548768|11707671|FG001|Overall Study|Physician Decision|0
7428642|NCT01548768|11707672|FG002|Overall Study|Physician Decision|0
7428643|NCT01548768|11707673|FG003|Overall Study|Physician Decision|0
7428644|NCT01548768|11707670|FG000|Overall Study|Adverse Event|0
7428645|NCT01548768|11707671|FG001|Overall Study|Adverse Event|0
7428646|NCT01548768|11707672|FG002|Overall Study|Adverse Event|0
7428647|NCT01548768|11707673|FG003|Overall Study|Adverse Event|1
7428648|NCT01548768|11707670|FG000|Overall Study|Non-Compliance|0
7428649|NCT01548768|11707671|FG001|Overall Study|Non-Compliance|0
7428650|NCT01548768|11707672|FG002|Overall Study|Non-Compliance|0
7428651|NCT01548768|11707673|FG003|Overall Study|Non-Compliance|3
7428652|NCT01549002|11707699|FG000|Overall Study|Excessive pain|0
7428653|NCT01549002|11707700|FG001|Overall Study|Excessive pain|2
7428654|NCT01549002|11707699|FG000|Overall Study|Moderate sedation required|0
7428655|NCT01549002|11707700|FG001|Overall Study|Moderate sedation required|2
7428656|NCT01549041|11707708|FG000|Overall Study|Lack of Efficacy|2
7428657|NCT01549041|11707709|FG001|Overall Study|Lack of Efficacy|4
7428658|NCT01549041|11707708|FG000|Overall Study|Adverse Event|0
7428659|NCT01549041|11707709|FG001|Overall Study|Adverse Event|4
7428660|NCT01549275|11707726|FG000|Overall Study|Lost to Follow-up|1
7428661|NCT01549275|11707727|FG001|Overall Study|Lost to Follow-up|0
7428662|NCT01549392|11707761|FG000|Overall Study|Withdrawal by Subject|1
7428663|NCT01549392|11707762|FG001|Overall Study|Withdrawal by Subject|0
7428664|NCT01549613|11707790|FG000|Overall Study|Lost to Follow-up|11
7428665|NCT01549613|11707791|FG001|Overall Study|Lost to Follow-up|11
7428666|NCT01549652|11707800|FG000|Overall Study|Did Not Receive Allocated Intervention|0
7428667|NCT01549652|11707801|FG001|Overall Study|Did Not Receive Allocated Intervention|0
7328470|NCT00796653|11561471|FG001|Overall Study|Withdrawal by Subject|8
7328471|NCT00796653|11561472|FG002|Overall Study|Withdrawal by Subject|8
7328472|NCT00796653|11561473|FG003|Overall Study|Withdrawal by Subject|13
7328473|NCT00796653|11561470|FG000|Overall Study|Lack of Efficacy|8
7328474|NCT00796653|11561471|FG001|Overall Study|Lack of Efficacy|1
7328475|NCT00796653|11561472|FG002|Overall Study|Lack of Efficacy|3
7328476|NCT00796653|11561473|FG003|Overall Study|Lack of Efficacy|2
7328477|NCT00796653|11561470|FG000|Overall Study|Non compliance with protocol|2
7328478|NCT00796653|11561471|FG001|Overall Study|Non compliance with protocol|2
7328479|NCT00796653|11561472|FG002|Overall Study|Non compliance with protocol|0
7428668|NCT01549652|11707802|FG002|Overall Study|Did Not Receive Allocated Intervention|2
7428669|NCT01549652|11707803|FG003|Overall Study|Did Not Receive Allocated Intervention|0
7428670|NCT01549652|11707800|FG000|Overall Study|Study Drug Titration Failure|5
7428671|NCT01549652|11707801|FG001|Overall Study|Study Drug Titration Failure|6
7428672|NCT01549652|11707802|FG002|Overall Study|Study Drug Titration Failure|0
7428673|NCT01549652|11707803|FG003|Overall Study|Study Drug Titration Failure|0
7428674|NCT01549652|11707800|FG000|Overall Study|Withdrawal Effect|0
7428675|NCT01549652|11707801|FG001|Overall Study|Withdrawal Effect|2
7428676|NCT01549652|11707802|FG002|Overall Study|Withdrawal Effect|0
7428677|NCT01549652|11707803|FG003|Overall Study|Withdrawal Effect|0
7428678|NCT01549652|11707800|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
7428679|NCT01549652|11707801|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
7428680|NCT01549652|11707802|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
7428681|NCT01549652|11707803|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
7428682|NCT01549652|11707800|FG000|Overall Study|Problem with Infusion|1
7428683|NCT01549652|11707801|FG001|Overall Study|Problem with Infusion|0
7428684|NCT01549652|11707802|FG002|Overall Study|Problem with Infusion|0
7428685|NCT01549652|11707803|FG003|Overall Study|Problem with Infusion|0
7428686|NCT01549652|11707800|FG000|Overall Study|Titration Non-Compliance|1
7428687|NCT01549652|11707801|FG001|Overall Study|Titration Non-Compliance|3
7428688|NCT01549652|11707802|FG002|Overall Study|Titration Non-Compliance|4
7428689|NCT01549652|11707803|FG003|Overall Study|Titration Non-Compliance|5
7428690|NCT01549652|11707800|FG000|Overall Study|Titration Side Effects|0
7428691|NCT01549652|11707801|FG001|Overall Study|Titration Side Effects|0
7428692|NCT01549652|11707802|FG002|Overall Study|Titration Side Effects|6
7428693|NCT01549652|11707803|FG003|Overall Study|Titration Side Effects|3
7428694|NCT01549652|11707800|FG000|Overall Study|Withdrawal by Subject|0
7428695|NCT01549652|11707801|FG001|Overall Study|Withdrawal by Subject|0
7428696|NCT01549652|11707802|FG002|Overall Study|Withdrawal by Subject|5
7428697|NCT01549652|11707803|FG003|Overall Study|Withdrawal by Subject|3
7428698|NCT01549860|11707811|FG000|Overall Study|Withdrawal by Subject|1
7428699|NCT01549860|11707812|FG001|Overall Study|Withdrawal by Subject|0
7428700|NCT01549860|11707811|FG000|Overall Study|Physician Decision|1
7428701|NCT01549860|11707812|FG001|Overall Study|Physician Decision|1
7428702|NCT01549873|11707820|FG000|Overall Study|Physician Decision|0
7428703|NCT01549873|11707821|FG001|Overall Study|Physician Decision|1
7428704|NCT01549886|11707829|FG000|Overall Study|Sponsor's decision|2
7428705|NCT01549886|11707830|FG001|Overall Study|Sponsor's decision|3
7428706|NCT01549951|11707847|FG000|Overall Study|Adverse Event|15
7428707|NCT01549951|11707847|FG000|Overall Study|Withdrawal by Subject|2
7428708|NCT01549951|11707847|FG000|Overall Study|Unsatisfactory therapeutic response|1
7428709|NCT01549951|11707847|FG000|Overall Study|Progressive disease|29
7428710|NCT01549951|11707847|FG000|Overall Study|Symptomatic deterioration|1
7428711|NCT01549951|11707847|FG000|Overall Study|Other|2
7428712|NCT01549964|11707855|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
7428713|NCT01549964|11707856|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
7428714|NCT01549964|11707857|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
7428715|NCT01549964|11707858|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
7428716|NCT01549964|11707855|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
7428717|NCT01549964|11707856|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
7428718|NCT01549964|11707857|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
7428719|NCT01549964|11707858|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
7428720|NCT01549964|11707855|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
7428721|NCT01549964|11707856|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7428722|NCT01549964|11707857|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7428723|NCT01549964|11707858|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
7428724|NCT01549964|11707855|FG000|24-Week Treatment Period|Lost to Follow-up|1
7328480|NCT00796653|11561473|FG003|Overall Study|Non compliance with protocol|2
7385054|NCT01198587|11642591|FG003|Overall Study|Lost to Follow-up|0
7385055|NCT01198600|11642606|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
7385056|NCT01198600|11642607|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7385057|NCT01198600|11642608|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7385058|NCT01198600|11642609|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
7385059|NCT01198600|11642606|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
7385060|NCT01198600|11642607|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7385061|NCT01198600|11642608|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7385062|NCT01198600|11642609|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
7428725|NCT01549964|11707856|FG001|24-Week Treatment Period|Lost to Follow-up|0
7428726|NCT01549964|11707857|FG002|24-Week Treatment Period|Lost to Follow-up|1
7428727|NCT01549964|11707858|FG003|24-Week Treatment Period|Lost to Follow-up|2
7428728|NCT01549964|11707855|FG000|24-Week Treatment Period|Lack of Efficacy|1
7428729|NCT01549964|11707856|FG001|24-Week Treatment Period|Lack of Efficacy|0
7428730|NCT01549964|11707857|FG002|24-Week Treatment Period|Lack of Efficacy|1
7428731|NCT01549964|11707858|FG003|24-Week Treatment Period|Lack of Efficacy|1
7428732|NCT01549964|11707855|FG000|24-Week Treatment Period|Other|1
7428733|NCT01549964|11707856|FG001|24-Week Treatment Period|Other|0
7428734|NCT01549964|11707857|FG002|24-Week Treatment Period|Other|1
7428735|NCT01549964|11707858|FG003|24-Week Treatment Period|Other|0
7428736|NCT01549964|11707855|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7428737|NCT01549964|11707856|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7532188|NCT02667912|11877728|FG001|Overall Study|Withdrawal by Subject|2
7532189|NCT02667912|11877727|FG000|Overall Study|Withdrawal by Subject|1
7532190|NCT02667912|11877728|FG001|Overall Study|Withdrawal by Subject|0
7532191|NCT02668185|11877752|FG000|First Intervention (4 Weeks)|Physician Decision|2
7532192|NCT02668185|11877753|FG001|First Intervention (4 Weeks)|Physician Decision|0
7532193|NCT02668185|11877752|FG000|Washout Period (2 Weeks)|Adverse Event|1
7532194|NCT02668185|11877753|FG001|Washout Period (2 Weeks)|Adverse Event|0
7532195|NCT02668185|11877752|FG000|Washout Period (2 Weeks)|Physician Decision|0
7532196|NCT02668185|11877753|FG001|Washout Period (2 Weeks)|Physician Decision|2
7532197|NCT02668185|11877752|FG000|Second Intervention (4 Weeks)|Physician Decision|1
7532198|NCT02668185|11877753|FG001|Second Intervention (4 Weeks)|Physician Decision|3
7532199|NCT02668302|11877766|FG000|Overall Study|Withdrawal by Subject|1
7532200|NCT02668302|11877767|FG001|Overall Study|Withdrawal by Subject|0
7532201|NCT02668393|11877775|FG000|Overall Study|Progressive disease|6
7532202|NCT02668393|11877776|FG001|Overall Study|Progressive disease|3
7532203|NCT02668393|11877775|FG000|Overall Study|Adverse Event|0
7532204|NCT02668393|11877776|FG001|Overall Study|Adverse Event|2
7532205|NCT02668393|11877775|FG000|Overall Study|Withdrawal from the trial|0
7532206|NCT02668393|11877776|FG001|Overall Study|Withdrawal from the trial|1
7532207|NCT02668393|11877775|FG000|Overall Study|Lack of benefit and side effects|1
7532208|NCT02668393|11877776|FG001|Overall Study|Lack of benefit and side effects|0
7532209|NCT02668640|11877792|FG000|Overall Study|Lost to Follow-up|13
7532210|NCT02668640|11877792|FG000|Overall Study|Other, not specified|1
7532211|NCT02668692|11877798|FG000|Overall Study|Adverse Event|1
7532212|NCT02668692|11877799|FG001|Overall Study|Adverse Event|0
7532213|NCT02669017|11877823|FG000|Overall Study|Death|1
7428738|NCT01549964|11707857|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
7428739|NCT01549964|11707858|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
7428740|NCT01549964|11707855|FG000|24-Week Treatment Period|Randomized but Not Treated|0
7428741|NCT01549964|11707856|FG001|24-Week Treatment Period|Randomized but Not Treated|0
7428742|NCT01549964|11707857|FG002|24-Week Treatment Period|Randomized but Not Treated|0
7428743|NCT01549964|11707858|FG003|24-Week Treatment Period|Randomized but Not Treated|1
7428744|NCT01549964|11707855|FG000|24-Week Treatment Period|Completion Status Unknown|1
7428745|NCT01549964|11707856|FG001|24-Week Treatment Period|Completion Status Unknown|0
7428746|NCT01549964|11707857|FG002|24-Week Treatment Period|Completion Status Unknown|1
7428747|NCT01549964|11707858|FG003|24-Week Treatment Period|Completion Status Unknown|0
7428748|NCT01549964|11707855|FG000|80-Week Extension Period|Pregnancy|0
7428749|NCT01549964|11707856|FG001|80-Week Extension Period|Pregnancy|0
7428750|NCT01549964|11707857|FG002|80-Week Extension Period|Pregnancy|1
7428751|NCT01549964|11707858|FG003|80-Week Extension Period|Pregnancy|0
7428752|NCT01549964|11707855|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
7428753|NCT01549964|11707856|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
7428754|NCT01549964|11707857|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
7428755|NCT01549964|11707858|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
7428756|NCT01549964|11707855|FG000|80-Week Extension Period|Voluntary Withdrawal|0
7428757|NCT01549964|11707856|FG001|80-Week Extension Period|Voluntary Withdrawal|1
7428758|NCT01549964|11707857|FG002|80-Week Extension Period|Voluntary Withdrawal|4
7428759|NCT01549964|11707858|FG003|80-Week Extension Period|Voluntary Withdrawal|2
7428760|NCT01549964|11707855|FG000|80-Week Extension Period|Lost to Follow-up|1
7428761|NCT01549964|11707856|FG001|80-Week Extension Period|Lost to Follow-up|0
7558620|NCT03131648|11924321|FG002|Maintenance Treatment Period|Discontinued IMP|3
7558621|NCT03131648|11924322|FG003|Maintenance Treatment Period|Discontinued IMP|5
7558622|NCT03131648|11924323|FG004|Maintenance Treatment Period|Discontinued IMP|4
7558623|NCT03131648|11924324|FG005|Maintenance Treatment Period|Discontinued IMP|4
7558624|NCT03131648|11924325|FG006|Maintenance Treatment Period|Discontinued IMP|0
7428762|NCT01549964|11707857|FG002|80-Week Extension Period|Lost to Follow-up|2
7428763|NCT01549964|11707858|FG003|80-Week Extension Period|Lost to Follow-up|1
7428764|NCT01549964|11707855|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7428765|NCT01549964|11707856|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
7428766|NCT01549964|11707857|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
7428767|NCT01549964|11707858|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
7428768|NCT01550744|11707932|FG000|Open-Label|Lost to Follow-up|7
7532214|NCT02669017|11877824|FG001|Overall Study|Death|2
7428769|NCT01550744|11707933|FG001|Open-Label|Lost to Follow-up|0
7428770|NCT01550744|11707934|FG002|Open-Label|Lost to Follow-up|0
7428771|NCT01550744|11707932|FG000|Open-Label|Withdrawal by Subject|13
7428772|NCT01550744|11707933|FG001|Open-Label|Withdrawal by Subject|0
7428773|NCT01550744|11707934|FG002|Open-Label|Withdrawal by Subject|0
7428774|NCT01550744|11707932|FG000|Open-Label|Adverse Event|11
7428775|NCT01550744|11707933|FG001|Open-Label|Adverse Event|0
7428776|NCT01550744|11707934|FG002|Open-Label|Adverse Event|0
7428777|NCT01550744|11707932|FG000|Open-Label|Lack of Efficacy|4
7428778|NCT01550744|11707933|FG001|Open-Label|Lack of Efficacy|0
7428779|NCT01550744|11707934|FG002|Open-Label|Lack of Efficacy|0
7428780|NCT01550744|11707932|FG000|Open-Label|Protocol Violation|4
7428781|NCT01550744|11707933|FG001|Open-Label|Protocol Violation|0
7428782|NCT01550744|11707934|FG002|Open-Label|Protocol Violation|0
7428783|NCT01550744|11707932|FG000|Open-Label|Not all 3 study drug injections received|2
7428784|NCT01550744|11707933|FG001|Open-Label|Not all 3 study drug injections received|0
7428785|NCT01550744|11707934|FG002|Open-Label|Not all 3 study drug injections received|0
7428786|NCT01550744|11707932|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
7428787|NCT01550744|11707933|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
7428788|NCT01550744|11707934|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
7428789|NCT01550744|11707932|FG000|Open-Label|Other|1
7428790|NCT01550744|11707933|FG001|Open-Label|Other|0
7428791|NCT01550744|11707934|FG002|Open-Label|Other|0
7428792|NCT01550744|11707932|FG000|Double-Blind|Lost to Follow-up|0
7428793|NCT01550744|11707933|FG001|Double-Blind|Lost to Follow-up|6
7428794|NCT01550744|11707934|FG002|Double-Blind|Lost to Follow-up|12
7428795|NCT01550744|11707932|FG000|Double-Blind|Withdrawal by Subject|0
7428796|NCT01550744|11707933|FG001|Double-Blind|Withdrawal by Subject|2
7428797|NCT01550744|11707934|FG002|Double-Blind|Withdrawal by Subject|15
7428798|NCT01550744|11707932|FG000|Double-Blind|Adverse Event|0
7428799|NCT01550744|11707933|FG001|Double-Blind|Adverse Event|4
7428800|NCT01550744|11707934|FG002|Double-Blind|Adverse Event|15
7428801|NCT01550744|11707932|FG000|Double-Blind|Death|0
7428802|NCT01550744|11707933|FG001|Double-Blind|Death|1
7428803|NCT01550744|11707934|FG002|Double-Blind|Death|0
7428804|NCT01550744|11707932|FG000|Double-Blind|Lack of Efficacy|0
7428805|NCT01550744|11707933|FG001|Double-Blind|Lack of Efficacy|2
7428806|NCT01550744|11707934|FG002|Double-Blind|Lack of Efficacy|8
7428807|NCT01550744|11707932|FG000|Double-Blind|Protocol Violation|0
7428808|NCT01550744|11707933|FG001|Double-Blind|Protocol Violation|0
7428809|NCT01550744|11707934|FG002|Double-Blind|Protocol Violation|4
7428810|NCT01550744|11707932|FG000|Double-Blind|Pregnancy|0
7428811|NCT01550744|11707933|FG001|Double-Blind|Pregnancy|0
7428812|NCT01550744|11707934|FG002|Double-Blind|Pregnancy|3
7428813|NCT01550744|11707932|FG000|Double-Blind|Other|0
7428814|NCT01550744|11707933|FG001|Double-Blind|Other|2
7428815|NCT01550744|11707934|FG002|Double-Blind|Other|10
7428816|NCT01550757|11707945|FG000|Overall Study|Lost to Follow-up|21
7428817|NCT01550757|11707946|FG001|Overall Study|Lost to Follow-up|14
7428818|NCT01550757|11707947|FG002|Overall Study|Lost to Follow-up|42
7428819|NCT01550757|11707948|FG003|Overall Study|Lost to Follow-up|53
7428820|NCT01550757|11707945|FG000|Overall Study|Withdrawal by Subject|2
7428821|NCT01550757|11707946|FG001|Overall Study|Withdrawal by Subject|0
7428822|NCT01550757|11707947|FG002|Overall Study|Withdrawal by Subject|3
7428823|NCT01550757|11707948|FG003|Overall Study|Withdrawal by Subject|1
7428824|NCT01550965|11707971|FG000|Overall Study|Adverse Event|26
7428825|NCT01550965|11707971|FG000|Overall Study|Withdrawal by Subject|10
7428826|NCT01550965|11707971|FG000|Overall Study|Lost to Follow-up|2
7428827|NCT01550965|11707971|FG000|Overall Study|Lack of Efficacy|59
7428828|NCT01550965|11707971|FG000|Overall Study|Other|13
7428829|NCT01551173|11707995|FG000|Overall Study|Withdrawal by Subject|11
7428830|NCT01551173|11707996|FG001|Overall Study|Withdrawal by Subject|16
7428831|NCT01551173|11707995|FG000|Overall Study|Adverse Event|7
7428832|NCT01551173|11707996|FG001|Overall Study|Adverse Event|6
7428833|NCT01551173|11707995|FG000|Overall Study|Lost to Follow-up|5
7428834|NCT01551173|11707996|FG001|Overall Study|Lost to Follow-up|7
7428835|NCT01551173|11707995|FG000|Overall Study|Other|5
7428836|NCT01551173|11707996|FG001|Overall Study|Other|3
7428837|NCT01551212|11708018|FG000|Overall Study|Graft loss/Retransplantation|0
7428838|NCT01551212|11708019|FG001|Overall Study|Graft loss/Retransplantation|1
7428839|NCT01551212|11708018|FG000|Overall Study|Administrative problems|1
7428840|NCT01551212|11708019|FG001|Overall Study|Administrative problems|2
7558625|NCT03131648|11924326|FG007|Maintenance Treatment Period|Discontinued IMP|0
7428841|NCT01551212|11708018|FG000|Overall Study|Lost to Follow-up|0
7558626|NCT03131648|11924319|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7558627|NCT03131648|11924320|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7428842|NCT01551212|11708019|FG001|Overall Study|Lost to Follow-up|1
7428843|NCT01551212|11708018|FG000|Overall Study|Protocol Violation|0
7428844|NCT01551212|11708019|FG001|Overall Study|Protocol Violation|1
7428845|NCT01551212|11708018|FG000|Overall Study|Withdrawal by Subject|0
7428846|NCT01551212|11708019|FG001|Overall Study|Withdrawal by Subject|7
7428847|NCT01551212|11708018|FG000|Overall Study|Death|2
7428848|NCT01551212|11708019|FG001|Overall Study|Death|4
7428849|NCT01551212|11708018|FG000|Overall Study|Never Received Study Treatment|2
7428850|NCT01551212|11708019|FG001|Overall Study|Never Received Study Treatment|4
7428851|NCT01551303|11708036|FG000|Overall Study|failed awareness check on vision test|4
7428852|NCT01551303|11708037|FG001|Overall Study|failed awareness check on vision test|7
7428853|NCT01551355|11708049|FG000|Overall Study|Lost to Follow-up|51
7428854|NCT01551355|11708050|FG001|Overall Study|Lost to Follow-up|49
7428855|NCT01551355|11708051|FG002|Overall Study|Lost to Follow-up|34
7428856|NCT01551355|11708052|FG003|Overall Study|Lost to Follow-up|24
7428857|NCT01551355|11708053|FG004|Overall Study|Lost to Follow-up|9
7428858|NCT01551355|11708054|FG005|Overall Study|Lost to Follow-up|6
7428859|NCT01551420|11708064|FG000|In-laboratory (Part A)|Lost to Follow-up|2
7428860|NCT01551420|11708065|FG001|In-laboratory (Part A)|Lost to Follow-up|1
7428861|NCT01551420|11708064|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
7428862|NCT01551420|11708065|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
7428863|NCT01551420|11708064|FG000|In-laboratory (Part A)|Scheduling conflict|2
7428864|NCT01551420|11708065|FG001|In-laboratory (Part A)|Scheduling conflict|1
7428865|NCT01551420|11708064|FG000|Screened for Part B Eligibility|Declined participation|8
7428866|NCT01551420|11708065|FG001|Screened for Part B Eligibility|Declined participation|1
7428867|NCT01551420|11708064|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
7428868|NCT01551420|11708065|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
7428869|NCT01551420|11708064|FG000|Home Use (Part B)|Withdrawal by Subject|6
7428870|NCT01551420|11708065|FG001|Home Use (Part B)|Withdrawal by Subject|0
7428871|NCT01551420|11708064|FG000|Home Use (Part B)|Withdrawal by staff|0
7428872|NCT01551420|11708065|FG001|Home Use (Part B)|Withdrawal by staff|1
7428873|NCT01551693|11708073|FG000|Overall Study|Disease Progression|1
7428874|NCT01551693|11708074|FG001|Overall Study|Disease Progression|0
7532215|NCT02669017|11877825|FG002|Overall Study|Death|2
7532216|NCT02669017|11877826|FG003|Overall Study|Death|3
7428875|NCT01551693|11708073|FG000|Overall Study|Adverse Event|0
7428876|NCT01551693|11708074|FG001|Overall Study|Adverse Event|1
7428877|NCT01551693|11708073|FG000|Overall Study|Withdrawal by Subject|0
7428878|NCT01551693|11708074|FG001|Overall Study|Withdrawal by Subject|1
7428879|NCT01551745|11708080|FG000|Overall Study|Withdrawal by Subject|1
7428880|NCT01551745|11708080|FG000|Overall Study|Disease Progression|2
7466917|NCT01895361|11766954|FG002|Overall Study|Withdrawal by Subject|6
7466918|NCT01895361|11766952|FG000|Overall Study|Lack of Efficacy|0
7466919|NCT01895361|11766953|FG001|Overall Study|Lack of Efficacy|1
7466920|NCT01895361|11766954|FG002|Overall Study|Lack of Efficacy|0
7466921|NCT01895361|11766952|FG000|Overall Study|Reasons different from categories above|7
7466922|NCT01895361|11766953|FG001|Overall Study|Reasons different from categories above|3
7466923|NCT01895361|11766954|FG002|Overall Study|Reasons different from categories above|4
7466924|NCT01895452|11766964|FG000|Overall Study|Adverse Event|1
7466925|NCT01895452|11766965|FG001|Overall Study|Adverse Event|4
7466926|NCT01895452|11766964|FG000|Overall Study|Lost to Follow-up|1
7466927|NCT01895452|11766965|FG001|Overall Study|Lost to Follow-up|5
7466928|NCT01895452|11766964|FG000|Overall Study|Pregnancy|0
7466929|NCT01895452|11766965|FG001|Overall Study|Pregnancy|1
7466930|NCT01895452|11766964|FG000|Overall Study|Withdrawal by Subject|2
7466931|NCT01895452|11766965|FG001|Overall Study|Withdrawal by Subject|14
7466932|NCT01895452|11766964|FG000|Overall Study|Underlying disease|0
7466933|NCT01895452|11766965|FG001|Overall Study|Underlying disease|3
7466934|NCT01895452|11766964|FG000|Overall Study|Noncompliance with study drug|0
7466935|NCT01895452|11766965|FG001|Overall Study|Noncompliance with study drug|1
7466936|NCT01895543|11766971|FG000|Overall Study|Withdrawal by Subject|43
7466937|NCT01895543|11766971|FG000|Overall Study|Lost to Follow-up|25
7466938|NCT01895543|11766971|FG000|Overall Study|Adverse Event|28
7466939|NCT01895543|11766971|FG000|Overall Study|Subject's substantial non-compliance|6
7466940|NCT01895543|11766971|FG000|Overall Study|Protocol Violation|1
7466941|NCT01895543|11766971|FG000|Overall Study|Physician Decision|2
7466942|NCT01895543|11766971|FG000|Overall Study|Other (Not fulfilling above criteria)|24
7466943|NCT01895608|11766979|FG000|Overall Study|change in health status|0
7466944|NCT01895608|11766980|FG001|Overall Study|change in health status|1
7466945|NCT01895608|11766981|FG002|Overall Study|change in health status|1
7466946|NCT01895608|11766982|FG003|Overall Study|change in health status|0
7466947|NCT01895608|11766979|FG000|Overall Study|Withdrawal by Subject|0
7466948|NCT01895608|11766980|FG001|Overall Study|Withdrawal by Subject|0
7466949|NCT01895608|11766981|FG002|Overall Study|Withdrawal by Subject|2
7466950|NCT01895608|11766982|FG003|Overall Study|Withdrawal by Subject|0
7466951|NCT01895777|11767011|FG000|Overall Study|Adverse Event|1
7466952|NCT01895777|11767012|FG001|Overall Study|Adverse Event|2
7466953|NCT01895777|11767011|FG000|Overall Study|Lost to Follow-up|2
7466954|NCT01895777|11767012|FG001|Overall Study|Lost to Follow-up|0
7466955|NCT01895777|11767011|FG000|Overall Study|Not treated|1
7466956|NCT01895777|11767012|FG001|Overall Study|Not treated|0
7466957|NCT01895777|11767011|FG000|Overall Study|Other reasons|3
7466958|NCT01895777|11767012|FG001|Overall Study|Other reasons|2
7466959|NCT01895777|11767011|FG000|Overall Study|Non-compliance with the CTP|2
7466960|NCT01895777|11767012|FG001|Overall Study|Non-compliance with the CTP|1
7466961|NCT01896050|11767049|FG000|Overall Study|Adverse Event|37
7466962|NCT01896050|11767050|FG001|Overall Study|Adverse Event|2
7466963|NCT01896050|11767049|FG000|Overall Study|Death|1
7466964|NCT01896050|11767050|FG001|Overall Study|Death|0
7466965|NCT01896128|11767074|FG000|Overall Study|Withdrawal by Subject|3
7466966|NCT01896128|11767075|FG001|Overall Study|Withdrawal by Subject|3
7466967|NCT01896193|11767085|FG000|Overall Study|Lack of Efficacy|20
7532217|NCT02669017|11877827|FG004|Overall Study|Death|8
7428881|NCT01551758|11708086|FG000|Overall Study|Adverse Event|29
7428882|NCT01551758|11708087|FG001|Overall Study|Adverse Event|43
7428883|NCT01551758|11708086|FG000|Overall Study|Lack of Efficacy|0
7428884|NCT01551758|11708087|FG001|Overall Study|Lack of Efficacy|1
7428885|NCT01551758|11708086|FG000|Overall Study|Protocol Violation|5
7428886|NCT01551758|11708087|FG001|Overall Study|Protocol Violation|6
7428887|NCT01551758|11708086|FG000|Overall Study|Met Protocol-defined stopping criteria|8
7428888|NCT01551758|11708087|FG001|Overall Study|Met Protocol-defined stopping criteria|10
7428889|NCT01551758|11708086|FG000|Overall Study|Lost to Follow-up|29
7428890|NCT01551758|11708087|FG001|Overall Study|Lost to Follow-up|25
7428891|NCT01551758|11708086|FG000|Overall Study|Physician Decision|9
7428892|NCT01551758|11708087|FG001|Overall Study|Physician Decision|3
7428893|NCT01551758|11708086|FG000|Overall Study|Withdrawal by Subject|14
7428894|NCT01551758|11708087|FG001|Overall Study|Withdrawal by Subject|17
7428895|NCT01552057|11708115|FG000|Overall Study|Adverse Event|14
7428896|NCT01552057|11708116|FG001|Overall Study|Adverse Event|15
7428897|NCT01552057|11708115|FG000|Overall Study|Lack of Efficacy|8
7428898|NCT01552057|11708116|FG001|Overall Study|Lack of Efficacy|23
7428899|NCT01552057|11708115|FG000|Overall Study|Withdrawal by Subject|5
7428900|NCT01552057|11708116|FG001|Overall Study|Withdrawal by Subject|8
7428901|NCT01552057|11708115|FG000|Overall Study|Entry Criteria Not Met|2
7428902|NCT01552057|11708116|FG001|Overall Study|Entry Criteria Not Met|2
7428903|NCT01552057|11708115|FG000|Overall Study|Physician Decision|1
7428904|NCT01552057|11708116|FG001|Overall Study|Physician Decision|0
7428905|NCT01552369|11708151|FG000|Overall Study|Did not consent to extended follow up|8
7428906|NCT01552369|11708152|FG001|Overall Study|Did not consent to extended follow up|9
7428907|NCT01552408|11708162|FG000|Overall Study|Lost to Follow-up|2
7428908|NCT01552408|11708163|FG001|Overall Study|Lost to Follow-up|0
7428909|NCT01552408|11708162|FG000|Overall Study|Relocation|0
7428910|NCT01552408|11708163|FG001|Overall Study|Relocation|1
7428911|NCT01552408|11708162|FG000|Overall Study|Withdrawal by Subject|2
7428912|NCT01552408|11708163|FG001|Overall Study|Withdrawal by Subject|1
7428913|NCT01552603|11708170|FG000|Overall Study|Physician Decision|1
7428914|NCT01552681|11708176|FG000|Overall Study|Withdrawal by Subject|4
7428915|NCT01552681|11708177|FG001|Overall Study|Withdrawal by Subject|0
7428916|NCT01552681|11708176|FG000|Overall Study|Physician Decision|1
7428917|NCT01552681|11708177|FG001|Overall Study|Physician Decision|0
7428918|NCT01552681|11708176|FG000|Overall Study|Subject moved away|0
7428919|NCT01552681|11708177|FG001|Overall Study|Subject moved away|1
7428920|NCT01552694|11708185|FG000|Overall Study|Lost to Follow-up|0
7428921|NCT01552694|11708186|FG001|Overall Study|Lost to Follow-up|1
7428922|NCT01552694|11708185|FG000|Overall Study|Protocol Violation|0
7428923|NCT01552694|11708186|FG001|Overall Study|Protocol Violation|1
7428924|NCT01552772|11708192|FG000|Overall Study|Lost to Follow-up|2
7428925|NCT01552772|11708192|FG000|Overall Study|Adverse Event|1
7428926|NCT01552772|11708192|FG000|Overall Study|Protocol Deviation|1
7428927|NCT01552902|11708224|FG000|Overall Study|Adverse Event|1
7428928|NCT01552902|11708225|FG001|Overall Study|Adverse Event|15
7428929|NCT01552902|11708226|FG002|Overall Study|Adverse Event|14
7428930|NCT01552902|11708224|FG000|Overall Study|Protocol Violation|3
7428931|NCT01552902|11708225|FG001|Overall Study|Protocol Violation|3
7428932|NCT01552902|11708226|FG002|Overall Study|Protocol Violation|3
7428933|NCT01552902|11708224|FG000|Overall Study|Lack of Efficacy|4
7428934|NCT01552902|11708225|FG001|Overall Study|Lack of Efficacy|3
7428935|NCT01552902|11708226|FG002|Overall Study|Lack of Efficacy|1
7428936|NCT01552902|11708224|FG000|Overall Study|Withdrawal by Subject|1
7428937|NCT01552902|11708225|FG001|Overall Study|Withdrawal by Subject|9
7428938|NCT01552902|11708226|FG002|Overall Study|Withdrawal by Subject|6
7428939|NCT01552902|11708224|FG000|Overall Study|Lost to Follow-up|1
7428940|NCT01552902|11708225|FG001|Overall Study|Lost to Follow-up|3
7428941|NCT01552902|11708226|FG002|Overall Study|Lost to Follow-up|6
7428942|NCT01552902|11708224|FG000|Overall Study|Other|3
7532218|NCT02669017|11877828|FG005|Overall Study|Death|18
7532219|NCT02669017|11877829|FG006|Overall Study|Death|10
7428943|NCT01552902|11708225|FG001|Overall Study|Other|4
7428944|NCT01552902|11708226|FG002|Overall Study|Other|3
7428945|NCT01552915|11708237|FG000|Overall Study|Adverse Event|3
7428946|NCT01552915|11708238|FG001|Overall Study|Adverse Event|14
7428947|NCT01552915|11708239|FG002|Overall Study|Adverse Event|3
7428948|NCT01552915|11708237|FG000|Overall Study|Lost to Follow-up|4
7428949|NCT01552915|11708238|FG001|Overall Study|Lost to Follow-up|6
7428950|NCT01552915|11708239|FG002|Overall Study|Lost to Follow-up|5
7428951|NCT01552915|11708237|FG000|Overall Study|Withdrawal by Subject|6
7428952|NCT01552915|11708238|FG001|Overall Study|Withdrawal by Subject|4
7428953|NCT01552915|11708239|FG002|Overall Study|Withdrawal by Subject|5
7428954|NCT01552915|11708237|FG000|Overall Study|Protocol Violation|0
7428955|NCT01552915|11708238|FG001|Overall Study|Protocol Violation|4
7428956|NCT01552915|11708239|FG002|Overall Study|Protocol Violation|4
7428957|NCT01552915|11708237|FG000|Overall Study|Lack of Efficacy|8
7428958|NCT01552915|11708238|FG001|Overall Study|Lack of Efficacy|1
7428959|NCT01552915|11708239|FG002|Overall Study|Lack of Efficacy|4
7428960|NCT01552915|11708237|FG000|Overall Study|Other|2
7428961|NCT01552915|11708238|FG001|Overall Study|Other|0
7428962|NCT01552915|11708239|FG002|Overall Study|Other|6
7428963|NCT01552928|11708251|FG000|Period 3|Adverse Event|0
7428964|NCT01552928|11708252|FG001|Period 3|Adverse Event|0
7532220|NCT02669017|11877830|FG007|Overall Study|Death|47
7428965|NCT01552928|11708253|FG002|Period 3|Adverse Event|1
7428966|NCT01552928|11708254|FG003|Period 3|Adverse Event|0
7428967|NCT01552954|11708273|FG000|Overall Study|Adverse Event|1
7428968|NCT01552954|11708274|FG001|Overall Study|Adverse Event|2
7428969|NCT01552954|11708273|FG000|Overall Study|Lost to Follow-up|1
7428970|NCT01552954|11708274|FG001|Overall Study|Lost to Follow-up|1
7428971|NCT01552954|11708273|FG000|Overall Study|Withdrawal by Subject|1
7428972|NCT01552954|11708274|FG001|Overall Study|Withdrawal by Subject|1
7428973|NCT01552954|11708273|FG000|Overall Study|Protocol Violation|1
7428974|NCT01552954|11708274|FG001|Overall Study|Protocol Violation|2
7428975|NCT01552954|11708273|FG000|Overall Study|diagnosed DM|1
7428976|NCT01552954|11708274|FG001|Overall Study|diagnosed DM|0
7428977|NCT01553084|11708300|FG000|Overall Study|Withdrawal by Subject|15
7428978|NCT01553084|11708301|FG001|Overall Study|Withdrawal by Subject|13
7428979|NCT01553084|11708302|FG002|Overall Study|Withdrawal by Subject|35
7428980|NCT01553136|11708314|FG000|Overall Study|Adverse Event|3
7428981|NCT01553136|11708315|FG001|Overall Study|Adverse Event|2
7428982|NCT01553136|11708314|FG000|Overall Study|Withdrawal by Subject|2
7428983|NCT01553136|11708315|FG001|Overall Study|Withdrawal by Subject|3
7428984|NCT01553136|11708314|FG000|Overall Study|Lost to Follow-up|4
7428985|NCT01553136|11708315|FG001|Overall Study|Lost to Follow-up|10
7428986|NCT01553136|11708314|FG000|Overall Study|Physician Decision|2
7428987|NCT01553136|11708315|FG001|Overall Study|Physician Decision|3
7428988|NCT01553136|11708314|FG000|Overall Study|Scheduling Difficulties|5
7428989|NCT01553136|11708315|FG001|Overall Study|Scheduling Difficulties|4
7428990|NCT01553188|11708325|FG000|Overall Study|Patient choice|1
7428991|NCT01553188|11708326|FG001|Overall Study|Patient choice|0
7428992|NCT01553188|11708327|FG002|Overall Study|Patient choice|0
7428993|NCT01553188|11708328|FG003|Overall Study|Patient choice|0
7428994|NCT01553188|11708325|FG000|Overall Study|Intercurrent illness and adverse event|0
7428995|NCT01553188|11708326|FG001|Overall Study|Intercurrent illness and adverse event|1
7428996|NCT01553188|11708327|FG002|Overall Study|Intercurrent illness and adverse event|2
7428997|NCT01553188|11708328|FG003|Overall Study|Intercurrent illness and adverse event|0
7428998|NCT01553279|11708352|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
7428999|NCT01553279|11708353|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
7429000|NCT01553279|11708352|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7429001|NCT01553279|11708353|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
7429002|NCT01553279|11708352|FG000|Interim Period|Withdrawal by Subject|2
7429003|NCT01553279|11708353|FG001|Interim Period|Withdrawal by Subject|2
7429004|NCT01553279|11708352|FG000|Interim Period|Lost to Follow-up|1
7429005|NCT01553279|11708353|FG001|Interim Period|Lost to Follow-up|0
7429006|NCT01553279|11708352|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
7429007|NCT01553279|11708353|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
7429008|NCT01553279|11708352|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
7429009|NCT01553279|11708353|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
7429010|NCT01553318|11708368|FG000|Overall Study|Protocol Violation|3
7429011|NCT01553318|11708369|FG001|Overall Study|Protocol Violation|2
7429012|NCT01553591|11708384|FG000|Overall Study|Voluntarily withdrew|94
7429013|NCT01553591|11708385|FG001|Overall Study|Voluntarily withdrew|79
7429014|NCT01553591|11708386|FG002|Overall Study|Voluntarily withdrew|96
7429015|NCT01553591|11708384|FG000|Overall Study|Adverse Event|36
7429016|NCT01553591|11708385|FG001|Overall Study|Adverse Event|45
7429017|NCT01553591|11708386|FG002|Overall Study|Adverse Event|16
7429018|NCT01553591|11708384|FG000|Overall Study|Lost to Follow-up|25
7429019|NCT01553591|11708385|FG001|Overall Study|Lost to Follow-up|23
7429020|NCT01553591|11708386|FG002|Overall Study|Lost to Follow-up|16
7429021|NCT01553591|11708384|FG000|Overall Study|Physician decision: other|11
7429022|NCT01553591|11708385|FG001|Overall Study|Physician decision: other|14
7429023|NCT01553591|11708386|FG002|Overall Study|Physician decision: other|16
7429024|NCT01553591|11708384|FG000|Overall Study|Physician decision: lack of efficacy|2
7429025|NCT01553591|11708385|FG001|Overall Study|Physician decision: lack of efficacy|3
7429026|NCT01553591|11708386|FG002|Overall Study|Physician decision: lack of efficacy|7
7429027|NCT01553591|11708384|FG000|Overall Study|Protocol Violation|3
7429028|NCT01553591|11708385|FG001|Overall Study|Protocol Violation|4
7429029|NCT01553591|11708386|FG002|Overall Study|Protocol Violation|4
7429030|NCT01553591|11708384|FG000|Overall Study|Sponsor decision|1
7429031|NCT01553591|11708385|FG001|Overall Study|Sponsor decision|0
7429032|NCT01553591|11708386|FG002|Overall Study|Sponsor decision|3
7429033|NCT01553591|11708384|FG000|Overall Study|Randomized and never dispensed drug|0
7429034|NCT01553591|11708385|FG001|Overall Study|Randomized and never dispensed drug|1
7429035|NCT01553591|11708386|FG002|Overall Study|Randomized and never dispensed drug|0
7429036|NCT01553747|11708406|FG000|Overall Study|Protocol Violation|0
7429037|NCT01553747|11708407|FG001|Overall Study|Protocol Violation|2
7429038|NCT01553747|11708408|FG002|Overall Study|Protocol Violation|0
7429039|NCT01553747|11708406|FG000|Overall Study|Voluntarily withdrew|70
7429040|NCT01553747|11708407|FG001|Overall Study|Voluntarily withdrew|66
7429041|NCT01553747|11708408|FG002|Overall Study|Voluntarily withdrew|74
7429042|NCT01553747|11708406|FG000|Overall Study|Adverse event or SAE|32
7429043|NCT01553747|11708407|FG001|Overall Study|Adverse event or SAE|28
7429044|NCT01553747|11708408|FG002|Overall Study|Adverse event or SAE|19
7429045|NCT01553747|11708406|FG000|Overall Study|Physician decision: other|10
7429046|NCT01553747|11708407|FG001|Overall Study|Physician decision: other|8
7429047|NCT01553747|11708408|FG002|Overall Study|Physician decision: other|7
7429048|NCT01553747|11708406|FG000|Overall Study|Lost to Follow-up|11
7429049|NCT01553747|11708407|FG001|Overall Study|Lost to Follow-up|5
7429050|NCT01553747|11708408|FG002|Overall Study|Lost to Follow-up|6
7429051|NCT01553747|11708406|FG000|Overall Study|Sponsor decision, specify|7
7429052|NCT01553747|11708407|FG001|Overall Study|Sponsor decision, specify|5
7429053|NCT01553747|11708408|FG002|Overall Study|Sponsor decision, specify|0
7429054|NCT01553747|11708406|FG000|Overall Study|Physician decision: lack of efficacy|1
7429055|NCT01553747|11708407|FG001|Overall Study|Physician decision: lack of efficacy|5
7429056|NCT01553747|11708408|FG002|Overall Study|Physician decision: lack of efficacy|3
7429057|NCT01553851|11708419|FG000|Overall Study|Adverse Event|2
7429058|NCT01553851|11708419|FG000|Overall Study|constipation|1
7429059|NCT01553916|11708423|FG000|Overall Study|Withdrawal by Subject|2
7429060|NCT01553916|11708423|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
7429061|NCT01554176|11708429|FG000|Treatment Phase|Protocol Violation|1
7429062|NCT01554176|11708430|FG001|Treatment Phase|Protocol Violation|2
7429063|NCT01554176|11708431|FG002|Treatment Phase|Protocol Violation|0
7429064|NCT01554176|11708432|FG003|Treatment Phase|Protocol Violation|0
7429065|NCT01554176|11708433|FG004|Treatment Phase|Protocol Violation|0
7429066|NCT01554176|11708429|FG000|Treatment Phase|Physician Decision|1
7429067|NCT01554176|11708430|FG001|Treatment Phase|Physician Decision|1
7429068|NCT01554176|11708431|FG002|Treatment Phase|Physician Decision|0
7429069|NCT01554176|11708432|FG003|Treatment Phase|Physician Decision|0
7429070|NCT01554176|11708433|FG004|Treatment Phase|Physician Decision|0
7429071|NCT01554176|11708429|FG000|Treatment Phase|Lack of Efficacy|0
7429072|NCT01554176|11708430|FG001|Treatment Phase|Lack of Efficacy|1
7429073|NCT01554176|11708431|FG002|Treatment Phase|Lack of Efficacy|0
7429074|NCT01554176|11708432|FG003|Treatment Phase|Lack of Efficacy|0
7429075|NCT01554176|11708433|FG004|Treatment Phase|Lack of Efficacy|0
7429076|NCT01554176|11708429|FG000|Treatment Phase|Adverse event, non-fatal|1
7429077|NCT01554176|11708430|FG001|Treatment Phase|Adverse event, non-fatal|1
7429078|NCT01554176|11708431|FG002|Treatment Phase|Adverse event, non-fatal|0
7429079|NCT01554176|11708432|FG003|Treatment Phase|Adverse event, non-fatal|0
7429080|NCT01554176|11708433|FG004|Treatment Phase|Adverse event, non-fatal|0
7429081|NCT01554176|11708429|FG000|Treatment Phase|Non-compliance with study drug|1
7429082|NCT01554176|11708430|FG001|Treatment Phase|Non-compliance with study drug|0
7429083|NCT01554176|11708431|FG002|Treatment Phase|Non-compliance with study drug|0
7429084|NCT01554176|11708432|FG003|Treatment Phase|Non-compliance with study drug|0
7429085|NCT01554176|11708433|FG004|Treatment Phase|Non-compliance with study drug|0
7429086|NCT01554176|11708429|FG000|Treatment Phase|Withdrawal by Subject|1
7429087|NCT01554176|11708430|FG001|Treatment Phase|Withdrawal by Subject|0
7429088|NCT01554176|11708431|FG002|Treatment Phase|Withdrawal by Subject|0
7429089|NCT01554176|11708432|FG003|Treatment Phase|Withdrawal by Subject|0
7429090|NCT01554176|11708433|FG004|Treatment Phase|Withdrawal by Subject|0
7429091|NCT01554176|11708429|FG000|Treatment Phase|Lost to Follow-up|3
7429092|NCT01554176|11708430|FG001|Treatment Phase|Lost to Follow-up|0
7429093|NCT01554176|11708431|FG002|Treatment Phase|Lost to Follow-up|0
7429094|NCT01554176|11708432|FG003|Treatment Phase|Lost to Follow-up|0
7429095|NCT01554176|11708433|FG004|Treatment Phase|Lost to Follow-up|0
7429096|NCT01554176|11708429|FG000|Run-out Phase|Protocol Violation|0
7429097|NCT01554176|11708430|FG001|Run-out Phase|Protocol Violation|0
7429098|NCT01554176|11708431|FG002|Run-out Phase|Protocol Violation|0
7429099|NCT01554176|11708432|FG003|Run-out Phase|Protocol Violation|1
7429100|NCT01554176|11708433|FG004|Run-out Phase|Protocol Violation|0
7429101|NCT01554241|11708449|FG000|Overall Study|Death|3
7429102|NCT01554241|11708450|FG001|Overall Study|Death|1
7429103|NCT01554241|11708451|FG002|Overall Study|Death|1
7429104|NCT01554241|11708452|FG003|Overall Study|Death|0
7429105|NCT01554241|11708449|FG000|Overall Study|protocol specified renal stone|0
7429106|NCT01554241|11708450|FG001|Overall Study|protocol specified renal stone|0
7429107|NCT01554241|11708451|FG002|Overall Study|protocol specified renal stone|0
7429108|NCT01554241|11708452|FG003|Overall Study|protocol specified renal stone|1
7429109|NCT01554241|11708449|FG000|Overall Study|protocol specified change in eGFR|0
7429110|NCT01554241|11708450|FG001|Overall Study|protocol specified change in eGFR|0
7429111|NCT01554241|11708451|FG002|Overall Study|protocol specified change in eGFR|1
7429112|NCT01554241|11708452|FG003|Overall Study|protocol specified change in eGFR|0
7429113|NCT01554241|11708449|FG000|Overall Study|Withdrawal by Subject|0
7429114|NCT01554241|11708450|FG001|Overall Study|Withdrawal by Subject|0
7429115|NCT01554241|11708451|FG002|Overall Study|Withdrawal by Subject|2
7429116|NCT01554241|11708452|FG003|Overall Study|Withdrawal by Subject|0
7429117|NCT01554514|11708487|FG000|Overall Study|1 patient ineligible with congenital TTP|1
7429118|NCT01554514|11708487|FG000|Overall Study|Physician Decision|1
7429119|NCT01554527|11708494|FG000|Overall Study|Withdrawal by Subject|1
7429120|NCT01554527|11708495|FG001|Overall Study|Withdrawal by Subject|0
7429121|NCT01554527|11708496|FG002|Overall Study|Withdrawal by Subject|3
7429122|NCT01554527|11708494|FG000|Overall Study|Lost to Follow-up|0
7429123|NCT01554527|11708495|FG001|Overall Study|Lost to Follow-up|0
7429124|NCT01554527|11708496|FG002|Overall Study|Lost to Follow-up|4
7429125|NCT01554527|11708494|FG000|Overall Study|Physician Decision|0
7429126|NCT01554527|11708495|FG001|Overall Study|Physician Decision|0
7429127|NCT01554527|11708496|FG002|Overall Study|Physician Decision|1
7429128|NCT01554579|11708507|FG000|Overall Study|Adverse Event|6
7429129|NCT01554579|11708508|FG001|Overall Study|Adverse Event|25
7429130|NCT01554579|11708507|FG000|Overall Study|Lack of Efficacy|2
7429131|NCT01554579|11708508|FG001|Overall Study|Lack of Efficacy|1
7429132|NCT01554579|11708507|FG000|Overall Study|Withdrawal by Subject|2
7429133|NCT01554579|11708508|FG001|Overall Study|Withdrawal by Subject|1
7429134|NCT01554618|11708517|FG000|Randomized Through Start of Treatment|Adverse Event|1
7429135|NCT01554618|11708518|FG001|Randomized Through Start of Treatment|Adverse Event|0
7429136|NCT01554618|11708517|FG000|Controlled Assessment Period|Lost to Follow-up|2
7429137|NCT01554618|11708518|FG001|Controlled Assessment Period|Lost to Follow-up|1
7429138|NCT01554618|11708517|FG000|Controlled Assessment Period|Withdrawal by Subject|6
7429139|NCT01554618|11708518|FG001|Controlled Assessment Period|Withdrawal by Subject|0
7429140|NCT01554618|11708517|FG000|Open-Label Extension Period|Withdrawal by Subject|2
7429141|NCT01554618|11708518|FG001|Open-Label Extension Period|Withdrawal by Subject|3
7429142|NCT01554618|11708517|FG000|Open-Label Extension Period|Physician Decision|0
7429143|NCT01554618|11708518|FG001|Open-Label Extension Period|Physician Decision|1
7429144|NCT01554618|11708517|FG000|Open-Label Extension Period|Lost to Follow-up|1
7429145|NCT01554618|11708518|FG001|Open-Label Extension Period|Lost to Follow-up|1
7429146|NCT01554904|11708554|FG000|Overall Study|Withdrawal by Subject|3
7429147|NCT01554904|11708554|FG000|Overall Study|Had sleep apnea on Home Study 1|1
7429148|NCT01555125|11708565|FG000|Induction Period|Lost to Follow-up|0
7429149|NCT01555125|11708566|FG001|Induction Period|Lost to Follow-up|2
7429150|NCT01555125|11708567|FG002|Induction Period|Lost to Follow-up|0
7429151|NCT01555125|11708568|FG003|Induction Period|Lost to Follow-up|0
7429152|NCT01555125|11708569|FG004|Induction Period|Lost to Follow-up|0
7429153|NCT01555125|11708565|FG000|Induction Period|Adverse Event|0
7429154|NCT01555125|11708566|FG001|Induction Period|Adverse Event|1
7429155|NCT01555125|11708567|FG002|Induction Period|Adverse Event|0
7429156|NCT01555125|11708568|FG003|Induction Period|Adverse Event|0
7429157|NCT01555125|11708569|FG004|Induction Period|Adverse Event|1
7429158|NCT01555125|11708565|FG000|Induction Period|Subject / guardian decision|0
7429159|NCT01555125|11708566|FG001|Induction Period|Subject / guardian decision|0
7429160|NCT01555125|11708567|FG002|Induction Period|Subject / guardian decision|0
7429161|NCT01555125|11708568|FG003|Induction Period|Subject / guardian decision|0
7429162|NCT01555125|11708569|FG004|Induction Period|Subject / guardian decision|2
7429163|NCT01555125|11708565|FG000|Induction Period|Death|1
7429164|NCT01555125|11708566|FG001|Induction Period|Death|0
7429165|NCT01555125|11708567|FG002|Induction Period|Death|0
7429166|NCT01555125|11708568|FG003|Induction Period|Death|0
7429167|NCT01555125|11708569|FG004|Induction Period|Death|0
7429168|NCT01555125|11708565|FG000|Maintenance Period|Adverse Event|1
7429169|NCT01555125|11708566|FG001|Maintenance Period|Adverse Event|1
7429170|NCT01555125|11708567|FG002|Maintenance Period|Adverse Event|0
7429171|NCT01555125|11708568|FG003|Maintenance Period|Adverse Event|0
7429172|NCT01555125|11708569|FG004|Maintenance Period|Adverse Event|0
7429173|NCT01555125|11708565|FG000|Maintenance Period|Subject / guardian decision|1
7429174|NCT01555125|11708566|FG001|Maintenance Period|Subject / guardian decision|2
7429175|NCT01555125|11708567|FG002|Maintenance Period|Subject / guardian decision|0
7429176|NCT01555125|11708568|FG003|Maintenance Period|Subject / guardian decision|0
7429177|NCT01555125|11708569|FG004|Maintenance Period|Subject / guardian decision|0
7429178|NCT01555125|11708565|FG000|Maintenance Period|Lost to Follow-up|2
7429179|NCT01555125|11708566|FG001|Maintenance Period|Lost to Follow-up|0
7429180|NCT01555125|11708567|FG002|Maintenance Period|Lost to Follow-up|0
7429181|NCT01555125|11708568|FG003|Maintenance Period|Lost to Follow-up|1
7429182|NCT01555125|11708569|FG004|Maintenance Period|Lost to Follow-up|0
7429183|NCT01555125|11708565|FG000|Maintenance Period|Lack of Efficacy|6
7429184|NCT01555125|11708566|FG001|Maintenance Period|Lack of Efficacy|1
7429185|NCT01555125|11708567|FG002|Maintenance Period|Lack of Efficacy|3
7429186|NCT01555125|11708568|FG003|Maintenance Period|Lack of Efficacy|0
7429187|NCT01555125|11708569|FG004|Maintenance Period|Lack of Efficacy|0
7429188|NCT01555125|11708565|FG000|Maintenance Period|Physician Decision|0
7429189|NCT01555125|11708566|FG001|Maintenance Period|Physician Decision|0
7429190|NCT01555125|11708567|FG002|Maintenance Period|Physician Decision|1
7429191|NCT01555125|11708568|FG003|Maintenance Period|Physician Decision|0
7429192|NCT01555125|11708569|FG004|Maintenance Period|Physician Decision|0
7429193|NCT01555125|11708565|FG000|Maintenance Period|Death|0
7429194|NCT01555125|11708566|FG001|Maintenance Period|Death|0
7429195|NCT01555125|11708567|FG002|Maintenance Period|Death|0
7429196|NCT01555125|11708568|FG003|Maintenance Period|Death|1
7429197|NCT01555125|11708569|FG004|Maintenance Period|Death|0
7429198|NCT01555125|11708565|FG000|Extension|Adverse Event|1
7429199|NCT01555125|11708566|FG001|Extension|Adverse Event|2
7429200|NCT01555125|11708567|FG002|Extension|Adverse Event|1
7429201|NCT01555125|11708568|FG003|Extension|Adverse Event|1
7429202|NCT01555125|11708569|FG004|Extension|Adverse Event|0
7429203|NCT01555125|11708565|FG000|Extension|Protocol deviation|1
7429204|NCT01555125|11708566|FG001|Extension|Protocol deviation|0
7429205|NCT01555125|11708567|FG002|Extension|Protocol deviation|0
7429206|NCT01555125|11708568|FG003|Extension|Protocol deviation|0
7429207|NCT01555125|11708569|FG004|Extension|Protocol deviation|0
7429208|NCT01555125|11708565|FG000|Extension|Lack of Efficacy|7
7429209|NCT01555125|11708566|FG001|Extension|Lack of Efficacy|6
7429210|NCT01555125|11708567|FG002|Extension|Lack of Efficacy|3
7429211|NCT01555125|11708568|FG003|Extension|Lack of Efficacy|0
7429212|NCT01555125|11708569|FG004|Extension|Lack of Efficacy|0
7429213|NCT01555125|11708565|FG000|Extension|Lost to Follow-up|2
7429214|NCT01555125|11708566|FG001|Extension|Lost to Follow-up|1
7429215|NCT01555125|11708567|FG002|Extension|Lost to Follow-up|2
7429216|NCT01555125|11708568|FG003|Extension|Lost to Follow-up|0
7429217|NCT01555125|11708569|FG004|Extension|Lost to Follow-up|0
7429218|NCT01555125|11708565|FG000|Extension|Study terminated by sponsor|32
7429219|NCT01555125|11708566|FG001|Extension|Study terminated by sponsor|33
7429220|NCT01555125|11708567|FG002|Extension|Study terminated by sponsor|16
7429221|NCT01555125|11708568|FG003|Extension|Study terminated by sponsor|20
7429222|NCT01555125|11708569|FG004|Extension|Study terminated by sponsor|0
7429223|NCT01555125|11708565|FG000|Extension|Subject/guardian decision|1
7429224|NCT01555125|11708566|FG001|Extension|Subject/guardian decision|9
7429225|NCT01555125|11708567|FG002|Extension|Subject/guardian decision|1
7429226|NCT01555125|11708568|FG003|Extension|Subject/guardian decision|0
7429227|NCT01555125|11708569|FG004|Extension|Subject/guardian decision|0
7429228|NCT01555125|11708565|FG000|Extension|Technical Problems|1
7429229|NCT01555125|11708566|FG001|Extension|Technical Problems|0
7429230|NCT01555125|11708567|FG002|Extension|Technical Problems|0
7429231|NCT01555125|11708568|FG003|Extension|Technical Problems|1
7429232|NCT01555125|11708569|FG004|Extension|Technical Problems|0
7429233|NCT01555125|11708565|FG000|Follow-Up Period|Lost to Follow-up|1
7429234|NCT01555125|11708566|FG001|Follow-Up Period|Lost to Follow-up|0
7429235|NCT01555125|11708567|FG002|Follow-Up Period|Lost to Follow-up|0
7429236|NCT01555125|11708568|FG003|Follow-Up Period|Lost to Follow-up|0
7429237|NCT01555125|11708569|FG004|Follow-Up Period|Lost to Follow-up|0
7429238|NCT01555125|11708565|FG000|Follow-Up Period|Subject / guardian decision|3
7429239|NCT01555125|11708566|FG001|Follow-Up Period|Subject / guardian decision|1
7429240|NCT01555125|11708567|FG002|Follow-Up Period|Subject / guardian decision|1
7429241|NCT01555125|11708568|FG003|Follow-Up Period|Subject / guardian decision|1
7429242|NCT01555125|11708569|FG004|Follow-Up Period|Subject / guardian decision|0
7429243|NCT01555138|11708586|FG000|Overall Study|Death|0
7429244|NCT01555138|11708587|FG001|Overall Study|Death|1
7429245|NCT01555138|11708586|FG000|Overall Study|Lost to Follow-up|1
7429246|NCT01555138|11708587|FG001|Overall Study|Lost to Follow-up|0
7429247|NCT01555138|11708586|FG000|Overall Study|Abnormal Lab reults|1
7429248|NCT01555138|11708587|FG001|Overall Study|Abnormal Lab reults|3
7429249|NCT01555138|11708586|FG000|Overall Study|Lack of Efficacy|2
7429250|NCT01555138|11708587|FG001|Overall Study|Lack of Efficacy|2
7429251|NCT01555138|11708586|FG000|Overall Study|Protocol Violation|5
7429252|NCT01555138|11708587|FG001|Overall Study|Protocol Violation|3
7429253|NCT01555138|11708586|FG000|Overall Study|Administrative problems|8
7429254|NCT01555138|11708587|FG001|Overall Study|Administrative problems|0
7429255|NCT01555138|11708586|FG000|Overall Study|Withdrawal by Subject|16
7429256|NCT01555138|11708587|FG001|Overall Study|Withdrawal by Subject|15
7429257|NCT01555138|11708586|FG000|Overall Study|Adverse Event|14
7429258|NCT01555138|11708587|FG001|Overall Study|Adverse Event|14
7429259|NCT01555151|11708597|FG000|Overall Study|Withdrawal by Subject|6
7429260|NCT01555151|11708598|FG001|Overall Study|Withdrawal by Subject|2
7429261|NCT01555151|11708599|FG002|Overall Study|Withdrawal by Subject|0
7429262|NCT01555151|11708600|FG003|Overall Study|Withdrawal by Subject|2
7429263|NCT01555151|11708597|FG000|Overall Study|Administrative|3
7429264|NCT01555151|11708598|FG001|Overall Study|Administrative|1
7429265|NCT01555151|11708599|FG002|Overall Study|Administrative|2
7429266|NCT01555151|11708600|FG003|Overall Study|Administrative|0
7429267|NCT01555151|11708597|FG000|Overall Study|Protocol Violation|3
7429268|NCT01555151|11708598|FG001|Overall Study|Protocol Violation|3
7429269|NCT01555151|11708599|FG002|Overall Study|Protocol Violation|3
7429270|NCT01555151|11708600|FG003|Overall Study|Protocol Violation|5
7429271|NCT01555151|11708597|FG000|Overall Study|Adverse Event|1
7429272|NCT01555151|11708598|FG001|Overall Study|Adverse Event|2
7429273|NCT01555151|11708599|FG002|Overall Study|Adverse Event|1
7429274|NCT01555151|11708600|FG003|Overall Study|Adverse Event|2
7429275|NCT01555151|11708597|FG000|Overall Study|Lost to Follow-up|0
7429276|NCT01555151|11708598|FG001|Overall Study|Lost to Follow-up|0
7429277|NCT01555151|11708599|FG002|Overall Study|Lost to Follow-up|0
7429278|NCT01555151|11708600|FG003|Overall Study|Lost to Follow-up|1
7429279|NCT01555164|11708613|FG000|Overall Study|Adverse Event|5
7429280|NCT01555164|11708614|FG001|Overall Study|Adverse Event|7
7429281|NCT01555164|11708613|FG000|Overall Study|Hyperglycemia|0
7429282|NCT01555164|11708614|FG001|Overall Study|Hyperglycemia|1
7429283|NCT01555164|11708613|FG000|Overall Study|Investigator's Discretion|2
7429284|NCT01555164|11708614|FG001|Overall Study|Investigator's Discretion|2
7429285|NCT01555164|11708613|FG000|Overall Study|Lost to Follow-up|4
7429286|NCT01555164|11708614|FG001|Overall Study|Lost to Follow-up|3
7429287|NCT01555164|11708613|FG000|Overall Study|Protocol Violation|9
7429288|NCT01555164|11708614|FG001|Overall Study|Protocol Violation|5
7429289|NCT01555164|11708613|FG000|Overall Study|Subject Non-compliance|14
7429290|NCT01555164|11708614|FG001|Overall Study|Subject Non-compliance|6
7429291|NCT01555164|11708613|FG000|Overall Study|Subject Withdrew Consent|6
7429292|NCT01555164|11708614|FG001|Overall Study|Subject Withdrew Consent|11
7429293|NCT01555463|11708622|FG000|Treatment|Adverse Event|6
7429294|NCT01555463|11708623|FG001|Treatment|Adverse Event|12
7429295|NCT01555463|11708622|FG000|Treatment|Withdrawal by Subject|24
7429296|NCT01555463|11708623|FG001|Treatment|Withdrawal by Subject|36
7429297|NCT01555463|11708622|FG000|Treatment|Lost to Follow-up|28
7429298|NCT01555463|11708623|FG001|Treatment|Lost to Follow-up|23
7429299|NCT01555463|11708622|FG000|Treatment|Protocol Violation|4
7429300|NCT01555463|11708623|FG001|Treatment|Protocol Violation|5
7429301|NCT01555463|11708622|FG000|Treatment|Other reason|2
7429302|NCT01555463|11708623|FG001|Treatment|Other reason|3
7429303|NCT01555463|11708622|FG000|Follow up|Adverse Event|2
7429304|NCT01555463|11708623|FG001|Follow up|Adverse Event|5
7429305|NCT01555463|11708622|FG000|Follow up|Death|0
7429306|NCT01555463|11708623|FG001|Follow up|Death|1
7429307|NCT01555463|11708622|FG000|Follow up|Withdrawal by Subject|22
7429308|NCT01555463|11708623|FG001|Follow up|Withdrawal by Subject|22
7429309|NCT01555463|11708622|FG000|Follow up|Lost to Follow-up|9
7429310|NCT01555463|11708623|FG001|Follow up|Lost to Follow-up|10
7429311|NCT01555463|11708622|FG000|Follow up|Protocol Violation|2
7429312|NCT01555463|11708623|FG001|Follow up|Protocol Violation|4
7429313|NCT01555463|11708622|FG000|Follow up|Other reason|3
7429314|NCT01555463|11708623|FG001|Follow up|Other reason|3
7429315|NCT01555671|11708648|FG000|Overall Study|Physician Decision|20
7429316|NCT01555671|11708649|FG001|Overall Study|Physician Decision|25
7429317|NCT01555762|11708684|FG000|Overall Study|No information on Bevacizumab intake|11
7429318|NCT01555762|11708684|FG000|Overall Study|Missing start date of infusion|8
7429319|NCT01555762|11708684|FG000|Overall Study|75 years old or more ticked No|1
7429320|NCT01555762|11708684|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
7429321|NCT01555762|11708684|FG000|Overall Study|Death linked to progression of disease|165
7429322|NCT01555762|11708684|FG000|Overall Study|Lost follow-up/moved house/changed team|35
7429323|NCT01555762|11708684|FG000|Overall Study|Investigator's decision|10
7429324|NCT01555762|11708684|FG000|Overall Study|Participant not wishing to continue|5
7429325|NCT01555762|11708684|FG000|Overall Study|Missing data|1
7429326|NCT01555762|11708684|FG000|Overall Study|Death linked to an adverse event|14
7429327|NCT01555931|11708690|FG000|Overall Study|Lost to Follow-up|2
7429328|NCT01555931|11708691|FG001|Overall Study|Lost to Follow-up|5
7429329|NCT01555983|11708706|FG000|Overall Study|Withdrawal by Subject|1
7429330|NCT01555983|11708707|FG001|Overall Study|Withdrawal by Subject|0
7429331|NCT01555983|11708708|FG002|Overall Study|Withdrawal by Subject|0
7429332|NCT01555983|11708709|FG003|Overall Study|Withdrawal by Subject|0
7429333|NCT01555983|11708710|FG004|Overall Study|Withdrawal by Subject|1
7429334|NCT01555983|11708711|FG005|Overall Study|Withdrawal by Subject|1
7429335|NCT01556165|11708736|FG000|Overall Study|Adverse Event|5
7429336|NCT01556165|11708737|FG001|Overall Study|Adverse Event|3
7429337|NCT01556165|11708736|FG000|Overall Study|Protocol Violation|0
7429338|NCT01556165|11708737|FG001|Overall Study|Protocol Violation|3
7429339|NCT01556165|11708736|FG000|Overall Study|Withdrawal of Consent|7
7429340|NCT01556165|11708737|FG001|Overall Study|Withdrawal of Consent|1
7429341|NCT01556438|11708799|FG000|Overall Study|Adverse Event|4
7429342|NCT01556438|11708800|FG001|Overall Study|Adverse Event|2
7429343|NCT01556438|11708799|FG000|Overall Study|Sponsor Decision|0
7429344|NCT01556438|11708800|FG001|Overall Study|Sponsor Decision|2
7429345|NCT01556438|11708799|FG000|Overall Study|Progressive Disease|0
7429346|NCT01556438|11708800|FG001|Overall Study|Progressive Disease|6
7429347|NCT01556438|11708799|FG000|Overall Study|Death|0
7429348|NCT01556438|11708800|FG001|Overall Study|Death|1
7429349|NCT01556763|11708869|FG000|Overall Study|Withdrawal by Subject|0
7429350|NCT01556763|11708870|FG001|Overall Study|Withdrawal by Subject|1
7429351|NCT01556763|11708871|FG002|Overall Study|Withdrawal by Subject|0
7429352|NCT01556932|11708885|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
7429353|NCT01556932|11708886|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
7429354|NCT01556997|11708894|FG000|Overall Study|Adverse Event|10
7429355|NCT01556997|11708895|FG001|Overall Study|Adverse Event|12
7429356|NCT01556997|11708896|FG002|Overall Study|Adverse Event|12
7429357|NCT01556997|11708894|FG000|Overall Study|Lost to Follow-up|6
7429358|NCT01556997|11708895|FG001|Overall Study|Lost to Follow-up|6
7429359|NCT01556997|11708896|FG002|Overall Study|Lost to Follow-up|4
7429360|NCT01556997|11708894|FG000|Overall Study|Physician Decision|1
7429361|NCT01556997|11708895|FG001|Overall Study|Physician Decision|1
7429362|NCT01556997|11708896|FG002|Overall Study|Physician Decision|1
7429363|NCT01556997|11708894|FG000|Overall Study|Withdrawal by Subject|7
7429364|NCT01556997|11708895|FG001|Overall Study|Withdrawal by Subject|6
7429365|NCT01556997|11708896|FG002|Overall Study|Withdrawal by Subject|8
7532221|NCT02669017|11877831|FG008|Overall Study|Death|20
7429366|NCT01556997|11708894|FG000|Overall Study|Other|2
7429367|NCT01556997|11708895|FG001|Overall Study|Other|3
7429368|NCT01556997|11708896|FG002|Overall Study|Other|7
7532222|NCT02669017|11877823|FG000|Overall Study|Withdrawal by Subject|0
7429369|NCT01557166|11708906|FG000|Overall Study|Adverse Event|20
7429370|NCT01557166|11708907|FG001|Overall Study|Adverse Event|6
7429371|NCT01557166|11708906|FG000|Overall Study|Lack of Efficacy|2
7429372|NCT01557166|11708907|FG001|Overall Study|Lack of Efficacy|1
7429373|NCT01557166|11708906|FG000|Overall Study|Protocol Violation|8
7429374|NCT01557166|11708907|FG001|Overall Study|Protocol Violation|5
7429375|NCT01557166|11708906|FG000|Overall Study|Withdrawn consent|12
7429376|NCT01557166|11708907|FG001|Overall Study|Withdrawn consent|20
7429377|NCT01557166|11708906|FG000|Overall Study|Target dose not tolerated|1
7429378|NCT01557166|11708907|FG001|Overall Study|Target dose not tolerated|0
7429379|NCT01557166|11708906|FG000|Overall Study|Psychiatric disorder|1
7532223|NCT02669017|11877824|FG001|Overall Study|Withdrawal by Subject|0
7558628|NCT03131648|11924321|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
7558629|NCT03131648|11924322|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
7558630|NCT03131648|11924323|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
7429380|NCT01557166|11708907|FG001|Overall Study|Psychiatric disorder|0
7558631|NCT03131648|11924324|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
7558632|NCT03131648|11924325|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7558633|NCT03131648|11924326|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
7558634|NCT03131648|11924319|FG000|Maintenance Treatment Period|Completed Week 50|0
7558635|NCT03131648|11924320|FG001|Maintenance Treatment Period|Completed Week 50|0
7558636|NCT03131648|11924321|FG002|Maintenance Treatment Period|Completed Week 50|0
7558637|NCT03131648|11924322|FG003|Maintenance Treatment Period|Completed Week 50|0
7558638|NCT03131648|11924323|FG004|Maintenance Treatment Period|Completed Week 50|1
7429381|NCT01557166|11708906|FG000|Overall Study|Unclassified|2
7429382|NCT01557166|11708907|FG001|Overall Study|Unclassified|5
7429383|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7429384|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7429385|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7429386|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7429387|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7429388|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
7429389|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
7429390|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
7429391|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7429392|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
7429393|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7429394|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7429395|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7429396|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
7429397|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
7429398|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429399|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429400|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429401|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429402|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429403|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
7429404|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
7429405|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7429406|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7429407|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7429408|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7429409|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
7429410|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
7429411|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429412|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
7429413|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429414|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429415|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429416|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429417|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
7429418|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7429419|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7429420|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7429421|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7429422|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
7429423|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7429424|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
7429425|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7429426|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7429427|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7429428|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7429429|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7429430|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
7429431|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
7558639|NCT03131648|11924324|FG005|Maintenance Treatment Period|Completed Week 50|0
7429432|NCT01557244|11708918|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
7429433|NCT01557244|11708919|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
7429434|NCT01557244|11708920|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
7429435|NCT01557244|11708921|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
7429436|NCT01557244|11708922|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
7429437|NCT01557244|11708923|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
7429438|NCT01557244|11708924|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
7429439|NCT01557244|11708918|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
7429440|NCT01557244|11708919|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
7429441|NCT01557244|11708920|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
7429442|NCT01557244|11708921|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
7429443|NCT01557244|11708922|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
7429444|NCT01557244|11708923|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
7429445|NCT01557244|11708924|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
7429446|NCT01557244|11708918|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7429447|NCT01557244|11708919|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
7429448|NCT01557244|11708920|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7429449|NCT01557244|11708921|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7429450|NCT01557244|11708922|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7429451|NCT01557244|11708923|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7429452|NCT01557244|11708924|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
7429453|NCT01557244|11708918|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429454|NCT01557244|11708919|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429455|NCT01557244|11708920|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429456|NCT01557244|11708921|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
7429457|NCT01557244|11708922|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429458|NCT01557244|11708923|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429459|NCT01557244|11708924|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
7429460|NCT01557244|11708918|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
7429461|NCT01557244|11708919|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
7429462|NCT01557244|11708920|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7429463|NCT01557244|11708921|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7429464|NCT01557244|11708922|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7429465|NCT01557244|11708923|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7429466|NCT01557244|11708924|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
7429467|NCT01557283|11708952|FG000|Overall Study|Lost to Follow-up|7
7429468|NCT01557283|11708952|FG000|Overall Study|Non-responder|19
7429469|NCT01557283|11708952|FG000|Overall Study|Adverse Event|7
7429470|NCT01557283|11708952|FG000|Overall Study|Lack of Efficacy|1
7429471|NCT01557283|11708952|FG000|Overall Study|Non-compliance|1
7429472|NCT01557283|11708952|FG000|Overall Study|Withdrawal by Subject|1
7429473|NCT01557283|11708952|FG000|Overall Study|Participant's weight too high for dose|1
7429474|NCT01557283|11708952|FG000|Overall Study|Worsening of psoriasis|1
7429475|NCT01557283|11708952|FG000|Overall Study|Other|6
7429476|NCT01557348|11708967|FG000|Overall Study|Adverse Event|6
7429477|NCT01557348|11708968|FG001|Overall Study|Adverse Event|16
7429478|NCT01557348|11708967|FG000|Overall Study|Infusion reaction event|5
7429479|NCT01557348|11708968|FG001|Overall Study|Infusion reaction event|5
7429480|NCT01557348|11708967|FG000|Overall Study|Death|7
7429481|NCT01557348|11708968|FG001|Overall Study|Death|4
7429482|NCT01557348|11708967|FG000|Overall Study|Insufficient Therapeutic Response|13
7429483|NCT01557348|11708968|FG001|Overall Study|Insufficient Therapeutic Response|28
7429484|NCT01557348|11708967|FG000|Overall Study|Withdrawal by Subject|5
7429485|NCT01557348|11708968|FG001|Overall Study|Withdrawal by Subject|4
7429486|NCT01557348|11708967|FG000|Overall Study|Lost to Follow-up|26
7429487|NCT01557348|11708968|FG001|Overall Study|Lost to Follow-up|22
7429488|NCT01557348|11708967|FG000|Overall Study|Administrative|18
7429489|NCT01557348|11708968|FG001|Overall Study|Administrative|11
7429490|NCT01557400|11708975|FG000|Overall Study|Transitioned to Commercial Drug Product|40
7429491|NCT01557400|11708975|FG000|Overall Study|Adverse Event|3
7429492|NCT01557400|11708975|FG000|Overall Study|Lost to Follow-up|5
7429493|NCT01557400|11708975|FG000|Overall Study|Withdrawal by Subject|9
7429494|NCT01557504|11708986|FG000|Overall Study|Physician Decision|1
7429495|NCT01557504|11708987|FG001|Overall Study|Physician Decision|0
7429496|NCT01557517|11709001|FG000|Overall Study|Death|1
7429497|NCT01557517|11709002|FG001|Overall Study|Death|0
7429498|NCT01557517|11709001|FG000|Overall Study|Refused further treatment|0
7429499|NCT01557517|11709002|FG001|Overall Study|Refused further treatment|2
7429500|NCT01557517|11709001|FG000|Overall Study|Adverse Event|0
7429501|NCT01557517|11709002|FG001|Overall Study|Adverse Event|2
7429502|NCT01557517|11709001|FG000|Overall Study|Pt declined before treatment started|1
7429503|NCT01557517|11709002|FG001|Overall Study|Pt declined before treatment started|0
7429504|NCT01557569|11709017|FG000|Overall Study|Adverse Event|2
7429505|NCT01557569|11709018|FG001|Overall Study|Adverse Event|0
7429506|NCT01557569|11709017|FG000|Overall Study|high blood pressure|0
7429507|NCT01557569|11709018|FG001|Overall Study|high blood pressure|1
7429508|NCT01557569|11709017|FG000|Overall Study|Withdrawal by Subject|3
7429509|NCT01557569|11709018|FG001|Overall Study|Withdrawal by Subject|5
7429510|NCT01557569|11709017|FG000|Overall Study|noncompliance with rules of residential|0
7429511|NCT01557569|11709018|FG001|Overall Study|noncompliance with rules of residential|1
7429512|NCT01557582|11709024|FG000|Overall Study|Protocol Violation|4
7429513|NCT01557582|11709024|FG000|Overall Study|Operator error|2
7429514|NCT01557842|11709054|FG000|Overall Study|Lost to Follow-up|0
7429515|NCT01557842|11709055|FG001|Overall Study|Lost to Follow-up|1
7429516|NCT01557842|11709054|FG000|Overall Study|Death|1
7429517|NCT01557842|11709055|FG001|Overall Study|Death|0
7429518|NCT01557842|11709054|FG000|Overall Study|Lack of Efficacy|0
7429519|NCT01557842|11709055|FG001|Overall Study|Lack of Efficacy|1
7429520|NCT01557842|11709054|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
7429521|NCT01557842|11709055|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
7429522|NCT01557842|11709054|FG000|Overall Study|Study Terminated by Sponsor|3
7429523|NCT01557842|11709055|FG001|Overall Study|Study Terminated by Sponsor|4
7429524|NCT01557842|11709054|FG000|Overall Study|Not Ablated|2
7429525|NCT01557842|11709055|FG001|Overall Study|Not Ablated|0
7429526|NCT01557920|11709080|FG000|Overall Study|Withdrawal by Subject|2
7429527|NCT01557920|11709081|FG001|Overall Study|Withdrawal by Subject|3
7429528|NCT01557920|11709080|FG000|Overall Study|Lack of Efficacy|1
7429529|NCT01557920|11709081|FG001|Overall Study|Lack of Efficacy|0
7429530|NCT01557946|11709116|FG000|Overall Study|Adverse Event|3
7429531|NCT01557946|11709117|FG001|Overall Study|Adverse Event|0
7429532|NCT01558089|11709148|FG000|Overall Study|Adverse Event|1
7429533|NCT01558089|11709148|FG000|Overall Study|Lack of Efficacy|1
7429534|NCT01558089|11709148|FG000|Overall Study|Lost to Follow-up|5
7429535|NCT01558089|11709148|FG000|Overall Study|Withdrawal by Subject|6
7429536|NCT01558271|11709159|FG000|Overall Study|Adverse Event|6
7429537|NCT01558271|11709160|FG001|Overall Study|Adverse Event|3
7429538|NCT01558271|11709161|FG002|Overall Study|Adverse Event|4
7429539|NCT01558271|11709159|FG000|Overall Study|Lost to Follow-up|1
7429540|NCT01558271|11709160|FG001|Overall Study|Lost to Follow-up|0
7429541|NCT01558271|11709161|FG002|Overall Study|Lost to Follow-up|0
7429542|NCT01558271|11709159|FG000|Overall Study|Protocol Violation|1
7429543|NCT01558271|11709160|FG001|Overall Study|Protocol Violation|0
7429544|NCT01558271|11709161|FG002|Overall Study|Protocol Violation|0
7429545|NCT01558271|11709159|FG000|Overall Study|Withdrawal by Subject|10
7429546|NCT01558271|11709160|FG001|Overall Study|Withdrawal by Subject|6
7429547|NCT01558271|11709161|FG002|Overall Study|Withdrawal by Subject|12
7429548|NCT01558271|11709159|FG000|Overall Study|Physician Decision|0
7429549|NCT01558271|11709160|FG001|Overall Study|Physician Decision|2
7429550|NCT01558271|11709161|FG002|Overall Study|Physician Decision|1
7429551|NCT01558297|11709176|FG000|Overall Study|Withdrawal by Subject|2
7532224|NCT02669017|11877825|FG002|Overall Study|Withdrawal by Subject|0
7429552|NCT01558297|11709177|FG001|Overall Study|Withdrawal by Subject|2
7429553|NCT01558297|11709178|FG002|Overall Study|Withdrawal by Subject|1
7429554|NCT01558596|11709188|FG000|Overall Study|Withdrawal by Subject|1
7429555|NCT01558596|11709189|FG001|Overall Study|Withdrawal by Subject|0
7429556|NCT01558596|11709188|FG000|Overall Study|surgery elsewhere or cancelled|1
7429557|NCT01558596|11709189|FG001|Overall Study|surgery elsewhere or cancelled|1
7429558|NCT01558596|11709188|FG000|Overall Study|Protocol Violation|1
7429559|NCT01558596|11709189|FG001|Overall Study|Protocol Violation|0
7429560|NCT01558635|11709195|FG000|Overall Study|Death|1
7429561|NCT01558635|11709195|FG000|Overall Study|Withdrawal by Subject|2
7429562|NCT01558635|11709195|FG000|Overall Study|Physician Decision|1
7429563|NCT01558635|11709195|FG000|Overall Study|Subject received other treatment|1
7429564|NCT01558635|11709195|FG000|Overall Study|Reveal XT was explanted|1
7466968|NCT01896193|11767086|FG001|Overall Study|Lack of Efficacy|11
7466969|NCT01896193|11767085|FG000|Overall Study|Protocol Violation|0
7466970|NCT01896193|11767086|FG001|Overall Study|Protocol Violation|1
7466971|NCT01896193|11767085|FG000|Overall Study|Withdrew Consent|1
7466972|NCT01896193|11767086|FG001|Overall Study|Withdrew Consent|0
7466973|NCT01896232|11767100|FG000|Overall Study|Death|6
7466974|NCT01896232|11767101|FG001|Overall Study|Death|10
7466975|NCT01896232|11767100|FG000|Overall Study|Withdrawal by Subject|32
7466976|NCT01896232|11767101|FG001|Overall Study|Withdrawal by Subject|31
7466977|NCT01896232|11767100|FG000|Overall Study|Sponsor Decision|2
7466978|NCT01896232|11767101|FG001|Overall Study|Sponsor Decision|0
7466979|NCT01896232|11767100|FG000|Overall Study|Lost to Follow-up|9
7466980|NCT01896232|11767101|FG001|Overall Study|Lost to Follow-up|12
7466981|NCT01896271|11767107|FG000|Overall Study|Physician Decision|10
7466982|NCT01896297|11767111|FG000|Overall Study|Died in post treatment phase|1
7466983|NCT01896557|11767133|FG000|Clopidogrel Alone|Adverse Event|1
7466984|NCT01896557|11767134|FG001|Clopidogrel Alone|Adverse Event|0
7466985|NCT01896557|11767133|FG000|Clopidogrel + GI Protector|low adherence|1
7466986|NCT01896557|11767134|FG001|Clopidogrel + GI Protector|low adherence|1
7466987|NCT01896557|11767133|FG000|Clopidogrel + GI Protector|Reading error|1
7466988|NCT01896557|11767134|FG001|Clopidogrel + GI Protector|Reading error|3
7466989|NCT01896700|11767151|FG000|Overall Study|Adverse Event|4
7466990|NCT01896700|11767152|FG001|Overall Study|Adverse Event|5
7466991|NCT01896700|11767151|FG000|Overall Study|Withdrawal by Subject|0
7466992|NCT01896700|11767152|FG001|Overall Study|Withdrawal by Subject|1
7466993|NCT01896726|11767158|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
7429565|NCT01558674|11709212|FG000|Part 1|Study Terminated by Sponsor|10
7429566|NCT01558674|11709213|FG001|Part 1|Study Terminated by Sponsor|0
7429567|NCT01558674|11709212|FG000|Part 1|Withdrawal by Subject|1
7429568|NCT01558674|11709213|FG001|Part 1|Withdrawal by Subject|0
7429569|NCT01558739|11709241|FG000|Overall Study|Adverse Event|7
7429570|NCT01558739|11709241|FG000|Overall Study|Withdrawal by Subject|2
7429571|NCT01558739|11709241|FG000|Overall Study|Death|3
7429572|NCT01558739|11709241|FG000|Overall Study|Disease Progression|4
7429573|NCT01558739|11709241|FG000|Overall Study|Protocol Violation|1
7429574|NCT01558752|11709247|FG000|Overall Study|Physician Decision|2
7429575|NCT01558752|11709248|FG001|Overall Study|Physician Decision|0
7429576|NCT01559012|11709267|FG000|Overall Study|Withdrawal by Subject|0
7429577|NCT01559012|11709268|FG001|Overall Study|Withdrawal by Subject|1
7429578|NCT01559090|11709305|FG000|Stage I|Withdrawal by Subject|2
7429579|NCT01559090|11709306|FG001|Stage I|Withdrawal by Subject|2
7429580|NCT01559090|11709307|FG002|Stage I|Withdrawal by Subject|3
7429581|NCT01559090|11709305|FG000|Stage II|Withdrawal by Subject|1
7429582|NCT01559090|11709306|FG001|Stage II|Withdrawal by Subject|0
7429583|NCT01559090|11709307|FG002|Stage II|Withdrawal by Subject|0
7429584|NCT01559116|11709315|FG000|Overall Study|Adverse Event|10
7429585|NCT01559116|11709315|FG000|Overall Study|Lack of Efficacy|1
7328481|NCT00796653|11561470|FG000|Overall Study|Other reason not described above|4
7328482|NCT00796653|11561471|FG001|Overall Study|Other reason not described above|9
7429586|NCT01559116|11709315|FG000|Overall Study|Lost to Follow-up|1
7429587|NCT01559116|11709315|FG000|Overall Study|Protocol Violation|1
7532225|NCT02669017|11877826|FG003|Overall Study|Withdrawal by Subject|1
7532226|NCT02669017|11877827|FG004|Overall Study|Withdrawal by Subject|2
7532227|NCT02669017|11877828|FG005|Overall Study|Withdrawal by Subject|0
7532228|NCT02669017|11877829|FG006|Overall Study|Withdrawal by Subject|0
7532229|NCT02669017|11877830|FG007|Overall Study|Withdrawal by Subject|2
7532230|NCT02669017|11877831|FG008|Overall Study|Withdrawal by Subject|2
7532231|NCT02669017|11877823|FG000|Overall Study|Lost to Follow-up|0
7532232|NCT02669017|11877824|FG001|Overall Study|Lost to Follow-up|0
7532233|NCT02669017|11877825|FG002|Overall Study|Lost to Follow-up|0
7532234|NCT02669017|11877826|FG003|Overall Study|Lost to Follow-up|0
7429588|NCT01559116|11709315|FG000|Overall Study|Withdrawal by Subject|4
7429589|NCT01559116|11709315|FG000|Overall Study|other than stated above|9
7429590|NCT01559129|11709334|FG000|Treatment Phase|Adverse Event|0
7429591|NCT01559129|11709335|FG001|Treatment Phase|Adverse Event|2
7429592|NCT01559129|11709334|FG000|Treatment Phase|Progressive Disease|1
7429593|NCT01559129|11709335|FG001|Treatment Phase|Progressive Disease|1
7429594|NCT01559129|11709334|FG000|Treatment Phase|Lack of Efficacy|0
7429595|NCT01559129|11709335|FG001|Treatment Phase|Lack of Efficacy|1
7429596|NCT01559129|11709334|FG000|Treatment Phase|Study Terminated by Sponsor|3
7429597|NCT01559129|11709335|FG001|Treatment Phase|Study Terminated by Sponsor|2
7532235|NCT02669017|11877827|FG004|Overall Study|Lost to Follow-up|0
7532236|NCT02669017|11877828|FG005|Overall Study|Lost to Follow-up|0
7532237|NCT02669017|11877829|FG006|Overall Study|Lost to Follow-up|0
7532238|NCT02669017|11877830|FG007|Overall Study|Lost to Follow-up|0
7532239|NCT02669017|11877831|FG008|Overall Study|Lost to Follow-up|1
7532240|NCT02669017|11877823|FG000|Overall Study|Miscellaneous|0
7328483|NCT00796653|11561472|FG002|Overall Study|Other reason not described above|7
7328484|NCT00796653|11561473|FG003|Overall Study|Other reason not described above|4
7328485|NCT00796666|11561493|FG000|Overall Study|Death|2
7328486|NCT00796666|11561494|FG001|Overall Study|Death|4
7328487|NCT00796666|11561493|FG000|Overall Study|Withdrawal by Subject|2
7328488|NCT00796666|11561494|FG001|Overall Study|Withdrawal by Subject|0
7328489|NCT00796666|11561493|FG000|Overall Study|Adverse Event|7
7328490|NCT00796666|11561494|FG001|Overall Study|Adverse Event|5
7328491|NCT00796666|11561493|FG000|Overall Study|Protocol Violation|1
7328492|NCT00796666|11561494|FG001|Overall Study|Protocol Violation|0
7328493|NCT00796666|11561493|FG000|Overall Study|Other|1
7328494|NCT00796666|11561494|FG001|Overall Study|Other|0
7328495|NCT00796666|11561493|FG000|Overall Study|Terminated by sponsor|53
7328496|NCT00796666|11561494|FG001|Overall Study|Terminated by sponsor|55
7328497|NCT00796666|11561493|FG000|Overall Study|Randomized and not treated|1
7328498|NCT00796666|11561494|FG001|Overall Study|Randomized and not treated|0
7328499|NCT00796718|11561519|FG000|Overall Study|Adverse Event|2
7328500|NCT00796718|11561519|FG000|Overall Study|Exclusion Criteria|1
7328501|NCT00796718|11561519|FG000|Overall Study|Lost to Follow-up|5
7328502|NCT00796718|11561519|FG000|Overall Study|Withdrawal by Informed Consent|1
7328503|NCT00796757|11561538|FG000|Overall Study|Withdrawal by Subject|14
7429598|NCT01559129|11709334|FG000|Treatment Phase|Protocol Exclusion Criteria|1
7429599|NCT01559129|11709335|FG001|Treatment Phase|Protocol Exclusion Criteria|0
7429600|NCT01559129|11709334|FG000|Treatment Phase|Did Not Receive Study Drug|0
7429601|NCT01559129|11709335|FG001|Treatment Phase|Did Not Receive Study Drug|1
7532241|NCT02669017|11877824|FG001|Overall Study|Miscellaneous|0
7429602|NCT01559129|11709334|FG000|Open-label Extension Period|Adverse Event|1
7429603|NCT01559129|11709335|FG001|Open-label Extension Period|Adverse Event|0
7429604|NCT01559129|11709334|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
7532242|NCT02669017|11877825|FG002|Overall Study|Miscellaneous|0
7532243|NCT02669017|11877826|FG003|Overall Study|Miscellaneous|0
7532244|NCT02669017|11877827|FG004|Overall Study|Miscellaneous|2
7429605|NCT01559129|11709335|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
7429606|NCT01559259|11709352|FG000|Overall Study|Withdrawal by Subject|0
7429607|NCT01559259|11709353|FG001|Overall Study|Withdrawal by Subject|0
7429608|NCT01559259|11709354|FG002|Overall Study|Withdrawal by Subject|0
7429609|NCT01559259|11709355|FG003|Overall Study|Withdrawal by Subject|1
7429610|NCT01559259|11709356|FG004|Overall Study|Withdrawal by Subject|0
7429611|NCT01559259|11709352|FG000|Overall Study|Adverse Event|0
7429612|NCT01559259|11709353|FG001|Overall Study|Adverse Event|1
7429613|NCT01559259|11709354|FG002|Overall Study|Adverse Event|1
7429614|NCT01559259|11709355|FG003|Overall Study|Adverse Event|0
7429615|NCT01559259|11709356|FG004|Overall Study|Adverse Event|0
7429616|NCT01559311|11709371|FG000|Overall Study|Protocol Violation|0
7429617|NCT01559311|11709372|FG001|Overall Study|Protocol Violation|0
7429618|NCT01559311|11709373|FG002|Overall Study|Protocol Violation|2
7429619|NCT01559311|11709371|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
7429620|NCT01559311|11709372|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
7429621|NCT01559311|11709373|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
7429622|NCT01559311|11709371|FG000|Overall Study|Withdrawal by Subject|2
7429623|NCT01559311|11709372|FG001|Overall Study|Withdrawal by Subject|1
7429624|NCT01559311|11709373|FG002|Overall Study|Withdrawal by Subject|0
7429625|NCT01559311|11709371|FG000|Overall Study|Death|0
7429626|NCT01559311|11709372|FG001|Overall Study|Death|2
7429627|NCT01559311|11709373|FG002|Overall Study|Death|3
7429628|NCT01559311|11709371|FG000|Overall Study|Lost to Follow-up|0
7429629|NCT01559311|11709372|FG001|Overall Study|Lost to Follow-up|3
7429630|NCT01559311|11709373|FG002|Overall Study|Lost to Follow-up|2
7429631|NCT01559311|11709371|FG000|Overall Study|Adverse Event|0
7429632|NCT01559311|11709372|FG001|Overall Study|Adverse Event|0
7429633|NCT01559311|11709373|FG002|Overall Study|Adverse Event|1
7429634|NCT01559389|11709383|FG000|Overall Study|Withdrawal by Subject|20
7429635|NCT01559389|11709384|FG001|Overall Study|Withdrawal by Subject|20
7429636|NCT01559454|11709396|FG000|Overall Study|Lost to Follow-up|3
7429637|NCT01559454|11709397|FG001|Overall Study|Lost to Follow-up|2
7429638|NCT01559454|11709396|FG000|Overall Study|Withdrawal by Subject|0
7429639|NCT01559454|11709397|FG001|Overall Study|Withdrawal by Subject|1
7429640|NCT01559454|11709396|FG000|Overall Study|Physician Decision|0
7429641|NCT01559454|11709397|FG001|Overall Study|Physician Decision|1
7429642|NCT01559454|11709396|FG000|Overall Study|Protocol Violation|0
7429643|NCT01559454|11709397|FG001|Overall Study|Protocol Violation|1
7429644|NCT01559454|11709396|FG000|Overall Study|Lack of Efficacy|0
7429645|NCT01559454|11709397|FG001|Overall Study|Lack of Efficacy|1
7429646|NCT01559675|11709424|FG000|Overall Study|Protocol Violation|1
7429647|NCT01559675|11709425|FG001|Overall Study|Protocol Violation|2
7429648|NCT01559675|11709424|FG000|Overall Study|2nd operation on same patient excluded|14
7429649|NCT01559675|11709425|FG001|Overall Study|2nd operation on same patient excluded|12
7429650|NCT01559844|11709431|FG000|Overall Study|Consent Withdrawn|7
7429651|NCT01559844|11709431|FG000|Overall Study|Death|5
7429652|NCT01559844|11709431|FG000|Overall Study|Efficacy Failure|10
7429653|NCT01559844|11709431|FG000|Overall Study|No Longer A Transplant Candidate|3
7429654|NCT01560234|11709480|FG000|Overall Study|Lost to Follow-up|3
7429655|NCT01560234|11709481|FG001|Overall Study|Lost to Follow-up|0
7429656|NCT01560234|11709482|FG002|Overall Study|Lost to Follow-up|1
7429657|NCT01560234|11709483|FG003|Overall Study|Lost to Follow-up|0
7429658|NCT01560234|11709484|FG004|Overall Study|Lost to Follow-up|0
7429659|NCT01560234|11709485|FG005|Overall Study|Lost to Follow-up|2
7429660|NCT01560234|11709486|FG006|Overall Study|Lost to Follow-up|0
7429661|NCT01560234|11709487|FG007|Overall Study|Lost to Follow-up|2
7429662|NCT01560403|11709521|FG000|Overall Study|Lost to Follow-up|0
7429663|NCT01560403|11709522|FG001|Overall Study|Lost to Follow-up|1
7429664|NCT01560416|11709530|FG000|Randomized Phase|Crossover Participants|7
7429665|NCT01560416|11709531|FG001|Randomized Phase|Crossover Participants|0
7429666|NCT01560429|11709541|FG000|Overall Study|Protocol Violation|3
7429667|NCT01560429|11709542|FG001|Overall Study|Protocol Violation|6
7429668|NCT01560780|11709561|FG000|Overall Study|Death|2
7429669|NCT01560780|11709562|FG001|Overall Study|Death|1
7429670|NCT01560780|11709561|FG000|Overall Study|Patient Preference|11
7429671|NCT01560780|11709562|FG001|Overall Study|Patient Preference|11
7429672|NCT01560819|11709570|FG000|Overall Study|Physician Decision|1
7429673|NCT01560819|11709571|FG001|Overall Study|Physician Decision|0
7558640|NCT03131648|11924325|FG006|Maintenance Treatment Period|Completed Week 50|0
7429674|NCT01560871|11709577|FG000|Overall Study|transportation issues|2
7429675|NCT01560871|11709578|FG001|Overall Study|transportation issues|1
7429676|NCT01560871|11709577|FG000|Overall Study|relocation|1
7429677|NCT01560871|11709578|FG001|Overall Study|relocation|0
7429678|NCT01560871|11709577|FG000|Overall Study|readmission to a hospital|2
7429679|NCT01560871|11709578|FG001|Overall Study|readmission to a hospital|1
7429680|NCT01560871|11709577|FG000|Overall Study|Lost to Follow-up|1
7429681|NCT01560871|11709578|FG001|Overall Study|Lost to Follow-up|0
7429682|NCT01560949|11709594|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
7429683|NCT01560949|11709594|FG000|Surgery Phase|Physician Decision|3
7429684|NCT01560988|11709610|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
7429685|NCT01560988|11709611|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
7429686|NCT01560988|11709610|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
7429687|NCT01560988|11709611|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
7429688|NCT01560988|11709610|FG000|Washout (Six Weeks)|Lost to Follow-up|2
7429689|NCT01560988|11709611|FG001|Washout (Six Weeks)|Lost to Follow-up|2
7429690|NCT01561079|11709640|FG000|Overall Study|Physician Decision|17
7429691|NCT01561079|11709640|FG000|Overall Study|Withdrawal by Subject|59
7429692|NCT01561079|11709640|FG000|Overall Study|Protocol Violation|2
7429693|NCT01561300|11709683|FG000|Run in on Placebo|Adverse Event|1
7429694|NCT01561300|11709684|FG001|Run in on Placebo|Adverse Event|0
7429695|NCT01561313|11709693|FG000|Overall Study|Withdrawal by Subject|1
7429696|NCT01561313|11709694|FG001|Overall Study|Withdrawal by Subject|0
7429697|NCT01561313|11709693|FG000|Overall Study|Adverse event and withdrawal by subject|1
7429698|NCT01561313|11709694|FG001|Overall Study|Adverse event and withdrawal by subject|0
7429699|NCT01561560|11709709|FG000|First Two Weeks of Wear|Time/job conflict|0
7429700|NCT01561560|11709710|FG001|First Two Weeks of Wear|Time/job conflict|1
7429701|NCT01561560|11709709|FG000|First Two Weeks of Wear|Adverse Event|0
7429702|NCT01561560|11709710|FG001|First Two Weeks of Wear|Adverse Event|1
7429703|NCT01561560|11709709|FG000|Second Two Weeks of Wear|Adverse Event|0
7429704|NCT01561560|11709710|FG001|Second Two Weeks of Wear|Adverse Event|1
7429705|NCT01561755|11709752|FG000|Overall Study|Lost to Follow-up|0
7429706|NCT01561755|11709753|FG001|Overall Study|Lost to Follow-up|1
7429707|NCT01561898|11709767|FG000|Overall Study|Withdrawal by Subject|0
7429708|NCT01561898|11709768|FG001|Overall Study|Withdrawal by Subject|8
7429709|NCT01561898|11709769|FG002|Overall Study|Withdrawal by Subject|12
7429710|NCT01561898|11709770|FG003|Overall Study|Withdrawal by Subject|5
7429711|NCT01561898|11709767|FG000|Overall Study|Lack of Efficacy|0
7429712|NCT01561898|11709768|FG001|Overall Study|Lack of Efficacy|8
7429713|NCT01561898|11709769|FG002|Overall Study|Lack of Efficacy|10
7429714|NCT01561898|11709770|FG003|Overall Study|Lack of Efficacy|5
7429715|NCT01561898|11709767|FG000|Overall Study|Worsening of complications|0
7429716|NCT01561898|11709768|FG001|Overall Study|Worsening of complications|1
7429717|NCT01561898|11709769|FG002|Overall Study|Worsening of complications|0
7429718|NCT01561898|11709770|FG003|Overall Study|Worsening of complications|0
7429719|NCT01561898|11709767|FG000|Overall Study|Lost to Follow-up|0
7429720|NCT01561898|11709768|FG001|Overall Study|Lost to Follow-up|0
7429721|NCT01561898|11709769|FG002|Overall Study|Lost to Follow-up|1
7429722|NCT01561898|11709770|FG003|Overall Study|Lost to Follow-up|0
7429723|NCT01561898|11709767|FG000|Overall Study|Adverse Event|1
7429724|NCT01561898|11709768|FG001|Overall Study|Adverse Event|19
7429725|NCT01561898|11709769|FG002|Overall Study|Adverse Event|14
7429726|NCT01561898|11709770|FG003|Overall Study|Adverse Event|9
7429727|NCT01561898|11709767|FG000|Overall Study|Physician Decision|1
7429728|NCT01561898|11709768|FG001|Overall Study|Physician Decision|5
7429729|NCT01561898|11709769|FG002|Overall Study|Physician Decision|7
7429730|NCT01561898|11709770|FG003|Overall Study|Physician Decision|1
7429731|NCT01561963|11709778|FG000|Overall Study|Adverse Event|1
7429732|NCT01561976|11709793|FG000|Period 1|Adverse Event|0
7429733|NCT01561976|11709794|FG001|Period 1|Adverse Event|0
7429734|NCT01561976|11709795|FG002|Period 1|Adverse Event|1
7429735|NCT01561976|11709796|FG003|Period 1|Adverse Event|0
7429736|NCT01561976|11709797|FG004|Period 1|Adverse Event|0
7429737|NCT01561976|11709798|FG005|Period 1|Adverse Event|0
7429738|NCT01561976|11709793|FG000|Washout Period 1 (7 Days)|Adverse Event|0
7429739|NCT01561976|11709794|FG001|Washout Period 1 (7 Days)|Adverse Event|0
7429740|NCT01561976|11709795|FG002|Washout Period 1 (7 Days)|Adverse Event|0
7429741|NCT01561976|11709796|FG003|Washout Period 1 (7 Days)|Adverse Event|1
7429742|NCT01561976|11709797|FG004|Washout Period 1 (7 Days)|Adverse Event|0
7429743|NCT01561976|11709798|FG005|Washout Period 1 (7 Days)|Adverse Event|0
7429744|NCT01561976|11709793|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7429745|NCT01561976|11709794|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7429746|NCT01561976|11709795|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7429747|NCT01561976|11709796|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7429748|NCT01561976|11709797|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7429749|NCT01561976|11709798|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7429750|NCT01561976|11709793|FG000|Washout Period 2 (7 Days)|Non-compliance|1
7429751|NCT01561976|11709794|FG001|Washout Period 2 (7 Days)|Non-compliance|0
7429752|NCT01561976|11709795|FG002|Washout Period 2 (7 Days)|Non-compliance|1
7429753|NCT01561976|11709796|FG003|Washout Period 2 (7 Days)|Non-compliance|0
7429754|NCT01561976|11709797|FG004|Washout Period 2 (7 Days)|Non-compliance|0
7429755|NCT01561976|11709798|FG005|Washout Period 2 (7 Days)|Non-compliance|0
7429760|NCT01562275|11709841|FG000|Stage 1|Adverse Event|0
7429761|NCT01562275|11709842|FG001|Stage 1|Adverse Event|0
7429762|NCT01562275|11709843|FG002|Stage 1|Adverse Event|0
7429763|NCT01562275|11709844|FG003|Stage 1|Adverse Event|1
7429764|NCT01562275|11709845|FG004|Stage 1|Adverse Event|1
7532245|NCT02669017|11877828|FG005|Overall Study|Miscellaneous|1
7429765|NCT01562275|11709846|FG005|Stage 1|Adverse Event|0
7429766|NCT01562275|11709847|FG006|Stage 1|Adverse Event|0
7429767|NCT01562275|11709848|FG007|Stage 1|Adverse Event|0
7429768|NCT01562275|11709849|FG008|Stage 1|Adverse Event|0
7429769|NCT01562275|11709850|FG009|Stage 1|Adverse Event|1
7429770|NCT01562275|11709851|FG010|Stage 1|Adverse Event|0
7429771|NCT01562275|11709852|FG011|Stage 1|Adverse Event|0
7429772|NCT01562275|11709853|FG012|Stage 1|Adverse Event|0
7429773|NCT01562275|11709841|FG000|Stage 1|Death|1
7429774|NCT01562275|11709842|FG001|Stage 1|Death|0
7429775|NCT01562275|11709843|FG002|Stage 1|Death|0
7429776|NCT01562275|11709844|FG003|Stage 1|Death|0
7429777|NCT01562275|11709845|FG004|Stage 1|Death|0
7429778|NCT01562275|11709846|FG005|Stage 1|Death|0
7429779|NCT01562275|11709847|FG006|Stage 1|Death|0
7429780|NCT01562275|11709848|FG007|Stage 1|Death|0
7429781|NCT01562275|11709849|FG008|Stage 1|Death|0
7429782|NCT01562275|11709850|FG009|Stage 1|Death|0
7429783|NCT01562275|11709851|FG010|Stage 1|Death|0
7429784|NCT01562275|11709852|FG011|Stage 1|Death|0
7429785|NCT01562275|11709853|FG012|Stage 1|Death|0
7429786|NCT01562275|11709841|FG000|Stage 1|Non Compliance|0
7429787|NCT01562275|11709842|FG001|Stage 1|Non Compliance|0
7429788|NCT01562275|11709843|FG002|Stage 1|Non Compliance|1
7429789|NCT01562275|11709844|FG003|Stage 1|Non Compliance|0
7429790|NCT01562275|11709845|FG004|Stage 1|Non Compliance|0
7429791|NCT01562275|11709846|FG005|Stage 1|Non Compliance|0
7429792|NCT01562275|11709847|FG006|Stage 1|Non Compliance|0
7429793|NCT01562275|11709848|FG007|Stage 1|Non Compliance|0
7558641|NCT03131648|11924326|FG007|Maintenance Treatment Period|Completed Week 50|0
7558642|NCT03131648|11924319|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
7558643|NCT03131648|11924320|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
7558644|NCT03131648|11924321|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
7558645|NCT03131648|11924322|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
7558646|NCT03131648|11924323|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
7558647|NCT03131648|11924324|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
7558648|NCT03131648|11924325|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
7429794|NCT01562275|11709849|FG008|Stage 1|Non Compliance|0
7429795|NCT01562275|11709850|FG009|Stage 1|Non Compliance|0
7429796|NCT01562275|11709851|FG010|Stage 1|Non Compliance|0
7429797|NCT01562275|11709852|FG011|Stage 1|Non Compliance|0
7429798|NCT01562275|11709853|FG012|Stage 1|Non Compliance|0
7429799|NCT01562275|11709841|FG000|Stage 1|Physician Decision|0
7429800|NCT01562275|11709842|FG001|Stage 1|Physician Decision|0
7429801|NCT01562275|11709843|FG002|Stage 1|Physician Decision|0
7429802|NCT01562275|11709844|FG003|Stage 1|Physician Decision|0
7429803|NCT01562275|11709845|FG004|Stage 1|Physician Decision|1
7429804|NCT01562275|11709846|FG005|Stage 1|Physician Decision|0
7429805|NCT01562275|11709847|FG006|Stage 1|Physician Decision|1
7429806|NCT01562275|11709848|FG007|Stage 1|Physician Decision|0
7429807|NCT01562275|11709849|FG008|Stage 1|Physician Decision|1
7429808|NCT01562275|11709850|FG009|Stage 1|Physician Decision|0
7429809|NCT01562275|11709851|FG010|Stage 1|Physician Decision|0
7429810|NCT01562275|11709852|FG011|Stage 1|Physician Decision|0
7429811|NCT01562275|11709853|FG012|Stage 1|Physician Decision|0
7429812|NCT01562275|11709841|FG000|Stage 1|Progression of Disease|2
7429813|NCT01562275|11709842|FG001|Stage 1|Progression of Disease|6
7429814|NCT01562275|11709843|FG002|Stage 1|Progression of Disease|2
7429815|NCT01562275|11709844|FG003|Stage 1|Progression of Disease|1
7429816|NCT01562275|11709845|FG004|Stage 1|Progression of Disease|2
7429817|NCT01562275|11709846|FG005|Stage 1|Progression of Disease|4
7429818|NCT01562275|11709847|FG006|Stage 1|Progression of Disease|1
7429819|NCT01562275|11709848|FG007|Stage 1|Progression of Disease|7
7429820|NCT01562275|11709849|FG008|Stage 1|Progression of Disease|2
7429821|NCT01562275|11709850|FG009|Stage 1|Progression of Disease|5
7429822|NCT01562275|11709851|FG010|Stage 1|Progression of Disease|3
7429823|NCT01562275|11709852|FG011|Stage 1|Progression of Disease|0
7429824|NCT01562275|11709853|FG012|Stage 1|Progression of Disease|0
7429825|NCT01562275|11709841|FG000|Stage 1|Withdrawal by Subject|0
7429826|NCT01562275|11709842|FG001|Stage 1|Withdrawal by Subject|1
7429827|NCT01562275|11709843|FG002|Stage 1|Withdrawal by Subject|0
7429828|NCT01562275|11709844|FG003|Stage 1|Withdrawal by Subject|2
7429829|NCT01562275|11709845|FG004|Stage 1|Withdrawal by Subject|0
7429830|NCT01562275|11709846|FG005|Stage 1|Withdrawal by Subject|0
7429831|NCT01562275|11709847|FG006|Stage 1|Withdrawal by Subject|1
7429832|NCT01562275|11709848|FG007|Stage 1|Withdrawal by Subject|0
7429833|NCT01562275|11709849|FG008|Stage 1|Withdrawal by Subject|0
7429834|NCT01562275|11709850|FG009|Stage 1|Withdrawal by Subject|1
7429835|NCT01562275|11709851|FG010|Stage 1|Withdrawal by Subject|0
7429836|NCT01562275|11709852|FG011|Stage 1|Withdrawal by Subject|0
7429837|NCT01562275|11709853|FG012|Stage 1|Withdrawal by Subject|0
7429838|NCT01562275|11709841|FG000|Stage 2|Death|0
7429839|NCT01562275|11709842|FG001|Stage 2|Death|0
7429840|NCT01562275|11709843|FG002|Stage 2|Death|0
7558649|NCT03131648|11924326|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
7429841|NCT01562275|11709844|FG003|Stage 2|Death|0
7558650|NCT03131687|11924349|FG000|Overall Study|Adverse Event|0
7558651|NCT03131687|11924350|FG001|Overall Study|Adverse Event|1
7429842|NCT01562275|11709845|FG004|Stage 2|Death|0
7429843|NCT01562275|11709846|FG005|Stage 2|Death|0
7429844|NCT01562275|11709847|FG006|Stage 2|Death|0
7429845|NCT01562275|11709848|FG007|Stage 2|Death|0
7429846|NCT01562275|11709849|FG008|Stage 2|Death|0
7429847|NCT01562275|11709850|FG009|Stage 2|Death|0
7429848|NCT01562275|11709851|FG010|Stage 2|Death|0
7429849|NCT01562275|11709852|FG011|Stage 2|Death|2
7429850|NCT01562275|11709853|FG012|Stage 2|Death|1
7429851|NCT01562275|11709841|FG000|Stage 2|Progression of Disease|0
7429852|NCT01562275|11709842|FG001|Stage 2|Progression of Disease|0
7558652|NCT03131687|11924351|FG002|Overall Study|Adverse Event|0
7558653|NCT03131687|11924352|FG003|Overall Study|Adverse Event|1
7558654|NCT03131687|11924353|FG004|Overall Study|Adverse Event|2
7558655|NCT03131687|11924354|FG005|Overall Study|Adverse Event|2
7558656|NCT03131687|11924349|FG000|Overall Study|Death|1
7429853|NCT01562275|11709843|FG002|Stage 2|Progression of Disease|0
7429854|NCT01562275|11709844|FG003|Stage 2|Progression of Disease|0
7429855|NCT01562275|11709845|FG004|Stage 2|Progression of Disease|0
7429856|NCT01562275|11709846|FG005|Stage 2|Progression of Disease|0
7429857|NCT01562275|11709847|FG006|Stage 2|Progression of Disease|0
7429858|NCT01562275|11709848|FG007|Stage 2|Progression of Disease|0
7429859|NCT01562275|11709849|FG008|Stage 2|Progression of Disease|0
7429860|NCT01562275|11709850|FG009|Stage 2|Progression of Disease|0
7429861|NCT01562275|11709851|FG010|Stage 2|Progression of Disease|0
7429862|NCT01562275|11709852|FG011|Stage 2|Progression of Disease|12
7429863|NCT01562275|11709853|FG012|Stage 2|Progression of Disease|4
7429864|NCT01562314|11709885|FG000|Overall Study|Adverse Event|10
7429865|NCT01562314|11709886|FG001|Overall Study|Adverse Event|5
7429866|NCT01562314|11709885|FG000|Overall Study|Met Withdrawal Criteria|3
7429867|NCT01562314|11709886|FG001|Overall Study|Met Withdrawal Criteria|2
7429868|NCT01562314|11709885|FG000|Overall Study|Withdrawal by Subject|0
7429869|NCT01562314|11709886|FG001|Overall Study|Withdrawal by Subject|1
7429870|NCT01562327|11709892|FG000|Overall Study|Adverse Event|2
7429871|NCT01562327|11709892|FG000|Overall Study|Lack of Efficacy|1
7429872|NCT01562327|11709892|FG000|Overall Study|Participant drop-out|1
7429873|NCT01562327|11709892|FG000|Overall Study|Infusion not received at 6 month window|4
7429874|NCT01562444|11709921|FG000|Overall Study|Did not meet entry criteria|2
7429875|NCT01562444|11709922|FG001|Overall Study|Did not meet entry criteria|0
7429876|NCT01562444|11709923|FG002|Overall Study|Did not meet entry criteria|3
7429877|NCT01562444|11709921|FG000|Overall Study|Did not comply with blood draw schedule|1
7429878|NCT01562444|11709922|FG001|Overall Study|Did not comply with blood draw schedule|0
7429879|NCT01562444|11709923|FG002|Overall Study|Did not comply with blood draw schedule|1
7429880|NCT01562444|11709921|FG000|Overall Study|Unavailable serological results|0
7429881|NCT01562444|11709922|FG001|Overall Study|Unavailable serological results|2
7429882|NCT01562444|11709923|FG002|Overall Study|Unavailable serological results|2
7429883|NCT01562444|11709921|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
7429884|NCT01562444|11709922|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
7429885|NCT01562444|11709923|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
7429886|NCT01562444|11709921|FG000|Overall Study|Protocol forbidden medication|1
7429887|NCT01562444|11709922|FG001|Overall Study|Protocol forbidden medication|0
7429888|NCT01562444|11709923|FG002|Overall Study|Protocol forbidden medication|0
7429889|NCT01562548|11709935|FG000|Overall Study|Lost to Follow-up|0
7429890|NCT01562548|11709936|FG001|Overall Study|Lost to Follow-up|0
7429891|NCT01562548|11709937|FG002|Overall Study|Lost to Follow-up|1
7429892|NCT01562548|11709938|FG003|Overall Study|Lost to Follow-up|0
7429893|NCT01562613|11709950|FG000|Overall Study|Lost to Follow-up|2
7429894|NCT01562613|11709950|FG000|Overall Study|Withdrawal by Subject|2
7429895|NCT01562743|11709963|FG000|Overall Study|Adverse Event|29
7429896|NCT01562743|11709963|FG000|Overall Study|Lack of Efficacy|3
7429897|NCT01562743|11709963|FG000|Overall Study|Withdrawal by Subject|13
7429898|NCT01562743|11709963|FG000|Overall Study|Protocol Violation|1
7429899|NCT01562743|11709963|FG000|Overall Study|Discontinuation criteria|2
7429900|NCT01562743|11709963|FG000|Overall Study|Lost to Follow-up|2
7429901|NCT01562743|11709963|FG000|Overall Study|Physician Decision|2
7429902|NCT01562782|11709973|FG000|Overall Study|Withdrawal by Subject|3
7429903|NCT01562782|11709974|FG001|Overall Study|Withdrawal by Subject|3
7429904|NCT01562782|11709973|FG000|Overall Study|screen failure|1
7429905|NCT01562782|11709974|FG001|Overall Study|screen failure|2
7429906|NCT01562873|11709980|FG000|Overall Study|Disease Progression per RECIST|10
7429907|NCT01562873|11709981|FG001|Overall Study|Disease Progression per RECIST|0
7429908|NCT01562873|11709980|FG000|Overall Study|Adverse Event|1
7429909|NCT01562873|11709981|FG001|Overall Study|Adverse Event|0
7429910|NCT01562873|11709980|FG000|Overall Study|Clinical Disease Progression|9
7429911|NCT01562873|11709981|FG001|Overall Study|Clinical Disease Progression|0
7429912|NCT01562873|11709980|FG000|Overall Study|Clinical PD and adverse event|1
7429913|NCT01562873|11709981|FG001|Overall Study|Clinical PD and adverse event|0
7429914|NCT01563029|11710003|FG000|Overall Study|Adverse Event|1
7429915|NCT01563029|11710004|FG001|Overall Study|Adverse Event|0
7429916|NCT01563029|11710005|FG002|Overall Study|Adverse Event|1
7429917|NCT01563029|11710006|FG003|Overall Study|Adverse Event|2
7429918|NCT01563029|11710007|FG004|Overall Study|Adverse Event|1
7429919|NCT01563029|11710003|FG000|Overall Study|Lack of Efficacy|42
7429920|NCT01563029|11710004|FG001|Overall Study|Lack of Efficacy|16
7429921|NCT01563029|11710005|FG002|Overall Study|Lack of Efficacy|23
7429922|NCT01563029|11710006|FG003|Overall Study|Lack of Efficacy|21
7429923|NCT01563029|11710007|FG004|Overall Study|Lack of Efficacy|19
7429924|NCT01563029|11710003|FG000|Overall Study|Protocol Violation|1
7429925|NCT01563029|11710004|FG001|Overall Study|Protocol Violation|2
7429926|NCT01563029|11710005|FG002|Overall Study|Protocol Violation|3
7558657|NCT03131687|11924350|FG001|Overall Study|Death|0
7429927|NCT01563029|11710006|FG003|Overall Study|Protocol Violation|1
7429928|NCT01563029|11710007|FG004|Overall Study|Protocol Violation|3
7429929|NCT01563029|11710003|FG000|Overall Study|Protocol defined stopping criteria|1
7429930|NCT01563029|11710004|FG001|Overall Study|Protocol defined stopping criteria|0
7429931|NCT01563029|11710005|FG002|Overall Study|Protocol defined stopping criteria|0
7429932|NCT01563029|11710006|FG003|Overall Study|Protocol defined stopping criteria|0
7429933|NCT01563029|11710007|FG004|Overall Study|Protocol defined stopping criteria|0
7429934|NCT01563029|11710003|FG000|Overall Study|Lost to Follow-up|1
7429935|NCT01563029|11710004|FG001|Overall Study|Lost to Follow-up|0
7429936|NCT01563029|11710005|FG002|Overall Study|Lost to Follow-up|1
7429937|NCT01563029|11710006|FG003|Overall Study|Lost to Follow-up|1
7429938|NCT01563029|11710007|FG004|Overall Study|Lost to Follow-up|1
7429939|NCT01563029|11710003|FG000|Overall Study|Physician Decision|3
7429940|NCT01563029|11710004|FG001|Overall Study|Physician Decision|5
7429941|NCT01563029|11710005|FG002|Overall Study|Physician Decision|2
7429942|NCT01563029|11710006|FG003|Overall Study|Physician Decision|4
7429943|NCT01563029|11710007|FG004|Overall Study|Physician Decision|2
7429944|NCT01563029|11710003|FG000|Overall Study|Withdrawal by Subject|4
7429945|NCT01563029|11710004|FG001|Overall Study|Withdrawal by Subject|1
7429946|NCT01563029|11710005|FG002|Overall Study|Withdrawal by Subject|3
7429947|NCT01563029|11710006|FG003|Overall Study|Withdrawal by Subject|4
7429948|NCT01563029|11710007|FG004|Overall Study|Withdrawal by Subject|3
7429949|NCT01563172|11710040|FG000|Overall Study|Adverse Event|5
7429950|NCT01563172|11710040|FG000|Overall Study|Lost to Follow-up|2
7429951|NCT01563172|11710040|FG000|Overall Study|Other (Protocol deviation)|5
7429952|NCT01563172|11710040|FG000|Overall Study|Other (Not specified)|1
7429953|NCT01563185|11710055|FG000|Overall Study|Withdrawal by Subject|1
7429954|NCT01563185|11710055|FG000|Overall Study|Non-Compliance with study drug|1
7429955|NCT01563237|11710063|FG000|Overall Study|Lost to Follow-up|6
7429956|NCT01563237|11710064|FG001|Overall Study|Lost to Follow-up|0
7429957|NCT01563237|11710063|FG000|Overall Study|Withdrawal by Subject|1
7429958|NCT01563237|11710064|FG001|Overall Study|Withdrawal by Subject|0
7429959|NCT01563237|11710063|FG000|Overall Study|Adverse Event|1
7429960|NCT01563237|11710064|FG001|Overall Study|Adverse Event|0
7429961|NCT01563237|11710063|FG000|Overall Study|Medical Reasons|1
7429962|NCT01563237|11710064|FG001|Overall Study|Medical Reasons|0
7429963|NCT01563237|11710063|FG000|Overall Study|Death|1
7429964|NCT01563237|11710064|FG001|Overall Study|Death|0
7429965|NCT01563354|11710072|FG000|Core Phase|Adverse Event|5
7429966|NCT01563354|11710073|FG001|Core Phase|Adverse Event|15
7429967|NCT01563354|11710074|FG002|Core Phase|Adverse Event|13
7429968|NCT01563354|11710072|FG000|Core Phase|Withdrawal by Subject|1
7429969|NCT01563354|11710073|FG001|Core Phase|Withdrawal by Subject|0
7429970|NCT01563354|11710074|FG002|Core Phase|Withdrawal by Subject|3
7429971|NCT01563354|11710072|FG000|Core Phase|Lost to Follow-up|1
7429972|NCT01563354|11710073|FG001|Core Phase|Lost to Follow-up|0
7328504|NCT00796757|11561538|FG000|Overall Study|Death|61
7328505|NCT00796757|11561538|FG000|Overall Study|Protocol Violation|1
7328506|NCT00796757|11561538|FG000|Overall Study|Participant noncompliance|1
7328507|NCT00796757|11561538|FG000|Overall Study|Investigator's decision|2
7328508|NCT00796757|11561538|FG000|Overall Study|Other|7
7328509|NCT00796822|11561544|FG000|Overall Study|Lost to Follow-up|2
7328510|NCT00796822|11561545|FG001|Overall Study|Lost to Follow-up|0
7328511|NCT00796822|11561544|FG000|Overall Study|Adverse Event|1
7328512|NCT00796822|11561545|FG001|Overall Study|Adverse Event|0
7328513|NCT00796978|11561560|FG000|Overall Study|Cardiac adverse event|5
7328514|NCT00796978|11561560|FG000|Overall Study|Adverse Event|4
7328515|NCT00796978|11561560|FG000|Overall Study|Withdrawal by Subject|3
7328516|NCT00796991|11561567|FG000|Overall Study|Adverse Event|0
7429973|NCT01563354|11710074|FG002|Core Phase|Lost to Follow-up|0
7429974|NCT01563354|11710072|FG000|Core Phase|Death|1
7429975|NCT01563354|11710073|FG001|Core Phase|Death|5
7429976|NCT01563354|11710074|FG002|Core Phase|Death|2
7429977|NCT01563354|11710072|FG000|Core Phase|Diseasse progression|18
7429978|NCT01563354|11710073|FG001|Core Phase|Diseasse progression|7
7429979|NCT01563354|11710074|FG002|Core Phase|Diseasse progression|8
7429980|NCT01563354|11710072|FG000|Core Phase|Protocol deviation|2
7429981|NCT01563354|11710073|FG001|Core Phase|Protocol deviation|0
7429982|NCT01563354|11710074|FG002|Core Phase|Protocol deviation|0
7328517|NCT00796991|11561568|FG001|Overall Study|Adverse Event|0
7328518|NCT00796991|11561569|FG002|Overall Study|Adverse Event|1
7328519|NCT00796991|11561567|FG000|Overall Study|Death|2
7328520|NCT00796991|11561568|FG001|Overall Study|Death|0
7429983|NCT01563354|11710072|FG000|Core Phase|PI decision - did not enter extension|0
7429984|NCT01563354|11710073|FG001|Core Phase|PI decision - did not enter extension|1
7429985|NCT01563354|11710074|FG002|Core Phase|PI decision - did not enter extension|0
7429986|NCT01563354|11710072|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
7429987|NCT01563354|11710073|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
7429988|NCT01563354|11710074|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
7429989|NCT01563354|11710072|FG000|Extension Phase|Adverse Event|0
7328521|NCT00796991|11561569|FG002|Overall Study|Death|0
7429990|NCT01563354|11710073|FG001|Extension Phase|Adverse Event|3
7429991|NCT01563354|11710074|FG002|Extension Phase|Adverse Event|2
7429992|NCT01563354|11710072|FG000|Extension Phase|Withdrawal by Subject|0
7429993|NCT01563354|11710073|FG001|Extension Phase|Withdrawal by Subject|1
7429994|NCT01563354|11710074|FG002|Extension Phase|Withdrawal by Subject|0
7429995|NCT01563354|11710072|FG000|Extension Phase|Administration problems|3
7429996|NCT01563354|11710073|FG001|Extension Phase|Administration problems|2
7429997|NCT01563354|11710074|FG002|Extension Phase|Administration problems|3
7429998|NCT01563354|11710072|FG000|Extension Phase|Disease progression|9
7429999|NCT01563354|11710073|FG001|Extension Phase|Disease progression|8
7430000|NCT01563354|11710074|FG002|Extension Phase|Disease progression|10
7430001|NCT01563536|11710105|FG000|Overall Study|Withdrawal by Subject|0
7430002|NCT01563536|11710106|FG001|Overall Study|Withdrawal by Subject|2
7430003|NCT01563536|11710105|FG000|Overall Study|Lost to Follow-up|1
7430004|NCT01563536|11710106|FG001|Overall Study|Lost to Follow-up|0
7430005|NCT01563913|11710114|FG000|Overall Study|Physician Decision|1
7430006|NCT01563913|11710115|FG001|Overall Study|Physician Decision|0
7430007|NCT01563913|11710114|FG000|Overall Study|Spouse Passed Away|1
7430008|NCT01563913|11710115|FG001|Overall Study|Spouse Passed Away|0
7430009|NCT01563978|11710123|FG000|Overall Study|Physician Decision|1
7430010|NCT01563978|11710124|FG001|Overall Study|Physician Decision|0
7430011|NCT01563978|11710123|FG000|Overall Study|Lost to Follow-up|1
7430012|NCT01563978|11710124|FG001|Overall Study|Lost to Follow-up|0
7430013|NCT01563978|11710123|FG000|Overall Study|Dev. of study specific discont. criteria|1
7430014|NCT01563978|11710124|FG001|Overall Study|Dev. of study specific discont. criteria|0
7430015|NCT01563978|11710123|FG000|Overall Study|Adverse Event|1
7430016|NCT01563978|11710124|FG001|Overall Study|Adverse Event|2
7430017|NCT01564277|11710132|FG000|Overall Study|Protocol Violation|0
7430018|NCT01564277|11710133|FG001|Overall Study|Protocol Violation|1
7430019|NCT01564277|11710132|FG000|Overall Study|Physician Decision|1
7430020|NCT01564277|11710133|FG001|Overall Study|Physician Decision|0
7430021|NCT01564394|11710141|FG000|Overall Study|Withdrawal by Subject|6
7430022|NCT01564394|11710142|FG001|Overall Study|Withdrawal by Subject|10
7430023|NCT01564407|11710153|FG000|Overall Study|Lost to Follow-up|0
7430024|NCT01564407|11710154|FG001|Overall Study|Lost to Follow-up|1
7430025|NCT01564407|11710155|FG002|Overall Study|Lost to Follow-up|0
7430026|NCT01564407|11710156|FG003|Overall Study|Lost to Follow-up|0
7430027|NCT01564407|11710157|FG004|Overall Study|Lost to Follow-up|0
7430028|NCT01564407|11710153|FG000|Overall Study|Withdrawal by Subject|0
7430029|NCT01564407|11710154|FG001|Overall Study|Withdrawal by Subject|1
7430030|NCT01564407|11710155|FG002|Overall Study|Withdrawal by Subject|0
7430031|NCT01564407|11710156|FG003|Overall Study|Withdrawal by Subject|0
7430032|NCT01564407|11710157|FG004|Overall Study|Withdrawal by Subject|0
7430033|NCT01564407|11710153|FG000|Overall Study|funding lost, study ended|0
7430034|NCT01564407|11710154|FG001|Overall Study|funding lost, study ended|0
7430035|NCT01564407|11710155|FG002|Overall Study|funding lost, study ended|0
7430036|NCT01564407|11710156|FG003|Overall Study|funding lost, study ended|1
7430037|NCT01564407|11710157|FG004|Overall Study|funding lost, study ended|0
7430038|NCT01564459|11710181|FG000|Run-In|Adverse Event|7
7430039|NCT01564459|11710182|FG001|Run-In|Adverse Event|0
7430040|NCT01564459|11710183|FG002|Run-In|Adverse Event|0
7430041|NCT01564459|11710181|FG000|Run-In|Lost to Follow-up|1
7430042|NCT01564459|11710182|FG001|Run-In|Lost to Follow-up|0
7430043|NCT01564459|11710183|FG002|Run-In|Lost to Follow-up|0
7430044|NCT01564459|11710181|FG000|Run-In|Non-compliance with study drug|2
7430045|NCT01564459|11710182|FG001|Run-In|Non-compliance with study drug|0
7558658|NCT03131687|11924351|FG002|Overall Study|Death|0
7558659|NCT03131687|11924352|FG003|Overall Study|Death|0
7558660|NCT03131687|11924353|FG004|Overall Study|Death|0
7558661|NCT03131687|11924354|FG005|Overall Study|Death|0
7558662|NCT03131687|11924349|FG000|Overall Study|Withdrawal by Subject|3
7558663|NCT03131687|11924350|FG001|Overall Study|Withdrawal by Subject|3
7558664|NCT03131687|11924351|FG002|Overall Study|Withdrawal by Subject|3
7558665|NCT03131687|11924352|FG003|Overall Study|Withdrawal by Subject|1
7558666|NCT03131687|11924353|FG004|Overall Study|Withdrawal by Subject|2
7558667|NCT03131687|11924354|FG005|Overall Study|Withdrawal by Subject|1
7558668|NCT03131687|11924349|FG000|Overall Study|Lost to Follow-up|1
7558669|NCT03131687|11924350|FG001|Overall Study|Lost to Follow-up|4
7558670|NCT03131687|11924351|FG002|Overall Study|Lost to Follow-up|0
7558671|NCT03131687|11924352|FG003|Overall Study|Lost to Follow-up|1
7558672|NCT03131687|11924353|FG004|Overall Study|Lost to Follow-up|4
7558673|NCT03131687|11924354|FG005|Overall Study|Lost to Follow-up|2
7558674|NCT03131687|11924349|FG000|Overall Study|Participant Started New Diabetic Drug|1
7558675|NCT03131687|11924350|FG001|Overall Study|Participant Started New Diabetic Drug|0
7558676|NCT03131687|11924351|FG002|Overall Study|Participant Started New Diabetic Drug|0
7558677|NCT03131687|11924352|FG003|Overall Study|Participant Started New Diabetic Drug|0
7430046|NCT01564459|11710183|FG002|Run-In|Non-compliance with study drug|0
7430047|NCT01564459|11710181|FG000|Run-In|Protocol Violation|1
7430048|NCT01564459|11710182|FG001|Run-In|Protocol Violation|0
7430049|NCT01564459|11710183|FG002|Run-In|Protocol Violation|0
7558678|NCT03131687|11924353|FG004|Overall Study|Participant Started New Diabetic Drug|0
7558679|NCT03131687|11924354|FG005|Overall Study|Participant Started New Diabetic Drug|0
7430050|NCT01564459|11710181|FG000|Run-In|Withdrawal by Subject|1
7430051|NCT01564459|11710182|FG001|Run-In|Withdrawal by Subject|0
7430052|NCT01564459|11710183|FG002|Run-In|Withdrawal by Subject|0
7430053|NCT01564459|11710181|FG000|Double-blind Treatment|Adverse Event|0
7430054|NCT01564459|11710182|FG001|Double-blind Treatment|Adverse Event|0
7430055|NCT01564459|11710183|FG002|Double-blind Treatment|Adverse Event|1
7430056|NCT01564758|11710230|FG000|Overall Study|Death|8
7430057|NCT01564758|11710230|FG000|Overall Study|Adverse Event|3
7430058|NCT01564758|11710230|FG000|Overall Study|Other|3
7430059|NCT01564784|11710236|FG000|Overall Study|Other|1
7430060|NCT01564784|11710237|FG001|Overall Study|Other|0
7430061|NCT01564784|11710236|FG000|Overall Study|Subject refused further follow-up|1
7430062|NCT01564784|11710237|FG001|Overall Study|Subject refused further follow-up|6
7430063|NCT01564784|11710236|FG000|Overall Study|Lost to Follow-up|1
7430064|NCT01564784|11710237|FG001|Overall Study|Lost to Follow-up|1
7430065|NCT01564784|11710236|FG000|Overall Study|Death|131
7430066|NCT01564784|11710237|FG001|Overall Study|Death|126
7430067|NCT01564862|11710246|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7430068|NCT01564862|11710247|FG001|Overall Study|Pretreatment Event or Adverse Event|12
7430069|NCT01564862|11710248|FG002|Overall Study|Pretreatment Event or Adverse Event|6
7430070|NCT01564862|11710246|FG000|Overall Study|Major Protocol Deviation|3
7430071|NCT01564862|11710247|FG001|Overall Study|Major Protocol Deviation|3
7430072|NCT01564862|11710248|FG002|Overall Study|Major Protocol Deviation|4
7430073|NCT01564862|11710246|FG000|Overall Study|Lost to Follow-up|10
7430074|NCT01564862|11710247|FG001|Overall Study|Lost to Follow-up|8
7430075|NCT01564862|11710248|FG002|Overall Study|Lost to Follow-up|6
7430076|NCT01564862|11710246|FG000|Overall Study|Voluntary Withdrawal|9
7430077|NCT01564862|11710247|FG001|Overall Study|Voluntary Withdrawal|6
7430078|NCT01564862|11710248|FG002|Overall Study|Voluntary Withdrawal|8
7430079|NCT01564862|11710246|FG000|Overall Study|Lack of Efficacy|1
7430080|NCT01564862|11710247|FG001|Overall Study|Lack of Efficacy|5
7430081|NCT01564862|11710248|FG002|Overall Study|Lack of Efficacy|6
7430082|NCT01564862|11710246|FG000|Overall Study|Other reason(s)|1
7430083|NCT01564862|11710247|FG001|Overall Study|Other reason(s)|0
7430084|NCT01564862|11710248|FG002|Overall Study|Other reason(s)|0
7430085|NCT01565083|11710278|FG000|Overall Study|Withdrawal by Subject|6
7430086|NCT01565083|11710279|FG001|Overall Study|Withdrawal by Subject|4
7430087|NCT01565083|11710278|FG000|Overall Study|Lost to Follow-up|2
7430088|NCT01565083|11710279|FG001|Overall Study|Lost to Follow-up|7
7430089|NCT01565083|11710278|FG000|Overall Study|Death|22
7430090|NCT01565083|11710279|FG001|Overall Study|Death|23
7430091|NCT01565083|11710278|FG000|Overall Study|Other|3
7430092|NCT01565083|11710279|FG001|Overall Study|Other|5
7430093|NCT01565148|11710289|FG000|Overall Study|Withdrawal by Subject|1
7430094|NCT01565148|11710290|FG001|Overall Study|Withdrawal by Subject|1
7430095|NCT01565148|11710291|FG002|Overall Study|Withdrawal by Subject|1
7430096|NCT01565148|11710292|FG003|Overall Study|Withdrawal by Subject|2
7430097|NCT01565148|11710289|FG000|Overall Study|Lost to Follow-up|4
7430098|NCT01565148|11710290|FG001|Overall Study|Lost to Follow-up|4
7430099|NCT01565148|11710291|FG002|Overall Study|Lost to Follow-up|0
7430100|NCT01565148|11710292|FG003|Overall Study|Lost to Follow-up|3
7430101|NCT01565148|11710289|FG000|Overall Study|Rescue Therapy|8
7430102|NCT01565148|11710290|FG001|Overall Study|Rescue Therapy|5
7430103|NCT01565148|11710291|FG002|Overall Study|Rescue Therapy|5
7430104|NCT01565148|11710292|FG003|Overall Study|Rescue Therapy|8
7430105|NCT01565148|11710289|FG000|Overall Study|Death|0
7430106|NCT01565148|11710290|FG001|Overall Study|Death|0
7430107|NCT01565148|11710291|FG002|Overall Study|Death|1
7430108|NCT01565148|11710292|FG003|Overall Study|Death|0
7430109|NCT01565148|11710289|FG000|Overall Study|Physician Decision|2
7430110|NCT01565148|11710290|FG001|Overall Study|Physician Decision|5
7430111|NCT01565148|11710291|FG002|Overall Study|Physician Decision|0
7430112|NCT01565148|11710292|FG003|Overall Study|Physician Decision|0
7430113|NCT01565291|11710308|FG000|Overall Study|Withdrawal by Subject|1
7430114|NCT01565291|11710309|FG001|Overall Study|Withdrawal by Subject|0
7430115|NCT01565343|11710336|FG000|Overall Study|Administrative decision/technical issues|1
7430116|NCT01565343|11710337|FG001|Overall Study|Administrative decision/technical issues|0
7430117|NCT01565343|11710338|FG002|Overall Study|Administrative decision/technical issues|0
7466994|NCT01896726|11767158|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
7466995|NCT01896856|11767171|FG000|Overall Study|Transportation issues / Non-compliance|0
7466996|NCT01896856|11767172|FG001|Overall Study|Transportation issues / Non-compliance|0
7466997|NCT01896856|11767173|FG002|Overall Study|Transportation issues / Non-compliance|1
7466998|NCT01896856|11767174|FG003|Overall Study|Transportation issues / Non-compliance|0
7466999|NCT01896856|11767175|FG004|Overall Study|Transportation issues / Non-compliance|0
7467000|NCT01896856|11767176|FG005|Overall Study|Transportation issues / Non-compliance|0
7467001|NCT01896869|11767193|FG000|Overall Study|Withdrawal by Subject|0
7467002|NCT01896869|11767194|FG001|Overall Study|Withdrawal by Subject|6
7467003|NCT01896869|11767193|FG000|Overall Study|Lost to Follow-up|1
7467004|NCT01896869|11767194|FG001|Overall Study|Lost to Follow-up|0
7467005|NCT01896895|11767205|FG000|Double-blind MP|Physician Decision|0
7467006|NCT01896895|11767206|FG001|Double-blind MP|Physician Decision|0
7467007|NCT01896895|11767207|FG002|Double-blind MP|Physician Decision|1
7467008|NCT01896895|11767208|FG003|Double-blind MP|Physician Decision|0
7467009|NCT01896895|11767205|FG000|Double-blind MP|Withdrawal by Subject|0
7467010|NCT01896895|11767206|FG001|Double-blind MP|Withdrawal by Subject|2
7467011|NCT01896895|11767207|FG002|Double-blind MP|Withdrawal by Subject|1
7467012|NCT01896895|11767208|FG003|Double-blind MP|Withdrawal by Subject|0
7467013|NCT01896895|11767205|FG000|Double-blind MP|Lost to Follow-up|1
7467014|NCT01896895|11767206|FG001|Double-blind MP|Lost to Follow-up|0
7467015|NCT01896895|11767207|FG002|Double-blind MP|Lost to Follow-up|1
7430118|NCT01565499|11710360|FG000|Overall Study|Physician Decision|1
7430119|NCT01565499|11710360|FG000|Overall Study|Adverse Event|5
7430120|NCT01565499|11710360|FG000|Overall Study|Withdrawal by Subject|2
7430121|NCT01565564|11710384|FG000|Overall Study|Lost to Follow-up|5
7430122|NCT01565564|11710385|FG001|Overall Study|Lost to Follow-up|1
7430123|NCT01565642|11710397|FG000|Overall Study|Withdrawal by Subject|2
7430124|NCT01565642|11710398|FG001|Overall Study|Withdrawal by Subject|1
7430125|NCT01565668|11710406|FG000|Overall Study|Death|2
7430126|NCT01565668|11710407|FG001|Overall Study|Death|1
7430127|NCT01565668|11710406|FG000|Overall Study|Lack of Efficacy|4
7430128|NCT01565668|11710407|FG001|Overall Study|Lack of Efficacy|2
7430129|NCT01565668|11710406|FG000|Overall Study|Participant went on Hospice Care|1
7430130|NCT01565668|11710407|FG001|Overall Study|Participant went on Hospice Care|0
7430131|NCT01565668|11710406|FG000|Overall Study|Adverse Event|6
7430132|NCT01565668|11710407|FG001|Overall Study|Adverse Event|1
7430133|NCT01565668|11710406|FG000|Overall Study|Randomized, but never received drug|0
7430134|NCT01565668|11710407|FG001|Overall Study|Randomized, but never received drug|2
7430135|NCT01565668|11710406|FG000|Overall Study|Progressive disease|13
7430136|NCT01565668|11710407|FG001|Overall Study|Progressive disease|14
7430137|NCT01565668|11710406|FG000|Overall Study|Withdrawal by Subject|1
7430138|NCT01565668|11710407|FG001|Overall Study|Withdrawal by Subject|3
7430139|NCT01565668|11710406|FG000|Overall Study|HSCT Transplant|11
7430140|NCT01565668|11710407|FG001|Overall Study|HSCT Transplant|15
7430141|NCT01565694|11710413|FG000|Dose-Titration Period|Adverse Event|4
7430142|NCT01565694|11710413|FG000|Dose-Titration Period|Protocol Violation|10
7430143|NCT01565694|11710413|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
7430144|NCT01565707|11710421|FG000|Overall Study|Adverse Event|1
7430145|NCT01565707|11710422|FG001|Overall Study|Adverse Event|6
7430146|NCT01565707|11710423|FG002|Overall Study|Adverse Event|2
7430147|NCT01565707|11710424|FG003|Overall Study|Adverse Event|1
7430148|NCT01565707|11710421|FG000|Overall Study|Lost to Follow-up|1
7430149|NCT01565707|11710422|FG001|Overall Study|Lost to Follow-up|0
7430150|NCT01565707|11710423|FG002|Overall Study|Lost to Follow-up|0
7430151|NCT01565707|11710424|FG003|Overall Study|Lost to Follow-up|0
7430152|NCT01565707|11710421|FG000|Overall Study|Protocol Violation|1
7430153|NCT01565707|11710422|FG001|Overall Study|Protocol Violation|0
7430154|NCT01565707|11710423|FG002|Overall Study|Protocol Violation|0
7430155|NCT01565707|11710424|FG003|Overall Study|Protocol Violation|1
7430156|NCT01565707|11710421|FG000|Overall Study|Withdrawal by Subject|3
7430157|NCT01565707|11710422|FG001|Overall Study|Withdrawal by Subject|1
7430158|NCT01565707|11710423|FG002|Overall Study|Withdrawal by Subject|1
7430159|NCT01565707|11710424|FG003|Overall Study|Withdrawal by Subject|1
7430160|NCT01565707|11710421|FG000|Overall Study|Randomized but not evaluable|2
7430161|NCT01565707|11710422|FG001|Overall Study|Randomized but not evaluable|0
7430162|NCT01565707|11710423|FG002|Overall Study|Randomized but not evaluable|0
7430163|NCT01565707|11710424|FG003|Overall Study|Randomized but not evaluable|0
7430164|NCT01565707|11710421|FG000|Overall Study|Miscellaneous|1
7430165|NCT01565707|11710422|FG001|Overall Study|Miscellaneous|1
7430166|NCT01565707|11710423|FG002|Overall Study|Miscellaneous|0
7430167|NCT01565707|11710424|FG003|Overall Study|Miscellaneous|2
7430168|NCT01565850|11710443|FG000|Overall Study|Adverse Event|0
7430169|NCT01565850|11710444|FG001|Overall Study|Adverse Event|1
7430170|NCT01565850|11710443|FG000|Overall Study|Lost to Follow-up|12
7430171|NCT01565850|11710444|FG001|Overall Study|Lost to Follow-up|4
7430172|NCT01565850|11710443|FG000|Overall Study|Investigator's Discretion|2
7430173|NCT01565850|11710444|FG001|Overall Study|Investigator's Discretion|1
7430174|NCT01565850|11710443|FG000|Overall Study|Participant noncompliance|2
7430175|NCT01565850|11710444|FG001|Overall Study|Participant noncompliance|0
7430176|NCT01565850|11710443|FG000|Overall Study|Withdrew Consent|4
7430177|NCT01565850|11710444|FG001|Overall Study|Withdrew Consent|2
7430178|NCT01565889|11710456|FG000|Part A|Withdrawal by Subject|1
7430179|NCT01565889|11710457|FG001|Part A|Withdrawal by Subject|0
7430180|NCT01565889|11710458|FG002|Part A|Withdrawal by Subject|0
7430181|NCT01565889|11710459|FG003|Part A|Withdrawal by Subject|0
7430182|NCT01565889|11710460|FG004|Part A|Withdrawal by Subject|0
7430183|NCT01565889|11710461|FG005|Part A|Withdrawal by Subject|0
7430184|NCT01565889|11710456|FG000|Part B|Withdrawal by Subject|0
7430185|NCT01565889|11710457|FG001|Part B|Withdrawal by Subject|0
7430186|NCT01565889|11710458|FG002|Part B|Withdrawal by Subject|0
7430187|NCT01565889|11710459|FG003|Part B|Withdrawal by Subject|0
7430188|NCT01565889|11710460|FG004|Part B|Withdrawal by Subject|0
7430189|NCT01565889|11710461|FG005|Part B|Withdrawal by Subject|1
7430190|NCT01565889|11710456|FG000|Part B|Lack of Efficacy|0
7430191|NCT01565889|11710457|FG001|Part B|Lack of Efficacy|0
7430192|NCT01565889|11710458|FG002|Part B|Lack of Efficacy|0
7430193|NCT01565889|11710459|FG003|Part B|Lack of Efficacy|0
7430194|NCT01565889|11710460|FG004|Part B|Lack of Efficacy|0
7430195|NCT01565889|11710461|FG005|Part B|Lack of Efficacy|2
7430196|NCT01565889|11710456|FG000|Part B|Lost to Follow-up|0
7430197|NCT01565889|11710457|FG001|Part B|Lost to Follow-up|0
7430198|NCT01565889|11710458|FG002|Part B|Lost to Follow-up|0
7430199|NCT01565889|11710459|FG003|Part B|Lost to Follow-up|0
7430200|NCT01565889|11710460|FG004|Part B|Lost to Follow-up|0
7430201|NCT01565889|11710461|FG005|Part B|Lost to Follow-up|1
7430202|NCT01565928|11710496|FG000|Overall Study|Adverse Event|3
7430203|NCT01565928|11710496|FG000|Overall Study|Other|3
7430204|NCT01565928|11710496|FG000|Overall Study|Progressive Disease|13
7430205|NCT01565928|11710496|FG000|Overall Study|Withdrawal by Subject|1
7430206|NCT01565928|11710496|FG000|Overall Study|Death|2
7430211|NCT01565980|11710516|FG000|Overall Study|Death|1
7430212|NCT01565980|11710517|FG001|Overall Study|Death|0
7430213|NCT01565980|11710516|FG000|Overall Study|Lost to Follow-up|1
7430214|NCT01565980|11710517|FG001|Overall Study|Lost to Follow-up|0
7430215|NCT01565980|11710516|FG000|Overall Study|health complications|1
7430216|NCT01565980|11710517|FG001|Overall Study|health complications|1
7430217|NCT01565980|11710516|FG000|Overall Study|stopped medical treatment|1
7430218|NCT01565980|11710517|FG001|Overall Study|stopped medical treatment|0
7430219|NCT01565980|11710516|FG000|Overall Study|Withdrawal by Subject|0
7430220|NCT01565980|11710517|FG001|Overall Study|Withdrawal by Subject|3
7430221|NCT01565993|11710529|FG000|Overall Study|Physician Decision|0
7430222|NCT01565993|11710530|FG001|Overall Study|Physician Decision|3
7430223|NCT01566214|11710559|FG000|Overall Study|Lost to Follow-up|3
7430224|NCT01566214|11710560|FG001|Overall Study|Lost to Follow-up|0
7430225|NCT01566435|11710584|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
7430226|NCT01566604|11710653|FG000|Overall Study|Patient's inability to use the device|1
7430227|NCT01566604|11710654|FG001|Overall Study|Patient's inability to use the device|0
7430228|NCT01566604|11710653|FG000|Overall Study|Administrative problems|1
7430229|NCT01566604|11710654|FG001|Overall Study|Administrative problems|0
7430230|NCT01566604|11710653|FG000|Overall Study|Lack of Efficacy|1
7430231|NCT01566604|11710654|FG001|Overall Study|Lack of Efficacy|2
7430232|NCT01566604|11710653|FG000|Overall Study|Protocol deviation|2
7430233|NCT01566604|11710654|FG001|Overall Study|Protocol deviation|0
7430234|NCT01566604|11710653|FG000|Overall Study|Abnormal laboratory value|2
7430235|NCT01566604|11710654|FG001|Overall Study|Abnormal laboratory value|0
7430236|NCT01566604|11710653|FG000|Overall Study|Death|4
7430237|NCT01566604|11710654|FG001|Overall Study|Death|1
7430238|NCT01566604|11710653|FG000|Overall Study|Adverse Event|4
7430239|NCT01566604|11710654|FG001|Overall Study|Adverse Event|2
7430240|NCT01566604|11710653|FG000|Overall Study|Withdrawal by Subject|9
7430241|NCT01566604|11710654|FG001|Overall Study|Withdrawal by Subject|6
7430242|NCT01566721|11710681|FG000|Treatment Period|Withdrawal by Subject|35
7430243|NCT01566721|11710682|FG001|Treatment Period|Withdrawal by Subject|9
7430244|NCT01566721|11710681|FG000|Treatment Period|Disease Progression/Recurrence|37
7430245|NCT01566721|11710682|FG001|Treatment Period|Disease Progression/Recurrence|13
7430246|NCT01566721|11710681|FG000|Treatment Period|Investigator/Sponsor Decision|6
7430247|NCT01566721|11710682|FG001|Treatment Period|Investigator/Sponsor Decision|3
7430248|NCT01566721|11710681|FG000|Treatment Period|Other|13
7430249|NCT01566721|11710682|FG001|Treatment Period|Other|2
7430250|NCT01566721|11710681|FG000|Treatment Period|Lack of Compliance|5
7430251|NCT01566721|11710682|FG001|Treatment Period|Lack of Compliance|1
7430252|NCT01566721|11710681|FG000|Treatment Period|Adverse Event|100
7430253|NCT01566721|11710682|FG001|Treatment Period|Adverse Event|30
7430254|NCT01566721|11710681|FG000|Treatment Period|Pregnancy|1
7430255|NCT01566721|11710682|FG001|Treatment Period|Pregnancy|0
7430256|NCT01566721|11710681|FG000|Safety Follow-up|Physician Decision|6
7430257|NCT01566721|11710682|FG001|Safety Follow-up|Physician Decision|4
7430258|NCT01566721|11710681|FG000|Safety Follow-up|Lost to Follow-up|101
7430259|NCT01566721|11710682|FG001|Safety Follow-up|Lost to Follow-up|48
7430260|NCT01566721|11710681|FG000|Safety Follow-up|Withdrawal by Subject|155
7430261|NCT01566721|11710682|FG001|Safety Follow-up|Withdrawal by Subject|49
7430262|NCT01566721|11710681|FG000|Safety Follow-up|Death|28
7430263|NCT01566721|11710682|FG001|Safety Follow-up|Death|4
7430264|NCT01566721|11710681|FG000|Safety Follow-up|Non-compliance|7
7430265|NCT01566721|11710682|FG001|Safety Follow-up|Non-compliance|3
7430266|NCT01566721|11710681|FG000|Safety Follow-up|Protocol Violation|7
7430267|NCT01566721|11710682|FG001|Safety Follow-up|Protocol Violation|0
7430268|NCT01566721|11710681|FG000|Safety Follow-up|Site closure|2
7430269|NCT01566721|11710682|FG001|Safety Follow-up|Site closure|3
7430270|NCT01566721|11710681|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
7430271|NCT01566721|11710682|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
7430272|NCT01566721|11710681|FG000|Safety Follow-up|Missing|7
7430273|NCT01566721|11710682|FG001|Safety Follow-up|Missing|2
7430274|NCT01566721|11710681|FG000|Safety Follow-up|Disease progression /disease recurrence|223
7430275|NCT01566721|11710682|FG001|Safety Follow-up|Disease progression /disease recurrence|90
7430276|NCT01566721|11710681|FG000|Safety Follow-up|Sponsor decision|1
7430277|NCT01566721|11710682|FG001|Safety Follow-up|Sponsor decision|0
7430278|NCT01566721|11710681|FG000|Safety Follow-up|Adverse Event|8
7430279|NCT01566721|11710682|FG001|Safety Follow-up|Adverse Event|4
7430280|NCT01566773|11710695|FG000|Overall Study|Protocol specified criteria|4
7430281|NCT01566773|11710695|FG000|Overall Study|Protocol Violation|4
7430282|NCT01566773|11710695|FG000|Overall Study|Withdrawal by Subject|9
7430283|NCT01566773|11710695|FG000|Overall Study|Administrative reason|1
7430284|NCT01566773|11710695|FG000|Overall Study|Adverse Event|10
7430285|NCT01566773|11710695|FG000|Overall Study|Physician Decision|2
7430286|NCT01566981|11710726|FG000|Overall Study|Lost to Follow-up|5
7430287|NCT01566981|11710727|FG001|Overall Study|Lost to Follow-up|8
7430288|NCT01567085|11710752|FG000|Overall Study|Death|6
7430289|NCT01567085|11710752|FG000|Overall Study|Adverse Event|6
7430290|NCT01567085|11710752|FG000|Overall Study|Lost to Follow-up|3
7430291|NCT01567085|11710752|FG000|Overall Study|Graft loss|2
7430292|NCT01567085|11710752|FG000|Overall Study|Renal transplantectomy|1
7430293|NCT01567085|11710752|FG000|Overall Study|Returned to chronic dialysis|1
7430294|NCT01567085|11710752|FG000|Overall Study|Terminal chronic kidney dysfunction|1
7430295|NCT01567163|11710765|FG000|Overall Study|Progressive Disease|2
7430296|NCT01567163|11710765|FG000|Overall Study|Lost to Follow-up|2
7430297|NCT01567306|11710780|FG000|Overall Study|Protocol Violation|2
7430298|NCT01567306|11710781|FG001|Overall Study|Protocol Violation|2
7430299|NCT01567306|11710782|FG002|Overall Study|Protocol Violation|0
7430300|NCT01567306|11710783|FG003|Overall Study|Protocol Violation|3
7430301|NCT01567306|11710784|FG004|Overall Study|Protocol Violation|1
7430302|NCT01567306|11710785|FG005|Overall Study|Protocol Violation|1
7430303|NCT01567306|11710780|FG000|Overall Study|Change site living|1
7430304|NCT01567306|11710781|FG001|Overall Study|Change site living|0
7430305|NCT01567306|11710782|FG002|Overall Study|Change site living|0
7430306|NCT01567306|11710783|FG003|Overall Study|Change site living|0
7430307|NCT01567306|11710784|FG004|Overall Study|Change site living|0
7430308|NCT01567306|11710785|FG005|Overall Study|Change site living|0
7430309|NCT01567306|11710780|FG000|Overall Study|Adverse Event|0
7430310|NCT01567306|11710781|FG001|Overall Study|Adverse Event|0
7430311|NCT01567306|11710782|FG002|Overall Study|Adverse Event|0
7430312|NCT01567306|11710783|FG003|Overall Study|Adverse Event|2
7430313|NCT01567306|11710784|FG004|Overall Study|Adverse Event|4
7430314|NCT01567306|11710785|FG005|Overall Study|Adverse Event|1
7430315|NCT01567306|11710780|FG000|Overall Study|Lost to Follow-up|0
7430316|NCT01567306|11710781|FG001|Overall Study|Lost to Follow-up|0
7430317|NCT01567306|11710782|FG002|Overall Study|Lost to Follow-up|0
7430318|NCT01567306|11710783|FG003|Overall Study|Lost to Follow-up|0
7430319|NCT01567306|11710784|FG004|Overall Study|Lost to Follow-up|2
7430320|NCT01567306|11710785|FG005|Overall Study|Lost to Follow-up|0
7430321|NCT01567306|11710780|FG000|Overall Study|Withdrawal by Subject|0
7430322|NCT01567306|11710781|FG001|Overall Study|Withdrawal by Subject|0
7430323|NCT01567306|11710782|FG002|Overall Study|Withdrawal by Subject|0
7430324|NCT01567306|11710783|FG003|Overall Study|Withdrawal by Subject|0
7430325|NCT01567306|11710784|FG004|Overall Study|Withdrawal by Subject|0
7430326|NCT01567306|11710785|FG005|Overall Study|Withdrawal by Subject|1
7430327|NCT01567462|11710805|FG000|Overall Study|Withdrawal by Subject|4
7430328|NCT01567462|11710806|FG001|Overall Study|Withdrawal by Subject|7
7430329|NCT01567527|11710814|FG000|Conversion Phase.|Protocol deviation|3
7430330|NCT01567527|11710815|FG001|Conversion Phase.|Protocol deviation|0
7430331|NCT01567527|11710816|FG002|Conversion Phase.|Protocol deviation|0
7430332|NCT01567527|11710817|FG003|Conversion Phase.|Protocol deviation|0
7430333|NCT01567527|11710818|FG004|Conversion Phase.|Protocol deviation|0
7430334|NCT01567527|11710814|FG000|Conversion Phase.|Met withdrawal criteria|10
7430335|NCT01567527|11710815|FG001|Conversion Phase.|Met withdrawal criteria|0
7430336|NCT01567527|11710816|FG002|Conversion Phase.|Met withdrawal criteria|0
7430337|NCT01567527|11710817|FG003|Conversion Phase.|Met withdrawal criteria|0
7430338|NCT01567527|11710818|FG004|Conversion Phase.|Met withdrawal criteria|0
7430339|NCT01567527|11710814|FG000|Conversion Phase.|Withdrawal by Subject|32
7430340|NCT01567527|11710815|FG001|Conversion Phase.|Withdrawal by Subject|0
7430341|NCT01567527|11710816|FG002|Conversion Phase.|Withdrawal by Subject|0
7430342|NCT01567527|11710817|FG003|Conversion Phase.|Withdrawal by Subject|0
7430343|NCT01567527|11710818|FG004|Conversion Phase.|Withdrawal by Subject|0
7430344|NCT01567527|11710814|FG000|Conversion Phase.|Lost to Follow-up|16
7430345|NCT01567527|11710815|FG001|Conversion Phase.|Lost to Follow-up|0
7328522|NCT00796991|11561567|FG000|Overall Study|Disease Progression|10
7328523|NCT00796991|11561568|FG001|Overall Study|Disease Progression|9
7328524|NCT00796991|11561569|FG002|Overall Study|Disease Progression|7
7328525|NCT00796991|11561567|FG000|Overall Study|Study Drug Toxicity|3
7328526|NCT00796991|11561568|FG001|Overall Study|Study Drug Toxicity|3
7328527|NCT00796991|11561569|FG002|Overall Study|Study Drug Toxicity|5
7328528|NCT00796991|11561567|FG000|Overall Study|Withdrawal by Subject|0
7328529|NCT00796991|11561568|FG001|Overall Study|Withdrawal by Subject|0
7328530|NCT00796991|11561569|FG002|Overall Study|Withdrawal by Subject|1
7328531|NCT00797108|11561580|FG000|Overall Study|Adverse Event|1
7328532|NCT00797108|11561581|FG001|Overall Study|Adverse Event|0
7430346|NCT01567527|11710816|FG002|Conversion Phase.|Lost to Follow-up|0
7430347|NCT01567527|11710817|FG003|Conversion Phase.|Lost to Follow-up|0
7430348|NCT01567527|11710818|FG004|Conversion Phase.|Lost to Follow-up|0
7430349|NCT01567527|11710814|FG000|Conversion Phase.|Lack of Efficacy|2
7430350|NCT01567527|11710815|FG001|Conversion Phase.|Lack of Efficacy|0
7430351|NCT01567527|11710816|FG002|Conversion Phase.|Lack of Efficacy|0
7430352|NCT01567527|11710817|FG003|Conversion Phase.|Lack of Efficacy|0
7430353|NCT01567527|11710818|FG004|Conversion Phase.|Lack of Efficacy|0
7430354|NCT01567527|11710814|FG000|Conversion Phase.|Adverse Event|33
7430355|NCT01567527|11710815|FG001|Conversion Phase.|Adverse Event|0
7430356|NCT01567527|11710816|FG002|Conversion Phase.|Adverse Event|0
7430357|NCT01567527|11710817|FG003|Conversion Phase.|Adverse Event|0
7430358|NCT01567527|11710818|FG004|Conversion Phase.|Adverse Event|0
7430359|NCT01567527|11710814|FG000|Conversion Phase.|Withdrawn by the investigator|3
7328533|NCT00797108|11561582|FG002|Overall Study|Adverse Event|3
7430360|NCT01567527|11710815|FG001|Conversion Phase.|Withdrawn by the investigator|0
7430361|NCT01567527|11710816|FG002|Conversion Phase.|Withdrawn by the investigator|0
7430362|NCT01567527|11710817|FG003|Conversion Phase.|Withdrawn by the investigator|0
7430363|NCT01567527|11710818|FG004|Conversion Phase.|Withdrawn by the investigator|0
7430364|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7430365|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
7430366|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7430367|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7430368|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
7430369|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7430370|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
7430371|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7430372|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7430373|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
7430374|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7430375|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
7430376|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7430377|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7430378|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
7430379|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7430380|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
7430381|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7430382|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7430383|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
7430384|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7430385|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
7430386|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7430387|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7430388|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
7430389|NCT01567527|11710814|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7430390|NCT01567527|11710815|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
7430391|NCT01567527|11710816|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7430392|NCT01567527|11710817|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7430393|NCT01567527|11710818|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
7430394|NCT01567527|11710814|FG000|IM Depot Stabilization.|Protocol deviation|0
7430395|NCT01567527|11710815|FG001|IM Depot Stabilization.|Protocol deviation|0
7430396|NCT01567527|11710816|FG002|IM Depot Stabilization.|Protocol deviation|5
7430397|NCT01567527|11710817|FG003|IM Depot Stabilization.|Protocol deviation|0
7430398|NCT01567527|11710818|FG004|IM Depot Stabilization.|Protocol deviation|0
7430399|NCT01567527|11710814|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
7430400|NCT01567527|11710815|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
7430401|NCT01567527|11710816|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
7430402|NCT01567527|11710817|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
7430403|NCT01567527|11710818|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
7430404|NCT01567527|11710814|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
7430405|NCT01567527|11710815|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
7430474|NCT01567826|11710829|FG000|Overall Study|Lost to Follow-up|3
7430406|NCT01567527|11710816|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
7430407|NCT01567527|11710817|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
7430408|NCT01567527|11710818|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
7430409|NCT01567527|11710814|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
7430410|NCT01567527|11710815|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
7430411|NCT01567527|11710816|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
7430412|NCT01567527|11710817|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
7430413|NCT01567527|11710818|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
7430414|NCT01567527|11710814|FG000|IM Depot Stabilization.|Lost to Follow-up|0
7430415|NCT01567527|11710815|FG001|IM Depot Stabilization.|Lost to Follow-up|0
7430416|NCT01567527|11710816|FG002|IM Depot Stabilization.|Lost to Follow-up|21
7430417|NCT01567527|11710817|FG003|IM Depot Stabilization.|Lost to Follow-up|0
7430418|NCT01567527|11710818|FG004|IM Depot Stabilization.|Lost to Follow-up|0
7430419|NCT01567527|11710814|FG000|IM Depot Stabilization.|Lack of Efficacy|0
7430420|NCT01567527|11710815|FG001|IM Depot Stabilization.|Lack of Efficacy|0
7430421|NCT01567527|11710816|FG002|IM Depot Stabilization.|Lack of Efficacy|7
7430422|NCT01567527|11710817|FG003|IM Depot Stabilization.|Lack of Efficacy|0
7430423|NCT01567527|11710818|FG004|IM Depot Stabilization.|Lack of Efficacy|0
7430424|NCT01567527|11710814|FG000|IM Depot Stabilization.|Adverse Event|0
7430425|NCT01567527|11710815|FG001|IM Depot Stabilization.|Adverse Event|0
7430426|NCT01567527|11710816|FG002|IM Depot Stabilization.|Adverse Event|37
7430427|NCT01567527|11710817|FG003|IM Depot Stabilization.|Adverse Event|0
7430428|NCT01567527|11710818|FG004|IM Depot Stabilization.|Adverse Event|0
7430429|NCT01567527|11710814|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
7430430|NCT01567527|11710815|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
7430431|NCT01567527|11710816|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
7430432|NCT01567527|11710817|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
7430433|NCT01567527|11710818|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
7430434|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7430435|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7430436|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
7430437|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7430438|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
7430439|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7430440|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7430441|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
7430442|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
7430443|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
7430444|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7430445|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7430446|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
7430447|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
7430448|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
7430449|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7430450|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7430451|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
7430452|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
7430453|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
7430454|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7430455|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7430456|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7430457|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
7430458|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
7430459|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7430460|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7430461|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
7430462|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
7430463|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
7430464|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7430465|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7430466|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
7430467|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
7430468|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
7430469|NCT01567527|11710814|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7430470|NCT01567527|11710815|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7430471|NCT01567527|11710816|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7430472|NCT01567527|11710817|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
7430473|NCT01567527|11710818|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
7430475|NCT01567826|11710830|FG001|Overall Study|Lost to Follow-up|2
7430476|NCT01567852|11710848|FG000|Overall Study|Withdrawal by Subject|3
7430477|NCT01567852|11710849|FG001|Overall Study|Withdrawal by Subject|6
7430478|NCT01567852|11710848|FG000|Overall Study|ECT discontinued|1
7430479|NCT01567852|11710849|FG001|Overall Study|ECT discontinued|1
7430480|NCT01567865|11710859|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
7430481|NCT01567865|11710860|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
7430482|NCT01567865|11710861|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
7430483|NCT01567865|11710862|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
7430484|NCT01567865|11710859|FG000|Evaluated for Immunogenicity|Missing blood sample|17
7430485|NCT01567865|11710860|FG001|Evaluated for Immunogenicity|Missing blood sample|24
7430486|NCT01567865|11710861|FG002|Evaluated for Immunogenicity|Missing blood sample|16
7430487|NCT01567865|11710862|FG003|Evaluated for Immunogenicity|Missing blood sample|28
7430488|NCT01568034|11710904|FG000|Overall Study|Withdrawal by Subject|1
7430489|NCT01568034|11710905|FG001|Overall Study|Withdrawal by Subject|0
7430490|NCT01568034|11710906|FG002|Overall Study|Withdrawal by Subject|0
7430491|NCT01568034|11710907|FG003|Overall Study|Withdrawal by Subject|0
7430492|NCT01568047|11710921|FG000|Overall Study|Ineligibility|1
7430493|NCT01568047|11710922|FG001|Overall Study|Ineligibility|0
7430494|NCT01568047|11710923|FG002|Overall Study|Ineligibility|0
7430495|NCT01568047|11710924|FG003|Overall Study|Ineligibility|0
7430496|NCT01568047|11710921|FG000|Overall Study|Withdrawal by Subject|0
7430497|NCT01568047|11710922|FG001|Overall Study|Withdrawal by Subject|1
7430498|NCT01568047|11710923|FG002|Overall Study|Withdrawal by Subject|0
7430499|NCT01568047|11710924|FG003|Overall Study|Withdrawal by Subject|0
7430500|NCT01568047|11710921|FG000|Overall Study|Adverse Event|0
7430501|NCT01568047|11710922|FG001|Overall Study|Adverse Event|0
7430502|NCT01568047|11710923|FG002|Overall Study|Adverse Event|1
7430503|NCT01568047|11710924|FG003|Overall Study|Adverse Event|1
7430504|NCT01568112|11710959|FG000|Overall Study|Randomized But Not Treated|0
7430505|NCT01568112|11710960|FG001|Overall Study|Randomized But Not Treated|1
7430506|NCT01568112|11710961|FG002|Overall Study|Randomized But Not Treated|0
7430507|NCT01568112|11710962|FG003|Overall Study|Randomized But Not Treated|0
7430508|NCT01568112|11710959|FG000|Overall Study|Withdrew due to Adverse Event|2
7430509|NCT01568112|11710960|FG001|Overall Study|Withdrew due to Adverse Event|4
7430510|NCT01568112|11710961|FG002|Overall Study|Withdrew due to Adverse Event|6
7430511|NCT01568112|11710962|FG003|Overall Study|Withdrew due to Adverse Event|3
7430512|NCT01568112|11710959|FG000|Overall Study|Lost to Follow-up|0
7430513|NCT01568112|11710960|FG001|Overall Study|Lost to Follow-up|0
7430514|NCT01568112|11710961|FG002|Overall Study|Lost to Follow-up|0
7430515|NCT01568112|11710962|FG003|Overall Study|Lost to Follow-up|1
7430516|NCT01568112|11710959|FG000|Overall Study|Withdrawal by Subject|2
7430517|NCT01568112|11710960|FG001|Overall Study|Withdrawal by Subject|3
7430518|NCT01568112|11710961|FG002|Overall Study|Withdrawal by Subject|0
7430519|NCT01568112|11710962|FG003|Overall Study|Withdrawal by Subject|7
7430520|NCT01568112|11710959|FG000|Overall Study|Withdrawal by Physician|1
7430521|NCT01568112|11710960|FG001|Overall Study|Withdrawal by Physician|0
7430522|NCT01568112|11710961|FG002|Overall Study|Withdrawal by Physician|1
7430523|NCT01568112|11710962|FG003|Overall Study|Withdrawal by Physician|1
7430524|NCT01568320|11710982|FG000|Overall Study|Death|20
7430525|NCT01568320|11710982|FG000|Overall Study|Lost to Follow-up|9
7430526|NCT01568320|11710982|FG000|Overall Study|Withdrawal by Subject|10
7430527|NCT01568320|11710982|FG000|Overall Study|Conversion to open repair|1
7430528|NCT01568320|11710982|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
7430529|NCT01568593|11711001|FG000|Overall Study|Lack of Efficacy|4
7430530|NCT01568593|11711002|FG001|Overall Study|Lack of Efficacy|1
7430531|NCT01568593|11711001|FG000|Overall Study|Adverse Event|3
7430532|NCT01568593|11711002|FG001|Overall Study|Adverse Event|2
7430551|NCT01568892|11711032|FG000|Open-label Phase|Adverse Event|2
7430552|NCT01568892|11711033|FG001|Open-label Phase|Adverse Event|0
7430553|NCT01568892|11711032|FG000|Open-label Phase|Lack of Efficacy|4
7430554|NCT01568892|11711033|FG001|Open-label Phase|Lack of Efficacy|2
7430555|NCT01568892|11711032|FG000|Open-label Phase|Lost to Follow-up|0
7430556|NCT01568892|11711033|FG001|Open-label Phase|Lost to Follow-up|1
7430557|NCT01569022|11711062|FG000|First Intervention|Lost to Follow-up|2
7430558|NCT01569022|11711063|FG001|First Intervention|Lost to Follow-up|1
7430559|NCT01569022|11711062|FG000|Second Intervention|Lost to Follow-up|2
7430560|NCT01569022|11711063|FG001|Second Intervention|Lost to Follow-up|2
7430561|NCT01569074|11711076|FG000|Overall Study|Study stopped|6
7430562|NCT01569074|11711077|FG001|Overall Study|Study stopped|6
7430563|NCT01569074|11711078|FG002|Overall Study|Study stopped|8
7430564|NCT01569074|11711079|FG003|Overall Study|Study stopped|7
7430565|NCT01569074|11711080|FG004|Overall Study|Study stopped|7
7430566|NCT01569074|11711076|FG000|Overall Study|Study-specific discontinuation criteria|0
7430567|NCT01569074|11711077|FG001|Overall Study|Study-specific discontinuation criteria|1
7430568|NCT01569074|11711078|FG002|Overall Study|Study-specific discontinuation criteria|0
7430569|NCT01569074|11711079|FG003|Overall Study|Study-specific discontinuation criteria|0
7430570|NCT01569074|11711080|FG004|Overall Study|Study-specific discontinuation criteria|0
7430571|NCT01569074|11711076|FG000|Overall Study|Severe non-compliance to protocol|0
7430572|NCT01569074|11711077|FG001|Overall Study|Severe non-compliance to protocol|0
7430573|NCT01569074|11711078|FG002|Overall Study|Severe non-compliance to protocol|1
7430574|NCT01569074|11711079|FG003|Overall Study|Severe non-compliance to protocol|0
7430575|NCT01569074|11711080|FG004|Overall Study|Severe non-compliance to protocol|0
7430576|NCT01569074|11711076|FG000|Overall Study|eg change in circumstances|0
7430577|NCT01569074|11711077|FG001|Overall Study|eg change in circumstances|2
7430578|NCT01569074|11711078|FG002|Overall Study|eg change in circumstances|0
7430579|NCT01569074|11711079|FG003|Overall Study|eg change in circumstances|1
7430580|NCT01569074|11711080|FG004|Overall Study|eg change in circumstances|1
7430581|NCT01569074|11711076|FG000|Overall Study|Adverse Event|1
7430582|NCT01569074|11711077|FG001|Overall Study|Adverse Event|0
7430583|NCT01569074|11711078|FG002|Overall Study|Adverse Event|3
7430584|NCT01569074|11711079|FG003|Overall Study|Adverse Event|0
7430585|NCT01569074|11711080|FG004|Overall Study|Adverse Event|0
7430586|NCT01569152|11711141|FG000|Phase IIa, Period 1|Early Escape|5
7430587|NCT01569152|11711142|FG001|Phase IIa, Period 1|Early Escape|22
7430588|NCT01569152|11711143|FG002|Phase IIa, Period 1|Early Escape|0
7430589|NCT01569152|11711141|FG000|Phase IIa, Period 1|Adverse Event|4
7430590|NCT01569152|11711142|FG001|Phase IIa, Period 1|Adverse Event|0
7430591|NCT01569152|11711143|FG002|Phase IIa, Period 1|Adverse Event|0
7430592|NCT01569152|11711141|FG000|Phase IIa, Period 1|Lost to Follow-up|1
7430593|NCT01569152|11711142|FG001|Phase IIa, Period 1|Lost to Follow-up|0
7430594|NCT01569152|11711143|FG002|Phase IIa, Period 1|Lost to Follow-up|0
7430595|NCT01569152|11711141|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
7430596|NCT01569152|11711142|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
7430597|NCT01569152|11711143|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
7430598|NCT01569152|11711141|FG000|Phase IIa, Period 1|Protocol Violation|0
7430599|NCT01569152|11711142|FG001|Phase IIa, Period 1|Protocol Violation|1
7430600|NCT01569152|11711143|FG002|Phase IIa, Period 1|Protocol Violation|0
7430601|NCT01569152|11711141|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
7430602|NCT01569152|11711142|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
7430603|NCT01569152|11711143|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
7430604|NCT01569152|11711141|FG000|Safety Extension, Period 3|Adverse Event|0
7430605|NCT01569152|11711142|FG001|Safety Extension, Period 3|Adverse Event|0
7430606|NCT01569152|11711143|FG002|Safety Extension, Period 3|Adverse Event|4
7430607|NCT01569152|11711141|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
7430608|NCT01569152|11711142|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
7430609|NCT01569152|11711143|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
7430610|NCT01569152|11711141|FG000|Safety Extension, Period 3|Physician Decision|0
7430611|NCT01569152|11711142|FG001|Safety Extension, Period 3|Physician Decision|0
7430612|NCT01569152|11711143|FG002|Safety Extension, Period 3|Physician Decision|2
7430613|NCT01569152|11711141|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
7430614|NCT01569152|11711142|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
7430615|NCT01569152|11711143|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
7430616|NCT01569295|11711165|FG000|Overall Study|Progressive Disease|75
7430617|NCT01569295|11711166|FG001|Overall Study|Progressive Disease|139
7430618|NCT01569295|11711165|FG000|Overall Study|Adverse Event|39
7430619|NCT01569295|11711166|FG001|Overall Study|Adverse Event|14
7430620|NCT01569295|11711165|FG000|Overall Study|Withdrawal by Subject|25
7430621|NCT01569295|11711166|FG001|Overall Study|Withdrawal by Subject|12
7430622|NCT01569295|11711165|FG000|Overall Study|Death|19
7430623|NCT01569295|11711166|FG001|Overall Study|Death|15
7430624|NCT01569295|11711165|FG000|Overall Study|Physician Decision|13
7430625|NCT01569295|11711166|FG001|Overall Study|Physician Decision|18
7430626|NCT01569295|11711165|FG000|Overall Study|Study Terminated by Sponsor|24
7430627|NCT01569295|11711166|FG001|Overall Study|Study Terminated by Sponsor|2
7430628|NCT01569295|11711165|FG000|Overall Study|Other Reason not Specified|3
7430629|NCT01569295|11711166|FG001|Overall Study|Other Reason not Specified|5
7430630|NCT01569295|11711165|FG000|Overall Study|Non-Compliance with Study Drug|6
7430631|NCT01569295|11711166|FG001|Overall Study|Non-Compliance with Study Drug|1
7430632|NCT01569295|11711165|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
7430633|NCT01569295|11711166|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
7430634|NCT01569295|11711165|FG000|Overall Study|Lost to Follow-up|1
7430635|NCT01569295|11711166|FG001|Overall Study|Lost to Follow-up|1
7430636|NCT01569438|11711175|FG000|Overall Study|Lack of Efficacy|1
7430637|NCT01569438|11711176|FG001|Overall Study|Lack of Efficacy|2
7430638|NCT01569438|11711175|FG000|Overall Study|Withdrawal by Subject|0
7430639|NCT01569438|11711176|FG001|Overall Study|Withdrawal by Subject|3
7430640|NCT01569438|11711175|FG000|Overall Study|Adverse Event|2
7430641|NCT01569438|11711176|FG001|Overall Study|Adverse Event|15
7430642|NCT01569438|11711175|FG000|Overall Study|Protocol Violation|2
7430643|NCT01569438|11711176|FG001|Overall Study|Protocol Violation|0
7430644|NCT01569438|11711175|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
7430645|NCT01569438|11711176|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
7430646|NCT01569438|11711175|FG000|Overall Study|Sponsor/Physician decision|1
7430647|NCT01569438|11711176|FG001|Overall Study|Sponsor/Physician decision|1
7430648|NCT01569438|11711175|FG000|Overall Study|Unable to adhere to study schedule|0
7430649|NCT01569438|11711176|FG001|Overall Study|Unable to adhere to study schedule|1
7430650|NCT01569464|11711195|FG000|Overall Study|Adverse Event|4
7430651|NCT01569464|11711196|FG001|Overall Study|Adverse Event|0
7430652|NCT01569464|11711195|FG000|Overall Study|Lack of Efficacy|1
7430653|NCT01569464|11711196|FG001|Overall Study|Lack of Efficacy|0
7430654|NCT01569464|11711195|FG000|Overall Study|Protocol Violation|1
7430655|NCT01569464|11711196|FG001|Overall Study|Protocol Violation|0
7430656|NCT01569464|11711195|FG000|Overall Study|Lost to Follow-up|2
7430657|NCT01569464|11711196|FG001|Overall Study|Lost to Follow-up|3
7430658|NCT01569464|11711195|FG000|Overall Study|Withdrawal by Subject|1
7430659|NCT01569464|11711196|FG001|Overall Study|Withdrawal by Subject|1
7430660|NCT01569464|11711195|FG000|Overall Study|Other|1
7430661|NCT01569464|11711196|FG001|Overall Study|Other|1
7430662|NCT01569568|11711215|FG000|Overall Study|Physician Decision|0
7430663|NCT01569568|11711216|FG001|Overall Study|Physician Decision|2
7430664|NCT01569594|11711222|FG000|Overall Study|Physician Decision|4
7430665|NCT01569594|11711222|FG000|Overall Study|Death|13
7430666|NCT01569594|11711222|FG000|Overall Study|Lost to Follow-up|22
7430667|NCT01569594|11711222|FG000|Overall Study|Adverse Event|2
7430668|NCT01569594|11711222|FG000|Overall Study|Withdrawal by Subject|13
7430669|NCT01569594|11711222|FG000|Overall Study|Other|4
7430670|NCT01569594|11711222|FG000|Overall Study|No ECM used|9
7430671|NCT01569763|11711241|FG000|Overall Study|Lack of Efficacy|2
7430672|NCT01569763|11711242|FG001|Overall Study|Lack of Efficacy|7
7430673|NCT01569763|11711241|FG000|Overall Study|Adverse Event|1
7430674|NCT01569763|11711242|FG001|Overall Study|Adverse Event|0
7430675|NCT01569841|11711276|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
7430676|NCT01569841|11711277|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
7430677|NCT01570192|11711296|FG000|Overall Study|no qualifying organism|6
7430678|NCT01570192|11711297|FG001|Overall Study|no qualifying organism|12
7430679|NCT01570192|11711296|FG000|Overall Study|changed to palliative care|1
7430680|NCT01570192|11711297|FG001|Overall Study|changed to palliative care|0
7430681|NCT01570192|11711296|FG000|Overall Study|Physician Decision|0
7430682|NCT01570192|11711297|FG001|Overall Study|Physician Decision|1
7430683|NCT01570244|11711308|FG000|Microgynon+Faldaprevir|Adverse Event|1
7430684|NCT01570283|11711317|FG000|Cohort 1: Dose Level 1|Death|0
7430685|NCT01570283|11711318|FG001|Cohort 1: Dose Level 1|Death|1
7430686|NCT01570283|11711319|FG002|Cohort 1: Dose Level 1|Death|0
7430687|NCT01570283|11711320|FG003|Cohort 1: Dose Level 1|Death|0
7430688|NCT01570283|11711321|FG004|Cohort 1: Dose Level 1|Death|0
7430689|NCT01570283|11711322|FG005|Cohort 1: Dose Level 1|Death|0
7430690|NCT01570283|11711317|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7430691|NCT01570283|11711318|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
7430692|NCT01570283|11711319|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7430693|NCT01570283|11711320|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7430694|NCT01570283|11711321|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7430695|NCT01570283|11711322|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
7430696|NCT01570283|11711317|FG000|Cohort 2: Dose Level 2|Death|0
7430697|NCT01570283|11711318|FG001|Cohort 2: Dose Level 2|Death|0
7430698|NCT01570283|11711319|FG002|Cohort 2: Dose Level 2|Death|1
7430699|NCT01570283|11711320|FG003|Cohort 2: Dose Level 2|Death|0
7430700|NCT01570283|11711321|FG004|Cohort 2: Dose Level 2|Death|0
7430701|NCT01570283|11711322|FG005|Cohort 2: Dose Level 2|Death|0
7328534|NCT00797108|11561580|FG000|Overall Study|Did Not Meet Entrance Criteria|0
7328535|NCT00797108|11561581|FG001|Overall Study|Did Not Meet Entrance Criteria|1
7328536|NCT00797108|11561582|FG002|Overall Study|Did Not Meet Entrance Criteria|0
7328537|NCT00797108|11561580|FG000|Overall Study|Global Deterioration of Health Status|0
7328538|NCT00797108|11561581|FG001|Overall Study|Global Deterioration of Health Status|1
7328539|NCT00797108|11561582|FG002|Overall Study|Global Deterioration of Health Status|0
7328540|NCT00797108|11561580|FG000|Overall Study|Lack of Efficacy|1
7328541|NCT00797108|11561581|FG001|Overall Study|Lack of Efficacy|0
7328542|NCT00797108|11561582|FG002|Overall Study|Lack of Efficacy|1
7328543|NCT00797108|11561580|FG000|Overall Study|Other|0
7328544|NCT00797108|11561581|FG001|Overall Study|Other|0
7328545|NCT00797108|11561582|FG002|Overall Study|Other|2
7328546|NCT00797108|11561580|FG000|Overall Study|Randomized but not Treated|2
7328547|NCT00797108|11561581|FG001|Overall Study|Randomized but not Treated|0
7328548|NCT00797108|11561582|FG002|Overall Study|Randomized but not Treated|0
7328549|NCT00797225|11561598|FG000|Weeks 1 to 12|Adverse Event|0
7328550|NCT00797225|11561599|FG001|Weeks 1 to 12|Adverse Event|0
7328551|NCT00797225|11561600|FG002|Weeks 1 to 12|Adverse Event|1
7328552|NCT00797225|11561601|FG003|Weeks 1 to 12|Adverse Event|0
7328553|NCT00797225|11561602|FG004|Weeks 1 to 12|Adverse Event|0
7328554|NCT00797225|11561603|FG005|Weeks 1 to 12|Adverse Event|0
7328555|NCT00797225|11561604|FG006|Weeks 1 to 12|Adverse Event|0
7328556|NCT00797225|11561605|FG007|Weeks 1 to 12|Adverse Event|0
7328557|NCT00797225|11561598|FG000|Weeks 1 to 12|Non-compliance|0
7328558|NCT00797225|11561599|FG001|Weeks 1 to 12|Non-compliance|1
7328559|NCT00797225|11561600|FG002|Weeks 1 to 12|Non-compliance|0
7328560|NCT00797225|11561601|FG003|Weeks 1 to 12|Non-compliance|0
7328561|NCT00797225|11561602|FG004|Weeks 1 to 12|Non-compliance|0
7328562|NCT00797225|11561603|FG005|Weeks 1 to 12|Non-compliance|0
7328563|NCT00797225|11561604|FG006|Weeks 1 to 12|Non-compliance|0
7328564|NCT00797225|11561605|FG007|Weeks 1 to 12|Non-compliance|0
7430702|NCT01570283|11711317|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7430703|NCT01570283|11711318|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7430704|NCT01570283|11711319|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7430705|NCT01570283|11711320|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
7430706|NCT01570283|11711321|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7430707|NCT01570283|11711322|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
7430708|NCT01570283|11711317|FG000|Cohort 3: Dose Level 3|Death|0
7430709|NCT01570283|11711318|FG001|Cohort 3: Dose Level 3|Death|0
7328565|NCT00797225|11561598|FG000|Weeks 1 to 12|Lack of Efficacy|1
7328566|NCT00797225|11561599|FG001|Weeks 1 to 12|Lack of Efficacy|0
7328567|NCT00797225|11561600|FG002|Weeks 1 to 12|Lack of Efficacy|0
7328568|NCT00797225|11561601|FG003|Weeks 1 to 12|Lack of Efficacy|0
7328569|NCT00797225|11561602|FG004|Weeks 1 to 12|Lack of Efficacy|0
7430710|NCT01570283|11711319|FG002|Cohort 3: Dose Level 3|Death|0
7430711|NCT01570283|11711320|FG003|Cohort 3: Dose Level 3|Death|0
7430712|NCT01570283|11711321|FG004|Cohort 3: Dose Level 3|Death|0
7430713|NCT01570283|11711322|FG005|Cohort 3: Dose Level 3|Death|1
7430714|NCT01570283|11711317|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7430715|NCT01570283|11711318|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7430716|NCT01570283|11711319|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7430717|NCT01570283|11711320|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7430718|NCT01570283|11711321|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
7430719|NCT01570283|11711322|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
7430720|NCT01570309|11711338|FG000|Overall Study|Withdrawal by Subject|3
7430721|NCT01570309|11711339|FG001|Overall Study|Withdrawal by Subject|3
7430722|NCT01570361|11711355|FG000|Overall Study|Subject discontinued|1
7430723|NCT01570361|11711356|FG001|Overall Study|Subject discontinued|2
7430724|NCT01570361|11711355|FG000|Overall Study|Sponsor closing the study|51
7430725|NCT01570361|11711356|FG001|Overall Study|Sponsor closing the study|50
7430726|NCT01570361|11711355|FG000|Overall Study|Subject excluded|5
7430727|NCT01570361|11711356|FG001|Overall Study|Subject excluded|3
7430728|NCT01570361|11711355|FG000|Overall Study|Subject withdrew consent|14
7430729|NCT01570361|11711356|FG001|Overall Study|Subject withdrew consent|9
7430730|NCT01570361|11711355|FG000|Overall Study|Adverse Event|2
7430731|NCT01570361|11711356|FG001|Overall Study|Adverse Event|1
7430732|NCT01570361|11711355|FG000|Overall Study|Lost to Follow-up|4
7430733|NCT01570361|11711356|FG001|Overall Study|Lost to Follow-up|4
7430734|NCT01570361|11711355|FG000|Overall Study|Death|5
7430735|NCT01570361|11711356|FG001|Overall Study|Death|4
7430736|NCT01570361|11711355|FG000|Overall Study|Other|0
7430737|NCT01570361|11711356|FG001|Overall Study|Other|2
7430738|NCT01570387|11711369|FG000|Overall Study|Adverse Event|1
7430739|NCT01570387|11711370|FG001|Overall Study|Adverse Event|0
7430740|NCT01570387|11711371|FG002|Overall Study|Adverse Event|0
7430741|NCT01570387|11711372|FG003|Overall Study|Adverse Event|0
7430742|NCT01570387|11711369|FG000|Overall Study|Death|0
7430743|NCT01570387|11711370|FG001|Overall Study|Death|0
7430744|NCT01570387|11711371|FG002|Overall Study|Death|0
7430745|NCT01570387|11711372|FG003|Overall Study|Death|1
7430746|NCT01570387|11711369|FG000|Overall Study|Withdrawal by Subject|0
7430747|NCT01570387|11711370|FG001|Overall Study|Withdrawal by Subject|0
7430748|NCT01570387|11711371|FG002|Overall Study|Withdrawal by Subject|0
7430749|NCT01570387|11711372|FG003|Overall Study|Withdrawal by Subject|1
7430750|NCT01570491|11711381|FG000|Overall Study|Lost to Follow-up|3
7430751|NCT01570491|11711382|FG001|Overall Study|Lost to Follow-up|1
7430752|NCT01570491|11711381|FG000|Overall Study|treatment: not given or discontinued|2
7430753|NCT01570491|11711382|FG001|Overall Study|treatment: not given or discontinued|0
7430754|NCT01570686|11711390|FG000|Overall Study|Abnormal test procedure result(s)|1
7430755|NCT01570686|11711391|FG001|Overall Study|Abnormal test procedure result(s)|1
7430756|NCT01570686|11711390|FG000|Overall Study|Administrative problems|0
7430757|NCT01570686|11711391|FG001|Overall Study|Administrative problems|1
7430758|NCT01570686|11711390|FG000|Overall Study|Adverse Event|8
7430759|NCT01570686|11711391|FG001|Overall Study|Adverse Event|6
7430760|NCT01570686|11711390|FG000|Overall Study|Lost to Follow-up|4
7430761|NCT01570686|11711391|FG001|Overall Study|Lost to Follow-up|3
7430762|NCT01570686|11711390|FG000|Overall Study|Protocol Deviation|3
7430763|NCT01570686|11711391|FG001|Overall Study|Protocol Deviation|0
7430764|NCT01570686|11711390|FG000|Overall Study|Withdrawal by Subject|4
7430765|NCT01570686|11711391|FG001|Overall Study|Withdrawal by Subject|4
7430766|NCT01570686|11711390|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7328570|NCT00797225|11561603|FG005|Weeks 1 to 12|Lack of Efficacy|0
7328571|NCT00797225|11561604|FG006|Weeks 1 to 12|Lack of Efficacy|0
7328572|NCT00797225|11561605|FG007|Weeks 1 to 12|Lack of Efficacy|0
7328573|NCT00797225|11561598|FG000|Weeks 1 to 12|Sponsor Decision|1
7328574|NCT00797225|11561599|FG001|Weeks 1 to 12|Sponsor Decision|0
7328575|NCT00797225|11561600|FG002|Weeks 1 to 12|Sponsor Decision|0
7328576|NCT00797225|11561601|FG003|Weeks 1 to 12|Sponsor Decision|0
7328577|NCT00797225|11561602|FG004|Weeks 1 to 12|Sponsor Decision|0
7328578|NCT00797225|11561603|FG005|Weeks 1 to 12|Sponsor Decision|0
7328579|NCT00797225|11561604|FG006|Weeks 1 to 12|Sponsor Decision|0
7430767|NCT01570686|11711391|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7430768|NCT01570751|11711399|FG000|Period A (16 Weeks)|Protocol Violation|1
7430769|NCT01570751|11711400|FG001|Period A (16 Weeks)|Protocol Violation|1
7430770|NCT01570751|11711399|FG000|Period A (16 Weeks)|Withdrawal criteria|0
7430771|NCT01570751|11711400|FG001|Period A (16 Weeks)|Withdrawal criteria|1
7430772|NCT01570751|11711399|FG000|Period A (16 Weeks)|Unclassified|2
7430773|NCT01570751|11711400|FG001|Period A (16 Weeks)|Unclassified|3
7430774|NCT01570751|11711399|FG000|Period B (16 Weeks)|Adverse Event|1
7430775|NCT01570751|11711400|FG001|Period B (16 Weeks)|Adverse Event|0
7430776|NCT01570751|11711399|FG000|Period B (16 Weeks)|Protocol Violation|0
7328580|NCT00797225|11561605|FG007|Weeks 1 to 12|Sponsor Decision|0
7430777|NCT01570751|11711400|FG001|Period B (16 Weeks)|Protocol Violation|1
7430778|NCT01570868|11711419|FG000|Overall Study|Adverse Event|8
7328581|NCT00797225|11561598|FG000|Weeks 13 to 24|Non-compliance|0
7328582|NCT00797225|11561599|FG001|Weeks 13 to 24|Non-compliance|2
7328583|NCT00797225|11561600|FG002|Weeks 13 to 24|Non-compliance|0
7430779|NCT01570868|11711420|FG001|Overall Study|Adverse Event|1
7430780|NCT01570868|11711419|FG000|Overall Study|FDA Recommendation|23
7430781|NCT01570868|11711420|FG001|Overall Study|FDA Recommendation|3
7430782|NCT01570868|11711419|FG000|Overall Study|Physician Decision|10
7430783|NCT01570868|11711420|FG001|Overall Study|Physician Decision|4
7430784|NCT01570868|11711419|FG000|Overall Study|Lost to Follow-up|1
7430785|NCT01570868|11711420|FG001|Overall Study|Lost to Follow-up|0
7430786|NCT01570868|11711419|FG000|Overall Study|Withdrawal by Subject|1
7430787|NCT01570868|11711420|FG001|Overall Study|Withdrawal by Subject|0
7558680|NCT03131687|11924349|FG000|Overall Study|Principle Investigator Decision|0
7558681|NCT03131687|11924350|FG001|Overall Study|Principle Investigator Decision|1
7558682|NCT03131687|11924351|FG002|Overall Study|Principle Investigator Decision|0
7558683|NCT03131687|11924352|FG003|Overall Study|Principle Investigator Decision|0
7558684|NCT03131687|11924353|FG004|Overall Study|Principle Investigator Decision|0
7558685|NCT03131687|11924354|FG005|Overall Study|Principle Investigator Decision|0
7558686|NCT03131687|11924349|FG000|Overall Study|Inadvertent Enrollment|0
7328584|NCT00797225|11561601|FG003|Weeks 13 to 24|Non-compliance|0
7558687|NCT03131687|11924350|FG001|Overall Study|Inadvertent Enrollment|0
7558688|NCT03131687|11924351|FG002|Overall Study|Inadvertent Enrollment|0
7558689|NCT03131687|11924352|FG003|Overall Study|Inadvertent Enrollment|1
7558690|NCT03131687|11924353|FG004|Overall Study|Inadvertent Enrollment|0
7558691|NCT03131687|11924354|FG005|Overall Study|Inadvertent Enrollment|0
7328585|NCT00797225|11561602|FG004|Weeks 13 to 24|Non-compliance|0
7430788|NCT01571232|11711432|FG000|Overall Study|Lost to Follow-up|0
7430789|NCT01571232|11711433|FG001|Overall Study|Lost to Follow-up|1
7430790|NCT01571232|11711432|FG000|Overall Study|Withdrawal by Subject|1
7430791|NCT01571232|11711433|FG001|Overall Study|Withdrawal by Subject|0
7430792|NCT01571284|11711440|FG000|Overall Study|Participant's decision|84
7430793|NCT01571284|11711440|FG000|Overall Study|Lost to Follow-up|3
7430794|NCT01571284|11711440|FG000|Overall Study|Enrolled but not treated|2
7430795|NCT01571284|11711440|FG000|Overall Study|Other than specified above|80
7430796|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
7430797|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7430798|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
7430799|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
7430800|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
7430801|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
7430802|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
7430803|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
7430804|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
7532246|NCT02669017|11877829|FG006|Overall Study|Miscellaneous|1
7532247|NCT02669017|11877830|FG007|Overall Study|Miscellaneous|13
7532248|NCT02669017|11877831|FG008|Overall Study|Miscellaneous|2
7532249|NCT02669043|11877859|FG000|Overall Study|Didn't meet I/E criteria|4
7532250|NCT02669082|11877863|FG000|Overall Study|Adverse Event|1
7532251|NCT02669095|11877869|FG000|Overall Study|Adverse Event|1
7532252|NCT02669095|11877870|FG001|Overall Study|Adverse Event|0
7328586|NCT00797225|11561603|FG005|Weeks 13 to 24|Non-compliance|0
7328587|NCT00797225|11561604|FG006|Weeks 13 to 24|Non-compliance|0
7328588|NCT00797225|11561605|FG007|Weeks 13 to 24|Non-compliance|0
7328589|NCT00797225|11561598|FG000|Weeks 13 to 24|Withdrawal by Subject|0
7328590|NCT00797225|11561599|FG001|Weeks 13 to 24|Withdrawal by Subject|1
7328591|NCT00797225|11561600|FG002|Weeks 13 to 24|Withdrawal by Subject|1
7328592|NCT00797225|11561601|FG003|Weeks 13 to 24|Withdrawal by Subject|0
7328593|NCT00797225|11561602|FG004|Weeks 13 to 24|Withdrawal by Subject|0
7328594|NCT00797225|11561603|FG005|Weeks 13 to 24|Withdrawal by Subject|0
7328595|NCT00797225|11561604|FG006|Weeks 13 to 24|Withdrawal by Subject|0
7328596|NCT00797225|11561605|FG007|Weeks 13 to 24|Withdrawal by Subject|0
7328597|NCT00797225|11561598|FG000|Weeks 13 to 24|Lost to Follow-up|0
7328598|NCT00797225|11561599|FG001|Weeks 13 to 24|Lost to Follow-up|0
7328599|NCT00797225|11561600|FG002|Weeks 13 to 24|Lost to Follow-up|1
7328600|NCT00797225|11561601|FG003|Weeks 13 to 24|Lost to Follow-up|0
7328601|NCT00797225|11561602|FG004|Weeks 13 to 24|Lost to Follow-up|1
7328602|NCT00797225|11561603|FG005|Weeks 13 to 24|Lost to Follow-up|0
7328603|NCT00797225|11561604|FG006|Weeks 13 to 24|Lost to Follow-up|0
7328604|NCT00797225|11561605|FG007|Weeks 13 to 24|Lost to Follow-up|0
7328605|NCT00797225|11561598|FG000|Weeks 13 to 24|Adverse Event|0
7328606|NCT00797225|11561599|FG001|Weeks 13 to 24|Adverse Event|1
7328607|NCT00797225|11561600|FG002|Weeks 13 to 24|Adverse Event|0
7328608|NCT00797225|11561601|FG003|Weeks 13 to 24|Adverse Event|0
7328609|NCT00797225|11561602|FG004|Weeks 13 to 24|Adverse Event|0
7328610|NCT00797225|11561603|FG005|Weeks 13 to 24|Adverse Event|0
7328611|NCT00797225|11561604|FG006|Weeks 13 to 24|Adverse Event|1
7328612|NCT00797225|11561605|FG007|Weeks 13 to 24|Adverse Event|0
7328613|NCT00797225|11561598|FG000|Weeks 13 to 24|Sponsor Decision|0
7328614|NCT00797225|11561599|FG001|Weeks 13 to 24|Sponsor Decision|0
7532253|NCT02669095|11877869|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7532254|NCT02669095|11877870|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7532255|NCT02669095|11877869|FG000|Overall Study|Torn Lens|0
7532256|NCT02669095|11877870|FG001|Overall Study|Torn Lens|1
7532257|NCT02669095|11877869|FG000|Overall Study|Visit 5 assessments not completed|0
7532258|NCT02669095|11877870|FG001|Overall Study|Visit 5 assessments not completed|1
7430805|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
7430806|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7430807|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
7430808|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
7430809|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7430810|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
7430811|NCT01571362|11711444|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
7430812|NCT01571362|11711445|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
7430813|NCT01571362|11711446|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
7430814|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7430815|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
7430816|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
7430817|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Protocol Violation|0
7430818|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Protocol Violation|8
7430819|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Protocol Violation|9
7430820|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Adverse Event|0
7430821|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Adverse Event|9
7430822|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Adverse Event|14
7430823|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7430824|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
7430825|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
7430826|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
7430827|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
7430828|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
7430829|NCT01571362|11711444|FG000|Double-Blind Treatment Period|Other - unspecified|0
7430830|NCT01571362|11711445|FG001|Double-Blind Treatment Period|Other - unspecified|6
7430831|NCT01571362|11711446|FG002|Double-Blind Treatment Period|Other - unspecified|1
7467016|NCT01896895|11767208|FG003|Double-blind MP|Lost to Follow-up|0
7467017|NCT01896934|11767221|FG000|Overall Study|Adverse Event|1
7467018|NCT01896934|11767221|FG000|Overall Study|Withdrawal by Subject|1
7467019|NCT01896986|11767227|FG000|Overall Study|samples lost|14
7467020|NCT01896986|11767228|FG001|Overall Study|samples lost|23
7468668|NCT01912872|11769558|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7468669|NCT01912872|11769559|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7468670|NCT01912872|11769560|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7468671|NCT01912872|11769561|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7468672|NCT01912872|11769558|FG000|Overall Study|Withdrawal of study medication|0
7468673|NCT01912872|11769559|FG001|Overall Study|Withdrawal of study medication|0
7468674|NCT01912872|11769560|FG002|Overall Study|Withdrawal of study medication|0
7468675|NCT01912872|11769561|FG003|Overall Study|Withdrawal of study medication|2
7468676|NCT01912872|11769558|FG000|Overall Study|Missing|0
7468677|NCT01912872|11769559|FG001|Overall Study|Missing|0
7558692|NCT03131713|11924383|FG000|Overall Study|Lost to Follow-up|5
7558693|NCT03131713|11924384|FG001|Overall Study|Lost to Follow-up|0
7558694|NCT03131895|11924394|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
7558695|NCT03131895|11924395|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
7558696|NCT03131895|11924396|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
7558697|NCT03131895|11924397|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
7558698|NCT03131895|11924394|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7558699|NCT03131895|11924395|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7558700|NCT03131895|11924396|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
7558701|NCT03131895|11924397|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
7558702|NCT03131895|11924394|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7558703|NCT03131895|11924395|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
7558704|NCT03131895|11924396|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7558705|NCT03131895|11924397|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7558706|NCT03131895|11924394|FG000|Washout Period (at Least 5 Days)|Other|0
7558707|NCT03131895|11924395|FG001|Washout Period (at Least 5 Days)|Other|0
7468678|NCT01912872|11769560|FG002|Overall Study|Missing|0
7468679|NCT01912872|11769561|FG003|Overall Study|Missing|1
7468680|NCT01912963|11769575|FG000|Overall Study|Disease Progression (RECIST1.1)|6
7468681|NCT01912963|11769576|FG001|Overall Study|Disease Progression (RECIST1.1)|9
7468682|NCT01912963|11769577|FG002|Overall Study|Disease Progression (RECIST1.1)|5
7468683|NCT01912963|11769575|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
7532259|NCT02669121|11877878|FG000|Overall Study|Adverse Event|4
7532260|NCT02669121|11877879|FG001|Overall Study|Adverse Event|5
7532261|NCT02669121|11877878|FG000|Overall Study|Lost to Follow-up|15
7532262|NCT02669121|11877879|FG001|Overall Study|Lost to Follow-up|27
7532263|NCT02669121|11877878|FG000|Overall Study|Withdrawal by Subject|132
7532264|NCT02669121|11877879|FG001|Overall Study|Withdrawal by Subject|140
7532265|NCT02669121|11877878|FG000|Overall Study|Pregnancy|0
7532266|NCT02669121|11877879|FG001|Overall Study|Pregnancy|1
7532267|NCT02669121|11877878|FG000|Overall Study|Discharged from US Military Active Service|117
7532268|NCT02669121|11877879|FG001|Overall Study|Discharged from US Military Active Service|91
7532269|NCT02669121|11877878|FG000|Overall Study|Reason not Specified|22
7430832|NCT01571453|11711465|FG000|Overall Study|Adverse Event|14
7430833|NCT01571453|11711466|FG001|Overall Study|Adverse Event|32
7430834|NCT01571453|11711465|FG000|Overall Study|Lack of Efficacy|8
7430835|NCT01571453|11711466|FG001|Overall Study|Lack of Efficacy|3
7430836|NCT01571453|11711465|FG000|Overall Study|Non-compliance|2
7430837|NCT01571453|11711466|FG001|Overall Study|Non-compliance|4
7430838|NCT01571453|11711465|FG000|Overall Study|Protocol Violation|1
7430839|NCT01571453|11711466|FG001|Overall Study|Protocol Violation|5
7430840|NCT01571453|11711465|FG000|Overall Study|Withdrawal of consent|5
7430841|NCT01571453|11711466|FG001|Overall Study|Withdrawal of consent|13
7430842|NCT01571453|11711465|FG000|Overall Study|Lost to Follow-up|4
7430843|NCT01571453|11711466|FG001|Overall Study|Lost to Follow-up|2
7430844|NCT01571453|11711465|FG000|Overall Study|Administrative or other reason(s)|4
7430845|NCT01571453|11711466|FG001|Overall Study|Administrative or other reason(s)|3
7430846|NCT01571596|11711479|FG000|Overall Study|Adverse Event|2
7430847|NCT01571596|11711480|FG001|Overall Study|Adverse Event|0
7430848|NCT01571596|11711481|FG002|Overall Study|Adverse Event|0
7430849|NCT01571596|11711479|FG000|Overall Study|Study Terminated by the Sponsor|0
7430850|NCT01571596|11711480|FG001|Overall Study|Study Terminated by the Sponsor|1
7430851|NCT01571596|11711481|FG002|Overall Study|Study Terminated by the Sponsor|1
7430852|NCT01572038|11711491|FG000|Overall Study|Death|648
7430853|NCT01572038|11711491|FG000|Overall Study|Withdrawal by Subject|204
7430854|NCT01572038|11711491|FG000|Overall Study|Lost to Follow-up|81
7430855|NCT01572038|11711491|FG000|Overall Study|Physician Decision|20
7430856|NCT01572038|11711491|FG000|Overall Study|Patient Decision|14
7430857|NCT01572038|11711491|FG000|Overall Study|Progressive Disease|8
7430858|NCT01572038|11711491|FG000|Overall Study|Site Closed Before Completing Form|6
7430859|NCT01572038|11711491|FG000|Overall Study|Enrolled into Another Trial|3
7430860|NCT01572038|11711491|FG000|Overall Study|Participated in Another Trial|3
7430861|NCT01572038|11711491|FG000|Overall Study|Termination by Sponsor|2
7430862|NCT01572038|11711491|FG000|Overall Study|Patient Deterioration|1
7430863|NCT01572038|11711491|FG000|Overall Study|Sponsor Decision|1
7430864|NCT01572389|11711530|FG000|Overall Study|Death|1
7430865|NCT01572389|11711531|FG001|Overall Study|Death|3
7430866|NCT01572389|11711530|FG000|Overall Study|Withdrawal by Subject|14
7430867|NCT01572389|11711531|FG001|Overall Study|Withdrawal by Subject|2
7430868|NCT01572389|11711530|FG000|Overall Study|Lost to Follow-up|25
7430869|NCT01572389|11711531|FG001|Overall Study|Lost to Follow-up|14
7430870|NCT01572389|11711530|FG000|Overall Study|Only A1C or Assessment was Collected|6
7430871|NCT01572389|11711531|FG001|Overall Study|Only A1C or Assessment was Collected|2
7430872|NCT01572727|11711548|FG000|Overall Study|Adverse Event|43
7430873|NCT01572727|11711549|FG001|Overall Study|Adverse Event|15
7430874|NCT01572727|11711548|FG000|Overall Study|Lost to Follow-up|1
7430875|NCT01572727|11711549|FG001|Overall Study|Lost to Follow-up|1
7430876|NCT01572727|11711548|FG000|Overall Study|Physician Decision|23
7430877|NCT01572727|11711549|FG001|Overall Study|Physician Decision|9
7430878|NCT01572727|11711548|FG000|Overall Study|Progressive disease|59
7430879|NCT01572727|11711549|FG001|Overall Study|Progressive disease|82
7430880|NCT01572727|11711548|FG000|Overall Study|Protocol Violation|0
7430881|NCT01572727|11711549|FG001|Overall Study|Protocol Violation|1
7430882|NCT01572727|11711548|FG000|Overall Study|Study terminated by sponsor|61
7430883|NCT01572727|11711549|FG001|Overall Study|Study terminated by sponsor|83
7430884|NCT01572727|11711548|FG000|Overall Study|Parent/guardian decision|14
7430885|NCT01572727|11711549|FG001|Overall Study|Parent/guardian decision|9
7430886|NCT01572727|11711548|FG000|Overall Study|Death|2
7430887|NCT01572727|11711549|FG001|Overall Study|Death|2
7430888|NCT01572727|11711548|FG000|Overall Study|Untreated|4
7430889|NCT01572727|11711549|FG001|Overall Study|Untreated|7
7430890|NCT01572740|11711557|FG000|Overall Study|Adverse Event|1
7430891|NCT01572740|11711558|FG001|Overall Study|Adverse Event|1
7430892|NCT01572740|11711557|FG000|Overall Study|Withdrawal by Subject|1
7430893|NCT01572740|11711558|FG001|Overall Study|Withdrawal by Subject|1
7430894|NCT01572740|11711557|FG000|Overall Study|unclassified|4
7430895|NCT01572740|11711558|FG001|Overall Study|unclassified|3
7430896|NCT01572792|11711569|FG000|Lead-in Study|Lost to Follow-up|5
7430897|NCT01572792|11711570|FG001|Lead-in Study|Lost to Follow-up|9
7430898|NCT01572792|11711571|FG002|Lead-in Study|Lost to Follow-up|4
7430899|NCT01572792|11711572|FG003|Lead-in Study|Lost to Follow-up|2
7430900|NCT01572792|11711573|FG004|Lead-in Study|Lost to Follow-up|4
7430901|NCT01572792|11711569|FG000|Lead-in Study|Withdrawal by Subject|22
7430902|NCT01572792|11711570|FG001|Lead-in Study|Withdrawal by Subject|11
7430903|NCT01572792|11711571|FG002|Lead-in Study|Withdrawal by Subject|12
7430904|NCT01572792|11711572|FG003|Lead-in Study|Withdrawal by Subject|24
7430905|NCT01572792|11711573|FG004|Lead-in Study|Withdrawal by Subject|11
7430906|NCT01572792|11711569|FG000|Lead-in Study|Protocol Violation|19
7430907|NCT01572792|11711570|FG001|Lead-in Study|Protocol Violation|10
7430908|NCT01572792|11711571|FG002|Lead-in Study|Protocol Violation|12
7430909|NCT01572792|11711572|FG003|Lead-in Study|Protocol Violation|13
7430910|NCT01572792|11711573|FG004|Lead-in Study|Protocol Violation|21
7430911|NCT01572792|11711569|FG000|Lead-in Study|Lack of Efficacy|20
7430912|NCT01572792|11711570|FG001|Lead-in Study|Lack of Efficacy|5
7430913|NCT01572792|11711571|FG002|Lead-in Study|Lack of Efficacy|4
7430914|NCT01572792|11711572|FG003|Lead-in Study|Lack of Efficacy|8
7430915|NCT01572792|11711573|FG004|Lead-in Study|Lack of Efficacy|10
7430916|NCT01572792|11711569|FG000|Lead-in Study|Adverse Event|21
7430917|NCT01572792|11711570|FG001|Lead-in Study|Adverse Event|21
7430918|NCT01572792|11711571|FG002|Lead-in Study|Adverse Event|22
7430919|NCT01572792|11711572|FG003|Lead-in Study|Adverse Event|16
7430920|NCT01572792|11711573|FG004|Lead-in Study|Adverse Event|14
7430921|NCT01572792|11711569|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
7430922|NCT01572792|11711570|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
7430923|NCT01572792|11711571|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
7430924|NCT01572792|11711572|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
7430925|NCT01572792|11711573|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
7430926|NCT01572792|11711569|FG000|Extension Study|Lost to Follow-up|6
7430927|NCT01572792|11711570|FG001|Extension Study|Lost to Follow-up|2
7430928|NCT01572792|11711571|FG002|Extension Study|Lost to Follow-up|0
7430929|NCT01572792|11711572|FG003|Extension Study|Lost to Follow-up|3
7430930|NCT01572792|11711573|FG004|Extension Study|Lost to Follow-up|3
7430931|NCT01572792|11711569|FG000|Extension Study|Withdrawal by Subject|7
7430932|NCT01572792|11711570|FG001|Extension Study|Withdrawal by Subject|6
7430933|NCT01572792|11711571|FG002|Extension Study|Withdrawal by Subject|11
7430934|NCT01572792|11711572|FG003|Extension Study|Withdrawal by Subject|8
7430935|NCT01572792|11711573|FG004|Extension Study|Withdrawal by Subject|14
7430936|NCT01572792|11711569|FG000|Extension Study|Protocol Violation|0
7430937|NCT01572792|11711570|FG001|Extension Study|Protocol Violation|4
7430938|NCT01572792|11711571|FG002|Extension Study|Protocol Violation|3
7430939|NCT01572792|11711572|FG003|Extension Study|Protocol Violation|4
7430940|NCT01572792|11711573|FG004|Extension Study|Protocol Violation|3
7430941|NCT01572792|11711569|FG000|Extension Study|Lack of Efficacy|2
7430942|NCT01572792|11711570|FG001|Extension Study|Lack of Efficacy|3
7430943|NCT01572792|11711571|FG002|Extension Study|Lack of Efficacy|3
7430944|NCT01572792|11711572|FG003|Extension Study|Lack of Efficacy|2
7430945|NCT01572792|11711573|FG004|Extension Study|Lack of Efficacy|2
7430946|NCT01572792|11711569|FG000|Extension Study|Adverse Event|7
7430947|NCT01572792|11711570|FG001|Extension Study|Adverse Event|6
7430948|NCT01572792|11711571|FG002|Extension Study|Adverse Event|5
7430949|NCT01572792|11711572|FG003|Extension Study|Adverse Event|6
7430950|NCT01572792|11711573|FG004|Extension Study|Adverse Event|4
7430951|NCT01572792|11711569|FG000|Extension Study|Site termination/COPD exacerbation/other|3
7430952|NCT01572792|11711570|FG001|Extension Study|Site termination/COPD exacerbation/other|8
7430953|NCT01572792|11711571|FG002|Extension Study|Site termination/COPD exacerbation/other|4
7430954|NCT01572792|11711572|FG003|Extension Study|Site termination/COPD exacerbation/other|6
7430955|NCT01572792|11711573|FG004|Extension Study|Site termination/COPD exacerbation/other|6
7430956|NCT01572844|11711586|FG000|Overall Study|Physician Decision|1
7430957|NCT01572844|11711587|FG001|Overall Study|Physician Decision|1
7430958|NCT01572909|11711598|FG000|Overall Study|Adverse Event|7
7430959|NCT01572909|11711599|FG001|Overall Study|Adverse Event|2
7430960|NCT01572909|11711598|FG000|Overall Study|Death|3
7430961|NCT01572909|11711599|FG001|Overall Study|Death|1
7430962|NCT01572909|11711598|FG000|Overall Study|Lost to Follow-up|8
7430963|NCT01572909|11711599|FG001|Overall Study|Lost to Follow-up|7
7430964|NCT01572909|11711598|FG000|Overall Study|Physician Decision|1
7430965|NCT01572909|11711599|FG001|Overall Study|Physician Decision|1
7430966|NCT01572909|11711598|FG000|Overall Study|Technical Issues|1
7430967|NCT01572909|11711599|FG001|Overall Study|Technical Issues|0
7430968|NCT01572909|11711598|FG000|Overall Study|Withdrawal by Subject|12
7430969|NCT01572909|11711599|FG001|Overall Study|Withdrawal by Subject|11
7430970|NCT01572909|11711598|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
7430971|NCT01572909|11711599|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
7430972|NCT01572922|11711607|FG000|Overall Study|Adverse Event|1
7430973|NCT01572922|11711607|FG000|Overall Study|Protocol Violation|1
7430974|NCT01572922|11711607|FG000|Overall Study|Death|1
7430975|NCT01572948|11711618|FG000|Overall Study|Lost to Follow-up|1
7430976|NCT01572948|11711619|FG001|Overall Study|Lost to Follow-up|0
7430977|NCT01572948|11711618|FG000|Overall Study|unable to contact|0
7430978|NCT01572948|11711619|FG001|Overall Study|unable to contact|1
7430979|NCT01573000|11711631|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
7430980|NCT01573000|11711632|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
7430981|NCT01573000|11711631|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
7430982|NCT01573000|11711632|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
7430983|NCT01573000|11711631|FG000|Dosimetric and Therapeutic Treatment|Death|0
7430984|NCT01573000|11711632|FG001|Dosimetric and Therapeutic Treatment|Death|1
7430985|NCT01573000|11711631|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
7430986|NCT01573000|11711632|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
7430987|NCT01573000|11711631|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
7430988|NCT01573000|11711632|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
7430989|NCT01573000|11711631|FG000|Crossover Phase|Lack of Efficacy|0
7430990|NCT01573000|11711632|FG001|Crossover Phase|Lack of Efficacy|13
7430991|NCT01573000|11711631|FG000|Crossover Phase|Lost to Follow-up|0
7430992|NCT01573000|11711632|FG001|Crossover Phase|Lost to Follow-up|2
7430993|NCT01573000|11711631|FG000|Crossover Phase|Death|0
7430994|NCT01573000|11711632|FG001|Crossover Phase|Death|3
7430995|NCT01573000|11711631|FG000|Long-Term Follow-Up|Death|3
7430996|NCT01573000|11711632|FG001|Long-Term Follow-Up|Death|0
7430997|NCT01573000|11711631|FG000|Long-Term Follow-Up|Lost to Follow-up|0
7430998|NCT01573000|11711632|FG001|Long-Term Follow-Up|Lost to Follow-up|1
7430999|NCT01573442|11711720|FG000|Overall Study|Cancels|9
7431000|NCT01573442|11711721|FG001|Overall Study|Cancels|10
7431001|NCT01573624|11711735|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7431002|NCT01573624|11711736|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7431003|NCT01573624|11711737|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7431004|NCT01573624|11711738|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7431005|NCT01573624|11711739|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7431006|NCT01573624|11711740|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
7431007|NCT01573624|11711741|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
7431008|NCT01573624|11711735|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
7431009|NCT01573624|11711736|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
7431010|NCT01573624|11711737|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
7431011|NCT01573624|11711738|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7431012|NCT01573624|11711739|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
7431013|NCT01573624|11711740|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
7431014|NCT01573624|11711741|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
7431015|NCT01573624|11711735|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
7431016|NCT01573624|11711736|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431017|NCT01573624|11711737|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431018|NCT01573624|11711738|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431019|NCT01573624|11711739|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431020|NCT01573624|11711740|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431021|NCT01573624|11711741|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
7431022|NCT01573624|11711735|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7431023|NCT01573624|11711736|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7431024|NCT01573624|11711737|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7431025|NCT01573624|11711738|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7431026|NCT01573624|11711739|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7431027|NCT01573624|11711740|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
7431028|NCT01573624|11711741|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7431029|NCT01573624|11711735|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7431030|NCT01573624|11711736|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7431031|NCT01573624|11711737|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7431032|NCT01573624|11711738|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7431033|NCT01573624|11711739|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
7431034|NCT01573624|11711740|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7431035|NCT01573624|11711741|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
7431036|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431037|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431038|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431039|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431040|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431041|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
7431042|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
7431043|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7431044|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7431045|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7558708|NCT03131895|11924396|FG002|Washout Period (at Least 5 Days)|Other|2
7558709|NCT03131895|11924397|FG003|Washout Period (at Least 5 Days)|Other|0
7558710|NCT03131895|11924394|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7558711|NCT03131895|11924395|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
7431046|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7431047|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7431048|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
7431049|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
7431050|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7431051|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7431052|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
7431053|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
7431054|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7431055|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7431056|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
7431057|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431058|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431059|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431060|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431061|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431062|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
7431063|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
7431064|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7431065|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7431066|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7431067|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
7431068|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7431069|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7431070|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7328615|NCT00797225|11561600|FG002|Weeks 13 to 24|Sponsor Decision|0
7328616|NCT00797225|11561601|FG003|Weeks 13 to 24|Sponsor Decision|0
7328617|NCT00797225|11561602|FG004|Weeks 13 to 24|Sponsor Decision|0
7328618|NCT00797225|11561603|FG005|Weeks 13 to 24|Sponsor Decision|0
7328619|NCT00797225|11561604|FG006|Weeks 13 to 24|Sponsor Decision|1
7328620|NCT00797225|11561605|FG007|Weeks 13 to 24|Sponsor Decision|0
7328621|NCT00797316|11561633|FG000|Overall Study|Administrative problems|1
7431071|NCT01573624|11711735|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7431072|NCT01573624|11711736|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7431073|NCT01573624|11711737|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7431074|NCT01573624|11711738|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7431075|NCT01573624|11711739|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7431076|NCT01573624|11711740|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
7431077|NCT01573624|11711741|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
7431078|NCT01573624|11711735|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
7431079|NCT01573624|11711736|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
7558712|NCT03131895|11924396|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7558713|NCT03131895|11924397|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
7431080|NCT01573624|11711737|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7431081|NCT01573624|11711738|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
7431082|NCT01573624|11711739|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
7431083|NCT01573624|11711740|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
7431084|NCT01573624|11711741|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
7431085|NCT01573624|11711735|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7431086|NCT01573624|11711736|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
7431087|NCT01573624|11711737|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7431088|NCT01573624|11711738|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7431089|NCT01573624|11711739|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7431090|NCT01573624|11711740|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
7431091|NCT01573624|11711741|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
7431092|NCT01573624|11711735|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
7431093|NCT01573624|11711736|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431094|NCT01573624|11711737|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431095|NCT01573624|11711738|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431096|NCT01573624|11711739|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431097|NCT01573624|11711740|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431098|NCT01573624|11711741|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
7431099|NCT01573624|11711735|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7431100|NCT01573624|11711736|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7431101|NCT01573624|11711737|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7431102|NCT01573624|11711738|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7532293|NCT02669264|11877893|FG001|Overall Study|Miscellaneous|0
7431103|NCT01573624|11711739|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7431104|NCT01573624|11711740|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7431105|NCT01573624|11711741|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7431106|NCT01573624|11711735|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
7431107|NCT01573624|11711736|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431108|NCT01573624|11711737|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431109|NCT01573624|11711738|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431110|NCT01573624|11711739|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431111|NCT01573624|11711740|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431112|NCT01573624|11711741|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
7431113|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7431114|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7431115|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7431116|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7558714|NCT03131895|11924394|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
7431117|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7431118|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
7431119|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
7431120|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7431121|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7431122|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7431123|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7431124|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7431125|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
7431126|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
7431127|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431128|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
7431129|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431130|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431131|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431132|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431133|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
7431134|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431135|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
7431136|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431137|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431138|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431139|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431140|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
7431141|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7431142|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7431143|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7431144|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7431145|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7431146|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7431147|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7431148|NCT01573624|11711735|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7431149|NCT01573624|11711736|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7532270|NCT02669121|11877879|FG001|Overall Study|Reason not Specified|18
7532271|NCT02669264|11877892|FG000|Overall Study|Death|5
7532272|NCT02669264|11877893|FG001|Overall Study|Death|5
7532273|NCT02669264|11877894|FG002|Overall Study|Death|3
7532274|NCT02669264|11877895|FG003|Overall Study|Death|3
7532275|NCT02669264|11877896|FG004|Overall Study|Death|3
7532276|NCT02669264|11877897|FG005|Overall Study|Death|6
7532277|NCT02669264|11877898|FG006|Overall Study|Death|3
7532278|NCT02669264|11877892|FG000|Overall Study|Withdrawal by Subject|0
7532279|NCT02669264|11877893|FG001|Overall Study|Withdrawal by Subject|1
7532280|NCT02669264|11877894|FG002|Overall Study|Withdrawal by Subject|0
7532281|NCT02669264|11877895|FG003|Overall Study|Withdrawal by Subject|0
7532282|NCT02669264|11877896|FG004|Overall Study|Withdrawal by Subject|1
7532283|NCT02669264|11877897|FG005|Overall Study|Withdrawal by Subject|0
7532284|NCT02669264|11877898|FG006|Overall Study|Withdrawal by Subject|0
7532285|NCT02669264|11877892|FG000|Overall Study|Lost to Follow-up|0
7532286|NCT02669264|11877893|FG001|Overall Study|Lost to Follow-up|0
7532287|NCT02669264|11877894|FG002|Overall Study|Lost to Follow-up|0
7532288|NCT02669264|11877895|FG003|Overall Study|Lost to Follow-up|0
7532289|NCT02669264|11877896|FG004|Overall Study|Lost to Follow-up|1
7532290|NCT02669264|11877897|FG005|Overall Study|Lost to Follow-up|0
7532291|NCT02669264|11877898|FG006|Overall Study|Lost to Follow-up|0
7532292|NCT02669264|11877892|FG000|Overall Study|Miscellaneous|0
7532294|NCT02669264|11877894|FG002|Overall Study|Miscellaneous|0
7532295|NCT02669264|11877895|FG003|Overall Study|Miscellaneous|0
7431150|NCT01573624|11711737|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7431151|NCT01573624|11711738|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7431152|NCT01573624|11711739|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7431153|NCT01573624|11711740|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
7431154|NCT01573624|11711741|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
7431155|NCT01573624|11711735|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
7532296|NCT02669264|11877896|FG004|Overall Study|Miscellaneous|0
7532297|NCT02669264|11877897|FG005|Overall Study|Miscellaneous|0
7532298|NCT02669264|11877898|FG006|Overall Study|Miscellaneous|2
7532299|NCT02669407|11877920|FG000|Overall Study|Physician Decision|3
7532300|NCT02669433|11877927|FG000|Overall Study|Protocol Violation|0
7532301|NCT02669433|11877928|FG001|Overall Study|Protocol Violation|4
7532302|NCT02669433|11877929|FG002|Overall Study|Protocol Violation|1
7532303|NCT02669433|11877927|FG000|Overall Study|Disease Progression|1
7532304|NCT02669433|11877928|FG001|Overall Study|Disease Progression|0
7431156|NCT01573624|11711736|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7431157|NCT01573624|11711737|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7558715|NCT03131895|11924395|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7558716|NCT03131895|11924396|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7558717|NCT03131895|11924397|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
7558718|NCT03131999|11924409|FG000|Overall Study|Withdrawal by Subject|0
7558719|NCT03131999|11924410|FG001|Overall Study|Withdrawal by Subject|1
7431158|NCT01573624|11711738|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
7431159|NCT01573624|11711739|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7431160|NCT01573624|11711740|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
7431161|NCT01573624|11711741|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
7431162|NCT01573624|11711735|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7431163|NCT01573624|11711736|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7431164|NCT01573624|11711737|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7431165|NCT01573624|11711738|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7431166|NCT01573624|11711739|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7431167|NCT01573624|11711740|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
7431168|NCT01573624|11711741|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
7431169|NCT01573624|11711735|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
7431170|NCT01573624|11711736|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431171|NCT01573624|11711737|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431172|NCT01573624|11711738|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431173|NCT01573624|11711739|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431174|NCT01573624|11711740|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431175|NCT01573624|11711741|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
7431176|NCT01573624|11711735|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7431177|NCT01573624|11711736|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7431178|NCT01573624|11711737|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7431179|NCT01573624|11711738|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7431180|NCT01573624|11711739|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
7431181|NCT01573624|11711740|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
7431182|NCT01573624|11711741|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
7431183|NCT01573624|11711735|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
7431184|NCT01573624|11711736|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431185|NCT01573624|11711737|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431186|NCT01573624|11711738|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431187|NCT01573624|11711739|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431188|NCT01573624|11711740|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431189|NCT01573624|11711741|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
7431190|NCT01573767|11711772|FG000|Overall Study|Adverse Event|0
7431191|NCT01573767|11711773|FG001|Overall Study|Adverse Event|1
7431192|NCT01573767|11711774|FG002|Overall Study|Adverse Event|0
7431193|NCT01573767|11711775|FG003|Overall Study|Adverse Event|1
7431194|NCT01573767|11711772|FG000|Overall Study|Lack of Efficacy|18
7431195|NCT01573767|11711773|FG001|Overall Study|Lack of Efficacy|15
7431196|NCT01573767|11711774|FG002|Overall Study|Lack of Efficacy|12
7431197|NCT01573767|11711775|FG003|Overall Study|Lack of Efficacy|17
7431198|NCT01573767|11711772|FG000|Overall Study|Protocol Violation|3
7431199|NCT01573767|11711773|FG001|Overall Study|Protocol Violation|1
7431200|NCT01573767|11711774|FG002|Overall Study|Protocol Violation|1
7431201|NCT01573767|11711775|FG003|Overall Study|Protocol Violation|3
7431202|NCT01573767|11711772|FG000|Overall Study|Lost to Follow-up|0
7431203|NCT01573767|11711773|FG001|Overall Study|Lost to Follow-up|1
7431204|NCT01573767|11711774|FG002|Overall Study|Lost to Follow-up|1
7431205|NCT01573767|11711775|FG003|Overall Study|Lost to Follow-up|1
7431206|NCT01573767|11711772|FG000|Overall Study|Physician Decision|1
7431207|NCT01573767|11711773|FG001|Overall Study|Physician Decision|2
7431208|NCT01573767|11711774|FG002|Overall Study|Physician Decision|0
7431209|NCT01573767|11711775|FG003|Overall Study|Physician Decision|2
7431210|NCT01573767|11711772|FG000|Overall Study|Withdrawal by Subject|0
7431211|NCT01573767|11711773|FG001|Overall Study|Withdrawal by Subject|1
7431212|NCT01573767|11711774|FG002|Overall Study|Withdrawal by Subject|0
7431213|NCT01573767|11711775|FG003|Overall Study|Withdrawal by Subject|0
7431214|NCT01573910|11711787|FG000|Overall Study|Adverse Event|4
7431215|NCT01573910|11711788|FG001|Overall Study|Adverse Event|4
7431216|NCT01573910|11711787|FG000|Overall Study|Lost to Follow-up|2
7431217|NCT01573910|11711788|FG001|Overall Study|Lost to Follow-up|1
7431218|NCT01573910|11711787|FG000|Overall Study|Withdrawal by Subject|0
7431219|NCT01573910|11711788|FG001|Overall Study|Withdrawal by Subject|1
7558720|NCT03132220|11924418|FG000|Overall Study|Lost to Follow-up|17
7558721|NCT03132220|11924419|FG001|Overall Study|Lost to Follow-up|8
7431220|NCT01573910|11711787|FG000|Overall Study|Protocol Violation|3
7431221|NCT01573910|11711788|FG001|Overall Study|Protocol Violation|0
7431222|NCT01573910|11711787|FG000|Overall Study|Patient decision unrelated to Advs Event|11
7431223|NCT01573910|11711788|FG001|Overall Study|Patient decision unrelated to Advs Event|11
7431224|NCT01574079|11711800|FG000|Overall Study|Physician Decision|0
7431225|NCT01574079|11711801|FG001|Overall Study|Physician Decision|2
7431226|NCT01574079|11711800|FG000|Overall Study|Lost to Follow-up|1
7431227|NCT01574079|11711801|FG001|Overall Study|Lost to Follow-up|0
7431228|NCT01574157|11711823|FG000|Overall Study|Withdrawal by Subject|4
7431229|NCT01574157|11711824|FG001|Overall Study|Withdrawal by Subject|5
7431230|NCT01574157|11711823|FG000|Overall Study|Lost to Follow-up|0
7431231|NCT01574157|11711824|FG001|Overall Study|Lost to Follow-up|3
7431232|NCT01574248|11711847|FG000|Overall Study|Withdrawal by Subject|2
7431233|NCT01574248|11711848|FG001|Overall Study|Withdrawal by Subject|0
7431234|NCT01574248|11711847|FG000|Overall Study|Missing primary endpoint data|1
7431235|NCT01574248|11711848|FG001|Overall Study|Missing primary endpoint data|0
7431236|NCT01574326|11711860|FG000|Overall Study|Randomized but not treated|0
7558722|NCT03132220|11924418|FG000|Overall Study|Withdrawal by Subject|1
7558723|NCT03132220|11924419|FG001|Overall Study|Withdrawal by Subject|4
7558724|NCT03133481|11924454|FG000|Overall Study|FC Catheter fell out post operative day1|0
7431237|NCT01574326|11711861|FG001|Overall Study|Randomized but not treated|1
7431238|NCT01574326|11711860|FG000|Overall Study|Withdrawal by Participant|2
7431239|NCT01574326|11711861|FG001|Overall Study|Withdrawal by Participant|4
7431240|NCT01574326|11711860|FG000|Overall Study|Physician Decision|5
7431241|NCT01574326|11711861|FG001|Overall Study|Physician Decision|3
7431242|NCT01574326|11711860|FG000|Overall Study|Adverse Event|1
7431243|NCT01574326|11711861|FG001|Overall Study|Adverse Event|3
7431244|NCT01574326|11711860|FG000|Overall Study|Other: Mainly kidney transplant|8
7431245|NCT01574326|11711861|FG001|Overall Study|Other: Mainly kidney transplant|8
7431246|NCT01574352|11711874|FG000|Overall Study|Withdrawal by Subject|6
7431247|NCT01574352|11711875|FG001|Overall Study|Withdrawal by Subject|13
7431248|NCT01574352|11711874|FG000|Overall Study|Injury in non-camp related sport|1
7431249|NCT01574352|11711875|FG001|Overall Study|Injury in non-camp related sport|0
7431250|NCT01574612|11711881|FG000|Overall Study|Adverse Event|3
7431251|NCT01574612|11711881|FG000|Overall Study|non compliant with drug|2
7431252|NCT01574612|11711881|FG000|Overall Study|Withdrawal by Subject|1
7532305|NCT02669433|11877929|FG002|Overall Study|Disease Progression|0
7574823|NCT03695367|11958009|FG001|Overall Study|Lost to Follow-up|1
7431253|NCT01574612|11711881|FG000|Overall Study|Lost to Follow-up|2
7431254|NCT01574651|11711887|FG000|Overall Study|Lost to Follow-up|2
7431255|NCT01574651|11711888|FG001|Overall Study|Lost to Follow-up|4
7431256|NCT01574651|11711887|FG000|Overall Study|Administrative problems|0
7431257|NCT01574651|11711888|FG001|Overall Study|Administrative problems|1
7431258|NCT01574651|11711887|FG000|Overall Study|Death|3
7431259|NCT01574651|11711888|FG001|Overall Study|Death|3
7431260|NCT01574651|11711887|FG000|Overall Study|Patient's inability to use the device|0
7431261|NCT01574651|11711888|FG001|Overall Study|Patient's inability to use the device|1
7431262|NCT01574651|11711887|FG000|Overall Study|Adverse Event|36
7431263|NCT01574651|11711888|FG001|Overall Study|Adverse Event|27
7431264|NCT01574651|11711887|FG000|Overall Study|Abnormal laboratory value(s)|1
7431265|NCT01574651|11711888|FG001|Overall Study|Abnormal laboratory value(s)|0
7431266|NCT01574651|11711887|FG000|Overall Study|Abnormal test procedure result(s)|1
7431267|NCT01574651|11711888|FG001|Overall Study|Abnormal test procedure result(s)|1
7431268|NCT01574651|11711887|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7431269|NCT01574651|11711888|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7431270|NCT01574651|11711887|FG000|Overall Study|Protocol Violation|3
7431271|NCT01574651|11711888|FG001|Overall Study|Protocol Violation|5
7431272|NCT01574651|11711887|FG000|Overall Study|Withdrawal by Subject|9
7431273|NCT01574651|11711888|FG001|Overall Study|Withdrawal by Subject|10
7431274|NCT01574703|11711898|FG000|Overall Study|Adverse Event|0
7431275|NCT01574703|11711899|FG001|Overall Study|Adverse Event|2
7431276|NCT01574703|11711900|FG002|Overall Study|Adverse Event|1
7431277|NCT01574703|11711901|FG003|Overall Study|Adverse Event|1
7431278|NCT01574703|11711898|FG000|Overall Study|Protocol Violation|0
7431279|NCT01574703|11711899|FG001|Overall Study|Protocol Violation|0
7431280|NCT01574703|11711900|FG002|Overall Study|Protocol Violation|0
7431281|NCT01574703|11711901|FG003|Overall Study|Protocol Violation|1
7431282|NCT01574703|11711898|FG000|Overall Study|Unspecified Reason|27
7431283|NCT01574703|11711899|FG001|Overall Study|Unspecified Reason|15
7431284|NCT01574703|11711900|FG002|Overall Study|Unspecified Reason|20
7431285|NCT01574703|11711901|FG003|Overall Study|Unspecified Reason|16
7431286|NCT01574703|11711898|FG000|Overall Study|Withdrawal by Subject|53
7431287|NCT01574703|11711899|FG001|Overall Study|Withdrawal by Subject|52
7431288|NCT01574703|11711900|FG002|Overall Study|Withdrawal by Subject|36
7431289|NCT01574703|11711901|FG003|Overall Study|Withdrawal by Subject|61
7431290|NCT01574703|11711898|FG000|Overall Study|Met Withdrawal Criteria|0
7431291|NCT01574703|11711899|FG001|Overall Study|Met Withdrawal Criteria|1
7431292|NCT01574703|11711900|FG002|Overall Study|Met Withdrawal Criteria|1
7431293|NCT01574703|11711901|FG003|Overall Study|Met Withdrawal Criteria|0
7431294|NCT01574703|11711898|FG000|Overall Study|Lost to Follow-up|43
7431295|NCT01574703|11711899|FG001|Overall Study|Lost to Follow-up|41
7431296|NCT01574703|11711900|FG002|Overall Study|Lost to Follow-up|46
7431297|NCT01574703|11711901|FG003|Overall Study|Lost to Follow-up|35
7431298|NCT01574703|11711898|FG000|Overall Study|Death|2
7431299|NCT01574703|11711899|FG001|Overall Study|Death|1
7431300|NCT01574703|11711900|FG002|Overall Study|Death|1
7431301|NCT01574703|11711901|FG003|Overall Study|Death|0
7431302|NCT01574716|11711916|FG000|Part 1|Death|3
7532306|NCT02669433|11877927|FG000|Overall Study|Physician Decision|1
7431303|NCT01574716|11711917|FG001|Part 1|Death|1
7431304|NCT01574716|11711918|FG002|Part 1|Death|8
7431305|NCT01574716|11711919|FG003|Part 1|Death|0
7431306|NCT01574716|11711920|FG004|Part 1|Death|0
7431307|NCT01574716|11711916|FG000|Part 1|Discontinuation of study by sponsor|0
7431308|NCT01574716|11711917|FG001|Part 1|Discontinuation of study by sponsor|0
7431309|NCT01574716|11711918|FG002|Part 1|Discontinuation of study by sponsor|1
7431310|NCT01574716|11711919|FG003|Part 1|Discontinuation of study by sponsor|0
7532307|NCT02669433|11877928|FG001|Overall Study|Physician Decision|1
7532308|NCT02669433|11877929|FG002|Overall Study|Physician Decision|0
7532309|NCT02669433|11877927|FG000|Overall Study|Adverse Event|6
7532310|NCT02669433|11877928|FG001|Overall Study|Adverse Event|7
7532311|NCT02669433|11877929|FG002|Overall Study|Adverse Event|10
7431311|NCT01574716|11711920|FG004|Part 1|Discontinuation of study by sponsor|0
7431312|NCT01574716|11711916|FG000|Part 1|Withdrawal by Subject|0
7431313|NCT01574716|11711917|FG001|Part 1|Withdrawal by Subject|2
7431314|NCT01574716|11711918|FG002|Part 1|Withdrawal by Subject|0
7431315|NCT01574716|11711919|FG003|Part 1|Withdrawal by Subject|0
7431316|NCT01574716|11711920|FG004|Part 1|Withdrawal by Subject|0
7431317|NCT01574716|11711916|FG000|Part 1|Lost to Follow-up|0
7431318|NCT01574716|11711917|FG001|Part 1|Lost to Follow-up|1
7431319|NCT01574716|11711918|FG002|Part 1|Lost to Follow-up|0
7431320|NCT01574716|11711919|FG003|Part 1|Lost to Follow-up|0
7431321|NCT01574716|11711920|FG004|Part 1|Lost to Follow-up|0
7431322|NCT01574716|11711916|FG000|Part 2|Progressive disease|0
7431323|NCT01574716|11711917|FG001|Part 2|Progressive disease|0
7431324|NCT01574716|11711918|FG002|Part 2|Progressive disease|0
7431325|NCT01574716|11711919|FG003|Part 2|Progressive disease|1
7431326|NCT01574716|11711920|FG004|Part 2|Progressive disease|0
7431327|NCT01574716|11711916|FG000|Part 2|Death|0
7431328|NCT01574716|11711917|FG001|Part 2|Death|0
7431329|NCT01574716|11711918|FG002|Part 2|Death|0
7431330|NCT01574716|11711919|FG003|Part 2|Death|76
7431331|NCT01574716|11711920|FG004|Part 2|Death|35
7431332|NCT01574716|11711916|FG000|Part 2|Discontinuation of study by sponsor|0
7431333|NCT01574716|11711917|FG001|Part 2|Discontinuation of study by sponsor|0
7431334|NCT01574716|11711918|FG002|Part 2|Discontinuation of study by sponsor|0
7431335|NCT01574716|11711919|FG003|Part 2|Discontinuation of study by sponsor|51
7431336|NCT01574716|11711920|FG004|Part 2|Discontinuation of study by sponsor|31
7431337|NCT01574716|11711916|FG000|Part 2|Withdrawal by Subject|0
7431338|NCT01574716|11711917|FG001|Part 2|Withdrawal by Subject|0
7431339|NCT01574716|11711918|FG002|Part 2|Withdrawal by Subject|0
7431340|NCT01574716|11711919|FG003|Part 2|Withdrawal by Subject|5
7431341|NCT01574716|11711920|FG004|Part 2|Withdrawal by Subject|4
7431342|NCT01574716|11711916|FG000|Part 2|Brain metastases|0
7431343|NCT01574716|11711917|FG001|Part 2|Brain metastases|0
7431344|NCT01574716|11711918|FG002|Part 2|Brain metastases|0
7431345|NCT01574716|11711919|FG003|Part 2|Brain metastases|1
7431346|NCT01574716|11711920|FG004|Part 2|Brain metastases|0
7431347|NCT01574716|11711916|FG000|Part 2|Lost to Follow-up|0
7431348|NCT01574716|11711917|FG001|Part 2|Lost to Follow-up|0
7431349|NCT01574716|11711918|FG002|Part 2|Lost to Follow-up|0
7431350|NCT01574716|11711919|FG003|Part 2|Lost to Follow-up|3
7431351|NCT01574716|11711920|FG004|Part 2|Lost to Follow-up|0
7431352|NCT01575054|11711937|FG000|Overall Study|Other Reasons|5
7431353|NCT01575054|11711938|FG001|Overall Study|Other Reasons|3
7431354|NCT01575054|11711937|FG000|Overall Study|Protocol Violation|2
7431355|NCT01575054|11711938|FG001|Overall Study|Protocol Violation|1
7431356|NCT01575054|11711937|FG000|Overall Study|Personal Reasons|10
7431357|NCT01575054|11711938|FG001|Overall Study|Personal Reasons|11
7431358|NCT01575054|11711937|FG000|Overall Study|Lost to Follow-up|3
7431359|NCT01575054|11711938|FG001|Overall Study|Lost to Follow-up|3
7431360|NCT01575054|11711937|FG000|Overall Study|Adverse Event|9
7431361|NCT01575054|11711938|FG001|Overall Study|Adverse Event|8
7431362|NCT01575197|11711956|FG000|Overall Study|Migration out of study area|1
7431363|NCT01575197|11711957|FG001|Overall Study|Migration out of study area|5
7431364|NCT01575197|11711958|FG002|Overall Study|Migration out of study area|4
7431365|NCT01575197|11711956|FG000|Overall Study|SAE|0
7431366|NCT01575197|11711957|FG001|Overall Study|SAE|1
7431367|NCT01575197|11711958|FG002|Overall Study|SAE|0
7431368|NCT01575197|11711956|FG000|Overall Study|Lost to Follow-up|0
7431369|NCT01575197|11711957|FG001|Overall Study|Lost to Follow-up|1
7431370|NCT01575197|11711958|FG002|Overall Study|Lost to Follow-up|0
7431371|NCT01575197|11711956|FG000|Overall Study|Withdrawal by Subject|0
7431372|NCT01575197|11711957|FG001|Overall Study|Withdrawal by Subject|1
7431373|NCT01575197|11711958|FG002|Overall Study|Withdrawal by Subject|1
7431374|NCT01575197|11711956|FG000|Overall Study|Protocol Violation|2
7431375|NCT01575197|11711957|FG001|Overall Study|Protocol Violation|1
7431376|NCT01575197|11711958|FG002|Overall Study|Protocol Violation|1
7431377|NCT01575561|11711977|FG000|Overall Study|Adverse Event|9
7431378|NCT01575561|11711977|FG000|Overall Study|Lack of Efficacy|8
7431379|NCT01575561|11711977|FG000|Overall Study|Lost to Follow-up|6
7431380|NCT01575561|11711977|FG000|Overall Study|Protocol Violation|4
7431381|NCT01575561|11711977|FG000|Overall Study|Withdrawal by Subject|11
7431382|NCT01575561|11711977|FG000|Overall Study|administration|1
7431383|NCT01575769|11711989|FG000|Overall Study|Adverse Event|1
7431384|NCT01575769|11711989|FG000|Overall Study|Study terminated by sponsor|40
7532312|NCT02669433|11877927|FG000|Overall Study|Sponsor Termination|1
7532313|NCT02669433|11877928|FG001|Overall Study|Sponsor Termination|0
7431385|NCT01575808|11711997|FG000|Overall Study|Death|2
7431386|NCT01575808|11711998|FG001|Overall Study|Death|0
7431387|NCT01575808|11711997|FG000|Overall Study|Withdrawal by Subject|1
7431388|NCT01575808|11711998|FG001|Overall Study|Withdrawal by Subject|0
7328622|NCT00797316|11561634|FG001|Overall Study|Administrative problems|0
7328623|NCT00797316|11561633|FG000|Overall Study|Adverse Event|5
7328624|NCT00797316|11561634|FG001|Overall Study|Adverse Event|3
7328625|NCT00797316|11561633|FG000|Overall Study|Lost to Follow-up|4
7328626|NCT00797316|11561634|FG001|Overall Study|Lost to Follow-up|8
7328627|NCT00797316|11561633|FG000|Overall Study|Protocol Deviation|1
7328628|NCT00797316|11561634|FG001|Overall Study|Protocol Deviation|2
7431409|NCT01575873|11712023|FG000|Overall Study|Withdrawal by Subject|15
7431410|NCT01575873|11712024|FG001|Overall Study|Withdrawal by Subject|20
7431411|NCT01575873|11712025|FG002|Overall Study|Withdrawal by Subject|34
7431412|NCT01575873|11712026|FG003|Overall Study|Withdrawal by Subject|34
7431413|NCT01575873|11712023|FG000|Overall Study|Adverse Event|7
7431414|NCT01575873|11712024|FG001|Overall Study|Adverse Event|7
7431415|NCT01575873|11712025|FG002|Overall Study|Adverse Event|9
7431416|NCT01575873|11712026|FG003|Overall Study|Adverse Event|12
7431417|NCT01575873|11712023|FG000|Overall Study|Lost to Follow-up|1
7431418|NCT01575873|11712024|FG001|Overall Study|Lost to Follow-up|3
7431419|NCT01575873|11712025|FG002|Overall Study|Lost to Follow-up|13
7431420|NCT01575873|11712026|FG003|Overall Study|Lost to Follow-up|5
7431421|NCT01575873|11712023|FG000|Overall Study|Death|3
7431422|NCT01575873|11712024|FG001|Overall Study|Death|2
7431423|NCT01575873|11712025|FG002|Overall Study|Death|8
7431424|NCT01575873|11712026|FG003|Overall Study|Death|9
7431425|NCT01575873|11712023|FG000|Overall Study|Noncompliance|1
7431426|NCT01575873|11712024|FG001|Overall Study|Noncompliance|2
7431427|NCT01575873|11712025|FG002|Overall Study|Noncompliance|4
7431428|NCT01575873|11712026|FG003|Overall Study|Noncompliance|3
7431429|NCT01575873|11712023|FG000|Overall Study|Administrative decision|1
7431430|NCT01575873|11712024|FG001|Overall Study|Administrative decision|1
7431431|NCT01575873|11712025|FG002|Overall Study|Administrative decision|1
7431432|NCT01575873|11712026|FG003|Overall Study|Administrative decision|0
7431433|NCT01575873|11712023|FG000|Overall Study|Protocol deviation|0
7431434|NCT01575873|11712024|FG001|Overall Study|Protocol deviation|1
7431435|NCT01575873|11712025|FG002|Overall Study|Protocol deviation|0
7431436|NCT01575873|11712026|FG003|Overall Study|Protocol deviation|1
7431437|NCT01575873|11712023|FG000|Overall Study|Requirement for Alternative Therapy|0
7431438|NCT01575873|11712024|FG001|Overall Study|Requirement for Alternative Therapy|0
7431439|NCT01575873|11712025|FG002|Overall Study|Requirement for Alternative Therapy|1
7431440|NCT01575873|11712026|FG003|Overall Study|Requirement for Alternative Therapy|1
7431441|NCT01575873|11712023|FG000|Overall Study|Other|0
7431442|NCT01575873|11712024|FG001|Overall Study|Other|0
7328629|NCT00797316|11561633|FG000|Overall Study|Patient withdrew consent|12
7328630|NCT00797316|11561634|FG001|Overall Study|Patient withdrew consent|6
7328631|NCT00797316|11561633|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7328632|NCT00797316|11561634|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7328633|NCT00797511|11561648|FG000|Overall Study|Withdrawal by Subject|1
7328634|NCT00797563|11561653|FG000|Overall Study|Adverse Event|1
7328635|NCT00797667|11561660|FG000|Overall Study|Lack of Efficacy|0
7328636|NCT00797667|11561661|FG001|Overall Study|Lack of Efficacy|1
7328637|NCT00797667|11561662|FG002|Overall Study|Lack of Efficacy|0
7431443|NCT01575873|11712025|FG002|Overall Study|Other|4
7431444|NCT01575873|11712026|FG003|Overall Study|Other|2
7431445|NCT01575899|11712037|FG000|Overall Study|Lost to Follow-up|3
7431446|NCT01575899|11712038|FG001|Overall Study|Lost to Follow-up|4
7431447|NCT01575899|11712039|FG002|Overall Study|Lost to Follow-up|2
7431448|NCT01575899|11712037|FG000|Overall Study|Protocol Violation|2
7431449|NCT01575899|11712038|FG001|Overall Study|Protocol Violation|1
7431450|NCT01575899|11712039|FG002|Overall Study|Protocol Violation|0
7431451|NCT01576016|11712077|FG000|Lead Safety|Death|132
7431452|NCT01576016|11712078|FG001|Lead Safety|Death|0
7431453|NCT01576016|11712077|FG000|Lead Safety|Withdrawal by Subject|81
7431454|NCT01576016|11712078|FG001|Lead Safety|Withdrawal by Subject|0
7431455|NCT01576016|11712077|FG000|Lead Safety|System Explanted without Replacement|24
7431456|NCT01576016|11712078|FG001|Lead Safety|System Explanted without Replacement|0
7431457|NCT01576016|11712077|FG000|Lead Safety|Physician Decision|14
7431458|NCT01576016|11712078|FG001|Lead Safety|Physician Decision|0
7431459|NCT01576016|11712077|FG000|Lead Safety|Lost to Follow-up|13
7431460|NCT01576016|11712078|FG001|Lead Safety|Lost to Follow-up|0
7431461|NCT01576016|11712077|FG000|Lead Safety|Unsuccessful implant|2
7431462|NCT01576016|11712078|FG001|Lead Safety|Unsuccessful implant|0
7431463|NCT01576016|11712077|FG000|Lead Safety|Sponsor request|1
7431464|NCT01576016|11712078|FG001|Lead Safety|Sponsor request|0
7431465|NCT01576016|11712077|FG000|Lead Safety|Device replaced with CRT-D|1
7431466|NCT01576016|11712078|FG001|Lead Safety|Device replaced with CRT-D|0
7431467|NCT01576016|11712077|FG000|Lead Safety|Patient on Palliative Care|1
7431468|NCT01576016|11712078|FG001|Lead Safety|Patient on Palliative Care|0
7431469|NCT01576016|11712077|FG000|Lead Safety|Patient noncompliance|1
7431470|NCT01576016|11712078|FG001|Lead Safety|Patient noncompliance|0
7431471|NCT01576016|11712077|FG000|Lead Safety|Too far from study site|1
7431472|NCT01576016|11712078|FG001|Lead Safety|Too far from study site|0
7431473|NCT01576016|11712077|FG000|Lead Safety|System deactivated|1
7431474|NCT01576016|11712078|FG001|Lead Safety|System deactivated|0
7431475|NCT01576016|11712077|FG000|Lead Safety|Patient no longer followed by study PI|1
7431476|NCT01576016|11712078|FG001|Lead Safety|Patient no longer followed by study PI|0
7431477|NCT01576016|11712077|FG000|MRI Safety|Withdrawal by Subject|0
7431478|NCT01576016|11712078|FG001|MRI Safety|Withdrawal by Subject|10
7431479|NCT01576016|11712077|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
7431480|NCT01576016|11712078|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
7431481|NCT01576016|11712077|FG000|MRI Safety|Has not yet completed MRI scan|0
7431482|NCT01576016|11712078|FG001|MRI Safety|Has not yet completed MRI scan|56
7431483|NCT01576016|11712077|FG000|MRI Safety|MRI scan not performed at MRI visit|0
7431484|NCT01576016|11712078|FG001|MRI Safety|MRI scan not performed at MRI visit|3
7431485|NCT01576042|11712088|FG000|Overall Study|Physician Decision|2
7431486|NCT01576042|11712089|FG001|Overall Study|Physician Decision|0
7431487|NCT01576146|11712113|FG000|Extension Period 1|Adverse Event|2
7431488|NCT01576146|11712113|FG000|Extension Period 1|Death|2
7431489|NCT01576146|11712113|FG000|Extension Period 1|Physician Decision|2
7431490|NCT01576146|11712113|FG000|Extension Period 1|Withdrawal by Subject|1
7431491|NCT01576146|11712113|FG000|Extension Period 1|Lost to Follow-up|1
7431492|NCT01576146|11712113|FG000|Extension Period 1|Parathyroidectomy|1
7431493|NCT01576146|11712113|FG000|Extension Period 1|Renal Transplant|1
7431494|NCT01576146|11712113|FG000|Extension Period 2|Sponsor Decision|13
7431495|NCT01576146|11712113|FG000|Extension Period 2|Death|1
7431496|NCT01576146|11712113|FG000|Extension Period 2|Adverse Event|1
7431497|NCT01576146|11712113|FG000|Extension Period 2|Renal Transplant|1
7431498|NCT01576146|11712113|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
7431499|NCT01576159|11712121|FG000|Overall Study|Withdrawal by Subject|0
7431500|NCT01576159|11712122|FG001|Overall Study|Withdrawal by Subject|1
7431501|NCT01576159|11712123|FG002|Overall Study|Withdrawal by Subject|0
7431502|NCT01576159|11712124|FG003|Overall Study|Withdrawal by Subject|0
7431503|NCT01576159|11712121|FG000|Overall Study|Physician Decision|0
7431504|NCT01576159|11712122|FG001|Overall Study|Physician Decision|0
7431505|NCT01576159|11712123|FG002|Overall Study|Physician Decision|1
7431506|NCT01576159|11712124|FG003|Overall Study|Physician Decision|0
7431507|NCT01576159|11712121|FG000|Overall Study|Lost to Follow-up|0
7431508|NCT01576159|11712122|FG001|Overall Study|Lost to Follow-up|0
7431509|NCT01576159|11712123|FG002|Overall Study|Lost to Follow-up|0
7431510|NCT01576159|11712124|FG003|Overall Study|Lost to Follow-up|1
7431511|NCT01576159|11712121|FG000|Overall Study|Protocol Violation|1
7431512|NCT01576159|11712122|FG001|Overall Study|Protocol Violation|0
7431513|NCT01576159|11712123|FG002|Overall Study|Protocol Violation|0
7431514|NCT01576159|11712124|FG003|Overall Study|Protocol Violation|0
7431515|NCT01576172|11712143|FG000|Overall Study|Ineligible|2
7431516|NCT01576172|11712144|FG001|Overall Study|Ineligible|1
7431517|NCT01576172|11712143|FG000|Overall Study|Withdrawal by Subject|2
7431518|NCT01576172|11712144|FG001|Overall Study|Withdrawal by Subject|0
7431519|NCT01576172|11712143|FG000|Overall Study|Insurance issue|1
7431520|NCT01576172|11712144|FG001|Overall Study|Insurance issue|0
7431521|NCT01576341|11712162|FG000|Overall Study|Withdrawal by Subject|24
7431522|NCT01576341|11712162|FG000|Overall Study|Adverse Event|10
7431523|NCT01576341|11712162|FG000|Overall Study|Death|21
7431524|NCT01576341|11712162|FG000|Overall Study|Physician Decision|2
7431525|NCT01576341|11712162|FG000|Overall Study|Lost to Follow-up|2
7431526|NCT01576341|11712162|FG000|Overall Study|Kidney transplantation|10
7431527|NCT01576341|11712162|FG000|Overall Study|Protocol Violation|12
7431528|NCT01576341|11712162|FG000|Overall Study|Other|12
7431529|NCT01576367|11712169|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7431530|NCT01576367|11712169|FG000|Overall Study|Moved to commercial use after 6 months|1
7431531|NCT01576406|11712179|FG000|Overall Study|Lost to Follow-up|1
7431532|NCT01576406|11712180|FG001|Overall Study|Lost to Follow-up|2
7431533|NCT01576406|11712181|FG002|Overall Study|Lost to Follow-up|0
7431534|NCT01576406|11712182|FG003|Overall Study|Lost to Follow-up|0
7431535|NCT01576406|11712183|FG004|Overall Study|Lost to Follow-up|0
7431536|NCT01576406|11712184|FG005|Overall Study|Lost to Follow-up|0
7431537|NCT01576406|11712179|FG000|Overall Study|Death|3
7431538|NCT01576406|11712180|FG001|Overall Study|Death|4
7431539|NCT01576406|11712181|FG002|Overall Study|Death|8
7431540|NCT01576406|11712182|FG003|Overall Study|Death|5
7431541|NCT01576406|11712183|FG004|Overall Study|Death|7
7431542|NCT01576406|11712184|FG005|Overall Study|Death|9
7431543|NCT01576406|11712179|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
7431544|NCT01576406|11712180|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
7431545|NCT01576406|11712181|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
7431546|NCT01576406|11712182|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
7431547|NCT01576406|11712183|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
7431548|NCT01576406|11712184|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
7431549|NCT01576406|11712179|FG000|Overall Study|Withdrawal the consent|2
7431550|NCT01576406|11712180|FG001|Overall Study|Withdrawal the consent|2
7431551|NCT01576406|11712181|FG002|Overall Study|Withdrawal the consent|5
7431552|NCT01576406|11712182|FG003|Overall Study|Withdrawal the consent|1
7431553|NCT01576406|11712183|FG004|Overall Study|Withdrawal the consent|1
7431554|NCT01576406|11712184|FG005|Overall Study|Withdrawal the consent|3
7431555|NCT01576406|11712179|FG000|Overall Study|Other|0
7431556|NCT01576406|11712180|FG001|Overall Study|Other|0
7431557|NCT01576406|11712181|FG002|Overall Study|Other|2
7431558|NCT01576406|11712182|FG003|Overall Study|Other|2
7431559|NCT01576406|11712183|FG004|Overall Study|Other|0
7431560|NCT01576406|11712184|FG005|Overall Study|Other|0
7431561|NCT01576484|11712209|FG000|Overall Study|Adverse Event|1
7431562|NCT01576484|11712210|FG001|Overall Study|Adverse Event|1
7431563|NCT01576484|11712209|FG000|Overall Study|Protocol Violation|0
7431564|NCT01576484|11712210|FG001|Overall Study|Protocol Violation|2
7431565|NCT01576484|11712209|FG000|Overall Study|Sponsor Decision|2
7431566|NCT01576484|11712210|FG001|Overall Study|Sponsor Decision|8
7431567|NCT01576484|11712209|FG000|Overall Study|Withdrawal by Subject|0
7431568|NCT01576484|11712210|FG001|Overall Study|Withdrawal by Subject|3
7431569|NCT01576484|11712209|FG000|Overall Study|Other|2
7431570|NCT01576484|11712210|FG001|Overall Study|Other|5
7431571|NCT01576705|11712251|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
7431572|NCT01576705|11712252|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
7431573|NCT01576705|11712253|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
7431574|NCT01576705|11712254|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
7431575|NCT01576705|11712251|FG000|Overall Study|invalid ICF|0
7431576|NCT01576705|11712252|FG001|Overall Study|invalid ICF|1
7431577|NCT01576705|11712253|FG002|Overall Study|invalid ICF|0
7431578|NCT01576705|11712254|FG003|Overall Study|invalid ICF|0
7431579|NCT01576718|11712270|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
7431580|NCT01576718|11712271|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431581|NCT01576718|11712272|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431582|NCT01576718|11712273|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431583|NCT01576718|11712274|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431584|NCT01576718|11712275|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431585|NCT01576718|11712276|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
7431586|NCT01576718|11712270|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
7431587|NCT01576718|11712271|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431588|NCT01576718|11712272|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431589|NCT01576718|11712273|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431590|NCT01576718|11712274|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431591|NCT01576718|11712275|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431592|NCT01576718|11712276|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
7431593|NCT01576718|11712270|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
7431594|NCT01576718|11712271|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431595|NCT01576718|11712272|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431596|NCT01576718|11712273|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431597|NCT01576718|11712274|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431598|NCT01576718|11712275|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431599|NCT01576718|11712276|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
7431600|NCT01576718|11712270|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
7431601|NCT01576718|11712271|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431602|NCT01576718|11712272|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431603|NCT01576718|11712273|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431604|NCT01576718|11712274|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431605|NCT01576718|11712275|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431606|NCT01576718|11712276|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
7431607|NCT01576718|11712270|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
7431608|NCT01576718|11712271|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
7431609|NCT01576718|11712272|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
7431610|NCT01576718|11712273|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
7431611|NCT01576718|11712274|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
7431612|NCT01576718|11712275|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
7431613|NCT01576718|11712276|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
7431614|NCT01576718|11712270|FG000|Treatment Period|Adverse Event|0
7431615|NCT01576718|11712271|FG001|Treatment Period|Adverse Event|1
7431616|NCT01576718|11712272|FG002|Treatment Period|Adverse Event|1
7431617|NCT01576718|11712273|FG003|Treatment Period|Adverse Event|1
7431618|NCT01576718|11712274|FG004|Treatment Period|Adverse Event|1
7431619|NCT01576718|11712275|FG005|Treatment Period|Adverse Event|1
7431620|NCT01576718|11712276|FG006|Treatment Period|Adverse Event|0
7431621|NCT01576718|11712270|FG000|Treatment Period|Withdrawal by Subject|0
7431622|NCT01576718|11712271|FG001|Treatment Period|Withdrawal by Subject|1
7431623|NCT01576718|11712272|FG002|Treatment Period|Withdrawal by Subject|1
7431624|NCT01576718|11712273|FG003|Treatment Period|Withdrawal by Subject|0
7431625|NCT01576718|11712274|FG004|Treatment Period|Withdrawal by Subject|2
7431626|NCT01576718|11712275|FG005|Treatment Period|Withdrawal by Subject|4
7431627|NCT01576718|11712276|FG006|Treatment Period|Withdrawal by Subject|2
7431628|NCT01576718|11712270|FG000|Treatment Period|Physician Decision|0
7431629|NCT01576718|11712271|FG001|Treatment Period|Physician Decision|1
7431630|NCT01576718|11712272|FG002|Treatment Period|Physician Decision|1
7431631|NCT01576718|11712273|FG003|Treatment Period|Physician Decision|1
7431632|NCT01576718|11712274|FG004|Treatment Period|Physician Decision|1
7431633|NCT01576718|11712275|FG005|Treatment Period|Physician Decision|0
7431634|NCT01576718|11712276|FG006|Treatment Period|Physician Decision|0
7431635|NCT01576718|11712270|FG000|Treatment Period|Protocol Violation|0
7431636|NCT01576718|11712271|FG001|Treatment Period|Protocol Violation|5
7431637|NCT01576718|11712272|FG002|Treatment Period|Protocol Violation|4
7431638|NCT01576718|11712273|FG003|Treatment Period|Protocol Violation|10
7431639|NCT01576718|11712274|FG004|Treatment Period|Protocol Violation|6
7431640|NCT01576718|11712275|FG005|Treatment Period|Protocol Violation|8
7431641|NCT01576718|11712276|FG006|Treatment Period|Protocol Violation|12
7431642|NCT01576718|11712270|FG000|Treatment Period|Sponsor request|0
7431643|NCT01576718|11712271|FG001|Treatment Period|Sponsor request|1
7431644|NCT01576718|11712272|FG002|Treatment Period|Sponsor request|0
7431645|NCT01576718|11712273|FG003|Treatment Period|Sponsor request|0
7431646|NCT01576718|11712274|FG004|Treatment Period|Sponsor request|0
7431647|NCT01576718|11712275|FG005|Treatment Period|Sponsor request|1
7431648|NCT01576718|11712276|FG006|Treatment Period|Sponsor request|0
7431649|NCT01576718|11712270|FG000|Treatment Period|Met stopping criteria|0
7431650|NCT01576718|11712271|FG001|Treatment Period|Met stopping criteria|16
7431651|NCT01576718|11712272|FG002|Treatment Period|Met stopping criteria|13
7431652|NCT01576718|11712273|FG003|Treatment Period|Met stopping criteria|19
7431653|NCT01576718|11712274|FG004|Treatment Period|Met stopping criteria|16
7431654|NCT01576718|11712275|FG005|Treatment Period|Met stopping criteria|33
7431655|NCT01576718|11712276|FG006|Treatment Period|Met stopping criteria|15
7431656|NCT01576718|11712270|FG000|Treatment Period|Lost to Follow-up|0
7431657|NCT01576718|11712271|FG001|Treatment Period|Lost to Follow-up|0
7431658|NCT01576718|11712272|FG002|Treatment Period|Lost to Follow-up|0
7431659|NCT01576718|11712273|FG003|Treatment Period|Lost to Follow-up|0
7431660|NCT01576718|11712274|FG004|Treatment Period|Lost to Follow-up|1
7431661|NCT01576718|11712275|FG005|Treatment Period|Lost to Follow-up|0
7431662|NCT01576718|11712276|FG006|Treatment Period|Lost to Follow-up|0
7431663|NCT01576718|11712270|FG000|Treatment Period|Noncompliance to study medication|0
7431664|NCT01576718|11712271|FG001|Treatment Period|Noncompliance to study medication|0
7431665|NCT01576718|11712272|FG002|Treatment Period|Noncompliance to study medication|0
7431666|NCT01576718|11712273|FG003|Treatment Period|Noncompliance to study medication|0
7431667|NCT01576718|11712274|FG004|Treatment Period|Noncompliance to study medication|0
7431668|NCT01576718|11712275|FG005|Treatment Period|Noncompliance to study medication|1
7431669|NCT01576718|11712276|FG006|Treatment Period|Noncompliance to study medication|1
7431670|NCT01576783|11712292|FG000|Overall Study|Change in Medical Care|1
7431671|NCT01576783|11712293|FG001|Overall Study|Change in Medical Care|0
7431672|NCT01576783|11712292|FG000|Overall Study|Lost to Follow-up|14
7431673|NCT01576783|11712293|FG001|Overall Study|Lost to Follow-up|16
7431674|NCT01576783|11712292|FG000|Overall Study|Withdrawal by Subject|5
7431675|NCT01576783|11712293|FG001|Overall Study|Withdrawal by Subject|1
7431676|NCT01577160|11712334|FG000|Overall Study|Adverse Event|9
7431677|NCT01577160|11712334|FG000|Overall Study|Lack of Efficacy|15
7558725|NCT03133481|11924455|FG001|Overall Study|FC Catheter fell out post operative day1|4
7558726|NCT03133767|11924507|FG000|Overall Study|Lost to Follow-up|38
7558727|NCT03133767|11924508|FG001|Overall Study|Lost to Follow-up|24
7431678|NCT01577160|11712334|FG000|Overall Study|Lost to Follow-up|40
7431679|NCT01577160|11712334|FG000|Overall Study|Withdrawal by Subject|18
7431680|NCT01577160|11712334|FG000|Overall Study|Subject Uncooperative|7
7431681|NCT01577160|11712334|FG000|Overall Study|Other|9
7431682|NCT01577186|11712338|FG000|Overall Study|Adverse Event|23
7431683|NCT01577186|11712338|FG000|Overall Study|Death|1
7431684|NCT01577186|11712338|FG000|Overall Study|Lost to Follow-up|28
7431685|NCT01577186|11712338|FG000|Overall Study|Withdrawal by Subject|35
7431686|NCT01577186|11712338|FG000|Overall Study|Insufficient Response|18
7431687|NCT01577186|11712338|FG000|Overall Study|Ineligible to Continue|15
7431688|NCT01577186|11712338|FG000|Overall Study|Non-Compliant|8
7431689|NCT01577186|11712338|FG000|Overall Study|Other|2
7431690|NCT01577381|11712364|FG000|Overall Study|Discontinued|2
7431691|NCT01577381|11712365|FG001|Overall Study|Discontinued|1
7431692|NCT01577381|11712366|FG002|Overall Study|Discontinued|2
7431693|NCT01577381|11712367|FG003|Overall Study|Discontinued|2
7431694|NCT01577381|11712364|FG000|Overall Study|Ongoing at Date of Cut-Off|0
7431695|NCT01577381|11712365|FG001|Overall Study|Ongoing at Date of Cut-Off|2
7431696|NCT01577381|11712366|FG002|Overall Study|Ongoing at Date of Cut-Off|1
7431697|NCT01577381|11712367|FG003|Overall Study|Ongoing at Date of Cut-Off|0
7431698|NCT01577745|11712406|FG000|Overall Study|Withdrawal by Subject|0
7431699|NCT01577745|11712407|FG001|Overall Study|Withdrawal by Subject|1
7431700|NCT01577745|11712408|FG002|Overall Study|Withdrawal by Subject|0
7431701|NCT01577745|11712409|FG003|Overall Study|Withdrawal by Subject|3
7431702|NCT01577745|11712410|FG004|Overall Study|Withdrawal by Subject|2
7431703|NCT01577745|11712411|FG005|Overall Study|Withdrawal by Subject|0
7431704|NCT01577745|11712406|FG000|Overall Study|Death|3
7431705|NCT01577745|11712407|FG001|Overall Study|Death|2
7431706|NCT01577745|11712408|FG002|Overall Study|Death|2
7431707|NCT01577745|11712409|FG003|Overall Study|Death|1
7431708|NCT01577745|11712410|FG004|Overall Study|Death|1
7431709|NCT01577745|11712411|FG005|Overall Study|Death|3
7431710|NCT01577745|11712406|FG000|Overall Study|Physician Decision|0
7431711|NCT01577745|11712407|FG001|Overall Study|Physician Decision|0
7431712|NCT01577745|11712408|FG002|Overall Study|Physician Decision|0
7431713|NCT01577745|11712409|FG003|Overall Study|Physician Decision|1
7431714|NCT01577745|11712410|FG004|Overall Study|Physician Decision|1
7431715|NCT01577745|11712411|FG005|Overall Study|Physician Decision|0
7431716|NCT01577745|11712406|FG000|Overall Study|Lost to Follow-up|0
7431717|NCT01577745|11712407|FG001|Overall Study|Lost to Follow-up|0
7431718|NCT01577745|11712408|FG002|Overall Study|Lost to Follow-up|0
7431719|NCT01577745|11712409|FG003|Overall Study|Lost to Follow-up|0
7431720|NCT01577745|11712410|FG004|Overall Study|Lost to Follow-up|0
7431721|NCT01577745|11712411|FG005|Overall Study|Lost to Follow-up|1
7431722|NCT01577745|11712406|FG000|Overall Study|Alternative Therapy|0
7431723|NCT01577745|11712407|FG001|Overall Study|Alternative Therapy|0
7431724|NCT01577745|11712408|FG002|Overall Study|Alternative Therapy|0
7431725|NCT01577745|11712409|FG003|Overall Study|Alternative Therapy|1
7431726|NCT01577745|11712410|FG004|Overall Study|Alternative Therapy|1
7431727|NCT01577745|11712411|FG005|Overall Study|Alternative Therapy|0
7431728|NCT01577758|11712430|FG000|Dose Escalation Phase|Adverse Event|0
7431729|NCT01577758|11712431|FG001|Dose Escalation Phase|Adverse Event|0
7431730|NCT01577758|11712432|FG002|Dose Escalation Phase|Adverse Event|0
7431731|NCT01577758|11712433|FG003|Dose Escalation Phase|Adverse Event|0
7431732|NCT01577758|11712434|FG004|Dose Escalation Phase|Adverse Event|0
7431733|NCT01577758|11712435|FG005|Dose Escalation Phase|Adverse Event|2
7431734|NCT01577758|11712436|FG006|Dose Escalation Phase|Adverse Event|1
7431735|NCT01577758|11712437|FG007|Dose Escalation Phase|Adverse Event|0
7431736|NCT01577758|11712430|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7431737|NCT01577758|11712431|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7431738|NCT01577758|11712432|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7431739|NCT01577758|11712433|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7431740|NCT01577758|11712434|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
7431741|NCT01577758|11712435|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
7431742|NCT01577758|11712436|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7431743|NCT01577758|11712437|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7431744|NCT01577758|11712430|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7431745|NCT01577758|11712431|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7431746|NCT01577758|11712432|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7431747|NCT01577758|11712433|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7431748|NCT01577758|11712434|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7431749|NCT01577758|11712435|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7431750|NCT01577758|11712436|FG006|Dose Escalation Phase|Withdrawal by Subject|0
7431751|NCT01577758|11712437|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7431752|NCT01577758|11712430|FG000|Dose Escalation Phase|Progression Disease|2
7558728|NCT03133767|11924507|FG000|Overall Study|Protocol Violation|0
7558729|NCT03133767|11924508|FG001|Overall Study|Protocol Violation|1
7431753|NCT01577758|11712431|FG001|Dose Escalation Phase|Progression Disease|2
7431754|NCT01577758|11712432|FG002|Dose Escalation Phase|Progression Disease|1
7431755|NCT01577758|11712433|FG003|Dose Escalation Phase|Progression Disease|2
7431756|NCT01577758|11712434|FG004|Dose Escalation Phase|Progression Disease|5
7431757|NCT01577758|11712435|FG005|Dose Escalation Phase|Progression Disease|0
7431758|NCT01577758|11712436|FG006|Dose Escalation Phase|Progression Disease|0
7431759|NCT01577758|11712437|FG007|Dose Escalation Phase|Progression Disease|0
7431760|NCT01577758|11712430|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
7431761|NCT01577758|11712431|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
7431762|NCT01577758|11712432|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
7431763|NCT01577758|11712433|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
7431764|NCT01577758|11712434|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
7431765|NCT01577758|11712435|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
7431766|NCT01577758|11712436|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
7431767|NCT01577758|11712437|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
7431768|NCT01577758|11712430|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
7431769|NCT01577758|11712431|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
7431770|NCT01577758|11712432|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
7431771|NCT01577758|11712433|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
7431772|NCT01577758|11712434|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
7431773|NCT01577758|11712435|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
7431774|NCT01577758|11712436|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
7431775|NCT01577758|11712437|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
7431776|NCT01577758|11712430|FG000|mCRC Expansion Phase|Progression Disease|0
7431777|NCT01577758|11712431|FG001|mCRC Expansion Phase|Progression Disease|0
7431778|NCT01577758|11712432|FG002|mCRC Expansion Phase|Progression Disease|0
7431779|NCT01577758|11712433|FG003|mCRC Expansion Phase|Progression Disease|0
7431780|NCT01577758|11712434|FG004|mCRC Expansion Phase|Progression Disease|0
7431781|NCT01577758|11712435|FG005|mCRC Expansion Phase|Progression Disease|0
7431782|NCT01577758|11712436|FG006|mCRC Expansion Phase|Progression Disease|0
7431783|NCT01577758|11712437|FG007|mCRC Expansion Phase|Progression Disease|19
7431784|NCT01578187|11712485|FG000|Usability Phase|Withdrawal by Subject|1
7431785|NCT01578330|11712517|FG000|Overall Study|Adverse Event|2
7431786|NCT01578330|11712517|FG000|Overall Study|Protocol Violation|5
7431787|NCT01578486|11712521|FG000|Overall Study|Physician Decision|3
7431788|NCT01578486|11712521|FG000|Overall Study|Withdrawal by Subject|2
7467021|NCT01897233|11767252|FG000|Part B (24 Weeks)|Adverse Event|1
7467022|NCT01897233|11767252|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
7467023|NCT01897233|11767252|FG000|Part B (24 Weeks)|Physician Decision|1
7467024|NCT01897493|11767281|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
7467025|NCT01897532|11767290|FG000|Discontinuation From Treatment|Not Treated|7
7467026|NCT01897532|11767291|FG001|Discontinuation From Treatment|Not Treated|5
7467027|NCT01897532|11767290|FG000|Discontinuation From Treatment|Other reason than specified|196
7467028|NCT01897532|11767291|FG001|Discontinuation From Treatment|Other reason than specified|176
7467029|NCT01897532|11767290|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
7467030|NCT01897532|11767291|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
7467031|NCT01897532|11767290|FG000|Discontinuation From Treatment|Non compliance|24
7467032|NCT01897532|11767291|FG001|Discontinuation From Treatment|Non compliance|15
7467033|NCT01897532|11767290|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
7467034|NCT01897532|11767291|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
7467035|NCT01897532|11767290|FG000|Discontinuation From Trial|Not Treated|7
7467036|NCT01897532|11767291|FG001|Discontinuation From Trial|Not Treated|5
7467037|NCT01897532|11767290|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
7467038|NCT01897532|11767291|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
7467039|NCT01897714|11767303|FG000|Phase I (Dose Escalation)|Disease progression|3
7467040|NCT01897714|11767304|FG001|Phase I (Dose Escalation)|Disease progression|5
7467041|NCT01897714|11767305|FG002|Phase I (Dose Escalation)|Disease progression|1
7467042|NCT01897714|11767306|FG003|Phase I (Dose Escalation)|Disease progression|3
7467043|NCT01897714|11767307|FG004|Phase I (Dose Escalation)|Disease progression|0
7467044|NCT01897714|11767308|FG005|Phase I (Dose Escalation)|Disease progression|0
7467045|NCT01897714|11767303|FG000|Phase I (Dose Escalation)|Adverse Event|0
7467046|NCT01897714|11767304|FG001|Phase I (Dose Escalation)|Adverse Event|1
7467047|NCT01897714|11767305|FG002|Phase I (Dose Escalation)|Adverse Event|4
7467048|NCT01897714|11767306|FG003|Phase I (Dose Escalation)|Adverse Event|3
7467049|NCT01897714|11767307|FG004|Phase I (Dose Escalation)|Adverse Event|0
7467050|NCT01897714|11767308|FG005|Phase I (Dose Escalation)|Adverse Event|0
7467051|NCT01897714|11767303|FG000|Phase I (Dose Escalation)|Other|0
7467052|NCT01897714|11767304|FG001|Phase I (Dose Escalation)|Other|1
7467053|NCT01897714|11767305|FG002|Phase I (Dose Escalation)|Other|0
7467054|NCT01897714|11767306|FG003|Phase I (Dose Escalation)|Other|0
7467055|NCT01897714|11767307|FG004|Phase I (Dose Escalation)|Other|0
7467056|NCT01897714|11767308|FG005|Phase I (Dose Escalation)|Other|0
7467057|NCT01897714|11767303|FG000|Phase II (MTD)|Withdrawal by Subject|0
7467058|NCT01897714|11767304|FG001|Phase II (MTD)|Withdrawal by Subject|0
7467059|NCT01897714|11767305|FG002|Phase II (MTD)|Withdrawal by Subject|0
7467060|NCT01897714|11767306|FG003|Phase II (MTD)|Withdrawal by Subject|0
7467061|NCT01897714|11767307|FG004|Phase II (MTD)|Withdrawal by Subject|0
7467062|NCT01897714|11767308|FG005|Phase II (MTD)|Withdrawal by Subject|1
7467063|NCT01897714|11767303|FG000|Phase II (MTD)|Lost to Follow-up|0
7467064|NCT01897714|11767304|FG001|Phase II (MTD)|Lost to Follow-up|0
7467065|NCT01897714|11767305|FG002|Phase II (MTD)|Lost to Follow-up|0
7467066|NCT01897714|11767306|FG003|Phase II (MTD)|Lost to Follow-up|0
7467067|NCT01897714|11767307|FG004|Phase II (MTD)|Lost to Follow-up|1
7467068|NCT01897714|11767308|FG005|Phase II (MTD)|Lost to Follow-up|0
7467069|NCT01897714|11767303|FG000|Phase II (MTD)|Death|0
7467070|NCT01897714|11767304|FG001|Phase II (MTD)|Death|0
7467071|NCT01897714|11767305|FG002|Phase II (MTD)|Death|0
7467072|NCT01897714|11767306|FG003|Phase II (MTD)|Death|0
7467073|NCT01897714|11767307|FG004|Phase II (MTD)|Death|25
7467074|NCT01897714|11767308|FG005|Phase II (MTD)|Death|10
7467075|NCT01897714|11767303|FG000|Phase II (MTD)|Study terminated with patient alive|0
7467076|NCT01897714|11767304|FG001|Phase II (MTD)|Study terminated with patient alive|0
7467077|NCT01897714|11767305|FG002|Phase II (MTD)|Study terminated with patient alive|0
7467078|NCT01897714|11767306|FG003|Phase II (MTD)|Study terminated with patient alive|0
7467079|NCT01897714|11767307|FG004|Phase II (MTD)|Study terminated with patient alive|1
7467080|NCT01897714|11767308|FG005|Phase II (MTD)|Study terminated with patient alive|0
7467081|NCT01897714|11767303|FG000|Phase II (MTD)|Other|0
7467082|NCT01897714|11767304|FG001|Phase II (MTD)|Other|0
7467083|NCT01897714|11767305|FG002|Phase II (MTD)|Other|0
7467084|NCT01897714|11767306|FG003|Phase II (MTD)|Other|0
7431789|NCT01578499|11712527|FG000|Overall Study|Reason not Specified|0
7431790|NCT01578499|11712528|FG001|Overall Study|Reason not Specified|1
7431791|NCT01578499|11712527|FG000|Overall Study|Lost to Follow-up|2
7431792|NCT01578499|11712528|FG001|Overall Study|Lost to Follow-up|1
7431793|NCT01578499|11712527|FG000|Overall Study|Withdrawal by Subject|10
7431794|NCT01578499|11712528|FG001|Overall Study|Withdrawal by Subject|16
7431795|NCT01578499|11712527|FG000|Overall Study|Death|20
7431796|NCT01578499|11712528|FG001|Overall Study|Death|25
7431797|NCT01578499|11712527|FG000|Overall Study|Died and End of Study Page not Completed|2
7431798|NCT01578499|11712528|FG001|Overall Study|Died and End of Study Page not Completed|0
7431799|NCT01578551|11712540|FG000|Overall Study|Adverse Event|1
7431800|NCT01578551|11712541|FG001|Overall Study|Adverse Event|0
7431801|NCT01578850|11712587|FG000|Period 1|Insufficient Clinical Response|1
7431802|NCT01578850|11712588|FG001|Period 1|Insufficient Clinical Response|0
7431803|NCT01578850|11712589|FG002|Period 1|Insufficient Clinical Response|0
7431804|NCT01578850|11712587|FG000|Period 1|Adverse Event|11
7431805|NCT01578850|11712588|FG001|Period 1|Adverse Event|0
7431806|NCT01578850|11712589|FG002|Period 1|Adverse Event|0
7431807|NCT01578850|11712587|FG000|Period 1|Death|1
7431808|NCT01578850|11712588|FG001|Period 1|Death|0
7431809|NCT01578850|11712589|FG002|Period 1|Death|0
7431810|NCT01578850|11712587|FG000|Period 1|Does Not Meet Entrance Criteria|12
7431811|NCT01578850|11712588|FG001|Period 1|Does Not Meet Entrance Criteria|0
7431812|NCT01578850|11712589|FG002|Period 1|Does Not Meet Entrance Criteria|0
7431813|NCT01578850|11712587|FG000|Period 1|Withdrawal by Subject|9
7431814|NCT01578850|11712588|FG001|Period 1|Withdrawal by Subject|0
7431815|NCT01578850|11712589|FG002|Period 1|Withdrawal by Subject|0
7431816|NCT01578850|11712587|FG000|Period 1|Study Terminated by Sponsor|3
7431817|NCT01578850|11712588|FG001|Period 1|Study Terminated by Sponsor|0
7431818|NCT01578850|11712589|FG002|Period 1|Study Terminated by Sponsor|0
7431819|NCT01578850|11712587|FG000|Period 2|Insufficient Clinical Response|0
7431820|NCT01578850|11712588|FG001|Period 2|Insufficient Clinical Response|1
7431821|NCT01578850|11712589|FG002|Period 2|Insufficient Clinical Response|0
7431822|NCT01578850|11712587|FG000|Period 2|Adverse Event|0
7431823|NCT01578850|11712588|FG001|Period 2|Adverse Event|3
7431824|NCT01578850|11712589|FG002|Period 2|Adverse Event|6
7431825|NCT01578850|11712587|FG000|Period 2|Lost to Follow-up|0
7431826|NCT01578850|11712588|FG001|Period 2|Lost to Follow-up|1
7431827|NCT01578850|11712589|FG002|Period 2|Lost to Follow-up|2
7431828|NCT01578850|11712587|FG000|Period 2|Withdrawal by Subject|0
7431829|NCT01578850|11712588|FG001|Period 2|Withdrawal by Subject|2
7431830|NCT01578850|11712589|FG002|Period 2|Withdrawal by Subject|2
7431831|NCT01578850|11712587|FG000|Period 2|Study Terminated by Sponsor|0
7431832|NCT01578850|11712588|FG001|Period 2|Study Terminated by Sponsor|5
7431833|NCT01578850|11712589|FG002|Period 2|Study Terminated by Sponsor|4
7431834|NCT01578850|11712587|FG000|Period 2|Unspecified Reasons|0
7431835|NCT01578850|11712588|FG001|Period 2|Unspecified Reasons|1
7431836|NCT01578850|11712589|FG002|Period 2|Unspecified Reasons|0
7431837|NCT01579006|11712612|FG000|Overall Study|Lack of Efficacy|10
7431838|NCT01579006|11712612|FG000|Overall Study|Adverse Event|13
7431839|NCT01579006|11712612|FG000|Overall Study|Withdrawal by Subject|5
7431840|NCT01579006|11712612|FG000|Overall Study|Non-compliance|3
7431841|NCT01579006|11712612|FG000|Overall Study|Due to participant's health fund|1
7431842|NCT01579006|11712612|FG000|Overall Study|Scheduled surgery|1
7431843|NCT01579318|11712703|FG000|Overall Study|Disease Progression|1
7431844|NCT01579474|11712713|FG000|Overall Study|Adverse Event|1
7431845|NCT01579474|11712714|FG001|Overall Study|Adverse Event|13
7431846|NCT01579474|11712715|FG002|Overall Study|Adverse Event|2
7431847|NCT01579474|11712716|FG003|Overall Study|Adverse Event|0
7431848|NCT01579474|11712717|FG004|Overall Study|Adverse Event|0
7431849|NCT01579474|11712718|FG005|Overall Study|Adverse Event|1
7431850|NCT01579474|11712713|FG000|Overall Study|Lack of Efficacy|1
7431851|NCT01579474|11712714|FG001|Overall Study|Lack of Efficacy|0
7431852|NCT01579474|11712715|FG002|Overall Study|Lack of Efficacy|0
7431853|NCT01579474|11712716|FG003|Overall Study|Lack of Efficacy|0
7431854|NCT01579474|11712717|FG004|Overall Study|Lack of Efficacy|1
7431855|NCT01579474|11712718|FG005|Overall Study|Lack of Efficacy|0
7431856|NCT01579474|11712713|FG000|Overall Study|Withdrawal by Subject|1
7431857|NCT01579474|11712714|FG001|Overall Study|Withdrawal by Subject|0
7431858|NCT01579474|11712715|FG002|Overall Study|Withdrawal by Subject|0
7431859|NCT01579474|11712716|FG003|Overall Study|Withdrawal by Subject|0
7431860|NCT01579474|11712717|FG004|Overall Study|Withdrawal by Subject|0
7431861|NCT01579474|11712718|FG005|Overall Study|Withdrawal by Subject|0
7431862|NCT01579565|11712742|FG000|Randomized|Adverse Event|1
7431863|NCT01579565|11712743|FG001|Randomized|Adverse Event|3
7431864|NCT01579565|11712742|FG000|Randomized|Withdrawal by Subject|3
7431865|NCT01579565|11712743|FG001|Randomized|Withdrawal by Subject|0
7431866|NCT01579565|11712742|FG000|Randomized|inadequate preoperative pupil dilation|0
7431867|NCT01579565|11712743|FG001|Randomized|inadequate preoperative pupil dilation|1
7431868|NCT01579565|11712742|FG000|Randomized|prohibited preoperative eating|1
7431869|NCT01579565|11712743|FG001|Randomized|prohibited preoperative eating|0
7431870|NCT01579565|11712742|FG000|Randomized|prohibited preoperative medication|0
7431871|NCT01579565|11712743|FG001|Randomized|prohibited preoperative medication|1
7431872|NCT01579565|11712742|FG000|Treated|Physician Decision|0
7431873|NCT01579565|11712743|FG001|Treated|Physician Decision|1
7431874|NCT01579565|11712742|FG000|Treated|Lost to Follow-up|2
7431875|NCT01579565|11712743|FG001|Treated|Lost to Follow-up|1
7431876|NCT01579565|11712742|FG000|Treated|declined to return for final visit|0
7431877|NCT01579565|11712743|FG001|Treated|declined to return for final visit|1
7431878|NCT01579578|11712753|FG000|Overall Study|Death|4
7431879|NCT01579578|11712754|FG001|Overall Study|Death|1
7431880|NCT01579578|11712753|FG000|Overall Study|Lost to Follow-up|1
7431881|NCT01579578|11712754|FG001|Overall Study|Lost to Follow-up|1
7431882|NCT01579578|11712753|FG000|Overall Study|Withdrawal by Subject|2
7431883|NCT01579578|11712754|FG001|Overall Study|Withdrawal by Subject|1
7431884|NCT01579578|11712753|FG000|Overall Study|Eligibility criteria|3
7431885|NCT01579578|11712754|FG001|Overall Study|Eligibility criteria|9
7431886|NCT01579578|11712753|FG000|Overall Study|Ongoing|3
7431887|NCT01579578|11712754|FG001|Overall Study|Ongoing|0
7431888|NCT01579812|11712778|FG000|Overall Study|Ineligible after treatment start|40
7431889|NCT01579812|11712778|FG000|Overall Study|Patient choice|3
7431890|NCT01579812|11712778|FG000|Overall Study|Noncompliance|3
7431891|NCT01579812|11712778|FG000|Overall Study|Withdrawal by Subject|6
7431892|NCT01579916|11712787|FG000|Overall Study|Lost to Follow-up|6
7431893|NCT01579916|11712788|FG001|Overall Study|Lost to Follow-up|1
7431894|NCT01579916|11712787|FG000|Overall Study|Withdrawal by Subject|1
7431895|NCT01579916|11712788|FG001|Overall Study|Withdrawal by Subject|1
7431896|NCT01579916|11712787|FG000|Overall Study|Death|1
7431897|NCT01579916|11712788|FG001|Overall Study|Death|0
7431898|NCT01580020|11712796|FG000|Overall Study|Lack of Efficacy|0
7431899|NCT01580020|11712797|FG001|Overall Study|Lack of Efficacy|5
7431900|NCT01580020|11712798|FG002|Overall Study|Lack of Efficacy|0
7431901|NCT01580020|11712799|FG003|Overall Study|Lack of Efficacy|1
7431902|NCT01580020|11712796|FG000|Overall Study|Withdrawal by Subject|0
7431903|NCT01580020|11712797|FG001|Overall Study|Withdrawal by Subject|1
7431904|NCT01580020|11712798|FG002|Overall Study|Withdrawal by Subject|1
7431905|NCT01580020|11712799|FG003|Overall Study|Withdrawal by Subject|0
7431906|NCT01580020|11712796|FG000|Overall Study|Adverse Event|1
7431907|NCT01580020|11712797|FG001|Overall Study|Adverse Event|1
7431908|NCT01580020|11712798|FG002|Overall Study|Adverse Event|1
7431909|NCT01580020|11712799|FG003|Overall Study|Adverse Event|1
7431910|NCT01580020|11712796|FG000|Overall Study|Administrative Problems|0
7431911|NCT01580020|11712797|FG001|Overall Study|Administrative Problems|0
7431912|NCT01580020|11712798|FG002|Overall Study|Administrative Problems|1
7431913|NCT01580020|11712799|FG003|Overall Study|Administrative Problems|0
7431914|NCT01580020|11712796|FG000|Overall Study|Lost to Follow-up|0
7431915|NCT01580020|11712797|FG001|Overall Study|Lost to Follow-up|0
7431916|NCT01580020|11712798|FG002|Overall Study|Lost to Follow-up|1
7431917|NCT01580020|11712799|FG003|Overall Study|Lost to Follow-up|0
7431918|NCT01580293|11712840|FG000|Part A_Main Trial|Adverse Event|0
7532314|NCT02669433|11877929|FG002|Overall Study|Sponsor Termination|1
7532315|NCT02669433|11877927|FG000|Overall Study|Withdrawal by Subject|5
7532316|NCT02669433|11877928|FG001|Overall Study|Withdrawal by Subject|1
7532317|NCT02669433|11877929|FG002|Overall Study|Withdrawal by Subject|0
7532318|NCT02669433|11877927|FG000|Overall Study|Withdrawal by Caregiver|1
7532319|NCT02669433|11877928|FG001|Overall Study|Withdrawal by Caregiver|0
7558730|NCT03134183|11924547|FG000|Overall Study|Withdrawal by Subject|1
7558731|NCT03134183|11924548|FG001|Overall Study|Withdrawal by Subject|1
7558732|NCT03134222|11924570|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
7558733|NCT03134222|11924571|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
7558734|NCT03134222|11924572|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
7558735|NCT03134222|11924573|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
7558736|NCT03134222|11924574|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
7558737|NCT03134222|11924570|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7532320|NCT02669433|11877929|FG002|Overall Study|Withdrawal by Caregiver|2
7532321|NCT02669433|11877927|FG000|Overall Study|Death|0
7532322|NCT02669433|11877928|FG001|Overall Study|Death|1
7532323|NCT02669433|11877929|FG002|Overall Study|Death|1
7532324|NCT02669667|11877948|FG000|Overall Study|Lost to Follow-up|0
7532325|NCT02669667|11877949|FG001|Overall Study|Lost to Follow-up|0
7532326|NCT02669667|11877950|FG002|Overall Study|Lost to Follow-up|0
7532327|NCT02669667|11877951|FG003|Overall Study|Lost to Follow-up|0
7558738|NCT03134222|11924571|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7558739|NCT03134222|11924572|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
7558740|NCT03134222|11924573|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7558741|NCT03134222|11924574|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
7431919|NCT01580293|11712841|FG001|Part A_Main Trial|Adverse Event|2
7431920|NCT01580293|11712842|FG002|Part A_Main Trial|Adverse Event|0
7431921|NCT01580293|11712840|FG000|Part A_Main Trial|Withdrawal by Subject|1
7431922|NCT01580293|11712841|FG001|Part A_Main Trial|Withdrawal by Subject|4
7431923|NCT01580293|11712842|FG002|Part A_Main Trial|Withdrawal by Subject|0
7532328|NCT02669667|11877952|FG004|Overall Study|Lost to Follow-up|0
7431924|NCT01580293|11712840|FG000|Part A_Main Trial|Non-adherence to the protocol|1
7431925|NCT01580293|11712841|FG001|Part A_Main Trial|Non-adherence to the protocol|0
7431926|NCT01580293|11712842|FG002|Part A_Main Trial|Non-adherence to the protocol|0
7532329|NCT02669667|11877953|FG005|Overall Study|Lost to Follow-up|1
7532330|NCT02669667|11877954|FG006|Overall Study|Lost to Follow-up|0
7532331|NCT02669758|11877976|FG000|Overall Study|Withdrawal by Subject|43
7532332|NCT02669758|11877976|FG000|Overall Study|Lost to Follow-up|19
7532333|NCT02669758|11877976|FG000|Overall Study|Adverse Event|16
7532334|NCT02669758|11877976|FG000|Overall Study|Non-Compliance with Study Drug|8
7532335|NCT02669758|11877976|FG000|Overall Study|Lack of Efficacy|5
7532336|NCT02669758|11877976|FG000|Overall Study|Pregnancy|1
7532337|NCT02669758|11877976|FG000|Overall Study|Study noncompliance|1
7532338|NCT02669758|11877976|FG000|Overall Study|Protocol Violation|1
7532339|NCT02669849|11877992|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7532340|NCT02669849|11877993|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
7532341|NCT02669849|11877994|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
7532342|NCT02669849|11877992|FG000|Overall Study|Lost to Follow-up|1
7532343|NCT02669849|11877993|FG001|Overall Study|Lost to Follow-up|0
7532344|NCT02669849|11877994|FG002|Overall Study|Lost to Follow-up|3
7532345|NCT02669849|11877992|FG000|Overall Study|Death|1
7532346|NCT02669849|11877993|FG001|Overall Study|Death|1
7532347|NCT02669849|11877994|FG002|Overall Study|Death|2
7532348|NCT02669849|11877992|FG000|Overall Study|Study terminated by sponsor|16
7532349|NCT02669849|11877993|FG001|Overall Study|Study terminated by sponsor|1
7532350|NCT02669849|11877994|FG002|Overall Study|Study terminated by sponsor|14
7532351|NCT02669849|11877992|FG000|Overall Study|Other|0
7532352|NCT02669849|11877993|FG001|Overall Study|Other|0
7532353|NCT02669849|11877994|FG002|Overall Study|Other|2
7532354|NCT02669862|11878005|FG000|Overall Study|Lost to Follow-up|0
7532355|NCT02669862|11878006|FG001|Overall Study|Lost to Follow-up|2
7532356|NCT02669862|11878007|FG002|Overall Study|Lost to Follow-up|1
7532357|NCT02669862|11878005|FG000|Overall Study|Withdrawal by Subject|2
7532358|NCT02669862|11878006|FG001|Overall Study|Withdrawal by Subject|2
7532359|NCT02669862|11878007|FG002|Overall Study|Withdrawal by Subject|3
7532360|NCT02669862|11878005|FG000|Overall Study|moved|0
7532361|NCT02669862|11878006|FG001|Overall Study|moved|1
7532362|NCT02669862|11878007|FG002|Overall Study|moved|0
7532363|NCT02669862|11878005|FG000|Overall Study|Protocol Violation|0
7532364|NCT02669862|11878006|FG001|Overall Study|Protocol Violation|0
7532365|NCT02669862|11878007|FG002|Overall Study|Protocol Violation|1
7532366|NCT02669940|11878033|FG000|Overall Study|Failure to return|0
7532367|NCT02669940|11878034|FG001|Overall Study|Failure to return|3
7532368|NCT02669940|11878033|FG000|Overall Study|Insufficient follow-up data|1
7532369|NCT02669940|11878034|FG001|Overall Study|Insufficient follow-up data|0
7532370|NCT02670083|11878049|FG000|Overall Study|Adverse Event|16
7532371|NCT02670083|11878050|FG001|Overall Study|Adverse Event|13
7532372|NCT02670083|11878049|FG000|Overall Study|Death|4
7532373|NCT02670083|11878050|FG001|Overall Study|Death|6
7532374|NCT02670083|11878049|FG000|Overall Study|Lost to Follow-up|2
7532375|NCT02670083|11878050|FG001|Overall Study|Lost to Follow-up|2
7532376|NCT02670083|11878049|FG000|Overall Study|Multiple Reasons|9
7532377|NCT02670083|11878050|FG001|Overall Study|Multiple Reasons|9
7532378|NCT02670083|11878049|FG000|Overall Study|Physician Decision|0
7532379|NCT02670083|11878050|FG001|Overall Study|Physician Decision|2
7532380|NCT02670083|11878049|FG000|Overall Study|Study Terminated By Sponsor|257
7532381|NCT02670083|11878050|FG001|Overall Study|Study Terminated By Sponsor|254
7532382|NCT02670083|11878049|FG000|Overall Study|Symptomatic Deterioration|0
7532383|NCT02670083|11878050|FG001|Overall Study|Symptomatic Deterioration|2
7532384|NCT02670083|11878049|FG000|Overall Study|Withdrawal by Subject|32
7532385|NCT02670083|11878050|FG001|Overall Study|Withdrawal by Subject|31
7532386|NCT02670083|11878049|FG000|Overall Study|Non-Compliance With Study Drug|1
7532387|NCT02670083|11878050|FG001|Overall Study|Non-Compliance With Study Drug|0
7532388|NCT02670122|11878057|FG000|Overall Study|Lost to Follow-up|4
7532389|NCT02670330|11878070|FG000|Overall Study|Protocol Deviation|1
7532390|NCT02670330|11878071|FG001|Overall Study|Protocol Deviation|0
7532391|NCT02670330|11878070|FG000|Overall Study|Study Terminated By Sponsor|36
7532392|NCT02670330|11878071|FG001|Overall Study|Study Terminated By Sponsor|43
7532393|NCT02670330|11878070|FG000|Overall Study|Adverse Event|1
7532394|NCT02670330|11878071|FG001|Overall Study|Adverse Event|3
7532395|NCT02670330|11878070|FG000|Overall Study|Withdrawal by Subject|34
7532396|NCT02670330|11878071|FG001|Overall Study|Withdrawal by Subject|29
7532397|NCT02670330|11878070|FG000|Overall Study|Lost to Follow-up|3
7532398|NCT02670330|11878071|FG001|Overall Study|Lost to Follow-up|2
7537637|NCT02811861|11886774|FG000|Overall Study|Radiological Disease Progression|123
7537638|NCT02811861|11886775|FG001|Overall Study|Radiological Disease Progression|97
7537639|NCT02811861|11886776|FG002|Overall Study|Radiological Disease Progression|174
7537640|NCT02811861|11886774|FG000|Overall Study|Clinical Disease Progression|20
7537641|NCT02811861|11886775|FG001|Overall Study|Clinical Disease Progression|19
7537642|NCT02811861|11886776|FG002|Overall Study|Clinical Disease Progression|22
7537643|NCT02811861|11886774|FG000|Overall Study|Adverse Event|63
7537644|NCT02811861|11886775|FG001|Overall Study|Adverse Event|60
7537645|NCT02811861|11886776|FG002|Overall Study|Adverse Event|41
7537646|NCT02811861|11886774|FG000|Overall Study|Lost to Follow-up|0
7537647|NCT02811861|11886775|FG001|Overall Study|Lost to Follow-up|0
7537648|NCT02811861|11886776|FG002|Overall Study|Lost to Follow-up|1
7537649|NCT02811861|11886774|FG000|Overall Study|Subject Choice|29
7537650|NCT02811861|11886775|FG001|Overall Study|Subject Choice|17
7537651|NCT02811861|11886776|FG002|Overall Study|Subject Choice|23
7537652|NCT02811861|11886774|FG000|Overall Study|Withdrawal by Subject|4
7532399|NCT02670382|11878081|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
7532400|NCT02670382|11878082|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
7532401|NCT02670473|11878090|FG000|Overall Study|Withdrawal by Subject|1
7532402|NCT02670538|11878106|FG000|Overall Study|Withdrawal of Consent|8
7532403|NCT02670538|11878107|FG001|Overall Study|Withdrawal of Consent|6
7532404|NCT02670538|11878108|FG002|Overall Study|Withdrawal of Consent|5
7532405|NCT02670538|11878106|FG000|Overall Study|Lost to Follow-up|8
7532406|NCT02670538|11878107|FG001|Overall Study|Lost to Follow-up|12
7532407|NCT02670538|11878108|FG002|Overall Study|Lost to Follow-up|7
7532408|NCT02670538|11878106|FG000|Overall Study|Adverse Event|5
7532409|NCT02670538|11878107|FG001|Overall Study|Adverse Event|5
7532410|NCT02670538|11878108|FG002|Overall Study|Adverse Event|11
7532411|NCT02670538|11878106|FG000|Overall Study|Lack of Efficacy|7
7532412|NCT02670538|11878107|FG001|Overall Study|Lack of Efficacy|1
7532413|NCT02670538|11878108|FG002|Overall Study|Lack of Efficacy|2
7532414|NCT02670538|11878106|FG000|Overall Study|Protocol Violation|3
7532415|NCT02670538|11878107|FG001|Overall Study|Protocol Violation|4
7532416|NCT02670538|11878108|FG002|Overall Study|Protocol Violation|1
7532417|NCT02670538|11878106|FG000|Overall Study|Noncompliance with Study Drug|1
7532418|NCT02670538|11878107|FG001|Overall Study|Noncompliance with Study Drug|3
7532419|NCT02670538|11878108|FG002|Overall Study|Noncompliance with Study Drug|2
7532420|NCT02670538|11878106|FG000|Overall Study|Other Miscellaneous Reasons|0
7532421|NCT02670538|11878107|FG001|Overall Study|Other Miscellaneous Reasons|1
7532422|NCT02670538|11878108|FG002|Overall Study|Other Miscellaneous Reasons|2
7532423|NCT02670551|11878119|FG000|Overall Study|Adverse Event|4
7532424|NCT02670551|11878120|FG001|Overall Study|Adverse Event|7
7532425|NCT02670551|11878121|FG002|Overall Study|Adverse Event|9
7532426|NCT02670551|11878119|FG000|Overall Study|Lack of Efficacy|2
7532427|NCT02670551|11878120|FG001|Overall Study|Lack of Efficacy|0
7532428|NCT02670551|11878121|FG002|Overall Study|Lack of Efficacy|3
7532429|NCT02670551|11878119|FG000|Overall Study|Withdrawal of Consent|6
7532430|NCT02670551|11878120|FG001|Overall Study|Withdrawal of Consent|3
7532431|NCT02670551|11878121|FG002|Overall Study|Withdrawal of Consent|8
7532432|NCT02670551|11878119|FG000|Overall Study|Lost to Follow-up|5
7532433|NCT02670551|11878120|FG001|Overall Study|Lost to Follow-up|7
7532434|NCT02670551|11878121|FG002|Overall Study|Lost to Follow-up|6
7532435|NCT02670551|11878119|FG000|Overall Study|Protocol Violation|1
7532436|NCT02670551|11878120|FG001|Overall Study|Protocol Violation|0
7532437|NCT02670551|11878121|FG002|Overall Study|Protocol Violation|0
7532438|NCT02670551|11878119|FG000|Overall Study|Noncompliance with study drug|3
7532439|NCT02670551|11878120|FG001|Overall Study|Noncompliance with study drug|3
7532440|NCT02670551|11878121|FG002|Overall Study|Noncompliance with study drug|2
7532441|NCT02670551|11878119|FG000|Overall Study|Other Miscellaneous Reasons|2
7532442|NCT02670551|11878120|FG001|Overall Study|Other Miscellaneous Reasons|3
7532443|NCT02670551|11878121|FG002|Overall Study|Other Miscellaneous Reasons|3
7532444|NCT02670551|11878119|FG000|Overall Study|Did Not Receive Treatment|5
7532445|NCT02670551|11878120|FG001|Overall Study|Did Not Receive Treatment|3
7532446|NCT02670551|11878121|FG002|Overall Study|Did Not Receive Treatment|0
7532447|NCT02670915|11878150|FG000|Overall Study|Withdrawal by Subject|0
7532448|NCT02670915|11878151|FG001|Overall Study|Withdrawal by Subject|1
7532449|NCT02670915|11878152|FG002|Overall Study|Withdrawal by Subject|4
7532450|NCT02670915|11878150|FG000|Overall Study|Withdrawal by parent/guardian|4
7532451|NCT02670915|11878151|FG001|Overall Study|Withdrawal by parent/guardian|4
7532452|NCT02670915|11878152|FG002|Overall Study|Withdrawal by parent/guardian|1
7532453|NCT02670915|11878150|FG000|Overall Study|Unclassified|0
7532454|NCT02670915|11878151|FG001|Overall Study|Unclassified|3
7558742|NCT03134222|11924570|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
7431927|NCT01580293|11712840|FG000|Part A_Extension|Adverse Event|0
7431928|NCT01580293|11712841|FG001|Part A_Extension|Adverse Event|2
7431929|NCT01580293|11712842|FG002|Part A_Extension|Adverse Event|0
7431930|NCT01580293|11712840|FG000|Part A_Extension|Withdrawal by Subject|0
7431931|NCT01580293|11712841|FG001|Part A_Extension|Withdrawal by Subject|3
7431932|NCT01580293|11712842|FG002|Part A_Extension|Withdrawal by Subject|0
7431933|NCT01580293|11712840|FG000|Part A_Extension|Lost to Follow-up|0
7431934|NCT01580293|11712841|FG001|Part A_Extension|Lost to Follow-up|1
7431935|NCT01580293|11712842|FG002|Part A_Extension|Lost to Follow-up|0
7431936|NCT01580293|11712840|FG000|Part A_Extension|Other Reason|0
7431937|NCT01580293|11712841|FG001|Part A_Extension|Other Reason|1
7431938|NCT01580293|11712842|FG002|Part A_Extension|Other Reason|0
7532455|NCT02670915|11878152|FG002|Overall Study|Unclassified|0
7532456|NCT02670928|11878162|FG000|Overall Study|Adverse Event|3
7532457|NCT02670928|11878163|FG001|Overall Study|Adverse Event|1
7532458|NCT02670928|11878162|FG000|Overall Study|Withdrawal by Subject|4
7532459|NCT02670928|11878163|FG001|Overall Study|Withdrawal by Subject|0
7532460|NCT02670928|11878162|FG000|Overall Study|Lost to Follow-up|1
7532461|NCT02670928|11878163|FG001|Overall Study|Lost to Follow-up|0
7532462|NCT02670928|11878162|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
7532463|NCT02670928|11878163|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
7532464|NCT02671266|11878175|FG000|Overall Study|Withdrawal by Subject|1
7532465|NCT02671266|11878176|FG001|Overall Study|Withdrawal by Subject|1
7532466|NCT02671422|11878182|FG000|Overall Study|Lost to Follow-up|1
7532467|NCT02671422|11878182|FG000|Overall Study|Adverse Event|68
7532468|NCT02671422|11878182|FG000|Overall Study|Lack of Efficacy|1
7431939|NCT01580293|11712840|FG000|Part A_Extension|Completed Japan only|0
7431940|NCT01580293|11712841|FG001|Part A_Extension|Completed Japan only|5
7431941|NCT01580293|11712842|FG002|Part A_Extension|Completed Japan only|0
7431942|NCT01580293|11712840|FG000|Part B|Withdrawal by Subject|0
7431943|NCT01580293|11712841|FG001|Part B|Withdrawal by Subject|0
7431944|NCT01580293|11712842|FG002|Part B|Withdrawal by Subject|1
7431945|NCT01580293|11712840|FG000|Part B|Other reason|0
7431946|NCT01580293|11712841|FG001|Part B|Other reason|0
7431947|NCT01580293|11712842|FG002|Part B|Other reason|1
7431948|NCT01580488|11712903|FG000|Overall Study|Withdrawal by Subject|1
7431949|NCT01580670|11712939|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
7431950|NCT01580670|11712939|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
7431951|NCT01580969|11712956|FG000|Overall Study|Physician Decision|3
7431952|NCT01580969|11712957|FG001|Overall Study|Physician Decision|0
7431953|NCT01580969|11712958|FG002|Overall Study|Physician Decision|0
7431954|NCT01580995|11712968|FG000|Overall Study|Lost to Follow-up|2
7431955|NCT01580995|11712969|FG001|Overall Study|Lost to Follow-up|2
7431956|NCT01581021|11712987|FG000|Overall Study|Lost to Follow-up|4
7431957|NCT01581021|11712988|FG001|Overall Study|Lost to Follow-up|6
7431958|NCT01581021|11712987|FG000|Overall Study|More than 2 hooks in thoracic|3
7431959|NCT01581021|11712988|FG001|Overall Study|More than 2 hooks in thoracic|0
7431960|NCT01581021|11712987|FG000|Overall Study|Neuromuscular|2
7431961|NCT01581021|11712988|FG001|Overall Study|Neuromuscular|1
7431962|NCT01581021|11712987|FG000|Overall Study|Not Randomized|1
7431963|NCT01581021|11712988|FG001|Overall Study|Not Randomized|2
7431964|NCT01581021|11712987|FG000|Overall Study|Lenke 6 Classification|0
7431965|NCT01581021|11712988|FG001|Overall Study|Lenke 6 Classification|1
7431966|NCT01581021|11712987|FG000|Overall Study|Lack of Efficacy|0
7431967|NCT01581021|11712988|FG001|Overall Study|Lack of Efficacy|1
7431968|NCT01581281|11712997|FG000|Overall Study|Early Study Closure|15
7431969|NCT01581281|11712998|FG001|Overall Study|Early Study Closure|6
7431970|NCT01581281|11712999|FG002|Overall Study|Early Study Closure|12
7431971|NCT01581307|11713008|FG000|Overall Study|Withdrawal by Subject|1
7431972|NCT01581593|11713055|FG000|Overall Study|Withdrawal by Subject|1
7431973|NCT01581619|11713063|FG000|Overall Study|Withdrawal by Subject|1
7431974|NCT01581619|11713063|FG000|Overall Study|Lost to Follow-up|1
7431975|NCT01581684|11713096|FG000|Overall Study|Other reason not defined|0
7431976|NCT01581684|11713097|FG001|Overall Study|Other reason not defined|0
7431977|NCT01581684|11713098|FG002|Overall Study|Other reason not defined|0
7431978|NCT01581684|11713099|FG003|Overall Study|Other reason not defined|0
7431979|NCT01581684|11713100|FG004|Overall Study|Other reason not defined|0
7431980|NCT01581684|11713101|FG005|Overall Study|Other reason not defined|0
7431981|NCT01581684|11713102|FG006|Overall Study|Other reason not defined|0
7431982|NCT01581684|11713103|FG007|Overall Study|Other reason not defined|0
7431983|NCT01581684|11713104|FG008|Overall Study|Other reason not defined|1
7431984|NCT01581684|11713105|FG009|Overall Study|Other reason not defined|0
7431985|NCT01581931|11713149|FG000|Washout|Adverse Event|0
7431986|NCT01581931|11713150|FG001|Washout|Adverse Event|1
7431989|NCT01582061|11713166|FG000|Overall Study|Lack of Efficacy|3
7431990|NCT01582061|11713167|FG001|Overall Study|Lack of Efficacy|23
7431991|NCT01582061|11713166|FG000|Overall Study|Adverse Event|12
7431992|NCT01582061|11713167|FG001|Overall Study|Adverse Event|8
7431993|NCT01582061|11713166|FG000|Overall Study|Withdrawal by Subject|10
7431994|NCT01582061|11713167|FG001|Overall Study|Withdrawal by Subject|4
7431995|NCT01582061|11713166|FG000|Overall Study|Abnormal laboratory value(s)|1
7431996|NCT01582061|11713167|FG001|Overall Study|Abnormal laboratory value(s)|0
7431997|NCT01582061|11713166|FG000|Overall Study|Death|0
7431998|NCT01582061|11713167|FG001|Overall Study|Death|1
7431999|NCT01582061|11713166|FG000|Overall Study|condition no longer requires study drug|1
7432000|NCT01582061|11713167|FG001|Overall Study|condition no longer requires study drug|0
7432001|NCT01582061|11713166|FG000|Overall Study|Lost to Follow-up|1
7432002|NCT01582061|11713167|FG001|Overall Study|Lost to Follow-up|0
7432003|NCT01582152|11713194|FG000|Overall Study|Disease Progression|4
7432004|NCT01582152|11713195|FG001|Overall Study|Disease Progression|5
7432005|NCT01582152|11713194|FG000|Overall Study|Adverse Event|2
7432006|NCT01582152|11713195|FG001|Overall Study|Adverse Event|1
7432007|NCT01582178|11713203|FG000|Overall Study|Physician Decision|6
7432008|NCT01582178|11713204|FG001|Overall Study|Physician Decision|5
7432009|NCT01582243|11713210|FG000|Overall Study|Withdrawal by Subject|1
7432010|NCT01582243|11713210|FG000|Overall Study|Adverse Event|1
7432011|NCT01582243|11713210|FG000|Overall Study|Lost to Follow-up|1
7432012|NCT01582282|11713217|FG000|Overall Study|Adverse Event|1
7432013|NCT01582282|11713218|FG001|Overall Study|Adverse Event|1
7432014|NCT01582282|11713219|FG002|Overall Study|Adverse Event|0
7432015|NCT01582282|11713217|FG000|Overall Study|Lost to Follow-up|1
7432016|NCT01582282|11713218|FG001|Overall Study|Lost to Follow-up|0
7432017|NCT01582282|11713219|FG002|Overall Study|Lost to Follow-up|0
7432018|NCT01582282|11713217|FG000|Overall Study|fasting blood glucose outside Protocol|0
7432019|NCT01582282|11713218|FG001|Overall Study|fasting blood glucose outside Protocol|1
7432020|NCT01582282|11713219|FG002|Overall Study|fasting blood glucose outside Protocol|0
7432021|NCT01582308|11713227|FG000|Period 1|Withdrawal by Subject|0
7432022|NCT01582308|11713228|FG001|Period 1|Withdrawal by Subject|0
7432023|NCT01582308|11713229|FG002|Period 1|Withdrawal by Subject|0
7432024|NCT01582308|11713230|FG003|Period 1|Withdrawal by Subject|0
7432025|NCT01582308|11713231|FG004|Period 1|Withdrawal by Subject|0
7432026|NCT01582308|11713232|FG005|Period 1|Withdrawal by Subject|0
7432027|NCT01582308|11713233|FG006|Period 1|Withdrawal by Subject|1
7432028|NCT01582308|11713234|FG007|Period 1|Withdrawal by Subject|0
7432029|NCT01582308|11713235|FG008|Period 1|Withdrawal by Subject|0
7432030|NCT01582308|11713236|FG009|Period 1|Withdrawal by Subject|0
7432031|NCT01582308|11713227|FG000|10-day Washout Following Period 1|Physician Decision|0
7432032|NCT01582308|11713228|FG001|10-day Washout Following Period 1|Physician Decision|0
7432033|NCT01582308|11713229|FG002|10-day Washout Following Period 1|Physician Decision|0
7432034|NCT01582308|11713230|FG003|10-day Washout Following Period 1|Physician Decision|0
7432035|NCT01582308|11713231|FG004|10-day Washout Following Period 1|Physician Decision|1
7432036|NCT01582308|11713232|FG005|10-day Washout Following Period 1|Physician Decision|0
7432037|NCT01582308|11713233|FG006|10-day Washout Following Period 1|Physician Decision|0
7432038|NCT01582308|11713234|FG007|10-day Washout Following Period 1|Physician Decision|0
7432039|NCT01582308|11713235|FG008|10-day Washout Following Period 1|Physician Decision|0
7432040|NCT01582308|11713236|FG009|10-day Washout Following Period 1|Physician Decision|0
7432041|NCT01582308|11713227|FG000|Period 4|Physician Decision|1
7432042|NCT01582308|11713228|FG001|Period 4|Physician Decision|0
7432043|NCT01582308|11713229|FG002|Period 4|Physician Decision|0
7432044|NCT01582308|11713230|FG003|Period 4|Physician Decision|0
7432045|NCT01582308|11713231|FG004|Period 4|Physician Decision|0
7432046|NCT01582308|11713232|FG005|Period 4|Physician Decision|1
7432047|NCT01582308|11713233|FG006|Period 4|Physician Decision|0
7432048|NCT01582308|11713234|FG007|Period 4|Physician Decision|0
7432049|NCT01582308|11713235|FG008|Period 4|Physician Decision|0
7432050|NCT01582308|11713236|FG009|Period 4|Physician Decision|1
7432051|NCT01582451|11713251|FG000|Overall Study|Adverse Event|1
7432052|NCT01582451|11713252|FG001|Overall Study|Adverse Event|3
7432053|NCT01582451|11713251|FG000|Overall Study|Death|3
7432054|NCT01582451|11713252|FG001|Overall Study|Death|3
7432055|NCT01582451|11713251|FG000|Overall Study|Lost to Follow-up|0
7432056|NCT01582451|11713252|FG001|Overall Study|Lost to Follow-up|2
7432057|NCT01582451|11713251|FG000|Overall Study|Protocol Violation|11
7432058|NCT01582451|11713252|FG001|Overall Study|Protocol Violation|3
7432059|NCT01582451|11713251|FG000|Overall Study|Withdrawal by Subject|13
7432060|NCT01582451|11713252|FG001|Overall Study|Withdrawal by Subject|9
7432061|NCT01582451|11713251|FG000|Overall Study|Physician Decision|3
7432062|NCT01582451|11713252|FG001|Overall Study|Physician Decision|0
7432063|NCT01582451|11713251|FG000|Overall Study|Sponsor Decision|1
7432064|NCT01582451|11713252|FG001|Overall Study|Sponsor Decision|0
7432065|NCT01582789|11713278|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
7432066|NCT01582789|11713279|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
7432067|NCT01582854|11713289|FG000|Overall Study|Death|8
7432068|NCT01582854|11713290|FG001|Overall Study|Death|5
7432069|NCT01582854|11713289|FG000|Overall Study|Adverse Event|2
7432070|NCT01582854|11713290|FG001|Overall Study|Adverse Event|3
7432071|NCT01582854|11713289|FG000|Overall Study|Withdrawal by Participant|8
7432072|NCT01582854|11713290|FG001|Overall Study|Withdrawal by Participant|11
7432073|NCT01582854|11713289|FG000|Overall Study|Lost to Follow-up|1
7432074|NCT01582854|11713290|FG001|Overall Study|Lost to Follow-up|2
7432075|NCT01582854|11713289|FG000|Overall Study|Physician Decision|0
7432076|NCT01582854|11713290|FG001|Overall Study|Physician Decision|1
7432077|NCT01582854|11713289|FG000|Overall Study|Recurrent Stroke|13
7432078|NCT01582854|11713290|FG001|Overall Study|Recurrent Stroke|8
7432079|NCT01582854|11713289|FG000|Overall Study|Disallowed Concomitant Medication|3
7432080|NCT01582854|11713290|FG001|Overall Study|Disallowed Concomitant Medication|2
7432081|NCT01582854|11713289|FG000|Overall Study|Carotid or Neurosurgery|0
7432082|NCT01582854|11713290|FG001|Overall Study|Carotid or Neurosurgery|1
7432083|NCT01582854|11713289|FG000|Overall Study|General Anaesthesia|0
7432084|NCT01582854|11713290|FG001|Overall Study|General Anaesthesia|1
7432085|NCT01582854|11713289|FG000|Overall Study|Other Miscellaneous Reason|1
7432086|NCT01582854|11713290|FG001|Overall Study|Other Miscellaneous Reason|0
7432087|NCT01582945|11713300|FG000|Overall Study|Intolerable side-effects|1
7432088|NCT01582945|11713300|FG000|Overall Study|Scheduling conflicts|1
7432089|NCT01582971|11713306|FG000|Overall Study|Death|2
7432090|NCT01582971|11713307|FG001|Overall Study|Death|1
7432091|NCT01582971|11713306|FG000|Overall Study|Lost to Follow-up|18
7432092|NCT01582971|11713307|FG001|Overall Study|Lost to Follow-up|21
7432093|NCT01582971|11713306|FG000|Overall Study|Withdrawal by Subject|4
7432094|NCT01582971|11713307|FG001|Overall Study|Withdrawal by Subject|2
7432095|NCT01582971|11713306|FG000|Overall Study|Other|15
7432096|NCT01582971|11713307|FG001|Overall Study|Other|13
7432097|NCT01583166|11713330|FG000|Overall Study|Withdrawal by Subject|4
7432098|NCT01583166|11713331|FG001|Overall Study|Withdrawal by Subject|6
7432099|NCT01583179|11713339|FG000|Overall Study|Screen failure|1
7432100|NCT01583179|11713340|FG001|Overall Study|Screen failure|2
7432101|NCT01583218|11713348|FG000|Overall Study|Withdrawal by Subject|43
7432102|NCT01583218|11713349|FG001|Overall Study|Withdrawal by Subject|29
7432103|NCT01583218|11713348|FG000|Overall Study|Death|206
7432104|NCT01583218|11713349|FG001|Overall Study|Death|211
7432105|NCT01583218|11713348|FG000|Overall Study|Lost to Follow-up|11
7432106|NCT01583218|11713349|FG001|Overall Study|Lost to Follow-up|17
7432107|NCT01583218|11713348|FG000|Overall Study|Adverse event or serious adverse event|3
7432108|NCT01583218|11713349|FG001|Overall Study|Adverse event or serious adverse event|3
7432109|NCT01583218|11713348|FG000|Overall Study|Patient /Family decision|3
7432110|NCT01583218|11713349|FG001|Overall Study|Patient /Family decision|0
7432111|NCT01583218|11713348|FG000|Overall Study|Cannot contact patient directly|1
7432112|NCT01583218|11713349|FG001|Overall Study|Cannot contact patient directly|2
7432113|NCT01583218|11713348|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
7432114|NCT01583218|11713349|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
7432115|NCT01583218|11713348|FG000|Overall Study|Patient did not wish to attend visits|0
7432116|NCT01583218|11713349|FG001|Overall Study|Patient did not wish to attend visits|1
7432117|NCT01583218|11713348|FG000|Overall Study|Patient randomized but not dosed|17
7432118|NCT01583218|11713349|FG001|Overall Study|Patient randomized but not dosed|16
7432119|NCT01583218|11713348|FG000|Overall Study|Patient was assessed via phone in person|1
7432120|NCT01583218|11713349|FG001|Overall Study|Patient was assessed via phone in person|0
7432121|NCT01583218|11713348|FG000|Overall Study|Patient deemed ineligible after random|2
7432122|NCT01583218|11713349|FG001|Overall Study|Patient deemed ineligible after random|0
7432123|NCT01583218|11713348|FG000|Overall Study|Patient was early terminated from study|0
7432124|NCT01583218|11713349|FG001|Overall Study|Patient was early terminated from study|1
7432125|NCT01583218|11713348|FG000|Overall Study|Patient was randomized due to mistake|1
7432126|NCT01583218|11713349|FG001|Overall Study|Patient was randomized due to mistake|0
7432127|NCT01583218|11713348|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
7432128|NCT01583218|11713349|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
7432129|NCT01583218|11713348|FG000|Overall Study|Withdraw of consent on day of random|1
7432130|NCT01583218|11713349|FG001|Overall Study|Withdraw of consent on day of random|0
7432131|NCT01583296|11713357|FG000|Overall Study|Withdrawal by Subject|11
7432132|NCT01583296|11713358|FG001|Overall Study|Withdrawal by Subject|10
7432133|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
7432134|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
7432135|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
7432136|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432137|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432138|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432139|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432140|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432141|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7432142|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
7432143|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
7432144|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7432145|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432146|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432147|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432148|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432149|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432150|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7432151|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7432152|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7432153|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432154|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432155|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432156|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432157|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432158|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432159|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7432160|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
7432161|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7432162|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7432163|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432164|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432165|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432166|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432167|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432168|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7432169|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
7432170|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
7432171|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432172|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432173|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432174|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432175|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432176|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432177|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
7432178|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432179|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432180|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
7432181|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432182|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432183|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432184|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432185|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432186|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7432187|NCT01583374|11713367|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
7432188|NCT01583374|11713368|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
7432189|NCT01583374|11713369|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
7432190|NCT01583374|11713370|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
7432191|NCT01583374|11713371|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
7432192|NCT01583374|11713372|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
7432193|NCT01583374|11713373|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
7432194|NCT01583374|11713374|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
7432195|NCT01583374|11713375|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
7432196|NCT01583374|11713367|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432197|NCT01583374|11713368|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432198|NCT01583374|11713369|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432199|NCT01583374|11713370|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432200|NCT01583374|11713371|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432201|NCT01583374|11713372|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432202|NCT01583374|11713373|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432203|NCT01583374|11713374|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7432204|NCT01583374|11713375|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7432205|NCT01583374|11713367|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7432206|NCT01583374|11713368|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7432207|NCT01583374|11713369|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
7432208|NCT01583374|11713370|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7432209|NCT01583374|11713371|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7432210|NCT01583374|11713372|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7432211|NCT01583374|11713373|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7432212|NCT01583374|11713374|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7432213|NCT01583374|11713375|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
7432214|NCT01583374|11713367|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7432215|NCT01583374|11713368|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7432216|NCT01583374|11713369|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7432217|NCT01583374|11713370|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
7432218|NCT01583374|11713371|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
7432219|NCT01583374|11713372|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7432220|NCT01583374|11713373|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
7432221|NCT01583374|11713374|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7432222|NCT01583374|11713375|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
7432223|NCT01583374|11713367|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432224|NCT01583374|11713368|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
7432225|NCT01583374|11713369|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7432226|NCT01583374|11713370|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432227|NCT01583374|11713371|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
7432228|NCT01583374|11713372|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432229|NCT01583374|11713373|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432230|NCT01583374|11713374|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432231|NCT01583374|11713375|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
7432232|NCT01583374|11713367|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432233|NCT01583374|11713368|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432234|NCT01583374|11713369|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7432235|NCT01583374|11713370|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432236|NCT01583374|11713371|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7432237|NCT01583374|11713372|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
7432238|NCT01583374|11713373|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432239|NCT01583374|11713374|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432240|NCT01583374|11713375|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7432241|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
7432242|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
7432243|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7432244|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7432245|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
7432246|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7432247|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
7432248|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
7432249|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
7432250|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
7432251|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7432252|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
7432253|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7432254|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
7432255|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
7432256|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7532469|NCT02671422|11878182|FG000|Overall Study|Lost to Follow-up|4
7532470|NCT02671422|11878182|FG000|Overall Study|Withdrawal by Subject|7
7532471|NCT02671422|11878182|FG000|Overall Study|Progressive Disease|156
7532472|NCT02671422|11878182|FG000|Overall Study|Worsening of Disease|4
7532473|NCT02671422|11878182|FG000|Overall Study|Sponsor decision|5
7532474|NCT02671422|11878182|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
7532475|NCT02671422|11878182|FG000|Overall Study|Not treated with Vargatef®|3
7532476|NCT02671422|11878182|FG000|Overall Study|Other not defined above|3
7532477|NCT02671500|11878186|FG000|Overall Study|Lack of Efficacy|12
7532478|NCT02671500|11878186|FG000|Overall Study|Lost to Follow-up|2
7532479|NCT02671760|11878194|FG000|Overall Study|Lost to Follow-up|0
7532480|NCT02671760|11878195|FG001|Overall Study|Lost to Follow-up|1
7532481|NCT02671760|11878196|FG002|Overall Study|Lost to Follow-up|0
7532482|NCT02672423|11878229|FG000|Period 1|Adverse Event|0
7532483|NCT02672423|11878230|FG001|Period 1|Adverse Event|0
7532484|NCT02672423|11878231|FG002|Period 1|Adverse Event|0
7532485|NCT02672423|11878232|FG003|Period 1|Adverse Event|0
7432257|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
7432258|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
7432259|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432260|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432261|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432262|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432263|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7432264|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432265|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
7432266|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7432267|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
7432268|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
7432269|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7432270|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
7432271|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
7432272|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
7432273|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
7432274|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
7432275|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7432276|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
7432277|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
7432278|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
7432279|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
7432280|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
7432281|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
7432282|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
7432283|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
7432284|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
7432285|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
7432286|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7432287|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7432288|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7432289|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7432290|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7432291|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7432292|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
7432293|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7432294|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
7432295|NCT01583374|11713367|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7432296|NCT01583374|11713368|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7532486|NCT02672423|11878233|FG004|Period 1|Adverse Event|1
7532487|NCT02672423|11878234|FG005|Period 1|Adverse Event|0
7532488|NCT02672423|11878235|FG006|Period 1|Adverse Event|0
7532489|NCT02672423|11878236|FG007|Period 1|Adverse Event|0
7532490|NCT02672423|11878237|FG008|Period 1|Adverse Event|0
7432297|NCT01583374|11713369|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7432298|NCT01583374|11713370|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
7432299|NCT01583374|11713371|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7432300|NCT01583374|11713372|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7432301|NCT01583374|11713373|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
7432302|NCT01583374|11713374|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
7432303|NCT01583374|11713375|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
7432304|NCT01583530|11713412|FG000|Overall Study|Adverse Event|0
7432305|NCT01583530|11713413|FG001|Overall Study|Adverse Event|0
7432306|NCT01583530|11713414|FG002|Overall Study|Adverse Event|0
7432307|NCT01583530|11713415|FG003|Overall Study|Adverse Event|0
7432308|NCT01583530|11713416|FG004|Overall Study|Adverse Event|0
7432309|NCT01583530|11713417|FG005|Overall Study|Adverse Event|1
7432310|NCT01583530|11713412|FG000|Overall Study|Withdrawal by Subject|0
7432311|NCT01583530|11713413|FG001|Overall Study|Withdrawal by Subject|3
7432312|NCT01583530|11713414|FG002|Overall Study|Withdrawal by Subject|0
7432313|NCT01583530|11713415|FG003|Overall Study|Withdrawal by Subject|1
7432314|NCT01583530|11713416|FG004|Overall Study|Withdrawal by Subject|1
7432315|NCT01583530|11713417|FG005|Overall Study|Withdrawal by Subject|2
7432316|NCT01583530|11713412|FG000|Overall Study|Lost to Follow-up|0
7432317|NCT01583530|11713413|FG001|Overall Study|Lost to Follow-up|0
7432318|NCT01583530|11713414|FG002|Overall Study|Lost to Follow-up|0
7432319|NCT01583530|11713415|FG003|Overall Study|Lost to Follow-up|0
7432320|NCT01583530|11713416|FG004|Overall Study|Lost to Follow-up|3
7432321|NCT01583530|11713417|FG005|Overall Study|Lost to Follow-up|0
7432322|NCT01583530|11713412|FG000|Overall Study|Lack of compliance|0
7432323|NCT01583530|11713413|FG001|Overall Study|Lack of compliance|0
7432324|NCT01583530|11713414|FG002|Overall Study|Lack of compliance|0
7432325|NCT01583530|11713415|FG003|Overall Study|Lack of compliance|0
7432326|NCT01583530|11713416|FG004|Overall Study|Lack of compliance|1
7432327|NCT01583530|11713417|FG005|Overall Study|Lack of compliance|0
7432328|NCT01584024|11713491|FG000|Overall Study|Lost to Follow-up|10
7432329|NCT01584024|11713491|FG000|Overall Study|Withdrawal by Subject|3
7432330|NCT01584232|11713498|FG000|Overall Study|Adverse Event|3
7432331|NCT01584232|11713499|FG001|Overall Study|Adverse Event|1
7432332|NCT01584232|11713498|FG000|Overall Study|Withdrawal by Subject|2
7432333|NCT01584232|11713499|FG001|Overall Study|Withdrawal by Subject|1
7432334|NCT01584232|11713498|FG000|Overall Study|Physician Decision|2
7432335|NCT01584232|11713499|FG001|Overall Study|Physician Decision|1
7432336|NCT01584232|11713498|FG000|Overall Study|Lost to Follow-up|1
7432337|NCT01584232|11713499|FG001|Overall Study|Lost to Follow-up|0
7432338|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
7432339|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7432340|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7432341|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7432342|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
7432343|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Adverse Event|5
7432344|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Adverse Event|3
7432345|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Adverse Event|0
7432346|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Adverse Event|0
7432347|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Adverse Event|0
7432348|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
7432349|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
7432350|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
7432351|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
7432352|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
7432353|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
7432354|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
7432355|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
7432356|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
7432357|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
7432358|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
7432359|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7432360|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7432361|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7432362|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
7432363|NCT01584440|11713525|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7432364|NCT01584440|11713526|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
7432365|NCT01584440|11713527|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7432366|NCT01584440|11713528|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7432367|NCT01584440|11713529|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
7432368|NCT01584440|11713525|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7432369|NCT01584440|11713526|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7432370|NCT01584440|11713527|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
7432371|NCT01584440|11713528|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
7432372|NCT01584440|11713529|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
7432373|NCT01584440|11713525|FG000|Stage 2 (5 Weeks)|Adverse Event|0
7432374|NCT01584440|11713526|FG001|Stage 2 (5 Weeks)|Adverse Event|0
7432375|NCT01584440|11713527|FG002|Stage 2 (5 Weeks)|Adverse Event|1
7432376|NCT01584440|11713528|FG003|Stage 2 (5 Weeks)|Adverse Event|2
7432377|NCT01584440|11713529|FG004|Stage 2 (5 Weeks)|Adverse Event|1
7328638|NCT00797667|11561660|FG000|Overall Study|Lost to Follow-up|8
7328639|NCT00797667|11561661|FG001|Overall Study|Lost to Follow-up|12
7328640|NCT00797667|11561662|FG002|Overall Study|Lost to Follow-up|2
7328641|NCT00797667|11561660|FG000|Overall Study|Physician Decision|3
7328642|NCT00797667|11561661|FG001|Overall Study|Physician Decision|1
7328643|NCT00797667|11561662|FG002|Overall Study|Physician Decision|0
7328644|NCT00797667|11561660|FG000|Overall Study|Pregnancy|2
7328645|NCT00797667|11561661|FG001|Overall Study|Pregnancy|0
7328646|NCT00797667|11561662|FG002|Overall Study|Pregnancy|0
7328647|NCT00797667|11561660|FG000|Overall Study|Protocol Violation|2
7328648|NCT00797667|11561661|FG001|Overall Study|Protocol Violation|7
7328649|NCT00797667|11561662|FG002|Overall Study|Protocol Violation|0
7328650|NCT00797667|11561660|FG000|Overall Study|Study Terminated by Sponsor|217
7328651|NCT00797667|11561661|FG001|Overall Study|Study Terminated by Sponsor|216
7328652|NCT00797667|11561662|FG002|Overall Study|Study Terminated by Sponsor|115
7328653|NCT00797667|11561660|FG000|Overall Study|Withdrawal by Subject|9
7328654|NCT00797667|11561661|FG001|Overall Study|Withdrawal by Subject|14
7328655|NCT00797667|11561662|FG002|Overall Study|Withdrawal by Subject|2
7328656|NCT00797667|11561660|FG000|Overall Study|Adverse Event|19
7328657|NCT00797667|11561661|FG001|Overall Study|Adverse Event|8
7328658|NCT00797667|11561662|FG002|Overall Study|Adverse Event|8
7328659|NCT00797732|11561672|FG000|Overall Study|Withdrawal by Subject|3
7328660|NCT00797732|11561673|FG001|Overall Study|Withdrawal by Subject|3
7328661|NCT00797732|11561674|FG002|Overall Study|Withdrawal by Subject|0
7328662|NCT00797732|11561672|FG000|Overall Study|Lost to Follow-up|1
7328663|NCT00797732|11561673|FG001|Overall Study|Lost to Follow-up|0
7328664|NCT00797732|11561674|FG002|Overall Study|Lost to Follow-up|0
7328665|NCT00797732|11561672|FG000|Overall Study|Death|1
7328666|NCT00797732|11561673|FG001|Overall Study|Death|0
7328667|NCT00797732|11561674|FG002|Overall Study|Death|0
7328668|NCT00797732|11561672|FG000|Overall Study|Not meet inclusion criteria|0
7328669|NCT00797732|11561673|FG001|Overall Study|Not meet inclusion criteria|0
7328670|NCT00797732|11561674|FG002|Overall Study|Not meet inclusion criteria|7
7328671|NCT00797732|11561672|FG000|Overall Study|Excluded due to time constraints|0
7328672|NCT00797732|11561673|FG001|Overall Study|Excluded due to time constraints|0
7328673|NCT00797732|11561674|FG002|Overall Study|Excluded due to time constraints|24
7328674|NCT00797732|11561672|FG000|Overall Study|Refused to Participate|0
7328675|NCT00797732|11561673|FG001|Overall Study|Refused to Participate|0
7328676|NCT00797732|11561674|FG002|Overall Study|Refused to Participate|123
7328677|NCT00797823|11561692|FG000|First Period (Initial Randomization)|Physician Decision|1
7328678|NCT00797823|11561693|FG001|First Period (Initial Randomization)|Physician Decision|0
7328679|NCT00797823|11561694|FG002|First Period (Initial Randomization)|Physician Decision|0
7328680|NCT00797862|11561704|FG000|Overall Study|Adverse Event|86
7328681|NCT00797862|11561705|FG001|Overall Study|Adverse Event|44
7328682|NCT00797862|11561706|FG002|Overall Study|Adverse Event|58
7328683|NCT00797862|11561704|FG000|Overall Study|Abnormal Test Procedure Result|0
7328684|NCT00797862|11561705|FG001|Overall Study|Abnormal Test Procedure Result|1
7328685|NCT00797862|11561706|FG002|Overall Study|Abnormal Test Procedure Result|1
7328686|NCT00797862|11561704|FG000|Overall Study|Lack of Efficacy|1
7328687|NCT00797862|11561705|FG001|Overall Study|Lack of Efficacy|7
7328688|NCT00797862|11561706|FG002|Overall Study|Lack of Efficacy|6
7328689|NCT00797862|11561704|FG000|Overall Study|No longer required study medication|1
7328690|NCT00797862|11561705|FG001|Overall Study|No longer required study medication|0
7328691|NCT00797862|11561706|FG002|Overall Study|No longer required study medication|0
7328692|NCT00797862|11561704|FG000|Overall Study|Withdrawal by Subject|14
7328693|NCT00797862|11561705|FG001|Overall Study|Withdrawal by Subject|7
7328694|NCT00797862|11561706|FG002|Overall Study|Withdrawal by Subject|7
7328695|NCT00797862|11561704|FG000|Overall Study|Lost to Follow-up|11
7328696|NCT00797862|11561705|FG001|Overall Study|Lost to Follow-up|0
7328697|NCT00797862|11561706|FG002|Overall Study|Lost to Follow-up|5
7328698|NCT00797862|11561704|FG000|Overall Study|Administrative Problem|4
7328699|NCT00797862|11561705|FG001|Overall Study|Administrative Problem|0
7328700|NCT00797862|11561706|FG002|Overall Study|Administrative Problem|0
7328701|NCT00797862|11561704|FG000|Overall Study|Protocol Violation|4
7328702|NCT00797862|11561705|FG001|Overall Study|Protocol Violation|6
7328703|NCT00797862|11561706|FG002|Overall Study|Protocol Violation|8
7328704|NCT00797862|11561704|FG000|Overall Study|Mis-randomized|3
7328705|NCT00797862|11561705|FG001|Overall Study|Mis-randomized|3
7328706|NCT00797862|11561706|FG002|Overall Study|Mis-randomized|1
7328707|NCT00797966|11561718|FG000|Phase A|Lost to Follow-up|0
7328708|NCT00797966|11561719|FG001|Phase A|Lost to Follow-up|0
7328709|NCT00797966|11561720|FG002|Phase A|Lost to Follow-up|0
7328710|NCT00797966|11561721|FG003|Phase A|Lost to Follow-up|0
7328711|NCT00797966|11561722|FG004|Phase A|Lost to Follow-up|33
7328712|NCT00797966|11561723|FG005|Phase A|Lost to Follow-up|0
7328713|NCT00797966|11561718|FG000|Phase A|Adverse Event|0
7328714|NCT00797966|11561719|FG001|Phase A|Adverse Event|0
7328715|NCT00797966|11561720|FG002|Phase A|Adverse Event|0
7328716|NCT00797966|11561721|FG003|Phase A|Adverse Event|0
7328717|NCT00797966|11561722|FG004|Phase A|Adverse Event|46
7328718|NCT00797966|11561723|FG005|Phase A|Adverse Event|0
7328719|NCT00797966|11561718|FG000|Phase A|Met withdrawal criteria|0
7328720|NCT00797966|11561719|FG001|Phase A|Met withdrawal criteria|0
7432378|NCT01584440|11713525|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7432379|NCT01584440|11713526|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7558743|NCT03134222|11924571|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
7558744|NCT03134222|11924572|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
7558745|NCT03134222|11924573|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
7558746|NCT03134222|11924574|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
7558747|NCT03134222|11924570|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
7558748|NCT03134222|11924571|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
7558749|NCT03134222|11924572|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
7558750|NCT03134222|11924573|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
7558751|NCT03134222|11924574|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
7558752|NCT03134222|11924570|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7558753|NCT03134222|11924571|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
7558754|NCT03134222|11924572|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7558755|NCT03134222|11924573|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
7558756|NCT03134222|11924574|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
7558757|NCT03134222|11924570|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
7558758|NCT03134222|11924571|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7558759|NCT03134222|11924572|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7558760|NCT03134222|11924573|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7558761|NCT03134222|11924574|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
7558762|NCT03134222|11924570|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7558763|NCT03134222|11924571|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7558764|NCT03134222|11924572|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7558765|NCT03134222|11924573|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
7558766|NCT03134222|11924574|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
7558767|NCT03134222|11924570|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7558768|NCT03134222|11924571|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
7558769|NCT03134222|11924572|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7558770|NCT03134222|11924573|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7558771|NCT03134222|11924574|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
7558772|NCT03134599|11924607|FG000|Week 1|Lost to Follow-up|0
7558773|NCT03134599|11924608|FG001|Week 1|Lost to Follow-up|0
7558774|NCT03134599|11924609|FG002|Week 1|Lost to Follow-up|0
7558775|NCT03134599|11924610|FG003|Week 1|Lost to Follow-up|0
7558776|NCT03134599|11924611|FG004|Week 1|Lost to Follow-up|1
7558777|NCT03134599|11924612|FG005|Week 1|Lost to Follow-up|0
7558778|NCT03134599|11924607|FG000|Week 2|Lost to Follow-up|1
7558779|NCT03134599|11924608|FG001|Week 2|Lost to Follow-up|0
7558780|NCT03134599|11924609|FG002|Week 2|Lost to Follow-up|0
7558781|NCT03134599|11924610|FG003|Week 2|Lost to Follow-up|1
7558782|NCT03134599|11924611|FG004|Week 2|Lost to Follow-up|1
7558783|NCT03134599|11924612|FG005|Week 2|Lost to Follow-up|0
7558784|NCT03134599|11924607|FG000|Week 3|Lost to Follow-up|0
7558785|NCT03134599|11924608|FG001|Week 3|Lost to Follow-up|0
7558786|NCT03134599|11924609|FG002|Week 3|Lost to Follow-up|0
7558787|NCT03134599|11924610|FG003|Week 3|Lost to Follow-up|1
7558788|NCT03134599|11924611|FG004|Week 3|Lost to Follow-up|0
7558789|NCT03134599|11924612|FG005|Week 3|Lost to Follow-up|1
7558790|NCT03134911|11924635|FG000|Overall Study|Screen failure|31
7558791|NCT03134911|11924635|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
7558792|NCT03135028|11924718|FG000|Overall Study|Death|6
7558793|NCT03135028|11924718|FG000|Overall Study|Study Terminated by Sponsor|2
7558794|NCT03135028|11924718|FG000|Overall Study|Withdrew Consent|1
7558795|NCT03135210|11924724|FG000|Overall Study|Death|0
7558796|NCT03135210|11924725|FG001|Overall Study|Death|1
7558797|NCT03135431|11924742|FG000|Overall Study|Study Surgeon not available|2
7558798|NCT03135431|11924743|FG001|Overall Study|Study Surgeon not available|0
7558799|NCT03135522|11924751|FG000|Overall Study|Adverse Event|1
7558800|NCT03135522|11924752|FG001|Overall Study|Adverse Event|0
7558801|NCT03135548|11924765|FG000|Overall Study|Lost to Follow-up|3
7558802|NCT03135548|11924766|FG001|Overall Study|Lost to Follow-up|0
7558803|NCT03135548|11924767|FG002|Overall Study|Lost to Follow-up|0
7558804|NCT03135548|11924765|FG000|Overall Study|Withdrawal by Subject|2
7558805|NCT03135548|11924766|FG001|Overall Study|Withdrawal by Subject|2
7558806|NCT03135548|11924767|FG002|Overall Study|Withdrawal by Subject|1
7558807|NCT03135548|11924765|FG000|Overall Study|Other than listed|0
7558808|NCT03135548|11924766|FG001|Overall Study|Other than listed|2
7558809|NCT03135548|11924767|FG002|Overall Study|Other than listed|2
7558810|NCT03135899|11924783|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
7558811|NCT03135899|11924784|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
7559025|NCT03137303|11924965|FG001|T3: 9-month Follow-up|Death|0
7558812|NCT03135899|11924785|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
7558813|NCT03135899|11924786|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
7558814|NCT03135899|11924787|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
7558815|NCT03135899|11924788|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
7558816|NCT03135899|11924789|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
7558817|NCT03135899|11924790|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
7558818|NCT03135899|11924783|FG000|Overall Study|Withdrawal by Subject|0
7558819|NCT03135899|11924784|FG001|Overall Study|Withdrawal by Subject|0
7558820|NCT03135899|11924785|FG002|Overall Study|Withdrawal by Subject|0
7558821|NCT03135899|11924786|FG003|Overall Study|Withdrawal by Subject|0
7558822|NCT03135899|11924787|FG004|Overall Study|Withdrawal by Subject|0
7558823|NCT03135899|11924788|FG005|Overall Study|Withdrawal by Subject|2
7558824|NCT03135899|11924789|FG006|Overall Study|Withdrawal by Subject|0
7558825|NCT03135899|11924790|FG007|Overall Study|Withdrawal by Subject|0
7558826|NCT03136068|11924806|FG000|Overall Study|Lost to Follow-up|1
7558827|NCT03136068|11924807|FG001|Overall Study|Lost to Follow-up|1
7558828|NCT03136068|11924806|FG000|Overall Study|Protocol Violation|1
7558829|NCT03136068|11924807|FG001|Overall Study|Protocol Violation|0
7558830|NCT03136107|11924813|FG000|Overall Study|Other (Not specified)|1
7532491|NCT02672423|11878238|FG009|Period 1|Adverse Event|0
7532492|NCT02672423|11878229|FG000|Period 2|Withdrawal by Subject|0
7532493|NCT02672423|11878230|FG001|Period 2|Withdrawal by Subject|0
7532494|NCT02672423|11878231|FG002|Period 2|Withdrawal by Subject|1
7532495|NCT02672423|11878232|FG003|Period 2|Withdrawal by Subject|0
7532496|NCT02672423|11878233|FG004|Period 2|Withdrawal by Subject|0
7532497|NCT02672423|11878234|FG005|Period 2|Withdrawal by Subject|0
7532498|NCT02672423|11878235|FG006|Period 2|Withdrawal by Subject|0
7532499|NCT02672423|11878236|FG007|Period 2|Withdrawal by Subject|0
7532500|NCT02672423|11878237|FG008|Period 2|Withdrawal by Subject|0
7558831|NCT03136159|11924823|FG000|Overall Study|chorioamnionitis|2
7558832|NCT03136159|11924824|FG001|Overall Study|chorioamnionitis|0
7558833|NCT03136159|11924823|FG000|Overall Study|vertical skin incision|1
7558834|NCT03136159|11924824|FG001|Overall Study|vertical skin incision|0
7558835|NCT03136159|11924823|FG000|Overall Study|additional dressing|1
7558836|NCT03136159|11924824|FG001|Overall Study|additional dressing|0
7558837|NCT03136159|11924823|FG000|Overall Study|never got dressing placed|1
7558838|NCT03136159|11924824|FG001|Overall Study|never got dressing placed|0
7558839|NCT03136198|11924832|FG000|Overall Study|Withdrawal by Subject|0
7558840|NCT03136198|11924833|FG001|Overall Study|Withdrawal by Subject|1
7558841|NCT03136367|11924847|FG000|T1 Consultation|discontinued mistakenly included|2
7558842|NCT03136367|11924848|FG001|T1 Consultation|discontinued mistakenly included|6
7558843|NCT03136367|11924849|FG002|T1 Consultation|discontinued mistakenly included|1
7558844|NCT03136367|11924847|FG000|T1 Consultation|Discontinued other|0
7558845|NCT03136367|11924848|FG001|T1 Consultation|Discontinued other|1
7558846|NCT03136367|11924849|FG002|T1 Consultation|Discontinued other|0
7558847|NCT03136367|11924847|FG000|T2 Post-consultation|Withdrawal by Subject|1
7558848|NCT03136367|11924848|FG001|T2 Post-consultation|Withdrawal by Subject|1
7558849|NCT03136367|11924849|FG002|T2 Post-consultation|Withdrawal by Subject|5
7558850|NCT03136367|11924847|FG000|T2 Post-consultation|discontinued mistakenly included|2
7558851|NCT03136367|11924848|FG001|T2 Post-consultation|discontinued mistakenly included|2
7558852|NCT03136367|11924849|FG002|T2 Post-consultation|discontinued mistakenly included|17
7558853|NCT03136367|11924847|FG000|T2 Post-consultation|Discontinued other|0
7558854|NCT03136367|11924848|FG001|T2 Post-consultation|Discontinued other|2
7558855|NCT03136367|11924849|FG002|T2 Post-consultation|Discontinued other|6
7558856|NCT03136367|11924847|FG000|T2 Post-consultation|Discontinued transferred care|0
7558857|NCT03136367|11924848|FG001|T2 Post-consultation|Discontinued transferred care|0
7558858|NCT03136367|11924849|FG002|T2 Post-consultation|Discontinued transferred care|3
7558859|NCT03136367|11924847|FG000|T2 Post-consultation|Discontinued lost contact|0
7558860|NCT03136367|11924848|FG001|T2 Post-consultation|Discontinued lost contact|1
7558861|NCT03136367|11924849|FG002|T2 Post-consultation|Discontinued lost contact|0
7558862|NCT03136367|11924847|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
7558863|NCT03136367|11924848|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
7558864|NCT03136367|11924849|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
7558865|NCT03136367|11924847|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
7558866|NCT03136367|11924848|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
7558867|NCT03136367|11924849|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
7467085|NCT01897714|11767307|FG004|Phase II (MTD)|Other|3
7558868|NCT03136367|11924847|FG000|T3 1 Week After Surgery|other discontinued|2
7558869|NCT03136367|11924848|FG001|T3 1 Week After Surgery|other discontinued|4
7558870|NCT03136367|11924849|FG002|T3 1 Week After Surgery|other discontinued|3
7558871|NCT03136367|11924847|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
7558872|NCT03136367|11924848|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
7558873|NCT03136367|11924849|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
7558874|NCT03136367|11924847|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
7558875|NCT03136367|11924848|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
7558876|NCT03136367|11924849|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
7558877|NCT03136367|11924847|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
7558878|NCT03136367|11924848|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
7558879|NCT03136367|11924849|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
7558880|NCT03136367|11924847|FG000|T4 12 Weeks After Surgery|Death|0
7558881|NCT03136367|11924848|FG001|T4 12 Weeks After Surgery|Death|1
7558882|NCT03136367|11924849|FG002|T4 12 Weeks After Surgery|Death|3
7532501|NCT02672423|11878238|FG009|Period 2|Withdrawal by Subject|0
7532502|NCT02672423|11878229|FG000|Period 3|Withdrawal by Subject|0
7558883|NCT03136367|11924847|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
7558884|NCT03136367|11924848|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
7532503|NCT02672423|11878230|FG001|Period 3|Withdrawal by Subject|0
7558885|NCT03136367|11924849|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
7558886|NCT03136367|11924847|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
7558887|NCT03136367|11924848|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
7558888|NCT03136367|11924849|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
7558889|NCT03136367|11924847|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7558890|NCT03136367|11924848|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
7558891|NCT03136367|11924849|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
7558892|NCT03136367|11924847|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
7558893|NCT03136367|11924848|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
7558894|NCT03136367|11924849|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
7558895|NCT03136367|11924847|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
7558896|NCT03136367|11924848|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
7558897|NCT03136367|11924849|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
7558898|NCT03136367|11924847|FG000|T5 1 Year After Surgery|Death|0
7558899|NCT03136367|11924848|FG001|T5 1 Year After Surgery|Death|0
7558900|NCT03136367|11924849|FG002|T5 1 Year After Surgery|Death|1
7558901|NCT03136367|11924847|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
7558902|NCT03136367|11924848|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
7558903|NCT03136367|11924849|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
7558904|NCT03136367|11924847|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
7558905|NCT03136367|11924848|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
7558906|NCT03136367|11924849|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
7558907|NCT03136367|11924847|FG000|T5 1 Year After Surgery|study ended before due|31
7558908|NCT03136367|11924848|FG001|T5 1 Year After Surgery|study ended before due|103
7558909|NCT03136367|11924849|FG002|T5 1 Year After Surgery|study ended before due|110
7558910|NCT03136367|11924847|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
7558911|NCT03136367|11924848|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
7558912|NCT03136367|11924849|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
7558913|NCT03136380|11924862|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7558914|NCT03136380|11924863|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
7558915|NCT03136380|11924864|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7558916|NCT03136380|11924865|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7558917|NCT03136380|11924866|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
7558918|NCT03136484|11924886|FG000|Overall Study|Withdrawal by Subject|19
7558919|NCT03136484|11924887|FG001|Overall Study|Withdrawal by Subject|14
7558920|NCT03136484|11924886|FG000|Overall Study|Lost to Follow-up|7
7558921|NCT03136484|11924887|FG001|Overall Study|Lost to Follow-up|8
7558922|NCT03136484|11924886|FG000|Overall Study|Death|1
7558923|NCT03136484|11924887|FG001|Overall Study|Death|0
7558924|NCT03136861|11924900|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
7558925|NCT03136861|11924901|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
7558926|NCT03136861|11924902|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7558927|NCT03136861|11924903|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7558928|NCT03136861|11924904|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7558929|NCT03136861|11924905|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7558930|NCT03136861|11924906|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
7558931|NCT03136861|11924900|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7558932|NCT03136861|11924901|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
7558933|NCT03136861|11924902|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7558934|NCT03136861|11924903|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7558935|NCT03136861|11924904|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7558936|NCT03136861|11924905|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7558937|NCT03136861|11924906|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
7558938|NCT03136861|11924900|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
7558939|NCT03136861|11924901|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
7558940|NCT03136861|11924902|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7558941|NCT03136861|11924903|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7558942|NCT03136861|11924904|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7558943|NCT03136861|11924905|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7558944|NCT03136861|11924906|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
7558945|NCT03136861|11924900|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558946|NCT03136861|11924901|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
7558947|NCT03136861|11924902|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558948|NCT03136861|11924903|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558949|NCT03136861|11924904|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558950|NCT03136861|11924905|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558951|NCT03136861|11924906|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
7558952|NCT03136861|11924900|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7558953|NCT03136861|11924901|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
7558954|NCT03136861|11924902|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7558955|NCT03136861|11924903|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7558956|NCT03136861|11924904|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7558957|NCT03136861|11924905|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7558958|NCT03136861|11924906|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
7558959|NCT03136861|11924900|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7558960|NCT03136861|11924901|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7558961|NCT03136861|11924902|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7558962|NCT03136861|11924903|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7558963|NCT03136861|11924904|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
7558964|NCT03136861|11924905|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
7558965|NCT03136861|11924906|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
7558966|NCT03136861|11924900|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558967|NCT03136861|11924901|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558968|NCT03136861|11924902|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
7558969|NCT03136861|11924903|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558970|NCT03136861|11924904|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558971|NCT03136861|11924905|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558972|NCT03136861|11924906|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
7558973|NCT03136861|11924900|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558974|NCT03136861|11924901|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558975|NCT03136861|11924902|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
7558976|NCT03136861|11924903|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558977|NCT03136861|11924904|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558978|NCT03136861|11924905|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558979|NCT03136861|11924906|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
7558980|NCT03137069|11924930|FG000|Overall Study|Withdrawal by Subject|1
7558981|NCT03137069|11924931|FG001|Overall Study|Withdrawal by Subject|2
7558982|NCT03137069|11924932|FG002|Overall Study|Withdrawal by Subject|2
7558983|NCT03137069|11924933|FG003|Overall Study|Withdrawal by Subject|2
7558984|NCT03137069|11924934|FG004|Overall Study|Withdrawal by Subject|0
7558985|NCT03137069|11924935|FG005|Overall Study|Withdrawal by Subject|0
7558986|NCT03137069|11924930|FG000|Overall Study|Adverse Event|0
7558987|NCT03137069|11924931|FG001|Overall Study|Adverse Event|3
7558988|NCT03137069|11924932|FG002|Overall Study|Adverse Event|1
7558989|NCT03137069|11924933|FG003|Overall Study|Adverse Event|1
7558990|NCT03137069|11924934|FG004|Overall Study|Adverse Event|0
7558991|NCT03137069|11924935|FG005|Overall Study|Adverse Event|1
7558992|NCT03137069|11924930|FG000|Overall Study|Protocol Violation|0
7558993|NCT03137069|11924931|FG001|Overall Study|Protocol Violation|1
7558994|NCT03137069|11924932|FG002|Overall Study|Protocol Violation|0
7558995|NCT03137069|11924933|FG003|Overall Study|Protocol Violation|1
7558996|NCT03137069|11924934|FG004|Overall Study|Protocol Violation|1
7558997|NCT03137069|11924935|FG005|Overall Study|Protocol Violation|1
7558998|NCT03137069|11924930|FG000|Overall Study|Physician Decision|0
7558999|NCT03137069|11924931|FG001|Overall Study|Physician Decision|0
7559000|NCT03137069|11924932|FG002|Overall Study|Physician Decision|0
7559001|NCT03137069|11924933|FG003|Overall Study|Physician Decision|1
7559002|NCT03137069|11924934|FG004|Overall Study|Physician Decision|0
7559003|NCT03137069|11924935|FG005|Overall Study|Physician Decision|0
7559004|NCT03137069|11924930|FG000|Overall Study|Study Terminated by Sponsor|0
7559005|NCT03137069|11924931|FG001|Overall Study|Study Terminated by Sponsor|0
7559006|NCT03137069|11924932|FG002|Overall Study|Study Terminated by Sponsor|0
7559007|NCT03137069|11924933|FG003|Overall Study|Study Terminated by Sponsor|0
7559008|NCT03137069|11924934|FG004|Overall Study|Study Terminated by Sponsor|1
7559009|NCT03137069|11924935|FG005|Overall Study|Study Terminated by Sponsor|0
7559010|NCT03137069|11924930|FG000|Overall Study|Data Entry Error|0
7559011|NCT03137069|11924931|FG001|Overall Study|Data Entry Error|0
7559012|NCT03137069|11924932|FG002|Overall Study|Data Entry Error|0
7559013|NCT03137069|11924933|FG003|Overall Study|Data Entry Error|1
7559014|NCT03137069|11924934|FG004|Overall Study|Data Entry Error|0
7559015|NCT03137069|11924935|FG005|Overall Study|Data Entry Error|0
7559016|NCT03137121|11924955|FG000|Overall Study|Withdrawal by Subject|0
7559017|NCT03137121|11924956|FG001|Overall Study|Withdrawal by Subject|1
7559018|NCT03137303|11924964|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
7559019|NCT03137303|11924965|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
7559020|NCT03137303|11924964|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
7559021|NCT03137303|11924965|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
7559022|NCT03137303|11924964|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
7559023|NCT03137303|11924965|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
7559024|NCT03137303|11924964|FG000|T3: 9-month Follow-up|Death|1
7559026|NCT03137303|11924964|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
7559027|NCT03137303|11924965|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
7559028|NCT03137303|11924964|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
7559029|NCT03137303|11924965|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
7559030|NCT03137303|11924964|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
7559031|NCT03137303|11924965|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
7559032|NCT03137459|11924973|FG000|2-month Assessment|Withdrawal by Subject|13
7559033|NCT03137459|11924974|FG001|2-month Assessment|Withdrawal by Subject|3
7559034|NCT03137459|11924973|FG000|2-month Assessment|Unable to reach|42
7559035|NCT03137459|11924974|FG001|2-month Assessment|Unable to reach|32
7559036|NCT03137459|11924973|FG000|2-month Assessment|Refused assessment|7
7559037|NCT03137459|11924974|FG001|2-month Assessment|Refused assessment|5
7559038|NCT03137459|11924973|FG000|2-month Assessment|Acutely ill|6
7559039|NCT03137459|11924974|FG001|2-month Assessment|Acutely ill|2
7559040|NCT03137459|11924973|FG000|4-month Assessment|Death|4
7559041|NCT03137459|11924974|FG001|4-month Assessment|Death|2
7559042|NCT03137459|11924973|FG000|4-month Assessment|Withdrawal by Subject|4
7559043|NCT03137459|11924974|FG001|4-month Assessment|Withdrawal by Subject|2
7559044|NCT03137459|11924973|FG000|4-month Assessment|Unable to reach|44
7559045|NCT03137459|11924974|FG001|4-month Assessment|Unable to reach|29
7559046|NCT03137459|11924973|FG000|4-month Assessment|Refused assessment|24
7559047|NCT03137459|11924974|FG001|4-month Assessment|Refused assessment|10
7559048|NCT03137459|11924973|FG000|4-month Assessment|Acutely ill|2
7559049|NCT03137459|11924974|FG001|4-month Assessment|Acutely ill|3
7559050|NCT03137459|11924973|FG000|6-months|Lost to Follow-up|14
7559051|NCT03137459|11924974|FG001|6-months|Lost to Follow-up|11
7559052|NCT03137459|11924973|FG000|6-months|Death|0
7559053|NCT03137459|11924974|FG001|6-months|Death|2
7559054|NCT03137459|11924973|FG000|6-months|Refused assessment|6
7559055|NCT03137459|11924974|FG001|6-months|Refused assessment|3
7559056|NCT03137459|11924973|FG000|6-months|Acutely ill|1
7559057|NCT03137459|11924974|FG001|6-months|Acutely ill|1
7559058|NCT03137784|11924981|FG000|Overall Study|Adverse Event|1
7559059|NCT03137784|11924982|FG001|Overall Study|Adverse Event|1
7559060|NCT03137784|11924983|FG002|Overall Study|Adverse Event|0
7559061|NCT03137784|11924984|FG003|Overall Study|Adverse Event|0
7559062|NCT03137784|11924985|FG004|Overall Study|Adverse Event|0
7559063|NCT03137784|11924986|FG005|Overall Study|Adverse Event|0
7559064|NCT03137784|11924981|FG000|Overall Study|Subject/guardian decision|1
7559065|NCT03137784|11924982|FG001|Overall Study|Subject/guardian decision|0
7559066|NCT03137784|11924983|FG002|Overall Study|Subject/guardian decision|0
7559067|NCT03137784|11924984|FG003|Overall Study|Subject/guardian decision|0
7559068|NCT03137784|11924985|FG004|Overall Study|Subject/guardian decision|0
7559069|NCT03137784|11924986|FG005|Overall Study|Subject/guardian decision|0
7559070|NCT03137784|11924981|FG000|Overall Study|Non-compliance with study treatment|0
7559071|NCT03137784|11924982|FG001|Overall Study|Non-compliance with study treatment|0
7559072|NCT03137784|11924983|FG002|Overall Study|Non-compliance with study treatment|0
7559073|NCT03137784|11924984|FG003|Overall Study|Non-compliance with study treatment|0
7559074|NCT03137784|11924985|FG004|Overall Study|Non-compliance with study treatment|1
7432380|NCT01584440|11713527|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
7432381|NCT01584440|11713528|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7432382|NCT01584440|11713529|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
7432383|NCT01584648|11713600|FG000|Overall Study|Death|136
7432384|NCT01584648|11713601|FG001|Overall Study|Death|146
7432385|NCT01584648|11713600|FG000|Overall Study|Lost to Follow-up|9
7432386|NCT01584648|11713601|FG001|Overall Study|Lost to Follow-up|9
7432387|NCT01584648|11713600|FG000|Overall Study|Investigator discretion|3
7432388|NCT01584648|11713601|FG001|Overall Study|Investigator discretion|2
7432389|NCT01584648|11713600|FG000|Overall Study|Withdrew consent|13
7432390|NCT01584648|11713601|FG001|Overall Study|Withdrew consent|4
7432391|NCT01584648|11713600|FG000|Overall Study|Study closed/terminated|50
7432392|NCT01584648|11713601|FG001|Overall Study|Study closed/terminated|23
7432393|NCT01584648|11713600|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
7432394|NCT01584648|11713601|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
7432395|NCT01584843|11713614|FG000|First Treatment Period|Adverse Event|0
7432396|NCT01584843|11713615|FG001|First Treatment Period|Adverse Event|0
7432397|NCT01584843|11713616|FG002|First Treatment Period|Adverse Event|1
7432398|NCT01584843|11713617|FG003|First Treatment Period|Adverse Event|0
7432399|NCT01584843|11713618|FG004|First Treatment Period|Adverse Event|0
7432400|NCT01584843|11713619|FG005|First Treatment Period|Adverse Event|0
7432401|NCT01584843|11713614|FG000|First Treatment Period|Protocol Violation|0
7432402|NCT01584843|11713615|FG001|First Treatment Period|Protocol Violation|0
7432403|NCT01584843|11713616|FG002|First Treatment Period|Protocol Violation|0
7432404|NCT01584843|11713617|FG003|First Treatment Period|Protocol Violation|0
7432405|NCT01584843|11713618|FG004|First Treatment Period|Protocol Violation|0
7432406|NCT01584843|11713619|FG005|First Treatment Period|Protocol Violation|1
7432407|NCT01584843|11713614|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7432408|NCT01584843|11713615|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7432409|NCT01584843|11713616|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7559075|NCT03137784|11924986|FG005|Overall Study|Non-compliance with study treatment|0
7559076|NCT03137992|11924994|FG000|Washout Period 1|Adverse Event|1
7559077|NCT03137992|11924995|FG001|Washout Period 1|Adverse Event|1
7559078|NCT03137992|11924996|FG002|Washout Period 1|Adverse Event|0
7559079|NCT03137992|11924997|FG003|Washout Period 1|Adverse Event|0
7559080|NCT03137992|11924998|FG004|Washout Period 1|Adverse Event|0
7559081|NCT03137992|11924999|FG005|Washout Period 1|Adverse Event|1
7559082|NCT03137992|11924994|FG000|Washout Period 1|Withdrawal by Subject|0
7432410|NCT01584843|11713617|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7432411|NCT01584843|11713618|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
7432412|NCT01584843|11713619|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
7432413|NCT01584843|11713614|FG000|Second Treatment Period|Withdrawal by Subject|0
7432414|NCT01584843|11713615|FG001|Second Treatment Period|Withdrawal by Subject|0
7432415|NCT01584843|11713616|FG002|Second Treatment Period|Withdrawal by Subject|0
7432416|NCT01584843|11713617|FG003|Second Treatment Period|Withdrawal by Subject|0
7432417|NCT01584843|11713618|FG004|Second Treatment Period|Withdrawal by Subject|0
7432418|NCT01584843|11713619|FG005|Second Treatment Period|Withdrawal by Subject|1
7432419|NCT01585025|11713638|FG000|Overall Study|Withdrawal by Subject|0
7432420|NCT01585025|11713639|FG001|Overall Study|Withdrawal by Subject|3
7432421|NCT01585025|11713640|FG002|Overall Study|Withdrawal by Subject|4
7432422|NCT01585038|11713650|FG000|Overall Study|Adverse Event|2
7432423|NCT01585038|11713651|FG001|Overall Study|Adverse Event|2
7432424|NCT01585155|11713666|FG000|Overall Study|Adverse Event|1
7432425|NCT01585155|11713666|FG000|Overall Study|Lack of Efficacy|2
7432426|NCT01585155|11713666|FG000|Overall Study|Worsening ulcerative colitis|2
7432427|NCT01585168|11713672|FG000|Overall Study|Lost to Follow-up|3
7432428|NCT01585168|11713673|FG001|Overall Study|Lost to Follow-up|1
7432429|NCT01585168|11713674|FG002|Overall Study|Lost to Follow-up|1
7432430|NCT01585168|11713675|FG003|Overall Study|Lost to Follow-up|1
7432431|NCT01585194|11713683|FG000|Overall Study|Withdrawal by Subject|1
7432432|NCT01585194|11713683|FG000|Overall Study|Physician Decision|2
7432433|NCT01585194|11713683|FG000|Overall Study|Lack of insurance|1
7432434|NCT01585246|11713696|FG000|Overall Study|Lost to Follow-up|0
7432435|NCT01585246|11713697|FG001|Overall Study|Lost to Follow-up|0
7432436|NCT01585246|11713698|FG002|Overall Study|Lost to Follow-up|2
7432437|NCT01585246|11713699|FG003|Overall Study|Lost to Follow-up|1
7432438|NCT01585246|11713700|FG004|Overall Study|Lost to Follow-up|0
7432439|NCT01585246|11713696|FG000|Overall Study|Protocol Violation|0
7432440|NCT01585246|11713697|FG001|Overall Study|Protocol Violation|0
7432441|NCT01585246|11713698|FG002|Overall Study|Protocol Violation|0
7432442|NCT01585246|11713699|FG003|Overall Study|Protocol Violation|0
7432443|NCT01585246|11713700|FG004|Overall Study|Protocol Violation|1
7432444|NCT01585246|11713696|FG000|Overall Study|Withdrawal by Subject|0
7432445|NCT01585246|11713697|FG001|Overall Study|Withdrawal by Subject|0
7432446|NCT01585246|11713698|FG002|Overall Study|Withdrawal by Subject|1
7432447|NCT01585246|11713699|FG003|Overall Study|Withdrawal by Subject|2
7432448|NCT01585246|11713700|FG004|Overall Study|Withdrawal by Subject|1
7432449|NCT01585246|11713696|FG000|Overall Study|Other|0
7432450|NCT01585246|11713697|FG001|Overall Study|Other|1
7432451|NCT01585246|11713698|FG002|Overall Study|Other|1
7432452|NCT01585246|11713699|FG003|Overall Study|Other|1
7432453|NCT01585246|11713700|FG004|Overall Study|Other|0
7432454|NCT01585272|11713715|FG000|Overall Study|Adverse Event|22
7432455|NCT01585272|11713715|FG000|Overall Study|Protocol Violation|7
7432456|NCT01585272|11713715|FG000|Overall Study|Withdrawal by Subject|10
7432457|NCT01585298|11713719|FG000|Overall Study|Study completion was not documented.|1
7432458|NCT01585298|11713719|FG000|Overall Study|Protocol deviation|1
7432459|NCT01585298|11713719|FG000|Overall Study|Administrative problems|4
7432460|NCT01585298|11713719|FG000|Overall Study|Lost to Follow-up|2
7432461|NCT01585298|11713719|FG000|Overall Study|Withdrawal by Subject|4
7432462|NCT01585298|11713719|FG000|Overall Study|Abnormal test procedure results|1
7432463|NCT01585298|11713719|FG000|Overall Study|Adverse Event|24
7467086|NCT01897714|11767308|FG005|Phase II (MTD)|Other|0
7559083|NCT03137992|11924995|FG001|Washout Period 1|Withdrawal by Subject|1
7559084|NCT03137992|11924996|FG002|Washout Period 1|Withdrawal by Subject|1
7559085|NCT03137992|11924997|FG003|Washout Period 1|Withdrawal by Subject|0
7559086|NCT03137992|11924998|FG004|Washout Period 1|Withdrawal by Subject|0
7559087|NCT03137992|11924999|FG005|Washout Period 1|Withdrawal by Subject|0
7559088|NCT03137992|11924994|FG000|Washout Period 1|Principal Investigator Discretion|0
7559089|NCT03137992|11924995|FG001|Washout Period 1|Principal Investigator Discretion|1
7559090|NCT03137992|11924996|FG002|Washout Period 1|Principal Investigator Discretion|0
7467087|NCT01897727|11767326|FG000|Overall Study|Exclusion: central sleep apnea|0
7467088|NCT01897727|11767327|FG001|Overall Study|Exclusion: central sleep apnea|1
7467089|NCT01897896|11767352|FG000|Overall Study|Death|1
7467090|NCT01897896|11767353|FG001|Overall Study|Death|0
7467091|NCT01897896|11767352|FG000|Overall Study|Adverse Event|11
7467092|NCT01897896|11767353|FG001|Overall Study|Adverse Event|1
7467093|NCT01897896|11767352|FG000|Overall Study|Lost to Follow-up|1
7467094|NCT01897896|11767353|FG001|Overall Study|Lost to Follow-up|0
7467095|NCT01897896|11767352|FG000|Overall Study|Non-compliance with study drug dosing|1
7467096|NCT01897896|11767353|FG001|Overall Study|Non-compliance with study drug dosing|1
7467097|NCT01897896|11767352|FG000|Overall Study|Withdrawal by Subject|7
7467098|NCT01897896|11767353|FG001|Overall Study|Withdrawal by Subject|1
7467099|NCT01897896|11767352|FG000|Overall Study|Require drug that interfere with study|1
7467100|NCT01897896|11767353|FG001|Overall Study|Require drug that interfere with study|4
7467101|NCT01897896|11767352|FG000|Overall Study|Protocol Violation|1
7467102|NCT01897896|11767353|FG001|Overall Study|Protocol Violation|1
7467103|NCT01897896|11767352|FG000|Overall Study|Withdrawal per Investigator's judgement|1
7467104|NCT01897896|11767353|FG001|Overall Study|Withdrawal per Investigator's judgement|1
7532504|NCT02672423|11878231|FG002|Period 3|Withdrawal by Subject|0
7559091|NCT03137992|11924997|FG003|Washout Period 1|Principal Investigator Discretion|0
7559092|NCT03137992|11924998|FG004|Washout Period 1|Principal Investigator Discretion|0
7559093|NCT03137992|11924999|FG005|Washout Period 1|Principal Investigator Discretion|0
7432464|NCT01585428|11713731|FG000|Overall Study|Death during treatment|1
7432465|NCT01585428|11713732|FG001|Overall Study|Death during treatment|0
7432466|NCT01585558|11713751|FG000|Overall Study|Withdrawal by Subject|4
7432467|NCT01585558|11713752|FG001|Overall Study|Withdrawal by Subject|5
7432468|NCT01585558|11713753|FG002|Overall Study|Withdrawal by Subject|8
7432469|NCT01585558|11713751|FG000|Overall Study|Lost to Follow-up|2
7432470|NCT01585558|11713752|FG001|Overall Study|Lost to Follow-up|0
7432471|NCT01585558|11713753|FG002|Overall Study|Lost to Follow-up|3
7432472|NCT01585558|11713751|FG000|Overall Study|Adverse Event|3
7432473|NCT01585558|11713752|FG001|Overall Study|Adverse Event|4
7432474|NCT01585558|11713753|FG002|Overall Study|Adverse Event|1
7432475|NCT01585558|11713751|FG000|Overall Study|Protocol Violation|4
7432476|NCT01585558|11713752|FG001|Overall Study|Protocol Violation|3
7432477|NCT01585558|11713753|FG002|Overall Study|Protocol Violation|2
7432478|NCT01585558|11713751|FG000|Overall Study|Lack of Efficacy|0
7432479|NCT01585558|11713752|FG001|Overall Study|Lack of Efficacy|0
7432480|NCT01585558|11713753|FG002|Overall Study|Lack of Efficacy|1
7432481|NCT01585584|11713761|FG000|Overall Study|Lack of Efficacy|1
7432482|NCT01585584|11713761|FG000|Overall Study|Withdrawal by Subject|1
7432483|NCT01585584|11713761|FG000|Overall Study|Physician Decision|2
7432484|NCT01585766|11713775|FG000|Overall Study|Withdrawal by Subject|0
7432485|NCT01585766|11713776|FG001|Overall Study|Withdrawal by Subject|1
7432486|NCT01585766|11713777|FG002|Overall Study|Withdrawal by Subject|1
7432487|NCT01585766|11713778|FG003|Overall Study|Withdrawal by Subject|0
7432488|NCT01585766|11713779|FG004|Overall Study|Withdrawal by Subject|0
7432489|NCT01585766|11713780|FG005|Overall Study|Withdrawal by Subject|0
7432490|NCT01585766|11713775|FG000|Overall Study|Death|0
7432491|NCT01585766|11713776|FG001|Overall Study|Death|1
7432492|NCT01585766|11713777|FG002|Overall Study|Death|0
7432493|NCT01585766|11713778|FG003|Overall Study|Death|0
7432494|NCT01585766|11713779|FG004|Overall Study|Death|0
7432495|NCT01585766|11713780|FG005|Overall Study|Death|0
7432496|NCT01585766|11713775|FG000|Overall Study|Physician Decision|0
7432497|NCT01585766|11713776|FG001|Overall Study|Physician Decision|0
7432498|NCT01585766|11713777|FG002|Overall Study|Physician Decision|1
7432499|NCT01585766|11713778|FG003|Overall Study|Physician Decision|0
7432500|NCT01585766|11713779|FG004|Overall Study|Physician Decision|0
7432501|NCT01585766|11713780|FG005|Overall Study|Physician Decision|0
7432502|NCT01585831|11713813|FG000|Overall Study|Physician Decision|0
7432503|NCT01585831|11713814|FG001|Overall Study|Physician Decision|1
7432504|NCT01585831|11713813|FG000|Overall Study|Withdrawal by Subject|2
7432505|NCT01585831|11713814|FG001|Overall Study|Withdrawal by Subject|1
7432506|NCT01585961|11713820|FG000|Overall Study|Death|6
7432507|NCT01585961|11713820|FG000|Overall Study|Physician Decision|1
7432508|NCT01585961|11713820|FG000|Overall Study|Decision to use non-study catheter|1
7432509|NCT01585961|11713820|FG000|Overall Study|Withdrawal by Subject|1
7432510|NCT01585961|11713820|FG000|Overall Study|Lost to Follow-up|23
7432511|NCT01585961|11713820|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
7432512|NCT01585987|11713826|FG000|Randomized|Withdrawal by Subject|0
7432513|NCT01585987|11713827|FG001|Randomized|Withdrawal by Subject|4
7432514|NCT01585987|11713826|FG000|Randomized|No longer met criteria|0
7432515|NCT01585987|11713827|FG001|Randomized|No longer met criteria|2
7432516|NCT01585987|11713826|FG000|Treated|Disease Progression|39
7432517|NCT01585987|11713827|FG001|Treated|Disease Progression|36
7432518|NCT01585987|11713826|FG000|Treated|Study Drug Toxicity|9
7432519|NCT01585987|11713827|FG001|Treated|Study Drug Toxicity|5
7432520|NCT01585987|11713826|FG000|Treated|Adverse Event|3
7432521|NCT01585987|11713827|FG001|Treated|Adverse Event|0
7432522|NCT01585987|11713826|FG000|Treated|Withdrawal by Subject|1
7432523|NCT01585987|11713827|FG001|Treated|Withdrawal by Subject|2
7432524|NCT01585987|11713826|FG000|Treated|Death|1
7432525|NCT01585987|11713827|FG001|Treated|Death|0
7432526|NCT01585987|11713826|FG000|Treated|Lost to Follow-up|0
7432527|NCT01585987|11713827|FG001|Treated|Lost to Follow-up|1
7432528|NCT01585987|11713826|FG000|Treated|Maximum Clinical Benefit|0
7432529|NCT01585987|11713827|FG001|Treated|Maximum Clinical Benefit|1
7432530|NCT01585987|11713826|FG000|Treated|Non-Specified|1
7432531|NCT01585987|11713827|FG001|Treated|Non-Specified|2
7432532|NCT01585987|11713826|FG000|Treated|Subject Request|0
7432533|NCT01585987|11713827|FG001|Treated|Subject Request|1
7432534|NCT01585987|11713826|FG000|Treated|Poor/Non-Compliance|0
7432535|NCT01585987|11713827|FG001|Treated|Poor/Non-Compliance|1
7432536|NCT01586156|11713880|FG000|Overall Study|Pregnancy|0
7432537|NCT01586156|11713881|FG001|Overall Study|Pregnancy|1
7432538|NCT01586156|11713882|FG002|Overall Study|Pregnancy|0
7432539|NCT01586195|11713890|FG000|Overall Study|Death|11
7432540|NCT01586195|11713890|FG000|Overall Study|Withdrawal of Consent|5
7432541|NCT01586195|11713890|FG000|Overall Study|Started new anti-melanoma therapy|1
7432542|NCT01586195|11713890|FG000|Overall Study|Reason not specified|9
7432543|NCT01586338|11713903|FG000|Overall Study|Adverse Event|3
7432544|NCT01586338|11713903|FG000|Overall Study|Lost to Follow-up|1
7432545|NCT01586338|11713903|FG000|Overall Study|Withdrawal by participant|3
7432546|NCT01586338|11713903|FG000|Overall Study|Other|1
7432547|NCT01586364|11713907|FG000|Overall Study|Withdrawal by Subject|40
7532505|NCT02672423|11878232|FG003|Period 3|Withdrawal by Subject|0
7532506|NCT02672423|11878233|FG004|Period 3|Withdrawal by Subject|0
7532507|NCT02672423|11878234|FG005|Period 3|Withdrawal by Subject|0
7532508|NCT02672423|11878235|FG006|Period 3|Withdrawal by Subject|0
7432548|NCT01586364|11713907|FG000|Overall Study|Adverse Event|37
7432549|NCT01586364|11713907|FG000|Overall Study|Lost to Follow-up|17
7432550|NCT01586364|11713907|FG000|Overall Study|Protocol Violation|16
7432551|NCT01586364|11713907|FG000|Overall Study|Lack of Efficacy|1
7432552|NCT01586364|11713907|FG000|Overall Study|Other-Did not feel better post-treatment|1
7432553|NCT01586364|11713907|FG000|Overall Study|Other-Subject wasn't getting much relief|1
7432554|NCT01586364|11713907|FG000|Overall Study|Other-Site closure due to PI illness|1
7432555|NCT01586364|11713907|FG000|Overall Study|Other-PI discretion, site closing|2
7432556|NCT01586364|11713907|FG000|Overall Study|Other-Not specified|1
7432557|NCT01586624|11713919|FG000|Overall Study|Adverse Event|3
7432558|NCT01586624|11713920|FG001|Overall Study|Adverse Event|0
7432559|NCT01586624|11713921|FG002|Overall Study|Adverse Event|2
7432560|NCT01586624|11713922|FG003|Overall Study|Adverse Event|1
7432561|NCT01586624|11713923|FG004|Overall Study|Adverse Event|3
7432562|NCT01586624|11713924|FG005|Overall Study|Adverse Event|3
7432563|NCT01586624|11713925|FG006|Overall Study|Adverse Event|2
7432564|NCT01586624|11713926|FG007|Overall Study|Adverse Event|3
7432565|NCT01586624|11713919|FG000|Overall Study|Physician Decision|0
7432566|NCT01586624|11713920|FG001|Overall Study|Physician Decision|1
7432567|NCT01586624|11713921|FG002|Overall Study|Physician Decision|1
7432568|NCT01586624|11713922|FG003|Overall Study|Physician Decision|0
7432569|NCT01586624|11713923|FG004|Overall Study|Physician Decision|2
7432570|NCT01586624|11713924|FG005|Overall Study|Physician Decision|0
7432571|NCT01586624|11713925|FG006|Overall Study|Physician Decision|1
7432572|NCT01586624|11713926|FG007|Overall Study|Physician Decision|1
7432573|NCT01586624|11713919|FG000|Overall Study|Withdrawal by Subject|0
7432574|NCT01586624|11713920|FG001|Overall Study|Withdrawal by Subject|0
7432575|NCT01586624|11713921|FG002|Overall Study|Withdrawal by Subject|0
7432576|NCT01586624|11713922|FG003|Overall Study|Withdrawal by Subject|1
7432577|NCT01586624|11713923|FG004|Overall Study|Withdrawal by Subject|0
7432578|NCT01586624|11713924|FG005|Overall Study|Withdrawal by Subject|0
7432579|NCT01586624|11713925|FG006|Overall Study|Withdrawal by Subject|0
7432580|NCT01586624|11713926|FG007|Overall Study|Withdrawal by Subject|0
7432581|NCT01586624|11713919|FG000|Overall Study|Evidence of disease progression|1
7432582|NCT01586624|11713920|FG001|Overall Study|Evidence of disease progression|3
7432583|NCT01586624|11713921|FG002|Overall Study|Evidence of disease progression|2
7432584|NCT01586624|11713922|FG003|Overall Study|Evidence of disease progression|5
7532509|NCT02672423|11878236|FG007|Period 3|Withdrawal by Subject|1
7532510|NCT02672423|11878237|FG008|Period 3|Withdrawal by Subject|0
7532511|NCT02672423|11878238|FG009|Period 3|Withdrawal by Subject|0
7532512|NCT02672423|11878229|FG000|Period 3|Physician Decision|0
7532513|NCT02672423|11878230|FG001|Period 3|Physician Decision|0
7532514|NCT02672423|11878231|FG002|Period 3|Physician Decision|0
7532515|NCT02672423|11878232|FG003|Period 3|Physician Decision|0
7532516|NCT02672423|11878233|FG004|Period 3|Physician Decision|0
7532517|NCT02672423|11878234|FG005|Period 3|Physician Decision|1
7532518|NCT02672423|11878235|FG006|Period 3|Physician Decision|0
7532519|NCT02672423|11878236|FG007|Period 3|Physician Decision|0
7559094|NCT03137992|11924994|FG000|Washout Period 1|COPD Exacerbation|1
7432585|NCT01586624|11713923|FG004|Overall Study|Evidence of disease progression|3
7432586|NCT01586624|11713924|FG005|Overall Study|Evidence of disease progression|5
7432587|NCT01586624|11713925|FG006|Overall Study|Evidence of disease progression|4
7432588|NCT01586624|11713926|FG007|Overall Study|Evidence of disease progression|6
7432589|NCT01586624|11713919|FG000|Overall Study|Screen failure (no treatment received)|0
7432590|NCT01586624|11713920|FG001|Overall Study|Screen failure (no treatment received)|0
7432591|NCT01586624|11713921|FG002|Overall Study|Screen failure (no treatment received)|0
7432592|NCT01586624|11713922|FG003|Overall Study|Screen failure (no treatment received)|0
7432593|NCT01586624|11713923|FG004|Overall Study|Screen failure (no treatment received)|0
7432594|NCT01586624|11713924|FG005|Overall Study|Screen failure (no treatment received)|0
7432595|NCT01586624|11713925|FG006|Overall Study|Screen failure (no treatment received)|1
7432596|NCT01586624|11713926|FG007|Overall Study|Screen failure (no treatment received)|0
7432597|NCT01586806|11713961|FG000|Overall Study|Protocol Violation|0
7432598|NCT01586806|11713962|FG001|Overall Study|Protocol Violation|1
7432599|NCT01586806|11713963|FG002|Overall Study|Protocol Violation|0
7532520|NCT02672423|11878237|FG008|Period 3|Physician Decision|0
7532521|NCT02672423|11878238|FG009|Period 3|Physician Decision|0
7532522|NCT02672553|11878270|FG000|Overall Study|Death|3
7559095|NCT03137992|11924995|FG001|Washout Period 1|COPD Exacerbation|1
7559096|NCT03137992|11924996|FG002|Washout Period 1|COPD Exacerbation|1
7432600|NCT01586806|11713961|FG000|Overall Study|Withdrawal by Subject|1
7432601|NCT01586806|11713962|FG001|Overall Study|Withdrawal by Subject|0
7432602|NCT01586806|11713963|FG002|Overall Study|Withdrawal by Subject|0
7432603|NCT01586806|11713961|FG000|Overall Study|Lost to Follow-up|2
7432604|NCT01586806|11713962|FG001|Overall Study|Lost to Follow-up|3
7432605|NCT01586806|11713963|FG002|Overall Study|Lost to Follow-up|2
7432606|NCT01586819|11713973|FG000|Overall Study|Withdrawal by Subject|1
7532523|NCT02672553|11878271|FG001|Overall Study|Death|5
7432607|NCT01586819|11713974|FG001|Overall Study|Withdrawal by Subject|0
7432608|NCT01587001|11714023|FG000|Overall Study|Lost to Follow-up|2
7432609|NCT01587001|11714024|FG001|Overall Study|Lost to Follow-up|0
7432610|NCT01587001|11714023|FG000|Overall Study|Insufficient samples to complete testing|4
7432611|NCT01587001|11714024|FG001|Overall Study|Insufficient samples to complete testing|1
7432612|NCT01587014|11714031|FG000|Overall Study|Death|2
7432613|NCT01587079|11714044|FG000|Overall Study|Protocol-specified criteria|9
7432614|NCT01587079|11714044|FG000|Overall Study|Protocol Violation|5
7432615|NCT01587079|11714044|FG000|Overall Study|Lost to Follow-up|2
7432616|NCT01587079|11714044|FG000|Overall Study|Physician Decision|2
7432617|NCT01587079|11714044|FG000|Overall Study|Withdrawal by Subject|7
7432618|NCT01587079|11714044|FG000|Overall Study|Adverse Event|14
7432619|NCT01587118|11714087|FG000|Overall Study|Adverse Event|3
7432620|NCT01587118|11714087|FG000|Overall Study|Lost to Follow-up|2
7432621|NCT01587118|11714087|FG000|Overall Study|Relocation|1
7432622|NCT01587118|11714087|FG000|Overall Study|nonresponse|1
7432623|NCT01587274|11714094|FG000|Overall Study|Lost to Follow-up|4
7432624|NCT01587274|11714095|FG001|Overall Study|Lost to Follow-up|5
7432625|NCT01587274|11714096|FG002|Overall Study|Lost to Follow-up|3
7432626|NCT01587651|11714107|FG000|Overall Study|Adverse Event|0
7432627|NCT01587651|11714108|FG001|Overall Study|Adverse Event|1
7432628|NCT01587651|11714109|FG002|Overall Study|Adverse Event|0
7432629|NCT01587651|11714107|FG000|Overall Study|Protocol Violation|0
7432630|NCT01587651|11714108|FG001|Overall Study|Protocol Violation|1
7432631|NCT01587651|11714109|FG002|Overall Study|Protocol Violation|1
7432632|NCT01587651|11714107|FG000|Overall Study|Withdrawal by Subject|0
7432633|NCT01587651|11714108|FG001|Overall Study|Withdrawal by Subject|1
7432634|NCT01587651|11714109|FG002|Overall Study|Withdrawal by Subject|0
7432635|NCT01587703|11714136|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
7432636|NCT01587703|11714137|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432637|NCT01587703|11714138|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432638|NCT01587703|11714139|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432639|NCT01587703|11714140|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432640|NCT01587703|11714141|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432641|NCT01587703|11714142|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432642|NCT01587703|11714143|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432643|NCT01587703|11714144|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432644|NCT01587703|11714145|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432645|NCT01587703|11714146|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432646|NCT01587703|11714147|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432647|NCT01587703|11714148|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432648|NCT01587703|11714149|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432649|NCT01587703|11714150|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432650|NCT01587703|11714151|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432651|NCT01587703|11714152|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432652|NCT01587703|11714153|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432653|NCT01587703|11714154|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
7432654|NCT01587703|11714136|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432655|NCT01587703|11714137|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432656|NCT01587703|11714138|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432657|NCT01587703|11714139|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432658|NCT01587703|11714140|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432659|NCT01587703|11714141|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
7432660|NCT01587703|11714142|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432661|NCT01587703|11714143|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
7432662|NCT01587703|11714144|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432663|NCT01587703|11714145|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432664|NCT01587703|11714146|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432665|NCT01587703|11714147|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432666|NCT01587703|11714148|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432667|NCT01587703|11714149|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432668|NCT01587703|11714150|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432669|NCT01587703|11714151|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432670|NCT01587703|11714152|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432671|NCT01587703|11714153|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432672|NCT01587703|11714154|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
7432673|NCT01587703|11714136|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432674|NCT01587703|11714137|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432675|NCT01587703|11714138|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432676|NCT01587703|11714139|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432677|NCT01587703|11714140|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7433047|NCT01588951|11714505|FG002|Overall Study|Ineligible in retrospect|1
7432678|NCT01587703|11714141|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432679|NCT01587703|11714142|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
7432680|NCT01587703|11714143|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432681|NCT01587703|11714144|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432682|NCT01587703|11714145|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432683|NCT01587703|11714146|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432684|NCT01587703|11714147|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432685|NCT01587703|11714148|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432686|NCT01587703|11714149|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432687|NCT01587703|11714150|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432688|NCT01587703|11714151|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432689|NCT01587703|11714152|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432690|NCT01587703|11714153|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432691|NCT01587703|11714154|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
7432692|NCT01587703|11714136|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
7432693|NCT01587703|11714137|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
7432694|NCT01587703|11714138|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
7432695|NCT01587703|11714139|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
7432696|NCT01587703|11714140|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
7432697|NCT01587703|11714141|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
7432698|NCT01587703|11714142|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
7432699|NCT01587703|11714143|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
7432700|NCT01587703|11714144|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
7432701|NCT01587703|11714145|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
7432702|NCT01587703|11714146|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
7432703|NCT01587703|11714147|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
7432704|NCT01587703|11714148|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
7432705|NCT01587703|11714149|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
7432706|NCT01587703|11714150|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
7432707|NCT01587703|11714151|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
7432708|NCT01587703|11714152|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
7432709|NCT01587703|11714153|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
7432710|NCT01587703|11714154|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
7432711|NCT01587703|11714136|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
7432712|NCT01587703|11714137|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
7432713|NCT01587703|11714138|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
7432714|NCT01587703|11714139|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
7432715|NCT01587703|11714140|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
7432716|NCT01587703|11714141|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
7432717|NCT01587703|11714142|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
7432718|NCT01587703|11714143|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
7432719|NCT01587703|11714144|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
7432720|NCT01587703|11714145|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
7432721|NCT01587703|11714146|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
7432722|NCT01587703|11714147|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
7432723|NCT01587703|11714148|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
7432724|NCT01587703|11714149|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
7432725|NCT01587703|11714150|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
7432726|NCT01587703|11714151|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
7432727|NCT01587703|11714152|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
7432728|NCT01587703|11714153|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
7432729|NCT01587703|11714154|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
7432730|NCT01587703|11714136|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432731|NCT01587703|11714137|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432732|NCT01587703|11714138|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432733|NCT01587703|11714139|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432734|NCT01587703|11714140|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432735|NCT01587703|11714141|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432736|NCT01587703|11714142|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432737|NCT01587703|11714143|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432738|NCT01587703|11714144|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7432739|NCT01587703|11714145|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432740|NCT01587703|11714146|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
7432741|NCT01587703|11714147|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432742|NCT01587703|11714148|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432743|NCT01587703|11714149|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432744|NCT01587703|11714150|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432745|NCT01587703|11714151|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432746|NCT01587703|11714152|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432747|NCT01587703|11714153|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432748|NCT01587703|11714154|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
7432749|NCT01587703|11714136|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432750|NCT01587703|11714137|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432751|NCT01587703|11714138|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432752|NCT01587703|11714139|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432753|NCT01587703|11714140|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432754|NCT01587703|11714141|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432755|NCT01587703|11714142|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432756|NCT01587703|11714143|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432757|NCT01587703|11714144|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432758|NCT01587703|11714145|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7432759|NCT01587703|11714146|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
7432760|NCT01587703|11714147|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432761|NCT01587703|11714148|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432762|NCT01587703|11714149|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432763|NCT01587703|11714150|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432764|NCT01587703|11714151|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432765|NCT01587703|11714152|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432766|NCT01587703|11714153|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432767|NCT01587703|11714154|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
7432768|NCT01587703|11714136|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432769|NCT01587703|11714137|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432770|NCT01587703|11714138|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432771|NCT01587703|11714139|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432772|NCT01587703|11714140|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432773|NCT01587703|11714141|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432774|NCT01587703|11714142|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432775|NCT01587703|11714143|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432776|NCT01587703|11714144|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
7432777|NCT01587703|11714145|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432778|NCT01587703|11714146|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432779|NCT01587703|11714147|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432780|NCT01587703|11714148|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432781|NCT01587703|11714149|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432782|NCT01587703|11714150|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432783|NCT01587703|11714151|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432784|NCT01587703|11714152|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432785|NCT01587703|11714153|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432786|NCT01587703|11714154|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
7432787|NCT01587703|11714136|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432788|NCT01587703|11714137|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432789|NCT01587703|11714138|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432790|NCT01587703|11714139|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432791|NCT01587703|11714140|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432792|NCT01587703|11714141|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432793|NCT01587703|11714142|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432794|NCT01587703|11714143|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432795|NCT01587703|11714144|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432796|NCT01587703|11714145|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432797|NCT01587703|11714146|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432798|NCT01587703|11714147|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432799|NCT01587703|11714148|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432800|NCT01587703|11714149|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432801|NCT01587703|11714150|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432802|NCT01587703|11714151|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432803|NCT01587703|11714152|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432804|NCT01587703|11714153|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
7432805|NCT01587703|11714154|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
7432806|NCT01587703|11714136|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432807|NCT01587703|11714137|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432808|NCT01587703|11714138|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432809|NCT01587703|11714139|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432810|NCT01587703|11714140|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432811|NCT01587703|11714141|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432812|NCT01587703|11714142|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432813|NCT01587703|11714143|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432814|NCT01587703|11714144|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432815|NCT01587703|11714145|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432816|NCT01587703|11714146|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432817|NCT01587703|11714147|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432818|NCT01587703|11714148|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432819|NCT01587703|11714149|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432820|NCT01587703|11714150|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432821|NCT01587703|11714151|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432822|NCT01587703|11714152|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
7432823|NCT01587703|11714153|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
7432824|NCT01587703|11714154|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
7432825|NCT01587703|11714136|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432826|NCT01587703|11714137|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432827|NCT01587703|11714138|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432828|NCT01587703|11714139|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432829|NCT01587703|11714140|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432830|NCT01587703|11714141|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432831|NCT01587703|11714142|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432832|NCT01587703|11714143|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432833|NCT01587703|11714144|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432834|NCT01587703|11714145|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432835|NCT01587703|11714146|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432836|NCT01587703|11714147|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432837|NCT01587703|11714148|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432838|NCT01587703|11714149|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432839|NCT01587703|11714150|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432840|NCT01587703|11714151|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
7432841|NCT01587703|11714152|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432842|NCT01587703|11714153|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432843|NCT01587703|11714154|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
7432844|NCT01587703|11714136|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432845|NCT01587703|11714137|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432846|NCT01587703|11714138|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432847|NCT01587703|11714139|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432848|NCT01587703|11714140|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432849|NCT01587703|11714141|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432850|NCT01587703|11714142|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432851|NCT01587703|11714143|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432852|NCT01587703|11714144|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432853|NCT01587703|11714145|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432854|NCT01587703|11714146|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432855|NCT01587703|11714147|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
7432856|NCT01587703|11714148|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432857|NCT01587703|11714149|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432858|NCT01587703|11714150|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
7432859|NCT01587703|11714151|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432860|NCT01587703|11714152|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432861|NCT01587703|11714153|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432862|NCT01587703|11714154|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
7432863|NCT01587703|11714136|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432864|NCT01587703|11714137|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432865|NCT01587703|11714138|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432866|NCT01587703|11714139|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432867|NCT01587703|11714140|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432868|NCT01587703|11714141|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432869|NCT01587703|11714142|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432870|NCT01587703|11714143|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432871|NCT01587703|11714144|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432872|NCT01587703|11714145|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432873|NCT01587703|11714146|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432874|NCT01587703|11714147|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
7432875|NCT01587703|11714148|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
7432876|NCT01587703|11714149|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
7432877|NCT01587703|11714150|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
7432878|NCT01587703|11714151|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
7432879|NCT01587703|11714152|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
7432880|NCT01587703|11714153|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432881|NCT01587703|11714154|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
7432882|NCT01587703|11714136|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
7432883|NCT01587703|11714137|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
7432884|NCT01587703|11714138|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
7432885|NCT01587703|11714139|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
7432886|NCT01587703|11714140|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
7432887|NCT01587703|11714141|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
7432888|NCT01587703|11714142|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
7432889|NCT01587703|11714143|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
7432890|NCT01587703|11714144|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
7432891|NCT01587703|11714145|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
7432892|NCT01587703|11714146|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
7432893|NCT01587703|11714147|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
7432894|NCT01587703|11714148|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
7432895|NCT01587703|11714149|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
7432896|NCT01587703|11714150|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
7432897|NCT01587703|11714151|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
7432898|NCT01587703|11714152|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
7432899|NCT01587703|11714153|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
7432900|NCT01587703|11714154|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
7432901|NCT01587703|11714136|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432902|NCT01587703|11714137|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432903|NCT01587703|11714138|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432904|NCT01587703|11714139|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432905|NCT01587703|11714140|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432906|NCT01587703|11714141|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432907|NCT01587703|11714142|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432908|NCT01587703|11714143|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432909|NCT01587703|11714144|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432910|NCT01587703|11714145|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432911|NCT01587703|11714146|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432912|NCT01587703|11714147|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
7432913|NCT01587703|11714148|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432914|NCT01587703|11714149|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432915|NCT01587703|11714150|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432916|NCT01587703|11714151|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432917|NCT01587703|11714152|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432918|NCT01587703|11714153|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432919|NCT01587703|11714154|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
7432920|NCT01587885|11714213|FG000|Treatment Period 1|Failure to Return|0
7432921|NCT01587885|11714214|FG001|Treatment Period 1|Failure to Return|1
7432922|NCT01587885|11714213|FG000|Treatment Period 1|Protocol Violation|0
7432923|NCT01587885|11714214|FG001|Treatment Period 1|Protocol Violation|2
7432924|NCT01587898|11714225|FG000|Overall Study|Adverse Event|1
7432925|NCT01587898|11714226|FG001|Overall Study|Adverse Event|1
7432926|NCT01587898|11714227|FG002|Overall Study|Adverse Event|0
7432927|NCT01587898|11714228|FG003|Overall Study|Adverse Event|0
7432928|NCT01587898|11714225|FG000|Overall Study|Protocol Violation|0
7432929|NCT01587898|11714226|FG001|Overall Study|Protocol Violation|2
7432930|NCT01587898|11714227|FG002|Overall Study|Protocol Violation|1
7432931|NCT01587898|11714228|FG003|Overall Study|Protocol Violation|1
7432932|NCT01587898|11714225|FG000|Overall Study|Lost to Follow-up|0
7432933|NCT01587898|11714226|FG001|Overall Study|Lost to Follow-up|0
7432934|NCT01587898|11714227|FG002|Overall Study|Lost to Follow-up|0
7432935|NCT01587898|11714228|FG003|Overall Study|Lost to Follow-up|1
7432936|NCT01587898|11714225|FG000|Overall Study|Withdrawal by Subject|2
7432937|NCT01587898|11714226|FG001|Overall Study|Withdrawal by Subject|1
7432938|NCT01587898|11714227|FG002|Overall Study|Withdrawal by Subject|0
7432939|NCT01587898|11714228|FG003|Overall Study|Withdrawal by Subject|0
7432940|NCT01587898|11714225|FG000|Overall Study|Met haemoglobin stopping criteria|1
7432941|NCT01587898|11714226|FG001|Overall Study|Met haemoglobin stopping criteria|1
7432942|NCT01587898|11714227|FG002|Overall Study|Met haemoglobin stopping criteria|1
7432943|NCT01587898|11714228|FG003|Overall Study|Met haemoglobin stopping criteria|0
7432944|NCT01587924|11714245|FG000|Overall Study|Adverse Event|0
7432945|NCT01587924|11714246|FG001|Overall Study|Adverse Event|2
7432946|NCT01587924|11714247|FG002|Overall Study|Adverse Event|0
7432947|NCT01587924|11714248|FG003|Overall Study|Adverse Event|0
7432948|NCT01587924|11714245|FG000|Overall Study|Protocol Violation|2
7432949|NCT01587924|11714246|FG001|Overall Study|Protocol Violation|1
7432950|NCT01587924|11714247|FG002|Overall Study|Protocol Violation|2
7432951|NCT01587924|11714248|FG003|Overall Study|Protocol Violation|1
7432952|NCT01587924|11714245|FG000|Overall Study|Met Hemoglobin stopping criteria|2
7432953|NCT01587924|11714246|FG001|Overall Study|Met Hemoglobin stopping criteria|0
7432954|NCT01587924|11714247|FG002|Overall Study|Met Hemoglobin stopping criteria|1
7432955|NCT01587924|11714248|FG003|Overall Study|Met Hemoglobin stopping criteria|0
7432956|NCT01587924|11714245|FG000|Overall Study|Withdrawal by Subject|0
7432957|NCT01587924|11714246|FG001|Overall Study|Withdrawal by Subject|1
7432958|NCT01587924|11714247|FG002|Overall Study|Withdrawal by Subject|1
7432959|NCT01587924|11714248|FG003|Overall Study|Withdrawal by Subject|0
7432960|NCT01587989|11714273|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
7432961|NCT01587989|11714274|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
7432962|NCT01587989|11714275|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
7432963|NCT01587989|11714273|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
7432964|NCT01587989|11714274|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7432965|NCT01587989|11714275|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
7432966|NCT01587989|11714273|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
7432967|NCT01587989|11714274|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
7432968|NCT01587989|11714275|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
7432969|NCT01587989|11714273|FG000|Randomized Study Treatment|Withdrawal by Subject|0
7432970|NCT01587989|11714274|FG001|Randomized Study Treatment|Withdrawal by Subject|1
7432971|NCT01587989|11714275|FG002|Randomized Study Treatment|Withdrawal by Subject|0
7432972|NCT01587989|11714273|FG000|Randomized Study Treatment|Screening failure|0
7432973|NCT01587989|11714274|FG001|Randomized Study Treatment|Screening failure|1
7432974|NCT01587989|11714275|FG002|Randomized Study Treatment|Screening failure|0
7432975|NCT01587989|11714273|FG000|Randomized Study Treatment|Physician Decision|0
7432976|NCT01587989|11714274|FG001|Randomized Study Treatment|Physician Decision|0
7432977|NCT01587989|11714275|FG002|Randomized Study Treatment|Physician Decision|1
7432978|NCT01588106|11714283|FG000|Overall Study|Withdrawal by Subject|5
7432979|NCT01588106|11714284|FG001|Overall Study|Withdrawal by Subject|4
7432980|NCT01588184|11714305|FG000|Overall Study|Death|1
7432981|NCT01588184|11714306|FG001|Overall Study|Death|0
7432982|NCT01588184|11714307|FG002|Overall Study|Death|0
7432983|NCT01588184|11714308|FG003|Overall Study|Death|1
7432984|NCT01588184|11714309|FG004|Overall Study|Death|1
7432985|NCT01588184|11714310|FG005|Overall Study|Death|1
7432986|NCT01588184|11714305|FG000|Overall Study|Withdrawal by Subject|2
7432987|NCT01588184|11714306|FG001|Overall Study|Withdrawal by Subject|4
7432988|NCT01588184|11714307|FG002|Overall Study|Withdrawal by Subject|0
7432989|NCT01588184|11714308|FG003|Overall Study|Withdrawal by Subject|1
7432990|NCT01588184|11714309|FG004|Overall Study|Withdrawal by Subject|0
7432991|NCT01588184|11714310|FG005|Overall Study|Withdrawal by Subject|0
7432992|NCT01588184|11714305|FG000|Overall Study|Bevacizumab treatment provision changed|0
7432993|NCT01588184|11714306|FG001|Overall Study|Bevacizumab treatment provision changed|6
7432994|NCT01588184|11714307|FG002|Overall Study|Bevacizumab treatment provision changed|2
7432995|NCT01588184|11714308|FG003|Overall Study|Bevacizumab treatment provision changed|0
7432996|NCT01588184|11714309|FG004|Overall Study|Bevacizumab treatment provision changed|1
7432997|NCT01588184|11714310|FG005|Overall Study|Bevacizumab treatment provision changed|3
7432998|NCT01588184|11714305|FG000|Overall Study|multiple reasons|0
7432999|NCT01588184|11714306|FG001|Overall Study|multiple reasons|3
7433000|NCT01588184|11714307|FG002|Overall Study|multiple reasons|0
7433001|NCT01588184|11714308|FG003|Overall Study|multiple reasons|1
7433002|NCT01588184|11714309|FG004|Overall Study|multiple reasons|0
7433003|NCT01588184|11714310|FG005|Overall Study|multiple reasons|0
7433004|NCT01588197|11714326|FG000|Overall Study|Lack of Efficacy|0
7433005|NCT01588197|11714327|FG001|Overall Study|Lack of Efficacy|1
7433006|NCT01588197|11714326|FG000|Overall Study|No MRI|1
7433007|NCT01588197|11714327|FG001|Overall Study|No MRI|0
7433008|NCT01588353|11714349|FG000|Step2|Withdrawal by Subject|0
7433009|NCT01588353|11714350|FG001|Step2|Withdrawal by Subject|1
7433010|NCT01588353|11714351|FG002|Step2|Withdrawal by Subject|0
7433011|NCT01588353|11714349|FG000|Step3|Adverse Event|0
7433012|NCT01588353|11714350|FG001|Step3|Adverse Event|0
7433013|NCT01588353|11714351|FG002|Step3|Adverse Event|2
7433014|NCT01588366|11714363|FG000|Overall Study|Adverse Event|0
7433015|NCT01588366|11714364|FG001|Overall Study|Adverse Event|1
7433016|NCT01588366|11714365|FG002|Overall Study|Adverse Event|0
7433017|NCT01588366|11714366|FG003|Overall Study|Adverse Event|1
7433018|NCT01588366|11714367|FG004|Overall Study|Adverse Event|0
7433019|NCT01588366|11714368|FG005|Overall Study|Adverse Event|2
7433020|NCT01588405|11714384|FG000|Overall Study|Adverse Event|1
7433021|NCT01588405|11714384|FG000|Overall Study|Clinical Worsening|1
7433022|NCT01588496|11714444|FG000|Overall Study|Withdrawal by Subject|0
7433023|NCT01588496|11714445|FG001|Overall Study|Withdrawal by Subject|1
7433024|NCT01588496|11714446|FG002|Overall Study|Withdrawal by Subject|0
7433025|NCT01588509|11714456|FG000|Overall Study|Lost to Follow-up|1
7433026|NCT01588509|11714457|FG001|Overall Study|Lost to Follow-up|0
7433027|NCT01588548|11714469|FG000|Overall Study|Withdrawal by Subject|0
7433028|NCT01588548|11714470|FG001|Overall Study|Withdrawal by Subject|1
7433029|NCT01588548|11714471|FG002|Overall Study|Withdrawal by Subject|1
7433030|NCT01588548|11714472|FG003|Overall Study|Withdrawal by Subject|1
7433031|NCT01588548|11714473|FG004|Overall Study|Withdrawal by Subject|2
7433032|NCT01588548|11714474|FG005|Overall Study|Withdrawal by Subject|3
7433033|NCT01588548|11714469|FG000|Overall Study|Adverse Event|0
7433034|NCT01588548|11714470|FG001|Overall Study|Adverse Event|0
7433035|NCT01588548|11714471|FG002|Overall Study|Adverse Event|1
7433036|NCT01588548|11714472|FG003|Overall Study|Adverse Event|2
7433037|NCT01588548|11714473|FG004|Overall Study|Adverse Event|1
7433038|NCT01588548|11714474|FG005|Overall Study|Adverse Event|0
7433039|NCT01588548|11714469|FG000|Overall Study|Condition Under Investigation Worsened|3
7433040|NCT01588548|11714470|FG001|Overall Study|Condition Under Investigation Worsened|6
7433041|NCT01588548|11714471|FG002|Overall Study|Condition Under Investigation Worsened|4
7433042|NCT01588548|11714472|FG003|Overall Study|Condition Under Investigation Worsened|4
7433043|NCT01588548|11714473|FG004|Overall Study|Condition Under Investigation Worsened|3
7433044|NCT01588548|11714474|FG005|Overall Study|Condition Under Investigation Worsened|3
7433045|NCT01588951|11714503|FG000|Overall Study|Ineligible in retrospect|0
7433046|NCT01588951|11714504|FG001|Overall Study|Ineligible in retrospect|0
7433048|NCT01588990|11714513|FG000|Phase A|Withdrawal by Subject|5
7433049|NCT01588990|11714513|FG000|Phase A|Physician Decision|11
7433050|NCT01588990|11714513|FG000|Phase A|Other|14
7433051|NCT01588990|11714513|FG000|Phase A|Lost to Follow-up|1
7433052|NCT01588990|11714513|FG000|Phase A|Death|5
7433053|NCT01588990|11714513|FG000|Phase A|Adverse Event|28
7433054|NCT01588990|11714513|FG000|Phase A|Still on therapy at end of study|6
7433055|NCT01588990|11714513|FG000|Phase B|Adverse Event|2
7433056|NCT01588990|11714513|FG000|Phase B|Still on therapy at end of study|5
7433057|NCT01588990|11714513|FG000|Phase B|Withdrawal by Subject|3
7433058|NCT01588990|11714513|FG000|Phase B|Physician Decision|4
7433059|NCT01588990|11714513|FG000|Phase B|Other|2
7433060|NCT01589094|11714521|FG000|Overall Study|Did not receive treatment|2
7433061|NCT01589185|11714530|FG000|Overall Study|Death|1
7433062|NCT01589185|11714531|FG001|Overall Study|Death|2
7433063|NCT01589185|11714532|FG002|Overall Study|Death|2
7433064|NCT01589185|11714533|FG003|Overall Study|Death|0
7433065|NCT01589185|11714534|FG004|Overall Study|Death|1
7433066|NCT01589185|11714530|FG000|Overall Study|Lost to Follow-up|1
7433067|NCT01589185|11714531|FG001|Overall Study|Lost to Follow-up|0
7433068|NCT01589185|11714532|FG002|Overall Study|Lost to Follow-up|2
7433069|NCT01589185|11714533|FG003|Overall Study|Lost to Follow-up|3
7433070|NCT01589185|11714534|FG004|Overall Study|Lost to Follow-up|0
7433071|NCT01589237|11714551|FG000|Part A (52 Weeks)|Subject/guardian decision|2
7433072|NCT01589237|11714552|FG001|Part A (52 Weeks)|Subject/guardian decision|3
7433073|NCT01589237|11714553|FG002|Part A (52 Weeks)|Subject/guardian decision|2
7433074|NCT01589237|11714554|FG003|Part A (52 Weeks)|Subject/guardian decision|0
7433075|NCT01589237|11714551|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7433076|NCT01589237|11714552|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
7433077|NCT01589237|11714553|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7433078|NCT01589237|11714554|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
7433079|NCT01589237|11714551|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7433080|NCT01589237|11714552|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
7433081|NCT01589237|11714553|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
7433082|NCT01589237|11714554|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
7433083|NCT01589237|11714551|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7433084|NCT01589237|11714552|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7433085|NCT01589237|11714553|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
7433086|NCT01589237|11714554|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
7433087|NCT01589445|11714586|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
7433088|NCT01589445|11714586|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
7433089|NCT01589445|11714586|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
7433090|NCT01589445|11714586|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
7433091|NCT01589445|11714586|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
7433092|NCT01589445|11714586|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
7433093|NCT01589445|11714586|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
7433094|NCT01589445|11714586|FG000|002 (Metformin)-3 Months|Protocol Violation|2
7433095|NCT01589445|11714586|FG000|002 (Metformin)-3 Months|Adverse Event|2
7433096|NCT01589445|11714586|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
7433097|NCT01589497|11714603|FG000|Overall Study|Withdrawal by Subject|0
7433098|NCT01589497|11714604|FG001|Overall Study|Withdrawal by Subject|1
7433099|NCT01589497|11714605|FG002|Overall Study|Withdrawal by Subject|0
7433100|NCT01589497|11714606|FG003|Overall Study|Withdrawal by Subject|1
7433101|NCT01589497|11714603|FG000|Overall Study|Death|1
7433102|NCT01589497|11714604|FG001|Overall Study|Death|0
7433103|NCT01589497|11714605|FG002|Overall Study|Death|0
7433104|NCT01589497|11714606|FG003|Overall Study|Death|0
7433105|NCT01589497|11714603|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
7433106|NCT01589497|11714604|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
7433107|NCT01589497|11714605|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
7433108|NCT01589497|11714606|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
7433109|NCT01589653|11714636|FG000|Overall Study|Protocol Violation|3
7433110|NCT01589653|11714637|FG001|Overall Study|Protocol Violation|1
7433111|NCT01589653|11714636|FG000|Overall Study|Withdrawal criteria|4
7433112|NCT01589653|11714637|FG001|Overall Study|Withdrawal criteria|7
7433113|NCT01589653|11714636|FG000|Overall Study|Unclassified|0
7433114|NCT01589653|11714637|FG001|Overall Study|Unclassified|3
7433115|NCT01589770|11714645|FG000|Overall Study|EGFR <60ml/min|6
7433116|NCT01589770|11714646|FG001|Overall Study|EGFR <60ml/min|4
7433117|NCT01589770|11714645|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
7433118|NCT01589770|11714646|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
7433119|NCT01589822|11714655|FG000|Overall Study|Withdrawal by Subject|1
7433120|NCT01589822|11714656|FG001|Overall Study|Withdrawal by Subject|2
7433121|NCT01589822|11714657|FG002|Overall Study|Withdrawal by Subject|0
7433122|NCT01589822|11714655|FG000|Overall Study|Death|1
7433123|NCT01589822|11714656|FG001|Overall Study|Death|0
7433124|NCT01589822|11714657|FG002|Overall Study|Death|0
7433125|NCT01589822|11714655|FG000|Overall Study|Missed 90 day visit|2
7433126|NCT01589822|11714656|FG001|Overall Study|Missed 90 day visit|1
7433127|NCT01589822|11714657|FG002|Overall Study|Missed 90 day visit|1
7433132|NCT01590082|11714678|FG000|Overall Study|Withdrawal by Subject|1
7433133|NCT01590082|11714679|FG001|Overall Study|Withdrawal by Subject|0
7433134|NCT01590082|11714678|FG000|Overall Study|Ineligible|1
7433135|NCT01590082|11714679|FG001|Overall Study|Ineligible|0
7433136|NCT01590212|11714688|FG000|Overall Study|Withdrawal by Subject|2
7433137|NCT01590212|11714689|FG001|Overall Study|Withdrawal by Subject|2
7433138|NCT01590212|11714690|FG002|Overall Study|Withdrawal by Subject|2
7433139|NCT01590212|11714688|FG000|Overall Study|Lost to Follow-up|1
7433140|NCT01590212|11714689|FG001|Overall Study|Lost to Follow-up|2
7433141|NCT01590212|11714690|FG002|Overall Study|Lost to Follow-up|3
7433142|NCT01590433|11714709|FG000|Overall Study|Lost to Follow-up|20
7433143|NCT01590433|11714710|FG001|Overall Study|Lost to Follow-up|8
7433144|NCT01590433|11714709|FG000|Overall Study|Withdrawal by Subject|21
7433145|NCT01590433|11714710|FG001|Overall Study|Withdrawal by Subject|11
7433146|NCT01590433|11714709|FG000|Overall Study|Adverse Event|11
7433147|NCT01590433|11714710|FG001|Overall Study|Adverse Event|3
7433148|NCT01590563|11714721|FG000|Overall Study|simple uterine hyperplasia - not related|1
7433149|NCT01590758|11714728|FG000|Overall Study|Withdrawal by Subject|0
7433150|NCT01590758|11714729|FG001|Overall Study|Withdrawal by Subject|3
7433151|NCT01590758|11714728|FG000|Overall Study|Physician Decision|1
7433152|NCT01590758|11714729|FG001|Overall Study|Physician Decision|2
7433153|NCT01590758|11714728|FG000|Overall Study|Lost to Follow-up|4
7433154|NCT01590758|11714729|FG001|Overall Study|Lost to Follow-up|2
7433155|NCT01590771|11714737|FG000|Overall Study|Other Protocol Specified Criteria|5
7433156|NCT01590771|11714738|FG001|Overall Study|Other Protocol Specified Criteria|14
7433157|NCT01590771|11714737|FG000|Overall Study|Withdrawal by Subject|8
7433158|NCT01590771|11714738|FG001|Overall Study|Withdrawal by Subject|15
7433159|NCT01590771|11714737|FG000|Overall Study|Protocol Violation|1
7433160|NCT01590771|11714738|FG001|Overall Study|Protocol Violation|2
7433161|NCT01590771|11714737|FG000|Overall Study|Lost to Follow-up|1
7433162|NCT01590771|11714738|FG001|Overall Study|Lost to Follow-up|1
7433163|NCT01590771|11714737|FG000|Overall Study|Lack of Efficacy|1
7433164|NCT01590771|11714738|FG001|Overall Study|Lack of Efficacy|0
7433165|NCT01590771|11714737|FG000|Overall Study|Adverse Event|3
7433166|NCT01590771|11714738|FG001|Overall Study|Adverse Event|7
7433167|NCT01590797|11714746|FG000|Overall Study|Adverse Event|4
7433168|NCT01590797|11714747|FG001|Overall Study|Adverse Event|3
7433169|NCT01590797|11714746|FG000|Overall Study|Lack of Efficacy|0
7433170|NCT01590797|11714747|FG001|Overall Study|Lack of Efficacy|2
7433171|NCT01590797|11714746|FG000|Overall Study|Lost to Follow-up|0
7433172|NCT01590797|11714747|FG001|Overall Study|Lost to Follow-up|1
7433173|NCT01590797|11714746|FG000|Overall Study|Protocol Violation|4
7433174|NCT01590797|11714747|FG001|Overall Study|Protocol Violation|1
7433175|NCT01590797|11714746|FG000|Overall Study|Withdrawal by Subject|7
7433176|NCT01590797|11714747|FG001|Overall Study|Withdrawal by Subject|5
7433177|NCT01590797|11714746|FG000|Overall Study|Other Protocol Specified Criteria|2
7433178|NCT01590797|11714747|FG001|Overall Study|Other Protocol Specified Criteria|4
7433179|NCT01590810|11714758|FG000|Overall Study|Physician Decision|0
7433180|NCT01590810|11714759|FG001|Overall Study|Physician Decision|1
7433181|NCT01590810|11714760|FG002|Overall Study|Physician Decision|1
7433182|NCT01590810|11714761|FG003|Overall Study|Physician Decision|0
7433183|NCT01590810|11714762|FG004|Overall Study|Physician Decision|0
7433184|NCT01590888|11714809|FG000|Overall Study|Adverse Event|3
7433185|NCT01590888|11714810|FG001|Overall Study|Adverse Event|0
7433186|NCT01590888|11714811|FG002|Overall Study|Adverse Event|1
7433187|NCT01590888|11714809|FG000|Overall Study|Lost to Follow-up|1
7433188|NCT01590888|11714810|FG001|Overall Study|Lost to Follow-up|0
7433189|NCT01590888|11714811|FG002|Overall Study|Lost to Follow-up|0
7433190|NCT01591330|11714894|FG000|Period 1|Adverse Event|1
7433191|NCT01591330|11714895|FG001|Period 1|Adverse Event|0
7433192|NCT01591330|11714896|FG002|Period 1|Adverse Event|0
7433193|NCT01591330|11714897|FG003|Period 1|Adverse Event|0
7433194|NCT01591330|11714894|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
7433195|NCT01591330|11714895|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
7433196|NCT01591330|11714896|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
7433197|NCT01591330|11714897|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
7433198|NCT01591330|11714894|FG000|Period 2|Adverse Event|1
7433199|NCT01591330|11714895|FG001|Period 2|Adverse Event|0
7433200|NCT01591330|11714896|FG002|Period 2|Adverse Event|0
7433201|NCT01591330|11714897|FG003|Period 2|Adverse Event|0
7433202|NCT01591382|11714909|FG000|Overall Study|Discharged Prior to Study Completion|2
7433203|NCT01591382|11714910|FG001|Overall Study|Discharged Prior to Study Completion|1
7433204|NCT01591382|11714909|FG000|Overall Study|Participant Opted for Morphine PCA|1
7433205|NCT01591382|11714910|FG001|Overall Study|Participant Opted for Morphine PCA|1
7433206|NCT01591460|11714925|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7433207|NCT01591460|11714925|FG000|Overall Study|Futility Rule (Week 12)|7
7433208|NCT01591460|11714925|FG000|Overall Study|Futility Rule (Week 24)|3
7433209|NCT01591460|11714925|FG000|Overall Study|Rebound or Breakthrough|3
7433210|NCT01591460|11714925|FG000|Overall Study|Treatment Discontinued by Error|1
7433211|NCT01591460|11714925|FG000|Overall Study|Lost to Follow-up|1
7433212|NCT01591460|11714925|FG000|Overall Study|Noncompliance|1
7433213|NCT01591460|11714925|FG000|Overall Study|Participant Refusal|3
7433214|NCT01591460|11714925|FG000|Overall Study|Withdrawal by Subject|1
7433215|NCT01591460|11714925|FG000|Overall Study|Protocol Violation|1
7433216|NCT01591499|11714937|FG000|Baseline Visit|Withdrawal by Subject|0
7433217|NCT01591499|11714938|FG001|Baseline Visit|Withdrawal by Subject|2
7433218|NCT01591499|11714939|FG002|Baseline Visit|Withdrawal by Subject|0
7433219|NCT01591499|11714940|FG003|Baseline Visit|Withdrawal by Subject|2
7433220|NCT01591499|11714937|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7433221|NCT01591499|11714938|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7433222|NCT01591499|11714939|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
7433223|NCT01591499|11714940|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
7433224|NCT01591499|11714937|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
7433225|NCT01591499|11714938|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7433226|NCT01591499|11714939|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
7433227|NCT01591499|11714940|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
7467105|NCT01897896|11767352|FG000|Overall Study|Caregiver can no longer participate|0
7467106|NCT01897896|11767353|FG001|Overall Study|Caregiver can no longer participate|2
7467107|NCT01897896|11767352|FG000|Overall Study|Other than specified|2
7467108|NCT01897896|11767353|FG001|Overall Study|Other than specified|1
7467109|NCT01898078|11767372|FG000|Overall Study|Progressive Disease|1
7467110|NCT01898078|11767373|FG001|Overall Study|Progressive Disease|5
7467111|NCT01898078|11767372|FG000|Overall Study|Adverse Event|2
7467112|NCT01898078|11767373|FG001|Overall Study|Adverse Event|1
7467113|NCT01898078|11767372|FG000|Overall Study|Withdrawal by Subject|1
7467114|NCT01898078|11767373|FG001|Overall Study|Withdrawal by Subject|1
7467115|NCT01898078|11767372|FG000|Overall Study|Symptomatic Deterioration|2
7467116|NCT01898078|11767373|FG001|Overall Study|Symptomatic Deterioration|0
7467117|NCT01898078|11767372|FG000|Overall Study|Reason not Specified|0
7467118|NCT01898078|11767373|FG001|Overall Study|Reason not Specified|1
7467119|NCT01898091|11767383|FG000|Overall Study|Lost to Follow-up|1
7467120|NCT01898091|11767384|FG001|Overall Study|Lost to Follow-up|1
7467121|NCT01898091|11767383|FG000|Overall Study|Withdrawal by Subject|1
7467122|NCT01898091|11767384|FG001|Overall Study|Withdrawal by Subject|5
7467123|NCT01898130|11767390|FG000|Treatment|Withdrawal by Subject|2
7467124|NCT01898130|11767390|FG000|Treatment|Progressive Disease|4
7467125|NCT01898130|11767390|FG000|Follow up Until PD or Death|Lost to Follow-up|1
7467126|NCT01898195|11767397|FG000|Smoking Abstinence|Did not have good measurements|35
7467127|NCT01898195|11767398|FG001|Smoking Abstinence|Did not have good measurements|38
7467128|NCT01898195|11767399|FG002|Smoking Abstinence|Did not have good measurements|36
7467129|NCT01898208|11767410|FG000|Overall Study|Positive blood culture|17
7467130|NCT01898208|11767411|FG001|Overall Study|Positive blood culture|23
7467131|NCT01898208|11767412|FG002|Overall Study|Positive blood culture|15
7467132|NCT01898208|11767410|FG000|Overall Study|Death/comfort care within 24 hours|10
7467133|NCT01898208|11767411|FG001|Overall Study|Death/comfort care within 24 hours|9
7467134|NCT01898208|11767412|FG002|Overall Study|Death/comfort care within 24 hours|8
7467135|NCT01898208|11767410|FG000|Overall Study|Negative Gram Stain|6
7467136|NCT01898208|11767411|FG001|Overall Study|Negative Gram Stain|9
7467137|NCT01898208|11767412|FG002|Overall Study|Negative Gram Stain|6
7467138|NCT01898208|11767410|FG000|Overall Study|Non-Blood Specimens in Bottles|3
7467139|NCT01898208|11767411|FG001|Overall Study|Non-Blood Specimens in Bottles|5
7467140|NCT01898208|11767412|FG002|Overall Study|Non-Blood Specimens in Bottles|4
7467141|NCT01898208|11767410|FG000|Overall Study|System/Technical Error|1
7467142|NCT01898208|11767411|FG001|Overall Study|System/Technical Error|2
7467143|NCT01898208|11767412|FG002|Overall Study|System/Technical Error|3
7467144|NCT01898208|11767410|FG000|Overall Study|Lost to Follow-up|3
7467145|NCT01898208|11767411|FG001|Overall Study|Lost to Follow-up|1
7467146|NCT01898208|11767412|FG002|Overall Study|Lost to Follow-up|1
7467147|NCT01898286|11767420|FG000|Overall Study|Withdrawal by Subject|1
7467148|NCT01898286|11767420|FG000|Overall Study|Protocol Violation|1
7467149|NCT01898286|11767420|FG000|Overall Study|Lost to Follow-up|1
7467150|NCT01898299|11767426|FG000|Post Treatment (One Month)|Lost to Follow-up|3
7467151|NCT01898299|11767427|FG001|Post Treatment (One Month)|Lost to Follow-up|4
7467152|NCT01898442|11767448|FG000|Overall Study|Hemolysis/technical problems|1
7467153|NCT01898442|11767449|FG001|Overall Study|Hemolysis/technical problems|2
7467154|NCT01898442|11767450|FG002|Overall Study|Hemolysis/technical problems|2
7467155|NCT01898442|11767448|FG000|Overall Study|Patient vomited pills|0
7467156|NCT01898442|11767449|FG001|Overall Study|Patient vomited pills|0
7467157|NCT01898442|11767450|FG002|Overall Study|Patient vomited pills|1
7467158|NCT01898598|11767460|FG000|Overall Study|Adverse Event|1
7467159|NCT01898598|11767461|FG001|Overall Study|Adverse Event|0
7467160|NCT01898598|11767460|FG000|Overall Study|Withdrawal by Subject|3
7467161|NCT01898598|11767461|FG001|Overall Study|Withdrawal by Subject|0
7467162|NCT01898598|11767460|FG000|Overall Study|Lost to Follow-up|0
7467163|NCT01898598|11767461|FG001|Overall Study|Lost to Follow-up|1
7467164|NCT01898598|11767460|FG000|Overall Study|Other|0
7467165|NCT01898598|11767461|FG001|Overall Study|Other|1
7467166|NCT01898806|11767496|FG000|Overall Study|Withdrawal by Subject|2
7467167|NCT01898806|11767496|FG000|Overall Study|Physician Decision|1
7467168|NCT01898884|11767505|FG000|Multiple Dose Period|Adverse Event|0
7433228|NCT01591616|11714964|FG000|Overall Study|Withdrawal by Subject|1
7433229|NCT01591681|11715112|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
7433230|NCT01591681|11715112|FG000|Overall Study|Failed to use system during run-in|1
7433231|NCT01591785|11715135|FG000|Overall Study|worsening condition|1
7433232|NCT01591785|11715136|FG001|Overall Study|worsening condition|2
7433233|NCT01591785|11715135|FG000|Overall Study|Protocol Violation|2
7433234|NCT01591785|11715136|FG001|Overall Study|Protocol Violation|0
7433235|NCT01591785|11715135|FG000|Overall Study|Lost to Follow-up|1
7433236|NCT01591785|11715136|FG001|Overall Study|Lost to Follow-up|0
7559097|NCT03137992|11924997|FG003|Washout Period 1|COPD Exacerbation|0
7559098|NCT03137992|11924998|FG004|Washout Period 1|COPD Exacerbation|1
7559099|NCT03137992|11924999|FG005|Washout Period 1|COPD Exacerbation|1
7559100|NCT03137992|11924994|FG000|Washout Period 1|Subject Noncompliance|1
7559101|NCT03137992|11924995|FG001|Washout Period 1|Subject Noncompliance|0
7559102|NCT03137992|11924996|FG002|Washout Period 1|Subject Noncompliance|0
7433237|NCT01591863|11715151|FG000|Overall Study|Adverse Event|3
7433238|NCT01591863|11715151|FG000|Overall Study|Withdrawal by Subject|1
7433239|NCT01591863|11715151|FG000|Overall Study|recurrence|9
7433240|NCT01591863|11715151|FG000|Overall Study|Lack of Efficacy|1
7433241|NCT01592045|11715161|FG000|Overall Study|Disease Progression|1
7433242|NCT01592045|11715162|FG001|Overall Study|Disease Progression|1
7433243|NCT01592045|11715161|FG000|Overall Study|Adverse Event|1
7433244|NCT01592045|11715162|FG001|Overall Study|Adverse Event|1
7433245|NCT01592045|11715161|FG000|Overall Study|Withdrawal by Subject|1
7433246|NCT01592045|11715162|FG001|Overall Study|Withdrawal by Subject|0
7433247|NCT01592045|11715161|FG000|Overall Study|Moved out of country|2
7433248|NCT01592045|11715162|FG001|Overall Study|Moved out of country|0
7433249|NCT01592240|11715179|FG000|Overall Study|Adverse Event|1
7433250|NCT01592240|11715180|FG001|Overall Study|Adverse Event|0
7433251|NCT01592240|11715181|FG002|Overall Study|Adverse Event|0
7433252|NCT01592240|11715182|FG003|Overall Study|Adverse Event|1
7433253|NCT01592240|11715183|FG004|Overall Study|Adverse Event|1
7433254|NCT01592240|11715184|FG005|Overall Study|Adverse Event|0
7433255|NCT01592240|11715185|FG006|Overall Study|Adverse Event|0
7433256|NCT01592240|11715179|FG000|Overall Study|Death|0
7433257|NCT01592240|11715180|FG001|Overall Study|Death|1
7433258|NCT01592240|11715181|FG002|Overall Study|Death|0
7433259|NCT01592240|11715182|FG003|Overall Study|Death|0
7433260|NCT01592240|11715183|FG004|Overall Study|Death|0
7433261|NCT01592240|11715184|FG005|Overall Study|Death|0
7433262|NCT01592240|11715185|FG006|Overall Study|Death|0
7433263|NCT01592240|11715179|FG000|Overall Study|Lost to Follow-up|1
7433264|NCT01592240|11715180|FG001|Overall Study|Lost to Follow-up|3
7433265|NCT01592240|11715181|FG002|Overall Study|Lost to Follow-up|1
7559103|NCT03137992|11924997|FG003|Washout Period 1|Subject Noncompliance|0
7559104|NCT03137992|11924998|FG004|Washout Period 1|Subject Noncompliance|1
7559105|NCT03137992|11924999|FG005|Washout Period 1|Subject Noncompliance|0
7559106|NCT03137992|11924994|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
7559107|NCT03137992|11924995|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
7559108|NCT03137992|11924996|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
7559109|NCT03137992|11924997|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
7559110|NCT03137992|11924998|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
7559111|NCT03137992|11924999|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
7559112|NCT03137992|11924994|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
7559113|NCT03137992|11924995|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
7559114|NCT03137992|11924996|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
7559115|NCT03137992|11924997|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
7559116|NCT03137992|11924998|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
7559117|NCT03137992|11924999|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
7559118|NCT03137992|11924994|FG000|Period 2 (Visit 3)|Adverse Event|0
7559119|NCT03137992|11924995|FG001|Period 2 (Visit 3)|Adverse Event|1
7559120|NCT03137992|11924996|FG002|Period 2 (Visit 3)|Adverse Event|0
7559121|NCT03137992|11924997|FG003|Period 2 (Visit 3)|Adverse Event|0
7559122|NCT03137992|11924998|FG004|Period 2 (Visit 3)|Adverse Event|0
7559123|NCT03137992|11924999|FG005|Period 2 (Visit 3)|Adverse Event|0
7559124|NCT03137992|11924994|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
7559125|NCT03137992|11924995|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
7559126|NCT03137992|11924996|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
7559127|NCT03137992|11924997|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
7559128|NCT03137992|11924998|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
7559129|NCT03137992|11924999|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
7559130|NCT03137992|11924994|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
7559131|NCT03137992|11924995|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
7559132|NCT03137992|11924996|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
7559133|NCT03137992|11924997|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
7559134|NCT03137992|11924998|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
7433266|NCT01592240|11715182|FG003|Overall Study|Lost to Follow-up|0
7433267|NCT01592240|11715183|FG004|Overall Study|Lost to Follow-up|3
7433268|NCT01592240|11715184|FG005|Overall Study|Lost to Follow-up|2
7433269|NCT01592240|11715185|FG006|Overall Study|Lost to Follow-up|0
7433270|NCT01592240|11715179|FG000|Overall Study|Protocol Violation|0
7433271|NCT01592240|11715180|FG001|Overall Study|Protocol Violation|0
7433272|NCT01592240|11715181|FG002|Overall Study|Protocol Violation|0
7433273|NCT01592240|11715182|FG003|Overall Study|Protocol Violation|0
7433274|NCT01592240|11715183|FG004|Overall Study|Protocol Violation|0
7433275|NCT01592240|11715184|FG005|Overall Study|Protocol Violation|1
7433276|NCT01592240|11715185|FG006|Overall Study|Protocol Violation|0
7433277|NCT01592240|11715179|FG000|Overall Study|Withdrawal by Subject|0
7433278|NCT01592240|11715180|FG001|Overall Study|Withdrawal by Subject|4
7433279|NCT01592240|11715181|FG002|Overall Study|Withdrawal by Subject|4
7433280|NCT01592240|11715182|FG003|Overall Study|Withdrawal by Subject|1
7433281|NCT01592240|11715183|FG004|Overall Study|Withdrawal by Subject|3
7433282|NCT01592240|11715184|FG005|Overall Study|Withdrawal by Subject|0
7433283|NCT01592240|11715185|FG006|Overall Study|Withdrawal by Subject|2
7433284|NCT01592240|11715179|FG000|Overall Study|Other|0
7433285|NCT01592240|11715180|FG001|Overall Study|Other|3
7433286|NCT01592240|11715181|FG002|Overall Study|Other|1
7433287|NCT01592240|11715182|FG003|Overall Study|Other|1
7433288|NCT01592240|11715183|FG004|Overall Study|Other|0
7433289|NCT01592240|11715184|FG005|Overall Study|Other|0
7433290|NCT01592240|11715185|FG006|Overall Study|Other|1
7433291|NCT01592240|11715179|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7433292|NCT01592240|11715180|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7433293|NCT01592240|11715181|FG002|Overall Study|Did Not Meet Entrance Criteria|1
7433294|NCT01592240|11715182|FG003|Overall Study|Did Not Meet Entrance Criteria|0
7433295|NCT01592240|11715183|FG004|Overall Study|Did Not Meet Entrance Criteria|0
7433296|NCT01592240|11715184|FG005|Overall Study|Did Not Meet Entrance Criteria|0
7433297|NCT01592240|11715185|FG006|Overall Study|Did Not Meet Entrance Criteria|0
7433298|NCT01592292|11715208|FG000|Overall Study|Follow-up loss|3
7433299|NCT01592292|11715209|FG001|Overall Study|Follow-up loss|3
7433300|NCT01592292|11715210|FG002|Overall Study|Follow-up loss|1
7433301|NCT01592292|11715211|FG003|Overall Study|Follow-up loss|0
7433302|NCT01592292|11715208|FG000|Overall Study|Withdrew consent|2
7433303|NCT01592292|11715209|FG001|Overall Study|Withdrew consent|1
7433304|NCT01592292|11715210|FG002|Overall Study|Withdrew consent|0
7433305|NCT01592292|11715211|FG003|Overall Study|Withdrew consent|0
7433306|NCT01592292|11715208|FG000|Overall Study|Other|1
7433307|NCT01592292|11715209|FG001|Overall Study|Other|1
7433308|NCT01592292|11715210|FG002|Overall Study|Other|2
7433309|NCT01592292|11715211|FG003|Overall Study|Other|1
7433310|NCT01592344|11715219|FG000|Overall Study|Adverse Event|1
7433311|NCT01592344|11715220|FG001|Overall Study|Adverse Event|1
7433312|NCT01592344|11715219|FG000|Overall Study|Lack of Efficacy|1
7433313|NCT01592344|11715220|FG001|Overall Study|Lack of Efficacy|0
7433314|NCT01592344|11715219|FG000|Overall Study|not available at primary outcome visit|2
7433315|NCT01592344|11715220|FG001|Overall Study|not available at primary outcome visit|4
7433316|NCT01592409|11715238|FG000|Overall Study|Withdrawal by Subject|0
7433317|NCT01592409|11715239|FG001|Overall Study|Withdrawal by Subject|1
7433318|NCT01592695|11715270|FG000|Overall Study|Lost to Follow-up|8
7433319|NCT01592695|11715271|FG001|Overall Study|Lost to Follow-up|4
7433320|NCT01592708|11715279|FG000|Overall Study|Protocol Violation|3
7433321|NCT01592708|11715280|FG001|Overall Study|Protocol Violation|0
7433322|NCT01592747|11715292|FG000|Overall Study|Loss of Therapeutic Response|107
7433323|NCT01592747|11715293|FG001|Overall Study|Loss of Therapeutic Response|108
7433324|NCT01592747|11715294|FG002|Overall Study|Loss of Therapeutic Response|100
7433325|NCT01592747|11715292|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7433326|NCT01592747|11715293|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7433327|NCT01592747|11715294|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
7433328|NCT01592747|11715292|FG000|Overall Study|Adverse Event|1
7433329|NCT01592747|11715293|FG001|Overall Study|Adverse Event|0
7433330|NCT01592747|11715294|FG002|Overall Study|Adverse Event|0
7433331|NCT01592747|11715292|FG000|Overall Study|Protocol Violation|4
7433332|NCT01592747|11715293|FG001|Overall Study|Protocol Violation|0
7433333|NCT01592747|11715294|FG002|Overall Study|Protocol Violation|4
7433334|NCT01592747|11715292|FG000|Overall Study|Lack of Efficacy|0
7433335|NCT01592747|11715293|FG001|Overall Study|Lack of Efficacy|1
7433336|NCT01592747|11715294|FG002|Overall Study|Lack of Efficacy|0
7433337|NCT01592747|11715292|FG000|Overall Study|Withdrawal by Subject|2
7433338|NCT01592747|11715293|FG001|Overall Study|Withdrawal by Subject|0
7433339|NCT01592747|11715294|FG002|Overall Study|Withdrawal by Subject|2
7433340|NCT01592747|11715292|FG000|Overall Study|Lost to Follow-up|1
7433341|NCT01592747|11715293|FG001|Overall Study|Lost to Follow-up|0
7433342|NCT01592747|11715294|FG002|Overall Study|Lost to Follow-up|1
7433343|NCT01592747|11715292|FG000|Overall Study|Other Reasons|1
7433344|NCT01592747|11715293|FG001|Overall Study|Other Reasons|1
7433345|NCT01592747|11715294|FG002|Overall Study|Other Reasons|0
7433346|NCT01592760|11715306|FG000|24-hour Follow-Up|Lost to Follow-up|4
7433347|NCT01592760|11715307|FG001|24-hour Follow-Up|Lost to Follow-up|3
7433348|NCT01592760|11715308|FG002|24-hour Follow-Up|Lost to Follow-up|2
7433349|NCT01592773|11715319|FG000|Overall Study|Study Terminated by Sponsor|582
7433350|NCT01592773|11715319|FG000|Overall Study|Withdrawal by Subject|35
7433351|NCT01592773|11715319|FG000|Overall Study|Lost to Follow-up|19
7433352|NCT01592773|11715319|FG000|Overall Study|Adverse Event|17
7433353|NCT01592773|11715319|FG000|Overall Study|Lack of Efficacy|9
7433354|NCT01592773|11715319|FG000|Overall Study|Protocol Violation|2
7433355|NCT01592773|11715319|FG000|Overall Study|Inclusion/exclusion not meet|1
7433356|NCT01592773|11715319|FG000|Overall Study|Other Reason|1
7433357|NCT01592786|11715323|FG000|Overall Study|Adverse Event|60
7433358|NCT01592786|11715323|FG000|Overall Study|Lack of Efficacy|19
7433359|NCT01592786|11715323|FG000|Overall Study|Protocol Violation|14
7433360|NCT01592786|11715323|FG000|Overall Study|Withdrawal by Subject|23
7433361|NCT01592786|11715323|FG000|Overall Study|Lost to Follow-up|19
7433362|NCT01592786|11715323|FG000|Overall Study|Other|3
7433363|NCT01592864|11715344|FG000|Overall Study|Withdrawal by Subject|0
7433364|NCT01592864|11715345|FG001|Overall Study|Withdrawal by Subject|1
7433365|NCT01593020|11715353|FG000|Overall Study|Adverse Event|1
7433366|NCT01593020|11715354|FG001|Overall Study|Adverse Event|1
7433367|NCT01593020|11715353|FG000|Overall Study|Death|0
7433368|NCT01593020|11715354|FG001|Overall Study|Death|1
7433369|NCT01593020|11715353|FG000|Overall Study|Ineligible|1
7433370|NCT01593020|11715354|FG001|Overall Study|Ineligible|0
7433371|NCT01593696|11715386|FG000|Dose Escalation|Progressive Disease|2
7433372|NCT01593696|11715387|FG001|Dose Escalation|Progressive Disease|0
7433373|NCT01593696|11715388|FG002|Dose Escalation|Progressive Disease|0
7433374|NCT01593696|11715389|FG003|Dose Escalation|Progressive Disease|0
7433375|NCT01593696|11715386|FG000|Dose Expansion|Fungal infection|0
7433376|NCT01593696|11715387|FG001|Dose Expansion|Fungal infection|0
7433377|NCT01593696|11715388|FG002|Dose Expansion|Fungal infection|1
7433378|NCT01593696|11715389|FG003|Dose Expansion|Fungal infection|0
7433379|NCT01593787|11715422|FG000|Overall Study|Adverse Event|1
7433380|NCT01593787|11715423|FG001|Overall Study|Adverse Event|0
7433381|NCT01593787|11715424|FG002|Overall Study|Adverse Event|0
7433382|NCT01593917|11715434|FG000|Overall Study|Death|67
7433383|NCT01593917|11715434|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
7433384|NCT01593917|11715434|FG000|Overall Study|Withdrawal by Subject|23
7433385|NCT01593917|11715434|FG000|Overall Study|Lost to Follow-up|12
7433386|NCT01593917|11715434|FG000|Overall Study|Protocol Violation|5
7433387|NCT01593917|11715434|FG000|Overall Study|Physician Decision|3
7433388|NCT01594125|11715443|FG000|Overall Study|Withdrawal by Subject|1
7433389|NCT01594125|11715444|FG001|Overall Study|Withdrawal by Subject|0
7433390|NCT01594125|11715445|FG002|Overall Study|Withdrawal by Subject|0
7433391|NCT01594125|11715446|FG003|Overall Study|Withdrawal by Subject|1
7433392|NCT01594125|11715447|FG004|Overall Study|Withdrawal by Subject|0
7433393|NCT01594125|11715443|FG000|Overall Study|Progressive Disease|3
7433394|NCT01594125|11715444|FG001|Overall Study|Progressive Disease|12
7433395|NCT01594125|11715445|FG002|Overall Study|Progressive Disease|3
7433396|NCT01594125|11715446|FG003|Overall Study|Progressive Disease|3
7433397|NCT01594125|11715447|FG004|Overall Study|Progressive Disease|7
7433398|NCT01594281|11715462|FG000|Interventional Core Phase|Protocol Deviation|1
7433399|NCT01594281|11715463|FG001|Interventional Core Phase|Protocol Deviation|0
7433400|NCT01594281|11715464|FG002|Interventional Core Phase|Protocol Deviation|0
7433401|NCT01594281|11715462|FG000|Interventional Core Phase|Subject Withdrew Consent|0
7433402|NCT01594281|11715463|FG001|Interventional Core Phase|Subject Withdrew Consent|1
7433403|NCT01594281|11715464|FG002|Interventional Core Phase|Subject Withdrew Consent|1
7433404|NCT01594281|11715462|FG000|Interventional Core Phase|Death|1
7433405|NCT01594281|11715463|FG001|Interventional Core Phase|Death|1
7433406|NCT01594281|11715464|FG002|Interventional Core Phase|Death|2
7433407|NCT01594281|11715462|FG000|Interventional Core Phase|Lost to Follow-up|1
7433408|NCT01594281|11715463|FG001|Interventional Core Phase|Lost to Follow-up|4
7433409|NCT01594281|11715464|FG002|Interventional Core Phase|Lost to Follow-up|1
7433410|NCT01594281|11715462|FG000|Interventional Core Phase|Adverse Event|4
7433411|NCT01594281|11715463|FG001|Interventional Core Phase|Adverse Event|4
7433412|NCT01594281|11715464|FG002|Interventional Core Phase|Adverse Event|4
7433413|NCT01594281|11715462|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7433414|NCT01594281|11715463|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
7433415|NCT01594281|11715464|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
7433416|NCT01594281|11715462|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
7433417|NCT01594281|11715463|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
7433418|NCT01594281|11715464|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
7433419|NCT01594281|11715462|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7433420|NCT01594281|11715463|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
7433421|NCT01594281|11715464|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
7433422|NCT01594333|11715486|FG000|Overall Study|Death|96
7433423|NCT01594333|11715487|FG001|Overall Study|Death|83
7433424|NCT01594333|11715486|FG000|Overall Study|Lost to Follow-up|5
7433425|NCT01594333|11715487|FG001|Overall Study|Lost to Follow-up|5
7433426|NCT01594333|11715486|FG000|Overall Study|Withdrawal by Subject|60
7433427|NCT01594333|11715487|FG001|Overall Study|Withdrawal by Subject|63
7433428|NCT01594411|11715506|FG000|Overall Study|Lost to Follow-up|2
7433429|NCT01594476|11715519|FG000|Overall Study|Protocol Violation|1
7433430|NCT01594476|11715520|FG001|Overall Study|Protocol Violation|3
7433431|NCT01594749|11715584|FG000|Overall Study|Adverse Event|2
7433432|NCT01594749|11715585|FG001|Overall Study|Adverse Event|1
7433433|NCT01594749|11715584|FG000|Overall Study|Withdrawal by Subject|2
7433434|NCT01594749|11715585|FG001|Overall Study|Withdrawal by Subject|2
7433435|NCT01594749|11715584|FG000|Overall Study|Protocol Violation|2
7433436|NCT01594749|11715585|FG001|Overall Study|Protocol Violation|0
7433437|NCT01594749|11715584|FG000|Overall Study|Physician Decision|1
7433438|NCT01594749|11715585|FG001|Overall Study|Physician Decision|1
7433439|NCT01594749|11715584|FG000|Overall Study|Non-compliance with Protocol|0
7433440|NCT01594749|11715585|FG001|Overall Study|Non-compliance with Protocol|1
7433441|NCT01594749|11715584|FG000|Overall Study|Lost to Follow-up|1
7433442|NCT01594749|11715585|FG001|Overall Study|Lost to Follow-up|0
7433443|NCT01594749|11715584|FG000|Overall Study|Death|9
7433444|NCT01594749|11715585|FG001|Overall Study|Death|3
7433445|NCT01594749|11715584|FG000|Overall Study|Not Treated|4
7433446|NCT01594749|11715585|FG001|Overall Study|Not Treated|10
7433447|NCT01594749|11715584|FG000|Overall Study|Lost Source Documentation|1
7433448|NCT01594749|11715585|FG001|Overall Study|Lost Source Documentation|0
7433449|NCT01594762|11715593|FG000|Overall Study|Withdrawal by Subject|1
7433450|NCT01594762|11715594|FG001|Overall Study|Withdrawal by Subject|0
7433451|NCT01594762|11715593|FG000|Overall Study|Lost to Follow-up|10
7433452|NCT01594762|11715594|FG001|Overall Study|Lost to Follow-up|10
7433453|NCT01594827|11715602|FG000|Overall Study|Adverse Event|1
7433454|NCT01594827|11715603|FG001|Overall Study|Adverse Event|0
7433455|NCT01594827|11715602|FG000|Overall Study|Physician Decision|3
7433456|NCT01594827|11715603|FG001|Overall Study|Physician Decision|0
7433457|NCT01594853|11715613|FG000|Overall Study|Withdrawal by Subject|1
7433458|NCT01594853|11715614|FG001|Overall Study|Withdrawal by Subject|1
7433459|NCT01594853|11715613|FG000|Overall Study|Lost to Follow-up|1
7433460|NCT01594853|11715614|FG001|Overall Study|Lost to Follow-up|1
7433461|NCT01594853|11715613|FG000|Overall Study|noncompliance with exercise|0
7433462|NCT01594853|11715614|FG001|Overall Study|noncompliance with exercise|1
7433463|NCT01594931|11715623|FG000|Overall Study|Adverse Event|3
7433464|NCT01594931|11715624|FG001|Overall Study|Adverse Event|1
7433465|NCT01594931|11715625|FG002|Overall Study|Adverse Event|1
7433466|NCT01594931|11715623|FG000|Overall Study|Withdrawal by Subject|2
7433467|NCT01594931|11715624|FG001|Overall Study|Withdrawal by Subject|1
7433468|NCT01594931|11715625|FG002|Overall Study|Withdrawal by Subject|1
7433469|NCT01594931|11715623|FG000|Overall Study|Lack of Efficacy|7
7433470|NCT01594931|11715624|FG001|Overall Study|Lack of Efficacy|2
7433471|NCT01594931|11715625|FG002|Overall Study|Lack of Efficacy|2
7433472|NCT01594931|11715623|FG000|Overall Study|Lost to Follow-up|4
7433473|NCT01594931|11715624|FG001|Overall Study|Lost to Follow-up|3
7433474|NCT01594931|11715625|FG002|Overall Study|Lost to Follow-up|3
7433475|NCT01594931|11715623|FG000|Overall Study|Protocol Violation|2
7433476|NCT01594931|11715624|FG001|Overall Study|Protocol Violation|1
7433477|NCT01594931|11715625|FG002|Overall Study|Protocol Violation|0
7433478|NCT01594931|11715623|FG000|Overall Study|No defiined|11
7433479|NCT01594931|11715624|FG001|Overall Study|No defiined|4
7433480|NCT01594931|11715625|FG002|Overall Study|No defiined|7
7433481|NCT01594970|11715636|FG000|Overall Study|Non-Adverse Event Related|4
7433482|NCT01594970|11715637|FG001|Overall Study|Non-Adverse Event Related|5
7433483|NCT01594970|11715638|FG002|Overall Study|Non-Adverse Event Related|6
7433484|NCT01594970|11715636|FG000|Overall Study|Adverse Event|17
7433485|NCT01594970|11715637|FG001|Overall Study|Adverse Event|23
7433486|NCT01594970|11715638|FG002|Overall Study|Adverse Event|23
7433487|NCT01594970|11715636|FG000|Overall Study|Lost to Follow-up|54
7433488|NCT01594970|11715637|FG001|Overall Study|Lost to Follow-up|54
7433489|NCT01594970|11715638|FG002|Overall Study|Lost to Follow-up|37
7433490|NCT01595438|11715666|FG000|Overall Study|Lost to Follow-up|20
7433491|NCT01595438|11715667|FG001|Overall Study|Lost to Follow-up|20
7433492|NCT01595438|11715666|FG000|Overall Study|Withdrawal by Subject|12
7433493|NCT01595438|11715667|FG001|Overall Study|Withdrawal by Subject|12
7433494|NCT01595438|11715666|FG000|Overall Study|Other Eligibility criteria|11
7433495|NCT01595438|11715667|FG001|Overall Study|Other Eligibility criteria|9
7433496|NCT01595529|11715702|FG000|Overall Study|Adverse Event|2
7433497|NCT01595529|11715703|FG001|Overall Study|Adverse Event|0
7433498|NCT01595529|11715702|FG000|Overall Study|Subject Non-Compliant|2
7433499|NCT01595529|11715703|FG001|Overall Study|Subject Non-Compliant|0
7433500|NCT01595529|11715702|FG000|Overall Study|Lost to Follow-up|8
7433501|NCT01595529|11715703|FG001|Overall Study|Lost to Follow-up|14
7433502|NCT01595529|11715702|FG000|Overall Study|Protocol Violation|1
7433503|NCT01595529|11715703|FG001|Overall Study|Protocol Violation|2
7433504|NCT01595529|11715702|FG000|Overall Study|Physician Decision|1
7433505|NCT01595529|11715703|FG001|Overall Study|Physician Decision|0
7433506|NCT01595529|11715702|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7433507|NCT01595529|11715703|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
7433508|NCT01595529|11715702|FG000|Overall Study|Administrative Decision|1
7433509|NCT01595529|11715703|FG001|Overall Study|Administrative Decision|0
7433510|NCT01595529|11715702|FG000|Overall Study|Entry Failure/Screening Failure|6
7433511|NCT01595529|11715703|FG001|Overall Study|Entry Failure/Screening Failure|1
7433512|NCT01595646|11715712|FG000|Overall Study|Withdrawal by Subject|1
7433513|NCT01595646|11715713|FG001|Overall Study|Withdrawal by Subject|0
7433514|NCT01595646|11715714|FG002|Overall Study|Withdrawal by Subject|0
7433515|NCT01596062|11715755|FG000|Overall Study|Adverse Event|1
7433516|NCT01596062|11715756|FG001|Overall Study|Adverse Event|0
7433517|NCT01596062|11715757|FG002|Overall Study|Adverse Event|2
7433518|NCT01596062|11715755|FG000|Overall Study|Lack of Efficacy|0
7433519|NCT01596062|11715756|FG001|Overall Study|Lack of Efficacy|0
7433520|NCT01596062|11715757|FG002|Overall Study|Lack of Efficacy|1
7433521|NCT01596127|11715769|FG000|Overall Study|Patient Ineligible|1
7433522|NCT01596335|11715795|FG000|Overall Study|exacerbation of primary disease|5
7433523|NCT01596335|11715796|FG001|Overall Study|exacerbation of primary disease|9
7433524|NCT01596504|11715805|FG000|Overall Study|Participant's Private Reason|0
7433525|NCT01596504|11715806|FG001|Overall Study|Participant's Private Reason|1
7433526|NCT01596504|11715807|FG002|Overall Study|Participant's Private Reason|0
7433527|NCT01596504|11715805|FG000|Overall Study|Adverse Event|1
7433528|NCT01596504|11715806|FG001|Overall Study|Adverse Event|2
7433529|NCT01596504|11715807|FG002|Overall Study|Adverse Event|1
7433530|NCT01596504|11715805|FG000|Overall Study|Withdrawal by Subject|1
7433531|NCT01596504|11715806|FG001|Overall Study|Withdrawal by Subject|0
7433532|NCT01596504|11715807|FG002|Overall Study|Withdrawal by Subject|0
7433533|NCT01596582|11715818|FG000|Overall Study|Deemed ineligible after study visit|3
7433534|NCT01596582|11715819|FG001|Overall Study|Deemed ineligible after study visit|6
7433535|NCT01596582|11715818|FG000|Overall Study|Missing all outcome data|1
7433536|NCT01596582|11715819|FG001|Overall Study|Missing all outcome data|1
7433537|NCT01596972|11715890|FG000|Overall Study|Physician Decision|1
7433538|NCT01596972|11715891|FG001|Overall Study|Physician Decision|9
7433539|NCT01596972|11715890|FG000|Overall Study|Lost to Follow-up|0
7433540|NCT01596972|11715891|FG001|Overall Study|Lost to Follow-up|4
7433541|NCT01596972|11715890|FG000|Overall Study|Withdrawal by Subject|0
7433542|NCT01596972|11715891|FG001|Overall Study|Withdrawal by Subject|1
7433543|NCT01597050|11715899|FG000|Overall Study|Withdrawal by Subject|1
7433544|NCT01597050|11715900|FG001|Overall Study|Withdrawal by Subject|0
7433545|NCT01597193|11715933|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
7433546|NCT01597193|11715934|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
7433547|NCT01597193|11715935|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7433548|NCT01597193|11715936|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7433549|NCT01597193|11715937|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7433550|NCT01597193|11715938|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7433551|NCT01597193|11715939|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
7433552|NCT01597193|11715933|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7433553|NCT01597193|11715934|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7433554|NCT01597193|11715935|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7433555|NCT01597193|11715936|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
7433556|NCT01597193|11715937|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
7433557|NCT01597193|11715938|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
7433558|NCT01597193|11715939|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
7433559|NCT01597193|11715933|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7433560|NCT01597193|11715934|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
7433561|NCT01597193|11715935|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7433562|NCT01597193|11715936|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7433563|NCT01597193|11715937|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
7433564|NCT01597193|11715938|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
7433565|NCT01597193|11715939|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
7433566|NCT01597193|11715933|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
7433567|NCT01597193|11715934|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
7433568|NCT01597193|11715935|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
7433569|NCT01597193|11715936|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
7433570|NCT01597193|11715937|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
7433571|NCT01597193|11715938|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
7433572|NCT01597193|11715939|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
7433573|NCT01597193|11715933|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7433574|NCT01597193|11715934|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7433575|NCT01597193|11715935|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7433576|NCT01597193|11715936|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7433577|NCT01597193|11715937|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7433578|NCT01597193|11715938|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
7433579|NCT01597193|11715939|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
7433580|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
7433581|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
7433582|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
7433583|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
7433584|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433585|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433586|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433587|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
7559135|NCT03137992|11924999|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
7433588|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433589|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433590|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433591|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433592|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433593|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433594|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433595|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433596|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433597|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433598|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433599|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433600|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
7433601|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7433602|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
7433603|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
7433604|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
7433605|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433606|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433607|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433608|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433609|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433610|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433611|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433612|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433613|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433614|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433615|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433616|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433617|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433618|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433619|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433620|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433621|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
7433622|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7433623|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
7433624|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
7433625|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
7433626|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433627|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433628|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433629|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433630|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433631|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433632|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433633|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433634|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433635|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433636|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433637|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433638|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433639|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433640|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433641|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433642|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
7433643|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
7532524|NCT02672553|11878270|FG000|Overall Study|Valve Explant|1
7532525|NCT02672553|11878271|FG001|Overall Study|Valve Explant|0
7532526|NCT02672553|11878270|FG000|Overall Study|Conversion to Commercial Valve|3
7532527|NCT02672553|11878271|FG001|Overall Study|Conversion to Commercial Valve|0
7532528|NCT02672553|11878270|FG000|Overall Study|Withdrawal by Subject|3
7532529|NCT02672553|11878271|FG001|Overall Study|Withdrawal by Subject|3
7532530|NCT02672553|11878270|FG000|Overall Study|Intraoperative screen failure|2
7532531|NCT02672553|11878271|FG001|Overall Study|Intraoperative screen failure|0
7532532|NCT02672852|11878280|FG000|Part A1|Disease Worsening|1
7532533|NCT02672852|11878281|FG001|Part A1|Disease Worsening|0
7532534|NCT02672852|11878282|FG002|Part A1|Disease Worsening|0
7532535|NCT02672852|11878283|FG003|Part A1|Disease Worsening|0
7532536|NCT02672852|11878284|FG004|Part A1|Disease Worsening|0
7433644|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
7433645|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
7433646|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433647|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433648|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433649|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433650|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433651|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433652|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7467169|NCT01898884|11767506|FG001|Multiple Dose Period|Adverse Event|0
7467170|NCT01898884|11767507|FG002|Multiple Dose Period|Adverse Event|0
7467171|NCT01898884|11767508|FG003|Multiple Dose Period|Adverse Event|0
7467172|NCT01898884|11767509|FG004|Multiple Dose Period|Adverse Event|0
7467173|NCT01898884|11767510|FG005|Multiple Dose Period|Adverse Event|0
7433653|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433654|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433655|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433656|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433657|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433658|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433659|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433660|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433661|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433662|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433663|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
7433664|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
7433665|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433666|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433667|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
7433668|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433669|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433670|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433671|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433672|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433673|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433674|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433675|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433676|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433677|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433678|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433679|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433680|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433681|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433682|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433683|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433684|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
7433685|NCT01597245|11715964|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7433686|NCT01597245|11715965|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
7433687|NCT01597245|11715966|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
7433688|NCT01597245|11715967|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433689|NCT01597245|11715968|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433690|NCT01597245|11715969|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433691|NCT01597245|11715970|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433692|NCT01597245|11715971|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433693|NCT01597245|11715972|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433694|NCT01597245|11715973|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433695|NCT01597245|11715974|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433696|NCT01597245|11715975|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433697|NCT01597245|11715976|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433698|NCT01597245|11715977|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433699|NCT01597245|11715978|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433700|NCT01597245|11715979|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433701|NCT01597245|11715980|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433702|NCT01597245|11715981|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433703|NCT01597245|11715982|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433704|NCT01597245|11715983|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433705|NCT01597245|11715984|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
7433706|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433707|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433708|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433709|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433710|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433711|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7433712|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
7433713|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433714|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433715|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433716|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433717|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433718|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433719|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433720|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433721|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433722|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433723|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433724|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433725|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7532614|NCT02672852|11878285|FG005|Part B|Worsening pre-existing condition|1
7433726|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
7433727|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433728|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433729|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433730|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433731|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
7433732|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
7433733|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
7433734|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
7433735|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433736|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
7433737|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433738|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433739|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433740|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433741|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433742|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433743|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433744|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433745|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433746|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433747|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
7433748|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433749|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433750|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433751|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433752|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433753|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
7433754|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433755|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433756|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
7433757|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433758|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
7433759|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
7433760|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
7433761|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7532537|NCT02672852|11878285|FG005|Part A1|Disease Worsening|0
7532538|NCT02672852|11878286|FG006|Part A1|Disease Worsening|0
7532539|NCT02672852|11878280|FG000|Part A1|Adverse Event|0
7532540|NCT02672852|11878281|FG001|Part A1|Adverse Event|1
7532541|NCT02672852|11878282|FG002|Part A1|Adverse Event|0
7532542|NCT02672852|11878283|FG003|Part A1|Adverse Event|0
7532543|NCT02672852|11878284|FG004|Part A1|Adverse Event|0
7532544|NCT02672852|11878285|FG005|Part A1|Adverse Event|0
7532545|NCT02672852|11878286|FG006|Part A1|Adverse Event|0
7532546|NCT02672852|11878280|FG000|Part A1|Lost to Follow-up|1
7532547|NCT02672852|11878281|FG001|Part A1|Lost to Follow-up|2
7532548|NCT02672852|11878282|FG002|Part A1|Lost to Follow-up|0
7532549|NCT02672852|11878283|FG003|Part A1|Lost to Follow-up|0
7532550|NCT02672852|11878284|FG004|Part A1|Lost to Follow-up|0
7433762|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433763|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433764|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433765|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433766|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433767|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433768|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
7433769|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433770|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433771|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433772|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433773|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
7433774|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7433775|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
7433776|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7532551|NCT02672852|11878285|FG005|Part A1|Lost to Follow-up|0
7532552|NCT02672852|11878286|FG006|Part A1|Lost to Follow-up|0
7532553|NCT02672852|11878280|FG000|Part A1|Withdrawal by Subject|1
7532554|NCT02672852|11878281|FG001|Part A1|Withdrawal by Subject|1
7532555|NCT02672852|11878282|FG002|Part A1|Withdrawal by Subject|0
7532556|NCT02672852|11878283|FG003|Part A1|Withdrawal by Subject|0
7433777|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7532557|NCT02672852|11878284|FG004|Part A1|Withdrawal by Subject|0
7532558|NCT02672852|11878285|FG005|Part A1|Withdrawal by Subject|0
7532559|NCT02672852|11878286|FG006|Part A1|Withdrawal by Subject|0
7433778|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7433779|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
7433780|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
7433781|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
7433782|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433783|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433784|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433785|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433786|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433787|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433788|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433789|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
7433790|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433791|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433792|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433793|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433794|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7433795|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
7433796|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7433797|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433798|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7433799|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
7433800|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
7433801|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
7433802|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
7433803|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433804|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433805|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433806|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433807|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433808|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433809|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433810|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
7433811|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433812|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433813|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433814|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433815|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7433816|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433817|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433818|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433819|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
7433820|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7433821|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
7433822|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433823|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
7433824|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433825|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433826|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433827|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433828|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433829|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433830|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433831|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
7433832|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433833|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433834|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433835|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433836|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
7433837|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
7433838|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7532560|NCT02672852|11878280|FG000|Part A2|Disease worsening|0
7532561|NCT02672852|11878281|FG001|Part A2|Disease worsening|0
7532562|NCT02672852|11878282|FG002|Part A2|Disease worsening|1
7433839|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433840|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7433841|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7433842|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7433843|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
7433844|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
7433845|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433846|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433847|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433848|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433849|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433850|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433851|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433852|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
7433853|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433854|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433855|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433856|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433857|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433858|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7433859|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433860|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433861|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7433862|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7433863|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7433864|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
7433865|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433866|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433867|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433868|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433869|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433870|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433871|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433872|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433873|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
7433874|NCT01597245|11715964|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433875|NCT01597245|11715965|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433876|NCT01597245|11715966|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433877|NCT01597245|11715967|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433878|NCT01597245|11715968|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433879|NCT01597245|11715969|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433880|NCT01597245|11715970|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433881|NCT01597245|11715971|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433882|NCT01597245|11715972|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433883|NCT01597245|11715973|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433884|NCT01597245|11715974|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
7433885|NCT01597245|11715975|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433886|NCT01597245|11715976|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433887|NCT01597245|11715977|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433888|NCT01597245|11715978|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433889|NCT01597245|11715979|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433890|NCT01597245|11715980|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433891|NCT01597245|11715981|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433892|NCT01597245|11715982|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433893|NCT01597245|11715983|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433894|NCT01597245|11715984|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
7433895|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433896|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433897|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433898|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433899|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433900|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433901|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433902|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433903|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433904|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433905|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433906|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433907|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433908|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
7433909|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
7433910|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
7433911|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433912|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7532615|NCT02672852|11878286|FG006|Part B|Worsening pre-existing condition|0
7433913|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433914|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433915|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
7433916|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433917|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433918|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433919|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433920|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433921|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433922|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433923|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433924|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433925|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433926|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433927|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433928|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433929|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
7433930|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
7433931|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
7433932|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433933|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433934|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433935|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433936|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
7433937|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433938|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433939|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433940|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433941|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433942|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433943|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433944|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433945|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433946|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433947|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433948|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433949|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433950|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433951|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7433952|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
7433953|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433954|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433955|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433956|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433957|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
7433958|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433959|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433960|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433961|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433962|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433963|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433964|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433965|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433966|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433967|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433968|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7532563|NCT02672852|11878283|FG003|Part A2|Disease worsening|0
7532564|NCT02672852|11878284|FG004|Part A2|Disease worsening|0
7532565|NCT02672852|11878285|FG005|Part A2|Disease worsening|0
7532566|NCT02672852|11878286|FG006|Part A2|Disease worsening|0
7532567|NCT02672852|11878280|FG000|Part A2|Adverse Event|0
7532568|NCT02672852|11878281|FG001|Part A2|Adverse Event|0
7532569|NCT02672852|11878282|FG002|Part A2|Adverse Event|3
7532570|NCT02672852|11878283|FG003|Part A2|Adverse Event|0
7433969|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433970|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433971|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433972|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7433973|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
7433974|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433975|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433976|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433977|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433978|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
7433979|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433980|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433981|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433982|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433983|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433984|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433985|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433986|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433987|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433988|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433989|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433990|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433991|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433992|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
7433993|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
7433994|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
7433995|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433996|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433997|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433998|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7433999|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
7434000|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
7434001|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
7434002|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
7434003|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
7434004|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
7434005|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
7434006|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
7434007|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
7434008|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
7532571|NCT02672852|11878284|FG004|Part A2|Adverse Event|0
7532572|NCT02672852|11878285|FG005|Part A2|Adverse Event|0
7532573|NCT02672852|11878286|FG006|Part A2|Adverse Event|0
7532574|NCT02672852|11878280|FG000|Part A2|Lost to Follow-up|0
7532575|NCT02672852|11878281|FG001|Part A2|Lost to Follow-up|0
7532576|NCT02672852|11878282|FG002|Part A2|Lost to Follow-up|2
7532577|NCT02672852|11878283|FG003|Part A2|Lost to Follow-up|0
7532578|NCT02672852|11878284|FG004|Part A2|Lost to Follow-up|0
7532579|NCT02672852|11878285|FG005|Part A2|Lost to Follow-up|0
7532580|NCT02672852|11878286|FG006|Part A2|Lost to Follow-up|0
7532581|NCT02672852|11878280|FG000|Part A2|Withdrawal by Subject|0
7532582|NCT02672852|11878281|FG001|Part A2|Withdrawal by Subject|0
7532583|NCT02672852|11878282|FG002|Part A2|Withdrawal by Subject|1
7532584|NCT02672852|11878283|FG003|Part A2|Withdrawal by Subject|0
7532585|NCT02672852|11878284|FG004|Part A2|Withdrawal by Subject|0
7532586|NCT02672852|11878285|FG005|Part A2|Withdrawal by Subject|0
7532587|NCT02672852|11878286|FG006|Part A2|Withdrawal by Subject|0
7532588|NCT02672852|11878280|FG000|Part A2|Other|0
7532589|NCT02672852|11878281|FG001|Part A2|Other|0
7532590|NCT02672852|11878282|FG002|Part A2|Other|3
7532591|NCT02672852|11878283|FG003|Part A2|Other|0
7532592|NCT02672852|11878284|FG004|Part A2|Other|0
7532593|NCT02672852|11878285|FG005|Part A2|Other|0
7532594|NCT02672852|11878286|FG006|Part A2|Other|0
7434009|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
7434010|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
7532595|NCT02672852|11878280|FG000|Part A2|Not entered in Part B|0
7532596|NCT02672852|11878281|FG001|Part A2|Not entered in Part B|0
7532597|NCT02672852|11878282|FG002|Part A2|Not entered in Part B|0
7532598|NCT02672852|11878283|FG003|Part A2|Not entered in Part B|4
7532599|NCT02672852|11878284|FG004|Part A2|Not entered in Part B|0
7532600|NCT02672852|11878285|FG005|Part A2|Not entered in Part B|0
7532601|NCT02672852|11878286|FG006|Part A2|Not entered in Part B|0
7532602|NCT02672852|11878280|FG000|Part B|Disease worsening|0
7532603|NCT02672852|11878281|FG001|Part B|Disease worsening|0
7532604|NCT02672852|11878282|FG002|Part B|Disease worsening|0
7532605|NCT02672852|11878283|FG003|Part B|Disease worsening|0
7532606|NCT02672852|11878284|FG004|Part B|Disease worsening|1
7532607|NCT02672852|11878285|FG005|Part B|Disease worsening|0
7532608|NCT02672852|11878286|FG006|Part B|Disease worsening|1
7532609|NCT02672852|11878280|FG000|Part B|Worsening pre-existing condition|0
7532610|NCT02672852|11878281|FG001|Part B|Worsening pre-existing condition|0
7532611|NCT02672852|11878282|FG002|Part B|Worsening pre-existing condition|0
7532612|NCT02672852|11878283|FG003|Part B|Worsening pre-existing condition|0
7532613|NCT02672852|11878284|FG004|Part B|Worsening pre-existing condition|0
7532616|NCT02672852|11878280|FG000|Part B|Other adverse event|0
7532617|NCT02672852|11878281|FG001|Part B|Other adverse event|0
7532618|NCT02672852|11878282|FG002|Part B|Other adverse event|0
7532619|NCT02672852|11878283|FG003|Part B|Other adverse event|0
7532620|NCT02672852|11878284|FG004|Part B|Other adverse event|3
7532621|NCT02672852|11878285|FG005|Part B|Other adverse event|5
7532622|NCT02672852|11878286|FG006|Part B|Other adverse event|1
7532623|NCT02672852|11878280|FG000|Part B|Lost to Follow-up|0
7532624|NCT02672852|11878281|FG001|Part B|Lost to Follow-up|0
7532625|NCT02672852|11878282|FG002|Part B|Lost to Follow-up|0
7532626|NCT02672852|11878283|FG003|Part B|Lost to Follow-up|0
7532627|NCT02672852|11878284|FG004|Part B|Lost to Follow-up|3
7532628|NCT02672852|11878285|FG005|Part B|Lost to Follow-up|4
7532629|NCT02672852|11878286|FG006|Part B|Lost to Follow-up|1
7532630|NCT02672852|11878280|FG000|Part B|Withdrawal by Subject|0
7532631|NCT02672852|11878281|FG001|Part B|Withdrawal by Subject|0
7532632|NCT02672852|11878282|FG002|Part B|Withdrawal by Subject|0
7532633|NCT02672852|11878283|FG003|Part B|Withdrawal by Subject|0
7532634|NCT02672852|11878284|FG004|Part B|Withdrawal by Subject|5
7532635|NCT02672852|11878285|FG005|Part B|Withdrawal by Subject|0
7532636|NCT02672852|11878286|FG006|Part B|Withdrawal by Subject|7
7532637|NCT02672852|11878280|FG000|Part B|Other|0
7532638|NCT02672852|11878281|FG001|Part B|Other|0
7532639|NCT02672852|11878282|FG002|Part B|Other|0
7532640|NCT02672852|11878283|FG003|Part B|Other|0
7532641|NCT02672852|11878284|FG004|Part B|Other|4
7532642|NCT02672852|11878285|FG005|Part B|Other|1
7532643|NCT02672852|11878286|FG006|Part B|Other|2
7532644|NCT02673489|11878314|FG000|Treatment Period|Lost to Follow-up|3
7532645|NCT02673489|11878315|FG001|Treatment Period|Lost to Follow-up|0
7532646|NCT02673489|11878314|FG000|Treatment Period|Participant request to discontinue|1
7532647|NCT02673489|11878315|FG001|Treatment Period|Participant request to discontinue|1
7532648|NCT02673489|11878314|FG000|Treatment Period|Participant moved to another province|1
7532649|NCT02673489|11878315|FG001|Treatment Period|Participant moved to another province|0
7532650|NCT02673489|11878314|FG000|Treatment Period|Participant was incarcerated|0
7532651|NCT02673489|11878315|FG001|Treatment Period|Participant was incarcerated|1
7532652|NCT02673489|11878314|FG000|Treatment Period|Adverse Event|0
7532653|NCT02673489|11878315|FG001|Treatment Period|Adverse Event|1
7532654|NCT02673489|11878314|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
7532655|NCT02673489|11878315|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
7532656|NCT02673489|11878314|FG000|Follow Up Period|Unable to return for follow-up|0
7532657|NCT02673489|11878315|FG001|Follow Up Period|Unable to return for follow-up|1
7532658|NCT02673515|11878324|FG000|Overall Study|Lack of motivation|2
7532659|NCT02673515|11878325|FG001|Overall Study|Lack of motivation|1
7532660|NCT02673619|11878344|FG000|Overall Study|Lost to Follow-up|1
7532661|NCT02673619|11878345|FG001|Overall Study|Lost to Follow-up|0
7532662|NCT02673619|11878346|FG002|Overall Study|Lost to Follow-up|0
7532663|NCT02673619|11878347|FG003|Overall Study|Lost to Follow-up|0
7532664|NCT02673619|11878344|FG000|Overall Study|Withdrawal by Subject|1
7532665|NCT02673619|11878345|FG001|Overall Study|Withdrawal by Subject|1
7532666|NCT02673619|11878346|FG002|Overall Study|Withdrawal by Subject|1
7532667|NCT02673619|11878347|FG003|Overall Study|Withdrawal by Subject|0
7532668|NCT02673619|11878344|FG000|Overall Study|Adverse Event|0
7532669|NCT02673619|11878345|FG001|Overall Study|Adverse Event|0
7532670|NCT02673619|11878346|FG002|Overall Study|Adverse Event|1
7532671|NCT02673619|11878347|FG003|Overall Study|Adverse Event|0
7532672|NCT02673619|11878344|FG000|Overall Study|Lack of Efficacy|0
7532673|NCT02673619|11878345|FG001|Overall Study|Lack of Efficacy|0
7532674|NCT02673619|11878346|FG002|Overall Study|Lack of Efficacy|1
7532675|NCT02673619|11878347|FG003|Overall Study|Lack of Efficacy|0
7532676|NCT02674334|11878376|FG000|Overall Study|Lost to Follow-up|5
7532677|NCT02674334|11878377|FG001|Overall Study|Lost to Follow-up|3
7532678|NCT02674334|11878376|FG000|Overall Study|participant difficulty breathing|1
7532679|NCT02674334|11878377|FG001|Overall Study|participant difficulty breathing|0
7532680|NCT02674334|11878376|FG000|Overall Study|NIRS not recording|1
7532681|NCT02674334|11878377|FG001|Overall Study|NIRS not recording|0
7532682|NCT02674386|11878386|FG000|Overall Study|Lost to Follow-up|0
7532683|NCT02674386|11878387|FG001|Overall Study|Lost to Follow-up|1
7532684|NCT02674386|11878388|FG002|Overall Study|Lost to Follow-up|1
7532685|NCT02674386|11878386|FG000|Overall Study|Withdrawal by Subject|0
7532686|NCT02674386|11878387|FG001|Overall Study|Withdrawal by Subject|4
7532687|NCT02674386|11878388|FG002|Overall Study|Withdrawal by Subject|0
7532688|NCT02674386|11878386|FG000|Overall Study|Other|0
7532689|NCT02674386|11878387|FG001|Overall Study|Other|1
7532690|NCT02674386|11878388|FG002|Overall Study|Other|0
7532691|NCT02674386|11878386|FG000|Overall Study|Enrolled but not evaluated|0
7532692|NCT02674386|11878387|FG001|Overall Study|Enrolled but not evaluated|4
7532693|NCT02674386|11878388|FG002|Overall Study|Enrolled but not evaluated|0
7532694|NCT02674399|11878403|FG000|Overall Study|Lost to Follow-up|2
7532695|NCT02674399|11878404|FG001|Overall Study|Lost to Follow-up|0
7532696|NCT02674477|11878420|FG000|Overall Study|Protocol Violation|8
7532697|NCT02674477|11878421|FG001|Overall Study|Protocol Violation|2
7532698|NCT02674568|11878427|FG000|Overall Study|Withdrawal by Subject|5
7532699|NCT02674568|11878427|FG000|Overall Study|Death|303
7532700|NCT02674568|11878427|FG000|Overall Study|Physician Decision|2
7532701|NCT02674568|11878427|FG000|Overall Study|Lost to Follow-up|9
7532702|NCT02674568|11878427|FG000|Overall Study|Other, Not Specified|20
7559136|NCT03137992|11924994|FG000|Washout Period 2|COPD Exacerbation|1
7559137|NCT03137992|11924995|FG001|Washout Period 2|COPD Exacerbation|1
7559138|NCT03137992|11924996|FG002|Washout Period 2|COPD Exacerbation|0
7559139|NCT03137992|11924997|FG003|Washout Period 2|COPD Exacerbation|0
7559140|NCT03137992|11924998|FG004|Washout Period 2|COPD Exacerbation|1
7559141|NCT03137992|11924999|FG005|Washout Period 2|COPD Exacerbation|0
7434011|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
7434012|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
7434013|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
7434014|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
7434015|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
7434016|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
7434017|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
7434018|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
7434019|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
7434020|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
7434021|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434022|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434023|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434024|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434025|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434026|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434027|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434028|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434029|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434030|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434031|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434032|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434033|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434034|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434035|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7434036|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
7434037|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434038|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434039|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434040|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434041|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
7434042|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434043|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434044|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434045|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434046|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434047|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434048|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434049|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434050|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434051|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434052|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434053|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434054|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434055|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434056|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7434057|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
7434058|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434059|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434060|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434061|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7532703|NCT02674633|11878438|FG000|Overall Study|Lost to Follow-up|3
7532704|NCT02674633|11878439|FG001|Overall Study|Lost to Follow-up|2
7532705|NCT02674633|11878438|FG000|Overall Study|Physician Decision|1
7559142|NCT03137992|11924994|FG000|Washout Period 2|Subject Non-compliance|0
7434062|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
7434063|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434064|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434065|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434066|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434067|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434068|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434069|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434070|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434071|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434072|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434073|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434074|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434075|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434076|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434077|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7559143|NCT03137992|11924995|FG001|Washout Period 2|Subject Non-compliance|1
7559144|NCT03137992|11924996|FG002|Washout Period 2|Subject Non-compliance|0
7434078|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
7434079|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434080|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434081|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434082|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434083|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
7434084|NCT01597245|11715964|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434085|NCT01597245|11715965|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434086|NCT01597245|11715966|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434087|NCT01597245|11715967|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434088|NCT01597245|11715968|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434089|NCT01597245|11715969|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434090|NCT01597245|11715970|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434091|NCT01597245|11715971|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434092|NCT01597245|11715972|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434093|NCT01597245|11715973|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434094|NCT01597245|11715974|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434095|NCT01597245|11715975|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434096|NCT01597245|11715976|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434097|NCT01597245|11715977|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
7434098|NCT01597245|11715978|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434099|NCT01597245|11715979|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434100|NCT01597245|11715980|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434101|NCT01597245|11715981|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434102|NCT01597245|11715982|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434103|NCT01597245|11715983|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434104|NCT01597245|11715984|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
7434105|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434106|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434107|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434108|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434109|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434110|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434111|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434112|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434113|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434114|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434115|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434116|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434117|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434118|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434119|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434120|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
7434121|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
7434122|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
7434123|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
7434124|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
7434125|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
7434126|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7559145|NCT03137992|11924997|FG003|Washout Period 2|Subject Non-compliance|0
7434127|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434128|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434129|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434130|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434131|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434132|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434133|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434134|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434135|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434136|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434137|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434138|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434139|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434140|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434141|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434142|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
7434143|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7434144|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
7434145|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
7434146|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
7434147|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434148|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434149|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434150|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434151|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434152|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434153|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434154|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434155|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434156|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434157|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434158|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434159|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434160|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434161|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434162|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434163|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
7434164|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434165|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
7434166|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
7434167|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
7434168|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434169|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434170|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434171|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434172|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434173|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434174|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434175|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434176|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434177|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434178|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434179|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434180|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434181|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434182|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434183|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434184|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434185|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
7434186|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
7434187|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
7434188|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
7434189|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434190|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434191|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434192|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434193|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434194|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434195|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434196|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434197|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434198|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434199|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434200|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434201|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434202|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434203|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434204|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434205|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7434206|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434207|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
7434208|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
7434209|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
7434210|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434211|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434212|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434213|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434214|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434215|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434216|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434217|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434218|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434219|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434220|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434221|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434222|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434223|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434224|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434225|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434226|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
7434227|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434228|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
7434229|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
7434230|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
7434231|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434232|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434233|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434234|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434235|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434236|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434237|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434238|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434239|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434240|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434241|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434242|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434243|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434244|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434245|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434246|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434247|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
7434248|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434249|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434250|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
7434251|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
7434252|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7559146|NCT03137992|11924998|FG004|Washout Period 2|Subject Non-compliance|0
7559147|NCT03137992|11924999|FG005|Washout Period 2|Subject Non-compliance|0
7559148|NCT03137992|11924994|FG000|Washout Period 2|Adverse Event|0
7559149|NCT03137992|11924995|FG001|Washout Period 2|Adverse Event|0
7559150|NCT03137992|11924996|FG002|Washout Period 2|Adverse Event|0
7559151|NCT03137992|11924997|FG003|Washout Period 2|Adverse Event|1
7434253|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434254|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434255|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434256|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434257|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434258|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434259|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434260|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434261|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434262|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434263|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434264|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434265|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434266|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434267|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434268|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7434269|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434270|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434271|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
7434272|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
7434273|NCT01597245|11715964|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434274|NCT01597245|11715965|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434275|NCT01597245|11715966|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434276|NCT01597245|11715967|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434277|NCT01597245|11715968|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434278|NCT01597245|11715969|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434279|NCT01597245|11715970|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434280|NCT01597245|11715971|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434281|NCT01597245|11715972|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434282|NCT01597245|11715973|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434283|NCT01597245|11715974|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434284|NCT01597245|11715975|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434285|NCT01597245|11715976|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434286|NCT01597245|11715977|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434287|NCT01597245|11715978|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434288|NCT01597245|11715979|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434289|NCT01597245|11715980|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434290|NCT01597245|11715981|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434291|NCT01597245|11715982|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434292|NCT01597245|11715983|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
7434293|NCT01597245|11715984|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
7434294|NCT01597258|11716017|FG000|Overall Study|No Drug Administration|1
7434295|NCT01597375|11716021|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
7434296|NCT01597375|11716022|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
7434297|NCT01597375|11716021|FG000|First Intervention (4 Weeks)|Needed surgery|1
7434298|NCT01597375|11716022|FG001|First Intervention (4 Weeks)|Needed surgery|0
7434299|NCT01597375|11716021|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
7434300|NCT01597375|11716022|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
7434301|NCT01597375|11716021|FG000|Washout (2 Weeks)|Adverse Event|1
7434302|NCT01597375|11716022|FG001|Washout (2 Weeks)|Adverse Event|0
7434303|NCT01597375|11716021|FG000|Second Intervention|Failed to react at both Aspirin|1
7434304|NCT01597375|11716022|FG001|Second Intervention|Failed to react at both Aspirin|1
7434305|NCT01597479|11716042|FG000|Overall Study|Protocol Violation|1
7434306|NCT01597479|11716043|FG001|Overall Study|Protocol Violation|0
7434307|NCT01597479|11716042|FG000|Overall Study|Lost to Follow-up|1
7434308|NCT01597479|11716043|FG001|Overall Study|Lost to Follow-up|0
7434309|NCT01597492|11716052|FG000|Overall Study|Withdrawal by Subject|1
7434310|NCT01597492|11716053|FG001|Overall Study|Withdrawal by Subject|2
7434311|NCT01597492|11716052|FG000|Overall Study|Adverse Event|3
7434312|NCT01597492|11716053|FG001|Overall Study|Adverse Event|0
7434313|NCT01597492|11716052|FG000|Overall Study|Lost to Follow-up|0
7434314|NCT01597492|11716053|FG001|Overall Study|Lost to Follow-up|2
7434315|NCT01597492|11716052|FG000|Overall Study|Other Reason|2
7434316|NCT01597492|11716053|FG001|Overall Study|Other Reason|0
7434317|NCT01597505|11716061|FG000|Overall Study|Physician Decision|5
7434318|NCT01597505|11716062|FG001|Overall Study|Physician Decision|0
7434319|NCT01597505|11716061|FG000|Overall Study|Adverse Event|19
7434320|NCT01597505|11716062|FG001|Overall Study|Adverse Event|7
7434321|NCT01597505|11716061|FG000|Overall Study|Lost to Follow-up|4
7434322|NCT01597505|11716062|FG001|Overall Study|Lost to Follow-up|2
7434323|NCT01597505|11716061|FG000|Overall Study|Withdrawal by Subject|10
7434324|NCT01597505|11716062|FG001|Overall Study|Withdrawal by Subject|18
7434325|NCT01597505|11716061|FG000|Overall Study|Other|5
7434326|NCT01597505|11716062|FG001|Overall Study|Other|6
7434327|NCT01597505|11716061|FG000|Overall Study|Missing|1
7434328|NCT01597505|11716062|FG001|Overall Study|Missing|0
7434329|NCT01597557|11716071|FG000|Overall Study|Did not undergo cardioversion procedure|4
7434330|NCT01597557|11716072|FG001|Overall Study|Did not undergo cardioversion procedure|3
7434331|NCT01597596|11716080|FG000|Overall Study|Study terminated by sponsor|1
7434332|NCT01597596|11716081|FG001|Overall Study|Study terminated by sponsor|0
7434333|NCT01597596|11716080|FG000|Overall Study|Physician Decision|0
7434334|NCT01597596|11716081|FG001|Overall Study|Physician Decision|1
7434335|NCT01597622|11716087|FG000|Overall Study|Adverse Event|7
7434336|NCT01597622|11716087|FG000|Overall Study|Lack of Efficacy|3
7434337|NCT01597622|11716087|FG000|Overall Study|Protocol Violation|1
7434338|NCT01597622|11716087|FG000|Overall Study|Lost to Follow-up|1
7434339|NCT01597622|11716087|FG000|Overall Study|Investigator Discretion|5
7434340|NCT01597622|11716087|FG000|Overall Study|Withdrawal by Subject|20
7434341|NCT01597622|11716087|FG000|Overall Study|Death|1
7434342|NCT01597635|11716094|FG000|Part A|Adverse Event|3
7434343|NCT01597635|11716095|FG001|Part A|Adverse Event|0
7434344|NCT01597635|11716096|FG002|Part A|Adverse Event|0
7434345|NCT01597635|11716094|FG000|Part B|Adverse Event|0
7434346|NCT01597635|11716095|FG001|Part B|Adverse Event|0
7434347|NCT01597635|11716096|FG002|Part B|Adverse Event|1
7434348|NCT01597635|11716094|FG000|Part B|Protocol Violation|0
7434349|NCT01597635|11716095|FG001|Part B|Protocol Violation|1
7434350|NCT01597635|11716096|FG002|Part B|Protocol Violation|0
7434351|NCT01597635|11716094|FG000|Part B|Protocol-defined stopping criteria|0
7434352|NCT01597635|11716095|FG001|Part B|Protocol-defined stopping criteria|4
7434353|NCT01597635|11716096|FG002|Part B|Protocol-defined stopping criteria|3
7434354|NCT01597635|11716094|FG000|Part B|Withdrawal by Subject|0
7434355|NCT01597635|11716095|FG001|Part B|Withdrawal by Subject|1
7434356|NCT01597635|11716096|FG002|Part B|Withdrawal by Subject|0
7434357|NCT01597791|11716136|FG000|Overall Study|Physician Decision|2
7434358|NCT01597791|11716137|FG001|Overall Study|Physician Decision|1
7434359|NCT01597791|11716136|FG000|Overall Study|Cesarean Section|6
7434360|NCT01597791|11716137|FG001|Overall Study|Cesarean Section|7
7434361|NCT01597791|11716136|FG000|Overall Study|Subject withdrawal|0
7434362|NCT01597791|11716137|FG001|Overall Study|Subject withdrawal|1
7434363|NCT01597791|11716136|FG000|Overall Study|Protocol Violation|0
7434364|NCT01597791|11716137|FG001|Overall Study|Protocol Violation|1
7434365|NCT01597908|11716172|FG000|Randomized Phase|Death|217
7434366|NCT01597908|11716173|FG001|Randomized Phase|Death|238
7434367|NCT01597908|11716174|FG002|Randomized Phase|Death|0
7434368|NCT01597908|11716172|FG000|Randomized Phase|Sponsor Decision|93
7434369|NCT01597908|11716173|FG001|Randomized Phase|Sponsor Decision|39
7434370|NCT01597908|11716174|FG002|Randomized Phase|Sponsor Decision|0
7434371|NCT01597908|11716172|FG000|Randomized Phase|Lost to Follow-up|9
7532706|NCT02674633|11878439|FG001|Overall Study|Physician Decision|0
7532707|NCT02674633|11878438|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7532708|NCT02674633|11878439|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7532709|NCT02674685|11878454|FG000|Overall Study|Protocol Violation|4
7532710|NCT02674854|11878461|FG000|Overall Study|Adverse Event|17
7532711|NCT02674854|11878462|FG001|Overall Study|Adverse Event|15
7532712|NCT02674854|11878463|FG002|Overall Study|Adverse Event|5
7532713|NCT02674854|11878461|FG000|Overall Study|Withdrawal by Subject|1
7532714|NCT02674854|11878462|FG001|Overall Study|Withdrawal by Subject|5
7532715|NCT02674854|11878463|FG002|Overall Study|Withdrawal by Subject|4
7532716|NCT02674854|11878461|FG000|Overall Study|No-compliant subject|1
7532717|NCT02674854|11878462|FG001|Overall Study|No-compliant subject|0
7532718|NCT02674854|11878463|FG002|Overall Study|No-compliant subject|1
7532719|NCT02674854|11878461|FG000|Overall Study|Lost to Follow-up|1
7532720|NCT02674854|11878462|FG001|Overall Study|Lost to Follow-up|0
7532721|NCT02674854|11878463|FG002|Overall Study|Lost to Follow-up|2
7532722|NCT02674854|11878461|FG000|Overall Study|Lack of Efficacy|0
7532723|NCT02674854|11878462|FG001|Overall Study|Lack of Efficacy|3
7532724|NCT02674854|11878463|FG002|Overall Study|Lack of Efficacy|0
7434372|NCT01597908|11716173|FG001|Randomized Phase|Lost to Follow-up|16
7434373|NCT01597908|11716174|FG002|Randomized Phase|Lost to Follow-up|0
7434374|NCT01597908|11716172|FG000|Randomized Phase|Physician Decision|6
7434375|NCT01597908|11716173|FG001|Randomized Phase|Physician Decision|3
7434376|NCT01597908|11716174|FG002|Randomized Phase|Physician Decision|0
7434377|NCT01597908|11716172|FG000|Randomized Phase|Withdrawal by Subject|26
7434378|NCT01597908|11716173|FG001|Randomized Phase|Withdrawal by Subject|22
7434379|NCT01597908|11716174|FG002|Randomized Phase|Withdrawal by Subject|0
7434380|NCT01597908|11716172|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7434381|NCT01597908|11716173|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
7434382|NCT01597908|11716174|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
7434383|NCT01597908|11716172|FG000|Crossover Phase|Death|0
7532725|NCT02674854|11878461|FG000|Overall Study|Disallowed Concurrent Medication|2
7532726|NCT02674854|11878462|FG001|Overall Study|Disallowed Concurrent Medication|2
7532727|NCT02674854|11878463|FG002|Overall Study|Disallowed Concurrent Medication|0
7532728|NCT02674854|11878461|FG000|Overall Study|Protocol Violation|1
7532729|NCT02674854|11878462|FG001|Overall Study|Protocol Violation|1
7434384|NCT01597908|11716173|FG001|Crossover Phase|Death|0
7434385|NCT01597908|11716174|FG002|Crossover Phase|Death|11
7434386|NCT01597908|11716172|FG000|Crossover Phase|Withdrawal by Subject|0
7434387|NCT01597908|11716173|FG001|Crossover Phase|Withdrawal by Subject|0
7434388|NCT01597908|11716174|FG002|Crossover Phase|Withdrawal by Subject|3
7434389|NCT01597908|11716172|FG000|Crossover Phase|Sponsor Decision|0
7434390|NCT01597908|11716173|FG001|Crossover Phase|Sponsor Decision|0
7434391|NCT01597908|11716174|FG002|Crossover Phase|Sponsor Decision|20
7434392|NCT01597973|11716185|FG000|Overall Study|Found ineligible before study medication started|4
7434393|NCT01597973|11716186|FG001|Overall Study|Found ineligible before study medication started|2
7434394|NCT01597973|11716185|FG000|Overall Study|Eligible pathogen not confirmed|14
7434395|NCT01597973|11716186|FG001|Overall Study|Eligible pathogen not confirmed|15
7434396|NCT01597973|11716185|FG000|Overall Study|LAR not authorized to consent|0
7434397|NCT01597973|11716186|FG001|Overall Study|LAR not authorized to consent|1
7434398|NCT01597973|11716185|FG000|Overall Study|Ineligible due to early seizures|1
7434399|NCT01597973|11716186|FG001|Overall Study|Ineligible due to early seizures|0
7434400|NCT01597973|11716185|FG000|Overall Study|Ineligible due to non-target infection|1
7434401|NCT01597973|11716186|FG001|Overall Study|Ineligible due to non-target infection|1
7434402|NCT01598090|11716208|FG000|Treatment Period|Poor/non-compliance|0
7434403|NCT01598090|11716209|FG001|Treatment Period|Poor/non-compliance|2
7434404|NCT01598090|11716210|FG002|Treatment Period|Poor/non-compliance|0
7434405|NCT01598090|11716208|FG000|Treatment Period|No longer meet study criteria|0
7434406|NCT01598090|11716209|FG001|Treatment Period|No longer meet study criteria|1
7434407|NCT01598090|11716210|FG002|Treatment Period|No longer meet study criteria|0
7434408|NCT01598090|11716208|FG000|Treatment Period|Lack of Efficacy|5
7434409|NCT01598090|11716209|FG001|Treatment Period|Lack of Efficacy|14
7434410|NCT01598090|11716210|FG002|Treatment Period|Lack of Efficacy|6
7434411|NCT01598090|11716208|FG000|Treatment Period|Adverse Event|2
7434412|NCT01598090|11716209|FG001|Treatment Period|Adverse Event|33
7434413|NCT01598090|11716210|FG002|Treatment Period|Adverse Event|17
7434414|NCT01598090|11716208|FG000|Treatment Period|Other reasons|0
7434415|NCT01598090|11716209|FG001|Treatment Period|Other reasons|4
7434416|NCT01598090|11716210|FG002|Treatment Period|Other reasons|1
7434417|NCT01598090|11716208|FG000|Treatment Period|Withdrawal by Subject|3
7434418|NCT01598090|11716209|FG001|Treatment Period|Withdrawal by Subject|13
7434419|NCT01598090|11716210|FG002|Treatment Period|Withdrawal by Subject|10
7434420|NCT01598090|11716208|FG000|Treatment Period|Lost to Follow-up|1
7434421|NCT01598090|11716209|FG001|Treatment Period|Lost to Follow-up|5
7434422|NCT01598090|11716210|FG002|Treatment Period|Lost to Follow-up|1
7434423|NCT01598090|11716208|FG000|Follow-up Period|Death|0
7434424|NCT01598090|11716209|FG001|Follow-up Period|Death|1
7434425|NCT01598090|11716210|FG002|Follow-up Period|Death|0
7434426|NCT01598090|11716208|FG000|Follow-up Period|No longer required per protocol|1
7434427|NCT01598090|11716209|FG001|Follow-up Period|No longer required per protocol|3
7434428|NCT01598090|11716210|FG002|Follow-up Period|No longer required per protocol|2
7434429|NCT01598090|11716208|FG000|Follow-up Period|Not reported|0
7434430|NCT01598090|11716209|FG001|Follow-up Period|Not reported|10
7434431|NCT01598090|11716210|FG002|Follow-up Period|Not reported|4
7434432|NCT01598090|11716208|FG000|Follow-up Period|Withdrawal by Subject|0
7434433|NCT01598090|11716209|FG001|Follow-up Period|Withdrawal by Subject|3
7434434|NCT01598090|11716210|FG002|Follow-up Period|Withdrawal by Subject|2
7434435|NCT01598090|11716208|FG000|Follow-up Period|Other reasons|2
7434436|NCT01598090|11716209|FG001|Follow-up Period|Other reasons|8
7434437|NCT01598090|11716210|FG002|Follow-up Period|Other reasons|8
7434438|NCT01598090|11716208|FG000|Follow-up Period|Lost to Follow-up|2
7434439|NCT01598090|11716209|FG001|Follow-up Period|Lost to Follow-up|10
7434440|NCT01598090|11716210|FG002|Follow-up Period|Lost to Follow-up|12
7434441|NCT01598129|11716221|FG000|Overall Study|Disease progression|6
7434442|NCT01598129|11716221|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
7434443|NCT01598129|11716221|FG000|Overall Study|Withdrawal by Subject|1
7434444|NCT01598298|11716250|FG000|Overall Study|Not eligible|5
7434445|NCT01598298|11716251|FG001|Overall Study|Not eligible|5
7434446|NCT01598298|11716250|FG000|Overall Study|Adverse Event|21
7434447|NCT01598298|11716251|FG001|Overall Study|Adverse Event|19
7434448|NCT01598298|11716250|FG000|Overall Study|Progression/relapse|0
7434449|NCT01598298|11716251|FG001|Overall Study|Progression/relapse|2
7434450|NCT01598298|11716250|FG000|Overall Study|Withdrawal by Subject|10
7434451|NCT01598298|11716251|FG001|Overall Study|Withdrawal by Subject|15
7434452|NCT01598298|11716250|FG000|Overall Study|Other reason (not protocol specified)|4
7434453|NCT01598298|11716251|FG001|Overall Study|Other reason (not protocol specified)|0
7434470|NCT01598506|11716275|FG000|Overall Study|Withdrawal by Subject|2
7434471|NCT01598532|11716280|FG000|Overall Study|Lost to Follow-up|3
7434472|NCT01598532|11716280|FG000|Overall Study|Did not meet inclusion criteria|8
7434473|NCT01598610|11716291|FG000|Overall Study|Adverse Event|1
7434474|NCT01598662|11716297|FG000|Overall Study|Lost to Follow-up|10
7434475|NCT01598662|11716298|FG001|Overall Study|Lost to Follow-up|17
7434476|NCT01598662|11716297|FG000|Overall Study|Physician Decision|1
7434477|NCT01598662|11716298|FG001|Overall Study|Physician Decision|2
7434478|NCT01598662|11716297|FG000|Overall Study|IUD expelled before month 6|0
7434479|NCT01598662|11716298|FG001|Overall Study|IUD expelled before month 6|2
7434480|NCT01598753|11716327|FG000|Overall Study|Adverse Event|1
7434481|NCT01598753|11716328|FG001|Overall Study|Adverse Event|9
7434482|NCT01598753|11716329|FG002|Overall Study|Adverse Event|1
7434483|NCT01598753|11716330|FG003|Overall Study|Adverse Event|7
7559152|NCT03137992|11924998|FG004|Washout Period 2|Adverse Event|1
7434484|NCT01598753|11716327|FG000|Overall Study|Lost to Follow-up|4
7434485|NCT01598753|11716328|FG001|Overall Study|Lost to Follow-up|3
7434486|NCT01598753|11716329|FG002|Overall Study|Lost to Follow-up|7
7434487|NCT01598753|11716330|FG003|Overall Study|Lost to Follow-up|5
7434488|NCT01598753|11716327|FG000|Overall Study|Physician Decision|0
7559153|NCT03137992|11924999|FG005|Washout Period 2|Adverse Event|0
7559154|NCT03137992|11924994|FG000|Washout Period 2|Withdrawal by Subject|1
7434489|NCT01598753|11716328|FG001|Overall Study|Physician Decision|1
7434490|NCT01598753|11716329|FG002|Overall Study|Physician Decision|0
7434491|NCT01598753|11716330|FG003|Overall Study|Physician Decision|2
7434492|NCT01598753|11716327|FG000|Overall Study|Withdrawal by Subject|7
7434493|NCT01598753|11716328|FG001|Overall Study|Withdrawal by Subject|2
7434494|NCT01598753|11716329|FG002|Overall Study|Withdrawal by Subject|0
7434495|NCT01598753|11716330|FG003|Overall Study|Withdrawal by Subject|1
7434496|NCT01598896|11716355|FG000|Overall Study|Withdrawal by Subject|0
7434497|NCT01598896|11716356|FG001|Overall Study|Withdrawal by Subject|1
7434498|NCT01598896|11716355|FG000|Overall Study|Lack of Efficacy|0
7434499|NCT01598896|11716356|FG001|Overall Study|Lack of Efficacy|1
7434500|NCT01598987|11716371|FG000|Baseline to Month 12|Administrative problems|2
7434501|NCT01598987|11716371|FG000|Baseline to Month 12|Withdrawal by Subject|4
7434502|NCT01598987|11716371|FG000|Baseline to 24 Month|Withdrawal by Subject|5
7434503|NCT01598987|11716371|FG000|Baseline to 24 Month|Administrative problems|2
7434504|NCT01598987|11716371|FG000|Baseline to 24 Month|Lost to Follow-up|1
7434505|NCT01599104|11716385|FG000|Overall Study|Withdrawal by Subject|1
7434506|NCT01599104|11716386|FG001|Overall Study|Withdrawal by Subject|1
7434507|NCT01599104|11716387|FG002|Overall Study|Withdrawal by Subject|2
7434508|NCT01599104|11716385|FG000|Overall Study|Technical Problems|1
7434509|NCT01599104|11716386|FG001|Overall Study|Technical Problems|0
7434510|NCT01599104|11716387|FG002|Overall Study|Technical Problems|0
7434511|NCT01599104|11716385|FG000|Overall Study|Physician Decision|3
7434512|NCT01599104|11716386|FG001|Overall Study|Physician Decision|2
7434513|NCT01599104|11716387|FG002|Overall Study|Physician Decision|2
7434514|NCT01599104|11716385|FG000|Overall Study|Non-compliance with study treatment|0
7434515|NCT01599104|11716386|FG001|Overall Study|Non-compliance with study treatment|1
7434516|NCT01599104|11716387|FG002|Overall Study|Non-compliance with study treatment|0
7434517|NCT01599104|11716385|FG000|Overall Study|Lack of Efficacy|4
7434518|NCT01599104|11716386|FG001|Overall Study|Lack of Efficacy|4
7434519|NCT01599104|11716387|FG002|Overall Study|Lack of Efficacy|10
7434520|NCT01599104|11716385|FG000|Overall Study|Adverse Event|7
7434521|NCT01599104|11716386|FG001|Overall Study|Adverse Event|6
7434522|NCT01599104|11716387|FG002|Overall Study|Adverse Event|12
7434523|NCT01599234|11716397|FG000|Overall Study|Adverse Event|9
7434524|NCT01599234|11716398|FG001|Overall Study|Adverse Event|5
7434525|NCT01599234|11716397|FG000|Overall Study|Withdrawal by Subject|2
7434526|NCT01599234|11716398|FG001|Overall Study|Withdrawal by Subject|1
7434527|NCT01599234|11716397|FG000|Overall Study|Lost to Follow-up|1
7434528|NCT01599234|11716398|FG001|Overall Study|Lost to Follow-up|2
7434529|NCT01599234|11716397|FG000|Overall Study|Lack of Efficacy|2
7434530|NCT01599234|11716398|FG001|Overall Study|Lack of Efficacy|4
7434531|NCT01599234|11716397|FG000|Overall Study|Unable to operate spray|1
7434532|NCT01599234|11716398|FG001|Overall Study|Unable to operate spray|0
7434533|NCT01599234|11716397|FG000|Overall Study|Sponsor request as creatinine levels <50|0
7434534|NCT01599234|11716398|FG001|Overall Study|Sponsor request as creatinine levels <50|1
7434535|NCT01599234|11716397|FG000|Overall Study|Death|1
7434536|NCT01599234|11716398|FG001|Overall Study|Death|0
7559155|NCT03137992|11924995|FG001|Washout Period 2|Withdrawal by Subject|0
7434537|NCT01599234|11716397|FG000|Overall Study|Patient would not stop driving|1
7434538|NCT01599234|11716398|FG001|Overall Study|Patient would not stop driving|0
7434539|NCT01599234|11716397|FG000|Overall Study|Contra-indication discovered|0
7434540|NCT01599234|11716398|FG001|Overall Study|Contra-indication discovered|1
7434541|NCT01599234|11716397|FG000|Overall Study|Pregnancy|0
7434542|NCT01599234|11716398|FG001|Overall Study|Pregnancy|1
7434543|NCT01599325|11716413|FG000|Primary Parent Phase|Adverse Event|5
7434544|NCT01599325|11716413|FG000|Primary Parent Phase|Disease Progression|7
7434545|NCT01599325|11716413|FG000|Primary Parent Phase|Withdrawal by Subject|20
7434546|NCT01599325|11716413|FG000|Primary Parent Phase|Death|13
7434547|NCT01599325|11716413|FG000|Primary Parent Phase|Protocol Violation|1
7434548|NCT01599325|11716413|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
7434549|NCT01599325|11716413|FG000|Primary Parent Phase|Other|2
7434550|NCT01599325|11716413|FG000|Extension Phase|Study Closure|1
7434551|NCT01599325|11716413|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
7434552|NCT01599325|11716413|FG000|Extension Phase|Lack of Therapeutic Effect|4
7434553|NCT01599325|11716413|FG000|Extension Phase|Disease Progression|1
7434554|NCT01599325|11716413|FG000|Extension Phase|Withdrawal by Subject|8
7434555|NCT01599585|11716420|FG000|Overall Study|Withdrawal by Subject|16
7434556|NCT01599585|11716421|FG001|Overall Study|Withdrawal by Subject|9
7434557|NCT01599585|11716420|FG000|Overall Study|Lost to Follow-up|3
7434558|NCT01599585|11716421|FG001|Overall Study|Lost to Follow-up|5
7434559|NCT01599585|11716420|FG000|Overall Study|randomized did not start treatment|3
7434560|NCT01599585|11716421|FG001|Overall Study|randomized did not start treatment|3
7434561|NCT01599637|11716430|FG000|Overall Study|administrative problems|0
7434562|NCT01599637|11716431|FG001|Overall Study|administrative problems|2
7434563|NCT01599637|11716432|FG002|Overall Study|administrative problems|0
7434564|NCT01599637|11716430|FG000|Overall Study|Adverse Event|1
7434565|NCT01599637|11716431|FG001|Overall Study|Adverse Event|0
7434566|NCT01599637|11716432|FG002|Overall Study|Adverse Event|0
7434567|NCT01599650|11716445|FG000|Overall Study|Administrative issue|1
7434568|NCT01599650|11716446|FG001|Overall Study|Administrative issue|0
7434569|NCT01599650|11716447|FG002|Overall Study|Administrative issue|1
7434570|NCT01599650|11716445|FG000|Overall Study|Physician Decision|2
7434571|NCT01599650|11716446|FG001|Overall Study|Physician Decision|0
7434572|NCT01599650|11716447|FG002|Overall Study|Physician Decision|7
7434573|NCT01599650|11716445|FG000|Overall Study|Protocol Violation|0
7434574|NCT01599650|11716446|FG001|Overall Study|Protocol Violation|3
7434575|NCT01599650|11716447|FG002|Overall Study|Protocol Violation|0
7434576|NCT01599650|11716445|FG000|Overall Study|Death|2
7434577|NCT01599650|11716446|FG001|Overall Study|Death|1
7434578|NCT01599650|11716447|FG002|Overall Study|Death|2
7434579|NCT01599650|11716445|FG000|Overall Study|Lost to Follow-up|3
7434580|NCT01599650|11716446|FG001|Overall Study|Lost to Follow-up|3
7434581|NCT01599650|11716447|FG002|Overall Study|Lost to Follow-up|3
7434582|NCT01599650|11716445|FG000|Overall Study|Withdrawal by Subject|11
7434583|NCT01599650|11716446|FG001|Overall Study|Withdrawal by Subject|11
7434584|NCT01599650|11716447|FG002|Overall Study|Withdrawal by Subject|10
7434585|NCT01599650|11716445|FG000|Overall Study|Adverse Event|3
7434586|NCT01599650|11716446|FG001|Overall Study|Adverse Event|8
7434587|NCT01599650|11716447|FG002|Overall Study|Adverse Event|4
7434588|NCT01599754|11716459|FG000|Overall Study|Anticancer therapy need not in protocol|5
7434589|NCT01599754|11716460|FG001|Overall Study|Anticancer therapy need not in protocol|2
7434590|NCT01599754|11716459|FG000|Overall Study|Participant noncompliance|4
7434591|NCT01599754|11716460|FG001|Overall Study|Participant noncompliance|4
7434592|NCT01599754|11716459|FG000|Overall Study|Lost to Follow-up|13
7434593|NCT01599754|11716460|FG001|Overall Study|Lost to Follow-up|6
7434594|NCT01599754|11716459|FG000|Overall Study|Death|31
7434595|NCT01599754|11716460|FG001|Overall Study|Death|33
7434596|NCT01599754|11716459|FG000|Overall Study|Adverse Event|3
7434597|NCT01599754|11716460|FG001|Overall Study|Adverse Event|2
7434598|NCT01599754|11716459|FG000|Overall Study|Investigator decision|1
7434599|NCT01599754|11716460|FG001|Overall Study|Investigator decision|3
7434600|NCT01599754|11716459|FG000|Overall Study|Withdrawal by Subject|24
7434601|NCT01599754|11716460|FG001|Overall Study|Withdrawal by Subject|25
7434602|NCT01599754|11716459|FG000|Overall Study|Study terminated by sponsor|282
7434603|NCT01599754|11716460|FG001|Overall Study|Study terminated by sponsor|285
7434604|NCT01599793|11716466|FG000|Overall Study|Adverse Event|2
7434605|NCT01599806|11716472|FG000|Overall Study|Lost to Follow-up|20
7434606|NCT01599806|11716473|FG001|Overall Study|Lost to Follow-up|20
7434607|NCT01599806|11716472|FG000|Overall Study|Withdrawal by Subject|12
7434608|NCT01599806|11716473|FG001|Overall Study|Withdrawal by Subject|12
7434609|NCT01599806|11716472|FG000|Overall Study|Other Eligibility criteria|11
7434610|NCT01599806|11716473|FG001|Overall Study|Other Eligibility criteria|9
7434611|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
7434612|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
7434613|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
7434614|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
7434615|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
7434616|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
7434617|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Other|27
7434618|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Other|0
7434619|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
7434620|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
7434621|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
7434622|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
7434623|NCT01600014|11716483|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
7434624|NCT01600014|11716484|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
7434625|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
7434626|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
7434627|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
7434628|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
7434629|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
7434630|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
7434631|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
7434632|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
7434633|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
7434634|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
7434635|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7434636|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
7434637|NCT01600014|11716483|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
7434638|NCT01600014|11716484|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
7434639|NCT01600014|11716483|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
7434640|NCT01600014|11716484|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
7434641|NCT01600014|11716483|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
7434642|NCT01600014|11716484|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
7434643|NCT01600014|11716483|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
7434644|NCT01600014|11716484|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
7434645|NCT01600053|11716502|FG000|Overall Study|Adverse Event|2
7434646|NCT01600053|11716502|FG000|Overall Study|trial will not meet the interim endpoint|9
7434647|NCT01600092|11716508|FG000|Overall Study|Adverse Event|2
7434648|NCT01600092|11716509|FG001|Overall Study|Adverse Event|0
7434649|NCT01600092|11716508|FG000|Overall Study|Lost to Follow-up|4
7434650|NCT01600092|11716509|FG001|Overall Study|Lost to Follow-up|6
7434651|NCT01600092|11716508|FG000|Overall Study|Withdrawal by parent/guardian|8
7434652|NCT01600092|11716509|FG001|Overall Study|Withdrawal by parent/guardian|6
7434653|NCT01600092|11716508|FG000|Overall Study|Physician Decision|1
7434654|NCT01600092|11716509|FG001|Overall Study|Physician Decision|1
7434655|NCT01600092|11716508|FG000|Overall Study|Randomized but not vaccinated|3
7434656|NCT01600092|11716509|FG001|Overall Study|Randomized but not vaccinated|3
7434657|NCT01600105|11716517|FG000|Total Participants|Withdrawal by Subject|1
7434658|NCT01600105|11716518|FG001|Total Participants|Withdrawal by Subject|0
7434659|NCT01600105|11716517|FG000|Total Participants|No images in PACS|10
7434660|NCT01600105|11716518|FG001|Total Participants|No images in PACS|0
7434661|NCT01600105|11716517|FG000|Total Participants|Insufficient image quality|30
7434662|NCT01600105|11716518|FG001|Total Participants|Insufficient image quality|10
7434663|NCT01600105|11716517|FG000|Sub Study I|Insufficient image quality|0
7434664|NCT01600105|11716518|FG001|Sub Study I|Insufficient image quality|10
7434665|NCT01600105|11716517|FG000|Sub Study II|Withdrawal by Subject|1
7434666|NCT01600105|11716518|FG001|Sub Study II|Withdrawal by Subject|0
7434667|NCT01600105|11716517|FG000|Sub Study II|No images in PACS|1
7434668|NCT01600105|11716518|FG001|Sub Study II|No images in PACS|0
7434669|NCT01600105|11716517|FG000|Sub Study II|Insufficient image quality|3
7434670|NCT01600105|11716518|FG001|Sub Study II|Insufficient image quality|0
7434671|NCT01600105|11716517|FG000|Sub Study III|Insufficient image quality|5
7434672|NCT01600105|11716518|FG001|Sub Study III|Insufficient image quality|0
7434673|NCT01600105|11716517|FG000|Sub Study V|Poor Image Quality|2
7434674|NCT01600105|11716518|FG001|Sub Study V|Poor Image Quality|0
7434675|NCT01600326|11716555|FG000|Overall Study|Lost to Follow-up|1
7434676|NCT01600326|11716556|FG001|Overall Study|Lost to Follow-up|1
7434677|NCT01600586|11716583|FG000|Overall Study|Physician Decision|3
7434678|NCT01600586|11716584|FG001|Overall Study|Physician Decision|3
7434679|NCT01600716|11716619|FG000|Overall Study|Other Reasons|3
7434680|NCT01600716|11716620|FG001|Overall Study|Other Reasons|1
7434681|NCT01600716|11716619|FG000|Overall Study|Personal Reasons|0
7434682|NCT01600716|11716620|FG001|Overall Study|Personal Reasons|2
7434683|NCT01600716|11716619|FG000|Overall Study|Lost to Follow-up|0
7434684|NCT01600716|11716620|FG001|Overall Study|Lost to Follow-up|2
7434685|NCT01600716|11716619|FG000|Overall Study|Pregnancy|1
7434686|NCT01600716|11716620|FG001|Overall Study|Pregnancy|0
7434687|NCT01600716|11716619|FG000|Overall Study|Lack of Efficacy|2
7434688|NCT01600716|11716620|FG001|Overall Study|Lack of Efficacy|1
7434689|NCT01600716|11716619|FG000|Overall Study|Adverse Event|1
7434690|NCT01600716|11716620|FG001|Overall Study|Adverse Event|1
7434691|NCT01600885|11716632|FG000|First Period|Adverse Event|1
7434692|NCT01600885|11716633|FG001|First Period|Adverse Event|1
7434693|NCT01600885|11716632|FG000|First Period|moved out of area|1
7434694|NCT01600885|11716633|FG001|First Period|moved out of area|0
7434695|NCT01601132|11716655|FG000|Overall Study|Patient withdrew consent|1
7434696|NCT01601132|11716655|FG000|Overall Study|Protocol deviation|1
7434697|NCT01601470|11716691|FG000|Period 2 - LCZ696|Physician Decision|1
7434698|NCT01601496|11716697|FG000|Overall Study|Physician Decision|1
7434699|NCT01601496|11716697|FG000|Overall Study|Withdrawal by Subject|1
7434700|NCT01601496|11716697|FG000|Overall Study|Lost to Follow-up|6
7434701|NCT01601496|11716697|FG000|Overall Study|Death|4
7434702|NCT01601496|11716697|FG000|Overall Study|Other: patient refusal to continue|3
7434703|NCT01601535|11716707|FG000|Phase 1|Adverse Event|1
7434704|NCT01601535|11716708|FG001|Phase 1|Adverse Event|0
7434705|NCT01601535|11716709|FG002|Phase 1|Adverse Event|2
7434706|NCT01601535|11716710|FG003|Phase 1|Adverse Event|1
7434707|NCT01601535|11716711|FG004|Phase 1|Adverse Event|0
7434708|NCT01601535|11716712|FG005|Phase 1|Adverse Event|0
7434709|NCT01601535|11716707|FG000|Phase 1|Withdrawal by Subject|2
7434710|NCT01601535|11716708|FG001|Phase 1|Withdrawal by Subject|1
7434711|NCT01601535|11716709|FG002|Phase 1|Withdrawal by Subject|1
7434712|NCT01601535|11716710|FG003|Phase 1|Withdrawal by Subject|2
7434713|NCT01601535|11716711|FG004|Phase 1|Withdrawal by Subject|0
7434714|NCT01601535|11716712|FG005|Phase 1|Withdrawal by Subject|0
7434715|NCT01601535|11716707|FG000|Phase 1|Progressive Disease|2
7434716|NCT01601535|11716708|FG001|Phase 1|Progressive Disease|3
7434717|NCT01601535|11716709|FG002|Phase 1|Progressive Disease|2
7434718|NCT01601535|11716710|FG003|Phase 1|Progressive Disease|1
7434719|NCT01601535|11716711|FG004|Phase 1|Progressive Disease|0
7434720|NCT01601535|11716712|FG005|Phase 1|Progressive Disease|0
7434721|NCT01601535|11716707|FG000|Phase 1|Started Another Treatment|1
7434722|NCT01601535|11716708|FG001|Phase 1|Started Another Treatment|2
7434723|NCT01601535|11716709|FG002|Phase 1|Started Another Treatment|0
7434724|NCT01601535|11716710|FG003|Phase 1|Started Another Treatment|0
7434725|NCT01601535|11716711|FG004|Phase 1|Started Another Treatment|0
7434726|NCT01601535|11716712|FG005|Phase 1|Started Another Treatment|0
7434727|NCT01601535|11716707|FG000|Phase 2|Adverse Event|0
7434728|NCT01601535|11716708|FG001|Phase 2|Adverse Event|0
7434729|NCT01601535|11716709|FG002|Phase 2|Adverse Event|0
7434730|NCT01601535|11716710|FG003|Phase 2|Adverse Event|0
7434731|NCT01601535|11716711|FG004|Phase 2|Adverse Event|5
7434732|NCT01601535|11716712|FG005|Phase 2|Adverse Event|1
7434733|NCT01601535|11716707|FG000|Phase 2|Withdrawal by Subject|0
7434734|NCT01601535|11716708|FG001|Phase 2|Withdrawal by Subject|0
7434735|NCT01601535|11716709|FG002|Phase 2|Withdrawal by Subject|0
7434736|NCT01601535|11716710|FG003|Phase 2|Withdrawal by Subject|0
7434737|NCT01601535|11716711|FG004|Phase 2|Withdrawal by Subject|8
7434738|NCT01601535|11716712|FG005|Phase 2|Withdrawal by Subject|2
7434739|NCT01601535|11716707|FG000|Phase 2|Progressive Disease|0
7434740|NCT01601535|11716708|FG001|Phase 2|Progressive Disease|0
7434741|NCT01601535|11716709|FG002|Phase 2|Progressive Disease|0
7434742|NCT01601535|11716710|FG003|Phase 2|Progressive Disease|0
7434743|NCT01601535|11716711|FG004|Phase 2|Progressive Disease|5
7434744|NCT01601535|11716712|FG005|Phase 2|Progressive Disease|7
7434745|NCT01601535|11716707|FG000|Phase 2|Started Another Treatment|0
7434746|NCT01601535|11716708|FG001|Phase 2|Started Another Treatment|0
7434747|NCT01601535|11716709|FG002|Phase 2|Started Another Treatment|0
7434748|NCT01601535|11716710|FG003|Phase 2|Started Another Treatment|0
7434749|NCT01601535|11716711|FG004|Phase 2|Started Another Treatment|1
7434750|NCT01601535|11716712|FG005|Phase 2|Started Another Treatment|2
7434751|NCT01601626|11716738|FG000|Overall Study|Death|1
7434752|NCT01601626|11716739|FG001|Overall Study|Death|1
7434753|NCT01601626|11716740|FG002|Overall Study|Death|1
7434754|NCT01601626|11716738|FG000|Overall Study|Lost to Follow-up|1
7434755|NCT01601626|11716739|FG001|Overall Study|Lost to Follow-up|2
7434756|NCT01601626|11716740|FG002|Overall Study|Lost to Follow-up|0
7434757|NCT01601626|11716738|FG000|Overall Study|Unable to Get to Clinic|0
7434758|NCT01601626|11716739|FG001|Overall Study|Unable to Get to Clinic|1
7434759|NCT01601626|11716740|FG002|Overall Study|Unable to Get to Clinic|0
7434760|NCT01601626|11716738|FG000|Overall Study|Withdrawal by Subject|0
7434761|NCT01601626|11716739|FG001|Overall Study|Withdrawal by Subject|1
7434762|NCT01601626|11716740|FG002|Overall Study|Withdrawal by Subject|1
7434763|NCT01601626|11716738|FG000|Overall Study|Not Willing to Adhere to Requirements|1
7434764|NCT01601626|11716739|FG001|Overall Study|Not Willing to Adhere to Requirements|0
7434765|NCT01601626|11716740|FG002|Overall Study|Not Willing to Adhere to Requirements|0
7434766|NCT01601652|11716748|FG000|Overall Study|Death|1
7434767|NCT01601704|11716758|FG000|Overall Study|Randomized but not dispensed study med|1
7434768|NCT01601704|11716759|FG001|Overall Study|Randomized but not dispensed study med|4
7434769|NCT01601821|11716771|FG000|Overall Study|Death|2
7434770|NCT01601821|11716772|FG001|Overall Study|Death|5
7434771|NCT01601821|11716771|FG000|Overall Study|Protocol Violation|2
7434772|NCT01601821|11716772|FG001|Overall Study|Protocol Violation|2
7434773|NCT01601821|11716771|FG000|Overall Study|Lost to Follow-up|6
7434774|NCT01601821|11716772|FG001|Overall Study|Lost to Follow-up|14
7434775|NCT01601821|11716771|FG000|Overall Study|Withdrawal by Subject|1
7434776|NCT01601821|11716772|FG001|Overall Study|Withdrawal by Subject|0
7434777|NCT01601821|11716771|FG000|Overall Study|Graft Loss|6
7434778|NCT01601821|11716772|FG001|Overall Study|Graft Loss|6
7434779|NCT01601821|11716771|FG000|Overall Study|Study Events|7
7434780|NCT01601821|11716772|FG001|Overall Study|Study Events|1
7434781|NCT01601821|11716771|FG000|Overall Study|Other|5
7434782|NCT01601821|11716772|FG001|Overall Study|Other|1
7434783|NCT01601847|11716780|FG000|Overall Study|Death|1
7434784|NCT01601847|11716781|FG001|Overall Study|Death|0
7434785|NCT01601847|11716780|FG000|Overall Study|Withdrawal by Subject|11
7434786|NCT01601847|11716781|FG001|Overall Study|Withdrawal by Subject|7
7434787|NCT01601847|11716780|FG000|Overall Study|Lost to Follow-up|1
7434788|NCT01601847|11716781|FG001|Overall Study|Lost to Follow-up|3
7434789|NCT01601873|11716799|FG000|Overall Study|Lost to Follow-up|2
7434790|NCT01601873|11716800|FG001|Overall Study|Lost to Follow-up|3
7434791|NCT01602120|11716825|FG000|Overall Study|Adverse Event|3
7434792|NCT01602120|11716826|FG001|Overall Study|Adverse Event|6
7434793|NCT01602120|11716827|FG002|Overall Study|Adverse Event|0
7434794|NCT01602120|11716828|FG003|Overall Study|Adverse Event|2
7434795|NCT01602120|11716825|FG000|Overall Study|Death|0
7434796|NCT01602120|11716826|FG001|Overall Study|Death|4
7434797|NCT01602120|11716827|FG002|Overall Study|Death|0
7434798|NCT01602120|11716828|FG003|Overall Study|Death|0
7434799|NCT01602120|11716825|FG000|Overall Study|Lost to Follow-up|0
7434800|NCT01602120|11716826|FG001|Overall Study|Lost to Follow-up|1
7434801|NCT01602120|11716827|FG002|Overall Study|Lost to Follow-up|0
7434802|NCT01602120|11716828|FG003|Overall Study|Lost to Follow-up|1
7434803|NCT01602120|11716825|FG000|Overall Study|Protocol Violation|1
7434804|NCT01602120|11716826|FG001|Overall Study|Protocol Violation|1
7434805|NCT01602120|11716827|FG002|Overall Study|Protocol Violation|0
7434806|NCT01602120|11716828|FG003|Overall Study|Protocol Violation|0
7434807|NCT01602120|11716825|FG000|Overall Study|Non-compliance|0
7434808|NCT01602120|11716826|FG001|Overall Study|Non-compliance|3
7434809|NCT01602120|11716827|FG002|Overall Study|Non-compliance|0
7434810|NCT01602120|11716828|FG003|Overall Study|Non-compliance|1
7434811|NCT01602120|11716825|FG000|Overall Study|Withdrawal by Subject|8
7434812|NCT01602120|11716826|FG001|Overall Study|Withdrawal by Subject|17
7434813|NCT01602120|11716827|FG002|Overall Study|Withdrawal by Subject|0
7434814|NCT01602120|11716828|FG003|Overall Study|Withdrawal by Subject|3
7434815|NCT01602120|11716825|FG000|Overall Study|Study Terminated by Sponsor|12
7434816|NCT01602120|11716826|FG001|Overall Study|Study Terminated by Sponsor|24
7434817|NCT01602120|11716827|FG002|Overall Study|Study Terminated by Sponsor|17
7434818|NCT01602120|11716828|FG003|Overall Study|Study Terminated by Sponsor|44
7434819|NCT01602120|11716825|FG000|Overall Study|Physician Decision|2
7434820|NCT01602120|11716826|FG001|Overall Study|Physician Decision|3
7434821|NCT01602120|11716827|FG002|Overall Study|Physician Decision|0
7434822|NCT01602120|11716828|FG003|Overall Study|Physician Decision|0
7434823|NCT01602120|11716825|FG000|Overall Study|Unspecified Reason|3
7434824|NCT01602120|11716826|FG001|Overall Study|Unspecified Reason|1
7434825|NCT01602120|11716827|FG002|Overall Study|Unspecified Reason|0
7434826|NCT01602120|11716828|FG003|Overall Study|Unspecified Reason|2
7434827|NCT01602224|11716862|FG000|Overall Study|Adverse Event|0
7434828|NCT01602224|11716863|FG001|Overall Study|Adverse Event|1
7434829|NCT01602224|11716864|FG002|Overall Study|Adverse Event|0
7434830|NCT01602224|11716862|FG000|Overall Study|Investigator Decison|1
7434831|NCT01602224|11716863|FG001|Overall Study|Investigator Decison|0
7434832|NCT01602224|11716864|FG002|Overall Study|Investigator Decison|0
7434833|NCT01602224|11716862|FG000|Overall Study|Lost to Follow-up|0
7434834|NCT01602224|11716863|FG001|Overall Study|Lost to Follow-up|0
7434835|NCT01602224|11716864|FG002|Overall Study|Lost to Follow-up|1
7434836|NCT01602224|11716862|FG000|Overall Study|Protocol Violation|0
7434837|NCT01602224|11716863|FG001|Overall Study|Protocol Violation|1
7434838|NCT01602224|11716864|FG002|Overall Study|Protocol Violation|0
7434839|NCT01602224|11716862|FG000|Overall Study|Sponsor Decision|2
7434840|NCT01602224|11716863|FG001|Overall Study|Sponsor Decision|3
7434841|NCT01602224|11716864|FG002|Overall Study|Sponsor Decision|2
7434842|NCT01602224|11716862|FG000|Overall Study|Withdrawal by Subject|5
7434843|NCT01602224|11716863|FG001|Overall Study|Withdrawal by Subject|3
7434844|NCT01602224|11716864|FG002|Overall Study|Withdrawal by Subject|3
7434845|NCT01602315|11716881|FG000|Overall Study|Protocol Violation|0
7434846|NCT01602315|11716882|FG001|Overall Study|Protocol Violation|0
7434847|NCT01602315|11716883|FG002|Overall Study|Protocol Violation|0
7434848|NCT01602315|11716884|FG003|Overall Study|Protocol Violation|0
7434849|NCT01602315|11716885|FG004|Overall Study|Protocol Violation|0
7434850|NCT01602315|11716886|FG005|Overall Study|Protocol Violation|1
7434851|NCT01602315|11716887|FG006|Overall Study|Protocol Violation|0
7434852|NCT01602315|11716881|FG000|Overall Study|Physician Decision|2
7434853|NCT01602315|11716882|FG001|Overall Study|Physician Decision|0
7434854|NCT01602315|11716883|FG002|Overall Study|Physician Decision|0
7434855|NCT01602315|11716884|FG003|Overall Study|Physician Decision|0
7434856|NCT01602315|11716885|FG004|Overall Study|Physician Decision|2
7434857|NCT01602315|11716886|FG005|Overall Study|Physician Decision|1
7434858|NCT01602315|11716887|FG006|Overall Study|Physician Decision|1
7434859|NCT01602315|11716881|FG000|Overall Study|Disease progression|6
7434860|NCT01602315|11716882|FG001|Overall Study|Disease progression|3
7434861|NCT01602315|11716883|FG002|Overall Study|Disease progression|10
7434862|NCT01602315|11716884|FG003|Overall Study|Disease progression|1
7434863|NCT01602315|11716885|FG004|Overall Study|Disease progression|41
7434864|NCT01602315|11716886|FG005|Overall Study|Disease progression|12
7434865|NCT01602315|11716887|FG006|Overall Study|Disease progression|15
7434866|NCT01602315|11716881|FG000|Overall Study|Death|1
7434867|NCT01602315|11716882|FG001|Overall Study|Death|1
7434868|NCT01602315|11716883|FG002|Overall Study|Death|1
7434869|NCT01602315|11716884|FG003|Overall Study|Death|1
7434870|NCT01602315|11716885|FG004|Overall Study|Death|7
7434871|NCT01602315|11716886|FG005|Overall Study|Death|2
7434872|NCT01602315|11716887|FG006|Overall Study|Death|2
7434873|NCT01602315|11716881|FG000|Overall Study|Withdrawal by Subject|2
7434874|NCT01602315|11716882|FG001|Overall Study|Withdrawal by Subject|0
7434875|NCT01602315|11716883|FG002|Overall Study|Withdrawal by Subject|2
7434876|NCT01602315|11716884|FG003|Overall Study|Withdrawal by Subject|0
7434877|NCT01602315|11716885|FG004|Overall Study|Withdrawal by Subject|6
7434878|NCT01602315|11716886|FG005|Overall Study|Withdrawal by Subject|0
7434879|NCT01602315|11716887|FG006|Overall Study|Withdrawal by Subject|1
7434880|NCT01602315|11716881|FG000|Overall Study|Adverse Event|5
7434881|NCT01602315|11716882|FG001|Overall Study|Adverse Event|1
7434882|NCT01602315|11716883|FG002|Overall Study|Adverse Event|5
7434883|NCT01602315|11716884|FG003|Overall Study|Adverse Event|4
7434884|NCT01602315|11716885|FG004|Overall Study|Adverse Event|15
7434885|NCT01602315|11716886|FG005|Overall Study|Adverse Event|3
7434886|NCT01602315|11716887|FG006|Overall Study|Adverse Event|9
7434887|NCT01602315|11716881|FG000|Overall Study|Subject/guardian decision|0
7434888|NCT01602315|11716882|FG001|Overall Study|Subject/guardian decision|0
7434889|NCT01602315|11716883|FG002|Overall Study|Subject/guardian decision|0
7434890|NCT01602315|11716884|FG003|Overall Study|Subject/guardian decision|0
7434891|NCT01602315|11716885|FG004|Overall Study|Subject/guardian decision|0
7434892|NCT01602315|11716886|FG005|Overall Study|Subject/guardian decision|0
7434893|NCT01602315|11716887|FG006|Overall Study|Subject/guardian decision|1
7434894|NCT01602315|11716881|FG000|Overall Study|Cross-over patients to combo treatment|0
7434895|NCT01602315|11716882|FG001|Overall Study|Cross-over patients to combo treatment|0
7434896|NCT01602315|11716883|FG002|Overall Study|Cross-over patients to combo treatment|0
7434897|NCT01602315|11716884|FG003|Overall Study|Cross-over patients to combo treatment|0
7434898|NCT01602315|11716885|FG004|Overall Study|Cross-over patients to combo treatment|0
7434899|NCT01602315|11716886|FG005|Overall Study|Cross-over patients to combo treatment|16
7434900|NCT01602315|11716887|FG006|Overall Study|Cross-over patients to combo treatment|0
7434901|NCT01602341|11716925|FG000|Overall Study|Adverse Event|0
7434902|NCT01602341|11716926|FG001|Overall Study|Adverse Event|1
7434903|NCT01602419|11716936|FG000|Overall Study|Not treated with Wilate|9
7434904|NCT01602419|11716936|FG000|Overall Study|Adverse Drug Reaction|4
7434905|NCT01602419|11716936|FG000|Overall Study|Insurance issues|3
7434906|NCT01602419|11716936|FG000|Overall Study|Changed treatment centre|1
7434907|NCT01602419|11716936|FG000|Overall Study|Treatment centre closed|1
7434908|NCT01602419|11716936|FG000|Overall Study|Withdrawal by Subject|5
7434909|NCT01602419|11716936|FG000|Overall Study|Lost to Follow-up|6
7434910|NCT01602484|11716983|FG000|Overall Study|Airway issues unrelated to study|0
7434911|NCT01602484|11716984|FG001|Overall Study|Airway issues unrelated to study|1
7434912|NCT01602510|11716990|FG000|Open Label Phase|Adverse Event|46
7434913|NCT01602510|11716991|FG001|Open Label Phase|Adverse Event|0
7434914|NCT01602510|11716992|FG002|Open Label Phase|Adverse Event|0
7434915|NCT01602510|11716990|FG000|Open Label Phase|Lack of Efficacy|22
7434916|NCT01602510|11716991|FG001|Open Label Phase|Lack of Efficacy|0
7434917|NCT01602510|11716992|FG002|Open Label Phase|Lack of Efficacy|0
7434918|NCT01602510|11716990|FG000|Open Label Phase|Protocol Violation|15
7434919|NCT01602510|11716991|FG001|Open Label Phase|Protocol Violation|0
7434920|NCT01602510|11716992|FG002|Open Label Phase|Protocol Violation|0
7434921|NCT01602510|11716990|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
7434922|NCT01602510|11716991|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
7434923|NCT01602510|11716992|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
7434924|NCT01602510|11716990|FG000|Open Label Phase|Lost to Follow-up|22
7434925|NCT01602510|11716991|FG001|Open Label Phase|Lost to Follow-up|0
7434926|NCT01602510|11716992|FG002|Open Label Phase|Lost to Follow-up|0
7434927|NCT01602510|11716990|FG000|Open Label Phase|Physician Decision|19
7434928|NCT01602510|11716991|FG001|Open Label Phase|Physician Decision|0
7434929|NCT01602510|11716992|FG002|Open Label Phase|Physician Decision|0
7434930|NCT01602510|11716990|FG000|Open Label Phase|Withdrawal by Subject|57
7434931|NCT01602510|11716991|FG001|Open Label Phase|Withdrawal by Subject|0
7559156|NCT03137992|11924996|FG002|Washout Period 2|Withdrawal by Subject|0
7559157|NCT03137992|11924997|FG003|Washout Period 2|Withdrawal by Subject|0
7559158|NCT03137992|11924998|FG004|Washout Period 2|Withdrawal by Subject|1
7559159|NCT03137992|11924999|FG005|Washout Period 2|Withdrawal by Subject|0
7559160|NCT03137992|11924994|FG000|Washout Period 2|Sponsor Decision|0
7559161|NCT03137992|11924995|FG001|Washout Period 2|Sponsor Decision|0
7559162|NCT03137992|11924996|FG002|Washout Period 2|Sponsor Decision|0
7559163|NCT03137992|11924997|FG003|Washout Period 2|Sponsor Decision|0
7559164|NCT03137992|11924998|FG004|Washout Period 2|Sponsor Decision|0
7559165|NCT03137992|11924999|FG005|Washout Period 2|Sponsor Decision|1
7559166|NCT03137992|11924994|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
7559167|NCT03137992|11924995|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
7559168|NCT03137992|11924996|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
7559169|NCT03137992|11924997|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
7559170|NCT03137992|11924998|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
7559171|NCT03137992|11924999|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
7559172|NCT03137992|11924994|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
7559173|NCT03137992|11924995|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
7559174|NCT03137992|11924996|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
7559175|NCT03137992|11924997|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
7559176|NCT03137992|11924998|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
7434932|NCT01602510|11716992|FG002|Open Label Phase|Withdrawal by Subject|0
7434933|NCT01602510|11716990|FG000|Randomized Phase|Adverse Event|0
7434934|NCT01602510|11716991|FG001|Randomized Phase|Adverse Event|2
7434935|NCT01602510|11716992|FG002|Randomized Phase|Adverse Event|6
7434936|NCT01602510|11716990|FG000|Randomized Phase|Lack of Efficacy|0
7434937|NCT01602510|11716991|FG001|Randomized Phase|Lack of Efficacy|4
7559177|NCT03137992|11924999|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
7559178|NCT03137992|11924994|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7559179|NCT03137992|11924995|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7434938|NCT01602510|11716992|FG002|Randomized Phase|Lack of Efficacy|4
7574824|NCT03695367|11958008|FG000|Overall Study|Withdrawal by Subject|0
7559180|NCT03137992|11924996|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
7559181|NCT03137992|11924997|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7434939|NCT01602510|11716990|FG000|Randomized Phase|Protocol Violation|0
7434940|NCT01602510|11716991|FG001|Randomized Phase|Protocol Violation|3
7434941|NCT01602510|11716992|FG002|Randomized Phase|Protocol Violation|3
7434942|NCT01602510|11716990|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
7434943|NCT01602510|11716991|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
7434944|NCT01602510|11716992|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
7434945|NCT01602510|11716990|FG000|Randomized Phase|Lost to Follow-up|0
7434946|NCT01602510|11716991|FG001|Randomized Phase|Lost to Follow-up|1
7434947|NCT01602510|11716992|FG002|Randomized Phase|Lost to Follow-up|3
7434948|NCT01602510|11716990|FG000|Randomized Phase|Physician Decision|0
7434949|NCT01602510|11716991|FG001|Randomized Phase|Physician Decision|0
7434950|NCT01602510|11716992|FG002|Randomized Phase|Physician Decision|2
7434951|NCT01602510|11716990|FG000|Randomized Phase|Withdrawal by Subject|0
7434952|NCT01602510|11716991|FG001|Randomized Phase|Withdrawal by Subject|6
7434953|NCT01602510|11716992|FG002|Randomized Phase|Withdrawal by Subject|7
7434954|NCT01602549|11717000|FG000|Overall Study|Protocol Violation|0
7434955|NCT01602549|11717001|FG001|Overall Study|Protocol Violation|1
7434956|NCT01602549|11717000|FG000|Overall Study|Withdrawal by Subject|1
7434957|NCT01602549|11717001|FG001|Overall Study|Withdrawal by Subject|0
7434958|NCT01602562|11717011|FG000|Overall Study|Adverse Event|3
7434959|NCT01602562|11717012|FG001|Overall Study|Adverse Event|1
7434960|NCT01602562|11717011|FG000|Overall Study|Physician Decision|1
7434961|NCT01602562|11717012|FG001|Overall Study|Physician Decision|1
7434962|NCT01602562|11717011|FG000|Overall Study|Withdrawal by Subject|1
7434963|NCT01602562|11717012|FG001|Overall Study|Withdrawal by Subject|1
7434964|NCT01602744|11717070|FG000|Overall Study|Death|17
7434965|NCT01602744|11717071|FG001|Overall Study|Death|15
7434966|NCT01602744|11717070|FG000|Overall Study|Lost to Follow-up|13
7434967|NCT01602744|11717071|FG001|Overall Study|Lost to Follow-up|8
7434968|NCT01602965|11717079|FG000|Overall Study|Lost to Follow-up|4
7434969|NCT01602965|11717080|FG001|Overall Study|Lost to Follow-up|2
7434970|NCT01603082|11717097|FG000|Overall Study|Adverse Event|0
7434971|NCT01603082|11717098|FG001|Overall Study|Adverse Event|1
7434972|NCT01603082|11717097|FG000|Overall Study|Withdrawal by Subject|1
7434973|NCT01603082|11717098|FG001|Overall Study|Withdrawal by Subject|0
7434974|NCT01603082|11717097|FG000|Overall Study|Failed inclusion criterion after dosed|1
7434975|NCT01603082|11717098|FG001|Overall Study|Failed inclusion criterion after dosed|0
7434976|NCT01603277|11717106|FG000|Overall Study|Adverse Event|1
7434977|NCT01603277|11717107|FG001|Overall Study|Adverse Event|2
7434978|NCT01603277|11717106|FG000|Overall Study|Physician Decision|0
7434979|NCT01603277|11717107|FG001|Overall Study|Physician Decision|1
7559182|NCT03137992|11924998|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7559183|NCT03137992|11924999|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
7559184|NCT03137992|11924994|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
7559185|NCT03137992|11924995|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
7559186|NCT03137992|11924996|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
7559187|NCT03137992|11924997|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
7559188|NCT03137992|11924998|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
7559189|NCT03137992|11924999|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
7559190|NCT03137992|11924994|FG000|Part 2 (Open-label Extension)|Per study team|1
7559191|NCT03137992|11924995|FG001|Part 2 (Open-label Extension)|Per study team|0
7559192|NCT03137992|11924996|FG002|Part 2 (Open-label Extension)|Per study team|0
7559193|NCT03137992|11924997|FG003|Part 2 (Open-label Extension)|Per study team|0
7559194|NCT03137992|11924998|FG004|Part 2 (Open-label Extension)|Per study team|0
7559195|NCT03137992|11924999|FG005|Part 2 (Open-label Extension)|Per study team|0
7559196|NCT03137992|11924994|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
7559197|NCT03137992|11924995|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
7559198|NCT03137992|11924996|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
7559199|NCT03137992|11924997|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
7559200|NCT03137992|11924998|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
7559201|NCT03137992|11924999|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
7559202|NCT03138655|11925059|FG000|Overall Study|Adverse Event|2
7559203|NCT03138655|11925060|FG001|Overall Study|Adverse Event|1
7559204|NCT03138655|11925061|FG002|Overall Study|Adverse Event|2
7559205|NCT03138655|11925062|FG003|Overall Study|Adverse Event|1
7559206|NCT03138655|11925063|FG004|Overall Study|Adverse Event|1
7559207|NCT03138655|11925064|FG005|Overall Study|Adverse Event|4
7559208|NCT03138655|11925065|FG006|Overall Study|Adverse Event|2
7559209|NCT03138655|11925066|FG007|Overall Study|Adverse Event|2
7559210|NCT03138655|11925059|FG000|Overall Study|Withdrawal by Subject|0
7559211|NCT03138655|11925060|FG001|Overall Study|Withdrawal by Subject|1
7434980|NCT01603277|11717106|FG000|Overall Study|Protocol Violation|6
7434981|NCT01603277|11717107|FG001|Overall Study|Protocol Violation|10
7434982|NCT01603277|11717106|FG000|Overall Study|Withdrawal by Subject|5
7434983|NCT01603277|11717107|FG001|Overall Study|Withdrawal by Subject|4
7434984|NCT01603277|11717106|FG000|Overall Study|Non-Compliance|2
7434985|NCT01603277|11717107|FG001|Overall Study|Non-Compliance|1
7434986|NCT01603355|11717113|FG000|Overall Study|Lack of Efficacy|2
7434987|NCT01603459|11717138|FG000|Overall Study|Adverse Event|5
7434988|NCT01603459|11717138|FG000|Overall Study|Withdrawal by Subject|5
7434989|NCT01603459|11717138|FG000|Overall Study|Lost to Follow-up|3
7434990|NCT01603459|11717138|FG000|Overall Study|Predefined discontinuation criteria|3
7434991|NCT01603459|11717138|FG000|Overall Study|Non-compliance|1
7434992|NCT01603459|11717138|FG000|Overall Study|Administrative reason|1
7434993|NCT01603602|11717163|FG000|Overall Study|Adverse Event|1
7434994|NCT01603602|11717164|FG001|Overall Study|Adverse Event|0
7559212|NCT03138655|11925061|FG002|Overall Study|Withdrawal by Subject|0
7559213|NCT03138655|11925062|FG003|Overall Study|Withdrawal by Subject|0
7559214|NCT03138655|11925063|FG004|Overall Study|Withdrawal by Subject|0
7559215|NCT03138655|11925064|FG005|Overall Study|Withdrawal by Subject|0
7559216|NCT03138655|11925065|FG006|Overall Study|Withdrawal by Subject|1
7559217|NCT03138655|11925066|FG007|Overall Study|Withdrawal by Subject|0
7559218|NCT03138655|11925059|FG000|Overall Study|Reason not Specified|1
7559219|NCT03138655|11925060|FG001|Overall Study|Reason not Specified|0
7559220|NCT03138655|11925061|FG002|Overall Study|Reason not Specified|0
7559221|NCT03138655|11925062|FG003|Overall Study|Reason not Specified|2
7559222|NCT03138655|11925063|FG004|Overall Study|Reason not Specified|1
7559223|NCT03138655|11925064|FG005|Overall Study|Reason not Specified|1
7559224|NCT03138655|11925065|FG006|Overall Study|Reason not Specified|0
7559225|NCT03138655|11925066|FG007|Overall Study|Reason not Specified|0
7559226|NCT03138967|11925104|FG000|Overall Study|Death|0
7434995|NCT01603602|11717165|FG002|Overall Study|Adverse Event|0
7434996|NCT01603602|11717163|FG000|Overall Study|Personal Reasons|1
7434997|NCT01603602|11717164|FG001|Overall Study|Personal Reasons|0
7434998|NCT01603602|11717165|FG002|Overall Study|Personal Reasons|1
7434999|NCT01603615|11717173|FG000|Overall Study|Did not Receive Treatment|7
7435000|NCT01603615|11717173|FG000|Overall Study|Lost to Follow-up|9
7435001|NCT01603615|11717173|FG000|Overall Study|Personal Reasons|17
7435002|NCT01603615|11717173|FG000|Overall Study|Other Miscellaneous|1
7435003|NCT01603628|11717180|FG000|Overall Study|Personal Reasons|1
7435004|NCT01603628|11717181|FG001|Overall Study|Personal Reasons|1
7435005|NCT01603628|11717182|FG002|Overall Study|Personal Reasons|2
7435006|NCT01603628|11717180|FG000|Overall Study|Protocol Violation|1
7435007|NCT01603628|11717181|FG001|Overall Study|Protocol Violation|1
7435008|NCT01603628|11717182|FG002|Overall Study|Protocol Violation|0
7435009|NCT01603628|11717180|FG000|Overall Study|Lost to Follow-up|0
7435010|NCT01603628|11717181|FG001|Overall Study|Lost to Follow-up|1
7435011|NCT01603628|11717182|FG002|Overall Study|Lost to Follow-up|0
7435012|NCT01603628|11717180|FG000|Overall Study|Other Miscellaneous Reason|1
7435013|NCT01603628|11717181|FG001|Overall Study|Other Miscellaneous Reason|0
7435014|NCT01603628|11717182|FG002|Overall Study|Other Miscellaneous Reason|0
7435015|NCT01603641|11717190|FG000|Overall Study|Did not Receive Treatment|3
7435016|NCT01603641|11717190|FG000|Overall Study|Adverse Event|1
7435017|NCT01603641|11717190|FG000|Overall Study|Lack of Efficacy|1
7435018|NCT01603641|11717190|FG000|Overall Study|Lost to Follow-up|6
7435019|NCT01603641|11717190|FG000|Overall Study|Personal Reasons|18
7435020|NCT01603641|11717190|FG000|Overall Study|Other Miscellaneous Reasons|6
7435021|NCT01603875|11717197|FG000|Overall Study|Preexisting rabies antibody|3
7435022|NCT01603875|11717198|FG001|Overall Study|Preexisting rabies antibody|4
7435023|NCT01603875|11717199|FG002|Overall Study|Preexisting rabies antibody|3
7435024|NCT01603875|11717197|FG000|Overall Study|Lost to Follow-up|4
7435025|NCT01603875|11717198|FG001|Overall Study|Lost to Follow-up|3
7435026|NCT01603875|11717199|FG002|Overall Study|Lost to Follow-up|6
7435027|NCT01603875|11717197|FG000|Overall Study|Protocol Violation|0
7435028|NCT01603875|11717198|FG001|Overall Study|Protocol Violation|1
7435029|NCT01603875|11717199|FG002|Overall Study|Protocol Violation|0
7435030|NCT01604265|11717237|FG000|Overall Study|Adverse Event|1
7435031|NCT01604265|11717238|FG001|Overall Study|Adverse Event|0
7435032|NCT01604265|11717237|FG000|Overall Study|Withdrawal by Subject|1
7435033|NCT01604265|11717238|FG001|Overall Study|Withdrawal by Subject|0
7435034|NCT01604278|11717246|FG000|Overall Study|Lack of Efficacy|0
7435035|NCT01604278|11717247|FG001|Overall Study|Lack of Efficacy|1
7435036|NCT01604278|11717246|FG000|Overall Study|Lost to Follow-up|1
7435037|NCT01604278|11717247|FG001|Overall Study|Lost to Follow-up|0
7435038|NCT01604278|11717246|FG000|Overall Study|Administrative problems|2
7435039|NCT01604278|11717247|FG001|Overall Study|Administrative problems|1
7559227|NCT03138967|11925105|FG001|Overall Study|Death|1
7559228|NCT03138967|11925104|FG000|Overall Study|Physician Decision|1
7559229|NCT03138967|11925105|FG001|Overall Study|Physician Decision|3
7559230|NCT03139240|11925120|FG000|Overall Study|Lost to Follow-up|0
7435040|NCT01604278|11717246|FG000|Overall Study|Withdrawal by Subject|3
7435041|NCT01604278|11717247|FG001|Overall Study|Withdrawal by Subject|3
7435042|NCT01604278|11717246|FG000|Overall Study|Adverse Event|3
7435043|NCT01604278|11717247|FG001|Overall Study|Adverse Event|5
7435044|NCT01604278|11717246|FG000|Overall Study|Protocol Deviation|5
7435045|NCT01604278|11717247|FG001|Overall Study|Protocol Deviation|3
7435046|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
7435047|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7435048|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
7435049|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
7435050|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
7532730|NCT02674854|11878463|FG002|Overall Study|Protocol Violation|2
7532731|NCT02674854|11878461|FG000|Overall Study|Death|0
7532732|NCT02674854|11878462|FG001|Overall Study|Death|1
7532733|NCT02674854|11878463|FG002|Overall Study|Death|0
7532734|NCT02674854|11878461|FG000|Overall Study|Subject missed V6.2|1
7532735|NCT02674854|11878462|FG001|Overall Study|Subject missed V6.2|0
7532736|NCT02674854|11878463|FG002|Overall Study|Subject missed V6.2|0
7532737|NCT02675075|11878473|FG000|Overall Study|Lost to Follow-up|3
7532738|NCT02675075|11878474|FG001|Overall Study|Lost to Follow-up|0
7532739|NCT02675517|11878482|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
7532740|NCT02675517|11878482|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
7532741|NCT02675634|11878495|FG000|Test Period 1|Adverse Event|0
7532742|NCT02675634|11878496|FG001|Test Period 1|Adverse Event|1
7435051|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
7435052|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7435053|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
7435054|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
7435055|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
7532743|NCT02675634|11878497|FG002|Test Period 1|Adverse Event|0
7532744|NCT02675634|11878498|FG003|Test Period 1|Adverse Event|1
7532745|NCT02675634|11878499|FG004|Test Period 1|Adverse Event|0
7532746|NCT02675634|11878500|FG005|Test Period 1|Adverse Event|0
7532747|NCT02675634|11878495|FG000|Test Period 1|Device deficiency that did not lead to A|0
7532748|NCT02675634|11878496|FG001|Test Period 1|Device deficiency that did not lead to A|0
7532749|NCT02675634|11878497|FG002|Test Period 1|Device deficiency that did not lead to A|1
7532750|NCT02675634|11878498|FG003|Test Period 1|Device deficiency that did not lead to A|0
7532751|NCT02675634|11878499|FG004|Test Period 1|Device deficiency that did not lead to A|0
7532752|NCT02675634|11878500|FG005|Test Period 1|Device deficiency that did not lead to A|0
7532753|NCT02675634|11878495|FG000|Test Period 2|Lack of Efficacy|1
7532754|NCT02675634|11878496|FG001|Test Period 2|Lack of Efficacy|0
7532755|NCT02675634|11878497|FG002|Test Period 2|Lack of Efficacy|0
7532756|NCT02675634|11878498|FG003|Test Period 2|Lack of Efficacy|0
7532757|NCT02675634|11878499|FG004|Test Period 2|Lack of Efficacy|0
7532758|NCT02675634|11878500|FG005|Test Period 2|Lack of Efficacy|0
7532759|NCT02675634|11878495|FG000|Test Period 2|Adverse Event|0
7532760|NCT02675634|11878496|FG001|Test Period 2|Adverse Event|0
7532761|NCT02675634|11878497|FG002|Test Period 2|Adverse Event|0
7532762|NCT02675634|11878498|FG003|Test Period 2|Adverse Event|0
7532763|NCT02675634|11878499|FG004|Test Period 2|Adverse Event|0
7532764|NCT02675634|11878500|FG005|Test Period 2|Adverse Event|1
7532765|NCT02675907|11878519|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7532766|NCT02675907|11878520|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
7532767|NCT02675907|11878519|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7532768|NCT02675907|11878520|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
7532769|NCT02675907|11878519|FG000|Study Overall|Lack of Efficacy|1
7532770|NCT02675907|11878520|FG001|Study Overall|Lack of Efficacy|0
7532771|NCT02675907|11878519|FG000|Study Overall|Withdrawal by Subject|2
7532772|NCT02675907|11878520|FG001|Study Overall|Withdrawal by Subject|2
7532773|NCT02675907|11878519|FG000|Study Overall|Lost to Follow-up|0
7532774|NCT02675907|11878520|FG001|Study Overall|Lost to Follow-up|2
7532775|NCT02675998|11878530|FG000|8-Week Treatment Period|Adverse Event|6
7532776|NCT02675998|11878531|FG001|8-Week Treatment Period|Adverse Event|5
7532777|NCT02675998|11878532|FG002|8-Week Treatment Period|Adverse Event|6
7532778|NCT02675998|11878533|FG003|8-Week Treatment Period|Adverse Event|0
7532779|NCT02675998|11878530|FG000|8-Week Treatment Period|Withdrawal by Subject|3
7435056|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
7435057|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
7435058|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
7435059|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
7435060|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
7435061|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Death|5
7435062|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Death|0
7435063|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Death|2
7532780|NCT02675998|11878531|FG001|8-Week Treatment Period|Withdrawal by Subject|3
7532781|NCT02675998|11878532|FG002|8-Week Treatment Period|Withdrawal by Subject|3
7532782|NCT02675998|11878533|FG003|8-Week Treatment Period|Withdrawal by Subject|0
7532783|NCT02675998|11878530|FG000|8-Week Treatment Period|Lack of Efficacy|2
7532784|NCT02675998|11878531|FG001|8-Week Treatment Period|Lack of Efficacy|5
7532785|NCT02675998|11878532|FG002|8-Week Treatment Period|Lack of Efficacy|3
7559231|NCT03139240|11925121|FG001|Overall Study|Lost to Follow-up|1
7559232|NCT03139240|11925122|FG002|Overall Study|Lost to Follow-up|1
7559233|NCT03139240|11925123|FG003|Overall Study|Lost to Follow-up|0
7559234|NCT03139279|11925133|FG000|Overall Study|Physician Decision|2
7559235|NCT03139279|11925134|FG001|Overall Study|Physician Decision|0
7559236|NCT03139279|11925133|FG000|Overall Study|Protocol Violation|5
7559237|NCT03139279|11925134|FG001|Overall Study|Protocol Violation|4
7559238|NCT03139279|11925133|FG000|Overall Study|Withdrawal by Subject|0
7559239|NCT03139279|11925134|FG001|Overall Study|Withdrawal by Subject|2
7435064|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Death|0
7435065|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Death|4
7435066|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
7435067|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7435068|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
7435069|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
7435070|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
7435071|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
7435072|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
7435073|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
7435074|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
7435075|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
7435076|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
7435077|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
7435078|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
7435079|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
7435080|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
7435081|NCT01604343|11717281|FG000|Prior to W52 Administration(Through W52)|Other|15
7435082|NCT01604343|11717282|FG001|Prior to W52 Administration(Through W52)|Other|0
7435083|NCT01604343|11717283|FG002|Prior to W52 Administration(Through W52)|Other|10
7435084|NCT01604343|11717284|FG003|Prior to W52 Administration(Through W52)|Other|0
7435085|NCT01604343|11717285|FG004|Prior to W52 Administration(Through W52)|Other|6
7435086|NCT01604343|11717281|FG000|Week 52 to Week 104|Lost to Follow-up|0
7435087|NCT01604343|11717282|FG001|Week 52 to Week 104|Lost to Follow-up|2
7435088|NCT01604343|11717283|FG002|Week 52 to Week 104|Lost to Follow-up|4
7435089|NCT01604343|11717284|FG003|Week 52 to Week 104|Lost to Follow-up|2
7435090|NCT01604343|11717285|FG004|Week 52 to Week 104|Lost to Follow-up|1
7435091|NCT01604343|11717281|FG000|Week 52 to Week 104|Withdrawal by Subject|0
7435092|NCT01604343|11717282|FG001|Week 52 to Week 104|Withdrawal by Subject|7
7435093|NCT01604343|11717283|FG002|Week 52 to Week 104|Withdrawal by Subject|12
7435094|NCT01604343|11717284|FG003|Week 52 to Week 104|Withdrawal by Subject|8
7435095|NCT01604343|11717285|FG004|Week 52 to Week 104|Withdrawal by Subject|4
7435096|NCT01604343|11717281|FG000|Week 52 to Week 104|Adverse Event|0
7435097|NCT01604343|11717282|FG001|Week 52 to Week 104|Adverse Event|12
7435098|NCT01604343|11717283|FG002|Week 52 to Week 104|Adverse Event|26
7435099|NCT01604343|11717284|FG003|Week 52 to Week 104|Adverse Event|21
7435100|NCT01604343|11717285|FG004|Week 52 to Week 104|Adverse Event|27
7435101|NCT01604343|11717281|FG000|Week 52 to Week 104|Death|0
7435102|NCT01604343|11717282|FG001|Week 52 to Week 104|Death|4
7435103|NCT01604343|11717283|FG002|Week 52 to Week 104|Death|2
7435104|NCT01604343|11717284|FG003|Week 52 to Week 104|Death|5
7435105|NCT01604343|11717285|FG004|Week 52 to Week 104|Death|0
7435106|NCT01604343|11717281|FG000|Week 52 to Week 104|Lack of Efficacy|0
7435107|NCT01604343|11717282|FG001|Week 52 to Week 104|Lack of Efficacy|6
7435108|NCT01604343|11717283|FG002|Week 52 to Week 104|Lack of Efficacy|11
7435109|NCT01604343|11717284|FG003|Week 52 to Week 104|Lack of Efficacy|2
7435110|NCT01604343|11717285|FG004|Week 52 to Week 104|Lack of Efficacy|3
7435111|NCT01604343|11717281|FG000|Week 52 to Week 104|Physician Decision|0
7435112|NCT01604343|11717282|FG001|Week 52 to Week 104|Physician Decision|1
7435113|NCT01604343|11717283|FG002|Week 52 to Week 104|Physician Decision|0
7435114|NCT01604343|11717284|FG003|Week 52 to Week 104|Physician Decision|0
7435115|NCT01604343|11717285|FG004|Week 52 to Week 104|Physician Decision|2
7435116|NCT01604343|11717281|FG000|Week 52 to Week 104|Pregnancy|0
7435117|NCT01604343|11717282|FG001|Week 52 to Week 104|Pregnancy|0
7435118|NCT01604343|11717283|FG002|Week 52 to Week 104|Pregnancy|1
7435119|NCT01604343|11717284|FG003|Week 52 to Week 104|Pregnancy|2
7435120|NCT01604343|11717285|FG004|Week 52 to Week 104|Pregnancy|1
7435121|NCT01604343|11717281|FG000|Week 52 to Week 104|Other|0
7435122|NCT01604343|11717282|FG001|Week 52 to Week 104|Other|11
7435123|NCT01604343|11717283|FG002|Week 52 to Week 104|Other|11
7435124|NCT01604343|11717284|FG003|Week 52 to Week 104|Other|6
7435125|NCT01604343|11717285|FG004|Week 52 to Week 104|Other|3
7435126|NCT01604343|11717281|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
7435127|NCT01604343|11717282|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7435128|NCT01604343|11717283|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
7435129|NCT01604343|11717284|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7435130|NCT01604343|11717285|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
7435131|NCT01604343|11717281|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
7435132|NCT01604343|11717282|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
7435133|NCT01604343|11717283|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
7435134|NCT01604343|11717284|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
7435135|NCT01604343|11717285|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
7435136|NCT01604343|11717281|FG000|Safety Follow-up Period (Week 104-120)|Other|15
7435137|NCT01604343|11717282|FG001|Safety Follow-up Period (Week 104-120)|Other|2
7435138|NCT01604343|11717283|FG002|Safety Follow-up Period (Week 104-120)|Other|20
7435139|NCT01604343|11717284|FG003|Safety Follow-up Period (Week 104-120)|Other|6
7435140|NCT01604343|11717285|FG004|Safety Follow-up Period (Week 104-120)|Other|14
7435141|NCT01604408|11717297|FG000|Treatment Period 1|Protocol Violation|0
7435142|NCT01604408|11717298|FG001|Treatment Period 1|Protocol Violation|1
7435143|NCT01604408|11717297|FG000|Treatment Period 2|Withdrawal by Subject|1
7435144|NCT01604408|11717298|FG001|Treatment Period 2|Withdrawal by Subject|1
7435145|NCT01604408|11717297|FG000|Treatment Period 2|Protocol Violation|1
7435146|NCT01604408|11717298|FG001|Treatment Period 2|Protocol Violation|0
7435147|NCT01604408|11717297|FG000|Treatment Period 2|Adverse Event|0
7435148|NCT01604408|11717298|FG001|Treatment Period 2|Adverse Event|1
7435149|NCT01604408|11717297|FG000|Treatment Period 3|Protocol Violation|1
7435150|NCT01604408|11717298|FG001|Treatment Period 3|Protocol Violation|1
7435151|NCT01604408|11717297|FG000|Treatment Period 3|Adverse Event|0
7435152|NCT01604408|11717298|FG001|Treatment Period 3|Adverse Event|3
7435153|NCT01604408|11717297|FG000|Treatment Period 3|Withdrawal by Subject|3
7435154|NCT01604408|11717298|FG001|Treatment Period 3|Withdrawal by Subject|1
7435155|NCT01604408|11717297|FG000|Treatment Period 3|Sponsor Decision|1
7435156|NCT01604408|11717298|FG001|Treatment Period 3|Sponsor Decision|0
7435157|NCT01604408|11717297|FG000|Treatment Period 4|Death|1
7435158|NCT01604408|11717298|FG001|Treatment Period 4|Death|0
7435159|NCT01604408|11717297|FG000|Treatment Period 4|Withdrawal by Subject|2
7435160|NCT01604408|11717298|FG001|Treatment Period 4|Withdrawal by Subject|1
7435161|NCT01604408|11717297|FG000|Treatment Period 4|Adverse Event|0
7435162|NCT01604408|11717298|FG001|Treatment Period 4|Adverse Event|1
7435163|NCT01604408|11717297|FG000|Treatment Period 5|Adverse Event|4
7435164|NCT01604408|11717298|FG001|Treatment Period 5|Adverse Event|0
7435165|NCT01604408|11717297|FG000|Treatment Period 6|Lost to Follow-up|0
7435166|NCT01604408|11717298|FG001|Treatment Period 6|Lost to Follow-up|1
7435167|NCT01604408|11717297|FG000|Treatment Period 6|Adverse Event|2
7435168|NCT01604408|11717298|FG001|Treatment Period 6|Adverse Event|0
7435169|NCT01604408|11717297|FG000|Treatment Period 6|Sponsor decision|0
7435170|NCT01604408|11717298|FG001|Treatment Period 6|Sponsor decision|1
7435171|NCT01604408|11717297|FG000|Observation Period|Adverse Event|1
7435172|NCT01604408|11717298|FG001|Observation Period|Adverse Event|1
7435173|NCT01604408|11717297|FG000|Observation Period|Withdrawal by Subject|0
7435174|NCT01604408|11717298|FG001|Observation Period|Withdrawal by Subject|2
7435175|NCT01604785|11717311|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
7435176|NCT01604785|11717312|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
7467174|NCT01898884|11767511|FG006|Multiple Dose Period|Adverse Event|1
7467175|NCT01898884|11767512|FG007|Multiple Dose Period|Adverse Event|0
7467176|NCT01898884|11767513|FG008|Multiple Dose Period|Adverse Event|0
7467177|NCT01898884|11767505|FG000|Multiple Dose Period|Randomized Not Treated|0
7467178|NCT01898884|11767506|FG001|Multiple Dose Period|Randomized Not Treated|0
7467179|NCT01898884|11767507|FG002|Multiple Dose Period|Randomized Not Treated|0
7467180|NCT01898884|11767508|FG003|Multiple Dose Period|Randomized Not Treated|0
7467181|NCT01898884|11767509|FG004|Multiple Dose Period|Randomized Not Treated|0
7467182|NCT01898884|11767510|FG005|Multiple Dose Period|Randomized Not Treated|0
7467183|NCT01898884|11767511|FG006|Multiple Dose Period|Randomized Not Treated|0
7467184|NCT01898884|11767512|FG007|Multiple Dose Period|Randomized Not Treated|0
7467185|NCT01898884|11767513|FG008|Multiple Dose Period|Randomized Not Treated|1
7467186|NCT01898923|11767551|FG000|Overall Study|Lack of Efficacy|5
7559240|NCT03139448|11925142|FG000|Overall Study|Lack of Efficacy|6
7559241|NCT03139448|11925143|FG001|Overall Study|Lack of Efficacy|7
7559242|NCT03139448|11925142|FG000|Overall Study|Location of procedure changed|2
7559243|NCT03139448|11925143|FG001|Overall Study|Location of procedure changed|8
7559244|NCT03139448|11925142|FG000|Overall Study|Withdrawal by Subject|3
7559245|NCT03139448|11925143|FG001|Overall Study|Withdrawal by Subject|6
7559246|NCT03139448|11925142|FG000|Overall Study|Screen fail|1
7559247|NCT03139448|11925143|FG001|Overall Study|Screen fail|3
7467187|NCT01898923|11767552|FG001|Overall Study|Lack of Efficacy|6
7467188|NCT01898923|11767551|FG000|Overall Study|Adverse Event|3
7467189|NCT01898923|11767552|FG001|Overall Study|Adverse Event|1
7467190|NCT01898923|11767551|FG000|Overall Study|Lost to Follow-up|0
7467191|NCT01898923|11767552|FG001|Overall Study|Lost to Follow-up|1
7467192|NCT01898923|11767551|FG000|Overall Study|Withdrawal by Subject|4
7467193|NCT01898923|11767552|FG001|Overall Study|Withdrawal by Subject|7
7467194|NCT01898923|11767551|FG000|Overall Study|Physician Decision|3
7467195|NCT01898923|11767552|FG001|Overall Study|Physician Decision|4
7467196|NCT01898923|11767551|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
7467197|NCT01898923|11767552|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
7559248|NCT03139448|11925142|FG000|Overall Study|Physician Decision|0
7559249|NCT03139448|11925143|FG001|Overall Study|Physician Decision|2
7559250|NCT03139552|11925149|FG000|Overall Study|unable to attend tasting due to schedule|3
7559251|NCT03139604|11925175|FG000|Overall Study|Other|7
7559252|NCT03139604|11925176|FG001|Overall Study|Other|3
7559253|NCT03139604|11925175|FG000|Overall Study|Withdrawal by Subject|16
7559254|NCT03139604|11925176|FG001|Overall Study|Withdrawal by Subject|17
7559255|NCT03139604|11925175|FG000|Overall Study|Physician Decision|1
7559256|NCT03139604|11925176|FG001|Overall Study|Physician Decision|2
7559257|NCT03139604|11925175|FG000|Overall Study|Lost to Follow-up|3
7467198|NCT01899053|11767572|FG000|Overall Study|Progressive Disease|4
7467199|NCT01899053|11767573|FG001|Overall Study|Progressive Disease|0
7467200|NCT01899053|11767574|FG002|Overall Study|Progressive Disease|3
7559258|NCT03139604|11925176|FG001|Overall Study|Lost to Follow-up|1
7559259|NCT03139604|11925175|FG000|Overall Study|Death|65
7559260|NCT03139604|11925176|FG001|Overall Study|Death|67
7559261|NCT03139604|11925175|FG000|Overall Study|Study Terminated by Sponsor|122
7559262|NCT03139604|11925176|FG001|Overall Study|Study Terminated by Sponsor|127
7559263|NCT03139604|11925175|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
7559264|NCT03139604|11925176|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
7559265|NCT03141086|11925210|FG000|Overall Study|Study Terminated By Sponsor|1
7559266|NCT03141086|11925211|FG001|Overall Study|Study Terminated By Sponsor|1
7559267|NCT03141086|11925210|FG000|Overall Study|Withdrawal by Subject|0
7559268|NCT03141086|11925211|FG001|Overall Study|Withdrawal by Subject|1
7559269|NCT03141086|11925210|FG000|Overall Study|Protocol Violation|0
7435177|NCT01604824|11717322|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7435178|NCT01604824|11717323|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7435179|NCT01604824|11717324|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7435180|NCT01604824|11717325|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7435181|NCT01604824|11717326|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
7435182|NCT01604824|11717327|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
7435183|NCT01604824|11717322|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
7435184|NCT01604824|11717323|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
7435185|NCT01604824|11717324|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
7435186|NCT01604824|11717325|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
7435187|NCT01604824|11717326|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
7435188|NCT01604824|11717327|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
7532786|NCT02675998|11878533|FG003|8-Week Treatment Period|Lack of Efficacy|0
7532787|NCT02675998|11878530|FG000|8-Week Treatment Period|Physician Decision|1
7532788|NCT02675998|11878531|FG001|8-Week Treatment Period|Physician Decision|0
7532789|NCT02675998|11878532|FG002|8-Week Treatment Period|Physician Decision|2
7435189|NCT01604850|11717341|FG000|Overall Study|Enrolled but never treated|0
7435190|NCT01604850|11717342|FG001|Overall Study|Enrolled but never treated|1
7435191|NCT01604850|11717341|FG000|Overall Study|Efficacy Failure|50
7435192|NCT01604850|11717342|FG001|Overall Study|Efficacy Failure|29
7435193|NCT01604850|11717341|FG000|Overall Study|Lost to Follow-up|1
7435194|NCT01604850|11717342|FG001|Overall Study|Lost to Follow-up|0
7435195|NCT01604850|11717341|FG000|Overall Study|Subject withdrew consent|1
7435196|NCT01604850|11717342|FG001|Overall Study|Subject withdrew consent|0
7435197|NCT01604941|11717350|FG000|Overall Study|Adverse Event|1
7435198|NCT01604941|11717351|FG001|Overall Study|Adverse Event|2
7435199|NCT01604941|11717352|FG002|Overall Study|Adverse Event|0
7435200|NCT01604941|11717353|FG003|Overall Study|Adverse Event|0
7435201|NCT01604941|11717354|FG004|Overall Study|Adverse Event|1
7435202|NCT01604941|11717355|FG005|Overall Study|Adverse Event|5
7435203|NCT01604941|11717350|FG000|Overall Study|Non-compliance|1
7435204|NCT01604941|11717351|FG001|Overall Study|Non-compliance|0
7435205|NCT01604941|11717352|FG002|Overall Study|Non-compliance|0
7435206|NCT01604941|11717353|FG003|Overall Study|Non-compliance|0
7435207|NCT01604941|11717354|FG004|Overall Study|Non-compliance|0
7435208|NCT01604941|11717355|FG005|Overall Study|Non-compliance|0
7435209|NCT01604941|11717350|FG000|Overall Study|Participant Decision|0
7435210|NCT01604941|11717351|FG001|Overall Study|Participant Decision|0
7435211|NCT01604941|11717352|FG002|Overall Study|Participant Decision|0
7435212|NCT01604941|11717353|FG003|Overall Study|Participant Decision|0
7435213|NCT01604941|11717354|FG004|Overall Study|Participant Decision|0
7435214|NCT01604941|11717355|FG005|Overall Study|Participant Decision|2
7435215|NCT01604941|11717350|FG000|Overall Study|Early Study Termination|9
7435216|NCT01604941|11717351|FG001|Overall Study|Early Study Termination|2
7435217|NCT01604941|11717352|FG002|Overall Study|Early Study Termination|3
7435218|NCT01604941|11717353|FG003|Overall Study|Early Study Termination|3
7435219|NCT01604941|11717354|FG004|Overall Study|Early Study Termination|0
7435220|NCT01604941|11717355|FG005|Overall Study|Early Study Termination|0
7435221|NCT01605071|11717367|FG000|Overall Study|Withdrawal by Subject|3
7435222|NCT01605071|11717368|FG001|Overall Study|Withdrawal by Subject|2
7435223|NCT01605097|11717376|FG000|Overall Study|Protocol Violation|1
7435224|NCT01605136|11717383|FG000|Study Period|Withdrawal by Subject|2
7435225|NCT01605136|11717384|FG001|Study Period|Withdrawal by Subject|0
7435226|NCT01605136|11717383|FG000|Study Period|Physician Decision|1
7435227|NCT01605136|11717384|FG001|Study Period|Physician Decision|1
7435228|NCT01605136|11717383|FG000|Study Period|Lost to Follow-up|0
7435229|NCT01605136|11717384|FG001|Study Period|Lost to Follow-up|2
7467201|NCT01899053|11767575|FG003|Overall Study|Progressive Disease|0
7532790|NCT02675998|11878533|FG003|8-Week Treatment Period|Physician Decision|0
7532791|NCT02675998|11878530|FG000|8-Week Treatment Period|GI side Effects|1
7532792|NCT02675998|11878531|FG001|8-Week Treatment Period|GI side Effects|4
7532793|NCT02675998|11878532|FG002|8-Week Treatment Period|GI side Effects|2
7532794|NCT02675998|11878533|FG003|8-Week Treatment Period|GI side Effects|0
7532795|NCT02675998|11878530|FG000|8-Week Treatment Period|Protocol Violation|1
7532796|NCT02675998|11878531|FG001|8-Week Treatment Period|Protocol Violation|1
7532797|NCT02675998|11878532|FG002|8-Week Treatment Period|Protocol Violation|1
7532798|NCT02675998|11878533|FG003|8-Week Treatment Period|Protocol Violation|0
7435230|NCT01605136|11717383|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
7435231|NCT01605136|11717384|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
7435232|NCT01605227|11717392|FG000|Overall Study|Did not receive study treatment|2
7435233|NCT01605227|11717393|FG001|Overall Study|Did not receive study treatment|3
7435234|NCT01605227|11717392|FG000|Overall Study|Adverse Event|228
7435235|NCT01605227|11717393|FG001|Overall Study|Adverse Event|42
7435236|NCT01605227|11717392|FG000|Overall Study|Progressive Disease|132
7435237|NCT01605227|11717393|FG001|Overall Study|Progressive Disease|128
7435238|NCT01605227|11717392|FG000|Overall Study|Clinical Deterioration|227
7435239|NCT01605227|11717393|FG001|Overall Study|Clinical Deterioration|133
7435240|NCT01605227|11717392|FG000|Overall Study|Lost to Follow-up|1
7559270|NCT03141086|11925211|FG001|Overall Study|Protocol Violation|1
7559271|NCT03141086|11925210|FG000|Overall Study|Adverse Event|0
7559272|NCT03141086|11925211|FG001|Overall Study|Adverse Event|2
7435241|NCT01605227|11717393|FG001|Overall Study|Lost to Follow-up|0
7435242|NCT01605227|11717392|FG000|Overall Study|Protocol Violation|1
7435243|NCT01605227|11717393|FG001|Overall Study|Protocol Violation|0
7435244|NCT01605227|11717392|FG000|Overall Study|Physician Decision|9
7435245|NCT01605227|11717393|FG001|Overall Study|Physician Decision|7
7435246|NCT01605227|11717392|FG000|Overall Study|Withdrawal by Subject|18
7435247|NCT01605227|11717393|FG001|Overall Study|Withdrawal by Subject|14
7435248|NCT01605227|11717392|FG000|Overall Study|Sponsor Decision|2
7435249|NCT01605227|11717393|FG001|Overall Study|Sponsor Decision|0
7435250|NCT01605227|11717392|FG000|Overall Study|Started New Therapy|1
7435251|NCT01605227|11717393|FG001|Overall Study|Started New Therapy|0
7435252|NCT01605227|11717392|FG000|Overall Study|Subject Decision|0
7435253|NCT01605227|11717393|FG001|Overall Study|Subject Decision|1
7435254|NCT01605227|11717392|FG000|Overall Study|Dose Held >6 weeks|0
7435255|NCT01605227|11717393|FG001|Overall Study|Dose Held >6 weeks|1
7435256|NCT01605396|11717410|FG000|Overall Study|Adverse Event|5
7435257|NCT01605396|11717411|FG001|Overall Study|Adverse Event|3
7435258|NCT01605396|11717410|FG000|Overall Study|Lost to Follow-up|1
7435259|NCT01605396|11717411|FG001|Overall Study|Lost to Follow-up|0
7435260|NCT01605396|11717410|FG000|Overall Study|Non-Compliance With Study Drug|1
7435261|NCT01605396|11717411|FG001|Overall Study|Non-Compliance With Study Drug|1
7435262|NCT01605396|11717410|FG000|Overall Study|Physician Decision|2
7435263|NCT01605396|11717411|FG001|Overall Study|Physician Decision|2
7435264|NCT01605396|11717410|FG000|Overall Study|Progressive Disease|23
7435265|NCT01605396|11717411|FG001|Overall Study|Progressive Disease|27
7435266|NCT01605396|11717410|FG000|Overall Study|Withdrawal by Subject|4
7435267|NCT01605396|11717411|FG001|Overall Study|Withdrawal by Subject|2
7435268|NCT01605396|11717410|FG000|Overall Study|Transfer Off Study|4
7435269|NCT01605396|11717411|FG001|Overall Study|Transfer Off Study|5
7435270|NCT01605461|11717435|FG000|Overall Study|Lost to Follow-up|3
7435271|NCT01605461|11717435|FG000|Overall Study|Withdrawal by Subject|1
7435272|NCT01605799|11717468|FG000|Overall Study|Withdrawal by Subject|2
7435273|NCT01605799|11717469|FG001|Overall Study|Withdrawal by Subject|1
7435274|NCT01605825|11717477|FG000|Overall Study|Adverse Event|4
7435275|NCT01605825|11717478|FG001|Overall Study|Adverse Event|2
7435276|NCT01605825|11717477|FG000|Overall Study|Withdrawal by Subject|0
7435277|NCT01605825|11717478|FG001|Overall Study|Withdrawal by Subject|1
7435278|NCT01605825|11717477|FG000|Overall Study|Non-Compliance -Investigational Drug|3
7435279|NCT01605825|11717478|FG001|Overall Study|Non-Compliance -Investigational Drug|0
7435280|NCT01605825|11717477|FG000|Overall Study|Non-Compliance with Protocol|3
7435281|NCT01605825|11717478|FG001|Overall Study|Non-Compliance with Protocol|0
7435282|NCT01605877|11717484|FG000|Overall Study|Withdrawal by Subject|1
7435283|NCT01605916|11717524|FG000|Overall Study|Adverse Event|1
7435284|NCT01605916|11717525|FG001|Overall Study|Adverse Event|0
7435285|NCT01605916|11717526|FG002|Overall Study|Adverse Event|0
7559273|NCT03141151|11925219|FG000|Overall Study|Lost to Follow-up|3
7559274|NCT03141151|11925220|FG001|Overall Study|Lost to Follow-up|2
7559275|NCT03141151|11925219|FG000|Overall Study|Withdrawal by Subject|3
7559276|NCT03141151|11925220|FG001|Overall Study|Withdrawal by Subject|2
7559277|NCT03141307|11925255|FG000|In-Hospital|Withdrawal by Subject|0
7559278|NCT03141307|11925256|FG001|In-Hospital|Withdrawal by Subject|2
7559279|NCT03141307|11925255|FG000|In-Hospital|Protocol Violation|4
7559280|NCT03141307|11925256|FG001|In-Hospital|Protocol Violation|0
7435286|NCT01605916|11717527|FG003|Overall Study|Adverse Event|1
7435287|NCT01605916|11717528|FG004|Overall Study|Adverse Event|0
7435288|NCT01605916|11717524|FG000|Overall Study|Lack of Efficacy|2
7559281|NCT03141307|11925255|FG000|Follow-Up|Lost to Follow-up|97
7559282|NCT03141307|11925256|FG001|Follow-Up|Lost to Follow-up|54
7559283|NCT03141788|11925282|FG000|Overall Study|Lost to Follow-up|1
7559284|NCT03141788|11925282|FG000|Overall Study|Protocol Violation|3
7559285|NCT03141788|11925282|FG000|Overall Study|Withdrawal by Subject|4
7559286|NCT03141905|11925291|FG000|Overall Study|Death|3
7435289|NCT01605916|11717525|FG001|Overall Study|Lack of Efficacy|3
7435290|NCT01605916|11717526|FG002|Overall Study|Lack of Efficacy|3
7435291|NCT01605916|11717527|FG003|Overall Study|Lack of Efficacy|5
7435292|NCT01605916|11717528|FG004|Overall Study|Lack of Efficacy|4
7559287|NCT03141905|11925292|FG001|Overall Study|Death|2
7559288|NCT03141905|11925291|FG000|Overall Study|Withdrawal by Subject|1
7559289|NCT03141905|11925292|FG001|Overall Study|Withdrawal by Subject|0
7559290|NCT03141905|11925291|FG000|Overall Study|Lost to Follow-up|3
7559291|NCT03141905|11925292|FG001|Overall Study|Lost to Follow-up|7
7435293|NCT01605916|11717524|FG000|Overall Study|Withdrawal by Subject|1
7435294|NCT01605916|11717525|FG001|Overall Study|Withdrawal by Subject|1
7435295|NCT01605916|11717526|FG002|Overall Study|Withdrawal by Subject|0
7435296|NCT01605916|11717527|FG003|Overall Study|Withdrawal by Subject|0
7435297|NCT01605916|11717528|FG004|Overall Study|Withdrawal by Subject|2
7435298|NCT01606007|11717553|FG000|Overall Study|Reason 'Other' in the protocol|0
7435299|NCT01606007|11717554|FG001|Overall Study|Reason 'Other' in the protocol|1
7435300|NCT01606007|11717555|FG002|Overall Study|Reason 'Other' in the protocol|1
7435301|NCT01606007|11717553|FG000|Overall Study|Pregnancy|0
7435302|NCT01606007|11717554|FG001|Overall Study|Pregnancy|1
7435303|NCT01606007|11717555|FG002|Overall Study|Pregnancy|1
7435304|NCT01606007|11717553|FG000|Overall Study|Withdrawal by Subject|8
7435305|NCT01606007|11717554|FG001|Overall Study|Withdrawal by Subject|6
7328721|NCT00797966|11561720|FG002|Phase A|Met withdrawal criteria|0
7328722|NCT00797966|11561721|FG003|Phase A|Met withdrawal criteria|0
7328723|NCT00797966|11561722|FG004|Phase A|Met withdrawal criteria|4
7328724|NCT00797966|11561723|FG005|Phase A|Met withdrawal criteria|0
7328725|NCT00797966|11561718|FG000|Phase A|Physician Decision|0
7328726|NCT00797966|11561719|FG001|Phase A|Physician Decision|0
7328727|NCT00797966|11561720|FG002|Phase A|Physician Decision|0
7328728|NCT00797966|11561721|FG003|Phase A|Physician Decision|0
7328729|NCT00797966|11561722|FG004|Phase A|Physician Decision|13
7328730|NCT00797966|11561723|FG005|Phase A|Physician Decision|0
7328731|NCT00797966|11561718|FG000|Phase A|Withdrawal by Subject|0
7328732|NCT00797966|11561719|FG001|Phase A|Withdrawal by Subject|0
7328733|NCT00797966|11561720|FG002|Phase A|Withdrawal by Subject|0
7328734|NCT00797966|11561721|FG003|Phase A|Withdrawal by Subject|0
7328735|NCT00797966|11561722|FG004|Phase A|Withdrawal by Subject|33
7328736|NCT00797966|11561723|FG005|Phase A|Withdrawal by Subject|0
7328737|NCT00797966|11561718|FG000|Phase A|Protocol deviation|0
7328738|NCT00797966|11561719|FG001|Phase A|Protocol deviation|0
7328739|NCT00797966|11561720|FG002|Phase A|Protocol deviation|0
7328740|NCT00797966|11561721|FG003|Phase A|Protocol deviation|0
7328741|NCT00797966|11561722|FG004|Phase A|Protocol deviation|56
7328742|NCT00797966|11561723|FG005|Phase A|Protocol deviation|0
7328743|NCT00797966|11561718|FG000|Phase B|Lost to Follow-up|0
7328744|NCT00797966|11561719|FG001|Phase B|Lost to Follow-up|1
7559292|NCT03141905|11925291|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
7559293|NCT03141905|11925292|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
7559294|NCT03142451|11925314|FG000|Overall Study|Adverse Event|5
7559295|NCT03142451|11925315|FG001|Overall Study|Adverse Event|2
7559296|NCT03142451|11925314|FG000|Overall Study|Lost to Follow-up|25
7559297|NCT03142451|11925315|FG001|Overall Study|Lost to Follow-up|8
7559298|NCT03142451|11925314|FG000|Overall Study|Participant request|24
7559299|NCT03142451|11925315|FG001|Overall Study|Participant request|12
7559300|NCT03142451|11925314|FG000|Overall Study|Protocol Violation|3
7559301|NCT03142451|11925315|FG001|Overall Study|Protocol Violation|1
7559302|NCT03142451|11925314|FG000|Overall Study|Other|1
7559303|NCT03142451|11925315|FG001|Overall Study|Other|1
7328745|NCT00797966|11561720|FG002|Phase B|Lost to Follow-up|3
7328746|NCT00797966|11561721|FG003|Phase B|Lost to Follow-up|0
7328747|NCT00797966|11561722|FG004|Phase B|Lost to Follow-up|0
7328748|NCT00797966|11561723|FG005|Phase B|Lost to Follow-up|0
7328749|NCT00797966|11561718|FG000|Phase B|Adverse Event|2
7328750|NCT00797966|11561719|FG001|Phase B|Adverse Event|1
7435306|NCT01606007|11717555|FG002|Overall Study|Withdrawal by Subject|1
7435307|NCT01606007|11717553|FG000|Overall Study|Adverse Event|0
7435308|NCT01606007|11717554|FG001|Overall Study|Adverse Event|1
7435309|NCT01606007|11717555|FG002|Overall Study|Adverse Event|1
7559304|NCT03142750|11925323|FG000|Overall Study|Lost to Follow-up|4
7559305|NCT03142750|11925324|FG001|Overall Study|Lost to Follow-up|1
7559306|NCT03142932|11925336|FG000|Overall Study|Lost to Follow-up|2
7559307|NCT03142932|11925337|FG001|Overall Study|Lost to Follow-up|11
7559308|NCT03143101|11925346|FG000|Overall Study|Withdrawal by Subject|0
7559309|NCT03143101|11925347|FG001|Overall Study|Withdrawal by Subject|1
7559310|NCT03143101|11925348|FG002|Overall Study|Withdrawal by Subject|0
7559311|NCT03143101|11925346|FG000|Overall Study|Lost to Follow-up|2
7559312|NCT03143101|11925347|FG001|Overall Study|Lost to Follow-up|2
7559313|NCT03143101|11925348|FG002|Overall Study|Lost to Follow-up|0
7559314|NCT03143166|11925356|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
7559315|NCT03143855|11925375|FG000|Overall Study|Withdrawal by Subject|4
7328751|NCT00797966|11561720|FG002|Phase B|Adverse Event|3
7328752|NCT00797966|11561721|FG003|Phase B|Adverse Event|1
7328753|NCT00797966|11561722|FG004|Phase B|Adverse Event|0
7435310|NCT01606007|11717553|FG000|Overall Study|discontinue study treatment|0
7435311|NCT01606007|11717554|FG001|Overall Study|discontinue study treatment|2
7328754|NCT00797966|11561723|FG005|Phase B|Adverse Event|0
7328755|NCT00797966|11561718|FG000|Phase B|Met Withdrawal Criteria|3
7328756|NCT00797966|11561719|FG001|Phase B|Met Withdrawal Criteria|3
7328757|NCT00797966|11561720|FG002|Phase B|Met Withdrawal Criteria|6
7559316|NCT03143855|11925376|FG001|Overall Study|Withdrawal by Subject|3
7328758|NCT00797966|11561721|FG003|Phase B|Met Withdrawal Criteria|1
7328759|NCT00797966|11561722|FG004|Phase B|Met Withdrawal Criteria|0
7328760|NCT00797966|11561723|FG005|Phase B|Met Withdrawal Criteria|0
7559317|NCT03143855|11925375|FG000|Overall Study|Protocol Violation|1
7559318|NCT03143855|11925376|FG001|Overall Study|Protocol Violation|0
7435312|NCT01606007|11717555|FG002|Overall Study|discontinue study treatment|1
7435313|NCT01606007|11717553|FG000|Overall Study|Lost to Follow-up|6
7435314|NCT01606007|11717554|FG001|Overall Study|Lost to Follow-up|8
7435315|NCT01606007|11717555|FG002|Overall Study|Lost to Follow-up|5
7435316|NCT01606007|11717553|FG000|Overall Study|Poor/Non-compliance|1
7435317|NCT01606007|11717554|FG001|Overall Study|Poor/Non-compliance|0
7435318|NCT01606007|11717555|FG002|Overall Study|Poor/Non-compliance|0
7435319|NCT01606137|11717572|FG000|Overall Study|Adverse Event|85
7435320|NCT01606137|11717572|FG000|Overall Study|Withdrawal by Subject|74
7435321|NCT01606137|11717572|FG000|Overall Study|Lack of Efficacy|56
7435322|NCT01606137|11717572|FG000|Overall Study|Lost to Follow-up|15
7435323|NCT01606137|11717572|FG000|Overall Study|Protocol Violation|1
7435324|NCT01606137|11717572|FG000|Overall Study|Patient non-compliance|9
7435325|NCT01606137|11717572|FG000|Overall Study|Death|1
7435326|NCT01606137|11717572|FG000|Overall Study|Decreased/no pain|4
7435327|NCT01606137|11717572|FG000|Overall Study|Issues with driving|4
7435328|NCT01606137|11717572|FG000|Overall Study|multiple sclerosis less stable|1
7435329|NCT01606137|11717572|FG000|Overall Study|Increased bilirubin|1
7435330|NCT01606137|11717572|FG000|Overall Study|Spray causes nausea|1
7435331|NCT01606137|11717572|FG000|Overall Study|Not enough improvement|4
7435332|NCT01606137|11717572|FG000|Overall Study|Wanted to try another treatment|1
7435333|NCT01606137|11717572|FG000|Overall Study|Patient leaving country|1
7435334|NCT01606137|11717572|FG000|Overall Study|Personal reasons|1
7435335|NCT01606137|11717572|FG000|Overall Study|Unable to tolerate study med. taste|1
7435336|NCT01606137|11717572|FG000|Overall Study|Patient moving|1
7435337|NCT01606137|11717572|FG000|Overall Study|Unable to collect consistent data|1
7435338|NCT01606176|11717578|FG000|Overall Study|Adverse Event|2
7435339|NCT01606176|11717579|FG001|Overall Study|Adverse Event|3
7435340|NCT01606176|11717578|FG000|Overall Study|Disease progression|1
7435341|NCT01606176|11717579|FG001|Overall Study|Disease progression|0
7435342|NCT01606176|11717578|FG000|Overall Study|Withdrawal by Subject|1
7435343|NCT01606176|11717579|FG001|Overall Study|Withdrawal by Subject|0
7435344|NCT01606189|11717585|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
7435345|NCT01606189|11717586|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
7435346|NCT01606189|11717587|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
7435347|NCT01606189|11717588|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
7435348|NCT01606189|11717589|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
7435349|NCT01606189|11717590|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
7435350|NCT01606189|11717585|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7435351|NCT01606189|11717586|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7435352|NCT01606189|11717587|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7435353|NCT01606189|11717588|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7435354|NCT01606189|11717589|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
7435355|NCT01606189|11717590|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
7435356|NCT01606202|11717600|FG000|Overall Study|Adverse Event|5
7435357|NCT01606202|11717601|FG001|Overall Study|Adverse Event|0
7435358|NCT01606202|11717600|FG000|Overall Study|Withdrawal by Subject|2
7435359|NCT01606202|11717601|FG001|Overall Study|Withdrawal by Subject|1
7435360|NCT01606202|11717600|FG000|Overall Study|Personal problems|0
7435361|NCT01606202|11717601|FG001|Overall Study|Personal problems|1
7435362|NCT01606202|11717600|FG000|Overall Study|Problems with administration|0
7435363|NCT01606202|11717601|FG001|Overall Study|Problems with administration|1
7435364|NCT01606228|11717607|FG000|Overall Study|Lost to Follow-up|20
7435365|NCT01606228|11717607|FG000|Overall Study|Withdrawal by Subject|3
7435366|NCT01606228|11717607|FG000|Overall Study|Non-compliant|3
7435367|NCT01606228|11717607|FG000|Overall Study|Lack of Efficacy|2
7435368|NCT01606228|11717607|FG000|Overall Study|Adverse Event|1
7435369|NCT01606254|11717615|FG000|Overall Study|Withdrawal by Subject|1
7435370|NCT01606254|11717616|FG001|Overall Study|Withdrawal by Subject|3
7435371|NCT01606254|11717617|FG002|Overall Study|Withdrawal by Subject|0
7435372|NCT01606254|11717618|FG003|Overall Study|Withdrawal by Subject|2
7435373|NCT01606254|11717615|FG000|Overall Study|Adverse Event|1
7435374|NCT01606254|11717616|FG001|Overall Study|Adverse Event|1
7435375|NCT01606254|11717617|FG002|Overall Study|Adverse Event|0
7435376|NCT01606254|11717618|FG003|Overall Study|Adverse Event|1
7435377|NCT01606306|11717634|FG000|Overall Study|Lack of Efficacy|2
7435378|NCT01606306|11717635|FG001|Overall Study|Lack of Efficacy|1
7435379|NCT01606306|11717636|FG002|Overall Study|Lack of Efficacy|4
7435380|NCT01606306|11717637|FG003|Overall Study|Lack of Efficacy|4
7435381|NCT01606306|11717638|FG004|Overall Study|Lack of Efficacy|1
7435382|NCT01606306|11717639|FG005|Overall Study|Lack of Efficacy|2
7435383|NCT01606306|11717634|FG000|Overall Study|Adverse Event|1
7435384|NCT01606306|11717635|FG001|Overall Study|Adverse Event|0
7435385|NCT01606306|11717636|FG002|Overall Study|Adverse Event|1
7435386|NCT01606306|11717637|FG003|Overall Study|Adverse Event|1
7435387|NCT01606306|11717638|FG004|Overall Study|Adverse Event|2
7435388|NCT01606306|11717639|FG005|Overall Study|Adverse Event|0
7435389|NCT01606306|11717634|FG000|Overall Study|Lost to Follow-up|7
7435390|NCT01606306|11717635|FG001|Overall Study|Lost to Follow-up|4
7435391|NCT01606306|11717636|FG002|Overall Study|Lost to Follow-up|5
7435392|NCT01606306|11717637|FG003|Overall Study|Lost to Follow-up|4
7435393|NCT01606306|11717638|FG004|Overall Study|Lost to Follow-up|3
7435394|NCT01606306|11717639|FG005|Overall Study|Lost to Follow-up|5
7435395|NCT01606306|11717634|FG000|Overall Study|Withdrawal by Subject|4
7435396|NCT01606306|11717635|FG001|Overall Study|Withdrawal by Subject|3
7435397|NCT01606306|11717636|FG002|Overall Study|Withdrawal by Subject|4
7435398|NCT01606306|11717637|FG003|Overall Study|Withdrawal by Subject|4
7435399|NCT01606306|11717638|FG004|Overall Study|Withdrawal by Subject|5
7435400|NCT01606306|11717639|FG005|Overall Study|Withdrawal by Subject|4
7435401|NCT01606306|11717634|FG000|Overall Study|Physician Decision|1
7435402|NCT01606306|11717635|FG001|Overall Study|Physician Decision|2
7435403|NCT01606306|11717636|FG002|Overall Study|Physician Decision|0
7435404|NCT01606306|11717637|FG003|Overall Study|Physician Decision|0
7435405|NCT01606306|11717638|FG004|Overall Study|Physician Decision|0
7435406|NCT01606306|11717639|FG005|Overall Study|Physician Decision|0
7435407|NCT01606319|11717647|FG000|Overall Study|Lost to Follow-up|17
7435408|NCT01606319|11717648|FG001|Overall Study|Lost to Follow-up|14
7435409|NCT01606319|11717647|FG000|Overall Study|Withdrawal by Subject|9
7435410|NCT01606319|11717648|FG001|Overall Study|Withdrawal by Subject|12
7435411|NCT01606319|11717647|FG000|Overall Study|Physician Decision|1
7435412|NCT01606319|11717648|FG001|Overall Study|Physician Decision|2
7435413|NCT01606319|11717647|FG000|Overall Study|Lack of Efficacy|6
7435414|NCT01606319|11717648|FG001|Overall Study|Lack of Efficacy|8
7435415|NCT01606319|11717647|FG000|Overall Study|Adverse Event|1
7435416|NCT01606319|11717648|FG001|Overall Study|Adverse Event|4
7435417|NCT01606670|11717654|FG000|Overall Study|Adverse Event|6
7435418|NCT01606670|11717654|FG000|Overall Study|Lack of Efficacy|2
7435419|NCT01606670|11717654|FG000|Overall Study|Lost to Follow-up|3
7435420|NCT01606670|11717654|FG000|Overall Study|Withdrawal by Subject|3
7435421|NCT01606670|11717654|FG000|Overall Study|Other Reason|2
7435422|NCT01606748|11717673|FG000|Overall Study|Adverse Event|1
7435423|NCT01606748|11717674|FG001|Overall Study|Adverse Event|0
7435424|NCT01606748|11717673|FG000|Overall Study|Progressive Disease|1
7435425|NCT01606748|11717674|FG001|Overall Study|Progressive Disease|0
7559319|NCT03143855|11925375|FG000|Overall Study|Participant experienced withdrawal|0
7559320|NCT03143855|11925376|FG001|Overall Study|Participant experienced withdrawal|1
7435426|NCT01606748|11717673|FG000|Overall Study|Withdrawal by Subject|1
7435427|NCT01606748|11717674|FG001|Overall Study|Withdrawal by Subject|0
7435428|NCT01606761|11717695|FG000|Prior to Week 24|Lost to Follow-up|0
7435429|NCT01606761|11717696|FG001|Prior to Week 24|Lost to Follow-up|3
7435430|NCT01606761|11717697|FG002|Prior to Week 24|Lost to Follow-up|2
7435431|NCT01606761|11717698|FG003|Prior to Week 24|Lost to Follow-up|0
7435432|NCT01606761|11717699|FG004|Prior to Week 24|Lost to Follow-up|0
7435433|NCT01606761|11717695|FG000|Prior to Week 24|Withdrawal by Subject|12
7435434|NCT01606761|11717696|FG001|Prior to Week 24|Withdrawal by Subject|10
7435435|NCT01606761|11717697|FG002|Prior to Week 24|Withdrawal by Subject|9
7435436|NCT01606761|11717698|FG003|Prior to Week 24|Withdrawal by Subject|0
7435437|NCT01606761|11717699|FG004|Prior to Week 24|Withdrawal by Subject|0
7435438|NCT01606761|11717695|FG000|Prior to Week 24|Adverse Event|11
7435439|NCT01606761|11717696|FG001|Prior to Week 24|Adverse Event|18
7435440|NCT01606761|11717697|FG002|Prior to Week 24|Adverse Event|22
7435441|NCT01606761|11717698|FG003|Prior to Week 24|Adverse Event|0
7435442|NCT01606761|11717699|FG004|Prior to Week 24|Adverse Event|0
7435443|NCT01606761|11717695|FG000|Prior to Week 24|Lack of Efficacy|15
7435444|NCT01606761|11717696|FG001|Prior to Week 24|Lack of Efficacy|14
7435445|NCT01606761|11717697|FG002|Prior to Week 24|Lack of Efficacy|8
7435446|NCT01606761|11717698|FG003|Prior to Week 24|Lack of Efficacy|0
7435447|NCT01606761|11717699|FG004|Prior to Week 24|Lack of Efficacy|0
7559321|NCT03144180|11925406|FG000|Overall Study|STAT Delivery|1
7559322|NCT03144180|11925407|FG001|Overall Study|STAT Delivery|1
7559323|NCT03144180|11925406|FG000|Overall Study|Provider forgot to fill out forms|1
7559324|NCT03144180|11925407|FG001|Overall Study|Provider forgot to fill out forms|3
7559325|NCT03144180|11925406|FG000|Overall Study|Provider forgot to use the Q-cup|0
7559326|NCT03144180|11925407|FG001|Overall Study|Provider forgot to use the Q-cup|1
7559327|NCT03144180|11925406|FG000|Overall Study|Scrub tech removed tube cap|0
7559328|NCT03144180|11925407|FG001|Overall Study|Scrub tech removed tube cap|1
7559329|NCT03144804|11925431|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
7574825|NCT03695367|11958009|FG001|Overall Study|Withdrawal by Subject|1
7574826|NCT03695367|11958008|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
7435448|NCT01606761|11717695|FG000|Prior to Week 24|Physician Decision|0
7435449|NCT01606761|11717696|FG001|Prior to Week 24|Physician Decision|3
7435450|NCT01606761|11717697|FG002|Prior to Week 24|Physician Decision|1
7435451|NCT01606761|11717698|FG003|Prior to Week 24|Physician Decision|0
7435452|NCT01606761|11717699|FG004|Prior to Week 24|Physician Decision|0
7435453|NCT01606761|11717695|FG000|Prior to Week 24|Other|4
7435454|NCT01606761|11717696|FG001|Prior to Week 24|Other|7
7435455|NCT01606761|11717697|FG002|Prior to Week 24|Other|5
7435456|NCT01606761|11717698|FG003|Prior to Week 24|Other|0
7435457|NCT01606761|11717699|FG004|Prior to Week 24|Other|0
7435458|NCT01606761|11717695|FG000|Week 24 to Week 52|Lost to Follow-up|0
7435459|NCT01606761|11717696|FG001|Week 24 to Week 52|Lost to Follow-up|1
7435460|NCT01606761|11717697|FG002|Week 24 to Week 52|Lost to Follow-up|1
7435461|NCT01606761|11717698|FG003|Week 24 to Week 52|Lost to Follow-up|1
7435462|NCT01606761|11717699|FG004|Week 24 to Week 52|Lost to Follow-up|0
7435463|NCT01606761|11717695|FG000|Week 24 to Week 52|Withdrawal by Subject|0
7435464|NCT01606761|11717696|FG001|Week 24 to Week 52|Withdrawal by Subject|6
7435465|NCT01606761|11717697|FG002|Week 24 to Week 52|Withdrawal by Subject|3
7435466|NCT01606761|11717698|FG003|Week 24 to Week 52|Withdrawal by Subject|0
7435467|NCT01606761|11717699|FG004|Week 24 to Week 52|Withdrawal by Subject|0
7435468|NCT01606761|11717695|FG000|Week 24 to Week 52|Adverse Event|0
7435469|NCT01606761|11717696|FG001|Week 24 to Week 52|Adverse Event|11
7435470|NCT01606761|11717697|FG002|Week 24 to Week 52|Adverse Event|14
7435471|NCT01606761|11717698|FG003|Week 24 to Week 52|Adverse Event|3
7435472|NCT01606761|11717699|FG004|Week 24 to Week 52|Adverse Event|15
7435473|NCT01606761|11717695|FG000|Week 24 to Week 52|Death|0
7435474|NCT01606761|11717696|FG001|Week 24 to Week 52|Death|0
7435475|NCT01606761|11717697|FG002|Week 24 to Week 52|Death|2
7435476|NCT01606761|11717698|FG003|Week 24 to Week 52|Death|1
7435477|NCT01606761|11717699|FG004|Week 24 to Week 52|Death|0
7435478|NCT01606761|11717695|FG000|Week 24 to Week 52|Lack of Efficacy|0
7435479|NCT01606761|11717696|FG001|Week 24 to Week 52|Lack of Efficacy|13
7435480|NCT01606761|11717697|FG002|Week 24 to Week 52|Lack of Efficacy|7
7559330|NCT03145064|11925435|FG000|Overall Study|Death|24
7559331|NCT03145064|11925435|FG000|Overall Study|Lost to Follow-up|3
7559332|NCT03145064|11925435|FG000|Overall Study|Withdrawal by Subject|6
7559333|NCT03145064|11925435|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
7559334|NCT03145064|11925435|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
7559335|NCT03145207|11925440|FG000|Overall Study|volunteer started taking allergy shots|1
7435539|NCT01607593|11717861|FG000|Overall Study|Continuation|33
7559336|NCT03145207|11925440|FG000|Overall Study|baseline blood pressure high|1
7559337|NCT03146403|11925479|FG000|Overall Study|Withdrawal by Subject|0
7559338|NCT03146403|11925480|FG001|Overall Study|Withdrawal by Subject|3
7559339|NCT03146403|11925479|FG000|Overall Study|Lost to Follow-up|2
7559340|NCT03146403|11925480|FG001|Overall Study|Lost to Follow-up|0
7559341|NCT03146663|11925501|FG000|Overall Study|Did not receive study treatment|1
7559342|NCT03146663|11925502|FG001|Overall Study|Did not receive study treatment|1
7559343|NCT03146741|11925509|FG000|Overall Study|Txp with non-HCV+ heart|4
7559344|NCT03146741|11925509|FG000|Overall Study|Listeted for MOT|2
7559345|NCT03146741|11925509|FG000|Overall Study|Physician Decision|2
7559346|NCT03146741|11925509|FG000|Overall Study|Awaiting txp|2
7559347|NCT03147248|11925535|FG000|Overall Study|Adverse Event|0
7559348|NCT03147248|11925536|FG001|Overall Study|Adverse Event|2
7559349|NCT03147248|11925537|FG002|Overall Study|Adverse Event|2
7559350|NCT03147248|11925538|FG003|Overall Study|Adverse Event|2
7559351|NCT03147248|11925539|FG004|Overall Study|Adverse Event|6
7559352|NCT03147248|11925540|FG005|Overall Study|Adverse Event|11
7559353|NCT03147248|11925535|FG000|Overall Study|Disease progression|1
7559354|NCT03147248|11925536|FG001|Overall Study|Disease progression|0
7435481|NCT01606761|11717698|FG003|Week 24 to Week 52|Lack of Efficacy|10
7435482|NCT01606761|11717699|FG004|Week 24 to Week 52|Lack of Efficacy|3
7435483|NCT01606761|11717695|FG000|Week 24 to Week 52|Physician Decision|0
7435484|NCT01606761|11717696|FG001|Week 24 to Week 52|Physician Decision|1
7435485|NCT01606761|11717697|FG002|Week 24 to Week 52|Physician Decision|1
7435486|NCT01606761|11717698|FG003|Week 24 to Week 52|Physician Decision|0
7435487|NCT01606761|11717699|FG004|Week 24 to Week 52|Physician Decision|0
7435488|NCT01606761|11717695|FG000|Week 24 to Week 52|Other|0
7435489|NCT01606761|11717696|FG001|Week 24 to Week 52|Other|1
7435490|NCT01606761|11717697|FG002|Week 24 to Week 52|Other|5
7435491|NCT01606761|11717698|FG003|Week 24 to Week 52|Other|2
7435492|NCT01606761|11717699|FG004|Week 24 to Week 52|Other|2
7435493|NCT01606761|11717695|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7435494|NCT01606761|11717696|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7435495|NCT01606761|11717697|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
7435496|NCT01606761|11717698|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
7435497|NCT01606761|11717699|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
7435498|NCT01606761|11717695|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
7435499|NCT01606761|11717696|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7435500|NCT01606761|11717697|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
7435501|NCT01606761|11717698|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
7435502|NCT01606761|11717699|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
7435503|NCT01606761|11717695|FG000|Safety Follow-up Period (Week 52-68)|Death|0
7435504|NCT01606761|11717696|FG001|Safety Follow-up Period (Week 52-68)|Death|0
7435505|NCT01606761|11717697|FG002|Safety Follow-up Period (Week 52-68)|Death|0
7435506|NCT01606761|11717698|FG003|Safety Follow-up Period (Week 52-68)|Death|0
7435507|NCT01606761|11717699|FG004|Safety Follow-up Period (Week 52-68)|Death|1
7559355|NCT03147248|11925537|FG002|Overall Study|Disease progression|0
7559356|NCT03147248|11925538|FG003|Overall Study|Disease progression|0
7435508|NCT01606761|11717695|FG000|Safety Follow-up Period (Week 52-68)|Other|0
7435509|NCT01606761|11717696|FG001|Safety Follow-up Period (Week 52-68)|Other|3
7559357|NCT03147248|11925539|FG004|Overall Study|Disease progression|0
7435510|NCT01606761|11717697|FG002|Safety Follow-up Period (Week 52-68)|Other|9
7435511|NCT01606761|11717698|FG003|Safety Follow-up Period (Week 52-68)|Other|1
7435512|NCT01606761|11717699|FG004|Safety Follow-up Period (Week 52-68)|Other|3
7435513|NCT01606787|11717716|FG000|Overall Study|Withdrawal by Subject|4
7559358|NCT03147248|11925540|FG005|Overall Study|Disease progression|2
7559359|NCT03147248|11925535|FG000|Overall Study|Withdrawal by Subject|0
7435514|NCT01606787|11717717|FG001|Overall Study|Withdrawal by Subject|5
7435515|NCT01606787|11717716|FG000|Overall Study|Surgery canceled|0
7435516|NCT01606787|11717717|FG001|Overall Study|Surgery canceled|2
7435517|NCT01606800|11717725|FG000|Overall Study|Adverse Event|3
7435518|NCT01606800|11717726|FG001|Overall Study|Adverse Event|1
7435519|NCT01606800|11717725|FG000|Overall Study|Participant withdrew consent|0
7435520|NCT01606800|11717726|FG001|Overall Study|Participant withdrew consent|1
7435521|NCT01606800|11717725|FG000|Overall Study|Missing completion status|2
7435522|NCT01606800|11717726|FG001|Overall Study|Missing completion status|0
7435523|NCT01607073|11717741|FG000|Overall Study|Adverse Event|1
7435524|NCT01607346|11717784|FG000|Overall Study|Adverse Event|3
7435525|NCT01607398|11717790|FG000|Overall Study|Adverse Event|0
7435526|NCT01607398|11717791|FG001|Overall Study|Adverse Event|2
7435527|NCT01607398|11717790|FG000|Overall Study|Severe COPD|2
7435528|NCT01607398|11717791|FG001|Overall Study|Severe COPD|0
7435529|NCT01607476|11717847|FG000|Overall Study|Withdrawal by Subject|1
7435530|NCT01607476|11717848|FG001|Overall Study|Withdrawal by Subject|0
7435531|NCT01607476|11717849|FG002|Overall Study|Withdrawal by Subject|1
7435532|NCT01607476|11717847|FG000|Overall Study|Lost to Follow-up|0
7435533|NCT01607476|11717848|FG001|Overall Study|Lost to Follow-up|0
7435534|NCT01607476|11717849|FG002|Overall Study|Lost to Follow-up|2
7435535|NCT01607554|11717857|FG000|Overall Study|Disease progression|2
7435536|NCT01607593|11717861|FG000|Overall Study|Adverse Event|15
7435537|NCT01607593|11717861|FG000|Overall Study|Lack of Efficacy|16
7435538|NCT01607593|11717861|FG000|Overall Study|Lost to Follow-up|25
7435540|NCT01607593|11717861|FG000|Overall Study|Other|4
7435541|NCT01607892|11717903|FG000|Overall Study|Need of treatment not allowed per protocol|0
7435542|NCT01607892|11717904|FG001|Overall Study|Need of treatment not allowed per protocol|0
7435543|NCT01607892|11717905|FG002|Overall Study|Need of treatment not allowed per protocol|0
7435544|NCT01607892|11717906|FG003|Overall Study|Need of treatment not allowed per protocol|1
7435545|NCT01607892|11717907|FG004|Overall Study|Need of treatment not allowed per protocol|0
7435546|NCT01607892|11717903|FG000|Overall Study|Death|4
7435547|NCT01607892|11717904|FG001|Overall Study|Death|2
7435548|NCT01607892|11717905|FG002|Overall Study|Death|8
7435549|NCT01607892|11717906|FG003|Overall Study|Death|10
7435550|NCT01607892|11717907|FG004|Overall Study|Death|3
7435551|NCT01607892|11717903|FG000|Overall Study|Investigator discretion|2
7435552|NCT01607892|11717904|FG001|Overall Study|Investigator discretion|4
7435553|NCT01607892|11717905|FG002|Overall Study|Investigator discretion|4
7435554|NCT01607892|11717906|FG003|Overall Study|Investigator discretion|8
7435555|NCT01607892|11717907|FG004|Overall Study|Investigator discretion|0
7435556|NCT01607892|11717903|FG000|Overall Study|Other treatments became available|1
7435557|NCT01607892|11717904|FG001|Overall Study|Other treatments became available|1
7435558|NCT01607892|11717905|FG002|Overall Study|Other treatments became available|0
7435559|NCT01607892|11717906|FG003|Overall Study|Other treatments became available|0
7435560|NCT01607892|11717907|FG004|Overall Study|Other treatments became available|2
7435561|NCT01607892|11717903|FG000|Overall Study|Intercurrent illness|1
7435562|NCT01607892|11717904|FG001|Overall Study|Intercurrent illness|0
7435563|NCT01607892|11717905|FG002|Overall Study|Intercurrent illness|0
7435564|NCT01607892|11717906|FG003|Overall Study|Intercurrent illness|3
7435565|NCT01607892|11717907|FG004|Overall Study|Intercurrent illness|0
7435566|NCT01607892|11717903|FG000|Overall Study|Non-Compliance with study procedures|0
7435567|NCT01607892|11717904|FG001|Overall Study|Non-Compliance with study procedures|0
7435568|NCT01607892|11717905|FG002|Overall Study|Non-Compliance with study procedures|1
7435569|NCT01607892|11717906|FG003|Overall Study|Non-Compliance with study procedures|0
7435570|NCT01607892|11717907|FG004|Overall Study|Non-Compliance with study procedures|0
7435571|NCT01607892|11717903|FG000|Overall Study|Consent withdrawn by participant|9
7435572|NCT01607892|11717904|FG001|Overall Study|Consent withdrawn by participant|4
7435573|NCT01607892|11717905|FG002|Overall Study|Consent withdrawn by participant|24
7435574|NCT01607892|11717906|FG003|Overall Study|Consent withdrawn by participant|14
7435575|NCT01607892|11717907|FG004|Overall Study|Consent withdrawn by participant|4
7435576|NCT01607892|11717903|FG000|Overall Study|Disease progression|38
7435577|NCT01607892|11717904|FG001|Overall Study|Disease progression|13
7435578|NCT01607892|11717905|FG002|Overall Study|Disease progression|37
7435579|NCT01607892|11717906|FG003|Overall Study|Disease progression|57
7435580|NCT01607892|11717907|FG004|Overall Study|Disease progression|9
7435581|NCT01607892|11717903|FG000|Overall Study|Incidence or severity of Adverse events|3
7435582|NCT01607892|11717904|FG001|Overall Study|Incidence or severity of Adverse events|3
7435583|NCT01607892|11717905|FG002|Overall Study|Incidence or severity of Adverse events|7
7559360|NCT03147248|11925536|FG001|Overall Study|Withdrawal by Subject|0
7559361|NCT03147248|11925537|FG002|Overall Study|Withdrawal by Subject|0
7559362|NCT03147248|11925538|FG003|Overall Study|Withdrawal by Subject|0
7559363|NCT03147248|11925539|FG004|Overall Study|Withdrawal by Subject|12
7559364|NCT03147248|11925540|FG005|Overall Study|Withdrawal by Subject|9
7559365|NCT03147248|11925535|FG000|Overall Study|Protocol Violation|0
7559366|NCT03147248|11925536|FG001|Overall Study|Protocol Violation|0
7559367|NCT03147248|11925537|FG002|Overall Study|Protocol Violation|0
7559368|NCT03147248|11925538|FG003|Overall Study|Protocol Violation|0
7435584|NCT01607892|11717906|FG003|Overall Study|Incidence or severity of Adverse events|2
7559369|NCT03147248|11925539|FG004|Overall Study|Protocol Violation|2
7435585|NCT01607892|11717907|FG004|Overall Study|Incidence or severity of Adverse events|6
7435586|NCT01607905|11717940|FG000|Overall Study|Withdrawal by participant|7
7435587|NCT01607905|11717941|FG001|Overall Study|Withdrawal by participant|2
7435588|NCT01607905|11717942|FG002|Overall Study|Withdrawal by participant|4
7435589|NCT01607905|11717943|FG003|Overall Study|Withdrawal by participant|6
7435590|NCT01607905|11717944|FG004|Overall Study|Withdrawal by participant|0
7435591|NCT01607905|11717945|FG005|Overall Study|Withdrawal by participant|4
7435592|NCT01607905|11717946|FG006|Overall Study|Withdrawal by participant|12
7435593|NCT01607905|11717940|FG000|Overall Study|Incidence or severity of AEs|5
7435594|NCT01607905|11717941|FG001|Overall Study|Incidence or severity of AEs|1
7435595|NCT01607905|11717942|FG002|Overall Study|Incidence or severity of AEs|1
7435596|NCT01607905|11717943|FG003|Overall Study|Incidence or severity of AEs|3
7435597|NCT01607905|11717944|FG004|Overall Study|Incidence or severity of AEs|0
7435598|NCT01607905|11717945|FG005|Overall Study|Incidence or severity of AEs|2
7435599|NCT01607905|11717946|FG006|Overall Study|Incidence or severity of AEs|8
7435600|NCT01607905|11717940|FG000|Overall Study|Disease progression|44
7435601|NCT01607905|11717941|FG001|Overall Study|Disease progression|16
7435602|NCT01607905|11717942|FG002|Overall Study|Disease progression|15
7435603|NCT01607905|11717943|FG003|Overall Study|Disease progression|11
7435604|NCT01607905|11717944|FG004|Overall Study|Disease progression|6
7435605|NCT01607905|11717945|FG005|Overall Study|Disease progression|7
7435606|NCT01607905|11717946|FG006|Overall Study|Disease progression|21
7435607|NCT01607905|11717940|FG000|Overall Study|Non-compliance with study procedures|0
7435608|NCT01607905|11717941|FG001|Overall Study|Non-compliance with study procedures|0
7435609|NCT01607905|11717942|FG002|Overall Study|Non-compliance with study procedures|0
7435610|NCT01607905|11717943|FG003|Overall Study|Non-compliance with study procedures|0
7435611|NCT01607905|11717944|FG004|Overall Study|Non-compliance with study procedures|0
7435612|NCT01607905|11717945|FG005|Overall Study|Non-compliance with study procedures|0
7435613|NCT01607905|11717946|FG006|Overall Study|Non-compliance with study procedures|1
7435614|NCT01607905|11717940|FG000|Overall Study|Death|1
7435615|NCT01607905|11717941|FG001|Overall Study|Death|1
7435616|NCT01607905|11717942|FG002|Overall Study|Death|1
7435617|NCT01607905|11717943|FG003|Overall Study|Death|1
7435618|NCT01607905|11717944|FG004|Overall Study|Death|0
7435619|NCT01607905|11717945|FG005|Overall Study|Death|0
7435620|NCT01607905|11717946|FG006|Overall Study|Death|3
7435621|NCT01607905|11717940|FG000|Overall Study|Other treatments become available|1
7435622|NCT01607905|11717941|FG001|Overall Study|Other treatments become available|0
7435623|NCT01607905|11717942|FG002|Overall Study|Other treatments become available|0
7435624|NCT01607905|11717943|FG003|Overall Study|Other treatments become available|0
7435625|NCT01607905|11717944|FG004|Overall Study|Other treatments become available|0
7435626|NCT01607905|11717945|FG005|Overall Study|Other treatments become available|0
7435627|NCT01607905|11717946|FG006|Overall Study|Other treatments become available|1
7435628|NCT01607905|11717940|FG000|Overall Study|Investigator discretion|0
7435629|NCT01607905|11717941|FG001|Overall Study|Investigator discretion|0
7435630|NCT01607905|11717942|FG002|Overall Study|Investigator discretion|0
7435631|NCT01607905|11717943|FG003|Overall Study|Investigator discretion|0
7435632|NCT01607905|11717944|FG004|Overall Study|Investigator discretion|0
7435633|NCT01607905|11717945|FG005|Overall Study|Investigator discretion|1
7435634|NCT01607905|11717946|FG006|Overall Study|Investigator discretion|0
7435635|NCT01607905|11717940|FG000|Overall Study|Other|1
7435636|NCT01607905|11717941|FG001|Overall Study|Other|0
7435637|NCT01607905|11717942|FG002|Overall Study|Other|0
7435638|NCT01607905|11717943|FG003|Overall Study|Other|0
7435639|NCT01607905|11717944|FG004|Overall Study|Other|0
7435640|NCT01607905|11717945|FG005|Overall Study|Other|0
7435641|NCT01607905|11717946|FG006|Overall Study|Other|1
7435642|NCT01607905|11717940|FG000|Overall Study|Randomized but not treated|1
7435643|NCT01607905|11717941|FG001|Overall Study|Randomized but not treated|0
7435644|NCT01607905|11717942|FG002|Overall Study|Randomized but not treated|0
7435645|NCT01607905|11717943|FG003|Overall Study|Randomized but not treated|0
7435646|NCT01607905|11717944|FG004|Overall Study|Randomized but not treated|1
7435647|NCT01607905|11717945|FG005|Overall Study|Randomized but not treated|1
7435648|NCT01607905|11717946|FG006|Overall Study|Randomized but not treated|0
7435649|NCT01607957|11718006|FG000|Overall Study|Not treated|1
7435650|NCT01607957|11718007|FG001|Overall Study|Not treated|1
7435651|NCT01607957|11718006|FG000|Overall Study|Death|367
7435652|NCT01607957|11718007|FG001|Overall Study|Death|211
7435653|NCT01607957|11718006|FG000|Overall Study|Lost to Follow-up|3
7435654|NCT01607957|11718007|FG001|Overall Study|Lost to Follow-up|3
7435655|NCT01607957|11718006|FG000|Overall Study|Participant refusal|1
7435656|NCT01607957|11718007|FG001|Overall Study|Participant refusal|0
7435657|NCT01608087|11718026|FG000|Overall Study|Lost to Follow-up|0
7435658|NCT01608087|11718027|FG001|Overall Study|Lost to Follow-up|1
7435659|NCT01608087|11718028|FG002|Overall Study|Lost to Follow-up|0
7435660|NCT01608087|11718026|FG000|Overall Study|Other Reason|0
7435661|NCT01608087|11718027|FG001|Overall Study|Other Reason|1
7435662|NCT01608087|11718028|FG002|Overall Study|Other Reason|0
7435663|NCT01608308|11718074|FG000|Overall Study|pretreatment medical and billing reasons|0
7435664|NCT01608308|11718075|FG001|Overall Study|pretreatment medical and billing reasons|2
7435665|NCT01608321|11718083|FG000|Overall Study|Withdrawal by Subject|1
7435666|NCT01608321|11718084|FG001|Overall Study|Withdrawal by Subject|0
7435667|NCT01608724|11718107|FG000|Overall Study|Withdrawal by Subject|131
7435668|NCT01608724|11718107|FG000|Overall Study|Lost to Follow-up|41
7435669|NCT01608724|11718107|FG000|Overall Study|Study-specific discontinuation criteria|32
7435670|NCT01608724|11718107|FG000|Overall Study|Adverse Event|29
7435671|NCT01608724|11718107|FG000|Overall Study|Protocol Violation|6
7435672|NCT01608724|11718107|FG000|Overall Study|bood sugar too high, etc.|3
7435673|NCT01608724|11718107|FG000|Overall Study|Safety reasons|1
7435674|NCT01609010|11718138|FG000|Overall Study|Stable disease (SD)|22
7559370|NCT03147248|11925540|FG005|Overall Study|Protocol Violation|0
7559371|NCT03147248|11925535|FG000|Overall Study|Lost to Follow-up|0
7559372|NCT03147248|11925536|FG001|Overall Study|Lost to Follow-up|0
7559373|NCT03147248|11925537|FG002|Overall Study|Lost to Follow-up|0
7559374|NCT03147248|11925538|FG003|Overall Study|Lost to Follow-up|0
7559375|NCT03147248|11925539|FG004|Overall Study|Lost to Follow-up|2
7559376|NCT03147248|11925540|FG005|Overall Study|Lost to Follow-up|0
7559377|NCT03147248|11925535|FG000|Overall Study|Pregnancy|0
7559378|NCT03147248|11925536|FG001|Overall Study|Pregnancy|0
7559379|NCT03147248|11925537|FG002|Overall Study|Pregnancy|0
7559380|NCT03147248|11925538|FG003|Overall Study|Pregnancy|0
7435675|NCT01609010|11718139|FG001|Overall Study|Stable disease (SD)|16
7435676|NCT01609010|11718138|FG000|Overall Study|Progressive disease (PD)|8
7435677|NCT01609010|11718139|FG001|Overall Study|Progressive disease (PD)|10
7435678|NCT01609010|11718138|FG000|Overall Study|Adverse Event|3
7435679|NCT01609010|11718139|FG001|Overall Study|Adverse Event|6
7435680|NCT01609010|11718138|FG000|Overall Study|Withdrawal by Subject|2
7435681|NCT01609010|11718139|FG001|Overall Study|Withdrawal by Subject|2
7435682|NCT01609010|11718138|FG000|Overall Study|Other|2
7435683|NCT01609010|11718139|FG001|Overall Study|Other|0
7435684|NCT01609010|11718138|FG000|Overall Study|Other malignancy|1
7435685|NCT01609010|11718139|FG001|Overall Study|Other malignancy|0
7435686|NCT01609010|11718138|FG000|Overall Study|Pathology review|2
7435687|NCT01609010|11718139|FG001|Overall Study|Pathology review|1
7435688|NCT01609010|11718138|FG000|Overall Study|Protocol Violation|1
7435689|NCT01609010|11718139|FG001|Overall Study|Protocol Violation|1
7435690|NCT01609010|11718138|FG000|Overall Study|New cancer|1
7435691|NCT01609010|11718139|FG001|Overall Study|New cancer|0
7559381|NCT03147248|11925539|FG004|Overall Study|Pregnancy|1
7559382|NCT03147248|11925540|FG005|Overall Study|Pregnancy|0
7559383|NCT03147248|11925535|FG000|Overall Study|Death|0
7559384|NCT03147248|11925536|FG001|Overall Study|Death|0
7559385|NCT03147248|11925537|FG002|Overall Study|Death|0
7559386|NCT03147248|11925538|FG003|Overall Study|Death|0
7559387|NCT03147248|11925539|FG004|Overall Study|Death|0
7559388|NCT03147248|11925540|FG005|Overall Study|Death|4
7559389|NCT03147248|11925535|FG000|Overall Study|Physician Decision|0
7435692|NCT01609010|11718138|FG000|Overall Study|Lost to Follow-up|1
7435693|NCT01609010|11718139|FG001|Overall Study|Lost to Follow-up|1
7559390|NCT03147248|11925536|FG001|Overall Study|Physician Decision|0
7559391|NCT03147248|11925537|FG002|Overall Study|Physician Decision|0
7559392|NCT03147248|11925538|FG003|Overall Study|Physician Decision|0
7559393|NCT03147248|11925539|FG004|Overall Study|Physician Decision|2
7559394|NCT03147248|11925540|FG005|Overall Study|Physician Decision|4
7435694|NCT01609023|11718145|FG000|Overall Study|Lack of Efficacy|3
7435695|NCT01609023|11718145|FG000|Overall Study|Withdrawal by Subject|4
7435696|NCT01609023|11718145|FG000|Overall Study|Lost to Follow-up|8
7435697|NCT01609023|11718145|FG000|Overall Study|Toxicity|3
7435698|NCT01609023|11718145|FG000|Overall Study|Disease progression|10
7435699|NCT01609023|11718145|FG000|Overall Study|Physician Decision|2
7435700|NCT01609023|11718145|FG000|Overall Study|Death|2
7435701|NCT01609023|11718145|FG000|Overall Study|Personal reasons|1
7435702|NCT01609062|11718151|FG000|Extension Phase|Terminated by Sponsor|14
7435703|NCT01609062|11718152|FG001|Extension Phase|Terminated by Sponsor|9
7435704|NCT01609062|11718151|FG000|Extension Phase|Discontinued drug and then was pregnant|1
7435705|NCT01609062|11718152|FG001|Extension Phase|Discontinued drug and then was pregnant|0
7435706|NCT01609062|11718151|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
7435707|NCT01609062|11718152|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
7435708|NCT01609218|11718159|FG000|Period 1|Adverse Event|3
7435709|NCT01609218|11718160|FG001|Period 1|Adverse Event|5
7435710|NCT01609218|11718159|FG000|Period 1|Sponsor Decision|0
7435711|NCT01609218|11718160|FG001|Period 1|Sponsor Decision|1
7559395|NCT03147248|11925535|FG000|Overall Study|Prolonged Dosing Interval|0
7559396|NCT03147248|11925536|FG001|Overall Study|Prolonged Dosing Interval|0
7559397|NCT03147248|11925537|FG002|Overall Study|Prolonged Dosing Interval|0
7435712|NCT01609218|11718159|FG000|Period 2|Adverse Event|1
7435713|NCT01609218|11718160|FG001|Period 2|Adverse Event|0
7435714|NCT01609257|11718168|FG000|Overall Study|Lost to Follow-up|2
7435715|NCT01609257|11718169|FG001|Overall Study|Lost to Follow-up|1
7435716|NCT01609257|11718168|FG000|Overall Study|Voluntary Withdrawal by Subject|0
7435717|NCT01609257|11718169|FG001|Overall Study|Voluntary Withdrawal by Subject|1
7435718|NCT01609257|11718168|FG000|Overall Study|Non-compliance/Protocol deviation|4
7435719|NCT01609257|11718169|FG001|Overall Study|Non-compliance/Protocol deviation|6
7435720|NCT01609296|11718178|FG000|Overall Study|Death|253
7559398|NCT03147248|11925538|FG003|Overall Study|Prolonged Dosing Interval|0
7559399|NCT03147248|11925539|FG004|Overall Study|Prolonged Dosing Interval|1
7559400|NCT03147248|11925540|FG005|Overall Study|Prolonged Dosing Interval|1
7435721|NCT01609296|11718178|FG000|Overall Study|Withdrawal by Subject|151
7435722|NCT01609296|11718178|FG000|Overall Study|Lost to Follow-up|21
7435723|NCT01609296|11718178|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
7435724|NCT01609296|11718178|FG000|Overall Study|missed visit but known to be alive|28
7435725|NCT01609478|11718198|FG000|Overall Study|Adverse Event|3
7435726|NCT01609478|11718199|FG001|Overall Study|Adverse Event|1
7435727|NCT01609478|11718200|FG002|Overall Study|Adverse Event|5
7435728|NCT01609478|11718198|FG000|Overall Study|Protocol Deviation|0
7435729|NCT01609478|11718199|FG001|Overall Study|Protocol Deviation|1
7435730|NCT01609478|11718200|FG002|Overall Study|Protocol Deviation|1
7435731|NCT01609478|11718198|FG000|Overall Study|Non-Compliance with study treatment|1
7435732|NCT01609478|11718199|FG001|Overall Study|Non-Compliance with study treatment|0
7435733|NCT01609478|11718200|FG002|Overall Study|Non-Compliance with study treatment|0
7435734|NCT01609478|11718198|FG000|Overall Study|Physician Decision|1
7435735|NCT01609478|11718199|FG001|Overall Study|Physician Decision|0
7435736|NCT01609478|11718200|FG002|Overall Study|Physician Decision|1
7435737|NCT01609478|11718198|FG000|Overall Study|Withdrawal by Subject|2
7435738|NCT01609478|11718199|FG001|Overall Study|Withdrawal by Subject|0
7435739|NCT01609478|11718200|FG002|Overall Study|Withdrawal by Subject|2
7559401|NCT03147495|11925556|FG000|Overall Study|Physician Decision|0
7559402|NCT03147495|11925557|FG001|Overall Study|Physician Decision|6
7559403|NCT03148067|11925580|FG000|Overall Study|Lost to Follow-up|3
7559404|NCT03148067|11925580|FG000|Overall Study|Death|1
7559405|NCT03148691|11925623|FG000|Overall Study|Protocol Violation|1
7559406|NCT03148691|11925624|FG001|Overall Study|Protocol Violation|2
7559407|NCT03148691|11925625|FG002|Overall Study|Protocol Violation|7
7559408|NCT03148691|11925623|FG000|Overall Study|Lost to Follow-up|0
7559409|NCT03148691|11925624|FG001|Overall Study|Lost to Follow-up|0
7559410|NCT03148691|11925625|FG002|Overall Study|Lost to Follow-up|1
7559411|NCT03148691|11925623|FG000|Overall Study|Other|1
7559412|NCT03148691|11925624|FG001|Overall Study|Other|0
7559413|NCT03148691|11925625|FG002|Overall Study|Other|0
7559414|NCT03148691|11925623|FG000|Overall Study|Withdrawal by Subject|1
7435740|NCT01609543|11718208|FG000|Overall Study|Disease Progression|28
7435741|NCT01609543|11718208|FG000|Overall Study|Adverse Event|5
7435742|NCT01609543|11718208|FG000|Overall Study|Withdrawal by Subject|1
7435743|NCT01609543|11718208|FG000|Overall Study|Protocol Violation|1
7435744|NCT01609543|11718208|FG000|Overall Study|Death|7
7435745|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435746|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435747|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435748|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435749|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7435750|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435751|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435752|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7435753|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7435754|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435755|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7435756|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
7435757|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435758|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435759|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435760|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
7435761|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7435762|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7435763|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7435764|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
7435765|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
7435766|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
7435767|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
7435768|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
7435769|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7435770|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7435771|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
7435772|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
7435773|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7435774|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7435775|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7435776|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
7435777|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435778|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7559415|NCT03148691|11925624|FG001|Overall Study|Withdrawal by Subject|0
7559416|NCT03148691|11925625|FG002|Overall Study|Withdrawal by Subject|0
7559417|NCT03149042|11925633|FG000|Overall Study|Invasive FFR not performed|21
7559418|NCT03149042|11925633|FG000|Overall Study|Poor CT Image Quality|1
7559419|NCT03149042|11925633|FG000|Overall Study|Invasive FFR Measurement cancelled|1
7559420|NCT03149055|11925638|FG000|Overall Study|Not treated|4
7559421|NCT03149328|11925657|FG000|Overall Study|Withdrawal by Subject|30
7435779|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435780|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435781|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435782|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7435783|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7435784|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435785|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435786|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7435787|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
7435788|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
7435789|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435790|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435791|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435792|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
7435793|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435794|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435795|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435796|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435797|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435798|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7435799|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435800|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435801|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435802|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7559422|NCT03149328|11925658|FG001|Overall Study|Withdrawal by Subject|26
7559423|NCT03149328|11925657|FG000|Overall Study|Changed Dialysis Modality|18
7559424|NCT03149328|11925658|FG001|Overall Study|Changed Dialysis Modality|1
7559425|NCT03149328|11925657|FG000|Overall Study|Transplant|9
7559426|NCT03149328|11925658|FG001|Overall Study|Transplant|1
7559427|NCT03149328|11925657|FG000|Overall Study|Lost to Follow-up|25
7559428|NCT03149328|11925658|FG001|Overall Study|Lost to Follow-up|16
7559429|NCT03149328|11925657|FG000|Overall Study|Left Study Site|1
7559430|NCT03149328|11925658|FG001|Overall Study|Left Study Site|2
7559431|NCT03149328|11925657|FG000|Overall Study|Language Barrier|1
7559432|NCT03149328|11925658|FG001|Overall Study|Language Barrier|0
7559433|NCT03149848|11925664|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
7559434|NCT03149848|11925664|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
7559459|NCT03150082|11925722|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
7435803|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435804|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
7435805|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435806|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7559460|NCT03150082|11925723|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
7559461|NCT03150485|11925759|FG000|Overall Study|Unsatisfactory Lens Fitting|0
7559462|NCT03150485|11925760|FG001|Overall Study|Unsatisfactory Lens Fitting|1
7559463|NCT03150485|11925761|FG002|Overall Study|Unsatisfactory Lens Fitting|0
7559464|NCT03150485|11925762|FG003|Overall Study|Unsatisfactory Lens Fitting|0
7559465|NCT03150485|11925763|FG004|Overall Study|Unsatisfactory Lens Fitting|0
7559466|NCT03150485|11925764|FG005|Overall Study|Unsatisfactory Lens Fitting|0
7559467|NCT03150589|11925771|FG000|Overall Study|Withdrawal by Subject|16
7559468|NCT03150589|11925772|FG001|Overall Study|Withdrawal by Subject|9
7435807|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435808|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
7435809|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435810|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435811|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435812|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435813|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435814|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
7435815|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435816|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435817|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435818|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435819|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435820|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435821|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435822|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435823|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435824|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
7435825|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435826|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435827|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435828|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435829|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435830|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435831|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435832|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435833|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
7435834|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435835|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435836|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435837|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435838|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435839|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435840|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
7435841|NCT01609556|11718229|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
7435842|NCT01609556|11718230|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435843|NCT01609556|11718231|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435844|NCT01609556|11718232|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435845|NCT01609556|11718233|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435846|NCT01609556|11718234|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
7435847|NCT01609556|11718235|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435848|NCT01609556|11718236|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435849|NCT01609556|11718237|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435850|NCT01609556|11718238|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435851|NCT01609556|11718239|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
7435852|NCT01609556|11718240|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435853|NCT01609556|11718241|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435854|NCT01609556|11718242|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435855|NCT01609556|11718243|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435856|NCT01609556|11718244|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
7435857|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435858|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435859|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435860|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435861|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435862|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7559469|NCT03150589|11925771|FG000|Overall Study|Adverse Event|7
7559470|NCT03150589|11925772|FG001|Overall Study|Adverse Event|6
7559471|NCT03150589|11925771|FG000|Overall Study|Protocol Violation|4
7559472|NCT03150589|11925772|FG001|Overall Study|Protocol Violation|3
7559473|NCT03150589|11925771|FG000|Overall Study|Lost to Follow-up|3
7559474|NCT03150589|11925772|FG001|Overall Study|Lost to Follow-up|3
7559475|NCT03150589|11925771|FG000|Overall Study|Death|2
7559476|NCT03150589|11925772|FG001|Overall Study|Death|3
7559477|NCT03150589|11925771|FG000|Overall Study|IP non-compliance and other reasons|12
7559478|NCT03150589|11925772|FG001|Overall Study|IP non-compliance and other reasons|3
7559479|NCT03150719|11925780|FG000|Overall Study|Adverse Event|0
7435863|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7559480|NCT03150719|11925781|FG001|Overall Study|Adverse Event|1
7559481|NCT03150719|11925780|FG000|Overall Study|Death|0
7559482|NCT03150719|11925781|FG001|Overall Study|Death|1
7559483|NCT03150719|11925780|FG000|Overall Study|Other|1
7435864|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435865|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435866|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435867|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435868|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
7435869|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
7435870|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7435871|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7435872|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
7435873|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435874|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435875|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435876|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435877|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435878|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435879|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435880|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435881|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435882|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435883|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435884|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
7435885|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
7435886|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
7435887|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
7435888|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
7435889|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435890|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435891|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435892|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435893|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435894|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435895|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435896|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435897|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435898|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435899|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435900|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
7435901|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7435902|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7435903|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
7435904|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
7435905|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435906|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435907|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435908|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435909|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435910|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435911|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435912|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435913|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435914|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435915|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435916|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435917|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
7435918|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435919|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435920|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
7435921|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435922|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7559484|NCT03150719|11925781|FG001|Overall Study|Other|0
7559485|NCT03151148|11925802|FG000|Overall Study|Lost to Follow-up|1
7559486|NCT03151148|11925803|FG001|Overall Study|Lost to Follow-up|0
7559487|NCT03151148|11925802|FG000|Overall Study|Withdrawal by Subject|1
7559488|NCT03151148|11925803|FG001|Overall Study|Withdrawal by Subject|0
7559489|NCT03151395|11925819|FG000|Overall Study|Adverse Event|2
7559490|NCT03151395|11925819|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7559491|NCT03151395|11925819|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
7559492|NCT03151395|11925819|FG000|Overall Study|Unspecified reason|4
7559493|NCT03151551|11925841|FG000|Open-Label Treatment Period|Adverse Event|0
7559494|NCT03151551|11925842|FG001|Open-Label Treatment Period|Adverse Event|2
7435923|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435924|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435925|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435926|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435927|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435928|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435929|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435930|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435931|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435932|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
7435933|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
7435934|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
7435935|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
7435936|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
7435937|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435938|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435939|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435940|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435941|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435942|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435943|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435944|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435945|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435946|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435947|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435948|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435949|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435950|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435951|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
7435952|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
7435953|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
7435954|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
7435955|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
7435956|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
7435957|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
7435958|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
7435959|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
7435960|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
7435961|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
7435962|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
7435963|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
7435964|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
7435965|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
7435966|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
7435967|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
7435968|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
7435969|NCT01609556|11718229|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435970|NCT01609556|11718230|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435971|NCT01609556|11718231|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435972|NCT01609556|11718232|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435973|NCT01609556|11718233|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435974|NCT01609556|11718234|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435975|NCT01609556|11718235|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435976|NCT01609556|11718236|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435977|NCT01609556|11718237|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435978|NCT01609556|11718238|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435979|NCT01609556|11718239|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435980|NCT01609556|11718240|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435981|NCT01609556|11718241|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
7435982|NCT01609556|11718242|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435983|NCT01609556|11718243|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435984|NCT01609556|11718244|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
7435985|NCT01609582|11718287|FG000|Overall Study|Adverse Event|20
7435986|NCT01609582|11718288|FG001|Overall Study|Adverse Event|18
7435987|NCT01609582|11718287|FG000|Overall Study|Lost to Follow-up|10
7435988|NCT01609582|11718288|FG001|Overall Study|Lost to Follow-up|10
7435989|NCT01609582|11718287|FG000|Overall Study|Withdrawal by Subject|21
7435990|NCT01609582|11718288|FG001|Overall Study|Withdrawal by Subject|15
7435991|NCT01609582|11718287|FG000|Overall Study|Study Terminated by Sponsor|1543
7435992|NCT01609582|11718288|FG001|Overall Study|Study Terminated by Sponsor|1548
7435993|NCT01609582|11718287|FG000|Overall Study|Other|9
7435994|NCT01609582|11718288|FG001|Overall Study|Other|10
7435995|NCT01609582|11718287|FG000|Overall Study|Randomized, but not treated|0
7435996|NCT01609582|11718288|FG001|Overall Study|Randomized, but not treated|3
7435997|NCT01609933|11718294|FG000|Overall Study|Adverse Event|1
7435998|NCT01609933|11718294|FG000|Overall Study|Withdrawal by Subject|3
7435999|NCT01610037|11718312|FG000|All Patients|Adverse Event|27
7436000|NCT01610037|11718313|FG001|All Patients|Adverse Event|22
7436001|NCT01610037|11718314|FG002|All Patients|Adverse Event|26
7436002|NCT01610037|11718312|FG000|All Patients|Withdrawal by Subject|12
7436003|NCT01610037|11718313|FG001|All Patients|Withdrawal by Subject|10
7436004|NCT01610037|11718314|FG002|All Patients|Withdrawal by Subject|20
7436005|NCT01610037|11718312|FG000|All Patients|Unsatisfactory therapeutic effect|9
7436006|NCT01610037|11718313|FG001|All Patients|Unsatisfactory therapeutic effect|8
7436007|NCT01610037|11718314|FG002|All Patients|Unsatisfactory therapeutic effect|27
7436008|NCT01610037|11718312|FG000|All Patients|Death|4
7436009|NCT01610037|11718313|FG001|All Patients|Death|2
7436010|NCT01610037|11718314|FG002|All Patients|Death|1
7436011|NCT01610037|11718312|FG000|All Patients|Protocol deviation|4
7436012|NCT01610037|11718313|FG001|All Patients|Protocol deviation|3
7436013|NCT01610037|11718314|FG002|All Patients|Protocol deviation|3
7436014|NCT01610037|11718312|FG000|All Patients|Abnormal laboratory value|1
7436015|NCT01610037|11718313|FG001|All Patients|Abnormal laboratory value|1
7436016|NCT01610037|11718314|FG002|All Patients|Abnormal laboratory value|0
7436017|NCT01610037|11718312|FG000|All Patients|Administrative problems|1
7436018|NCT01610037|11718313|FG001|All Patients|Administrative problems|4
7436019|NCT01610037|11718314|FG002|All Patients|Administrative problems|4
7436020|NCT01610037|11718312|FG000|All Patients|Lost to Follow-up|1
7436021|NCT01610037|11718313|FG001|All Patients|Lost to Follow-up|0
7436022|NCT01610037|11718314|FG002|All Patients|Lost to Follow-up|0
7436023|NCT01610037|11718312|FG000|All Patients|Abnormal test procedure result(s)|0
7436024|NCT01610037|11718313|FG001|All Patients|Abnormal test procedure result(s)|1
7436025|NCT01610037|11718314|FG002|All Patients|Abnormal test procedure result(s)|3
7436026|NCT01610037|11718312|FG000|Treatment and Follow up Period|Subject withdrew consent|13
7436027|NCT01610037|11718313|FG001|Treatment and Follow up Period|Subject withdrew consent|14
7436028|NCT01610037|11718314|FG002|Treatment and Follow up Period|Subject withdrew consent|16
7436029|NCT01610037|11718312|FG000|Treatment and Follow up Period|Death|10
7436030|NCT01610037|11718313|FG001|Treatment and Follow up Period|Death|5
7436031|NCT01610037|11718314|FG002|Treatment and Follow up Period|Death|4
7436032|NCT01610037|11718312|FG000|Treatment and Follow up Period|Administrative problems|1
7436033|NCT01610037|11718313|FG001|Treatment and Follow up Period|Administrative problems|3
7436034|NCT01610037|11718314|FG002|Treatment and Follow up Period|Administrative problems|2
7559495|NCT03151551|11925841|FG000|Open-Label Treatment Period|Lost to Follow-up|1
7559496|NCT03151551|11925842|FG001|Open-Label Treatment Period|Lost to Follow-up|1
7559497|NCT03151551|11925841|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
7559498|NCT03151551|11925842|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
7559499|NCT03151551|11925841|FG000|Open-Label Treatment Period|Lack of Efficacy|1
7559500|NCT03151551|11925842|FG001|Open-Label Treatment Period|Lack of Efficacy|1
7559501|NCT03151551|11925841|FG000|Open-Label Treatment Period|Physician Decision|3
7559502|NCT03151551|11925842|FG001|Open-Label Treatment Period|Physician Decision|0
7559503|NCT03151551|11925841|FG000|Open-Label Treatment Period|Protocol Deviation|1
7559504|NCT03151551|11925842|FG001|Open-Label Treatment Period|Protocol Deviation|2
7559505|NCT03151551|11925841|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
7559506|NCT03151551|11925842|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
7559507|NCT03151551|11925841|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7559508|NCT03151551|11925842|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7559509|NCT03151551|11925841|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
7559510|NCT03151551|11925842|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
7436035|NCT01610037|11718312|FG000|Treatment and Follow up Period|Lost to Follow-up|1
7436036|NCT01610037|11718313|FG001|Treatment and Follow up Period|Lost to Follow-up|6
7436037|NCT01610037|11718314|FG002|Treatment and Follow up Period|Lost to Follow-up|4
7436038|NCT01610063|11718324|FG000|Overall Study|Lost to Follow-up|42
7436039|NCT01610063|11718325|FG001|Overall Study|Lost to Follow-up|20
7436040|NCT01610076|11718333|FG000|Overall Study|Technical issue with video|0
7436041|NCT01610076|11718334|FG001|Overall Study|Technical issue with video|1
7436042|NCT01610076|11718333|FG000|Overall Study|Lost to Follow-up|3
7436043|NCT01610076|11718334|FG001|Overall Study|Lost to Follow-up|4
7436044|NCT01610167|11718350|FG000|Overall Study|Scheduling conflict.|0
7436045|NCT01610167|11718351|FG001|Overall Study|Scheduling conflict.|0
7436046|NCT01610167|11718352|FG002|Overall Study|Scheduling conflict.|2
7436047|NCT01610206|11718362|FG000|Overall Study|Adverse Event|10
7436048|NCT01610206|11718363|FG001|Overall Study|Adverse Event|30
7436049|NCT01610271|11718371|FG000|Overall Study|Surgery not complete|0
7436050|NCT01610271|11718372|FG001|Overall Study|Surgery not complete|1
7436051|NCT01610271|11718371|FG000|Overall Study|Prosthesis not implanted|2
7436052|NCT01610271|11718372|FG001|Overall Study|Prosthesis not implanted|3
7436053|NCT01610284|11718382|FG000|Randomization Phase|Adverse Event|1
7436054|NCT01610284|11718383|FG001|Randomization Phase|Adverse Event|0
7436055|NCT01610284|11718382|FG000|Randomization Phase|Physician Decision|1
7436056|NCT01610284|11718383|FG001|Randomization Phase|Physician Decision|1
7436057|NCT01610284|11718382|FG000|Randomization Phase|Death|0
7436058|NCT01610284|11718383|FG001|Randomization Phase|Death|1
7559511|NCT03151551|11925841|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7436059|NCT01610284|11718382|FG000|Treatment Phase|Adverse Event|80
7436060|NCT01610284|11718383|FG001|Treatment Phase|Adverse Event|12
7436061|NCT01610284|11718382|FG000|Treatment Phase|Lost to Follow-up|1
7436062|NCT01610284|11718383|FG001|Treatment Phase|Lost to Follow-up|0
7436063|NCT01610284|11718382|FG000|Treatment Phase|Non-compliance with Study Treatment|8
7436064|NCT01610284|11718383|FG001|Treatment Phase|Non-compliance with Study Treatment|1
7436065|NCT01610284|11718382|FG000|Treatment Phase|Physician Decision|27
7436066|NCT01610284|11718383|FG001|Treatment Phase|Physician Decision|24
7436067|NCT01610284|11718382|FG000|Treatment Phase|Progressive Disease|377
7436068|NCT01610284|11718383|FG001|Treatment Phase|Progressive Disease|486
7436069|NCT01610284|11718382|FG000|Treatment Phase|Protocol Deviation|2
7436070|NCT01610284|11718383|FG001|Treatment Phase|Protocol Deviation|3
7436071|NCT01610284|11718382|FG000|Treatment Phase|Study terminated by Sponsor|18
7436072|NCT01610284|11718383|FG001|Treatment Phase|Study terminated by Sponsor|15
7436073|NCT01610284|11718382|FG000|Treatment Phase|Subject/Guardian Decision|55
7436074|NCT01610284|11718383|FG001|Treatment Phase|Subject/Guardian Decision|23
7436075|NCT01610284|11718382|FG000|Treatment Phase|Death|6
7436076|NCT01610284|11718383|FG001|Treatment Phase|Death|5
7436077|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7436078|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7436079|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
7436080|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
7436081|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
7436082|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
7436083|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
7436084|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7436085|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
7436086|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
7436087|NCT01610284|11718382|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
7436166|NCT01610336|11718414|FG010|Overall Study|Protocol Deviation|0
7436088|NCT01610284|11718383|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
7436089|NCT01610297|11718389|FG000|Overall Study|Lost to Follow-up|1
7436090|NCT01610336|11718404|FG000|Overall Study|Progressive Disease|4
7436091|NCT01610336|11718405|FG001|Overall Study|Progressive Disease|6
7436092|NCT01610336|11718406|FG002|Overall Study|Progressive Disease|6
7436093|NCT01610336|11718407|FG003|Overall Study|Progressive Disease|5
7436094|NCT01610336|11718408|FG004|Overall Study|Progressive Disease|3
7436095|NCT01610336|11718409|FG005|Overall Study|Progressive Disease|10
7436096|NCT01610336|11718410|FG006|Overall Study|Progressive Disease|1
7436097|NCT01610336|11718411|FG007|Overall Study|Progressive Disease|6
7436098|NCT01610336|11718412|FG008|Overall Study|Progressive Disease|6
7436099|NCT01610336|11718413|FG009|Overall Study|Progressive Disease|40
7436100|NCT01610336|11718414|FG010|Overall Study|Progressive Disease|36
7436101|NCT01610336|11718404|FG000|Overall Study|Adverse Event|0
7436102|NCT01610336|11718405|FG001|Overall Study|Adverse Event|0
7436103|NCT01610336|11718406|FG002|Overall Study|Adverse Event|0
7436104|NCT01610336|11718407|FG003|Overall Study|Adverse Event|1
7436105|NCT01610336|11718408|FG004|Overall Study|Adverse Event|1
7436106|NCT01610336|11718409|FG005|Overall Study|Adverse Event|1
7436107|NCT01610336|11718410|FG006|Overall Study|Adverse Event|0
7436108|NCT01610336|11718411|FG007|Overall Study|Adverse Event|0
7436109|NCT01610336|11718412|FG008|Overall Study|Adverse Event|2
7436110|NCT01610336|11718413|FG009|Overall Study|Adverse Event|8
7436111|NCT01610336|11718414|FG010|Overall Study|Adverse Event|6
7436112|NCT01610336|11718404|FG000|Overall Study|Subject/Guardian decision|1
7436113|NCT01610336|11718405|FG001|Overall Study|Subject/Guardian decision|1
7436114|NCT01610336|11718406|FG002|Overall Study|Subject/Guardian decision|0
7436115|NCT01610336|11718407|FG003|Overall Study|Subject/Guardian decision|1
7436116|NCT01610336|11718408|FG004|Overall Study|Subject/Guardian decision|0
7436117|NCT01610336|11718409|FG005|Overall Study|Subject/Guardian decision|0
7436118|NCT01610336|11718410|FG006|Overall Study|Subject/Guardian decision|0
7436119|NCT01610336|11718411|FG007|Overall Study|Subject/Guardian decision|1
7436120|NCT01610336|11718412|FG008|Overall Study|Subject/Guardian decision|0
7532799|NCT02675998|11878530|FG000|8-Week Treatment Period|Other|3
7532800|NCT02675998|11878531|FG001|8-Week Treatment Period|Other|1
7436121|NCT01610336|11718413|FG009|Overall Study|Subject/Guardian decision|2
7436122|NCT01610336|11718414|FG010|Overall Study|Subject/Guardian decision|2
7436123|NCT01610336|11718404|FG000|Overall Study|Death|0
7436124|NCT01610336|11718405|FG001|Overall Study|Death|0
7436125|NCT01610336|11718406|FG002|Overall Study|Death|0
7436126|NCT01610336|11718407|FG003|Overall Study|Death|0
7436127|NCT01610336|11718408|FG004|Overall Study|Death|0
7436128|NCT01610336|11718409|FG005|Overall Study|Death|1
7436129|NCT01610336|11718410|FG006|Overall Study|Death|3
7436130|NCT01610336|11718411|FG007|Overall Study|Death|0
7436131|NCT01610336|11718412|FG008|Overall Study|Death|0
7436132|NCT01610336|11718413|FG009|Overall Study|Death|1
7436133|NCT01610336|11718414|FG010|Overall Study|Death|2
7532801|NCT02675998|11878532|FG002|8-Week Treatment Period|Other|2
7436134|NCT01610336|11718404|FG000|Overall Study|Non-Compliance with study treatment|0
7436135|NCT01610336|11718405|FG001|Overall Study|Non-Compliance with study treatment|0
7436136|NCT01610336|11718406|FG002|Overall Study|Non-Compliance with study treatment|0
7436137|NCT01610336|11718407|FG003|Overall Study|Non-Compliance with study treatment|0
7436138|NCT01610336|11718408|FG004|Overall Study|Non-Compliance with study treatment|0
7436139|NCT01610336|11718409|FG005|Overall Study|Non-Compliance with study treatment|0
7436140|NCT01610336|11718410|FG006|Overall Study|Non-Compliance with study treatment|0
7436141|NCT01610336|11718411|FG007|Overall Study|Non-Compliance with study treatment|0
7436142|NCT01610336|11718412|FG008|Overall Study|Non-Compliance with study treatment|0
7436143|NCT01610336|11718413|FG009|Overall Study|Non-Compliance with study treatment|1
7436144|NCT01610336|11718414|FG010|Overall Study|Non-Compliance with study treatment|0
7436145|NCT01610336|11718404|FG000|Overall Study|Physician Decision|0
7436146|NCT01610336|11718405|FG001|Overall Study|Physician Decision|0
7436147|NCT01610336|11718406|FG002|Overall Study|Physician Decision|0
7436148|NCT01610336|11718407|FG003|Overall Study|Physician Decision|0
7436149|NCT01610336|11718408|FG004|Overall Study|Physician Decision|0
7436150|NCT01610336|11718409|FG005|Overall Study|Physician Decision|0
7436151|NCT01610336|11718410|FG006|Overall Study|Physician Decision|1
7436152|NCT01610336|11718411|FG007|Overall Study|Physician Decision|0
7436153|NCT01610336|11718412|FG008|Overall Study|Physician Decision|0
7436154|NCT01610336|11718413|FG009|Overall Study|Physician Decision|0
7436155|NCT01610336|11718414|FG010|Overall Study|Physician Decision|0
7436156|NCT01610336|11718404|FG000|Overall Study|Protocol Deviation|0
7436157|NCT01610336|11718405|FG001|Overall Study|Protocol Deviation|0
7436158|NCT01610336|11718406|FG002|Overall Study|Protocol Deviation|0
7436159|NCT01610336|11718407|FG003|Overall Study|Protocol Deviation|0
7436160|NCT01610336|11718408|FG004|Overall Study|Protocol Deviation|0
7436161|NCT01610336|11718409|FG005|Overall Study|Protocol Deviation|0
7436162|NCT01610336|11718410|FG006|Overall Study|Protocol Deviation|0
7436163|NCT01610336|11718411|FG007|Overall Study|Protocol Deviation|0
7436164|NCT01610336|11718412|FG008|Overall Study|Protocol Deviation|0
7436165|NCT01610336|11718413|FG009|Overall Study|Protocol Deviation|1
7559512|NCT03151551|11925842|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
7559513|NCT03152019|11925852|FG000|Overall Study|Adverse Event|0
7559514|NCT03152019|11925853|FG001|Overall Study|Adverse Event|1
7559515|NCT03152110|11925868|FG000|Overall Study|Withdrawal by Subject|3
7559516|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Death|0
7436167|NCT01610336|11718404|FG000|Overall Study|Transfer to another trial|0
7436168|NCT01610336|11718405|FG001|Overall Study|Transfer to another trial|0
7436169|NCT01610336|11718406|FG002|Overall Study|Transfer to another trial|0
7436170|NCT01610336|11718407|FG003|Overall Study|Transfer to another trial|0
7436171|NCT01610336|11718408|FG004|Overall Study|Transfer to another trial|0
7436172|NCT01610336|11718409|FG005|Overall Study|Transfer to another trial|0
7436173|NCT01610336|11718410|FG006|Overall Study|Transfer to another trial|0
7436174|NCT01610336|11718411|FG007|Overall Study|Transfer to another trial|0
7436175|NCT01610336|11718412|FG008|Overall Study|Transfer to another trial|0
7436176|NCT01610336|11718413|FG009|Overall Study|Transfer to another trial|0
7436177|NCT01610336|11718414|FG010|Overall Study|Transfer to another trial|1
7436178|NCT01610414|11718444|FG000|Study Start - Month 13|Serious Adverse Event|65
7436179|NCT01610414|11718445|FG001|Study Start - Month 13|Serious Adverse Event|67
7436180|NCT01610414|11718444|FG000|Study Start - Month 13|Adverse Event|14
7436181|NCT01610414|11718445|FG001|Study Start - Month 13|Adverse Event|14
7436182|NCT01610414|11718444|FG000|Study Start - Month 13|Protocol Violation|3
7436183|NCT01610414|11718445|FG001|Study Start - Month 13|Protocol Violation|1
7436184|NCT01610414|11718444|FG000|Study Start - Month 13|Withdrawal by Subject|23
7436185|NCT01610414|11718445|FG001|Study Start - Month 13|Withdrawal by Subject|30
7436186|NCT01610414|11718444|FG000|Study Start - Month 13|Migrated/moved from study area|2
7436187|NCT01610414|11718445|FG001|Study Start - Month 13|Migrated/moved from study area|4
7436188|NCT01610414|11718444|FG000|Study Start - Month 13|Lost to Follow-up|4
7436189|NCT01610414|11718445|FG001|Study Start - Month 13|Lost to Follow-up|6
7436190|NCT01610414|11718444|FG000|Study Start - Month 13|Suspected HZ episode|1
7436191|NCT01610414|11718445|FG001|Study Start - Month 13|Suspected HZ episode|3
7436192|NCT01610414|11718444|FG000|Study Start - Month 13|Other reasons for withdrawal|3
7436193|NCT01610414|11718445|FG001|Study Start - Month 13|Other reasons for withdrawal|4
7436194|NCT01610414|11718444|FG000|Month 13 - Month 25|Serious Adverse Event|35
7436195|NCT01610414|11718445|FG001|Month 13 - Month 25|Serious Adverse Event|38
7436196|NCT01610414|11718444|FG000|Month 13 - Month 25|Adverse Event|8
7436197|NCT01610414|11718445|FG001|Month 13 - Month 25|Adverse Event|4
7436198|NCT01610414|11718444|FG000|Month 13 - Month 25|Withdrawal by Subject|7
7436199|NCT01610414|11718445|FG001|Month 13 - Month 25|Withdrawal by Subject|8
7436200|NCT01610414|11718444|FG000|Month 13 - Month 25|Migrated/moved from study area|4
7436201|NCT01610414|11718445|FG001|Month 13 - Month 25|Migrated/moved from study area|2
7436202|NCT01610414|11718444|FG000|Month 13 - Month 25|Protocol Violation|0
7436203|NCT01610414|11718445|FG001|Month 13 - Month 25|Protocol Violation|2
7436204|NCT01610414|11718444|FG000|Month 13 - Month 25|Lost to Follow-up|5
7436205|NCT01610414|11718445|FG001|Month 13 - Month 25|Lost to Follow-up|9
7436206|NCT01610414|11718444|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
7436207|NCT01610414|11718445|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
7436208|NCT01610414|11718444|FG000|After Month 25|Study end not reached|48
7436209|NCT01610414|11718445|FG001|After Month 25|Study end not reached|53
7436210|NCT01610492|11718461|FG000|Overall Study|Adverse Event|1
7436211|NCT01610492|11718461|FG000|Overall Study|Lack of Efficacy|3
7559517|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Death|1
7559518|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Death|0
7436212|NCT01610492|11718461|FG000|Overall Study|Other: Reached stopping criteria|1
7436213|NCT01610492|11718461|FG000|Overall Study|Other:Treatment stopped due to remission|1
7436214|NCT01610557|11718469|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7436215|NCT01610557|11718470|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
7436216|NCT01610557|11718471|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7436217|NCT01610557|11718472|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7436218|NCT01610557|11718473|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
7436219|NCT01610557|11718469|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
7436220|NCT01610557|11718470|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
7436221|NCT01610557|11718471|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
7436222|NCT01610557|11718472|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
7436223|NCT01610557|11718473|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
7436224|NCT01610596|11718509|FG000|Overall Study|Lost to Follow-up|0
7436225|NCT01610596|11718510|FG001|Overall Study|Lost to Follow-up|1
7436226|NCT01610687|11718516|FG000|Overall Study|Lack of Efficacy|26
7436227|NCT01610687|11718516|FG000|Overall Study|Adverse Event|18
7436228|NCT01610687|11718516|FG000|Overall Study|Moved out of area|6
7436229|NCT01610687|11718516|FG000|Overall Study|Withdrawal by Subject|7
7436230|NCT01610687|11718516|FG000|Overall Study|Lost to Follow-up|4
7436231|NCT01610687|11718516|FG000|Overall Study|Symptom control without study medication|2
7436232|NCT01610687|11718516|FG000|Overall Study|Unable to make journey|1
7436233|NCT01610687|11718516|FG000|Overall Study|Death|1
7436234|NCT01610687|11718516|FG000|Overall Study|Cannabis affecting job|1
7436235|NCT01610687|11718516|FG000|Overall Study|Felt more alter without study medication|1
7436236|NCT01610700|11718522|FG000|Overall Study|Adverse Event|3
7436237|NCT01610700|11718523|FG001|Overall Study|Adverse Event|1
7436238|NCT01610700|11718522|FG000|Overall Study|Withdrawal by Subject|0
7436239|NCT01610700|11718523|FG001|Overall Study|Withdrawal by Subject|1
7436240|NCT01610700|11718522|FG000|Overall Study|subject took one dose of street cannabis|0
7436241|NCT01610700|11718523|FG001|Overall Study|subject took one dose of street cannabis|1
7467202|NCT01899053|11767576|FG004|Overall Study|Progressive Disease|3
7467203|NCT01899053|11767577|FG005|Overall Study|Progressive Disease|1
7467204|NCT01899053|11767578|FG006|Overall Study|Progressive Disease|1
7467205|NCT01899053|11767579|FG007|Overall Study|Progressive Disease|1
7467206|NCT01899053|11767580|FG008|Overall Study|Progressive Disease|4
7467207|NCT01899053|11767581|FG009|Overall Study|Progressive Disease|3
7467208|NCT01899053|11767582|FG010|Overall Study|Progressive Disease|12
7467209|NCT01899053|11767583|FG011|Overall Study|Progressive Disease|5
7467210|NCT01899053|11767584|FG012|Overall Study|Progressive Disease|8
7467211|NCT01899053|11767585|FG013|Overall Study|Progressive Disease|17
7467212|NCT01899053|11767572|FG000|Overall Study|Adverse Event|1
7467213|NCT01899053|11767573|FG001|Overall Study|Adverse Event|1
7467214|NCT01899053|11767574|FG002|Overall Study|Adverse Event|1
7467215|NCT01899053|11767575|FG003|Overall Study|Adverse Event|3
7467216|NCT01899053|11767576|FG004|Overall Study|Adverse Event|1
7467217|NCT01899053|11767577|FG005|Overall Study|Adverse Event|1
7467218|NCT01899053|11767578|FG006|Overall Study|Adverse Event|1
7467219|NCT01899053|11767579|FG007|Overall Study|Adverse Event|0
7467220|NCT01899053|11767580|FG008|Overall Study|Adverse Event|2
7467221|NCT01899053|11767581|FG009|Overall Study|Adverse Event|0
7467222|NCT01899053|11767582|FG010|Overall Study|Adverse Event|3
7467223|NCT01899053|11767583|FG011|Overall Study|Adverse Event|1
7467224|NCT01899053|11767584|FG012|Overall Study|Adverse Event|2
7467225|NCT01899053|11767585|FG013|Overall Study|Adverse Event|2
7467226|NCT01899053|11767572|FG000|Overall Study|Reason Not Specified|0
7467227|NCT01899053|11767573|FG001|Overall Study|Reason Not Specified|0
7467228|NCT01899053|11767574|FG002|Overall Study|Reason Not Specified|0
7467229|NCT01899053|11767575|FG003|Overall Study|Reason Not Specified|0
7467230|NCT01899053|11767576|FG004|Overall Study|Reason Not Specified|0
7467231|NCT01899053|11767577|FG005|Overall Study|Reason Not Specified|0
7467232|NCT01899053|11767578|FG006|Overall Study|Reason Not Specified|1
7467233|NCT01899053|11767579|FG007|Overall Study|Reason Not Specified|0
7467234|NCT01899053|11767580|FG008|Overall Study|Reason Not Specified|0
7467235|NCT01899053|11767581|FG009|Overall Study|Reason Not Specified|0
7467236|NCT01899053|11767582|FG010|Overall Study|Reason Not Specified|0
7467237|NCT01899053|11767583|FG011|Overall Study|Reason Not Specified|0
7467238|NCT01899053|11767584|FG012|Overall Study|Reason Not Specified|1
7467239|NCT01899053|11767585|FG013|Overall Study|Reason Not Specified|0
7467240|NCT01899053|11767572|FG000|Overall Study|Withdrawal by Subject|1
7467241|NCT01899053|11767573|FG001|Overall Study|Withdrawal by Subject|1
7467242|NCT01899053|11767574|FG002|Overall Study|Withdrawal by Subject|2
7532802|NCT02675998|11878533|FG003|8-Week Treatment Period|Other|0
7467243|NCT01899053|11767575|FG003|Overall Study|Withdrawal by Subject|0
7467244|NCT01899053|11767576|FG004|Overall Study|Withdrawal by Subject|2
7467245|NCT01899053|11767577|FG005|Overall Study|Withdrawal by Subject|0
7467246|NCT01899053|11767578|FG006|Overall Study|Withdrawal by Subject|0
7467247|NCT01899053|11767579|FG007|Overall Study|Withdrawal by Subject|1
7467248|NCT01899053|11767580|FG008|Overall Study|Withdrawal by Subject|0
7467249|NCT01899053|11767581|FG009|Overall Study|Withdrawal by Subject|0
7467250|NCT01899053|11767582|FG010|Overall Study|Withdrawal by Subject|0
7532803|NCT02675998|11878530|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
7436242|NCT01610713|11718532|FG000|Overall Study|Adverse Event|3
7436243|NCT01610713|11718533|FG001|Overall Study|Adverse Event|0
7436244|NCT01610713|11718532|FG000|Overall Study|Lack of Efficacy|1
7436245|NCT01610713|11718533|FG001|Overall Study|Lack of Efficacy|0
7436246|NCT01610713|11718532|FG000|Overall Study|low mood and poor motivation|1
7436247|NCT01610713|11718533|FG001|Overall Study|low mood and poor motivation|0
7436248|NCT01610713|11718532|FG000|Overall Study|adv. to use original dose/amitriptyline|1
7436249|NCT01610713|11718533|FG001|Overall Study|adv. to use original dose/amitriptyline|0
7436250|NCT01610713|11718532|FG000|Overall Study|Lost to Follow-up|0
7436251|NCT01610713|11718533|FG001|Overall Study|Lost to Follow-up|1
7436252|NCT01610752|11718542|FG000|Overall Study|Miscarriage/Pregnancy loss|0
7559519|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Death|0
7559520|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Death|1
7559521|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7559522|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1
7559523|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7559524|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7559525|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0
7559526|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
7559527|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
7559528|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7559529|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
7559530|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
7559531|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7559532|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7559533|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7559534|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7559535|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7559536|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0
7559537|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0
7559538|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1
7559539|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0
7559540|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0
7559541|NCT03152552|11925890|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7559542|NCT03152552|11925891|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7559543|NCT03152552|11925892|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7559544|NCT03152552|11925893|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
7559545|NCT03152552|11925894|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
7559546|NCT03152552|11925890|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
7559547|NCT03152552|11925891|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
7559548|NCT03152552|11925892|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7559549|NCT03152552|11925893|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
7559550|NCT03152552|11925894|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
7559551|NCT03154047|11925925|FG000|Overall Study|Death|1
7559552|NCT03154047|11925925|FG000|Overall Study|Study terminated by sponsor|76
7328761|NCT00797966|11561718|FG000|Phase B|Physician Decision|1
7328762|NCT00797966|11561719|FG001|Phase B|Physician Decision|0
7328763|NCT00797966|11561720|FG002|Phase B|Physician Decision|3
7328764|NCT00797966|11561721|FG003|Phase B|Physician Decision|1
7559553|NCT03154047|11925925|FG000|Overall Study|Withdrawal by Subject|3
7559554|NCT03154086|11925944|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559555|NCT03154086|11925945|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559556|NCT03154086|11925946|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559557|NCT03154086|11925947|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
7559558|NCT03154086|11925948|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559559|NCT03154086|11925949|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559560|NCT03154086|11925950|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559561|NCT03154086|11925951|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559562|NCT03154086|11925952|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559563|NCT03154086|11925953|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559564|NCT03154086|11925954|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559565|NCT03154086|11925955|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559566|NCT03154086|11925956|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559567|NCT03154086|11925957|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559568|NCT03154086|11925958|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
7559569|NCT03154086|11925944|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559570|NCT03154086|11925945|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
7559571|NCT03154086|11925946|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559572|NCT03154086|11925947|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559573|NCT03154086|11925948|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7328765|NCT00797966|11561722|FG004|Phase B|Physician Decision|0
7436253|NCT01610752|11718543|FG001|Overall Study|Miscarriage/Pregnancy loss|0
7436254|NCT01610752|11718544|FG002|Overall Study|Miscarriage/Pregnancy loss|4
7436255|NCT01610791|11718552|FG000|Overall Study|Lost to Follow-up|7
7436256|NCT01610791|11718552|FG000|Overall Study|Adverse Event|6
7436257|NCT01610791|11718552|FG000|Overall Study|Physician Decision|1
7436258|NCT01610791|11718552|FG000|Overall Study|Adverse event and Investigator decision|1
7436259|NCT01610791|11718552|FG000|Overall Study|Death|1
7436260|NCT01610791|11718552|FG000|Overall Study|Not determined|5
7436261|NCT01611090|11718558|FG000|Randomized Period|Lost to Follow-up|8
7436262|NCT01611090|11718559|FG001|Randomized Period|Lost to Follow-up|3
7436263|NCT01611090|11718560|FG002|Randomized Period|Lost to Follow-up|0
7436264|NCT01611090|11718558|FG000|Randomized Period|Withdrawal by Subject|22
7436265|NCT01611090|11718559|FG001|Randomized Period|Withdrawal by Subject|26
7436266|NCT01611090|11718560|FG002|Randomized Period|Withdrawal by Subject|0
7436267|NCT01611090|11718558|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7436268|NCT01611090|11718559|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
7436269|NCT01611090|11718560|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
7436270|NCT01611090|11718558|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7436271|NCT01611090|11718559|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
7436272|NCT01611090|11718560|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
7436273|NCT01611155|11718569|FG000|Overall Study|Adverse Event|1
7436274|NCT01611155|11718570|FG001|Overall Study|Adverse Event|1
7436275|NCT01611155|11718569|FG000|Overall Study|Refused further treatment|6
7436276|NCT01611155|11718570|FG001|Overall Study|Refused further treatment|4
7436277|NCT01611155|11718569|FG000|Overall Study|Disease progression|1
7436278|NCT01611155|11718570|FG001|Overall Study|Disease progression|0
7436279|NCT01611155|11718569|FG000|Overall Study|Withdrawal by Subject|1
7436280|NCT01611155|11718570|FG001|Overall Study|Withdrawal by Subject|0
7436281|NCT01611155|11718569|FG000|Overall Study|Alternative treatment|0
7436282|NCT01611155|11718570|FG001|Overall Study|Alternative treatment|1
7436283|NCT01611155|11718569|FG000|Overall Study|Ineligible patient|0
7436284|NCT01611155|11718570|FG001|Overall Study|Ineligible patient|1
7436285|NCT01611194|11718578|FG000|Overall Study|Lost to Follow-up|0
7436286|NCT01611194|11718579|FG001|Overall Study|Lost to Follow-up|1
7436287|NCT01611194|11718578|FG000|Overall Study|Withdrawal by Subject|0
7436288|NCT01611194|11718579|FG001|Overall Study|Withdrawal by Subject|1
7559574|NCT03154086|11925949|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559575|NCT03154086|11925950|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559576|NCT03154086|11925951|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559577|NCT03154086|11925952|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559578|NCT03154086|11925953|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559579|NCT03154086|11925954|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559580|NCT03154086|11925955|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559581|NCT03154086|11925956|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559582|NCT03154086|11925957|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559583|NCT03154086|11925958|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
7559584|NCT03154086|11925944|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559585|NCT03154086|11925945|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559586|NCT03154086|11925946|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
7559587|NCT03154086|11925947|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7436289|NCT01611194|11718578|FG000|Overall Study|drug use|0
7436290|NCT01611194|11718579|FG001|Overall Study|drug use|1
7436291|NCT01611259|11718585|FG000|Overall Study|Physician Decision|1
7436292|NCT01611259|11718585|FG000|Overall Study|Lack of Efficacy|2
7436293|NCT01611259|11718585|FG000|Overall Study|Adverse Event|4
7436294|NCT01611259|11718585|FG000|Overall Study|Withdrawal by Subject|7
7436295|NCT01611298|11718589|FG000|Overall Study|Relapsed|2
7436296|NCT01611454|11718595|FG000|Overall Study|Lack of Efficacy|18
7436297|NCT01611454|11718596|FG001|Overall Study|Lack of Efficacy|10
7436298|NCT01611558|11718606|FG000|Induction Phase|Study drug toxicity|15
7436299|NCT01611558|11718606|FG000|Induction Phase|Disease progression|18
7436300|NCT01611558|11718606|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
7436301|NCT01611558|11718606|FG000|Induction Phase|Adverse event unrelated to study drug|3
7436302|NCT01611558|11718606|FG000|Induction Phase|Death|1
7436303|NCT01611558|11718606|FG000|Maintenance Phase|Withdrawal by Subject|1
7436304|NCT01611558|11718606|FG000|Maintenance Phase|Elevated Uric acid|1
7436305|NCT01611792|11718634|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
7436306|NCT01611792|11718635|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
7436307|NCT01611792|11718634|FG000|Followup: at 6 Months|Lost to Follow-up|6
7436308|NCT01611792|11718635|FG001|Followup: at 6 Months|Lost to Follow-up|13
7436309|NCT01611857|11718644|FG000|Overall Study|Withdrawal by Subject|0
7436310|NCT01611857|11718645|FG001|Overall Study|Withdrawal by Subject|2
7436311|NCT01611935|11718655|FG000|Overall Study|Family Declined Participation|1
7436312|NCT01611935|11718656|FG001|Overall Study|Family Declined Participation|0
7436313|NCT01611974|11718674|FG000|Overall Study|Death|10
7436314|NCT01611974|11718675|FG001|Overall Study|Death|12
7436315|NCT01611974|11718676|FG002|Overall Study|Death|10
7436316|NCT01611974|11718674|FG000|Overall Study|Lost to Follow-up|0
7436317|NCT01611974|11718675|FG001|Overall Study|Lost to Follow-up|1
7436318|NCT01611974|11718676|FG002|Overall Study|Lost to Follow-up|0
7436319|NCT01611974|11718674|FG000|Overall Study|Physician Decision|5
7436320|NCT01611974|11718675|FG001|Overall Study|Physician Decision|1
7436321|NCT01611974|11718676|FG002|Overall Study|Physician Decision|2
7436322|NCT01611974|11718674|FG000|Overall Study|Withdrawal by Subject|0
7436323|NCT01611974|11718675|FG001|Overall Study|Withdrawal by Subject|1
7436324|NCT01611974|11718676|FG002|Overall Study|Withdrawal by Subject|4
7436325|NCT01612000|11718688|FG000|Overall Study|Lost to Follow-up|6
7436326|NCT01612000|11718689|FG001|Overall Study|Lost to Follow-up|4
7436327|NCT01612000|11718690|FG002|Overall Study|Lost to Follow-up|4
7436328|NCT01612000|11718691|FG003|Overall Study|Lost to Follow-up|8
7436329|NCT01612000|11718688|FG000|Overall Study|Physician Decision|0
7436330|NCT01612000|11718689|FG001|Overall Study|Physician Decision|0
7436331|NCT01612000|11718690|FG002|Overall Study|Physician Decision|1
7436332|NCT01612000|11718691|FG003|Overall Study|Physician Decision|0
7436333|NCT01612000|11718688|FG000|Overall Study|Withdrawal by Subject|3
7436334|NCT01612000|11718689|FG001|Overall Study|Withdrawal by Subject|1
7436335|NCT01612000|11718690|FG002|Overall Study|Withdrawal by Subject|2
7436336|NCT01612000|11718691|FG003|Overall Study|Withdrawal by Subject|2
7436337|NCT01612156|11718703|FG000|Overall Study|Protocol Violation|2
7436338|NCT01612156|11718704|FG001|Overall Study|Protocol Violation|0
7436339|NCT01612676|11718736|FG000|Overall Study|Adverse Event|2
7436340|NCT01612676|11718737|FG001|Overall Study|Adverse Event|3
7436341|NCT01612676|11718738|FG002|Overall Study|Adverse Event|1
7436342|NCT01612676|11718739|FG003|Overall Study|Adverse Event|3
7436343|NCT01612676|11718736|FG000|Overall Study|Protocol Violation|0
7436344|NCT01612676|11718737|FG001|Overall Study|Protocol Violation|1
7436345|NCT01612676|11718738|FG002|Overall Study|Protocol Violation|0
7436346|NCT01612676|11718739|FG003|Overall Study|Protocol Violation|0
7436347|NCT01612702|11718753|FG000|Overall Study|Protocol Violation|11
7559588|NCT03154086|11925948|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559589|NCT03154086|11925949|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559590|NCT03154086|11925950|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559591|NCT03154086|11925951|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559592|NCT03154086|11925952|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559593|NCT03154086|11925953|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559594|NCT03154086|11925954|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559595|NCT03154086|11925955|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559596|NCT03154086|11925956|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559597|NCT03154086|11925957|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559598|NCT03154086|11925958|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
7559599|NCT03154086|11925944|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
7559600|NCT03154086|11925945|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559601|NCT03154086|11925946|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559602|NCT03154086|11925947|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559603|NCT03154086|11925948|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559604|NCT03154086|11925949|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559605|NCT03154086|11925950|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559606|NCT03154086|11925951|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559607|NCT03154086|11925952|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559608|NCT03154086|11925953|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559609|NCT03154086|11925954|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559610|NCT03154086|11925955|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559611|NCT03154086|11925956|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559612|NCT03154086|11925957|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559613|NCT03154086|11925958|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
7559614|NCT03154086|11925944|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559615|NCT03154086|11925945|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559616|NCT03154086|11925946|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559617|NCT03154086|11925947|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559618|NCT03154086|11925948|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559619|NCT03154086|11925949|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559620|NCT03154086|11925950|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559621|NCT03154086|11925951|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559622|NCT03154086|11925952|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
7559623|NCT03154086|11925953|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559624|NCT03154086|11925954|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559625|NCT03154086|11925955|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559626|NCT03154086|11925956|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559627|NCT03154086|11925957|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7436348|NCT01612702|11718754|FG001|Overall Study|Protocol Violation|11
7436349|NCT01612780|11718785|FG000|Overall Study|Treatment not completed|1
7436350|NCT01612780|11718785|FG000|Overall Study|Withdrawal by Subject|5
7436351|NCT01612858|11718800|FG000|Overall Study|Withdrawal by Subject|5
7436352|NCT01612858|11718801|FG001|Overall Study|Withdrawal by Subject|1
7436353|NCT01613027|11718825|FG000|Overall Study|Lost to Follow-up|5
7436354|NCT01613027|11718825|FG000|Overall Study|Switched Physician|1
7436355|NCT01613027|11718825|FG000|Overall Study|Lack of Efficacy|1
7559628|NCT03154086|11925958|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
7559629|NCT03154086|11925944|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559630|NCT03154086|11925945|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7436356|NCT01613027|11718825|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
7436357|NCT01613131|11718831|FG000|Overall Study|Withdrawal by Subject|3
7436358|NCT01613131|11718832|FG001|Overall Study|Withdrawal by Subject|5
7436359|NCT01613222|11718838|FG000|Overall Study|Physician Decision|1
7436360|NCT01613222|11718838|FG000|Overall Study|Unable to place arterial line|1
7436361|NCT01613222|11718838|FG000|Overall Study|Reused disposable sensors|10
7436362|NCT01613248|11718857|FG000|Overall Study|Adverse Event|0
7436363|NCT01613248|11718858|FG001|Overall Study|Adverse Event|0
7436364|NCT01613248|11718859|FG002|Overall Study|Adverse Event|0
7436365|NCT01613248|11718860|FG003|Overall Study|Adverse Event|1
7436366|NCT01613248|11718861|FG004|Overall Study|Adverse Event|0
7436367|NCT01613248|11718862|FG005|Overall Study|Adverse Event|0
7436368|NCT01613248|11718857|FG000|Overall Study|Withdrawal by Subject|3
7436369|NCT01613248|11718858|FG001|Overall Study|Withdrawal by Subject|2
7436370|NCT01613248|11718859|FG002|Overall Study|Withdrawal by Subject|2
7436371|NCT01613248|11718860|FG003|Overall Study|Withdrawal by Subject|5
7436372|NCT01613248|11718861|FG004|Overall Study|Withdrawal by Subject|0
7436373|NCT01613248|11718862|FG005|Overall Study|Withdrawal by Subject|1
7436374|NCT01613248|11718857|FG000|Overall Study|Lost to Follow-up|5
7436375|NCT01613248|11718858|FG001|Overall Study|Lost to Follow-up|7
7436376|NCT01613248|11718859|FG002|Overall Study|Lost to Follow-up|4
7436377|NCT01613248|11718860|FG003|Overall Study|Lost to Follow-up|8
7436378|NCT01613248|11718861|FG004|Overall Study|Lost to Follow-up|4
7436379|NCT01613248|11718862|FG005|Overall Study|Lost to Follow-up|2
7436380|NCT01613248|11718857|FG000|Overall Study|Study Terminated by Sponsor|4
7436381|NCT01613248|11718858|FG001|Overall Study|Study Terminated by Sponsor|6
7436382|NCT01613248|11718859|FG002|Overall Study|Study Terminated by Sponsor|8
7436383|NCT01613248|11718860|FG003|Overall Study|Study Terminated by Sponsor|8
7436384|NCT01613248|11718861|FG004|Overall Study|Study Terminated by Sponsor|9
7436385|NCT01613248|11718862|FG005|Overall Study|Study Terminated by Sponsor|11
7436386|NCT01613248|11718857|FG000|Overall Study|Physician Decision|8
7436387|NCT01613248|11718858|FG001|Overall Study|Physician Decision|8
7436388|NCT01613248|11718859|FG002|Overall Study|Physician Decision|9
7436389|NCT01613248|11718860|FG003|Overall Study|Physician Decision|4
7436390|NCT01613248|11718861|FG004|Overall Study|Physician Decision|7
7559631|NCT03154086|11925946|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559632|NCT03154086|11925947|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559633|NCT03154086|11925948|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559634|NCT03154086|11925949|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559635|NCT03154086|11925950|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559636|NCT03154086|11925951|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
7559637|NCT03154086|11925952|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559638|NCT03154086|11925953|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559639|NCT03154086|11925954|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7436391|NCT01613248|11718862|FG005|Overall Study|Physician Decision|6
7436392|NCT01613248|11718857|FG000|Overall Study|Lack of Qualifying Event|9
7436393|NCT01613248|11718858|FG001|Overall Study|Lack of Qualifying Event|11
7559640|NCT03154086|11925955|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559641|NCT03154086|11925956|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559642|NCT03154086|11925957|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559643|NCT03154086|11925958|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
7559644|NCT03154086|11925944|FG000|Part B (Up to 25 Days)|Adverse Event|0
7559645|NCT03154086|11925945|FG001|Part B (Up to 25 Days)|Adverse Event|0
7559646|NCT03154086|11925946|FG002|Part B (Up to 25 Days)|Adverse Event|0
7559647|NCT03154086|11925947|FG003|Part B (Up to 25 Days)|Adverse Event|0
7559648|NCT03154086|11925948|FG004|Part B (Up to 25 Days)|Adverse Event|0
7559649|NCT03154086|11925949|FG005|Part B (Up to 25 Days)|Adverse Event|0
7559650|NCT03154086|11925950|FG006|Part B (Up to 25 Days)|Adverse Event|0
7559651|NCT03154086|11925951|FG007|Part B (Up to 25 Days)|Adverse Event|0
7559652|NCT03154086|11925952|FG008|Part B (Up to 25 Days)|Adverse Event|0
7559653|NCT03154086|11925953|FG009|Part B (Up to 25 Days)|Adverse Event|0
7559654|NCT03154086|11925954|FG010|Part B (Up to 25 Days)|Adverse Event|1
7559655|NCT03154086|11925955|FG011|Part B (Up to 25 Days)|Adverse Event|0
7559656|NCT03154086|11925956|FG012|Part B (Up to 25 Days)|Adverse Event|0
7559657|NCT03154086|11925957|FG013|Part B (Up to 25 Days)|Adverse Event|0
7559658|NCT03154086|11925958|FG014|Part B (Up to 25 Days)|Adverse Event|0
7559659|NCT03154476|11926026|FG000|Overall Study|Lost to Follow-up|4
7436394|NCT01613248|11718859|FG002|Overall Study|Lack of Qualifying Event|10
7436395|NCT01613248|11718860|FG003|Overall Study|Lack of Qualifying Event|11
7436396|NCT01613248|11718861|FG004|Overall Study|Lack of Qualifying Event|15
7436397|NCT01613248|11718862|FG005|Overall Study|Lack of Qualifying Event|18
7559660|NCT03154476|11926027|FG001|Overall Study|Lost to Follow-up|4
7559661|NCT03155178|11926055|FG000|Overall Study|Did not meet treatment day baseline|7
7436398|NCT01613248|11718857|FG000|Overall Study|Pregnancy|0
7436399|NCT01613248|11718858|FG001|Overall Study|Pregnancy|0
7436400|NCT01613248|11718859|FG002|Overall Study|Pregnancy|0
7436401|NCT01613248|11718860|FG003|Overall Study|Pregnancy|1
7436402|NCT01613248|11718861|FG004|Overall Study|Pregnancy|0
7436403|NCT01613248|11718862|FG005|Overall Study|Pregnancy|0
7436404|NCT01613326|11718895|FG000|Overall Study|Adverse Event|7
7436405|NCT01613326|11718896|FG001|Overall Study|Adverse Event|5
7436406|NCT01613326|11718895|FG000|Overall Study|Withdrawal by Subject|3
7436407|NCT01613326|11718896|FG001|Overall Study|Withdrawal by Subject|4
7436408|NCT01613326|11718895|FG000|Overall Study|Abnormal test procedure result(s)|2
7436409|NCT01613326|11718896|FG001|Overall Study|Abnormal test procedure result(s)|0
7436410|NCT01613326|11718895|FG000|Overall Study|inability to use device|1
7436411|NCT01613326|11718896|FG001|Overall Study|inability to use device|0
7436412|NCT01613326|11718895|FG000|Overall Study|Lack of Efficacy|0
7436413|NCT01613326|11718896|FG001|Overall Study|Lack of Efficacy|1
7436414|NCT01613326|11718895|FG000|Overall Study|Lost to Follow-up|0
7436415|NCT01613326|11718896|FG001|Overall Study|Lost to Follow-up|1
7436416|NCT01613326|11718895|FG000|Overall Study|Administrative|0
7436417|NCT01613326|11718896|FG001|Overall Study|Administrative|2
7436418|NCT01613326|11718895|FG000|Overall Study|Protocol Violation|0
7436419|NCT01613326|11718896|FG001|Overall Study|Protocol Violation|1
7436420|NCT01613378|11718910|FG000|Overall Study|Lack of Efficacy|13
7436421|NCT01613378|11718910|FG000|Overall Study|Adverse Event|11
7436422|NCT01613378|11718910|FG000|Overall Study|Withdrawal by Subject|8
7436423|NCT01613378|11718910|FG000|Overall Study|Death|2
7436424|NCT01613378|11718910|FG000|Overall Study|Lost to Follow-up|1
7436425|NCT01613378|11718910|FG000|Overall Study|Other Reason|4
7436426|NCT01613417|11718916|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
7436427|NCT01613417|11718917|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
7436428|NCT01613599|11718933|FG000|Overall Study|Death|9
7436429|NCT01613599|11718933|FG000|Overall Study|Lost to Follow-up|5
7436430|NCT01613599|11718933|FG000|Overall Study|Withdrawal by Subject|8
7436431|NCT01613599|11718933|FG000|Overall Study|Reason not specified|3
7436432|NCT01613716|11718937|FG000|Overall Study|screen failures|3
7436433|NCT01613716|11718937|FG000|Overall Study|Lost to Follow-up|4
7436434|NCT01614093|11718946|FG000|Overall Study|Withdrawal by Subject|1
7436435|NCT01614249|11718957|FG000|Overall Study|Lost to Follow-up|11
7436436|NCT01614249|11718958|FG001|Overall Study|Lost to Follow-up|23
7436437|NCT01614457|11718975|FG000|Overall Study|Non-Compliance|1
7436438|NCT01614457|11718976|FG001|Overall Study|Non-Compliance|0
7436439|NCT01614457|11718975|FG000|Overall Study|Pregnancy (Self or Partner)|1
7436440|NCT01614457|11718976|FG001|Overall Study|Pregnancy (Self or Partner)|0
7436441|NCT01614470|11718984|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
7436442|NCT01614470|11718985|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7436443|NCT01614470|11718986|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
7436444|NCT01614470|11718984|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7436445|NCT01614470|11718985|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
7436446|NCT01614470|11718986|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
7436447|NCT01614600|11719008|FG000|Overall Study|Unacceptable fit|1
7436448|NCT01614600|11719008|FG000|Overall Study|Discomfort|1
7436449|NCT01614600|11719008|FG000|Overall Study|Unable to remove lens at the end of day|1
7436450|NCT01614600|11719008|FG000|Overall Study|Protocol deviation|1
7436451|NCT01614769|11719026|FG000|Period 1|Discontinued due to Hypoglycemia|0
7436452|NCT01614769|11719027|FG001|Period 1|Discontinued due to Hypoglycemia|0
7436453|NCT01614769|11719028|FG002|Period 1|Discontinued due to Hypoglycemia|0
7436454|NCT01614769|11719029|FG003|Period 1|Discontinued due to Hypoglycemia|1
7436455|NCT01614769|11719030|FG004|Period 1|Discontinued due to Hypoglycemia|0
7436456|NCT01614769|11719031|FG005|Period 1|Discontinued due to Hypoglycemia|1
7436457|NCT01614769|11719026|FG000|Period 1|Protocol Violation|0
7436458|NCT01614769|11719027|FG001|Period 1|Protocol Violation|0
7436459|NCT01614769|11719028|FG002|Period 1|Protocol Violation|0
7436460|NCT01614769|11719029|FG003|Period 1|Protocol Violation|1
7436461|NCT01614769|11719030|FG004|Period 1|Protocol Violation|0
7436462|NCT01614769|11719031|FG005|Period 1|Protocol Violation|0
7436463|NCT01614769|11719026|FG000|Period 1|Withdrawal by Subject|1
7436464|NCT01614769|11719027|FG001|Period 1|Withdrawal by Subject|0
7436465|NCT01614769|11719028|FG002|Period 1|Withdrawal by Subject|0
7436466|NCT01614769|11719029|FG003|Period 1|Withdrawal by Subject|0
7436467|NCT01614769|11719030|FG004|Period 1|Withdrawal by Subject|0
7436468|NCT01614769|11719031|FG005|Period 1|Withdrawal by Subject|0
7436469|NCT01614769|11719026|FG000|Period 3|Withdrawal by Subject|0
7436470|NCT01614769|11719027|FG001|Period 3|Withdrawal by Subject|0
7436471|NCT01614769|11719028|FG002|Period 3|Withdrawal by Subject|1
7436472|NCT01614769|11719029|FG003|Period 3|Withdrawal by Subject|0
7436473|NCT01614769|11719030|FG004|Period 3|Withdrawal by Subject|0
7436474|NCT01614769|11719031|FG005|Period 3|Withdrawal by Subject|0
7436475|NCT01614795|11719043|FG000|Overall Study|Adverse Event|0
7436476|NCT01614795|11719044|FG001|Overall Study|Adverse Event|0
7436477|NCT01614795|11719045|FG002|Overall Study|Adverse Event|1
7436478|NCT01614795|11719046|FG003|Overall Study|Adverse Event|1
7436479|NCT01614795|11719043|FG000|Overall Study|Lack of Efficacy|10
7436480|NCT01614795|11719044|FG001|Overall Study|Lack of Efficacy|10
7436481|NCT01614795|11719045|FG002|Overall Study|Lack of Efficacy|9
7436482|NCT01614795|11719046|FG003|Overall Study|Lack of Efficacy|8
7436483|NCT01614795|11719043|FG000|Overall Study|Physician Decision|1
7436484|NCT01614795|11719044|FG001|Overall Study|Physician Decision|0
7436485|NCT01614795|11719045|FG002|Overall Study|Physician Decision|1
7436486|NCT01614795|11719046|FG003|Overall Study|Physician Decision|1
7436487|NCT01614795|11719043|FG000|Overall Study|Withdrawal by Subject|0
7436488|NCT01614795|11719044|FG001|Overall Study|Withdrawal by Subject|1
7436489|NCT01614795|11719045|FG002|Overall Study|Withdrawal by Subject|0
7436490|NCT01614795|11719046|FG003|Overall Study|Withdrawal by Subject|2
7436491|NCT01614795|11719043|FG000|Overall Study|Ineligible|0
7436492|NCT01614795|11719044|FG001|Overall Study|Ineligible|1
7436493|NCT01614795|11719045|FG002|Overall Study|Ineligible|0
7436494|NCT01614795|11719046|FG003|Overall Study|Ineligible|0
7436495|NCT01614886|11719077|FG000|Overall Study|Adverse Event|15
7436496|NCT01614886|11719078|FG001|Overall Study|Adverse Event|20
7436497|NCT01614886|11719077|FG000|Overall Study|Withdrawal by Subject|4
7436498|NCT01614886|11719078|FG001|Overall Study|Withdrawal by Subject|4
7436499|NCT01614886|11719077|FG000|Overall Study|Death|1
7436500|NCT01614886|11719078|FG001|Overall Study|Death|0
7436501|NCT01614886|11719077|FG000|Overall Study|Protocol deviation|0
7436502|NCT01614886|11719078|FG001|Overall Study|Protocol deviation|2
7436503|NCT01614925|11719086|FG000|Overall Study|Withdrawal by Subject|1
7436504|NCT01614925|11719087|FG001|Overall Study|Withdrawal by Subject|0
7436505|NCT01614925|11719086|FG000|Overall Study|Protocol Violation|3
7436506|NCT01614925|11719087|FG001|Overall Study|Protocol Violation|2
7436507|NCT01615198|11719104|FG000|Overall Study|Withdrawal by Subject|5
7436508|NCT01615198|11719105|FG001|Overall Study|Withdrawal by Subject|5
7436509|NCT01615198|11719104|FG000|Overall Study|Protocol deviation|1
7436510|NCT01615198|11719105|FG001|Overall Study|Protocol deviation|1
7436511|NCT01615198|11719104|FG000|Overall Study|Physician Decision|5
7436512|NCT01615198|11719105|FG001|Overall Study|Physician Decision|1
7436513|NCT01615198|11719104|FG000|Overall Study|Lost to Follow-up|1
7436514|NCT01615198|11719105|FG001|Overall Study|Lost to Follow-up|1
7436515|NCT01615198|11719104|FG000|Overall Study|Lack of Efficacy|1
7436516|NCT01615198|11719105|FG001|Overall Study|Lack of Efficacy|6
7436517|NCT01615198|11719104|FG000|Overall Study|Adverse Event|11
7436518|NCT01615198|11719105|FG001|Overall Study|Adverse Event|5
7436519|NCT01615263|11719113|FG000|Overall Study|Post-randomization exclusion|0
7436520|NCT01615263|11719114|FG001|Overall Study|Post-randomization exclusion|2
7436521|NCT01615328|11719122|FG000|Overall Study|Lost to Follow-up|3
7532804|NCT02675998|11878531|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7532805|NCT02675998|11878532|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
7532806|NCT02675998|11878533|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
7532807|NCT02675998|11878530|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
7436522|NCT01615328|11719123|FG001|Overall Study|Lost to Follow-up|5
7559662|NCT03155178|11926056|FG001|Overall Study|Did not meet treatment day baseline|7
7559663|NCT03155178|11926057|FG002|Overall Study|Did not meet treatment day baseline|7
7559664|NCT03155178|11926058|FG003|Overall Study|Did not meet treatment day baseline|7
7559665|NCT03155269|11926074|FG000|Overall Study|Withdrawal by Subject|4
7436523|NCT01615822|11719167|FG000|Period 1|Withdrawal by Subject|0
7559666|NCT03155269|11926075|FG001|Overall Study|Withdrawal by Subject|5
7559667|NCT03155269|11926074|FG000|Overall Study|Lost to Follow-up|1
7559668|NCT03155269|11926075|FG001|Overall Study|Lost to Follow-up|2
7559669|NCT03155724|11926081|FG000|Overall Study|Death|3
7559670|NCT03155724|11926081|FG000|Overall Study|Physician Decision|1
7559671|NCT03155724|11926081|FG000|Overall Study|Study closure|7
7559672|NCT03155945|11926087|FG000|Overall Study|Lost to Follow-up|0
7559673|NCT03155945|11926088|FG001|Overall Study|Lost to Follow-up|1
7559674|NCT03155945|11926087|FG000|Overall Study|Withdrawal by Subject|0
7559675|NCT03155945|11926088|FG001|Overall Study|Withdrawal by Subject|1
7559676|NCT03155945|11926087|FG000|Overall Study|Other Reason|0
7559677|NCT03155945|11926088|FG001|Overall Study|Other Reason|1
7559678|NCT03156270|11926094|FG000|Overall Study|Failed pre-treatment screening|1
7559679|NCT03156270|11926094|FG000|Overall Study|Lost to Follow-up|1
7559680|NCT03156543|11926102|FG000|Overall Study|Withdrawal by Subject|1
7559681|NCT03156543|11926103|FG001|Overall Study|Withdrawal by Subject|0
7559682|NCT03156621|11926111|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
7559683|NCT03156621|11926112|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
7559684|NCT03156621|11926111|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
7559685|NCT03156621|11926112|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
7559686|NCT03157089|11926123|FG000|Overall Study|Treated only with pembrolizumab|1
7559687|NCT03157089|11926124|FG001|Overall Study|Treated only with pembrolizumab|0
7532808|NCT02675998|11878531|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
7532809|NCT02675998|11878532|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
7436524|NCT01615822|11719168|FG001|Period 1|Withdrawal by Subject|1
7436525|NCT01615822|11719169|FG002|Period 1|Withdrawal by Subject|0
7436526|NCT01615822|11719167|FG000|Period 1|Adverse Event|1
7436527|NCT01615822|11719168|FG001|Period 1|Adverse Event|1
7436528|NCT01615822|11719169|FG002|Period 1|Adverse Event|0
7436529|NCT01615822|11719167|FG000|Period 2|Lost to Follow-up|0
7532810|NCT02675998|11878533|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
7532811|NCT02675998|11878530|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
7532812|NCT02675998|11878531|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
7532813|NCT02675998|11878532|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
7532814|NCT02675998|11878533|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
7532815|NCT02675998|11878530|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
7436530|NCT01615822|11719168|FG001|Period 2|Lost to Follow-up|1
7436531|NCT01615822|11719169|FG002|Period 2|Lost to Follow-up|2
7436532|NCT01615939|11719182|FG000|Overall Study|Lost to Follow-up|5
7436533|NCT01615939|11719183|FG001|Overall Study|Lost to Follow-up|0
7436534|NCT01616173|11719210|FG000|Overall Study|Lost to Follow-up|0
7436535|NCT01616173|11719211|FG001|Overall Study|Lost to Follow-up|2
7436536|NCT01616173|11719212|FG002|Overall Study|Lost to Follow-up|0
7436537|NCT01616459|11719224|FG000|Overall Study|Adverse Event|1
7436538|NCT01616459|11719225|FG001|Overall Study|Adverse Event|1
7436539|NCT01616459|11719226|FG002|Overall Study|Adverse Event|2
7436540|NCT01616459|11719227|FG003|Overall Study|Adverse Event|0
7436541|NCT01616459|11719224|FG000|Overall Study|Lost to Follow-up|1
7436542|NCT01616459|11719225|FG001|Overall Study|Lost to Follow-up|11
7436543|NCT01616459|11719226|FG002|Overall Study|Lost to Follow-up|3
7436544|NCT01616459|11719227|FG003|Overall Study|Lost to Follow-up|2
7436545|NCT01616459|11719224|FG000|Overall Study|Protocol Violation|0
7436546|NCT01616459|11719225|FG001|Overall Study|Protocol Violation|0
7436547|NCT01616459|11719226|FG002|Overall Study|Protocol Violation|0
7436548|NCT01616459|11719227|FG003|Overall Study|Protocol Violation|2
7436549|NCT01616459|11719224|FG000|Overall Study|Withdrawal by Subject|2
7436550|NCT01616459|11719225|FG001|Overall Study|Withdrawal by Subject|4
7436551|NCT01616459|11719226|FG002|Overall Study|Withdrawal by Subject|4
7436552|NCT01616459|11719227|FG003|Overall Study|Withdrawal by Subject|4
7436553|NCT01616459|11719224|FG000|Overall Study|Other reason|0
7436554|NCT01616459|11719225|FG001|Overall Study|Other reason|1
7436555|NCT01616459|11719226|FG002|Overall Study|Other reason|1
7436556|NCT01616459|11719227|FG003|Overall Study|Other reason|0
7436557|NCT01616563|11719242|FG000|Overall Study|Lost to Follow-up|40
7436558|NCT01616654|11719264|FG000|Overall Study|Lack of Efficacy|1
7436559|NCT01616654|11719265|FG001|Overall Study|Lack of Efficacy|0
7436560|NCT01616654|11719266|FG002|Overall Study|Lack of Efficacy|0
7436561|NCT01616654|11719267|FG003|Overall Study|Lack of Efficacy|0
7436562|NCT01616654|11719268|FG004|Overall Study|Lack of Efficacy|1
7436563|NCT01616654|11719264|FG000|Overall Study|Adverse Event|0
7436564|NCT01616654|11719265|FG001|Overall Study|Adverse Event|1
7436565|NCT01616654|11719266|FG002|Overall Study|Adverse Event|2
7436566|NCT01616654|11719267|FG003|Overall Study|Adverse Event|1
7436567|NCT01616654|11719268|FG004|Overall Study|Adverse Event|0
7436568|NCT01616654|11719264|FG000|Overall Study|Withdrawal by Subject|2
7436569|NCT01616654|11719265|FG001|Overall Study|Withdrawal by Subject|2
7436570|NCT01616654|11719266|FG002|Overall Study|Withdrawal by Subject|3
7436571|NCT01616654|11719267|FG003|Overall Study|Withdrawal by Subject|1
7436572|NCT01616654|11719268|FG004|Overall Study|Withdrawal by Subject|5
7436573|NCT01616654|11719264|FG000|Overall Study|Protocol Violation|0
7436574|NCT01616654|11719265|FG001|Overall Study|Protocol Violation|5
7436575|NCT01616654|11719266|FG002|Overall Study|Protocol Violation|2
7436576|NCT01616654|11719267|FG003|Overall Study|Protocol Violation|4
7436577|NCT01616654|11719268|FG004|Overall Study|Protocol Violation|4
7436578|NCT01616654|11719264|FG000|Overall Study|Lost to Follow-up|1
7436579|NCT01616654|11719265|FG001|Overall Study|Lost to Follow-up|0
7436580|NCT01616654|11719266|FG002|Overall Study|Lost to Follow-up|3
7436581|NCT01616654|11719267|FG003|Overall Study|Lost to Follow-up|2
7436582|NCT01616654|11719268|FG004|Overall Study|Lost to Follow-up|1
7436583|NCT01616654|11719264|FG000|Overall Study|Pregnancy|1
7436584|NCT01616654|11719265|FG001|Overall Study|Pregnancy|0
7436585|NCT01616654|11719266|FG002|Overall Study|Pregnancy|0
7436586|NCT01616654|11719267|FG003|Overall Study|Pregnancy|0
7436587|NCT01616654|11719268|FG004|Overall Study|Pregnancy|1
7436588|NCT01616693|11719285|FG000|Evaluated for Safety|Physician Decision|1
7436589|NCT01616693|11719286|FG001|Evaluated for Safety|Physician Decision|0
7436590|NCT01616693|11719287|FG002|Evaluated for Safety|Physician Decision|1
7436591|NCT01616693|11719288|FG003|Evaluated for Safety|Physician Decision|0
7436592|NCT01616693|11719285|FG000|Received Both Vaccines|Adverse Event|2
7436593|NCT01616693|11719286|FG001|Received Both Vaccines|Adverse Event|0
7436594|NCT01616693|11719287|FG002|Received Both Vaccines|Adverse Event|0
7436595|NCT01616693|11719288|FG003|Received Both Vaccines|Adverse Event|0
7436596|NCT01616693|11719285|FG000|Received Both Vaccines|Withdrawal by Subject|7
7436597|NCT01616693|11719286|FG001|Received Both Vaccines|Withdrawal by Subject|7
7436598|NCT01616693|11719287|FG002|Received Both Vaccines|Withdrawal by Subject|8
7436599|NCT01616693|11719288|FG003|Received Both Vaccines|Withdrawal by Subject|15
7436600|NCT01616693|11719285|FG000|Received Both Vaccines|Lost to Follow-up|4
7436601|NCT01616693|11719286|FG001|Received Both Vaccines|Lost to Follow-up|3
7436602|NCT01616693|11719287|FG002|Received Both Vaccines|Lost to Follow-up|4
7436603|NCT01616693|11719288|FG003|Received Both Vaccines|Lost to Follow-up|4
7436604|NCT01616693|11719285|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
7436605|NCT01616693|11719286|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
7436606|NCT01616693|11719287|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
7436607|NCT01616693|11719288|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
7436608|NCT01616771|11719302|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
7436609|NCT01616953|11719313|FG000|Overall Study|Lost to Follow-up|1
7436610|NCT01616953|11719314|FG001|Overall Study|Lost to Follow-up|0
7436611|NCT01616953|11719313|FG000|Overall Study|lack of bone and soft tissue|1
7436612|NCT01616953|11719314|FG001|Overall Study|lack of bone and soft tissue|0
7436613|NCT01617005|11719320|FG000|Overall Study|Pregnancy|1
7467251|NCT01899053|11767583|FG011|Overall Study|Withdrawal by Subject|0
7436614|NCT01617005|11719320|FG000|Overall Study|Lack of motivation for treatment|1
7436615|NCT01617070|11719324|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
7436616|NCT01617434|11719363|FG000|Overall Study|Adverse Event|12
7436617|NCT01617434|11719364|FG001|Overall Study|Adverse Event|3
7436618|NCT01617434|11719363|FG000|Overall Study|Protocol Violation|8
7436619|NCT01617434|11719364|FG001|Overall Study|Protocol Violation|7
7436620|NCT01617434|11719363|FG000|Overall Study|Withdrawal Criteria|12
7436621|NCT01617434|11719364|FG001|Overall Study|Withdrawal Criteria|37
7436622|NCT01617434|11719363|FG000|Overall Study|Unclassified|3
7436623|NCT01617434|11719364|FG001|Overall Study|Unclassified|4
7436624|NCT01617447|11719372|FG000|Overall Study|Adverse Event|0
7436625|NCT01617447|11719373|FG001|Overall Study|Adverse Event|1
7436626|NCT01617447|11719372|FG000|Overall Study|Physician Decision|0
7436627|NCT01617447|11719373|FG001|Overall Study|Physician Decision|2
7436628|NCT01617460|11719379|FG000|Overall Study|Adverse Event|10
7436629|NCT01617460|11719379|FG000|Overall Study|Physician Decision|16
7436630|NCT01617460|11719379|FG000|Overall Study|Protocol Violation|5
7436631|NCT01617460|11719379|FG000|Overall Study|Withdrawal by Subject|9
7436632|NCT01617629|11719406|FG000|Overall Study|Death|2
7436633|NCT01617629|11719406|FG000|Overall Study|Investigator's Clinical Judgement|1
7436634|NCT01617629|11719406|FG000|Overall Study|Reason Not Specified|1
7436635|NCT01617629|11719406|FG000|Overall Study|Participant Withdrew Consent|2
7436636|NCT01617655|11719412|FG000|Overall Study|Adverse Event|2
7436637|NCT01617655|11719413|FG001|Overall Study|Adverse Event|3
7436638|NCT01617655|11719412|FG000|Overall Study|Poor compliance to protocol|1
7436639|NCT01617655|11719413|FG001|Overall Study|Poor compliance to protocol|4
7436640|NCT01617655|11719412|FG000|Overall Study|Participants moved|0
7436641|NCT01617655|11719413|FG001|Overall Study|Participants moved|4
7436642|NCT01617655|11719412|FG000|Overall Study|Consent withdrawn by participant|1
7436643|NCT01617655|11719413|FG001|Overall Study|Consent withdrawn by participant|1
7436644|NCT01617655|11719412|FG000|Overall Study|Last visit outside protocol visit window|1
7436645|NCT01617655|11719413|FG001|Overall Study|Last visit outside protocol visit window|10
7436646|NCT01617655|11719412|FG000|Overall Study|Site closure|3
7436647|NCT01617655|11719413|FG001|Overall Study|Site closure|5
7436648|NCT01617655|11719412|FG000|Overall Study|Other than specified above|1
7436649|NCT01617655|11719413|FG001|Overall Study|Other than specified above|2
7436650|NCT01617668|11719423|FG000|Overall Study|Adverse Event|7
7436651|NCT01617668|11719424|FG001|Overall Study|Adverse Event|0
7436652|NCT01617668|11719425|FG002|Overall Study|Adverse Event|12
7436653|NCT01617668|11719426|FG003|Overall Study|Adverse Event|5
7436654|NCT01617668|11719423|FG000|Overall Study|Physician Decision|1
7436655|NCT01617668|11719424|FG001|Overall Study|Physician Decision|2
7436656|NCT01617668|11719425|FG002|Overall Study|Physician Decision|3
7436657|NCT01617668|11719426|FG003|Overall Study|Physician Decision|0
7436658|NCT01617668|11719423|FG000|Overall Study|Progressive Disease|4
7436659|NCT01617668|11719424|FG001|Overall Study|Progressive Disease|4
7436660|NCT01617668|11719425|FG002|Overall Study|Progressive Disease|6
7436661|NCT01617668|11719426|FG003|Overall Study|Progressive Disease|9
7559688|NCT03157089|11926123|FG000|Overall Study|Adverse Event|5
7559689|NCT03157089|11926124|FG001|Overall Study|Adverse Event|4
7559690|NCT03157089|11926123|FG000|Overall Study|Progressive disease|6
7559691|NCT03157089|11926124|FG001|Overall Study|Progressive disease|8
7559692|NCT03157531|11926135|FG000|Overall Study|Death|2
7559693|NCT03157531|11926135|FG000|Overall Study|Lost to Follow-up|4
7559694|NCT03157583|11926139|FG000|Overall Study|Other (did not meet study criteria)|1
7559695|NCT03158012|11926159|FG000|Overall Study|Withdrawal by Subject|0
7559696|NCT03158012|11926160|FG001|Overall Study|Withdrawal by Subject|1
7559697|NCT03158220|11926181|FG000|Overall Study|Screen Failure|0
7559698|NCT03158220|11926182|FG001|Overall Study|Screen Failure|1
7559699|NCT03158220|11926181|FG000|Overall Study|Withdrawal by Subject|8
7559700|NCT03158220|11926182|FG001|Overall Study|Withdrawal by Subject|9
7559701|NCT03158220|11926181|FG000|Overall Study|Status unknown|0
7559702|NCT03158220|11926182|FG001|Overall Study|Status unknown|1
7559703|NCT03158220|11926181|FG000|Overall Study|Lost to Follow-up|8
7559704|NCT03158220|11926182|FG001|Overall Study|Lost to Follow-up|5
7559705|NCT03158220|11926181|FG000|Overall Study|Physician Decision|1
7559706|NCT03158220|11926182|FG001|Overall Study|Physician Decision|0
7559707|NCT03158272|11926192|FG000|Overall Study|Disease progression|3
7559708|NCT03158272|11926193|FG001|Overall Study|Disease progression|3
7559709|NCT03158272|11926194|FG002|Overall Study|Disease progression|4
7559710|NCT03158272|11926195|FG003|Overall Study|Disease progression|6
7559711|NCT03158272|11926192|FG000|Overall Study|Death|0
7559712|NCT03158272|11926193|FG001|Overall Study|Death|0
7559713|NCT03158272|11926194|FG002|Overall Study|Death|1
7436662|NCT01617668|11719423|FG000|Overall Study|Subject/guardian decision|1
7436663|NCT01617668|11719424|FG001|Overall Study|Subject/guardian decision|3
7436664|NCT01617668|11719425|FG002|Overall Study|Subject/guardian decision|2
7436665|NCT01617668|11719426|FG003|Overall Study|Subject/guardian decision|1
7559714|NCT03158272|11926195|FG003|Overall Study|Death|0
7559715|NCT03158272|11926192|FG000|Overall Study|Other reasons|0
7559716|NCT03158272|11926193|FG001|Overall Study|Other reasons|0
7559717|NCT03158272|11926194|FG002|Overall Study|Other reasons|1
7559718|NCT03158272|11926195|FG003|Overall Study|Other reasons|0
7436666|NCT01617681|11719444|FG000|Period 1 Double Blind|Adverse Event|2
7559719|NCT03158272|11926192|FG000|Overall Study|Adverse event unrelated to the drug|0
7436667|NCT01617681|11719445|FG001|Period 1 Double Blind|Adverse Event|0
7436668|NCT01617681|11719446|FG002|Period 1 Double Blind|Adverse Event|0
7436669|NCT01617681|11719447|FG003|Period 1 Double Blind|Adverse Event|2
7436670|NCT01617681|11719448|FG004|Period 1 Double Blind|Adverse Event|0
7436671|NCT01617681|11719444|FG000|Period 1 Double Blind|Withdrawal by Subject|1
7436672|NCT01617681|11719445|FG001|Period 1 Double Blind|Withdrawal by Subject|1
7436673|NCT01617681|11719446|FG002|Period 1 Double Blind|Withdrawal by Subject|1
7559720|NCT03158272|11926193|FG001|Overall Study|Adverse event unrelated to the drug|1
7436674|NCT01617681|11719447|FG003|Period 1 Double Blind|Withdrawal by Subject|0
7436675|NCT01617681|11719448|FG004|Period 1 Double Blind|Withdrawal by Subject|0
7436676|NCT01617681|11719444|FG000|Period 2 Open Label|Adverse Event|0
7436677|NCT01617681|11719445|FG001|Period 2 Open Label|Adverse Event|0
7436678|NCT01617681|11719446|FG002|Period 2 Open Label|Adverse Event|0
7436679|NCT01617681|11719447|FG003|Period 2 Open Label|Adverse Event|0
7436680|NCT01617681|11719448|FG004|Period 2 Open Label|Adverse Event|3
7436681|NCT01617681|11719444|FG000|Period 2 Open Label|Withdrawal by Subject|0
7436682|NCT01617681|11719445|FG001|Period 2 Open Label|Withdrawal by Subject|0
7436683|NCT01617681|11719446|FG002|Period 2 Open Label|Withdrawal by Subject|0
7436684|NCT01617681|11719447|FG003|Period 2 Open Label|Withdrawal by Subject|0
7436685|NCT01617681|11719448|FG004|Period 2 Open Label|Withdrawal by Subject|3
7436686|NCT01617967|11719463|FG000|Overall Study|Protocol Violation|0
7436687|NCT01617967|11719464|FG001|Overall Study|Protocol Violation|0
7436688|NCT01617967|11719465|FG002|Overall Study|Protocol Violation|0
7436689|NCT01617967|11719466|FG003|Overall Study|Protocol Violation|1
7436690|NCT01617967|11719467|FG004|Overall Study|Protocol Violation|0
7436691|NCT01617967|11719468|FG005|Overall Study|Protocol Violation|0
7436692|NCT01617967|11719463|FG000|Overall Study|Withdrawal by Subject|0
7436693|NCT01617967|11719464|FG001|Overall Study|Withdrawal by Subject|0
7436694|NCT01617967|11719465|FG002|Overall Study|Withdrawal by Subject|0
7436695|NCT01617967|11719466|FG003|Overall Study|Withdrawal by Subject|0
7436696|NCT01617967|11719467|FG004|Overall Study|Withdrawal by Subject|0
7436697|NCT01617967|11719468|FG005|Overall Study|Withdrawal by Subject|1
7436698|NCT01617967|11719463|FG000|Overall Study|Dosing Suspended by Sponsor|1
7436699|NCT01617967|11719464|FG001|Overall Study|Dosing Suspended by Sponsor|0
7436700|NCT01617967|11719465|FG002|Overall Study|Dosing Suspended by Sponsor|0
7436701|NCT01617967|11719466|FG003|Overall Study|Dosing Suspended by Sponsor|0
7436702|NCT01617967|11719467|FG004|Overall Study|Dosing Suspended by Sponsor|0
7436703|NCT01617967|11719468|FG005|Overall Study|Dosing Suspended by Sponsor|0
7436704|NCT01618019|11719485|FG000|Overall Study|Withdrawal by Subject|14
7436705|NCT01618019|11719486|FG001|Overall Study|Withdrawal by Subject|14
7436706|NCT01618162|11719494|FG000|Overall Study|Protocol Violation|13
7436707|NCT01618162|11719495|FG001|Overall Study|Protocol Violation|10
7436708|NCT01618162|11719494|FG000|Overall Study|Adverse Event|9
7436709|NCT01618162|11719495|FG001|Overall Study|Adverse Event|2
7436710|NCT01618162|11719494|FG000|Overall Study|Withdrawal Criteria|2
7436711|NCT01618162|11719495|FG001|Overall Study|Withdrawal Criteria|10
7436712|NCT01618162|11719494|FG000|Overall Study|Unclassified|14
7436713|NCT01618162|11719495|FG001|Overall Study|Unclassified|13
7559721|NCT03158272|11926194|FG002|Overall Study|Adverse event unrelated to the drug|0
7559722|NCT03158272|11926195|FG003|Overall Study|Adverse event unrelated to the drug|0
7559723|NCT03158311|11926210|FG000|Overall Study|Subject/Guardian Decision|10
7559724|NCT03158311|11926211|FG001|Overall Study|Subject/Guardian Decision|6
7559725|NCT03158311|11926212|FG002|Overall Study|Subject/Guardian Decision|11
7559726|NCT03158311|11926210|FG000|Overall Study|Adverse Event|5
7559727|NCT03158311|11926211|FG001|Overall Study|Adverse Event|3
7559728|NCT03158311|11926212|FG002|Overall Study|Adverse Event|3
7559729|NCT03158311|11926210|FG000|Overall Study|Techinical Problems|3
7559730|NCT03158311|11926211|FG001|Overall Study|Techinical Problems|1
7559731|NCT03158311|11926212|FG002|Overall Study|Techinical Problems|5
7559732|NCT03158311|11926210|FG000|Overall Study|Physician Decision|2
7559733|NCT03158311|11926211|FG001|Overall Study|Physician Decision|3
7559734|NCT03158311|11926212|FG002|Overall Study|Physician Decision|7
7559735|NCT03158311|11926210|FG000|Overall Study|Lost to Follow-up|1
7559736|NCT03158311|11926211|FG001|Overall Study|Lost to Follow-up|1
7559737|NCT03158311|11926212|FG002|Overall Study|Lost to Follow-up|1
7559738|NCT03158311|11926210|FG000|Overall Study|Sponsor decision|1
7559739|NCT03158311|11926211|FG001|Overall Study|Sponsor decision|0
7559740|NCT03158311|11926212|FG002|Overall Study|Sponsor decision|0
7436714|NCT01618214|11719503|FG000|Overall Study|Adverse Event|3
7436715|NCT01618214|11719504|FG001|Overall Study|Adverse Event|1
7436716|NCT01618214|11719503|FG000|Overall Study|Lack of Efficacy|1
7559741|NCT03158311|11926210|FG000|Overall Study|Pregnancy|0
7559742|NCT03158311|11926211|FG001|Overall Study|Pregnancy|2
7559743|NCT03158311|11926212|FG002|Overall Study|Pregnancy|0
7559744|NCT03158311|11926210|FG000|Overall Study|Randomized in error|0
7559745|NCT03158311|11926211|FG001|Overall Study|Randomized in error|0
7559746|NCT03158311|11926212|FG002|Overall Study|Randomized in error|1
7559747|NCT03159091|11926235|FG000|Overall Study|Incorrect inclusion ineligible patient|5
7559748|NCT03159091|11926236|FG001|Overall Study|Incorrect inclusion ineligible patient|3
7436717|NCT01618214|11719504|FG001|Overall Study|Lack of Efficacy|1
7559749|NCT03159091|11926235|FG000|Overall Study|Patient has taken no dose of study drug|0
7436718|NCT01618214|11719503|FG000|Overall Study|Protocol Violation|1
7436719|NCT01618214|11719504|FG001|Overall Study|Protocol Violation|4
7559750|NCT03159091|11926236|FG001|Overall Study|Patient has taken no dose of study drug|1
7436720|NCT01618214|11719503|FG000|Overall Study|Withdrawal Criteria|1
7436721|NCT01618214|11719504|FG001|Overall Study|Withdrawal Criteria|2
7436722|NCT01618214|11719503|FG000|Overall Study|Unclassified|4
7436723|NCT01618214|11719504|FG001|Overall Study|Unclassified|5
7467252|NCT01899053|11767584|FG012|Overall Study|Withdrawal by Subject|1
7467253|NCT01899053|11767585|FG013|Overall Study|Withdrawal by Subject|1
7467254|NCT01899053|11767572|FG000|Overall Study|Protocol Violation|0
7467255|NCT01899053|11767573|FG001|Overall Study|Protocol Violation|0
7467256|NCT01899053|11767574|FG002|Overall Study|Protocol Violation|1
7467257|NCT01899053|11767575|FG003|Overall Study|Protocol Violation|0
7467258|NCT01899053|11767576|FG004|Overall Study|Protocol Violation|0
7467259|NCT01899053|11767577|FG005|Overall Study|Protocol Violation|0
7467260|NCT01899053|11767578|FG006|Overall Study|Protocol Violation|0
7467261|NCT01899053|11767579|FG007|Overall Study|Protocol Violation|0
7467262|NCT01899053|11767580|FG008|Overall Study|Protocol Violation|0
7467263|NCT01899053|11767581|FG009|Overall Study|Protocol Violation|0
7467264|NCT01899053|11767582|FG010|Overall Study|Protocol Violation|0
7559751|NCT03159455|11926270|FG000|Overall Study|Adverse Event|0
7559752|NCT03159455|11926271|FG001|Overall Study|Adverse Event|0
7559753|NCT03159455|11926272|FG002|Overall Study|Adverse Event|0
7559754|NCT03159455|11926273|FG003|Overall Study|Adverse Event|0
7559755|NCT03159455|11926274|FG004|Overall Study|Adverse Event|0
7559756|NCT03159455|11926275|FG005|Overall Study|Adverse Event|1
7559757|NCT03159468|11926299|FG000|Overall Study|Withdrawal by Subject|0
7559758|NCT03159468|11926300|FG001|Overall Study|Withdrawal by Subject|0
7559759|NCT03159468|11926301|FG002|Overall Study|Withdrawal by Subject|3
7559760|NCT03159468|11926302|FG003|Overall Study|Withdrawal by Subject|0
7559761|NCT03159468|11926303|FG004|Overall Study|Withdrawal by Subject|0
7559762|NCT03159468|11926304|FG005|Overall Study|Withdrawal by Subject|0
7559763|NCT03159611|11926320|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
7559764|NCT03159611|11926321|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
7559765|NCT03159611|11926320|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
7559766|NCT03159611|11926321|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
7559767|NCT03159611|11926320|FG000|Overall Study|Protocol Violation|7
7559768|NCT03159611|11926321|FG001|Overall Study|Protocol Violation|4
7559769|NCT03159611|11926320|FG000|Overall Study|Adverse Event|1
7559770|NCT03159611|11926321|FG001|Overall Study|Adverse Event|0
7559771|NCT03159611|11926320|FG000|Overall Study|Withdrawal by Subject|1
7559772|NCT03159611|11926321|FG001|Overall Study|Withdrawal by Subject|1
7559773|NCT03159611|11926320|FG000|Overall Study|Non-compliance with protocol requirement|3
7559774|NCT03159611|11926321|FG001|Overall Study|Non-compliance with protocol requirement|2
7559775|NCT03159611|11926320|FG000|Overall Study|Inability to perform procedures|1
7559776|NCT03159611|11926321|FG001|Overall Study|Inability to perform procedures|0
7559777|NCT03160560|11926371|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
7559778|NCT03160560|11926372|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7559779|NCT03160560|11926373|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
7559780|NCT03160560|11926374|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
7559781|NCT03160560|11926371|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
7559782|NCT03160560|11926372|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7559783|NCT03160560|11926373|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7559784|NCT03160560|11926374|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
7559785|NCT03160573|11926388|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
7559786|NCT03160573|11926389|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
7559787|NCT03160573|11926390|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
7559788|NCT03160573|11926391|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
7559789|NCT03160703|11926405|FG000|Overall Study|Withdrawal by Subject|0
7559790|NCT03160703|11926406|FG001|Overall Study|Withdrawal by Subject|0
7559791|NCT03160703|11926407|FG002|Overall Study|Withdrawal by Subject|0
7559792|NCT03160703|11926408|FG003|Overall Study|Withdrawal by Subject|1
7559794|NCT03160885|11926424|FG000|Initial Treatment Period|Not dosed|2
7559795|NCT03160885|11926425|FG001|Initial Treatment Period|Not dosed|0
7559796|NCT03160885|11926426|FG002|Initial Treatment Period|Not dosed|0
7559797|NCT03160885|11926427|FG003|Initial Treatment Period|Not dosed|0
7559798|NCT03160885|11926428|FG004|Initial Treatment Period|Not dosed|0
7559799|NCT03160885|11926429|FG005|Initial Treatment Period|Not dosed|0
7559800|NCT03160885|11926430|FG006|Initial Treatment Period|Not dosed|0
7559801|NCT03160885|11926424|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
7559802|NCT03160885|11926425|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
7559803|NCT03160885|11926426|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
7559804|NCT03160885|11926427|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
7559805|NCT03160885|11926428|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
7559806|NCT03160885|11926429|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
7559807|NCT03160885|11926430|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
7467265|NCT01899053|11767583|FG011|Overall Study|Protocol Violation|0
7467266|NCT01899053|11767584|FG012|Overall Study|Protocol Violation|0
7559808|NCT03160885|11926424|FG000|Open-label Treatment|Not dosed|0
7559809|NCT03160885|11926425|FG001|Open-label Treatment|Not dosed|0
7559810|NCT03160885|11926426|FG002|Open-label Treatment|Not dosed|0
7467267|NCT01899053|11767585|FG013|Overall Study|Protocol Violation|0
7436724|NCT01618266|11719523|FG000|Overall Study|Lost to Follow-up|9
7436725|NCT01618266|11719523|FG000|Overall Study|Treatment satisfaction|10
7436726|NCT01618266|11719523|FG000|Overall Study|Other reasons|11
7436727|NCT01618266|11719523|FG000|Overall Study|Lack of Efficacy|23
7436728|NCT01618266|11719523|FG000|Overall Study|Protocol Violation|43
7436729|NCT01618305|11719529|FG000|Overall Study|Death|0
7436730|NCT01618305|11719530|FG001|Overall Study|Death|1
7436731|NCT01618305|11719529|FG000|Overall Study|Lost to Follow-up|11
7436732|NCT01618305|11719530|FG001|Overall Study|Lost to Follow-up|7
7559811|NCT03160885|11926427|FG003|Open-label Treatment|Not dosed|0
7559812|NCT03160885|11926428|FG004|Open-label Treatment|Not dosed|0
7436733|NCT01618305|11719529|FG000|Overall Study|Protocol Violation|1
7436734|NCT01618305|11719530|FG001|Overall Study|Protocol Violation|0
7436735|NCT01618305|11719529|FG000|Overall Study|Withdrawal by Subject|3
7436736|NCT01618305|11719530|FG001|Overall Study|Withdrawal by Subject|2
7436737|NCT01618669|11719555|FG000|Overall Study|Lost to Follow-up|1
7436738|NCT01618669|11719556|FG001|Overall Study|Lost to Follow-up|1
7436739|NCT01618669|11719555|FG000|Overall Study|Randomized but Never Received Study Drug|3
7436740|NCT01618669|11719556|FG001|Overall Study|Randomized but Never Received Study Drug|2
7436741|NCT01618669|11719555|FG000|Overall Study|Adverse Event|16
7436742|NCT01618669|11719556|FG001|Overall Study|Adverse Event|7
7436743|NCT01618669|11719555|FG000|Overall Study|Protocol Violation|5
7436744|NCT01618669|11719556|FG001|Overall Study|Protocol Violation|3
7436745|NCT01618669|11719555|FG000|Overall Study|Withdrawal by Subject|9
7436746|NCT01618669|11719556|FG001|Overall Study|Withdrawal by Subject|9
7436747|NCT01618669|11719555|FG000|Overall Study|Miscellaneous Reason|0
7436748|NCT01618669|11719556|FG001|Overall Study|Miscellaneous Reason|1
7436749|NCT01618695|11719578|FG000|Core Phase|Adverse Event|4
7436750|NCT01618695|11719579|FG001|Core Phase|Adverse Event|5
7436751|NCT01618695|11719580|FG002|Core Phase|Adverse Event|15
7436752|NCT01618695|11719581|FG003|Core Phase|Adverse Event|20
7436753|NCT01618695|11719578|FG000|Core Phase|Lost to Follow-up|0
7436754|NCT01618695|11719579|FG001|Core Phase|Lost to Follow-up|0
7436755|NCT01618695|11719580|FG002|Core Phase|Lost to Follow-up|1
7436756|NCT01618695|11719581|FG003|Core Phase|Lost to Follow-up|0
7436757|NCT01618695|11719578|FG000|Core Phase|Withdrawal by Subject|16
7436758|NCT01618695|11719579|FG001|Core Phase|Withdrawal by Subject|11
7436759|NCT01618695|11719580|FG002|Core Phase|Withdrawal by Subject|9
7436760|NCT01618695|11719581|FG003|Core Phase|Withdrawal by Subject|13
7436761|NCT01618695|11719578|FG000|Core Phase|Pregnancy|2
7436762|NCT01618695|11719579|FG001|Core Phase|Pregnancy|0
7436763|NCT01618695|11719580|FG002|Core Phase|Pregnancy|0
7436764|NCT01618695|11719581|FG003|Core Phase|Pregnancy|0
7436765|NCT01618695|11719578|FG000|Core Phase|Lack of Efficacy|1
7436766|NCT01618695|11719579|FG001|Core Phase|Lack of Efficacy|2
7436767|NCT01618695|11719580|FG002|Core Phase|Lack of Efficacy|1
7436768|NCT01618695|11719581|FG003|Core Phase|Lack of Efficacy|1
7436769|NCT01618695|11719578|FG000|Core Phase|Other than specified|1
7436770|NCT01618695|11719579|FG001|Core Phase|Other than specified|2
7436771|NCT01618695|11719580|FG002|Core Phase|Other than specified|2
7436772|NCT01618695|11719581|FG003|Core Phase|Other than specified|2
7436773|NCT01618695|11719578|FG000|Core Phase|Not treated|1
7436774|NCT01618695|11719579|FG001|Core Phase|Not treated|0
7436775|NCT01618695|11719580|FG002|Core Phase|Not treated|2
7436776|NCT01618695|11719581|FG003|Core Phase|Not treated|0
7436777|NCT01618695|11719578|FG000|Extension Phase|Lack of Efficacy|17
7436778|NCT01618695|11719579|FG001|Extension Phase|Lack of Efficacy|33
7436779|NCT01618695|11719580|FG002|Extension Phase|Lack of Efficacy|26
7436780|NCT01618695|11719581|FG003|Extension Phase|Lack of Efficacy|24
7436781|NCT01618695|11719578|FG000|Extension Phase|Pregnancy|2
7559813|NCT03160885|11926429|FG005|Open-label Treatment|Not dosed|0
7559814|NCT03160885|11926430|FG006|Open-label Treatment|Not dosed|2
7436782|NCT01618695|11719579|FG001|Extension Phase|Pregnancy|0
7436783|NCT01618695|11719580|FG002|Extension Phase|Pregnancy|1
7436784|NCT01618695|11719581|FG003|Extension Phase|Pregnancy|1
7436785|NCT01618695|11719578|FG000|Extension Phase|Withdrawal by Subject|43
7559815|NCT03160885|11926424|FG000|Open-label Treatment|Discontinued IMP|0
7559816|NCT03160885|11926425|FG001|Open-label Treatment|Discontinued IMP|0
7559817|NCT03160885|11926426|FG002|Open-label Treatment|Discontinued IMP|0
7559818|NCT03160885|11926427|FG003|Open-label Treatment|Discontinued IMP|0
7559819|NCT03160885|11926428|FG004|Open-label Treatment|Discontinued IMP|0
7559820|NCT03160885|11926429|FG005|Open-label Treatment|Discontinued IMP|0
7559821|NCT03160885|11926430|FG006|Open-label Treatment|Discontinued IMP|131
7559822|NCT03160885|11926424|FG000|Open-label Treatment|Completed Week 50|0
7559823|NCT03160885|11926425|FG001|Open-label Treatment|Completed Week 50|0
7559824|NCT03160885|11926426|FG002|Open-label Treatment|Completed Week 50|0
7436786|NCT01618695|11719579|FG001|Extension Phase|Withdrawal by Subject|48
7436787|NCT01618695|11719580|FG002|Extension Phase|Withdrawal by Subject|42
7436788|NCT01618695|11719581|FG003|Extension Phase|Withdrawal by Subject|33
7436789|NCT01618695|11719578|FG000|Extension Phase|Adverse Event|18
7436790|NCT01618695|11719579|FG001|Extension Phase|Adverse Event|16
7436791|NCT01618695|11719580|FG002|Extension Phase|Adverse Event|9
7559825|NCT03160885|11926427|FG003|Open-label Treatment|Completed Week 50|0
7559826|NCT03160885|11926428|FG004|Open-label Treatment|Completed Week 50|0
7559827|NCT03160885|11926429|FG005|Open-label Treatment|Completed Week 50|0
7436792|NCT01618695|11719581|FG003|Extension Phase|Adverse Event|20
7436793|NCT01618695|11719578|FG000|Extension Phase|Lost to Follow-up|2
7436794|NCT01618695|11719579|FG001|Extension Phase|Lost to Follow-up|1
7436795|NCT01618695|11719580|FG002|Extension Phase|Lost to Follow-up|1
7436796|NCT01618695|11719581|FG003|Extension Phase|Lost to Follow-up|1
7436797|NCT01618695|11719578|FG000|Extension Phase|Other than specified|13
7436798|NCT01618695|11719579|FG001|Extension Phase|Other than specified|18
7436799|NCT01618695|11719580|FG002|Extension Phase|Other than specified|13
7436800|NCT01618695|11719581|FG003|Extension Phase|Other than specified|18
7436801|NCT01618708|11719594|FG000|Overall Study|Adverse Event|10
7436802|NCT01618708|11719595|FG001|Overall Study|Adverse Event|10
7436803|NCT01618708|11719594|FG000|Overall Study|Lost to Follow-up|3
7436804|NCT01618708|11719595|FG001|Overall Study|Lost to Follow-up|3
7436805|NCT01618708|11719594|FG000|Overall Study|Withdrawal by Subject|17
7436806|NCT01618708|11719595|FG001|Overall Study|Withdrawal by Subject|22
7436807|NCT01618708|11719594|FG000|Overall Study|Lack of Efficacy|8
7436808|NCT01618708|11719595|FG001|Overall Study|Lack of Efficacy|8
7436809|NCT01618708|11719594|FG000|Overall Study|Technical problems|2
7436810|NCT01618708|11719595|FG001|Overall Study|Technical problems|0
7436811|NCT01618708|11719594|FG000|Overall Study|Other than specified above|1
7436812|NCT01618708|11719595|FG001|Overall Study|Other than specified above|1
7436813|NCT01618708|11719594|FG000|Overall Study|Randomized but not treated|3
7436814|NCT01618708|11719595|FG001|Overall Study|Randomized but not treated|2
7436815|NCT01618838|11719602|FG000|Overall Study|slow accrual, trial closed prematurely.|4
7436816|NCT01618864|11719607|FG000|Overall Study|Withdrawal by Subject|2
7436817|NCT01618864|11719607|FG000|Overall Study|Lost to Follow-up|2
7436818|NCT01618916|11719622|FG000|Overall Study|Adverse Event|1
7436819|NCT01618916|11719623|FG001|Overall Study|Adverse Event|0
7436820|NCT01618916|11719624|FG002|Overall Study|Adverse Event|0
7436821|NCT01618916|11719625|FG003|Overall Study|Adverse Event|0
7436822|NCT01618916|11719626|FG004|Overall Study|Adverse Event|0
7436823|NCT01618916|11719627|FG005|Overall Study|Adverse Event|0
7436824|NCT01618916|11719622|FG000|Overall Study|Withdrawal by Subject|0
7436825|NCT01618916|11719623|FG001|Overall Study|Withdrawal by Subject|1
7436826|NCT01618916|11719624|FG002|Overall Study|Withdrawal by Subject|1
7436827|NCT01618916|11719625|FG003|Overall Study|Withdrawal by Subject|0
7436828|NCT01618916|11719626|FG004|Overall Study|Withdrawal by Subject|1
7436829|NCT01618916|11719627|FG005|Overall Study|Withdrawal by Subject|0
7436830|NCT01618916|11719622|FG000|Overall Study|Lost to Follow-up|1
7436831|NCT01618916|11719623|FG001|Overall Study|Lost to Follow-up|0
7436832|NCT01618916|11719624|FG002|Overall Study|Lost to Follow-up|0
7436833|NCT01618916|11719625|FG003|Overall Study|Lost to Follow-up|2
7436834|NCT01618916|11719626|FG004|Overall Study|Lost to Follow-up|0
7436835|NCT01618916|11719627|FG005|Overall Study|Lost to Follow-up|0
7436836|NCT01618968|11719670|FG000|Overall Study|Adverse Event|1
7436837|NCT01618968|11719671|FG001|Overall Study|Adverse Event|0
7436838|NCT01618968|11719672|FG002|Overall Study|Adverse Event|0
7436839|NCT01618968|11719673|FG003|Overall Study|Adverse Event|0
7436840|NCT01618968|11719670|FG000|Overall Study|Death|0
7436841|NCT01618968|11719671|FG001|Overall Study|Death|0
7436842|NCT01618968|11719672|FG002|Overall Study|Death|0
7436843|NCT01618968|11719673|FG003|Overall Study|Death|1
7436844|NCT01619059|11719684|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
7436845|NCT01619059|11719685|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
7436846|NCT01619059|11719684|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
7436847|NCT01619059|11719685|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
7436848|NCT01619059|11719684|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
7436849|NCT01619059|11719685|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
7436850|NCT01619059|11719684|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
7436851|NCT01619059|11719685|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
7436852|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
7436853|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
7436854|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
7436855|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
7559828|NCT03160885|11926430|FG006|Open-label Treatment|Completed Week 50|4
7559829|NCT03160885|11926424|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559830|NCT03160885|11926425|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559831|NCT03160885|11926426|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559832|NCT03160885|11926427|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
7559833|NCT03160885|11926428|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559834|NCT03160885|11926429|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559835|NCT03160885|11926430|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
7559836|NCT03160885|11926424|FG000|Maintenance Treatment Period|Discontinued IMP|0
7559837|NCT03160885|11926425|FG001|Maintenance Treatment Period|Discontinued IMP|0
7559838|NCT03160885|11926426|FG002|Maintenance Treatment Period|Discontinued IMP|9
7559839|NCT03160885|11926427|FG003|Maintenance Treatment Period|Discontinued IMP|13
7436856|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
7436857|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
7436858|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Death|1
7559840|NCT03160885|11926428|FG004|Maintenance Treatment Period|Discontinued IMP|5
7436859|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Death|0
7436860|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7436861|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
7436862|NCT01619059|11719684|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
7436863|NCT01619059|11719685|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
7436864|NCT01619410|11719693|FG000|Overall Study|Lost to Follow-up|7
7436865|NCT01619410|11719694|FG001|Overall Study|Lost to Follow-up|4
7436866|NCT01619423|11719704|FG000|Part 1 (Dose Escalation)|High basal Mn|0
7436867|NCT01619423|11719705|FG001|Part 1 (Dose Escalation)|High basal Mn|2
7436868|NCT01619423|11719706|FG002|Part 1 (Dose Escalation)|High basal Mn|0
7436869|NCT01619423|11719707|FG003|Part 1 (Dose Escalation)|High basal Mn|0
7436870|NCT01619579|11719720|FG000|Overall Study|Withdrawal by Subject|0
7436871|NCT01619579|11719721|FG001|Overall Study|Withdrawal by Subject|3
7436872|NCT01619787|11719733|FG000|Overall Study|Lost to Follow-up|5
7436873|NCT01619852|11719759|FG000|24 Hour Assessment|Withdrawal by Subject|1
7436874|NCT01619852|11719760|FG001|24 Hour Assessment|Withdrawal by Subject|1
7436875|NCT01619852|11719759|FG000|3 Month Follow up|Lost to Follow-up|31
7436876|NCT01619852|11719760|FG001|3 Month Follow up|Lost to Follow-up|34
7436877|NCT01619865|11719767|FG000|Overall Study|Adverse Event|1
7436878|NCT01619865|11719767|FG000|Overall Study|Death|2
7436879|NCT01619865|11719767|FG000|Overall Study|subject not able to comply|1
7436880|NCT01619878|11719772|FG000|6 Week Follow-up Phase|Adverse Event|1
7436881|NCT01619878|11719772|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
7436882|NCT01619878|11719772|FG000|Follow-up at 12 Months of Age|Death|2
7436883|NCT01620060|11719802|FG000|Overall Study|Adverse Event|9
7436884|NCT01620060|11719802|FG000|Overall Study|Protocol Violation|1
7436885|NCT01620060|11719802|FG000|Overall Study|Withdrawal by Subject|1
7436886|NCT01620060|11719802|FG000|Overall Study|Did not comply with Study Produre|1
7436887|NCT01620060|11719802|FG000|Overall Study|Family emergency|1
7436888|NCT01620060|11719802|FG000|Overall Study|Per Sponsor Decision|2
7436889|NCT01620086|11719808|FG000|Overall Study|Withdrawal by Subject|3
7436890|NCT01620086|11719809|FG001|Overall Study|Withdrawal by Subject|3
7436891|NCT01620086|11719810|FG002|Overall Study|Withdrawal by Subject|0
7436892|NCT01620086|11719808|FG000|Overall Study|failed study criteria|1
7436893|NCT01620086|11719809|FG001|Overall Study|failed study criteria|4
7436894|NCT01620086|11719810|FG002|Overall Study|failed study criteria|0
7436895|NCT01620086|11719808|FG000|Overall Study|Physician Decision|1
7436896|NCT01620086|11719809|FG001|Overall Study|Physician Decision|0
7436897|NCT01620086|11719810|FG002|Overall Study|Physician Decision|0
7436898|NCT01620138|11719821|FG000|Overall Study|Withdrawal by Subject|3
7436899|NCT01620138|11719822|FG001|Overall Study|Withdrawal by Subject|0
7436900|NCT01620138|11719821|FG000|Overall Study|Lack of Efficacy|1
7436901|NCT01620138|11719822|FG001|Overall Study|Lack of Efficacy|0
7436902|NCT01620138|11719821|FG000|Overall Study|Adverse Event|2
7436903|NCT01620138|11719822|FG001|Overall Study|Adverse Event|0
7436904|NCT01620177|11719828|FG000|Overall Study|Failure at Screening Visit|43
7436905|NCT01620177|11719828|FG000|Overall Study|Withdrawal by Subject|26
7436906|NCT01620177|11719828|FG000|Overall Study|Lost to Follow-up|7
7436907|NCT01620177|11719828|FG000|Overall Study|Physician Decision|2
7436908|NCT01620177|11719828|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
7436909|NCT01620255|11719883|FG000|Overall Study|Withdrawal by Subject|4
7436910|NCT01620255|11719884|FG001|Overall Study|Withdrawal by Subject|1
7436911|NCT01620255|11719885|FG002|Overall Study|Withdrawal by Subject|1
7436912|NCT01620255|11719886|FG003|Overall Study|Withdrawal by Subject|2
7436913|NCT01620255|11719887|FG004|Overall Study|Withdrawal by Subject|4
7436914|NCT01620255|11719883|FG000|Overall Study|Participant underwent fecal transplant|0
7436915|NCT01620255|11719884|FG001|Overall Study|Participant underwent fecal transplant|0
7436916|NCT01620255|11719885|FG002|Overall Study|Participant underwent fecal transplant|1
7436917|NCT01620255|11719886|FG003|Overall Study|Participant underwent fecal transplant|0
7436918|NCT01620255|11719887|FG004|Overall Study|Participant underwent fecal transplant|0
7436919|NCT01620255|11719883|FG000|Overall Study|Non-compliance|0
7532816|NCT02675998|11878531|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
7532817|NCT02675998|11878532|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
7532818|NCT02675998|11878533|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
7532819|NCT02675998|11878530|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7532820|NCT02675998|11878531|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7532821|NCT02675998|11878532|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
7532822|NCT02675998|11878533|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
7532823|NCT02676466|11878564|FG000|Overall Study|Death|0
7532824|NCT02676466|11878565|FG001|Overall Study|Death|2
7532825|NCT02676466|11878566|FG002|Overall Study|Death|1
7532826|NCT02676466|11878567|FG003|Overall Study|Death|0
7532827|NCT02676466|11878568|FG004|Overall Study|Death|0
7532828|NCT02676466|11878569|FG005|Overall Study|Death|0
7436920|NCT01620255|11719884|FG001|Overall Study|Non-compliance|1
7436921|NCT01620255|11719885|FG002|Overall Study|Non-compliance|0
7436922|NCT01620255|11719886|FG003|Overall Study|Non-compliance|0
7436923|NCT01620255|11719887|FG004|Overall Study|Non-compliance|0
7436924|NCT01620255|11719883|FG000|Overall Study|Adverse Event|0
7436925|NCT01620255|11719884|FG001|Overall Study|Adverse Event|4
7436926|NCT01620255|11719885|FG002|Overall Study|Adverse Event|0
7436927|NCT01620255|11719886|FG003|Overall Study|Adverse Event|1
7436928|NCT01620255|11719887|FG004|Overall Study|Adverse Event|1
7436929|NCT01620255|11719883|FG000|Overall Study|Withdrawn at discretion of investigator|0
7436930|NCT01620255|11719884|FG001|Overall Study|Withdrawn at discretion of investigator|0
7436931|NCT01620255|11719885|FG002|Overall Study|Withdrawn at discretion of investigator|0
7436932|NCT01620255|11719886|FG003|Overall Study|Withdrawn at discretion of investigator|0
7436933|NCT01620255|11719887|FG004|Overall Study|Withdrawn at discretion of investigator|1
7436934|NCT01620489|11719901|FG000|Overall Study|Adverse Event|17
7436935|NCT01620489|11719902|FG001|Overall Study|Adverse Event|4
7436936|NCT01620489|11719901|FG000|Overall Study|Protocol Violation|0
7436937|NCT01620489|11719902|FG001|Overall Study|Protocol Violation|3
7436938|NCT01620489|11719901|FG000|Overall Study|Withdrawal Criteria|17
7436939|NCT01620489|11719902|FG001|Overall Study|Withdrawal Criteria|25
7436940|NCT01620489|11719901|FG000|Overall Study|Unclassified|1
7436941|NCT01620489|11719902|FG001|Overall Study|Unclassified|2
7436942|NCT01620528|11719911|FG000|Treatment Period|Did Not Receive Study Drug|0
7436943|NCT01620528|11719912|FG001|Treatment Period|Did Not Receive Study Drug|0
7436944|NCT01620528|11719913|FG002|Treatment Period|Did Not Receive Study Drug|1
7436945|NCT01620528|11719911|FG000|Treatment Period|Withdrawal by Subject|35
7436946|NCT01620528|11719912|FG001|Treatment Period|Withdrawal by Subject|21
7436947|NCT01620528|11719913|FG002|Treatment Period|Withdrawal by Subject|16
7436948|NCT01620528|11719911|FG000|Treatment Period|Adverse Event|17
7436949|NCT01620528|11719912|FG001|Treatment Period|Adverse Event|13
7436950|NCT01620528|11719913|FG002|Treatment Period|Adverse Event|21
7436951|NCT01620528|11719911|FG000|Treatment Period|Lost to Follow-up|16
7436952|NCT01620528|11719912|FG001|Treatment Period|Lost to Follow-up|8
7436953|NCT01620528|11719913|FG002|Treatment Period|Lost to Follow-up|14
7436954|NCT01620528|11719911|FG000|Treatment Period|Other|9
7436955|NCT01620528|11719912|FG001|Treatment Period|Other|5
7436956|NCT01620528|11719913|FG002|Treatment Period|Other|7
7436957|NCT01620528|11719911|FG000|Treatment Period|Subject Noncompliant|11
7436958|NCT01620528|11719912|FG001|Treatment Period|Subject Noncompliant|2
7436959|NCT01620528|11719913|FG002|Treatment Period|Subject Noncompliant|2
7436960|NCT01620528|11719911|FG000|Treatment Period|Pregnancy|7
7436961|NCT01620528|11719912|FG001|Treatment Period|Pregnancy|2
7436962|NCT01620528|11719913|FG002|Treatment Period|Pregnancy|2
7436963|NCT01620528|11719911|FG000|Treatment Period|Surgery/Invasive Intervention|5
7436964|NCT01620528|11719912|FG001|Treatment Period|Surgery/Invasive Intervention|1
7436965|NCT01620528|11719913|FG002|Treatment Period|Surgery/Invasive Intervention|3
7436966|NCT01620528|11719911|FG000|Treatment Period|Exclusionary Medication Received|0
7436967|NCT01620528|11719912|FG001|Treatment Period|Exclusionary Medication Received|1
7436968|NCT01620528|11719913|FG002|Treatment Period|Exclusionary Medication Received|0
7436969|NCT01620528|11719911|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7436970|NCT01620528|11719912|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
7436971|NCT01620528|11719913|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7436972|NCT01620528|11719911|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7436973|NCT01620528|11719912|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7436974|NCT01620528|11719913|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
7559841|NCT03160885|11926429|FG005|Maintenance Treatment Period|Discontinued IMP|7
7559842|NCT03160885|11926430|FG006|Maintenance Treatment Period|Discontinued IMP|0
7559843|NCT03160885|11926424|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
7559844|NCT03160885|11926425|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
7559845|NCT03160885|11926426|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
7559846|NCT03160885|11926427|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
7559847|NCT03160885|11926428|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
7559848|NCT03160885|11926429|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
7559849|NCT03160885|11926430|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
7559850|NCT03160885|11926424|FG000|Maintenance Treatment Period|Completed Week 50|0
7559851|NCT03160885|11926425|FG001|Maintenance Treatment Period|Completed Week 50|0
7559852|NCT03160885|11926426|FG002|Maintenance Treatment Period|Completed Week 50|1
7559853|NCT03160885|11926427|FG003|Maintenance Treatment Period|Completed Week 50|0
7559854|NCT03160885|11926428|FG004|Maintenance Treatment Period|Completed Week 50|0
7559855|NCT03160885|11926429|FG005|Maintenance Treatment Period|Completed Week 50|0
7559856|NCT03160885|11926430|FG006|Maintenance Treatment Period|Completed Week 50|0
7559857|NCT03160898|11926451|FG000|Overall Study|Adverse Event|4
7559858|NCT03160898|11926452|FG001|Overall Study|Adverse Event|8
7559859|NCT03160898|11926453|FG002|Overall Study|Adverse Event|7
7559860|NCT03160898|11926454|FG003|Overall Study|Adverse Event|10
7559861|NCT03160898|11926451|FG000|Overall Study|Death|1
7559862|NCT03160898|11926452|FG001|Overall Study|Death|0
7559863|NCT03160898|11926453|FG002|Overall Study|Death|0
7559864|NCT03160898|11926454|FG003|Overall Study|Death|1
7559865|NCT03160898|11926451|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
7559866|NCT03160898|11926452|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
7559867|NCT03160898|11926453|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
7436975|NCT01620528|11719911|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
7559868|NCT03160898|11926454|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
7559869|NCT03160898|11926451|FG000|Overall Study|Lost to Follow-up|1
7436976|NCT01620528|11719912|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7436977|NCT01620528|11719913|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
7436978|NCT01620528|11719911|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
7436979|NCT01620528|11719912|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
7436980|NCT01620528|11719913|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
7436981|NCT01620528|11719911|FG000|Post-Treatment Follow-Up Period|Other|6
7436982|NCT01620528|11719912|FG001|Post-Treatment Follow-Up Period|Other|4
7436983|NCT01620528|11719913|FG002|Post-Treatment Follow-Up Period|Other|2
7436984|NCT01620762|11719945|FG000|Overall Study|Protocol Violation|1
7436985|NCT01620762|11719946|FG001|Overall Study|Protocol Violation|1
7436986|NCT01620762|11719947|FG002|Overall Study|Protocol Violation|1
7436987|NCT01620762|11719945|FG000|Overall Study|Adverse Event|9
7436988|NCT01620762|11719946|FG001|Overall Study|Adverse Event|5
7436989|NCT01620762|11719947|FG002|Overall Study|Adverse Event|2
7436990|NCT01620762|11719945|FG000|Overall Study|Withdrawal by Subject|23
7436991|NCT01620762|11719946|FG001|Overall Study|Withdrawal by Subject|26
7436992|NCT01620762|11719947|FG002|Overall Study|Withdrawal by Subject|27
7436993|NCT01620762|11719945|FG000|Overall Study|Lost to Follow-up|11
7436994|NCT01620762|11719946|FG001|Overall Study|Lost to Follow-up|17
7436995|NCT01620762|11719947|FG002|Overall Study|Lost to Follow-up|10
7436996|NCT01620762|11719945|FG000|Overall Study|Protocol deviation|1
7436997|NCT01620762|11719946|FG001|Overall Study|Protocol deviation|1
7436998|NCT01620762|11719947|FG002|Overall Study|Protocol deviation|6
7436999|NCT01620762|11719945|FG000|Overall Study|Subject deterioration|0
7437000|NCT01620762|11719946|FG001|Overall Study|Subject deterioration|1
7437001|NCT01620762|11719947|FG002|Overall Study|Subject deterioration|1
7437002|NCT01620762|11719945|FG000|Overall Study|Non-specified|3
7437003|NCT01620762|11719946|FG001|Overall Study|Non-specified|6
7437004|NCT01620762|11719947|FG002|Overall Study|Non-specified|5
7437005|NCT01620762|11719945|FG000|Overall Study|Use of prohibted therapies|0
7437006|NCT01620762|11719946|FG001|Overall Study|Use of prohibted therapies|1
7437007|NCT01620762|11719947|FG002|Overall Study|Use of prohibted therapies|1
7559870|NCT03160898|11926452|FG001|Overall Study|Lost to Follow-up|1
7559871|NCT03160898|11926453|FG002|Overall Study|Lost to Follow-up|1
7437008|NCT01620983|11719958|FG000|Overall Study|Lost to Follow-up|8
7559872|NCT03160898|11926454|FG003|Overall Study|Lost to Follow-up|2
7559873|NCT03160898|11926451|FG000|Overall Study|Physician Decision|1
7559874|NCT03160898|11926452|FG001|Overall Study|Physician Decision|0
7559875|NCT03160898|11926453|FG002|Overall Study|Physician Decision|0
7559876|NCT03160898|11926454|FG003|Overall Study|Physician Decision|1
7559877|NCT03160898|11926451|FG000|Overall Study|Progressive Disease|4
7559878|NCT03160898|11926452|FG001|Overall Study|Progressive Disease|1
7559879|NCT03160898|11926453|FG002|Overall Study|Progressive Disease|2
7559880|NCT03160898|11926454|FG003|Overall Study|Progressive Disease|1
7559881|NCT03160898|11926451|FG000|Overall Study|Protocol Violation|1
7559882|NCT03160898|11926452|FG001|Overall Study|Protocol Violation|0
7559883|NCT03160898|11926453|FG002|Overall Study|Protocol Violation|2
7559884|NCT03160898|11926454|FG003|Overall Study|Protocol Violation|0
7559885|NCT03160898|11926451|FG000|Overall Study|Sponsor Discretion|2
7559886|NCT03160898|11926452|FG001|Overall Study|Sponsor Discretion|0
7559887|NCT03160898|11926453|FG002|Overall Study|Sponsor Discretion|0
7559888|NCT03160898|11926454|FG003|Overall Study|Sponsor Discretion|0
7559889|NCT03160898|11926451|FG000|Overall Study|Withdrawal by Subject|1
7559890|NCT03160898|11926452|FG001|Overall Study|Withdrawal by Subject|3
7559891|NCT03160898|11926453|FG002|Overall Study|Withdrawal by Subject|2
7559892|NCT03160898|11926454|FG003|Overall Study|Withdrawal by Subject|1
7559893|NCT03160898|11926451|FG000|Overall Study|Other|2
7559894|NCT03160898|11926452|FG001|Overall Study|Other|0
7437009|NCT01620983|11719959|FG001|Overall Study|Lost to Follow-up|4
7437010|NCT01620983|11719960|FG002|Overall Study|Lost to Follow-up|9
7437011|NCT01620983|11719958|FG000|Overall Study|Withdrawal by Subject|6
7559895|NCT03160898|11926453|FG002|Overall Study|Other|2
7559896|NCT03160898|11926454|FG003|Overall Study|Other|2
7559897|NCT03161405|11926479|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
7559898|NCT03161483|11926490|FG000|Overall Study|Death|1
7559899|NCT03161483|11926491|FG001|Overall Study|Death|0
7559900|NCT03161483|11926492|FG002|Overall Study|Death|0
7559901|NCT03161483|11926493|FG003|Overall Study|Death|0
7559902|NCT03161483|11926490|FG000|Overall Study|Adverse Event|5
7559903|NCT03161483|11926491|FG001|Overall Study|Adverse Event|1
7559904|NCT03161483|11926492|FG002|Overall Study|Adverse Event|11
7559905|NCT03161483|11926493|FG003|Overall Study|Adverse Event|2
7559906|NCT03161483|11926490|FG000|Overall Study|Pregnancy|1
7559907|NCT03161483|11926491|FG001|Overall Study|Pregnancy|0
7559908|NCT03161483|11926492|FG002|Overall Study|Pregnancy|0
7559909|NCT03161483|11926493|FG003|Overall Study|Pregnancy|0
7559910|NCT03161483|11926490|FG000|Overall Study|Lack of Efficacy|0
7559911|NCT03161483|11926491|FG001|Overall Study|Lack of Efficacy|0
7559912|NCT03161483|11926492|FG002|Overall Study|Lack of Efficacy|1
7437012|NCT01620983|11719959|FG001|Overall Study|Withdrawal by Subject|8
7437013|NCT01620983|11719960|FG002|Overall Study|Withdrawal by Subject|1
7437014|NCT01620983|11719958|FG000|Overall Study|Death|2
7559913|NCT03161483|11926493|FG003|Overall Study|Lack of Efficacy|0
7559914|NCT03161483|11926490|FG000|Overall Study|Withdrawal by Subject|2
7437015|NCT01620983|11719959|FG001|Overall Study|Death|0
7559915|NCT03161483|11926491|FG001|Overall Study|Withdrawal by Subject|2
7559916|NCT03161483|11926492|FG002|Overall Study|Withdrawal by Subject|6
7559917|NCT03161483|11926493|FG003|Overall Study|Withdrawal by Subject|5
7559918|NCT03161483|11926490|FG000|Overall Study|Lost to Follow-up|0
7559919|NCT03161483|11926491|FG001|Overall Study|Lost to Follow-up|0
7559920|NCT03161483|11926492|FG002|Overall Study|Lost to Follow-up|1
7559921|NCT03161483|11926493|FG003|Overall Study|Lost to Follow-up|0
7559922|NCT03161483|11926490|FG000|Overall Study|Protocol Violation|0
7559923|NCT03161483|11926491|FG001|Overall Study|Protocol Violation|0
7437016|NCT01620983|11719960|FG002|Overall Study|Death|0
7437017|NCT01620983|11719958|FG000|Overall Study|Physician Decision|3
7437018|NCT01620983|11719959|FG001|Overall Study|Physician Decision|10
7437019|NCT01620983|11719960|FG002|Overall Study|Physician Decision|5
7437020|NCT01621126|11719983|FG000|Overall Study|Physician Decision|6
7559924|NCT03161483|11926492|FG002|Overall Study|Protocol Violation|1
7559925|NCT03161483|11926493|FG003|Overall Study|Protocol Violation|0
7559926|NCT03161483|11926490|FG000|Overall Study|Other reasons|1
7559927|NCT03161483|11926491|FG001|Overall Study|Other reasons|0
7559928|NCT03161483|11926492|FG002|Overall Study|Other reasons|0
7559929|NCT03161483|11926493|FG003|Overall Study|Other reasons|1
7559930|NCT03162055|11926514|FG000|Overall Study|Adverse Event|6
7559931|NCT03162055|11926515|FG001|Overall Study|Adverse Event|5
7559932|NCT03162055|11926514|FG000|Overall Study|Death|3
7559933|NCT03162055|11926515|FG001|Overall Study|Death|3
7559934|NCT03162055|11926514|FG000|Overall Study|Lost to Follow-up|0
7559935|NCT03162055|11926515|FG001|Overall Study|Lost to Follow-up|1
7559936|NCT03162055|11926514|FG000|Overall Study|Study-specific withdrawal criteria|22
7559937|NCT03162055|11926515|FG001|Overall Study|Study-specific withdrawal criteria|14
7559938|NCT03162055|11926514|FG000|Overall Study|Withdrawal by Subject|17
7559939|NCT03162055|11926515|FG001|Overall Study|Withdrawal by Subject|2
7559940|NCT03162055|11926514|FG000|Overall Study|Did not receive treatment|2
7559941|NCT03162055|11926515|FG001|Overall Study|Did not receive treatment|0
7559942|NCT03162055|11926514|FG000|Overall Study|Incorrect randomization|4
7559943|NCT03162055|11926515|FG001|Overall Study|Incorrect randomization|3
7559944|NCT03162055|11926514|FG000|Overall Study|Other|8
7559945|NCT03162055|11926515|FG001|Overall Study|Other|15
7559946|NCT03162328|11926521|FG000|Screening Period|Did not meet inclusion/exclusion|21
7559947|NCT03162328|11926522|FG001|Screening Period|Did not meet inclusion/exclusion|0
7559948|NCT03162328|11926523|FG002|Screening Period|Did not meet inclusion/exclusion|0
7559949|NCT03162328|11926521|FG000|Screening Period|Withdrawal by Subject|1
7559950|NCT03162328|11926522|FG001|Screening Period|Withdrawal by Subject|0
7559951|NCT03162328|11926523|FG002|Screening Period|Withdrawal by Subject|0
7559952|NCT03162328|11926521|FG000|Study Period|Withdrawal by Subject|0
7559953|NCT03162328|11926522|FG001|Study Period|Withdrawal by Subject|0
7559954|NCT03162328|11926523|FG002|Study Period|Withdrawal by Subject|1
7559955|NCT03162614|11926563|FG000|Overall Study|Lost to Follow-up|2
7559956|NCT03162614|11926564|FG001|Overall Study|Lost to Follow-up|1
7559957|NCT03162614|11926565|FG002|Overall Study|Lost to Follow-up|1
7559958|NCT03162614|11926566|FG003|Overall Study|Lost to Follow-up|1
7559959|NCT03162614|11926567|FG004|Overall Study|Lost to Follow-up|2
7559960|NCT03162614|11926568|FG005|Overall Study|Lost to Follow-up|0
7559961|NCT03162614|11926563|FG000|Overall Study|Protocol Violation|0
7559962|NCT03162614|11926564|FG001|Overall Study|Protocol Violation|1
7559963|NCT03162614|11926565|FG002|Overall Study|Protocol Violation|0
7559964|NCT03162614|11926566|FG003|Overall Study|Protocol Violation|1
7559965|NCT03162614|11926567|FG004|Overall Study|Protocol Violation|0
7559966|NCT03162614|11926568|FG005|Overall Study|Protocol Violation|0
7559967|NCT03162614|11926563|FG000|Overall Study|Withdrawal by Subject|2
7559968|NCT03162614|11926564|FG001|Overall Study|Withdrawal by Subject|1
7559969|NCT03162614|11926565|FG002|Overall Study|Withdrawal by Subject|1
7559970|NCT03162614|11926566|FG003|Overall Study|Withdrawal by Subject|1
7559971|NCT03162614|11926567|FG004|Overall Study|Withdrawal by Subject|0
7559972|NCT03162614|11926568|FG005|Overall Study|Withdrawal by Subject|0
7559973|NCT03162614|11926563|FG000|Overall Study|Missed vaccination, exclusion criteria|2
7559974|NCT03162614|11926564|FG001|Overall Study|Missed vaccination, exclusion criteria|2
7559975|NCT03162614|11926565|FG002|Overall Study|Missed vaccination, exclusion criteria|2
7559976|NCT03162614|11926566|FG003|Overall Study|Missed vaccination, exclusion criteria|4
7559977|NCT03162614|11926567|FG004|Overall Study|Missed vaccination, exclusion criteria|3
7559978|NCT03162614|11926568|FG005|Overall Study|Missed vaccination, exclusion criteria|0
7559979|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
7559980|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
7559981|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
7559982|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
7559983|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7559984|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
7559985|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
7559986|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
7559987|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
7559988|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
7559989|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7437021|NCT01621178|11719990|FG000|Overall Study|Adverse Event|5
7437022|NCT01621178|11719991|FG001|Overall Study|Adverse Event|2
7437023|NCT01621178|11719992|FG002|Overall Study|Adverse Event|8
7437024|NCT01621178|11719990|FG000|Overall Study|Death|6
7437025|NCT01621178|11719991|FG001|Overall Study|Death|7
7437026|NCT01621178|11719992|FG002|Overall Study|Death|2
7437027|NCT01621178|11719990|FG000|Overall Study|Lost to Follow-up|1
7437028|NCT01621178|11719991|FG001|Overall Study|Lost to Follow-up|2
7437029|NCT01621178|11719992|FG002|Overall Study|Lost to Follow-up|1
7437030|NCT01621178|11719990|FG000|Overall Study|Withdrawal by Subject|14
7437031|NCT01621178|11719991|FG001|Overall Study|Withdrawal by Subject|17
7437032|NCT01621178|11719992|FG002|Overall Study|Withdrawal by Subject|18
7437033|NCT01621178|11719990|FG000|Overall Study|Physician Decision|5
7437034|NCT01621178|11719991|FG001|Overall Study|Physician Decision|2
7437035|NCT01621178|11719992|FG002|Overall Study|Physician Decision|7
7437036|NCT01621191|11720004|FG000|Overall Study|Adverse Event|9
7437037|NCT01621191|11720004|FG000|Overall Study|Withdrawal by Subject|8
7437038|NCT01621191|11720004|FG000|Overall Study|Lack of Efficacy|6
7437039|NCT01621191|11720004|FG000|Overall Study|Lost to Follow-up|1
7437040|NCT01621191|11720004|FG000|Overall Study|Site Removed From Study|1
7437041|NCT01621490|11720034|FG000|Overall Study|Participant completed treatment|4
7437042|NCT01621490|11720035|FG001|Overall Study|Participant completed treatment|4
7437043|NCT01621490|11720036|FG002|Overall Study|Participant completed treatment|1
7437044|NCT01621490|11720037|FG003|Overall Study|Participant completed treatment|0
7437045|NCT01621490|11720038|FG004|Overall Study|Participant completed treatment|0
7437046|NCT01621490|11720039|FG005|Overall Study|Participant completed treatment|0
7437047|NCT01621490|11720040|FG006|Overall Study|Participant completed treatment|0
7437048|NCT01621490|11720041|FG007|Overall Study|Participant completed treatment|1
7437049|NCT01621490|11720042|FG008|Overall Study|Participant completed treatment|0
7437050|NCT01621490|11720034|FG000|Overall Study|Patient could not travel|1
7437051|NCT01621490|11720035|FG001|Overall Study|Patient could not travel|0
7437052|NCT01621490|11720036|FG002|Overall Study|Patient could not travel|0
7437053|NCT01621490|11720037|FG003|Overall Study|Patient could not travel|0
7437054|NCT01621490|11720038|FG004|Overall Study|Patient could not travel|0
7437055|NCT01621490|11720039|FG005|Overall Study|Patient could not travel|0
7437056|NCT01621490|11720040|FG006|Overall Study|Patient could not travel|0
7437057|NCT01621490|11720041|FG007|Overall Study|Patient could not travel|0
7437058|NCT01621490|11720042|FG008|Overall Study|Patient could not travel|0
7437059|NCT01621490|11720034|FG000|Overall Study|Subject no longer meets study criteria|0
7437060|NCT01621490|11720035|FG001|Overall Study|Subject no longer meets study criteria|0
7437061|NCT01621490|11720036|FG002|Overall Study|Subject no longer meets study criteria|0
7437062|NCT01621490|11720037|FG003|Overall Study|Subject no longer meets study criteria|0
7437063|NCT01621490|11720038|FG004|Overall Study|Subject no longer meets study criteria|1
7437064|NCT01621490|11720039|FG005|Overall Study|Subject no longer meets study criteria|0
7437065|NCT01621490|11720040|FG006|Overall Study|Subject no longer meets study criteria|0
7437066|NCT01621490|11720041|FG007|Overall Study|Subject no longer meets study criteria|0
7437067|NCT01621490|11720042|FG008|Overall Study|Subject no longer meets study criteria|0
7437068|NCT01621490|11720034|FG000|Overall Study|Maximum clinical benefit|3
7437069|NCT01621490|11720035|FG001|Overall Study|Maximum clinical benefit|2
7559990|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
7559991|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
7559992|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
7559993|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
7559994|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
7559995|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7559996|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
7559997|NCT03162796|11926585|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
7559998|NCT03162796|11926586|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
7559999|NCT03162796|11926587|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
7560000|NCT03162796|11926585|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7560001|NCT03162796|11926586|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7560002|NCT03162796|11926587|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
7560003|NCT03162796|11926585|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7560004|NCT03162796|11926586|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7560005|NCT03162796|11926587|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
7560006|NCT03162796|11926585|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
7560007|NCT03162796|11926586|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
7560008|NCT03162796|11926587|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
7560009|NCT03162796|11926585|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7560010|NCT03162796|11926586|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
7560011|NCT03162796|11926587|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
7574827|NCT03695367|11958009|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
7437070|NCT01621490|11720036|FG002|Overall Study|Maximum clinical benefit|0
7437071|NCT01621490|11720037|FG003|Overall Study|Maximum clinical benefit|0
7437072|NCT01621490|11720038|FG004|Overall Study|Maximum clinical benefit|0
7437073|NCT01621490|11720039|FG005|Overall Study|Maximum clinical benefit|0
7437074|NCT01621490|11720040|FG006|Overall Study|Maximum clinical benefit|1
7437075|NCT01621490|11720041|FG007|Overall Study|Maximum clinical benefit|2
7437076|NCT01621490|11720042|FG008|Overall Study|Maximum clinical benefit|0
7437077|NCT01621490|11720034|FG000|Overall Study|Withdrawal by Subject|1
7437078|NCT01621490|11720035|FG001|Overall Study|Withdrawal by Subject|0
7437079|NCT01621490|11720036|FG002|Overall Study|Withdrawal by Subject|0
7437080|NCT01621490|11720037|FG003|Overall Study|Withdrawal by Subject|0
7437081|NCT01621490|11720038|FG004|Overall Study|Withdrawal by Subject|0
7437082|NCT01621490|11720039|FG005|Overall Study|Withdrawal by Subject|3
7437083|NCT01621490|11720040|FG006|Overall Study|Withdrawal by Subject|0
7437084|NCT01621490|11720041|FG007|Overall Study|Withdrawal by Subject|0
7437085|NCT01621490|11720042|FG008|Overall Study|Withdrawal by Subject|0
7437086|NCT01621490|11720034|FG000|Overall Study|Subject request to discontinue study|1
7437087|NCT01621490|11720035|FG001|Overall Study|Subject request to discontinue study|3
7437088|NCT01621490|11720036|FG002|Overall Study|Subject request to discontinue study|1
7437089|NCT01621490|11720037|FG003|Overall Study|Subject request to discontinue study|1
7560012|NCT03163446|11926628|FG000|Overall Study|Unable to return for Day 180 visit|2
7560013|NCT03163446|11926629|FG001|Overall Study|Unable to return for Day 180 visit|0
7560014|NCT03163446|11926628|FG000|Overall Study|Withdrawal by Subject|2
7560015|NCT03163446|11926629|FG001|Overall Study|Withdrawal by Subject|6
7560016|NCT03163446|11926628|FG000|Overall Study|Death|16
7560017|NCT03163446|11926629|FG001|Overall Study|Death|5
7560018|NCT03163446|11926628|FG000|Overall Study|Lost to Follow-up|6
7560019|NCT03163446|11926629|FG001|Overall Study|Lost to Follow-up|5
7560020|NCT03163446|11926628|FG000|Overall Study|Physician Decision|1
7560021|NCT03163446|11926629|FG001|Overall Study|Physician Decision|1
7560022|NCT03163446|11926628|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
7560023|NCT03163446|11926629|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
7560024|NCT03164551|11926672|FG000|Overall Study|Imaging discontinued prior completion|8
7560025|NCT03164551|11926673|FG001|Overall Study|Imaging discontinued prior completion|0
7560026|NCT03164551|11926672|FG000|Overall Study|Participant was non-compliant|1
7560027|NCT03164551|11926673|FG001|Overall Study|Participant was non-compliant|0
7560028|NCT03164551|11926672|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
7560029|NCT03164551|11926673|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
7560030|NCT03164551|11926672|FG000|Overall Study|Other|8
7560031|NCT03164551|11926673|FG001|Overall Study|Other|2
7560032|NCT03165045|11926688|FG000|Visit 1|No registration after visit 1|9
7560033|NCT03165045|11926688|FG000|Visit 1|No treatment documented|10
7560034|NCT03165045|11926688|FG000|Visit 1|No visit 1|10
7560035|NCT03165045|11926688|FG000|Visit 2|Available CCQ score at visit 1 only|109
7560036|NCT03165045|11926688|FG000|Visit 2|No available total CCQ score at all|29
7560037|NCT03165045|11926688|FG000|Visit 2|Available total CCQ score at vist 2 only|44
7560038|NCT03165110|11926703|FG000|Overall Study|Anroid phone software incompatibility|1
7560039|NCT03166124|11926754|FG000|Treatment Period 1|Adverse Event|0
7560040|NCT03166124|11926755|FG001|Treatment Period 1|Adverse Event|0
7560041|NCT03166124|11926756|FG002|Treatment Period 1|Adverse Event|1
7560042|NCT03166124|11926757|FG003|Treatment Period 1|Adverse Event|0
7560043|NCT03166124|11926754|FG000|Wash-out Period|Withdrawal by Subject|0
7560044|NCT03166124|11926755|FG001|Wash-out Period|Withdrawal by Subject|1
7560045|NCT03166124|11926756|FG002|Wash-out Period|Withdrawal by Subject|0
7560046|NCT03166124|11926757|FG003|Wash-out Period|Withdrawal by Subject|1
7560047|NCT03166124|11926754|FG000|Wash-out Period|Adverse Event|0
7560048|NCT03166124|11926755|FG001|Wash-out Period|Adverse Event|1
7560049|NCT03166124|11926756|FG002|Wash-out Period|Adverse Event|1
7560050|NCT03166124|11926757|FG003|Wash-out Period|Adverse Event|0
7560051|NCT03166215|11926770|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7560052|NCT03166215|11926771|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
7560053|NCT03166215|11926772|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
7560054|NCT03166215|11926770|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7560055|NCT03166215|11926771|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
7560056|NCT03166215|11926772|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
7560057|NCT03166735|11926788|FG000|Overall Study|Not Treated|1
7560058|NCT03166735|11926789|FG001|Overall Study|Not Treated|0
7560059|NCT03166735|11926790|FG002|Overall Study|Not Treated|0
7560060|NCT03166735|11926791|FG003|Overall Study|Not Treated|0
7560061|NCT03166735|11926792|FG004|Overall Study|Not Treated|0
7560062|NCT03166735|11926788|FG000|Overall Study|follow-up not completed as planned|0
7560063|NCT03166735|11926789|FG001|Overall Study|follow-up not completed as planned|1
7560064|NCT03166735|11926790|FG002|Overall Study|follow-up not completed as planned|1
7560065|NCT03166735|11926791|FG003|Overall Study|follow-up not completed as planned|0
7560066|NCT03166735|11926792|FG004|Overall Study|follow-up not completed as planned|1
7560067|NCT03166735|11926788|FG000|Overall Study|Withdrawal by Subject|0
7560068|NCT03166735|11926789|FG001|Overall Study|Withdrawal by Subject|0
7560069|NCT03166735|11926790|FG002|Overall Study|Withdrawal by Subject|1
7437090|NCT01621490|11720038|FG004|Overall Study|Subject request to discontinue study|0
7437091|NCT01621490|11720039|FG005|Overall Study|Subject request to discontinue study|2
7437092|NCT01621490|11720040|FG006|Overall Study|Subject request to discontinue study|1
7560070|NCT03166735|11926791|FG003|Overall Study|Withdrawal by Subject|1
7560071|NCT03166735|11926792|FG004|Overall Study|Withdrawal by Subject|2
7437093|NCT01621490|11720041|FG007|Overall Study|Subject request to discontinue study|0
7437094|NCT01621490|11720042|FG008|Overall Study|Subject request to discontinue study|1
7437095|NCT01621490|11720034|FG000|Overall Study|Adverse event unrelated to study drug|2
7437096|NCT01621490|11720035|FG001|Overall Study|Adverse event unrelated to study drug|1
7437097|NCT01621490|11720036|FG002|Overall Study|Adverse event unrelated to study drug|0
7437098|NCT01621490|11720037|FG003|Overall Study|Adverse event unrelated to study drug|0
7437099|NCT01621490|11720038|FG004|Overall Study|Adverse event unrelated to study drug|0
7437100|NCT01621490|11720039|FG005|Overall Study|Adverse event unrelated to study drug|0
7437101|NCT01621490|11720040|FG006|Overall Study|Adverse event unrelated to study drug|0
7437102|NCT01621490|11720041|FG007|Overall Study|Adverse event unrelated to study drug|2
7437103|NCT01621490|11720042|FG008|Overall Study|Adverse event unrelated to study drug|1
7437104|NCT01621490|11720034|FG000|Overall Study|Disease progression|27
7437105|NCT01621490|11720035|FG001|Overall Study|Disease progression|28
7437106|NCT01621490|11720036|FG002|Overall Study|Disease progression|1
7437107|NCT01621490|11720037|FG003|Overall Study|Disease progression|5
7437108|NCT01621490|11720038|FG004|Overall Study|Disease progression|3
7437109|NCT01621490|11720039|FG005|Overall Study|Disease progression|8
7437110|NCT01621490|11720040|FG006|Overall Study|Disease progression|7
7437111|NCT01621490|11720041|FG007|Overall Study|Disease progression|0
7437112|NCT01621490|11720042|FG008|Overall Study|Disease progression|4
7437113|NCT01621490|11720034|FG000|Overall Study|Study drug toxicity|1
7437114|NCT01621490|11720035|FG001|Overall Study|Study drug toxicity|4
7437115|NCT01621490|11720036|FG002|Overall Study|Study drug toxicity|5
7437116|NCT01621490|11720037|FG003|Overall Study|Study drug toxicity|3
7437117|NCT01621490|11720038|FG004|Overall Study|Study drug toxicity|1
7437118|NCT01621490|11720039|FG005|Overall Study|Study drug toxicity|10
7437119|NCT01621490|11720040|FG006|Overall Study|Study drug toxicity|1
7437120|NCT01621490|11720041|FG007|Overall Study|Study drug toxicity|4
7437121|NCT01621490|11720042|FG008|Overall Study|Study drug toxicity|1
7437122|NCT01621490|11720034|FG000|Overall Study|Death|0
7437123|NCT01621490|11720035|FG001|Overall Study|Death|0
7437124|NCT01621490|11720036|FG002|Overall Study|Death|0
7437125|NCT01621490|11720037|FG003|Overall Study|Death|0
7437126|NCT01621490|11720038|FG004|Overall Study|Death|0
7437127|NCT01621490|11720039|FG005|Overall Study|Death|0
7437128|NCT01621490|11720040|FG006|Overall Study|Death|0
7437129|NCT01621490|11720041|FG007|Overall Study|Death|1
7437130|NCT01621490|11720042|FG008|Overall Study|Death|0
7437131|NCT01621490|11720034|FG000|Overall Study|Grade 4 Lipase elevation|1
7437132|NCT01621490|11720035|FG001|Overall Study|Grade 4 Lipase elevation|0
7437133|NCT01621490|11720036|FG002|Overall Study|Grade 4 Lipase elevation|0
7437134|NCT01621490|11720037|FG003|Overall Study|Grade 4 Lipase elevation|0
7560072|NCT03166735|11926788|FG000|Overall Study|Lost to Follow-up|0
7560073|NCT03166735|11926789|FG001|Overall Study|Lost to Follow-up|2
7560074|NCT03166735|11926790|FG002|Overall Study|Lost to Follow-up|1
7560075|NCT03166735|11926791|FG003|Overall Study|Lost to Follow-up|0
7560076|NCT03166735|11926792|FG004|Overall Study|Lost to Follow-up|1
7560077|NCT03167073|11926807|FG000|Overall Study|Stillbirth|1
7560078|NCT03167073|11926808|FG001|Overall Study|Stillbirth|0
7560079|NCT03167151|11926817|FG000|Overall Study|Withdrawal by Subject|1
7560080|NCT03167151|11926818|FG001|Overall Study|Withdrawal by Subject|0
7560081|NCT03167151|11926819|FG002|Overall Study|Withdrawal by Subject|0
7560082|NCT03167151|11926817|FG000|Overall Study|No evidence of tumour at surgery|0
7560083|NCT03167151|11926818|FG001|Overall Study|No evidence of tumour at surgery|1
7560084|NCT03167151|11926819|FG002|Overall Study|No evidence of tumour at surgery|1
7560085|NCT03167359|11926827|FG000|Overall Study|Physician Decision|1
7560086|NCT03167359|11926827|FG000|Overall Study|Lost to Follow-up|1
7560087|NCT03167411|11926833|FG000|Overall Study|Adverse Event|0
7560088|NCT03167411|11926834|FG001|Overall Study|Adverse Event|1
7560089|NCT03168425|11926904|FG000|Overall Study|Lost to Follow-up|5
7560090|NCT03168425|11926905|FG001|Overall Study|Lost to Follow-up|8
7560091|NCT03168425|11926904|FG000|Overall Study|unable to confirm post op opioids|2
7560092|NCT03168425|11926905|FG001|Overall Study|unable to confirm post op opioids|3
7560093|NCT03168711|11926921|FG000|Overall Study|Adverse Event|2
7560094|NCT03168711|11926922|FG001|Overall Study|Adverse Event|0
7560095|NCT03168711|11926921|FG000|Overall Study|Withdrawal by Subject|0
7560096|NCT03168711|11926922|FG001|Overall Study|Withdrawal by Subject|1
7560097|NCT03168711|11926921|FG000|Overall Study|Death|0
7560098|NCT03168711|11926922|FG001|Overall Study|Death|1
7437135|NCT01621490|11720038|FG004|Overall Study|Grade 4 Lipase elevation|0
7437136|NCT01621490|11720039|FG005|Overall Study|Grade 4 Lipase elevation|0
7437137|NCT01621490|11720040|FG006|Overall Study|Grade 4 Lipase elevation|0
7437138|NCT01621490|11720041|FG007|Overall Study|Grade 4 Lipase elevation|0
7560099|NCT03168919|11926932|FG000|Overall Study|Withdrawal by Subject|2
7560100|NCT03169153|11926944|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7560101|NCT03169153|11926945|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7560102|NCT03169153|11926944|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
7560103|NCT03169153|11926945|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
7437139|NCT01621490|11720042|FG008|Overall Study|Grade 4 Lipase elevation|0
7437140|NCT01621490|11720034|FG000|Overall Study|BMS informed of patient status|0
7437141|NCT01621490|11720035|FG001|Overall Study|BMS informed of patient status|0
7437142|NCT01621490|11720036|FG002|Overall Study|BMS informed of patient status|1
7560104|NCT03169153|11926944|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
7437143|NCT01621490|11720037|FG003|Overall Study|BMS informed of patient status|0
7437144|NCT01621490|11720038|FG004|Overall Study|BMS informed of patient status|0
7437145|NCT01621490|11720039|FG005|Overall Study|BMS informed of patient status|0
7437146|NCT01621490|11720040|FG006|Overall Study|BMS informed of patient status|0
7437147|NCT01621490|11720041|FG007|Overall Study|BMS informed of patient status|0
7437148|NCT01621490|11720042|FG008|Overall Study|BMS informed of patient status|0
7437149|NCT01621490|11720034|FG000|Overall Study|Investigator decision|0
7437150|NCT01621490|11720035|FG001|Overall Study|Investigator decision|0
7437151|NCT01621490|11720036|FG002|Overall Study|Investigator decision|1
7437152|NCT01621490|11720037|FG003|Overall Study|Investigator decision|0
7437153|NCT01621490|11720038|FG004|Overall Study|Investigator decision|1
7437154|NCT01621490|11720039|FG005|Overall Study|Investigator decision|0
7437155|NCT01621490|11720040|FG006|Overall Study|Investigator decision|1
7437156|NCT01621490|11720041|FG007|Overall Study|Investigator decision|0
7437157|NCT01621490|11720042|FG008|Overall Study|Investigator decision|0
7437158|NCT01621490|11720034|FG000|Overall Study|Documented disease progression|0
7437159|NCT01621490|11720035|FG001|Overall Study|Documented disease progression|0
7437160|NCT01621490|11720036|FG002|Overall Study|Documented disease progression|1
7437161|NCT01621490|11720037|FG003|Overall Study|Documented disease progression|0
7437162|NCT01621490|11720038|FG004|Overall Study|Documented disease progression|0
7437163|NCT01621490|11720039|FG005|Overall Study|Documented disease progression|0
7437164|NCT01621490|11720040|FG006|Overall Study|Documented disease progression|0
7437165|NCT01621490|11720041|FG007|Overall Study|Documented disease progression|0
7437166|NCT01621490|11720042|FG008|Overall Study|Documented disease progression|0
7437167|NCT01621490|11720034|FG000|Overall Study|Patient reached treatment 2 yr limit|0
7437168|NCT01621490|11720035|FG001|Overall Study|Patient reached treatment 2 yr limit|1
7437169|NCT01621490|11720036|FG002|Overall Study|Patient reached treatment 2 yr limit|0
7560105|NCT03169153|11926945|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
7560106|NCT03169153|11926944|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
7560107|NCT03169153|11926945|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
7560108|NCT03169244|11926953|FG000|Overall Study|Lost to Follow-up|1
7560109|NCT03169244|11926954|FG001|Overall Study|Lost to Follow-up|2
7560110|NCT03169244|11926953|FG000|Overall Study|Adverse Event|1
7560111|NCT03169244|11926954|FG001|Overall Study|Adverse Event|0
7560112|NCT03169244|11926953|FG000|Overall Study|Withdrawal by Subject|2
7560113|NCT03169244|11926954|FG001|Overall Study|Withdrawal by Subject|2
7560114|NCT03169244|11926953|FG000|Overall Study|Physician Decision|1
7560115|NCT03169244|11926954|FG001|Overall Study|Physician Decision|0
7560116|NCT03170154|11926969|FG000|Overall Study|Lost to Follow-up|4
7560117|NCT03170154|11926969|FG000|Overall Study|Death|2
7560118|NCT03170154|11926969|FG000|Overall Study|Withdrawal by Subject|2
7560119|NCT03170193|11926985|FG000|Overall Study|Withdrawal by Subject|0
7560120|NCT03170193|11926986|FG001|Overall Study|Withdrawal by Subject|0
7560121|NCT03170193|11926987|FG002|Overall Study|Withdrawal by Subject|0
7560122|NCT03170193|11926988|FG003|Overall Study|Withdrawal by Subject|1
7560123|NCT03170193|11926989|FG004|Overall Study|Withdrawal by Subject|0
7560124|NCT03170193|11926990|FG005|Overall Study|Withdrawal by Subject|0
7560125|NCT03170193|11926991|FG006|Overall Study|Withdrawal by Subject|0
7560126|NCT03170193|11926985|FG000|Overall Study|Lost to Follow-up|1
7560127|NCT03170193|11926986|FG001|Overall Study|Lost to Follow-up|1
7560128|NCT03170193|11926987|FG002|Overall Study|Lost to Follow-up|0
7560129|NCT03170193|11926988|FG003|Overall Study|Lost to Follow-up|0
7560130|NCT03170193|11926989|FG004|Overall Study|Lost to Follow-up|0
7560131|NCT03170193|11926990|FG005|Overall Study|Lost to Follow-up|0
7560132|NCT03170193|11926991|FG006|Overall Study|Lost to Follow-up|0
7560133|NCT03170232|11927024|FG000|Overall Study|Adverse Event|0
7560134|NCT03170232|11927025|FG001|Overall Study|Adverse Event|1
7560135|NCT03170232|11927024|FG000|Overall Study|Protocol Violation|0
7560136|NCT03170232|11927025|FG001|Overall Study|Protocol Violation|1
7560137|NCT03170232|11927024|FG000|Overall Study|Lack of Efficacy|0
7560138|NCT03170232|11927025|FG001|Overall Study|Lack of Efficacy|1
7560139|NCT03170232|11927024|FG000|Overall Study|Study closed/terminated|26
7560140|NCT03170232|11927025|FG001|Overall Study|Study closed/terminated|23
7560141|NCT03170232|11927024|FG000|Overall Study|Lost to Follow-up|1
7560142|NCT03170232|11927025|FG001|Overall Study|Lost to Follow-up|0
7560143|NCT03170232|11927024|FG000|Overall Study|Withdrawal by Subject|0
7560144|NCT03170232|11927025|FG001|Overall Study|Withdrawal by Subject|1
7560145|NCT03170271|11927033|FG000|Overall Study|Adverse Event|7
7560146|NCT03170271|11927034|FG001|Overall Study|Adverse Event|2
7560147|NCT03170271|11927033|FG000|Overall Study|Lost to Follow-up|0
7560148|NCT03170271|11927034|FG001|Overall Study|Lost to Follow-up|1
7560149|NCT03170271|11927033|FG000|Overall Study|Physician Decision|1
7560150|NCT03170271|11927034|FG001|Overall Study|Physician Decision|0
7560151|NCT03170271|11927033|FG000|Overall Study|Protocol-specified withdrawal criterion|2
7560152|NCT03170271|11927034|FG001|Overall Study|Protocol-specified withdrawal criterion|1
7560153|NCT03170271|11927033|FG000|Overall Study|Withdrawal by Subject|17
7437170|NCT01621490|11720037|FG003|Overall Study|Patient reached treatment 2 yr limit|0
7560154|NCT03170271|11927034|FG001|Overall Study|Withdrawal by Subject|5
7560155|NCT03170271|11927033|FG000|Overall Study|Other|2
7560156|NCT03170271|11927034|FG001|Overall Study|Other|2
7560157|NCT03170271|11927033|FG000|Overall Study|Randomized in error|4
7437171|NCT01621490|11720038|FG004|Overall Study|Patient reached treatment 2 yr limit|0
7437172|NCT01621490|11720039|FG005|Overall Study|Patient reached treatment 2 yr limit|0
7437173|NCT01621490|11720040|FG006|Overall Study|Patient reached treatment 2 yr limit|0
7560158|NCT03170271|11927034|FG001|Overall Study|Randomized in error|0
7560159|NCT03170544|11927073|FG000|Part 1|Lost to Follow-up|1
7560160|NCT03170544|11927074|FG001|Part 1|Lost to Follow-up|0
7560161|NCT03170544|11927075|FG002|Part 1|Lost to Follow-up|0
7560162|NCT03170544|11927076|FG003|Part 1|Lost to Follow-up|0
7560163|NCT03170544|11927077|FG004|Part 1|Lost to Follow-up|0
7560164|NCT03170544|11927078|FG005|Part 1|Lost to Follow-up|0
7560165|NCT03170544|11927079|FG006|Part 1|Lost to Follow-up|0
7560166|NCT03170544|11927080|FG007|Part 1|Lost to Follow-up|0
7560167|NCT03170544|11927081|FG008|Part 1|Lost to Follow-up|0
7560168|NCT03170544|11927082|FG009|Part 1|Lost to Follow-up|0
7560169|NCT03170544|11927083|FG010|Part 1|Lost to Follow-up|0
7560170|NCT03170544|11927084|FG011|Part 1|Lost to Follow-up|0
7560171|NCT03170544|11927073|FG000|Part 1|Not treated|0
7560172|NCT03170544|11927074|FG001|Part 1|Not treated|0
7560173|NCT03170544|11927075|FG002|Part 1|Not treated|0
7560174|NCT03170544|11927076|FG003|Part 1|Not treated|1
7560175|NCT03170544|11927077|FG004|Part 1|Not treated|0
7560176|NCT03170544|11927078|FG005|Part 1|Not treated|0
7560177|NCT03170544|11927079|FG006|Part 1|Not treated|0
7560178|NCT03170544|11927080|FG007|Part 1|Not treated|0
7560179|NCT03170544|11927081|FG008|Part 1|Not treated|0
7560180|NCT03170544|11927082|FG009|Part 1|Not treated|0
7560181|NCT03170544|11927083|FG010|Part 1|Not treated|0
7560182|NCT03170544|11927084|FG011|Part 1|Not treated|0
7560183|NCT03170609|11927174|FG000|Overall Study|Death|0
7560184|NCT03170609|11927175|FG001|Overall Study|Death|0
7560185|NCT03170609|11927176|FG002|Overall Study|Death|1
7560186|NCT03170609|11927177|FG003|Overall Study|Death|0
7560187|NCT03170609|11927178|FG004|Overall Study|Death|0
7560188|NCT03170609|11927179|FG005|Overall Study|Death|0
7560189|NCT03170609|11927180|FG006|Overall Study|Death|0
7560190|NCT03170609|11927174|FG000|Overall Study|Withdrawal by Subject|1
7560191|NCT03170609|11927175|FG001|Overall Study|Withdrawal by Subject|2
7560192|NCT03170609|11927176|FG002|Overall Study|Withdrawal by Subject|0
7560193|NCT03170609|11927177|FG003|Overall Study|Withdrawal by Subject|0
7560194|NCT03170609|11927178|FG004|Overall Study|Withdrawal by Subject|0
7560195|NCT03170609|11927179|FG005|Overall Study|Withdrawal by Subject|0
7560196|NCT03170609|11927180|FG006|Overall Study|Withdrawal by Subject|1
7560197|NCT03170609|11927174|FG000|Overall Study|Lost to Follow-up|1
7560198|NCT03170609|11927175|FG001|Overall Study|Lost to Follow-up|0
7560199|NCT03170609|11927176|FG002|Overall Study|Lost to Follow-up|5
7560200|NCT03170609|11927177|FG003|Overall Study|Lost to Follow-up|2
7560201|NCT03170609|11927178|FG004|Overall Study|Lost to Follow-up|1
7560202|NCT03170609|11927179|FG005|Overall Study|Lost to Follow-up|1
7560203|NCT03170609|11927180|FG006|Overall Study|Lost to Follow-up|0
7560204|NCT03170609|11927174|FG000|Overall Study|Other|1
7560205|NCT03170609|11927175|FG001|Overall Study|Other|0
7560206|NCT03170609|11927176|FG002|Overall Study|Other|0
7560207|NCT03170609|11927177|FG003|Overall Study|Other|0
7560208|NCT03170609|11927178|FG004|Overall Study|Other|0
7560209|NCT03170609|11927179|FG005|Overall Study|Other|1
7560210|NCT03170609|11927180|FG006|Overall Study|Other|0
7328766|NCT00797966|11561723|FG005|Phase B|Physician Decision|0
7328767|NCT00797966|11561718|FG000|Phase B|Withdrawal by Subject|1
7328768|NCT00797966|11561719|FG001|Phase B|Withdrawal by Subject|4
7328769|NCT00797966|11561720|FG002|Phase B|Withdrawal by Subject|3
7328770|NCT00797966|11561721|FG003|Phase B|Withdrawal by Subject|3
7560211|NCT03171415|11927217|FG000|Overall Study|Lost to Follow-up|0
7560212|NCT03171415|11927218|FG001|Overall Study|Lost to Follow-up|0
7560213|NCT03171415|11927219|FG002|Overall Study|Lost to Follow-up|0
7560214|NCT03171415|11927220|FG003|Overall Study|Lost to Follow-up|0
7328771|NCT00797966|11561722|FG004|Phase B|Withdrawal by Subject|0
7328772|NCT00797966|11561723|FG005|Phase B|Withdrawal by Subject|0
7328773|NCT00797966|11561718|FG000|Phase B|Protocol Deviation|4
7328774|NCT00797966|11561719|FG001|Phase B|Protocol Deviation|8
7328775|NCT00797966|11561720|FG002|Phase B|Protocol Deviation|2
7328776|NCT00797966|11561721|FG003|Phase B|Protocol Deviation|6
7328777|NCT00797966|11561722|FG004|Phase B|Protocol Deviation|0
7328778|NCT00797966|11561723|FG005|Phase B|Protocol Deviation|0
7328779|NCT00797966|11561718|FG000|Phase B|Lack of Efficacy|0
7328780|NCT00797966|11561719|FG001|Phase B|Lack of Efficacy|1
7328781|NCT00797966|11561720|FG002|Phase B|Lack of Efficacy|1
7328782|NCT00797966|11561721|FG003|Phase B|Lack of Efficacy|4
7560215|NCT03171415|11927221|FG004|Overall Study|Lost to Follow-up|2
7328783|NCT00797966|11561722|FG004|Phase B|Lack of Efficacy|0
7328784|NCT00797966|11561723|FG005|Phase B|Lack of Efficacy|0
7328785|NCT00797966|11561718|FG000|Phase A+|Lost to Follow-up|0
7328786|NCT00797966|11561719|FG001|Phase A+|Lost to Follow-up|0
7560216|NCT03172130|11927246|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
7560217|NCT03172130|11927247|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
7560218|NCT03172325|11927255|FG000|Overall Study|Adverse Event|2
7560219|NCT03172325|11927256|FG001|Overall Study|Adverse Event|3
7328787|NCT00797966|11561720|FG002|Phase A+|Lost to Follow-up|0
7560220|NCT03172325|11927255|FG000|Overall Study|Positive PPD|1
7560221|NCT03172325|11927256|FG001|Overall Study|Positive PPD|0
7560222|NCT03172325|11927255|FG000|Overall Study|Poor Compliance|1
7437174|NCT01621490|11720041|FG007|Overall Study|Patient reached treatment 2 yr limit|0
7437175|NCT01621490|11720042|FG008|Overall Study|Patient reached treatment 2 yr limit|0
7437176|NCT01621490|11720034|FG000|Overall Study|Clinical deterioration|0
7437177|NCT01621490|11720035|FG001|Overall Study|Clinical deterioration|1
7437178|NCT01621490|11720036|FG002|Overall Study|Clinical deterioration|0
7437179|NCT01621490|11720037|FG003|Overall Study|Clinical deterioration|0
7437180|NCT01621490|11720038|FG004|Overall Study|Clinical deterioration|0
7437181|NCT01621490|11720039|FG005|Overall Study|Clinical deterioration|0
7437182|NCT01621490|11720040|FG006|Overall Study|Clinical deterioration|0
7437183|NCT01621490|11720041|FG007|Overall Study|Clinical deterioration|0
7560223|NCT03172325|11927256|FG001|Overall Study|Poor Compliance|1
7560224|NCT03172364|11927264|FG000|Overall Study|Adverse Event|1
7560225|NCT03172364|11927265|FG001|Overall Study|Adverse Event|1
7560226|NCT03172364|11927264|FG000|Overall Study|Protocol Violation|1
7560227|NCT03172364|11927265|FG001|Overall Study|Protocol Violation|0
7560228|NCT03172481|11927273|FG000|Double-blind|Withdrawal by Subject|1
7560229|NCT03172481|11927274|FG001|Double-blind|Withdrawal by Subject|0
7560230|NCT03172494|11927283|FG000|Overall Study|Adverse Event|5
7560231|NCT03172494|11927284|FG001|Overall Study|Adverse Event|1
7560232|NCT03172494|11927285|FG002|Overall Study|Adverse Event|15
7560233|NCT03172494|11927283|FG000|Overall Study|Protocol Violation|3
7560234|NCT03172494|11927284|FG001|Overall Study|Protocol Violation|2
7560235|NCT03172494|11927285|FG002|Overall Study|Protocol Violation|1
7560236|NCT03172494|11927283|FG000|Overall Study|Lack of Efficacy|0
7560237|NCT03172494|11927284|FG001|Overall Study|Lack of Efficacy|0
7560238|NCT03172494|11927285|FG002|Overall Study|Lack of Efficacy|4
7560239|NCT03172494|11927283|FG000|Overall Study|Pregnancy|0
7560240|NCT03172494|11927284|FG001|Overall Study|Pregnancy|1
7560241|NCT03172494|11927285|FG002|Overall Study|Pregnancy|0
7560242|NCT03172494|11927283|FG000|Overall Study|Withdrawal by Subject|10
7560243|NCT03172494|11927284|FG001|Overall Study|Withdrawal by Subject|8
7560244|NCT03172494|11927285|FG002|Overall Study|Withdrawal by Subject|8
7560245|NCT03172494|11927283|FG000|Overall Study|Severe hypoglycaemic episode|0
7560246|NCT03172494|11927284|FG001|Overall Study|Severe hypoglycaemic episode|0
7560247|NCT03172494|11927285|FG002|Overall Study|Severe hypoglycaemic episode|1
7560248|NCT03172494|11927283|FG000|Overall Study|Non-compliance towards treatment|2
7560249|NCT03172494|11927284|FG001|Overall Study|Non-compliance towards treatment|0
7560250|NCT03172494|11927285|FG002|Overall Study|Non-compliance towards treatment|0
7560251|NCT03172702|11927294|FG000|Overall Study|Adverse Event|9
7560252|NCT03172702|11927294|FG000|Overall Study|Death|2
7560253|NCT03172702|11927294|FG000|Overall Study|Study-specific Withdrawal Criteria|10
7560254|NCT03172702|11927294|FG000|Overall Study|Withdrawal by Subject|5
7560255|NCT03172702|11927294|FG000|Overall Study|Other|2
7560256|NCT03173313|11927326|FG000|Overall Study|Lost to Follow-up|2
7560257|NCT03173313|11927327|FG001|Overall Study|Lost to Follow-up|3
7560258|NCT03173313|11927326|FG000|Overall Study|Withdrawal by Subject|0
7560259|NCT03173313|11927327|FG001|Overall Study|Withdrawal by Subject|1
7560260|NCT03173313|11927326|FG000|Overall Study|Death|5
7560261|NCT03173313|11927327|FG001|Overall Study|Death|0
7560262|NCT03173313|11927326|FG000|Overall Study|Physician Decision|1
7560263|NCT03173313|11927327|FG001|Overall Study|Physician Decision|0
7560264|NCT03173313|11927326|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
7560265|NCT03173313|11927327|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
7560266|NCT03173313|11927326|FG000|Overall Study|Bone Fracture|1
7560267|NCT03173313|11927327|FG001|Overall Study|Bone Fracture|0
7560268|NCT03173547|11927335|FG000|Overall Study|Adverse Event|2
7560269|NCT03173547|11927336|FG001|Overall Study|Adverse Event|0
7560270|NCT03173547|11927335|FG000|Overall Study|Withdrawal by Subject|2
7560271|NCT03173547|11927336|FG001|Overall Study|Withdrawal by Subject|2
7437184|NCT01621490|11720042|FG008|Overall Study|Clinical deterioration|0
7437185|NCT01621490|11720034|FG000|Overall Study|Complete response|0
7437186|NCT01621490|11720035|FG001|Overall Study|Complete response|0
7437187|NCT01621490|11720036|FG002|Overall Study|Complete response|0
7560282|NCT03174925|11927384|FG000|Overall Study|Elastographic images not retrievable|2
7437188|NCT01621490|11720037|FG003|Overall Study|Complete response|0
7437189|NCT01621490|11720038|FG004|Overall Study|Complete response|0
7437190|NCT01621490|11720039|FG005|Overall Study|Complete response|0
7437191|NCT01621490|11720040|FG006|Overall Study|Complete response|0
7437192|NCT01621490|11720041|FG007|Overall Study|Complete response|0
7437193|NCT01621490|11720042|FG008|Overall Study|Complete response|1
7437194|NCT01621490|11720034|FG000|Overall Study|Patient delayed due to toxicity|0
7437195|NCT01621490|11720035|FG001|Overall Study|Patient delayed due to toxicity|0
7437196|NCT01621490|11720036|FG002|Overall Study|Patient delayed due to toxicity|0
7437197|NCT01621490|11720037|FG003|Overall Study|Patient delayed due to toxicity|0
7437198|NCT01621490|11720038|FG004|Overall Study|Patient delayed due to toxicity|0
7437199|NCT01621490|11720039|FG005|Overall Study|Patient delayed due to toxicity|1
7437200|NCT01621490|11720040|FG006|Overall Study|Patient delayed due to toxicity|0
7560283|NCT03174925|11927384|FG000|Overall Study|Elastography image not interpretable|1
7560284|NCT03175120|11927390|FG000|Overall Study|Adverse Event|2
7560285|NCT03175120|11927391|FG001|Overall Study|Adverse Event|2
7560286|NCT03175120|11927390|FG000|Overall Study|Protocol Violation|5
7560287|NCT03175120|11927391|FG001|Overall Study|Protocol Violation|2
7560288|NCT03175120|11927390|FG000|Overall Study|Lost to Follow-up|1
7560289|NCT03175120|11927391|FG001|Overall Study|Lost to Follow-up|0
7560290|NCT03175120|11927390|FG000|Overall Study|Withdrawal by Subject|2
7560291|NCT03175120|11927391|FG001|Overall Study|Withdrawal by Subject|5
7560292|NCT03175120|11927390|FG000|Overall Study|Other|2
7560293|NCT03175120|11927391|FG001|Overall Study|Other|3
7560294|NCT03175172|11927397|FG000|Overall Study|Death|3
7560295|NCT03175172|11927397|FG000|Overall Study|Withdrawal by Subject|3
7560296|NCT03175172|11927397|FG000|Overall Study|Lost to Follow-up|1
7560297|NCT03175172|11927397|FG000|Overall Study|Study Terminated by Sponsor|3
7560298|NCT03175562|11927401|FG000|Overall Study|Adverse Event|1
7560299|NCT03175562|11927401|FG000|Overall Study|Lost to Follow-up|3
7560300|NCT03175562|11927401|FG000|Overall Study|Withdrawal by Subject|7
7560301|NCT03175562|11927401|FG000|Overall Study|Other (Not Specified)|5
7560302|NCT03176238|11927419|FG000|Overall Study|Unacceptable AEs|15
7560303|NCT03176238|11927420|FG001|Overall Study|Unacceptable AEs|8
7560304|NCT03176238|11927419|FG000|Overall Study|Abnormal lab value(s)|2
7560305|NCT03176238|11927420|FG001|Overall Study|Abnormal lab value(s)|0
7560306|NCT03176238|11927419|FG000|Overall Study|Inter-current illness|0
7560307|NCT03176238|11927420|FG001|Overall Study|Inter-current illness|1
7560308|NCT03176238|11927419|FG000|Overall Study|Consent withdrawal|14
7560309|NCT03176238|11927420|FG001|Overall Study|Consent withdrawal|2
7560310|NCT03176238|11927419|FG000|Overall Study|Lost to Follow-up|3
7560311|NCT03176238|11927420|FG001|Overall Study|Lost to Follow-up|0
7560312|NCT03176238|11927419|FG000|Overall Study|Administrative problems|1
7560313|NCT03176238|11927420|FG001|Overall Study|Administrative problems|0
7560314|NCT03176238|11927419|FG000|Overall Study|Death|3
7560315|NCT03176238|11927420|FG001|Overall Study|Death|0
7560316|NCT03176238|11927419|FG000|Overall Study|Disease Progression|133
7560317|NCT03176238|11927420|FG001|Overall Study|Disease Progression|22
7560318|NCT03176238|11927419|FG000|Overall Study|Tx duration completed per EAP|0
7560319|NCT03176238|11927420|FG001|Overall Study|Tx duration completed per EAP|1
7560320|NCT03176238|11927419|FG000|Overall Study|Patient is switched to commercial drug|16
7560321|NCT03176238|11927420|FG001|Overall Study|Patient is switched to commercial drug|1
7560322|NCT03176238|11927419|FG000|Overall Study|Protocol Violation|1
7560323|NCT03176238|11927420|FG001|Overall Study|Protocol Violation|0
7560324|NCT03176238|11927419|FG000|Overall Study|Changes in the patient's condition|2
7560325|NCT03176238|11927420|FG001|Overall Study|Changes in the patient's condition|1
7560326|NCT03176238|11927419|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
7560327|NCT03176238|11927420|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
7560328|NCT03176407|11927430|FG000|Overall Study|Protocol Violation|1
7560329|NCT03176407|11927430|FG000|Overall Study|human failure|1
7560330|NCT03176407|11927430|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
7560331|NCT03176459|11927438|FG000|Overall Study|Lost to Follow-up|5
7560332|NCT03176459|11927439|FG001|Overall Study|Lost to Follow-up|7
7560333|NCT03176784|11927458|FG000|Overall Study|Lost to Follow-up|77
7560334|NCT03176784|11927459|FG001|Overall Study|Lost to Follow-up|79
7560335|NCT03176784|11927460|FG002|Overall Study|Lost to Follow-up|79
7560336|NCT03176784|11927461|FG003|Overall Study|Lost to Follow-up|49
7560337|NCT03176784|11927458|FG000|Overall Study|Withdrawal by Subject|28
7560338|NCT03176784|11927459|FG001|Overall Study|Withdrawal by Subject|34
7560339|NCT03176784|11927460|FG002|Overall Study|Withdrawal by Subject|34
7560340|NCT03176784|11927461|FG003|Overall Study|Withdrawal by Subject|21
7560341|NCT03178266|11927529|FG000|Overall Study|Death|0
7560342|NCT03178266|11927530|FG001|Overall Study|Death|1
7560343|NCT03178266|11927529|FG000|Overall Study|Disont. Early|0
7560344|NCT03178266|11927530|FG001|Overall Study|Disont. Early|1
7560345|NCT03178266|11927529|FG000|Overall Study|Withdrawal by Subject|0
7560346|NCT03178266|11927530|FG001|Overall Study|Withdrawal by Subject|2
7560347|NCT03178669|11927548|FG000|Overall Study|Adverse Event|4
7560348|NCT03178669|11927549|FG001|Overall Study|Adverse Event|1
7560349|NCT03178669|11927550|FG002|Overall Study|Adverse Event|4
7560350|NCT03178669|11927551|FG003|Overall Study|Adverse Event|2
7437201|NCT01621490|11720041|FG007|Overall Study|Patient delayed due to toxicity|0
7437202|NCT01621490|11720042|FG008|Overall Study|Patient delayed due to toxicity|0
7437203|NCT01621542|11720161|FG000|Overall Study|Adverse Event|0
7437204|NCT01621542|11720162|FG001|Overall Study|Adverse Event|0
7437205|NCT01621542|11720163|FG002|Overall Study|Adverse Event|1
7437206|NCT01621542|11720164|FG003|Overall Study|Adverse Event|3
7437207|NCT01621542|11720165|FG004|Overall Study|Adverse Event|0
7437208|NCT01621542|11720166|FG005|Overall Study|Adverse Event|0
7437209|NCT01621542|11720161|FG000|Overall Study|Death|0
7437210|NCT01621542|11720162|FG001|Overall Study|Death|1
7437211|NCT01621542|11720163|FG002|Overall Study|Death|0
7437212|NCT01621542|11720164|FG003|Overall Study|Death|0
7437213|NCT01621542|11720165|FG004|Overall Study|Death|0
7437214|NCT01621542|11720166|FG005|Overall Study|Death|0
7437215|NCT01621542|11720161|FG000|Overall Study|Physician Decision|1
7437216|NCT01621542|11720162|FG001|Overall Study|Physician Decision|0
7560351|NCT03178669|11927552|FG004|Overall Study|Adverse Event|2
7560352|NCT03178669|11927548|FG000|Overall Study|Lack of Efficacy|0
7560353|NCT03178669|11927549|FG001|Overall Study|Lack of Efficacy|0
7560354|NCT03178669|11927550|FG002|Overall Study|Lack of Efficacy|2
7560355|NCT03178669|11927551|FG003|Overall Study|Lack of Efficacy|0
7560356|NCT03178669|11927552|FG004|Overall Study|Lack of Efficacy|1
7560357|NCT03178669|11927548|FG000|Overall Study|Physician Decision|0
7560358|NCT03178669|11927549|FG001|Overall Study|Physician Decision|0
7560359|NCT03178669|11927550|FG002|Overall Study|Physician Decision|0
7560360|NCT03178669|11927551|FG003|Overall Study|Physician Decision|0
7560361|NCT03178669|11927552|FG004|Overall Study|Physician Decision|1
7560362|NCT03178669|11927548|FG000|Overall Study|Withdrawal by Subject|1
7560363|NCT03178669|11927549|FG001|Overall Study|Withdrawal by Subject|0
7560364|NCT03178669|11927550|FG002|Overall Study|Withdrawal by Subject|1
7560365|NCT03178669|11927551|FG003|Overall Study|Withdrawal by Subject|1
7560366|NCT03178669|11927552|FG004|Overall Study|Withdrawal by Subject|0
7560367|NCT03178669|11927548|FG000|Overall Study|Lost to Follow-up|0
7560368|NCT03178669|11927549|FG001|Overall Study|Lost to Follow-up|0
7560369|NCT03178669|11927550|FG002|Overall Study|Lost to Follow-up|0
7560370|NCT03178669|11927551|FG003|Overall Study|Lost to Follow-up|1
7560371|NCT03178669|11927552|FG004|Overall Study|Lost to Follow-up|0
7560372|NCT03178773|11927566|FG000|Overall Study|Death|0
7560373|NCT03178773|11927567|FG001|Overall Study|Death|1
7560374|NCT03178773|11927566|FG000|Overall Study|Lost to Follow-up|29
7560375|NCT03178773|11927567|FG001|Overall Study|Lost to Follow-up|25
7560376|NCT03178773|11927566|FG000|Overall Study|Withdrawal by Subject|10
7560377|NCT03178773|11927567|FG001|Overall Study|Withdrawal by Subject|14
7560378|NCT03178851|11927577|FG000|Overall Study|Death|48
7560379|NCT03178851|11927578|FG001|Overall Study|Death|2
7560380|NCT03178851|11927579|FG002|Overall Study|Death|25
7560381|NCT03178851|11927577|FG000|Overall Study|Withdrawal by Subject|8
7560382|NCT03178851|11927578|FG001|Overall Study|Withdrawal by Subject|0
7560383|NCT03178851|11927579|FG002|Overall Study|Withdrawal by Subject|0
7560384|NCT03178851|11927577|FG000|Overall Study|Lost to Follow-up|5
7560385|NCT03178851|11927578|FG001|Overall Study|Lost to Follow-up|2
7560386|NCT03178851|11927579|FG002|Overall Study|Lost to Follow-up|0
7560387|NCT03178851|11927577|FG000|Overall Study|Adverse Event|0
7560388|NCT03178851|11927578|FG001|Overall Study|Adverse Event|0
7560389|NCT03178851|11927579|FG002|Overall Study|Adverse Event|1
7560390|NCT03178851|11927577|FG000|Overall Study|Study Termination by Sponsor|31
7560391|NCT03178851|11927578|FG001|Overall Study|Study Termination by Sponsor|7
7560392|NCT03178851|11927579|FG002|Overall Study|Study Termination by Sponsor|26
7560393|NCT03178942|11927590|FG000|Overall Study|Withdrawal by Subject|2
7560394|NCT03178942|11927591|FG001|Overall Study|Withdrawal by Subject|0
7560395|NCT03178942|11927590|FG000|Overall Study|Lost to Follow-up|1
7560396|NCT03178942|11927591|FG001|Overall Study|Lost to Follow-up|2
7560397|NCT03179319|11927599|FG000|Overall Study|Lost to Follow-up|6
7560398|NCT03179319|11927600|FG001|Overall Study|Lost to Follow-up|0
7560399|NCT03179787|11927633|FG000|Overall Study|Lost to Follow-up|15
7560400|NCT03179787|11927633|FG000|Overall Study|Case report failures|2
7560401|NCT03179787|11927633|FG000|Overall Study|Treatment not administered|1
7560402|NCT03179891|11927637|FG000|First Intervention|Withdrawal by Subject|1
7560403|NCT03179891|11927638|FG001|First Intervention|Withdrawal by Subject|1
7560404|NCT03179891|11927637|FG000|First Intervention|Unspecified reason|1
7560405|NCT03179891|11927638|FG001|First Intervention|Unspecified reason|0
7560406|NCT03179891|11927637|FG000|First Intervention|Protocol Violation|0
7560407|NCT03179891|11927638|FG001|First Intervention|Protocol Violation|1
7560408|NCT03180138|11927650|FG000|Overall Study|Mobile-phone could not be verified|2
7560409|NCT03180138|11927651|FG001|Overall Study|Mobile-phone could not be verified|13
7437217|NCT01621542|11720163|FG002|Overall Study|Physician Decision|1
7560410|NCT03180138|11927652|FG002|Overall Study|Mobile-phone could not be verified|15
7560411|NCT03180138|11927650|FG000|Overall Study|No prior immunization records|17
7560412|NCT03180138|11927651|FG001|Overall Study|No prior immunization records|0
7560413|NCT03180138|11927652|FG002|Overall Study|No prior immunization records|6
7560414|NCT03180138|11927650|FG000|Overall Study|Found to be >24 mon after randomization|3
7437218|NCT01621542|11720164|FG003|Overall Study|Physician Decision|13
7437219|NCT01621542|11720165|FG004|Overall Study|Physician Decision|3
7437220|NCT01621542|11720166|FG005|Overall Study|Physician Decision|1
7437221|NCT01621542|11720161|FG000|Overall Study|Withdrawal by Subject|2
7560415|NCT03180138|11927651|FG001|Overall Study|Found to be >24 mon after randomization|0
7560416|NCT03180138|11927652|FG002|Overall Study|Found to be >24 mon after randomization|3
7437222|NCT01621542|11720162|FG001|Overall Study|Withdrawal by Subject|0
7437223|NCT01621542|11720163|FG002|Overall Study|Withdrawal by Subject|1
7437224|NCT01621542|11720164|FG003|Overall Study|Withdrawal by Subject|3
7437225|NCT01621542|11720165|FG004|Overall Study|Withdrawal by Subject|3
7437226|NCT01621542|11720166|FG005|Overall Study|Withdrawal by Subject|3
7437227|NCT01621542|11720161|FG000|Overall Study|progression/treatment failure|2
7560417|NCT03180528|11927694|FG000|Overall Study|Adverse Event|1
7560418|NCT03180528|11927694|FG000|Overall Study|Withdrawal by Subject|1
7560419|NCT03180528|11927694|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
7560420|NCT03180619|11927701|FG000|Overall Study|Withdrew Consent|5
7560421|NCT03180619|11927702|FG001|Overall Study|Withdrew Consent|0
7560422|NCT03180619|11927703|FG002|Overall Study|Withdrew Consent|2
7560423|NCT03180619|11927701|FG000|Overall Study|Death|2
7560424|NCT03180619|11927702|FG001|Overall Study|Death|1
7560425|NCT03180619|11927703|FG002|Overall Study|Death|2
7560426|NCT03180619|11927701|FG000|Overall Study|Adverse Event|2
7560427|NCT03180619|11927702|FG001|Overall Study|Adverse Event|0
7560428|NCT03180619|11927703|FG002|Overall Study|Adverse Event|1
7560429|NCT03180619|11927701|FG000|Overall Study|Investigator's discretion|2
7560430|NCT03180619|11927702|FG001|Overall Study|Investigator's discretion|0
7560431|NCT03180619|11927703|FG002|Overall Study|Investigator's discretion|1
7574828|NCT03695393|11958017|FG000|Overall Study|Death|3
7574829|NCT03695393|11958018|FG001|Overall Study|Death|1
7574830|NCT03695393|11958017|FG000|Overall Study|Lost to Follow-up|0
7574831|NCT03695393|11958018|FG001|Overall Study|Lost to Follow-up|1
7574832|NCT03696108|11958030|FG000|Overall Study|Physician Decision|1
7574833|NCT03696108|11958031|FG001|Overall Study|Physician Decision|0
7574834|NCT03696108|11958030|FG000|Overall Study|Withdrawal by Subject|3
7574835|NCT03696108|11958031|FG001|Overall Study|Withdrawal by Subject|6
7574836|NCT03696342|11958039|FG000|Overall Study|Lost to Follow-up|1
7574837|NCT03696342|11958040|FG001|Overall Study|Lost to Follow-up|0
7574838|NCT03696576|11958048|FG000|Overall Study|Soreness of throat after therapy|1
7574839|NCT03696576|11958049|FG001|Overall Study|Soreness of throat after therapy|1
7574840|NCT03696576|11958048|FG000|Overall Study|Lost to Follow-up|2
7574841|NCT03696576|11958049|FG001|Overall Study|Lost to Follow-up|4
7574842|NCT03697252|11958094|FG000|Overall Study|Adverse Event|3
7574843|NCT03697252|11958095|FG001|Overall Study|Adverse Event|2
7574844|NCT03697252|11958094|FG000|Overall Study|Withdrawal by Subject|14
7574845|NCT03697252|11958095|FG001|Overall Study|Withdrawal by Subject|14
7574846|NCT03697252|11958094|FG000|Overall Study|Lost to Follow-up|0
7574847|NCT03697252|11958095|FG001|Overall Study|Lost to Follow-up|1
7574848|NCT03697252|11958094|FG000|Overall Study|Physician Decision|1
7574849|NCT03697252|11958095|FG001|Overall Study|Physician Decision|1
7574850|NCT03697252|11958094|FG000|Overall Study|Other|0
7574851|NCT03697252|11958095|FG001|Overall Study|Other|1
7574852|NCT03697460|11958101|FG000|Overall Study|Withdrawal by Subject|3
7574853|NCT03697993|11958107|FG000|Overall Study|Became Ineligible after Enrollment|1
7574854|NCT03697993|11958108|FG001|Overall Study|Became Ineligible after Enrollment|3
7574855|NCT03697993|11958107|FG000|Overall Study|Enrolled but Treatment not Administered|2
7574856|NCT03697993|11958108|FG001|Overall Study|Enrolled but Treatment not Administered|1
7574857|NCT03697993|11958107|FG000|Overall Study|Lost to Follow-up|3
7574858|NCT03697993|11958108|FG001|Overall Study|Lost to Follow-up|0
7574859|NCT03697993|11958107|FG000|Overall Study|Physician Decision|4
7574860|NCT03697993|11958108|FG001|Overall Study|Physician Decision|0
7574861|NCT03697993|11958107|FG000|Overall Study|Initial Urine Culture Negative|0
7574862|NCT03697993|11958108|FG001|Overall Study|Initial Urine Culture Negative|1
7574863|NCT03698331|11958117|FG000|Overall Study|Adverse Event|2
7574864|NCT03698331|11958118|FG001|Overall Study|Adverse Event|3
7574865|NCT03698331|11958117|FG000|Overall Study|Withdrawal by Subject|1
7574866|NCT03698331|11958118|FG001|Overall Study|Withdrawal by Subject|1
7574867|NCT03698331|11958117|FG000|Overall Study|Lost to Follow-up|0
7574868|NCT03698331|11958118|FG001|Overall Study|Lost to Follow-up|2
7574869|NCT03698331|11958117|FG000|Overall Study|Non-compliance with study drug|1
7574870|NCT03698331|11958118|FG001|Overall Study|Non-compliance with study drug|0
7437228|NCT01621542|11720162|FG001|Overall Study|progression/treatment failure|4
7574871|NCT03698591|11958126|FG000|Overall Study|Withdrawal by Subject|2
7574872|NCT03698591|11958127|FG001|Overall Study|Withdrawal by Subject|2
7574873|NCT03698591|11958126|FG000|Overall Study|Failed drug screen|1
7574874|NCT03698591|11958127|FG001|Overall Study|Failed drug screen|1
7574875|NCT03698591|11958126|FG000|Overall Study|Failed health screen|0
7574876|NCT03698591|11958127|FG001|Overall Study|Failed health screen|1
7574877|NCT03698591|11958126|FG000|Overall Study|Ineligible for financial compensation|1
7574878|NCT03698591|11958127|FG001|Overall Study|Ineligible for financial compensation|0
7574879|NCT03698591|11958126|FG000|Overall Study|Equipment Error|1
7574880|NCT03698591|11958127|FG001|Overall Study|Equipment Error|0
7574881|NCT03698591|11958126|FG000|Overall Study|Could not establish TMS dosage|0
7574882|NCT03698591|11958127|FG001|Overall Study|Could not establish TMS dosage|1
7574883|NCT03699124|11958136|FG000|Overall Study|Adverse Event|6
7574884|NCT03699124|11958137|FG001|Overall Study|Adverse Event|5
7574885|NCT03699124|11958138|FG002|Overall Study|Adverse Event|2
7437229|NCT01621542|11720163|FG002|Overall Study|progression/treatment failure|3
7574886|NCT03699124|11958136|FG000|Overall Study|Death|0
7574887|NCT03699124|11958137|FG001|Overall Study|Death|2
7437230|NCT01621542|11720164|FG003|Overall Study|progression/treatment failure|7
7437231|NCT01621542|11720165|FG004|Overall Study|progression/treatment failure|3
7437232|NCT01621542|11720166|FG005|Overall Study|progression/treatment failure|5
7560432|NCT04448756|11927740|FG000|Overall Study|Adverse Event|0
7560433|NCT04448756|11927741|FG001|Overall Study|Adverse Event|1
7560434|NCT04448756|11927742|FG002|Overall Study|Adverse Event|0
7560435|NCT04448756|11927740|FG000|Overall Study|Participant unable to attend Day 60 visit|1
7560436|NCT04448756|11927741|FG001|Overall Study|Participant unable to attend Day 60 visit|0
7560437|NCT04448756|11927742|FG002|Overall Study|Participant unable to attend Day 60 visit|0
7560438|NCT04448756|11927740|FG000|Overall Study|Withdrawal by Subject|0
7560439|NCT04448756|11927741|FG001|Overall Study|Withdrawal by Subject|3
7560440|NCT04448756|11927742|FG002|Overall Study|Withdrawal by Subject|1
7560441|NCT04448756|11927740|FG000|Overall Study|Death|2
7560442|NCT04448756|11927741|FG001|Overall Study|Death|1
7560443|NCT04448756|11927742|FG002|Overall Study|Death|0
7560444|NCT04397718|11927752|FG000|Overall Study|Death|7
7560445|NCT04397718|11927753|FG001|Overall Study|Death|11
7560446|NCT04397718|11927752|FG000|Overall Study|Lost to Follow-up|0
7560447|NCT04397718|11927753|FG001|Overall Study|Lost to Follow-up|4
7560448|NCT04352127|11927762|FG000|Overall Study|Unable to obtain readings|4
7560449|NCT04352127|11927763|FG001|Overall Study|Unable to obtain readings|1
7560450|NCT04352127|11927764|FG002|Overall Study|Unable to obtain readings|0
7560461|NCT03975920|11927790|FG000|Overall Study|Lost to Follow-up|1
7560462|NCT03975920|11927791|FG001|Overall Study|Lost to Follow-up|2
7560463|NCT03975920|11927790|FG000|Overall Study|Protocol Violation|1
7560464|NCT03975920|11927791|FG001|Overall Study|Protocol Violation|1
7560465|NCT03975920|11927790|FG000|Overall Study|Did not complete survey|2
7560466|NCT03975920|11927791|FG001|Overall Study|Did not complete survey|1
7560477|NCT03746483|11927809|FG000|Overall Study|Adverse Event|0
7560478|NCT03746483|11927810|FG001|Overall Study|Adverse Event|1
7560479|NCT03746483|11927809|FG000|Overall Study|Lack of Efficacy|3
7560480|NCT03746483|11927810|FG001|Overall Study|Lack of Efficacy|2
7560481|NCT03746483|11927809|FG000|Overall Study|Lost to Follow-up|1
7560482|NCT03746483|11927810|FG001|Overall Study|Lost to Follow-up|0
7560483|NCT03746483|11927809|FG000|Overall Study|Protocol Violation|2
7560484|NCT03746483|11927810|FG001|Overall Study|Protocol Violation|0
7560485|NCT03694327|11927824|FG000|Overall Study|Lost to Follow-up|13
7560486|NCT03694327|11927825|FG001|Overall Study|Lost to Follow-up|23
7560487|NCT03624036|11927835|FG000|Overall Study|Still on Study|5
7560488|NCT03624036|11927836|FG001|Overall Study|Still on Study|1
7560489|NCT03624036|11927837|FG002|Overall Study|Still on Study|3
7560490|NCT03624036|11927838|FG003|Overall Study|Still on Study|3
7560491|NCT03624036|11927835|FG000|Overall Study|Death|1
7560492|NCT03624036|11927836|FG001|Overall Study|Death|2
7560493|NCT03624036|11927837|FG002|Overall Study|Death|0
7560494|NCT03624036|11927838|FG003|Overall Study|Death|0
7560495|NCT03624036|11927835|FG000|Overall Study|Enrolled but Never Treated|1
7560496|NCT03624036|11927836|FG001|Overall Study|Enrolled but Never Treated|0
7437233|NCT01621542|11720161|FG000|Overall Study|Protocol Violation|0
7560497|NCT03624036|11927837|FG002|Overall Study|Enrolled but Never Treated|0
7560498|NCT03624036|11927838|FG003|Overall Study|Enrolled but Never Treated|0
7560499|NCT03057951|11927854|FG000|Overall Study|Adverse Event|553
7560500|NCT03057951|11927855|FG001|Overall Study|Adverse Event|575
7560501|NCT03057951|11927854|FG000|Overall Study|Protocol Violation|30
7560502|NCT03057951|11927855|FG001|Overall Study|Protocol Violation|24
7560503|NCT03057951|11927854|FG000|Overall Study|Lost to Follow-up|6
7560504|NCT03057951|11927855|FG001|Overall Study|Lost to Follow-up|16
7560505|NCT03057951|11927854|FG000|Overall Study|Patient refusal to continue, not due to AE|304
7560506|NCT03057951|11927855|FG001|Overall Study|Patient refusal to continue, not due to AE|284
7560507|NCT03057951|11927854|FG000|Overall Study|Study drug stopped, reason missing|6
7560508|NCT03057951|11927855|FG001|Overall Study|Study drug stopped, reason missing|1
7560509|NCT03057951|11927854|FG000|Overall Study|Medical advice|6
7560510|NCT03057951|11927855|FG001|Overall Study|Medical advice|2
7560511|NCT03057951|11927854|FG000|Overall Study|Due to Covid-19 Pandemic|2
7560512|NCT03057951|11927855|FG001|Overall Study|Due to Covid-19 Pandemic|8
7437234|NCT01621542|11720162|FG001|Overall Study|Protocol Violation|0
7437235|NCT01621542|11720163|FG002|Overall Study|Protocol Violation|0
7560513|NCT03057951|11927854|FG000|Overall Study|Investigator decision|2
7560514|NCT03057951|11927855|FG001|Overall Study|Investigator decision|0
7560515|NCT03057951|11927854|FG000|Overall Study|Patient decision|5
7560516|NCT03057951|11927855|FG001|Overall Study|Patient decision|2
7560517|NCT03057951|11927854|FG000|Overall Study|Not attending study visits|3
7560518|NCT03057951|11927855|FG001|Overall Study|Not attending study visits|0
7560519|NCT03057951|11927854|FG000|Overall Study|Patient moved away|3
7560520|NCT03057951|11927855|FG001|Overall Study|Patient moved away|4
7560521|NCT03057951|11927854|FG000|Overall Study|Other reason than stated above|23
7560522|NCT03057951|11927855|FG001|Overall Study|Other reason than stated above|29
7560523|NCT03057951|11927854|FG000|Overall Study|Not treated|2
7560524|NCT03057951|11927855|FG001|Overall Study|Not treated|1
7560525|NCT03007888|11927861|FG000|First Intervention (14 Days)|Adverse Event|1
7560526|NCT03007888|11927862|FG001|First Intervention (14 Days)|Adverse Event|0
7560528|NCT02949934|11927894|FG000|Natural Drinking Period|Adverse Event|1
7560529|NCT02949934|11927895|FG001|Natural Drinking Period|Adverse Event|0
7560530|NCT02949934|11927896|FG002|Natural Drinking Period|Adverse Event|0
7560531|NCT02949934|11927897|FG003|Natural Drinking Period|Adverse Event|1
7560532|NCT02949934|11927898|FG004|Natural Drinking Period|Adverse Event|0
7560533|NCT02949934|11927899|FG005|Natural Drinking Period|Adverse Event|0
7560534|NCT02949934|11927894|FG000|Natural Drinking Period|Lost to Follow-up|0
7560535|NCT02949934|11927895|FG001|Natural Drinking Period|Lost to Follow-up|0
7560536|NCT02949934|11927896|FG002|Natural Drinking Period|Lost to Follow-up|0
7560537|NCT02949934|11927897|FG003|Natural Drinking Period|Lost to Follow-up|0
7560538|NCT02949934|11927898|FG004|Natural Drinking Period|Lost to Follow-up|1
7560539|NCT02949934|11927899|FG005|Natural Drinking Period|Lost to Follow-up|0
7560540|NCT02949934|11927894|FG000|Neuroimaging|Protocol Violation|2
7560541|NCT02949934|11927895|FG001|Neuroimaging|Protocol Violation|0
7560542|NCT02949934|11927896|FG002|Neuroimaging|Protocol Violation|0
7560543|NCT02949934|11927897|FG003|Neuroimaging|Protocol Violation|0
7560544|NCT02949934|11927898|FG004|Neuroimaging|Protocol Violation|1
7560545|NCT02949934|11927899|FG005|Neuroimaging|Protocol Violation|0
7560546|NCT02949934|11927894|FG000|Neuroimaging|Motion artifacts in imaging data|1
7560547|NCT02949934|11927895|FG001|Neuroimaging|Motion artifacts in imaging data|0
7560548|NCT02949934|11927896|FG002|Neuroimaging|Motion artifacts in imaging data|1
7560549|NCT02949934|11927897|FG003|Neuroimaging|Motion artifacts in imaging data|0
7560550|NCT02949934|11927898|FG004|Neuroimaging|Motion artifacts in imaging data|1
7560551|NCT02949934|11927899|FG005|Neuroimaging|Motion artifacts in imaging data|0
7560552|NCT02949934|11927894|FG000|Neuroimaging|Not scanned|0
7560553|NCT02949934|11927895|FG001|Neuroimaging|Not scanned|0
7560554|NCT02949934|11927896|FG002|Neuroimaging|Not scanned|1
7560555|NCT02949934|11927897|FG003|Neuroimaging|Not scanned|0
7560556|NCT02949934|11927898|FG004|Neuroimaging|Not scanned|0
7560557|NCT02949934|11927899|FG005|Neuroimaging|Not scanned|2
7560558|NCT02949934|11927894|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0
7560559|NCT02949934|11927895|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7560560|NCT02949934|11927896|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7560561|NCT02949934|11927897|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3
7560562|NCT02949934|11927898|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
7560563|NCT02949934|11927899|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1
7560564|NCT02949934|11927894|FG000|Bar Laboratory|Adverse Event|1
7560565|NCT02949934|11927895|FG001|Bar Laboratory|Adverse Event|0
7560566|NCT02949934|11927896|FG002|Bar Laboratory|Adverse Event|2
7560567|NCT02949934|11927897|FG003|Bar Laboratory|Adverse Event|0
7560568|NCT02949934|11927898|FG004|Bar Laboratory|Adverse Event|1
7560569|NCT02949934|11927899|FG005|Bar Laboratory|Adverse Event|0
7560570|NCT02949934|11927894|FG000|Bar Laboratory|Protocol Violation|0
7560571|NCT02949934|11927895|FG001|Bar Laboratory|Protocol Violation|0
7560572|NCT02949934|11927896|FG002|Bar Laboratory|Protocol Violation|0
7560573|NCT02949934|11927897|FG003|Bar Laboratory|Protocol Violation|1
7560574|NCT02949934|11927898|FG004|Bar Laboratory|Protocol Violation|0
7560575|NCT02949934|11927899|FG005|Bar Laboratory|Protocol Violation|0
7560576|NCT02658656|11927927|FG000|Screening|Failed eligibility criteria|0
7560577|NCT02658656|11927928|FG001|Screening|Failed eligibility criteria|0
7560578|NCT02658656|11927929|FG002|Screening|Failed eligibility criteria|263
7560579|NCT02658656|11927927|FG000|Randomization|Withdrawal by Subject|8
7560580|NCT02658656|11927928|FG001|Randomization|Withdrawal by Subject|7
7560581|NCT02658656|11927929|FG002|Randomization|Withdrawal by Subject|0
7560582|NCT02658656|11927927|FG000|Randomization|Lost to Follow-up|1
7560583|NCT02658656|11927928|FG001|Randomization|Lost to Follow-up|3
7560584|NCT02658656|11927929|FG002|Randomization|Lost to Follow-up|0
7560585|NCT02658656|11927927|FG000|Randomization|Adverse Event|4
7560586|NCT02658656|11927928|FG001|Randomization|Adverse Event|0
7560587|NCT02658656|11927929|FG002|Randomization|Adverse Event|0
7560588|NCT02658656|11927927|FG000|Randomization|Administrative Termination|3
7560589|NCT02658656|11927928|FG001|Randomization|Administrative Termination|1
7560590|NCT02658656|11927929|FG002|Randomization|Administrative Termination|0
7560591|NCT02658656|11927927|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13
7560592|NCT02658656|11927928|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15
7437236|NCT01621542|11720164|FG003|Overall Study|Protocol Violation|1
7437237|NCT01621542|11720165|FG004|Overall Study|Protocol Violation|0
7437238|NCT01621542|11720166|FG005|Overall Study|Protocol Violation|0
7437239|NCT01621542|11720161|FG000|Overall Study|study stopped by sponsor|0
7437240|NCT01621542|11720162|FG001|Overall Study|study stopped by sponsor|0
7437241|NCT01621542|11720163|FG002|Overall Study|study stopped by sponsor|0
7437242|NCT01621542|11720164|FG003|Overall Study|study stopped by sponsor|1
7437243|NCT01621542|11720165|FG004|Overall Study|study stopped by sponsor|0
7437244|NCT01621542|11720166|FG005|Overall Study|study stopped by sponsor|0
7437245|NCT01621802|11720225|FG000|Overall Study|Protocol Violation|0
7437246|NCT01621802|11720226|FG001|Overall Study|Protocol Violation|0
7437247|NCT01621802|11720227|FG002|Overall Study|Protocol Violation|0
7437248|NCT01621802|11720228|FG003|Overall Study|Protocol Violation|0
7437249|NCT01621802|11720229|FG004|Overall Study|Protocol Violation|0
7437250|NCT01621802|11720230|FG005|Overall Study|Protocol Violation|1
7437251|NCT01621802|11720225|FG000|Overall Study|Withdrawal by Subject|8
7437252|NCT01621802|11720226|FG001|Overall Study|Withdrawal by Subject|4
7437253|NCT01621802|11720227|FG002|Overall Study|Withdrawal by Subject|4
7437254|NCT01621802|11720228|FG003|Overall Study|Withdrawal by Subject|2
7437255|NCT01621802|11720229|FG004|Overall Study|Withdrawal by Subject|2
7437256|NCT01621802|11720230|FG005|Overall Study|Withdrawal by Subject|0
7437257|NCT01621802|11720225|FG000|Overall Study|Migrated/moved from study area|0
7437258|NCT01621802|11720226|FG001|Overall Study|Migrated/moved from study area|0
7437259|NCT01621802|11720227|FG002|Overall Study|Migrated/moved from study area|2
7437260|NCT01621802|11720228|FG003|Overall Study|Migrated/moved from study area|0
7437261|NCT01621802|11720229|FG004|Overall Study|Migrated/moved from study area|1
7437262|NCT01621802|11720230|FG005|Overall Study|Migrated/moved from study area|0
7437263|NCT01621802|11720225|FG000|Overall Study|Others|3
7437264|NCT01621802|11720226|FG001|Overall Study|Others|3
7437265|NCT01621802|11720227|FG002|Overall Study|Others|3
7437266|NCT01621802|11720228|FG003|Overall Study|Others|2
7437267|NCT01621802|11720229|FG004|Overall Study|Others|1
7437268|NCT01621802|11720230|FG005|Overall Study|Others|0
7560593|NCT02658656|11927929|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0
7560594|NCT02658656|11927927|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2
7560595|NCT02658656|11927928|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7560596|NCT02658656|11927929|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0
7560597|NCT02658656|11927927|FG000|Randomization|Not eligible for Randomization|1
7560598|NCT02658656|11927928|FG001|Randomization|Not eligible for Randomization|0
7560599|NCT02658656|11927929|FG002|Randomization|Not eligible for Randomization|0
7560600|NCT02658656|11927927|FG000|Randomization|Protocol Violation|1
7560601|NCT02658656|11927928|FG001|Randomization|Protocol Violation|0
7560602|NCT02658656|11927929|FG002|Randomization|Protocol Violation|0
7574888|NCT03699124|11958138|FG002|Overall Study|Death|0
7574889|NCT03699124|11958136|FG000|Overall Study|Lost to Follow-up|20
7574890|NCT03699124|11958137|FG001|Overall Study|Lost to Follow-up|16
7574891|NCT03699124|11958138|FG002|Overall Study|Lost to Follow-up|15
7574892|NCT03699124|11958136|FG000|Overall Study|Protocol Violation|1
7574893|NCT03699124|11958137|FG001|Overall Study|Protocol Violation|0
7574894|NCT03699124|11958138|FG002|Overall Study|Protocol Violation|0
7574895|NCT03699124|11958136|FG000|Overall Study|Withdrawal by Subject|13
7574896|NCT03699124|11958137|FG001|Overall Study|Withdrawal by Subject|14
7574897|NCT03699124|11958138|FG002|Overall Study|Withdrawal by Subject|13
7574898|NCT03699124|11958136|FG000|Overall Study|Other reasons|5
7574899|NCT03699124|11958137|FG001|Overall Study|Other reasons|3
7574900|NCT03699124|11958138|FG002|Overall Study|Other reasons|10
7574901|NCT03700320|11958148|FG000|Overall Study|Adverse Event|5
7574902|NCT03700320|11958149|FG001|Overall Study|Adverse Event|31
7574903|NCT03700320|11958148|FG000|Overall Study|Lack of Efficacy|2
7574904|NCT03700320|11958149|FG001|Overall Study|Lack of Efficacy|5
7574905|NCT03700320|11958148|FG000|Overall Study|Withdrawal by Subject|29
7574906|NCT03700320|11958149|FG001|Overall Study|Withdrawal by Subject|75
7574907|NCT03700320|11958148|FG000|Overall Study|Lost to Follow-up|16
7574908|NCT03700320|11958149|FG001|Overall Study|Lost to Follow-up|23
7574909|NCT03700320|11958148|FG000|Overall Study|Pregnancy|2
7574910|NCT03700320|11958149|FG001|Overall Study|Pregnancy|4
7574911|NCT03700320|11958148|FG000|Overall Study|Protocol Deviation|7
7574912|NCT03700320|11958149|FG001|Overall Study|Protocol Deviation|31
7574913|NCT03700320|11958148|FG000|Overall Study|Non-compliance with Study Drug|1
7574914|NCT03700320|11958149|FG001|Overall Study|Non-compliance with Study Drug|3
7574915|NCT03700320|11958148|FG000|Overall Study|Reason not Specified|0
7574916|NCT03700320|11958149|FG001|Overall Study|Reason not Specified|1
7574917|NCT03700385|11958159|FG000|Overall Study|Lost to Follow-up|1
7437269|NCT01621802|11720225|FG000|Overall Study|Lost to Follow-up|36
7574918|NCT03700671|11958165|FG000|Overall Study|Lack of Efficacy|1
7574919|NCT03700671|11958166|FG001|Overall Study|Lack of Efficacy|2
7574920|NCT03700736|11958176|FG000|Overall Study|Pregnancy|1
7574921|NCT03700736|11958177|FG001|Overall Study|Pregnancy|1
7437270|NCT01621802|11720226|FG001|Overall Study|Lost to Follow-up|16
7574922|NCT03700736|11958176|FG000|Overall Study|Withdrawal by Subject|2
7574923|NCT03700736|11958177|FG001|Overall Study|Withdrawal by Subject|6
7574924|NCT03700892|11958188|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7574925|NCT03700892|11958189|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
7560609|NCT01667081|11927985|FG000|Overall Study|Death|43
7560610|NCT01667081|11927986|FG001|Overall Study|Death|3
7560611|NCT01667081|11927985|FG000|Overall Study|Lost to Follow-up|99
7560612|NCT01667081|11927986|FG001|Overall Study|Lost to Follow-up|48
7560613|NCT01667081|11927985|FG000|Overall Study|Physician Decision|16
7560614|NCT01667081|11927986|FG001|Overall Study|Physician Decision|2
7560615|NCT01667081|11927985|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529
7560616|NCT01667081|11927986|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269
7560617|NCT01667081|11927985|FG000|Overall Study|Withdrawal by Subject|90
7560618|NCT01667081|11927986|FG001|Overall Study|Withdrawal by Subject|35
7560620|NCT00634504|11928010|FG000|Overall Study|Protocol Violation|1
7560621|NCT00634504|11928011|FG001|Overall Study|Protocol Violation|0
7560622|NCT00352027|11928028|FG000|Overall Study|Progressive disease|3
7560623|NCT00104676|11928056|FG000|Overall Study|Death|3
7560624|NCT00104676|11928057|FG001|Overall Study|Death|2
7560625|NCT00104676|11928056|FG000|Overall Study|Withdrawal by Subject|0
7560626|NCT00104676|11928057|FG001|Overall Study|Withdrawal by Subject|2
7560627|NCT00104676|11928056|FG000|Overall Study|treatment interruption|4
7560628|NCT00104676|11928057|FG001|Overall Study|treatment interruption|10
7560629|NCT04042103|11928076|FG000|Overall Study|Lost to Follow-up|1
7560630|NCT04042103|11928076|FG000|Overall Study|Withdrawal by Subject|1
7560631|NCT04004208|11928082|FG000|Overall Study|Withdrawal by parent/guardian|1
7560632|NCT04004208|11928083|FG001|Overall Study|Withdrawal by parent/guardian|1
7560633|NCT04004208|11928082|FG000|Overall Study|Death|3
7560634|NCT04004208|11928083|FG001|Overall Study|Death|0
7560635|NCT04004208|11928082|FG000|Overall Study|COVID-19 pandemic|1
7560636|NCT04004208|11928083|FG001|Overall Study|COVID-19 pandemic|0
7560637|NCT04004208|11928082|FG000|Overall Study|Physician Decision|1
7560638|NCT04004208|11928083|FG001|Overall Study|Physician Decision|0
7560639|NCT04004208|11928082|FG000|Overall Study|Adverse Event|1
7560640|NCT04004208|11928083|FG001|Overall Study|Adverse Event|1
7560655|NCT03041311|11928104|FG000|Overall Study|Death|39
7560656|NCT03041311|11928105|FG001|Overall Study|Death|42
7560657|NCT03041311|11928104|FG000|Overall Study|Lost to Follow-up|0
7560658|NCT03041311|11928105|FG001|Overall Study|Lost to Follow-up|1
7560659|NCT03041311|11928104|FG000|Overall Study|Withdrawal by Subject|8
7560660|NCT03041311|11928105|FG001|Overall Study|Withdrawal by Subject|5
7560661|NCT03041311|11928104|FG000|Overall Study|Sponsor Terminated Study|2
7560662|NCT03041311|11928105|FG001|Overall Study|Sponsor Terminated Study|4
7560663|NCT03041311|11928104|FG000|Overall Study|Disease Progression|3
7560664|NCT03041311|11928105|FG001|Overall Study|Disease Progression|1
7560665|NCT03041311|11928104|FG000|Overall Study|Randomized in error, did not receive drug|2
7560666|NCT03041311|11928105|FG001|Overall Study|Randomized in error, did not receive drug|0
7560667|NCT03020914|11928121|FG000|Overall Study|Surgery Cancelled|1
7560668|NCT03020914|11928122|FG001|Overall Study|Surgery Cancelled|0
7560669|NCT02698891|11928137|FG000|Overall Study|Withdrawal by Subject|2
7560670|NCT02698891|11928137|FG000|Overall Study|deemed ineligible|1
7560671|NCT02698891|11928137|FG000|Overall Study|Adverse Event|9
7560672|NCT02537678|11928143|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4
7560673|NCT02537678|11928144|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3
7560674|NCT02537678|11928143|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7560675|NCT02537678|11928144|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4
7560676|NCT02537678|11928143|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6
7560677|NCT02537678|11928144|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5
7560678|NCT02537678|11928143|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2
7560679|NCT02537678|11928144|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3
7560680|NCT02537678|11928143|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14
7560681|NCT02537678|11928144|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6
7560682|NCT02537678|11928143|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8
7560683|NCT02537678|11928144|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7
7560684|NCT02537678|11928143|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0
7560685|NCT02537678|11928144|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1
7560686|NCT02400476|11928160|FG000|Overall Study|Adverse Event|57
7560687|NCT02400476|11928161|FG001|Overall Study|Adverse Event|10
7560688|NCT02400476|11928162|FG002|Overall Study|Adverse Event|22
7560689|NCT02400476|11928163|FG003|Overall Study|Adverse Event|19
7560690|NCT02400476|11928164|FG004|Overall Study|Adverse Event|5
7560691|NCT02400476|11928165|FG005|Overall Study|Adverse Event|8
7560692|NCT02400476|11928160|FG000|Overall Study|Withdrawal by Subject|4
7560693|NCT02400476|11928161|FG001|Overall Study|Withdrawal by Subject|1
7560694|NCT02400476|11928162|FG002|Overall Study|Withdrawal by Subject|12
7560641|NCT03817190|11928091|FG000|Overall Study|Early Termination|13
7560642|NCT03817190|11928092|FG001|Overall Study|Early Termination|20
7560643|NCT03817190|11928091|FG000|Overall Study|Adverse Event|10
7560644|NCT03817190|11928092|FG001|Overall Study|Adverse Event|17
7560645|NCT03817190|11928091|FG000|Overall Study|Withdrawal by Subject|12
7560646|NCT03817190|11928092|FG001|Overall Study|Withdrawal by Subject|8
7560647|NCT03817190|11928091|FG000|Overall Study|Lost to Follow-up|11
7560648|NCT03817190|11928092|FG001|Overall Study|Lost to Follow-up|7
7560649|NCT03817190|11928091|FG000|Overall Study|Lack of Efficacy|7
7560650|NCT03817190|11928092|FG001|Overall Study|Lack of Efficacy|5
7560651|NCT03817190|11928091|FG000|Overall Study|Investigator Decision|5
7560652|NCT03817190|11928092|FG001|Overall Study|Investigator Decision|1
7437271|NCT01621802|11720227|FG002|Overall Study|Lost to Follow-up|24
7437272|NCT01621802|11720228|FG003|Overall Study|Lost to Follow-up|7
7437273|NCT01621802|11720229|FG004|Overall Study|Lost to Follow-up|31
7437274|NCT01621802|11720230|FG005|Overall Study|Lost to Follow-up|11
7437275|NCT01621880|11720249|FG000|Overall Study|Adverse Event|5
7437276|NCT01621880|11720250|FG001|Overall Study|Adverse Event|1
7437277|NCT01621880|11720249|FG000|Overall Study|Withdrawal by Subject|5
7437278|NCT01621880|11720250|FG001|Overall Study|Withdrawal by Subject|4
7437279|NCT01622231|11720268|FG000|Overall Study|Physician Decision|1
7437280|NCT01622231|11720268|FG000|Overall Study|Withdrawal by Subject|1
7437281|NCT01622348|11720294|FG000|Overall Study|Withdrawal by Subject|1
7437282|NCT01622348|11720295|FG001|Overall Study|Withdrawal by Subject|0
7437283|NCT01622348|11720296|FG002|Overall Study|Withdrawal by Subject|1
7437284|NCT01622569|11720317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
7437285|NCT01622569|11720318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7437286|NCT01622569|11720319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
7437287|NCT01622569|11720320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7437288|NCT01622569|11720317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7437289|NCT01622569|11720318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7437290|NCT01622569|11720319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
7437291|NCT01622569|11720320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
7437292|NCT01622569|11720317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
7437293|NCT01622569|11720318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7437294|NCT01622569|11720319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
7437295|NCT01622569|11720320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
7437296|NCT01622569|11720317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7437297|NCT01622569|11720318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
7437298|NCT01622569|11720319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7437299|NCT01622569|11720320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7437300|NCT01622569|11720317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7437301|NCT01622569|11720318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7437302|NCT01622569|11720319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
7437303|NCT01622569|11720320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7437304|NCT01622569|11720317|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7437305|NCT01622569|11720318|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
7437306|NCT01622569|11720319|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7437307|NCT01622569|11720320|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7437308|NCT01622569|11720317|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7437309|NCT01622569|11720318|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7437310|NCT01622569|11720319|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
7437311|NCT01622569|11720320|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7437312|NCT01622569|11720317|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437313|NCT01622569|11720318|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437314|NCT01622569|11720319|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437315|NCT01622569|11720320|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7437316|NCT01622660|11720340|FG000|Overall Study|Adverse Event|1
7437317|NCT01622673|11720350|FG000|Treatment Period 1|Withdrawal by Subject|0
7437318|NCT01622673|11720351|FG001|Treatment Period 1|Withdrawal by Subject|0
7437319|NCT01622673|11720352|FG002|Treatment Period 1|Withdrawal by Subject|0
7437320|NCT01622673|11720353|FG003|Treatment Period 1|Withdrawal by Subject|1
7437321|NCT01622673|11720354|FG004|Treatment Period 1|Withdrawal by Subject|0
7437322|NCT01622673|11720355|FG005|Treatment Period 1|Withdrawal by Subject|0
7437323|NCT01622673|11720350|FG000|Treatment Period 1|Protocol Violation|0
7437324|NCT01622673|11720351|FG001|Treatment Period 1|Protocol Violation|1
7437325|NCT01622673|11720352|FG002|Treatment Period 1|Protocol Violation|0
7437326|NCT01622673|11720353|FG003|Treatment Period 1|Protocol Violation|0
7437327|NCT01622673|11720354|FG004|Treatment Period 1|Protocol Violation|0
7437328|NCT01622673|11720355|FG005|Treatment Period 1|Protocol Violation|0
7437329|NCT01622673|11720350|FG000|Treatment Period 2|Withdrawal by Subject|0
7437330|NCT01622673|11720351|FG001|Treatment Period 2|Withdrawal by Subject|0
7437331|NCT01622673|11720352|FG002|Treatment Period 2|Withdrawal by Subject|0
7560653|NCT03817190|11928091|FG000|Overall Study|Missing Effect|2
7560654|NCT03817190|11928092|FG001|Overall Study|Missing Effect|1
7560695|NCT02400476|11928163|FG003|Overall Study|Withdrawal by Subject|7
7532829|NCT02676466|11878570|FG006|Overall Study|Death|0
7532830|NCT02676466|11878571|FG007|Overall Study|Death|0
7532831|NCT02676466|11878564|FG000|Overall Study|Withdrawal by Subject|4
7532832|NCT02676466|11878565|FG001|Overall Study|Withdrawal by Subject|3
7532833|NCT02676466|11878566|FG002|Overall Study|Withdrawal by Subject|1
7532834|NCT02676466|11878567|FG003|Overall Study|Withdrawal by Subject|0
7532835|NCT02676466|11878568|FG004|Overall Study|Withdrawal by Subject|3
7532836|NCT02676466|11878569|FG005|Overall Study|Withdrawal by Subject|1
7532837|NCT02676466|11878570|FG006|Overall Study|Withdrawal by Subject|1
7532838|NCT02676466|11878571|FG007|Overall Study|Withdrawal by Subject|1
7532839|NCT02676778|11878596|FG000|Overall Study|Disease Progression|7
7532840|NCT02676778|11878597|FG001|Overall Study|Disease Progression|3
7532841|NCT02676778|11878598|FG002|Overall Study|Disease Progression|1
7532842|NCT02676778|11878596|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1
7532843|NCT02676778|11878597|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1
7532844|NCT02676778|11878598|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0
7532845|NCT02676778|11878596|FG000|Overall Study|Withdrawal by Subject|3
7532846|NCT02676778|11878597|FG001|Overall Study|Withdrawal by Subject|2
7437332|NCT01622673|11720353|FG003|Treatment Period 2|Withdrawal by Subject|1
7437333|NCT01622673|11720354|FG004|Treatment Period 2|Withdrawal by Subject|0
7437334|NCT01622673|11720355|FG005|Treatment Period 2|Withdrawal by Subject|0
7437335|NCT01622673|11720350|FG000|Treatment Period 3|Protocol Violation|0
7437336|NCT01622673|11720351|FG001|Treatment Period 3|Protocol Violation|1
7437337|NCT01622673|11720352|FG002|Treatment Period 3|Protocol Violation|0
7437338|NCT01622673|11720353|FG003|Treatment Period 3|Protocol Violation|0
7437339|NCT01622673|11720354|FG004|Treatment Period 3|Protocol Violation|0
7437340|NCT01622673|11720355|FG005|Treatment Period 3|Protocol Violation|0
7437341|NCT01623050|11720389|FG000|Overall Study|Lost to Follow-up|9
7437342|NCT01623115|11720395|FG000|Overall Study|Randomized but not treated|0
7437343|NCT01623115|11720396|FG001|Overall Study|Randomized but not treated|1
7437344|NCT01623115|11720395|FG000|Overall Study|Physician Decision|1
7437345|NCT01623115|11720396|FG001|Overall Study|Physician Decision|0
7437346|NCT01623115|11720395|FG000|Overall Study|Participants moved|1
7437347|NCT01623115|11720396|FG001|Overall Study|Participants moved|5
7437348|NCT01623115|11720395|FG000|Overall Study|Adverse Event|10
7437349|NCT01623115|11720396|FG001|Overall Study|Adverse Event|13
7437350|NCT01623115|11720395|FG000|Overall Study|Poor compliance to protocol|4
7437351|NCT01623115|11720396|FG001|Overall Study|Poor compliance to protocol|10
7437352|NCT01623115|11720395|FG000|Overall Study|Consent withdrawn by participant|2
7437353|NCT01623115|11720396|FG001|Overall Study|Consent withdrawn by participant|6
7437354|NCT01623115|11720395|FG000|Overall Study|Related to study drug administration|0
7437355|NCT01623115|11720396|FG001|Overall Study|Related to study drug administration|2
7437356|NCT01623115|11720395|FG000|Overall Study|Last visit outside protocol visit window|14
7437357|NCT01623115|11720396|FG001|Overall Study|Last visit outside protocol visit window|26
7437358|NCT01623115|11720395|FG000|Overall Study|Site closure|1
7437359|NCT01623115|11720396|FG001|Overall Study|Site closure|7
7437360|NCT01623115|11720395|FG000|Overall Study|Death|0
7437361|NCT01623115|11720396|FG001|Overall Study|Death|4
7437362|NCT01623115|11720395|FG000|Overall Study|Other than specified above|0
7437363|NCT01623115|11720396|FG001|Overall Study|Other than specified above|3
7437364|NCT01623154|11720402|FG000|Overall Study|Did not drink Pranactin Citric|4
7437365|NCT01623271|11720408|FG000|Overall Study|Withdrawal by Subject|2
7437366|NCT01623310|11720412|FG000|Overall Study|Adverse Event|21
7437367|NCT01623310|11720412|FG000|Overall Study|Lost to Follow-up|18
7437368|NCT01623310|11720412|FG000|Overall Study|Lack of Efficacy|6
7437369|NCT01623310|11720412|FG000|Overall Study|Protocol Violation|6
7437370|NCT01623310|11720412|FG000|Overall Study|Withdrawal by Subject|25
7437371|NCT01623310|11720412|FG000|Overall Study|Became potentially child-bearing|1
7437372|NCT01623310|11720412|FG000|Overall Study|Diagnoses of bilateral cateracts|1
7437373|NCT01623310|11720412|FG000|Overall Study|Investigators Discretion-Noncompliant|1
7437374|NCT01623531|11720435|FG000|Overall Study|Death|1
7437375|NCT01623531|11720436|FG001|Overall Study|Death|0
7437376|NCT01623531|11720435|FG000|Overall Study|Protocol Violation|2
7437377|NCT01623531|11720436|FG001|Overall Study|Protocol Violation|1
7437378|NCT01623531|11720435|FG000|Overall Study|Missing data at primary outcome time poi|1
7437379|NCT01623531|11720436|FG001|Overall Study|Missing data at primary outcome time poi|1
7437380|NCT01623596|11720447|FG000|Overall Study|Abnormal laboratory values|2
7437381|NCT01623596|11720448|FG001|Overall Study|Abnormal laboratory values|0
7437382|NCT01623596|11720447|FG000|Overall Study|Administrative problems|9
7437383|NCT01623596|11720448|FG001|Overall Study|Administrative problems|13
7437384|NCT01623596|11720447|FG000|Overall Study|Adverse Event|20
7437385|NCT01623596|11720448|FG001|Overall Study|Adverse Event|29
7437386|NCT01623596|11720447|FG000|Overall Study|Death|0
7437387|NCT01623596|11720448|FG001|Overall Study|Death|2
7437388|NCT01623596|11720447|FG000|Overall Study|Lost to Follow-up|12
7437389|NCT01623596|11720448|FG001|Overall Study|Lost to Follow-up|16
7437390|NCT01623596|11720447|FG000|Overall Study|Withdrawal by Subject|13
7437391|NCT01623596|11720448|FG001|Overall Study|Withdrawal by Subject|31
7532847|NCT02676778|11878598|FG002|Overall Study|Withdrawal by Subject|0
7437392|NCT01623596|11720447|FG000|Overall Study|Patient no longer requires study drug|1
7437393|NCT01623596|11720448|FG001|Overall Study|Patient no longer requires study drug|0
7437394|NCT01623596|11720447|FG000|Overall Study|Protocol Violation|0
7437395|NCT01623596|11720448|FG001|Overall Study|Protocol Violation|6
7437396|NCT01623596|11720447|FG000|Overall Study|Lack of Efficacy|5
7437397|NCT01623596|11720448|FG001|Overall Study|Lack of Efficacy|3
7437398|NCT01623752|11720469|FG000|Phase 1 (78 Weeks)|No Data|249
7437399|NCT01623752|11720470|FG001|Phase 1 (78 Weeks)|No Data|66
7437400|NCT01623752|11720471|FG002|Phase 1 (78 Weeks)|No Data|2
7437401|NCT01623752|11720469|FG000|Phase 1 (78 Weeks)|Other|33
7437402|NCT01623752|11720470|FG001|Phase 1 (78 Weeks)|Other|20
7437403|NCT01623752|11720471|FG002|Phase 1 (78 Weeks)|Other|0
7437404|NCT01623752|11720469|FG000|Phase 1 (78 Weeks)|Adverse Event|122
7437405|NCT01623752|11720470|FG001|Phase 1 (78 Weeks)|Adverse Event|39
7437406|NCT01623752|11720471|FG002|Phase 1 (78 Weeks)|Adverse Event|0
7437407|NCT01623752|11720469|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
7437408|NCT01623752|11720470|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
7437409|NCT01623752|11720471|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
7437410|NCT01623752|11720469|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
7437411|NCT01623752|11720470|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
7437412|NCT01623752|11720471|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
7437413|NCT01623752|11720469|FG000|Phase 2 (78 Weeks)|Other|5
7437414|NCT01623752|11720470|FG001|Phase 2 (78 Weeks)|Other|1
7437415|NCT01623752|11720471|FG002|Phase 2 (78 Weeks)|Other|0
7437416|NCT01623752|11720469|FG000|Phase 2 (78 Weeks)|No Data|43
7437417|NCT01623752|11720470|FG001|Phase 2 (78 Weeks)|No Data|11
7437418|NCT01623752|11720471|FG002|Phase 2 (78 Weeks)|No Data|0
7437419|NCT01623752|11720469|FG000|Phase 2 (78 Weeks)|Adverse Event|4
7437420|NCT01623752|11720470|FG001|Phase 2 (78 Weeks)|Adverse Event|4
7437421|NCT01623752|11720471|FG002|Phase 2 (78 Weeks)|Adverse Event|0
7437422|NCT01623830|11720482|FG000|Overall Study|Withdrawal by Subject|6
7437423|NCT01623830|11720483|FG001|Overall Study|Withdrawal by Subject|7
7437424|NCT01623830|11720482|FG000|Overall Study|Exclusion from Study|1
7437425|NCT01623830|11720483|FG001|Overall Study|Exclusion from Study|2
7437426|NCT01624090|11720497|FG000|Overall Study|DLT, taken off therapy|0
7437427|NCT01624090|11720498|FG001|Overall Study|DLT, taken off therapy|1
7437428|NCT01624090|11720499|FG002|Overall Study|DLT, taken off therapy|0
7437429|NCT01624090|11720500|FG003|Overall Study|DLT, taken off therapy|0
7437430|NCT01624090|11720497|FG000|Overall Study|Withdrew prior to treatment|0
7437431|NCT01624090|11720498|FG001|Overall Study|Withdrew prior to treatment|1
7437432|NCT01624090|11720499|FG002|Overall Study|Withdrew prior to treatment|0
7437433|NCT01624090|11720500|FG003|Overall Study|Withdrew prior to treatment|0
7437434|NCT01624090|11720497|FG000|Overall Study|Died on study|0
7437435|NCT01624090|11720498|FG001|Overall Study|Died on study|0
7437436|NCT01624090|11720499|FG002|Overall Study|Died on study|2
7437437|NCT01624090|11720500|FG003|Overall Study|Died on study|0
7437438|NCT01624090|11720497|FG000|Overall Study|Did not complete 1 crse of therapy|0
7437439|NCT01624090|11720498|FG001|Overall Study|Did not complete 1 crse of therapy|0
7437440|NCT01624090|11720499|FG002|Overall Study|Did not complete 1 crse of therapy|2
7437441|NCT01624090|11720500|FG003|Overall Study|Did not complete 1 crse of therapy|0
7437442|NCT01624090|11720497|FG000|Overall Study|Dose escalated|0
7437443|NCT01624090|11720498|FG001|Overall Study|Dose escalated|0
7437444|NCT01624090|11720499|FG002|Overall Study|Dose escalated|3
7437445|NCT01624090|11720500|FG003|Overall Study|Dose escalated|0
7437446|NCT01624142|11720512|FG000|Overall Study|Withdrawal by Subject|14
7437447|NCT01624142|11720513|FG001|Overall Study|Withdrawal by Subject|4
7437448|NCT01624142|11720512|FG000|Overall Study|Death|3
7437449|NCT01624142|11720513|FG001|Overall Study|Death|6
7437450|NCT01624142|11720512|FG000|Overall Study|Study Closure|12
7437451|NCT01624142|11720513|FG001|Overall Study|Study Closure|6
7437452|NCT01624142|11720512|FG000|Overall Study|Lost to Follow-up|2
7437453|NCT01624142|11720513|FG001|Overall Study|Lost to Follow-up|0
7437454|NCT01624142|11720512|FG000|Overall Study|Other|1
7437455|NCT01624142|11720513|FG001|Overall Study|Other|0
7437456|NCT01624194|11720535|FG000|Overall Study|Lost to Follow-up|1
7437457|NCT01624194|11720536|FG001|Overall Study|Lost to Follow-up|0
7437458|NCT01624194|11720535|FG000|Overall Study|Withdrawal by Subject|1
7437459|NCT01624194|11720536|FG001|Overall Study|Withdrawal by Subject|0
7437460|NCT01624233|11720543|FG000|Period 2 - Induction|Adverse Event|1
7437461|NCT01624233|11720543|FG000|Period 3 - Maintenance|Adverse Event|2
7437462|NCT01624233|11720543|FG000|Period 3 - Maintenance|Lack of Efficacy|1
7437463|NCT01624233|11720543|FG000|Period 3 - Maintenance|Physician Decision|2
7437464|NCT01624233|11720543|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
7437465|NCT01624233|11720543|FG000|Period 4 - Drug Free Period|Relapsed|61
7437466|NCT01624233|11720543|FG000|Period 5 - Retreatment Period|Adverse Event|5
7437467|NCT01624233|11720543|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
7437468|NCT01624233|11720543|FG000|Period 5 - Retreatment Period|Physician Decision|1
7437469|NCT01624233|11720543|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
7437470|NCT01624233|11720543|FG000|Period 6: Follow-up|Adverse Event|3
7437471|NCT01624233|11720543|FG000|Period 6: Follow-up|Lack of Efficacy|2
7437472|NCT01624233|11720543|FG000|Period 6: Follow-up|Physician Decision|1
7437473|NCT01624233|11720543|FG000|Period 6: Follow-up|Withdrawal by Subject|3
7437474|NCT01624259|11720553|FG000|Overall Study|Adverse Event|18
7437475|NCT01624259|11720554|FG001|Overall Study|Adverse Event|18
7437476|NCT01624259|11720553|FG000|Overall Study|Protocol Violation|1
7437477|NCT01624259|11720554|FG001|Overall Study|Protocol Violation|2
7437478|NCT01624259|11720553|FG000|Overall Study|Withdrawal by Subject|5
7532848|NCT02676778|11878596|FG000|Overall Study|Other|4
7437479|NCT01624259|11720554|FG001|Overall Study|Withdrawal by Subject|7
7437480|NCT01624259|11720553|FG000|Overall Study|Physician Decision|1
7437481|NCT01624259|11720554|FG001|Overall Study|Physician Decision|1
7437482|NCT01624259|11720553|FG000|Overall Study|Lost to Follow-up|2
7437483|NCT01624259|11720554|FG001|Overall Study|Lost to Follow-up|3
7437484|NCT01624259|11720553|FG000|Overall Study|Abnormal laboratory measure|3
7437485|NCT01624259|11720554|FG001|Overall Study|Abnormal laboratory measure|0
7437486|NCT01624467|11720586|FG000|Overall Study|Withdrawal by Subject|2
7437487|NCT01624467|11720586|FG000|Overall Study|Lost to Follow-up|1
7437488|NCT01624467|11720586|FG000|Overall Study|Adverse Event|7
7437489|NCT01624467|11720586|FG000|Overall Study|Progressive Disease|19
7437490|NCT01624467|11720586|FG000|Overall Study|Per Sponsor Requirement|1
7437491|NCT01624467|11720586|FG000|Overall Study|Subject Withdrew from Treatment|1
7437492|NCT01624506|11720594|FG000|Overall Study|Lost to Follow-up|29
7437493|NCT01624506|11720595|FG001|Overall Study|Lost to Follow-up|15
7437494|NCT01624506|11720594|FG000|Overall Study|Withdrawal by Subject|9
7437495|NCT01624506|11720595|FG001|Overall Study|Withdrawal by Subject|2
7437496|NCT01624506|11720594|FG000|Overall Study|Death|1
7437497|NCT01624506|11720595|FG001|Overall Study|Death|0
7437498|NCT01624506|11720594|FG000|Overall Study|LINX explants|23
7437499|NCT01624506|11720595|FG001|Overall Study|LINX explants|0
7437500|NCT01624506|11720594|FG000|Overall Study|Adverse Event|3
7437501|NCT01624506|11720595|FG001|Overall Study|Adverse Event|0
7437502|NCT01624662|11720605|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
7437503|NCT01624662|11720606|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7437504|NCT01624662|11720607|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
7437505|NCT01624662|11720608|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
7437506|NCT01624662|11720605|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
7437507|NCT01624662|11720606|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
7437508|NCT01624662|11720607|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7437509|NCT01624662|11720608|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
7437510|NCT01624662|11720605|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7437511|NCT01624662|11720606|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
7437512|NCT01624662|11720607|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7437513|NCT01624662|11720608|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
7437514|NCT01624662|11720605|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7437515|NCT01624662|11720606|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7437516|NCT01624662|11720607|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
7437517|NCT01624662|11720608|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
7437518|NCT01624662|11720605|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7437519|NCT01624662|11720606|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7437520|NCT01624662|11720607|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
7437521|NCT01624662|11720608|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
7437522|NCT01624662|11720605|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437523|NCT01624662|11720606|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
7437524|NCT01624662|11720607|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437525|NCT01624662|11720608|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
7437526|NCT01624662|11720605|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7437527|NCT01624662|11720606|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7437528|NCT01624662|11720607|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
7437529|NCT01624662|11720608|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
7437530|NCT01624870|11720629|FG000|Overall Study|Death|19
7437531|NCT01624870|11720629|FG000|Overall Study|Withdrawal by Subject|1
7437532|NCT01624870|11720629|FG000|Overall Study|CoreValve not implanted|6
7437533|NCT01624870|11720629|FG000|Overall Study|Lost to follow up|1
7437534|NCT01624974|11720660|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
7560696|NCT02400476|11928164|FG004|Overall Study|Withdrawal by Subject|5
7437535|NCT01624974|11720661|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
7437536|NCT01624974|11720660|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
7437537|NCT01624974|11720661|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
7532849|NCT02676778|11878597|FG001|Overall Study|Other|3
7532850|NCT02676778|11878598|FG002|Overall Study|Other|0
7532851|NCT02676778|11878596|FG000|Overall Study|Adverse Event|2
7532852|NCT02676778|11878597|FG001|Overall Study|Adverse Event|3
7532853|NCT02676778|11878598|FG002|Overall Study|Adverse Event|0
7532854|NCT02676882|11878614|FG000|Overall Study|Adverse Event|1
7532855|NCT02676882|11878615|FG001|Overall Study|Adverse Event|0
7532856|NCT02676882|11878614|FG000|Overall Study|Lost to Follow-up|1
7532857|NCT02676882|11878615|FG001|Overall Study|Lost to Follow-up|0
7437538|NCT01624974|11720660|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
7437539|NCT01624974|11720661|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
7437540|NCT01624974|11720660|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
7437541|NCT01624974|11720661|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
7532858|NCT02676882|11878614|FG000|Overall Study|Withdrawal by Subject|1
7532859|NCT02676882|11878615|FG001|Overall Study|Withdrawal by Subject|2
7437542|NCT01624974|11720660|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
7437543|NCT01624974|11720661|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
7437544|NCT01624974|11720660|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7437545|NCT01624974|11720661|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
7437546|NCT01624974|11720660|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
7437547|NCT01624974|11720661|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
7437548|NCT01624974|11720660|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
7437549|NCT01624974|11720661|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
7437550|NCT01624974|11720660|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
7437551|NCT01624974|11720661|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
7560697|NCT02400476|11928165|FG005|Overall Study|Withdrawal by Subject|5
7560698|NCT02400476|11928160|FG000|Overall Study|Lost to Follow-up|0
7560699|NCT02400476|11928161|FG001|Overall Study|Lost to Follow-up|0
7560700|NCT02400476|11928162|FG002|Overall Study|Lost to Follow-up|0
7560701|NCT02400476|11928163|FG003|Overall Study|Lost to Follow-up|1
7560702|NCT02400476|11928164|FG004|Overall Study|Lost to Follow-up|3
7560703|NCT02400476|11928165|FG005|Overall Study|Lost to Follow-up|1
7560704|NCT02400476|11928160|FG000|Overall Study|Physician Decision|0
7560705|NCT02400476|11928161|FG001|Overall Study|Physician Decision|0
7560706|NCT02400476|11928162|FG002|Overall Study|Physician Decision|1
7560707|NCT02400476|11928163|FG003|Overall Study|Physician Decision|1
7560708|NCT02400476|11928164|FG004|Overall Study|Physician Decision|0
7560709|NCT02400476|11928165|FG005|Overall Study|Physician Decision|1
7560710|NCT02400476|11928160|FG000|Overall Study|Other, Disease Progression|0
7560711|NCT02400476|11928161|FG001|Overall Study|Other, Disease Progression|1
7560712|NCT02400476|11928162|FG002|Overall Study|Other, Disease Progression|2
7560713|NCT02400476|11928163|FG003|Overall Study|Other, Disease Progression|1
7560714|NCT02400476|11928164|FG004|Overall Study|Other, Disease Progression|2
7560715|NCT02400476|11928165|FG005|Overall Study|Other, Disease Progression|1
7560716|NCT02400476|11928160|FG000|Overall Study|Other, Decreased Quality of Life|0
7560717|NCT02400476|11928161|FG001|Overall Study|Other, Decreased Quality of Life|0
7560718|NCT02400476|11928162|FG002|Overall Study|Other, Decreased Quality of Life|2
7560719|NCT02400476|11928163|FG003|Overall Study|Other, Decreased Quality of Life|0
7560720|NCT02400476|11928164|FG004|Overall Study|Other, Decreased Quality of Life|0
7328788|NCT00797966|11561721|FG003|Phase A+|Lost to Follow-up|0
7328789|NCT00797966|11561722|FG004|Phase A+|Lost to Follow-up|0
7437552|NCT01624974|11720660|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
7437553|NCT01624974|11720661|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
7437554|NCT01624974|11720660|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
7437555|NCT01624974|11720661|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
7437556|NCT01624974|11720660|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
7437557|NCT01624974|11720661|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
7437558|NCT01625000|11720673|FG000|Overall Study|Physician Decision|15
7437559|NCT01625000|11720674|FG001|Overall Study|Physician Decision|7
7437560|NCT01625000|11720675|FG002|Overall Study|Physician Decision|7
7437561|NCT01625000|11720676|FG003|Overall Study|Physician Decision|2
7437562|NCT01625000|11720677|FG004|Overall Study|Physician Decision|15
7437563|NCT01625000|11720673|FG000|Overall Study|Protocol Violation|3
7437564|NCT01625000|11720674|FG001|Overall Study|Protocol Violation|10
7437565|NCT01625000|11720675|FG002|Overall Study|Protocol Violation|4
7437566|NCT01625000|11720676|FG003|Overall Study|Protocol Violation|1
7437567|NCT01625000|11720677|FG004|Overall Study|Protocol Violation|2
7437568|NCT01625000|11720673|FG000|Overall Study|Withdrawal by Subject|19
7437569|NCT01625000|11720674|FG001|Overall Study|Withdrawal by Subject|16
7437570|NCT01625000|11720675|FG002|Overall Study|Withdrawal by Subject|11
7437571|NCT01625000|11720676|FG003|Overall Study|Withdrawal by Subject|9
7437572|NCT01625000|11720677|FG004|Overall Study|Withdrawal by Subject|17
7437573|NCT01625000|11720673|FG000|Overall Study|Adverse Event (including Death)|15
7437574|NCT01625000|11720674|FG001|Overall Study|Adverse Event (including Death)|19
7437575|NCT01625000|11720675|FG002|Overall Study|Adverse Event (including Death)|11
7437576|NCT01625000|11720676|FG003|Overall Study|Adverse Event (including Death)|7
7437577|NCT01625000|11720677|FG004|Overall Study|Adverse Event (including Death)|21
7437578|NCT01625091|11720696|FG000|Intervention|Death|1
7437579|NCT01625091|11720697|FG001|Intervention|Death|1
7437580|NCT01625091|11720696|FG000|Intervention|Withdrawal by Subject|4
7437581|NCT01625091|11720697|FG001|Intervention|Withdrawal by Subject|1
7437582|NCT01625091|11720696|FG000|Intervention|Adverse Event|0
7437583|NCT01625091|11720697|FG001|Intervention|Adverse Event|2
7437584|NCT01625091|11720696|FG000|Intervention|Lost to Follow-up|4
7437585|NCT01625091|11720697|FG001|Intervention|Lost to Follow-up|4
7437586|NCT01625091|11720696|FG000|Intervention|Study termination|2
7328790|NCT00797966|11561723|FG005|Phase A+|Lost to Follow-up|9
7328791|NCT00797966|11561718|FG000|Phase A+|Met withdrawal criteria|0
7328792|NCT00797966|11561719|FG001|Phase A+|Met withdrawal criteria|0
7328793|NCT00797966|11561720|FG002|Phase A+|Met withdrawal criteria|0
7437587|NCT01625091|11720697|FG001|Intervention|Study termination|3
7437588|NCT01625091|11720696|FG000|Post-intervention|Death|0
7560721|NCT02400476|11928165|FG005|Overall Study|Other, Decreased Quality of Life|0
7560722|NCT02400476|11928160|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0
7560723|NCT02400476|11928161|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0
7560724|NCT02400476|11928162|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2
7437589|NCT01625091|11720697|FG001|Post-intervention|Death|1
7437590|NCT01625091|11720696|FG000|Post-intervention|Lost to Follow-up|2
7437591|NCT01625091|11720697|FG001|Post-intervention|Lost to Follow-up|0
7437592|NCT01625091|11720696|FG000|Post-intervention|Study termination|2
7437593|NCT01625091|11720697|FG001|Post-intervention|Study termination|1
7437594|NCT01625182|11720718|FG000|Overall Study|Administrative problems|1
7437595|NCT01625182|11720719|FG001|Overall Study|Administrative problems|0
7437596|NCT01625182|11720718|FG000|Overall Study|Protocol deviation|0
7437597|NCT01625182|11720719|FG001|Overall Study|Protocol deviation|2
7437598|NCT01625182|11720718|FG000|Overall Study|Adverse Event|2
7437599|NCT01625182|11720719|FG001|Overall Study|Adverse Event|0
7437600|NCT01625182|11720718|FG000|Overall Study|Withdrawal by Subject|5
7437601|NCT01625182|11720719|FG001|Overall Study|Withdrawal by Subject|1
7437602|NCT01625182|11720718|FG000|Overall Study|Lack of Efficacy|12
7437603|NCT01625182|11720719|FG001|Overall Study|Lack of Efficacy|8
7467268|NCT01899053|11767572|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
7467269|NCT01899053|11767573|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
7467270|NCT01899053|11767574|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7467271|NCT01899053|11767575|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
7467272|NCT01899053|11767576|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
7467273|NCT01899053|11767577|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
7467274|NCT01899053|11767578|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
7467275|NCT01899053|11767579|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
7467276|NCT01899053|11767580|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
7467277|NCT01899053|11767581|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
7467278|NCT01899053|11767582|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
7467279|NCT01899053|11767583|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
7467280|NCT01899053|11767584|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
7467281|NCT01899053|11767585|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
7467282|NCT01899053|11767572|FG000|Overall Study|Symptomatic Deterioration|0
7467283|NCT01899053|11767573|FG001|Overall Study|Symptomatic Deterioration|0
7467284|NCT01899053|11767574|FG002|Overall Study|Symptomatic Deterioration|0
7467285|NCT01899053|11767575|FG003|Overall Study|Symptomatic Deterioration|0
7467286|NCT01899053|11767576|FG004|Overall Study|Symptomatic Deterioration|0
7467287|NCT01899053|11767577|FG005|Overall Study|Symptomatic Deterioration|1
7467288|NCT01899053|11767578|FG006|Overall Study|Symptomatic Deterioration|0
7467289|NCT01899053|11767579|FG007|Overall Study|Symptomatic Deterioration|1
7467290|NCT01899053|11767580|FG008|Overall Study|Symptomatic Deterioration|0
7467291|NCT01899053|11767581|FG009|Overall Study|Symptomatic Deterioration|0
7467292|NCT01899053|11767582|FG010|Overall Study|Symptomatic Deterioration|0
7467293|NCT01899053|11767583|FG011|Overall Study|Symptomatic Deterioration|1
7467294|NCT01899053|11767584|FG012|Overall Study|Symptomatic Deterioration|2
7467295|NCT01899053|11767585|FG013|Overall Study|Symptomatic Deterioration|0
7467296|NCT01899742|11767635|FG000|Overall Study|Adverse Event|5
7467297|NCT01899742|11767636|FG001|Overall Study|Adverse Event|4
7467298|NCT01899742|11767635|FG000|Overall Study|Lack of Efficacy|1
7467299|NCT01899742|11767636|FG001|Overall Study|Lack of Efficacy|5
7467300|NCT01899742|11767635|FG000|Overall Study|Protocol Violation|2
7467301|NCT01899742|11767636|FG001|Overall Study|Protocol Violation|2
7467302|NCT01899742|11767635|FG000|Overall Study|Withdrawal by Subject|9
7467303|NCT01899742|11767636|FG001|Overall Study|Withdrawal by Subject|5
7467304|NCT01899768|11767642|FG000|Part A|Adverse Event|2
7467305|NCT01899768|11767642|FG000|Part A|Withdrawal by Subject|1
7467306|NCT01899768|11767642|FG000|Part B|Adverse Event|1
7467307|NCT01899768|11767642|FG000|Part B|Withdrawal by Subject|1
7467308|NCT01900054|11767654|FG000|Overall Study|Physician Decision|1
7467309|NCT01900054|11767654|FG000|Overall Study|Withdrawal by Subject|1
7467310|NCT01900314|11767682|FG000|Overall Study|Lost to Follow-up|1
7467311|NCT01900314|11767683|FG001|Overall Study|Lost to Follow-up|0
7467312|NCT01900314|11767682|FG000|Overall Study|Protocol Violation|0
7467313|NCT01900314|11767683|FG001|Overall Study|Protocol Violation|1
7467314|NCT01900314|11767682|FG000|Overall Study|Withdrawal by Subject|3
7467315|NCT01900314|11767683|FG001|Overall Study|Withdrawal by Subject|3
7467316|NCT01900431|11767705|FG000|Principal Treatment Period (Part A)|Adverse Event|1
7467317|NCT01900431|11767706|FG001|Principal Treatment Period (Part A)|Adverse Event|3
7467318|NCT01900431|11767707|FG002|Principal Treatment Period (Part A)|Adverse Event|0
7467319|NCT01900431|11767705|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
7467320|NCT01900431|11767706|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
7467321|NCT01900431|11767707|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
7467322|NCT01900431|11767705|FG000|Principal Treatment Period (Part A)|Other than specified above|0
7560725|NCT02400476|11928163|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1
7560726|NCT02400476|11928164|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0
7560727|NCT02400476|11928165|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0
7560738|NCT01507545|11928189|FG000|Overall Study|Withdrawal by Subject|6
7560739|NCT01507545|11928190|FG001|Overall Study|Withdrawal by Subject|2
7560740|NCT01507545|11928189|FG000|Overall Study|Lost to Follow-up|1
7560741|NCT01507545|11928190|FG001|Overall Study|Lost to Follow-up|0
7560742|NCT01507545|11928189|FG000|Overall Study|Discontinuation of the study by sponsor|11
7560743|NCT01507545|11928190|FG001|Overall Study|Discontinuation of the study by sponsor|9
7560744|NCT01507545|11928189|FG000|Overall Study|Progressive disease|60
7560745|NCT01507545|11928190|FG001|Overall Study|Progressive disease|27
7560746|NCT01507545|11928189|FG000|Overall Study|Other|6
7560747|NCT01507545|11928190|FG001|Overall Study|Other|4
7560748|NCT00920816|11928204|FG000|Overall Study|Death|116
7560749|NCT00920816|11928205|FG001|Overall Study|Death|63
7560750|NCT00920816|11928206|FG002|Overall Study|Death|8
7560751|NCT00920816|11928207|FG003|Overall Study|Death|3
7560752|NCT00920816|11928204|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11
7560753|NCT00920816|11928205|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5
7560754|NCT00920816|11928206|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1
7560755|NCT00920816|11928207|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0
7560756|NCT00920816|11928204|FG000|Overall Study|Global deterioration of health status|2
7560757|NCT00920816|11928205|FG001|Overall Study|Global deterioration of health status|0
7560758|NCT00920816|11928206|FG002|Overall Study|Global deterioration of health status|0
7560759|NCT00920816|11928207|FG003|Overall Study|Global deterioration of health status|0
7560760|NCT00920816|11928204|FG000|Overall Study|Objective progression or relapse|6
7560761|NCT00920816|11928205|FG001|Overall Study|Objective progression or relapse|2
7560762|NCT00920816|11928206|FG002|Overall Study|Objective progression or relapse|0
7560763|NCT00920816|11928207|FG003|Overall Study|Objective progression or relapse|0
7560764|NCT00920816|11928204|FG000|Overall Study|Other|26
7560765|NCT00920816|11928205|FG001|Overall Study|Other|15
7560766|NCT00920816|11928206|FG002|Overall Study|Other|1
7560767|NCT00920816|11928207|FG003|Overall Study|Other|2
7560768|NCT00920816|11928204|FG000|Overall Study|Lost to Follow-up|11
7560769|NCT00920816|11928205|FG001|Overall Study|Lost to Follow-up|2
7560770|NCT00920816|11928206|FG002|Overall Study|Lost to Follow-up|0
7560771|NCT00920816|11928207|FG003|Overall Study|Lost to Follow-up|0
7560772|NCT00920816|11928204|FG000|Overall Study|Adverse Event|1
7560773|NCT00920816|11928205|FG001|Overall Study|Adverse Event|1
7560774|NCT00920816|11928206|FG002|Overall Study|Adverse Event|1
7560775|NCT00920816|11928207|FG003|Overall Study|Adverse Event|0
7560776|NCT00920816|11928204|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16
7560777|NCT00920816|11928205|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8
7560778|NCT00920816|11928206|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124
7560779|NCT00920816|11928207|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64
7560780|NCT00920816|11928204|FG000|Overall Study|Randomized but not treated|3
7560781|NCT00920816|11928205|FG001|Overall Study|Randomized but not treated|0
7560782|NCT00920816|11928206|FG002|Overall Study|Randomized but not treated|0
7560783|NCT00920816|11928207|FG003|Overall Study|Randomized but not treated|0
7560784|NCT03180645|11928220|FG000|Overall Study|Adverse Event|0
7560785|NCT03180645|11928221|FG001|Overall Study|Adverse Event|1
7560786|NCT03180645|11928222|FG002|Overall Study|Adverse Event|2
7560787|NCT03180801|11928237|FG000|Overall Study|Physician Decision|3
7560788|NCT03180801|11928238|FG001|Overall Study|Physician Decision|3
7560789|NCT03180801|11928239|FG002|Overall Study|Physician Decision|1
7560790|NCT03180801|11928237|FG000|Overall Study|Non-compliance|1
7560791|NCT03180801|11928238|FG001|Overall Study|Non-compliance|4
7560792|NCT03180801|11928239|FG002|Overall Study|Non-compliance|0
7560793|NCT03180801|11928237|FG000|Overall Study|Inoculation Target Reached|1
7560794|NCT03180801|11928238|FG001|Overall Study|Inoculation Target Reached|1
7560795|NCT03180801|11928239|FG002|Overall Study|Inoculation Target Reached|3
7560796|NCT03180801|11928237|FG000|Overall Study|Adverse Event|1
7560797|NCT03180801|11928238|FG001|Overall Study|Adverse Event|0
7560798|NCT03180801|11928239|FG002|Overall Study|Adverse Event|2
7560799|NCT03180801|11928237|FG000|Overall Study|Withdrawal by Subject|2
7560800|NCT03180801|11928238|FG001|Overall Study|Withdrawal by Subject|2
7560801|NCT03180801|11928239|FG002|Overall Study|Withdrawal by Subject|1
7560802|NCT03180801|11928237|FG000|Overall Study|Lost to Follow-up|0
7560803|NCT03180801|11928238|FG001|Overall Study|Lost to Follow-up|2
7560804|NCT03180801|11928239|FG002|Overall Study|Lost to Follow-up|3
7560805|NCT03181451|11928271|FG000|Overall Study|Adverse Event|0
7560806|NCT03181451|11928272|FG001|Overall Study|Adverse Event|1
7560807|NCT03181451|11928273|FG002|Overall Study|Adverse Event|0
7560808|NCT03181451|11928271|FG000|Overall Study|Withdrawal by Subject|0
7560809|NCT03181451|11928272|FG001|Overall Study|Withdrawal by Subject|1
7560810|NCT03181451|11928273|FG002|Overall Study|Withdrawal by Subject|0
7560811|NCT03181503|11928285|FG000|Overall Study|Adverse Event|2
7560812|NCT03181503|11928286|FG001|Overall Study|Adverse Event|2
7560813|NCT03181503|11928285|FG000|Overall Study|Protocol Violation|1
7560814|NCT03181503|11928286|FG001|Overall Study|Protocol Violation|0
7560815|NCT03181503|11928285|FG000|Overall Study|Withdrawal by Subject|3
7560816|NCT03181503|11928286|FG001|Overall Study|Withdrawal by Subject|0
7560817|NCT03181503|11928285|FG000|Overall Study|Lost to Follow-up|1
7560818|NCT03181503|11928286|FG001|Overall Study|Lost to Follow-up|1
7560819|NCT03181594|11928295|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
7560820|NCT03181594|11928295|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
7560821|NCT03181594|11928295|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
7560822|NCT03181594|11928295|FG000|Initial Study Protocol (12-month FU)|Death|1
7560823|NCT03181594|11928295|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
7560824|NCT03181594|11928295|FG000|Long-term Extension (15-24 Month FU)|Death|2
7560825|NCT03181932|11928310|FG000|Period 1 (Double-blind Period)|Adverse Event|5
7560826|NCT03181932|11928311|FG001|Period 1 (Double-blind Period)|Adverse Event|1
7560827|NCT03181932|11928310|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
7560828|NCT03181932|11928311|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
7560829|NCT03181932|11928310|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
7560830|NCT03181932|11928311|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
7560831|NCT03181932|11928310|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
7560832|NCT03181932|11928311|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
7560833|NCT03181932|11928310|FG000|Period 2 (Open-label Period)|Adverse Event|1
7560834|NCT03181932|11928311|FG001|Period 2 (Open-label Period)|Adverse Event|6
7560835|NCT03181932|11928310|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
7560836|NCT03181932|11928311|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
7560837|NCT03181932|11928310|FG000|Period 2 (Open-label Period)|Protocol Violation|3
7560838|NCT03181932|11928311|FG001|Period 2 (Open-label Period)|Protocol Violation|1
7560839|NCT03181932|11928310|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
7560840|NCT03181932|11928311|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
7560841|NCT03181932|11928310|FG000|Period 2 (Open-label Period)|Reason missing|2
7560842|NCT03181932|11928311|FG001|Period 2 (Open-label Period)|Reason missing|0
7560843|NCT03181958|11928321|FG000|Overall Study|Lost to Follow-up|17
7560844|NCT03181958|11928322|FG001|Overall Study|Lost to Follow-up|21
7560845|NCT03181958|11928323|FG002|Overall Study|Lost to Follow-up|15
7560846|NCT03182738|11928354|FG000|Overall Study|Lost to Follow-up|9
7560847|NCT03182738|11928355|FG001|Overall Study|Lost to Follow-up|3
7560848|NCT03182738|11928354|FG000|Overall Study|Pregnancy|0
7560849|NCT03182738|11928355|FG001|Overall Study|Pregnancy|1
7560850|NCT03182738|11928354|FG000|Overall Study|Withdrawal by Subject|0
7560851|NCT03182738|11928355|FG001|Overall Study|Withdrawal by Subject|1
7560852|NCT03183063|11928384|FG000|Overall Study|Withdrawal by Subject|2
7560853|NCT03183063|11928385|FG001|Overall Study|Withdrawal by Subject|0
7560854|NCT03183063|11928386|FG002|Overall Study|Withdrawal by Subject|0
7560855|NCT03183063|11928384|FG000|Overall Study|Physician Decision|3
7560856|NCT03183063|11928385|FG001|Overall Study|Physician Decision|4
7560857|NCT03183063|11928386|FG002|Overall Study|Physician Decision|4
7560858|NCT03183518|11928400|FG000|Overall Study|Other (Not specified)|2
7560859|NCT03183518|11928400|FG000|Overall Study|Other (Withdrawal of consent)|1
7560860|NCT03183908|11928416|FG000|Overall Study|Missing Symptom Diary Data|0
7560861|NCT03183908|11928417|FG001|Overall Study|Missing Symptom Diary Data|2
7560862|NCT03184077|11928429|FG000|Overall Study|Lost to Follow-up|21
7560863|NCT03184077|11928430|FG001|Overall Study|Lost to Follow-up|21
7560864|NCT03184441|11928452|FG000|Overall Study|Withdrawal by Subject|1
7560865|NCT03184519|11928459|FG000|Overall Study|Lost to Follow-up|6
7560866|NCT03184519|11928459|FG000|Overall Study|Physician Decision|21
7560867|NCT03184558|11928463|FG000|Overall Study|Withdrawal by Subject|2
7560868|NCT03184558|11928463|FG000|Overall Study|Death|16
7560869|NCT03184558|11928463|FG000|Overall Study|Lost to Follow-up|2
7560870|NCT03184558|11928463|FG000|Overall Study|Other|9
7560871|NCT03184701|11928467|FG000|Overall Study|Death|3
7560872|NCT03184701|11928467|FG000|Overall Study|Physician Decision|3
7560873|NCT03184701|11928467|FG000|Overall Study|Withdrawal by Subject|6
7560874|NCT03184701|11928467|FG000|Overall Study|Lost to Follow-up|5
7560875|NCT03184987|11928474|FG000|Overall Study|Withdrawal by Subject|0
7560876|NCT03184987|11928475|FG001|Overall Study|Withdrawal by Subject|1
7560877|NCT03184987|11928476|FG002|Overall Study|Withdrawal by Subject|2
7560878|NCT03184987|11928474|FG000|Overall Study|Physician Decision|0
7560879|NCT03184987|11928475|FG001|Overall Study|Physician Decision|0
7560880|NCT03184987|11928476|FG002|Overall Study|Physician Decision|1
7560881|NCT03184987|11928474|FG000|Overall Study|Adverse Event|1
7560882|NCT03184987|11928475|FG001|Overall Study|Adverse Event|0
7560883|NCT03184987|11928476|FG002|Overall Study|Adverse Event|1
7574926|NCT03700892|11958190|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
7574927|NCT03701074|11958210|FG000|Overall Study|Physician Decision|1
7574928|NCT03701074|11958211|FG001|Overall Study|Physician Decision|0
7574929|NCT03702010|11958219|FG000|Follow-up (30days)|Lack of Efficacy|2
7574930|NCT03702010|11958220|FG001|Follow-up (30days)|Lack of Efficacy|2
7574931|NCT03702166|11958232|FG000|Overall Study|Lost to Follow-up|1
7574932|NCT03702166|11958232|FG000|Overall Study|Withdrawal by Subject|1
7574933|NCT03703336|11958243|FG000|Overall Study|Parent withdrew consent|29
7574934|NCT03703336|11958244|FG001|Overall Study|Parent withdrew consent|8
7574935|NCT03703336|11958243|FG000|Overall Study|Migration|3
7574936|NCT03703336|11958244|FG001|Overall Study|Migration|3
7574937|NCT03703336|11958243|FG000|Overall Study|Protocol Violation|3
7574938|NCT03703336|11958244|FG001|Overall Study|Protocol Violation|1
7574939|NCT03703336|11958243|FG000|Overall Study|Physician Decision|2
7574940|NCT03703336|11958244|FG001|Overall Study|Physician Decision|0
7574941|NCT03703336|11958243|FG000|Overall Study|Adverse Event|0
7574942|NCT03703336|11958244|FG001|Overall Study|Adverse Event|2
7574943|NCT03703336|11958243|FG000|Overall Study|Lost to Follow-up|1
7574944|NCT03703336|11958244|FG001|Overall Study|Lost to Follow-up|0
7574945|NCT03703817|11958252|FG000|Overall Study|Not meeting eligibility criteria|7
7574946|NCT03703817|11958253|FG001|Overall Study|Not meeting eligibility criteria|4
7574947|NCT03704194|11958261|FG000|Overall Study|Withdrawal by Subject|0
7574948|NCT03704194|11958262|FG001|Overall Study|Withdrawal by Subject|1
7574949|NCT03705494|11958301|FG000|Overall Study|Lost to Follow-up|2
7574950|NCT03705494|11958302|FG001|Overall Study|Lost to Follow-up|1
7574951|NCT03705494|11958301|FG000|Overall Study|Withdrawal by Subject|5
7574952|NCT03705494|11958302|FG001|Overall Study|Withdrawal by Subject|2
7574957|NCT03706040|11958320|FG000|Period A (Week 0 to Week 16)|Adverse Event|3
7574958|NCT03706040|11958321|FG001|Period A (Week 0 to Week 16)|Adverse Event|2
7574959|NCT03706040|11958322|FG002|Period A (Week 0 to Week 16)|Adverse Event|1
7574960|NCT03706040|11958323|FG003|Period A (Week 0 to Week 16)|Adverse Event|0
7574961|NCT03706040|11958324|FG004|Period A (Week 0 to Week 16)|Adverse Event|0
7574962|NCT03706040|11958325|FG005|Period A (Week 0 to Week 16)|Adverse Event|0
7574963|NCT03706040|11958326|FG006|Period A (Week 0 to Week 16)|Adverse Event|0
7574964|NCT03706040|11958320|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3
7574965|NCT03706040|11958321|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5
7574966|NCT03706040|11958322|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4
7574967|NCT03706040|11958323|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0
7574968|NCT03706040|11958324|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0
7560884|NCT03185481|11928516|FG000|Overall Study|Adverse Event|1
7560885|NCT03185481|11928516|FG000|Overall Study|Study Terminated by Sponsor|4
7560886|NCT03186378|11928565|FG000|Overall Study|Lost to Follow-up|1
7560887|NCT03186378|11928566|FG001|Overall Study|Lost to Follow-up|0
7560888|NCT03186781|11928599|FG000|Overall Study|Lost to Follow-up|0
7560889|NCT03186781|11928600|FG001|Overall Study|Lost to Follow-up|0
7560890|NCT03186781|11928601|FG002|Overall Study|Lost to Follow-up|1
7560891|NCT03186781|11928602|FG003|Overall Study|Lost to Follow-up|0
7560892|NCT03186781|11928603|FG004|Overall Study|Lost to Follow-up|1
7560893|NCT03186781|11928604|FG005|Overall Study|Lost to Follow-up|0
7560894|NCT03186781|11928599|FG000|Overall Study|Moved from Area|0
7560895|NCT03186781|11928600|FG001|Overall Study|Moved from Area|0
7560896|NCT03186781|11928601|FG002|Overall Study|Moved from Area|0
7560897|NCT03186781|11928602|FG003|Overall Study|Moved from Area|0
7560898|NCT03186781|11928603|FG004|Overall Study|Moved from Area|1
7560899|NCT03186781|11928604|FG005|Overall Study|Moved from Area|0
7560900|NCT03186781|11928599|FG000|Overall Study|Withdrawal by Subject|0
7560901|NCT03186781|11928600|FG001|Overall Study|Withdrawal by Subject|0
7560902|NCT03186781|11928601|FG002|Overall Study|Withdrawal by Subject|0
7560903|NCT03186781|11928602|FG003|Overall Study|Withdrawal by Subject|0
7560904|NCT03186781|11928603|FG004|Overall Study|Withdrawal by Subject|1
7560905|NCT03186781|11928604|FG005|Overall Study|Withdrawal by Subject|0
7560906|NCT03187132|11928642|FG000|Inpatient Trauma Only|Lost to Follow-up|3
7560907|NCT03187132|11928643|FG001|Inpatient Trauma Only|Lost to Follow-up|12
7560908|NCT03187132|11928642|FG000|Inpatient Trauma Only|socioeconomic burden|1
7560909|NCT03187132|11928643|FG001|Inpatient Trauma Only|socioeconomic burden|0
7560910|NCT03187132|11928642|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
7560911|NCT03187132|11928643|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
7560912|NCT03187132|11928642|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
7560913|NCT03187132|11928643|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
7560914|NCT03187132|11928642|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
7560915|NCT03187132|11928643|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
7560916|NCT03187132|11928642|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
7560917|NCT03187132|11928643|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
7560918|NCT03187132|11928642|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
7560919|NCT03187132|11928643|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
7560920|NCT03187132|11928642|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
7560921|NCT03187132|11928643|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
7560922|NCT03187132|11928642|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
7560923|NCT03187132|11928643|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
7560924|NCT03187132|11928642|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
7560925|NCT03187132|11928643|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
7560926|NCT03187132|11928642|FG000|Pain Clinic Only, Fully Remote|EMR|0
7560927|NCT03187132|11928643|FG001|Pain Clinic Only, Fully Remote|EMR|1
7560928|NCT03187197|11928652|FG000|Overall Study|Stopped Pradaxa®/VKA|11
7560929|NCT03187197|11928653|FG001|Overall Study|Stopped Pradaxa®/VKA|65
7560930|NCT03187197|11928654|FG002|Overall Study|Stopped Pradaxa®/VKA|4
7560931|NCT03187197|11928652|FG000|Overall Study|Withdrawal by Subject|8
7560932|NCT03187197|11928653|FG001|Overall Study|Withdrawal by Subject|63
7560933|NCT03187197|11928654|FG002|Overall Study|Withdrawal by Subject|4
7560934|NCT03187197|11928652|FG000|Overall Study|Lost to Follow-up|1
7560935|NCT03187197|11928653|FG001|Overall Study|Lost to Follow-up|60
7560936|NCT03187197|11928654|FG002|Overall Study|Lost to Follow-up|7
7560937|NCT03187197|11928652|FG000|Overall Study|Adverse Event|6
7560938|NCT03187197|11928653|FG001|Overall Study|Adverse Event|29
7560939|NCT03187197|11928654|FG002|Overall Study|Adverse Event|0
7560940|NCT03187197|11928652|FG000|Overall Study|Death|0
7560941|NCT03187197|11928653|FG001|Overall Study|Death|11
7560942|NCT03187197|11928654|FG002|Overall Study|Death|0
7560943|NCT03187197|11928652|FG000|Overall Study|Administrative problem|1
7560944|NCT03187197|11928653|FG001|Overall Study|Administrative problem|1
7560945|NCT03187197|11928654|FG002|Overall Study|Administrative problem|0
7560946|NCT03187197|11928652|FG000|Overall Study|Reason not listed|2
7560947|NCT03187197|11928653|FG001|Overall Study|Reason not listed|54
7560948|NCT03187197|11928654|FG002|Overall Study|Reason not listed|1
7560949|NCT03187197|11928652|FG000|Overall Study|Missing|1
7560950|NCT03187197|11928653|FG001|Overall Study|Missing|32
7560951|NCT03187197|11928654|FG002|Overall Study|Missing|3
7560952|NCT03187197|11928652|FG000|Overall Study|Status missing|2
7560953|NCT03187197|11928653|FG001|Overall Study|Status missing|33
7560954|NCT03187197|11928654|FG002|Overall Study|Status missing|3
7560955|NCT03187197|11928652|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
7560956|NCT03187197|11928653|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
7560957|NCT03187197|11928654|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
7560958|NCT03187301|11928662|FG000|Titration Period|Adverse Event|0
7560959|NCT03187301|11928663|FG001|Titration Period|Adverse Event|0
7560960|NCT03187301|11928664|FG002|Titration Period|Adverse Event|0
7560961|NCT03187301|11928665|FG003|Titration Period|Adverse Event|0
7560962|NCT03187301|11928666|FG004|Titration Period|Adverse Event|0
7560963|NCT03187301|11928667|FG005|Titration Period|Adverse Event|0
7560964|NCT03187301|11928668|FG006|Titration Period|Adverse Event|5
7560965|NCT03187301|11928662|FG000|Titration Period|Withdrawal by Subject|0
7560966|NCT03187301|11928663|FG001|Titration Period|Withdrawal by Subject|0
7437604|NCT01625338|11720733|FG000|Overall Study|Enrolled but not Treated|0
7437605|NCT01625338|11720734|FG001|Overall Study|Enrolled but not Treated|0
7437606|NCT01625338|11720735|FG002|Overall Study|Enrolled but not Treated|1
7437607|NCT01625338|11720733|FG000|Overall Study|Efficacy Failure|27
7437608|NCT01625338|11720734|FG001|Overall Study|Efficacy Failure|39
7437609|NCT01625338|11720735|FG002|Overall Study|Efficacy Failure|31
7437610|NCT01625338|11720733|FG000|Overall Study|Lost to Follow-up|3
7437611|NCT01625338|11720734|FG001|Overall Study|Lost to Follow-up|3
7437612|NCT01625338|11720735|FG002|Overall Study|Lost to Follow-up|2
7437613|NCT01625338|11720733|FG000|Overall Study|Investigator Decision|0
7437614|NCT01625338|11720734|FG001|Overall Study|Investigator Decision|2
7437615|NCT01625338|11720735|FG002|Overall Study|Investigator Decision|1
7437616|NCT01625338|11720733|FG000|Overall Study|Subject Withdrew Consent|1
7437617|NCT01625338|11720734|FG001|Overall Study|Subject Withdrew Consent|0
7437618|NCT01625338|11720735|FG002|Overall Study|Subject Withdrew Consent|2
7437619|NCT01625338|11720733|FG000|Overall Study|Adverse Event|1
7437620|NCT01625338|11720734|FG001|Overall Study|Adverse Event|0
7437621|NCT01625338|11720735|FG002|Overall Study|Adverse Event|1
7437622|NCT01625338|11720733|FG000|Overall Study|Study Discontinued by Sponsor|0
7437623|NCT01625338|11720734|FG001|Overall Study|Study Discontinued by Sponsor|0
7437624|NCT01625338|11720735|FG002|Overall Study|Study Discontinued by Sponsor|1
7437625|NCT01625377|11720745|FG000|Overall Study|Death|1
7437626|NCT01625377|11720746|FG001|Overall Study|Death|1
7437627|NCT01625377|11720745|FG000|Overall Study|Administrative Problem|1
7437628|NCT01625377|11720746|FG001|Overall Study|Administrative Problem|1
7437629|NCT01625377|11720745|FG000|Overall Study|Protocol Violation|0
7437630|NCT01625377|11720746|FG001|Overall Study|Protocol Violation|3
7437631|NCT01625377|11720745|FG000|Overall Study|Adverse Event|3
7437632|NCT01625377|11720746|FG001|Overall Study|Adverse Event|16
7560967|NCT03187301|11928664|FG002|Titration Period|Withdrawal by Subject|0
7560968|NCT03187301|11928665|FG003|Titration Period|Withdrawal by Subject|0
7560969|NCT03187301|11928666|FG004|Titration Period|Withdrawal by Subject|0
7560970|NCT03187301|11928667|FG005|Titration Period|Withdrawal by Subject|0
7560971|NCT03187301|11928668|FG006|Titration Period|Withdrawal by Subject|1
7560972|NCT03187301|11928662|FG000|Titration Period|Exclusion Criteria Met|0
7560973|NCT03187301|11928663|FG001|Titration Period|Exclusion Criteria Met|0
7560974|NCT03187301|11928664|FG002|Titration Period|Exclusion Criteria Met|0
7560975|NCT03187301|11928665|FG003|Titration Period|Exclusion Criteria Met|0
7560976|NCT03187301|11928666|FG004|Titration Period|Exclusion Criteria Met|0
7560977|NCT03187301|11928667|FG005|Titration Period|Exclusion Criteria Met|0
7560978|NCT03187301|11928668|FG006|Titration Period|Exclusion Criteria Met|1
7560979|NCT03187301|11928662|FG000|Pre-Intervention|Withdrawal by Subject|1
7560980|NCT03187301|11928663|FG001|Pre-Intervention|Withdrawal by Subject|0
7560981|NCT03187301|11928664|FG002|Pre-Intervention|Withdrawal by Subject|0
7560982|NCT03187301|11928665|FG003|Pre-Intervention|Withdrawal by Subject|0
7560983|NCT03187301|11928666|FG004|Pre-Intervention|Withdrawal by Subject|0
7560984|NCT03187301|11928667|FG005|Pre-Intervention|Withdrawal by Subject|0
7560985|NCT03187301|11928668|FG006|Pre-Intervention|Withdrawal by Subject|0
7560986|NCT03187756|11928706|FG000|Overall Study|Termination of study|4
7560987|NCT03188055|11928712|FG000|Overall Study|Unavailable for training|0
7560988|NCT03188055|11928713|FG001|Overall Study|Unavailable for training|0
7560989|NCT03188055|11928714|FG002|Overall Study|Unavailable for training|19
7560990|NCT03188055|11928715|FG003|Overall Study|Unavailable for training|0
7560991|NCT03188055|11928716|FG004|Overall Study|Unavailable for training|0
7560992|NCT03188055|11928717|FG005|Overall Study|Unavailable for training|
7560993|NCT03188055|11928712|FG000|Overall Study|Lost to Follow-up|0
7560994|NCT03188055|11928713|FG001|Overall Study|Lost to Follow-up|18
7560995|NCT03188055|11928714|FG002|Overall Study|Lost to Follow-up|0
7560996|NCT03188055|11928715|FG003|Overall Study|Lost to Follow-up|11
7560997|NCT03188055|11928716|FG004|Overall Study|Lost to Follow-up|0
7560998|NCT03188055|11928717|FG005|Overall Study|Lost to Follow-up|
7560999|NCT03188055|11928712|FG000|Overall Study|Withdrawal by Subject|0
7561000|NCT03188055|11928713|FG001|Overall Study|Withdrawal by Subject|1
7561001|NCT03188055|11928714|FG002|Overall Study|Withdrawal by Subject|0
7561002|NCT03188055|11928715|FG003|Overall Study|Withdrawal by Subject|1
7561003|NCT03188055|11928716|FG004|Overall Study|Withdrawal by Subject|0
7561004|NCT03188055|11928717|FG005|Overall Study|Withdrawal by Subject|
7561005|NCT03188120|11928728|FG000|Overall Study|Adverse Event|4
7437633|NCT01625377|11720745|FG000|Overall Study|Graft loss|1
7437634|NCT01625377|11720746|FG001|Overall Study|Graft loss|0
7437635|NCT01625377|11720745|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7437636|NCT01625377|11720746|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7561006|NCT03188120|11928728|FG000|Overall Study|Insufficient Effectiveness|8
7561007|NCT03188120|11928728|FG000|Overall Study|Improved|12
7561008|NCT03188120|11928728|FG000|Overall Study|Lost to Follow-up|7
7561009|NCT03188120|11928728|FG000|Overall Study|Other than specified|3
7437637|NCT01625377|11720745|FG000|Overall Study|Abnormal laboratory values|1
7437638|NCT01625377|11720746|FG001|Overall Study|Abnormal laboratory values|0
7561010|NCT03188120|11928728|FG000|Overall Study|No visit after the first visit|13
7561011|NCT03188185|11928734|FG000|Stage 1|Adverse Event|4
7561012|NCT03188185|11928735|FG001|Stage 1|Adverse Event|12
7561013|NCT03188185|11928736|FG002|Stage 1|Adverse Event|0
7561014|NCT03188185|11928737|FG003|Stage 1|Adverse Event|0
7561015|NCT03188185|11928734|FG000|Stage 1|Lack of Efficacy|0
7561016|NCT03188185|11928735|FG001|Stage 1|Lack of Efficacy|2
7561017|NCT03188185|11928736|FG002|Stage 1|Lack of Efficacy|0
7561018|NCT03188185|11928737|FG003|Stage 1|Lack of Efficacy|0
7561019|NCT03188185|11928734|FG000|Stage 1|Lost to Follow-up|6
7561020|NCT03188185|11928735|FG001|Stage 1|Lost to Follow-up|1
7561021|NCT03188185|11928736|FG002|Stage 1|Lost to Follow-up|0
7561022|NCT03188185|11928737|FG003|Stage 1|Lost to Follow-up|0
7561023|NCT03188185|11928734|FG000|Stage 1|Withdrawal by Subject|9
7561024|NCT03188185|11928735|FG001|Stage 1|Withdrawal by Subject|0
7561025|NCT03188185|11928736|FG002|Stage 1|Withdrawal by Subject|0
7561026|NCT03188185|11928737|FG003|Stage 1|Withdrawal by Subject|0
7561027|NCT03188185|11928734|FG000|Stage 1|Identified as a professional patient|0
7561028|NCT03188185|11928735|FG001|Stage 1|Identified as a professional patient|1
7561029|NCT03188185|11928736|FG002|Stage 1|Identified as a professional patient|0
7561030|NCT03188185|11928737|FG003|Stage 1|Identified as a professional patient|0
7561031|NCT03188185|11928734|FG000|Stage 2|Adverse Event|0
7561032|NCT03188185|11928735|FG001|Stage 2|Adverse Event|0
7561033|NCT03188185|11928736|FG002|Stage 2|Adverse Event|2
7561034|NCT03188185|11928737|FG003|Stage 2|Adverse Event|4
7437639|NCT01625689|11720778|FG000|Overall Study|Migration|2
7561035|NCT03188185|11928734|FG000|Stage 2|Lack of Efficacy|0
7561036|NCT03188185|11928735|FG001|Stage 2|Lack of Efficacy|0
7561037|NCT03188185|11928736|FG002|Stage 2|Lack of Efficacy|3
7561038|NCT03188185|11928737|FG003|Stage 2|Lack of Efficacy|0
7561039|NCT03188185|11928734|FG000|Stage 2|Lost to Follow-up|0
7561040|NCT03188185|11928735|FG001|Stage 2|Lost to Follow-up|0
7561041|NCT03188185|11928736|FG002|Stage 2|Lost to Follow-up|1
7561042|NCT03188185|11928737|FG003|Stage 2|Lost to Follow-up|0
7561043|NCT03188185|11928734|FG000|Stage 2|Physician Decision|0
7561044|NCT03188185|11928735|FG001|Stage 2|Physician Decision|0
7561045|NCT03188185|11928736|FG002|Stage 2|Physician Decision|0
7561046|NCT03188185|11928737|FG003|Stage 2|Physician Decision|1
7561047|NCT03188185|11928734|FG000|Stage 2|Withdrawal by Subject|0
7561048|NCT03188185|11928735|FG001|Stage 2|Withdrawal by Subject|0
7561049|NCT03188185|11928736|FG002|Stage 2|Withdrawal by Subject|3
7561050|NCT03188185|11928737|FG003|Stage 2|Withdrawal by Subject|1
7561051|NCT03188263|11928749|FG000|Overall Study|Withdrawal by Subject|3
7561052|NCT03188263|11928750|FG001|Overall Study|Withdrawal by Subject|0
7561053|NCT03188263|11928749|FG000|Overall Study|Physician Decision|1
7561054|NCT03188263|11928750|FG001|Overall Study|Physician Decision|0
7561055|NCT03188536|11928767|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
7437640|NCT01625689|11720779|FG001|Overall Study|Migration|1
7437641|NCT01625845|11720787|FG000|Overall Study|Adverse Event|1
7437642|NCT01625845|11720788|FG001|Overall Study|Adverse Event|2
7437643|NCT01625845|11720787|FG000|Overall Study|Lost to Follow-up|2
7437644|NCT01625845|11720788|FG001|Overall Study|Lost to Follow-up|1
7437645|NCT01625845|11720787|FG000|Overall Study|Withdrawal by Subject|2
7437646|NCT01625845|11720788|FG001|Overall Study|Withdrawal by Subject|0
7437647|NCT01625897|11720796|FG000|Overall Study|Adverse Event|27
7437648|NCT01625897|11720797|FG001|Overall Study|Adverse Event|10
7437649|NCT01625897|11720796|FG000|Overall Study|Physician Decision|0
7437650|NCT01625897|11720797|FG001|Overall Study|Physician Decision|1
7437651|NCT01625897|11720796|FG000|Overall Study|Withdrawal by Subject|25
7437652|NCT01625897|11720797|FG001|Overall Study|Withdrawal by Subject|3
7437653|NCT01625910|11720805|FG000|Overall Study|Lost to Follow-up|3
7437654|NCT01625910|11720806|FG001|Overall Study|Lost to Follow-up|4
7437655|NCT01625988|11720821|FG000|Overall Study|Lost to Follow-up|5
7437656|NCT01625988|11720822|FG001|Overall Study|Lost to Follow-up|6
7437657|NCT01625988|11720821|FG000|Overall Study|Withdrawal by Subject|8
7437658|NCT01625988|11720822|FG001|Overall Study|Withdrawal by Subject|3
7437659|NCT01625988|11720821|FG000|Overall Study|Adverse Event|0
7437660|NCT01625988|11720822|FG001|Overall Study|Adverse Event|1
7437661|NCT01625988|11720821|FG000|Overall Study|Lack of Efficacy|0
7437662|NCT01625988|11720822|FG001|Overall Study|Lack of Efficacy|1
7437663|NCT01625988|11720821|FG000|Overall Study|Randomized Inappropriately|1
7437664|NCT01625988|11720822|FG001|Overall Study|Randomized Inappropriately|0
7437665|NCT01625988|11720821|FG000|Overall Study|Protocol Violation|0
7437666|NCT01625988|11720822|FG001|Overall Study|Protocol Violation|2
7437667|NCT01626118|11720839|FG000|Overall Study|Lack of Efficacy|1
7437668|NCT01626118|11720840|FG001|Overall Study|Lack of Efficacy|0
7437669|NCT01626118|11720841|FG002|Overall Study|Lack of Efficacy|1
7437670|NCT01626118|11720842|FG003|Overall Study|Lack of Efficacy|3
7437671|NCT01626118|11720839|FG000|Overall Study|Lost to Follow-up|1
7437672|NCT01626118|11720840|FG001|Overall Study|Lost to Follow-up|0
7437673|NCT01626118|11720841|FG002|Overall Study|Lost to Follow-up|0
7561056|NCT03188536|11928767|FG000|Overall Study|Not participated/met inclusion criteria|1
7561057|NCT03188718|11928771|FG000|Overall Study|Participant noncompliance|4
7561058|NCT03188718|11928771|FG000|Overall Study|Withdrawal by Subject|1
7437674|NCT01626118|11720842|FG003|Overall Study|Lost to Follow-up|0
7437675|NCT01626118|11720839|FG000|Overall Study|Adverse Event|0
7437676|NCT01626118|11720840|FG001|Overall Study|Adverse Event|1
7561059|NCT03188718|11928771|FG000|Overall Study|Device failure|3
7561060|NCT03188991|11928779|FG000|Overall Study|Withdrawal by Subject|0
7561061|NCT03188991|11928780|FG001|Overall Study|Withdrawal by Subject|0
7561062|NCT03188991|11928781|FG002|Overall Study|Withdrawal by Subject|0
7561063|NCT03188991|11928782|FG003|Overall Study|Withdrawal by Subject|1
7437677|NCT01626118|11720841|FG002|Overall Study|Adverse Event|1
7437678|NCT01626118|11720842|FG003|Overall Study|Adverse Event|0
7437679|NCT01626118|11720839|FG000|Overall Study|Investigator Decision|0
7437680|NCT01626118|11720840|FG001|Overall Study|Investigator Decision|1
7437681|NCT01626118|11720841|FG002|Overall Study|Investigator Decision|0
7437682|NCT01626118|11720842|FG003|Overall Study|Investigator Decision|0
7437683|NCT01626352|11720852|FG000|Overall Study|Disease Progression|3
7437684|NCT01626352|11720852|FG000|Overall Study|Intercurrent Illness|2
7437685|NCT01626352|11720852|FG000|Overall Study|Death|2
7437686|NCT01626352|11720852|FG000|Overall Study|Withdrawal by Subject|1
7437687|NCT01626352|11720852|FG000|Overall Study|Non-Compliance|1
7437688|NCT01626352|11720852|FG000|Overall Study|Never Treated|1
7437689|NCT01626391|11720861|FG000|Overall Study|Physician Decision|1
7437690|NCT01626391|11720862|FG001|Overall Study|Physician Decision|0
7437691|NCT01626391|11720861|FG000|Overall Study|Withdrawal by Subject|1
7437692|NCT01626391|11720862|FG001|Overall Study|Withdrawal by Subject|0
7437693|NCT01626456|11720870|FG000|Overall Study|Withdrawal by Subject|21
7437694|NCT01626456|11720871|FG001|Overall Study|Withdrawal by Subject|46
7437695|NCT01626456|11720870|FG000|Overall Study|Adverse Event|2
7437696|NCT01626456|11720871|FG001|Overall Study|Adverse Event|27
7437697|NCT01626456|11720870|FG000|Overall Study|Lost to Follow-up|2
7437698|NCT01626456|11720871|FG001|Overall Study|Lost to Follow-up|27
7437699|NCT01626456|11720870|FG000|Overall Study|Lack of Efficacy|6
7437700|NCT01626456|11720871|FG001|Overall Study|Lack of Efficacy|7
7437701|NCT01626456|11720870|FG000|Overall Study|Physician Decision|1
7437702|NCT01626456|11720871|FG001|Overall Study|Physician Decision|4
7437703|NCT01626456|11720870|FG000|Overall Study|Protocol Violation|1
7437704|NCT01626456|11720871|FG001|Overall Study|Protocol Violation|1
7437705|NCT01626456|11720870|FG000|Overall Study|Site Closure|2
7437706|NCT01626456|11720871|FG001|Overall Study|Site Closure|3
7437707|NCT01626456|11720870|FG000|Overall Study|Incarceration|0
7437708|NCT01626456|11720871|FG001|Overall Study|Incarceration|2
7437709|NCT01626495|11720886|FG000|Overall Study|Adverse Event|3
7437710|NCT01626495|11720886|FG000|Overall Study|Disease progression|27
7437711|NCT01626495|11720886|FG000|Overall Study|Withdrawal by Subject|1
7437712|NCT01626495|11720886|FG000|Overall Study|Administrative problem|1
7437713|NCT01626495|11720886|FG000|Overall Study|Death|2
7437714|NCT01626495|11720886|FG000|Overall Study|Physician Decision|1
7437715|NCT01626495|11720886|FG000|Overall Study|New cancer therapy|16
7437716|NCT01626495|11720886|FG000|Overall Study|Manufacturing failure|1
7437717|NCT01626690|11720903|FG000|Overall Study|Protocol Violation|1
7437718|NCT01626690|11720904|FG001|Overall Study|Protocol Violation|0
7437719|NCT01626690|11720903|FG000|Overall Study|Adverse Event|1
7437720|NCT01626690|11720904|FG001|Overall Study|Adverse Event|0
7437721|NCT01626859|11720925|FG000|Overall Study|Adverse Event|1
7437722|NCT01626859|11720926|FG001|Overall Study|Adverse Event|3
7437723|NCT01626859|11720927|FG002|Overall Study|Adverse Event|2
7437724|NCT01626859|11720925|FG000|Overall Study|Physician Decision|0
7437725|NCT01626859|11720926|FG001|Overall Study|Physician Decision|1
7437726|NCT01626859|11720927|FG002|Overall Study|Physician Decision|0
7437727|NCT01626859|11720925|FG000|Overall Study|Withdrawal by Subject|1
7437728|NCT01626859|11720926|FG001|Overall Study|Withdrawal by Subject|4
7437729|NCT01626859|11720927|FG002|Overall Study|Withdrawal by Subject|2
7437730|NCT01626872|11720938|FG000|Overall Study|Physician Decision|13
7437731|NCT01626872|11720939|FG001|Overall Study|Physician Decision|9
7437732|NCT01626872|11720940|FG002|Overall Study|Physician Decision|6
7437733|NCT01626872|11720938|FG000|Overall Study|Withdrawal by Subject|19
7437734|NCT01626872|11720939|FG001|Overall Study|Withdrawal by Subject|27
7437735|NCT01626872|11720940|FG002|Overall Study|Withdrawal by Subject|8
7437736|NCT01626872|11720938|FG000|Overall Study|Adverse Event (including Death)|20
7437737|NCT01626872|11720939|FG001|Overall Study|Adverse Event (including Death)|28
7437738|NCT01626872|11720940|FG002|Overall Study|Adverse Event (including Death)|8
7437739|NCT01626872|11720938|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
7437740|NCT01626872|11720939|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
7437741|NCT01626872|11720940|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
7437742|NCT01626885|11720948|FG000|Overall Study|Adverse Event|8
7437743|NCT01626885|11720948|FG000|Overall Study|Withdrawal by Subject|4
7437744|NCT01626989|11720952|FG000|Screening Period|Screen Failure|15
7437745|NCT01626989|11720953|FG001|Screening Period|Screen Failure|0
7437746|NCT01626989|11720954|FG002|Screening Period|Screen Failure|0
7437747|NCT01626989|11720952|FG000|Screening Period|Withdrawal by Subject|2
7437748|NCT01626989|11720953|FG001|Screening Period|Withdrawal by Subject|0
7437749|NCT01626989|11720954|FG002|Screening Period|Withdrawal by Subject|0
7437750|NCT01627067|11721000|FG000|Overall Study|Screen Failure|1
7437751|NCT01627249|11721009|FG000|Overall Study|Death|3
7437752|NCT01627249|11721010|FG001|Overall Study|Death|5
7437753|NCT01627249|11721011|FG002|Overall Study|Death|3
7437754|NCT01627249|11721009|FG000|Overall Study|Withdrawal by Subject|12
7437755|NCT01627249|11721010|FG001|Overall Study|Withdrawal by Subject|6
7437756|NCT01627249|11721011|FG002|Overall Study|Withdrawal by Subject|9
7437757|NCT01627249|11721009|FG000|Overall Study|Missed Visit|1
7437758|NCT01627249|11721010|FG001|Overall Study|Missed Visit|1
7437759|NCT01627249|11721011|FG002|Overall Study|Missed Visit|0
7437760|NCT01627327|11721040|FG000|Overall Study|Adverse Event|6
7437761|NCT01627327|11721041|FG001|Overall Study|Adverse Event|12
7437762|NCT01627327|11721040|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
7437763|NCT01627327|11721041|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
7437764|NCT01627327|11721040|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
7437765|NCT01627327|11721041|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
7437766|NCT01627327|11721040|FG000|Overall Study|Protocol Violation|4
7437767|NCT01627327|11721041|FG001|Overall Study|Protocol Violation|10
7437768|NCT01627327|11721040|FG000|Overall Study|Lost to Follow-up|1
7437769|NCT01627327|11721041|FG001|Overall Study|Lost to Follow-up|3
7437770|NCT01627327|11721040|FG000|Overall Study|Physician Decision|1
7437771|NCT01627327|11721041|FG001|Overall Study|Physician Decision|0
7437772|NCT01627327|11721040|FG000|Overall Study|Withdrawal by Subject|3
7437773|NCT01627327|11721041|FG001|Overall Study|Withdrawal by Subject|3
7437774|NCT01627340|11721049|FG000|Overall Study|Adverse Event|1
7437775|NCT01627340|11721050|FG001|Overall Study|Adverse Event|0
7437776|NCT01627340|11721049|FG000|Overall Study|Lost to Follow-up|8
7437777|NCT01627340|11721050|FG001|Overall Study|Lost to Follow-up|4
7437778|NCT01627340|11721049|FG000|Overall Study|Pregnancy|1
7437779|NCT01627340|11721050|FG001|Overall Study|Pregnancy|0
7437780|NCT01627340|11721049|FG000|Overall Study|Withdrawal by Subject|2
7437781|NCT01627340|11721050|FG001|Overall Study|Withdrawal by Subject|0
7437782|NCT01627691|11721058|FG000|Overall Study|Death|11
7437783|NCT01627691|11721058|FG000|Overall Study|Lost to Follow-up|3
7437784|NCT01627691|11721058|FG000|Overall Study|Withdrawal by Subject|1
7437785|NCT01627691|11721058|FG000|Overall Study|Missed the visit|3
7437786|NCT01627782|11721066|FG000|Overall Study|Adverse Event|1
7437787|NCT01627782|11721067|FG001|Overall Study|Adverse Event|2
7437788|NCT01627782|11721068|FG002|Overall Study|Adverse Event|0
7437789|NCT01627782|11721069|FG003|Overall Study|Adverse Event|1
7437790|NCT01627782|11721066|FG000|Overall Study|Lack of Efficacy|11
7437791|NCT01627782|11721067|FG001|Overall Study|Lack of Efficacy|1
7437792|NCT01627782|11721068|FG002|Overall Study|Lack of Efficacy|15
7437793|NCT01627782|11721069|FG003|Overall Study|Lack of Efficacy|2
7437794|NCT01627782|11721066|FG000|Overall Study|Protocol Violation|1
7437795|NCT01627782|11721067|FG001|Overall Study|Protocol Violation|0
7437796|NCT01627782|11721068|FG002|Overall Study|Protocol Violation|0
7437797|NCT01627782|11721069|FG003|Overall Study|Protocol Violation|0
7437798|NCT01627782|11721066|FG000|Overall Study|Withdrawal by Subject|2
7437799|NCT01627782|11721067|FG001|Overall Study|Withdrawal by Subject|1
7437800|NCT01627782|11721068|FG002|Overall Study|Withdrawal by Subject|0
7437801|NCT01627782|11721069|FG003|Overall Study|Withdrawal by Subject|0
7437802|NCT01627782|11721066|FG000|Overall Study|Other|0
7437803|NCT01627782|11721067|FG001|Overall Study|Other|2
7437804|NCT01627782|11721068|FG002|Overall Study|Other|0
7437805|NCT01627782|11721069|FG003|Overall Study|Other|3
7437806|NCT01627782|11721066|FG000|Overall Study|Randomized But Not Treated|1
7437807|NCT01627782|11721067|FG001|Overall Study|Randomized But Not Treated|0
7437808|NCT01627782|11721068|FG002|Overall Study|Randomized But Not Treated|0
7437809|NCT01627782|11721069|FG003|Overall Study|Randomized But Not Treated|0
7437810|NCT01627860|11721083|FG000|Overall Study|Adverse Event|9
7437811|NCT01627860|11721084|FG001|Overall Study|Adverse Event|4
7437812|NCT01627860|11721083|FG000|Overall Study|Withdrawal by Subject|2
7437813|NCT01627860|11721084|FG001|Overall Study|Withdrawal by Subject|1
7437814|NCT01627860|11721083|FG000|Overall Study|Seizure frequency doubled|0
7437815|NCT01627860|11721084|FG001|Overall Study|Seizure frequency doubled|1
7437816|NCT01627860|11721083|FG000|Overall Study|Protocol Violation|1
7437817|NCT01627860|11721084|FG001|Overall Study|Protocol Violation|0
7437818|NCT01628107|11721122|FG000|Overall Study|Withdrawal by Subject|17
7437819|NCT01628107|11721122|FG000|Overall Study|Lost to Follow-up|4
7437820|NCT01628107|11721122|FG000|Overall Study|Adverse Event|33
7437821|NCT01628107|11721122|FG000|Overall Study|Physician Decision|2
7437822|NCT01628107|11721122|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
7437823|NCT01628107|11721122|FG000|Overall Study|Non-compliant with Study Procedures|10
7437824|NCT01628107|11721122|FG000|Overall Study|Not Treated|8
7437825|NCT01628107|11721122|FG000|Overall Study|Sponsor Decision|11
7437826|NCT01628107|11721122|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
7437827|NCT01628107|11721122|FG000|Overall Study|Relocated|8
7437828|NCT01628107|11721122|FG000|Overall Study|Kidney Transplant|9
7437829|NCT01628107|11721122|FG000|Overall Study|Use of Standard of Care|9
7437830|NCT01628120|11721126|FG000|Overall Study|Withdrawal by Subject|7
7437831|NCT01628120|11721126|FG000|Overall Study|Adverse Event|12
7437832|NCT01628120|11721126|FG000|Overall Study|Lost to Follow-up|1
7437833|NCT01628120|11721126|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
7437834|NCT01628120|11721126|FG000|Overall Study|Non-compliant with Study Procedures|1
7532860|NCT02676895|11878624|FG000|Overall Study|Administrative reason|1
7437835|NCT01628120|11721126|FG000|Overall Study|Not Treated|3
7437836|NCT01628120|11721126|FG000|Overall Study|Sponsor Decision|5
7437837|NCT01628120|11721126|FG000|Overall Study|Switched Dialysis Method|2
7437838|NCT01628120|11721126|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
7437839|NCT01628120|11721126|FG000|Overall Study|Moved or Relocated|5
7437840|NCT01628120|11721126|FG000|Overall Study|Kidney Transplant|2
7437841|NCT01628120|11721126|FG000|Overall Study|Use of Standard of Care|1
7437842|NCT01628198|11721134|FG000|Overall Study|Lost to Follow-up|7
7437843|NCT01628198|11721134|FG000|Overall Study|Withdrawal by Subject|10
7437844|NCT01628198|11721134|FG000|Overall Study|Screen failure|1
7437845|NCT01628367|11721149|FG000|Overall Study|Adverse Event|1
7437846|NCT01628367|11721150|FG001|Overall Study|Adverse Event|0
7437847|NCT01628393|11721159|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
7437848|NCT01628393|11721160|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
7437849|NCT01628393|11721161|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
7437850|NCT01628393|11721162|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
7437851|NCT01628393|11721163|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
7437852|NCT01628393|11721159|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
7437853|NCT01628393|11721160|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
7437854|NCT01628393|11721161|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
7437855|NCT01628393|11721162|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
7437856|NCT01628393|11721163|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
7437857|NCT01628393|11721159|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
7437858|NCT01628393|11721160|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7437859|NCT01628393|11721161|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
7437860|NCT01628393|11721162|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7437861|NCT01628393|11721163|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
7437862|NCT01628393|11721159|FG000|Blinded Active Extension Period|Adverse Event|0
7437863|NCT01628393|11721160|FG001|Blinded Active Extension Period|Adverse Event|1
7437864|NCT01628393|11721161|FG002|Blinded Active Extension Period|Adverse Event|0
7437865|NCT01628393|11721162|FG003|Blinded Active Extension Period|Adverse Event|2
7437866|NCT01628393|11721163|FG004|Blinded Active Extension Period|Adverse Event|2
7437867|NCT01628393|11721159|FG000|Blinded Active Extension Period|Lack of Efficacy|0
7437868|NCT01628393|11721160|FG001|Blinded Active Extension Period|Lack of Efficacy|0
7437869|NCT01628393|11721161|FG002|Blinded Active Extension Period|Lack of Efficacy|2
7437870|NCT01628393|11721162|FG003|Blinded Active Extension Period|Lack of Efficacy|0
7437871|NCT01628393|11721163|FG004|Blinded Active Extension Period|Lack of Efficacy|2
7437872|NCT01628393|11721159|FG000|Blinded Active Extension Period|Physician Decision|0
7437873|NCT01628393|11721160|FG001|Blinded Active Extension Period|Physician Decision|3
7437874|NCT01628393|11721161|FG002|Blinded Active Extension Period|Physician Decision|0
7437875|NCT01628393|11721162|FG003|Blinded Active Extension Period|Physician Decision|1
7437876|NCT01628393|11721163|FG004|Blinded Active Extension Period|Physician Decision|0
7437877|NCT01628393|11721159|FG000|Blinded Active Extension Period|Protocol Violation|0
7437878|NCT01628393|11721160|FG001|Blinded Active Extension Period|Protocol Violation|0
7437879|NCT01628393|11721161|FG002|Blinded Active Extension Period|Protocol Violation|2
7437880|NCT01628393|11721162|FG003|Blinded Active Extension Period|Protocol Violation|1
7437881|NCT01628393|11721163|FG004|Blinded Active Extension Period|Protocol Violation|0
7437882|NCT01628393|11721159|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
7437883|NCT01628393|11721160|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
7437884|NCT01628393|11721161|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
7437885|NCT01628393|11721162|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
7437886|NCT01628393|11721163|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
7437887|NCT01628510|11721179|FG000|Overall Study|Withdrawal by Subject|0
7437888|NCT01628510|11721180|FG001|Overall Study|Withdrawal by Subject|4
7437889|NCT01628510|11721179|FG000|Overall Study|Death|3
7437890|NCT01628510|11721180|FG001|Overall Study|Death|1
7437891|NCT01628549|11721197|FG000|Overall Study|Adverse Event|1
7437892|NCT01628549|11721198|FG001|Overall Study|Adverse Event|1
7437893|NCT01628549|11721199|FG002|Overall Study|Adverse Event|0
7437894|NCT01628549|11721200|FG003|Overall Study|Adverse Event|4
7437895|NCT01628549|11721197|FG000|Overall Study|Lost to Follow-up|3
7437896|NCT01628549|11721198|FG001|Overall Study|Lost to Follow-up|4
7437897|NCT01628549|11721199|FG002|Overall Study|Lost to Follow-up|3
7437898|NCT01628549|11721200|FG003|Overall Study|Lost to Follow-up|3
7437899|NCT01628549|11721197|FG000|Overall Study|Withdrawal by Subject|3
7437900|NCT01628549|11721198|FG001|Overall Study|Withdrawal by Subject|4
7437901|NCT01628549|11721199|FG002|Overall Study|Withdrawal by Subject|4
7437902|NCT01628549|11721200|FG003|Overall Study|Withdrawal by Subject|1
7437903|NCT01628549|11721197|FG000|Overall Study|Protocol Violation|2
7437904|NCT01628549|11721198|FG001|Overall Study|Protocol Violation|1
7437905|NCT01628549|11721199|FG002|Overall Study|Protocol Violation|1
7437906|NCT01628549|11721200|FG003|Overall Study|Protocol Violation|0
7437907|NCT01628549|11721197|FG000|Overall Study|withdrawn for noncompliance|0
7437908|NCT01628549|11721198|FG001|Overall Study|withdrawn for noncompliance|2
7437909|NCT01628549|11721199|FG002|Overall Study|withdrawn for noncompliance|1
7437910|NCT01628549|11721200|FG003|Overall Study|withdrawn for noncompliance|0
7437911|NCT01628549|11721197|FG000|Overall Study|abnormal laboratory test results|0
7437912|NCT01628549|11721198|FG001|Overall Study|abnormal laboratory test results|0
7437913|NCT01628549|11721199|FG002|Overall Study|abnormal laboratory test results|1
7437914|NCT01628549|11721200|FG003|Overall Study|abnormal laboratory test results|0
7437915|NCT01628549|11721197|FG000|Overall Study|positive pregnancy test|0
7437916|NCT01628549|11721198|FG001|Overall Study|positive pregnancy test|0
7437917|NCT01628549|11721199|FG002|Overall Study|positive pregnancy test|0
7437918|NCT01628549|11721200|FG003|Overall Study|positive pregnancy test|1
7437919|NCT01628692|11721228|FG000|Overall Study|Lack of Efficacy|4
7437920|NCT01628692|11721229|FG001|Overall Study|Lack of Efficacy|4
7437921|NCT01628692|11721230|FG002|Overall Study|Lack of Efficacy|5
7437922|NCT01628692|11721231|FG003|Overall Study|Lack of Efficacy|1
7437923|NCT01628692|11721232|FG004|Overall Study|Lack of Efficacy|4
7437924|NCT01628692|11721233|FG005|Overall Study|Lack of Efficacy|7
7437925|NCT01628692|11721228|FG000|Overall Study|Adverse Event|2
7437926|NCT01628692|11721229|FG001|Overall Study|Adverse Event|0
7437927|NCT01628692|11721230|FG002|Overall Study|Adverse Event|2
7437928|NCT01628692|11721231|FG003|Overall Study|Adverse Event|0
7437929|NCT01628692|11721232|FG004|Overall Study|Adverse Event|0
7437930|NCT01628692|11721233|FG005|Overall Study|Adverse Event|0
7437931|NCT01628692|11721228|FG000|Overall Study|Withdrawal by Subject|0
7437932|NCT01628692|11721229|FG001|Overall Study|Withdrawal by Subject|1
7437933|NCT01628692|11721230|FG002|Overall Study|Withdrawal by Subject|1
7437934|NCT01628692|11721231|FG003|Overall Study|Withdrawal by Subject|0
7437935|NCT01628692|11721232|FG004|Overall Study|Withdrawal by Subject|0
7437936|NCT01628692|11721233|FG005|Overall Study|Withdrawal by Subject|0
7561064|NCT03189446|11928796|FG000|Overall Study|Adverse Event|2
7561065|NCT03189446|11928796|FG000|Overall Study|Withdrawal by Subject|2
7561066|NCT03189446|11928796|FG000|Overall Study|Physician Decision|1
7561067|NCT03189524|11928803|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
7561068|NCT03189524|11928804|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
7561069|NCT03189524|11928805|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
7561070|NCT03189524|11928803|FG000|Overall Study|Death|2
7561071|NCT03189524|11928804|FG001|Overall Study|Death|2
7437937|NCT01628692|11721228|FG000|Overall Study|Death|0
7437938|NCT01628692|11721229|FG001|Overall Study|Death|1
7437939|NCT01628692|11721230|FG002|Overall Study|Death|0
7437940|NCT01628692|11721231|FG003|Overall Study|Death|0
7437941|NCT01628692|11721232|FG004|Overall Study|Death|0
7437942|NCT01628692|11721233|FG005|Overall Study|Death|0
7437943|NCT01628692|11721228|FG000|Overall Study|Poor compliance/noncompliance|1
7437944|NCT01628692|11721229|FG001|Overall Study|Poor compliance/noncompliance|0
7437945|NCT01628692|11721230|FG002|Overall Study|Poor compliance/noncompliance|0
7437946|NCT01628692|11721231|FG003|Overall Study|Poor compliance/noncompliance|0
7437947|NCT01628692|11721232|FG004|Overall Study|Poor compliance/noncompliance|0
7437948|NCT01628692|11721233|FG005|Overall Study|Poor compliance/noncompliance|0
7437949|NCT01628692|11721228|FG000|Overall Study|Administrative reason by sponsor|0
7437950|NCT01628692|11721229|FG001|Overall Study|Administrative reason by sponsor|0
7437951|NCT01628692|11721230|FG002|Overall Study|Administrative reason by sponsor|0
7437952|NCT01628692|11721231|FG003|Overall Study|Administrative reason by sponsor|0
7437953|NCT01628692|11721232|FG004|Overall Study|Administrative reason by sponsor|0
7437954|NCT01628692|11721233|FG005|Overall Study|Administrative reason by sponsor|1
7437955|NCT01628692|11721228|FG000|Overall Study|Completed 12 Week only|0
7437956|NCT01628692|11721229|FG001|Overall Study|Completed 12 Week only|0
7437957|NCT01628692|11721230|FG002|Overall Study|Completed 12 Week only|0
7437958|NCT01628692|11721231|FG003|Overall Study|Completed 12 Week only|0
7437959|NCT01628692|11721232|FG004|Overall Study|Completed 12 Week only|0
7437960|NCT01628692|11721233|FG005|Overall Study|Completed 12 Week only|1
7437961|NCT01628848|11721261|FG000|Overall Study|Adverse Event|9
7437962|NCT01628848|11721262|FG001|Overall Study|Adverse Event|7
7437963|NCT01628848|11721261|FG000|Overall Study|Lack of Efficacy|0
7437964|NCT01628848|11721262|FG001|Overall Study|Lack of Efficacy|4
7437965|NCT01628848|11721261|FG000|Overall Study|Withdrawal by Subject|0
7437966|NCT01628848|11721262|FG001|Overall Study|Withdrawal by Subject|2
7437967|NCT01628848|11721261|FG000|Overall Study|Physician Decision|3
7437968|NCT01628848|11721262|FG001|Overall Study|Physician Decision|1
7437969|NCT01628874|11721270|FG000|Overall Study|Physician Decision|1
7437970|NCT01628874|11721271|FG001|Overall Study|Physician Decision|1
7437971|NCT01628874|11721270|FG000|Overall Study|Age >4 months|4
7437972|NCT01628874|11721271|FG001|Overall Study|Age >4 months|2
7437973|NCT01628913|11721279|FG000|Overall Study|Adverse Event|12
7437974|NCT01628913|11721280|FG001|Overall Study|Adverse Event|5
7437975|NCT01628913|11721279|FG000|Overall Study|Disease Progression|11
7437976|NCT01628913|11721280|FG001|Overall Study|Disease Progression|14
7437977|NCT01628913|11721279|FG000|Overall Study|Protocol Violation|1
7437978|NCT01628913|11721280|FG001|Overall Study|Protocol Violation|0
7437979|NCT01628913|11721279|FG000|Overall Study|Death|1
7437980|NCT01628913|11721280|FG001|Overall Study|Death|0
7532861|NCT02676895|11878625|FG001|Overall Study|Administrative reason|0
7532862|NCT02676895|11878626|FG002|Overall Study|Administrative reason|0
7532863|NCT02676895|11878624|FG000|Overall Study|Protocol Violation|1
7437981|NCT01628913|11721279|FG000|Overall Study|study terminated by Sponsor|4
7437982|NCT01628913|11721280|FG001|Overall Study|study terminated by Sponsor|9
7437983|NCT01628913|11721279|FG000|Overall Study|Withdrawal by Subject|1
7437984|NCT01628913|11721280|FG001|Overall Study|Withdrawal by Subject|0
7532864|NCT02676895|11878625|FG001|Overall Study|Protocol Violation|0
7532865|NCT02676895|11878626|FG002|Overall Study|Protocol Violation|0
7532866|NCT02676895|11878624|FG000|Overall Study|Adverse Event|0
7532867|NCT02676895|11878625|FG001|Overall Study|Adverse Event|3
7532868|NCT02676895|11878626|FG002|Overall Study|Adverse Event|1
7532869|NCT02676895|11878624|FG000|Overall Study|Lost to Follow-up|0
7532870|NCT02676895|11878625|FG001|Overall Study|Lost to Follow-up|0
7532871|NCT02676895|11878626|FG002|Overall Study|Lost to Follow-up|1
7532872|NCT02676895|11878624|FG000|Overall Study|Withdrawal by Subject|0
7437985|NCT01628913|11721279|FG000|Overall Study|Physician Decision|1
7437986|NCT01628913|11721280|FG001|Overall Study|Physician Decision|3
7437987|NCT01628926|11721289|FG000|Overall Study|Adverse Event|13
7437988|NCT01628926|11721290|FG001|Overall Study|Adverse Event|11
7437989|NCT01628926|11721291|FG002|Overall Study|Adverse Event|9
7437990|NCT01628926|11721289|FG000|Overall Study|Lack of Efficacy|2
7437991|NCT01628926|11721290|FG001|Overall Study|Lack of Efficacy|1
7437992|NCT01628926|11721291|FG002|Overall Study|Lack of Efficacy|5
7437993|NCT01628926|11721289|FG000|Overall Study|Withdrawal by Subject|6
7437994|NCT01628926|11721290|FG001|Overall Study|Withdrawal by Subject|4
7437995|NCT01628926|11721291|FG002|Overall Study|Withdrawal by Subject|2
7437996|NCT01628926|11721289|FG000|Overall Study|Protocol Violation|0
7437997|NCT01628926|11721290|FG001|Overall Study|Protocol Violation|1
7437998|NCT01628926|11721291|FG002|Overall Study|Protocol Violation|0
7437999|NCT01628926|11721289|FG000|Overall Study|Discontinuation criteria|3
7438000|NCT01628926|11721290|FG001|Overall Study|Discontinuation criteria|4
7438001|NCT01628926|11721291|FG002|Overall Study|Discontinuation criteria|0
7438002|NCT01628926|11721289|FG000|Overall Study|Physician Decision|2
7438003|NCT01628926|11721290|FG001|Overall Study|Physician Decision|2
7438004|NCT01628926|11721291|FG002|Overall Study|Physician Decision|1
7438005|NCT01628965|11721300|FG000|Overall Study|Adverse Event|30
7438006|NCT01628965|11721300|FG000|Overall Study|Lack of Efficacy|7
7438007|NCT01628965|11721300|FG000|Overall Study|Withdrawal by Subject|3
7438008|NCT01628965|11721300|FG000|Overall Study|Lost to Follow-up|1
7438009|NCT01628965|11721300|FG000|Overall Study|Discontinuation criteria|8
7438010|NCT01629381|11721320|FG000|Overall Study|Withdrawal by Subject|2
7438011|NCT01629381|11721321|FG001|Overall Study|Withdrawal by Subject|5
7438012|NCT01629563|11721333|FG000|Overall Study|Adverse Event|16
7438013|NCT01629563|11721334|FG001|Overall Study|Adverse Event|16
7438014|NCT01629563|11721333|FG000|Overall Study|Death|2
7438015|NCT01629563|11721334|FG001|Overall Study|Death|0
7438016|NCT01629563|11721333|FG000|Overall Study|Lack of Efficacy|2
7438017|NCT01629563|11721334|FG001|Overall Study|Lack of Efficacy|3
7438018|NCT01629563|11721333|FG000|Overall Study|Lost to Follow-up|1
7438019|NCT01629563|11721334|FG001|Overall Study|Lost to Follow-up|0
7438020|NCT01629563|11721333|FG000|Overall Study|Pregnancy|1
7438021|NCT01629563|11721334|FG001|Overall Study|Pregnancy|2
7438022|NCT01629563|11721333|FG000|Overall Study|Protocol Violation|0
7438023|NCT01629563|11721334|FG001|Overall Study|Protocol Violation|1
7438024|NCT01629563|11721333|FG000|Overall Study|Withdrawal by Subject|27
7438025|NCT01629563|11721334|FG001|Overall Study|Withdrawal by Subject|20
7438026|NCT01629563|11721333|FG000|Overall Study|surgery|0
7438027|NCT01629563|11721334|FG001|Overall Study|surgery|3
7438028|NCT01629563|11721333|FG000|Overall Study|Lack of return of menses|12
7438029|NCT01629563|11721334|FG001|Overall Study|Lack of return of menses|7
7438030|NCT01629563|11721333|FG000|Overall Study|Protocol Violation|0
7438031|NCT01629563|11721334|FG001|Overall Study|Protocol Violation|1
7438032|NCT01629589|11721342|FG000|Overall Study|Protocol Violation|4
7438033|NCT01629589|11721343|FG001|Overall Study|Protocol Violation|2
7438034|NCT01629589|11721342|FG000|Overall Study|Lost to Follow-up|2
7438035|NCT01629589|11721343|FG001|Overall Study|Lost to Follow-up|1
7438036|NCT01629589|11721342|FG000|Overall Study|Withdrawal by Subject|2
7438037|NCT01629589|11721343|FG001|Overall Study|Withdrawal by Subject|3
7438038|NCT01629589|11721342|FG000|Overall Study|Did not receive study vaccine|0
7438039|NCT01629589|11721343|FG001|Overall Study|Did not receive study vaccine|1
7438040|NCT01629667|11721356|FG000|Overall Study|Lost to Follow-up|0
7438041|NCT01629667|11721357|FG001|Overall Study|Lost to Follow-up|1
7438042|NCT01629667|11721358|FG002|Overall Study|Lost to Follow-up|1
7438043|NCT01629667|11721356|FG000|Overall Study|Withdrawal by Subject|31
7438044|NCT01629667|11721357|FG001|Overall Study|Withdrawal by Subject|20
7438045|NCT01629667|11721358|FG002|Overall Study|Withdrawal by Subject|28
7438046|NCT01629667|11721356|FG000|Overall Study|Death|1
7438047|NCT01629667|11721357|FG001|Overall Study|Death|5
7438048|NCT01629667|11721358|FG002|Overall Study|Death|3
7438049|NCT01629667|11721356|FG000|Overall Study|Randomized, not treated|2
7438050|NCT01629667|11721357|FG001|Overall Study|Randomized, not treated|1
7438051|NCT01629667|11721358|FG002|Overall Study|Randomized, not treated|0
7438052|NCT01629667|11721356|FG000|Overall Study|Ongoing AE worsening right heart failure|0
7438053|NCT01629667|11721357|FG001|Overall Study|Ongoing AE worsening right heart failure|1
7438054|NCT01629667|11721358|FG002|Overall Study|Ongoing AE worsening right heart failure|0
7438055|NCT01629667|11721356|FG000|Overall Study|Requiring lung transplant|2
7438056|NCT01629667|11721357|FG001|Overall Study|Requiring lung transplant|1
7438057|NCT01629667|11721358|FG002|Overall Study|Requiring lung transplant|3
7438058|NCT01629667|11721356|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
7438059|NCT01629667|11721357|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
7438060|NCT01629667|11721358|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
7438061|NCT01629667|11721356|FG000|Overall Study|Started other medicine|1
7438062|NCT01629667|11721357|FG001|Overall Study|Started other medicine|0
7438063|NCT01629667|11721358|FG002|Overall Study|Started other medicine|1
7438064|NCT01629667|11721356|FG000|Overall Study|Site error in safety follow-up|0
7438065|NCT01629667|11721357|FG001|Overall Study|Site error in safety follow-up|0
7438066|NCT01629667|11721358|FG002|Overall Study|Site error in safety follow-up|1
7438067|NCT01629667|11721356|FG000|Overall Study|Enrolled in another clinical study|0
7438068|NCT01629667|11721357|FG001|Overall Study|Enrolled in another clinical study|1
7438069|NCT01629667|11721358|FG002|Overall Study|Enrolled in another clinical study|0
7438070|NCT01629667|11721356|FG000|Overall Study|Code break|1
7438071|NCT01629667|11721357|FG001|Overall Study|Code break|0
7438072|NCT01629667|11721358|FG002|Overall Study|Code break|0
7438073|NCT01629693|11721370|FG000|Overall Study|Lost to Follow-up|2
7438074|NCT01629693|11721371|FG001|Overall Study|Lost to Follow-up|4
7438075|NCT01629693|11721370|FG000|Overall Study|Withdrawal by Subject|2
7438076|NCT01629693|11721371|FG001|Overall Study|Withdrawal by Subject|2
7438077|NCT01629693|11721370|FG000|Overall Study|Adverse Event|1
7438078|NCT01629693|11721371|FG001|Overall Study|Adverse Event|0
7438079|NCT01629693|11721370|FG000|Overall Study|Investigator decision|0
7438080|NCT01629693|11721371|FG001|Overall Study|Investigator decision|1
7438081|NCT01629693|11721370|FG000|Overall Study|Poor comfort of study lenses|0
7438082|NCT01629693|11721371|FG001|Overall Study|Poor comfort of study lenses|2
7438083|NCT01629693|11721370|FG000|Overall Study|Subject decision unrelated to AE|0
7438084|NCT01629693|11721371|FG001|Overall Study|Subject decision unrelated to AE|1
7438085|NCT01629706|11721377|FG000|Phase 1 PureVision|Screen Failure|4
7438086|NCT01629706|11721377|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
7438087|NCT01629706|11721377|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
7438088|NCT01629706|11721377|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
7438089|NCT01629706|11721377|FG000|Phase 2 Habitual|Screen Failure|6
7438090|NCT01629706|11721377|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
7438091|NCT01629706|11721377|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
7438092|NCT01629706|11721377|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
7438093|NCT01629706|11721377|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
7532873|NCT02676895|11878625|FG001|Overall Study|Withdrawal by Subject|0
7532874|NCT02676895|11878626|FG002|Overall Study|Withdrawal by Subject|1
7532875|NCT02677116|11878644|FG000|Overall Study|Adverse Event|0
7532876|NCT02677116|11878645|FG001|Overall Study|Adverse Event|1
7561072|NCT03189524|11928805|FG002|Overall Study|Death|1
7561073|NCT03189524|11928803|FG000|Overall Study|Lost to Follow-up|1
7561074|NCT03189524|11928804|FG001|Overall Study|Lost to Follow-up|0
7561075|NCT03189524|11928805|FG002|Overall Study|Lost to Follow-up|8
7561076|NCT03189524|11928803|FG000|Overall Study|Withdrawal by Subject|1
7561077|NCT03189524|11928804|FG001|Overall Study|Withdrawal by Subject|1
7561078|NCT03189524|11928805|FG002|Overall Study|Withdrawal by Subject|3
7561079|NCT03189524|11928803|FG000|Overall Study|Progressive Disease|0
7561080|NCT03189524|11928804|FG001|Overall Study|Progressive Disease|2
7561081|NCT03189524|11928805|FG002|Overall Study|Progressive Disease|0
7561082|NCT03189745|11928828|FG000|Overall Study|Conflict in work schedule of participant|1
7561083|NCT03189745|11928829|FG001|Overall Study|Conflict in work schedule of participant|1
7561084|NCT03191396|11928883|FG000|Overall Study|Lost to Follow-up|0
7561085|NCT03191396|11928884|FG001|Overall Study|Lost to Follow-up|3
7561086|NCT03191396|11928883|FG000|Overall Study|Withdrawal by Subject|3
7561087|NCT03191396|11928884|FG001|Overall Study|Withdrawal by Subject|2
7561088|NCT03191552|11928893|FG000|Overall Study|Lost to Follow-up|1
7561089|NCT03191552|11928894|FG001|Overall Study|Lost to Follow-up|0
7561090|NCT03191552|11928895|FG002|Overall Study|Lost to Follow-up|0
7561091|NCT03191552|11928893|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
7561092|NCT03191552|11928894|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
7561093|NCT03191552|11928895|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
7561094|NCT03191630|11928909|FG000|Overall Study|Lost to Follow-up|7
7561095|NCT03191630|11928910|FG001|Overall Study|Lost to Follow-up|7
7561096|NCT03191799|11928918|FG000|Overall Study|Withdrawal by Subject|4
7561097|NCT03191799|11928918|FG000|Overall Study|Physician Decision|2
7561098|NCT03191799|11928918|FG000|Overall Study|Lost to Follow-up|1
7561099|NCT03191799|11928918|FG000|Overall Study|Death|2
7561100|NCT03192137|11928924|FG000|Overall Study|Adverse Event|10
7561101|NCT03192137|11928925|FG001|Overall Study|Adverse Event|11
7561102|NCT03192137|11928924|FG000|Overall Study|Physician Decision|1
7561103|NCT03192137|11928925|FG001|Overall Study|Physician Decision|0
7561104|NCT03192137|11928924|FG000|Overall Study|Lack of Efficacy|20
7561105|NCT03192137|11928925|FG001|Overall Study|Lack of Efficacy|37
7438094|NCT01629823|11721411|FG000|Trial Period|Missed visit|11
7438095|NCT01629823|11721412|FG001|Trial Period|Missed visit|9
7438096|NCT01629823|11721413|FG002|Trial Period|Missed visit|8
7532877|NCT02677116|11878646|FG002|Overall Study|Adverse Event|0
7532878|NCT02677116|11878647|FG003|Overall Study|Adverse Event|0
7532879|NCT02677116|11878648|FG004|Overall Study|Adverse Event|0
7532880|NCT02677116|11878649|FG005|Overall Study|Adverse Event|1
7532881|NCT02677116|11878650|FG006|Overall Study|Adverse Event|1
7561106|NCT03192137|11928924|FG000|Overall Study|Withdrawal by Subject|3
7438097|NCT01629823|11721411|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7438098|NCT01629823|11721412|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7561107|NCT03192137|11928925|FG001|Overall Study|Withdrawal by Subject|3
7561108|NCT03192137|11928924|FG000|Overall Study|Protocol Violation|4
7561109|NCT03192137|11928925|FG001|Overall Study|Protocol Violation|3
7561110|NCT03192137|11928924|FG000|Overall Study|Surgery Cancelled|4
7532882|NCT02677116|11878651|FG007|Overall Study|Adverse Event|0
7532883|NCT02677116|11878652|FG008|Overall Study|Adverse Event|0
7532884|NCT02677116|11878644|FG000|Overall Study|Physician Decision|0
7532885|NCT02677116|11878645|FG001|Overall Study|Physician Decision|2
7532886|NCT02677116|11878646|FG002|Overall Study|Physician Decision|3
7438099|NCT01629823|11721413|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
7438100|NCT01629823|11721411|FG000|Trial Period|Pregnancy|1
7438101|NCT01629823|11721412|FG001|Trial Period|Pregnancy|0
7438102|NCT01629823|11721413|FG002|Trial Period|Pregnancy|0
7438103|NCT01629823|11721411|FG000|Trial Period|Adverse Event|0
7438104|NCT01629823|11721412|FG001|Trial Period|Adverse Event|1
7438105|NCT01629823|11721413|FG002|Trial Period|Adverse Event|0
7438106|NCT01629823|11721411|FG000|Trial Period|Out-of-window visit|0
7438107|NCT01629823|11721412|FG001|Trial Period|Out-of-window visit|2
7438108|NCT01629823|11721413|FG002|Trial Period|Out-of-window visit|0
7438109|NCT01629823|11721411|FG000|Trial Period|Failed to hold medication|0
7438110|NCT01629823|11721412|FG001|Trial Period|Failed to hold medication|0
7438111|NCT01629823|11721413|FG002|Trial Period|Failed to hold medication|1
7438112|NCT01629823|11721411|FG000|Washout Period|Safety|2
7438113|NCT01629823|11721412|FG001|Washout Period|Safety|5
7438114|NCT01629823|11721413|FG002|Washout Period|Safety|0
7438115|NCT01629823|11721411|FG000|Washout Period|Pregnancy|1
7438116|NCT01629823|11721412|FG001|Washout Period|Pregnancy|0
7438117|NCT01629823|11721413|FG002|Washout Period|Pregnancy|0
7438118|NCT01629823|11721411|FG000|Washout Period|Protocol Violation|0
7438119|NCT01629823|11721412|FG001|Washout Period|Protocol Violation|1
7438120|NCT01629823|11721413|FG002|Washout Period|Protocol Violation|0
7438121|NCT01629953|11721432|FG000|Overall Study|Death|3
7438122|NCT01629953|11721433|FG001|Overall Study|Death|1
7438123|NCT01629953|11721432|FG000|Overall Study|Lost to Follow-up|10
7438124|NCT01629953|11721433|FG001|Overall Study|Lost to Follow-up|14
7438125|NCT01629966|11721442|FG000|Overall Study|Pregnancy|0
7438126|NCT01629966|11721443|FG001|Overall Study|Pregnancy|1
7438127|NCT01629966|11721444|FG002|Overall Study|Pregnancy|0
7438128|NCT01629966|11721442|FG000|Overall Study|Lost to Follow-up|10
7438129|NCT01629966|11721443|FG001|Overall Study|Lost to Follow-up|13
7438130|NCT01629966|11721444|FG002|Overall Study|Lost to Follow-up|9
7438131|NCT01629966|11721442|FG000|Overall Study|Withdrawal by Subject|8
7438132|NCT01629966|11721443|FG001|Overall Study|Withdrawal by Subject|9
7438133|NCT01629966|11721444|FG002|Overall Study|Withdrawal by Subject|16
7438134|NCT01629966|11721442|FG000|Overall Study|Protocol Violation|7
7438135|NCT01629966|11721443|FG001|Overall Study|Protocol Violation|9
7438136|NCT01629966|11721444|FG002|Overall Study|Protocol Violation|7
7438137|NCT01629966|11721442|FG000|Overall Study|Lack of Efficacy|5
7438138|NCT01629966|11721443|FG001|Overall Study|Lack of Efficacy|2
7438139|NCT01629966|11721444|FG002|Overall Study|Lack of Efficacy|4
7438140|NCT01629966|11721442|FG000|Overall Study|Adverse Event|11
7438141|NCT01629966|11721443|FG001|Overall Study|Adverse Event|18
7438142|NCT01629966|11721444|FG002|Overall Study|Adverse Event|30
7438143|NCT01630135|11721473|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
7438144|NCT01630135|11721474|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
7438145|NCT01630616|11721495|FG000|Overall Study|Adverse Event|0
7438146|NCT01630616|11721496|FG001|Overall Study|Adverse Event|0
7438147|NCT01630616|11721497|FG002|Overall Study|Adverse Event|0
7438148|NCT01630616|11721498|FG003|Overall Study|Adverse Event|1
7438149|NCT01630616|11721499|FG004|Overall Study|Adverse Event|0
7438150|NCT01630616|11721500|FG005|Overall Study|Adverse Event|0
7438151|NCT01630616|11721495|FG000|Overall Study|Withdrawal by Subject|0
7438152|NCT01630616|11721496|FG001|Overall Study|Withdrawal by Subject|0
7438153|NCT01630616|11721497|FG002|Overall Study|Withdrawal by Subject|0
7438154|NCT01630616|11721498|FG003|Overall Study|Withdrawal by Subject|2
7438155|NCT01630616|11721499|FG004|Overall Study|Withdrawal by Subject|0
7438156|NCT01630616|11721500|FG005|Overall Study|Withdrawal by Subject|0
7438157|NCT01630811|11721526|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
7438158|NCT01630811|11721527|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7438159|NCT01630889|11721535|FG000|Overall Study|Death|2
7438160|NCT01630889|11721535|FG000|Overall Study|Withdrawal by Subject|1
7438161|NCT01630889|11721535|FG000|Overall Study|Other than Specified|2
7438162|NCT01630889|11721535|FG000|Overall Study|Lost to Follow-up|4
7438163|NCT01630889|11721535|FG000|Overall Study|Other|1
7438164|NCT01631188|11721566|FG000|Overall Study|Physician Decision|75
7438165|NCT01631214|11721572|FG000|Overall Study|Withdrawal by Subject|276
7438166|NCT01631214|11721573|FG001|Overall Study|Withdrawal by Subject|290
7438167|NCT01631214|11721572|FG000|Overall Study|Death|113
7438168|NCT01631214|11721573|FG001|Overall Study|Death|106
7438169|NCT01631214|11721572|FG000|Overall Study|Lost to Follow-up|54
7438170|NCT01631214|11721573|FG001|Overall Study|Lost to Follow-up|40
7438171|NCT01631214|11721572|FG000|Overall Study|Adverse Event|45
7438172|NCT01631214|11721573|FG001|Overall Study|Adverse Event|45
7438173|NCT01631214|11721572|FG000|Overall Study|Other|22
7438174|NCT01631214|11721573|FG001|Overall Study|Other|19
7438175|NCT01631214|11721572|FG000|Overall Study|Noncompliance|16
7438176|NCT01631214|11721573|FG001|Overall Study|Noncompliance|15
7438177|NCT01631214|11721572|FG000|Overall Study|Requirement for Alternative Therapy|8
7438178|NCT01631214|11721573|FG001|Overall Study|Requirement for Alternative Therapy|3
7438179|NCT01631214|11721572|FG000|Overall Study|Protocol Deviation|4
7438180|NCT01631214|11721573|FG001|Overall Study|Protocol Deviation|3
7438181|NCT01631214|11721572|FG000|Overall Study|Ineligibility determined|5
7438182|NCT01631214|11721573|FG001|Overall Study|Ineligibility determined|2
7438183|NCT01631214|11721572|FG000|Overall Study|Administrative Decision|1
7438184|NCT01631214|11721573|FG001|Overall Study|Administrative Decision|0
7438185|NCT01631227|11721583|FG000|Overall Study|withdrawn consent|27
7438186|NCT01631227|11721584|FG001|Overall Study|withdrawn consent|21
7438187|NCT01631227|11721583|FG000|Overall Study|Adverse Event|1
7438188|NCT01631227|11721584|FG001|Overall Study|Adverse Event|0
7438189|NCT01631227|11721583|FG000|Overall Study|administrative|2
7438190|NCT01631227|11721584|FG001|Overall Study|administrative|1
7438191|NCT01631435|11721595|FG000|Overall Study|Adverse Event|2
7438192|NCT01631435|11721595|FG000|Overall Study|Withdrawal by Subject|2
7438193|NCT01631435|11721595|FG000|Overall Study|incomplete study procedure|5
7438194|NCT01631474|11721605|FG000|Overall Study|Lost to Follow-up|8
7438195|NCT01631474|11721606|FG001|Overall Study|Lost to Follow-up|5
7438196|NCT01631474|11721607|FG002|Overall Study|Lost to Follow-up|7
7438197|NCT01631474|11721608|FG003|Overall Study|Lost to Follow-up|5
7438198|NCT01631474|11721609|FG004|Overall Study|Lost to Follow-up|5
7438199|NCT01631474|11721605|FG000|Overall Study|Withdrawal by Subject|4
7438200|NCT01631474|11721606|FG001|Overall Study|Withdrawal by Subject|4
7438201|NCT01631474|11721607|FG002|Overall Study|Withdrawal by Subject|2
7438202|NCT01631474|11721608|FG003|Overall Study|Withdrawal by Subject|6
7438203|NCT01631474|11721609|FG004|Overall Study|Withdrawal by Subject|5
7438204|NCT01631474|11721605|FG000|Overall Study|Lack of Efficacy|2
7438205|NCT01631474|11721606|FG001|Overall Study|Lack of Efficacy|2
7561111|NCT03192137|11928925|FG001|Overall Study|Surgery Cancelled|1
7561112|NCT03192137|11928924|FG000|Overall Study|Other - Various Administrative Reasons|8
7532887|NCT02677116|11878647|FG003|Overall Study|Physician Decision|2
7532888|NCT02677116|11878648|FG004|Overall Study|Physician Decision|1
7532889|NCT02677116|11878649|FG005|Overall Study|Physician Decision|3
7532890|NCT02677116|11878650|FG006|Overall Study|Physician Decision|1
7438206|NCT01631474|11721607|FG002|Overall Study|Lack of Efficacy|0
7438207|NCT01631474|11721608|FG003|Overall Study|Lack of Efficacy|0
7438208|NCT01631474|11721609|FG004|Overall Study|Lack of Efficacy|2
7438209|NCT01631474|11721605|FG000|Overall Study|Noncompliance with Study Drug|0
7438210|NCT01631474|11721606|FG001|Overall Study|Noncompliance with Study Drug|0
7438211|NCT01631474|11721607|FG002|Overall Study|Noncompliance with Study Drug|0
7438212|NCT01631474|11721608|FG003|Overall Study|Noncompliance with Study Drug|0
7438213|NCT01631474|11721609|FG004|Overall Study|Noncompliance with Study Drug|1
7438214|NCT01631474|11721605|FG000|Overall Study|Adverse Event|0
7438215|NCT01631474|11721606|FG001|Overall Study|Adverse Event|1
7438216|NCT01631474|11721607|FG002|Overall Study|Adverse Event|0
7438217|NCT01631474|11721608|FG003|Overall Study|Adverse Event|0
7438218|NCT01631474|11721609|FG004|Overall Study|Adverse Event|0
7438219|NCT01631747|11721677|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
7438220|NCT01631747|11721678|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
7438221|NCT01631747|11721677|FG000|Live Birth|Pregnancy Termination|1
7438222|NCT01631747|11721678|FG001|Live Birth|Pregnancy Termination|0
7438223|NCT01631747|11721677|FG000|Live Birth|MIscarriage|2
7438224|NCT01631747|11721678|FG001|Live Birth|MIscarriage|0
7532891|NCT02677116|11878651|FG007|Overall Study|Physician Decision|1
7532892|NCT02677116|11878652|FG008|Overall Study|Physician Decision|2
7532893|NCT02677116|11878644|FG000|Overall Study|Withdrawal by parent or guardian|2
7532894|NCT02677116|11878645|FG001|Overall Study|Withdrawal by parent or guardian|1
7532895|NCT02677116|11878646|FG002|Overall Study|Withdrawal by parent or guardian|0
7532896|NCT02677116|11878647|FG003|Overall Study|Withdrawal by parent or guardian|1
7532897|NCT02677116|11878648|FG004|Overall Study|Withdrawal by parent or guardian|0
7532898|NCT02677116|11878649|FG005|Overall Study|Withdrawal by parent or guardian|0
7532899|NCT02677116|11878650|FG006|Overall Study|Withdrawal by parent or guardian|2
7532900|NCT02677116|11878651|FG007|Overall Study|Withdrawal by parent or guardian|1
7532901|NCT02677116|11878652|FG008|Overall Study|Withdrawal by parent or guardian|0
7532902|NCT02677116|11878644|FG000|Overall Study|Withdrawal by Subject|1
7532903|NCT02677116|11878645|FG001|Overall Study|Withdrawal by Subject|0
7532904|NCT02677116|11878646|FG002|Overall Study|Withdrawal by Subject|0
7532905|NCT02677116|11878647|FG003|Overall Study|Withdrawal by Subject|0
7532906|NCT02677116|11878648|FG004|Overall Study|Withdrawal by Subject|0
7561113|NCT03192137|11928925|FG001|Overall Study|Other - Various Administrative Reasons|3
7438225|NCT01631747|11721677|FG000|Live Birth|Stillbirth|1
7438226|NCT01631747|11721678|FG001|Live Birth|Stillbirth|1
7438227|NCT01631747|11721677|FG000|One Year Infant Outcomes|Patient Refused|13
7438228|NCT01631747|11721678|FG001|One Year Infant Outcomes|Patient Refused|9
7438229|NCT01631812|11721685|FG000|Overall Study|Adverse Event|25
7438230|NCT01631812|11721685|FG000|Overall Study|Lack of Efficacy|5
7438231|NCT01631812|11721685|FG000|Overall Study|Withdrawal by Subject|4
7438232|NCT01631812|11721685|FG000|Overall Study|Physician Decision|3
7438233|NCT01631825|11721689|FG000|Overall Study|Adverse Event|42
7438234|NCT01631825|11721689|FG000|Overall Study|Lack of Efficacy|7
7438235|NCT01631825|11721689|FG000|Overall Study|Withdrawal by Subject|9
7438236|NCT01631825|11721689|FG000|Overall Study|Protocol Violation|4
7438237|NCT01631825|11721689|FG000|Overall Study|Discontinuation criteria|1
7438238|NCT01631825|11721689|FG000|Overall Study|Physician Decision|2
7438239|NCT01631864|11721695|FG000|Overall Study|Withdrawal by Subject|0
7438240|NCT01631864|11721696|FG001|Overall Study|Withdrawal by Subject|1
7438241|NCT01631864|11721695|FG000|Overall Study|Adverse Event|2
7438242|NCT01631864|11721696|FG001|Overall Study|Adverse Event|3
7438243|NCT01632150|11721711|FG000|Overall Study|Disease progression|27
7438244|NCT01632150|11721711|FG000|Overall Study|Study drug toxicity|1
7438245|NCT01632150|11721711|FG000|Overall Study|Unrelated adverse event|7
7438246|NCT01632150|11721711|FG000|Overall Study|Withdrawal by Subject|2
7438247|NCT01632150|11721711|FG000|Overall Study|Patient underwent autologous transplant|1
7438248|NCT01632150|11721711|FG000|Overall Study|Moved to compassionate program|2
7438249|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Site Closed|3
7438250|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Site Closed|5
7438251|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
7438252|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
7438253|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
7438254|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
7438255|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
7438256|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
7438257|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
7438258|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
7438259|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
7438260|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
7438261|NCT01632241|11721738|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
7438262|NCT01632241|11721739|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
7438263|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
7438264|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
7438265|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
7438266|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
7561114|NCT03192150|11928933|FG000|Overall Study|Adverse Event|14
7561115|NCT03192150|11928934|FG001|Overall Study|Adverse Event|12
7561116|NCT03192150|11928933|FG000|Overall Study|Lack of Efficacy|23
7561117|NCT03192150|11928934|FG001|Overall Study|Lack of Efficacy|30
7438267|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
7438268|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
7438269|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
7438270|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
7438271|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
7438272|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
7438273|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
7438274|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
7438275|NCT01632241|11721738|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
7438276|NCT01632241|11721739|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
7467323|NCT01900431|11767706|FG001|Principal Treatment Period (Part A)|Other than specified above|1
7467324|NCT01900431|11767707|FG002|Principal Treatment Period (Part A)|Other than specified above|0
7467325|NCT01900431|11767705|FG000|Extended Treatment Period (Part B)|Adverse Event|0
7467326|NCT01900431|11767706|FG001|Extended Treatment Period (Part B)|Adverse Event|2
7467327|NCT01900431|11767707|FG002|Extended Treatment Period (Part B)|Adverse Event|0
7467328|NCT01900431|11767705|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
7467329|NCT01900431|11767706|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
7467330|NCT01900431|11767707|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
7467331|NCT01900431|11767705|FG000|Extended Treatment Period (Part B)|Other than specified above|0
7467332|NCT01900431|11767706|FG001|Extended Treatment Period (Part B)|Other than specified above|1
7467333|NCT01900431|11767707|FG002|Extended Treatment Period (Part B)|Other than specified above|0
7467334|NCT01900431|11767705|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
7467335|NCT01900431|11767706|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
7467336|NCT01900431|11767707|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
7467337|NCT01900431|11767705|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7467338|NCT01900431|11767706|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
7467339|NCT01900431|11767707|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
7467340|NCT01900431|11767705|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7467341|NCT01900431|11767706|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
7467342|NCT01900431|11767707|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
7467343|NCT01900652|11767726|FG000|Overall Study|Progressive Disease|1
7467344|NCT01900652|11767727|FG001|Overall Study|Progressive Disease|0
7467345|NCT01900652|11767726|FG000|Overall Study|Consent withdrawn by subject|1
7561118|NCT03192150|11928933|FG000|Overall Study|Lost to Follow-up|1
7467346|NCT01900652|11767727|FG001|Overall Study|Consent withdrawn by subject|1
7467347|NCT01900652|11767726|FG000|Overall Study|Death|3
7467348|NCT01900652|11767727|FG001|Overall Study|Death|0
7467349|NCT01900652|11767726|FG000|Overall Study|Adverse Event|2
7467350|NCT01900652|11767727|FG001|Overall Study|Adverse Event|1
7467351|NCT01900652|11767726|FG000|Overall Study|Physician Decision|1
7467352|NCT01900652|11767727|FG001|Overall Study|Physician Decision|1
7467353|NCT01900665|11767740|FG000|Placebo Controlled Period|Death|9
7467354|NCT01900665|11767741|FG001|Placebo Controlled Period|Death|16
7467355|NCT01900665|11767740|FG000|Placebo Controlled Period|Adverse Event|48
7467356|NCT01900665|11767741|FG001|Placebo Controlled Period|Adverse Event|39
7467357|NCT01900665|11767740|FG000|Placebo Controlled Period|Protocol Violation|1
7467358|NCT01900665|11767741|FG001|Placebo Controlled Period|Protocol Violation|7
7467359|NCT01900665|11767740|FG000|Placebo Controlled Period|Withdrawal by Subject|33
7467360|NCT01900665|11767741|FG001|Placebo Controlled Period|Withdrawal by Subject|45
7561119|NCT03192150|11928934|FG001|Overall Study|Lost to Follow-up|1
7438277|NCT01632280|11721757|FG000|Overall Study|Withdrawal by Subject|1
7438278|NCT01632280|11721758|FG001|Overall Study|Withdrawal by Subject|0
7438279|NCT01632306|11721766|FG000|Overall Study|Protocol Violation|1
7438280|NCT01632306|11721767|FG001|Overall Study|Protocol Violation|0
7438281|NCT01632306|11721768|FG002|Overall Study|Protocol Violation|0
7438282|NCT01632345|11721779|FG000|Treatment: Part I|Adverse Event|1
7438283|NCT01632345|11721780|FG001|Treatment: Part I|Adverse Event|4
7438284|NCT01632345|11721781|FG002|Treatment: Part I|Adverse Event|2
7438285|NCT01632345|11721782|FG003|Treatment: Part I|Adverse Event|1
7438286|NCT01632345|11721783|FG004|Treatment: Part I|Adverse Event|3
7438287|NCT01632345|11721784|FG005|Treatment: Part I|Adverse Event|0
7438288|NCT01632345|11721785|FG006|Treatment: Part I|Adverse Event|0
7438289|NCT01632345|11721779|FG000|Treatment: Part I|Lack of Efficacy|0
7438290|NCT01632345|11721780|FG001|Treatment: Part I|Lack of Efficacy|1
7438291|NCT01632345|11721781|FG002|Treatment: Part I|Lack of Efficacy|0
7438292|NCT01632345|11721782|FG003|Treatment: Part I|Lack of Efficacy|1
7438293|NCT01632345|11721783|FG004|Treatment: Part I|Lack of Efficacy|1
7438294|NCT01632345|11721784|FG005|Treatment: Part I|Lack of Efficacy|0
7438295|NCT01632345|11721785|FG006|Treatment: Part I|Lack of Efficacy|0
7438296|NCT01632345|11721779|FG000|Treatment: Part I|Lost to Follow-up|3
7438297|NCT01632345|11721780|FG001|Treatment: Part I|Lost to Follow-up|2
7438298|NCT01632345|11721781|FG002|Treatment: Part I|Lost to Follow-up|1
7438299|NCT01632345|11721782|FG003|Treatment: Part I|Lost to Follow-up|3
7438300|NCT01632345|11721783|FG004|Treatment: Part I|Lost to Follow-up|4
7438301|NCT01632345|11721784|FG005|Treatment: Part I|Lost to Follow-up|0
7438302|NCT01632345|11721785|FG006|Treatment: Part I|Lost to Follow-up|0
7438303|NCT01632345|11721779|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
7438304|NCT01632345|11721780|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
7438305|NCT01632345|11721781|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
7438306|NCT01632345|11721782|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
7438307|NCT01632345|11721783|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
7438308|NCT01632345|11721784|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
7438309|NCT01632345|11721785|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
7438310|NCT01632345|11721779|FG000|Treatment: Part I|Physician Decision|2
7438311|NCT01632345|11721780|FG001|Treatment: Part I|Physician Decision|1
7438312|NCT01632345|11721781|FG002|Treatment: Part I|Physician Decision|0
7438313|NCT01632345|11721782|FG003|Treatment: Part I|Physician Decision|0
7438314|NCT01632345|11721783|FG004|Treatment: Part I|Physician Decision|1
7438315|NCT01632345|11721784|FG005|Treatment: Part I|Physician Decision|0
7438316|NCT01632345|11721785|FG006|Treatment: Part I|Physician Decision|0
7438317|NCT01632345|11721779|FG000|Treatment: Part I|Pregnancy|0
7438318|NCT01632345|11721780|FG001|Treatment: Part I|Pregnancy|1
7438319|NCT01632345|11721781|FG002|Treatment: Part I|Pregnancy|0
7438320|NCT01632345|11721782|FG003|Treatment: Part I|Pregnancy|0
7438321|NCT01632345|11721783|FG004|Treatment: Part I|Pregnancy|0
7438322|NCT01632345|11721784|FG005|Treatment: Part I|Pregnancy|0
7438323|NCT01632345|11721785|FG006|Treatment: Part I|Pregnancy|0
7438324|NCT01632345|11721779|FG000|Treatment: Part I|Protocol Deviation|0
7438325|NCT01632345|11721780|FG001|Treatment: Part I|Protocol Deviation|0
7438326|NCT01632345|11721781|FG002|Treatment: Part I|Protocol Deviation|1
7438327|NCT01632345|11721782|FG003|Treatment: Part I|Protocol Deviation|1
7438328|NCT01632345|11721783|FG004|Treatment: Part I|Protocol Deviation|0
7438329|NCT01632345|11721784|FG005|Treatment: Part I|Protocol Deviation|0
7438330|NCT01632345|11721785|FG006|Treatment: Part I|Protocol Deviation|0
7438331|NCT01632345|11721779|FG000|Treatment: Part I|Withdrawal by Subject|3
7438332|NCT01632345|11721780|FG001|Treatment: Part I|Withdrawal by Subject|4
7438333|NCT01632345|11721781|FG002|Treatment: Part I|Withdrawal by Subject|4
7438334|NCT01632345|11721782|FG003|Treatment: Part I|Withdrawal by Subject|1
7438335|NCT01632345|11721783|FG004|Treatment: Part I|Withdrawal by Subject|4
7438336|NCT01632345|11721784|FG005|Treatment: Part I|Withdrawal by Subject|0
7438337|NCT01632345|11721785|FG006|Treatment: Part I|Withdrawal by Subject|0
7438338|NCT01632345|11721779|FG000|Treatment: Part II|Adverse Event|0
7438339|NCT01632345|11721780|FG001|Treatment: Part II|Adverse Event|0
7438340|NCT01632345|11721781|FG002|Treatment: Part II|Adverse Event|0
7438341|NCT01632345|11721782|FG003|Treatment: Part II|Adverse Event|0
7438342|NCT01632345|11721783|FG004|Treatment: Part II|Adverse Event|0
7438343|NCT01632345|11721784|FG005|Treatment: Part II|Adverse Event|3
7438344|NCT01632345|11721785|FG006|Treatment: Part II|Adverse Event|8
7438345|NCT01632345|11721779|FG000|Treatment: Part II|Lost to Follow-up|0
7438346|NCT01632345|11721780|FG001|Treatment: Part II|Lost to Follow-up|0
7438347|NCT01632345|11721781|FG002|Treatment: Part II|Lost to Follow-up|0
7438348|NCT01632345|11721782|FG003|Treatment: Part II|Lost to Follow-up|0
7438349|NCT01632345|11721783|FG004|Treatment: Part II|Lost to Follow-up|0
7438350|NCT01632345|11721784|FG005|Treatment: Part II|Lost to Follow-up|3
7438351|NCT01632345|11721785|FG006|Treatment: Part II|Lost to Follow-up|1
7438352|NCT01632345|11721779|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
7438353|NCT01632345|11721780|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
7438354|NCT01632345|11721781|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
7438355|NCT01632345|11721782|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
7438356|NCT01632345|11721783|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
7438357|NCT01632345|11721784|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
7438358|NCT01632345|11721785|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
7438359|NCT01632345|11721779|FG000|Treatment: Part II|Withdrawal by Subject|0
7438360|NCT01632345|11721780|FG001|Treatment: Part II|Withdrawal by Subject|0
7438361|NCT01632345|11721781|FG002|Treatment: Part II|Withdrawal by Subject|0
7438362|NCT01632345|11721782|FG003|Treatment: Part II|Withdrawal by Subject|0
7438363|NCT01632345|11721783|FG004|Treatment: Part II|Withdrawal by Subject|0
7532907|NCT02677116|11878649|FG005|Overall Study|Withdrawal by Subject|0
7532908|NCT02677116|11878650|FG006|Overall Study|Withdrawal by Subject|0
7532909|NCT02677116|11878651|FG007|Overall Study|Withdrawal by Subject|0
7532910|NCT02677116|11878652|FG008|Overall Study|Withdrawal by Subject|0
7532911|NCT02677220|11878695|FG000|Overall Study|Adverse Event|1
7532912|NCT02677714|11878753|FG000|Overall Study|Withdrawal by Subject|2
7532913|NCT02677714|11878754|FG001|Overall Study|Withdrawal by Subject|0
7532914|NCT02677844|11878798|FG000|Period 3|Withdrawal by Subject|0
7532915|NCT02677844|11878799|FG001|Period 3|Withdrawal by Subject|0
7532916|NCT02677844|11878800|FG002|Period 3|Withdrawal by Subject|0
7532917|NCT02677844|11878801|FG003|Period 3|Withdrawal by Subject|1
7532918|NCT02677844|11878802|FG004|Period 3|Withdrawal by Subject|0
7532919|NCT02677844|11878803|FG005|Period 3|Withdrawal by Subject|0
7438364|NCT01632345|11721784|FG005|Treatment: Part II|Withdrawal by Subject|2
7438365|NCT01632345|11721785|FG006|Treatment: Part II|Withdrawal by Subject|2
7438366|NCT01632566|11721809|FG000|Overall Study|Withdrawal by Subject|0
7438367|NCT01632566|11721810|FG001|Overall Study|Withdrawal by Subject|1
7438368|NCT01632566|11721811|FG002|Overall Study|Withdrawal by Subject|0
7438369|NCT01632566|11721812|FG003|Overall Study|Withdrawal by Subject|0
7438370|NCT01632566|11721813|FG004|Overall Study|Withdrawal by Subject|0
7438371|NCT01632566|11721809|FG000|Overall Study|Sponsor Decision|0
7438372|NCT01632566|11721810|FG001|Overall Study|Sponsor Decision|2
7438373|NCT01632566|11721811|FG002|Overall Study|Sponsor Decision|9
7438374|NCT01632566|11721812|FG003|Overall Study|Sponsor Decision|2
7438375|NCT01632566|11721813|FG004|Overall Study|Sponsor Decision|2
7438376|NCT01632579|11721829|FG000|Washout Period|Adverse Event|1
7438377|NCT01632579|11721830|FG001|Washout Period|Adverse Event|0
7438378|NCT01632579|11721831|FG002|Washout Period|Adverse Event|0
7438379|NCT01632579|11721832|FG003|Washout Period|Adverse Event|0
7438380|NCT01632579|11721833|FG004|Washout Period|Adverse Event|0
7438381|NCT01632579|11721834|FG005|Washout Period|Adverse Event|0
7438382|NCT01632579|11721835|FG006|Washout Period|Adverse Event|0
7438383|NCT01632579|11721836|FG007|Washout Period|Adverse Event|0
7438384|NCT01632579|11721837|FG008|Washout Period|Adverse Event|0
7438385|NCT01632579|11721829|FG000|Period 2 (Second Intervention)|Adverse Event|1
7438386|NCT01632579|11721830|FG001|Period 2 (Second Intervention)|Adverse Event|0
7438387|NCT01632579|11721831|FG002|Period 2 (Second Intervention)|Adverse Event|0
7438388|NCT01632579|11721832|FG003|Period 2 (Second Intervention)|Adverse Event|0
7438389|NCT01632579|11721833|FG004|Period 2 (Second Intervention)|Adverse Event|0
7438390|NCT01632579|11721834|FG005|Period 2 (Second Intervention)|Adverse Event|0
7438391|NCT01632579|11721835|FG006|Period 2 (Second Intervention)|Adverse Event|0
7438392|NCT01632579|11721836|FG007|Period 2 (Second Intervention)|Adverse Event|0
7438393|NCT01632579|11721837|FG008|Period 2 (Second Intervention)|Adverse Event|0
7438394|NCT01632800|11721894|FG000|Overall Study|Subject did not fit in apparatus|1
7438395|NCT01632891|11721900|FG000|Overall Study|Lost to Follow-up|0
7438396|NCT01632891|11721901|FG001|Overall Study|Lost to Follow-up|1
7438397|NCT01632891|11721900|FG000|Overall Study|Withdrawal by Subject|1
7438398|NCT01632891|11721901|FG001|Overall Study|Withdrawal by Subject|0
7438399|NCT01632904|11721913|FG000|Overall Study|Adverse Event|4
7438400|NCT01632904|11721914|FG001|Overall Study|Adverse Event|1
7438401|NCT01632904|11721913|FG000|Overall Study|Physician Decision|0
7438402|NCT01632904|11721914|FG001|Overall Study|Physician Decision|1
7438403|NCT01632904|11721913|FG000|Overall Study|Subject decision|3
7438404|NCT01632904|11721914|FG001|Overall Study|Subject decision|2
7438405|NCT01632904|11721913|FG000|Overall Study|Disease Progression|0
7438406|NCT01632904|11721914|FG001|Overall Study|Disease Progression|1
7438407|NCT01632904|11721913|FG000|Overall Study|Reason for discontinuation not available|0
7438408|NCT01632904|11721914|FG001|Overall Study|Reason for discontinuation not available|1
7438409|NCT01633060|11721928|FG000|Randomization Phase|Protocol deviation|1
7438410|NCT01633060|11721929|FG001|Randomization Phase|Protocol deviation|2
7438411|NCT01633060|11721928|FG000|Randomization Phase|Technical problem|0
7438412|NCT01633060|11721929|FG001|Randomization Phase|Technical problem|1
7532920|NCT02677844|11878804|FG006|Period 3|Withdrawal by Subject|0
7532921|NCT02678000|11878828|FG000|PART 2|Adverse Event|0
7438413|NCT01633060|11721928|FG000|Treatment Phase|Adverse Event|24
7438414|NCT01633060|11721929|FG001|Treatment Phase|Adverse Event|3
7438415|NCT01633060|11721928|FG000|Treatment Phase|Lost to Follow-up|1
7438416|NCT01633060|11721929|FG001|Treatment Phase|Lost to Follow-up|0
7438417|NCT01633060|11721928|FG000|Treatment Phase|Physician Decision|16
7438418|NCT01633060|11721929|FG001|Treatment Phase|Physician Decision|7
7438419|NCT01633060|11721928|FG000|Treatment Phase|Progressive Disease|210
7438420|NCT01633060|11721929|FG001|Treatment Phase|Progressive Disease|120
7438421|NCT01633060|11721928|FG000|Treatment Phase|Protocol Deviation|1
7438422|NCT01633060|11721929|FG001|Treatment Phase|Protocol Deviation|0
7438423|NCT01633060|11721928|FG000|Treatment Phase|Study Terminated by sponsor|7
7438424|NCT01633060|11721929|FG001|Treatment Phase|Study Terminated by sponsor|3
7532922|NCT02678000|11878829|FG001|PART 2|Adverse Event|0
7532923|NCT02678000|11878830|FG002|PART 2|Adverse Event|2
7438425|NCT01633060|11721928|FG000|Treatment Phase|Subject/guardian decision|25
7438426|NCT01633060|11721929|FG001|Treatment Phase|Subject/guardian decision|4
7438427|NCT01633060|11721928|FG000|Treatment Phase|Death|4
7438428|NCT01633060|11721929|FG001|Treatment Phase|Death|3
7438429|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
7438430|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
7438431|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
7438432|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
7438433|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
7438434|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
7438435|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
7438436|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
7438437|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7438438|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
7438439|NCT01633060|11721928|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
7438440|NCT01633060|11721929|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
7438441|NCT01633112|11721939|FG000|Overall Study|Lack of Efficacy|1
7438442|NCT01633112|11721940|FG001|Overall Study|Lack of Efficacy|6
7438443|NCT01633112|11721941|FG002|Overall Study|Lack of Efficacy|13
7438444|NCT01633112|11721939|FG000|Overall Study|Abnormal laboratory value(s)|3
7438445|NCT01633112|11721940|FG001|Overall Study|Abnormal laboratory value(s)|1
7438446|NCT01633112|11721941|FG002|Overall Study|Abnormal laboratory value(s)|0
7438447|NCT01633112|11721939|FG000|Overall Study|Abnormal test procedure result(s)|0
7438448|NCT01633112|11721940|FG001|Overall Study|Abnormal test procedure result(s)|1
7438449|NCT01633112|11721941|FG002|Overall Study|Abnormal test procedure result(s)|0
7438450|NCT01633112|11721939|FG000|Overall Study|Administrative problems|1
7438451|NCT01633112|11721940|FG001|Overall Study|Administrative problems|2
7438452|NCT01633112|11721941|FG002|Overall Study|Administrative problems|5
7438453|NCT01633112|11721939|FG000|Overall Study|Adverse Event|16
7438454|NCT01633112|11721940|FG001|Overall Study|Adverse Event|18
7438455|NCT01633112|11721941|FG002|Overall Study|Adverse Event|20
7438456|NCT01633112|11721939|FG000|Overall Study|Lost to Follow-up|7
7438457|NCT01633112|11721940|FG001|Overall Study|Lost to Follow-up|19
7438458|NCT01633112|11721941|FG002|Overall Study|Lost to Follow-up|6
7438459|NCT01633112|11721939|FG000|Overall Study|Protocol Violation|4
7438460|NCT01633112|11721940|FG001|Overall Study|Protocol Violation|0
7438461|NCT01633112|11721941|FG002|Overall Study|Protocol Violation|2
7438462|NCT01633112|11721939|FG000|Overall Study|Subject no longer requires study drug|0
7438463|NCT01633112|11721940|FG001|Overall Study|Subject no longer requires study drug|0
7438464|NCT01633112|11721941|FG002|Overall Study|Subject no longer requires study drug|1
7438465|NCT01633112|11721939|FG000|Overall Study|Withdrawal by Subject|20
7438466|NCT01633112|11721940|FG001|Overall Study|Withdrawal by Subject|12
7438467|NCT01633112|11721941|FG002|Overall Study|Withdrawal by Subject|41
7438468|NCT01633112|11721939|FG000|Overall Study|missing Study Completion CRF|1
7438469|NCT01633112|11721940|FG001|Overall Study|missing Study Completion CRF|1
7438470|NCT01633112|11721941|FG002|Overall Study|missing Study Completion CRF|4
7438471|NCT01633788|11721972|FG000|Overall Study|Adverse Event|1
7438472|NCT01633788|11721973|FG001|Overall Study|Adverse Event|3
7438473|NCT01633788|11721974|FG002|Overall Study|Adverse Event|3
7438474|NCT01633788|11721975|FG003|Overall Study|Adverse Event|3
7561120|NCT03192150|11928933|FG000|Overall Study|Withdrawal by Subject|4
7532924|NCT02678000|11878831|FG003|PART 2|Adverse Event|1
7438475|NCT01633788|11721972|FG000|Overall Study|Lost to Follow-up|2
7438476|NCT01633788|11721973|FG001|Overall Study|Lost to Follow-up|2
7438477|NCT01633788|11721974|FG002|Overall Study|Lost to Follow-up|2
7438478|NCT01633788|11721975|FG003|Overall Study|Lost to Follow-up|0
7438479|NCT01633788|11721972|FG000|Overall Study|Personal Reasons|3
7561121|NCT03192150|11928934|FG001|Overall Study|Withdrawal by Subject|2
7438480|NCT01633788|11721973|FG001|Overall Study|Personal Reasons|1
7438481|NCT01633788|11721974|FG002|Overall Study|Personal Reasons|1
7438482|NCT01633788|11721975|FG003|Overall Study|Personal Reasons|3
7438483|NCT01633788|11721972|FG000|Overall Study|Protocol Violation|1
7438484|NCT01633788|11721973|FG001|Overall Study|Protocol Violation|0
7438485|NCT01633788|11721974|FG002|Overall Study|Protocol Violation|1
7438486|NCT01633788|11721975|FG003|Overall Study|Protocol Violation|0
7438487|NCT01633788|11721972|FG000|Overall Study|Other Reasons|0
7438488|NCT01633788|11721973|FG001|Overall Study|Other Reasons|2
7438489|NCT01633788|11721974|FG002|Overall Study|Other Reasons|3
7438490|NCT01633788|11721975|FG003|Overall Study|Other Reasons|7
7438491|NCT01633944|11722015|FG000|Open-label Titration Phase|Adverse Event|109
7438492|NCT01633944|11722016|FG001|Open-label Titration Phase|Adverse Event|0
7532925|NCT02678000|11878832|FG004|PART 2|Adverse Event|0
7532926|NCT02678000|11878828|FG000|PART 2|Withdrawal by Subject|0
7532927|NCT02678000|11878829|FG001|PART 2|Withdrawal by Subject|0
7532928|NCT02678000|11878830|FG002|PART 2|Withdrawal by Subject|1
7532929|NCT02678000|11878831|FG003|PART 2|Withdrawal by Subject|0
7532930|NCT02678000|11878832|FG004|PART 2|Withdrawal by Subject|0
7532931|NCT02678247|11878868|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
7532932|NCT02678247|11878869|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
7532933|NCT02678247|11878868|FG000|First Intervention (7 Weeks)|Adverse Event|1
7438493|NCT01633944|11722017|FG002|Open-label Titration Phase|Adverse Event|0
7438494|NCT01633944|11722015|FG000|Open-label Titration Phase|Lack of Efficacy|33
7438495|NCT01633944|11722016|FG001|Open-label Titration Phase|Lack of Efficacy|0
7438496|NCT01633944|11722017|FG002|Open-label Titration Phase|Lack of Efficacy|0
7438497|NCT01633944|11722015|FG000|Open-label Titration Phase|Withdrawal by Subject|34
7438498|NCT01633944|11722016|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7438499|NCT01633944|11722017|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7438500|NCT01633944|11722015|FG000|Open-label Titration Phase|Protocol Violation|24
7438501|NCT01633944|11722016|FG001|Open-label Titration Phase|Protocol Violation|0
7438502|NCT01633944|11722017|FG002|Open-label Titration Phase|Protocol Violation|0
7438503|NCT01633944|11722015|FG000|Open-label Titration Phase|Lost to Follow-up|22
7438504|NCT01633944|11722016|FG001|Open-label Titration Phase|Lost to Follow-up|0
7438505|NCT01633944|11722017|FG002|Open-label Titration Phase|Lost to Follow-up|0
7438506|NCT01633944|11722015|FG000|Open-label Titration Phase|Other|68
7438507|NCT01633944|11722016|FG001|Open-label Titration Phase|Other|0
7438508|NCT01633944|11722017|FG002|Open-label Titration Phase|Other|0
7438509|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Adverse Event|0
7438510|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Adverse Event|13
7438511|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Adverse Event|7
7438512|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7438513|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
7438514|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
7438515|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7438516|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7438517|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
7438518|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Protocol Violation|0
7438519|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Protocol Violation|7
7438520|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Protocol Violation|10
7438521|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7438522|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
7438523|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
7438524|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7438525|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
7438526|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7438527|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
7438528|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
7438529|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
7438530|NCT01633944|11722015|FG000|Double-blind Treatment Phase|Other|0
7438531|NCT01633944|11722016|FG001|Double-blind Treatment Phase|Other|7
7438532|NCT01633944|11722017|FG002|Double-blind Treatment Phase|Other|0
7438533|NCT01634100|11722025|FG000|Overall Study|Withdrawal by Subject|1
7438534|NCT01634100|11722026|FG001|Overall Study|Withdrawal by Subject|0
7438535|NCT01634100|11722027|FG002|Overall Study|Withdrawal by Subject|1
7438536|NCT01634100|11722028|FG003|Overall Study|Withdrawal by Subject|0
7438537|NCT01634100|11722029|FG004|Overall Study|Withdrawal by Subject|0
7438538|NCT01634100|11722030|FG005|Overall Study|Withdrawal by Subject|0
7438539|NCT01634113|11722041|FG000|Overall Study|Not treated|0
7438540|NCT01634113|11722042|FG001|Overall Study|Not treated|0
7438541|NCT01634113|11722043|FG002|Overall Study|Not treated|1
7438542|NCT01634139|11722054|FG000|Overall Study|Non compliant with protocol|1
7438543|NCT01634139|11722055|FG001|Overall Study|Non compliant with protocol|0
7438544|NCT01634139|11722056|FG002|Overall Study|Non compliant with protocol|0
7438545|NCT01634139|11722054|FG000|Overall Study|Consent withdrawn not due to AE|4
7438546|NCT01634139|11722055|FG001|Overall Study|Consent withdrawn not due to AE|3
7438547|NCT01634139|11722056|FG002|Overall Study|Consent withdrawn not due to AE|2
7438548|NCT01634139|11722054|FG000|Overall Study|Other|4
7438549|NCT01634139|11722055|FG001|Overall Study|Other|0
7438550|NCT01634139|11722056|FG002|Overall Study|Other|3
7438551|NCT01634139|11722054|FG000|Overall Study|Lost to Follow-up|0
7438552|NCT01634139|11722055|FG001|Overall Study|Lost to Follow-up|2
7438553|NCT01634139|11722056|FG002|Overall Study|Lost to Follow-up|0
7438554|NCT01634139|11722054|FG000|Overall Study|Not treated|1
7438555|NCT01634139|11722055|FG001|Overall Study|Not treated|1
7438556|NCT01634139|11722056|FG002|Overall Study|Not treated|0
7438557|NCT01634152|11722067|FG000|Overall Study|Adverse Event|2
7438558|NCT01634152|11722068|FG001|Overall Study|Adverse Event|0
7438559|NCT01634152|11722069|FG002|Overall Study|Adverse Event|2
7438560|NCT01634152|11722067|FG000|Overall Study|Consent withdrawn not due to AE|1
7438561|NCT01634152|11722068|FG001|Overall Study|Consent withdrawn not due to AE|0
7438562|NCT01634152|11722069|FG002|Overall Study|Consent withdrawn not due to AE|1
7438563|NCT01634152|11722067|FG000|Overall Study|Not treated|0
7438564|NCT01634152|11722068|FG001|Overall Study|Not treated|1
7438565|NCT01634152|11722069|FG002|Overall Study|Not treated|0
7438566|NCT01634152|11722067|FG000|Overall Study|Other reason not defined above|1
7438567|NCT01634152|11722068|FG001|Overall Study|Other reason not defined above|0
7438568|NCT01634152|11722069|FG002|Overall Study|Other reason not defined above|1
7438569|NCT01634165|11722077|FG000|Period 2|Adverse Event|0
7438570|NCT01634165|11722078|FG001|Period 2|Adverse Event|1
7438571|NCT01634165|11722079|FG002|Period 2|Adverse Event|0
7438572|NCT01634165|11722080|FG003|Period 2|Adverse Event|0
7438573|NCT01634178|11722090|FG000|Treatment Period 1|Adverse Event|0
7438574|NCT01634178|11722091|FG001|Treatment Period 1|Adverse Event|1
7438575|NCT01634178|11722090|FG000|Treatment Period 2|Adverse Event|1
7438576|NCT01634178|11722091|FG001|Treatment Period 2|Adverse Event|0
7438577|NCT01634243|11722122|FG000|Overall Study|Adverse Event|5
7438578|NCT01634243|11722123|FG001|Overall Study|Adverse Event|5
7438579|NCT01634243|11722122|FG000|Overall Study|Lack of Efficacy|1
7438580|NCT01634243|11722123|FG001|Overall Study|Lack of Efficacy|0
7438581|NCT01634360|11722150|FG000|Overall Study|Adverse Event|10
7438582|NCT01634360|11722151|FG001|Overall Study|Adverse Event|34
7438583|NCT01634360|11722150|FG000|Overall Study|subject withdrew consent|13
7438584|NCT01634360|11722151|FG001|Overall Study|subject withdrew consent|23
7438585|NCT01634360|11722150|FG000|Overall Study|Protocol Violation|1
7438586|NCT01634360|11722151|FG001|Overall Study|Protocol Violation|1
7438587|NCT01634360|11722150|FG000|Overall Study|Lack of Efficacy|4
7438588|NCT01634360|11722151|FG001|Overall Study|Lack of Efficacy|14
7438589|NCT01634360|11722150|FG000|Overall Study|Other|3
7438590|NCT01634360|11722151|FG001|Overall Study|Other|20
7438591|NCT01634360|11722150|FG000|Overall Study|Study termination by sponsor|18
7438592|NCT01634360|11722151|FG001|Overall Study|Study termination by sponsor|44
7438593|NCT01634555|11722157|FG000|Overall Study|Adverse Event|3
7438594|NCT01634555|11722157|FG000|Overall Study|Physician Decision|1
7438595|NCT01634659|11722173|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
7438596|NCT01634659|11722174|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
7438597|NCT01634659|11722173|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
7438598|NCT01634659|11722174|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
7438599|NCT01634854|11722182|FG000|Overall Study|Cesarean delivery|2
7438600|NCT01634854|11722183|FG001|Overall Study|Cesarean delivery|7
7438601|NCT01635153|11722220|FG000|Overall Study|Lost to Follow-up|40
7438602|NCT01635153|11722221|FG001|Overall Study|Lost to Follow-up|43
7438603|NCT01635218|11722230|FG000|Overall Study|Lost to Follow-up|3
7438604|NCT01635218|11722231|FG001|Overall Study|Lost to Follow-up|7
7438605|NCT01635218|11722232|FG002|Overall Study|Lost to Follow-up|6
7438606|NCT01635283|11722253|FG000|Overall Study|Tumor Progression|3
7438607|NCT01635283|11722253|FG000|Overall Study|Lost to Follow-up|1
7438608|NCT01635764|11722278|FG000|Overall Study|Adverse Event|46
7438609|NCT01635764|11722278|FG000|Overall Study|Lack of Efficacy|76
7438610|NCT01635764|11722278|FG000|Overall Study|Exceed Protocol-specified Interventions|2
7438611|NCT01635764|11722278|FG000|Overall Study|Protocol Deviation|1
7438612|NCT01635764|11722278|FG000|Overall Study|Withdrew Consent|67
7438613|NCT01635764|11722278|FG000|Overall Study|Lost to Follow-up|53
7438614|NCT01635764|11722278|FG000|Overall Study|Other|28
7438615|NCT01635855|11722289|FG000|Overall Study|Withdrawal by Subject|4
7438616|NCT01635920|11722299|FG000|Overall Study|Adverse Event|1
7438617|NCT01635920|11722300|FG001|Overall Study|Adverse Event|0
7438618|NCT01635920|11722299|FG000|Overall Study|Lost to Follow-up|0
7438619|NCT01635920|11722300|FG001|Overall Study|Lost to Follow-up|1
7438620|NCT01635920|11722299|FG000|Overall Study|Subject decision|2
7438621|NCT01635920|11722300|FG001|Overall Study|Subject decision|0
7438622|NCT01635933|11722309|FG000|Overall Study|Adverse Event|1
7438623|NCT01635933|11722310|FG001|Overall Study|Adverse Event|0
7438624|NCT01635933|11722309|FG000|Overall Study|Lost to Follow-up|0
7438625|NCT01635933|11722310|FG001|Overall Study|Lost to Follow-up|5
7438626|NCT01635933|11722309|FG000|Overall Study|Subject decision|1
7438627|NCT01635933|11722310|FG001|Overall Study|Subject decision|1
7438628|NCT01635933|11722309|FG000|Overall Study|Noncompliance|0
7438629|NCT01635933|11722310|FG001|Overall Study|Noncompliance|1
7438630|NCT01635933|11722309|FG000|Overall Study|No longer had transportation|0
7438631|NCT01635933|11722310|FG001|Overall Study|No longer had transportation|1
7438632|NCT01635998|11722318|FG000|Overall Study|Death|1
7438633|NCT01635998|11722319|FG001|Overall Study|Death|1
7438634|NCT01635998|11722318|FG000|Overall Study|Lost to Follow-up|2
7438635|NCT01635998|11722319|FG001|Overall Study|Lost to Follow-up|1
7438636|NCT01635998|11722318|FG000|Overall Study|Withdrawal by Subject|1
7438637|NCT01635998|11722319|FG001|Overall Study|Withdrawal by Subject|5
7438638|NCT01636076|11722336|FG000|Overall Study|Terminated by sponsor|1
7438639|NCT01636076|11722337|FG001|Overall Study|Terminated by sponsor|1
7438640|NCT01636076|11722336|FG000|Overall Study|Lack of Efficacy|0
7438641|NCT01636076|11722337|FG001|Overall Study|Lack of Efficacy|1
7438642|NCT01636076|11722336|FG000|Overall Study|Lost to Follow-up|1
7438643|NCT01636076|11722337|FG001|Overall Study|Lost to Follow-up|0
7438644|NCT01636076|11722336|FG000|Overall Study|Physician Decision|1
7438645|NCT01636076|11722337|FG001|Overall Study|Physician Decision|1
7438646|NCT01636076|11722336|FG000|Overall Study|Non-compliance with study treatment|1
7438647|NCT01636076|11722337|FG001|Overall Study|Non-compliance with study treatment|1
7438648|NCT01636076|11722336|FG000|Overall Study|Adverse Event|6
7438649|NCT01636076|11722337|FG001|Overall Study|Adverse Event|11
7438650|NCT01636076|11722336|FG000|Overall Study|Withdrawal by Subject|7
7438651|NCT01636076|11722337|FG001|Overall Study|Withdrawal by Subject|10
7438652|NCT01636362|11722388|FG000|Overall Study|Physician Decision|6
7438653|NCT01636362|11722388|FG000|Overall Study|Subject healed, not returning|1
7438654|NCT01636362|11722388|FG000|Overall Study|Withdrawal by Subject|1
7438655|NCT01636687|11722421|FG000|Induction Period|Withdrawal by Subject|1
7438656|NCT01636687|11722422|FG001|Induction Period|Withdrawal by Subject|0
7438657|NCT01636687|11722423|FG002|Induction Period|Withdrawal by Subject|0
7561122|NCT03192150|11928933|FG000|Overall Study|Protocol Violation|5
7561123|NCT03192150|11928934|FG001|Overall Study|Protocol Violation|2
7561124|NCT03192150|11928933|FG000|Overall Study|Surgery Canceled|6
7438658|NCT01636687|11722424|FG003|Induction Period|Withdrawal by Subject|0
7438659|NCT01636687|11722425|FG004|Induction Period|Withdrawal by Subject|0
7438660|NCT01636687|11722421|FG000|Induction Period|Adverse Event|1
7438661|NCT01636687|11722422|FG001|Induction Period|Adverse Event|0
7438662|NCT01636687|11722423|FG002|Induction Period|Adverse Event|0
7438663|NCT01636687|11722424|FG003|Induction Period|Adverse Event|0
7438664|NCT01636687|11722425|FG004|Induction Period|Adverse Event|1
7438665|NCT01636687|11722421|FG000|Induction Period|Lack of Efficacy|0
7438666|NCT01636687|11722422|FG001|Induction Period|Lack of Efficacy|0
7438667|NCT01636687|11722423|FG002|Induction Period|Lack of Efficacy|0
7438668|NCT01636687|11722424|FG003|Induction Period|Lack of Efficacy|0
7438669|NCT01636687|11722425|FG004|Induction Period|Lack of Efficacy|1
7438670|NCT01636687|11722421|FG000|Induction Period|Physician Decision|1
7438671|NCT01636687|11722422|FG001|Induction Period|Physician Decision|0
7438672|NCT01636687|11722423|FG002|Induction Period|Physician Decision|0
7438673|NCT01636687|11722424|FG003|Induction Period|Physician Decision|0
7438674|NCT01636687|11722425|FG004|Induction Period|Physician Decision|0
7438675|NCT01636687|11722421|FG000|Maintenance Period|Withdrawal by Subject|2
7438676|NCT01636687|11722422|FG001|Maintenance Period|Withdrawal by Subject|0
7438677|NCT01636687|11722423|FG002|Maintenance Period|Withdrawal by Subject|2
7438678|NCT01636687|11722424|FG003|Maintenance Period|Withdrawal by Subject|0
7438679|NCT01636687|11722425|FG004|Maintenance Period|Withdrawal by Subject|0
7438680|NCT01636687|11722421|FG000|Maintenance Period|Adverse Event|1
7438681|NCT01636687|11722422|FG001|Maintenance Period|Adverse Event|0
7438682|NCT01636687|11722423|FG002|Maintenance Period|Adverse Event|0
7438683|NCT01636687|11722424|FG003|Maintenance Period|Adverse Event|0
7438684|NCT01636687|11722425|FG004|Maintenance Period|Adverse Event|0
7438685|NCT01636687|11722421|FG000|Maintenance Period|Lack of Efficacy|4
7438686|NCT01636687|11722422|FG001|Maintenance Period|Lack of Efficacy|1
7438687|NCT01636687|11722423|FG002|Maintenance Period|Lack of Efficacy|0
7438688|NCT01636687|11722424|FG003|Maintenance Period|Lack of Efficacy|0
7438689|NCT01636687|11722425|FG004|Maintenance Period|Lack of Efficacy|0
7438690|NCT01636687|11722421|FG000|Maintenance Period|Lost to Follow-up|1
7438691|NCT01636687|11722422|FG001|Maintenance Period|Lost to Follow-up|1
7438692|NCT01636687|11722423|FG002|Maintenance Period|Lost to Follow-up|0
7438693|NCT01636687|11722424|FG003|Maintenance Period|Lost to Follow-up|0
7438694|NCT01636687|11722425|FG004|Maintenance Period|Lost to Follow-up|1
7438695|NCT01636687|11722421|FG000|Maintenance Period|Physician Decision|0
7438696|NCT01636687|11722422|FG001|Maintenance Period|Physician Decision|0
7438697|NCT01636687|11722423|FG002|Maintenance Period|Physician Decision|0
7438698|NCT01636687|11722424|FG003|Maintenance Period|Physician Decision|0
7438699|NCT01636687|11722425|FG004|Maintenance Period|Physician Decision|1
7438700|NCT01636687|11722421|FG000|Extension Period|technical problems|0
7438701|NCT01636687|11722422|FG001|Extension Period|technical problems|1
7438702|NCT01636687|11722423|FG002|Extension Period|technical problems|2
7438703|NCT01636687|11722424|FG003|Extension Period|technical problems|1
7438704|NCT01636687|11722425|FG004|Extension Period|technical problems|0
7438705|NCT01636687|11722421|FG000|Extension Period|Adverse Event|4
7438706|NCT01636687|11722422|FG001|Extension Period|Adverse Event|3
7438707|NCT01636687|11722423|FG002|Extension Period|Adverse Event|2
7438708|NCT01636687|11722424|FG003|Extension Period|Adverse Event|1
7438709|NCT01636687|11722425|FG004|Extension Period|Adverse Event|0
7438710|NCT01636687|11722421|FG000|Extension Period|Lack of Efficacy|7
7438711|NCT01636687|11722422|FG001|Extension Period|Lack of Efficacy|0
7438712|NCT01636687|11722423|FG002|Extension Period|Lack of Efficacy|2
7438713|NCT01636687|11722424|FG003|Extension Period|Lack of Efficacy|1
7438714|NCT01636687|11722425|FG004|Extension Period|Lack of Efficacy|0
7438715|NCT01636687|11722421|FG000|Extension Period|Lost to Follow-up|1
7438716|NCT01636687|11722422|FG001|Extension Period|Lost to Follow-up|0
7438717|NCT01636687|11722423|FG002|Extension Period|Lost to Follow-up|1
7438718|NCT01636687|11722424|FG003|Extension Period|Lost to Follow-up|0
7438719|NCT01636687|11722425|FG004|Extension Period|Lost to Follow-up|0
7438720|NCT01636687|11722421|FG000|Extension Period|Physician Decision|1
7438721|NCT01636687|11722422|FG001|Extension Period|Physician Decision|0
7438722|NCT01636687|11722423|FG002|Extension Period|Physician Decision|0
7438723|NCT01636687|11722424|FG003|Extension Period|Physician Decision|1
7438724|NCT01636687|11722425|FG004|Extension Period|Physician Decision|0
7438725|NCT01636687|11722421|FG000|Extension Period|study terminated by sponsor|33
7438726|NCT01636687|11722422|FG001|Extension Period|study terminated by sponsor|50
7438727|NCT01636687|11722423|FG002|Extension Period|study terminated by sponsor|17
7438728|NCT01636687|11722424|FG003|Extension Period|study terminated by sponsor|23
7438729|NCT01636687|11722425|FG004|Extension Period|study terminated by sponsor|0
7438730|NCT01636687|11722421|FG000|Extension Period|Withdrawal by Subject|1
7438731|NCT01636687|11722422|FG001|Extension Period|Withdrawal by Subject|0
7438732|NCT01636687|11722423|FG002|Extension Period|Withdrawal by Subject|1
7438733|NCT01636687|11722424|FG003|Extension Period|Withdrawal by Subject|1
7438734|NCT01636687|11722425|FG004|Extension Period|Withdrawal by Subject|0
7438735|NCT01636687|11722421|FG000|Follow-up Period|Withdrawal by Subject|1
7438736|NCT01636687|11722422|FG001|Follow-up Period|Withdrawal by Subject|0
7438737|NCT01636687|11722423|FG002|Follow-up Period|Withdrawal by Subject|0
7438738|NCT01636687|11722424|FG003|Follow-up Period|Withdrawal by Subject|0
7438739|NCT01636687|11722425|FG004|Follow-up Period|Withdrawal by Subject|1
7438740|NCT01636713|11722446|FG000|Overall Study|Adverse Event|16
7438741|NCT01636713|11722447|FG001|Overall Study|Adverse Event|16
7438742|NCT01636713|11722448|FG002|Overall Study|Adverse Event|7
7438743|NCT01636713|11722446|FG000|Overall Study|Lack of Efficacy|6
7438744|NCT01636713|11722447|FG001|Overall Study|Lack of Efficacy|6
7438745|NCT01636713|11722448|FG002|Overall Study|Lack of Efficacy|2
7438746|NCT01636713|11722446|FG000|Overall Study|Protocol Violation|3
7438747|NCT01636713|11722447|FG001|Overall Study|Protocol Violation|0
7438748|NCT01636713|11722448|FG002|Overall Study|Protocol Violation|1
7438749|NCT01636713|11722446|FG000|Overall Study|Lost to Follow-up|0
7438750|NCT01636713|11722447|FG001|Overall Study|Lost to Follow-up|0
7438751|NCT01636713|11722448|FG002|Overall Study|Lost to Follow-up|1
7438752|NCT01636713|11722446|FG000|Overall Study|Withdrawal by Subject|5
7438753|NCT01636713|11722447|FG001|Overall Study|Withdrawal by Subject|4
7438754|NCT01636713|11722448|FG002|Overall Study|Withdrawal by Subject|8
7438755|NCT01636713|11722446|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
7438756|NCT01636713|11722447|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
7438757|NCT01636713|11722448|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
7438758|NCT01636778|11722460|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
7438759|NCT01636778|11722461|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7438760|NCT01636778|11722462|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
7438761|NCT01636778|11722460|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
7438762|NCT01636778|11722461|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7438763|NCT01636778|11722462|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
7438764|NCT01636778|11722460|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
7438765|NCT01636778|11722461|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
7438766|NCT01636778|11722462|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
7438767|NCT01636778|11722460|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7438768|NCT01636778|11722461|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
7438769|NCT01636778|11722462|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
7438770|NCT01636778|11722460|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
7438771|NCT01636778|11722461|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
7438772|NCT01636778|11722462|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
7438773|NCT01636778|11722460|FG000|Follow-up Period After Part 2|Other|0
7438774|NCT01636778|11722461|FG001|Follow-up Period After Part 2|Other|0
7438775|NCT01636778|11722462|FG002|Follow-up Period After Part 2|Other|1
7438776|NCT01636778|11722460|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7438777|NCT01636778|11722461|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
7438778|NCT01636778|11722462|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
7438779|NCT01636778|11722460|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
7438780|NCT01636778|11722461|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
7438781|NCT01636778|11722462|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
7438782|NCT01636934|11722476|FG000|Overall Study|Withdrawal by Subject|3
7438783|NCT01636934|11722477|FG001|Overall Study|Withdrawal by Subject|2
7438784|NCT01636934|11722476|FG000|Overall Study|Chemo cancel|1
7438785|NCT01636934|11722477|FG001|Overall Study|Chemo cancel|0
7438786|NCT01636934|11722476|FG000|Overall Study|Too ill to continue|1
7438787|NCT01636934|11722477|FG001|Overall Study|Too ill to continue|0
7438788|NCT01636934|11722476|FG000|Overall Study|Never started study medication|1
7438789|NCT01636934|11722477|FG001|Overall Study|Never started study medication|1
7438790|NCT01636947|11722485|FG000|Overall Study|Not Treated|2
7438791|NCT01636947|11722486|FG001|Overall Study|Not Treated|2
7438792|NCT01636947|11722485|FG000|Overall Study|Lost to Follow-up|4
7438793|NCT01636947|11722486|FG001|Overall Study|Lost to Follow-up|0
7438794|NCT01636947|11722485|FG000|Overall Study|Protocol Violation|1
7438795|NCT01636947|11722486|FG001|Overall Study|Protocol Violation|1
7438796|NCT01636947|11722485|FG000|Overall Study|Withdrawal by Subject|3
7438797|NCT01636947|11722486|FG001|Overall Study|Withdrawal by Subject|3
7438798|NCT01636947|11722485|FG000|Overall Study|Adverse Event|1
7438799|NCT01636947|11722486|FG001|Overall Study|Adverse Event|1
7438800|NCT01636947|11722485|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7438801|NCT01636947|11722486|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
7438802|NCT01636960|11722492|FG000|Induction Phase|Adverse Event|2
7438803|NCT01636960|11722492|FG000|Maintenance Phase|Continued drug after regulatory approval|3
7438804|NCT01636960|11722492|FG000|Maintenance Phase|Adverse Event|3
7438805|NCT01636960|11722492|FG000|Maintenance Phase|Progressive disease|1
7438806|NCT01636986|11722498|FG000|Overall Study|Withdrawal by Subject|0
7438807|NCT01636986|11722499|FG001|Overall Study|Withdrawal by Subject|1
7438808|NCT01636986|11722498|FG000|Overall Study|Corneal Staining|0
7438809|NCT01636986|11722499|FG001|Overall Study|Corneal Staining|1
7438810|NCT01637077|11722507|FG000|Overall Study|Cancel|1
7438811|NCT01637077|11722508|FG001|Overall Study|Cancel|1
7438812|NCT01637077|11722507|FG000|Overall Study|Withdrawal by Subject|1
7438813|NCT01637077|11722508|FG001|Overall Study|Withdrawal by Subject|0
7438814|NCT01637077|11722507|FG000|Overall Study|No cycle 1 questionnaire data|2
7438815|NCT01637077|11722508|FG001|Overall Study|No cycle 1 questionnaire data|0
7438816|NCT01637142|11722518|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
7438817|NCT01637272|11722528|FG000|Overall Study|Adverse Event|6
7438818|NCT01637272|11722528|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7438819|NCT01637272|11722528|FG000|Overall Study|Withdrawal by Subject|3
7561125|NCT03192150|11928934|FG001|Overall Study|Surgery Canceled|2
7438820|NCT01637272|11722528|FG000|Overall Study|Lost to Follow-up|2
7438821|NCT01637272|11722528|FG000|Overall Study|completed core, did not enter ext. phase|4
7438822|NCT01637272|11722528|FG000|Overall Study|Administrative problems|1
7438823|NCT01637272|11722528|FG000|Overall Study|Protocol Violation|2
7438824|NCT01637402|11722547|FG000|Standard Dose Regimen|Lack of Efficacy|2
7438825|NCT01637402|11722548|FG001|Standard Dose Regimen|Lack of Efficacy|0
7438826|NCT01637402|11722547|FG000|Standard Dose Regimen|Adverse Event|1
7438827|NCT01637402|11722548|FG001|Standard Dose Regimen|Adverse Event|0
7438828|NCT01637402|11722547|FG000|Week 12 Evaluation|Lack of Efficacy|6
7438829|NCT01637402|11722548|FG001|Week 12 Evaluation|Lack of Efficacy|0
7438830|NCT01637402|11722547|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
7438831|NCT01637402|11722548|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
7438832|NCT01637402|11722547|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
7438833|NCT01637402|11722548|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7438834|NCT01637402|11722547|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
7438835|NCT01637402|11722548|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
7438836|NCT01637584|11722575|FG000|Overall Study|Withdrawal by Subject|1
7438837|NCT01637584|11722576|FG001|Overall Study|Withdrawal by Subject|3
7438838|NCT01637623|11722586|FG000|Overall Study|Lost to Follow-up|0
7438839|NCT01637623|11722587|FG001|Overall Study|Lost to Follow-up|0
7438840|NCT01637623|11722588|FG002|Overall Study|Lost to Follow-up|2
7438841|NCT01637623|11722586|FG000|Overall Study|Physician Decision|1
7438842|NCT01637623|11722587|FG001|Overall Study|Physician Decision|0
7438843|NCT01637623|11722588|FG002|Overall Study|Physician Decision|1
7438844|NCT01637922|11722602|FG000|Overall Study|Adverse Event|0
7438845|NCT01637922|11722603|FG001|Overall Study|Adverse Event|1
7438846|NCT01637922|11722602|FG000|Overall Study|Protocol Violation|0
7438847|NCT01637922|11722603|FG001|Overall Study|Protocol Violation|1
7438848|NCT01637922|11722602|FG000|Overall Study|Withdrawal by Subject|0
7438849|NCT01637922|11722603|FG001|Overall Study|Withdrawal by Subject|3
7438850|NCT01637922|11722602|FG000|Overall Study|Lost to Follow-up|2
7438851|NCT01637922|11722603|FG001|Overall Study|Lost to Follow-up|0
7438852|NCT01637961|11722619|FG000|Overall Study|Ineligible: wrong primary|1
7438853|NCT01637961|11722619|FG000|Overall Study|Ineligible: inadequate pathology|1
7438854|NCT01638000|11722631|FG000|Overall Study|Randomized but Never Received Drug|7
7438855|NCT01638000|11722632|FG001|Overall Study|Randomized but Never Received Drug|10
7438856|NCT01638000|11722631|FG000|Overall Study|Adverse Event|14
7438857|NCT01638000|11722632|FG001|Overall Study|Adverse Event|16
7438858|NCT01638000|11722631|FG000|Overall Study|Lack of Efficacy|5
7438859|NCT01638000|11722632|FG001|Overall Study|Lack of Efficacy|6
7438860|NCT01638000|11722631|FG000|Overall Study|Protocol Violation|11
7438861|NCT01638000|11722632|FG001|Overall Study|Protocol Violation|13
7438862|NCT01638000|11722631|FG000|Overall Study|Withdrawal by Subject|21
7438863|NCT01638000|11722632|FG001|Overall Study|Withdrawal by Subject|24
7438864|NCT01638000|11722631|FG000|Overall Study|Miscellaneous|2
7438865|NCT01638000|11722632|FG001|Overall Study|Miscellaneous|2
7438866|NCT01638013|11722641|FG000|Overall Study|Adverse Event|36
7438867|NCT01638013|11722642|FG001|Overall Study|Adverse Event|29
7438868|NCT01638013|11722643|FG002|Overall Study|Adverse Event|48
7438869|NCT01638013|11722641|FG000|Overall Study|Lack of Efficacy|39
7438870|NCT01638013|11722642|FG001|Overall Study|Lack of Efficacy|11
7438871|NCT01638013|11722643|FG002|Overall Study|Lack of Efficacy|14
7438872|NCT01638013|11722641|FG000|Overall Study|Protocol Violation|10
7438873|NCT01638013|11722642|FG001|Overall Study|Protocol Violation|7
7438874|NCT01638013|11722643|FG002|Overall Study|Protocol Violation|11
7438875|NCT01638013|11722641|FG000|Overall Study|Met discontinuation criteria|4
7438876|NCT01638013|11722642|FG001|Overall Study|Met discontinuation criteria|0
7438877|NCT01638013|11722643|FG002|Overall Study|Met discontinuation criteria|7
7438878|NCT01638013|11722641|FG000|Overall Study|Subject Lost to Follow up|1
7438879|NCT01638013|11722642|FG001|Overall Study|Subject Lost to Follow up|0
7438880|NCT01638013|11722643|FG002|Overall Study|Subject Lost to Follow up|1
7438881|NCT01638013|11722641|FG000|Overall Study|Miscellaneous|25
7438882|NCT01638013|11722642|FG001|Overall Study|Miscellaneous|19
7438883|NCT01638013|11722643|FG002|Overall Study|Miscellaneous|23
7438884|NCT01638013|11722641|FG000|Overall Study|Withdrawal of Consent|16
7438885|NCT01638013|11722642|FG001|Overall Study|Withdrawal of Consent|12
7438886|NCT01638013|11722643|FG002|Overall Study|Withdrawal of Consent|16
7438887|NCT01638013|11722641|FG000|Overall Study|Not met inclusion or exclusion criteria|0
7438888|NCT01638013|11722642|FG001|Overall Study|Not met inclusion or exclusion criteria|0
7438889|NCT01638013|11722643|FG002|Overall Study|Not met inclusion or exclusion criteria|1
7438890|NCT01638390|11722673|FG000|Overall Study|screening failures|21
7438891|NCT01638429|11722694|FG000|Overall Study|Withdrawal by Subject|1
7438892|NCT01638546|11722714|FG000|Overall Study|Adverse Event|1
7532934|NCT02678247|11878869|FG001|First Intervention (7 Weeks)|Adverse Event|2
7438893|NCT01638546|11722715|FG001|Overall Study|Adverse Event|3
7438894|NCT01638559|11722723|FG000|Overall Study|Lost to Follow-up|1
7561126|NCT03192150|11928933|FG000|Overall Study|Other-Various Administrative Reasons|2
7438895|NCT01638559|11722723|FG000|Overall Study|Withdrawal by Subject|1
7438896|NCT01638559|11722723|FG000|Overall Study|Subject declined to travel for biopsy|1
7438897|NCT01638819|11722740|FG000|Overall Study|Lost to Follow-up|1
7438898|NCT01638819|11722741|FG001|Overall Study|Lost to Follow-up|0
7438899|NCT01639001|11722748|FG000|Overall Study|Refused further follow-up|9
7438900|NCT01639001|11722749|FG001|Overall Study|Refused further follow-up|12
7438901|NCT01639001|11722748|FG000|Overall Study|Lost to Follow-up|3
7438902|NCT01639001|11722749|FG001|Overall Study|Lost to Follow-up|0
7438903|NCT01639001|11722748|FG000|Overall Study|Death|62
7438904|NCT01639001|11722749|FG001|Overall Study|Death|61
7438905|NCT01639001|11722748|FG000|Overall Study|Randomized but not treated|0
7438906|NCT01639001|11722749|FG001|Overall Study|Randomized but not treated|2
7438907|NCT01639001|11722748|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
7438908|NCT01639001|11722749|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
7438909|NCT01639040|11722759|FG000|Overall Study|Adverse Event|1
7438910|NCT01639040|11722760|FG001|Overall Study|Adverse Event|0
7438911|NCT01639144|11722771|FG000|Overall Study|Withdrawal by Subject|4
7438912|NCT01639144|11722772|FG001|Overall Study|Withdrawal by Subject|2
7438913|NCT01639144|11722771|FG000|Overall Study|Physician Decision|2
7438914|NCT01639144|11722772|FG001|Overall Study|Physician Decision|0
7438915|NCT01639144|11722771|FG000|Overall Study|Met postoperative exclusion criteria|4
7438916|NCT01639144|11722772|FG001|Overall Study|Met postoperative exclusion criteria|3
7467361|NCT01900665|11767740|FG000|Placebo Controlled Period|Physician Decision|11
7467362|NCT01900665|11767741|FG001|Placebo Controlled Period|Physician Decision|7
7467363|NCT01900665|11767740|FG000|Placebo Controlled Period|Lost to Follow-up|3
7467364|NCT01900665|11767741|FG001|Placebo Controlled Period|Lost to Follow-up|0
7467365|NCT01900665|11767740|FG000|Placebo Controlled Period|Caregiver Decision|33
7467366|NCT01900665|11767741|FG001|Placebo Controlled Period|Caregiver Decision|41
7467367|NCT01900665|11767740|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
7467368|NCT01900665|11767741|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
7467369|NCT01900665|11767740|FG000|Open Label Period|Adverse Event|16
7467370|NCT01900665|11767741|FG001|Open Label Period|Adverse Event|20
7467371|NCT01900665|11767740|FG000|Open Label Period|Death|5
7467372|NCT01900665|11767741|FG001|Open Label Period|Death|6
7467373|NCT01900665|11767740|FG000|Open Label Period|Lost to Follow-up|1
7467374|NCT01900665|11767741|FG001|Open Label Period|Lost to Follow-up|1
7467375|NCT01900665|11767740|FG000|Open Label Period|Parent/Caregiver Decision|33
7467376|NCT01900665|11767741|FG001|Open Label Period|Parent/Caregiver Decision|34
7467377|NCT01900665|11767740|FG000|Open Label Period|Physician Decision|4
7467378|NCT01900665|11767741|FG001|Open Label Period|Physician Decision|4
7467379|NCT01900665|11767740|FG000|Open Label Period|Protocol Violation|0
7467380|NCT01900665|11767741|FG001|Open Label Period|Protocol Violation|1
7467381|NCT01900665|11767740|FG000|Open Label Period|Sponsor Decision|802
7467382|NCT01900665|11767741|FG001|Open Label Period|Sponsor Decision|765
7467383|NCT01900665|11767740|FG000|Open Label Period|Withdrawal by Subject|20
7467384|NCT01900665|11767741|FG001|Open Label Period|Withdrawal by Subject|28
7467385|NCT01900899|11767766|FG000|Overall Study|Withdrawal by Subject|7
7467386|NCT01900899|11767767|FG001|Overall Study|Withdrawal by Subject|1
7467387|NCT01900899|11767766|FG000|Overall Study|Migrated from study area|2
7467388|NCT01900899|11767767|FG001|Overall Study|Migrated from study area|0
7467389|NCT01901055|11767775|FG000|Randomization But Not Titrated|Did not come to titration study|1
7467390|NCT01901055|11767776|FG001|Randomization But Not Titrated|Did not come to titration study|1
7467391|NCT01901055|11767775|FG000|Randomization But Not Titrated|Physician Decision|0
7467392|NCT01901055|11767776|FG001|Randomization But Not Titrated|Physician Decision|1
7467393|NCT01901055|11767775|FG000|Started Protocol to Week 6|Physician Decision|2
7467394|NCT01901055|11767776|FG001|Started Protocol to Week 6|Physician Decision|1
7467395|NCT01901055|11767775|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
7467396|NCT01901055|11767776|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
7467397|NCT01901055|11767775|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
7467398|NCT01901055|11767776|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
7467399|NCT01901055|11767775|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
7467400|NCT01901055|11767776|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
7467401|NCT01901055|11767775|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
7467402|NCT01901055|11767776|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
7467403|NCT01901055|11767775|FG000|Week 12 Assessment|Withdrawal by Subject|0
7467404|NCT01901055|11767776|FG001|Week 12 Assessment|Withdrawal by Subject|4
7467405|NCT01901055|11767775|FG000|Week 24|Withdrawal by Subject|13
7467406|NCT01901055|11767776|FG001|Week 24|Withdrawal by Subject|19
7467407|NCT01901055|11767775|FG000|Week 24|Physician Decision|1
7467408|NCT01901055|11767776|FG001|Week 24|Physician Decision|0
7467409|NCT01901055|11767775|FG000|Week 36|Withdrawal by Subject|0
7467410|NCT01901055|11767776|FG001|Week 36|Withdrawal by Subject|5
7467411|NCT01901146|11767787|FG000|Neoadjuvant Phase|Death|1
7467412|NCT01901146|11767788|FG001|Neoadjuvant Phase|Death|2
7467413|NCT01901146|11767789|FG002|Neoadjuvant Phase|Death|0
7467414|NCT01901146|11767790|FG003|Neoadjuvant Phase|Death|0
7438917|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
7438918|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
7438919|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
7438920|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
7438921|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
7438922|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
7438923|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
7438924|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
7438925|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
7438926|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
7438927|NCT01639339|11722793|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
7438928|NCT01639339|11722794|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
7438929|NCT01639339|11722793|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
7438930|NCT01639339|11722794|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
7438931|NCT01639339|11722793|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
7438932|NCT01639339|11722794|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
7438933|NCT01639339|11722793|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
7438934|NCT01639339|11722794|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
7438935|NCT01639339|11722793|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
7438936|NCT01639339|11722794|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
7438937|NCT01639469|11722819|FG000|Overall Study|Death|4
7438938|NCT01639469|11722820|FG001|Overall Study|Death|2
7438939|NCT01639469|11722819|FG000|Overall Study|Lost to Follow-up|1
7438940|NCT01639469|11722820|FG001|Overall Study|Lost to Follow-up|1
7438941|NCT01639495|11722826|FG000|Overall Study|Lost to Follow-up|6
7438942|NCT01639495|11722826|FG000|Overall Study|Consented but didn't have study catheter|4
7438943|NCT01639495|11722826|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
7438944|NCT01639495|11722826|FG000|Overall Study|No radiofrequency energy applied|2
7438945|NCT01639560|11722832|FG000|Overall Study|Withdrawal by Subject|9
7438946|NCT01639560|11722833|FG001|Overall Study|Withdrawal by Subject|14
7438947|NCT01639560|11722832|FG000|Overall Study|Lack of Efficacy|1
7438948|NCT01639560|11722833|FG001|Overall Study|Lack of Efficacy|2
7438949|NCT01639560|11722832|FG000|Overall Study|Lost to Follow-up|9
7438950|NCT01639560|11722833|FG001|Overall Study|Lost to Follow-up|11
7438951|NCT01639560|11722832|FG000|Overall Study|Adverse Event|0
7438952|NCT01639560|11722833|FG001|Overall Study|Adverse Event|2
7438953|NCT01639703|11722862|FG000|Overall Study|Withdrawal by Subject|5
7438954|NCT01639703|11722862|FG000|Overall Study|Other reason|7
7438955|NCT01639729|11722878|FG000|Overall Study|Withdrawal by Subject|1
7438956|NCT01639729|11722879|FG001|Overall Study|Withdrawal by Subject|0
7438957|NCT01639729|11722880|FG002|Overall Study|Withdrawal by Subject|1
7438958|NCT01639729|11722881|FG003|Overall Study|Withdrawal by Subject|1
7438959|NCT01639729|11722882|FG004|Overall Study|Withdrawal by Subject|0
7438960|NCT01639729|11722883|FG005|Overall Study|Withdrawal by Subject|0
7438961|NCT01639742|11722893|FG000|Overall Study|Study Ongoing|17
7438962|NCT01639742|11722893|FG000|Overall Study|Lost to Follow-up|1
7438963|NCT01639755|11722897|FG000|Overall Study|Study Ongoing|15
7438964|NCT01639755|11722897|FG000|Overall Study|Patient had device explantation|4
7438965|NCT01639833|11722903|FG000|Overall Study|Death|4
7438966|NCT01639833|11722904|FG001|Overall Study|Death|2
7438967|NCT01639833|11722903|FG000|Overall Study|Withdrawal by Subject|2
7438968|NCT01639833|11722904|FG001|Overall Study|Withdrawal by Subject|2
7438969|NCT01640054|11722919|FG000|Overall Study|Study-specific disc criteria|1
7438970|NCT01640054|11722919|FG000|Overall Study|Lack of Efficacy|3
7438971|NCT01640054|11722919|FG000|Overall Study|Adverse Event|2
7438972|NCT01640184|11722931|FG000|Overall Study|Death|1
7438973|NCT01640184|11722932|FG001|Overall Study|Death|0
7438974|NCT01640184|11722933|FG002|Overall Study|Death|0
7438975|NCT01640184|11722931|FG000|Overall Study|Lost to Follow-up|4
7438976|NCT01640184|11722932|FG001|Overall Study|Lost to Follow-up|1
7438977|NCT01640184|11722933|FG002|Overall Study|Lost to Follow-up|0
7438978|NCT01640184|11722931|FG000|Overall Study|Physician Decision|3
7438979|NCT01640184|11722932|FG001|Overall Study|Physician Decision|0
7438980|NCT01640184|11722933|FG002|Overall Study|Physician Decision|0
7438981|NCT01640184|11722931|FG000|Overall Study|Withdrawal by Subject|0
7438982|NCT01640184|11722932|FG001|Overall Study|Withdrawal by Subject|1
7438983|NCT01640184|11722933|FG002|Overall Study|Withdrawal by Subject|1
7438984|NCT01640184|11722931|FG000|Overall Study|Protocol Violation|0
7438985|NCT01640184|11722932|FG001|Overall Study|Protocol Violation|0
7438986|NCT01640184|11722933|FG002|Overall Study|Protocol Violation|1
7438987|NCT01640249|11722960|FG000|Period 1|Withdrawal by Subject|1
7438988|NCT01640249|11722961|FG001|Period 1|Withdrawal by Subject|0
7438989|NCT01640249|11722962|FG002|Period 1|Withdrawal by Subject|0
7438990|NCT01640249|11722963|FG003|Period 1|Withdrawal by Subject|0
7438991|NCT01640249|11722964|FG004|Period 1|Withdrawal by Subject|0
7438992|NCT01640249|11722965|FG005|Period 1|Withdrawal by Subject|1
7438993|NCT01640249|11722966|FG006|Period 1|Withdrawal by Subject|0
7438994|NCT01640288|11722987|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
7438995|NCT01640288|11722988|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
7438996|NCT01640288|11722987|FG000|Overall Study|Screen Failure|20
7438997|NCT01640288|11722988|FG001|Overall Study|Screen Failure|18
7438998|NCT01640288|11722987|FG000|Overall Study|Withdrawn by PI|5
7438999|NCT01640288|11722988|FG001|Overall Study|Withdrawn by PI|0
7439000|NCT01640288|11722987|FG000|Overall Study|Withdrawal by Subject|1
7439001|NCT01640288|11722988|FG001|Overall Study|Withdrawal by Subject|0
7439002|NCT01640314|11722997|FG000|Overall Study|Protocol Violation|0
7439003|NCT01640314|11722998|FG001|Overall Study|Protocol Violation|1
7439004|NCT01640353|11723022|FG000|Overall Study|Withdrew prior to treatment|10
7439005|NCT01640353|11723022|FG000|Overall Study|Withdrawn from analysis at term site|12
7439006|NCT01640353|11723022|FG000|Overall Study|Withdrawal by Subject|5
7439007|NCT01640353|11723022|FG000|Overall Study|Death|2
7439008|NCT01640353|11723022|FG000|Overall Study|Early site termination|3
7439009|NCT01640353|11723022|FG000|Overall Study|Lost to Follow-up|12
7439010|NCT01640353|11723022|FG000|Overall Study|Physician Decision|1
7439011|NCT01640366|11723026|FG000|Overall Study|Withdrawal by Subject|1
7439012|NCT01640366|11723026|FG000|Overall Study|Protocol Violation|16
7439013|NCT01640366|11723026|FG000|Overall Study|Lost to Follow-up|5
7439014|NCT01640808|11723048|FG000|Overall Study|Unable to continue dynamic CT|14
7439015|NCT01640808|11723049|FG001|Overall Study|Unable to continue dynamic CT|4
7439016|NCT01640808|11723048|FG000|Overall Study|Withdrawal by Subject|12
7439017|NCT01640808|11723049|FG001|Overall Study|Withdrawal by Subject|4
7439018|NCT01640808|11723048|FG000|Overall Study|Lost to Follow-up|4
7439019|NCT01640808|11723049|FG001|Overall Study|Lost to Follow-up|0
7439020|NCT01640808|11723048|FG000|Overall Study|Start an antiviral therapy using IFN|3
7439021|NCT01640808|11723049|FG001|Overall Study|Start an antiviral therapy using IFN|0
7439022|NCT01640808|11723048|FG000|Overall Study|Administration of anticancer drugs|2
7439023|NCT01640808|11723049|FG001|Overall Study|Administration of anticancer drugs|1
7439024|NCT01640808|11723048|FG000|Overall Study|Physician Decision|19
7439025|NCT01640808|11723049|FG001|Overall Study|Physician Decision|5
7439026|NCT01640808|11723048|FG000|Overall Study|Randomized but not treated|4
7439027|NCT01640808|11723049|FG001|Overall Study|Randomized but not treated|2
7439028|NCT01640873|11723072|FG000|Overall Study|Protocol Violation|2
7439029|NCT01640873|11723073|FG001|Overall Study|Protocol Violation|1
7439030|NCT01640925|11723081|FG000|Overall Study|Withdrawal by Subject|1
7439031|NCT01640925|11723082|FG001|Overall Study|Withdrawal by Subject|0
7439032|NCT01640925|11723081|FG000|Overall Study|Previously enrolled in this trial|13
7439033|NCT01640925|11723082|FG001|Overall Study|Previously enrolled in this trial|11
7439034|NCT01640951|11723096|FG000|Overall Study|Adverse Event|8
7439035|NCT01640951|11723097|FG001|Overall Study|Adverse Event|3
7439036|NCT01640951|11723098|FG002|Overall Study|Adverse Event|10
7439037|NCT01640951|11723099|FG003|Overall Study|Adverse Event|6
7439038|NCT01640951|11723100|FG004|Overall Study|Adverse Event|1
7439039|NCT01640951|11723101|FG005|Overall Study|Adverse Event|11
7439040|NCT01640951|11723102|FG006|Overall Study|Adverse Event|1
7439041|NCT01640951|11723103|FG007|Overall Study|Adverse Event|3
7439042|NCT01640951|11723096|FG000|Overall Study|Lack of Efficacy|20
7439043|NCT01640951|11723097|FG001|Overall Study|Lack of Efficacy|1
7439044|NCT01640951|11723098|FG002|Overall Study|Lack of Efficacy|7
7439045|NCT01640951|11723099|FG003|Overall Study|Lack of Efficacy|14
7439046|NCT01640951|11723100|FG004|Overall Study|Lack of Efficacy|0
7439047|NCT01640951|11723101|FG005|Overall Study|Lack of Efficacy|6
7439048|NCT01640951|11723102|FG006|Overall Study|Lack of Efficacy|5
7439049|NCT01640951|11723103|FG007|Overall Study|Lack of Efficacy|6
7439050|NCT01640951|11723096|FG000|Overall Study|Lost to Follow-up|1
7439051|NCT01640951|11723097|FG001|Overall Study|Lost to Follow-up|0
7439052|NCT01640951|11723098|FG002|Overall Study|Lost to Follow-up|6
7439053|NCT01640951|11723099|FG003|Overall Study|Lost to Follow-up|2
7439054|NCT01640951|11723100|FG004|Overall Study|Lost to Follow-up|2
7439055|NCT01640951|11723101|FG005|Overall Study|Lost to Follow-up|3
7439056|NCT01640951|11723102|FG006|Overall Study|Lost to Follow-up|1
7439057|NCT01640951|11723103|FG007|Overall Study|Lost to Follow-up|1
7439058|NCT01640951|11723096|FG000|Overall Study|Non-compliance with study treatment|0
7439059|NCT01640951|11723097|FG001|Overall Study|Non-compliance with study treatment|0
7439060|NCT01640951|11723098|FG002|Overall Study|Non-compliance with study treatment|1
7439061|NCT01640951|11723099|FG003|Overall Study|Non-compliance with study treatment|1
7439062|NCT01640951|11723100|FG004|Overall Study|Non-compliance with study treatment|1
7439063|NCT01640951|11723101|FG005|Overall Study|Non-compliance with study treatment|4
7439064|NCT01640951|11723102|FG006|Overall Study|Non-compliance with study treatment|1
7439065|NCT01640951|11723103|FG007|Overall Study|Non-compliance with study treatment|0
7439066|NCT01640951|11723096|FG000|Overall Study|Physician Decision|2
7439067|NCT01640951|11723097|FG001|Overall Study|Physician Decision|5
7439068|NCT01640951|11723098|FG002|Overall Study|Physician Decision|2
7439069|NCT01640951|11723099|FG003|Overall Study|Physician Decision|2
7439070|NCT01640951|11723100|FG004|Overall Study|Physician Decision|2
7439071|NCT01640951|11723101|FG005|Overall Study|Physician Decision|3
7439072|NCT01640951|11723102|FG006|Overall Study|Physician Decision|3
7439073|NCT01640951|11723103|FG007|Overall Study|Physician Decision|0
7439074|NCT01640951|11723096|FG000|Overall Study|Pregnancy|3
7439075|NCT01640951|11723097|FG001|Overall Study|Pregnancy|0
7439076|NCT01640951|11723098|FG002|Overall Study|Pregnancy|0
7439077|NCT01640951|11723099|FG003|Overall Study|Pregnancy|4
7439078|NCT01640951|11723100|FG004|Overall Study|Pregnancy|0
7439079|NCT01640951|11723101|FG005|Overall Study|Pregnancy|0
7439080|NCT01640951|11723102|FG006|Overall Study|Pregnancy|2
7439081|NCT01640951|11723103|FG007|Overall Study|Pregnancy|0
7439082|NCT01640951|11723096|FG000|Overall Study|Protocol Deviation|0
7439083|NCT01640951|11723097|FG001|Overall Study|Protocol Deviation|1
7439084|NCT01640951|11723098|FG002|Overall Study|Protocol Deviation|2
7439085|NCT01640951|11723099|FG003|Overall Study|Protocol Deviation|1
7439086|NCT01640951|11723100|FG004|Overall Study|Protocol Deviation|0
7439087|NCT01640951|11723101|FG005|Overall Study|Protocol Deviation|1
7439088|NCT01640951|11723102|FG006|Overall Study|Protocol Deviation|0
7439089|NCT01640951|11723103|FG007|Overall Study|Protocol Deviation|0
7439090|NCT01640951|11723096|FG000|Overall Study|Subject/Guardian decision|12
7439091|NCT01640951|11723097|FG001|Overall Study|Subject/Guardian decision|4
7439092|NCT01640951|11723098|FG002|Overall Study|Subject/Guardian decision|13
7439093|NCT01640951|11723099|FG003|Overall Study|Subject/Guardian decision|15
7439094|NCT01640951|11723100|FG004|Overall Study|Subject/Guardian decision|7
7439095|NCT01640951|11723101|FG005|Overall Study|Subject/Guardian decision|19
7439096|NCT01640951|11723102|FG006|Overall Study|Subject/Guardian decision|5
7439097|NCT01640951|11723103|FG007|Overall Study|Subject/Guardian decision|4
7439098|NCT01640951|11723096|FG000|Overall Study|Death|0
7439099|NCT01640951|11723097|FG001|Overall Study|Death|1
7439100|NCT01640951|11723098|FG002|Overall Study|Death|1
7439101|NCT01640951|11723099|FG003|Overall Study|Death|0
7439102|NCT01640951|11723100|FG004|Overall Study|Death|0
7439103|NCT01640951|11723101|FG005|Overall Study|Death|0
7439104|NCT01640951|11723102|FG006|Overall Study|Death|0
7439105|NCT01640951|11723103|FG007|Overall Study|Death|2
7439106|NCT01640964|11723126|FG000|Overall Study|Lost to Follow-up|0
7439107|NCT01640964|11723127|FG001|Overall Study|Lost to Follow-up|0
7439108|NCT01640964|11723128|FG002|Overall Study|Lost to Follow-up|1
7439109|NCT01640964|11723126|FG000|Overall Study|Protocol Deviation|1
7439110|NCT01640964|11723127|FG001|Overall Study|Protocol Deviation|1
7439111|NCT01640964|11723128|FG002|Overall Study|Protocol Deviation|2
7439112|NCT01641081|11723146|FG000|Period 1|Sponsor request (potential unblinding)|0
7439113|NCT01641081|11723147|FG001|Period 1|Sponsor request (potential unblinding)|0
7439114|NCT01641081|11723148|FG002|Period 1|Sponsor request (potential unblinding)|0
7439115|NCT01641081|11723149|FG003|Period 1|Sponsor request (potential unblinding)|0
7439116|NCT01641081|11723150|FG004|Period 1|Sponsor request (potential unblinding)|0
7439117|NCT01641081|11723151|FG005|Period 1|Sponsor request (potential unblinding)|0
7439118|NCT01641081|11723152|FG006|Period 1|Sponsor request (potential unblinding)|1
7439119|NCT01641081|11723153|FG007|Period 1|Sponsor request (potential unblinding)|0
7439120|NCT01641081|11723154|FG008|Period 1|Sponsor request (potential unblinding)|0
7439121|NCT01641081|11723155|FG009|Period 1|Sponsor request (potential unblinding)|0
7439122|NCT01641081|11723146|FG000|Period 1|Protocol Violation|0
7439123|NCT01641081|11723147|FG001|Period 1|Protocol Violation|0
7439124|NCT01641081|11723148|FG002|Period 1|Protocol Violation|0
7439125|NCT01641081|11723149|FG003|Period 1|Protocol Violation|0
7439126|NCT01641081|11723150|FG004|Period 1|Protocol Violation|1
7439127|NCT01641081|11723151|FG005|Period 1|Protocol Violation|0
7439128|NCT01641081|11723152|FG006|Period 1|Protocol Violation|0
7439129|NCT01641081|11723153|FG007|Period 1|Protocol Violation|1
7439130|NCT01641081|11723154|FG008|Period 1|Protocol Violation|0
7439131|NCT01641081|11723155|FG009|Period 1|Protocol Violation|0
7439132|NCT01641081|11723146|FG000|Period 1|Adverse Event|1
7439133|NCT01641081|11723147|FG001|Period 1|Adverse Event|0
7439134|NCT01641081|11723148|FG002|Period 1|Adverse Event|0
7439135|NCT01641081|11723149|FG003|Period 1|Adverse Event|0
7439136|NCT01641081|11723150|FG004|Period 1|Adverse Event|0
7439137|NCT01641081|11723151|FG005|Period 1|Adverse Event|0
7439138|NCT01641081|11723152|FG006|Period 1|Adverse Event|0
7439139|NCT01641081|11723153|FG007|Period 1|Adverse Event|2
7439140|NCT01641081|11723154|FG008|Period 1|Adverse Event|0
7439141|NCT01641081|11723155|FG009|Period 1|Adverse Event|0
7439142|NCT01641081|11723146|FG000|Period 2|Adverse Event|0
7439143|NCT01641081|11723147|FG001|Period 2|Adverse Event|0
7439144|NCT01641081|11723148|FG002|Period 2|Adverse Event|0
7439145|NCT01641081|11723149|FG003|Period 2|Adverse Event|0
7439146|NCT01641081|11723150|FG004|Period 2|Adverse Event|0
7439147|NCT01641081|11723151|FG005|Period 2|Adverse Event|1
7439148|NCT01641081|11723152|FG006|Period 2|Adverse Event|0
7439149|NCT01641081|11723153|FG007|Period 2|Adverse Event|0
7439150|NCT01641081|11723154|FG008|Period 2|Adverse Event|0
7439151|NCT01641081|11723155|FG009|Period 2|Adverse Event|0
7439152|NCT01641081|11723146|FG000|Period 2|Withdrawal by Subject|0
7439153|NCT01641081|11723147|FG001|Period 2|Withdrawal by Subject|0
7439154|NCT01641081|11723148|FG002|Period 2|Withdrawal by Subject|0
7439155|NCT01641081|11723149|FG003|Period 2|Withdrawal by Subject|1
7439156|NCT01641081|11723150|FG004|Period 2|Withdrawal by Subject|0
7439157|NCT01641081|11723151|FG005|Period 2|Withdrawal by Subject|0
7439158|NCT01641081|11723152|FG006|Period 2|Withdrawal by Subject|2
7439159|NCT01641081|11723153|FG007|Period 2|Withdrawal by Subject|0
7439160|NCT01641081|11723154|FG008|Period 2|Withdrawal by Subject|0
7439161|NCT01641081|11723155|FG009|Period 2|Withdrawal by Subject|0
7439162|NCT01641081|11723146|FG000|Period 2|Protocol Violation|1
7439163|NCT01641081|11723147|FG001|Period 2|Protocol Violation|0
7439164|NCT01641081|11723148|FG002|Period 2|Protocol Violation|0
7439165|NCT01641081|11723149|FG003|Period 2|Protocol Violation|0
7439166|NCT01641081|11723150|FG004|Period 2|Protocol Violation|0
7439167|NCT01641081|11723151|FG005|Period 2|Protocol Violation|0
7439168|NCT01641081|11723152|FG006|Period 2|Protocol Violation|0
7439169|NCT01641081|11723153|FG007|Period 2|Protocol Violation|0
7439170|NCT01641081|11723154|FG008|Period 2|Protocol Violation|0
7439171|NCT01641081|11723155|FG009|Period 2|Protocol Violation|0
7439172|NCT01641081|11723146|FG000|Period 3|Adverse Event|0
7439173|NCT01641081|11723147|FG001|Period 3|Adverse Event|0
7439174|NCT01641081|11723148|FG002|Period 3|Adverse Event|1
7439175|NCT01641081|11723149|FG003|Period 3|Adverse Event|0
7439176|NCT01641081|11723150|FG004|Period 3|Adverse Event|0
7439177|NCT01641081|11723151|FG005|Period 3|Adverse Event|0
7439178|NCT01641081|11723152|FG006|Period 3|Adverse Event|0
7439179|NCT01641081|11723153|FG007|Period 3|Adverse Event|0
7439180|NCT01641081|11723154|FG008|Period 3|Adverse Event|0
7439181|NCT01641081|11723155|FG009|Period 3|Adverse Event|0
7439182|NCT01641081|11723146|FG000|Period 3|Withdrawal by Subject|0
7439183|NCT01641081|11723147|FG001|Period 3|Withdrawal by Subject|0
7439184|NCT01641081|11723148|FG002|Period 3|Withdrawal by Subject|0
7439185|NCT01641081|11723149|FG003|Period 3|Withdrawal by Subject|0
7561127|NCT03192150|11928934|FG001|Overall Study|Other-Various Administrative Reasons|5
7561128|NCT03192176|11928948|FG000|Overall Study|Adverse Event|1
7561129|NCT03192176|11928949|FG001|Overall Study|Adverse Event|0
7561130|NCT03192176|11928950|FG002|Overall Study|Adverse Event|4
7561131|NCT03192176|11928951|FG003|Overall Study|Adverse Event|5
7561132|NCT03192176|11928952|FG004|Overall Study|Adverse Event|3
7561133|NCT03192176|11928953|FG005|Overall Study|Adverse Event|2
7561134|NCT03192176|11928954|FG006|Overall Study|Adverse Event|3
7561135|NCT03192176|11928955|FG007|Overall Study|Adverse Event|3
7561136|NCT03192176|11928948|FG000|Overall Study|Lost to Follow-up|0
7561137|NCT03192176|11928949|FG001|Overall Study|Lost to Follow-up|0
7561138|NCT03192176|11928950|FG002|Overall Study|Lost to Follow-up|1
7561139|NCT03192176|11928951|FG003|Overall Study|Lost to Follow-up|2
7561140|NCT03192176|11928952|FG004|Overall Study|Lost to Follow-up|3
7561141|NCT03192176|11928953|FG005|Overall Study|Lost to Follow-up|1
7561142|NCT03192176|11928954|FG006|Overall Study|Lost to Follow-up|1
7561143|NCT03192176|11928955|FG007|Overall Study|Lost to Follow-up|1
7561144|NCT03192176|11928948|FG000|Overall Study|Physician Decision|1
7561145|NCT03192176|11928949|FG001|Overall Study|Physician Decision|0
7561146|NCT03192176|11928950|FG002|Overall Study|Physician Decision|0
7561147|NCT03192176|11928951|FG003|Overall Study|Physician Decision|0
7561148|NCT03192176|11928952|FG004|Overall Study|Physician Decision|0
7561149|NCT03192176|11928953|FG005|Overall Study|Physician Decision|2
7561150|NCT03192176|11928954|FG006|Overall Study|Physician Decision|1
7561151|NCT03192176|11928955|FG007|Overall Study|Physician Decision|0
7561152|NCT03192176|11928948|FG000|Overall Study|Protocol Deviation|1
7561153|NCT03192176|11928949|FG001|Overall Study|Protocol Deviation|1
7561154|NCT03192176|11928950|FG002|Overall Study|Protocol Deviation|0
7561155|NCT03192176|11928951|FG003|Overall Study|Protocol Deviation|0
7561156|NCT03192176|11928952|FG004|Overall Study|Protocol Deviation|2
7561157|NCT03192176|11928953|FG005|Overall Study|Protocol Deviation|0
7561158|NCT03192176|11928954|FG006|Overall Study|Protocol Deviation|0
7561159|NCT03192176|11928955|FG007|Overall Study|Protocol Deviation|0
7561160|NCT03192176|11928948|FG000|Overall Study|Withdrawal by Subject|3
7561161|NCT03192176|11928949|FG001|Overall Study|Withdrawal by Subject|4
7561162|NCT03192176|11928950|FG002|Overall Study|Withdrawal by Subject|0
7561163|NCT03192176|11928951|FG003|Overall Study|Withdrawal by Subject|4
7561164|NCT03192176|11928952|FG004|Overall Study|Withdrawal by Subject|3
7561165|NCT03192176|11928953|FG005|Overall Study|Withdrawal by Subject|4
7561166|NCT03192176|11928954|FG006|Overall Study|Withdrawal by Subject|4
7439186|NCT01641081|11723150|FG004|Period 3|Withdrawal by Subject|0
7439187|NCT01641081|11723151|FG005|Period 3|Withdrawal by Subject|0
7439188|NCT01641081|11723152|FG006|Period 3|Withdrawal by Subject|0
7439189|NCT01641081|11723153|FG007|Period 3|Withdrawal by Subject|0
7439190|NCT01641081|11723154|FG008|Period 3|Withdrawal by Subject|1
7439191|NCT01641081|11723155|FG009|Period 3|Withdrawal by Subject|0
7439192|NCT01641081|11723146|FG000|Period 4|Adverse Event|0
7439193|NCT01641081|11723147|FG001|Period 4|Adverse Event|1
7439194|NCT01641081|11723148|FG002|Period 4|Adverse Event|0
7439195|NCT01641081|11723149|FG003|Period 4|Adverse Event|1
7439196|NCT01641081|11723150|FG004|Period 4|Adverse Event|0
7439197|NCT01641081|11723151|FG005|Period 4|Adverse Event|0
7439198|NCT01641081|11723152|FG006|Period 4|Adverse Event|0
7439199|NCT01641081|11723153|FG007|Period 4|Adverse Event|0
7439200|NCT01641081|11723154|FG008|Period 4|Adverse Event|0
7439201|NCT01641081|11723155|FG009|Period 4|Adverse Event|0
7439202|NCT01641081|11723146|FG000|Period 5|Adverse Event|0
7439203|NCT01641081|11723147|FG001|Period 5|Adverse Event|0
7561167|NCT03192176|11928955|FG007|Overall Study|Withdrawal by Subject|2
7561168|NCT03192176|11928948|FG000|Overall Study|Miscellaneous|1
7561169|NCT03192176|11928949|FG001|Overall Study|Miscellaneous|0
7561170|NCT03192176|11928950|FG002|Overall Study|Miscellaneous|1
7439204|NCT01641081|11723148|FG002|Period 5|Adverse Event|2
7439205|NCT01641081|11723149|FG003|Period 5|Adverse Event|0
7439206|NCT01641081|11723150|FG004|Period 5|Adverse Event|0
7439207|NCT01641081|11723151|FG005|Period 5|Adverse Event|0
7439208|NCT01641081|11723152|FG006|Period 5|Adverse Event|0
7439209|NCT01641081|11723153|FG007|Period 5|Adverse Event|0
7439210|NCT01641081|11723154|FG008|Period 5|Adverse Event|0
7439211|NCT01641081|11723155|FG009|Period 5|Adverse Event|0
7561171|NCT03192176|11928951|FG003|Overall Study|Miscellaneous|1
7561172|NCT03192176|11928952|FG004|Overall Study|Miscellaneous|1
7561173|NCT03192176|11928953|FG005|Overall Study|Miscellaneous|2
7561174|NCT03192176|11928954|FG006|Overall Study|Miscellaneous|0
7439212|NCT01641133|11723177|FG000|Overall Study|Protocol Violation|0
7439213|NCT01641133|11723178|FG001|Overall Study|Protocol Violation|1
7439214|NCT01641133|11723179|FG002|Overall Study|Protocol Violation|1
7439215|NCT01641133|11723177|FG000|Overall Study|Migrated/moved from study area|5
7439216|NCT01641133|11723178|FG001|Overall Study|Migrated/moved from study area|3
7439217|NCT01641133|11723179|FG002|Overall Study|Migrated/moved from study area|1
7439218|NCT01641133|11723177|FG000|Overall Study|Adverse Event|0
7439219|NCT01641133|11723178|FG001|Overall Study|Adverse Event|0
7439220|NCT01641133|11723179|FG002|Overall Study|Adverse Event|1
7439221|NCT01641133|11723177|FG000|Overall Study|Withdrawal by Subject|5
7439222|NCT01641133|11723178|FG001|Overall Study|Withdrawal by Subject|3
7439223|NCT01641133|11723179|FG002|Overall Study|Withdrawal by Subject|3
7439224|NCT01641133|11723177|FG000|Overall Study|Lost to Follow-up|0
7439225|NCT01641133|11723178|FG001|Overall Study|Lost to Follow-up|2
7439226|NCT01641133|11723179|FG002|Overall Study|Lost to Follow-up|2
7439227|NCT01641159|11723189|FG000|Overall Study|Lost to Follow-up|2
7439228|NCT01641159|11723190|FG001|Overall Study|Lost to Follow-up|1
7439229|NCT01641159|11723189|FG000|Overall Study|Withdrawal by Subject|0
7439230|NCT01641159|11723190|FG001|Overall Study|Withdrawal by Subject|1
7439231|NCT01641198|11723199|FG000|After 12 Months of Function|Lost to Follow-up|3
7439232|NCT01641198|11723200|FG001|After 12 Months of Function|Lost to Follow-up|2
7439233|NCT01641198|11723201|FG002|After 12 Months of Function|Lost to Follow-up|2
7439234|NCT01641198|11723199|FG000|After 12 Months of Function|Protocol Violation|1
7439235|NCT01641198|11723200|FG001|After 12 Months of Function|Protocol Violation|0
7439236|NCT01641198|11723201|FG002|After 12 Months of Function|Protocol Violation|0
7439237|NCT01641198|11723199|FG000|After 12 Months of Function|Adverse Event|0
7439238|NCT01641198|11723200|FG001|After 12 Months of Function|Adverse Event|1
7439239|NCT01641198|11723201|FG002|After 12 Months of Function|Adverse Event|0
7439240|NCT01641198|11723199|FG000|After 24 Months of Function|Lost to Follow-up|4
7439241|NCT01641198|11723200|FG001|After 24 Months of Function|Lost to Follow-up|9
7439242|NCT01641198|11723201|FG002|After 24 Months of Function|Lost to Follow-up|6
7439243|NCT01641198|11723199|FG000|At 15-20 Years of Function|Lost to Follow-up|5
7439244|NCT01641198|11723200|FG001|At 15-20 Years of Function|Lost to Follow-up|1
7439245|NCT01641198|11723201|FG002|At 15-20 Years of Function|Lost to Follow-up|1
7439246|NCT01641198|11723199|FG000|At 15-20 Years of Function|Death|1
7439247|NCT01641198|11723200|FG001|At 15-20 Years of Function|Death|0
7439248|NCT01641198|11723201|FG002|At 15-20 Years of Function|Death|1
7439249|NCT01641237|11723210|FG000|Period II|Withdrawal by Subject|1
7439250|NCT01641237|11723211|FG001|Period II|Withdrawal by Subject|0
7439251|NCT01641237|11723212|FG002|Period II|Withdrawal by Subject|0
7439252|NCT01641237|11723213|FG003|Period II|Withdrawal by Subject|0
7439253|NCT01641237|11723210|FG000|Period III|Lost to Follow-up|1
7439254|NCT01641237|11723211|FG001|Period III|Lost to Follow-up|0
7439255|NCT01641237|11723212|FG002|Period III|Lost to Follow-up|0
7439256|NCT01641237|11723213|FG003|Period III|Lost to Follow-up|0
7439257|NCT01641367|11723229|FG000|Cohorts|Death|18
7439258|NCT01641367|11723230|FG001|Cohorts|Death|1
7439259|NCT01641367|11723231|FG002|Cohorts|Death|2
7439260|NCT01641367|11723232|FG003|Cohorts|Death|0
7439261|NCT01641367|11723233|FG004|Cohorts|Death|1
7439262|NCT01641367|11723234|FG005|Cohorts|Death|1
7439263|NCT01641367|11723235|FG006|Cohorts|Death|0
7439264|NCT01641367|11723236|FG007|Cohorts|Death|0
7439265|NCT01641367|11723229|FG000|Cohorts|Lost to Follow-up|16
7439266|NCT01641367|11723230|FG001|Cohorts|Lost to Follow-up|0
7439267|NCT01641367|11723231|FG002|Cohorts|Lost to Follow-up|2
7439268|NCT01641367|11723232|FG003|Cohorts|Lost to Follow-up|0
7439269|NCT01641367|11723233|FG004|Cohorts|Lost to Follow-up|2
7439270|NCT01641367|11723234|FG005|Cohorts|Lost to Follow-up|0
7439271|NCT01641367|11723235|FG006|Cohorts|Lost to Follow-up|0
7439272|NCT01641367|11723236|FG007|Cohorts|Lost to Follow-up|0
7439273|NCT01641367|11723229|FG000|Randomized Adherence Intervention|Death|0
7439274|NCT01641367|11723230|FG001|Randomized Adherence Intervention|Death|0
7439275|NCT01641367|11723231|FG002|Randomized Adherence Intervention|Death|0
7439276|NCT01641367|11723232|FG003|Randomized Adherence Intervention|Death|0
7439277|NCT01641367|11723233|FG004|Randomized Adherence Intervention|Death|0
7439278|NCT01641367|11723234|FG005|Randomized Adherence Intervention|Death|0
7439279|NCT01641367|11723235|FG006|Randomized Adherence Intervention|Death|11
7439280|NCT01641367|11723236|FG007|Randomized Adherence Intervention|Death|12
7439281|NCT01641367|11723229|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
7439282|NCT01641367|11723230|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
7439283|NCT01641367|11723231|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
7439284|NCT01641367|11723232|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
7439285|NCT01641367|11723233|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
7439286|NCT01641367|11723234|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
7439287|NCT01641367|11723235|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
7439288|NCT01641367|11723236|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
7439289|NCT01641471|11723280|FG000|Overall Study|Withdrawal by Subject|19
7439290|NCT01641471|11723281|FG001|Overall Study|Withdrawal by Subject|19
7439291|NCT01641471|11723280|FG000|Overall Study|Lost to Follow-up|2
7439292|NCT01641471|11723281|FG001|Overall Study|Lost to Follow-up|4
7439293|NCT01641471|11723280|FG000|Overall Study|Protocol Violation|2
7439294|NCT01641471|11723281|FG001|Overall Study|Protocol Violation|4
7439295|NCT01641640|11723287|FG000|Overall Study|Enrolled but not treated|1
7439296|NCT01641640|11723287|FG000|Overall Study|Efficacy failure|29
7439297|NCT01641640|11723287|FG000|Overall Study|Lost to Follow-up|3
7439298|NCT01641640|11723287|FG000|Overall Study|Withdrawal by Subject|2
7439299|NCT01641640|11723287|FG000|Overall Study|Adverse Event|1
7439300|NCT01641692|11723303|FG000|Treatment Period 1|Adverse Event|1
7439301|NCT01641692|11723304|FG001|Treatment Period 1|Adverse Event|0
7439302|NCT01641692|11723305|FG002|Treatment Period 1|Adverse Event|0
7439303|NCT01641692|11723306|FG003|Treatment Period 1|Adverse Event|0
7439304|NCT01641692|11723307|FG004|Treatment Period 1|Adverse Event|0
7439305|NCT01641692|11723308|FG005|Treatment Period 1|Adverse Event|0
7439306|NCT01641692|11723309|FG006|Treatment Period 1|Adverse Event|0
7439307|NCT01641692|11723310|FG007|Treatment Period 1|Adverse Event|0
7439308|NCT01641692|11723303|FG000|Treatment Period 1|Lack of Efficacy|0
7439309|NCT01641692|11723304|FG001|Treatment Period 1|Lack of Efficacy|0
7439310|NCT01641692|11723305|FG002|Treatment Period 1|Lack of Efficacy|0
7439311|NCT01641692|11723306|FG003|Treatment Period 1|Lack of Efficacy|0
7439312|NCT01641692|11723307|FG004|Treatment Period 1|Lack of Efficacy|0
7439313|NCT01641692|11723308|FG005|Treatment Period 1|Lack of Efficacy|0
7439314|NCT01641692|11723309|FG006|Treatment Period 1|Lack of Efficacy|0
7439315|NCT01641692|11723310|FG007|Treatment Period 1|Lack of Efficacy|1
7439316|NCT01641692|11723303|FG000|Treatment Period 1|Protocol Violation|1
7439317|NCT01641692|11723304|FG001|Treatment Period 1|Protocol Violation|0
7439318|NCT01641692|11723305|FG002|Treatment Period 1|Protocol Violation|0
7439319|NCT01641692|11723306|FG003|Treatment Period 1|Protocol Violation|0
7439320|NCT01641692|11723307|FG004|Treatment Period 1|Protocol Violation|2
7439321|NCT01641692|11723308|FG005|Treatment Period 1|Protocol Violation|0
7439322|NCT01641692|11723309|FG006|Treatment Period 1|Protocol Violation|0
7439323|NCT01641692|11723310|FG007|Treatment Period 1|Protocol Violation|0
7439324|NCT01641692|11723303|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439325|NCT01641692|11723304|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439326|NCT01641692|11723305|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439327|NCT01641692|11723306|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439328|NCT01641692|11723307|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
7439329|NCT01641692|11723308|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439330|NCT01641692|11723309|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
7439331|NCT01641692|11723310|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
7439332|NCT01641692|11723303|FG000|Treatment Period 1|Lost to Follow-up|0
7439333|NCT01641692|11723304|FG001|Treatment Period 1|Lost to Follow-up|0
7439334|NCT01641692|11723305|FG002|Treatment Period 1|Lost to Follow-up|1
7439335|NCT01641692|11723306|FG003|Treatment Period 1|Lost to Follow-up|0
7439336|NCT01641692|11723307|FG004|Treatment Period 1|Lost to Follow-up|0
7439337|NCT01641692|11723308|FG005|Treatment Period 1|Lost to Follow-up|0
7439338|NCT01641692|11723309|FG006|Treatment Period 1|Lost to Follow-up|0
7439339|NCT01641692|11723310|FG007|Treatment Period 1|Lost to Follow-up|0
7439340|NCT01641692|11723303|FG000|Treatment Period 1|Physician Decision|0
7439341|NCT01641692|11723304|FG001|Treatment Period 1|Physician Decision|0
7439342|NCT01641692|11723305|FG002|Treatment Period 1|Physician Decision|0
7439343|NCT01641692|11723306|FG003|Treatment Period 1|Physician Decision|0
7439344|NCT01641692|11723307|FG004|Treatment Period 1|Physician Decision|1
7439345|NCT01641692|11723308|FG005|Treatment Period 1|Physician Decision|0
7439346|NCT01641692|11723309|FG006|Treatment Period 1|Physician Decision|0
7439347|NCT01641692|11723310|FG007|Treatment Period 1|Physician Decision|0
7439348|NCT01641692|11723303|FG000|Treatment Period 1|Withdrawal by Subject|0
7439349|NCT01641692|11723304|FG001|Treatment Period 1|Withdrawal by Subject|0
7439350|NCT01641692|11723305|FG002|Treatment Period 1|Withdrawal by Subject|0
7439351|NCT01641692|11723306|FG003|Treatment Period 1|Withdrawal by Subject|0
7439352|NCT01641692|11723307|FG004|Treatment Period 1|Withdrawal by Subject|0
7439353|NCT01641692|11723308|FG005|Treatment Period 1|Withdrawal by Subject|2
7439354|NCT01641692|11723309|FG006|Treatment Period 1|Withdrawal by Subject|0
7439355|NCT01641692|11723310|FG007|Treatment Period 1|Withdrawal by Subject|1
7439356|NCT01641692|11723303|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
7439357|NCT01641692|11723304|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
7439358|NCT01641692|11723305|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
7439359|NCT01641692|11723306|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
7439360|NCT01641692|11723307|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
7439361|NCT01641692|11723308|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
7439362|NCT01641692|11723309|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
7439363|NCT01641692|11723310|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
7439364|NCT01641692|11723303|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439365|NCT01641692|11723304|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439366|NCT01641692|11723305|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439367|NCT01641692|11723306|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439368|NCT01641692|11723307|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439369|NCT01641692|11723308|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439370|NCT01641692|11723309|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
7439371|NCT01641692|11723310|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
7439372|NCT01641692|11723303|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7439373|NCT01641692|11723304|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7467415|NCT01901146|11767791|FG004|Neoadjuvant Phase|Death|0
7439374|NCT01641692|11723305|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7439375|NCT01641692|11723306|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7439376|NCT01641692|11723307|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
7439377|NCT01641692|11723308|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439378|NCT01641692|11723309|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439379|NCT01641692|11723310|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
7439380|NCT01641692|11723303|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7439381|NCT01641692|11723304|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7439382|NCT01641692|11723305|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7439383|NCT01641692|11723306|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7439384|NCT01641692|11723307|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7439385|NCT01641692|11723308|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7439386|NCT01641692|11723309|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
7439387|NCT01641692|11723310|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
7439388|NCT01641692|11723303|FG000|Treatment Period 2|Lack of Efficacy|1
7439389|NCT01641692|11723304|FG001|Treatment Period 2|Lack of Efficacy|0
7439390|NCT01641692|11723305|FG002|Treatment Period 2|Lack of Efficacy|0
7439391|NCT01641692|11723306|FG003|Treatment Period 2|Lack of Efficacy|0
7439392|NCT01641692|11723307|FG004|Treatment Period 2|Lack of Efficacy|0
7439393|NCT01641692|11723308|FG005|Treatment Period 2|Lack of Efficacy|0
7439394|NCT01641692|11723309|FG006|Treatment Period 2|Lack of Efficacy|0
7439395|NCT01641692|11723310|FG007|Treatment Period 2|Lack of Efficacy|0
7439396|NCT01641692|11723303|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
7439397|NCT01641692|11723304|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439398|NCT01641692|11723305|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439399|NCT01641692|11723306|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439400|NCT01641692|11723307|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439401|NCT01641692|11723308|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439402|NCT01641692|11723309|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439403|NCT01641692|11723310|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
7439404|NCT01641692|11723303|FG000|Treatment Period 2|Lost to Follow-up|0
7439405|NCT01641692|11723304|FG001|Treatment Period 2|Lost to Follow-up|0
7439406|NCT01641692|11723305|FG002|Treatment Period 2|Lost to Follow-up|0
7439407|NCT01641692|11723306|FG003|Treatment Period 2|Lost to Follow-up|0
7439408|NCT01641692|11723307|FG004|Treatment Period 2|Lost to Follow-up|0
7439409|NCT01641692|11723308|FG005|Treatment Period 2|Lost to Follow-up|1
7439410|NCT01641692|11723309|FG006|Treatment Period 2|Lost to Follow-up|0
7439411|NCT01641692|11723310|FG007|Treatment Period 2|Lost to Follow-up|0
7439412|NCT01641692|11723303|FG000|Treatment Period 2|Withdrawal by Subject|1
7439413|NCT01641692|11723304|FG001|Treatment Period 2|Withdrawal by Subject|0
7439414|NCT01641692|11723305|FG002|Treatment Period 2|Withdrawal by Subject|0
7439415|NCT01641692|11723306|FG003|Treatment Period 2|Withdrawal by Subject|0
7439416|NCT01641692|11723307|FG004|Treatment Period 2|Withdrawal by Subject|0
7439417|NCT01641692|11723308|FG005|Treatment Period 2|Withdrawal by Subject|1
7439418|NCT01641692|11723309|FG006|Treatment Period 2|Withdrawal by Subject|0
7439419|NCT01641692|11723310|FG007|Treatment Period 2|Withdrawal by Subject|1
7439420|NCT01641692|11723303|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439421|NCT01641692|11723304|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439422|NCT01641692|11723305|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439423|NCT01641692|11723306|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439424|NCT01641692|11723307|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
7439425|NCT01641692|11723308|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439426|NCT01641692|11723309|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
7439427|NCT01641692|11723310|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
7439428|NCT01641692|11723303|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7439576|NCT01641822|11723358|FG002|Comparative Phase|Pregnancy|1
7439429|NCT01641692|11723304|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7439430|NCT01641692|11723305|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7439431|NCT01641692|11723306|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7439432|NCT01641692|11723307|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7439433|NCT01641692|11723308|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7439434|NCT01641692|11723309|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
7439435|NCT01641692|11723310|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
7439436|NCT01641692|11723303|FG000|Treatment Period 3|Adverse Event|0
7439437|NCT01641692|11723304|FG001|Treatment Period 3|Adverse Event|0
7439438|NCT01641692|11723305|FG002|Treatment Period 3|Adverse Event|0
7439439|NCT01641692|11723306|FG003|Treatment Period 3|Adverse Event|0
7439440|NCT01641692|11723307|FG004|Treatment Period 3|Adverse Event|0
7439441|NCT01641692|11723308|FG005|Treatment Period 3|Adverse Event|0
7439442|NCT01641692|11723309|FG006|Treatment Period 3|Adverse Event|1
7439443|NCT01641692|11723310|FG007|Treatment Period 3|Adverse Event|0
7439444|NCT01641692|11723303|FG000|Treatment Period 3|Protocol Violation|0
7439445|NCT01641692|11723304|FG001|Treatment Period 3|Protocol Violation|0
7439446|NCT01641692|11723305|FG002|Treatment Period 3|Protocol Violation|1
7439447|NCT01641692|11723306|FG003|Treatment Period 3|Protocol Violation|0
7439448|NCT01641692|11723307|FG004|Treatment Period 3|Protocol Violation|0
7439449|NCT01641692|11723308|FG005|Treatment Period 3|Protocol Violation|0
7439450|NCT01641692|11723309|FG006|Treatment Period 3|Protocol Violation|0
7439451|NCT01641692|11723310|FG007|Treatment Period 3|Protocol Violation|0
7439452|NCT01641692|11723303|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439453|NCT01641692|11723304|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439454|NCT01641692|11723305|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439455|NCT01641692|11723306|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439456|NCT01641692|11723307|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439457|NCT01641692|11723308|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439458|NCT01641692|11723309|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
7439459|NCT01641692|11723310|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
7439460|NCT01641692|11723303|FG000|Treatment Period 3|Lost to Follow-up|0
7439461|NCT01641692|11723304|FG001|Treatment Period 3|Lost to Follow-up|1
7439462|NCT01641692|11723305|FG002|Treatment Period 3|Lost to Follow-up|0
7439463|NCT01641692|11723306|FG003|Treatment Period 3|Lost to Follow-up|0
7439464|NCT01641692|11723307|FG004|Treatment Period 3|Lost to Follow-up|0
7439465|NCT01641692|11723308|FG005|Treatment Period 3|Lost to Follow-up|0
7439466|NCT01641692|11723309|FG006|Treatment Period 3|Lost to Follow-up|0
7439467|NCT01641692|11723310|FG007|Treatment Period 3|Lost to Follow-up|0
7439468|NCT01641692|11723303|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
7439469|NCT01641692|11723304|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
7439470|NCT01641692|11723305|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
7439471|NCT01641692|11723306|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
7439472|NCT01641692|11723307|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
7439473|NCT01641692|11723308|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
7439474|NCT01641692|11723309|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
7439475|NCT01641692|11723310|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
7439476|NCT01641692|11723303|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7439477|NCT01641692|11723304|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7439478|NCT01641692|11723305|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7439479|NCT01641692|11723306|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7439480|NCT01641692|11723307|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7439481|NCT01641692|11723308|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7439482|NCT01641692|11723309|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
7439483|NCT01641692|11723310|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
7439484|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7439485|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7439486|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
7439487|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
7439488|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7439489|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7439490|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
7439491|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
7439492|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
7439493|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
7439494|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
7439495|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
7439496|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
7439497|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7439498|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
7439499|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
7439500|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
7439501|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
7439502|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
7439503|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
7439504|NCT01641809|11723333|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
7439505|NCT01641809|11723334|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
7439506|NCT01641809|11723335|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
7439507|NCT01641809|11723336|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
7439508|NCT01641809|11723333|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
7439509|NCT01641809|11723334|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
7439510|NCT01641809|11723335|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
7439511|NCT01641809|11723336|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
7439512|NCT01641809|11723333|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7439513|NCT01641809|11723334|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
7439514|NCT01641809|11723335|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7439515|NCT01641809|11723336|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
7439516|NCT01641809|11723333|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7439517|NCT01641809|11723334|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
7439518|NCT01641809|11723335|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
7439519|NCT01641809|11723336|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
7439520|NCT01641809|11723333|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7439521|NCT01641809|11723334|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
7439522|NCT01641809|11723335|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
7439523|NCT01641809|11723336|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
7439524|NCT01641809|11723333|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7439525|NCT01641809|11723334|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
7439526|NCT01641809|11723335|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
7439527|NCT01641809|11723336|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
7439528|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
7439529|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
7439530|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
7439531|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
7439532|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
7439533|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
7439534|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
7439535|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
7439536|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7439537|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
7439538|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
7439539|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
7439540|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Site closed|1
7439541|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Site closed|0
7439542|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Site closed|0
7439543|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Site closed|0
7439544|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
7439545|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
7439546|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
7439547|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
7439548|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
7439549|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
7439550|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7439551|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
7439552|NCT01641809|11723333|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
7439553|NCT01641809|11723334|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
7439554|NCT01641809|11723335|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
7439555|NCT01641809|11723336|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
7439556|NCT01641822|11723356|FG000|Run-in Phase|Noncompliance with study drug|1
7439557|NCT01641822|11723357|FG001|Run-in Phase|Noncompliance with study drug|0
7439558|NCT01641822|11723358|FG002|Run-in Phase|Noncompliance with study drug|0
7439559|NCT01641822|11723356|FG000|Run-in Phase|Adverse Event|3
7439560|NCT01641822|11723357|FG001|Run-in Phase|Adverse Event|0
7439561|NCT01641822|11723358|FG002|Run-in Phase|Adverse Event|0
7439562|NCT01641822|11723356|FG000|Run-in Phase|Withdrew consent|1
7439563|NCT01641822|11723357|FG001|Run-in Phase|Withdrew consent|0
7439564|NCT01641822|11723358|FG002|Run-in Phase|Withdrew consent|0
7439565|NCT01641822|11723356|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
7439566|NCT01641822|11723357|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
7439567|NCT01641822|11723358|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
7439568|NCT01641822|11723356|FG000|Comparative Phase|Noncompliance with study drug|0
7439569|NCT01641822|11723357|FG001|Comparative Phase|Noncompliance with study drug|1
7439570|NCT01641822|11723358|FG002|Comparative Phase|Noncompliance with study drug|0
7439571|NCT01641822|11723356|FG000|Comparative Phase|Investigator's discretion|0
7439572|NCT01641822|11723357|FG001|Comparative Phase|Investigator's discretion|0
7439573|NCT01641822|11723358|FG002|Comparative Phase|Investigator's discretion|1
7439574|NCT01641822|11723356|FG000|Comparative Phase|Pregnancy|0
7439575|NCT01641822|11723357|FG001|Comparative Phase|Pregnancy|0
7439577|NCT01641822|11723356|FG000|Comparative Phase|Adverse event, serious fatal|0
7439578|NCT01641822|11723357|FG001|Comparative Phase|Adverse event, serious fatal|1
7439579|NCT01641822|11723358|FG002|Comparative Phase|Adverse event, serious fatal|0
7439580|NCT01641822|11723356|FG000|Comparative Phase|Withdrew consent|0
7439581|NCT01641822|11723357|FG001|Comparative Phase|Withdrew consent|3
7439582|NCT01641822|11723358|FG002|Comparative Phase|Withdrew consent|7
7439583|NCT01641822|11723356|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
7439584|NCT01641822|11723357|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
7439585|NCT01641822|11723358|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
7439586|NCT01641861|11723371|FG000|Overall Study|Lost to Follow-up|21
7439587|NCT01641861|11723372|FG001|Overall Study|Lost to Follow-up|16
7439588|NCT01641861|11723371|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
7439589|NCT01641861|11723372|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
7439590|NCT01641861|11723371|FG000|Overall Study|Died due to drowning|0
7439591|NCT01641861|11723372|FG001|Overall Study|Died due to drowning|1
7439592|NCT01641900|11723380|FG000|Overall Study|Withdrawal by Subject|2
7439593|NCT01641900|11723381|FG001|Overall Study|Withdrawal by Subject|2
7439594|NCT01641926|11723393|FG000|Overall Study|Adverse Event|5
7439595|NCT01641926|11723394|FG001|Overall Study|Adverse Event|2
7439596|NCT01641926|11723395|FG002|Overall Study|Adverse Event|3
7439597|NCT01641926|11723396|FG003|Overall Study|Adverse Event|1
7439598|NCT01641926|11723393|FG000|Overall Study|Lost to Follow-up|2
7439599|NCT01641926|11723394|FG001|Overall Study|Lost to Follow-up|2
7439600|NCT01641926|11723395|FG002|Overall Study|Lost to Follow-up|1
7439601|NCT01641926|11723396|FG003|Overall Study|Lost to Follow-up|0
7439602|NCT01641926|11723393|FG000|Overall Study|Physician Decision|6
7439603|NCT01641926|11723394|FG001|Overall Study|Physician Decision|5
7439604|NCT01641926|11723395|FG002|Overall Study|Physician Decision|0
7439605|NCT01641926|11723396|FG003|Overall Study|Physician Decision|1
7561175|NCT03192176|11928955|FG007|Overall Study|Miscellaneous|1
7561176|NCT03192306|11928976|FG000|Overall Study|Did not treat cold sore during study|149
7561177|NCT03192306|11928977|FG001|Overall Study|Did not treat cold sore during study|143
7561178|NCT03192306|11928976|FG000|Overall Study|Withdrawal by Subject|1
7561179|NCT03192306|11928977|FG001|Overall Study|Withdrawal by Subject|1
7561180|NCT03192306|11928976|FG000|Overall Study|Lost to Follow-up|1
7561181|NCT03192306|11928977|FG001|Overall Study|Lost to Follow-up|0
7561182|NCT03192306|11928976|FG000|Overall Study|Protocol Violation|1
7561183|NCT03192306|11928977|FG001|Overall Study|Protocol Violation|1
7439606|NCT01641926|11723393|FG000|Overall Study|Protocol Violation|1
7439607|NCT01641926|11723394|FG001|Overall Study|Protocol Violation|0
7439608|NCT01641926|11723395|FG002|Overall Study|Protocol Violation|0
7439609|NCT01641926|11723396|FG003|Overall Study|Protocol Violation|1
7439610|NCT01641926|11723393|FG000|Overall Study|Withdrawal by Subject|13
7439611|NCT01641926|11723394|FG001|Overall Study|Withdrawal by Subject|5
7439612|NCT01641926|11723395|FG002|Overall Study|Withdrawal by Subject|6
7439613|NCT01641926|11723396|FG003|Overall Study|Withdrawal by Subject|1
7439614|NCT01641926|11723393|FG000|Overall Study|Not Treated|1
7439615|NCT01641926|11723394|FG001|Overall Study|Not Treated|1
7439616|NCT01641926|11723395|FG002|Overall Study|Not Treated|1
7439617|NCT01641926|11723396|FG003|Overall Study|Not Treated|0
7439618|NCT01641939|11723409|FG000|Overall Study|Death|90
7439619|NCT01641939|11723410|FG001|Overall Study|Death|187
7439620|NCT01641939|11723411|FG002|Overall Study|Death|61
7439621|NCT01641939|11723409|FG000|Overall Study|Lost to Follow-up|3
7439622|NCT01641939|11723410|FG001|Overall Study|Lost to Follow-up|2
7439623|NCT01641939|11723411|FG002|Overall Study|Lost to Follow-up|1
7439624|NCT01641939|11723409|FG000|Overall Study|Withdrawal by Subject|14
7439625|NCT01641939|11723410|FG001|Overall Study|Withdrawal by Subject|11
7439626|NCT01641939|11723411|FG002|Overall Study|Withdrawal by Subject|5
7439627|NCT01641939|11723409|FG000|Overall Study|Study Terminated by Sponsor|10
7439628|NCT01641939|11723410|FG001|Overall Study|Study Terminated by Sponsor|28
7439629|NCT01641939|11723411|FG002|Overall Study|Study Terminated by Sponsor|3
7439630|NCT01641952|11723421|FG000|Overall Study|Lost to Follow-up|28
7439631|NCT01641952|11723421|FG000|Overall Study|Adverse Event|6
7439632|NCT01641991|11723437|FG000|Overall Study|Physician Decision|0
7439633|NCT01641991|11723438|FG001|Overall Study|Physician Decision|1
7439634|NCT01641991|11723439|FG002|Overall Study|Physician Decision|7
7439635|NCT01641991|11723440|FG003|Overall Study|Physician Decision|5
7439636|NCT01641991|11723437|FG000|Overall Study|Withdrawal by Subject|4
7439637|NCT01641991|11723438|FG001|Overall Study|Withdrawal by Subject|2
7439638|NCT01641991|11723439|FG002|Overall Study|Withdrawal by Subject|1
7439639|NCT01641991|11723440|FG003|Overall Study|Withdrawal by Subject|5
7439640|NCT01641991|11723437|FG000|Overall Study|Adverse Event|2
7439641|NCT01641991|11723438|FG001|Overall Study|Adverse Event|1
7439642|NCT01641991|11723439|FG002|Overall Study|Adverse Event|2
7439643|NCT01641991|11723440|FG003|Overall Study|Adverse Event|1
7439644|NCT01641991|11723437|FG000|Overall Study|Lost to Follow-up|0
7439645|NCT01641991|11723438|FG001|Overall Study|Lost to Follow-up|2
7439646|NCT01641991|11723439|FG002|Overall Study|Lost to Follow-up|3
7439647|NCT01641991|11723440|FG003|Overall Study|Lost to Follow-up|1
7439648|NCT01641991|11723437|FG000|Overall Study|Protocol Violation|1
7439649|NCT01641991|11723438|FG001|Overall Study|Protocol Violation|1
7439650|NCT01641991|11723439|FG002|Overall Study|Protocol Violation|3
7439651|NCT01641991|11723440|FG003|Overall Study|Protocol Violation|0
7439652|NCT01641991|11723437|FG000|Overall Study|Pregnancy|0
7439653|NCT01641991|11723438|FG001|Overall Study|Pregnancy|0
7561184|NCT03192475|11928985|FG000|Overall Study|Death|0
7439654|NCT01641991|11723439|FG002|Overall Study|Pregnancy|1
7439655|NCT01641991|11723440|FG003|Overall Study|Pregnancy|0
7439656|NCT01641991|11723437|FG000|Overall Study|no longer eligible|2
7439657|NCT01641991|11723438|FG001|Overall Study|no longer eligible|1
7439658|NCT01641991|11723439|FG002|Overall Study|no longer eligible|0
7439659|NCT01641991|11723440|FG003|Overall Study|no longer eligible|4
7439660|NCT01642212|11723484|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
7439661|NCT01642212|11723485|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7439662|NCT01642212|11723486|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7439663|NCT01642212|11723487|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7439664|NCT01642212|11723488|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
7439665|NCT01642212|11723484|FG000|Double-blind Treatment|Other|0
7439666|NCT01642212|11723485|FG001|Double-blind Treatment|Other|2
7439667|NCT01642212|11723486|FG002|Double-blind Treatment|Other|1
7439668|NCT01642212|11723487|FG003|Double-blind Treatment|Other|0
7439669|NCT01642212|11723488|FG004|Double-blind Treatment|Other|0
7439670|NCT01642212|11723484|FG000|Double-blind Treatment|Non-compliance|0
7439671|NCT01642212|11723485|FG001|Double-blind Treatment|Non-compliance|1
7439672|NCT01642212|11723486|FG002|Double-blind Treatment|Non-compliance|0
7439673|NCT01642212|11723487|FG003|Double-blind Treatment|Non-compliance|0
7439674|NCT01642212|11723488|FG004|Double-blind Treatment|Non-compliance|0
7439675|NCT01642212|11723484|FG000|Double-blind Treatment|Adverse Event|0
7439676|NCT01642212|11723485|FG001|Double-blind Treatment|Adverse Event|0
7439677|NCT01642212|11723486|FG002|Double-blind Treatment|Adverse Event|1
7439678|NCT01642212|11723487|FG003|Double-blind Treatment|Adverse Event|0
7439679|NCT01642212|11723488|FG004|Double-blind Treatment|Adverse Event|0
7439680|NCT01642212|11723484|FG000|Open-label Extension|Adverse Event|0
7439681|NCT01642212|11723485|FG001|Open-label Extension|Adverse Event|0
7439682|NCT01642212|11723486|FG002|Open-label Extension|Adverse Event|0
7439683|NCT01642212|11723487|FG003|Open-label Extension|Adverse Event|3
7439684|NCT01642212|11723488|FG004|Open-label Extension|Adverse Event|0
7439685|NCT01642212|11723484|FG000|Open-label Extension|Sponsor Decision|0
7439686|NCT01642212|11723485|FG001|Open-label Extension|Sponsor Decision|0
7439687|NCT01642212|11723486|FG002|Open-label Extension|Sponsor Decision|0
7439688|NCT01642212|11723487|FG003|Open-label Extension|Sponsor Decision|7
7439689|NCT01642212|11723488|FG004|Open-label Extension|Sponsor Decision|4
7439690|NCT01642212|11723484|FG000|Open-label Extension|Consent Withdrawn|0
7439691|NCT01642212|11723485|FG001|Open-label Extension|Consent Withdrawn|0
7439692|NCT01642212|11723486|FG002|Open-label Extension|Consent Withdrawn|0
7439693|NCT01642212|11723487|FG003|Open-label Extension|Consent Withdrawn|0
7439694|NCT01642212|11723488|FG004|Open-label Extension|Consent Withdrawn|2
7439695|NCT01642212|11723484|FG000|Open-label Extension|Lost to Follow-up|0
7439696|NCT01642212|11723485|FG001|Open-label Extension|Lost to Follow-up|0
7439697|NCT01642212|11723486|FG002|Open-label Extension|Lost to Follow-up|0
7439698|NCT01642212|11723487|FG003|Open-label Extension|Lost to Follow-up|0
7439699|NCT01642212|11723488|FG004|Open-label Extension|Lost to Follow-up|1
7439700|NCT01642212|11723484|FG000|Open-label Extension|Other|0
7439701|NCT01642212|11723485|FG001|Open-label Extension|Other|0
7439702|NCT01642212|11723486|FG002|Open-label Extension|Other|0
7439703|NCT01642212|11723487|FG003|Open-label Extension|Other|0
7439704|NCT01642212|11723488|FG004|Open-label Extension|Other|1
7439705|NCT01642251|11723506|FG000|Overall Study|Progressive disease|0
7439706|NCT01642251|11723507|FG001|Overall Study|Progressive disease|0
7439707|NCT01642251|11723508|FG002|Overall Study|Progressive disease|3
7439708|NCT01642251|11723509|FG003|Overall Study|Progressive disease|3
7439709|NCT01642251|11723506|FG000|Overall Study|Adverse Event|0
7439710|NCT01642251|11723507|FG001|Overall Study|Adverse Event|0
7439711|NCT01642251|11723508|FG002|Overall Study|Adverse Event|5
7439712|NCT01642251|11723509|FG003|Overall Study|Adverse Event|4
7439713|NCT01642251|11723506|FG000|Overall Study|Death|0
7439714|NCT01642251|11723507|FG001|Overall Study|Death|0
7439715|NCT01642251|11723508|FG002|Overall Study|Death|1
7439716|NCT01642251|11723509|FG003|Overall Study|Death|3
7439717|NCT01642251|11723506|FG000|Overall Study|Withdrawal by Subject|0
7439718|NCT01642251|11723507|FG001|Overall Study|Withdrawal by Subject|0
7439719|NCT01642251|11723508|FG002|Overall Study|Withdrawal by Subject|1
7439720|NCT01642251|11723509|FG003|Overall Study|Withdrawal by Subject|3
7439721|NCT01642251|11723506|FG000|Overall Study|Alternative therapy|0
7439722|NCT01642251|11723507|FG001|Overall Study|Alternative therapy|0
7439723|NCT01642251|11723508|FG002|Overall Study|Alternative therapy|0
7439724|NCT01642251|11723509|FG003|Overall Study|Alternative therapy|2
7439725|NCT01642251|11723506|FG000|Overall Study|Other complicating disease|0
7439726|NCT01642251|11723507|FG001|Overall Study|Other complicating disease|0
7439727|NCT01642251|11723508|FG002|Overall Study|Other complicating disease|1
7439728|NCT01642251|11723509|FG003|Overall Study|Other complicating disease|0
7439729|NCT01642251|11723506|FG000|Overall Study|Ineligible/never start protocol therapy|0
7439730|NCT01642251|11723507|FG001|Overall Study|Ineligible/never start protocol therapy|0
7439731|NCT01642251|11723508|FG002|Overall Study|Ineligible/never start protocol therapy|11
7439732|NCT01642251|11723509|FG003|Overall Study|Ineligible/never start protocol therapy|8
7439733|NCT01642277|11723520|FG000|Overall Study|Adverse Event|10
7439734|NCT01642277|11723521|FG001|Overall Study|Adverse Event|0
7439735|NCT01642277|11723520|FG000|Overall Study|Physician Decision|2
7439736|NCT01642277|11723521|FG001|Overall Study|Physician Decision|0
7439737|NCT01642277|11723520|FG000|Overall Study|Protocol Violation|1
7439738|NCT01642277|11723521|FG001|Overall Study|Protocol Violation|0
7439739|NCT01642277|11723520|FG000|Overall Study|Withdrawal by Subject|11
7439740|NCT01642277|11723521|FG001|Overall Study|Withdrawal by Subject|0
7439741|NCT01642407|11723528|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
7439742|NCT01642407|11723528|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
7439743|NCT01642407|11723528|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
7439744|NCT01642589|11723559|FG000|Overall Study|Withdrawal by Subject|1
7439745|NCT01642589|11723560|FG001|Overall Study|Withdrawal by Subject|1
7439746|NCT01642602|11723566|FG000|Overall Study|Adverse Event|2
7439747|NCT01642615|11723570|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
7439748|NCT01642615|11723571|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7439749|NCT01642615|11723572|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
7468731|NCT01914393|11769700|FG000|Overall Study|no reason given|14
7439750|NCT01642615|11723570|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
7439751|NCT01642615|11723571|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
7439752|NCT01642615|11723572|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
7439753|NCT01642615|11723570|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
7439754|NCT01642615|11723571|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
7439755|NCT01642615|11723572|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
7439756|NCT01642615|11723570|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
7561185|NCT03192475|11928986|FG001|Overall Study|Death|1
7561186|NCT03192475|11928985|FG000|Overall Study|Lost to Follow-up|13
7561187|NCT03192475|11928986|FG001|Overall Study|Lost to Follow-up|8
7561188|NCT03192488|11928993|FG000|First Washout (>6d)|Withdrawal by Subject|0
7561189|NCT03192488|11928994|FG001|First Washout (>6d)|Withdrawal by Subject|0
7561190|NCT03192488|11928995|FG002|First Washout (>6d)|Withdrawal by Subject|1
7561191|NCT03192488|11928996|FG003|First Washout (>6d)|Withdrawal by Subject|0
7561192|NCT03192488|11928997|FG004|First Washout (>6d)|Withdrawal by Subject|0
7561193|NCT03192488|11928998|FG005|First Washout (>6d)|Withdrawal by Subject|1
7561194|NCT03192488|11928993|FG000|Third Intervention (d1)|Adverse Event|0
7561195|NCT03192488|11928994|FG001|Third Intervention (d1)|Adverse Event|0
7561196|NCT03192488|11928995|FG002|Third Intervention (d1)|Adverse Event|0
7439757|NCT01642615|11723571|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
7439758|NCT01642615|11723572|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
7439759|NCT01642615|11723570|FG000|Open Label Maintenance Phase|Did not receive treatment|1
7439760|NCT01642615|11723571|FG001|Open Label Maintenance Phase|Did not receive treatment|0
7439761|NCT01642615|11723572|FG002|Open Label Maintenance Phase|Did not receive treatment|0
7439762|NCT01642615|11723570|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
7439763|NCT01642615|11723571|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
7439764|NCT01642615|11723572|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
7439765|NCT01642615|11723570|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
7439766|NCT01642615|11723571|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
7439767|NCT01642615|11723572|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
7439768|NCT01642615|11723570|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7439769|NCT01642615|11723571|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
7439770|NCT01642615|11723572|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
7439771|NCT01642615|11723570|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7439772|NCT01642615|11723571|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
7439773|NCT01642615|11723572|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
7439774|NCT01642914|11723583|FG000|Overall Study|Adverse Event|11
7439775|NCT01642914|11723584|FG001|Overall Study|Adverse Event|7
7439776|NCT01642914|11723585|FG002|Overall Study|Adverse Event|15
7439777|NCT01642914|11723583|FG000|Overall Study|Lack of Efficacy|9
7439778|NCT01642914|11723584|FG001|Overall Study|Lack of Efficacy|4
7439779|NCT01642914|11723585|FG002|Overall Study|Lack of Efficacy|2
7439780|NCT01642914|11723583|FG000|Overall Study|Protocol Violation|15
7439781|NCT01642914|11723584|FG001|Overall Study|Protocol Violation|13
7439782|NCT01642914|11723585|FG002|Overall Study|Protocol Violation|6
7439783|NCT01642914|11723583|FG000|Overall Study|Withdrawal by Subject|5
7439784|NCT01642914|11723584|FG001|Overall Study|Withdrawal by Subject|5
7439785|NCT01642914|11723585|FG002|Overall Study|Withdrawal by Subject|10
7439786|NCT01642914|11723583|FG000|Overall Study|Lost to Follow-up|5
7439787|NCT01642914|11723584|FG001|Overall Study|Lost to Follow-up|3
7439788|NCT01642914|11723585|FG002|Overall Study|Lost to Follow-up|7
7439789|NCT01642914|11723583|FG000|Overall Study|Other Reason|1
7439790|NCT01642914|11723584|FG001|Overall Study|Other Reason|0
7439791|NCT01642914|11723585|FG002|Overall Study|Other Reason|0
7439792|NCT01643044|11723597|FG000|Overall Study|Lost to Follow-up|1
7439793|NCT01643044|11723598|FG001|Overall Study|Lost to Follow-up|1
7439794|NCT01643044|11723597|FG000|Overall Study|Miscarried baby|2
7439795|NCT01643044|11723598|FG001|Overall Study|Miscarried baby|2
7439796|NCT01643044|11723597|FG000|Overall Study|Delivered outside of hospital|1
7439797|NCT01643044|11723598|FG001|Overall Study|Delivered outside of hospital|2
7439798|NCT01643408|11723622|FG000|Overall Study|Adverse Event|12
7439799|NCT01643408|11723622|FG000|Overall Study|Other|2
7439800|NCT01643473|11723628|FG000|Overall Study|Lost to Follow-up|1
7439801|NCT01643473|11723629|FG001|Overall Study|Lost to Follow-up|0
7439802|NCT01643668|11723644|FG000|Overall Study|Death|1
7439803|NCT01643772|11723664|FG000|Overall Study|Protocol Violation|0
7439804|NCT01643772|11723665|FG001|Overall Study|Protocol Violation|0
7561197|NCT03192488|11928996|FG003|Third Intervention (d1)|Adverse Event|0
7561198|NCT03192488|11928997|FG004|Third Intervention (d1)|Adverse Event|1
7561199|NCT03192488|11928998|FG005|Third Intervention (d1)|Adverse Event|0
7439805|NCT01643772|11723666|FG002|Overall Study|Protocol Violation|0
7439806|NCT01643772|11723667|FG003|Overall Study|Protocol Violation|1
7439807|NCT01643772|11723664|FG000|Overall Study|Adverse Event|0
7439808|NCT01643772|11723665|FG001|Overall Study|Adverse Event|0
7439809|NCT01643772|11723666|FG002|Overall Study|Adverse Event|0
7439810|NCT01643772|11723667|FG003|Overall Study|Adverse Event|1
7439811|NCT01643798|11723679|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
7439812|NCT01643798|11723680|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
7439813|NCT01643850|11723700|FG000|Overall Study|Withdrawal by Subject|0
7561200|NCT03192904|11929027|FG000|Overall Study|Physician Decision|3
7439814|NCT01643850|11723701|FG001|Overall Study|Withdrawal by Subject|0
7439815|NCT01643850|11723702|FG002|Overall Study|Withdrawal by Subject|0
7439816|NCT01643850|11723703|FG003|Overall Study|Withdrawal by Subject|0
7439817|NCT01643850|11723704|FG004|Overall Study|Withdrawal by Subject|1
7439818|NCT01643850|11723705|FG005|Overall Study|Withdrawal by Subject|0
7439819|NCT01643850|11723706|FG006|Overall Study|Withdrawal by Subject|0
7439820|NCT01643850|11723707|FG007|Overall Study|Withdrawal by Subject|0
7439821|NCT01643850|11723708|FG008|Overall Study|Withdrawal by Subject|0
7439822|NCT01643850|11723700|FG000|Overall Study|Lost to Follow-up|0
7439823|NCT01643850|11723701|FG001|Overall Study|Lost to Follow-up|0
7439824|NCT01643850|11723702|FG002|Overall Study|Lost to Follow-up|0
7439825|NCT01643850|11723703|FG003|Overall Study|Lost to Follow-up|0
7439826|NCT01643850|11723704|FG004|Overall Study|Lost to Follow-up|0
7439827|NCT01643850|11723705|FG005|Overall Study|Lost to Follow-up|0
7439828|NCT01643850|11723706|FG006|Overall Study|Lost to Follow-up|1
7439829|NCT01643850|11723707|FG007|Overall Study|Lost to Follow-up|0
7439830|NCT01643850|11723708|FG008|Overall Study|Lost to Follow-up|1
7439831|NCT01643850|11723700|FG000|Overall Study|Adverse Event|0
7439832|NCT01643850|11723701|FG001|Overall Study|Adverse Event|0
7439833|NCT01643850|11723702|FG002|Overall Study|Adverse Event|0
7439834|NCT01643850|11723703|FG003|Overall Study|Adverse Event|0
7439835|NCT01643850|11723704|FG004|Overall Study|Adverse Event|1
7439836|NCT01643850|11723705|FG005|Overall Study|Adverse Event|0
7439837|NCT01643850|11723706|FG006|Overall Study|Adverse Event|0
7439838|NCT01643850|11723707|FG007|Overall Study|Adverse Event|0
7439839|NCT01643850|11723708|FG008|Overall Study|Adverse Event|0
7439840|NCT01643850|11723700|FG000|Overall Study|Administrative Problems|0
7439841|NCT01643850|11723701|FG001|Overall Study|Administrative Problems|0
7439842|NCT01643850|11723702|FG002|Overall Study|Administrative Problems|1
7439843|NCT01643850|11723703|FG003|Overall Study|Administrative Problems|0
7439844|NCT01643850|11723704|FG004|Overall Study|Administrative Problems|1
7439845|NCT01643850|11723705|FG005|Overall Study|Administrative Problems|0
7439846|NCT01643850|11723706|FG006|Overall Study|Administrative Problems|0
7439847|NCT01643850|11723707|FG007|Overall Study|Administrative Problems|0
7439848|NCT01643850|11723708|FG008|Overall Study|Administrative Problems|0
7439849|NCT01643928|11723788|FG000|Overall Study|Lost to Follow-up|1
7439850|NCT01643928|11723789|FG001|Overall Study|Lost to Follow-up|0
7439851|NCT01643928|11723790|FG002|Overall Study|Lost to Follow-up|2
7439852|NCT01643928|11723791|FG003|Overall Study|Lost to Follow-up|0
7439853|NCT01643928|11723792|FG004|Overall Study|Lost to Follow-up|0
7439854|NCT01643928|11723788|FG000|Overall Study|Withdrawal by Subject|2
7439855|NCT01643928|11723789|FG001|Overall Study|Withdrawal by Subject|0
7439856|NCT01643928|11723790|FG002|Overall Study|Withdrawal by Subject|0
7439857|NCT01643928|11723791|FG003|Overall Study|Withdrawal by Subject|1
7439858|NCT01643928|11723792|FG004|Overall Study|Withdrawal by Subject|0
7439859|NCT01643928|11723788|FG000|Overall Study|Pregnancy|0
7439860|NCT01643928|11723789|FG001|Overall Study|Pregnancy|0
7439861|NCT01643928|11723790|FG002|Overall Study|Pregnancy|0
7439862|NCT01643928|11723791|FG003|Overall Study|Pregnancy|1
7561201|NCT03192904|11929028|FG001|Overall Study|Physician Decision|1
7561202|NCT03192904|11929027|FG000|Overall Study|Lost to Follow-up|0
7561203|NCT03192904|11929028|FG001|Overall Study|Lost to Follow-up|1
7561204|NCT03193021|11929036|FG000|Overall Study|Lost to Follow-up|1
7439863|NCT01643928|11723792|FG004|Overall Study|Pregnancy|0
7439864|NCT01643928|11723788|FG000|Overall Study|Other|5
7439865|NCT01643928|11723789|FG001|Overall Study|Other|1
7439866|NCT01643928|11723790|FG002|Overall Study|Other|1
7439867|NCT01643928|11723791|FG003|Overall Study|Other|0
7439868|NCT01643928|11723792|FG004|Overall Study|Other|0
7439869|NCT01643928|11723788|FG000|Overall Study|Adverse Event|2
7439870|NCT01643928|11723789|FG001|Overall Study|Adverse Event|1
7439871|NCT01643928|11723790|FG002|Overall Study|Adverse Event|0
7439872|NCT01643928|11723791|FG003|Overall Study|Adverse Event|1
7439873|NCT01643928|11723792|FG004|Overall Study|Adverse Event|2
7439874|NCT01644149|11723840|FG000|Overall Study|Withdrawal by Subject|1
7439875|NCT01644149|11723841|FG001|Overall Study|Withdrawal by Subject|0
7439876|NCT01644149|11723840|FG000|Overall Study|Lost to Follow-up|3
7439877|NCT01644149|11723841|FG001|Overall Study|Lost to Follow-up|1
7439878|NCT01644175|11723850|FG000|Overall Study|Randomized But Not Treated|0
7439879|NCT01644175|11723851|FG001|Overall Study|Randomized But Not Treated|2
7439880|NCT01644175|11723850|FG000|Overall Study|Adverse Event|8
7439881|NCT01644175|11723851|FG001|Overall Study|Adverse Event|13
7439882|NCT01644175|11723850|FG000|Overall Study|Death|1
7439883|NCT01644175|11723851|FG001|Overall Study|Death|2
7439884|NCT01644175|11723850|FG000|Overall Study|Poor compliance to protocol|9
7439885|NCT01644175|11723851|FG001|Overall Study|Poor compliance to protocol|10
7561205|NCT03193021|11929037|FG001|Overall Study|Lost to Follow-up|1
7439886|NCT01644175|11723850|FG000|Overall Study|Physician Decision|1
7439887|NCT01644175|11723851|FG001|Overall Study|Physician Decision|2
7439888|NCT01644175|11723850|FG000|Overall Study|Participant Moved|1
7439889|NCT01644175|11723851|FG001|Overall Study|Participant Moved|2
7439890|NCT01644175|11723850|FG000|Overall Study|Consent withdrawn by participant|3
7439891|NCT01644175|11723851|FG001|Overall Study|Consent withdrawn by participant|4
7439892|NCT01644175|11723850|FG000|Overall Study|Related to Autoinjector Administration|2
7439893|NCT01644175|11723851|FG001|Overall Study|Related to Autoinjector Administration|1
7561206|NCT03193047|11929045|FG000|Overall Study|Physician Decision|1
7439894|NCT01644175|11723850|FG000|Overall Study|Last visit outside protocol visit window|4
7439895|NCT01644175|11723851|FG001|Overall Study|Last visit outside protocol visit window|11
7439896|NCT01644175|11723850|FG000|Overall Study|Selection criteria finally not met|0
7439897|NCT01644175|11723851|FG001|Overall Study|Selection criteria finally not met|1
7439898|NCT01644175|11723850|FG000|Overall Study|Site closure|2
7439899|NCT01644175|11723851|FG001|Overall Study|Site closure|2
7439900|NCT01644175|11723850|FG000|Overall Study|Lost to Follow-up|1
7439901|NCT01644175|11723851|FG001|Overall Study|Lost to Follow-up|0
7439902|NCT01644175|11723850|FG000|Overall Study|Other than specified above|0
7439903|NCT01644175|11723851|FG001|Overall Study|Other than specified above|3
7439904|NCT01644188|11723859|FG000|Overall Study|Adverse Event|44
7439905|NCT01644188|11723860|FG001|Overall Study|Adverse Event|20
7439906|NCT01644188|11723859|FG000|Overall Study|Poor compliance to protocol|26
7439907|NCT01644188|11723860|FG001|Overall Study|Poor compliance to protocol|14
7439908|NCT01644188|11723859|FG000|Overall Study|Physician Decision|1
7439909|NCT01644188|11723860|FG001|Overall Study|Physician Decision|3
7439910|NCT01644188|11723859|FG000|Overall Study|Participant moved|7
7439911|NCT01644188|11723860|FG001|Overall Study|Participant moved|2
7439912|NCT01644188|11723859|FG000|Overall Study|Related to auto-injector administration|2
7439913|NCT01644188|11723860|FG001|Overall Study|Related to auto-injector administration|2
7439914|NCT01644188|11723859|FG000|Overall Study|Consent withdrawn by participant|14
7439915|NCT01644188|11723860|FG001|Overall Study|Consent withdrawn by participant|7
7439916|NCT01644188|11723859|FG000|Overall Study|Selection criteria finally not met|2
7439917|NCT01644188|11723860|FG001|Overall Study|Selection criteria finally not met|0
7439918|NCT01644188|11723859|FG000|Overall Study|Lost to Follow-up|1
7439919|NCT01644188|11723860|FG001|Overall Study|Lost to Follow-up|0
7439920|NCT01644188|11723859|FG000|Overall Study|Death|4
7439921|NCT01644188|11723860|FG001|Overall Study|Death|3
7439922|NCT01644188|11723859|FG000|Overall Study|Last visit outside protocol visit window|14
7439923|NCT01644188|11723860|FG001|Overall Study|Last visit outside protocol visit window|16
7439924|NCT01644188|11723859|FG000|Overall Study|Site closure|1
7439925|NCT01644188|11723860|FG001|Overall Study|Site closure|1
7439926|NCT01644188|11723859|FG000|Overall Study|Other than specified above|6
7439927|NCT01644188|11723860|FG001|Overall Study|Other than specified above|7
7439928|NCT01644474|11723899|FG000|Overall Study|Poor compliance to protocol|1
7439929|NCT01644474|11723900|FG001|Overall Study|Poor compliance to protocol|0
7439930|NCT01644474|11723899|FG000|Overall Study|Consent withdrawn by participant|0
7439931|NCT01644474|11723900|FG001|Overall Study|Consent withdrawn by participant|1
7439932|NCT01644474|11723899|FG000|Overall Study|Participant moved|0
7439933|NCT01644474|11723900|FG001|Overall Study|Participant moved|1
7439934|NCT01644474|11723899|FG000|Overall Study|Adverse Event|4
7439935|NCT01644474|11723900|FG001|Overall Study|Adverse Event|5
7439936|NCT01644474|11723899|FG000|Overall Study|Site scheduling error|1
7439937|NCT01644474|11723900|FG001|Overall Study|Site scheduling error|1
7439938|NCT01644474|11723899|FG000|Overall Study|Protocol Violation|1
7439939|NCT01644474|11723900|FG001|Overall Study|Protocol Violation|0
7439940|NCT01644500|11723909|FG000|Overall Study|Adverse Event|6
7439941|NCT01644500|11723910|FG001|Overall Study|Adverse Event|1
7439942|NCT01644500|11723911|FG002|Overall Study|Adverse Event|2
7439943|NCT01644500|11723909|FG000|Overall Study|Death|0
7439944|NCT01644500|11723910|FG001|Overall Study|Death|1
7439945|NCT01644500|11723911|FG002|Overall Study|Death|0
7439946|NCT01644500|11723909|FG000|Overall Study|Lost to Follow-up|3
7439947|NCT01644500|11723910|FG001|Overall Study|Lost to Follow-up|8
7439948|NCT01644500|11723911|FG002|Overall Study|Lost to Follow-up|0
7439949|NCT01644500|11723909|FG000|Overall Study|Protocol Violation|1
7439950|NCT01644500|11723910|FG001|Overall Study|Protocol Violation|1
7439951|NCT01644500|11723911|FG002|Overall Study|Protocol Violation|0
7439952|NCT01644500|11723909|FG000|Overall Study|Withdrawal by Subject|11
7439953|NCT01644500|11723910|FG001|Overall Study|Withdrawal by Subject|12
7439954|NCT01644500|11723911|FG002|Overall Study|Withdrawal by Subject|12
7439955|NCT01644500|11723909|FG000|Overall Study|Physician Decision|1
7439956|NCT01644500|11723910|FG001|Overall Study|Physician Decision|1
7561207|NCT03193047|11929046|FG001|Overall Study|Physician Decision|0
7561208|NCT03193047|11929045|FG000|Overall Study|Participant Left State|1
7561209|NCT03193047|11929046|FG001|Overall Study|Participant Left State|0
7561210|NCT03193736|11929092|FG000|Overall Study|Death|2
7561211|NCT03193736|11929092|FG000|Overall Study|Withdrawal by Subject|1
7439957|NCT01644500|11723911|FG002|Overall Study|Physician Decision|1
7439958|NCT01644565|11723919|FG000|Overall Study|Undisclosed Medical History|1
7439959|NCT01644565|11723920|FG001|Overall Study|Undisclosed Medical History|0
7439960|NCT01644565|11723921|FG002|Overall Study|Undisclosed Medical History|0
7439961|NCT01644565|11723922|FG003|Overall Study|Undisclosed Medical History|0
7439962|NCT01644565|11723923|FG004|Overall Study|Undisclosed Medical History|0
7439963|NCT01644565|11723924|FG005|Overall Study|Undisclosed Medical History|0
7439964|NCT01644565|11723925|FG006|Overall Study|Undisclosed Medical History|0
7439965|NCT01644565|11723926|FG007|Overall Study|Undisclosed Medical History|0
7439966|NCT01644565|11723927|FG008|Overall Study|Undisclosed Medical History|0
7439967|NCT01644565|11723919|FG000|Overall Study|Lost to Follow-up|0
7439968|NCT01644565|11723920|FG001|Overall Study|Lost to Follow-up|0
7439969|NCT01644565|11723921|FG002|Overall Study|Lost to Follow-up|0
7439970|NCT01644565|11723922|FG003|Overall Study|Lost to Follow-up|1
7439971|NCT01644565|11723923|FG004|Overall Study|Lost to Follow-up|0
7561212|NCT03193736|11929092|FG000|Overall Study|Lost to Follow-up|1
7561213|NCT03193736|11929092|FG000|Overall Study|implant not received|1
7561214|NCT03194217|11929100|FG000|Overall Study|Adverse Event|0
7561215|NCT03194217|11929101|FG001|Overall Study|Adverse Event|2
7561216|NCT03194217|11929102|FG002|Overall Study|Adverse Event|3
7439972|NCT01644565|11723924|FG005|Overall Study|Lost to Follow-up|0
7439973|NCT01644565|11723925|FG006|Overall Study|Lost to Follow-up|0
7439974|NCT01644565|11723926|FG007|Overall Study|Lost to Follow-up|2
7439975|NCT01644565|11723927|FG008|Overall Study|Lost to Follow-up|0
7439976|NCT01644565|11723919|FG000|Overall Study|Family emergency|0
7439977|NCT01644565|11723920|FG001|Overall Study|Family emergency|0
7439978|NCT01644565|11723921|FG002|Overall Study|Family emergency|0
7439979|NCT01644565|11723922|FG003|Overall Study|Family emergency|0
7439980|NCT01644565|11723923|FG004|Overall Study|Family emergency|1
7439981|NCT01644565|11723924|FG005|Overall Study|Family emergency|0
7439982|NCT01644565|11723925|FG006|Overall Study|Family emergency|0
7439983|NCT01644565|11723926|FG007|Overall Study|Family emergency|0
7439984|NCT01644565|11723927|FG008|Overall Study|Family emergency|0
7439985|NCT01644565|11723919|FG000|Overall Study|Relocation|0
7439986|NCT01644565|11723920|FG001|Overall Study|Relocation|0
7439987|NCT01644565|11723921|FG002|Overall Study|Relocation|0
7439988|NCT01644565|11723922|FG003|Overall Study|Relocation|0
7439989|NCT01644565|11723923|FG004|Overall Study|Relocation|0
7439990|NCT01644565|11723924|FG005|Overall Study|Relocation|0
7439991|NCT01644565|11723925|FG006|Overall Study|Relocation|0
7439992|NCT01644565|11723926|FG007|Overall Study|Relocation|0
7439993|NCT01644565|11723927|FG008|Overall Study|Relocation|1
7439994|NCT01644617|11723950|FG000|Overall Study|Withdrawal by Subject|3
7439995|NCT01644617|11723951|FG001|Overall Study|Withdrawal by Subject|4
7439996|NCT01644617|11723952|FG002|Overall Study|Withdrawal by Subject|1
7439997|NCT01644617|11723950|FG000|Overall Study|Lost to Follow-up|0
7439998|NCT01644617|11723951|FG001|Overall Study|Lost to Follow-up|1
7439999|NCT01644617|11723952|FG002|Overall Study|Lost to Follow-up|0
7440000|NCT01644617|11723950|FG000|Overall Study|Adverse Event|3
7440001|NCT01644617|11723951|FG001|Overall Study|Adverse Event|0
7440002|NCT01644617|11723952|FG002|Overall Study|Adverse Event|6
7440003|NCT01644643|11723964|FG000|Overall Study|Death|1
7440004|NCT01644643|11723965|FG001|Overall Study|Death|0
7440005|NCT01644643|11723966|FG002|Overall Study|Death|3
7440006|NCT01644643|11723967|FG003|Overall Study|Death|3
7440007|NCT01644643|11723964|FG000|Overall Study|Lost to Follow-up|0
7440008|NCT01644643|11723965|FG001|Overall Study|Lost to Follow-up|0
7440009|NCT01644643|11723966|FG002|Overall Study|Lost to Follow-up|0
7440010|NCT01644643|11723967|FG003|Overall Study|Lost to Follow-up|4
7440011|NCT01644643|11723964|FG000|Overall Study|Withdrawal by Subject|1
7440012|NCT01644643|11723965|FG001|Overall Study|Withdrawal by Subject|0
7440013|NCT01644643|11723966|FG002|Overall Study|Withdrawal by Subject|2
7440014|NCT01644643|11723967|FG003|Overall Study|Withdrawal by Subject|1
7440015|NCT01644643|11723964|FG000|Overall Study|Other Eligibility criteria|0
7440016|NCT01644643|11723965|FG001|Overall Study|Other Eligibility criteria|0
7440017|NCT01644643|11723966|FG002|Overall Study|Other Eligibility criteria|0
7440018|NCT01644643|11723967|FG003|Overall Study|Other Eligibility criteria|2
7440019|NCT01644734|11723987|FG000|Overall Study|Adverse Event|4
7440020|NCT01644734|11723987|FG000|Overall Study|Lost to Follow-up|17
7440021|NCT01644734|11723987|FG000|Overall Study|Reasons other than stated above|7
7440022|NCT01644734|11723987|FG000|Overall Study|Missing documentation|238
7440023|NCT01644890|11723993|FG000|Overall Study|Adverse Event|7
7440024|NCT01644890|11723994|FG001|Overall Study|Adverse Event|20
7440025|NCT01644890|11723993|FG000|Overall Study|Death|1
7440026|NCT01644890|11723994|FG001|Overall Study|Death|3
7440027|NCT01644890|11723993|FG000|Overall Study|Physician Decision|3
7440028|NCT01644890|11723994|FG001|Overall Study|Physician Decision|9
7440029|NCT01644890|11723993|FG000|Overall Study|Protocol Violation|6
7440030|NCT01644890|11723994|FG001|Overall Study|Protocol Violation|7
7440031|NCT01644890|11723993|FG000|Overall Study|Withdrawal by Subject|19
7440032|NCT01644890|11723994|FG001|Overall Study|Withdrawal by Subject|27
7440033|NCT01644890|11723993|FG000|Overall Study|Progression Disease|160
7440034|NCT01644890|11723994|FG001|Overall Study|Progression Disease|131
7440035|NCT01644890|11723993|FG000|Overall Study|Clinical Progression|6
7440036|NCT01644890|11723994|FG001|Overall Study|Clinical Progression|6
7440037|NCT01644890|11723993|FG000|Overall Study|> 28 days since last dose of study drug|6
7440038|NCT01644890|11723994|FG001|Overall Study|> 28 days since last dose of study drug|3
7440039|NCT01644890|11723993|FG000|Overall Study|Other|8
7561217|NCT03194217|11929103|FG003|Overall Study|Adverse Event|3
7440040|NCT01644890|11723994|FG001|Overall Study|Other|9
7467416|NCT01901146|11767787|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
7467417|NCT01901146|11767788|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
7467418|NCT01901146|11767789|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
7467419|NCT01901146|11767790|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
7467420|NCT01901146|11767791|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
7467421|NCT01901146|11767787|FG000|Neoadjuvant Phase|Lost to Follow-up|0
7467422|NCT01901146|11767788|FG001|Neoadjuvant Phase|Lost to Follow-up|1
7467423|NCT01901146|11767789|FG002|Neoadjuvant Phase|Lost to Follow-up|0
7467424|NCT01901146|11767790|FG003|Neoadjuvant Phase|Lost to Follow-up|0
7467425|NCT01901146|11767791|FG004|Neoadjuvant Phase|Lost to Follow-up|0
7561218|NCT03194217|11929100|FG000|Overall Study|Failure to meet randomisation criteria|0
7440041|NCT01645111|11724018|FG000|Overall Study|Did not require Clevidipine|15
7440042|NCT01645176|11724022|FG000|Overall Study|Lack of Efficacy|4
7440043|NCT01645176|11724022|FG000|Overall Study|did not complete final MRI|1
7440044|NCT01645280|11724031|FG000|Overall Study|Death|0
7440045|NCT01645280|11724032|FG001|Overall Study|Death|1
7440046|NCT01645280|11724033|FG002|Overall Study|Death|0
7440047|NCT01645280|11724034|FG003|Overall Study|Death|0
7440048|NCT01645280|11724035|FG004|Overall Study|Death|0
7440049|NCT01645280|11724031|FG000|Overall Study|Withdrawal by Subject|4
7440050|NCT01645280|11724032|FG001|Overall Study|Withdrawal by Subject|0
7440051|NCT01645280|11724033|FG002|Overall Study|Withdrawal by Subject|2
7440052|NCT01645280|11724034|FG003|Overall Study|Withdrawal by Subject|4
7440053|NCT01645280|11724035|FG004|Overall Study|Withdrawal by Subject|5
7440054|NCT01645280|11724031|FG000|Overall Study|Lost to Follow-up|0
7440055|NCT01645280|11724032|FG001|Overall Study|Lost to Follow-up|0
7440056|NCT01645280|11724033|FG002|Overall Study|Lost to Follow-up|0
7440057|NCT01645280|11724034|FG003|Overall Study|Lost to Follow-up|2
7440058|NCT01645280|11724035|FG004|Overall Study|Lost to Follow-up|1
7440059|NCT01645280|11724031|FG000|Overall Study|Other|1
7440060|NCT01645280|11724032|FG001|Overall Study|Other|1
7440061|NCT01645280|11724033|FG002|Overall Study|Other|2
7440062|NCT01645280|11724034|FG003|Overall Study|Other|0
7440063|NCT01645280|11724035|FG004|Overall Study|Other|0
7440064|NCT01645280|11724031|FG000|Overall Study|Treatment not completed/Completed f/u|1
7440065|NCT01645280|11724032|FG001|Overall Study|Treatment not completed/Completed f/u|1
7440066|NCT01645280|11724033|FG002|Overall Study|Treatment not completed/Completed f/u|2
7440067|NCT01645280|11724034|FG003|Overall Study|Treatment not completed/Completed f/u|0
7440068|NCT01645280|11724035|FG004|Overall Study|Treatment not completed/Completed f/u|2
7440069|NCT01645735|11724063|FG000|Overall Study|Physician Decision|2
7440070|NCT01645735|11724064|FG001|Overall Study|Physician Decision|0
7440071|NCT01645735|11724063|FG000|Overall Study|Withdrawal by Subject|1
7440072|NCT01645735|11724064|FG001|Overall Study|Withdrawal by Subject|0
7440073|NCT01645735|11724063|FG000|Overall Study|Protocol Violation|1
7440074|NCT01645735|11724064|FG001|Overall Study|Protocol Violation|0
7440075|NCT01645735|11724063|FG000|Overall Study|Adverse Event|0
7440076|NCT01645735|11724064|FG001|Overall Study|Adverse Event|1
7440077|NCT01645930|11724071|FG000|Overall Study|Participants Ongoing on Study Treatment|22
7440078|NCT01645930|11724071|FG000|Overall Study|Progressive Disease|12
7440079|NCT01645930|11724071|FG000|Overall Study|Adverse Event|4
7440080|NCT01645930|11724071|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
7440081|NCT01645930|11724071|FG000|Overall Study|Withdrawal by Participant|2
7440082|NCT01645930|11724071|FG000|Overall Study|Reason not Defined|1
7440083|NCT01646021|11724077|FG000|Overall Study|Death|77
7440084|NCT01646021|11724078|FG001|Overall Study|Death|83
7440085|NCT01646021|11724077|FG000|Overall Study|Study Terminated by Sponsor|50
7440086|NCT01646021|11724078|FG001|Overall Study|Study Terminated by Sponsor|41
7440087|NCT01646021|11724077|FG000|Overall Study|Lost to Follow-up|2
7440088|NCT01646021|11724078|FG001|Overall Study|Lost to Follow-up|2
7440089|NCT01646021|11724077|FG000|Overall Study|Withdrawal by Subject|10
7440090|NCT01646021|11724078|FG001|Overall Study|Withdrawal by Subject|15
7440091|NCT01646073|11724086|FG000|Period A (12 Weeks)|Adverse Event|0
7440092|NCT01646073|11724087|FG001|Period A (12 Weeks)|Adverse Event|2
7440093|NCT01646073|11724086|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
7440094|NCT01646073|11724087|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
7440095|NCT01646073|11724086|FG000|Period A (12 Weeks)|Lack of Efficacy|1
7440096|NCT01646073|11724087|FG001|Period A (12 Weeks)|Lack of Efficacy|0
7440097|NCT01646073|11724086|FG000|Period A (12 Weeks)|Protocol Violation|0
7440098|NCT01646073|11724087|FG001|Period A (12 Weeks)|Protocol Violation|1
7440099|NCT01646073|11724086|FG000|Period A (12 Weeks)|Other|0
7440100|NCT01646073|11724087|FG001|Period A (12 Weeks)|Other|1
7440101|NCT01646073|11724086|FG000|Period B (12 Weeks)|Adverse Event|0
7440102|NCT01646073|11724087|FG001|Period B (12 Weeks)|Adverse Event|7
7561219|NCT03194217|11929101|FG001|Overall Study|Failure to meet randomisation criteria|0
7561220|NCT03194217|11929102|FG002|Overall Study|Failure to meet randomisation criteria|0
7561221|NCT03194217|11929103|FG003|Overall Study|Failure to meet randomisation criteria|1
7561222|NCT03194217|11929100|FG000|Overall Study|Other|0
7561223|NCT03194217|11929101|FG001|Overall Study|Other|1
7440103|NCT01646073|11724086|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
7440104|NCT01646073|11724087|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
7440105|NCT01646073|11724086|FG000|Period B (12 Weeks)|Lost to Follow-up|0
7440106|NCT01646073|11724087|FG001|Period B (12 Weeks)|Lost to Follow-up|1
7440107|NCT01646125|11724098|FG000|Overall Study|Untreated|2
7440108|NCT01646125|11724099|FG001|Overall Study|Untreated|5
7440109|NCT01646125|11724098|FG000|Overall Study|Adverse Event|2
7440110|NCT01646125|11724099|FG001|Overall Study|Adverse Event|1
7440111|NCT01646125|11724098|FG000|Overall Study|Death|1
7561224|NCT03194217|11929102|FG002|Overall Study|Other|1
7440112|NCT01646125|11724099|FG001|Overall Study|Death|1
7440113|NCT01646125|11724098|FG000|Overall Study|Physician Decision|1
7440114|NCT01646125|11724099|FG001|Overall Study|Physician Decision|3
7440115|NCT01646125|11724098|FG000|Overall Study|Progressive disease|22
7440116|NCT01646125|11724099|FG001|Overall Study|Progressive disease|16
7440117|NCT01646125|11724098|FG000|Overall Study|Study terminated by sponsor|2
7440118|NCT01646125|11724099|FG001|Overall Study|Study terminated by sponsor|1
7440119|NCT01646125|11724098|FG000|Overall Study|Subject/Guardian decision|1
7440120|NCT01646125|11724099|FG001|Overall Study|Subject/Guardian decision|1
7440121|NCT01646138|11724111|FG000|Overall Study|Lost to Follow-up|0
7440122|NCT01646138|11724112|FG001|Overall Study|Lost to Follow-up|0
7440123|NCT01646138|11724113|FG002|Overall Study|Lost to Follow-up|0
7440124|NCT01646138|11724114|FG003|Overall Study|Lost to Follow-up|0
7440125|NCT01646138|11724115|FG004|Overall Study|Lost to Follow-up|2
7440126|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
7440127|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
7440128|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
7440129|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
7440130|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440131|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440132|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7561225|NCT03194217|11929103|FG003|Overall Study|Other|0
7561226|NCT03194464|11929131|FG000|Overall Study|data not usable|2
7561227|NCT03194490|11929139|FG000|Overall Study|Lost to Follow-up|1
7561228|NCT03194490|11929140|FG001|Overall Study|Lost to Follow-up|3
7561229|NCT03194490|11929139|FG000|Overall Study|participant developed specific neck pain|1
7561230|NCT03194490|11929140|FG001|Overall Study|participant developed specific neck pain|0
7561231|NCT03196193|11929220|FG000|Overall Study|Adverse Event|1
7561232|NCT03196193|11929221|FG001|Overall Study|Adverse Event|0
7561233|NCT03196193|11929220|FG000|Overall Study|Computed Tomography (CT) data missing|2
7561234|NCT03196193|11929221|FG001|Overall Study|Computed Tomography (CT) data missing|0
7561235|NCT03196284|11929233|FG000|Main Part|Withdrawal by Subject|0
7561236|NCT03196284|11929234|FG001|Main Part|Withdrawal by Subject|1
7561237|NCT03196284|11929235|FG002|Main Part|Withdrawal by Subject|0
7561238|NCT03196284|11929233|FG000|Extension Part|Lack of Efficacy|0
7561239|NCT03196284|11929234|FG001|Extension Part|Lack of Efficacy|0
7561240|NCT03196284|11929235|FG002|Extension Part|Lack of Efficacy|1
7440133|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440134|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440135|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440136|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440137|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
7440138|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
7440139|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
7440140|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
7440141|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
7440142|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440143|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440144|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440145|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440146|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440147|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440148|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440149|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
7440150|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
7440151|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
7440152|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7440153|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
7440154|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440155|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440156|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440157|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440158|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440159|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440160|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7561241|NCT03196284|11929233|FG000|Extension Part|Withdrawal by Subject|0
7561242|NCT03196284|11929234|FG001|Extension Part|Withdrawal by Subject|0
7561243|NCT03196284|11929235|FG002|Extension Part|Withdrawal by Subject|1
7561244|NCT03196284|11929233|FG000|Extension Part|Physician Decision|0
7561245|NCT03196284|11929234|FG001|Extension Part|Physician Decision|0
7561246|NCT03196284|11929235|FG002|Extension Part|Physician Decision|1
7561247|NCT03196297|11929255|FG000|Main Period|Withdrawal by Subject|4
7561248|NCT03196297|11929255|FG000|Extension Period|Withdrawal by Subject|1
7561249|NCT03196297|11929255|FG000|Extension Period|Lack of Efficacy|2
7561250|NCT03196349|11929274|FG000|Overall Study|Did not receive study drug|0
7561251|NCT03196349|11929275|FG001|Overall Study|Did not receive study drug|1
7561252|NCT03196349|11929276|FG002|Overall Study|Did not receive study drug|2
7561253|NCT03196349|11929274|FG000|Overall Study|No data entered|2
7561254|NCT03196349|11929275|FG001|Overall Study|No data entered|4
7561255|NCT03196349|11929276|FG002|Overall Study|No data entered|0
7561256|NCT03196349|11929274|FG000|Overall Study|Study Terminated early|15
7561257|NCT03196349|11929275|FG001|Overall Study|Study Terminated early|9
7561258|NCT03196349|11929276|FG002|Overall Study|Study Terminated early|11
7561259|NCT03196505|11929286|FG000|Overall Study|Physician Decision|26
7440161|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
7440162|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7440163|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7440164|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
7440165|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
7440166|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440167|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440168|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440169|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440170|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440171|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440172|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440173|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
7440174|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440175|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440176|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
7440177|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
7440178|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440179|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440180|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440181|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440182|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440183|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440184|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440185|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
7440186|NCT01646177|11724135|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
7440187|NCT01646177|11724136|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7440188|NCT01646177|11724137|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
7440189|NCT01646177|11724138|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440190|NCT01646177|11724139|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7561260|NCT03196505|11929287|FG001|Overall Study|Physician Decision|26
7561261|NCT03196635|11929293|FG000|Overall Study|Withdrawal by Subject|1
7561262|NCT03196791|11929313|FG000|Overall Study|Protocol Violation|7
7440191|NCT01646177|11724140|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440192|NCT01646177|11724141|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440193|NCT01646177|11724142|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440194|NCT01646177|11724143|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440195|NCT01646177|11724144|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440196|NCT01646177|11724145|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440197|NCT01646177|11724146|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
7440198|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440199|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440200|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440201|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440202|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
7440203|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
7440204|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
7440205|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
7440206|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440207|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440208|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440209|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
7440210|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440211|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440212|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440213|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440214|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
7440215|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
7440216|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
7440217|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
7440218|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440219|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440220|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440221|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
7440222|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440223|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7561263|NCT03196791|11929314|FG001|Overall Study|Protocol Violation|3
7561264|NCT03196791|11929313|FG000|Overall Study|Withdrawal by Subject|3
7561265|NCT03196791|11929314|FG001|Overall Study|Withdrawal by Subject|2
7561266|NCT03196973|11929323|FG000|Overall Study|Adverse Event|1
7440224|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440225|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440226|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
7440227|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
7440228|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
7440229|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
7440230|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440231|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440232|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440233|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
7440234|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440235|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440236|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440237|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440238|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
7440239|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
7440240|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
7440241|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
7440242|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440243|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440244|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440245|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
7440246|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440247|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440248|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440249|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440250|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
7440251|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7440252|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7440253|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
7440254|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440255|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440256|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440257|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
7440258|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440259|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440260|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440261|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440262|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
7440263|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
7440264|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440265|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
7440266|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440267|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440268|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440269|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
7440270|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440271|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440272|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440273|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440274|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
7440275|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7561267|NCT03196973|11929324|FG001|Overall Study|Adverse Event|1
7440276|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7440277|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
7440278|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440279|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440280|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440281|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
7440282|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Death|0
7440283|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Death|0
7440284|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Death|0
7440285|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Death|0
7561268|NCT03196973|11929325|FG002|Overall Study|Adverse Event|2
7561269|NCT03196973|11929323|FG000|Overall Study|Lack of Efficacy|2
7561270|NCT03196973|11929324|FG001|Overall Study|Lack of Efficacy|6
7561271|NCT03196973|11929325|FG002|Overall Study|Lack of Efficacy|1
7561272|NCT03196973|11929323|FG000|Overall Study|Lost to Follow-up|4
7440286|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Death|1
7440287|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Death|3
7440288|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Death|1
7440289|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Death|3
7440290|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Death|0
7440291|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Death|0
7440292|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Death|0
7440293|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Death|0
7440294|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440295|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440296|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440297|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440298|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7440299|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7440300|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
7440301|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
7440302|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440303|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440304|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440305|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
7440306|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440307|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440308|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440309|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440310|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440311|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440312|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440313|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
7440314|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440315|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440316|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440317|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
7440318|NCT01646177|11724135|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440319|NCT01646177|11724136|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440320|NCT01646177|11724137|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440321|NCT01646177|11724138|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440322|NCT01646177|11724139|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440323|NCT01646177|11724140|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
7440324|NCT01646177|11724141|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
7440325|NCT01646177|11724142|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
7440326|NCT01646177|11724143|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440327|NCT01646177|11724144|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440328|NCT01646177|11724145|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440329|NCT01646177|11724146|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
7440330|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440331|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440332|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440333|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440334|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440335|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440336|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440337|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
7440338|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
7440339|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
7440340|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
7440341|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
7440342|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440343|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440344|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440345|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440346|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440347|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440348|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440349|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
7440350|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
7440351|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
7467426|NCT01901146|11767787|FG000|Neoadjuvant Phase|Physician Decision|1
7440352|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7440353|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
7440354|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440355|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440356|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440357|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440358|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440359|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440360|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440361|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
7440362|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
7440363|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
7440364|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7440365|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
7440366|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440367|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440368|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440369|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440370|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440371|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440372|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440373|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
7440374|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
7440375|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7440376|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
7440377|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
7440378|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440379|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440380|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440381|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440382|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440383|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440384|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440385|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
7440386|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
7440387|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
7440388|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
7440389|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
7440390|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440391|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440392|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440393|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440394|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440395|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440396|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440397|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
7440398|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
7440399|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7440400|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
7440401|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
7440402|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440403|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440404|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440405|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440406|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440407|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440408|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440409|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440410|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
7440411|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7440412|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
7440413|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
7440414|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440415|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440416|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440417|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440418|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440419|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440420|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440421|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440422|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
7440423|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7440424|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7440425|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
7440426|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440427|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440428|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440429|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440430|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440431|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440432|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440433|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440434|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7440435|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
7440436|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7440437|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
7440438|NCT01646177|11724135|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440439|NCT01646177|11724136|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440440|NCT01646177|11724137|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440441|NCT01646177|11724138|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440442|NCT01646177|11724139|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440443|NCT01646177|11724140|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440444|NCT01646177|11724141|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440445|NCT01646177|11724142|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440446|NCT01646177|11724143|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440447|NCT01646177|11724144|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
7440448|NCT01646177|11724145|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7440449|NCT01646177|11724146|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
7440450|NCT01646203|11724169|FG000|Overall Study|Adverse Event|2
7440451|NCT01646203|11724170|FG001|Overall Study|Adverse Event|0
7440452|NCT01646203|11724171|FG002|Overall Study|Adverse Event|1
7440453|NCT01646203|11724169|FG000|Overall Study|Withdrawal by Subject|0
7440454|NCT01646203|11724170|FG001|Overall Study|Withdrawal by Subject|1
7440455|NCT01646203|11724171|FG002|Overall Study|Withdrawal by Subject|0
7440456|NCT01646203|11724169|FG000|Overall Study|Physician's Decision|0
7440457|NCT01646203|11724170|FG001|Overall Study|Physician's Decision|1
7440458|NCT01646203|11724171|FG002|Overall Study|Physician's Decision|0
7440459|NCT01646216|11724186|FG000|Overall Study|Baseline step length difference (<5cm)|10
7440460|NCT01646216|11724187|FG001|Overall Study|Baseline step length difference (<5cm)|10
7440461|NCT01646216|11724186|FG000|Overall Study|Did not complete training|0
7440462|NCT01646216|11724187|FG001|Overall Study|Did not complete training|2
7440463|NCT01646216|11724186|FG000|Overall Study|Investigator decision|1
7440464|NCT01646216|11724187|FG001|Overall Study|Investigator decision|1
7440465|NCT01646255|11724199|FG000|Overall Study|Adverse Event|7
7440466|NCT01646255|11724200|FG001|Overall Study|Adverse Event|8
7440467|NCT01646255|11724199|FG000|Overall Study|Lack of Efficacy|2
7440468|NCT01646255|11724200|FG001|Overall Study|Lack of Efficacy|0
7440469|NCT01646255|11724199|FG000|Overall Study|Withdrawal by Subject|10
7440470|NCT01646255|11724200|FG001|Overall Study|Withdrawal by Subject|6
7440471|NCT01646255|11724199|FG000|Overall Study|Compliance is not well|1
7440472|NCT01646255|11724200|FG001|Overall Study|Compliance is not well|0
7440473|NCT01646255|11724199|FG000|Overall Study|Inclusion Criteria Deviation|1
7440474|NCT01646255|11724200|FG001|Overall Study|Inclusion Criteria Deviation|0
7440475|NCT01646268|11724209|FG000|Overall Study|Adverse Event|6
7440476|NCT01646268|11724210|FG001|Overall Study|Adverse Event|7
7440477|NCT01646268|11724209|FG000|Overall Study|Lack of Efficacy|1
7440478|NCT01646268|11724210|FG001|Overall Study|Lack of Efficacy|3
7440479|NCT01646268|11724209|FG000|Overall Study|Protocol Violation|0
7440480|NCT01646268|11724210|FG001|Overall Study|Protocol Violation|1
7440481|NCT01646268|11724209|FG000|Overall Study|Withdrawal by Subject|2
7440482|NCT01646268|11724210|FG001|Overall Study|Withdrawal by Subject|5
7440483|NCT01646268|11724209|FG000|Overall Study|Other|2
7440484|NCT01646268|11724210|FG001|Overall Study|Other|0
7440485|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
7440486|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
7440487|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7440488|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
7440489|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
7440490|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
7440491|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|Other|1
7440492|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|Other|0
7440493|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7440494|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7440495|NCT01646320|11724218|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
7440496|NCT01646320|11724219|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
7440497|NCT01646320|11724218|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
7440498|NCT01646320|11724219|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
7440499|NCT01646320|11724218|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
7440500|NCT01646320|11724219|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
7440501|NCT01646320|11724218|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
7440502|NCT01646320|11724219|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
7440503|NCT01646320|11724218|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
7440504|NCT01646320|11724219|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
7440505|NCT01646320|11724218|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
7440506|NCT01646320|11724219|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
7440507|NCT01646385|11724231|FG000|Overall Study|Death|202
7440508|NCT01646385|11724232|FG001|Overall Study|Death|222
7440509|NCT01646385|11724231|FG000|Overall Study|Switched to alternate biologic|636
7440510|NCT01646385|11724232|FG001|Overall Study|Switched to alternate biologic|649
7440511|NCT01646398|11724240|FG000|Overall Study|Withdrawal by Subject|1
7440512|NCT01646398|11724241|FG001|Overall Study|Withdrawal by Subject|0
7440513|NCT01646645|11724247|FG000|Overall Study|No Treated|1
7440514|NCT01646645|11724247|FG000|Overall Study|Inevaluable Donor|29
7440515|NCT01646827|11724272|FG000|Overall Study|Lost to Follow-up|0
7440516|NCT01646827|11724273|FG001|Overall Study|Lost to Follow-up|3
7440517|NCT01646827|11724272|FG000|Overall Study|Physician Decision|1
7440518|NCT01646827|11724273|FG001|Overall Study|Physician Decision|2
7440519|NCT01646827|11724272|FG000|Overall Study|Withdrawal by Subject|1
7440520|NCT01646827|11724273|FG001|Overall Study|Withdrawal by Subject|0
7440521|NCT01647282|11724292|FG000|Overall Study|Physician Decision|7
7440522|NCT01647282|11724293|FG001|Overall Study|Physician Decision|5
7440523|NCT01647516|11724315|FG000|Induction Period (IP)|Physician Decision|2
7440524|NCT01647516|11724316|FG001|Induction Period (IP)|Physician Decision|0
7440525|NCT01647516|11724317|FG002|Induction Period (IP)|Physician Decision|0
7440526|NCT01647516|11724318|FG003|Induction Period (IP)|Physician Decision|0
7440527|NCT01647516|11724319|FG004|Induction Period (IP)|Physician Decision|0
7440528|NCT01647516|11724320|FG005|Induction Period (IP)|Physician Decision|0
7440529|NCT01647516|11724315|FG000|Induction Period (IP)|Adverse Event|1
7440530|NCT01647516|11724316|FG001|Induction Period (IP)|Adverse Event|2
7440531|NCT01647516|11724317|FG002|Induction Period (IP)|Adverse Event|0
7440532|NCT01647516|11724318|FG003|Induction Period (IP)|Adverse Event|0
7440533|NCT01647516|11724319|FG004|Induction Period (IP)|Adverse Event|0
7440534|NCT01647516|11724320|FG005|Induction Period (IP)|Adverse Event|0
7440535|NCT01647516|11724315|FG000|Induction Period (IP)|Withdrawal by Subject|1
7440536|NCT01647516|11724316|FG001|Induction Period (IP)|Withdrawal by Subject|0
7440537|NCT01647516|11724317|FG002|Induction Period (IP)|Withdrawal by Subject|3
7440538|NCT01647516|11724318|FG003|Induction Period (IP)|Withdrawal by Subject|0
7440539|NCT01647516|11724319|FG004|Induction Period (IP)|Withdrawal by Subject|0
7440540|NCT01647516|11724320|FG005|Induction Period (IP)|Withdrawal by Subject|0
7440541|NCT01647516|11724315|FG000|Induction Period (IP)|Participant Choice|0
7440542|NCT01647516|11724316|FG001|Induction Period (IP)|Participant Choice|0
7440543|NCT01647516|11724317|FG002|Induction Period (IP)|Participant Choice|1
7440544|NCT01647516|11724318|FG003|Induction Period (IP)|Participant Choice|0
7440545|NCT01647516|11724319|FG004|Induction Period (IP)|Participant Choice|0
7440546|NCT01647516|11724320|FG005|Induction Period (IP)|Participant Choice|0
7440547|NCT01647516|11724315|FG000|Induction Period (IP)|Lack of Efficacy|1
7440548|NCT01647516|11724316|FG001|Induction Period (IP)|Lack of Efficacy|0
7440549|NCT01647516|11724317|FG002|Induction Period (IP)|Lack of Efficacy|0
7440550|NCT01647516|11724318|FG003|Induction Period (IP)|Lack of Efficacy|0
7440551|NCT01647516|11724319|FG004|Induction Period (IP)|Lack of Efficacy|0
7440552|NCT01647516|11724320|FG005|Induction Period (IP)|Lack of Efficacy|0
7440553|NCT01647516|11724315|FG000|Induction Period (IP)|No study drug received|1
7440554|NCT01647516|11724316|FG001|Induction Period (IP)|No study drug received|1
7440555|NCT01647516|11724317|FG002|Induction Period (IP)|No study drug received|0
7440556|NCT01647516|11724318|FG003|Induction Period (IP)|No study drug received|0
7440557|NCT01647516|11724319|FG004|Induction Period (IP)|No study drug received|0
7440558|NCT01647516|11724320|FG005|Induction Period (IP)|No study drug received|0
7440559|NCT01647516|11724315|FG000|Maintenance Period (MP)|Adverse Event|2
7440560|NCT01647516|11724316|FG001|Maintenance Period (MP)|Adverse Event|1
7440561|NCT01647516|11724317|FG002|Maintenance Period (MP)|Adverse Event|0
7440562|NCT01647516|11724318|FG003|Maintenance Period (MP)|Adverse Event|0
7440563|NCT01647516|11724319|FG004|Maintenance Period (MP)|Adverse Event|0
7440564|NCT01647516|11724320|FG005|Maintenance Period (MP)|Adverse Event|0
7440565|NCT01647516|11724315|FG000|Maintenance Period (MP)|Non-compliance|1
7440566|NCT01647516|11724316|FG001|Maintenance Period (MP)|Non-compliance|0
7440567|NCT01647516|11724317|FG002|Maintenance Period (MP)|Non-compliance|0
7440568|NCT01647516|11724318|FG003|Maintenance Period (MP)|Non-compliance|0
7440569|NCT01647516|11724319|FG004|Maintenance Period (MP)|Non-compliance|0
7440570|NCT01647516|11724320|FG005|Maintenance Period (MP)|Non-compliance|0
7440571|NCT01647516|11724315|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
7440572|NCT01647516|11724316|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
7440573|NCT01647516|11724317|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
7440574|NCT01647516|11724318|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
7440575|NCT01647516|11724319|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
7440576|NCT01647516|11724320|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
7440577|NCT01647516|11724315|FG000|Maintenance Period (MP)|Lack of Efficacy|1
7440578|NCT01647516|11724316|FG001|Maintenance Period (MP)|Lack of Efficacy|4
7440579|NCT01647516|11724317|FG002|Maintenance Period (MP)|Lack of Efficacy|1
7440580|NCT01647516|11724318|FG003|Maintenance Period (MP)|Lack of Efficacy|0
7440581|NCT01647516|11724319|FG004|Maintenance Period (MP)|Lack of Efficacy|0
7440582|NCT01647516|11724320|FG005|Maintenance Period (MP)|Lack of Efficacy|0
7440583|NCT01647516|11724315|FG000|Open-Label Period|Adverse Event|0
7440584|NCT01647516|11724316|FG001|Open-Label Period|Adverse Event|0
7440585|NCT01647516|11724317|FG002|Open-Label Period|Adverse Event|0
7440586|NCT01647516|11724318|FG003|Open-Label Period|Adverse Event|5
7440587|NCT01647516|11724319|FG004|Open-Label Period|Adverse Event|6
7440588|NCT01647516|11724320|FG005|Open-Label Period|Adverse Event|3
7440589|NCT01647516|11724315|FG000|Open-Label Period|Pregnancy|0
7440590|NCT01647516|11724316|FG001|Open-Label Period|Pregnancy|0
7440591|NCT01647516|11724317|FG002|Open-Label Period|Pregnancy|0
7440592|NCT01647516|11724318|FG003|Open-Label Period|Pregnancy|0
7440593|NCT01647516|11724319|FG004|Open-Label Period|Pregnancy|0
7440594|NCT01647516|11724320|FG005|Open-Label Period|Pregnancy|1
7440595|NCT01647516|11724315|FG000|Open-Label Period|Non-compliance|0
7440596|NCT01647516|11724316|FG001|Open-Label Period|Non-compliance|0
7440597|NCT01647516|11724317|FG002|Open-Label Period|Non-compliance|0
7440598|NCT01647516|11724318|FG003|Open-Label Period|Non-compliance|1
7440599|NCT01647516|11724319|FG004|Open-Label Period|Non-compliance|0
7440600|NCT01647516|11724320|FG005|Open-Label Period|Non-compliance|1
7440601|NCT01647516|11724315|FG000|Open-Label Period|Physician Decision|0
7440602|NCT01647516|11724316|FG001|Open-Label Period|Physician Decision|0
7440603|NCT01647516|11724317|FG002|Open-Label Period|Physician Decision|0
7440604|NCT01647516|11724318|FG003|Open-Label Period|Physician Decision|1
7440605|NCT01647516|11724319|FG004|Open-Label Period|Physician Decision|1
7440606|NCT01647516|11724320|FG005|Open-Label Period|Physician Decision|0
7440607|NCT01647516|11724315|FG000|Open-Label Period|Withdrawal by Subject|0
7440608|NCT01647516|11724316|FG001|Open-Label Period|Withdrawal by Subject|0
7440609|NCT01647516|11724317|FG002|Open-Label Period|Withdrawal by Subject|0
7440610|NCT01647516|11724318|FG003|Open-Label Period|Withdrawal by Subject|9
7440611|NCT01647516|11724319|FG004|Open-Label Period|Withdrawal by Subject|11
7440612|NCT01647516|11724320|FG005|Open-Label Period|Withdrawal by Subject|6
7440613|NCT01647516|11724315|FG000|Open-Label Period|Lost to Follow-up|0
7440614|NCT01647516|11724316|FG001|Open-Label Period|Lost to Follow-up|0
7440615|NCT01647516|11724317|FG002|Open-Label Period|Lost to Follow-up|0
7440616|NCT01647516|11724318|FG003|Open-Label Period|Lost to Follow-up|1
7440617|NCT01647516|11724319|FG004|Open-Label Period|Lost to Follow-up|0
7440618|NCT01647516|11724320|FG005|Open-Label Period|Lost to Follow-up|1
7440619|NCT01647516|11724315|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7440620|NCT01647516|11724316|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7440621|NCT01647516|11724317|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
7440622|NCT01647516|11724318|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
7440623|NCT01647516|11724319|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
7440624|NCT01647516|11724320|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
7440625|NCT01647516|11724315|FG000|Open-Label Period|Lack of Efficacy|0
7440626|NCT01647516|11724316|FG001|Open-Label Period|Lack of Efficacy|0
7440627|NCT01647516|11724317|FG002|Open-Label Period|Lack of Efficacy|0
7440628|NCT01647516|11724318|FG003|Open-Label Period|Lack of Efficacy|7
7440629|NCT01647516|11724319|FG004|Open-Label Period|Lack of Efficacy|9
7440630|NCT01647516|11724320|FG005|Open-Label Period|Lack of Efficacy|10
7440631|NCT01647516|11724315|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
7440632|NCT01647516|11724316|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
7440633|NCT01647516|11724317|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
7440634|NCT01647516|11724318|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
7440635|NCT01647516|11724319|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
7440636|NCT01647516|11724320|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
7440637|NCT01647516|11724315|FG000|Open-Label Period|No completion / discontinuation visit|0
7440638|NCT01647516|11724316|FG001|Open-Label Period|No completion / discontinuation visit|0
7440639|NCT01647516|11724317|FG002|Open-Label Period|No completion / discontinuation visit|0
7440640|NCT01647516|11724318|FG003|Open-Label Period|No completion / discontinuation visit|0
7440641|NCT01647516|11724319|FG004|Open-Label Period|No completion / discontinuation visit|2
7561273|NCT03196973|11929324|FG001|Overall Study|Lost to Follow-up|3
7561274|NCT03196973|11929325|FG002|Overall Study|Lost to Follow-up|2
7561275|NCT03196973|11929323|FG000|Overall Study|Consent withdrawn|2
7561276|NCT03196973|11929324|FG001|Overall Study|Consent withdrawn|1
7561277|NCT03196973|11929325|FG002|Overall Study|Consent withdrawn|0
7561278|NCT03196973|11929323|FG000|Overall Study|Administration of a wrong kit of study medication|0
7561279|NCT03196973|11929324|FG001|Overall Study|Administration of a wrong kit of study medication|1
7561280|NCT03196973|11929325|FG002|Overall Study|Administration of a wrong kit of study medication|0
7440642|NCT01647516|11724320|FG005|Open-Label Period|No completion / discontinuation visit|1
7440643|NCT01647542|11724338|FG000|Overall Study|Major Protocol Deviation|1
7440644|NCT01647542|11724339|FG001|Overall Study|Major Protocol Deviation|0
7440645|NCT01647542|11724340|FG002|Overall Study|Major Protocol Deviation|0
7440646|NCT01647542|11724338|FG000|Overall Study|Adverse Event|4
7440647|NCT01647542|11724339|FG001|Overall Study|Adverse Event|5
7440648|NCT01647542|11724340|FG002|Overall Study|Adverse Event|4
7440649|NCT01647542|11724338|FG000|Overall Study|Lost to Follow-up|0
7440650|NCT01647542|11724339|FG001|Overall Study|Lost to Follow-up|2
7561281|NCT03197129|11929348|FG000|Overall Study|did not answer the VPT: shyness|4
7440651|NCT01647542|11724340|FG002|Overall Study|Lost to Follow-up|2
7440652|NCT01647542|11724338|FG000|Overall Study|Withdrawal by Subject|6
7440653|NCT01647542|11724339|FG001|Overall Study|Withdrawal by Subject|4
7440654|NCT01647542|11724340|FG002|Overall Study|Withdrawal by Subject|0
7440655|NCT01647542|11724338|FG000|Overall Study|Study Termination|64
7440656|NCT01647542|11724339|FG001|Overall Study|Study Termination|61
7440657|NCT01647542|11724340|FG002|Overall Study|Study Termination|65
7440658|NCT01647542|11724338|FG000|Overall Study|Lack of Efficacy|1
7440659|NCT01647542|11724339|FG001|Overall Study|Lack of Efficacy|1
7440660|NCT01647542|11724340|FG002|Overall Study|Lack of Efficacy|0
7440661|NCT01647542|11724338|FG000|Overall Study|Death|0
7440662|NCT01647542|11724339|FG001|Overall Study|Death|0
7440663|NCT01647542|11724340|FG002|Overall Study|Death|1
7440664|NCT01647711|11724362|FG000|Overall Study|Progressive disease|6
7440665|NCT01647711|11724363|FG001|Overall Study|Progressive disease|2
7440666|NCT01647711|11724364|FG002|Overall Study|Progressive disease|6
7440667|NCT01647711|11724365|FG003|Overall Study|Progressive disease|8
7440668|NCT01647711|11724366|FG004|Overall Study|Progressive disease|2
7440669|NCT01647711|11724362|FG000|Overall Study|Other adverse event|0
7440670|NCT01647711|11724363|FG001|Overall Study|Other adverse event|0
7440671|NCT01647711|11724364|FG002|Overall Study|Other adverse event|2
7440672|NCT01647711|11724365|FG003|Overall Study|Other adverse event|0
7440673|NCT01647711|11724366|FG004|Overall Study|Other adverse event|2
7440674|NCT01647711|11724362|FG000|Overall Study|Protocol Violation|0
7440675|NCT01647711|11724363|FG001|Overall Study|Protocol Violation|0
7440676|NCT01647711|11724364|FG002|Overall Study|Protocol Violation|0
7440677|NCT01647711|11724365|FG003|Overall Study|Protocol Violation|0
7440678|NCT01647711|11724366|FG004|Overall Study|Protocol Violation|1
7440679|NCT01647711|11724362|FG000|Overall Study|Refused to continue taking medication|0
7440680|NCT01647711|11724363|FG001|Overall Study|Refused to continue taking medication|0
7440681|NCT01647711|11724364|FG002|Overall Study|Refused to continue taking medication|0
7440682|NCT01647711|11724365|FG003|Overall Study|Refused to continue taking medication|2
7440683|NCT01647711|11724366|FG004|Overall Study|Refused to continue taking medication|1
7440684|NCT01647711|11724362|FG000|Overall Study|Other reason not defined|0
7440685|NCT01647711|11724363|FG001|Overall Study|Other reason not defined|1
7440686|NCT01647711|11724364|FG002|Overall Study|Other reason not defined|1
7440687|NCT01647711|11724365|FG003|Overall Study|Other reason not defined|1
7440688|NCT01647711|11724366|FG004|Overall Study|Other reason not defined|0
7440689|NCT01647958|11724408|FG000|Initial Study|Lost to Follow-up|2
7440690|NCT01647958|11724409|FG001|Initial Study|Lost to Follow-up|3
7440691|NCT01647958|11724408|FG000|Continuation Phase|treatment received during Overall Study|39
7440692|NCT01647958|11724409|FG001|Continuation Phase|treatment received during Overall Study|0
7440693|NCT01647958|11724408|FG000|Extended Follow-up Phase|Lost to Follow-up|8
7440694|NCT01647958|11724409|FG001|Extended Follow-up Phase|Lost to Follow-up|0
7440695|NCT01648101|11724427|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
7440696|NCT01648101|11724428|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
7440697|NCT01648101|11724429|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
7440698|NCT01648101|11724427|FG000|Titration Phase (4 Weeks)|Adverse Event|0
7440699|NCT01648101|11724428|FG001|Titration Phase (4 Weeks)|Adverse Event|2
7440700|NCT01648101|11724429|FG002|Titration Phase (4 Weeks)|Adverse Event|3
7440701|NCT01648101|11724427|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7440702|NCT01648101|11724428|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
7440703|NCT01648101|11724429|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
7440704|NCT01648101|11724427|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7440705|NCT01648101|11724428|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
7440706|NCT01648101|11724429|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
7440707|NCT01648101|11724427|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7440708|NCT01648101|11724428|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
7440709|NCT01648101|11724429|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
7440710|NCT01648101|11724427|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
7440711|NCT01648101|11724428|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
7440712|NCT01648101|11724429|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
7440713|NCT01648101|11724427|FG000|Transition Phase (4 Weeks)|Adverse Event|4
7440714|NCT01648101|11724428|FG001|Transition Phase (4 Weeks)|Adverse Event|3
7440715|NCT01648101|11724429|FG002|Transition Phase (4 Weeks)|Adverse Event|2
7440716|NCT01648101|11724427|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
7440717|NCT01648101|11724428|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
7440718|NCT01648101|11724429|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
7561282|NCT03197129|11929349|FG001|Overall Study|did not answer the VPT: shyness|5
7440719|NCT01648101|11724427|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7561283|NCT03197324|11929357|FG000|Overall Study|Adverse Event|0
7440720|NCT01648101|11724428|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
7561284|NCT03197324|11929358|FG001|Overall Study|Adverse Event|1
7561285|NCT03197376|11929368|FG000|Primary and Booster Phase|Adverse Event|0
7561286|NCT03197376|11929369|FG001|Primary and Booster Phase|Adverse Event|0
7561287|NCT03197376|11929370|FG002|Primary and Booster Phase|Adverse Event|0
7561288|NCT03197376|11929371|FG003|Primary and Booster Phase|Adverse Event|1
7561289|NCT03197376|11929368|FG000|Primary and Booster Phase|Death|1
7440721|NCT01648101|11724429|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
7440722|NCT01648101|11724427|FG000|Transition Phase (4 Weeks)|Study Terminated|1
7440723|NCT01648101|11724428|FG001|Transition Phase (4 Weeks)|Study Terminated|0
7440724|NCT01648101|11724429|FG002|Transition Phase (4 Weeks)|Study Terminated|0
7440725|NCT01648101|11724427|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7440726|NCT01648101|11724428|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
7440727|NCT01648101|11724429|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
7440728|NCT01648140|11724445|FG000|Overall Study|Physician Decision|1
7440729|NCT01648140|11724446|FG001|Overall Study|Physician Decision|0
7440730|NCT01648140|11724447|FG002|Overall Study|Physician Decision|0
7440731|NCT01648140|11724448|FG003|Overall Study|Physician Decision|0
7440732|NCT01648140|11724445|FG000|Overall Study|Lack of Efficacy|4
7440733|NCT01648140|11724446|FG001|Overall Study|Lack of Efficacy|7
7440734|NCT01648140|11724447|FG002|Overall Study|Lack of Efficacy|1
7440735|NCT01648140|11724448|FG003|Overall Study|Lack of Efficacy|0
7440736|NCT01648140|11724445|FG000|Overall Study|Adverse Event|3
7440737|NCT01648140|11724446|FG001|Overall Study|Adverse Event|1
7440738|NCT01648140|11724447|FG002|Overall Study|Adverse Event|2
7440739|NCT01648140|11724448|FG003|Overall Study|Adverse Event|0
7440740|NCT01648140|11724445|FG000|Overall Study|Withdrawal by Subject|2
7440741|NCT01648140|11724446|FG001|Overall Study|Withdrawal by Subject|3
7440742|NCT01648140|11724447|FG002|Overall Study|Withdrawal by Subject|3
7440743|NCT01648140|11724448|FG003|Overall Study|Withdrawal by Subject|2
7440744|NCT01648140|11724445|FG000|Overall Study|Lost to Follow-up|2
7440745|NCT01648140|11724446|FG001|Overall Study|Lost to Follow-up|1
7440746|NCT01648140|11724447|FG002|Overall Study|Lost to Follow-up|2
7440747|NCT01648140|11724448|FG003|Overall Study|Lost to Follow-up|0
7440748|NCT01648166|11724469|FG000|Overall Study|inadequate toenail samples|53
7440749|NCT01648166|11724470|FG001|Overall Study|inadequate toenail samples|100
7440750|NCT01648283|11724476|FG000|Overall Study|Withdrawal by Subject|14
7440751|NCT01648348|11724518|FG000|Overall Study|Cancel|1
7440752|NCT01648348|11724519|FG001|Overall Study|Cancel|0
7440753|NCT01648348|11724520|FG002|Overall Study|Cancel|0
7440754|NCT01648348|11724521|FG003|Overall Study|Cancel|0
7440755|NCT01648348|11724522|FG004|Overall Study|Cancel|3
7440756|NCT01648348|11724523|FG005|Overall Study|Cancel|6
7440757|NCT01648348|11724518|FG000|Overall Study|Replaced for MTD analysis|1
7440758|NCT01648348|11724519|FG001|Overall Study|Replaced for MTD analysis|0
7440759|NCT01648348|11724520|FG002|Overall Study|Replaced for MTD analysis|1
7440760|NCT01648348|11724521|FG003|Overall Study|Replaced for MTD analysis|0
7440761|NCT01648348|11724522|FG004|Overall Study|Replaced for MTD analysis|0
7440762|NCT01648348|11724523|FG005|Overall Study|Replaced for MTD analysis|0
7440763|NCT01648582|11724556|FG000|Overall Study|Adverse Event|6
7440764|NCT01648582|11724557|FG001|Overall Study|Adverse Event|11
7440765|NCT01648582|11724558|FG002|Overall Study|Adverse Event|2
7440766|NCT01648582|11724556|FG000|Overall Study|Lost to Follow-up|9
7440767|NCT01648582|11724557|FG001|Overall Study|Lost to Follow-up|6
7440768|NCT01648582|11724558|FG002|Overall Study|Lost to Follow-up|8
7440769|NCT01648582|11724556|FG000|Overall Study|Protocol Violation|1
7440770|NCT01648582|11724557|FG001|Overall Study|Protocol Violation|2
7440771|NCT01648582|11724558|FG002|Overall Study|Protocol Violation|1
7440772|NCT01648582|11724556|FG000|Overall Study|Withdrawal by Subject|15
7440773|NCT01648582|11724557|FG001|Overall Study|Withdrawal by Subject|17
7440774|NCT01648582|11724558|FG002|Overall Study|Withdrawal by Subject|17
7440775|NCT01648582|11724556|FG000|Overall Study|Physician Decision|0
7440776|NCT01648582|11724557|FG001|Overall Study|Physician Decision|1
7440777|NCT01648582|11724558|FG002|Overall Study|Physician Decision|3
7440778|NCT01648582|11724556|FG000|Overall Study|Death|1
7440779|NCT01648582|11724557|FG001|Overall Study|Death|0
7440780|NCT01648582|11724558|FG002|Overall Study|Death|0
7440781|NCT01648582|11724556|FG000|Overall Study|Sponsor Decision|0
7440782|NCT01648582|11724557|FG001|Overall Study|Sponsor Decision|1
7440783|NCT01648582|11724558|FG002|Overall Study|Sponsor Decision|1
7440784|NCT01648699|11724569|FG000|Overall Study|Death|1
7440785|NCT01648699|11724569|FG000|Overall Study|Lost to Follow-up|2
7440786|NCT01648699|11724569|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
7440787|NCT01648764|11724596|FG000|Overall Study|Progressive Disease|0
7440788|NCT01648764|11724597|FG001|Overall Study|Progressive Disease|1
7440789|NCT01648764|11724598|FG002|Overall Study|Progressive Disease|0
7440790|NCT01648764|11724599|FG003|Overall Study|Progressive Disease|0
7440791|NCT01648764|11724600|FG004|Overall Study|Progressive Disease|0
7440792|NCT01648764|11724601|FG005|Overall Study|Progressive Disease|1
7440793|NCT01648764|11724602|FG006|Overall Study|Progressive Disease|1
7440794|NCT01648764|11724603|FG007|Overall Study|Progressive Disease|0
7440795|NCT01648764|11724604|FG008|Overall Study|Progressive Disease|0
7440796|NCT01648764|11724605|FG009|Overall Study|Progressive Disease|2
7440797|NCT01648764|11724606|FG010|Overall Study|Progressive Disease|0
7440798|NCT01648764|11724607|FG011|Overall Study|Progressive Disease|1
7440799|NCT01648764|11724608|FG012|Overall Study|Progressive Disease|2
7440800|NCT01648764|11724609|FG013|Overall Study|Progressive Disease|1
7440801|NCT01648764|11724596|FG000|Overall Study|Adverse Event|0
7440802|NCT01648764|11724597|FG001|Overall Study|Adverse Event|0
7440803|NCT01648764|11724598|FG002|Overall Study|Adverse Event|0
7440804|NCT01648764|11724599|FG003|Overall Study|Adverse Event|0
7440805|NCT01648764|11724600|FG004|Overall Study|Adverse Event|0
7440806|NCT01648764|11724601|FG005|Overall Study|Adverse Event|1
7440807|NCT01648764|11724602|FG006|Overall Study|Adverse Event|0
7440808|NCT01648764|11724603|FG007|Overall Study|Adverse Event|0
7440809|NCT01648764|11724604|FG008|Overall Study|Adverse Event|0
7440810|NCT01648764|11724605|FG009|Overall Study|Adverse Event|1
7440811|NCT01648764|11724606|FG010|Overall Study|Adverse Event|0
7440812|NCT01648764|11724607|FG011|Overall Study|Adverse Event|3
7440813|NCT01648764|11724608|FG012|Overall Study|Adverse Event|1
7440814|NCT01648764|11724609|FG013|Overall Study|Adverse Event|1
7440815|NCT01648764|11724596|FG000|Overall Study|Death|0
7440816|NCT01648764|11724597|FG001|Overall Study|Death|0
7440817|NCT01648764|11724598|FG002|Overall Study|Death|0
7440818|NCT01648764|11724599|FG003|Overall Study|Death|0
7440819|NCT01648764|11724600|FG004|Overall Study|Death|0
7440820|NCT01648764|11724601|FG005|Overall Study|Death|0
7440821|NCT01648764|11724602|FG006|Overall Study|Death|1
7440822|NCT01648764|11724603|FG007|Overall Study|Death|0
7440823|NCT01648764|11724604|FG008|Overall Study|Death|0
7440824|NCT01648764|11724605|FG009|Overall Study|Death|0
7440825|NCT01648764|11724606|FG010|Overall Study|Death|0
7440826|NCT01648764|11724607|FG011|Overall Study|Death|0
7440827|NCT01648764|11724608|FG012|Overall Study|Death|0
7440828|NCT01648764|11724609|FG013|Overall Study|Death|1
7440829|NCT01648764|11724596|FG000|Overall Study|Withdrawal by Subject|0
7440830|NCT01648764|11724597|FG001|Overall Study|Withdrawal by Subject|0
7440831|NCT01648764|11724598|FG002|Overall Study|Withdrawal by Subject|0
7440832|NCT01648764|11724599|FG003|Overall Study|Withdrawal by Subject|0
7440833|NCT01648764|11724600|FG004|Overall Study|Withdrawal by Subject|0
7440834|NCT01648764|11724601|FG005|Overall Study|Withdrawal by Subject|0
7440835|NCT01648764|11724602|FG006|Overall Study|Withdrawal by Subject|2
7440836|NCT01648764|11724603|FG007|Overall Study|Withdrawal by Subject|0
7440837|NCT01648764|11724604|FG008|Overall Study|Withdrawal by Subject|0
7440838|NCT01648764|11724605|FG009|Overall Study|Withdrawal by Subject|0
7440839|NCT01648764|11724606|FG010|Overall Study|Withdrawal by Subject|0
7440840|NCT01648764|11724607|FG011|Overall Study|Withdrawal by Subject|0
7440841|NCT01648764|11724608|FG012|Overall Study|Withdrawal by Subject|1
7440842|NCT01648764|11724609|FG013|Overall Study|Withdrawal by Subject|0
7440843|NCT01648764|11724596|FG000|Overall Study|Investigator Decision|0
7440844|NCT01648764|11724597|FG001|Overall Study|Investigator Decision|0
7440845|NCT01648764|11724598|FG002|Overall Study|Investigator Decision|0
7440846|NCT01648764|11724599|FG003|Overall Study|Investigator Decision|0
7440847|NCT01648764|11724600|FG004|Overall Study|Investigator Decision|0
7440848|NCT01648764|11724601|FG005|Overall Study|Investigator Decision|0
7440849|NCT01648764|11724602|FG006|Overall Study|Investigator Decision|1
7440850|NCT01648764|11724603|FG007|Overall Study|Investigator Decision|0
7440851|NCT01648764|11724604|FG008|Overall Study|Investigator Decision|0
7440852|NCT01648764|11724605|FG009|Overall Study|Investigator Decision|0
7440853|NCT01648764|11724606|FG010|Overall Study|Investigator Decision|0
7440854|NCT01648764|11724607|FG011|Overall Study|Investigator Decision|1
7440855|NCT01648764|11724608|FG012|Overall Study|Investigator Decision|0
7440856|NCT01648764|11724609|FG013|Overall Study|Investigator Decision|0
7440857|NCT01648790|11724643|FG000|Treatment 3|Withdrawal by Subject|0
7440858|NCT01648790|11724644|FG001|Treatment 3|Withdrawal by Subject|0
7440859|NCT01648790|11724645|FG002|Treatment 3|Withdrawal by Subject|0
7440860|NCT01648790|11724646|FG003|Treatment 3|Withdrawal by Subject|1
7440861|NCT01648790|11724647|FG004|Treatment 3|Withdrawal by Subject|0
7440862|NCT01649232|11724673|FG000|Overall Study|Physician Decision|2
7440863|NCT01649232|11724674|FG001|Overall Study|Physician Decision|0
7440864|NCT01649271|11724688|FG000|Overall Study|Progressive disease|4
7440865|NCT01649271|11724689|FG001|Overall Study|Progressive disease|5
7440866|NCT01649271|11724688|FG000|Overall Study|Other Adverse Event|0
7440867|NCT01649271|11724689|FG001|Overall Study|Other Adverse Event|2
7440868|NCT01649271|11724688|FG000|Overall Study|Withdrawal by Subject|1
7440869|NCT01649271|11724689|FG001|Overall Study|Withdrawal by Subject|0
7440870|NCT01649271|11724688|FG000|Overall Study|Other than stated above|1
7440871|NCT01649271|11724689|FG001|Overall Study|Other than stated above|0
7440872|NCT01649297|11724701|FG000|Overall Study|Adverse Event|5
7440873|NCT01649297|11724702|FG001|Overall Study|Adverse Event|5
7440874|NCT01649297|11724703|FG002|Overall Study|Adverse Event|4
7440875|NCT01649297|11724704|FG003|Overall Study|Adverse Event|13
7440876|NCT01649297|11724705|FG004|Overall Study|Adverse Event|1
7440877|NCT01649297|11724701|FG000|Overall Study|Lack of Efficacy|0
7440878|NCT01649297|11724702|FG001|Overall Study|Lack of Efficacy|0
7440879|NCT01649297|11724703|FG002|Overall Study|Lack of Efficacy|0
7440880|NCT01649297|11724704|FG003|Overall Study|Lack of Efficacy|0
7440881|NCT01649297|11724705|FG004|Overall Study|Lack of Efficacy|1
7440882|NCT01649297|11724701|FG000|Overall Study|Non compliant with Protocol|1
7440883|NCT01649297|11724702|FG001|Overall Study|Non compliant with Protocol|0
7440884|NCT01649297|11724703|FG002|Overall Study|Non compliant with Protocol|3
7440885|NCT01649297|11724704|FG003|Overall Study|Non compliant with Protocol|2
7440886|NCT01649297|11724705|FG004|Overall Study|Non compliant with Protocol|1
7440887|NCT01649297|11724701|FG000|Overall Study|Lost to Follow-up|1
7440888|NCT01649297|11724702|FG001|Overall Study|Lost to Follow-up|1
7440889|NCT01649297|11724703|FG002|Overall Study|Lost to Follow-up|4
7440890|NCT01649297|11724704|FG003|Overall Study|Lost to Follow-up|3
7440891|NCT01649297|11724705|FG004|Overall Study|Lost to Follow-up|0
7440892|NCT01649297|11724701|FG000|Overall Study|Patient withdrawal (not due to AE)|3
7440893|NCT01649297|11724702|FG001|Overall Study|Patient withdrawal (not due to AE)|6
7440894|NCT01649297|11724703|FG002|Overall Study|Patient withdrawal (not due to AE)|4
7440895|NCT01649297|11724704|FG003|Overall Study|Patient withdrawal (not due to AE)|1
7440896|NCT01649297|11724705|FG004|Overall Study|Patient withdrawal (not due to AE)|1
7440897|NCT01649297|11724701|FG000|Overall Study|For other reason|4
7440898|NCT01649297|11724702|FG001|Overall Study|For other reason|1
7440899|NCT01649297|11724703|FG002|Overall Study|For other reason|2
7440900|NCT01649297|11724704|FG003|Overall Study|For other reason|0
7440901|NCT01649297|11724705|FG004|Overall Study|For other reason|0
7440902|NCT01649375|11724729|FG000|Up to Week 16|Adverse Event|2
7440903|NCT01649375|11724730|FG001|Up to Week 16|Adverse Event|5
7440904|NCT01649375|11724731|FG002|Up to Week 16|Adverse Event|4
7440905|NCT01649375|11724732|FG003|Up to Week 16|Adverse Event|0
7440906|NCT01649375|11724733|FG004|Up to Week 16|Adverse Event|0
7440907|NCT01649375|11724729|FG000|Up to Week 16|Lack of Efficacy|0
7440908|NCT01649375|11724730|FG001|Up to Week 16|Lack of Efficacy|0
7440909|NCT01649375|11724731|FG002|Up to Week 16|Lack of Efficacy|1
7440910|NCT01649375|11724732|FG003|Up to Week 16|Lack of Efficacy|0
7440911|NCT01649375|11724733|FG004|Up to Week 16|Lack of Efficacy|0
7440912|NCT01649375|11724729|FG000|Up to Week 16|Physician Decision|0
7440913|NCT01649375|11724730|FG001|Up to Week 16|Physician Decision|0
7440914|NCT01649375|11724731|FG002|Up to Week 16|Physician Decision|1
7440915|NCT01649375|11724732|FG003|Up to Week 16|Physician Decision|0
7440916|NCT01649375|11724733|FG004|Up to Week 16|Physician Decision|0
7440917|NCT01649375|11724729|FG000|Up to Week 16|Withdrawal by Subject|2
7440918|NCT01649375|11724730|FG001|Up to Week 16|Withdrawal by Subject|1
7440919|NCT01649375|11724731|FG002|Up to Week 16|Withdrawal by Subject|2
7440920|NCT01649375|11724732|FG003|Up to Week 16|Withdrawal by Subject|0
7440921|NCT01649375|11724733|FG004|Up to Week 16|Withdrawal by Subject|0
7440922|NCT01649375|11724729|FG000|Up to Week 16|Death|1
7440923|NCT01649375|11724730|FG001|Up to Week 16|Death|0
7440924|NCT01649375|11724731|FG002|Up to Week 16|Death|0
7440925|NCT01649375|11724732|FG003|Up to Week 16|Death|0
7440926|NCT01649375|11724733|FG004|Up to Week 16|Death|0
7440927|NCT01649375|11724729|FG000|Week 16 up to Week 260|Lack of Efficacy|7
7440928|NCT01649375|11724730|FG001|Week 16 up to Week 260|Lack of Efficacy|4
7440929|NCT01649375|11724731|FG002|Week 16 up to Week 260|Lack of Efficacy|0
7440930|NCT01649375|11724732|FG003|Week 16 up to Week 260|Lack of Efficacy|4
7440931|NCT01649375|11724733|FG004|Week 16 up to Week 260|Lack of Efficacy|2
7440932|NCT01649375|11724729|FG000|Week 16 up to Week 260|Non-compliance|0
7440933|NCT01649375|11724730|FG001|Week 16 up to Week 260|Non-compliance|1
7440934|NCT01649375|11724731|FG002|Week 16 up to Week 260|Non-compliance|0
7440935|NCT01649375|11724732|FG003|Week 16 up to Week 260|Non-compliance|1
7440936|NCT01649375|11724733|FG004|Week 16 up to Week 260|Non-compliance|0
7440937|NCT01649375|11724729|FG000|Week 16 up to Week 260|Physician Decision|0
7440938|NCT01649375|11724730|FG001|Week 16 up to Week 260|Physician Decision|2
7440939|NCT01649375|11724731|FG002|Week 16 up to Week 260|Physician Decision|0
7440940|NCT01649375|11724732|FG003|Week 16 up to Week 260|Physician Decision|0
7440941|NCT01649375|11724733|FG004|Week 16 up to Week 260|Physician Decision|0
7440942|NCT01649375|11724729|FG000|Week 16 up to Week 260|Technical issues|0
7440943|NCT01649375|11724730|FG001|Week 16 up to Week 260|Technical issues|1
7440944|NCT01649375|11724731|FG002|Week 16 up to Week 260|Technical issues|0
7440945|NCT01649375|11724732|FG003|Week 16 up to Week 260|Technical issues|1
7440946|NCT01649375|11724733|FG004|Week 16 up to Week 260|Technical issues|0
7440947|NCT01649375|11724729|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
7440948|NCT01649375|11724730|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
7440949|NCT01649375|11724731|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
7440950|NCT01649375|11724732|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
7440951|NCT01649375|11724733|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
7440952|NCT01649375|11724729|FG000|Week 16 up to Week 260|Death|1
7440953|NCT01649375|11724730|FG001|Week 16 up to Week 260|Death|1
7440954|NCT01649375|11724731|FG002|Week 16 up to Week 260|Death|0
7440955|NCT01649375|11724732|FG003|Week 16 up to Week 260|Death|0
7561290|NCT03197376|11929369|FG001|Primary and Booster Phase|Death|0
7561291|NCT03197376|11929370|FG002|Primary and Booster Phase|Death|0
7440956|NCT01649375|11724733|FG004|Week 16 up to Week 260|Death|0
7440957|NCT01649375|11724729|FG000|Week 16 up to Week 260|Adverse Event|5
7440958|NCT01649375|11724730|FG001|Week 16 up to Week 260|Adverse Event|2
7440959|NCT01649375|11724731|FG002|Week 16 up to Week 260|Adverse Event|0
7440960|NCT01649375|11724732|FG003|Week 16 up to Week 260|Adverse Event|3
7440961|NCT01649375|11724733|FG004|Week 16 up to Week 260|Adverse Event|2
7440962|NCT01649427|11724743|FG000|Overall Study|Adverse Event|1
7440963|NCT01649427|11724744|FG001|Overall Study|Adverse Event|1
7440964|NCT01649427|11724743|FG000|Overall Study|Withdrawal by Subject|8
7440965|NCT01649427|11724744|FG001|Overall Study|Withdrawal by Subject|7
7440966|NCT01649427|11724743|FG000|Overall Study|Lost to Follow-up|0
7440967|NCT01649427|11724744|FG001|Overall Study|Lost to Follow-up|1
7440968|NCT01649427|11724743|FG000|Overall Study|Graft loss|0
7561292|NCT03197376|11929371|FG003|Primary and Booster Phase|Death|2
7561293|NCT03197376|11929368|FG000|Primary and Booster Phase|Lost to Follow-up|0
7561294|NCT03197376|11929369|FG001|Primary and Booster Phase|Lost to Follow-up|0
7561295|NCT03197376|11929370|FG002|Primary and Booster Phase|Lost to Follow-up|1
7561296|NCT03197376|11929371|FG003|Primary and Booster Phase|Lost to Follow-up|0
7561297|NCT03197376|11929368|FG000|Primary and Booster Phase|Physician Decision|1
7561298|NCT03197376|11929369|FG001|Primary and Booster Phase|Physician Decision|0
7561299|NCT03197376|11929370|FG002|Primary and Booster Phase|Physician Decision|1
7561300|NCT03197376|11929371|FG003|Primary and Booster Phase|Physician Decision|3
7561301|NCT03197376|11929368|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
7561302|NCT03197376|11929369|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
7561303|NCT03197376|11929370|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
7561304|NCT03197376|11929371|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
7561305|NCT03197376|11929368|FG000|Primary and Booster Phase|Ineligibility criteria|1
7561306|NCT03197376|11929369|FG001|Primary and Booster Phase|Ineligibility criteria|1
7561307|NCT03197376|11929370|FG002|Primary and Booster Phase|Ineligibility criteria|4
7561308|NCT03197376|11929371|FG003|Primary and Booster Phase|Ineligibility criteria|2
7561309|NCT03197376|11929368|FG000|Primary and Booster Phase|Not vaccine related|1
7561310|NCT03197376|11929369|FG001|Primary and Booster Phase|Not vaccine related|2
7561311|NCT03197376|11929370|FG002|Primary and Booster Phase|Not vaccine related|0
7561312|NCT03197376|11929371|FG003|Primary and Booster Phase|Not vaccine related|6
7561313|NCT03197376|11929368|FG000|Immune Persistence Phase|Lost to Follow-up|0
7561314|NCT03197376|11929369|FG001|Immune Persistence Phase|Lost to Follow-up|0
7561315|NCT03197376|11929370|FG002|Immune Persistence Phase|Lost to Follow-up|2
7561316|NCT03197376|11929371|FG003|Immune Persistence Phase|Lost to Follow-up|1
7561317|NCT03197376|11929368|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
7561318|NCT03197376|11929369|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
7561319|NCT03197376|11929370|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
7561320|NCT03197376|11929371|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
7561321|NCT03197376|11929368|FG000|Immune Persistence Phase|Not vaccine related|1
7561322|NCT03197376|11929369|FG001|Immune Persistence Phase|Not vaccine related|0
7561323|NCT03197376|11929370|FG002|Immune Persistence Phase|Not vaccine related|1
7561324|NCT03197376|11929371|FG003|Immune Persistence Phase|Not vaccine related|1
7561325|NCT03197558|11929429|FG000|Overall Study|Tubes not placed|1
7561326|NCT03197883|11929435|FG000|Overall Study|Adverse Event|1
7561327|NCT03197883|11929436|FG001|Overall Study|Adverse Event|1
7561328|NCT03197883|11929435|FG000|Overall Study|Lost to Follow-up|1
7561329|NCT03197883|11929436|FG001|Overall Study|Lost to Follow-up|0
7561330|NCT03197883|11929435|FG000|Overall Study|Protocol Violation|1
7561331|NCT03197883|11929436|FG001|Overall Study|Protocol Violation|0
7561332|NCT03197883|11929435|FG000|Overall Study|Other (Not Specified)|0
7561333|NCT03197883|11929436|FG001|Overall Study|Other (Not Specified)|5
7561334|NCT03198507|11929474|FG000|Overall Study|Withdrawal by Subject|1
7561335|NCT03198507|11929475|FG001|Overall Study|Withdrawal by Subject|0
7561336|NCT03198520|11929481|FG000|Overall Study|Physician Decision|2
7561337|NCT03198520|11929481|FG000|Overall Study|Protocol Violation|2
7561338|NCT03198520|11929481|FG000|Overall Study|Withdrawal by Subject|1
7561339|NCT03198520|11929481|FG000|Overall Study|Study Ended|1
7561340|NCT03198715|11929498|FG000|Overall Study|Death|0
7561341|NCT03198715|11929499|FG001|Overall Study|Death|0
7561342|NCT03198715|11929500|FG002|Overall Study|Death|1
7561343|NCT03198715|11929501|FG003|Overall Study|Death|0
7561344|NCT03198715|11929502|FG004|Overall Study|Death|2
7561345|NCT03198715|11929498|FG000|Overall Study|Other|0
7561346|NCT03198715|11929499|FG001|Overall Study|Other|1
7561347|NCT03198715|11929500|FG002|Overall Study|Other|1
7561348|NCT03198715|11929501|FG003|Overall Study|Other|0
7561349|NCT03198715|11929502|FG004|Overall Study|Other|0
7561350|NCT03198754|11929516|FG000|Overall Study|Withdrawal by Subject|5
7561351|NCT03198754|11929517|FG001|Overall Study|Withdrawal by Subject|4
7561352|NCT03198754|11929516|FG000|Overall Study|Lost to Follow-up|4
7561353|NCT03198754|11929517|FG001|Overall Study|Lost to Follow-up|3
7561354|NCT03198754|11929516|FG000|Overall Study|Ineligible|2
7561355|NCT03198754|11929517|FG001|Overall Study|Ineligible|1
7561356|NCT03198767|11929530|FG000|Overall Study|Protocol Violation|0
7561357|NCT03198767|11929531|FG001|Overall Study|Protocol Violation|0
7561358|NCT03198767|11929532|FG002|Overall Study|Protocol Violation|0
7561359|NCT03198767|11929533|FG003|Overall Study|Protocol Violation|6
7561360|NCT03198767|11929534|FG004|Overall Study|Protocol Violation|0
7561361|NCT03198767|11929535|FG005|Overall Study|Protocol Violation|0
7561362|NCT03198767|11929536|FG006|Overall Study|Protocol Violation|0
7561363|NCT03199911|11929603|FG000|Overall Study|Lost to Follow-up|5
7561364|NCT03199911|11929604|FG001|Overall Study|Lost to Follow-up|5
7561365|NCT03199911|11929603|FG000|Overall Study|Did not proceed with surgery|2
7561366|NCT03199911|11929604|FG001|Overall Study|Did not proceed with surgery|1
7561379|NCT03200366|11929624|FG000|Patient Navigation Intervention Given|Death|0
7561380|NCT03200366|11929625|FG001|Patient Navigation Intervention Given|Death|2
7561381|NCT03200366|11929626|FG002|Patient Navigation Intervention Given|Death|0
7561382|NCT03200366|11929624|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
7561383|NCT03200366|11929625|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
7561384|NCT03200366|11929626|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
7561385|NCT03200366|11929624|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7561386|NCT03200366|11929625|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
7561387|NCT03200366|11929626|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
7561388|NCT03200366|11929624|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7561389|NCT03200366|11929625|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
7561390|NCT03200366|11929626|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
7561391|NCT03200366|11929624|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
7561392|NCT03200366|11929625|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
7561393|NCT03200366|11929626|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
7561394|NCT03200366|11929624|FG000|6 Month Post-Baseline Interview|Death|1
7561395|NCT03200366|11929625|FG001|6 Month Post-Baseline Interview|Death|1
7561396|NCT03200366|11929626|FG002|6 Month Post-Baseline Interview|Death|1
7561397|NCT03200366|11929624|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
7561398|NCT03200366|11929625|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
7561399|NCT03200366|11929626|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
7561400|NCT03200366|11929624|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7561401|NCT03200366|11929625|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
7561402|NCT03200366|11929626|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
7561403|NCT03200366|11929624|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
7561404|NCT03200366|11929625|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7561405|NCT03200366|11929626|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
7561406|NCT03200366|11929624|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7561407|NCT03200366|11929625|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
7561408|NCT03200366|11929626|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
7561409|NCT03200366|11929624|FG000|9 Month Post-Baseline Interview|Death|1
7561410|NCT03200366|11929625|FG001|9 Month Post-Baseline Interview|Death|1
7561411|NCT03200366|11929626|FG002|9 Month Post-Baseline Interview|Death|1
7561412|NCT03200366|11929624|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
7561413|NCT03200366|11929625|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
7561414|NCT03200366|11929626|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
7561415|NCT03200366|11929624|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
7561416|NCT03200366|11929625|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
7561417|NCT03200366|11929626|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
7561418|NCT03200366|11929624|FG000|9 Month Post-Baseline Interview|Refused interview|0
7561419|NCT03200366|11929625|FG001|9 Month Post-Baseline Interview|Refused interview|2
7561420|NCT03200366|11929626|FG002|9 Month Post-Baseline Interview|Refused interview|0
7561421|NCT03200860|11929655|FG000|Overall Study|Withdrawal by Subject|1
7561422|NCT03200860|11929656|FG001|Overall Study|Withdrawal by Subject|0
7561423|NCT03200912|11929665|FG000|Overall Study|Adverse Event|3
7561424|NCT03200912|11929666|FG001|Overall Study|Adverse Event|0
7561425|NCT03200912|11929667|FG002|Overall Study|Adverse Event|0
7561426|NCT03200912|11929665|FG000|Overall Study|Withdrawal by Subject|1
7561427|NCT03200912|11929666|FG001|Overall Study|Withdrawal by Subject|2
7561428|NCT03200912|11929667|FG002|Overall Study|Withdrawal by Subject|4
7561429|NCT03200912|11929665|FG000|Overall Study|Non-compliance with study drug|0
7561430|NCT03200912|11929666|FG001|Overall Study|Non-compliance with study drug|1
7561431|NCT03200912|11929667|FG002|Overall Study|Non-compliance with study drug|0
7561432|NCT03201003|11929686|FG000|Overall Study|Adverse Event|14
7561433|NCT03201003|11929687|FG001|Overall Study|Adverse Event|1
7561434|NCT03201003|11929686|FG000|Overall Study|Other reasons|5
7561435|NCT03201003|11929687|FG001|Overall Study|Other reasons|1
7561436|NCT03201003|11929686|FG000|Overall Study|Withdrawal by Subject|4
7561437|NCT03201003|11929687|FG001|Overall Study|Withdrawal by Subject|1
7561438|NCT03201003|11929686|FG000|Overall Study|Lost to Follow-up|2
7561439|NCT03201003|11929687|FG001|Overall Study|Lost to Follow-up|0
7561440|NCT03201003|11929686|FG000|Overall Study|Protocol Violation|1
7561441|NCT03201003|11929687|FG001|Overall Study|Protocol Violation|0
7561442|NCT03201211|11929696|FG000|Overall Study|Adverse Event|1
7561443|NCT03201211|11929697|FG001|Overall Study|Adverse Event|0
7561444|NCT03201211|11929698|FG002|Overall Study|Adverse Event|0
7561445|NCT03201211|11929696|FG000|Overall Study|Protocol Violation|1
7561446|NCT03201211|11929697|FG001|Overall Study|Protocol Violation|0
7561447|NCT03201211|11929698|FG002|Overall Study|Protocol Violation|0
7561448|NCT03201211|11929696|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7561449|NCT03201211|11929697|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7561450|NCT03201211|11929698|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7561451|NCT03201211|11929696|FG000|Overall Study|OTHER unknown reasons|0
7561452|NCT03201211|11929697|FG001|Overall Study|OTHER unknown reasons|1
7561453|NCT03201211|11929698|FG002|Overall Study|OTHER unknown reasons|0
7574969|NCT03706040|11958325|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0
7574970|NCT03706040|11958326|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0
7574971|NCT03706040|11958320|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7574972|NCT03706040|11958321|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1
7440969|NCT01649427|11724744|FG001|Overall Study|Graft loss|1
7440970|NCT01649427|11724743|FG000|Overall Study|Surgical problems during nephrectomy|2
7440971|NCT01649427|11724744|FG001|Overall Study|Surgical problems during nephrectomy|2
7440972|NCT01649557|11724753|FG000|Overall Study|Lost to Follow-up|5
7440973|NCT01649557|11724754|FG001|Overall Study|Lost to Follow-up|0
7440974|NCT01649557|11724755|FG002|Overall Study|Lost to Follow-up|3
7440975|NCT01649557|11724753|FG000|Overall Study|Adverse Event|7
7440976|NCT01649557|11724754|FG001|Overall Study|Adverse Event|5
7440977|NCT01649557|11724755|FG002|Overall Study|Adverse Event|1
7440978|NCT01649557|11724753|FG000|Overall Study|Met withdrawal criteria|4
7440979|NCT01649557|11724754|FG001|Overall Study|Met withdrawal criteria|0
7440980|NCT01649557|11724755|FG002|Overall Study|Met withdrawal criteria|0
7440981|NCT01649557|11724753|FG000|Overall Study|Physician Decision|8
7440982|NCT01649557|11724754|FG001|Overall Study|Physician Decision|2
7440983|NCT01649557|11724755|FG002|Overall Study|Physician Decision|1
7440984|NCT01649557|11724753|FG000|Overall Study|Withdrawal by Subject|15
7440985|NCT01649557|11724754|FG001|Overall Study|Withdrawal by Subject|5
7440986|NCT01649557|11724755|FG002|Overall Study|Withdrawal by Subject|4
7440987|NCT01649557|11724753|FG000|Overall Study|Protocol deviation|0
7440988|NCT01649557|11724754|FG001|Overall Study|Protocol deviation|2
7440989|NCT01649557|11724755|FG002|Overall Study|Protocol deviation|0
7440990|NCT01649557|11724753|FG000|Overall Study|Lack of Efficacy|5
7440991|NCT01649557|11724754|FG001|Overall Study|Lack of Efficacy|0
7440992|NCT01649557|11724755|FG002|Overall Study|Lack of Efficacy|0
7440993|NCT01649765|11724783|FG000|Overall Study|Adverse Event|5
7440994|NCT01649765|11724784|FG001|Overall Study|Adverse Event|3
7440995|NCT01649765|11724783|FG000|Overall Study|Lack of Efficacy|1
7440996|NCT01649765|11724784|FG001|Overall Study|Lack of Efficacy|1
7440997|NCT01649765|11724783|FG000|Overall Study|Physician Decision|0
7440998|NCT01649765|11724784|FG001|Overall Study|Physician Decision|3
7440999|NCT01649765|11724783|FG000|Overall Study|Protocol Violation|1
7441000|NCT01649765|11724784|FG001|Overall Study|Protocol Violation|0
7441001|NCT01649765|11724783|FG000|Overall Study|Withdrawal by Subject|2
7441002|NCT01649765|11724784|FG001|Overall Study|Withdrawal by Subject|1
7441003|NCT01649791|11724791|FG000|Overall Study|Disease Progression|2
7441004|NCT01649791|11724791|FG000|Overall Study|Adverse Event|1
7441005|NCT01649804|11724795|FG000|Overall Study|Administrative/Other|8
7441006|NCT01649856|11724801|FG000|Overall Study|Withdrawal by Subject|14
7441007|NCT01649856|11724802|FG001|Overall Study|Withdrawal by Subject|14
7441008|NCT01649856|11724801|FG000|Overall Study|Protocol Violation|4
7441009|NCT01649856|11724802|FG001|Overall Study|Protocol Violation|4
7441010|NCT01649856|11724801|FG000|Overall Study|Treatment Failure|1
7441011|NCT01649856|11724802|FG001|Overall Study|Treatment Failure|1
7441012|NCT01649856|11724801|FG000|Overall Study|Death|69
7441013|NCT01649856|11724802|FG001|Overall Study|Death|34
7441014|NCT01649856|11724801|FG000|Overall Study|Stable or Progressed Disease|5
7441015|NCT01649856|11724802|FG001|Overall Study|Stable or Progressed Disease|3
7441016|NCT01649856|11724801|FG000|Overall Study|Lost to Follow-up|20
7441017|NCT01649856|11724802|FG001|Overall Study|Lost to Follow-up|16
7441018|NCT01649856|11724801|FG000|Overall Study|Lack of Compliance|6
7574973|NCT03706040|11958322|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4
7574974|NCT03706040|11958323|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7441019|NCT01649856|11724802|FG001|Overall Study|Lack of Compliance|1
7441020|NCT01649856|11724801|FG000|Overall Study|Other|20
7441021|NCT01649856|11724802|FG001|Overall Study|Other|5
7441022|NCT01649869|11724810|FG000|Overall Study|Family member illness|1
7441023|NCT01649869|11724811|FG001|Overall Study|Family member illness|0
7441024|NCT01649869|11724810|FG000|Overall Study|Required treatment outside protocol|1
7441025|NCT01649869|11724811|FG001|Overall Study|Required treatment outside protocol|0
7441026|NCT01649869|11724810|FG000|Overall Study|Severe hearing loss borderline eligible|0
7441027|NCT01649869|11724811|FG001|Overall Study|Severe hearing loss borderline eligible|1
7441028|NCT01650194|11724829|FG000|Overall Study|Progressive Disease (PD)|35
7441029|NCT01650194|11724829|FG000|Overall Study|Withdrawal by Subject|2
7441030|NCT01650194|11724829|FG000|Overall Study|Miscellaneous|10
7441031|NCT01650246|11724834|FG000|Overall Study|Adverse Event|23
7441032|NCT01650246|11724834|FG000|Overall Study|Protocol Violation|5
7441033|NCT01650246|11724834|FG000|Overall Study|Sponsor terminated study|53
7441034|NCT01650246|11724834|FG000|Overall Study|Lost to Follow-up|5
7441035|NCT01650246|11724834|FG000|Overall Study|Withdrawal by Subject|26
7441036|NCT01650246|11724834|FG000|Overall Study|Death|1
7441037|NCT01650246|11724834|FG000|Overall Study|Lack of Efficacy|30
7441038|NCT01650259|11724840|FG000|Overall Study|Improvement|105
7441039|NCT01650259|11724841|FG001|Overall Study|Improvement|0
7441040|NCT01650259|11724840|FG000|Overall Study|Adverse Event|127
7441041|NCT01650259|11724841|FG001|Overall Study|Adverse Event|0
7441042|NCT01650259|11724840|FG000|Overall Study|Lack of Efficacy|143
7441043|NCT01650259|11724841|FG001|Overall Study|Lack of Efficacy|0
7441044|NCT01650259|11724840|FG000|Overall Study|Lost to Follow-up|435
7441045|NCT01650259|11724841|FG001|Overall Study|Lost to Follow-up|0
7441046|NCT01650259|11724840|FG000|Overall Study|Patients had no visit after entry|70
7441047|NCT01650259|11724841|FG001|Overall Study|Patients had no visit after entry|0
7441048|NCT01650259|11724840|FG000|Overall Study|CRF not collected|98
7441049|NCT01650259|11724841|FG001|Overall Study|CRF not collected|82
7441050|NCT01650259|11724840|FG000|Overall Study|Not treated|1
7441051|NCT01650259|11724841|FG001|Overall Study|Not treated|7
7441052|NCT01650259|11724840|FG000|Overall Study|Other than listed|64
7441053|NCT01650259|11724841|FG001|Overall Study|Other than listed|146
7441054|NCT01650519|11724891|FG000|Overall Study|Withdrawal by Subject|1
7441055|NCT01650519|11724892|FG001|Overall Study|Withdrawal by Subject|0
7441074|NCT01650636|11724932|FG000|Washout up to 5 Months|Withdrawal by Subject|4
7441075|NCT01650636|11724933|FG001|Washout up to 5 Months|Withdrawal by Subject|8
7441076|NCT01650636|11724932|FG000|Washout up to 5 Months|Physician Decision|2
7441077|NCT01650636|11724933|FG001|Washout up to 5 Months|Physician Decision|2
7441078|NCT01650636|11724932|FG000|Washout up to 5 Months|Death|1
7441079|NCT01650636|11724933|FG001|Washout up to 5 Months|Death|0
7441080|NCT01650636|11724932|FG000|Washout up to 5 Months|Lost to Follow-up|2
7441081|NCT01650636|11724933|FG001|Washout up to 5 Months|Lost to Follow-up|8
7441082|NCT01650636|11724932|FG000|Washout up to 9 Months|Withdrawal by Subject|4
7441083|NCT01650636|11724933|FG001|Washout up to 9 Months|Withdrawal by Subject|2
7441084|NCT01650636|11724932|FG000|Washout up to 9 Months|Lost to Follow-up|2
7441085|NCT01650636|11724933|FG001|Washout up to 9 Months|Lost to Follow-up|1
7441086|NCT01650779|11724939|FG000|Overall Study|Withdrawal by Subject|1
7441087|NCT01650805|11724945|FG000|Overall Study|Withdrawal by Subject|1
7441088|NCT01650805|11724946|FG001|Overall Study|Withdrawal by Subject|0
7441089|NCT01650831|11724952|FG000|Overall Study|Screen failure|1
7441090|NCT01651000|11724971|FG000|Overall Study|Adverse Event|2
7441091|NCT01651000|11724972|FG001|Overall Study|Adverse Event|8
7441092|NCT01651000|11724971|FG000|Overall Study|Lost to Follow-up|3
7441093|NCT01651000|11724972|FG001|Overall Study|Lost to Follow-up|2
7441094|NCT01651000|11724971|FG000|Overall Study|Protocol Violation|0
7441095|NCT01651000|11724972|FG001|Overall Study|Protocol Violation|3
7441096|NCT01651000|11724971|FG000|Overall Study|Withdrawal by Subject|2
7441097|NCT01651000|11724972|FG001|Overall Study|Withdrawal by Subject|10
7441098|NCT01651000|11724971|FG000|Overall Study|Subject noncompliance|0
7441099|NCT01651000|11724972|FG001|Overall Study|Subject noncompliance|3
7441100|NCT01651000|11724971|FG000|Overall Study|Lack of Efficacy|1
7441101|NCT01651000|11724972|FG001|Overall Study|Lack of Efficacy|1
7441102|NCT01651000|11724971|FG000|Overall Study|Physician Decision|1
7441103|NCT01651000|11724972|FG001|Overall Study|Physician Decision|0
7441104|NCT01651000|11724971|FG000|Overall Study|Administrative reason|1
7441105|NCT01651000|11724972|FG001|Overall Study|Administrative reason|0
7441106|NCT01651000|11724971|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
7441107|NCT01651000|11724972|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
7441108|NCT01651039|11724978|FG000|Overall Study|Non-evaluables|5
7441109|NCT01651039|11724978|FG000|Overall Study|Physician Decision|2
7441110|NCT01651039|11724978|FG000|Overall Study|Withdrawal by Subject|1
7441111|NCT01651039|11724978|FG000|Overall Study|Progressive Disease|22
7441112|NCT01651052|11724982|FG000|Overall Study|Death|21
7441113|NCT01651052|11724982|FG000|Overall Study|Explant|1
7441114|NCT01651052|11724982|FG000|Overall Study|Withdrawal by Subject|1
7441115|NCT01651052|11724982|FG000|Overall Study|Lost to Follow-up|3
7441116|NCT01651117|11724998|FG000|Overall Study|Death|2
7441117|NCT01651117|11724999|FG001|Overall Study|Death|3
7441118|NCT01651117|11725000|FG002|Overall Study|Death|2
7441119|NCT01651117|11725001|FG003|Overall Study|Death|2
7441120|NCT01651208|11725037|FG000|Overall Study|Lost to Follow-up|14
7441121|NCT01651208|11725038|FG001|Overall Study|Lost to Follow-up|16
7441122|NCT01651260|11725045|FG000|Overall Study|unable to apply product|3
7441123|NCT01651780|11725081|FG000|Overall Study|Physician decision: No 30-day visit|2
7441124|NCT01651780|11725082|FG001|Overall Study|Physician decision: No 30-day visit|1
7441125|NCT01651780|11725081|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
7441126|NCT01651780|11725082|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
7441127|NCT01651780|11725081|FG000|Overall Study|Withdrawal by Subject|2
7441128|NCT01651780|11725082|FG001|Overall Study|Withdrawal by Subject|0
7441129|NCT01651780|11725081|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
7441130|NCT01651780|11725082|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7441131|NCT01651780|11725081|FG000|Overall Study|Lost to Follow-up|1
7441132|NCT01651780|11725082|FG001|Overall Study|Lost to Follow-up|2
7441133|NCT01651780|11725081|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
7441134|NCT01651780|11725082|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
7441135|NCT01651936|11725133|FG000|Base Study|Adverse Event|3
7441136|NCT01651936|11725134|FG001|Base Study|Adverse Event|0
7441137|NCT01651936|11725135|FG002|Base Study|Adverse Event|0
7441138|NCT01651936|11725133|FG000|Base Study|Withdrawal by Subject|1
7441139|NCT01651936|11725134|FG001|Base Study|Withdrawal by Subject|1
7441140|NCT01651936|11725135|FG002|Base Study|Withdrawal by Subject|0
7561463|NCT03201809|11929721|FG000|Overall Study|Lost to Follow-up|2
7561464|NCT03201809|11929722|FG001|Overall Study|Lost to Follow-up|0
7561465|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
7561466|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
7561467|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
7561468|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
7561469|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
7561470|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
7561471|NCT03201900|11929728|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
7561472|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
7561473|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
7441141|NCT01651936|11725133|FG000|Base Study|Early Escape|2
7441142|NCT01651936|11725134|FG001|Base Study|Early Escape|8
7441143|NCT01651936|11725135|FG002|Base Study|Early Escape|0
7441144|NCT01651936|11725133|FG000|Base Study|Study terminated by sponsor|21
7441145|NCT01651936|11725134|FG001|Base Study|Study terminated by sponsor|16
7441146|NCT01651936|11725135|FG002|Base Study|Study terminated by sponsor|0
7441147|NCT01651936|11725133|FG000|Extension Study|Lack of Efficacy|0
7441148|NCT01651936|11725134|FG001|Extension Study|Lack of Efficacy|0
7441149|NCT01651936|11725135|FG002|Extension Study|Lack of Efficacy|1
7441150|NCT01651936|11725133|FG000|Extension Study|Study terminated by sponsor|0
7441151|NCT01651936|11725134|FG001|Extension Study|Study terminated by sponsor|0
7441152|NCT01651936|11725135|FG002|Extension Study|Study terminated by sponsor|13
7441153|NCT01651949|11725145|FG000|Overall Study|Unknown status|4
7441154|NCT01651949|11725146|FG001|Overall Study|Unknown status|4
7441155|NCT01651949|11725147|FG002|Overall Study|Unknown status|0
7441156|NCT01651949|11725145|FG000|Overall Study|Lost to Follow-up|30
7441157|NCT01651949|11725146|FG001|Overall Study|Lost to Follow-up|56
7441158|NCT01651949|11725147|FG002|Overall Study|Lost to Follow-up|20
7441159|NCT01651949|11725145|FG000|Overall Study|Protocol Violation|0
7441160|NCT01651949|11725146|FG001|Overall Study|Protocol Violation|2
7441161|NCT01651949|11725147|FG002|Overall Study|Protocol Violation|1
7561474|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
7561475|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
7561476|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
7561477|NCT03201900|11929728|FG000|Extension Phase (From Week 63 to 156)|Other|1
7561478|NCT03202511|11929751|FG000|Overall Study|Withdrawal by Subject|1
7561479|NCT03202511|11929752|FG001|Overall Study|Withdrawal by Subject|0
7561480|NCT03203291|11929767|FG000|Overall Study|Withdrawal by Subject|1
7561481|NCT03203447|11929773|FG000|Overall Study|Withdrawal by Subject|2
7561482|NCT03203447|11929774|FG001|Overall Study|Withdrawal by Subject|1
7561483|NCT03203447|11929773|FG000|Overall Study|Lost to Follow-up|1
7561484|NCT03203447|11929774|FG001|Overall Study|Lost to Follow-up|10
7561485|NCT03203447|11929773|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
7561486|NCT03203447|11929774|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
7441162|NCT01651949|11725145|FG000|Overall Study|Physician Decision|0
7441163|NCT01651949|11725146|FG001|Overall Study|Physician Decision|2
7441164|NCT01651949|11725147|FG002|Overall Study|Physician Decision|0
7441165|NCT01651949|11725145|FG000|Overall Study|Adverse Event|0
7441166|NCT01651949|11725146|FG001|Overall Study|Adverse Event|2
7561487|NCT03204279|11929803|FG000|Overall Study|Withdrawal by Subject|0
7561488|NCT03204279|11929804|FG001|Overall Study|Withdrawal by Subject|1
7561489|NCT03204981|11929833|FG000|Overall Study|Physician Decision|2
7561490|NCT03204981|11929833|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
7561491|NCT03205046|11929841|FG000|Overall Study|Death|10
7561492|NCT03205046|11929842|FG001|Overall Study|Death|6
7561493|NCT03205046|11929841|FG000|Overall Study|Withdrawal by Subject|1
7561494|NCT03205046|11929842|FG001|Overall Study|Withdrawal by Subject|2
7561495|NCT03205046|11929841|FG000|Overall Study|Lost to Follow-up|0
7561496|NCT03205046|11929842|FG001|Overall Study|Lost to Follow-up|1
7561497|NCT03205046|11929841|FG000|Overall Study|Study terminated by sponsor|2
7561498|NCT03205046|11929842|FG001|Overall Study|Study terminated by sponsor|1
7561499|NCT03205150|11929851|FG000|Overall Study|Protocol deviation|1
7561500|NCT03205150|11929852|FG001|Overall Study|Protocol deviation|3
7561501|NCT03205150|11929853|FG002|Overall Study|Protocol deviation|0
7561502|NCT03205150|11929851|FG000|Overall Study|Patient/guardian decision|0
7561503|NCT03205150|11929852|FG001|Overall Study|Patient/guardian decision|3
7561504|NCT03205150|11929853|FG002|Overall Study|Patient/guardian decision|0
7561505|NCT03205150|11929851|FG000|Overall Study|Adverse Event|1
7561506|NCT03205150|11929852|FG001|Overall Study|Adverse Event|1
7561507|NCT03205150|11929853|FG002|Overall Study|Adverse Event|1
7561508|NCT03205150|11929851|FG000|Overall Study|Lost to Follow-up|0
7561509|NCT03205150|11929852|FG001|Overall Study|Lost to Follow-up|0
7561510|NCT03205150|11929853|FG002|Overall Study|Lost to Follow-up|1
7561511|NCT03205488|11929865|FG000|Overall Study|Adverse Event|1
7561512|NCT03205488|11929866|FG001|Overall Study|Adverse Event|2
7561513|NCT03205488|11929867|FG002|Overall Study|Adverse Event|4
7561514|NCT03205488|11929865|FG000|Overall Study|Protocol Violation|0
7561515|NCT03205488|11929866|FG001|Overall Study|Protocol Violation|0
7561516|NCT03205488|11929867|FG002|Overall Study|Protocol Violation|1
7561517|NCT03205566|11929881|FG000|Phase 1|Protocol Violation|1
7561518|NCT03205566|11929882|FG001|Phase 1|Protocol Violation|1
7561519|NCT03206749|11929895|FG000|Overall Study|Withdrawal of consent|5
7561520|NCT03206749|11929896|FG001|Overall Study|Withdrawal of consent|3
7561521|NCT03206749|11929897|FG002|Overall Study|Withdrawal of consent|6
7561522|NCT03206749|11929895|FG000|Overall Study|Lost to Follow-up|0
7561523|NCT03206749|11929896|FG001|Overall Study|Lost to Follow-up|0
7561524|NCT03206749|11929897|FG002|Overall Study|Lost to Follow-up|1
7561525|NCT03206788|11929908|FG000|Overall Study|Withdrawal by Subject|0
7561526|NCT03206788|11929909|FG001|Overall Study|Withdrawal by Subject|1
7561527|NCT03206788|11929908|FG000|Overall Study|Adverse Event|0
7561528|NCT03206788|11929909|FG001|Overall Study|Adverse Event|1
7561529|NCT03206788|11929908|FG000|Overall Study|Physician Decision|0
7561530|NCT03206788|11929909|FG001|Overall Study|Physician Decision|1
7561531|NCT03206918|11929915|FG000|Overall Study|Death|11
7561532|NCT03206918|11929915|FG000|Overall Study|Withdrawal by Subject|5
7561533|NCT03206918|11929915|FG000|Overall Study|Study terminated by sponsor|12
7561534|NCT03206918|11929915|FG000|Overall Study|Lost to Follow-up|3
7561535|NCT03206918|11929915|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
7561536|NCT03206970|11929920|FG000|Overall Study|Death|21
7561537|NCT03206970|11929920|FG000|Overall Study|Withdrawal by Subject|13
7561538|NCT03206970|11929920|FG000|Overall Study|Lost to Follow-up|3
7561539|NCT03206970|11929920|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
7328794|NCT00797966|11561721|FG003|Phase A+|Met withdrawal criteria|0
7328795|NCT00797966|11561722|FG004|Phase A+|Met withdrawal criteria|0
7561540|NCT03207243|11929948|FG000|Overall Study|Adverse Event|2
7561541|NCT03207243|11929949|FG001|Overall Study|Adverse Event|2
7561542|NCT03207243|11929948|FG000|Overall Study|Loss of Asthma Control|47
7561543|NCT03207243|11929949|FG001|Overall Study|Loss of Asthma Control|31
7561544|NCT03207243|11929948|FG000|Overall Study|Withdrawal by Subject|2
7561545|NCT03207243|11929949|FG001|Overall Study|Withdrawal by Subject|4
7561546|NCT03207243|11929948|FG000|Overall Study|Physician Decision|1
7561547|NCT03207243|11929949|FG001|Overall Study|Physician Decision|1
7561548|NCT03207243|11929948|FG000|Overall Study|Lost to Follow-up|0
7561549|NCT03207243|11929949|FG001|Overall Study|Lost to Follow-up|1
7561550|NCT03207243|11929948|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
7561551|NCT03207243|11929949|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
7561552|NCT03207243|11929948|FG000|Overall Study|Protocol Violation|0
7561553|NCT03207243|11929949|FG001|Overall Study|Protocol Violation|3
7561554|NCT03207750|11929989|FG000|Overall Study|Adverse Event|3
7561555|NCT03207750|11929990|FG001|Overall Study|Adverse Event|2
7561556|NCT03207750|11929989|FG000|Overall Study|Lost to Follow-up|21
7561557|NCT03207750|11929990|FG001|Overall Study|Lost to Follow-up|29
7328796|NCT00797966|11561723|FG005|Phase A+|Met withdrawal criteria|5
7561558|NCT03207750|11929989|FG000|Overall Study|Protocol Violation|0
7561559|NCT03207750|11929990|FG001|Overall Study|Protocol Violation|1
7328797|NCT00797966|11561718|FG000|Phase A+|Withdrawal by Subject|0
7561560|NCT03207750|11929989|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
7561561|NCT03207750|11929990|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
7441167|NCT01651949|11725147|FG002|Overall Study|Adverse Event|1
7441168|NCT01651949|11725145|FG000|Overall Study|Screen failure|2
7441169|NCT01651949|11725146|FG001|Overall Study|Screen failure|2
7441170|NCT01651949|11725147|FG002|Overall Study|Screen failure|0
7441171|NCT01651949|11725145|FG000|Overall Study|Withdrawal by Subject|17
7441172|NCT01651949|11725146|FG001|Overall Study|Withdrawal by Subject|18
7441173|NCT01651949|11725147|FG002|Overall Study|Withdrawal by Subject|9
7467427|NCT01901146|11767788|FG001|Neoadjuvant Phase|Physician Decision|2
7467428|NCT01901146|11767789|FG002|Neoadjuvant Phase|Physician Decision|0
7467429|NCT01901146|11767790|FG003|Neoadjuvant Phase|Physician Decision|0
7467430|NCT01901146|11767791|FG004|Neoadjuvant Phase|Physician Decision|0
7467431|NCT01901146|11767787|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
7467432|NCT01901146|11767788|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
7467433|NCT01901146|11767789|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
7467434|NCT01901146|11767790|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
7467435|NCT01901146|11767791|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
7467436|NCT01901146|11767787|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7467437|NCT01901146|11767788|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
7467438|NCT01901146|11767789|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7467439|NCT01901146|11767790|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7467440|NCT01901146|11767791|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
7467441|NCT01901146|11767787|FG000|Adjuvant Phase|Other|0
7467442|NCT01901146|11767788|FG001|Adjuvant Phase|Other|0
7467443|NCT01901146|11767789|FG002|Adjuvant Phase|Other|1
7467444|NCT01901146|11767790|FG003|Adjuvant Phase|Other|0
7467445|NCT01901146|11767791|FG004|Adjuvant Phase|Other|0
7467446|NCT01901146|11767787|FG000|Adjuvant Phase|Death|0
7467447|NCT01901146|11767788|FG001|Adjuvant Phase|Death|0
7467448|NCT01901146|11767789|FG002|Adjuvant Phase|Death|0
7467449|NCT01901146|11767790|FG003|Adjuvant Phase|Death|0
7467450|NCT01901146|11767791|FG004|Adjuvant Phase|Death|3
7467451|NCT01901146|11767787|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
7467452|NCT01901146|11767788|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
7467453|NCT01901146|11767789|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
7467454|NCT01901146|11767790|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
7467455|NCT01901146|11767791|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
7467456|NCT01901146|11767787|FG000|Adjuvant Phase|Physician Decision|0
7467457|NCT01901146|11767788|FG001|Adjuvant Phase|Physician Decision|0
7467458|NCT01901146|11767789|FG002|Adjuvant Phase|Physician Decision|9
7467459|NCT01901146|11767790|FG003|Adjuvant Phase|Physician Decision|2
7467460|NCT01901146|11767791|FG004|Adjuvant Phase|Physician Decision|4
7467461|NCT01901146|11767787|FG000|Adjuvant Phase|Withdrawal by Subject|0
7467462|NCT01901146|11767788|FG001|Adjuvant Phase|Withdrawal by Subject|0
7467463|NCT01901146|11767789|FG002|Adjuvant Phase|Withdrawal by Subject|4
7467464|NCT01901146|11767790|FG003|Adjuvant Phase|Withdrawal by Subject|1
7467465|NCT01901146|11767791|FG004|Adjuvant Phase|Withdrawal by Subject|4
7467466|NCT01901185|11767800|FG000|Overall Study|Withdrawal by Subject|2
7467467|NCT01901302|11767824|FG000|Overall Study|Adverse Event|2
7467468|NCT01901302|11767825|FG001|Overall Study|Adverse Event|1
7467469|NCT01901302|11767824|FG000|Overall Study|Lack of Efficacy|0
7467470|NCT01901302|11767825|FG001|Overall Study|Lack of Efficacy|2
7467471|NCT01901302|11767824|FG000|Overall Study|Study Terminated by Sponsor|23
7467472|NCT01901302|11767825|FG001|Overall Study|Study Terminated by Sponsor|20
7467473|NCT01901302|11767824|FG000|Overall Study|Withdrawal by Subject|2
7467474|NCT01901302|11767825|FG001|Overall Study|Withdrawal by Subject|0
7467475|NCT01901328|11767833|FG000|Overall Study|Lost to Follow-up|1
7467476|NCT01901328|11767834|FG001|Overall Study|Lost to Follow-up|0
7467477|NCT01901328|11767833|FG000|Overall Study|Physician Decision|0
7467478|NCT01901328|11767834|FG001|Overall Study|Physician Decision|1
7561562|NCT03207750|11929989|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
7561563|NCT03207750|11929990|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
7561564|NCT03207750|11929989|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
7561565|NCT03207750|11929990|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
7561566|NCT03207750|11929989|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
7561567|NCT03207750|11929990|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
7561568|NCT03207750|11929989|FG000|Overall Study|OTHER, NOT SPECIFIED|5
7561569|NCT03207750|11929990|FG001|Overall Study|OTHER, NOT SPECIFIED|4
7561570|NCT03207763|11929998|FG000|Overall Study|Lost to Follow-up|1
7561571|NCT03207763|11929999|FG001|Overall Study|Lost to Follow-up|0
7561572|NCT03208088|11930014|FG000|Period 2|Withdrawal by Subject|0
7561573|NCT03208088|11930015|FG001|Period 2|Withdrawal by Subject|0
7561574|NCT03208088|11930016|FG002|Period 2|Withdrawal by Subject|0
7561575|NCT03208088|11930017|FG003|Period 2|Withdrawal by Subject|0
7561576|NCT03208088|11930018|FG004|Period 2|Withdrawal by Subject|0
7561577|NCT03208088|11930019|FG005|Period 2|Withdrawal by Subject|0
7561578|NCT03208088|11930020|FG006|Period 2|Withdrawal by Subject|0
7561579|NCT03208088|11930021|FG007|Period 2|Withdrawal by Subject|0
7561580|NCT03208088|11930022|FG008|Period 2|Withdrawal by Subject|1
7561581|NCT03208088|11930023|FG009|Period 2|Withdrawal by Subject|0
7561582|NCT03208088|11930014|FG000|Period 3|Unsatisfactory Test Article|0
7467479|NCT01901328|11767833|FG000|Overall Study|Protocol Violation|1
7467480|NCT01901328|11767834|FG001|Overall Study|Protocol Violation|1
7467481|NCT01901328|11767833|FG000|Overall Study|Study Terminated by Sponsor|19
7561583|NCT03208088|11930015|FG001|Period 3|Unsatisfactory Test Article|0
7561584|NCT03208088|11930016|FG002|Period 3|Unsatisfactory Test Article|0
7561585|NCT03208088|11930017|FG003|Period 3|Unsatisfactory Test Article|1
7561586|NCT03208088|11930018|FG004|Period 3|Unsatisfactory Test Article|0
7561587|NCT03208088|11930019|FG005|Period 3|Unsatisfactory Test Article|0
7561588|NCT03208088|11930020|FG006|Period 3|Unsatisfactory Test Article|0
7561589|NCT03208088|11930021|FG007|Period 3|Unsatisfactory Test Article|0
7441174|NCT01652287|11725176|FG000|Overall Study|Withdrawal by Subject|2
7441175|NCT01652287|11725177|FG001|Overall Study|Withdrawal by Subject|0
7441180|NCT01652573|11725205|FG000|Overall Study|Adverse Event|0
7441181|NCT01652573|11725206|FG001|Overall Study|Adverse Event|1
7441182|NCT01652664|11725214|FG000|Overall Study|Treatment Failure|5
7441183|NCT01652664|11725215|FG001|Overall Study|Treatment Failure|1
7441184|NCT01652664|11725214|FG000|Overall Study|Inadequate IOP control|1
7441185|NCT01652664|11725215|FG001|Overall Study|Inadequate IOP control|0
7441186|NCT01652690|11725224|FG000|Overall Study|Withdrawal by Subject|16
7441187|NCT01652690|11725225|FG001|Overall Study|Withdrawal by Subject|4
7441188|NCT01652690|11725224|FG000|Overall Study|Other|8
7441189|NCT01652690|11725225|FG001|Overall Study|Other|9
7441190|NCT01652690|11725224|FG000|Overall Study|Lost to Follow-up|6
7441191|NCT01652690|11725225|FG001|Overall Study|Lost to Follow-up|6
7441192|NCT01652690|11725224|FG000|Overall Study|Death|5
7441193|NCT01652690|11725225|FG001|Overall Study|Death|2
7441194|NCT01652703|11725237|FG000|Overall Study|Withdrawal by Subject|0
7441195|NCT01652703|11725238|FG001|Overall Study|Withdrawal by Subject|1
7441196|NCT01652703|11725239|FG002|Overall Study|Withdrawal by Subject|3
7441197|NCT01652703|11725240|FG003|Overall Study|Withdrawal by Subject|1
7441198|NCT01652703|11725241|FG004|Overall Study|Withdrawal by Subject|0
7441199|NCT01652703|11725242|FG005|Overall Study|Withdrawal by Subject|1
7441200|NCT01652703|11725237|FG000|Overall Study|Other|0
7441201|NCT01652703|11725238|FG001|Overall Study|Other|0
7441202|NCT01652703|11725239|FG002|Overall Study|Other|0
7441203|NCT01652703|11725240|FG003|Overall Study|Other|1
7441204|NCT01652703|11725241|FG004|Overall Study|Other|1
7441205|NCT01652703|11725242|FG005|Overall Study|Other|1
7441206|NCT01652716|11725258|FG000|Overall Study|Loss of glucose control|1
7441207|NCT01652716|11725259|FG001|Overall Study|Loss of glucose control|0
7441208|NCT01652716|11725258|FG000|Overall Study|Administrative|0
7441209|NCT01652716|11725259|FG001|Overall Study|Administrative|2
7441210|NCT01652716|11725258|FG000|Overall Study|Investigator decision|1
7441211|NCT01652716|11725259|FG001|Overall Study|Investigator decision|4
7441212|NCT01652716|11725258|FG000|Overall Study|Lost to Follow-up|12
7441213|NCT01652716|11725259|FG001|Overall Study|Lost to Follow-up|11
7441214|NCT01652716|11725258|FG000|Overall Study|Protocol Violation|2
7441215|NCT01652716|11725259|FG001|Overall Study|Protocol Violation|1
7441216|NCT01652716|11725258|FG000|Overall Study|Adverse Event|7
7441217|NCT01652716|11725259|FG001|Overall Study|Adverse Event|10
7441218|NCT01652716|11725258|FG000|Overall Study|Withdrawal by Subject|33
7441219|NCT01652716|11725259|FG001|Overall Study|Withdrawal by Subject|18
7441220|NCT01652729|11725268|FG000|Overall Study|Withdrawal by Subject|14
7441221|NCT01652729|11725269|FG001|Overall Study|Withdrawal by Subject|7
7441222|NCT01652729|11725270|FG002|Overall Study|Withdrawal by Subject|7
7441223|NCT01652729|11725268|FG000|Overall Study|Adverse Event|4
7441224|NCT01652729|11725269|FG001|Overall Study|Adverse Event|0
7441225|NCT01652729|11725270|FG002|Overall Study|Adverse Event|3
7441226|NCT01652729|11725268|FG000|Overall Study|Physician Decision|1
7441227|NCT01652729|11725269|FG001|Overall Study|Physician Decision|0
7441228|NCT01652729|11725270|FG002|Overall Study|Physician Decision|1
7441229|NCT01652729|11725268|FG000|Overall Study|Protocol Violation|1
7441230|NCT01652729|11725269|FG001|Overall Study|Protocol Violation|0
7441231|NCT01652729|11725270|FG002|Overall Study|Protocol Violation|0
7441232|NCT01652729|11725268|FG000|Overall Study|Lost to Follow-up|6
7441233|NCT01652729|11725269|FG001|Overall Study|Lost to Follow-up|6
7441234|NCT01652729|11725270|FG002|Overall Study|Lost to Follow-up|3
7441235|NCT01652729|11725268|FG000|Overall Study|Administrative|1
7441236|NCT01652729|11725269|FG001|Overall Study|Administrative|0
7441237|NCT01652729|11725270|FG002|Overall Study|Administrative|0
7561590|NCT03208088|11930022|FG008|Period 3|Unsatisfactory Test Article|0
7441246|NCT01652885|11725287|FG000|Overall Study|Adverse Event|1
7441247|NCT01653132|11725316|FG000|First Intervention|Protocol Violation|1
7441248|NCT01653132|11725317|FG001|First Intervention|Protocol Violation|0
7441249|NCT01653158|11725327|FG000|Overall Study|Death|0
7441250|NCT01653158|11725328|FG001|Overall Study|Death|0
7441251|NCT01653158|11725329|FG002|Overall Study|Death|0
7561591|NCT03208088|11930023|FG009|Period 3|Unsatisfactory Test Article|0
7441252|NCT01653158|11725330|FG003|Overall Study|Death|1
7441253|NCT01653158|11725331|FG004|Overall Study|Death|0
7441254|NCT01653158|11725332|FG005|Overall Study|Death|0
7441255|NCT01653158|11725333|FG006|Overall Study|Death|0
7441256|NCT01653158|11725334|FG007|Overall Study|Death|2
7441257|NCT01653158|11725327|FG000|Overall Study|Adverse Event|0
7441258|NCT01653158|11725328|FG001|Overall Study|Adverse Event|0
7441259|NCT01653158|11725329|FG002|Overall Study|Adverse Event|0
7441260|NCT01653158|11725330|FG003|Overall Study|Adverse Event|1
7441261|NCT01653158|11725331|FG004|Overall Study|Adverse Event|0
7441262|NCT01653158|11725332|FG005|Overall Study|Adverse Event|0
7441263|NCT01653158|11725333|FG006|Overall Study|Adverse Event|0
7441264|NCT01653158|11725334|FG007|Overall Study|Adverse Event|3
7441265|NCT01653158|11725327|FG000|Overall Study|Other|0
7441266|NCT01653158|11725328|FG001|Overall Study|Other|0
7441267|NCT01653158|11725329|FG002|Overall Study|Other|0
7441268|NCT01653158|11725330|FG003|Overall Study|Other|0
7441269|NCT01653158|11725331|FG004|Overall Study|Other|0
7441270|NCT01653158|11725332|FG005|Overall Study|Other|0
7441271|NCT01653158|11725333|FG006|Overall Study|Other|0
7441272|NCT01653158|11725334|FG007|Overall Study|Other|1
7441273|NCT01653158|11725327|FG000|Overall Study|Progressive disease|0
7441274|NCT01653158|11725328|FG001|Overall Study|Progressive disease|0
7441275|NCT01653158|11725329|FG002|Overall Study|Progressive disease|0
7441276|NCT01653158|11725330|FG003|Overall Study|Progressive disease|0
7441277|NCT01653158|11725331|FG004|Overall Study|Progressive disease|1
7441278|NCT01653158|11725332|FG005|Overall Study|Progressive disease|1
7441279|NCT01653158|11725333|FG006|Overall Study|Progressive disease|2
7441280|NCT01653158|11725334|FG007|Overall Study|Progressive disease|9
7441281|NCT01653158|11725327|FG000|Overall Study|Withdrawal by Subject|1
7441282|NCT01653158|11725328|FG001|Overall Study|Withdrawal by Subject|0
7441283|NCT01653158|11725329|FG002|Overall Study|Withdrawal by Subject|0
7441284|NCT01653158|11725330|FG003|Overall Study|Withdrawal by Subject|0
7441285|NCT01653158|11725331|FG004|Overall Study|Withdrawal by Subject|0
7441286|NCT01653158|11725332|FG005|Overall Study|Withdrawal by Subject|0
7441287|NCT01653158|11725333|FG006|Overall Study|Withdrawal by Subject|0
7441288|NCT01653158|11725334|FG007|Overall Study|Withdrawal by Subject|0
7441289|NCT01653262|11725361|FG000|Overall Study|Lack of Efficacy|1
7441290|NCT01653262|11725361|FG000|Overall Study|SAE, non-fatal|1
7441291|NCT01653262|11725361|FG000|Overall Study|AE, non-serious non-fatal|1
7441292|NCT01653327|11725376|FG000|Overall Study|Withdrawal by Subject|1
7441293|NCT01653704|11725417|FG000|Overall Study|Technical failure during recording|1
7441294|NCT01653704|11725418|FG001|Overall Study|Technical failure during recording|1
7441295|NCT01653704|11725417|FG000|Overall Study|Performance not reflective of training|1
7441296|NCT01653704|11725418|FG001|Overall Study|Performance not reflective of training|0
7441297|NCT01653743|11725426|FG000|Overall Study|Withdrawal by Subject|1
7441298|NCT01653743|11725427|FG001|Overall Study|Withdrawal by Subject|0
7441299|NCT01653743|11725426|FG000|Overall Study|Investigator discretion|3
7441300|NCT01653743|11725427|FG001|Overall Study|Investigator discretion|0
7441301|NCT01653782|11725436|FG000|Overall Study|Withdrawal by Subject|9
7441302|NCT01653782|11725437|FG001|Overall Study|Withdrawal by Subject|15
7441303|NCT01653782|11725438|FG002|Overall Study|Withdrawal by Subject|4
7441304|NCT01653782|11725436|FG000|Overall Study|Lost to Follow-up|7
7441305|NCT01653782|11725437|FG001|Overall Study|Lost to Follow-up|3
7441306|NCT01653782|11725438|FG002|Overall Study|Lost to Follow-up|2
7441307|NCT01653847|11725448|FG000|Overall Study|Withdrawal by Subject|1
7441308|NCT01653847|11725449|FG001|Overall Study|Withdrawal by Subject|0
7441309|NCT01653912|11725457|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7441310|NCT01653912|11725458|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
7441311|NCT01653912|11725459|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7441312|NCT01653912|11725460|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7441313|NCT01653912|11725461|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7441314|NCT01653912|11725462|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
7441315|NCT01653912|11725457|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7441316|NCT01653912|11725458|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7441317|NCT01653912|11725459|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
7441318|NCT01653912|11725460|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7441319|NCT01653912|11725461|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7441320|NCT01653912|11725462|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
7441321|NCT01653912|11725457|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7441322|NCT01653912|11725458|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7441323|NCT01653912|11725459|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7441324|NCT01653912|11725460|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
7441325|NCT01653912|11725461|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7441326|NCT01653912|11725462|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
7441397|NCT01654666|11725622|FG000|Overall Study|Withdrawal by Subject|4
7441327|NCT01653912|11725457|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7441328|NCT01653912|11725458|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7441329|NCT01653912|11725459|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7441330|NCT01653912|11725460|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
7441331|NCT01653912|11725461|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7441332|NCT01653912|11725462|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
7441333|NCT01653912|11725457|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
7441334|NCT01653912|11725458|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
7441335|NCT01653912|11725459|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
7441336|NCT01653912|11725460|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
7441337|NCT01653912|11725461|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
7441338|NCT01653912|11725462|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
7441339|NCT01653912|11725457|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7441340|NCT01653912|11725458|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7441341|NCT01653912|11725459|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7441342|NCT01653912|11725460|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7441343|NCT01653912|11725461|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
7561592|NCT03208088|11930014|FG000|Period 4|Unsatisfactory Test Article|0
7561593|NCT03208088|11930015|FG001|Period 4|Unsatisfactory Test Article|0
7561594|NCT03208088|11930016|FG002|Period 4|Unsatisfactory Test Article|0
7561595|NCT03208088|11930017|FG003|Period 4|Unsatisfactory Test Article|1
7561596|NCT03208088|11930018|FG004|Period 4|Unsatisfactory Test Article|0
7561597|NCT03208088|11930019|FG005|Period 4|Unsatisfactory Test Article|0
7561598|NCT03208088|11930020|FG006|Period 4|Unsatisfactory Test Article|0
7561599|NCT03208088|11930021|FG007|Period 4|Unsatisfactory Test Article|0
7561600|NCT03208088|11930022|FG008|Period 4|Unsatisfactory Test Article|0
7561601|NCT03208088|11930023|FG009|Period 4|Unsatisfactory Test Article|0
7441344|NCT01653912|11725462|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
7441345|NCT01653912|11725457|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7441346|NCT01653912|11725458|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7441347|NCT01653912|11725459|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7441348|NCT01653912|11725460|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7441349|NCT01653912|11725461|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
7441350|NCT01653912|11725462|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
7441351|NCT01654224|11725487|FG000|Overall Study|Lost to Follow-up|2
7441352|NCT01654224|11725488|FG001|Overall Study|Lost to Follow-up|2
7441353|NCT01654224|11725487|FG000|Overall Study|Did not receive allocation|1
7441354|NCT01654224|11725488|FG001|Overall Study|Did not receive allocation|8
7441355|NCT01654224|11725487|FG000|Overall Study|Insufficient blood sample|3
7441356|NCT01654224|11725488|FG001|Overall Study|Insufficient blood sample|2
7441357|NCT01654250|11725496|FG000|Overall Study|Lost to Follow-up|1
7441358|NCT01654250|11725497|FG001|Overall Study|Lost to Follow-up|0
7441359|NCT01654276|11725526|FG000|Overall Study|Lack of Efficacy|1
7441360|NCT01654276|11725526|FG000|Overall Study|Lost to Follow-up|4
7441361|NCT01654276|11725526|FG000|Overall Study|Withdrawal by Subject|1
7441362|NCT01654289|11725533|FG000|Overall Study|Withdrawal by Subject|10
7441363|NCT01654289|11725534|FG001|Overall Study|Withdrawal by Subject|8
7441364|NCT01654289|11725535|FG002|Overall Study|Withdrawal by Subject|5
7441365|NCT01654289|11725533|FG000|Overall Study|Withdrew from intervention only|17
7441366|NCT01654289|11725534|FG001|Overall Study|Withdrew from intervention only|20
7441367|NCT01654289|11725535|FG002|Overall Study|Withdrew from intervention only|0
7441368|NCT01654302|11725545|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
7441369|NCT01654302|11725546|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
7441370|NCT01654380|11725554|FG000|Part B, Period 1|Physician Decision|0
7441371|NCT01654380|11725555|FG001|Part B, Period 1|Physician Decision|0
7441372|NCT01654380|11725556|FG002|Part B, Period 1|Physician Decision|1
7441373|NCT01654380|11725557|FG003|Part B, Period 1|Physician Decision|0
7441374|NCT01654523|11725583|FG000|Overall Study|Withdrawal by Subject|1
7441375|NCT01654536|11725589|FG000|Overall Study|Lost to Follow-up|5
7441376|NCT01654536|11725590|FG001|Overall Study|Lost to Follow-up|5
7441377|NCT01654536|11725589|FG000|Overall Study|Physician Decision|12
7441378|NCT01654536|11725590|FG001|Overall Study|Physician Decision|8
7441379|NCT01654536|11725589|FG000|Overall Study|Withdrawal by Subject|27
7441380|NCT01654536|11725590|FG001|Overall Study|Withdrawal by Subject|25
7441381|NCT01654549|11725599|FG000|Overall Study|H.pylori eradication not successful|0
7441382|NCT01654549|11725600|FG001|Overall Study|H.pylori eradication not successful|1
7441383|NCT01654601|11725612|FG000|1st Administration|Withdrawal by Subject|2
7441384|NCT01654601|11725613|FG001|1st Administration|Withdrawal by Subject|0
7441385|NCT01654601|11725612|FG000|1st Administration|Protocol Violation|0
7441386|NCT01654601|11725613|FG001|1st Administration|Protocol Violation|2
7441387|NCT01654601|11725612|FG000|2nd Administration|Adverse Event|1
7441388|NCT01654601|11725613|FG001|2nd Administration|Adverse Event|0
7441389|NCT01654601|11725612|FG000|2nd Administration|Protocol Violation|0
7441390|NCT01654601|11725613|FG001|2nd Administration|Protocol Violation|1
7441391|NCT01654666|11725622|FG000|Overall Study|Protocol Violation|7
7441392|NCT01654666|11725623|FG001|Overall Study|Protocol Violation|4
7441393|NCT01654666|11725624|FG002|Overall Study|Protocol Violation|8
7441394|NCT01654666|11725622|FG000|Overall Study|Lost to Follow-up|4
7441395|NCT01654666|11725623|FG001|Overall Study|Lost to Follow-up|5
7441396|NCT01654666|11725624|FG002|Overall Study|Lost to Follow-up|5
7441398|NCT01654666|11725623|FG001|Overall Study|Withdrawal by Subject|4
7561602|NCT03208933|11930059|FG000|Overall Study|Death|3
7441399|NCT01654666|11725624|FG002|Overall Study|Withdrawal by Subject|1
7441400|NCT01655069|11725668|FG000|Overall Study|Physician Decision|0
7561603|NCT03208933|11930059|FG000|Overall Study|Withdrawal by Subject|3
7561604|NCT03208933|11930059|FG000|Overall Study|Adverse Event|1
7561605|NCT03208933|11930059|FG000|Overall Study|Lost to Follow-up|2
7561606|NCT03208933|11930059|FG000|Overall Study|Physician Decision|3
7561607|NCT03208933|11930059|FG000|Overall Study|Protocol Violation|1
7561608|NCT03209362|11930070|FG000|Overall Study|Adverse Event|0
7561609|NCT03209362|11930071|FG001|Overall Study|Adverse Event|1
7561610|NCT03209362|11930070|FG000|Overall Study|Lost to Follow-up|0
7561611|NCT03209362|11930071|FG001|Overall Study|Lost to Follow-up|1
7561612|NCT03209362|11930070|FG000|Overall Study|Withdrawal by Subject|2
7561613|NCT03209362|11930071|FG001|Overall Study|Withdrawal by Subject|0
7561614|NCT03209362|11930070|FG000|Overall Study|Other|0
7561615|NCT03209362|11930071|FG001|Overall Study|Other|1
7561616|NCT03209492|11930077|FG000|Overall Study|Case Report Forms Uncollected|5
7561617|NCT03209518|11930088|FG000|Overall Study|Case Report Forms Uncollected|1
7561618|NCT03209518|11930088|FG000|Overall Study|Protocol Deviation|1
7561619|NCT03209570|11930094|FG000|Overall Study|Death|1
7561620|NCT03209570|11930095|FG001|Overall Study|Death|0
7561621|NCT03209570|11930094|FG000|Overall Study|Incomplete Data|8
7561622|NCT03209570|11930095|FG001|Overall Study|Incomplete Data|10
7561623|NCT03209570|11930094|FG000|Overall Study|Protocol Violation|1
7561624|NCT03209570|11930095|FG001|Overall Study|Protocol Violation|0
7561625|NCT03209570|11930094|FG000|Overall Study|Withdrawal by Subject|0
7561626|NCT03209570|11930095|FG001|Overall Study|Withdrawal by Subject|3
7561627|NCT03209973|11930112|FG000|Overall Study|Withdrawal by Subject|7
7561628|NCT03209973|11930112|FG000|Overall Study|Lost to Follow-up|2
7561629|NCT03209973|11930112|FG000|Overall Study|Death|8
7561630|NCT03209973|11930112|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
7561631|NCT03209973|11930112|FG000|Overall Study|Sponsor Decision|18
7561632|NCT03209973|11930112|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
7561633|NCT03209973|11930112|FG000|Overall Study|Participant Refused to Return to Treatment|2
7561634|NCT03210220|11930129|FG000|Overall Study|Physician Decision|1
7561635|NCT03210220|11930130|FG001|Overall Study|Physician Decision|0
7561636|NCT03210259|11930138|FG000|12-Week Run-in Period|Adverse Event|1
7561637|NCT03210259|11930139|FG001|12-Week Run-in Period|Adverse Event|0
7561638|NCT03210259|11930140|FG002|12-Week Run-in Period|Adverse Event|0
7561639|NCT03210259|11930138|FG000|12-Week Run-in Period|Death|1
7561640|NCT03210259|11930139|FG001|12-Week Run-in Period|Death|0
7561641|NCT03210259|11930140|FG002|12-Week Run-in Period|Death|0
7561642|NCT03210259|11930138|FG000|12-Week Run-in Period|Withdrawal by Subject|9
7561643|NCT03210259|11930139|FG001|12-Week Run-in Period|Withdrawal by Subject|0
7561644|NCT03210259|11930140|FG002|12-Week Run-in Period|Withdrawal by Subject|0
7561645|NCT03210259|11930138|FG000|12-Week Run-in Period|Lost to Follow-up|4
7561646|NCT03210259|11930139|FG001|12-Week Run-in Period|Lost to Follow-up|0
7561647|NCT03210259|11930140|FG002|12-Week Run-in Period|Lost to Follow-up|0
7561648|NCT03210259|11930138|FG000|12-Week Run-in Period|Lack of Efficacy|6
7561649|NCT03210259|11930139|FG001|12-Week Run-in Period|Lack of Efficacy|0
7561650|NCT03210259|11930140|FG002|12-Week Run-in Period|Lack of Efficacy|0
7441401|NCT01655069|11725669|FG001|Overall Study|Physician Decision|0
7441402|NCT01655069|11725670|FG002|Overall Study|Physician Decision|0
7441403|NCT01655069|11725671|FG003|Overall Study|Physician Decision|1
7441404|NCT01655069|11725668|FG000|Overall Study|Adverse Event|6
7441405|NCT01655069|11725669|FG001|Overall Study|Adverse Event|7
7441406|NCT01655069|11725670|FG002|Overall Study|Adverse Event|2
7441407|NCT01655069|11725671|FG003|Overall Study|Adverse Event|3
7441408|NCT01655069|11725668|FG000|Overall Study|Lack of Efficacy|0
7441409|NCT01655069|11725669|FG001|Overall Study|Lack of Efficacy|1
7441410|NCT01655069|11725670|FG002|Overall Study|Lack of Efficacy|0
7441411|NCT01655069|11725671|FG003|Overall Study|Lack of Efficacy|0
7441412|NCT01655069|11725668|FG000|Overall Study|No Treatment Needed|0
7441413|NCT01655069|11725669|FG001|Overall Study|No Treatment Needed|1
7441414|NCT01655069|11725670|FG002|Overall Study|No Treatment Needed|0
7441415|NCT01655069|11725671|FG003|Overall Study|No Treatment Needed|0
7441416|NCT01655069|11725668|FG000|Overall Study|Withdrawal by Subject|2
7441417|NCT01655069|11725669|FG001|Overall Study|Withdrawal by Subject|3
7441418|NCT01655069|11725670|FG002|Overall Study|Withdrawal by Subject|0
7441419|NCT01655069|11725671|FG003|Overall Study|Withdrawal by Subject|0
7441420|NCT01655381|11725693|FG000|Overall Study|Investigator Decision|1
7441421|NCT01655381|11725693|FG000|Overall Study|Moved to Another City|1
7561651|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Missed study visit|0
7561652|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Missed study visit|1
7561653|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Missed study visit|2
7561654|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
7561655|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
7561656|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
7561657|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Pregnancy|0
7441422|NCT01655381|11725693|FG000|Overall Study|Insufficient Treatment Response|1
7441423|NCT01655498|11725698|FG000|Overall Study|Unrelated health issue|2
7441424|NCT01655498|11725698|FG000|Overall Study|Protocol Violation|2
7441425|NCT01655498|11725698|FG000|Overall Study|Withdrawal by Subject|1
7561658|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Pregnancy|1
7561659|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Pregnancy|0
7561660|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Physician Decision|0
7441426|NCT01655693|11725717|FG000|Overall Study|Progression of Disease|92
7441427|NCT01655693|11725718|FG001|Overall Study|Progression of Disease|76
7441428|NCT01655693|11725719|FG002|Overall Study|Progression of Disease|58
7441429|NCT01655693|11725717|FG000|Overall Study|Death|8
7441430|NCT01655693|11725718|FG001|Overall Study|Death|9
7441431|NCT01655693|11725719|FG002|Overall Study|Death|12
7441432|NCT01655693|11725717|FG000|Overall Study|Serious Adverse Event|3
7441433|NCT01655693|11725718|FG001|Overall Study|Serious Adverse Event|15
7441434|NCT01655693|11725719|FG002|Overall Study|Serious Adverse Event|11
7441435|NCT01655693|11725717|FG000|Overall Study|Withdrawal by Subject|3
7441436|NCT01655693|11725718|FG001|Overall Study|Withdrawal by Subject|2
7441437|NCT01655693|11725719|FG002|Overall Study|Withdrawal by Subject|20
7441438|NCT01655693|11725717|FG000|Overall Study|Adverse Event|3
7441439|NCT01655693|11725718|FG001|Overall Study|Adverse Event|11
7441440|NCT01655693|11725719|FG002|Overall Study|Adverse Event|3
7441441|NCT01655693|11725717|FG000|Overall Study|Aggravation of Liver Dysfunction|5
7441442|NCT01655693|11725718|FG001|Overall Study|Aggravation of Liver Dysfunction|4
7441443|NCT01655693|11725719|FG002|Overall Study|Aggravation of Liver Dysfunction|0
7441444|NCT01655693|11725717|FG000|Overall Study|Non-Compliance|0
7441445|NCT01655693|11725718|FG001|Overall Study|Non-Compliance|0
7441446|NCT01655693|11725719|FG002|Overall Study|Non-Compliance|7
7441447|NCT01655693|11725717|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
7441448|NCT01655693|11725718|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
7441449|NCT01655693|11725719|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
7441450|NCT01655693|11725717|FG000|Overall Study|Protocol Violation|1
7441451|NCT01655693|11725718|FG001|Overall Study|Protocol Violation|0
7441452|NCT01655693|11725719|FG002|Overall Study|Protocol Violation|3
7441453|NCT01655693|11725717|FG000|Overall Study|Lost to Follow-up|1
7441454|NCT01655693|11725718|FG001|Overall Study|Lost to Follow-up|0
7441455|NCT01655693|11725719|FG002|Overall Study|Lost to Follow-up|1
7441456|NCT01655693|11725717|FG000|Overall Study|Screening Failure|1
7441457|NCT01655693|11725718|FG001|Overall Study|Screening Failure|0
7441458|NCT01655693|11725719|FG002|Overall Study|Screening Failure|0
7441459|NCT01655693|11725717|FG000|Overall Study|Other|8
7441460|NCT01655693|11725718|FG001|Overall Study|Other|6
7441461|NCT01655693|11725719|FG002|Overall Study|Other|15
7441462|NCT01655823|11725746|FG000|Overall Study|Lost to Follow-up|0
7441463|NCT01655823|11725747|FG001|Overall Study|Lost to Follow-up|1
7441464|NCT01655823|11725748|FG002|Overall Study|Lost to Follow-up|0
7441465|NCT01655823|11725749|FG003|Overall Study|Lost to Follow-up|0
7441466|NCT01655823|11725750|FG004|Overall Study|Lost to Follow-up|1
7441467|NCT01655823|11725746|FG000|Overall Study|Withdrawal by Subject|0
7441468|NCT01655823|11725747|FG001|Overall Study|Withdrawal by Subject|1
7441469|NCT01655823|11725748|FG002|Overall Study|Withdrawal by Subject|0
7441470|NCT01655823|11725749|FG003|Overall Study|Withdrawal by Subject|1
7441471|NCT01655823|11725750|FG004|Overall Study|Withdrawal by Subject|0
7441472|NCT01655901|11725762|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
7441473|NCT01655901|11725763|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
7441474|NCT01655901|11725764|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
7441475|NCT01655901|11725765|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
7441476|NCT01655901|11725766|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
7441477|NCT01655901|11725767|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
7441478|NCT01656161|11725780|FG000|Overall Study|Death|3
7441479|NCT01656161|11725780|FG000|Overall Study|Adverse Event|2
7441480|NCT01656161|11725780|FG000|Overall Study|Protocol Violation|1
7441481|NCT01656161|11725780|FG000|Overall Study|Withdrawal by Subject|1
7441482|NCT01656200|11725796|FG000|Overall Study|Withdrawal by Subject|1
7441483|NCT01656304|11725806|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
7441484|NCT01656395|11725816|FG000|Overall Study|Adverse Event|1
7441485|NCT01656395|11725817|FG001|Overall Study|Adverse Event|14
7441486|NCT01656395|11725818|FG002|Overall Study|Adverse Event|5
7441487|NCT01656395|11725819|FG003|Overall Study|Adverse Event|4
7441488|NCT01656395|11725820|FG004|Overall Study|Adverse Event|5
7441489|NCT01656395|11725821|FG005|Overall Study|Adverse Event|7
7441490|NCT01656395|11725822|FG006|Overall Study|Adverse Event|0
7441491|NCT01656395|11725823|FG007|Overall Study|Adverse Event|0
7441492|NCT01656395|11725816|FG000|Overall Study|Lack of Efficacy|1
7441493|NCT01656395|11725817|FG001|Overall Study|Lack of Efficacy|8
7441494|NCT01656395|11725818|FG002|Overall Study|Lack of Efficacy|6
7441495|NCT01656395|11725819|FG003|Overall Study|Lack of Efficacy|1
7441496|NCT01656395|11725820|FG004|Overall Study|Lack of Efficacy|1
7441497|NCT01656395|11725821|FG005|Overall Study|Lack of Efficacy|6
7441498|NCT01656395|11725822|FG006|Overall Study|Lack of Efficacy|0
7441499|NCT01656395|11725823|FG007|Overall Study|Lack of Efficacy|0
7441500|NCT01656395|11725816|FG000|Overall Study|Lost to Follow-up|1
7441501|NCT01656395|11725817|FG001|Overall Study|Lost to Follow-up|0
7441502|NCT01656395|11725818|FG002|Overall Study|Lost to Follow-up|0
7441503|NCT01656395|11725819|FG003|Overall Study|Lost to Follow-up|0
7441504|NCT01656395|11725820|FG004|Overall Study|Lost to Follow-up|0
7441505|NCT01656395|11725821|FG005|Overall Study|Lost to Follow-up|0
7441506|NCT01656395|11725822|FG006|Overall Study|Lost to Follow-up|0
7441507|NCT01656395|11725823|FG007|Overall Study|Lost to Follow-up|0
7441508|NCT01656395|11725816|FG000|Overall Study|Non-Compliance with Study Drug|1
7441509|NCT01656395|11725817|FG001|Overall Study|Non-Compliance with Study Drug|1
7441510|NCT01656395|11725818|FG002|Overall Study|Non-Compliance with Study Drug|0
7441511|NCT01656395|11725819|FG003|Overall Study|Non-Compliance with Study Drug|0
7441512|NCT01656395|11725820|FG004|Overall Study|Non-Compliance with Study Drug|1
7441513|NCT01656395|11725821|FG005|Overall Study|Non-Compliance with Study Drug|1
7441514|NCT01656395|11725822|FG006|Overall Study|Non-Compliance with Study Drug|0
7441515|NCT01656395|11725823|FG007|Overall Study|Non-Compliance with Study Drug|0
7441516|NCT01656395|11725816|FG000|Overall Study|Other|0
7441517|NCT01656395|11725817|FG001|Overall Study|Other|0
7441518|NCT01656395|11725818|FG002|Overall Study|Other|1
7441519|NCT01656395|11725819|FG003|Overall Study|Other|0
7441520|NCT01656395|11725820|FG004|Overall Study|Other|0
7441521|NCT01656395|11725821|FG005|Overall Study|Other|1
7441522|NCT01656395|11725822|FG006|Overall Study|Other|0
7441523|NCT01656395|11725823|FG007|Overall Study|Other|0
7441524|NCT01656395|11725816|FG000|Overall Study|Physician Decision|2
7441525|NCT01656395|11725817|FG001|Overall Study|Physician Decision|3
7441526|NCT01656395|11725818|FG002|Overall Study|Physician Decision|3
7441527|NCT01656395|11725819|FG003|Overall Study|Physician Decision|2
7441528|NCT01656395|11725820|FG004|Overall Study|Physician Decision|3
7441529|NCT01656395|11725821|FG005|Overall Study|Physician Decision|3
7441530|NCT01656395|11725822|FG006|Overall Study|Physician Decision|0
7441531|NCT01656395|11725823|FG007|Overall Study|Physician Decision|0
7441532|NCT01656395|11725816|FG000|Overall Study|Pregnancy|0
7441533|NCT01656395|11725817|FG001|Overall Study|Pregnancy|0
7441534|NCT01656395|11725818|FG002|Overall Study|Pregnancy|1
7441535|NCT01656395|11725819|FG003|Overall Study|Pregnancy|0
7441536|NCT01656395|11725820|FG004|Overall Study|Pregnancy|0
7441537|NCT01656395|11725821|FG005|Overall Study|Pregnancy|0
7441538|NCT01656395|11725822|FG006|Overall Study|Pregnancy|0
7441539|NCT01656395|11725823|FG007|Overall Study|Pregnancy|0
7441540|NCT01656395|11725816|FG000|Overall Study|Progressive Disease|0
7441541|NCT01656395|11725817|FG001|Overall Study|Progressive Disease|0
7441542|NCT01656395|11725818|FG002|Overall Study|Progressive Disease|0
7441543|NCT01656395|11725819|FG003|Overall Study|Progressive Disease|0
7441544|NCT01656395|11725820|FG004|Overall Study|Progressive Disease|0
7441545|NCT01656395|11725821|FG005|Overall Study|Progressive Disease|1
7441546|NCT01656395|11725822|FG006|Overall Study|Progressive Disease|0
7441547|NCT01656395|11725823|FG007|Overall Study|Progressive Disease|0
7441548|NCT01656395|11725816|FG000|Overall Study|Protocol Violation|6
7441549|NCT01656395|11725817|FG001|Overall Study|Protocol Violation|6
7441550|NCT01656395|11725818|FG002|Overall Study|Protocol Violation|9
7441551|NCT01656395|11725819|FG003|Overall Study|Protocol Violation|2
7441552|NCT01656395|11725820|FG004|Overall Study|Protocol Violation|4
7441553|NCT01656395|11725821|FG005|Overall Study|Protocol Violation|10
7441554|NCT01656395|11725822|FG006|Overall Study|Protocol Violation|0
7441555|NCT01656395|11725823|FG007|Overall Study|Protocol Violation|0
7441556|NCT01656395|11725816|FG000|Overall Study|Screen Failure|2
7441557|NCT01656395|11725817|FG001|Overall Study|Screen Failure|1
7441558|NCT01656395|11725818|FG002|Overall Study|Screen Failure|7
7441559|NCT01656395|11725819|FG003|Overall Study|Screen Failure|1
7441560|NCT01656395|11725820|FG004|Overall Study|Screen Failure|0
7441561|NCT01656395|11725821|FG005|Overall Study|Screen Failure|8
7441562|NCT01656395|11725822|FG006|Overall Study|Screen Failure|0
7441563|NCT01656395|11725823|FG007|Overall Study|Screen Failure|0
7441564|NCT01656395|11725816|FG000|Overall Study|Withdrawal by Subject|3
7441565|NCT01656395|11725817|FG001|Overall Study|Withdrawal by Subject|1
7441566|NCT01656395|11725818|FG002|Overall Study|Withdrawal by Subject|4
7441567|NCT01656395|11725819|FG003|Overall Study|Withdrawal by Subject|2
7441568|NCT01656395|11725820|FG004|Overall Study|Withdrawal by Subject|0
7441569|NCT01656395|11725821|FG005|Overall Study|Withdrawal by Subject|3
7441570|NCT01656395|11725822|FG006|Overall Study|Withdrawal by Subject|0
7441571|NCT01656395|11725823|FG007|Overall Study|Withdrawal by Subject|0
7441572|NCT01656408|11725847|FG000|Overall Study|Adverse Event|0
7441573|NCT01656408|11725848|FG001|Overall Study|Adverse Event|0
7441574|NCT01656408|11725849|FG002|Overall Study|Adverse Event|1
7441575|NCT01656408|11725850|FG003|Overall Study|Adverse Event|0
7441576|NCT01656408|11725851|FG004|Overall Study|Adverse Event|0
7441577|NCT01656408|11725852|FG005|Overall Study|Adverse Event|1
7441578|NCT01656408|11725853|FG006|Overall Study|Adverse Event|1
7441579|NCT01656408|11725854|FG007|Overall Study|Adverse Event|0
7441580|NCT01656408|11725855|FG008|Overall Study|Adverse Event|1
7441581|NCT01656408|11725856|FG009|Overall Study|Adverse Event|0
7441582|NCT01656408|11725847|FG000|Overall Study|Physician Decision|1
7441583|NCT01656408|11725848|FG001|Overall Study|Physician Decision|0
7441584|NCT01656408|11725849|FG002|Overall Study|Physician Decision|1
7441585|NCT01656408|11725850|FG003|Overall Study|Physician Decision|0
7441586|NCT01656408|11725851|FG004|Overall Study|Physician Decision|1
7441587|NCT01656408|11725852|FG005|Overall Study|Physician Decision|1
7441588|NCT01656408|11725853|FG006|Overall Study|Physician Decision|0
7441589|NCT01656408|11725854|FG007|Overall Study|Physician Decision|1
7441590|NCT01656408|11725855|FG008|Overall Study|Physician Decision|1
7441591|NCT01656408|11725856|FG009|Overall Study|Physician Decision|3
7441592|NCT01656733|11725930|FG000|Overall Study|No permission to collect birth outcomes|0
7441593|NCT01656733|11725931|FG001|Overall Study|No permission to collect birth outcomes|1
7441594|NCT01656733|11725930|FG000|Overall Study|Delivery at another hospital|0
7441595|NCT01656733|11725931|FG001|Overall Study|Delivery at another hospital|2
7441596|NCT01656733|11725930|FG000|Overall Study|Spontaneous abortion|0
7441597|NCT01656733|11725931|FG001|Overall Study|Spontaneous abortion|1
7441598|NCT01656759|11725939|FG000|Overall Study|Protocol Violation|2
7441599|NCT01656759|11725940|FG001|Overall Study|Protocol Violation|3
7441600|NCT01656850|11725957|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
7441601|NCT01656850|11725958|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
7441602|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Adverse Event|10
7441603|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Adverse Event|4
7441604|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Death|0
7441605|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Death|1
7441606|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
7441607|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
7441608|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
7441609|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
7441610|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
7441611|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
7441612|NCT01656889|11725970|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
7441613|NCT01656889|11725971|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
7441614|NCT01656889|11725970|FG000|Post Treatment Follow-Up, 3 Months|Death|1
7441615|NCT01656889|11725971|FG001|Post Treatment Follow-Up, 3 Months|Death|5
7441616|NCT01656889|11725970|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
7441617|NCT01656889|11725971|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
7441618|NCT01656889|11725970|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
7441619|NCT01656889|11725971|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
7441620|NCT01656889|11725970|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
7441621|NCT01656889|11725971|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
7441622|NCT01656967|11725979|FG000|Overall Study|faulty monitor|1
7441623|NCT01656967|11725980|FG001|Overall Study|faulty monitor|0
7441624|NCT01656967|11725979|FG000|Overall Study|unsuccessful ETT insertion|3
7441625|NCT01656967|11725980|FG001|Overall Study|unsuccessful ETT insertion|2
7441626|NCT01657019|11725990|FG000|Overall Study|Withdrawal by Subject|65
7441627|NCT01657019|11725990|FG000|Overall Study|Adverse Event|55
7441628|NCT01657019|11725990|FG000|Overall Study|Lost to Follow-up|48
7441629|NCT01657019|11725990|FG000|Overall Study|Protocol Violation|6
7441630|NCT01657019|11725990|FG000|Overall Study|Lack of Efficacy|3
7441631|NCT01657019|11725990|FG000|Overall Study|Other|58
7441632|NCT01657032|11725996|FG000|Overall Study|Lost to Follow-up|0
7441633|NCT01657032|11725997|FG001|Overall Study|Lost to Follow-up|7
7441634|NCT01657162|11726005|FG000|Overall Study|Adverse Event|26
7441635|NCT01657162|11726006|FG001|Overall Study|Adverse Event|36
7441636|NCT01657162|11726005|FG000|Overall Study|Withdrawal by Subject|13
7441637|NCT01657162|11726006|FG001|Overall Study|Withdrawal by Subject|13
7441638|NCT01657162|11726005|FG000|Overall Study|Continuing Significant Deterioration|9
7441639|NCT01657162|11726006|FG001|Overall Study|Continuing Significant Deterioration|3
7441640|NCT01657162|11726005|FG000|Overall Study|Refusal of Treatment|4
7441641|NCT01657162|11726006|FG001|Overall Study|Refusal of Treatment|6
7441642|NCT01657162|11726005|FG000|Overall Study|Lost to Follow-up|3
7441643|NCT01657162|11726006|FG001|Overall Study|Lost to Follow-up|4
7441644|NCT01657162|11726005|FG000|Overall Study|Death|2
7441645|NCT01657162|11726006|FG001|Overall Study|Death|3
7441646|NCT01657162|11726005|FG000|Overall Study|Inability to Complete Study Procedures|1
7441647|NCT01657162|11726006|FG001|Overall Study|Inability to Complete Study Procedures|7
7441648|NCT01657162|11726005|FG000|Overall Study|Protocol Violation|1
7441649|NCT01657162|11726006|FG001|Overall Study|Protocol Violation|0
7441650|NCT01657162|11726005|FG000|Overall Study|Hypersensitivity to Alendronate|0
7441651|NCT01657162|11726006|FG001|Overall Study|Hypersensitivity to Alendronate|1
7441652|NCT01657162|11726005|FG000|Overall Study|Other than Specified|0
7441653|NCT01657162|11726006|FG001|Overall Study|Other than Specified|2
7441654|NCT01657253|11726014|FG000|Overall Study|Lost to Follow-up|6
7441655|NCT01657253|11726015|FG001|Overall Study|Lost to Follow-up|5
7441656|NCT01657253|11726014|FG000|Overall Study|Withdrawal by Subject|11
7441657|NCT01657253|11726015|FG001|Overall Study|Withdrawal by Subject|12
7441658|NCT01657253|11726014|FG000|Overall Study|Adverse Event|0
7441659|NCT01657253|11726015|FG001|Overall Study|Adverse Event|1
7441660|NCT01657266|11726023|FG000|Overall Study|Lost to Follow-up|2
7441661|NCT01657266|11726024|FG001|Overall Study|Lost to Follow-up|2
7441662|NCT01657266|11726023|FG000|Overall Study|Adverse Event|2
7441663|NCT01657266|11726024|FG001|Overall Study|Adverse Event|3
7441664|NCT01657292|11726030|FG000|Overall Study|Adverse Event|6
7441665|NCT01657292|11726030|FG000|Overall Study|Withdrawal by Subject|2
7441666|NCT01657292|11726030|FG000|Overall Study|Violation of eligibility criteria|1
7532935|NCT02678247|11878868|FG000|First Intervention (7 Weeks)|Physician Decision|1
7532936|NCT02678247|11878869|FG001|First Intervention (7 Weeks)|Physician Decision|0
7532937|NCT02678247|11878868|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7532938|NCT02678247|11878869|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
7532939|NCT02678247|11878868|FG000|Second Intervention (7 Weeks)|Adverse Event|2
7532940|NCT02678247|11878869|FG001|Second Intervention (7 Weeks)|Adverse Event|1
7532941|NCT02678247|11878868|FG000|Second Intervention (7 Weeks)|Physician Decision|1
7532942|NCT02678247|11878869|FG001|Second Intervention (7 Weeks)|Physician Decision|0
7441667|NCT01657292|11726030|FG000|Overall Study|Change of therapy|1
7441668|NCT01657305|11726037|FG000|Overall Study|Lack of Wound Closure at Day 28|15
7441669|NCT01657305|11726037|FG000|Overall Study|Withdrawal by Subject|4
7441670|NCT01657305|11726037|FG000|Overall Study|Adverse Event|1
7441671|NCT01657305|11726037|FG000|Overall Study|Lost to Follow-up|1
7441672|NCT01657305|11726037|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
7441673|NCT01657370|11726099|FG000|Overall Study|Withdrawal by Subject|0
7441674|NCT01657370|11726100|FG001|Overall Study|Withdrawal by Subject|0
7441675|NCT01657370|11726101|FG002|Overall Study|Withdrawal by Subject|1
7441676|NCT01657370|11726102|FG003|Overall Study|Withdrawal by Subject|0
7441677|NCT01657370|11726103|FG004|Overall Study|Withdrawal by Subject|0
7441678|NCT01657370|11726104|FG005|Overall Study|Withdrawal by Subject|1
7441679|NCT01657370|11726099|FG000|Overall Study|Physician Decision|2
7441680|NCT01657370|11726100|FG001|Overall Study|Physician Decision|3
7441681|NCT01657370|11726101|FG002|Overall Study|Physician Decision|1
7441682|NCT01657370|11726102|FG003|Overall Study|Physician Decision|2
7441683|NCT01657370|11726103|FG004|Overall Study|Physician Decision|5
7441684|NCT01657370|11726104|FG005|Overall Study|Physician Decision|0
7441685|NCT01657370|11726099|FG000|Overall Study|Lack of Qualifying Event|1
7441686|NCT01657370|11726100|FG001|Overall Study|Lack of Qualifying Event|0
7441687|NCT01657370|11726101|FG002|Overall Study|Lack of Qualifying Event|3
7441688|NCT01657370|11726102|FG003|Overall Study|Lack of Qualifying Event|2
7441689|NCT01657370|11726103|FG004|Overall Study|Lack of Qualifying Event|1
7441690|NCT01657370|11726104|FG005|Overall Study|Lack of Qualifying Event|2
7441691|NCT01657370|11726099|FG000|Overall Study|Adverse Event|0
7441692|NCT01657370|11726100|FG001|Overall Study|Adverse Event|0
7441693|NCT01657370|11726101|FG002|Overall Study|Adverse Event|0
7441694|NCT01657370|11726102|FG003|Overall Study|Adverse Event|0
7441695|NCT01657370|11726103|FG004|Overall Study|Adverse Event|1
7441696|NCT01657370|11726104|FG005|Overall Study|Adverse Event|0
7441697|NCT01657370|11726099|FG000|Overall Study|Protocol Violation|1
7441698|NCT01657370|11726100|FG001|Overall Study|Protocol Violation|1
7441699|NCT01657370|11726101|FG002|Overall Study|Protocol Violation|1
7441700|NCT01657370|11726102|FG003|Overall Study|Protocol Violation|1
7441701|NCT01657370|11726103|FG004|Overall Study|Protocol Violation|0
7441702|NCT01657370|11726104|FG005|Overall Study|Protocol Violation|0
7441703|NCT01657370|11726099|FG000|Overall Study|Lost to Follow-up|2
7441704|NCT01657370|11726100|FG001|Overall Study|Lost to Follow-up|0
7441705|NCT01657370|11726101|FG002|Overall Study|Lost to Follow-up|1
7441706|NCT01657370|11726102|FG003|Overall Study|Lost to Follow-up|0
7441707|NCT01657370|11726103|FG004|Overall Study|Lost to Follow-up|0
7441708|NCT01657370|11726104|FG005|Overall Study|Lost to Follow-up|1
7441709|NCT01657461|11726125|FG000|Overall Study|Death|9
7441710|NCT01657461|11726126|FG001|Overall Study|Death|12
7441711|NCT01657461|11726125|FG000|Overall Study|Lost to Follow-up|0
7441712|NCT01657461|11726126|FG001|Overall Study|Lost to Follow-up|3
7441713|NCT01657461|11726125|FG000|Overall Study|Physician Decision|0
7441714|NCT01657461|11726126|FG001|Overall Study|Physician Decision|2
7441715|NCT01657461|11726125|FG000|Overall Study|Withdrawal by Subject|1
7441716|NCT01657461|11726126|FG001|Overall Study|Withdrawal by Subject|3
7441717|NCT01657760|11726138|FG000|Overall Study|Withdrawal by Subject|0
7441718|NCT01657760|11726139|FG001|Overall Study|Withdrawal by Subject|0
7441719|NCT01657760|11726140|FG002|Overall Study|Withdrawal by Subject|0
7441720|NCT01657760|11726141|FG003|Overall Study|Withdrawal by Subject|1
7441721|NCT01657760|11726138|FG000|Overall Study|Physician Decision|1
7441722|NCT01657760|11726139|FG001|Overall Study|Physician Decision|1
7441723|NCT01657760|11726140|FG002|Overall Study|Physician Decision|1
7441724|NCT01657760|11726141|FG003|Overall Study|Physician Decision|2
7441725|NCT01657799|11726156|FG000|Overall Study|Adverse Event Related to progression|6
7441726|NCT01657799|11726157|FG001|Overall Study|Adverse Event Related to progression|8
7441727|NCT01657799|11726158|FG002|Overall Study|Adverse Event Related to progression|12
7441728|NCT01657799|11726156|FG000|Overall Study|Adverse Event Not Related to Progression|5
7441729|NCT01657799|11726157|FG001|Overall Study|Adverse Event Not Related to Progression|4
7441730|NCT01657799|11726158|FG002|Overall Study|Adverse Event Not Related to Progression|4
7441731|NCT01657799|11726156|FG000|Overall Study|Withdrawal by Subject|13
7441732|NCT01657799|11726157|FG001|Overall Study|Withdrawal by Subject|10
7441733|NCT01657799|11726158|FG002|Overall Study|Withdrawal by Subject|10
7441734|NCT01657799|11726156|FG000|Overall Study|Lost to Follow-up|1
7441735|NCT01657799|11726157|FG001|Overall Study|Lost to Follow-up|0
7441736|NCT01657799|11726158|FG002|Overall Study|Lost to Follow-up|1
7441737|NCT01657799|11726156|FG000|Overall Study|Disease Progression|2
7441738|NCT01657799|11726157|FG001|Overall Study|Disease Progression|4
7441739|NCT01657799|11726158|FG002|Overall Study|Disease Progression|4
7441740|NCT01657799|11726156|FG000|Overall Study|Progressive Disease Clinical|7
7441741|NCT01657799|11726157|FG001|Overall Study|Progressive Disease Clinical|4
7441742|NCT01657799|11726158|FG002|Overall Study|Progressive Disease Clinical|7
7441743|NCT01657799|11726156|FG000|Overall Study|Radiographic & Clinical Progression|16
7441744|NCT01657799|11726157|FG001|Overall Study|Radiographic & Clinical Progression|11
7441745|NCT01657799|11726158|FG002|Overall Study|Radiographic & Clinical Progression|15
7441746|NCT01657799|11726156|FG000|Overall Study|Other|52
7441747|NCT01657799|11726157|FG001|Overall Study|Other|62
7441748|NCT01657799|11726158|FG002|Overall Study|Other|49
7441749|NCT01657877|11726166|FG000|Overall Study|Withdrawal by Subject|4
7441750|NCT01657877|11726166|FG000|Overall Study|Protocol Violation|6
7441751|NCT01657877|11726166|FG000|Overall Study|Adverse Event|2
7441752|NCT01657877|11726166|FG000|Overall Study|Other Reason|2
7441753|NCT01657903|11726183|FG000|Overall Study|Lost to Follow-up|1
7441754|NCT01657903|11726183|FG000|Overall Study|Withdrawal by Subject|1
7441755|NCT01658020|11726196|FG000|Overall Study|Adverse Event|3
7441756|NCT01658020|11726197|FG001|Overall Study|Adverse Event|3
7441757|NCT01658020|11726196|FG000|Overall Study|Lost to Follow-up|1
7441758|NCT01658020|11726197|FG001|Overall Study|Lost to Follow-up|0
7441759|NCT01658020|11726196|FG000|Overall Study|Withdrawal by Subject|4
7441760|NCT01658020|11726197|FG001|Overall Study|Withdrawal by Subject|5
7441761|NCT01658020|11726196|FG000|Overall Study|Protocol Violation|0
7441762|NCT01658020|11726197|FG001|Overall Study|Protocol Violation|1
7441763|NCT01658072|11726213|FG000|Overall Study|Protocol Violation|4
7441764|NCT01658072|11726214|FG001|Overall Study|Protocol Violation|2
7441765|NCT01658150|11726220|FG000|Overall Study|Withdrawal by Subject|1
7441766|NCT01658436|11726234|FG000|Overall Study|Adverse Event|6
7441767|NCT01658436|11726235|FG001|Overall Study|Adverse Event|5
7441768|NCT01658436|11726234|FG000|Overall Study|Physician Decision|1
7441769|NCT01658436|11726235|FG001|Overall Study|Physician Decision|0
7441770|NCT01658436|11726234|FG000|Overall Study|Progressive disease|12
7441771|NCT01658436|11726235|FG001|Overall Study|Progressive disease|4
7441772|NCT01658436|11726234|FG000|Overall Study|Study terminated by sponsor|0
7441773|NCT01658436|11726235|FG001|Overall Study|Study terminated by sponsor|1
7441774|NCT01658436|11726234|FG000|Overall Study|Subject/guardian decision|0
7441775|NCT01658436|11726235|FG001|Overall Study|Subject/guardian decision|1
7441776|NCT01658436|11726234|FG000|Overall Study|Death|1
7441777|NCT01658436|11726235|FG001|Overall Study|Death|0
7441778|NCT01658514|11726244|FG000|Overall Study|Protocol Violation|1
7441779|NCT01658514|11726245|FG001|Overall Study|Protocol Violation|0
7441780|NCT01658514|11726246|FG002|Overall Study|Protocol Violation|2
7441781|NCT01658579|11726257|FG000|Treatment Period A|Other|0
7441782|NCT01658579|11726258|FG001|Treatment Period A|Other|0
7441783|NCT01658579|11726259|FG002|Treatment Period A|Other|1
7441784|NCT01658579|11726260|FG003|Treatment Period A|Other|1
7441785|NCT01658579|11726257|FG000|Treatment Period A|Adverse Event|1
7441786|NCT01658579|11726258|FG001|Treatment Period A|Adverse Event|0
7441787|NCT01658579|11726259|FG002|Treatment Period A|Adverse Event|0
7441788|NCT01658579|11726260|FG003|Treatment Period A|Adverse Event|0
7441789|NCT01658579|11726257|FG000|Treatment Period B|Other|0
7441790|NCT01658579|11726258|FG001|Treatment Period B|Other|0
7441791|NCT01658579|11726259|FG002|Treatment Period B|Other|0
7441792|NCT01658579|11726260|FG003|Treatment Period B|Other|1
7441793|NCT01658735|11726278|FG000|Overall Study|Lack of Efficacy|1
7441794|NCT01658735|11726279|FG001|Overall Study|Lack of Efficacy|0
7441795|NCT01658735|11726280|FG002|Overall Study|Lack of Efficacy|1
7441796|NCT01658735|11726278|FG000|Overall Study|Lost to Follow-up|1
7441797|NCT01658735|11726279|FG001|Overall Study|Lost to Follow-up|1
7441798|NCT01658735|11726280|FG002|Overall Study|Lost to Follow-up|0
7441799|NCT01658735|11726278|FG000|Overall Study|Protocol Violation|0
7441800|NCT01658735|11726279|FG001|Overall Study|Protocol Violation|1
7441801|NCT01658735|11726280|FG002|Overall Study|Protocol Violation|0
7441802|NCT01658735|11726278|FG000|Overall Study|Withdrawal by Subject|3
7441803|NCT01658735|11726279|FG001|Overall Study|Withdrawal by Subject|5
7441804|NCT01658735|11726280|FG002|Overall Study|Withdrawal by Subject|3
7467482|NCT01901328|11767834|FG001|Overall Study|Study Terminated by Sponsor|16
7467483|NCT01901328|11767833|FG000|Overall Study|Withdrawal by Subject|1
7467484|NCT01901328|11767834|FG001|Overall Study|Withdrawal by Subject|2
7467485|NCT01901328|11767833|FG000|Overall Study|Lack of Efficacy|0
7467486|NCT01901328|11767834|FG001|Overall Study|Lack of Efficacy|1
7467487|NCT01901341|11767843|FG000|Overall Study|Adverse Event|4
7467488|NCT01901341|11767844|FG001|Overall Study|Adverse Event|2
7467489|NCT01901341|11767843|FG000|Overall Study|Lack of Efficacy|0
7467490|NCT01901341|11767844|FG001|Overall Study|Lack of Efficacy|2
7467491|NCT01901341|11767843|FG000|Overall Study|Lost to Follow-up|0
7467492|NCT01901341|11767844|FG001|Overall Study|Lost to Follow-up|1
7467493|NCT01901341|11767843|FG000|Overall Study|Protocol Violation|2
7467494|NCT01901341|11767844|FG001|Overall Study|Protocol Violation|0
7467495|NCT01901341|11767843|FG000|Overall Study|Study Terminated by Sponsor|13
7467496|NCT01901341|11767844|FG001|Overall Study|Study Terminated by Sponsor|15
7467497|NCT01901341|11767843|FG000|Overall Study|Withdrawal by Subject|1
7467498|NCT01901341|11767844|FG001|Overall Study|Withdrawal by Subject|1
7467499|NCT01901393|11767853|FG000|Overall Study|Adverse Event|1
7467500|NCT01901393|11767854|FG001|Overall Study|Adverse Event|0
7467501|NCT01901419|11767862|FG000|Overall Study|Protocol Violation|2
7467502|NCT01901419|11767863|FG001|Overall Study|Protocol Violation|6
7467503|NCT01901419|11767862|FG000|Overall Study|unavailable researchers|6
7467504|NCT01901419|11767863|FG001|Overall Study|unavailable researchers|3
7467505|NCT01901614|11767885|FG000|Overall Study|Adverse Event|0
7467506|NCT01901614|11767886|FG001|Overall Study|Adverse Event|1
7467507|NCT01901614|11767885|FG000|Overall Study|Lost to Follow-up|1
7467508|NCT01901614|11767886|FG001|Overall Study|Lost to Follow-up|0
7467509|NCT01901614|11767885|FG000|Overall Study|Screen Fail|1
7467510|NCT01901614|11767886|FG001|Overall Study|Screen Fail|0
7467511|NCT01901653|11767905|FG000|Overall Study|Death|2
7467512|NCT01901653|11767906|FG001|Overall Study|Death|1
7467513|NCT01901653|11767907|FG002|Overall Study|Death|8
7467514|NCT01901653|11767908|FG003|Overall Study|Death|3
7467515|NCT01901653|11767909|FG004|Overall Study|Death|2
7467516|NCT01901653|11767910|FG005|Overall Study|Death|2
7467517|NCT01901653|11767911|FG006|Overall Study|Death|6
7441805|NCT01658904|11726295|FG000|Overall Study|Principal Investigator discretion|2
7441806|NCT01658904|11726296|FG001|Overall Study|Principal Investigator discretion|0
7441807|NCT01658904|11726297|FG002|Overall Study|Principal Investigator discretion|0
7441808|NCT01658943|11726310|FG000|Overall Study|Adverse Event|6
7441809|NCT01658943|11726311|FG001|Overall Study|Adverse Event|13
7441810|NCT01658943|11726310|FG000|Overall Study|Withdrawal by Subject|9
7441811|NCT01658943|11726311|FG001|Overall Study|Withdrawal by Subject|2
7441812|NCT01658943|11726310|FG000|Overall Study|Progression/Relapse|39
7441813|NCT01658943|11726311|FG001|Overall Study|Progression/Relapse|40
7441814|NCT01658943|11726310|FG000|Overall Study|Death|4
7441815|NCT01658943|11726311|FG001|Overall Study|Death|2
7441816|NCT01658943|11726310|FG000|Overall Study|not protocol specified|4
7441817|NCT01658943|11726311|FG001|Overall Study|not protocol specified|1
7441818|NCT01658943|11726310|FG000|Overall Study|Not eligible|7
7441819|NCT01658943|11726311|FG001|Overall Study|Not eligible|9
7441820|NCT01658943|11726310|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
7441821|NCT01658943|11726311|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
7441822|NCT01659021|11726328|FG000|Main Study|Adverse Event|2
7441823|NCT01659021|11726329|FG001|Main Study|Adverse Event|3
7441824|NCT01659021|11726328|FG000|Main Study|Lost to Follow-up|1
7441825|NCT01659021|11726329|FG001|Main Study|Lost to Follow-up|0
7441826|NCT01659021|11726328|FG000|Main Study|Unknown Reasons|2
7441827|NCT01659021|11726329|FG001|Main Study|Unknown Reasons|1
7441828|NCT01659021|11726328|FG000|Main Study|Physician Decision|34
7441829|NCT01659021|11726329|FG001|Main Study|Physician Decision|16
7441830|NCT01659021|11726328|FG000|Main Study|Withdrawal by Subject|19
7441831|NCT01659021|11726329|FG001|Main Study|Withdrawal by Subject|16
7441832|NCT01659021|11726328|FG000|Main Study|Study Terminated by Sponsor|16
7441833|NCT01659021|11726329|FG001|Main Study|Study Terminated by Sponsor|1
7441834|NCT01659021|11726328|FG000|Long-Term Follow Up|Lost to Follow-up|3
7441835|NCT01659021|11726329|FG001|Long-Term Follow Up|Lost to Follow-up|3
7441836|NCT01659021|11726328|FG000|Long-Term Follow Up|Withdrawal by Subject|2
7441837|NCT01659021|11726329|FG001|Long-Term Follow Up|Withdrawal by Subject|1
7441838|NCT01659125|11726339|FG000|Overall Study|Withdrawal by Subject|2
7441839|NCT01659125|11726339|FG000|Overall Study|Lost to Follow-up|7
7441840|NCT01659125|11726339|FG000|Overall Study|Technical Problem|1
7441841|NCT01659125|11726339|FG000|Overall Study|Time Constraints|2
7441842|NCT01659125|11726339|FG000|Overall Study|Failed to Start Treatment|2
7441843|NCT01659255|11726360|FG000|Overall Study|Adverse Event|0
7441844|NCT01659255|11726361|FG001|Overall Study|Adverse Event|0
7441845|NCT01659255|11726362|FG002|Overall Study|Adverse Event|0
7441846|NCT01659255|11726363|FG003|Overall Study|Adverse Event|0
7441847|NCT01659255|11726364|FG004|Overall Study|Adverse Event|0
7441848|NCT01659255|11726365|FG005|Overall Study|Adverse Event|1
7441849|NCT01659255|11726366|FG006|Overall Study|Adverse Event|1
7441850|NCT01659255|11726367|FG007|Overall Study|Adverse Event|0
7441851|NCT01659255|11726368|FG008|Overall Study|Adverse Event|0
7441852|NCT01659255|11726369|FG009|Overall Study|Adverse Event|1
7441853|NCT01659255|11726370|FG010|Overall Study|Adverse Event|0
7441854|NCT01659255|11726371|FG011|Overall Study|Adverse Event|1
7441855|NCT01659255|11726372|FG012|Overall Study|Adverse Event|0
7441856|NCT01659255|11726373|FG013|Overall Study|Adverse Event|2
7441857|NCT01659255|11726374|FG014|Overall Study|Adverse Event|0
7441858|NCT01659255|11726375|FG015|Overall Study|Adverse Event|1
7441859|NCT01659255|11726376|FG016|Overall Study|Adverse Event|0
7441860|NCT01659255|11726360|FG000|Overall Study|Death|0
7441861|NCT01659255|11726361|FG001|Overall Study|Death|1
7441862|NCT01659255|11726362|FG002|Overall Study|Death|0
7441863|NCT01659255|11726363|FG003|Overall Study|Death|0
7441864|NCT01659255|11726364|FG004|Overall Study|Death|0
7441865|NCT01659255|11726365|FG005|Overall Study|Death|0
7441866|NCT01659255|11726366|FG006|Overall Study|Death|0
7441867|NCT01659255|11726367|FG007|Overall Study|Death|1
7441868|NCT01659255|11726368|FG008|Overall Study|Death|1
7441869|NCT01659255|11726369|FG009|Overall Study|Death|0
7441870|NCT01659255|11726370|FG010|Overall Study|Death|0
7441871|NCT01659255|11726371|FG011|Overall Study|Death|0
7441872|NCT01659255|11726372|FG012|Overall Study|Death|1
7441873|NCT01659255|11726373|FG013|Overall Study|Death|1
7441874|NCT01659255|11726374|FG014|Overall Study|Death|2
7441875|NCT01659255|11726375|FG015|Overall Study|Death|1
7441876|NCT01659255|11726376|FG016|Overall Study|Death|0
7441877|NCT01659255|11726360|FG000|Overall Study|Progressive Disease|2
7441878|NCT01659255|11726361|FG001|Overall Study|Progressive Disease|0
7441879|NCT01659255|11726362|FG002|Overall Study|Progressive Disease|0
7441880|NCT01659255|11726363|FG003|Overall Study|Progressive Disease|0
7441881|NCT01659255|11726364|FG004|Overall Study|Progressive Disease|0
7441882|NCT01659255|11726365|FG005|Overall Study|Progressive Disease|0
7441883|NCT01659255|11726366|FG006|Overall Study|Progressive Disease|0
7441884|NCT01659255|11726367|FG007|Overall Study|Progressive Disease|1
7441885|NCT01659255|11726368|FG008|Overall Study|Progressive Disease|0
7441886|NCT01659255|11726369|FG009|Overall Study|Progressive Disease|2
7441887|NCT01659255|11726370|FG010|Overall Study|Progressive Disease|2
7441888|NCT01659255|11726371|FG011|Overall Study|Progressive Disease|3
7441889|NCT01659255|11726372|FG012|Overall Study|Progressive Disease|5
7441890|NCT01659255|11726373|FG013|Overall Study|Progressive Disease|13
7441891|NCT01659255|11726374|FG014|Overall Study|Progressive Disease|6
7441892|NCT01659255|11726375|FG015|Overall Study|Progressive Disease|2
7441893|NCT01659255|11726376|FG016|Overall Study|Progressive Disease|3
7441894|NCT01659255|11726360|FG000|Overall Study|Withdrew Consent|0
7441895|NCT01659255|11726361|FG001|Overall Study|Withdrew Consent|0
7441896|NCT01659255|11726362|FG002|Overall Study|Withdrew Consent|0
7441897|NCT01659255|11726363|FG003|Overall Study|Withdrew Consent|0
7441898|NCT01659255|11726364|FG004|Overall Study|Withdrew Consent|0
7441899|NCT01659255|11726365|FG005|Overall Study|Withdrew Consent|0
7441900|NCT01659255|11726366|FG006|Overall Study|Withdrew Consent|0
7441901|NCT01659255|11726367|FG007|Overall Study|Withdrew Consent|0
7441902|NCT01659255|11726368|FG008|Overall Study|Withdrew Consent|0
7441903|NCT01659255|11726369|FG009|Overall Study|Withdrew Consent|0
7441904|NCT01659255|11726370|FG010|Overall Study|Withdrew Consent|1
7441905|NCT01659255|11726371|FG011|Overall Study|Withdrew Consent|0
7441906|NCT01659255|11726372|FG012|Overall Study|Withdrew Consent|0
7441907|NCT01659255|11726373|FG013|Overall Study|Withdrew Consent|1
7441908|NCT01659255|11726374|FG014|Overall Study|Withdrew Consent|0
7441909|NCT01659255|11726375|FG015|Overall Study|Withdrew Consent|0
7441910|NCT01659255|11726376|FG016|Overall Study|Withdrew Consent|0
7441911|NCT01659255|11726360|FG000|Overall Study|Investigator Decision|0
7441912|NCT01659255|11726361|FG001|Overall Study|Investigator Decision|0
7441913|NCT01659255|11726362|FG002|Overall Study|Investigator Decision|0
7441914|NCT01659255|11726363|FG003|Overall Study|Investigator Decision|0
7441915|NCT01659255|11726364|FG004|Overall Study|Investigator Decision|0
7441916|NCT01659255|11726365|FG005|Overall Study|Investigator Decision|0
7441917|NCT01659255|11726366|FG006|Overall Study|Investigator Decision|0
7441918|NCT01659255|11726367|FG007|Overall Study|Investigator Decision|0
7441919|NCT01659255|11726368|FG008|Overall Study|Investigator Decision|0
7441920|NCT01659255|11726369|FG009|Overall Study|Investigator Decision|0
7441921|NCT01659255|11726370|FG010|Overall Study|Investigator Decision|0
7441922|NCT01659255|11726371|FG011|Overall Study|Investigator Decision|0
7441923|NCT01659255|11726372|FG012|Overall Study|Investigator Decision|1
7441924|NCT01659255|11726373|FG013|Overall Study|Investigator Decision|1
7441925|NCT01659255|11726374|FG014|Overall Study|Investigator Decision|0
7441926|NCT01659255|11726375|FG015|Overall Study|Investigator Decision|0
7441927|NCT01659255|11726376|FG016|Overall Study|Investigator Decision|0
7441928|NCT01659255|11726360|FG000|Overall Study|Sponsor's Decision|0
7441929|NCT01659255|11726361|FG001|Overall Study|Sponsor's Decision|0
7441930|NCT01659255|11726362|FG002|Overall Study|Sponsor's Decision|0
7441931|NCT01659255|11726363|FG003|Overall Study|Sponsor's Decision|0
7441932|NCT01659255|11726364|FG004|Overall Study|Sponsor's Decision|0
7441933|NCT01659255|11726365|FG005|Overall Study|Sponsor's Decision|0
7441934|NCT01659255|11726366|FG006|Overall Study|Sponsor's Decision|1
7441935|NCT01659255|11726367|FG007|Overall Study|Sponsor's Decision|0
7441936|NCT01659255|11726368|FG008|Overall Study|Sponsor's Decision|0
7441937|NCT01659255|11726369|FG009|Overall Study|Sponsor's Decision|0
7441938|NCT01659255|11726370|FG010|Overall Study|Sponsor's Decision|0
7441939|NCT01659255|11726371|FG011|Overall Study|Sponsor's Decision|0
7441940|NCT01659255|11726372|FG012|Overall Study|Sponsor's Decision|0
7441941|NCT01659255|11726373|FG013|Overall Study|Sponsor's Decision|0
7441942|NCT01659255|11726374|FG014|Overall Study|Sponsor's Decision|0
7441943|NCT01659255|11726375|FG015|Overall Study|Sponsor's Decision|0
7441944|NCT01659255|11726376|FG016|Overall Study|Sponsor's Decision|0
7441945|NCT01659255|11726360|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
7441946|NCT01659255|11726361|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
7441947|NCT01659255|11726362|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
7441948|NCT01659255|11726363|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
7441949|NCT01659255|11726364|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
7441950|NCT01659255|11726365|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
7441951|NCT01659255|11726366|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
7441952|NCT01659255|11726367|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
7441953|NCT01659255|11726368|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
7441954|NCT01659255|11726369|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
7441955|NCT01659255|11726370|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
7441956|NCT01659255|11726371|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
7441957|NCT01659255|11726372|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
7441958|NCT01659255|11726373|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
7441959|NCT01659255|11726374|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
7441960|NCT01659255|11726375|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
7441961|NCT01659255|11726376|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
7441962|NCT01659255|11726360|FG000|Overall Study|Participant Went on to Have an Allograft|0
7441963|NCT01659255|11726361|FG001|Overall Study|Participant Went on to Have an Allograft|0
7441964|NCT01659255|11726362|FG002|Overall Study|Participant Went on to Have an Allograft|0
7441965|NCT01659255|11726363|FG003|Overall Study|Participant Went on to Have an Allograft|0
7441966|NCT01659255|11726364|FG004|Overall Study|Participant Went on to Have an Allograft|0
7442030|NCT01660256|11726578|FG000|Overall Study|Adverse Event|4
7441967|NCT01659255|11726365|FG005|Overall Study|Participant Went on to Have an Allograft|0
7441968|NCT01659255|11726366|FG006|Overall Study|Participant Went on to Have an Allograft|0
7441969|NCT01659255|11726367|FG007|Overall Study|Participant Went on to Have an Allograft|0
7441970|NCT01659255|11726368|FG008|Overall Study|Participant Went on to Have an Allograft|0
7441971|NCT01659255|11726369|FG009|Overall Study|Participant Went on to Have an Allograft|0
7441972|NCT01659255|11726370|FG010|Overall Study|Participant Went on to Have an Allograft|0
7441973|NCT01659255|11726371|FG011|Overall Study|Participant Went on to Have an Allograft|0
7441974|NCT01659255|11726372|FG012|Overall Study|Participant Went on to Have an Allograft|1
7441975|NCT01659255|11726373|FG013|Overall Study|Participant Went on to Have an Allograft|0
7441976|NCT01659255|11726374|FG014|Overall Study|Participant Went on to Have an Allograft|0
7441977|NCT01659255|11726375|FG015|Overall Study|Participant Went on to Have an Allograft|0
7441978|NCT01659255|11726376|FG016|Overall Study|Participant Went on to Have an Allograft|0
7441979|NCT01659320|11726423|FG000|Overall Study|Withdrawal by Subject|2
7441980|NCT01659320|11726423|FG000|Overall Study|Physician Decision|1
7441981|NCT01659567|11726427|FG000|Overall Study|Lack of Efficacy|22
7441982|NCT01659567|11726427|FG000|Overall Study|Switched to Pegferon|6
7441983|NCT01659567|11726427|FG000|Overall Study|Adverse Event|12
7441984|NCT01659567|11726427|FG000|Overall Study|Good result at early stage of treatment|5
7441985|NCT01659567|11726427|FG000|Overall Study|Withdrawal by Subject|64
7441986|NCT01659567|11726427|FG000|Overall Study|Progression of the main disease|1
7441987|NCT01659567|11726427|FG000|Overall Study|Other|13
7441988|NCT01659736|11726433|FG000|Treatment Period|Adverse Event|1
7441989|NCT01659736|11726434|FG001|Treatment Period|Adverse Event|1
7441990|NCT01659736|11726433|FG000|Treatment Period|Protocol Violation|3
7441991|NCT01659736|11726434|FG001|Treatment Period|Protocol Violation|1
7441992|NCT01659736|11726433|FG000|Treatment Period|Withdrawal by Subject|1
7441993|NCT01659736|11726434|FG001|Treatment Period|Withdrawal by Subject|0
7441994|NCT01659736|11726433|FG000|3-month Follow-up|Lost to Follow-up|0
7441995|NCT01659736|11726434|FG001|3-month Follow-up|Lost to Follow-up|1
7442000|NCT01659996|11726463|FG000|Overall Study|Protocol Violation|3
7442001|NCT01659996|11726464|FG001|Overall Study|Protocol Violation|3
7561661|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Physician Decision|0
7561662|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Physician Decision|1
7561663|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
7442002|NCT01659996|11726465|FG002|Overall Study|Protocol Violation|3
7442003|NCT01659996|11726463|FG000|Overall Study|Lost to Follow-up|1
7442004|NCT01659996|11726464|FG001|Overall Study|Lost to Follow-up|3
7442005|NCT01659996|11726465|FG002|Overall Study|Lost to Follow-up|2
7442006|NCT01659996|11726463|FG000|Overall Study|Adverse Event|0
7442007|NCT01659996|11726464|FG001|Overall Study|Adverse Event|0
7442008|NCT01659996|11726465|FG002|Overall Study|Adverse Event|1
7442009|NCT01659996|11726463|FG000|Overall Study|Withdrawal by Subject|4
7442010|NCT01659996|11726464|FG001|Overall Study|Withdrawal by Subject|1
7442011|NCT01659996|11726465|FG002|Overall Study|Withdrawal by Subject|5
7442012|NCT01660022|11726481|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
7442013|NCT01660022|11726482|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
7442014|NCT01660022|11726483|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
7442015|NCT01660022|11726484|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
7442016|NCT01660022|11726485|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
7442017|NCT01660022|11726486|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
7442018|NCT01660022|11726481|FG000|First Sequence (7 Days)|Adverse Event|0
7442019|NCT01660022|11726482|FG001|First Sequence (7 Days)|Adverse Event|0
7442020|NCT01660022|11726483|FG002|First Sequence (7 Days)|Adverse Event|0
7442021|NCT01660022|11726484|FG003|First Sequence (7 Days)|Adverse Event|0
7442022|NCT01660022|11726485|FG004|First Sequence (7 Days)|Adverse Event|1
7442023|NCT01660022|11726486|FG005|First Sequence (7 Days)|Adverse Event|3
7442024|NCT01660022|11726481|FG000|First Sequence (7 Days)|Protocol Violation|0
7442025|NCT01660022|11726482|FG001|First Sequence (7 Days)|Protocol Violation|0
7442026|NCT01660022|11726483|FG002|First Sequence (7 Days)|Protocol Violation|0
7328798|NCT00797966|11561719|FG001|Phase A+|Withdrawal by Subject|0
7328799|NCT00797966|11561720|FG002|Phase A+|Withdrawal by Subject|0
7328800|NCT00797966|11561721|FG003|Phase A+|Withdrawal by Subject|0
7328801|NCT00797966|11561722|FG004|Phase A+|Withdrawal by Subject|0
7328802|NCT00797966|11561723|FG005|Phase A+|Withdrawal by Subject|6
7328803|NCT00797966|11561718|FG000|Phase A+|Adverse Event|0
7328804|NCT00797966|11561719|FG001|Phase A+|Adverse Event|0
7328805|NCT00797966|11561720|FG002|Phase A+|Adverse Event|0
7328806|NCT00797966|11561721|FG003|Phase A+|Adverse Event|0
7328807|NCT00797966|11561722|FG004|Phase A+|Adverse Event|0
7328808|NCT00797966|11561723|FG005|Phase A+|Adverse Event|4
7328809|NCT00797966|11561718|FG000|Phase A+|Protocol deviation|0
7328810|NCT00797966|11561719|FG001|Phase A+|Protocol deviation|0
7328811|NCT00797966|11561720|FG002|Phase A+|Protocol deviation|0
7328812|NCT00797966|11561721|FG003|Phase A+|Protocol deviation|0
7442027|NCT01660022|11726484|FG003|First Sequence (7 Days)|Protocol Violation|0
7442028|NCT01660022|11726485|FG004|First Sequence (7 Days)|Protocol Violation|0
7442029|NCT01660022|11726486|FG005|First Sequence (7 Days)|Protocol Violation|1
7442031|NCT01660256|11726579|FG001|Overall Study|Adverse Event|0
7442032|NCT01660256|11726580|FG002|Overall Study|Adverse Event|2
7442033|NCT01660256|11726578|FG000|Overall Study|Withdrawal by Subject|1
7328813|NCT00797966|11561722|FG004|Phase A+|Protocol deviation|0
7328814|NCT00797966|11561723|FG005|Phase A+|Protocol deviation|4
7328815|NCT00798096|11561752|FG000|Overall Study|Ongoing|2
7328816|NCT00798135|11561756|FG000|Overall Study|Disease progression, relapse|11
7328817|NCT00798135|11561756|FG000|Overall Study|Disease progression, refractory|1
7328818|NCT00798135|11561756|FG000|Overall Study|Physician Decision|1
7328819|NCT00798161|11561767|FG000|Overall Study|Adverse Event|3
7328820|NCT00798161|11561768|FG001|Overall Study|Adverse Event|4
7328821|NCT00798161|11561769|FG002|Overall Study|Adverse Event|6
7328822|NCT00798161|11561770|FG003|Overall Study|Adverse Event|6
7328823|NCT00798161|11561771|FG004|Overall Study|Adverse Event|5
7328824|NCT00798161|11561772|FG005|Overall Study|Adverse Event|2
7328825|NCT00798161|11561773|FG006|Overall Study|Adverse Event|4
7328826|NCT00798161|11561767|FG000|Overall Study|Protocol Violation|2
7328827|NCT00798161|11561768|FG001|Overall Study|Protocol Violation|1
7328828|NCT00798161|11561769|FG002|Overall Study|Protocol Violation|3
7328829|NCT00798161|11561770|FG003|Overall Study|Protocol Violation|3
7328830|NCT00798161|11561771|FG004|Overall Study|Protocol Violation|3
7328831|NCT00798161|11561772|FG005|Overall Study|Protocol Violation|2
7328832|NCT00798161|11561773|FG006|Overall Study|Protocol Violation|0
7328833|NCT00798161|11561767|FG000|Overall Study|Lost to Follow-up|1
7328834|NCT00798161|11561768|FG001|Overall Study|Lost to Follow-up|3
7328835|NCT00798161|11561769|FG002|Overall Study|Lost to Follow-up|4
7328836|NCT00798161|11561770|FG003|Overall Study|Lost to Follow-up|3
7328837|NCT00798161|11561771|FG004|Overall Study|Lost to Follow-up|4
7328838|NCT00798161|11561772|FG005|Overall Study|Lost to Follow-up|0
7328839|NCT00798161|11561773|FG006|Overall Study|Lost to Follow-up|0
7328840|NCT00798161|11561767|FG000|Overall Study|Withdrawal by Subject|5
7328841|NCT00798161|11561768|FG001|Overall Study|Withdrawal by Subject|4
7328842|NCT00798161|11561769|FG002|Overall Study|Withdrawal by Subject|5
7328843|NCT00798161|11561770|FG003|Overall Study|Withdrawal by Subject|4
7328844|NCT00798161|11561771|FG004|Overall Study|Withdrawal by Subject|2
7328845|NCT00798161|11561772|FG005|Overall Study|Withdrawal by Subject|3
7442034|NCT01660256|11726579|FG001|Overall Study|Withdrawal by Subject|0
7442035|NCT01660256|11726580|FG002|Overall Study|Withdrawal by Subject|2
7442036|NCT01660334|11726592|FG000|Overall Study|Lost to Follow-up|1
7442037|NCT01660412|11726596|FG000|Overall Study|Protocol Violation|0
7442038|NCT01660412|11726597|FG001|Overall Study|Protocol Violation|3
7442039|NCT01660711|11726617|FG000|Overall Study|Adverse Event|7
7442040|NCT01660711|11726617|FG000|Overall Study|Withdrawal by Subject|1
7442041|NCT01660763|11726627|FG000|Overall Study|Lack of Efficacy|45
7442042|NCT01660763|11726628|FG001|Overall Study|Lack of Efficacy|50
7442043|NCT01660763|11726627|FG000|Overall Study|Adverse Event|22
7442044|NCT01660763|11726628|FG001|Overall Study|Adverse Event|7
7442045|NCT01660763|11726627|FG000|Overall Study|Protocol Violation|1
7442046|NCT01660763|11726628|FG001|Overall Study|Protocol Violation|0
7442047|NCT01660763|11726627|FG000|Overall Study|Withdrawal by Subject|4
7442048|NCT01660763|11726628|FG001|Overall Study|Withdrawal by Subject|0
7442049|NCT01660763|11726627|FG000|Overall Study|Patient ready for early discharge|28
7442050|NCT01660763|11726628|FG001|Overall Study|Patient ready for early discharge|4
7442051|NCT01660906|11726661|FG000|Overall Study|Discontinued due to study drug toxicity|3
7442052|NCT01661062|11726665|FG000|Overall Study|Completed Treatment Off Study|3
7442053|NCT01661062|11726665|FG000|Overall Study|Withdrawal by Subject|2
7442054|NCT01661140|11726677|FG000|Open-Label Period|Adverse Event|44
7442055|NCT01661140|11726678|FG001|Open-Label Period|Adverse Event|0
7442056|NCT01661140|11726679|FG002|Open-Label Period|Adverse Event|0
7442057|NCT01661140|11726677|FG000|Open-Label Period|Protocol Violation|3
7442058|NCT01661140|11726678|FG001|Open-Label Period|Protocol Violation|0
7561664|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
7561665|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
7561666|NCT03210259|11930138|FG000|48-Week Randomized Responder Period|Adverse Event|0
7561667|NCT03210259|11930139|FG001|48-Week Randomized Responder Period|Adverse Event|1
7561668|NCT03210259|11930140|FG002|48-Week Randomized Responder Period|Adverse Event|1
7561669|NCT03210519|11930167|FG000|Overall Study|Adverse Event|2
7561670|NCT03210519|11930168|FG001|Overall Study|Adverse Event|0
7561671|NCT03210961|11930193|FG000|Overall Study|Adverse Event|0
7561672|NCT03210961|11930194|FG001|Overall Study|Adverse Event|0
7561673|NCT03210961|11930195|FG002|Overall Study|Adverse Event|0
7561674|NCT03210961|11930196|FG003|Overall Study|Adverse Event|0
7561675|NCT03210961|11930197|FG004|Overall Study|Adverse Event|0
7561676|NCT03210961|11930198|FG005|Overall Study|Adverse Event|0
7561677|NCT03210961|11930199|FG006|Overall Study|Adverse Event|0
7561678|NCT03210961|11930200|FG007|Overall Study|Adverse Event|0
7561679|NCT03210961|11930201|FG008|Overall Study|Adverse Event|0
7561680|NCT03210961|11930202|FG009|Overall Study|Adverse Event|0
7561681|NCT03210961|11930203|FG010|Overall Study|Adverse Event|0
7561682|NCT03210961|11930204|FG011|Overall Study|Adverse Event|0
7561683|NCT03210961|11930205|FG012|Overall Study|Adverse Event|0
7561684|NCT03210961|11930206|FG013|Overall Study|Adverse Event|1
7561685|NCT03210961|11930207|FG014|Overall Study|Adverse Event|0
7442059|NCT01661140|11726679|FG002|Open-Label Period|Protocol Violation|0
7442060|NCT01661140|11726677|FG000|Open-Label Period|Withdrawal by Subject|5
7442061|NCT01661140|11726678|FG001|Open-Label Period|Withdrawal by Subject|0
7442062|NCT01661140|11726679|FG002|Open-Label Period|Withdrawal by Subject|0
7442063|NCT01661140|11726677|FG000|Open-Label Period|Investigator Decision|3
7442064|NCT01661140|11726678|FG001|Open-Label Period|Investigator Decision|0
7442065|NCT01661140|11726679|FG002|Open-Label Period|Investigator Decision|0
7442066|NCT01661140|11726677|FG000|Open-Label Period|Death|1
7442067|NCT01661140|11726678|FG001|Open-Label Period|Death|0
7442068|NCT01661140|11726679|FG002|Open-Label Period|Death|0
7442069|NCT01661140|11726677|FG000|Open-Label Period|Administrative/Other|1
7442070|NCT01661140|11726678|FG001|Open-Label Period|Administrative/Other|0
7442071|NCT01661140|11726679|FG002|Open-Label Period|Administrative/Other|0
7442072|NCT01661140|11726677|FG000|Open-Label Period|Sponsor termination|16
7442073|NCT01661140|11726678|FG001|Open-Label Period|Sponsor termination|0
7442074|NCT01661140|11726679|FG002|Open-Label Period|Sponsor termination|0
7442075|NCT01661140|11726677|FG000|Open-Label Period|Did not meet EULAR criteria|1
7442076|NCT01661140|11726678|FG001|Open-Label Period|Did not meet EULAR criteria|0
7442077|NCT01661140|11726679|FG002|Open-Label Period|Did not meet EULAR criteria|0
7442078|NCT01661140|11726677|FG000|Open-Label Period|Lost to Follow-up|2
7442079|NCT01661140|11726678|FG001|Open-Label Period|Lost to Follow-up|0
7442080|NCT01661140|11726679|FG002|Open-Label Period|Lost to Follow-up|0
7442081|NCT01661140|11726677|FG000|Double-Blind Period|Refused Treatment|0
7442082|NCT01661140|11726678|FG001|Double-Blind Period|Refused Treatment|0
7442083|NCT01661140|11726679|FG002|Double-Blind Period|Refused Treatment|1
7442084|NCT01661140|11726677|FG000|Double-Blind Period|Adverse Event|0
7442085|NCT01661140|11726678|FG001|Double-Blind Period|Adverse Event|16
7442086|NCT01661140|11726679|FG002|Double-Blind Period|Adverse Event|18
7442087|NCT01661140|11726677|FG000|Double-Blind Period|Protocol Violation|0
7442088|NCT01661140|11726678|FG001|Double-Blind Period|Protocol Violation|2
7442089|NCT01661140|11726679|FG002|Double-Blind Period|Protocol Violation|3
7442090|NCT01661140|11726677|FG000|Double-Blind Period|Withdrawal by Subject|0
7442091|NCT01661140|11726678|FG001|Double-Blind Period|Withdrawal by Subject|1
7442092|NCT01661140|11726679|FG002|Double-Blind Period|Withdrawal by Subject|3
7442093|NCT01661140|11726677|FG000|Double-Blind Period|Investigator's Decision|0
7442094|NCT01661140|11726678|FG001|Double-Blind Period|Investigator's Decision|1
7442095|NCT01661140|11726679|FG002|Double-Blind Period|Investigator's Decision|2
7442096|NCT01661140|11726677|FG000|Double-Blind Period|Sponsor Termination|0
7442097|NCT01661140|11726678|FG001|Double-Blind Period|Sponsor Termination|14
7442098|NCT01661140|11726679|FG002|Double-Blind Period|Sponsor Termination|17
7442099|NCT01661140|11726677|FG000|Double-Blind Period|Administrative/Other|0
7442100|NCT01661140|11726678|FG001|Double-Blind Period|Administrative/Other|7
7442101|NCT01661140|11726679|FG002|Double-Blind Period|Administrative/Other|6
7442102|NCT01661179|11726687|FG000|Overall Study|Death|1
7442103|NCT01661179|11726687|FG000|Overall Study|Withdrawal by Subject|1
7442104|NCT01661179|11726687|FG000|Overall Study|Other Eligibility criteria|4
7442105|NCT01661205|11726691|FG000|Overall Study|Physician Decision|2
7442106|NCT01661595|11726713|FG000|Phase 1: Week 0-4|Adverse Event|1
7442107|NCT01661595|11726714|FG001|Phase 1: Week 0-4|Adverse Event|0
7442108|NCT01661595|11726715|FG002|Phase 1: Week 0-4|Adverse Event|0
7442109|NCT01661595|11726716|FG003|Phase 1: Week 0-4|Adverse Event|0
7442110|NCT01661595|11726713|FG000|Phase 2: Week 5-8.|Protocol Violation|0
7442111|NCT01661595|11726714|FG001|Phase 2: Week 5-8.|Protocol Violation|0
7442112|NCT01661595|11726715|FG002|Phase 2: Week 5-8.|Protocol Violation|1
7442113|NCT01661595|11726716|FG003|Phase 2: Week 5-8.|Protocol Violation|0
7442114|NCT01661686|11726744|FG000|Overall Study|Lost to Follow-up|2
7442115|NCT01661686|11726745|FG001|Overall Study|Lost to Follow-up|1
7442116|NCT01661686|11726744|FG000|Overall Study|did not receive allocated intervention|0
7442117|NCT01661686|11726745|FG001|Overall Study|did not receive allocated intervention|1
7442118|NCT01661790|11726793|FG000|Overall Study|Lost to Follow-up|0
7442119|NCT01661790|11726794|FG001|Overall Study|Lost to Follow-up|2
7442120|NCT01661933|11726800|FG000|Low-dose Gluten Challenge|Physician Decision|2
7442121|NCT01661933|11726800|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
7442122|NCT01661972|11726817|FG000|Overall Study|Adverse Event|1
7442123|NCT01661972|11726818|FG001|Overall Study|Adverse Event|2
7442124|NCT01661972|11726817|FG000|Overall Study|Death during Treatment period|1
7442125|NCT01661972|11726818|FG001|Overall Study|Death during Treatment period|1
7442126|NCT01661972|11726817|FG000|Overall Study|Withdrawal by Subject|0
7442127|NCT01661972|11726818|FG001|Overall Study|Withdrawal by Subject|1
7442128|NCT01662024|11726826|FG000|Overall Study|Pregnancy|2
7442129|NCT01662024|11726826|FG000|Overall Study|Withdrawal by Subject|3
7442130|NCT01662063|11726835|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
7442131|NCT01662063|11726836|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
7442132|NCT01662063|11726837|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
7442133|NCT01662063|11726835|FG000|Overall Study|Lack of Efficacy|1
7442134|NCT01662063|11726836|FG001|Overall Study|Lack of Efficacy|6
7442135|NCT01662063|11726837|FG002|Overall Study|Lack of Efficacy|0
7442136|NCT01662063|11726835|FG000|Overall Study|Lost to Follow-up|0
7442137|NCT01662063|11726836|FG001|Overall Study|Lost to Follow-up|4
7442138|NCT01662063|11726837|FG002|Overall Study|Lost to Follow-up|0
7442139|NCT01662063|11726835|FG000|Overall Study|Protocol Violation|1
7442140|NCT01662063|11726836|FG001|Overall Study|Protocol Violation|0
7442141|NCT01662063|11726837|FG002|Overall Study|Protocol Violation|0
7442142|NCT01662063|11726835|FG000|Overall Study|Withdrawal by Subject|2
7442143|NCT01662063|11726836|FG001|Overall Study|Withdrawal by Subject|4
7442144|NCT01662063|11726837|FG002|Overall Study|Withdrawal by Subject|1
7442145|NCT01662063|11726835|FG000|Overall Study|Physician Decision|0
7442146|NCT01662063|11726836|FG001|Overall Study|Physician Decision|2
7442147|NCT01662063|11726837|FG002|Overall Study|Physician Decision|0
7442148|NCT01662063|11726835|FG000|Overall Study|Other|0
7442149|NCT01662063|11726836|FG001|Overall Study|Other|1
7442150|NCT01662063|11726837|FG002|Overall Study|Other|0
7442151|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Adverse Event|11
7442152|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Adverse Event|0
7442153|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Adverse Event|0
7442154|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Adverse Event|0
7442155|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Adverse Event|0
7442156|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
7442157|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
7442158|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
7442159|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
7442160|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
7442161|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
7442162|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
7442163|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
7442164|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
7442165|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
7442166|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Protocol Violation|15
7442167|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Protocol Violation|0
7442168|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Protocol Violation|0
7442169|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Protocol Violation|0
7442170|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Protocol Violation|0
7442171|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
7442172|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
7442173|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
7442174|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
7442175|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
7442176|NCT01662310|11726867|FG000|Run-In or Stabilization Phase|Other|1
7442177|NCT01662310|11726868|FG001|Run-In or Stabilization Phase|Other|0
7442178|NCT01662310|11726869|FG002|Run-In or Stabilization Phase|Other|0
7442179|NCT01662310|11726870|FG003|Run-In or Stabilization Phase|Other|0
7442180|NCT01662310|11726871|FG004|Run-In or Stabilization Phase|Other|0
7442181|NCT01662310|11726867|FG000|Double-Blind Phase|Adverse Event|0
7442182|NCT01662310|11726868|FG001|Double-Blind Phase|Adverse Event|0
7442183|NCT01662310|11726869|FG002|Double-Blind Phase|Adverse Event|1
7442184|NCT01662310|11726870|FG003|Double-Blind Phase|Adverse Event|0
7442185|NCT01662310|11726871|FG004|Double-Blind Phase|Adverse Event|0
7442186|NCT01662310|11726867|FG000|Double-Blind Phase|Lost to Follow-up|0
7442187|NCT01662310|11726868|FG001|Double-Blind Phase|Lost to Follow-up|3
7442188|NCT01662310|11726869|FG002|Double-Blind Phase|Lost to Follow-up|0
7442189|NCT01662310|11726870|FG003|Double-Blind Phase|Lost to Follow-up|0
7442190|NCT01662310|11726871|FG004|Double-Blind Phase|Lost to Follow-up|0
7442191|NCT01662310|11726867|FG000|Double-Blind Phase|Pregnancy|0
7442192|NCT01662310|11726868|FG001|Double-Blind Phase|Pregnancy|2
7442193|NCT01662310|11726869|FG002|Double-Blind Phase|Pregnancy|0
7442194|NCT01662310|11726870|FG003|Double-Blind Phase|Pregnancy|0
7442195|NCT01662310|11726871|FG004|Double-Blind Phase|Pregnancy|0
7442196|NCT01662310|11726867|FG000|Double-Blind Phase|Withdrawal by Subject|0
7442197|NCT01662310|11726868|FG001|Double-Blind Phase|Withdrawal by Subject|9
7442198|NCT01662310|11726869|FG002|Double-Blind Phase|Withdrawal by Subject|3
7442199|NCT01662310|11726870|FG003|Double-Blind Phase|Withdrawal by Subject|0
7442200|NCT01662310|11726871|FG004|Double-Blind Phase|Withdrawal by Subject|0
7442201|NCT01662310|11726867|FG000|Double-Blind Phase|Other|0
7442202|NCT01662310|11726868|FG001|Double-Blind Phase|Other|0
7442203|NCT01662310|11726869|FG002|Double-Blind Phase|Other|1
7442204|NCT01662310|11726870|FG003|Double-Blind Phase|Other|0
7561686|NCT03210961|11930193|FG000|Overall Study|Lost to Follow-up|0
7561687|NCT03210961|11930194|FG001|Overall Study|Lost to Follow-up|0
7561688|NCT03210961|11930195|FG002|Overall Study|Lost to Follow-up|0
7561689|NCT03210961|11930196|FG003|Overall Study|Lost to Follow-up|0
7561690|NCT03210961|11930197|FG004|Overall Study|Lost to Follow-up|0
7561691|NCT03210961|11930198|FG005|Overall Study|Lost to Follow-up|0
7561692|NCT03210961|11930199|FG006|Overall Study|Lost to Follow-up|0
7561693|NCT03210961|11930200|FG007|Overall Study|Lost to Follow-up|0
7561694|NCT03210961|11930201|FG008|Overall Study|Lost to Follow-up|0
7561695|NCT03210961|11930202|FG009|Overall Study|Lost to Follow-up|0
7561696|NCT03210961|11930203|FG010|Overall Study|Lost to Follow-up|0
7561697|NCT03210961|11930204|FG011|Overall Study|Lost to Follow-up|0
7442205|NCT01662310|11726871|FG004|Double-Blind Phase|Other|0
7442206|NCT01662310|11726867|FG000|Double-Blind Phase|Randomized but not treated|0
7561698|NCT03210961|11930205|FG012|Overall Study|Lost to Follow-up|0
7561699|NCT03210961|11930206|FG013|Overall Study|Lost to Follow-up|0
7561700|NCT03210961|11930207|FG014|Overall Study|Lost to Follow-up|1
7442207|NCT01662310|11726868|FG001|Double-Blind Phase|Randomized but not treated|1
7442208|NCT01662310|11726869|FG002|Double-Blind Phase|Randomized but not treated|0
7442209|NCT01662310|11726870|FG003|Double-Blind Phase|Randomized but not treated|0
7442210|NCT01662310|11726871|FG004|Double-Blind Phase|Randomized but not treated|0
7442211|NCT01662310|11726867|FG000|Open-Label Extension Phase|Adverse Event|0
7442212|NCT01662310|11726868|FG001|Open-Label Extension Phase|Adverse Event|0
7442213|NCT01662310|11726869|FG002|Open-Label Extension Phase|Adverse Event|0
7442214|NCT01662310|11726870|FG003|Open-Label Extension Phase|Adverse Event|3
7561701|NCT03210961|11930193|FG000|Overall Study|Withdrawal by Subject|0
7561702|NCT03210961|11930194|FG001|Overall Study|Withdrawal by Subject|0
7561703|NCT03210961|11930195|FG002|Overall Study|Withdrawal by Subject|0
7561704|NCT03210961|11930196|FG003|Overall Study|Withdrawal by Subject|0
7561705|NCT03210961|11930197|FG004|Overall Study|Withdrawal by Subject|0
7561706|NCT03210961|11930198|FG005|Overall Study|Withdrawal by Subject|0
7561707|NCT03210961|11930199|FG006|Overall Study|Withdrawal by Subject|0
7561708|NCT03210961|11930200|FG007|Overall Study|Withdrawal by Subject|0
7561709|NCT03210961|11930201|FG008|Overall Study|Withdrawal by Subject|0
7561710|NCT03210961|11930202|FG009|Overall Study|Withdrawal by Subject|0
7561711|NCT03210961|11930203|FG010|Overall Study|Withdrawal by Subject|0
7561712|NCT03210961|11930204|FG011|Overall Study|Withdrawal by Subject|0
7561713|NCT03210961|11930205|FG012|Overall Study|Withdrawal by Subject|0
7561714|NCT03210961|11930206|FG013|Overall Study|Withdrawal by Subject|0
7561715|NCT03210961|11930207|FG014|Overall Study|Withdrawal by Subject|1
7561716|NCT03210961|11930193|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7561717|NCT03210961|11930194|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7561718|NCT03210961|11930195|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7561719|NCT03210961|11930196|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7561720|NCT03210961|11930197|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7561721|NCT03210961|11930198|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7442215|NCT01662310|11726871|FG004|Open-Label Extension Phase|Adverse Event|0
7442216|NCT01662310|11726867|FG000|Open-Label Extension Phase|Death|0
7442217|NCT01662310|11726868|FG001|Open-Label Extension Phase|Death|0
7442218|NCT01662310|11726869|FG002|Open-Label Extension Phase|Death|0
7442219|NCT01662310|11726870|FG003|Open-Label Extension Phase|Death|1
7442220|NCT01662310|11726871|FG004|Open-Label Extension Phase|Death|0
7442221|NCT01662310|11726867|FG000|Open-Label Extension Phase|Lack of Efficacy|0
7442222|NCT01662310|11726868|FG001|Open-Label Extension Phase|Lack of Efficacy|0
7442223|NCT01662310|11726869|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7442224|NCT01662310|11726870|FG003|Open-Label Extension Phase|Lack of Efficacy|2
7442225|NCT01662310|11726871|FG004|Open-Label Extension Phase|Lack of Efficacy|2
7442226|NCT01662310|11726867|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7442227|NCT01662310|11726868|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7442228|NCT01662310|11726869|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7442229|NCT01662310|11726870|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7442230|NCT01662310|11726871|FG004|Open-Label Extension Phase|Lost to Follow-up|1
7442231|NCT01662310|11726867|FG000|Open-Label Extension Phase|Pregnancy|0
7442232|NCT01662310|11726868|FG001|Open-Label Extension Phase|Pregnancy|0
7442233|NCT01662310|11726869|FG002|Open-Label Extension Phase|Pregnancy|0
7442234|NCT01662310|11726870|FG003|Open-Label Extension Phase|Pregnancy|1
7442235|NCT01662310|11726871|FG004|Open-Label Extension Phase|Pregnancy|0
7442236|NCT01662310|11726867|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
7442237|NCT01662310|11726868|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
7442238|NCT01662310|11726869|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7442239|NCT01662310|11726870|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
7442240|NCT01662310|11726871|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
7442241|NCT01662336|11726883|FG000|Overall Study|Adverse Event|1
7442242|NCT01662336|11726883|FG000|Overall Study|No longer on LPV/r|30
7442243|NCT01662336|11726883|FG000|Overall Study|Other|29
7442244|NCT01662336|11726883|FG000|Overall Study|Withdrawal by Subject|6
7442245|NCT01662362|11726892|FG000|Overall Study|Lost to Follow-up|38
7442246|NCT01662440|11726901|FG000|Overall Study|Adverse Event|1
7442247|NCT01662440|11726902|FG001|Overall Study|Adverse Event|0
7442248|NCT01662440|11726903|FG002|Overall Study|Adverse Event|0
7442249|NCT01662440|11726904|FG003|Overall Study|Adverse Event|1
7442250|NCT01662440|11726901|FG000|Overall Study|Death|0
7442251|NCT01662440|11726902|FG001|Overall Study|Death|1
7442252|NCT01662440|11726903|FG002|Overall Study|Death|0
7442253|NCT01662440|11726904|FG003|Overall Study|Death|0
7442254|NCT01662440|11726901|FG000|Overall Study|Lost to Follow-up|2
7442255|NCT01662440|11726902|FG001|Overall Study|Lost to Follow-up|2
7442256|NCT01662440|11726903|FG002|Overall Study|Lost to Follow-up|4
7442257|NCT01662440|11726904|FG003|Overall Study|Lost to Follow-up|1
7561722|NCT03210961|11930199|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7561723|NCT03210961|11930200|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7561724|NCT03210961|11930201|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
7561725|NCT03210961|11930202|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7561726|NCT03210961|11930203|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
7561727|NCT03210961|11930204|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
7561728|NCT03210961|11930205|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
7561729|NCT03210961|11930206|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
7561730|NCT03210961|11930207|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
7561731|NCT03210961|11930193|FG000|Overall Study|Other|0
7442258|NCT01662440|11726901|FG000|Overall Study|Subject moved to another country.|0
7442259|NCT01662440|11726902|FG001|Overall Study|Subject moved to another country.|1
7442260|NCT01662440|11726903|FG002|Overall Study|Subject moved to another country.|0
7442261|NCT01662440|11726904|FG003|Overall Study|Subject moved to another country.|0
7442262|NCT01662440|11726901|FG000|Overall Study|Protocol Violation|1
7442263|NCT01662440|11726902|FG001|Overall Study|Protocol Violation|0
7442264|NCT01662440|11726903|FG002|Overall Study|Protocol Violation|0
7442265|NCT01662440|11726904|FG003|Overall Study|Protocol Violation|0
7442266|NCT01662440|11726901|FG000|Overall Study|Withdrawal by Subject|5
7442267|NCT01662440|11726902|FG001|Overall Study|Withdrawal by Subject|2
7442268|NCT01662440|11726903|FG002|Overall Study|Withdrawal by Subject|2
7442269|NCT01662440|11726904|FG003|Overall Study|Withdrawal by Subject|2
7442270|NCT01662492|11726927|FG000|Overall Study|Other miscellaneous reasons.|1
7442271|NCT01662492|11726928|FG001|Overall Study|Other miscellaneous reasons.|0
7442272|NCT01662492|11726929|FG002|Overall Study|Other miscellaneous reasons.|1
7442273|NCT01662492|11726927|FG000|Overall Study|Withdrawal by Subject|0
7442274|NCT01662492|11726928|FG001|Overall Study|Withdrawal by Subject|0
7442275|NCT01662492|11726929|FG002|Overall Study|Withdrawal by Subject|1
7442276|NCT01662492|11726927|FG000|Overall Study|Protocol Violation|1
7442277|NCT01662492|11726928|FG001|Overall Study|Protocol Violation|0
7442278|NCT01662492|11726929|FG002|Overall Study|Protocol Violation|0
7442279|NCT01662492|11726927|FG000|Overall Study|Lost to Follow-up|0
7442280|NCT01662492|11726928|FG001|Overall Study|Lost to Follow-up|0
7442281|NCT01662492|11726929|FG002|Overall Study|Lost to Follow-up|2
7442282|NCT01662492|11726927|FG000|Overall Study|Lack of Efficacy|1
7442283|NCT01662492|11726928|FG001|Overall Study|Lack of Efficacy|1
7442284|NCT01662492|11726929|FG002|Overall Study|Lack of Efficacy|2
7442285|NCT01662505|11726940|FG000|Overall Study|Progressive disease|6
7442286|NCT01662505|11726941|FG001|Overall Study|Progressive disease|1
7442287|NCT01662505|11726942|FG002|Overall Study|Progressive disease|5
7442288|NCT01662505|11726940|FG000|Overall Study|Refused cont. medication|0
7442289|NCT01662505|11726941|FG001|Overall Study|Refused cont. medication|0
7442290|NCT01662505|11726942|FG002|Overall Study|Refused cont. medication|1
7442291|NCT01662505|11726940|FG000|Overall Study|Not specified above|1
7442292|NCT01662505|11726941|FG001|Overall Study|Not specified above|3
7442293|NCT01662505|11726942|FG002|Overall Study|Not specified above|2
7442294|NCT01662635|11726972|FG000|Overall Study|scarce samples for evaluation|30
7442295|NCT01662648|11726980|FG000|Overall Study|Death|1
7442296|NCT01662648|11726981|FG001|Overall Study|Death|3
7442297|NCT01662648|11726980|FG000|Overall Study|Adverse Event|40
7442298|NCT01662648|11726981|FG001|Overall Study|Adverse Event|37
7442299|NCT01662648|11726980|FG000|Overall Study|Lack of Efficacy|17
7442300|NCT01662648|11726981|FG001|Overall Study|Lack of Efficacy|16
7442301|NCT01662648|11726980|FG000|Overall Study|Participant ineligible to continue trial|1
7442302|NCT01662648|11726981|FG001|Overall Study|Participant ineligible to continue trial|1
7442303|NCT01662648|11726980|FG000|Overall Study|Lost to Follow-up|24
7442304|NCT01662648|11726981|FG001|Overall Study|Lost to Follow-up|36
7442305|NCT01662648|11726980|FG000|Overall Study|Withdrawal by Subject|36
7442306|NCT01662648|11726981|FG001|Overall Study|Withdrawal by Subject|53
7442307|NCT01662648|11726980|FG000|Overall Study|Participant non-compliant|16
7442308|NCT01662648|11726981|FG001|Overall Study|Participant non-compliant|20
7442309|NCT01662648|11726980|FG000|Overall Study|Other|8
7442310|NCT01662648|11726981|FG001|Overall Study|Other|11
7442311|NCT01662648|11726980|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
7442312|NCT01662648|11726981|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
7442313|NCT01662648|11726980|FG000|Overall Study|LOE and other reason unspecified|1
7442314|NCT01662648|11726981|FG001|Overall Study|LOE and other reason unspecified|0
7442315|NCT01662648|11726980|FG000|Overall Study|LOE and Participant non-compliant|0
7442316|NCT01662648|11726981|FG001|Overall Study|LOE and Participant non-compliant|1
7442317|NCT01662895|11727055|FG000|Overall Study|Lost to Follow-up|0
7442318|NCT01662895|11727056|FG001|Overall Study|Lost to Follow-up|1
7442319|NCT01662986|11727090|FG000|Overall Study|Adverse Event|5
7442320|NCT01662986|11727091|FG001|Overall Study|Adverse Event|4
7442321|NCT01662986|11727090|FG000|Overall Study|Protocol Violation|2
7442322|NCT01662986|11727091|FG001|Overall Study|Protocol Violation|3
7442323|NCT01662986|11727090|FG000|Overall Study|Lost to Follow-up|5
7442324|NCT01662986|11727091|FG001|Overall Study|Lost to Follow-up|4
7561732|NCT03210961|11930194|FG001|Overall Study|Other|0
7561733|NCT03210961|11930195|FG002|Overall Study|Other|0
7442325|NCT01662986|11727090|FG000|Overall Study|Withdrawal by Subject|2
7442326|NCT01662986|11727091|FG001|Overall Study|Withdrawal by Subject|2
7442327|NCT01662986|11727090|FG000|Overall Study|Not Treated|1
7442328|NCT01662986|11727091|FG001|Overall Study|Not Treated|0
7442329|NCT01662986|11727090|FG000|Overall Study|Other than stated above|3
7442330|NCT01662986|11727091|FG001|Overall Study|Other than stated above|0
7442331|NCT01662999|11727103|FG000|Period 3|Withdrawal by Subject|0
7442332|NCT01662999|11727104|FG001|Period 3|Withdrawal by Subject|1
7442333|NCT01662999|11727105|FG002|Period 3|Withdrawal by Subject|0
7442334|NCT01662999|11727106|FG003|Period 3|Withdrawal by Subject|0
7442335|NCT01662999|11727107|FG004|Period 3|Withdrawal by Subject|0
7442336|NCT01662999|11727108|FG005|Period 3|Withdrawal by Subject|0
7561734|NCT03210961|11930196|FG003|Overall Study|Other|1
7561735|NCT03210961|11930197|FG004|Overall Study|Other|0
7442337|NCT01663103|11727144|FG000|Overall Study|Withdrawal by Subject|1
7442338|NCT01663103|11727145|FG001|Overall Study|Withdrawal by Subject|2
7442339|NCT01663103|11727144|FG000|Overall Study|Adverse Event|1
7561736|NCT03210961|11930198|FG005|Overall Study|Other|0
7442340|NCT01663103|11727145|FG001|Overall Study|Adverse Event|0
7442341|NCT01663103|11727144|FG000|Overall Study|dog bite|1
7442342|NCT01663103|11727145|FG001|Overall Study|dog bite|0
7442343|NCT01663233|11727157|FG000|Overall Study|Withdrawal by Subject|3
7442344|NCT01663233|11727158|FG001|Overall Study|Withdrawal by Subject|2
7442345|NCT01663233|11727157|FG000|Overall Study|Protocol Deviation|1
7442346|NCT01663233|11727158|FG001|Overall Study|Protocol Deviation|4
7442347|NCT01663233|11727157|FG000|Overall Study|Lost to Follow-up|0
7442348|NCT01663233|11727158|FG001|Overall Study|Lost to Follow-up|1
7442349|NCT01663402|11727180|FG000|Overall Study|Randomized but not treated|19
7442350|NCT01663402|11727181|FG001|Overall Study|Randomized but not treated|11
7442351|NCT01663402|11727180|FG000|Overall Study|Adverse Event|347
7442352|NCT01663402|11727181|FG001|Overall Study|Adverse Event|362
7442353|NCT01663402|11727180|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
7442354|NCT01663402|11727181|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
7442355|NCT01663402|11727180|FG000|Overall Study|Poor compliance to protocol|529
7442356|NCT01663402|11727181|FG001|Overall Study|Poor compliance to protocol|454
7442357|NCT01663402|11727180|FG000|Overall Study|Physician Decision|77
7442358|NCT01663402|11727181|FG001|Overall Study|Physician Decision|62
7442359|NCT01663402|11727180|FG000|Overall Study|Site terminated by sponsor|1
7442360|NCT01663402|11727181|FG001|Overall Study|Site terminated by sponsor|3
7442361|NCT01663402|11727180|FG000|Overall Study|Participant moved|139
7442362|NCT01663402|11727181|FG001|Overall Study|Participant moved|104
7442363|NCT01663402|11727180|FG000|Overall Study|Withdrawal by Subject|118
7442364|NCT01663402|11727181|FG001|Overall Study|Withdrawal by Subject|91
7442365|NCT01663402|11727180|FG000|Overall Study|Related to study drug administration|96
7442366|NCT01663402|11727181|FG001|Overall Study|Related to study drug administration|105
7442367|NCT01663402|11727180|FG000|Overall Study|Lost to Follow-up|17
7442368|NCT01663402|11727181|FG001|Overall Study|Lost to Follow-up|15
7442369|NCT01663402|11727180|FG000|Overall Study|Other than specified above|172
7442370|NCT01663402|11727181|FG001|Overall Study|Other than specified above|147
7442371|NCT01663506|11727187|FG000|Overall Study|Lack of Efficacy|3
7442372|NCT01663506|11727187|FG000|Overall Study|Consent Withdrawal by Subject|1
7442373|NCT01663506|11727187|FG000|Overall Study|Lost to Follow-up|1
7442374|NCT01663506|11727187|FG000|Overall Study|Adverse Event|1
7442375|NCT01663506|11727187|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
7442376|NCT01663532|11727193|FG000|Overall Study|Lost to Follow-up|9
7442377|NCT01663532|11727194|FG001|Overall Study|Lost to Follow-up|10
7442378|NCT01663532|11727193|FG000|Overall Study|Adverse Event|7
7442379|NCT01663532|11727194|FG001|Overall Study|Adverse Event|13
7442380|NCT01663532|11727193|FG000|Overall Study|Met Withdrawal Criteria|7
7442381|NCT01663532|11727194|FG001|Overall Study|Met Withdrawal Criteria|6
7442382|NCT01663532|11727193|FG000|Overall Study|Physician Decision|1
7442383|NCT01663532|11727194|FG001|Overall Study|Physician Decision|1
7442384|NCT01663532|11727193|FG000|Overall Study|Withdrawal by Subject|35
7442385|NCT01663532|11727194|FG001|Overall Study|Withdrawal by Subject|17
7442386|NCT01663532|11727193|FG000|Overall Study|Lack of Efficacy|15
7442387|NCT01663532|11727194|FG001|Overall Study|Lack of Efficacy|60
7442388|NCT01663623|11727202|FG000|Overall Study|Adverse Event|3
7442389|NCT01663623|11727203|FG001|Overall Study|Adverse Event|7
7442390|NCT01663623|11727202|FG000|Overall Study|Lack of Efficacy|5
7442391|NCT01663623|11727203|FG001|Overall Study|Lack of Efficacy|6
7442392|NCT01663623|11727202|FG000|Overall Study|Protocol Violation|0
7442393|NCT01663623|11727203|FG001|Overall Study|Protocol Violation|1
7442394|NCT01663623|11727202|FG000|Overall Study|Other-Study closed/terminated|1
7442395|NCT01663623|11727203|FG001|Overall Study|Other-Study closed/terminated|1
7442396|NCT01663623|11727202|FG000|Overall Study|Physician Decision|1
7442397|NCT01663623|11727203|FG001|Overall Study|Physician Decision|4
7442398|NCT01663623|11727202|FG000|Overall Study|Withdrawal by Subject|2
7442399|NCT01663623|11727203|FG001|Overall Study|Withdrawal by Subject|1
7442400|NCT01663636|11727211|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
7442401|NCT01663636|11727212|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
7442402|NCT01663714|11727218|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7442403|NCT01663714|11727218|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
7442404|NCT01663714|11727218|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
7442405|NCT01663714|11727218|FG000|Long-Term Follow-Up|Lost to Follow-up|1
7442406|NCT01663714|11727218|FG000|Long-Term Follow-Up|Death|4
7442407|NCT01663714|11727218|FG000|Long-Term Follow-Up|Non-compliance|1
7442408|NCT01663727|11727226|FG000|Overall Study|Death|161
7442409|NCT01663727|11727227|FG001|Overall Study|Death|155
7442410|NCT01663727|11727226|FG000|Overall Study|Lost to Follow-up|10
7442411|NCT01663727|11727227|FG001|Overall Study|Lost to Follow-up|8
7442412|NCT01663727|11727226|FG000|Overall Study|Withdrawal by Subject|18
7442413|NCT01663727|11727227|FG001|Overall Study|Withdrawal by Subject|25
7442414|NCT01663727|11727226|FG000|Overall Study|Study Terminated|51
7442415|NCT01663727|11727227|FG001|Overall Study|Study Terminated|50
7442416|NCT01663727|11727226|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
7442417|NCT01663727|11727227|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
7442418|NCT01663727|11727226|FG000|Overall Study|Withdrawal prior to dosing.|1
7442419|NCT01663727|11727227|FG001|Overall Study|Withdrawal prior to dosing.|0
7442420|NCT01663740|11727235|FG000|Overall Study|Lost to Follow-up|1
7442421|NCT01663740|11727236|FG001|Overall Study|Lost to Follow-up|4
7442422|NCT01663740|11727235|FG000|Overall Study|Other|9
7442423|NCT01663740|11727236|FG001|Overall Study|Other|2
7442424|NCT01663740|11727235|FG000|Overall Study|Inclusion/Exclusion not met|1
7442425|NCT01663740|11727236|FG001|Overall Study|Inclusion/Exclusion not met|0
7442426|NCT01663740|11727235|FG000|Overall Study|Death|0
7442427|NCT01663740|11727236|FG001|Overall Study|Death|1
7442428|NCT01663740|11727235|FG000|Overall Study|Withdrawal by Subject|2
7442429|NCT01663740|11727236|FG001|Overall Study|Withdrawal by Subject|1
7442430|NCT01663740|11727235|FG000|Overall Study|No end of study status|3
7442431|NCT01663740|11727236|FG001|Overall Study|No end of study status|0
7442432|NCT01663857|11727255|FG000|Overall Study|Withdrew Consent to Study Participation|0
7442433|NCT01663857|11727256|FG001|Overall Study|Withdrew Consent to Study Participation|1
7442434|NCT01663857|11727257|FG002|Overall Study|Withdrew Consent to Study Participation|7
7442435|NCT01663857|11727258|FG003|Overall Study|Withdrew Consent to Study Participation|3
7442436|NCT01663857|11727255|FG000|Overall Study|Lost to Follow-up|0
7442437|NCT01663857|11727256|FG001|Overall Study|Lost to Follow-up|0
7442438|NCT01663857|11727257|FG002|Overall Study|Lost to Follow-up|3
7442439|NCT01663857|11727258|FG003|Overall Study|Lost to Follow-up|1
7442440|NCT01663896|11727274|FG000|Overall Study|Various reasons|43
7442441|NCT01663987|11727291|FG000|Overall Study|Adverse Event|7
7442442|NCT01663987|11727292|FG001|Overall Study|Adverse Event|2
7442443|NCT01663987|11727291|FG000|Overall Study|Lost to Follow-up|1
7442444|NCT01663987|11727292|FG001|Overall Study|Lost to Follow-up|1
7442445|NCT01663987|11727291|FG000|Overall Study|Withdrawal by Subject|2
7442446|NCT01663987|11727292|FG001|Overall Study|Withdrawal by Subject|3
7442447|NCT01663987|11727291|FG000|Overall Study|Other reason not defined above|3
7442448|NCT01663987|11727292|FG001|Overall Study|Other reason not defined above|0
7442449|NCT01664039|11727300|FG000|Overall Study|Adverse Event|3
7442450|NCT01664039|11727301|FG001|Overall Study|Adverse Event|4
7442451|NCT01664039|11727300|FG000|Overall Study|Lost to Follow-up|1
7442452|NCT01664039|11727301|FG001|Overall Study|Lost to Follow-up|1
7442453|NCT01664039|11727300|FG000|Overall Study|Withdrawal by Subject|1
7442454|NCT01664039|11727301|FG001|Overall Study|Withdrawal by Subject|3
7442455|NCT01664039|11727300|FG000|Overall Study|Noncompliance|1
7442456|NCT01664039|11727301|FG001|Overall Study|Noncompliance|1
7442457|NCT01664052|11727309|FG000|Phase 1|No device placement|6
7442458|NCT01664052|11727310|FG001|Phase 1|No device placement|0
7442459|NCT01664052|11727309|FG000|Phase 1|No HSG 1 hr post placement|1
7442460|NCT01664052|11727310|FG001|Phase 1|No HSG 1 hr post placement|0
7561737|NCT03210961|11930199|FG006|Overall Study|Other|1
7561738|NCT03210961|11930200|FG007|Overall Study|Other|0
7561739|NCT03210961|11930201|FG008|Overall Study|Other|0
7561740|NCT03210961|11930202|FG009|Overall Study|Other|0
7561741|NCT03210961|11930203|FG010|Overall Study|Other|1
7561742|NCT03210961|11930204|FG011|Overall Study|Other|0
7561743|NCT03210961|11930205|FG012|Overall Study|Other|2
7561744|NCT03210961|11930206|FG013|Overall Study|Other|2
7561745|NCT03210961|11930207|FG014|Overall Study|Other|0
7561746|NCT03211156|11930267|FG000|Overall Study|Withdrawal by Subject|0
7561747|NCT03211156|11930268|FG001|Overall Study|Withdrawal by Subject|2
7561748|NCT03211156|11930267|FG000|Overall Study|Lost to Follow-up|1
7561749|NCT03211156|11930268|FG001|Overall Study|Lost to Follow-up|1
7561750|NCT03211156|11930267|FG000|Overall Study|Adverse Event|1
7561751|NCT03211156|11930268|FG001|Overall Study|Adverse Event|0
7561752|NCT03212261|11930287|FG000|Overall Study|Became ineligible d/t tech|2
7561753|NCT03212261|11930287|FG000|Overall Study|Tech Trouble- No first study visit|1
7561754|NCT03212261|11930287|FG000|Overall Study|Lost to Follow-up|7
7561755|NCT03212261|11930287|FG000|Overall Study|Family Emergency|1
7561756|NCT03212261|11930287|FG000|Overall Study|Too busy/ No time|5
7561757|NCT03212326|11930292|FG000|Overall Study|Physician Decision|4
7561758|NCT03212365|11930298|FG000|Overall Study|Discharged prior to Xa level|12
7561759|NCT03212365|11930299|FG001|Overall Study|Discharged prior to Xa level|8
7561760|NCT03212365|11930298|FG000|Overall Study|Bled requiring enoxaparin cessation|4
7561761|NCT03212365|11930299|FG001|Overall Study|Bled requiring enoxaparin cessation|2
7561762|NCT03212365|11930298|FG000|Overall Study|Refused study medication|3
7561763|NCT03212365|11930299|FG001|Overall Study|Refused study medication|0
7561764|NCT03212365|11930298|FG000|Overall Study|Initiated heparin infusion on floor|1
7561765|NCT03212365|11930299|FG001|Overall Study|Initiated heparin infusion on floor|1
7561766|NCT03212365|11930298|FG000|Overall Study|Unexpected return to OR|1
7561767|NCT03212365|11930299|FG001|Overall Study|Unexpected return to OR|1
7561768|NCT03212365|11930298|FG000|Overall Study|Medication distribution error|1
7561769|NCT03212365|11930299|FG001|Overall Study|Medication distribution error|0
7561770|NCT03212365|11930298|FG000|Overall Study|Required epidural placement|1
7561771|NCT03212365|11930299|FG001|Overall Study|Required epidural placement|0
7442461|NCT01664052|11727309|FG000|Phase 2|No device placement|0
7442462|NCT01664052|11727310|FG001|Phase 2|No device placement|4
7442463|NCT01664078|11727317|FG000|Overall Study|Death|9
7442464|NCT01664078|11727317|FG000|Overall Study|Withdrawal by Subject|4
7442465|NCT01664078|11727317|FG000|Overall Study|Lost to Follow-up|2
7442466|NCT01664078|11727317|FG000|Overall Study|missed 5 year visit|1
7442467|NCT01664078|11727317|FG000|Overall Study|Other|53
7442468|NCT01664091|11727367|FG000|Overall Study|Death|1
7442469|NCT01664091|11727367|FG000|Overall Study|Disease Progression|2
7442470|NCT01664091|11727367|FG000|Overall Study|Lost to Follow-up|2
7442471|NCT01664091|11727367|FG000|Overall Study|Withdrawal by Subject|1
7442472|NCT01664104|11727372|FG000|Overall Study|Adverse Event|6
7442473|NCT01664104|11727372|FG000|Overall Study|Lack of Efficacy|2
7442474|NCT01664104|11727372|FG000|Overall Study|Withdrawal by Subject|1
7442475|NCT01664104|11727372|FG000|Overall Study|Lost to Follow-up|4
7442476|NCT01664104|11727372|FG000|Overall Study|Other|1
7442477|NCT01664104|11727372|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
7442478|NCT01664130|11727385|FG000|Overall Study|competing secondary disease|2
7442479|NCT01664247|11727394|FG000|Overall Study|Adverse Event|5
7442480|NCT01664247|11727395|FG001|Overall Study|Adverse Event|3
7442481|NCT01664247|11727394|FG000|Overall Study|Protocol Violation|3
7442482|NCT01664247|11727395|FG001|Overall Study|Protocol Violation|5
7442483|NCT01664247|11727394|FG000|Overall Study|Withdrawal Criteria|1
7442484|NCT01664247|11727395|FG001|Overall Study|Withdrawal Criteria|4
7442485|NCT01664247|11727394|FG000|Overall Study|Unclassified|5
7442486|NCT01664247|11727395|FG001|Overall Study|Unclassified|29
7442487|NCT01664494|11727401|FG000|Overall Study|Withdrawal by Subject|27
7442488|NCT01664494|11727401|FG000|Overall Study|Death|18
7442489|NCT01664494|11727401|FG000|Overall Study|Other|49
7442490|NCT01664494|11727401|FG000|Overall Study|Lost to Follow-up|99
7467518|NCT01901653|11767912|FG007|Overall Study|Death|9
7467519|NCT01901653|11767913|FG008|Overall Study|Death|1
7467520|NCT01901653|11767914|FG009|Overall Study|Death|16
7467521|NCT01901653|11767915|FG010|Overall Study|Death|2
7467522|NCT01901653|11767916|FG011|Overall Study|Death|15
7467523|NCT01901653|11767917|FG012|Overall Study|Death|4
7467524|NCT01901653|11767905|FG000|Overall Study|Lost to Follow-up|1
7467525|NCT01901653|11767906|FG001|Overall Study|Lost to Follow-up|0
7467526|NCT01901653|11767907|FG002|Overall Study|Lost to Follow-up|2
7467527|NCT01901653|11767908|FG003|Overall Study|Lost to Follow-up|0
7561772|NCT03212365|11930298|FG000|Overall Study|Withdrawal by Subject|0
7467528|NCT01901653|11767909|FG004|Overall Study|Lost to Follow-up|0
7561773|NCT03212365|11930299|FG001|Overall Study|Withdrawal by Subject|1
7561774|NCT03212365|11930298|FG000|Overall Study|developed acute renal failure|0
7561775|NCT03212365|11930299|FG001|Overall Study|developed acute renal failure|1
7561776|NCT03212521|11930305|FG000|Overall Study|Adverse Event|1
7467529|NCT01901653|11767910|FG005|Overall Study|Lost to Follow-up|1
7467530|NCT01901653|11767911|FG006|Overall Study|Lost to Follow-up|0
7467531|NCT01901653|11767912|FG007|Overall Study|Lost to Follow-up|1
7467532|NCT01901653|11767913|FG008|Overall Study|Lost to Follow-up|0
7467533|NCT01901653|11767914|FG009|Overall Study|Lost to Follow-up|0
7467534|NCT01901653|11767915|FG010|Overall Study|Lost to Follow-up|0
7467535|NCT01901653|11767916|FG011|Overall Study|Lost to Follow-up|0
7467536|NCT01901653|11767917|FG012|Overall Study|Lost to Follow-up|0
7467537|NCT01901653|11767905|FG000|Overall Study|Withdrawal by Subject|0
7467538|NCT01901653|11767906|FG001|Overall Study|Withdrawal by Subject|0
7467539|NCT01901653|11767907|FG002|Overall Study|Withdrawal by Subject|0
7467540|NCT01901653|11767908|FG003|Overall Study|Withdrawal by Subject|0
7467541|NCT01901653|11767909|FG004|Overall Study|Withdrawal by Subject|0
7467542|NCT01901653|11767910|FG005|Overall Study|Withdrawal by Subject|0
7467543|NCT01901653|11767911|FG006|Overall Study|Withdrawal by Subject|1
7467544|NCT01901653|11767912|FG007|Overall Study|Withdrawal by Subject|0
7467545|NCT01901653|11767913|FG008|Overall Study|Withdrawal by Subject|0
7467546|NCT01901653|11767914|FG009|Overall Study|Withdrawal by Subject|0
7467547|NCT01901653|11767915|FG010|Overall Study|Withdrawal by Subject|0
7467548|NCT01901653|11767916|FG011|Overall Study|Withdrawal by Subject|0
7467549|NCT01901653|11767917|FG012|Overall Study|Withdrawal by Subject|0
7467550|NCT01901653|11767905|FG000|Overall Study|Alive at Study Termination by Sponsor|0
7467551|NCT01901653|11767906|FG001|Overall Study|Alive at Study Termination by Sponsor|0
7467552|NCT01901653|11767907|FG002|Overall Study|Alive at Study Termination by Sponsor|1
7467553|NCT01901653|11767908|FG003|Overall Study|Alive at Study Termination by Sponsor|0
7467554|NCT01901653|11767909|FG004|Overall Study|Alive at Study Termination by Sponsor|0
7467555|NCT01901653|11767910|FG005|Overall Study|Alive at Study Termination by Sponsor|0
7467556|NCT01901653|11767911|FG006|Overall Study|Alive at Study Termination by Sponsor|0
7467557|NCT01901653|11767912|FG007|Overall Study|Alive at Study Termination by Sponsor|0
7467558|NCT01901653|11767913|FG008|Overall Study|Alive at Study Termination by Sponsor|0
7467559|NCT01901653|11767914|FG009|Overall Study|Alive at Study Termination by Sponsor|2
7467560|NCT01901653|11767915|FG010|Overall Study|Alive at Study Termination by Sponsor|0
7561777|NCT03212521|11930305|FG000|Overall Study|Lost to Follow-up|4
7561778|NCT03212521|11930305|FG000|Overall Study|Withdrawal by Subject|1
7561779|NCT03212521|11930305|FG000|Overall Study|Other|1
7467561|NCT01901653|11767916|FG011|Overall Study|Alive at Study Termination by Sponsor|1
7467562|NCT01901653|11767917|FG012|Overall Study|Alive at Study Termination by Sponsor|1
7467563|NCT01901848|11767966|FG000|Randomized and Treated|Lost to Follow-up|3
7467564|NCT01901848|11767967|FG001|Randomized and Treated|Lost to Follow-up|6
7467565|NCT01901848|11767966|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
7561780|NCT03212690|11930327|FG000|Overall Study|Protocol Violation|1
7467566|NCT01901848|11767967|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
7467567|NCT01901874|11767973|FG000|Screening Committee Retrospective Review|Protocol Violation|47
7467568|NCT01901874|11767973|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
7467569|NCT01901874|11767973|FG000|1-Year (365-Day) MAE Evaluation|Death|7
7467570|NCT01901874|11767973|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
7561781|NCT03213210|11930331|FG000|Overall Study|Lost to Follow-up|2
7561782|NCT03213210|11930331|FG000|Overall Study|Study termination|3
7561783|NCT03213366|11930337|FG000|Overall Study|Lost to Follow-up|9
7442491|NCT01664533|11727405|FG000|Overall Study|Death|42
7442492|NCT01664533|11727405|FG000|Overall Study|Lost to Follow-up|3
7442493|NCT01664533|11727405|FG000|Overall Study|Study termination|9
7442494|NCT01664533|11727405|FG000|Overall Study|Protocol Violation|3
7442495|NCT01664624|11727423|FG000|Overall Study|Adverse Event|0
7442496|NCT01664624|11727424|FG001|Overall Study|Adverse Event|1
7442497|NCT01664624|11727425|FG002|Overall Study|Adverse Event|0
7442498|NCT01664624|11727426|FG003|Overall Study|Adverse Event|0
7442499|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Death|8
7442500|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Death|6
7442501|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
7442502|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
7442503|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
7442504|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
7442505|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
7442506|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
7442507|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
7442508|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
7442509|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
7442510|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
7442511|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Other|3
7442512|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Other|4
7442513|NCT01664923|11727490|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
7442514|NCT01664923|11727491|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
7442515|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|Death|3
7442516|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|Death|1
7442517|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
7442518|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
7442519|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
7442520|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
7442521|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|Other|3
7442522|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|Other|1
7442523|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
7442524|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
7442525|NCT01664923|11727490|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
7442526|NCT01664923|11727491|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
7442527|NCT01664949|11727503|FG000|Overall Study|Adverse Event|11
7442528|NCT01664949|11727504|FG001|Overall Study|Adverse Event|12
7442529|NCT01664949|11727503|FG000|Overall Study|Lack of Efficacy|1
7442530|NCT01664949|11727504|FG001|Overall Study|Lack of Efficacy|1
7442531|NCT01664949|11727503|FG000|Overall Study|Lost to Follow-up|1
7442532|NCT01664949|11727504|FG001|Overall Study|Lost to Follow-up|2
7442533|NCT01664949|11727503|FG000|Overall Study|Personal Reasons|3
7442534|NCT01664949|11727504|FG001|Overall Study|Personal Reasons|4
7442535|NCT01664949|11727503|FG000|Overall Study|Protocol Violation|5
7442536|NCT01664949|11727504|FG001|Overall Study|Protocol Violation|5
7442537|NCT01664949|11727503|FG000|Overall Study|Other Miscellaneous Reasons|3
7442538|NCT01664949|11727504|FG001|Overall Study|Other Miscellaneous Reasons|1
7442539|NCT01665430|11727578|FG000|Overall Study|Adverse Event|1
7442540|NCT01665430|11727578|FG000|Overall Study|Withdrawal by Subject|6
7442541|NCT01665430|11727578|FG000|Overall Study|Other Unspecified|2
7442542|NCT01665599|11727591|FG000|Overall Study|Adverse Event|1
7442543|NCT01665599|11727591|FG000|Overall Study|Consent Withdrawn|1
7442544|NCT01665599|11727591|FG000|Overall Study|Investigator/Sponsor decision|1
7442545|NCT01665599|11727591|FG000|Overall Study|Death|1
7442546|NCT01665599|11727591|FG000|Overall Study|Lost to Follow-up|2
7442547|NCT01665599|11727591|FG000|Overall Study|Participant Left for More Than 3 Months|1
7442548|NCT01665599|11727591|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
7442549|NCT01665768|11727595|FG000|Overall Study|Adverse Event|3
7442550|NCT01665768|11727595|FG000|Overall Study|Lack of Efficacy|19
7442551|NCT01665768|11727595|FG000|Overall Study|Withdrawal by Subject|1
7442552|NCT01665807|11727602|FG000|Overall Study|Withdrawal by Subject|2
7442553|NCT01665807|11727603|FG001|Overall Study|Withdrawal by Subject|0
7442554|NCT01665807|11727604|FG002|Overall Study|Withdrawal by Subject|1
7442555|NCT01665911|11727621|FG000|Overall Study|Protocol Violation|4
7442556|NCT01665911|11727621|FG000|Overall Study|Withdrawal by Subject|1
7442557|NCT01665911|11727621|FG000|Overall Study|Adverse Event|1
7442558|NCT01666002|11727641|FG000|Overall Study|Lost to Follow-up|5
7561784|NCT03213366|11930338|FG001|Overall Study|Lost to Follow-up|4
7561785|NCT03213509|11930363|FG000|Overall Study|Did not consent for verbal autopsy|4
7561786|NCT03213509|11930364|FG001|Overall Study|Did not consent for verbal autopsy|5
7561787|NCT03213626|11930371|FG000|Overall Study|Adverse Event|1
7561788|NCT03213626|11930371|FG000|Overall Study|Progressive Disease|6
7442559|NCT01666002|11727642|FG001|Overall Study|Lost to Follow-up|0
7442560|NCT01666119|11727649|FG000|Overall Study|Adverse Event|6
7442561|NCT01666119|11727649|FG000|Overall Study|Withdrawal by Subject|16
7442562|NCT01666119|11727649|FG000|Overall Study|Lost to Follow-up|7
7442563|NCT01666119|11727649|FG000|Overall Study|non compliance with study medication, pa|18
7442564|NCT01666119|11727649|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
7442565|NCT01666314|11727679|FG000|Overall Study|Adverse Event|3
7442566|NCT01666314|11727680|FG001|Overall Study|Adverse Event|13
7442567|NCT01666314|11727681|FG002|Overall Study|Adverse Event|7
7442568|NCT01666314|11727682|FG003|Overall Study|Adverse Event|7
7442569|NCT01666314|11727679|FG000|Overall Study|Progressive Disease|11
7442570|NCT01666314|11727680|FG001|Overall Study|Progressive Disease|9
7442571|NCT01666314|11727681|FG002|Overall Study|Progressive Disease|19
7442572|NCT01666314|11727682|FG003|Overall Study|Progressive Disease|20
7442573|NCT01666314|11727679|FG000|Overall Study|Symptomatic Deterioration|1
7442574|NCT01666314|11727680|FG001|Overall Study|Symptomatic Deterioration|0
7442575|NCT01666314|11727681|FG002|Overall Study|Symptomatic Deterioration|2
7442576|NCT01666314|11727682|FG003|Overall Study|Symptomatic Deterioration|0
7442577|NCT01666314|11727679|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
7442578|NCT01666314|11727680|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
7442579|NCT01666314|11727681|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
7442580|NCT01666314|11727682|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
7442581|NCT01666314|11727679|FG000|Overall Study|Withdrawal by Subject|1
7442582|NCT01666314|11727680|FG001|Overall Study|Withdrawal by Subject|1
7442583|NCT01666314|11727681|FG002|Overall Study|Withdrawal by Subject|2
7442584|NCT01666314|11727682|FG003|Overall Study|Withdrawal by Subject|3
7442585|NCT01666314|11727679|FG000|Overall Study|Reason not Specified|10
7442586|NCT01666314|11727680|FG001|Overall Study|Reason not Specified|7
7442587|NCT01666314|11727681|FG002|Overall Study|Reason not Specified|5
7442588|NCT01666314|11727682|FG003|Overall Study|Reason not Specified|5
7442589|NCT01666444|11727705|FG000|Overall Study|Did not initiate treatment|2
7442590|NCT01666444|11727706|FG001|Overall Study|Did not initiate treatment|1
7442591|NCT01666652|11727717|FG000|Overall Study|Serious Adverse Event|0
7442592|NCT01666652|11727718|FG001|Overall Study|Serious Adverse Event|0
7442593|NCT01666652|11727719|FG002|Overall Study|Serious Adverse Event|0
7442594|NCT01666652|11727720|FG003|Overall Study|Serious Adverse Event|1
7442595|NCT01666652|11727721|FG004|Overall Study|Serious Adverse Event|0
7442596|NCT01666652|11727717|FG000|Overall Study|Withdrawal by Subject|0
7442597|NCT01666652|11727718|FG001|Overall Study|Withdrawal by Subject|0
7442598|NCT01666652|11727719|FG002|Overall Study|Withdrawal by Subject|0
7442599|NCT01666652|11727720|FG003|Overall Study|Withdrawal by Subject|0
7442600|NCT01666652|11727721|FG004|Overall Study|Withdrawal by Subject|1
7442601|NCT01666652|11727717|FG000|Overall Study|Moved from study area|1
7442602|NCT01666652|11727718|FG001|Overall Study|Moved from study area|0
7442603|NCT01666652|11727719|FG002|Overall Study|Moved from study area|0
7442604|NCT01666652|11727720|FG003|Overall Study|Moved from study area|2
7442605|NCT01666652|11727721|FG004|Overall Study|Moved from study area|0
7442606|NCT01666652|11727717|FG000|Overall Study|Lost to Follow-up|1
7442607|NCT01666652|11727718|FG001|Overall Study|Lost to Follow-up|1
7442608|NCT01666652|11727719|FG002|Overall Study|Lost to Follow-up|1
7442609|NCT01666652|11727720|FG003|Overall Study|Lost to Follow-up|1
7442610|NCT01666652|11727721|FG004|Overall Study|Lost to Follow-up|0
7442611|NCT01666730|11727733|FG000|Overall Study|Adverse Event|16
7442612|NCT01666730|11727733|FG000|Overall Study|Death|2
7442613|NCT01666730|11727733|FG000|Overall Study|Physician Decision|5
7442614|NCT01666730|11727733|FG000|Overall Study|Withdrawal by Subject|9
7442615|NCT01666730|11727733|FG000|Overall Study|Disease progression/relapse|18
7442616|NCT01666782|11727739|FG000|Overall Study|Received 2 doses of vaccine|0
7442617|NCT01666782|11727740|FG001|Overall Study|Received 2 doses of vaccine|1
7442618|NCT01666782|11727739|FG000|Overall Study|Enrolled both years; year 1 data used|4
7442619|NCT01666782|11727740|FG001|Overall Study|Enrolled both years; year 1 data used|0
7442620|NCT01666951|11727757|FG000|Overall Study|Not dosed|1
7442621|NCT01666951|11727758|FG001|Overall Study|Not dosed|1
7442622|NCT01667107|11727773|FG000|Overall Study|Adverse Event|4
7442623|NCT01667107|11727774|FG001|Overall Study|Adverse Event|3
7442624|NCT01667107|11727773|FG000|Overall Study|Tolerability issues|0
7442625|NCT01667107|11727774|FG001|Overall Study|Tolerability issues|2
7442626|NCT01667107|11727773|FG000|Overall Study|Protocol Violation|0
7442627|NCT01667107|11727774|FG001|Overall Study|Protocol Violation|1
7442628|NCT01667107|11727773|FG000|Overall Study|Lack of Efficacy|0
7442629|NCT01667107|11727774|FG001|Overall Study|Lack of Efficacy|1
7442630|NCT01667224|11727782|FG000|Overall Study|Withdrawal by Subject|3
7442631|NCT01667224|11727783|FG001|Overall Study|Withdrawal by Subject|1
7442632|NCT01667224|11727782|FG000|Overall Study|Protocol Violation|1
7442633|NCT01667224|11727783|FG001|Overall Study|Protocol Violation|1
7442634|NCT01667419|11727877|FG000|Overall Study|Reason Not Specified|1
7442635|NCT01667419|11727878|FG001|Overall Study|Reason Not Specified|0
7442636|NCT01667419|11727879|FG002|Overall Study|Reason Not Specified|0
7442637|NCT01667419|11727880|FG003|Overall Study|Reason Not Specified|0
7442638|NCT01667419|11727877|FG000|Overall Study|Withdrawal by Subject|16
7442639|NCT01667419|11727878|FG001|Overall Study|Withdrawal by Subject|8
7442640|NCT01667419|11727879|FG002|Overall Study|Withdrawal by Subject|9
7442641|NCT01667419|11727880|FG003|Overall Study|Withdrawal by Subject|8
7442642|NCT01667419|11727877|FG000|Overall Study|Non-compliance|0
7442643|NCT01667419|11727878|FG001|Overall Study|Non-compliance|0
7442644|NCT01667419|11727879|FG002|Overall Study|Non-compliance|0
7442645|NCT01667419|11727880|FG003|Overall Study|Non-compliance|1
7442646|NCT01667419|11727877|FG000|Overall Study|Protocol Violation|1
7442647|NCT01667419|11727878|FG001|Overall Study|Protocol Violation|0
7442648|NCT01667419|11727879|FG002|Overall Study|Protocol Violation|0
7442649|NCT01667419|11727880|FG003|Overall Study|Protocol Violation|0
7442650|NCT01667419|11727877|FG000|Overall Study|Lost to Follow-up|7
7442651|NCT01667419|11727878|FG001|Overall Study|Lost to Follow-up|6
7442652|NCT01667419|11727879|FG002|Overall Study|Lost to Follow-up|2
7442653|NCT01667419|11727880|FG003|Overall Study|Lost to Follow-up|4
7442654|NCT01667419|11727877|FG000|Overall Study|Death|18
7442655|NCT01667419|11727878|FG001|Overall Study|Death|33
7442656|NCT01667419|11727879|FG002|Overall Study|Death|25
7442657|NCT01667419|11727880|FG003|Overall Study|Death|26
7442658|NCT01667432|11727891|FG000|Overall Study|Premature Study Termination|26
7442659|NCT01667432|11727891|FG000|Overall Study|Failure to Return|10
7442660|NCT01667432|11727891|FG000|Overall Study|Moved to Another Center|3
7442661|NCT01667432|11727891|FG000|Overall Study|Lost to Follow-up|3
7442662|NCT01667432|11727891|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
7442663|NCT01667432|11727891|FG000|Overall Study|Insufficient Therapeutic Response|4
7442664|NCT01667432|11727891|FG000|Overall Study|Adverse Event|1
7442665|NCT01667432|11727891|FG000|Overall Study|Protocol Deviation|2
7442666|NCT01667432|11727891|FG000|Overall Study|Principal Investigator Decision|1
7442667|NCT01667432|11727891|FG000|Overall Study|Reason Not Specified|2
7442668|NCT01667432|11727891|FG000|Overall Study|Missing Information|4
7442669|NCT01667549|11727912|FG000|Overall Study|Withdrawal by Subject|3
7442670|NCT01667549|11727913|FG001|Overall Study|Withdrawal by Subject|5
7442671|NCT01667549|11727914|FG002|Overall Study|Withdrawal by Subject|7
7442672|NCT01667549|11727915|FG003|Overall Study|Withdrawal by Subject|6
7442673|NCT01667549|11727916|FG004|Overall Study|Withdrawal by Subject|1
7442674|NCT01667562|11727933|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
7442675|NCT01667562|11727934|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
7442676|NCT01667562|11727933|FG000|Erlotinib Phase|Lost to Follow-up|0
7442677|NCT01667562|11727934|FG001|Erlotinib Phase|Lost to Follow-up|1
7442678|NCT01667562|11727933|FG000|Erlotinib Phase|Adverse Event|0
7442679|NCT01667562|11727934|FG001|Erlotinib Phase|Adverse Event|1
7442680|NCT01667562|11727933|FG000|Erlotinib Phase|Switch to Commercial Drug|0
7442681|NCT01667562|11727934|FG001|Erlotinib Phase|Switch to Commercial Drug|1
7442682|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
7442683|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
7442684|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
7442685|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
7442686|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
7442687|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
7442688|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
7442689|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
7442690|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
7442691|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
7442692|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7442693|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
7442694|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
7442695|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
7442696|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
7442697|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
7442698|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
7442699|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
7442700|NCT01667679|11727941|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
7442701|NCT01667679|11727942|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
7442702|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
7442703|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
7442704|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
7442705|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
7442706|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
7442707|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
7442708|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
7442709|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
7442710|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
7442711|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
7442712|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
7442713|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
7442714|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
7442715|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
7442716|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
7442717|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
7442718|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
7442719|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
7468732|NCT01914393|11769701|FG001|Overall Study|no reason given|8
7442720|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
7442721|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
7442722|NCT01667679|11727941|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
7442723|NCT01667679|11727942|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
7442724|NCT01667731|11727955|FG000|Overall Study|Enrolled but not treated|0
7442725|NCT01667731|11727956|FG001|Overall Study|Enrolled but not treated|0
7442726|NCT01667731|11727957|FG002|Overall Study|Enrolled but not treated|0
7442727|NCT01667731|11727958|FG003|Overall Study|Enrolled but not treated|0
7442728|NCT01667731|11727959|FG004|Overall Study|Enrolled but not treated|1
7442729|NCT01667731|11727955|FG000|Overall Study|Efficacy Failure|1
7442730|NCT01667731|11727956|FG001|Overall Study|Efficacy Failure|12
7442731|NCT01667731|11727957|FG002|Overall Study|Efficacy Failure|0
7442732|NCT01667731|11727958|FG003|Overall Study|Efficacy Failure|1
7442733|NCT01667731|11727959|FG004|Overall Study|Efficacy Failure|24
7442734|NCT01667731|11727955|FG000|Overall Study|Lost to Follow-up|2
7442735|NCT01667731|11727956|FG001|Overall Study|Lost to Follow-up|3
7442736|NCT01667731|11727957|FG002|Overall Study|Lost to Follow-up|1
7442737|NCT01667731|11727958|FG003|Overall Study|Lost to Follow-up|1
7442738|NCT01667731|11727959|FG004|Overall Study|Lost to Follow-up|2
7442739|NCT01667731|11727955|FG000|Overall Study|Subject Withdrew Consent|2
7442740|NCT01667731|11727956|FG001|Overall Study|Subject Withdrew Consent|0
7442741|NCT01667731|11727957|FG002|Overall Study|Subject Withdrew Consent|1
7442742|NCT01667731|11727958|FG003|Overall Study|Subject Withdrew Consent|0
7442743|NCT01667731|11727959|FG004|Overall Study|Subject Withdrew Consent|1
7442744|NCT01667731|11727955|FG000|Overall Study|Death|0
7442745|NCT01667731|11727956|FG001|Overall Study|Death|1
7442746|NCT01667731|11727957|FG002|Overall Study|Death|0
7442747|NCT01667731|11727958|FG003|Overall Study|Death|0
7442748|NCT01667731|11727959|FG004|Overall Study|Death|0
7442749|NCT01667900|11727999|FG000|Part B|Death|0
7442750|NCT01667900|11728000|FG001|Part B|Death|0
7442751|NCT01667900|11728001|FG002|Part B|Death|0
7442752|NCT01667900|11728002|FG003|Part B|Death|0
7442753|NCT01667900|11728003|FG004|Part B|Death|0
7442754|NCT01667900|11728004|FG005|Part B|Death|0
7442755|NCT01667900|11728005|FG006|Part B|Death|0
7442756|NCT01667900|11728006|FG007|Part B|Death|0
7442757|NCT01667900|11728007|FG008|Part B|Death|0
7442758|NCT01667900|11728008|FG009|Part B|Death|0
7442759|NCT01667900|11728009|FG010|Part B|Death|0
7442760|NCT01667900|11728010|FG011|Part B|Death|0
7442761|NCT01667900|11728011|FG012|Part B|Death|0
7442762|NCT01667900|11728012|FG013|Part B|Death|0
7442763|NCT01667900|11728013|FG014|Part B|Death|0
7442764|NCT01667900|11728014|FG015|Part B|Death|0
7442765|NCT01667900|11728015|FG016|Part B|Death|1
7442766|NCT01667900|11728016|FG017|Part B|Death|0
7442767|NCT01667900|11728017|FG018|Part B|Death|0
7442768|NCT01667900|11728018|FG019|Part B|Death|0
7442769|NCT01667926|11728040|FG000|Overall Study|Withdrawal by Subject|1
7442770|NCT01667926|11728041|FG001|Overall Study|Withdrawal by Subject|2
7442771|NCT01667926|11728042|FG002|Overall Study|Withdrawal by Subject|2
7442772|NCT01667926|11728040|FG000|Overall Study|Physician Decision|0
7442773|NCT01667926|11728041|FG001|Overall Study|Physician Decision|0
7442774|NCT01667926|11728042|FG002|Overall Study|Physician Decision|1
7442775|NCT01667926|11728040|FG000|Overall Study|Time committment|0
7442776|NCT01667926|11728041|FG001|Overall Study|Time committment|0
7442777|NCT01667926|11728042|FG002|Overall Study|Time committment|2
7442778|NCT01667926|11728040|FG000|Overall Study|Inclusion/Exclusion Criteria|0
7442779|NCT01667926|11728041|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7442780|NCT01667926|11728042|FG002|Overall Study|Inclusion/Exclusion Criteria|5
7442781|NCT01667926|11728040|FG000|Overall Study|Lost to Follow-up|1
7442782|NCT01667926|11728041|FG001|Overall Study|Lost to Follow-up|2
7442783|NCT01667926|11728042|FG002|Overall Study|Lost to Follow-up|1
7442784|NCT01667926|11728040|FG000|Overall Study|Side effects|3
7442785|NCT01667926|11728041|FG001|Overall Study|Side effects|0
7442786|NCT01667926|11728042|FG002|Overall Study|Side effects|0
7442787|NCT01668004|11728057|FG000|Overall Study|Adverse Event|7
7442788|NCT01668004|11728057|FG000|Overall Study|Withdrawal by Subject|2
7442789|NCT01668004|11728057|FG000|Overall Study|Lost to Follow-up|5
7442790|NCT01668004|11728057|FG000|Overall Study|Lack of Efficacy|9
7442791|NCT01668004|11728057|FG000|Overall Study|Non-compliance with treatment|2
7442792|NCT01668173|11728105|FG000|Overall Study|Adverse Event|3
7442793|NCT01668173|11728105|FG000|Overall Study|Trial suspension|4
7442794|NCT01668355|11728111|FG000|Overall Study|Death|3
7442795|NCT01668355|11728112|FG001|Overall Study|Death|1
7442796|NCT01668355|11728111|FG000|Overall Study|Withdrawal by Subject|6
7442797|NCT01668355|11728112|FG001|Overall Study|Withdrawal by Subject|1
7442798|NCT01668537|11728121|FG000|Overall Study|Request to Discontinue Prematurely|1
7442799|NCT01668537|11728122|FG001|Overall Study|Request to Discontinue Prematurely|1
7442800|NCT01668537|11728121|FG000|Overall Study|Subject unwilling/unable to comply|5
7442801|NCT01668537|11728122|FG001|Overall Study|Subject unwilling/unable to comply|0
7442802|NCT01668537|11728121|FG000|Overall Study|Reason Precludes Participation|1
7442803|NCT01668537|11728122|FG001|Overall Study|Reason Precludes Participation|0
7442804|NCT01668537|11728121|FG000|Overall Study|Lost to Follow-up|13
7442805|NCT01668537|11728122|FG001|Overall Study|Lost to Follow-up|6
7442806|NCT01668537|11728121|FG000|Overall Study|Other|2
7442807|NCT01668537|11728122|FG001|Overall Study|Other|3
7442808|NCT01668589|11728132|FG000|Overall Study|Lost to Follow-up|29
7442809|NCT01668589|11728133|FG001|Overall Study|Lost to Follow-up|37
7442810|NCT01668589|11728134|FG002|Overall Study|Lost to Follow-up|15
7442811|NCT01668589|11728135|FG003|Overall Study|Lost to Follow-up|5
7442812|NCT01668589|11728132|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
7442813|NCT01668589|11728133|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
7442814|NCT01668589|11728134|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
7442815|NCT01668589|11728135|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
7442816|NCT01668589|11728132|FG000|Overall Study|Death|12
7442817|NCT01668589|11728133|FG001|Overall Study|Death|3
7442818|NCT01668589|11728134|FG002|Overall Study|Death|2
7442819|NCT01668589|11728135|FG003|Overall Study|Death|11
7442820|NCT01668589|11728132|FG000|Overall Study|Other|44
7442821|NCT01668589|11728133|FG001|Overall Study|Other|10
7442822|NCT01668589|11728134|FG002|Overall Study|Other|7
7442823|NCT01668589|11728135|FG003|Overall Study|Other|15
7442824|NCT01668654|11728173|FG000|Overall Study|Study Closed/Terminated|3
7442825|NCT01668654|11728173|FG000|Overall Study|Withdrawal by Subject|1
7442826|NCT01668667|11728181|FG000|Overall Study|Adverse Event|3
7442827|NCT01668667|11728182|FG001|Overall Study|Adverse Event|6
7442828|NCT01668667|11728183|FG002|Overall Study|Adverse Event|4
7442829|NCT01668667|11728184|FG003|Overall Study|Adverse Event|4
7442830|NCT01668667|11728181|FG000|Overall Study|Lack of Efficacy|3
7442831|NCT01668667|11728182|FG001|Overall Study|Lack of Efficacy|2
7442832|NCT01668667|11728183|FG002|Overall Study|Lack of Efficacy|2
7442833|NCT01668667|11728184|FG003|Overall Study|Lack of Efficacy|3
7442834|NCT01668667|11728181|FG000|Overall Study|Protocol Violation|6
7442835|NCT01668667|11728182|FG001|Overall Study|Protocol Violation|10
7442836|NCT01668667|11728183|FG002|Overall Study|Protocol Violation|12
7442837|NCT01668667|11728184|FG003|Overall Study|Protocol Violation|5
7442838|NCT01668667|11728181|FG000|Overall Study|Lost to Follow-up|9
7442839|NCT01668667|11728182|FG001|Overall Study|Lost to Follow-up|4
7442840|NCT01668667|11728183|FG002|Overall Study|Lost to Follow-up|7
7442841|NCT01668667|11728184|FG003|Overall Study|Lost to Follow-up|6
7442842|NCT01668667|11728181|FG000|Overall Study|Physician Decision|3
7442843|NCT01668667|11728182|FG001|Overall Study|Physician Decision|0
7442844|NCT01668667|11728183|FG002|Overall Study|Physician Decision|1
7442845|NCT01668667|11728184|FG003|Overall Study|Physician Decision|0
7442846|NCT01668667|11728181|FG000|Overall Study|Withdrawal by Subject|7
7442847|NCT01668667|11728182|FG001|Overall Study|Withdrawal by Subject|4
7442848|NCT01668667|11728183|FG002|Overall Study|Withdrawal by Subject|5
7442849|NCT01668667|11728184|FG003|Overall Study|Withdrawal by Subject|5
7442850|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
7442851|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
7442852|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
7442853|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
7442854|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
7442855|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7442856|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7442857|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
7442858|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Physician Decision|2
7442859|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Physician Decision|0
7442860|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Physician Decision|0
7442861|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Physician Decision|0
7442862|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
7442863|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
7442864|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
7442865|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
7442866|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Protocol Violation|2
7442867|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Protocol Violation|0
7442868|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Protocol Violation|0
7442869|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Protocol Violation|0
7442870|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
7442871|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
7442872|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
7442873|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
7442874|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
7442875|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7442876|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7442877|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
7442878|NCT01668797|11728196|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
7442879|NCT01668797|11728197|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7442880|NCT01668797|11728198|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7442881|NCT01668797|11728199|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
7442882|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
7442883|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
7442884|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
7442885|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
7561797|NCT03214081|11930384|FG000|Overall Study|Case Report Forms Uncollected|9
7561798|NCT03214081|11930384|FG000|Overall Study|Protocol Deviation|54
7561799|NCT03214094|11930388|FG000|Overall Study|Case Report Forms Uncollected|14
7561800|NCT03214094|11930388|FG000|Overall Study|Protocol Deviation|46
7561801|NCT03214198|11930392|FG000|Overall Study|Case Report Forms Uncollected|18
7561802|NCT03214198|11930392|FG000|Overall Study|Protocol Deviation|18
7561803|NCT03214224|11930396|FG000|Overall Study|Protocol Violation|1
7561804|NCT03214224|11930396|FG000|Overall Study|Withdrawal by Subject|2
7561805|NCT03214224|11930396|FG000|Overall Study|Practice controls or therapists|6
7561806|NCT03214367|11930406|FG000|Lead-in Period|Withdrawal by Subject|50
7561807|NCT03214367|11930407|FG001|Lead-in Period|Withdrawal by Subject|0
7561808|NCT03214367|11930408|FG002|Lead-in Period|Withdrawal by Subject|0
7442886|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7442887|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
7442888|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7442889|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
7442890|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Physician Decision|0
7442891|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Physician Decision|11
7442892|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Physician Decision|0
7442893|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Physician Decision|0
7442894|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7442895|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
7442896|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7442897|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
7442898|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
7442899|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
7442900|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
7442901|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
7442902|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
7442903|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
7442904|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
7442905|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
7442906|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7442907|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
7442908|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7442909|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
7442910|NCT01668797|11728196|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7442911|NCT01668797|11728197|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
7442912|NCT01668797|11728198|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7442913|NCT01668797|11728199|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
7442914|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7442915|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
7442916|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
7442917|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
7442918|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7442919|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
7442920|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7442921|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
7442922|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7442923|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
7442924|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
7442925|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
7442926|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7442927|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
7442928|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
7442929|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
7442930|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7442931|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7442932|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
7442933|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
7442934|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7561809|NCT03214367|11930409|FG003|Lead-in Period|Withdrawal by Subject|0
7561810|NCT03214367|11930410|FG004|Lead-in Period|Withdrawal by Subject|2
7561811|NCT03214367|11930411|FG005|Lead-in Period|Withdrawal by Subject|0
7561812|NCT03214367|11930412|FG006|Lead-in Period|Withdrawal by Subject|0
7442935|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
7443014|NCT01670279|11728449|FG003|Overall Study|Adverse Event|0
7442936|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
7442937|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
7442938|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7442939|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
7442940|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
7442941|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
7442942|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7442943|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
7442944|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
7442945|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
7442946|NCT01668797|11728196|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7442947|NCT01668797|11728197|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
7442948|NCT01668797|11728198|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
7442949|NCT01668797|11728199|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
7442950|NCT01668966|11728229|FG000|Overall Study|Withdrawal by Subject|1
7442951|NCT01668966|11728229|FG000|Overall Study|Death|1
7442952|NCT01668966|11728229|FG000|Overall Study|Not treated|2
7442953|NCT01669122|11728237|FG000|Period I|Lost to Follow-up|1
7442954|NCT01669122|11728237|FG000|Washout Period II|Protocol Violation|2
7442955|NCT01669174|11728250|FG000|Overall Study|Subject withdrew consent|2
7442956|NCT01669174|11728251|FG001|Overall Study|Subject withdrew consent|2
7442957|NCT01669174|11728250|FG000|Overall Study|Lost to Follow-up|1
7442958|NCT01669174|11728251|FG001|Overall Study|Lost to Follow-up|0
7442959|NCT01669174|11728250|FG000|Overall Study|Adverse Event|2
7442960|NCT01669174|11728251|FG001|Overall Study|Adverse Event|2
7442961|NCT01669174|11728250|FG000|Overall Study|Administrative problems|1
7442962|NCT01669174|11728251|FG001|Overall Study|Administrative problems|2
7442963|NCT01669343|11728257|FG000|Part A: All Patients|Withdrawal by Subject|7
7442964|NCT01669343|11728257|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
7442965|NCT01669343|11728257|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
7442966|NCT01669343|11728257|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
7442967|NCT01669343|11728257|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
7442968|NCT01669421|11728264|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
7442969|NCT01669421|11728264|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
7442970|NCT01669577|11728296|FG000|Overall Study|Death|22
7442971|NCT01669577|11728296|FG000|Overall Study|Lost to Follow-up|78
7442972|NCT01669577|11728296|FG000|Overall Study|Physician Decision|34
7442973|NCT01669629|11728309|FG000|Period 1|protocol deviation|1
7442974|NCT01669629|11728310|FG001|Period 1|protocol deviation|2
7442975|NCT01669798|11728366|FG000|Overall Study|Physician Decision|5
7442976|NCT01669811|11728372|FG000|Overall Study|Investigator decision|0
7442977|NCT01669811|11728373|FG001|Overall Study|Investigator decision|1
7442978|NCT01669811|11728372|FG000|Overall Study|Withdrawal by Subject|1
7442979|NCT01669811|11728373|FG001|Overall Study|Withdrawal by Subject|2
7442980|NCT01669811|11728372|FG000|Overall Study|Adverse Event|2
7442981|NCT01669811|11728373|FG001|Overall Study|Adverse Event|6
7442982|NCT01669811|11728372|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
7442983|NCT01669811|11728373|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
7442984|NCT01669902|11728384|FG000|Overall Study|Adverse Event|11
7442985|NCT01669902|11728384|FG000|Overall Study|Lack of Efficacy|10
7442986|NCT01669902|11728384|FG000|Overall Study|Other|8
7442987|NCT01669928|11728390|FG000|First Intervention|Withdrawal by Subject|3
7442988|NCT01669928|11728391|FG001|First Intervention|Withdrawal by Subject|5
7442989|NCT01670019|11728401|FG000|Overall Study|Adverse Event|3
7442990|NCT01670019|11728402|FG001|Overall Study|Adverse Event|0
7442991|NCT01670019|11728401|FG000|Overall Study|Withdrawal by Subject|6
7442992|NCT01670019|11728402|FG001|Overall Study|Withdrawal by Subject|0
7442993|NCT01670045|11728408|FG000|Overall Study|Withdrawal by Subject|3
7442994|NCT01670045|11728408|FG000|Overall Study|Adverse Event|1
7442995|NCT01670045|11728408|FG000|Overall Study|Death|1
7442996|NCT01670045|11728408|FG000|Overall Study|Lost to Follow-up|11
7442997|NCT01670097|11728414|FG000|Overall Study|Started Phase 1 cancer treatment|1
7442998|NCT01670097|11728415|FG001|Overall Study|Started Phase 1 cancer treatment|0
7442999|NCT01670097|11728414|FG000|Overall Study|Study burden|1
7443000|NCT01670097|11728415|FG001|Overall Study|Study burden|0
7443001|NCT01670097|11728414|FG000|Overall Study|COPD exacerbation|0
7443002|NCT01670097|11728415|FG001|Overall Study|COPD exacerbation|1
7443003|NCT01670097|11728414|FG000|Overall Study|Neutropenia|0
7443004|NCT01670097|11728415|FG001|Overall Study|Neutropenia|1
7443005|NCT01670097|11728414|FG000|Overall Study|Clinical deterioration|0
7443006|NCT01670097|11728415|FG001|Overall Study|Clinical deterioration|1
7443007|NCT01670097|11728414|FG000|Overall Study|Disease progression|0
7443008|NCT01670097|11728415|FG001|Overall Study|Disease progression|1
7443009|NCT01670188|11728432|FG000|Overall Study|Death|0
7443010|NCT01670188|11728433|FG001|Overall Study|Death|1
7443011|NCT01670279|11728446|FG000|Overall Study|Adverse Event|0
7443012|NCT01670279|11728447|FG001|Overall Study|Adverse Event|1
7443013|NCT01670279|11728448|FG002|Overall Study|Adverse Event|0
7443015|NCT01670279|11728446|FG000|Overall Study|Physician Decision|0
7443016|NCT01670279|11728447|FG001|Overall Study|Physician Decision|1
7443017|NCT01670279|11728448|FG002|Overall Study|Physician Decision|0
7443018|NCT01670279|11728449|FG003|Overall Study|Physician Decision|0
7443019|NCT01670279|11728446|FG000|Overall Study|Participant met withdrawal criteria|0
7443020|NCT01670279|11728447|FG001|Overall Study|Participant met withdrawal criteria|0
7443021|NCT01670279|11728448|FG002|Overall Study|Participant met withdrawal criteria|0
7443022|NCT01670279|11728449|FG003|Overall Study|Participant met withdrawal criteria|1
7443023|NCT01670292|11728457|FG000|Overall Study|Lost to Follow-up|14
7443024|NCT01670526|11728480|FG000|Overall Study|Withdrawal by Subject|3
7443025|NCT01670526|11728481|FG001|Overall Study|Withdrawal by Subject|1
7443026|NCT01670526|11728480|FG000|Overall Study|Lost to Follow-up|9
7443027|NCT01670526|11728481|FG001|Overall Study|Lost to Follow-up|5
7443028|NCT01670721|11728487|FG000|Overall Study|Participant's decision|15
7443029|NCT01670721|11728487|FG000|Overall Study|Other than specified above|38
7443030|NCT01671007|11728515|FG000|Overall Study|Other reasons than listed|166
7443031|NCT01671007|11728516|FG001|Overall Study|Other reasons than listed|373
7443032|NCT01671007|11728517|FG002|Overall Study|Other reasons than listed|197
7443033|NCT01671007|11728518|FG003|Overall Study|Other reasons than listed|228
7443034|NCT01671007|11728519|FG004|Overall Study|Other reasons than listed|14
7443035|NCT01671007|11728520|FG005|Overall Study|Other reasons than listed|71
7443036|NCT01671007|11728521|FG006|Overall Study|Other reasons than listed|17
7443037|NCT01671007|11728522|FG007|Overall Study|Other reasons than listed|66
7443038|NCT01671007|11728523|FG008|Overall Study|Other reasons than listed|0
7443039|NCT01671007|11728515|FG000|Overall Study|Withdrawal by Subject|36
7443040|NCT01671007|11728516|FG001|Overall Study|Withdrawal by Subject|59
7443041|NCT01671007|11728517|FG002|Overall Study|Withdrawal by Subject|53
7443042|NCT01671007|11728518|FG003|Overall Study|Withdrawal by Subject|58
7443043|NCT01671007|11728519|FG004|Overall Study|Withdrawal by Subject|4
7443044|NCT01671007|11728520|FG005|Overall Study|Withdrawal by Subject|15
7443045|NCT01671007|11728521|FG006|Overall Study|Withdrawal by Subject|1
7443046|NCT01671007|11728522|FG007|Overall Study|Withdrawal by Subject|19
7443047|NCT01671007|11728523|FG008|Overall Study|Withdrawal by Subject|0
7443048|NCT01671007|11728515|FG000|Overall Study|Lost to Follow-up|93
7443049|NCT01671007|11728516|FG001|Overall Study|Lost to Follow-up|142
7443050|NCT01671007|11728517|FG002|Overall Study|Lost to Follow-up|91
7443051|NCT01671007|11728518|FG003|Overall Study|Lost to Follow-up|63
7443052|NCT01671007|11728519|FG004|Overall Study|Lost to Follow-up|7
7443053|NCT01671007|11728520|FG005|Overall Study|Lost to Follow-up|20
7443054|NCT01671007|11728521|FG006|Overall Study|Lost to Follow-up|2
7443055|NCT01671007|11728522|FG007|Overall Study|Lost to Follow-up|28
7443056|NCT01671007|11728523|FG008|Overall Study|Lost to Follow-up|0
7443057|NCT01671007|11728515|FG000|Overall Study|No end of study case report form|3
7443058|NCT01671007|11728516|FG001|Overall Study|No end of study case report form|1
7443059|NCT01671007|11728517|FG002|Overall Study|No end of study case report form|0
7443060|NCT01671007|11728518|FG003|Overall Study|No end of study case report form|2
7443061|NCT01671007|11728519|FG004|Overall Study|No end of study case report form|0
7443062|NCT01671007|11728520|FG005|Overall Study|No end of study case report form|0
7443063|NCT01671007|11728521|FG006|Overall Study|No end of study case report form|0
7443064|NCT01671007|11728522|FG007|Overall Study|No end of study case report form|0
7443065|NCT01671007|11728523|FG008|Overall Study|No end of study case report form|0
7443066|NCT01671007|11728515|FG000|Overall Study|Not eligible|23
7443067|NCT01671007|11728516|FG001|Overall Study|Not eligible|76
7443068|NCT01671007|11728517|FG002|Overall Study|Not eligible|25
7443069|NCT01671007|11728518|FG003|Overall Study|Not eligible|17
7443070|NCT01671007|11728519|FG004|Overall Study|Not eligible|0
7443071|NCT01671007|11728520|FG005|Overall Study|Not eligible|6
7443072|NCT01671007|11728521|FG006|Overall Study|Not eligible|1
7561813|NCT03214367|11930413|FG007|Lead-in Period|Withdrawal by Subject|0
7561814|NCT03214367|11930406|FG000|Lead-in Period|Adverse Event|3
7561815|NCT03214367|11930407|FG001|Lead-in Period|Adverse Event|0
7561816|NCT03214367|11930408|FG002|Lead-in Period|Adverse Event|0
7561817|NCT03214367|11930409|FG003|Lead-in Period|Adverse Event|0
7561818|NCT03214367|11930410|FG004|Lead-in Period|Adverse Event|0
7561819|NCT03214367|11930411|FG005|Lead-in Period|Adverse Event|0
7561820|NCT03214367|11930412|FG006|Lead-in Period|Adverse Event|0
7561821|NCT03214367|11930413|FG007|Lead-in Period|Adverse Event|0
7561822|NCT03214367|11930406|FG000|Lead-in Period|Lost to Follow-up|12
7561823|NCT03214367|11930407|FG001|Lead-in Period|Lost to Follow-up|0
7561824|NCT03214367|11930408|FG002|Lead-in Period|Lost to Follow-up|0
7561825|NCT03214367|11930409|FG003|Lead-in Period|Lost to Follow-up|0
7443073|NCT01671007|11728522|FG007|Overall Study|Not eligible|19
7443074|NCT01671007|11728523|FG008|Overall Study|Not eligible|0
7443075|NCT01671059|11728534|FG000|Overall Study|Adverse Event|4
7443076|NCT01671059|11728534|FG000|Overall Study|Lack of Efficacy|1
7467571|NCT01901874|11767973|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
7467572|NCT01901874|11767973|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
7467573|NCT01902134|11767992|FG000|Overall Study|Adverse Event|3
7467574|NCT01902134|11767993|FG001|Overall Study|Adverse Event|1
7467575|NCT01902134|11767994|FG002|Overall Study|Adverse Event|2
7561826|NCT03214367|11930410|FG004|Lead-in Period|Lost to Follow-up|0
7443077|NCT01671085|11728541|FG000|Overall Study|Withdrawal by Subject|1
7443078|NCT01671085|11728542|FG001|Overall Study|Withdrawal by Subject|0
7443079|NCT01671111|11728549|FG000|Overall Study|Adverse Event|2
7443080|NCT01671111|11728549|FG000|Overall Study|Lack of Efficacy|1
7443081|NCT01671111|11728549|FG000|Overall Study|Withdrawal by Subject|2
7443082|NCT01671111|11728549|FG000|Overall Study|Physician Decision|1
7443083|NCT01671111|11728549|FG000|Overall Study|Other|24
7443084|NCT01671280|11728557|FG000|Overall Study|Withdrawal by Subject|2
7443085|NCT01671319|11728570|FG000|Overall Study|Withdrawal by Subject|1
7443086|NCT01671332|11728576|FG000|Overall Study|Withdrawal by Subject|1
7443087|NCT01671332|11728577|FG001|Overall Study|Withdrawal by Subject|1
7443088|NCT01671345|11728585|FG000|Overall Study|Lost to Follow-up|10
7443089|NCT01671345|11728586|FG001|Overall Study|Lost to Follow-up|6
7443090|NCT01671345|11728585|FG000|Overall Study|visit with non-participating physician|3
7443091|NCT01671345|11728586|FG001|Overall Study|visit with non-participating physician|3
7443092|NCT01671488|11728604|FG000|Overall Study|Withdrawal by Subject|1
7443093|NCT01671748|11728619|FG000|4 Week run-in Phase|Withdrawal by Subject|1
7443094|NCT01671748|11728620|FG001|4 Week run-in Phase|Withdrawal by Subject|0
7443095|NCT01671748|11728619|FG000|4 Week run-in Phase|Adverse Event|1
7443096|NCT01671748|11728620|FG001|4 Week run-in Phase|Adverse Event|0
7443097|NCT01671748|11728619|FG000|4 Week run-in Phase|Not eligible|9
7443098|NCT01671748|11728620|FG001|4 Week run-in Phase|Not eligible|0
7443099|NCT01672294|11728637|FG000|Overall Study|Withdrawal by Subject|4
7443100|NCT01672294|11728638|FG001|Overall Study|Withdrawal by Subject|4
7443101|NCT01672294|11728639|FG002|Overall Study|Withdrawal by Subject|4
7443102|NCT01672294|11728640|FG003|Overall Study|Withdrawal by Subject|4
7443103|NCT01672294|11728637|FG000|Overall Study|Excluded by study|1
7443104|NCT01672294|11728638|FG001|Overall Study|Excluded by study|1
7443105|NCT01672294|11728639|FG002|Overall Study|Excluded by study|0
7443106|NCT01672294|11728640|FG003|Overall Study|Excluded by study|0
7443107|NCT01672294|11728637|FG000|Overall Study|Lost to Follow-up|1
7443108|NCT01672294|11728638|FG001|Overall Study|Lost to Follow-up|16
7443109|NCT01672294|11728639|FG002|Overall Study|Lost to Follow-up|7
7443110|NCT01672294|11728640|FG003|Overall Study|Lost to Follow-up|9
7443111|NCT01672710|11728661|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
7443112|NCT01672710|11728662|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
7443113|NCT01672710|11728661|FG000|3 Month Follow up|Lost to Follow-up|2
7443114|NCT01672710|11728662|FG001|3 Month Follow up|Lost to Follow-up|3
7443115|NCT01672710|11728661|FG000|3 Month Follow up|follow up due after termination date|4
7443116|NCT01672710|11728662|FG001|3 Month Follow up|follow up due after termination date|1
7443117|NCT01672723|11728668|FG000|First Intervention|Adverse Event|3
7443118|NCT01672723|11728669|FG001|First Intervention|Adverse Event|0
7443119|NCT01672736|11728675|FG000|Overall Study|Available drug expired on 31 May 16|3
7443120|NCT01672788|11728679|FG000|Washout Period 2 (7 Days)|Adverse Event|0
7443121|NCT01672788|11728680|FG001|Washout Period 2 (7 Days)|Adverse Event|0
7443122|NCT01672788|11728681|FG002|Washout Period 2 (7 Days)|Adverse Event|0
7443123|NCT01672788|11728682|FG003|Washout Period 2 (7 Days)|Adverse Event|1
7443124|NCT01672801|11728694|FG000|Overall Study|Screen Failure|0
7443125|NCT01672801|11728695|FG001|Overall Study|Screen Failure|1
7561827|NCT03214367|11930411|FG005|Lead-in Period|Lost to Follow-up|0
7561828|NCT03214367|11930412|FG006|Lead-in Period|Lost to Follow-up|0
7561829|NCT03214367|11930413|FG007|Lead-in Period|Lost to Follow-up|0
7561830|NCT03214367|11930406|FG000|Lead-in Period|Sponsor Decision|11
7561831|NCT03214367|11930407|FG001|Lead-in Period|Sponsor Decision|0
7561832|NCT03214367|11930408|FG002|Lead-in Period|Sponsor Decision|0
7561833|NCT03214367|11930409|FG003|Lead-in Period|Sponsor Decision|0
7561834|NCT03214367|11930410|FG004|Lead-in Period|Sponsor Decision|0
7443126|NCT01672853|11728710|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
7443127|NCT01672853|11728711|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
7443128|NCT01672853|11728712|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
7443129|NCT01672853|11728710|FG000|Overall Study|Pregnancy|0
7443130|NCT01672853|11728711|FG001|Overall Study|Pregnancy|1
7443131|NCT01672853|11728712|FG002|Overall Study|Pregnancy|0
7443132|NCT01672853|11728710|FG000|Overall Study|Investigator's Discretion|1
7443133|NCT01672853|11728711|FG001|Overall Study|Investigator's Discretion|0
7443134|NCT01672853|11728712|FG002|Overall Study|Investigator's Discretion|0
7443135|NCT01672853|11728710|FG000|Overall Study|Withdrew Consent|5
7443136|NCT01672853|11728711|FG001|Overall Study|Withdrew Consent|5
7443137|NCT01672853|11728712|FG002|Overall Study|Withdrew Consent|5
7443138|NCT01672853|11728710|FG000|Overall Study|Adverse Event|4
7443139|NCT01672853|11728711|FG001|Overall Study|Adverse Event|6
7443140|NCT01672853|11728712|FG002|Overall Study|Adverse Event|8
7561835|NCT03214367|11930411|FG005|Lead-in Period|Sponsor Decision|0
7561836|NCT03214367|11930412|FG006|Lead-in Period|Sponsor Decision|0
7443141|NCT01672853|11728710|FG000|Overall Study|Lost to Follow-up|0
7443142|NCT01672853|11728711|FG001|Overall Study|Lost to Follow-up|1
7443143|NCT01672853|11728712|FG002|Overall Study|Lost to Follow-up|0
7443144|NCT01672853|11728710|FG000|Overall Study|Randomized but Never Treated|0
7443145|NCT01672853|11728711|FG001|Overall Study|Randomized but Never Treated|0
7443146|NCT01672853|11728712|FG002|Overall Study|Randomized but Never Treated|1
7443147|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
7561837|NCT03214367|11930413|FG007|Lead-in Period|Sponsor Decision|0
7561838|NCT03214367|11930406|FG000|Lead-in Period|Physician Decision|12
7443148|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
7443149|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
7443150|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
7443151|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
7443152|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
7443153|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7443154|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
7443155|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
7443156|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7443157|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7443158|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
7443159|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7443160|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
7443161|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
7443162|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
7443163|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7443164|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
7443165|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Death|0
7443166|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Death|0
7443167|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Death|1
7443168|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
7443169|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7443170|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
7443171|NCT01672866|11728723|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
7443172|NCT01672866|11728724|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
7443173|NCT01672866|11728725|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
7443174|NCT01672866|11728723|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
7443175|NCT01672866|11728724|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7443176|NCT01672866|11728725|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
7443177|NCT01672866|11728723|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7443178|NCT01672866|11728724|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
7443179|NCT01672866|11728725|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
7443180|NCT01672866|11728723|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
7443181|NCT01672866|11728724|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
7443182|NCT01672866|11728725|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
7443183|NCT01672866|11728723|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
7443184|NCT01672866|11728724|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7443185|NCT01672866|11728725|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
7443186|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
7443187|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
7443188|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
7443189|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
7443190|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
7443191|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
7443192|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
7443193|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
7443194|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
7443195|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
7443196|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
7443197|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
7443198|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
7443199|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
7443200|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
7443201|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
7443202|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
7443203|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
7443204|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
7443205|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
7443206|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
7443207|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7443208|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
7443209|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
7443210|NCT01672879|11728738|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
7443211|NCT01672879|11728739|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
7443212|NCT01672879|11728740|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
7443213|NCT01672879|11728738|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
7443214|NCT01672879|11728739|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
7443215|NCT01672879|11728740|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
7443216|NCT01672879|11728738|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
7443217|NCT01672879|11728739|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7443218|NCT01672879|11728740|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
7561839|NCT03214367|11930407|FG001|Lead-in Period|Physician Decision|0
7561840|NCT03214367|11930408|FG002|Lead-in Period|Physician Decision|0
7561841|NCT03214367|11930409|FG003|Lead-in Period|Physician Decision|0
7561842|NCT03214367|11930410|FG004|Lead-in Period|Physician Decision|0
7561843|NCT03214367|11930411|FG005|Lead-in Period|Physician Decision|0
7561844|NCT03214367|11930412|FG006|Lead-in Period|Physician Decision|0
7561845|NCT03214367|11930413|FG007|Lead-in Period|Physician Decision|0
7561846|NCT03214367|11930406|FG000|Lead-in Period|Protocol Violation|5
7561847|NCT03214367|11930407|FG001|Lead-in Period|Protocol Violation|0
7561848|NCT03214367|11930408|FG002|Lead-in Period|Protocol Violation|0
7561849|NCT03214367|11930409|FG003|Lead-in Period|Protocol Violation|0
7561850|NCT03214367|11930410|FG004|Lead-in Period|Protocol Violation|0
7561851|NCT03214367|11930411|FG005|Lead-in Period|Protocol Violation|0
7561852|NCT03214367|11930412|FG006|Lead-in Period|Protocol Violation|0
7561853|NCT03214367|11930413|FG007|Lead-in Period|Protocol Violation|0
7561854|NCT03214367|11930406|FG000|Lead-in Period|Treatment Interruption|1
7561855|NCT03214367|11930407|FG001|Lead-in Period|Treatment Interruption|0
7561856|NCT03214367|11930408|FG002|Lead-in Period|Treatment Interruption|0
7561857|NCT03214367|11930409|FG003|Lead-in Period|Treatment Interruption|0
7561858|NCT03214367|11930410|FG004|Lead-in Period|Treatment Interruption|0
7561859|NCT03214367|11930411|FG005|Lead-in Period|Treatment Interruption|0
7561860|NCT03214367|11930412|FG006|Lead-in Period|Treatment Interruption|0
7561861|NCT03214367|11930413|FG007|Lead-in Period|Treatment Interruption|0
7561862|NCT03214367|11930406|FG000|Treatment Period|Adverse Event|0
7561863|NCT03214367|11930407|FG001|Treatment Period|Adverse Event|1
7561864|NCT03214367|11930408|FG002|Treatment Period|Adverse Event|4
7561865|NCT03214367|11930409|FG003|Treatment Period|Adverse Event|2
7561866|NCT03214367|11930410|FG004|Treatment Period|Adverse Event|0
7561867|NCT03214367|11930411|FG005|Treatment Period|Adverse Event|0
7561868|NCT03214367|11930412|FG006|Treatment Period|Adverse Event|0
7561869|NCT03214367|11930413|FG007|Treatment Period|Adverse Event|0
7561870|NCT03214367|11930406|FG000|Treatment Period|Death|0
7561871|NCT03214367|11930407|FG001|Treatment Period|Death|1
7561872|NCT03214367|11930408|FG002|Treatment Period|Death|1
7561873|NCT03214367|11930409|FG003|Treatment Period|Death|1
7561874|NCT03214367|11930410|FG004|Treatment Period|Death|0
7561875|NCT03214367|11930411|FG005|Treatment Period|Death|0
7561876|NCT03214367|11930412|FG006|Treatment Period|Death|0
7561877|NCT03214367|11930413|FG007|Treatment Period|Death|0
7561878|NCT03214367|11930406|FG000|Treatment Period|Lost to Follow-up|0
7561879|NCT03214367|11930407|FG001|Treatment Period|Lost to Follow-up|5
7561880|NCT03214367|11930408|FG002|Treatment Period|Lost to Follow-up|3
7561881|NCT03214367|11930409|FG003|Treatment Period|Lost to Follow-up|2
7561882|NCT03214367|11930410|FG004|Treatment Period|Lost to Follow-up|0
7561883|NCT03214367|11930411|FG005|Treatment Period|Lost to Follow-up|2
7561884|NCT03214367|11930412|FG006|Treatment Period|Lost to Follow-up|1
7561885|NCT03214367|11930413|FG007|Treatment Period|Lost to Follow-up|0
7561886|NCT03214367|11930406|FG000|Treatment Period|Sponsor Decision|0
7561887|NCT03214367|11930407|FG001|Treatment Period|Sponsor Decision|3
7561888|NCT03214367|11930408|FG002|Treatment Period|Sponsor Decision|0
7561889|NCT03214367|11930409|FG003|Treatment Period|Sponsor Decision|0
7561890|NCT03214367|11930410|FG004|Treatment Period|Sponsor Decision|0
7561891|NCT03214367|11930411|FG005|Treatment Period|Sponsor Decision|0
7561892|NCT03214367|11930412|FG006|Treatment Period|Sponsor Decision|0
7561893|NCT03214367|11930413|FG007|Treatment Period|Sponsor Decision|0
7561894|NCT03214367|11930406|FG000|Treatment Period|Physician Decision|0
7561895|NCT03214367|11930407|FG001|Treatment Period|Physician Decision|1
7561896|NCT03214367|11930408|FG002|Treatment Period|Physician Decision|2
7561897|NCT03214367|11930409|FG003|Treatment Period|Physician Decision|0
7561898|NCT03214367|11930410|FG004|Treatment Period|Physician Decision|0
7561899|NCT03214367|11930411|FG005|Treatment Period|Physician Decision|0
7561900|NCT03214367|11930412|FG006|Treatment Period|Physician Decision|0
7561901|NCT03214367|11930413|FG007|Treatment Period|Physician Decision|0
7561902|NCT03214367|11930406|FG000|Treatment Period|Protocol Violation|0
7561903|NCT03214367|11930407|FG001|Treatment Period|Protocol Violation|3
7561904|NCT03214367|11930408|FG002|Treatment Period|Protocol Violation|0
7561905|NCT03214367|11930409|FG003|Treatment Period|Protocol Violation|0
7561906|NCT03214367|11930410|FG004|Treatment Period|Protocol Violation|0
7561907|NCT03214367|11930411|FG005|Treatment Period|Protocol Violation|0
7561908|NCT03214367|11930412|FG006|Treatment Period|Protocol Violation|0
7561909|NCT03214367|11930413|FG007|Treatment Period|Protocol Violation|0
7561910|NCT03214367|11930406|FG000|Treatment Period|Withdrawal by Subject|0
7561911|NCT03214367|11930407|FG001|Treatment Period|Withdrawal by Subject|20
7561912|NCT03214367|11930408|FG002|Treatment Period|Withdrawal by Subject|23
7561913|NCT03214367|11930409|FG003|Treatment Period|Withdrawal by Subject|14
7561914|NCT03214367|11930410|FG004|Treatment Period|Withdrawal by Subject|0
7561915|NCT03214367|11930411|FG005|Treatment Period|Withdrawal by Subject|1
7561916|NCT03214367|11930412|FG006|Treatment Period|Withdrawal by Subject|1
7561917|NCT03214367|11930413|FG007|Treatment Period|Withdrawal by Subject|1
7561918|NCT03214380|11930431|FG000|Lead-in|Adverse Event|3
7561919|NCT03214380|11930432|FG001|Lead-in|Adverse Event|0
7561920|NCT03214380|11930433|FG002|Lead-in|Adverse Event|0
7561921|NCT03214380|11930434|FG003|Lead-in|Adverse Event|1
7561922|NCT03214380|11930435|FG004|Lead-in|Adverse Event|0
7561923|NCT03214380|11930436|FG005|Lead-in|Adverse Event|0
7561924|NCT03214380|11930431|FG000|Lead-in|Lost to Follow-up|4
7561925|NCT03214380|11930432|FG001|Lead-in|Lost to Follow-up|0
7561926|NCT03214380|11930433|FG002|Lead-in|Lost to Follow-up|0
7561927|NCT03214380|11930434|FG003|Lead-in|Lost to Follow-up|1
7561928|NCT03214380|11930435|FG004|Lead-in|Lost to Follow-up|0
7561929|NCT03214380|11930436|FG005|Lead-in|Lost to Follow-up|0
7561930|NCT03214380|11930431|FG000|Lead-in|Eligibility Criteria|3
7561931|NCT03214380|11930432|FG001|Lead-in|Eligibility Criteria|0
7561932|NCT03214380|11930433|FG002|Lead-in|Eligibility Criteria|0
7443219|NCT01672879|11728738|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7443220|NCT01672879|11728739|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
7443221|NCT01672879|11728740|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
7443222|NCT01672879|11728738|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
7443223|NCT01672879|11728739|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7443224|NCT01672879|11728740|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
7443225|NCT01672957|11728749|FG000|Overall Study|Protocol Violation|48
7443226|NCT01672957|11728749|FG000|Overall Study|Death|2
7443227|NCT01672957|11728749|FG000|Overall Study|ICF Signed After Transplantation|5
7443228|NCT01672970|11728753|FG000|Overall Study|Lack of Efficacy|12
7443229|NCT01672970|11728753|FG000|Overall Study|Adverse Event|18
7443230|NCT01672970|11728753|FG000|Overall Study|Withdrawal by Subject|2
7443231|NCT01672970|11728753|FG000|Overall Study|Lost to Follow-up|5
7443232|NCT01672970|11728753|FG000|Overall Study|Other|9
7443233|NCT01672970|11728753|FG000|Overall Study|Enrolled but not treated|1
7443234|NCT01673009|11728815|FG000|Overall Study|Physician Decision|5
7443235|NCT01673009|11728815|FG000|Overall Study|Withdrawal by Subject|8
7443236|NCT01673126|11728835|FG000|Overall Study|change of diagnosis|4
7443237|NCT01673126|11728836|FG001|Overall Study|change of diagnosis|3
7443238|NCT01673178|11728847|FG000|Overall Study|Lost to Follow-up|0
7443239|NCT01673178|11728848|FG001|Overall Study|Lost to Follow-up|1
7443240|NCT01673178|11728849|FG002|Overall Study|Lost to Follow-up|0
7443241|NCT01673178|11728850|FG003|Overall Study|Lost to Follow-up|0
7443242|NCT01673178|11728851|FG004|Overall Study|Lost to Follow-up|0
7443243|NCT01673178|11728847|FG000|Overall Study|Withdrawal by Subject|0
7443244|NCT01673178|11728848|FG001|Overall Study|Withdrawal by Subject|0
7443245|NCT01673178|11728849|FG002|Overall Study|Withdrawal by Subject|1
7443246|NCT01673178|11728850|FG003|Overall Study|Withdrawal by Subject|4
7443247|NCT01673178|11728851|FG004|Overall Study|Withdrawal by Subject|2
7443248|NCT01673178|11728847|FG000|Overall Study|Protocol Violation|1
7443249|NCT01673178|11728848|FG001|Overall Study|Protocol Violation|1
7443250|NCT01673178|11728849|FG002|Overall Study|Protocol Violation|0
7443251|NCT01673178|11728850|FG003|Overall Study|Protocol Violation|1
7443252|NCT01673178|11728851|FG004|Overall Study|Protocol Violation|0
7443253|NCT01673178|11728847|FG000|Overall Study|Adverse Event|1
7443254|NCT01673178|11728848|FG001|Overall Study|Adverse Event|0
7443255|NCT01673178|11728849|FG002|Overall Study|Adverse Event|0
7443256|NCT01673178|11728850|FG003|Overall Study|Adverse Event|2
7443257|NCT01673178|11728851|FG004|Overall Study|Adverse Event|0
7443258|NCT01673178|11728847|FG000|Overall Study|Other|1
7443259|NCT01673178|11728848|FG001|Overall Study|Other|0
7443260|NCT01673178|11728849|FG002|Overall Study|Other|2
7561933|NCT03214380|11930434|FG003|Lead-in|Eligibility Criteria|0
7561934|NCT03214380|11930435|FG004|Lead-in|Eligibility Criteria|0
7561935|NCT03214380|11930436|FG005|Lead-in|Eligibility Criteria|0
7561936|NCT03214380|11930431|FG000|Lead-in|Physician Decision|6
7561937|NCT03214380|11930432|FG001|Lead-in|Physician Decision|0
7561938|NCT03214380|11930433|FG002|Lead-in|Physician Decision|0
7561939|NCT03214380|11930434|FG003|Lead-in|Physician Decision|0
7561940|NCT03214380|11930435|FG004|Lead-in|Physician Decision|0
7561941|NCT03214380|11930436|FG005|Lead-in|Physician Decision|0
7561942|NCT03214380|11930431|FG000|Lead-in|Protocol Deviation|7
7561943|NCT03214380|11930432|FG001|Lead-in|Protocol Deviation|0
7561944|NCT03214380|11930433|FG002|Lead-in|Protocol Deviation|0
7561945|NCT03214380|11930434|FG003|Lead-in|Protocol Deviation|3
7561946|NCT03214380|11930435|FG004|Lead-in|Protocol Deviation|0
7561947|NCT03214380|11930436|FG005|Lead-in|Protocol Deviation|0
7561948|NCT03214380|11930431|FG000|Lead-in|Withdrawal by Subject|41
7561949|NCT03214380|11930432|FG001|Lead-in|Withdrawal by Subject|0
7561950|NCT03214380|11930433|FG002|Lead-in|Withdrawal by Subject|0
7561951|NCT03214380|11930434|FG003|Lead-in|Withdrawal by Subject|14
7561952|NCT03214380|11930435|FG004|Lead-in|Withdrawal by Subject|0
7561953|NCT03214380|11930436|FG005|Lead-in|Withdrawal by Subject|0
7443261|NCT01673178|11728850|FG003|Overall Study|Other|1
7443262|NCT01673178|11728851|FG004|Overall Study|Other|0
7561954|NCT03214380|11930431|FG000|Lead-in|Family Emergency|1
7443263|NCT01673282|11728882|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
7443264|NCT01673282|11728883|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
7443265|NCT01673282|11728882|FG000|Overall Study|Lack of Efficacy|9
7443266|NCT01673282|11728883|FG001|Overall Study|Lack of Efficacy|2
7443267|NCT01673282|11728882|FG000|Overall Study|Lost to Follow-up|11
7561955|NCT03214380|11930432|FG001|Lead-in|Family Emergency|0
7561956|NCT03214380|11930433|FG002|Lead-in|Family Emergency|0
7561957|NCT03214380|11930434|FG003|Lead-in|Family Emergency|0
7561958|NCT03214380|11930435|FG004|Lead-in|Family Emergency|0
7561959|NCT03214380|11930436|FG005|Lead-in|Family Emergency|0
7561960|NCT03214380|11930431|FG000|Lead-in|Natural Disaster|9
7561961|NCT03214380|11930432|FG001|Lead-in|Natural Disaster|0
7561962|NCT03214380|11930433|FG002|Lead-in|Natural Disaster|0
7561963|NCT03214380|11930434|FG003|Lead-in|Natural Disaster|0
7443268|NCT01673282|11728883|FG001|Overall Study|Lost to Follow-up|10
7443269|NCT01673282|11728882|FG000|Overall Study|Withdrawal by Subject|3
7443270|NCT01673282|11728883|FG001|Overall Study|Withdrawal by Subject|3
7443271|NCT01673282|11728882|FG000|Overall Study|Other|1
7443272|NCT01673282|11728883|FG001|Overall Study|Other|6
7443273|NCT01673347|11728889|FG000|Overall Study|failure of allograft|7
7443274|NCT01673373|11728893|FG000|Overall Study|Death|2
7443275|NCT01673386|11728897|FG000|Overall Study|Study terminated by sponsor|16
7443276|NCT01673386|11728898|FG001|Overall Study|Study terminated by sponsor|22
7443277|NCT01673386|11728897|FG000|Overall Study|Adverse Event|5
7443278|NCT01673386|11728898|FG001|Overall Study|Adverse Event|2
7443279|NCT01673386|11728897|FG000|Overall Study|Progressive disease|4
7443280|NCT01673386|11728898|FG001|Overall Study|Progressive disease|1
7443281|NCT01673386|11728897|FG000|Overall Study|Withdrawal by Subject|0
7443282|NCT01673386|11728898|FG001|Overall Study|Withdrawal by Subject|2
7443283|NCT01673490|11728904|FG000|Overall Study|Lost to Follow-up|1
7443284|NCT01673490|11728904|FG000|Overall Study|Adverse Event|3
7443285|NCT01673490|11728904|FG000|Overall Study|Withdrawal by Subject|3
7443286|NCT01673594|11728919|FG000|Overall Study|Adverse Event|3
7443287|NCT01673594|11728920|FG001|Overall Study|Adverse Event|1
7443288|NCT01673594|11728919|FG000|Overall Study|Lost to Follow-up|1
7443289|NCT01673594|11728920|FG001|Overall Study|Lost to Follow-up|0
7443290|NCT01673594|11728919|FG000|Overall Study|Physician Decision|2
7443291|NCT01673594|11728920|FG001|Overall Study|Physician Decision|4
7443292|NCT01673594|11728919|FG000|Overall Study|Withdrawal by Subject|0
7443293|NCT01673594|11728920|FG001|Overall Study|Withdrawal by Subject|1
7443294|NCT01673646|11728929|FG000|Overall Study|Adverse Event|2
7561964|NCT03214380|11930435|FG004|Lead-in|Natural Disaster|0
7561965|NCT03214380|11930436|FG005|Lead-in|Natural Disaster|0
7561966|NCT03214380|11930431|FG000|Lead-in|Non Compliance|1
7561967|NCT03214380|11930432|FG001|Lead-in|Non Compliance|0
7561968|NCT03214380|11930433|FG002|Lead-in|Non Compliance|0
7561969|NCT03214380|11930434|FG003|Lead-in|Non Compliance|0
7561970|NCT03214380|11930435|FG004|Lead-in|Non Compliance|0
7443295|NCT01673646|11728930|FG001|Overall Study|Adverse Event|1
7443296|NCT01673646|11728931|FG002|Overall Study|Adverse Event|1
7443297|NCT01673646|11728929|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7443298|NCT01673646|11728930|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7443299|NCT01673646|11728931|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7443300|NCT01673646|11728929|FG000|Overall Study|Condition no longer requires study drug|0
7561971|NCT03214380|11930436|FG005|Lead-in|Non Compliance|0
7561972|NCT03214380|11930431|FG000|Lead-in|Participant Schedule|2
7561973|NCT03214380|11930432|FG001|Lead-in|Participant Schedule|0
7561974|NCT03214380|11930433|FG002|Lead-in|Participant Schedule|0
7561975|NCT03214380|11930434|FG003|Lead-in|Participant Schedule|0
7561976|NCT03214380|11930435|FG004|Lead-in|Participant Schedule|0
7561977|NCT03214380|11930436|FG005|Lead-in|Participant Schedule|0
7561978|NCT03214380|11930431|FG000|Treatment Period|Adverse Event|0
7561979|NCT03214380|11930432|FG001|Treatment Period|Adverse Event|1
7561980|NCT03214380|11930433|FG002|Treatment Period|Adverse Event|1
7561981|NCT03214380|11930434|FG003|Treatment Period|Adverse Event|0
7561982|NCT03214380|11930435|FG004|Treatment Period|Adverse Event|1
7443301|NCT01673646|11728930|FG001|Overall Study|Condition no longer requires study drug|1
7443302|NCT01673646|11728931|FG002|Overall Study|Condition no longer requires study drug|0
7443303|NCT01673646|11728929|FG000|Overall Study|Withdrawal by Subject|0
7443304|NCT01673646|11728930|FG001|Overall Study|Withdrawal by Subject|2
7443305|NCT01673646|11728931|FG002|Overall Study|Withdrawal by Subject|2
7443306|NCT01673646|11728929|FG000|Overall Study|Completed Core/did not enter Ext.|2
7443307|NCT01673646|11728930|FG001|Overall Study|Completed Core/did not enter Ext.|1
7443308|NCT01673646|11728931|FG002|Overall Study|Completed Core/did not enter Ext.|1
7443309|NCT01673698|11728945|FG000|Overall Study|Lost to Follow-up|51
7443310|NCT01673698|11728946|FG001|Overall Study|Lost to Follow-up|13
7443311|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
7443312|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
7443313|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
7443314|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
7443315|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
7443316|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
7561983|NCT03214380|11930436|FG005|Treatment Period|Adverse Event|0
7561984|NCT03214380|11930431|FG000|Treatment Period|Non-Compliance with Study Drug|0
7561985|NCT03214380|11930432|FG001|Treatment Period|Non-Compliance with Study Drug|0
7561986|NCT03214380|11930433|FG002|Treatment Period|Non-Compliance with Study Drug|0
7561987|NCT03214380|11930434|FG003|Treatment Period|Non-Compliance with Study Drug|0
7561988|NCT03214380|11930435|FG004|Treatment Period|Non-Compliance with Study Drug|1
7561989|NCT03214380|11930436|FG005|Treatment Period|Non-Compliance with Study Drug|0
7561990|NCT03214380|11930431|FG000|Treatment Period|Withdrawal by Subject|0
7561991|NCT03214380|11930432|FG001|Treatment Period|Withdrawal by Subject|10
7561992|NCT03214380|11930433|FG002|Treatment Period|Withdrawal by Subject|8
7561993|NCT03214380|11930434|FG003|Treatment Period|Withdrawal by Subject|0
7561994|NCT03214380|11930435|FG004|Treatment Period|Withdrawal by Subject|7
7443317|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
7443318|NCT01673854|11728966|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
7443319|NCT01673854|11728966|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
7443320|NCT01673854|11728966|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
7443321|NCT01673854|11728966|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
7443322|NCT01673854|11728966|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
7443323|NCT01673984|11728984|FG000|Overall Study|Adverse Event|1
7443324|NCT01673984|11728985|FG001|Overall Study|Adverse Event|0
7443325|NCT01673984|11728984|FG000|Overall Study|Study termination|9
7443326|NCT01673984|11728985|FG001|Overall Study|Study termination|6
7443327|NCT01674010|11728991|FG000|Open Treatment Phase 1|Adverse Event|10
7443328|NCT01674010|11728992|FG001|Open Treatment Phase 1|Adverse Event|0
7443329|NCT01674010|11728993|FG002|Open Treatment Phase 1|Adverse Event|0
7443330|NCT01674010|11728991|FG000|Open Treatment Phase 1|Death|1
7443331|NCT01674010|11728992|FG001|Open Treatment Phase 1|Death|0
7443332|NCT01674010|11728993|FG002|Open Treatment Phase 1|Death|0
7443333|NCT01674010|11728991|FG000|Open Treatment Phase 1|Lost to Follow-up|19
7443334|NCT01674010|11728992|FG001|Open Treatment Phase 1|Lost to Follow-up|0
7443335|NCT01674010|11728993|FG002|Open Treatment Phase 1|Lost to Follow-up|0
7443336|NCT01674010|11728991|FG000|Open Treatment Phase 1|Physician Decision|9
7443337|NCT01674010|11728992|FG001|Open Treatment Phase 1|Physician Decision|0
7443338|NCT01674010|11728993|FG002|Open Treatment Phase 1|Physician Decision|0
7443339|NCT01674010|11728991|FG000|Open Treatment Phase 1|Protocol Violation|7
7443340|NCT01674010|11728992|FG001|Open Treatment Phase 1|Protocol Violation|0
7443341|NCT01674010|11728993|FG002|Open Treatment Phase 1|Protocol Violation|0
7443342|NCT01674010|11728991|FG000|Open Treatment Phase 1|Sponsor Decision|79
7443343|NCT01674010|11728992|FG001|Open Treatment Phase 1|Sponsor Decision|0
7443344|NCT01674010|11728993|FG002|Open Treatment Phase 1|Sponsor Decision|0
7443345|NCT01674010|11728991|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
7443346|NCT01674010|11728992|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
7443347|NCT01674010|11728993|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
7443348|NCT01674010|11728991|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
7443349|NCT01674010|11728992|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
7443350|NCT01674010|11728993|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
7443351|NCT01674010|11728991|FG000|Randomization Phase 2|Adverse Event|0
7443352|NCT01674010|11728992|FG001|Randomization Phase 2|Adverse Event|1
7443353|NCT01674010|11728993|FG002|Randomization Phase 2|Adverse Event|1
7443354|NCT01674010|11728991|FG000|Randomization Phase 2|Lost to Follow-up|0
7443355|NCT01674010|11728992|FG001|Randomization Phase 2|Lost to Follow-up|1
7443356|NCT01674010|11728993|FG002|Randomization Phase 2|Lost to Follow-up|2
7443357|NCT01674010|11728991|FG000|Randomization Phase 2|Mood episode recurrence|0
7443358|NCT01674010|11728992|FG001|Randomization Phase 2|Mood episode recurrence|8
7443359|NCT01674010|11728993|FG002|Randomization Phase 2|Mood episode recurrence|2
7443360|NCT01674010|11728991|FG000|Randomization Phase 2|Physician Decision|0
7443361|NCT01674010|11728992|FG001|Randomization Phase 2|Physician Decision|0
7443362|NCT01674010|11728993|FG002|Randomization Phase 2|Physician Decision|2
7443363|NCT01674010|11728991|FG000|Randomization Phase 2|Pregnancy|0
7443364|NCT01674010|11728992|FG001|Randomization Phase 2|Pregnancy|1
7443365|NCT01674010|11728993|FG002|Randomization Phase 2|Pregnancy|1
7443366|NCT01674010|11728991|FG000|Randomization Phase 2|Protocol Violation|0
7443367|NCT01674010|11728992|FG001|Randomization Phase 2|Protocol Violation|1
7443368|NCT01674010|11728993|FG002|Randomization Phase 2|Protocol Violation|1
7443369|NCT01674010|11728991|FG000|Randomization Phase 2|Sponsor Decision|0
7443370|NCT01674010|11728992|FG001|Randomization Phase 2|Sponsor Decision|42
7443371|NCT01674010|11728993|FG002|Randomization Phase 2|Sponsor Decision|45
7443372|NCT01674010|11728991|FG000|Randomization Phase 2|Withdrawal by Subject|0
7443373|NCT01674010|11728992|FG001|Randomization Phase 2|Withdrawal by Subject|8
7443374|NCT01674010|11728993|FG002|Randomization Phase 2|Withdrawal by Subject|7
7443375|NCT01674062|11729003|FG000|Overall Study|Insufficient Therapeutic Response|56
7443376|NCT01674062|11729004|FG001|Overall Study|Insufficient Therapeutic Response|26
7443377|NCT01674062|11729003|FG000|Overall Study|Other|8
7443378|NCT01674062|11729004|FG001|Overall Study|Other|1
7443379|NCT01674062|11729003|FG000|Overall Study|Adverse Event|1
7443380|NCT01674062|11729004|FG001|Overall Study|Adverse Event|1
7443381|NCT01674062|11729003|FG000|Overall Study|Death|0
7443382|NCT01674062|11729004|FG001|Overall Study|Death|1
7443383|NCT01674062|11729003|FG000|Overall Study|Programming Error|1
7443384|NCT01674062|11729004|FG001|Overall Study|Programming Error|0
7443385|NCT01674569|11729019|FG000|Overall Study|Adverse Event|0
7443386|NCT01674569|11729020|FG001|Overall Study|Adverse Event|2
7443387|NCT01674569|11729021|FG002|Overall Study|Adverse Event|0
7443388|NCT01674569|11729022|FG003|Overall Study|Adverse Event|1
7443389|NCT01674569|11729023|FG004|Overall Study|Adverse Event|2
7443390|NCT01674569|11729024|FG005|Overall Study|Adverse Event|2
7443391|NCT01674569|11729019|FG000|Overall Study|Protocol Violation|0
7443392|NCT01674569|11729020|FG001|Overall Study|Protocol Violation|1
7532943|NCT02678286|11878882|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
7532944|NCT02678286|11878883|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
7443393|NCT01674569|11729021|FG002|Overall Study|Protocol Violation|1
7443394|NCT01674569|11729022|FG003|Overall Study|Protocol Violation|0
7443395|NCT01674569|11729023|FG004|Overall Study|Protocol Violation|0
7443396|NCT01674569|11729024|FG005|Overall Study|Protocol Violation|0
7443397|NCT01674569|11729019|FG000|Overall Study|Withdrawal by Subject|0
7443398|NCT01674569|11729020|FG001|Overall Study|Withdrawal by Subject|0
7443399|NCT01674569|11729021|FG002|Overall Study|Withdrawal by Subject|1
7443400|NCT01674569|11729022|FG003|Overall Study|Withdrawal by Subject|0
7443401|NCT01674569|11729023|FG004|Overall Study|Withdrawal by Subject|0
7443402|NCT01674569|11729024|FG005|Overall Study|Withdrawal by Subject|0
7443403|NCT01674621|11729033|FG000|Overall Study|Adverse Event|3
7443404|NCT01674621|11729034|FG001|Overall Study|Adverse Event|2
7443405|NCT01674621|11729035|FG002|Overall Study|Adverse Event|5
7443406|NCT01674621|11729036|FG003|Overall Study|Adverse Event|5
7443407|NCT01674621|11729037|FG004|Overall Study|Adverse Event|1
7443408|NCT01674621|11729033|FG000|Overall Study|Inability to Complete Study Procedures|0
7443409|NCT01674621|11729034|FG001|Overall Study|Inability to Complete Study Procedures|0
7443410|NCT01674621|11729035|FG002|Overall Study|Inability to Complete Study Procedures|0
7443411|NCT01674621|11729036|FG003|Overall Study|Inability to Complete Study Procedures|0
7443412|NCT01674621|11729037|FG004|Overall Study|Inability to Complete Study Procedures|2
7443413|NCT01674621|11729033|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7443414|NCT01674621|11729034|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7443415|NCT01674621|11729035|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7443416|NCT01674621|11729036|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
7443417|NCT01674621|11729037|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
7443418|NCT01674621|11729033|FG000|Overall Study|Withdrawal by Subject|2
7443419|NCT01674621|11729034|FG001|Overall Study|Withdrawal by Subject|5
7443420|NCT01674621|11729035|FG002|Overall Study|Withdrawal by Subject|2
7443421|NCT01674621|11729036|FG003|Overall Study|Withdrawal by Subject|0
7443422|NCT01674621|11729037|FG004|Overall Study|Withdrawal by Subject|1
7443423|NCT01674621|11729033|FG000|Overall Study|Other than specified|0
7443424|NCT01674621|11729034|FG001|Overall Study|Other than specified|1
7443425|NCT01674621|11729035|FG002|Overall Study|Other than specified|0
7443426|NCT01674621|11729036|FG003|Overall Study|Other than specified|0
7443427|NCT01674621|11729037|FG004|Overall Study|Other than specified|2
7443428|NCT01674634|11729050|FG000|Overall Study|Withdrawal by Subject|3
7443429|NCT01674634|11729050|FG000|Overall Study|Lost to Follow-up|3
7443430|NCT01674647|11729060|FG000|Treatment Period|Death|4
7443431|NCT01674647|11729061|FG001|Treatment Period|Death|1
7443432|NCT01674647|11729060|FG000|Treatment Period|Efficacy outcome reached|0
7443433|NCT01674647|11729061|FG001|Treatment Period|Efficacy outcome reached|1
7443434|NCT01674647|11729060|FG000|Treatment Period|Physician Decision|3
7443435|NCT01674647|11729061|FG001|Treatment Period|Physician Decision|1
7443436|NCT01674647|11729060|FG000|Treatment Period|Adverse Event|60
7561995|NCT03214380|11930436|FG005|Treatment Period|Withdrawal by Subject|11
7561996|NCT03214380|11930431|FG000|Treatment Period|Death|0
7443437|NCT01674647|11729061|FG001|Treatment Period|Adverse Event|22
7443438|NCT01674647|11729060|FG000|Treatment Period|Non-compliance with study drug|3
7443439|NCT01674647|11729061|FG001|Treatment Period|Non-compliance with study drug|0
7443440|NCT01674647|11729060|FG000|Treatment Period|Lost to Follow-up|1
7443441|NCT01674647|11729061|FG001|Treatment Period|Lost to Follow-up|1
7443442|NCT01674647|11729060|FG000|Treatment Period|Withdrawal by Subject|19
7443443|NCT01674647|11729061|FG001|Treatment Period|Withdrawal by Subject|16
7443444|NCT01674647|11729060|FG000|Treatment Period|Switching to other therapy|5
7443445|NCT01674647|11729061|FG001|Treatment Period|Switching to other therapy|2
7443446|NCT01674647|11729060|FG000|Treatment Period|Logistical difficulties|5
7443447|NCT01674647|11729061|FG001|Treatment Period|Logistical difficulties|8
7443448|NCT01674647|11729060|FG000|Treatment Period|Treatment failure|0
7443449|NCT01674647|11729061|FG001|Treatment Period|Treatment failure|14
7443450|NCT01674647|11729060|FG000|Treatment Period|Protocol Violation|56
7443451|NCT01674647|11729061|FG001|Treatment Period|Protocol Violation|36
7443452|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Death|3
7443453|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Death|2
7443454|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
7443455|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
7443456|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Protocol Violation|39
7443457|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Protocol Violation|22
7443458|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
7443459|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
7443460|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
7443461|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
7561997|NCT03214380|11930432|FG001|Treatment Period|Death|1
7561998|NCT03214380|11930433|FG002|Treatment Period|Death|2
7443462|NCT01674647|11729060|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
7443463|NCT01674647|11729061|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
7443464|NCT01674712|11729072|FG000|Overall Study|Adverse Event|5
7443465|NCT01674712|11729073|FG001|Overall Study|Adverse Event|6
7443466|NCT01674712|11729074|FG002|Overall Study|Adverse Event|3
7443467|NCT01674712|11729075|FG003|Overall Study|Adverse Event|4
7561999|NCT03214380|11930434|FG003|Treatment Period|Death|0
7562000|NCT03214380|11930435|FG004|Treatment Period|Death|0
7562001|NCT03214380|11930436|FG005|Treatment Period|Death|0
7443468|NCT01674712|11729076|FG004|Overall Study|Adverse Event|6
7443469|NCT01674712|11729072|FG000|Overall Study|Lost to Follow-up|1
7443470|NCT01674712|11729073|FG001|Overall Study|Lost to Follow-up|0
7443471|NCT01674712|11729074|FG002|Overall Study|Lost to Follow-up|0
7443472|NCT01674712|11729075|FG003|Overall Study|Lost to Follow-up|0
7443473|NCT01674712|11729076|FG004|Overall Study|Lost to Follow-up|0
7443474|NCT01674712|11729072|FG000|Overall Study|Protocol Violation|2
7443475|NCT01674712|11729073|FG001|Overall Study|Protocol Violation|0
7443476|NCT01674712|11729074|FG002|Overall Study|Protocol Violation|0
7443477|NCT01674712|11729075|FG003|Overall Study|Protocol Violation|0
7443478|NCT01674712|11729076|FG004|Overall Study|Protocol Violation|0
7443479|NCT01674712|11729072|FG000|Overall Study|Withdrawal by Subject|2
7443480|NCT01674712|11729073|FG001|Overall Study|Withdrawal by Subject|2
7443481|NCT01674712|11729074|FG002|Overall Study|Withdrawal by Subject|5
7443482|NCT01674712|11729075|FG003|Overall Study|Withdrawal by Subject|4
7443483|NCT01674712|11729076|FG004|Overall Study|Withdrawal by Subject|3
7443484|NCT01674712|11729072|FG000|Overall Study|Administrative|0
7443485|NCT01674712|11729073|FG001|Overall Study|Administrative|1
7443486|NCT01674712|11729074|FG002|Overall Study|Administrative|0
7443487|NCT01674712|11729075|FG003|Overall Study|Administrative|0
7443488|NCT01674712|11729076|FG004|Overall Study|Administrative|1
7443489|NCT01674712|11729072|FG000|Overall Study|Lack of Efficacy|0
7443490|NCT01674712|11729073|FG001|Overall Study|Lack of Efficacy|0
7443491|NCT01674712|11729074|FG002|Overall Study|Lack of Efficacy|1
7443492|NCT01674712|11729075|FG003|Overall Study|Lack of Efficacy|0
7443493|NCT01674712|11729076|FG004|Overall Study|Lack of Efficacy|1
7443494|NCT01674725|11729090|FG000|Overall Study|Adverse Event|1
7443495|NCT01674725|11729091|FG001|Overall Study|Adverse Event|0
7443496|NCT01674725|11729090|FG000|Overall Study|Did not receive study drug|1
7443497|NCT01674725|11729091|FG001|Overall Study|Did not receive study drug|0
7443498|NCT01674725|11729090|FG000|Overall Study|Withdrawal by Subject|1
7443499|NCT01674725|11729091|FG001|Overall Study|Withdrawal by Subject|0
7443500|NCT01674725|11729090|FG000|Overall Study|Lost to Follow-up|0
7443501|NCT01674725|11729091|FG001|Overall Study|Lost to Follow-up|1
7443502|NCT01675050|11729099|FG000|Period One Treatment|Withdrawal by Subject|1
7443503|NCT01675050|11729100|FG001|Period One Treatment|Withdrawal by Subject|0
7443504|NCT01675128|11729113|FG000|Overall Study|Disease progression on study|1
7443505|NCT01675128|11729114|FG001|Overall Study|Disease progression on study|1
7443506|NCT01675128|11729115|FG002|Overall Study|Disease progression on study|1
7443507|NCT01675128|11729113|FG000|Overall Study|Refused further treatment|1
7443508|NCT01675128|11729114|FG001|Overall Study|Refused further treatment|0
7443509|NCT01675128|11729115|FG002|Overall Study|Refused further treatment|0
7443510|NCT01675128|11729113|FG000|Overall Study|Pulmonary complication; off study|0
7443511|NCT01675128|11729114|FG001|Overall Study|Pulmonary complication; off study|1
7443512|NCT01675128|11729115|FG002|Overall Study|Pulmonary complication; off study|0
7443513|NCT01675141|11729130|FG000|Overall Study|Lenalidomide outside NIH|3
7443514|NCT01675141|11729130|FG000|Overall Study|Withdrawal by Subject|3
7443515|NCT01675141|11729130|FG000|Overall Study|Physician Decision|4
7443516|NCT01675141|11729130|FG000|Overall Study|No treatment, per protocol|1
7443517|NCT01675154|11729138|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7443518|NCT01675154|11729139|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
7443519|NCT01675154|11729140|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7443520|NCT01675154|11729141|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
7443521|NCT01675167|11729165|FG000|Open-label Titration Phase|Adverse Event|81
7443522|NCT01675167|11729166|FG001|Open-label Titration Phase|Adverse Event|0
7443523|NCT01675167|11729167|FG002|Open-label Titration Phase|Adverse Event|0
7443524|NCT01675167|11729165|FG000|Open-label Titration Phase|Lack of Efficacy|63
7443525|NCT01675167|11729166|FG001|Open-label Titration Phase|Lack of Efficacy|0
7443526|NCT01675167|11729167|FG002|Open-label Titration Phase|Lack of Efficacy|0
7443527|NCT01675167|11729165|FG000|Open-label Titration Phase|Withdrawal by Subject|46
7443528|NCT01675167|11729166|FG001|Open-label Titration Phase|Withdrawal by Subject|0
7443529|NCT01675167|11729167|FG002|Open-label Titration Phase|Withdrawal by Subject|0
7443530|NCT01675167|11729165|FG000|Open-label Titration Phase|Protocol Violation|43
7443531|NCT01675167|11729166|FG001|Open-label Titration Phase|Protocol Violation|0
7443532|NCT01675167|11729167|FG002|Open-label Titration Phase|Protocol Violation|0
7443533|NCT01675167|11729165|FG000|Open-label Titration Phase|Lost to Follow-up|15
7443534|NCT01675167|11729166|FG001|Open-label Titration Phase|Lost to Follow-up|0
7443535|NCT01675167|11729167|FG002|Open-label Titration Phase|Lost to Follow-up|0
7443536|NCT01675167|11729165|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
7443537|NCT01675167|11729166|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7443538|NCT01675167|11729167|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
7443539|NCT01675167|11729165|FG000|Open-label Titration Phase|Other|55
7443540|NCT01675167|11729166|FG001|Open-label Titration Phase|Other|0
7443541|NCT01675167|11729167|FG002|Open-label Titration Phase|Other|0
7443542|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7443543|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
7443544|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
7443545|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7443546|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
7467576|NCT01902134|11767995|FG003|Overall Study|Adverse Event|1
7443547|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
7443548|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Adverse Event|0
7443549|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Adverse Event|5
7443550|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Adverse Event|13
7443551|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Protocol Violation|0
7443552|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Protocol Violation|4
7443553|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Protocol Violation|11
7443554|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7443555|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7443556|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
7443557|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
7443558|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
7443559|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
7443560|NCT01675167|11729165|FG000|Double-blind Treatment Phase|Other|0
7443561|NCT01675167|11729166|FG001|Double-blind Treatment Phase|Other|7
7443562|NCT01675167|11729167|FG002|Double-blind Treatment Phase|Other|5
7443563|NCT01675427|11729184|FG000|Overall Study|Withdrawal by Subject|7
7443564|NCT01675427|11729184|FG000|Overall Study|Participant Refused Sample Collection|18
7443565|NCT01675427|11729184|FG000|Overall Study|Sample not Collected by Mistake|2
7443566|NCT01675427|11729184|FG000|Overall Study|Lost to Follow-up|5
7443567|NCT01675427|11729184|FG000|Overall Study|Other|2
7443568|NCT01675492|11729227|FG000|Overall Study|study completed early - product approval|42
7443569|NCT01675531|11729232|FG000|Overall Study|Adverse Event|9
7443570|NCT01675531|11729232|FG000|Overall Study|Withdrawal by Subject|7
7443571|NCT01675531|11729232|FG000|Overall Study|Lack of Efficacy|1
7443572|NCT01675531|11729232|FG000|Overall Study|Protocol Violation|8
7443573|NCT01675544|11729237|FG000|Overall Study|Withdrawal by Subject|2
7443574|NCT01675596|11729241|FG000|Overall Study|Death|6
7443575|NCT01675596|11729241|FG000|Overall Study|Exit with other reason|1
7443576|NCT01675596|11729241|FG000|Overall Study|Missed Visit|1
7443577|NCT01675622|11729247|FG000|Overall Study|Withdrawal by Subject|2
7443578|NCT01675622|11729248|FG001|Overall Study|Withdrawal by Subject|2
7443579|NCT01675622|11729247|FG000|Overall Study|Adverse Event|12
7443580|NCT01675622|11729248|FG001|Overall Study|Adverse Event|10
7443581|NCT01675622|11729247|FG000|Overall Study|Protocol Violation|4
7443582|NCT01675622|11729248|FG001|Overall Study|Protocol Violation|1
7443583|NCT01675622|11729247|FG000|Overall Study|Lack of Efficacy|2
7443584|NCT01675622|11729248|FG001|Overall Study|Lack of Efficacy|4
7443585|NCT01675622|11729247|FG000|Overall Study|Lost to Follow-up|1
7443586|NCT01675622|11729248|FG001|Overall Study|Lost to Follow-up|3
7443587|NCT01675622|11729247|FG000|Overall Study|Other|5
7443588|NCT01675622|11729248|FG001|Overall Study|Other|4
7443589|NCT01675661|11729270|FG000|Overall Study|Lost to Follow-up|22
7443590|NCT01675661|11729271|FG001|Overall Study|Lost to Follow-up|23
7443591|NCT01675661|11729270|FG000|Overall Study|Practical problems|9
7225156|NCT00064701|11434644|FG002|One Year Post-transplant|Did not receive study drug|11
7225157|NCT00064701|11434642|FG000|One Year Post-transplant|Adverse Event|23
7225158|NCT00064701|11434643|FG001|One Year Post-transplant|Adverse Event|19
7225159|NCT00064701|11434644|FG002|One Year Post-transplant|Adverse Event|37
7443592|NCT01675661|11729271|FG001|Overall Study|Practical problems|5
7443593|NCT01675661|11729270|FG000|Overall Study|Moved away|5
7443594|NCT01675661|11729271|FG001|Overall Study|Moved away|6
7443595|NCT01675661|11729270|FG000|Overall Study|Withdrawal by Subject|3
7443596|NCT01675661|11729271|FG001|Overall Study|Withdrawal by Subject|7
7443597|NCT01675661|11729270|FG000|Overall Study|Physician Decision|0
7443598|NCT01675661|11729271|FG001|Overall Study|Physician Decision|2
7443599|NCT01675661|11729270|FG000|Overall Study|Death|0
7443600|NCT01675661|11729271|FG001|Overall Study|Death|1
7443601|NCT01675661|11729270|FG000|Overall Study|Other reason|1
7443602|NCT01675661|11729271|FG001|Overall Study|Other reason|2
7443603|NCT01675765|11729279|FG000|Overall Study|Progressive disease|4
7443604|NCT01675765|11729280|FG001|Overall Study|Progressive disease|4
7443605|NCT01675765|11729279|FG000|Overall Study|Adverse Event|1
7443606|NCT01675765|11729280|FG001|Overall Study|Adverse Event|2
7443607|NCT01675765|11729279|FG000|Overall Study|Withdrawal by Subject|2
7443608|NCT01675765|11729280|FG001|Overall Study|Withdrawal by Subject|0
7443609|NCT01675765|11729279|FG000|Overall Study|Death|1
7443610|NCT01675765|11729280|FG001|Overall Study|Death|0
7443611|NCT01675765|11729279|FG000|Overall Study|Clinical progression|3
7443612|NCT01675765|11729280|FG001|Overall Study|Clinical progression|2
7443613|NCT01675882|11729299|FG000|Overall Study|Adverse Event|0
7443614|NCT01675882|11729300|FG001|Overall Study|Adverse Event|2
7443615|NCT01675882|11729301|FG002|Overall Study|Adverse Event|1
7443616|NCT01675882|11729302|FG003|Overall Study|Adverse Event|0
7443617|NCT01675882|11729299|FG000|Overall Study|Participant unwilling to continue|2
7443618|NCT01675882|11729300|FG001|Overall Study|Participant unwilling to continue|4
7443619|NCT01675882|11729301|FG002|Overall Study|Participant unwilling to continue|2
7443620|NCT01675882|11729302|FG003|Overall Study|Participant unwilling to continue|1
7443621|NCT01675882|11729299|FG000|Overall Study|Lost to Follow-up|0
7443622|NCT01675882|11729300|FG001|Overall Study|Lost to Follow-up|1
7443623|NCT01675882|11729301|FG002|Overall Study|Lost to Follow-up|0
7443624|NCT01675882|11729302|FG003|Overall Study|Lost to Follow-up|0
7443625|NCT01675882|11729299|FG000|Overall Study|Non-compliance|0
7443626|NCT01675882|11729300|FG001|Overall Study|Non-compliance|0
7443627|NCT01675882|11729301|FG002|Overall Study|Non-compliance|0
7443628|NCT01675882|11729302|FG003|Overall Study|Non-compliance|1
7443629|NCT01676012|11729312|FG000|Overall Study|Adverse Event|2
7443630|NCT01676012|11729312|FG000|Overall Study|incomplete set of videos|1
7443631|NCT01676116|11729318|FG000|Overall Study|Withdrawal criteria|2
7443632|NCT01676116|11729319|FG001|Overall Study|Withdrawal criteria|14
7443633|NCT01676116|11729318|FG000|Overall Study|Adverse Event|1
7443634|NCT01676116|11729319|FG001|Overall Study|Adverse Event|2
7443635|NCT01676116|11729318|FG000|Overall Study|Unclassified|4
7443636|NCT01676116|11729319|FG001|Overall Study|Unclassified|10
7443637|NCT01676116|11729318|FG000|Overall Study|Protocol Violation|9
7443638|NCT01676116|11729319|FG001|Overall Study|Protocol Violation|3
7443639|NCT01676220|11729327|FG000|Overall Study|Randomized But Not Treated|4
7443640|NCT01676220|11729328|FG001|Overall Study|Randomized But Not Treated|1
7443641|NCT01676220|11729327|FG000|Overall Study|Adverse Event|10
7443642|NCT01676220|11729328|FG001|Overall Study|Adverse Event|8
7443643|NCT01676220|11729327|FG000|Overall Study|Lack of Efficacy|2
7443644|NCT01676220|11729328|FG001|Overall Study|Lack of Efficacy|5
7443645|NCT01676220|11729327|FG000|Overall Study|Protocol Violation|11
7443646|NCT01676220|11729328|FG001|Overall Study|Protocol Violation|12
7443647|NCT01676220|11729327|FG000|Overall Study|Received Rescue Therapy|14
7443648|NCT01676220|11729328|FG001|Overall Study|Received Rescue Therapy|22
7443649|NCT01676220|11729327|FG000|Overall Study|Personal Reason|34
7443650|NCT01676220|11729328|FG001|Overall Study|Personal Reason|45
7443651|NCT01676220|11729327|FG000|Overall Study|Lost to Follow-up|11
7443652|NCT01676220|11729328|FG001|Overall Study|Lost to Follow-up|18
7443653|NCT01676220|11729327|FG000|Overall Study|Selection Criterion/Protocol Violation|9
7443654|NCT01676220|11729328|FG001|Overall Study|Selection Criterion/Protocol Violation|9
7443655|NCT01676220|11729327|FG000|Overall Study|Site Closure/Site Withdrawal|1
7443656|NCT01676220|11729328|FG001|Overall Study|Site Closure/Site Withdrawal|4
7443657|NCT01676220|11729327|FG000|Overall Study|Perceived Lack of Efficacy|3
7443658|NCT01676220|11729328|FG001|Overall Study|Perceived Lack of Efficacy|1
7443659|NCT01676220|11729327|FG000|Overall Study|Non Serious Hypoglycemia|2
7443660|NCT01676220|11729328|FG001|Overall Study|Non Serious Hypoglycemia|0
7443661|NCT01676220|11729327|FG000|Overall Study|No More Need of Insulin|1
7443662|NCT01676220|11729328|FG001|Overall Study|No More Need of Insulin|0
7443663|NCT01676727|11729401|FG000|Overall Study|Death|18
7443664|NCT01676727|11729401|FG000|Overall Study|Withdrawal by Subject|6
7443665|NCT01676727|11729401|FG000|Overall Study|Screening failure|5
7443666|NCT01676727|11729401|FG000|Overall Study|Not willing to attend 1-year visit|2
7443667|NCT01676727|11729401|FG000|Overall Study|Valve explanted|1
7443668|NCT01676896|11729418|FG000|Overall Study|Withdrawal by Subject|12
7443669|NCT01676896|11729419|FG001|Overall Study|Withdrawal by Subject|7
7443670|NCT01676896|11729420|FG002|Overall Study|Withdrawal by Subject|19
7443671|NCT01676909|11729430|FG000|Overall Study|Withdrawal by Subject|3
7443672|NCT01676909|11729431|FG001|Overall Study|Withdrawal by Subject|5
7443673|NCT01676909|11729430|FG000|Overall Study|Lost to Follow-up|15
7443674|NCT01676909|11729431|FG001|Overall Study|Lost to Follow-up|9
7443675|NCT01677182|11729442|FG000|Overall Study|Adverse Event|2
7443676|NCT01677182|11729443|FG001|Overall Study|Adverse Event|1
7443677|NCT01677182|11729444|FG002|Overall Study|Adverse Event|8
7443678|NCT01677182|11729442|FG000|Overall Study|Protocol Violation|5
7562002|NCT03214380|11930431|FG000|Treatment Period|Lost to Follow-up|0
7562003|NCT03214380|11930432|FG001|Treatment Period|Lost to Follow-up|6
7562004|NCT03214380|11930433|FG002|Treatment Period|Lost to Follow-up|3
7562005|NCT03214380|11930434|FG003|Treatment Period|Lost to Follow-up|0
7562006|NCT03214380|11930435|FG004|Treatment Period|Lost to Follow-up|0
7562007|NCT03214380|11930436|FG005|Treatment Period|Lost to Follow-up|0
7562008|NCT03214380|11930431|FG000|Treatment Period|Participant schedule|0
7562009|NCT03214380|11930432|FG001|Treatment Period|Participant schedule|0
7562010|NCT03214380|11930433|FG002|Treatment Period|Participant schedule|1
7562011|NCT03214380|11930434|FG003|Treatment Period|Participant schedule|0
7562012|NCT03214380|11930435|FG004|Treatment Period|Participant schedule|0
7562013|NCT03214380|11930436|FG005|Treatment Period|Participant schedule|0
7443679|NCT01677182|11729443|FG001|Overall Study|Protocol Violation|1
7443680|NCT01677182|11729444|FG002|Overall Study|Protocol Violation|4
7443681|NCT01677182|11729442|FG000|Overall Study|Lost to Follow-up|4
7443682|NCT01677182|11729443|FG001|Overall Study|Lost to Follow-up|0
7443683|NCT01677182|11729444|FG002|Overall Study|Lost to Follow-up|3
7443684|NCT01677182|11729442|FG000|Overall Study|Withdrawal by Subject|7
7443685|NCT01677182|11729443|FG001|Overall Study|Withdrawal by Subject|12
7443686|NCT01677182|11729444|FG002|Overall Study|Withdrawal by Subject|10
7443687|NCT01677182|11729442|FG000|Overall Study|Study termination|12
7443688|NCT01677182|11729443|FG001|Overall Study|Study termination|9
7443689|NCT01677182|11729444|FG002|Overall Study|Study termination|11
7562014|NCT03214380|11930431|FG000|Treatment Period|Treatment Interruption|0
7562015|NCT03214380|11930432|FG001|Treatment Period|Treatment Interruption|0
7562016|NCT03214380|11930433|FG002|Treatment Period|Treatment Interruption|1
7443690|NCT01677182|11729442|FG000|Overall Study|Lack of Efficacy|3
7443691|NCT01677182|11729443|FG001|Overall Study|Lack of Efficacy|0
7443692|NCT01677182|11729444|FG002|Overall Study|Lack of Efficacy|1
7443693|NCT01677182|11729442|FG000|Overall Study|Other reasons|1
7443694|NCT01677182|11729443|FG001|Overall Study|Other reasons|5
7443695|NCT01677182|11729444|FG002|Overall Study|Other reasons|2
7443696|NCT01677195|11729455|FG000|Overall Study|Lost to Follow-up|14
7443697|NCT01677195|11729456|FG001|Overall Study|Lost to Follow-up|22
7443698|NCT01677195|11729457|FG002|Overall Study|Lost to Follow-up|22
7443699|NCT01677195|11729455|FG000|Overall Study|Withdrawal by Subject|1
7443700|NCT01677195|11729456|FG001|Overall Study|Withdrawal by Subject|0
7443701|NCT01677195|11729457|FG002|Overall Study|Withdrawal by Subject|1
7443702|NCT01677195|11729455|FG000|Overall Study|Adverse Event|6
7443703|NCT01677195|11729456|FG001|Overall Study|Adverse Event|4
7443704|NCT01677195|11729457|FG002|Overall Study|Adverse Event|1
7443705|NCT01677195|11729455|FG000|Overall Study|Physician Decision|1
7443706|NCT01677195|11729456|FG001|Overall Study|Physician Decision|2
7443707|NCT01677195|11729457|FG002|Overall Study|Physician Decision|2
7443708|NCT01677195|11729455|FG000|Overall Study|Pregnancy|0
7443709|NCT01677195|11729456|FG001|Overall Study|Pregnancy|1
7443710|NCT01677195|11729457|FG002|Overall Study|Pregnancy|0
7443711|NCT01677195|11729455|FG000|Overall Study|Protocol Violation|7
7443712|NCT01677195|11729456|FG001|Overall Study|Protocol Violation|3
7443713|NCT01677195|11729457|FG002|Overall Study|Protocol Violation|4
7443714|NCT01677299|11729475|FG000|Overall Study|Adverse Event|0
7443715|NCT01677299|11729476|FG001|Overall Study|Adverse Event|2
7443716|NCT01677299|11729477|FG002|Overall Study|Adverse Event|1
7443717|NCT01677299|11729478|FG003|Overall Study|Adverse Event|0
7443718|NCT01677299|11729475|FG000|Overall Study|Withdrawal by Subject|0
7443719|NCT01677299|11729476|FG001|Overall Study|Withdrawal by Subject|1
7443720|NCT01677299|11729477|FG002|Overall Study|Withdrawal by Subject|0
7443721|NCT01677299|11729478|FG003|Overall Study|Withdrawal by Subject|1
7467577|NCT01902134|11767996|FG004|Overall Study|Adverse Event|1
7467578|NCT01902134|11767997|FG005|Overall Study|Adverse Event|3
7467579|NCT01902134|11767992|FG000|Overall Study|Lack of Efficacy|0
7467580|NCT01902134|11767993|FG001|Overall Study|Lack of Efficacy|0
7467581|NCT01902134|11767994|FG002|Overall Study|Lack of Efficacy|2
7467582|NCT01902134|11767995|FG003|Overall Study|Lack of Efficacy|0
7467583|NCT01902134|11767996|FG004|Overall Study|Lack of Efficacy|0
7467584|NCT01902134|11767997|FG005|Overall Study|Lack of Efficacy|1
7467585|NCT01902134|11767992|FG000|Overall Study|Physician Decision|0
7467586|NCT01902134|11767993|FG001|Overall Study|Physician Decision|1
7467587|NCT01902134|11767994|FG002|Overall Study|Physician Decision|0
7467588|NCT01902134|11767995|FG003|Overall Study|Physician Decision|0
7467589|NCT01902134|11767996|FG004|Overall Study|Physician Decision|0
7467590|NCT01902134|11767997|FG005|Overall Study|Physician Decision|0
7467591|NCT01902134|11767992|FG000|Overall Study|Protocol Violation|0
7467592|NCT01902134|11767993|FG001|Overall Study|Protocol Violation|0
7467593|NCT01902134|11767994|FG002|Overall Study|Protocol Violation|0
7467594|NCT01902134|11767995|FG003|Overall Study|Protocol Violation|0
7467595|NCT01902134|11767996|FG004|Overall Study|Protocol Violation|0
7467596|NCT01902134|11767997|FG005|Overall Study|Protocol Violation|1
7467597|NCT01902134|11767992|FG000|Overall Study|Withdrawal by Subject|4
7467598|NCT01902134|11767993|FG001|Overall Study|Withdrawal by Subject|8
7467599|NCT01902134|11767994|FG002|Overall Study|Withdrawal by Subject|9
7467600|NCT01902134|11767995|FG003|Overall Study|Withdrawal by Subject|1
7467601|NCT01902134|11767996|FG004|Overall Study|Withdrawal by Subject|5
7467602|NCT01902134|11767997|FG005|Overall Study|Withdrawal by Subject|4
7467603|NCT01902134|11767992|FG000|Overall Study|no compliance|1
7467604|NCT01902134|11767993|FG001|Overall Study|no compliance|0
7467605|NCT01902134|11767994|FG002|Overall Study|no compliance|0
7467606|NCT01902134|11767995|FG003|Overall Study|no compliance|0
7467607|NCT01902134|11767996|FG004|Overall Study|no compliance|0
7467608|NCT01902134|11767997|FG005|Overall Study|no compliance|0
7467609|NCT01902134|11767992|FG000|Overall Study|Other|0
7467610|NCT01902134|11767993|FG001|Overall Study|Other|1
7467611|NCT01902134|11767994|FG002|Overall Study|Other|2
7467612|NCT01902134|11767995|FG003|Overall Study|Other|0
7467613|NCT01902134|11767996|FG004|Overall Study|Other|1
7467614|NCT01902134|11767997|FG005|Overall Study|Other|0
7467615|NCT01902303|11768015|FG000|Overall Study|Adverse Event|0
7467616|NCT01902303|11768016|FG001|Overall Study|Adverse Event|1
7467617|NCT01902303|11768015|FG000|Overall Study|Lost to Follow-up|0
7467618|NCT01902303|11768016|FG001|Overall Study|Lost to Follow-up|1
7467619|NCT01902303|11768015|FG000|Overall Study|Protocol Violation|2
7467620|NCT01902303|11768016|FG001|Overall Study|Protocol Violation|2
7467621|NCT01902303|11768015|FG000|Overall Study|subject lost investigational product|0
7467622|NCT01902303|11768016|FG001|Overall Study|subject lost investigational product|1
7467623|NCT01902303|11768015|FG000|Overall Study|Did not develop a cold sore|21
7467624|NCT01902303|11768016|FG001|Overall Study|Did not develop a cold sore|19
7467625|NCT01902628|11768033|FG000|Overall Study|Withdrawal of participant's consent|7
7467626|NCT01902628|11768033|FG000|Overall Study|Adverse Event|41
7467627|NCT01902628|11768033|FG000|Overall Study|Lost to Follow-up|35
7467628|NCT01903031|11768069|FG000|Overall Study|Not Able to Attend Clinic|1
7467629|NCT01903031|11768070|FG001|Overall Study|Not Able to Attend Clinic|1
7467630|NCT01903031|11768071|FG002|Overall Study|Not Able to Attend Clinic|0
7467631|NCT01903031|11768069|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
7467632|NCT01903031|11768070|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7467633|NCT01903031|11768071|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
7467634|NCT01903031|11768069|FG000|Overall Study|Adverse Event|0
7443722|NCT01677377|11729504|FG000|Overall Study|Protocol Violation|1
7443723|NCT01677377|11729505|FG001|Overall Study|Protocol Violation|0
7443724|NCT01677377|11729506|FG002|Overall Study|Protocol Violation|0
7443725|NCT01677377|11729504|FG000|Overall Study|Lost to Follow-up|0
7443726|NCT01677377|11729505|FG001|Overall Study|Lost to Follow-up|1
7443727|NCT01677377|11729506|FG002|Overall Study|Lost to Follow-up|1
7443728|NCT01677377|11729504|FG000|Overall Study|Withdrawal by Subject|0
7443729|NCT01677377|11729505|FG001|Overall Study|Withdrawal by Subject|0
7443730|NCT01677377|11729506|FG002|Overall Study|Withdrawal by Subject|3
7443731|NCT01677377|11729504|FG000|Overall Study|Lack of Efficacy|0
7443732|NCT01677377|11729505|FG001|Overall Study|Lack of Efficacy|0
7443733|NCT01677377|11729506|FG002|Overall Study|Lack of Efficacy|1
7443734|NCT01677377|11729504|FG000|Overall Study|Pregnancy|0
7562017|NCT03214380|11930434|FG003|Treatment Period|Treatment Interruption|0
7562018|NCT03214380|11930435|FG004|Treatment Period|Treatment Interruption|0
7562019|NCT03214380|11930436|FG005|Treatment Period|Treatment Interruption|0
7562020|NCT03214406|11930450|FG000|Overall Study|did not meet enrollment criteria|9
7562021|NCT03214406|11930451|FG001|Overall Study|did not meet enrollment criteria|13
7562022|NCT03214406|11930450|FG000|Overall Study|Withdrawal by Subject|1
7562023|NCT03214406|11930451|FG001|Overall Study|Withdrawal by Subject|0
7562024|NCT03214406|11930450|FG000|Overall Study|Lost to Follow-up|0
7443735|NCT01677377|11729505|FG001|Overall Study|Pregnancy|0
7443736|NCT01677377|11729506|FG002|Overall Study|Pregnancy|1
7443737|NCT01677507|11729514|FG000|Initial Assignment|Adverse Event|0
7443738|NCT01677507|11729515|FG001|Initial Assignment|Adverse Event|1
7443739|NCT01677507|11729514|FG000|Initial Assignment|Protocol Violation|0
7443740|NCT01677507|11729515|FG001|Initial Assignment|Protocol Violation|1
7443741|NCT01677507|11729514|FG000|Second Assigment|Withdrawal by Subject|2
7443742|NCT01677507|11729515|FG001|Second Assigment|Withdrawal by Subject|2
7443743|NCT01677507|11729514|FG000|Second Assigment|Adverse Event|1
7443744|NCT01677507|11729515|FG001|Second Assigment|Adverse Event|3
7443745|NCT01677624|11729523|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
7443746|NCT01677741|11729535|FG000|Overall Study|Death|0
7443747|NCT01677741|11729536|FG001|Overall Study|Death|0
7443748|NCT01677741|11729537|FG002|Overall Study|Death|0
7443749|NCT01677741|11729538|FG003|Overall Study|Death|1
7443750|NCT01677741|11729539|FG004|Overall Study|Death|0
7443751|NCT01677741|11729540|FG005|Overall Study|Death|1
7443752|NCT01677741|11729541|FG006|Overall Study|Death|0
7443753|NCT01677741|11729542|FG007|Overall Study|Death|0
7443754|NCT01677741|11729535|FG000|Overall Study|Withdrawal by Subject|2
7443755|NCT01677741|11729536|FG001|Overall Study|Withdrawal by Subject|7
7443756|NCT01677741|11729537|FG002|Overall Study|Withdrawal by Subject|5
7443757|NCT01677741|11729538|FG003|Overall Study|Withdrawal by Subject|4
7443758|NCT01677741|11729539|FG004|Overall Study|Withdrawal by Subject|11
7443759|NCT01677741|11729540|FG005|Overall Study|Withdrawal by Subject|20
7443760|NCT01677741|11729541|FG006|Overall Study|Withdrawal by Subject|4
7443761|NCT01677741|11729542|FG007|Overall Study|Withdrawal by Subject|2
7443762|NCT01677741|11729535|FG000|Overall Study|Enrolled in a rollover study|0
7443763|NCT01677741|11729536|FG001|Overall Study|Enrolled in a rollover study|3
7443764|NCT01677741|11729537|FG002|Overall Study|Enrolled in a rollover study|2
7443765|NCT01677741|11729538|FG003|Overall Study|Enrolled in a rollover study|1
7443766|NCT01677741|11729539|FG004|Overall Study|Enrolled in a rollover study|6
7443767|NCT01677741|11729540|FG005|Overall Study|Enrolled in a rollover study|6
7443768|NCT01677741|11729541|FG006|Overall Study|Enrolled in a rollover study|7
7443769|NCT01677741|11729542|FG007|Overall Study|Enrolled in a rollover study|0
7443770|NCT01677741|11729535|FG000|Overall Study|Progressive disease|1
7443771|NCT01677741|11729536|FG001|Overall Study|Progressive disease|0
7443772|NCT01677741|11729537|FG002|Overall Study|Progressive disease|1
7443773|NCT01677741|11729538|FG003|Overall Study|Progressive disease|0
7443774|NCT01677741|11729539|FG004|Overall Study|Progressive disease|0
7443775|NCT01677741|11729540|FG005|Overall Study|Progressive disease|1
7443776|NCT01677741|11729541|FG006|Overall Study|Progressive disease|0
7443777|NCT01677741|11729542|FG007|Overall Study|Progressive disease|0
7467635|NCT01903031|11768070|FG001|Overall Study|Adverse Event|1
7467636|NCT01903031|11768071|FG002|Overall Study|Adverse Event|0
7467637|NCT01903031|11768069|FG000|Overall Study|Withdrawal by Subject|0
7467638|NCT01903031|11768070|FG001|Overall Study|Withdrawal by Subject|1
7467639|NCT01903031|11768071|FG002|Overall Study|Withdrawal by Subject|1
7467640|NCT01903031|11768069|FG000|Overall Study|Protocol Violation|0
7467641|NCT01903031|11768070|FG001|Overall Study|Protocol Violation|0
7467642|NCT01903031|11768071|FG002|Overall Study|Protocol Violation|2
7467643|NCT01903031|11768069|FG000|Overall Study|Lost to Follow-up|0
7467644|NCT01903031|11768070|FG001|Overall Study|Lost to Follow-up|0
7467645|NCT01903031|11768071|FG002|Overall Study|Lost to Follow-up|1
7467646|NCT01903031|11768069|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
7467647|NCT01903031|11768070|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
7467648|NCT01903031|11768071|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
7562025|NCT03214406|11930451|FG001|Overall Study|Lost to Follow-up|2
7467649|NCT01903252|11768102|FG000|Double-Blind Induction|Adverse Event|20
7467650|NCT01903252|11768103|FG001|Double-Blind Induction|Adverse Event|18
7467651|NCT01903252|11768104|FG002|Double-Blind Induction|Adverse Event|0
7467652|NCT01903252|11768105|FG003|Double-Blind Induction|Adverse Event|0
7467653|NCT01903252|11768106|FG004|Double-Blind Induction|Adverse Event|0
7443778|NCT01677767|11729576|FG000|Overall Study|Adverse Event|1
7443779|NCT01677767|11729576|FG000|Overall Study|Death|4
7443780|NCT01677767|11729576|FG000|Overall Study|Protocol Violation|4
7443781|NCT01677767|11729576|FG000|Overall Study|Withdrawal by Subject|10
7443782|NCT01677767|11729576|FG000|Overall Study|Non-compliance by the participants|3
7443813|NCT01677910|11729611|FG000|Double-Blind Treatment Period|Adverse Event|6
7443814|NCT01677910|11729612|FG001|Double-Blind Treatment Period|Adverse Event|2
7443815|NCT01677910|11729613|FG002|Double-Blind Treatment Period|Adverse Event|3
7443816|NCT01677910|11729614|FG003|Double-Blind Treatment Period|Adverse Event|0
7443817|NCT01677910|11729611|FG000|Double-Blind Treatment Period|Physician Decision|0
7443818|NCT01677910|11729612|FG001|Double-Blind Treatment Period|Physician Decision|0
7443819|NCT01677910|11729613|FG002|Double-Blind Treatment Period|Physician Decision|1
7443820|NCT01677910|11729614|FG003|Double-Blind Treatment Period|Physician Decision|0
7443821|NCT01677910|11729611|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
7443822|NCT01677910|11729612|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
7443823|NCT01677910|11729613|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
7443824|NCT01677910|11729614|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
7443825|NCT01677910|11729611|FG000|Double-Blind Treatment Period|Reason Not Specified|0
7443826|NCT01677910|11729612|FG001|Double-Blind Treatment Period|Reason Not Specified|1
7443827|NCT01677910|11729613|FG002|Double-Blind Treatment Period|Reason Not Specified|0
7443828|NCT01677910|11729614|FG003|Double-Blind Treatment Period|Reason Not Specified|0
7443829|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
7443830|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
7443831|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
7443832|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
7443833|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
7443834|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
7443835|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
7443836|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
7443837|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7443838|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7443839|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
7443840|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
7443841|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7443842|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7443843|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
7443844|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
7443845|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
7443846|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
7443847|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
7443848|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
7443849|NCT01677910|11729611|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7443850|NCT01677910|11729612|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7443851|NCT01677910|11729613|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
7443852|NCT01677910|11729614|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
7443853|NCT01677936|11729626|FG000|Overall Study|Lost to Follow-up|4
7443854|NCT01677936|11729627|FG001|Overall Study|Lost to Follow-up|1
7443855|NCT01677936|11729626|FG000|Overall Study|Protocol Violation|3
7443856|NCT01677936|11729627|FG001|Overall Study|Protocol Violation|0
7443857|NCT01677936|11729626|FG000|Overall Study|Adverse Event|1
7443858|NCT01677936|11729627|FG001|Overall Study|Adverse Event|0
7443859|NCT01677936|11729626|FG000|Overall Study|Lost to Follow-up|1
7443860|NCT01677936|11729627|FG001|Overall Study|Lost to Follow-up|0
7443861|NCT01677936|11729626|FG000|Overall Study|Protocol Violation|0
7443862|NCT01677936|11729627|FG001|Overall Study|Protocol Violation|4
7443863|NCT01677988|11729633|FG000|Overall Study|Lack of Efficacy|2
7443870|NCT01678144|11729651|FG000|Stage 1: MAR Classic|Adverse Event|1
7443871|NCT01678209|11729667|FG000|Overall Study|could not scan twice|1
7443872|NCT01678209|11729668|FG001|Overall Study|could not scan twice|1
7443873|NCT01678209|11729669|FG002|Overall Study|could not scan twice|1
7443874|NCT01678209|11729667|FG000|Overall Study|scheduling conflicts|0
7443875|NCT01678209|11729668|FG001|Overall Study|scheduling conflicts|0
7443876|NCT01678209|11729669|FG002|Overall Study|scheduling conflicts|1
7443877|NCT01678209|11729667|FG000|Overall Study|screen fail|16
7443878|NCT01678209|11729668|FG001|Overall Study|screen fail|17
7443879|NCT01678209|11729669|FG002|Overall Study|screen fail|16
7443880|NCT01678313|11729679|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
7443881|NCT01678313|11729680|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
7443882|NCT01678313|11729679|FG000|Completed the 3-month Therapy|Physician Decision|3
7443883|NCT01678313|11729680|FG001|Completed the 3-month Therapy|Physician Decision|4
7443884|NCT01678313|11729679|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
7443885|NCT01678313|11729680|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
7443886|NCT01678313|11729679|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
7443887|NCT01678313|11729680|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
7443888|NCT01678560|11729692|FG000|Overall Study|Physician Decision|4
7443889|NCT01678560|11729693|FG001|Overall Study|Physician Decision|4
7443890|NCT01678560|11729692|FG000|Overall Study|Death|0
7443891|NCT01678560|11729693|FG001|Overall Study|Death|1
7443892|NCT01678560|11729692|FG000|Overall Study|Withdrawal by Subject|0
7443893|NCT01678560|11729693|FG001|Overall Study|Withdrawal by Subject|1
7443894|NCT01678807|11729715|FG000|Overall Study|Adverse Event|4
7443895|NCT01678807|11729716|FG001|Overall Study|Adverse Event|4
7443896|NCT01678807|11729717|FG002|Overall Study|Adverse Event|0
7443897|NCT01678807|11729715|FG000|Overall Study|Withdrawn by Parent/Guardian|0
7443898|NCT01678807|11729716|FG001|Overall Study|Withdrawn by Parent/Guardian|1
7443899|NCT01678807|11729717|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7443900|NCT01678820|11729728|FG000|Overall Study|Study Terminated by Sponsor|45
7443901|NCT01678820|11729729|FG001|Overall Study|Study Terminated by Sponsor|43
7443902|NCT01678820|11729730|FG002|Overall Study|Study Terminated by Sponsor|43
7443903|NCT01678820|11729728|FG000|Overall Study|Withdrawal by Subject|2
7443904|NCT01678820|11729729|FG001|Overall Study|Withdrawal by Subject|5
7443905|NCT01678820|11729730|FG002|Overall Study|Withdrawal by Subject|2
7443906|NCT01678820|11729728|FG000|Overall Study|Protocol Specified Criteria|2
7443907|NCT01678820|11729729|FG001|Overall Study|Protocol Specified Criteria|3
7443908|NCT01678820|11729730|FG002|Overall Study|Protocol Specified Criteria|1
7443909|NCT01678820|11729728|FG000|Overall Study|Adverse Event|2
7443910|NCT01678820|11729729|FG001|Overall Study|Adverse Event|2
7443911|NCT01678820|11729730|FG002|Overall Study|Adverse Event|2
7443912|NCT01678820|11729728|FG000|Overall Study|Lost to Follow-up|7
7443913|NCT01678820|11729729|FG001|Overall Study|Lost to Follow-up|2
7443914|NCT01678820|11729730|FG002|Overall Study|Lost to Follow-up|2
7443915|NCT01678820|11729728|FG000|Overall Study|Non-compliance with study drug|0
7443916|NCT01678820|11729729|FG001|Overall Study|Non-compliance with study drug|1
7443917|NCT01678820|11729730|FG002|Overall Study|Non-compliance with study drug|0
7443918|NCT01678820|11729728|FG000|Overall Study|Physician Decision|0
7443919|NCT01678820|11729729|FG001|Overall Study|Physician Decision|0
7443920|NCT01678820|11729730|FG002|Overall Study|Physician Decision|1
7443921|NCT01678820|11729728|FG000|Overall Study|Protocol Violation|4
7443922|NCT01678820|11729729|FG001|Overall Study|Protocol Violation|5
7443923|NCT01678820|11729730|FG002|Overall Study|Protocol Violation|4
7443924|NCT01678820|11729728|FG000|Overall Study|Not treated with double-blind study drug|0
7443925|NCT01678820|11729729|FG001|Overall Study|Not treated with double-blind study drug|2
7443926|NCT01678820|11729730|FG002|Overall Study|Not treated with double-blind study drug|2
7443927|NCT01678898|11729765|FG000|PB-102-F01|Adverse Event|0
7443928|NCT01678898|11729766|FG001|PB-102-F01|Adverse Event|1
7443929|NCT01678898|11729767|FG002|PB-102-F01|Adverse Event|0
7443930|NCT01678898|11729765|FG000|PB-102-F01|Physician Decision|0
7443931|NCT01678898|11729766|FG001|PB-102-F01|Physician Decision|1
7443932|NCT01678898|11729767|FG002|PB-102-F01|Physician Decision|0
7443933|NCT01678911|11729784|FG000|Second Intervention|Lost to Follow-up|2
7443934|NCT01678911|11729785|FG001|Second Intervention|Lost to Follow-up|0
7443935|NCT01678924|11729795|FG000|Overall Study|Adverse Event|1
7443936|NCT01678924|11729796|FG001|Overall Study|Adverse Event|1
7443937|NCT01678924|11729797|FG002|Overall Study|Adverse Event|0
7443938|NCT01678924|11729798|FG003|Overall Study|Adverse Event|1
7443939|NCT01678924|11729795|FG000|Overall Study|Lack of Efficacy|7
7443940|NCT01678924|11729796|FG001|Overall Study|Lack of Efficacy|2
7443941|NCT01678924|11729797|FG002|Overall Study|Lack of Efficacy|0
7443942|NCT01678924|11729798|FG003|Overall Study|Lack of Efficacy|5
7443943|NCT01678924|11729795|FG000|Overall Study|Lost to Follow-up|0
7443944|NCT01678924|11729796|FG001|Overall Study|Lost to Follow-up|4
7443945|NCT01678924|11729797|FG002|Overall Study|Lost to Follow-up|0
7443946|NCT01678924|11729798|FG003|Overall Study|Lost to Follow-up|2
7443947|NCT01678924|11729795|FG000|Overall Study|Personal Reasons|2
7443948|NCT01678924|11729796|FG001|Overall Study|Personal Reasons|2
7443949|NCT01678924|11729797|FG002|Overall Study|Personal Reasons|2
7443950|NCT01678924|11729798|FG003|Overall Study|Personal Reasons|7
7443951|NCT01678924|11729795|FG000|Overall Study|Withdrawal by Subject|0
7443952|NCT01678924|11729796|FG001|Overall Study|Withdrawal by Subject|3
7443953|NCT01678924|11729797|FG002|Overall Study|Withdrawal by Subject|0
7443954|NCT01678924|11729798|FG003|Overall Study|Withdrawal by Subject|2
7443955|NCT01678924|11729795|FG000|Overall Study|Unable to attend scheduled visits|0
7443956|NCT01678924|11729796|FG001|Overall Study|Unable to attend scheduled visits|0
7443957|NCT01678924|11729797|FG002|Overall Study|Unable to attend scheduled visits|0
7443958|NCT01678924|11729798|FG003|Overall Study|Unable to attend scheduled visits|1
7443959|NCT01679002|11729824|FG000|Overall Study|Adverse Event|1
7443960|NCT01679002|11729825|FG001|Overall Study|Adverse Event|1
7443961|NCT01679002|11729826|FG002|Overall Study|Adverse Event|0
7443962|NCT01679236|11729871|FG000|Overall Study|Lost to Follow-up|15
7443963|NCT01679236|11729872|FG001|Overall Study|Lost to Follow-up|15
7443964|NCT01679301|11729878|FG000|Screening Period|screen failure|3
7443965|NCT01679301|11729879|FG001|Screening Period|screen failure|0
7443966|NCT01679301|11729880|FG002|Screening Period|screen failure|0
7443967|NCT01679405|11729901|FG000|Overall Study|Death|2
7443968|NCT01679405|11729902|FG001|Overall Study|Death|5
7443969|NCT01679613|11729917|FG000|Overall Study|other than stated above|0
7443970|NCT01679613|11729918|FG001|Overall Study|other than stated above|1
7443971|NCT01679613|11729919|FG002|Overall Study|other than stated above|2
7443972|NCT01679613|11729920|FG003|Overall Study|other than stated above|2
7443973|NCT01680016|11729929|FG000|Overall Study|Adverse Event|0
7443974|NCT01680016|11729930|FG001|Overall Study|Adverse Event|0
7443975|NCT01680016|11729931|FG002|Overall Study|Adverse Event|1
7443976|NCT01680016|11729932|FG003|Overall Study|Adverse Event|4
7443977|NCT01680016|11729929|FG000|Overall Study|The Subject went out of The Trial|1
7443978|NCT01680016|11729930|FG001|Overall Study|The Subject went out of The Trial|0
7443979|NCT01680016|11729931|FG002|Overall Study|The Subject went out of The Trial|3
7443980|NCT01680016|11729932|FG003|Overall Study|The Subject went out of The Trial|0
7443981|NCT01680016|11729929|FG000|Overall Study|Protocol Violation|0
7443982|NCT01680016|11729930|FG001|Overall Study|Protocol Violation|1
7443983|NCT01680016|11729931|FG002|Overall Study|Protocol Violation|0
7443984|NCT01680016|11729932|FG003|Overall Study|Protocol Violation|0
7443985|NCT01680016|11729929|FG000|Overall Study|Withdrawal by Subject|5
7443986|NCT01680016|11729930|FG001|Overall Study|Withdrawal by Subject|7
7443987|NCT01680016|11729931|FG002|Overall Study|Withdrawal by Subject|1
7443988|NCT01680016|11729932|FG003|Overall Study|Withdrawal by Subject|1
7443989|NCT01680159|11729958|FG000|Screening Period|Not meet criteria for dose-up period|7
7443990|NCT01680159|11729958|FG000|Increased Dose Period|Adverse Event|6
7443991|NCT01680159|11729958|FG000|Increased Dose Period|Withdrawal by Subject|2
7443992|NCT01680341|11730024|FG000|Overall Study|Adverse Event|3
7443993|NCT01680341|11730025|FG001|Overall Study|Adverse Event|2
7443994|NCT01680341|11730024|FG000|Overall Study|Unclassified|18
7443995|NCT01680341|11730025|FG001|Overall Study|Unclassified|15
7443996|NCT01680458|11730031|FG000|Overall Study|Protocol Violation|3
7443997|NCT01680497|11730035|FG000|Overall Study|Lost to Follow-up|2
7443998|NCT01680861|11730102|FG000|Early Post-transplant Period|Protocol Violation|1
7443999|NCT01680861|11730103|FG001|Early Post-transplant Period|Protocol Violation|1
7444000|NCT01680991|11730132|FG000|Overall Study|Adverse Event|1
7444001|NCT01680991|11730133|FG001|Overall Study|Adverse Event|0
7444002|NCT01680991|11730134|FG002|Overall Study|Adverse Event|0
7444003|NCT01680991|11730132|FG000|Overall Study|Death|1
7444004|NCT01680991|11730133|FG001|Overall Study|Death|0
7444005|NCT01680991|11730134|FG002|Overall Study|Death|1
7444006|NCT01680991|11730132|FG000|Overall Study|Protocol Violation|0
7444007|NCT01680991|11730133|FG001|Overall Study|Protocol Violation|1
7444008|NCT01680991|11730134|FG002|Overall Study|Protocol Violation|0
7444009|NCT01680991|11730132|FG000|Overall Study|Withdrawal by Subject|5
7444010|NCT01680991|11730133|FG001|Overall Study|Withdrawal by Subject|1
7444011|NCT01680991|11730134|FG002|Overall Study|Withdrawal by Subject|0
7444012|NCT01680991|11730132|FG000|Overall Study|Progressive disease (PD)|0
7444013|NCT01680991|11730133|FG001|Overall Study|Progressive disease (PD)|10
7444014|NCT01680991|11730134|FG002|Overall Study|Progressive disease (PD)|0
7444015|NCT01680991|11730132|FG000|Overall Study|Physician Decision|0
7444016|NCT01680991|11730133|FG001|Overall Study|Physician Decision|7
7444017|NCT01680991|11730134|FG002|Overall Study|Physician Decision|2
7444018|NCT01680991|11730132|FG000|Overall Study|Bad physical condition|0
7444019|NCT01680991|11730133|FG001|Overall Study|Bad physical condition|0
7444020|NCT01680991|11730134|FG002|Overall Study|Bad physical condition|1
7444021|NCT01680991|11730132|FG000|Overall Study|PD confirmed in other hospital|1
7444022|NCT01680991|11730133|FG001|Overall Study|PD confirmed in other hospital|0
7444023|NCT01680991|11730134|FG002|Overall Study|PD confirmed in other hospital|0
7444024|NCT01681004|11730146|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
7444025|NCT01681004|11730147|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
7444026|NCT01681004|11730146|FG000|Study Completion|Lost to Follow-up|8
7444027|NCT01681004|11730147|FG001|Study Completion|Lost to Follow-up|3
7444028|NCT01681004|11730146|FG000|Study Completion|Physician Decision|1
7444029|NCT01681004|11730147|FG001|Study Completion|Physician Decision|3
7444030|NCT01681004|11730146|FG000|Study Completion|Site Termination|2
7444031|NCT01681004|11730147|FG001|Study Completion|Site Termination|1
7444032|NCT01681004|11730146|FG000|Study Completion|Death|1
7444033|NCT01681004|11730147|FG001|Study Completion|Death|1
7444034|NCT01681069|11730172|FG000|Overall Study|Withdrawal by Subject|4
7444035|NCT01681069|11730173|FG001|Overall Study|Withdrawal by Subject|5
7444036|NCT01681069|11730172|FG000|Overall Study|Protocol Violation|1
7444037|NCT01681069|11730173|FG001|Overall Study|Protocol Violation|1
7444038|NCT01681069|11730172|FG000|Overall Study|Adverse Event|0
7444039|NCT01681069|11730173|FG001|Overall Study|Adverse Event|1
7444040|NCT01681186|11730207|FG000|Washout Period From Second Intervention|Adverse Event|0
7444041|NCT01681186|11730208|FG001|Washout Period From Second Intervention|Adverse Event|0
7444042|NCT01681186|11730209|FG002|Washout Period From Second Intervention|Adverse Event|0
7444043|NCT01681186|11730210|FG003|Washout Period From Second Intervention|Adverse Event|0
7444044|NCT01681186|11730211|FG004|Washout Period From Second Intervention|Adverse Event|0
7444045|NCT01681186|11730212|FG005|Washout Period From Second Intervention|Adverse Event|0
7444046|NCT01681186|11730213|FG006|Washout Period From Second Intervention|Adverse Event|1
7444047|NCT01681186|11730214|FG007|Washout Period From Second Intervention|Adverse Event|0
7444048|NCT01681186|11730207|FG000|Washout Period From Second Intervention|Protocol Violation|0
7444049|NCT01681186|11730208|FG001|Washout Period From Second Intervention|Protocol Violation|0
7444050|NCT01681186|11730209|FG002|Washout Period From Second Intervention|Protocol Violation|0
7444051|NCT01681186|11730210|FG003|Washout Period From Second Intervention|Protocol Violation|0
7444052|NCT01681186|11730211|FG004|Washout Period From Second Intervention|Protocol Violation|0
7444053|NCT01681186|11730212|FG005|Washout Period From Second Intervention|Protocol Violation|0
7444054|NCT01681186|11730213|FG006|Washout Period From Second Intervention|Protocol Violation|0
7444055|NCT01681186|11730214|FG007|Washout Period From Second Intervention|Protocol Violation|1
7444056|NCT01681186|11730207|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
7444057|NCT01681186|11730208|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
7444058|NCT01681186|11730209|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
7444059|NCT01681186|11730210|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
7444060|NCT01681186|11730211|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
7444061|NCT01681186|11730212|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
7444062|NCT01681186|11730213|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
7444063|NCT01681186|11730214|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
7444064|NCT01681186|11730207|FG000|Fourth Intervention|Protocol Violation|0
7444065|NCT01681186|11730208|FG001|Fourth Intervention|Protocol Violation|0
7444066|NCT01681186|11730209|FG002|Fourth Intervention|Protocol Violation|0
7444067|NCT01681186|11730210|FG003|Fourth Intervention|Protocol Violation|0
7444068|NCT01681186|11730211|FG004|Fourth Intervention|Protocol Violation|0
7444069|NCT01681186|11730212|FG005|Fourth Intervention|Protocol Violation|0
7444070|NCT01681186|11730213|FG006|Fourth Intervention|Protocol Violation|0
7444071|NCT01681186|11730214|FG007|Fourth Intervention|Protocol Violation|1
7444072|NCT01681212|11730244|FG000|Overall Study|No longer met study criteria|5
7444073|NCT01681212|11730244|FG000|Overall Study|Administrative reason by sponsor|1
7444074|NCT01681277|11730253|FG000|Overall Study|Adverse Event|1
7444075|NCT01681277|11730254|FG001|Overall Study|Adverse Event|0
7444076|NCT01681277|11730255|FG002|Overall Study|Adverse Event|0
7444077|NCT01681277|11730256|FG003|Overall Study|Adverse Event|0
7444078|NCT01681277|11730257|FG004|Overall Study|Adverse Event|0
7444079|NCT01681368|11730273|FG000|Overall Study|Refused further treatment|1
7444080|NCT01681368|11730273|FG000|Overall Study|Refused further follow up|1
7562026|NCT03214588|11930460|FG000|Overall Study|Adverse Event|1
7562027|NCT03214588|11930461|FG001|Overall Study|Adverse Event|0
7562028|NCT03214588|11930462|FG002|Overall Study|Adverse Event|2
7562029|NCT03214588|11930460|FG000|Overall Study|Reason Not Specified|0
7562030|NCT03214588|11930461|FG001|Overall Study|Reason Not Specified|1
7562031|NCT03214588|11930462|FG002|Overall Study|Reason Not Specified|0
7562032|NCT03214640|11930474|FG000|Overall Study|Protocol Violation|1
7562033|NCT03214640|11930475|FG001|Overall Study|Protocol Violation|2
7562034|NCT03214640|11930476|FG002|Overall Study|Protocol Violation|1
7562035|NCT03214640|11930477|FG003|Overall Study|Protocol Violation|4
7562036|NCT03214952|11930487|FG000|Overall Study|Protocol Deviation|45
7562037|NCT03214952|11930487|FG000|Overall Study|Case Report Forms Uncollected|13
7444091|NCT01681472|11730290|FG000|Overall Study|Adverse Event|0
7444092|NCT01681472|11730291|FG001|Overall Study|Adverse Event|1
7444093|NCT01681472|11730292|FG002|Overall Study|Adverse Event|0
7444094|NCT01681472|11730293|FG003|Overall Study|Adverse Event|0
7444095|NCT01681511|11730314|FG000|Overall Study|No Treatment Received|1
7444096|NCT01681511|11730315|FG001|Overall Study|No Treatment Received|3
7444097|NCT01681511|11730314|FG000|Overall Study|Failed Inclusion/Exclusion|3
7532945|NCT02678286|11878882|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
7562038|NCT03215667|11930491|FG000|Overall Study|Physician Decision|4
7444098|NCT01681511|11730315|FG001|Overall Study|Failed Inclusion/Exclusion|0
7444099|NCT01681511|11730314|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
7444100|NCT01681511|11730315|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
7444101|NCT01681511|11730314|FG000|Overall Study|No Daily Urine Sample Collected|0
7444102|NCT01681511|11730315|FG001|Overall Study|No Daily Urine Sample Collected|1
7444103|NCT01681511|11730314|FG000|Overall Study|No post-catheter sample collected|11
7444104|NCT01681511|11730315|FG001|Overall Study|No post-catheter sample collected|4
7444105|NCT01681576|11730323|FG000|Period 1|Adverse Event|1
7444106|NCT01681576|11730324|FG001|Period 1|Adverse Event|0
7444107|NCT01681576|11730323|FG000|Period 1|Protocol Deviation|1
7444108|NCT01681576|11730324|FG001|Period 1|Protocol Deviation|0
7444109|NCT01681576|11730323|FG000|Period 2|subject/guardian decision|3
7444110|NCT01681576|11730324|FG001|Period 2|subject/guardian decision|1
7444111|NCT01681576|11730323|FG000|Period 2|Non-compliance with study treatment|1
7444112|NCT01681576|11730324|FG001|Period 2|Non-compliance with study treatment|0
7444113|NCT01681628|11730334|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
7444114|NCT01681628|11730335|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
7444115|NCT01681628|11730334|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
7444116|NCT01681628|11730335|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
7444117|NCT01681628|11730334|FG000|19 Months Follow-up|Death|1
7444118|NCT01681628|11730335|FG001|19 Months Follow-up|Death|0
7444119|NCT01681628|11730334|FG000|19 Months Follow-up|Lost to Follow-up|61
7444120|NCT01681628|11730335|FG001|19 Months Follow-up|Lost to Follow-up|43
7444121|NCT01681771|11730346|FG000|Overall Study|Lost to Follow-up|4
7444122|NCT01681771|11730347|FG001|Overall Study|Lost to Follow-up|2
7444123|NCT01681836|11730357|FG000|Second Intervention|Withdrawal by Subject|0
7444124|NCT01681836|11730358|FG001|Second Intervention|Withdrawal by Subject|1
7444125|NCT01681849|11730367|FG000|Overall Study|Protocol Violation|2
7444126|NCT01681849|11730368|FG001|Overall Study|Protocol Violation|0
7444127|NCT01681849|11730369|FG002|Overall Study|Protocol Violation|0
7444128|NCT01681849|11730367|FG000|Overall Study|Withdrawal by Subject|3
7444129|NCT01681849|11730368|FG001|Overall Study|Withdrawal by Subject|5
7444130|NCT01681849|11730369|FG002|Overall Study|Withdrawal by Subject|33
7444131|NCT01681849|11730367|FG000|Overall Study|Lost to Follow-up|3
7444132|NCT01681849|11730368|FG001|Overall Study|Lost to Follow-up|2
7444133|NCT01681849|11730369|FG002|Overall Study|Lost to Follow-up|6
7444134|NCT01681992|11730379|FG000|Overall Study|Adverse Event|3
7444135|NCT01681992|11730380|FG001|Overall Study|Adverse Event|2
7444136|NCT01681992|11730381|FG002|Overall Study|Adverse Event|3
7444137|NCT01681992|11730379|FG000|Overall Study|Lost to Follow-up|36
7444138|NCT01681992|11730380|FG001|Overall Study|Lost to Follow-up|38
7444139|NCT01681992|11730381|FG002|Overall Study|Lost to Follow-up|53
7444140|NCT01681992|11730379|FG000|Overall Study|As Per Sponsor Decision|0
7444141|NCT01681992|11730380|FG001|Overall Study|As Per Sponsor Decision|0
7444142|NCT01681992|11730381|FG002|Overall Study|As Per Sponsor Decision|1
7444143|NCT01681992|11730379|FG000|Overall Study|Protocol Violation|0
7444144|NCT01681992|11730380|FG001|Overall Study|Protocol Violation|0
7444145|NCT01681992|11730381|FG002|Overall Study|Protocol Violation|1
7444146|NCT01681992|11730379|FG000|Overall Study|Withdrawal by Subject|27
7444147|NCT01681992|11730380|FG001|Overall Study|Withdrawal by Subject|30
7444148|NCT01681992|11730381|FG002|Overall Study|Withdrawal by Subject|25
7444149|NCT01682031|11730391|FG000|Overall Study|Withdrawal by Subject|0
7444150|NCT01682031|11730392|FG001|Overall Study|Withdrawal by Subject|1
7444151|NCT01682031|11730391|FG000|Overall Study|Adverse Event|0
7444152|NCT01682031|11730392|FG001|Overall Study|Adverse Event|2
7444153|NCT01682031|11730391|FG000|Overall Study|MRI results indicate increased nodul|0
7444154|NCT01682031|11730392|FG001|Overall Study|MRI results indicate increased nodul|1
7444155|NCT01682031|11730391|FG000|Overall Study|Patient could not swallow tablets|1
7444156|NCT01682031|11730392|FG001|Overall Study|Patient could not swallow tablets|0
7444157|NCT01682031|11730391|FG000|Overall Study|Patient stopped selenium on his own|0
7444158|NCT01682031|11730392|FG001|Overall Study|Patient stopped selenium on his own|1
7444159|NCT01682044|11730398|FG000|Overall Study|Death|1
7444160|NCT01682044|11730398|FG000|Overall Study|Progression|3
7444175|NCT01682213|11730440|FG000|Overall Study|Withdrawal by Subject|2
7444176|NCT01682460|11730445|FG000|Overall Study|Withdrawal by Subject|2
7444177|NCT01682460|11730445|FG000|Overall Study|Did not meet inclusion criteria|2
7444178|NCT01682512|11730452|FG000|Overall Study|Adverse Event|6
7444179|NCT01682512|11730453|FG001|Overall Study|Adverse Event|5
7444180|NCT01682512|11730454|FG002|Overall Study|Adverse Event|2
7444181|NCT01682512|11730452|FG000|Overall Study|Withdrawal by Subject|2
7444182|NCT01682512|11730453|FG001|Overall Study|Withdrawal by Subject|6
7444183|NCT01682512|11730454|FG002|Overall Study|Withdrawal by Subject|3
7444184|NCT01682512|11730452|FG000|Overall Study|Physician Decision|0
7444185|NCT01682512|11730453|FG001|Overall Study|Physician Decision|2
7444186|NCT01682512|11730454|FG002|Overall Study|Physician Decision|0
7444187|NCT01682512|11730452|FG000|Overall Study|Study terminated by sponsor|46
7444188|NCT01682512|11730453|FG001|Overall Study|Study terminated by sponsor|43
7444189|NCT01682512|11730454|FG002|Overall Study|Study terminated by sponsor|0
7444190|NCT01682512|11730452|FG000|Overall Study|Lost to Follow-up|3
7444191|NCT01682512|11730453|FG001|Overall Study|Lost to Follow-up|0
7444192|NCT01682512|11730454|FG002|Overall Study|Lost to Follow-up|2
7444193|NCT01682512|11730452|FG000|Overall Study|Protocol Violation|2
7444194|NCT01682512|11730453|FG001|Overall Study|Protocol Violation|3
7444195|NCT01682512|11730454|FG002|Overall Study|Protocol Violation|2
7444196|NCT01682512|11730452|FG000|Overall Study|Primary lack of efficacy|10
7444197|NCT01682512|11730453|FG001|Overall Study|Primary lack of efficacy|7
7444198|NCT01682512|11730454|FG002|Overall Study|Primary lack of efficacy|7
7444199|NCT01682512|11730452|FG000|Overall Study|Secondary lack of efficacy|1
7444200|NCT01682512|11730453|FG001|Overall Study|Secondary lack of efficacy|1
7444201|NCT01682512|11730454|FG002|Overall Study|Secondary lack of efficacy|0
7444202|NCT01682512|11730452|FG000|Overall Study|Other than stated above|2
7444203|NCT01682512|11730453|FG001|Overall Study|Other than stated above|4
7444204|NCT01682512|11730454|FG002|Overall Study|Other than stated above|2
7444205|NCT01682603|11730477|FG000|Overall Study|Lost to Follow-up|3
7444206|NCT01682681|11730498|FG000|Overall Study|Lack of Efficacy|62
7444207|NCT01682681|11730498|FG000|Overall Study|Withdrawal by Subject|1
7444208|NCT01682681|11730498|FG000|Overall Study|Moved to other hospital|10
7444209|NCT01682681|11730498|FG000|Overall Study|Lost to Follow-up|174
7444210|NCT01682681|11730498|FG000|Overall Study|Adverse Event|46
7444211|NCT01682681|11730498|FG000|Overall Study|tapering of topiramate|5
7444212|NCT01682681|11730498|FG000|Overall Study|Other|21
7444213|NCT01682681|11730498|FG000|Overall Study|Low compliance|13
7444214|NCT01682720|11730506|FG000|Overall Study|Randomized but Not Treated|0
7444215|NCT01682720|11730507|FG001|Overall Study|Randomized but Not Treated|1
7444216|NCT01682720|11730508|FG002|Overall Study|Randomized but Not Treated|1
7444217|NCT01682720|11730509|FG003|Overall Study|Randomized but Not Treated|0
7444218|NCT01682720|11730506|FG000|Overall Study|Terminated by Sponsor|83
7444219|NCT01682720|11730507|FG001|Overall Study|Terminated by Sponsor|0
7444220|NCT01682720|11730508|FG002|Overall Study|Terminated by Sponsor|0
7444221|NCT01682720|11730509|FG003|Overall Study|Terminated by Sponsor|0
7444222|NCT01682720|11730506|FG000|Overall Study|Efficacy Failure|0
7444223|NCT01682720|11730507|FG001|Overall Study|Efficacy Failure|3
7444224|NCT01682720|11730508|FG002|Overall Study|Efficacy Failure|3
7444225|NCT01682720|11730509|FG003|Overall Study|Efficacy Failure|30
7444226|NCT01682720|11730506|FG000|Overall Study|Lost to Follow-up|1
7444227|NCT01682720|11730507|FG001|Overall Study|Lost to Follow-up|1
7444228|NCT01682720|11730508|FG002|Overall Study|Lost to Follow-up|0
7444229|NCT01682720|11730509|FG003|Overall Study|Lost to Follow-up|6
7444230|NCT01682720|11730506|FG000|Overall Study|Subject Withdrew Consent|0
7444231|NCT01682720|11730507|FG001|Overall Study|Subject Withdrew Consent|0
7444232|NCT01682720|11730508|FG002|Overall Study|Subject Withdrew Consent|2
7444233|NCT01682720|11730509|FG003|Overall Study|Subject Withdrew Consent|2
7444234|NCT01682720|11730506|FG000|Overall Study|Adverse Event|1
7444235|NCT01682720|11730507|FG001|Overall Study|Adverse Event|0
7444236|NCT01682720|11730508|FG002|Overall Study|Adverse Event|1
7444237|NCT01682720|11730509|FG003|Overall Study|Adverse Event|1
7444238|NCT01682759|11730521|FG000|Overall Study|Death|2
7444239|NCT01682759|11730522|FG001|Overall Study|Death|1
7444240|NCT01682759|11730521|FG000|Overall Study|Lost to Follow-up|10
7444241|NCT01682759|11730522|FG001|Overall Study|Lost to Follow-up|13
7444242|NCT01682759|11730521|FG000|Overall Study|Physician Decision|1
7444243|NCT01682759|11730522|FG001|Overall Study|Physician Decision|1
7444244|NCT01682759|11730521|FG000|Overall Study|Withdrawal by Subject|56
7444245|NCT01682759|11730522|FG001|Overall Study|Withdrawal by Subject|55
7444246|NCT01682811|11730535|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
7444247|NCT01682811|11730536|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
7444248|NCT01682811|11730537|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
7444249|NCT01682811|11730538|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
7444250|NCT01682811|11730539|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
7444251|NCT01682811|11730540|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
7444252|NCT01682811|11730541|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
7444253|NCT01682811|11730535|FG000|Part 2 Dose Level 1|Protocol Violation|0
7444254|NCT01682811|11730536|FG001|Part 2 Dose Level 1|Protocol Violation|0
7444255|NCT01682811|11730537|FG002|Part 2 Dose Level 1|Protocol Violation|0
7444256|NCT01682811|11730538|FG003|Part 2 Dose Level 1|Protocol Violation|0
7444257|NCT01682811|11730539|FG004|Part 2 Dose Level 1|Protocol Violation|4
7444258|NCT01682811|11730540|FG005|Part 2 Dose Level 1|Protocol Violation|0
7444259|NCT01682811|11730541|FG006|Part 2 Dose Level 1|Protocol Violation|0
7444260|NCT01682811|11730535|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
7444261|NCT01682811|11730536|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
7444262|NCT01682811|11730537|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
7444263|NCT01682811|11730538|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
7444264|NCT01682811|11730539|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
7444265|NCT01682811|11730540|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
7444266|NCT01682811|11730541|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
7444267|NCT01682811|11730535|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
7444268|NCT01682811|11730536|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
7444269|NCT01682811|11730537|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
7444270|NCT01682811|11730538|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
7444271|NCT01682811|11730539|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
7444272|NCT01682811|11730540|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
7444273|NCT01682811|11730541|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
7444274|NCT01682837|11730560|FG000|Baseline|Withdrawal by Subject|5
7444275|NCT01682863|11730573|FG000|Overall Study|Subject/guardian decision|19
7444276|NCT01682863|11730574|FG001|Overall Study|Subject/guardian decision|12
7444277|NCT01682863|11730575|FG002|Overall Study|Subject/guardian decision|10
7444278|NCT01682863|11730573|FG000|Overall Study|Lost to Follow-up|5
7444279|NCT01682863|11730574|FG001|Overall Study|Lost to Follow-up|1
7444280|NCT01682863|11730575|FG002|Overall Study|Lost to Follow-up|6
7444281|NCT01682863|11730573|FG000|Overall Study|Death|1
7444282|NCT01682863|11730574|FG001|Overall Study|Death|3
7444283|NCT01682863|11730575|FG002|Overall Study|Death|4
7444284|NCT01682863|11730573|FG000|Overall Study|Protocol deviation|1
7444285|NCT01682863|11730574|FG001|Overall Study|Protocol deviation|0
7444286|NCT01682863|11730575|FG002|Overall Study|Protocol deviation|1
7444287|NCT01682863|11730573|FG000|Overall Study|Technical problems|1
7444288|NCT01682863|11730574|FG001|Overall Study|Technical problems|0
7444289|NCT01682863|11730575|FG002|Overall Study|Technical problems|0
7444290|NCT01682863|11730573|FG000|Overall Study|Adverse Event|0
7444291|NCT01682863|11730574|FG001|Overall Study|Adverse Event|1
7444292|NCT01682863|11730575|FG002|Overall Study|Adverse Event|2
7444293|NCT01682863|11730573|FG000|Overall Study|Physician Decision|0
7444294|NCT01682863|11730574|FG001|Overall Study|Physician Decision|0
7444295|NCT01682863|11730575|FG002|Overall Study|Physician Decision|1
7444296|NCT01682876|11730587|FG000|Overall Study|Administrative reason|4
7444297|NCT01682876|11730588|FG001|Overall Study|Administrative reason|4
7444298|NCT01682876|11730589|FG002|Overall Study|Administrative reason|0
7444299|NCT01682876|11730590|FG003|Overall Study|Administrative reason|3
7444300|NCT01682876|11730587|FG000|Overall Study|Adverse Event|0
7444301|NCT01682876|11730588|FG001|Overall Study|Adverse Event|0
7444302|NCT01682876|11730589|FG002|Overall Study|Adverse Event|0
7444303|NCT01682876|11730590|FG003|Overall Study|Adverse Event|1
7444304|NCT01682876|11730587|FG000|Overall Study|Lost to Follow-up|11
7444305|NCT01682876|11730588|FG001|Overall Study|Lost to Follow-up|15
7444306|NCT01682876|11730589|FG002|Overall Study|Lost to Follow-up|9
7444307|NCT01682876|11730590|FG003|Overall Study|Lost to Follow-up|11
7444308|NCT01682876|11730587|FG000|Overall Study|Protocol Violation|1
7444309|NCT01682876|11730588|FG001|Overall Study|Protocol Violation|1
7444310|NCT01682876|11730589|FG002|Overall Study|Protocol Violation|1
7444311|NCT01682876|11730590|FG003|Overall Study|Protocol Violation|1
7444312|NCT01682876|11730587|FG000|Overall Study|Withdrawal by Subject|4
7444313|NCT01682876|11730588|FG001|Overall Study|Withdrawal by Subject|0
7444314|NCT01682876|11730589|FG002|Overall Study|Withdrawal by Subject|0
7444315|NCT01682876|11730590|FG003|Overall Study|Withdrawal by Subject|2
7444316|NCT01682876|11730587|FG000|Overall Study|Other|1
7444317|NCT01682876|11730588|FG001|Overall Study|Other|0
7444318|NCT01682876|11730589|FG002|Overall Study|Other|1
7444319|NCT01682876|11730590|FG003|Overall Study|Other|1
7444320|NCT01683019|11730615|FG000|Overall Study|Withdrawal by Subject|2
7444321|NCT01683019|11730616|FG001|Overall Study|Withdrawal by Subject|1
7444322|NCT01683019|11730617|FG002|Overall Study|Withdrawal by Subject|4
7444323|NCT01683058|11730625|FG000|Overall Study|Lost to Follow-up|9
7444324|NCT01683058|11730625|FG000|Overall Study|Adverse Event|6
7444325|NCT01683058|11730625|FG000|Overall Study|Subject Met Withdrawal Criteria|5
7444326|NCT01683058|11730625|FG000|Overall Study|Withdrawal by Subject|7
7444327|NCT01683058|11730625|FG000|Overall Study|Lack of Efficacy|2
7444328|NCT01683071|11730636|FG000|Part 1|Lack of Efficacy|1
7444329|NCT01683071|11730637|FG001|Part 1|Lack of Efficacy|0
7444330|NCT01683071|11730638|FG002|Part 1|Lack of Efficacy|0
7444331|NCT01683071|11730639|FG003|Part 1|Lack of Efficacy|3
7444332|NCT01683071|11730640|FG004|Part 1|Lack of Efficacy|0
7444333|NCT01683071|11730641|FG005|Part 1|Lack of Efficacy|0
7444334|NCT01683071|11730636|FG000|Part 1|Withdrawal by Subject|1
7444335|NCT01683071|11730637|FG001|Part 1|Withdrawal by Subject|2
7444336|NCT01683071|11730638|FG002|Part 1|Withdrawal by Subject|2
7444337|NCT01683071|11730639|FG003|Part 1|Withdrawal by Subject|1
7444338|NCT01683071|11730640|FG004|Part 1|Withdrawal by Subject|0
7444339|NCT01683071|11730641|FG005|Part 1|Withdrawal by Subject|0
7444340|NCT01683071|11730636|FG000|Part 1|Surgery Cancelled|1
7444341|NCT01683071|11730637|FG001|Part 1|Surgery Cancelled|0
7444342|NCT01683071|11730638|FG002|Part 1|Surgery Cancelled|0
7444343|NCT01683071|11730639|FG003|Part 1|Surgery Cancelled|0
7444344|NCT01683071|11730640|FG004|Part 1|Surgery Cancelled|0
7444345|NCT01683071|11730641|FG005|Part 1|Surgery Cancelled|0
7444346|NCT01683071|11730636|FG000|Part 1|Did not receive study drug|1
7444347|NCT01683071|11730637|FG001|Part 1|Did not receive study drug|0
7444348|NCT01683071|11730638|FG002|Part 1|Did not receive study drug|0
7444349|NCT01683071|11730639|FG003|Part 1|Did not receive study drug|1
7444350|NCT01683071|11730640|FG004|Part 1|Did not receive study drug|0
7444351|NCT01683071|11730641|FG005|Part 1|Did not receive study drug|0
7444352|NCT01683071|11730636|FG000|Part 1|Early termination; met exclusion criteria|0
7444353|NCT01683071|11730637|FG001|Part 1|Early termination; met exclusion criteria|2
7444354|NCT01683071|11730638|FG002|Part 1|Early termination; met exclusion criteria|1
7444355|NCT01683071|11730639|FG003|Part 1|Early termination; met exclusion criteria|0
7444356|NCT01683071|11730640|FG004|Part 1|Early termination; met exclusion criteria|0
7444357|NCT01683071|11730641|FG005|Part 1|Early termination; met exclusion criteria|0
7444358|NCT01683071|11730636|FG000|Part 2|Lack of Efficacy|0
7444359|NCT01683071|11730637|FG001|Part 2|Lack of Efficacy|0
7444360|NCT01683071|11730638|FG002|Part 2|Lack of Efficacy|0
7444361|NCT01683071|11730639|FG003|Part 2|Lack of Efficacy|0
7444362|NCT01683071|11730640|FG004|Part 2|Lack of Efficacy|3
7444363|NCT01683071|11730641|FG005|Part 2|Lack of Efficacy|4
7444364|NCT01683071|11730636|FG000|Part 2|Lost to Follow-up|0
7444365|NCT01683071|11730637|FG001|Part 2|Lost to Follow-up|0
7444366|NCT01683071|11730638|FG002|Part 2|Lost to Follow-up|0
7444367|NCT01683071|11730639|FG003|Part 2|Lost to Follow-up|0
7444368|NCT01683071|11730640|FG004|Part 2|Lost to Follow-up|2
7444369|NCT01683071|11730641|FG005|Part 2|Lost to Follow-up|0
7444370|NCT01683071|11730636|FG000|Part 2|Withdrawal by Subject|0
7444371|NCT01683071|11730637|FG001|Part 2|Withdrawal by Subject|0
7444372|NCT01683071|11730638|FG002|Part 2|Withdrawal by Subject|0
7444373|NCT01683071|11730639|FG003|Part 2|Withdrawal by Subject|0
7444374|NCT01683071|11730640|FG004|Part 2|Withdrawal by Subject|3
7444375|NCT01683071|11730641|FG005|Part 2|Withdrawal by Subject|3
7444376|NCT01683071|11730636|FG000|Part 2|Surgery cancelled|0
7444377|NCT01683071|11730637|FG001|Part 2|Surgery cancelled|0
7444378|NCT01683071|11730638|FG002|Part 2|Surgery cancelled|0
7444379|NCT01683071|11730639|FG003|Part 2|Surgery cancelled|0
7444380|NCT01683071|11730640|FG004|Part 2|Surgery cancelled|4
7444381|NCT01683071|11730641|FG005|Part 2|Surgery cancelled|2
7444382|NCT01683071|11730636|FG000|Part 2|Did not receive study drug|0
7444383|NCT01683071|11730637|FG001|Part 2|Did not receive study drug|0
7444384|NCT01683071|11730638|FG002|Part 2|Did not receive study drug|0
7444385|NCT01683071|11730639|FG003|Part 2|Did not receive study drug|0
7444386|NCT01683071|11730640|FG004|Part 2|Did not receive study drug|2
7444387|NCT01683071|11730641|FG005|Part 2|Did not receive study drug|1
7444388|NCT01683071|11730636|FG000|Part 2|Met exclusion criterion|0
7444389|NCT01683071|11730637|FG001|Part 2|Met exclusion criterion|0
7444390|NCT01683071|11730638|FG002|Part 2|Met exclusion criterion|0
7444391|NCT01683071|11730639|FG003|Part 2|Met exclusion criterion|0
7444392|NCT01683071|11730640|FG004|Part 2|Met exclusion criterion|1
7444393|NCT01683071|11730641|FG005|Part 2|Met exclusion criterion|1
7444394|NCT01683071|11730636|FG000|Part 2|Protocol deviation|0
7444395|NCT01683071|11730637|FG001|Part 2|Protocol deviation|0
7444396|NCT01683071|11730638|FG002|Part 2|Protocol deviation|0
7444397|NCT01683071|11730639|FG003|Part 2|Protocol deviation|0
7444398|NCT01683071|11730640|FG004|Part 2|Protocol deviation|1
7444399|NCT01683071|11730641|FG005|Part 2|Protocol deviation|2
7444400|NCT01683071|11730636|FG000|Part 2|Withdrawal by investigator decision|0
7444401|NCT01683071|11730637|FG001|Part 2|Withdrawal by investigator decision|0
7444402|NCT01683071|11730638|FG002|Part 2|Withdrawal by investigator decision|0
7444403|NCT01683071|11730639|FG003|Part 2|Withdrawal by investigator decision|0
7444404|NCT01683071|11730640|FG004|Part 2|Withdrawal by investigator decision|1
7444405|NCT01683071|11730641|FG005|Part 2|Withdrawal by investigator decision|2
7444406|NCT01683266|11730663|FG000|Overall Study|Adverse Event|5
7444407|NCT01683266|11730664|FG001|Overall Study|Adverse Event|4
7444408|NCT01683266|11730663|FG000|Overall Study|Lack of Efficacy|5
7444409|NCT01683266|11730664|FG001|Overall Study|Lack of Efficacy|2
7444410|NCT01683266|11730663|FG000|Overall Study|Protocol Violation|13
7444411|NCT01683266|11730664|FG001|Overall Study|Protocol Violation|6
7444412|NCT01683266|11730663|FG000|Overall Study|Personal Reason|17
7444413|NCT01683266|11730664|FG001|Overall Study|Personal Reason|25
7444414|NCT01683266|11730663|FG000|Overall Study|Selection Criterion / Protocol Violation|7
7444415|NCT01683266|11730664|FG001|Overall Study|Selection Criterion / Protocol Violation|5
7444416|NCT01683266|11730663|FG000|Overall Study|Lost to Follow-up|5
7444417|NCT01683266|11730664|FG001|Overall Study|Lost to Follow-up|0
7444418|NCT01683266|11730663|FG000|Overall Study|Site Closure / Site Withdrawal|1
7444419|NCT01683266|11730664|FG001|Overall Study|Site Closure / Site Withdrawal|3
7444420|NCT01683266|11730663|FG000|Overall Study|Nonserious Hypoglycemia|0
7444421|NCT01683266|11730664|FG001|Overall Study|Nonserious Hypoglycemia|3
7444422|NCT01683266|11730663|FG000|Overall Study|Perceived Lack of Efficacy|1
7444423|NCT01683266|11730664|FG001|Overall Study|Perceived Lack of Efficacy|1
7444424|NCT01683266|11730663|FG000|Overall Study|Possibly Hypoglycemia|1
7444425|NCT01683266|11730664|FG001|Overall Study|Possibly Hypoglycemia|0
7444426|NCT01683266|11730663|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
7444427|NCT01683266|11730664|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
7444428|NCT01683383|11730681|FG000|Overall Study|Infant was not transported|1
7444429|NCT01683383|11730682|FG001|Overall Study|Infant was not transported|0
7444430|NCT01683409|11730693|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7444431|NCT01683409|11730694|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7444432|NCT01683409|11730695|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
7444433|NCT01683409|11730696|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7444434|NCT01683409|11730697|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
7444435|NCT01683409|11730693|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
7444436|NCT01683409|11730694|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
7444437|NCT01683409|11730695|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
7444438|NCT01683409|11730696|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
7444439|NCT01683409|11730697|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
7444440|NCT01683409|11730693|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7444441|NCT01683409|11730694|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
7444442|NCT01683409|11730695|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7444443|NCT01683409|11730696|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7444444|NCT01683409|11730697|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
7444445|NCT01683409|11730693|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7444446|NCT01683409|11730694|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7444447|NCT01683409|11730695|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
7444448|NCT01683409|11730696|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7444449|NCT01683409|11730697|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
7444450|NCT01683409|11730693|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7444451|NCT01683409|11730694|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7444452|NCT01683409|11730695|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
7444453|NCT01683409|11730696|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7444454|NCT01683409|11730697|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
7444455|NCT01683409|11730693|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7444456|NCT01683409|11730694|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7444457|NCT01683409|11730695|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7444458|NCT01683409|11730696|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
7444459|NCT01683409|11730697|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
7444460|NCT01683409|11730693|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7444461|NCT01683409|11730694|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7444462|NCT01683409|11730695|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7444463|NCT01683409|11730696|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
7444464|NCT01683409|11730697|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
7444465|NCT01683409|11730693|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
7444466|NCT01683409|11730694|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7444467|NCT01683409|11730695|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7444468|NCT01683409|11730696|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7444469|NCT01683409|11730697|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
7444470|NCT01683409|11730693|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7444471|NCT01683409|11730694|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
7444472|NCT01683409|11730695|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
7444473|NCT01683409|11730696|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
7444474|NCT01683409|11730697|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
7444475|NCT01683409|11730693|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7444476|NCT01683409|11730694|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7444477|NCT01683409|11730695|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7444478|NCT01683409|11730696|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
7444479|NCT01683409|11730697|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
7444480|NCT01683409|11730693|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7444481|NCT01683409|11730694|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7444482|NCT01683409|11730695|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
7444483|NCT01683409|11730696|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7444484|NCT01683409|11730697|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
7444485|NCT01683565|11730738|FG000|Overall Study|Lost to Follow-up|2
7444486|NCT01683565|11730739|FG001|Overall Study|Lost to Follow-up|0
7444487|NCT01683565|11730738|FG000|Overall Study|Discontinued Intervention|1
7444488|NCT01683565|11730739|FG001|Overall Study|Discontinued Intervention|1
7444489|NCT01683604|11730747|FG000|Overall Study|Adverse Event|2
7444490|NCT01683604|11730747|FG000|Overall Study|Lack of Efficacy|1
7444491|NCT01683604|11730747|FG000|Overall Study|Other|2
7444492|NCT01683838|11730771|FG000|Overall Study|Adverse Event|12
7444493|NCT01683838|11730772|FG001|Overall Study|Adverse Event|2
7444494|NCT01683838|11730771|FG000|Overall Study|Protocol Violation|3
7444495|NCT01683838|11730772|FG001|Overall Study|Protocol Violation|1
7444496|NCT01683838|11730771|FG000|Overall Study|Withdrawal by Subject|6
7444497|NCT01683838|11730772|FG001|Overall Study|Withdrawal by Subject|5
7444498|NCT01683838|11730771|FG000|Overall Study|Lost to Follow-up|1
7444499|NCT01683838|11730772|FG001|Overall Study|Lost to Follow-up|1
7444500|NCT01683838|11730771|FG000|Overall Study|Other|4
7444501|NCT01683838|11730772|FG001|Overall Study|Other|3
7467654|NCT01903252|11768107|FG005|Double-Blind Induction|Adverse Event|0
7467655|NCT01903252|11768102|FG000|Double-Blind Induction|Withdrawal by Subject|10
7467656|NCT01903252|11768103|FG001|Double-Blind Induction|Withdrawal by Subject|13
7467657|NCT01903252|11768104|FG002|Double-Blind Induction|Withdrawal by Subject|0
7467658|NCT01903252|11768105|FG003|Double-Blind Induction|Withdrawal by Subject|0
7467659|NCT01903252|11768106|FG004|Double-Blind Induction|Withdrawal by Subject|0
7467660|NCT01903252|11768107|FG005|Double-Blind Induction|Withdrawal by Subject|0
7467661|NCT01903252|11768102|FG000|Double-Blind Induction|Physician Decision|2
7467662|NCT01903252|11768103|FG001|Double-Blind Induction|Physician Decision|3
7467663|NCT01903252|11768104|FG002|Double-Blind Induction|Physician Decision|0
7467664|NCT01903252|11768105|FG003|Double-Blind Induction|Physician Decision|0
7444502|NCT01683994|11730783|FG000|Overall Study|Withdrawal by Subject|1
7444503|NCT01683994|11730784|FG001|Overall Study|Withdrawal by Subject|0
7444504|NCT01683994|11730785|FG002|Overall Study|Withdrawal by Subject|0
7444505|NCT01683994|11730786|FG003|Overall Study|Withdrawal by Subject|1
7444506|NCT01683994|11730787|FG004|Overall Study|Withdrawal by Subject|0
7444507|NCT01683994|11730783|FG000|Overall Study|Intercurrent illness|0
7444508|NCT01683994|11730784|FG001|Overall Study|Intercurrent illness|0
7444509|NCT01683994|11730785|FG002|Overall Study|Intercurrent illness|0
7444510|NCT01683994|11730786|FG003|Overall Study|Intercurrent illness|2
7444511|NCT01683994|11730787|FG004|Overall Study|Intercurrent illness|1
7444512|NCT01684033|11730823|FG000|Period 1, First 30 Days|Adverse Event|1
7444513|NCT01684033|11730824|FG001|Period 1, First 30 Days|Adverse Event|1
7444514|NCT01684033|11730823|FG000|Period 1, First 30 Days|Noncompliance|1
7444515|NCT01684033|11730824|FG001|Period 1, First 30 Days|Noncompliance|0
7444516|NCT01684033|11730823|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
7444517|NCT01684033|11730824|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
7444518|NCT01684033|11730823|FG000|Period 1, First 30 Days|Lost to Follow-up|1
7444519|NCT01684033|11730824|FG001|Period 1, First 30 Days|Lost to Follow-up|0
7444520|NCT01684033|11730823|FG000|Period 2, Second 30 Days|Adverse Event|1
7444521|NCT01684033|11730824|FG001|Period 2, Second 30 Days|Adverse Event|0
7444522|NCT01684046|11730830|FG000|Period 1, First 30 Days|Adverse Event|0
7444523|NCT01684046|11730831|FG001|Period 1, First 30 Days|Adverse Event|2
7444524|NCT01684202|11730841|FG000|Dose-escalation Period|Adverse Event|0
7444525|NCT01684202|11730842|FG001|Dose-escalation Period|Adverse Event|1
7444526|NCT01684202|11730843|FG002|Dose-escalation Period|Adverse Event|0
7444527|NCT01684202|11730844|FG003|Dose-escalation Period|Adverse Event|0
7444528|NCT01684202|11730841|FG000|Dose-escalation Period|Withdrawal by Subject|1
7444529|NCT01684202|11730842|FG001|Dose-escalation Period|Withdrawal by Subject|0
7444530|NCT01684202|11730843|FG002|Dose-escalation Period|Withdrawal by Subject|0
7444531|NCT01684202|11730844|FG003|Dose-escalation Period|Withdrawal by Subject|0
7444532|NCT01684202|11730841|FG000|Maintenance Period|Adverse Event|1
7444533|NCT01684202|11730842|FG001|Maintenance Period|Adverse Event|1
7444534|NCT01684202|11730843|FG002|Maintenance Period|Adverse Event|1
7444535|NCT01684202|11730844|FG003|Maintenance Period|Adverse Event|1
7444536|NCT01684202|11730841|FG000|Maintenance Period|Physician Decision|0
7444537|NCT01684202|11730842|FG001|Maintenance Period|Physician Decision|1
7444538|NCT01684202|11730843|FG002|Maintenance Period|Physician Decision|0
7444539|NCT01684202|11730844|FG003|Maintenance Period|Physician Decision|0
7444540|NCT01684202|11730841|FG000|Maintenance Period|Withdrawal by Subject|0
7444541|NCT01684202|11730842|FG001|Maintenance Period|Withdrawal by Subject|1
7444542|NCT01684202|11730843|FG002|Maintenance Period|Withdrawal by Subject|0
7444543|NCT01684202|11730844|FG003|Maintenance Period|Withdrawal by Subject|0
7444544|NCT01684215|11730858|FG000|Phase 1, Part 1|Adverse Event|1
7444545|NCT01684215|11730859|FG001|Phase 1, Part 1|Adverse Event|0
7444546|NCT01684215|11730860|FG002|Phase 1, Part 1|Adverse Event|0
7444547|NCT01684215|11730861|FG003|Phase 1, Part 1|Adverse Event|0
7444548|NCT01684215|11730858|FG000|Phase 1, Part 1|Objective progression or relapse|5
7444549|NCT01684215|11730859|FG001|Phase 1, Part 1|Objective progression or relapse|6
7444550|NCT01684215|11730860|FG002|Phase 1, Part 1|Objective progression or relapse|0
7444551|NCT01684215|11730861|FG003|Phase 1, Part 1|Objective progression or relapse|0
7444552|NCT01684215|11730858|FG000|Phase 1, Part 2|Adverse Event|0
7444553|NCT01684215|11730859|FG001|Phase 1, Part 2|Adverse Event|0
7444554|NCT01684215|11730860|FG002|Phase 1, Part 2|Adverse Event|1
7444555|NCT01684215|11730861|FG003|Phase 1, Part 2|Adverse Event|0
7444556|NCT01684215|11730858|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7444557|NCT01684215|11730859|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7444558|NCT01684215|11730860|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
7444559|NCT01684215|11730861|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
7444560|NCT01684215|11730858|FG000|Phase 1, Part 2|Withdrawal by Subject|0
7444561|NCT01684215|11730859|FG001|Phase 1, Part 2|Withdrawal by Subject|0
7444562|NCT01684215|11730860|FG002|Phase 1, Part 2|Withdrawal by Subject|1
7444563|NCT01684215|11730861|FG003|Phase 1, Part 2|Withdrawal by Subject|0
7444564|NCT01684215|11730858|FG000|Phase 2|Death|0
7444565|NCT01684215|11730859|FG001|Phase 2|Death|0
7444566|NCT01684215|11730860|FG002|Phase 2|Death|0
7444567|NCT01684215|11730861|FG003|Phase 2|Death|8
7444568|NCT01684215|11730858|FG000|Phase 2|Study terminated by sponsor|0
7444569|NCT01684215|11730859|FG001|Phase 2|Study terminated by sponsor|0
7444570|NCT01684215|11730860|FG002|Phase 2|Study terminated by sponsor|0
7444571|NCT01684215|11730861|FG003|Phase 2|Study terminated by sponsor|30
7444572|NCT01684215|11730858|FG000|Phase 2|Enrolled but not treated|0
7444573|NCT01684215|11730859|FG001|Phase 2|Enrolled but not treated|0
7444574|NCT01684215|11730860|FG002|Phase 2|Enrolled but not treated|0
7444575|NCT01684215|11730861|FG003|Phase 2|Enrolled but not treated|1
7444576|NCT01684215|11730858|FG000|Phase 2|Lost to Follow-up|0
7444577|NCT01684215|11730859|FG001|Phase 2|Lost to Follow-up|0
7444578|NCT01684215|11730860|FG002|Phase 2|Lost to Follow-up|0
7444579|NCT01684215|11730861|FG003|Phase 2|Lost to Follow-up|4
7444580|NCT01684423|11730892|FG000|Overall Study|Withdrawal by Subject|0
7444581|NCT01684423|11730893|FG001|Overall Study|Withdrawal by Subject|0
7444582|NCT01684423|11730894|FG002|Overall Study|Withdrawal by Subject|1
7444583|NCT01684423|11730895|FG003|Overall Study|Withdrawal by Subject|0
7444584|NCT01684423|11730896|FG004|Overall Study|Withdrawal by Subject|0
7444585|NCT01684878|11730949|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7444586|NCT01684878|11730950|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
7444587|NCT01684878|11730951|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7444588|NCT01684878|11730952|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
7444589|NCT01684878|11730949|FG000|Part 1: Safety Run in Phase|Death|15
7444590|NCT01684878|11730950|FG001|Part 1: Safety Run in Phase|Death|20
7444591|NCT01684878|11730951|FG002|Part 1: Safety Run in Phase|Death|0
7444592|NCT01684878|11730952|FG003|Part 1: Safety Run in Phase|Death|0
7444593|NCT01684878|11730949|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
7444594|NCT01684878|11730950|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
7444595|NCT01684878|11730951|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
7444596|NCT01684878|11730952|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
7444597|NCT01684878|11730949|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
7444598|NCT01684878|11730950|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
7444599|NCT01684878|11730951|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
7444600|NCT01684878|11730952|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
7444601|NCT01684878|11730949|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
7444602|NCT01684878|11730950|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
7444603|NCT01684878|11730951|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
7444604|NCT01684878|11730952|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
7444605|NCT01684878|11730949|FG000|Part 2: Randomized Phase|Death|0
7444606|NCT01684878|11730950|FG001|Part 2: Randomized Phase|Death|0
7444607|NCT01684878|11730951|FG002|Part 2: Randomized Phase|Death|62
7562039|NCT03215758|11930497|FG000|Overall Study|Technical Problems|1
7562040|NCT03215758|11930498|FG001|Overall Study|Technical Problems|0
7562041|NCT03215758|11930497|FG000|Overall Study|Protocol deviation|0
7532946|NCT02678286|11878883|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
7562042|NCT03215758|11930498|FG001|Overall Study|Protocol deviation|1
7562043|NCT03215758|11930497|FG000|Overall Study|Physician Decision|0
7562044|NCT03215758|11930498|FG001|Overall Study|Physician Decision|1
7444608|NCT01684878|11730952|FG003|Part 2: Randomized Phase|Death|68
7444609|NCT01684878|11730949|FG000|Part 2: Randomized Phase|Alive at data-cut|0
7444610|NCT01684878|11730950|FG001|Part 2: Randomized Phase|Alive at data-cut|0
7444611|NCT01684878|11730951|FG002|Part 2: Randomized Phase|Alive at data-cut|13
7444612|NCT01684878|11730952|FG003|Part 2: Randomized Phase|Alive at data-cut|7
7444613|NCT01684878|11730949|FG000|Part 2: Randomized Phase|Participant noncompliance|0
7444614|NCT01684878|11730950|FG001|Part 2: Randomized Phase|Participant noncompliance|0
7444615|NCT01684878|11730951|FG002|Part 2: Randomized Phase|Participant noncompliance|0
7444616|NCT01684878|11730952|FG003|Part 2: Randomized Phase|Participant noncompliance|1
7444617|NCT01684930|11730981|FG000|Overall Study|Withdrawal by Subject|3
7444618|NCT01684930|11730982|FG001|Overall Study|Withdrawal by Subject|1
7444619|NCT01684943|11730991|FG000|Overall Study|Inadequate Venous Access|3
7444620|NCT01684943|11730992|FG001|Overall Study|Inadequate Venous Access|0
7444621|NCT01684943|11730993|FG002|Overall Study|Inadequate Venous Access|0
7444622|NCT01684943|11730991|FG000|Overall Study|Principal Investigator Determination|1
7444623|NCT01684943|11730992|FG001|Overall Study|Principal Investigator Determination|0
7444624|NCT01684943|11730993|FG002|Overall Study|Principal Investigator Determination|0
7444625|NCT01684943|11730991|FG000|Overall Study|Excluded from Analysis|1
7444626|NCT01684943|11730992|FG001|Overall Study|Excluded from Analysis|1
7444627|NCT01684943|11730993|FG002|Overall Study|Excluded from Analysis|1
7444628|NCT01684943|11730991|FG000|Overall Study|Lost to Follow-up|3
7444629|NCT01684943|11730992|FG001|Overall Study|Lost to Follow-up|0
7444630|NCT01684943|11730993|FG002|Overall Study|Lost to Follow-up|0
7444631|NCT01684943|11730991|FG000|Overall Study|Planning Pregnancy|1
7444632|NCT01684943|11730992|FG001|Overall Study|Planning Pregnancy|0
7444633|NCT01684943|11730993|FG002|Overall Study|Planning Pregnancy|0
7444634|NCT01685047|11731010|FG000|Overall Study|Withdrawal by Subject|20
7444635|NCT01685047|11731010|FG000|Overall Study|Death|26
7444636|NCT01685047|11731010|FG000|Overall Study|Lost to Follow-up|8
7444637|NCT01685047|11731010|FG000|Overall Study|Physician Decision|25
7444638|NCT01685047|11731010|FG000|Overall Study|Adverse Event|5
7444639|NCT01685047|11731010|FG000|Overall Study|patient withdrawn by sponsor|1
7444640|NCT01685060|11731014|FG000|Overall Study|Rollover patients|16
7444641|NCT01685060|11731014|FG000|Overall Study|Adverse Event|12
7444642|NCT01685060|11731014|FG000|Overall Study|Progressive disease|69
7444643|NCT01685060|11731014|FG000|Overall Study|Physician Decision|14
7444644|NCT01685060|11731014|FG000|Overall Study|Subject/guardian decision|20
7444645|NCT01685060|11731014|FG000|Overall Study|Lost to Follow-up|1
7444646|NCT01685060|11731014|FG000|Overall Study|Death|8
7444647|NCT01685073|11731020|FG000|Overall Study|Lost to Follow-up|6
7444648|NCT01685073|11731021|FG001|Overall Study|Lost to Follow-up|8
7444649|NCT01685073|11731020|FG000|Overall Study|Withdrawal by Subject|24
7532947|NCT02678286|11878882|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
7532948|NCT02678286|11878883|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
7532949|NCT02678286|11878882|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
7532950|NCT02678286|11878883|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
7532951|NCT02678286|11878882|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7532952|NCT02678286|11878883|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
7562045|NCT03215758|11930497|FG000|Overall Study|Death|0
7444650|NCT01685073|11731021|FG001|Overall Study|Withdrawal by Subject|24
7444651|NCT01685138|11731027|FG000|Overall Study|Lost to Follow-up|1
7444652|NCT01685138|11731027|FG000|Overall Study|Protocol Violation|1
7444653|NCT01685138|11731027|FG000|Overall Study|No longer requires treatment|1
7444654|NCT01685138|11731027|FG000|Overall Study|Subject/guardian decision|2
7444655|NCT01685138|11731027|FG000|Overall Study|Physician Decision|6
7444656|NCT01685138|11731027|FG000|Overall Study|Death|10
7444657|NCT01685138|11731027|FG000|Overall Study|Adverse Event|18
7444658|NCT01685138|11731027|FG000|Overall Study|Progressive disease|53
7444659|NCT01685203|11731038|FG000|Overall Study|Lost to Follow-up|3
7444660|NCT01685203|11731039|FG001|Overall Study|Lost to Follow-up|3
7444661|NCT01685203|11731040|FG002|Overall Study|Lost to Follow-up|0
7444662|NCT01685203|11731041|FG003|Overall Study|Lost to Follow-up|1
7444663|NCT01685203|11731042|FG004|Overall Study|Lost to Follow-up|0
7444664|NCT01685203|11731043|FG005|Overall Study|Lost to Follow-up|0
7444665|NCT01685203|11731044|FG006|Overall Study|Lost to Follow-up|0
7444666|NCT01685203|11731038|FG000|Overall Study|Adverse Event|0
7444667|NCT01685203|11731039|FG001|Overall Study|Adverse Event|0
7444668|NCT01685203|11731040|FG002|Overall Study|Adverse Event|0
7444669|NCT01685203|11731041|FG003|Overall Study|Adverse Event|0
7444670|NCT01685203|11731042|FG004|Overall Study|Adverse Event|0
7444671|NCT01685203|11731043|FG005|Overall Study|Adverse Event|2
7444672|NCT01685203|11731044|FG006|Overall Study|Adverse Event|0
7444673|NCT01685203|11731038|FG000|Overall Study|Adverse event and withdrew consent|1
7444674|NCT01685203|11731039|FG001|Overall Study|Adverse event and withdrew consent|0
7444675|NCT01685203|11731040|FG002|Overall Study|Adverse event and withdrew consent|0
7444676|NCT01685203|11731041|FG003|Overall Study|Adverse event and withdrew consent|0
7444677|NCT01685203|11731042|FG004|Overall Study|Adverse event and withdrew consent|0
7444678|NCT01685203|11731043|FG005|Overall Study|Adverse event and withdrew consent|0
7444679|NCT01685203|11731044|FG006|Overall Study|Adverse event and withdrew consent|0
7444680|NCT01685203|11731038|FG000|Overall Study|Patient's decision|0
7444681|NCT01685203|11731039|FG001|Overall Study|Patient's decision|0
7444682|NCT01685203|11731040|FG002|Overall Study|Patient's decision|0
7444683|NCT01685203|11731041|FG003|Overall Study|Patient's decision|0
7444684|NCT01685203|11731042|FG004|Overall Study|Patient's decision|0
7444685|NCT01685203|11731043|FG005|Overall Study|Patient's decision|1
7444686|NCT01685203|11731044|FG006|Overall Study|Patient's decision|0
7444687|NCT01685216|11731060|FG000|Overall Study|Did not receive study drug|1
7444688|NCT01685229|11731066|FG000|Overall Study|Subjects missing Study Exit form|3
7444689|NCT01685229|11731067|FG001|Overall Study|Subjects missing Study Exit form|1
7444690|NCT01685229|11731066|FG000|Overall Study|Lost to Follow-up|16
7444691|NCT01685229|11731067|FG001|Overall Study|Lost to Follow-up|10
7444692|NCT01685229|11731066|FG000|Overall Study|Withdrawal by Subject|6
7444693|NCT01685229|11731067|FG001|Overall Study|Withdrawal by Subject|5
7444694|NCT01685229|11731066|FG000|Overall Study|Death|1
7444695|NCT01685229|11731067|FG001|Overall Study|Death|0
7444696|NCT01685372|11731096|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
7444697|NCT01685372|11731097|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
7444698|NCT01685437|11731107|FG000|Overall Study|Withdrawal by Subject|22
7444699|NCT01685437|11731107|FG000|Overall Study|Lost to Follow-up|3
7444700|NCT01685437|11731107|FG000|Overall Study|Adverse Event|1
7444701|NCT01685437|11731107|FG000|Overall Study|Protocol Violation|4
7444702|NCT01685437|11731107|FG000|Overall Study|Unable to make visits due to work|1
7444703|NCT01685697|11731138|FG000|Overall Study|Protocol Violation|3
7444704|NCT01685697|11731139|FG001|Overall Study|Protocol Violation|3
7444705|NCT01685801|11731149|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7444706|NCT01685801|11731150|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7444707|NCT01685801|11731151|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
7444708|NCT01685801|11731152|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
7444709|NCT01685801|11731149|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7444710|NCT01685801|11731150|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7444711|NCT01685801|11731151|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
7444712|NCT01685801|11731152|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
7444713|NCT01685840|11731171|FG000|Overall Study|Death|77
7444714|NCT01685840|11731172|FG001|Overall Study|Death|66
7444715|NCT01685840|11731171|FG000|Overall Study|Lost to Follow-up|27
7444716|NCT01685840|11731172|FG001|Overall Study|Lost to Follow-up|25
7444717|NCT01685840|11731171|FG000|Overall Study|Physician Decision|3
7444718|NCT01685840|11731172|FG001|Overall Study|Physician Decision|7
7444719|NCT01685840|11731171|FG000|Overall Study|Withdrawal by Subject|14
7444720|NCT01685840|11731172|FG001|Overall Study|Withdrawal by Subject|17
7444721|NCT01685840|11731171|FG000|Overall Study|Futility|197
7444722|NCT01685840|11731172|FG001|Overall Study|Futility|200
7444723|NCT01685840|11731171|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
7444724|NCT01685840|11731172|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
7444725|NCT01685983|11731180|FG000|Overall Study|Adverse Event|7
7444726|NCT01685983|11731180|FG000|Overall Study|Death|1
7444727|NCT01685983|11731180|FG000|Overall Study|Withdrawal by Subject|19
7444728|NCT01685983|11731180|FG000|Overall Study|Protocol Violation|2
7444729|NCT01685983|11731180|FG000|Overall Study|Physician Decision|13
7444730|NCT01685983|11731180|FG000|Overall Study|Other|7
7444731|NCT01685983|11731180|FG000|Overall Study|Progressive Disease|32
7444732|NCT01685983|11731180|FG000|Overall Study|Noncompliance with Study Drug|1
7444733|NCT01686152|11731196|FG000|Overall Study|Withdrawal by Subject|11
7444734|NCT01686152|11731197|FG001|Overall Study|Withdrawal by Subject|11
7444735|NCT01686152|11731198|FG002|Overall Study|Withdrawal by Subject|3
7444736|NCT01686152|11731196|FG000|Overall Study|Drug Code Unblinded|0
7444737|NCT01686152|11731197|FG001|Overall Study|Drug Code Unblinded|1
7444738|NCT01686152|11731198|FG002|Overall Study|Drug Code Unblinded|0
7444739|NCT01686152|11731196|FG000|Overall Study|Protocol Violation|6
7444740|NCT01686152|11731197|FG001|Overall Study|Protocol Violation|1
7444741|NCT01686152|11731198|FG002|Overall Study|Protocol Violation|0
7444742|NCT01686152|11731196|FG000|Overall Study|Adverse Event|12
7444743|NCT01686152|11731197|FG001|Overall Study|Adverse Event|11
7444744|NCT01686152|11731198|FG002|Overall Study|Adverse Event|0
7444745|NCT01686152|11731196|FG000|Overall Study|Lack of Efficacy|0
7444746|NCT01686152|11731197|FG001|Overall Study|Lack of Efficacy|0
7444747|NCT01686152|11731198|FG002|Overall Study|Lack of Efficacy|1
7444748|NCT01686152|11731196|FG000|Overall Study|IP Non-compliance|5
7444749|NCT01686152|11731197|FG001|Overall Study|IP Non-compliance|5
7444750|NCT01686152|11731198|FG002|Overall Study|IP Non-compliance|0
7444751|NCT01686152|11731196|FG000|Overall Study|Lost to Follow-up|7
7444752|NCT01686152|11731197|FG001|Overall Study|Lost to Follow-up|6
7444753|NCT01686152|11731198|FG002|Overall Study|Lost to Follow-up|5
7444754|NCT01686373|11731212|FG000|Overall Study|Lost to Follow-up|3
7444755|NCT01686373|11731213|FG001|Overall Study|Lost to Follow-up|0
7444756|NCT01686373|11731212|FG000|Overall Study|Withdrawal by Subject|0
7444757|NCT01686373|11731213|FG001|Overall Study|Withdrawal by Subject|1
7444758|NCT01686373|11731212|FG000|Overall Study|Adverse Event|0
7444759|NCT01686373|11731213|FG001|Overall Study|Adverse Event|1
7444760|NCT01686438|11731222|FG000|Overall Study|Lost to Follow-up|8
7444761|NCT01686438|11731223|FG001|Overall Study|Lost to Follow-up|9
7444762|NCT01686438|11731224|FG002|Overall Study|Lost to Follow-up|10
7444763|NCT01686438|11731222|FG000|Overall Study|Adverse Event|0
7444764|NCT01686438|11731223|FG001|Overall Study|Adverse Event|0
7444765|NCT01686438|11731224|FG002|Overall Study|Adverse Event|1
7444766|NCT01686438|11731222|FG000|Overall Study|Protocol Violation|0
7444767|NCT01686438|11731223|FG001|Overall Study|Protocol Violation|0
7444768|NCT01686438|11731224|FG002|Overall Study|Protocol Violation|1
7444769|NCT01686438|11731222|FG000|Overall Study|Withdrawal by Subject|0
7444770|NCT01686438|11731223|FG001|Overall Study|Withdrawal by Subject|0
7444771|NCT01686438|11731224|FG002|Overall Study|Withdrawal by Subject|1
7444772|NCT01686568|11731264|FG000|Main Study|Withdrawal by Subject|1
7444773|NCT01686568|11731265|FG001|Main Study|Withdrawal by Subject|3
7444774|NCT01686568|11731264|FG000|Main Study|Noncompliance with protocol|0
7444775|NCT01686568|11731265|FG001|Main Study|Noncompliance with protocol|1
7444776|NCT01686568|11731264|FG000|Main Study|Liver enzymes above range of exclusion|1
7444777|NCT01686568|11731265|FG001|Main Study|Liver enzymes above range of exclusion|0
7444778|NCT01686568|11731264|FG000|Sub-Study|Not consented for sub-study|2
7444779|NCT01686568|11731265|FG001|Sub-Study|Not consented for sub-study|2
7444780|NCT01686581|11731271|FG000|Overall Study|Side-effects or Health Problems|15
7444781|NCT01686581|11731271|FG000|Overall Study|Lack of Efficacy|90
7444782|NCT01686581|11731271|FG000|Overall Study|Participant Concerned about Risks|6
7444783|NCT01686581|11731271|FG000|Overall Study|Thinks Injections Too Painful|8
7444784|NCT01686581|11731271|FG000|Overall Study|Thinks Injections Take Too Much Time|2
7444785|NCT01686581|11731271|FG000|Overall Study|Trying to get Pregnant or Nursing|2
7444786|NCT01686581|11731271|FG000|Overall Study|Thinks it is Inconvenient|17
7444787|NCT01686581|11731271|FG000|Overall Study|Other Miscellaneous Reasons|36
7444788|NCT01686581|11731271|FG000|Overall Study|Reason Missing|1
7444789|NCT01686633|11731278|FG000|Overall Study|Lack of Efficacy|33
7444790|NCT01686633|11731279|FG001|Overall Study|Lack of Efficacy|13
7444791|NCT01686633|11731280|FG002|Overall Study|Lack of Efficacy|11
7444792|NCT01686633|11731278|FG000|Overall Study|Withdrawal by Subject|8
7444793|NCT01686633|11731279|FG001|Overall Study|Withdrawal by Subject|8
7444794|NCT01686633|11731280|FG002|Overall Study|Withdrawal by Subject|5
7444795|NCT01686633|11731278|FG000|Overall Study|Physician Decision|3
7444796|NCT01686633|11731279|FG001|Overall Study|Physician Decision|4
7444797|NCT01686633|11731280|FG002|Overall Study|Physician Decision|4
7444798|NCT01686633|11731278|FG000|Overall Study|Adverse Event|4
7444799|NCT01686633|11731279|FG001|Overall Study|Adverse Event|3
7444800|NCT01686633|11731280|FG002|Overall Study|Adverse Event|3
7444801|NCT01686633|11731278|FG000|Overall Study|Protocol Violation|2
7444802|NCT01686633|11731279|FG001|Overall Study|Protocol Violation|3
7444803|NCT01686633|11731280|FG002|Overall Study|Protocol Violation|0
7444804|NCT01686633|11731278|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7444805|NCT01686633|11731279|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7444806|NCT01686633|11731280|FG002|Overall Study|Protocol-defined Stopping Criteria|1
7444807|NCT01686633|11731278|FG000|Overall Study|Lost to Follow-up|0
7444808|NCT01686633|11731279|FG001|Overall Study|Lost to Follow-up|1
7444809|NCT01686633|11731280|FG002|Overall Study|Lost to Follow-up|1
7444810|NCT01686828|11731320|FG000|Overall Study|Physician Decision|1
7444811|NCT01686828|11731321|FG001|Overall Study|Physician Decision|0
7444812|NCT01686828|11731322|FG002|Overall Study|Physician Decision|0
7444813|NCT01686828|11731323|FG003|Overall Study|Physician Decision|0
7444814|NCT01686828|11731320|FG000|Overall Study|New Job|0
7444815|NCT01686828|11731321|FG001|Overall Study|New Job|1
7444816|NCT01686828|11731322|FG002|Overall Study|New Job|0
7444817|NCT01686828|11731323|FG003|Overall Study|New Job|0
7444818|NCT01686828|11731320|FG000|Overall Study|Weight Loss|0
7444819|NCT01686828|11731321|FG001|Overall Study|Weight Loss|0
7444820|NCT01686828|11731322|FG002|Overall Study|Weight Loss|1
7444821|NCT01686828|11731323|FG003|Overall Study|Weight Loss|0
7444822|NCT01686932|11731339|FG000|Period 1|Adverse Event|1
7444823|NCT01686932|11731340|FG001|Period 1|Adverse Event|1
7444824|NCT01686958|11731346|FG000|Overall Study|Withdrawal by Subject|1
7444825|NCT01687101|11731364|FG000|Overall Study|Lost to Follow-up|7
7444826|NCT01687166|11731376|FG000|Overall Study|Attempt subject|2
7444827|NCT01687166|11731377|FG001|Overall Study|Attempt subject|3
7562046|NCT03215758|11930498|FG001|Overall Study|Death|1
7444828|NCT01687166|11731378|FG002|Overall Study|Attempt subject|2
7444829|NCT01687166|11731379|FG003|Overall Study|Attempt subject|0
7444830|NCT01687166|11731376|FG000|Overall Study|Did not meet eligibility criteria|4
7444831|NCT01687166|11731377|FG001|Overall Study|Did not meet eligibility criteria|6
7444832|NCT01687166|11731378|FG002|Overall Study|Did not meet eligibility criteria|1
7444833|NCT01687166|11731379|FG003|Overall Study|Did not meet eligibility criteria|1
7444834|NCT01687166|11731376|FG000|Overall Study|Adverse Event|2
7444835|NCT01687166|11731377|FG001|Overall Study|Adverse Event|1
7444836|NCT01687166|11731378|FG002|Overall Study|Adverse Event|0
7444837|NCT01687166|11731379|FG003|Overall Study|Adverse Event|0
7444838|NCT01687166|11731376|FG000|Overall Study|Physician Decision|3
7444839|NCT01687166|11731377|FG001|Overall Study|Physician Decision|2
7444840|NCT01687166|11731378|FG002|Overall Study|Physician Decision|1
7444841|NCT01687166|11731379|FG003|Overall Study|Physician Decision|0
7444842|NCT01687166|11731376|FG000|Overall Study|Withdrawal by Subject|11
7444843|NCT01687166|11731377|FG001|Overall Study|Withdrawal by Subject|4
7444844|NCT01687166|11731378|FG002|Overall Study|Withdrawal by Subject|3
7444845|NCT01687166|11731379|FG003|Overall Study|Withdrawal by Subject|0
7444846|NCT01687166|11731376|FG000|Overall Study|Lost to Follow-up|2
7444847|NCT01687166|11731377|FG001|Overall Study|Lost to Follow-up|5
7444848|NCT01687166|11731378|FG002|Overall Study|Lost to Follow-up|1
7444849|NCT01687166|11731379|FG003|Overall Study|Lost to Follow-up|0
7444850|NCT01687166|11731376|FG000|Overall Study|Equipment/Device Availability|0
7444851|NCT01687166|11731377|FG001|Overall Study|Equipment/Device Availability|1
7444852|NCT01687166|11731378|FG002|Overall Study|Equipment/Device Availability|0
7444853|NCT01687166|11731379|FG003|Overall Study|Equipment/Device Availability|0
7444854|NCT01687166|11731376|FG000|Overall Study|Death|1
7444855|NCT01687166|11731377|FG001|Overall Study|Death|1
7444856|NCT01687166|11731378|FG002|Overall Study|Death|0
7444857|NCT01687166|11731379|FG003|Overall Study|Death|0
7444858|NCT01687166|11731376|FG000|Overall Study|Protocol Violation|1
7444859|NCT01687166|11731377|FG001|Overall Study|Protocol Violation|1
7444860|NCT01687166|11731378|FG002|Overall Study|Protocol Violation|1
7444861|NCT01687166|11731379|FG003|Overall Study|Protocol Violation|0
7444862|NCT01687166|11731376|FG000|Overall Study|Subject moved out of state|0
7444863|NCT01687166|11731377|FG001|Overall Study|Subject moved out of state|1
7444864|NCT01687166|11731378|FG002|Overall Study|Subject moved out of state|0
7444865|NCT01687166|11731379|FG003|Overall Study|Subject moved out of state|0
7562047|NCT03215758|11930497|FG000|Overall Study|Adverse Event|1
7562048|NCT03215758|11930498|FG001|Overall Study|Adverse Event|2
7562049|NCT03215758|11930497|FG000|Overall Study|Subject/Guardian Decision|3
7444866|NCT01687166|11731376|FG000|Overall Study|Patient unable to be compliant|1
7444867|NCT01687166|11731377|FG001|Overall Study|Patient unable to be compliant|0
7444868|NCT01687166|11731378|FG002|Overall Study|Patient unable to be compliant|0
7444869|NCT01687166|11731379|FG003|Overall Study|Patient unable to be compliant|0
7444870|NCT01687166|11731376|FG000|Overall Study|Physician choice to use different device|1
7444871|NCT01687166|11731377|FG001|Overall Study|Physician choice to use different device|2
7444872|NCT01687166|11731378|FG002|Overall Study|Physician choice to use different device|4
7444873|NCT01687166|11731379|FG003|Overall Study|Physician choice to use different device|0
7444874|NCT01687166|11731376|FG000|Overall Study|Insurance|0
7444875|NCT01687166|11731377|FG001|Overall Study|Insurance|0
7444876|NCT01687166|11731378|FG002|Overall Study|Insurance|1
7444877|NCT01687166|11731379|FG003|Overall Study|Insurance|1
7444878|NCT01687218|11731400|FG000|Overall Study|Withdrawal by Subject|2
7444879|NCT01687218|11731401|FG001|Overall Study|Withdrawal by Subject|3
7444880|NCT01687218|11731402|FG002|Overall Study|Withdrawal by Subject|0
7444881|NCT01687218|11731403|FG003|Overall Study|Withdrawal by Subject|1
7444882|NCT01687218|11731404|FG004|Overall Study|Withdrawal by Subject|1
7444883|NCT01687218|11731405|FG005|Overall Study|Withdrawal by Subject|0
7444884|NCT01687218|11731400|FG000|Overall Study|Relocated, no follow-up planned|1
7444885|NCT01687218|11731401|FG001|Overall Study|Relocated, no follow-up planned|0
7444886|NCT01687218|11731402|FG002|Overall Study|Relocated, no follow-up planned|1
7444887|NCT01687218|11731403|FG003|Overall Study|Relocated, no follow-up planned|1
7444888|NCT01687218|11731404|FG004|Overall Study|Relocated, no follow-up planned|0
7444889|NCT01687218|11731405|FG005|Overall Study|Relocated, no follow-up planned|0
7444890|NCT01687257|11731432|FG000|Overall Study|Efficacy Failure|6
7444891|NCT01687257|11731433|FG001|Overall Study|Efficacy Failure|0
7444892|NCT01687257|11731434|FG002|Overall Study|Efficacy Failure|5
7444893|NCT01687257|11731432|FG000|Overall Study|Subject Withdrew Consent|1
7562050|NCT03215758|11930498|FG001|Overall Study|Subject/Guardian Decision|3
7444894|NCT01687257|11731433|FG001|Overall Study|Subject Withdrew Consent|1
7444895|NCT01687257|11731434|FG002|Overall Study|Subject Withdrew Consent|1
7444896|NCT01687257|11731432|FG000|Overall Study|Adverse Event|1
7444897|NCT01687257|11731433|FG001|Overall Study|Adverse Event|0
7444898|NCT01687257|11731434|FG002|Overall Study|Adverse Event|0
7444899|NCT01687257|11731432|FG000|Overall Study|Investigator's Discretion|0
7444900|NCT01687257|11731433|FG001|Overall Study|Investigator's Discretion|3
7444901|NCT01687257|11731434|FG002|Overall Study|Investigator's Discretion|0
7444902|NCT01687270|11731448|FG000|Overall Study|Lack of Efficacy|11
7444903|NCT01687270|11731448|FG000|Overall Study|Lost to Follow-up|1
7444904|NCT01687283|11731454|FG000|Overall Study|Adverse Event|11
7444905|NCT01687283|11731455|FG001|Overall Study|Adverse Event|4
7444906|NCT01687283|11731454|FG000|Overall Study|Lack of Efficacy|3
7444907|NCT01687283|11731455|FG001|Overall Study|Lack of Efficacy|1
7444908|NCT01687283|11731454|FG000|Overall Study|Protocol Violation|1
7444909|NCT01687283|11731455|FG001|Overall Study|Protocol Violation|3
7444910|NCT01687283|11731454|FG000|Overall Study|protocol defined stopping criteria|8
7444911|NCT01687283|11731455|FG001|Overall Study|protocol defined stopping criteria|10
7444912|NCT01687283|11731454|FG000|Overall Study|Lost to Follow-up|1
7444913|NCT01687283|11731455|FG001|Overall Study|Lost to Follow-up|1
7444914|NCT01687283|11731454|FG000|Overall Study|Investigator discretion|2
7444915|NCT01687283|11731455|FG001|Overall Study|Investigator discretion|0
7444916|NCT01687283|11731454|FG000|Overall Study|Withdrawal by Subject|9
7444917|NCT01687283|11731455|FG001|Overall Study|Withdrawal by Subject|8
7444918|NCT01687296|11731463|FG000|Overall Study|Lack of Efficacy|1
7444919|NCT01687296|11731464|FG001|Overall Study|Lack of Efficacy|1
7444920|NCT01687296|11731463|FG000|Overall Study|Protocol Violation|0
7444921|NCT01687296|11731464|FG001|Overall Study|Protocol Violation|1
7444922|NCT01687296|11731463|FG000|Overall Study|Withdrawal by Subject|6
7444923|NCT01687296|11731464|FG001|Overall Study|Withdrawal by Subject|3
7444924|NCT01687413|11731494|FG000|Overall Study|Withdrawal by Subject|0
7444925|NCT01687413|11731495|FG001|Overall Study|Withdrawal by Subject|2
7444926|NCT01687413|11731494|FG000|Overall Study|Not eligible|0
7444927|NCT01687413|11731495|FG001|Overall Study|Not eligible|2
7444928|NCT01687413|11731494|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
7444929|NCT01687413|11731495|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
7444930|NCT01687478|11731521|FG000|Overall Study|Adverse Event|3
7444931|NCT01687478|11731522|FG001|Overall Study|Adverse Event|10
7444932|NCT01687478|11731521|FG000|Overall Study|Lost to Follow-up|1
7444933|NCT01687478|11731522|FG001|Overall Study|Lost to Follow-up|3
7444934|NCT01687478|11731521|FG000|Overall Study|Protocol Violation|0
7444935|NCT01687478|11731522|FG001|Overall Study|Protocol Violation|2
7444936|NCT01687478|11731521|FG000|Overall Study|Withdrawal by Subject|21
7444937|NCT01687478|11731522|FG001|Overall Study|Withdrawal by Subject|19
7444938|NCT01687478|11731521|FG000|Overall Study|Physician Decision|1
7444939|NCT01687478|11731522|FG001|Overall Study|Physician Decision|3
7444940|NCT01687478|11731521|FG000|Overall Study|Entry Criteria Not Met|6
7444941|NCT01687478|11731522|FG001|Overall Study|Entry Criteria Not Met|2
7444942|NCT01687595|11731530|FG000|Overall Study|Withdrawal by Subject|8
7444943|NCT01687595|11731531|FG001|Overall Study|Withdrawal by Subject|0
7444944|NCT01687595|11731530|FG000|Overall Study|Lost to Follow-up|3
7444945|NCT01687595|11731531|FG001|Overall Study|Lost to Follow-up|1
7444946|NCT01687595|11731530|FG000|Overall Study|Investigator's decision|1
7444947|NCT01687595|11731531|FG001|Overall Study|Investigator's decision|0
7444948|NCT01687595|11731530|FG000|Overall Study|Sponsor's decision|1
7444949|NCT01687595|11731531|FG001|Overall Study|Sponsor's decision|0
7444950|NCT01687595|11731530|FG000|Overall Study|Noncompliance|1
7444951|NCT01687595|11731531|FG001|Overall Study|Noncompliance|2
7444952|NCT01687595|11731530|FG000|Overall Study|Other than specified|56
7444953|NCT01687595|11731531|FG001|Overall Study|Other than specified|7
7444954|NCT01687673|11731537|FG000|Overall Study|Physician Decision|1
7444955|NCT01687712|11731543|FG000|Cycle 1|Not Biochemically Pregnant|386
7444956|NCT01687712|11731544|FG001|Cycle 1|Not Biochemically Pregnant|348
7444957|NCT01687712|11731543|FG000|Cycle 1|Early Pregnancy Loss|43
7444958|NCT01687712|11731544|FG001|Cycle 1|Early Pregnancy Loss|60
7444959|NCT01687712|11731543|FG000|Cycle 1|Ectopic Pregnancy|5
7444960|NCT01687712|11731544|FG001|Cycle 1|Ectopic Pregnancy|5
7444961|NCT01687712|11731543|FG000|Cycle 1|Heterotropic Pregnancy|1
7444962|NCT01687712|11731544|FG001|Cycle 1|Heterotropic Pregnancy|0
7444963|NCT01687712|11731543|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
7444964|NCT01687712|11731544|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
7444965|NCT01687712|11731543|FG000|Cycle 1|Abortion|3
7444966|NCT01687712|11731544|FG001|Cycle 1|Abortion|0
7444967|NCT01687712|11731543|FG000|Cycle 1|Intrauterine Fetal Death|0
7444968|NCT01687712|11731544|FG001|Cycle 1|Intrauterine Fetal Death|1
7444969|NCT01687712|11731543|FG000|Cycle 1|Lost to Follow-up|1
7444970|NCT01687712|11731544|FG001|Cycle 1|Lost to Follow-up|1
7444971|NCT01687712|11731543|FG000|Cycle 2|Not Biochemically Pregnant|74
7444972|NCT01687712|11731544|FG001|Cycle 2|Not Biochemically Pregnant|77
7444973|NCT01687712|11731543|FG000|Cycle 2|Early Pregnancy Loss|18
7444974|NCT01687712|11731544|FG001|Cycle 2|Early Pregnancy Loss|16
7444975|NCT01687712|11731543|FG000|Cycle 2|Ectopic Pregnancy|0
7444976|NCT01687712|11731544|FG001|Cycle 2|Ectopic Pregnancy|1
7444977|NCT01687712|11731543|FG000|Cycle 2|Still Birth|1
7444978|NCT01687712|11731544|FG001|Cycle 2|Still Birth|0
7444979|NCT01687712|11731543|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
7444980|NCT01687712|11731544|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
7444981|NCT01687712|11731543|FG000|Cycle 3|Not Biochemically Pregnant|21
7444982|NCT01687712|11731544|FG001|Cycle 3|Not Biochemically Pregnant|22
7444983|NCT01687712|11731543|FG000|Cycle 3|Early Pregnancy Loss|1
7444984|NCT01687712|11731544|FG001|Cycle 3|Early Pregnancy Loss|2
7444985|NCT01687712|11731543|FG000|Cycle 3|Ectopic Pregnancy|1
7444986|NCT01687712|11731544|FG001|Cycle 3|Ectopic Pregnancy|0
7444987|NCT01687712|11731543|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
7444988|NCT01687712|11731544|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
7444989|NCT01687998|11731570|FG000|Overall Study|Withdrawal by Subject|49
7444990|NCT01687998|11731571|FG001|Overall Study|Withdrawal by Subject|51
7444991|NCT01687998|11731570|FG000|Overall Study|Known to be Alive at Study End|54
7444992|NCT01687998|11731571|FG001|Overall Study|Known to be Alive at Study End|62
7444993|NCT01687998|11731570|FG000|Overall Study|Lost to Follow-up|9
7444994|NCT01687998|11731571|FG001|Overall Study|Lost to Follow-up|7
7444995|NCT01688037|11731580|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7444996|NCT01688037|11731581|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7444997|NCT01688037|11731582|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
7444998|NCT01688037|11731580|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
7444999|NCT01688037|11731581|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7445000|NCT01688037|11731582|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7445001|NCT01688037|11731580|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
7445002|NCT01688037|11731581|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
7445003|NCT01688037|11731582|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7445004|NCT01688037|11731580|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7445005|NCT01688037|11731581|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7445006|NCT01688037|11731582|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7445007|NCT01688037|11731580|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7445008|NCT01688037|11731581|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
7445009|NCT01688037|11731582|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
7445010|NCT01688037|11731580|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
7445011|NCT01688037|11731581|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
7445012|NCT01688037|11731582|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
7445013|NCT01688037|11731580|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
7445014|NCT01688037|11731581|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
7445015|NCT01688037|11731582|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
7445016|NCT01688037|11731580|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
7445017|NCT01688037|11731581|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
7445018|NCT01688037|11731582|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
7445019|NCT01688037|11731580|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7445020|NCT01688037|11731581|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
7445021|NCT01688037|11731582|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
7445022|NCT01688037|11731580|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7445023|NCT01688037|11731581|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
7445024|NCT01688037|11731582|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
7445025|NCT01688050|11731594|FG000|Overall Study|Death|7
7445026|NCT01688050|11731594|FG000|Overall Study|Conversion to open repair|1
7445027|NCT01688050|11731594|FG000|Overall Study|Lost to Follow-up|13
7445028|NCT01688050|11731594|FG000|Overall Study|Withdrawal by Subject|10
7445029|NCT01688466|11731634|FG000|Overall Study|Withdrawal by Subject|2
7445030|NCT01688466|11731635|FG001|Overall Study|Withdrawal by Subject|1
7445031|NCT01688466|11731634|FG000|Overall Study|Death|0
7445032|NCT01688466|11731635|FG001|Overall Study|Death|1
7445033|NCT01688466|11731634|FG000|Overall Study|Adverse Event|0
7445034|NCT01688466|11731635|FG001|Overall Study|Adverse Event|4
7445035|NCT01688466|11731634|FG000|Overall Study|Not evaluable|0
7445036|NCT01688466|11731635|FG001|Overall Study|Not evaluable|1
7445037|NCT01688635|11731654|FG000|Washout 1|Withdrawal by Subject|1
7445038|NCT01688635|11731655|FG001|Washout 1|Withdrawal by Subject|0
7445039|NCT01688635|11731654|FG000|Washout 1|Adverse Event|0
7445040|NCT01688635|11731655|FG001|Washout 1|Adverse Event|1
7445041|NCT01688635|11731654|FG000|Washout 1|Physician Decision|0
7445042|NCT01688635|11731655|FG001|Washout 1|Physician Decision|1
7445043|NCT01688635|11731654|FG000|Washout 2|Physician Decision|1
7445044|NCT01688635|11731655|FG001|Washout 2|Physician Decision|0
7445045|NCT01688635|11731654|FG000|Washout 2|Withdrawal by Subject|1
7445046|NCT01688635|11731655|FG001|Washout 2|Withdrawal by Subject|0
7445047|NCT01688635|11731654|FG000|Washout 2|Sponsor Decision|1
7445048|NCT01688635|11731655|FG001|Washout 2|Sponsor Decision|2
7445049|NCT01688635|11731654|FG000|Washout 3|Withdrawal by Subject|1
7445050|NCT01688635|11731655|FG001|Washout 3|Withdrawal by Subject|0
7445051|NCT01688726|11731664|FG000|Overall Study|Adverse Event|1
7445052|NCT01688726|11731665|FG001|Overall Study|Adverse Event|0
7445053|NCT01688726|11731664|FG000|Overall Study|Relocated abroad|0
7445054|NCT01688726|11731665|FG001|Overall Study|Relocated abroad|1
7445055|NCT01688739|11731685|FG000|Overall Study|Administrative Decision|1
7445056|NCT01688739|11731686|FG001|Overall Study|Administrative Decision|0
7445057|NCT01688739|11731687|FG002|Overall Study|Administrative Decision|0
7445058|NCT01688739|11731688|FG003|Overall Study|Administrative Decision|0
7445059|NCT01688739|11731689|FG004|Overall Study|Administrative Decision|0
7445060|NCT01688739|11731690|FG005|Overall Study|Administrative Decision|0
7445061|NCT01688739|11731691|FG006|Overall Study|Administrative Decision|0
7445062|NCT01688739|11731692|FG007|Overall Study|Administrative Decision|0
7445063|NCT01688739|11731693|FG008|Overall Study|Administrative Decision|0
7445064|NCT01688739|11731694|FG009|Overall Study|Administrative Decision|0
7445065|NCT01688830|11731745|FG000|Overall Study|Lost to Follow-up|0
7445066|NCT01688830|11731746|FG001|Overall Study|Lost to Follow-up|0
7445067|NCT01688830|11731747|FG002|Overall Study|Lost to Follow-up|0
7445068|NCT01688830|11731748|FG003|Overall Study|Lost to Follow-up|0
7445069|NCT01688830|11731749|FG004|Overall Study|Lost to Follow-up|0
7445070|NCT01688830|11731750|FG005|Overall Study|Lost to Follow-up|0
7445071|NCT01688830|11731751|FG006|Overall Study|Lost to Follow-up|0
7445072|NCT01688830|11731752|FG007|Overall Study|Lost to Follow-up|0
7445073|NCT01688830|11731753|FG008|Overall Study|Lost to Follow-up|0
7445074|NCT01688830|11731754|FG009|Overall Study|Lost to Follow-up|0
7445075|NCT01688830|11731755|FG010|Overall Study|Lost to Follow-up|1
7445076|NCT01688830|11731756|FG011|Overall Study|Lost to Follow-up|0
7445077|NCT01688830|11731757|FG012|Overall Study|Lost to Follow-up|0
7445078|NCT01688830|11731758|FG013|Overall Study|Lost to Follow-up|0
7445079|NCT01688830|11731759|FG014|Overall Study|Lost to Follow-up|0
7445080|NCT01688830|11731760|FG015|Overall Study|Lost to Follow-up|0
7445081|NCT01688830|11731761|FG016|Overall Study|Lost to Follow-up|0
7445082|NCT01688830|11731762|FG017|Overall Study|Lost to Follow-up|0
7445083|NCT01688830|11731763|FG018|Overall Study|Lost to Follow-up|0
7445084|NCT01688830|11731764|FG019|Overall Study|Lost to Follow-up|0
7445085|NCT01688830|11731765|FG020|Overall Study|Lost to Follow-up|0
7445086|NCT01688882|11731870|FG000|Overall Study|Adverse Event|1
7445087|NCT01688882|11731871|FG001|Overall Study|Adverse Event|0
7445088|NCT01688882|11731870|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7445089|NCT01688882|11731871|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7445090|NCT01688882|11731870|FG000|Overall Study|Administrative problems|1
7445091|NCT01688882|11731871|FG001|Overall Study|Administrative problems|0
7445092|NCT01688921|11731887|FG000|Overall Study|Lost to Follow-up|7
7445093|NCT01688921|11731888|FG001|Overall Study|Lost to Follow-up|13
7445094|NCT01688921|11731887|FG000|Overall Study|Physician Decision|6
7445095|NCT01688921|11731888|FG001|Overall Study|Physician Decision|1
7445096|NCT01688921|11731887|FG000|Overall Study|Protocol Violation|0
7445097|NCT01688921|11731888|FG001|Overall Study|Protocol Violation|1
7445098|NCT01688921|11731887|FG000|Overall Study|informed consent|3
7445099|NCT01688921|11731888|FG001|Overall Study|informed consent|0
7445100|NCT01688973|11731897|FG000|Overall Study|Ineligible|2
7445101|NCT01688973|11731898|FG001|Overall Study|Ineligible|3
7445102|NCT01688999|11731908|FG000|Overall Study|Withdrawal by Subject|5
7445103|NCT01688999|11731909|FG001|Overall Study|Withdrawal by Subject|1
7445104|NCT01688999|11731910|FG002|Overall Study|Withdrawal by Subject|1
7445105|NCT01688999|11731908|FG000|Overall Study|Adverse Event|2
7445106|NCT01688999|11731909|FG001|Overall Study|Adverse Event|0
7445107|NCT01688999|11731910|FG002|Overall Study|Adverse Event|2
7445108|NCT01688999|11731908|FG000|Overall Study|Ineligible/Not treated|1
7445109|NCT01688999|11731909|FG001|Overall Study|Ineligible/Not treated|0
7445110|NCT01688999|11731910|FG002|Overall Study|Ineligible/Not treated|0
7445111|NCT01689207|11731933|FG000|Overall Study|Adverse Event|0
7445112|NCT01689207|11731934|FG001|Overall Study|Adverse Event|1
7445113|NCT01689207|11731935|FG002|Overall Study|Adverse Event|0
7445114|NCT01689207|11731936|FG003|Overall Study|Adverse Event|0
7445115|NCT01689207|11731937|FG004|Overall Study|Adverse Event|2
7445116|NCT01689207|11731938|FG005|Overall Study|Adverse Event|1
7445117|NCT01689207|11731939|FG006|Overall Study|Adverse Event|0
7445118|NCT01689207|11731940|FG007|Overall Study|Adverse Event|0
7445119|NCT01689207|11731941|FG008|Overall Study|Adverse Event|1
7562051|NCT03215771|11930504|FG000|Overall Study|Withdrawal by Subject|2
7562052|NCT03215771|11930504|FG000|Overall Study|Physician Decision|1
7562053|NCT03216226|11930528|FG000|Overall Study|Adverse Event|3
7562054|NCT03216226|11930529|FG001|Overall Study|Adverse Event|0
7562055|NCT03216226|11930528|FG000|Overall Study|Protocol Violation|1
7562056|NCT03216226|11930529|FG001|Overall Study|Protocol Violation|3
7562057|NCT03216226|11930528|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
7562058|NCT03216226|11930529|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
7562059|NCT03216226|11930528|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
7562060|NCT03216226|11930529|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
7562061|NCT03216226|11930528|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
7562062|NCT03216226|11930529|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
7562063|NCT03216265|11930538|FG000|Overall Study|Adverse Event|2
7562064|NCT03216265|11930539|FG001|Overall Study|Adverse Event|0
7445120|NCT01689207|11731942|FG009|Overall Study|Adverse Event|0
7445121|NCT01689207|11731943|FG010|Overall Study|Adverse Event|0
7445122|NCT01689337|11731977|FG000|Overall Study|Study Discontinuation|1
7467665|NCT01903252|11768106|FG004|Double-Blind Induction|Physician Decision|0
7467666|NCT01903252|11768107|FG005|Double-Blind Induction|Physician Decision|0
7467667|NCT01903252|11768102|FG000|Double-Blind Induction|non-compliance,|7
7467668|NCT01903252|11768103|FG001|Double-Blind Induction|non-compliance,|7
7467669|NCT01903252|11768104|FG002|Double-Blind Induction|non-compliance,|0
7467670|NCT01903252|11768105|FG003|Double-Blind Induction|non-compliance,|0
7467671|NCT01903252|11768106|FG004|Double-Blind Induction|non-compliance,|0
7445123|NCT01689363|11731992|FG000|Overall Study|Protocol Violation|0
7445124|NCT01689363|11731993|FG001|Overall Study|Protocol Violation|1
7445125|NCT01689363|11731994|FG002|Overall Study|Protocol Violation|0
7445126|NCT01689363|11731995|FG003|Overall Study|Protocol Violation|0
7445127|NCT01689363|11731996|FG004|Overall Study|Protocol Violation|0
7445128|NCT01689363|11731997|FG005|Overall Study|Protocol Violation|0
7445129|NCT01689363|11731998|FG006|Overall Study|Protocol Violation|0
7445130|NCT01689363|11731999|FG007|Overall Study|Protocol Violation|0
7445131|NCT01689532|11732021|FG000|Overall Study|Adverse Event|9
7445132|NCT01689532|11732022|FG001|Overall Study|Adverse Event|5
7445133|NCT01689532|11732021|FG000|Overall Study|Lack of Efficacy|2
7445134|NCT01689532|11732022|FG001|Overall Study|Lack of Efficacy|2
7445135|NCT01689532|11732021|FG000|Overall Study|Withdrawal by Subject|1
7445136|NCT01689532|11732022|FG001|Overall Study|Withdrawal by Subject|2
7445137|NCT01689532|11732021|FG000|Overall Study|Physician Decision|2
7445138|NCT01689532|11732022|FG001|Overall Study|Physician Decision|0
7445139|NCT01689649|11732028|FG000|Overall Study|Lack of Efficacy|3
7445140|NCT01689649|11732028|FG000|Overall Study|Non-compliance|11
7445141|NCT01689649|11732028|FG000|Overall Study|Protocol Violation|3
7445142|NCT01689649|11732028|FG000|Overall Study|Lost to Follow-up|5
7445143|NCT01689857|11732052|FG000|Overall Study|Lost to Follow-up|5
7445144|NCT01689857|11732053|FG001|Overall Study|Lost to Follow-up|2
7445145|NCT01690052|11732068|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
7445146|NCT01690052|11732069|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
7445147|NCT01690130|11732088|FG000|Overall Study|Subject have cancelled visit.|1
7445148|NCT01690130|11732089|FG001|Overall Study|Subject have cancelled visit.|0
7445149|NCT01690143|11732095|FG000|Overall Study|Withdrawal by Subject|1
7445150|NCT01690520|11732119|FG000|Overall Study|Death|25
7445151|NCT01690520|11732120|FG001|Overall Study|Death|21
7445152|NCT01690520|11732119|FG000|Overall Study|Lost to Follow-up|2
7445153|NCT01690520|11732120|FG001|Overall Study|Lost to Follow-up|3
7445154|NCT01690520|11732119|FG000|Overall Study|Withdrawal by Subject|2
7445155|NCT01690520|11732120|FG001|Overall Study|Withdrawal by Subject|0
7445156|NCT01690520|11732119|FG000|Overall Study|Relapse|0
7445157|NCT01690520|11732120|FG001|Overall Study|Relapse|1
7445158|NCT01690520|11732119|FG000|Overall Study|Other|0
7445159|NCT01690520|11732120|FG001|Overall Study|Other|1
7445160|NCT01690520|11732119|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
7445161|NCT01690520|11732120|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
7445162|NCT01690988|11732155|FG000|Overall Study|Withdrawal by Subject|2
7445163|NCT01690988|11732156|FG001|Overall Study|Withdrawal by Subject|2
7445164|NCT01690988|11732157|FG002|Overall Study|Withdrawal by Subject|3
7445165|NCT01690988|11732155|FG000|Overall Study|Physician Decision|0
7445166|NCT01690988|11732156|FG001|Overall Study|Physician Decision|0
7445167|NCT01690988|11732157|FG002|Overall Study|Physician Decision|1
7445168|NCT01690988|11732155|FG000|Overall Study|Operation Cancelled|1
7445169|NCT01690988|11732156|FG001|Overall Study|Operation Cancelled|1
7445170|NCT01690988|11732157|FG002|Overall Study|Operation Cancelled|0
7445171|NCT01690988|11732155|FG000|Overall Study|Determined ineligible|1
7445172|NCT01690988|11732156|FG001|Overall Study|Determined ineligible|0
7445173|NCT01690988|11732157|FG002|Overall Study|Determined ineligible|0
7445174|NCT01690988|11732155|FG000|Overall Study|Death|1
7445175|NCT01690988|11732156|FG001|Overall Study|Death|1
7445176|NCT01690988|11732157|FG002|Overall Study|Death|1
7445177|NCT01690988|11732155|FG000|Overall Study|Sedated|1
7445178|NCT01690988|11732156|FG001|Overall Study|Sedated|1
7445179|NCT01690988|11732157|FG002|Overall Study|Sedated|2
7445180|NCT01691014|11732172|FG000|Overall Study|Premature Termination|1
7445181|NCT01691014|11732173|FG001|Overall Study|Premature Termination|6
7445182|NCT01691014|11732174|FG002|Overall Study|Premature Termination|0
7445183|NCT01691014|11732175|FG003|Overall Study|Premature Termination|3
7445184|NCT01691014|11732172|FG000|Overall Study|Other|0
7445185|NCT01691014|11732173|FG001|Overall Study|Other|0
7445186|NCT01691014|11732174|FG002|Overall Study|Other|2
7445187|NCT01691014|11732175|FG003|Overall Study|Other|0
7445188|NCT01691014|11732172|FG000|Overall Study|Withdrawal by Subject|0
7445189|NCT01691014|11732173|FG001|Overall Study|Withdrawal by Subject|1
7445190|NCT01691014|11732174|FG002|Overall Study|Withdrawal by Subject|1
7445191|NCT01691014|11732175|FG003|Overall Study|Withdrawal by Subject|1
7445192|NCT01691014|11732172|FG000|Overall Study|Adverse Event|0
7445193|NCT01691014|11732173|FG001|Overall Study|Adverse Event|5
7445194|NCT01691014|11732174|FG002|Overall Study|Adverse Event|1
7445195|NCT01691014|11732175|FG003|Overall Study|Adverse Event|1
7445196|NCT01691014|11732172|FG000|Overall Study|Lack of Efficacy|2
7445197|NCT01691014|11732173|FG001|Overall Study|Lack of Efficacy|3
7445198|NCT01691014|11732174|FG002|Overall Study|Lack of Efficacy|7
7445199|NCT01691014|11732175|FG003|Overall Study|Lack of Efficacy|0
7445200|NCT01691092|11732190|FG000|Overall Study|Lost to Follow-up|10
7445201|NCT01691092|11732190|FG000|Overall Study|Physician Decision|4
7445202|NCT01691092|11732190|FG000|Overall Study|Withdrawal by Subject|3
7445203|NCT01691092|11732190|FG000|Overall Study|non-compliance|3
7445204|NCT01691092|11732190|FG000|Overall Study|used for different study|2
7445205|NCT01691092|11732190|FG000|Overall Study|screen fail|19
7445206|NCT01691105|11732196|FG000|1 Month Follow-up|Lost to Follow-up|41
7445207|NCT01691105|11732197|FG001|1 Month Follow-up|Lost to Follow-up|38
7445208|NCT01691105|11732196|FG000|1 Month Follow-up|Death|2
7445209|NCT01691105|11732197|FG001|1 Month Follow-up|Death|3
7445210|NCT01691105|11732196|FG000|6 Month Follow-up|Lost to Follow-up|39
7445211|NCT01691105|11732197|FG001|6 Month Follow-up|Lost to Follow-up|58
7445212|NCT01691105|11732196|FG000|6 Month Follow-up|Death|13
7445213|NCT01691105|11732197|FG001|6 Month Follow-up|Death|13
7445214|NCT01691105|11732196|FG000|12 Month Follow-up|Lost to Follow-up|50
7445215|NCT01691105|11732197|FG001|12 Month Follow-up|Lost to Follow-up|71
7445216|NCT01691105|11732196|FG000|12 Month Follow-up|Death|22
7445217|NCT01691105|11732197|FG001|12 Month Follow-up|Death|30
7445218|NCT01691105|11732196|FG000|12 Month Biochemical Verification|Death|22
7445219|NCT01691105|11732197|FG001|12 Month Biochemical Verification|Death|30
7445220|NCT01691105|11732196|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
7445221|NCT01691105|11732197|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
7445222|NCT01691105|11732196|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
7445223|NCT01691105|11732197|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
7445224|NCT01691248|11732205|FG000|Overall Study|Protocol Violation|43
7445225|NCT01691248|11732206|FG001|Overall Study|Protocol Violation|27
7445226|NCT01691248|11732205|FG000|Overall Study|Adverse Event|24
7445227|NCT01691248|11732206|FG001|Overall Study|Adverse Event|22
7445228|NCT01691248|11732205|FG000|Overall Study|Withdrawal by Subject|20
7445229|NCT01691248|11732206|FG001|Overall Study|Withdrawal by Subject|18
7445230|NCT01691248|11732205|FG000|Overall Study|Confirmed CDAD|14
7445231|NCT01691248|11732206|FG001|Overall Study|Confirmed CDAD|31
7445232|NCT01691248|11732205|FG000|Overall Study|Lost to Follow-up|2
7445233|NCT01691248|11732206|FG001|Overall Study|Lost to Follow-up|5
7445234|NCT01691248|11732205|FG000|Overall Study|Reason not provided|4
7445235|NCT01691248|11732206|FG001|Overall Study|Reason not provided|4
7445236|NCT01691248|11732205|FG000|Overall Study|Not Treated|4
7445237|NCT01691248|11732206|FG001|Overall Study|Not Treated|7
7445238|NCT01691378|11732259|FG000|Overall Study|Withdrawal by Subject|2
7445239|NCT01691378|11732260|FG001|Overall Study|Withdrawal by Subject|0
7445240|NCT01691378|11732259|FG000|Overall Study|Lost to Follow-up|5
7445241|NCT01691378|11732260|FG001|Overall Study|Lost to Follow-up|2
7445242|NCT01691430|11732268|FG000|Overall Study|Death|17
7445243|NCT01691430|11732269|FG001|Overall Study|Death|16
7445244|NCT01691430|11732268|FG000|Overall Study|Withdrawal by Subject|5
7445245|NCT01691430|11732269|FG001|Overall Study|Withdrawal by Subject|1
7445246|NCT01691430|11732268|FG000|Overall Study|Lost to Follow-up|0
7445247|NCT01691430|11732269|FG001|Overall Study|Lost to Follow-up|3
7445248|NCT01691482|11732275|FG000|Treatment Period 2|Adverse Event|0
7445249|NCT01691482|11732276|FG001|Treatment Period 2|Adverse Event|1
7445250|NCT01691482|11732275|FG000|Treatment Period 2|Protocol Violation|1
7445251|NCT01691482|11732276|FG001|Treatment Period 2|Protocol Violation|1
7445252|NCT01691508|11732285|FG000|Overall Study|Adverse Event|3
7445253|NCT01691508|11732286|FG001|Overall Study|Adverse Event|3
7445254|NCT01691508|11732285|FG000|Overall Study|Withdrawal by Subject|1
7445255|NCT01691508|11732286|FG001|Overall Study|Withdrawal by Subject|0
7445256|NCT01691521|11732295|FG000|Overall Study|Adverse Event|4
7445257|NCT01691521|11732296|FG001|Overall Study|Adverse Event|0
7445258|NCT01691521|11732297|FG002|Overall Study|Adverse Event|1
7445259|NCT01691521|11732295|FG000|Overall Study|Lack of Efficacy|1
7445260|NCT01691521|11732296|FG001|Overall Study|Lack of Efficacy|1
7562065|NCT03216265|11930540|FG002|Overall Study|Adverse Event|2
7562066|NCT03216265|11930538|FG000|Overall Study|Lost to Follow-up|0
7562067|NCT03216265|11930539|FG001|Overall Study|Lost to Follow-up|1
7562068|NCT03216265|11930540|FG002|Overall Study|Lost to Follow-up|0
7562069|NCT03216265|11930538|FG000|Overall Study|Withdrawal by Subject|0
7562070|NCT03216265|11930539|FG001|Overall Study|Withdrawal by Subject|0
7562071|NCT03216265|11930540|FG002|Overall Study|Withdrawal by Subject|1
7562072|NCT03216746|11930579|FG000|Overall Study|Lost to Follow-up|6
7562073|NCT03216746|11930580|FG001|Overall Study|Lost to Follow-up|8
7562074|NCT03216746|11930581|FG002|Overall Study|Lost to Follow-up|5
7562075|NCT03216746|11930582|FG003|Overall Study|Lost to Follow-up|6
7562076|NCT03216850|11930592|FG000|Overall Study|Pre-analytical error|6
7562077|NCT03216954|11930629|FG000|Overall Study|Adverse Event|0
7562078|NCT03216954|11930630|FG001|Overall Study|Adverse Event|0
7562079|NCT03216954|11930631|FG002|Overall Study|Adverse Event|1
7562080|NCT03216954|11930632|FG003|Overall Study|Adverse Event|0
7562081|NCT03216954|11930633|FG004|Overall Study|Adverse Event|1
7562082|NCT03216954|11930629|FG000|Overall Study|Withdrawal by Subject|2
7562083|NCT03216954|11930630|FG001|Overall Study|Withdrawal by Subject|0
7445261|NCT01691521|11732297|FG002|Overall Study|Lack of Efficacy|2
7445262|NCT01691521|11732295|FG000|Overall Study|Protocol Violation|0
7445263|NCT01691521|11732296|FG001|Overall Study|Protocol Violation|3
7445264|NCT01691521|11732297|FG002|Overall Study|Protocol Violation|0
7445265|NCT01691521|11732295|FG000|Overall Study|Lost to Follow-up|0
7445266|NCT01691521|11732296|FG001|Overall Study|Lost to Follow-up|2
7445267|NCT01691521|11732297|FG002|Overall Study|Lost to Follow-up|2
7445268|NCT01691521|11732295|FG000|Overall Study|Physician Decision|2
7445269|NCT01691521|11732296|FG001|Overall Study|Physician Decision|1
7562084|NCT03216954|11930631|FG002|Overall Study|Withdrawal by Subject|0
7562085|NCT03216954|11930632|FG003|Overall Study|Withdrawal by Subject|0
7562086|NCT03216954|11930633|FG004|Overall Study|Withdrawal by Subject|0
7562087|NCT03216954|11930629|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7562088|NCT03216954|11930630|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
7562089|NCT03216954|11930631|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7562090|NCT03216954|11930632|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7562091|NCT03216954|11930633|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
7562092|NCT03217968|11930641|FG000|Overall Study|Withdrawal by Subject|4
7562093|NCT03217968|11930641|FG000|Overall Study|Lost to Follow-up|1
7562094|NCT03217968|11930641|FG000|Overall Study|Protocol Violation|6
7562095|NCT03218397|11930647|FG000|Overall Study|Prior positive blood culture|8
7562096|NCT03218397|11930648|FG001|Overall Study|Prior positive blood culture|13
7562097|NCT03218397|11930647|FG000|Overall Study|Comfort care|8
7562098|NCT03218397|11930648|FG001|Overall Study|Comfort care|5
7562099|NCT03218397|11930647|FG000|Overall Study|Comfort care and positive blood culture|1
7562100|NCT03218397|11930648|FG001|Overall Study|Comfort care and positive blood culture|0
7562101|NCT03218397|11930647|FG000|Overall Study|Comfort care and mixed culture|0
7562102|NCT03218397|11930648|FG001|Overall Study|Comfort care and mixed culture|1
7562103|NCT03218397|11930647|FG000|Overall Study|Mixed culture|2
7562104|NCT03218397|11930648|FG001|Overall Study|Mixed culture|2
7562105|NCT03218397|11930647|FG000|Overall Study|Inaccessible hospital records|2
7562106|NCT03218397|11930648|FG001|Overall Study|Inaccessible hospital records|5
7562107|NCT03218397|11930647|FG000|Overall Study|No gram-negative bacilli (GNB)|0
7562108|NCT03218397|11930648|FG001|Overall Study|No gram-negative bacilli (GNB)|2
7562109|NCT03218397|11930647|FG000|Overall Study|Randomized during laboratory off hours|2
7562110|NCT03218397|11930648|FG001|Overall Study|Randomized during laboratory off hours|1
7562111|NCT03218787|11930676|FG000|Overall Study|Lost to Follow-up|12
7562112|NCT03218787|11930676|FG000|Overall Study|Withdrawal by Subject|72
7562113|NCT03218787|11930676|FG000|Overall Study|Physician Decision|11
7562114|NCT03218787|11930676|FG000|Overall Study|Death|111
7562115|NCT03219216|11930682|FG000|Overall Study|Lost to Follow-up|0
7562116|NCT03219216|11930683|FG001|Overall Study|Lost to Follow-up|1
7574975|NCT03706040|11958324|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7574976|NCT03706040|11958325|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7328846|NCT00798161|11561773|FG006|Overall Study|Withdrawal by Subject|1
7328847|NCT00798161|11561767|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
7445270|NCT01691521|11732297|FG002|Overall Study|Physician Decision|0
7445271|NCT01691521|11732295|FG000|Overall Study|Withdrawal by Subject|5
7445272|NCT01691521|11732296|FG001|Overall Study|Withdrawal by Subject|9
7445273|NCT01691521|11732297|FG002|Overall Study|Withdrawal by Subject|4
7445274|NCT01691612|11732353|FG000|Overall Study|deemed ineligible after 1st visit|6
7445275|NCT01691612|11732353|FG000|Overall Study|Adverse Event|1
7445276|NCT01691768|11732371|FG000|Overall Study|Death|0
7445277|NCT01691768|11732372|FG001|Overall Study|Death|2
7445278|NCT01691768|11732371|FG000|Overall Study|Lost to Follow-up|4
7445279|NCT01691768|11732372|FG001|Overall Study|Lost to Follow-up|3
7445280|NCT01691768|11732371|FG000|Overall Study|Withdrawal by Subject|10
7445281|NCT01691768|11732372|FG001|Overall Study|Withdrawal by Subject|9
7445282|NCT01691768|11732371|FG000|Overall Study|Relocated|0
7445283|NCT01691768|11732372|FG001|Overall Study|Relocated|1
7445284|NCT01691768|11732371|FG000|Overall Study|Investigator decision|1
7445285|NCT01691768|11732372|FG001|Overall Study|Investigator decision|1
7445286|NCT01691781|11732381|FG000|Overall Study|Withdrawal by Subject|4
7445287|NCT01691781|11732382|FG001|Overall Study|Withdrawal by Subject|3
7445288|NCT01691781|11732381|FG000|Overall Study|Physician Decision|1
7445289|NCT01691781|11732382|FG001|Overall Study|Physician Decision|1
7445290|NCT01691781|11732381|FG000|Overall Study|Protocol Violation|2
7445291|NCT01691781|11732382|FG001|Overall Study|Protocol Violation|2
7445292|NCT01691781|11732381|FG000|Overall Study|Adverse Event|0
7445293|NCT01691781|11732382|FG001|Overall Study|Adverse Event|1
7445294|NCT01691794|11732391|FG000|Overall Study|Poor/Non-Compliance|1
7445295|NCT01691794|11732392|FG001|Overall Study|Poor/Non-Compliance|4
7445296|NCT01691794|11732393|FG002|Overall Study|Poor/Non-Compliance|1
7445297|NCT01691794|11732391|FG000|Overall Study|Death|0
7445298|NCT01691794|11732392|FG001|Overall Study|Death|0
7445299|NCT01691794|11732393|FG002|Overall Study|Death|1
7445300|NCT01691794|11732391|FG000|Overall Study|Lack of Efficacy|0
7445301|NCT01691794|11732392|FG001|Overall Study|Lack of Efficacy|7
7445302|NCT01691794|11732393|FG002|Overall Study|Lack of Efficacy|1
7445303|NCT01691794|11732391|FG000|Overall Study|Participant request to discontinue|0
7445304|NCT01691794|11732392|FG001|Overall Study|Participant request to discontinue|1
7445305|NCT01691794|11732393|FG002|Overall Study|Participant request to discontinue|0
7445306|NCT01691794|11732391|FG000|Overall Study|Adverse Event|0
7445307|NCT01691794|11732392|FG001|Overall Study|Adverse Event|1
7445308|NCT01691794|11732393|FG002|Overall Study|Adverse Event|1
7445309|NCT01691794|11732391|FG000|Overall Study|Completed Only first 24 weeks of study|0
7445310|NCT01691794|11732392|FG001|Overall Study|Completed Only first 24 weeks of study|2
7445311|NCT01691794|11732393|FG002|Overall Study|Completed Only first 24 weeks of study|3
7445312|NCT01691794|11732391|FG000|Overall Study|Did not complete first 24 weeks of study|0
7574977|NCT03706040|11958326|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0
7574978|NCT03706040|11958320|FG000|Period A (Week 0 to Week 16)|Other|2
7574979|NCT03706040|11958321|FG001|Period A (Week 0 to Week 16)|Other|0
7574980|NCT03706040|11958322|FG002|Period A (Week 0 to Week 16)|Other|2
7574981|NCT03706040|11958323|FG003|Period A (Week 0 to Week 16)|Other|0
7445313|NCT01691794|11732392|FG001|Overall Study|Did not complete first 24 weeks of study|3
7445314|NCT01691794|11732393|FG002|Overall Study|Did not complete first 24 weeks of study|3
7445315|NCT01691820|11732403|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
7445316|NCT01691820|11732404|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
7445317|NCT01691820|11732403|FG000|Overall Study|Migrated/moved from study area|7
7445318|NCT01691820|11732404|FG001|Overall Study|Migrated/moved from study area|4
7445319|NCT01691820|11732403|FG000|Overall Study|Lost to Follow-up|6
7445320|NCT01691820|11732404|FG001|Overall Study|Lost to Follow-up|17
7445321|NCT01691820|11732403|FG000|Overall Study|Other (unspecified)|4
7445322|NCT01691820|11732404|FG001|Overall Study|Other (unspecified)|1
7445323|NCT01691859|11732427|FG000|Overall Study|Adverse Event|19
7445324|NCT01691859|11732427|FG000|Overall Study|Lack of Efficacy|11
7445325|NCT01691859|11732427|FG000|Overall Study|Protocol Violation|4
7445326|NCT01691859|11732427|FG000|Overall Study|Product commercially available|221
7445327|NCT01691859|11732427|FG000|Overall Study|Study closed/terminated|50
7445328|NCT01691859|11732427|FG000|Overall Study|Lost to Follow-up|5
7445329|NCT01691859|11732427|FG000|Overall Study|Physician Decision|6
7445330|NCT01691859|11732427|FG000|Overall Study|Withdrawal by Subject|31
7445331|NCT01691885|11732431|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
7445332|NCT01691885|11732432|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
7445333|NCT01691885|11732431|FG000|Washout Period (7-9 Days)|Adverse Event|0
7445334|NCT01691885|11732432|FG001|Washout Period (7-9 Days)|Adverse Event|1
7445335|NCT01691898|11732444|FG000|Overall Study|Death|34
7445336|NCT01691898|11732445|FG001|Overall Study|Death|32
7445337|NCT01691898|11732446|FG002|Overall Study|Death|6
7445338|NCT01691898|11732447|FG003|Overall Study|Death|3
7445339|NCT01691898|11732448|FG004|Overall Study|Death|8
7445340|NCT01691898|11732449|FG005|Overall Study|Death|31
7445341|NCT01691898|11732444|FG000|Overall Study|Adverse Event|0
7445342|NCT01691898|11732445|FG001|Overall Study|Adverse Event|1
7445343|NCT01691898|11732446|FG002|Overall Study|Adverse Event|0
7445344|NCT01691898|11732447|FG003|Overall Study|Adverse Event|1
7445345|NCT01691898|11732448|FG004|Overall Study|Adverse Event|1
7445346|NCT01691898|11732449|FG005|Overall Study|Adverse Event|0
7445347|NCT01691898|11732444|FG000|Overall Study|Progression of Disease|1
7445348|NCT01691898|11732445|FG001|Overall Study|Progression of Disease|2
7445349|NCT01691898|11732446|FG002|Overall Study|Progression of Disease|1
7445350|NCT01691898|11732447|FG003|Overall Study|Progression of Disease|0
7445351|NCT01691898|11732448|FG004|Overall Study|Progression of Disease|0
7445352|NCT01691898|11732449|FG005|Overall Study|Progression of Disease|1
7445353|NCT01691898|11732444|FG000|Overall Study|Lost to Follow-up|3
7445354|NCT01691898|11732445|FG001|Overall Study|Lost to Follow-up|1
7445355|NCT01691898|11732446|FG002|Overall Study|Lost to Follow-up|0
7445356|NCT01691898|11732447|FG003|Overall Study|Lost to Follow-up|0
7445357|NCT01691898|11732448|FG004|Overall Study|Lost to Follow-up|1
7445358|NCT01691898|11732449|FG005|Overall Study|Lost to Follow-up|0
7445359|NCT01691898|11732444|FG000|Overall Study|Withdrawal by Subject|9
7445360|NCT01691898|11732445|FG001|Overall Study|Withdrawal by Subject|8
7445361|NCT01691898|11732446|FG002|Overall Study|Withdrawal by Subject|2
7445362|NCT01691898|11732447|FG003|Overall Study|Withdrawal by Subject|1
7445363|NCT01691898|11732448|FG004|Overall Study|Withdrawal by Subject|3
7445364|NCT01691898|11732449|FG005|Overall Study|Withdrawal by Subject|3
7445365|NCT01691898|11732444|FG000|Overall Study|Non-Compliance|0
7328848|NCT00798161|11561768|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
7445366|NCT01691898|11732445|FG001|Overall Study|Non-Compliance|0
7445367|NCT01691898|11732446|FG002|Overall Study|Non-Compliance|0
7445368|NCT01691898|11732447|FG003|Overall Study|Non-Compliance|0
7445369|NCT01691898|11732448|FG004|Overall Study|Non-Compliance|1
7445370|NCT01691898|11732449|FG005|Overall Study|Non-Compliance|0
7445371|NCT01692119|11732492|FG000|Overall Study|Protocol Violation|3
7445372|NCT01692119|11732493|FG001|Overall Study|Protocol Violation|1
7445373|NCT01692119|11732492|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
7445374|NCT01692119|11732493|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
7445375|NCT01692197|11732499|FG000|Overall Study|Failed Screening|3
7445376|NCT01692275|11732510|FG000|Overall Study|Lost to Follow-up|57
7445377|NCT01692275|11732511|FG001|Overall Study|Lost to Follow-up|48
7445378|NCT01692275|11732510|FG000|Overall Study|Withdrawal by Subject|9
7445379|NCT01692275|11732511|FG001|Overall Study|Withdrawal by Subject|11
7445380|NCT01692301|11732531|FG000|Overall Study|Adverse Event|15
7445381|NCT01692301|11732532|FG001|Overall Study|Adverse Event|12
7445382|NCT01692301|11732531|FG000|Overall Study|Death|1
7445383|NCT01692301|11732532|FG001|Overall Study|Death|2
7445384|NCT01692301|11732531|FG000|Overall Study|Lack of Efficacy|0
7445385|NCT01692301|11732532|FG001|Overall Study|Lack of Efficacy|5
7445386|NCT01692301|11732531|FG000|Overall Study|Non-compliance with study treatment|1
7445387|NCT01692301|11732532|FG001|Overall Study|Non-compliance with study treatment|2
7445388|NCT01692301|11732531|FG000|Overall Study|Protocol deviation|9
7445389|NCT01692301|11732532|FG001|Overall Study|Protocol deviation|2
7445390|NCT01692301|11732531|FG000|Overall Study|Patient/guardian decision|16
7445391|NCT01692301|11732532|FG001|Overall Study|Patient/guardian decision|15
7328849|NCT00798161|11561769|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
7445392|NCT01692301|11732531|FG000|Overall Study|Technical problems|0
7445393|NCT01692301|11732532|FG001|Overall Study|Technical problems|1
7445394|NCT01692301|11732531|FG000|Overall Study|Physician Decision|2
7445395|NCT01692301|11732532|FG001|Overall Study|Physician Decision|2
7445396|NCT01692301|11732531|FG000|Overall Study|Lost to Follow-up|1
7445397|NCT01692301|11732532|FG001|Overall Study|Lost to Follow-up|1
7445398|NCT01692626|11732556|FG000|Overall Study|Death|0
7445399|NCT01692626|11732557|FG001|Overall Study|Death|1
7445400|NCT01692626|11732556|FG000|Overall Study|Adverse Event|2
7445401|NCT01692626|11732557|FG001|Overall Study|Adverse Event|3
7445402|NCT01692626|11732556|FG000|Overall Study|Protocol Violation|1
7445403|NCT01692626|11732557|FG001|Overall Study|Protocol Violation|2
7445404|NCT01692626|11732556|FG000|Overall Study|Withdrawal by Subject|1
7445405|NCT01692626|11732557|FG001|Overall Study|Withdrawal by Subject|0
7445406|NCT01692730|11732564|FG000|Overall Study|Lost to Follow-up|225
7445407|NCT01692730|11732565|FG001|Overall Study|Lost to Follow-up|227
7445408|NCT01692782|11732604|FG000|Overall Study|Adverse Event|12
7445409|NCT01692782|11732605|FG001|Overall Study|Adverse Event|32
7445410|NCT01692782|11732606|FG002|Overall Study|Adverse Event|2
7445411|NCT01692782|11732604|FG000|Overall Study|Lack of Efficacy|1
7445412|NCT01692782|11732605|FG001|Overall Study|Lack of Efficacy|2
7445413|NCT01692782|11732606|FG002|Overall Study|Lack of Efficacy|0
7445414|NCT01692782|11732604|FG000|Overall Study|Lost to Follow-up|2
7445415|NCT01692782|11732605|FG001|Overall Study|Lost to Follow-up|7
7445416|NCT01692782|11732606|FG002|Overall Study|Lost to Follow-up|1
7445417|NCT01692782|11732604|FG000|Overall Study|Pregnancy|1
7445418|NCT01692782|11732605|FG001|Overall Study|Pregnancy|0
7445419|NCT01692782|11732606|FG002|Overall Study|Pregnancy|0
7445420|NCT01692782|11732604|FG000|Overall Study|Protocol Violation|1
7445421|NCT01692782|11732605|FG001|Overall Study|Protocol Violation|0
7445422|NCT01692782|11732606|FG002|Overall Study|Protocol Violation|2
7445423|NCT01692782|11732604|FG000|Overall Study|Non-complance with study drug|0
7445424|NCT01692782|11732605|FG001|Overall Study|Non-complance with study drug|4
7445425|NCT01692782|11732606|FG002|Overall Study|Non-complance with study drug|1
7445426|NCT01692782|11732604|FG000|Overall Study|Non-compliant with study visits|0
7445427|NCT01692782|11732605|FG001|Overall Study|Non-compliant with study visits|0
7445428|NCT01692782|11732606|FG002|Overall Study|Non-compliant with study visits|1
7445429|NCT01692782|11732604|FG000|Overall Study|SAE not related to study drug|0
7445430|NCT01692782|11732605|FG001|Overall Study|SAE not related to study drug|1
7445431|NCT01692782|11732606|FG002|Overall Study|SAE not related to study drug|0
7445432|NCT01692782|11732604|FG000|Overall Study|Withdrawal by Subject|3
7445433|NCT01692782|11732605|FG001|Overall Study|Withdrawal by Subject|10
7445434|NCT01692782|11732606|FG002|Overall Study|Withdrawal by Subject|3
7445435|NCT01692938|11732616|FG000|Overall Study|Protocol Deviation|1
7445436|NCT01692938|11732617|FG001|Overall Study|Protocol Deviation|1
7445437|NCT01692938|11732616|FG000|Overall Study|Study completed prior to site completion|3
7445438|NCT01692938|11732617|FG001|Overall Study|Study completed prior to site completion|3
7445439|NCT01693029|11732647|FG000|Overall Study|Withdrawal by Subject|15
7445440|NCT01693029|11732648|FG001|Overall Study|Withdrawal by Subject|22
7445441|NCT01693029|11732647|FG000|Overall Study|Kidney transplantation|7
7445442|NCT01693029|11732648|FG001|Overall Study|Kidney transplantation|7
7445443|NCT01693029|11732647|FG000|Overall Study|Bindinging anti-EPO antibodies|6
7445444|NCT01693029|11732648|FG001|Overall Study|Bindinging anti-EPO antibodies|2
7445445|NCT01693029|11732647|FG000|Overall Study|Protocol Violation|6
7445446|NCT01693029|11732648|FG001|Overall Study|Protocol Violation|7
7445447|NCT01693029|11732647|FG000|Overall Study|Change in dialysis modality|2
7445448|NCT01693029|11732648|FG001|Overall Study|Change in dialysis modality|1
7445449|NCT01693029|11732647|FG000|Overall Study|Physician Decision|0
7445450|NCT01693029|11732648|FG001|Overall Study|Physician Decision|2
7445451|NCT01693029|11732647|FG000|Overall Study|Lost to Follow-up|0
7445452|NCT01693029|11732648|FG001|Overall Study|Lost to Follow-up|1
7445453|NCT01693029|11732647|FG000|Overall Study|Adverse Event|1
7445454|NCT01693029|11732648|FG001|Overall Study|Adverse Event|6
7445455|NCT01693029|11732647|FG000|Overall Study|Death|5
7445456|NCT01693029|11732648|FG001|Overall Study|Death|8
7445457|NCT01693029|11732647|FG000|Overall Study|Non-compliance|2
7445458|NCT01693029|11732648|FG001|Overall Study|Non-compliance|1
7445459|NCT01693068|11732656|FG000|Randomization Period|On-study|2
7445460|NCT01693068|11732657|FG001|Randomization Period|On-study|5
7445461|NCT01693068|11732658|FG002|Randomization Period|On-study|0
7445462|NCT01693068|11732656|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7445463|NCT01693068|11732657|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
7445464|NCT01693068|11732658|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
7445465|NCT01693120|11732666|FG000|Enrollment|Lost to Follow-up|1
7445466|NCT01693120|11732666|FG000|Enrollment|Withdrawal by Subject|10
7445467|NCT01693120|11732666|FG000|Enrollment|Protocol Violation|46
7445468|NCT01693120|11732666|FG000|Enrollment|Physician Decision|3
7445469|NCT01693120|11732666|FG000|Enrollment|Adverse Event|1
7445470|NCT01693120|11732666|FG000|Enrollment|Study closed|8
7445471|NCT01693120|11732666|FG000|Enrollment|Other|1
7445472|NCT01693120|11732666|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
7445473|NCT01693120|11732666|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
7445474|NCT01693120|11732666|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
7445475|NCT01693120|11732666|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
7445476|NCT01693120|11732666|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
7467672|NCT01903252|11768107|FG005|Double-Blind Induction|non-compliance,|0
7445477|NCT01693185|11732672|FG000|Overall Study|diagnostic procedure after colonoscopy|0
7445478|NCT01693185|11732673|FG001|Overall Study|diagnostic procedure after colonoscopy|6
7445479|NCT01693250|11732681|FG000|Overall Study|Lost to Follow-up|2
7445480|NCT01693250|11732682|FG001|Overall Study|Lost to Follow-up|2
7445481|NCT01693523|11732693|FG000|Overall Study|Adverse Event|2
7445482|NCT01693523|11732694|FG001|Overall Study|Adverse Event|1
7445483|NCT01693523|11732695|FG002|Overall Study|Adverse Event|0
7445484|NCT01693523|11732693|FG000|Overall Study|Death|0
7445485|NCT01693523|11732694|FG001|Overall Study|Death|1
7445486|NCT01693523|11732695|FG002|Overall Study|Death|1
7445487|NCT01693523|11732693|FG000|Overall Study|Lost to Follow-up|0
7445488|NCT01693523|11732694|FG001|Overall Study|Lost to Follow-up|0
7445489|NCT01693523|11732695|FG002|Overall Study|Lost to Follow-up|4
7445490|NCT01693523|11732693|FG000|Overall Study|Physician Decision|0
7445491|NCT01693523|11732694|FG001|Overall Study|Physician Decision|0
7445492|NCT01693523|11732695|FG002|Overall Study|Physician Decision|1
7445493|NCT01693523|11732693|FG000|Overall Study|Withdrawal by Subject|1
7445494|NCT01693523|11732694|FG001|Overall Study|Withdrawal by Subject|2
7445495|NCT01693523|11732695|FG002|Overall Study|Withdrawal by Subject|2
7445496|NCT01693523|11732693|FG000|Overall Study|Lack of compliance study medication|1
7445497|NCT01693523|11732694|FG001|Overall Study|Lack of compliance study medication|2
7445498|NCT01693523|11732695|FG002|Overall Study|Lack of compliance study medication|0
7445499|NCT01693523|11732693|FG000|Overall Study|Chemotherapy was held|1
7445500|NCT01693523|11732694|FG001|Overall Study|Chemotherapy was held|2
7445501|NCT01693523|11732695|FG002|Overall Study|Chemotherapy was held|0
7445502|NCT01693562|11732725|FG000|Escalation Phase|Withdrawal by Subject|0
7445503|NCT01693562|11732726|FG001|Escalation Phase|Withdrawal by Subject|1
7445504|NCT01693562|11732727|FG002|Escalation Phase|Withdrawal by Subject|0
7445505|NCT01693562|11732728|FG003|Escalation Phase|Withdrawal by Subject|0
7445506|NCT01693562|11732729|FG004|Escalation Phase|Withdrawal by Subject|0
7445507|NCT01693562|11732730|FG005|Escalation Phase|Withdrawal by Subject|2
7445508|NCT01693562|11732731|FG006|Escalation Phase|Withdrawal by Subject|0
7445509|NCT01693562|11732732|FG007|Escalation Phase|Withdrawal by Subject|0
7445510|NCT01693562|11732733|FG008|Escalation Phase|Withdrawal by Subject|0
7445511|NCT01693562|11732734|FG009|Escalation Phase|Withdrawal by Subject|0
7445512|NCT01693562|11732735|FG010|Escalation Phase|Withdrawal by Subject|0
7445513|NCT01693562|11732736|FG011|Escalation Phase|Withdrawal by Subject|0
7445514|NCT01693562|11732737|FG012|Escalation Phase|Withdrawal by Subject|0
7445515|NCT01693562|11732738|FG013|Escalation Phase|Withdrawal by Subject|0
7445516|NCT01693562|11732739|FG014|Escalation Phase|Withdrawal by Subject|0
7445517|NCT01693562|11732740|FG015|Escalation Phase|Withdrawal by Subject|0
7445518|NCT01693562|11732741|FG016|Escalation Phase|Withdrawal by Subject|0
7445519|NCT01693562|11732742|FG017|Escalation Phase|Withdrawal by Subject|0
7445520|NCT01693562|11732743|FG018|Escalation Phase|Withdrawal by Subject|0
7445521|NCT01693562|11732744|FG019|Escalation Phase|Withdrawal by Subject|0
7445522|NCT01693562|11732745|FG020|Escalation Phase|Withdrawal by Subject|0
7445523|NCT01693562|11732746|FG021|Escalation Phase|Withdrawal by Subject|0
7445524|NCT01693562|11732747|FG022|Escalation Phase|Withdrawal by Subject|0
7445525|NCT01693562|11732725|FG000|Escalation Phase|Death|4
7445526|NCT01693562|11732726|FG001|Escalation Phase|Death|2
7445527|NCT01693562|11732727|FG002|Escalation Phase|Death|0
7445528|NCT01693562|11732728|FG003|Escalation Phase|Death|3
7445529|NCT01693562|11732729|FG004|Escalation Phase|Death|6
7445530|NCT01693562|11732730|FG005|Escalation Phase|Death|4
7445531|NCT01693562|11732731|FG006|Escalation Phase|Death|0
7445532|NCT01693562|11732732|FG007|Escalation Phase|Death|0
7445533|NCT01693562|11732733|FG008|Escalation Phase|Death|0
7445534|NCT01693562|11732734|FG009|Escalation Phase|Death|0
7445535|NCT01693562|11732735|FG010|Escalation Phase|Death|0
7445536|NCT01693562|11732736|FG011|Escalation Phase|Death|0
7445537|NCT01693562|11732737|FG012|Escalation Phase|Death|0
7445538|NCT01693562|11732738|FG013|Escalation Phase|Death|0
7445539|NCT01693562|11732739|FG014|Escalation Phase|Death|0
7445540|NCT01693562|11732740|FG015|Escalation Phase|Death|0
7445541|NCT01693562|11732741|FG016|Escalation Phase|Death|0
7445542|NCT01693562|11732742|FG017|Escalation Phase|Death|0
7445543|NCT01693562|11732743|FG018|Escalation Phase|Death|0
7445544|NCT01693562|11732744|FG019|Escalation Phase|Death|0
7445545|NCT01693562|11732745|FG020|Escalation Phase|Death|0
7445546|NCT01693562|11732746|FG021|Escalation Phase|Death|0
7445547|NCT01693562|11732747|FG022|Escalation Phase|Death|0
7445548|NCT01693562|11732725|FG000|Escalation Phase|Lost to Follow-up|0
7445549|NCT01693562|11732726|FG001|Escalation Phase|Lost to Follow-up|1
7445550|NCT01693562|11732727|FG002|Escalation Phase|Lost to Follow-up|1
7445551|NCT01693562|11732728|FG003|Escalation Phase|Lost to Follow-up|0
7445552|NCT01693562|11732729|FG004|Escalation Phase|Lost to Follow-up|0
7445553|NCT01693562|11732730|FG005|Escalation Phase|Lost to Follow-up|0
7532953|NCT02678390|11878891|FG000|AE (1 Day)|Withdrawal by Subject|0
7445554|NCT01693562|11732731|FG006|Escalation Phase|Lost to Follow-up|0
7445555|NCT01693562|11732732|FG007|Escalation Phase|Lost to Follow-up|0
7532954|NCT02678390|11878892|FG001|AE (1 Day)|Withdrawal by Subject|1
7445556|NCT01693562|11732733|FG008|Escalation Phase|Lost to Follow-up|0
7445557|NCT01693562|11732734|FG009|Escalation Phase|Lost to Follow-up|0
7445558|NCT01693562|11732735|FG010|Escalation Phase|Lost to Follow-up|0
7445559|NCT01693562|11732736|FG011|Escalation Phase|Lost to Follow-up|0
7445560|NCT01693562|11732737|FG012|Escalation Phase|Lost to Follow-up|0
7445561|NCT01693562|11732738|FG013|Escalation Phase|Lost to Follow-up|0
7445562|NCT01693562|11732739|FG014|Escalation Phase|Lost to Follow-up|0
7445563|NCT01693562|11732740|FG015|Escalation Phase|Lost to Follow-up|0
7445564|NCT01693562|11732741|FG016|Escalation Phase|Lost to Follow-up|0
7445565|NCT01693562|11732742|FG017|Escalation Phase|Lost to Follow-up|0
7445566|NCT01693562|11732743|FG018|Escalation Phase|Lost to Follow-up|0
7445567|NCT01693562|11732744|FG019|Escalation Phase|Lost to Follow-up|0
7445568|NCT01693562|11732745|FG020|Escalation Phase|Lost to Follow-up|0
7445569|NCT01693562|11732746|FG021|Escalation Phase|Lost to Follow-up|0
7445570|NCT01693562|11732747|FG022|Escalation Phase|Lost to Follow-up|0
7445571|NCT01693562|11732725|FG000|Escalation Phase|Other|0
7445572|NCT01693562|11732726|FG001|Escalation Phase|Other|0
7445573|NCT01693562|11732727|FG002|Escalation Phase|Other|2
7445574|NCT01693562|11732728|FG003|Escalation Phase|Other|0
7445575|NCT01693562|11732729|FG004|Escalation Phase|Other|0
7445576|NCT01693562|11732730|FG005|Escalation Phase|Other|1
7445577|NCT01693562|11732731|FG006|Escalation Phase|Other|0
7445578|NCT01693562|11732732|FG007|Escalation Phase|Other|0
7445579|NCT01693562|11732733|FG008|Escalation Phase|Other|0
7445580|NCT01693562|11732734|FG009|Escalation Phase|Other|0
7445581|NCT01693562|11732735|FG010|Escalation Phase|Other|0
7445582|NCT01693562|11732736|FG011|Escalation Phase|Other|0
7445583|NCT01693562|11732737|FG012|Escalation Phase|Other|0
7445584|NCT01693562|11732738|FG013|Escalation Phase|Other|0
7445585|NCT01693562|11732739|FG014|Escalation Phase|Other|0
7445586|NCT01693562|11732740|FG015|Escalation Phase|Other|0
7445587|NCT01693562|11732741|FG016|Escalation Phase|Other|0
7445588|NCT01693562|11732742|FG017|Escalation Phase|Other|0
7445589|NCT01693562|11732743|FG018|Escalation Phase|Other|0
7445590|NCT01693562|11732744|FG019|Escalation Phase|Other|0
7445591|NCT01693562|11732745|FG020|Escalation Phase|Other|0
7445592|NCT01693562|11732746|FG021|Escalation Phase|Other|0
7445593|NCT01693562|11732747|FG022|Escalation Phase|Other|0
7445594|NCT01693562|11732725|FG000|Exploration Phase|Withdrawal by Subject|0
7562117|NCT03219723|11930714|FG000|Overall Study|Case Report Forms Uncollected|6
7562118|NCT03219723|11930714|FG000|Overall Study|Protocol Deviation|4
7562119|NCT03220217|11930780|FG000|Overall Study|Withdrawal by Subject|0
7562120|NCT03220217|11930781|FG001|Overall Study|Withdrawal by Subject|1
7562121|NCT03220217|11930782|FG002|Overall Study|Withdrawal by Subject|0
7445595|NCT01693562|11732726|FG001|Exploration Phase|Withdrawal by Subject|0
7445596|NCT01693562|11732727|FG002|Exploration Phase|Withdrawal by Subject|0
7445597|NCT01693562|11732728|FG003|Exploration Phase|Withdrawal by Subject|0
7445598|NCT01693562|11732729|FG004|Exploration Phase|Withdrawal by Subject|0
7445599|NCT01693562|11732730|FG005|Exploration Phase|Withdrawal by Subject|0
7445600|NCT01693562|11732731|FG006|Exploration Phase|Withdrawal by Subject|2
7445601|NCT01693562|11732732|FG007|Exploration Phase|Withdrawal by Subject|0
7445602|NCT01693562|11732733|FG008|Exploration Phase|Withdrawal by Subject|0
7445603|NCT01693562|11732734|FG009|Exploration Phase|Withdrawal by Subject|0
7445604|NCT01693562|11732735|FG010|Exploration Phase|Withdrawal by Subject|0
7445605|NCT01693562|11732736|FG011|Exploration Phase|Withdrawal by Subject|0
7445606|NCT01693562|11732737|FG012|Exploration Phase|Withdrawal by Subject|0
7445607|NCT01693562|11732738|FG013|Exploration Phase|Withdrawal by Subject|0
7445608|NCT01693562|11732739|FG014|Exploration Phase|Withdrawal by Subject|0
7445609|NCT01693562|11732740|FG015|Exploration Phase|Withdrawal by Subject|0
7445610|NCT01693562|11732741|FG016|Exploration Phase|Withdrawal by Subject|0
7445611|NCT01693562|11732742|FG017|Exploration Phase|Withdrawal by Subject|0
7445612|NCT01693562|11732743|FG018|Exploration Phase|Withdrawal by Subject|0
7445613|NCT01693562|11732744|FG019|Exploration Phase|Withdrawal by Subject|0
7445614|NCT01693562|11732745|FG020|Exploration Phase|Withdrawal by Subject|0
7445615|NCT01693562|11732746|FG021|Exploration Phase|Withdrawal by Subject|0
7445616|NCT01693562|11732747|FG022|Exploration Phase|Withdrawal by Subject|0
7445617|NCT01693562|11732725|FG000|Exploration Phase|Death|0
7445618|NCT01693562|11732726|FG001|Exploration Phase|Death|0
7445619|NCT01693562|11732727|FG002|Exploration Phase|Death|0
7445620|NCT01693562|11732728|FG003|Exploration Phase|Death|0
7445621|NCT01693562|11732729|FG004|Exploration Phase|Death|0
7445622|NCT01693562|11732730|FG005|Exploration Phase|Death|0
7445623|NCT01693562|11732731|FG006|Exploration Phase|Death|17
7445624|NCT01693562|11732732|FG007|Exploration Phase|Death|0
7445625|NCT01693562|11732733|FG008|Exploration Phase|Death|0
7445626|NCT01693562|11732734|FG009|Exploration Phase|Death|0
7445627|NCT01693562|11732735|FG010|Exploration Phase|Death|0
7445628|NCT01693562|11732736|FG011|Exploration Phase|Death|0
7445629|NCT01693562|11732737|FG012|Exploration Phase|Death|0
7445630|NCT01693562|11732738|FG013|Exploration Phase|Death|0
7445631|NCT01693562|11732739|FG014|Exploration Phase|Death|0
7445632|NCT01693562|11732740|FG015|Exploration Phase|Death|0
7445633|NCT01693562|11732741|FG016|Exploration Phase|Death|0
7445634|NCT01693562|11732742|FG017|Exploration Phase|Death|0
7445635|NCT01693562|11732743|FG018|Exploration Phase|Death|0
7445636|NCT01693562|11732744|FG019|Exploration Phase|Death|0
7445637|NCT01693562|11732745|FG020|Exploration Phase|Death|0
7445638|NCT01693562|11732746|FG021|Exploration Phase|Death|0
7562122|NCT03220217|11930780|FG000|Overall Study|Subject Missed Procedure|0
7445639|NCT01693562|11732747|FG022|Exploration Phase|Death|0
7445640|NCT01693562|11732725|FG000|Exploration Phase|Other|0
7445641|NCT01693562|11732726|FG001|Exploration Phase|Other|0
7445642|NCT01693562|11732727|FG002|Exploration Phase|Other|0
7445643|NCT01693562|11732728|FG003|Exploration Phase|Other|0
7445644|NCT01693562|11732729|FG004|Exploration Phase|Other|0
7445645|NCT01693562|11732730|FG005|Exploration Phase|Other|0
7445646|NCT01693562|11732731|FG006|Exploration Phase|Other|2
7445647|NCT01693562|11732732|FG007|Exploration Phase|Other|0
7445648|NCT01693562|11732733|FG008|Exploration Phase|Other|0
7445649|NCT01693562|11732734|FG009|Exploration Phase|Other|0
7445650|NCT01693562|11732735|FG010|Exploration Phase|Other|0
7445651|NCT01693562|11732736|FG011|Exploration Phase|Other|0
7445652|NCT01693562|11732737|FG012|Exploration Phase|Other|0
7445653|NCT01693562|11732738|FG013|Exploration Phase|Other|0
7445654|NCT01693562|11732739|FG014|Exploration Phase|Other|0
7445655|NCT01693562|11732740|FG015|Exploration Phase|Other|0
7445656|NCT01693562|11732741|FG016|Exploration Phase|Other|0
7445657|NCT01693562|11732742|FG017|Exploration Phase|Other|0
7445658|NCT01693562|11732743|FG018|Exploration Phase|Other|0
7445659|NCT01693562|11732744|FG019|Exploration Phase|Other|0
7445660|NCT01693562|11732745|FG020|Exploration Phase|Other|0
7445661|NCT01693562|11732746|FG021|Exploration Phase|Other|0
7445662|NCT01693562|11732747|FG022|Exploration Phase|Other|0
7445663|NCT01693562|11732725|FG000|Expansion Phase|Withdrawal by Subject|0
7445664|NCT01693562|11732726|FG001|Expansion Phase|Withdrawal by Subject|0
7445665|NCT01693562|11732727|FG002|Expansion Phase|Withdrawal by Subject|0
7445666|NCT01693562|11732728|FG003|Expansion Phase|Withdrawal by Subject|0
7445667|NCT01693562|11732729|FG004|Expansion Phase|Withdrawal by Subject|0
7445668|NCT01693562|11732730|FG005|Expansion Phase|Withdrawal by Subject|0
7445669|NCT01693562|11732731|FG006|Expansion Phase|Withdrawal by Subject|0
7445670|NCT01693562|11732732|FG007|Expansion Phase|Withdrawal by Subject|16
7445671|NCT01693562|11732733|FG008|Expansion Phase|Withdrawal by Subject|2
7445672|NCT01693562|11732734|FG009|Expansion Phase|Withdrawal by Subject|54
7445673|NCT01693562|11732735|FG010|Expansion Phase|Withdrawal by Subject|2
7445674|NCT01693562|11732736|FG011|Expansion Phase|Withdrawal by Subject|2
7445675|NCT01693562|11732737|FG012|Expansion Phase|Withdrawal by Subject|3
7445676|NCT01693562|11732738|FG013|Expansion Phase|Withdrawal by Subject|5
7445677|NCT01693562|11732739|FG014|Expansion Phase|Withdrawal by Subject|16
7445678|NCT01693562|11732740|FG015|Expansion Phase|Withdrawal by Subject|7
7445679|NCT01693562|11732741|FG016|Expansion Phase|Withdrawal by Subject|40
7445680|NCT01693562|11732742|FG017|Expansion Phase|Withdrawal by Subject|4
7445681|NCT01693562|11732743|FG018|Expansion Phase|Withdrawal by Subject|8
7445682|NCT01693562|11732744|FG019|Expansion Phase|Withdrawal by Subject|3
7445683|NCT01693562|11732745|FG020|Expansion Phase|Withdrawal by Subject|1
7445684|NCT01693562|11732746|FG021|Expansion Phase|Withdrawal by Subject|8
7562123|NCT03220217|11930781|FG001|Overall Study|Subject Missed Procedure|0
7562124|NCT03220217|11930782|FG002|Overall Study|Subject Missed Procedure|1
7562125|NCT03220737|11930833|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7562126|NCT03220737|11930834|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7562127|NCT03220737|11930835|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7562128|NCT03220737|11930836|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
7562129|NCT03220737|11930837|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
7562130|NCT03220737|11930838|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7562131|NCT03220737|11930839|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
7562132|NCT03220737|11930833|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
7562133|NCT03220737|11930834|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
7562134|NCT03220737|11930835|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
7562135|NCT03220737|11930836|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
7562136|NCT03220737|11930837|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
7562137|NCT03220737|11930838|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
7562138|NCT03220737|11930839|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
7562139|NCT03220737|11930833|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
7562140|NCT03220737|11930834|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
7562141|NCT03220737|11930835|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
7562142|NCT03220737|11930836|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
7562143|NCT03220737|11930837|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
7562144|NCT03220737|11930838|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
7562145|NCT03220737|11930839|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
7562146|NCT03220737|11930833|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562147|NCT03220737|11930834|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562148|NCT03220737|11930835|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
7562149|NCT03220737|11930836|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562150|NCT03220737|11930837|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562151|NCT03220737|11930838|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562152|NCT03220737|11930839|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
7562153|NCT03220737|11930833|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7562154|NCT03220737|11930834|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7445685|NCT01693562|11732747|FG022|Expansion Phase|Withdrawal by Subject|1
7445686|NCT01693562|11732725|FG000|Expansion Phase|Death|0
7445687|NCT01693562|11732726|FG001|Expansion Phase|Death|0
7445688|NCT01693562|11732727|FG002|Expansion Phase|Death|0
7445689|NCT01693562|11732728|FG003|Expansion Phase|Death|0
7445690|NCT01693562|11732729|FG004|Expansion Phase|Death|0
7445691|NCT01693562|11732730|FG005|Expansion Phase|Death|0
7562155|NCT03220737|11930835|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7445692|NCT01693562|11732731|FG006|Expansion Phase|Death|0
7445693|NCT01693562|11732732|FG007|Expansion Phase|Death|42
7445694|NCT01693562|11732733|FG008|Expansion Phase|Death|17
7445695|NCT01693562|11732734|FG009|Expansion Phase|Death|208
7445696|NCT01693562|11732735|FG010|Expansion Phase|Death|30
7445697|NCT01693562|11732736|FG011|Expansion Phase|Death|8
7445698|NCT01693562|11732737|FG012|Expansion Phase|Death|19
7445699|NCT01693562|11732738|FG013|Expansion Phase|Death|42
7445700|NCT01693562|11732739|FG014|Expansion Phase|Death|23
7445701|NCT01693562|11732740|FG015|Expansion Phase|Death|23
7445702|NCT01693562|11732741|FG016|Expansion Phase|Death|128
7445703|NCT01693562|11732742|FG017|Expansion Phase|Death|16
7445704|NCT01693562|11732743|FG018|Expansion Phase|Death|36
7445705|NCT01693562|11732744|FG019|Expansion Phase|Death|16
7445706|NCT01693562|11732745|FG020|Expansion Phase|Death|17
7445707|NCT01693562|11732746|FG021|Expansion Phase|Death|35
7445708|NCT01693562|11732747|FG022|Expansion Phase|Death|7
7445709|NCT01693562|11732725|FG000|Expansion Phase|Lost to Follow-up|0
7445710|NCT01693562|11732726|FG001|Expansion Phase|Lost to Follow-up|0
7445711|NCT01693562|11732727|FG002|Expansion Phase|Lost to Follow-up|0
7445712|NCT01693562|11732728|FG003|Expansion Phase|Lost to Follow-up|0
7445713|NCT01693562|11732729|FG004|Expansion Phase|Lost to Follow-up|0
7445714|NCT01693562|11732730|FG005|Expansion Phase|Lost to Follow-up|0
7445715|NCT01693562|11732731|FG006|Expansion Phase|Lost to Follow-up|0
7445716|NCT01693562|11732732|FG007|Expansion Phase|Lost to Follow-up|1
7445717|NCT01693562|11732733|FG008|Expansion Phase|Lost to Follow-up|2
7445718|NCT01693562|11732734|FG009|Expansion Phase|Lost to Follow-up|10
7445719|NCT01693562|11732735|FG010|Expansion Phase|Lost to Follow-up|4
7445720|NCT01693562|11732736|FG011|Expansion Phase|Lost to Follow-up|4
7445721|NCT01693562|11732737|FG012|Expansion Phase|Lost to Follow-up|1
7445722|NCT01693562|11732738|FG013|Expansion Phase|Lost to Follow-up|3
7445723|NCT01693562|11732739|FG014|Expansion Phase|Lost to Follow-up|0
7445724|NCT01693562|11732740|FG015|Expansion Phase|Lost to Follow-up|1
7445725|NCT01693562|11732741|FG016|Expansion Phase|Lost to Follow-up|1
7445726|NCT01693562|11732742|FG017|Expansion Phase|Lost to Follow-up|0
7445727|NCT01693562|11732743|FG018|Expansion Phase|Lost to Follow-up|2
7445728|NCT01693562|11732744|FG019|Expansion Phase|Lost to Follow-up|1
7445729|NCT01693562|11732745|FG020|Expansion Phase|Lost to Follow-up|2
7445730|NCT01693562|11732746|FG021|Expansion Phase|Lost to Follow-up|2
7445731|NCT01693562|11732747|FG022|Expansion Phase|Lost to Follow-up|1
7445732|NCT01693562|11732725|FG000|Expansion Phase|Other|0
7445733|NCT01693562|11732726|FG001|Expansion Phase|Other|0
7445734|NCT01693562|11732727|FG002|Expansion Phase|Other|0
7445735|NCT01693562|11732728|FG003|Expansion Phase|Other|0
7445736|NCT01693562|11732729|FG004|Expansion Phase|Other|0
7445737|NCT01693562|11732730|FG005|Expansion Phase|Other|0
7445738|NCT01693562|11732731|FG006|Expansion Phase|Other|0
7445739|NCT01693562|11732732|FG007|Expansion Phase|Other|3
7445740|NCT01693562|11732733|FG008|Expansion Phase|Other|1
7445741|NCT01693562|11732734|FG009|Expansion Phase|Other|28
7445742|NCT01693562|11732735|FG010|Expansion Phase|Other|4
7445743|NCT01693562|11732736|FG011|Expansion Phase|Other|7
7445744|NCT01693562|11732737|FG012|Expansion Phase|Other|0
7445745|NCT01693562|11732738|FG013|Expansion Phase|Other|1
7445746|NCT01693562|11732739|FG014|Expansion Phase|Other|1
7445747|NCT01693562|11732740|FG015|Expansion Phase|Other|0
7445748|NCT01693562|11732741|FG016|Expansion Phase|Other|28
7445749|NCT01693562|11732742|FG017|Expansion Phase|Other|0
7445750|NCT01693562|11732743|FG018|Expansion Phase|Other|1
7445751|NCT01693562|11732744|FG019|Expansion Phase|Other|0
7445752|NCT01693562|11732745|FG020|Expansion Phase|Other|1
7445753|NCT01693562|11732746|FG021|Expansion Phase|Other|17
7445754|NCT01693562|11732747|FG022|Expansion Phase|Other|1
7445755|NCT01693614|11732833|FG000|Overall Study|Adverse Event|7
7445756|NCT01693614|11732834|FG001|Overall Study|Adverse Event|11
7445757|NCT01693614|11732835|FG002|Overall Study|Adverse Event|5
7445758|NCT01693614|11732833|FG000|Overall Study|Disease progression|11
7445759|NCT01693614|11732834|FG001|Overall Study|Disease progression|8
7445760|NCT01693614|11732835|FG002|Overall Study|Disease progression|7
7445761|NCT01693614|11732833|FG000|Overall Study|Protocol Violation|5
7445762|NCT01693614|11732834|FG001|Overall Study|Protocol Violation|2
7445763|NCT01693614|11732835|FG002|Overall Study|Protocol Violation|1
7562156|NCT03220737|11930836|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7562157|NCT03220737|11930837|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
7562158|NCT03220737|11930838|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7445764|NCT01693614|11732833|FG000|Overall Study|Death|1
7445765|NCT01693614|11732834|FG001|Overall Study|Death|0
7445766|NCT01693614|11732835|FG002|Overall Study|Death|0
7445767|NCT01693614|11732833|FG000|Overall Study|Physician Decision|1
7445768|NCT01693614|11732834|FG001|Overall Study|Physician Decision|1
7445769|NCT01693614|11732835|FG002|Overall Study|Physician Decision|4
7445770|NCT01693614|11732833|FG000|Overall Study|Withdrawal by subject/guardian|0
7445771|NCT01693614|11732834|FG001|Overall Study|Withdrawal by subject/guardian|0
7445772|NCT01693614|11732835|FG002|Overall Study|Withdrawal by subject/guardian|2
7445773|NCT01693614|11732833|FG000|Overall Study|Withdrawal by Subject|1
7445774|NCT01693614|11732834|FG001|Overall Study|Withdrawal by Subject|0
7445775|NCT01693614|11732835|FG002|Overall Study|Withdrawal by Subject|5
7445776|NCT01694121|11732871|FG000|Overall Study|Participant used false ID, was withdrawn|1
7445777|NCT01694121|11732872|FG001|Overall Study|Participant used false ID, was withdrawn|0
7445778|NCT01694420|11732896|FG000|Overall Study|Lost to Follow-up|3
7445779|NCT01694433|11732902|FG000|Overall Study|Adverse Event|7
7445780|NCT01694433|11732903|FG001|Overall Study|Adverse Event|0
7445781|NCT01694433|11732902|FG000|Overall Study|Physician Decision|1
7445782|NCT01694433|11732903|FG001|Overall Study|Physician Decision|0
7445783|NCT01694433|11732902|FG000|Overall Study|Withdrawal by Subject|3
7445784|NCT01694433|11732903|FG001|Overall Study|Withdrawal by Subject|4
7445785|NCT01694485|11732914|FG000|Overall Study|Withdrawal by Subject|20
7445786|NCT01694485|11732915|FG001|Overall Study|Withdrawal by Subject|6
7445787|NCT01694485|11732916|FG002|Overall Study|Withdrawal by Subject|7
7445788|NCT01694485|11732917|FG003|Overall Study|Withdrawal by Subject|25
7445789|NCT01694485|11732918|FG004|Overall Study|Withdrawal by Subject|18
7445790|NCT01694485|11732914|FG000|Overall Study|Sponsor Decision|3
7445791|NCT01694485|11732915|FG001|Overall Study|Sponsor Decision|0
7445792|NCT01694485|11732916|FG002|Overall Study|Sponsor Decision|0
7445793|NCT01694485|11732917|FG003|Overall Study|Sponsor Decision|2
7445794|NCT01694485|11732918|FG004|Overall Study|Sponsor Decision|0
7445795|NCT01694485|11732914|FG000|Overall Study|Lost to Follow-up|9
7445796|NCT01694485|11732915|FG001|Overall Study|Lost to Follow-up|1
7445797|NCT01694485|11732916|FG002|Overall Study|Lost to Follow-up|6
7445798|NCT01694485|11732917|FG003|Overall Study|Lost to Follow-up|10
7445799|NCT01694485|11732918|FG004|Overall Study|Lost to Follow-up|7
7445800|NCT01694485|11732914|FG000|Overall Study|Death|1
7445801|NCT01694485|11732915|FG001|Overall Study|Death|0
7445802|NCT01694485|11732916|FG002|Overall Study|Death|0
7445803|NCT01694485|11732917|FG003|Overall Study|Death|1
7445804|NCT01694485|11732918|FG004|Overall Study|Death|0
7445805|NCT01694706|11732961|FG000|Overall Study|Adverse Event|0
7445806|NCT01694706|11732962|FG001|Overall Study|Adverse Event|1
7445807|NCT01694706|11732963|FG002|Overall Study|Adverse Event|0
7445808|NCT01694706|11732961|FG000|Overall Study|other reason not defined above|1
7445809|NCT01694706|11732962|FG001|Overall Study|other reason not defined above|0
7445810|NCT01694706|11732963|FG002|Overall Study|other reason not defined above|0
7445811|NCT01694771|11732974|FG000|Overall Study|Adverse Event|18
7445812|NCT01694771|11732975|FG001|Overall Study|Adverse Event|16
7445813|NCT01694771|11732974|FG000|Overall Study|Lack of Efficacy|1
7445814|NCT01694771|11732975|FG001|Overall Study|Lack of Efficacy|0
7445815|NCT01694771|11732974|FG000|Overall Study|Non compliance protocol|7
7445816|NCT01694771|11732975|FG001|Overall Study|Non compliance protocol|6
7445817|NCT01694771|11732974|FG000|Overall Study|Lost to Follow-up|2
7445818|NCT01694771|11732975|FG001|Overall Study|Lost to Follow-up|3
7445819|NCT01694771|11732974|FG000|Overall Study|Consent withdrawn|7
7445820|NCT01694771|11732975|FG001|Overall Study|Consent withdrawn|9
7445821|NCT01694771|11732974|FG000|Overall Study|Other reasons|5
7445822|NCT01694771|11732975|FG001|Overall Study|Other reasons|6
7445823|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Progressive disease|50
7445824|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Progressive disease|110
7445825|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Progressive disease|0
7445826|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Progressive disease|0
7445827|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
7445828|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
7445829|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
7445830|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
7445831|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Adverse Event|7
7445832|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Adverse Event|7
7445833|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Adverse Event|0
7445834|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Adverse Event|0
7445835|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Other|1
7445836|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Other|3
7445837|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Other|0
7445838|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Other|0
7445839|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Physician Decision|6
7532955|NCT02678416|11878900|FG000|Part 1|Withdrawal by Subject|1
7532956|NCT02678416|11878900|FG000|Part 2|Adverse Event|2
7532957|NCT02678416|11878900|FG000|Part 2|Withdrawal by Subject|1
7532958|NCT02678676|11878929|FG000|Overall Study|Death|619
7532959|NCT02678676|11878930|FG001|Overall Study|Death|649
7532960|NCT02678676|11878929|FG000|Overall Study|Withdrawal by Subject|13
7532961|NCT02678676|11878930|FG001|Overall Study|Withdrawal by Subject|5
7532962|NCT02678676|11878929|FG000|Overall Study|Lost to Follow-up|171
7532963|NCT02678676|11878930|FG001|Overall Study|Lost to Follow-up|151
7532964|NCT02678676|11878929|FG000|Overall Study|Unconfirmed for lost to follow-up|85
7532965|NCT02678676|11878930|FG001|Overall Study|Unconfirmed for lost to follow-up|67
7537653|NCT02811861|11886775|FG001|Overall Study|Withdrawal by Subject|4
7445840|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Physician Decision|3
7445841|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Physician Decision|0
7445842|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Physician Decision|0
7445843|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Death|1
7445844|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Death|1
7445845|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Death|0
7445846|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Death|0
7445847|NCT01695135|11733006|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
7445848|NCT01695135|11733007|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
7445849|NCT01695135|11733008|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
7445850|NCT01695135|11733009|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
7445851|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Progressive disease|0
7445852|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Progressive disease|0
7445853|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Progressive disease|13
7445854|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Progressive disease|22
7445855|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7445856|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
7445857|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
7445858|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
7445859|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Adverse Event|0
7445860|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Adverse Event|0
7445861|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Adverse Event|11
7445862|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Adverse Event|16
7445863|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Other|0
7445864|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Other|0
7445865|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Other|4
7445866|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Other|7
7445867|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Physician Decision|0
7445868|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Physician Decision|0
7445869|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Physician Decision|4
7445870|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Physician Decision|1
7445871|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Death|0
7445872|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Death|0
7445873|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Death|2
7445874|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Death|7
7445875|NCT01695135|11733006|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7445876|NCT01695135|11733007|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7445877|NCT01695135|11733008|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
7445878|NCT01695135|11733009|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
7445879|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7445880|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
7445881|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
7445882|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
7445883|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445884|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445885|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445886|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445887|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445888|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445889|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445890|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445891|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445892|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
7445893|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
7445894|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
7445895|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
7445896|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
7445897|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
7445898|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
7445899|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
7445900|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
7445901|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
7445902|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
7445903|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
7445904|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
7445905|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
7445906|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
7445907|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
7445908|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445909|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
7445910|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445911|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445912|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445913|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445914|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445915|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445916|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445917|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445918|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445919|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445920|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
7445921|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
7445922|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7445923|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
7445924|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445925|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445926|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7328850|NCT00798161|11561770|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
7328851|NCT00798161|11561771|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
7328852|NCT00798161|11561772|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
7562159|NCT03220737|11930839|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
7445927|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445928|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445929|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445930|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445931|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445932|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445933|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445934|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
7445935|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
7445936|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445937|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
7445938|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445939|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445940|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445941|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445942|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445943|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445944|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445945|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445946|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445947|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445948|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
7445949|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7445950|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445951|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
7445952|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445953|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445954|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445955|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445956|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445957|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445958|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445959|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445960|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445961|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445962|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
7445963|NCT01695239|11733021|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
7445964|NCT01695239|11733022|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445965|NCT01695239|11733023|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445966|NCT01695239|11733024|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445967|NCT01695239|11733025|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445968|NCT01695239|11733026|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445969|NCT01695239|11733027|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445970|NCT01695239|11733028|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445971|NCT01695239|11733029|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445972|NCT01695239|11733030|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445973|NCT01695239|11733031|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445974|NCT01695239|11733032|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445975|NCT01695239|11733033|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
7445976|NCT01695239|11733034|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
7562160|NCT03220737|11930833|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
7562161|NCT03220737|11930834|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7562162|NCT03220737|11930835|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7562163|NCT03220737|11930836|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7562164|NCT03220737|11930837|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7562165|NCT03220737|11930838|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7328853|NCT00798161|11561773|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
7445977|NCT01695239|11733021|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445978|NCT01695239|11733022|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445979|NCT01695239|11733023|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445980|NCT01695239|11733024|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445981|NCT01695239|11733025|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445982|NCT01695239|11733026|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445983|NCT01695239|11733027|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445984|NCT01695239|11733028|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
7445985|NCT01695239|11733029|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445986|NCT01695239|11733030|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445987|NCT01695239|11733031|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445988|NCT01695239|11733032|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445989|NCT01695239|11733033|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445990|NCT01695239|11733034|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
7445991|NCT01695239|11733021|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445992|NCT01695239|11733022|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445993|NCT01695239|11733023|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445994|NCT01695239|11733024|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445995|NCT01695239|11733025|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445996|NCT01695239|11733026|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445997|NCT01695239|11733027|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7445998|NCT01695239|11733028|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
7445999|NCT01695239|11733029|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446000|NCT01695239|11733030|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446001|NCT01695239|11733031|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446002|NCT01695239|11733032|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446003|NCT01695239|11733033|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446004|NCT01695239|11733034|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
7446005|NCT01695239|11733021|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446006|NCT01695239|11733022|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446007|NCT01695239|11733023|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446008|NCT01695239|11733024|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446009|NCT01695239|11733025|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446010|NCT01695239|11733026|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446011|NCT01695239|11733027|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446012|NCT01695239|11733028|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
7446013|NCT01695239|11733029|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7562166|NCT03220737|11930839|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
7446014|NCT01695239|11733030|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446015|NCT01695239|11733031|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446016|NCT01695239|11733032|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446017|NCT01695239|11733033|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446018|NCT01695239|11733034|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
7446019|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446020|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446021|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446022|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446023|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446024|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446025|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446026|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446027|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
7446028|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
7446029|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446030|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446031|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446032|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
7446033|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Adverse Event|0
7446034|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Adverse Event|0
7446035|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Adverse Event|0
7446036|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Adverse Event|0
7446037|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Adverse Event|0
7446038|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Adverse Event|0
7446039|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Adverse Event|0
7446040|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Adverse Event|0
7446041|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Adverse Event|15
7446042|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Adverse Event|21
7446043|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Adverse Event|0
7446044|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Adverse Event|0
7446045|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Adverse Event|0
7446046|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Adverse Event|0
7446047|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446048|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446049|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446050|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446051|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446052|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446053|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446054|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446055|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
7446056|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
7446057|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446058|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446059|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446060|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
7446061|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Physician Decision|0
7446062|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Physician Decision|0
7446063|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Physician Decision|0
7446064|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Physician Decision|0
7446065|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Physician Decision|0
7446066|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Physician Decision|0
7446067|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Physician Decision|0
7446068|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Physician Decision|0
7446069|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Physician Decision|3
7446070|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Physician Decision|0
7446071|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Physician Decision|0
7446072|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Physician Decision|0
7446073|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Physician Decision|0
7446074|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Physician Decision|0
7446075|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446076|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446077|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446078|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446079|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446080|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446081|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446082|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446083|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
7446084|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
7446085|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446086|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446087|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446088|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
7446089|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
7446090|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
7446091|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
7446092|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
7446093|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
7446094|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
7446095|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
7446096|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
7446097|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
7446098|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
7446099|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
7446100|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
7446101|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
7446102|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
7446103|NCT01695239|11733021|FG000|Extension Long-Term Extension Periods|Death|0
7446104|NCT01695239|11733022|FG001|Extension Long-Term Extension Periods|Death|0
7446105|NCT01695239|11733023|FG002|Extension Long-Term Extension Periods|Death|0
7446106|NCT01695239|11733024|FG003|Extension Long-Term Extension Periods|Death|0
7446107|NCT01695239|11733025|FG004|Extension Long-Term Extension Periods|Death|0
7446108|NCT01695239|11733026|FG005|Extension Long-Term Extension Periods|Death|0
7446109|NCT01695239|11733027|FG006|Extension Long-Term Extension Periods|Death|0
7446110|NCT01695239|11733028|FG007|Extension Long-Term Extension Periods|Death|0
7446111|NCT01695239|11733029|FG008|Extension Long-Term Extension Periods|Death|1
7446112|NCT01695239|11733030|FG009|Extension Long-Term Extension Periods|Death|0
7446113|NCT01695239|11733031|FG010|Extension Long-Term Extension Periods|Death|0
7446114|NCT01695239|11733032|FG011|Extension Long-Term Extension Periods|Death|0
7446115|NCT01695239|11733033|FG012|Extension Long-Term Extension Periods|Death|0
7446116|NCT01695239|11733034|FG013|Extension Long-Term Extension Periods|Death|0
7446117|NCT01695239|11733021|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446118|NCT01695239|11733022|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446119|NCT01695239|11733023|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446120|NCT01695239|11733024|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446121|NCT01695239|11733025|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446122|NCT01695239|11733026|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446123|NCT01695239|11733027|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446124|NCT01695239|11733028|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446125|NCT01695239|11733029|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446126|NCT01695239|11733030|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446127|NCT01695239|11733031|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7446128|NCT01695239|11733032|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7446129|NCT01695239|11733033|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
7446130|NCT01695239|11733034|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
7446131|NCT01695239|11733021|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446132|NCT01695239|11733022|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446133|NCT01695239|11733023|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446134|NCT01695239|11733024|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446135|NCT01695239|11733025|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446136|NCT01695239|11733026|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446137|NCT01695239|11733027|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446138|NCT01695239|11733028|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446139|NCT01695239|11733029|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446140|NCT01695239|11733030|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446141|NCT01695239|11733031|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446142|NCT01695239|11733032|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
7446143|NCT01695239|11733033|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7446144|NCT01695239|11733034|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7446145|NCT01695239|11733021|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
7446146|NCT01695239|11733022|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
7446147|NCT01695239|11733023|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
7446148|NCT01695239|11733024|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
7446149|NCT01695239|11733025|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
7446150|NCT01695239|11733026|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
7446151|NCT01695239|11733027|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
7446152|NCT01695239|11733028|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
7446153|NCT01695239|11733029|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
7446154|NCT01695239|11733030|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
7446155|NCT01695239|11733031|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
7446156|NCT01695239|11733032|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
7446157|NCT01695239|11733033|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
7446158|NCT01695239|11733034|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
7446159|NCT01695239|11733021|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
7446160|NCT01695239|11733022|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
7446161|NCT01695239|11733023|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
7446162|NCT01695239|11733024|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
7446163|NCT01695239|11733025|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
7446164|NCT01695239|11733026|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
7562167|NCT03220737|11930833|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
7562168|NCT03220737|11930834|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562169|NCT03220737|11930835|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562170|NCT03220737|11930836|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562171|NCT03220737|11930837|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562172|NCT03220737|11930838|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562173|NCT03220737|11930839|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
7562174|NCT03220737|11930833|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
7562175|NCT03220737|11930834|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562176|NCT03220737|11930835|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562177|NCT03220737|11930836|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562178|NCT03220737|11930837|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562179|NCT03220737|11930838|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562180|NCT03220737|11930839|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
7562181|NCT03221387|11930874|FG000|Overall Study|Lost to Follow-up|1
7562182|NCT03221387|11930874|FG000|Overall Study|Lung transplant|1
7562183|NCT03222141|11930902|FG000|Overall Study|Death|15
7562184|NCT03222141|11930902|FG000|Overall Study|Lost to Follow-up|3
7562185|NCT03222349|11930907|FG000|Overall Study|Treatment B not done|5
7446165|NCT01695239|11733027|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
7446166|NCT01695239|11733028|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
7446167|NCT01695239|11733029|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
7446168|NCT01695239|11733030|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
7446169|NCT01695239|11733031|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
7446170|NCT01695239|11733032|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
7446171|NCT01695239|11733033|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
7446172|NCT01695239|11733034|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
7446173|NCT01695746|11733101|FG000|Overall Study|Adverse Event|1
7446174|NCT01695746|11733101|FG000|Overall Study|Non-compliance by the participant|3
7446175|NCT01695746|11733101|FG000|Overall Study|Protocol Violation|5
7446176|NCT01695746|11733101|FG000|Overall Study|Participant not willing to participate|3
7446177|NCT01695772|11733106|FG000|Overall Study|Withdrawal by Subject|18
7446178|NCT01695772|11733106|FG000|Overall Study|Progressive Disease|8
7446179|NCT01695772|11733106|FG000|Overall Study|Investigator Decision|5
7446180|NCT01695772|11733106|FG000|Overall Study|Lost to Follow-up|4
7446181|NCT01695772|11733106|FG000|Overall Study|Protocol Violation|2
7446182|NCT01695772|11733106|FG000|Overall Study|Unspecified Reason|1
7446183|NCT01695954|11733112|FG000|Overall Study|Withdrawal by Subject|4
7446184|NCT01695954|11733113|FG001|Overall Study|Withdrawal by Subject|0
7446185|NCT01695954|11733112|FG000|Overall Study|Adverse Event|0
7446186|NCT01695954|11733113|FG001|Overall Study|Adverse Event|2
7446187|NCT01695993|11733124|FG000|Overall Study|Lost to Follow-up|2
7562186|NCT03222349|11930908|FG001|Overall Study|Treatment B not done|0
7562187|NCT03222349|11930907|FG000|Overall Study|Lost to Follow-up|1
7562188|NCT03222349|11930908|FG001|Overall Study|Lost to Follow-up|2
7562189|NCT03222349|11930907|FG000|Overall Study|Withdrawal by Subject|1
7562190|NCT03222349|11930908|FG001|Overall Study|Withdrawal by Subject|0
7562191|NCT03222349|11930907|FG000|Overall Study|Treatment A not done|0
7562192|NCT03222349|11930908|FG001|Overall Study|Treatment A not done|5
7562193|NCT03222349|11930907|FG000|Overall Study|Study terminated by sponsor|1
7562194|NCT03222349|11930908|FG001|Overall Study|Study terminated by sponsor|0
7562195|NCT03222583|11930947|FG000|Overall Study|Withdrawal by Subject|3
7562196|NCT03222583|11930948|FG001|Overall Study|Withdrawal by Subject|3
7562197|NCT03222583|11930947|FG000|Overall Study|Lost to Follow-up|1
7562198|NCT03222583|11930948|FG001|Overall Study|Lost to Follow-up|0
7562199|NCT03222583|11930947|FG000|Overall Study|Other|1
7562200|NCT03222583|11930948|FG001|Overall Study|Other|3
7562201|NCT03223909|11930996|FG000|Overall Study|Protocol Violation|48
7562202|NCT03223909|11930997|FG001|Overall Study|Protocol Violation|45
7562203|NCT03223909|11930998|FG002|Overall Study|Protocol Violation|16
7562204|NCT03224130|11931008|FG000|Overall Study|consent issue|0
7562205|NCT03224130|11931009|FG001|Overall Study|consent issue|1
7562206|NCT03224182|11931017|FG000|Overall Study|Study Drug Not Instilled|6
7562207|NCT03224182|11931018|FG001|Overall Study|Study Drug Not Instilled|1
7562208|NCT03224182|11931017|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
7562209|NCT03224182|11931018|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
7562210|NCT03224182|11931017|FG000|Overall Study|Withdrew of Consent|4
7562211|NCT03224182|11931018|FG001|Overall Study|Withdrew of Consent|2
7562212|NCT03224182|11931017|FG000|Overall Study|Investigator Decision|3
7562213|NCT03224182|11931018|FG001|Overall Study|Investigator Decision|1
7562214|NCT03224182|11931017|FG000|Overall Study|Sponsor Decision|26
7562215|NCT03224182|11931018|FG001|Overall Study|Sponsor Decision|12
7562216|NCT03224182|11931017|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
7562217|NCT03224182|11931018|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
7562218|NCT03224182|11931017|FG000|Overall Study|Lost to Follow-up|1
7562219|NCT03224182|11931018|FG001|Overall Study|Lost to Follow-up|0
7562220|NCT03224182|11931017|FG000|Overall Study|Participant Had Recurrence|11
7562221|NCT03224182|11931018|FG001|Overall Study|Participant Had Recurrence|5
7562222|NCT03224182|11931017|FG000|Overall Study|Death|0
7562223|NCT03224182|11931018|FG001|Overall Study|Death|1
7562224|NCT03224182|11931017|FG000|Overall Study|Reason not Specified|3
7562225|NCT03224182|11931018|FG001|Overall Study|Reason not Specified|3
7562226|NCT03224182|11931017|FG000|Overall Study|Other|1
7562227|NCT03224182|11931018|FG001|Overall Study|Other|0
7562228|NCT03224234|11931028|FG000|Main Study|Lost to Follow-up|5
7562229|NCT03224234|11931029|FG001|Main Study|Lost to Follow-up|5
7562230|NCT03224325|11931063|FG000|Overall Study|Adverse Event|1
7562231|NCT03224325|11931064|FG001|Overall Study|Adverse Event|0
7562232|NCT03224325|11931065|FG002|Overall Study|Adverse Event|0
7562233|NCT03224325|11931066|FG003|Overall Study|Adverse Event|0
7562234|NCT03224325|11931067|FG004|Overall Study|Adverse Event|0
7562235|NCT03224325|11931068|FG005|Overall Study|Adverse Event|0
7562236|NCT03224325|11931069|FG006|Overall Study|Adverse Event|1
7562237|NCT03224325|11931063|FG000|Overall Study|Withdrawal by Subject|0
7562238|NCT03224325|11931064|FG001|Overall Study|Withdrawal by Subject|0
7562239|NCT03224325|11931065|FG002|Overall Study|Withdrawal by Subject|0
7446188|NCT01695993|11733125|FG001|Overall Study|Lost to Follow-up|1
7446189|NCT01695993|11733126|FG002|Overall Study|Lost to Follow-up|3
7446190|NCT01695993|11733124|FG000|Overall Study|Withdrawal by Subject|2
7446191|NCT01695993|11733125|FG001|Overall Study|Withdrawal by Subject|2
7446192|NCT01695993|11733126|FG002|Overall Study|Withdrawal by Subject|2
7446193|NCT01695993|11733124|FG000|Overall Study|To ill to continue|1
7446194|NCT01695993|11733125|FG001|Overall Study|To ill to continue|2
7446195|NCT01695993|11733126|FG002|Overall Study|To ill to continue|0
7446196|NCT01695993|11733124|FG000|Overall Study|Changed Medical Facility|0
7446197|NCT01695993|11733125|FG001|Overall Study|Changed Medical Facility|0
7446198|NCT01695993|11733126|FG002|Overall Study|Changed Medical Facility|1
7446199|NCT01696032|11733138|FG000|Overall Study|Withdrawal by Subject|0
7446200|NCT01696032|11733139|FG001|Overall Study|Withdrawal by Subject|0
7446201|NCT01696032|11733140|FG002|Overall Study|Withdrawal by Subject|1
7446202|NCT01696032|11733141|FG003|Overall Study|Withdrawal by Subject|2
7446203|NCT01696032|11733138|FG000|Overall Study|Death|14
7446204|NCT01696032|11733139|FG001|Overall Study|Death|4
7446205|NCT01696032|11733140|FG002|Overall Study|Death|43
7446206|NCT01696032|11733141|FG003|Overall Study|Death|18
7328854|NCT00798174|11561789|FG000|Overall Study|inability to implant azygos coil|3
7328855|NCT00798174|11561790|FG001|Overall Study|inability to implant azygos coil|3
7446207|NCT01696032|11733138|FG000|Overall Study|Lost to Follow-up|0
7446208|NCT01696032|11733139|FG001|Overall Study|Lost to Follow-up|1
7446209|NCT01696032|11733140|FG002|Overall Study|Lost to Follow-up|0
7446210|NCT01696032|11733141|FG003|Overall Study|Lost to Follow-up|0
7446211|NCT01696032|11733138|FG000|Overall Study|Database lock|0
7446212|NCT01696032|11733139|FG001|Overall Study|Database lock|1
7446213|NCT01696032|11733140|FG002|Overall Study|Database lock|7
7446214|NCT01696032|11733141|FG003|Overall Study|Database lock|2
7446215|NCT01696045|11733157|FG000|Overall Study|Study drug toxicity|1
7446216|NCT01696045|11733158|FG001|Overall Study|Study drug toxicity|5
7446217|NCT01696045|11733157|FG000|Overall Study|Disease progression|2
7446218|NCT01696045|11733158|FG001|Overall Study|Disease progression|2
7446219|NCT01696058|11733166|FG000|Overall Study|Adverse Event|21
7446220|NCT01696058|11733167|FG001|Overall Study|Adverse Event|11
7446221|NCT01696058|11733166|FG000|Overall Study|Lack of Efficacy|2
7446222|NCT01696058|11733167|FG001|Overall Study|Lack of Efficacy|3
7446223|NCT01696058|11733166|FG000|Overall Study|Protocol Violation|9
7446224|NCT01696058|11733167|FG001|Overall Study|Protocol Violation|3
7387570|NCT01215097|11646121|FG000|Overall Study|Lack of Efficacy|0
7562240|NCT03224325|11931066|FG003|Overall Study|Withdrawal by Subject|1
7562241|NCT03224325|11931067|FG004|Overall Study|Withdrawal by Subject|0
7562242|NCT03224325|11931068|FG005|Overall Study|Withdrawal by Subject|0
7562243|NCT03224325|11931069|FG006|Overall Study|Withdrawal by Subject|0
7562244|NCT03224598|11931188|FG000|Overall Study|Lost to Follow-up|0
7562245|NCT03224598|11931189|FG001|Overall Study|Lost to Follow-up|2
7562246|NCT03224598|11931190|FG002|Overall Study|Lost to Follow-up|0
7562247|NCT03224598|11931188|FG000|Overall Study|Other|0
7446225|NCT01696058|11733166|FG000|Overall Study|Lost to Follow-up|2
7446226|NCT01696058|11733167|FG001|Overall Study|Lost to Follow-up|5
7446227|NCT01696058|11733166|FG000|Overall Study|Withdrawal by Subject|4
7446228|NCT01696058|11733167|FG001|Overall Study|Withdrawal by Subject|6
7446229|NCT01696058|11733166|FG000|Overall Study|Other reason prematurely discontinued|5
7446230|NCT01696058|11733167|FG001|Overall Study|Other reason prematurely discontinued|3
7446231|NCT01696071|11733173|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
7562248|NCT03224598|11931189|FG001|Overall Study|Other|1
7562249|NCT03224598|11931190|FG002|Overall Study|Other|0
7562250|NCT03226249|11931238|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
7562251|NCT03226249|11931238|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
7562252|NCT03226249|11931238|FG000|Survival Follow-up|Patients still in follow-up.|30
7562253|NCT03226275|11931246|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7562254|NCT03226275|11931247|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7562255|NCT03226275|11931248|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
7562256|NCT03226275|11931249|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
7562257|NCT03226275|11931246|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7562258|NCT03226275|11931247|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7562259|NCT03226275|11931248|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
7387571|NCT01215097|11646122|FG001|Overall Study|Lack of Efficacy|3
7387572|NCT01215097|11646121|FG000|Overall Study|patient's refusal to come|2
7387573|NCT01215097|11646122|FG001|Overall Study|patient's refusal to come|2
7387574|NCT01215097|11646121|FG000|Overall Study|patient's private reason|1
7387575|NCT01215097|11646122|FG001|Overall Study|patient's private reason|1
7387576|NCT01215175|11646162|FG000|Overall Study|Lost to Follow-up|0
7387577|NCT01215175|11646163|FG001|Overall Study|Lost to Follow-up|1
7387578|NCT01215175|11646164|FG002|Overall Study|Lost to Follow-up|0
7387579|NCT01215175|11646165|FG003|Overall Study|Lost to Follow-up|1
7446232|NCT01696071|11733174|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
7446233|NCT01696188|11733192|FG000|Overall Study|Protocol Violation|1
7446234|NCT01696188|11733193|FG001|Overall Study|Protocol Violation|1
7446235|NCT01696214|11733203|FG000|Overall Study|Lost to Follow-up|1
7446236|NCT01696214|11733204|FG001|Overall Study|Lost to Follow-up|0
7446237|NCT01696214|11733205|FG002|Overall Study|Lost to Follow-up|0
7446238|NCT01696214|11733206|FG003|Overall Study|Lost to Follow-up|0
7467673|NCT01903252|11768102|FG000|Extended Induction, Open-Label|Adverse Event|0
7467674|NCT01903252|11768103|FG001|Extended Induction, Open-Label|Adverse Event|0
7467675|NCT01903252|11768104|FG002|Extended Induction, Open-Label|Adverse Event|17
7467676|NCT01903252|11768105|FG003|Extended Induction, Open-Label|Adverse Event|0
7467677|NCT01903252|11768106|FG004|Extended Induction, Open-Label|Adverse Event|0
7467678|NCT01903252|11768107|FG005|Extended Induction, Open-Label|Adverse Event|0
7467679|NCT01903252|11768102|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
7467680|NCT01903252|11768103|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
7467681|NCT01903252|11768104|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
7467682|NCT01903252|11768105|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
7467683|NCT01903252|11768106|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
7467684|NCT01903252|11768107|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
7467685|NCT01903252|11768102|FG000|Extended Induction, Open-Label|Physician Decision|0
7467686|NCT01903252|11768103|FG001|Extended Induction, Open-Label|Physician Decision|0
7467687|NCT01903252|11768104|FG002|Extended Induction, Open-Label|Physician Decision|1
7467688|NCT01903252|11768105|FG003|Extended Induction, Open-Label|Physician Decision|0
7467689|NCT01903252|11768106|FG004|Extended Induction, Open-Label|Physician Decision|0
7467690|NCT01903252|11768107|FG005|Extended Induction, Open-Label|Physician Decision|0
7467691|NCT01903252|11768102|FG000|Maintenance, Open-Label|Adverse Event|0
7467692|NCT01903252|11768103|FG001|Maintenance, Open-Label|Adverse Event|0
7467693|NCT01903252|11768104|FG002|Maintenance, Open-Label|Adverse Event|0
7467694|NCT01903252|11768105|FG003|Maintenance, Open-Label|Adverse Event|3
7467695|NCT01903252|11768106|FG004|Maintenance, Open-Label|Adverse Event|9
7467696|NCT01903252|11768107|FG005|Maintenance, Open-Label|Adverse Event|14
7467697|NCT01903252|11768102|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
7467698|NCT01903252|11768103|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
7467699|NCT01903252|11768104|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
7467700|NCT01903252|11768105|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
7467701|NCT01903252|11768106|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
7467702|NCT01903252|11768107|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
7467703|NCT01903252|11768102|FG000|Maintenance, Open-Label|Other|0
7467704|NCT01903252|11768103|FG001|Maintenance, Open-Label|Other|0
7467705|NCT01903252|11768104|FG002|Maintenance, Open-Label|Other|0
7467706|NCT01903252|11768105|FG003|Maintenance, Open-Label|Other|2
7467707|NCT01903252|11768106|FG004|Maintenance, Open-Label|Other|6
7467708|NCT01903252|11768107|FG005|Maintenance, Open-Label|Other|2
7467709|NCT01903356|11768134|FG000|Overall Study|Lost to Follow-up|7
7467710|NCT01903356|11768134|FG000|Overall Study|Violated inclusion/exclusion criteria|5
7467711|NCT01903356|11768134|FG000|Overall Study|Violated the dosage and administration|3
7467712|NCT01903434|11768138|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
7467713|NCT01903434|11768139|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
7467714|NCT01903434|11768138|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
7467715|NCT01903434|11768139|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
7467716|NCT01903460|11768149|FG000|Overall Study|Adverse Event|0
7467717|NCT01903460|11768150|FG001|Overall Study|Adverse Event|0
7467718|NCT01903460|11768151|FG002|Overall Study|Adverse Event|0
7467719|NCT01903460|11768152|FG003|Overall Study|Adverse Event|1
7467720|NCT01903525|11768163|FG000|Overall Study|Lost to Follow-up|5
7467721|NCT01903525|11768164|FG001|Overall Study|Lost to Follow-up|9
7467722|NCT01903525|11768163|FG000|Overall Study|Adverse Event|0
7467723|NCT01903525|11768164|FG001|Overall Study|Adverse Event|1
7467724|NCT01903720|11768179|FG000|Overall Study|Inclusion / exclusion criteria not met|6
7467725|NCT01903720|11768179|FG000|Overall Study|Adverse Event|1
7467726|NCT01903720|11768179|FG000|Overall Study|Rescinding of informed consent|2
7467727|NCT01903720|11768179|FG000|Overall Study|Lost to Follow-up|2
7467728|NCT01903720|11768179|FG000|Overall Study|Treatment with alternative drug|1
7532966|NCT02678923|11878938|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
7446239|NCT01696279|11733224|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
7446240|NCT01696279|11733225|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7446241|NCT01696279|11733226|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7446242|NCT01696279|11733227|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
7446243|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7446244|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
7446245|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7446246|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
7562260|NCT03226275|11931249|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
7446247|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7446248|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
7446249|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7446250|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
7446251|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7446252|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
7446253|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7446254|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
7446255|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7446256|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
7446257|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7446258|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
7446259|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7446260|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
7446261|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7446262|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
7446263|NCT01696279|11733224|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7446264|NCT01696279|11733225|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
7446265|NCT01696279|11733226|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7446266|NCT01696279|11733227|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
7446267|NCT01696279|11733224|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7446268|NCT01696279|11733225|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7446269|NCT01696279|11733226|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
7446270|NCT01696279|11733227|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
7446271|NCT01696279|11733224|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7446272|NCT01696279|11733225|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7446273|NCT01696279|11733226|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
7446274|NCT01696279|11733227|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
7446275|NCT01696279|11733224|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7446276|NCT01696279|11733225|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7446277|NCT01696279|11733226|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
7446278|NCT01696279|11733227|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
7446279|NCT01696279|11733224|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7446280|NCT01696279|11733225|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7446281|NCT01696279|11733226|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
7446282|NCT01696279|11733227|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
7446283|NCT01696396|11733249|FG000|Overall Study|Withdrawal by Subject|19
7446284|NCT01696396|11733250|FG001|Overall Study|Withdrawal by Subject|5
7446285|NCT01696396|11733251|FG002|Overall Study|Withdrawal by Subject|19
7446286|NCT01696396|11733252|FG003|Overall Study|Withdrawal by Subject|11
7446287|NCT01696396|11733249|FG000|Overall Study|Decision by Sponsor|3
7446288|NCT01696396|11733250|FG001|Overall Study|Decision by Sponsor|1
7446289|NCT01696396|11733251|FG002|Overall Study|Decision by Sponsor|2
7446290|NCT01696396|11733252|FG003|Overall Study|Decision by Sponsor|2
7446291|NCT01696396|11733249|FG000|Overall Study|Lost to Follow-up|9
7446292|NCT01696396|11733250|FG001|Overall Study|Lost to Follow-up|1
7446293|NCT01696396|11733251|FG002|Overall Study|Lost to Follow-up|4
7446294|NCT01696396|11733252|FG003|Overall Study|Lost to Follow-up|1
7446295|NCT01696396|11733249|FG000|Overall Study|Death|0
7446296|NCT01696396|11733250|FG001|Overall Study|Death|0
7446297|NCT01696396|11733251|FG002|Overall Study|Death|1
7446298|NCT01696396|11733252|FG003|Overall Study|Death|0
7562261|NCT03226353|11931259|FG000|Overall Study|Withdrawal by Subject|1
7562262|NCT03226353|11931259|FG000|Overall Study|Screen Failure|5
7562263|NCT03226392|11931285|FG000|Overall Study|Protocol Deviation|1
7562264|NCT03226392|11931286|FG001|Overall Study|Protocol Deviation|0
7562265|NCT03226392|11931285|FG000|Overall Study|Physician Decision|1
7562266|NCT03226392|11931286|FG001|Overall Study|Physician Decision|0
7562267|NCT03226392|11931285|FG000|Overall Study|Lost to Follow-up|1
7446299|NCT01696643|11733268|FG000|Overall Study|Adverse Event|15
7446300|NCT01696643|11733269|FG001|Overall Study|Adverse Event|7
7446301|NCT01696643|11733268|FG000|Overall Study|Death|1
7446302|NCT01696643|11733269|FG001|Overall Study|Death|2
7562268|NCT03226392|11931286|FG001|Overall Study|Lost to Follow-up|0
7562269|NCT03226392|11931285|FG000|Overall Study|Adverse Event|1
7562270|NCT03226392|11931286|FG001|Overall Study|Adverse Event|0
7446303|NCT01696643|11733268|FG000|Overall Study|Lack of Efficacy|3
7446304|NCT01696643|11733269|FG001|Overall Study|Lack of Efficacy|0
7446305|NCT01696643|11733268|FG000|Overall Study|Lost to Follow-up|67
7446306|NCT01696643|11733269|FG001|Overall Study|Lost to Follow-up|67
7446307|NCT01696643|11733268|FG000|Overall Study|Physician Decision|3
7446308|NCT01696643|11733269|FG001|Overall Study|Physician Decision|2
7446309|NCT01696643|11733268|FG000|Overall Study|Pregnancy|0
7446310|NCT01696643|11733269|FG001|Overall Study|Pregnancy|1
7446311|NCT01696643|11733268|FG000|Overall Study|Protocol Violation|7
7446312|NCT01696643|11733269|FG001|Overall Study|Protocol Violation|7
7446313|NCT01696643|11733268|FG000|Overall Study|Study Terminated by Sponsor|286
7446314|NCT01696643|11733269|FG001|Overall Study|Study Terminated by Sponsor|294
7446315|NCT01696643|11733268|FG000|Overall Study|Withdrawal by Subject|142
7446316|NCT01696643|11733269|FG001|Overall Study|Withdrawal by Subject|149
7446317|NCT01696643|11733268|FG000|Overall Study|Participant on Restricted Bed Rest|1
7446318|NCT01696643|11733269|FG001|Overall Study|Participant on Restricted Bed Rest|0
7446319|NCT01696643|11733268|FG000|Overall Study|Site Error|2
7446320|NCT01696643|11733269|FG001|Overall Study|Site Error|1
7446321|NCT01696643|11733268|FG000|Overall Study|Participant Incarcerated|0
7446322|NCT01696643|11733269|FG001|Overall Study|Participant Incarcerated|1
7446323|NCT01696643|11733268|FG000|Overall Study|Medical Monitor Decision|0
7446324|NCT01696643|11733269|FG001|Overall Study|Medical Monitor Decision|2
7446325|NCT01696643|11733268|FG000|Overall Study|Participant Did Not Receive Study Drug|2
7446326|NCT01696643|11733269|FG001|Overall Study|Participant Did Not Receive Study Drug|2
7446327|NCT01696695|11733275|FG000|Overall Study|Disease progression|373
7446328|NCT01696695|11733275|FG000|Overall Study|Death|29
7446329|NCT01696695|11733275|FG000|Overall Study|Adverse Event|74
7446330|NCT01696695|11733275|FG000|Overall Study|Withdrawal by Subject|92
7446331|NCT01696695|11733275|FG000|Overall Study|Lost to Follow-up|48
7446332|NCT01696695|11733275|FG000|Overall Study|Other|74
7446333|NCT01696695|11733275|FG000|Overall Study|Major Protocol Violation|192
7446334|NCT01696773|11733290|FG000|Days 15-27, Washout|Adverse Event|1
7446335|NCT01696773|11733291|FG001|Days 15-27, Washout|Adverse Event|0
7446336|NCT01696877|11733299|FG000|Overall Study|Adverse Event|0
7446337|NCT01696877|11733300|FG001|Overall Study|Adverse Event|1
7446338|NCT01696929|11733308|FG000|Overall Study|Physician Decision|1
7446339|NCT01696942|11733314|FG000|Overall Study|Withdrawal by Subject|1
7446340|NCT01696942|11733315|FG001|Overall Study|Withdrawal by Subject|0
7446341|NCT01696942|11733314|FG000|Overall Study|Protocol Violation|1
7446342|NCT01696942|11733315|FG001|Overall Study|Protocol Violation|2
7446343|NCT01696942|11733314|FG000|Overall Study|screen failure|0
7446344|NCT01696942|11733315|FG001|Overall Study|screen failure|1
7562271|NCT03226392|11931285|FG000|Overall Study|Technical Problems|0
7562272|NCT03226392|11931286|FG001|Overall Study|Technical Problems|2
7562273|NCT03226392|11931285|FG000|Overall Study|Subject/Guardian Decision|7
7562274|NCT03226392|11931286|FG001|Overall Study|Subject/Guardian Decision|6
7562275|NCT03226769|11931309|FG000|Overall Study|Withdrawal by Subject|0
7562276|NCT03226769|11931310|FG001|Overall Study|Withdrawal by Subject|1
7562277|NCT03227445|11931325|FG000|Period 1 (28 Days)|Adverse Event|1
7562278|NCT03227445|11931326|FG001|Period 1 (28 Days)|Adverse Event|2
7562279|NCT03227445|11931327|FG002|Period 1 (28 Days)|Adverse Event|0
7562280|NCT03227445|11931328|FG003|Period 1 (28 Days)|Adverse Event|1
7562281|NCT03227445|11931325|FG000|Period 1 (28 Days)|Protocol Violation|1
7562282|NCT03227445|11931326|FG001|Period 1 (28 Days)|Protocol Violation|0
7562283|NCT03227445|11931327|FG002|Period 1 (28 Days)|Protocol Violation|0
7562284|NCT03227445|11931328|FG003|Period 1 (28 Days)|Protocol Violation|0
7562285|NCT03227445|11931325|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
7562286|NCT03227445|11931326|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
7562287|NCT03227445|11931327|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
7562288|NCT03227445|11931328|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
7562289|NCT03227445|11931325|FG000|Period 2 (28 Days)|Adverse Event|1
7562290|NCT03227445|11931326|FG001|Period 2 (28 Days)|Adverse Event|0
7562291|NCT03227445|11931327|FG002|Period 2 (28 Days)|Adverse Event|2
7562292|NCT03227445|11931328|FG003|Period 2 (28 Days)|Adverse Event|1
7562293|NCT03227445|11931325|FG000|Period 2 (28 Days)|Protocol Violation|0
7562294|NCT03227445|11931326|FG001|Period 2 (28 Days)|Protocol Violation|0
7562295|NCT03227445|11931327|FG002|Period 2 (28 Days)|Protocol Violation|0
7562296|NCT03227445|11931328|FG003|Period 2 (28 Days)|Protocol Violation|1
7562297|NCT03227445|11931325|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
7562298|NCT03227445|11931326|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
7562299|NCT03227445|11931327|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
7562300|NCT03227445|11931328|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
7562301|NCT03227692|11931339|FG000|Overall Study|Protocol Violation|1
7562302|NCT03227692|11931340|FG001|Overall Study|Protocol Violation|1
7562303|NCT03227692|11931339|FG000|Overall Study|Lost to Follow-up|4
7562304|NCT03227692|11931340|FG001|Overall Study|Lost to Follow-up|2
7562305|NCT03227692|11931339|FG000|Overall Study|Adverse Event|0
7562306|NCT03227692|11931340|FG001|Overall Study|Adverse Event|2
7446345|NCT01696955|11733323|FG000|Main Study|Protocol Violation|1
7562307|NCT03227861|11931346|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
7446346|NCT01696955|11733324|FG001|Main Study|Protocol Violation|0
7446347|NCT01696955|11733323|FG000|Main Study|Withdrawal by Subject|1
7446348|NCT01696955|11733324|FG001|Main Study|Withdrawal by Subject|1
7562308|NCT03227861|11931346|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
7446349|NCT01697319|11733337|FG000|Primary Phase|Withdrawal by Subject|1
7446350|NCT01697319|11733337|FG000|Extension Phase|Terminated by Sponsor|15
7446351|NCT01697345|11733341|FG000|Overall Study|Withdrawal by Subject|1
7446352|NCT01697358|11733362|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
7446353|NCT01697358|11733363|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
7446354|NCT01697358|11733362|FG000|Period I: Randomization to 6 Months|Physician Decision|4
7446355|NCT01697358|11733363|FG001|Period I: Randomization to 6 Months|Physician Decision|0
7446356|NCT01697358|11733362|FG000|Period I: Randomization to 6 Months|Adverse Event|1
7446357|NCT01697358|11733363|FG001|Period I: Randomization to 6 Months|Adverse Event|1
7446358|NCT01697358|11733362|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
7446359|NCT01697358|11733363|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
7446360|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
7446361|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
7446362|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
7446363|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
7446364|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7446365|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
7446366|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Death|1
7446367|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Death|1
7446368|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
7446369|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
7446370|NCT01697358|11733362|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
7446371|NCT01697358|11733363|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
7446372|NCT01697449|11733369|FG000|Overall Study|Disease progression|47
7446373|NCT01697449|11733369|FG000|Overall Study|Adverse Event|7
7446374|NCT01697449|11733369|FG000|Overall Study|Lost to Follow-up|5
7446375|NCT01697449|11733369|FG000|Overall Study|Withdrawal by Subject|2
7446376|NCT01697449|11733369|FG000|Overall Study|Physician Decision|1
7446377|NCT01697449|11733369|FG000|Overall Study|Death|2
7446378|NCT01697449|11733369|FG000|Overall Study|Other|1
7446379|NCT01697449|11733369|FG000|Overall Study|Missing|25
7446380|NCT01697462|11733376|FG000|Overall Study|Disease Progression|1
7446381|NCT01697462|11733376|FG000|Overall Study|Adverse Event|6
7446382|NCT01697462|11733376|FG000|Overall Study|Lost to Follow-up|21
7446383|NCT01697462|11733376|FG000|Overall Study|Withdrawal by Subject|12
7446384|NCT01697462|11733376|FG000|Overall Study|Investigator Decision|21
7446385|NCT01697462|11733376|FG000|Overall Study|Death|1
7446386|NCT01697462|11733376|FG000|Overall Study|Other|10
7446387|NCT01697462|11733376|FG000|Overall Study|Missing|5
7446388|NCT01697501|11733380|FG000|Overall Study|Protocol Violation|2
7446389|NCT01697579|11733398|FG000|Base Study-Cycle 1|Adverse Event|1
7446390|NCT01697579|11733399|FG001|Base Study-Cycle 1|Adverse Event|0
7446391|NCT01697579|11733400|FG002|Base Study-Cycle 1|Adverse Event|0
7446392|NCT01697579|11733401|FG003|Base Study-Cycle 1|Adverse Event|0
7446393|NCT01697579|11733402|FG004|Base Study-Cycle 1|Adverse Event|0
7446394|NCT01697579|11733403|FG005|Base Study-Cycle 1|Adverse Event|0
7446395|NCT01697579|11733404|FG006|Base Study-Cycle 1|Adverse Event|0
7446396|NCT01697579|11733398|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
7446397|NCT01697579|11733399|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446398|NCT01697579|11733400|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446399|NCT01697579|11733401|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446400|NCT01697579|11733402|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446401|NCT01697579|11733403|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446402|NCT01697579|11733404|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
7446403|NCT01697579|11733398|FG000|Base Study-Cycle 1|Protocol Violation|0
7446404|NCT01697579|11733399|FG001|Base Study-Cycle 1|Protocol Violation|0
7446405|NCT01697579|11733400|FG002|Base Study-Cycle 1|Protocol Violation|0
7446406|NCT01697579|11733401|FG003|Base Study-Cycle 1|Protocol Violation|0
7446407|NCT01697579|11733402|FG004|Base Study-Cycle 1|Protocol Violation|3
7446408|NCT01697579|11733403|FG005|Base Study-Cycle 1|Protocol Violation|0
7446409|NCT01697579|11733404|FG006|Base Study-Cycle 1|Protocol Violation|0
7446410|NCT01697579|11733398|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7446411|NCT01697579|11733399|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
7446412|NCT01697579|11733400|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7446413|NCT01697579|11733401|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7446414|NCT01697579|11733402|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7446415|NCT01697579|11733403|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7532967|NCT02678923|11878939|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
7446416|NCT01697579|11733404|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
7446417|NCT01697579|11733398|FG000|Base Study-Cycle 1|Technical Problems|0
7446418|NCT01697579|11733399|FG001|Base Study-Cycle 1|Technical Problems|0
7446419|NCT01697579|11733400|FG002|Base Study-Cycle 1|Technical Problems|1
7446420|NCT01697579|11733401|FG003|Base Study-Cycle 1|Technical Problems|1
7532968|NCT02678923|11878938|FG000|Overall Study|Withdrawal by Subject|3
7446421|NCT01697579|11733402|FG004|Base Study-Cycle 1|Technical Problems|0
7446422|NCT01697579|11733403|FG005|Base Study-Cycle 1|Technical Problems|0
7446423|NCT01697579|11733404|FG006|Base Study-Cycle 1|Technical Problems|0
7446424|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Death|0
7446425|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Death|0
7446426|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Death|0
7446427|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Death|0
7446428|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Death|0
7446429|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Death|0
7446430|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Death|2
7446431|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7446432|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7446433|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7446434|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7446435|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
7446436|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
7446437|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
7562309|NCT03227861|11931346|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
7562310|NCT03227861|11931346|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
7562311|NCT03227861|11931346|FG000|Main Study Period (Week 0 to Week 48)|Other|5
7562312|NCT03227861|11931346|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
7562313|NCT03227861|11931346|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
7562314|NCT03227861|11931346|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
7562315|NCT03227861|11931346|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
7562316|NCT03227861|11931346|FG000|Extension Period (Week 48 to Week 96)|Other|2
7562317|NCT03228212|11931361|FG000|Period 1|Adverse Event|1
7562318|NCT03228212|11931362|FG001|Period 1|Adverse Event|0
7562319|NCT03228212|11931361|FG000|Period 1|no longer meets eligibility criteria|0
7562320|NCT03228212|11931362|FG001|Period 1|no longer meets eligibility criteria|1
7562321|NCT03228212|11931361|FG000|Period 2|Lost to Follow-up|1
7562322|NCT03228212|11931362|FG001|Period 2|Lost to Follow-up|0
7562323|NCT03228420|11931370|FG000|Overall Study|Lost to Follow-up|5
7562324|NCT03228420|11931371|FG001|Overall Study|Lost to Follow-up|3
7562325|NCT03228420|11931370|FG000|Overall Study|Withdrawal by Subject|10
7562326|NCT03228420|11931371|FG001|Overall Study|Withdrawal by Subject|0
7562327|NCT03228420|11931370|FG000|Overall Study|Adverse Event|5
7562328|NCT03228420|11931371|FG001|Overall Study|Adverse Event|2
7562329|NCT03228433|11931383|FG000|Overall Study|Lost to Follow-up|1
7562330|NCT03228433|11931384|FG001|Overall Study|Lost to Follow-up|0
7562331|NCT03228433|11931385|FG002|Overall Study|Lost to Follow-up|0
7562332|NCT03228433|11931386|FG003|Overall Study|Lost to Follow-up|0
7562333|NCT03228433|11931387|FG004|Overall Study|Lost to Follow-up|0
7562334|NCT03228433|11931388|FG005|Overall Study|Lost to Follow-up|0
7562335|NCT03228433|11931383|FG000|Overall Study|Positive alcohol test|0
7562336|NCT03228433|11931384|FG001|Overall Study|Positive alcohol test|0
7562337|NCT03228433|11931385|FG002|Overall Study|Positive alcohol test|0
7562338|NCT03228433|11931386|FG003|Overall Study|Positive alcohol test|1
7562339|NCT03228433|11931387|FG004|Overall Study|Positive alcohol test|0
7562340|NCT03228433|11931388|FG005|Overall Study|Positive alcohol test|0
7562341|NCT03228836|11931410|FG000|Overall Study|Adverse Event|3
7562342|NCT03228836|11931410|FG000|Overall Study|Withdrawal by Subject|1
7562343|NCT03228836|11931410|FG000|Overall Study|Death|1
7562344|NCT03228836|11931410|FG000|Overall Study|Physician Decision|1
7562345|NCT03228836|11931410|FG000|Overall Study|Disease Progression|7
7562346|NCT03228836|11931410|FG000|Overall Study|Other|4
7562347|NCT03229109|11931425|FG000|Overall Study|Withdrawal by Subject|0
7562348|NCT03229109|11931426|FG001|Overall Study|Withdrawal by Subject|0
7562349|NCT03229109|11931427|FG002|Overall Study|Withdrawal by Subject|0
7562350|NCT03229109|11931428|FG003|Overall Study|Withdrawal by Subject|1
7562351|NCT03229486|11931453|FG000|Overall Study|Protocol Violation|0
7562352|NCT03229486|11931454|FG001|Overall Study|Protocol Violation|1
7562353|NCT03229759|11931460|FG000|Overall Study|Screen Failure|30
7562354|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
7562355|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
7562356|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
7562357|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
7562358|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7562359|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
7562360|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7562361|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
7562362|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
7562363|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
7562364|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
7562365|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
7562366|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
7562367|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
7562368|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7562369|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
7446438|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
7562370|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
7446439|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
7446440|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
7446441|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
7446442|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
7446443|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
7446444|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
7446445|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
7446446|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
7446447|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
7446448|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
7446449|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
7446450|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
7446451|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
7446452|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
7446453|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
7446454|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
7446455|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
7446456|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
7446457|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
7446458|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
7446459|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446460|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446461|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446462|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446463|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446464|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
7446465|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
7446466|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7446467|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7446468|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7446469|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7446470|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
7446471|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
7446472|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
7446473|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7446474|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7446475|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7562371|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
7562372|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7562373|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
7562374|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
7562375|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
7562376|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
7562377|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
7562378|NCT03230864|11931473|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
7562379|NCT03230864|11931474|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7562380|NCT03230864|11931475|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7562381|NCT03230864|11931476|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
7562382|NCT03230864|11931473|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
7562383|NCT03230864|11931474|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
7562384|NCT03230864|11931475|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
7562385|NCT03230864|11931476|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
7562386|NCT03230864|11931473|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7562387|NCT03230864|11931474|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
7562388|NCT03230864|11931475|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7562389|NCT03230864|11931476|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
7562390|NCT03230864|11931473|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7562391|NCT03230864|11931474|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7562392|NCT03230864|11931475|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
7562393|NCT03230864|11931476|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
7562394|NCT03231228|11931488|FG000|Overall Study|Lost to Follow-up|2
7562395|NCT03231228|11931489|FG001|Overall Study|Lost to Follow-up|0
7562396|NCT03231228|11931488|FG000|Overall Study|Physician Decision|1
7562397|NCT03231228|11931489|FG001|Overall Study|Physician Decision|0
7562398|NCT03231371|11931499|FG000|Overall Study|Withdrawal by Subject|1
7562399|NCT03231371|11931499|FG000|Overall Study|chose or were ineligible to have MRI|12
7562400|NCT03231709|11931505|FG000|Treatment Period 1|Reason not Specified|0
7562401|NCT03231709|11931506|FG001|Treatment Period 1|Reason not Specified|1
7446476|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7446477|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
7446478|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
7446479|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
7446480|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446481|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446482|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446483|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446484|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446485|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
7446486|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
7446487|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
7446488|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
7446489|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
7446490|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
7446491|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
7446492|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
7446493|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
7446494|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
7446495|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
7446496|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
7446497|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
7446498|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
7446499|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
7446500|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
7446501|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7446502|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7446503|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7446504|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7446505|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
7446506|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
7446507|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
7446508|NCT01697579|11733398|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446509|NCT01697579|11733399|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446510|NCT01697579|11733400|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446511|NCT01697579|11733401|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446512|NCT01697579|11733402|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446513|NCT01697579|11733403|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
7446514|NCT01697579|11733404|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
7446515|NCT01697592|11733442|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
7446516|NCT01697592|11733443|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446517|NCT01697592|11733444|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446518|NCT01697592|11733445|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446519|NCT01697592|11733446|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446520|NCT01697592|11733447|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446521|NCT01697592|11733448|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446522|NCT01697592|11733449|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446523|NCT01697592|11733450|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446524|NCT01697592|11733451|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
7446525|NCT01697592|11733442|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
7446526|NCT01697592|11733443|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7446527|NCT01697592|11733444|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7446528|NCT01697592|11733445|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
7446529|NCT01697592|11733446|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
7446530|NCT01697592|11733447|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
7446531|NCT01697592|11733448|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
7446532|NCT01697592|11733449|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
7446533|NCT01697592|11733450|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
7446534|NCT01697592|11733451|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
7446535|NCT01697592|11733442|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
7446536|NCT01697592|11733443|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446537|NCT01697592|11733444|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446538|NCT01697592|11733445|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446539|NCT01697592|11733446|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446540|NCT01697592|11733447|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446541|NCT01697592|11733448|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446542|NCT01697592|11733449|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446543|NCT01697592|11733450|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446544|NCT01697592|11733451|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
7446545|NCT01697592|11733442|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7532969|NCT02678923|11878939|FG001|Overall Study|Withdrawal by Subject|2
7532970|NCT02678923|11878938|FG000|Overall Study|Lost to Follow-up|1
7446546|NCT01697592|11733443|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7446547|NCT01697592|11733444|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7562402|NCT03231709|11931505|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
7562403|NCT03231709|11931506|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
7562404|NCT03231800|11931518|FG000|Overall Study|Lost to Follow-up|0
7562405|NCT03231800|11931519|FG001|Overall Study|Lost to Follow-up|2
7446548|NCT01697592|11733445|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7446549|NCT01697592|11733446|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7446550|NCT01697592|11733447|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7446551|NCT01697592|11733448|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7446552|NCT01697592|11733449|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7446553|NCT01697592|11733450|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7446554|NCT01697592|11733451|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7446555|NCT01697592|11733442|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
7446556|NCT01697592|11733443|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
7446557|NCT01697592|11733444|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
7446558|NCT01697592|11733445|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
7446559|NCT01697592|11733446|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
7446560|NCT01697592|11733447|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
7446561|NCT01697592|11733448|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
7446562|NCT01697592|11733449|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
7446563|NCT01697592|11733450|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
7446564|NCT01697592|11733451|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
7446565|NCT01697592|11733442|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
7446566|NCT01697592|11733443|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
7446567|NCT01697592|11733444|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
7446568|NCT01697592|11733445|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
7446569|NCT01697592|11733446|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
7446570|NCT01697592|11733447|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
7446571|NCT01697592|11733448|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
7446572|NCT01697592|11733449|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
7446573|NCT01697592|11733450|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
7446574|NCT01697592|11733451|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
7446575|NCT01697592|11733442|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
7446576|NCT01697592|11733443|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446577|NCT01697592|11733444|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7562406|NCT03231800|11931518|FG000|Overall Study|Protocol Violation|1
7562407|NCT03231800|11931519|FG001|Overall Study|Protocol Violation|1
7562408|NCT03231800|11931518|FG000|Overall Study|reason not provided|2
7562409|NCT03231800|11931519|FG001|Overall Study|reason not provided|0
7562410|NCT03231943|11931541|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562411|NCT03231943|11931542|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7562412|NCT03231943|11931543|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
7562413|NCT03231943|11931544|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562414|NCT03231943|11931545|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562415|NCT03231943|11931546|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562416|NCT03231943|11931547|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562417|NCT03231943|11931548|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562418|NCT03231943|11931549|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562419|NCT03231943|11931550|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562420|NCT03231943|11931551|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562421|NCT03231943|11931552|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562422|NCT03231943|11931553|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
7562423|NCT03231943|11931541|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562424|NCT03231943|11931542|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
7562425|NCT03231943|11931543|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562426|NCT03231943|11931544|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562427|NCT03231943|11931545|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562428|NCT03231943|11931546|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562429|NCT03231943|11931547|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562430|NCT03231943|11931548|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562431|NCT03231943|11931549|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562432|NCT03231943|11931550|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562433|NCT03231943|11931551|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562434|NCT03231943|11931552|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562435|NCT03231943|11931553|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
7562436|NCT03231943|11931541|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
7562437|NCT03231943|11931542|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562438|NCT03231943|11931543|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562439|NCT03231943|11931544|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562440|NCT03231943|11931545|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562441|NCT03231943|11931546|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7446578|NCT01697592|11733445|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446579|NCT01697592|11733446|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446580|NCT01697592|11733447|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7446581|NCT01697592|11733448|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446582|NCT01697592|11733449|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
7446583|NCT01697592|11733450|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446584|NCT01697592|11733451|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
7446585|NCT01697592|11733442|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
7446586|NCT01697592|11733443|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
7446587|NCT01697592|11733444|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
7446588|NCT01697592|11733445|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
7446589|NCT01697592|11733446|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
7446590|NCT01697592|11733447|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
7446591|NCT01697592|11733448|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
7446592|NCT01697592|11733449|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
7446593|NCT01697592|11733450|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
7446594|NCT01697592|11733451|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
7446595|NCT01697696|11733489|FG000|Overall Study|Study terminated by sponsor|0
7446596|NCT01697696|11733490|FG001|Overall Study|Study terminated by sponsor|3
7446597|NCT01697696|11733489|FG000|Overall Study|Protocol deviation|1
7446598|NCT01697696|11733490|FG001|Overall Study|Protocol deviation|0
7446599|NCT01697696|11733489|FG000|Overall Study|Physician Decision|1
7446600|NCT01697696|11733490|FG001|Overall Study|Physician Decision|0
7446601|NCT01697696|11733489|FG000|Overall Study|Death|4
7446602|NCT01697696|11733490|FG001|Overall Study|Death|2
7446603|NCT01697696|11733489|FG000|Overall Study|Lost to Follow-up|10
7446604|NCT01697696|11733490|FG001|Overall Study|Lost to Follow-up|7
7446605|NCT01697696|11733489|FG000|Overall Study|Subject/guardian decision|31
7446606|NCT01697696|11733490|FG001|Overall Study|Subject/guardian decision|35
7446607|NCT01697748|11733507|FG000|Overall Study|ineligible skin incision|1
7446608|NCT01697748|11733508|FG001|Overall Study|ineligible skin incision|2
7562442|NCT03231943|11931547|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562443|NCT03231943|11931548|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562444|NCT03231943|11931549|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562445|NCT03231943|11931550|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562446|NCT03231943|11931551|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562447|NCT03231943|11931552|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562448|NCT03231943|11931553|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
7562449|NCT03231943|11931541|FG000|Part 2|Adverse Event|0
7562450|NCT03231943|11931542|FG001|Part 2|Adverse Event|0
7562451|NCT03231943|11931543|FG002|Part 2|Adverse Event|0
7562452|NCT03231943|11931544|FG003|Part 2|Adverse Event|0
7562453|NCT03231943|11931545|FG004|Part 2|Adverse Event|0
7562454|NCT03231943|11931546|FG005|Part 2|Adverse Event|0
7562455|NCT03231943|11931547|FG006|Part 2|Adverse Event|0
7562456|NCT03231943|11931548|FG007|Part 2|Adverse Event|0
7562457|NCT03231943|11931549|FG008|Part 2|Adverse Event|0
7562458|NCT03231943|11931550|FG009|Part 2|Adverse Event|0
7562459|NCT03231943|11931551|FG010|Part 2|Adverse Event|1
7562460|NCT03231943|11931552|FG011|Part 2|Adverse Event|0
7562461|NCT03231943|11931553|FG012|Part 2|Adverse Event|0
7562462|NCT03231943|11931541|FG000|Part 2|Withdrawal by Subject|0
7562463|NCT03231943|11931542|FG001|Part 2|Withdrawal by Subject|0
7562464|NCT03231943|11931543|FG002|Part 2|Withdrawal by Subject|0
7562465|NCT03231943|11931544|FG003|Part 2|Withdrawal by Subject|0
7446609|NCT01697748|11733507|FG000|Overall Study|ineligible uterine incision|4
7446610|NCT01697748|11733508|FG001|Overall Study|ineligible uterine incision|1
7446611|NCT01697748|11733507|FG000|Overall Study|Lost to Follow-up|53
7562466|NCT03231943|11931545|FG004|Part 2|Withdrawal by Subject|0
7562467|NCT03231943|11931546|FG005|Part 2|Withdrawal by Subject|0
7562468|NCT03231943|11931547|FG006|Part 2|Withdrawal by Subject|0
7562469|NCT03231943|11931548|FG007|Part 2|Withdrawal by Subject|0
7562470|NCT03231943|11931549|FG008|Part 2|Withdrawal by Subject|0
7562471|NCT03231943|11931550|FG009|Part 2|Withdrawal by Subject|0
7562472|NCT03231943|11931551|FG010|Part 2|Withdrawal by Subject|0
7562473|NCT03231943|11931552|FG011|Part 2|Withdrawal by Subject|1
7562474|NCT03231943|11931553|FG012|Part 2|Withdrawal by Subject|0
7562475|NCT03232281|11931602|FG000|Overall Study|Adverse Event|1
7562476|NCT03232281|11931603|FG001|Overall Study|Adverse Event|1
7562477|NCT03232281|11931602|FG000|Overall Study|Withdrawal by Subject|5
7562478|NCT03232281|11931603|FG001|Overall Study|Withdrawal by Subject|4
7562479|NCT03232281|11931602|FG000|Overall Study|Protocol Deviation|1
7562480|NCT03232281|11931603|FG001|Overall Study|Protocol Deviation|1
7562481|NCT03232333|11931609|FG000|Overall Study|Infection or Osteomyelitis|9
7562482|NCT03232333|11931609|FG000|Overall Study|Lost to Follow-up|4
7562483|NCT03232333|11931609|FG000|Overall Study|Withdrawal by Subject|2
7562484|NCT03232567|11931617|FG000|Overall Study|Withdrawal by Subject|0
7562485|NCT03232567|11931618|FG001|Overall Study|Withdrawal by Subject|1
7562486|NCT03232567|11931619|FG002|Overall Study|Withdrawal by Subject|0
7562487|NCT03232567|11931620|FG003|Overall Study|Withdrawal by Subject|0
7446612|NCT01697748|11733508|FG001|Overall Study|Lost to Follow-up|65
7446613|NCT01697956|11733516|FG000|Overall Study|Protocol Violation|1
7446614|NCT01697956|11733517|FG001|Overall Study|Protocol Violation|1
7446615|NCT01697969|11733529|FG000|Overall Study|Did not meet inc/exc criteria|3
7562488|NCT03232983|11931653|FG000|Period 1|Physician Decision|0
7562489|NCT03232983|11931654|FG001|Period 1|Physician Decision|0
7562490|NCT03232983|11931655|FG002|Period 1|Physician Decision|1
7446616|NCT01698008|11733536|FG000|Overall Study|Withdrawal by Subject|1
7446617|NCT01698008|11733537|FG001|Overall Study|Withdrawal by Subject|2
7446618|NCT01698268|11733545|FG000|Overall Study|Physician Decision|2
7446619|NCT01698268|11733546|FG001|Overall Study|Physician Decision|1
7446620|NCT01698320|11733554|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
7446621|NCT01698320|11733555|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7446622|NCT01698320|11733556|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
7446623|NCT01698320|11733554|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
7446624|NCT01698320|11733555|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7446625|NCT01698320|11733556|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
7446626|NCT01698320|11733554|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
7446627|NCT01698320|11733555|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7446628|NCT01698320|11733556|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
7446629|NCT01698320|11733554|FG000|Run-In Period (Week -1 to Day 0)|Other|1
7446630|NCT01698320|11733555|FG001|Run-In Period (Week -1 to Day 0)|Other|0
7446631|NCT01698320|11733556|FG002|Run-In Period (Week -1 to Day 0)|Other|0
7446632|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Adverse Event|0
7446633|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Adverse Event|1
7446634|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Adverse Event|1
7446635|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
7446636|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
7446637|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
7446638|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Protocol Violation|0
7446639|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Protocol Violation|0
7446640|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Protocol Violation|2
7446641|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Pregnancy|0
7446642|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Pregnancy|1
7446643|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Pregnancy|1
7446644|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7446645|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
7446646|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
7446647|NCT01698320|11733554|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
7446648|NCT01698320|11733555|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
7446649|NCT01698320|11733556|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
7446650|NCT01698320|11733554|FG000|40-Week Open-Label Period|Adverse Event|0
7446651|NCT01698320|11733555|FG001|40-Week Open-Label Period|Adverse Event|3
7446652|NCT01698320|11733556|FG002|40-Week Open-Label Period|Adverse Event|2
7446653|NCT01698320|11733554|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
7446654|NCT01698320|11733555|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
7446655|NCT01698320|11733556|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
7446656|NCT01698320|11733554|FG000|40-Week Open-Label Period|Pregnancy|0
7446657|NCT01698320|11733555|FG001|40-Week Open-Label Period|Pregnancy|2
7446658|NCT01698320|11733556|FG002|40-Week Open-Label Period|Pregnancy|1
7446659|NCT01698320|11733554|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7446660|NCT01698320|11733555|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
7446661|NCT01698320|11733556|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
7446662|NCT01698320|11733554|FG000|40-Week Open-Label Period|Lost to Follow-up|0
7446663|NCT01698320|11733555|FG001|40-Week Open-Label Period|Lost to Follow-up|2
7446664|NCT01698320|11733556|FG002|40-Week Open-Label Period|Lost to Follow-up|0
7446665|NCT01698554|11733594|FG000|Overall Study|Adverse Event|2
7446666|NCT01698554|11733595|FG001|Overall Study|Adverse Event|5
7446667|NCT01698554|11733596|FG002|Overall Study|Adverse Event|0
7446668|NCT01698554|11733597|FG003|Overall Study|Adverse Event|1
7446669|NCT01698554|11733594|FG000|Overall Study|Lost to Follow-up|1
7446670|NCT01698554|11733595|FG001|Overall Study|Lost to Follow-up|0
7562491|NCT03232983|11931656|FG003|Period 1|Physician Decision|0
7562492|NCT03232983|11931653|FG000|Washout Period 2|Physician Decision|0
7562493|NCT03232983|11931654|FG001|Washout Period 2|Physician Decision|0
7562494|NCT03232983|11931655|FG002|Washout Period 2|Physician Decision|1
7562495|NCT03232983|11931656|FG003|Washout Period 2|Physician Decision|0
7562496|NCT03232983|11931653|FG000|Washout Period 2|Withdrawal by Subject|0
7562497|NCT03232983|11931654|FG001|Washout Period 2|Withdrawal by Subject|0
7562498|NCT03232983|11931655|FG002|Washout Period 2|Withdrawal by Subject|0
7562499|NCT03232983|11931656|FG003|Washout Period 2|Withdrawal by Subject|1
7562500|NCT03232983|11931653|FG000|Period 4|Withdrawal by Subject|1
7562501|NCT03232983|11931654|FG001|Period 4|Withdrawal by Subject|0
7562502|NCT03232983|11931655|FG002|Period 4|Withdrawal by Subject|0
7562503|NCT03232983|11931656|FG003|Period 4|Withdrawal by Subject|0
7562504|NCT03233009|11931668|FG000|Overall Study|Lost to Follow-up|1
7446671|NCT01698554|11733596|FG002|Overall Study|Lost to Follow-up|0
7446672|NCT01698554|11733597|FG003|Overall Study|Lost to Follow-up|0
7446673|NCT01698554|11733594|FG000|Overall Study|Personal Reasons|0
7446674|NCT01698554|11733595|FG001|Overall Study|Personal Reasons|5
7446675|NCT01698554|11733596|FG002|Overall Study|Personal Reasons|1
7446676|NCT01698554|11733597|FG003|Overall Study|Personal Reasons|1
7562505|NCT03233230|11931685|FG000|Overall Study|Adverse Event|6
7562506|NCT03233230|11931686|FG001|Overall Study|Adverse Event|3
7562507|NCT03233230|11931687|FG002|Overall Study|Adverse Event|6
7446677|NCT01698554|11733594|FG000|Overall Study|Protocol Violation|2
7446678|NCT01698554|11733595|FG001|Overall Study|Protocol Violation|0
7446679|NCT01698554|11733596|FG002|Overall Study|Protocol Violation|1
7446680|NCT01698554|11733597|FG003|Overall Study|Protocol Violation|0
7446681|NCT01698554|11733594|FG000|Overall Study|Other Miscellaneous Reasons|1
7446682|NCT01698554|11733595|FG001|Overall Study|Other Miscellaneous Reasons|0
7446683|NCT01698554|11733596|FG002|Overall Study|Other Miscellaneous Reasons|0
7446684|NCT01698554|11733597|FG003|Overall Study|Other Miscellaneous Reasons|0
7446685|NCT01698775|11733626|FG000|Phase A|Adverse Event|2
7446686|NCT01698775|11733627|FG001|Phase A|Adverse Event|1
7446687|NCT01698775|11733626|FG000|Phase A|Death|1
7446688|NCT01698775|11733627|FG001|Phase A|Death|1
7446689|NCT01698775|11733626|FG000|Phase A|Lack of Efficacy|1
7446690|NCT01698775|11733627|FG001|Phase A|Lack of Efficacy|0
7446691|NCT01698775|11733626|FG000|Phase A|Lost to Follow-up|1
7446692|NCT01698775|11733627|FG001|Phase A|Lost to Follow-up|2
7446693|NCT01698775|11733626|FG000|Phase A|Protocol Violation|1
7446694|NCT01698775|11733627|FG001|Phase A|Protocol Violation|0
7446695|NCT01698775|11733626|FG000|Phase A|Withdrawal by Subject|3
7446696|NCT01698775|11733627|FG001|Phase A|Withdrawal by Subject|4
7446697|NCT01698775|11733626|FG000|Phase A|Kidney [transplant]|0
7446698|NCT01698775|11733627|FG001|Phase A|Kidney [transplant]|1
7446699|NCT01698775|11733626|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
7446700|NCT01698775|11733627|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
7446701|NCT01698775|11733626|FG000|Phase B|Adverse Event|6
7446702|NCT01698775|11733627|FG001|Phase B|Adverse Event|3
7446703|NCT01698775|11733626|FG000|Phase B|Death|0
7446704|NCT01698775|11733627|FG001|Phase B|Death|1
7446705|NCT01698775|11733626|FG000|Phase B|Lack of Efficacy|0
7446706|NCT01698775|11733627|FG001|Phase B|Lack of Efficacy|1
7446707|NCT01698775|11733626|FG000|Phase B|Lost to Follow-up|0
7446708|NCT01698775|11733627|FG001|Phase B|Lost to Follow-up|1
7446709|NCT01698775|11733626|FG000|Phase B|Physician Decision|1
7446710|NCT01698775|11733627|FG001|Phase B|Physician Decision|1
7446711|NCT01698775|11733626|FG000|Phase B|Protocol Violation|1
7446712|NCT01698775|11733627|FG001|Phase B|Protocol Violation|1
7446713|NCT01698775|11733626|FG000|Phase B|Withdrawal by Subject|6
7446714|NCT01698775|11733627|FG001|Phase B|Withdrawal by Subject|2
7446715|NCT01698801|11733637|FG000|Treatment Phase|Adverse Event|4
7446716|NCT01698801|11733637|FG000|Treatment Phase|Protocol Violation|1
7446717|NCT01698801|11733637|FG000|Treatment Phase|Other|4
7446718|NCT01698801|11733637|FG000|Treatment Phase|Withdrawal by Subject|1
7446719|NCT01698801|11733637|FG000|Treatment Phase|Disease progression|1
7446720|NCT01698801|11733637|FG000|Follow Up Phase|Withdrawal by Subject|1
7446721|NCT01698801|11733637|FG000|Follow Up Phase|Death|4
7446722|NCT01698814|11733644|FG000|Overall Study|Adverse Event|0
7446723|NCT01698814|11733645|FG001|Overall Study|Adverse Event|2
7446724|NCT01698814|11733644|FG000|Overall Study|Lost to Follow-up|0
7446725|NCT01698814|11733645|FG001|Overall Study|Lost to Follow-up|1
7446726|NCT01698814|11733644|FG000|Overall Study|Pregnancy|1
7446727|NCT01698814|11733645|FG001|Overall Study|Pregnancy|0
7446728|NCT01698814|11733644|FG000|Overall Study|Randomized in error|1
7446729|NCT01698814|11733645|FG001|Overall Study|Randomized in error|0
7446730|NCT01698879|11733654|FG000|Overall Study|Withdrawal by Subject|1
7446731|NCT01698879|11733655|FG001|Overall Study|Withdrawal by Subject|0
7446732|NCT01698879|11733656|FG002|Overall Study|Withdrawal by Subject|0
7446733|NCT01699022|11733670|FG000|Overall Study|Early discontinuation from the study|3
7446734|NCT01699087|11733675|FG000|Overall Study|Lost to Follow-up|7
7446735|NCT01699087|11733675|FG000|Overall Study|Screen failure (prior to treatment)|15
7446736|NCT01699087|11733675|FG000|Overall Study|Unable to make future visits|2
7446737|NCT01699178|11733682|FG000|Overall Study|Adverse Event|1
7446738|NCT01699178|11733683|FG001|Overall Study|Adverse Event|5
7446739|NCT01699178|11733682|FG000|Overall Study|Lost to Follow-up|1
7446740|NCT01699178|11733683|FG001|Overall Study|Lost to Follow-up|6
7446741|NCT01699178|11733682|FG000|Overall Study|Non-compliance with Study Drug|3
7446742|NCT01699178|11733683|FG001|Overall Study|Non-compliance with Study Drug|1
7446743|NCT01699178|11733682|FG000|Overall Study|Physician Decision|1
7446744|NCT01699178|11733683|FG001|Overall Study|Physician Decision|0
7446745|NCT01699178|11733682|FG000|Overall Study|Withdrawal by Subject|4
7446746|NCT01699178|11733683|FG001|Overall Study|Withdrawal by Subject|12
7446747|NCT01699178|11733682|FG000|Overall Study|Hematocrit >54%|1
7446748|NCT01699178|11733683|FG001|Overall Study|Hematocrit >54%|1
7446749|NCT01699178|11733682|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
7446750|NCT01699178|11733683|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
7446751|NCT01699178|11733682|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
7446752|NCT01699178|11733683|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
7446753|NCT01699503|11733700|FG000|Overall Study|Death|31
7446754|NCT01699503|11733701|FG001|Overall Study|Death|40
7446755|NCT01699503|11733700|FG000|Overall Study|Withdrawal by Subject|65
7446756|NCT01699503|11733701|FG001|Overall Study|Withdrawal by Subject|57
7446757|NCT01699503|11733700|FG000|Overall Study|Lost to Follow-up|121
7446758|NCT01699503|11733701|FG001|Overall Study|Lost to Follow-up|117
7446759|NCT01699503|11733700|FG000|Overall Study|Excluded due to quality|783
7446760|NCT01699503|11733701|FG001|Overall Study|Excluded due to quality|791
7446761|NCT01699685|11733726|FG000|Period 1|Adverse Event|1
7446762|NCT01699685|11733727|FG001|Period 1|Adverse Event|1
7446763|NCT01699685|11733726|FG000|Period 1|Medical or ethical, noncompliance|2
7446764|NCT01699685|11733727|FG001|Period 1|Medical or ethical, noncompliance|0
7446765|NCT01699685|11733726|FG000|Period 1|Other|0
7446766|NCT01699685|11733727|FG001|Period 1|Other|1
7446767|NCT01699685|11733726|FG000|Period 1|Patient request|0
7446768|NCT01699685|11733727|FG001|Period 1|Patient request|1
7446769|NCT01699685|11733726|FG000|Period 2|Lost to Follow-up|1
7446770|NCT01699685|11733727|FG001|Period 2|Lost to Follow-up|0
7446771|NCT01699750|11733745|FG000|Overall Study|Withdrew Consent|0
7446772|NCT01699750|11733746|FG001|Overall Study|Withdrew Consent|1
7446773|NCT01699750|11733745|FG000|Overall Study|Other|0
7446774|NCT01699750|11733746|FG001|Overall Study|Other|2
7446775|NCT01699789|11733762|FG000|Overall Study|Withdrawal by Subject|18
7446776|NCT01699789|11733763|FG001|Overall Study|Withdrawal by Subject|23
7446777|NCT01699789|11733762|FG000|Overall Study|Death|1
7446778|NCT01699789|11733763|FG001|Overall Study|Death|2
7446779|NCT01699789|11733762|FG000|Overall Study|Lost to Follow-up|83
7446780|NCT01699789|11733763|FG001|Overall Study|Lost to Follow-up|101
7446781|NCT01699815|11733773|FG000|Overall Study|Protocol Violation|4
7446782|NCT01699815|11733774|FG001|Overall Study|Protocol Violation|7
7446783|NCT01699815|11733773|FG000|Overall Study|record could not be located|1
7446784|NCT01699815|11733774|FG001|Overall Study|record could not be located|0
7446785|NCT01699815|11733773|FG000|Overall Study|Adverse Event|0
7446786|NCT01699815|11733774|FG001|Overall Study|Adverse Event|1
7446787|NCT01699867|11733780|FG000|Overall Study|Screening Failure|3
7446788|NCT01700049|11733788|FG000|Overall Study|Withdrawal by Subject|1
7446789|NCT01700140|11733796|FG000|Overall Study|Use of rescue drugs|3
7446790|NCT01700140|11733797|FG001|Overall Study|Use of rescue drugs|3
7446791|NCT01700140|11733798|FG002|Overall Study|Use of rescue drugs|1
7446792|NCT01700140|11733796|FG000|Overall Study|Discontinuation of radiotherapy|1
7446793|NCT01700140|11733797|FG001|Overall Study|Discontinuation of radiotherapy|0
7446794|NCT01700140|11733798|FG002|Overall Study|Discontinuation of radiotherapy|0
7446795|NCT01700140|11733796|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
7446796|NCT01700140|11733797|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
7446797|NCT01700140|11733798|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
7446798|NCT01700140|11733796|FG000|Overall Study|Aggravation of symptoms|1
7446799|NCT01700140|11733797|FG001|Overall Study|Aggravation of symptoms|0
7446800|NCT01700140|11733798|FG002|Overall Study|Aggravation of symptoms|0
7446801|NCT01700140|11733796|FG000|Overall Study|Adverse Event|0
7446802|NCT01700140|11733797|FG001|Overall Study|Adverse Event|1
7446803|NCT01700140|11733798|FG002|Overall Study|Adverse Event|0
7446804|NCT01700140|11733796|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
7446805|NCT01700140|11733797|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
7446806|NCT01700140|11733798|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
7446807|NCT01700179|11733809|FG000|Overall Study|Physician Decision|2
7446808|NCT01700192|11733815|FG000|Overall Study|Adverse Event|73
7446809|NCT01700192|11733816|FG001|Overall Study|Adverse Event|18
7446810|NCT01700192|11733815|FG000|Overall Study|Lack of Efficacy|1
7446811|NCT01700192|11733816|FG001|Overall Study|Lack of Efficacy|0
7446812|NCT01700192|11733815|FG000|Overall Study|Lost to Follow-up|42
7446813|NCT01700192|11733816|FG001|Overall Study|Lost to Follow-up|29
7446814|NCT01700192|11733815|FG000|Overall Study|Noncompliance with study drug|0
7446815|NCT01700192|11733816|FG001|Overall Study|Noncompliance with study drug|5
7446816|NCT01700192|11733815|FG000|Overall Study|Physician Decision|2
7446817|NCT01700192|11733816|FG001|Overall Study|Physician Decision|3
7446818|NCT01700192|11733815|FG000|Overall Study|Pregnancy|1
7446819|NCT01700192|11733816|FG001|Overall Study|Pregnancy|4
7446820|NCT01700192|11733815|FG000|Overall Study|Progressive disease|1
7446821|NCT01700192|11733816|FG001|Overall Study|Progressive disease|0
7446822|NCT01700192|11733815|FG000|Overall Study|Protocol Violation|3
7446823|NCT01700192|11733816|FG001|Overall Study|Protocol Violation|4
7562508|NCT03233230|11931688|FG003|Overall Study|Adverse Event|3
7562509|NCT03233230|11931685|FG000|Overall Study|Protocol Violation|1
7562510|NCT03233230|11931686|FG001|Overall Study|Protocol Violation|2
7562511|NCT03233230|11931687|FG002|Overall Study|Protocol Violation|1
7562512|NCT03233230|11931688|FG003|Overall Study|Protocol Violation|1
7562513|NCT03233230|11931685|FG000|Overall Study|Lack of Efficacy|1
7562514|NCT03233230|11931686|FG001|Overall Study|Lack of Efficacy|0
7562515|NCT03233230|11931687|FG002|Overall Study|Lack of Efficacy|0
7562516|NCT03233230|11931688|FG003|Overall Study|Lack of Efficacy|0
7562517|NCT03233230|11931685|FG000|Overall Study|Other|5
7446824|NCT01700192|11733815|FG000|Overall Study|Technical problems|0
7446825|NCT01700192|11733816|FG001|Overall Study|Technical problems|1
7562518|NCT03233230|11931686|FG001|Overall Study|Other|5
7562519|NCT03233230|11931687|FG002|Overall Study|Other|5
7446826|NCT01700192|11733815|FG000|Overall Study|Withdrawal by Subject|56
7446827|NCT01700192|11733816|FG001|Overall Study|Withdrawal by Subject|64
7446828|NCT01700192|11733815|FG000|Overall Study|Never received study drug|1
7446829|NCT01700192|11733816|FG001|Overall Study|Never received study drug|0
7446830|NCT01700205|11733824|FG000|Overall Study|Withdrawal by Subject|13
7446831|NCT01700205|11733825|FG001|Overall Study|Withdrawal by Subject|13
7446832|NCT01700205|11733824|FG000|Overall Study|Protocol Violation|2
7446833|NCT01700205|11733825|FG001|Overall Study|Protocol Violation|2
7562520|NCT03233230|11931688|FG003|Overall Study|Other|3
7446834|NCT01700387|11733841|FG000|Overall Study|Withdrawal by Subject|1
7562521|NCT03233230|11931685|FG000|Overall Study|Withdrawal by Subject|2
7446835|NCT01700387|11733842|FG001|Overall Study|Withdrawal by Subject|2
7446836|NCT01700387|11733841|FG000|Overall Study|Adverse Event|1
7446837|NCT01700387|11733842|FG001|Overall Study|Adverse Event|1
7446838|NCT01700387|11733841|FG000|Overall Study|Lost to Follow-up|2
7446839|NCT01700387|11733842|FG001|Overall Study|Lost to Follow-up|1
7446840|NCT01700530|11733868|FG000|Overall Study|Withdrawal by Subject|0
7446841|NCT01700530|11733869|FG001|Overall Study|Withdrawal by Subject|3
7446842|NCT01700530|11733870|FG002|Overall Study|Withdrawal by Subject|1
7446843|NCT01700621|11733880|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
7446844|NCT01700621|11733881|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
7446845|NCT01700621|11733880|FG000|Analyzed for Immunogenicity|Protocol Violation|5
7446846|NCT01700621|11733881|FG001|Analyzed for Immunogenicity|Protocol Violation|1
7446847|NCT01700621|11733880|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
7446848|NCT01700621|11733881|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
7446849|NCT01700829|11733912|FG000|Overall Study|Withdrawal by Subject|1
7446850|NCT01700829|11733913|FG001|Overall Study|Withdrawal by Subject|1
7446851|NCT01700959|11733934|FG000|Overall Study|Adverse Event|0
7562522|NCT03233230|11931686|FG001|Overall Study|Withdrawal by Subject|2
7562523|NCT03233230|11931687|FG002|Overall Study|Withdrawal by Subject|0
7562524|NCT03233230|11931688|FG003|Overall Study|Withdrawal by Subject|1
7446852|NCT01700959|11733935|FG001|Overall Study|Adverse Event|1
7562525|NCT03233230|11931685|FG000|Overall Study|Lost to Follow-up|0
7562526|NCT03233230|11931686|FG001|Overall Study|Lost to Follow-up|3
7562527|NCT03233230|11931687|FG002|Overall Study|Lost to Follow-up|0
7562528|NCT03233230|11931688|FG003|Overall Study|Lost to Follow-up|0
7562529|NCT03233308|11931698|FG000|Overall Study|Adverse Event|1
7562530|NCT03233308|11931698|FG000|Overall Study|Protocol Violation|1
7562531|NCT03233438|11931711|FG000|Overall Study|Lost to Follow-up|4
7562532|NCT03233438|11931712|FG001|Overall Study|Lost to Follow-up|9
7562533|NCT03233438|11931711|FG000|Overall Study|Withdrawal by Subject|2
7562534|NCT03233438|11931712|FG001|Overall Study|Withdrawal by Subject|1
7562535|NCT03233438|11931711|FG000|Overall Study|No recording of dalbavancin|0
7562536|NCT03233438|11931712|FG001|Overall Study|No recording of dalbavancin|1
7562537|NCT03233529|11931718|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
7562538|NCT03233529|11931718|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
7562539|NCT03234036|11931751|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7562540|NCT03234036|11931752|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
7562541|NCT03234036|11931753|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7562542|NCT03234036|11931754|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
7562543|NCT03234465|11931781|FG000|Overall Study|Adverse Event|4
7562544|NCT03234465|11931782|FG001|Overall Study|Adverse Event|2
7562545|NCT03234465|11931781|FG000|Overall Study|Death|0
7562546|NCT03234465|11931782|FG001|Overall Study|Death|1
7562547|NCT03234465|11931781|FG000|Overall Study|Lost to Follow-up|1
7562548|NCT03234465|11931782|FG001|Overall Study|Lost to Follow-up|1
7562549|NCT03234465|11931781|FG000|Overall Study|Withdrawal by Subject|12
7562550|NCT03234465|11931782|FG001|Overall Study|Withdrawal by Subject|27
7562551|NCT03234465|11931781|FG000|Overall Study|Symptomatic deterioration|0
7562552|NCT03234465|11931782|FG001|Overall Study|Symptomatic deterioration|1
7562553|NCT03234465|11931781|FG000|Overall Study|Non-compliance|2
7562554|NCT03234465|11931782|FG001|Overall Study|Non-compliance|0
7562555|NCT03234465|11931781|FG000|Overall Study|Other|14
7562556|NCT03234465|11931782|FG001|Overall Study|Other|8
7562557|NCT03234608|11931790|FG000|Overall Study|Lost to Follow-up|23
7562558|NCT03234608|11931791|FG001|Overall Study|Lost to Follow-up|21
7562559|NCT03235050|11931802|FG000|Overall Study|Adverse Event|0
7562560|NCT03235050|11931803|FG001|Overall Study|Adverse Event|0
7562561|NCT03235050|11931804|FG002|Overall Study|Adverse Event|1
7562562|NCT03235050|11931805|FG003|Overall Study|Adverse Event|4
7562563|NCT03235050|11931806|FG004|Overall Study|Adverse Event|1
7562564|NCT03235050|11931802|FG000|Overall Study|Death|0
7562565|NCT03235050|11931803|FG001|Overall Study|Death|0
7562566|NCT03235050|11931804|FG002|Overall Study|Death|0
7562567|NCT03235050|11931805|FG003|Overall Study|Death|2
7562568|NCT03235050|11931806|FG004|Overall Study|Death|1
7562569|NCT03235050|11931802|FG000|Overall Study|Lost to Follow-up|1
7562570|NCT03235050|11931803|FG001|Overall Study|Lost to Follow-up|2
7562571|NCT03235050|11931804|FG002|Overall Study|Lost to Follow-up|1
7562572|NCT03235050|11931805|FG003|Overall Study|Lost to Follow-up|2
7562573|NCT03235050|11931806|FG004|Overall Study|Lost to Follow-up|0
7562574|NCT03235050|11931802|FG000|Overall Study|Withdrawal by Subject|3
7562575|NCT03235050|11931803|FG001|Overall Study|Withdrawal by Subject|2
7562576|NCT03235050|11931804|FG002|Overall Study|Withdrawal by Subject|2
7562577|NCT03235050|11931805|FG003|Overall Study|Withdrawal by Subject|5
7446853|NCT01700959|11733936|FG002|Overall Study|Adverse Event|1
7562578|NCT03235050|11931806|FG004|Overall Study|Withdrawal by Subject|7
7562579|NCT03235050|11931802|FG000|Overall Study|Other reasons|0
7562580|NCT03235050|11931803|FG001|Overall Study|Other reasons|1
7446854|NCT01700959|11733937|FG003|Overall Study|Adverse Event|2
7562581|NCT03235050|11931804|FG002|Overall Study|Other reasons|0
7562582|NCT03235050|11931805|FG003|Overall Study|Other reasons|1
7562583|NCT03235050|11931806|FG004|Overall Study|Other reasons|2
7562584|NCT03235089|11931818|FG000|Overall Study|Lost to Follow-up|1
7562585|NCT03235089|11931819|FG001|Overall Study|Lost to Follow-up|1
7562586|NCT03235089|11931818|FG000|Overall Study|Physician Decision|2
7562587|NCT03235089|11931819|FG001|Overall Study|Physician Decision|2
7562588|NCT03235115|11931826|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7562589|NCT03235115|11931827|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7562590|NCT03235115|11931828|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7562591|NCT03235115|11931829|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7446855|NCT01700959|11733938|FG004|Overall Study|Adverse Event|0
7446856|NCT01700959|11733939|FG005|Overall Study|Adverse Event|2
7446857|NCT01700959|11733934|FG000|Overall Study|Withdrawal by Subject|15
7446858|NCT01700959|11733935|FG001|Overall Study|Withdrawal by Subject|9
7446859|NCT01700959|11733936|FG002|Overall Study|Withdrawal by Subject|12
7446860|NCT01700959|11733937|FG003|Overall Study|Withdrawal by Subject|11
7446861|NCT01700959|11733938|FG004|Overall Study|Withdrawal by Subject|8
7446862|NCT01700959|11733939|FG005|Overall Study|Withdrawal by Subject|12
7446863|NCT01700959|11733934|FG000|Overall Study|Ineligible|2
7446864|NCT01700959|11733935|FG001|Overall Study|Ineligible|1
7446865|NCT01700959|11733936|FG002|Overall Study|Ineligible|2
7446866|NCT01700959|11733937|FG003|Overall Study|Ineligible|0
7446867|NCT01700959|11733938|FG004|Overall Study|Ineligible|0
7446868|NCT01700959|11733939|FG005|Overall Study|Ineligible|1
7446869|NCT01700959|11733934|FG000|Overall Study|Noncompliant|9
7446870|NCT01700959|11733935|FG001|Overall Study|Noncompliant|9
7446871|NCT01700959|11733936|FG002|Overall Study|Noncompliant|17
7446872|NCT01700959|11733937|FG003|Overall Study|Noncompliant|18
7446873|NCT01700959|11733938|FG004|Overall Study|Noncompliant|15
7446874|NCT01700959|11733939|FG005|Overall Study|Noncompliant|9
7446875|NCT01700959|11733934|FG000|Overall Study|Side effects|1
7446876|NCT01700959|11733935|FG001|Overall Study|Side effects|4
7446877|NCT01700959|11733936|FG002|Overall Study|Side effects|8
7446878|NCT01700959|11733937|FG003|Overall Study|Side effects|4
7446879|NCT01700959|11733938|FG004|Overall Study|Side effects|4
7446880|NCT01700959|11733939|FG005|Overall Study|Side effects|1
7446881|NCT01700985|11733957|FG000|Overall Study|Incarcerated|0
7446882|NCT01700985|11733958|FG001|Overall Study|Incarcerated|1
7446883|NCT01701063|11733995|FG000|Overall Study|Lost to Follow-up|0
7446884|NCT01701063|11733996|FG001|Overall Study|Lost to Follow-up|1
7446885|NCT01701063|11733997|FG002|Overall Study|Lost to Follow-up|0
7446886|NCT01701063|11733995|FG000|Overall Study|Withdrawal by Subject|0
7446887|NCT01701063|11733996|FG001|Overall Study|Withdrawal by Subject|0
7446888|NCT01701063|11733997|FG002|Overall Study|Withdrawal by Subject|1
7446889|NCT01701063|11733995|FG000|Overall Study|Other|0
7446890|NCT01701063|11733996|FG001|Overall Study|Other|0
7446891|NCT01701063|11733997|FG002|Overall Study|Other|1
7562592|NCT03235115|11931830|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
7562593|NCT03235115|11931831|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
7562594|NCT03235154|11931839|FG000|Overall Study|Withdrawal by Subject|1
7562595|NCT03235154|11931839|FG000|Overall Study|Adverse Event|1
7562596|NCT03235154|11931839|FG000|Overall Study|Lost to Follow-up|2
7574982|NCT03706040|11958324|FG004|Period A (Week 0 to Week 16)|Other|0
7574983|NCT03706040|11958325|FG005|Period A (Week 0 to Week 16)|Other|0
7574984|NCT03706040|11958326|FG006|Period A (Week 0 to Week 16)|Other|0
7574985|NCT03706040|11958320|FG000|Period B (Week 16 to Week 52)|Adverse Event|0
7574986|NCT03706040|11958321|FG001|Period B (Week 16 to Week 52)|Adverse Event|0
7574987|NCT03706040|11958322|FG002|Period B (Week 16 to Week 52)|Adverse Event|0
7574988|NCT03706040|11958323|FG003|Period B (Week 16 to Week 52)|Adverse Event|1
7574989|NCT03706040|11958324|FG004|Period B (Week 16 to Week 52)|Adverse Event|2
7574990|NCT03706040|11958325|FG005|Period B (Week 16 to Week 52)|Adverse Event|3
7574991|NCT03706040|11958326|FG006|Period B (Week 16 to Week 52)|Adverse Event|0
7574992|NCT03706040|11958320|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0
7574993|NCT03706040|11958321|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0
7574994|NCT03706040|11958322|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0
7574995|NCT03706040|11958323|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3
7574996|NCT03706040|11958324|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2
7574997|NCT03706040|11958325|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1
7574998|NCT03706040|11958326|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10
7574999|NCT03706040|11958320|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7575000|NCT03706040|11958321|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7575001|NCT03706040|11958322|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7575002|NCT03706040|11958323|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7575003|NCT03706040|11958324|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0
7575004|NCT03706040|11958325|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7575005|NCT03706040|11958326|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1
7575006|NCT03706040|11958320|FG000|Period B (Week 16 to Week 52)|Other|0
7575007|NCT03706040|11958321|FG001|Period B (Week 16 to Week 52)|Other|0
7446892|NCT01701193|11734036|FG000|Overall Study|Withdrawal by Subject|2
7446893|NCT01701193|11734037|FG001|Overall Study|Withdrawal by Subject|2
7446894|NCT01701193|11734038|FG002|Overall Study|Withdrawal by Subject|1
7446895|NCT01701193|11734039|FG003|Overall Study|Withdrawal by Subject|2
7446896|NCT01701193|11734036|FG000|Overall Study|Adverse Event|1
7446897|NCT01701193|11734037|FG001|Overall Study|Adverse Event|0
7446898|NCT01701193|11734038|FG002|Overall Study|Adverse Event|0
7446899|NCT01701193|11734039|FG003|Overall Study|Adverse Event|0
7446900|NCT01701245|11734054|FG000|Overall Study|Protocol Violation|1
7446901|NCT01701245|11734055|FG001|Overall Study|Protocol Violation|3
7446902|NCT01701245|11734054|FG000|Overall Study|Did not complete the open label period|11
7446903|NCT01701245|11734055|FG001|Overall Study|Did not complete the open label period|12
7446904|NCT01701258|11734065|FG000|Assessment and Scheduling|Found to be Ineligible|57
7446905|NCT01701258|11734066|FG001|Assessment and Scheduling|Found to be Ineligible|0
7446906|NCT01701258|11734067|FG002|Assessment and Scheduling|Found to be Ineligible|0
7446907|NCT01701258|11734068|FG003|Assessment and Scheduling|Found to be Ineligible|0
7446908|NCT01701258|11734069|FG004|Assessment and Scheduling|Found to be Ineligible|0
7446909|NCT01701258|11734070|FG005|Assessment and Scheduling|Found to be Ineligible|0
7446910|NCT01701258|11734071|FG006|Assessment and Scheduling|Found to be Ineligible|0
7446911|NCT01701258|11734072|FG007|Assessment and Scheduling|Found to be Ineligible|0
7446912|NCT01701258|11734073|FG008|Assessment and Scheduling|Found to be Ineligible|0
7446913|NCT01701258|11734074|FG009|Assessment and Scheduling|Found to be Ineligible|0
7446914|NCT01701258|11734075|FG010|Assessment and Scheduling|Found to be Ineligible|0
7446915|NCT01701258|11734076|FG011|Assessment and Scheduling|Found to be Ineligible|0
7446916|NCT01701258|11734077|FG012|Assessment and Scheduling|Found to be Ineligible|0
7446917|NCT01701258|11734065|FG000|Assessment and Scheduling|Lost to Follow-up|10
7446918|NCT01701258|11734066|FG001|Assessment and Scheduling|Lost to Follow-up|0
7446919|NCT01701258|11734067|FG002|Assessment and Scheduling|Lost to Follow-up|0
7446920|NCT01701258|11734068|FG003|Assessment and Scheduling|Lost to Follow-up|0
7446921|NCT01701258|11734069|FG004|Assessment and Scheduling|Lost to Follow-up|0
7446922|NCT01701258|11734070|FG005|Assessment and Scheduling|Lost to Follow-up|0
7446923|NCT01701258|11734071|FG006|Assessment and Scheduling|Lost to Follow-up|0
7446924|NCT01701258|11734072|FG007|Assessment and Scheduling|Lost to Follow-up|0
7446925|NCT01701258|11734073|FG008|Assessment and Scheduling|Lost to Follow-up|0
7446926|NCT01701258|11734074|FG009|Assessment and Scheduling|Lost to Follow-up|0
7446927|NCT01701258|11734075|FG010|Assessment and Scheduling|Lost to Follow-up|0
7446928|NCT01701258|11734076|FG011|Assessment and Scheduling|Lost to Follow-up|0
7446929|NCT01701258|11734077|FG012|Assessment and Scheduling|Lost to Follow-up|0
7446930|NCT01701258|11734065|FG000|Assessment and Scheduling|Withdrawal by Subject|14
7446931|NCT01701258|11734066|FG001|Assessment and Scheduling|Withdrawal by Subject|0
7446932|NCT01701258|11734067|FG002|Assessment and Scheduling|Withdrawal by Subject|0
7446933|NCT01701258|11734068|FG003|Assessment and Scheduling|Withdrawal by Subject|0
7446934|NCT01701258|11734069|FG004|Assessment and Scheduling|Withdrawal by Subject|0
7446935|NCT01701258|11734070|FG005|Assessment and Scheduling|Withdrawal by Subject|0
7446936|NCT01701258|11734071|FG006|Assessment and Scheduling|Withdrawal by Subject|0
7446937|NCT01701258|11734072|FG007|Assessment and Scheduling|Withdrawal by Subject|0
7446938|NCT01701258|11734073|FG008|Assessment and Scheduling|Withdrawal by Subject|0
7446939|NCT01701258|11734074|FG009|Assessment and Scheduling|Withdrawal by Subject|0
7446940|NCT01701258|11734075|FG010|Assessment and Scheduling|Withdrawal by Subject|0
7446941|NCT01701258|11734076|FG011|Assessment and Scheduling|Withdrawal by Subject|0
7446942|NCT01701258|11734077|FG012|Assessment and Scheduling|Withdrawal by Subject|0
7446943|NCT01701258|11734065|FG000|Assessment and Scheduling|Investigator Terminated|2
7446944|NCT01701258|11734066|FG001|Assessment and Scheduling|Investigator Terminated|0
7446945|NCT01701258|11734067|FG002|Assessment and Scheduling|Investigator Terminated|0
7446946|NCT01701258|11734068|FG003|Assessment and Scheduling|Investigator Terminated|0
7446947|NCT01701258|11734069|FG004|Assessment and Scheduling|Investigator Terminated|0
7446948|NCT01701258|11734070|FG005|Assessment and Scheduling|Investigator Terminated|0
7446949|NCT01701258|11734071|FG006|Assessment and Scheduling|Investigator Terminated|0
7446950|NCT01701258|11734072|FG007|Assessment and Scheduling|Investigator Terminated|0
7446951|NCT01701258|11734073|FG008|Assessment and Scheduling|Investigator Terminated|0
7446952|NCT01701258|11734074|FG009|Assessment and Scheduling|Investigator Terminated|0
7446953|NCT01701258|11734075|FG010|Assessment and Scheduling|Investigator Terminated|0
7446954|NCT01701258|11734076|FG011|Assessment and Scheduling|Investigator Terminated|0
7446955|NCT01701258|11734077|FG012|Assessment and Scheduling|Investigator Terminated|0
7446956|NCT01701362|11734112|FG000|Overall Study|Adverse events not related to study drug|1
7446957|NCT01701362|11734113|FG001|Overall Study|Adverse events not related to study drug|6
7446958|NCT01701362|11734112|FG000|Overall Study|Adverse events related to study drug|12
7446959|NCT01701362|11734113|FG001|Overall Study|Adverse events related to study drug|10
7446960|NCT01701362|11734112|FG000|Overall Study|Protocol Violation|5
7446961|NCT01701362|11734113|FG001|Overall Study|Protocol Violation|3
7446962|NCT01701362|11734112|FG000|Overall Study|No longer willing to participate|8
7446963|NCT01701362|11734113|FG001|Overall Study|No longer willing to participate|14
7446964|NCT01701362|11734112|FG000|Overall Study|Lost to Follow-up|6
7446965|NCT01701362|11734113|FG001|Overall Study|Lost to Follow-up|9
7446966|NCT01701362|11734112|FG000|Overall Study|Insufficient clinical response|6
7446967|NCT01701362|11734113|FG001|Overall Study|Insufficient clinical response|6
7446968|NCT01701362|11734112|FG000|Overall Study|Death|0
7446969|NCT01701362|11734113|FG001|Overall Study|Death|1
7446970|NCT01701362|11734112|FG000|Overall Study|Randomized but not treated|1
7446971|NCT01701362|11734113|FG001|Overall Study|Randomized but not treated|2
7446972|NCT01701362|11734112|FG000|Overall Study|Reasons other than those mentioned above|3
7446973|NCT01701362|11734113|FG001|Overall Study|Reasons other than those mentioned above|5
7446974|NCT01701401|11734127|FG000|Overall Study|Randomized But Not Treated|3
7446975|NCT01701401|11734128|FG001|Overall Study|Randomized But Not Treated|1
7446976|NCT01701401|11734129|FG002|Overall Study|Randomized But Not Treated|0
7446977|NCT01701401|11734130|FG003|Overall Study|Randomized But Not Treated|1
7446978|NCT01701401|11734127|FG000|Overall Study|Lost to Follow-up|5
7446979|NCT01701401|11734128|FG001|Overall Study|Lost to Follow-up|5
7446980|NCT01701401|11734129|FG002|Overall Study|Lost to Follow-up|1
7446981|NCT01701401|11734130|FG003|Overall Study|Lost to Follow-up|3
7446982|NCT01701401|11734127|FG000|Overall Study|Withdrew Consent|0
7446983|NCT01701401|11734128|FG001|Overall Study|Withdrew Consent|3
7446984|NCT01701401|11734129|FG002|Overall Study|Withdrew Consent|1
7446985|NCT01701401|11734130|FG003|Overall Study|Withdrew Consent|2
7446986|NCT01701401|11734127|FG000|Overall Study|Lack of Efficacy|1
7446987|NCT01701401|11734128|FG001|Overall Study|Lack of Efficacy|0
7446988|NCT01701401|11734129|FG002|Overall Study|Lack of Efficacy|2
7446989|NCT01701401|11734130|FG003|Overall Study|Lack of Efficacy|0
7446990|NCT01701401|11734127|FG000|Overall Study|Adverse Event|1
7446991|NCT01701401|11734128|FG001|Overall Study|Adverse Event|0
7446992|NCT01701401|11734129|FG002|Overall Study|Adverse Event|0
7446993|NCT01701401|11734130|FG003|Overall Study|Adverse Event|0
7446994|NCT01701401|11734127|FG000|Overall Study|Protocol Violation|0
7446995|NCT01701401|11734128|FG001|Overall Study|Protocol Violation|0
7446996|NCT01701401|11734129|FG002|Overall Study|Protocol Violation|1
7446997|NCT01701401|11734130|FG003|Overall Study|Protocol Violation|0
7446998|NCT01701973|11734177|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
7446999|NCT01701973|11734178|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
7447000|NCT01701973|11734179|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447001|NCT01701973|11734180|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447002|NCT01701973|11734181|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447003|NCT01701973|11734182|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447004|NCT01701973|11734183|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447005|NCT01701973|11734184|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
7447006|NCT01702025|11734237|FG000|Overall Study|Equipment failure|1
7447007|NCT01702025|11734238|FG001|Overall Study|Equipment failure|0
7447008|NCT01702025|11734239|FG002|Overall Study|Equipment failure|0
7447009|NCT01702025|11734240|FG003|Overall Study|Equipment failure|0
7447010|NCT01702025|11734237|FG000|Overall Study|Adverse Event|1
7447011|NCT01702025|11734238|FG001|Overall Study|Adverse Event|1
7447012|NCT01702025|11734239|FG002|Overall Study|Adverse Event|1
7447013|NCT01702025|11734240|FG003|Overall Study|Adverse Event|0
7447014|NCT01702246|11734268|FG000|Overall Study|Lost to Follow-up|2
7447015|NCT01702246|11734268|FG000|Overall Study|Withdrawal by Subject|2
7447016|NCT01702246|11734268|FG000|Overall Study|Physician Decision|1
7447017|NCT01702298|11734284|FG000|Overall Study|Withdrawal by Subject|1
7447018|NCT01702311|11734290|FG000|Overall Study|Withdrawal by Subject|3
7447019|NCT01702311|11734291|FG001|Overall Study|Withdrawal by Subject|2
7447020|NCT01702311|11734290|FG000|Overall Study|Discharge less than 24 hours|10
7447021|NCT01702311|11734291|FG001|Overall Study|Discharge less than 24 hours|7
7447022|NCT01702311|11734290|FG000|Overall Study|Physician Decision|3
7447023|NCT01702311|11734291|FG001|Overall Study|Physician Decision|4
7447024|NCT01702363|11734300|FG000|Overall Study|Adverse Event|14
7447025|NCT01702363|11734300|FG000|Overall Study|Lack of Efficacy|4
7447026|NCT01702363|11734300|FG000|Overall Study|Withdrawal by Subject|2
7447027|NCT01702428|11734309|FG000|Overall Study|Adverse Event|2
7447028|NCT01702428|11734310|FG001|Overall Study|Adverse Event|0
7447029|NCT01702428|11734311|FG002|Overall Study|Adverse Event|0
7447030|NCT01702428|11734312|FG003|Overall Study|Adverse Event|0
7447031|NCT01702428|11734309|FG000|Overall Study|Lost to Follow-up|33
7447032|NCT01702428|11734310|FG001|Overall Study|Lost to Follow-up|41
7447033|NCT01702428|11734311|FG002|Overall Study|Lost to Follow-up|37
7447034|NCT01702428|11734312|FG003|Overall Study|Lost to Follow-up|44
7447035|NCT01702428|11734309|FG000|Overall Study|Parents cannot assist to site|1
7447036|NCT01702428|11734310|FG001|Overall Study|Parents cannot assist to site|0
7447037|NCT01702428|11734311|FG002|Overall Study|Parents cannot assist to site|1
7447038|NCT01702428|11734312|FG003|Overall Study|Parents cannot assist to site|0
7447039|NCT01702428|11734309|FG000|Overall Study|Lost Coverage|0
7447040|NCT01702428|11734310|FG001|Overall Study|Lost Coverage|0
7447041|NCT01702428|11734311|FG002|Overall Study|Lost Coverage|0
7447042|NCT01702428|11734312|FG003|Overall Study|Lost Coverage|1
7447043|NCT01702428|11734309|FG000|Overall Study|Lost Health Plan|3
7447044|NCT01702428|11734310|FG001|Overall Study|Lost Health Plan|5
7447045|NCT01702428|11734311|FG002|Overall Study|Lost Health Plan|0
7447046|NCT01702428|11734312|FG003|Overall Study|Lost Health Plan|2
7447047|NCT01702428|11734309|FG000|Overall Study|Mother transferred care|0
7447048|NCT01702428|11734310|FG001|Overall Study|Mother transferred care|1
7447049|NCT01702428|11734311|FG002|Overall Study|Mother transferred care|0
7447050|NCT01702428|11734312|FG003|Overall Study|Mother transferred care|0
7447051|NCT01702428|11734309|FG000|Overall Study|Parents too busy|1
7447052|NCT01702428|11734310|FG001|Overall Study|Parents too busy|0
7447053|NCT01702428|11734311|FG002|Overall Study|Parents too busy|0
7447054|NCT01702428|11734312|FG003|Overall Study|Parents too busy|0
7447055|NCT01702428|11734309|FG000|Overall Study|Protocol Violation|3
7447056|NCT01702428|11734310|FG001|Overall Study|Protocol Violation|0
7447057|NCT01702428|11734311|FG002|Overall Study|Protocol Violation|1
7447058|NCT01702428|11734312|FG003|Overall Study|Protocol Violation|0
7447059|NCT01702428|11734309|FG000|Overall Study|Withdrawal by Subject|21
7447060|NCT01702428|11734310|FG001|Overall Study|Withdrawal by Subject|23
7447061|NCT01702428|11734311|FG002|Overall Study|Withdrawal by Subject|14
7447062|NCT01702428|11734312|FG003|Overall Study|Withdrawal by Subject|10
7447063|NCT01702454|11734331|FG000|Overall Study|Consent withdrawal|0
7447064|NCT01702454|11734332|FG001|Overall Study|Consent withdrawal|1
7447065|NCT01702454|11734331|FG000|Overall Study|Migrated/moved from study area|0
7447066|NCT01702454|11734332|FG001|Overall Study|Migrated/moved from study area|1
7447067|NCT01702454|11734331|FG000|Overall Study|Lost to Follow-up|3
7447068|NCT01702454|11734332|FG001|Overall Study|Lost to Follow-up|6
7447069|NCT01702519|11734343|FG000|Washout Period|Lost to Follow-up|1
7447070|NCT01702519|11734344|FG001|Washout Period|Lost to Follow-up|0
7447071|NCT01702519|11734343|FG000|Washout Period|Withdrawal by Subject|0
7447072|NCT01702519|11734344|FG001|Washout Period|Withdrawal by Subject|2
7447073|NCT01702532|11734356|FG000|Overall Study|Adverse Event|0
7447074|NCT01702532|11734357|FG001|Overall Study|Adverse Event|1
7447075|NCT01702558|11734369|FG000|Overall Study|Withdrawal by Subject|0
7447076|NCT01702558|11734370|FG001|Overall Study|Withdrawal by Subject|0
7447077|NCT01702558|11734371|FG002|Overall Study|Withdrawal by Subject|0
7447078|NCT01702558|11734372|FG003|Overall Study|Withdrawal by Subject|12
7447079|NCT01702558|11734373|FG004|Overall Study|Withdrawal by Subject|4
7447080|NCT01702558|11734369|FG000|Overall Study|Lost to Follow-up|0
7447081|NCT01702558|11734370|FG001|Overall Study|Lost to Follow-up|0
7447082|NCT01702558|11734371|FG002|Overall Study|Lost to Follow-up|0
7447083|NCT01702558|11734372|FG003|Overall Study|Lost to Follow-up|3
7447084|NCT01702558|11734373|FG004|Overall Study|Lost to Follow-up|0
7562597|NCT03235284|11931852|FG000|Overall Study|Adverse Event|1
7562598|NCT03235284|11931853|FG001|Overall Study|Adverse Event|2
7562599|NCT03235284|11931854|FG002|Overall Study|Adverse Event|1
7562600|NCT03235349|11931862|FG000|Overall Study|Adverse Event|1
7562601|NCT03235349|11931862|FG000|Overall Study|Other|1
7562602|NCT03235479|11931872|FG000|Overall Study|Lost to Follow-up|8
7562603|NCT03235479|11931873|FG001|Overall Study|Lost to Follow-up|11
7562604|NCT03235479|11931872|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
7562605|NCT03235479|11931873|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
7562606|NCT03235479|11931872|FG000|Overall Study|Pregnancy|1
7562607|NCT03235479|11931873|FG001|Overall Study|Pregnancy|0
7562608|NCT03235479|11931872|FG000|Overall Study|Protocol Deviation|1
7562609|NCT03235479|11931873|FG001|Overall Study|Protocol Deviation|3
7562610|NCT03235479|11931872|FG000|Overall Study|Technical Problems|3
7562611|NCT03235479|11931873|FG001|Overall Study|Technical Problems|2
7562612|NCT03235479|11931872|FG000|Overall Study|Withdrawal by Subject|2
7562613|NCT03235479|11931873|FG001|Overall Study|Withdrawal by Subject|2
7562614|NCT03235479|11931872|FG000|Overall Study|Other Reasons|3
7562615|NCT03235479|11931873|FG001|Overall Study|Other Reasons|5
7562616|NCT03235726|11931887|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562617|NCT03235726|11931888|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562618|NCT03235726|11931889|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562619|NCT03235726|11931890|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562620|NCT03235726|11931891|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
7562621|NCT03235726|11931892|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562622|NCT03235726|11931893|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562623|NCT03235726|11931894|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562624|NCT03235726|11931895|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562625|NCT03235726|11931896|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
7562626|NCT03235726|11931887|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562627|NCT03235726|11931888|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562628|NCT03235726|11931889|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562629|NCT03235726|11931890|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562701|NCT03237845|11932025|FG000|Overall Study|Lost to Follow-up|13
7562630|NCT03235726|11931891|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
7562631|NCT03235726|11931892|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562632|NCT03235726|11931893|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562633|NCT03235726|11931894|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562634|NCT03235726|11931895|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562635|NCT03235726|11931896|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
7562636|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
7562637|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
7562638|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
7562639|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
7562640|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
7562641|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
7562642|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Investigator Judgement|1
7562643|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Investigator Judgement|1
7562644|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
7447085|NCT01702558|11734369|FG000|Overall Study|Death|4
7447086|NCT01702558|11734370|FG001|Overall Study|Death|3
7447087|NCT01702558|11734371|FG002|Overall Study|Death|3
7447088|NCT01702558|11734372|FG003|Overall Study|Death|16
7447089|NCT01702558|11734373|FG004|Overall Study|Death|20
7447090|NCT01702558|11734369|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
7447091|NCT01702558|11734370|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
7562645|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
7562646|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
7562647|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
7562648|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Death|3
7562649|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Death|1
7562650|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Protocol Violation|0
7562651|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Protocol Violation|2
7562652|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Adverse Event|7
7562653|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Adverse Event|8
7562654|NCT03236246|11931937|FG000|24-Week Dose Titration Period|Captured as Other|1
7562655|NCT03236246|11931938|FG001|24-Week Dose Titration Period|Captured as Other|2
7562656|NCT03236246|11931937|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
7562657|NCT03236246|11931938|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
7562658|NCT03236246|11931937|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
7562659|NCT03236246|11931938|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
7562660|NCT03236246|11931937|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
7562661|NCT03236246|11931938|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
7562662|NCT03236246|11931937|FG000|24-Week Dose Maintenance Period|Death|0
7562663|NCT03236246|11931938|FG001|24-Week Dose Maintenance Period|Death|1
7562664|NCT03236246|11931937|FG000|24-Week Dose Maintenance Period|Adverse Event|0
7562665|NCT03236246|11931938|FG001|24-Week Dose Maintenance Period|Adverse Event|1
7562666|NCT03236506|11931947|FG000|Overall Study|Death|1
7562667|NCT03236506|11931948|FG001|Overall Study|Death|1
7562668|NCT03236506|11931949|FG002|Overall Study|Death|1
7562669|NCT03236506|11931947|FG000|Overall Study|Withdrawal by Subject|3
7562670|NCT03236506|11931948|FG001|Overall Study|Withdrawal by Subject|3
7562671|NCT03236506|11931949|FG002|Overall Study|Withdrawal by Subject|4
7562672|NCT03236506|11931947|FG000|Overall Study|Did not initiate treatment|2
7562673|NCT03236506|11931948|FG001|Overall Study|Did not initiate treatment|1
7562674|NCT03236506|11931949|FG002|Overall Study|Did not initiate treatment|2
7562675|NCT03236779|11931959|FG000|Overall Study|Lost to Follow-up|13
7562676|NCT03236779|11931960|FG001|Overall Study|Lost to Follow-up|21
7562677|NCT03237013|11931971|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
7562678|NCT03237013|11931972|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
7562679|NCT03237013|11931973|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
7562680|NCT03237065|11931983|FG000|Overall Study|Adverse Event|0
7562681|NCT03237065|11931984|FG001|Overall Study|Adverse Event|2
7562682|NCT03237065|11931983|FG000|Overall Study|Protocol Violation|0
7562683|NCT03237065|11931984|FG001|Overall Study|Protocol Violation|1
7562684|NCT03237065|11931983|FG000|Overall Study|Withdrawal by Subject|3
7562685|NCT03237065|11931984|FG001|Overall Study|Withdrawal by Subject|0
7562686|NCT03237065|11931983|FG000|Overall Study|Lost to Follow-up|1
7562687|NCT03237065|11931984|FG001|Overall Study|Lost to Follow-up|0
7562688|NCT03237065|11931983|FG000|Overall Study|Unable to obtain venous access|0
7562689|NCT03237065|11931984|FG001|Overall Study|Unable to obtain venous access|1
7562690|NCT03237481|11932013|FG000|Overall Study|Lost to Follow-up|1
7562691|NCT03237481|11932014|FG001|Overall Study|Lost to Follow-up|0
7562692|NCT03237481|11932015|FG002|Overall Study|Lost to Follow-up|0
7562693|NCT03237481|11932013|FG000|Overall Study|Protocol Violation|1
7562694|NCT03237481|11932014|FG001|Overall Study|Protocol Violation|0
7562695|NCT03237481|11932015|FG002|Overall Study|Protocol Violation|0
7562696|NCT03237481|11932013|FG000|Overall Study|Withdrawal by Subject|3
7562697|NCT03237481|11932014|FG001|Overall Study|Withdrawal by Subject|2
7562698|NCT03237481|11932015|FG002|Overall Study|Withdrawal by Subject|1
7562699|NCT03237845|11932025|FG000|Overall Study|Adverse Event|0
7562700|NCT03237845|11932026|FG001|Overall Study|Adverse Event|1
7562702|NCT03237845|11932026|FG001|Overall Study|Lost to Follow-up|10
7562703|NCT03237845|11932025|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
7562704|NCT03237845|11932026|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
7562705|NCT03237845|11932025|FG000|Overall Study|Non-Compliance With Study Treatment|0
7562706|NCT03237845|11932026|FG001|Overall Study|Non-Compliance With Study Treatment|1
7562707|NCT03237845|11932025|FG000|Overall Study|Physician Decision|1
7562708|NCT03237845|11932026|FG001|Overall Study|Physician Decision|2
7562709|NCT03237845|11932025|FG000|Overall Study|Pregnancy|1
7562710|NCT03237845|11932026|FG001|Overall Study|Pregnancy|0
7562711|NCT03237845|11932025|FG000|Overall Study|Protocol Deviation|0
7562712|NCT03237845|11932026|FG001|Overall Study|Protocol Deviation|1
7562713|NCT03237845|11932025|FG000|Overall Study|Technical Problems|8
7562714|NCT03237845|11932026|FG001|Overall Study|Technical Problems|1
7562715|NCT03237845|11932025|FG000|Overall Study|Withdrawal by Subject|3
7562716|NCT03237845|11932026|FG001|Overall Study|Withdrawal by Subject|3
7562717|NCT03237845|11932025|FG000|Overall Study|Other Reasons|4
7562718|NCT03237845|11932026|FG001|Overall Study|Other Reasons|0
7562719|NCT03238001|11932036|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
7562720|NCT03238001|11932036|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
7562721|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
7447092|NCT01702558|11734371|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
7447093|NCT01702558|11734372|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
7447094|NCT01702558|11734373|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
7447095|NCT01702558|11734369|FG000|Overall Study|Study Terminated by Sponsor|0
7447096|NCT01702558|11734370|FG001|Overall Study|Study Terminated by Sponsor|1
7447097|NCT01702558|11734371|FG002|Overall Study|Study Terminated by Sponsor|0
7447098|NCT01702558|11734372|FG003|Overall Study|Study Terminated by Sponsor|0
7562722|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
7447099|NCT01702558|11734373|FG004|Overall Study|Study Terminated by Sponsor|1
7447100|NCT01702558|11734369|FG000|Overall Study|Other|0
7447101|NCT01702558|11734370|FG001|Overall Study|Other|0
7447102|NCT01702558|11734371|FG002|Overall Study|Other|0
7447103|NCT01702558|11734372|FG003|Overall Study|Other|16
7447104|NCT01702558|11734373|FG004|Overall Study|Other|17
7447105|NCT01702844|11734386|FG000|Overall Study|Adverse Event|9
7447106|NCT01702844|11734386|FG000|Overall Study|Death|1
7447107|NCT01702844|11734386|FG000|Overall Study|Withdrawal by Subject|3
7447108|NCT01702844|11734386|FG000|Overall Study|Physician Decision|6
7447109|NCT01702961|11734390|FG000|Overall Study|Additional treatment|3
7447110|NCT01702961|11734390|FG000|Overall Study|Progressive disease|5
7447111|NCT01702961|11734390|FG000|Overall Study|Relapse|20
7447112|NCT01702961|11734390|FG000|Overall Study|Death|6
7447113|NCT01702961|11734390|FG000|Overall Study|Lost to Follow-up|2
7447114|NCT01702961|11734390|FG000|Overall Study|Ongoing|11
7467753|NCT01903811|11768229|FG000|Overall Study|No measurable disease|1
7467754|NCT01903811|11768230|FG001|Overall Study|No measurable disease|1
7467755|NCT01903811|11768229|FG000|Overall Study|Incomplete/discontinued prior therapy|1
7467756|NCT01903811|11768230|FG001|Overall Study|Incomplete/discontinued prior therapy|1
7467757|NCT01903811|11768229|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
7467758|NCT01903811|11768230|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
7467759|NCT01903811|11768229|FG000|Overall Study|Withdrawal by Subject|0
7467760|NCT01903811|11768230|FG001|Overall Study|Withdrawal by Subject|1
7467761|NCT01903837|11768243|FG000|Part A|Withdrawal by Subject|4
7467762|NCT01903837|11768244|FG001|Part A|Withdrawal by Subject|9
7467763|NCT01903837|11768245|FG002|Part A|Withdrawal by Subject|8
7467764|NCT01903837|11768246|FG003|Part A|Withdrawal by Subject|5
7467765|NCT01903837|11768243|FG000|Part A|Adverse Event|3
7467766|NCT01903837|11768244|FG001|Part A|Adverse Event|6
7467767|NCT01903837|11768245|FG002|Part A|Adverse Event|9
7467768|NCT01903837|11768246|FG003|Part A|Adverse Event|6
7467769|NCT01903837|11768243|FG000|Part A|Lost to Follow-up|9
7467770|NCT01903837|11768244|FG001|Part A|Lost to Follow-up|7
7467771|NCT01903837|11768245|FG002|Part A|Lost to Follow-up|7
7467772|NCT01903837|11768246|FG003|Part A|Lost to Follow-up|2
7467773|NCT01903837|11768243|FG000|Part A|Non-compliance with study drug|1
7467774|NCT01903837|11768244|FG001|Part A|Non-compliance with study drug|4
7467775|NCT01903837|11768245|FG002|Part A|Non-compliance with study drug|4
7467776|NCT01903837|11768246|FG003|Part A|Non-compliance with study drug|0
7467777|NCT01903837|11768243|FG000|Part A|Physician Decision|1
7467778|NCT01903837|11768244|FG001|Part A|Physician Decision|1
7467779|NCT01903837|11768245|FG002|Part A|Physician Decision|0
7467780|NCT01903837|11768246|FG003|Part A|Physician Decision|0
7467781|NCT01903837|11768243|FG000|Part A|Protocol Violation|1
7467782|NCT01903837|11768244|FG001|Part A|Protocol Violation|1
7467783|NCT01903837|11768245|FG002|Part A|Protocol Violation|0
7467784|NCT01903837|11768246|FG003|Part A|Protocol Violation|0
7467785|NCT01903837|11768243|FG000|Part B|Lost to Follow-up|0
7467786|NCT01903837|11768244|FG001|Part B|Lost to Follow-up|3
7467787|NCT01903837|11768245|FG002|Part B|Lost to Follow-up|3
7467788|NCT01903837|11768246|FG003|Part B|Lost to Follow-up|4
7467789|NCT01903837|11768243|FG000|Part B|Withdrawal by Subject|1
7467790|NCT01903837|11768244|FG001|Part B|Withdrawal by Subject|2
7467791|NCT01903837|11768245|FG002|Part B|Withdrawal by Subject|0
7467792|NCT01903837|11768246|FG003|Part B|Withdrawal by Subject|3
7467793|NCT01903837|11768243|FG000|Part B|Adverse Event|3
7467794|NCT01903837|11768244|FG001|Part B|Adverse Event|0
7467795|NCT01903837|11768245|FG002|Part B|Adverse Event|2
7467796|NCT01903837|11768246|FG003|Part B|Adverse Event|0
7467797|NCT01903837|11768243|FG000|Part B|Non-compliance with study drug|2
7467798|NCT01903837|11768244|FG001|Part B|Non-compliance with study drug|0
7467799|NCT01903837|11768245|FG002|Part B|Non-compliance with study drug|0
7467800|NCT01903837|11768246|FG003|Part B|Non-compliance with study drug|1
7467801|NCT01903837|11768243|FG000|Part B|Incarceration|2
7467802|NCT01903837|11768244|FG001|Part B|Incarceration|0
7467803|NCT01903837|11768245|FG002|Part B|Incarceration|0
7467804|NCT01903837|11768246|FG003|Part B|Incarceration|1
7467805|NCT01903837|11768243|FG000|Part B|Physician Decision|1
7467806|NCT01903837|11768244|FG001|Part B|Physician Decision|0
7467807|NCT01903837|11768245|FG002|Part B|Physician Decision|0
7467808|NCT01903837|11768246|FG003|Part B|Physician Decision|2
7467809|NCT01903837|11768243|FG000|Part B|Lack of Efficacy|0
7447115|NCT01702987|11734396|FG000|Overall Study|Withdrawal by Subject|1
7447116|NCT01702987|11734397|FG001|Overall Study|Withdrawal by Subject|0
7447117|NCT01703000|11734403|FG000|Overall Study|Death|1
7447118|NCT01703065|11734420|FG000|Overall Study|Lack of Efficacy|1
7447119|NCT01703065|11734421|FG001|Overall Study|Lack of Efficacy|0
7447120|NCT01703091|11734430|FG000|Overall Study|Adverse Event|5
7447121|NCT01703091|11734431|FG001|Overall Study|Adverse Event|3
7447122|NCT01703091|11734430|FG000|Overall Study|Physician Decision|2
7447123|NCT01703091|11734431|FG001|Overall Study|Physician Decision|1
7447124|NCT01703091|11734430|FG000|Overall Study|Withdrawal by Subject|1
7447125|NCT01703091|11734431|FG001|Overall Study|Withdrawal by Subject|0
7447126|NCT01703091|11734430|FG000|Overall Study|Sponsor Decision|1
7447127|NCT01703091|11734431|FG001|Overall Study|Sponsor Decision|0
7447128|NCT01703117|11734439|FG000|Overall Study|Adverse Event|4
7447129|NCT01703117|11734440|FG001|Overall Study|Adverse Event|3
7447130|NCT01703117|11734439|FG000|Overall Study|Withdrawal by Subject|0
7447131|NCT01703117|11734440|FG001|Overall Study|Withdrawal by Subject|1
7447132|NCT01703208|11734454|FG000|Overall Study|Death|61
7447133|NCT01703208|11734455|FG001|Overall Study|Death|48
7447134|NCT01703208|11734454|FG000|Overall Study|Lack of Efficacy|1
7447135|NCT01703208|11734455|FG001|Overall Study|Lack of Efficacy|2
7447136|NCT01703208|11734454|FG000|Overall Study|Lost to Follow-up|68
7447137|NCT01703208|11734455|FG001|Overall Study|Lost to Follow-up|62
7447138|NCT01703208|11734454|FG000|Overall Study|Non-Compliance with Study Drug|1
7447139|NCT01703208|11734455|FG001|Overall Study|Non-Compliance with Study Drug|0
7447140|NCT01703208|11734454|FG000|Overall Study|Excluded Medication|1
7447141|NCT01703208|11734455|FG001|Overall Study|Excluded Medication|2
7447142|NCT01703208|11734454|FG000|Overall Study|Site Discontinued Study Participation|23
7447143|NCT01703208|11734455|FG001|Overall Study|Site Discontinued Study Participation|27
7447144|NCT01703208|11734454|FG000|Overall Study|Physician Decision|11
7447145|NCT01703208|11734455|FG001|Overall Study|Physician Decision|13
7447146|NCT01703208|11734454|FG000|Overall Study|Progressive disease|2
7562723|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
7562724|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
7562725|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
7562726|NCT03238001|11932036|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
7562727|NCT03238352|11932051|FG000|Overall Study|Lost to Follow-up|0
7562728|NCT03238352|11932052|FG001|Overall Study|Lost to Follow-up|2
7562729|NCT03238352|11932053|FG002|Overall Study|Lost to Follow-up|1
7562730|NCT03238352|11932051|FG000|Overall Study|Withdrawal by Subject|0
7562731|NCT03238352|11932052|FG001|Overall Study|Withdrawal by Subject|1
7562732|NCT03238352|11932053|FG002|Overall Study|Withdrawal by Subject|0
7562733|NCT03238417|11932063|FG000|Overall|non-response|955
7562734|NCT03238417|11932064|FG001|Overall|non-response|1920
7562735|NCT03238417|11932063|FG000|Overall|partial completion|48
7225160|NCT00064701|11434642|FG000|One Year Post-transplant|Rejection|0
7225161|NCT00064701|11434643|FG001|One Year Post-transplant|Rejection|1
7225162|NCT00064701|11434644|FG002|One Year Post-transplant|Rejection|16
7225163|NCT00064701|11434642|FG000|One Year Post-transplant|Non-compliance|4
7225164|NCT00064701|11434643|FG001|One Year Post-transplant|Non-compliance|2
7562736|NCT03238417|11932064|FG001|Overall|partial completion|68
7562737|NCT03238417|11932063|FG000|Baseline|Partial completion|17
7562738|NCT03238417|11932064|FG001|Baseline|Partial completion|48
7562739|NCT03238417|11932063|FG000|Baseline|non-response|372
7562740|NCT03238417|11932064|FG001|Baseline|non-response|669
7562741|NCT03238417|11932063|FG000|12-month|non-response|296
7562742|NCT03238417|11932064|FG001|12-month|non-response|669
7562743|NCT03238417|11932063|FG000|12-month|partial completion|23
7562744|NCT03238417|11932064|FG001|12-month|partial completion|37
7562745|NCT03238417|11932063|FG000|24-month|non-response|287
7562746|NCT03238417|11932064|FG001|24-month|non-response|594
7562747|NCT03238417|11932063|FG000|24-month|partial completion|8
7562748|NCT03238417|11932064|FG001|24-month|partial completion|31
7562749|NCT03238651|11932075|FG000|Overall Study|Other|0
7562750|NCT03238651|11932076|FG001|Overall Study|Other|0
7562751|NCT03238651|11932077|FG002|Overall Study|Other|0
7447147|NCT01703208|11734455|FG001|Overall Study|Progressive disease|2
7447148|NCT01703208|11734454|FG000|Overall Study|Protocol Violation|1
7447149|NCT01703208|11734455|FG001|Overall Study|Protocol Violation|1
7447150|NCT01703208|11734454|FG000|Overall Study|Study Terminated by Sponsor|1710
7562752|NCT03238651|11932078|FG003|Overall Study|Other|0
7562753|NCT03238651|11932079|FG004|Overall Study|Other|1
7562754|NCT03238651|11932075|FG000|Overall Study|Progressive Disease|2
7562755|NCT03238651|11932076|FG001|Overall Study|Progressive Disease|2
7562756|NCT03238651|11932077|FG002|Overall Study|Progressive Disease|2
7562757|NCT03238651|11932078|FG003|Overall Study|Progressive Disease|2
7562758|NCT03238651|11932079|FG004|Overall Study|Progressive Disease|0
7562759|NCT03238651|11932075|FG000|Overall Study|Withdrawal by Subject|0
7562760|NCT03238651|11932076|FG001|Overall Study|Withdrawal by Subject|1
7225165|NCT00064701|11434644|FG002|One Year Post-transplant|Non-compliance|5
7447151|NCT01703208|11734455|FG001|Overall Study|Study Terminated by Sponsor|1716
7447152|NCT01703208|11734454|FG000|Overall Study|Withdrawal by Subject|205
7447153|NCT01703208|11734455|FG001|Overall Study|Withdrawal by Subject|209
7447154|NCT01703208|11734454|FG000|Overall Study|Adverse Event|14
7447155|NCT01703208|11734455|FG001|Overall Study|Adverse Event|19
7562761|NCT03238651|11932077|FG002|Overall Study|Withdrawal by Subject|0
7447156|NCT01703208|11734454|FG000|Overall Study|Technical Problems|0
7447157|NCT01703208|11734455|FG001|Overall Study|Technical Problems|1
7562762|NCT03238651|11932078|FG003|Overall Study|Withdrawal by Subject|1
7562763|NCT03238651|11932079|FG004|Overall Study|Withdrawal by Subject|0
7562764|NCT03238651|11932075|FG000|Overall Study|Adverse Event|1
7562765|NCT03238651|11932076|FG001|Overall Study|Adverse Event|3
7562766|NCT03238651|11932077|FG002|Overall Study|Adverse Event|2
7562767|NCT03238651|11932078|FG003|Overall Study|Adverse Event|0
7562768|NCT03238651|11932079|FG004|Overall Study|Adverse Event|0
7562769|NCT03238781|11932095|FG000|Overall Study|Adverse Event|1
7562770|NCT03238781|11932096|FG001|Overall Study|Adverse Event|1
7562771|NCT03238781|11932097|FG002|Overall Study|Adverse Event|2
7562772|NCT03238781|11932095|FG000|Overall Study|Lost to Follow-up|2
7562773|NCT03238781|11932096|FG001|Overall Study|Lost to Follow-up|1
7562774|NCT03238781|11932097|FG002|Overall Study|Lost to Follow-up|2
7562775|NCT03238781|11932095|FG000|Overall Study|Withdrawal by Subject|23
7562776|NCT03238781|11932096|FG001|Overall Study|Withdrawal by Subject|14
7562777|NCT03238781|11932097|FG002|Overall Study|Withdrawal by Subject|16
7562778|NCT03238781|11932095|FG000|Overall Study|Decision by sponsor|0
7562779|NCT03238781|11932096|FG001|Overall Study|Decision by sponsor|1
7562780|NCT03238781|11932097|FG002|Overall Study|Decision by sponsor|0
7562781|NCT03238911|11932107|FG000|Overall Study|Withdrawal by Subject|1
7562782|NCT03238911|11932108|FG001|Overall Study|Withdrawal by Subject|2
7562783|NCT03238911|11932107|FG000|Overall Study|Lost to Follow-up|2
7562784|NCT03238911|11932108|FG001|Overall Study|Lost to Follow-up|1
7562785|NCT03238924|11932117|FG000|Overall Study|Withdrawal by Subject|2
7562786|NCT03238924|11932118|FG001|Overall Study|Withdrawal by Subject|2
7562787|NCT03238963|11932126|FG000|Overall Study|Prohibited medication given due to hospital stay|1
7562788|NCT03238963|11932127|FG001|Overall Study|Prohibited medication given due to hospital stay|0
7562789|NCT03238963|11932126|FG000|Overall Study|Withdrawal by Subject|1
7562790|NCT03238963|11932127|FG001|Overall Study|Withdrawal by Subject|1
7562791|NCT03238963|11932126|FG000|Overall Study|Lost to Follow-up|1
7562792|NCT03238963|11932127|FG001|Overall Study|Lost to Follow-up|0
7562793|NCT03238963|11932126|FG000|Overall Study|Protocol Violation|1
7562794|NCT03238963|11932127|FG001|Overall Study|Protocol Violation|1
7562795|NCT03238963|11932126|FG000|Overall Study|Adverse Event|1
7562796|NCT03238963|11932127|FG001|Overall Study|Adverse Event|0
7562797|NCT03239470|11932138|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
7562798|NCT03239470|11932139|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
7562799|NCT03239483|11932145|FG000|Overall Study|Lost to Follow-up|1
7562800|NCT03239483|11932146|FG001|Overall Study|Lost to Follow-up|0
7562801|NCT03239483|11932145|FG000|Overall Study|Withdrawal by Subject|1
7562802|NCT03239483|11932146|FG001|Overall Study|Withdrawal by Subject|0
7562803|NCT03239873|11932199|FG000|Overall Study|Lost to Follow-up|15
7562804|NCT03239873|11932200|FG001|Overall Study|Lost to Follow-up|16
7562805|NCT03239873|11932199|FG000|Overall Study|Physician Decision|1
7562806|NCT03239873|11932200|FG001|Overall Study|Physician Decision|0
7562807|NCT03239873|11932199|FG000|Overall Study|Withdrawal by Parent/Guardian|12
7562808|NCT03239873|11932200|FG001|Overall Study|Withdrawal by Parent/Guardian|11
7562809|NCT03239873|11932199|FG000|Overall Study|Withdrawal by Subject|2
7562810|NCT03239873|11932200|FG001|Overall Study|Withdrawal by Subject|0
7562811|NCT03239873|11932199|FG000|Overall Study|Contraindication to study medication|1
7562812|NCT03239873|11932200|FG001|Overall Study|Contraindication to study medication|0
7562813|NCT03239873|11932199|FG000|Overall Study|Protocol Violation|1
7562814|NCT03239873|11932200|FG001|Overall Study|Protocol Violation|0
7562815|NCT03240081|11932208|FG000|Overall Study|Withdrawal by Subject|0
7562816|NCT03240081|11932209|FG001|Overall Study|Withdrawal by Subject|2
7562817|NCT03240081|11932208|FG000|Overall Study|Lost to Follow-up|0
7562818|NCT03240081|11932209|FG001|Overall Study|Lost to Follow-up|1
7562819|NCT03240133|11932218|FG000|Overall Study|Withdrawal by Subject|0
7562820|NCT03240133|11932219|FG001|Overall Study|Withdrawal by Subject|1
7562821|NCT03240133|11932220|FG002|Overall Study|Withdrawal by Subject|0
7562822|NCT03240133|11932218|FG000|Overall Study|Adverse Event|1
7562823|NCT03240133|11932219|FG001|Overall Study|Adverse Event|1
7562824|NCT03240133|11932220|FG002|Overall Study|Adverse Event|0
7562825|NCT03240133|11932218|FG000|Overall Study|Rash|1
7562826|NCT03240133|11932219|FG001|Overall Study|Rash|0
7562827|NCT03240133|11932220|FG002|Overall Study|Rash|0
7562950|NCT03244618|11932462|FG001|Overall Study|Protocol Violation|3
7562828|NCT03240133|11932218|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
7562829|NCT03240133|11932219|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
7562830|NCT03240133|11932220|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
7562831|NCT03240133|11932218|FG000|Overall Study|Intercurrent illness.|0
7562832|NCT03240133|11932219|FG001|Overall Study|Intercurrent illness.|1
7562833|NCT03240133|11932220|FG002|Overall Study|Intercurrent illness.|0
7562834|NCT03240133|11932218|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7562835|NCT03240133|11932219|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
7562836|NCT03240133|11932220|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
7562837|NCT03240575|11932248|FG000|Overall Study|Adverse Event|0
7562838|NCT03240575|11932249|FG001|Overall Study|Adverse Event|2
7562839|NCT03240575|11932250|FG002|Overall Study|Adverse Event|0
7562840|NCT03240575|11932251|FG003|Overall Study|Adverse Event|1
7447158|NCT01703208|11734454|FG000|Overall Study|Protocol Deviation|2
7447159|NCT01703208|11734455|FG001|Overall Study|Protocol Deviation|0
7447160|NCT01703221|11734464|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
7447161|NCT01703221|11734465|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
7447162|NCT01703221|11734466|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
7447163|NCT01703221|11734464|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
7447164|NCT01703221|11734465|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
7447165|NCT01703221|11734466|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
7447166|NCT01703221|11734464|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
7447167|NCT01703221|11734465|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
7447168|NCT01703221|11734466|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
7447169|NCT01703221|11734464|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
7447170|NCT01703221|11734465|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
7447171|NCT01703221|11734466|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
7447172|NCT01703221|11734464|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
7447173|NCT01703221|11734465|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
7447174|NCT01703221|11734466|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
7447175|NCT01703221|11734464|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
7447176|NCT01703221|11734465|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
7447177|NCT01703221|11734466|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
7447178|NCT01703221|11734464|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
7447179|NCT01703221|11734465|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
7562841|NCT03240575|11932248|FG000|Overall Study|Withdrawal by Subject|2
7562842|NCT03240575|11932249|FG001|Overall Study|Withdrawal by Subject|11
7562843|NCT03240575|11932250|FG002|Overall Study|Withdrawal by Subject|0
7562844|NCT03240575|11932251|FG003|Overall Study|Withdrawal by Subject|1
7562845|NCT03240575|11932248|FG000|Overall Study|Other|0
7562846|NCT03240575|11932249|FG001|Overall Study|Other|1
7562847|NCT03240575|11932250|FG002|Overall Study|Other|0
7562848|NCT03240575|11932251|FG003|Overall Study|Other|0
7562849|NCT03241342|11932271|FG000|Overall Study|Adverse Event|5
7562850|NCT03241342|11932272|FG001|Overall Study|Adverse Event|8
7562851|NCT03241342|11932273|FG002|Overall Study|Adverse Event|4
7562852|NCT03241342|11932271|FG000|Overall Study|Lack of Efficacy|0
7562853|NCT03241342|11932272|FG001|Overall Study|Lack of Efficacy|0
7562854|NCT03241342|11932273|FG002|Overall Study|Lack of Efficacy|1
7562855|NCT03241342|11932271|FG000|Overall Study|noncompliance with study drug|2
7562856|NCT03241342|11932272|FG001|Overall Study|noncompliance with study drug|1
7562857|NCT03241342|11932273|FG002|Overall Study|noncompliance with study drug|1
7562858|NCT03241342|11932271|FG000|Overall Study|sponsor decision|0
7562859|NCT03241342|11932272|FG001|Overall Study|sponsor decision|1
7562860|NCT03241342|11932273|FG002|Overall Study|sponsor decision|2
7562861|NCT03241342|11932271|FG000|Overall Study|not reported|15
7562862|NCT03241342|11932272|FG001|Overall Study|not reported|21
7562863|NCT03241342|11932273|FG002|Overall Study|not reported|19
7562864|NCT03241368|11932281|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
7562865|NCT03241368|11932281|FG000|Overall Study|Lost to Follow-up|1
7562866|NCT03241368|11932281|FG000|Overall Study|Physician Decision|6
7562867|NCT03241368|11932281|FG000|Overall Study|Withdrawal by Subject|6
7562868|NCT03241368|11932281|FG000|Overall Study|Protocol Violation|1
7562869|NCT03241927|11932313|FG000|Overall Study|study terminated|1
7562870|NCT03241927|11932314|FG001|Overall Study|study terminated|0
7562871|NCT03242018|11932323|FG000|Overall Study|Adverse Event|7
7562872|NCT03242018|11932324|FG001|Overall Study|Adverse Event|7
7562873|NCT03242018|11932325|FG002|Overall Study|Adverse Event|6
7562874|NCT03242018|11932323|FG000|Overall Study|Lost to Follow-up|2
7562875|NCT03242018|11932324|FG001|Overall Study|Lost to Follow-up|2
7562876|NCT03242018|11932325|FG002|Overall Study|Lost to Follow-up|2
7562877|NCT03242018|11932323|FG000|Overall Study|At the Participant's Own Request|5
7562878|NCT03242018|11932324|FG001|Overall Study|At the Participant's Own Request|1
7562879|NCT03242018|11932325|FG002|Overall Study|At the Participant's Own Request|4
7562880|NCT03242018|11932323|FG000|Overall Study|Reason Not Specified|3
7562881|NCT03242018|11932324|FG001|Overall Study|Reason Not Specified|4
7562882|NCT03242018|11932325|FG002|Overall Study|Reason Not Specified|1
7562883|NCT03242018|11932323|FG000|Overall Study|Study Terminated by Sponsor|1
7562884|NCT03242018|11932324|FG001|Overall Study|Study Terminated by Sponsor|0
7562885|NCT03242018|11932325|FG002|Overall Study|Study Terminated by Sponsor|1
7562886|NCT03242252|11932341|FG000|Overall Study|At the Participant's own Request|18
7562887|NCT03242252|11932342|FG001|Overall Study|At the Participant's own Request|10
7447180|NCT01703221|11734466|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
7447181|NCT01703221|11734464|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
7447182|NCT01703221|11734465|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
7562888|NCT03242252|11932343|FG002|Overall Study|At the Participant's own Request|15
7562889|NCT03242252|11932341|FG000|Overall Study|Adverse Event|8
7562890|NCT03242252|11932342|FG001|Overall Study|Adverse Event|6
7562891|NCT03242252|11932343|FG002|Overall Study|Adverse Event|9
7562892|NCT03242252|11932341|FG000|Overall Study|Poor Compliance to Protocol|0
7562893|NCT03242252|11932342|FG001|Overall Study|Poor Compliance to Protocol|2
7562894|NCT03242252|11932343|FG002|Overall Study|Poor Compliance to Protocol|3
7562895|NCT03242252|11932341|FG000|Overall Study|Study Terminated by Sponsor|1
7562896|NCT03242252|11932342|FG001|Overall Study|Study Terminated by Sponsor|0
7562897|NCT03242252|11932343|FG002|Overall Study|Study Terminated by Sponsor|0
7447183|NCT01703221|11734466|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
7447184|NCT01703260|11734483|FG000|Overall Study|Adverse Event|1
7447185|NCT01703260|11734484|FG001|Overall Study|Adverse Event|2
7447186|NCT01703260|11734485|FG002|Overall Study|Adverse Event|2
7447187|NCT01703260|11734483|FG000|Overall Study|Lost to Follow-up|1
7447188|NCT01703260|11734484|FG001|Overall Study|Lost to Follow-up|0
7447189|NCT01703260|11734485|FG002|Overall Study|Lost to Follow-up|0
7447190|NCT01703260|11734483|FG000|Overall Study|Withdrawal by Subject|0
7447191|NCT01703260|11734484|FG001|Overall Study|Withdrawal by Subject|0
7447192|NCT01703260|11734485|FG002|Overall Study|Withdrawal by Subject|1
7447193|NCT01703260|11734483|FG000|Overall Study|Study Termination|1
7447194|NCT01703260|11734484|FG001|Overall Study|Study Termination|2
7447195|NCT01703260|11734485|FG002|Overall Study|Study Termination|0
7447196|NCT01703286|11734493|FG000|Period 1 Including Washout|Withdrawal by Subject|0
7447197|NCT01703286|11734494|FG001|Period 1 Including Washout|Withdrawal by Subject|0
7447198|NCT01703286|11734495|FG002|Period 1 Including Washout|Withdrawal by Subject|0
7447199|NCT01703286|11734496|FG003|Period 1 Including Washout|Withdrawal by Subject|1
7447200|NCT01703286|11734497|FG004|Period 1 Including Washout|Withdrawal by Subject|0
7562898|NCT03242252|11932341|FG000|Overall Study|Reason not Specified|4
7562899|NCT03242252|11932342|FG001|Overall Study|Reason not Specified|4
7562900|NCT03242252|11932343|FG002|Overall Study|Reason not Specified|1
7562901|NCT03242252|11932341|FG000|Overall Study|Lost to Follow-up|5
7562902|NCT03242252|11932342|FG001|Overall Study|Lost to Follow-up|1
7562903|NCT03242252|11932343|FG002|Overall Study|Lost to Follow-up|4
7562904|NCT03242434|11932363|FG000|Overall Study|Death|0
7562905|NCT03242434|11932364|FG001|Overall Study|Death|2
7562906|NCT03242759|11932377|FG000|Overall Study|Adverse Event|5
7562907|NCT03242759|11932378|FG001|Overall Study|Adverse Event|1
7562908|NCT03242759|11932377|FG000|Overall Study|Withdrawal by Subject|4
7562909|NCT03242759|11932378|FG001|Overall Study|Withdrawal by Subject|3
7562910|NCT03242759|11932377|FG000|Overall Study|Lost to Follow-up|3
7562911|NCT03242759|11932378|FG001|Overall Study|Lost to Follow-up|1
7562912|NCT03242759|11932377|FG000|Overall Study|Administrative problems|1
7562913|NCT03242759|11932378|FG001|Overall Study|Administrative problems|1
7562914|NCT03242759|11932377|FG000|Overall Study|Death|22
7562915|NCT03242759|11932378|FG001|Overall Study|Death|0
7562916|NCT03242759|11932377|FG000|Overall Study|Change visit schedule|0
7562917|NCT03242759|11932378|FG001|Overall Study|Change visit schedule|1
7562918|NCT03242863|11932384|FG000|Study Week 1|Withdrawal by Subject|0
7562919|NCT03242863|11932385|FG001|Study Week 1|Withdrawal by Subject|1
7562920|NCT03242863|11932386|FG002|Study Week 1|Withdrawal by Subject|0
7562921|NCT03242863|11932387|FG003|Study Week 1|Withdrawal by Subject|0
7562922|NCT03242863|11932388|FG004|Study Week 1|Withdrawal by Subject|3
7562923|NCT03242863|11932389|FG005|Study Week 1|Withdrawal by Subject|0
7562924|NCT03242928|11932399|FG000|Overall Study|Adverse Event|2
7562925|NCT03242928|11932400|FG001|Overall Study|Adverse Event|1
7562926|NCT03242928|11932399|FG000|Overall Study|Lost to Follow-up|2
7562927|NCT03242928|11932400|FG001|Overall Study|Lost to Follow-up|0
7562928|NCT03242928|11932399|FG000|Overall Study|Physician Decision|0
7562929|NCT03242928|11932400|FG001|Overall Study|Physician Decision|1
7562930|NCT03242928|11932399|FG000|Overall Study|Withdrawal by Subject|5
7562931|NCT03242928|11932400|FG001|Overall Study|Withdrawal by Subject|3
7562932|NCT03243084|11932430|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
7562933|NCT03243084|11932431|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
7562934|NCT03243305|11932438|FG000|Overall Study|Lost to Follow-up|250
7562935|NCT03243305|11932438|FG000|Overall Study|Withdrawal by Subject|170
7562936|NCT03243305|11932438|FG000|Overall Study|Pregnancy|104
7562937|NCT03243305|11932438|FG000|Overall Study|Non-Compliance with Study Drug|38
7562938|NCT03243305|11932438|FG000|Overall Study|Adverse Event|23
7562939|NCT03243305|11932438|FG000|Overall Study|No sexually active|26
7562940|NCT03243305|11932438|FG000|Overall Study|Physician Decision|22
7562941|NCT03243305|11932438|FG000|Overall Study|Protocol Violation|22
7562942|NCT03243305|11932438|FG000|Overall Study|Study method no longer primary method|12
7562943|NCT03243305|11932438|FG000|Overall Study|Study Terminated by Sponsor|1
7562944|NCT03243305|11932438|FG000|Overall Study|Early terminations|267
7562945|NCT03243630|11932442|FG000|Overall Study|Protocol Violation|1
7562946|NCT03243630|11932442|FG000|Overall Study|Physician Decision|1
7562947|NCT03244618|11932461|FG000|Overall Study|Lost to Follow-up|3
7562948|NCT03244618|11932462|FG001|Overall Study|Lost to Follow-up|4
7562949|NCT03244618|11932461|FG000|Overall Study|Protocol Violation|4
7562951|NCT03244618|11932461|FG000|Overall Study|Withdrawal by Subject|0
7562952|NCT03244618|11932462|FG001|Overall Study|Withdrawal by Subject|2
7562953|NCT03244800|11932472|FG000|Overall Study|Adverse Event|0
7562954|NCT03244800|11932473|FG001|Overall Study|Adverse Event|1
7562955|NCT03244800|11932474|FG002|Overall Study|Adverse Event|0
7562956|NCT03244800|11932475|FG003|Overall Study|Adverse Event|1
7562957|NCT03244800|11932472|FG000|Overall Study|Withdrew treatment|0
7562958|NCT03244800|11932473|FG001|Overall Study|Withdrew treatment|0
7562959|NCT03244800|11932474|FG002|Overall Study|Withdrew treatment|0
7562960|NCT03244800|11932475|FG003|Overall Study|Withdrew treatment|1
7447201|NCT01703286|11734498|FG005|Period 1 Including Washout|Withdrawal by Subject|1
7447202|NCT01703286|11734493|FG000|Period 2 Including Washout|Adverse Event|0
7562961|NCT03244917|11932494|FG000|Overall Study|Lost to Follow-up|2
7562962|NCT03244917|11932495|FG001|Overall Study|Lost to Follow-up|2
7447203|NCT01703286|11734494|FG001|Period 2 Including Washout|Adverse Event|0
7447204|NCT01703286|11734495|FG002|Period 2 Including Washout|Adverse Event|0
7447205|NCT01703286|11734496|FG003|Period 2 Including Washout|Adverse Event|1
7447206|NCT01703286|11734497|FG004|Period 2 Including Washout|Adverse Event|0
7447207|NCT01703286|11734498|FG005|Period 2 Including Washout|Adverse Event|0
7447208|NCT01703741|11734543|FG000|Overall Study|Withdrawal by Subject|6
7562963|NCT03245398|11932512|FG000|Overall Study|Travelled to another island|1
7562964|NCT03245398|11932513|FG001|Overall Study|Travelled to another island|0
7562965|NCT03245619|11932547|FG000|Part A (Up to Day 22)|Physician Decision|4
7562966|NCT03245619|11932548|FG001|Part A (Up to Day 22)|Physician Decision|6
7562967|NCT03245619|11932549|FG002|Part A (Up to Day 22)|Physician Decision|6
7562968|NCT03245619|11932550|FG003|Part A (Up to Day 22)|Physician Decision|0
7562969|NCT03245619|11932551|FG004|Part A (Up to Day 22)|Physician Decision|0
7562970|NCT03245619|11932552|FG005|Part A (Up to Day 22)|Physician Decision|0
7562971|NCT03245619|11932553|FG006|Part A (Up to Day 22)|Physician Decision|0
7562972|NCT03245619|11932554|FG007|Part A (Up to Day 22)|Physician Decision|0
7562973|NCT03245619|11932555|FG008|Part A (Up to Day 22)|Physician Decision|0
7562974|NCT03245619|11932556|FG009|Part A (Up to Day 22)|Physician Decision|0
7562975|NCT03245619|11932557|FG010|Part A (Up to Day 22)|Physician Decision|0
7562976|NCT03245619|11932558|FG011|Part A (Up to Day 22)|Physician Decision|0
7562977|NCT03245619|11932559|FG012|Part A (Up to Day 22)|Physician Decision|0
7562978|NCT03245619|11932560|FG013|Part A (Up to Day 22)|Physician Decision|0
7562979|NCT03245619|11932561|FG014|Part A (Up to Day 22)|Physician Decision|0
7562980|NCT03245619|11932562|FG015|Part A (Up to Day 22)|Physician Decision|0
7562981|NCT03245619|11932563|FG016|Part A (Up to Day 22)|Physician Decision|0
7562982|NCT03245723|11932624|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
7562983|NCT03245723|11932625|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
7562984|NCT03245723|11932624|FG000|Overall Study|Claustrophobia from wearing the mask|1
7562985|NCT03245723|11932625|FG001|Overall Study|Claustrophobia from wearing the mask|0
7562986|NCT03245723|11932624|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
7562987|NCT03245723|11932625|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
7562988|NCT03245723|11932624|FG000|Overall Study|Image acquisition/reconstruction failure|1
7562989|NCT03245723|11932625|FG001|Overall Study|Image acquisition/reconstruction failure|1
7562990|NCT03245736|11932631|FG000|Overall Study|Adverse Event|1
7562991|NCT03245736|11932631|FG000|Overall Study|Progressive Disease|4
7562994|NCT03246152|11932655|FG000|Overall Study|Lost to Follow-up|2
7562995|NCT03246152|11932655|FG000|Overall Study|Protocol Violation|1
7562996|NCT03246646|11932661|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
7562997|NCT03246646|11932662|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
7562998|NCT03246646|11932661|FG000|Overall Study|Withdrawal by Subject|3
7562999|NCT03246646|11932662|FG001|Overall Study|Withdrawal by Subject|0
7563000|NCT03246646|11932661|FG000|Overall Study|Lost to Follow-up|7
7563001|NCT03246646|11932662|FG001|Overall Study|Lost to Follow-up|0
7563002|NCT03246672|11932668|FG000|Overall Study|Lost to Follow-up|2
7563003|NCT03246724|11932676|FG000|Overall Study|Withdrawal by Subject|5
7563004|NCT03246724|11932677|FG001|Overall Study|Withdrawal by Subject|2
7563005|NCT03246724|11932678|FG002|Overall Study|Withdrawal by Subject|4
7563006|NCT03246724|11932679|FG003|Overall Study|Withdrawal by Subject|2
7563007|NCT03246724|11932676|FG000|Overall Study|Ineligible on day of surgery|7
7563008|NCT03246724|11932677|FG001|Overall Study|Ineligible on day of surgery|2
7563009|NCT03246724|11932678|FG002|Overall Study|Ineligible on day of surgery|0
7563010|NCT03246724|11932679|FG003|Overall Study|Ineligible on day of surgery|3
7563011|NCT03246724|11932676|FG000|Overall Study|Study completed before surgical date|2
7563012|NCT03246724|11932677|FG001|Overall Study|Study completed before surgical date|1
7563013|NCT03246724|11932678|FG002|Overall Study|Study completed before surgical date|8
7563014|NCT03246724|11932679|FG003|Overall Study|Study completed before surgical date|1
7563015|NCT03246724|11932676|FG000|Overall Study|Transferred to other arm|0
7563016|NCT03246724|11932677|FG001|Overall Study|Transferred to other arm|0
7563017|NCT03246724|11932678|FG002|Overall Study|Transferred to other arm|1
7563018|NCT03246724|11932679|FG003|Overall Study|Transferred to other arm|0
7563019|NCT03246724|11932676|FG000|Overall Study|Unable to obtain medication timely|0
7563020|NCT03246724|11932677|FG001|Overall Study|Unable to obtain medication timely|2
7563021|NCT03246724|11932678|FG002|Overall Study|Unable to obtain medication timely|2
7563022|NCT03246724|11932679|FG003|Overall Study|Unable to obtain medication timely|1
7563023|NCT03246724|11932676|FG000|Overall Study|Re-consented to participate|0
7563024|NCT03246724|11932677|FG001|Overall Study|Re-consented to participate|0
7563025|NCT03246724|11932678|FG002|Overall Study|Re-consented to participate|0
7563026|NCT03246724|11932679|FG003|Overall Study|Re-consented to participate|1
7563027|NCT03247517|11932703|FG000|Overall Study|Adverse Event|0
7563028|NCT03247517|11932704|FG001|Overall Study|Adverse Event|4
7563029|NCT03247517|11932705|FG002|Overall Study|Adverse Event|2
7563030|NCT03247517|11932703|FG000|Overall Study|Lost to Follow-up|2
7447209|NCT01703741|11734543|FG000|Overall Study|Adverse Event|2
7447210|NCT01703741|11734543|FG000|Overall Study|Physician Decision|2
7447211|NCT01703741|11734543|FG000|Overall Study|Protocol Violation|1
7447212|NCT01703741|11734543|FG000|Overall Study|Lost to Follow-up|3
7447213|NCT01703741|11734543|FG000|Overall Study|Subject did not want to continue|2
7447214|NCT01703741|11734543|FG000|Overall Study|Subject cannot comply with study visits|1
7447215|NCT01703741|11734543|FG000|Overall Study|Subject started testosterone injections|1
7447216|NCT01703819|11734549|FG000|Overall Study|Adverse Event|0
7447217|NCT01703819|11734550|FG001|Overall Study|Adverse Event|1
7447218|NCT01703819|11734549|FG000|Overall Study|Withdrawal by Subject|0
7447219|NCT01703819|11734550|FG001|Overall Study|Withdrawal by Subject|1
7447220|NCT01703832|11734558|FG000|Overall Study|Withdrawal by Subject|1
7447221|NCT01703832|11734559|FG001|Overall Study|Withdrawal by Subject|0
7447222|NCT01703845|11734567|FG000|Overall Study|Adverse Event|1
7447223|NCT01703845|11734568|FG001|Overall Study|Adverse Event|0
7447224|NCT01703845|11734567|FG000|Overall Study|Protocol Violation|1
7447225|NCT01703845|11734568|FG001|Overall Study|Protocol Violation|0
7447226|NCT01703845|11734567|FG000|Overall Study|other than stated above|1
7447227|NCT01703845|11734568|FG001|Overall Study|other than stated above|0
7447228|NCT01703858|11734579|FG000|Overall Study|Withdrawal by Subject|0
7447229|NCT01703858|11734580|FG001|Overall Study|Withdrawal by Subject|1
7447230|NCT01703858|11734581|FG002|Overall Study|Withdrawal by Subject|0
7447231|NCT01703988|11734598|FG000|Overall Study|Investigator Judgment|0
7447232|NCT01703988|11734599|FG001|Overall Study|Investigator Judgment|0
7447233|NCT01703988|11734600|FG002|Overall Study|Investigator Judgment|0
7447234|NCT01703988|11734601|FG003|Overall Study|Investigator Judgment|1
7447235|NCT01704079|11734614|FG000|Overall Study|Withdrawal by Subject|5
7447236|NCT01704079|11734615|FG001|Overall Study|Withdrawal by Subject|7
7447237|NCT01704079|11734614|FG000|Overall Study|Lost to Follow-up|2
7447238|NCT01704079|11734615|FG001|Overall Study|Lost to Follow-up|5
7447239|NCT01704079|11734614|FG000|Overall Study|Adverse Event|4
7447240|NCT01704079|11734615|FG001|Overall Study|Adverse Event|7
7447241|NCT01704079|11734614|FG000|Overall Study|Protocol Violation|1
7447242|NCT01704079|11734615|FG001|Overall Study|Protocol Violation|0
7447243|NCT01704079|11734614|FG000|Overall Study|Subject noncompliance|2
7447244|NCT01704079|11734615|FG001|Overall Study|Subject noncompliance|3
7447245|NCT01704079|11734614|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
7447246|NCT01704079|11734615|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
7447247|NCT01704261|11734632|FG000|Overall Study|Withdrawal by Subject|12
7447248|NCT01704261|11734633|FG001|Overall Study|Withdrawal by Subject|15
7447249|NCT01704261|11734632|FG000|Overall Study|Lost to Follow-up|1
7447250|NCT01704261|11734633|FG001|Overall Study|Lost to Follow-up|0
7447251|NCT01704287|11734642|FG000|Initial Treatment Period|Death|139
7447252|NCT01704287|11734643|FG001|Initial Treatment Period|Death|129
7447253|NCT01704287|11734644|FG002|Initial Treatment Period|Death|71
7447254|NCT01704287|11734645|FG003|Initial Treatment Period|Death|0
7447255|NCT01704287|11734646|FG004|Initial Treatment Period|Death|0
7447256|NCT01704287|11734642|FG000|Initial Treatment Period|Withdrawal by Subject|3
7447257|NCT01704287|11734643|FG001|Initial Treatment Period|Withdrawal by Subject|2
7447258|NCT01704287|11734644|FG002|Initial Treatment Period|Withdrawal by Subject|4
7447259|NCT01704287|11734645|FG003|Initial Treatment Period|Withdrawal by Subject|0
7447260|NCT01704287|11734646|FG004|Initial Treatment Period|Withdrawal by Subject|0
7447261|NCT01704287|11734642|FG000|Initial Treatment Period|Lost to Follow-up|5
7447262|NCT01704287|11734643|FG001|Initial Treatment Period|Lost to Follow-up|3
7447263|NCT01704287|11734644|FG002|Initial Treatment Period|Lost to Follow-up|0
7447264|NCT01704287|11734645|FG003|Initial Treatment Period|Lost to Follow-up|0
7447265|NCT01704287|11734646|FG004|Initial Treatment Period|Lost to Follow-up|0
7447266|NCT01704287|11734642|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
7447267|NCT01704287|11734643|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
7447268|NCT01704287|11734644|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
7447269|NCT01704287|11734645|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
7563031|NCT03247517|11932704|FG001|Overall Study|Lost to Follow-up|6
7563032|NCT03247517|11932705|FG002|Overall Study|Lost to Follow-up|4
7563033|NCT03247517|11932703|FG000|Overall Study|Consent withdrawn by caregiver|1
7563034|NCT03247517|11932704|FG001|Overall Study|Consent withdrawn by caregiver|4
7563035|NCT03247517|11932705|FG002|Overall Study|Consent withdrawn by caregiver|7
7563036|NCT03247517|11932703|FG000|Overall Study|Assent/consent withdrawn by subject|2
7563037|NCT03247517|11932704|FG001|Overall Study|Assent/consent withdrawn by subject|3
7563038|NCT03247517|11932705|FG002|Overall Study|Assent/consent withdrawn by subject|1
7563039|NCT03247517|11932703|FG000|Overall Study|Protocol Violation|0
7563040|NCT03247517|11932704|FG001|Overall Study|Protocol Violation|2
7563041|NCT03247517|11932705|FG002|Overall Study|Protocol Violation|0
7563042|NCT03247517|11932703|FG000|Overall Study|Multiple reasons|3
7563043|NCT03247517|11932704|FG001|Overall Study|Multiple reasons|1
7563044|NCT03247517|11932705|FG002|Overall Study|Multiple reasons|0
7447270|NCT01704287|11734646|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
7447271|NCT01704287|11734642|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7447272|NCT01704287|11734643|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7447273|NCT01704287|11734644|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
7563045|NCT03247530|11932716|FG000|Overall Study|Withdrawal by caregiver|19
7563046|NCT03247530|11932717|FG001|Overall Study|Withdrawal by caregiver|8
7563047|NCT03247530|11932718|FG002|Overall Study|Withdrawal by caregiver|10
7447274|NCT01704287|11734645|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
7447275|NCT01704287|11734646|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
7447276|NCT01704287|11734642|FG000|Switch to Pembrolizumab Treatment Period|Death|0
7447277|NCT01704287|11734643|FG001|Switch to Pembrolizumab Treatment Period|Death|0
7447278|NCT01704287|11734644|FG002|Switch to Pembrolizumab Treatment Period|Death|0
7447279|NCT01704287|11734645|FG003|Switch to Pembrolizumab Treatment Period|Death|35
7447280|NCT01704287|11734646|FG004|Switch to Pembrolizumab Treatment Period|Death|37
7447281|NCT01704287|11734642|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7447282|NCT01704287|11734643|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7447283|NCT01704287|11734644|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7447284|NCT01704287|11734645|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
7447285|NCT01704287|11734646|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
7447286|NCT01704456|11734667|FG000|Overall Study|Lost to Follow-up|8
7447287|NCT01704456|11734668|FG001|Overall Study|Lost to Follow-up|14
7447288|NCT01704495|11734678|FG000|Subjects Randomized|Other Reason|3
7447289|NCT01704495|11734679|FG001|Subjects Randomized|Other Reason|2
7447290|NCT01704495|11734680|FG002|Subjects Randomized|Other Reason|3
7447291|NCT01704495|11734681|FG003|Subjects Randomized|Other Reason|2
7447292|NCT01704495|11734678|FG000|Subjects Randomized|Discontinuation criteria met|4
7447293|NCT01704495|11734679|FG001|Subjects Randomized|Discontinuation criteria met|2
7447294|NCT01704495|11734680|FG002|Subjects Randomized|Discontinuation criteria met|2
7447295|NCT01704495|11734681|FG003|Subjects Randomized|Discontinuation criteria met|0
7447296|NCT01704495|11734678|FG000|Subjects Randomized|Adverse Event|8
7447297|NCT01704495|11734679|FG001|Subjects Randomized|Adverse Event|2
7447298|NCT01704495|11734680|FG002|Subjects Randomized|Adverse Event|0
7447299|NCT01704495|11734681|FG003|Subjects Randomized|Adverse Event|7
7447300|NCT01704495|11734678|FG000|Subjects Randomized|Withdrawal by Subject|5
7447301|NCT01704495|11734679|FG001|Subjects Randomized|Withdrawal by Subject|5
7447302|NCT01704495|11734680|FG002|Subjects Randomized|Withdrawal by Subject|5
7447303|NCT01704495|11734681|FG003|Subjects Randomized|Withdrawal by Subject|5
7447304|NCT01704495|11734678|FG000|Subjects Randomized|Protocol Violation|1
7447305|NCT01704495|11734679|FG001|Subjects Randomized|Protocol Violation|1
7447306|NCT01704495|11734680|FG002|Subjects Randomized|Protocol Violation|2
7447307|NCT01704495|11734681|FG003|Subjects Randomized|Protocol Violation|0
7447308|NCT01704495|11734678|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
7447309|NCT01704495|11734679|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
7447310|NCT01704495|11734680|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
7447311|NCT01704495|11734681|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
7447312|NCT01704495|11734678|FG000|Optional Safety Extension|Adverse Event|0
7447313|NCT01704495|11734679|FG001|Optional Safety Extension|Adverse Event|4
7447314|NCT01704495|11734680|FG002|Optional Safety Extension|Adverse Event|0
7447315|NCT01704495|11734681|FG003|Optional Safety Extension|Adverse Event|1
7447316|NCT01704495|11734678|FG000|Optional Safety Extension|Other reason|27
7447317|NCT01704495|11734679|FG001|Optional Safety Extension|Other reason|29
7447318|NCT01704495|11734680|FG002|Optional Safety Extension|Other reason|30
7447319|NCT01704495|11734681|FG003|Optional Safety Extension|Other reason|28
7447320|NCT01704495|11734678|FG000|Optional Safety Extension|Withdrawal by Subject|2
7447321|NCT01704495|11734679|FG001|Optional Safety Extension|Withdrawal by Subject|0
7447322|NCT01704495|11734680|FG002|Optional Safety Extension|Withdrawal by Subject|1
7563048|NCT03247530|11932716|FG000|Overall Study|Lost to Follow-up|3
7563049|NCT03247530|11932717|FG001|Overall Study|Lost to Follow-up|9
7563050|NCT03247530|11932718|FG002|Overall Study|Lost to Follow-up|6
7563051|NCT03247530|11932716|FG000|Overall Study|Adverse Event|2
7563052|NCT03247530|11932717|FG001|Overall Study|Adverse Event|5
7563053|NCT03247530|11932718|FG002|Overall Study|Adverse Event|2
7563054|NCT03247530|11932716|FG000|Overall Study|Failure to follow procedure|1
7563055|NCT03247530|11932717|FG001|Overall Study|Failure to follow procedure|1
7563056|NCT03247530|11932718|FG002|Overall Study|Failure to follow procedure|1
7563057|NCT03247530|11932716|FG000|Overall Study|Withdrawal by Subject|1
7563058|NCT03247530|11932717|FG001|Overall Study|Withdrawal by Subject|1
7563059|NCT03247530|11932718|FG002|Overall Study|Withdrawal by Subject|0
7563060|NCT03247530|11932716|FG000|Overall Study|Study medication misuse|0
7563061|NCT03247530|11932717|FG001|Overall Study|Study medication misuse|1
7563062|NCT03247530|11932718|FG002|Overall Study|Study medication misuse|0
7563063|NCT03247530|11932716|FG000|Overall Study|Other, multiple categories|1
7563064|NCT03247530|11932717|FG001|Overall Study|Other, multiple categories|3
7563065|NCT03247530|11932718|FG002|Overall Study|Other, multiple categories|1
7563066|NCT03247543|11932732|FG000|Overall Study|Adverse Event|3
7563067|NCT03247543|11932733|FG001|Overall Study|Adverse Event|6
7532971|NCT02678923|11878939|FG001|Overall Study|Lost to Follow-up|0
7563068|NCT03247543|11932734|FG002|Overall Study|Adverse Event|4
7563069|NCT03247543|11932732|FG000|Overall Study|Lost to Follow-up|10
7563070|NCT03247543|11932733|FG001|Overall Study|Lost to Follow-up|7
7563071|NCT03247543|11932734|FG002|Overall Study|Lost to Follow-up|8
7447323|NCT01704495|11734681|FG003|Optional Safety Extension|Withdrawal by Subject|2
7447324|NCT01704599|11734700|FG000|Overall Study|Adverse Event|1
7447325|NCT01704651|11734729|FG000|Overall Study|Pre-op withdrawal by subject|1
7447326|NCT01704651|11734730|FG001|Overall Study|Pre-op withdrawal by subject|1
7447327|NCT01704651|11734729|FG000|Overall Study|Pre-op change in treatment plan|1
7447328|NCT01704651|11734730|FG001|Overall Study|Pre-op change in treatment plan|4
7447329|NCT01704651|11734729|FG000|Overall Study|Nasogastric tube placement in surgery|1
7447330|NCT01704651|11734730|FG001|Overall Study|Nasogastric tube placement in surgery|1
7447331|NCT01704651|11734729|FG000|Overall Study|Post-op did not have laparotomy|2
7447332|NCT01704651|11734730|FG001|Overall Study|Post-op did not have laparotomy|1
7447333|NCT01704755|11734738|FG000|Overall Study|Adverse Event|4
7447334|NCT01704755|11734739|FG001|Overall Study|Adverse Event|1
7447335|NCT01704755|11734738|FG000|Overall Study|Lost to Follow-up|3
7447336|NCT01704755|11734739|FG001|Overall Study|Lost to Follow-up|4
7447337|NCT01704755|11734738|FG000|Overall Study|Withdrew consent|1
7447338|NCT01704755|11734739|FG001|Overall Study|Withdrew consent|1
7447339|NCT01704755|11734738|FG000|Overall Study|Other (not specified)|3
7447340|NCT01704755|11734739|FG001|Overall Study|Other (not specified)|1
7447341|NCT01704755|11734738|FG000|Overall Study|Withdrew consent and personal issues|1
7447342|NCT01704755|11734739|FG001|Overall Study|Withdrew consent and personal issues|0
7447343|NCT01704846|11734770|FG000|Treatment Period 2|Withdrawal by Subject|0
7447344|NCT01704846|11734771|FG001|Treatment Period 2|Withdrawal by Subject|1
7447345|NCT01705080|11734789|FG000|Overall Study|Missed visit|10
7447346|NCT01705080|11734790|FG001|Overall Study|Missed visit|4
7447347|NCT01705080|11734791|FG002|Overall Study|Missed visit|1
7447348|NCT01705080|11734789|FG000|Overall Study|Death|4
7447349|NCT01705080|11734790|FG001|Overall Study|Death|4
7447350|NCT01705080|11734791|FG002|Overall Study|Death|6
7447351|NCT01705080|11734789|FG000|Overall Study|Withdrawal by Subject|61
7447352|NCT01705080|11734790|FG001|Overall Study|Withdrawal by Subject|44
7447353|NCT01705080|11734791|FG002|Overall Study|Withdrawal by Subject|9
7447354|NCT01705145|11734799|FG000|Part B|Adverse Event|1
7447355|NCT01705236|11734815|FG000|Overall Study|Lost to Follow-up|1
7447356|NCT01705236|11734815|FG000|Overall Study|Administrative problems|2
7447357|NCT01705236|11734815|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7563072|NCT03247543|11932732|FG000|Overall Study|Consent withdrawn by caregiver|2
7563073|NCT03247543|11932733|FG001|Overall Study|Consent withdrawn by caregiver|2
7563074|NCT03247543|11932734|FG002|Overall Study|Consent withdrawn by caregiver|9
7563075|NCT03247543|11932732|FG000|Overall Study|Withdrawal by Subject|0
7563076|NCT03247543|11932733|FG001|Overall Study|Withdrawal by Subject|0
7563077|NCT03247543|11932734|FG002|Overall Study|Withdrawal by Subject|1
7563078|NCT03247543|11932732|FG000|Overall Study|Failure to Follow study procedures|1
7563079|NCT03247543|11932733|FG001|Overall Study|Failure to Follow study procedures|3
7563080|NCT03247543|11932734|FG002|Overall Study|Failure to Follow study procedures|1
7563081|NCT03247543|11932732|FG000|Overall Study|Lack of Efficacy|1
7563082|NCT03247543|11932733|FG001|Overall Study|Lack of Efficacy|0
7563083|NCT03247543|11932734|FG002|Overall Study|Lack of Efficacy|0
7563084|NCT03247543|11932732|FG000|Overall Study|Non-compliance with study visits|0
7563085|NCT03247543|11932733|FG001|Overall Study|Non-compliance with study visits|1
7563086|NCT03247543|11932734|FG002|Overall Study|Non-compliance with study visits|0
7563087|NCT03247556|11932747|FG000|Overall Study|Adverse Event|1
7563088|NCT03247556|11932748|FG001|Overall Study|Adverse Event|4
7563089|NCT03247556|11932749|FG002|Overall Study|Adverse Event|5
7563090|NCT03247556|11932747|FG000|Overall Study|Lost to Follow-up|5
7563091|NCT03247556|11932748|FG001|Overall Study|Lost to Follow-up|5
7563092|NCT03247556|11932749|FG002|Overall Study|Lost to Follow-up|4
7563093|NCT03247556|11932747|FG000|Overall Study|Consent Withdrawn by Caregiver|4
7563094|NCT03247556|11932748|FG001|Overall Study|Consent Withdrawn by Caregiver|1
7563095|NCT03247556|11932749|FG002|Overall Study|Consent Withdrawn by Caregiver|5
7563096|NCT03247556|11932747|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
7563097|NCT03247556|11932748|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
7563098|NCT03247556|11932749|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
7563099|NCT03247556|11932747|FG000|Overall Study|Protocol Violation|2
7563100|NCT03247556|11932748|FG001|Overall Study|Protocol Violation|0
7563101|NCT03247556|11932749|FG002|Overall Study|Protocol Violation|1
7563102|NCT03247556|11932747|FG000|Overall Study|Subject did not meet inclusion criteria|0
7563103|NCT03247556|11932748|FG001|Overall Study|Subject did not meet inclusion criteria|0
7563104|NCT03247556|11932749|FG002|Overall Study|Subject did not meet inclusion criteria|1
7563105|NCT03247673|11932760|FG000|Overall Study|Withdrawal by Subject|1
7563106|NCT03247673|11932761|FG001|Overall Study|Withdrawal by Subject|0
7563107|NCT03247673|11932762|FG002|Overall Study|Withdrawal by Subject|3
7563108|NCT03247673|11932760|FG000|Overall Study|Lost to Follow-up|0
7563109|NCT03247673|11932761|FG001|Overall Study|Lost to Follow-up|0
7563110|NCT03247673|11932762|FG002|Overall Study|Lost to Follow-up|1
7563111|NCT03247686|11932772|FG000|Overall Study|Withdrawal by Subject|1
7563112|NCT03247686|11932773|FG001|Overall Study|Withdrawal by Subject|2
7563113|NCT03247816|11932797|FG000|Overall Study|Adverse Event|12
7447358|NCT01705236|11734815|FG000|Overall Study|Protocol Violation|3
7447359|NCT01705236|11734815|FG000|Overall Study|Abnormal test procedure result(s)|4
7447360|NCT01705236|11734815|FG000|Overall Study|Abnormal laboratory value(s)|4
7447361|NCT01705236|11734815|FG000|Overall Study|Withdrawal by Subject|5
7447362|NCT01705236|11734815|FG000|Overall Study|Adverse Event|5
7447363|NCT01705509|11734832|FG000|Inclusion CPET|Screen Failure|5
7447364|NCT01705509|11734832|FG000|Inclusion CPET|Withdrawal by Subject|2
7447365|NCT01705509|11734832|FG000|CPET w/ Ranexa|Screen Failure|2
7447366|NCT01705574|11734838|FG000|Double-Blind Phase|Lost to Follow-up|12
7447367|NCT01705574|11734839|FG001|Double-Blind Phase|Lost to Follow-up|16
7447368|NCT01705574|11734840|FG002|Double-Blind Phase|Lost to Follow-up|0
7447369|NCT01705574|11734841|FG003|Double-Blind Phase|Lost to Follow-up|0
7447370|NCT01705574|11734838|FG000|Double-Blind Phase|Adverse Event|3
7447371|NCT01705574|11734839|FG001|Double-Blind Phase|Adverse Event|10
7447372|NCT01705574|11734840|FG002|Double-Blind Phase|Adverse Event|0
7447373|NCT01705574|11734841|FG003|Double-Blind Phase|Adverse Event|0
7447374|NCT01705574|11734838|FG000|Double-Blind Phase|Withdrew Consent|8
7447375|NCT01705574|11734839|FG001|Double-Blind Phase|Withdrew Consent|5
7447376|NCT01705574|11734840|FG002|Double-Blind Phase|Withdrew Consent|0
7447377|NCT01705574|11734841|FG003|Double-Blind Phase|Withdrew Consent|0
7447378|NCT01705574|11734838|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7447379|NCT01705574|11734839|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
7447380|NCT01705574|11734840|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
7447381|NCT01705574|11734841|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
7447382|NCT01705574|11734838|FG000|Double-Blind Phase|Pregnancy|1
7447383|NCT01705574|11734839|FG001|Double-Blind Phase|Pregnancy|1
7447384|NCT01705574|11734840|FG002|Double-Blind Phase|Pregnancy|0
7447385|NCT01705574|11734841|FG003|Double-Blind Phase|Pregnancy|0
7447386|NCT01705574|11734838|FG000|Double-Blind Phase|Protocol Violation|1
7447387|NCT01705574|11734839|FG001|Double-Blind Phase|Protocol Violation|0
7447388|NCT01705574|11734840|FG002|Double-Blind Phase|Protocol Violation|0
7447389|NCT01705574|11734841|FG003|Double-Blind Phase|Protocol Violation|0
7447390|NCT01705574|11734838|FG000|Double-Blind Phase|Randomized but Not Treated|4
7447391|NCT01705574|11734839|FG001|Double-Blind Phase|Randomized but Not Treated|4
7447392|NCT01705574|11734840|FG002|Double-Blind Phase|Randomized but Not Treated|0
7447393|NCT01705574|11734841|FG003|Double-Blind Phase|Randomized but Not Treated|0
7447394|NCT01705574|11734838|FG000|Open-Label Extension Phase|Lost to Follow-up|6
7447395|NCT01705574|11734839|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7447396|NCT01705574|11734840|FG002|Open-Label Extension Phase|Lost to Follow-up|2
7447397|NCT01705574|11734841|FG003|Open-Label Extension Phase|Lost to Follow-up|2
7447398|NCT01705574|11734838|FG000|Open-Label Extension Phase|Withdrew Consent|4
7447399|NCT01705574|11734839|FG001|Open-Label Extension Phase|Withdrew Consent|0
7447400|NCT01705574|11734840|FG002|Open-Label Extension Phase|Withdrew Consent|4
7447401|NCT01705574|11734841|FG003|Open-Label Extension Phase|Withdrew Consent|1
7447402|NCT01705574|11734838|FG000|Open-Label Extension Phase|Adverse Event|3
7447403|NCT01705574|11734839|FG001|Open-Label Extension Phase|Adverse Event|0
7447404|NCT01705574|11734840|FG002|Open-Label Extension Phase|Adverse Event|0
7447405|NCT01705574|11734841|FG003|Open-Label Extension Phase|Adverse Event|1
7447406|NCT01705574|11734838|FG000|Open-Label Extension Phase|Death|2
7447407|NCT01705574|11734839|FG001|Open-Label Extension Phase|Death|0
7447408|NCT01705574|11734840|FG002|Open-Label Extension Phase|Death|1
7447409|NCT01705574|11734841|FG003|Open-Label Extension Phase|Death|0
7447410|NCT01705574|11734838|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7447411|NCT01705574|11734839|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7447412|NCT01705574|11734840|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
7447413|NCT01705574|11734841|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
7447414|NCT01705574|11734838|FG000|Open-Label Extension Phase|Physician Decision|0
7447415|NCT01705574|11734839|FG001|Open-Label Extension Phase|Physician Decision|0
7563114|NCT03247816|11932797|FG000|Overall Study|Physician Decision|3
7563115|NCT03247816|11932797|FG000|Overall Study|Lack of Efficacy|1
7563116|NCT03247816|11932797|FG000|Overall Study|Lost to Follow-up|10
7563117|NCT03247816|11932797|FG000|Overall Study|Missing Feraccru stop date|3
7447416|NCT01705574|11734840|FG002|Open-Label Extension Phase|Physician Decision|2
7447417|NCT01705574|11734841|FG003|Open-Label Extension Phase|Physician Decision|0
7563118|NCT03248037|11932814|FG000|Overall Study|Withdrawal by Subject|6
7563119|NCT03248037|11932815|FG001|Overall Study|Withdrawal by Subject|9
7563120|NCT03248037|11932814|FG000|Overall Study|Adverse Event|15
7563121|NCT03248037|11932815|FG001|Overall Study|Adverse Event|0
7563122|NCT03248492|11932835|FG000|Overall Study|Ongoing|23
7563123|NCT03248492|11932836|FG001|Overall Study|Ongoing|26
7563124|NCT03248492|11932837|FG002|Overall Study|Ongoing|3
7563125|NCT03248492|11932838|FG003|Overall Study|Ongoing|85
7563126|NCT03248492|11932839|FG004|Overall Study|Ongoing|2
7563127|NCT03248492|11932835|FG000|Overall Study|Progressive disease per RECIST v1.1|16
7563128|NCT03248492|11932836|FG001|Overall Study|Progressive disease per RECIST v1.1|12
7563129|NCT03248492|11932837|FG002|Overall Study|Progressive disease per RECIST v1.1|9
7563130|NCT03248492|11932838|FG003|Overall Study|Progressive disease per RECIST v1.1|22
7563131|NCT03248492|11932839|FG004|Overall Study|Progressive disease per RECIST v1.1|0
7447418|NCT01705574|11734838|FG000|Open-Label Extension Phase|Pregnancy|0
7447419|NCT01705574|11734839|FG001|Open-Label Extension Phase|Pregnancy|0
7447420|NCT01705574|11734840|FG002|Open-Label Extension Phase|Pregnancy|1
7447421|NCT01705574|11734841|FG003|Open-Label Extension Phase|Pregnancy|1
7447422|NCT01705587|11734859|FG000|Overall Study|Withdrawal by Subject|0
7447423|NCT01705587|11734860|FG001|Overall Study|Withdrawal by Subject|1
7447424|NCT01705652|11734868|FG000|Overall Study|Adverse Event|1
7563132|NCT03248492|11932835|FG000|Overall Study|Adverse Event|6
7563133|NCT03248492|11932836|FG001|Overall Study|Adverse Event|6
7563134|NCT03248492|11932837|FG002|Overall Study|Adverse Event|8
7563135|NCT03248492|11932838|FG003|Overall Study|Adverse Event|8
7563136|NCT03248492|11932839|FG004|Overall Study|Adverse Event|1
7447425|NCT01705652|11734869|FG001|Overall Study|Adverse Event|0
7447426|NCT01705652|11734868|FG000|Overall Study|Withdrawal by Subject|1
7447427|NCT01705652|11734869|FG001|Overall Study|Withdrawal by Subject|2
7447428|NCT01705652|11734868|FG000|Overall Study|non-compliance|1
7447429|NCT01705652|11734869|FG001|Overall Study|non-compliance|1
7447430|NCT01705691|11734877|FG000|Overall Study|Death|1
7447431|NCT01705691|11734878|FG001|Overall Study|Death|2
7563137|NCT03248492|11932835|FG000|Overall Study|Withdrawal by Subject|3
7563138|NCT03248492|11932836|FG001|Overall Study|Withdrawal by Subject|3
7563139|NCT03248492|11932837|FG002|Overall Study|Withdrawal by Subject|0
7563140|NCT03248492|11932838|FG003|Overall Study|Withdrawal by Subject|3
7563141|NCT03248492|11932839|FG004|Overall Study|Withdrawal by Subject|1
7563142|NCT03248492|11932835|FG000|Overall Study|Physician Decision|1
7563143|NCT03248492|11932836|FG001|Overall Study|Physician Decision|0
7563144|NCT03248492|11932837|FG002|Overall Study|Physician Decision|1
7563145|NCT03248492|11932838|FG003|Overall Study|Physician Decision|2
7563146|NCT03248492|11932839|FG004|Overall Study|Physician Decision|0
7563147|NCT03248492|11932835|FG000|Overall Study|Death|1
7563148|NCT03248492|11932836|FG001|Overall Study|Death|0
7563149|NCT03248492|11932837|FG002|Overall Study|Death|0
7563150|NCT03248492|11932838|FG003|Overall Study|Death|6
7563151|NCT03248492|11932839|FG004|Overall Study|Death|0
7563152|NCT03248492|11932835|FG000|Overall Study|Other|0
7563153|NCT03248492|11932836|FG001|Overall Study|Other|1
7563154|NCT03248492|11932837|FG002|Overall Study|Other|0
7563155|NCT03248492|11932838|FG003|Overall Study|Other|4
7563156|NCT03248492|11932839|FG004|Overall Study|Other|0
7563157|NCT03248882|11932864|FG000|Overall Study|Adverse Event|3
7563158|NCT03248882|11932865|FG001|Overall Study|Adverse Event|3
7563159|NCT03248882|11932866|FG002|Overall Study|Adverse Event|2
7563160|NCT03248882|11932867|FG003|Overall Study|Adverse Event|6
7563161|NCT03248882|11932868|FG004|Overall Study|Adverse Event|9
7563162|NCT03248882|11932864|FG000|Overall Study|Lost to Follow-up|0
7563163|NCT03248882|11932865|FG001|Overall Study|Lost to Follow-up|0
7563164|NCT03248882|11932866|FG002|Overall Study|Lost to Follow-up|0
7563165|NCT03248882|11932867|FG003|Overall Study|Lost to Follow-up|0
7563166|NCT03248882|11932868|FG004|Overall Study|Lost to Follow-up|1
7563167|NCT03248882|11932864|FG000|Overall Study|Protocol Violation|2
7563168|NCT03248882|11932865|FG001|Overall Study|Protocol Violation|0
7563169|NCT03248882|11932866|FG002|Overall Study|Protocol Violation|2
7563170|NCT03248882|11932867|FG003|Overall Study|Protocol Violation|0
7563171|NCT03248882|11932868|FG004|Overall Study|Protocol Violation|1
7563172|NCT03248882|11932864|FG000|Overall Study|Withdrawal by Subject|2
7563173|NCT03248882|11932865|FG001|Overall Study|Withdrawal by Subject|2
7563174|NCT03248882|11932866|FG002|Overall Study|Withdrawal by Subject|3
7563175|NCT03248882|11932867|FG003|Overall Study|Withdrawal by Subject|4
7563176|NCT03248882|11932868|FG004|Overall Study|Withdrawal by Subject|2
7563177|NCT03249454|11932927|FG000|Overall Study|Withdrawal by Subject|0
7563178|NCT03249454|11932928|FG001|Overall Study|Withdrawal by Subject|0
7563179|NCT03249454|11932929|FG002|Overall Study|Withdrawal by Subject|0
7563180|NCT03249454|11932930|FG003|Overall Study|Withdrawal by Subject|0
7563181|NCT03249454|11932931|FG004|Overall Study|Withdrawal by Subject|0
7563182|NCT03249454|11932932|FG005|Overall Study|Withdrawal by Subject|0
7563183|NCT03249454|11932933|FG006|Overall Study|Withdrawal by Subject|0
7563184|NCT03249454|11932934|FG007|Overall Study|Withdrawal by Subject|0
7563185|NCT03249454|11932935|FG008|Overall Study|Withdrawal by Subject|0
7563186|NCT03249454|11932936|FG009|Overall Study|Withdrawal by Subject|1
7563187|NCT03249454|11932937|FG010|Overall Study|Withdrawal by Subject|1
7563188|NCT03249909|11932963|FG000|Overall Study|Withdrawal by Subject|3
7563189|NCT03249909|11932964|FG001|Overall Study|Withdrawal by Subject|0
7563190|NCT03249909|11932965|FG002|Overall Study|Withdrawal by Subject|0
7563191|NCT03249909|11932963|FG000|Overall Study|Adverse Event|3
7563192|NCT03249909|11932964|FG001|Overall Study|Adverse Event|0
7563193|NCT03249909|11932965|FG002|Overall Study|Adverse Event|0
7563194|NCT03249909|11932963|FG000|Overall Study|Lost to Follow-up|0
7563195|NCT03249909|11932964|FG001|Overall Study|Lost to Follow-up|1
7563196|NCT03249909|11932965|FG002|Overall Study|Lost to Follow-up|0
7563197|NCT03249935|11932976|FG000|Overall Study|Discharged from facility early|36
7447432|NCT01705691|11734877|FG000|Overall Study|Withdrawal by Subject|1
7447433|NCT01705691|11734878|FG001|Overall Study|Withdrawal by Subject|2
7447434|NCT01705691|11734877|FG000|Overall Study|Lost to Follow-up|1
7563198|NCT03249935|11932976|FG000|Overall Study|Negative for chlamydia at enrollment|4
7563199|NCT03249935|11932976|FG000|Overall Study|Protocol Violation|5
7563200|NCT03250182|11932982|FG000|Overall Study|Withdrawal by Subject|1
7575008|NCT03706040|11958322|FG002|Period B (Week 16 to Week 52)|Other|0
7575009|NCT03706040|11958323|FG003|Period B (Week 16 to Week 52)|Other|4
7575010|NCT03706040|11958324|FG004|Period B (Week 16 to Week 52)|Other|5
7575011|NCT03706040|11958325|FG005|Period B (Week 16 to Week 52)|Other|23
7575012|NCT03706040|11958326|FG006|Period B (Week 16 to Week 52)|Other|17
7447435|NCT01705691|11734878|FG001|Overall Study|Lost to Follow-up|1
7575015|NCT03707522|11958403|FG000|Overall Study|Lost to Follow-up|24
7575016|NCT03707522|11958404|FG001|Overall Study|Lost to Follow-up|27
7575017|NCT03707522|11958405|FG002|Overall Study|Lost to Follow-up|41
7575018|NCT03707522|11958406|FG003|Overall Study|Lost to Follow-up|36
7447436|NCT01705691|11734877|FG000|Overall Study|Other|0
7447437|NCT01705691|11734878|FG001|Overall Study|Other|1
7447438|NCT01705717|11734886|FG000|Overall Study|Adverse Event|2
7447439|NCT01705717|11734887|FG001|Overall Study|Adverse Event|2
7447440|NCT01705717|11734886|FG000|Overall Study|Lack of Efficacy|0
7447441|NCT01705717|11734887|FG001|Overall Study|Lack of Efficacy|1
7447442|NCT01705717|11734886|FG000|Overall Study|Other|0
7447443|NCT01705717|11734887|FG001|Overall Study|Other|2
7447444|NCT01705730|11734892|FG000|Overall Study|Lack of Efficacy|1
7447445|NCT01705730|11734892|FG000|Overall Study|Adverse Event|3
7447446|NCT01705730|11734892|FG000|Overall Study|Lost to Follow-up|1
7447447|NCT01705730|11734892|FG000|Overall Study|Reason not Specified|4
7447448|NCT01706003|11734907|FG000|Overall Study|Withdrawal by Subject|2
7447449|NCT01706003|11734908|FG001|Overall Study|Withdrawal by Subject|0
7447450|NCT01706003|11734907|FG000|Overall Study|Not scheduled|3
7447451|NCT01706003|11734908|FG001|Overall Study|Not scheduled|0
7447452|NCT01706003|11734907|FG000|Overall Study|Lost to Follow-up|6
7447453|NCT01706003|11734908|FG001|Overall Study|Lost to Follow-up|4
7447454|NCT01706146|11734923|FG000|Overall Study|Withdrawal by Subject|1
7447455|NCT01706146|11734923|FG000|Overall Study|Adverse Event|3
7447456|NCT01706146|11734923|FG000|Overall Study|Developed AF and need for antiplatelets|2
7447457|NCT01706159|11734929|FG000|Overall Study|Withdrawal Criteria|2
7447458|NCT01706159|11734930|FG001|Overall Study|Withdrawal Criteria|1
7447459|NCT01706159|11734929|FG000|Overall Study|Unclassified|6
7447460|NCT01706159|11734930|FG001|Overall Study|Unclassified|1
7447461|NCT01706198|11734938|FG000|Overall Study|Adverse Event|12
7447462|NCT01706198|11734939|FG001|Overall Study|Adverse Event|15
7447463|NCT01706198|11734938|FG000|Overall Study|Protocol Violation|7
7447464|NCT01706198|11734939|FG001|Overall Study|Protocol Violation|5
7447465|NCT01706198|11734938|FG000|Overall Study|Other: Subject reached stopping criteria|11
7447466|NCT01706198|11734939|FG001|Overall Study|Other: Subject reached stopping criteria|13
7447467|NCT01706198|11734938|FG000|Overall Study|Lost to Follow-up|97
7447468|NCT01706198|11734939|FG001|Overall Study|Lost to Follow-up|93
7447469|NCT01706198|11734938|FG000|Overall Study|Physician Decision|23
7447470|NCT01706198|11734939|FG001|Overall Study|Physician Decision|37
7447471|NCT01706198|11734938|FG000|Overall Study|Withdrawal by Subject|23
7447472|NCT01706198|11734939|FG001|Overall Study|Withdrawal by Subject|31
7447473|NCT01706250|11734945|FG000|Overall Study|Lost to Follow-up|2
7447474|NCT01706328|11734961|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
7447475|NCT01706328|11734962|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7447476|NCT01706328|11734963|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
7447477|NCT01706328|11734961|FG000|2-week Run-in Period|Withdrawal by Subject|15
7447478|NCT01706328|11734962|FG001|2-week Run-in Period|Withdrawal by Subject|0
7447479|NCT01706328|11734963|FG002|2-week Run-in Period|Withdrawal by Subject|0
7447480|NCT01706328|11734961|FG000|2-week Run-in Period|Physician Decision|4
7447481|NCT01706328|11734962|FG001|2-week Run-in Period|Physician Decision|0
7447482|NCT01706328|11734963|FG002|2-week Run-in Period|Physician Decision|0
7447483|NCT01706328|11734961|FG000|2-week Run-in Period|Adverse Event|4
7447484|NCT01706328|11734962|FG001|2-week Run-in Period|Adverse Event|0
7447485|NCT01706328|11734963|FG002|2-week Run-in Period|Adverse Event|0
7447486|NCT01706328|11734961|FG000|2-week Run-in Period|Lost to Follow-up|2
7447487|NCT01706328|11734962|FG001|2-week Run-in Period|Lost to Follow-up|0
7447488|NCT01706328|11734963|FG002|2-week Run-in Period|Lost to Follow-up|0
7447489|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Adverse Event|0
7447490|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Adverse Event|14
7447491|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Adverse Event|16
7447492|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
7447493|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
7447494|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
7447495|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
7447496|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
7447497|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
7447498|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
7447499|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
7447500|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
7447501|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
7447502|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
7447503|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
7447504|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Physician Decision|0
7447505|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Physician Decision|2
7447506|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Physician Decision|2
7447507|NCT01706328|11734961|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
7447508|NCT01706328|11734962|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
7447509|NCT01706328|11734963|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
7447510|NCT01706458|11734971|FG000|Overall Study|Physician Decision|3
7447511|NCT01706458|11734972|FG001|Overall Study|Physician Decision|4
7447512|NCT01706536|11734987|FG000|Overall Study|Withdrawal by Subject|1
7447513|NCT01706536|11734988|FG001|Overall Study|Withdrawal by Subject|0
7447514|NCT01706536|11734989|FG002|Overall Study|Withdrawal by Subject|1
7447515|NCT01706536|11734990|FG003|Overall Study|Withdrawal by Subject|0
7447516|NCT01706536|11734991|FG004|Overall Study|Withdrawal by Subject|0
7447517|NCT01706536|11734987|FG000|Overall Study|Adverse Event|2
7447518|NCT01706536|11734988|FG001|Overall Study|Adverse Event|3
7447519|NCT01706536|11734989|FG002|Overall Study|Adverse Event|4
7447520|NCT01706536|11734990|FG003|Overall Study|Adverse Event|3
7447521|NCT01706536|11734991|FG004|Overall Study|Adverse Event|2
7447522|NCT01706536|11734987|FG000|Overall Study|Lack of Efficacy|1
7447523|NCT01706536|11734988|FG001|Overall Study|Lack of Efficacy|0
7447524|NCT01706536|11734989|FG002|Overall Study|Lack of Efficacy|0
7447525|NCT01706536|11734990|FG003|Overall Study|Lack of Efficacy|1
7447526|NCT01706536|11734991|FG004|Overall Study|Lack of Efficacy|0
7447527|NCT01706536|11734987|FG000|Overall Study|non compliance|0
7447528|NCT01706536|11734988|FG001|Overall Study|non compliance|1
7447529|NCT01706536|11734989|FG002|Overall Study|non compliance|0
7447530|NCT01706536|11734990|FG003|Overall Study|non compliance|0
7563201|NCT03251482|11933016|FG000|Overall Study|Withdrawal by Subject|0
7563202|NCT03251482|11933017|FG001|Overall Study|Withdrawal by Subject|1
7563203|NCT03251482|11933018|FG002|Overall Study|Withdrawal by Subject|0
7563204|NCT03251482|11933019|FG003|Overall Study|Withdrawal by Subject|0
7563205|NCT03251482|11933020|FG004|Overall Study|Withdrawal by Subject|0
7447531|NCT01706536|11734991|FG004|Overall Study|non compliance|0
7447532|NCT01706575|11735008|FG000|Overall Study|Participant Withdrew Consent|4
7447533|NCT01706575|11735008|FG000|Overall Study|Lost to Follow-up|2
7447534|NCT01706575|11735008|FG000|Overall Study|Started but not Treated|6
7447535|NCT01706770|11735048|FG000|Overall Study|Lost to Follow-up|1
7563206|NCT03251963|11933038|FG000|Overall Study|inappropriate Xa level timing|6
7563207|NCT03251963|11933039|FG001|Overall Study|inappropriate Xa level timing|3
7447536|NCT01706770|11735049|FG001|Overall Study|Lost to Follow-up|0
7447537|NCT01706770|11735048|FG000|Overall Study|Physician Decision|1
7447538|NCT01706770|11735049|FG001|Overall Study|Physician Decision|0
7563208|NCT03251963|11933038|FG000|Overall Study|no peak Xa level drawn|2
7563209|NCT03251963|11933039|FG001|Overall Study|no peak Xa level drawn|0
7563210|NCT03251963|11933038|FG000|Overall Study|bled prior to Xa level|1
7563211|NCT03251963|11933039|FG001|Overall Study|bled prior to Xa level|2
7563212|NCT03252015|11933049|FG000|Overall Study|Withdrawal by Subject|0
7563213|NCT03252015|11933050|FG001|Overall Study|Withdrawal by Subject|1
7563214|NCT03252015|11933051|FG002|Overall Study|Withdrawal by Subject|1
7563215|NCT03252015|11933052|FG003|Overall Study|Withdrawal by Subject|0
7563216|NCT03252015|11933049|FG000|Overall Study|Adverse Event|1
7563217|NCT03252015|11933050|FG001|Overall Study|Adverse Event|0
7563218|NCT03252015|11933051|FG002|Overall Study|Adverse Event|0
7563219|NCT03252015|11933052|FG003|Overall Study|Adverse Event|1
7563220|NCT03252145|11933078|FG000|Overall Study|Withdrawal by Subject|1
7563221|NCT03252145|11933079|FG001|Overall Study|Withdrawal by Subject|0
7563222|NCT03252145|11933078|FG000|Overall Study|Complicating Disease|1
7563223|NCT03252145|11933079|FG001|Overall Study|Complicating Disease|2
7563224|NCT03253094|11933116|FG000|Overall Study|Adverse Event|2
7563225|NCT03253094|11933117|FG001|Overall Study|Adverse Event|0
7563226|NCT03253094|11933118|FG002|Overall Study|Adverse Event|0
7563227|NCT03253094|11933119|FG003|Overall Study|Adverse Event|0
7563228|NCT03253094|11933120|FG004|Overall Study|Adverse Event|0
7563229|NCT03253094|11933121|FG005|Overall Study|Adverse Event|0
7563230|NCT03253094|11933116|FG000|Overall Study|Lack of Efficacy|0
7563231|NCT03253094|11933117|FG001|Overall Study|Lack of Efficacy|0
7563232|NCT03253094|11933118|FG002|Overall Study|Lack of Efficacy|2
7563233|NCT03253094|11933119|FG003|Overall Study|Lack of Efficacy|1
7563234|NCT03253094|11933120|FG004|Overall Study|Lack of Efficacy|2
7563235|NCT03253094|11933121|FG005|Overall Study|Lack of Efficacy|1
7563236|NCT03253094|11933116|FG000|Overall Study|Lost to Follow-up|0
7563237|NCT03253094|11933117|FG001|Overall Study|Lost to Follow-up|0
7563238|NCT03253094|11933118|FG002|Overall Study|Lost to Follow-up|1
7563239|NCT03253094|11933119|FG003|Overall Study|Lost to Follow-up|1
7563240|NCT03253094|11933120|FG004|Overall Study|Lost to Follow-up|0
7563241|NCT03253094|11933121|FG005|Overall Study|Lost to Follow-up|1
7563242|NCT03253094|11933116|FG000|Overall Study|Physician Decision|1
7563243|NCT03253094|11933117|FG001|Overall Study|Physician Decision|0
7563244|NCT03253094|11933118|FG002|Overall Study|Physician Decision|0
7563245|NCT03253094|11933119|FG003|Overall Study|Physician Decision|1
7563246|NCT03253094|11933120|FG004|Overall Study|Physician Decision|0
7563247|NCT03253094|11933121|FG005|Overall Study|Physician Decision|2
7563248|NCT03253094|11933116|FG000|Overall Study|Withdrawal by Subject|1
7563249|NCT03253094|11933117|FG001|Overall Study|Withdrawal by Subject|2
7563250|NCT03253094|11933118|FG002|Overall Study|Withdrawal by Subject|1
7563251|NCT03253094|11933119|FG003|Overall Study|Withdrawal by Subject|0
7563252|NCT03253094|11933120|FG004|Overall Study|Withdrawal by Subject|3
7563253|NCT03253094|11933121|FG005|Overall Study|Withdrawal by Subject|0
7563254|NCT03253094|11933116|FG000|Overall Study|Other|0
7563255|NCT03253094|11933117|FG001|Overall Study|Other|1
7563256|NCT03253094|11933118|FG002|Overall Study|Other|2
7563257|NCT03253094|11933119|FG003|Overall Study|Other|1
7563258|NCT03253094|11933120|FG004|Overall Study|Other|0
7563259|NCT03253094|11933121|FG005|Overall Study|Other|0
7563260|NCT03254108|11933140|FG000|Overall Study|Adverse Event|0
7563261|NCT03254108|11933141|FG001|Overall Study|Adverse Event|2
7563262|NCT03254108|11933142|FG002|Overall Study|Adverse Event|0
7563263|NCT03254108|11933143|FG003|Overall Study|Adverse Event|1
7563264|NCT03254108|11933144|FG004|Overall Study|Adverse Event|1
7563265|NCT03254108|11933140|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7563266|NCT03254108|11933141|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7563267|NCT03254108|11933142|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7563268|NCT03254108|11933143|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
7563269|NCT03254108|11933144|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
7563270|NCT03254134|11933158|FG000|Overall Study|Not eligible patients|599
7563271|NCT03254134|11933159|FG001|Overall Study|Not eligible patients|3630
7563272|NCT03254459|11933171|FG000|Overall Study|Adverse Event|7
7563273|NCT03254459|11933172|FG001|Overall Study|Adverse Event|20
7447539|NCT01706926|11735063|FG000|Overall Study|Lost to Follow-up|0
7563274|NCT03254459|11933171|FG000|Overall Study|Withdrawal by Subject Consent|3
7563275|NCT03254459|11933172|FG001|Overall Study|Withdrawal by Subject Consent|1
7563276|NCT03254459|11933171|FG000|Overall Study|Lost to Follow-up|0
7563277|NCT03254459|11933172|FG001|Overall Study|Lost to Follow-up|1
7563278|NCT03254459|11933171|FG000|Overall Study|Miscellaneous|0
7563279|NCT03254459|11933172|FG001|Overall Study|Miscellaneous|1
7563280|NCT03254602|11933178|FG000|Overall Study|Lost to Follow-up|4
7447540|NCT01706926|11735064|FG001|Overall Study|Lost to Follow-up|0
7447541|NCT01706926|11735065|FG002|Overall Study|Lost to Follow-up|1
7563285|NCT03255291|11933201|FG000|Overall Study|Determined to be ineligible|10
7563286|NCT03255291|11933202|FG001|Overall Study|Determined to be ineligible|12
7563287|NCT03255291|11933203|FG002|Overall Study|Determined to be ineligible|6
7563288|NCT03255291|11933204|FG003|Overall Study|Determined to be ineligible|6
7563289|NCT03255291|11933205|FG004|Overall Study|Determined to be ineligible|5
7563290|NCT03255291|11933206|FG005|Overall Study|Determined to be ineligible|10
7563291|NCT03255291|11933201|FG000|Overall Study|Baseline data collection issues|3
7563292|NCT03255291|11933202|FG001|Overall Study|Baseline data collection issues|0
7563293|NCT03255291|11933203|FG002|Overall Study|Baseline data collection issues|0
7563294|NCT03255291|11933204|FG003|Overall Study|Baseline data collection issues|0
7563295|NCT03255291|11933205|FG004|Overall Study|Baseline data collection issues|2
7563296|NCT03255291|11933206|FG005|Overall Study|Baseline data collection issues|0
7563297|NCT03255382|11933226|FG000|Overall Study|Adverse Event|3
7563298|NCT03255382|11933227|FG001|Overall Study|Adverse Event|0
7563299|NCT03255382|11933226|FG000|Overall Study|Lost to Follow-up|2
7563300|NCT03255382|11933227|FG001|Overall Study|Lost to Follow-up|0
7563301|NCT03255382|11933226|FG000|Overall Study|Withdrawal by Subject|2
7563302|NCT03255382|11933227|FG001|Overall Study|Withdrawal by Subject|0
7563303|NCT03255382|11933226|FG000|Overall Study|Other|6
7563304|NCT03255382|11933227|FG001|Overall Study|Other|0
7563305|NCT03255655|11933236|FG000|Overall Study|Lost to Follow-up|7
7563306|NCT03255655|11933237|FG001|Overall Study|Lost to Follow-up|4
7563307|NCT03255733|11933243|FG000|Overall Study|Lost to Follow-up|4
7563308|NCT03255824|11933249|FG000|Overall Study|Under-sedation|2
7563309|NCT03255824|11933250|FG001|Overall Study|Under-sedation|1
7563310|NCT03255941|11933264|FG000|Overall Study|Not eligible or refused injection|37
7563311|NCT03255941|11933265|FG001|Overall Study|Not eligible or refused injection|44
7563312|NCT03255941|11933266|FG002|Overall Study|Not eligible or refused injection|5
7563313|NCT03255941|11933267|FG003|Overall Study|Not eligible or refused injection|6
7563314|NCT03255941|11933264|FG000|Overall Study|Did not complete exit interview|1
7563315|NCT03255941|11933265|FG001|Overall Study|Did not complete exit interview|2
7563316|NCT03255941|11933266|FG002|Overall Study|Did not complete exit interview|0
7563317|NCT03255941|11933267|FG003|Overall Study|Did not complete exit interview|0
7563318|NCT03255980|11933293|FG000|Overall Study|Grade =>3 Skin Toxicity|1
7563319|NCT03255980|11933294|FG001|Overall Study|Grade =>3 Skin Toxicity|4
7563320|NCT03255980|11933295|FG002|Overall Study|Grade =>3 Skin Toxicity|6
7563321|NCT03255980|11933296|FG003|Overall Study|Grade =>3 Skin Toxicity|5
7563322|NCT03255980|11933293|FG000|Overall Study|Adverse Event|1
7563323|NCT03255980|11933294|FG001|Overall Study|Adverse Event|1
7563324|NCT03255980|11933295|FG002|Overall Study|Adverse Event|0
7563325|NCT03255980|11933296|FG003|Overall Study|Adverse Event|1
7563326|NCT03255980|11933293|FG000|Overall Study|Lack of compliance to study or assessmen|0
7563327|NCT03255980|11933294|FG001|Overall Study|Lack of compliance to study or assessmen|1
7563328|NCT03255980|11933295|FG002|Overall Study|Lack of compliance to study or assessmen|0
7563329|NCT03255980|11933296|FG003|Overall Study|Lack of compliance to study or assessmen|0
7563330|NCT03255980|11933293|FG000|Overall Study|Lost to Follow-up|1
7563331|NCT03255980|11933294|FG001|Overall Study|Lost to Follow-up|1
7563332|NCT03255980|11933295|FG002|Overall Study|Lost to Follow-up|0
7563333|NCT03255980|11933296|FG003|Overall Study|Lost to Follow-up|3
7563334|NCT03255980|11933293|FG000|Overall Study|Withdrawal by Subject|0
7563335|NCT03255980|11933294|FG001|Overall Study|Withdrawal by Subject|1
7563336|NCT03255980|11933295|FG002|Overall Study|Withdrawal by Subject|0
7563337|NCT03255980|11933296|FG003|Overall Study|Withdrawal by Subject|3
7563338|NCT03256526|11933339|FG000|Overall Study|Adverse Event|1
7563339|NCT03256526|11933340|FG001|Overall Study|Adverse Event|0
7563340|NCT03256526|11933341|FG002|Overall Study|Adverse Event|1
7563341|NCT03256526|11933339|FG000|Overall Study|Lost to Follow-up|1
7563342|NCT03256526|11933340|FG001|Overall Study|Lost to Follow-up|0
7563343|NCT03256526|11933341|FG002|Overall Study|Lost to Follow-up|2
7563344|NCT03256552|11933349|FG000|Overall Study|Protocol Violation|1
7563345|NCT03256552|11933349|FG000|Overall Study|Physician Decision|1
7563346|NCT03256552|11933349|FG000|Overall Study|Adverse Event|1
7563347|NCT03256552|11933349|FG000|Overall Study|Withdrawal by Subject|2
7563348|NCT03256578|11933361|FG000|Overall Study|Excluded Post Randomization|66
7563349|NCT03256578|11933362|FG001|Overall Study|Excluded Post Randomization|56
7563350|NCT03256695|11933368|FG000|Overall Study|Adverse Event|8
7563351|NCT03256695|11933368|FG000|Overall Study|Death|2
7563352|NCT03256695|11933368|FG000|Overall Study|Withdrawal by Subject|14
7563353|NCT03256695|11933368|FG000|Overall Study|Non-compliance with study drug|1
7563354|NCT03256695|11933368|FG000|Overall Study|Lost to Follow-up|3
7563355|NCT03256695|11933368|FG000|Overall Study|Lack of Efficacy|3
7563356|NCT03256695|11933368|FG000|Overall Study|Protocol Violation|5
7563357|NCT03256695|11933368|FG000|Overall Study|Other than specified|3
7563358|NCT03256851|11933378|FG000|Overall Study|Withdrawal by Subject|1
7563359|NCT03256851|11933379|FG001|Overall Study|Withdrawal by Subject|0
7563360|NCT03257358|11933405|FG000|Overall Study|Adverse Event|25
7563361|NCT03257358|11933406|FG001|Overall Study|Adverse Event|12
7563362|NCT03257358|11933405|FG000|Overall Study|Lack of Efficacy|1
7563363|NCT03257358|11933406|FG001|Overall Study|Lack of Efficacy|1
7563364|NCT03257358|11933405|FG000|Overall Study|Lost to Follow-up|12
7563365|NCT03257358|11933406|FG001|Overall Study|Lost to Follow-up|4
7575019|NCT03707587|11958418|FG000|Overall Study|Death|0
7447542|NCT01706926|11735066|FG003|Overall Study|Lost to Follow-up|0
7447543|NCT01706926|11735063|FG000|Overall Study|Withdrawal by Subject|2
7447544|NCT01706926|11735064|FG001|Overall Study|Withdrawal by Subject|0
7447545|NCT01706926|11735065|FG002|Overall Study|Withdrawal by Subject|1
7447546|NCT01706926|11735066|FG003|Overall Study|Withdrawal by Subject|2
7447547|NCT01706926|11735063|FG000|Overall Study|Other|4
7447548|NCT01706926|11735064|FG001|Overall Study|Other|4
7447549|NCT01706926|11735065|FG002|Overall Study|Other|4
7447550|NCT01706926|11735066|FG003|Overall Study|Other|3
7447551|NCT01707004|11735103|FG000|Overall Study|Physician Decision|3
7575020|NCT03707587|11958419|FG001|Overall Study|Death|1
7447552|NCT01707030|11735110|FG000|Overall Study|Death|1
7447553|NCT01707030|11735111|FG001|Overall Study|Death|1
7447554|NCT01707030|11735110|FG000|Overall Study|Withdrawal by Subject|2
7447555|NCT01707030|11735111|FG001|Overall Study|Withdrawal by Subject|3
7447556|NCT01707030|11735110|FG000|Overall Study|Lost to Follow-up|8
7447557|NCT01707030|11735111|FG001|Overall Study|Lost to Follow-up|13
7447558|NCT01707147|11735144|FG000|Overall Study|Administered Trajenta prior to contract|5
7447559|NCT01707147|11735144|FG000|Overall Study|Patients who have not taken Trajenta|1
7447560|NCT01707147|11735144|FG000|Overall Study|Follow-up failure|17
7447561|NCT01707147|11735144|FG000|Overall Study|Violated inclusion/exclusion criteria|77
7447562|NCT01707290|11735164|FG000|Overall Study|Adverse event (AE)|1
7447563|NCT01707290|11735165|FG001|Overall Study|Adverse event (AE)|0
7447564|NCT01707290|11735164|FG000|Overall Study|Physician Decision|1
7447565|NCT01707290|11735165|FG001|Overall Study|Physician Decision|0
7447566|NCT01707290|11735164|FG000|Overall Study|Lost to Follow-up|3
7447567|NCT01707290|11735165|FG001|Overall Study|Lost to Follow-up|0
7447568|NCT01707290|11735164|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
7447569|NCT01707290|11735165|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
7447570|NCT01707290|11735164|FG000|Overall Study|Commercial drug available|60
7447571|NCT01707290|11735165|FG001|Overall Study|Commercial drug available|1
7447572|NCT01707290|11735164|FG000|Overall Study|Other unspecified|17
7447573|NCT01707290|11735165|FG001|Overall Study|Other unspecified|0
7447574|NCT01707667|11735215|FG000|Period 1|expulsion of colonic sensor catheter|1
7447575|NCT01707667|11735216|FG001|Period 1|expulsion of colonic sensor catheter|0
7447576|NCT01707693|11735224|FG000|Overall Study Allocation|Withdrawal by Subject|9
7447577|NCT01707693|11735225|FG001|Overall Study Allocation|Withdrawal by Subject|5
7447578|NCT01707693|11735224|FG000|Overall Study Allocation|Protocol Violation|4
7447579|NCT01707693|11735225|FG001|Overall Study Allocation|Protocol Violation|3
7447580|NCT01707693|11735224|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
7447581|NCT01707693|11735225|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
7447582|NCT01707693|11735224|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
7447583|NCT01707693|11735225|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
7447584|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
7447585|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
7447711|NCT01708161|11735271|FG001|Overall Study|Withdrawal by Subject|1
7447586|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
7447587|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7447588|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7447589|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
7447590|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
7447591|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
7447592|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
7447593|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7447594|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7447595|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
7447596|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
7537654|NCT02811861|11886776|FG002|Overall Study|Withdrawal by Subject|9
7447597|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
7447598|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
7447599|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7447600|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7447601|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
7447602|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
7447603|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7447604|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7447605|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7447606|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7537655|NCT02811861|11886774|FG000|Overall Study|Other|4
7537656|NCT02811861|11886775|FG001|Overall Study|Other|13
7537657|NCT02811861|11886776|FG002|Overall Study|Other|3
7537658|NCT02811861|11886774|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
7537659|NCT02811861|11886775|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
7537660|NCT02811861|11886776|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
7537661|NCT02811861|11886774|FG000|Overall Study|Randomized but not treated|2
7537662|NCT02811861|11886775|FG001|Overall Study|Randomized but not treated|3
7537663|NCT02811861|11886776|FG002|Overall Study|Randomized but not treated|17
7537664|NCT02759185|11886788|FG000|Stage 1|Adverse Event|0
7537665|NCT02759185|11886789|FG001|Stage 1|Adverse Event|1
7447607|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
7447608|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
7447609|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
7447610|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
7447611|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7447612|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7447613|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
7447614|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
7447615|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
7447616|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
7447617|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7447618|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7447619|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
7447620|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Death|2
7447621|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Death|1
7447622|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Death|1
7447623|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Death|0
7447624|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Death|0
7447625|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Death|0
7447626|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
7447627|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
7447628|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
7447629|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7447630|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7447631|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
7447632|NCT01707992|11735235|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
7447633|NCT01707992|11735236|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
7447634|NCT01707992|11735237|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
7447635|NCT01707992|11735238|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
7447636|NCT01707992|11735239|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
7447637|NCT01707992|11735240|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
7447638|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
7447639|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
7447640|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
7447641|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
7447642|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
7447643|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
7447644|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7447645|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7447646|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
7447647|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
7447648|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
7447649|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
7447650|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7447651|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7447652|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
7447653|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
7447654|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
7447655|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
7447656|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
7447657|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
7447658|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
7447659|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
7447660|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
7447661|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
7447662|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7447663|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7447664|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
7447665|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
7447666|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
7447667|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
7563366|NCT03257358|11933405|FG000|Overall Study|Non-compliance with fingolimod treatment|4
7563367|NCT03257358|11933406|FG001|Overall Study|Non-compliance with fingolimod treatment|2
7563368|NCT03257358|11933405|FG000|Overall Study|Physician Decision|2
7563369|NCT03257358|11933406|FG001|Overall Study|Physician Decision|2
7563370|NCT03257358|11933405|FG000|Overall Study|Protocol Violation|5
7563371|NCT03257358|11933406|FG001|Overall Study|Protocol Violation|3
7563372|NCT03257358|11933405|FG000|Overall Study|Technical problems|4
7563373|NCT03257358|11933406|FG001|Overall Study|Technical problems|1
7447668|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Death|0
7563374|NCT03257358|11933405|FG000|Overall Study|Withdrawal by Subject|8
7447669|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Death|0
7447670|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Death|0
7447671|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Death|2
7447672|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Death|0
7447673|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Death|0
7447674|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Other than specified|0
7447675|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Other than specified|0
7447676|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Other than specified|0
7447677|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Other than specified|1
7447678|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Other than specified|5
7447679|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Other than specified|2
7447680|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
7447681|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
7447682|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
7447683|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
7447684|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
7447685|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
7447686|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7447687|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7447688|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
7447689|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
7447690|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
7447691|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
7447692|NCT01707992|11735235|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7447693|NCT01707992|11735236|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7447694|NCT01707992|11735237|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7447695|NCT01707992|11735238|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7447696|NCT01707992|11735239|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
7447697|NCT01707992|11735240|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
7447698|NCT01708161|11735270|FG000|Overall Study|Adverse Event|1
7447699|NCT01708161|11735271|FG001|Overall Study|Adverse Event|3
7447700|NCT01708161|11735272|FG002|Overall Study|Adverse Event|4
7447701|NCT01708161|11735273|FG003|Overall Study|Adverse Event|2
7447702|NCT01708161|11735274|FG004|Overall Study|Adverse Event|3
7447703|NCT01708161|11735275|FG005|Overall Study|Adverse Event|0
7447704|NCT01708161|11735270|FG000|Overall Study|Death|0
7447705|NCT01708161|11735271|FG001|Overall Study|Death|0
7447706|NCT01708161|11735272|FG002|Overall Study|Death|0
7447707|NCT01708161|11735273|FG003|Overall Study|Death|1
7447708|NCT01708161|11735274|FG004|Overall Study|Death|0
7447709|NCT01708161|11735275|FG005|Overall Study|Death|1
7447710|NCT01708161|11735270|FG000|Overall Study|Withdrawal by Subject|0
7447712|NCT01708161|11735272|FG002|Overall Study|Withdrawal by Subject|1
7447713|NCT01708161|11735273|FG003|Overall Study|Withdrawal by Subject|0
7447714|NCT01708161|11735274|FG004|Overall Study|Withdrawal by Subject|0
7447715|NCT01708161|11735275|FG005|Overall Study|Withdrawal by Subject|0
7447716|NCT01708161|11735270|FG000|Overall Study|Administrative problems|0
7447717|NCT01708161|11735271|FG001|Overall Study|Administrative problems|1
7447718|NCT01708161|11735272|FG002|Overall Study|Administrative problems|0
7447719|NCT01708161|11735273|FG003|Overall Study|Administrative problems|0
7447720|NCT01708161|11735274|FG004|Overall Study|Administrative problems|0
7447721|NCT01708161|11735275|FG005|Overall Study|Administrative problems|0
7447722|NCT01708161|11735270|FG000|Overall Study|Disease progression|3
7447723|NCT01708161|11735271|FG001|Overall Study|Disease progression|5
7447724|NCT01708161|11735272|FG002|Overall Study|Disease progression|5
7447725|NCT01708161|11735273|FG003|Overall Study|Disease progression|13
7447726|NCT01708161|11735274|FG004|Overall Study|Disease progression|3
7447727|NCT01708161|11735275|FG005|Overall Study|Disease progression|0
7447728|NCT01708174|11735292|FG000|Treatment Period|Withdrawal by Subject|1
7447729|NCT01708174|11735293|FG001|Treatment Period|Withdrawal by Subject|0
7447730|NCT01708174|11735294|FG002|Treatment Period|Withdrawal by Subject|0
7447731|NCT01708174|11735292|FG000|Treatment Period|Progressive disease|0
7447732|NCT01708174|11735293|FG001|Treatment Period|Progressive disease|1
7447733|NCT01708174|11735294|FG002|Treatment Period|Progressive disease|0
7447734|NCT01708174|11735292|FG000|Treatment Period|Death|0
7447735|NCT01708174|11735293|FG001|Treatment Period|Death|0
7447736|NCT01708174|11735294|FG002|Treatment Period|Death|1
7447737|NCT01708174|11735292|FG000|Treatment Period|Adverse Event|0
7447738|NCT01708174|11735293|FG001|Treatment Period|Adverse Event|1
7447739|NCT01708174|11735294|FG002|Treatment Period|Adverse Event|0
7447740|NCT01708187|11735305|FG000|Overall Study|Lost to Follow-up|0
7447741|NCT01708187|11735306|FG001|Overall Study|Lost to Follow-up|1
7447742|NCT01708291|11735343|FG000|Overall Study|fighting|2
7447743|NCT01708291|11735344|FG001|Overall Study|fighting|1
7447744|NCT01708902|11735430|FG000|Overall Study|Adverse Event|3
7447745|NCT01708902|11735431|FG001|Overall Study|Adverse Event|4
7447746|NCT01708902|11735432|FG002|Overall Study|Adverse Event|9
7447747|NCT01708902|11735433|FG003|Overall Study|Adverse Event|2
7447748|NCT01708902|11735434|FG004|Overall Study|Adverse Event|7
7447749|NCT01708902|11735435|FG005|Overall Study|Adverse Event|3
7447750|NCT01708902|11735436|FG006|Overall Study|Adverse Event|5
7447751|NCT01708902|11735430|FG000|Overall Study|Lack of Efficacy|3
7447752|NCT01708902|11735431|FG001|Overall Study|Lack of Efficacy|1
7447753|NCT01708902|11735432|FG002|Overall Study|Lack of Efficacy|0
7447754|NCT01708902|11735433|FG003|Overall Study|Lack of Efficacy|0
7447755|NCT01708902|11735434|FG004|Overall Study|Lack of Efficacy|0
7447756|NCT01708902|11735435|FG005|Overall Study|Lack of Efficacy|1
7447757|NCT01708902|11735436|FG006|Overall Study|Lack of Efficacy|0
7447758|NCT01708902|11735430|FG000|Overall Study|Non compliance with protocol|0
7447759|NCT01708902|11735431|FG001|Overall Study|Non compliance with protocol|2
7447760|NCT01708902|11735432|FG002|Overall Study|Non compliance with protocol|1
7447761|NCT01708902|11735433|FG003|Overall Study|Non compliance with protocol|3
7447762|NCT01708902|11735434|FG004|Overall Study|Non compliance with protocol|0
7447763|NCT01708902|11735435|FG005|Overall Study|Non compliance with protocol|0
7447764|NCT01708902|11735436|FG006|Overall Study|Non compliance with protocol|0
7447765|NCT01708902|11735430|FG000|Overall Study|Lost to Follow-up|2
7447766|NCT01708902|11735431|FG001|Overall Study|Lost to Follow-up|1
7447767|NCT01708902|11735432|FG002|Overall Study|Lost to Follow-up|2
7447768|NCT01708902|11735433|FG003|Overall Study|Lost to Follow-up|2
7447769|NCT01708902|11735434|FG004|Overall Study|Lost to Follow-up|0
7447770|NCT01708902|11735435|FG005|Overall Study|Lost to Follow-up|0
7447771|NCT01708902|11735436|FG006|Overall Study|Lost to Follow-up|1
7447772|NCT01708902|11735430|FG000|Overall Study|Refused to continue trial medication|8
7447773|NCT01708902|11735431|FG001|Overall Study|Refused to continue trial medication|0
7447774|NCT01708902|11735432|FG002|Overall Study|Refused to continue trial medication|4
7447775|NCT01708902|11735433|FG003|Overall Study|Refused to continue trial medication|2
7447776|NCT01708902|11735434|FG004|Overall Study|Refused to continue trial medication|8
7447777|NCT01708902|11735435|FG005|Overall Study|Refused to continue trial medication|1
7447778|NCT01708902|11735436|FG006|Overall Study|Refused to continue trial medication|1
7447779|NCT01708902|11735430|FG000|Overall Study|Other Reason|1
7447780|NCT01708902|11735431|FG001|Overall Study|Other Reason|0
7447781|NCT01708902|11735432|FG002|Overall Study|Other Reason|1
7447782|NCT01708902|11735433|FG003|Overall Study|Other Reason|1
7447783|NCT01708902|11735434|FG004|Overall Study|Other Reason|1
7447784|NCT01708902|11735435|FG005|Overall Study|Other Reason|2
7447785|NCT01708902|11735436|FG006|Overall Study|Other Reason|0
7447786|NCT01708915|11735459|FG000|Overall Study|Adverse Event|1
7447787|NCT01708915|11735460|FG001|Overall Study|Adverse Event|0
7447788|NCT01708915|11735461|FG002|Overall Study|Adverse Event|9
7447789|NCT01708915|11735462|FG003|Overall Study|Adverse Event|13
7447790|NCT01708915|11735459|FG000|Overall Study|Lack of Efficacy|84
7447791|NCT01708915|11735460|FG001|Overall Study|Lack of Efficacy|60
7447792|NCT01708915|11735461|FG002|Overall Study|Lack of Efficacy|35
7447793|NCT01708915|11735462|FG003|Overall Study|Lack of Efficacy|15
7447794|NCT01708915|11735459|FG000|Overall Study|Protocol Violation|0
7447795|NCT01708915|11735460|FG001|Overall Study|Protocol Violation|0
7447796|NCT01708915|11735461|FG002|Overall Study|Protocol Violation|0
7447797|NCT01708915|11735462|FG003|Overall Study|Protocol Violation|1
7447798|NCT01708915|11735459|FG000|Overall Study|Withdrawal by Subject|0
7447799|NCT01708915|11735460|FG001|Overall Study|Withdrawal by Subject|1
7447800|NCT01708915|11735461|FG002|Overall Study|Withdrawal by Subject|2
7447801|NCT01708915|11735462|FG003|Overall Study|Withdrawal by Subject|2
7447802|NCT01708915|11735459|FG000|Overall Study|Other reasons than stated above|1
7447803|NCT01708915|11735460|FG001|Overall Study|Other reasons than stated above|1
7447804|NCT01708915|11735461|FG002|Overall Study|Other reasons than stated above|0
7447805|NCT01708915|11735462|FG003|Overall Study|Other reasons than stated above|2
7467810|NCT01903837|11768244|FG001|Part B|Lack of Efficacy|1
7467811|NCT01903837|11768245|FG002|Part B|Lack of Efficacy|0
7467812|NCT01903837|11768246|FG003|Part B|Lack of Efficacy|0
7467813|NCT01903863|11768279|FG000|Overall Study|Physician Decision|2
7467814|NCT01903863|11768280|FG001|Overall Study|Physician Decision|0
7467815|NCT01903876|11768288|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
7467816|NCT01903876|11768289|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
7467817|NCT01903876|11768288|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
7467818|NCT01903876|11768289|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
7467819|NCT01903993|11768297|FG000|Overall Study|Death|118
7467820|NCT01903993|11768298|FG001|Overall Study|Death|121
7467821|NCT01903993|11768297|FG000|Overall Study|Withdrawal by Subject|15
7467822|NCT01903993|11768298|FG001|Overall Study|Withdrawal by Subject|4
7467823|NCT01903993|11768297|FG000|Overall Study|Lost to Follow-up|2
7467824|NCT01903993|11768298|FG001|Overall Study|Lost to Follow-up|3
7467825|NCT01903993|11768297|FG000|Overall Study|Study Terminated by Sponsor|8
7467826|NCT01903993|11768298|FG001|Overall Study|Study Terminated by Sponsor|14
7467827|NCT01903993|11768297|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
7467828|NCT01903993|11768298|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
7467829|NCT01904019|11768305|FG000|1 Year Follow-up|Withdrawal by Subject|4
7467830|NCT01904019|11768305|FG000|1 Year Follow-up|Impossibility to contact patient|5
7467831|NCT01904019|11768305|FG000|3 Year Follow-up|Withdrawal by Subject|1
7467832|NCT01904019|11768305|FG000|3 Year Follow-up|Impossibility to contact patient|14
7467833|NCT01904019|11768305|FG000|5 Year Follow-up|Withdrawal by Subject|2
7447806|NCT01709084|11735488|FG000|Overall Study|Lost to Follow-up|4
7447807|NCT01709084|11735489|FG001|Overall Study|Lost to Follow-up|7
7563375|NCT03257358|11933406|FG001|Overall Study|Withdrawal by Subject|3
7563376|NCT03257358|11933405|FG000|Overall Study|Withdrawal of informed consent|9
7447808|NCT01709084|11735488|FG000|Overall Study|Withdrawal by Subject|2
7447809|NCT01709084|11735489|FG001|Overall Study|Withdrawal by Subject|2
7447810|NCT01709084|11735488|FG000|Overall Study|Adverse Event|5
7447811|NCT01709084|11735489|FG001|Overall Study|Adverse Event|0
7447812|NCT01709084|11735488|FG000|Overall Study|Other|5
7328856|NCT00798174|11561789|FG000|Overall Study|Inability to sedate for DFT testing|1
7328857|NCT00798174|11561790|FG001|Overall Study|Inability to sedate for DFT testing|0
7328858|NCT00798304|11561797|FG000|Overall Study|Adverse Event|0
7328859|NCT00798304|11561798|FG001|Overall Study|Adverse Event|1
7328860|NCT00798304|11561799|FG002|Overall Study|Adverse Event|1
7328861|NCT00798304|11561797|FG000|Overall Study|Discontinuation by Sponsor|14
7328862|NCT00798304|11561798|FG001|Overall Study|Discontinuation by Sponsor|21
7328863|NCT00798304|11561799|FG002|Overall Study|Discontinuation by Sponsor|9
7328864|NCT00798317|11561809|FG000|Overall Study|Physician Decision|0
7328865|NCT00798317|11561810|FG001|Overall Study|Physician Decision|1
7328866|NCT00798317|11561809|FG000|Overall Study|Withdrawal by Subject|5
7328867|NCT00798317|11561810|FG001|Overall Study|Withdrawal by Subject|4
7328868|NCT00798317|11561809|FG000|Overall Study|Lost to Follow-up|2
7328869|NCT00798317|11561810|FG001|Overall Study|Lost to Follow-up|2
7328870|NCT00798317|11561809|FG000|Overall Study|Adverse Event|2
7447813|NCT01709084|11735489|FG001|Overall Study|Other|3
7447814|NCT01709084|11735488|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
7447815|NCT01709084|11735489|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
7447816|NCT01709084|11735488|FG000|Overall Study|Not Treated|0
7447817|NCT01709084|11735489|FG001|Overall Study|Not Treated|2
7447818|NCT01709110|11735497|FG000|Overall Study|Adverse Event|56
7447819|NCT01709110|11735498|FG001|Overall Study|Adverse Event|48
7447820|NCT01709110|11735497|FG000|Overall Study|Death|14
7447821|NCT01709110|11735498|FG001|Overall Study|Death|6
7447822|NCT01709110|11735497|FG000|Overall Study|Lost to Follow-up|7
7447823|NCT01709110|11735498|FG001|Overall Study|Lost to Follow-up|5
7447824|NCT01709110|11735497|FG000|Overall Study|Protocol Violation|4
7447825|NCT01709110|11735498|FG001|Overall Study|Protocol Violation|6
7447826|NCT01709110|11735497|FG000|Overall Study|Withdrawal by Subject|96
7447827|NCT01709110|11735498|FG001|Overall Study|Withdrawal by Subject|89
7447828|NCT01709110|11735497|FG000|Overall Study|Physician Decision|4
7447829|NCT01709110|11735498|FG001|Overall Study|Physician Decision|10
7447830|NCT01709110|11735497|FG000|Overall Study|Sponsor Decision|2
7447831|NCT01709110|11735498|FG001|Overall Study|Sponsor Decision|2
7447832|NCT01709110|11735497|FG000|Overall Study|Lack of Efficacy|1
7563377|NCT03257358|11933406|FG001|Overall Study|Withdrawal of informed consent|5
7563378|NCT03257358|11933405|FG000|Overall Study|New therapy for study indication|1
7563379|NCT03257358|11933406|FG001|Overall Study|New therapy for study indication|0
7563380|NCT03257358|11933405|FG000|Overall Study|No longer requires treatment|0
7563381|NCT03257358|11933406|FG001|Overall Study|No longer requires treatment|1
7563382|NCT03257371|11933412|FG000|Overall Study|Lost to Follow-up|1
7563383|NCT03257410|11933418|FG000|Overall Study|Adverse Event|2
7563384|NCT03257410|11933419|FG001|Overall Study|Adverse Event|3
7563385|NCT03257410|11933418|FG000|Overall Study|Protocol Violation|1
7563386|NCT03257410|11933419|FG001|Overall Study|Protocol Violation|2
7563387|NCT03257410|11933418|FG000|Overall Study|Lost to Follow-up|1
7563388|NCT03257410|11933419|FG001|Overall Study|Lost to Follow-up|0
7563389|NCT03257410|11933418|FG000|Overall Study|Withdrawal by Subject|1
7563390|NCT03257410|11933419|FG001|Overall Study|Withdrawal by Subject|2
7563391|NCT03257410|11933418|FG000|Overall Study|Physician Decision|1
7563392|NCT03257410|11933419|FG001|Overall Study|Physician Decision|1
7563393|NCT03257410|11933418|FG000|Overall Study|Renal transplantation|2
7563394|NCT03257410|11933419|FG001|Overall Study|Renal transplantation|0
7563395|NCT03257410|11933418|FG000|Overall Study|Switch to peritoneal dialysis|1
7563396|NCT03257410|11933419|FG001|Overall Study|Switch to peritoneal dialysis|0
7563397|NCT03257410|11933418|FG000|Overall Study|Death|3
7563398|NCT03257410|11933419|FG001|Overall Study|Death|2
7563399|NCT03257410|11933418|FG000|Overall Study|Change to another dialysis center|2
7563400|NCT03257410|11933419|FG001|Overall Study|Change to another dialysis center|2
7563401|NCT03257410|11933418|FG000|Overall Study|Missing 3 consecutive study treatments|5
7563402|NCT03257410|11933419|FG001|Overall Study|Missing 3 consecutive study treatments|6
7563403|NCT03257410|11933418|FG000|Overall Study|Miscellaneous|2
7563404|NCT03257410|11933419|FG001|Overall Study|Miscellaneous|2
7447833|NCT01709110|11735498|FG001|Overall Study|Lack of Efficacy|1
7447834|NCT01709110|11735497|FG000|Overall Study|Caregiver Decision|1
7447835|NCT01709110|11735498|FG001|Overall Study|Caregiver Decision|1
7447836|NCT01709149|11735507|FG000|Open-label Lead-in Phase|Adverse Event|109
7563405|NCT03257410|11933418|FG000|Overall Study|Other|0
7328871|NCT00798317|11561810|FG001|Overall Study|Adverse Event|0
7447837|NCT01709149|11735508|FG001|Open-label Lead-in Phase|Adverse Event|0
7447838|NCT01709149|11735509|FG002|Open-label Lead-in Phase|Adverse Event|0
7447839|NCT01709149|11735507|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
7563406|NCT03257410|11933419|FG001|Overall Study|Other|1
7563407|NCT03257657|11933427|FG000|Overall Study|Lost to Follow-up|0
7447840|NCT01709149|11735508|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
7447841|NCT01709149|11735509|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
7447842|NCT01709149|11735507|FG000|Open-label Lead-in Phase|Death|1
7447843|NCT01709149|11735508|FG001|Open-label Lead-in Phase|Death|0
7447844|NCT01709149|11735509|FG002|Open-label Lead-in Phase|Death|0
7447845|NCT01709149|11735507|FG000|Open-label Lead-in Phase|Protocol Violation|3
7447846|NCT01709149|11735508|FG001|Open-label Lead-in Phase|Protocol Violation|0
7447847|NCT01709149|11735509|FG002|Open-label Lead-in Phase|Protocol Violation|0
7447848|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
7447849|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
7447850|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
7447851|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
7447852|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
7447853|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
7447854|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
7447855|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
7447856|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
7447857|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|Death|0
7447858|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|Death|2
7447859|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|Death|0
7447860|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|not defined|0
7447861|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|not defined|1
7447862|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|not defined|2
7447863|NCT01709149|11735507|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7447864|NCT01709149|11735508|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
7447865|NCT01709149|11735509|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
7447866|NCT01709162|11735518|FG000|Overall Study|Disease progression|3
7447867|NCT01709162|11735519|FG001|Overall Study|Disease progression|3
7447868|NCT01709162|11735518|FG000|Overall Study|Study drug toxicity|2
7447869|NCT01709162|11735519|FG001|Overall Study|Study drug toxicity|0
7447870|NCT01709162|11735518|FG000|Overall Study|Administrative reason by sponsor|0
7447871|NCT01709162|11735519|FG001|Overall Study|Administrative reason by sponsor|1
7447872|NCT01709162|11735518|FG000|Overall Study|Other|1
7447873|NCT01709162|11735519|FG001|Overall Study|Other|0
7447874|NCT01709162|11735518|FG000|Overall Study|Withdrawal by Subject|0
7447875|NCT01709162|11735519|FG001|Overall Study|Withdrawal by Subject|1
7447876|NCT01709227|11735527|FG000|Overall Study|Physician Decision|1
7447877|NCT01709227|11735528|FG001|Overall Study|Physician Decision|0
7447878|NCT01709227|11735527|FG000|Overall Study|Pleural Peritoneal communication|0
7447879|NCT01709227|11735528|FG001|Overall Study|Pleural Peritoneal communication|9
7447880|NCT01709305|11735535|FG000|Phase 1|Clinical Adverse Event|80
7447881|NCT01709305|11735536|FG001|Phase 1|Clinical Adverse Event|0
7447882|NCT01709305|11735537|FG002|Phase 1|Clinical Adverse Event|0
7447883|NCT01709305|11735538|FG003|Phase 1|Clinical Adverse Event|0
7447884|NCT01709305|11735539|FG004|Phase 1|Clinical Adverse Event|0
7447885|NCT01709305|11735535|FG000|Phase 1|Death|2
7447886|NCT01709305|11735536|FG001|Phase 1|Death|0
7447887|NCT01709305|11735537|FG002|Phase 1|Death|0
7447888|NCT01709305|11735538|FG003|Phase 1|Death|0
7447889|NCT01709305|11735539|FG004|Phase 1|Death|0
7447890|NCT01709305|11735535|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
7447891|NCT01709305|11735536|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
7447892|NCT01709305|11735537|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
7447893|NCT01709305|11735538|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
7447894|NCT01709305|11735539|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
7447895|NCT01709305|11735535|FG000|Phase 1|Laboratory Adverse Event|16
7447896|NCT01709305|11735536|FG001|Phase 1|Laboratory Adverse Event|0
7447897|NCT01709305|11735537|FG002|Phase 1|Laboratory Adverse Event|0
7447898|NCT01709305|11735538|FG003|Phase 1|Laboratory Adverse Event|0
7447899|NCT01709305|11735539|FG004|Phase 1|Laboratory Adverse Event|0
7447900|NCT01709305|11735535|FG000|Phase 1|Lost to Follow-up|147
7447901|NCT01709305|11735536|FG001|Phase 1|Lost to Follow-up|0
7447902|NCT01709305|11735537|FG002|Phase 1|Lost to Follow-up|0
7447903|NCT01709305|11735538|FG003|Phase 1|Lost to Follow-up|0
7447904|NCT01709305|11735539|FG004|Phase 1|Lost to Follow-up|0
7447905|NCT01709305|11735535|FG000|Phase 1|Travel, moving, etc.|30
7447906|NCT01709305|11735536|FG001|Phase 1|Travel, moving, etc.|0
7447907|NCT01709305|11735537|FG002|Phase 1|Travel, moving, etc.|0
7447908|NCT01709305|11735538|FG003|Phase 1|Travel, moving, etc.|0
7447909|NCT01709305|11735539|FG004|Phase 1|Travel, moving, etc.|0
7447910|NCT01709305|11735535|FG000|Phase 1|Physician Decision|13
7447911|NCT01709305|11735536|FG001|Phase 1|Physician Decision|0
7447912|NCT01709305|11735537|FG002|Phase 1|Physician Decision|0
7532972|NCT02678923|11878938|FG000|Overall Study|Did Not Return for Study Visits|1
7532973|NCT02678923|11878939|FG001|Overall Study|Did Not Return for Study Visits|0
7447913|NCT01709305|11735538|FG003|Phase 1|Physician Decision|0
7447914|NCT01709305|11735539|FG004|Phase 1|Physician Decision|0
7447915|NCT01709305|11735535|FG000|Phase 1|Protocol Violation|118
7447916|NCT01709305|11735536|FG001|Phase 1|Protocol Violation|0
7447917|NCT01709305|11735537|FG002|Phase 1|Protocol Violation|0
7447918|NCT01709305|11735538|FG003|Phase 1|Protocol Violation|0
7447919|NCT01709305|11735539|FG004|Phase 1|Protocol Violation|0
7447920|NCT01709305|11735535|FG000|Phase 1|Withdrawal by Subject|218
7447921|NCT01709305|11735536|FG001|Phase 1|Withdrawal by Subject|0
7447922|NCT01709305|11735537|FG002|Phase 1|Withdrawal by Subject|0
7447923|NCT01709305|11735538|FG003|Phase 1|Withdrawal by Subject|0
7447924|NCT01709305|11735539|FG004|Phase 1|Withdrawal by Subject|0
7447925|NCT01709305|11735535|FG000|Phase 2|Clinical Adverse Event|0
7447926|NCT01709305|11735536|FG001|Phase 2|Clinical Adverse Event|10
7447927|NCT01709305|11735537|FG002|Phase 2|Clinical Adverse Event|10
7447928|NCT01709305|11735538|FG003|Phase 2|Clinical Adverse Event|6
7447929|NCT01709305|11735539|FG004|Phase 2|Clinical Adverse Event|11
7447930|NCT01709305|11735535|FG000|Phase 2|Death|0
7447931|NCT01709305|11735536|FG001|Phase 2|Death|0
7447932|NCT01709305|11735537|FG002|Phase 2|Death|1
7447933|NCT01709305|11735538|FG003|Phase 2|Death|0
7447934|NCT01709305|11735539|FG004|Phase 2|Death|0
7447935|NCT01709305|11735535|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
7447936|NCT01709305|11735536|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
7447937|NCT01709305|11735537|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
7447938|NCT01709305|11735538|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
7447939|NCT01709305|11735539|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
7447940|NCT01709305|11735535|FG000|Phase 2|Laboratory Adverse Event|0
7447941|NCT01709305|11735536|FG001|Phase 2|Laboratory Adverse Event|1
7447942|NCT01709305|11735537|FG002|Phase 2|Laboratory Adverse Event|0
7447943|NCT01709305|11735538|FG003|Phase 2|Laboratory Adverse Event|1
7447944|NCT01709305|11735539|FG004|Phase 2|Laboratory Adverse Event|1
7447945|NCT01709305|11735535|FG000|Phase 2|Lost to Follow-up|0
7447946|NCT01709305|11735536|FG001|Phase 2|Lost to Follow-up|10
7447947|NCT01709305|11735537|FG002|Phase 2|Lost to Follow-up|6
7447948|NCT01709305|11735538|FG003|Phase 2|Lost to Follow-up|9
7447949|NCT01709305|11735539|FG004|Phase 2|Lost to Follow-up|5
7447950|NCT01709305|11735535|FG000|Phase 2|Travel, moving, etc.|0
7447951|NCT01709305|11735536|FG001|Phase 2|Travel, moving, etc.|2
7447952|NCT01709305|11735537|FG002|Phase 2|Travel, moving, etc.|3
7447953|NCT01709305|11735538|FG003|Phase 2|Travel, moving, etc.|3
7447954|NCT01709305|11735539|FG004|Phase 2|Travel, moving, etc.|5
7447955|NCT01709305|11735535|FG000|Phase 2|Physician Decision|0
7447956|NCT01709305|11735536|FG001|Phase 2|Physician Decision|2
7447957|NCT01709305|11735537|FG002|Phase 2|Physician Decision|0
7447958|NCT01709305|11735538|FG003|Phase 2|Physician Decision|1
7447959|NCT01709305|11735539|FG004|Phase 2|Physician Decision|2
7447960|NCT01709305|11735535|FG000|Phase 2|Protocol Violation|0
7447961|NCT01709305|11735536|FG001|Phase 2|Protocol Violation|19
7447962|NCT01709305|11735537|FG002|Phase 2|Protocol Violation|19
7447963|NCT01709305|11735538|FG003|Phase 2|Protocol Violation|13
7447964|NCT01709305|11735539|FG004|Phase 2|Protocol Violation|9
7447965|NCT01709305|11735535|FG000|Phase 2|Withdrawal by Subject|0
7447966|NCT01709305|11735536|FG001|Phase 2|Withdrawal by Subject|8
7447967|NCT01709305|11735537|FG002|Phase 2|Withdrawal by Subject|6
7447968|NCT01709305|11735538|FG003|Phase 2|Withdrawal by Subject|15
7447969|NCT01709305|11735539|FG004|Phase 2|Withdrawal by Subject|12
7447970|NCT01709383|11735556|FG000|Overall Study|Lost to Follow-up|1
7447971|NCT01709383|11735557|FG001|Overall Study|Lost to Follow-up|0
7447972|NCT01709409|11735567|FG000|Overall Study|Protocol Violation|1
7447973|NCT01709409|11735568|FG001|Overall Study|Protocol Violation|0
7447974|NCT01709500|11735596|FG000|Overall Study|Randomized but not treated|0
7563408|NCT03257657|11933428|FG001|Overall Study|Lost to Follow-up|3
7563409|NCT03257657|11933427|FG000|Overall Study|Withdrawn|0
7563410|NCT03257657|11933428|FG001|Overall Study|Withdrawn|1
7563411|NCT03257657|11933427|FG000|Overall Study|Noted not eligible right after enrolled|0
7563412|NCT03257657|11933428|FG001|Overall Study|Noted not eligible right after enrolled|1
7563413|NCT03257813|11933437|FG000|Overall Study|Protocol Violation|6
7563414|NCT03257813|11933438|FG001|Overall Study|Protocol Violation|3
7563415|NCT03257865|11933449|FG000|Overall Study|Adverse Event|4
7563416|NCT03257865|11933450|FG001|Overall Study|Adverse Event|8
7563417|NCT03257865|11933449|FG000|Overall Study|Lack of Efficacy|1
7563418|NCT03257865|11933450|FG001|Overall Study|Lack of Efficacy|2
7563419|NCT03257865|11933449|FG000|Overall Study|Non-compliance with Study Drug|0
7563420|NCT03257865|11933450|FG001|Overall Study|Non-compliance with Study Drug|2
7563421|NCT03257865|11933449|FG000|Overall Study|Withdrawal by Subject|23
7563422|NCT03257865|11933450|FG001|Overall Study|Withdrawal by Subject|17
7563423|NCT03257865|11933449|FG000|Overall Study|Physician Decision|3
7563424|NCT03257865|11933450|FG001|Overall Study|Physician Decision|1
7563425|NCT03257865|11933449|FG000|Overall Study|Other|0
7563426|NCT03257865|11933450|FG001|Overall Study|Other|1
7447975|NCT01709500|11735597|FG001|Overall Study|Randomized but not treated|1
7447976|NCT01709500|11735596|FG000|Overall Study|Adverse Event|5
7447977|NCT01709500|11735597|FG001|Overall Study|Adverse Event|1
7447978|NCT01709500|11735596|FG000|Overall Study|Poor compliance to protocol|2
7447979|NCT01709500|11735597|FG001|Overall Study|Poor compliance to protocol|1
7447980|NCT01709500|11735596|FG000|Overall Study|Other|3
7447981|NCT01709500|11735597|FG001|Overall Study|Other|1
7447982|NCT01709500|11735596|FG000|Overall Study|Related to IMP administration|1
7447983|NCT01709500|11735597|FG001|Overall Study|Related to IMP administration|0
7447984|NCT01709500|11735596|FG000|Overall Study|Treatment ongoing|156
7447985|NCT01709500|11735597|FG001|Overall Study|Treatment ongoing|78
7447986|NCT01709513|11735606|FG000|Overall Study|Randomized but not treated|0
7447987|NCT01709513|11735607|FG001|Overall Study|Randomized but not treated|1
7563427|NCT03257865|11933449|FG000|Overall Study|Lost to Follow-up|4
7447988|NCT01709513|11735608|FG002|Overall Study|Randomized but not treated|0
7447989|NCT01709513|11735606|FG000|Overall Study|Adverse Event|16
7447990|NCT01709513|11735607|FG001|Overall Study|Adverse Event|31
7447991|NCT01709513|11735608|FG002|Overall Study|Adverse Event|23
7447992|NCT01709513|11735606|FG000|Overall Study|Poor compliance to protocol|2
7447993|NCT01709513|11735607|FG001|Overall Study|Poor compliance to protocol|0
7447994|NCT01709513|11735608|FG002|Overall Study|Poor compliance to protocol|0
7447995|NCT01709513|11735606|FG000|Overall Study|Other|3
7447996|NCT01709513|11735607|FG001|Overall Study|Other|11
7447997|NCT01709513|11735608|FG002|Overall Study|Other|7
7447998|NCT01709578|11735622|FG000|Overall Study|Rescued and entered in long term safety|63
7447999|NCT01709578|11735623|FG001|Overall Study|Rescued and entered in long term safety|25
7448000|NCT01709578|11735624|FG002|Overall Study|Rescued and entered in long term safety|26
7448001|NCT01709578|11735622|FG000|Overall Study|Adverse Event|9
7448002|NCT01709578|11735623|FG001|Overall Study|Adverse Event|18
7448003|NCT01709578|11735624|FG002|Overall Study|Adverse Event|17
7448004|NCT01709578|11735622|FG000|Overall Study|Lack of Efficacy|5
7448005|NCT01709578|11735623|FG001|Overall Study|Lack of Efficacy|4
7448006|NCT01709578|11735624|FG002|Overall Study|Lack of Efficacy|2
7448007|NCT01709578|11735622|FG000|Overall Study|Poor compliance to protocol|1
7448008|NCT01709578|11735623|FG001|Overall Study|Poor compliance to protocol|2
7448009|NCT01709578|11735624|FG002|Overall Study|Poor compliance to protocol|1
7448010|NCT01709578|11735622|FG000|Overall Study|Other, not related to safety or efficacy|2
7448011|NCT01709578|11735623|FG001|Overall Study|Other, not related to safety or efficacy|7
7448012|NCT01709578|11735624|FG002|Overall Study|Other, not related to safety or efficacy|5
7448013|NCT01709695|11735634|FG000|Overall Study|Withdrawal by Subject|1
7448014|NCT01709695|11735635|FG001|Overall Study|Withdrawal by Subject|1
7448015|NCT01709708|11735643|FG000|Overall Study|Protocol Violation|1
7448016|NCT01709708|11735644|FG001|Overall Study|Protocol Violation|2
7448017|NCT01709721|11735654|FG000|Open Label Phase|Withdrawal by Subject|0
7448018|NCT01709721|11735655|FG001|Open Label Phase|Withdrawal by Subject|0
7448019|NCT01709721|11735656|FG002|Open Label Phase|Withdrawal by Subject|5
7448020|NCT01709721|11735654|FG000|Open Label Phase|Adverse Event|0
7448021|NCT01709721|11735655|FG001|Open Label Phase|Adverse Event|0
7448022|NCT01709721|11735656|FG002|Open Label Phase|Adverse Event|8
7448023|NCT01709721|11735654|FG000|Open Label Phase|Non-compliance With Study Drug|0
7448024|NCT01709721|11735655|FG001|Open Label Phase|Non-compliance With Study Drug|0
7448025|NCT01709721|11735656|FG002|Open Label Phase|Non-compliance With Study Drug|3
7448026|NCT01709721|11735654|FG000|Open Label Phase|Investigator Decision|0
7448027|NCT01709721|11735655|FG001|Open Label Phase|Investigator Decision|0
7448028|NCT01709721|11735656|FG002|Open Label Phase|Investigator Decision|1
7448029|NCT01709721|11735654|FG000|Open Label Phase|Sponsor Decision|0
7448030|NCT01709721|11735655|FG001|Open Label Phase|Sponsor Decision|0
7448031|NCT01709721|11735656|FG002|Open Label Phase|Sponsor Decision|2
7448032|NCT01709721|11735654|FG000|Open Label Phase|Protocol Violation|0
7448033|NCT01709721|11735655|FG001|Open Label Phase|Protocol Violation|0
7448034|NCT01709721|11735656|FG002|Open Label Phase|Protocol Violation|1
7448035|NCT01709721|11735654|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7563428|NCT03257865|11933450|FG001|Overall Study|Lost to Follow-up|4
7563429|NCT03257995|11933456|FG000|Overall Study|Adverse Event|0
7448036|NCT01709721|11735655|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
7448037|NCT01709721|11735656|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
7448038|NCT01709721|11735654|FG000|Open Label Phase|Inadequate Pain Control|0
7448039|NCT01709721|11735655|FG001|Open Label Phase|Inadequate Pain Control|0
7448040|NCT01709721|11735656|FG002|Open Label Phase|Inadequate Pain Control|37
7448041|NCT01709721|11735654|FG000|Open Label Phase|Other, Specify in text field in database|0
7448042|NCT01709721|11735655|FG001|Open Label Phase|Other, Specify in text field in database|0
7448043|NCT01709721|11735656|FG002|Open Label Phase|Other, Specify in text field in database|14
7448044|NCT01709721|11735654|FG000|Randomized Phase|Adverse Event|0
7448045|NCT01709721|11735655|FG001|Randomized Phase|Adverse Event|1
7448046|NCT01709721|11735656|FG002|Randomized Phase|Adverse Event|0
7448047|NCT01709721|11735654|FG000|Randomized Phase|Lost to Follow-up|1
7448048|NCT01709721|11735655|FG001|Randomized Phase|Lost to Follow-up|0
7448049|NCT01709721|11735656|FG002|Randomized Phase|Lost to Follow-up|0
7448050|NCT01709721|11735654|FG000|Randomized Phase|Inadequate Pain Control|1
7448051|NCT01709721|11735655|FG001|Randomized Phase|Inadequate Pain Control|2
7448052|NCT01709721|11735656|FG002|Randomized Phase|Inadequate Pain Control|0
7448053|NCT01709721|11735654|FG000|Randomized Phase|Other, Specify text field in database|1
7448054|NCT01709721|11735655|FG001|Randomized Phase|Other, Specify text field in database|3
7448055|NCT01709721|11735656|FG002|Randomized Phase|Other, Specify text field in database|0
7448056|NCT01709838|11735688|FG000|Overall Study|Withdrawal by Subject|21
7448057|NCT01709838|11735688|FG000|Overall Study|Lost to Follow-up|16
7448058|NCT01709838|11735688|FG000|Overall Study|Pregnancy|10
7448059|NCT01709838|11735688|FG000|Overall Study|Subject/guardian decision|8
7448060|NCT01709838|11735688|FG000|Overall Study|Adverse Event|4
7448061|NCT01709838|11735688|FG000|Overall Study|Physician Decision|4
7448062|NCT01709838|11735688|FG000|Overall Study|Death|3
7448063|NCT01709838|11735688|FG000|Overall Study|Protocol Violation|1
7448064|NCT01709864|11735696|FG000|Overall Study|Physician Decision|0
7563430|NCT03257995|11933457|FG001|Overall Study|Adverse Event|1
7448065|NCT01709864|11735697|FG001|Overall Study|Physician Decision|1
7448066|NCT01709864|11735696|FG000|Overall Study|subject/guardian decision|5
7448067|NCT01709864|11735697|FG001|Overall Study|subject/guardian decision|6
7448068|NCT01709864|11735696|FG000|Overall Study|Lost to Follow-up|1
7448069|NCT01709864|11735697|FG001|Overall Study|Lost to Follow-up|0
7448070|NCT01709864|11735696|FG000|Overall Study|non-compliance with study treatment|1
7448071|NCT01709864|11735697|FG001|Overall Study|non-compliance with study treatment|1
7448072|NCT01709864|11735696|FG000|Overall Study|Adverse Event|0
7448073|NCT01709864|11735697|FG001|Overall Study|Adverse Event|2
7448074|NCT01709864|11735696|FG000|Overall Study|Death|0
7448075|NCT01709864|11735697|FG001|Overall Study|Death|1
7448076|NCT01709903|11735705|FG000|Overall Study|administrative problems|2
7448077|NCT01709903|11735706|FG001|Overall Study|administrative problems|6
7448078|NCT01709903|11735705|FG000|Overall Study|Abnormal test procedure results|1
7448079|NCT01709903|11735706|FG001|Overall Study|Abnormal test procedure results|0
7448080|NCT01709903|11735705|FG000|Overall Study|In ability to use device|1
7448081|NCT01709903|11735706|FG001|Overall Study|In ability to use device|1
7448082|NCT01709903|11735705|FG000|Overall Study|no longer needed study drug|0
7448083|NCT01709903|11735706|FG001|Overall Study|no longer needed study drug|1
7448084|NCT01709903|11735705|FG000|Overall Study|Lost to Follow-up|0
7448085|NCT01709903|11735706|FG001|Overall Study|Lost to Follow-up|2
7448086|NCT01709903|11735705|FG000|Overall Study|Death|2
7448087|NCT01709903|11735706|FG001|Overall Study|Death|0
7448088|NCT01709903|11735705|FG000|Overall Study|Protocol Violation|3
7448089|NCT01709903|11735706|FG001|Overall Study|Protocol Violation|2
7448090|NCT01709903|11735705|FG000|Overall Study|Lack of Efficacy|3
7448091|NCT01709903|11735706|FG001|Overall Study|Lack of Efficacy|3
7448092|NCT01709903|11735705|FG000|Overall Study|Withdrawal by Subject|6
7448093|NCT01709903|11735706|FG001|Overall Study|Withdrawal by Subject|6
7448094|NCT01709903|11735705|FG000|Overall Study|Adverse Event|11
7448095|NCT01709903|11735706|FG001|Overall Study|Adverse Event|18
7448096|NCT01710020|11735712|FG000|Period 1|Protocol Violation|1
7448097|NCT01710033|11735722|FG000|Stage 2|Adverse Event|0
7448098|NCT01710033|11735723|FG001|Stage 2|Adverse Event|0
7448099|NCT01710033|11735724|FG002|Stage 2|Adverse Event|0
7448100|NCT01710033|11735725|FG003|Stage 2|Adverse Event|0
7448101|NCT01710033|11735726|FG004|Stage 2|Adverse Event|1
7448102|NCT01710046|11735741|FG000|Overall Study|Lost to Follow-up|1
7448103|NCT01710046|11735742|FG001|Overall Study|Lost to Follow-up|0
7448104|NCT01710345|11735783|FG000|Overall Study|Adverse Event|0
7448105|NCT01710345|11735784|FG001|Overall Study|Adverse Event|2
7448106|NCT01710345|11735785|FG002|Overall Study|Adverse Event|0
7448107|NCT01710345|11735783|FG000|Overall Study|Lack of Efficacy|2
7448108|NCT01710345|11735784|FG001|Overall Study|Lack of Efficacy|3
7448109|NCT01710345|11735785|FG002|Overall Study|Lack of Efficacy|1
7448110|NCT01710345|11735783|FG000|Overall Study|Drug Dosing Error|1
7448111|NCT01710345|11735784|FG001|Overall Study|Drug Dosing Error|0
7448112|NCT01710345|11735785|FG002|Overall Study|Drug Dosing Error|0
7448113|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
7448114|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
7448115|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
7448116|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
7448117|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
7448118|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
7448119|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
7448120|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7448121|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
7448122|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
7448123|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
7448124|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
7448125|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7448126|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
7448127|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
7448128|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
7448129|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7448130|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
7448131|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
7448132|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7448133|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
7448134|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
7448135|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
7448136|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
7448137|NCT01710358|11735796|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7448138|NCT01710358|11735797|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
7448139|NCT01710358|11735798|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
7448140|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
7448141|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
7448142|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
7448143|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
7448144|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
7448145|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
7448146|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7448147|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
7448148|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
7448149|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7448150|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
7448151|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
7448152|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7448153|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
7448154|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
7448155|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
7448156|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
7448157|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
7448158|NCT01710358|11735796|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
7448159|NCT01710358|11735797|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
7448160|NCT01710358|11735798|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
7448161|NCT01710358|11735796|FG000|Rescue Period|Adverse Event|0
7448162|NCT01710358|11735797|FG001|Rescue Period|Adverse Event|15
7448163|NCT01710358|11735798|FG002|Rescue Period|Adverse Event|0
7448164|NCT01710358|11735796|FG000|Rescue Period|Death|0
7448165|NCT01710358|11735797|FG001|Rescue Period|Death|1
7448166|NCT01710358|11735798|FG002|Rescue Period|Death|0
7448167|NCT01710358|11735796|FG000|Rescue Period|Lack of Efficacy|0
7448168|NCT01710358|11735797|FG001|Rescue Period|Lack of Efficacy|7
7448169|NCT01710358|11735798|FG002|Rescue Period|Lack of Efficacy|0
7448170|NCT01710358|11735796|FG000|Rescue Period|Withdrawal by Subject|0
7448171|NCT01710358|11735797|FG001|Rescue Period|Withdrawal by Subject|8
7448172|NCT01710358|11735798|FG002|Rescue Period|Withdrawal by Subject|0
7448173|NCT01710501|11735822|FG000|Overall Study|Lost to Follow-up|2
7448174|NCT01710501|11735823|FG001|Overall Study|Lost to Follow-up|0
7448175|NCT01710501|11735824|FG002|Overall Study|Lost to Follow-up|0
7448176|NCT01710514|11735834|FG000|Overall Study|Adverse Event|6
7448177|NCT01710514|11735835|FG001|Overall Study|Adverse Event|7
7448178|NCT01710514|11735834|FG000|Overall Study|Withdrawal by Subject|1
7448179|NCT01710514|11735835|FG001|Overall Study|Withdrawal by Subject|0
7448180|NCT01710527|11735844|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
7448181|NCT01710527|11735845|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
7448182|NCT01710657|11735854|FG000|Overall Study|Lost to Follow-up|2
7448183|NCT01710657|11735855|FG001|Overall Study|Lost to Follow-up|0
7448184|NCT01710657|11735856|FG002|Overall Study|Lost to Follow-up|1
7448185|NCT01710657|11735854|FG000|Overall Study|Protocol Violation|2
7448186|NCT01710657|11735855|FG001|Overall Study|Protocol Violation|2
7448187|NCT01710657|11735856|FG002|Overall Study|Protocol Violation|0
7448188|NCT01710657|11735854|FG000|Overall Study|Adverse Event|14
7448189|NCT01710657|11735855|FG001|Overall Study|Adverse Event|8
7448190|NCT01710657|11735856|FG002|Overall Study|Adverse Event|28
7448191|NCT01710657|11735854|FG000|Overall Study|Withdrawal by Subject|0
7448192|NCT01710657|11735855|FG001|Overall Study|Withdrawal by Subject|1
7448193|NCT01710657|11735856|FG002|Overall Study|Withdrawal by Subject|2
7448194|NCT01710657|11735854|FG000|Overall Study|Lack of Efficacy|0
7448195|NCT01710657|11735855|FG001|Overall Study|Lack of Efficacy|1
7448196|NCT01710657|11735856|FG002|Overall Study|Lack of Efficacy|1
7448197|NCT01710709|11735864|FG000|Overall Study|Lost to Follow-up|29
7448198|NCT01710709|11735864|FG000|Overall Study|Adverse Event|48
7448199|NCT01710709|11735864|FG000|Overall Study|Participant met withdrawal criteria|33
7448200|NCT01710709|11735864|FG000|Overall Study|Participant withdrawn by investigator|2
7448201|NCT01710709|11735864|FG000|Overall Study|Withdrawal by Subject|53
7448202|NCT01710709|11735864|FG000|Overall Study|Protocol Violation|5
7448203|NCT01710709|11735864|FG000|Overall Study|Lack of Efficacy|3
7448204|NCT01710800|11735882|FG000|Overall Study|Withdrawal by Subject|21
7448205|NCT01710800|11735882|FG000|Overall Study|Protocol Violation|1
7448206|NCT01711216|11735919|FG000|Overall Study|Adverse Event|4
7448207|NCT01711216|11735919|FG000|Overall Study|Pregnancy|56
7448208|NCT01711216|11735919|FG000|Overall Study|Withdrawal by Subject|6
7448209|NCT01711216|11735919|FG000|Overall Study|Lost to Follow-up|46
7448210|NCT01711216|11735919|FG000|Overall Study|variety of other minor reasons|83
7448211|NCT01711216|11735919|FG000|Overall Study|no reason specified|22
7448212|NCT01711359|11735939|FG000|Treatment Period|Withdrawal by Subject|18
7448213|NCT01711359|11735940|FG001|Treatment Period|Withdrawal by Subject|7
7448214|NCT01711359|11735941|FG002|Treatment Period|Withdrawal by Subject|13
7448215|NCT01711359|11735939|FG000|Treatment Period|Lack of Efficacy|13
7448216|NCT01711359|11735940|FG001|Treatment Period|Lack of Efficacy|2
7448217|NCT01711359|11735941|FG002|Treatment Period|Lack of Efficacy|2
7448218|NCT01711359|11735939|FG000|Treatment Period|Adverse Event|8
7448219|NCT01711359|11735940|FG001|Treatment Period|Adverse Event|10
7448220|NCT01711359|11735941|FG002|Treatment Period|Adverse Event|24
7448221|NCT01711359|11735939|FG000|Treatment Period|Physician Decision|4
7448222|NCT01711359|11735940|FG001|Treatment Period|Physician Decision|3
7448223|NCT01711359|11735941|FG002|Treatment Period|Physician Decision|2
7448224|NCT01711359|11735939|FG000|Treatment Period|Death|3
7448225|NCT01711359|11735940|FG001|Treatment Period|Death|0
7448226|NCT01711359|11735941|FG002|Treatment Period|Death|0
7448227|NCT01711359|11735939|FG000|Treatment Period|Entry Criteria Not Met|1
7448228|NCT01711359|11735940|FG001|Treatment Period|Entry Criteria Not Met|0
7448229|NCT01711359|11735941|FG002|Treatment Period|Entry Criteria Not Met|0
7448230|NCT01711359|11735939|FG000|Treatment Period|Sponsor Decision|1
7448231|NCT01711359|11735940|FG001|Treatment Period|Sponsor Decision|0
7448232|NCT01711359|11735941|FG002|Treatment Period|Sponsor Decision|0
7448233|NCT01711359|11735939|FG000|Treatment Period|Lost to Follow-up|1
7448234|NCT01711359|11735940|FG001|Treatment Period|Lost to Follow-up|1
7448235|NCT01711359|11735941|FG002|Treatment Period|Lost to Follow-up|1
7448236|NCT01711359|11735939|FG000|Treatment Period|Randomized, Not Treated|3
7448237|NCT01711359|11735940|FG001|Treatment Period|Randomized, Not Treated|1
7448238|NCT01711359|11735941|FG002|Treatment Period|Randomized, Not Treated|0
7448239|NCT01711619|11735968|FG000|Overall Study|Early study termination|10
7448240|NCT01711619|11735969|FG001|Overall Study|Early study termination|14
7448241|NCT01711619|11735968|FG000|Overall Study|Withdrawal by Subject|3
7448242|NCT01711619|11735969|FG001|Overall Study|Withdrawal by Subject|7
7448243|NCT01711619|11735968|FG000|Overall Study|Protocol Violation|2
7448244|NCT01711619|11735969|FG001|Overall Study|Protocol Violation|3
7448245|NCT01711619|11735968|FG000|Overall Study|Adverse Event|2
7448246|NCT01711619|11735969|FG001|Overall Study|Adverse Event|0
7448247|NCT01711619|11735968|FG000|Overall Study|Lost to Follow-up|1
7448248|NCT01711619|11735969|FG001|Overall Study|Lost to Follow-up|0
7448249|NCT01711645|11735975|FG000|Overall Study|Withdrawal by Subject|8
7448250|NCT01711645|11735975|FG000|Overall Study|Lost to Follow-up|6
7448251|NCT01711645|11735975|FG000|Overall Study|Physician Decision|5
7448252|NCT01711736|11735990|FG000|Overall Study|Lost to Follow-up|4
7448253|NCT01711736|11735991|FG001|Overall Study|Lost to Follow-up|1
7448254|NCT01711736|11735990|FG000|Overall Study|Withdrawal by Subject|6
7448255|NCT01711736|11735991|FG001|Overall Study|Withdrawal by Subject|6
7448256|NCT01711736|11735990|FG000|Overall Study|Migrated/moved from study area|2
7448257|NCT01711736|11735991|FG001|Overall Study|Migrated/moved from study area|1
7448258|NCT01711853|11735998|FG000|Overall Study|Not treated|3
7448259|NCT01711866|11736002|FG000|Overall Study|Noncompliant|3
7448260|NCT01711866|11736002|FG000|Overall Study|Withdrawal by Subject|3
7448261|NCT01711866|11736002|FG000|Overall Study|Adverse Event|2
7448262|NCT01711983|11736010|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
7448263|NCT01711983|11736010|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
7448264|NCT01711983|11736010|FG000|36-Month Closure Evaluation|Test Device Removal|2
7448265|NCT01711983|11736010|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
7448266|NCT01712009|11736017|FG000|Overall Study|Withdrawal by Subject|24
7448267|NCT01712009|11736018|FG001|Overall Study|Withdrawal by Subject|15
7448268|NCT01712009|11736019|FG002|Overall Study|Withdrawal by Subject|8
7448269|NCT01712009|11736017|FG000|Overall Study|Lost to Follow-up|2
7448270|NCT01712009|11736018|FG001|Overall Study|Lost to Follow-up|0
7448271|NCT01712009|11736019|FG002|Overall Study|Lost to Follow-up|1
7448272|NCT01712009|11736017|FG000|Overall Study|Decision by Sponsor|12
7448273|NCT01712009|11736018|FG001|Overall Study|Decision by Sponsor|14
7448274|NCT01712009|11736019|FG002|Overall Study|Decision by Sponsor|12
7448275|NCT01712061|11736029|FG000|Overall Study|Adverse Event|4
7448276|NCT01712061|11736030|FG001|Overall Study|Adverse Event|9
7448277|NCT01712061|11736031|FG002|Overall Study|Adverse Event|5
7448278|NCT01712061|11736029|FG000|Overall Study|Death|0
7448279|NCT01712061|11736030|FG001|Overall Study|Death|0
7448280|NCT01712061|11736031|FG002|Overall Study|Death|1
7448281|NCT01712061|11736029|FG000|Overall Study|Lost to Follow-up|1
7448282|NCT01712061|11736030|FG001|Overall Study|Lost to Follow-up|0
7448283|NCT01712061|11736031|FG002|Overall Study|Lost to Follow-up|1
7448284|NCT01712061|11736029|FG000|Overall Study|Did Not Meet Entrance Criteria|4
7448285|NCT01712061|11736030|FG001|Overall Study|Did Not Meet Entrance Criteria|6
7448286|NCT01712061|11736031|FG002|Overall Study|Did Not Meet Entrance Criteria|3
7448287|NCT01712061|11736029|FG000|Overall Study|Medication Error Without Associated AE|0
7448288|NCT01712061|11736030|FG001|Overall Study|Medication Error Without Associated AE|1
7448289|NCT01712061|11736031|FG002|Overall Study|Medication Error Without Associated AE|0
7448290|NCT01712061|11736029|FG000|Overall Study|Withdrawal by Subject|1
7448291|NCT01712061|11736030|FG001|Overall Study|Withdrawal by Subject|7
7448292|NCT01712061|11736031|FG002|Overall Study|Withdrawal by Subject|1
7448293|NCT01712061|11736029|FG000|Overall Study|Other|0
7448294|NCT01712061|11736030|FG001|Overall Study|Other|3
7448295|NCT01712061|11736031|FG002|Overall Study|Other|0
7448296|NCT01712074|11736043|FG000|Placebo Run-in Period|Adverse Event|2
7448297|NCT01712074|11736044|FG001|Placebo Run-in Period|Adverse Event|0
7448298|NCT01712074|11736045|FG002|Placebo Run-in Period|Adverse Event|0
7448299|NCT01712074|11736043|FG000|Placebo Run-in Period|Lost to Follow-up|1
7448300|NCT01712074|11736044|FG001|Placebo Run-in Period|Lost to Follow-up|0
7448301|NCT01712074|11736045|FG002|Placebo Run-in Period|Lost to Follow-up|0
7448302|NCT01712074|11736043|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
7448303|NCT01712074|11736044|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
7448304|NCT01712074|11736045|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
7448305|NCT01712074|11736043|FG000|Placebo Run-in Period|Other|1
7448306|NCT01712074|11736044|FG001|Placebo Run-in Period|Other|0
7448307|NCT01712074|11736045|FG002|Placebo Run-in Period|Other|0
7448308|NCT01712074|11736043|FG000|Placebo Run-in Period|No longer willing to participate|1
7448309|NCT01712074|11736044|FG001|Placebo Run-in Period|No longer willing to participate|0
7448310|NCT01712074|11736045|FG002|Placebo Run-in Period|No longer willing to participate|0
7448311|NCT01712074|11736043|FG000|Double Blind Period|Adverse Event|0
7448312|NCT01712074|11736044|FG001|Double Blind Period|Adverse Event|2
7448313|NCT01712074|11736045|FG002|Double Blind Period|Adverse Event|1
7448314|NCT01712074|11736043|FG000|Double Blind Period|No longer willing to participate|0
7448315|NCT01712074|11736044|FG001|Double Blind Period|No longer willing to participate|2
7448316|NCT01712074|11736045|FG002|Double Blind Period|No longer willing to participate|4
7448317|NCT01712074|11736043|FG000|Double Blind Period|Death|0
7448318|NCT01712074|11736044|FG001|Double Blind Period|Death|1
7448319|NCT01712074|11736045|FG002|Double Blind Period|Death|0
7448320|NCT01712074|11736043|FG000|Double Blind Period|Lost to Follow-up|0
7448321|NCT01712074|11736044|FG001|Double Blind Period|Lost to Follow-up|2
7448322|NCT01712074|11736045|FG002|Double Blind Period|Lost to Follow-up|1
7448323|NCT01712074|11736043|FG000|Double Blind Period|Other|0
7448324|NCT01712074|11736044|FG001|Double Blind Period|Other|4
7448325|NCT01712074|11736045|FG002|Double Blind Period|Other|1
7448326|NCT01712074|11736043|FG000|Double Blind Period|Protocol Violation|0
7448327|NCT01712074|11736044|FG001|Double Blind Period|Protocol Violation|0
7448328|NCT01712074|11736045|FG002|Double Blind Period|Protocol Violation|1
7448329|NCT01712074|11736043|FG000|Double Blind Period|No longer met eligibility criteria|0
7448330|NCT01712074|11736044|FG001|Double Blind Period|No longer met eligibility criteria|3
7448331|NCT01712074|11736045|FG002|Double Blind Period|No longer met eligibility criteria|0
7448332|NCT01712178|11736062|FG000|Overall Study|Withdrew consent due to an adverse event|1
7448333|NCT01712178|11736063|FG001|Overall Study|Withdrew consent due to an adverse event|1
7448334|NCT01712178|11736062|FG000|Overall Study|Serious adverse event/withdrew consent|0
7448335|NCT01712178|11736063|FG001|Overall Study|Serious adverse event/withdrew consent|1
7448336|NCT01712178|11736062|FG000|Overall Study|Lost to Follow-up|0
7448337|NCT01712178|11736063|FG001|Overall Study|Lost to Follow-up|1
7448338|NCT01712204|11736071|FG000|Overall Study|Adverse Event|3
7448339|NCT01712204|11736072|FG001|Overall Study|Adverse Event|1
7448340|NCT01712204|11736071|FG000|Overall Study|Withdrawal by Subject|3
7448341|NCT01712204|11736072|FG001|Overall Study|Withdrawal by Subject|3
7448342|NCT01712204|11736071|FG000|Overall Study|Lost to Follow-up|1
7448343|NCT01712204|11736072|FG001|Overall Study|Lost to Follow-up|0
7448344|NCT01712204|11736071|FG000|Overall Study|Protocol Violation|1
7448345|NCT01712204|11736072|FG001|Overall Study|Protocol Violation|1
7448346|NCT01712256|11736091|FG000|Overall Study|Lost to Follow-up|1
7448347|NCT01712334|11736095|FG000|Treatment Period 1|Randomized in Error|0
7448348|NCT01712334|11736096|FG001|Treatment Period 1|Randomized in Error|2
7448349|NCT01712399|11736125|FG000|Overall Study|Lost to Follow-up|1
7448350|NCT01712399|11736125|FG000|Overall Study|Withdrawal by Subject|39
7448351|NCT01712399|11736125|FG000|Overall Study|Death|1
7448352|NCT01712399|11736125|FG000|Overall Study|Adverse Event|11
7448353|NCT01712399|11736125|FG000|Overall Study|Study closure|345
7448354|NCT01712438|11736129|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
7448355|NCT01712438|11736129|FG000|Overall Study|Ongoing ITI treatment|6
7448439|NCT01713582|11736275|FG004|Overall Study|Death|1
7448356|NCT01712438|11736129|FG000|Overall Study|Violated inclusion & exclusion criteria|4
7448357|NCT01712438|11736129|FG000|Overall Study|Prematurely Discontinued|25
7448358|NCT01712516|11736142|FG000|Overall Study|Technical problems|0
7448359|NCT01712516|11736143|FG001|Overall Study|Technical problems|0
7448360|NCT01712516|11736144|FG002|Overall Study|Technical problems|0
7448361|NCT01712516|11736145|FG003|Overall Study|Technical problems|2
7448362|NCT01712516|11736142|FG000|Overall Study|Lost to Follow-up|0
7448363|NCT01712516|11736143|FG001|Overall Study|Lost to Follow-up|0
7448364|NCT01712516|11736144|FG002|Overall Study|Lost to Follow-up|2
7448365|NCT01712516|11736145|FG003|Overall Study|Lost to Follow-up|1
7448366|NCT01712516|11736142|FG000|Overall Study|Death|0
7448367|NCT01712516|11736143|FG001|Overall Study|Death|1
7448368|NCT01712516|11736144|FG002|Overall Study|Death|0
7448369|NCT01712516|11736145|FG003|Overall Study|Death|0
7448370|NCT01712516|11736142|FG000|Overall Study|Protocol deviation|1
7448371|NCT01712516|11736143|FG001|Overall Study|Protocol deviation|0
7448372|NCT01712516|11736144|FG002|Overall Study|Protocol deviation|1
7448373|NCT01712516|11736145|FG003|Overall Study|Protocol deviation|0
7448374|NCT01712516|11736142|FG000|Overall Study|Physician Decision|2
7448375|NCT01712516|11736143|FG001|Overall Study|Physician Decision|0
7448376|NCT01712516|11736144|FG002|Overall Study|Physician Decision|0
7448377|NCT01712516|11736145|FG003|Overall Study|Physician Decision|1
7448378|NCT01712516|11736142|FG000|Overall Study|Withdrawal by Subject|3
7448379|NCT01712516|11736143|FG001|Overall Study|Withdrawal by Subject|9
7448380|NCT01712516|11736144|FG002|Overall Study|Withdrawal by Subject|3
7448381|NCT01712516|11736145|FG003|Overall Study|Withdrawal by Subject|9
7448382|NCT01712685|11736155|FG000|Overall Study|pt declined to participate before trmt|1
7448383|NCT01712984|11736180|FG000|Overall Study|Adverse Event|0
7448384|NCT01712984|11736181|FG001|Overall Study|Adverse Event|0
7448385|NCT01712984|11736182|FG002|Overall Study|Adverse Event|1
7448386|NCT01712984|11736180|FG000|Overall Study|Protocol Violation|2
7448387|NCT01712984|11736181|FG001|Overall Study|Protocol Violation|0
7448388|NCT01712984|11736182|FG002|Overall Study|Protocol Violation|1
7448389|NCT01712984|11736180|FG000|Overall Study|Lost to Follow-up|8
7448390|NCT01712984|11736181|FG001|Overall Study|Lost to Follow-up|10
7448391|NCT01712984|11736182|FG002|Overall Study|Lost to Follow-up|1
7563431|NCT03257995|11933458|FG002|Overall Study|Adverse Event|0
7563432|NCT03257995|11933459|FG003|Overall Study|Adverse Event|0
7563433|NCT03257995|11933460|FG004|Overall Study|Adverse Event|0
7563434|NCT03257995|11933461|FG005|Overall Study|Adverse Event|0
7328872|NCT00798317|11561809|FG000|Overall Study|Death|1
7448392|NCT01712984|11736180|FG000|Overall Study|Withdrawal by Subject|6
7448393|NCT01712984|11736181|FG001|Overall Study|Withdrawal by Subject|6
7448394|NCT01712984|11736182|FG002|Overall Study|Withdrawal by Subject|7
7448395|NCT01713036|11736190|FG000|Overall Study|Death|1
7448396|NCT01713283|11736204|FG000|Overall Study|Lack of Efficacy|10
7448397|NCT01713283|11736205|FG001|Overall Study|Lack of Efficacy|2
7448398|NCT01713283|11736204|FG000|Overall Study|Lost to Follow-up|1
7448399|NCT01713283|11736205|FG001|Overall Study|Lost to Follow-up|1
7448400|NCT01713348|11736219|FG000|Overall Study|Withdrawal by Subject|3
7448401|NCT01713348|11736220|FG001|Overall Study|Withdrawal by Subject|2
7448402|NCT01713348|11736221|FG002|Overall Study|Withdrawal by Subject|2
7448403|NCT01713348|11736222|FG003|Overall Study|Withdrawal by Subject|0
7448404|NCT01713348|11736219|FG000|Overall Study|Lost to Follow-up|1
7448405|NCT01713348|11736220|FG001|Overall Study|Lost to Follow-up|0
7448406|NCT01713348|11736221|FG002|Overall Study|Lost to Follow-up|0
7448407|NCT01713348|11736222|FG003|Overall Study|Lost to Follow-up|0
7448408|NCT01713530|11736243|FG000|Overall Study|Adverse Event|0
7448409|NCT01713530|11736244|FG001|Overall Study|Adverse Event|5
7448410|NCT01713530|11736243|FG000|Overall Study|Withdrawal criteria|21
7448411|NCT01713530|11736244|FG001|Overall Study|Withdrawal criteria|12
7448412|NCT01713530|11736243|FG000|Overall Study|Unclassified|4
7448413|NCT01713530|11736244|FG001|Overall Study|Unclassified|2
7448414|NCT01713582|11736271|FG000|Overall Study|Disease progression|3
7448415|NCT01713582|11736272|FG001|Overall Study|Disease progression|3
7448416|NCT01713582|11736273|FG002|Overall Study|Disease progression|3
7448417|NCT01713582|11736274|FG003|Overall Study|Disease progression|2
7448418|NCT01713582|11736275|FG004|Overall Study|Disease progression|3
7448419|NCT01713582|11736276|FG005|Overall Study|Disease progression|3
7448420|NCT01713582|11736277|FG006|Overall Study|Disease progression|3
7448421|NCT01713582|11736278|FG007|Overall Study|Disease progression|3
7448422|NCT01713582|11736279|FG008|Overall Study|Disease progression|3
7448423|NCT01713582|11736280|FG009|Overall Study|Disease progression|11
7448424|NCT01713582|11736281|FG010|Overall Study|Disease progression|10
7448425|NCT01713582|11736282|FG011|Overall Study|Disease progression|5
7448426|NCT01713582|11736283|FG012|Overall Study|Disease progression|3
7448427|NCT01713582|11736284|FG013|Overall Study|Disease progression|3
7448428|NCT01713582|11736285|FG014|Overall Study|Disease progression|6
7448429|NCT01713582|11736286|FG015|Overall Study|Disease progression|6
7448430|NCT01713582|11736287|FG016|Overall Study|Disease progression|5
7448431|NCT01713582|11736288|FG017|Overall Study|Disease progression|2
7448432|NCT01713582|11736289|FG018|Overall Study|Disease progression|3
7448433|NCT01713582|11736290|FG019|Overall Study|Disease progression|5
7448434|NCT01713582|11736291|FG020|Overall Study|Disease progression|15
7448435|NCT01713582|11736271|FG000|Overall Study|Death|0
7448436|NCT01713582|11736272|FG001|Overall Study|Death|0
7448437|NCT01713582|11736273|FG002|Overall Study|Death|0
7448438|NCT01713582|11736274|FG003|Overall Study|Death|1
7448440|NCT01713582|11736276|FG005|Overall Study|Death|3
7448441|NCT01713582|11736277|FG006|Overall Study|Death|3
7448442|NCT01713582|11736278|FG007|Overall Study|Death|2
7448443|NCT01713582|11736279|FG008|Overall Study|Death|3
7448444|NCT01713582|11736280|FG009|Overall Study|Death|4
7448445|NCT01713582|11736281|FG010|Overall Study|Death|3
7448446|NCT01713582|11736282|FG011|Overall Study|Death|0
7448447|NCT01713582|11736283|FG012|Overall Study|Death|0
7448448|NCT01713582|11736284|FG013|Overall Study|Death|0
7448449|NCT01713582|11736285|FG014|Overall Study|Death|0
7448450|NCT01713582|11736286|FG015|Overall Study|Death|0
7448451|NCT01713582|11736287|FG016|Overall Study|Death|0
7448452|NCT01713582|11736288|FG017|Overall Study|Death|0
7563435|NCT03257995|11933456|FG000|Overall Study|Protocol deviation|0
7328873|NCT00798317|11561810|FG001|Overall Study|Death|0
7328874|NCT00798369|11561822|FG000|Overall Study|Subject withdrew consent|0
7328875|NCT00798369|11561823|FG001|Overall Study|Subject withdrew consent|0
7328876|NCT00798369|11561824|FG002|Overall Study|Subject withdrew consent|1
7328877|NCT00798369|11561825|FG003|Overall Study|Subject withdrew consent|1
7328878|NCT00798369|11561826|FG004|Overall Study|Subject withdrew consent|0
7328879|NCT00798369|11561827|FG005|Overall Study|Subject withdrew consent|2
7328880|NCT00798369|11561822|FG000|Overall Study|Lost to Follow-up|1
7328881|NCT00798369|11561823|FG001|Overall Study|Lost to Follow-up|1
7328882|NCT00798369|11561824|FG002|Overall Study|Lost to Follow-up|1
7328883|NCT00798369|11561825|FG003|Overall Study|Lost to Follow-up|0
7328884|NCT00798369|11561826|FG004|Overall Study|Lost to Follow-up|1
7448453|NCT01713582|11736289|FG018|Overall Study|Death|0
7328885|NCT00798369|11561827|FG005|Overall Study|Lost to Follow-up|0
7448454|NCT01713582|11736290|FG019|Overall Study|Death|0
7448455|NCT01713582|11736291|FG020|Overall Study|Death|0
7448456|NCT01713582|11736271|FG000|Overall Study|Adverse event-related|0
7448457|NCT01713582|11736272|FG001|Overall Study|Adverse event-related|0
7563436|NCT03257995|11933457|FG001|Overall Study|Protocol deviation|0
7448458|NCT01713582|11736273|FG002|Overall Study|Adverse event-related|0
7448459|NCT01713582|11736274|FG003|Overall Study|Adverse event-related|0
7448460|NCT01713582|11736275|FG004|Overall Study|Adverse event-related|0
7448461|NCT01713582|11736276|FG005|Overall Study|Adverse event-related|0
7448462|NCT01713582|11736277|FG006|Overall Study|Adverse event-related|0
7448463|NCT01713582|11736278|FG007|Overall Study|Adverse event-related|0
7448464|NCT01713582|11736279|FG008|Overall Study|Adverse event-related|0
7448465|NCT01713582|11736280|FG009|Overall Study|Adverse event-related|1
7448466|NCT01713582|11736281|FG010|Overall Study|Adverse event-related|1
7448467|NCT01713582|11736282|FG011|Overall Study|Adverse event-related|0
7448468|NCT01713582|11736283|FG012|Overall Study|Adverse event-related|0
7448469|NCT01713582|11736284|FG013|Overall Study|Adverse event-related|0
7448470|NCT01713582|11736285|FG014|Overall Study|Adverse event-related|0
7448471|NCT01713582|11736286|FG015|Overall Study|Adverse event-related|0
7448472|NCT01713582|11736287|FG016|Overall Study|Adverse event-related|0
7448473|NCT01713582|11736288|FG017|Overall Study|Adverse event-related|0
7448474|NCT01713582|11736289|FG018|Overall Study|Adverse event-related|1
7448475|NCT01713582|11736290|FG019|Overall Study|Adverse event-related|0
7448476|NCT01713582|11736291|FG020|Overall Study|Adverse event-related|0
7448477|NCT01713582|11736271|FG000|Overall Study|Adverse event-unrelated|0
7448478|NCT01713582|11736272|FG001|Overall Study|Adverse event-unrelated|0
7448479|NCT01713582|11736273|FG002|Overall Study|Adverse event-unrelated|0
7448480|NCT01713582|11736274|FG003|Overall Study|Adverse event-unrelated|0
7448481|NCT01713582|11736275|FG004|Overall Study|Adverse event-unrelated|0
7448482|NCT01713582|11736276|FG005|Overall Study|Adverse event-unrelated|1
7448483|NCT01713582|11736277|FG006|Overall Study|Adverse event-unrelated|1
7448484|NCT01713582|11736278|FG007|Overall Study|Adverse event-unrelated|1
7448485|NCT01713582|11736279|FG008|Overall Study|Adverse event-unrelated|0
7448486|NCT01713582|11736280|FG009|Overall Study|Adverse event-unrelated|0
7448487|NCT01713582|11736281|FG010|Overall Study|Adverse event-unrelated|0
7448488|NCT01713582|11736282|FG011|Overall Study|Adverse event-unrelated|0
7448489|NCT01713582|11736283|FG012|Overall Study|Adverse event-unrelated|0
7448490|NCT01713582|11736284|FG013|Overall Study|Adverse event-unrelated|1
7448491|NCT01713582|11736285|FG014|Overall Study|Adverse event-unrelated|1
7448492|NCT01713582|11736286|FG015|Overall Study|Adverse event-unrelated|0
7448493|NCT01713582|11736287|FG016|Overall Study|Adverse event-unrelated|0
7448494|NCT01713582|11736288|FG017|Overall Study|Adverse event-unrelated|0
7448495|NCT01713582|11736289|FG018|Overall Study|Adverse event-unrelated|0
7448496|NCT01713582|11736290|FG019|Overall Study|Adverse event-unrelated|0
7448497|NCT01713582|11736291|FG020|Overall Study|Adverse event-unrelated|0
7448498|NCT01713582|11736271|FG000|Overall Study|Withdrawal of consent|0
7448499|NCT01713582|11736272|FG001|Overall Study|Withdrawal of consent|0
7448500|NCT01713582|11736273|FG002|Overall Study|Withdrawal of consent|1
7448501|NCT01713582|11736274|FG003|Overall Study|Withdrawal of consent|0
7448502|NCT01713582|11736275|FG004|Overall Study|Withdrawal of consent|0
7448503|NCT01713582|11736276|FG005|Overall Study|Withdrawal of consent|1
7448504|NCT01713582|11736277|FG006|Overall Study|Withdrawal of consent|0
7448505|NCT01713582|11736278|FG007|Overall Study|Withdrawal of consent|0
7448506|NCT01713582|11736279|FG008|Overall Study|Withdrawal of consent|0
7448507|NCT01713582|11736280|FG009|Overall Study|Withdrawal of consent|1
7448508|NCT01713582|11736281|FG010|Overall Study|Withdrawal of consent|0
7448509|NCT01713582|11736282|FG011|Overall Study|Withdrawal of consent|0
7448510|NCT01713582|11736283|FG012|Overall Study|Withdrawal of consent|0
7448511|NCT01713582|11736284|FG013|Overall Study|Withdrawal of consent|0
7448512|NCT01713582|11736285|FG014|Overall Study|Withdrawal of consent|0
7448513|NCT01713582|11736286|FG015|Overall Study|Withdrawal of consent|0
7448514|NCT01713582|11736287|FG016|Overall Study|Withdrawal of consent|0
7448515|NCT01713582|11736288|FG017|Overall Study|Withdrawal of consent|0
7448516|NCT01713582|11736289|FG018|Overall Study|Withdrawal of consent|1
7448517|NCT01713582|11736290|FG019|Overall Study|Withdrawal of consent|0
7448518|NCT01713582|11736291|FG020|Overall Study|Withdrawal of consent|0
7448519|NCT01713582|11736271|FG000|Overall Study|Lack of Efficacy|0
7448520|NCT01713582|11736272|FG001|Overall Study|Lack of Efficacy|0
7448521|NCT01713582|11736273|FG002|Overall Study|Lack of Efficacy|0
7448522|NCT01713582|11736274|FG003|Overall Study|Lack of Efficacy|0
7448523|NCT01713582|11736275|FG004|Overall Study|Lack of Efficacy|0
7448524|NCT01713582|11736276|FG005|Overall Study|Lack of Efficacy|0
7448525|NCT01713582|11736277|FG006|Overall Study|Lack of Efficacy|0
7448526|NCT01713582|11736278|FG007|Overall Study|Lack of Efficacy|0
7448527|NCT01713582|11736279|FG008|Overall Study|Lack of Efficacy|0
7448528|NCT01713582|11736280|FG009|Overall Study|Lack of Efficacy|1
7448529|NCT01713582|11736281|FG010|Overall Study|Lack of Efficacy|2
7448530|NCT01713582|11736282|FG011|Overall Study|Lack of Efficacy|0
7448531|NCT01713582|11736283|FG012|Overall Study|Lack of Efficacy|0
7448532|NCT01713582|11736284|FG013|Overall Study|Lack of Efficacy|0
7448533|NCT01713582|11736285|FG014|Overall Study|Lack of Efficacy|0
7448534|NCT01713582|11736286|FG015|Overall Study|Lack of Efficacy|0
7448535|NCT01713582|11736287|FG016|Overall Study|Lack of Efficacy|0
7448536|NCT01713582|11736288|FG017|Overall Study|Lack of Efficacy|0
7448537|NCT01713582|11736289|FG018|Overall Study|Lack of Efficacy|0
7448538|NCT01713582|11736290|FG019|Overall Study|Lack of Efficacy|0
7448539|NCT01713582|11736291|FG020|Overall Study|Lack of Efficacy|0
7448540|NCT01713582|11736271|FG000|Overall Study|Withdrawal by Subject|0
7448541|NCT01713582|11736272|FG001|Overall Study|Withdrawal by Subject|0
7448542|NCT01713582|11736273|FG002|Overall Study|Withdrawal by Subject|0
7448543|NCT01713582|11736274|FG003|Overall Study|Withdrawal by Subject|0
7448544|NCT01713582|11736275|FG004|Overall Study|Withdrawal by Subject|0
7448545|NCT01713582|11736276|FG005|Overall Study|Withdrawal by Subject|0
7448546|NCT01713582|11736277|FG006|Overall Study|Withdrawal by Subject|0
7448547|NCT01713582|11736278|FG007|Overall Study|Withdrawal by Subject|0
7448548|NCT01713582|11736279|FG008|Overall Study|Withdrawal by Subject|0
7448549|NCT01713582|11736280|FG009|Overall Study|Withdrawal by Subject|0
7448550|NCT01713582|11736281|FG010|Overall Study|Withdrawal by Subject|0
7448551|NCT01713582|11736282|FG011|Overall Study|Withdrawal by Subject|0
7448552|NCT01713582|11736283|FG012|Overall Study|Withdrawal by Subject|0
7448553|NCT01713582|11736284|FG013|Overall Study|Withdrawal by Subject|0
7448554|NCT01713582|11736285|FG014|Overall Study|Withdrawal by Subject|0
7448555|NCT01713582|11736286|FG015|Overall Study|Withdrawal by Subject|0
7448556|NCT01713582|11736287|FG016|Overall Study|Withdrawal by Subject|0
7563437|NCT03257995|11933458|FG002|Overall Study|Protocol deviation|0
7563438|NCT03257995|11933459|FG003|Overall Study|Protocol deviation|0
7563439|NCT03257995|11933460|FG004|Overall Study|Protocol deviation|0
7563440|NCT03257995|11933461|FG005|Overall Study|Protocol deviation|2
7563441|NCT03258710|11933483|FG000|Overall Study|Adverse Event|1
7563442|NCT03258710|11933483|FG000|Overall Study|Protocol-defined stopping criteria|1
7563443|NCT03258710|11933483|FG000|Overall Study|Physician Decision|1
7563444|NCT03258762|11933489|FG000|Overall Study|Lost to Follow-up|0
7563445|NCT03258762|11933490|FG001|Overall Study|Lost to Follow-up|1
7563446|NCT03258814|11933499|FG000|Overall Study|Early Termination|4
7563447|NCT03258814|11933500|FG001|Overall Study|Early Termination|3
7563448|NCT03258814|11933501|FG002|Overall Study|Early Termination|10
7563449|NCT03259087|11933513|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
7563450|NCT03259087|11933514|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
7563451|NCT03259087|11933515|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
7563452|NCT03259087|11933516|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
7563453|NCT03259087|11933517|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
7563454|NCT03259087|11933513|FG000|Period 2 of Part 2|Adverse Event|0
7563455|NCT03259087|11933514|FG001|Period 2 of Part 2|Adverse Event|0
7563456|NCT03259087|11933515|FG002|Period 2 of Part 2|Adverse Event|0
7563457|NCT03259087|11933516|FG003|Period 2 of Part 2|Adverse Event|0
7563458|NCT03259087|11933517|FG004|Period 2 of Part 2|Adverse Event|1
7563459|NCT03259308|11933570|FG000|Overall Study|Adverse Event|5
7563460|NCT03259308|11933571|FG001|Overall Study|Adverse Event|4
7563461|NCT03259308|11933572|FG002|Overall Study|Adverse Event|1
7563462|NCT03259308|11933570|FG000|Overall Study|Withdrawal by Subject|2
7563463|NCT03259308|11933571|FG001|Overall Study|Withdrawal by Subject|1
7563464|NCT03259308|11933572|FG002|Overall Study|Withdrawal by Subject|3
7563465|NCT03259308|11933570|FG000|Overall Study|Lost to Follow-up|0
7563466|NCT03259308|11933571|FG001|Overall Study|Lost to Follow-up|0
7563467|NCT03259308|11933572|FG002|Overall Study|Lost to Follow-up|1
7563468|NCT03259308|11933570|FG000|Overall Study|Pregnancy|0
7563469|NCT03259308|11933571|FG001|Overall Study|Pregnancy|0
7563470|NCT03259308|11933572|FG002|Overall Study|Pregnancy|1
7563471|NCT03259308|11933570|FG000|Overall Study|Protocol Deviation|0
7563472|NCT03259308|11933571|FG001|Overall Study|Protocol Deviation|3
7563473|NCT03259308|11933572|FG002|Overall Study|Protocol Deviation|0
7563474|NCT03259308|11933570|FG000|Overall Study|Lack of Efficacy|0
7563475|NCT03259308|11933571|FG001|Overall Study|Lack of Efficacy|0
7563476|NCT03259308|11933572|FG002|Overall Study|Lack of Efficacy|1
7563477|NCT03259334|11933583|FG000|Overall Study|Adverse Event|3
7563478|NCT03259334|11933584|FG001|Overall Study|Adverse Event|8
7563479|NCT03259334|11933585|FG002|Overall Study|Adverse Event|5
7563480|NCT03259334|11933583|FG000|Overall Study|Withdrawal by Subject|4
7563481|NCT03259334|11933584|FG001|Overall Study|Withdrawal by Subject|2
7563482|NCT03259334|11933585|FG002|Overall Study|Withdrawal by Subject|4
7563483|NCT03259334|11933583|FG000|Overall Study|Physician Decision|1
7563484|NCT03259334|11933584|FG001|Overall Study|Physician Decision|0
7563485|NCT03259334|11933585|FG002|Overall Study|Physician Decision|0
7563486|NCT03259334|11933583|FG000|Overall Study|Lost to Follow-up|0
7448557|NCT01713582|11736288|FG017|Overall Study|Withdrawal by Subject|1
7448558|NCT01713582|11736289|FG018|Overall Study|Withdrawal by Subject|0
7563487|NCT03259334|11933584|FG001|Overall Study|Lost to Follow-up|2
7563488|NCT03259334|11933585|FG002|Overall Study|Lost to Follow-up|1
7563489|NCT03259334|11933583|FG000|Overall Study|Protocol Deviation|0
7563490|NCT03259334|11933584|FG001|Overall Study|Protocol Deviation|3
7563491|NCT03259334|11933585|FG002|Overall Study|Protocol Deviation|2
7563492|NCT03259334|11933583|FG000|Overall Study|Lack of Efficacy|2
7563493|NCT03259334|11933584|FG001|Overall Study|Lack of Efficacy|0
7563494|NCT03259334|11933585|FG002|Overall Study|Lack of Efficacy|1
7448559|NCT01713582|11736290|FG019|Overall Study|Withdrawal by Subject|0
7563495|NCT03259334|11933583|FG000|Overall Study|Randomized but never treated|0
7563496|NCT03259334|11933584|FG001|Overall Study|Randomized but never treated|2
7563497|NCT03259334|11933585|FG002|Overall Study|Randomized but never treated|0
7563498|NCT03259490|11933595|FG000|Period 1|Withdrawal by Subject|0
7563499|NCT03259490|11933596|FG001|Period 1|Withdrawal by Subject|1
7563500|NCT03259490|11933595|FG000|Period 2|Protocol Violation|1
7563501|NCT03259490|11933596|FG001|Period 2|Protocol Violation|0
7563502|NCT03259555|11933604|FG000|Overall Study|Adverse Event|6
7563503|NCT03259555|11933605|FG001|Overall Study|Adverse Event|4
7563504|NCT03259555|11933604|FG000|Overall Study|Lack of Efficacy|6
7563505|NCT03259555|11933605|FG001|Overall Study|Lack of Efficacy|4
7563506|NCT03259555|11933604|FG000|Overall Study|Lost to Follow-up|0
7563507|NCT03259555|11933605|FG001|Overall Study|Lost to Follow-up|2
7563508|NCT03259555|11933604|FG000|Overall Study|Non-Compliance With Study Drug|1
7563509|NCT03259555|11933605|FG001|Overall Study|Non-Compliance With Study Drug|0
7563510|NCT03259555|11933604|FG000|Overall Study|Progressive Disease|0
7563511|NCT03259555|11933605|FG001|Overall Study|Progressive Disease|2
7563512|NCT03259555|11933604|FG000|Overall Study|Withdrawal by Subject|19
7563513|NCT03259555|11933605|FG001|Overall Study|Withdrawal by Subject|16
7563514|NCT03259555|11933604|FG000|Overall Study|Physician Decision|1
7563515|NCT03259555|11933605|FG001|Overall Study|Physician Decision|2
7563516|NCT03259555|11933604|FG000|Overall Study|Other|1
7563517|NCT03259555|11933605|FG001|Overall Study|Other|0
7563518|NCT03259789|11933614|FG000|Overall Study|Adverse Event|3
7563519|NCT03259789|11933615|FG001|Overall Study|Adverse Event|2
7563520|NCT03259789|11933616|FG002|Overall Study|Adverse Event|1
7563521|NCT03259789|11933614|FG000|Overall Study|Withdrawal by Subject|9
7563522|NCT03259789|11933615|FG001|Overall Study|Withdrawal by Subject|5
7563523|NCT03259789|11933616|FG002|Overall Study|Withdrawal by Subject|1
7563524|NCT03259789|11933614|FG000|Overall Study|Lost to Follow-up|5
7563525|NCT03259789|11933615|FG001|Overall Study|Lost to Follow-up|9
7563526|NCT03259789|11933616|FG002|Overall Study|Lost to Follow-up|4
7563527|NCT03259789|11933614|FG000|Overall Study|Physician Decision|0
7563528|NCT03259789|11933615|FG001|Overall Study|Physician Decision|1
7563529|NCT03259789|11933616|FG002|Overall Study|Physician Decision|0
7563530|NCT03260205|11933630|FG000|Overall Study|Adverse Event|2
7563531|NCT03260205|11933631|FG001|Overall Study|Adverse Event|0
7563532|NCT03260205|11933632|FG002|Overall Study|Adverse Event|2
7563533|NCT03260205|11933633|FG003|Overall Study|Adverse Event|2
7563534|NCT03260205|11933634|FG004|Overall Study|Adverse Event|4
7563535|NCT03260205|11933630|FG000|Overall Study|Lost to Follow-up|2
7328886|NCT00798369|11561822|FG000|Overall Study|Adminstrative problems|0
7328887|NCT00798369|11561823|FG001|Overall Study|Adminstrative problems|0
7328888|NCT00798369|11561824|FG002|Overall Study|Adminstrative problems|0
7328889|NCT00798369|11561825|FG003|Overall Study|Adminstrative problems|0
7328890|NCT00798369|11561826|FG004|Overall Study|Adminstrative problems|0
7328891|NCT00798369|11561827|FG005|Overall Study|Adminstrative problems|1
7328892|NCT00798434|11561844|FG000|Double-Blind|Adverse Event|22
7328893|NCT00798434|11561845|FG001|Double-Blind|Adverse Event|46
7328894|NCT00798434|11561844|FG000|Double-Blind|Death|0
7328895|NCT00798434|11561845|FG001|Double-Blind|Death|1
7448560|NCT01713582|11736291|FG020|Overall Study|Withdrawal by Subject|0
7448561|NCT01713582|11736271|FG000|Overall Study|Stopped to receive bone marrow graft|0
7448562|NCT01713582|11736272|FG001|Overall Study|Stopped to receive bone marrow graft|0
7448563|NCT01713582|11736273|FG002|Overall Study|Stopped to receive bone marrow graft|0
7448564|NCT01713582|11736274|FG003|Overall Study|Stopped to receive bone marrow graft|0
7448565|NCT01713582|11736275|FG004|Overall Study|Stopped to receive bone marrow graft|0
7448566|NCT01713582|11736276|FG005|Overall Study|Stopped to receive bone marrow graft|0
7448567|NCT01713582|11736277|FG006|Overall Study|Stopped to receive bone marrow graft|0
7448568|NCT01713582|11736278|FG007|Overall Study|Stopped to receive bone marrow graft|0
7448569|NCT01713582|11736279|FG008|Overall Study|Stopped to receive bone marrow graft|0
7448570|NCT01713582|11736280|FG009|Overall Study|Stopped to receive bone marrow graft|0
7448571|NCT01713582|11736281|FG010|Overall Study|Stopped to receive bone marrow graft|0
7448572|NCT01713582|11736282|FG011|Overall Study|Stopped to receive bone marrow graft|0
7448573|NCT01713582|11736283|FG012|Overall Study|Stopped to receive bone marrow graft|0
7448574|NCT01713582|11736284|FG013|Overall Study|Stopped to receive bone marrow graft|0
7448575|NCT01713582|11736285|FG014|Overall Study|Stopped to receive bone marrow graft|0
7448576|NCT01713582|11736286|FG015|Overall Study|Stopped to receive bone marrow graft|0
7448577|NCT01713582|11736287|FG016|Overall Study|Stopped to receive bone marrow graft|1
7448578|NCT01713582|11736288|FG017|Overall Study|Stopped to receive bone marrow graft|0
7448579|NCT01713582|11736289|FG018|Overall Study|Stopped to receive bone marrow graft|0
7448580|NCT01713582|11736290|FG019|Overall Study|Stopped to receive bone marrow graft|0
7448581|NCT01713582|11736291|FG020|Overall Study|Stopped to receive bone marrow graft|0
7448582|NCT01713582|11736271|FG000|Overall Study|Disease progression and adverse event|0
7448583|NCT01713582|11736272|FG001|Overall Study|Disease progression and adverse event|0
7448584|NCT01713582|11736273|FG002|Overall Study|Disease progression and adverse event|0
7448585|NCT01713582|11736274|FG003|Overall Study|Disease progression and adverse event|0
7448586|NCT01713582|11736275|FG004|Overall Study|Disease progression and adverse event|0
7448587|NCT01713582|11736276|FG005|Overall Study|Disease progression and adverse event|0
7563536|NCT03260205|11933631|FG001|Overall Study|Lost to Follow-up|2
7563537|NCT03260205|11933632|FG002|Overall Study|Lost to Follow-up|1
7563538|NCT03260205|11933633|FG003|Overall Study|Lost to Follow-up|1
7563539|NCT03260205|11933634|FG004|Overall Study|Lost to Follow-up|5
7563540|NCT03260205|11933630|FG000|Overall Study|Protocol Violation|0
7563541|NCT03260205|11933631|FG001|Overall Study|Protocol Violation|0
7328896|NCT00798434|11561844|FG000|Double-Blind|Lost to Follow-up|1
7328897|NCT00798434|11561845|FG001|Double-Blind|Lost to Follow-up|0
7328898|NCT00798434|11561844|FG000|Double-Blind|Lack of Efficacy|8
7448588|NCT01713582|11736277|FG006|Overall Study|Disease progression and adverse event|0
7448589|NCT01713582|11736278|FG007|Overall Study|Disease progression and adverse event|0
7448590|NCT01713582|11736279|FG008|Overall Study|Disease progression and adverse event|0
7448591|NCT01713582|11736280|FG009|Overall Study|Disease progression and adverse event|0
7448592|NCT01713582|11736281|FG010|Overall Study|Disease progression and adverse event|0
7448593|NCT01713582|11736282|FG011|Overall Study|Disease progression and adverse event|0
7448594|NCT01713582|11736283|FG012|Overall Study|Disease progression and adverse event|0
7448595|NCT01713582|11736284|FG013|Overall Study|Disease progression and adverse event|0
7448596|NCT01713582|11736285|FG014|Overall Study|Disease progression and adverse event|0
7448597|NCT01713582|11736286|FG015|Overall Study|Disease progression and adverse event|0
7448598|NCT01713582|11736287|FG016|Overall Study|Disease progression and adverse event|1
7448599|NCT01713582|11736288|FG017|Overall Study|Disease progression and adverse event|0
7448600|NCT01713582|11736289|FG018|Overall Study|Disease progression and adverse event|0
7448601|NCT01713582|11736290|FG019|Overall Study|Disease progression and adverse event|0
7448602|NCT01713582|11736291|FG020|Overall Study|Disease progression and adverse event|0
7448603|NCT01713686|11736378|FG000|Overall Study|Lost to Follow-up|9
7448604|NCT01713686|11736378|FG000|Overall Study|Withdrawal by Subject|6
7448605|NCT01713933|11736401|FG000|Overall Study|Lost to Follow-up|2
7448606|NCT01713933|11736401|FG000|Overall Study|Withdrawal by Subject|3
7448607|NCT01713933|11736401|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
7448608|NCT01713946|11736408|FG000|Overall Study|Death|0
7448609|NCT01713946|11736409|FG001|Overall Study|Death|2
7448610|NCT01713946|11736410|FG002|Overall Study|Death|2
7448611|NCT01713946|11736408|FG000|Overall Study|Adverse Event|19
7448612|NCT01713946|11736409|FG001|Overall Study|Adverse Event|14
7448613|NCT01713946|11736410|FG002|Overall Study|Adverse Event|13
7448614|NCT01713946|11736408|FG000|Overall Study|Withdrawal by Subject|12
7448615|NCT01713946|11736409|FG001|Overall Study|Withdrawal by Subject|12
7448616|NCT01713946|11736410|FG002|Overall Study|Withdrawal by Subject|8
7448617|NCT01713946|11736408|FG000|Overall Study|Lack of Efficacy|8
7448618|NCT01713946|11736409|FG001|Overall Study|Lack of Efficacy|8
7448619|NCT01713946|11736410|FG002|Overall Study|Lack of Efficacy|14
7448620|NCT01713946|11736408|FG000|Overall Study|Protocol Violation|2
7448621|NCT01713946|11736409|FG001|Overall Study|Protocol Violation|4
7448622|NCT01713946|11736410|FG002|Overall Study|Protocol Violation|1
7448623|NCT01713946|11736408|FG000|Overall Study|Lost to Follow-up|0
7448624|NCT01713946|11736409|FG001|Overall Study|Lost to Follow-up|0
7448625|NCT01713946|11736410|FG002|Overall Study|Lost to Follow-up|1
7448626|NCT01713946|11736408|FG000|Overall Study|Administrative problems|1
7448627|NCT01713946|11736409|FG001|Overall Study|Administrative problems|0
7448628|NCT01713946|11736410|FG002|Overall Study|Administrative problems|0
7448629|NCT01713946|11736408|FG000|Overall Study|Did not continue in Ext|0
7448630|NCT01713946|11736409|FG001|Overall Study|Did not continue in Ext|3
7448631|NCT01713946|11736410|FG002|Overall Study|Did not continue in Ext|0
7448632|NCT01713946|11736408|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
7448633|NCT01713946|11736409|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
7448634|NCT01713946|11736410|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
7448635|NCT01713946|11736408|FG000|Overall Study|Patients never switched to everolimus|0
7448636|NCT01713946|11736409|FG001|Overall Study|Patients never switched to everolimus|0
7448637|NCT01713946|11736410|FG002|Overall Study|Patients never switched to everolimus|5
7448638|NCT01713998|11736439|FG000|Overall Study|Lost to Follow-up|2
7448639|NCT01713998|11736440|FG001|Overall Study|Lost to Follow-up|0
7448640|NCT01713998|11736441|FG002|Overall Study|Lost to Follow-up|2
7448641|NCT01713998|11736439|FG000|Overall Study|Withdrawal by Subject|1
7448642|NCT01713998|11736440|FG001|Overall Study|Withdrawal by Subject|0
7448643|NCT01713998|11736441|FG002|Overall Study|Withdrawal by Subject|0
7448644|NCT01714063|11736471|FG000|Overall Study|Equipment malfunction|2
7448645|NCT01714310|11736486|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
7448646|NCT01714310|11736487|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
7448647|NCT01714310|11736488|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
7448648|NCT01714310|11736486|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
7448649|NCT01714310|11736487|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
7448650|NCT01714310|11736488|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
7448651|NCT01714310|11736486|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
7448652|NCT01714310|11736487|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
7448653|NCT01714310|11736488|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
7448654|NCT01714310|11736486|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
7448655|NCT01714310|11736487|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
7448656|NCT01714310|11736488|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
7448657|NCT01714544|11736536|FG000|Overall Study|Lost to Follow-up|1
7448658|NCT01714544|11736536|FG000|Overall Study|Physician Decision|1
7448659|NCT01714544|11736536|FG000|Overall Study|Withdrawal by Subject|1
7448660|NCT01714609|11736542|FG000|Overall Study|Protocol Violation|1
7448661|NCT01714609|11736543|FG001|Overall Study|Protocol Violation|0
7448662|NCT01714635|11736552|FG000|Overall Study|Discontinued|1
7448663|NCT01714635|11736553|FG001|Overall Study|Discontinued|0
7448664|NCT01714635|11736554|FG002|Overall Study|Discontinued|2
7448665|NCT01714635|11736552|FG000|Overall Study|Missed 6-month exam|1
7448666|NCT01714635|11736553|FG001|Overall Study|Missed 6-month exam|0
7448667|NCT01714635|11736554|FG002|Overall Study|Missed 6-month exam|0
7448668|NCT01714687|11736564|FG000|Overall Study|Withdrawal by Subject|1
7448669|NCT01714687|11736565|FG001|Overall Study|Withdrawal by Subject|0
7448670|NCT01714687|11736564|FG000|Overall Study|Lost to Follow-up|2
7448671|NCT01714687|11736565|FG001|Overall Study|Lost to Follow-up|4
7448672|NCT01714726|11736575|FG000|Double-Blinded Induction Period|Subject not in open label period|3
7448673|NCT01714726|11736576|FG001|Double-Blinded Induction Period|Subject not in open label period|1
7448674|NCT01714726|11736577|FG002|Double-Blinded Induction Period|Subject not in open label period|0
7448675|NCT01714726|11736578|FG003|Double-Blinded Induction Period|Subject not in open label period|0
7448676|NCT01714726|11736575|FG000|Double-Blinded Induction Period|Adverse Event|0
7448677|NCT01714726|11736576|FG001|Double-Blinded Induction Period|Adverse Event|1
7448678|NCT01714726|11736577|FG002|Double-Blinded Induction Period|Adverse Event|0
7448679|NCT01714726|11736578|FG003|Double-Blinded Induction Period|Adverse Event|0
7448680|NCT01714726|11736575|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
7448681|NCT01714726|11736576|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
7448682|NCT01714726|11736577|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
7448683|NCT01714726|11736578|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
7448684|NCT01714726|11736575|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
7448685|NCT01714726|11736576|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
7448686|NCT01714726|11736577|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
7448687|NCT01714726|11736578|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
7448688|NCT01714726|11736575|FG000|Open-Label Period|Other|0
7448689|NCT01714726|11736576|FG001|Open-Label Period|Other|0
7448690|NCT01714726|11736577|FG002|Open-Label Period|Other|1
7448691|NCT01714726|11736578|FG003|Open-Label Period|Other|3
7448692|NCT01714726|11736575|FG000|Open-Label Period|Adverse Event|0
7448693|NCT01714726|11736576|FG001|Open-Label Period|Adverse Event|0
7448694|NCT01714726|11736577|FG002|Open-Label Period|Adverse Event|1
7448695|NCT01714726|11736578|FG003|Open-Label Period|Adverse Event|0
7448696|NCT01714726|11736575|FG000|Open-Label Period|Withdrawal by Subject|0
7448697|NCT01714726|11736576|FG001|Open-Label Period|Withdrawal by Subject|0
7448698|NCT01714726|11736577|FG002|Open-Label Period|Withdrawal by Subject|9
7448699|NCT01714726|11736578|FG003|Open-Label Period|Withdrawal by Subject|19
7448700|NCT01714726|11736575|FG000|Open-Label Period|Developed specific withdrawal criteria|0
7448701|NCT01714726|11736576|FG001|Open-Label Period|Developed specific withdrawal criteria|0
7448702|NCT01714726|11736577|FG002|Open-Label Period|Developed specific withdrawal criteria|5
7448703|NCT01714726|11736578|FG003|Open-Label Period|Developed specific withdrawal criteria|2
7448704|NCT01714726|11736575|FG000|Open-Label Period|Lost to Follow-up|0
7448705|NCT01714726|11736576|FG001|Open-Label Period|Lost to Follow-up|0
7448706|NCT01714726|11736577|FG002|Open-Label Period|Lost to Follow-up|3
7448707|NCT01714726|11736578|FG003|Open-Label Period|Lost to Follow-up|4
7467834|NCT01904019|11768305|FG000|5 Year Follow-up|Impossibility to contact patient|4
7467835|NCT01904058|11768313|FG000|Overall Study|Adverse Event|2
7467836|NCT01904058|11768314|FG001|Overall Study|Adverse Event|0
7467837|NCT01904058|11768315|FG002|Overall Study|Adverse Event|0
7467838|NCT01904058|11768316|FG003|Overall Study|Adverse Event|0
7467839|NCT01904058|11768313|FG000|Overall Study|Withdrawal by Subject|1
7467840|NCT01904058|11768314|FG001|Overall Study|Withdrawal by Subject|0
7467841|NCT01904058|11768315|FG002|Overall Study|Withdrawal by Subject|1
7467842|NCT01904058|11768316|FG003|Overall Study|Withdrawal by Subject|0
7467843|NCT01904058|11768313|FG000|Overall Study|Pregnancy|0
7467844|NCT01904058|11768314|FG001|Overall Study|Pregnancy|0
7467845|NCT01904058|11768315|FG002|Overall Study|Pregnancy|0
7467846|NCT01904058|11768316|FG003|Overall Study|Pregnancy|1
7467847|NCT01904149|11768351|FG000|Overall Study|Adverse Event|3
7467848|NCT01904149|11768352|FG001|Overall Study|Adverse Event|4
7467849|NCT01904149|11768353|FG002|Overall Study|Adverse Event|0
7467850|NCT01904149|11768354|FG003|Overall Study|Adverse Event|1
7467851|NCT01904149|11768355|FG004|Overall Study|Adverse Event|1
7467852|NCT01904149|11768356|FG005|Overall Study|Adverse Event|2
7467853|NCT01904149|11768351|FG000|Overall Study|Lack of Efficacy|0
7467854|NCT01904149|11768352|FG001|Overall Study|Lack of Efficacy|3
7467855|NCT01904149|11768353|FG002|Overall Study|Lack of Efficacy|1
7467856|NCT01904149|11768354|FG003|Overall Study|Lack of Efficacy|3
7467857|NCT01904149|11768355|FG004|Overall Study|Lack of Efficacy|3
7467858|NCT01904149|11768356|FG005|Overall Study|Lack of Efficacy|1
7467859|NCT01904149|11768351|FG000|Overall Study|Withdrawal by Subject|1
7467860|NCT01904149|11768352|FG001|Overall Study|Withdrawal by Subject|3
7467861|NCT01904149|11768353|FG002|Overall Study|Withdrawal by Subject|1
7467862|NCT01904149|11768354|FG003|Overall Study|Withdrawal by Subject|0
7467863|NCT01904149|11768355|FG004|Overall Study|Withdrawal by Subject|1
7467864|NCT01904149|11768356|FG005|Overall Study|Withdrawal by Subject|0
7467865|NCT01904149|11768351|FG000|Overall Study|Protocol Violation|0
7467866|NCT01904149|11768352|FG001|Overall Study|Protocol Violation|1
7467867|NCT01904149|11768353|FG002|Overall Study|Protocol Violation|0
7467868|NCT01904149|11768354|FG003|Overall Study|Protocol Violation|0
7467869|NCT01904149|11768355|FG004|Overall Study|Protocol Violation|0
7467870|NCT01904149|11768356|FG005|Overall Study|Protocol Violation|0
7467871|NCT01904149|11768351|FG000|Overall Study|non compliance with study drug|1
7467872|NCT01904149|11768352|FG001|Overall Study|non compliance with study drug|0
7467873|NCT01904149|11768353|FG002|Overall Study|non compliance with study drug|0
7448708|NCT01714947|11736604|FG000|Part B|Progressive Disease|3
7448709|NCT01715129|11736617|FG000|Overall Study|Adverse Event, fatal|1
7448710|NCT01715129|11736617|FG000|Overall Study|Lack of Efficacy|3
7448711|NCT01715129|11736617|FG000|Overall Study|Protocol Violation|1
7448712|NCT01715129|11736617|FG000|Overall Study|Consent Withdrawn|2
7448713|NCT01715129|11736617|FG000|Overall Study|Lost to Follow-up|1
7448714|NCT01715129|11736617|FG000|Overall Study|Other|1
7448715|NCT01715298|11736639|FG000|Overall Study|Lost to Follow-up|0
7448716|NCT01715298|11736640|FG001|Overall Study|Lost to Follow-up|2
7448717|NCT01715298|11736639|FG000|Overall Study|Patient/guardian decision|7
7448718|NCT01715298|11736640|FG001|Overall Study|Patient/guardian decision|9
7448719|NCT01715415|11736648|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
7448720|NCT01715415|11736649|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
7448721|NCT01715415|11736648|FG000|Double-blind Treatment|Adverse Event|3
7448722|NCT01715415|11736649|FG001|Double-blind Treatment|Adverse Event|0
7448723|NCT01715415|11736648|FG000|Double-blind Treatment|Withdrawal by Subject|1
7448724|NCT01715415|11736649|FG001|Double-blind Treatment|Withdrawal by Subject|1
7448725|NCT01715415|11736648|FG000|Double-blind Treatment|Other|1
7448726|NCT01715415|11736649|FG001|Double-blind Treatment|Other|0
7448727|NCT01715415|11736648|FG000|Open-label Treatment|Adverse Event|0
7448728|NCT01715415|11736649|FG001|Open-label Treatment|Adverse Event|1
7448729|NCT01715415|11736648|FG000|Open-label Treatment|Subject Noncompliant|0
7448730|NCT01715415|11736649|FG001|Open-label Treatment|Subject Noncompliant|1
7448731|NCT01715571|11736656|FG000|Overall Study|Lost to Follow-up|8
7448732|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
7448733|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
7448734|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
7448735|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
7448736|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
7448737|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7448738|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7448739|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
7448740|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
7448741|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
7448742|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
7448743|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
7448744|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
7448745|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7448746|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7448747|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
7448748|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
7448749|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7448750|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7448751|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
7448752|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
7448753|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7448754|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7448755|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
7448756|NCT01715805|11736660|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
7448757|NCT01715805|11736661|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7448758|NCT01715805|11736662|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7448759|NCT01715805|11736663|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
7448760|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7448761|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7448762|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
7448763|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
7448764|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Adverse Event|0
7448765|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Adverse Event|3
7448766|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Adverse Event|23
7448767|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Adverse Event|2
7448768|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
7448769|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
7448770|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
7448771|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
7448772|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
7448773|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
7448774|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
7448775|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
7448776|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
7448777|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
7448778|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
7448779|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
7448780|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7468733|NCT01914393|11769702|FG002|Overall Study|no reason given|16
7448781|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
7448782|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
7448783|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
7448784|NCT01715805|11736660|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7448785|NCT01715805|11736661|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
7448786|NCT01715805|11736662|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7448787|NCT01715805|11736663|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
7448788|NCT01715831|11736671|FG000|Overall Study|Adverse Event|1
7448789|NCT01715857|11736675|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
7448790|NCT01715896|11736686|FG000|Overall Study|Lost to Follow-up|0
7448791|NCT01715896|11736687|FG001|Overall Study|Lost to Follow-up|2
7448792|NCT01715896|11736686|FG000|Overall Study|Withdrawal by Subject|1
7448793|NCT01715896|11736687|FG001|Overall Study|Withdrawal by Subject|4
7448794|NCT01715896|11736686|FG000|Overall Study|Other|2
7448795|NCT01715896|11736687|FG001|Overall Study|Other|5
7448796|NCT01716104|11736739|FG000|Overall Study|Do not meet inclusion criteria|6
7448797|NCT01716104|11736740|FG001|Overall Study|Do not meet inclusion criteria|7
7448798|NCT01716156|11736749|FG000|Overall Study|Protocol Violation|1
7448799|NCT01716156|11736750|FG001|Overall Study|Protocol Violation|0
7448800|NCT01716156|11736751|FG002|Overall Study|Protocol Violation|0
7448801|NCT01716156|11736749|FG000|Overall Study|Withdrawal by Subject|0
7448802|NCT01716156|11736750|FG001|Overall Study|Withdrawal by Subject|1
7448803|NCT01716156|11736751|FG002|Overall Study|Withdrawal by Subject|2
7448804|NCT01716156|11736749|FG000|Overall Study|Lost to Follow-up|1
7448805|NCT01716156|11736750|FG001|Overall Study|Lost to Follow-up|0
7448806|NCT01716156|11736751|FG002|Overall Study|Lost to Follow-up|0
7448807|NCT01716169|11736763|FG000|Overall Study|Adverse Event|1
7448808|NCT01716169|11736763|FG000|Overall Study|Lost to Follow-up|1
7448809|NCT01716169|11736763|FG000|Overall Study|Withdrawal by Subject|1
7448810|NCT01716169|11736763|FG000|Overall Study|inconsistent dressing application|1
7448811|NCT01716234|11736800|FG000|Overall Study|Protocol Violation|0
7448812|NCT01716234|11736801|FG001|Overall Study|Protocol Violation|0
7448813|NCT01716234|11736802|FG002|Overall Study|Protocol Violation|0
7448814|NCT01716234|11736803|FG003|Overall Study|Protocol Violation|1
7448815|NCT01716234|11736804|FG004|Overall Study|Protocol Violation|1
7448816|NCT01716234|11736805|FG005|Overall Study|Protocol Violation|1
7448817|NCT01716234|11736806|FG006|Overall Study|Protocol Violation|0
7448818|NCT01716234|11736800|FG000|Overall Study|Lack of Efficacy|0
7448819|NCT01716234|11736801|FG001|Overall Study|Lack of Efficacy|0
7448820|NCT01716234|11736802|FG002|Overall Study|Lack of Efficacy|0
7448821|NCT01716234|11736803|FG003|Overall Study|Lack of Efficacy|1
7448822|NCT01716234|11736804|FG004|Overall Study|Lack of Efficacy|0
7448823|NCT01716234|11736805|FG005|Overall Study|Lack of Efficacy|0
7448824|NCT01716234|11736806|FG006|Overall Study|Lack of Efficacy|0
7448825|NCT01716234|11736800|FG000|Overall Study|Did not meet protocol eligibility|0
7448826|NCT01716234|11736801|FG001|Overall Study|Did not meet protocol eligibility|0
7448827|NCT01716234|11736802|FG002|Overall Study|Did not meet protocol eligibility|1
7448828|NCT01716234|11736803|FG003|Overall Study|Did not meet protocol eligibility|0
7448829|NCT01716234|11736804|FG004|Overall Study|Did not meet protocol eligibility|0
7448830|NCT01716234|11736805|FG005|Overall Study|Did not meet protocol eligibility|4
7448831|NCT01716234|11736806|FG006|Overall Study|Did not meet protocol eligibility|0
7448832|NCT01716234|11736800|FG000|Overall Study|Adverse Event|7
7448833|NCT01716234|11736801|FG001|Overall Study|Adverse Event|10
7448834|NCT01716234|11736802|FG002|Overall Study|Adverse Event|2
7448835|NCT01716234|11736803|FG003|Overall Study|Adverse Event|8
7448836|NCT01716234|11736804|FG004|Overall Study|Adverse Event|3
7448837|NCT01716234|11736805|FG005|Overall Study|Adverse Event|6
7448838|NCT01716234|11736806|FG006|Overall Study|Adverse Event|0
7448839|NCT01716234|11736800|FG000|Overall Study|Withdrawal by Subject|3
7448840|NCT01716234|11736801|FG001|Overall Study|Withdrawal by Subject|0
7448841|NCT01716234|11736802|FG002|Overall Study|Withdrawal by Subject|2
7448842|NCT01716234|11736803|FG003|Overall Study|Withdrawal by Subject|2
7448843|NCT01716234|11736804|FG004|Overall Study|Withdrawal by Subject|1
7448844|NCT01716234|11736805|FG005|Overall Study|Withdrawal by Subject|3
7448845|NCT01716234|11736806|FG006|Overall Study|Withdrawal by Subject|0
7448846|NCT01716520|11736848|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7448847|NCT01716520|11736849|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7448848|NCT01716520|11736850|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
7448849|NCT01716520|11736851|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
7448850|NCT01716520|11736852|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
7448851|NCT01716520|11736853|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
7448852|NCT01716520|11736848|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7448853|NCT01716520|11736849|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7448854|NCT01716520|11736850|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
7448855|NCT01716520|11736851|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7448856|NCT01716520|11736852|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
7448857|NCT01716520|11736853|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
7448858|NCT01716520|11736848|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7448859|NCT01716520|11736849|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7448860|NCT01716520|11736850|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7448861|NCT01716520|11736851|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7448862|NCT01716520|11736852|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7448863|NCT01716520|11736853|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7448864|NCT01716520|11736848|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7448865|NCT01716520|11736849|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
7448866|NCT01716520|11736850|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7448867|NCT01716520|11736851|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7448868|NCT01716520|11736852|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7448869|NCT01716520|11736853|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
7448870|NCT01716520|11736848|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7563542|NCT03260205|11933632|FG002|Overall Study|Protocol Violation|2
7563543|NCT03260205|11933633|FG003|Overall Study|Protocol Violation|0
7563544|NCT03260205|11933634|FG004|Overall Study|Protocol Violation|1
7448871|NCT01716520|11736849|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7448872|NCT01716520|11736850|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7448873|NCT01716520|11736851|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7448874|NCT01716520|11736852|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
7448875|NCT01716520|11736853|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
7448876|NCT01716520|11736848|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7448877|NCT01716520|11736849|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7448878|NCT01716520|11736850|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7448879|NCT01716520|11736851|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7448880|NCT01716520|11736852|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
7448881|NCT01716520|11736853|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
7448882|NCT01716520|11736848|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
7448883|NCT01716520|11736849|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
7448884|NCT01716520|11736850|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
7448885|NCT01716520|11736851|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
7448886|NCT01716520|11736852|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
7448887|NCT01716520|11736853|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
7448888|NCT01716520|11736848|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
7448889|NCT01716520|11736849|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
7448890|NCT01716520|11736850|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
7448891|NCT01716520|11736851|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
7448892|NCT01716520|11736852|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
7448893|NCT01716520|11736853|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
7448894|NCT01716520|11736848|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7448895|NCT01716520|11736849|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7448896|NCT01716520|11736850|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7448897|NCT01716520|11736851|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
7448898|NCT01716520|11736852|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7448899|NCT01716520|11736853|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
7448900|NCT01716520|11736848|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7448901|NCT01716520|11736849|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7448902|NCT01716520|11736850|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7448903|NCT01716520|11736851|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7448904|NCT01716520|11736852|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
7448905|NCT01716520|11736853|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
7448906|NCT01716520|11736848|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
7448907|NCT01716520|11736849|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7448908|NCT01716520|11736850|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7448909|NCT01716520|11736851|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7448910|NCT01716520|11736852|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7448911|NCT01716520|11736853|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
7448912|NCT01716520|11736848|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7448913|NCT01716520|11736849|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7448914|NCT01716520|11736850|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7448915|NCT01716520|11736851|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7448916|NCT01716520|11736852|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
7448917|NCT01716520|11736853|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
7448918|NCT01716520|11736848|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7448919|NCT01716520|11736849|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
7448920|NCT01716520|11736850|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7448921|NCT01716520|11736851|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7448922|NCT01716520|11736852|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7448923|NCT01716520|11736853|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
7448924|NCT01716520|11736848|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7448925|NCT01716520|11736849|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7448926|NCT01716520|11736850|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7563545|NCT03260205|11933630|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
7575021|NCT03707821|11958427|FG000|Overall Study|Protocol Violation|0
7448927|NCT01716520|11736851|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7448928|NCT01716520|11736852|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
7448929|NCT01716520|11736853|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
7448930|NCT01716520|11736848|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7448931|NCT01716520|11736849|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7448932|NCT01716520|11736850|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
7448933|NCT01716520|11736851|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7448934|NCT01716520|11736852|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7448935|NCT01716520|11736853|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
7448936|NCT01716533|11736865|FG000|Overall Study|Failure of antibiotic treatment to treat|0
7448937|NCT01716533|11736866|FG001|Overall Study|Failure of antibiotic treatment to treat|0
7563546|NCT03260205|11933631|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
7563547|NCT03260205|11933632|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
7563548|NCT03260205|11933633|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
7563549|NCT03260205|11933634|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
7563550|NCT03260205|11933630|FG000|Overall Study|Other: Unspecified|0
7563551|NCT03260205|11933631|FG001|Overall Study|Other: Unspecified|0
7563552|NCT03260205|11933632|FG002|Overall Study|Other: Unspecified|3
7563553|NCT03260205|11933633|FG003|Overall Study|Other: Unspecified|1
7563554|NCT03260205|11933634|FG004|Overall Study|Other: Unspecified|1
7563555|NCT03260205|11933630|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
7563556|NCT03260205|11933631|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
7563557|NCT03260205|11933632|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
7563558|NCT03260205|11933633|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
7563559|NCT03260205|11933634|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
7563560|NCT03261037|11933695|FG000|Overall Study|Withdrawal by Subject|2
7563561|NCT03261037|11933696|FG001|Overall Study|Withdrawal by Subject|13
7563562|NCT03261037|11933697|FG002|Overall Study|Withdrawal by Subject|0
7563563|NCT03261037|11933698|FG003|Overall Study|Withdrawal by Subject|18
7563564|NCT03261037|11933695|FG000|Overall Study|Non-compliance with study procedures|0
7563565|NCT03261037|11933696|FG001|Overall Study|Non-compliance with study procedures|2
7563566|NCT03261037|11933697|FG002|Overall Study|Non-compliance with study procedures|0
7563567|NCT03261037|11933698|FG003|Overall Study|Non-compliance with study procedures|6
7448938|NCT01716533|11736867|FG002|Overall Study|Failure of antibiotic treatment to treat|5
7448939|NCT01716533|11736868|FG003|Overall Study|Failure of antibiotic treatment to treat|0
7448940|NCT01716533|11736865|FG000|Overall Study|Withdrawal by Subject|0
7448941|NCT01716533|11736866|FG001|Overall Study|Withdrawal by Subject|0
7448942|NCT01716533|11736867|FG002|Overall Study|Withdrawal by Subject|0
7448943|NCT01716533|11736868|FG003|Overall Study|Withdrawal by Subject|5
7448944|NCT01716533|11736865|FG000|Overall Study|Death|0
7448945|NCT01716533|11736866|FG001|Overall Study|Death|0
7448946|NCT01716533|11736867|FG002|Overall Study|Death|0
7448947|NCT01716533|11736868|FG003|Overall Study|Death|2
7448948|NCT01716533|11736865|FG000|Overall Study|Immunosuppressants>14days past 6months|0
7448949|NCT01716533|11736866|FG001|Overall Study|Immunosuppressants>14days past 6months|0
7448950|NCT01716533|11736867|FG002|Overall Study|Immunosuppressants>14days past 6months|0
7448951|NCT01716533|11736868|FG003|Overall Study|Immunosuppressants>14days past 6months|1
7448952|NCT01716559|11736882|FG000|Overall Study|Adverse Event|11
7448953|NCT01716559|11736882|FG000|Overall Study|Death|21
7448954|NCT01716559|11736882|FG000|Overall Study|Withdrawal by Subject|4
7448955|NCT01716559|11736882|FG000|Overall Study|Other withdrawal reason|75
7448956|NCT01716585|11736888|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
7448957|NCT01716585|11736889|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
7448958|NCT01716585|11736888|FG000|Double-blind Treatment|Adverse Event|2
7448959|NCT01716585|11736889|FG001|Double-blind Treatment|Adverse Event|1
7448960|NCT01716585|11736888|FG000|Double-blind Treatment|Withdrawal by Subject|3
7448961|NCT01716585|11736889|FG001|Double-blind Treatment|Withdrawal by Subject|0
7448962|NCT01716585|11736888|FG000|Double-blind Treatment|Lost to Follow-up|2
7448963|NCT01716585|11736889|FG001|Double-blind Treatment|Lost to Follow-up|0
7448964|NCT01716585|11736888|FG000|Double-blind Treatment|Subject Noncompliant|1
7448965|NCT01716585|11736889|FG001|Double-blind Treatment|Subject Noncompliant|0
7448966|NCT01716585|11736888|FG000|Double-blind Treatment|Other|1
7448967|NCT01716585|11736889|FG001|Double-blind Treatment|Other|0
7448968|NCT01716585|11736888|FG000|Open-label Treatment|Adverse Event|0
7448969|NCT01716585|11736889|FG001|Open-label Treatment|Adverse Event|2
7448970|NCT01716585|11736888|FG000|Open-label Treatment|Virologic Failure|0
7448971|NCT01716585|11736889|FG001|Open-label Treatment|Virologic Failure|2
7448972|NCT01716585|11736888|FG000|Open-label Treatment|Withdrawal by Subject|0
7448973|NCT01716585|11736889|FG001|Open-label Treatment|Withdrawal by Subject|3
7448974|NCT01716663|11736896|FG000|Overall Study|Withdrawn prior to procedure|4
7448975|NCT01716663|11736896|FG000|Overall Study|Treated with non-study catheter|2
7448976|NCT01716715|11736902|FG000|Overall Study|Never Treated|2
7563568|NCT03261037|11933695|FG000|Overall Study|Participant moving away and can no longer be in study|0
7563569|NCT03261037|11933696|FG001|Overall Study|Participant moving away and can no longer be in study|1
7563570|NCT03261037|11933697|FG002|Overall Study|Participant moving away and can no longer be in study|0
7563571|NCT03261037|11933698|FG003|Overall Study|Participant moving away and can no longer be in study|0
7448977|NCT01716715|11736903|FG001|Overall Study|Never Treated|4
7448978|NCT01716754|11736915|FG000|Overall Study|Death|0
7448979|NCT01716754|11736916|FG001|Overall Study|Death|0
7448980|NCT01716754|11736917|FG002|Overall Study|Death|0
7448981|NCT01716754|11736918|FG003|Overall Study|Death|1
7448982|NCT01716754|11736915|FG000|Overall Study|Protocol deviation|0
7448983|NCT01716754|11736916|FG001|Overall Study|Protocol deviation|2
7448984|NCT01716754|11736917|FG002|Overall Study|Protocol deviation|7
7448985|NCT01716754|11736918|FG003|Overall Study|Protocol deviation|2
7448986|NCT01716754|11736915|FG000|Overall Study|Non-compliance with study treatment|0
7448987|NCT01716754|11736916|FG001|Overall Study|Non-compliance with study treatment|0
7448988|NCT01716754|11736917|FG002|Overall Study|Non-compliance with study treatment|1
7448989|NCT01716754|11736918|FG003|Overall Study|Non-compliance with study treatment|0
7448990|NCT01716754|11736915|FG000|Overall Study|Physician Decision|1
7448991|NCT01716754|11736916|FG001|Overall Study|Physician Decision|0
7448992|NCT01716754|11736917|FG002|Overall Study|Physician Decision|0
7448993|NCT01716754|11736918|FG003|Overall Study|Physician Decision|0
7448994|NCT01716754|11736915|FG000|Overall Study|Lost to Follow-up|1
7448995|NCT01716754|11736916|FG001|Overall Study|Lost to Follow-up|0
7448996|NCT01716754|11736917|FG002|Overall Study|Lost to Follow-up|0
7448997|NCT01716754|11736918|FG003|Overall Study|Lost to Follow-up|1
7448998|NCT01716754|11736915|FG000|Overall Study|Adverse Event|4
7448999|NCT01716754|11736916|FG001|Overall Study|Adverse Event|2
7449000|NCT01716754|11736917|FG002|Overall Study|Adverse Event|2
7449001|NCT01716754|11736918|FG003|Overall Study|Adverse Event|1
7449002|NCT01716754|11736915|FG000|Overall Study|Withdrawal by Subject|5
7449003|NCT01716754|11736916|FG001|Overall Study|Withdrawal by Subject|0
7449004|NCT01716754|11736917|FG002|Overall Study|Withdrawal by Subject|4
7449005|NCT01716754|11736918|FG003|Overall Study|Withdrawal by Subject|3
7449006|NCT01717040|11736942|FG000|Overall Study|Lost to Follow-up|2
7449007|NCT01717040|11736943|FG001|Overall Study|Lost to Follow-up|3
7449008|NCT01717040|11736942|FG000|Overall Study|Lack of Efficacy|1
7449009|NCT01717040|11736943|FG001|Overall Study|Lack of Efficacy|1
7449010|NCT01717040|11736942|FG000|Overall Study|Adverse Event|1
7449011|NCT01717040|11736943|FG001|Overall Study|Adverse Event|0
7449012|NCT01717040|11736942|FG000|Overall Study|Required Medication Change|0
7449013|NCT01717040|11736943|FG001|Overall Study|Required Medication Change|1
7449014|NCT01717040|11736942|FG000|Overall Study|New Substance Use Disorder|1
7449015|NCT01717040|11736943|FG001|Overall Study|New Substance Use Disorder|0
7449016|NCT01717287|11736959|FG000|Overall Study|Lost to Follow-up|0
7449017|NCT01717287|11736960|FG001|Overall Study|Lost to Follow-up|2
7449018|NCT01717287|11736959|FG000|Overall Study|Protocol Violation|0
7449019|NCT01717287|11736960|FG001|Overall Study|Protocol Violation|1
7449020|NCT01717313|11736968|FG000|Phase A (Weeks 0 to 24)|Death|0
7449021|NCT01717313|11736969|FG001|Phase A (Weeks 0 to 24)|Death|1
7449022|NCT01717313|11736968|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
7449023|NCT01717313|11736969|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
7449024|NCT01717313|11736968|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
7449025|NCT01717313|11736969|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
7449026|NCT01717313|11736968|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
7449027|NCT01717313|11736969|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
7449028|NCT01717313|11736968|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7449029|NCT01717313|11736969|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
7449030|NCT01717313|11736968|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
7449031|NCT01717313|11736969|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
7449032|NCT01717313|11736968|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7449033|NCT01717313|11736969|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
7449034|NCT01717313|11736968|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
7449035|NCT01717313|11736969|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
7449036|NCT01717313|11736968|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
7449037|NCT01717313|11736969|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
7449038|NCT01717326|11736995|FG000|Overall Study|Death|0
7449039|NCT01717326|11736996|FG001|Overall Study|Death|0
7449040|NCT01717326|11736997|FG002|Overall Study|Death|0
7449041|NCT01717326|11736998|FG003|Overall Study|Death|0
7449042|NCT01717326|11736999|FG004|Overall Study|Death|0
7449043|NCT01717326|11737000|FG005|Overall Study|Death|0
7449044|NCT01717326|11737001|FG006|Overall Study|Death|0
7449045|NCT01717326|11737002|FG007|Overall Study|Death|0
7449046|NCT01717326|11737003|FG008|Overall Study|Death|0
7449047|NCT01717326|11737004|FG009|Overall Study|Death|0
7449048|NCT01717326|11737005|FG010|Overall Study|Death|1
7449049|NCT01717326|11737006|FG011|Overall Study|Death|0
7449050|NCT01717326|11737007|FG012|Overall Study|Death|0
7449051|NCT01717326|11737008|FG013|Overall Study|Death|0
7449052|NCT01717326|11737009|FG014|Overall Study|Death|0
7449053|NCT01717326|11737010|FG015|Overall Study|Death|0
7449054|NCT01717326|11737011|FG016|Overall Study|Death|0
7449055|NCT01717326|11737012|FG017|Overall Study|Death|0
7449056|NCT01717326|11737013|FG018|Overall Study|Death|0
7449057|NCT01717326|11737014|FG019|Overall Study|Death|0
7449058|NCT01717326|11736995|FG000|Overall Study|Lost to Follow-up|3
7449059|NCT01717326|11736996|FG001|Overall Study|Lost to Follow-up|0
7449060|NCT01717326|11736997|FG002|Overall Study|Lost to Follow-up|0
7449061|NCT01717326|11736998|FG003|Overall Study|Lost to Follow-up|2
7449062|NCT01717326|11736999|FG004|Overall Study|Lost to Follow-up|1
7449063|NCT01717326|11737000|FG005|Overall Study|Lost to Follow-up|0
7449064|NCT01717326|11737001|FG006|Overall Study|Lost to Follow-up|1
7449065|NCT01717326|11737002|FG007|Overall Study|Lost to Follow-up|0
7449066|NCT01717326|11737003|FG008|Overall Study|Lost to Follow-up|0
7449067|NCT01717326|11737004|FG009|Overall Study|Lost to Follow-up|0
7449068|NCT01717326|11737005|FG010|Overall Study|Lost to Follow-up|1
7449069|NCT01717326|11737006|FG011|Overall Study|Lost to Follow-up|0
7449070|NCT01717326|11737007|FG012|Overall Study|Lost to Follow-up|0
7449071|NCT01717326|11737008|FG013|Overall Study|Lost to Follow-up|0
7449072|NCT01717326|11737009|FG014|Overall Study|Lost to Follow-up|0
7449073|NCT01717326|11737010|FG015|Overall Study|Lost to Follow-up|2
7449074|NCT01717326|11737011|FG016|Overall Study|Lost to Follow-up|1
7449075|NCT01717326|11737012|FG017|Overall Study|Lost to Follow-up|0
7449076|NCT01717326|11737013|FG018|Overall Study|Lost to Follow-up|2
7449077|NCT01717326|11737014|FG019|Overall Study|Lost to Follow-up|3
7449078|NCT01717326|11736995|FG000|Overall Study|Physician Decision|0
7449079|NCT01717326|11736996|FG001|Overall Study|Physician Decision|0
7449080|NCT01717326|11736997|FG002|Overall Study|Physician Decision|0
7449081|NCT01717326|11736998|FG003|Overall Study|Physician Decision|0
7449082|NCT01717326|11736999|FG004|Overall Study|Physician Decision|0
7449083|NCT01717326|11737000|FG005|Overall Study|Physician Decision|0
7449084|NCT01717326|11737001|FG006|Overall Study|Physician Decision|0
7449085|NCT01717326|11737002|FG007|Overall Study|Physician Decision|0
7449086|NCT01717326|11737003|FG008|Overall Study|Physician Decision|0
7449087|NCT01717326|11737004|FG009|Overall Study|Physician Decision|1
7449088|NCT01717326|11737005|FG010|Overall Study|Physician Decision|0
7449089|NCT01717326|11737006|FG011|Overall Study|Physician Decision|0
7449090|NCT01717326|11737007|FG012|Overall Study|Physician Decision|0
7449091|NCT01717326|11737008|FG013|Overall Study|Physician Decision|0
7449092|NCT01717326|11737009|FG014|Overall Study|Physician Decision|0
7449093|NCT01717326|11737010|FG015|Overall Study|Physician Decision|0
7449094|NCT01717326|11737011|FG016|Overall Study|Physician Decision|0
7449095|NCT01717326|11737012|FG017|Overall Study|Physician Decision|0
7449096|NCT01717326|11737013|FG018|Overall Study|Physician Decision|0
7449097|NCT01717326|11737014|FG019|Overall Study|Physician Decision|0
7449098|NCT01717326|11736995|FG000|Overall Study|Protocol Violation|0
7449099|NCT01717326|11736996|FG001|Overall Study|Protocol Violation|0
7449100|NCT01717326|11736997|FG002|Overall Study|Protocol Violation|0
7449101|NCT01717326|11736998|FG003|Overall Study|Protocol Violation|0
7449102|NCT01717326|11736999|FG004|Overall Study|Protocol Violation|1
7449103|NCT01717326|11737000|FG005|Overall Study|Protocol Violation|0
7449104|NCT01717326|11737001|FG006|Overall Study|Protocol Violation|0
7449105|NCT01717326|11737002|FG007|Overall Study|Protocol Violation|0
7449106|NCT01717326|11737003|FG008|Overall Study|Protocol Violation|0
7449107|NCT01717326|11737004|FG009|Overall Study|Protocol Violation|0
7449108|NCT01717326|11737005|FG010|Overall Study|Protocol Violation|0
7449109|NCT01717326|11737006|FG011|Overall Study|Protocol Violation|0
7449110|NCT01717326|11737007|FG012|Overall Study|Protocol Violation|0
7449111|NCT01717326|11737008|FG013|Overall Study|Protocol Violation|0
7449112|NCT01717326|11737009|FG014|Overall Study|Protocol Violation|0
7449113|NCT01717326|11737010|FG015|Overall Study|Protocol Violation|0
7449114|NCT01717326|11737011|FG016|Overall Study|Protocol Violation|0
7449115|NCT01717326|11737012|FG017|Overall Study|Protocol Violation|0
7449116|NCT01717326|11737013|FG018|Overall Study|Protocol Violation|0
7449117|NCT01717326|11737014|FG019|Overall Study|Protocol Violation|0
7449118|NCT01717326|11736995|FG000|Overall Study|Withdrawal by Subject|0
7449119|NCT01717326|11736996|FG001|Overall Study|Withdrawal by Subject|1
7449120|NCT01717326|11736997|FG002|Overall Study|Withdrawal by Subject|0
7449121|NCT01717326|11736998|FG003|Overall Study|Withdrawal by Subject|0
7449122|NCT01717326|11736999|FG004|Overall Study|Withdrawal by Subject|0
7449123|NCT01717326|11737000|FG005|Overall Study|Withdrawal by Subject|0
7449124|NCT01717326|11737001|FG006|Overall Study|Withdrawal by Subject|0
7449125|NCT01717326|11737002|FG007|Overall Study|Withdrawal by Subject|0
7449126|NCT01717326|11737003|FG008|Overall Study|Withdrawal by Subject|0
7449127|NCT01717326|11737004|FG009|Overall Study|Withdrawal by Subject|1
7449128|NCT01717326|11737005|FG010|Overall Study|Withdrawal by Subject|0
7449129|NCT01717326|11737006|FG011|Overall Study|Withdrawal by Subject|0
7449130|NCT01717326|11737007|FG012|Overall Study|Withdrawal by Subject|1
7449131|NCT01717326|11737008|FG013|Overall Study|Withdrawal by Subject|0
7449132|NCT01717326|11737009|FG014|Overall Study|Withdrawal by Subject|0
7449133|NCT01717326|11737010|FG015|Overall Study|Withdrawal by Subject|1
7449134|NCT01717326|11737011|FG016|Overall Study|Withdrawal by Subject|0
7449135|NCT01717326|11737012|FG017|Overall Study|Withdrawal by Subject|0
7449136|NCT01717326|11737013|FG018|Overall Study|Withdrawal by Subject|2
7449137|NCT01717326|11737014|FG019|Overall Study|Withdrawal by Subject|3
7449138|NCT01717391|11737056|FG000|Overall Study|Withdrawal by Subject|5
7449139|NCT01717391|11737056|FG000|Overall Study|Physician Decision|1
7449140|NCT01717391|11737056|FG000|Overall Study|FLT technical failure|3
7449141|NCT01717456|11737064|FG000|End of Treatment|Physician Decision|0
7449142|NCT01717456|11737065|FG001|End of Treatment|Physician Decision|1
7449143|NCT01717456|11737064|FG000|End of Treatment|Lost to Follow-up|0
7449144|NCT01717456|11737065|FG001|End of Treatment|Lost to Follow-up|1
7449145|NCT01717456|11737064|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7449146|NCT01717456|11737065|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
7449147|NCT01717638|11737089|FG000|Overall Study|Lost to Follow-up|0
7449148|NCT01717638|11737090|FG001|Overall Study|Lost to Follow-up|0
7449149|NCT01717638|11737091|FG002|Overall Study|Lost to Follow-up|0
7449150|NCT01717638|11737092|FG003|Overall Study|Lost to Follow-up|0
7449151|NCT01717638|11737093|FG004|Overall Study|Lost to Follow-up|0
7449152|NCT01717638|11737094|FG005|Overall Study|Lost to Follow-up|1
7449153|NCT01717638|11737095|FG006|Overall Study|Lost to Follow-up|0
7449154|NCT01717638|11737096|FG007|Overall Study|Lost to Follow-up|0
7449155|NCT01717638|11737097|FG008|Overall Study|Lost to Follow-up|0
7449156|NCT01717638|11737098|FG009|Overall Study|Lost to Follow-up|0
7449157|NCT01717638|11737099|FG010|Overall Study|Lost to Follow-up|0
7449158|NCT01717638|11737100|FG011|Overall Study|Lost to Follow-up|0
7449159|NCT01717638|11737101|FG012|Overall Study|Lost to Follow-up|0
7449160|NCT01717638|11737089|FG000|Overall Study|Father in hospital|0
7449161|NCT01717638|11737090|FG001|Overall Study|Father in hospital|0
7449162|NCT01717638|11737091|FG002|Overall Study|Father in hospital|0
7449163|NCT01717638|11737092|FG003|Overall Study|Father in hospital|0
7449164|NCT01717638|11737093|FG004|Overall Study|Father in hospital|0
7449165|NCT01717638|11737094|FG005|Overall Study|Father in hospital|0
7449166|NCT01717638|11737095|FG006|Overall Study|Father in hospital|0
7449167|NCT01717638|11737096|FG007|Overall Study|Father in hospital|0
7449168|NCT01717638|11737097|FG008|Overall Study|Father in hospital|0
7449169|NCT01717638|11737098|FG009|Overall Study|Father in hospital|0
7449170|NCT01717638|11737099|FG010|Overall Study|Father in hospital|0
7449171|NCT01717638|11737100|FG011|Overall Study|Father in hospital|0
7449172|NCT01717638|11737101|FG012|Overall Study|Father in hospital|1
7449173|NCT01717638|11737089|FG000|Overall Study|Withdrawal by Subject|0
7449174|NCT01717638|11737090|FG001|Overall Study|Withdrawal by Subject|1
7449175|NCT01717638|11737091|FG002|Overall Study|Withdrawal by Subject|1
7449176|NCT01717638|11737092|FG003|Overall Study|Withdrawal by Subject|0
7449177|NCT01717638|11737093|FG004|Overall Study|Withdrawal by Subject|1
7449178|NCT01717638|11737094|FG005|Overall Study|Withdrawal by Subject|0
7449179|NCT01717638|11737095|FG006|Overall Study|Withdrawal by Subject|2
7449180|NCT01717638|11737096|FG007|Overall Study|Withdrawal by Subject|1
7449181|NCT01717638|11737097|FG008|Overall Study|Withdrawal by Subject|2
7449182|NCT01717638|11737098|FG009|Overall Study|Withdrawal by Subject|1
7449183|NCT01717638|11737099|FG010|Overall Study|Withdrawal by Subject|0
7449184|NCT01717638|11737100|FG011|Overall Study|Withdrawal by Subject|0
7449185|NCT01717638|11737101|FG012|Overall Study|Withdrawal by Subject|18
7449186|NCT01717768|11737154|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449187|NCT01717768|11737155|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
7449188|NCT01717768|11737156|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449189|NCT01717768|11737157|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449190|NCT01717768|11737158|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449191|NCT01717768|11737159|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449192|NCT01717768|11737160|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449193|NCT01717768|11737161|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449194|NCT01717768|11737162|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449195|NCT01717768|11737163|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449196|NCT01717768|11737164|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449197|NCT01717768|11737165|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
7449198|NCT01717768|11737154|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449199|NCT01717768|11737155|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449275|NCT01718509|11737287|FG000|Overall Study|Other|13
7449200|NCT01717768|11737156|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449201|NCT01717768|11737157|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449202|NCT01717768|11737158|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449203|NCT01717768|11737159|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449204|NCT01717768|11737160|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449205|NCT01717768|11737161|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449206|NCT01717768|11737162|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449207|NCT01717768|11737163|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449208|NCT01717768|11737164|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
7449209|NCT01717768|11737165|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
7449210|NCT01717768|11737154|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449211|NCT01717768|11737155|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449212|NCT01717768|11737156|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449213|NCT01717768|11737157|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449214|NCT01717768|11737158|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449215|NCT01717768|11737159|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449216|NCT01717768|11737160|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449217|NCT01717768|11737161|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
7449218|NCT01717768|11737162|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449219|NCT01717768|11737163|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449220|NCT01717768|11737164|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449221|NCT01717768|11737165|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
7449222|NCT01717768|11737154|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7468734|NCT01914393|11769700|FG000|Overall Study|Adverse Event|29
7449223|NCT01717768|11737155|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449224|NCT01717768|11737156|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449225|NCT01717768|11737157|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449226|NCT01717768|11737158|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449227|NCT01717768|11737159|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449228|NCT01717768|11737160|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449229|NCT01717768|11737161|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449230|NCT01717768|11737162|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449231|NCT01717768|11737163|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
7449232|NCT01717768|11737164|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449233|NCT01717768|11737165|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
7449234|NCT01717859|11737191|FG000|Overall Study|Adverse Event|5
7449235|NCT01717859|11737191|FG000|Overall Study|Moved out of state|1
7449236|NCT01717859|11737191|FG000|Overall Study|Patient concerned about mental health|1
7449237|NCT01717859|11737191|FG000|Overall Study|Lost to Follow-up|1
7449238|NCT01717859|11737191|FG000|Overall Study|Withdrawal by Subject|2
7449239|NCT01717976|11737230|FG000|Overall Study|Protocol Violation|0
7449240|NCT01717976|11737231|FG001|Overall Study|Protocol Violation|1
7449241|NCT01717989|11737237|FG000|Overall Study|Ineligibility determined|6
7449242|NCT01717989|11737237|FG000|Overall Study|Protocol deviation|6
7449243|NCT01717989|11737237|FG000|Overall Study|Withdrawal by Subject|11
7449244|NCT01717989|11737237|FG000|Overall Study|Physician Decision|2
7449245|NCT01717989|11737237|FG000|Overall Study|Lost to Follow-up|11
7449246|NCT01717989|11737237|FG000|Overall Study|Death|439
7449247|NCT01717989|11737237|FG000|Overall Study|Protocol-specified criteria|551
7449248|NCT01717989|11737237|FG000|Overall Study|Other|40
7449249|NCT01718353|11737267|FG000|Overall Study|Lost to Follow-up|0
7449250|NCT01718353|11737268|FG001|Overall Study|Lost to Follow-up|1
7449251|NCT01718353|11737267|FG000|Overall Study|Principal Investigator's Decision|10
7449252|NCT01718353|11737268|FG001|Overall Study|Principal Investigator's Decision|4
7449253|NCT01718353|11737267|FG000|Overall Study|Randomized but not treated|2
7449254|NCT01718353|11737268|FG001|Overall Study|Randomized but not treated|0
7449255|NCT01718483|11737278|FG000|Overall Study|Withdrawal by Subject|14
7449256|NCT01718483|11737279|FG001|Overall Study|Withdrawal by Subject|12
7449257|NCT01718483|11737278|FG000|Overall Study|Adverse Event|5
7449258|NCT01718483|11737279|FG001|Overall Study|Adverse Event|12
7449259|NCT01718483|11737278|FG000|Overall Study|Lost to Follow-up|8
7449260|NCT01718483|11737279|FG001|Overall Study|Lost to Follow-up|3
7449261|NCT01718483|11737278|FG000|Overall Study|Protocol Violation|4
7449262|NCT01718483|11737279|FG001|Overall Study|Protocol Violation|2
7449263|NCT01718483|11737278|FG000|Overall Study|Other|1
7449264|NCT01718483|11737279|FG001|Overall Study|Other|4
7449265|NCT01718483|11737278|FG000|Overall Study|Pregnancy|1
7449266|NCT01718483|11737279|FG001|Overall Study|Pregnancy|1
7449267|NCT01718483|11737278|FG000|Overall Study|Lack of Efficacy|1
7449268|NCT01718483|11737279|FG001|Overall Study|Lack of Efficacy|0
7449269|NCT01718509|11737287|FG000|Overall Study|Lost to Follow-up|18
7449270|NCT01718509|11737288|FG001|Overall Study|Lost to Follow-up|15
7449271|NCT01718509|11737287|FG000|Overall Study|Withdrawal by Subject|7
7449272|NCT01718509|11737288|FG001|Overall Study|Withdrawal by Subject|13
7449273|NCT01718509|11737287|FG000|Overall Study|Adverse Event|5
7449274|NCT01718509|11737288|FG001|Overall Study|Adverse Event|7
7449276|NCT01718509|11737288|FG001|Overall Study|Other|11
7449277|NCT01718509|11737287|FG000|Overall Study|Protocol Violation|4
7449278|NCT01718509|11737288|FG001|Overall Study|Protocol Violation|2
7449279|NCT01718509|11737287|FG000|Overall Study|Lack of Efficacy|1
7449280|NCT01718509|11737288|FG001|Overall Study|Lack of Efficacy|0
7449281|NCT01718535|11737311|FG000|Overall Study|Bidirectional Sequencing not possible|1
7449282|NCT01718535|11737312|FG001|Overall Study|Bidirectional Sequencing not possible|0
7449283|NCT01718535|11737313|FG002|Overall Study|Bidirectional Sequencing not possible|0
7449284|NCT01718535|11737314|FG003|Overall Study|Bidirectional Sequencing not possible|1
7449285|NCT01718535|11737315|FG004|Overall Study|Bidirectional Sequencing not possible|0
7449286|NCT01718535|11737316|FG005|Overall Study|Bidirectional Sequencing not possible|0
7449287|NCT01718535|11737317|FG006|Overall Study|Bidirectional Sequencing not possible|0
7449288|NCT01718535|11737318|FG007|Overall Study|Bidirectional Sequencing not possible|0
7449289|NCT01718535|11737319|FG008|Overall Study|Bidirectional Sequencing not possible|0
7449290|NCT01718535|11737320|FG009|Overall Study|Bidirectional Sequencing not possible|0
7449291|NCT01719003|11737364|FG000|Overall Study|Non compliant with protocol|1
7449292|NCT01719003|11737365|FG001|Overall Study|Non compliant with protocol|1
7449293|NCT01719003|11737366|FG002|Overall Study|Non compliant with protocol|0
7449294|NCT01719003|11737367|FG003|Overall Study|Non compliant with protocol|1
7449295|NCT01719003|11737368|FG004|Overall Study|Non compliant with protocol|2
7449296|NCT01719003|11737369|FG005|Overall Study|Non compliant with protocol|1
7449297|NCT01719003|11737370|FG006|Overall Study|Non compliant with protocol|2
7449298|NCT01719003|11737371|FG007|Overall Study|Non compliant with protocol|3
7449299|NCT01719003|11737372|FG008|Overall Study|Non compliant with protocol|0
7449300|NCT01719003|11737364|FG000|Overall Study|Adverse Event|6
7449301|NCT01719003|11737365|FG001|Overall Study|Adverse Event|5
7449302|NCT01719003|11737366|FG002|Overall Study|Adverse Event|4
7449303|NCT01719003|11737367|FG003|Overall Study|Adverse Event|3
7449304|NCT01719003|11737368|FG004|Overall Study|Adverse Event|4
7449305|NCT01719003|11737369|FG005|Overall Study|Adverse Event|3
7449306|NCT01719003|11737370|FG006|Overall Study|Adverse Event|6
7449307|NCT01719003|11737371|FG007|Overall Study|Adverse Event|5
7449308|NCT01719003|11737372|FG008|Overall Study|Adverse Event|0
7449309|NCT01719003|11737364|FG000|Overall Study|Lost to Follow-up|0
7449310|NCT01719003|11737365|FG001|Overall Study|Lost to Follow-up|6
7449311|NCT01719003|11737366|FG002|Overall Study|Lost to Follow-up|7
7449312|NCT01719003|11737367|FG003|Overall Study|Lost to Follow-up|2
7449313|NCT01719003|11737368|FG004|Overall Study|Lost to Follow-up|3
7449314|NCT01719003|11737369|FG005|Overall Study|Lost to Follow-up|4
7449315|NCT01719003|11737370|FG006|Overall Study|Lost to Follow-up|3
7449316|NCT01719003|11737371|FG007|Overall Study|Lost to Follow-up|2
7449317|NCT01719003|11737372|FG008|Overall Study|Lost to Follow-up|2
7449318|NCT01719003|11737364|FG000|Overall Study|Refusal to continue, not due to AE|2
7449319|NCT01719003|11737365|FG001|Overall Study|Refusal to continue, not due to AE|5
7449320|NCT01719003|11737366|FG002|Overall Study|Refusal to continue, not due to AE|4
7449321|NCT01719003|11737367|FG003|Overall Study|Refusal to continue, not due to AE|4
7449322|NCT01719003|11737368|FG004|Overall Study|Refusal to continue, not due to AE|4
7449323|NCT01719003|11737369|FG005|Overall Study|Refusal to continue, not due to AE|3
7449324|NCT01719003|11737370|FG006|Overall Study|Refusal to continue, not due to AE|8
7449325|NCT01719003|11737371|FG007|Overall Study|Refusal to continue, not due to AE|7
7449326|NCT01719003|11737372|FG008|Overall Study|Refusal to continue, not due to AE|1
7449327|NCT01719003|11737364|FG000|Overall Study|Reason other than those specified|0
7449328|NCT01719003|11737365|FG001|Overall Study|Reason other than those specified|0
7449329|NCT01719003|11737366|FG002|Overall Study|Reason other than those specified|2
7449330|NCT01719003|11737367|FG003|Overall Study|Reason other than those specified|3
7449331|NCT01719003|11737368|FG004|Overall Study|Reason other than those specified|4
7449332|NCT01719003|11737369|FG005|Overall Study|Reason other than those specified|1
7449333|NCT01719003|11737370|FG006|Overall Study|Reason other than those specified|0
7449334|NCT01719003|11737371|FG007|Overall Study|Reason other than those specified|3
7449335|NCT01719003|11737372|FG008|Overall Study|Reason other than those specified|1
7449336|NCT01719003|11737364|FG000|Overall Study|Lack of Efficacy|0
7449337|NCT01719003|11737365|FG001|Overall Study|Lack of Efficacy|0
7449338|NCT01719003|11737366|FG002|Overall Study|Lack of Efficacy|0
7449339|NCT01719003|11737367|FG003|Overall Study|Lack of Efficacy|0
7449340|NCT01719003|11737368|FG004|Overall Study|Lack of Efficacy|0
7449341|NCT01719003|11737369|FG005|Overall Study|Lack of Efficacy|0
7449342|NCT01719003|11737370|FG006|Overall Study|Lack of Efficacy|1
7449343|NCT01719003|11737371|FG007|Overall Study|Lack of Efficacy|0
7449344|NCT01719003|11737372|FG008|Overall Study|Lack of Efficacy|0
7449345|NCT01719172|11737391|FG000|Overall Study|Lost to Follow-up|1
7449346|NCT01719172|11737391|FG000|Overall Study|Death|1
7449347|NCT01719224|11737395|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
7449348|NCT01719224|11737396|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
7449349|NCT01719380|11737422|FG000|Overall Study|Adverse Event|0
7449350|NCT01719380|11737423|FG001|Overall Study|Adverse Event|0
7449351|NCT01719380|11737424|FG002|Overall Study|Adverse Event|1
7449352|NCT01719380|11737425|FG003|Overall Study|Adverse Event|2
7449353|NCT01719380|11737426|FG004|Overall Study|Adverse Event|0
7449354|NCT01719380|11737427|FG005|Overall Study|Adverse Event|1
7449355|NCT01719380|11737428|FG006|Overall Study|Adverse Event|0
7449356|NCT01719380|11737429|FG007|Overall Study|Adverse Event|1
7449357|NCT01719380|11737430|FG008|Overall Study|Adverse Event|4
7449358|NCT01719380|11737431|FG009|Overall Study|Adverse Event|3
7449359|NCT01719380|11737422|FG000|Overall Study|Death|0
7449360|NCT01719380|11737423|FG001|Overall Study|Death|1
7449361|NCT01719380|11737424|FG002|Overall Study|Death|0
7449362|NCT01719380|11737425|FG003|Overall Study|Death|0
7449363|NCT01719380|11737426|FG004|Overall Study|Death|0
7449364|NCT01719380|11737427|FG005|Overall Study|Death|0
7449365|NCT01719380|11737428|FG006|Overall Study|Death|0
7449366|NCT01719380|11737429|FG007|Overall Study|Death|0
7449367|NCT01719380|11737430|FG008|Overall Study|Death|3
7449368|NCT01719380|11737431|FG009|Overall Study|Death|3
7449369|NCT01719380|11737422|FG000|Overall Study|Participant/Guardian Decision|0
7449370|NCT01719380|11737423|FG001|Overall Study|Participant/Guardian Decision|0
7449371|NCT01719380|11737424|FG002|Overall Study|Participant/Guardian Decision|1
7449372|NCT01719380|11737425|FG003|Overall Study|Participant/Guardian Decision|0
7449373|NCT01719380|11737426|FG004|Overall Study|Participant/Guardian Decision|0
7449374|NCT01719380|11737427|FG005|Overall Study|Participant/Guardian Decision|0
7449375|NCT01719380|11737428|FG006|Overall Study|Participant/Guardian Decision|0
7449376|NCT01719380|11737429|FG007|Overall Study|Participant/Guardian Decision|0
7449377|NCT01719380|11737430|FG008|Overall Study|Participant/Guardian Decision|2
7449378|NCT01719380|11737431|FG009|Overall Study|Participant/Guardian Decision|2
7449379|NCT01719380|11737422|FG000|Overall Study|Physician Decision|0
7449380|NCT01719380|11737423|FG001|Overall Study|Physician Decision|0
7449381|NCT01719380|11737424|FG002|Overall Study|Physician Decision|2
7449382|NCT01719380|11737425|FG003|Overall Study|Physician Decision|0
7449383|NCT01719380|11737426|FG004|Overall Study|Physician Decision|0
7449384|NCT01719380|11737427|FG005|Overall Study|Physician Decision|0
7449385|NCT01719380|11737428|FG006|Overall Study|Physician Decision|0
7449386|NCT01719380|11737429|FG007|Overall Study|Physician Decision|0
7449387|NCT01719380|11737430|FG008|Overall Study|Physician Decision|1
7449388|NCT01719380|11737431|FG009|Overall Study|Physician Decision|1
7449389|NCT01719380|11737422|FG000|Overall Study|Lack of Efficacy|2
7449390|NCT01719380|11737423|FG001|Overall Study|Lack of Efficacy|6
7449391|NCT01719380|11737424|FG002|Overall Study|Lack of Efficacy|5
7449392|NCT01719380|11737425|FG003|Overall Study|Lack of Efficacy|6
7449393|NCT01719380|11737426|FG004|Overall Study|Lack of Efficacy|3
7449394|NCT01719380|11737427|FG005|Overall Study|Lack of Efficacy|7
7449395|NCT01719380|11737428|FG006|Overall Study|Lack of Efficacy|10
7449396|NCT01719380|11737429|FG007|Overall Study|Lack of Efficacy|6
7449397|NCT01719380|11737430|FG008|Overall Study|Lack of Efficacy|39
7449398|NCT01719380|11737431|FG009|Overall Study|Lack of Efficacy|42
7449399|NCT01719380|11737422|FG000|Overall Study|Progressive Disease|0
7449400|NCT01719380|11737423|FG001|Overall Study|Progressive Disease|0
7449401|NCT01719380|11737424|FG002|Overall Study|Progressive Disease|0
7449402|NCT01719380|11737425|FG003|Overall Study|Progressive Disease|0
7449403|NCT01719380|11737426|FG004|Overall Study|Progressive Disease|0
7449404|NCT01719380|11737427|FG005|Overall Study|Progressive Disease|0
7449405|NCT01719380|11737428|FG006|Overall Study|Progressive Disease|0
7449406|NCT01719380|11737429|FG007|Overall Study|Progressive Disease|0
7449407|NCT01719380|11737430|FG008|Overall Study|Progressive Disease|1
7449408|NCT01719380|11737431|FG009|Overall Study|Progressive Disease|0
7449409|NCT01719757|11737481|FG000|Overall Study|Adverse Event|38
7449410|NCT01719757|11737481|FG000|Overall Study|Withdrawal by Subject|15
7449411|NCT01719757|11737481|FG000|Overall Study|Lost to Follow-up|20
7449412|NCT01719757|11737481|FG000|Overall Study|Protocol Violation|1
7449413|NCT01719757|11737481|FG000|Overall Study|well controlled pain|27
7449414|NCT01719783|11737489|FG000|Dose 2|Physician Decision|1
7449415|NCT01719783|11737490|FG001|Dose 2|Physician Decision|0
7449416|NCT01719861|11737516|FG000|Cycle 1|Death|4
7449417|NCT01719861|11737516|FG000|Cycle 2|Death|1
7449418|NCT01720043|11737530|FG000|Overall Study|Withdrawal by Subject|1
7449419|NCT01720069|11737537|FG000|Overall Study|Could not use e-diary correctly|0
7449420|NCT01720069|11737538|FG001|Overall Study|Could not use e-diary correctly|1
7449421|NCT01720069|11737539|FG002|Overall Study|Could not use e-diary correctly|1
7449422|NCT01720069|11737537|FG000|Overall Study|Randomised without baseline values|0
7449423|NCT01720069|11737538|FG001|Overall Study|Randomised without baseline values|0
7449424|NCT01720069|11737539|FG002|Overall Study|Randomised without baseline values|1
7449425|NCT01720069|11737537|FG000|Overall Study|Adverse Event|0
7449426|NCT01720069|11737538|FG001|Overall Study|Adverse Event|0
7449427|NCT01720069|11737539|FG002|Overall Study|Adverse Event|1
7449428|NCT01720069|11737537|FG000|Overall Study|Lack of Efficacy|0
7449429|NCT01720069|11737538|FG001|Overall Study|Lack of Efficacy|4
7449430|NCT01720069|11737539|FG002|Overall Study|Lack of Efficacy|0
7449431|NCT01720069|11737537|FG000|Overall Study|Treatment period withdrawal criteria met|4
7449432|NCT01720069|11737538|FG001|Overall Study|Treatment period withdrawal criteria met|8
7449433|NCT01720069|11737539|FG002|Overall Study|Treatment period withdrawal criteria met|9
7449434|NCT01720069|11737537|FG000|Overall Study|Withdrawal by Subject|0
7449435|NCT01720069|11737538|FG001|Overall Study|Withdrawal by Subject|2
7449436|NCT01720069|11737539|FG002|Overall Study|Withdrawal by Subject|1
7449437|NCT01720069|11737537|FG000|Overall Study|OCS bursts occured, discontinued in line|1
7449438|NCT01720069|11737538|FG001|Overall Study|OCS bursts occured, discontinued in line|0
7449439|NCT01720069|11737539|FG002|Overall Study|OCS bursts occured, discontinued in line|0
7449440|NCT01720069|11737537|FG000|Overall Study|Non-compliance on using e-diary|0
7449513|NCT01721044|11737683|FG002|Treatment Period|Withdrawal by Subject|1
7563572|NCT03261037|11933695|FG000|Overall Study|Participant came out of study due to investigator discretion|0
7563573|NCT03261037|11933696|FG001|Overall Study|Participant came out of study due to investigator discretion|2
7563574|NCT03261037|11933697|FG002|Overall Study|Participant came out of study due to investigator discretion|0
7563575|NCT03261037|11933698|FG003|Overall Study|Participant came out of study due to investigator discretion|0
7563576|NCT03261037|11933695|FG000|Overall Study|Diagnosed but protocol deviation|1
7563577|NCT03261037|11933696|FG001|Overall Study|Diagnosed but protocol deviation|0
7563578|NCT03261037|11933697|FG002|Overall Study|Diagnosed but protocol deviation|0
7563579|NCT03261037|11933698|FG003|Overall Study|Diagnosed but protocol deviation|0
7563580|NCT03261037|11933695|FG000|Overall Study|Participant did not want to continue the study|0
7563581|NCT03261037|11933696|FG001|Overall Study|Participant did not want to continue the study|1
7563582|NCT03261037|11933697|FG002|Overall Study|Participant did not want to continue the study|0
7449441|NCT01720069|11737538|FG001|Overall Study|Non-compliance on using e-diary|0
7449442|NCT01720069|11737539|FG002|Overall Study|Non-compliance on using e-diary|1
7449443|NCT01720069|11737537|FG000|Overall Study|Lost to Follow-up|0
7449444|NCT01720069|11737538|FG001|Overall Study|Lost to Follow-up|0
7449445|NCT01720069|11737539|FG002|Overall Study|Lost to Follow-up|1
7449446|NCT01720225|11737553|FG000|Overall Study|Withdrawal by Subject|0
7449447|NCT01720225|11737554|FG001|Overall Study|Withdrawal by Subject|1
7449448|NCT01720225|11737553|FG000|Overall Study|Did not complete 2 cycles of therapy|3
7449449|NCT01720225|11737554|FG001|Overall Study|Did not complete 2 cycles of therapy|0
7449450|NCT01720264|11737573|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
7449451|NCT01720264|11737573|FG000|Post-transplant (Day 16) to 1 Year|Death|8
7449452|NCT01720264|11737573|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
7449453|NCT01720446|11737627|FG000|Overall Study|Lost to Follow-up|12
7449454|NCT01720446|11737628|FG001|Overall Study|Lost to Follow-up|6
7449455|NCT01720446|11737629|FG002|Overall Study|Lost to Follow-up|16
7449456|NCT01720446|11737630|FG003|Overall Study|Lost to Follow-up|16
7449457|NCT01720446|11737627|FG000|Overall Study|Withdrawal by Subject|2
7449458|NCT01720446|11737628|FG001|Overall Study|Withdrawal by Subject|5
7449459|NCT01720446|11737629|FG002|Overall Study|Withdrawal by Subject|4
7449460|NCT01720446|11737630|FG003|Overall Study|Withdrawal by Subject|4
7449461|NCT01720524|11737645|FG000|Part A|Insufficient Clinical Response|2
7449462|NCT01720524|11737646|FG001|Part A|Insufficient Clinical Response|4
7449463|NCT01720524|11737645|FG000|Part A|Adverse Event|2
7449464|NCT01720524|11737646|FG001|Part A|Adverse Event|2
7449465|NCT01720524|11737645|FG000|Part A|Death|2
7449466|NCT01720524|11737646|FG001|Part A|Death|1
7449467|NCT01720524|11737645|FG000|Part A|Lost to Follow-up|0
7449468|NCT01720524|11737646|FG001|Part A|Lost to Follow-up|1
7449469|NCT01720524|11737645|FG000|Part A|Missed 28 day follow-up visit|1
7449470|NCT01720524|11737646|FG001|Part A|Missed 28 day follow-up visit|1
7449471|NCT01720524|11737645|FG000|Part A|Withdrawal by Subject|0
7449472|NCT01720524|11737646|FG001|Part A|Withdrawal by Subject|1
7449473|NCT01720524|11737645|FG000|Part A|Other|0
7449474|NCT01720524|11737646|FG001|Part A|Other|1
7449475|NCT01720524|11737645|FG000|Part A|Lost to Follow-up|0
7449476|NCT01720524|11737646|FG001|Part A|Lost to Follow-up|1
7449477|NCT01720524|11737645|FG000|Part B|No longer willing to participate in study|1
7449478|NCT01720524|11737646|FG001|Part B|No longer willing to participate in study|4
7449479|NCT01720524|11737645|FG000|Part B|Other|2
7449480|NCT01720524|11737646|FG001|Part B|Other|0
7449481|NCT01720524|11737645|FG000|Part B|Lost to Follow-up|2
7449482|NCT01720524|11737646|FG001|Part B|Lost to Follow-up|3
7449483|NCT01720524|11737645|FG000|Part B|Death|0
7449484|NCT01720524|11737646|FG001|Part B|Death|2
7449485|NCT01720602|11737654|FG000|Overall Study|Adverse Event|3
7449486|NCT01720602|11737654|FG000|Overall Study|Progressive disease on therapy|2
7449487|NCT01720667|11737660|FG000|Overall Study|Adverse Event|1
7449488|NCT01720667|11737661|FG001|Overall Study|Adverse Event|1
7449489|NCT01720667|11737660|FG000|Overall Study|Withdrawal by Subject|3
7449490|NCT01720667|11737661|FG001|Overall Study|Withdrawal by Subject|0
7449491|NCT01720797|11737671|FG000|Overall Study|Withdrawal by Subject|3
7449492|NCT01720797|11737672|FG001|Overall Study|Withdrawal by Subject|0
7449493|NCT01721044|11737681|FG000|Treatment Period|Adverse Event|7
7449494|NCT01721044|11737682|FG001|Treatment Period|Adverse Event|7
7449495|NCT01721044|11737683|FG002|Treatment Period|Adverse Event|10
7449496|NCT01721044|11737681|FG000|Treatment Period|Death|0
7449497|NCT01721044|11737682|FG001|Treatment Period|Death|0
7449498|NCT01721044|11737683|FG002|Treatment Period|Death|1
7449499|NCT01721044|11737681|FG000|Treatment Period|Lack of Efficacy|16
7449500|NCT01721044|11737682|FG001|Treatment Period|Lack of Efficacy|4
7449501|NCT01721044|11737683|FG002|Treatment Period|Lack of Efficacy|4
7449502|NCT01721044|11737681|FG000|Treatment Period|Lost to Follow-up|0
7449503|NCT01721044|11737682|FG001|Treatment Period|Lost to Follow-up|0
7449504|NCT01721044|11737683|FG002|Treatment Period|Lost to Follow-up|1
7449505|NCT01721044|11737681|FG000|Treatment Period|Physician Decision|1
7449506|NCT01721044|11737682|FG001|Treatment Period|Physician Decision|0
7449507|NCT01721044|11737683|FG002|Treatment Period|Physician Decision|2
7449508|NCT01721044|11737681|FG000|Treatment Period|Protocol Violation|1
7449509|NCT01721044|11737682|FG001|Treatment Period|Protocol Violation|0
7449510|NCT01721044|11737683|FG002|Treatment Period|Protocol Violation|0
7449511|NCT01721044|11737681|FG000|Treatment Period|Withdrawal by Subject|7
7449512|NCT01721044|11737682|FG001|Treatment Period|Withdrawal by Subject|6
7449514|NCT01721057|11737705|FG000|Treatment Period|Withdrawal by Subject|11
7449515|NCT01721057|11737706|FG001|Treatment Period|Withdrawal by Subject|5
7449516|NCT01721057|11737707|FG002|Treatment Period|Withdrawal by Subject|8
7449517|NCT01721057|11737708|FG003|Treatment Period|Withdrawal by Subject|0
7449518|NCT01721057|11737709|FG004|Treatment Period|Withdrawal by Subject|0
7449519|NCT01721057|11737710|FG005|Treatment Period|Withdrawal by Subject|0
7449520|NCT01721057|11737711|FG006|Treatment Period|Withdrawal by Subject|0
7449521|NCT01721057|11737705|FG000|Treatment Period|Adverse Event|7
7449522|NCT01721057|11737706|FG001|Treatment Period|Adverse Event|10
7449523|NCT01721057|11737707|FG002|Treatment Period|Adverse Event|12
7449524|NCT01721057|11737708|FG003|Treatment Period|Adverse Event|0
7449525|NCT01721057|11737709|FG004|Treatment Period|Adverse Event|0
7449526|NCT01721057|11737710|FG005|Treatment Period|Adverse Event|0
7449527|NCT01721057|11737711|FG006|Treatment Period|Adverse Event|0
7449528|NCT01721057|11737705|FG000|Treatment Period|Lack of Efficacy|7
7449529|NCT01721057|11737706|FG001|Treatment Period|Lack of Efficacy|3
7449530|NCT01721057|11737707|FG002|Treatment Period|Lack of Efficacy|0
7449531|NCT01721057|11737708|FG003|Treatment Period|Lack of Efficacy|0
7449532|NCT01721057|11737709|FG004|Treatment Period|Lack of Efficacy|0
7449533|NCT01721057|11737710|FG005|Treatment Period|Lack of Efficacy|0
7449534|NCT01721057|11737711|FG006|Treatment Period|Lack of Efficacy|0
7449535|NCT01721057|11737705|FG000|Treatment Period|Lost to Follow-up|1
7449536|NCT01721057|11737706|FG001|Treatment Period|Lost to Follow-up|0
7449537|NCT01721057|11737707|FG002|Treatment Period|Lost to Follow-up|0
7449538|NCT01721057|11737708|FG003|Treatment Period|Lost to Follow-up|0
7449539|NCT01721057|11737709|FG004|Treatment Period|Lost to Follow-up|0
7449540|NCT01721057|11737710|FG005|Treatment Period|Lost to Follow-up|0
7449541|NCT01721057|11737711|FG006|Treatment Period|Lost to Follow-up|0
7449542|NCT01721057|11737705|FG000|Treatment Period|Physician Decision|0
7449543|NCT01721057|11737706|FG001|Treatment Period|Physician Decision|1
7449544|NCT01721057|11737707|FG002|Treatment Period|Physician Decision|3
7449545|NCT01721057|11737708|FG003|Treatment Period|Physician Decision|0
7449546|NCT01721057|11737709|FG004|Treatment Period|Physician Decision|0
7449547|NCT01721057|11737710|FG005|Treatment Period|Physician Decision|0
7449548|NCT01721057|11737711|FG006|Treatment Period|Physician Decision|0
7449549|NCT01721057|11737705|FG000|Treatment Period|Death|2
7449550|NCT01721057|11737706|FG001|Treatment Period|Death|0
7449551|NCT01721057|11737707|FG002|Treatment Period|Death|0
7449552|NCT01721057|11737708|FG003|Treatment Period|Death|0
7449553|NCT01721057|11737709|FG004|Treatment Period|Death|0
7449554|NCT01721057|11737710|FG005|Treatment Period|Death|0
7449555|NCT01721057|11737711|FG006|Treatment Period|Death|0
7449556|NCT01721057|11737705|FG000|Rescue Period|Adverse Event|0
7449557|NCT01721057|11737706|FG001|Rescue Period|Adverse Event|0
7449558|NCT01721057|11737707|FG002|Rescue Period|Adverse Event|0
7449559|NCT01721057|11737708|FG003|Rescue Period|Adverse Event|1
7449560|NCT01721057|11737709|FG004|Rescue Period|Adverse Event|0
7449561|NCT01721057|11737710|FG005|Rescue Period|Adverse Event|0
7449562|NCT01721057|11737711|FG006|Rescue Period|Adverse Event|0
7449563|NCT01721057|11737705|FG000|Rescue Period|Lack of Efficacy|0
7449564|NCT01721057|11737706|FG001|Rescue Period|Lack of Efficacy|0
7449565|NCT01721057|11737707|FG002|Rescue Period|Lack of Efficacy|0
7449566|NCT01721057|11737708|FG003|Rescue Period|Lack of Efficacy|2
7449567|NCT01721057|11737709|FG004|Rescue Period|Lack of Efficacy|0
7449568|NCT01721057|11737710|FG005|Rescue Period|Lack of Efficacy|0
7449569|NCT01721057|11737711|FG006|Rescue Period|Lack of Efficacy|0
7449570|NCT01721070|11737738|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
7449571|NCT01721109|11737756|FG000|Overall Study|Lack of Efficacy|1
7449572|NCT01721109|11737756|FG000|Overall Study|Non- Compliance with Study Drug|3
7449573|NCT01721109|11737756|FG000|Overall Study|Withdrew Consent|1
7449574|NCT01721109|11737756|FG000|Overall Study|Lost to Follow-up|2
7449575|NCT01721161|11737762|FG000|Overall Study|Adverse Event|2
7449576|NCT01721161|11737763|FG001|Overall Study|Adverse Event|3
7449577|NCT01721161|11737762|FG000|Overall Study|Lost to Follow-up|1
7449578|NCT01721161|11737763|FG001|Overall Study|Lost to Follow-up|2
7449579|NCT01721161|11737762|FG000|Overall Study|Withdrawal by Subject|1
7449580|NCT01721161|11737763|FG001|Overall Study|Withdrawal by Subject|1
7449581|NCT01721161|11737762|FG000|Overall Study|Other|0
7449582|NCT01721161|11737763|FG001|Overall Study|Other|1
7449583|NCT01721200|11737772|FG000|Overall Study|Lost to Follow-up|3
7449584|NCT01721200|11737773|FG001|Overall Study|Lost to Follow-up|5
7449585|NCT01721317|11737795|FG000|Overall Study|Study Closed / Terminated|2
7449586|NCT01721317|11737796|FG001|Overall Study|Study Closed / Terminated|2
7449587|NCT01721317|11737795|FG000|Overall Study|Physician Decision|0
7449588|NCT01721317|11737796|FG001|Overall Study|Physician Decision|1
7449589|NCT01721317|11737795|FG000|Overall Study|Withdrawal by Subject|0
7449590|NCT01721317|11737796|FG001|Overall Study|Withdrawal by Subject|1
7449591|NCT01721330|11737804|FG000|Overall Study|Withdrawal by Subject|0
7449592|NCT01721330|11737805|FG001|Overall Study|Withdrawal by Subject|1
7449593|NCT01721369|11737811|FG000|Overall Study|Not initial etiological diagnosis|12
7449594|NCT01721408|11737817|FG000|Overall Study|Adverse Event|6
7449595|NCT01721408|11737818|FG001|Overall Study|Adverse Event|1
7449596|NCT01721408|11737817|FG000|Overall Study|Death|1
7449597|NCT01721408|11737818|FG001|Overall Study|Death|0
7449598|NCT01721408|11737817|FG000|Overall Study|Insufficient clinical response|15
7449599|NCT01721408|11737818|FG001|Overall Study|Insufficient clinical response|6
7449600|NCT01721408|11737817|FG000|Overall Study|No longer willing to participate study|9
7449601|NCT01721408|11737818|FG001|Overall Study|No longer willing to participate study|10
7449602|NCT01721408|11737817|FG000|Overall Study|Protocol Violation|0
7449603|NCT01721408|11737818|FG001|Overall Study|Protocol Violation|2
7449604|NCT01721408|11737817|FG000|Overall Study|Other|3
7449605|NCT01721408|11737818|FG001|Overall Study|Other|3
7449606|NCT01721408|11737817|FG000|Overall Study|Lost to Follow-up|1
7449607|NCT01721408|11737818|FG001|Overall Study|Lost to Follow-up|2
7449608|NCT01721408|11737817|FG000|Overall Study|Does not meet entrance criteria|1
7449609|NCT01721408|11737818|FG001|Overall Study|Does not meet entrance criteria|0
7449610|NCT01721486|11737857|FG000|Overall Study|Protocol Violation|1
7449611|NCT01721486|11737858|FG001|Overall Study|Protocol Violation|0
7532974|NCT02679079|11878948|FG000|Overall Study|Adverse Event|2
7532975|NCT02679079|11878949|FG001|Overall Study|Adverse Event|0
7449612|NCT01721486|11737857|FG000|Overall Study|Physician Decision|0
7449613|NCT01721486|11737858|FG001|Overall Study|Physician Decision|1
7467874|NCT01904149|11768354|FG003|Overall Study|non compliance with study drug|0
7467875|NCT01904149|11768355|FG004|Overall Study|non compliance with study drug|0
7467876|NCT01904149|11768356|FG005|Overall Study|non compliance with study drug|0
7532976|NCT02679079|11878950|FG002|Overall Study|Adverse Event|2
7467877|NCT01904383|11768372|FG000|Overall Study|CRF not collected|117
7467878|NCT01904383|11768372|FG000|Overall Study|Reason not listed|147
7467879|NCT01904383|11768372|FG000|Overall Study|Lost to Follow-up|674
7467880|NCT01904383|11768372|FG000|Overall Study|Lack of Efficacy|370
7467881|NCT01904383|11768372|FG000|Overall Study|Improvement|141
7467882|NCT01904383|11768372|FG000|Overall Study|Adverse Event|271
7467883|NCT01904383|11768372|FG000|Overall Study|No patient visit after entry|54
7532977|NCT02679079|11878948|FG000|Overall Study|Protocol Violation|0
7563583|NCT03261037|11933698|FG003|Overall Study|Participant did not want to continue the study|0
7563584|NCT03261037|11933695|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
7563585|NCT03261037|11933696|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
7563586|NCT03261037|11933697|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
7563587|NCT03261037|11933698|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
7563588|NCT03261037|11933695|FG000|Overall Study|Participant presented clinical improvement|0
7563589|NCT03261037|11933696|FG001|Overall Study|Participant presented clinical improvement|2
7563590|NCT03261037|11933697|FG002|Overall Study|Participant presented clinical improvement|0
7563591|NCT03261037|11933698|FG003|Overall Study|Participant presented clinical improvement|0
7563592|NCT03261037|11933695|FG000|Overall Study|Technical difficulties|0
7563593|NCT03261037|11933696|FG001|Overall Study|Technical difficulties|0
7563594|NCT03261037|11933697|FG002|Overall Study|Technical difficulties|0
7449626|NCT01721876|11737891|FG000|Overall Study|Not treated|1
7449627|NCT01721876|11737892|FG001|Overall Study|Not treated|4
7449628|NCT01721876|11737891|FG000|Overall Study|Disease progression / relapse|123
7449629|NCT01721876|11737892|FG001|Overall Study|Disease progression / relapse|156
7449630|NCT01721876|11737891|FG000|Overall Study|Death|6
7449631|NCT01721876|11737892|FG001|Overall Study|Death|13
7449632|NCT01721876|11737891|FG000|Overall Study|Adverse Event|41
7449633|NCT01721876|11737892|FG001|Overall Study|Adverse Event|165
7449634|NCT01721876|11737891|FG000|Overall Study|Protocol Violation|2
7449635|NCT01721876|11737892|FG001|Overall Study|Protocol Violation|1
7449636|NCT01721876|11737891|FG000|Overall Study|Withdrawal by Subject|15
7449637|NCT01721876|11737892|FG001|Overall Study|Withdrawal by Subject|38
7449638|NCT01721876|11737891|FG000|Overall Study|Reason not listed|34
7563595|NCT03261037|11933698|FG003|Overall Study|Technical difficulties|1
7563596|NCT03261037|11933695|FG000|Overall Study|Equipment failed to work|0
7563597|NCT03261037|11933696|FG001|Overall Study|Equipment failed to work|0
7563598|NCT03261037|11933697|FG002|Overall Study|Equipment failed to work|0
7563599|NCT03261037|11933698|FG003|Overall Study|Equipment failed to work|1
7449639|NCT01721876|11737892|FG001|Overall Study|Reason not listed|63
7449640|NCT01721876|11737891|FG000|Overall Study|Sponsor terminated trial|0
7449641|NCT01721876|11737892|FG001|Overall Study|Sponsor terminated trial|4
7449642|NCT01721954|11737900|FG000|Overall Study|Death|58
7449643|NCT01721954|11737901|FG001|Overall Study|Death|64
7449644|NCT01721954|11737900|FG000|Overall Study|Withdrawal by Subject|8
7449645|NCT01721954|11737901|FG001|Overall Study|Withdrawal by Subject|4
7449646|NCT01721954|11737900|FG000|Overall Study|Adverse Event|2
7449647|NCT01721954|11737901|FG001|Overall Study|Adverse Event|0
7449648|NCT01721954|11737900|FG000|Overall Study|Lost to Follow-up|2
7449649|NCT01721954|11737901|FG001|Overall Study|Lost to Follow-up|1
7449650|NCT01722045|11737911|FG000|Overall Study|Adverse Event|8
7449651|NCT01722045|11737911|FG000|Overall Study|Death|3
7449652|NCT01722045|11737911|FG000|Overall Study|Withdrawal by Subject|8
7449653|NCT01722045|11737911|FG000|Overall Study|Lost to Follow-up|4
7449654|NCT01722045|11737911|FG000|Overall Study|Protocol Deviation|1
7449655|NCT01722045|11737911|FG000|Overall Study|Physician Decision|3
7449656|NCT01722045|11737911|FG000|Overall Study|Relocation (did not wish to transfer)|1
7449657|NCT01722071|11737915|FG000|Overall Study|Protocol Violation|1
7449658|NCT01722071|11737916|FG001|Overall Study|Protocol Violation|0
7449659|NCT01722097|11737924|FG000|Overall Study|Patient sheets not returned|6
7449660|NCT01722097|11737925|FG001|Overall Study|Patient sheets not returned|5
7449661|NCT01722162|11737933|FG000|Overall Study|Withdrawal by Subject|1
7449662|NCT01722162|11737934|FG001|Overall Study|Withdrawal by Subject|1
7449663|NCT01722162|11737933|FG000|Overall Study|Found ineligible|1
7449664|NCT01722162|11737934|FG001|Overall Study|Found ineligible|0
7449665|NCT01722162|11737933|FG000|Overall Study|Unrelated to study adverse event|2
7449666|NCT01722162|11737934|FG001|Overall Study|Unrelated to study adverse event|2
7449667|NCT01722162|11737933|FG000|Overall Study|Adverse Event|1
7449668|NCT01722162|11737934|FG001|Overall Study|Adverse Event|1
7449669|NCT01722162|11737933|FG000|Overall Study|Insurance denial post enrollment|0
7449670|NCT01722162|11737934|FG001|Overall Study|Insurance denial post enrollment|1
7449671|NCT01722162|11737933|FG000|Overall Study|Noncompliance|0
7449672|NCT01722162|11737934|FG001|Overall Study|Noncompliance|1
7449673|NCT01722266|11737944|FG000|Overall Study|Withdrawal by Subject|1
7449674|NCT01722266|11737945|FG001|Overall Study|Withdrawal by Subject|2
7449675|NCT01722266|11737946|FG002|Overall Study|Withdrawal by Subject|0
7449676|NCT01722266|11737947|FG003|Overall Study|Withdrawal by Subject|0
7449677|NCT01722266|11737944|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
7449678|NCT01722266|11737945|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
7449679|NCT01722266|11737946|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
7449680|NCT01722266|11737947|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
7449681|NCT01722266|11737944|FG000|Overall Study|Dropped out due to Nausea|0
7449682|NCT01722266|11737945|FG001|Overall Study|Dropped out due to Nausea|0
7449683|NCT01722266|11737946|FG002|Overall Study|Dropped out due to Nausea|2
7449684|NCT01722266|11737947|FG003|Overall Study|Dropped out due to Nausea|0
7449685|NCT01722669|11738056|FG000|Overall Study|Withdrawal by Subject|0
7449686|NCT01722669|11738057|FG001|Overall Study|Withdrawal by Subject|0
7449687|NCT01722669|11738058|FG002|Overall Study|Withdrawal by Subject|0
7449688|NCT01722669|11738059|FG003|Overall Study|Withdrawal by Subject|0
7449689|NCT01722669|11738060|FG004|Overall Study|Withdrawal by Subject|0
7449690|NCT01722669|11738061|FG005|Overall Study|Withdrawal by Subject|2
7449691|NCT01722877|11738094|FG000|Overall Study|Death|1
7449692|NCT01722877|11738094|FG000|Overall Study|Lost to Follow-up|1
7449693|NCT01722994|11738102|FG000|Overall Study|Missing data|25
7449694|NCT01722994|11738103|FG001|Overall Study|Missing data|17
7449695|NCT01723072|11738113|FG000|Overall Study|Withdrawal by Subject|7
7449696|NCT01723072|11738114|FG001|Overall Study|Withdrawal by Subject|13
7449697|NCT01723072|11738113|FG000|Overall Study|Discon for rescue medication after wk 24|0
7449698|NCT01723072|11738114|FG001|Overall Study|Discon for rescue medication after wk 24|5
7449699|NCT01723072|11738113|FG000|Overall Study|Other|4
7449700|NCT01723072|11738114|FG001|Overall Study|Other|3
7449701|NCT01723163|11738122|FG000|Treatment Phase|Withdrawal by Subject|14
7449702|NCT01723163|11738123|FG001|Treatment Phase|Withdrawal by Subject|6
7449703|NCT01723163|11738122|FG000|Treatment Phase|Withdrawal by PI|5
7449704|NCT01723163|11738123|FG001|Treatment Phase|Withdrawal by PI|1
7449705|NCT01723163|11738122|FG000|3-Month Follow-up|Withdrawal by Subject|1
7449706|NCT01723163|11738123|FG001|3-Month Follow-up|Withdrawal by Subject|0
7449707|NCT01723163|11738122|FG000|3-Month Follow-up|Unable to Contact|12
7449708|NCT01723163|11738123|FG001|3-Month Follow-up|Unable to Contact|19
7449709|NCT01723163|11738122|FG000|6-Month Follow-up|Death|1
7449710|NCT01723163|11738123|FG001|6-Month Follow-up|Death|0
7449711|NCT01723163|11738122|FG000|6-Month Follow-up|Unable to Contact|17
7449712|NCT01723163|11738123|FG001|6-Month Follow-up|Unable to Contact|15
7449713|NCT01723163|11738122|FG000|12-Month Follow-up|Death|1
7449714|NCT01723163|11738123|FG001|12-Month Follow-up|Death|0
7449715|NCT01723163|11738122|FG000|12-Month Follow-up|Unable to Contact|23
7449716|NCT01723163|11738123|FG001|12-Month Follow-up|Unable to Contact|28
7449717|NCT01723228|11738131|FG000|Overall Study|Adverse Event|2
7449718|NCT01723228|11738132|FG001|Overall Study|Adverse Event|6
7449719|NCT01723228|11738131|FG000|Overall Study|Withdrawal by Subject|2
7449720|NCT01723228|11738132|FG001|Overall Study|Withdrawal by Subject|1
7449721|NCT01723228|11738131|FG000|Overall Study|Protocol Violation|0
7449722|NCT01723228|11738132|FG001|Overall Study|Protocol Violation|2
7449723|NCT01723228|11738131|FG000|Overall Study|Lost to Follow-up|2
7449724|NCT01723228|11738132|FG001|Overall Study|Lost to Follow-up|1
7449725|NCT01723228|11738131|FG000|Overall Study|Other|2
7449726|NCT01723228|11738132|FG001|Overall Study|Other|1
7449727|NCT01723254|11738146|FG000|Overall Study|Conflict with work schedule|0
7449728|NCT01723254|11738147|FG001|Overall Study|Conflict with work schedule|0
7449729|NCT01723254|11738148|FG002|Overall Study|Conflict with work schedule|0
7449730|NCT01723254|11738149|FG003|Overall Study|Conflict with work schedule|0
7449731|NCT01723254|11738150|FG004|Overall Study|Conflict with work schedule|0
7449732|NCT01723254|11738151|FG005|Overall Study|Conflict with work schedule|0
7449733|NCT01723254|11738152|FG006|Overall Study|Conflict with work schedule|0
7449734|NCT01723254|11738153|FG007|Overall Study|Conflict with work schedule|1
7449735|NCT01723254|11738146|FG000|Overall Study|Personal issues|0
7449736|NCT01723254|11738147|FG001|Overall Study|Personal issues|0
7449737|NCT01723254|11738148|FG002|Overall Study|Personal issues|0
7449738|NCT01723254|11738149|FG003|Overall Study|Personal issues|0
7449739|NCT01723254|11738150|FG004|Overall Study|Personal issues|0
7449740|NCT01723254|11738151|FG005|Overall Study|Personal issues|1
7449741|NCT01723254|11738152|FG006|Overall Study|Personal issues|0
7449742|NCT01723254|11738153|FG007|Overall Study|Personal issues|0
7449743|NCT01723254|11738146|FG000|Overall Study|No longer have time to participate|0
7449744|NCT01723254|11738147|FG001|Overall Study|No longer have time to participate|0
7449745|NCT01723254|11738148|FG002|Overall Study|No longer have time to participate|0
7449746|NCT01723254|11738149|FG003|Overall Study|No longer have time to participate|1
7449747|NCT01723254|11738150|FG004|Overall Study|No longer have time to participate|0
7449748|NCT01723254|11738151|FG005|Overall Study|No longer have time to participate|0
7449749|NCT01723254|11738152|FG006|Overall Study|No longer have time to participate|0
7449750|NCT01723254|11738153|FG007|Overall Study|No longer have time to participate|0
7449751|NCT01723254|11738146|FG000|Overall Study|Move/Left to another country/city|0
7449752|NCT01723254|11738147|FG001|Overall Study|Move/Left to another country/city|0
7449753|NCT01723254|11738148|FG002|Overall Study|Move/Left to another country/city|2
7449754|NCT01723254|11738149|FG003|Overall Study|Move/Left to another country/city|1
7449755|NCT01723254|11738150|FG004|Overall Study|Move/Left to another country/city|1
7449756|NCT01723254|11738151|FG005|Overall Study|Move/Left to another country/city|0
7449757|NCT01723254|11738152|FG006|Overall Study|Move/Left to another country/city|0
7449758|NCT01723254|11738153|FG007|Overall Study|Move/Left to another country/city|0
7449759|NCT01723254|11738146|FG000|Overall Study|Protocol Violation|0
7449760|NCT01723254|11738147|FG001|Overall Study|Protocol Violation|1
7449761|NCT01723254|11738148|FG002|Overall Study|Protocol Violation|0
7449762|NCT01723254|11738149|FG003|Overall Study|Protocol Violation|0
7449763|NCT01723254|11738150|FG004|Overall Study|Protocol Violation|0
7449764|NCT01723254|11738151|FG005|Overall Study|Protocol Violation|0
7449765|NCT01723254|11738152|FG006|Overall Study|Protocol Violation|0
7449766|NCT01723254|11738153|FG007|Overall Study|Protocol Violation|0
7449767|NCT01723254|11738146|FG000|Overall Study|Withdrawal by Subject|1
7449768|NCT01723254|11738147|FG001|Overall Study|Withdrawal by Subject|2
7449769|NCT01723254|11738148|FG002|Overall Study|Withdrawal by Subject|1
7449770|NCT01723254|11738149|FG003|Overall Study|Withdrawal by Subject|0
7449771|NCT01723254|11738150|FG004|Overall Study|Withdrawal by Subject|1
7449772|NCT01723254|11738151|FG005|Overall Study|Withdrawal by Subject|1
7449773|NCT01723254|11738152|FG006|Overall Study|Withdrawal by Subject|1
7449774|NCT01723254|11738153|FG007|Overall Study|Withdrawal by Subject|2
7449775|NCT01723397|11738182|FG000|Study Period 1|Protocol Violation|0
7449776|NCT01723397|11738183|FG001|Study Period 1|Protocol Violation|1
7449777|NCT01723397|11738182|FG000|Study Period 2|Protocol Violation|0
7449778|NCT01723397|11738183|FG001|Study Period 2|Protocol Violation|1
7449779|NCT01723826|11738246|FG000|Overall Study|Adverse Event|4
7449780|NCT01723826|11738247|FG001|Overall Study|Adverse Event|1
7449781|NCT01723826|11738248|FG002|Overall Study|Adverse Event|4
7449782|NCT01723826|11738249|FG003|Overall Study|Adverse Event|5
7449783|NCT01723826|11738246|FG000|Overall Study|Death according to AE eCRF|2
7449784|NCT01723826|11738247|FG001|Overall Study|Death according to AE eCRF|3
7449785|NCT01723826|11738248|FG002|Overall Study|Death according to AE eCRF|3
7449786|NCT01723826|11738249|FG003|Overall Study|Death according to AE eCRF|7
7449787|NCT01723826|11738246|FG000|Overall Study|Lost to Follow-up|1
7449788|NCT01723826|11738247|FG001|Overall Study|Lost to Follow-up|3
7449789|NCT01723826|11738248|FG002|Overall Study|Lost to Follow-up|1
7449790|NCT01723826|11738249|FG003|Overall Study|Lost to Follow-up|1
7449791|NCT01723826|11738246|FG000|Overall Study|Non-compliance|0
7449792|NCT01723826|11738247|FG001|Overall Study|Non-compliance|1
7449793|NCT01723826|11738248|FG002|Overall Study|Non-compliance|3
7449794|NCT01723826|11738249|FG003|Overall Study|Non-compliance|3
7449795|NCT01723826|11738246|FG000|Overall Study|Non-compliance With Study Drug|0
7449796|NCT01723826|11738247|FG001|Overall Study|Non-compliance With Study Drug|1
7449797|NCT01723826|11738248|FG002|Overall Study|Non-compliance With Study Drug|0
7449798|NCT01723826|11738249|FG003|Overall Study|Non-compliance With Study Drug|0
7449799|NCT01723826|11738246|FG000|Overall Study|Other Reason|8
7449800|NCT01723826|11738247|FG001|Overall Study|Other Reason|6
7449801|NCT01723826|11738248|FG002|Overall Study|Other Reason|12
7449802|NCT01723826|11738249|FG003|Overall Study|Other Reason|14
7449803|NCT01723826|11738246|FG000|Overall Study|Physician Decision|1
7449804|NCT01723826|11738247|FG001|Overall Study|Physician Decision|3
7449805|NCT01723826|11738248|FG002|Overall Study|Physician Decision|4
7449806|NCT01723826|11738249|FG003|Overall Study|Physician Decision|11
7449807|NCT01723826|11738246|FG000|Overall Study|Protocol Violation|1
7449808|NCT01723826|11738247|FG001|Overall Study|Protocol Violation|1
7449809|NCT01723826|11738248|FG002|Overall Study|Protocol Violation|3
7449810|NCT01723826|11738249|FG003|Overall Study|Protocol Violation|1
7449811|NCT01723826|11738246|FG000|Overall Study|Withdrawal by Subject|10
7449812|NCT01723826|11738247|FG001|Overall Study|Withdrawal by Subject|17
7449813|NCT01723826|11738248|FG002|Overall Study|Withdrawal by Subject|27
7449814|NCT01723826|11738249|FG003|Overall Study|Withdrawal by Subject|48
7449815|NCT01723904|11738259|FG000|Overall Study|Noncompliant|3
7449816|NCT01723904|11738259|FG000|Overall Study|Adverse Event|5
7449817|NCT01723904|11738259|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
7449818|NCT01724021|11738265|FG000|Overall Study|Adverse Event|11
7449819|NCT01724021|11738266|FG001|Overall Study|Adverse Event|6
7449820|NCT01724021|11738265|FG000|Overall Study|Death|46
7449821|NCT01724021|11738266|FG001|Overall Study|Death|58
7449822|NCT01724021|11738265|FG000|Overall Study|Participant request/ Withdrew consent|18
7449823|NCT01724021|11738266|FG001|Overall Study|Participant request/ Withdrew consent|14
7449824|NCT01724021|11738265|FG000|Overall Study|Lost to Follow-up|15
7449825|NCT01724021|11738266|FG001|Overall Study|Lost to Follow-up|15
7449826|NCT01724021|11738265|FG000|Overall Study|Reason Not Specified|36
7449827|NCT01724021|11738266|FG001|Overall Study|Reason Not Specified|39
7449828|NCT01724021|11738265|FG000|Overall Study|Missing|1
7449829|NCT01724021|11738266|FG001|Overall Study|Missing|1
7449830|NCT01724177|11738307|FG000|Overall Study|Adverse Event|8
7449831|NCT01724177|11738307|FG000|Overall Study|Progressive disease or Relapsed Disease|16
7449832|NCT01724177|11738307|FG000|Overall Study|Nervous participant|1
7449833|NCT01724177|11738307|FG000|Overall Study|Serious Adverse Event Related|1
7449834|NCT01724216|11738312|FG000|Overall Study|Scan was not completed|1
7449835|NCT01724359|11738316|FG000|Overall Study|Adverse Event|10
7449836|NCT01724359|11738316|FG000|Overall Study|Death|1
7449837|NCT01724359|11738316|FG000|Overall Study|Other|20
7449838|NCT01724489|11738324|FG000|Overall Study|Adverse Event|8
7449839|NCT01724489|11738325|FG001|Overall Study|Adverse Event|3
7449840|NCT01724489|11738324|FG000|Overall Study|Surgery, medication|1
7449841|NCT01724489|11738325|FG001|Overall Study|Surgery, medication|1
7449842|NCT01724489|11738324|FG000|Overall Study|Lost to Follow-up|1
7449843|NCT01724489|11738325|FG001|Overall Study|Lost to Follow-up|2
7449844|NCT01724489|11738324|FG000|Overall Study|Withdrawal by Subject|6
7449845|NCT01724489|11738325|FG001|Overall Study|Withdrawal by Subject|6
7449846|NCT01724528|11738333|FG000|Overall Study|Death|3
7449847|NCT01724528|11738334|FG001|Overall Study|Death|0
7449848|NCT01724528|11738333|FG000|Overall Study|Withdrawal by Subject|0
7449849|NCT01724528|11738334|FG001|Overall Study|Withdrawal by Subject|2
7449850|NCT01724528|11738333|FG000|Overall Study|Protocol Violation|0
7449851|NCT01724528|11738334|FG001|Overall Study|Protocol Violation|1
7449852|NCT01724528|11738333|FG000|Overall Study|Patient refused to attend last visit|1
7449853|NCT01724528|11738334|FG001|Overall Study|Patient refused to attend last visit|0
7449854|NCT01725126|11738346|FG000|Overall Study|Protocol Violation|0
7449855|NCT01725126|11738347|FG001|Overall Study|Protocol Violation|1
7449856|NCT01725126|11738348|FG002|Overall Study|Protocol Violation|0
7449857|NCT01725126|11738349|FG003|Overall Study|Protocol Violation|0
7449858|NCT01725126|11738350|FG004|Overall Study|Protocol Violation|0
7449859|NCT01725126|11738351|FG005|Overall Study|Protocol Violation|0
7449860|NCT01725126|11738346|FG000|Overall Study|Withdrawal by Subject|0
7449861|NCT01725126|11738347|FG001|Overall Study|Withdrawal by Subject|0
7449862|NCT01725126|11738348|FG002|Overall Study|Withdrawal by Subject|0
7449863|NCT01725126|11738349|FG003|Overall Study|Withdrawal by Subject|1
7449864|NCT01725126|11738350|FG004|Overall Study|Withdrawal by Subject|0
7449865|NCT01725126|11738351|FG005|Overall Study|Withdrawal by Subject|0
7449866|NCT01725217|11738377|FG000|Overall Study|Withdrawal by Subject|1
7449867|NCT01725217|11738378|FG001|Overall Study|Withdrawal by Subject|0
7449868|NCT01725217|11738379|FG002|Overall Study|Withdrawal by Subject|0
7449869|NCT01725282|11738400|FG000|Overall Study|Adverse Event|1
7449870|NCT01725282|11738401|FG001|Overall Study|Adverse Event|3
7449871|NCT01725282|11738402|FG002|Overall Study|Adverse Event|6
7449872|NCT01725282|11738403|FG003|Overall Study|Adverse Event|4
7449873|NCT01725282|11738400|FG000|Overall Study|Exacerbation of Target Disease|1
7449874|NCT01725282|11738401|FG001|Overall Study|Exacerbation of Target Disease|0
7449875|NCT01725282|11738402|FG002|Overall Study|Exacerbation of Target Disease|0
7449876|NCT01725282|11738403|FG003|Overall Study|Exacerbation of Target Disease|1
7449877|NCT01725282|11738400|FG000|Overall Study|Met Exclusion Criteria|0
7449878|NCT01725282|11738401|FG001|Overall Study|Met Exclusion Criteria|0
7449879|NCT01725282|11738402|FG002|Overall Study|Met Exclusion Criteria|1
7449880|NCT01725282|11738403|FG003|Overall Study|Met Exclusion Criteria|0
7449881|NCT01725282|11738400|FG000|Overall Study|Study Site Withdrawal|0
7449882|NCT01725282|11738401|FG001|Overall Study|Study Site Withdrawal|1
7449883|NCT01725282|11738402|FG002|Overall Study|Study Site Withdrawal|0
7449884|NCT01725282|11738403|FG003|Overall Study|Study Site Withdrawal|0
7449885|NCT01725282|11738400|FG000|Overall Study|Withdrawal by Subject|0
7563600|NCT03261037|11933695|FG000|Overall Study|End of study for participant and no follow up|0
7563601|NCT03261037|11933696|FG001|Overall Study|End of study for participant and no follow up|0
7563602|NCT03261037|11933697|FG002|Overall Study|End of study for participant and no follow up|0
7563603|NCT03261037|11933698|FG003|Overall Study|End of study for participant and no follow up|1
7563604|NCT03261037|11933695|FG000|Overall Study|Participant was too weak to continue in study|1
7563605|NCT03261037|11933696|FG001|Overall Study|Participant was too weak to continue in study|0
7563606|NCT03261037|11933697|FG002|Overall Study|Participant was too weak to continue in study|0
7449886|NCT01725282|11738401|FG001|Overall Study|Withdrawal by Subject|0
7449887|NCT01725282|11738402|FG002|Overall Study|Withdrawal by Subject|1
7449888|NCT01725282|11738403|FG003|Overall Study|Withdrawal by Subject|1
7449889|NCT01725282|11738400|FG000|Overall Study|Lack of Efficacy|0
7449890|NCT01725282|11738401|FG001|Overall Study|Lack of Efficacy|1
7449891|NCT01725282|11738402|FG002|Overall Study|Lack of Efficacy|0
7449892|NCT01725282|11738403|FG003|Overall Study|Lack of Efficacy|1
7449893|NCT01725308|11738416|FG000|Treatment Period I|Did Not Receive Drug|1
7449894|NCT01725308|11738417|FG001|Treatment Period I|Did Not Receive Drug|0
7449895|NCT01725308|11738418|FG002|Treatment Period I|Did Not Receive Drug|0
7449896|NCT01725308|11738416|FG000|Treatment Period I|Adverse Event|5
7449897|NCT01725308|11738417|FG001|Treatment Period I|Adverse Event|4
7449898|NCT01725308|11738418|FG002|Treatment Period I|Adverse Event|21
7449899|NCT01725308|11738416|FG000|Treatment Period I|Insufficient Response|7
7449900|NCT01725308|11738417|FG001|Treatment Period I|Insufficient Response|0
7449901|NCT01725308|11738418|FG002|Treatment Period I|Insufficient Response|5
7449902|NCT01725308|11738416|FG000|Treatment Period I|Worsening of the Target Disease|8
7449950|NCT01725386|11738435|FG000|Overall Study|Death|84
7449903|NCT01725308|11738417|FG001|Treatment Period I|Worsening of the Target Disease|0
7449904|NCT01725308|11738418|FG002|Treatment Period I|Worsening of the Target Disease|2
7449905|NCT01725308|11738416|FG000|Treatment Period I|Changes in the Episodes|3
7449906|NCT01725308|11738417|FG001|Treatment Period I|Changes in the Episodes|0
7449907|NCT01725308|11738418|FG002|Treatment Period I|Changes in the Episodes|2
7449908|NCT01725308|11738416|FG000|Treatment Period I|Withdrawal of Consent|12
7449909|NCT01725308|11738417|FG001|Treatment Period I|Withdrawal of Consent|7
7449910|NCT01725308|11738418|FG002|Treatment Period I|Withdrawal of Consent|5
7449911|NCT01725308|11738416|FG000|Treatment Period I|Lost to Follow-up|3
7449912|NCT01725308|11738417|FG001|Treatment Period I|Lost to Follow-up|2
7449913|NCT01725308|11738418|FG002|Treatment Period I|Lost to Follow-up|2
7449914|NCT01725308|11738416|FG000|Treatment Period I|Protocol Deviations|3
7449915|NCT01725308|11738417|FG001|Treatment Period I|Protocol Deviations|1
7449916|NCT01725308|11738418|FG002|Treatment Period I|Protocol Deviations|1
7449917|NCT01725308|11738416|FG000|Treatment Period I|Miscellaneous|2
7449918|NCT01725308|11738417|FG001|Treatment Period I|Miscellaneous|0
7449919|NCT01725308|11738418|FG002|Treatment Period I|Miscellaneous|3
7449920|NCT01725308|11738416|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
7449921|NCT01725308|11738417|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
7449922|NCT01725308|11738418|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
7449923|NCT01725308|11738416|FG000|Treatment Period II|Did Not Receive Drug|4
7563607|NCT03261037|11933698|FG003|Overall Study|Participant was too weak to continue in study|0
7563608|NCT03261167|11933711|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
7449924|NCT01725308|11738417|FG001|Treatment Period II|Did Not Receive Drug|0
7449925|NCT01725308|11738418|FG002|Treatment Period II|Did Not Receive Drug|0
7449926|NCT01725308|11738416|FG000|Treatment Period II|Adverse Event|13
7563609|NCT03261167|11933712|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
7563610|NCT03261167|11933711|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
7563611|NCT03261167|11933712|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
7563612|NCT03261167|11933711|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
7563613|NCT03261167|11933712|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
7563614|NCT03261167|11933711|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
7563615|NCT03261167|11933712|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
7563616|NCT03261167|11933711|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7563617|NCT03261167|11933712|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
7563618|NCT03261336|11933724|FG000|Overall Study|Adverse Event|1
7563619|NCT03261947|11933733|FG000|Overall Study|Death|10
7563620|NCT03261947|11933734|FG001|Overall Study|Death|13
7563621|NCT03261947|11933735|FG002|Overall Study|Death|17
7563622|NCT03261947|11933736|FG003|Overall Study|Death|12
7563623|NCT03261947|11933737|FG004|Overall Study|Death|8
7563624|NCT03261947|11933733|FG000|Overall Study|Lost to Follow-up|0
7563625|NCT03261947|11933734|FG001|Overall Study|Lost to Follow-up|0
7563626|NCT03261947|11933735|FG002|Overall Study|Lost to Follow-up|2
7563627|NCT03261947|11933736|FG003|Overall Study|Lost to Follow-up|1
7563628|NCT03261947|11933737|FG004|Overall Study|Lost to Follow-up|0
7563629|NCT03261947|11933733|FG000|Overall Study|Withdrawal by Subject|0
7563630|NCT03261947|11933734|FG001|Overall Study|Withdrawal by Subject|0
7563631|NCT03261947|11933735|FG002|Overall Study|Withdrawal by Subject|3
7563632|NCT03261947|11933736|FG003|Overall Study|Withdrawal by Subject|0
7563633|NCT03261947|11933737|FG004|Overall Study|Withdrawal by Subject|1
7563634|NCT03261947|11933733|FG000|Overall Study|Site Terminated by Sponsor|0
7563635|NCT03261947|11933734|FG001|Overall Study|Site Terminated by Sponsor|0
7563636|NCT03261947|11933735|FG002|Overall Study|Site Terminated by Sponsor|4
7563637|NCT03261947|11933736|FG003|Overall Study|Site Terminated by Sponsor|7
7563638|NCT03261947|11933737|FG004|Overall Study|Site Terminated by Sponsor|5
7449927|NCT01725308|11738417|FG001|Treatment Period II|Adverse Event|8
7449928|NCT01725308|11738418|FG002|Treatment Period II|Adverse Event|20
7449929|NCT01725308|11738416|FG000|Treatment Period II|Insufficient Response|2
7449930|NCT01725308|11738417|FG001|Treatment Period II|Insufficient Response|4
7449931|NCT01725308|11738418|FG002|Treatment Period II|Insufficient Response|6
7449932|NCT01725308|11738416|FG000|Treatment Period II|Worsening of the Target Disease|1
7449933|NCT01725308|11738417|FG001|Treatment Period II|Worsening of the Target Disease|4
7449934|NCT01725308|11738418|FG002|Treatment Period II|Worsening of the Target Disease|2
7449935|NCT01725308|11738416|FG000|Treatment Period II|Changes in the Episodes|1
7449936|NCT01725308|11738417|FG001|Treatment Period II|Changes in the Episodes|0
7449937|NCT01725308|11738418|FG002|Treatment Period II|Changes in the Episodes|5
7449938|NCT01725308|11738416|FG000|Treatment Period II|Withdrawal of Consent|28
7449939|NCT01725308|11738417|FG001|Treatment Period II|Withdrawal of Consent|2
7449940|NCT01725308|11738418|FG002|Treatment Period II|Withdrawal of Consent|16
7449941|NCT01725308|11738416|FG000|Treatment Period II|Lost to Follow-up|1
7449942|NCT01725308|11738417|FG001|Treatment Period II|Lost to Follow-up|5
7449943|NCT01725308|11738418|FG002|Treatment Period II|Lost to Follow-up|3
7449944|NCT01725308|11738416|FG000|Treatment Period II|Protocol Deviations|0
7449945|NCT01725308|11738417|FG001|Treatment Period II|Protocol Deviations|0
7449946|NCT01725308|11738418|FG002|Treatment Period II|Protocol Deviations|1
7449947|NCT01725308|11738416|FG000|Treatment Period II|Miscellaneous|5
7449948|NCT01725308|11738417|FG001|Treatment Period II|Miscellaneous|3
7449949|NCT01725308|11738418|FG002|Treatment Period II|Miscellaneous|7
7563639|NCT03261947|11933733|FG000|Overall Study|Reason not Specified|2
7563640|NCT03261947|11933734|FG001|Overall Study|Reason not Specified|0
7563641|NCT03261947|11933735|FG002|Overall Study|Reason not Specified|4
7563642|NCT03261947|11933736|FG003|Overall Study|Reason not Specified|1
7563643|NCT03261947|11933737|FG004|Overall Study|Reason not Specified|3
7563644|NCT03262012|11933774|FG000|Overall Study|Withdrawal by Subject|15
7563645|NCT03262012|11933775|FG001|Overall Study|Withdrawal by Subject|13
7563646|NCT03262012|11933776|FG002|Overall Study|Withdrawal by Subject|8
7563647|NCT03262012|11933777|FG003|Overall Study|Withdrawal by Subject|7
7563648|NCT03262012|11933774|FG000|Overall Study|Adverse Event|10
7449951|NCT01725386|11738436|FG001|Overall Study|Death|40
7449952|NCT01725386|11738435|FG000|Overall Study|Lost to Follow-up|81
7449953|NCT01725386|11738436|FG001|Overall Study|Lost to Follow-up|6
7449954|NCT01725386|11738435|FG000|Overall Study|Withdrawal by Subject|10
7449955|NCT01725386|11738436|FG001|Overall Study|Withdrawal by Subject|0
7449956|NCT01725451|11738442|FG000|Period 1|Withdrawal by Subject|1
7449957|NCT01725451|11738443|FG001|Period 1|Withdrawal by Subject|0
7449958|NCT01725451|11738444|FG002|Period 1|Withdrawal by Subject|0
7449959|NCT01725451|11738445|FG003|Period 1|Withdrawal by Subject|0
7449960|NCT01725451|11738442|FG000|Washout From Period 3|Protocol Violation|0
7449961|NCT01725451|11738443|FG001|Washout From Period 3|Protocol Violation|0
7563649|NCT03262012|11933775|FG001|Overall Study|Adverse Event|12
7563650|NCT03262012|11933776|FG002|Overall Study|Adverse Event|4
7563651|NCT03262012|11933777|FG003|Overall Study|Adverse Event|6
7449962|NCT01725451|11738444|FG002|Washout From Period 3|Protocol Violation|1
7449963|NCT01725451|11738445|FG003|Washout From Period 3|Protocol Violation|0
7449964|NCT01725451|11738442|FG000|Washout From Period 3|Adverse Event|0
7449965|NCT01725451|11738443|FG001|Washout From Period 3|Adverse Event|1
7449966|NCT01725451|11738444|FG002|Washout From Period 3|Adverse Event|0
7449967|NCT01725451|11738445|FG003|Washout From Period 3|Adverse Event|0
7449968|NCT01725451|11738442|FG000|Period 4|Adverse Event|0
7449969|NCT01725451|11738443|FG001|Period 4|Adverse Event|0
7449970|NCT01725451|11738444|FG002|Period 4|Adverse Event|1
7449971|NCT01725451|11738445|FG003|Period 4|Adverse Event|0
7449972|NCT01725529|11738463|FG000|Overall Study|Adverse Event|1
7449973|NCT01725529|11738464|FG001|Overall Study|Adverse Event|0
7449974|NCT01725529|11738465|FG002|Overall Study|Adverse Event|0
7449975|NCT01725529|11738463|FG000|Overall Study|Lost to Follow-up|2
7449976|NCT01725529|11738464|FG001|Overall Study|Lost to Follow-up|1
7449977|NCT01725529|11738465|FG002|Overall Study|Lost to Follow-up|1
7449978|NCT01725529|11738463|FG000|Overall Study|Protocol Violation|0
7449979|NCT01725529|11738464|FG001|Overall Study|Protocol Violation|1
7449980|NCT01725529|11738465|FG002|Overall Study|Protocol Violation|1
7449981|NCT01725529|11738463|FG000|Overall Study|Withdrawal by Subject|12
7449982|NCT01725529|11738464|FG001|Overall Study|Withdrawal by Subject|14
7449983|NCT01725529|11738465|FG002|Overall Study|Withdrawal by Subject|8
7449984|NCT01725750|11738475|FG000|Overall Study|Adverse Event|1
7449985|NCT01725750|11738476|FG001|Overall Study|Adverse Event|0
7449986|NCT01725750|11738475|FG000|Overall Study|Lost to Follow-up|1
7449987|NCT01725750|11738476|FG001|Overall Study|Lost to Follow-up|1
7449988|NCT01725750|11738475|FG000|Overall Study|Withdrawal by Subject|0
7449989|NCT01725750|11738476|FG001|Overall Study|Withdrawal by Subject|9
7449990|NCT01726023|11738504|FG000|Overall Study|Death|1
7449991|NCT01726023|11738505|FG001|Overall Study|Death|1
7449992|NCT01726023|11738504|FG000|Overall Study|Lost to Follow-up|5
7449993|NCT01726023|11738505|FG001|Overall Study|Lost to Follow-up|10
7449994|NCT01726023|11738504|FG000|Overall Study|Other Eligibility criteria|7
7449995|NCT01726023|11738505|FG001|Overall Study|Other Eligibility criteria|7
7449996|NCT01726023|11738504|FG000|Overall Study|Withdrawal by Subject|16
7449997|NCT01726023|11738505|FG001|Overall Study|Withdrawal by Subject|8
7449998|NCT01726049|11738529|FG000|Overall Study|Death|1
7449999|NCT01726049|11738530|FG001|Overall Study|Death|1
7450000|NCT01726049|11738529|FG000|Overall Study|Adverse Event|4
7450001|NCT01726049|11738530|FG001|Overall Study|Adverse Event|1
7450002|NCT01726049|11738529|FG000|Overall Study|refused second HC|0
7450003|NCT01726049|11738530|FG001|Overall Study|refused second HC|2
7450004|NCT01726270|11738536|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
7450005|NCT01726270|11738536|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
7450006|NCT01726270|11738536|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
7450007|NCT01726270|11738536|FG000|Part 2, Actual-Use Phase|Adverse Event|6
7450008|NCT01726270|11738536|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
7450009|NCT01726270|11738536|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
7450010|NCT01726335|11738542|FG000|Overall Study|Lost to Follow-up|2
7450011|NCT01726335|11738542|FG000|Overall Study|Withdrawal by Subject|15
7450012|NCT01726335|11738542|FG000|Overall Study|Adverse Event|4
7450013|NCT01726335|11738542|FG000|Overall Study|Lost to Follow-up|2
7450014|NCT01726335|11738542|FG000|Overall Study|Exacerbation of psychotic symptoms|1
7450015|NCT01726517|11738560|FG000|Overall Study|Withdrawal by Subject|0
7450016|NCT01726517|11738561|FG001|Overall Study|Withdrawal by Subject|0
7450017|NCT01726517|11738562|FG002|Overall Study|Withdrawal by Subject|1
7450018|NCT01726517|11738563|FG003|Overall Study|Withdrawal by Subject|0
7450019|NCT01726517|11738564|FG004|Overall Study|Withdrawal by Subject|0
7450020|NCT01726803|11738595|FG000|Overall Study|Lost to Follow-up|6
7450021|NCT01726803|11738596|FG001|Overall Study|Lost to Follow-up|1
7450022|NCT01726803|11738595|FG000|Overall Study|Withdrawal by Subject|1
7450023|NCT01726803|11738596|FG001|Overall Study|Withdrawal by Subject|0
7450024|NCT01727024|11738602|FG000|Period 1|Lost to Follow-up|1
7450025|NCT01727024|11738603|FG001|Period 1|Lost to Follow-up|1
7450026|NCT01727024|11738602|FG000|Period 1|Withdrawal by Subject|2
7450027|NCT01727024|11738603|FG001|Period 1|Withdrawal by Subject|3
7450028|NCT01727141|11738622|FG000|Overall Study|Physician Decision|0
7450029|NCT01727141|11738623|FG001|Overall Study|Physician Decision|1
7450030|NCT01727141|11738624|FG002|Overall Study|Physician Decision|0
7450031|NCT01727141|11738625|FG003|Overall Study|Physician Decision|2
7450032|NCT01727141|11738622|FG000|Overall Study|Lost to Follow-up|0
7450033|NCT01727141|11738623|FG001|Overall Study|Lost to Follow-up|2
7450034|NCT01727141|11738624|FG002|Overall Study|Lost to Follow-up|0
7450035|NCT01727141|11738625|FG003|Overall Study|Lost to Follow-up|0
7450036|NCT01727141|11738622|FG000|Overall Study|Death|0
7450037|NCT01727141|11738623|FG001|Overall Study|Death|1
7450038|NCT01727141|11738624|FG002|Overall Study|Death|1
7450039|NCT01727141|11738625|FG003|Overall Study|Death|1
7450040|NCT01727141|11738622|FG000|Overall Study|Protocol deviation|1
7450041|NCT01727141|11738623|FG001|Overall Study|Protocol deviation|1
7450042|NCT01727141|11738624|FG002|Overall Study|Protocol deviation|0
7450043|NCT01727141|11738625|FG003|Overall Study|Protocol deviation|1
7450044|NCT01727141|11738622|FG000|Overall Study|Withdrawal by Subject|4
7450045|NCT01727141|11738623|FG001|Overall Study|Withdrawal by Subject|4
7450046|NCT01727141|11738624|FG002|Overall Study|Withdrawal by Subject|2
7450047|NCT01727141|11738625|FG003|Overall Study|Withdrawal by Subject|11
7450048|NCT01727154|11738635|FG000|Overall Study|Death|17
7450049|NCT01727154|11738635|FG000|Overall Study|Withdrawal by Subject|14
7450050|NCT01727154|11738635|FG000|Overall Study|Subject Withdrew Consent|18
7450051|NCT01727154|11738635|FG000|Overall Study|Study Terminated|6
7450052|NCT01727154|11738635|FG000|Overall Study|No Discontinuation Documentation|4
7450053|NCT01727258|11738646|FG000|Overall Study|Adverse Event|0
7450054|NCT01727258|11738647|FG001|Overall Study|Adverse Event|2
7450055|NCT01727258|11738648|FG002|Overall Study|Adverse Event|0
7450056|NCT01727258|11738646|FG000|Overall Study|Noncompliance with Study Drug|0
7450057|NCT01727258|11738647|FG001|Overall Study|Noncompliance with Study Drug|0
7450058|NCT01727258|11738648|FG002|Overall Study|Noncompliance with Study Drug|1
7450059|NCT01727258|11738646|FG000|Overall Study|Withdrawal by Subject|1
7450060|NCT01727258|11738647|FG001|Overall Study|Withdrawal by Subject|1
7450061|NCT01727258|11738648|FG002|Overall Study|Withdrawal by Subject|0
7450062|NCT01727258|11738646|FG000|Overall Study|Lost to Follow-up|1
7450063|NCT01727258|11738647|FG001|Overall Study|Lost to Follow-up|0
7450064|NCT01727258|11738648|FG002|Overall Study|Lost to Follow-up|0
7450065|NCT01727297|11738656|FG000|Overall Study|Death|13
7450066|NCT01727297|11738657|FG001|Overall Study|Death|0
7450067|NCT01727297|11738656|FG000|Overall Study|Protocol Violation|1
7450068|NCT01727297|11738657|FG001|Overall Study|Protocol Violation|10
7450069|NCT01727297|11738656|FG000|Overall Study|Adverse Event|3
7450070|NCT01727297|11738657|FG001|Overall Study|Adverse Event|1
7450071|NCT01727297|11738656|FG000|Overall Study|Lost to Follow-up|11
7450072|NCT01727297|11738657|FG001|Overall Study|Lost to Follow-up|0
7450073|NCT01727297|11738656|FG000|Overall Study|Withdrawal by Subject|26
7450074|NCT01727297|11738657|FG001|Overall Study|Withdrawal by Subject|27
7450075|NCT01727297|11738656|FG000|Overall Study|Physician Decision|19
7450076|NCT01727297|11738657|FG001|Overall Study|Physician Decision|5
7450077|NCT01727297|11738656|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
7450078|NCT01727297|11738657|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
7450079|NCT01727336|11738676|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7450080|NCT01727336|11738677|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
7450081|NCT01727336|11738678|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
7450082|NCT01727336|11738679|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7450083|NCT01727336|11738680|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7450084|NCT01727336|11738681|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
7450085|NCT01727336|11738676|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7450086|NCT01727336|11738677|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
7450087|NCT01727336|11738678|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
7450088|NCT01727336|11738679|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7450089|NCT01727336|11738680|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7450090|NCT01727336|11738681|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
7450091|NCT01727336|11738676|FG000|Part 2 Blinded|Death|0
7450092|NCT01727336|11738677|FG001|Part 2 Blinded|Death|0
7450093|NCT01727336|11738678|FG002|Part 2 Blinded|Death|0
7450094|NCT01727336|11738679|FG003|Part 2 Blinded|Death|0
7450095|NCT01727336|11738680|FG004|Part 2 Blinded|Death|20
7450096|NCT01727336|11738681|FG005|Part 2 Blinded|Death|16
7450097|NCT01727336|11738676|FG000|Part 2 Blinded|Lack of Efficacy|0
7450098|NCT01727336|11738677|FG001|Part 2 Blinded|Lack of Efficacy|0
7450099|NCT01727336|11738678|FG002|Part 2 Blinded|Lack of Efficacy|0
7450100|NCT01727336|11738679|FG003|Part 2 Blinded|Lack of Efficacy|0
7450101|NCT01727336|11738680|FG004|Part 2 Blinded|Lack of Efficacy|42
7450102|NCT01727336|11738681|FG005|Part 2 Blinded|Lack of Efficacy|44
7450103|NCT01727336|11738676|FG000|Part 2 Blinded|Lost to Follow-up|0
7450104|NCT01727336|11738677|FG001|Part 2 Blinded|Lost to Follow-up|0
7450105|NCT01727336|11738678|FG002|Part 2 Blinded|Lost to Follow-up|0
7450106|NCT01727336|11738679|FG003|Part 2 Blinded|Lost to Follow-up|0
7450107|NCT01727336|11738680|FG004|Part 2 Blinded|Lost to Follow-up|0
7450108|NCT01727336|11738681|FG005|Part 2 Blinded|Lost to Follow-up|1
7450109|NCT01727336|11738676|FG000|Part 2 Blinded|Withdrawal by Subject|0
7450110|NCT01727336|11738677|FG001|Part 2 Blinded|Withdrawal by Subject|0
7450111|NCT01727336|11738678|FG002|Part 2 Blinded|Withdrawal by Subject|0
7450112|NCT01727336|11738679|FG003|Part 2 Blinded|Withdrawal by Subject|0
7450113|NCT01727336|11738680|FG004|Part 2 Blinded|Withdrawal by Subject|0
7450114|NCT01727336|11738681|FG005|Part 2 Blinded|Withdrawal by Subject|4
7450115|NCT01727336|11738676|FG000|Part 2 Blinded|use of prohibited medications|0
7450116|NCT01727336|11738677|FG001|Part 2 Blinded|use of prohibited medications|0
7450117|NCT01727336|11738678|FG002|Part 2 Blinded|use of prohibited medications|0
7450118|NCT01727336|11738679|FG003|Part 2 Blinded|use of prohibited medications|0
7450119|NCT01727336|11738680|FG004|Part 2 Blinded|use of prohibited medications|1
7450120|NCT01727336|11738681|FG005|Part 2 Blinded|use of prohibited medications|3
7450121|NCT01727505|11738710|FG000|First 24 Hours|Adverse Event|0
7450122|NCT01727505|11738711|FG001|First 24 Hours|Adverse Event|1
7450123|NCT01727505|11738710|FG000|Second 24 Hours|Missing data|0
7450124|NCT01727505|11738711|FG001|Second 24 Hours|Missing data|1
7450125|NCT01727700|11738720|FG000|Overall Study|Adverse Event|0
7450126|NCT01727700|11738721|FG001|Overall Study|Adverse Event|7
7450127|NCT01727700|11738722|FG002|Overall Study|Adverse Event|1
7450128|NCT01727700|11738720|FG000|Overall Study|Particpant withdrew consent|0
7450129|NCT01727700|11738721|FG001|Overall Study|Particpant withdrew consent|3
7450130|NCT01727700|11738722|FG002|Overall Study|Particpant withdrew consent|1
7450131|NCT01727700|11738720|FG000|Overall Study|Protocol Violation|2
7450132|NCT01727700|11738721|FG001|Overall Study|Protocol Violation|0
7450133|NCT01727700|11738722|FG002|Overall Study|Protocol Violation|0
7450134|NCT01727713|11738730|FG000|Overall Study|Lost to Follow-up|5
7450135|NCT01727713|11738730|FG000|Overall Study|Adverse Event|10
7450136|NCT01727713|11738730|FG000|Overall Study|Participant Met Withdrawal Criteria|5
7450137|NCT01727713|11738730|FG000|Overall Study|Withdrawal by Subject|13
7450138|NCT01727713|11738730|FG000|Overall Study|Protocol Deviation|2
7450139|NCT01728077|11738771|FG000|Overall Study|Lack of Efficacy|3
7450140|NCT01728077|11738772|FG001|Overall Study|Lack of Efficacy|1
7450141|NCT01728077|11738771|FG000|Overall Study|Lost to Follow-up|1
7450142|NCT01728077|11738772|FG001|Overall Study|Lost to Follow-up|0
7450143|NCT01728077|11738771|FG000|Overall Study|Subject choice|2
7450144|NCT01728077|11738772|FG001|Overall Study|Subject choice|3
7450145|NCT01728077|11738771|FG000|Overall Study|Death|0
7450146|NCT01728077|11738772|FG001|Overall Study|Death|1
7450147|NCT01728077|11738771|FG000|Overall Study|Patient moving|1
7450148|NCT01728077|11738772|FG001|Overall Study|Patient moving|0
7450149|NCT01728077|11738771|FG000|Overall Study|Non compliance|1
7450150|NCT01728077|11738772|FG001|Overall Study|Non compliance|0
7450151|NCT01728116|11738781|FG000|Overall Study|Sponsor Terminated Study|106
7450152|NCT01728116|11738782|FG001|Overall Study|Sponsor Terminated Study|35
7450153|NCT01728116|11738781|FG000|Overall Study|Withdrawal by Subject|16
7450154|NCT01728116|11738782|FG001|Overall Study|Withdrawal by Subject|9
7450155|NCT01728116|11738781|FG000|Overall Study|Adverse Event|13
7450156|NCT01728116|11738782|FG001|Overall Study|Adverse Event|0
7450157|NCT01728116|11738781|FG000|Overall Study|Procedure/device failure|7
7450158|NCT01728116|11738782|FG001|Overall Study|Procedure/device failure|0
7450159|NCT01728116|11738781|FG000|Overall Study|Lost to Follow-up|9
7450160|NCT01728116|11738782|FG001|Overall Study|Lost to Follow-up|2
7450161|NCT01728116|11738781|FG000|Overall Study|Physician Decision|2
7450162|NCT01728116|11738782|FG001|Overall Study|Physician Decision|0
7450163|NCT01728116|11738781|FG000|Overall Study|Subject Non-Compliance|2
7450164|NCT01728116|11738782|FG001|Overall Study|Subject Non-Compliance|0
7450165|NCT01728116|11738781|FG000|Overall Study|Inter-current finding at procedure|1
7450166|NCT01728116|11738782|FG001|Overall Study|Inter-current finding at procedure|0
7450167|NCT01728116|11738781|FG000|Overall Study|Incorrectly enrolled in Study|0
7450168|NCT01728116|11738782|FG001|Overall Study|Incorrectly enrolled in Study|1
7450169|NCT01728116|11738781|FG000|Overall Study|various not noted previously|5
7450170|NCT01728116|11738782|FG001|Overall Study|various not noted previously|0
7450171|NCT01728194|11738791|FG000|Overall Study|Lost to Follow-up|4
7450172|NCT01728194|11738792|FG001|Overall Study|Lost to Follow-up|3
7450173|NCT01728194|11738791|FG000|Overall Study|Physician Decision|4
7450174|NCT01728194|11738792|FG001|Overall Study|Physician Decision|0
7450175|NCT01728194|11738791|FG000|Overall Study|Withdrawal by Subject|7
7450176|NCT01728194|11738792|FG001|Overall Study|Withdrawal by Subject|3
7450177|NCT01728194|11738791|FG000|Overall Study|Perceived Medication Side Effects|4
7450178|NCT01728194|11738792|FG001|Overall Study|Perceived Medication Side Effects|0
7450179|NCT01728194|11738791|FG000|Overall Study|Family Member Request|1
7450180|NCT01728194|11738792|FG001|Overall Study|Family Member Request|0
7450181|NCT01728246|11738800|FG000|Overall Study|Participant needed rescue medication|1
7450182|NCT01728246|11738801|FG001|Overall Study|Participant needed rescue medication|5
7450183|NCT01728246|11738800|FG000|Overall Study|Protocol Violation|1
7450184|NCT01728246|11738801|FG001|Overall Study|Protocol Violation|0
7450185|NCT01728246|11738800|FG000|Overall Study|Withdrawal by Subject|2
7450186|NCT01728246|11738801|FG001|Overall Study|Withdrawal by Subject|3
7450187|NCT01728246|11738800|FG000|Overall Study|Lost to Follow-up|23
7450188|NCT01728246|11738801|FG001|Overall Study|Lost to Follow-up|22
7450189|NCT01728246|11738800|FG000|Overall Study|Lack of Efficacy|1
7450190|NCT01728246|11738801|FG001|Overall Study|Lack of Efficacy|1
7450191|NCT01728246|11738800|FG000|Overall Study|Adverse Event|8
7450192|NCT01728246|11738801|FG001|Overall Study|Adverse Event|5
7450193|NCT01728324|11738810|FG000|Termination of DBV|Adverse Event|14
7450194|NCT01728324|11738811|FG001|Termination of DBV|Adverse Event|13
7450195|NCT01728324|11738812|FG002|Termination of DBV|Adverse Event|4
7450196|NCT01728324|11738810|FG000|Termination of DBV|Lack of Efficacy|14
7450197|NCT01728324|11738811|FG001|Termination of DBV|Lack of Efficacy|12
7450198|NCT01728324|11738812|FG002|Termination of DBV|Lack of Efficacy|8
7450199|NCT01728324|11738810|FG000|Termination of DBV|Withdrawal by Subject|9
7450200|NCT01728324|11738811|FG001|Termination of DBV|Withdrawal by Subject|6
7450201|NCT01728324|11738812|FG002|Termination of DBV|Withdrawal by Subject|2
7450202|NCT01728324|11738810|FG000|Termination of DBV|Other than stated|1
7450203|NCT01728324|11738811|FG001|Termination of DBV|Other than stated|3
7450204|NCT01728324|11738812|FG002|Termination of DBV|Other than stated|0
7450205|NCT01728324|11738810|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
7450206|NCT01728324|11738811|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
7450207|NCT01728324|11738812|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
7450208|NCT01728324|11738810|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
7450209|NCT01728324|11738811|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
7450210|NCT01728324|11738812|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
7450211|NCT01728324|11738810|FG000|Termination of FDV|Adverse Event|14
7450212|NCT01728324|11738811|FG001|Termination of FDV|Adverse Event|13
7450213|NCT01728324|11738812|FG002|Termination of FDV|Adverse Event|4
7450214|NCT01728324|11738810|FG000|Termination of FDV|Lack of Efficacy|14
7450215|NCT01728324|11738811|FG001|Termination of FDV|Lack of Efficacy|12
7450216|NCT01728324|11738812|FG002|Termination of FDV|Lack of Efficacy|8
7450217|NCT01728324|11738810|FG000|Termination of FDV|Withdrawal by Subject|9
7450218|NCT01728324|11738811|FG001|Termination of FDV|Withdrawal by Subject|6
7450219|NCT01728324|11738812|FG002|Termination of FDV|Withdrawal by Subject|2
7450220|NCT01728324|11738810|FG000|Termination of FDV|Other than stated|1
7450221|NCT01728324|11738811|FG001|Termination of FDV|Other than stated|3
7450222|NCT01728324|11738812|FG002|Termination of FDV|Other than stated|0
7450223|NCT01728324|11738810|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
7450224|NCT01728324|11738811|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
7450225|NCT01728324|11738812|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
7450226|NCT01728324|11738810|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
7450227|NCT01728324|11738811|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
7450228|NCT01728324|11738812|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
7450229|NCT01728324|11738810|FG000|Termination of RBV|Adverse Event|15
7450230|NCT01728324|11738811|FG001|Termination of RBV|Adverse Event|16
7450231|NCT01728324|11738812|FG002|Termination of RBV|Adverse Event|5
7450232|NCT01728324|11738810|FG000|Termination of RBV|Lack of Efficacy|14
7450233|NCT01728324|11738811|FG001|Termination of RBV|Lack of Efficacy|11
7450234|NCT01728324|11738812|FG002|Termination of RBV|Lack of Efficacy|7
7450235|NCT01728324|11738810|FG000|Termination of RBV|Withdrawal by Subject|9
7450236|NCT01728324|11738811|FG001|Termination of RBV|Withdrawal by Subject|5
7450237|NCT01728324|11738812|FG002|Termination of RBV|Withdrawal by Subject|2
7450238|NCT01728324|11738810|FG000|Termination of RBV|Other than stated|1
7450239|NCT01728324|11738811|FG001|Termination of RBV|Other than stated|3
7450240|NCT01728324|11738812|FG002|Termination of RBV|Other than stated|1
7450241|NCT01728324|11738810|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
7450242|NCT01728324|11738811|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
7450243|NCT01728324|11738812|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
7450244|NCT01728324|11738810|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
7450245|NCT01728324|11738811|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
7450246|NCT01728324|11738812|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
7450247|NCT01728376|11738834|FG000|Overall Study|Adverse Event|1
7450248|NCT01728376|11738835|FG001|Overall Study|Adverse Event|1
7450249|NCT01728376|11738836|FG002|Overall Study|Adverse Event|1
7450250|NCT01728376|11738837|FG003|Overall Study|Adverse Event|1
7450251|NCT01728376|11738838|FG004|Overall Study|Adverse Event|1
7450252|NCT01728376|11738839|FG005|Overall Study|Adverse Event|0
7450253|NCT01728376|11738834|FG000|Overall Study|Persistent Positive Blood Cultures|1
7450254|NCT01728376|11738835|FG001|Overall Study|Persistent Positive Blood Cultures|0
7563652|NCT03262012|11933774|FG000|Overall Study|Physician Decision|2
7563653|NCT03262012|11933775|FG001|Overall Study|Physician Decision|5
7563654|NCT03262012|11933776|FG002|Overall Study|Physician Decision|1
7563655|NCT03262012|11933777|FG003|Overall Study|Physician Decision|0
7450255|NCT01728376|11738836|FG002|Overall Study|Persistent Positive Blood Cultures|1
7450256|NCT01728376|11738837|FG003|Overall Study|Persistent Positive Blood Cultures|0
7450257|NCT01728376|11738838|FG004|Overall Study|Persistent Positive Blood Cultures|0
7450258|NCT01728376|11738839|FG005|Overall Study|Persistent Positive Blood Cultures|0
7450259|NCT01728376|11738834|FG000|Overall Study|No relevant bacteria|2
7450260|NCT01728376|11738835|FG001|Overall Study|No relevant bacteria|0
7450261|NCT01728376|11738836|FG002|Overall Study|No relevant bacteria|0
7450262|NCT01728376|11738837|FG003|Overall Study|No relevant bacteria|0
7450263|NCT01728376|11738838|FG004|Overall Study|No relevant bacteria|1
7450264|NCT01728376|11738839|FG005|Overall Study|No relevant bacteria|1
7450265|NCT01728376|11738834|FG000|Overall Study|Did not receive treatment|0
7450266|NCT01728376|11738835|FG001|Overall Study|Did not receive treatment|1
7450267|NCT01728376|11738836|FG002|Overall Study|Did not receive treatment|0
7450268|NCT01728376|11738837|FG003|Overall Study|Did not receive treatment|0
7450269|NCT01728376|11738838|FG004|Overall Study|Did not receive treatment|0
7450270|NCT01728376|11738839|FG005|Overall Study|Did not receive treatment|0
7450271|NCT01728376|11738834|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
7450272|NCT01728376|11738835|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
7450273|NCT01728376|11738836|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
7450274|NCT01728376|11738837|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
7450275|NCT01728376|11738838|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
7450276|NCT01728376|11738839|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
7450277|NCT01728454|11738856|FG000|Stage 1 and 2|Pregnancy|1
7450278|NCT01728454|11738857|FG001|Stage 1 and 2|Pregnancy|0
7450279|NCT01728454|11738858|FG002|Stage 1 and 2|Pregnancy|0
7450280|NCT01728454|11738856|FG000|Stage 1 and 2|Non-compliance with Protocol|0
7450281|NCT01728454|11738857|FG001|Stage 1 and 2|Non-compliance with Protocol|0
7450282|NCT01728454|11738858|FG002|Stage 1 and 2|Non-compliance with Protocol|1
7450283|NCT01728454|11738856|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
7450284|NCT01728454|11738857|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7450285|NCT01728454|11738858|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
7450286|NCT01728454|11738856|FG000|Stage 1 and 2|Lost to Follow-up|1
7450287|NCT01728454|11738857|FG001|Stage 1 and 2|Lost to Follow-up|1
7450288|NCT01728454|11738858|FG002|Stage 1 and 2|Lost to Follow-up|0
7563656|NCT03262012|11933774|FG000|Overall Study|Lack of Efficacy|0
7450289|NCT01728454|11738856|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
7450290|NCT01728454|11738857|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7450291|NCT01728454|11738858|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
7450292|NCT01728454|11738856|FG000|Stage 3|Reason Missing|0
7450293|NCT01728454|11738857|FG001|Stage 3|Reason Missing|0
7450294|NCT01728454|11738858|FG002|Stage 3|Reason Missing|1
7450295|NCT01728454|11738856|FG000|Stage 3|Subject Required Other Treatment|0
7450296|NCT01728454|11738857|FG001|Stage 3|Subject Required Other Treatment|1
7450297|NCT01728454|11738858|FG002|Stage 3|Subject Required Other Treatment|0
7450298|NCT01728454|11738856|FG000|Stage 3|Pregnancy|1
7450299|NCT01728454|11738857|FG001|Stage 3|Pregnancy|0
7450300|NCT01728454|11738858|FG002|Stage 3|Pregnancy|0
7450301|NCT01728454|11738856|FG000|Stage 3|Withdrew Consent|1
7450302|NCT01728454|11738857|FG001|Stage 3|Withdrew Consent|0
7450303|NCT01728454|11738858|FG002|Stage 3|Withdrew Consent|1
7450304|NCT01728454|11738856|FG000|Stage 3|Non-compliance with Protocol|0
7450305|NCT01728454|11738857|FG001|Stage 3|Non-compliance with Protocol|0
7450306|NCT01728454|11738858|FG002|Stage 3|Non-compliance with Protocol|1
7450307|NCT01728454|11738856|FG000|Stage 3|Lost to Follow-up|0
7450308|NCT01728454|11738857|FG001|Stage 3|Lost to Follow-up|3
7450309|NCT01728454|11738858|FG002|Stage 3|Lost to Follow-up|1
7450310|NCT01728454|11738856|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
7450311|NCT01728454|11738857|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7450312|NCT01728454|11738858|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
7450313|NCT01728584|11738873|FG000|Overall Study|Adverse Event|1
7450314|NCT01728584|11738874|FG001|Overall Study|Adverse Event|0
7450315|NCT01728584|11738875|FG002|Overall Study|Adverse Event|0
7450316|NCT01728584|11738876|FG003|Overall Study|Adverse Event|0
7450317|NCT01728584|11738873|FG000|Overall Study|Physician Decision|4
7450318|NCT01728584|11738874|FG001|Overall Study|Physician Decision|0
7450319|NCT01728584|11738875|FG002|Overall Study|Physician Decision|1
7450320|NCT01728584|11738876|FG003|Overall Study|Physician Decision|0
7450321|NCT01728584|11738873|FG000|Overall Study|Withdrawal by Subject|1
7450322|NCT01728584|11738874|FG001|Overall Study|Withdrawal by Subject|0
7450323|NCT01728584|11738875|FG002|Overall Study|Withdrawal by Subject|0
7450324|NCT01728584|11738876|FG003|Overall Study|Withdrawal by Subject|0
7450325|NCT01728584|11738873|FG000|Overall Study|Screen failure|1
7450326|NCT01728584|11738874|FG001|Overall Study|Screen failure|0
7450327|NCT01728584|11738875|FG002|Overall Study|Screen failure|0
7450328|NCT01728584|11738876|FG003|Overall Study|Screen failure|0
7450329|NCT01728584|11738873|FG000|Overall Study|Other reason (not specified)|1
7450330|NCT01728584|11738874|FG001|Overall Study|Other reason (not specified)|0
7450331|NCT01728584|11738875|FG002|Overall Study|Other reason (not specified)|0
7450332|NCT01728584|11738876|FG003|Overall Study|Other reason (not specified)|1
7450333|NCT01728623|11738893|FG000|Overall Study|Disease progression|26
7450334|NCT01728623|11738893|FG000|Overall Study|Adverse Event|1
7450335|NCT01728623|11738893|FG000|Overall Study|Withdrawal by Subject|1
7450336|NCT01728779|11738909|FG000|Overall Study|Withdrawal by Subject|1
7450337|NCT01728792|11738918|FG000|Overall Study|Withdrawal of Consent|1
7450338|NCT01728792|11738919|FG001|Overall Study|Withdrawal of Consent|1
7450339|NCT01728792|11738920|FG002|Overall Study|Withdrawal of Consent|0
7563657|NCT03262012|11933775|FG001|Overall Study|Lack of Efficacy|5
7450340|NCT01728792|11738921|FG003|Overall Study|Withdrawal of Consent|1
7450341|NCT01728792|11738922|FG004|Overall Study|Withdrawal of Consent|0
7450342|NCT01728792|11738918|FG000|Overall Study|Lost to Follow-up|2
7450343|NCT01728792|11738919|FG001|Overall Study|Lost to Follow-up|1
7450344|NCT01728792|11738920|FG002|Overall Study|Lost to Follow-up|4
7450345|NCT01728792|11738921|FG003|Overall Study|Lost to Follow-up|2
7450346|NCT01728792|11738922|FG004|Overall Study|Lost to Follow-up|0
7450347|NCT01729026|11738964|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
7450348|NCT01729026|11738965|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
7450349|NCT01729026|11738964|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
7450350|NCT01729026|11738965|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
7450351|NCT01729039|11738976|FG000|Overall Study|disqualified|2
7450352|NCT01729039|11738977|FG001|Overall Study|disqualified|5
7450353|NCT01729039|11738976|FG000|Overall Study|Withdrawal by Subject|8
7450354|NCT01729039|11738977|FG001|Overall Study|Withdrawal by Subject|7
7450355|NCT01729156|11738989|FG000|Overall Study|Withdrawal by Subject|1
7450356|NCT01729156|11738990|FG001|Overall Study|Withdrawal by Subject|0
7450357|NCT01729156|11738991|FG002|Overall Study|Withdrawal by Subject|0
7450358|NCT01729208|11739002|FG000|Baseline|Physician Decision|5
7450359|NCT01729208|11739003|FG001|Baseline|Physician Decision|4
7563658|NCT03262012|11933776|FG002|Overall Study|Lack of Efficacy|1
7450360|NCT01729208|11739002|FG000|12 Months Follow-up|Withdrawal by Subject|4
7450361|NCT01729208|11739003|FG001|12 Months Follow-up|Withdrawal by Subject|7
7450362|NCT01729208|11739002|FG000|12 Months Follow-up|Lost to Follow-up|3
7450363|NCT01729208|11739003|FG001|12 Months Follow-up|Lost to Follow-up|3
7450364|NCT01729208|11739002|FG000|24 Months Follow-up|Lost to Follow-up|3
7450365|NCT01729208|11739003|FG001|24 Months Follow-up|Lost to Follow-up|0
7450366|NCT01729208|11739002|FG000|36 Months Follow-up|Physician Decision|1
7450367|NCT01729208|11739003|FG001|36 Months Follow-up|Physician Decision|0
7450368|NCT01729208|11739002|FG000|36 Months Follow-up|Withdrawal by Subject|2
7563659|NCT03262012|11933777|FG003|Overall Study|Lack of Efficacy|2
7450369|NCT01729208|11739003|FG001|36 Months Follow-up|Withdrawal by Subject|4
7450370|NCT01729559|11739039|FG000|Overall Study|Protocol Violation|31
7450371|NCT01729559|11739040|FG001|Overall Study|Protocol Violation|28
7467884|NCT01904604|11768392|FG000|Overall Study|Withdrew before receiving dosing|0
7467885|NCT01904604|11768393|FG001|Overall Study|Withdrew before receiving dosing|1
7467886|NCT01904604|11768394|FG002|Overall Study|Withdrew before receiving dosing|0
7467887|NCT01904604|11768392|FG000|Overall Study|Non-compliance|1
7467888|NCT01904604|11768393|FG001|Overall Study|Non-compliance|0
7467889|NCT01904604|11768394|FG002|Overall Study|Non-compliance|0
7467890|NCT01904604|11768392|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
7467891|NCT01904604|11768393|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
7467892|NCT01904604|11768394|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
7467893|NCT01904604|11768392|FG000|Overall Study|Patch site reactions|1
7467894|NCT01904604|11768393|FG001|Overall Study|Patch site reactions|1
7467895|NCT01904604|11768394|FG002|Overall Study|Patch site reactions|0
7467896|NCT01904604|11768392|FG000|Overall Study|Increased syncope|0
7467897|NCT01904604|11768393|FG001|Overall Study|Increased syncope|1
7467898|NCT01904604|11768394|FG002|Overall Study|Increased syncope|0
7467899|NCT01904604|11768392|FG000|Overall Study|Unrelated illness|0
7467900|NCT01904604|11768393|FG001|Overall Study|Unrelated illness|1
7467901|NCT01904604|11768394|FG002|Overall Study|Unrelated illness|0
7467902|NCT01904604|11768392|FG000|Overall Study|Passed Week 52 OFC|1
7467903|NCT01904604|11768393|FG001|Overall Study|Passed Week 52 OFC|0
7467904|NCT01904604|11768394|FG002|Overall Study|Passed Week 52 OFC|0
7467905|NCT01904604|11768392|FG000|Overall Study|Withdrawal by Subject|1
7467906|NCT01904604|11768393|FG001|Overall Study|Withdrawal by Subject|2
7467907|NCT01904604|11768394|FG002|Overall Study|Withdrawal by Subject|0
7467908|NCT01904604|11768392|FG000|Overall Study|Participant Relocated|1
7467909|NCT01904604|11768393|FG001|Overall Study|Participant Relocated|1
7467910|NCT01904604|11768394|FG002|Overall Study|Participant Relocated|1
7467911|NCT01904604|11768392|FG000|Overall Study|Lost to Follow-up|0
7467912|NCT01904604|11768393|FG001|Overall Study|Lost to Follow-up|0
7467913|NCT01904604|11768394|FG002|Overall Study|Lost to Follow-up|1
7467914|NCT01904721|11768412|FG000|Overall Study|Other Reasons|0
7467915|NCT01904721|11768413|FG001|Overall Study|Other Reasons|0
7467916|NCT01904721|11768414|FG002|Overall Study|Other Reasons|1
7467917|NCT01904721|11768415|FG003|Overall Study|Other Reasons|1
7467918|NCT01904721|11768416|FG004|Overall Study|Other Reasons|2
7467919|NCT01904721|11768417|FG005|Overall Study|Other Reasons|2
7467920|NCT01904721|11768418|FG006|Overall Study|Other Reasons|2
7467921|NCT01904721|11768412|FG000|Overall Study|Personal Reasons|0
7467922|NCT01904721|11768413|FG001|Overall Study|Personal Reasons|0
7467923|NCT01904721|11768414|FG002|Overall Study|Personal Reasons|0
7467924|NCT01904721|11768415|FG003|Overall Study|Personal Reasons|0
7467925|NCT01904721|11768416|FG004|Overall Study|Personal Reasons|2
7467926|NCT01904721|11768417|FG005|Overall Study|Personal Reasons|3
7467927|NCT01904721|11768418|FG006|Overall Study|Personal Reasons|3
7467928|NCT01904721|11768412|FG000|Overall Study|Lost to Follow-up|0
7467929|NCT01904721|11768413|FG001|Overall Study|Lost to Follow-up|0
7467930|NCT01904721|11768414|FG002|Overall Study|Lost to Follow-up|0
7467931|NCT01904721|11768415|FG003|Overall Study|Lost to Follow-up|0
7467932|NCT01904721|11768416|FG004|Overall Study|Lost to Follow-up|1
7467933|NCT01904721|11768417|FG005|Overall Study|Lost to Follow-up|3
7467934|NCT01904721|11768418|FG006|Overall Study|Lost to Follow-up|1
7467935|NCT01904721|11768412|FG000|Overall Study|Lack of Efficacy|0
7467936|NCT01904721|11768413|FG001|Overall Study|Lack of Efficacy|0
7467937|NCT01904721|11768414|FG002|Overall Study|Lack of Efficacy|0
7467938|NCT01904721|11768415|FG003|Overall Study|Lack of Efficacy|0
7467939|NCT01904721|11768416|FG004|Overall Study|Lack of Efficacy|0
7467940|NCT01904721|11768417|FG005|Overall Study|Lack of Efficacy|0
7467941|NCT01904721|11768418|FG006|Overall Study|Lack of Efficacy|1
7563660|NCT03262012|11933774|FG000|Overall Study|Protocol Discontinuation Criteria|0
7563661|NCT03262012|11933775|FG001|Overall Study|Protocol Discontinuation Criteria|1
7563662|NCT03262012|11933776|FG002|Overall Study|Protocol Discontinuation Criteria|0
7563663|NCT03262012|11933777|FG003|Overall Study|Protocol Discontinuation Criteria|0
7563664|NCT03262038|11933789|FG000|Overall Study|Withdrawal by Subject|0
7563665|NCT03262038|11933790|FG001|Overall Study|Withdrawal by Subject|1
7563666|NCT03262233|11933800|FG000|Overall Study|Withdrawal by Subject|12
7563667|NCT03262233|11933801|FG001|Overall Study|Withdrawal by Subject|8
7467942|NCT01904721|11768412|FG000|Overall Study|Adverse Event|0
7467943|NCT01904721|11768413|FG001|Overall Study|Adverse Event|0
7467944|NCT01904721|11768414|FG002|Overall Study|Adverse Event|0
7467945|NCT01904721|11768415|FG003|Overall Study|Adverse Event|0
7467946|NCT01904721|11768416|FG004|Overall Study|Adverse Event|3
7467947|NCT01904721|11768417|FG005|Overall Study|Adverse Event|1
7563668|NCT03262233|11933802|FG002|Overall Study|Withdrawal by Subject|21
7467948|NCT01904721|11768418|FG006|Overall Study|Adverse Event|0
7467949|NCT01904760|11768432|FG000|Overall Study|Protocol Violation|1
7467950|NCT01904760|11768433|FG001|Overall Study|Protocol Violation|0
7467951|NCT01904773|11768439|FG000|Screen|Screen failure|3
7467952|NCT01904773|11768440|FG001|Screen|Screen failure|0
7467953|NCT01904773|11768441|FG002|Screen|Screen failure|0
7467954|NCT01904773|11768442|FG003|Screen|Screen failure|0
7467955|NCT01904773|11768443|FG004|Screen|Screen failure|0
7467956|NCT01904773|11768444|FG005|Screen|Screen failure|0
7450372|NCT01729728|11739058|FG000|Overall Study|Adverse Event|0
7450373|NCT01729728|11739059|FG001|Overall Study|Adverse Event|6
7450374|NCT01729728|11739060|FG002|Overall Study|Adverse Event|0
7450375|NCT01729728|11739058|FG000|Overall Study|Protocol Violation|1
7450376|NCT01729728|11739059|FG001|Overall Study|Protocol Violation|0
7450377|NCT01729728|11739060|FG002|Overall Study|Protocol Violation|1
7450378|NCT01729819|11739193|FG000|Overall Study|Adverse Event|2
7450379|NCT01729819|11739194|FG001|Overall Study|Adverse Event|4
7450380|NCT01729819|11739193|FG000|Overall Study|Lack of Efficacy|1
7450381|NCT01729819|11739194|FG001|Overall Study|Lack of Efficacy|0
7450382|NCT01729819|11739193|FG000|Overall Study|Lost to Follow-up|2
7450383|NCT01729819|11739194|FG001|Overall Study|Lost to Follow-up|0
7450384|NCT01729819|11739193|FG000|Overall Study|Other reason|1
7450385|NCT01729819|11739194|FG001|Overall Study|Other reason|0
7450386|NCT01729819|11739193|FG000|Overall Study|Protocol Violation|0
7450387|NCT01729819|11739194|FG001|Overall Study|Protocol Violation|1
7450388|NCT01729819|11739193|FG000|Overall Study|Withdrawal by Subject|0
7450389|NCT01729819|11739194|FG001|Overall Study|Withdrawal by Subject|2
7450390|NCT01729871|11739220|FG000|Overall Study|Adverse Event|7
7450391|NCT01729871|11739221|FG001|Overall Study|Adverse Event|7
7450392|NCT01729871|11739220|FG000|Overall Study|Death|0
7450393|NCT01729871|11739221|FG001|Overall Study|Death|1
7450394|NCT01729871|11739220|FG000|Overall Study|Lack of Efficacy|0
7450395|NCT01729871|11739221|FG001|Overall Study|Lack of Efficacy|1
7450396|NCT01729871|11739220|FG000|Overall Study|Physician Decision|0
7450397|NCT01729871|11739221|FG001|Overall Study|Physician Decision|2
7450398|NCT01729871|11739220|FG000|Overall Study|Protocol Violation|1
7450399|NCT01729871|11739221|FG001|Overall Study|Protocol Violation|0
7450400|NCT01729871|11739220|FG000|Overall Study|Withdrawal by Subject|0
7450401|NCT01729871|11739221|FG001|Overall Study|Withdrawal by Subject|3
7450402|NCT01729871|11739220|FG000|Overall Study|Other|4
7450403|NCT01729871|11739221|FG001|Overall Study|Other|9
7450404|NCT01730040|11739238|FG000|Overall Study|Randomized but not treated|0
7450405|NCT01730040|11739239|FG001|Overall Study|Randomized but not treated|0
7450406|NCT01730040|11739240|FG002|Overall Study|Randomized but not treated|0
7450407|NCT01730040|11739241|FG003|Overall Study|Randomized but not treated|0
7450408|NCT01730040|11739242|FG004|Overall Study|Randomized but not treated|0
7450409|NCT01730040|11739243|FG005|Overall Study|Randomized but not treated|1
7450410|NCT01730040|11739244|FG006|Overall Study|Randomized but not treated|0
7450411|NCT01730040|11739238|FG000|Overall Study|Subject moved|0
7450412|NCT01730040|11739239|FG001|Overall Study|Subject moved|0
7450413|NCT01730040|11739240|FG002|Overall Study|Subject moved|1
7450414|NCT01730040|11739241|FG003|Overall Study|Subject moved|0
7450415|NCT01730040|11739242|FG004|Overall Study|Subject moved|0
7450416|NCT01730040|11739243|FG005|Overall Study|Subject moved|0
7450417|NCT01730040|11739244|FG006|Overall Study|Subject moved|1
7450418|NCT01730040|11739238|FG000|Overall Study|Physician Decision|0
7450419|NCT01730040|11739239|FG001|Overall Study|Physician Decision|0
7450420|NCT01730040|11739240|FG002|Overall Study|Physician Decision|0
7450421|NCT01730040|11739241|FG003|Overall Study|Physician Decision|0
7450422|NCT01730040|11739242|FG004|Overall Study|Physician Decision|0
7450423|NCT01730040|11739243|FG005|Overall Study|Physician Decision|1
7450424|NCT01730040|11739244|FG006|Overall Study|Physician Decision|1
7450425|NCT01730040|11739238|FG000|Overall Study|Other than specified|7
7450426|NCT01730040|11739239|FG001|Overall Study|Other than specified|8
7450427|NCT01730040|11739240|FG002|Overall Study|Other than specified|5
7450428|NCT01730040|11739241|FG003|Overall Study|Other than specified|5
7450429|NCT01730040|11739242|FG004|Overall Study|Other than specified|5
7450430|NCT01730040|11739243|FG005|Overall Study|Other than specified|4
7450431|NCT01730040|11739244|FG006|Overall Study|Other than specified|4
7450432|NCT01730040|11739238|FG000|Overall Study|Adverse Event|4
7450433|NCT01730040|11739239|FG001|Overall Study|Adverse Event|3
7450434|NCT01730040|11739240|FG002|Overall Study|Adverse Event|5
7450435|NCT01730040|11739241|FG003|Overall Study|Adverse Event|3
7450436|NCT01730040|11739242|FG004|Overall Study|Adverse Event|1
7450437|NCT01730040|11739243|FG005|Overall Study|Adverse Event|1
7450438|NCT01730040|11739244|FG006|Overall Study|Adverse Event|2
7450439|NCT01730040|11739238|FG000|Overall Study|Poor compliance to protocol|2
7450440|NCT01730040|11739239|FG001|Overall Study|Poor compliance to protocol|4
7450441|NCT01730040|11739240|FG002|Overall Study|Poor compliance to protocol|0
7450442|NCT01730040|11739241|FG003|Overall Study|Poor compliance to protocol|0
7450443|NCT01730040|11739242|FG004|Overall Study|Poor compliance to protocol|0
7450444|NCT01730040|11739243|FG005|Overall Study|Poor compliance to protocol|0
7450445|NCT01730040|11739244|FG006|Overall Study|Poor compliance to protocol|1
7450446|NCT01730053|11739266|FG000|Overall Study|Participant moved|0
7450447|NCT01730053|11739267|FG001|Overall Study|Participant moved|0
7450448|NCT01730053|11739268|FG002|Overall Study|Participant moved|1
7450449|NCT01730053|11739269|FG003|Overall Study|Participant moved|0
7450450|NCT01730053|11739270|FG004|Overall Study|Participant moved|0
7450451|NCT01730053|11739271|FG005|Overall Study|Participant moved|0
7450452|NCT01730053|11739266|FG000|Overall Study|Physician Decision|0
7450453|NCT01730053|11739267|FG001|Overall Study|Physician Decision|0
7450454|NCT01730053|11739268|FG002|Overall Study|Physician Decision|0
7450455|NCT01730053|11739269|FG003|Overall Study|Physician Decision|1
7450456|NCT01730053|11739270|FG004|Overall Study|Physician Decision|0
7450457|NCT01730053|11739271|FG005|Overall Study|Physician Decision|0
7450458|NCT01730053|11739266|FG000|Overall Study|Adverse Event|2
7450459|NCT01730053|11739267|FG001|Overall Study|Adverse Event|6
7450460|NCT01730053|11739268|FG002|Overall Study|Adverse Event|3
7450461|NCT01730053|11739269|FG003|Overall Study|Adverse Event|3
7450462|NCT01730053|11739270|FG004|Overall Study|Adverse Event|2
7450463|NCT01730053|11739271|FG005|Overall Study|Adverse Event|2
7450464|NCT01730053|11739266|FG000|Overall Study|Poor compliance to protocol|1
7450465|NCT01730053|11739267|FG001|Overall Study|Poor compliance to protocol|2
7450466|NCT01730053|11739268|FG002|Overall Study|Poor compliance to protocol|2
7450467|NCT01730053|11739269|FG003|Overall Study|Poor compliance to protocol|0
7450468|NCT01730053|11739270|FG004|Overall Study|Poor compliance to protocol|0
7450469|NCT01730053|11739271|FG005|Overall Study|Poor compliance to protocol|2
7450470|NCT01730053|11739266|FG000|Overall Study|Other than specified|2
7450471|NCT01730053|11739267|FG001|Overall Study|Other than specified|6
7450472|NCT01730053|11739268|FG002|Overall Study|Other than specified|5
7450473|NCT01730053|11739269|FG003|Overall Study|Other than specified|4
7450474|NCT01730053|11739270|FG004|Overall Study|Other than specified|7
7450475|NCT01730053|11739271|FG005|Overall Study|Other than specified|9
7450476|NCT01730339|11739288|FG000|Overall Study|Withdrawal by Subject|3
7450477|NCT01730339|11739289|FG001|Overall Study|Withdrawal by Subject|2
7450478|NCT01730339|11739288|FG000|Overall Study|Lost to Follow-up|1
7450479|NCT01730339|11739289|FG001|Overall Study|Lost to Follow-up|1
7450480|NCT01730339|11739288|FG000|Overall Study|Un-specified|1
7450481|NCT01730339|11739289|FG001|Overall Study|Un-specified|0
7450482|NCT01730378|11739307|FG000|Overall Study|Lost to Follow-up|1
7450483|NCT01730378|11739308|FG001|Overall Study|Lost to Follow-up|0
7450484|NCT01730534|11739317|FG000|Overall Study|Withdrawal by Subject|97
7450485|NCT01730534|11739318|FG001|Overall Study|Withdrawal by Subject|127
7450486|NCT01730534|11739317|FG000|Overall Study|Lost to Follow-up|12
7450487|NCT01730534|11739318|FG001|Overall Study|Lost to Follow-up|18
7450488|NCT01730586|11739324|FG000|Overall Study|Progressive Disease|2
7450489|NCT01730586|11739324|FG000|Overall Study|Inadequate Trial|8
7450490|NCT01730586|11739324|FG000|Overall Study|Adverse Event|2
7450491|NCT01730586|11739324|FG000|Overall Study|Hospice|1
7450492|NCT01730729|11739330|FG000|Overall Study|Adverse Event|1
7450493|NCT01730729|11739330|FG000|Overall Study|Death|1
7450494|NCT01730729|11739330|FG000|Overall Study|Progressive Disease|12
7450495|NCT01730950|11739361|FG000|Overall Study|Protocol Violation|6
7450496|NCT01730950|11739362|FG001|Overall Study|Protocol Violation|6
7450497|NCT01731002|11739372|FG000|Overall Study|Adverse Event|0
7450498|NCT01731002|11739373|FG001|Overall Study|Adverse Event|2
7450499|NCT01731002|11739374|FG002|Overall Study|Adverse Event|2
7450500|NCT01731002|11739372|FG000|Overall Study|Non-Compliant|0
7450501|NCT01731002|11739373|FG001|Overall Study|Non-Compliant|1
7450502|NCT01731002|11739374|FG002|Overall Study|Non-Compliant|0
7450503|NCT01731002|11739372|FG000|Overall Study|Lost to Follow-up|1
7450504|NCT01731002|11739373|FG001|Overall Study|Lost to Follow-up|0
7450505|NCT01731002|11739374|FG002|Overall Study|Lost to Follow-up|0
7450506|NCT01731002|11739372|FG000|Overall Study|Test Agent Discontinuation|0
7450507|NCT01731002|11739373|FG001|Overall Study|Test Agent Discontinuation|1
7450508|NCT01731002|11739374|FG002|Overall Study|Test Agent Discontinuation|0
7450509|NCT01731002|11739372|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
7450510|NCT01731002|11739373|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7450511|NCT01731002|11739374|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
7450512|NCT01731002|11739372|FG000|Overall Study|Elevated IOP|1
7450513|NCT01731002|11739373|FG001|Overall Study|Elevated IOP|0
7450514|NCT01731002|11739374|FG002|Overall Study|Elevated IOP|0
7450515|NCT01731002|11739372|FG000|Overall Study|Inappropriate use of study medications|0
7450516|NCT01731002|11739373|FG001|Overall Study|Inappropriate use of study medications|0
7450517|NCT01731002|11739374|FG002|Overall Study|Inappropriate use of study medications|1
7450518|NCT01731171|11739397|FG000|Overall Study|Withdrawal by Subject|4
7450519|NCT01731171|11739398|FG001|Overall Study|Withdrawal by Subject|1
7450520|NCT01731171|11739397|FG000|Overall Study|Lost to Follow-up|3
7450521|NCT01731171|11739398|FG001|Overall Study|Lost to Follow-up|2
7450522|NCT01731171|11739397|FG000|Overall Study|Moved out of Area|0
7450523|NCT01731171|11739398|FG001|Overall Study|Moved out of Area|2
7450524|NCT01731171|11739397|FG000|Overall Study|Terminated for Lack of Adherence|0
7450525|NCT01731171|11739398|FG001|Overall Study|Terminated for Lack of Adherence|1
7450526|NCT01731171|11739397|FG000|Overall Study|Terminated for Safety Reasons|0
7450527|NCT01731171|11739398|FG001|Overall Study|Terminated for Safety Reasons|1
7450528|NCT01731470|11739404|FG000|Overall Study|Withdrawal by Subject|1
7450529|NCT01731470|11739404|FG000|Overall Study|Did not meet study criteria|1
7450530|NCT01731600|11739410|FG000|Overall Study|Adverse Event|2
7450531|NCT01731600|11739411|FG001|Overall Study|Adverse Event|0
7450532|NCT01731600|11739410|FG000|Overall Study|Withdrawal criteria|1
7450533|NCT01731600|11739411|FG001|Overall Study|Withdrawal criteria|0
7450534|NCT01731600|11739410|FG000|Overall Study|Other reasons|3
7450535|NCT01731600|11739411|FG001|Overall Study|Other reasons|0
7450536|NCT01731678|11739421|FG000|Overall Study|Withdrawal by Subject|3
7450537|NCT01731678|11739421|FG000|Overall Study|Did not meet inclusion criteria|1
7450538|NCT01731678|11739421|FG000|Overall Study|RMT too high, making TMS difficult|3
7450539|NCT01731886|11739443|FG000|Overall Study|Death|1
7450540|NCT01731886|11739444|FG001|Overall Study|Death|0
7450541|NCT01731886|11739443|FG000|Overall Study|Never started treatment|0
7450542|NCT01731886|11739444|FG001|Overall Study|Never started treatment|1
7450543|NCT01731886|11739443|FG000|Overall Study|Non-compliant|1
7450544|NCT01731886|11739444|FG001|Overall Study|Non-compliant|0
7450545|NCT01731912|11739451|FG000|Overall Study|noncompliance|2
7450546|NCT01731938|11739459|FG000|Preliminary Part I|Withdrawal by Subject|2
7450547|NCT01731938|11739460|FG001|Preliminary Part I|Withdrawal by Subject|2
7450548|NCT01731938|11739459|FG000|Preliminary Part I|Physician Decision|1
7450549|NCT01731938|11739460|FG001|Preliminary Part I|Physician Decision|0
7450550|NCT01731938|11739459|FG000|Preliminary Part I|Lost to Follow-up|0
7450551|NCT01731938|11739460|FG001|Preliminary Part I|Lost to Follow-up|3
7450552|NCT01731938|11739459|FG000|Preliminary Part I|Missed Week 6 visit|0
7450553|NCT01731938|11739460|FG001|Preliminary Part I|Missed Week 6 visit|3
7450554|NCT01731938|11739459|FG000|Primary Part II|Withdrawal by Subject|5
7563669|NCT03262233|11933803|FG003|Overall Study|Withdrawal by Subject|13
7563670|NCT03262233|11933800|FG000|Overall Study|Declined due to shock|1
7563671|NCT03262233|11933801|FG001|Overall Study|Declined due to shock|2
7450555|NCT01731938|11739460|FG001|Primary Part II|Withdrawal by Subject|4
7450556|NCT01731938|11739459|FG000|Primary Part II|Lost to Follow-up|4
7450557|NCT01731938|11739460|FG001|Primary Part II|Lost to Follow-up|5
7450558|NCT01731938|11739459|FG000|Primary Part II|Death|2
7450559|NCT01731938|11739460|FG001|Primary Part II|Death|1
7450560|NCT01731938|11739459|FG000|Primary Part II|Missed Week 6 visit|2
7450561|NCT01731938|11739460|FG001|Primary Part II|Missed Week 6 visit|3
7450562|NCT01731951|11739473|FG000|Overall Study|Documented Disease Progression|1
7450563|NCT01731951|11739474|FG001|Overall Study|Documented Disease Progression|0
7450564|NCT01731951|11739475|FG002|Overall Study|Documented Disease Progression|0
7450565|NCT01731951|11739476|FG003|Overall Study|Documented Disease Progression|0
7450566|NCT01731951|11739477|FG004|Overall Study|Documented Disease Progression|0
7450567|NCT01731951|11739478|FG005|Overall Study|Documented Disease Progression|0
7450568|NCT01731951|11739473|FG000|Overall Study|Lost to Follow-up|2
7450569|NCT01731951|11739474|FG001|Overall Study|Lost to Follow-up|0
7450570|NCT01731951|11739475|FG002|Overall Study|Lost to Follow-up|0
7450571|NCT01731951|11739476|FG003|Overall Study|Lost to Follow-up|1
7450572|NCT01731951|11739477|FG004|Overall Study|Lost to Follow-up|3
7450573|NCT01731951|11739478|FG005|Overall Study|Lost to Follow-up|1
7450574|NCT01731951|11739473|FG000|Overall Study|Withdrawal of Consent|1
7450575|NCT01731951|11739474|FG001|Overall Study|Withdrawal of Consent|0
7450576|NCT01731951|11739475|FG002|Overall Study|Withdrawal of Consent|0
7450577|NCT01731951|11739476|FG003|Overall Study|Withdrawal of Consent|0
7450578|NCT01731951|11739477|FG004|Overall Study|Withdrawal of Consent|0
7450579|NCT01731951|11739478|FG005|Overall Study|Withdrawal of Consent|2
7450580|NCT01731951|11739473|FG000|Overall Study|Death|13
7450581|NCT01731951|11739474|FG001|Overall Study|Death|15
7450582|NCT01731951|11739475|FG002|Overall Study|Death|9
7450583|NCT01731951|11739476|FG003|Overall Study|Death|8
7450584|NCT01731951|11739477|FG004|Overall Study|Death|9
7450585|NCT01731951|11739478|FG005|Overall Study|Death|6
7450586|NCT01731990|11739498|FG000|Overall Study|Adverse Event|1
7450587|NCT01731990|11739499|FG001|Overall Study|Adverse Event|5
7450588|NCT01731990|11739498|FG000|Overall Study|Withdrawal by Subject|1
7450589|NCT01731990|11739499|FG001|Overall Study|Withdrawal by Subject|1
7450590|NCT01731990|11739498|FG000|Overall Study|Protocol deviation|1
7450591|NCT01731990|11739499|FG001|Overall Study|Protocol deviation|2
7450592|NCT01731990|11739498|FG000|Overall Study|Death|1
7450593|NCT01731990|11739499|FG001|Overall Study|Death|0
7563672|NCT03262233|11933802|FG002|Overall Study|Declined due to shock|2
7563673|NCT03262233|11933803|FG003|Overall Study|Declined due to shock|3
7563674|NCT03262233|11933800|FG000|Overall Study|Protocol Violation|5
7563675|NCT03262233|11933801|FG001|Overall Study|Protocol Violation|10
7450598|NCT01732458|11739556|FG000|Overall Study|Lost to Follow-up|0
7450599|NCT01732458|11739557|FG001|Overall Study|Lost to Follow-up|2
7450600|NCT01732458|11739558|FG002|Overall Study|Lost to Follow-up|0
7450601|NCT01732458|11739559|FG003|Overall Study|Lost to Follow-up|0
7450602|NCT01732458|11739556|FG000|Overall Study|Non-Compliance With Study Drug|0
7563676|NCT03262233|11933802|FG002|Overall Study|Protocol Violation|2
7563677|NCT03262233|11933803|FG003|Overall Study|Protocol Violation|13
7563678|NCT03262233|11933800|FG000|Overall Study|data collection artifact|0
7563679|NCT03262233|11933801|FG001|Overall Study|data collection artifact|1
7563680|NCT03262233|11933802|FG002|Overall Study|data collection artifact|0
7563681|NCT03262233|11933803|FG003|Overall Study|data collection artifact|0
7563682|NCT03262389|11933814|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
7563683|NCT03262389|11933814|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
7563684|NCT03262389|11933814|FG000|Overall Study|opted out of PET/MR|1
7563685|NCT03262441|11933818|FG000|Overall Study|Withdrawal by Subject|1
7450603|NCT01732458|11739557|FG001|Overall Study|Non-Compliance With Study Drug|0
7450604|NCT01732458|11739558|FG002|Overall Study|Non-Compliance With Study Drug|1
7450605|NCT01732458|11739559|FG003|Overall Study|Non-Compliance With Study Drug|0
7450606|NCT01732458|11739556|FG000|Overall Study|Physician Decision|1
7450607|NCT01732458|11739557|FG001|Overall Study|Physician Decision|2
7563686|NCT03263442|11933824|FG000|Inpatient Phase|Death|1
7450608|NCT01732458|11739558|FG002|Overall Study|Physician Decision|2
7450609|NCT01732458|11739559|FG003|Overall Study|Physician Decision|0
7450610|NCT01732458|11739556|FG000|Overall Study|Protocol Violation|2
7563687|NCT03263442|11933825|FG001|Inpatient Phase|Death|0
7450611|NCT01732458|11739557|FG001|Overall Study|Protocol Violation|0
7450612|NCT01732458|11739558|FG002|Overall Study|Protocol Violation|0
7450613|NCT01732458|11739559|FG003|Overall Study|Protocol Violation|2
7450614|NCT01732458|11739556|FG000|Overall Study|Screen Failure|0
7450615|NCT01732458|11739557|FG001|Overall Study|Screen Failure|1
7450616|NCT01732458|11739558|FG002|Overall Study|Screen Failure|0
7450617|NCT01732458|11739559|FG003|Overall Study|Screen Failure|0
7563688|NCT03263442|11933824|FG000|Inpatient Phase|Withdrawal by Subject|1
7563689|NCT03263442|11933825|FG001|Inpatient Phase|Withdrawal by Subject|0
7563690|NCT03263442|11933824|FG000|Inpatient Phase|Inadequate Drug Exposure|0
7563691|NCT03263442|11933825|FG001|Inpatient Phase|Inadequate Drug Exposure|1
7563692|NCT03263442|11933824|FG000|1-month Follow-Up|Lost to Follow-up|1
7563693|NCT03263442|11933825|FG001|1-month Follow-Up|Lost to Follow-up|0
7563694|NCT03263442|11933824|FG000|3-month Follow-Up|Lost to Follow-up|1
7563695|NCT03263442|11933825|FG001|3-month Follow-Up|Lost to Follow-up|3
7563696|NCT03263442|11933824|FG000|6-month Follow-Up|Lost to Follow-up|2
7563697|NCT03263442|11933825|FG001|6-month Follow-Up|Lost to Follow-up|2
7450618|NCT01732471|11739581|FG000|Overall Study|Withdrawal by Subject|1
7450619|NCT01732484|11739585|FG000|Overall Study|Death|7
7450620|NCT01732484|11739585|FG000|Overall Study|Lost to Follow-up|14
7450621|NCT01732484|11739585|FG000|Overall Study|chronical illness|5
7450622|NCT01732510|11739598|FG000|Overall Study|Adverse Event|0
7450623|NCT01732510|11739599|FG001|Overall Study|Adverse Event|1
7450624|NCT01732510|11739600|FG002|Overall Study|Adverse Event|1
7450625|NCT01732510|11739601|FG003|Overall Study|Adverse Event|0
7450626|NCT01732510|11739602|FG004|Overall Study|Adverse Event|0
7450627|NCT01732510|11739603|FG005|Overall Study|Adverse Event|0
7450628|NCT01732510|11739604|FG006|Overall Study|Adverse Event|1
7450629|NCT01732510|11739598|FG000|Overall Study|Protocol Violation|0
7450630|NCT01732510|11739599|FG001|Overall Study|Protocol Violation|0
7450631|NCT01732510|11739600|FG002|Overall Study|Protocol Violation|0
7450632|NCT01732510|11739601|FG003|Overall Study|Protocol Violation|1
7450633|NCT01732510|11739602|FG004|Overall Study|Protocol Violation|0
7450634|NCT01732510|11739603|FG005|Overall Study|Protocol Violation|0
7450635|NCT01732510|11739604|FG006|Overall Study|Protocol Violation|0
7450636|NCT01732510|11739598|FG000|Overall Study|Withdrawal by Subject|1
7450637|NCT01732510|11739599|FG001|Overall Study|Withdrawal by Subject|3
7450638|NCT01732510|11739600|FG002|Overall Study|Withdrawal by Subject|2
7450639|NCT01732510|11739601|FG003|Overall Study|Withdrawal by Subject|1
7450640|NCT01732510|11739602|FG004|Overall Study|Withdrawal by Subject|5
7450641|NCT01732510|11739603|FG005|Overall Study|Withdrawal by Subject|0
7450642|NCT01732510|11739604|FG006|Overall Study|Withdrawal by Subject|1
7450643|NCT01732510|11739598|FG000|Overall Study|Lost to Follow-up|0
7450644|NCT01732510|11739599|FG001|Overall Study|Lost to Follow-up|0
7450645|NCT01732510|11739600|FG002|Overall Study|Lost to Follow-up|1
7450646|NCT01732510|11739601|FG003|Overall Study|Lost to Follow-up|1
7450647|NCT01732510|11739602|FG004|Overall Study|Lost to Follow-up|0
7450648|NCT01732510|11739603|FG005|Overall Study|Lost to Follow-up|1
7450649|NCT01732510|11739604|FG006|Overall Study|Lost to Follow-up|0
7450650|NCT01732510|11739598|FG000|Overall Study|Physician Decision|0
7450651|NCT01732510|11739599|FG001|Overall Study|Physician Decision|1
7450652|NCT01732510|11739600|FG002|Overall Study|Physician Decision|0
7450653|NCT01732510|11739601|FG003|Overall Study|Physician Decision|0
7450654|NCT01732510|11739602|FG004|Overall Study|Physician Decision|0
7450655|NCT01732510|11739603|FG005|Overall Study|Physician Decision|0
7450656|NCT01732510|11739604|FG006|Overall Study|Physician Decision|0
7450657|NCT01732510|11739598|FG000|Overall Study|Pregnancy|0
7450658|NCT01732510|11739599|FG001|Overall Study|Pregnancy|0
7450659|NCT01732510|11739600|FG002|Overall Study|Pregnancy|0
7450660|NCT01732510|11739601|FG003|Overall Study|Pregnancy|1
7450661|NCT01732510|11739602|FG004|Overall Study|Pregnancy|0
7450662|NCT01732510|11739603|FG005|Overall Study|Pregnancy|0
7450663|NCT01732510|11739604|FG006|Overall Study|Pregnancy|0
7450664|NCT01732510|11739598|FG000|Overall Study|Study Terminated By Sponsor|0
7450665|NCT01732510|11739599|FG001|Overall Study|Study Terminated By Sponsor|0
7450666|NCT01732510|11739600|FG002|Overall Study|Study Terminated By Sponsor|0
7450667|NCT01732510|11739601|FG003|Overall Study|Study Terminated By Sponsor|1
7450668|NCT01732510|11739602|FG004|Overall Study|Study Terminated By Sponsor|0
7450669|NCT01732510|11739603|FG005|Overall Study|Study Terminated By Sponsor|12
7450670|NCT01732510|11739604|FG006|Overall Study|Study Terminated By Sponsor|6
7450671|NCT01732536|11739625|FG000|Overall Study|Withdrawal by Subject|1
7450672|NCT01732536|11739626|FG001|Overall Study|Withdrawal by Subject|1
7450673|NCT01732549|11739637|FG000|Overall Study|Adverse Event|13
7450674|NCT01732549|11739638|FG001|Overall Study|Adverse Event|3
7450675|NCT01732549|11739637|FG000|Overall Study|Consent withdrawn|13
7450676|NCT01732549|11739638|FG001|Overall Study|Consent withdrawn|6
7450677|NCT01732549|11739637|FG000|Overall Study|Disease progression|37
7450678|NCT01732549|11739638|FG001|Overall Study|Disease progression|50
7450679|NCT01732549|11739637|FG000|Overall Study|Other|8
7450680|NCT01732549|11739638|FG001|Overall Study|Other|14
7450681|NCT01732588|11739648|FG000|First Intervention (7 Days)|Adverse Event|0
7563698|NCT03263702|11933835|FG000|Overall Study|Lost to Follow-up|2
7563699|NCT03263702|11933836|FG001|Overall Study|Lost to Follow-up|2
7563700|NCT03263702|11933835|FG000|Overall Study|Withdrawal by Subject|1
7450682|NCT01732588|11739649|FG001|First Intervention (7 Days)|Adverse Event|1
7450683|NCT01732588|11739650|FG002|First Intervention (7 Days)|Adverse Event|0
7450684|NCT01732640|11739658|FG000|Overall Study|Adverse Event|0
7450685|NCT01732640|11739659|FG001|Overall Study|Adverse Event|1
7450686|NCT01732640|11739658|FG000|Overall Study|Death|0
7450687|NCT01732640|11739659|FG001|Overall Study|Death|1
7450688|NCT01732692|11739671|FG000|Overall Study|Adverse Event|0
7450689|NCT01732692|11739672|FG001|Overall Study|Adverse Event|1
7450690|NCT01732757|11739694|FG000|Overall Study|Lost to Follow-up|1
7450691|NCT01732757|11739695|FG001|Overall Study|Lost to Follow-up|0
7450692|NCT01732757|11739696|FG002|Overall Study|Lost to Follow-up|0
7450693|NCT01732770|11739706|FG000|Overall Study|Lost to Follow-up|2
7450694|NCT01732770|11739707|FG001|Overall Study|Lost to Follow-up|3
7450695|NCT01732770|11739706|FG000|Overall Study|Withdrawal by Subject|5
7450696|NCT01732770|11739707|FG001|Overall Study|Withdrawal by Subject|3
7450697|NCT01732770|11739706|FG000|Overall Study|Decision by Sponsor|2
7450698|NCT01732770|11739707|FG001|Overall Study|Decision by Sponsor|2
7450699|NCT01732770|11739706|FG000|Overall Study|Death|1
7450700|NCT01732770|11739707|FG001|Overall Study|Death|0
7450701|NCT01732783|11739716|FG000|Overall Study|Discontinued Panitumumab Treatment|106
7450702|NCT01732783|11739717|FG001|Overall Study|Discontinued Panitumumab Treatment|25
7450703|NCT01732783|11739718|FG002|Overall Study|Discontinued Panitumumab Treatment|7
7450704|NCT01732783|11739716|FG000|Overall Study|Death|13
7450705|NCT01732783|11739717|FG001|Overall Study|Death|4
7450706|NCT01732783|11739718|FG002|Overall Study|Death|1
7450707|NCT01732783|11739716|FG000|Overall Study|Lost to Follow-up|7
7450708|NCT01732783|11739717|FG001|Overall Study|Lost to Follow-up|1
7450709|NCT01732783|11739718|FG002|Overall Study|Lost to Follow-up|1
7450710|NCT01732783|11739716|FG000|Overall Study|Administrative Decision|8
7450711|NCT01732783|11739717|FG001|Overall Study|Administrative Decision|2
7450712|NCT01732783|11739718|FG002|Overall Study|Administrative Decision|1
7450713|NCT01732783|11739716|FG000|Overall Study|Withdrawal by Subject|1
7450714|NCT01732783|11739717|FG001|Overall Study|Withdrawal by Subject|0
7450715|NCT01732783|11739718|FG002|Overall Study|Withdrawal by Subject|0
7450716|NCT01732796|11739729|FG000|Overall Study|Adverse Event|16
7450717|NCT01732796|11739730|FG001|Overall Study|Adverse Event|16
7450718|NCT01732796|11739731|FG002|Overall Study|Adverse Event|4
7450719|NCT01732796|11739729|FG000|Overall Study|Lack of Efficacy|21
7450720|NCT01732796|11739730|FG001|Overall Study|Lack of Efficacy|18
7450721|NCT01732796|11739731|FG002|Overall Study|Lack of Efficacy|5
7450722|NCT01732796|11739729|FG000|Overall Study|Lost to Follow-up|2
7450723|NCT01732796|11739730|FG001|Overall Study|Lost to Follow-up|0
7450724|NCT01732796|11739731|FG002|Overall Study|Lost to Follow-up|0
7450725|NCT01732796|11739729|FG000|Overall Study|Withdrawal by Subject|6
7450726|NCT01732796|11739730|FG001|Overall Study|Withdrawal by Subject|8
7450727|NCT01732796|11739731|FG002|Overall Study|Withdrawal by Subject|2
7450728|NCT01732796|11739729|FG000|Overall Study|Other reason not defined above|1
7450729|NCT01732796|11739730|FG001|Overall Study|Other reason not defined above|0
7450730|NCT01732796|11739731|FG002|Overall Study|Other reason not defined above|2
7467957|NCT01904773|11768445|FG006|Screen|Screen failure|0
7467958|NCT01904773|11768446|FG007|Screen|Screen failure|0
7467959|NCT01904773|11768447|FG008|Screen|Screen failure|0
7467960|NCT01904773|11768439|FG000|Screen|Withdrawal by Subject|1
7467961|NCT01904773|11768440|FG001|Screen|Withdrawal by Subject|0
7467962|NCT01904773|11768441|FG002|Screen|Withdrawal by Subject|0
7467963|NCT01904773|11768442|FG003|Screen|Withdrawal by Subject|0
7467964|NCT01904773|11768443|FG004|Screen|Withdrawal by Subject|0
7467965|NCT01904773|11768444|FG005|Screen|Withdrawal by Subject|0
7467966|NCT01904773|11768445|FG006|Screen|Withdrawal by Subject|0
7467967|NCT01904773|11768446|FG007|Screen|Withdrawal by Subject|0
7467968|NCT01904773|11768447|FG008|Screen|Withdrawal by Subject|0
7467969|NCT01904773|11768439|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
7467970|NCT01904773|11768440|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467971|NCT01904773|11768441|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467972|NCT01904773|11768442|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467973|NCT01904773|11768443|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467974|NCT01904773|11768444|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467975|NCT01904773|11768445|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467976|NCT01904773|11768446|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467977|NCT01904773|11768447|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
7467978|NCT01904773|11768439|FG000|First Intervention|Adverse Event|0
7467979|NCT01904773|11768440|FG001|First Intervention|Adverse Event|0
7467980|NCT01904773|11768441|FG002|First Intervention|Adverse Event|0
7467981|NCT01904773|11768442|FG003|First Intervention|Adverse Event|0
7467982|NCT01904773|11768443|FG004|First Intervention|Adverse Event|0
7467983|NCT01904773|11768444|FG005|First Intervention|Adverse Event|0
7467984|NCT01904773|11768445|FG006|First Intervention|Adverse Event|1
7467985|NCT01904773|11768446|FG007|First Intervention|Adverse Event|0
7467986|NCT01904773|11768447|FG008|First Intervention|Adverse Event|0
7467987|NCT01904773|11768439|FG000|Placebo Washout First Intervention|Condition worsened|0
7467988|NCT01904773|11768440|FG001|Placebo Washout First Intervention|Condition worsened|1
7467989|NCT01904773|11768441|FG002|Placebo Washout First Intervention|Condition worsened|0
7467990|NCT01904773|11768442|FG003|Placebo Washout First Intervention|Condition worsened|0
7467991|NCT01904773|11768443|FG004|Placebo Washout First Intervention|Condition worsened|0
7467992|NCT01904773|11768444|FG005|Placebo Washout First Intervention|Condition worsened|0
7450731|NCT04537234|11739743|FG000|Overall Study|Withdrawal by Subject|2
7450732|NCT04537234|11739744|FG001|Overall Study|Withdrawal by Subject|0
7450733|NCT03478956|11739780|FG000|Overall Study|Adverse Event|1
7450734|NCT03478956|11739781|FG001|Overall Study|Adverse Event|0
7450735|NCT03478956|11739780|FG000|Overall Study|Withdrawal by Subject|0
7450736|NCT03478956|11739781|FG001|Overall Study|Withdrawal by Subject|1
7450737|NCT03478956|11739780|FG000|Overall Study|Ongoing in the Study|11
7450738|NCT03478956|11739781|FG001|Overall Study|Ongoing in the Study|11
7450762|NCT02498392|11739858|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7
7450763|NCT02498392|11739859|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0
7450764|NCT02498392|11739858|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3
7450765|NCT02498392|11739859|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0
7450766|NCT02498392|11739858|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0
7450767|NCT02498392|11739859|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2
7450768|NCT02498392|11739858|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0
7450769|NCT02498392|11739859|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2
7450770|NCT02498392|11739858|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2
7450771|NCT02498392|11739859|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3
7450772|NCT02498392|11739858|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1
7450773|NCT02498392|11739859|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3
7450774|NCT01899729|11739884|FG000|Overall Study|Adverse Event|1
7450775|NCT01899729|11739885|FG001|Overall Study|Adverse Event|0
7450776|NCT01899729|11739886|FG002|Overall Study|Adverse Event|0
7450777|NCT01899729|11739887|FG003|Overall Study|Adverse Event|0
7450778|NCT01899729|11739888|FG004|Overall Study|Adverse Event|1
7450779|NCT01899729|11739884|FG000|Overall Study|Withdrawal by Subject|1
7450780|NCT01899729|11739885|FG001|Overall Study|Withdrawal by Subject|2
7450781|NCT01899729|11739886|FG002|Overall Study|Withdrawal by Subject|0
7450782|NCT01899729|11739887|FG003|Overall Study|Withdrawal by Subject|0
7450783|NCT01899729|11739888|FG004|Overall Study|Withdrawal by Subject|0
7450784|NCT01899729|11739884|FG000|Overall Study|Lack of Efficacy|0
7450785|NCT01899729|11739885|FG001|Overall Study|Lack of Efficacy|0
7450786|NCT01899729|11739886|FG002|Overall Study|Lack of Efficacy|2
7450787|NCT01899729|11739887|FG003|Overall Study|Lack of Efficacy|0
7450788|NCT01899729|11739888|FG004|Overall Study|Lack of Efficacy|1
7450789|NCT01648205|11739909|FG000|Placebo|Pregnancy|1
7450790|NCT01648205|11739909|FG000|Placebo|Withdrawal by Subject|1
7450791|NCT01648205|11739909|FG000|Placebo|Protocol Violation|2
7450792|NCT01648205|11739909|FG000|Ranolazine|Death|1
7450793|NCT01648205|11739909|FG000|Ranolazine|Withdrawal by Subject|1
7450794|NCT01648205|11739909|FG000|Ranolazine|Protocol Violation|3
7450795|NCT00915681|11739930|FG000|Overall Study|Screening failures|46
7450796|NCT00145158|11739936|FG000|Overall Study|premature withdrawal|2
7450797|NCT00145158|11739937|FG001|Overall Study|premature withdrawal|3
7450798|NCT01732822|11739955|FG000|Overall Study|Withdrawal by Subject|123
7450799|NCT01732822|11739956|FG001|Overall Study|Withdrawal by Subject|113
7450800|NCT01732835|11739984|FG000|6-month Primary Endpoint|Did not receive device|19
7450801|NCT01732835|11739984|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
7450802|NCT01732835|11739984|FG000|6-month Primary Endpoint|Adverse Event|3
7450803|NCT01732835|11739984|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
7450804|NCT01732835|11739984|FG000|2-year Extended Follow-up|Adverse Event|3
7450805|NCT01732835|11739984|FG000|2-year Extended Follow-up|Death|1
7450806|NCT01732874|11739990|FG000|Overall Study|Withdrawal by Subject|5
7450807|NCT01732874|11739991|FG001|Overall Study|Withdrawal by Subject|1
7450808|NCT01732874|11739990|FG000|Overall Study|Death of Infant|3
7450809|NCT01732874|11739991|FG001|Overall Study|Death of Infant|2
7450810|NCT01733121|11740024|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
7450811|NCT01733121|11740025|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
7450812|NCT01733121|11740024|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
7450813|NCT01733121|11740025|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
7450814|NCT01733121|11740024|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
7450815|NCT01733121|11740025|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
7450816|NCT01733121|11740024|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
7450817|NCT01733121|11740025|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
7450818|NCT01733316|11740064|FG000|RP103 Phase|Non-compliance|1
7450819|NCT01733316|11740064|FG000|Long Term Extension Phase|Adverse Event|1
7450820|NCT01733316|11740064|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
7450821|NCT01733316|11740064|FG000|Long Term Extension Phase|Sponsor Decision|2
7450822|NCT01733329|11740077|FG000|Overall Study|Protocol Violation|1
7450823|NCT01733329|11740078|FG001|Overall Study|Protocol Violation|1
7450824|NCT01733329|11740077|FG000|Overall Study|Uterine artery injury|1
7450825|NCT01733329|11740078|FG001|Overall Study|Uterine artery injury|0
7450826|NCT01733680|11740115|FG000|Overall Study|Withdrawal by Subject|0
7450827|NCT01733680|11740116|FG001|Overall Study|Withdrawal by Subject|1
7450828|NCT01733732|11740128|FG000|Overall Study|Adverse Event|1
7450829|NCT01733732|11740129|FG001|Overall Study|Adverse Event|0
7450830|NCT01733732|11740128|FG000|Overall Study|Did not attend all study visits|1
7450831|NCT01733732|11740129|FG001|Overall Study|Did not attend all study visits|0
7450832|NCT01733758|11740158|FG000|Overall Study|Adverse Event|5
7450739|NCT03348930|11739787|FG000|Washout (1 Week)|Lost to Follow-up|1
7450740|NCT03348930|11739788|FG001|Washout (1 Week)|Lost to Follow-up|1
7450741|NCT03282240|11739797|FG000|Overall Study|Adverse Event|2
7450742|NCT03282240|11739798|FG001|Overall Study|Adverse Event|2
7450743|NCT03282240|11739799|FG002|Overall Study|Adverse Event|0
7450744|NCT03282240|11739797|FG000|Overall Study|Lost to Follow-up|3
7450745|NCT03282240|11739798|FG001|Overall Study|Lost to Follow-up|0
7450746|NCT03282240|11739799|FG002|Overall Study|Lost to Follow-up|0
7450747|NCT03282240|11739797|FG000|Overall Study|Protocol Deviation|4
7450748|NCT03282240|11739798|FG001|Overall Study|Protocol Deviation|1
7450749|NCT03282240|11739799|FG002|Overall Study|Protocol Deviation|2
7450750|NCT03282240|11739797|FG000|Overall Study|Withdrawal by Subject|1
7450751|NCT03282240|11739798|FG001|Overall Study|Withdrawal by Subject|0
7450752|NCT03282240|11739799|FG002|Overall Study|Withdrawal by Subject|1
7450753|NCT03260868|11739812|FG000|Overall Study|Poor Compliance to Protocol|0
7450754|NCT03260868|11739813|FG001|Overall Study|Poor Compliance to Protocol|2
7450755|NCT03260868|11739812|FG000|Overall Study|Study Terminated By Sponsor|2
7450756|NCT03260868|11739813|FG001|Overall Study|Study Terminated By Sponsor|1
7450757|NCT03260868|11739812|FG000|Overall Study|Other than specified above|1
7450758|NCT03260868|11739813|FG001|Overall Study|Other than specified above|0
7450759|NCT03157037|11739828|FG000|Overall Study|Death|1
7450760|NCT03128931|11739852|FG000|Overall Study|Physician Decision|1
7450761|NCT03128931|11739852|FG000|Overall Study|Equipment Issues|3
7450833|NCT01733758|11740159|FG001|Overall Study|Adverse Event|7
7450834|NCT01733758|11740160|FG002|Overall Study|Adverse Event|8
7450835|NCT01733758|11740161|FG003|Overall Study|Adverse Event|1
7450836|NCT01733758|11740158|FG000|Overall Study|Withdrawal by Subject|1
7450837|NCT01733758|11740159|FG001|Overall Study|Withdrawal by Subject|1
7450838|NCT01733758|11740160|FG002|Overall Study|Withdrawal by Subject|5
7450839|NCT01733758|11740161|FG003|Overall Study|Withdrawal by Subject|3
7450840|NCT01733758|11740158|FG000|Overall Study|Persistent Hyperglycemia|3
7450841|NCT01733758|11740159|FG001|Overall Study|Persistent Hyperglycemia|2
7450842|NCT01733758|11740160|FG002|Overall Study|Persistent Hyperglycemia|0
7450843|NCT01733758|11740161|FG003|Overall Study|Persistent Hyperglycemia|0
7450844|NCT01733758|11740158|FG000|Overall Study|Protocol Violation|0
7450845|NCT01733758|11740159|FG001|Overall Study|Protocol Violation|1
7450846|NCT01733758|11740160|FG002|Overall Study|Protocol Violation|2
7563701|NCT03263702|11933836|FG001|Overall Study|Withdrawal by Subject|2
7563702|NCT03263780|11933842|FG000|Overall Study|Withdrawal by Subject|3
7563703|NCT03263780|11933842|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
7563704|NCT03264066|11933852|FG000|Overall Study|Adverse Event|1
7563705|NCT03264066|11933853|FG001|Overall Study|Adverse Event|1
7450847|NCT01733758|11740161|FG003|Overall Study|Protocol Violation|2
7450848|NCT01733758|11740158|FG000|Overall Study|Non-compliance|1
7450849|NCT01733758|11740159|FG001|Overall Study|Non-compliance|0
7450850|NCT01733758|11740160|FG002|Overall Study|Non-compliance|0
7450851|NCT01733758|11740161|FG003|Overall Study|Non-compliance|0
7450852|NCT01733758|11740158|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
7450853|NCT01733758|11740159|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
7450854|NCT01733758|11740160|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
7450855|NCT01733758|11740161|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
7450856|NCT01733758|11740158|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
7450857|NCT01733758|11740159|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
7450858|NCT01733758|11740160|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
7450859|NCT01733758|11740161|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
7450860|NCT01734382|11740207|FG000|Part 1|Adverse Event|2
7450861|NCT01734382|11740208|FG001|Part 1|Adverse Event|0
7450862|NCT01734382|11740209|FG002|Part 1|Adverse Event|0
7450863|NCT01734382|11740207|FG000|Part 2|Adverse Event|0
7450864|NCT01734382|11740208|FG001|Part 2|Adverse Event|0
7450865|NCT01734382|11740209|FG002|Part 2|Adverse Event|1
7450866|NCT01734382|11740207|FG000|Part 2|Lack of Efficacy|0
7450867|NCT01734382|11740208|FG001|Part 2|Lack of Efficacy|1
7450868|NCT01734382|11740209|FG002|Part 2|Lack of Efficacy|1
7450869|NCT01734382|11740207|FG000|Part 2|Other|0
7450870|NCT01734382|11740208|FG001|Part 2|Other|0
7450871|NCT01734382|11740209|FG002|Part 2|Other|1
7450872|NCT01734382|11740207|FG000|Part 2|Physician Decision|0
7450873|NCT01734382|11740208|FG001|Part 2|Physician Decision|0
7450874|NCT01734382|11740209|FG002|Part 2|Physician Decision|3
7450875|NCT01734382|11740207|FG000|Part 2|Protocol Violation|0
7450876|NCT01734382|11740208|FG001|Part 2|Protocol Violation|1
7450877|NCT01734382|11740209|FG002|Part 2|Protocol Violation|0
7450878|NCT01734382|11740207|FG000|Part 2|Withdrawal by Subject|0
7450879|NCT01734382|11740208|FG001|Part 2|Withdrawal by Subject|0
7450880|NCT01734382|11740209|FG002|Part 2|Withdrawal by Subject|1
7450881|NCT01734395|11740221|FG000|Overall Study|Other|65
7450882|NCT01734395|11740221|FG000|Overall Study|Lost to Follow-up|287
7450883|NCT01734395|11740221|FG000|Overall Study|Lack of Efficacy|5
7450884|NCT01734395|11740221|FG000|Overall Study|Adverse Event|40
7450885|NCT01734395|11740221|FG000|Overall Study|Withdrawal by Subject|10
7450886|NCT01734395|11740221|FG000|Overall Study|Missing the reasons for not completed|3
7450887|NCT01734434|11740229|FG000|Overall Study|Death Infant|3
7450888|NCT01734434|11740230|FG001|Overall Study|Death Infant|1
7450889|NCT01734434|11740231|FG002|Overall Study|Death Infant|17
7563706|NCT03264066|11933854|FG002|Overall Study|Adverse Event|0
7450890|NCT01734434|11740232|FG003|Overall Study|Death Infant|5
7450891|NCT01734434|11740229|FG000|Overall Study|Lost to Follow-up|2
7450892|NCT01734434|11740230|FG001|Overall Study|Lost to Follow-up|9
7450893|NCT01734434|11740231|FG002|Overall Study|Lost to Follow-up|67
7450894|NCT01734434|11740232|FG003|Overall Study|Lost to Follow-up|11
7450895|NCT01734434|11740229|FG000|Overall Study|No Live Birth|1
7450896|NCT01734434|11740230|FG001|Overall Study|No Live Birth|2
7450897|NCT01734434|11740231|FG002|Overall Study|No Live Birth|32
7450898|NCT01734434|11740232|FG003|Overall Study|No Live Birth|6
7450899|NCT01734434|11740229|FG000|Overall Study|Withdrawal by Subject|4
7450900|NCT01734434|11740230|FG001|Overall Study|Withdrawal by Subject|0
7450901|NCT01734434|11740231|FG002|Overall Study|Withdrawal by Subject|8
7450902|NCT01734434|11740232|FG003|Overall Study|Withdrawal by Subject|1
7450903|NCT01734434|11740229|FG000|Overall Study|Signed Adult Version of Consent Form|0
7450904|NCT01734434|11740230|FG001|Overall Study|Signed Adult Version of Consent Form|0
7450905|NCT01734434|11740231|FG002|Overall Study|Signed Adult Version of Consent Form|1
7450906|NCT01734434|11740232|FG003|Overall Study|Signed Adult Version of Consent Form|0
7450907|NCT01734434|11740229|FG000|Overall Study|Subject Not Reachable|0
7450908|NCT01734434|11740230|FG001|Overall Study|Subject Not Reachable|0
7450909|NCT01734434|11740231|FG002|Overall Study|Subject Not Reachable|1
7450910|NCT01734434|11740232|FG003|Overall Study|Subject Not Reachable|0
7450911|NCT01734434|11740229|FG000|Overall Study|Treatment Defaulter|0
7450912|NCT01734434|11740230|FG001|Overall Study|Treatment Defaulter|0
7450913|NCT01734434|11740231|FG002|Overall Study|Treatment Defaulter|1
7563707|NCT03264066|11933855|FG003|Overall Study|Adverse Event|0
7563708|NCT03264066|11933856|FG004|Overall Study|Adverse Event|0
7563709|NCT03264066|11933857|FG005|Overall Study|Adverse Event|0
7563710|NCT03264066|11933852|FG000|Overall Study|Death|12
7450914|NCT01734434|11740232|FG003|Overall Study|Treatment Defaulter|0
7450915|NCT01734434|11740229|FG000|Overall Study|Wrong Version of Consent Form Signed|0
7450916|NCT01734434|11740230|FG001|Overall Study|Wrong Version of Consent Form Signed|0
7450917|NCT01734434|11740231|FG002|Overall Study|Wrong Version of Consent Form Signed|1
7450918|NCT01734434|11740232|FG003|Overall Study|Wrong Version of Consent Form Signed|0
7450919|NCT01734434|11740229|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
7450920|NCT01734434|11740230|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
7450921|NCT01734434|11740231|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
7450922|NCT01734434|11740232|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
7450923|NCT01734772|11740277|FG000|Overall Study|Adverse Event|1
7450924|NCT01734772|11740278|FG001|Overall Study|Adverse Event|2
7450925|NCT01734772|11740277|FG000|Overall Study|Withdrawal by Subject|0
7450926|NCT01734772|11740278|FG001|Overall Study|Withdrawal by Subject|1
7450927|NCT01734785|11740293|FG000|Open-Label Period|Adverse Event|0
7450928|NCT01734785|11740294|FG001|Open-Label Period|Adverse Event|0
7450929|NCT01734785|11740295|FG002|Open-Label Period|Adverse Event|0
7450930|NCT01734785|11740296|FG003|Open-Label Period|Adverse Event|9
7450931|NCT01734785|11740293|FG000|Open-Label Period|Lack of Efficacy|0
7450932|NCT01734785|11740294|FG001|Open-Label Period|Lack of Efficacy|0
7450933|NCT01734785|11740295|FG002|Open-Label Period|Lack of Efficacy|0
7450934|NCT01734785|11740296|FG003|Open-Label Period|Lack of Efficacy|1
7450935|NCT01734785|11740293|FG000|Open-Label Period|Protocol Violation|0
7450936|NCT01734785|11740294|FG001|Open-Label Period|Protocol Violation|0
7450937|NCT01734785|11740295|FG002|Open-Label Period|Protocol Violation|0
7450938|NCT01734785|11740296|FG003|Open-Label Period|Protocol Violation|13
7450939|NCT01734785|11740293|FG000|Open-Label Period|Lost to Follow-up|0
7450940|NCT01734785|11740294|FG001|Open-Label Period|Lost to Follow-up|0
7450941|NCT01734785|11740295|FG002|Open-Label Period|Lost to Follow-up|0
7450942|NCT01734785|11740296|FG003|Open-Label Period|Lost to Follow-up|14
7450943|NCT01734785|11740293|FG000|Open-Label Period|Withdrawal by Subject|0
7450944|NCT01734785|11740294|FG001|Open-Label Period|Withdrawal by Subject|0
7450945|NCT01734785|11740295|FG002|Open-Label Period|Withdrawal by Subject|0
7450946|NCT01734785|11740296|FG003|Open-Label Period|Withdrawal by Subject|12
7450947|NCT01734785|11740293|FG000|Open-Label Period|Other Reasons|0
7450948|NCT01734785|11740294|FG001|Open-Label Period|Other Reasons|0
7450949|NCT01734785|11740295|FG002|Open-Label Period|Other Reasons|0
7450950|NCT01734785|11740296|FG003|Open-Label Period|Other Reasons|224
7563711|NCT03264066|11933853|FG001|Overall Study|Death|12
7563712|NCT03264066|11933854|FG002|Overall Study|Death|8
7563713|NCT03264066|11933855|FG003|Overall Study|Death|10
7563714|NCT03264066|11933856|FG004|Overall Study|Death|6
7563715|NCT03264066|11933857|FG005|Overall Study|Death|1
7450951|NCT01734785|11740293|FG000|Double-Blind Period|Adverse Event|0
7450952|NCT01734785|11740294|FG001|Double-Blind Period|Adverse Event|3
7450953|NCT01734785|11740295|FG002|Double-Blind Period|Adverse Event|2
7450954|NCT01734785|11740296|FG003|Double-Blind Period|Adverse Event|0
7450955|NCT01734785|11740293|FG000|Double-Blind Period|Lack of Efficacy|0
7450956|NCT01734785|11740294|FG001|Double-Blind Period|Lack of Efficacy|1
7450957|NCT01734785|11740295|FG002|Double-Blind Period|Lack of Efficacy|0
7450958|NCT01734785|11740296|FG003|Double-Blind Period|Lack of Efficacy|0
7450959|NCT01734785|11740293|FG000|Double-Blind Period|Protocol Violation|0
7450960|NCT01734785|11740294|FG001|Double-Blind Period|Protocol Violation|1
7563716|NCT03264066|11933852|FG000|Overall Study|Lost to Follow-up|1
7563717|NCT03264066|11933853|FG001|Overall Study|Lost to Follow-up|0
7563718|NCT03264066|11933854|FG002|Overall Study|Lost to Follow-up|0
7450961|NCT01734785|11740295|FG002|Double-Blind Period|Protocol Violation|1
7450962|NCT01734785|11740296|FG003|Double-Blind Period|Protocol Violation|0
7450963|NCT01734785|11740293|FG000|Double-Blind Period|Lost to Follow-up|2
7450964|NCT01734785|11740294|FG001|Double-Blind Period|Lost to Follow-up|4
7450965|NCT01734785|11740295|FG002|Double-Blind Period|Lost to Follow-up|2
7450966|NCT01734785|11740296|FG003|Double-Blind Period|Lost to Follow-up|0
7450967|NCT01734785|11740293|FG000|Double-Blind Period|Withdrawal by Subject|2
7450968|NCT01734785|11740294|FG001|Double-Blind Period|Withdrawal by Subject|0
7450969|NCT01734785|11740295|FG002|Double-Blind Period|Withdrawal by Subject|0
7450970|NCT01734785|11740296|FG003|Double-Blind Period|Withdrawal by Subject|0
7450971|NCT01734785|11740293|FG000|Double-Blind Period|Not treated|1
7450972|NCT01734785|11740294|FG001|Double-Blind Period|Not treated|0
7450973|NCT01734785|11740295|FG002|Double-Blind Period|Not treated|0
7450974|NCT01734785|11740296|FG003|Double-Blind Period|Not treated|0
7450975|NCT01734811|11740307|FG000|Overall Study|Lost to Follow-up|2
7450976|NCT01734811|11740308|FG001|Overall Study|Lost to Follow-up|3
7450977|NCT01734811|11740307|FG000|Overall Study|Withdrawal by Subject|2
7450978|NCT01734811|11740308|FG001|Overall Study|Withdrawal by Subject|0
7467993|NCT01904773|11768445|FG006|Placebo Washout First Intervention|Condition worsened|0
7467994|NCT01904773|11768446|FG007|Placebo Washout First Intervention|Condition worsened|0
7467995|NCT01904773|11768447|FG008|Placebo Washout First Intervention|Condition worsened|0
7467996|NCT01904773|11768439|FG000|Fifth Intervention|Adverse Event|0
7467997|NCT01904773|11768440|FG001|Fifth Intervention|Adverse Event|0
7467998|NCT01904773|11768441|FG002|Fifth Intervention|Adverse Event|0
7467999|NCT01904773|11768442|FG003|Fifth Intervention|Adverse Event|0
7468000|NCT01904773|11768443|FG004|Fifth Intervention|Adverse Event|0
7468001|NCT01904773|11768444|FG005|Fifth Intervention|Adverse Event|0
7468002|NCT01904773|11768445|FG006|Fifth Intervention|Adverse Event|0
7468003|NCT01904773|11768446|FG007|Fifth Intervention|Adverse Event|1
7468004|NCT01904773|11768447|FG008|Fifth Intervention|Adverse Event|0
7468005|NCT01904773|11768439|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468006|NCT01904773|11768440|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
7468007|NCT01904773|11768441|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468008|NCT01904773|11768442|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468009|NCT01904773|11768443|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468010|NCT01904773|11768444|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7563719|NCT03264066|11933855|FG003|Overall Study|Lost to Follow-up|0
7563720|NCT03264066|11933856|FG004|Overall Study|Lost to Follow-up|0
7563721|NCT03264066|11933857|FG005|Overall Study|Lost to Follow-up|0
7563722|NCT03264066|11933852|FG000|Overall Study|Progressive Disease|0
7563723|NCT03264066|11933853|FG001|Overall Study|Progressive Disease|2
7563724|NCT03264066|11933854|FG002|Overall Study|Progressive Disease|1
7563725|NCT03264066|11933855|FG003|Overall Study|Progressive Disease|0
7563726|NCT03264066|11933856|FG004|Overall Study|Progressive Disease|0
7563727|NCT03264066|11933857|FG005|Overall Study|Progressive Disease|0
7563728|NCT03264066|11933852|FG000|Overall Study|Study Terminated by Sponsor|5
7563729|NCT03264066|11933853|FG001|Overall Study|Study Terminated by Sponsor|5
7563730|NCT03264066|11933854|FG002|Overall Study|Study Terminated by Sponsor|8
7563731|NCT03264066|11933855|FG003|Overall Study|Study Terminated by Sponsor|5
7563732|NCT03264066|11933856|FG004|Overall Study|Study Terminated by Sponsor|1
7563733|NCT03264066|11933857|FG005|Overall Study|Study Terminated by Sponsor|2
7563734|NCT03264066|11933852|FG000|Overall Study|Withdrawal by Subject|1
7563735|NCT03264066|11933853|FG001|Overall Study|Withdrawal by Subject|0
7563736|NCT03264066|11933854|FG002|Overall Study|Withdrawal by Subject|0
7563737|NCT03264066|11933855|FG003|Overall Study|Withdrawal by Subject|5
7563738|NCT03264066|11933856|FG004|Overall Study|Withdrawal by Subject|0
7563739|NCT03264066|11933857|FG005|Overall Study|Withdrawal by Subject|0
7563740|NCT03264456|11933906|FG000|Overall Study|Withdrawal by Subject|3
7563741|NCT03264456|11933906|FG000|Overall Study|Lost to Follow-up|1
7563742|NCT03265119|11933912|FG000|Overall Study|Adverse Event|2
7563743|NCT03265119|11933913|FG001|Overall Study|Adverse Event|1
7563744|NCT03265119|11933912|FG000|Overall Study|Lack of Efficacy|3
7563745|NCT03265119|11933913|FG001|Overall Study|Lack of Efficacy|0
7563746|NCT03265119|11933912|FG000|Overall Study|Protocol Violation|1
7563747|NCT03265119|11933913|FG001|Overall Study|Protocol Violation|2
7563748|NCT03265119|11933912|FG000|Overall Study|Withdrawal by Subject|2
7563749|NCT03265119|11933913|FG001|Overall Study|Withdrawal by Subject|4
7563750|NCT03265119|11933912|FG000|Overall Study|Lost to Follow-up|1
7563751|NCT03265119|11933913|FG001|Overall Study|Lost to Follow-up|0
7563752|NCT03265119|11933912|FG000|Overall Study|Lack of Compliance|1
7563753|NCT03265119|11933913|FG001|Overall Study|Lack of Compliance|0
7563754|NCT03265132|11933921|FG000|Overall Study|Adverse Event|0
7563755|NCT03265132|11933922|FG001|Overall Study|Adverse Event|1
7563756|NCT03265132|11933921|FG000|Overall Study|Lack of Efficacy|0
7563757|NCT03265132|11933922|FG001|Overall Study|Lack of Efficacy|2
7563758|NCT03265132|11933921|FG000|Overall Study|Progressive disease|0
7563759|NCT03265132|11933922|FG001|Overall Study|Progressive disease|2
7468735|NCT01914393|11769701|FG001|Overall Study|Adverse Event|18
7563760|NCT03265132|11933921|FG000|Overall Study|Withdrawal by Subject|0
7563761|NCT03265132|11933922|FG001|Overall Study|Withdrawal by Subject|1
7563762|NCT03265600|11933932|FG000|Overall Study|Lost to Follow-up|17
7563763|NCT03265600|11933933|FG001|Overall Study|Lost to Follow-up|5
7563764|NCT03265600|11933932|FG000|Overall Study|Withdrawal by Subject|4
7563765|NCT03265600|11933933|FG001|Overall Study|Withdrawal by Subject|2
7450979|NCT01734850|11740317|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
7450980|NCT01734850|11740318|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
7450981|NCT01734850|11740319|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
7450982|NCT01734850|11740317|FG000|Overall Study|Not infused due to manufacturing failure|0
7450983|NCT01734850|11740318|FG001|Overall Study|Not infused due to manufacturing failure|0
7450984|NCT01734850|11740319|FG002|Overall Study|Not infused due to manufacturing failure|1
7450985|NCT01734902|11740337|FG000|Overall Study|Other than listed|0
7450986|NCT01734902|11740338|FG001|Overall Study|Other than listed|2
7450987|NCT01734993|11740344|FG000|Overall Study|Adverse Event|1
7450988|NCT01734993|11740344|FG000|Overall Study|Lack of Efficacy|1
7450989|NCT01735175|11740351|FG000|Overall Study|Withdrawal by Subject|9
7450990|NCT01735175|11740352|FG001|Overall Study|Withdrawal by Subject|2
7450991|NCT01735175|11740351|FG000|Overall Study|Lost to Follow-up|4
7450992|NCT01735175|11740352|FG001|Overall Study|Lost to Follow-up|2
7450993|NCT01735175|11740351|FG000|Overall Study|Death|3
7450994|NCT01735175|11740352|FG001|Overall Study|Death|2
7450995|NCT01735175|11740351|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
7450996|NCT01735175|11740352|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
7450997|NCT01735201|11740366|FG000|Overall Study|Adverse Event|1
7450998|NCT01735201|11740367|FG001|Overall Study|Adverse Event|1
7450999|NCT01735201|11740368|FG002|Overall Study|Adverse Event|0
7451000|NCT01735201|11740369|FG003|Overall Study|Adverse Event|1
7451001|NCT01735201|11740370|FG004|Overall Study|Adverse Event|1
7451002|NCT01735201|11740371|FG005|Overall Study|Adverse Event|3
7451003|NCT01735201|11740372|FG006|Overall Study|Adverse Event|2
7451004|NCT01735201|11740373|FG007|Overall Study|Adverse Event|1
7451005|NCT01735201|11740366|FG000|Overall Study|Personal Reasons|1
7451006|NCT01735201|11740367|FG001|Overall Study|Personal Reasons|0
7451007|NCT01735201|11740368|FG002|Overall Study|Personal Reasons|0
7451008|NCT01735201|11740369|FG003|Overall Study|Personal Reasons|0
7451009|NCT01735201|11740370|FG004|Overall Study|Personal Reasons|0
7451010|NCT01735201|11740371|FG005|Overall Study|Personal Reasons|0
7451011|NCT01735201|11740372|FG006|Overall Study|Personal Reasons|0
7451012|NCT01735201|11740373|FG007|Overall Study|Personal Reasons|0
7451013|NCT01735201|11740366|FG000|Overall Study|Protocol Violation|1
7451014|NCT01735201|11740367|FG001|Overall Study|Protocol Violation|0
7451015|NCT01735201|11740368|FG002|Overall Study|Protocol Violation|0
7451016|NCT01735201|11740369|FG003|Overall Study|Protocol Violation|0
7451017|NCT01735201|11740370|FG004|Overall Study|Protocol Violation|0
7451018|NCT01735201|11740371|FG005|Overall Study|Protocol Violation|0
7451019|NCT01735201|11740372|FG006|Overall Study|Protocol Violation|0
7451020|NCT01735201|11740373|FG007|Overall Study|Protocol Violation|0
7451021|NCT01735201|11740366|FG000|Overall Study|Other Miscellaneous Reasons|0
7451022|NCT01735201|11740367|FG001|Overall Study|Other Miscellaneous Reasons|0
7451023|NCT01735201|11740368|FG002|Overall Study|Other Miscellaneous Reasons|0
7451024|NCT01735201|11740369|FG003|Overall Study|Other Miscellaneous Reasons|1
7451025|NCT01735201|11740370|FG004|Overall Study|Other Miscellaneous Reasons|0
7451026|NCT01735201|11740371|FG005|Overall Study|Other Miscellaneous Reasons|2
7451027|NCT01735201|11740372|FG006|Overall Study|Other Miscellaneous Reasons|1
7451028|NCT01735201|11740373|FG007|Overall Study|Other Miscellaneous Reasons|1
7451029|NCT01735279|11740397|FG000|Overall Study|Lost to Follow-up|11
7451030|NCT01735279|11740398|FG001|Overall Study|Lost to Follow-up|8
7451031|NCT01735396|11740404|FG000|Overall Study|not evaluable|1
7451032|NCT01735630|11740417|FG000|Overall Study|Adverse Event|8
7451033|NCT01735630|11740418|FG001|Overall Study|Adverse Event|7
7451034|NCT01735630|11740417|FG000|Overall Study|Lost to Follow-up|1
7451035|NCT01735630|11740418|FG001|Overall Study|Lost to Follow-up|0
7451036|NCT01735630|11740417|FG000|Overall Study|Physician Decision|0
7451037|NCT01735630|11740418|FG001|Overall Study|Physician Decision|1
7451038|NCT01735630|11740417|FG000|Overall Study|Sponsor Decision|2
7451039|NCT01735630|11740418|FG001|Overall Study|Sponsor Decision|1
7451040|NCT01735630|11740417|FG000|Overall Study|Withdrawal by Subject|7
7451041|NCT01735630|11740418|FG001|Overall Study|Withdrawal by Subject|9
7451042|NCT01735916|11740436|FG000|Overall Study|Subject not eligible to be randomized|11
7451043|NCT01735916|11740437|FG001|Overall Study|Subject not eligible to be randomized|0
7451044|NCT01735916|11740438|FG002|Overall Study|Subject not eligible to be randomized|0
7451045|NCT01735916|11740436|FG000|Overall Study|Early termination of study by sponsor|4
7451046|NCT01735916|11740437|FG001|Overall Study|Early termination of study by sponsor|19
7451047|NCT01735916|11740438|FG002|Overall Study|Early termination of study by sponsor|7
7563766|NCT03265600|11933932|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
7563767|NCT03265600|11933933|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
7451048|NCT01735916|11740436|FG000|Overall Study|Withdrawal by Subject|3
7451049|NCT01735916|11740437|FG001|Overall Study|Withdrawal by Subject|0
7451050|NCT01735916|11740438|FG002|Overall Study|Withdrawal by Subject|0
7451051|NCT01735994|11740458|FG000|Overall Study|Withdrawal by Subject|6
7451052|NCT01735994|11740459|FG001|Overall Study|Withdrawal by Subject|4
7451053|NCT01735994|11740458|FG000|Overall Study|Injury|2
7451054|NCT01735994|11740459|FG001|Overall Study|Injury|0
7451055|NCT01735994|11740458|FG000|Overall Study|Kicked off team|5
7451056|NCT01735994|11740459|FG001|Overall Study|Kicked off team|0
7451057|NCT01735994|11740458|FG000|Overall Study|Lost to Follow-up|50
7451058|NCT01735994|11740459|FG001|Overall Study|Lost to Follow-up|62
7451059|NCT01736124|11740489|FG000|Post-intervention Assessment|Death|2
7451060|NCT01736124|11740490|FG001|Post-intervention Assessment|Death|2
7451061|NCT01736124|11740489|FG000|Post-intervention Assessment|lost computer access|1
7451062|NCT01736124|11740490|FG001|Post-intervention Assessment|lost computer access|1
7451063|NCT01736124|11740489|FG000|Post-intervention Assessment|Moved away|3
7451064|NCT01736124|11740490|FG001|Post-intervention Assessment|Moved away|1
7451065|NCT01736124|11740489|FG000|Post-intervention Assessment|Withdrawal by Subject|11
7451066|NCT01736124|11740490|FG001|Post-intervention Assessment|Withdrawal by Subject|9
7451067|NCT01736124|11740489|FG000|Post-intervention Assessment|Illness|3
7451068|NCT01736124|11740490|FG001|Post-intervention Assessment|Illness|2
7451069|NCT01736124|11740489|FG000|Post-intervention Assessment|Lost to Follow-up|8
7451070|NCT01736124|11740490|FG001|Post-intervention Assessment|Lost to Follow-up|5
7451071|NCT01736124|11740489|FG000|Post-intervention Assessment|Temporarily away|3
7451072|NCT01736124|11740490|FG001|Post-intervention Assessment|Temporarily away|1
7451073|NCT01736124|11740489|FG000|6 Mo. Post-Intervention Assessment|Death|0
7451074|NCT01736124|11740490|FG001|6 Mo. Post-Intervention Assessment|Death|1
7451075|NCT01736124|11740489|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
7451076|NCT01736124|11740490|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
7451077|NCT01736124|11740489|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7451078|NCT01736124|11740490|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
7451079|NCT01736124|11740489|FG000|6 Mo. Post-Intervention Assessment|Illness|1
7451080|NCT01736124|11740490|FG001|6 Mo. Post-Intervention Assessment|Illness|2
7451081|NCT01736124|11740489|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
7563768|NCT03265938|11933939|FG000|Overall Study|Withdrawal by Subject|1
7563769|NCT03265938|11933939|FG000|Overall Study|Physician Decision|1
7563770|NCT03265938|11933939|FG000|Overall Study|friable mass|6
7563771|NCT03266094|11933944|FG000|Overall Study|Lost to Follow-up|1
7563772|NCT03266094|11933944|FG000|Overall Study|Withdrawal by Subject|1
7563773|NCT03266107|11933950|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
7563774|NCT03266107|11933950|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
7563775|NCT03266107|11933950|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
7563776|NCT03266107|11933950|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
7451082|NCT01736124|11740490|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
7451083|NCT01736124|11740489|FG000|12 Mo. Post-Intervention Assessment|Death|1
7451084|NCT01736124|11740490|FG001|12 Mo. Post-Intervention Assessment|Death|0
7451085|NCT01736124|11740489|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
7451086|NCT01736124|11740490|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
7451087|NCT01736124|11740489|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
7451088|NCT01736124|11740490|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
7451089|NCT01736124|11740489|FG000|12 Mo. Post-Intervention Assessment|End of study|10
7451090|NCT01736124|11740490|FG001|12 Mo. Post-Intervention Assessment|End of study|10
7451091|NCT01736176|11740498|FG000|Overall Study|Adverse Event|3
7451092|NCT01736176|11740498|FG000|Overall Study|Withdrawal by Subject|4
7451093|NCT01736176|11740498|FG000|Overall Study|Lack of Efficacy|3
7451094|NCT01736176|11740498|FG000|Overall Study|Unable to Complete PEG Placement|1
7451095|NCT01736189|11740506|FG000|Overall Study|Violation of registration criteria|41
7451096|NCT01736189|11740506|FG000|Overall Study|Protocol Violation|4
7451097|NCT01736189|11740506|FG000|Overall Study|Criteria and protocol violations|1
7451098|NCT01736215|11740510|FG000|Overall Study|Early termination of erythropoietin use|1
7451099|NCT01736215|11740510|FG000|Overall Study|Adverse Event|4
7451100|NCT01736215|11740510|FG000|Overall Study|Progressive disease stop chemotherapy|1
7451101|NCT01736215|11740510|FG000|Overall Study|Insufficient data to perform analysis|8
7451102|NCT01736254|11740544|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
7451103|NCT01736254|11740544|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
7451104|NCT01736397|11740567|FG000|Overall Study|Lack of Efficacy|1
7451105|NCT01736397|11740568|FG001|Overall Study|Lack of Efficacy|11
7451106|NCT01736397|11740567|FG000|Overall Study|Withdrawal by Subject|6
7451107|NCT01736397|11740568|FG001|Overall Study|Withdrawal by Subject|5
7451108|NCT01736397|11740567|FG000|Overall Study|Lost to Follow-up|0
7451109|NCT01736397|11740568|FG001|Overall Study|Lost to Follow-up|1
7451110|NCT01736397|11740567|FG000|Overall Study|Adverse Event|6
7451111|NCT01736397|11740568|FG001|Overall Study|Adverse Event|3
7451112|NCT01736397|11740567|FG000|Overall Study|Not stated|1
7451113|NCT01736397|11740568|FG001|Overall Study|Not stated|4
7451114|NCT01736475|11740576|FG000|Overall Study|Adverse Event|4
7451115|NCT01736475|11740577|FG001|Overall Study|Adverse Event|0
7451116|NCT01736475|11740576|FG000|Overall Study|Withdrawal by Subject|2
7451117|NCT01736475|11740577|FG001|Overall Study|Withdrawal by Subject|0
7451118|NCT01736475|11740576|FG000|Overall Study|Protocol Violation|4
7451119|NCT01736475|11740577|FG001|Overall Study|Protocol Violation|0
7451120|NCT01736475|11740576|FG000|Overall Study|Other - Screen failure|1
7451121|NCT01736475|11740577|FG001|Overall Study|Other - Screen failure|0
7451122|NCT01736475|11740576|FG000|Overall Study|Other - Surgical procedure|1
7451123|NCT01736475|11740577|FG001|Overall Study|Other - Surgical procedure|0
7451124|NCT01736540|11740598|FG000|Overall Study|Did not complete scan within 45 days|2
7563777|NCT03266172|11933959|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
7563778|NCT03266172|11933960|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7563779|NCT03266172|11933961|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
7451125|NCT01736540|11740598|FG000|Overall Study|Death|1
7451126|NCT01736540|11740598|FG000|Overall Study|Abnormal test procedure|1
7451127|NCT01736540|11740598|FG000|Overall Study|Withdrawal by Subject|5
7451128|NCT01736540|11740598|FG000|Overall Study|Protocol Violation|1
7451129|NCT01736540|11740598|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
7451130|NCT01736540|11740598|FG000|Overall Study|No show for MRI appointment|1
7451131|NCT01736540|11740598|FG000|Overall Study|Unable to make MRI appointment|3
7451132|NCT01736553|11740611|FG000|Overall Study|Death|12
7451133|NCT01736553|11740612|FG001|Overall Study|Death|0
7451134|NCT01736553|11740611|FG000|Overall Study|Withdrawal by Subject|5
7451135|NCT01736553|11740612|FG001|Overall Study|Withdrawal by Subject|2
7451136|NCT01736553|11740611|FG000|Overall Study|Lost to Follow-up|2
7451137|NCT01736553|11740612|FG001|Overall Study|Lost to Follow-up|2
7451138|NCT01736566|11740641|FG000|Long Term Follow-up|Still collecting data|42
7451139|NCT01736566|11740642|FG001|Long Term Follow-up|Still collecting data|0
7451140|NCT01736566|11740643|FG002|Long Term Follow-up|Still collecting data|49
7451141|NCT01736566|11740644|FG003|Long Term Follow-up|Still collecting data|0
7451142|NCT01736566|11740645|FG004|Long Term Follow-up|Still collecting data|1
7451143|NCT01736579|11740672|FG000|Overall Study|Termination of Study by Sponsor|2
7451144|NCT01736579|11740673|FG001|Overall Study|Termination of Study by Sponsor|2
7451145|NCT01736657|11740679|FG000|Overall Study|insufficient vascular access|1
7451146|NCT01736683|11740688|FG000|Overall Study|Disease Relapse|0
7451147|NCT01736683|11740689|FG001|Overall Study|Disease Relapse|0
7451148|NCT01736683|11740690|FG002|Overall Study|Disease Relapse|2
7451149|NCT01736683|11740691|FG003|Overall Study|Disease Relapse|1
7451150|NCT01736683|11740692|FG004|Overall Study|Disease Relapse|0
7451151|NCT01736683|11740688|FG000|Overall Study|Adverse Event|0
7451152|NCT01736683|11740689|FG001|Overall Study|Adverse Event|2
7451153|NCT01736683|11740690|FG002|Overall Study|Adverse Event|2
7451154|NCT01736683|11740691|FG003|Overall Study|Adverse Event|3
7451155|NCT01736683|11740692|FG004|Overall Study|Adverse Event|2
7451156|NCT01736683|11740688|FG000|Overall Study|Withdrawal by Subject|0
7451157|NCT01736683|11740689|FG001|Overall Study|Withdrawal by Subject|0
7451158|NCT01736683|11740690|FG002|Overall Study|Withdrawal by Subject|3
7451159|NCT01736683|11740691|FG003|Overall Study|Withdrawal by Subject|1
7451160|NCT01736683|11740692|FG004|Overall Study|Withdrawal by Subject|1
7451161|NCT01736683|11740688|FG000|Overall Study|Lack of Therapeutic Effect|7
7451162|NCT01736683|11740689|FG001|Overall Study|Lack of Therapeutic Effect|4
7451163|NCT01736683|11740690|FG002|Overall Study|Lack of Therapeutic Effect|13
7451164|NCT01736683|11740691|FG003|Overall Study|Lack of Therapeutic Effect|20
7451165|NCT01736683|11740692|FG004|Overall Study|Lack of Therapeutic Effect|1
7451166|NCT01736683|11740688|FG000|Overall Study|Progressive Disease|0
7451167|NCT01736683|11740689|FG001|Overall Study|Progressive Disease|0
7451168|NCT01736683|11740690|FG002|Overall Study|Progressive Disease|0
7451169|NCT01736683|11740691|FG003|Overall Study|Progressive Disease|1
7451170|NCT01736683|11740692|FG004|Overall Study|Progressive Disease|0
7451171|NCT01736683|11740688|FG000|Overall Study|Other|0
7451172|NCT01736683|11740689|FG001|Overall Study|Other|0
7451173|NCT01736683|11740690|FG002|Overall Study|Other|1
7451174|NCT01736683|11740691|FG003|Overall Study|Other|9
7451175|NCT01736683|11740692|FG004|Overall Study|Other|1
7451176|NCT01736696|11740713|FG000|Overall Study|Withdrawal by Subject|0
7451177|NCT01736696|11740714|FG001|Overall Study|Withdrawal by Subject|0
7451178|NCT01736696|11740715|FG002|Overall Study|Withdrawal by Subject|1
7451179|NCT01736696|11740716|FG003|Overall Study|Withdrawal by Subject|0
7451180|NCT01736696|11740717|FG004|Overall Study|Withdrawal by Subject|0
7451181|NCT01736696|11740718|FG005|Overall Study|Withdrawal by Subject|0
7451182|NCT01736696|11740719|FG006|Overall Study|Withdrawal by Subject|0
7451183|NCT01736917|11740761|FG000|Overall Study|Adverse Event|1
7451184|NCT01736917|11740761|FG000|Overall Study|Protocol Violation|10
7451185|NCT01737268|11740777|FG000|Overall Study|Adverse Event|6
7451186|NCT01737268|11740777|FG000|Overall Study|Worsening of Target Disease|2
7451187|NCT01737268|11740777|FG000|Overall Study|In consideration of the patient's safety|1
7451188|NCT01737398|11740793|FG000|Overall Study|Adverse event or SAE|16
7451189|NCT01737398|11740794|FG001|Overall Study|Adverse event or SAE|1
7451190|NCT01737398|11740793|FG000|Overall Study|Stopping rule met|2
7451191|NCT01737398|11740794|FG001|Overall Study|Stopping rule met|1
7451192|NCT01737398|11740793|FG000|Overall Study|Voluntary withdrawal|2
7451193|NCT01737398|11740794|FG001|Overall Study|Voluntary withdrawal|3
7451194|NCT01737398|11740793|FG000|Overall Study|Ineligibility|1
7451195|NCT01737398|11740794|FG001|Overall Study|Ineligibility|0
7451196|NCT01737398|11740793|FG000|Overall Study|Liver transplant|1
7451197|NCT01737398|11740794|FG001|Overall Study|Liver transplant|0
7451198|NCT01737398|11740793|FG000|Overall Study|Disease progression|2
7451199|NCT01737398|11740794|FG001|Overall Study|Disease progression|3
7451200|NCT01737398|11740793|FG000|Overall Study|Sponsor's decision|2
7451201|NCT01737398|11740794|FG001|Overall Study|Sponsor's decision|0
7451202|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
7451203|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
7451204|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
7451205|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
7451206|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
7451207|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
7451208|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
7451209|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
7451210|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
7451211|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
7451212|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
7451213|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
7451214|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
7451215|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
7451216|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
7451217|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7451218|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
7451219|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
7451220|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451221|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451222|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451223|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451224|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451225|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451226|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451227|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451228|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451229|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451230|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7451231|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
7563780|NCT03266172|11933959|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
7563781|NCT03266172|11933960|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
7563782|NCT03266172|11933961|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
7563783|NCT03266172|11933959|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
7563784|NCT03266172|11933960|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7563785|NCT03266172|11933961|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
7563786|NCT03266172|11933959|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
7563787|NCT03266172|11933960|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
7563788|NCT03266172|11933961|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
7563789|NCT03266172|11933959|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7563790|NCT03266172|11933960|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7563791|NCT03266172|11933961|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7563792|NCT03266172|11933959|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7563793|NCT03266172|11933960|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
7563794|NCT03266172|11933961|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
7563795|NCT03266588|11934023|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
7563796|NCT03266588|11934024|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
7563797|NCT03266588|11934025|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
7563798|NCT03266588|11934023|FG000|Observational Period|Withdrawal by Subject|44
7563799|NCT03266588|11934024|FG001|Observational Period|Withdrawal by Subject|22
7563800|NCT03266588|11934025|FG002|Observational Period|Withdrawal by Subject|13
7563801|NCT03266588|11934023|FG000|Observational Period|Non-compliance|18
7563802|NCT03266588|11934024|FG001|Observational Period|Non-compliance|12
7563803|NCT03266588|11934025|FG002|Observational Period|Non-compliance|10
7563804|NCT03266588|11934023|FG000|Observational Period|Lost to Follow-up|8
7563805|NCT03266588|11934024|FG001|Observational Period|Lost to Follow-up|12
7563806|NCT03266588|11934025|FG002|Observational Period|Lost to Follow-up|4
7563807|NCT03266588|11934023|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
7563808|NCT03266588|11934024|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
7563809|NCT03266588|11934025|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
7563810|NCT03266588|11934023|FG000|Observational Period|Protocol Deviation|1
7563811|NCT03266588|11934024|FG001|Observational Period|Protocol Deviation|0
7563812|NCT03266588|11934025|FG002|Observational Period|Protocol Deviation|0
7563813|NCT03266588|11934023|FG000|Observational Period|Other Reasons|3
7563814|NCT03266588|11934024|FG001|Observational Period|Other Reasons|0
7563815|NCT03266588|11934025|FG002|Observational Period|Other Reasons|1
7563816|NCT03266588|11934023|FG000|Long-term Treatment Period|Adverse Event|33
7563817|NCT03266588|11934024|FG001|Long-term Treatment Period|Adverse Event|17
7563818|NCT03266588|11934025|FG002|Long-term Treatment Period|Adverse Event|8
7563819|NCT03266588|11934023|FG000|Long-term Treatment Period|Lack of Efficacy|41
7563820|NCT03266588|11934024|FG001|Long-term Treatment Period|Lack of Efficacy|31
7563821|NCT03266588|11934025|FG002|Long-term Treatment Period|Lack of Efficacy|5
7563822|NCT03266588|11934023|FG000|Long-term Treatment Period|Lost to Follow-up|39
7563823|NCT03266588|11934024|FG001|Long-term Treatment Period|Lost to Follow-up|37
7563824|NCT03266588|11934025|FG002|Long-term Treatment Period|Lost to Follow-up|8
7563825|NCT03266588|11934023|FG000|Long-term Treatment Period|Non-Compliance|126
7563826|NCT03266588|11934024|FG001|Long-term Treatment Period|Non-Compliance|57
7563827|NCT03266588|11934025|FG002|Long-term Treatment Period|Non-Compliance|7
7563828|NCT03266588|11934023|FG000|Long-term Treatment Period|Pregnancy|11
7563829|NCT03266588|11934024|FG001|Long-term Treatment Period|Pregnancy|5
7563830|NCT03266588|11934025|FG002|Long-term Treatment Period|Pregnancy|0
7563831|NCT03266588|11934023|FG000|Long-term Treatment Period|Protocol Deviation|17
7451232|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
7451233|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
7451234|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
7451235|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
7451236|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
7451237|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
7451238|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
7451239|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
7451240|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
7451241|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
7451242|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
7451243|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
7451244|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
7451245|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
7451246|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
7451247|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451248|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
7451249|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451250|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451251|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451252|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451253|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451254|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451255|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451256|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451257|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451258|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451259|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451260|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451261|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
7451262|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451263|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451264|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451265|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451266|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
7451267|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451268|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451269|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451270|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451271|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451272|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451273|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451274|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451275|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451276|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
7451277|NCT01737697|11740834|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451278|NCT01737697|11740835|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7451279|NCT01737697|11740836|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7451280|NCT01737697|11740837|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
7451281|NCT01737697|11740838|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
7451282|NCT01737697|11740839|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451283|NCT01737697|11740840|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451284|NCT01737697|11740841|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451285|NCT01737697|11740842|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451286|NCT01737697|11740843|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451287|NCT01737697|11740844|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451288|NCT01737697|11740845|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451289|NCT01737697|11740846|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451290|NCT01737697|11740847|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451291|NCT01737697|11740848|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
7451292|NCT01737697|11740834|FG000|Subacute Phase|Adverse Event|0
7451293|NCT01737697|11740835|FG001|Subacute Phase|Adverse Event|0
7451294|NCT01737697|11740836|FG002|Subacute Phase|Adverse Event|0
7451295|NCT01737697|11740837|FG003|Subacute Phase|Adverse Event|0
7451296|NCT01737697|11740838|FG004|Subacute Phase|Adverse Event|0
7451297|NCT01737697|11740839|FG005|Subacute Phase|Adverse Event|1
7451298|NCT01737697|11740840|FG006|Subacute Phase|Adverse Event|1
7451299|NCT01737697|11740841|FG007|Subacute Phase|Adverse Event|1
7451300|NCT01737697|11740842|FG008|Subacute Phase|Adverse Event|1
7451301|NCT01737697|11740843|FG009|Subacute Phase|Adverse Event|1
7451302|NCT01737697|11740844|FG010|Subacute Phase|Adverse Event|4
7451303|NCT01737697|11740845|FG011|Subacute Phase|Adverse Event|1
7451304|NCT01737697|11740846|FG012|Subacute Phase|Adverse Event|1
7451305|NCT01737697|11740847|FG013|Subacute Phase|Adverse Event|0
7451306|NCT01737697|11740848|FG014|Subacute Phase|Adverse Event|0
7451307|NCT01737697|11740834|FG000|Subacute Phase|Withdrawal by Subject|0
7451308|NCT01737697|11740835|FG001|Subacute Phase|Withdrawal by Subject|0
7451309|NCT01737697|11740836|FG002|Subacute Phase|Withdrawal by Subject|0
7451310|NCT01737697|11740837|FG003|Subacute Phase|Withdrawal by Subject|0
7451311|NCT01737697|11740838|FG004|Subacute Phase|Withdrawal by Subject|0
7451312|NCT01737697|11740839|FG005|Subacute Phase|Withdrawal by Subject|1
7563832|NCT03266588|11934024|FG001|Long-term Treatment Period|Protocol Deviation|10
7563833|NCT03266588|11934025|FG002|Long-term Treatment Period|Protocol Deviation|4
7563834|NCT03266588|11934023|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
7563835|NCT03266588|11934024|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7563836|NCT03266588|11934025|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
7563837|NCT03266588|11934023|FG000|Long-term Treatment Period|Withdrawal by Subject|100
7563838|NCT03266588|11934024|FG001|Long-term Treatment Period|Withdrawal by Subject|63
7563839|NCT03266588|11934025|FG002|Long-term Treatment Period|Withdrawal by Subject|16
7563840|NCT03266588|11934023|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
7563841|NCT03266588|11934024|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
7563842|NCT03266588|11934025|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
7563843|NCT03266588|11934023|FG000|Long-term Treatment Period|Other Reasons|5
7563844|NCT03266588|11934024|FG001|Long-term Treatment Period|Other Reasons|0
7563845|NCT03266588|11934025|FG002|Long-term Treatment Period|Other Reasons|0
7563846|NCT03266588|11934023|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7451313|NCT01737697|11740840|FG006|Subacute Phase|Withdrawal by Subject|0
7451314|NCT01737697|11740841|FG007|Subacute Phase|Withdrawal by Subject|2
7451315|NCT01737697|11740842|FG008|Subacute Phase|Withdrawal by Subject|0
7451316|NCT01737697|11740843|FG009|Subacute Phase|Withdrawal by Subject|1
7451317|NCT01737697|11740844|FG010|Subacute Phase|Withdrawal by Subject|0
7451318|NCT01737697|11740845|FG011|Subacute Phase|Withdrawal by Subject|1
7451319|NCT01737697|11740846|FG012|Subacute Phase|Withdrawal by Subject|1
7451320|NCT01737697|11740847|FG013|Subacute Phase|Withdrawal by Subject|1
7451321|NCT01737697|11740848|FG014|Subacute Phase|Withdrawal by Subject|0
7451322|NCT01737697|11740834|FG000|Subacute Phase|Lost to Follow-up|0
7451323|NCT01737697|11740835|FG001|Subacute Phase|Lost to Follow-up|0
7451324|NCT01737697|11740836|FG002|Subacute Phase|Lost to Follow-up|0
7451325|NCT01737697|11740837|FG003|Subacute Phase|Lost to Follow-up|0
7451326|NCT01737697|11740838|FG004|Subacute Phase|Lost to Follow-up|0
7451327|NCT01737697|11740839|FG005|Subacute Phase|Lost to Follow-up|0
7451328|NCT01737697|11740840|FG006|Subacute Phase|Lost to Follow-up|0
7451329|NCT01737697|11740841|FG007|Subacute Phase|Lost to Follow-up|0
7451330|NCT01737697|11740842|FG008|Subacute Phase|Lost to Follow-up|0
7451331|NCT01737697|11740843|FG009|Subacute Phase|Lost to Follow-up|0
7451332|NCT01737697|11740844|FG010|Subacute Phase|Lost to Follow-up|0
7451333|NCT01737697|11740845|FG011|Subacute Phase|Lost to Follow-up|0
7451334|NCT01737697|11740846|FG012|Subacute Phase|Lost to Follow-up|0
7451335|NCT01737697|11740847|FG013|Subacute Phase|Lost to Follow-up|0
7451336|NCT01737697|11740848|FG014|Subacute Phase|Lost to Follow-up|1
7451337|NCT01737697|11740834|FG000|Subacute Phase|Hypo-or hyperkalemia|0
7451338|NCT01737697|11740835|FG001|Subacute Phase|Hypo-or hyperkalemia|0
7451339|NCT01737697|11740836|FG002|Subacute Phase|Hypo-or hyperkalemia|0
7451340|NCT01737697|11740837|FG003|Subacute Phase|Hypo-or hyperkalemia|0
7451341|NCT01737697|11740838|FG004|Subacute Phase|Hypo-or hyperkalemia|0
7451342|NCT01737697|11740839|FG005|Subacute Phase|Hypo-or hyperkalemia|0
7451343|NCT01737697|11740840|FG006|Subacute Phase|Hypo-or hyperkalemia|0
7451344|NCT01737697|11740841|FG007|Subacute Phase|Hypo-or hyperkalemia|0
7451345|NCT01737697|11740842|FG008|Subacute Phase|Hypo-or hyperkalemia|0
7451346|NCT01737697|11740843|FG009|Subacute Phase|Hypo-or hyperkalemia|0
7451347|NCT01737697|11740844|FG010|Subacute Phase|Hypo-or hyperkalemia|0
7451348|NCT01737697|11740845|FG011|Subacute Phase|Hypo-or hyperkalemia|1
7451349|NCT01737697|11740846|FG012|Subacute Phase|Hypo-or hyperkalemia|0
7451350|NCT01737697|11740847|FG013|Subacute Phase|Hypo-or hyperkalemia|1
7451351|NCT01737697|11740848|FG014|Subacute Phase|Hypo-or hyperkalemia|0
7451352|NCT01737697|11740834|FG000|Subacute Phase|Protocol Violation|0
7451353|NCT01737697|11740835|FG001|Subacute Phase|Protocol Violation|0
7451354|NCT01737697|11740836|FG002|Subacute Phase|Protocol Violation|0
7451355|NCT01737697|11740837|FG003|Subacute Phase|Protocol Violation|0
7451356|NCT01737697|11740838|FG004|Subacute Phase|Protocol Violation|0
7451357|NCT01737697|11740839|FG005|Subacute Phase|Protocol Violation|1
7451358|NCT01737697|11740840|FG006|Subacute Phase|Protocol Violation|0
7451359|NCT01737697|11740841|FG007|Subacute Phase|Protocol Violation|0
7451360|NCT01737697|11740842|FG008|Subacute Phase|Protocol Violation|0
7451361|NCT01737697|11740843|FG009|Subacute Phase|Protocol Violation|0
7451362|NCT01737697|11740844|FG010|Subacute Phase|Protocol Violation|1
7451363|NCT01737697|11740845|FG011|Subacute Phase|Protocol Violation|0
7451364|NCT01737697|11740846|FG012|Subacute Phase|Protocol Violation|0
7451365|NCT01737697|11740847|FG013|Subacute Phase|Protocol Violation|0
7451366|NCT01737697|11740848|FG014|Subacute Phase|Protocol Violation|0
7451367|NCT01737697|11740834|FG000|Subacute Phase|Physician Decision|0
7451368|NCT01737697|11740835|FG001|Subacute Phase|Physician Decision|0
7451369|NCT01737697|11740836|FG002|Subacute Phase|Physician Decision|0
7451370|NCT01737697|11740837|FG003|Subacute Phase|Physician Decision|0
7451371|NCT01737697|11740838|FG004|Subacute Phase|Physician Decision|0
7451372|NCT01737697|11740839|FG005|Subacute Phase|Physician Decision|0
7451373|NCT01737697|11740840|FG006|Subacute Phase|Physician Decision|0
7451374|NCT01737697|11740841|FG007|Subacute Phase|Physician Decision|0
7451375|NCT01737697|11740842|FG008|Subacute Phase|Physician Decision|1
7451376|NCT01737697|11740843|FG009|Subacute Phase|Physician Decision|0
7451377|NCT01737697|11740844|FG010|Subacute Phase|Physician Decision|0
7451378|NCT01737697|11740845|FG011|Subacute Phase|Physician Decision|0
7451379|NCT01737697|11740846|FG012|Subacute Phase|Physician Decision|0
7451380|NCT01737697|11740847|FG013|Subacute Phase|Physician Decision|0
7451381|NCT01737697|11740848|FG014|Subacute Phase|Physician Decision|0
7451382|NCT01737697|11740834|FG000|Subacute Phase|Death|0
7451383|NCT01737697|11740835|FG001|Subacute Phase|Death|0
7451384|NCT01737697|11740836|FG002|Subacute Phase|Death|0
7451385|NCT01737697|11740837|FG003|Subacute Phase|Death|0
7451386|NCT01737697|11740838|FG004|Subacute Phase|Death|0
7451387|NCT01737697|11740839|FG005|Subacute Phase|Death|0
7451388|NCT01737697|11740840|FG006|Subacute Phase|Death|0
7451389|NCT01737697|11740841|FG007|Subacute Phase|Death|0
7451390|NCT01737697|11740842|FG008|Subacute Phase|Death|0
7451391|NCT01737697|11740843|FG009|Subacute Phase|Death|0
7451392|NCT01737697|11740844|FG010|Subacute Phase|Death|1
7451393|NCT01737697|11740845|FG011|Subacute Phase|Death|0
7451394|NCT01737697|11740846|FG012|Subacute Phase|Death|0
7451395|NCT01737697|11740847|FG013|Subacute Phase|Death|0
7451396|NCT01737697|11740848|FG014|Subacute Phase|Death|0
7451397|NCT01737710|11740886|FG000|Overall Study|Lost to Follow-up|0
7451398|NCT01737710|11740887|FG001|Overall Study|Lost to Follow-up|2
7451399|NCT01737710|11740888|FG002|Overall Study|Lost to Follow-up|2
7451400|NCT01737710|11740889|FG003|Overall Study|Lost to Follow-up|0
7451401|NCT01737710|11740890|FG004|Overall Study|Lost to Follow-up|0
7451402|NCT01737710|11740886|FG000|Overall Study|Withdrawal by Subject|1
7451403|NCT01737710|11740887|FG001|Overall Study|Withdrawal by Subject|1
7451404|NCT01737710|11740888|FG002|Overall Study|Withdrawal by Subject|1
7451405|NCT01737710|11740889|FG003|Overall Study|Withdrawal by Subject|0
7451406|NCT01737710|11740890|FG004|Overall Study|Withdrawal by Subject|0
7451407|NCT01737710|11740886|FG000|Overall Study|Vaccinated in Error/Ineligible|1
7451408|NCT01737710|11740887|FG001|Overall Study|Vaccinated in Error/Ineligible|1
7451409|NCT01737710|11740888|FG002|Overall Study|Vaccinated in Error/Ineligible|0
7451410|NCT01737710|11740889|FG003|Overall Study|Vaccinated in Error/Ineligible|0
7451411|NCT01737710|11740890|FG004|Overall Study|Vaccinated in Error/Ineligible|0
7451412|NCT01737762|11740903|FG000|Overall Study|Adverse Event|2
7451413|NCT01737762|11740904|FG001|Overall Study|Adverse Event|2
7451414|NCT01737762|11740903|FG000|Overall Study|Lost to Follow-up|1
7451415|NCT01737762|11740904|FG001|Overall Study|Lost to Follow-up|0
7451416|NCT01737762|11740903|FG000|Overall Study|Withdrawal by Subject|2
7451417|NCT01737762|11740904|FG001|Overall Study|Withdrawal by Subject|2
7451418|NCT01737762|11740903|FG000|Overall Study|Progressive disease|1
7451419|NCT01737762|11740904|FG001|Overall Study|Progressive disease|2
7451420|NCT01737762|11740903|FG000|Overall Study|Physician Decision|1
7451421|NCT01737762|11740904|FG001|Overall Study|Physician Decision|1
7451422|NCT01737762|11740903|FG000|Overall Study|Moved from area|2
7451423|NCT01737762|11740904|FG001|Overall Study|Moved from area|1
7451424|NCT01737762|11740903|FG000|Overall Study|Trial termination|11
7451425|NCT01737762|11740904|FG001|Overall Study|Trial termination|9
7451426|NCT01737840|11740912|FG000|Overall Study|Diagnosed with an other pathology|2
7451427|NCT01737840|11740913|FG001|Overall Study|Diagnosed with an other pathology|2
7451428|NCT01737879|11740921|FG000|Overall Study|Death|1
7451429|NCT01737879|11740921|FG000|Overall Study|Sponsor decision|40
7451430|NCT01737931|11740928|FG000|Overall Study|Withdrawal by Subject|0
7451431|NCT01737931|11740929|FG001|Overall Study|Withdrawal by Subject|1
7451432|NCT01737931|11740930|FG002|Overall Study|Withdrawal by Subject|1
7451433|NCT01737931|11740928|FG000|Overall Study|Physician Decision|0
7451434|NCT01737931|11740929|FG001|Overall Study|Physician Decision|1
7451435|NCT01737931|11740930|FG002|Overall Study|Physician Decision|0
7451436|NCT01737996|11740955|FG000|Overall Study|Adverse Event|0
7451437|NCT01737996|11740956|FG001|Overall Study|Adverse Event|1
7451438|NCT01737996|11740957|FG002|Overall Study|Adverse Event|1
7451439|NCT01737996|11740955|FG000|Overall Study|Withdrawal by Subject|0
7451440|NCT01737996|11740956|FG001|Overall Study|Withdrawal by Subject|0
7451441|NCT01737996|11740957|FG002|Overall Study|Withdrawal by Subject|1
7451442|NCT01738191|11740967|FG000|Overall Study|Withdrawal by Subject|4
7451443|NCT01738191|11740968|FG001|Overall Study|Withdrawal by Subject|1
7451444|NCT01738438|11740983|FG000|Overall Study|Disease Progression|32
7451445|NCT01738438|11740983|FG000|Overall Study|Adverse Event|3
7451446|NCT01738477|11740989|FG000|Overall Study|Lost to Follow-up|1
7451447|NCT01738477|11740990|FG001|Overall Study|Lost to Follow-up|4
7451448|NCT01738503|11741004|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
7563847|NCT03266588|11934024|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
7451449|NCT01738503|11741005|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
7328899|NCT00798434|11561845|FG001|Double-Blind|Lack of Efficacy|12
7328900|NCT00798434|11561844|FG000|Double-Blind|Withdrawal by Subject|17
7451450|NCT01738503|11741006|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
7451451|NCT01738503|11741007|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
7451452|NCT01738503|11741008|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
7451453|NCT01738503|11741009|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
7451454|NCT01738503|11741010|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
7451455|NCT01738503|11741004|FG000|Treatment Period|Adverse Event|0
7451456|NCT01738503|11741005|FG001|Treatment Period|Adverse Event|1
7451457|NCT01738503|11741006|FG002|Treatment Period|Adverse Event|0
7451458|NCT01738503|11741007|FG003|Treatment Period|Adverse Event|1
7451459|NCT01738503|11741008|FG004|Treatment Period|Adverse Event|2
7451460|NCT01738503|11741009|FG005|Treatment Period|Adverse Event|2
7451461|NCT01738503|11741010|FG006|Treatment Period|Adverse Event|2
7451462|NCT01738503|11741004|FG000|Treatment Period|Lost to Follow-up|0
7451463|NCT01738503|11741005|FG001|Treatment Period|Lost to Follow-up|0
7451464|NCT01738503|11741006|FG002|Treatment Period|Lost to Follow-up|3
7451465|NCT01738503|11741007|FG003|Treatment Period|Lost to Follow-up|4
7451466|NCT01738503|11741008|FG004|Treatment Period|Lost to Follow-up|1
7451467|NCT01738503|11741009|FG005|Treatment Period|Lost to Follow-up|1
7451468|NCT01738503|11741010|FG006|Treatment Period|Lost to Follow-up|5
7451469|NCT01738503|11741004|FG000|Treatment Period|Withdrawal by Subject|0
7451470|NCT01738503|11741005|FG001|Treatment Period|Withdrawal by Subject|1
7451471|NCT01738503|11741006|FG002|Treatment Period|Withdrawal by Subject|0
7451472|NCT01738503|11741007|FG003|Treatment Period|Withdrawal by Subject|1
7451473|NCT01738503|11741008|FG004|Treatment Period|Withdrawal by Subject|1
7451474|NCT01738503|11741009|FG005|Treatment Period|Withdrawal by Subject|1
7451475|NCT01738503|11741010|FG006|Treatment Period|Withdrawal by Subject|1
7451476|NCT01738503|11741004|FG000|Treatment Period|Protocol Violation|0
7451477|NCT01738503|11741005|FG001|Treatment Period|Protocol Violation|3
7451478|NCT01738503|11741006|FG002|Treatment Period|Protocol Violation|1
7451479|NCT01738503|11741007|FG003|Treatment Period|Protocol Violation|0
7451480|NCT01738503|11741008|FG004|Treatment Period|Protocol Violation|4
7451481|NCT01738503|11741009|FG005|Treatment Period|Protocol Violation|2
7451482|NCT01738503|11741010|FG006|Treatment Period|Protocol Violation|0
7451483|NCT01738503|11741004|FG000|Treatment Period|Other|0
7451484|NCT01738503|11741005|FG001|Treatment Period|Other|0
7451485|NCT01738503|11741006|FG002|Treatment Period|Other|1
7451486|NCT01738503|11741007|FG003|Treatment Period|Other|0
7451487|NCT01738503|11741008|FG004|Treatment Period|Other|0
7451488|NCT01738503|11741009|FG005|Treatment Period|Other|0
7451489|NCT01738503|11741010|FG006|Treatment Period|Other|0
7451490|NCT01738503|11741004|FG000|PET Imaging Sub-study|Adverse Event|0
7451491|NCT01738503|11741005|FG001|PET Imaging Sub-study|Adverse Event|0
7451492|NCT01738503|11741006|FG002|PET Imaging Sub-study|Adverse Event|0
7451493|NCT01738503|11741007|FG003|PET Imaging Sub-study|Adverse Event|0
7451494|NCT01738503|11741008|FG004|PET Imaging Sub-study|Adverse Event|0
7451495|NCT01738503|11741009|FG005|PET Imaging Sub-study|Adverse Event|1
7451496|NCT01738503|11741010|FG006|PET Imaging Sub-study|Adverse Event|0
7451497|NCT01738503|11741004|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7451498|NCT01738503|11741005|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7451499|NCT01738503|11741006|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7451500|NCT01738503|11741007|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7451501|NCT01738503|11741008|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
7451502|NCT01738503|11741009|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7451503|NCT01738503|11741010|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
7451504|NCT01738581|11741034|FG000|Overall Study|Lost to Follow-up|1
7451505|NCT01738581|11741035|FG001|Overall Study|Lost to Follow-up|0
7451506|NCT01738594|11741044|FG000|Registration and Treatment Start|Adverse Event|0
7451507|NCT01738594|11741045|FG001|Registration and Treatment Start|Adverse Event|1
7451508|NCT01738594|11741046|FG002|Registration and Treatment Start|Adverse Event|0
7451509|NCT01738594|11741047|FG003|Registration and Treatment Start|Adverse Event|0
7451510|NCT01738594|11741048|FG004|Registration and Treatment Start|Adverse Event|0
7451511|NCT01738594|11741049|FG005|Registration and Treatment Start|Adverse Event|0
7451512|NCT01738594|11741050|FG006|Registration and Treatment Start|Adverse Event|0
7451513|NCT01738594|11741051|FG007|Registration and Treatment Start|Adverse Event|0
7451514|NCT01738594|11741044|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451515|NCT01738594|11741045|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451516|NCT01738594|11741046|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451584|NCT01738984|11741128|FG000|Overall Study|Withdrawal by Subject|1
7451517|NCT01738594|11741047|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451518|NCT01738594|11741048|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451519|NCT01738594|11741049|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
7451520|NCT01738594|11741050|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451521|NCT01738594|11741051|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
7451522|NCT01738594|11741044|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
7451523|NCT01738594|11741045|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
7451524|NCT01738594|11741046|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
7532978|NCT02679079|11878949|FG001|Overall Study|Protocol Violation|1
7451525|NCT01738594|11741047|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
7451526|NCT01738594|11741048|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
7451527|NCT01738594|11741049|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
7451528|NCT01738594|11741050|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
7451529|NCT01738594|11741051|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
7451530|NCT01738594|11741044|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
7468736|NCT01914393|11769702|FG002|Overall Study|Adverse Event|31
7532979|NCT02679079|11878950|FG002|Overall Study|Protocol Violation|0
7451531|NCT01738594|11741045|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451532|NCT01738594|11741046|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451533|NCT01738594|11741047|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451534|NCT01738594|11741048|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451535|NCT01738594|11741049|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
7451536|NCT01738594|11741050|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451537|NCT01738594|11741051|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
7451538|NCT01738594|11741044|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451539|NCT01738594|11741045|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451540|NCT01738594|11741046|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451541|NCT01738594|11741047|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451542|NCT01738594|11741048|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451543|NCT01738594|11741049|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
7451544|NCT01738594|11741050|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451545|NCT01738594|11741051|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
7451546|NCT01738594|11741044|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451547|NCT01738594|11741045|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451548|NCT01738594|11741046|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451549|NCT01738594|11741047|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451550|NCT01738594|11741048|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
7451551|NCT01738594|11741049|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451552|NCT01738594|11741050|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451553|NCT01738594|11741051|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
7451554|NCT01738594|11741044|FG000|Follow up for 1 Year|Death|0
7451555|NCT01738594|11741045|FG001|Follow up for 1 Year|Death|0
7451556|NCT01738594|11741046|FG002|Follow up for 1 Year|Death|0
7563848|NCT03266588|11934025|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
7563849|NCT03267212|11934033|FG000|First Intervention|Lost to Follow-up|0
7563850|NCT03267212|11934034|FG001|First Intervention|Lost to Follow-up|2
7563851|NCT03267212|11934033|FG000|First Intervention|Withdrawal by Subject|1
7563852|NCT03267212|11934034|FG001|First Intervention|Withdrawal by Subject|1
7563853|NCT03267212|11934033|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
7451557|NCT01738594|11741047|FG003|Follow up for 1 Year|Death|0
7451558|NCT01738594|11741048|FG004|Follow up for 1 Year|Death|0
7451559|NCT01738594|11741049|FG005|Follow up for 1 Year|Death|1
7451560|NCT01738594|11741050|FG006|Follow up for 1 Year|Death|0
7451561|NCT01738594|11741051|FG007|Follow up for 1 Year|Death|0
7451562|NCT01738594|11741044|FG000|Follow up for 1 Year|Other|0
7451563|NCT01738594|11741045|FG001|Follow up for 1 Year|Other|0
7451564|NCT01738594|11741046|FG002|Follow up for 1 Year|Other|0
7451565|NCT01738594|11741047|FG003|Follow up for 1 Year|Other|0
7451566|NCT01738594|11741048|FG004|Follow up for 1 Year|Other|0
7451567|NCT01738594|11741049|FG005|Follow up for 1 Year|Other|2
7451568|NCT01738594|11741050|FG006|Follow up for 1 Year|Other|0
7451569|NCT01738594|11741051|FG007|Follow up for 1 Year|Other|0
7451570|NCT01738646|11741061|FG000|Overall Study|Still Receiving Treatment|2
7451571|NCT01738919|11741104|FG000|Overall Study|Lost to Follow-up|1
7451572|NCT01738919|11741105|FG001|Overall Study|Lost to Follow-up|0
7451573|NCT01738919|11741104|FG000|Overall Study|Immigrated|0
7451574|NCT01738919|11741105|FG001|Overall Study|Immigrated|1
7451575|NCT01738919|11741104|FG000|Overall Study|Withdrawal by Subject|0
7451576|NCT01738919|11741105|FG001|Overall Study|Withdrawal by Subject|1
7451577|NCT01738919|11741104|FG000|Overall Study|Not treated in accordance to guidelines|0
7451578|NCT01738919|11741105|FG001|Overall Study|Not treated in accordance to guidelines|1
7451579|NCT01738971|11741116|FG000|Overall Study|Lost to Follow-up|19
7451580|NCT01738971|11741117|FG001|Overall Study|Lost to Follow-up|30
7451581|NCT01738971|11741118|FG002|Overall Study|Lost to Follow-up|17
7451582|NCT01738984|11741128|FG000|Overall Study|Pregnancy|4
7451583|NCT01738984|11741129|FG001|Overall Study|Pregnancy|0
7451585|NCT01738984|11741129|FG001|Overall Study|Withdrawal by Subject|0
7451586|NCT01738984|11741128|FG000|Overall Study|Lost to Follow-up|59
7451587|NCT01738984|11741129|FG001|Overall Study|Lost to Follow-up|39
7451588|NCT01739309|11741162|FG000|Overall Study|On study treatment|3
7451589|NCT01739335|11741170|FG000|Overall Study|Lost to Follow-up|7
7451590|NCT01739335|11741171|FG001|Overall Study|Lost to Follow-up|4
7451591|NCT01739335|11741170|FG000|Overall Study|Ineligible patient randomized|0
7451592|NCT01739335|11741171|FG001|Overall Study|Ineligible patient randomized|1
7563854|NCT03267212|11934034|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
7451593|NCT01739348|11741185|FG000|Part I (Base Study)|Adverse Event|41
7451594|NCT01739348|11741186|FG001|Part I (Base Study)|Adverse Event|52
7451595|NCT01739348|11741187|FG002|Part I (Base Study)|Adverse Event|8
7451596|NCT01739348|11741188|FG003|Part I (Base Study)|Adverse Event|33
7451597|NCT01739348|11741185|FG000|Part I (Base Study)|Death|10
7451598|NCT01739348|11741186|FG001|Part I (Base Study)|Death|7
7451599|NCT01739348|11741187|FG002|Part I (Base Study)|Death|2
7451600|NCT01739348|11741188|FG003|Part I (Base Study)|Death|8
7451601|NCT01739348|11741185|FG000|Part I (Base Study)|Lack of Efficacy|3
7451602|NCT01739348|11741186|FG001|Part I (Base Study)|Lack of Efficacy|8
7451603|NCT01739348|11741187|FG002|Part I (Base Study)|Lack of Efficacy|0
7451604|NCT01739348|11741188|FG003|Part I (Base Study)|Lack of Efficacy|7
7451605|NCT01739348|11741185|FG000|Part I (Base Study)|Lost to Follow-up|4
7451606|NCT01739348|11741186|FG001|Part I (Base Study)|Lost to Follow-up|2
7451607|NCT01739348|11741187|FG002|Part I (Base Study)|Lost to Follow-up|4
7451608|NCT01739348|11741188|FG003|Part I (Base Study)|Lost to Follow-up|4
7451609|NCT01739348|11741185|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
7451610|NCT01739348|11741186|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
7451611|NCT01739348|11741187|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
7451612|NCT01739348|11741188|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
7451613|NCT01739348|11741185|FG000|Part I (Base Study)|Physician Decision|10
7451614|NCT01739348|11741186|FG001|Part I (Base Study)|Physician Decision|7
7451615|NCT01739348|11741187|FG002|Part I (Base Study)|Physician Decision|1
7451616|NCT01739348|11741188|FG003|Part I (Base Study)|Physician Decision|4
7451617|NCT01739348|11741185|FG000|Part I (Base Study)|Protocol Violation|2
7451618|NCT01739348|11741186|FG001|Part I (Base Study)|Protocol Violation|0
7451619|NCT01739348|11741187|FG002|Part I (Base Study)|Protocol Violation|1
7451620|NCT01739348|11741188|FG003|Part I (Base Study)|Protocol Violation|2
7451621|NCT01739348|11741185|FG000|Part I (Base Study)|Screen Failure|2
7451622|NCT01739348|11741186|FG001|Part I (Base Study)|Screen Failure|0
7451623|NCT01739348|11741187|FG002|Part I (Base Study)|Screen Failure|0
7451624|NCT01739348|11741188|FG003|Part I (Base Study)|Screen Failure|0
7451625|NCT01739348|11741185|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
7451626|NCT01739348|11741186|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
7451627|NCT01739348|11741187|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
7451628|NCT01739348|11741188|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
7451629|NCT01739348|11741185|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
7451630|NCT01739348|11741186|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
7451631|NCT01739348|11741187|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
7451632|NCT01739348|11741188|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
7451633|NCT01739348|11741185|FG000|Part I (Base Study)|Participant Moved|4
7451634|NCT01739348|11741186|FG001|Part I (Base Study)|Participant Moved|3
7451635|NCT01739348|11741187|FG002|Part I (Base Study)|Participant Moved|1
7451636|NCT01739348|11741188|FG003|Part I (Base Study)|Participant Moved|7
7451637|NCT01739348|11741185|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
7451638|NCT01739348|11741186|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
7451639|NCT01739348|11741187|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
7451640|NCT01739348|11741188|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
7451641|NCT01739348|11741185|FG000|Part I (Base Study)|Withdrawal by Subject|23
7451642|NCT01739348|11741186|FG001|Part I (Base Study)|Withdrawal by Subject|21
7451643|NCT01739348|11741187|FG002|Part I (Base Study)|Withdrawal by Subject|7
7451644|NCT01739348|11741188|FG003|Part I (Base Study)|Withdrawal by Subject|20
7451645|NCT01739348|11741185|FG000|Part II (Extension Study)|Adverse Event|10
7451646|NCT01739348|11741186|FG001|Part II (Extension Study)|Adverse Event|11
7451647|NCT01739348|11741187|FG002|Part II (Extension Study)|Adverse Event|7
7451648|NCT01739348|11741188|FG003|Part II (Extension Study)|Adverse Event|26
7451649|NCT01739348|11741185|FG000|Part II (Extension Study)|Death|3
7451650|NCT01739348|11741186|FG001|Part II (Extension Study)|Death|3
7451651|NCT01739348|11741187|FG002|Part II (Extension Study)|Death|2
7451652|NCT01739348|11741188|FG003|Part II (Extension Study)|Death|6
7451653|NCT01739348|11741185|FG000|Part II (Extension Study)|Lack of Efficacy|1
7451654|NCT01739348|11741186|FG001|Part II (Extension Study)|Lack of Efficacy|5
7451655|NCT01739348|11741187|FG002|Part II (Extension Study)|Lack of Efficacy|0
7451656|NCT01739348|11741188|FG003|Part II (Extension Study)|Lack of Efficacy|1
7451657|NCT01739348|11741185|FG000|Part II (Extension Study)|Lost to Follow-up|3
7451658|NCT01739348|11741186|FG001|Part II (Extension Study)|Lost to Follow-up|4
7451659|NCT01739348|11741187|FG002|Part II (Extension Study)|Lost to Follow-up|0
7451660|NCT01739348|11741188|FG003|Part II (Extension Study)|Lost to Follow-up|1
7451661|NCT01739348|11741185|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
7451662|NCT01739348|11741186|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
7451663|NCT01739348|11741187|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
7451664|NCT01739348|11741188|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
7451665|NCT01739348|11741185|FG000|Part II (Extension Study)|Physician Decision|7
7451666|NCT01739348|11741186|FG001|Part II (Extension Study)|Physician Decision|11
7451667|NCT01739348|11741187|FG002|Part II (Extension Study)|Physician Decision|6
7451668|NCT01739348|11741188|FG003|Part II (Extension Study)|Physician Decision|12
7451669|NCT01739348|11741185|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
7451670|NCT01739348|11741186|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
7451671|NCT01739348|11741187|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
7451672|NCT01739348|11741188|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
7451673|NCT01739348|11741185|FG000|Part II (Extension Study)|Participant Moved|3
7451674|NCT01739348|11741186|FG001|Part II (Extension Study)|Participant Moved|3
7451675|NCT01739348|11741187|FG002|Part II (Extension Study)|Participant Moved|0
7451676|NCT01739348|11741188|FG003|Part II (Extension Study)|Participant Moved|3
7451677|NCT01739348|11741185|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
7468737|NCT01914393|11769700|FG000|Overall Study|Withdrawal by Subject|38
7451678|NCT01739348|11741186|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
7451679|NCT01739348|11741187|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
7451680|NCT01739348|11741188|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
7451681|NCT01739348|11741185|FG000|Part II (Extension Study)|Withdrawal by Subject|5
7451682|NCT01739348|11741186|FG001|Part II (Extension Study)|Withdrawal by Subject|2
7451683|NCT01739348|11741187|FG002|Part II (Extension Study)|Withdrawal by Subject|4
7451684|NCT01739348|11741188|FG003|Part II (Extension Study)|Withdrawal by Subject|7
7451685|NCT01739400|11741213|FG000|Overall Study|Physician Decision|3
7451686|NCT01739400|11741214|FG001|Overall Study|Physician Decision|0
7451687|NCT01739400|11741213|FG000|Overall Study|Lost to Follow-up|2
7451688|NCT01739400|11741214|FG001|Overall Study|Lost to Follow-up|0
7451689|NCT01739400|11741213|FG000|Overall Study|Death|5
7451690|NCT01739400|11741214|FG001|Overall Study|Death|2
7451691|NCT01739400|11741213|FG000|Overall Study|Withdrawal by Subject|7
7451692|NCT01739400|11741214|FG001|Overall Study|Withdrawal by Subject|7
7451693|NCT01739595|11741222|FG000|Overall Study|Adverse Event|3
7451694|NCT01739595|11741223|FG001|Overall Study|Adverse Event|0
7451695|NCT01739595|11741224|FG002|Overall Study|Adverse Event|0
7451696|NCT01739595|11741222|FG000|Overall Study|Lost to Follow-up|2
7451697|NCT01739595|11741223|FG001|Overall Study|Lost to Follow-up|0
7451698|NCT01739595|11741224|FG002|Overall Study|Lost to Follow-up|0
7451699|NCT01739595|11741222|FG000|Overall Study|Withdrawal by Subject|2
7451700|NCT01739595|11741223|FG001|Overall Study|Withdrawal by Subject|1
7451701|NCT01739595|11741224|FG002|Overall Study|Withdrawal by Subject|2
7451702|NCT01739595|11741222|FG000|Overall Study|Eligibility issue|3
7451703|NCT01739595|11741223|FG001|Overall Study|Eligibility issue|0
7451704|NCT01739595|11741224|FG002|Overall Study|Eligibility issue|0
7451705|NCT01739595|11741222|FG000|Overall Study|Protocol Violation|1
7451706|NCT01739595|11741223|FG001|Overall Study|Protocol Violation|0
7451707|NCT01739595|11741224|FG002|Overall Study|Protocol Violation|0
7451708|NCT01739595|11741222|FG000|Overall Study|Lab assessment|1
7451709|NCT01739595|11741223|FG001|Overall Study|Lab assessment|0
7451710|NCT01739595|11741224|FG002|Overall Study|Lab assessment|0
7451711|NCT01739595|11741222|FG000|Overall Study|Drug discrepancy|1
7451712|NCT01739595|11741223|FG001|Overall Study|Drug discrepancy|0
7451713|NCT01739595|11741224|FG002|Overall Study|Drug discrepancy|0
7451714|NCT01739764|11741243|FG000|Overall Study|Adverse Event|0
7451715|NCT01739764|11741244|FG001|Overall Study|Adverse Event|3
7451716|NCT01739764|11741245|FG002|Overall Study|Adverse Event|4
7451717|NCT01739764|11741243|FG000|Overall Study|Death|4
7451718|NCT01739764|11741244|FG001|Overall Study|Death|6
7451719|NCT01739764|11741245|FG002|Overall Study|Death|38
7451720|NCT01739764|11741243|FG000|Overall Study|Lost to Follow-up|0
7451721|NCT01739764|11741244|FG001|Overall Study|Lost to Follow-up|0
7451722|NCT01739764|11741245|FG002|Overall Study|Lost to Follow-up|5
7451723|NCT01739764|11741243|FG000|Overall Study|Non-Compliance|0
7451724|NCT01739764|11741244|FG001|Overall Study|Non-Compliance|0
7451725|NCT01739764|11741245|FG002|Overall Study|Non-Compliance|1
7451726|NCT01739764|11741243|FG000|Overall Study|Multiple Reasons|3
7451727|NCT01739764|11741244|FG001|Overall Study|Multiple Reasons|2
7451728|NCT01739764|11741245|FG002|Overall Study|Multiple Reasons|3
7451729|NCT01739764|11741243|FG000|Overall Study|Physician Decision|2
7451730|NCT01739764|11741244|FG001|Overall Study|Physician Decision|2
7451731|NCT01739764|11741245|FG002|Overall Study|Physician Decision|4
7451732|NCT01739764|11741243|FG000|Overall Study|Progressive Disease|3
7451733|NCT01739764|11741244|FG001|Overall Study|Progressive Disease|5
7451734|NCT01739764|11741245|FG002|Overall Study|Progressive Disease|16
7451735|NCT01739764|11741243|FG000|Overall Study|Protocol Violation|0
7451736|NCT01739764|11741244|FG001|Overall Study|Protocol Violation|0
7451737|NCT01739764|11741245|FG002|Overall Study|Protocol Violation|2
7451738|NCT01739764|11741243|FG000|Overall Study|Study Terminated by Sponsor|8
7451739|NCT01739764|11741244|FG001|Overall Study|Study Terminated by Sponsor|13
7451740|NCT01739764|11741245|FG002|Overall Study|Study Terminated by Sponsor|26
7451741|NCT01739764|11741243|FG000|Overall Study|Withdrawal by Subject|6
7451742|NCT01739764|11741244|FG001|Overall Study|Withdrawal by Subject|5
7451743|NCT01739764|11741245|FG002|Overall Study|Withdrawal by Subject|27
7451744|NCT01739790|11741255|FG000|Overall Study|Early Trial Termination|2
7451745|NCT01739790|11741256|FG001|Overall Study|Early Trial Termination|4
7451746|NCT01739803|11741264|FG000|Overall Study|Lost to Follow-up|9
7451747|NCT01739803|11741265|FG001|Overall Study|Lost to Follow-up|6
7451748|NCT01739933|11741273|FG000|Overall Study|Death|89
7451749|NCT01739933|11741274|FG001|Overall Study|Death|86
7451750|NCT01739933|11741273|FG000|Overall Study|Withdrawal by Subject|10
7451751|NCT01739933|11741274|FG001|Overall Study|Withdrawal by Subject|8
7451752|NCT01739933|11741273|FG000|Overall Study|Lost to Follow-up|3
7451753|NCT01739933|11741274|FG001|Overall Study|Lost to Follow-up|10
7451754|NCT01739933|11741273|FG000|Overall Study|Did not speak English required for neurospychological testing|4
7451755|NCT01739933|11741274|FG001|Overall Study|Did not speak English required for neurospychological testing|3
7451756|NCT01740089|11741283|FG000|First 12 Weeks of Treatment|Adverse Event|0
7451757|NCT01740089|11741284|FG001|First 12 Weeks of Treatment|Adverse Event|1
7451758|NCT01740089|11741285|FG002|First 12 Weeks of Treatment|Adverse Event|2
7451759|NCT01740089|11741283|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
7451760|NCT01740089|11741284|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
7451761|NCT01740089|11741285|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
7563855|NCT03267264|11934044|FG000|Overall Study|Withdrawal by Subject|1
7563856|NCT03267264|11934045|FG001|Overall Study|Withdrawal by Subject|0
7563857|NCT03267264|11934046|FG002|Overall Study|Withdrawal by Subject|2
7563858|NCT03267264|11934047|FG003|Overall Study|Withdrawal by Subject|4
7563859|NCT03267511|11934064|FG000|Overall Study|Lost to Follow-up|0
7563860|NCT03267511|11934065|FG001|Overall Study|Lost to Follow-up|0
7563861|NCT03267511|11934066|FG002|Overall Study|Lost to Follow-up|0
7563862|NCT03267511|11934067|FG003|Overall Study|Lost to Follow-up|1
7563863|NCT03267576|11934081|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
7563864|NCT03267576|11934082|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
7563865|NCT03267576|11934081|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
7563866|NCT03267576|11934082|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
7563867|NCT03267940|11934094|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
7563868|NCT03267940|11934095|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
7563869|NCT03267940|11934096|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7563870|NCT03267940|11934097|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7563871|NCT03267940|11934098|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7563872|NCT03267940|11934099|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
7563873|NCT03267940|11934094|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7563874|NCT03267940|11934095|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
7563875|NCT03267940|11934096|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7563876|NCT03267940|11934097|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7563877|NCT03267940|11934098|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7563878|NCT03267940|11934099|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
7563879|NCT03267940|11934094|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7563880|NCT03267940|11934095|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
7563881|NCT03267940|11934096|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7451762|NCT01740089|11741283|FG000|After 12 Weeks|Lack of Efficacy|3
7451763|NCT01740089|11741284|FG001|After 12 Weeks|Lack of Efficacy|1
7451764|NCT01740089|11741285|FG002|After 12 Weeks|Lack of Efficacy|4
7451765|NCT01740089|11741283|FG000|After 12 Weeks|Adverse Event|2
7451766|NCT01740089|11741284|FG001|After 12 Weeks|Adverse Event|0
7451767|NCT01740089|11741285|FG002|After 12 Weeks|Adverse Event|5
7451768|NCT01740089|11741283|FG000|After 12 Weeks|Protocol Violation|1
7451769|NCT01740089|11741284|FG001|After 12 Weeks|Protocol Violation|1
7451770|NCT01740089|11741285|FG002|After 12 Weeks|Protocol Violation|1
7563882|NCT03267940|11934097|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7563883|NCT03267940|11934098|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7451771|NCT01740089|11741283|FG000|After 12 Weeks|Withdrawal by Subject|1
7451772|NCT01740089|11741284|FG001|After 12 Weeks|Withdrawal by Subject|1
7451773|NCT01740089|11741285|FG002|After 12 Weeks|Withdrawal by Subject|1
7451774|NCT01740128|11741296|FG000|Overall Study|Pregnancy|0
7451775|NCT01740128|11741297|FG001|Overall Study|Pregnancy|1
7451776|NCT01740128|11741296|FG000|Overall Study|Protocol Violation|1
7451777|NCT01740128|11741297|FG001|Overall Study|Protocol Violation|2
7451778|NCT01740128|11741296|FG000|Overall Study|Lost to Follow-up|2
7451779|NCT01740128|11741297|FG001|Overall Study|Lost to Follow-up|2
7451780|NCT01740128|11741296|FG000|Overall Study|Withdrawal by Subject|1
7451781|NCT01740128|11741297|FG001|Overall Study|Withdrawal by Subject|0
7451782|NCT01740128|11741296|FG000|Overall Study|Insufficient protocol compliance|2
7451783|NCT01740128|11741297|FG001|Overall Study|Insufficient protocol compliance|2
7451784|NCT01740323|11741318|FG000|Overall Study|Adverse Event|1
7451785|NCT01740323|11741319|FG001|Overall Study|Adverse Event|0
7451786|NCT01740323|11741318|FG000|Overall Study|Randomized but did not take study drug|1
7451787|NCT01740323|11741319|FG001|Overall Study|Randomized but did not take study drug|0
7451788|NCT01740388|11741344|FG000|Overall Study|Withdrawal by Subject|1
7563884|NCT03267940|11934099|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
7451789|NCT01740388|11741345|FG001|Overall Study|Withdrawal by Subject|2
7451790|NCT01740388|11741344|FG000|Overall Study|Lost to Follow-up|2
7451791|NCT01740388|11741345|FG001|Overall Study|Lost to Follow-up|0
7451792|NCT01740388|11741344|FG000|Overall Study|Physician Decision|2
7451793|NCT01740388|11741345|FG001|Overall Study|Physician Decision|6
7451794|NCT01740388|11741344|FG000|Overall Study|Subjects missing data, completed|41
7451795|NCT01740388|11741345|FG001|Overall Study|Subjects missing data, completed|36
7451796|NCT01740401|11741351|FG000|Overall Study|Progression of disease|6
7451797|NCT01740401|11741351|FG000|Overall Study|Adverse Event|2
7451798|NCT01740401|11741351|FG000|Overall Study|Did not reach primary endpoint|2
7451799|NCT01740440|11741369|FG000|Overall Study|Lost to Follow-up|3
7563885|NCT03267940|11934094|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
7563886|NCT03267940|11934095|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
7563887|NCT03267940|11934096|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7563888|NCT03267940|11934097|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7563889|NCT03267940|11934098|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7563890|NCT03267940|11934099|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
7575022|NCT03707821|11958428|FG001|Overall Study|Protocol Violation|1
7451800|NCT01740791|11741404|FG000|Overall Study|Randomized but never treated|5
7451801|NCT01740791|11741405|FG001|Overall Study|Randomized but never treated|3
7451802|NCT01740791|11741406|FG002|Overall Study|Randomized but never treated|2
7451803|NCT01740791|11741407|FG003|Overall Study|Randomized but never treated|2
7451804|NCT01740791|11741408|FG004|Overall Study|Randomized but never treated|1
7451805|NCT01740791|11741409|FG005|Overall Study|Randomized but never treated|3
7451806|NCT01740791|11741404|FG000|Overall Study|Lost to Follow-up|2
7451807|NCT01740791|11741405|FG001|Overall Study|Lost to Follow-up|0
7451808|NCT01740791|11741406|FG002|Overall Study|Lost to Follow-up|2
7451809|NCT01740791|11741407|FG003|Overall Study|Lost to Follow-up|3
7451810|NCT01740791|11741408|FG004|Overall Study|Lost to Follow-up|2
7451811|NCT01740791|11741409|FG005|Overall Study|Lost to Follow-up|3
7451812|NCT01740791|11741404|FG000|Overall Study|Withdrew Consent|4
7451813|NCT01740791|11741405|FG001|Overall Study|Withdrew Consent|0
7451814|NCT01740791|11741406|FG002|Overall Study|Withdrew Consent|1
7451815|NCT01740791|11741407|FG003|Overall Study|Withdrew Consent|2
7451816|NCT01740791|11741408|FG004|Overall Study|Withdrew Consent|0
7451817|NCT01740791|11741409|FG005|Overall Study|Withdrew Consent|3
7451818|NCT01740791|11741404|FG000|Overall Study|Investigator's discretion|1
7451819|NCT01740791|11741405|FG001|Overall Study|Investigator's discretion|0
7451820|NCT01740791|11741406|FG002|Overall Study|Investigator's discretion|1
7451821|NCT01740791|11741407|FG003|Overall Study|Investigator's discretion|0
7451822|NCT01740791|11741408|FG004|Overall Study|Investigator's discretion|0
7451823|NCT01740791|11741409|FG005|Overall Study|Investigator's discretion|1
7451824|NCT01740791|11741404|FG000|Overall Study|Adverse Event|0
7451825|NCT01740791|11741405|FG001|Overall Study|Adverse Event|0
7451826|NCT01740791|11741406|FG002|Overall Study|Adverse Event|0
7451827|NCT01740791|11741407|FG003|Overall Study|Adverse Event|0
7451828|NCT01740791|11741408|FG004|Overall Study|Adverse Event|0
7451829|NCT01740791|11741409|FG005|Overall Study|Adverse Event|1
7451830|NCT01741012|11741471|FG000|Overall Study|Lost to Follow-up|1
7451831|NCT01741012|11741471|FG000|Overall Study|Withdrawal by Subject|2
7451832|NCT01741259|11741478|FG000|Overall Study|Protocol Violation|6
7451833|NCT01741259|11741479|FG001|Overall Study|Protocol Violation|4
7451834|NCT01741259|11741478|FG000|Overall Study|Withdrawal by Subject|0
7451835|NCT01741259|11741479|FG001|Overall Study|Withdrawal by Subject|2
7451836|NCT01741532|11741526|FG000|Overall Study|Adverse Event|4
7451837|NCT01741532|11741527|FG001|Overall Study|Adverse Event|0
7451838|NCT01741532|11741526|FG000|Overall Study|Withdrawal by Subject|1
7451839|NCT01741532|11741527|FG001|Overall Study|Withdrawal by Subject|1
7451840|NCT01741532|11741526|FG000|Overall Study|Protocol Violation|0
7451841|NCT01741532|11741527|FG001|Overall Study|Protocol Violation|1
7451842|NCT01741532|11741526|FG000|Overall Study|Worsening of the disease|3
7451843|NCT01741532|11741527|FG001|Overall Study|Worsening of the disease|1
7451844|NCT01741532|11741526|FG000|Overall Study|Sponsor decision|1
7451845|NCT01741532|11741527|FG001|Overall Study|Sponsor decision|0
7451846|NCT01741532|11741526|FG000|Overall Study|Medical event|1
7451847|NCT01741532|11741527|FG001|Overall Study|Medical event|0
7451848|NCT01741545|11741539|FG000|Treatment Period|Lack of Efficacy|0
7451849|NCT01741545|11741540|FG001|Treatment Period|Lack of Efficacy|1
7451850|NCT01741545|11741539|FG000|Treatment Period|Adverse event, non-fatal|1
7451851|NCT01741545|11741540|FG001|Treatment Period|Adverse event, non-fatal|3
7451852|NCT01741545|11741539|FG000|Follow-up Period (24 Weeks)|Other than specified|0
7451853|NCT01741545|11741540|FG001|Follow-up Period (24 Weeks)|Other than specified|1
7451854|NCT01741545|11741539|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7451855|NCT01741545|11741540|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
7451856|NCT01741688|11741546|FG000|Overall Study|Lack of insurance coverage|2
7451857|NCT01741688|11741546|FG000|Overall Study|Withdrawal by Subject|1
7468011|NCT01904773|11768445|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468012|NCT01904773|11768446|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468013|NCT01904773|11768447|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
7468684|NCT01912963|11769576|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
7468685|NCT01912963|11769577|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
7468686|NCT01912963|11769575|FG000|Overall Study|Adverse Event|0
7468687|NCT01912963|11769576|FG001|Overall Study|Adverse Event|1
7468688|NCT01912963|11769577|FG002|Overall Study|Adverse Event|1
7468689|NCT01912963|11769575|FG000|Overall Study|Withdrawal by Subject|0
7468690|NCT01912963|11769576|FG001|Overall Study|Withdrawal by Subject|1
7468691|NCT01912963|11769577|FG002|Overall Study|Withdrawal by Subject|0
7468692|NCT01912963|11769575|FG000|Overall Study|Sought treatment locally|0
7468693|NCT01912963|11769576|FG001|Overall Study|Sought treatment locally|1
7468694|NCT01912963|11769577|FG002|Overall Study|Sought treatment locally|0
7468695|NCT01913041|11769585|FG000|Overall Study|Protocol Violation|35
7468696|NCT01913041|11769585|FG000|Overall Study|Withdrawal by Subject|3
7468697|NCT01913041|11769585|FG000|Overall Study|Physician Decision|1
7468698|NCT01913340|11769595|FG000|Overall Study|Death|2
7468699|NCT01913340|11769596|FG001|Overall Study|Death|5
7468700|NCT01913340|11769595|FG000|Overall Study|Lost to Follow-up|1
7468701|NCT01913340|11769596|FG001|Overall Study|Lost to Follow-up|1
7468702|NCT01913353|11769604|FG000|Overall Study|Adverse Event|2
7468703|NCT01913353|11769605|FG001|Overall Study|Adverse Event|0
7468704|NCT01913353|11769604|FG000|Overall Study|Physician Decision|0
7468705|NCT01913353|11769605|FG001|Overall Study|Physician Decision|2
7468706|NCT01913353|11769604|FG000|Overall Study|Withdrawal by Subject|20
7468707|NCT01913353|11769605|FG001|Overall Study|Withdrawal by Subject|6
7451858|NCT01741701|11741553|FG000|Overall Study|Adverse Event|5
7451859|NCT01741701|11741554|FG001|Overall Study|Adverse Event|1
7451860|NCT01741701|11741553|FG000|Overall Study|Withdrawal by Subject|0
7451861|NCT01741701|11741554|FG001|Overall Study|Withdrawal by Subject|1
7451862|NCT01741792|11741563|FG000|Overall Study|Death|6
7451863|NCT01741792|11741564|FG001|Overall Study|Death|1
7451864|NCT01741792|11741565|FG002|Overall Study|Death|12
7451865|NCT01742078|11741597|FG000|Overall Study|Withdrawal by Subject|0
7451866|NCT01742078|11741598|FG001|Overall Study|Withdrawal by Subject|0
7563891|NCT03267940|11934094|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7563892|NCT03267940|11934095|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7563893|NCT03267940|11934096|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7563894|NCT03267940|11934097|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
7563895|NCT03267940|11934098|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
7563896|NCT03267940|11934099|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
7563897|NCT03267940|11934094|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7563898|NCT03267940|11934095|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7563899|NCT03267940|11934096|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7563900|NCT03267940|11934097|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
7563901|NCT03267940|11934098|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
7563902|NCT03267940|11934099|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
7563903|NCT03267940|11934094|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7563904|NCT03267940|11934095|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
7563905|NCT03267940|11934096|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
7563906|NCT03267940|11934097|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7563907|NCT03267940|11934098|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7563908|NCT03267940|11934099|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
7563909|NCT03267940|11934094|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7563910|NCT03267940|11934095|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
7563911|NCT03267940|11934096|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
7563912|NCT03267940|11934097|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
7563913|NCT03267940|11934098|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
7563914|NCT03267940|11934099|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
7563915|NCT03267940|11934094|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
7563916|NCT03267940|11934095|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
7563917|NCT03267940|11934096|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
7563918|NCT03267940|11934097|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
7563919|NCT03267940|11934098|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
7563920|NCT03267940|11934099|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
7563921|NCT03268590|11934125|FG000|Overall Study|Previously unknown exclusion criteria|1
7563922|NCT03268746|11934132|FG000|Overall Study|Withdrawal by Subject|1
7563923|NCT03268941|11934147|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563924|NCT03268941|11934148|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563925|NCT03268941|11934149|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563926|NCT03268941|11934150|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
7563927|NCT03268941|11934151|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563928|NCT03268941|11934152|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563929|NCT03268941|11934153|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
7563930|NCT03268941|11934147|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
7563931|NCT03268941|11934148|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
7563932|NCT03268941|11934149|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
7563933|NCT03268941|11934150|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
7563934|NCT03268941|11934151|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
7563935|NCT03268941|11934152|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
7563936|NCT03268941|11934153|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
7563937|NCT03268941|11934147|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
7451867|NCT01742078|11741599|FG002|Overall Study|Withdrawal by Subject|0
7451868|NCT01742078|11741600|FG003|Overall Study|Withdrawal by Subject|1
7451869|NCT01742078|11741601|FG004|Overall Study|Withdrawal by Subject|0
7451870|NCT01742078|11741602|FG005|Overall Study|Withdrawal by Subject|0
7451871|NCT01742078|11741603|FG006|Overall Study|Withdrawal by Subject|0
7451872|NCT01742078|11741604|FG007|Overall Study|Withdrawal by Subject|0
7451873|NCT01742078|11741605|FG008|Overall Study|Withdrawal by Subject|0
7451874|NCT01742091|11741633|FG000|Overall Study|Adverse Event|0
7451875|NCT01742091|11741634|FG001|Overall Study|Adverse Event|0
7451876|NCT01742091|11741635|FG002|Overall Study|Adverse Event|0
7451877|NCT01742091|11741636|FG003|Overall Study|Adverse Event|0
7451878|NCT01742091|11741637|FG004|Overall Study|Adverse Event|1
7451879|NCT01742091|11741638|FG005|Overall Study|Adverse Event|0
7451880|NCT01742091|11741633|FG000|Overall Study|Physician Decision|0
7451881|NCT01742091|11741634|FG001|Overall Study|Physician Decision|0
7451882|NCT01742091|11741635|FG002|Overall Study|Physician Decision|0
7451883|NCT01742091|11741636|FG003|Overall Study|Physician Decision|0
7451884|NCT01742091|11741637|FG004|Overall Study|Physician Decision|0
7451885|NCT01742091|11741638|FG005|Overall Study|Physician Decision|1
7451886|NCT01742091|11741633|FG000|Overall Study|Withdrawal by Subject|0
7451887|NCT01742091|11741634|FG001|Overall Study|Withdrawal by Subject|0
7451888|NCT01742091|11741635|FG002|Overall Study|Withdrawal by Subject|0
7451889|NCT01742091|11741636|FG003|Overall Study|Withdrawal by Subject|1
7451890|NCT01742091|11741637|FG004|Overall Study|Withdrawal by Subject|0
7451891|NCT01742091|11741638|FG005|Overall Study|Withdrawal by Subject|0
7451892|NCT01742091|11741633|FG000|Overall Study|Lost to Follow-up|0
7451893|NCT01742091|11741634|FG001|Overall Study|Lost to Follow-up|0
7451894|NCT01742091|11741635|FG002|Overall Study|Lost to Follow-up|0
7451895|NCT01742091|11741636|FG003|Overall Study|Lost to Follow-up|0
7451896|NCT01742091|11741637|FG004|Overall Study|Lost to Follow-up|0
7451897|NCT01742091|11741638|FG005|Overall Study|Lost to Follow-up|1
7451898|NCT01742286|11741683|FG000|Escalation Phase|Administrative problems|1
7451899|NCT01742286|11741684|FG001|Escalation Phase|Administrative problems|1
7451900|NCT01742286|11741685|FG002|Escalation Phase|Administrative problems|0
7451901|NCT01742286|11741686|FG003|Escalation Phase|Administrative problems|0
7451902|NCT01742286|11741687|FG004|Escalation Phase|Administrative problems|0
7451903|NCT01742286|11741688|FG005|Escalation Phase|Administrative problems|0
7451904|NCT01742286|11741689|FG006|Escalation Phase|Administrative problems|2
7451905|NCT01742286|11741683|FG000|Escalation Phase|Adverse Event|0
7451906|NCT01742286|11741684|FG001|Escalation Phase|Adverse Event|1
7451907|NCT01742286|11741685|FG002|Escalation Phase|Adverse Event|2
7451908|NCT01742286|11741686|FG003|Escalation Phase|Adverse Event|0
7451909|NCT01742286|11741687|FG004|Escalation Phase|Adverse Event|0
7451910|NCT01742286|11741688|FG005|Escalation Phase|Adverse Event|1
7451911|NCT01742286|11741689|FG006|Escalation Phase|Adverse Event|0
7451912|NCT01742286|11741683|FG000|Escalation Phase|Disease progression|3
7451913|NCT01742286|11741684|FG001|Escalation Phase|Disease progression|7
7451914|NCT01742286|11741685|FG002|Escalation Phase|Disease progression|4
7451915|NCT01742286|11741686|FG003|Escalation Phase|Disease progression|1
7451916|NCT01742286|11741687|FG004|Escalation Phase|Disease progression|4
7451917|NCT01742286|11741688|FG005|Escalation Phase|Disease progression|3
7451918|NCT01742286|11741689|FG006|Escalation Phase|Disease progression|2
7451919|NCT01742286|11741683|FG000|Escalation Phase|Death|0
7451920|NCT01742286|11741684|FG001|Escalation Phase|Death|0
7451921|NCT01742286|11741685|FG002|Escalation Phase|Death|0
7451922|NCT01742286|11741686|FG003|Escalation Phase|Death|0
7451923|NCT01742286|11741687|FG004|Escalation Phase|Death|0
7451924|NCT01742286|11741688|FG005|Escalation Phase|Death|1
7451925|NCT01742286|11741689|FG006|Escalation Phase|Death|0
7451926|NCT01742286|11741683|FG000|Escalation Phase|Physician Decision|0
7451927|NCT01742286|11741684|FG001|Escalation Phase|Physician Decision|3
7451928|NCT01742286|11741685|FG002|Escalation Phase|Physician Decision|0
7451929|NCT01742286|11741686|FG003|Escalation Phase|Physician Decision|1
7451930|NCT01742286|11741687|FG004|Escalation Phase|Physician Decision|0
7451931|NCT01742286|11741688|FG005|Escalation Phase|Physician Decision|0
7451932|NCT01742286|11741689|FG006|Escalation Phase|Physician Decision|2
7451933|NCT01742286|11741683|FG000|Escalation Phase|Subject/guardian decision|1
7451934|NCT01742286|11741684|FG001|Escalation Phase|Subject/guardian decision|0
7451935|NCT01742286|11741685|FG002|Escalation Phase|Subject/guardian decision|0
7451936|NCT01742286|11741686|FG003|Escalation Phase|Subject/guardian decision|0
7451937|NCT01742286|11741687|FG004|Escalation Phase|Subject/guardian decision|0
7451938|NCT01742286|11741688|FG005|Escalation Phase|Subject/guardian decision|0
7563938|NCT03268941|11934148|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
7563939|NCT03268941|11934149|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
7563940|NCT03268941|11934150|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
7451939|NCT01742286|11741689|FG006|Escalation Phase|Subject/guardian decision|0
7451940|NCT01742286|11741683|FG000|Expansion Phase|Administrative problems|0
7451941|NCT01742286|11741684|FG001|Expansion Phase|Administrative problems|0
7451942|NCT01742286|11741685|FG002|Expansion Phase|Administrative problems|0
7451943|NCT01742286|11741686|FG003|Expansion Phase|Administrative problems|0
7451944|NCT01742286|11741687|FG004|Expansion Phase|Administrative problems|0
7451945|NCT01742286|11741688|FG005|Expansion Phase|Administrative problems|0
7451946|NCT01742286|11741689|FG006|Expansion Phase|Administrative problems|5
7451947|NCT01742286|11741683|FG000|Expansion Phase|Physician Decision|0
7451948|NCT01742286|11741684|FG001|Expansion Phase|Physician Decision|0
7451949|NCT01742286|11741685|FG002|Expansion Phase|Physician Decision|4
7451950|NCT01742286|11741686|FG003|Expansion Phase|Physician Decision|0
7451951|NCT01742286|11741687|FG004|Expansion Phase|Physician Decision|0
7451952|NCT01742286|11741688|FG005|Expansion Phase|Physician Decision|0
7451953|NCT01742286|11741689|FG006|Expansion Phase|Physician Decision|9
7451954|NCT01742286|11741683|FG000|Expansion Phase|Adverse Event|0
7451955|NCT01742286|11741684|FG001|Expansion Phase|Adverse Event|0
7451956|NCT01742286|11741685|FG002|Expansion Phase|Adverse Event|0
7451957|NCT01742286|11741686|FG003|Expansion Phase|Adverse Event|0
7451958|NCT01742286|11741687|FG004|Expansion Phase|Adverse Event|0
7451959|NCT01742286|11741688|FG005|Expansion Phase|Adverse Event|0
7451960|NCT01742286|11741689|FG006|Expansion Phase|Adverse Event|6
7451961|NCT01742286|11741683|FG000|Expansion Phase|Disease progression|0
7451962|NCT01742286|11741684|FG001|Expansion Phase|Disease progression|0
7451963|NCT01742286|11741685|FG002|Expansion Phase|Disease progression|3
7451964|NCT01742286|11741686|FG003|Expansion Phase|Disease progression|0
7451965|NCT01742286|11741687|FG004|Expansion Phase|Disease progression|0
7451966|NCT01742286|11741688|FG005|Expansion Phase|Disease progression|0
7451967|NCT01742286|11741689|FG006|Expansion Phase|Disease progression|15
7451968|NCT01742286|11741683|FG000|Expansion Phase|Withdrawal by Subject|0
7451969|NCT01742286|11741684|FG001|Expansion Phase|Withdrawal by Subject|0
7451970|NCT01742286|11741685|FG002|Expansion Phase|Withdrawal by Subject|0
7451971|NCT01742286|11741686|FG003|Expansion Phase|Withdrawal by Subject|0
7451972|NCT01742286|11741687|FG004|Expansion Phase|Withdrawal by Subject|0
7451973|NCT01742286|11741688|FG005|Expansion Phase|Withdrawal by Subject|0
7451974|NCT01742286|11741689|FG006|Expansion Phase|Withdrawal by Subject|1
7451975|NCT01742897|11741739|FG000|Overall Study|Adverse Event|3
7451976|NCT01742897|11741739|FG000|Overall Study|Withdrawal by Subject|1
7451977|NCT01742897|11741739|FG000|Overall Study|Other|1
7451978|NCT01743001|11741764|FG000|Overall Study|Physician Decision|1
7451979|NCT01743001|11741765|FG001|Overall Study|Physician Decision|0
7451980|NCT01743001|11741764|FG000|Overall Study|Pregnancy|1
7451981|NCT01743001|11741765|FG001|Overall Study|Pregnancy|0
7451982|NCT01743001|11741764|FG000|Overall Study|Death|1
7451983|NCT01743001|11741765|FG001|Overall Study|Death|0
7451984|NCT01743027|11741775|FG000|Overall Study|Adverse Event|2
7451985|NCT01743027|11741776|FG001|Overall Study|Adverse Event|0
7451986|NCT01743027|11741777|FG002|Overall Study|Adverse Event|0
7451987|NCT01743027|11741778|FG003|Overall Study|Adverse Event|0
7451988|NCT01743027|11741775|FG000|Overall Study|Lost to Follow-up|0
7451989|NCT01743027|11741776|FG001|Overall Study|Lost to Follow-up|0
7451990|NCT01743027|11741777|FG002|Overall Study|Lost to Follow-up|2
7451991|NCT01743027|11741778|FG003|Overall Study|Lost to Follow-up|0
7451992|NCT01743027|11741775|FG000|Overall Study|Progressive Disease|1
7451993|NCT01743027|11741776|FG001|Overall Study|Progressive Disease|4
7451994|NCT01743027|11741777|FG002|Overall Study|Progressive Disease|3
7451995|NCT01743027|11741778|FG003|Overall Study|Progressive Disease|0
7451996|NCT01743027|11741775|FG000|Overall Study|Protocol Violation|1
7451997|NCT01743027|11741776|FG001|Overall Study|Protocol Violation|1
7451998|NCT01743027|11741777|FG002|Overall Study|Protocol Violation|1
7451999|NCT01743027|11741778|FG003|Overall Study|Protocol Violation|0
7452000|NCT01743027|11741775|FG000|Overall Study|Withdrawal by Subject|1
7452001|NCT01743027|11741776|FG001|Overall Study|Withdrawal by Subject|0
7452002|NCT01743027|11741777|FG002|Overall Study|Withdrawal by Subject|3
7452003|NCT01743027|11741778|FG003|Overall Study|Withdrawal by Subject|1
7452004|NCT01743040|11741788|FG000|Overall Study|Death|1
7452005|NCT01743040|11741788|FG000|Overall Study|Lost to Follow-up|66
7452006|NCT01743040|11741788|FG000|Overall Study|Physician Decision|40
7452007|NCT01743040|11741788|FG000|Overall Study|Protocol Violation|1
7452008|NCT01743040|11741788|FG000|Overall Study|Withdrawal by Subject|121
7452009|NCT01743092|11741794|FG000|Overall Study|Lost to Follow-up|14
7452010|NCT01743092|11741795|FG001|Overall Study|Lost to Follow-up|15
7452011|NCT01743469|11741822|FG000|Active Treatment Phase|Adverse Event|10
7452012|NCT01743469|11741823|FG001|Active Treatment Phase|Adverse Event|5
7452013|NCT01743469|11741824|FG002|Active Treatment Phase|Adverse Event|8
7452014|NCT01743469|11741825|FG003|Active Treatment Phase|Adverse Event|1
7452015|NCT01743469|11741822|FG000|Active Treatment Phase|Disease Progression|40
7452016|NCT01743469|11741823|FG001|Active Treatment Phase|Disease Progression|47
7452017|NCT01743469|11741824|FG002|Active Treatment Phase|Disease Progression|30
7452018|NCT01743469|11741825|FG003|Active Treatment Phase|Disease Progression|20
7452019|NCT01743469|11741822|FG000|Active Treatment Phase|Withdrawal by Subject|2
7452020|NCT01743469|11741823|FG001|Active Treatment Phase|Withdrawal by Subject|3
7452021|NCT01743469|11741824|FG002|Active Treatment Phase|Withdrawal by Subject|0
7452022|NCT01743469|11741825|FG003|Active Treatment Phase|Withdrawal by Subject|0
7452023|NCT01743469|11741822|FG000|Active Treatment Phase|Missing|1
7452024|NCT01743469|11741823|FG001|Active Treatment Phase|Missing|0
7452025|NCT01743469|11741824|FG002|Active Treatment Phase|Missing|0
7452026|NCT01743469|11741825|FG003|Active Treatment Phase|Missing|0
7452027|NCT01743469|11741822|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7452028|NCT01743469|11741823|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7452029|NCT01743469|11741824|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
7452030|NCT01743469|11741825|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
7452031|NCT01743469|11741822|FG000|Follow-up Period - Post-Treatment|Death|43
7452032|NCT01743469|11741823|FG001|Follow-up Period - Post-Treatment|Death|47
7452033|NCT01743469|11741824|FG002|Follow-up Period - Post-Treatment|Death|22
7452034|NCT01743469|11741825|FG003|Follow-up Period - Post-Treatment|Death|16
7452035|NCT01743469|11741822|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7452036|NCT01743469|11741823|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
7452037|NCT01743469|11741824|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7452038|NCT01743469|11741825|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
7452039|NCT01743560|11741850|FG000|Overall Study|Disease progression|26
7452040|NCT01743560|11741850|FG000|Overall Study|Adverse Event|8
7452041|NCT01743560|11741850|FG000|Overall Study|Death|3
7452042|NCT01743560|11741850|FG000|Overall Study|Withdrawal by Subject|2
7452043|NCT01743560|11741850|FG000|Overall Study|Protocol Violation|1
7452044|NCT01743560|11741850|FG000|Overall Study|>1 dose of study drug|3
7452045|NCT01743989|11741912|FG000|Treatment Phase|Unstable MR4.0|0
7452046|NCT01743989|11741913|FG001|Treatment Phase|Unstable MR4.0|6
7452047|NCT01743989|11741914|FG002|Treatment Phase|Unstable MR4.0|263
7452048|NCT01743989|11741912|FG000|Treatment Phase|Adverse Event|0
7452049|NCT01743989|11741913|FG001|Treatment Phase|Adverse Event|4
7452050|NCT01743989|11741914|FG002|Treatment Phase|Adverse Event|67
7452051|NCT01743989|11741912|FG000|Treatment Phase|Withdrawal by Subject|1
7452052|NCT01743989|11741913|FG001|Treatment Phase|Withdrawal by Subject|3
7452053|NCT01743989|11741914|FG002|Treatment Phase|Withdrawal by Subject|28
7452054|NCT01743989|11741912|FG000|Treatment Phase|Death|0
7452055|NCT01743989|11741913|FG001|Treatment Phase|Death|1
7452056|NCT01743989|11741914|FG002|Treatment Phase|Death|3
7452057|NCT01743989|11741912|FG000|Treatment Phase|Abnormal laboratory value(s)|0
7452058|NCT01743989|11741913|FG001|Treatment Phase|Abnormal laboratory value(s)|0
7452059|NCT01743989|11741914|FG002|Treatment Phase|Abnormal laboratory value(s)|3
7452060|NCT01743989|11741912|FG000|Treatment Phase|Protocol deviation|0
7452061|NCT01743989|11741913|FG001|Treatment Phase|Protocol deviation|0
7452062|NCT01743989|11741914|FG002|Treatment Phase|Protocol deviation|3
7452063|NCT01743989|11741912|FG000|Treatment Phase|Pregnancy|0
7452064|NCT01743989|11741913|FG001|Treatment Phase|Pregnancy|0
7452065|NCT01743989|11741914|FG002|Treatment Phase|Pregnancy|2
7452066|NCT01743989|11741912|FG000|Treatment Phase|Lost to Follow-up|0
7452067|NCT01743989|11741913|FG001|Treatment Phase|Lost to Follow-up|0
7452068|NCT01743989|11741914|FG002|Treatment Phase|Lost to Follow-up|2
7452069|NCT01743989|11741912|FG000|Treatment Phase|Abnormal test procedure result(s)|0
7452070|NCT01743989|11741913|FG001|Treatment Phase|Abnormal test procedure result(s)|0
7452071|NCT01743989|11741914|FG002|Treatment Phase|Abnormal test procedure result(s)|1
7452072|NCT01743989|11741912|FG000|Treatment Phase|Administrative problems|0
7452073|NCT01743989|11741913|FG001|Treatment Phase|Administrative problems|0
7452074|NCT01743989|11741914|FG002|Treatment Phase|Administrative problems|1
7452075|NCT01743989|11741912|FG000|Treatment Phase|New cancer (CML) therapy|0
7452076|NCT01743989|11741913|FG001|Treatment Phase|New cancer (CML) therapy|1
7452077|NCT01743989|11741914|FG002|Treatment Phase|New cancer (CML) therapy|0
7452078|NCT01743989|11741912|FG000|Treatment Phase|Physician Decision|0
7452079|NCT01743989|11741913|FG001|Treatment Phase|Physician Decision|0
7452080|NCT01743989|11741914|FG002|Treatment Phase|Physician Decision|3
7452081|NCT01743989|11741912|FG000|Treatment Phase|Patient non-compliance to treatment|0
7452082|NCT01743989|11741913|FG001|Treatment Phase|Patient non-compliance to treatment|0
7452083|NCT01743989|11741914|FG002|Treatment Phase|Patient non-compliance to treatment|3
7452084|NCT01743989|11741912|FG000|Treatment Phase|Not randomized by mistake|0
7452085|NCT01743989|11741913|FG001|Treatment Phase|Not randomized by mistake|0
7452086|NCT01743989|11741914|FG002|Treatment Phase|Not randomized by mistake|1
7452087|NCT01743989|11741912|FG000|Treatment Phase|Included by mistake|0
7452088|NCT01743989|11741913|FG001|Treatment Phase|Included by mistake|0
7452089|NCT01743989|11741914|FG002|Treatment Phase|Included by mistake|1
7452090|NCT01743989|11741912|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
7452091|NCT01743989|11741913|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
7452092|NCT01743989|11741914|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
7452093|NCT01743989|11741912|FG000|TFR Phase|Adverse Event|0
7452094|NCT01743989|11741913|FG001|TFR Phase|Adverse Event|1
7452095|NCT01743989|11741914|FG002|TFR Phase|Adverse Event|0
7452096|NCT01743989|11741912|FG000|TFR Phase|Lost to Follow-up|0
7452097|NCT01743989|11741913|FG001|TFR Phase|Lost to Follow-up|2
7452098|NCT01743989|11741914|FG002|TFR Phase|Lost to Follow-up|0
7452099|NCT01743989|11741912|FG000|TFR Phase|Physician Decision|0
7452100|NCT01743989|11741913|FG001|TFR Phase|Physician Decision|1
7452101|NCT01743989|11741914|FG002|TFR Phase|Physician Decision|0
7452102|NCT01743989|11741912|FG000|TFR Phase|Logistical problems|0
7452103|NCT01743989|11741913|FG001|TFR Phase|Logistical problems|2
7452104|NCT01743989|11741914|FG002|TFR Phase|Logistical problems|0
7452105|NCT01743989|11741912|FG000|TFR Phase|Protocol deviation|0
7563941|NCT03268941|11934151|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
7563942|NCT03268941|11934152|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
7563943|NCT03268941|11934153|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
7563944|NCT03268941|11934147|FG000|Part 2: Days 17 to 25|Reason not specified|0
7563945|NCT03268941|11934148|FG001|Part 2: Days 17 to 25|Reason not specified|0
7563946|NCT03268941|11934149|FG002|Part 2: Days 17 to 25|Reason not specified|0
7563947|NCT03268941|11934150|FG003|Part 2: Days 17 to 25|Reason not specified|0
7563948|NCT03268941|11934151|FG004|Part 2: Days 17 to 25|Reason not specified|0
7563949|NCT03268941|11934152|FG005|Part 2: Days 17 to 25|Reason not specified|0
7563950|NCT03268941|11934153|FG006|Part 2: Days 17 to 25|Reason not specified|1
7563951|NCT03268941|11934147|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
7563952|NCT03268941|11934148|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
7563953|NCT03268941|11934149|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
7563954|NCT03268941|11934150|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
7563955|NCT03268941|11934151|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
7452106|NCT01743989|11741913|FG001|TFR Phase|Protocol deviation|1
7452107|NCT01743989|11741914|FG002|TFR Phase|Protocol deviation|0
7452108|NCT01743989|11741912|FG000|TFR Phase|Withdrawal by Subject|0
7452109|NCT01743989|11741913|FG001|TFR Phase|Withdrawal by Subject|2
7563956|NCT03268941|11934152|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
7452110|NCT01743989|11741914|FG002|TFR Phase|Withdrawal by Subject|0
7452111|NCT01743989|11741912|FG000|Re-treatment Phase|Adverse Event|8
7452112|NCT01743989|11741913|FG001|Re-treatment Phase|Adverse Event|4
7452113|NCT01743989|11741914|FG002|Re-treatment Phase|Adverse Event|0
7452114|NCT01743989|11741912|FG000|Re-treatment Phase|Death|1
7452115|NCT01743989|11741913|FG001|Re-treatment Phase|Death|1
7452116|NCT01743989|11741914|FG002|Re-treatment Phase|Death|0
7452117|NCT01743989|11741912|FG000|Re-treatment Phase|Administrative problems|1
7452118|NCT01743989|11741913|FG001|Re-treatment Phase|Administrative problems|1
7452119|NCT01743989|11741914|FG002|Re-treatment Phase|Administrative problems|0
7452120|NCT01743989|11741912|FG000|Re-treatment Phase|Withdrawal by Subject|5
7452121|NCT01743989|11741913|FG001|Re-treatment Phase|Withdrawal by Subject|1
7452122|NCT01743989|11741914|FG002|Re-treatment Phase|Withdrawal by Subject|0
7452123|NCT01743989|11741912|FG000|Re-treatment Phase|Unstable MR|1
7452124|NCT01743989|11741913|FG001|Re-treatment Phase|Unstable MR|0
7452125|NCT01743989|11741914|FG002|Re-treatment Phase|Unstable MR|0
7452126|NCT01743989|11741912|FG000|Re-treatment Phase|Physician Decision|0
7452127|NCT01743989|11741913|FG001|Re-treatment Phase|Physician Decision|1
7452128|NCT01743989|11741914|FG002|Re-treatment Phase|Physician Decision|0
7452129|NCT01743989|11741912|FG000|Re-treatment Phase|Lost to Follow-up|0
7452130|NCT01743989|11741913|FG001|Re-treatment Phase|Lost to Follow-up|1
7452131|NCT01743989|11741914|FG002|Re-treatment Phase|Lost to Follow-up|0
7452132|NCT01744197|11741927|FG000|Overall Study|Received 1 patch|2
7452133|NCT01744197|11741928|FG001|Overall Study|Received 1 patch|1
7452134|NCT01744197|11741927|FG000|Overall Study|No patch received|2
7452135|NCT01744197|11741928|FG001|Overall Study|No patch received|2
7452136|NCT01744392|11741954|FG000|Overall Study|Physician Decision|1
7563957|NCT03268941|11934153|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
7563958|NCT03269552|11934181|FG000|Overall Study|Adverse Event|2
7563959|NCT03270085|11934188|FG000|Overall Study|Withdrawal by Subject|1
7452137|NCT01744483|11741962|FG000|Overall Study|Death|9
7452138|NCT01744483|11741963|FG001|Overall Study|Death|4
7452139|NCT01744483|11741964|FG002|Overall Study|Death|11
7452140|NCT01744483|11741962|FG000|Overall Study|Lost to Follow-up|8
7452141|NCT01744483|11741963|FG001|Overall Study|Lost to Follow-up|9
7452142|NCT01744483|11741964|FG002|Overall Study|Lost to Follow-up|11
7452143|NCT01744483|11741962|FG000|Overall Study|Protocol Violation|1
7452144|NCT01744483|11741963|FG001|Overall Study|Protocol Violation|2
7452145|NCT01744483|11741964|FG002|Overall Study|Protocol Violation|1
7452146|NCT01744483|11741962|FG000|Overall Study|Withdrawal by Subject|4
7452147|NCT01744483|11741963|FG001|Overall Study|Withdrawal by Subject|6
7452148|NCT01744483|11741964|FG002|Overall Study|Withdrawal by Subject|2
7452149|NCT01744483|11741962|FG000|Overall Study|No ICU Admit|5
7452150|NCT01744483|11741963|FG001|Overall Study|No ICU Admit|1
7452151|NCT01744483|11741964|FG002|Overall Study|No ICU Admit|2
7452152|NCT01744483|11741962|FG000|Overall Study|Routed to OSH|2
7452153|NCT01744483|11741963|FG001|Overall Study|Routed to OSH|0
7452154|NCT01744483|11741964|FG002|Overall Study|Routed to OSH|1
7452155|NCT01744496|11741974|FG000|Titration Period|Adverse Event|2
7452156|NCT01744496|11741975|FG001|Titration Period|Adverse Event|1
7452157|NCT01744496|11741974|FG000|Titration Period|Personal reasons|0
7452158|NCT01744496|11741975|FG001|Titration Period|Personal reasons|1
7452159|NCT01744496|11741974|FG000|Maintenance Period|Adverse Event|1
7452160|NCT01744496|11741975|FG001|Maintenance Period|Adverse Event|3
7452161|NCT01744496|11741974|FG000|Maintenance Period|Protocol Violation|1
7452162|NCT01744496|11741975|FG001|Maintenance Period|Protocol Violation|0
7452163|NCT01744496|11741974|FG000|Maintenance Period|Withdrawal by Subject|1
7452164|NCT01744496|11741975|FG001|Maintenance Period|Withdrawal by Subject|1
7452165|NCT01744496|11741974|FG000|Maintenance Period|Subject left town|1
7452166|NCT01744496|11741975|FG001|Maintenance Period|Subject left town|0
7452167|NCT01744665|11741998|FG000|Monitoring Phase|Adverse Event|4
7452168|NCT01744665|11741998|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
7452169|NCT01744665|11741998|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
7452170|NCT01744665|11741998|FG000|Monitoring Phase|Withdrawal by Subject|5
7563960|NCT03270085|11934189|FG001|Overall Study|Withdrawal by Subject|0
7575023|NCT03707821|11958427|FG000|Overall Study|Unsatisfactory Visual Response|1
7575024|NCT03707821|11958428|FG001|Overall Study|Unsatisfactory Visual Response|0
7575025|NCT03707821|11958427|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7575026|NCT03707821|11958428|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7575027|NCT03707912|11958436|FG000|Overall Study|Violation of inclusion criteria|1
7452171|NCT01744665|11741998|FG000|Monitoring Phase|Did not achieve MR4.5|1
7452172|NCT01744665|11741998|FG000|Consolidation Phase|Adverse Event|2
7452173|NCT01744665|11741998|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
7452174|NCT01744665|11741998|FG000|Consolidation Phase|Withdrawal by Subject|4
7452175|NCT01744665|11741998|FG000|Consolidation Phase|Administrative problems|9
7452176|NCT01744665|11741998|FG000|Re-initiation Phase|Administrative problems|10
7452177|NCT01744665|11741998|FG000|Re-initiation Phase|Adverse Event|1
7452178|NCT01744665|11741998|FG000|Re-initiation Phase|No longer required treatment|1
7452179|NCT01744665|11741998|FG000|Re-initiation Phase|Withdrawal by Subject|1
7452180|NCT01744691|11742005|FG000|Overall Study|Progressive Disease|18
7452181|NCT01744691|11742005|FG000|Overall Study|Unacceptable toxicity, AE or death|18
7452182|NCT01744691|11742005|FG000|Overall Study|Withdrawal of consent for treatment|3
7452183|NCT01744691|11742005|FG000|Overall Study|Physician Decision|4
7452184|NCT01744782|11742081|FG000|Overall Study|Death|1
7452185|NCT01744977|11742116|FG000|Overall Study|Withdrawal by Subject|1
7452186|NCT01744977|11742117|FG001|Overall Study|Withdrawal by Subject|2
7452187|NCT01744977|11742116|FG000|Overall Study|Death|2
7452188|NCT01744977|11742117|FG001|Overall Study|Death|3
7452189|NCT01744977|11742116|FG000|Overall Study|Lost to Follow-up|2
7452190|NCT01744977|11742117|FG001|Overall Study|Lost to Follow-up|0
7452191|NCT01744977|11742116|FG000|Overall Study|No longer meets inclusion|6
7452192|NCT01744977|11742117|FG001|Overall Study|No longer meets inclusion|0
7452193|NCT01745094|11742136|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
7452194|NCT01745094|11742137|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
7452195|NCT01745094|11742138|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
7452196|NCT01745094|11742139|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
7452197|NCT01745094|11742136|FG000|Overall Study|Adverse Event|0
7452198|NCT01745094|11742137|FG001|Overall Study|Adverse Event|0
7452199|NCT01745094|11742138|FG002|Overall Study|Adverse Event|3
7452200|NCT01745094|11742139|FG003|Overall Study|Adverse Event|0
7452201|NCT01745094|11742136|FG000|Overall Study|Withdrawal by Subject|2
7452202|NCT01745094|11742137|FG001|Overall Study|Withdrawal by Subject|0
7452203|NCT01745094|11742138|FG002|Overall Study|Withdrawal by Subject|1
7452204|NCT01745094|11742139|FG003|Overall Study|Withdrawal by Subject|2
7452205|NCT01745094|11742136|FG000|Overall Study|Protocol Violation|1
7452206|NCT01745094|11742137|FG001|Overall Study|Protocol Violation|0
7452207|NCT01745094|11742138|FG002|Overall Study|Protocol Violation|3
7452208|NCT01745094|11742139|FG003|Overall Study|Protocol Violation|1
7452209|NCT01745094|11742136|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
7452210|NCT01745094|11742137|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
7452211|NCT01745094|11742138|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
7452212|NCT01745094|11742139|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
7452213|NCT01745094|11742136|FG000|Overall Study|Show no Stable Solifenacin Intake|0
7452214|NCT01745094|11742137|FG001|Overall Study|Show no Stable Solifenacin Intake|0
7452215|NCT01745094|11742138|FG002|Overall Study|Show no Stable Solifenacin Intake|1
7452216|NCT01745094|11742139|FG003|Overall Study|Show no Stable Solifenacin Intake|0
7452217|NCT01745094|11742136|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
7452218|NCT01745094|11742137|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
7452219|NCT01745094|11742138|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
7452220|NCT01745094|11742139|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
7452221|NCT01745120|11742154|FG000|Overall Study|Investigator decision|1
7452222|NCT01745120|11742155|FG001|Overall Study|Investigator decision|0
7452223|NCT01745146|11742179|FG000|Overall Study|Withdrawal by Subject|1
7452224|NCT01745146|11742180|FG001|Overall Study|Withdrawal by Subject|3
7452225|NCT01745146|11742179|FG000|Overall Study|Lost to Follow-up|2
7452226|NCT01745146|11742180|FG001|Overall Study|Lost to Follow-up|0
7452227|NCT01745367|11742193|FG000|Overall Study|Death|1
7452228|NCT01745367|11742194|FG001|Overall Study|Death|0
7452229|NCT01745367|11742193|FG000|Overall Study|Withdrawal by Subject|1
7452230|NCT01745367|11742194|FG001|Overall Study|Withdrawal by Subject|2
7452231|NCT01745367|11742193|FG000|Overall Study|Termination of The Study by The Sponsor|6
7452232|NCT01745367|11742194|FG001|Overall Study|Termination of The Study by The Sponsor|18
7452233|NCT01745367|11742193|FG000|Overall Study|Other Reasons Unspecified|0
7452234|NCT01745367|11742194|FG001|Overall Study|Other Reasons Unspecified|2
7452235|NCT01745380|11742202|FG000|Overall Study|Lost to Follow-up|1
7452236|NCT01745380|11742203|FG001|Overall Study|Lost to Follow-up|0
7452237|NCT01745380|11742202|FG000|Overall Study|Lack of Efficacy|0
7452238|NCT01745380|11742203|FG001|Overall Study|Lack of Efficacy|1
7452239|NCT01745393|11742211|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
7452240|NCT01745393|11742212|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
7452241|NCT01745393|11742211|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
7452242|NCT01745393|11742212|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
7452243|NCT01745393|11742211|FG000|12-month Follow-up|Lost to Follow-up|6
7452244|NCT01745393|11742212|FG001|12-month Follow-up|Lost to Follow-up|5
7452245|NCT01745848|11742231|FG000|Overall Study|Adverse Event|6
7452246|NCT01746017|11742262|FG000|Period 1|Withdrawal by Subject|0
7452247|NCT01746017|11742263|FG001|Period 1|Withdrawal by Subject|0
7452248|NCT01746017|11742264|FG002|Period 1|Withdrawal by Subject|0
7452249|NCT01746017|11742265|FG003|Period 1|Withdrawal by Subject|0
7452250|NCT01746017|11742266|FG004|Period 1|Withdrawal by Subject|0
7452251|NCT01746017|11742267|FG005|Period 1|Withdrawal by Subject|0
7452252|NCT01746017|11742268|FG006|Period 1|Withdrawal by Subject|1
7452253|NCT01746017|11742269|FG007|Period 1|Withdrawal by Subject|0
7452254|NCT01746017|11742270|FG008|Period 1|Withdrawal by Subject|0
7452255|NCT01746017|11742271|FG009|Period 1|Withdrawal by Subject|0
7452256|NCT01746017|11742272|FG010|Period 1|Withdrawal by Subject|0
7452257|NCT01746017|11742262|FG000|Period 3|Withdrawal by Subject|0
7452258|NCT01746017|11742263|FG001|Period 3|Withdrawal by Subject|0
7452259|NCT01746017|11742264|FG002|Period 3|Withdrawal by Subject|0
7452260|NCT01746017|11742265|FG003|Period 3|Withdrawal by Subject|0
7452261|NCT01746017|11742266|FG004|Period 3|Withdrawal by Subject|0
7452262|NCT01746017|11742267|FG005|Period 3|Withdrawal by Subject|1
7452263|NCT01746017|11742268|FG006|Period 3|Withdrawal by Subject|0
7452264|NCT01746017|11742269|FG007|Period 3|Withdrawal by Subject|0
7452265|NCT01746017|11742270|FG008|Period 3|Withdrawal by Subject|0
7452266|NCT01746017|11742271|FG009|Period 3|Withdrawal by Subject|0
7452267|NCT01746017|11742272|FG010|Period 3|Withdrawal by Subject|0
7452268|NCT01746108|11742348|FG000|Overall Study|Migrated /moved from study area|0
7452269|NCT01746108|11742349|FG001|Overall Study|Migrated /moved from study area|1
7452270|NCT01746108|11742350|FG002|Overall Study|Migrated /moved from study area|0
7452271|NCT01746108|11742348|FG000|Overall Study|Adverse event, non-fatal|0
7452272|NCT01746108|11742349|FG001|Overall Study|Adverse event, non-fatal|1
7532980|NCT02679079|11878948|FG000|Overall Study|Withdrawal by Subject|2
7532981|NCT02679079|11878949|FG001|Overall Study|Withdrawal by Subject|1
7532982|NCT02679079|11878950|FG002|Overall Study|Withdrawal by Subject|0
7532983|NCT02679222|11878958|FG000|Overall Study|No time for project|1
7532984|NCT02679235|11878970|FG000|Overall Study|Withdrawal by Subject|3
7532985|NCT02679235|11878970|FG000|Overall Study|Adverse Event|1
7532986|NCT02679274|11878976|FG000|Overall Study|Withdrawal by Subject|1
7532987|NCT02679274|11878977|FG001|Overall Study|Withdrawal by Subject|0
7532988|NCT02679287|11878985|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
7532989|NCT02679287|11878986|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
7532990|NCT02679287|11878985|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
7452273|NCT01746108|11742350|FG002|Overall Study|Adverse event, non-fatal|0
7452274|NCT01746108|11742348|FG000|Overall Study|Withdrawal by Subject|0
7452275|NCT01746108|11742349|FG001|Overall Study|Withdrawal by Subject|1
7452276|NCT01746108|11742350|FG002|Overall Study|Withdrawal by Subject|0
7452277|NCT01746108|11742348|FG000|Overall Study|Lost to Follow-up|0
7452278|NCT01746108|11742349|FG001|Overall Study|Lost to Follow-up|1
7452279|NCT01746108|11742350|FG002|Overall Study|Lost to Follow-up|0
7452280|NCT01746225|11742369|FG000|Overall Study|Death|1
7452281|NCT01746225|11742370|FG001|Overall Study|Death|0
7452282|NCT01746225|11742371|FG002|Overall Study|Death|1
7452283|NCT01746225|11742369|FG000|Overall Study|Withdrawal by Subject|5
7452284|NCT01746225|11742370|FG001|Overall Study|Withdrawal by Subject|15
7452285|NCT01746225|11742371|FG002|Overall Study|Withdrawal by Subject|19
7452286|NCT01746225|11742369|FG000|Overall Study|Physician Decision|14
7452287|NCT01746225|11742370|FG001|Overall Study|Physician Decision|11
7452288|NCT01746225|11742371|FG002|Overall Study|Physician Decision|3
7452289|NCT01746225|11742369|FG000|Overall Study|Adverse Event|15
7452290|NCT01746225|11742370|FG001|Overall Study|Adverse Event|12
7452291|NCT01746225|11742371|FG002|Overall Study|Adverse Event|17
7452292|NCT01746225|11742369|FG000|Overall Study|Continuing Treatment|5
7452293|NCT01746225|11742370|FG001|Overall Study|Continuing Treatment|8
7452294|NCT01746225|11742371|FG002|Overall Study|Continuing Treatment|3
7452295|NCT01746368|11742385|FG000|Overall Study|Lost to Follow-up|2
7452296|NCT01746368|11742386|FG001|Overall Study|Lost to Follow-up|0
7452297|NCT01746368|11742385|FG000|Overall Study|Withdrawal by Subject|0
7452298|NCT01746368|11742386|FG001|Overall Study|Withdrawal by Subject|1
7452299|NCT01746732|11742423|FG000|Lead-In Period|Withdrawal by Subject|1
7452300|NCT01746732|11742424|FG001|Lead-In Period|Withdrawal by Subject|0
7452301|NCT01746732|11742425|FG002|Lead-In Period|Withdrawal by Subject|0
7452302|NCT01746732|11742423|FG000|Period 1|Physician Decision|0
7452303|NCT01746732|11742424|FG001|Period 1|Physician Decision|1
7452304|NCT01746732|11742425|FG002|Period 1|Physician Decision|0
7452305|NCT01746732|11742423|FG000|Period 2|Withdrawal by Subject|0
7452306|NCT01746732|11742424|FG001|Period 2|Withdrawal by Subject|0
7452307|NCT01746732|11742425|FG002|Period 2|Withdrawal by Subject|2
7452308|NCT01746732|11742423|FG000|Period 2|Adverse Event|0
7452309|NCT01746732|11742424|FG001|Period 2|Adverse Event|0
7452310|NCT01746732|11742425|FG002|Period 2|Adverse Event|1
7452311|NCT01746732|11742423|FG000|Period 2|Lost to Follow-up|0
7452312|NCT01746732|11742424|FG001|Period 2|Lost to Follow-up|0
7452313|NCT01746732|11742425|FG002|Period 2|Lost to Follow-up|1
7452314|NCT01746862|11742469|FG000|Overall Study|Withdrawal by Subject|1
7452315|NCT01746862|11742470|FG001|Overall Study|Withdrawal by Subject|1
7452316|NCT01746862|11742469|FG000|Overall Study|Protocol Violation|1
7452317|NCT01746862|11742470|FG001|Overall Study|Protocol Violation|0
7452318|NCT01746862|11742469|FG000|Overall Study|Consent withdrawal by parent's guardian|5
7452319|NCT01746862|11742470|FG001|Overall Study|Consent withdrawal by parent's guardian|2
7452320|NCT01746862|11742469|FG000|Overall Study|Entered puberty during the study|1
7452321|NCT01746862|11742470|FG001|Overall Study|Entered puberty during the study|0
7452322|NCT01746901|11742477|FG000|Naloxone Challenge Phase|Adverse Event|2
7452323|NCT01746901|11742478|FG001|Naloxone Challenge Phase|Adverse Event|0
7452324|NCT01746901|11742479|FG002|Naloxone Challenge Phase|Adverse Event|0
7452325|NCT01746901|11742480|FG003|Naloxone Challenge Phase|Adverse Event|0
7452326|NCT01746901|11742481|FG004|Naloxone Challenge Phase|Adverse Event|0
7452327|NCT01746901|11742482|FG005|Naloxone Challenge Phase|Adverse Event|0
7452328|NCT01746901|11742483|FG006|Naloxone Challenge Phase|Adverse Event|0
7452329|NCT01746901|11742484|FG007|Naloxone Challenge Phase|Adverse Event|0
7452330|NCT01746901|11742485|FG008|Naloxone Challenge Phase|Adverse Event|0
7452331|NCT01746901|11742477|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
7452332|NCT01746901|11742478|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452333|NCT01746901|11742479|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452334|NCT01746901|11742480|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452335|NCT01746901|11742481|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452336|NCT01746901|11742482|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452337|NCT01746901|11742483|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452338|NCT01746901|11742484|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452339|NCT01746901|11742485|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
7452340|NCT01746901|11742477|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7452341|NCT01746901|11742478|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7452342|NCT01746901|11742479|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7452343|NCT01746901|11742480|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7452344|NCT01746901|11742481|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7452345|NCT01746901|11742482|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7452346|NCT01746901|11742483|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7452347|NCT01746901|11742484|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
7452348|NCT01746901|11742485|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
7452349|NCT01746901|11742477|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
7452350|NCT01746901|11742478|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
7452351|NCT01746901|11742479|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
7452352|NCT01746901|11742480|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
7452353|NCT01746901|11742481|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
7452354|NCT01746901|11742482|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
7452355|NCT01746901|11742483|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
7452356|NCT01746901|11742484|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
7452357|NCT01746901|11742485|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
7452358|NCT01746901|11742477|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452359|NCT01746901|11742478|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
7452360|NCT01746901|11742479|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
7452361|NCT01746901|11742480|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452362|NCT01746901|11742481|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452363|NCT01746901|11742482|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452364|NCT01746901|11742483|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452365|NCT01746901|11742484|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452366|NCT01746901|11742485|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
7452367|NCT01746901|11742477|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452368|NCT01746901|11742478|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
7452369|NCT01746901|11742479|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
7452370|NCT01746901|11742480|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452371|NCT01746901|11742481|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452372|NCT01746901|11742482|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452373|NCT01746901|11742483|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452374|NCT01746901|11742484|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452375|NCT01746901|11742485|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
7452376|NCT01746901|11742477|FG000|Treatment Phase: First Intervention|Protocol Violation|0
7452377|NCT01746901|11742478|FG001|Treatment Phase: First Intervention|Protocol Violation|0
7452378|NCT01746901|11742479|FG002|Treatment Phase: First Intervention|Protocol Violation|0
7452379|NCT01746901|11742480|FG003|Treatment Phase: First Intervention|Protocol Violation|0
7452380|NCT01746901|11742481|FG004|Treatment Phase: First Intervention|Protocol Violation|0
7452381|NCT01746901|11742482|FG005|Treatment Phase: First Intervention|Protocol Violation|0
7452382|NCT01746901|11742483|FG006|Treatment Phase: First Intervention|Protocol Violation|1
7452383|NCT01746901|11742484|FG007|Treatment Phase: First Intervention|Protocol Violation|0
7452384|NCT01746901|11742485|FG008|Treatment Phase: First Intervention|Protocol Violation|0
7452385|NCT01746901|11742477|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452386|NCT01746901|11742478|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452387|NCT01746901|11742479|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452388|NCT01746901|11742480|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452389|NCT01746901|11742481|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452390|NCT01746901|11742482|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452391|NCT01746901|11742483|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452392|NCT01746901|11742484|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
7452393|NCT01746901|11742485|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
7452394|NCT01746901|11742477|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
7452395|NCT01746901|11742478|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
7452396|NCT01746901|11742479|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
7452397|NCT01746901|11742480|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
7452398|NCT01746901|11742481|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
7452399|NCT01746901|11742482|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
7452400|NCT01746901|11742483|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
7452401|NCT01746901|11742484|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
7452402|NCT01746901|11742485|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
7452403|NCT01746901|11742477|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452404|NCT01746901|11742478|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452405|NCT01746901|11742479|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452406|NCT01746901|11742480|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
7452407|NCT01746901|11742481|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452408|NCT01746901|11742482|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452409|NCT01746901|11742483|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452410|NCT01746901|11742484|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452411|NCT01746901|11742485|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
7452412|NCT01746901|11742477|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
7452413|NCT01746901|11742478|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
7452414|NCT01746901|11742479|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
7452415|NCT01746901|11742480|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
7452416|NCT01746901|11742481|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
7452417|NCT01746901|11742482|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
7452418|NCT01746901|11742483|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
7452419|NCT01746901|11742484|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
7452420|NCT01746901|11742485|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
7452421|NCT01746901|11742477|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452422|NCT01746901|11742478|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452423|NCT01746901|11742479|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452424|NCT01746901|11742480|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452425|NCT01746901|11742481|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452426|NCT01746901|11742482|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452427|NCT01746901|11742483|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
7452428|NCT01746901|11742484|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
7452429|NCT01746901|11742485|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
7452430|NCT01747486|11742555|FG000|Stage 1|Physician Decision|3
7452431|NCT01747486|11742556|FG001|Stage 1|Physician Decision|0
7452432|NCT01747486|11742555|FG000|Stage 1|Withdrawal by Subject|4
7452433|NCT01747486|11742556|FG001|Stage 1|Withdrawal by Subject|3
7452434|NCT01747486|11742555|FG000|Stage 1|Disease progression|4
7452435|NCT01747486|11742556|FG001|Stage 1|Disease progression|9
7452436|NCT01747486|11742555|FG000|Stage 1|Death|1
7452437|NCT01747486|11742556|FG001|Stage 1|Death|1
7452438|NCT01747486|11742555|FG000|Stage 2|Physician Decision|2
7452439|NCT01747486|11742556|FG001|Stage 2|Physician Decision|0
7452440|NCT01747486|11742555|FG000|Stage 2|Withdrawal by Subject|1
7452441|NCT01747486|11742556|FG001|Stage 2|Withdrawal by Subject|0
7452442|NCT01747486|11742555|FG000|Stage 2|New Cancer Therapy|3
7452443|NCT01747486|11742556|FG001|Stage 2|New Cancer Therapy|0
7452444|NCT01747486|11742555|FG000|Stage 2|Disease Progression|3
7452445|NCT01747486|11742556|FG001|Stage 2|Disease Progression|0
7452446|NCT01747499|11742567|FG000|Overall Study|Steroid refractory aGvHD|1
7452447|NCT01747499|11742568|FG001|Overall Study|Steroid refractory aGvHD|0
7452448|NCT01747499|11742569|FG002|Overall Study|Steroid refractory aGvHD|0
7452449|NCT01747499|11742570|FG003|Overall Study|Steroid refractory aGvHD|1
7452450|NCT01747499|11742571|FG004|Overall Study|Steroid refractory aGvHD|4
7452451|NCT01747499|11742567|FG000|Overall Study|Physician Decision|0
7452452|NCT01747499|11742568|FG001|Overall Study|Physician Decision|1
7452453|NCT01747499|11742569|FG002|Overall Study|Physician Decision|0
7452454|NCT01747499|11742570|FG003|Overall Study|Physician Decision|0
7452455|NCT01747499|11742571|FG004|Overall Study|Physician Decision|2
7452456|NCT01747499|11742567|FG000|Overall Study|Death|0
7452457|NCT01747499|11742568|FG001|Overall Study|Death|0
7452458|NCT01747499|11742569|FG002|Overall Study|Death|0
7452459|NCT01747499|11742570|FG003|Overall Study|Death|1
7452460|NCT01747499|11742571|FG004|Overall Study|Death|1
7452461|NCT01747499|11742567|FG000|Overall Study|Withdrawal by Subject|0
7452462|NCT01747499|11742568|FG001|Overall Study|Withdrawal by Subject|0
7452463|NCT01747499|11742569|FG002|Overall Study|Withdrawal by Subject|0
7452464|NCT01747499|11742570|FG003|Overall Study|Withdrawal by Subject|0
7452465|NCT01747499|11742571|FG004|Overall Study|Withdrawal by Subject|6
7452466|NCT01747499|11742567|FG000|Overall Study|Developed AML and death|0
7452467|NCT01747499|11742568|FG001|Overall Study|Developed AML and death|0
7452468|NCT01747499|11742569|FG002|Overall Study|Developed AML and death|0
7452469|NCT01747499|11742570|FG003|Overall Study|Developed AML and death|0
7452470|NCT01747499|11742571|FG004|Overall Study|Developed AML and death|1
7452471|NCT01747499|11742567|FG000|Overall Study|Determined not to be eligible|0
7532991|NCT02679287|11878986|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
7532992|NCT02679287|11878985|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
7532993|NCT02679287|11878986|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
7532994|NCT02679287|11878985|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
7532995|NCT02679287|11878986|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
7532996|NCT02679287|11878985|FG000|Period 2|Work/Scheduling Conflict|1
7532997|NCT02679287|11878986|FG001|Period 2|Work/Scheduling Conflict|0
7452472|NCT01747499|11742568|FG001|Overall Study|Determined not to be eligible|0
7452473|NCT01747499|11742569|FG002|Overall Study|Determined not to be eligible|0
7452474|NCT01747499|11742570|FG003|Overall Study|Determined not to be eligible|0
7452475|NCT01747499|11742571|FG004|Overall Study|Determined not to be eligible|1
7452476|NCT01747551|11742587|FG000|Overall Study|Progressive Disease|24
7452477|NCT01747551|11742588|FG001|Overall Study|Progressive Disease|17
7452478|NCT01747551|11742587|FG000|Overall Study|Death|3
7452479|NCT01747551|11742588|FG001|Overall Study|Death|1
7452480|NCT01747551|11742587|FG000|Overall Study|Adverse Event|7
7452481|NCT01747551|11742588|FG001|Overall Study|Adverse Event|1
7452482|NCT01747551|11742587|FG000|Overall Study|Prolonged Treatment Delay|2
7452483|NCT01747551|11742588|FG001|Overall Study|Prolonged Treatment Delay|0
7452484|NCT01747551|11742587|FG000|Overall Study|Withdrawal by Subject|3
7452485|NCT01747551|11742588|FG001|Overall Study|Withdrawal by Subject|1
7452486|NCT01747551|11742587|FG000|Overall Study|Physician Decision|2
7452487|NCT01747551|11742588|FG001|Overall Study|Physician Decision|1
7452488|NCT01747551|11742587|FG000|Overall Study|Other|2
7452489|NCT01747551|11742588|FG001|Overall Study|Other|0
7452490|NCT01747629|11742596|FG000|Overall Study|Adverse Event|1
7452491|NCT01747629|11742597|FG001|Overall Study|Adverse Event|2
7452492|NCT01747629|11742596|FG000|Overall Study|Withdrawal by Subject|2
7452493|NCT01747629|11742597|FG001|Overall Study|Withdrawal by Subject|2
7452494|NCT01747629|11742596|FG000|Overall Study|Noncompliance|1
7452495|NCT01747629|11742597|FG001|Overall Study|Noncompliance|1
7452496|NCT01747629|11742596|FG000|Overall Study|Inclusion criteria not met|1
7452497|NCT01747629|11742597|FG001|Overall Study|Inclusion criteria not met|0
7452498|NCT01747629|11742596|FG000|Overall Study|Not treated|1
7452499|NCT01747629|11742597|FG001|Overall Study|Not treated|0
7452500|NCT01747629|11742596|FG000|Overall Study|Other|2
7452501|NCT01747629|11742597|FG001|Overall Study|Other|1
7452502|NCT01747655|11742603|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
7452503|NCT01747655|11742604|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
7452504|NCT01747655|11742603|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
7452505|NCT01747655|11742604|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
7452506|NCT01747655|11742603|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
7452507|NCT01747655|11742604|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
7452508|NCT01747772|11742610|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
7452509|NCT01747811|11742620|FG000|Overall Study|Lack of Efficacy|2
7452510|NCT01747811|11742621|FG001|Overall Study|Lack of Efficacy|4
7452511|NCT01747837|11742631|FG000|Overall Study|Lost to Follow-up|5
7452512|NCT01747837|11742632|FG001|Overall Study|Lost to Follow-up|2
7452513|NCT01747837|11742631|FG000|Overall Study|Death|4
7452514|NCT01747837|11742632|FG001|Overall Study|Death|4
7452515|NCT01747876|11742666|FG000|Overall Study|Adverse Event|1
7452516|NCT01747876|11742667|FG001|Overall Study|Adverse Event|0
7452517|NCT01747876|11742668|FG002|Overall Study|Adverse Event|2
7452518|NCT01747876|11742666|FG000|Overall Study|Withdrawal by Subject|0
7452519|NCT01747876|11742667|FG001|Overall Study|Withdrawal by Subject|1
7452520|NCT01747876|11742668|FG002|Overall Study|Withdrawal by Subject|1
7452521|NCT01747876|11742666|FG000|Overall Study|Disease progression|4
7452522|NCT01747876|11742667|FG001|Overall Study|Disease progression|13
7452523|NCT01747876|11742668|FG002|Overall Study|Disease progression|8
7452524|NCT01747876|11742666|FG000|Overall Study|Trtment duration compl. as per protocol|0
7452525|NCT01747876|11742667|FG001|Overall Study|Trtment duration compl. as per protocol|1
7452526|NCT01747876|11742668|FG002|Overall Study|Trtment duration compl. as per protocol|1
7452527|NCT01747915|11742682|FG000|Overall Study|Other|1
7452528|NCT01747915|11742683|FG001|Overall Study|Other|1
7452529|NCT01747915|11742684|FG002|Overall Study|Other|1
7452530|NCT01747915|11742682|FG000|Overall Study|Adverse Event|8
7452531|NCT01747915|11742683|FG001|Overall Study|Adverse Event|5
7452532|NCT01747915|11742684|FG002|Overall Study|Adverse Event|2
7452533|NCT01747915|11742682|FG000|Overall Study|Death|0
7452534|NCT01747915|11742683|FG001|Overall Study|Death|0
7452535|NCT01747915|11742684|FG002|Overall Study|Death|1
7452536|NCT01747915|11742682|FG000|Overall Study|Lack of Efficacy|0
7452537|NCT01747915|11742683|FG001|Overall Study|Lack of Efficacy|1
7452538|NCT01747915|11742684|FG002|Overall Study|Lack of Efficacy|0
7452539|NCT01747915|11742682|FG000|Overall Study|Lost to Follow-up|1
7452540|NCT01747915|11742683|FG001|Overall Study|Lost to Follow-up|0
7452541|NCT01747915|11742684|FG002|Overall Study|Lost to Follow-up|0
7452542|NCT01747915|11742682|FG000|Overall Study|Withdrawal by Subject|4
7452543|NCT01747915|11742683|FG001|Overall Study|Withdrawal by Subject|4
7452544|NCT01747915|11742684|FG002|Overall Study|Withdrawal by Subject|1
7452545|NCT01747915|11742682|FG000|Overall Study|Protocol Violation|1
7452546|NCT01747915|11742683|FG001|Overall Study|Protocol Violation|0
7452547|NCT01747915|11742684|FG002|Overall Study|Protocol Violation|0
7452548|NCT01747915|11742682|FG000|Overall Study|Pregnancy|0
7452549|NCT01747915|11742683|FG001|Overall Study|Pregnancy|0
7452550|NCT01747915|11742684|FG002|Overall Study|Pregnancy|1
7452551|NCT01748071|11742744|FG000|Overall Study|Adverse Event|2
7452552|NCT01748071|11742745|FG001|Overall Study|Adverse Event|2
7452553|NCT01748071|11742746|FG002|Overall Study|Adverse Event|0
7452554|NCT01748292|11742765|FG000|Overall Study|Adverse Event|2
7452555|NCT01748292|11742766|FG001|Overall Study|Adverse Event|4
7452556|NCT01748292|11742765|FG000|Overall Study|Lost to Follow-up|0
7452557|NCT01748292|11742766|FG001|Overall Study|Lost to Follow-up|3
7452558|NCT01748292|11742765|FG000|Overall Study|Death|0
7452559|NCT01748292|11742766|FG001|Overall Study|Death|3
7452560|NCT01748292|11742765|FG000|Overall Study|Withdrawal by Subject|0
7452561|NCT01748292|11742766|FG001|Overall Study|Withdrawal by Subject|2
7452562|NCT01748552|11742784|FG000|Intervention Period 2 and Washout|Physician Decision|0
7452563|NCT01748552|11742785|FG001|Intervention Period 2 and Washout|Physician Decision|0
7452564|NCT01748552|11742786|FG002|Intervention Period 2 and Washout|Physician Decision|1
7452565|NCT01748552|11742787|FG003|Intervention Period 2 and Washout|Physician Decision|0
7468014|NCT01905267|11768478|FG000|Overall Study|Physician Decision|2
7452566|NCT01748552|11742788|FG004|Intervention Period 2 and Washout|Physician Decision|0
7452567|NCT01748552|11742789|FG005|Intervention Period 2 and Washout|Physician Decision|0
7452568|NCT01748552|11742790|FG006|Intervention Period 2 and Washout|Physician Decision|0
7452569|NCT01748552|11742791|FG007|Intervention Period 2 and Washout|Physician Decision|0
7452570|NCT01748552|11742792|FG008|Intervention Period 2 and Washout|Physician Decision|0
7452571|NCT01748552|11742793|FG009|Intervention Period 2 and Washout|Physician Decision|0
7452572|NCT01748552|11742794|FG010|Intervention Period 2 and Washout|Physician Decision|0
7452573|NCT01748552|11742795|FG011|Intervention Period 2 and Washout|Physician Decision|0
7452574|NCT01748552|11742784|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
7452575|NCT01748552|11742785|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
7452576|NCT01748552|11742786|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
7452577|NCT01748552|11742787|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
7452578|NCT01748552|11742788|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
7452579|NCT01748552|11742789|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
7452580|NCT01748552|11742790|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
7452581|NCT01748552|11742791|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
7452582|NCT01748552|11742792|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
7452583|NCT01748552|11742793|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
7452584|NCT01748552|11742794|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
7452585|NCT01748552|11742795|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
7452586|NCT01748760|11742853|FG000|Overall Study|Withdrawal by Subject|1
7452587|NCT01748760|11742854|FG001|Overall Study|Withdrawal by Subject|1
7452588|NCT01748760|11742853|FG000|Overall Study|Lost to Follow-up|5
7452589|NCT01748760|11742854|FG001|Overall Study|Lost to Follow-up|1
7452590|NCT01748825|11742911|FG000|Dose Escalation|Refused further treatment|2
7452591|NCT01748825|11742912|FG001|Dose Escalation|Refused further treatment|2
7452592|NCT01748825|11742913|FG002|Dose Escalation|Refused further treatment|0
7452593|NCT01748825|11742914|FG003|Dose Escalation|Refused further treatment|0
7452594|NCT01748825|11742915|FG004|Dose Escalation|Refused further treatment|1
7452595|NCT01748825|11742916|FG005|Dose Escalation|Refused further treatment|2
7452596|NCT01748825|11742917|FG006|Dose Escalation|Refused further treatment|0
7452597|NCT01748825|11742918|FG007|Dose Escalation|Refused further treatment|0
7452598|NCT01748825|11742919|FG008|Dose Escalation|Refused further treatment|0
7452599|NCT01748825|11742920|FG009|Dose Escalation|Refused further treatment|0
7452600|NCT01748825|11742911|FG000|Dose Escalation|Switched to alternative treatment|0
7452601|NCT01748825|11742912|FG001|Dose Escalation|Switched to alternative treatment|0
7452602|NCT01748825|11742913|FG002|Dose Escalation|Switched to alternative treatment|0
7452603|NCT01748825|11742914|FG003|Dose Escalation|Switched to alternative treatment|1
7452604|NCT01748825|11742915|FG004|Dose Escalation|Switched to alternative treatment|0
7452605|NCT01748825|11742916|FG005|Dose Escalation|Switched to alternative treatment|0
7452606|NCT01748825|11742917|FG006|Dose Escalation|Switched to alternative treatment|0
7452607|NCT01748825|11742918|FG007|Dose Escalation|Switched to alternative treatment|0
7452608|NCT01748825|11742919|FG008|Dose Escalation|Switched to alternative treatment|0
7452609|NCT01748825|11742920|FG009|Dose Escalation|Switched to alternative treatment|0
7452610|NCT01748825|11742911|FG000|Dose Escalation|Adverse Event|0
7452611|NCT01748825|11742912|FG001|Dose Escalation|Adverse Event|0
7452612|NCT01748825|11742913|FG002|Dose Escalation|Adverse Event|0
7452613|NCT01748825|11742914|FG003|Dose Escalation|Adverse Event|0
7452614|NCT01748825|11742915|FG004|Dose Escalation|Adverse Event|0
7452615|NCT01748825|11742916|FG005|Dose Escalation|Adverse Event|0
7452616|NCT01748825|11742917|FG006|Dose Escalation|Adverse Event|1
7452617|NCT01748825|11742918|FG007|Dose Escalation|Adverse Event|0
7452618|NCT01748825|11742919|FG008|Dose Escalation|Adverse Event|0
7452619|NCT01748825|11742920|FG009|Dose Escalation|Adverse Event|0
7452620|NCT01748825|11742911|FG000|Dose Expansion|Refused further treatment|0
7452621|NCT01748825|11742912|FG001|Dose Expansion|Refused further treatment|0
7452622|NCT01748825|11742913|FG002|Dose Expansion|Refused further treatment|0
7452623|NCT01748825|11742914|FG003|Dose Expansion|Refused further treatment|0
7452624|NCT01748825|11742915|FG004|Dose Expansion|Refused further treatment|0
7452625|NCT01748825|11742916|FG005|Dose Expansion|Refused further treatment|0
7452626|NCT01748825|11742917|FG006|Dose Expansion|Refused further treatment|0
7452627|NCT01748825|11742918|FG007|Dose Expansion|Refused further treatment|0
7452628|NCT01748825|11742919|FG008|Dose Expansion|Refused further treatment|1
7452629|NCT01748825|11742920|FG009|Dose Expansion|Refused further treatment|1
7452630|NCT01748825|11742911|FG000|Dose Expansion|Switched to alternative treatment|0
7452631|NCT01748825|11742912|FG001|Dose Expansion|Switched to alternative treatment|0
7452632|NCT01748825|11742913|FG002|Dose Expansion|Switched to alternative treatment|0
7452633|NCT01748825|11742914|FG003|Dose Expansion|Switched to alternative treatment|0
7452634|NCT01748825|11742915|FG004|Dose Expansion|Switched to alternative treatment|0
7452635|NCT01748825|11742916|FG005|Dose Expansion|Switched to alternative treatment|0
7452636|NCT01748825|11742917|FG006|Dose Expansion|Switched to alternative treatment|0
7532998|NCT02679287|11878985|FG000|Period 2|Disliked Mobile System|2
7452637|NCT01748825|11742918|FG007|Dose Expansion|Switched to alternative treatment|0
7452638|NCT01748825|11742919|FG008|Dose Expansion|Switched to alternative treatment|0
7452639|NCT01748825|11742920|FG009|Dose Expansion|Switched to alternative treatment|1
7452640|NCT01748825|11742911|FG000|Dose Expansion|Adverse Event|0
7452641|NCT01748825|11742912|FG001|Dose Expansion|Adverse Event|0
7452642|NCT01748825|11742913|FG002|Dose Expansion|Adverse Event|0
7452643|NCT01748825|11742914|FG003|Dose Expansion|Adverse Event|0
7452644|NCT01748825|11742915|FG004|Dose Expansion|Adverse Event|0
7452645|NCT01748825|11742916|FG005|Dose Expansion|Adverse Event|0
7452646|NCT01748825|11742917|FG006|Dose Expansion|Adverse Event|0
7452647|NCT01748825|11742918|FG007|Dose Expansion|Adverse Event|0
7452648|NCT01748825|11742919|FG008|Dose Expansion|Adverse Event|0
7452649|NCT01748825|11742920|FG009|Dose Expansion|Adverse Event|3
7452650|NCT01748825|11742911|FG000|Dose Expansion|Physician Decision|0
7452651|NCT01748825|11742912|FG001|Dose Expansion|Physician Decision|0
7452652|NCT01748825|11742913|FG002|Dose Expansion|Physician Decision|0
7452653|NCT01748825|11742914|FG003|Dose Expansion|Physician Decision|0
7452654|NCT01748825|11742915|FG004|Dose Expansion|Physician Decision|0
7452655|NCT01748825|11742916|FG005|Dose Expansion|Physician Decision|0
7452656|NCT01748825|11742917|FG006|Dose Expansion|Physician Decision|0
7452657|NCT01748825|11742918|FG007|Dose Expansion|Physician Decision|0
7452658|NCT01748825|11742919|FG008|Dose Expansion|Physician Decision|1
7452659|NCT01748825|11742920|FG009|Dose Expansion|Physician Decision|0
7452660|NCT01748994|11742982|FG000|Overall Study|Lost to Follow-up|8
7452661|NCT01748994|11742983|FG001|Overall Study|Lost to Follow-up|6
7468015|NCT01905267|11768479|FG001|Overall Study|Physician Decision|2
7468016|NCT01905540|11768510|FG000|Period 3|Other|1
7468017|NCT01905540|11768511|FG001|Period 3|Other|0
7468018|NCT01905540|11768512|FG002|Period 3|Other|1
7468019|NCT01905540|11768513|FG003|Period 3|Other|1
7468020|NCT01905553|11768525|FG000|Period 2|Adverse Event|1
7468021|NCT01905553|11768526|FG001|Period 2|Adverse Event|0
7468022|NCT01905592|11768534|FG000|Overall Study|Disease Progression|51
7468023|NCT01905592|11768535|FG001|Overall Study|Disease Progression|104
7468024|NCT01905592|11768534|FG000|Overall Study|Toxicity|1
7468025|NCT01905592|11768535|FG001|Overall Study|Toxicity|16
7468026|NCT01905592|11768534|FG000|Overall Study|Physician Decision|0
7468027|NCT01905592|11768535|FG001|Overall Study|Physician Decision|2
7468028|NCT01905592|11768534|FG000|Overall Study|New anti-cancer|1
7468029|NCT01905592|11768535|FG001|Overall Study|New anti-cancer|0
7468030|NCT01905592|11768534|FG000|Overall Study|Protocol Violation|0
7468031|NCT01905592|11768535|FG001|Overall Study|Protocol Violation|1
7468032|NCT01905592|11768534|FG000|Overall Study|Sponsor's decision|1
7468033|NCT01905592|11768535|FG001|Overall Study|Sponsor's decision|0
7468034|NCT01905592|11768534|FG000|Overall Study|Not treated|7
7468035|NCT01905592|11768535|FG001|Overall Study|Not treated|3
7468036|NCT01905592|11768534|FG000|Overall Study|Ongoing in Study|0
7468037|NCT01905592|11768535|FG001|Overall Study|Ongoing in Study|7
7468038|NCT01905592|11768534|FG000|Overall Study|Withdrawal by Subject|10
7468039|NCT01905592|11768535|FG001|Overall Study|Withdrawal by Subject|2
7468040|NCT01905657|11768544|FG000|Overall Study|Adverse Event|23
7468041|NCT01905657|11768545|FG001|Overall Study|Adverse Event|17
7468042|NCT01905657|11768546|FG002|Overall Study|Adverse Event|18
7468043|NCT01905657|11768544|FG000|Overall Study|Clinical Progression|103
7468044|NCT01905657|11768545|FG001|Overall Study|Clinical Progression|78
7468045|NCT01905657|11768546|FG002|Overall Study|Clinical Progression|59
7468046|NCT01905657|11768544|FG000|Overall Study|Death|40
7468047|NCT01905657|11768545|FG001|Overall Study|Death|43
7468048|NCT01905657|11768546|FG002|Overall Study|Death|47
7468049|NCT01905657|11768544|FG000|Overall Study|Excluded Medication|13
7468050|NCT01905657|11768545|FG001|Overall Study|Excluded Medication|16
7532999|NCT02679287|11878986|FG001|Period 2|Disliked Mobile System|0
7533000|NCT02679287|11878985|FG000|Period 3|Work/Scheduling Conflict|0
7533001|NCT02679287|11878986|FG001|Period 3|Work/Scheduling Conflict|1
7533002|NCT02679573|11879004|FG000|Overall Study|Adverse Event|13
7533003|NCT02679573|11879005|FG001|Overall Study|Adverse Event|6
7533004|NCT02679573|11879004|FG000|Overall Study|Lack of Efficacy|12
7533005|NCT02679573|11879005|FG001|Overall Study|Lack of Efficacy|15
7533006|NCT02679573|11879004|FG000|Overall Study|Could not complete required study visits|6
7533007|NCT02679573|11879005|FG001|Overall Study|Could not complete required study visits|2
7533008|NCT02679573|11879004|FG000|Overall Study|Withdrawal by Subject|2
7533009|NCT02679573|11879005|FG001|Overall Study|Withdrawal by Subject|9
7533010|NCT02679573|11879004|FG000|Overall Study|Death|2
7533011|NCT02679573|11879005|FG001|Overall Study|Death|0
7468051|NCT01905657|11768546|FG002|Overall Study|Excluded Medication|9
7468052|NCT01905657|11768544|FG000|Overall Study|Lost to Follow-up|1
7468053|NCT01905657|11768545|FG001|Overall Study|Lost to Follow-up|2
7468054|NCT01905657|11768546|FG002|Overall Study|Lost to Follow-up|1
7468055|NCT01905657|11768544|FG000|Overall Study|Physician Decision|5
7468056|NCT01905657|11768545|FG001|Overall Study|Physician Decision|8
7468057|NCT01905657|11768546|FG002|Overall Study|Physician Decision|12
7468058|NCT01905657|11768544|FG000|Overall Study|Protocol Violation|2
7468059|NCT01905657|11768545|FG001|Overall Study|Protocol Violation|1
7468060|NCT01905657|11768546|FG002|Overall Study|Protocol Violation|1
7468061|NCT01905657|11768544|FG000|Overall Study|Screen Failure|0
7468062|NCT01905657|11768545|FG001|Overall Study|Screen Failure|1
7533012|NCT02679573|11879004|FG000|Overall Study|Physician Decision|2
7468063|NCT01905657|11768546|FG002|Overall Study|Screen Failure|0
7468064|NCT01905657|11768544|FG000|Overall Study|Withdrawal by Subject|15
7468065|NCT01905657|11768545|FG001|Overall Study|Withdrawal by Subject|21
7468066|NCT01905657|11768546|FG002|Overall Study|Withdrawal by Subject|53
7468067|NCT01905657|11768544|FG000|Overall Study|Sponsor Decision|1
7533013|NCT02679573|11879005|FG001|Overall Study|Physician Decision|4
7452662|NCT01749033|11742992|FG000|Overall Study|Did not receive allocated intervention|3
7452663|NCT01749033|11742993|FG001|Overall Study|Did not receive allocated intervention|3
7452664|NCT01749033|11742994|FG002|Overall Study|Did not receive allocated intervention|0
7452665|NCT01749033|11742992|FG000|Overall Study|Lost to Follow-up|0
7452666|NCT01749033|11742993|FG001|Overall Study|Lost to Follow-up|2
7452667|NCT01749033|11742994|FG002|Overall Study|Lost to Follow-up|1
7452668|NCT01749735|11743045|FG000|Overall Study|Withdrawal by Subject|1
7452669|NCT01749735|11743046|FG001|Overall Study|Withdrawal by Subject|0
7452670|NCT01749800|11743055|FG000|Overall Study|not meeting inclusion criteria|3
7452671|NCT01749800|11743056|FG001|Overall Study|not meeting inclusion criteria|0
7452672|NCT01749800|11743057|FG002|Overall Study|not meeting inclusion criteria|0
7452673|NCT01749800|11743055|FG000|Overall Study|Withdrawal by Subject|0
7452674|NCT01749800|11743056|FG001|Overall Study|Withdrawal by Subject|1
7452675|NCT01749800|11743057|FG002|Overall Study|Withdrawal by Subject|0
7452676|NCT01749982|11743100|FG000|Overall Study|Physician Decision|0
7452677|NCT01749982|11743101|FG001|Overall Study|Physician Decision|0
7452678|NCT01749982|11743102|FG002|Overall Study|Physician Decision|0
7452679|NCT01749982|11743103|FG003|Overall Study|Physician Decision|1
7563961|NCT03270644|11934224|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
7563962|NCT03270644|11934224|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
7452680|NCT01749982|11743100|FG000|Overall Study|Lost to Follow-up|0
7452681|NCT01749982|11743101|FG001|Overall Study|Lost to Follow-up|0
7452682|NCT01749982|11743102|FG002|Overall Study|Lost to Follow-up|0
7452683|NCT01749982|11743103|FG003|Overall Study|Lost to Follow-up|1
7452684|NCT01749982|11743100|FG000|Overall Study|Withdrawal by Subject|0
7452685|NCT01749982|11743101|FG001|Overall Study|Withdrawal by Subject|0
7452686|NCT01749982|11743102|FG002|Overall Study|Withdrawal by Subject|0
7452687|NCT01749982|11743103|FG003|Overall Study|Withdrawal by Subject|1
7452688|NCT01750190|11743128|FG000|Overall Study|Adverse Event|47
7452689|NCT01750190|11743129|FG001|Overall Study|Adverse Event|19
7452690|NCT01750190|11743128|FG000|Overall Study|Death|38
7452691|NCT01750190|11743129|FG001|Overall Study|Death|11
7452692|NCT01750190|11743128|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
7452693|NCT01750190|11743129|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
7452694|NCT01750190|11743128|FG000|Overall Study|Lost to Follow-up|28
7452695|NCT01750190|11743129|FG001|Overall Study|Lost to Follow-up|7
7452696|NCT01750190|11743128|FG000|Overall Study|Physician Decision|16
7452697|NCT01750190|11743129|FG001|Overall Study|Physician Decision|17
7452698|NCT01750190|11743128|FG000|Overall Study|Protocol Violation|6
7452699|NCT01750190|11743129|FG001|Overall Study|Protocol Violation|5
7452700|NCT01750190|11743128|FG000|Overall Study|Study/Site Terminated by Sponsor|4
7452701|NCT01750190|11743129|FG001|Overall Study|Study/Site Terminated by Sponsor|1
7563963|NCT03270657|11934235|FG000|Overall Study|Withdrawal by Subject|1
7452702|NCT01750190|11743128|FG000|Overall Study|Withdrawal by Subject|83
7452703|NCT01750190|11743129|FG001|Overall Study|Withdrawal by Subject|89
7452704|NCT01750190|11743128|FG000|Overall Study|Kidney Transplant|8
7452705|NCT01750190|11743129|FG001|Overall Study|Kidney Transplant|4
7452706|NCT01750190|11743128|FG000|Overall Study|Dialysis|22
7452707|NCT01750190|11743129|FG001|Overall Study|Dialysis|8
7452708|NCT01750190|11743128|FG000|Overall Study|Other than Specified|13
7452709|NCT01750190|11743129|FG001|Overall Study|Other than Specified|4
7452710|NCT01750229|11743135|FG000|Randomized Crossover Phase|Adverse Event|1
7452711|NCT01750229|11743135|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
7452712|NCT01750229|11743135|FG000|Long-term Follow-up Phase|Adverse Event|2
7452713|NCT01750229|11743135|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
7452714|NCT01750242|11743145|FG000|Overall Study|Unreadable Images|3
7452715|NCT01750268|11743162|FG000|Overall Study|Lost to Follow-up|0
7452716|NCT01750268|11743163|FG001|Overall Study|Lost to Follow-up|2
7452717|NCT01750268|11743162|FG000|Overall Study|Physician Decision|0
7452718|NCT01750268|11743163|FG001|Overall Study|Physician Decision|3
7452719|NCT01750268|11743162|FG000|Overall Study|Withdrawal by Subject|2
7452720|NCT01750268|11743163|FG001|Overall Study|Withdrawal by Subject|0
7452721|NCT01750294|11743169|FG000|Overall Study|Withdrawal by Subject|1
7452722|NCT01750294|11743169|FG000|Overall Study|Safety Endpoint|1
7452723|NCT01750346|11743176|FG000|Overall Study|Adverse Event|1
7452724|NCT01750346|11743177|FG001|Overall Study|Adverse Event|0
7452725|NCT01750346|11743178|FG002|Overall Study|Adverse Event|0
7452726|NCT01750684|11743206|FG000|Overall Study|Death|1
7452727|NCT01750684|11743207|FG001|Overall Study|Death|0
7563964|NCT03271307|11934253|FG000|Overall Study|Lost to Follow-up|0
7563965|NCT03271307|11934254|FG001|Overall Study|Lost to Follow-up|0
7563966|NCT03271307|11934255|FG002|Overall Study|Lost to Follow-up|0
7563967|NCT03271307|11934256|FG003|Overall Study|Lost to Follow-up|28
7563968|NCT03271307|11934257|FG004|Overall Study|Lost to Follow-up|91
7563969|NCT03271528|11934289|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
7563970|NCT03271528|11934290|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
7563971|NCT03271528|11934289|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
7563972|NCT03271528|11934290|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
7563973|NCT03271528|11934289|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
7563974|NCT03271528|11934290|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
7563975|NCT03271528|11934289|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
7452728|NCT01750684|11743206|FG000|Overall Study|Non-compliance with Study Drug|0
7452729|NCT01750684|11743207|FG001|Overall Study|Non-compliance with Study Drug|1
7452730|NCT01750684|11743206|FG000|Overall Study|Withdrawn by Sponsor|0
7452731|NCT01750684|11743207|FG001|Overall Study|Withdrawn by Sponsor|1
7452732|NCT01750684|11743206|FG000|Overall Study|Protocol Violation|1
7452733|NCT01750684|11743207|FG001|Overall Study|Protocol Violation|0
7452734|NCT01750697|11743214|FG000|Overall Study|Transferred Back to Local Hospital|1
7452735|NCT01750697|11743214|FG000|Overall Study|Physician and Family Decision|1
7452736|NCT01750697|11743214|FG000|Overall Study|Transferred to Adult Services|5
7452737|NCT01750697|11743214|FG000|Overall Study|Physician Decision|1
7452738|NCT01750697|11743214|FG000|Overall Study|Withdrawal by Subject|1
7452739|NCT01750840|11743221|FG000|Overall Study|Lost to Follow-up|4
7452740|NCT01750879|11743228|FG000|Overall Study|Adverse Event|8
7452741|NCT01750879|11743229|FG001|Overall Study|Adverse Event|0
7452742|NCT01750879|11743228|FG000|Overall Study|Lack of Efficacy|1
7452743|NCT01750879|11743229|FG001|Overall Study|Lack of Efficacy|0
7452744|NCT01750879|11743228|FG000|Overall Study|Withdrawal by Subject|1
7452745|NCT01750879|11743229|FG001|Overall Study|Withdrawal by Subject|0
7452746|NCT01750879|11743228|FG000|Overall Study|Did not complete per protocol|0
7452747|NCT01750879|11743229|FG001|Overall Study|Did not complete per protocol|3
7452748|NCT01750918|11743256|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
7452749|NCT01750918|11743257|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
7452750|NCT01750918|11743258|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
7452751|NCT01750918|11743259|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
7452752|NCT01750918|11743260|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
7452753|NCT01750918|11743261|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
7452754|NCT01750918|11743262|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
7452755|NCT01750918|11743263|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
7452756|NCT01750918|11743256|FG000|Overall Study|Lost to Follow-up|0
7452757|NCT01750918|11743257|FG001|Overall Study|Lost to Follow-up|0
7452758|NCT01750918|11743258|FG002|Overall Study|Lost to Follow-up|2
7452759|NCT01750918|11743259|FG003|Overall Study|Lost to Follow-up|2
7452760|NCT01750918|11743260|FG004|Overall Study|Lost to Follow-up|0
7452761|NCT01750918|11743261|FG005|Overall Study|Lost to Follow-up|0
7452762|NCT01750918|11743262|FG006|Overall Study|Lost to Follow-up|0
7452763|NCT01750918|11743263|FG007|Overall Study|Lost to Follow-up|1
7452764|NCT01750918|11743256|FG000|Overall Study|Withdrawal by Subject|0
7452765|NCT01750918|11743257|FG001|Overall Study|Withdrawal by Subject|0
7452766|NCT01750918|11743258|FG002|Overall Study|Withdrawal by Subject|1
7452767|NCT01750918|11743259|FG003|Overall Study|Withdrawal by Subject|2
7452768|NCT01750918|11743260|FG004|Overall Study|Withdrawal by Subject|1
7452769|NCT01750918|11743261|FG005|Overall Study|Withdrawal by Subject|1
7452770|NCT01750918|11743262|FG006|Overall Study|Withdrawal by Subject|2
7452771|NCT01750918|11743263|FG007|Overall Study|Withdrawal by Subject|2
7452772|NCT01751061|11743334|FG000|Overall Study|Death|1
7452773|NCT01751061|11743335|FG001|Overall Study|Death|0
7452774|NCT01751061|11743334|FG000|Overall Study|patient death|5
7452775|NCT01751061|11743335|FG001|Overall Study|patient death|0
7452776|NCT01751061|11743334|FG000|Overall Study|Lost to Follow-up|40
7452777|NCT01751061|11743335|FG001|Overall Study|Lost to Follow-up|25
7452778|NCT01751061|11743334|FG000|Overall Study|patient regained decisional capacity|4
7563976|NCT03271528|11934290|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
7563977|NCT03271528|11934289|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7563978|NCT03271528|11934290|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
7452779|NCT01751061|11743335|FG001|Overall Study|patient regained decisional capacity|8
7452780|NCT01751061|11743334|FG000|Overall Study|Withdrawal by Subject|4
7452781|NCT01751061|11743335|FG001|Overall Study|Withdrawal by Subject|1
7452782|NCT01751061|11743334|FG000|Overall Study|Physician Decision|2
7452783|NCT01751061|11743335|FG001|Overall Study|Physician Decision|0
7452784|NCT01751087|11743344|FG000|Overall Study|Withdrawal by Subject|1
7452785|NCT01751087|11743345|FG001|Overall Study|Withdrawal by Subject|0
7452786|NCT01751087|11743346|FG002|Overall Study|Withdrawal by Subject|0
7452787|NCT01751087|11743344|FG000|Overall Study|Physician Decision|0
7452788|NCT01751087|11743345|FG001|Overall Study|Physician Decision|0
7452789|NCT01751087|11743346|FG002|Overall Study|Physician Decision|1
7452790|NCT01751113|11743354|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
7452791|NCT01751113|11743355|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
7452792|NCT01751113|11743356|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
7452793|NCT01751113|11743357|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
7452794|NCT01751113|11743358|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
7452795|NCT01751113|11743359|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
7563979|NCT03271528|11934289|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
7452796|NCT01751113|11743354|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
7452797|NCT01751113|11743355|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
7452798|NCT01751113|11743356|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
7452799|NCT01751113|11743357|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
7452800|NCT01751113|11743358|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
7452801|NCT01751113|11743359|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
7452802|NCT01751139|11743368|FG000|Overall Study|Other|135
7452803|NCT01751139|11743368|FG000|Overall Study|Sponsor study termination|1609
7452804|NCT01751139|11743368|FG000|Overall Study|Lost to Follow-up|240
7452805|NCT01751139|11743368|FG000|Overall Study|Withdrawal by Subject|251
7452806|NCT01751139|11743368|FG000|Overall Study|Adverse Event|1
7452807|NCT01751139|11743368|FG000|Overall Study|Death|31
7452808|NCT01751165|11743375|FG000|Overall Study|Adverse event, serious fatal|1
7452809|NCT01751165|11743376|FG001|Overall Study|Adverse event, serious fatal|0
7452810|NCT01751165|11743377|FG002|Overall Study|Adverse event, serious fatal|1
7452811|NCT01751165|11743375|FG000|Overall Study|Withdrawal by Subject|0
7452812|NCT01751165|11743376|FG001|Overall Study|Withdrawal by Subject|0
7563980|NCT03271528|11934290|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
7563981|NCT03271528|11934289|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
7563982|NCT03271528|11934290|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
7452813|NCT01751165|11743377|FG002|Overall Study|Withdrawal by Subject|1
7452814|NCT01751165|11743375|FG000|Overall Study|Serious adverse event|0
7452815|NCT01751165|11743376|FG001|Overall Study|Serious adverse event|2
7452816|NCT01751165|11743377|FG002|Overall Study|Serious adverse event|0
7452817|NCT01751165|11743375|FG000|Overall Study|Lost to Follow-up|1
7452818|NCT01751165|11743376|FG001|Overall Study|Lost to Follow-up|1
7452819|NCT01751165|11743377|FG002|Overall Study|Lost to Follow-up|1
7452820|NCT01751178|11743390|FG000|Overall Study|Adverse Event|2
7452821|NCT01751178|11743391|FG001|Overall Study|Adverse Event|0
7452822|NCT01751178|11743392|FG002|Overall Study|Adverse Event|0
7452823|NCT01751178|11743390|FG000|Overall Study|Other Reason (unknown)|1
7452824|NCT01751178|11743391|FG001|Overall Study|Other Reason (unknown)|0
7452825|NCT01751178|11743392|FG002|Overall Study|Other Reason (unknown)|2
7452826|NCT01751412|11743468|FG000|Overall Study|Disease Progression Before Treatment|1
7452827|NCT01751568|11743488|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
7452828|NCT01751568|11743489|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7452829|NCT01751568|11743490|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
7452830|NCT01751646|11743500|FG000|Overall Study|Lost to Follow-up|5
7452831|NCT01751646|11743501|FG001|Overall Study|Lost to Follow-up|1
7452832|NCT01751646|11743500|FG000|Overall Study|Withdrawal by Subject|0
7452833|NCT01751646|11743501|FG001|Overall Study|Withdrawal by Subject|4
7452834|NCT01751646|11743500|FG000|Overall Study|Starting hormone therapy|1
7452835|NCT01751646|11743501|FG001|Overall Study|Starting hormone therapy|0
7452836|NCT01751646|11743500|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
7452837|NCT01751646|11743501|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
7452838|NCT01751646|11743500|FG000|Overall Study|Inadvertent enrollment|1
7452839|NCT01751646|11743501|FG001|Overall Study|Inadvertent enrollment|1
7452840|NCT01751646|11743500|FG000|Overall Study|Moved out of the area|1
7452841|NCT01751646|11743501|FG001|Overall Study|Moved out of the area|5
7452842|NCT01751646|11743500|FG000|Overall Study|Inability to attend required visits|0
7452843|NCT01751646|11743501|FG001|Overall Study|Inability to attend required visits|1
7452844|NCT01751646|11743500|FG000|Overall Study|Off study due to multiple obligations|0
7452845|NCT01751646|11743501|FG001|Overall Study|Off study due to multiple obligations|1
7452846|NCT01751646|11743500|FG000|Overall Study|Fails to comply with study requirements|0
7452847|NCT01751646|11743501|FG001|Overall Study|Fails to comply with study requirements|1
7452848|NCT01751646|11743500|FG000|Overall Study|Childcare issues|1
7452849|NCT01751646|11743501|FG001|Overall Study|Childcare issues|1
7452850|NCT01751724|11743513|FG000|Overall Study|extubated bef.start assigned treatment|1
7452851|NCT01751724|11743514|FG001|Overall Study|extubated bef.start assigned treatment|0
7452852|NCT01751724|11743513|FG000|Overall Study|withdrawn by parent|0
7452853|NCT01751724|11743514|FG001|Overall Study|withdrawn by parent|2
7452854|NCT01751802|11743522|FG000|Overall Study|Adverse Event|4
7452855|NCT01751802|11743523|FG001|Overall Study|Adverse Event|2
7452856|NCT01751867|11743537|FG000|Overall Study|Completed treatment,dropped in follow-up|4
7452857|NCT01751867|11743538|FG001|Overall Study|Completed treatment,dropped in follow-up|8
7452858|NCT01751867|11743537|FG000|Overall Study|Diease Progression|4
7452859|NCT01751867|11743538|FG001|Overall Study|Diease Progression|18
7452860|NCT01751867|11743537|FG000|Overall Study|Adverse Event|8
7452861|NCT01751867|11743538|FG001|Overall Study|Adverse Event|15
7452862|NCT01751867|11743537|FG000|Overall Study|Poor Compliance|0
7452863|NCT01751867|11743538|FG001|Overall Study|Poor Compliance|5
7452864|NCT01751867|11743537|FG000|Overall Study|Withdrawal by Subject|3
7452865|NCT01751867|11743538|FG001|Overall Study|Withdrawal by Subject|1
7563997|NCT03273166|11934305|FG000|Overall Study|Withdrawn prior to Completion|31
7563998|NCT03273257|11934312|FG000|Overall Study|Death|0
7563999|NCT03273257|11934313|FG001|Overall Study|Death|1
7564000|NCT03273257|11934312|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7564001|NCT03273257|11934313|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
7564002|NCT03273257|11934312|FG000|Overall Study|Study terminated|3
7564003|NCT03273257|11934313|FG001|Overall Study|Study terminated|2
7564004|NCT03273387|11934339|FG000|Overall Study|Death|2
7564005|NCT03273387|11934340|FG001|Overall Study|Death|2
7564006|NCT03273387|11934339|FG000|Overall Study|Withdrawal by Subject|1
7564007|NCT03273387|11934340|FG001|Overall Study|Withdrawal by Subject|1
7564008|NCT03273946|11934374|FG000|Overall Study|Withdrawal by Subject|5
7564009|NCT03273946|11934374|FG000|Overall Study|Unwillingness of the guardian|1
7564010|NCT03273946|11934374|FG000|Overall Study|Participant refused to use the drug|2
7564011|NCT03273946|11934374|FG000|Overall Study|Participant relative refused to use drug|1
7564012|NCT03274076|11934380|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
7564013|NCT03274076|11934381|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
7452866|NCT01751867|11743537|FG000|Overall Study|Physician Decision|4
7452867|NCT01751867|11743538|FG001|Overall Study|Physician Decision|7
7452868|NCT01751867|11743537|FG000|Overall Study|Protocol Violation|0
7452869|NCT01751867|11743538|FG001|Overall Study|Protocol Violation|2
7452870|NCT01751867|11743537|FG000|Overall Study|Death|0
7452871|NCT01751867|11743538|FG001|Overall Study|Death|5
7452872|NCT01751867|11743537|FG000|Overall Study|Other|11
7452873|NCT01751867|11743538|FG001|Overall Study|Other|37
7452874|NCT01751867|11743537|FG000|Overall Study|Randomized but not treated.|2
7452875|NCT01751867|11743538|FG001|Overall Study|Randomized but not treated.|1
7452876|NCT01752036|11743559|FG000|Overall Study|Death|2
7452877|NCT01752634|11743587|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7452878|NCT01752634|11743588|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7452879|NCT01752634|11743589|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
7452880|NCT01752634|11743590|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7452881|NCT01752634|11743591|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
7452882|NCT01752634|11743592|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
7452883|NCT01752634|11743587|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
7452884|NCT01752634|11743588|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
7452885|NCT01752634|11743589|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
7452886|NCT01752634|11743590|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
7452887|NCT01752634|11743591|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
7452888|NCT01752634|11743592|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
7452889|NCT01752634|11743587|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
7452890|NCT01752634|11743588|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7452891|NCT01752634|11743589|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7452892|NCT01752634|11743590|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7452893|NCT01752634|11743591|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
7452894|NCT01752634|11743592|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
7452895|NCT01752634|11743587|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
7452896|NCT01752634|11743588|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
7452897|NCT01752634|11743589|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
7452898|NCT01752634|11743590|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
7452899|NCT01752634|11743591|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
7452900|NCT01752634|11743592|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
7452901|NCT01752634|11743587|FG000|Week 24 to Week 260|Lack of Efficacy|15
7452902|NCT01752634|11743588|FG001|Week 24 to Week 260|Lack of Efficacy|7
7452903|NCT01752634|11743589|FG002|Week 24 to Week 260|Lack of Efficacy|7
7452904|NCT01752634|11743590|FG003|Week 24 to Week 260|Lack of Efficacy|3
7452905|NCT01752634|11743591|FG004|Week 24 to Week 260|Lack of Efficacy|4
7452906|NCT01752634|11743592|FG005|Week 24 to Week 260|Lack of Efficacy|0
7452907|NCT01752634|11743587|FG000|Week 24 to Week 260|Subject/guardian decision|12
7452908|NCT01752634|11743588|FG001|Week 24 to Week 260|Subject/guardian decision|10
7452909|NCT01752634|11743589|FG002|Week 24 to Week 260|Subject/guardian decision|9
7452910|NCT01752634|11743590|FG003|Week 24 to Week 260|Subject/guardian decision|5
7452911|NCT01752634|11743591|FG004|Week 24 to Week 260|Subject/guardian decision|5
7452912|NCT01752634|11743592|FG005|Week 24 to Week 260|Subject/guardian decision|0
7452913|NCT01752634|11743587|FG000|Week 24 to Week 260|Physician Decision|1
7452914|NCT01752634|11743588|FG001|Week 24 to Week 260|Physician Decision|2
7452915|NCT01752634|11743589|FG002|Week 24 to Week 260|Physician Decision|4
7452916|NCT01752634|11743590|FG003|Week 24 to Week 260|Physician Decision|2
7452917|NCT01752634|11743591|FG004|Week 24 to Week 260|Physician Decision|1
7452918|NCT01752634|11743592|FG005|Week 24 to Week 260|Physician Decision|0
7452919|NCT01752634|11743587|FG000|Week 24 to Week 260|Death|0
7452920|NCT01752634|11743588|FG001|Week 24 to Week 260|Death|1
7564014|NCT03274076|11934382|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
7564015|NCT03274076|11934383|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
7452921|NCT01752634|11743589|FG002|Week 24 to Week 260|Death|0
7452922|NCT01752634|11743590|FG003|Week 24 to Week 260|Death|0
7452923|NCT01752634|11743591|FG004|Week 24 to Week 260|Death|0
7564016|NCT03274076|11934380|FG000|24 Weeks Open Label|Adverse Event|0
7564017|NCT03274076|11934381|FG001|24 Weeks Open Label|Adverse Event|0
7564018|NCT03274076|11934382|FG002|24 Weeks Open Label|Adverse Event|2
7564019|NCT03274076|11934383|FG003|24 Weeks Open Label|Adverse Event|0
7564020|NCT03274076|11934380|FG000|24 Weeks Open Label|Withdrawal by Subject|0
7564021|NCT03274076|11934381|FG001|24 Weeks Open Label|Withdrawal by Subject|0
7564022|NCT03274076|11934382|FG002|24 Weeks Open Label|Withdrawal by Subject|0
7564023|NCT03274076|11934383|FG003|24 Weeks Open Label|Withdrawal by Subject|1
7564024|NCT03274440|11934402|FG000|Overall Study|Time commitment too great|1
7564025|NCT03274440|11934403|FG001|Overall Study|Time commitment too great|0
7564026|NCT03274440|11934404|FG002|Overall Study|Time commitment too great|0
7564027|NCT03274440|11934405|FG003|Overall Study|Time commitment too great|1
7564028|NCT03274440|11934406|FG004|Overall Study|Time commitment too great|0
7564029|NCT03274440|11934407|FG005|Overall Study|Time commitment too great|0
7564030|NCT03274453|11934419|FG000|Overall Study|Lost to Follow-up|2
7328901|NCT00798434|11561845|FG001|Double-Blind|Withdrawal by Subject|14
7328902|NCT00798434|11561844|FG000|Double-Blind|Protocol Violation|1
7328903|NCT00798434|11561845|FG001|Double-Blind|Protocol Violation|4
7328904|NCT00798434|11561844|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
7328905|NCT00798434|11561845|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
7328906|NCT00798434|11561844|FG000|Double-Blind|Other|1
7328907|NCT00798434|11561845|FG001|Double-Blind|Other|0
7328908|NCT00798434|11561844|FG000|Double-Blind|Not Treated|3
7328909|NCT00798434|11561845|FG001|Double-Blind|Not Treated|6
7328910|NCT00798434|11561844|FG000|Open-Label|Adverse Event|33
7328911|NCT00798434|11561845|FG001|Open-Label|Adverse Event|11
7328912|NCT00798434|11561844|FG000|Open-Label|Lack of Efficacy|5
7328913|NCT00798434|11561845|FG001|Open-Label|Lack of Efficacy|11
7328914|NCT00798434|11561844|FG000|Open-Label|Withdrawal by Subject|2
7452924|NCT01752634|11743592|FG005|Week 24 to Week 260|Death|0
7452925|NCT01752634|11743587|FG000|Week 24 to Week 260|Pregnancy|0
7452926|NCT01752634|11743588|FG001|Week 24 to Week 260|Pregnancy|0
7452927|NCT01752634|11743589|FG002|Week 24 to Week 260|Pregnancy|1
7452928|NCT01752634|11743590|FG003|Week 24 to Week 260|Pregnancy|0
7452929|NCT01752634|11743591|FG004|Week 24 to Week 260|Pregnancy|0
7452930|NCT01752634|11743592|FG005|Week 24 to Week 260|Pregnancy|0
7452931|NCT01752634|11743587|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
7452932|NCT01752634|11743588|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
7452933|NCT01752634|11743589|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
7452934|NCT01752634|11743590|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
7452935|NCT01752634|11743591|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
7452936|NCT01752634|11743592|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
7452937|NCT01752634|11743587|FG000|Week 24 to Week 260|Lost to Follow-up|2
7452938|NCT01752634|11743588|FG001|Week 24 to Week 260|Lost to Follow-up|2
7452939|NCT01752634|11743589|FG002|Week 24 to Week 260|Lost to Follow-up|3
7452940|NCT01752634|11743590|FG003|Week 24 to Week 260|Lost to Follow-up|0
7452941|NCT01752634|11743591|FG004|Week 24 to Week 260|Lost to Follow-up|2
7452942|NCT01752634|11743592|FG005|Week 24 to Week 260|Lost to Follow-up|0
7452943|NCT01752634|11743587|FG000|Week 24 to Week 260|Adverse Event|4
7452944|NCT01752634|11743588|FG001|Week 24 to Week 260|Adverse Event|8
7452945|NCT01752634|11743589|FG002|Week 24 to Week 260|Adverse Event|8
7452946|NCT01752634|11743590|FG003|Week 24 to Week 260|Adverse Event|4
7452947|NCT01752634|11743591|FG004|Week 24 to Week 260|Adverse Event|2
7452948|NCT01752634|11743592|FG005|Week 24 to Week 260|Adverse Event|0
7452949|NCT01752842|11743613|FG000|Overall Study|Adverse Event|3
7452950|NCT01752842|11743614|FG001|Overall Study|Adverse Event|0
7452951|NCT01752842|11743613|FG000|Overall Study|Withdrawal by Subject|0
7452952|NCT01752842|11743614|FG001|Overall Study|Withdrawal by Subject|2
7452953|NCT01752855|11743622|FG000|Overall Study|Adverse Event|1
7452954|NCT01752855|11743623|FG001|Overall Study|Adverse Event|0
7452955|NCT01752855|11743622|FG000|Overall Study|Withdrew Consent|0
7452956|NCT01752855|11743623|FG001|Overall Study|Withdrew Consent|2
7452957|NCT01752855|11743622|FG000|Overall Study|Lack of Efficacy|0
7452958|NCT01752855|11743623|FG001|Overall Study|Lack of Efficacy|2
7452959|NCT01752907|11743631|FG000|Overall Study|Withdrawal by Subject|4
7452960|NCT01752907|11743632|FG001|Overall Study|Withdrawal by Subject|10
7452961|NCT01752907|11743631|FG000|Overall Study|Lost to Follow-up|2
7452962|NCT01752907|11743632|FG001|Overall Study|Lost to Follow-up|1
7452963|NCT01752907|11743631|FG000|Overall Study|Decision by Sponsor|6
7452964|NCT01752907|11743632|FG001|Overall Study|Decision by Sponsor|9
7452965|NCT01752933|11743640|FG000|Treatment|Disease Progression|3
7452966|NCT01752933|11743641|FG001|Treatment|Disease Progression|29
7452967|NCT01752933|11743640|FG000|Treatment|Withdrawal by Subject|0
7452968|NCT01752933|11743641|FG001|Treatment|Withdrawal by Subject|5
7452969|NCT01752933|11743640|FG000|Treatment|Adverse Event|1
7452970|NCT01752933|11743641|FG001|Treatment|Adverse Event|4
7452971|NCT01752933|11743640|FG000|Treatment|Physician Decision|0
7452972|NCT01752933|11743641|FG001|Treatment|Physician Decision|3
7452973|NCT01752933|11743640|FG000|Treatment|Death|0
7452974|NCT01752933|11743641|FG001|Treatment|Death|2
7452975|NCT01752933|11743640|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
7452976|NCT01752933|11743641|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
7564031|NCT03274453|11934420|FG001|Overall Study|Lost to Follow-up|5
7452977|NCT01752933|11743640|FG000|Treatment|Patient noncompliant|0
7452978|NCT01752933|11743641|FG001|Treatment|Patient noncompliant|1
7452979|NCT01752933|11743640|FG000|Treatment|Patient unable to travel to appointments|0
7452980|NCT01752933|11743641|FG001|Treatment|Patient unable to travel to appointments|1
7452981|NCT01752933|11743640|FG000|Overall Study and Follow-up|Death|4
7452982|NCT01752933|11743641|FG001|Overall Study and Follow-up|Death|34
7452983|NCT01752933|11743640|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
7452984|NCT01752933|11743641|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
7452985|NCT01752933|11743640|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
7452986|NCT01752933|11743641|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
7452987|NCT01752933|11743640|FG000|Overall Study and Follow-up|Lost to Follow-up|0
7452988|NCT01752933|11743641|FG001|Overall Study and Follow-up|Lost to Follow-up|2
7452989|NCT01752985|11743651|FG000|Treatment Period|Subject request to discontinue treatment|1
7452990|NCT01752985|11743652|FG001|Treatment Period|Subject request to discontinue treatment|0
7452991|NCT01752985|11743653|FG002|Treatment Period|Subject request to discontinue treatment|1
7452992|NCT01752985|11743651|FG000|Treatment Period|Subject no longer meets study criteria|0
7452993|NCT01752985|11743652|FG001|Treatment Period|Subject no longer meets study criteria|1
7452994|NCT01752985|11743653|FG002|Treatment Period|Subject no longer meets study criteria|1
7564032|NCT03274453|11934421|FG002|Overall Study|Lost to Follow-up|4
7564033|NCT03274453|11934422|FG003|Overall Study|Lost to Follow-up|1
7564034|NCT03274453|11934419|FG000|Overall Study|Physician Decision|2
7452995|NCT01752985|11743651|FG000|Treatment Period|Adverse Event|2
7452996|NCT01752985|11743652|FG001|Treatment Period|Adverse Event|1
7452997|NCT01752985|11743653|FG002|Treatment Period|Adverse Event|2
7452998|NCT01752985|11743651|FG000|Treatment Period|Withdrawal by Subject|1
7452999|NCT01752985|11743652|FG001|Treatment Period|Withdrawal by Subject|1
7453000|NCT01752985|11743653|FG002|Treatment Period|Withdrawal by Subject|0
7453001|NCT01752985|11743651|FG000|Treatment Period|Lost to Follow-up|0
7453002|NCT01752985|11743652|FG001|Treatment Period|Lost to Follow-up|0
7453003|NCT01752985|11743653|FG002|Treatment Period|Lost to Follow-up|1
7453004|NCT01753076|11743663|FG000|Overall Study|Adverse Event|17
7453005|NCT01753076|11743664|FG001|Overall Study|Adverse Event|18
7453006|NCT01753076|11743663|FG000|Overall Study|Lack of Efficacy|3
7453007|NCT01753076|11743664|FG001|Overall Study|Lack of Efficacy|1
7453008|NCT01753076|11743663|FG000|Overall Study|Lost to Follow-up|2
7453009|NCT01753076|11743664|FG001|Overall Study|Lost to Follow-up|1
7453010|NCT01753076|11743663|FG000|Overall Study|Physician Decision|4
7453011|NCT01753076|11743664|FG001|Overall Study|Physician Decision|2
7453012|NCT01753076|11743663|FG000|Overall Study|Withdrawal by Subject|14
7453013|NCT01753076|11743664|FG001|Overall Study|Withdrawal by Subject|24
7453014|NCT01753076|11743663|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
7453015|NCT01753076|11743664|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
7453016|NCT01753115|11743675|FG000|Overall Study|Lost to Follow-up|3
7453017|NCT01753115|11743676|FG001|Overall Study|Lost to Follow-up|6
7453018|NCT01753115|11743677|FG002|Overall Study|Lost to Follow-up|8
7453019|NCT01753115|11743675|FG000|Overall Study|Withdrawal by Subject|6
7453020|NCT01753115|11743676|FG001|Overall Study|Withdrawal by Subject|5
7453021|NCT01753115|11743677|FG002|Overall Study|Withdrawal by Subject|6
7453022|NCT01753115|11743675|FG000|Overall Study|Subject non-compliant|3
7453023|NCT01753115|11743676|FG001|Overall Study|Subject non-compliant|3
7453024|NCT01753115|11743677|FG002|Overall Study|Subject non-compliant|0
7453025|NCT01753115|11743675|FG000|Overall Study|Used excluded drug|0
7453026|NCT01753115|11743676|FG001|Overall Study|Used excluded drug|1
7453027|NCT01753115|11743677|FG002|Overall Study|Used excluded drug|0
7453028|NCT01753193|11743685|FG000|Overall Study|Withdrawal by Subject|23
7453029|NCT01753193|11743685|FG000|Overall Study|Lost to Follow-up|6
7453030|NCT01753193|11743685|FG000|Overall Study|Death|1
7453031|NCT01753193|11743685|FG000|Overall Study|Other|16
7453032|NCT01753297|11743691|FG000|Overall Study|Lost to Follow-up|7
7453033|NCT01753297|11743692|FG001|Overall Study|Lost to Follow-up|2
7453034|NCT01753297|11743691|FG000|Overall Study|Withdrawal by Subject|26
7453035|NCT01753297|11743692|FG001|Overall Study|Withdrawal by Subject|23
7453036|NCT01753297|11743691|FG000|Overall Study|Adverse Event (up to Month 36)|1
7453037|NCT01753297|11743692|FG001|Overall Study|Adverse Event (up to Month 36)|1
7453038|NCT01753297|11743691|FG000|Overall Study|Death|0
7453039|NCT01753297|11743692|FG001|Overall Study|Death|2
7453040|NCT01753297|11743691|FG000|Overall Study|Did not attend end of study visit|7
7453041|NCT01753297|11743692|FG001|Overall Study|Did not attend end of study visit|8
7453042|NCT01753310|11743702|FG000|Overall Study|Entered into open label extension study|25
7453043|NCT01753310|11743703|FG001|Overall Study|Entered into open label extension study|22
7453044|NCT01753310|11743702|FG000|Overall Study|Adverse Event|1
7453045|NCT01753310|11743703|FG001|Overall Study|Adverse Event|0
7453046|NCT01753310|11743702|FG000|Overall Study|Lost to Follow-up|2
7453047|NCT01753310|11743703|FG001|Overall Study|Lost to Follow-up|0
7453048|NCT01753310|11743702|FG000|Overall Study|Subject decision|2
7453049|NCT01753310|11743703|FG001|Overall Study|Subject decision|2
7453050|NCT01753310|11743702|FG000|Overall Study|Sponsor decision|1
7453051|NCT01753310|11743703|FG001|Overall Study|Sponsor decision|0
7453052|NCT01753310|11743702|FG000|Overall Study|Withdrawal by Subject|1
7453053|NCT01753310|11743703|FG001|Overall Study|Withdrawal by Subject|0
7453054|NCT01753323|11743712|FG000|Overall Study|Lack of Efficacy|0
7453055|NCT01753323|11743713|FG001|Overall Study|Lack of Efficacy|0
7453056|NCT01753323|11743714|FG002|Overall Study|Lack of Efficacy|8
7453057|NCT01753323|11743712|FG000|Overall Study|Protocol deviation|1
7453058|NCT01753323|11743713|FG001|Overall Study|Protocol deviation|0
7453059|NCT01753323|11743714|FG002|Overall Study|Protocol deviation|0
7453060|NCT01753323|11743712|FG000|Overall Study|Adverse Event|0
7453061|NCT01753323|11743713|FG001|Overall Study|Adverse Event|0
7453062|NCT01753323|11743714|FG002|Overall Study|Adverse Event|1
7453063|NCT01753336|11743723|FG000|Overall Study|Patient decision|12
7453064|NCT01753336|11743723|FG000|Overall Study|Lost to Follow-up|3
7453065|NCT01753336|11743723|FG000|Overall Study|Physician Decision|2
7453066|NCT01753336|11743723|FG000|Overall Study|Sponsor's decision|2
7453067|NCT01753336|11743723|FG000|Overall Study|Withdrawal by Subject|1
7453068|NCT01753401|11743738|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
7453069|NCT01753401|11743739|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7453070|NCT01753401|11743740|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
7564035|NCT03274453|11934420|FG001|Overall Study|Physician Decision|0
7564036|NCT03274453|11934421|FG002|Overall Study|Physician Decision|0
7564037|NCT03274453|11934422|FG003|Overall Study|Physician Decision|3
7564038|NCT03274453|11934419|FG000|Overall Study|Surgery Cancelled|0
7564039|NCT03274453|11934420|FG001|Overall Study|Surgery Cancelled|1
7564040|NCT03274453|11934421|FG002|Overall Study|Surgery Cancelled|0
7564041|NCT03274453|11934422|FG003|Overall Study|Surgery Cancelled|0
7328915|NCT00798434|11561845|FG001|Open-Label|Withdrawal by Subject|7
7453071|NCT01753401|11743741|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
7453072|NCT01753401|11743738|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7453073|NCT01753401|11743739|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
7453074|NCT01753401|11743740|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7453075|NCT01753401|11743741|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
7453076|NCT01753401|11743738|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
7453077|NCT01753401|11743739|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
7453078|NCT01753401|11743740|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
7453079|NCT01753401|11743741|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
7453080|NCT01753401|11743738|FG000|Open Label Period (44 Weeks)|Adverse Event|0
7453081|NCT01753401|11743739|FG001|Open Label Period (44 Weeks)|Adverse Event|0
7453082|NCT01753401|11743740|FG002|Open Label Period (44 Weeks)|Adverse Event|3
7453083|NCT01753401|11743741|FG003|Open Label Period (44 Weeks)|Adverse Event|4
7453084|NCT01753401|11743738|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7453085|NCT01753401|11743739|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7453086|NCT01753401|11743740|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
7453087|NCT01753401|11743741|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
7453088|NCT01753401|11743738|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
7453089|NCT01753401|11743739|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
7453090|NCT01753401|11743740|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
7453091|NCT01753401|11743741|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
7453092|NCT01753401|11743738|FG000|Open Label Period (44 Weeks)|Reason not provided|0
7453093|NCT01753401|11743739|FG001|Open Label Period (44 Weeks)|Reason not provided|0
7453094|NCT01753401|11743740|FG002|Open Label Period (44 Weeks)|Reason not provided|0
7453095|NCT01753401|11743741|FG003|Open Label Period (44 Weeks)|Reason not provided|2
7453096|NCT01753518|11743753|FG000|Intention-to-Treat Analysis|Missing consent form|5
7328916|NCT00798434|11561844|FG000|Open-Label|Protocol Violation|1
7328917|NCT00798434|11561845|FG001|Open-Label|Protocol Violation|0
7328918|NCT00798434|11561844|FG000|Open-Label|Other|1
7328919|NCT00798434|11561845|FG001|Open-Label|Other|2
7328920|NCT00798434|11561844|FG000|Open-Label|Not Treated|0
7328921|NCT00798434|11561845|FG001|Open-Label|Not Treated|1
7328922|NCT00798603|11561869|FG000|Overall Study|Still on treatment as of 11/6/2012|1
7328923|NCT00798603|11561869|FG000|Overall Study|Withdrawal by Subject|10
7328924|NCT00798603|11561869|FG000|Overall Study|Adverse Event|22
7328925|NCT00798603|11561869|FG000|Overall Study|Physician Decision|1
7453097|NCT01753518|11743754|FG001|Intention-to-Treat Analysis|Missing consent form|3
7453098|NCT01753518|11743753|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
7453099|NCT01753518|11743754|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
7453100|NCT01753518|11743753|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
7453101|NCT01753518|11743754|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
7564056|NCT03274986|11934463|FG000|Overall Study|Withdrawal by Subject|0
7564057|NCT03274986|11934464|FG001|Overall Study|Withdrawal by Subject|1
7453102|NCT01753518|11743753|FG000|Postpartum Follow-up|Lost to Follow-up|22
7453103|NCT01753518|11743754|FG001|Postpartum Follow-up|Lost to Follow-up|15
7453104|NCT01753570|11743773|FG000|Overall Study|Adverse Event|1
7453105|NCT01753570|11743774|FG001|Overall Study|Adverse Event|0
7453106|NCT01753570|11743775|FG002|Overall Study|Adverse Event|1
7453107|NCT01753570|11743773|FG000|Overall Study|Physician Decision|0
7453108|NCT01753570|11743774|FG001|Overall Study|Physician Decision|1
7453109|NCT01753570|11743775|FG002|Overall Study|Physician Decision|0
7453110|NCT01753570|11743773|FG000|Overall Study|Withdrawal by Subject|1
7453111|NCT01753570|11743774|FG001|Overall Study|Withdrawal by Subject|4
7453112|NCT01753570|11743775|FG002|Overall Study|Withdrawal by Subject|0
7453113|NCT01753856|11743825|FG000|Overall Study|Adverse Event|1
7453114|NCT01753856|11743826|FG001|Overall Study|Adverse Event|0
7453115|NCT01753856|11743825|FG000|Overall Study|Withdrawal by Subject|0
7453116|NCT01753856|11743826|FG001|Overall Study|Withdrawal by Subject|2
7453117|NCT01753856|11743825|FG000|Overall Study|Sponsor Decision|2
7453118|NCT01753856|11743826|FG001|Overall Study|Sponsor Decision|0
7453119|NCT01753999|11743835|FG000|Period 1 - Initial Assignment|Physician Decision|2
7453120|NCT01753999|11743836|FG001|Period 1 - Initial Assignment|Physician Decision|3
7453121|NCT01753999|11743835|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
7453122|NCT01753999|11743836|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
7453123|NCT01753999|11743835|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
7453124|NCT01753999|11743836|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
7453125|NCT01753999|11743835|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
7453126|NCT01753999|11743836|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
7453127|NCT01753999|11743835|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
7453128|NCT01753999|11743836|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
7453129|NCT01753999|11743835|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
7453130|NCT01753999|11743836|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
7453131|NCT01754129|11743847|FG000|Overall Study|Death|13
7453132|NCT01754129|11743847|FG000|Overall Study|Duodopa discontinuation|9
7453133|NCT01754129|11743847|FG000|Overall Study|Lost to Follow-up|7
7453134|NCT01754129|11743847|FG000|Overall Study|Withdrew consent|1
7453135|NCT01754129|11743847|FG000|Overall Study|Inclusion/exclusion criteria violation|3
7453136|NCT01754194|11743860|FG000|Overall Study|Lost to Follow-up|39
7453137|NCT01754194|11743861|FG001|Overall Study|Lost to Follow-up|14
7453138|NCT01754194|11743860|FG000|Overall Study|Withdrawal by Subject|4
7453139|NCT01754194|11743861|FG001|Overall Study|Withdrawal by Subject|5
7453140|NCT01754194|11743860|FG000|Overall Study|Other|9
7453141|NCT01754194|11743861|FG001|Overall Study|Other|8
7453142|NCT01754259|11743875|FG000|Overall Study|Withdrawal by Subject|2
7453143|NCT01754259|11743876|FG001|Overall Study|Withdrawal by Subject|4
7453144|NCT01754259|11743875|FG000|Overall Study|Adverse Event|3
7453145|NCT01754259|11743876|FG001|Overall Study|Adverse Event|1
7453146|NCT01754259|11743875|FG000|Overall Study|Lost to Follow-up|0
7453147|NCT01754259|11743876|FG001|Overall Study|Lost to Follow-up|1
7453148|NCT01754376|11743891|FG000|Overall Study|Adverse Event|1
7453149|NCT01754376|11743891|FG000|Overall Study|Lack of Efficacy|2
7453150|NCT01754402|11743912|FG000|Overall Study|Death|0
7453151|NCT01754402|11743913|FG001|Overall Study|Death|0
7453152|NCT01754402|11743914|FG002|Overall Study|Death|1
7453153|NCT01754402|11743912|FG000|Overall Study|Adverse Event|2
7453154|NCT01754402|11743913|FG001|Overall Study|Adverse Event|2
7453155|NCT01754402|11743914|FG002|Overall Study|Adverse Event|1
7453156|NCT01754402|11743912|FG000|Overall Study|Withdrawal by Subject|0
7453157|NCT01754402|11743913|FG001|Overall Study|Withdrawal by Subject|0
7453158|NCT01754402|11743914|FG002|Overall Study|Withdrawal by Subject|1
7453159|NCT01754402|11743912|FG000|Overall Study|Lack of Efficacy|0
7453160|NCT01754402|11743913|FG001|Overall Study|Lack of Efficacy|0
7453161|NCT01754402|11743914|FG002|Overall Study|Lack of Efficacy|1
7453162|NCT01754467|11743923|FG000|Overall Study|Lost to Follow-up|1
7453163|NCT01754493|11743937|FG000|Overall Study|Adverse Event|1
7453164|NCT01754493|11743937|FG000|Overall Study|Lost to Follow-up|3
7453165|NCT01754493|11743937|FG000|Overall Study|Withdrawal by Subject|1
7453166|NCT01754493|11743937|FG000|Overall Study|Moved out of town|1
7453167|NCT01754493|11743937|FG000|Overall Study|Scheduling conflict|1
7453168|NCT01754727|11743974|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7453169|NCT01754753|11743980|FG000|Overall Study|Study close|43
7453170|NCT01754753|11743981|FG001|Overall Study|Study close|44
7453171|NCT01754753|11743980|FG000|Overall Study|Lost to Follow-up|9
7453172|NCT01754753|11743981|FG001|Overall Study|Lost to Follow-up|5
7453173|NCT01754766|11743990|FG000|Overall Study|Personal reasons|1
7453174|NCT01754766|11743991|FG001|Overall Study|Personal reasons|1
7453175|NCT01754766|11743992|FG002|Overall Study|Personal reasons|0
7453176|NCT01754922|11744011|FG000|Overall Study|Adverse Event|0
7453177|NCT01754922|11744012|FG001|Overall Study|Adverse Event|1
7453178|NCT01755026|11744021|FG000|Overall Study|Adverse Event|1
7453179|NCT01755026|11744022|FG001|Overall Study|Adverse Event|0
7453180|NCT01755026|11744021|FG000|Overall Study|Withdrawal by Subject|1
7453181|NCT01755026|11744022|FG001|Overall Study|Withdrawal by Subject|1
7453182|NCT01755091|11744031|FG000|Overall Study|Withdrawal by Subject|6
7453183|NCT01755091|11744032|FG001|Overall Study|Withdrawal by Subject|1
7453184|NCT01755091|11744033|FG002|Overall Study|Withdrawal by Subject|3
7453185|NCT01755091|11744031|FG000|Overall Study|Adverse Event|1
7453186|NCT01755091|11744032|FG001|Overall Study|Adverse Event|1
7453187|NCT01755091|11744033|FG002|Overall Study|Adverse Event|1
7453188|NCT01755091|11744031|FG000|Overall Study|Lost to Follow-up|1
7453189|NCT01755091|11744032|FG001|Overall Study|Lost to Follow-up|0
7453190|NCT01755091|11744033|FG002|Overall Study|Lost to Follow-up|1
7453191|NCT01755091|11744031|FG000|Overall Study|Physician Decision|1
7453192|NCT01755091|11744032|FG001|Overall Study|Physician Decision|1
7453193|NCT01755091|11744033|FG002|Overall Study|Physician Decision|2
7468068|NCT01905657|11768545|FG001|Overall Study|Sponsor Decision|0
7468069|NCT01905657|11768546|FG002|Overall Study|Sponsor Decision|0
7468070|NCT01905683|11768557|FG000|Overall Study|Protocol Violation|1
7468071|NCT01905683|11768557|FG000|Overall Study|Re-injection criteria not met; others|13
7468072|NCT01905683|11768557|FG000|Overall Study|Physician Decision|1
7468073|NCT01905683|11768557|FG000|Overall Study|Lack of Efficacy|8
7468074|NCT01905683|11768557|FG000|Overall Study|Withdrawal by Subject|20
7468075|NCT01905683|11768557|FG000|Overall Study|Adverse Event|4
7468076|NCT01905683|11768557|FG000|Overall Study|Lost to Follow-up|4
7468077|NCT01905943|11768561|FG000|Overall Study|Withdrawal of consent|90
7468078|NCT01905943|11768561|FG000|Overall Study|Lost to Follow-up|16
7468079|NCT01905943|11768561|FG000|Overall Study|Investigator discretion|7
7468080|NCT01905943|11768561|FG000|Overall Study|Death|186
7468081|NCT01905943|11768561|FG000|Overall Study|Adverse Event|3
7468082|NCT01905943|11768561|FG000|Overall Study|Other|12
7468083|NCT01906008|11768591|FG000|Overall Study|Lost to Follow-up|2
7468084|NCT01906008|11768592|FG001|Overall Study|Lost to Follow-up|0
7468085|NCT01906008|11768591|FG000|Overall Study|Oxaliplatin toxicity|2
7468086|NCT01906008|11768592|FG001|Overall Study|Oxaliplatin toxicity|0
7468087|NCT01906008|11768591|FG000|Overall Study|Protocol Violation|0
7468088|NCT01906008|11768592|FG001|Overall Study|Protocol Violation|1
7468089|NCT01906008|11768591|FG000|Overall Study|Withdrawal by Subject|1
7468090|NCT01906008|11768592|FG001|Overall Study|Withdrawal by Subject|5
7468091|NCT01906008|11768591|FG000|Overall Study|Did not start study med|3
7468092|NCT01906008|11768592|FG001|Overall Study|Did not start study med|4
7468093|NCT01906008|11768591|FG000|Overall Study|Oxaliplatin stops|10
7468094|NCT01906008|11768592|FG001|Overall Study|Oxaliplatin stops|8
7468095|NCT01906008|11768591|FG000|Overall Study|Hospice|1
7468096|NCT01906008|11768592|FG001|Overall Study|Hospice|0
7468097|NCT01906008|11768591|FG000|Overall Study|Physician Decision|3
7468098|NCT01906008|11768592|FG001|Overall Study|Physician Decision|3
7468099|NCT01906008|11768591|FG000|Overall Study|Lack of compliance of study med|5
7468100|NCT01906008|11768592|FG001|Overall Study|Lack of compliance of study med|3
7328926|NCT00798603|11561869|FG000|Overall Study|Lack of insurance coverage|1
7328927|NCT00798655|11561873|FG000|Overall Study|Did not receive at least one dose of pan|2
7328928|NCT00798694|11561879|FG000|Overall Study|Lost to Follow-up|1
7328929|NCT00798694|11561880|FG001|Overall Study|Lost to Follow-up|1
7328930|NCT00798694|11561879|FG000|Overall Study|Physician Decision|1
7328931|NCT00798694|11561880|FG001|Overall Study|Physician Decision|0
7328932|NCT00798707|11561895|FG000|Overall Study|Adverse Event|6
7328933|NCT00798707|11561896|FG001|Overall Study|Adverse Event|8
7328934|NCT00798707|11561897|FG002|Overall Study|Adverse Event|8
7328935|NCT00798707|11561895|FG000|Overall Study|Failed to return|2
7328936|NCT00798707|11561896|FG001|Overall Study|Failed to return|2
7328937|NCT00798707|11561897|FG002|Overall Study|Failed to return|0
7328938|NCT00798707|11561895|FG000|Overall Study|Investigator|0
7328939|NCT00798707|11561896|FG001|Overall Study|Investigator|1
7328940|NCT00798707|11561897|FG002|Overall Study|Investigator|2
7328941|NCT00798707|11561895|FG000|Overall Study|Lack of Efficacy|2
7328942|NCT00798707|11561896|FG001|Overall Study|Lack of Efficacy|2
7328943|NCT00798707|11561897|FG002|Overall Study|Lack of Efficacy|1
7328944|NCT00798707|11561895|FG000|Overall Study|Lost to Follow-up|5
7328945|NCT00798707|11561896|FG001|Overall Study|Lost to Follow-up|6
7328946|NCT00798707|11561897|FG002|Overall Study|Lost to Follow-up|6
7328947|NCT00798707|11561895|FG000|Overall Study|Other|0
7328948|NCT00798707|11561896|FG001|Overall Study|Other|1
7328949|NCT00798707|11561897|FG002|Overall Study|Other|0
7328950|NCT00798707|11561895|FG000|Overall Study|Protocol Violation|4
7328951|NCT00798707|11561896|FG001|Overall Study|Protocol Violation|0
7328952|NCT00798707|11561897|FG002|Overall Study|Protocol Violation|2
7328953|NCT00798707|11561895|FG000|Overall Study|Withdrawal by Subject|3
7468101|NCT01906008|11768591|FG000|Overall Study|Adverse Event|0
7468102|NCT01906008|11768592|FG001|Overall Study|Adverse Event|3
7468103|NCT01906346|11768598|FG000|Overall Study|AEs|1
7328954|NCT00798707|11561896|FG001|Overall Study|Withdrawal by Subject|8
7328955|NCT00798707|11561897|FG002|Overall Study|Withdrawal by Subject|2
7328956|NCT00798707|11561895|FG000|Overall Study|Randomized not treated|4
7328957|NCT00798707|11561896|FG001|Overall Study|Randomized not treated|5
7328958|NCT00798707|11561897|FG002|Overall Study|Randomized not treated|1
7328959|NCT00798759|11561911|FG000|Overall Study|Adverse Event|3
7328960|NCT00798759|11561912|FG001|Overall Study|Adverse Event|3
7328961|NCT00798759|11561911|FG000|Overall Study|Lost to Follow-up|1
7468104|NCT01906372|11768604|FG000|Overall Study|Withdrawal by Subject|2
7468105|NCT01906476|11768611|FG000|Overall Study|Lost to Follow-up|17
7468106|NCT01906476|11768612|FG001|Overall Study|Lost to Follow-up|16
7468107|NCT01907087|11768657|FG000|Overall Study|Withdrawal by Subject|1
7468108|NCT01907100|11768665|FG000|Overall Study|PD based on modified RECIST criteria|31
7328962|NCT00798759|11561912|FG001|Overall Study|Lost to Follow-up|1
7328963|NCT00798759|11561911|FG000|Overall Study|Protocol Violation|4
7453194|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Adverse Event|2
7453195|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Adverse Event|3
7453196|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
7453197|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
7453198|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
7453199|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
7453200|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
7453201|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
7453202|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Physician Decision|0
7453203|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Physician Decision|1
7453204|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
7453205|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
7453206|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
7453207|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
7453208|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
7453209|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
7453210|NCT01755156|11744052|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7453211|NCT01755156|11744053|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
7453212|NCT01755156|11744052|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
7453213|NCT01755156|11744053|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
7453214|NCT01755156|11744052|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
7453215|NCT01755156|11744053|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
7453216|NCT01755195|11744080|FG000|Overall Study|Participant noncompliance|2
7453217|NCT01755195|11744080|FG000|Overall Study|Switched to alternative treatment|4
7453218|NCT01755195|11744080|FG000|Overall Study|Withdrawal by Subject|1
7453219|NCT01755195|11744080|FG000|Overall Study|Participant refused to start treatment|1
7453220|NCT01755195|11744080|FG000|Overall Study|Participant has been consented for another trial|1
7453221|NCT01755195|11744080|FG000|Overall Study|Refused further treatment|3
7453222|NCT01755195|11744080|FG000|Overall Study|Complicating disease/intercurrent illness|1
7453223|NCT01755234|11744086|FG000|Overall Study|Lost to Follow-up|11
7453224|NCT01755234|11744087|FG001|Overall Study|Lost to Follow-up|6
7453225|NCT01755234|11744086|FG000|Overall Study|Change in surgical case|2
7453226|NCT01755234|11744087|FG001|Overall Study|Change in surgical case|1
7453227|NCT01755234|11744086|FG000|Overall Study|case cancelled|1
7453228|NCT01755234|11744087|FG001|Overall Study|case cancelled|0
7453229|NCT01755234|11744086|FG000|Overall Study|Withdrawal by Subject|0
7453230|NCT01755234|11744087|FG001|Overall Study|Withdrawal by Subject|1
7453231|NCT01755234|11744086|FG000|Overall Study|unblinded|1
7453232|NCT01755234|11744087|FG001|Overall Study|unblinded|0
7453233|NCT01755416|11744093|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
7453234|NCT01755416|11744094|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
7453235|NCT01755546|11744107|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
7453236|NCT01755546|11744107|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
7453237|NCT01755546|11744107|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
7453238|NCT01755546|11744107|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
7453239|NCT01755546|11744107|FG000|Titration Phase|Adverse Event|11
7453240|NCT01755546|11744107|FG000|Titration Phase|Lack of Efficacy|18
7453241|NCT01755546|11744107|FG000|Titration Phase|Protocol Violation|9
7453242|NCT01755546|11744107|FG000|Titration Phase|Lost to Follow-up|2
7453243|NCT01755546|11744107|FG000|Titration Phase|Other and Continuing|22
7453244|NCT01755546|11744107|FG000|Titration Phase|Withdrawal by Subject|8
7453245|NCT01755546|11744107|FG000|Long Term Treatment|Adverse Event|12
7453246|NCT01755546|11744107|FG000|Long Term Treatment|Lack of Efficacy|6
7453247|NCT01755546|11744107|FG000|Long Term Treatment|Protocol Violation|10
7453248|NCT01755546|11744107|FG000|Long Term Treatment|Withdrawal by Subject|35
7453249|NCT01755546|11744107|FG000|Long Term Treatment|Lost to Follow-up|17
7453250|NCT01755546|11744107|FG000|Long Term Treatment|other and ongoing|41
7453251|NCT01755598|11744113|FG000|Overall Study|Other|109
7453252|NCT01755598|11744114|FG001|Overall Study|Other|109
7453253|NCT01755598|11744113|FG000|Overall Study|Lost to Follow-up|32
7453254|NCT01755598|11744114|FG001|Overall Study|Lost to Follow-up|43
7453255|NCT01755598|11744113|FG000|Overall Study|Migrated/moved from study area|76
7453256|NCT01755598|11744114|FG001|Overall Study|Migrated/moved from study area|65
7453257|NCT01755598|11744113|FG000|Overall Study|Withdrawal by Subject|22
7453258|NCT01755598|11744114|FG001|Overall Study|Withdrawal by Subject|31
7453259|NCT01755598|11744113|FG000|Overall Study|Protocol Violation|7
7453260|NCT01755598|11744114|FG001|Overall Study|Protocol Violation|7
7453261|NCT01755598|11744113|FG000|Overall Study|Adverse Event|19
7453262|NCT01755598|11744114|FG001|Overall Study|Adverse Event|28
7453263|NCT01755637|11744120|FG000|Period 1|Adverse Event|0
7453264|NCT01755637|11744121|FG001|Period 1|Adverse Event|1
7453265|NCT01755702|11744133|FG000|Wash Out Period I|Other Reason|3
7453266|NCT01755702|11744133|FG000|Washout Period II|Other Reason|5
7453267|NCT01755767|11744147|FG000|Overall Study|Progressive Disease|8
7453268|NCT01755767|11744148|FG001|Overall Study|Progressive Disease|7
7453269|NCT01755767|11744149|FG002|Overall Study|Progressive Disease|91
7453270|NCT01755767|11744150|FG003|Overall Study|Progressive Disease|43
7328964|NCT00798759|11561912|FG001|Overall Study|Protocol Violation|8
7453271|NCT01755767|11744147|FG000|Overall Study|Clinical Disease Progression|4
7453272|NCT01755767|11744148|FG001|Overall Study|Clinical Disease Progression|2
7453273|NCT01755767|11744149|FG002|Overall Study|Clinical Disease Progression|29
7453274|NCT01755767|11744150|FG003|Overall Study|Clinical Disease Progression|20
7453275|NCT01755767|11744147|FG000|Overall Study|Radiographic Disease Progression|9
7453276|NCT01755767|11744148|FG001|Overall Study|Radiographic Disease Progression|4
7453277|NCT01755767|11744149|FG002|Overall Study|Radiographic Disease Progression|44
7453278|NCT01755767|11744150|FG003|Overall Study|Radiographic Disease Progression|27
7453279|NCT01755767|11744147|FG000|Overall Study|Adverse Event|6
7453280|NCT01755767|11744148|FG001|Overall Study|Adverse Event|0
7453281|NCT01755767|11744149|FG002|Overall Study|Adverse Event|28
7453282|NCT01755767|11744150|FG003|Overall Study|Adverse Event|11
7453283|NCT01755767|11744147|FG000|Overall Study|Death|1
7453284|NCT01755767|11744148|FG001|Overall Study|Death|2
7453285|NCT01755767|11744149|FG002|Overall Study|Death|15
7453286|NCT01755767|11744150|FG003|Overall Study|Death|4
7453287|NCT01755767|11744147|FG000|Overall Study|Subject Decision|0
7453288|NCT01755767|11744148|FG001|Overall Study|Subject Decision|0
7453289|NCT01755767|11744149|FG002|Overall Study|Subject Decision|10
7453290|NCT01755767|11744150|FG003|Overall Study|Subject Decision|3
7453291|NCT01755767|11744147|FG000|Overall Study|Withdrawal by Subject|0
7453292|NCT01755767|11744148|FG001|Overall Study|Withdrawal by Subject|0
7453293|NCT01755767|11744149|FG002|Overall Study|Withdrawal by Subject|2
7453294|NCT01755767|11744150|FG003|Overall Study|Withdrawal by Subject|1
7453295|NCT01755767|11744147|FG000|Overall Study|Other|0
7453296|NCT01755767|11744148|FG001|Overall Study|Other|0
7453297|NCT01755767|11744149|FG002|Overall Study|Other|2
7453298|NCT01755767|11744150|FG003|Overall Study|Other|3
7453299|NCT01755767|11744147|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7453300|NCT01755767|11744148|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
7453301|NCT01755767|11744149|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
7453302|NCT01755767|11744150|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
7453303|NCT01755858|11744162|FG000|Overall Study|Adverse Event|1
7453304|NCT01755858|11744163|FG001|Overall Study|Adverse Event|1
7453305|NCT01756053|11744196|FG000|Period 1 (10 Days)|Protocol Violation|1
7564058|NCT03274986|11934463|FG000|Overall Study|Lost to Follow-up|0
7564059|NCT03274986|11934464|FG001|Overall Study|Lost to Follow-up|1
7564060|NCT03275246|11934484|FG000|Overall Study|Protocol Violation|5
7564061|NCT03275246|11934484|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
7564062|NCT03275389|11934498|FG000|Overall Study|Lost to Follow-up|10
7564063|NCT03275389|11934499|FG001|Overall Study|Lost to Follow-up|10
7453306|NCT01756053|11744197|FG001|Period 1 (10 Days)|Protocol Violation|1
7453307|NCT01756053|11744196|FG000|Period 2 (10 Days)|Protocol Violation|0
7453308|NCT01756053|11744197|FG001|Period 2 (10 Days)|Protocol Violation|2
7453309|NCT01756079|11744203|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
7453310|NCT01756079|11744203|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
7453311|NCT01756079|11744203|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
7453312|NCT01756079|11744203|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
7453313|NCT01756079|11744203|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
7453314|NCT01756157|11744208|FG000|First Intervention Period|Withdrawal by Subject|1
7453315|NCT01756157|11744209|FG001|First Intervention Period|Withdrawal by Subject|0
7453316|NCT01756157|11744208|FG000|First Intervention Period|Lost to Follow-up|0
7453317|NCT01756157|11744209|FG001|First Intervention Period|Lost to Follow-up|2
7453318|NCT01756235|11744232|FG000|Overall Study|Adalimumab Treatment was not Documented|2
7453319|NCT01756274|11744236|FG000|Overall Study|Protocol Violation|2
7453320|NCT01756274|11744236|FG000|Overall Study|Laboratory error|1
7453321|NCT01756300|11744241|FG000|Overall Study|Death|1
7453322|NCT01756300|11744241|FG000|Overall Study|Withdrawal by Subject|1
7453323|NCT01756352|11744262|FG000|Overall Study|moved away and lost to followup|1
7453324|NCT01756456|11744276|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7453325|NCT01756456|11744277|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7453326|NCT01756456|11744278|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
7453327|NCT01756456|11744279|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7453328|NCT01756456|11744280|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7453329|NCT01756456|11744281|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
7453330|NCT01756456|11744276|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
7453331|NCT01756456|11744277|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
7453332|NCT01756456|11744278|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
7453333|NCT01756456|11744279|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
7453334|NCT01756456|11744280|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
7453335|NCT01756456|11744281|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
7453336|NCT01756456|11744276|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
7453337|NCT01756456|11744277|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
7453338|NCT01756456|11744278|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
7453339|NCT01756456|11744279|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
7453340|NCT01756456|11744280|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
7453341|NCT01756456|11744281|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
7564064|NCT03275389|11934500|FG002|Overall Study|Lost to Follow-up|19
7453342|NCT01756456|11744276|FG000|Treatment Period: Phase I/II|Adverse Event|1
7453343|NCT01756456|11744277|FG001|Treatment Period: Phase I/II|Adverse Event|0
7453344|NCT01756456|11744278|FG002|Treatment Period: Phase I/II|Adverse Event|2
7453345|NCT01756456|11744279|FG003|Treatment Period: Phase I/II|Adverse Event|3
7453346|NCT01756456|11744280|FG004|Treatment Period: Phase I/II|Adverse Event|9
7453347|NCT01756456|11744281|FG005|Treatment Period: Phase I/II|Adverse Event|1
7453348|NCT01756456|11744276|FG000|Treatment Period: Phase I/II|Other causes|0
7453349|NCT01756456|11744277|FG001|Treatment Period: Phase I/II|Other causes|0
7453350|NCT01756456|11744278|FG002|Treatment Period: Phase I/II|Other causes|0
7453351|NCT01756456|11744279|FG003|Treatment Period: Phase I/II|Other causes|1
7453352|NCT01756456|11744280|FG004|Treatment Period: Phase I/II|Other causes|2
7453353|NCT01756456|11744281|FG005|Treatment Period: Phase I/II|Other causes|2
7453354|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|still in study after week 20|0
7453355|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|still in study after week 20|0
7453356|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|still in study after week 20|0
7453357|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|still in study after week 20|25
7453358|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|still in study after week 20|23
7453359|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|still in study after week 20|25
7453360|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7453361|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
7453362|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7453363|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7453364|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7453365|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
7453366|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
7453367|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
7453368|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
7453369|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
7453370|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
7453371|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
7453372|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|Adverse Event|1
7453373|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|Adverse Event|0
7453374|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|Adverse Event|0
7453375|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|Adverse Event|5
7453376|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|Adverse Event|0
7453377|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|Adverse Event|1
7453378|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
7453379|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
7453380|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
7453381|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
7453382|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
7453383|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
7453384|NCT01756456|11744276|FG000|Follow Up Period Phase I/II|Other causes|0
7453385|NCT01756456|11744277|FG001|Follow Up Period Phase I/II|Other causes|0
7453386|NCT01756456|11744278|FG002|Follow Up Period Phase I/II|Other causes|0
7453387|NCT01756456|11744279|FG003|Follow Up Period Phase I/II|Other causes|1
7453388|NCT01756456|11744280|FG004|Follow Up Period Phase I/II|Other causes|3
7453389|NCT01756456|11744281|FG005|Follow Up Period Phase I/II|Other causes|5
7453390|NCT01756833|11744306|FG000|Overall Study|Withdrawal by Subject|4
7453391|NCT01756833|11744307|FG001|Overall Study|Withdrawal by Subject|3
7453392|NCT01756846|11744315|FG000|Overall Study|Lost to Follow-up|5
7453393|NCT01756846|11744316|FG001|Overall Study|Lost to Follow-up|10
7453394|NCT01756846|11744315|FG000|Overall Study|Withdrawal by Subject|1
7453395|NCT01756846|11744316|FG001|Overall Study|Withdrawal by Subject|2
7453396|NCT01756898|11744335|FG000|Overall Study|Adverse Event|7
7453397|NCT01756898|11744336|FG001|Overall Study|Adverse Event|1
7453398|NCT01756898|11744337|FG002|Overall Study|Adverse Event|0
7453399|NCT01756898|11744338|FG003|Overall Study|Adverse Event|0
7453400|NCT01756898|11744335|FG000|Overall Study|Lack of Efficacy|4
7453401|NCT01756898|11744336|FG001|Overall Study|Lack of Efficacy|7
7453402|NCT01756898|11744337|FG002|Overall Study|Lack of Efficacy|6
7225166|NCT00064701|11434642|FG000|One Year Post-transplant|Graft Failure|3
7225167|NCT00064701|11434643|FG001|One Year Post-transplant|Graft Failure|2
7225168|NCT00064701|11434644|FG002|One Year Post-transplant|Graft Failure|1
7225169|NCT00064701|11434642|FG000|One Year Post-transplant|Withdrawal by Subject|0
7225170|NCT00064701|11434643|FG001|One Year Post-transplant|Withdrawal by Subject|4
7453403|NCT01756898|11744338|FG003|Overall Study|Lack of Efficacy|6
7453404|NCT01756898|11744335|FG000|Overall Study|Lost to Follow-up|2
7453405|NCT01756898|11744336|FG001|Overall Study|Lost to Follow-up|4
7453406|NCT01756898|11744337|FG002|Overall Study|Lost to Follow-up|2
7533014|NCT02679573|11879004|FG000|Overall Study|Lost to Follow-up|0
7453407|NCT01756898|11744338|FG003|Overall Study|Lost to Follow-up|3
7453408|NCT01756898|11744335|FG000|Overall Study|Protocol Violation|1
7453409|NCT01756898|11744336|FG001|Overall Study|Protocol Violation|2
7453410|NCT01756898|11744337|FG002|Overall Study|Protocol Violation|2
7453411|NCT01756898|11744338|FG003|Overall Study|Protocol Violation|1
7453412|NCT01756898|11744335|FG000|Overall Study|Withdrew Consent|5
7533015|NCT02679573|11879005|FG001|Overall Study|Lost to Follow-up|3
7453413|NCT01756898|11744336|FG001|Overall Study|Withdrew Consent|3
7453414|NCT01756898|11744337|FG002|Overall Study|Withdrew Consent|5
7453415|NCT01756898|11744338|FG003|Overall Study|Withdrew Consent|6
7453416|NCT01756898|11744335|FG000|Overall Study|Other|0
7453417|NCT01756898|11744336|FG001|Overall Study|Other|2
7453418|NCT01756898|11744337|FG002|Overall Study|Other|2
7453419|NCT01756898|11744338|FG003|Overall Study|Other|0
7453420|NCT01757171|11744371|FG000|Overall Study|Adverse Event|5
7453421|NCT01757171|11744372|FG001|Overall Study|Adverse Event|1
7453422|NCT01757171|11744371|FG000|Overall Study|Disease Progression|1
7453423|NCT01757171|11744372|FG001|Overall Study|Disease Progression|0
7453424|NCT01757171|11744371|FG000|Overall Study|Hospitalization|1
7453425|NCT01757171|11744372|FG001|Overall Study|Hospitalization|0
7453426|NCT01757171|11744371|FG000|Overall Study|ECOG decline|1
7453427|NCT01757171|11744372|FG001|Overall Study|ECOG decline|0
7453428|NCT01757184|11744380|FG000|Double-blind Period|Adverse Event|1
7453429|NCT01757184|11744381|FG001|Double-blind Period|Adverse Event|0
7453430|NCT01757184|11744382|FG002|Double-blind Period|Adverse Event|0
7453431|NCT01757184|11744383|FG003|Double-blind Period|Adverse Event|0
7453432|NCT01757184|11744380|FG000|Open-label Period|Lost to Follow-up|0
7453433|NCT01757184|11744381|FG001|Open-label Period|Lost to Follow-up|0
7453434|NCT01757184|11744382|FG002|Open-label Period|Lost to Follow-up|2
7453435|NCT01757184|11744383|FG003|Open-label Period|Lost to Follow-up|0
7453436|NCT01757184|11744380|FG000|Open-label Period|Withdrawal by Subject|0
7453437|NCT01757184|11744381|FG001|Open-label Period|Withdrawal by Subject|0
7453438|NCT01757184|11744382|FG002|Open-label Period|Withdrawal by Subject|1
7453439|NCT01757184|11744383|FG003|Open-label Period|Withdrawal by Subject|1
7453440|NCT01757184|11744380|FG000|Open-label Period|Discontinued by Sponsor|0
7453441|NCT01757184|11744381|FG001|Open-label Period|Discontinued by Sponsor|0
7453442|NCT01757184|11744382|FG002|Open-label Period|Discontinued by Sponsor|1
7453443|NCT01757184|11744383|FG003|Open-label Period|Discontinued by Sponsor|2
7453444|NCT01757197|11744397|FG000|Overall Study|Death|2
7453445|NCT01757275|11744403|FG000|Overall Study|Lost to Follow-up|1
7453446|NCT01757275|11744404|FG001|Overall Study|Lost to Follow-up|2
7453447|NCT01757275|11744403|FG000|Overall Study|Adverse Event|3
7453448|NCT01757275|11744404|FG001|Overall Study|Adverse Event|3
7453449|NCT01757275|11744403|FG000|Overall Study|Withdrawal by Subject|2
7453450|NCT01757275|11744404|FG001|Overall Study|Withdrawal by Subject|4
7453451|NCT01757275|11744403|FG000|Overall Study|Not treated|3
7453452|NCT01757275|11744404|FG001|Overall Study|Not treated|4
7453453|NCT01757288|11744413|FG000|Overall Study|Consent withdrawal|0
7453454|NCT01757288|11744414|FG001|Overall Study|Consent withdrawal|4
7453455|NCT01757288|11744415|FG002|Overall Study|Consent withdrawal|4
7453456|NCT01757288|11744413|FG000|Overall Study|Patient off study, IRB hold.|0
7453457|NCT01757288|11744414|FG001|Overall Study|Patient off study, IRB hold.|0
7453458|NCT01757288|11744415|FG002|Overall Study|Patient off study, IRB hold.|1
7453459|NCT01757288|11744413|FG000|Overall Study|Patient death prior to starting treatment|0
7453460|NCT01757288|11744414|FG001|Overall Study|Patient death prior to starting treatment|0
7453461|NCT01757288|11744415|FG002|Overall Study|Patient death prior to starting treatment|1
7453462|NCT01757288|11744413|FG000|Overall Study|Wrong medication administered|0
7453463|NCT01757288|11744414|FG001|Overall Study|Wrong medication administered|1
7453464|NCT01757288|11744415|FG002|Overall Study|Wrong medication administered|0
7453465|NCT01757288|11744413|FG000|Overall Study|Liver metastasis identified at CT simulation|0
7453466|NCT01757288|11744414|FG001|Overall Study|Liver metastasis identified at CT simulation|1
7453467|NCT01757288|11744415|FG002|Overall Study|Liver metastasis identified at CT simulation|0
7453468|NCT01757288|11744413|FG000|Overall Study|Not meeting protocol constraints|0
7453469|NCT01757288|11744414|FG001|Overall Study|Not meeting protocol constraints|1
7453470|NCT01757288|11744415|FG002|Overall Study|Not meeting protocol constraints|1
7453471|NCT01757288|11744413|FG000|Overall Study|Multiple missed appointments|0
7453472|NCT01757288|11744414|FG001|Overall Study|Multiple missed appointments|1
7453473|NCT01757288|11744415|FG002|Overall Study|Multiple missed appointments|0
7453474|NCT01757288|11744413|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7453475|NCT01757288|11744414|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
7453476|NCT01757288|11744415|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
7453477|NCT01757288|11744413|FG000|Overall Study|>2 weeks treatment break|0
7453478|NCT01757288|11744414|FG001|Overall Study|>2 weeks treatment break|0
7453479|NCT01757288|11744415|FG002|Overall Study|>2 weeks treatment break|1
7453480|NCT01757392|11744435|FG000|Overall Study|Withdrawal by Subject|1
7453481|NCT01757392|11744435|FG000|Overall Study|Screen Fail|3
7453482|NCT01757405|11744441|FG000|Overall Study|Lost to Follow-up|1
7453483|NCT01757405|11744442|FG001|Overall Study|Lost to Follow-up|1
7453484|NCT01757405|11744441|FG000|Overall Study|Withdrawal by Subject|0
7453485|NCT01757405|11744442|FG001|Overall Study|Withdrawal by Subject|1
7453486|NCT01757691|11744473|FG000|Overall Study|Administrative problems|2
7453487|NCT01757691|11744474|FG001|Overall Study|Administrative problems|0
7453488|NCT01757704|11744482|FG000|Overall Study|Protocol Violation|1
7453489|NCT01757704|11744483|FG001|Overall Study|Protocol Violation|3
7453490|NCT01757821|11744493|FG000|Overall Study|Adverse Event|1
7453491|NCT01757847|11744503|FG000|Overall Study|Withdrawal by Subject|3
7453492|NCT01757847|11744504|FG001|Overall Study|Withdrawal by Subject|4
7453493|NCT01758289|11744517|FG000|Overall Study|Premature Study Termination|44
7453494|NCT01758289|11744517|FG000|Overall Study|Adverse Event|9
7453495|NCT01758523|11744556|FG000|Overall Study|Adverse Event|2
7453496|NCT01758523|11744557|FG001|Overall Study|Adverse Event|1
7453497|NCT01758523|11744556|FG000|Overall Study|Lack of Efficacy|4
7453498|NCT01758523|11744557|FG001|Overall Study|Lack of Efficacy|2
7453499|NCT01758523|11744556|FG000|Overall Study|Lost to Follow-up|3
7453500|NCT01758523|11744557|FG001|Overall Study|Lost to Follow-up|4
7453501|NCT01758523|11744556|FG000|Overall Study|Withdrawal by Subject|12
7453502|NCT01758523|11744557|FG001|Overall Study|Withdrawal by Subject|7
7453503|NCT01758731|11744578|FG000|Overall Study|Physician Decision|1
7453504|NCT01758900|11744584|FG000|Overall Study|difficulty for further intubation|7
7453505|NCT01758900|11744585|FG001|Overall Study|difficulty for further intubation|8
7453506|NCT01759264|11744604|FG000|Overall Study|Serious Adverse Events (SAEs)|1
7453507|NCT01759264|11744604|FG000|Overall Study|Adverse Event|1
7453508|NCT01759264|11744604|FG000|Overall Study|Other|2
7453509|NCT01759264|11744604|FG000|Overall Study|Lost to Follow-up|2
7453510|NCT01759264|11744604|FG000|Overall Study|Withdrawal by Subject|3
7453511|NCT01759264|11744604|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
7453512|NCT01759290|11744620|FG000|Overall Study|Subjects withdrawn consent|5
7453513|NCT01759290|11744620|FG000|Overall Study|Physician Decision|2
7453514|NCT01759290|11744620|FG000|Overall Study|Death|17
7453515|NCT01759290|11744620|FG000|Overall Study|Lost to Follow-up|53
7453516|NCT01759290|11744620|FG000|Overall Study|Unknown reason|4
7453517|NCT01759368|11744626|FG000|Overall Study|Lost to Follow-up|1
7453518|NCT01759368|11744627|FG001|Overall Study|Lost to Follow-up|0
7453519|NCT01759381|11744637|FG000|Overall Study|Death|1
7453520|NCT01759381|11744638|FG001|Overall Study|Death|0
7453521|NCT01759407|11744646|FG000|Overall Study|Protocol Violation|0
7453522|NCT01759407|11744647|FG001|Overall Study|Protocol Violation|2
7453523|NCT01759420|11744653|FG000|Overall Study|Screen failure|5
7453524|NCT01759420|11744653|FG000|Overall Study|Inaccurate EKG machine readings|1
7453525|NCT01759446|11744662|FG000|Overall Study|Protocol Violation|1
7453526|NCT01759446|11744663|FG001|Overall Study|Protocol Violation|0
7453527|NCT01759446|11744664|FG002|Overall Study|Protocol Violation|1
7453528|NCT01759446|11744665|FG003|Overall Study|Protocol Violation|0
7453529|NCT01759446|11744666|FG004|Overall Study|Protocol Violation|0
7453530|NCT01759446|11744662|FG000|Overall Study|Withdrawal by Subject|0
7453531|NCT01759446|11744663|FG001|Overall Study|Withdrawal by Subject|1
7453532|NCT01759446|11744664|FG002|Overall Study|Withdrawal by Subject|0
7453533|NCT01759446|11744665|FG003|Overall Study|Withdrawal by Subject|1
7453534|NCT01759446|11744666|FG004|Overall Study|Withdrawal by Subject|0
7453535|NCT01759511|11744678|FG000|Overall Study|Adverse Event|4
7453536|NCT01759511|11744678|FG000|Overall Study|Death|2
7453537|NCT01759511|11744678|FG000|Overall Study|Lack of Efficacy|2
7453538|NCT01759511|11744678|FG000|Overall Study|Physician Decision|1
7453539|NCT01759511|11744678|FG000|Overall Study|Progressive Disease|5
7453540|NCT01759511|11744678|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
7453541|NCT01759511|11744678|FG000|Overall Study|Study Terminated by Sponsor|13
7453542|NCT01759511|11744678|FG000|Overall Study|Withdrawal by Subject|3
7453543|NCT01759862|11744688|FG000|Overall Study|Physician Decision|3
7453544|NCT01759862|11744689|FG001|Overall Study|Physician Decision|1
7453545|NCT01759862|11744688|FG000|Overall Study|Adverse Event|0
7453546|NCT01759862|11744689|FG001|Overall Study|Adverse Event|1
7564065|NCT03275389|11934501|FG003|Overall Study|Lost to Follow-up|12
7564066|NCT03275389|11934502|FG004|Overall Study|Lost to Follow-up|11
7453575|NCT01760733|11744787|FG000|Waiting List|Death|18
7453576|NCT01760733|11744787|FG000|Waiting List|Removed from waiting list|41
7564067|NCT03275389|11934503|FG005|Overall Study|Lost to Follow-up|12
7453577|NCT01760733|11744787|FG000|Waiting List|Not received a transplant yet|13
7564068|NCT03275389|11934504|FG006|Overall Study|Lost to Follow-up|21
7564069|NCT03275389|11934505|FG007|Overall Study|Lost to Follow-up|15
7564070|NCT03275389|11934506|FG008|Overall Study|Lost to Follow-up|12
7564071|NCT03275389|11934507|FG009|Overall Study|Lost to Follow-up|14
7564072|NCT03275389|11934498|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564073|NCT03275389|11934499|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7453578|NCT01760733|11744787|FG000|Transplanted|Not reached 10 years post transplant|184
7453579|NCT01760733|11744787|FG000|Transplanted|Death|26
7453580|NCT01760733|11744787|FG000|Transplanted|Graft loss|7
7453581|NCT01760876|11744801|FG000|Overall Study|Non-cardiac death (head injury)|1
7453582|NCT01760876|11744801|FG000|Overall Study|Carcinoma of prostate|1
7453583|NCT01760876|11744801|FG000|Overall Study|Impaired renal function|1
7453584|NCT01760876|11744801|FG000|Overall Study|Major depression|1
7453585|NCT01760876|11744801|FG000|Overall Study|Very poor baseline OCT quality|2
7453586|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
7453587|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
7453588|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
7453589|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
7453590|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Adverse Event|5
7453591|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Adverse Event|3
7453592|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Adverse Event|4
7453593|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Adverse Event|10
7453594|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
7453595|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
7453596|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
7453597|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
7453598|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7453599|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7453600|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
7453601|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
7453602|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Pregnancy|5
7453603|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Pregnancy|0
7453604|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Pregnancy|3
7453605|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Pregnancy|2
7453606|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Non-compliance|1
7453607|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Non-compliance|4
7453608|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Non-compliance|0
7453609|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Non-compliance|3
7453610|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Other|0
7453611|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Other|3
7564074|NCT03275389|11934500|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564075|NCT03275389|11934501|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564076|NCT03275389|11934502|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564077|NCT03275389|11934503|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7564078|NCT03275389|11934504|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564079|NCT03275389|11934505|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564080|NCT03275389|11934506|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
7564081|NCT03275389|11934507|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
7564082|NCT03275389|11934498|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7564083|NCT03275389|11934499|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7564084|NCT03275389|11934500|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7564085|NCT03275389|11934501|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7564086|NCT03275389|11934502|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7564087|NCT03275389|11934503|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7564088|NCT03275389|11934504|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7564089|NCT03275389|11934505|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
7564090|NCT03275389|11934506|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7564091|NCT03275389|11934507|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7564092|NCT03275389|11934498|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564093|NCT03275389|11934499|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7564094|NCT03275389|11934500|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564095|NCT03275389|11934501|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7564096|NCT03275389|11934502|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564097|NCT03275389|11934503|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564098|NCT03275389|11934504|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7564099|NCT03275389|11934505|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564100|NCT03275389|11934506|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564101|NCT03275389|11934507|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7453612|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Other|3
7453613|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Other|1
7453614|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
7453615|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
7453616|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7564102|NCT03275389|11934498|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564103|NCT03275389|11934499|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564104|NCT03275389|11934500|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7564105|NCT03275389|11934501|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564106|NCT03275389|11934502|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564107|NCT03275389|11934503|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564108|NCT03275389|11934504|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564109|NCT03275389|11934505|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564110|NCT03275389|11934506|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7564111|NCT03275389|11934507|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7564112|NCT03275389|11934498|FG000|Overall Study|Other|0
7564113|NCT03275389|11934499|FG001|Overall Study|Other|4
7564114|NCT03275389|11934500|FG002|Overall Study|Other|3
7564115|NCT03275389|11934501|FG003|Overall Study|Other|2
7564116|NCT03275389|11934502|FG004|Overall Study|Other|2
7564117|NCT03275389|11934503|FG005|Overall Study|Other|2
7564118|NCT03275389|11934504|FG006|Overall Study|Other|0
7564119|NCT03275389|11934505|FG007|Overall Study|Other|0
7564120|NCT03275389|11934506|FG008|Overall Study|Other|1
7453617|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
7453618|NCT01760954|11744809|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
7453619|NCT01760954|11744810|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
7453620|NCT01760954|11744811|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
7453621|NCT01760954|11744812|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
7453622|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7453623|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
7453624|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
7453625|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
7453626|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
7453627|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
7453628|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
7453629|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
7453630|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
7453631|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
7453632|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7453633|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
7453634|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
7453635|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
7453636|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7453637|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
7453638|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7453639|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7453640|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
7453641|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
7453642|NCT01760954|11744809|FG000|Post-treatment Follow-up (12 Months)|Other|13
7453643|NCT01760954|11744810|FG001|Post-treatment Follow-up (12 Months)|Other|8
7453644|NCT01760954|11744811|FG002|Post-treatment Follow-up (12 Months)|Other|9
7453645|NCT01760954|11744812|FG003|Post-treatment Follow-up (12 Months)|Other|6
7453646|NCT01761162|11744836|FG000|Overall Study|Withdrawal by Subject|3
7453647|NCT01761292|11744858|FG000|Part 1|Adverse Event|1
7453648|NCT01761292|11744858|FG000|Part 1|not receiving treatment in Part 1|1
7453649|NCT01761292|11744858|FG000|Extension 1|Withdrawal by Subject|1
7453650|NCT01761565|11744869|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
7453651|NCT01762345|11744899|FG000|Overall Study|Adverse Event|5
7453652|NCT01762345|11744899|FG000|Overall Study|Protocol Violation|2
7453653|NCT01762800|11744933|FG000|Overall Study|Adverse Event|8
7453654|NCT01762800|11744934|FG001|Overall Study|Adverse Event|13
7453655|NCT01762800|11744933|FG000|Overall Study|Lack of Efficacy|3
7453656|NCT01762800|11744934|FG001|Overall Study|Lack of Efficacy|2
7453657|NCT01762800|11744933|FG000|Overall Study|Study Closed/Terminated|0
7453658|NCT01762800|11744934|FG001|Overall Study|Study Closed/Terminated|1
7453659|NCT01762800|11744933|FG000|Overall Study|Physician Decision|1
7453660|NCT01762800|11744934|FG001|Overall Study|Physician Decision|1
7453661|NCT01762800|11744933|FG000|Overall Study|Withdrawal by Subject|7
7453662|NCT01762800|11744934|FG001|Overall Study|Withdrawal by Subject|4
7453663|NCT01762943|11744955|FG000|Overall Study|Physician Decision|1
7453664|NCT01762943|11744956|FG001|Overall Study|Physician Decision|1
7453665|NCT01762943|11744955|FG000|Overall Study|Protocol Violation|1
7453666|NCT01762943|11744956|FG001|Overall Study|Protocol Violation|0
7453667|NCT01762943|11744955|FG000|Overall Study|Withdrawal by Subject|2
7453668|NCT01762943|11744956|FG001|Overall Study|Withdrawal by Subject|1
7564121|NCT03275389|11934507|FG009|Overall Study|Other|0
7564122|NCT03276026|11934561|FG000|Overall Study|Protocol Violation|1
7564123|NCT03276026|11934562|FG001|Overall Study|Protocol Violation|0
7564124|NCT03276078|11934568|FG000|Overall Study|Adverse Event|1
7453669|NCT01763047|11744972|FG000|Period 1|Test Article Not Available|4
7453670|NCT01763047|11744973|FG001|Period 1|Test Article Not Available|1
7453671|NCT01763047|11744972|FG000|Period 1|Protocol Violation|4
7453672|NCT01763047|11744973|FG001|Period 1|Protocol Violation|4
7453673|NCT01763047|11744972|FG000|Period 1|No Longer Meets Eligibility criteria|1
7453674|NCT01763047|11744973|FG001|Period 1|No Longer Meets Eligibility criteria|0
7453675|NCT01763047|11744972|FG000|Period 1|Adverse Event|0
7453676|NCT01763047|11744973|FG001|Period 1|Adverse Event|1
7453677|NCT01763047|11744972|FG000|Period 1|Unsatisfactory Visual Response|0
7453678|NCT01763047|11744973|FG001|Period 1|Unsatisfactory Visual Response|3
7453679|NCT01763047|11744972|FG000|Period 1|Lens Power Not Available|0
7453680|NCT01763047|11744973|FG001|Period 1|Lens Power Not Available|1
7453681|NCT01763047|11744972|FG000|Period 1|Study Site office Closed|0
7453682|NCT01763047|11744973|FG001|Period 1|Study Site office Closed|1
7453683|NCT01763047|11744972|FG000|Period 2|Lens Discomfort|1
7453684|NCT01763047|11744973|FG001|Period 2|Lens Discomfort|0
7453685|NCT01763047|11744972|FG000|Period 2|No longer meets Eligibility Criteria|1
7453686|NCT01763047|11744973|FG001|Period 2|No longer meets Eligibility Criteria|0
7453687|NCT01763047|11744972|FG000|Period 2|Study Site office Closed|1
7453688|NCT01763047|11744973|FG001|Period 2|Study Site office Closed|1
7453689|NCT01763047|11744972|FG000|Period 2|Unsatisfactory Visual Response|1
7453690|NCT01763047|11744973|FG001|Period 2|Unsatisfactory Visual Response|1
7453691|NCT01763047|11744972|FG000|Period 2|Protocol Violation|0
7453692|NCT01763047|11744973|FG001|Period 2|Protocol Violation|2
7453693|NCT01763047|11744972|FG000|Period 2|Unsatisfactory lens Fitting|0
7453694|NCT01763047|11744973|FG001|Period 2|Unsatisfactory lens Fitting|1
7453695|NCT01763164|11744984|FG000|Treatment Phase|Participant/Guardian decision|26
7453696|NCT01763164|11744985|FG001|Treatment Phase|Participant/Guardian decision|14
7453697|NCT01763164|11744984|FG000|Treatment Phase|Protocol Violation|1
7453698|NCT01763164|11744985|FG001|Treatment Phase|Protocol Violation|1
7453699|NCT01763164|11744984|FG000|Treatment Phase|Progressive Disease|142
7453700|NCT01763164|11744985|FG001|Treatment Phase|Progressive Disease|76
7453701|NCT01763164|11744984|FG000|Treatment Phase|Physician Decision|24
7453702|NCT01763164|11744985|FG001|Treatment Phase|Physician Decision|13
7564125|NCT03276975|11934592|FG000|Overall Study|Withdrawal by Subject|1
7564126|NCT03276975|11934593|FG001|Overall Study|Withdrawal by Subject|0
7564127|NCT03277352|11934612|FG000|Overall Study|Study Terminated By Sponsor|2
7564128|NCT03277352|11934612|FG000|Overall Study|Withdrawal by Subject|4
7564129|NCT03277352|11934612|FG000|Overall Study|Death|4
7564130|NCT03277794|11934632|FG000|Overall Study|Lost to Follow-up|2
7564131|NCT03277794|11934633|FG001|Overall Study|Lost to Follow-up|4
7564132|NCT03277794|11934632|FG000|Overall Study|Withdrew due to high acuity|1
7453703|NCT01763164|11744984|FG000|Treatment Phase|Death|10
7453704|NCT01763164|11744985|FG001|Treatment Phase|Death|1
7453705|NCT01763164|11744984|FG000|Treatment Phase|Adverse Event|66
7453706|NCT01763164|11744985|FG001|Treatment Phase|Adverse Event|8
7453707|NCT01763164|11744984|FG000|Treatment Phase|Randomized but not Treated|0
7453708|NCT01763164|11744985|FG001|Treatment Phase|Randomized but not Treated|19
7453709|NCT01763164|11744984|FG000|Treatment Phase|Other|0
7453710|NCT01763164|11744985|FG001|Treatment Phase|Other|1
7453711|NCT01763164|11744984|FG000|Follow up Phase|New therapy for study indication|12
7453712|NCT01763164|11744985|FG001|Follow up Phase|New therapy for study indication|3
7453713|NCT01763164|11744984|FG000|Follow up Phase|Death|21
7453714|NCT01763164|11744985|FG001|Follow up Phase|Death|4
7453715|NCT01763164|11744984|FG000|Follow up Phase|Subject/guardian decision|9
7453716|NCT01763164|11744985|FG001|Follow up Phase|Subject/guardian decision|2
7453717|NCT01763164|11744984|FG000|Follow up Phase|Progressive disease|127
7453718|NCT01763164|11744985|FG001|Follow up Phase|Progressive disease|62
7453719|NCT01763164|11744984|FG000|Follow up Phase|Physician Decision|10
7453720|NCT01763164|11744985|FG001|Follow up Phase|Physician Decision|3
7453721|NCT01763164|11744984|FG000|Follow up Phase|Lost to Follow-up|1
7453722|NCT01763164|11744985|FG001|Follow up Phase|Lost to Follow-up|0
7453723|NCT01763164|11744984|FG000|Follow up Phase|Adverse Event|17
7453724|NCT01763164|11744985|FG001|Follow up Phase|Adverse Event|1
7453725|NCT01763203|11744993|FG000|Overall Study|Death|4
7453726|NCT01763203|11744994|FG001|Overall Study|Death|7
7453727|NCT01763203|11744993|FG000|Overall Study|Lost to Follow-up|12
7453728|NCT01763203|11744994|FG001|Overall Study|Lost to Follow-up|12
7453729|NCT01763203|11744993|FG000|Overall Study|Withdrawal by Subject|8
7453730|NCT01763203|11744994|FG001|Overall Study|Withdrawal by Subject|12
7453731|NCT01763203|11744993|FG000|Overall Study|Moved out of study region|7
7453732|NCT01763203|11744994|FG001|Overall Study|Moved out of study region|10
7564133|NCT03277794|11934633|FG001|Overall Study|Withdrew due to high acuity|0
7453733|NCT01763203|11744993|FG000|Overall Study|Physician Decision|2
7453734|NCT01763203|11744994|FG001|Overall Study|Physician Decision|1
7453735|NCT01763684|11745096|FG000|Overall Study|Study terminated early due to low enrollment|126
7453736|NCT01763684|11745097|FG001|Overall Study|Study terminated early due to low enrollment|127
7453737|NCT01763684|11745096|FG000|Overall Study|Study surgery not performed|7
7453738|NCT01763684|11745097|FG001|Overall Study|Study surgery not performed|6
7468109|NCT01907100|11768666|FG001|Overall Study|PD based on modified RECIST criteria|32
7468110|NCT01907100|11768667|FG002|Overall Study|PD based on modified RECIST criteria|95
7468111|NCT01907100|11768668|FG003|Overall Study|PD based on modified RECIST criteria|92
7468112|NCT01907100|11768665|FG000|Overall Study|Withdrawal by Subject|2
7453739|NCT01763827|11745109|FG000|Overall Study|Withdrawal by Subject|1
7453740|NCT01763827|11745110|FG001|Overall Study|Withdrawal by Subject|0
7453741|NCT01763827|11745111|FG002|Overall Study|Withdrawal by Subject|0
7453742|NCT01763827|11745112|FG003|Overall Study|Withdrawal by Subject|0
7453743|NCT01763827|11745113|FG004|Overall Study|Withdrawal by Subject|2
7453744|NCT01763827|11745114|FG005|Overall Study|Withdrawal by Subject|0
7453745|NCT01763827|11745109|FG000|Overall Study|Decision by sponsor|2
7453746|NCT01763827|11745110|FG001|Overall Study|Decision by sponsor|0
7564134|NCT03277846|11934642|FG000|Overall Study|Inpatient stay too brief|12
7564135|NCT03277846|11934643|FG001|Overall Study|Inpatient stay too brief|11
7564136|NCT03278028|11934651|FG000|Overall Study|Lost to Follow-up|1
7564137|NCT03278028|11934652|FG001|Overall Study|Lost to Follow-up|0
7564138|NCT03278028|11934651|FG000|Overall Study|Withdrawal by Subject|3
7564139|NCT03278028|11934652|FG001|Overall Study|Withdrawal by Subject|1
7564140|NCT03278028|11934651|FG000|Overall Study|Pregnancy|0
7564141|NCT03278028|11934652|FG001|Overall Study|Pregnancy|1
7564142|NCT03278106|11934676|FG000|Overall Study|No protocol treatment|1
7564143|NCT03278613|11934691|FG000|Overall Study|Lost to Follow-up|3
7564144|NCT03278613|11934692|FG001|Overall Study|Lost to Follow-up|1
7564145|NCT03280108|11934730|FG000|Overall Study|Lost to Follow-up|2
7564146|NCT03280108|11934731|FG001|Overall Study|Lost to Follow-up|0
7564147|NCT03280121|11934742|FG000|Overall Study|Physician Decision|1
7564148|NCT03280121|11934742|FG000|Overall Study|Lost to Follow-up|1
7564149|NCT03280121|11934742|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
7564150|NCT03280264|11934746|FG000|Overall Study|Adverse Event|1
7564151|NCT03280264|11934746|FG000|Overall Study|Physician Decision|1
7564152|NCT03280264|11934746|FG000|Overall Study|Withdrawal by Subject|1
7564153|NCT03280381|11934753|FG000|Overall Study|Physician Decision|0
7564154|NCT03280381|11934754|FG001|Overall Study|Physician Decision|2
7564155|NCT03280537|11934763|FG000|Overall Study|Withdrawal by Subject|2
7564156|NCT03280537|11934764|FG001|Overall Study|Withdrawal by Subject|4
7564157|NCT03280550|11934772|FG000|Overall Study|Withdrawal by Subject|2
7564158|NCT03280550|11934773|FG001|Overall Study|Withdrawal by Subject|2
7564159|NCT03280550|11934772|FG000|Overall Study|Physician Decision|0
7564160|NCT03280550|11934773|FG001|Overall Study|Physician Decision|1
7564161|NCT03280615|11934781|FG000|Overall Study|Lost to Follow-up|1
7564162|NCT03280615|11934782|FG001|Overall Study|Lost to Follow-up|2
7564163|NCT03280615|11934781|FG000|Overall Study|Adverse Event|1
7564164|NCT03280615|11934782|FG001|Overall Study|Adverse Event|1
7564165|NCT03280615|11934781|FG000|Overall Study|Withdrawal by Subject|2
7564166|NCT03280615|11934782|FG001|Overall Study|Withdrawal by Subject|2
7564167|NCT03281577|11934800|FG000|Overall Study|Adverse Event|0
7564168|NCT03281577|11934801|FG001|Overall Study|Adverse Event|0
7564169|NCT03281577|11934802|FG002|Overall Study|Adverse Event|0
7328965|NCT00798759|11561911|FG000|Overall Study|Other|0
7328966|NCT00798759|11561912|FG001|Overall Study|Other|1
7328967|NCT00798889|11561918|FG000|Overall Study|Adverse Event|53
7328968|NCT00798889|11561918|FG000|Overall Study|Protocol Violation|2
7328969|NCT00798889|11561918|FG000|Overall Study|Withdrawal by Subject|31
7328970|NCT00798889|11561918|FG000|Overall Study|Lost to Follow-up|1
7328971|NCT00798889|11561918|FG000|Overall Study|Lack of Efficacy|213
7328972|NCT00798889|11561918|FG000|Overall Study|Decision of Sponsor|11
7328973|NCT00798889|11561918|FG000|Overall Study|Enrolled, Not treated|3
7328974|NCT00798967|11561924|FG000|Overall Study|Adverse Event|2
7328975|NCT00798967|11561925|FG001|Overall Study|Adverse Event|3
7328976|NCT00798967|11561924|FG000|Overall Study|Withdrawal by Subject|0
7328977|NCT00798967|11561925|FG001|Overall Study|Withdrawal by Subject|1
7328978|NCT00798967|11561924|FG000|Overall Study|Physician Decision|1
7328979|NCT00798967|11561925|FG001|Overall Study|Physician Decision|0
7328980|NCT00798967|11561924|FG000|Overall Study|Randomized in error by site|1
7328981|NCT00798967|11561925|FG001|Overall Study|Randomized in error by site|0
7328982|NCT00799383|11561938|FG000|Overall Study|Protocol Violation|1
7328983|NCT00799383|11561939|FG001|Overall Study|Protocol Violation|1
7328984|NCT00799383|11561938|FG000|Overall Study|Adverse Event|0
7328985|NCT00799383|11561939|FG001|Overall Study|Adverse Event|1
7328986|NCT00799383|11561938|FG000|Overall Study|Lost to Follow-up|1
7328987|NCT00799383|11561939|FG001|Overall Study|Lost to Follow-up|2
7328988|NCT00799383|11561938|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7328989|NCT00799383|11561939|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
7328990|NCT00799383|11561938|FG000|Overall Study|Withdrawal by Subject|0
7328991|NCT00799383|11561939|FG001|Overall Study|Withdrawal by Subject|1
7328992|NCT00799409|11561948|FG000|Overall Study|Withdrawal by Subject|1
7328993|NCT00799409|11561949|FG001|Overall Study|Withdrawal by Subject|0
7564170|NCT03281577|11934803|FG003|Overall Study|Adverse Event|1
7564171|NCT03281577|11934800|FG000|Overall Study|Withdrawal by Subject|1
7564172|NCT03281577|11934801|FG001|Overall Study|Withdrawal by Subject|0
7564173|NCT03281577|11934802|FG002|Overall Study|Withdrawal by Subject|0
7328994|NCT00799409|11561950|FG002|Overall Study|Withdrawal by Subject|0
7328995|NCT00799409|11561948|FG000|Overall Study|Lost to Follow-up|1
7328996|NCT00799409|11561949|FG001|Overall Study|Lost to Follow-up|0
7328997|NCT00799409|11561950|FG002|Overall Study|Lost to Follow-up|0
7328998|NCT00799409|11561948|FG000|Overall Study|Optimal Dose Not Achieved|2
7453747|NCT01763827|11745111|FG002|Overall Study|Decision by sponsor|3
7453748|NCT01763827|11745112|FG003|Overall Study|Decision by sponsor|0
7453749|NCT01763827|11745113|FG004|Overall Study|Decision by sponsor|2
7453750|NCT01763827|11745114|FG005|Overall Study|Decision by sponsor|1
7453751|NCT01763827|11745109|FG000|Overall Study|Lost to Follow-up|0
7453752|NCT01763827|11745110|FG001|Overall Study|Lost to Follow-up|1
7453753|NCT01763827|11745111|FG002|Overall Study|Lost to Follow-up|1
7453754|NCT01763827|11745112|FG003|Overall Study|Lost to Follow-up|1
7453755|NCT01763827|11745113|FG004|Overall Study|Lost to Follow-up|2
7453756|NCT01763827|11745114|FG005|Overall Study|Lost to Follow-up|1
7453757|NCT01763866|11745152|FG000|Overall Study|Withdrawal by Subject|2
7453758|NCT01763866|11745153|FG001|Overall Study|Withdrawal by Subject|1
7453759|NCT01763866|11745154|FG002|Overall Study|Withdrawal by Subject|4
7453760|NCT01763866|11745155|FG003|Overall Study|Withdrawal by Subject|0
7453761|NCT01763866|11745156|FG004|Overall Study|Withdrawal by Subject|0
7453762|NCT01763866|11745157|FG005|Overall Study|Withdrawal by Subject|3
7453763|NCT01763866|11745158|FG006|Overall Study|Withdrawal by Subject|4
7453764|NCT01763866|11745159|FG007|Overall Study|Withdrawal by Subject|0
7453765|NCT01763866|11745160|FG008|Overall Study|Withdrawal by Subject|1
7453766|NCT01763866|11745161|FG009|Overall Study|Withdrawal by Subject|1
7453767|NCT01763866|11745162|FG010|Overall Study|Withdrawal by Subject|2
7453768|NCT01763866|11745163|FG011|Overall Study|Withdrawal by Subject|2
7453769|NCT01763866|11745164|FG012|Overall Study|Withdrawal by Subject|2
7453770|NCT01763866|11745165|FG013|Overall Study|Withdrawal by Subject|0
7453771|NCT01763866|11745166|FG014|Overall Study|Withdrawal by Subject|6
7453772|NCT01763866|11745167|FG015|Overall Study|Withdrawal by Subject|3
7453773|NCT01763866|11745168|FG016|Overall Study|Withdrawal by Subject|0
7453774|NCT01763866|11745169|FG017|Overall Study|Withdrawal by Subject|1
7453775|NCT01763866|11745170|FG018|Overall Study|Withdrawal by Subject|1
7453776|NCT01763866|11745171|FG019|Overall Study|Withdrawal by Subject|1
7453777|NCT01763866|11745172|FG020|Overall Study|Withdrawal by Subject|2
7453778|NCT01763866|11745173|FG021|Overall Study|Withdrawal by Subject|1
7453779|NCT01763866|11745174|FG022|Overall Study|Withdrawal by Subject|2
7453780|NCT01763866|11745175|FG023|Overall Study|Withdrawal by Subject|1
7453781|NCT01763866|11745152|FG000|Overall Study|Decision by sponsor|0
7453782|NCT01763866|11745153|FG001|Overall Study|Decision by sponsor|0
7453783|NCT01763866|11745154|FG002|Overall Study|Decision by sponsor|1
7453784|NCT01763866|11745155|FG003|Overall Study|Decision by sponsor|0
7453785|NCT01763866|11745156|FG004|Overall Study|Decision by sponsor|2
7453786|NCT01763866|11745157|FG005|Overall Study|Decision by sponsor|0
7453787|NCT01763866|11745158|FG006|Overall Study|Decision by sponsor|2
7564174|NCT03281577|11934803|FG003|Overall Study|Withdrawal by Subject|0
7453788|NCT01763866|11745159|FG007|Overall Study|Decision by sponsor|0
7453789|NCT01763866|11745160|FG008|Overall Study|Decision by sponsor|2
7453790|NCT01763866|11745161|FG009|Overall Study|Decision by sponsor|0
7453791|NCT01763866|11745162|FG010|Overall Study|Decision by sponsor|6
7453792|NCT01763866|11745163|FG011|Overall Study|Decision by sponsor|0
7453793|NCT01763866|11745164|FG012|Overall Study|Decision by sponsor|1
7453794|NCT01763866|11745165|FG013|Overall Study|Decision by sponsor|0
7453795|NCT01763866|11745166|FG014|Overall Study|Decision by sponsor|5
7453796|NCT01763866|11745167|FG015|Overall Study|Decision by sponsor|0
7453797|NCT01763866|11745168|FG016|Overall Study|Decision by sponsor|0
7453798|NCT01763866|11745169|FG017|Overall Study|Decision by sponsor|0
7453799|NCT01763866|11745170|FG018|Overall Study|Decision by sponsor|4
7453800|NCT01763866|11745171|FG019|Overall Study|Decision by sponsor|0
7453801|NCT01763866|11745172|FG020|Overall Study|Decision by sponsor|2
7453802|NCT01763866|11745173|FG021|Overall Study|Decision by sponsor|0
7453803|NCT01763866|11745174|FG022|Overall Study|Decision by sponsor|1
7453804|NCT01763866|11745175|FG023|Overall Study|Decision by sponsor|0
7453805|NCT01763866|11745152|FG000|Overall Study|Lost to Follow-up|0
7453806|NCT01763866|11745153|FG001|Overall Study|Lost to Follow-up|0
7453807|NCT01763866|11745154|FG002|Overall Study|Lost to Follow-up|0
7453808|NCT01763866|11745155|FG003|Overall Study|Lost to Follow-up|0
7453809|NCT01763866|11745156|FG004|Overall Study|Lost to Follow-up|0
7564175|NCT03281668|11934816|FG000|Overall Study|Physician Decision|1
7328999|NCT00799409|11561949|FG001|Overall Study|Optimal Dose Not Achieved|0
7329000|NCT00799409|11561950|FG002|Overall Study|Optimal Dose Not Achieved|0
7329001|NCT00799409|11561948|FG000|Overall Study|Failure to follow study protocol)|1
7329002|NCT00799409|11561949|FG001|Overall Study|Failure to follow study protocol)|0
7329003|NCT00799409|11561950|FG002|Overall Study|Failure to follow study protocol)|0
7329004|NCT00799409|11561948|FG000|Overall Study|Did not attend lab school day 1|1
7564176|NCT03281668|11934816|FG000|Overall Study|scheduling conflict, family circumstance|2
7329005|NCT00799409|11561949|FG001|Overall Study|Did not attend lab school day 1|0
7329006|NCT00799409|11561950|FG002|Overall Study|Did not attend lab school day 1|0
7329007|NCT00799409|11561948|FG000|Overall Study|medication compliance|1
7329008|NCT00799409|11561949|FG001|Overall Study|medication compliance|0
7329009|NCT00799409|11561950|FG002|Overall Study|medication compliance|0
7453810|NCT01763866|11745157|FG005|Overall Study|Lost to Follow-up|0
7453811|NCT01763866|11745158|FG006|Overall Study|Lost to Follow-up|1
7453812|NCT01763866|11745159|FG007|Overall Study|Lost to Follow-up|0
7453813|NCT01763866|11745160|FG008|Overall Study|Lost to Follow-up|0
7453814|NCT01763866|11745161|FG009|Overall Study|Lost to Follow-up|0
7453815|NCT01763866|11745162|FG010|Overall Study|Lost to Follow-up|0
7453816|NCT01763866|11745163|FG011|Overall Study|Lost to Follow-up|0
7453817|NCT01763866|11745164|FG012|Overall Study|Lost to Follow-up|1
7453818|NCT01763866|11745165|FG013|Overall Study|Lost to Follow-up|0
7453819|NCT01763866|11745166|FG014|Overall Study|Lost to Follow-up|1
7453820|NCT01763866|11745167|FG015|Overall Study|Lost to Follow-up|0
7453821|NCT01763866|11745168|FG016|Overall Study|Lost to Follow-up|0
7453822|NCT01763866|11745169|FG017|Overall Study|Lost to Follow-up|0
7453823|NCT01763866|11745170|FG018|Overall Study|Lost to Follow-up|1
7453824|NCT01763866|11745171|FG019|Overall Study|Lost to Follow-up|1
7453825|NCT01763866|11745172|FG020|Overall Study|Lost to Follow-up|0
7453826|NCT01763866|11745173|FG021|Overall Study|Lost to Follow-up|0
7453827|NCT01763866|11745174|FG022|Overall Study|Lost to Follow-up|0
7564177|NCT03281668|11934816|FG000|Overall Study|Withdrawal by Subject|4
7564178|NCT03281668|11934816|FG000|Overall Study|Lost to Follow-up|1
7564179|NCT03281876|11934822|FG000|Overall Study|Adverse Event|4
7564180|NCT03281876|11934823|FG001|Overall Study|Adverse Event|15
7564181|NCT03281876|11934822|FG000|Overall Study|Lost to Follow-up|1
7453828|NCT01763866|11745175|FG023|Overall Study|Lost to Follow-up|1
7453829|NCT01763866|11745152|FG000|Overall Study|Death|0
7453830|NCT01763866|11745153|FG001|Overall Study|Death|0
7453831|NCT01763866|11745154|FG002|Overall Study|Death|0
7453832|NCT01763866|11745155|FG003|Overall Study|Death|0
7453833|NCT01763866|11745156|FG004|Overall Study|Death|0
7453834|NCT01763866|11745157|FG005|Overall Study|Death|0
7453835|NCT01763866|11745158|FG006|Overall Study|Death|0
7453836|NCT01763866|11745159|FG007|Overall Study|Death|0
7453837|NCT01763866|11745160|FG008|Overall Study|Death|0
7453838|NCT01763866|11745161|FG009|Overall Study|Death|0
7453839|NCT01763866|11745162|FG010|Overall Study|Death|0
7453840|NCT01763866|11745163|FG011|Overall Study|Death|0
7453841|NCT01763866|11745164|FG012|Overall Study|Death|0
7453842|NCT01763866|11745165|FG013|Overall Study|Death|0
7453843|NCT01763866|11745166|FG014|Overall Study|Death|0
7453844|NCT01763866|11745167|FG015|Overall Study|Death|0
7453845|NCT01763866|11745168|FG016|Overall Study|Death|1
7453846|NCT01763866|11745169|FG017|Overall Study|Death|0
7453847|NCT01763866|11745170|FG018|Overall Study|Death|0
7453848|NCT01763866|11745171|FG019|Overall Study|Death|0
7453849|NCT01763866|11745172|FG020|Overall Study|Death|0
7453850|NCT01763866|11745173|FG021|Overall Study|Death|0
7453851|NCT01763866|11745174|FG022|Overall Study|Death|0
7453852|NCT01763866|11745175|FG023|Overall Study|Death|0
7453853|NCT01763905|11745229|FG000|Overall Study|Withdrawal by Subject|1
7453854|NCT01763905|11745230|FG001|Overall Study|Withdrawal by Subject|1
7453855|NCT01763905|11745231|FG002|Overall Study|Withdrawal by Subject|0
7453856|NCT01763905|11745232|FG003|Overall Study|Withdrawal by Subject|1
7453857|NCT01763905|11745229|FG000|Overall Study|Decision by sponsor|5
7453858|NCT01763905|11745230|FG001|Overall Study|Decision by sponsor|0
7453859|NCT01763905|11745231|FG002|Overall Study|Decision by sponsor|8
7453860|NCT01763905|11745232|FG003|Overall Study|Decision by sponsor|0
7453861|NCT01763905|11745229|FG000|Overall Study|Lost to Follow-up|0
7453862|NCT01763905|11745230|FG001|Overall Study|Lost to Follow-up|0
7453863|NCT01763905|11745231|FG002|Overall Study|Lost to Follow-up|1
7453864|NCT01763905|11745232|FG003|Overall Study|Lost to Follow-up|0
7453865|NCT01763918|11745246|FG000|Overall Study|Withdrawal by Subject|2
7453866|NCT01763918|11745247|FG001|Overall Study|Withdrawal by Subject|1
7453867|NCT01763918|11745248|FG002|Overall Study|Withdrawal by Subject|1
7453868|NCT01763918|11745249|FG003|Overall Study|Withdrawal by Subject|2
7453869|NCT01763918|11745246|FG000|Overall Study|Sponsor Decision|4
7453870|NCT01763918|11745247|FG001|Overall Study|Sponsor Decision|0
7453871|NCT01763918|11745248|FG002|Overall Study|Sponsor Decision|9
7453872|NCT01763918|11745249|FG003|Overall Study|Sponsor Decision|0
7453873|NCT01763996|11745275|FG000|Treatment Period 2|Adverse Event|0
7453874|NCT01763996|11745276|FG001|Treatment Period 2|Adverse Event|1
7453875|NCT01764022|11745284|FG000|Overall Study|Death|3
7453876|NCT01764022|11745285|FG001|Overall Study|Death|5
7453877|NCT01764022|11745284|FG000|Overall Study|Withdrawal by Subject|2
7453878|NCT01764022|11745285|FG001|Overall Study|Withdrawal by Subject|6
7453879|NCT01764022|11745284|FG000|Overall Study|Lack of Efficacy|0
7453880|NCT01764022|11745285|FG001|Overall Study|Lack of Efficacy|1
7453881|NCT01764022|11745284|FG000|Overall Study|Physician Decision|0
7453882|NCT01764022|11745285|FG001|Overall Study|Physician Decision|2
7453883|NCT01764022|11745284|FG000|Overall Study|Lost to Follow-up|2
7453884|NCT01764022|11745285|FG001|Overall Study|Lost to Follow-up|0
7453885|NCT01764022|11745284|FG000|Overall Study|Protocol Violation|1
7453886|NCT01764022|11745285|FG001|Overall Study|Protocol Violation|0
7453887|NCT01764256|11745297|FG000|Received All Vaccinations|Adverse Event|1
7453888|NCT01764256|11745298|FG001|Received All Vaccinations|Adverse Event|1
7453889|NCT01764256|11745299|FG002|Received All Vaccinations|Adverse Event|0
7453890|NCT01764256|11745300|FG003|Received All Vaccinations|Adverse Event|0
7453891|NCT01764256|11745297|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
7453892|NCT01764256|11745298|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
7453976|NCT01764945|11745408|FG001|Overall Study|Adverse Event|1
7453893|NCT01764256|11745299|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
7453894|NCT01764256|11745300|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
7453895|NCT01764256|11745297|FG000|Received All Vaccinations|Lost to Follow-up|1
7453896|NCT01764256|11745298|FG001|Received All Vaccinations|Lost to Follow-up|0
7453897|NCT01764256|11745299|FG002|Received All Vaccinations|Lost to Follow-up|0
7453898|NCT01764256|11745300|FG003|Received All Vaccinations|Lost to Follow-up|0
7453899|NCT01764256|11745297|FG000|Completed Study|Lost to Follow-up|0
7564182|NCT03281876|11934823|FG001|Overall Study|Lost to Follow-up|4
7453900|NCT01764256|11745298|FG001|Completed Study|Lost to Follow-up|0
7453901|NCT01764256|11745299|FG002|Completed Study|Lost to Follow-up|0
7453902|NCT01764256|11745300|FG003|Completed Study|Lost to Follow-up|1
7453903|NCT01764386|11745316|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
7453904|NCT01764386|11745317|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
7453905|NCT01764386|11745316|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
7453906|NCT01764386|11745317|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
7453907|NCT01764386|11745316|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
7453908|NCT01764386|11745317|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
7453909|NCT01764386|11745316|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
7453910|NCT01764386|11745317|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
7453911|NCT01764386|11745316|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
7453912|NCT01764386|11745317|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
7453913|NCT01764386|11745316|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
7453914|NCT01764386|11745317|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
7453915|NCT01764386|11745316|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7453916|NCT01764386|11745317|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
7453917|NCT01764386|11745316|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7453918|NCT01764386|11745317|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
7453919|NCT01764464|11745326|FG000|First Intervention|Withdrawal by Subject|1
7453920|NCT01764464|11745327|FG001|First Intervention|Withdrawal by Subject|0
7453921|NCT01764464|11745326|FG000|First Intervention|Lost to Follow-up|1
7453922|NCT01764464|11745327|FG001|First Intervention|Lost to Follow-up|0
7453923|NCT01764464|11745326|FG000|First Intervention|Adverse Event|0
7453924|NCT01764464|11745327|FG001|First Intervention|Adverse Event|2
7453925|NCT01764464|11745326|FG000|First Intervention|did not receive study drug|0
7453926|NCT01764464|11745327|FG001|First Intervention|did not receive study drug|1
7453927|NCT01764464|11745326|FG000|Second Intervention (Cross-over)|Adverse Event|2
7453928|NCT01764464|11745327|FG001|Second Intervention (Cross-over)|Adverse Event|0
7453933|NCT01764659|11745346|FG000|Overall Study|Death|1
7453934|NCT01764659|11745346|FG000|Overall Study|Physician Decision|1
7453935|NCT01764841|11745365|FG000|Overall Study|Logistical Difficulties|0
7453936|NCT01764841|11745366|FG001|Overall Study|Logistical Difficulties|1
7453937|NCT01764841|11745367|FG002|Overall Study|Logistical Difficulties|0
7453938|NCT01764841|11745368|FG003|Overall Study|Logistical Difficulties|0
7453939|NCT01764841|11745365|FG000|Overall Study|Death|3
7453940|NCT01764841|11745366|FG001|Overall Study|Death|0
7453941|NCT01764841|11745367|FG002|Overall Study|Death|1
7453942|NCT01764841|11745368|FG003|Overall Study|Death|4
7453943|NCT01764841|11745365|FG000|Overall Study|No Follow Up|1
7453944|NCT01764841|11745366|FG001|Overall Study|No Follow Up|0
7453945|NCT01764841|11745367|FG002|Overall Study|No Follow Up|1
7453946|NCT01764841|11745368|FG003|Overall Study|No Follow Up|0
7453947|NCT01764841|11745365|FG000|Overall Study|Protocol Violation|0
7453948|NCT01764841|11745366|FG001|Overall Study|Protocol Violation|1
7453949|NCT01764841|11745367|FG002|Overall Study|Protocol Violation|0
7453950|NCT01764841|11745368|FG003|Overall Study|Protocol Violation|0
7453951|NCT01764841|11745365|FG000|Overall Study|Withdrawal by Subject|16
7453952|NCT01764841|11745366|FG001|Overall Study|Withdrawal by Subject|24
7453953|NCT01764841|11745367|FG002|Overall Study|Withdrawal by Subject|11
7453954|NCT01764841|11745368|FG003|Overall Study|Withdrawal by Subject|15
7453955|NCT01764841|11745365|FG000|Overall Study|Lost to Follow-up|3
7453956|NCT01764841|11745366|FG001|Overall Study|Lost to Follow-up|0
7453957|NCT01764841|11745367|FG002|Overall Study|Lost to Follow-up|1
7453958|NCT01764841|11745368|FG003|Overall Study|Lost to Follow-up|0
7453959|NCT01764854|11745382|FG000|Overall Study|Adverse Event|0
7453960|NCT01764854|11745383|FG001|Overall Study|Adverse Event|0
7453961|NCT01764854|11745384|FG002|Overall Study|Adverse Event|2
7453962|NCT01764854|11745385|FG003|Overall Study|Adverse Event|0
7453963|NCT01764854|11745382|FG000|Overall Study|Withdrawal by Subject|0
7453964|NCT01764854|11745383|FG001|Overall Study|Withdrawal by Subject|0
7453965|NCT01764854|11745384|FG002|Overall Study|Withdrawal by Subject|1
7453966|NCT01764854|11745385|FG003|Overall Study|Withdrawal by Subject|0
7453967|NCT01764854|11745382|FG000|Overall Study|relocation|0
7453968|NCT01764854|11745383|FG001|Overall Study|relocation|0
7453969|NCT01764854|11745384|FG002|Overall Study|relocation|2
7453970|NCT01764854|11745385|FG003|Overall Study|relocation|0
7453971|NCT01764854|11745382|FG000|Overall Study|Protocol Violation|0
7453972|NCT01764854|11745383|FG001|Overall Study|Protocol Violation|0
7453973|NCT01764854|11745384|FG002|Overall Study|Protocol Violation|1
7453974|NCT01764854|11745385|FG003|Overall Study|Protocol Violation|2
7453975|NCT01764945|11745407|FG000|Overall Study|Adverse Event|0
7453977|NCT01764945|11745409|FG002|Overall Study|Adverse Event|0
7453978|NCT01764945|11745410|FG003|Overall Study|Adverse Event|0
7453979|NCT01764945|11745411|FG004|Overall Study|Adverse Event|0
7453980|NCT01764945|11745412|FG005|Overall Study|Adverse Event|0
7453981|NCT01764945|11745413|FG006|Overall Study|Adverse Event|1
7453982|NCT01764945|11745414|FG007|Overall Study|Adverse Event|0
7453983|NCT01765153|11745434|FG000|Training Phase 1|Format of intervention differed|1
7453984|NCT01765153|11745435|FG001|Training Phase 1|Format of intervention differed|0
7453985|NCT01765153|11745434|FG000|Training Phase 1|Poor participation in intervention|0
7453986|NCT01765153|11745435|FG001|Training Phase 1|Poor participation in intervention|1
7453987|NCT01765153|11745434|FG000|Rest Phase 1|Withdrawal by Subject|0
7453988|NCT01765153|11745435|FG001|Rest Phase 1|Withdrawal by Subject|1
7453989|NCT01765153|11745434|FG000|Training Phase 2|Withdrawal by Subject|0
7453990|NCT01765153|11745435|FG001|Training Phase 2|Withdrawal by Subject|1
7453991|NCT01765153|11745434|FG000|Rest Phase 2|Lost to Follow-up|2
7453992|NCT01765153|11745435|FG001|Rest Phase 2|Lost to Follow-up|1
7453993|NCT01765179|11745445|FG000|Overall Study|Adverse Event|3
7453994|NCT01765179|11745445|FG000|Overall Study|Lost to Follow-up|5
7453995|NCT01765179|11745445|FG000|Overall Study|Non-compliance with study drug|2
7453996|NCT01765179|11745445|FG000|Overall Study|Protocol Violation|1
7453997|NCT01765179|11745445|FG000|Overall Study|Withdrawal by Subject|8
7453998|NCT01765179|11745445|FG000|Overall Study|Hematocrit >54%|3
7453999|NCT01765179|11745445|FG000|Overall Study|prohibited med|1
7454000|NCT01765179|11745445|FG000|Overall Study|Out of country unable to finish study|1
7454001|NCT01765179|11745445|FG000|Overall Study|lack of venous access|1
7454002|NCT01765179|11745445|FG000|Overall Study|work conflict|1
7454003|NCT01765179|11745445|FG000|Overall Study|Ca elevated 10.6|1
7454004|NCT01765192|11745451|FG000|Treatment Period 1|Adverse Event|0
7454005|NCT01765192|11745452|FG001|Treatment Period 1|Adverse Event|1
7454006|NCT01765192|11745451|FG000|Washout Period|Voluntary Withdrawal|1
7454007|NCT01765192|11745452|FG001|Washout Period|Voluntary Withdrawal|1
7454008|NCT01765192|11745451|FG000|Washout Period|Reason not specified|1
7454009|NCT01765192|11745452|FG001|Washout Period|Reason not specified|0
7454010|NCT01765192|11745451|FG000|Treatment Period 2|Reason not specified|0
7454011|NCT01765192|11745452|FG001|Treatment Period 2|Reason not specified|2
7454012|NCT01765192|11745451|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
7454013|NCT01765192|11745452|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
7454014|NCT01765270|11745460|FG000|Overall Study|Physician Decision|1
7454015|NCT01765270|11745461|FG001|Overall Study|Physician Decision|0
7454016|NCT01765270|11745460|FG000|Overall Study|Withdrawal by Subject|0
7454017|NCT01765270|11745461|FG001|Overall Study|Withdrawal by Subject|1
7454018|NCT01765426|11745472|FG000|Overall Study|Lost to Follow-up|0
7454019|NCT01765426|11745473|FG001|Overall Study|Lost to Follow-up|1
7454020|NCT01765426|11745474|FG002|Overall Study|Lost to Follow-up|0
7454021|NCT01765426|11745475|FG003|Overall Study|Lost to Follow-up|0
7454022|NCT01765543|11745505|FG000|Overall Study|Death|1
7454023|NCT01765543|11745505|FG000|Overall Study|Withdrawal by Subject|2
7454024|NCT01765569|11745513|FG000|Period B|Withdrawal by Subject|1
7454025|NCT01765569|11745513|FG000|Period C|Death|1
7454026|NCT01765582|11745523|FG000|Overall Study|Other|3
7454027|NCT01765582|11745524|FG001|Overall Study|Other|6
7454028|NCT01765582|11745525|FG002|Overall Study|Other|9
7454029|NCT01765582|11745523|FG000|Overall Study|Lost to Follow-up|2
7454030|NCT01765582|11745524|FG001|Overall Study|Lost to Follow-up|2
7454031|NCT01765582|11745525|FG002|Overall Study|Lost to Follow-up|1
7454032|NCT01765582|11745523|FG000|Overall Study|Death|31
7454033|NCT01765582|11745524|FG001|Overall Study|Death|36
7454034|NCT01765582|11745525|FG002|Overall Study|Death|33
7454035|NCT01765582|11745523|FG000|Overall Study|Sponsor Decision|46
7454036|NCT01765582|11745524|FG001|Overall Study|Sponsor Decision|42
7454037|NCT01765582|11745525|FG002|Overall Study|Sponsor Decision|42
7454038|NCT01765582|11745523|FG000|Overall Study|Withdrawal of Consent|11
7454039|NCT01765582|11745524|FG001|Overall Study|Withdrawal of Consent|6
7454040|NCT01765582|11745525|FG002|Overall Study|Withdrawal of Consent|10
7454041|NCT01765673|11745538|FG000|Overall Study|No transportation for 2nd/3rd visits|1
7454042|NCT01765751|11745557|FG000|Overall Study|Lost to Follow-up|0
7454043|NCT01765751|11745558|FG001|Overall Study|Lost to Follow-up|2
7454044|NCT01765751|11745559|FG002|Overall Study|Lost to Follow-up|1
7454045|NCT01765764|11745573|FG000|Treatment Period|Adverse Event|1
7454046|NCT01765764|11745574|FG001|Treatment Period|Adverse Event|2
7454047|NCT01765764|11745575|FG002|Treatment Period|Adverse Event|1
7454048|NCT01765764|11745573|FG000|Treatment Period|Lost to Follow-up|0
7454049|NCT01765764|11745574|FG001|Treatment Period|Lost to Follow-up|3
7454050|NCT01765764|11745575|FG002|Treatment Period|Lost to Follow-up|2
7454051|NCT01765764|11745573|FG000|Treatment Period|Personal Reasons|1
7454052|NCT01765764|11745574|FG001|Treatment Period|Personal Reasons|2
7454053|NCT01765764|11745575|FG002|Treatment Period|Personal Reasons|1
7454054|NCT01765764|11745573|FG000|Treatment Period|Other Miscellaneous Reasons|1
7454055|NCT01765764|11745574|FG001|Treatment Period|Other Miscellaneous Reasons|2
7454056|NCT01765764|11745575|FG002|Treatment Period|Other Miscellaneous Reasons|2
7454057|NCT01765920|11745589|FG000|Overall Study|Incorrect inclusion ineligible patient|2
7454058|NCT01765920|11745590|FG001|Overall Study|Incorrect inclusion ineligible patient|5
7454059|NCT01765920|11745589|FG000|Overall Study|Patient code disclosure|0
7454060|NCT01765920|11745590|FG001|Overall Study|Patient code disclosure|1
7454061|NCT01766037|11745622|FG000|Overall Study|Adverse Event|1
7454062|NCT01766037|11745623|FG001|Overall Study|Adverse Event|0
7454063|NCT01766037|11745622|FG000|Overall Study|Lack of Efficacy|1
7454064|NCT01766037|11745623|FG001|Overall Study|Lack of Efficacy|0
7454065|NCT01766037|11745622|FG000|Overall Study|Lost to Follow-up|0
7454066|NCT01766037|11745623|FG001|Overall Study|Lost to Follow-up|10
7454067|NCT01766037|11745622|FG000|Overall Study|Physician Decision|0
7454068|NCT01766037|11745623|FG001|Overall Study|Physician Decision|1
7454069|NCT01766037|11745622|FG000|Overall Study|Withdrawal by Subject|18
7454070|NCT01766037|11745623|FG001|Overall Study|Withdrawal by Subject|16
7454071|NCT01766037|11745622|FG000|Overall Study|Moved from area|5
7454072|NCT01766037|11745623|FG001|Overall Study|Moved from area|0
7454073|NCT01766037|11745622|FG000|Overall Study|medical - unrelated|1
7454074|NCT01766037|11745623|FG001|Overall Study|medical - unrelated|2
7454075|NCT01766037|11745622|FG000|Overall Study|nausea / discomfort|3
7454076|NCT01766037|11745623|FG001|Overall Study|nausea / discomfort|0
7454077|NCT01766050|11745629|FG000|Overall Study|Adverse Event|1
7454078|NCT01766050|11745629|FG000|Overall Study|Lost to Follow-up|1
7454079|NCT01766050|11745629|FG000|Overall Study|Withdrawal by Subject|2
7454080|NCT01766206|11745665|FG000|Overall Study|Withdrawal by Subject|22
7454081|NCT01766206|11745665|FG000|Overall Study|Lost to Follow-up|10
7454082|NCT01766206|11745665|FG000|Overall Study|Inappropriate enrollment|18
7454083|NCT01766206|11745665|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
7454084|NCT01766310|11745685|FG000|Overall Study|Lost to Follow-up|1
7454085|NCT01766310|11745686|FG001|Overall Study|Lost to Follow-up|3
7454086|NCT01766336|11745694|FG000|Overall Study|Adverse Event|11
7454087|NCT01766336|11745695|FG001|Overall Study|Adverse Event|8
7454088|NCT01766336|11745694|FG000|Overall Study|Death|4
7454089|NCT01766336|11745695|FG001|Overall Study|Death|3
7454090|NCT01766336|11745694|FG000|Overall Study|Lost to Follow-up|1
7454091|NCT01766336|11745695|FG001|Overall Study|Lost to Follow-up|3
7454092|NCT01766336|11745694|FG000|Overall Study|Physician Decision|4
7454093|NCT01766336|11745695|FG001|Overall Study|Physician Decision|2
7454094|NCT01766336|11745694|FG000|Overall Study|Protocol Violation|0
7454095|NCT01766336|11745695|FG001|Overall Study|Protocol Violation|1
7454096|NCT01766336|11745694|FG000|Overall Study|Sponsor Decision|52
7454097|NCT01766336|11745695|FG001|Overall Study|Sponsor Decision|43
7454098|NCT01766336|11745694|FG000|Overall Study|Withdrawal by Subject|18
7454099|NCT01766336|11745695|FG001|Overall Study|Withdrawal by Subject|15
7454100|NCT01766401|11745703|FG000|Overall Study|Adverse Event|7
7454101|NCT01766401|11745704|FG001|Overall Study|Adverse Event|22
7454102|NCT01766401|11745703|FG000|Overall Study|Lack of Efficacy|1
7454103|NCT01766401|11745704|FG001|Overall Study|Lack of Efficacy|2
7454104|NCT01766401|11745703|FG000|Overall Study|Protocol Violation|3
7454105|NCT01766401|11745704|FG001|Overall Study|Protocol Violation|8
7454106|NCT01766401|11745703|FG000|Overall Study|Withdrawal by Subject|15
7454107|NCT01766401|11745704|FG001|Overall Study|Withdrawal by Subject|12
7454108|NCT01766401|11745703|FG000|Overall Study|Lost to Follow-up|10
7454109|NCT01766401|11745704|FG001|Overall Study|Lost to Follow-up|11
7454110|NCT01766401|11745703|FG000|Overall Study|Pregnancy|1
7454111|NCT01766401|11745704|FG001|Overall Study|Pregnancy|1
7454112|NCT01766778|11745739|FG000|Overall Study|Adverse Event|4
7454113|NCT01766778|11745740|FG001|Overall Study|Adverse Event|4
7454114|NCT01766778|11745739|FG000|Overall Study|Withdrawal by Subject|1
7454115|NCT01766778|11745740|FG001|Overall Study|Withdrawal by Subject|0
7454116|NCT01766817|11745749|FG000|Overall Study|Drug-related adverse event|1
7454117|NCT01766817|11745750|FG001|Overall Study|Drug-related adverse event|2
7454118|NCT01766817|11745751|FG002|Overall Study|Drug-related adverse event|1
7454119|NCT01766817|11745749|FG000|Overall Study|Drug-unrelated adverse event|3
7454120|NCT01766817|11745750|FG001|Overall Study|Drug-unrelated adverse event|3
7454121|NCT01766817|11745751|FG002|Overall Study|Drug-unrelated adverse event|3
7454122|NCT01766817|11745749|FG000|Overall Study|Death|1
7454123|NCT01766817|11745750|FG001|Overall Study|Death|1
7454124|NCT01766817|11745751|FG002|Overall Study|Death|0
7454125|NCT01766817|11745749|FG000|Overall Study|Unable to take study drug|0
7454126|NCT01766817|11745750|FG001|Overall Study|Unable to take study drug|1
7454127|NCT01766817|11745751|FG002|Overall Study|Unable to take study drug|0
7454128|NCT01766817|11745749|FG000|Overall Study|Withdrawal by Subject|2
7454129|NCT01766817|11745750|FG001|Overall Study|Withdrawal by Subject|0
7454130|NCT01766817|11745751|FG002|Overall Study|Withdrawal by Subject|3
7454131|NCT01766817|11745749|FG000|Overall Study|Subject non-compliance|0
7454132|NCT01766817|11745750|FG001|Overall Study|Subject non-compliance|1
7454133|NCT01766817|11745751|FG002|Overall Study|Subject non-compliance|2
7454134|NCT01766817|11745749|FG000|Overall Study|Physician Decision|3
7454135|NCT01766817|11745750|FG001|Overall Study|Physician Decision|3
7454136|NCT01766817|11745751|FG002|Overall Study|Physician Decision|4
7454137|NCT01766817|11745749|FG000|Overall Study|Other|1
7454138|NCT01766817|11745750|FG001|Overall Study|Other|0
7454139|NCT01766817|11745751|FG002|Overall Study|Other|0
7454140|NCT01766921|11745761|FG000|Overall Study|Administrative Reason|5
7454141|NCT01766921|11745762|FG001|Overall Study|Administrative Reason|5
7454142|NCT01766921|11745761|FG000|Overall Study|Death|1
7454143|NCT01766921|11745762|FG001|Overall Study|Death|1
7454144|NCT01766921|11745761|FG000|Overall Study|Lost to Follow-up|1
7454145|NCT01766921|11745762|FG001|Overall Study|Lost to Follow-up|3
7454146|NCT01766921|11745761|FG000|Overall Study|Unclassified|2
7454147|NCT01766921|11745762|FG001|Overall Study|Unclassified|2
7454148|NCT01766921|11745761|FG000|Overall Study|Protocol Violation|1
7454149|NCT01766921|11745762|FG001|Overall Study|Protocol Violation|1
7454150|NCT01766921|11745761|FG000|Overall Study|Withdrawal by Subject|14
7454151|NCT01766921|11745762|FG001|Overall Study|Withdrawal by Subject|5
7454152|NCT01767116|11745807|FG000|Overall Study|Lost to Follow-up|2
7454153|NCT01767116|11745808|FG001|Overall Study|Lost to Follow-up|2
7454154|NCT01767142|11745814|FG000|Overall Study|Lost to Follow-up|3
7454155|NCT01767376|11745839|FG000|Overall Study|Lost to Follow-up|3
7454156|NCT01767376|11745840|FG001|Overall Study|Lost to Follow-up|2
7454157|NCT01767376|11745841|FG002|Overall Study|Lost to Follow-up|0
7454158|NCT01767376|11745839|FG000|Overall Study|Withdrawal by Subject|1
7454159|NCT01767376|11745840|FG001|Overall Study|Withdrawal by Subject|1
7454160|NCT01767376|11745841|FG002|Overall Study|Withdrawal by Subject|0
7454161|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
7454162|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
7454163|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
7454164|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
7454165|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
7454166|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
7454167|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
7454168|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
7454169|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
7454170|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
7454171|NCT01767467|11745857|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
7454172|NCT01767467|11745858|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
7454173|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
7454174|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
7454175|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
7454176|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
7454177|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
7454178|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
7454179|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
7454180|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
7454181|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
7454182|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
7454183|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
7454184|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
7454185|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
7454186|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
7454187|NCT01767467|11745857|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
7454188|NCT01767467|11745858|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
7454189|NCT01767493|11745871|FG000|Overall Study|screen failures|3
7454190|NCT01767519|11745887|FG000|Overall Study|Other Reasons|4
7454191|NCT01767519|11745888|FG001|Overall Study|Other Reasons|4
7454192|NCT01767519|11745889|FG002|Overall Study|Other Reasons|2
7454193|NCT01767519|11745887|FG000|Overall Study|Protocol Violation|0
7454194|NCT01767519|11745888|FG001|Overall Study|Protocol Violation|3
7454195|NCT01767519|11745889|FG002|Overall Study|Protocol Violation|0
7454196|NCT01767519|11745887|FG000|Overall Study|Personal Reasons|1
7454197|NCT01767519|11745888|FG001|Overall Study|Personal Reasons|0
7454198|NCT01767519|11745889|FG002|Overall Study|Personal Reasons|0
7454199|NCT01767519|11745887|FG000|Overall Study|Lost to Follow-up|3
7454200|NCT01767519|11745888|FG001|Overall Study|Lost to Follow-up|1
7454201|NCT01767519|11745889|FG002|Overall Study|Lost to Follow-up|2
7454202|NCT01767519|11745887|FG000|Overall Study|Lack of Efficacy|1
7454203|NCT01767519|11745888|FG001|Overall Study|Lack of Efficacy|0
7454204|NCT01767519|11745889|FG002|Overall Study|Lack of Efficacy|0
7454205|NCT01767519|11745887|FG000|Overall Study|Adverse Event|5
7454206|NCT01767519|11745888|FG001|Overall Study|Adverse Event|5
7454207|NCT01767519|11745889|FG002|Overall Study|Adverse Event|1
7454208|NCT01767597|11745899|FG000|Overall Study|Incomplete intervention|3
7454209|NCT01767597|11745900|FG001|Overall Study|Incomplete intervention|1
7454210|NCT01767597|11745899|FG000|Overall Study|Withdrawal by Subject|1
7454211|NCT01767597|11745900|FG001|Overall Study|Withdrawal by Subject|0
7454212|NCT01767857|11745931|FG000|Overall Study|Adverse Event|27
7454213|NCT01767857|11745932|FG001|Overall Study|Adverse Event|7
7454214|NCT01767857|11745931|FG000|Overall Study|Death|28
7454215|NCT01767857|11745932|FG001|Overall Study|Death|13
7454216|NCT01767857|11745931|FG000|Overall Study|Lack of Efficacy|299
7454217|NCT01767857|11745932|FG001|Overall Study|Lack of Efficacy|151
7454218|NCT01767857|11745931|FG000|Overall Study|Lost to Follow-up|1
7454219|NCT01767857|11745932|FG001|Overall Study|Lost to Follow-up|1
7454220|NCT01767857|11745931|FG000|Overall Study|Withdrawal by Subject|38
7454221|NCT01767857|11745932|FG001|Overall Study|Withdrawal by Subject|18
7454222|NCT01767857|11745931|FG000|Overall Study|Physician Decision|17
7454223|NCT01767857|11745932|FG001|Overall Study|Physician Decision|10
7454224|NCT01767857|11745931|FG000|Overall Study|Protocol Terminated|1
7454225|NCT01767857|11745932|FG001|Overall Study|Protocol Terminated|0
7454226|NCT01767857|11745931|FG000|Overall Study|Randomized But Never Treated|19
7454227|NCT01767857|11745932|FG001|Overall Study|Randomized But Never Treated|13
7454228|NCT01767909|11745941|FG000|Overall Study|Withdrawal by Subject|4
7454229|NCT01767909|11745942|FG001|Overall Study|Withdrawal by Subject|7
7454230|NCT01767909|11745941|FG000|Overall Study|Adverse Event|3
7454231|NCT01767909|11745942|FG001|Overall Study|Adverse Event|1
7454232|NCT01767909|11745941|FG000|Overall Study|Withdrawal by Study Partner|3
7454233|NCT01767909|11745942|FG001|Overall Study|Withdrawal by Study Partner|1
7454234|NCT01767909|11745941|FG000|Overall Study|Non-Compliance|2
7454235|NCT01767909|11745942|FG001|Overall Study|Non-Compliance|0
7454236|NCT01767909|11745941|FG000|Overall Study|Perceived Lack of Efficacy|1
7454237|NCT01767909|11745942|FG001|Overall Study|Perceived Lack of Efficacy|0
7454238|NCT01767909|11745941|FG000|Overall Study|Investigator Recommendation|0
7454239|NCT01767909|11745942|FG001|Overall Study|Investigator Recommendation|1
7454240|NCT01767909|11745941|FG000|Overall Study|Lost to Follow-up|0
7454241|NCT01767909|11745942|FG001|Overall Study|Lost to Follow-up|1
7454242|NCT01767909|11745941|FG000|Overall Study|LP uncessessful|0
7454243|NCT01767909|11745942|FG001|Overall Study|LP uncessessful|1
7454244|NCT01767987|11745956|FG000|Overall Study|Physician Decision|4
7454245|NCT01767987|11745957|FG001|Overall Study|Physician Decision|1
7454246|NCT01768117|11745986|FG000|Overall Study|Lost to Follow-up|1
7454247|NCT01768117|11745986|FG000|Overall Study|Withdrawal by Subject|2
7454248|NCT01768117|11745986|FG000|Overall Study|Protocol Violation|3
7454249|NCT01768286|11745994|FG000|Overall Study|Randomized But Not Treated|0
7454250|NCT01768286|11745995|FG001|Overall Study|Randomized But Not Treated|0
7454251|NCT01768286|11745996|FG002|Overall Study|Randomized But Not Treated|1
7454252|NCT01768286|11745997|FG003|Overall Study|Randomized But Not Treated|0
7454253|NCT01768286|11745994|FG000|Overall Study|Lack of Efficacy|7
7454254|NCT01768286|11745995|FG001|Overall Study|Lack of Efficacy|4
7454255|NCT01768286|11745996|FG002|Overall Study|Lack of Efficacy|0
7454256|NCT01768286|11745997|FG003|Overall Study|Lack of Efficacy|1
7454257|NCT01768286|11745994|FG000|Overall Study|Withdrew Consent|0
7454258|NCT01768286|11745995|FG001|Overall Study|Withdrew Consent|0
7454259|NCT01768286|11745996|FG002|Overall Study|Withdrew Consent|1
7454260|NCT01768286|11745997|FG003|Overall Study|Withdrew Consent|0
7454261|NCT01768559|11746034|FG000|Overall Study|Randomized but not treated|0
7454262|NCT01768559|11746035|FG001|Overall Study|Randomized but not treated|0
7454263|NCT01768559|11746036|FG002|Overall Study|Randomized but not treated|1
7454264|NCT01768559|11746034|FG000|Overall Study|Adverse Event|15
7454265|NCT01768559|11746035|FG001|Overall Study|Adverse Event|2
7454266|NCT01768559|11746036|FG002|Overall Study|Adverse Event|5
7454267|NCT01768559|11746034|FG000|Overall Study|Lack of Efficacy|6
7454268|NCT01768559|11746035|FG001|Overall Study|Lack of Efficacy|4
7454269|NCT01768559|11746036|FG002|Overall Study|Lack of Efficacy|0
7454270|NCT01768559|11746034|FG000|Overall Study|Poor compliance to protocol|0
7454271|NCT01768559|11746035|FG001|Overall Study|Poor compliance to protocol|3
7454272|NCT01768559|11746036|FG002|Overall Study|Poor compliance to protocol|2
7454273|NCT01768559|11746034|FG000|Overall Study|Other than specified|9
7454274|NCT01768559|11746035|FG001|Overall Study|Other than specified|8
7454275|NCT01768559|11746036|FG002|Overall Study|Other than specified|5
7454276|NCT01768572|11746051|FG000|Overall Study|Adverse Event|7
7454277|NCT01768572|11746052|FG001|Overall Study|Adverse Event|8
7454278|NCT01768572|11746053|FG002|Overall Study|Adverse Event|4
7454279|NCT01768572|11746051|FG000|Overall Study|Lack of Efficacy|1
7454280|NCT01768572|11746052|FG001|Overall Study|Lack of Efficacy|3
7454281|NCT01768572|11746053|FG002|Overall Study|Lack of Efficacy|1
7454282|NCT01768572|11746051|FG000|Overall Study|Other, Not due to an adverse event|1
7454283|NCT01768572|11746052|FG001|Overall Study|Other, Not due to an adverse event|1
7454284|NCT01768572|11746053|FG002|Overall Study|Other, Not due to an adverse event|1
7454285|NCT01768637|11746063|FG000|Overall Study|Lost to Follow-up|2
7454286|NCT01768637|11746064|FG001|Overall Study|Lost to Follow-up|7
7454287|NCT01768637|11746063|FG000|Overall Study|Difficult blood draw|1
7533016|NCT02679729|11879026|FG000|Overall Study|Lost to Follow-up|0
7564183|NCT03281876|11934822|FG000|Overall Study|Withdrawal by Subject|11
7564184|NCT03281876|11934823|FG001|Overall Study|Withdrawal by Subject|15
7564185|NCT03281876|11934822|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7564186|NCT03281876|11934823|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7564187|NCT03281876|11934822|FG000|Overall Study|OTHER|5
7564188|NCT03281876|11934823|FG001|Overall Study|OTHER|5
7564189|NCT03282227|11934840|FG000|Overall Study|Exposure Goals Achieved|60
7564190|NCT03282227|11934840|FG000|Overall Study|Non-compliance w/ protocol requirements|79
7454288|NCT01768637|11746064|FG001|Overall Study|Difficult blood draw|0
7454289|NCT01768676|11746072|FG000|Overall Study|Adverse Event|3
7454290|NCT01768676|11746073|FG001|Overall Study|Adverse Event|3
7454291|NCT01768676|11746072|FG000|Overall Study|Lost to Follow-up|13
7454292|NCT01768676|11746073|FG001|Overall Study|Lost to Follow-up|16
7454293|NCT01768676|11746072|FG000|Overall Study|Protocol Violation|1
7454294|NCT01768676|11746073|FG001|Overall Study|Protocol Violation|1
7454295|NCT01768676|11746072|FG000|Overall Study|Physician Decision|4
7454296|NCT01768676|11746073|FG001|Overall Study|Physician Decision|1
7454297|NCT01768676|11746072|FG000|Overall Study|Withdrawal by Subject|3
7454298|NCT01768676|11746073|FG001|Overall Study|Withdrawal by Subject|10
7454299|NCT01768858|11746096|FG000|Overall Study|Lost to Follow-up|9
7454300|NCT01768858|11746096|FG000|Overall Study|Lack of Efficacy|8
7454301|NCT01768858|11746096|FG000|Overall Study|Serious Adverse Event|1
7454302|NCT01768858|11746096|FG000|Overall Study|Participant moved to Germany|1
7454303|NCT01768858|11746096|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
7454304|NCT01768858|11746096|FG000|Overall Study|Exanthema|1
7454305|NCT01768858|11746096|FG000|Overall Study|Withdrawal by Subject|1
7454306|NCT01769105|11746102|FG000|First Intervention|Protocol Violation|2
7454307|NCT01769105|11746103|FG001|First Intervention|Protocol Violation|2
7454308|NCT01769105|11746102|FG000|Cross-over|Lost to Follow-up|5
7454309|NCT01769105|11746103|FG001|Cross-over|Lost to Follow-up|0
7454310|NCT01769196|11746122|FG000|Overall Study|Adverse Event|24
7454311|NCT01769196|11746123|FG001|Overall Study|Adverse Event|20
7454312|NCT01769196|11746122|FG000|Overall Study|Death|21
7454313|NCT01769196|11746123|FG001|Overall Study|Death|26
7454314|NCT01769196|11746122|FG000|Overall Study|Investigator Discretion|7
7454315|NCT01769196|11746123|FG001|Overall Study|Investigator Discretion|3
7454316|NCT01769196|11746122|FG000|Overall Study|Lack of Efficacy|3
7454317|NCT01769196|11746123|FG001|Overall Study|Lack of Efficacy|2
7454318|NCT01769196|11746122|FG000|Overall Study|Progressive disease|11
7454319|NCT01769196|11746123|FG001|Overall Study|Progressive disease|6
7454320|NCT01769196|11746122|FG000|Overall Study|Protocol defined criteria for withdrawal|9
7454321|NCT01769196|11746123|FG001|Overall Study|Protocol defined criteria for withdrawal|11
7454322|NCT01769196|11746122|FG000|Overall Study|Protocol Violation|0
7454323|NCT01769196|11746123|FG001|Overall Study|Protocol Violation|3
7454324|NCT01769196|11746122|FG000|Overall Study|Study terminated by sponsor|160
7454325|NCT01769196|11746123|FG001|Overall Study|Study terminated by sponsor|161
7454326|NCT01769196|11746122|FG000|Overall Study|Participant never dosed with study drug|1
7454327|NCT01769196|11746123|FG001|Overall Study|Participant never dosed with study drug|0
7454328|NCT01769196|11746122|FG000|Overall Study|Withdrew consent|36
7454329|NCT01769196|11746123|FG001|Overall Study|Withdrew consent|40
7454330|NCT01769326|11746170|FG000|Overall Study|Lost to Follow-up|1
7454331|NCT01769326|11746171|FG001|Overall Study|Lost to Follow-up|2
7454332|NCT01769326|11746172|FG002|Overall Study|Lost to Follow-up|0
7454333|NCT01769326|11746173|FG003|Overall Study|Lost to Follow-up|0
7454334|NCT01769326|11746170|FG000|Overall Study|unrelated injry|1
7454335|NCT01769326|11746171|FG001|Overall Study|unrelated injry|1
7454336|NCT01769326|11746172|FG002|Overall Study|unrelated injry|0
7454337|NCT01769326|11746173|FG003|Overall Study|unrelated injry|0
7454338|NCT01769326|11746170|FG000|Overall Study|got a job|0
7454339|NCT01769326|11746171|FG001|Overall Study|got a job|1
7454340|NCT01769326|11746172|FG002|Overall Study|got a job|0
7454341|NCT01769326|11746173|FG003|Overall Study|got a job|0
7454342|NCT01769326|11746170|FG000|Overall Study|Got sick and could not complete study|0
7454343|NCT01769326|11746171|FG001|Overall Study|Got sick and could not complete study|0
7454344|NCT01769326|11746172|FG002|Overall Study|Got sick and could not complete study|1
7454345|NCT01769326|11746173|FG003|Overall Study|Got sick and could not complete study|0
7454346|NCT01769339|11746183|FG000|Overall Study|Lost to Follow-up|42
7564191|NCT03282227|11934840|FG000|Overall Study|Adverse Event|15
7564192|NCT03282227|11934840|FG000|Overall Study|Lost to Follow-up|21
7564193|NCT03282227|11934840|FG000|Overall Study|Withdrawal by Subject|20
7564194|NCT03282227|11934840|FG000|Overall Study|Lack of Efficacy|12
7564195|NCT03282227|11934840|FG000|Overall Study|Sponsor decision|3
7564196|NCT03282227|11934840|FG000|Overall Study|Physician Decision|2
7564197|NCT03282227|11934840|FG000|Overall Study|Pregnancy|2
7329010|NCT00799422|11561958|FG000|First Week of Wear|Lost to Follow-up|0
7329011|NCT00799422|11561959|FG001|First Week of Wear|Lost to Follow-up|0
7329012|NCT00799422|11561960|FG002|First Week of Wear|Lost to Follow-up|1
7329013|NCT00799422|11561961|FG003|First Week of Wear|Lost to Follow-up|0
7329014|NCT00799422|11561962|FG004|First Week of Wear|Lost to Follow-up|0
7329015|NCT00799422|11561963|FG005|First Week of Wear|Lost to Follow-up|0
7329016|NCT00799422|11561958|FG000|First Week of Wear|Adverse Event|0
7329017|NCT00799422|11561959|FG001|First Week of Wear|Adverse Event|0
7329018|NCT00799422|11561960|FG002|First Week of Wear|Adverse Event|0
7329019|NCT00799422|11561961|FG003|First Week of Wear|Adverse Event|1
7329020|NCT00799422|11561962|FG004|First Week of Wear|Adverse Event|0
7329021|NCT00799422|11561963|FG005|First Week of Wear|Adverse Event|0
7329022|NCT00799487|11561987|FG000|Dose Adjustment Period|Lost to Follow-up|1
7329023|NCT00799487|11561988|FG001|Dose Adjustment Period|Lost to Follow-up|0
7329024|NCT00799487|11561989|FG002|Dose Adjustment Period|Lost to Follow-up|0
7329025|NCT00799487|11561987|FG000|Dose Adjustment Period|Adverse Event|2
7329026|NCT00799487|11561988|FG001|Dose Adjustment Period|Adverse Event|0
7454347|NCT01769339|11746183|FG000|Overall Study|Adverse Event|1
7454348|NCT01769378|11746220|FG000|Overall Study|Adverse Event|10
7454349|NCT01769378|11746221|FG001|Overall Study|Adverse Event|0
7454350|NCT01769378|11746220|FG000|Overall Study|Entry criteria not met|1
7454351|NCT01769378|11746221|FG001|Overall Study|Entry criteria not met|0
7454352|NCT01769378|11746220|FG000|Overall Study|Protocol Violation|1
7564198|NCT03282227|11934840|FG000|Overall Study|Other|1
7564199|NCT03282357|11934844|FG000|Overall Study|Lost to Follow-up|3
7564200|NCT03282357|11934844|FG000|Overall Study|Withdrawal by Subject|4
7329027|NCT00799487|11561989|FG002|Dose Adjustment Period|Adverse Event|0
7329028|NCT00799487|11561987|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
7329029|NCT00799487|11561988|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
7454353|NCT01769378|11746221|FG001|Overall Study|Protocol Violation|1
7454354|NCT01769378|11746220|FG000|Overall Study|Withdrawal by Subject|10
7329030|NCT00799487|11561989|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
7454355|NCT01769378|11746221|FG001|Overall Study|Withdrawal by Subject|3
7454356|NCT01769378|11746220|FG000|Overall Study|Sponsor Decision|1
7454357|NCT01769378|11746221|FG001|Overall Study|Sponsor Decision|0
7454358|NCT01769378|11746220|FG000|Overall Study|Lost to Follow-up|2
7454359|NCT01769378|11746221|FG001|Overall Study|Lost to Follow-up|0
7468113|NCT01907100|11768666|FG001|Overall Study|Withdrawal by Subject|5
7468114|NCT01907100|11768667|FG002|Overall Study|Withdrawal by Subject|10
7468115|NCT01907100|11768668|FG003|Overall Study|Withdrawal by Subject|13
7468116|NCT01907100|11768665|FG000|Overall Study|Protocol Violation|0
7468117|NCT01907100|11768666|FG001|Overall Study|Protocol Violation|0
7468118|NCT01907100|11768667|FG002|Overall Study|Protocol Violation|1
7468119|NCT01907100|11768668|FG003|Overall Study|Protocol Violation|1
7468120|NCT01907100|11768665|FG000|Overall Study|Lost to Follow-up|0
7468121|NCT01907100|11768666|FG001|Overall Study|Lost to Follow-up|0
7468122|NCT01907100|11768667|FG002|Overall Study|Lost to Follow-up|0
7468123|NCT01907100|11768668|FG003|Overall Study|Lost to Follow-up|1
7468124|NCT01907100|11768665|FG000|Overall Study|Not treated|2
7468125|NCT01907100|11768666|FG001|Overall Study|Not treated|0
7468126|NCT01907100|11768667|FG002|Overall Study|Not treated|1
7468127|NCT01907100|11768668|FG003|Overall Study|Not treated|2
7468128|NCT01907100|11768665|FG000|Overall Study|Other than reasons specified|1
7468129|NCT01907100|11768666|FG001|Overall Study|Other than reasons specified|0
7468130|NCT01907100|11768667|FG002|Overall Study|Other than reasons specified|10
7468131|NCT01907100|11768668|FG003|Overall Study|Other than reasons specified|6
7468132|NCT01907100|11768665|FG000|Overall Study|Adverse event (AE)|6
7468133|NCT01907100|11768666|FG001|Overall Study|Adverse event (AE)|3
7468134|NCT01907100|11768667|FG002|Overall Study|Adverse event (AE)|22
7468135|NCT01907100|11768668|FG003|Overall Study|Adverse event (AE)|23
7468136|NCT01907100|11768665|FG000|Overall Study|Worsening/AE underlying cancer disease|0
7468137|NCT01907100|11768666|FG001|Overall Study|Worsening/AE underlying cancer disease|0
7468138|NCT01907100|11768667|FG002|Overall Study|Worsening/AE underlying cancer disease|8
7468139|NCT01907100|11768668|FG003|Overall Study|Worsening/AE underlying cancer disease|8
7468140|NCT01907217|11768699|FG000|Overall Study|Withdrawal by Subject|0
7468141|NCT01907217|11768700|FG001|Overall Study|Withdrawal by Subject|2
7468142|NCT01907516|11768734|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
7468143|NCT01907516|11768735|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
7468144|NCT01907516|11768734|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
7468145|NCT01907516|11768735|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
7468146|NCT01907516|11768734|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
7468147|NCT01907516|11768735|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
7564201|NCT03282357|11934844|FG000|Overall Study|Adverse Event|1
7564202|NCT03282357|11934844|FG000|Overall Study|Other|9
7468148|NCT01907516|11768734|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
7468149|NCT01907516|11768735|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
7468150|NCT01907737|11768746|FG000|Overall Study|Withdrawal by Subject|1
7468151|NCT01907815|11768758|FG000|Overall Study|Withdrawal by Subject|1
7468152|NCT01907815|11768759|FG001|Overall Study|Withdrawal by Subject|0
7468153|NCT01907828|11768769|FG000|Overall Study|Exclusion criteria not met|0
7468154|NCT01907828|11768770|FG001|Overall Study|Exclusion criteria not met|1
7468155|NCT01907828|11768769|FG000|Overall Study|Withdrawal by Subject|3
7468156|NCT01907828|11768770|FG001|Overall Study|Withdrawal by Subject|4
7468157|NCT01907828|11768769|FG000|Overall Study|Lost to Follow-up|3
7468158|NCT01907828|11768770|FG001|Overall Study|Lost to Follow-up|0
7468159|NCT01907828|11768769|FG000|Overall Study|Participant refused 24-month follow-up|1
7468160|NCT01907828|11768770|FG001|Overall Study|Participant refused 24-month follow-up|0
7468161|NCT01907828|11768769|FG000|Overall Study|Participant met exclusion criteria|0
7468162|NCT01907828|11768770|FG001|Overall Study|Participant met exclusion criteria|1
7468163|NCT01907854|11768778|FG000|Overall Study|Protocol Violation|1
7468164|NCT01907854|11768779|FG001|Overall Study|Protocol Violation|1
7533017|NCT02679729|11879027|FG001|Overall Study|Lost to Follow-up|1
7533018|NCT02679729|11879028|FG002|Overall Study|Lost to Follow-up|0
7533019|NCT02679729|11879029|FG003|Overall Study|Lost to Follow-up|0
7564203|NCT03283098|11934874|FG000|Overall Study|Withdrawal by Subject|0
7564204|NCT03283098|11934875|FG001|Overall Study|Withdrawal by Subject|1
7564205|NCT03283319|11934887|FG000|Overall Study|Lost to Follow-up|5
7564206|NCT03283319|11934888|FG001|Overall Study|Lost to Follow-up|4
7564207|NCT03283319|11934889|FG002|Overall Study|Lost to Follow-up|5
7564208|NCT03283319|11934890|FG003|Overall Study|Lost to Follow-up|5
7564209|NCT03283319|11934891|FG004|Overall Study|Lost to Follow-up|4
7468165|NCT01907854|11768778|FG000|Overall Study|Withdrawal by Subject|9
7468166|NCT01907854|11768779|FG001|Overall Study|Withdrawal by Subject|7
7468167|NCT01907854|11768778|FG000|Overall Study|Lost to Follow-up|2
7468168|NCT01907854|11768779|FG001|Overall Study|Lost to Follow-up|2
7468169|NCT01907854|11768778|FG000|Overall Study|Unclassified|4
7468170|NCT01907854|11768779|FG001|Overall Study|Unclassified|3
7468171|NCT01907906|11768787|FG000|Overall Study|Withdrawal by Subject|1
7468172|NCT01907906|11768788|FG001|Overall Study|Withdrawal by Subject|0
7468173|NCT01907906|11768787|FG000|Overall Study|Physician Decision|3
7468174|NCT01907906|11768788|FG001|Overall Study|Physician Decision|1
7468175|NCT01908101|11768808|FG000|Overall Study|Physician Decision|1
7468176|NCT01908101|11768808|FG000|Overall Study|Withdrawal by Subject|1
7468177|NCT01908101|11768808|FG000|Overall Study|Incorrect Diagnosis|2
7468178|NCT01908101|11768808|FG000|Overall Study|Incorrect Starting Dose|1
7533020|NCT02679729|11879030|FG004|Overall Study|Lost to Follow-up|1
7564210|NCT03283319|11934892|FG005|Overall Study|Lost to Follow-up|3
7454360|NCT01769391|11746229|FG000|Overall Study|Death|10
7454361|NCT01769391|11746230|FG001|Overall Study|Death|1
7454362|NCT01769391|11746229|FG000|Overall Study|Adverse Event|0
7454363|NCT01769391|11746230|FG001|Overall Study|Adverse Event|3
7454364|NCT01769391|11746229|FG000|Overall Study|Progressive Disease|1
7454365|NCT01769391|11746230|FG001|Overall Study|Progressive Disease|2
7454366|NCT01769391|11746229|FG000|Overall Study|Withdrawal by Subject|4
7454367|NCT01769391|11746230|FG001|Overall Study|Withdrawal by Subject|3
7454368|NCT01769391|11746229|FG000|Overall Study|Investigator Decision|2
7454369|NCT01769391|11746230|FG001|Overall Study|Investigator Decision|0
7454370|NCT01769404|11746242|FG000|Treatment Period 1|Did not meet eligibility criteria|1
7454371|NCT01769404|11746243|FG001|Treatment Period 1|Did not meet eligibility criteria|0
7454372|NCT01769404|11746242|FG000|Treatment Period 1|Withdrawal by Subject|3
7454373|NCT01769404|11746243|FG001|Treatment Period 1|Withdrawal by Subject|0
7454374|NCT01769404|11746242|FG000|Treatment Period 1|Sponsor decision|1
7454375|NCT01769404|11746243|FG001|Treatment Period 1|Sponsor decision|0
7454376|NCT01769404|11746242|FG000|Treatment Period 2|Sponsor decision|7
7454377|NCT01769404|11746243|FG001|Treatment Period 2|Sponsor decision|0
7454378|NCT01769456|11746251|FG000|Overall Study|Lost to Follow-up|19
7454379|NCT01769456|11746251|FG000|Overall Study|Withdrawal by Subject|3
7454380|NCT01769456|11746251|FG000|Overall Study|Did not receive PCC intervention|6
7454381|NCT01769456|11746251|FG000|Overall Study|Moved out of the area|3
7454382|NCT01769456|11746251|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
7454383|NCT01769456|11746251|FG000|Overall Study|Parental request to youth to withdraw|1
7454384|NCT01769469|11746256|FG000|Overall Study|Consent Withdrawn|5
7454385|NCT01769469|11746256|FG000|Overall Study|Moved Out Of Area|3
7454386|NCT01769469|11746256|FG000|Overall Study|Lost to Follow-up|17
7454387|NCT01769469|11746256|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
7454388|NCT01769469|11746256|FG000|Overall Study|Subject Confirmed HIV Positive|3
7454389|NCT01769508|11746262|FG000|Overall Study|Death|3
7454390|NCT01769508|11746262|FG000|Overall Study|Withdrawal by Subject|1
7454391|NCT01769508|11746262|FG000|Overall Study|Adverse Event|1
7454392|NCT01769508|11746262|FG000|Overall Study|Lost to Follow-up|1
7454393|NCT01770145|11746302|FG000|Baseline|Adverse Event|20
7454394|NCT01770145|11746302|FG000|Baseline|Withdrawal by Subject|1
7454395|NCT01770145|11746302|FG000|Baseline|Lost to Follow-up|1
7454396|NCT01770145|11746302|FG000|Baseline|Unable to define optimal dose|4
7454397|NCT01770145|11746302|FG000|Treatment|Adverse Event|3
7454398|NCT01770145|11746302|FG000|Treatment|Withdrawal by Subject|1
7454399|NCT01770353|11746317|FG000|Overall Study|Progressive disease|2
7454400|NCT01770353|11746318|FG001|Overall Study|Progressive disease|1
7454401|NCT01770353|11746317|FG000|Overall Study|Adverse Event|0
7454402|NCT01770353|11746318|FG001|Overall Study|Adverse Event|1
7454403|NCT01770353|11746317|FG000|Overall Study|Protocol Violation|1
7454404|NCT01770353|11746318|FG001|Overall Study|Protocol Violation|0
7454405|NCT01770353|11746317|FG000|Overall Study|Physician Decision|0
7454406|NCT01770353|11746318|FG001|Overall Study|Physician Decision|3
7454407|NCT01770353|11746317|FG000|Overall Study|Clinical deterioration|3
7454408|NCT01770353|11746318|FG001|Overall Study|Clinical deterioration|6
7454409|NCT01770353|11746317|FG000|Overall Study|Toxicity related diarrhoea + progression|0
7454410|NCT01770353|11746318|FG001|Overall Study|Toxicity related diarrhoea + progression|1
7454411|NCT01770379|11746344|FG000|Overall Study|Technical issues|1
7454412|NCT01770379|11746345|FG001|Overall Study|Technical issues|0
7454413|NCT01770379|11746346|FG002|Overall Study|Technical issues|0
7454414|NCT01770379|11746344|FG000|Overall Study|Withdrawal by Subject|7
7454415|NCT01770379|11746345|FG001|Overall Study|Withdrawal by Subject|10
7454416|NCT01770379|11746346|FG002|Overall Study|Withdrawal by Subject|7
7454417|NCT01770379|11746344|FG000|Overall Study|study terminated by sponsor|22
7454418|NCT01770379|11746345|FG001|Overall Study|study terminated by sponsor|23
7454419|NCT01770379|11746346|FG002|Overall Study|study terminated by sponsor|22
7454420|NCT01770379|11746344|FG000|Overall Study|Protocol Violation|0
7454421|NCT01770379|11746345|FG001|Overall Study|Protocol Violation|1
7454422|NCT01770379|11746346|FG002|Overall Study|Protocol Violation|1
7454423|NCT01770379|11746344|FG000|Overall Study|Physician Decision|0
7454424|NCT01770379|11746345|FG001|Overall Study|Physician Decision|1
7454425|NCT01770379|11746346|FG002|Overall Study|Physician Decision|2
7454426|NCT01770379|11746344|FG000|Overall Study|Lost to Follow-up|0
7454427|NCT01770379|11746345|FG001|Overall Study|Lost to Follow-up|0
7454428|NCT01770379|11746346|FG002|Overall Study|Lost to Follow-up|2
7454429|NCT01770379|11746344|FG000|Overall Study|Lack of Efficacy|8
7454430|NCT01770379|11746345|FG001|Overall Study|Lack of Efficacy|6
7454431|NCT01770379|11746346|FG002|Overall Study|Lack of Efficacy|6
7454432|NCT01770379|11746344|FG000|Overall Study|Adverse Event|1
7454433|NCT01770379|11746345|FG001|Overall Study|Adverse Event|3
7454434|NCT01770379|11746346|FG002|Overall Study|Adverse Event|2
7454435|NCT01770392|11746356|FG000|Washout Period of at Least 14 Days|Adverse Event|1
7454436|NCT01770509|11746387|FG000|Overall Study|Injury|0
7454437|NCT01770509|11746388|FG001|Overall Study|Injury|1
7454438|NCT01770509|11746387|FG000|Overall Study|Lost to Follow-up|1
7454439|NCT01770509|11746388|FG001|Overall Study|Lost to Follow-up|2
7454440|NCT01770743|11746427|FG000|Overall Study|Adverse Event|1
7454441|NCT01770743|11746428|FG001|Overall Study|Adverse Event|0
7454442|NCT01770743|11746429|FG002|Overall Study|Adverse Event|0
7454443|NCT01770743|11746430|FG003|Overall Study|Adverse Event|0
7454444|NCT01770743|11746431|FG004|Overall Study|Adverse Event|0
7454445|NCT01770743|11746427|FG000|Overall Study|Withdrawal by Subject|0
7454446|NCT01770743|11746428|FG001|Overall Study|Withdrawal by Subject|0
7454447|NCT01770743|11746429|FG002|Overall Study|Withdrawal by Subject|1
7454448|NCT01770743|11746430|FG003|Overall Study|Withdrawal by Subject|1
7454449|NCT01770743|11746431|FG004|Overall Study|Withdrawal by Subject|1
7454450|NCT01770743|11746427|FG000|Overall Study|Lost to Follow-up|0
7454451|NCT01770743|11746428|FG001|Overall Study|Lost to Follow-up|2
7454452|NCT01770743|11746429|FG002|Overall Study|Lost to Follow-up|0
7454453|NCT01770743|11746430|FG003|Overall Study|Lost to Follow-up|0
7454454|NCT01770743|11746431|FG004|Overall Study|Lost to Follow-up|1
7454455|NCT01770743|11746427|FG000|Overall Study|Sponsor Terminated Subject|1
7454456|NCT01770743|11746428|FG001|Overall Study|Sponsor Terminated Subject|0
7454457|NCT01770743|11746429|FG002|Overall Study|Sponsor Terminated Subject|0
7454458|NCT01770743|11746430|FG003|Overall Study|Sponsor Terminated Subject|1
7454459|NCT01770743|11746431|FG004|Overall Study|Sponsor Terminated Subject|0
7454460|NCT01770743|11746427|FG000|Overall Study|Moving Out of State|0
7454461|NCT01770743|11746428|FG001|Overall Study|Moving Out of State|1
7564211|NCT03283319|11934887|FG000|Overall Study|Withdrawal by Subject|2
7564212|NCT03283319|11934888|FG001|Overall Study|Withdrawal by Subject|2
7564213|NCT03283319|11934889|FG002|Overall Study|Withdrawal by Subject|2
7564214|NCT03283319|11934890|FG003|Overall Study|Withdrawal by Subject|1
7454462|NCT01770743|11746429|FG002|Overall Study|Moving Out of State|0
7454463|NCT01770743|11746430|FG003|Overall Study|Moving Out of State|0
7454464|NCT01770743|11746431|FG004|Overall Study|Moving Out of State|0
7454465|NCT01770860|11746443|FG000|Overall Study|Withdrawal by Subject|4
7454466|NCT01770860|11746443|FG000|Overall Study|Lost to Follow-up|1
7454467|NCT01770860|11746443|FG000|Overall Study|Administrative decision made by the PI|1
7454468|NCT01770912|11746453|FG000|Overall Study|Lost to Follow-up|2
7454469|NCT01770912|11746454|FG001|Overall Study|Lost to Follow-up|0
7454470|NCT01771250|11746473|FG000|Period 1|Met exclusion criteria|1
7454471|NCT01771250|11746474|FG001|Period 1|Met exclusion criteria|0
7454472|NCT01771731|11746495|FG000|Overall Study|Physician Decision|1
7454473|NCT01771731|11746496|FG001|Overall Study|Physician Decision|0
7454474|NCT01771731|11746495|FG000|Overall Study|Protocol Violation|0
7454475|NCT01771731|11746496|FG001|Overall Study|Protocol Violation|1
7454476|NCT01771731|11746495|FG000|Overall Study|Adverse event: Pain Crisis|1
7454477|NCT01771731|11746496|FG001|Overall Study|Adverse event: Pain Crisis|1
7454478|NCT01771809|11746504|FG000|Overall Study|Adverse Event|4
7454479|NCT01771809|11746505|FG001|Overall Study|Adverse Event|12
7454480|NCT01771809|11746504|FG000|Overall Study|Protocol Violation|0
7454481|NCT01771809|11746505|FG001|Overall Study|Protocol Violation|1
7454482|NCT01771809|11746504|FG000|Overall Study|Withdrawal by Subject|34
7454483|NCT01771809|11746505|FG001|Overall Study|Withdrawal by Subject|42
7454484|NCT01771809|11746504|FG000|Overall Study|Lost to Follow-up|1
7454485|NCT01771809|11746505|FG001|Overall Study|Lost to Follow-up|3
7454486|NCT01771809|11746504|FG000|Overall Study|Other (Insufficient clinical response)|22
7454487|NCT01771809|11746505|FG001|Overall Study|Other (Insufficient clinical response)|20
7454488|NCT01771809|11746504|FG000|Overall Study|Death|1
7454489|NCT01771809|11746505|FG001|Overall Study|Death|0
7454490|NCT01771809|11746504|FG000|Overall Study|Other (other)|9
7454491|NCT01771809|11746505|FG001|Overall Study|Other (other)|5
7454492|NCT01771913|11746513|FG000|Overall Study|Withdrawal by Subject|1
7564215|NCT03283319|11934891|FG004|Overall Study|Withdrawal by Subject|0
7564216|NCT03283319|11934892|FG005|Overall Study|Withdrawal by Subject|1
7564217|NCT03283319|11934887|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
7564218|NCT03283319|11934888|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
7564219|NCT03283319|11934889|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
7564220|NCT03283319|11934890|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
7564221|NCT03283319|11934891|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
7564222|NCT03283319|11934892|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
7564223|NCT03283553|11934917|FG000|Patient Participant Flow|Death|5
7564224|NCT03283553|11934918|FG001|Patient Participant Flow|Death|10
7564225|NCT03283553|11934917|FG000|Patient Participant Flow|Withdrawal by Subject|4
7564226|NCT03283553|11934918|FG001|Patient Participant Flow|Withdrawal by Subject|2
7564227|NCT03283553|11934917|FG000|Patient Participant Flow|Lost to Follow-up|1
7564228|NCT03283553|11934918|FG001|Patient Participant Flow|Lost to Follow-up|1
7564229|NCT03283553|11934917|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
7454493|NCT01771913|11746514|FG001|Overall Study|Withdrawal by Subject|0
7454494|NCT01772134|11746551|FG000|Overall Study|Adverse Event|6
7454495|NCT01772134|11746552|FG001|Overall Study|Adverse Event|5
7454496|NCT01772134|11746553|FG002|Overall Study|Adverse Event|10
7454497|NCT01772134|11746551|FG000|Overall Study|Withdrew Consent|3
7454498|NCT01772134|11746552|FG001|Overall Study|Withdrew Consent|1
7454499|NCT01772134|11746553|FG002|Overall Study|Withdrew Consent|5
7454500|NCT01772134|11746551|FG000|Overall Study|Lost to Follow-up|2
7454501|NCT01772134|11746552|FG001|Overall Study|Lost to Follow-up|0
7454502|NCT01772134|11746553|FG002|Overall Study|Lost to Follow-up|0
7454503|NCT01772134|11746551|FG000|Overall Study|Protocol Deviation|4
7454504|NCT01772134|11746552|FG001|Overall Study|Protocol Deviation|3
7454505|NCT01772134|11746553|FG002|Overall Study|Protocol Deviation|3
7454506|NCT01772134|11746551|FG000|Overall Study|Lack of Efficacy|11
7564230|NCT03283553|11934918|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
7564231|NCT03283553|11934917|FG000|Care Partner Participant Flow|Lost to Follow-up|1
7564232|NCT03283553|11934918|FG001|Care Partner Participant Flow|Lost to Follow-up|1
7564233|NCT03283553|11934917|FG000|Care Partner Participant Flow|Discontinued because patient death|5
7564234|NCT03283553|11934918|FG001|Care Partner Participant Flow|Discontinued because patient death|11
7564235|NCT03283696|11934928|FG000|Overall Study|Physician Decision|5
7454507|NCT01772134|11746552|FG001|Overall Study|Lack of Efficacy|5
7454508|NCT01772134|11746553|FG002|Overall Study|Lack of Efficacy|3
7454509|NCT01772134|11746551|FG000|Overall Study|Protocol-defined Stopping Criteria|1
7454510|NCT01772134|11746552|FG001|Overall Study|Protocol-defined Stopping Criteria|0
7454511|NCT01772134|11746553|FG002|Overall Study|Protocol-defined Stopping Criteria|0
7454512|NCT01772134|11746551|FG000|Overall Study|Randomized Study Medication Not Received|2
7454513|NCT01772134|11746552|FG001|Overall Study|Randomized Study Medication Not Received|0
7454514|NCT01772134|11746553|FG002|Overall Study|Randomized Study Medication Not Received|1
7454515|NCT01772147|11746564|FG000|Overall Study|Adverse Event|13
7454516|NCT01772147|11746565|FG001|Overall Study|Adverse Event|10
7454517|NCT01772147|11746566|FG002|Overall Study|Adverse Event|6
7454518|NCT01772147|11746564|FG000|Overall Study|Withdrew Consent|7
7454519|NCT01772147|11746565|FG001|Overall Study|Withdrew Consent|8
7454520|NCT01772147|11746566|FG002|Overall Study|Withdrew Consent|4
7454521|NCT01772147|11746564|FG000|Overall Study|Lost to Follow-up|1
7454522|NCT01772147|11746565|FG001|Overall Study|Lost to Follow-up|0
7454523|NCT01772147|11746566|FG002|Overall Study|Lost to Follow-up|1
7454524|NCT01772147|11746564|FG000|Overall Study|Protocol Deviation|2
7454525|NCT01772147|11746565|FG001|Overall Study|Protocol Deviation|1
7454526|NCT01772147|11746566|FG002|Overall Study|Protocol Deviation|1
7454527|NCT01772147|11746564|FG000|Overall Study|Lack of Efficacy|8
7454528|NCT01772147|11746565|FG001|Overall Study|Lack of Efficacy|6
7454529|NCT01772147|11746566|FG002|Overall Study|Lack of Efficacy|6
7454530|NCT01772160|11746574|FG000|Overall Study|Death|3
7454531|NCT01772160|11746574|FG000|Overall Study|Eligibility criteria not fulfilled|3
7454532|NCT01772160|11746574|FG000|Overall Study|Consent withdrawal|3
7454533|NCT01772160|11746574|FG000|Overall Study|Migrated / moved from the study area|4
7454534|NCT01772160|11746574|FG000|Overall Study|Lost to Follow-up|30
7454535|NCT01772160|11746574|FG000|Overall Study|Other|5
7454536|NCT01772316|11746578|FG000|Overall Study|Serious adverse event|1
7454537|NCT01772316|11746578|FG000|Overall Study|Inform consent withdrawn|1
7454538|NCT01772316|11746578|FG000|Overall Study|Withdrawn by sponsor decision|5
7454539|NCT01772368|11746582|FG000|Overall Study|Adverse Event|1
7454540|NCT01772368|11746582|FG000|Overall Study|Withdrawal by Subject|3
7454541|NCT01772368|11746582|FG000|Overall Study|Protocol Violation|2
7454542|NCT01772368|11746582|FG000|Overall Study|Other|1
7454543|NCT01772537|11746601|FG000|Overall Study|unsuccessful lumbar drain placement|1
7454544|NCT01772537|11746602|FG001|Overall Study|unsuccessful lumbar drain placement|0
7454545|NCT01772537|11746603|FG002|Overall Study|unsuccessful lumbar drain placement|0
7454546|NCT01772550|11746616|FG000|Overall Study|Unable to insert IV in antecubital vein|1
7454547|NCT01772550|11746617|FG001|Overall Study|Unable to insert IV in antecubital vein|1
7454548|NCT01772550|11746618|FG002|Overall Study|Unable to insert IV in antecubital vein|5
7454549|NCT01772550|11746616|FG000|Overall Study|Adverse Event|0
7454550|NCT01772550|11746617|FG001|Overall Study|Adverse Event|0
7454551|NCT01772550|11746618|FG002|Overall Study|Adverse Event|1
7454552|NCT01772576|11746626|FG000|Overall Study|Death|15
7454553|NCT01772576|11746626|FG000|Overall Study|Protocol Violation|1
7454554|NCT01772576|11746626|FG000|Overall Study|Lost to Follow-up|3
7454555|NCT01772576|11746626|FG000|Overall Study|Study device not used|3
7454556|NCT01772576|11746626|FG000|Overall Study|Adverse Event|6
7454557|NCT01772576|11746626|FG000|Overall Study|Withdrawal by Subject|6
7454558|NCT01772693|11746641|FG000|Overall Study|Health Concerns Unrelated to Study|2
7454559|NCT01772693|11746642|FG001|Overall Study|Health Concerns Unrelated to Study|1
7454560|NCT01772693|11746641|FG000|Overall Study|Withdrawal by Subject|2
7454561|NCT01772693|11746642|FG001|Overall Study|Withdrawal by Subject|0
7454562|NCT01772693|11746641|FG000|Overall Study|Alternative Treatment|2
7454563|NCT01772693|11746642|FG001|Overall Study|Alternative Treatment|0
7454564|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
7454565|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
7454566|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7454567|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
7454568|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
7454569|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
7454570|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
7454571|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
7454572|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
7454573|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
7454574|NCT01772823|11746667|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
7454575|NCT01772823|11746668|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
7454576|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
7454577|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
7454578|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
7454579|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
7454580|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
7454581|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
7454582|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
7454583|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
7454584|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
7454585|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
7454586|NCT01772823|11746667|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7454587|NCT01772823|11746668|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
7454588|NCT01772823|11746667|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
7454589|NCT01772823|11746668|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
7454590|NCT01772823|11746667|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
7454591|NCT01772823|11746668|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
7454592|NCT01772823|11746667|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7454593|NCT01772823|11746668|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
7454594|NCT01772823|11746667|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
7454595|NCT01772823|11746668|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
7454596|NCT01773070|11746679|FG000|Overall Study|Withdrawal by Subject|24
7454597|NCT01773070|11746679|FG000|Overall Study|Lost to Follow-up|39
7454598|NCT01773070|11746679|FG000|Overall Study|Other|15
7454599|NCT01773070|11746679|FG000|Overall Study|Death (unrelated to study procedures)|3
7454600|NCT01773109|11746683|FG000|Overall Study|Symptomatic Progression|2
7454601|NCT01773109|11746683|FG000|Overall Study|Death|1
7454602|NCT01773122|11746691|FG000|Overall Study|Due to amended age eligibility criteria|3
7454603|NCT01773122|11746692|FG001|Overall Study|Due to amended age eligibility criteria|1
7454604|NCT01773122|11746693|FG002|Overall Study|Due to amended age eligibility criteria|0
7454605|NCT01773122|11746694|FG003|Overall Study|Due to amended age eligibility criteria|1
7454606|NCT01773226|11746720|FG000|Overall Study|Withdrawal by Subject|1
7454607|NCT01773291|11746727|FG000|Overall Study|Protocol Violation|1
7454608|NCT01773291|11746728|FG001|Overall Study|Protocol Violation|0
7454609|NCT01773291|11746729|FG002|Overall Study|Protocol Violation|0
7454610|NCT01773291|11746727|FG000|Overall Study|Withdrawal by Subject|0
7454611|NCT01773291|11746728|FG001|Overall Study|Withdrawal by Subject|0
7454612|NCT01773291|11746729|FG002|Overall Study|Withdrawal by Subject|1
7454613|NCT01773421|11746742|FG000|Treatment Phase|Other|0
7564236|NCT03283696|11934929|FG001|Overall Study|Physician Decision|6
7454614|NCT01773421|11746743|FG001|Treatment Phase|Other|0
7454615|NCT01773421|11746744|FG002|Treatment Phase|Other|2
7454616|NCT01773421|11746745|FG003|Treatment Phase|Other|0
7454617|NCT01773421|11746746|FG004|Treatment Phase|Other|0
7454618|NCT01773421|11746747|FG005|Treatment Phase|Other|0
7454619|NCT01773421|11746748|FG006|Treatment Phase|Other|0
7454620|NCT01773421|11746742|FG000|Treatment Phase|Adverse Event|0
7454621|NCT01773421|11746743|FG001|Treatment Phase|Adverse Event|0
7454622|NCT01773421|11746744|FG002|Treatment Phase|Adverse Event|3
7454623|NCT01773421|11746745|FG003|Treatment Phase|Adverse Event|1
7454624|NCT01773421|11746746|FG004|Treatment Phase|Adverse Event|0
7454625|NCT01773421|11746747|FG005|Treatment Phase|Adverse Event|0
7454626|NCT01773421|11746748|FG006|Treatment Phase|Adverse Event|0
7454627|NCT01773421|11746742|FG000|Treatment Phase|Withdrawal by Subject|0
7454628|NCT01773421|11746743|FG001|Treatment Phase|Withdrawal by Subject|0
7454629|NCT01773421|11746744|FG002|Treatment Phase|Withdrawal by Subject|1
7454630|NCT01773421|11746745|FG003|Treatment Phase|Withdrawal by Subject|1
7454631|NCT01773421|11746746|FG004|Treatment Phase|Withdrawal by Subject|0
7454632|NCT01773421|11746747|FG005|Treatment Phase|Withdrawal by Subject|0
7454633|NCT01773421|11746748|FG006|Treatment Phase|Withdrawal by Subject|0
7564237|NCT03283696|11934928|FG000|Overall Study|Withdrawal by Subject|2
7564238|NCT03283696|11934929|FG001|Overall Study|Withdrawal by Subject|0
7564239|NCT03284229|11934951|FG000|Overall Study|Lost to Follow-up|3
7564240|NCT03284710|11934989|FG000|Overall Study|Withdrawal by Subject|1
7564241|NCT03284710|11934990|FG001|Overall Study|Withdrawal by Subject|0
7564242|NCT03284710|11934991|FG002|Overall Study|Withdrawal by Subject|1
7564243|NCT03284710|11934992|FG003|Overall Study|Withdrawal by Subject|6
7564244|NCT03284710|11934989|FG000|Overall Study|Lost to Follow-up|3
7454634|NCT01773421|11746742|FG000|Extension Phase|Other|0
7454635|NCT01773421|11746743|FG001|Extension Phase|Other|0
7454636|NCT01773421|11746744|FG002|Extension Phase|Other|0
7454637|NCT01773421|11746745|FG003|Extension Phase|Other|0
7454638|NCT01773421|11746746|FG004|Extension Phase|Other|1
7454639|NCT01773421|11746747|FG005|Extension Phase|Other|2
7454640|NCT01773421|11746748|FG006|Extension Phase|Other|0
7454641|NCT01773421|11746742|FG000|Extension Phase|Adverse Event|0
7454642|NCT01773421|11746743|FG001|Extension Phase|Adverse Event|0
7454643|NCT01773421|11746744|FG002|Extension Phase|Adverse Event|0
7454644|NCT01773421|11746745|FG003|Extension Phase|Adverse Event|0
7454645|NCT01773421|11746746|FG004|Extension Phase|Adverse Event|2
7454646|NCT01773421|11746747|FG005|Extension Phase|Adverse Event|0
7564245|NCT03284710|11934990|FG001|Overall Study|Lost to Follow-up|3
7564246|NCT03284710|11934991|FG002|Overall Study|Lost to Follow-up|1
7454647|NCT01773421|11746748|FG006|Extension Phase|Adverse Event|0
7454648|NCT01773473|11746766|FG000|Overall Study|Adverse Event|3
7454649|NCT01773473|11746767|FG001|Overall Study|Adverse Event|2
7454650|NCT01773473|11746766|FG000|Overall Study|Protocol Violation|0
7454651|NCT01773473|11746767|FG001|Overall Study|Protocol Violation|4
7454652|NCT01773473|11746766|FG000|Overall Study|Physician Decision|3
7454653|NCT01773473|11746767|FG001|Overall Study|Physician Decision|5
7454654|NCT01773473|11746766|FG000|Overall Study|Sponsor Decision|2
7454655|NCT01773473|11746767|FG001|Overall Study|Sponsor Decision|0
7454656|NCT01773473|11746766|FG000|Overall Study|Lack of Efficacy|0
7454657|NCT01773473|11746767|FG001|Overall Study|Lack of Efficacy|1
7454658|NCT01773473|11746766|FG000|Overall Study|Non-Compliance with study drug|1
7454659|NCT01773473|11746767|FG001|Overall Study|Non-Compliance with study drug|4
7454660|NCT01773473|11746766|FG000|Overall Study|Withdrawal by Subject|5
7454661|NCT01773473|11746767|FG001|Overall Study|Withdrawal by Subject|3
7454662|NCT01773473|11746766|FG000|Overall Study|Lost to Follow-up|2
7454663|NCT01773473|11746767|FG001|Overall Study|Lost to Follow-up|0
7454664|NCT01773889|11746773|FG000|Overall Study|lack of funding|2
7454665|NCT01773967|11746783|FG000|Overall Study|Lost to Follow-up|15
7454666|NCT01773967|11746784|FG001|Overall Study|Lost to Follow-up|13
7454667|NCT01773993|11746790|FG000|Overall Study|No Visit After Treatment|35
7454668|NCT01774084|11746806|FG000|Overall Study|Personal reasons|1
7454669|NCT01774084|11746807|FG001|Overall Study|Personal reasons|0
7454670|NCT01774097|11746815|FG000|Overall Study|Withdrawal by Subject|1
7454671|NCT01774097|11746816|FG001|Overall Study|Withdrawal by Subject|1
7454672|NCT01774097|11746815|FG000|Overall Study|Adverse Event|1
7454673|NCT01774097|11746816|FG001|Overall Study|Adverse Event|1
7454674|NCT01774110|11746824|FG000|Overall Study|Lost to Follow-up|7
7454675|NCT01774305|11746840|FG000|Overall Study|Physician Decision|1
7454676|NCT01774305|11746841|FG001|Overall Study|Physician Decision|0
7454677|NCT01774344|11746849|FG000|Overall Study|Withdrawal by Subject|3
7454678|NCT01774344|11746850|FG001|Overall Study|Withdrawal by Subject|10
7454679|NCT01774344|11746849|FG000|Overall Study|Protocol Violation|0
7454680|NCT01774344|11746850|FG001|Overall Study|Protocol Violation|1
7454681|NCT01774344|11746849|FG000|Overall Study|Lost to Follow-up|4
7454682|NCT01774344|11746850|FG001|Overall Study|Lost to Follow-up|10
7454683|NCT01774344|11746849|FG000|Overall Study|End of survival follow-up not available|2
7454684|NCT01774344|11746850|FG001|Overall Study|End of survival follow-up not available|2
7454685|NCT01774344|11746849|FG000|Overall Study|Data collection finished|4
7454686|NCT01774344|11746850|FG001|Overall Study|Data collection finished|14
7454687|NCT01774344|11746849|FG000|Overall Study|Other|0
7454688|NCT01774344|11746850|FG001|Overall Study|Other|1
7454689|NCT01774344|11746849|FG000|Overall Study|Did not enter Survival Follow up|49
7454690|NCT01774344|11746850|FG001|Overall Study|Did not enter Survival Follow up|83
7454691|NCT01774591|11746858|FG000|Overall Study|Physician Decision|1
7454692|NCT01774591|11746859|FG001|Overall Study|Physician Decision|1
7454693|NCT01774591|11746858|FG000|Overall Study|Withdrawal by Subject|0
7454694|NCT01774591|11746859|FG001|Overall Study|Withdrawal by Subject|1
7454695|NCT01774591|11746858|FG000|Overall Study|Adverse Event|0
7454696|NCT01774591|11746859|FG001|Overall Study|Adverse Event|2
7454697|NCT01774786|11746880|FG000|Overall Study|Death|300
7454698|NCT01774786|11746881|FG001|Overall Study|Death|319
7454699|NCT01774786|11746880|FG000|Overall Study|Lost to Follow-up|6
7454700|NCT01774786|11746881|FG001|Overall Study|Lost to Follow-up|7
7454701|NCT01774786|11746880|FG000|Overall Study|Withdrawal by Subject|18
7454702|NCT01774786|11746881|FG001|Overall Study|Withdrawal by Subject|14
7454703|NCT01774786|11746880|FG000|Overall Study|Physician Decision|2
7454704|NCT01774786|11746881|FG001|Overall Study|Physician Decision|0
7454705|NCT01774786|11746880|FG000|Overall Study|Non-compliance|0
7454706|NCT01774786|11746881|FG001|Overall Study|Non-compliance|1
7454707|NCT01774786|11746880|FG000|Overall Study|Reason Not Specified|2
7454708|NCT01774786|11746881|FG001|Overall Study|Reason Not Specified|5
7454709|NCT01774799|11746891|FG000|Overall Study|Lost to Follow-up|1
7454710|NCT01774799|11746892|FG001|Overall Study|Lost to Follow-up|1
7454711|NCT01774799|11746893|FG002|Overall Study|Lost to Follow-up|0
7454712|NCT01774799|11746894|FG003|Overall Study|Lost to Follow-up|0
7454713|NCT01774903|11746909|FG000|Overall Study|Adverse Event|7
7454714|NCT01774903|11746909|FG000|Overall Study|Withdrawal by Subject|2
7454715|NCT01774903|11746909|FG000|Overall Study|Lack of Efficacy|1
7454716|NCT01774903|11746909|FG000|Overall Study|Ineligible to continue the trial|1
7454717|NCT01774929|11746914|FG000|Overall Study|Adverse Event|3
7454718|NCT01774968|11746920|FG000|Overall Study|Adverse Event|4
7454719|NCT01774968|11746921|FG001|Overall Study|Adverse Event|4
7454720|NCT01774968|11746920|FG000|Overall Study|Death|0
7454721|NCT01774968|11746921|FG001|Overall Study|Death|1
7454722|NCT01774968|11746920|FG000|Overall Study|Lost to Follow-up|1
7454723|NCT01774968|11746921|FG001|Overall Study|Lost to Follow-up|3
7454724|NCT01774968|11746920|FG000|Overall Study|Physician Decision|5
7454725|NCT01774968|11746921|FG001|Overall Study|Physician Decision|1
7454726|NCT01774968|11746920|FG000|Overall Study|Protocol Violation|14
7454727|NCT01774968|11746921|FG001|Overall Study|Protocol Violation|13
7454728|NCT01774968|11746920|FG000|Overall Study|Sponsor Decision|0
7454729|NCT01774968|11746921|FG001|Overall Study|Sponsor Decision|2
7454730|NCT01774968|11746920|FG000|Overall Study|Withdrawal by Subject|6
7454731|NCT01774968|11746921|FG001|Overall Study|Withdrawal by Subject|11
7454732|NCT01774981|11746935|FG000|Overall Study|Adverse Event|0
7454733|NCT01774981|11746936|FG001|Overall Study|Adverse Event|0
7454734|NCT01774981|11746937|FG002|Overall Study|Adverse Event|0
7454735|NCT01774981|11746938|FG003|Overall Study|Adverse Event|0
7454736|NCT01774981|11746939|FG004|Overall Study|Adverse Event|0
7454737|NCT01774981|11746940|FG005|Overall Study|Adverse Event|1
7454738|NCT01774981|11746941|FG006|Overall Study|Adverse Event|0
7454739|NCT01774981|11746942|FG007|Overall Study|Adverse Event|0
7454740|NCT01774981|11746935|FG000|Overall Study|Withdrawal by Subject|0
7454741|NCT01774981|11746936|FG001|Overall Study|Withdrawal by Subject|0
7454742|NCT01774981|11746937|FG002|Overall Study|Withdrawal by Subject|0
7454743|NCT01774981|11746938|FG003|Overall Study|Withdrawal by Subject|0
7454744|NCT01774981|11746939|FG004|Overall Study|Withdrawal by Subject|0
7454745|NCT01774981|11746940|FG005|Overall Study|Withdrawal by Subject|0
7454746|NCT01774981|11746941|FG006|Overall Study|Withdrawal by Subject|0
7454747|NCT01774981|11746942|FG007|Overall Study|Withdrawal by Subject|1
7454748|NCT01774981|11746935|FG000|Overall Study|Death|0
7454749|NCT01774981|11746936|FG001|Overall Study|Death|0
7454750|NCT01774981|11746937|FG002|Overall Study|Death|0
7454751|NCT01774981|11746938|FG003|Overall Study|Death|0
7454752|NCT01774981|11746939|FG004|Overall Study|Death|1
7454753|NCT01774981|11746940|FG005|Overall Study|Death|0
7454754|NCT01774981|11746941|FG006|Overall Study|Death|0
7454755|NCT01774981|11746942|FG007|Overall Study|Death|0
7454756|NCT01775124|11746967|FG000|Core Period|Disease Progression|0
7454757|NCT01775124|11746968|FG001|Core Period|Disease Progression|1
7454758|NCT01775124|11746967|FG000|Core Period|Physician Decision|1
7454759|NCT01775124|11746968|FG001|Core Period|Physician Decision|1
7454760|NCT01775124|11746967|FG000|Core Period|Death|0
7454761|NCT01775124|11746968|FG001|Core Period|Death|1
7454762|NCT01775124|11746967|FG000|Core Period|Administrative problems|1
7454763|NCT01775124|11746968|FG001|Core Period|Administrative problems|0
7454764|NCT01775124|11746967|FG000|Core Period|Withdrawal by Subject|4
7454765|NCT01775124|11746968|FG001|Core Period|Withdrawal by Subject|2
7454766|NCT01775124|11746967|FG000|Core Period|Adverse Event|5
7454767|NCT01775124|11746968|FG001|Core Period|Adverse Event|5
7454768|NCT01775124|11746967|FG000|Extension Period|Adverse Event|3
7454769|NCT01775124|11746968|FG001|Extension Period|Adverse Event|2
7454770|NCT01775124|11746967|FG000|Extension Period|Physician Decision|0
7454771|NCT01775124|11746968|FG001|Extension Period|Physician Decision|2
7454772|NCT01775124|11746967|FG000|Extension Period|Administrative problems|0
7454773|NCT01775124|11746968|FG001|Extension Period|Administrative problems|1
7454774|NCT01775124|11746967|FG000|Extension Period|Lost to Follow-up|0
7454775|NCT01775124|11746968|FG001|Extension Period|Lost to Follow-up|1
7454776|NCT01775124|11746967|FG000|Extension Period|Withdrawal by Subject|9
7454777|NCT01775124|11746968|FG001|Extension Period|Withdrawal by Subject|12
7454778|NCT01775137|11746975|FG000|Overall Study|Death|1
7454779|NCT01775137|11746975|FG000|Overall Study|Protocol deviation|2
7454780|NCT01775137|11746975|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7454781|NCT01775137|11746975|FG000|Overall Study|Adverse Event|1
7454782|NCT01775137|11746975|FG000|Overall Study|Withdrawal by participants|5
7454783|NCT01775189|11746982|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
7454784|NCT01775189|11746983|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
7454785|NCT01775189|11746984|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
7454786|NCT01775189|11746985|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
7454787|NCT01775189|11746986|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
7454788|NCT01775189|11746987|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
7454789|NCT01775189|11746988|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
7454790|NCT01775189|11746982|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454791|NCT01775189|11746983|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
7454792|NCT01775189|11746984|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454793|NCT01775189|11746985|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454794|NCT01775189|11746986|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454795|NCT01775189|11746987|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454796|NCT01775189|11746988|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
7454797|NCT01775189|11746982|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7454798|NCT01775189|11746983|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
7454799|NCT01775189|11746984|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
7454800|NCT01775189|11746985|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7454801|NCT01775189|11746986|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7454802|NCT01775189|11746987|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7454803|NCT01775189|11746988|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
7454804|NCT01775189|11746982|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
7454805|NCT01775189|11746983|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
7454806|NCT01775189|11746984|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
7454807|NCT01775189|11746985|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
7454808|NCT01775189|11746986|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
7454809|NCT01775189|11746987|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
7454810|NCT01775189|11746988|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
7454811|NCT01775189|11746982|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
7454812|NCT01775189|11746983|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
7454813|NCT01775189|11746984|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
7454814|NCT01775189|11746985|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
7454815|NCT01775189|11746986|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
7454816|NCT01775189|11746987|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
7454817|NCT01775189|11746988|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
7454818|NCT01775189|11746982|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
7454819|NCT01775189|11746983|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
7454820|NCT01775189|11746984|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
7454821|NCT01775189|11746985|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
7454822|NCT01775189|11746986|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
7454823|NCT01775189|11746987|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
7454824|NCT01775189|11746988|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
7454825|NCT01775501|11747031|FG000|Overall Study|Discontinued prior to treatment|1
7454826|NCT01775553|11747035|FG000|Overall Study|Adverse Event|1
7454827|NCT01775553|11747035|FG000|Overall Study|Disease Progression|12
7454828|NCT01775670|11747041|FG000|Overall Study|Lost to Follow-up|1
7454829|NCT01775670|11747042|FG001|Overall Study|Lost to Follow-up|1
7454830|NCT01775787|11747076|FG000|First 7-10 Days|Adverse Event|0
7454831|NCT01775787|11747077|FG001|First 7-10 Days|Adverse Event|1
7454832|NCT01775787|11747076|FG000|First 7-10 Days|family emergency|0
7454833|NCT01775787|11747077|FG001|First 7-10 Days|family emergency|1
7454834|NCT01775787|11747076|FG000|First 7-10 Days|time commitment|0
7454835|NCT01775787|11747077|FG001|First 7-10 Days|time commitment|2
7454836|NCT01775787|11747076|FG000|First 7-10 Days|concerns with using IV|1
7454837|NCT01775787|11747077|FG001|First 7-10 Days|concerns with using IV|2
7454838|NCT01775787|11747076|FG000|Second 7-10 Days|time commitment|0
7454839|NCT01775787|11747077|FG001|Second 7-10 Days|time commitment|1
7454840|NCT01775787|11747076|FG000|Second 7-10 Days|concerns with using IV|0
7454841|NCT01775787|11747077|FG001|Second 7-10 Days|concerns with using IV|1
7454842|NCT01775904|11747122|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
7454843|NCT01775904|11747122|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
7454844|NCT01775930|11747132|FG000|Overall Study|Futility stopping boundary met|1
7454845|NCT01775995|11747138|FG000|Overall Study|Lost to Follow-up|1
7454846|NCT01775995|11747139|FG001|Overall Study|Lost to Follow-up|1
7454847|NCT01776008|11747145|FG000|Overall Study|ineligible|2
7454848|NCT01776424|11747162|FG000|Overall Study|Lost to Follow-up|10
7454849|NCT01776424|11747163|FG001|Overall Study|Lost to Follow-up|8
7454850|NCT01776424|11747164|FG002|Overall Study|Lost to Follow-up|9
7454851|NCT01776424|11747162|FG000|Overall Study|Withdrawal by Subject|10
7454852|NCT01776424|11747163|FG001|Overall Study|Withdrawal by Subject|11
7454853|NCT01776424|11747164|FG002|Overall Study|Withdrawal by Subject|15
7454854|NCT01776541|11747174|FG000|Overall Study|Administrative Reason|6
7454855|NCT01776541|11747175|FG001|Overall Study|Administrative Reason|2
7454856|NCT01776541|11747174|FG000|Overall Study|Death|4
7454857|NCT01776541|11747175|FG001|Overall Study|Death|0
7454858|NCT01776541|11747174|FG000|Overall Study|Lost to Follow-up|27
7454859|NCT01776541|11747175|FG001|Overall Study|Lost to Follow-up|48
7454860|NCT01776541|11747174|FG000|Overall Study|Unclassified|5
7454861|NCT01776541|11747175|FG001|Overall Study|Unclassified|4
7454862|NCT01776541|11747174|FG000|Overall Study|Protocol Violation|2
7454863|NCT01776541|11747175|FG001|Overall Study|Protocol Violation|1
7454864|NCT01776541|11747174|FG000|Overall Study|Withdrawal by Subject|12
7454865|NCT01776541|11747175|FG001|Overall Study|Withdrawal by Subject|20
7454866|NCT01776554|11747184|FG000|Overall Study|Adverse Event|1
7454867|NCT01776554|11747185|FG001|Overall Study|Adverse Event|0
7454868|NCT01776554|11747184|FG000|Overall Study|Withdrawal by Subject|3
7454869|NCT01776554|11747185|FG001|Overall Study|Withdrawal by Subject|8
7454870|NCT01776554|11747184|FG000|Overall Study|Lost to Follow-up|6
7454871|NCT01776554|11747185|FG001|Overall Study|Lost to Follow-up|9
7454872|NCT01776554|11747184|FG000|Overall Study|Administrative Reason|2
7454873|NCT01776554|11747185|FG001|Overall Study|Administrative Reason|5
7454874|NCT01776554|11747184|FG000|Overall Study|Protocol Violation|1
7454875|NCT01776554|11747185|FG001|Overall Study|Protocol Violation|0
7454876|NCT01776554|11747184|FG000|Overall Study|Unclassified|4
7454877|NCT01776554|11747185|FG001|Overall Study|Unclassified|1
7468179|NCT01908101|11768808|FG000|Overall Study|Did not complete the first cycle|4
7468180|NCT01908140|11768823|FG000|Overall Study|Other or Progressive Disease|5
7468181|NCT01908140|11768824|FG001|Overall Study|Other or Progressive Disease|12
7468182|NCT01908140|11768823|FG000|Overall Study|Lack of Efficacy|7
7468183|NCT01908140|11768824|FG001|Overall Study|Lack of Efficacy|5
7468184|NCT01908140|11768823|FG000|Overall Study|Withdrawal by Subject|23
7468185|NCT01908140|11768824|FG001|Overall Study|Withdrawal by Subject|24
7468186|NCT01908140|11768823|FG000|Overall Study|Lost to Follow-up|1
7468187|NCT01908140|11768824|FG001|Overall Study|Lost to Follow-up|6
7468188|NCT01908140|11768823|FG000|Overall Study|Protocol Violation|8
7468189|NCT01908140|11768824|FG001|Overall Study|Protocol Violation|9
7468190|NCT01908140|11768823|FG000|Overall Study|Adverse Event|22
7468191|NCT01908140|11768824|FG001|Overall Study|Adverse Event|23
7468192|NCT01908205|11768832|FG000|Overall Study|Lost to Follow-up|2
7468193|NCT01908205|11768833|FG001|Overall Study|Lost to Follow-up|0
7468194|NCT01908205|11768832|FG000|Overall Study|Withdrawal by Subject|3
7468195|NCT01908205|11768833|FG001|Overall Study|Withdrawal by Subject|1
7454878|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
7454879|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
7454880|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
7454881|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
7454882|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
7454883|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
7454884|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
7454885|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
7454886|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
7454887|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
7454888|NCT01777139|11747220|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
7454889|NCT01777139|11747221|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
7454890|NCT01777139|11747220|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
7454891|NCT01777139|11747221|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
7454892|NCT01777139|11747220|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
7454893|NCT01777139|11747221|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
7454894|NCT01777152|11747230|FG000|Overall Study|Withdrawal by Subject|22
7454895|NCT01777152|11747231|FG001|Overall Study|Withdrawal by Subject|16
7454896|NCT01777152|11747230|FG000|Overall Study|Lost to Follow-up|3
7454897|NCT01777152|11747231|FG001|Overall Study|Lost to Follow-up|5
7454898|NCT01777152|11747230|FG000|Overall Study|Death|68
7454899|NCT01777152|11747231|FG001|Overall Study|Death|89
7454900|NCT01777152|11747230|FG000|Overall Study|Not eligible, no study drug received|1
7454901|NCT01777152|11747231|FG001|Overall Study|Not eligible, no study drug received|0
7454902|NCT01777152|11747230|FG000|Overall Study|Change of diagnosis|1
7454903|NCT01777152|11747231|FG001|Overall Study|Change of diagnosis|0
7454904|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
7454905|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
7454906|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7454907|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
7454908|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
7454909|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
7454910|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
7454911|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
7454912|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7454913|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
7454914|NCT01777191|11747240|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
7454915|NCT01777191|11747241|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
7454916|NCT01777191|11747240|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7454917|NCT01777191|11747241|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
7454918|NCT01777191|11747240|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
7454919|NCT01777191|11747241|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
7454920|NCT01777191|11747240|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7454921|NCT01777191|11747241|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
7454922|NCT01777191|11747240|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
7454923|NCT01777191|11747241|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
7454924|NCT01777191|11747240|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
7454925|NCT01777191|11747241|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
7454926|NCT01777269|11747261|FG000|Overall Study|Adverse Event|24
7454927|NCT01777269|11747262|FG001|Overall Study|Adverse Event|33
7454928|NCT01777269|11747261|FG000|Overall Study|Lack of Efficacy|8
7454929|NCT01777269|11747262|FG001|Overall Study|Lack of Efficacy|10
7454930|NCT01777269|11747261|FG000|Overall Study|Protocol Violation|4
7454931|NCT01777269|11747262|FG001|Overall Study|Protocol Violation|4
7454932|NCT01777269|11747261|FG000|Overall Study|Participants reached stopping criteria|1
7454933|NCT01777269|11747262|FG001|Overall Study|Participants reached stopping criteria|1
7454934|NCT01777269|11747261|FG000|Overall Study|Lost to Follow-up|4
7454935|NCT01777269|11747262|FG001|Overall Study|Lost to Follow-up|0
7454936|NCT01777269|11747261|FG000|Overall Study|Physician Decision|5
7454937|NCT01777269|11747262|FG001|Overall Study|Physician Decision|2
7454938|NCT01777269|11747261|FG000|Overall Study|Withdrawal by Subject|9
7454939|NCT01777269|11747262|FG001|Overall Study|Withdrawal by Subject|9
7454940|NCT01777282|11747273|FG000|Overall Study|Persistent Hyperglycemia|0
7454941|NCT01777282|11747274|FG001|Overall Study|Persistent Hyperglycemia|0
7454942|NCT01777282|11747275|FG002|Overall Study|Persistent Hyperglycemia|1
7454943|NCT01777282|11747276|FG003|Overall Study|Persistent Hyperglycemia|0
7454944|NCT01777282|11747277|FG004|Overall Study|Persistent Hyperglycemia|0
7454945|NCT01777282|11747273|FG000|Overall Study|New Antidiabetic Medication|0
7454946|NCT01777282|11747274|FG001|Overall Study|New Antidiabetic Medication|0
7454947|NCT01777282|11747275|FG002|Overall Study|New Antidiabetic Medication|1
7454948|NCT01777282|11747276|FG003|Overall Study|New Antidiabetic Medication|0
7454949|NCT01777282|11747277|FG004|Overall Study|New Antidiabetic Medication|0
7454950|NCT01777282|11747273|FG000|Overall Study|Adverse Event|4
7454951|NCT01777282|11747274|FG001|Overall Study|Adverse Event|4
7454952|NCT01777282|11747275|FG002|Overall Study|Adverse Event|2
7454953|NCT01777282|11747276|FG003|Overall Study|Adverse Event|1
7454954|NCT01777282|11747277|FG004|Overall Study|Adverse Event|3
7454955|NCT01777282|11747273|FG000|Overall Study|Withdrawal by Subject|4
7454956|NCT01777282|11747274|FG001|Overall Study|Withdrawal by Subject|0
7454957|NCT01777282|11747275|FG002|Overall Study|Withdrawal by Subject|0
7454958|NCT01777282|11747276|FG003|Overall Study|Withdrawal by Subject|1
7454959|NCT01777282|11747277|FG004|Overall Study|Withdrawal by Subject|2
7454960|NCT01777282|11747273|FG000|Overall Study|Protocol Violation|2
7454961|NCT01777282|11747274|FG001|Overall Study|Protocol Violation|0
7454962|NCT01777282|11747275|FG002|Overall Study|Protocol Violation|1
7454963|NCT01777282|11747276|FG003|Overall Study|Protocol Violation|0
7454964|NCT01777282|11747277|FG004|Overall Study|Protocol Violation|2
7454965|NCT01777282|11747273|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
7454966|NCT01777282|11747274|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
7454967|NCT01777282|11747275|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
7454968|NCT01777282|11747276|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
7454969|NCT01777282|11747277|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
7454970|NCT01777308|11747291|FG000|Overall Study|Withdrawal by Subject|5
7454971|NCT01777308|11747292|FG001|Overall Study|Withdrawal by Subject|1
7454972|NCT01777308|11747291|FG000|Overall Study|Migrated/moved from study area|1
7454973|NCT01777308|11747292|FG001|Overall Study|Migrated/moved from study area|0
7454974|NCT01777308|11747291|FG000|Overall Study|Lost to Follow-up|7
7454975|NCT01777308|11747292|FG001|Overall Study|Lost to Follow-up|2
7454976|NCT01777308|11747291|FG000|Overall Study|Blood draw refusal at Visit 3|1
7454977|NCT01777308|11747292|FG001|Overall Study|Blood draw refusal at Visit 3|0
7454978|NCT01777321|11747301|FG000|Overall Study|Withdrawal by Subject|0
7454979|NCT01777321|11747302|FG001|Overall Study|Withdrawal by Subject|1
7454980|NCT01777334|11747310|FG000|Overall Study|Adverse Event|18
7454981|NCT01777334|11747311|FG001|Overall Study|Adverse Event|14
7454982|NCT01777334|11747310|FG000|Overall Study|Lack of Efficacy|15
7454983|NCT01777334|11747311|FG001|Overall Study|Lack of Efficacy|29
7454984|NCT01777334|11747310|FG000|Overall Study|Protocol Violation|3
7454985|NCT01777334|11747311|FG001|Overall Study|Protocol Violation|7
7454986|NCT01777334|11747310|FG000|Overall Study|Lost to Follow-up|3
7454987|NCT01777334|11747311|FG001|Overall Study|Lost to Follow-up|2
7454988|NCT01777334|11747310|FG000|Overall Study|Withdrawal by Subject|14
7454989|NCT01777334|11747311|FG001|Overall Study|Withdrawal by Subject|11
7454990|NCT01777490|11747339|FG000|Overall Study|Dyad withdrew with data use prohibition|0
7454991|NCT01777490|11747340|FG001|Overall Study|Dyad withdrew with data use prohibition|0
7454992|NCT01777490|11747341|FG002|Overall Study|Dyad withdrew with data use prohibition|1
7454993|NCT01777490|11747342|FG003|Overall Study|Dyad withdrew with data use prohibition|1
7454994|NCT01777542|11747354|FG000|Second Intervention (20 Weeks)|Adverse Event|0
7454995|NCT01777542|11747355|FG001|Second Intervention (20 Weeks)|Adverse Event|1
7454996|NCT01777581|11747373|FG000|Overall Study|Lost to Follow-up|1
7454997|NCT01777581|11747374|FG001|Overall Study|Lost to Follow-up|1
7454998|NCT01777581|11747373|FG000|Overall Study|Adverse Event|2
7454999|NCT01777581|11747374|FG001|Overall Study|Adverse Event|0
7455000|NCT01777581|11747373|FG000|Overall Study|Lack of Efficacy|0
7455001|NCT01777581|11747374|FG001|Overall Study|Lack of Efficacy|1
7455002|NCT01777620|11747382|FG000|Overall Study|Subject Withdrawal|1
7455003|NCT01777620|11747383|FG001|Overall Study|Subject Withdrawal|0
7455004|NCT01777763|11747391|FG000|Overall Study|Adverse Event|2
7455005|NCT01777763|11747392|FG001|Overall Study|Adverse Event|32
7455006|NCT01777763|11747391|FG000|Overall Study|Protocol Violation|1
7455007|NCT01777763|11747392|FG001|Overall Study|Protocol Violation|7
7455008|NCT01777763|11747391|FG000|Overall Study|Withdrawal by Subject|0
7455009|NCT01777763|11747392|FG001|Overall Study|Withdrawal by Subject|2
7455010|NCT01777763|11747391|FG000|Overall Study|Treatment Failure|1
7455011|NCT01777763|11747392|FG001|Overall Study|Treatment Failure|6
7455012|NCT01777776|11747402|FG000|Overall Study|Adverse Event|2
7455013|NCT01777776|11747403|FG001|Overall Study|Adverse Event|4
7455014|NCT01777776|11747404|FG002|Overall Study|Adverse Event|0
7455015|NCT01777776|11747405|FG003|Overall Study|Adverse Event|0
7455016|NCT01777776|11747402|FG000|Overall Study|Disease Progression|4
7455017|NCT01777776|11747403|FG001|Overall Study|Disease Progression|8
7455018|NCT01777776|11747404|FG002|Overall Study|Disease Progression|6
7455019|NCT01777776|11747405|FG003|Overall Study|Disease Progression|3
7455020|NCT01777776|11747402|FG000|Overall Study|Withdrawal by Subject|0
7455021|NCT01777776|11747403|FG001|Overall Study|Withdrawal by Subject|0
7455022|NCT01777776|11747404|FG002|Overall Study|Withdrawal by Subject|0
7455023|NCT01777776|11747405|FG003|Overall Study|Withdrawal by Subject|1
7455024|NCT01777932|11747424|FG000|Overall Study|Disease progression|136
7455025|NCT01777932|11747424|FG000|Overall Study|Death|3
7455026|NCT01777932|11747424|FG000|Overall Study|Adverse Event|34
7455027|NCT01777932|11747424|FG000|Overall Study|Lost to Follow-up|3
7455028|NCT01777932|11747424|FG000|Overall Study|Investigator decision|10
7455029|NCT01777932|11747424|FG000|Overall Study|Reimbursement limit|9
7455030|NCT01777932|11747424|FG000|Overall Study|Patient refused further treatment|10
7455031|NCT01777997|11747432|FG000|12 Week lead-in of no ART|Severe debilitation|2
7455032|NCT01777997|11747432|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
7455033|NCT01777997|11747432|FG000|Weeks 48 to 72/96 on ART|Death|1
7455034|NCT01777997|11747432|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
7455035|NCT01778010|11747436|FG000|Overall Study|Withdrawal by Subject|2
7455036|NCT01778010|11747436|FG000|Overall Study|abnormal ECG before meds|1
7455037|NCT01778010|11747436|FG000|Overall Study|Arrested|1
7455038|NCT01778010|11747436|FG000|Overall Study|rash while on placebo|1
7455039|NCT01778023|11747455|FG000|Overall Study|Withdrawal by Subject|0
7455040|NCT01778023|11747456|FG001|Overall Study|Withdrawal by Subject|3
7455041|NCT01778049|11747464|FG000|Open Label Treatment Period|Adverse Event|5
7455042|NCT01778049|11747465|FG001|Open Label Treatment Period|Adverse Event|15
7455043|NCT01778049|11747466|FG002|Open Label Treatment Period|Adverse Event|0
7455044|NCT01778049|11747467|FG003|Open Label Treatment Period|Adverse Event|0
7455045|NCT01778049|11747468|FG004|Open Label Treatment Period|Adverse Event|0
7455046|NCT01778049|11747469|FG005|Open Label Treatment Period|Adverse Event|0
7455047|NCT01778049|11747464|FG000|Open Label Treatment Period|Lack of Efficacy|1
7455048|NCT01778049|11747465|FG001|Open Label Treatment Period|Lack of Efficacy|1
7455049|NCT01778049|11747466|FG002|Open Label Treatment Period|Lack of Efficacy|0
7455050|NCT01778049|11747467|FG003|Open Label Treatment Period|Lack of Efficacy|0
7455051|NCT01778049|11747468|FG004|Open Label Treatment Period|Lack of Efficacy|0
7455052|NCT01778049|11747469|FG005|Open Label Treatment Period|Lack of Efficacy|0
7455053|NCT01778049|11747464|FG000|Open Label Treatment Period|Protocol Violation|5
7455054|NCT01778049|11747465|FG001|Open Label Treatment Period|Protocol Violation|5
7455055|NCT01778049|11747466|FG002|Open Label Treatment Period|Protocol Violation|0
7455056|NCT01778049|11747467|FG003|Open Label Treatment Period|Protocol Violation|0
7455057|NCT01778049|11747468|FG004|Open Label Treatment Period|Protocol Violation|0
7455058|NCT01778049|11747469|FG005|Open Label Treatment Period|Protocol Violation|0
7455059|NCT01778049|11747464|FG000|Open Label Treatment Period|Lost to Follow-up|4
7455060|NCT01778049|11747465|FG001|Open Label Treatment Period|Lost to Follow-up|3
7455061|NCT01778049|11747466|FG002|Open Label Treatment Period|Lost to Follow-up|0
7455062|NCT01778049|11747467|FG003|Open Label Treatment Period|Lost to Follow-up|0
7455063|NCT01778049|11747468|FG004|Open Label Treatment Period|Lost to Follow-up|0
7455064|NCT01778049|11747469|FG005|Open Label Treatment Period|Lost to Follow-up|0
7455065|NCT01778049|11747464|FG000|Open Label Treatment Period|Withdrawal by Subject|4
7455066|NCT01778049|11747465|FG001|Open Label Treatment Period|Withdrawal by Subject|10
7455067|NCT01778049|11747466|FG002|Open Label Treatment Period|Withdrawal by Subject|0
7455068|NCT01778049|11747467|FG003|Open Label Treatment Period|Withdrawal by Subject|0
7455069|NCT01778049|11747468|FG004|Open Label Treatment Period|Withdrawal by Subject|0
7455070|NCT01778049|11747469|FG005|Open Label Treatment Period|Withdrawal by Subject|0
7455071|NCT01778049|11747464|FG000|Open Label Treatment Period|Not treated|2
7455072|NCT01778049|11747465|FG001|Open Label Treatment Period|Not treated|1
7455073|NCT01778049|11747466|FG002|Open Label Treatment Period|Not treated|0
7455074|NCT01778049|11747467|FG003|Open Label Treatment Period|Not treated|0
7455075|NCT01778049|11747468|FG004|Open Label Treatment Period|Not treated|0
7455076|NCT01778049|11747469|FG005|Open Label Treatment Period|Not treated|0
7455077|NCT01778049|11747464|FG000|Open Label Treatment Period|Other reason not defined above|77
7455078|NCT01778049|11747465|FG001|Open Label Treatment Period|Other reason not defined above|94
7455079|NCT01778049|11747466|FG002|Open Label Treatment Period|Other reason not defined above|0
7455080|NCT01778049|11747467|FG003|Open Label Treatment Period|Other reason not defined above|0
7455081|NCT01778049|11747468|FG004|Open Label Treatment Period|Other reason not defined above|0
7455082|NCT01778049|11747469|FG005|Open Label Treatment Period|Other reason not defined above|0
7455083|NCT01778049|11747464|FG000|Double Blind Treatment Period|Adverse Event|0
7455084|NCT01778049|11747465|FG001|Double Blind Treatment Period|Adverse Event|0
7455085|NCT01778049|11747466|FG002|Double Blind Treatment Period|Adverse Event|4
7455086|NCT01778049|11747467|FG003|Double Blind Treatment Period|Adverse Event|5
7455087|NCT01778049|11747468|FG004|Double Blind Treatment Period|Adverse Event|3
7455088|NCT01778049|11747469|FG005|Double Blind Treatment Period|Adverse Event|2
7455089|NCT01778049|11747464|FG000|Double Blind Treatment Period|Lack of Efficacy|0
7455090|NCT01778049|11747465|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7455091|NCT01778049|11747466|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7455092|NCT01778049|11747467|FG003|Double Blind Treatment Period|Lack of Efficacy|0
7455093|NCT01778049|11747468|FG004|Double Blind Treatment Period|Lack of Efficacy|0
7455094|NCT01778049|11747469|FG005|Double Blind Treatment Period|Lack of Efficacy|1
7455095|NCT01778049|11747464|FG000|Double Blind Treatment Period|Protocol Violation|0
7455096|NCT01778049|11747465|FG001|Double Blind Treatment Period|Protocol Violation|0
7455097|NCT01778049|11747466|FG002|Double Blind Treatment Period|Protocol Violation|2
7455098|NCT01778049|11747467|FG003|Double Blind Treatment Period|Protocol Violation|0
7455099|NCT01778049|11747468|FG004|Double Blind Treatment Period|Protocol Violation|0
7455100|NCT01778049|11747469|FG005|Double Blind Treatment Period|Protocol Violation|0
7455101|NCT01778049|11747464|FG000|Double Blind Treatment Period|Lost to Follow-up|0
7455102|NCT01778049|11747465|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7533021|NCT02679729|11879031|FG005|Overall Study|Lost to Follow-up|0
7455103|NCT01778049|11747466|FG002|Double Blind Treatment Period|Lost to Follow-up|4
7455104|NCT01778049|11747467|FG003|Double Blind Treatment Period|Lost to Follow-up|1
7455105|NCT01778049|11747468|FG004|Double Blind Treatment Period|Lost to Follow-up|5
7455106|NCT01778049|11747469|FG005|Double Blind Treatment Period|Lost to Follow-up|2
7455107|NCT01778049|11747464|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
7455108|NCT01778049|11747465|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
7455109|NCT01778049|11747466|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
7455110|NCT01778049|11747467|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
7455111|NCT01778049|11747468|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
7455112|NCT01778049|11747469|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
7455113|NCT01778049|11747464|FG000|Double Blind Treatment Period|Not treated|0
7455114|NCT01778049|11747465|FG001|Double Blind Treatment Period|Not treated|0
7455115|NCT01778049|11747466|FG002|Double Blind Treatment Period|Not treated|0
7455116|NCT01778049|11747467|FG003|Double Blind Treatment Period|Not treated|2
7455117|NCT01778049|11747468|FG004|Double Blind Treatment Period|Not treated|2
7455118|NCT01778049|11747469|FG005|Double Blind Treatment Period|Not treated|0
7455119|NCT01778049|11747464|FG000|Double Blind Treatment Period|Other reason not defined above|0
7455120|NCT01778049|11747465|FG001|Double Blind Treatment Period|Other reason not defined above|0
7455121|NCT01778049|11747466|FG002|Double Blind Treatment Period|Other reason not defined above|4
7455122|NCT01778049|11747467|FG003|Double Blind Treatment Period|Other reason not defined above|2
7455123|NCT01778049|11747468|FG004|Double Blind Treatment Period|Other reason not defined above|2
7455124|NCT01778049|11747469|FG005|Double Blind Treatment Period|Other reason not defined above|1
7455125|NCT01778062|11747483|FG000|Overall Study|Adverse Event|1
7455126|NCT01778062|11747484|FG001|Overall Study|Adverse Event|3
7455127|NCT01778062|11747483|FG000|Overall Study|Consent Withdrawal|1
7455128|NCT01778062|11747484|FG001|Overall Study|Consent Withdrawal|5
7455129|NCT01778062|11747483|FG000|Overall Study|major protocol deviation|4
7455130|NCT01778062|11747484|FG001|Overall Study|major protocol deviation|3
7455131|NCT01778127|11747493|FG000|Overall Study|Lost to Follow-up|5
7455132|NCT01778127|11747494|FG001|Overall Study|Lost to Follow-up|1
7455133|NCT01778127|11747495|FG002|Overall Study|Lost to Follow-up|2
7455134|NCT01778127|11747493|FG000|Overall Study|Withdrawal by Subject|3
7455135|NCT01778127|11747494|FG001|Overall Study|Withdrawal by Subject|1
7455136|NCT01778127|11747495|FG002|Overall Study|Withdrawal by Subject|4
7455137|NCT01778530|11747538|FG000|Overall Study|Progression on study|1
7455138|NCT01778530|11747538|FG000|Overall Study|Adverse event/side effect|1
7455139|NCT01778556|11747544|FG000|Intervention 1 (5 Days)|Protocol Violation|0
7455140|NCT01778556|11747545|FG001|Intervention 1 (5 Days)|Protocol Violation|1
7455141|NCT01778556|11747544|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7455142|NCT01778556|11747545|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
7455143|NCT01778556|11747544|FG000|Intervention 2 (14 Days)|Protocol Violation|1
7455144|NCT01778556|11747545|FG001|Intervention 2 (14 Days)|Protocol Violation|0
7455145|NCT01778556|11747544|FG000|Long-term Follow-up|noncompliance with metreleptin|1
7455146|NCT01778556|11747545|FG001|Long-term Follow-up|noncompliance with metreleptin|0
7455147|NCT01778751|11747566|FG000|Overall Study|Lost to Follow-up|1
7455148|NCT01778751|11747567|FG001|Overall Study|Lost to Follow-up|0
7455149|NCT01778751|11747566|FG000|Overall Study|Withdrawal by Subject|0
7455150|NCT01778751|11747567|FG001|Overall Study|Withdrawal by Subject|2
7455151|NCT01778751|11747566|FG000|Overall Study|Transfered care|1
7455152|NCT01778751|11747567|FG001|Overall Study|Transfered care|0
7455153|NCT01778855|11747575|FG000|Overall Study|Death|0
7455154|NCT01778855|11747576|FG001|Overall Study|Death|1
7455155|NCT01778985|11747584|FG000|Overall Study|Lost to Follow-up|1
7455156|NCT01778985|11747585|FG001|Overall Study|Lost to Follow-up|0
7455157|NCT01778985|11747584|FG000|Overall Study|Physician Decision|2
7455158|NCT01778985|11747585|FG001|Overall Study|Physician Decision|2
7455159|NCT01778985|11747584|FG000|Overall Study|Protocol Violation|4
7455160|NCT01778985|11747585|FG001|Overall Study|Protocol Violation|1
7455161|NCT01779440|11747628|FG000|Overall Study|Withdrawal by Subject|3
7455162|NCT01779440|11747629|FG001|Overall Study|Withdrawal by Subject|5
7455163|NCT01779648|11747637|FG000|Overall Study|Protocol Violation|1
7455164|NCT01779648|11747638|FG001|Overall Study|Protocol Violation|0
7455165|NCT01779700|11747646|FG000|Overall Study|Adverse Event|4
7455166|NCT01779700|11747647|FG001|Overall Study|Adverse Event|3
7455167|NCT01779700|11747646|FG000|Overall Study|Withdrawal by Subject|0
7455168|NCT01779700|11747647|FG001|Overall Study|Withdrawal by Subject|2
7455169|NCT01779856|11747653|FG000|Overall Study|Withdrawal by Subject|15
7455170|NCT01779856|11747653|FG000|Overall Study|Death|3
7455171|NCT01779856|11747653|FG000|Overall Study|Physician Decision|1
7455172|NCT01779856|11747653|FG000|Overall Study|Inclusion/Exclusion Not Met|2
7455173|NCT01779856|11747653|FG000|Overall Study|Delays in scheduling implant|1
7455174|NCT01779856|11747653|FG000|Overall Study|Subject ineligible for Implant|2
7533022|NCT02679729|11879032|FG006|Overall Study|Lost to Follow-up|0
7455175|NCT01779869|11747664|FG000|Overall Study|Physician Decision|2
7455176|NCT01780389|11747690|FG000|Overall Study|Adverse Event|1
7455177|NCT01780506|11747701|FG000|Double-Blind Phase|Randomized but not Treated|3
7455178|NCT01780506|11747702|FG001|Double-Blind Phase|Randomized but not Treated|2
7455179|NCT01780506|11747701|FG000|Double-Blind Phase|Adverse Event|4
7455180|NCT01780506|11747702|FG001|Double-Blind Phase|Adverse Event|14
7455181|NCT01780506|11747701|FG000|Double-Blind Phase|Death|1
7455182|NCT01780506|11747702|FG001|Double-Blind Phase|Death|2
7455183|NCT01780506|11747701|FG000|Double-Blind Phase|Pregnancy|2
7455184|NCT01780506|11747702|FG001|Double-Blind Phase|Pregnancy|1
7455185|NCT01780506|11747701|FG000|Double-Blind Phase|Lack of Efficacy|1
7455186|NCT01780506|11747702|FG001|Double-Blind Phase|Lack of Efficacy|1
7455187|NCT01780506|11747701|FG000|Double-Blind Phase|Investigator's Discretion|5
7455188|NCT01780506|11747702|FG001|Double-Blind Phase|Investigator's Discretion|2
7455189|NCT01780506|11747701|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
7455190|NCT01780506|11747702|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
7455191|NCT01780506|11747701|FG000|Double-Blind Phase|Protocol Violation|4
7455192|NCT01780506|11747702|FG001|Double-Blind Phase|Protocol Violation|3
7455193|NCT01780506|11747701|FG000|Double-Blind Phase|Withdrew Consent|23
7455194|NCT01780506|11747702|FG001|Double-Blind Phase|Withdrew Consent|24
7455195|NCT01780506|11747701|FG000|Double-Blind Phase|Lost to Follow-up|23
7455196|NCT01780506|11747702|FG001|Double-Blind Phase|Lost to Follow-up|26
7455197|NCT01780506|11747701|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
7455198|NCT01780506|11747702|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
7564247|NCT03284710|11934992|FG003|Overall Study|Lost to Follow-up|0
7564248|NCT03284710|11934989|FG000|Overall Study|Physician Decision|1
7564249|NCT03284710|11934990|FG001|Overall Study|Physician Decision|0
7564250|NCT03284710|11934991|FG002|Overall Study|Physician Decision|0
7455203|NCT01780584|11747725|FG000|Overall Study|Death|1
7455204|NCT01780584|11747726|FG001|Overall Study|Death|0
7455205|NCT01780584|11747727|FG002|Overall Study|Death|1
7455206|NCT01780584|11747725|FG000|Overall Study|Adverse Event|0
7455207|NCT01780584|11747726|FG001|Overall Study|Adverse Event|1
7455208|NCT01780584|11747727|FG002|Overall Study|Adverse Event|0
7455209|NCT01780584|11747725|FG000|Overall Study|Protocol Violation|0
7455210|NCT01780584|11747726|FG001|Overall Study|Protocol Violation|0
7455211|NCT01780584|11747727|FG002|Overall Study|Protocol Violation|1
7455212|NCT01780662|11747738|FG000|Overall Study|Adverse Event|1
7455213|NCT01780662|11747739|FG001|Overall Study|Adverse Event|0
7455214|NCT01780662|11747740|FG002|Overall Study|Adverse Event|2
7455215|NCT01780662|11747738|FG000|Overall Study|Physician Decision|0
7455216|NCT01780662|11747739|FG001|Overall Study|Physician Decision|5
7455217|NCT01780662|11747740|FG002|Overall Study|Physician Decision|7
7455218|NCT01780662|11747738|FG000|Overall Study|Protocol Violation|0
7455219|NCT01780662|11747739|FG001|Overall Study|Protocol Violation|1
7455220|NCT01780662|11747740|FG002|Overall Study|Protocol Violation|0
7455221|NCT01780662|11747738|FG000|Overall Study|Ineligible|0
7455222|NCT01780662|11747739|FG001|Overall Study|Ineligible|0
7455223|NCT01780662|11747740|FG002|Overall Study|Ineligible|1
7455224|NCT01780831|11747753|FG000|Overall Study|Withdrawal by Subject|0
7455225|NCT01780831|11747754|FG001|Overall Study|Withdrawal by Subject|0
7455226|NCT01780831|11747755|FG002|Overall Study|Withdrawal by Subject|4
7455227|NCT01780831|11747756|FG003|Overall Study|Withdrawal by Subject|0
7455228|NCT01780831|11747753|FG000|Overall Study|Lost to Follow-up|0
7455229|NCT01780831|11747754|FG001|Overall Study|Lost to Follow-up|0
7455230|NCT01780831|11747755|FG002|Overall Study|Lost to Follow-up|0
7455231|NCT01780831|11747756|FG003|Overall Study|Lost to Follow-up|1
7455232|NCT01780935|11747837|FG000|Overall Study|Admin problems due to early termination|321
7455233|NCT01780935|11747838|FG001|Overall Study|Admin problems due to early termination|309
7455234|NCT01780935|11747837|FG000|Overall Study|Adverse Event|2
7455235|NCT01780935|11747838|FG001|Overall Study|Adverse Event|4
7455236|NCT01780935|11747837|FG000|Overall Study|Death|1
7455237|NCT01780935|11747838|FG001|Overall Study|Death|6
7455238|NCT01780935|11747837|FG000|Overall Study|Lost to Follow-up|2
7455239|NCT01780935|11747838|FG001|Overall Study|Lost to Follow-up|6
7455240|NCT01780935|11747837|FG000|Overall Study|Physician Decision|1
7455241|NCT01780935|11747838|FG001|Overall Study|Physician Decision|1
7455242|NCT01780935|11747837|FG000|Overall Study|Protocol deviation|0
7455243|NCT01780935|11747838|FG001|Overall Study|Protocol deviation|1
7455244|NCT01780935|11747837|FG000|Overall Study|Patient withdrew consent|8
7455245|NCT01780935|11747838|FG001|Overall Study|Patient withdrew consent|9
7455246|NCT01780974|11747846|FG000|Overall Study|Death|1
7455247|NCT01780974|11747847|FG001|Overall Study|Death|0
7455248|NCT01780974|11747846|FG000|Overall Study|Adverse Event|1
7455249|NCT01780974|11747847|FG001|Overall Study|Adverse Event|3
7455250|NCT01780987|11747855|FG000|Overall Study|Adverse Event|0
7455251|NCT01780987|11747856|FG001|Overall Study|Adverse Event|4
7455252|NCT01780987|11747855|FG000|Overall Study|Withdrawal by Subject|2
7455253|NCT01780987|11747856|FG001|Overall Study|Withdrawal by Subject|0
7455254|NCT01780987|11747855|FG000|Overall Study|Request of Changing Hospital|0
7455255|NCT01780987|11747856|FG001|Overall Study|Request of Changing Hospital|1
7455256|NCT01780987|11747855|FG000|Overall Study|Changing Residence|1
7455257|NCT01780987|11747856|FG001|Overall Study|Changing Residence|0
7455258|NCT01780987|11747855|FG000|Overall Study|Not Receiving any Study Medication|0
7455259|NCT01780987|11747856|FG001|Overall Study|Not Receiving any Study Medication|1
7455260|NCT01781234|11747891|FG000|Overall Study|Adverse Event|2
7455261|NCT01781234|11747892|FG001|Overall Study|Adverse Event|0
7455262|NCT01781234|11747891|FG000|Overall Study|Protocol Violation|3
7455263|NCT01781234|11747892|FG001|Overall Study|Protocol Violation|0
7455264|NCT01781234|11747891|FG000|Overall Study|Withdrawal by Subject|4
7455265|NCT01781234|11747892|FG001|Overall Study|Withdrawal by Subject|3
7455266|NCT01781286|11747900|FG000|Overall Study|Lost to Follow-up|0
7455267|NCT01781286|11747901|FG001|Overall Study|Lost to Follow-up|0
7455268|NCT01781286|11747902|FG002|Overall Study|Lost to Follow-up|0
7455269|NCT01781286|11747903|FG003|Overall Study|Lost to Follow-up|0
7455270|NCT01781286|11747904|FG004|Overall Study|Lost to Follow-up|0
7455271|NCT01781286|11747905|FG005|Overall Study|Lost to Follow-up|1
7455272|NCT01781286|11747900|FG000|Overall Study|Time Constraints|2
7455273|NCT01781286|11747901|FG001|Overall Study|Time Constraints|0
7455274|NCT01781286|11747902|FG002|Overall Study|Time Constraints|2
7455275|NCT01781286|11747903|FG003|Overall Study|Time Constraints|0
7455276|NCT01781286|11747904|FG004|Overall Study|Time Constraints|0
7455277|NCT01781286|11747905|FG005|Overall Study|Time Constraints|0
7455278|NCT01781286|11747900|FG000|Overall Study|Noncompliance|0
7455279|NCT01781286|11747901|FG001|Overall Study|Noncompliance|0
7455280|NCT01781286|11747902|FG002|Overall Study|Noncompliance|0
7455281|NCT01781286|11747903|FG003|Overall Study|Noncompliance|1
7455282|NCT01781286|11747904|FG004|Overall Study|Noncompliance|0
7455283|NCT01781286|11747905|FG005|Overall Study|Noncompliance|0
7455284|NCT01781299|11747917|FG000|Overall Study|Withdrawal by Subject|0
7455285|NCT01781299|11747918|FG001|Overall Study|Withdrawal by Subject|1
7455286|NCT01781429|11747951|FG000|Overall Study|Death|0
7455287|NCT01781429|11747952|FG001|Overall Study|Death|0
7455288|NCT01781429|11747953|FG002|Overall Study|Death|0
7455289|NCT01781429|11747954|FG003|Overall Study|Death|0
7455290|NCT01781429|11747955|FG004|Overall Study|Death|0
7455291|NCT01781429|11747956|FG005|Overall Study|Death|0
7455292|NCT01781429|11747957|FG006|Overall Study|Death|0
7455293|NCT01781429|11747958|FG007|Overall Study|Death|0
7455294|NCT01781429|11747959|FG008|Overall Study|Death|0
7455295|NCT01781429|11747960|FG009|Overall Study|Death|1
7455296|NCT01781429|11747961|FG010|Overall Study|Death|0
7455297|NCT01781429|11747962|FG011|Overall Study|Death|0
7455298|NCT01781429|11747963|FG012|Overall Study|Death|1
7455299|NCT01781429|11747964|FG013|Overall Study|Death|0
7455300|NCT01781429|11747965|FG014|Overall Study|Death|1
7455301|NCT01781429|11747966|FG015|Overall Study|Death|0
7455302|NCT01781429|11747951|FG000|Overall Study|Withdrawal by Subject|0
7455303|NCT01781429|11747952|FG001|Overall Study|Withdrawal by Subject|0
7455304|NCT01781429|11747953|FG002|Overall Study|Withdrawal by Subject|0
7455305|NCT01781429|11747954|FG003|Overall Study|Withdrawal by Subject|0
7455306|NCT01781429|11747955|FG004|Overall Study|Withdrawal by Subject|0
7455307|NCT01781429|11747956|FG005|Overall Study|Withdrawal by Subject|0
7455308|NCT01781429|11747957|FG006|Overall Study|Withdrawal by Subject|0
7455309|NCT01781429|11747958|FG007|Overall Study|Withdrawal by Subject|0
7455310|NCT01781429|11747959|FG008|Overall Study|Withdrawal by Subject|1
7455311|NCT01781429|11747960|FG009|Overall Study|Withdrawal by Subject|3
7455312|NCT01781429|11747961|FG010|Overall Study|Withdrawal by Subject|1
7455313|NCT01781429|11747962|FG011|Overall Study|Withdrawal by Subject|1
7455314|NCT01781429|11747963|FG012|Overall Study|Withdrawal by Subject|5
7455315|NCT01781429|11747964|FG013|Overall Study|Withdrawal by Subject|2
7455316|NCT01781429|11747965|FG014|Overall Study|Withdrawal by Subject|3
7455317|NCT01781429|11747966|FG015|Overall Study|Withdrawal by Subject|0
7455318|NCT01781429|11747951|FG000|Overall Study|Disease Progression|1
7455319|NCT01781429|11747952|FG001|Overall Study|Disease Progression|0
7455320|NCT01781429|11747953|FG002|Overall Study|Disease Progression|1
7455321|NCT01781429|11747954|FG003|Overall Study|Disease Progression|1
7455322|NCT01781429|11747955|FG004|Overall Study|Disease Progression|1
7455323|NCT01781429|11747956|FG005|Overall Study|Disease Progression|4
7455324|NCT01781429|11747957|FG006|Overall Study|Disease Progression|7
7455325|NCT01781429|11747958|FG007|Overall Study|Disease Progression|4
7455326|NCT01781429|11747959|FG008|Overall Study|Disease Progression|6
7455327|NCT01781429|11747960|FG009|Overall Study|Disease Progression|15
7455328|NCT01781429|11747961|FG010|Overall Study|Disease Progression|15
7455329|NCT01781429|11747962|FG011|Overall Study|Disease Progression|15
7455330|NCT01781429|11747963|FG012|Overall Study|Disease Progression|15
7455331|NCT01781429|11747964|FG013|Overall Study|Disease Progression|4
7455332|NCT01781429|11747965|FG014|Overall Study|Disease Progression|11
7455333|NCT01781429|11747966|FG015|Overall Study|Disease Progression|0
7455334|NCT01781429|11747951|FG000|Overall Study|Unacceptable Toxicity|0
7455335|NCT01781429|11747952|FG001|Overall Study|Unacceptable Toxicity|0
7455336|NCT01781429|11747953|FG002|Overall Study|Unacceptable Toxicity|0
7455337|NCT01781429|11747954|FG003|Overall Study|Unacceptable Toxicity|0
7455338|NCT01781429|11747955|FG004|Overall Study|Unacceptable Toxicity|0
7455339|NCT01781429|11747956|FG005|Overall Study|Unacceptable Toxicity|0
7455340|NCT01781429|11747957|FG006|Overall Study|Unacceptable Toxicity|0
7455341|NCT01781429|11747958|FG007|Overall Study|Unacceptable Toxicity|0
7455342|NCT01781429|11747959|FG008|Overall Study|Unacceptable Toxicity|0
7455343|NCT01781429|11747960|FG009|Overall Study|Unacceptable Toxicity|0
7455344|NCT01781429|11747961|FG010|Overall Study|Unacceptable Toxicity|0
7455345|NCT01781429|11747962|FG011|Overall Study|Unacceptable Toxicity|2
7455346|NCT01781429|11747963|FG012|Overall Study|Unacceptable Toxicity|0
7455347|NCT01781429|11747964|FG013|Overall Study|Unacceptable Toxicity|0
7455348|NCT01781429|11747965|FG014|Overall Study|Unacceptable Toxicity|0
7455349|NCT01781429|11747966|FG015|Overall Study|Unacceptable Toxicity|0
7455350|NCT01781429|11747951|FG000|Overall Study|Patient Condition Changed|0
7455351|NCT01781429|11747952|FG001|Overall Study|Patient Condition Changed|0
7455352|NCT01781429|11747953|FG002|Overall Study|Patient Condition Changed|0
7455353|NCT01781429|11747954|FG003|Overall Study|Patient Condition Changed|0
7455354|NCT01781429|11747955|FG004|Overall Study|Patient Condition Changed|0
7455355|NCT01781429|11747956|FG005|Overall Study|Patient Condition Changed|0
7455356|NCT01781429|11747957|FG006|Overall Study|Patient Condition Changed|0
7455357|NCT01781429|11747958|FG007|Overall Study|Patient Condition Changed|0
7455358|NCT01781429|11747959|FG008|Overall Study|Patient Condition Changed|0
7455359|NCT01781429|11747960|FG009|Overall Study|Patient Condition Changed|4
7455360|NCT01781429|11747961|FG010|Overall Study|Patient Condition Changed|0
7455361|NCT01781429|11747962|FG011|Overall Study|Patient Condition Changed|1
7455362|NCT01781429|11747963|FG012|Overall Study|Patient Condition Changed|0
7455363|NCT01781429|11747964|FG013|Overall Study|Patient Condition Changed|1
7455364|NCT01781429|11747965|FG014|Overall Study|Patient Condition Changed|0
7455365|NCT01781429|11747966|FG015|Overall Study|Patient Condition Changed|0
7455366|NCT01781429|11747951|FG000|Overall Study|Other - as entered by PI in eCRF|0
7455367|NCT01781429|11747952|FG001|Overall Study|Other - as entered by PI in eCRF|1
7455368|NCT01781429|11747953|FG002|Overall Study|Other - as entered by PI in eCRF|0
7455369|NCT01781429|11747954|FG003|Overall Study|Other - as entered by PI in eCRF|0
7455370|NCT01781429|11747955|FG004|Overall Study|Other - as entered by PI in eCRF|0
7455371|NCT01781429|11747956|FG005|Overall Study|Other - as entered by PI in eCRF|0
7455372|NCT01781429|11747957|FG006|Overall Study|Other - as entered by PI in eCRF|0
7455373|NCT01781429|11747958|FG007|Overall Study|Other - as entered by PI in eCRF|0
7455374|NCT01781429|11747959|FG008|Overall Study|Other - as entered by PI in eCRF|0
7455375|NCT01781429|11747960|FG009|Overall Study|Other - as entered by PI in eCRF|1
7455376|NCT01781429|11747961|FG010|Overall Study|Other - as entered by PI in eCRF|1
7455377|NCT01781429|11747962|FG011|Overall Study|Other - as entered by PI in eCRF|2
7564251|NCT03284710|11934992|FG003|Overall Study|Physician Decision|0
7564252|NCT03284710|11934989|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7564253|NCT03284710|11934990|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7564254|NCT03284710|11934991|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7564255|NCT03284710|11934992|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7564256|NCT03284710|11934989|FG000|Overall Study|HIV Infection|0
7564257|NCT03284710|11934990|FG001|Overall Study|HIV Infection|2
7564258|NCT03284710|11934991|FG002|Overall Study|HIV Infection|2
7564259|NCT03284710|11934992|FG003|Overall Study|HIV Infection|1
7564260|NCT03285113|11935016|FG000|Overall Study|Unable to implant leads|2
7564261|NCT03285295|11935025|FG000|Alinity s HBsAg|Protocol Violation|11
7564262|NCT03285295|11935026|FG001|Alinity s HBsAg|Protocol Violation|0
7564263|NCT03285295|11935027|FG002|Alinity s HBsAg|Protocol Violation|0
7564264|NCT03285295|11935028|FG003|Alinity s HBsAg|Protocol Violation|0
7564265|NCT03285295|11935029|FG004|Alinity s HBsAg|Protocol Violation|0
7564266|NCT03285295|11935025|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
7564267|NCT03285295|11935026|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
7564268|NCT03285295|11935027|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
7564269|NCT03285295|11935028|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
7564270|NCT03285295|11935029|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
7564271|NCT03285295|11935025|FG000|Alinity s HBsAg|No Results Generated|74
7564272|NCT03285295|11935026|FG001|Alinity s HBsAg|No Results Generated|6
7455378|NCT01781429|11747963|FG012|Overall Study|Other - as entered by PI in eCRF|1
7455379|NCT01781429|11747964|FG013|Overall Study|Other - as entered by PI in eCRF|1
7455380|NCT01781429|11747965|FG014|Overall Study|Other - as entered by PI in eCRF|1
7455381|NCT01781429|11747966|FG015|Overall Study|Other - as entered by PI in eCRF|0
7455382|NCT01781429|11747951|FG000|Overall Study|Enrolled, but not treated|0
7455383|NCT01781429|11747952|FG001|Overall Study|Enrolled, but not treated|0
7455384|NCT01781429|11747953|FG002|Overall Study|Enrolled, but not treated|0
7455385|NCT01781429|11747954|FG003|Overall Study|Enrolled, but not treated|0
7455386|NCT01781429|11747955|FG004|Overall Study|Enrolled, but not treated|0
7455387|NCT01781429|11747956|FG005|Overall Study|Enrolled, but not treated|0
7455388|NCT01781429|11747957|FG006|Overall Study|Enrolled, but not treated|0
7455389|NCT01781429|11747958|FG007|Overall Study|Enrolled, but not treated|0
7455390|NCT01781429|11747959|FG008|Overall Study|Enrolled, but not treated|0
7564273|NCT03285295|11935027|FG002|Alinity s HBsAg|No Results Generated|0
7564274|NCT03285295|11935028|FG003|Alinity s HBsAg|No Results Generated|0
7564275|NCT03285295|11935029|FG004|Alinity s HBsAg|No Results Generated|0
7564276|NCT03285295|11935025|FG000|Alinity s HTLV I/II|Protocol Violation|6
7564277|NCT03285295|11935026|FG001|Alinity s HTLV I/II|Protocol Violation|0
7564278|NCT03285295|11935027|FG002|Alinity s HTLV I/II|Protocol Violation|0
7564279|NCT03285295|11935028|FG003|Alinity s HTLV I/II|Protocol Violation|0
7455391|NCT01781429|11747960|FG009|Overall Study|Enrolled, but not treated|0
7455392|NCT01781429|11747961|FG010|Overall Study|Enrolled, but not treated|1
7455393|NCT01781429|11747962|FG011|Overall Study|Enrolled, but not treated|0
7455394|NCT01781429|11747963|FG012|Overall Study|Enrolled, but not treated|0
7455395|NCT01781429|11747964|FG013|Overall Study|Enrolled, but not treated|0
7455396|NCT01781429|11747965|FG014|Overall Study|Enrolled, but not treated|0
7455397|NCT01781429|11747966|FG015|Overall Study|Enrolled, but not treated|0
7455398|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
7455399|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
7455400|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
7455401|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
7455402|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
7455403|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
7455404|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
7564280|NCT03285295|11935029|FG004|Alinity s HTLV I/II|Protocol Violation|0
7564281|NCT03285295|11935025|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
7564282|NCT03285295|11935026|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
7455405|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
7455406|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
7455407|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7455408|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
7455409|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
7455410|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
7455411|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
7455412|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
7455413|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
7455414|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7455415|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
7455416|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
7455417|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7455418|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
7455419|NCT01781572|11748069|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
7455420|NCT01781572|11748070|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7455421|NCT01781572|11748071|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
7455422|NCT01781572|11748069|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
7455423|NCT01781572|11748070|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
7455424|NCT01781572|11748071|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
7455425|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7455426|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
7455427|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
7455428|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
7455429|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
7455430|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
7455431|NCT01781572|11748069|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
7455432|NCT01781572|11748070|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
7455433|NCT01781572|11748071|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
7455434|NCT01781572|11748069|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
7455435|NCT01781572|11748070|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
7455436|NCT01781572|11748071|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
7455437|NCT01781572|11748069|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
7455438|NCT01781572|11748070|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
7564283|NCT03285295|11935027|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
7564284|NCT03285295|11935028|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
7564285|NCT03285295|11935029|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
7564286|NCT03285295|11935025|FG000|Alinity s HTLV I/II|No Results Generated|70
7564287|NCT03285295|11935026|FG001|Alinity s HTLV I/II|No Results Generated|0
7564288|NCT03285295|11935027|FG002|Alinity s HTLV I/II|No Results Generated|0
7564289|NCT03285295|11935028|FG003|Alinity s HTLV I/II|No Results Generated|0
7564290|NCT03285295|11935029|FG004|Alinity s HTLV I/II|No Results Generated|0
7564291|NCT03285295|11935025|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
7564292|NCT03285295|11935026|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7564293|NCT03285295|11935027|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7564294|NCT03285295|11935028|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7564295|NCT03285295|11935029|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
7564296|NCT03285295|11935025|FG000|Alinity s Anti-HCV|Protocol Violation|12
7564297|NCT03285295|11935026|FG001|Alinity s Anti-HCV|Protocol Violation|0
7564298|NCT03285295|11935027|FG002|Alinity s Anti-HCV|Protocol Violation|0
7564299|NCT03285295|11935028|FG003|Alinity s Anti-HCV|Protocol Violation|0
7564300|NCT03285295|11935029|FG004|Alinity s Anti-HCV|Protocol Violation|0
7564301|NCT03285295|11935025|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
7564302|NCT03285295|11935026|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
7564303|NCT03285295|11935027|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
7564304|NCT03285295|11935028|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
7564305|NCT03285295|11935029|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
7564306|NCT03285295|11935025|FG000|Alinity s Anti-HCV|No Results Generated|71
7564307|NCT03285295|11935026|FG001|Alinity s Anti-HCV|No Results Generated|0
7564308|NCT03285295|11935027|FG002|Alinity s Anti-HCV|No Results Generated|0
7564309|NCT03285295|11935028|FG003|Alinity s Anti-HCV|No Results Generated|0
7564310|NCT03285295|11935029|FG004|Alinity s Anti-HCV|No Results Generated|0
7564311|NCT03285295|11935025|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
7564312|NCT03285295|11935026|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7564313|NCT03285295|11935027|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7564314|NCT03285295|11935028|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7564315|NCT03285295|11935029|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
7564316|NCT03285295|11935025|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
7564317|NCT03285295|11935026|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7564318|NCT03285295|11935027|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7564319|NCT03285295|11935028|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7564320|NCT03285295|11935029|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
7564321|NCT03285295|11935025|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
7564322|NCT03285295|11935026|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7564323|NCT03285295|11935027|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7455439|NCT01781572|11748071|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
7455440|NCT01781572|11748069|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
7455441|NCT01781572|11748070|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
7455442|NCT01781572|11748071|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
7455557|NCT01782495|11748214|FG006|Overall Study|Withdrew Consent|0
7455443|NCT01781572|11748069|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
7455444|NCT01781572|11748070|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
7455445|NCT01781572|11748071|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
7455446|NCT01781572|11748069|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
7455447|NCT01781572|11748070|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
7455448|NCT01781572|11748071|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
7455449|NCT01781572|11748069|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
7455450|NCT01781572|11748070|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
7455451|NCT01781572|11748071|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
7455452|NCT01781611|11748102|FG000|Overall Study|Adverse Event|4
7455453|NCT01781611|11748103|FG001|Overall Study|Adverse Event|0
7455454|NCT01781832|11748119|FG000|Overall Study|Withdrawal by Subject|1
7455455|NCT01781962|11748123|FG000|Overall Study|Other Miscellaneous Reasons|5
7455456|NCT01781975|11748129|FG000|Overall Study|Death|1
7455457|NCT01781975|11748130|FG001|Overall Study|Death|0
7455458|NCT01781975|11748129|FG000|Overall Study|Withdrawal by Subject|1
7455459|NCT01781975|11748130|FG001|Overall Study|Withdrawal by Subject|1
7455460|NCT01782131|11748138|FG000|Overall Study|Death|93
7455461|NCT01782131|11748139|FG001|Overall Study|Death|96
7455462|NCT01782131|11748138|FG000|Overall Study|Lost to Follow-up|1
7455463|NCT01782131|11748139|FG001|Overall Study|Lost to Follow-up|3
7455464|NCT01782131|11748138|FG000|Overall Study|Withdrawal by Subject|10
7455465|NCT01782131|11748139|FG001|Overall Study|Withdrawal by Subject|10
7455466|NCT01782131|11748138|FG000|Overall Study|Randomized but not treated|5
7455467|NCT01782131|11748139|FG001|Overall Study|Randomized but not treated|5
7455468|NCT01782131|11748138|FG000|Overall Study|Reason not provided|0
7455469|NCT01782131|11748139|FG001|Overall Study|Reason not provided|1
7455470|NCT01782222|11748152|FG000|Overall Study|Adverse Event|4
7455471|NCT01782222|11748153|FG001|Overall Study|Adverse Event|5
7455472|NCT01782222|11748154|FG002|Overall Study|Adverse Event|3
7455473|NCT01782222|11748152|FG000|Overall Study|Lack of Efficacy|2
7455474|NCT01782222|11748153|FG001|Overall Study|Lack of Efficacy|1
7455475|NCT01782222|11748154|FG002|Overall Study|Lack of Efficacy|0
7455476|NCT01782222|11748152|FG000|Overall Study|Protocol Violation|1
7455477|NCT01782222|11748153|FG001|Overall Study|Protocol Violation|0
7455478|NCT01782222|11748154|FG002|Overall Study|Protocol Violation|0
7455479|NCT01782222|11748152|FG000|Overall Study|Withdrawal by Subject|1
7455480|NCT01782222|11748153|FG001|Overall Study|Withdrawal by Subject|4
7455481|NCT01782222|11748154|FG002|Overall Study|Withdrawal by Subject|1
7455482|NCT01782222|11748152|FG000|Overall Study|Moved to other state|0
7455483|NCT01782222|11748153|FG001|Overall Study|Moved to other state|1
7455484|NCT01782222|11748154|FG002|Overall Study|Moved to other state|0
7455485|NCT01782313|11748162|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
7455486|NCT01782313|11748162|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
7455487|NCT01782313|11748162|FG000|Treated Cycle 3|Progressive Disease|21
7455488|NCT01782313|11748162|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
7455489|NCT01782313|11748162|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
7455490|NCT01782313|11748162|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
7455491|NCT01782313|11748162|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
7455492|NCT01782313|11748162|FG000|Survival Follow up|Lost to Follow-up|1
7455493|NCT01782326|11748168|FG000|Planned Treatment Epoch|Subject/guardian decision|149
7455494|NCT01782326|11748169|FG001|Planned Treatment Epoch|Subject/guardian decision|151
7455495|NCT01782326|11748168|FG000|Planned Treatment Epoch|Death|29
7455496|NCT01782326|11748169|FG001|Planned Treatment Epoch|Death|30
7455497|NCT01782326|11748168|FG000|Planned Treatment Epoch|Physician Decision|18
7455498|NCT01782326|11748169|FG001|Planned Treatment Epoch|Physician Decision|16
7455499|NCT01782326|11748168|FG000|Planned Treatment Epoch|Protocol deviation|2
7455500|NCT01782326|11748169|FG001|Planned Treatment Epoch|Protocol deviation|3
7455501|NCT01782326|11748168|FG000|Planned Treatment Epoch|Lost to Follow-up|4
7455502|NCT01782326|11748169|FG001|Planned Treatment Epoch|Lost to Follow-up|4
7455503|NCT01782326|11748168|FG000|Planned Treatment Epoch|Technical problems|0
7455504|NCT01782326|11748169|FG001|Planned Treatment Epoch|Technical problems|4
7455505|NCT01782326|11748168|FG000|Double-blind Treatment|Adverse Event|129
7455506|NCT01782326|11748169|FG001|Double-blind Treatment|Adverse Event|145
7455507|NCT01782326|11748168|FG000|Double-blind Treatment|Subject/guardian decision|111
7455508|NCT01782326|11748169|FG001|Double-blind Treatment|Subject/guardian decision|125
7455509|NCT01782326|11748168|FG000|Double-blind Treatment|Lack of Efficacy|17
7455510|NCT01782326|11748169|FG001|Double-blind Treatment|Lack of Efficacy|22
7455511|NCT01782326|11748168|FG000|Double-blind Treatment|Physician Decision|13
7455512|NCT01782326|11748169|FG001|Double-blind Treatment|Physician Decision|16
7455513|NCT01782326|11748168|FG000|Double-blind Treatment|Protocol deviation|8
7455514|NCT01782326|11748169|FG001|Double-blind Treatment|Protocol deviation|7
7455515|NCT01782326|11748168|FG000|Double-blind Treatment|Technical problems|0
7455516|NCT01782326|11748169|FG001|Double-blind Treatment|Technical problems|5
7455517|NCT01782378|11748177|FG000|First Series|Lost to Follow-up|7
7455518|NCT01782378|11748178|FG001|First Series|Lost to Follow-up|8
7455519|NCT01782378|11748177|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
7455520|NCT01782378|11748178|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
7564324|NCT03285295|11935028|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7564325|NCT03285295|11935029|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
7564326|NCT03285295|11935025|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
7564327|NCT03285295|11935026|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7564328|NCT03285295|11935027|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7564329|NCT03285295|11935028|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7455521|NCT01782378|11748177|FG000|Second Series|Lost to Follow-up|8
7455522|NCT01782378|11748178|FG001|Second Series|Lost to Follow-up|7
7455523|NCT01782378|11748177|FG000|Second Series|Did not choose to complete S2 Optional|18
7455524|NCT01782378|11748178|FG001|Second Series|Did not choose to complete S2 Optional|0
7455525|NCT01782469|11748184|FG000|Overall Study|Lost to Follow-up|1
7455526|NCT01782482|11748190|FG000|Overall Study|Adverse Event|2
7455527|NCT01782482|11748191|FG001|Overall Study|Adverse Event|1
7455528|NCT01782482|11748190|FG000|Overall Study|Lost to Follow-up|2
7455529|NCT01782482|11748191|FG001|Overall Study|Lost to Follow-up|3
7455530|NCT01782482|11748190|FG000|Overall Study|Physician Decision|1
7455531|NCT01782482|11748191|FG001|Overall Study|Physician Decision|0
7455532|NCT01782482|11748190|FG000|Overall Study|Protocol Violation|1
7455533|NCT01782482|11748191|FG001|Overall Study|Protocol Violation|0
7455534|NCT01782482|11748190|FG000|Overall Study|Withdrawal by Subject|2
7455535|NCT01782482|11748191|FG001|Overall Study|Withdrawal by Subject|3
7455536|NCT01782482|11748190|FG000|Overall Study|Randomized in Error|2
7455537|NCT01782482|11748191|FG001|Overall Study|Randomized in Error|2
7455538|NCT01782482|11748190|FG000|Overall Study|Habitually wearing toric lens OS|0
7455539|NCT01782482|11748191|FG001|Overall Study|Habitually wearing toric lens OS|1
7455540|NCT01782495|11748208|FG000|Overall Study|Adverse Event|0
7455541|NCT01782495|11748209|FG001|Overall Study|Adverse Event|0
7455542|NCT01782495|11748210|FG002|Overall Study|Adverse Event|0
7455543|NCT01782495|11748211|FG003|Overall Study|Adverse Event|0
7455544|NCT01782495|11748212|FG004|Overall Study|Adverse Event|0
7455545|NCT01782495|11748213|FG005|Overall Study|Adverse Event|0
7455546|NCT01782495|11748214|FG006|Overall Study|Adverse Event|0
7455547|NCT01782495|11748215|FG007|Overall Study|Adverse Event|2
7455548|NCT01782495|11748216|FG008|Overall Study|Adverse Event|0
7455549|NCT01782495|11748217|FG009|Overall Study|Adverse Event|0
7455550|NCT01782495|11748218|FG010|Overall Study|Adverse Event|0
7455551|NCT01782495|11748208|FG000|Overall Study|Withdrew Consent|0
7564330|NCT03285295|11935029|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
7564331|NCT03285295|11935025|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
7564332|NCT03285295|11935026|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7564333|NCT03285295|11935027|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7564334|NCT03285295|11935028|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7564335|NCT03285295|11935029|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
7329031|NCT00799487|11561987|FG000|Dose Adjustment Period|Investigator Discretion|2
7329032|NCT00799487|11561988|FG001|Dose Adjustment Period|Investigator Discretion|0
7329033|NCT00799487|11561989|FG002|Dose Adjustment Period|Investigator Discretion|0
7329034|NCT00799487|11561987|FG000|Dose Adjustment Period|Withdrawal by Subject|3
7329035|NCT00799487|11561988|FG001|Dose Adjustment Period|Withdrawal by Subject|0
7329036|NCT00799487|11561989|FG002|Dose Adjustment Period|Withdrawal by Subject|0
7329037|NCT00799487|11561987|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
7329038|NCT00799487|11561988|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
7329039|NCT00799487|11561989|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
7329040|NCT00799487|11561987|FG000|Dose Adjustment Period|Child too young (exclusion)|1
7329041|NCT00799487|11561988|FG001|Dose Adjustment Period|Child too young (exclusion)|0
7329042|NCT00799487|11561989|FG002|Dose Adjustment Period|Child too young (exclusion)|0
7387580|NCT01215175|11646166|FG004|Overall Study|Lost to Follow-up|0
7387581|NCT01215188|11646181|FG000|Overall Study|Lost to Follow-up|22
7387582|NCT01215188|11646182|FG001|Overall Study|Lost to Follow-up|22
7387583|NCT01215188|11646183|FG002|Overall Study|Lost to Follow-up|16
7387584|NCT01215188|11646181|FG000|Overall Study|Adverse Event|1
7387585|NCT01215188|11646182|FG001|Overall Study|Adverse Event|1
7387586|NCT01215188|11646183|FG002|Overall Study|Adverse Event|3
7387587|NCT01215188|11646181|FG000|Overall Study|Physician Decision|2
7387588|NCT01215188|11646182|FG001|Overall Study|Physician Decision|1
7387589|NCT01215188|11646183|FG002|Overall Study|Physician Decision|0
7387590|NCT01215188|11646181|FG000|Overall Study|Lack of Efficacy|0
7387591|NCT01215188|11646182|FG001|Overall Study|Lack of Efficacy|0
7387592|NCT01215188|11646183|FG002|Overall Study|Lack of Efficacy|1
7387593|NCT01215188|11646181|FG000|Overall Study|Protocol Violation|1
7387594|NCT01215188|11646182|FG001|Overall Study|Protocol Violation|1
7387595|NCT01215188|11646183|FG002|Overall Study|Protocol Violation|1
7387596|NCT01215188|11646181|FG000|Overall Study|Withdrawal by Subject|32
7387597|NCT01215188|11646182|FG001|Overall Study|Withdrawal by Subject|34
7387598|NCT01215188|11646183|FG002|Overall Study|Withdrawal by Subject|31
7387599|NCT01215227|11646197|FG000|Overall Study|Adverse Event|11
7387600|NCT01215227|11646198|FG001|Overall Study|Adverse Event|11
7387601|NCT01215227|11646199|FG002|Overall Study|Adverse Event|4
7387602|NCT01215227|11646200|FG003|Overall Study|Adverse Event|8
7455552|NCT01782495|11748209|FG001|Overall Study|Withdrew Consent|1
7455553|NCT01782495|11748210|FG002|Overall Study|Withdrew Consent|0
7455554|NCT01782495|11748211|FG003|Overall Study|Withdrew Consent|0
7455555|NCT01782495|11748212|FG004|Overall Study|Withdrew Consent|0
7564336|NCT03285295|11935025|FG000|Alinity s Anti-HBc|Protocol Violation|8
7455556|NCT01782495|11748213|FG005|Overall Study|Withdrew Consent|0
7455558|NCT01782495|11748215|FG007|Overall Study|Withdrew Consent|1
7455559|NCT01782495|11748216|FG008|Overall Study|Withdrew Consent|0
7455560|NCT01782495|11748217|FG009|Overall Study|Withdrew Consent|0
7455561|NCT01782495|11748218|FG010|Overall Study|Withdrew Consent|0
7455562|NCT01782664|11748248|FG000|Overall Study|Adverse Event|2
7455563|NCT01782664|11748249|FG001|Overall Study|Adverse Event|2
7455564|NCT01782664|11748250|FG002|Overall Study|Adverse Event|2
7455565|NCT01782664|11748251|FG003|Overall Study|Adverse Event|2
7455566|NCT01782664|11748252|FG004|Overall Study|Adverse Event|0
7455567|NCT01782664|11748253|FG005|Overall Study|Adverse Event|0
7455568|NCT01782664|11748248|FG000|Overall Study|Lack of Efficacy|2
7455569|NCT01782664|11748249|FG001|Overall Study|Lack of Efficacy|0
7455570|NCT01782664|11748250|FG002|Overall Study|Lack of Efficacy|2
7455571|NCT01782664|11748251|FG003|Overall Study|Lack of Efficacy|2
7455572|NCT01782664|11748252|FG004|Overall Study|Lack of Efficacy|0
7455573|NCT01782664|11748253|FG005|Overall Study|Lack of Efficacy|0
7455574|NCT01782664|11748248|FG000|Overall Study|Protocol Violation|0
7455575|NCT01782664|11748249|FG001|Overall Study|Protocol Violation|1
7455576|NCT01782664|11748250|FG002|Overall Study|Protocol Violation|0
7455577|NCT01782664|11748251|FG003|Overall Study|Protocol Violation|1
7455578|NCT01782664|11748252|FG004|Overall Study|Protocol Violation|0
7455579|NCT01782664|11748253|FG005|Overall Study|Protocol Violation|0
7455580|NCT01782664|11748248|FG000|Overall Study|Withdrawal by Subject|2
7455581|NCT01782664|11748249|FG001|Overall Study|Withdrawal by Subject|2
7455582|NCT01782664|11748250|FG002|Overall Study|Withdrawal by Subject|0
7455583|NCT01782664|11748251|FG003|Overall Study|Withdrawal by Subject|0
7455584|NCT01782664|11748252|FG004|Overall Study|Withdrawal by Subject|0
7455585|NCT01782664|11748253|FG005|Overall Study|Withdrawal by Subject|0
7455586|NCT01782690|11748267|FG000|Overall Study|Not reported|7
7455587|NCT01782690|11748267|FG000|Overall Study|Toxicity of gemcitabine|1
7455588|NCT01782690|11748267|FG000|Overall Study|Toxicity of erlotinib|1
7455589|NCT01782690|11748267|FG000|Overall Study|Lost to Follow-up|31
7455590|NCT01782690|11748267|FG000|Overall Study|Withdrawal of informed consent|2
7455591|NCT01782690|11748267|FG000|Overall Study|Absent rash|9
7455592|NCT01782690|11748267|FG000|Overall Study|Physician Decision|13
7455593|NCT01782690|11748267|FG000|Overall Study|Patient's wish|21
7455594|NCT01782690|11748267|FG000|Overall Study|Tumor progression|74
7455595|NCT01782690|11748267|FG000|Overall Study|Death|133
7455596|NCT01782690|11748267|FG000|Overall Study|Study completion unknown|7
7455597|NCT01782742|11748273|FG000|Double-blind Treatment Phase|Adverse Event|1
7455598|NCT01782742|11748274|FG001|Double-blind Treatment Phase|Adverse Event|0
7455599|NCT01782859|11748288|FG000|Overall Study|Protocol Violation|6
7455600|NCT01782859|11748289|FG001|Overall Study|Protocol Violation|6
7455601|NCT01782859|11748288|FG000|Overall Study|Withdrawal by Subject|0
7455602|NCT01782859|11748289|FG001|Overall Study|Withdrawal by Subject|1
7455603|NCT01782872|11748300|FG000|Overall Study|Protocol Violation|0
7455604|NCT01782872|11748301|FG001|Overall Study|Protocol Violation|0
7455605|NCT01782872|11748302|FG002|Overall Study|Protocol Violation|0
7455606|NCT01782872|11748303|FG003|Overall Study|Protocol Violation|1
7455607|NCT01782872|11748300|FG000|Overall Study|Withdrawal by Subject|0
7455608|NCT01782872|11748301|FG001|Overall Study|Withdrawal by Subject|1
7455609|NCT01782872|11748302|FG002|Overall Study|Withdrawal by Subject|0
7455610|NCT01782872|11748303|FG003|Overall Study|Withdrawal by Subject|0
7455611|NCT01782885|11748315|FG000|Overall Study|Lost to Follow-up|4
7455612|NCT01782885|11748316|FG001|Overall Study|Lost to Follow-up|6
7468196|NCT01908426|11768854|FG000|Overall Study|Adverse Event|98
7468197|NCT01908426|11768855|FG001|Overall Study|Adverse Event|11
7468198|NCT01908426|11768854|FG000|Overall Study|Clinical Deterioration|72
7468199|NCT01908426|11768855|FG001|Overall Study|Clinical Deterioration|38
7468200|NCT01908426|11768854|FG000|Overall Study|Lack of Efficacy|3
7468201|NCT01908426|11768855|FG001|Overall Study|Lack of Efficacy|0
7468202|NCT01908426|11768854|FG000|Overall Study|Lost to Follow-up|0
7468203|NCT01908426|11768855|FG001|Overall Study|Lost to Follow-up|1
7468204|NCT01908426|11768854|FG000|Overall Study|Physician Decision|3
7468205|NCT01908426|11768855|FG001|Overall Study|Physician Decision|3
7468206|NCT01908426|11768854|FG000|Overall Study|Withdrawal by Subject|11
7564337|NCT03285295|11935026|FG001|Alinity s Anti-HBc|Protocol Violation|0
7468207|NCT01908426|11768855|FG001|Overall Study|Withdrawal by Subject|6
7468208|NCT01908426|11768854|FG000|Overall Study|Progressive Disease|206
7468209|NCT01908426|11768855|FG001|Overall Study|Progressive Disease|152
7468210|NCT01908426|11768854|FG000|Overall Study|Protocol Violation|1
7468211|NCT01908426|11768855|FG001|Overall Study|Protocol Violation|0
7468212|NCT01908426|11768854|FG000|Overall Study|No Study Treatment Given|3
7468213|NCT01908426|11768855|FG001|Overall Study|No Study Treatment Given|0
7468214|NCT01908582|11768877|FG000|Period 2|Physician Decision|1
7468215|NCT01908582|11768877|FG000|Period 2|Withdrawal by Subject|1
7468216|NCT01908634|11768884|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
7468217|NCT01908634|11768884|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
7455613|NCT01783418|11748358|FG000|Overall Study|Withdrawal by Subject|1
7455614|NCT01783418|11748359|FG001|Overall Study|Withdrawal by Subject|0
7455615|NCT01783444|11748368|FG000|Treatment Phase|Adverse Event|9
7455616|NCT01783444|11748369|FG001|Treatment Phase|Adverse Event|20
7455617|NCT01783444|11748370|FG002|Treatment Phase|Adverse Event|19
7455618|NCT01783444|11748368|FG000|Treatment Phase|Disease Progression|76
7455619|NCT01783444|11748369|FG001|Treatment Phase|Disease Progression|66
7455620|NCT01783444|11748370|FG002|Treatment Phase|Disease Progression|64
7455621|NCT01783444|11748368|FG000|Treatment Phase|Death|2
7455622|NCT01783444|11748369|FG001|Treatment Phase|Death|2
7455623|NCT01783444|11748370|FG002|Treatment Phase|Death|2
7455624|NCT01783444|11748368|FG000|Treatment Phase|Protocol Violation|1
7455625|NCT01783444|11748369|FG001|Treatment Phase|Protocol Violation|1
7455626|NCT01783444|11748370|FG002|Treatment Phase|Protocol Violation|2
7455627|NCT01783444|11748368|FG000|Treatment Phase|Withdrawal by Subject|6
7455628|NCT01783444|11748369|FG001|Treatment Phase|Withdrawal by Subject|8
7455629|NCT01783444|11748370|FG002|Treatment Phase|Withdrawal by Subject|9
7455630|NCT01783444|11748368|FG000|Treatment Phase|Administrative problems|2
7455631|NCT01783444|11748369|FG001|Treatment Phase|Administrative problems|0
7455632|NCT01783444|11748370|FG002|Treatment Phase|Administrative problems|1
7455633|NCT01783444|11748368|FG000|Treatment Phase|Physician Decision|8
7455634|NCT01783444|11748369|FG001|Treatment Phase|Physician Decision|6
7455635|NCT01783444|11748370|FG002|Treatment Phase|Physician Decision|5
7455636|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
7455637|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
7455638|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
7455639|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
7455640|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
7455641|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
7455642|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
7455643|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7455644|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
7455645|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7455646|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
7455647|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
7455648|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
7455649|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
7455650|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
7564338|NCT03285295|11935027|FG002|Alinity s Anti-HBc|Protocol Violation|0
7564339|NCT03285295|11935028|FG003|Alinity s Anti-HBc|Protocol Violation|0
7564340|NCT03285295|11935029|FG004|Alinity s Anti-HBc|Protocol Violation|0
7455651|NCT01783444|11748368|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
7455652|NCT01783444|11748369|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
7455653|NCT01783444|11748370|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
7455654|NCT01783483|11748389|FG000|Overall Study|Death|3
7455655|NCT01783483|11748390|FG001|Overall Study|Death|3
7455656|NCT01783483|11748389|FG000|Overall Study|Lost to Follow-up|14
7455657|NCT01783483|11748390|FG001|Overall Study|Lost to Follow-up|10
7455658|NCT01783483|11748389|FG000|Overall Study|Withdrawal by Subject|2
7455659|NCT01783483|11748390|FG001|Overall Study|Withdrawal by Subject|1
7455660|NCT01783483|11748389|FG000|Overall Study|Physician Decision|1
7455661|NCT01783483|11748390|FG001|Overall Study|Physician Decision|1
7455662|NCT01783496|11748402|FG000|Overall Study|Lost to Follow-up|0
7455663|NCT01783496|11748403|FG001|Overall Study|Lost to Follow-up|0
7455664|NCT01783496|11748404|FG002|Overall Study|Lost to Follow-up|0
7455665|NCT01783496|11748405|FG003|Overall Study|Lost to Follow-up|2
7455666|NCT01783496|11748406|FG004|Overall Study|Lost to Follow-up|0
7455667|NCT01783496|11748407|FG005|Overall Study|Lost to Follow-up|1
7455668|NCT01783496|11748402|FG000|Overall Study|Withdrawal by Subject|1
7455669|NCT01783496|11748403|FG001|Overall Study|Withdrawal by Subject|0
7455670|NCT01783496|11748404|FG002|Overall Study|Withdrawal by Subject|0
7455671|NCT01783496|11748405|FG003|Overall Study|Withdrawal by Subject|0
7455672|NCT01783496|11748406|FG004|Overall Study|Withdrawal by Subject|0
7455673|NCT01783496|11748407|FG005|Overall Study|Withdrawal by Subject|0
7564341|NCT03285295|11935025|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
7564342|NCT03285295|11935026|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
7455674|NCT01783548|11748432|FG000|Overall Study|Adverse Event|8
7455675|NCT01783548|11748433|FG001|Overall Study|Adverse Event|4
7455676|NCT01783548|11748432|FG000|Overall Study|Withdrawal by Subject|11
7455677|NCT01783548|11748433|FG001|Overall Study|Withdrawal by Subject|8
7455678|NCT01783548|11748432|FG000|Overall Study|Non-compliance|4
7455679|NCT01783548|11748433|FG001|Overall Study|Non-compliance|0
7455680|NCT01783548|11748432|FG000|Overall Study|Protocol Violation|2
7455681|NCT01783548|11748433|FG001|Overall Study|Protocol Violation|2
7455682|NCT01783548|11748432|FG000|Overall Study|Lost to Follow-up|8
7564343|NCT03285295|11935027|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
7455683|NCT01783548|11748433|FG001|Overall Study|Lost to Follow-up|3
7455684|NCT01783548|11748432|FG000|Overall Study|Lack of Efficacy|1
7455685|NCT01783548|11748433|FG001|Overall Study|Lack of Efficacy|1
7455686|NCT01783678|11748467|FG000|Overall Study|Randomized but Not Treated|0
7455687|NCT01783678|11748468|FG001|Overall Study|Randomized but Not Treated|0
7455688|NCT01783678|11748469|FG002|Overall Study|Randomized but Not Treated|0
7455689|NCT01783678|11748470|FG003|Overall Study|Randomized but Not Treated|1
7455690|NCT01783678|11748471|FG004|Overall Study|Randomized but Not Treated|0
7455691|NCT01783678|11748472|FG005|Overall Study|Randomized but Not Treated|0
7455692|NCT01783678|11748467|FG000|Overall Study|Lack of Efficacy|1
7455693|NCT01783678|11748468|FG001|Overall Study|Lack of Efficacy|13
7455694|NCT01783678|11748469|FG002|Overall Study|Lack of Efficacy|1
7455695|NCT01783678|11748470|FG003|Overall Study|Lack of Efficacy|3
7455696|NCT01783678|11748471|FG004|Overall Study|Lack of Efficacy|6
7455697|NCT01783678|11748472|FG005|Overall Study|Lack of Efficacy|5
7455698|NCT01783678|11748467|FG000|Overall Study|Lost to Follow-up|0
7455699|NCT01783678|11748468|FG001|Overall Study|Lost to Follow-up|4
7455700|NCT01783678|11748469|FG002|Overall Study|Lost to Follow-up|0
7455701|NCT01783678|11748470|FG003|Overall Study|Lost to Follow-up|2
7455702|NCT01783678|11748471|FG004|Overall Study|Lost to Follow-up|1
7455703|NCT01783678|11748472|FG005|Overall Study|Lost to Follow-up|0
7455704|NCT01783678|11748467|FG000|Overall Study|Withdrew Consent|1
7455705|NCT01783678|11748468|FG001|Overall Study|Withdrew Consent|1
7455706|NCT01783678|11748469|FG002|Overall Study|Withdrew Consent|0
7455707|NCT01783678|11748470|FG003|Overall Study|Withdrew Consent|2
7455708|NCT01783678|11748471|FG004|Overall Study|Withdrew Consent|0
7455709|NCT01783678|11748472|FG005|Overall Study|Withdrew Consent|0
7455710|NCT01783730|11748487|FG000|Overall Study|Failed to meet inclusion criteria|6
7455711|NCT01783743|11748493|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
7455712|NCT01783743|11748494|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
7455713|NCT01783743|11748493|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
7455714|NCT01783743|11748494|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
7455715|NCT01783743|11748493|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
7455716|NCT01783743|11748494|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
7455717|NCT01783821|11748502|FG000|Overall Study|Screen Failure|1
7455718|NCT01783821|11748503|FG001|Overall Study|Screen Failure|1
7455719|NCT01783886|11748537|FG000|Overall Study|Lost to Follow-up|0
7455720|NCT01783886|11748538|FG001|Overall Study|Lost to Follow-up|3
7455721|NCT01783886|11748539|FG002|Overall Study|Lost to Follow-up|0
7455722|NCT01783886|11748537|FG000|Overall Study|Protocol deviation|0
7455723|NCT01783886|11748538|FG001|Overall Study|Protocol deviation|0
7455724|NCT01783886|11748539|FG002|Overall Study|Protocol deviation|2
7455725|NCT01783886|11748537|FG000|Overall Study|Withdrawal of consent by participant|1
7455726|NCT01783886|11748538|FG001|Overall Study|Withdrawal of consent by participant|3
7455727|NCT01783886|11748539|FG002|Overall Study|Withdrawal of consent by participant|4
7455728|NCT01783886|11748537|FG000|Overall Study|Adverse Event|4
7455729|NCT01783886|11748538|FG001|Overall Study|Adverse Event|5
7455730|NCT01783886|11748539|FG002|Overall Study|Adverse Event|4
7455731|NCT01783938|11748562|FG000|Overall Study|Disease Progression|18
7455732|NCT01783938|11748563|FG001|Overall Study|Disease Progression|41
7455733|NCT01783938|11748562|FG000|Overall Study|Study Drug Toxicity|27
7455734|NCT01783938|11748563|FG001|Overall Study|Study Drug Toxicity|14
7455735|NCT01783938|11748562|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
7455736|NCT01783938|11748563|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
7455737|NCT01783938|11748562|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
7455738|NCT01783938|11748563|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
7455739|NCT01783938|11748562|FG000|Overall Study|Participant Withdrew Consent|2
7455740|NCT01783938|11748563|FG001|Overall Study|Participant Withdrew Consent|0
7455741|NCT01783938|11748562|FG000|Overall Study|Maximum Clinical Benefit|1
7455742|NCT01783938|11748563|FG001|Overall Study|Maximum Clinical Benefit|0
7455743|NCT01783938|11748562|FG000|Overall Study|Other Reasons|3
7455744|NCT01783938|11748563|FG001|Overall Study|Other Reasons|1
7455745|NCT01784029|11748583|FG000|Overall Study|Lost to Follow-up|19
7455746|NCT01784029|11748584|FG001|Overall Study|Lost to Follow-up|20
7455747|NCT01784029|11748585|FG002|Overall Study|Lost to Follow-up|22
7455748|NCT01784068|11748597|FG000|NTCS Phase|Adverse Event|5
7455749|NCT01784068|11748598|FG001|NTCS Phase|Adverse Event|0
7455750|NCT01784068|11748597|FG000|NTCS Phase|Physician Decision|2
7455751|NCT01784068|11748598|FG001|NTCS Phase|Physician Decision|0
7564344|NCT03285295|11935028|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
7564345|NCT03285295|11935029|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
7564346|NCT03285295|11935025|FG000|Alinity s Anti-HBc|No Results Generated|70
7564347|NCT03285295|11935026|FG001|Alinity s Anti-HBc|No Results Generated|0
7564348|NCT03285295|11935027|FG002|Alinity s Anti-HBc|No Results Generated|0
7564349|NCT03285295|11935028|FG003|Alinity s Anti-HBc|No Results Generated|0
7455752|NCT01784068|11748597|FG000|NTCS Phase|Patient/guardian decision|3
7455753|NCT01784068|11748598|FG001|NTCS Phase|Patient/guardian decision|0
7455754|NCT01784068|11748597|FG000|NTCS Phase|Death|2
7455755|NCT01784068|11748598|FG001|NTCS Phase|Death|0
7455756|NCT01784068|11748597|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
7455757|NCT01784068|11748598|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
7455758|NCT01784068|11748597|FG000|TFR Phase|Physician Decision|0
7455759|NCT01784068|11748598|FG001|TFR Phase|Physician Decision|1
7455760|NCT01784068|11748597|FG000|TFR Phase|Patient/guardian decision|0
7455761|NCT01784068|11748598|FG001|TFR Phase|Patient/guardian decision|3
7455762|NCT01784068|11748597|FG000|TFR Phase|Death|0
7455763|NCT01784068|11748598|FG001|TFR Phase|Death|1
7455764|NCT01784068|11748597|FG000|TFR Phase|Lack of Efficacy|0
7455765|NCT01784068|11748598|FG001|TFR Phase|Lack of Efficacy|88
7455766|NCT01784211|11748611|FG000|Part A (Days 1-15)|Adverse Event|1
7455767|NCT01784211|11748612|FG001|Part A (Days 1-15)|Adverse Event|1
7455768|NCT01784211|11748613|FG002|Part A (Days 1-15)|Adverse Event|0
7455769|NCT01784211|11748614|FG003|Part A (Days 1-15)|Adverse Event|0
7455770|NCT01784211|11748615|FG004|Part A (Days 1-15)|Adverse Event|0
7455771|NCT01784211|11748616|FG005|Part A (Days 1-15)|Adverse Event|0
7455772|NCT01784211|11748611|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
7455773|NCT01784211|11748612|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
7455774|NCT01784211|11748613|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
7455775|NCT01784211|11748614|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
7455776|NCT01784211|11748615|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
7455777|NCT01784211|11748616|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
7455778|NCT01784419|11748628|FG000|Overall Study|Adverse Event|3
7455779|NCT01784523|11748634|FG000|Overall Study|Study closed early|7
7455780|NCT01784523|11748635|FG001|Overall Study|Study closed early|4
7455781|NCT01784861|11748710|FG000|Overall Study|Adverse Event|0
7455782|NCT01784861|11748711|FG001|Overall Study|Adverse Event|0
7455783|NCT01784861|11748712|FG002|Overall Study|Adverse Event|1
7455784|NCT01784861|11748713|FG003|Overall Study|Adverse Event|2
7455785|NCT01784861|11748714|FG004|Overall Study|Adverse Event|1
7455786|NCT01784861|11748715|FG005|Overall Study|Adverse Event|0
7455787|NCT01784861|11748710|FG000|Overall Study|Withdrawal by Subject|0
7455788|NCT01784861|11748711|FG001|Overall Study|Withdrawal by Subject|0
7455789|NCT01784861|11748712|FG002|Overall Study|Withdrawal by Subject|0
7455790|NCT01784861|11748713|FG003|Overall Study|Withdrawal by Subject|1
7455791|NCT01784861|11748714|FG004|Overall Study|Withdrawal by Subject|0
7455792|NCT01784861|11748715|FG005|Overall Study|Withdrawal by Subject|0
7455793|NCT01784861|11748710|FG000|Overall Study|Physician Decision|0
7455794|NCT01784861|11748711|FG001|Overall Study|Physician Decision|0
7455795|NCT01784861|11748712|FG002|Overall Study|Physician Decision|0
7455796|NCT01784861|11748713|FG003|Overall Study|Physician Decision|2
7455797|NCT01784861|11748714|FG004|Overall Study|Physician Decision|0
7455798|NCT01784861|11748715|FG005|Overall Study|Physician Decision|1
7455799|NCT01784965|11748742|FG000|Overall Study|Withdrawal by Subject|6
7455800|NCT01784965|11748743|FG001|Overall Study|Withdrawal by Subject|3
7455801|NCT01784965|11748742|FG000|Overall Study|Adverse Event|0
7455802|NCT01784965|11748743|FG001|Overall Study|Adverse Event|8
7455803|NCT01785069|11748755|FG000|Overall Study|Implanted with nonstudy device|1
7455804|NCT01785069|11748756|FG001|Overall Study|Implanted with nonstudy device|2
7455805|NCT01785069|11748757|FG002|Overall Study|Implanted with nonstudy device|1
7455806|NCT01785069|11748758|FG003|Overall Study|Implanted with nonstudy device|0
7455807|NCT01785069|11748755|FG000|Overall Study|Death|0
7455808|NCT01785069|11748756|FG001|Overall Study|Death|0
7455809|NCT01785069|11748757|FG002|Overall Study|Death|2
7455810|NCT01785069|11748758|FG003|Overall Study|Death|0
7455811|NCT01785069|11748755|FG000|Overall Study|Subject choice|2
7455812|NCT01785069|11748756|FG001|Overall Study|Subject choice|2
7455813|NCT01785069|11748757|FG002|Overall Study|Subject choice|0
7455814|NCT01785069|11748758|FG003|Overall Study|Subject choice|1
7455815|NCT01785069|11748755|FG000|Overall Study|Lost to Follow-up|1
7455816|NCT01785069|11748756|FG001|Overall Study|Lost to Follow-up|2
7455817|NCT01785069|11748757|FG002|Overall Study|Lost to Follow-up|4
7455818|NCT01785069|11748758|FG003|Overall Study|Lost to Follow-up|1
7455819|NCT01785069|11748755|FG000|Overall Study|Reason not Specified|1
7455820|NCT01785069|11748756|FG001|Overall Study|Reason not Specified|2
7455821|NCT01785069|11748757|FG002|Overall Study|Reason not Specified|1
7455822|NCT01785069|11748758|FG003|Overall Study|Reason not Specified|4
7455823|NCT01785069|11748755|FG000|Overall Study|Not evaluable|7
7455824|NCT01785069|11748756|FG001|Overall Study|Not evaluable|4
7455825|NCT01785069|11748757|FG002|Overall Study|Not evaluable|5
7455826|NCT01785069|11748758|FG003|Overall Study|Not evaluable|8
7455827|NCT01785160|11748784|FG000|Treatment Period 1: Raltegravir|Not treated|1
7455828|NCT01785160|11748784|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
7455829|NCT01785472|11748825|FG000|Overall Study|Adverse Event|5
7455830|NCT01785472|11748826|FG001|Overall Study|Adverse Event|4
7455831|NCT01785472|11748827|FG002|Overall Study|Adverse Event|6
7455832|NCT01785472|11748825|FG000|Overall Study|Lack of Efficacy|2
7455833|NCT01785472|11748826|FG001|Overall Study|Lack of Efficacy|0
7455834|NCT01785472|11748827|FG002|Overall Study|Lack of Efficacy|1
7455835|NCT01785472|11748825|FG000|Overall Study|Lost to Follow-up|1
7455836|NCT01785472|11748826|FG001|Overall Study|Lost to Follow-up|2
7455837|NCT01785472|11748827|FG002|Overall Study|Lost to Follow-up|0
7455838|NCT01785472|11748825|FG000|Overall Study|Physician Decision|1
7455839|NCT01785472|11748826|FG001|Overall Study|Physician Decision|1
7455840|NCT01785472|11748827|FG002|Overall Study|Physician Decision|1
7455841|NCT01785472|11748825|FG000|Overall Study|Protocol deviation|0
7455842|NCT01785472|11748826|FG001|Overall Study|Protocol deviation|2
7455843|NCT01785472|11748827|FG002|Overall Study|Protocol deviation|2
7455844|NCT01785472|11748825|FG000|Overall Study|Subject/guardian decision|15
7455845|NCT01785472|11748826|FG001|Overall Study|Subject/guardian decision|10
7455846|NCT01785472|11748827|FG002|Overall Study|Subject/guardian decision|11
7455847|NCT01785472|11748825|FG000|Overall Study|Technical problems|0
7455848|NCT01785472|11748826|FG001|Overall Study|Technical problems|0
7455849|NCT01785472|11748827|FG002|Overall Study|Technical problems|1
7455850|NCT01785524|11748839|FG000|Overall Study|Withdrawal by Subject|2
7455851|NCT01785524|11748840|FG001|Overall Study|Withdrawal by Subject|2
7455852|NCT01785602|11748848|FG000|Overall Study|Withdrawal by Subject|2
7455853|NCT01785602|11748849|FG001|Overall Study|Withdrawal by Subject|0
7455854|NCT01785602|11748848|FG000|Overall Study|Lost to Follow-up|1
7455855|NCT01785602|11748849|FG001|Overall Study|Lost to Follow-up|1
7455856|NCT01785602|11748848|FG000|Overall Study|Adverse Event|3
7455857|NCT01785602|11748849|FG001|Overall Study|Adverse Event|5
7455858|NCT01785602|11748848|FG000|Overall Study|Administrative problems|7
7455859|NCT01785602|11748849|FG001|Overall Study|Administrative problems|3
7455860|NCT01785615|11748858|FG000|Dietary Phase|Lost to Follow-up|0
7455861|NCT01785615|11748859|FG001|Dietary Phase|Lost to Follow-up|0
7455862|NCT01785615|11748860|FG002|Dietary Phase|Lost to Follow-up|0
7455863|NCT01785615|11748861|FG003|Dietary Phase|Lost to Follow-up|24
7455864|NCT01785628|11748875|FG000|Overall Study|Lost to Follow-up|2
7455865|NCT01785628|11748876|FG001|Overall Study|Lost to Follow-up|3
7455866|NCT01785849|11748897|FG000|Overall Study|Death|7
7455867|NCT01785849|11748898|FG001|Overall Study|Death|9
7455868|NCT01785849|11748897|FG000|Overall Study|Protocol Specified Criteria|29
7455869|NCT01785849|11748898|FG001|Overall Study|Protocol Specified Criteria|1
7455870|NCT01785849|11748897|FG000|Overall Study|Withdrawal by Subject|15
7455871|NCT01785849|11748898|FG001|Overall Study|Withdrawal by Subject|12
7455872|NCT01785849|11748897|FG000|Overall Study|Sponsor Decision|0
7455873|NCT01785849|11748898|FG001|Overall Study|Sponsor Decision|1
7455874|NCT01785849|11748897|FG000|Overall Study|Lost to Follow-up|10
7455875|NCT01785849|11748898|FG001|Overall Study|Lost to Follow-up|11
7455876|NCT01785875|11748904|FG000|Overall Study|Withdrawal by Subject|41
7455877|NCT01785875|11748905|FG001|Overall Study|Withdrawal by Subject|34
7455878|NCT01785875|11748906|FG002|Overall Study|Withdrawal by Subject|36
7455879|NCT01785875|11748904|FG000|Overall Study|Lost to Follow-up|19
7455880|NCT01785875|11748905|FG001|Overall Study|Lost to Follow-up|22
7455881|NCT01785875|11748906|FG002|Overall Study|Lost to Follow-up|6
7455882|NCT01785875|11748904|FG000|Overall Study|Death|27
7455883|NCT01785875|11748905|FG001|Overall Study|Death|16
7455884|NCT01785875|11748906|FG002|Overall Study|Death|7
7455885|NCT01785875|11748904|FG000|Overall Study|Sponsor Decision|0
7455886|NCT01785875|11748905|FG001|Overall Study|Sponsor Decision|2
7455887|NCT01785875|11748906|FG002|Overall Study|Sponsor Decision|0
7455888|NCT01785875|11748904|FG000|Overall Study|Protocol Specified Criteria|207
7455889|NCT01785875|11748905|FG001|Overall Study|Protocol Specified Criteria|214
7455890|NCT01785875|11748906|FG002|Overall Study|Protocol Specified Criteria|55
7455891|NCT01785875|11748904|FG000|Overall Study|Missing|0
7455892|NCT01785875|11748905|FG001|Overall Study|Missing|1
7455893|NCT01785875|11748906|FG002|Overall Study|Missing|3
7455894|NCT01786109|11748920|FG000|Overall Study|fail manometry barostat tube placement|1
7455895|NCT01786109|11748921|FG001|Overall Study|fail manometry barostat tube placement|0
7455896|NCT01786109|11748922|FG002|Overall Study|fail manometry barostat tube placement|0
7455897|NCT01786109|11748920|FG000|Overall Study|unrelated illness|0
7455898|NCT01786109|11748921|FG001|Overall Study|unrelated illness|0
7455899|NCT01786109|11748922|FG002|Overall Study|unrelated illness|1
7455900|NCT01786109|11748920|FG000|Overall Study|adverse effects colon preparation|0
7455901|NCT01786109|11748921|FG001|Overall Study|adverse effects colon preparation|0
7455902|NCT01786109|11748922|FG002|Overall Study|adverse effects colon preparation|1
7455903|NCT01786148|11748932|FG000|Overall Study|Lost to Follow-up|21
7455904|NCT01786148|11748933|FG001|Overall Study|Lost to Follow-up|13
7455905|NCT01786148|11748932|FG000|Overall Study|Death|0
7455906|NCT01786148|11748933|FG001|Overall Study|Death|1
7455907|NCT01786148|11748932|FG000|Overall Study|Withdrawal by Subject|0
7455908|NCT01786148|11748933|FG001|Overall Study|Withdrawal by Subject|7
7455909|NCT01786148|11748932|FG000|Overall Study|Incarceration|1
7455910|NCT01786148|11748933|FG001|Overall Study|Incarceration|1
7455911|NCT01786174|11748952|FG000|Overall Study|Discontinued Study Drug|2
7455912|NCT01786174|11748953|FG001|Overall Study|Discontinued Study Drug|0
7533023|NCT02679729|11879033|FG007|Overall Study|Lost to Follow-up|0
7455913|NCT01786330|11748991|FG000|Overall Study|Withdrawal by Subject|0
7455914|NCT01786330|11748992|FG001|Overall Study|Withdrawal by Subject|1
7455915|NCT01786330|11748991|FG000|Overall Study|Lost to Follow-up|0
7455916|NCT01786330|11748992|FG001|Overall Study|Lost to Follow-up|1
7455917|NCT01786330|11748991|FG000|Overall Study|Excluded intraoperatively|0
7455918|NCT01786330|11748992|FG001|Overall Study|Excluded intraoperatively|1
7455919|NCT01786330|11748991|FG000|Overall Study|Protocol Violation|1
7455920|NCT01786330|11748992|FG001|Overall Study|Protocol Violation|0
7455921|NCT01786512|11749018|FG000|Overall Study|Lost to Follow-up|0
7455922|NCT01786512|11749019|FG001|Overall Study|Lost to Follow-up|0
7455923|NCT01786512|11749020|FG002|Overall Study|Lost to Follow-up|0
7455924|NCT01786512|11749021|FG003|Overall Study|Lost to Follow-up|0
7455925|NCT01786512|11749022|FG004|Overall Study|Lost to Follow-up|0
7455926|NCT01786512|11749023|FG005|Overall Study|Lost to Follow-up|0
7455927|NCT01786512|11749024|FG006|Overall Study|Lost to Follow-up|0
7455928|NCT01786512|11749025|FG007|Overall Study|Lost to Follow-up|0
7455929|NCT01786512|11749026|FG008|Overall Study|Lost to Follow-up|0
7455930|NCT01786512|11749027|FG009|Overall Study|Lost to Follow-up|1
7455931|NCT01786512|11749028|FG010|Overall Study|Lost to Follow-up|0
7455932|NCT01786512|11749018|FG000|Overall Study|Decision by sponsor|0
7455933|NCT01786512|11749019|FG001|Overall Study|Decision by sponsor|0
7455934|NCT01786512|11749020|FG002|Overall Study|Decision by sponsor|0
7455935|NCT01786512|11749021|FG003|Overall Study|Decision by sponsor|0
7564350|NCT03285295|11935029|FG004|Alinity s Anti-HBc|No Results Generated|0
7564351|NCT03285295|11935025|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
7564352|NCT03285295|11935026|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7564353|NCT03285295|11935027|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7564354|NCT03285295|11935028|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7564355|NCT03285295|11935029|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
7564356|NCT03285295|11935025|FG000|Alinity s Chagas|Protocol Violation|76
7564357|NCT03285295|11935026|FG001|Alinity s Chagas|Protocol Violation|0
7564358|NCT03285295|11935027|FG002|Alinity s Chagas|Protocol Violation|0
7564359|NCT03285295|11935028|FG003|Alinity s Chagas|Protocol Violation|0
7564360|NCT03285295|11935029|FG004|Alinity s Chagas|Protocol Violation|0
7564361|NCT03285295|11935025|FG000|Alinity s Chagas|No Results on Comparator Assay|38
7564362|NCT03285295|11935026|FG001|Alinity s Chagas|No Results on Comparator Assay|0
7564363|NCT03285295|11935027|FG002|Alinity s Chagas|No Results on Comparator Assay|0
7564364|NCT03285295|11935028|FG003|Alinity s Chagas|No Results on Comparator Assay|0
7564365|NCT03285295|11935029|FG004|Alinity s Chagas|No Results on Comparator Assay|0
7564366|NCT03285295|11935025|FG000|Alinity s Chagas|No Results Generated|105
7564367|NCT03285295|11935026|FG001|Alinity s Chagas|No Results Generated|0
7564368|NCT03285295|11935027|FG002|Alinity s Chagas|No Results Generated|0
7564369|NCT03285295|11935028|FG003|Alinity s Chagas|No Results Generated|0
7564370|NCT03285295|11935029|FG004|Alinity s Chagas|No Results Generated|0
7564371|NCT03285295|11935025|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
7564372|NCT03285295|11935026|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7564373|NCT03285295|11935027|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7564374|NCT03285295|11935028|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7564375|NCT03285295|11935029|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
7564376|NCT03285308|11935060|FG000|Overall Study|Adverse Event|3
7564377|NCT03285308|11935061|FG001|Overall Study|Adverse Event|7
7564378|NCT03285308|11935060|FG000|Overall Study|Withdrawal by Subject|8
7564379|NCT03285308|11935061|FG001|Overall Study|Withdrawal by Subject|9
7564380|NCT03285308|11935060|FG000|Overall Study|Lost to Follow-up|3
7564381|NCT03285308|11935061|FG001|Overall Study|Lost to Follow-up|1
7564382|NCT03285308|11935060|FG000|Overall Study|Protocol Deviation|6
7564383|NCT03285308|11935061|FG001|Overall Study|Protocol Deviation|5
7564384|NCT03285308|11935060|FG000|Overall Study|Reason not Specified|0
7564385|NCT03285308|11935061|FG001|Overall Study|Reason not Specified|1
7564386|NCT03285477|11935082|FG000|Treatment and Response Assessment Period|Death|1
7564387|NCT03285477|11935083|FG001|Treatment and Response Assessment Period|Death|0
7564388|NCT03285477|11935082|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
7564389|NCT03285477|11935083|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
7564390|NCT03285477|11935082|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
7329043|NCT00799487|11561987|FG000|Dose Adjustment Period|Missed laboratory day 1|1
7329044|NCT00799487|11561988|FG001|Dose Adjustment Period|Missed laboratory day 1|0
7329045|NCT00799487|11561989|FG002|Dose Adjustment Period|Missed laboratory day 1|0
7329046|NCT00799487|11561987|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
7329047|NCT00799487|11561988|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7329048|NCT00799487|11561989|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
7329049|NCT00799487|11561987|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
7329050|NCT00799487|11561988|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
7329051|NCT00799487|11561989|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
7329052|NCT00799487|11561987|FG000|Double-Blind Assessment Period|Subject was out of the state|0
7329053|NCT00799487|11561988|FG001|Double-Blind Assessment Period|Subject was out of the state|0
7329054|NCT00799487|11561989|FG002|Double-Blind Assessment Period|Subject was out of the state|1
7329055|NCT00799487|11561987|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7329056|NCT00799487|11561988|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
7329057|NCT00799487|11561989|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
7329058|NCT00799591|11562004|FG000|Overall Study|De-escalation of doses|20
7329059|NCT00799591|11562004|FG000|Overall Study|Death|14
7329060|NCT00799591|11562004|FG000|Overall Study|Technical failure|12
7329061|NCT00799591|11562004|FG000|Overall Study|Resistant germ|11
7329062|NCT00799591|11562004|FG000|Overall Study|New infection|4
7329063|NCT00799591|11562004|FG000|Overall Study|Resistance germ and technical failure|2
7329064|NCT00799591|11562004|FG000|Overall Study|Persistance of fever undetermined origin|1
7329065|NCT00799591|11562004|FG000|Overall Study|Antibiotic changed, no apparent reason|1
7329066|NCT00799591|11562004|FG000|Overall Study|Infectious origin not probable|1
7329067|NCT00799617|11562023|FG000|Main Testosterone Trial|Randomized in error|1
7329068|NCT00799617|11562024|FG001|Main Testosterone Trial|Randomized in error|1
7329069|NCT00799617|11562023|FG000|Main Testosterone Trial|Lost to Follow-up|18
7329070|NCT00799617|11562024|FG001|Main Testosterone Trial|Lost to Follow-up|20
7329071|NCT00799617|11562023|FG000|Sexual Funtion Trial|Lost to Follow-up|12
7455936|NCT01786512|11749022|FG004|Overall Study|Decision by sponsor|0
7455937|NCT01786512|11749023|FG005|Overall Study|Decision by sponsor|0
7455938|NCT01786512|11749024|FG006|Overall Study|Decision by sponsor|0
7455939|NCT01786512|11749025|FG007|Overall Study|Decision by sponsor|0
7455940|NCT01786512|11749026|FG008|Overall Study|Decision by sponsor|0
7455941|NCT01786512|11749027|FG009|Overall Study|Decision by sponsor|0
7455942|NCT01786512|11749028|FG010|Overall Study|Decision by sponsor|2
7455943|NCT01786512|11749018|FG000|Overall Study|Withdrawal by Subject|0
7455944|NCT01786512|11749019|FG001|Overall Study|Withdrawal by Subject|1
7455945|NCT01786512|11749020|FG002|Overall Study|Withdrawal by Subject|0
7455946|NCT01786512|11749021|FG003|Overall Study|Withdrawal by Subject|0
7455947|NCT01786512|11749022|FG004|Overall Study|Withdrawal by Subject|0
7455948|NCT01786512|11749023|FG005|Overall Study|Withdrawal by Subject|0
7455949|NCT01786512|11749024|FG006|Overall Study|Withdrawal by Subject|1
7455950|NCT01786512|11749025|FG007|Overall Study|Withdrawal by Subject|0
7455951|NCT01786512|11749026|FG008|Overall Study|Withdrawal by Subject|0
7455952|NCT01786512|11749027|FG009|Overall Study|Withdrawal by Subject|3
7455953|NCT01786512|11749028|FG010|Overall Study|Withdrawal by Subject|7
7455954|NCT01786512|11749018|FG000|Overall Study|Death|0
7455955|NCT01786512|11749019|FG001|Overall Study|Death|0
7455956|NCT01786512|11749020|FG002|Overall Study|Death|0
7455957|NCT01786512|11749021|FG003|Overall Study|Death|0
7455958|NCT01786512|11749022|FG004|Overall Study|Death|0
7455959|NCT01786512|11749023|FG005|Overall Study|Death|0
7455960|NCT01786512|11749024|FG006|Overall Study|Death|0
7455961|NCT01786512|11749025|FG007|Overall Study|Death|0
7455962|NCT01786512|11749026|FG008|Overall Study|Death|4
7455963|NCT01786512|11749027|FG009|Overall Study|Death|1
7455964|NCT01786512|11749028|FG010|Overall Study|Death|3
7455965|NCT01786551|11749060|FG000|Overall Study|Participant withdrew consent|2
7455966|NCT01786564|11749064|FG000|Overall Study|Lost to Follow-up|47
7455967|NCT01786564|11749064|FG000|Overall Study|Ineligible|17
7455968|NCT01786603|11749070|FG000|Overall Study|Death|5
7455969|NCT01786603|11749071|FG001|Overall Study|Death|1
7455970|NCT01786603|11749070|FG000|Overall Study|Adverse Event|6
7455971|NCT01786603|11749071|FG001|Overall Study|Adverse Event|2
7455972|NCT01786603|11749070|FG000|Overall Study|Physician decision to withdraw|6
7455973|NCT01786603|11749071|FG001|Overall Study|Physician decision to withdraw|7
7455974|NCT01786603|11749070|FG000|Overall Study|Lost to Follow-up|1
7455975|NCT01786603|11749071|FG001|Overall Study|Lost to Follow-up|2
7455976|NCT01786629|11749079|FG000|Overall Study|Lack of Efficacy|0
7455977|NCT01786629|11749080|FG001|Overall Study|Lack of Efficacy|4
7455978|NCT01786629|11749079|FG000|Overall Study|Adverse Event|0
7455979|NCT01786629|11749080|FG001|Overall Study|Adverse Event|1
7455980|NCT01786668|11749090|FG000|Overall Study|Adverse Event|0
7455981|NCT01786668|11749091|FG001|Overall Study|Adverse Event|1
7455982|NCT01786668|11749092|FG002|Overall Study|Adverse Event|1
7455983|NCT01786668|11749093|FG003|Overall Study|Adverse Event|2
7455984|NCT01786668|11749090|FG000|Overall Study|Withdrawal by Subject|0
7455985|NCT01786668|11749091|FG001|Overall Study|Withdrawal by Subject|0
7455986|NCT01786668|11749092|FG002|Overall Study|Withdrawal by Subject|3
7455987|NCT01786668|11749093|FG003|Overall Study|Withdrawal by Subject|1
7455988|NCT01786668|11749090|FG000|Overall Study|Pregnancy|0
7455989|NCT01786668|11749091|FG001|Overall Study|Pregnancy|0
7455990|NCT01786668|11749092|FG002|Overall Study|Pregnancy|0
7455991|NCT01786668|11749093|FG003|Overall Study|Pregnancy|1
7455992|NCT01786668|11749090|FG000|Overall Study|Lost to Follow-up|1
7455993|NCT01786668|11749091|FG001|Overall Study|Lost to Follow-up|0
7455994|NCT01786668|11749092|FG002|Overall Study|Lost to Follow-up|1
7455995|NCT01786668|11749093|FG003|Overall Study|Lost to Follow-up|0
7455996|NCT01786707|11749105|FG000|Overall Study|Lost to Follow-up|1
7455997|NCT01786707|11749106|FG001|Overall Study|Lost to Follow-up|1
7455998|NCT01786993|11749147|FG000|Overall Study|Death|6
7455999|NCT01786993|11749148|FG001|Overall Study|Death|7
7456000|NCT01786993|11749147|FG000|Overall Study|Withdrawal by Subject|3
7456001|NCT01786993|11749148|FG001|Overall Study|Withdrawal by Subject|2
7456002|NCT01786993|11749147|FG000|Overall Study|Lost to Follow-up|0
7456003|NCT01786993|11749148|FG001|Overall Study|Lost to Follow-up|1
7456004|NCT01786993|11749147|FG000|Overall Study|Subject Non-Compliance|1
7456005|NCT01786993|11749148|FG001|Overall Study|Subject Non-Compliance|0
7456006|NCT01786993|11749147|FG000|Overall Study|System Explant|1
7456007|NCT01786993|11749148|FG001|Overall Study|System Explant|0
7456008|NCT01786993|11749147|FG000|Overall Study|Hospice Admission|1
7456009|NCT01786993|11749148|FG001|Overall Study|Hospice Admission|0
7456010|NCT01787032|11749170|FG000|Overall Study|Protocol Violation|0
7456011|NCT01787032|11749171|FG001|Overall Study|Protocol Violation|0
7456012|NCT01787032|11749172|FG002|Overall Study|Protocol Violation|0
7456013|NCT01787032|11749173|FG003|Overall Study|Protocol Violation|0
7456014|NCT01787032|11749174|FG004|Overall Study|Protocol Violation|1
7456015|NCT01787032|11749175|FG005|Overall Study|Protocol Violation|1
7456016|NCT01787097|11749185|FG000|Overall Study|Withdrawal by Subject|1
7456017|NCT01787097|11749186|FG001|Overall Study|Withdrawal by Subject|0
7456018|NCT01787097|11749187|FG002|Overall Study|Withdrawal by Subject|0
7456019|NCT01787097|11749188|FG003|Overall Study|Withdrawal by Subject|0
7456020|NCT01787188|11749220|FG000|Overall Study|Adverse Event|2
7456021|NCT01787188|11749221|FG001|Overall Study|Adverse Event|4
7456022|NCT01787188|11749222|FG002|Overall Study|Adverse Event|6
7456023|NCT01787188|11749220|FG000|Overall Study|Lack of Efficacy|7
7456024|NCT01787188|11749221|FG001|Overall Study|Lack of Efficacy|3
7456025|NCT01787188|11749222|FG002|Overall Study|Lack of Efficacy|5
7456026|NCT01787188|11749220|FG000|Overall Study|Non-compliance with Study Drug|0
7456027|NCT01787188|11749221|FG001|Overall Study|Non-compliance with Study Drug|1
7456028|NCT01787188|11749222|FG002|Overall Study|Non-compliance with Study Drug|0
7456029|NCT01787188|11749220|FG000|Overall Study|Withdrawal by Subject|4
7456030|NCT01787188|11749221|FG001|Overall Study|Withdrawal by Subject|3
7456031|NCT01787188|11749222|FG002|Overall Study|Withdrawal by Subject|2
7456032|NCT01787188|11749220|FG000|Overall Study|Protocol Violation|3
7456033|NCT01787188|11749221|FG001|Overall Study|Protocol Violation|2
7456034|NCT01787188|11749222|FG002|Overall Study|Protocol Violation|3
7456035|NCT01787188|11749220|FG000|Overall Study|Lost to Follow-up|1
7456036|NCT01787188|11749221|FG001|Overall Study|Lost to Follow-up|2
7456037|NCT01787188|11749222|FG002|Overall Study|Lost to Follow-up|2
7456038|NCT01787188|11749220|FG000|Overall Study|Other, including patient moved|0
7456039|NCT01787188|11749221|FG001|Overall Study|Other, including patient moved|3
7456040|NCT01787188|11749222|FG002|Overall Study|Other, including patient moved|0
7456041|NCT01787279|11749242|FG000|Overall Study|Lost to Follow-up|2
7456042|NCT01787279|11749242|FG000|Overall Study|Lack of Efficacy|1
7456043|NCT01787292|11749246|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
7456044|NCT01787292|11749247|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
7456045|NCT01787292|11749246|FG000|Home Based Exercise Program|Withdrawal by Subject|3
7456046|NCT01787292|11749247|FG001|Home Based Exercise Program|Withdrawal by Subject|1
7456047|NCT01787331|11749258|FG000|Overall Study|Physician Decision|1
7456048|NCT01787331|11749258|FG000|Overall Study|Withdrawal by Subject|1
7456049|NCT01787461|11749281|FG000|Overall Study|Adverse Event|4
7456050|NCT01787461|11749282|FG001|Overall Study|Adverse Event|3
7456051|NCT01787461|11749281|FG000|Overall Study|Lost to Follow-up|3
7456052|NCT01787461|11749282|FG001|Overall Study|Lost to Follow-up|2
7456053|NCT01787461|11749281|FG000|Overall Study|No longer met eligibility criteria|1
7456054|NCT01787461|11749282|FG001|Overall Study|No longer met eligibility criteria|0
7456055|NCT01787461|11749281|FG000|Overall Study|Withdrawal by Subject|3
7456056|NCT01787461|11749282|FG001|Overall Study|Withdrawal by Subject|4
7456057|NCT01787461|11749281|FG000|Overall Study|Protocol Violation|3
7456058|NCT01787461|11749282|FG001|Overall Study|Protocol Violation|0
7456059|NCT01787591|11749290|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7456060|NCT01787591|11749291|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7456061|NCT01787591|11749292|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
7456062|NCT01787591|11749293|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
7456063|NCT01787760|11749316|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
7456064|NCT01787760|11749317|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
7456065|NCT01787760|11749318|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
7456066|NCT01787760|11749316|FG000|Overall Study|Decompensated on left exotropia|0
7456067|NCT01787760|11749317|FG001|Overall Study|Decompensated on left exotropia|0
7456068|NCT01787760|11749318|FG002|Overall Study|Decompensated on left exotropia|1
7456069|NCT01787760|11749316|FG000|Overall Study|Dryness|0
7456070|NCT01787760|11749317|FG001|Overall Study|Dryness|1
7456071|NCT01787760|11749318|FG002|Overall Study|Dryness|0
7456072|NCT01787760|11749316|FG000|Overall Study|Relocation|1
7456073|NCT01787760|11749317|FG001|Overall Study|Relocation|1
7456074|NCT01787760|11749318|FG002|Overall Study|Relocation|0
7456075|NCT01787760|11749316|FG000|Overall Study|Lens discomfort|3
7456076|NCT01787760|11749317|FG001|Overall Study|Lens discomfort|0
7456077|NCT01787760|11749318|FG002|Overall Study|Lens discomfort|0
7456078|NCT01787760|11749316|FG000|Overall Study|Lens handling difficulty|1
7456079|NCT01787760|11749317|FG001|Overall Study|Lens handling difficulty|2
7456080|NCT01787760|11749318|FG002|Overall Study|Lens handling difficulty|0
7456081|NCT01787760|11749316|FG000|Overall Study|Protocol Violation|6
7456082|NCT01787760|11749317|FG001|Overall Study|Protocol Violation|0
7456083|NCT01787760|11749318|FG002|Overall Study|Protocol Violation|1
7456084|NCT01787760|11749316|FG000|Overall Study|Withdrawal by Subject|5
7456085|NCT01787760|11749317|FG001|Overall Study|Withdrawal by Subject|1
7456086|NCT01787760|11749318|FG002|Overall Study|Withdrawal by Subject|2
7456087|NCT01787760|11749316|FG000|Overall Study|Lost to Follow-up|1
7456088|NCT01787760|11749317|FG001|Overall Study|Lost to Follow-up|0
7456089|NCT01787760|11749318|FG002|Overall Study|Lost to Follow-up|1
7456090|NCT01787760|11749316|FG000|Overall Study|Stroke|1
7456091|NCT01787760|11749317|FG001|Overall Study|Stroke|0
7456092|NCT01787760|11749318|FG002|Overall Study|Stroke|0
7456093|NCT01787760|11749316|FG000|Overall Study|Unsatisfactory lens fitting performance|3
7456094|NCT01787760|11749317|FG001|Overall Study|Unsatisfactory lens fitting performance|6
7456095|NCT01787760|11749318|FG002|Overall Study|Unsatisfactory lens fitting performance|0
7456096|NCT01787760|11749316|FG000|Overall Study|Unsatisfactory physiological response|2
7456097|NCT01787760|11749317|FG001|Overall Study|Unsatisfactory physiological response|4
7456098|NCT01787760|11749318|FG002|Overall Study|Unsatisfactory physiological response|0
7456099|NCT01787760|11749316|FG000|Overall Study|Unsatisfactory visual response|1
7456100|NCT01787760|11749317|FG001|Overall Study|Unsatisfactory visual response|1
7456101|NCT01787760|11749318|FG002|Overall Study|Unsatisfactory visual response|0
7456102|NCT01787760|11749316|FG000|Overall Study|Near vision blur|1
7456103|NCT01787760|11749317|FG001|Overall Study|Near vision blur|0
7456104|NCT01787760|11749318|FG002|Overall Study|Near vision blur|0
7456105|NCT01787825|11749331|FG000|Overall Study|Subject Did Not Ingest Capsules|1
7456106|NCT01787825|11749332|FG001|Overall Study|Subject Did Not Ingest Capsules|0
7456107|NCT01787825|11749331|FG000|Overall Study|Data Not Analyzable|5
7456108|NCT01787825|11749332|FG001|Overall Study|Data Not Analyzable|1
7456109|NCT01787838|11749339|FG000|Overall Study|refused|1413
7456110|NCT01788046|11749352|FG000|Overall Study|Withdrawal by Subject|12
7456111|NCT01788046|11749353|FG001|Overall Study|Withdrawal by Subject|12
7456112|NCT01788046|11749352|FG000|Overall Study|Lost to Follow-up|12
7456113|NCT01788046|11749353|FG001|Overall Study|Lost to Follow-up|19
7456114|NCT01788046|11749352|FG000|Overall Study|Death|7
7456115|NCT01788046|11749353|FG001|Overall Study|Death|5
7456116|NCT01788046|11749352|FG000|Overall Study|Protocol Specified Criteria|25
7456117|NCT01788046|11749353|FG001|Overall Study|Protocol Specified Criteria|1
7456118|NCT01788163|11749377|FG000|Overall Study|Other|53
7456119|NCT01788163|11749378|FG001|Overall Study|Other|0
7456120|NCT01788163|11749379|FG002|Overall Study|Other|0
7456121|NCT01788163|11749380|FG003|Overall Study|Other|0
7456122|NCT01788163|11749381|FG004|Overall Study|Other|0
7456123|NCT01788163|11749382|FG005|Overall Study|Other|7
7456124|NCT01788163|11749383|FG006|Overall Study|Other|1
7456125|NCT01788163|11749384|FG007|Overall Study|Other|48
7456126|NCT01788163|11749385|FG008|Overall Study|Other|15
7456127|NCT01788163|11749377|FG000|Overall Study|Withdrawal by Subject|2
7456128|NCT01788163|11749378|FG001|Overall Study|Withdrawal by Subject|0
7456129|NCT01788163|11749379|FG002|Overall Study|Withdrawal by Subject|0
7456130|NCT01788163|11749380|FG003|Overall Study|Withdrawal by Subject|0
7456131|NCT01788163|11749381|FG004|Overall Study|Withdrawal by Subject|0
7456132|NCT01788163|11749382|FG005|Overall Study|Withdrawal by Subject|0
7456133|NCT01788163|11749383|FG006|Overall Study|Withdrawal by Subject|0
7456134|NCT01788163|11749384|FG007|Overall Study|Withdrawal by Subject|0
7456135|NCT01788163|11749385|FG008|Overall Study|Withdrawal by Subject|1
7456136|NCT01788215|11749466|FG000|Overall Study|Withdrawal by Subject|0
7456137|NCT01788215|11749467|FG001|Overall Study|Withdrawal by Subject|1
7456138|NCT01788215|11749466|FG000|Overall Study|Lost to Follow-up|2
7456139|NCT01788215|11749467|FG001|Overall Study|Lost to Follow-up|0
7456140|NCT01788228|11749475|FG000|Overall Study|Migrated/moved from study area|1
7456141|NCT01788228|11749476|FG001|Overall Study|Migrated/moved from study area|0
7456142|NCT01788358|11749485|FG000|Overall Study|Other|11
7456143|NCT01788358|11749485|FG000|Overall Study|Logistical difficulties|1
7456144|NCT01788358|11749485|FG000|Overall Study|Lost to Follow-up|5
7456145|NCT01788358|11749485|FG000|Overall Study|Protocol Violation|3
7456146|NCT01788358|11749485|FG000|Overall Study|Withdrawal by Subject|26
7456147|NCT01788358|11749485|FG000|Overall Study|Lack of Efficacy|1
7564391|NCT03285477|11935083|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
7564392|NCT03285477|11935082|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
7564393|NCT03285477|11935083|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
7564394|NCT03285477|11935082|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
7564395|NCT03285477|11935083|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
7564396|NCT03285490|11935092|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7564397|NCT03285490|11935093|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
7564398|NCT03285490|11935092|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
7564399|NCT03285490|11935093|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
7564400|NCT03285594|11935130|FG000|Overall Study|At the Participant's Own Request|10
7564401|NCT03285594|11935131|FG001|Overall Study|At the Participant's Own Request|5
7564402|NCT03285594|11935132|FG002|Overall Study|At the Participant's Own Request|21
7564403|NCT03285594|11935130|FG000|Overall Study|Adverse Event|2
7564404|NCT03285594|11935131|FG001|Overall Study|Adverse Event|2
7564405|NCT03285594|11935132|FG002|Overall Study|Adverse Event|6
7564406|NCT03285594|11935130|FG000|Overall Study|Poor Compliance to Protocol|0
7564407|NCT03285594|11935131|FG001|Overall Study|Poor Compliance to Protocol|0
7456148|NCT01788358|11749485|FG000|Overall Study|Adverse Event|51
7456149|NCT01788423|11749492|FG000|Overall Study|See Comments in Completed (above)|0
7456150|NCT01788423|11749493|FG001|Overall Study|See Comments in Completed (above)|4
7456151|NCT01788423|11749494|FG002|Overall Study|See Comments in Completed (above)|5
7456152|NCT01788566|11749502|FG000|Overall Study|Death|4
7456153|NCT01788566|11749502|FG000|Overall Study|Adverse Event|1
7456154|NCT01788566|11749502|FG000|Overall Study|Clinical Progressive Disease|3
7456155|NCT01788943|11749517|FG000|Overall Study|Withdrawal by Subject|1
7456156|NCT01788943|11749518|FG001|Overall Study|Withdrawal by Subject|0
7456157|NCT01789047|11749526|FG000|Overall Study|Adverse Event|3
7564408|NCT03285594|11935132|FG002|Overall Study|Poor Compliance to Protocol|1
7564409|NCT03285594|11935130|FG000|Overall Study|Lost to Follow-up|0
7564410|NCT03285594|11935131|FG001|Overall Study|Lost to Follow-up|0
7564411|NCT03285594|11935132|FG002|Overall Study|Lost to Follow-up|1
7564412|NCT03285594|11935130|FG000|Overall Study|Reason Not Specified|3
7564413|NCT03285594|11935131|FG001|Overall Study|Reason Not Specified|4
7456158|NCT01789047|11749527|FG001|Overall Study|Adverse Event|2
7456159|NCT01789047|11749526|FG000|Overall Study|Withdrawal by Subject|1
7456160|NCT01789047|11749527|FG001|Overall Study|Withdrawal by Subject|2
7564414|NCT03285594|11935132|FG002|Overall Study|Reason Not Specified|8
7564415|NCT03285646|11935143|FG000|Overall Study|Adverse Event|1
7564416|NCT03285646|11935144|FG001|Overall Study|Adverse Event|0
7456161|NCT01789203|11749544|FG000|Overall Study|Adverse Event|2
7456162|NCT01789203|11749545|FG001|Overall Study|Adverse Event|2
7456163|NCT01789203|11749544|FG000|Overall Study|Withdrawal by Subject|1
7456164|NCT01789203|11749545|FG001|Overall Study|Withdrawal by Subject|0
7456165|NCT01789203|11749544|FG000|Overall Study|Death|1
7456166|NCT01789203|11749545|FG001|Overall Study|Death|0
7456167|NCT01789203|11749544|FG000|Overall Study|Protocol Violation|2
7456168|NCT01789203|11749545|FG001|Overall Study|Protocol Violation|1
7456169|NCT01789203|11749544|FG000|Overall Study|Other|1
7456170|NCT01789203|11749545|FG001|Overall Study|Other|1
7456171|NCT01789203|11749544|FG000|Overall Study|patient non-adherent|2
7456172|NCT01789203|11749545|FG001|Overall Study|patient non-adherent|0
7456173|NCT01789281|11749559|FG000|Overall Study|Disease progression|15
7456174|NCT01789281|11749560|FG001|Overall Study|Disease progression|4
7456175|NCT01789281|11749559|FG000|Overall Study|Adverse Event|5
7456176|NCT01789281|11749560|FG001|Overall Study|Adverse Event|5
7456177|NCT01789281|11749559|FG000|Overall Study|Withdrawal by Subject|1
7456178|NCT01789281|11749560|FG001|Overall Study|Withdrawal by Subject|0
7456179|NCT01789281|11749559|FG000|Overall Study|Lost to Follow-up|1
7456180|NCT01789281|11749560|FG001|Overall Study|Lost to Follow-up|0
7456181|NCT01789281|11749559|FG000|Overall Study|Administrative problems|0
7456182|NCT01789281|11749560|FG001|Overall Study|Administrative problems|1
7456183|NCT01789320|11749567|FG000|Overall Study|Re-enrolled into study|1
7456184|NCT01789320|11749567|FG000|Overall Study|Lost to Follow-up|1
7456185|NCT01789476|11749573|FG000|Overall Study|Lack of Efficacy|6
7456186|NCT01789476|11749574|FG001|Overall Study|Lack of Efficacy|2
7456187|NCT01789476|11749573|FG000|Overall Study|Adverse Event|1
7456188|NCT01789476|11749574|FG001|Overall Study|Adverse Event|0
7456189|NCT01789476|11749573|FG000|Overall Study|Unable to get IV access|1
7456190|NCT01789476|11749574|FG001|Overall Study|Unable to get IV access|0
7456191|NCT01789567|11749580|FG000|Overall Study|Death|6
7456192|NCT01789606|11749586|FG000|Overall Study|Participant not Purchased the Product|0
7456193|NCT01789606|11749587|FG001|Overall Study|Participant not Purchased the Product|20
7456194|NCT01789606|11749586|FG000|Overall Study|Withdrawal by Subject|0
7456195|NCT01789606|11749587|FG001|Overall Study|Withdrawal by Subject|1
7456196|NCT01789606|11749586|FG000|Overall Study|Ineligible|6
7456197|NCT01789606|11749587|FG001|Overall Study|Ineligible|2
7456198|NCT01789606|11749586|FG000|Overall Study|Administrative Reasons|17
7456199|NCT01789606|11749587|FG001|Overall Study|Administrative Reasons|6
7456200|NCT01789606|11749586|FG000|Overall Study|No Study Medication Taken|0
7456201|NCT01789606|11749587|FG001|Overall Study|No Study Medication Taken|1
7456202|NCT01789606|11749586|FG000|Overall Study|Protocol Violation|0
7456203|NCT01789606|11749587|FG001|Overall Study|Protocol Violation|55
7456204|NCT01789606|11749586|FG000|Overall Study|Adverse Event|0
7456205|NCT01789606|11749587|FG001|Overall Study|Adverse Event|3
7456206|NCT01789606|11749586|FG000|Overall Study|Lost to Follow-up|0
7456207|NCT01789606|11749587|FG001|Overall Study|Lost to Follow-up|14
7456208|NCT01789606|11749586|FG000|Overall Study|Ineligible or not Willing to Continue|0
7456209|NCT01789606|11749587|FG001|Overall Study|Ineligible or not Willing to Continue|348
7456210|NCT01789970|11749627|FG000|Open-label Titration Period|Adverse Event|68
7456211|NCT01789970|11749628|FG001|Open-label Titration Period|Adverse Event|0
7456212|NCT01789970|11749629|FG002|Open-label Titration Period|Adverse Event|0
7456213|NCT01789970|11749627|FG000|Open-label Titration Period|Lack of Efficacy|31
7456214|NCT01789970|11749628|FG001|Open-label Titration Period|Lack of Efficacy|0
7456215|NCT01789970|11749629|FG002|Open-label Titration Period|Lack of Efficacy|0
7456216|NCT01789970|11749627|FG000|Open-label Titration Period|Withdrawal by Subject|31
7456217|NCT01789970|11749628|FG001|Open-label Titration Period|Withdrawal by Subject|0
7456218|NCT01789970|11749629|FG002|Open-label Titration Period|Withdrawal by Subject|0
7456219|NCT01789970|11749627|FG000|Open-label Titration Period|Protocol Violation|18
7456220|NCT01789970|11749628|FG001|Open-label Titration Period|Protocol Violation|0
7456221|NCT01789970|11749629|FG002|Open-label Titration Period|Protocol Violation|0
7456222|NCT01789970|11749627|FG000|Open-label Titration Period|Lost to Follow-up|5
7456223|NCT01789970|11749628|FG001|Open-label Titration Period|Lost to Follow-up|0
7456224|NCT01789970|11749629|FG002|Open-label Titration Period|Lost to Follow-up|0
7456225|NCT01789970|11749627|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
7456226|NCT01789970|11749628|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
7456227|NCT01789970|11749629|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
7456228|NCT01789970|11749627|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
7456229|NCT01789970|11749628|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
7456230|NCT01789970|11749629|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
7456231|NCT01789970|11749627|FG000|Open-label Titration Period|Noncompliance with study procedures|8
7456232|NCT01789970|11749628|FG001|Open-label Titration Period|Noncompliance with study procedures|0
7456233|NCT01789970|11749629|FG002|Open-label Titration Period|Noncompliance with study procedures|0
7456234|NCT01789970|11749627|FG000|Open-label Titration Period|Pregnancy|2
7456235|NCT01789970|11749628|FG001|Open-label Titration Period|Pregnancy|0
7456236|NCT01789970|11749629|FG002|Open-label Titration Period|Pregnancy|0
7456237|NCT01789970|11749627|FG000|Open-label Titration Period|Other|76
7456238|NCT01789970|11749628|FG001|Open-label Titration Period|Other|0
7456239|NCT01789970|11749629|FG002|Open-label Titration Period|Other|0
7456240|NCT01789970|11749627|FG000|Open-label Titration Period|Dropped out prior to dosing|2
7456241|NCT01789970|11749628|FG001|Open-label Titration Period|Dropped out prior to dosing|0
7456242|NCT01789970|11749629|FG002|Open-label Titration Period|Dropped out prior to dosing|0
7456243|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
7456244|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
7456245|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
7456246|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7456247|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
7456248|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
7456249|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7456250|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
7456251|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
7456252|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
7456253|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
7456254|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
7456255|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
7456256|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7456257|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
7456258|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
7456259|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
7456260|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
7456261|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
7456262|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
7456263|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
7456264|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7456265|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
7456266|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
7456267|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
7456268|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
7456269|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
7456270|NCT01789970|11749627|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7456271|NCT01789970|11749628|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
7456272|NCT01789970|11749629|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
7456273|NCT01790048|11749645|FG000|Overall Study|Incorrect Age|9
7456274|NCT01790048|11749646|FG001|Overall Study|Incorrect Age|14
7456275|NCT01790048|11749645|FG000|Overall Study|data entry error|0
7456276|NCT01790048|11749646|FG001|Overall Study|data entry error|1
7456277|NCT01790048|11749645|FG000|Overall Study|Other|0
7456278|NCT01790048|11749646|FG001|Overall Study|Other|2
7456279|NCT01790048|11749645|FG000|Overall Study|SAM at Enrollment|2
7456280|NCT01790048|11749646|FG001|Overall Study|SAM at Enrollment|0
7456281|NCT01790048|11749645|FG000|Overall Study|Measurement error|1
7456282|NCT01790048|11749646|FG001|Overall Study|Measurement error|0
7456283|NCT01790113|11749656|FG000|Overall Study|Adverse Event|2
7456284|NCT01790113|11749657|FG001|Overall Study|Adverse Event|7
7456285|NCT01790113|11749656|FG000|Overall Study|Study ended due to FDA clearance|1
7456286|NCT01790113|11749657|FG001|Overall Study|Study ended due to FDA clearance|68
7456287|NCT01790126|11749666|FG000|Overall Study|PSA Progression|12
7456288|NCT01790126|11749667|FG001|Overall Study|PSA Progression|16
7456289|NCT01790126|11749668|FG002|Overall Study|PSA Progression|16
7456290|NCT01790126|11749666|FG000|Overall Study|Other|5
7456291|NCT01790126|11749667|FG001|Overall Study|Other|4
7456292|NCT01790126|11749668|FG002|Overall Study|Other|8
7456293|NCT01790126|11749666|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
7456294|NCT01790126|11749667|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
7456295|NCT01790126|11749668|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
7456296|NCT01790126|11749666|FG000|Overall Study|Withdrawal by Physician|1
7456297|NCT01790126|11749667|FG001|Overall Study|Withdrawal by Physician|1
7456298|NCT01790126|11749668|FG002|Overall Study|Withdrawal by Physician|2
7456299|NCT01790126|11749666|FG000|Overall Study|Withdrawal by Subject|3
7456300|NCT01790126|11749667|FG001|Overall Study|Withdrawal by Subject|1
7456301|NCT01790126|11749668|FG002|Overall Study|Withdrawal by Subject|2
7456302|NCT01790126|11749666|FG000|Overall Study|Lost to Follow-up|1
7456303|NCT01790126|11749667|FG001|Overall Study|Lost to Follow-up|0
7456304|NCT01790126|11749668|FG002|Overall Study|Lost to Follow-up|1
7456305|NCT01790126|11749666|FG000|Overall Study|Adverse Event|0
7456306|NCT01790126|11749667|FG001|Overall Study|Adverse Event|2
7456307|NCT01790126|11749668|FG002|Overall Study|Adverse Event|0
7456308|NCT01790126|11749666|FG000|Overall Study|Death|2
7456309|NCT01790126|11749667|FG001|Overall Study|Death|0
7456310|NCT01790126|11749668|FG002|Overall Study|Death|0
7456311|NCT01790126|11749666|FG000|Overall Study|Radiographic Progression|3
7456312|NCT01790126|11749667|FG001|Overall Study|Radiographic Progression|1
7456313|NCT01790126|11749668|FG002|Overall Study|Radiographic Progression|0
7456314|NCT01790295|11749695|FG000|Overall Study|Adverse Event|1
7456315|NCT01790295|11749695|FG000|Overall Study|Death|4
7456316|NCT01790295|11749695|FG000|Overall Study|Lack of Efficacy|2
7456317|NCT01790295|11749695|FG000|Overall Study|Study closure|4
7456318|NCT01790438|11749702|FG000|Overall Study|Adverse Event|3
7456319|NCT01790438|11749703|FG001|Overall Study|Adverse Event|2
7456320|NCT01790438|11749702|FG000|Overall Study|Death|4
7456321|NCT01790438|11749703|FG001|Overall Study|Death|0
7456322|NCT01790438|11749702|FG000|Overall Study|Lost to Follow-up|5
7456323|NCT01790438|11749703|FG001|Overall Study|Lost to Follow-up|2
7456324|NCT01790438|11749702|FG000|Overall Study|Withdrawal by Subject|13
7456325|NCT01790438|11749703|FG001|Overall Study|Withdrawal by Subject|2
7456326|NCT01790438|11749702|FG000|Overall Study|Physician Decision|3
7456327|NCT01790438|11749703|FG001|Overall Study|Physician Decision|1
7456328|NCT01790438|11749702|FG000|Overall Study|Sponsor Decision|0
7456329|NCT01790438|11749703|FG001|Overall Study|Sponsor Decision|3
7456330|NCT01790438|11749702|FG000|Overall Study|Protocol Required Discontinuation|7
7456331|NCT01790438|11749703|FG001|Overall Study|Protocol Required Discontinuation|1
7456332|NCT01790503|11749738|FG000|Overall Study|Adverse Event|1
7456333|NCT01790503|11749739|FG001|Overall Study|Adverse Event|0
7456334|NCT01790503|11749740|FG002|Overall Study|Adverse Event|0
7456335|NCT01790503|11749741|FG003|Overall Study|Adverse Event|0
7456336|NCT01790503|11749742|FG004|Overall Study|Adverse Event|0
7456337|NCT01790503|11749743|FG005|Overall Study|Adverse Event|2
7456338|NCT01790503|11749744|FG006|Overall Study|Adverse Event|0
7456339|NCT01790503|11749745|FG007|Overall Study|Adverse Event|0
7456340|NCT01790503|11749746|FG008|Overall Study|Adverse Event|2
7456341|NCT01790503|11749747|FG009|Overall Study|Adverse Event|4
7456342|NCT01790503|11749748|FG010|Overall Study|Adverse Event|7
7456343|NCT01790503|11749738|FG000|Overall Study|Withdrawal by Subject|0
7456344|NCT01790503|11749739|FG001|Overall Study|Withdrawal by Subject|0
7456345|NCT01790503|11749740|FG002|Overall Study|Withdrawal by Subject|1
7456346|NCT01790503|11749741|FG003|Overall Study|Withdrawal by Subject|1
7456347|NCT01790503|11749742|FG004|Overall Study|Withdrawal by Subject|1
7456348|NCT01790503|11749743|FG005|Overall Study|Withdrawal by Subject|2
7456349|NCT01790503|11749744|FG006|Overall Study|Withdrawal by Subject|1
7456350|NCT01790503|11749745|FG007|Overall Study|Withdrawal by Subject|0
7456351|NCT01790503|11749746|FG008|Overall Study|Withdrawal by Subject|0
7456352|NCT01790503|11749747|FG009|Overall Study|Withdrawal by Subject|0
7456353|NCT01790503|11749748|FG010|Overall Study|Withdrawal by Subject|1
7456354|NCT01790503|11749738|FG000|Overall Study|Disease progression|2
7456355|NCT01790503|11749739|FG001|Overall Study|Disease progression|1
7456356|NCT01790503|11749740|FG002|Overall Study|Disease progression|0
7456357|NCT01790503|11749741|FG003|Overall Study|Disease progression|1
7456358|NCT01790503|11749742|FG004|Overall Study|Disease progression|2
7456359|NCT01790503|11749743|FG005|Overall Study|Disease progression|1
7456360|NCT01790503|11749744|FG006|Overall Study|Disease progression|0
7456361|NCT01790503|11749745|FG007|Overall Study|Disease progression|1
7456362|NCT01790503|11749746|FG008|Overall Study|Disease progression|0
7456363|NCT01790503|11749747|FG009|Overall Study|Disease progression|17
7456364|NCT01790503|11749748|FG010|Overall Study|Disease progression|7
7456365|NCT01790503|11749738|FG000|Overall Study|Protocol Violation|0
7456366|NCT01790503|11749739|FG001|Overall Study|Protocol Violation|0
7456367|NCT01790503|11749740|FG002|Overall Study|Protocol Violation|0
7456368|NCT01790503|11749741|FG003|Overall Study|Protocol Violation|0
7456369|NCT01790503|11749742|FG004|Overall Study|Protocol Violation|0
7456370|NCT01790503|11749743|FG005|Overall Study|Protocol Violation|0
7456371|NCT01790503|11749744|FG006|Overall Study|Protocol Violation|0
7456372|NCT01790503|11749745|FG007|Overall Study|Protocol Violation|0
7456373|NCT01790503|11749746|FG008|Overall Study|Protocol Violation|0
7456374|NCT01790503|11749747|FG009|Overall Study|Protocol Violation|1
7456375|NCT01790503|11749748|FG010|Overall Study|Protocol Violation|0
7456376|NCT01790503|11749738|FG000|Overall Study|Physician Decision|0
7456377|NCT01790503|11749739|FG001|Overall Study|Physician Decision|0
7456378|NCT01790503|11749740|FG002|Overall Study|Physician Decision|0
7456379|NCT01790503|11749741|FG003|Overall Study|Physician Decision|0
7456380|NCT01790503|11749742|FG004|Overall Study|Physician Decision|0
7456381|NCT01790503|11749743|FG005|Overall Study|Physician Decision|0
7456382|NCT01790503|11749744|FG006|Overall Study|Physician Decision|0
7456383|NCT01790503|11749745|FG007|Overall Study|Physician Decision|0
7456384|NCT01790503|11749746|FG008|Overall Study|Physician Decision|0
7456385|NCT01790503|11749747|FG009|Overall Study|Physician Decision|1
7456386|NCT01790503|11749748|FG010|Overall Study|Physician Decision|1
7456387|NCT01790503|11749738|FG000|Overall Study|Death|0
7456388|NCT01790503|11749739|FG001|Overall Study|Death|0
7456389|NCT01790503|11749740|FG002|Overall Study|Death|0
7456390|NCT01790503|11749741|FG003|Overall Study|Death|0
7456391|NCT01790503|11749742|FG004|Overall Study|Death|0
7456392|NCT01790503|11749743|FG005|Overall Study|Death|0
7456393|NCT01790503|11749744|FG006|Overall Study|Death|0
7456394|NCT01790503|11749745|FG007|Overall Study|Death|0
7456395|NCT01790503|11749746|FG008|Overall Study|Death|0
7456396|NCT01790503|11749747|FG009|Overall Study|Death|1
7456397|NCT01790503|11749748|FG010|Overall Study|Death|0
7456398|NCT01790503|11749738|FG000|Overall Study|Non Compliance|0
7456399|NCT01790503|11749739|FG001|Overall Study|Non Compliance|0
7456400|NCT01790503|11749740|FG002|Overall Study|Non Compliance|0
7456401|NCT01790503|11749741|FG003|Overall Study|Non Compliance|0
7456402|NCT01790503|11749742|FG004|Overall Study|Non Compliance|1
7456403|NCT01790503|11749743|FG005|Overall Study|Non Compliance|0
7456404|NCT01790503|11749744|FG006|Overall Study|Non Compliance|0
7456405|NCT01790503|11749745|FG007|Overall Study|Non Compliance|0
7456406|NCT01790503|11749746|FG008|Overall Study|Non Compliance|0
7456407|NCT01790503|11749747|FG009|Overall Study|Non Compliance|0
7456408|NCT01790503|11749748|FG010|Overall Study|Non Compliance|0
7456409|NCT01790503|11749738|FG000|Overall Study|Other|0
7456410|NCT01790503|11749739|FG001|Overall Study|Other|0
7456411|NCT01790503|11749740|FG002|Overall Study|Other|0
7456412|NCT01790503|11749741|FG003|Overall Study|Other|0
7456413|NCT01790503|11749742|FG004|Overall Study|Other|1
7456414|NCT01790503|11749743|FG005|Overall Study|Other|0
7456415|NCT01790503|11749744|FG006|Overall Study|Other|0
7456416|NCT01790503|11749745|FG007|Overall Study|Other|0
7456417|NCT01790503|11749746|FG008|Overall Study|Other|1
7456418|NCT01790503|11749747|FG009|Overall Study|Other|2
7456419|NCT01790503|11749748|FG010|Overall Study|Other|0
7456420|NCT01790516|11749787|FG000|Overall Study|Physician Decision|1
7456421|NCT01790516|11749788|FG001|Overall Study|Physician Decision|0
7456422|NCT01790568|11749794|FG000|Overall Study|Progression prior to transplant|0
7456423|NCT01790568|11749795|FG001|Overall Study|Progression prior to transplant|1
7456424|NCT01790594|11749810|FG000|Overall Study|Death|1
7456425|NCT01790594|11749811|FG001|Overall Study|Death|0
7456426|NCT01790594|11749812|FG002|Overall Study|Death|0
7456427|NCT01790594|11749810|FG000|Overall Study|Physician Decision|2
7456428|NCT01790594|11749811|FG001|Overall Study|Physician Decision|1
7456429|NCT01790594|11749812|FG002|Overall Study|Physician Decision|0
7456430|NCT01790594|11749810|FG000|Overall Study|Withdrawal by Subject|2
7456431|NCT01790594|11749811|FG001|Overall Study|Withdrawal by Subject|0
7456432|NCT01790594|11749812|FG002|Overall Study|Withdrawal by Subject|0
7456433|NCT01790594|11749810|FG000|Overall Study|Transplant was not done|0
7456434|NCT01790594|11749811|FG001|Overall Study|Transplant was not done|0
7456435|NCT01790594|11749812|FG002|Overall Study|Transplant was not done|3
7456436|NCT01790594|11749810|FG000|Overall Study|Terminated prior to week 76|0
7456437|NCT01790594|11749811|FG001|Overall Study|Terminated prior to week 76|2
7456438|NCT01790594|11749812|FG002|Overall Study|Terminated prior to week 76|0
7456439|NCT01790633|11749821|FG000|Overall Study|Protocol Violation|1
7456440|NCT01790633|11749822|FG001|Overall Study|Protocol Violation|2
7456441|NCT01790633|11749821|FG000|Overall Study|Did not have serology performed|47
7456442|NCT01790633|11749822|FG001|Overall Study|Did not have serology performed|0
7456443|NCT01790633|11749821|FG000|Overall Study|RT failure and no follow-up ELISA|0
7456444|NCT01790633|11749822|FG001|Overall Study|RT failure and no follow-up ELISA|3
7564417|NCT03285646|11935143|FG000|Overall Study|Withdrawal by Subject|10
7564418|NCT03285646|11935144|FG001|Overall Study|Withdrawal by Subject|2
7564419|NCT03285646|11935143|FG000|Overall Study|Lost to Follow-up|2
7564420|NCT03285646|11935144|FG001|Overall Study|Lost to Follow-up|1
7564421|NCT03285646|11935143|FG000|Overall Study|Investigator/Sponsor Decision|0
7564422|NCT03285646|11935144|FG001|Overall Study|Investigator/Sponsor Decision|1
7564423|NCT03285711|11935153|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
7564424|NCT03285711|11935154|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
7564425|NCT03285711|11935155|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
7564426|NCT03285711|11935156|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
7564427|NCT03285711|11935153|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
7564428|NCT03285711|11935154|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
7564429|NCT03285711|11935155|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
7564430|NCT03285711|11935156|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
7564431|NCT03285711|11935153|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7564432|NCT03285711|11935154|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7564433|NCT03285711|11935155|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
7564434|NCT03285711|11935156|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
7564435|NCT03285711|11935153|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7564436|NCT03285711|11935154|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
7564437|NCT03285711|11935155|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7564438|NCT03285711|11935156|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
7564439|NCT03285958|11935172|FG000|Overall Study|Lost to Follow-up|1
7564440|NCT03285958|11935173|FG001|Overall Study|Lost to Follow-up|1
7564441|NCT03285958|11935172|FG000|Overall Study|Withdrawal by Subject|1
7564442|NCT03285958|11935173|FG001|Overall Study|Withdrawal by Subject|0
7456445|NCT01790828|11749852|FG000|Overall Study|Other|34
7456446|NCT01790932|11749856|FG000|Overall Study|Disease Progression|41
7456447|NCT01790932|11749856|FG000|Overall Study|Adverse Event|7
7456448|NCT01790932|11749856|FG000|Overall Study|Physician Decision|1
7456449|NCT01790932|11749856|FG000|Overall Study|Withdrawal by Subject|1
7456450|NCT01790984|11749862|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7456451|NCT01790984|11749863|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
7456452|NCT01790984|11749864|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7456453|NCT01790984|11749865|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
7456454|NCT01791127|11749888|FG000|Overall Study|Death|356
7456455|NCT01791127|11749888|FG000|Overall Study|Patient has withdrawn from study|293
7456456|NCT01791127|11749888|FG000|Overall Study|Lost to Follow-up|42
7564443|NCT03285958|11935172|FG000|Overall Study|Not able to attend required orientation|3
7564444|NCT03285958|11935173|FG001|Overall Study|Not able to attend required orientation|0
7564445|NCT03286218|11935192|FG000|Qualification Phase Period 1|Adverse Event|1
7564446|NCT03286218|11935193|FG001|Qualification Phase Period 1|Adverse Event|0
7564447|NCT03286218|11935194|FG002|Qualification Phase Period 1|Adverse Event|0
7564448|NCT03286218|11935195|FG003|Qualification Phase Period 1|Adverse Event|0
7564449|NCT03286218|11935196|FG004|Qualification Phase Period 1|Adverse Event|0
7564450|NCT03286218|11935197|FG005|Qualification Phase Period 1|Adverse Event|0
7564451|NCT03286218|11935198|FG006|Qualification Phase Period 1|Adverse Event|0
7456457|NCT01791127|11749888|FG000|Overall Study|All Siello leads are explanted|31
7456458|NCT01791127|11749888|FG000|Overall Study|Completion of 30 day safety registry|1
7456459|NCT01791127|11749888|FG000|Overall Study|Study terminated for EP Passion|749
7456460|NCT01791153|11749909|FG000|Part 1: Blinded Period|Adverse Event|7
7456461|NCT01791153|11749910|FG001|Part 1: Blinded Period|Adverse Event|3
7456462|NCT01791153|11749911|FG002|Part 1: Blinded Period|Adverse Event|2
7456463|NCT01791153|11749912|FG003|Part 1: Blinded Period|Adverse Event|0
7456464|NCT01791153|11749913|FG004|Part 1: Blinded Period|Adverse Event|0
7456465|NCT01791153|11749914|FG005|Part 1: Blinded Period|Adverse Event|0
7456466|NCT01791153|11749915|FG006|Part 1: Blinded Period|Adverse Event|0
7456467|NCT01791153|11749916|FG007|Part 1: Blinded Period|Adverse Event|0
7456468|NCT01791153|11749909|FG000|Part 1: Blinded Period|Lack of Efficacy|1
7456469|NCT01791153|11749910|FG001|Part 1: Blinded Period|Lack of Efficacy|3
7456470|NCT01791153|11749911|FG002|Part 1: Blinded Period|Lack of Efficacy|2
7456471|NCT01791153|11749912|FG003|Part 1: Blinded Period|Lack of Efficacy|2
7456472|NCT01791153|11749913|FG004|Part 1: Blinded Period|Lack of Efficacy|0
7456473|NCT01791153|11749914|FG005|Part 1: Blinded Period|Lack of Efficacy|0
7456474|NCT01791153|11749915|FG006|Part 1: Blinded Period|Lack of Efficacy|0
7456475|NCT01791153|11749916|FG007|Part 1: Blinded Period|Lack of Efficacy|0
7456476|NCT01791153|11749909|FG000|Part 1: Blinded Period|Non-Compliance|1
7456477|NCT01791153|11749910|FG001|Part 1: Blinded Period|Non-Compliance|0
7456478|NCT01791153|11749911|FG002|Part 1: Blinded Period|Non-Compliance|0
7456479|NCT01791153|11749912|FG003|Part 1: Blinded Period|Non-Compliance|0
7456480|NCT01791153|11749913|FG004|Part 1: Blinded Period|Non-Compliance|0
7456481|NCT01791153|11749914|FG005|Part 1: Blinded Period|Non-Compliance|0
7456482|NCT01791153|11749915|FG006|Part 1: Blinded Period|Non-Compliance|0
7456483|NCT01791153|11749916|FG007|Part 1: Blinded Period|Non-Compliance|0
7456484|NCT01791153|11749909|FG000|Part 1: Blinded Period|Physician Decision|0
7456485|NCT01791153|11749910|FG001|Part 1: Blinded Period|Physician Decision|0
7456486|NCT01791153|11749911|FG002|Part 1: Blinded Period|Physician Decision|0
7456487|NCT01791153|11749912|FG003|Part 1: Blinded Period|Physician Decision|1
7456488|NCT01791153|11749913|FG004|Part 1: Blinded Period|Physician Decision|0
7456489|NCT01791153|11749914|FG005|Part 1: Blinded Period|Physician Decision|0
7456490|NCT01791153|11749915|FG006|Part 1: Blinded Period|Physician Decision|0
7456491|NCT01791153|11749916|FG007|Part 1: Blinded Period|Physician Decision|0
7456492|NCT01791153|11749909|FG000|Part 1: Blinded Period|Protocol Violation|0
7456493|NCT01791153|11749910|FG001|Part 1: Blinded Period|Protocol Violation|0
7456494|NCT01791153|11749911|FG002|Part 1: Blinded Period|Protocol Violation|0
7456495|NCT01791153|11749912|FG003|Part 1: Blinded Period|Protocol Violation|1
7456496|NCT01791153|11749913|FG004|Part 1: Blinded Period|Protocol Violation|0
7456497|NCT01791153|11749914|FG005|Part 1: Blinded Period|Protocol Violation|0
7456498|NCT01791153|11749915|FG006|Part 1: Blinded Period|Protocol Violation|0
7456499|NCT01791153|11749916|FG007|Part 1: Blinded Period|Protocol Violation|0
7456500|NCT01791153|11749909|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
7456501|NCT01791153|11749910|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
7456502|NCT01791153|11749911|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
7456503|NCT01791153|11749912|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
7456504|NCT01791153|11749913|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
7456505|NCT01791153|11749914|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
7456506|NCT01791153|11749915|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
7456507|NCT01791153|11749916|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
7456508|NCT01791153|11749909|FG000|Part 2: Open-label Period|Adverse Event|0
7456509|NCT01791153|11749910|FG001|Part 2: Open-label Period|Adverse Event|0
7456510|NCT01791153|11749911|FG002|Part 2: Open-label Period|Adverse Event|0
7456511|NCT01791153|11749912|FG003|Part 2: Open-label Period|Adverse Event|0
7456512|NCT01791153|11749913|FG004|Part 2: Open-label Period|Adverse Event|0
7456513|NCT01791153|11749914|FG005|Part 2: Open-label Period|Adverse Event|1
7456514|NCT01791153|11749915|FG006|Part 2: Open-label Period|Adverse Event|1
7456515|NCT01791153|11749916|FG007|Part 2: Open-label Period|Adverse Event|2
7456516|NCT01791153|11749909|FG000|Part 2: Open-label Period|Death|0
7456517|NCT01791153|11749910|FG001|Part 2: Open-label Period|Death|0
7456518|NCT01791153|11749911|FG002|Part 2: Open-label Period|Death|0
7456519|NCT01791153|11749912|FG003|Part 2: Open-label Period|Death|0
7564452|NCT03286218|11935199|FG007|Qualification Phase Period 1|Adverse Event|0
7456520|NCT01791153|11749913|FG004|Part 2: Open-label Period|Death|0
7456521|NCT01791153|11749914|FG005|Part 2: Open-label Period|Death|1
7456522|NCT01791153|11749915|FG006|Part 2: Open-label Period|Death|1
7456523|NCT01791153|11749916|FG007|Part 2: Open-label Period|Death|1
7456524|NCT01791153|11749909|FG000|Part 2: Open-label Period|Lost to Follow-up|0
7456525|NCT01791153|11749910|FG001|Part 2: Open-label Period|Lost to Follow-up|0
7456526|NCT01791153|11749911|FG002|Part 2: Open-label Period|Lost to Follow-up|0
7456527|NCT01791153|11749912|FG003|Part 2: Open-label Period|Lost to Follow-up|0
7456528|NCT01791153|11749913|FG004|Part 2: Open-label Period|Lost to Follow-up|0
7564453|NCT03286218|11935200|FG008|Qualification Phase Period 1|Adverse Event|0
7456529|NCT01791153|11749914|FG005|Part 2: Open-label Period|Lost to Follow-up|0
7456530|NCT01791153|11749915|FG006|Part 2: Open-label Period|Lost to Follow-up|1
7456531|NCT01791153|11749916|FG007|Part 2: Open-label Period|Lost to Follow-up|0
7456532|NCT01791153|11749909|FG000|Part 2: Open-label Period|Lack of Efficacy|0
7564454|NCT03286218|11935201|FG009|Qualification Phase Period 1|Adverse Event|0
7564455|NCT03286218|11935202|FG010|Qualification Phase Period 1|Adverse Event|0
7564456|NCT03286218|11935203|FG011|Qualification Phase Period 1|Adverse Event|0
7564457|NCT03286218|11935192|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
7564458|NCT03286218|11935193|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
7564459|NCT03286218|11935194|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
7564460|NCT03286218|11935195|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
7564461|NCT03286218|11935196|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
7564462|NCT03286218|11935197|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
7456533|NCT01791153|11749910|FG001|Part 2: Open-label Period|Lack of Efficacy|0
7456534|NCT01791153|11749911|FG002|Part 2: Open-label Period|Lack of Efficacy|0
7456535|NCT01791153|11749912|FG003|Part 2: Open-label Period|Lack of Efficacy|0
7456536|NCT01791153|11749913|FG004|Part 2: Open-label Period|Lack of Efficacy|0
7456537|NCT01791153|11749914|FG005|Part 2: Open-label Period|Lack of Efficacy|0
7456538|NCT01791153|11749915|FG006|Part 2: Open-label Period|Lack of Efficacy|0
7456539|NCT01791153|11749916|FG007|Part 2: Open-label Period|Lack of Efficacy|1
7456540|NCT01791153|11749909|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
7456541|NCT01791153|11749910|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
7456542|NCT01791153|11749911|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
7456543|NCT01791153|11749912|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
7456544|NCT01791153|11749913|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
7456545|NCT01791153|11749914|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
7456546|NCT01791153|11749915|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
7456547|NCT01791153|11749916|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
7456548|NCT01791153|11749909|FG000|Part 2: Open-label Period|Physician Decision|0
7456549|NCT01791153|11749910|FG001|Part 2: Open-label Period|Physician Decision|0
7456550|NCT01791153|11749911|FG002|Part 2: Open-label Period|Physician Decision|0
7456551|NCT01791153|11749912|FG003|Part 2: Open-label Period|Physician Decision|0
7456552|NCT01791153|11749913|FG004|Part 2: Open-label Period|Physician Decision|1
7456553|NCT01791153|11749914|FG005|Part 2: Open-label Period|Physician Decision|1
7456554|NCT01791153|11749915|FG006|Part 2: Open-label Period|Physician Decision|0
7456555|NCT01791153|11749916|FG007|Part 2: Open-label Period|Physician Decision|0
7456556|NCT01791205|11749933|FG000|Phase II|Lack of Efficacy|6
7456557|NCT01791205|11749934|FG001|Phase II|Lack of Efficacy|0
7456558|NCT01791205|11749933|FG000|Phase II|Adverse Event|2
7456559|NCT01791205|11749934|FG001|Phase II|Adverse Event|0
7456560|NCT01791205|11749933|FG000|Phase II|Safety|1
7456561|NCT01791205|11749934|FG001|Phase II|Safety|0
7456562|NCT01791205|11749933|FG000|Phase II|Lost to Follow-up|1
7456563|NCT01791205|11749934|FG001|Phase II|Lost to Follow-up|0
7456564|NCT01791205|11749933|FG000|Phase II|Remission of disease|1
7456565|NCT01791205|11749934|FG001|Phase II|Remission of disease|0
7456566|NCT01791205|11749933|FG000|Phase II|Physician's decision|1
7456567|NCT01791205|11749934|FG001|Phase II|Physician's decision|0
7456568|NCT01791244|11749942|FG000|Overall Study|Adverse Event|5
7456569|NCT01791244|11749943|FG001|Overall Study|Adverse Event|7
7456570|NCT01791244|11749942|FG000|Overall Study|Insufficient clinical response|10
7456571|NCT01791244|11749943|FG001|Overall Study|Insufficient clinical response|10
7456572|NCT01791244|11749942|FG000|Overall Study|Laboratory Abnormality|0
7456573|NCT01791244|11749943|FG001|Overall Study|Laboratory Abnormality|1
7456574|NCT01791413|11749953|FG000|Overall Study|Lost to Follow-up|5
7456575|NCT01791413|11749954|FG001|Overall Study|Lost to Follow-up|1
7456576|NCT01791517|11749973|FG000|Phase I: Period 1|Withdrawal by Subject|0
7456577|NCT01791517|11749974|FG001|Phase I: Period 1|Withdrawal by Subject|1
7456578|NCT01791517|11749975|FG002|Phase I: Period 1|Withdrawal by Subject|1
7456579|NCT01791517|11749976|FG003|Phase I: Period 1|Withdrawal by Subject|0
7456580|NCT01791517|11749977|FG004|Phase I: Period 1|Withdrawal by Subject|1
7456581|NCT01791517|11749978|FG005|Phase I: Period 1|Withdrawal by Subject|1
7456582|NCT01791517|11749979|FG006|Phase I: Period 1|Withdrawal by Subject|0
7456583|NCT01791517|11749980|FG007|Phase I: Period 1|Withdrawal by Subject|0
7456584|NCT01791517|11749981|FG008|Phase I: Period 1|Withdrawal by Subject|0
7456585|NCT01791517|11749982|FG009|Phase I: Period 1|Withdrawal by Subject|0
7456586|NCT01791517|11749983|FG010|Phase I: Period 1|Withdrawal by Subject|0
7456587|NCT01791517|11749984|FG011|Phase I: Period 1|Withdrawal by Subject|0
7456588|NCT01791517|11749973|FG000|Phase I: Period 1|Adverse Event|0
7456589|NCT01791517|11749974|FG001|Phase I: Period 1|Adverse Event|0
7456590|NCT01791517|11749975|FG002|Phase I: Period 1|Adverse Event|1
7456591|NCT01791517|11749976|FG003|Phase I: Period 1|Adverse Event|1
7456592|NCT01791517|11749977|FG004|Phase I: Period 1|Adverse Event|0
7456593|NCT01791517|11749978|FG005|Phase I: Period 1|Adverse Event|0
7456594|NCT01791517|11749979|FG006|Phase I: Period 1|Adverse Event|0
7456595|NCT01791517|11749980|FG007|Phase I: Period 1|Adverse Event|0
7456596|NCT01791517|11749981|FG008|Phase I: Period 1|Adverse Event|0
7456597|NCT01791517|11749982|FG009|Phase I: Period 1|Adverse Event|0
7456598|NCT01791517|11749983|FG010|Phase I: Period 1|Adverse Event|0
7564463|NCT03286218|11935198|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
7456599|NCT01791517|11749984|FG011|Phase I: Period 1|Adverse Event|0
7456600|NCT01791517|11749973|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
7456601|NCT01791517|11749974|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456602|NCT01791517|11749975|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456603|NCT01791517|11749976|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456604|NCT01791517|11749977|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456605|NCT01791517|11749978|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456606|NCT01791517|11749979|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456607|NCT01791517|11749980|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456608|NCT01791517|11749981|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456609|NCT01791517|11749982|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456610|NCT01791517|11749983|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456611|NCT01791517|11749984|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
7456612|NCT01791517|11749973|FG000|Phase I: Period 1|Protocol Violation|0
7456613|NCT01791517|11749974|FG001|Phase I: Period 1|Protocol Violation|1
7456614|NCT01791517|11749975|FG002|Phase I: Period 1|Protocol Violation|0
7456615|NCT01791517|11749976|FG003|Phase I: Period 1|Protocol Violation|0
7456616|NCT01791517|11749977|FG004|Phase I: Period 1|Protocol Violation|0
7456617|NCT01791517|11749978|FG005|Phase I: Period 1|Protocol Violation|0
7456618|NCT01791517|11749979|FG006|Phase I: Period 1|Protocol Violation|0
7456619|NCT01791517|11749980|FG007|Phase I: Period 1|Protocol Violation|0
7456620|NCT01791517|11749981|FG008|Phase I: Period 1|Protocol Violation|0
7456621|NCT01791517|11749982|FG009|Phase I: Period 1|Protocol Violation|0
7456622|NCT01791517|11749983|FG010|Phase I: Period 1|Protocol Violation|0
7456623|NCT01791517|11749984|FG011|Phase I: Period 1|Protocol Violation|0
7456624|NCT01791517|11749973|FG000|Phase I: Period 1|Lost to Follow-up|0
7456625|NCT01791517|11749974|FG001|Phase I: Period 1|Lost to Follow-up|0
7456626|NCT01791517|11749975|FG002|Phase I: Period 1|Lost to Follow-up|0
7456627|NCT01791517|11749976|FG003|Phase I: Period 1|Lost to Follow-up|1
7456628|NCT01791517|11749977|FG004|Phase I: Period 1|Lost to Follow-up|0
7456629|NCT01791517|11749978|FG005|Phase I: Period 1|Lost to Follow-up|0
7456630|NCT01791517|11749979|FG006|Phase I: Period 1|Lost to Follow-up|1
7456631|NCT01791517|11749980|FG007|Phase I: Period 1|Lost to Follow-up|0
7456632|NCT01791517|11749981|FG008|Phase I: Period 1|Lost to Follow-up|1
7564464|NCT03286218|11935199|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
7564465|NCT03286218|11935200|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
7564466|NCT03286218|11935201|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
7564467|NCT03286218|11935202|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
7456633|NCT01791517|11749982|FG009|Phase I: Period 1|Lost to Follow-up|1
7456634|NCT01791517|11749983|FG010|Phase I: Period 1|Lost to Follow-up|0
7456635|NCT01791517|11749984|FG011|Phase I: Period 1|Lost to Follow-up|0
7456636|NCT01791517|11749973|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
7456637|NCT01791517|11749974|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
7456638|NCT01791517|11749975|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
7456639|NCT01791517|11749976|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
7456640|NCT01791517|11749977|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
7456641|NCT01791517|11749978|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
7456642|NCT01791517|11749979|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
7456643|NCT01791517|11749980|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
7456644|NCT01791517|11749981|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
7564468|NCT03286218|11935203|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
7564469|NCT03286218|11935192|FG000|Qualification Phase Period 2|Adverse Event|0
7564470|NCT03286218|11935193|FG001|Qualification Phase Period 2|Adverse Event|1
7564471|NCT03286218|11935194|FG002|Qualification Phase Period 2|Adverse Event|0
7564472|NCT03286218|11935195|FG003|Qualification Phase Period 2|Adverse Event|0
7564473|NCT03286218|11935196|FG004|Qualification Phase Period 2|Adverse Event|0
7564474|NCT03286218|11935197|FG005|Qualification Phase Period 2|Adverse Event|0
7564475|NCT03286218|11935198|FG006|Qualification Phase Period 2|Adverse Event|0
7564476|NCT03286218|11935199|FG007|Qualification Phase Period 2|Adverse Event|0
7564477|NCT03286218|11935200|FG008|Qualification Phase Period 2|Adverse Event|0
7564478|NCT03286218|11935201|FG009|Qualification Phase Period 2|Adverse Event|0
7564479|NCT03286218|11935202|FG010|Qualification Phase Period 2|Adverse Event|0
7456645|NCT01791517|11749982|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
7456646|NCT01791517|11749983|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
7456647|NCT01791517|11749984|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
7456648|NCT01791517|11749973|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
7456649|NCT01791517|11749974|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456650|NCT01791517|11749975|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456651|NCT01791517|11749976|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456652|NCT01791517|11749977|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456653|NCT01791517|11749978|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456654|NCT01791517|11749979|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456655|NCT01791517|11749980|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456656|NCT01791517|11749981|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456657|NCT01791517|11749982|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456658|NCT01791517|11749983|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456659|NCT01791517|11749984|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
7456660|NCT01791517|11749973|FG000|Phase I: Period 2|Protocol Violation|0
7456661|NCT01791517|11749974|FG001|Phase I: Period 2|Protocol Violation|0
7456662|NCT01791517|11749975|FG002|Phase I: Period 2|Protocol Violation|0
7456663|NCT01791517|11749976|FG003|Phase I: Period 2|Protocol Violation|1
7456664|NCT01791517|11749977|FG004|Phase I: Period 2|Protocol Violation|0
7456665|NCT01791517|11749978|FG005|Phase I: Period 2|Protocol Violation|0
7456666|NCT01791517|11749979|FG006|Phase I: Period 2|Protocol Violation|0
7456667|NCT01791517|11749980|FG007|Phase I: Period 2|Protocol Violation|0
7456668|NCT01791517|11749981|FG008|Phase I: Period 2|Protocol Violation|0
7456669|NCT01791517|11749982|FG009|Phase I: Period 2|Protocol Violation|0
7456670|NCT01791517|11749983|FG010|Phase I: Period 2|Protocol Violation|0
7456671|NCT01791517|11749984|FG011|Phase I: Period 2|Protocol Violation|0
7456672|NCT01791517|11749973|FG000|Phase I: Period 2|Withdrawal by Subject|0
7456673|NCT01791517|11749974|FG001|Phase I: Period 2|Withdrawal by Subject|0
7456674|NCT01791517|11749975|FG002|Phase I: Period 2|Withdrawal by Subject|0
7456675|NCT01791517|11749976|FG003|Phase I: Period 2|Withdrawal by Subject|0
7456676|NCT01791517|11749977|FG004|Phase I: Period 2|Withdrawal by Subject|0
7456677|NCT01791517|11749978|FG005|Phase I: Period 2|Withdrawal by Subject|0
7456678|NCT01791517|11749979|FG006|Phase I: Period 2|Withdrawal by Subject|0
7456679|NCT01791517|11749980|FG007|Phase I: Period 2|Withdrawal by Subject|0
7456680|NCT01791517|11749981|FG008|Phase I: Period 2|Withdrawal by Subject|0
7456681|NCT01791517|11749982|FG009|Phase I: Period 2|Withdrawal by Subject|1
7456682|NCT01791517|11749983|FG010|Phase I: Period 2|Withdrawal by Subject|1
7456683|NCT01791517|11749984|FG011|Phase I: Period 2|Withdrawal by Subject|0
7456684|NCT01791517|11749973|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
7456685|NCT01791517|11749974|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
7456686|NCT01791517|11749975|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
7456687|NCT01791517|11749976|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
7456688|NCT01791517|11749977|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
7456689|NCT01791517|11749978|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
7456690|NCT01791517|11749979|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
7456691|NCT01791517|11749980|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
7456692|NCT01791517|11749981|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
7456693|NCT01791517|11749982|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
7456694|NCT01791517|11749983|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
7456695|NCT01791517|11749984|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
7456696|NCT01791517|11749973|FG000|Phase I: Period 2|Lens Discomfort|0
7456697|NCT01791517|11749974|FG001|Phase I: Period 2|Lens Discomfort|0
7456698|NCT01791517|11749975|FG002|Phase I: Period 2|Lens Discomfort|0
7456699|NCT01791517|11749976|FG003|Phase I: Period 2|Lens Discomfort|0
7456700|NCT01791517|11749977|FG004|Phase I: Period 2|Lens Discomfort|0
7456701|NCT01791517|11749978|FG005|Phase I: Period 2|Lens Discomfort|1
7564480|NCT03286218|11935203|FG011|Qualification Phase Period 2|Adverse Event|0
7564481|NCT03286218|11935192|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
7564482|NCT03286218|11935193|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
7564483|NCT03286218|11935194|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564484|NCT03286218|11935195|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564485|NCT03286218|11935196|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564486|NCT03286218|11935197|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564487|NCT03286218|11935198|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564488|NCT03286218|11935199|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564489|NCT03286218|11935200|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564490|NCT03286218|11935201|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564491|NCT03286218|11935202|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564492|NCT03286218|11935203|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
7564493|NCT03286218|11935192|FG000|Qualification Phase Period 2|Lost to Follow-up|0
7564494|NCT03286218|11935193|FG001|Qualification Phase Period 2|Lost to Follow-up|1
7564495|NCT03286218|11935194|FG002|Qualification Phase Period 2|Lost to Follow-up|0
7564496|NCT03286218|11935195|FG003|Qualification Phase Period 2|Lost to Follow-up|0
7564497|NCT03286218|11935196|FG004|Qualification Phase Period 2|Lost to Follow-up|0
7564498|NCT03286218|11935197|FG005|Qualification Phase Period 2|Lost to Follow-up|0
7564499|NCT03286218|11935198|FG006|Qualification Phase Period 2|Lost to Follow-up|0
7456702|NCT01791517|11749979|FG006|Phase I: Period 2|Lens Discomfort|0
7456703|NCT01791517|11749980|FG007|Phase I: Period 2|Lens Discomfort|0
7456704|NCT01791517|11749981|FG008|Phase I: Period 2|Lens Discomfort|0
7456705|NCT01791517|11749982|FG009|Phase I: Period 2|Lens Discomfort|0
7456706|NCT01791517|11749983|FG010|Phase I: Period 2|Lens Discomfort|0
7456707|NCT01791517|11749984|FG011|Phase I: Period 2|Lens Discomfort|0
7456708|NCT01791517|11749973|FG000|Phase I: Period 2|Lost to Follow-up|0
7456709|NCT01791517|11749974|FG001|Phase I: Period 2|Lost to Follow-up|3
7456710|NCT01791517|11749975|FG002|Phase I: Period 2|Lost to Follow-up|2
7456711|NCT01791517|11749976|FG003|Phase I: Period 2|Lost to Follow-up|0
7456712|NCT01791517|11749977|FG004|Phase I: Period 2|Lost to Follow-up|0
7456713|NCT01791517|11749978|FG005|Phase I: Period 2|Lost to Follow-up|0
7456714|NCT01791517|11749979|FG006|Phase I: Period 2|Lost to Follow-up|0
7456715|NCT01791517|11749980|FG007|Phase I: Period 2|Lost to Follow-up|0
7456716|NCT01791517|11749981|FG008|Phase I: Period 2|Lost to Follow-up|0
7456717|NCT01791517|11749982|FG009|Phase I: Period 2|Lost to Follow-up|0
7456718|NCT01791517|11749983|FG010|Phase I: Period 2|Lost to Follow-up|0
7456719|NCT01791517|11749984|FG011|Phase I: Period 2|Lost to Follow-up|0
7456720|NCT01791517|11749973|FG000|Phase I: Period 3|Lens Discomfort|0
7456721|NCT01791517|11749974|FG001|Phase I: Period 3|Lens Discomfort|0
7456722|NCT01791517|11749975|FG002|Phase I: Period 3|Lens Discomfort|0
7456723|NCT01791517|11749976|FG003|Phase I: Period 3|Lens Discomfort|0
7456724|NCT01791517|11749977|FG004|Phase I: Period 3|Lens Discomfort|0
7456725|NCT01791517|11749978|FG005|Phase I: Period 3|Lens Discomfort|0
7456726|NCT01791517|11749979|FG006|Phase I: Period 3|Lens Discomfort|0
7456727|NCT01791517|11749980|FG007|Phase I: Period 3|Lens Discomfort|0
7456728|NCT01791517|11749981|FG008|Phase I: Period 3|Lens Discomfort|0
7456729|NCT01791517|11749982|FG009|Phase I: Period 3|Lens Discomfort|0
7456730|NCT01791517|11749983|FG010|Phase I: Period 3|Lens Discomfort|0
7456731|NCT01791517|11749984|FG011|Phase I: Period 3|Lens Discomfort|1
7456732|NCT01791517|11749973|FG000|Phase I: Period 3|Lost to Follow-up|0
7456733|NCT01791517|11749974|FG001|Phase I: Period 3|Lost to Follow-up|1
7456734|NCT01791517|11749975|FG002|Phase I: Period 3|Lost to Follow-up|0
7456735|NCT01791517|11749976|FG003|Phase I: Period 3|Lost to Follow-up|0
7456736|NCT01791517|11749977|FG004|Phase I: Period 3|Lost to Follow-up|1
7456737|NCT01791517|11749978|FG005|Phase I: Period 3|Lost to Follow-up|0
7456738|NCT01791517|11749979|FG006|Phase I: Period 3|Lost to Follow-up|0
7456739|NCT01791517|11749980|FG007|Phase I: Period 3|Lost to Follow-up|0
7456740|NCT01791517|11749981|FG008|Phase I: Period 3|Lost to Follow-up|0
7456741|NCT01791517|11749982|FG009|Phase I: Period 3|Lost to Follow-up|0
7456742|NCT01791517|11749983|FG010|Phase I: Period 3|Lost to Follow-up|0
7564500|NCT03286218|11935199|FG007|Qualification Phase Period 2|Lost to Follow-up|0
7564501|NCT03286218|11935200|FG008|Qualification Phase Period 2|Lost to Follow-up|0
7564502|NCT03286218|11935201|FG009|Qualification Phase Period 2|Lost to Follow-up|0
7564503|NCT03286218|11935202|FG010|Qualification Phase Period 2|Lost to Follow-up|0
7564504|NCT03286218|11935203|FG011|Qualification Phase Period 2|Lost to Follow-up|0
7564505|NCT03286218|11935192|FG000|Qualification Phase Period 2|Protocol Violation|2
7564506|NCT03286218|11935193|FG001|Qualification Phase Period 2|Protocol Violation|0
7564507|NCT03286218|11935194|FG002|Qualification Phase Period 2|Protocol Violation|0
7564508|NCT03286218|11935195|FG003|Qualification Phase Period 2|Protocol Violation|0
7564509|NCT03286218|11935196|FG004|Qualification Phase Period 2|Protocol Violation|0
7564510|NCT03286218|11935197|FG005|Qualification Phase Period 2|Protocol Violation|0
7564511|NCT03286218|11935198|FG006|Qualification Phase Period 2|Protocol Violation|0
7564512|NCT03286218|11935199|FG007|Qualification Phase Period 2|Protocol Violation|0
7564513|NCT03286218|11935200|FG008|Qualification Phase Period 2|Protocol Violation|0
7564514|NCT03286218|11935201|FG009|Qualification Phase Period 2|Protocol Violation|0
7564515|NCT03286218|11935202|FG010|Qualification Phase Period 2|Protocol Violation|0
7564516|NCT03286218|11935203|FG011|Qualification Phase Period 2|Protocol Violation|0
7564517|NCT03286218|11935192|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
7564518|NCT03286218|11935193|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
7564519|NCT03286218|11935194|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
7564520|NCT03286218|11935195|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
7564521|NCT03286218|11935196|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
7564522|NCT03286218|11935197|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
7564523|NCT03286218|11935198|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
7564524|NCT03286218|11935199|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
7564525|NCT03286218|11935200|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
7564526|NCT03286218|11935201|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
7564527|NCT03286218|11935202|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
7564528|NCT03286218|11935203|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
7564529|NCT03286218|11935192|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
7564530|NCT03286218|11935193|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
7564531|NCT03286218|11935194|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
7564532|NCT03286218|11935195|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
7564533|NCT03286218|11935196|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
7564534|NCT03286218|11935197|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
7564535|NCT03286218|11935198|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
7564536|NCT03286218|11935199|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
7456743|NCT01791517|11749984|FG011|Phase I: Period 3|Lost to Follow-up|0
7456744|NCT01791517|11749973|FG000|Phase I: Period 3|Adverse Event|0
7456745|NCT01791517|11749974|FG001|Phase I: Period 3|Adverse Event|0
7456746|NCT01791517|11749975|FG002|Phase I: Period 3|Adverse Event|0
7456747|NCT01791517|11749976|FG003|Phase I: Period 3|Adverse Event|1
7456748|NCT01791517|11749977|FG004|Phase I: Period 3|Adverse Event|0
7456749|NCT01791517|11749978|FG005|Phase I: Period 3|Adverse Event|0
7456750|NCT01791517|11749979|FG006|Phase I: Period 3|Adverse Event|0
7456751|NCT01791517|11749980|FG007|Phase I: Period 3|Adverse Event|0
7456752|NCT01791517|11749981|FG008|Phase I: Period 3|Adverse Event|0
7456753|NCT01791517|11749982|FG009|Phase I: Period 3|Adverse Event|0
7456754|NCT01791517|11749983|FG010|Phase I: Period 3|Adverse Event|0
7456755|NCT01791517|11749984|FG011|Phase I: Period 3|Adverse Event|0
7456756|NCT01791517|11749973|FG000|Phase II|Lost to Follow-up|1
7456757|NCT01791517|11749974|FG001|Phase II|Lost to Follow-up|0
7456758|NCT01791517|11749975|FG002|Phase II|Lost to Follow-up|1
7456759|NCT01791517|11749976|FG003|Phase II|Lost to Follow-up|0
7456760|NCT01791517|11749977|FG004|Phase II|Lost to Follow-up|1
7456761|NCT01791517|11749978|FG005|Phase II|Lost to Follow-up|2
7456762|NCT01791517|11749979|FG006|Phase II|Lost to Follow-up|0
7456763|NCT01791517|11749980|FG007|Phase II|Lost to Follow-up|1
7456764|NCT01791517|11749981|FG008|Phase II|Lost to Follow-up|1
7456765|NCT01791517|11749982|FG009|Phase II|Lost to Follow-up|1
7456766|NCT01791517|11749983|FG010|Phase II|Lost to Follow-up|0
7456767|NCT01791517|11749984|FG011|Phase II|Lost to Follow-up|0
7456768|NCT01791517|11749973|FG000|Phase II|Withdrawal by Subject|1
7456769|NCT01791517|11749974|FG001|Phase II|Withdrawal by Subject|0
7456770|NCT01791517|11749975|FG002|Phase II|Withdrawal by Subject|0
7456771|NCT01791517|11749976|FG003|Phase II|Withdrawal by Subject|0
7456772|NCT01791517|11749977|FG004|Phase II|Withdrawal by Subject|0
7456773|NCT01791517|11749978|FG005|Phase II|Withdrawal by Subject|2
7456774|NCT01791517|11749979|FG006|Phase II|Withdrawal by Subject|0
7456775|NCT01791517|11749980|FG007|Phase II|Withdrawal by Subject|1
7456776|NCT01791517|11749981|FG008|Phase II|Withdrawal by Subject|0
7456777|NCT01791517|11749982|FG009|Phase II|Withdrawal by Subject|0
7456778|NCT01791517|11749983|FG010|Phase II|Withdrawal by Subject|1
7456779|NCT01791517|11749984|FG011|Phase II|Withdrawal by Subject|0
7456780|NCT01791517|11749973|FG000|Phase II|Lack of Efficacy|0
7456781|NCT01791517|11749974|FG001|Phase II|Lack of Efficacy|0
7456782|NCT01791517|11749975|FG002|Phase II|Lack of Efficacy|0
7456783|NCT01791517|11749976|FG003|Phase II|Lack of Efficacy|0
7456784|NCT01791517|11749977|FG004|Phase II|Lack of Efficacy|1
7456785|NCT01791517|11749978|FG005|Phase II|Lack of Efficacy|0
7456786|NCT01791517|11749979|FG006|Phase II|Lack of Efficacy|0
7456787|NCT01791517|11749980|FG007|Phase II|Lack of Efficacy|0
7456788|NCT01791517|11749981|FG008|Phase II|Lack of Efficacy|0
7456789|NCT01791517|11749982|FG009|Phase II|Lack of Efficacy|0
7456790|NCT01791517|11749983|FG010|Phase II|Lack of Efficacy|0
7456791|NCT01791517|11749984|FG011|Phase II|Lack of Efficacy|0
7564537|NCT03286218|11935200|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
7564538|NCT03286218|11935201|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
7564539|NCT03286218|11935202|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
7564540|NCT03286218|11935203|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
7564541|NCT03286218|11935192|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
7564542|NCT03286218|11935193|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
7564543|NCT03286218|11935194|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
7564544|NCT03286218|11935195|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
7564545|NCT03286218|11935196|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
7564546|NCT03286218|11935197|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
7564547|NCT03286218|11935198|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
7564548|NCT03286218|11935199|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
7564549|NCT03286218|11935200|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
7564550|NCT03286218|11935201|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
7564551|NCT03286218|11935202|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
7564552|NCT03286218|11935203|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
7564553|NCT03286400|11935234|FG000|Overall Study|Death|10
7564554|NCT03286400|11935234|FG000|Overall Study|Lost to Follow-up|10
7564555|NCT03286400|11935234|FG000|Overall Study|Physician Decision|1
7564556|NCT03286400|11935234|FG000|Overall Study|Scheduling difficulty|4
7575028|NCT03707912|11958437|FG001|Overall Study|Violation of inclusion criteria|0
7575029|NCT03708211|11958445|FG000|Overall Study|Progressive Disease|10
7575030|NCT03708211|11958446|FG001|Overall Study|Progressive Disease|7
7575031|NCT03708211|11958445|FG000|Overall Study|Withdrawal by Subject|0
7575032|NCT03708211|11958446|FG001|Overall Study|Withdrawal by Subject|1
7575033|NCT03708211|11958445|FG000|Overall Study|Other|2
7575034|NCT03708211|11958446|FG001|Overall Study|Other|0
7575035|NCT03708744|11958477|FG000|Overall Study|Withdrawal by Subject|0
7575036|NCT03708744|11958478|FG001|Overall Study|Withdrawal by Subject|0
7575037|NCT03708744|11958479|FG002|Overall Study|Withdrawal by Subject|1
7575038|NCT03708744|11958480|FG003|Overall Study|Withdrawal by Subject|0
7575039|NCT03709654|11958507|FG000|Overall Study|Lost to Follow-up|1
7575040|NCT03709654|11958508|FG001|Overall Study|Lost to Follow-up|1
7456792|NCT01791517|11749973|FG000|Phase II|Adverse Event|0
7456793|NCT01791517|11749974|FG001|Phase II|Adverse Event|0
7456794|NCT01791517|11749975|FG002|Phase II|Adverse Event|0
7456795|NCT01791517|11749976|FG003|Phase II|Adverse Event|0
7456796|NCT01791517|11749977|FG004|Phase II|Adverse Event|0
7456797|NCT01791517|11749978|FG005|Phase II|Adverse Event|0
7456798|NCT01791517|11749979|FG006|Phase II|Adverse Event|2
7456799|NCT01791517|11749980|FG007|Phase II|Adverse Event|1
7456800|NCT01791517|11749981|FG008|Phase II|Adverse Event|0
7456801|NCT01791517|11749982|FG009|Phase II|Adverse Event|1
7456802|NCT01791517|11749983|FG010|Phase II|Adverse Event|0
7456803|NCT01791517|11749984|FG011|Phase II|Adverse Event|0
7575041|NCT03709654|11958507|FG000|Overall Study|Withdrawal by Subject|1
7575042|NCT03709654|11958508|FG001|Overall Study|Withdrawal by Subject|1
7456804|NCT01791517|11749973|FG000|Phase II|Lens Handling Difficulties|0
7456805|NCT01791517|11749974|FG001|Phase II|Lens Handling Difficulties|0
7456806|NCT01791517|11749975|FG002|Phase II|Lens Handling Difficulties|0
7456807|NCT01791517|11749976|FG003|Phase II|Lens Handling Difficulties|0
7456808|NCT01791517|11749977|FG004|Phase II|Lens Handling Difficulties|0
7456809|NCT01791517|11749978|FG005|Phase II|Lens Handling Difficulties|0
7456810|NCT01791517|11749979|FG006|Phase II|Lens Handling Difficulties|0
7564557|NCT03286543|11935249|FG000|Consented|Screen failure before randomization|2
7564558|NCT03286543|11935250|FG001|Consented|Screen failure before randomization|0
7564559|NCT03286543|11935251|FG002|Consented|Screen failure before randomization|0
7564560|NCT03286543|11935249|FG000|Consented|Screen failure before enrollment|4
7564561|NCT03286543|11935250|FG001|Consented|Screen failure before enrollment|0
7564562|NCT03286543|11935251|FG002|Consented|Screen failure before enrollment|0
7329072|NCT00799617|11562024|FG001|Sexual Funtion Trial|Lost to Follow-up|14
7329073|NCT00799617|11562023|FG000|Sexual Funtion Trial|No Baseline Data|4
7329074|NCT00799617|11562024|FG001|Sexual Funtion Trial|No Baseline Data|7
7329075|NCT00799617|11562023|FG000|Physical Function Trial|Lost to Follow-up|6
7329076|NCT00799617|11562024|FG001|Physical Function Trial|Lost to Follow-up|11
7329077|NCT00799617|11562023|FG000|Vitality Trial|Lost to Follow-up|7
7329078|NCT00799617|11562024|FG001|Vitality Trial|Lost to Follow-up|22
7329079|NCT00799617|11562023|FG000|Cardiovascular Trial|Month 12 scan not available|15
7329080|NCT00799617|11562024|FG001|Cardiovascular Trial|Month 12 scan not available|15
7329081|NCT00799617|11562023|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
7329082|NCT00799617|11562024|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
7329083|NCT00799617|11562023|FG000|Bone Trial|Month 12 scan not available|6
7329084|NCT00799617|11562024|FG001|Bone Trial|Month 12 scan not available|16
7329085|NCT00799617|11562023|FG000|Cognitive Function Trial|Lost to Follow-up|0
7329086|NCT00799617|11562024|FG001|Cognitive Function Trial|Lost to Follow-up|1
7329087|NCT00799617|11562023|FG000|Anemia Trial|Withdrawal by Subject|3
7329088|NCT00799617|11562024|FG001|Anemia Trial|Withdrawal by Subject|3
7456811|NCT01791517|11749980|FG007|Phase II|Lens Handling Difficulties|0
7456812|NCT01791517|11749981|FG008|Phase II|Lens Handling Difficulties|1
7564563|NCT03286543|11935249|FG000|Consented|TKA cancelled after enrollment|1
7564564|NCT03286543|11935250|FG001|Consented|TKA cancelled after enrollment|0
7564565|NCT03286543|11935251|FG002|Consented|TKA cancelled after enrollment|0
7564566|NCT03286543|11935249|FG000|Consented|Withdrawn from study|12
7564567|NCT03286543|11935250|FG001|Consented|Withdrawn from study|0
7564568|NCT03286543|11935251|FG002|Consented|Withdrawn from study|0
7564569|NCT03286543|11935249|FG000|Study Enrollment|TKA cancelled after enrollment|0
7564570|NCT03286543|11935250|FG001|Study Enrollment|TKA cancelled after enrollment|0
7564571|NCT03286543|11935251|FG002|Study Enrollment|TKA cancelled after enrollment|1
7564572|NCT03286543|11935249|FG000|Study Enrollment|Withdrawn from study|0
7564573|NCT03286543|11935250|FG001|Study Enrollment|Withdrawn from study|6
7564574|NCT03286543|11935251|FG002|Study Enrollment|Withdrawn from study|6
7564575|NCT03286751|11935257|FG000|Washout Period 1|Withdrawal by Subject|0
7564576|NCT03286751|11935258|FG001|Washout Period 1|Withdrawal by Subject|0
7564577|NCT03286751|11935259|FG002|Washout Period 1|Withdrawal by Subject|0
7564578|NCT03286751|11935260|FG003|Washout Period 1|Withdrawal by Subject|0
7564579|NCT03286751|11935261|FG004|Washout Period 1|Withdrawal by Subject|1
7564580|NCT03286751|11935262|FG005|Washout Period 1|Withdrawal by Subject|0
7564581|NCT03286751|11935257|FG000|Washout Period 2|Personal Reasons|0
7564582|NCT03286751|11935258|FG001|Washout Period 2|Personal Reasons|1
7564583|NCT03286751|11935259|FG002|Washout Period 2|Personal Reasons|0
7564584|NCT03286751|11935260|FG003|Washout Period 2|Personal Reasons|0
7564585|NCT03286751|11935261|FG004|Washout Period 2|Personal Reasons|0
7564586|NCT03286751|11935262|FG005|Washout Period 2|Personal Reasons|0
7564587|NCT03286751|11935257|FG000|Washout Period 5|Adverse Event|0
7564588|NCT03286751|11935258|FG001|Washout Period 5|Adverse Event|0
7456813|NCT01791517|11749982|FG009|Phase II|Lens Handling Difficulties|0
7456814|NCT01791517|11749983|FG010|Phase II|Lens Handling Difficulties|0
7456815|NCT01791517|11749984|FG011|Phase II|Lens Handling Difficulties|0
7456816|NCT01791517|11749973|FG000|Phase II|Unsatisfactory Lens Fitting|0
7456817|NCT01791517|11749974|FG001|Phase II|Unsatisfactory Lens Fitting|0
7456818|NCT01791517|11749975|FG002|Phase II|Unsatisfactory Lens Fitting|0
7456819|NCT01791517|11749976|FG003|Phase II|Unsatisfactory Lens Fitting|0
7456820|NCT01791517|11749977|FG004|Phase II|Unsatisfactory Lens Fitting|0
7456821|NCT01791517|11749978|FG005|Phase II|Unsatisfactory Lens Fitting|0
7456822|NCT01791517|11749979|FG006|Phase II|Unsatisfactory Lens Fitting|0
7456823|NCT01791517|11749980|FG007|Phase II|Unsatisfactory Lens Fitting|0
7456824|NCT01791517|11749981|FG008|Phase II|Unsatisfactory Lens Fitting|0
7456825|NCT01791517|11749982|FG009|Phase II|Unsatisfactory Lens Fitting|1
7456826|NCT01791517|11749983|FG010|Phase II|Unsatisfactory Lens Fitting|0
7456827|NCT01791517|11749984|FG011|Phase II|Unsatisfactory Lens Fitting|0
7456828|NCT01791517|11749973|FG000|Phase II|Pre-Existing Ocular Issue|0
7456829|NCT01791517|11749974|FG001|Phase II|Pre-Existing Ocular Issue|0
7456830|NCT01791517|11749975|FG002|Phase II|Pre-Existing Ocular Issue|0
7456831|NCT01791517|11749976|FG003|Phase II|Pre-Existing Ocular Issue|0
7456832|NCT01791517|11749977|FG004|Phase II|Pre-Existing Ocular Issue|0
7564589|NCT03286751|11935259|FG002|Washout Period 5|Adverse Event|0
7564590|NCT03286751|11935260|FG003|Washout Period 5|Adverse Event|0
7564591|NCT03286751|11935261|FG004|Washout Period 5|Adverse Event|1
7564592|NCT03286751|11935262|FG005|Washout Period 5|Adverse Event|0
7564593|NCT03287219|11935297|FG000|Overall Study|Protocol Violation|0
7564594|NCT03287219|11935298|FG001|Overall Study|Protocol Violation|2
7564595|NCT03287622|11935372|FG000|Overall Study|Withdrawal by Subject|1
7564596|NCT03287622|11935373|FG001|Overall Study|Withdrawal by Subject|0
7564597|NCT03287622|11935372|FG000|Overall Study|Lost to Follow-up|27
7564598|NCT03287622|11935373|FG001|Overall Study|Lost to Follow-up|15
7564599|NCT03287622|11935372|FG000|Overall Study|No prescripion after surgery|28
7564600|NCT03287622|11935373|FG001|Overall Study|No prescripion after surgery|31
7564601|NCT03287622|11935372|FG000|Overall Study|prolonged Length of stay|2
7564602|NCT03287622|11935373|FG001|Overall Study|prolonged Length of stay|0
7564603|NCT03287622|11935372|FG000|Overall Study|surgery related|0
7564604|NCT03287622|11935373|FG001|Overall Study|surgery related|2
7564605|NCT03287635|11935386|FG000|Overall Study|Lost to Follow-up|5
7564606|NCT03287635|11935386|FG000|Overall Study|Withdrawal by Subject|1
7564607|NCT03287635|11935386|FG000|Overall Study|Physician Decision|1
7564608|NCT03287791|11935398|FG000|Overall Study|Insufficient Therapeutic Response|0
7564609|NCT03287791|11935399|FG001|Overall Study|Insufficient Therapeutic Response|0
7564610|NCT03287791|11935400|FG002|Overall Study|Insufficient Therapeutic Response|1
7564611|NCT03287791|11935398|FG000|Overall Study|Adverse Event|0
7564612|NCT03287791|11935399|FG001|Overall Study|Adverse Event|4
7564613|NCT03287791|11935400|FG002|Overall Study|Adverse Event|3
7564614|NCT03287791|11935398|FG000|Overall Study|Withdrawal by Subject|12
7329089|NCT00799708|11562043|FG000|Overall Study|non-compliance|1
7329090|NCT00799708|11562044|FG001|Overall Study|non-compliance|0
7329091|NCT00799708|11562045|FG002|Overall Study|non-compliance|0
7329092|NCT00799825|11562067|FG000|Overall Study|Adverse Event|1
7329093|NCT00799825|11562067|FG000|Overall Study|Withdrawal by Subject|6
7329094|NCT00799825|11562067|FG000|Overall Study|Lost to Follow-up|38
7329095|NCT00799825|11562067|FG000|Overall Study|Pregnancy|3
7329096|NCT00799903|11562073|FG000|Overall Study|Investigator Site Closed|25
7329097|NCT00799903|11562074|FG001|Overall Study|Investigator Site Closed|23
7329098|NCT00799903|11562073|FG000|Overall Study|Withdrawal by Subject|179
7329099|NCT00799903|11562074|FG001|Overall Study|Withdrawal by Subject|175
7329100|NCT00799903|11562073|FG000|Overall Study|Lost to Follow-up|69
7329101|NCT00799903|11562074|FG001|Overall Study|Lost to Follow-up|80
7329102|NCT00800176|11562100|FG000|Overall Study|Adverse Event|2
7329103|NCT00800176|11562101|FG001|Overall Study|Adverse Event|1
7329104|NCT00800176|11562102|FG002|Overall Study|Adverse Event|0
7329105|NCT00800176|11562103|FG003|Overall Study|Adverse Event|2
7329106|NCT00800176|11562104|FG004|Overall Study|Adverse Event|1
7329107|NCT00800176|11562105|FG005|Overall Study|Adverse Event|1
7329108|NCT00800176|11562100|FG000|Overall Study|Refused treatment|3
7329109|NCT00800176|11562101|FG001|Overall Study|Refused treatment|2
7329110|NCT00800176|11562102|FG002|Overall Study|Refused treatment|0
7329111|NCT00800176|11562103|FG003|Overall Study|Refused treatment|0
7329112|NCT00800176|11562104|FG004|Overall Study|Refused treatment|1
7329113|NCT00800176|11562105|FG005|Overall Study|Refused treatment|4
7329114|NCT00800176|11562100|FG000|Overall Study|Failure to return|3
7456833|NCT01791517|11749978|FG005|Phase II|Pre-Existing Ocular Issue|0
7456834|NCT01791517|11749979|FG006|Phase II|Pre-Existing Ocular Issue|0
7456835|NCT01791517|11749980|FG007|Phase II|Pre-Existing Ocular Issue|0
7456836|NCT01791517|11749981|FG008|Phase II|Pre-Existing Ocular Issue|0
7456837|NCT01791517|11749982|FG009|Phase II|Pre-Existing Ocular Issue|0
7329115|NCT00800176|11562101|FG001|Overall Study|Failure to return|3
7329116|NCT00800176|11562102|FG002|Overall Study|Failure to return|0
7329117|NCT00800176|11562103|FG003|Overall Study|Failure to return|2
7329118|NCT00800176|11562104|FG004|Overall Study|Failure to return|0
7329119|NCT00800176|11562105|FG005|Overall Study|Failure to return|0
7329120|NCT00800176|11562100|FG000|Overall Study|Other|1
7329121|NCT00800176|11562101|FG001|Overall Study|Other|0
7456838|NCT01791517|11749983|FG010|Phase II|Pre-Existing Ocular Issue|0
7456839|NCT01791517|11749984|FG011|Phase II|Pre-Existing Ocular Issue|1
7456840|NCT01791725|11750005|FG000|Overall Study|Withdrawal by Subject|0
7456841|NCT01791725|11750006|FG001|Overall Study|Withdrawal by Subject|1
7456842|NCT01791725|11750007|FG002|Overall Study|Withdrawal by Subject|0
7564615|NCT03287791|11935399|FG001|Overall Study|Withdrawal by Subject|12
7564616|NCT03287791|11935400|FG002|Overall Study|Withdrawal by Subject|17
7564617|NCT03287791|11935398|FG000|Overall Study|Missed more than 6 consecutive doses|3
7564618|NCT03287791|11935399|FG001|Overall Study|Missed more than 6 consecutive doses|2
7564619|NCT03287791|11935400|FG002|Overall Study|Missed more than 6 consecutive doses|2
7564620|NCT03287791|11935398|FG000|Overall Study|Lost to Follow-up|8
7456843|NCT01791803|11750019|FG000|Overall Study|Withdrawal by Subject|0
7456844|NCT01791803|11750020|FG001|Overall Study|Withdrawal by Subject|0
7456845|NCT01791803|11750021|FG002|Overall Study|Withdrawal by Subject|0
7456846|NCT01791803|11750022|FG003|Overall Study|Withdrawal by Subject|2
7456847|NCT01791803|11750019|FG000|Overall Study|Physician Decision|0
7456848|NCT01791803|11750020|FG001|Overall Study|Physician Decision|2
7456849|NCT01791803|11750021|FG002|Overall Study|Physician Decision|0
7456850|NCT01791803|11750022|FG003|Overall Study|Physician Decision|1
7456851|NCT01791803|11750019|FG000|Overall Study|Death|0
7456852|NCT01791803|11750020|FG001|Overall Study|Death|0
7456853|NCT01791803|11750021|FG002|Overall Study|Death|2
7456854|NCT01791803|11750022|FG003|Overall Study|Death|2
7456855|NCT01791894|11750035|FG000|Overall Study|Adverse Event|1
7456856|NCT01792115|11750056|FG000|Overall Study|Lost to Follow-up|0
7456857|NCT01792115|11750057|FG001|Overall Study|Lost to Follow-up|1
7456858|NCT01792115|11750058|FG002|Overall Study|Lost to Follow-up|0
7456859|NCT01792284|11750066|FG000|Lead-in Period|Adverse Event|15
7456860|NCT01792284|11750067|FG001|Lead-in Period|Adverse Event|0
7456861|NCT01792284|11750068|FG002|Lead-in Period|Adverse Event|0
7456862|NCT01792284|11750066|FG000|Lead-in Period|Lost to Follow-up|2
7456863|NCT01792284|11750067|FG001|Lead-in Period|Lost to Follow-up|0
7456864|NCT01792284|11750068|FG002|Lead-in Period|Lost to Follow-up|0
7456865|NCT01792284|11750066|FG000|Lead-in Period|Protocol Violation|1
7456866|NCT01792284|11750067|FG001|Lead-in Period|Protocol Violation|0
7456867|NCT01792284|11750068|FG002|Lead-in Period|Protocol Violation|0
7456868|NCT01792284|11750066|FG000|Lead-in Period|Withdrawal by Subject|10
7456869|NCT01792284|11750067|FG001|Lead-in Period|Withdrawal by Subject|0
7456870|NCT01792284|11750068|FG002|Lead-in Period|Withdrawal by Subject|0
7456871|NCT01792284|11750066|FG000|Lead-in Period|Physician Decision|1
7456872|NCT01792284|11750067|FG001|Lead-in Period|Physician Decision|0
7456873|NCT01792284|11750068|FG002|Lead-in Period|Physician Decision|0
7456874|NCT01792284|11750066|FG000|Lead-in Period|Protocol Required Discontinuation|1
7456875|NCT01792284|11750067|FG001|Lead-in Period|Protocol Required Discontinuation|0
7456876|NCT01792284|11750068|FG002|Lead-in Period|Protocol Required Discontinuation|0
7456877|NCT01792284|11750066|FG000|Randomization Period 1|Withdrawal by Subject|0
7456878|NCT01792284|11750067|FG001|Randomization Period 1|Withdrawal by Subject|1
7456879|NCT01792284|11750068|FG002|Randomization Period 1|Withdrawal by Subject|1
7456880|NCT01792284|11750066|FG000|Randomization Period 1|Physician Decision|0
7456881|NCT01792284|11750067|FG001|Randomization Period 1|Physician Decision|1
7456882|NCT01792284|11750068|FG002|Randomization Period 1|Physician Decision|1
7456883|NCT01792284|11750066|FG000|Randomization Period 1|Adverse Event|0
7456884|NCT01792284|11750067|FG001|Randomization Period 1|Adverse Event|0
7456885|NCT01792284|11750068|FG002|Randomization Period 1|Adverse Event|2
7456886|NCT01792284|11750066|FG000|Randomization Period 1|Lost to Follow-up|0
7456887|NCT01792284|11750067|FG001|Randomization Period 1|Lost to Follow-up|0
7456888|NCT01792284|11750068|FG002|Randomization Period 1|Lost to Follow-up|1
7456889|NCT01792284|11750066|FG000|Randomization Period 2|Protocol Violation|0
7456890|NCT01792284|11750067|FG001|Randomization Period 2|Protocol Violation|1
7456891|NCT01792284|11750068|FG002|Randomization Period 2|Protocol Violation|0
7456892|NCT01792284|11750066|FG000|Randomization Period 2|Withdrawal by Subject|0
7456893|NCT01792284|11750067|FG001|Randomization Period 2|Withdrawal by Subject|2
7456894|NCT01792284|11750068|FG002|Randomization Period 2|Withdrawal by Subject|0
7564621|NCT03287791|11935399|FG001|Overall Study|Lost to Follow-up|14
7564622|NCT03287791|11935400|FG002|Overall Study|Lost to Follow-up|11
7564623|NCT03287791|11935398|FG000|Overall Study|Protocol Violation|7
7564624|NCT03287791|11935399|FG001|Overall Study|Protocol Violation|2
7564625|NCT03287791|11935400|FG002|Overall Study|Protocol Violation|1
7564626|NCT03287791|11935398|FG000|Overall Study|Participant was enrolled at 2 sites|1
7564627|NCT03287791|11935399|FG001|Overall Study|Participant was enrolled at 2 sites|0
7564628|NCT03287791|11935400|FG002|Overall Study|Participant was enrolled at 2 sites|1
7456895|NCT01792518|11750078|FG000|Overall Study|Adverse Event|3
7456896|NCT01792518|11750079|FG001|Overall Study|Adverse Event|4
7456897|NCT01792518|11750078|FG000|Overall Study|Protocol Violation|0
7564629|NCT03287791|11935398|FG000|Overall Study|Too much time between 2 visits|0
7564630|NCT03287791|11935399|FG001|Overall Study|Too much time between 2 visits|1
7456898|NCT01792518|11750079|FG001|Overall Study|Protocol Violation|1
7456899|NCT01792518|11750078|FG000|Overall Study|Lost to Follow-up|3
7456900|NCT01792518|11750079|FG001|Overall Study|Lost to Follow-up|1
7456901|NCT01792518|11750078|FG000|Overall Study|Withdrawal by Subject|2
7456902|NCT01792518|11750079|FG001|Overall Study|Withdrawal by Subject|0
7456903|NCT01792518|11750078|FG000|Overall Study|Other Reason|0
7456904|NCT01792518|11750079|FG001|Overall Study|Other Reason|1
7456905|NCT01792635|11750088|FG000|Part B|Adverse Event|0
7456906|NCT01792635|11750089|FG001|Part B|Adverse Event|0
7456907|NCT01792635|11750090|FG002|Part B|Adverse Event|1
7456908|NCT01792635|11750088|FG000|Part B|Study terminated|0
7456909|NCT01792635|11750089|FG001|Part B|Study terminated|4
7456910|NCT01792635|11750090|FG002|Part B|Study terminated|3
7456911|NCT01792830|11750121|FG000|Overall Study|Withdrawal by Subject|22
7456912|NCT01792830|11750122|FG001|Overall Study|Withdrawal by Subject|0
7456913|NCT01792830|11750123|FG002|Overall Study|Withdrawal by Subject|0
7456914|NCT01792830|11750124|FG003|Overall Study|Withdrawal by Subject|2
7456915|NCT01792830|11750125|FG004|Overall Study|Withdrawal by Subject|1
7456916|NCT01792830|11750126|FG005|Overall Study|Withdrawal by Subject|1
7456917|NCT01792830|11750127|FG006|Overall Study|Withdrawal by Subject|1
7456918|NCT01792830|11750128|FG007|Overall Study|Withdrawal by Subject|1
7456919|NCT01792830|11750129|FG008|Overall Study|Withdrawal by Subject|7
7456920|NCT01792830|11750130|FG009|Overall Study|Withdrawal by Subject|0
7456921|NCT01792830|11750131|FG010|Overall Study|Withdrawal by Subject|2
7456922|NCT01792830|11750121|FG000|Overall Study|Death|3
7456923|NCT01792830|11750122|FG001|Overall Study|Death|0
7456924|NCT01792830|11750123|FG002|Overall Study|Death|0
7456925|NCT01792830|11750124|FG003|Overall Study|Death|1
7456926|NCT01792830|11750125|FG004|Overall Study|Death|0
7456927|NCT01792830|11750126|FG005|Overall Study|Death|0
7456928|NCT01792830|11750127|FG006|Overall Study|Death|1
7456929|NCT01792830|11750128|FG007|Overall Study|Death|0
7456930|NCT01792830|11750129|FG008|Overall Study|Death|1
7456931|NCT01792830|11750130|FG009|Overall Study|Death|0
7456932|NCT01792830|11750131|FG010|Overall Study|Death|1
7456933|NCT01792830|11750121|FG000|Overall Study|Adverse Event|0
7456934|NCT01792830|11750122|FG001|Overall Study|Adverse Event|0
7456935|NCT01792830|11750123|FG002|Overall Study|Adverse Event|0
7456936|NCT01792830|11750124|FG003|Overall Study|Adverse Event|0
7456937|NCT01792830|11750125|FG004|Overall Study|Adverse Event|0
7456938|NCT01792830|11750126|FG005|Overall Study|Adverse Event|0
7456939|NCT01792830|11750127|FG006|Overall Study|Adverse Event|0
7456940|NCT01792830|11750128|FG007|Overall Study|Adverse Event|0
7456941|NCT01792830|11750129|FG008|Overall Study|Adverse Event|1
7456942|NCT01792830|11750130|FG009|Overall Study|Adverse Event|0
7456943|NCT01792830|11750131|FG010|Overall Study|Adverse Event|0
7456944|NCT01793051|11750167|FG000|Overall Study|Withdrawal by Subject|6
7456945|NCT01793051|11750168|FG001|Overall Study|Withdrawal by Subject|4
7456946|NCT01793051|11750167|FG000|Overall Study|Adverse Event|0
7456947|NCT01793051|11750168|FG001|Overall Study|Adverse Event|2
7456948|NCT01793051|11750167|FG000|Overall Study|Too ill to continue|1
7456949|NCT01793051|11750168|FG001|Overall Study|Too ill to continue|0
7456950|NCT01793051|11750167|FG000|Overall Study|Switched chemo|1
7456951|NCT01793051|11750168|FG001|Overall Study|Switched chemo|1
7456952|NCT01793051|11750167|FG000|Overall Study|Lack of compliance|1
7456953|NCT01793051|11750168|FG001|Overall Study|Lack of compliance|0
7456954|NCT01793051|11750167|FG000|Overall Study|Requested to be removed from the study|1
7456955|NCT01793051|11750168|FG001|Overall Study|Requested to be removed from the study|1
7456956|NCT01793142|11750174|FG000|Overall Study|Randomized not treated|7
7456957|NCT01793688|11750182|FG000|Overall Study|Protocol Violation|2
7456958|NCT01793792|11750186|FG000|Overall Study|Death|5
7456959|NCT01793792|11750186|FG000|Overall Study|Lost to Follow-up|5
7456960|NCT01793792|11750186|FG000|Overall Study|Withdrawal by Subject|1
7456961|NCT01793792|11750186|FG000|Overall Study|Device Not Implanted|1
7456962|NCT01793883|11750193|FG000|Overall Study|Withdrawal by Subject|3
7456963|NCT01793883|11750194|FG001|Overall Study|Withdrawal by Subject|7
7456964|NCT01793883|11750195|FG002|Overall Study|Withdrawal by Subject|3
7456965|NCT01793883|11750193|FG000|Overall Study|Subject noncompliance|0
7456966|NCT01793883|11750194|FG001|Overall Study|Subject noncompliance|1
7456967|NCT01793883|11750195|FG002|Overall Study|Subject noncompliance|1
7456968|NCT01793883|11750193|FG000|Overall Study|Lost to Follow-up|5
7456969|NCT01793883|11750194|FG001|Overall Study|Lost to Follow-up|1
7456970|NCT01793883|11750195|FG002|Overall Study|Lost to Follow-up|3
7456971|NCT01793883|11750193|FG000|Overall Study|Randomized in error|1
7456972|NCT01793883|11750194|FG001|Overall Study|Randomized in error|0
7456973|NCT01793883|11750195|FG002|Overall Study|Randomized in error|0
7456974|NCT01793883|11750193|FG000|Overall Study|Unable to complete spriometry|1
7456975|NCT01793883|11750194|FG001|Overall Study|Unable to complete spriometry|0
7456976|NCT01793883|11750195|FG002|Overall Study|Unable to complete spriometry|0
7456977|NCT01793883|11750193|FG000|Overall Study|Unable to complete measurements|1
7456978|NCT01793883|11750194|FG001|Overall Study|Unable to complete measurements|0
7456979|NCT01793883|11750195|FG002|Overall Study|Unable to complete measurements|0
7456980|NCT01793883|11750193|FG000|Overall Study|Met exclusion criteria|1
7456981|NCT01793883|11750194|FG001|Overall Study|Met exclusion criteria|0
7456982|NCT01793883|11750195|FG002|Overall Study|Met exclusion criteria|0
7456983|NCT01793883|11750193|FG000|Overall Study|Dosing error|0
7456984|NCT01793883|11750194|FG001|Overall Study|Dosing error|1
7456985|NCT01793883|11750195|FG002|Overall Study|Dosing error|0
7456986|NCT01793883|11750193|FG000|Overall Study|Respiratory distress during spirometry|0
7456987|NCT01793883|11750194|FG001|Overall Study|Respiratory distress during spirometry|0
7456988|NCT01793883|11750195|FG002|Overall Study|Respiratory distress during spirometry|1
7456989|NCT01793935|11750214|FG000|Overall Study|Pregnancy|1
7456990|NCT01793935|11750215|FG001|Overall Study|Pregnancy|0
7456991|NCT01793935|11750214|FG000|Overall Study|Protocol Violation|2
7456992|NCT01793935|11750215|FG001|Overall Study|Protocol Violation|1
7456993|NCT01793935|11750214|FG000|Overall Study|Adverse Event|2
7456994|NCT01793935|11750215|FG001|Overall Study|Adverse Event|0
7456995|NCT01793935|11750214|FG000|Overall Study|Patient did not take study medication|1
7456996|NCT01793935|11750215|FG001|Overall Study|Patient did not take study medication|1
7456997|NCT01793935|11750214|FG000|Overall Study|Lost to Follow-up|0
7456998|NCT01793935|11750215|FG001|Overall Study|Lost to Follow-up|1
7456999|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Adverse Event|5
7457000|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Adverse Event|2
7457001|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Death|1
7457002|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Death|2
7457003|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
7457004|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
7457005|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
7457006|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
7457007|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Physician Decision|2
7457008|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Physician Decision|0
7457009|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
7457010|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
7564631|NCT03287791|11935400|FG002|Overall Study|Too much time between 2 visits|0
7564632|NCT03287791|11935398|FG000|Overall Study|Non-compliance|0
7564633|NCT03287791|11935399|FG001|Overall Study|Non-compliance|1
7564634|NCT03287791|11935400|FG002|Overall Study|Non-compliance|0
7564635|NCT03287791|11935398|FG000|Overall Study|Did not meet inclusion criteria|1
7564636|NCT03287791|11935399|FG001|Overall Study|Did not meet inclusion criteria|0
7564637|NCT03287791|11935400|FG002|Overall Study|Did not meet inclusion criteria|0
7564638|NCT03287804|11935408|FG000|Overall Study|Death|1
7564639|NCT03287804|11935408|FG000|Overall Study|Physician Decision|2
7564640|NCT03287804|11935408|FG000|Overall Study|Progressive disease|8
7564641|NCT03287869|11935415|FG000|Overall Study|Adverse Event|14
7564642|NCT03287869|11935416|FG001|Overall Study|Adverse Event|12
7564643|NCT03287869|11935415|FG000|Overall Study|Lack of Efficacy|1
7564644|NCT03287869|11935416|FG001|Overall Study|Lack of Efficacy|0
7564645|NCT03287869|11935415|FG000|Overall Study|Lost to Follow-up|13
7564646|NCT03287869|11935416|FG001|Overall Study|Lost to Follow-up|19
7564647|NCT03287869|11935415|FG000|Overall Study|Non-Compliance With Study Drug|5
7564648|NCT03287869|11935416|FG001|Overall Study|Non-Compliance With Study Drug|9
7564649|NCT03287869|11935415|FG000|Overall Study|Progressive Disease|1
7564650|NCT03287869|11935416|FG001|Overall Study|Progressive Disease|0
7564651|NCT03287869|11935415|FG000|Overall Study|Protocol Deviation|2
7564652|NCT03287869|11935416|FG001|Overall Study|Protocol Deviation|1
7564653|NCT03287869|11935415|FG000|Overall Study|Withdrawal by Subject|36
7564654|NCT03287869|11935416|FG001|Overall Study|Withdrawal by Subject|43
7564655|NCT03287869|11935415|FG000|Overall Study|Early Closure of the Site|0
7564656|NCT03287869|11935416|FG001|Overall Study|Early Closure of the Site|1
7564657|NCT03287869|11935415|FG000|Overall Study|Physician Decision|5
7329122|NCT00800176|11562102|FG002|Overall Study|Other|0
7329123|NCT00800176|11562103|FG003|Overall Study|Other|0
7329124|NCT00800176|11562104|FG004|Overall Study|Other|2
7329125|NCT00800176|11562105|FG005|Overall Study|Other|0
7329126|NCT00800202|11562121|FG000|Overall Study|Adverse Event|7
7329127|NCT00800202|11562122|FG001|Overall Study|Adverse Event|6
7329128|NCT00800202|11562121|FG000|Overall Study|Death|1
7329129|NCT00800202|11562122|FG001|Overall Study|Death|0
7329130|NCT00800202|11562121|FG000|Overall Study|Other|5
7329131|NCT00800202|11562122|FG001|Overall Study|Other|0
7329132|NCT00800202|11562121|FG000|Overall Study|Disease Progression|54
7329133|NCT00800202|11562122|FG001|Overall Study|Disease Progression|18
7329134|NCT00800384|11562143|FG000|Overall Study|Withdrawal by Subject|24
7329135|NCT00800384|11562144|FG001|Overall Study|Withdrawal by Subject|17
7329136|NCT00800384|11562143|FG000|Overall Study|Lost to Follow-up|17
7329137|NCT00800384|11562144|FG001|Overall Study|Lost to Follow-up|26
7329138|NCT00800436|11562158|FG000|Overall Study|Withdrawal by Subject|0
7329139|NCT00800436|11562159|FG001|Overall Study|Withdrawal by Subject|0
7329140|NCT00800436|11562160|FG002|Overall Study|Withdrawal by Subject|1
7329141|NCT00800436|11562161|FG003|Overall Study|Withdrawal by Subject|1
7329142|NCT00800436|11562162|FG004|Overall Study|Withdrawal by Subject|0
7329143|NCT00800436|11562163|FG005|Overall Study|Withdrawal by Subject|0
7329144|NCT00800436|11562164|FG006|Overall Study|Withdrawal by Subject|0
7329145|NCT00800540|11562180|FG000|Period One: 6 Weeks|Noncompliance|1
7329146|NCT00800540|11562181|FG001|Period One: 6 Weeks|Noncompliance|0
7329147|NCT00800540|11562180|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
7329148|NCT00800540|11562181|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
7457011|NCT01794000|11750223|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
7457012|NCT01794000|11750224|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
7457013|NCT01794000|11750223|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
7457014|NCT01794000|11750224|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
7457015|NCT01794117|11750246|FG000|Overall Study|Adverse Event|1
7564658|NCT03287869|11935416|FG001|Overall Study|Physician Decision|5
7329149|NCT00800540|11562180|FG000|Period 2: 6 Weeks|Adverse Event|0
7457016|NCT01794117|11750247|FG001|Overall Study|Adverse Event|0
7457017|NCT01794117|11750248|FG002|Overall Study|Adverse Event|0
7457018|NCT01794117|11750249|FG003|Overall Study|Adverse Event|0
7457019|NCT01794117|11750246|FG000|Overall Study|Participant noncompliance|0
7457020|NCT01794117|11750247|FG001|Overall Study|Participant noncompliance|1
7457021|NCT01794117|11750248|FG002|Overall Study|Participant noncompliance|0
7457022|NCT01794117|11750249|FG003|Overall Study|Participant noncompliance|0
7457023|NCT01794117|11750246|FG000|Overall Study|Refused further treatment|0
7457024|NCT01794117|11750247|FG001|Overall Study|Refused further treatment|2
7457025|NCT01794117|11750248|FG002|Overall Study|Refused further treatment|0
7457026|NCT01794117|11750249|FG003|Overall Study|Refused further treatment|0
7457027|NCT01794299|11750260|FG000|Overall Study|ATIR manufacturing not possible|1
7457028|NCT01794299|11750260|FG000|Overall Study|Death|14
7457029|NCT01794299|11750260|FG000|Overall Study|Graft failure|1
7457030|NCT01794299|11750260|FG000|Overall Study|ATIR batch rejected|2
7457031|NCT01794299|11750260|FG000|Overall Study|Relapse|2
7457032|NCT01794299|11750260|FG000|Overall Study|Discontinued from active follow-up|1
7457033|NCT01794299|11750260|FG000|Overall Study|Relapse and rejection of ATIR batch|1
7457034|NCT01794689|11750286|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
7457035|NCT01794689|11750287|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
7457036|NCT01794689|11750288|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
7457037|NCT01794689|11750289|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
7457038|NCT01794689|11750286|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
7457039|NCT01794689|11750287|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
7457040|NCT01794689|11750288|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
7457041|NCT01794689|11750289|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
7457042|NCT01794689|11750286|FG000|Intervention 1 (2 Nights)|Physician Decision|1
7457043|NCT01794689|11750287|FG001|Intervention 1 (2 Nights)|Physician Decision|1
7457044|NCT01794689|11750288|FG002|Intervention 1 (2 Nights)|Physician Decision|0
7457045|NCT01794689|11750289|FG003|Intervention 1 (2 Nights)|Physician Decision|0
7457046|NCT01794689|11750286|FG000|Intervention 1 (2 Nights)|Adverse Event|0
7457047|NCT01794689|11750287|FG001|Intervention 1 (2 Nights)|Adverse Event|1
7457048|NCT01794689|11750288|FG002|Intervention 1 (2 Nights)|Adverse Event|0
7457049|NCT01794689|11750289|FG003|Intervention 1 (2 Nights)|Adverse Event|0
7457050|NCT01794780|11750335|FG000|Overall Study|Adverse Event|0
7457051|NCT01794780|11750336|FG001|Overall Study|Adverse Event|1
7457052|NCT01794780|11750337|FG002|Overall Study|Adverse Event|2
7457053|NCT01794780|11750338|FG003|Overall Study|Adverse Event|0
7457054|NCT01794780|11750339|FG004|Overall Study|Adverse Event|0
7457055|NCT01794780|11750340|FG005|Overall Study|Adverse Event|0
7457056|NCT01794780|11750341|FG006|Overall Study|Adverse Event|0
7457057|NCT01794780|11750342|FG007|Overall Study|Adverse Event|0
7457058|NCT01794780|11750335|FG000|Overall Study|Death|0
7457059|NCT01794780|11750336|FG001|Overall Study|Death|2
7457060|NCT01794780|11750337|FG002|Overall Study|Death|14
7457061|NCT01794780|11750338|FG003|Overall Study|Death|1
7457062|NCT01794780|11750339|FG004|Overall Study|Death|0
7457063|NCT01794780|11750340|FG005|Overall Study|Death|9
7457064|NCT01794780|11750341|FG006|Overall Study|Death|4
7457065|NCT01794780|11750342|FG007|Overall Study|Death|0
7457066|NCT01794780|11750335|FG000|Overall Study|Lost to Follow-up|10
7457067|NCT01794780|11750336|FG001|Overall Study|Lost to Follow-up|64
7457068|NCT01794780|11750337|FG002|Overall Study|Lost to Follow-up|165
7457069|NCT01794780|11750338|FG003|Overall Study|Lost to Follow-up|53
7457070|NCT01794780|11750339|FG004|Overall Study|Lost to Follow-up|2
7457071|NCT01794780|11750340|FG005|Overall Study|Lost to Follow-up|99
7457072|NCT01794780|11750341|FG006|Overall Study|Lost to Follow-up|30
7457073|NCT01794780|11750342|FG007|Overall Study|Lost to Follow-up|5
7457074|NCT01794780|11750335|FG000|Overall Study|Withdrew informed consent|7
7457075|NCT01794780|11750336|FG001|Overall Study|Withdrew informed consent|17
7457076|NCT01794780|11750337|FG002|Overall Study|Withdrew informed consent|36
7457077|NCT01794780|11750338|FG003|Overall Study|Withdrew informed consent|9
7457078|NCT01794780|11750339|FG004|Overall Study|Withdrew informed consent|0
7457079|NCT01794780|11750340|FG005|Overall Study|Withdrew informed consent|48
7457080|NCT01794780|11750341|FG006|Overall Study|Withdrew informed consent|4
7457081|NCT01794780|11750342|FG007|Overall Study|Withdrew informed consent|3
7457082|NCT01794780|11750335|FG000|Overall Study|Other|0
7457083|NCT01794780|11750336|FG001|Overall Study|Other|12
7457084|NCT01794780|11750337|FG002|Overall Study|Other|25
7457085|NCT01794780|11750338|FG003|Overall Study|Other|20
7457086|NCT01794780|11750339|FG004|Overall Study|Other|1
7457087|NCT01794780|11750340|FG005|Overall Study|Other|24
7457088|NCT01794780|11750341|FG006|Overall Study|Other|4
7457089|NCT01794780|11750342|FG007|Overall Study|Other|1
7457090|NCT01794845|11750376|FG000|Overall Study|Withdrawal by Subject|1
7457091|NCT01794923|11750383|FG000|Overall Study|Adverse Event|0
7457092|NCT01794923|11750384|FG001|Overall Study|Adverse Event|0
7457093|NCT01794923|11750385|FG002|Overall Study|Adverse Event|1
7457094|NCT01794949|11750395|FG000|Overall Study|Lost to Follow-up|1
7457095|NCT01794949|11750396|FG001|Overall Study|Lost to Follow-up|0
7457096|NCT01795495|11750419|FG000|Overall Study|Protocol Violation|1
7457097|NCT01795495|11750420|FG001|Overall Study|Protocol Violation|0
7457098|NCT01795495|11750421|FG002|Overall Study|Protocol Violation|1
7457099|NCT01795495|11750419|FG000|Overall Study|Physician Decision|0
7457100|NCT01795495|11750420|FG001|Overall Study|Physician Decision|0
7457101|NCT01795495|11750421|FG002|Overall Study|Physician Decision|1
7457102|NCT01795547|11750438|FG000|Overall Study|Adverse Event|16
7457103|NCT01795547|11750439|FG001|Overall Study|Adverse Event|27
7457104|NCT01795547|11750438|FG000|Overall Study|Lack of Efficacy|8
7457105|NCT01795547|11750439|FG001|Overall Study|Lack of Efficacy|3
7457106|NCT01795547|11750438|FG000|Overall Study|Protocol Violation|6
7457107|NCT01795547|11750439|FG001|Overall Study|Protocol Violation|4
7457108|NCT01795547|11750438|FG000|Overall Study|Lost to Follow-up|2
7457109|NCT01795547|11750439|FG001|Overall Study|Lost to Follow-up|5
7457110|NCT01795547|11750438|FG000|Overall Study|Withdrawal of consent|7
7457111|NCT01795547|11750439|FG001|Overall Study|Withdrawal of consent|12
7457112|NCT01795547|11750438|FG000|Overall Study|Not Treated|4
7457113|NCT01795547|11750439|FG001|Overall Study|Not Treated|10
7457114|NCT01795547|11750438|FG000|Overall Study|Non-compliance with IMP|1
7457115|NCT01795547|11750439|FG001|Overall Study|Non-compliance with IMP|1
7457116|NCT01795547|11750438|FG000|Overall Study|Others|4
7457117|NCT01795547|11750439|FG001|Overall Study|Others|1
7457118|NCT01795547|11750438|FG000|Overall Study|Not stated|0
7457119|NCT01795547|11750439|FG001|Overall Study|Not stated|1
7457120|NCT01795638|11750449|FG000|Overall Study|Death|0
7457121|NCT01795638|11750450|FG001|Overall Study|Death|3
7457122|NCT01795638|11750449|FG000|Overall Study|transferred to quaternary hospital|2
7457123|NCT01795638|11750450|FG001|Overall Study|transferred to quaternary hospital|3
7457124|NCT01795638|11750449|FG000|Overall Study|Protocol Violation|3
7457125|NCT01795638|11750450|FG001|Overall Study|Protocol Violation|0
7457126|NCT01795638|11750449|FG000|Overall Study|discharged from hospital|7
7457127|NCT01795638|11750450|FG001|Overall Study|discharged from hospital|5
7457128|NCT01795638|11750449|FG000|Overall Study|Withdrawal by Subject|1
7457129|NCT01795638|11750450|FG001|Overall Study|Withdrawal by Subject|0
7457130|NCT01795898|11750485|FG000|Overall Study|Adverse Event|27
7457131|NCT01795898|11750485|FG000|Overall Study|Lost to Follow-up|20
7457132|NCT01795898|11750485|FG000|Overall Study|Withdrawal of consent|6
7457133|NCT01795898|11750485|FG000|Overall Study|Diagnosed with metastasis|1
7457134|NCT01795898|11750485|FG000|Overall Study|No pain|1
7457135|NCT01795898|11750485|FG000|Overall Study|Death|1
7457136|NCT01795898|11750485|FG000|Overall Study|Withdrew consent & had adverse events|3
7457137|NCT01795898|11750485|FG000|Overall Study|Physician Decision|1
7457138|NCT01795937|11750492|FG000|Overall Study|Withdrawal by Subject|1
7457139|NCT01795937|11750493|FG001|Overall Study|Withdrawal by Subject|0
7457140|NCT01795937|11750494|FG002|Overall Study|Withdrawal by Subject|0
7457141|NCT01795937|11750492|FG000|Overall Study|Physician Decision|0
7457142|NCT01795937|11750493|FG001|Overall Study|Physician Decision|1
7457143|NCT01795937|11750494|FG002|Overall Study|Physician Decision|0
7457144|NCT01796301|11750522|FG000|Overall Study|Withdrawal by Subject|15
7457145|NCT01796301|11750523|FG001|Overall Study|Withdrawal by Subject|15
7457146|NCT01796301|11750522|FG000|Overall Study|Lost to Follow-up|3
7457147|NCT01796301|11750523|FG001|Overall Study|Lost to Follow-up|3
7457148|NCT01796301|11750522|FG000|Overall Study|Death|0
7457149|NCT01796301|11750523|FG001|Overall Study|Death|1
7457150|NCT01796301|11750522|FG000|Overall Study|Decision by Sponsor|0
7457151|NCT01796301|11750523|FG001|Overall Study|Decision by Sponsor|1
7457152|NCT01796392|11750531|FG000|Overall Study|Withdrawal by Subject|2
7457153|NCT01796392|11750532|FG001|Overall Study|Withdrawal by Subject|0
7457154|NCT01796392|11750531|FG000|Overall Study|Death|5
7457155|NCT01796392|11750532|FG001|Overall Study|Death|1
7457156|NCT01796392|11750531|FG000|Overall Study|Excluded for medical reasons|1
7457157|NCT01796392|11750532|FG001|Overall Study|Excluded for medical reasons|2
7457158|NCT01796392|11750531|FG000|Overall Study|Lost to Follow-up|1
7457159|NCT01796392|11750532|FG001|Overall Study|Lost to Follow-up|0
7457160|NCT01796470|11750543|FG000|Overall Study|Adverse Event|4
7457161|NCT01796470|11750544|FG001|Overall Study|Adverse Event|2
7457162|NCT01796470|11750545|FG002|Overall Study|Adverse Event|2
7457163|NCT01796470|11750546|FG003|Overall Study|Adverse Event|1
7457164|NCT01796470|11750547|FG004|Overall Study|Adverse Event|3
7457165|NCT01796470|11750543|FG000|Overall Study|Death|2
7457166|NCT01796470|11750544|FG001|Overall Study|Death|0
7457167|NCT01796470|11750545|FG002|Overall Study|Death|0
7457168|NCT01796470|11750546|FG003|Overall Study|Death|0
7457169|NCT01796470|11750547|FG004|Overall Study|Death|1
7457170|NCT01796470|11750543|FG000|Overall Study|Initiated New Therapy|9
7457171|NCT01796470|11750544|FG001|Overall Study|Initiated New Therapy|0
7457172|NCT01796470|11750545|FG002|Overall Study|Initiated New Therapy|0
7457173|NCT01796470|11750546|FG003|Overall Study|Initiated New Therapy|0
7457174|NCT01796470|11750547|FG004|Overall Study|Initiated New Therapy|2
7457175|NCT01796470|11750543|FG000|Overall Study|Lost to Follow-up|0
7457176|NCT01796470|11750544|FG001|Overall Study|Lost to Follow-up|1
7457177|NCT01796470|11750545|FG002|Overall Study|Lost to Follow-up|0
7457178|NCT01796470|11750546|FG003|Overall Study|Lost to Follow-up|0
7457179|NCT01796470|11750547|FG004|Overall Study|Lost to Follow-up|0
7457180|NCT01796470|11750543|FG000|Overall Study|Physician Decision|5
7457181|NCT01796470|11750544|FG001|Overall Study|Physician Decision|4
7457182|NCT01796470|11750545|FG002|Overall Study|Physician Decision|1
7457183|NCT01796470|11750546|FG003|Overall Study|Physician Decision|0
7457184|NCT01796470|11750547|FG004|Overall Study|Physician Decision|1
7457185|NCT01796470|11750543|FG000|Overall Study|Progressive Disease|7
7457186|NCT01796470|11750544|FG001|Overall Study|Progressive Disease|7
7457187|NCT01796470|11750545|FG002|Overall Study|Progressive Disease|3
7457188|NCT01796470|11750546|FG003|Overall Study|Progressive Disease|2
7457189|NCT01796470|11750547|FG004|Overall Study|Progressive Disease|0
7457190|NCT01796470|11750543|FG000|Overall Study|Protocol Criteria for Withdrawal|1
7457191|NCT01796470|11750544|FG001|Overall Study|Protocol Criteria for Withdrawal|0
7457192|NCT01796470|11750545|FG002|Overall Study|Protocol Criteria for Withdrawal|0
7457193|NCT01796470|11750546|FG003|Overall Study|Protocol Criteria for Withdrawal|0
7457194|NCT01796470|11750547|FG004|Overall Study|Protocol Criteria for Withdrawal|0
7457195|NCT01796470|11750543|FG000|Overall Study|Withdrawal by Subject|7
7457196|NCT01796470|11750544|FG001|Overall Study|Withdrawal by Subject|0
7457197|NCT01796470|11750545|FG002|Overall Study|Withdrawal by Subject|0
7457198|NCT01796470|11750546|FG003|Overall Study|Withdrawal by Subject|0
7457199|NCT01796470|11750547|FG004|Overall Study|Withdrawal by Subject|1
7457200|NCT01796548|11750563|FG000|Overall Study|Lost to Follow-up|1
7457201|NCT01796548|11750563|FG000|Overall Study|Other|2
7457202|NCT01796860|11750580|FG000|Overall Study|Withdrawal by Subject|3
7457203|NCT01796964|11750595|FG000|Overall Study|Adverse Event|1
7457204|NCT01796964|11750596|FG001|Overall Study|Adverse Event|1
7457205|NCT01796964|11750595|FG000|Overall Study|Death|1
7457206|NCT01796964|11750596|FG001|Overall Study|Death|0
7457207|NCT01796964|11750595|FG000|Overall Study|Protocol Violation|0
7457208|NCT01796964|11750596|FG001|Overall Study|Protocol Violation|1
7457209|NCT01796964|11750595|FG000|Overall Study|Withdrawal by Subject|1
7457210|NCT01796964|11750596|FG001|Overall Study|Withdrawal by Subject|1
7457211|NCT01797081|11750625|FG000|Overall Study|Adverse Event|1
7457212|NCT01797081|11750626|FG001|Overall Study|Adverse Event|0
7457213|NCT01797081|11750627|FG002|Overall Study|Adverse Event|1
7457214|NCT01797081|11750628|FG003|Overall Study|Adverse Event|0
7457215|NCT01797081|11750625|FG000|Overall Study|Pregnancy|1
7457216|NCT01797081|11750626|FG001|Overall Study|Pregnancy|0
7457217|NCT01797081|11750627|FG002|Overall Study|Pregnancy|0
7457218|NCT01797081|11750628|FG003|Overall Study|Pregnancy|0
7457219|NCT01797081|11750625|FG000|Overall Study|Personal Reasons|12
7457220|NCT01797081|11750626|FG001|Overall Study|Personal Reasons|4
7457221|NCT01797081|11750627|FG002|Overall Study|Personal Reasons|4
7457222|NCT01797081|11750628|FG003|Overall Study|Personal Reasons|8
7457223|NCT01797081|11750625|FG000|Overall Study|Protocol Violation|0
7457224|NCT01797081|11750626|FG001|Overall Study|Protocol Violation|0
7457225|NCT01797081|11750627|FG002|Overall Study|Protocol Violation|0
7457226|NCT01797081|11750628|FG003|Overall Study|Protocol Violation|1
7457227|NCT01797094|11750638|FG000|Overall Study|Adverse Event|1
7457228|NCT01797094|11750639|FG001|Overall Study|Adverse Event|1
7457229|NCT01797094|11750638|FG000|Overall Study|Personal Reasons|4
7457230|NCT01797094|11750639|FG001|Overall Study|Personal Reasons|0
7457231|NCT01797094|11750638|FG000|Overall Study|Protocol Violation|0
7457232|NCT01797094|11750639|FG001|Overall Study|Protocol Violation|1
7457233|NCT01797094|11750638|FG000|Overall Study|Other Miscellaneous Reasons|1
7457234|NCT01797094|11750639|FG001|Overall Study|Other Miscellaneous Reasons|0
7457235|NCT01797120|11750647|FG000|Overall Study|Disesae progression|37
7457236|NCT01797120|11750648|FG001|Overall Study|Disesae progression|49
7457237|NCT01797120|11750647|FG000|Overall Study|Adverse Event|13
7457238|NCT01797120|11750648|FG001|Overall Study|Adverse Event|5
7564659|NCT03287869|11935415|FG000|Overall Study|Reason not Specified|6
7564660|NCT03287869|11935416|FG001|Overall Study|Reason not Specified|3
7564661|NCT03288714|11935424|FG000|Overall Study|Lost to Follow-up|2
7564662|NCT03288714|11935425|FG001|Overall Study|Lost to Follow-up|1
7564663|NCT03288714|11935424|FG000|Overall Study|Non-compliance with study schedule|2
7329150|NCT00800540|11562181|FG001|Period 2: 6 Weeks|Adverse Event|1
7329151|NCT00800683|11562189|FG000|Overall Study|Adverse Event|11
7329152|NCT00800683|11562190|FG001|Overall Study|Adverse Event|8
7329153|NCT00800683|11562189|FG000|Overall Study|Lost to Follow-up|3
7329154|NCT00800683|11562190|FG001|Overall Study|Lost to Follow-up|1
7329155|NCT00800683|11562189|FG000|Overall Study|Withdrawal by Subject|1
7329156|NCT00800683|11562190|FG001|Overall Study|Withdrawal by Subject|7
7329157|NCT00800683|11562189|FG000|Overall Study|Lack of Efficacy|1
7457239|NCT01797120|11750647|FG000|Overall Study|Withdrawal by Subject|6
7457240|NCT01797120|11750648|FG001|Overall Study|Withdrawal by Subject|6
7564664|NCT03288714|11935425|FG001|Overall Study|Non-compliance with study schedule|0
7564665|NCT03288714|11935424|FG000|Overall Study|Withdrawal by Subject|3
7564666|NCT03288714|11935425|FG001|Overall Study|Withdrawal by Subject|1
7564667|NCT03288714|11935424|FG000|Overall Study|Clinical Worsening|2
7457241|NCT01797120|11750647|FG000|Overall Study|Symptomatic progression|2
7457242|NCT01797120|11750648|FG001|Overall Study|Symptomatic progression|1
7564668|NCT03288714|11935425|FG001|Overall Study|Clinical Worsening|1
7564669|NCT03288714|11935424|FG000|Overall Study|Adverse Event|1
7457243|NCT01797120|11750647|FG000|Overall Study|Non-compliance|1
7457244|NCT01797120|11750648|FG001|Overall Study|Non-compliance|0
7564670|NCT03288714|11935425|FG001|Overall Study|Adverse Event|0
7564671|NCT03288779|11935433|FG000|Overall Study|Withdrawal by Subject|3
7564672|NCT03288987|11935439|FG000|Overall Study|Protocol Violation|10
7564673|NCT03288987|11935440|FG001|Overall Study|Protocol Violation|4
7329158|NCT00800683|11562190|FG001|Overall Study|Lack of Efficacy|1
7457245|NCT01797120|11750647|FG000|Overall Study|Physician Decision|3
7457246|NCT01797120|11750648|FG001|Overall Study|Physician Decision|0
7457247|NCT01797120|11750647|FG000|Overall Study|still on treatment|2
7329159|NCT00800683|11562189|FG000|Overall Study|Other|1
7457248|NCT01797120|11750648|FG001|Overall Study|still on treatment|4
7457249|NCT01797120|11750647|FG000|Overall Study|never start protocol therapy|2
7457250|NCT01797120|11750648|FG001|Overall Study|never start protocol therapy|0
7468218|NCT01908699|11768894|FG000|Overall Study|Adverse Event|8
7468219|NCT01908699|11768895|FG001|Overall Study|Adverse Event|12
7468220|NCT01908699|11768894|FG000|Overall Study|Lack of Efficacy|2
7468221|NCT01908699|11768895|FG001|Overall Study|Lack of Efficacy|2
7468222|NCT01908699|11768894|FG000|Overall Study|Lost to Follow-up|2
7468223|NCT01908699|11768895|FG001|Overall Study|Lost to Follow-up|4
7468224|NCT01908699|11768894|FG000|Overall Study|Physician Decision|8
7468225|NCT01908699|11768895|FG001|Overall Study|Physician Decision|8
7564674|NCT03289208|11935462|FG000|Overall Study|Adverse Event|1
7564675|NCT03289208|11935463|FG001|Overall Study|Adverse Event|0
7564676|NCT03289208|11935464|FG002|Overall Study|Adverse Event|0
7564677|NCT03289455|11935488|FG000|Overall Study|Death|1
7564678|NCT03289455|11935489|FG001|Overall Study|Death|0
7564679|NCT03289455|11935490|FG002|Overall Study|Death|0
7564680|NCT03289455|11935488|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
7564681|NCT03289455|11935489|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
7564682|NCT03289455|11935490|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
7564683|NCT03289455|11935488|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7564684|NCT03289455|11935489|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
7564685|NCT03289455|11935490|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
7564686|NCT03289455|11935488|FG000|Overall Study|Progressive disease|3
7564687|NCT03289455|11935489|FG001|Overall Study|Progressive disease|4
7564688|NCT03289455|11935490|FG002|Overall Study|Progressive disease|5
7564689|NCT03289533|11935509|FG000|Overall Study|Death|12
7564690|NCT03289533|11935509|FG000|Overall Study|Terminated from study by sponsor|10
7564691|NCT03289676|11935515|FG000|Overall Study|Withdrawal by Subject|2
7564692|NCT03289676|11935516|FG001|Overall Study|Withdrawal by Subject|0
7564693|NCT03289676|11935515|FG000|Overall Study|Protocol Violation|2
7564694|NCT03289676|11935516|FG001|Overall Study|Protocol Violation|0
7564695|NCT03289676|11935515|FG000|Overall Study|Lost to Follow-up|0
7564696|NCT03289676|11935516|FG001|Overall Study|Lost to Follow-up|1
7564698|NCT03291288|11935593|FG000|Drug-drug Interaction Phase|Adverse Event|2
7564699|NCT03291288|11935594|FG001|Drug-drug Interaction Phase|Adverse Event|0
7564700|NCT03291288|11935593|FG000|Drug-drug Interaction Phase|Disease progression|1
7564701|NCT03291288|11935594|FG001|Drug-drug Interaction Phase|Disease progression|0
7564702|NCT03291288|11935593|FG000|Drug-drug Interaction Phase|Other|3
7564703|NCT03291288|11935594|FG001|Drug-drug Interaction Phase|Other|0
7564704|NCT03291288|11935593|FG000|Pexidartinib Only|Ongoing|0
7564705|NCT03291288|11935594|FG001|Pexidartinib Only|Ongoing|2
7564706|NCT03292016|11935623|FG000|Second Washout|Adverse Event|0
7564707|NCT03292016|11935624|FG001|Second Washout|Adverse Event|1
7564708|NCT03292016|11935625|FG002|Second Washout|Adverse Event|0
7564709|NCT03292016|11935626|FG003|Second Washout|Adverse Event|0
7564710|NCT03292016|11935627|FG004|Second Washout|Adverse Event|0
7564711|NCT03292016|11935628|FG005|Second Washout|Adverse Event|0
7564712|NCT03292406|11935639|FG000|Overall Study|Progressive Disease|6
7564713|NCT03292406|11935640|FG001|Overall Study|Progressive Disease|3
7564714|NCT03292406|11935641|FG002|Overall Study|Progressive Disease|4
7564715|NCT03292406|11935639|FG000|Overall Study|Adverse Event|7
7564716|NCT03292406|11935640|FG001|Overall Study|Adverse Event|1
7564717|NCT03292406|11935641|FG002|Overall Study|Adverse Event|4
7564718|NCT03292406|11935639|FG000|Overall Study|Withdrawal by Subject|0
7564719|NCT03292406|11935640|FG001|Overall Study|Withdrawal by Subject|7
7564720|NCT03292406|11935641|FG002|Overall Study|Withdrawal by Subject|2
7564721|NCT03292406|11935639|FG000|Overall Study|Protocol Violation|0
7564722|NCT03292406|11935640|FG001|Overall Study|Protocol Violation|1
7564723|NCT03292406|11935641|FG002|Overall Study|Protocol Violation|1
7564724|NCT03292406|11935639|FG000|Overall Study|Other|0
7564725|NCT03292406|11935640|FG001|Overall Study|Other|1
7564726|NCT03292406|11935641|FG002|Overall Study|Other|2
7564727|NCT03292432|11935651|FG000|Overall Study|Lost to Follow-up|11
7564728|NCT03292432|11935652|FG001|Overall Study|Lost to Follow-up|8
7564729|NCT03292432|11935651|FG000|Overall Study|Death|2
7564730|NCT03292432|11935652|FG001|Overall Study|Death|1
7564731|NCT03292432|11935651|FG000|Overall Study|Withdrawal by Subject|1
7564732|NCT03292432|11935652|FG001|Overall Study|Withdrawal by Subject|2
7564733|NCT03292432|11935651|FG000|Overall Study|Site closed before any data collected|1
7564734|NCT03292432|11935652|FG001|Overall Study|Site closed before any data collected|0
7564735|NCT03292640|11935673|FG000|Overall Study|Withdrawal by Subject|17
7564736|NCT03292640|11935674|FG001|Overall Study|Withdrawal by Subject|16
7564737|NCT03292640|11935673|FG000|Overall Study|Adverse Event|20
7564738|NCT03292640|11935674|FG001|Overall Study|Adverse Event|2
7564739|NCT03292640|11935673|FG000|Overall Study|Lost to Follow-up|24
7564740|NCT03292640|11935674|FG001|Overall Study|Lost to Follow-up|24
7564741|NCT03292653|11935687|FG000|Overall Study|Adverse Event|0
7564742|NCT03292653|11935688|FG001|Overall Study|Adverse Event|0
7564743|NCT03292653|11935689|FG002|Overall Study|Adverse Event|1
7564744|NCT03292653|11935687|FG000|Overall Study|Did not Receive Treatment|1
7564745|NCT03292653|11935688|FG001|Overall Study|Did not Receive Treatment|0
7564746|NCT03292653|11935689|FG002|Overall Study|Did not Receive Treatment|0
7468226|NCT01908699|11768894|FG000|Overall Study|Withdrawal by Subject|15
7457251|NCT01797185|11750662|FG000|Overall Study|Adverse Event|5
7457252|NCT01797185|11750663|FG001|Overall Study|Adverse Event|15
7457253|NCT01797185|11750664|FG002|Overall Study|Adverse Event|6
7457254|NCT01797185|11750662|FG000|Overall Study|Withdrawal by Subject|6
7457255|NCT01797185|11750663|FG001|Overall Study|Withdrawal by Subject|9
7457256|NCT01797185|11750664|FG002|Overall Study|Withdrawal by Subject|5
7457257|NCT01797185|11750662|FG000|Overall Study|Site terminated|8
7457258|NCT01797185|11750663|FG001|Overall Study|Site terminated|4
7457259|NCT01797185|11750664|FG002|Overall Study|Site terminated|0
7457260|NCT01797185|11750662|FG000|Overall Study|Lost to Follow-up|2
7457261|NCT01797185|11750663|FG001|Overall Study|Lost to Follow-up|6
7457262|NCT01797185|11750664|FG002|Overall Study|Lost to Follow-up|1
7457263|NCT01797185|11750662|FG000|Overall Study|Withdrawn per sponsor|5
7457264|NCT01797185|11750663|FG001|Overall Study|Withdrawn per sponsor|0
7457265|NCT01797185|11750664|FG002|Overall Study|Withdrawn per sponsor|0
7564747|NCT03293394|11935748|FG000|Follow-up (6 Months)|Adverse Event|4
7564748|NCT03293394|11935749|FG001|Follow-up (6 Months)|Adverse Event|2
7564749|NCT03293485|11935755|FG000|Overall Study|Death|1
7564750|NCT03293485|11935755|FG000|Overall Study|Screen Failure|2
7564751|NCT03293485|11935755|FG000|Overall Study|Withdrawal by Subject|2
7457266|NCT01797185|11750662|FG000|Overall Study|Physician Decision|1
7457267|NCT01797185|11750663|FG001|Overall Study|Physician Decision|3
7457268|NCT01797185|11750664|FG002|Overall Study|Physician Decision|0
7457269|NCT01797185|11750662|FG000|Overall Study|Protocol Violation|1
7457270|NCT01797185|11750663|FG001|Overall Study|Protocol Violation|1
7457271|NCT01797185|11750664|FG002|Overall Study|Protocol Violation|0
7457272|NCT01797263|11750674|FG000|Overall Study|Withdrawal by Subject|21
7457273|NCT01797263|11750675|FG001|Overall Study|Withdrawal by Subject|25
7457274|NCT01797263|11750674|FG000|Overall Study|Death|1
7457275|NCT01797263|11750675|FG001|Overall Study|Death|0
7457276|NCT01797263|11750674|FG000|Overall Study|Lost to Follow-up|15
7457277|NCT01797263|11750675|FG001|Overall Study|Lost to Follow-up|15
7457278|NCT01797302|11750684|FG000|Overall Study|Lost to Follow-up|16
7457279|NCT01797302|11750685|FG001|Overall Study|Lost to Follow-up|23
7457280|NCT01797302|11750686|FG002|Overall Study|Lost to Follow-up|22
7457281|NCT01797302|11750684|FG000|Overall Study|Withdrawal by Subject|1
7457282|NCT01797302|11750685|FG001|Overall Study|Withdrawal by Subject|3
7457283|NCT01797302|11750686|FG002|Overall Study|Withdrawal by Subject|4
7457284|NCT01797432|11750703|FG000|Overall Study|Lost to Follow-up|1
7457285|NCT01797432|11750703|FG000|Overall Study|Adverse Event|1
7457286|NCT01797432|11750703|FG000|Overall Study|Withdrawal by Subject|1
7457287|NCT01797432|11750703|FG000|Overall Study|lived too far from study site|1
7457288|NCT01797445|11750709|FG000|Double-Blind Phase|Randomized but Not Treated|4
7457289|NCT01797445|11750710|FG001|Double-Blind Phase|Randomized but Not Treated|2
7457290|NCT01797445|11750709|FG000|Double-Blind Phase|Adverse Event|3
7457291|NCT01797445|11750710|FG001|Double-Blind Phase|Adverse Event|0
7457292|NCT01797445|11750709|FG000|Double-Blind Phase|Death|5
7457293|NCT01797445|11750710|FG001|Double-Blind Phase|Death|4
7457294|NCT01797445|11750709|FG000|Double-Blind Phase|Pregnancy|0
7457295|NCT01797445|11750710|FG001|Double-Blind Phase|Pregnancy|1
7457296|NCT01797445|11750709|FG000|Double-Blind Phase|Lack of Efficacy|1
7457297|NCT01797445|11750710|FG001|Double-Blind Phase|Lack of Efficacy|2
7457298|NCT01797445|11750709|FG000|Double-Blind Phase|Investigator's Discretion|15
7457299|NCT01797445|11750710|FG001|Double-Blind Phase|Investigator's Discretion|17
7457300|NCT01797445|11750709|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
7457301|NCT01797445|11750710|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
7457302|NCT01797445|11750709|FG000|Double-Blind Phase|Protocol Violation|0
7457303|NCT01797445|11750710|FG001|Double-Blind Phase|Protocol Violation|1
7457304|NCT01797445|11750709|FG000|Double-Blind Phase|Withdrew Consent|20
7457305|NCT01797445|11750710|FG001|Double-Blind Phase|Withdrew Consent|35
7457306|NCT01797445|11750709|FG000|Double-Blind Phase|Lost to Follow-up|34
7457307|NCT01797445|11750710|FG001|Double-Blind Phase|Lost to Follow-up|26
7457308|NCT01797445|11750709|FG000|Open-Label Extension Phase|Investigator's Discretion|1
7457309|NCT01797445|11750710|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7457310|NCT01797536|11750757|FG000|Overall Study|Adverse Event|0
7457311|NCT01797536|11750758|FG001|Overall Study|Adverse Event|1
7457312|NCT01797536|11750759|FG002|Overall Study|Adverse Event|0
7457313|NCT01797536|11750760|FG003|Overall Study|Adverse Event|0
7457314|NCT01797562|11750770|FG000|Overall Study|Protocol Violation|5
7457315|NCT01797705|11750796|FG000|Overall Study|Equipment anomalies during sleep studies|4
7457316|NCT01797705|11750796|FG000|Overall Study|Withdrawal by Subject|1
7457317|NCT01797731|11750802|FG000|Overall Study|Didn't have proper radiographs required|3
7457318|NCT01797731|11750803|FG001|Overall Study|Didn't have proper radiographs required|3
7457319|NCT01797783|11750811|FG000|Overall Study|Adverse Event|1
7457320|NCT01797783|11750812|FG001|Overall Study|Adverse Event|1
7457321|NCT01797783|11750811|FG000|Overall Study|Withdrawal by Subject|1
7457322|NCT01797783|11750812|FG001|Overall Study|Withdrawal by Subject|0
7564752|NCT03293654|11935764|FG000|Overall Study|Lost to Follow-up|0
7457323|NCT01797835|11750834|FG000|Overall Study|Lost to Follow-up|31
7457324|NCT01797835|11750835|FG001|Overall Study|Lost to Follow-up|27
7457325|NCT01797965|11750845|FG000|Overall Study|Adverse Event|104
7457326|NCT01797965|11750846|FG001|Overall Study|Adverse Event|129
7457327|NCT01797965|11750847|FG002|Overall Study|Adverse Event|4
7457328|NCT01797965|11750848|FG003|Overall Study|Adverse Event|21
7457329|NCT01797965|11750845|FG000|Overall Study|Lost to Follow-up|9
7457330|NCT01797965|11750846|FG001|Overall Study|Lost to Follow-up|8
7457331|NCT01797965|11750847|FG002|Overall Study|Lost to Follow-up|1
7457332|NCT01797965|11750848|FG003|Overall Study|Lost to Follow-up|2
7457333|NCT01797965|11750845|FG000|Overall Study|Consent withdrawn|130
7457334|NCT01797965|11750846|FG001|Overall Study|Consent withdrawn|117
7564753|NCT03293654|11935765|FG001|Overall Study|Lost to Follow-up|1
7564754|NCT03293654|11935766|FG002|Overall Study|Lost to Follow-up|0
7564755|NCT03294317|11935778|FG000|Overall Study|Physician Decision|1
7564756|NCT03294317|11935778|FG000|Overall Study|Withdrawal by Subject|6
7564757|NCT03294317|11935778|FG000|Overall Study|Lost to Follow-up|1
7564758|NCT03294317|11935778|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
7564759|NCT03294317|11935778|FG000|Overall Study|Failed HB lead implant|8
7564760|NCT03294317|11935778|FG000|Overall Study|Received CRT instead|1
7564761|NCT03294317|11935778|FG000|Overall Study|Exited after lead revision|2
7564762|NCT03294538|11935785|FG000|Overall Study|Adverse Event|0
7564763|NCT03294538|11935786|FG001|Overall Study|Adverse Event|1
7564764|NCT03294538|11935787|FG002|Overall Study|Adverse Event|1
7564765|NCT03294538|11935785|FG000|Overall Study|Lost to Follow-up|1
7564766|NCT03294538|11935786|FG001|Overall Study|Lost to Follow-up|0
7564767|NCT03294538|11935787|FG002|Overall Study|Lost to Follow-up|0
7564768|NCT03294538|11935785|FG000|Overall Study|Outside of Visit Window|4
7564769|NCT03294538|11935786|FG001|Overall Study|Outside of Visit Window|4
7564770|NCT03294538|11935787|FG002|Overall Study|Outside of Visit Window|1
7564771|NCT03294681|11935804|FG000|Overall Study|Withdrawal by Subject|1
7564772|NCT03294941|11935819|FG000|Overall Study|Withdrawal by Subject|0
7564773|NCT03294941|11935820|FG001|Overall Study|Withdrawal by Subject|2
7564774|NCT03295201|11935829|FG000|Overall Study|Lost to Follow-up|1
7564775|NCT03295201|11935830|FG001|Overall Study|Lost to Follow-up|1
7329160|NCT00800683|11562190|FG001|Overall Study|Other|2
7329161|NCT00800735|11562196|FG000|Overall Study|Administrative/Other|2
7329162|NCT00800735|11562196|FG000|Overall Study|Insufficient Therapeutic Response|2
7329163|NCT00800735|11562196|FG000|Overall Study|Violation of Selection Criteria at Entry|7
7329164|NCT00800735|11562196|FG000|Overall Study|Withdrew Consent|3
7329165|NCT00800982|11562215|FG000|Overall Study|Lost to Follow-up|1
7329166|NCT00800982|11562216|FG001|Overall Study|Lost to Follow-up|2
7329167|NCT00800982|11562215|FG000|Overall Study|Withdrawal by Subject|0
7329168|NCT00800982|11562216|FG001|Overall Study|Withdrawal by Subject|1
7329169|NCT00800982|11562215|FG000|Overall Study|Patient moved out of state|1
7329170|NCT00800982|11562216|FG001|Overall Study|Patient moved out of state|0
7329171|NCT00801099|11562222|FG000|Overall Study|Lost to Follow-up|101
7329172|NCT00801229|11562245|FG000|Signed Consent|Withdrawal by Subject|2
7329173|NCT00801229|11562246|FG001|Signed Consent|Withdrawal by Subject|2
7329174|NCT00801229|11562245|FG000|Signed Consent|Found Ineligible|1
7329175|NCT00801229|11562246|FG001|Signed Consent|Found Ineligible|1
7329176|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
7329177|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
7329178|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
7329179|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
7329180|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Simulator sickness|1
7329181|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Simulator sickness|1
7329182|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
7329183|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
7329184|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
7329185|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
7329186|NCT00801229|11562245|FG000|Received Study Drug/Placebo|Adverse Event|1
7329187|NCT00801229|11562246|FG001|Received Study Drug/Placebo|Adverse Event|1
7329188|NCT00801242|11562252|FG000|Overall Study|Adverse Event|10
7329189|NCT00801242|11562252|FG000|Overall Study|Withdrawal by Subject|13
7329190|NCT00801242|11562252|FG000|Overall Study|Protocol Violation|5
7329191|NCT00801242|11562252|FG000|Overall Study|Physician Decision|3
7329192|NCT00801242|11562252|FG000|Overall Study|Lost to Follow-up|1
7329193|NCT00801242|11562252|FG000|Overall Study|Miscellaneous reasons|20
7329194|NCT00801632|11562295|FG000|Overall Study|Re-transplant|1
7329195|NCT00801892|11562336|FG000|Main Study Period|Withdrawal by Subject|0
7329196|NCT00801892|11562337|FG001|Main Study Period|Withdrawal by Subject|1
7329197|NCT00801892|11562336|FG000|Sham Crossover Period|Lost to Follow-up|0
7329198|NCT00801892|11562337|FG001|Sham Crossover Period|Lost to Follow-up|2
7457335|NCT01797965|11750847|FG002|Overall Study|Consent withdrawn|3
7564776|NCT03295201|11935829|FG000|Overall Study|Hospital admission|0
7564777|NCT03295201|11935830|FG001|Overall Study|Hospital admission|1
7564778|NCT03295318|11935848|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
7564779|NCT03295318|11935849|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7564780|NCT03295318|11935850|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
7564781|NCT03295318|11935848|FG000|Overall Study|Death|1
7329199|NCT00801983|11562347|FG000|Period 1|Lost to Follow-up|2
7329200|NCT00801983|11562348|FG001|Period 1|Lost to Follow-up|0
7329201|NCT00801983|11562347|FG000|Period 1|Withdrawal by Subject|2
7329202|NCT00801983|11562348|FG001|Period 1|Withdrawal by Subject|8
7329203|NCT00801983|11562347|FG000|Period 2|Withdrawal by Subject|2
7329204|NCT00801983|11562348|FG001|Period 2|Withdrawal by Subject|1
7329205|NCT00802074|11562360|FG000|Overall Study|Adverse Event|1
7329206|NCT00802074|11562361|FG001|Overall Study|Adverse Event|1
7457336|NCT01797965|11750848|FG003|Overall Study|Consent withdrawn|35
7457337|NCT01797965|11750845|FG000|Overall Study|Investigator decision|21
7457338|NCT01797965|11750846|FG001|Overall Study|Investigator decision|15
7457339|NCT01797965|11750847|FG002|Overall Study|Investigator decision|0
7457340|NCT01797965|11750848|FG003|Overall Study|Investigator decision|0
7457341|NCT01797965|11750845|FG000|Overall Study|Death|2
7457342|NCT01797965|11750846|FG001|Overall Study|Death|4
7457343|NCT01797965|11750847|FG002|Overall Study|Death|0
7457344|NCT01797965|11750848|FG003|Overall Study|Death|0
7457345|NCT01797965|11750845|FG000|Overall Study|Disease progression, defined by protocol|3
7457346|NCT01797965|11750846|FG001|Overall Study|Disease progression, defined by protocol|1
7457347|NCT01797965|11750847|FG002|Overall Study|Disease progression, defined by protocol|0
7457348|NCT01797965|11750848|FG003|Overall Study|Disease progression, defined by protocol|0
7457349|NCT01797965|11750845|FG000|Overall Study|Reason Not Specified|280
7457350|NCT01797965|11750846|FG001|Overall Study|Reason Not Specified|295
7457351|NCT01797965|11750847|FG002|Overall Study|Reason Not Specified|0
7457352|NCT01797965|11750848|FG003|Overall Study|Reason Not Specified|15
7457353|NCT01798056|11750861|FG000|Overall Study|Serious Adverse Event|13
7564782|NCT03295318|11935849|FG001|Overall Study|Death|1
7564783|NCT03295318|11935850|FG002|Overall Study|Death|1
7564784|NCT03295318|11935848|FG000|Overall Study|Protocol Violation|4
7564785|NCT03295318|11935849|FG001|Overall Study|Protocol Violation|3
7564786|NCT03295318|11935850|FG002|Overall Study|Protocol Violation|3
7564787|NCT03295318|11935848|FG000|Overall Study|Withdrawal by Subject|0
7564788|NCT03295318|11935849|FG001|Overall Study|Withdrawal by Subject|0
7564789|NCT03295318|11935850|FG002|Overall Study|Withdrawal by Subject|1
7564790|NCT03295318|11935848|FG000|Overall Study|Subject discontinued due to travel|0
7564791|NCT03295318|11935849|FG001|Overall Study|Subject discontinued due to travel|1
7564792|NCT03295318|11935850|FG002|Overall Study|Subject discontinued due to travel|0
7564793|NCT03295721|11935884|FG000|Overall Study|Adverse Event|1
7564794|NCT03295721|11935885|FG001|Overall Study|Adverse Event|0
7564795|NCT03295721|11935886|FG002|Overall Study|Adverse Event|0
7564796|NCT03295721|11935884|FG000|Overall Study|Lost to Follow-up|1
7564797|NCT03295721|11935885|FG001|Overall Study|Lost to Follow-up|1
7564798|NCT03295721|11935886|FG002|Overall Study|Lost to Follow-up|1
7564799|NCT03295721|11935884|FG000|Overall Study|Withdrawal by Subject|1
7564800|NCT03295721|11935885|FG001|Overall Study|Withdrawal by Subject|0
7564801|NCT03295721|11935886|FG002|Overall Study|Withdrawal by Subject|1
7564802|NCT03295721|11935884|FG000|Overall Study|Death|0
7564803|NCT03295721|11935885|FG001|Overall Study|Death|0
7564804|NCT03295721|11935886|FG002|Overall Study|Death|1
7564805|NCT03296527|11935934|FG000|Overall Study|Adverse Event|15
7564806|NCT03296527|11935935|FG001|Overall Study|Adverse Event|33
7564807|NCT03296527|11935934|FG000|Overall Study|Protocol Deviation|4
7564808|NCT03296527|11935935|FG001|Overall Study|Protocol Deviation|0
7564809|NCT03296527|11935934|FG000|Overall Study|Subject withdrew consent|3
7564810|NCT03296527|11935935|FG001|Overall Study|Subject withdrew consent|1
7564811|NCT03296527|11935934|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
7329284|NCT00802464|11562458|FG001|Month 8 - Month 14|Withdrawal by Subject|1
7564812|NCT03296527|11935935|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
7564813|NCT03296527|11935934|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
7564814|NCT03296527|11935935|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
7564815|NCT03296527|11935934|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
7564816|NCT03296527|11935935|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
7564817|NCT03296527|11935934|FG000|Overall Study|Discontinuation due to liquid in uterus|1
7564818|NCT03296527|11935935|FG001|Overall Study|Discontinuation due to liquid in uterus|0
7329207|NCT00802074|11562362|FG002|Overall Study|Adverse Event|1
7329208|NCT00802074|11562363|FG003|Overall Study|Adverse Event|0
7457354|NCT01798056|11750862|FG001|Overall Study|Serious Adverse Event|12
7457355|NCT01798056|11750861|FG000|Overall Study|Withdrawal by Subject|12
7564819|NCT03296527|11935934|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
7564820|NCT03296527|11935935|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
7564821|NCT03296566|11935944|FG000|Overall Study|Lost to Follow-up|19
7564822|NCT03296566|11935945|FG001|Overall Study|Lost to Follow-up|46
7564823|NCT03296566|11935944|FG000|Overall Study|Withdrawal by Subject|0
7457356|NCT01798056|11750862|FG001|Overall Study|Withdrawal by Subject|9
7564824|NCT03296566|11935945|FG001|Overall Study|Withdrawal by Subject|3
7564825|NCT03297021|11936000|FG000|Overall Study|Incomplete/illegible data sheet|4
7564826|NCT03297021|11936001|FG001|Overall Study|Incomplete/illegible data sheet|2
7564827|NCT03297021|11936002|FG002|Overall Study|Incomplete/illegible data sheet|3
7564828|NCT03297021|11936000|FG000|Overall Study|Missing Post-Op Data|1
7564829|NCT03297021|11936001|FG001|Overall Study|Missing Post-Op Data|2
7564830|NCT03297021|11936002|FG002|Overall Study|Missing Post-Op Data|1
7564831|NCT03297216|11936016|FG000|Overall Study|Death|0
7564832|NCT03297216|11936017|FG001|Overall Study|Death|1
7564833|NCT03297216|11936016|FG000|Overall Study|Miscarriage|0
7564834|NCT03297216|11936017|FG001|Overall Study|Miscarriage|2
7564835|NCT03297216|11936016|FG000|Overall Study|Lost to Follow-up|3
7564836|NCT03297216|11936017|FG001|Overall Study|Lost to Follow-up|2
7564837|NCT03297294|11936032|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
7457357|NCT01798056|11750861|FG000|Overall Study|Migrated/moved from study area|1
7457358|NCT01798056|11750862|FG001|Overall Study|Migrated/moved from study area|1
7457359|NCT01798056|11750861|FG000|Overall Study|Lost to Follow-up|1
7457360|NCT01798056|11750862|FG001|Overall Study|Lost to Follow-up|1
7564838|NCT03297294|11936033|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
7564839|NCT03297294|11936034|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7564840|NCT03297294|11936035|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7329209|NCT00802074|11562364|FG004|Overall Study|Adverse Event|0
7329210|NCT00802074|11562365|FG005|Overall Study|Adverse Event|0
7329211|NCT00802074|11562360|FG000|Overall Study|Withdrawal by Subject|1
7329212|NCT00802074|11562361|FG001|Overall Study|Withdrawal by Subject|0
7329213|NCT00802074|11562362|FG002|Overall Study|Withdrawal by Subject|0
7329214|NCT00802074|11562363|FG003|Overall Study|Withdrawal by Subject|0
7329215|NCT00802074|11562364|FG004|Overall Study|Withdrawal by Subject|0
7329216|NCT00802074|11562365|FG005|Overall Study|Withdrawal by Subject|0
7329217|NCT00802178|11562405|FG000|Overall Study|Lack of Efficacy|36
7329218|NCT00802178|11562405|FG000|Overall Study|Insufficient tolerability (IT)|17
7329219|NCT00802178|11562405|FG000|Overall Study|Withdrawal by Subject|18
7329220|NCT00802178|11562405|FG000|Overall Study|Other|32
7329221|NCT00802178|11562405|FG000|Overall Study|Lack of efficacy and patient wish|1
7329222|NCT00802178|11562405|FG000|Overall Study|IT and patient wish|8
7329223|NCT00802178|11562405|FG000|Overall Study|Patients wish and other reason|1
7385063|NCT01198600|11642606|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7385064|NCT01198600|11642607|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
7385065|NCT01198600|11642608|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7385066|NCT01198600|11642609|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
7385067|NCT01198600|11642606|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7564841|NCT03297294|11936036|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
7564842|NCT03297294|11936032|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7564843|NCT03297294|11936033|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
7385068|NCT01198600|11642607|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
7385069|NCT01198600|11642608|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7385070|NCT01198600|11642609|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
7385071|NCT01198600|11642606|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
7385072|NCT01198600|11642607|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
7385073|NCT01198600|11642608|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
7385074|NCT01198600|11642609|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
7385075|NCT01198600|11642606|FG000|Phase 2: 56 Days of Wear|Relocation|0
7385076|NCT01198600|11642607|FG001|Phase 2: 56 Days of Wear|Relocation|0
7385077|NCT01198600|11642608|FG002|Phase 2: 56 Days of Wear|Relocation|2
7385078|NCT01198600|11642609|FG003|Phase 2: 56 Days of Wear|Relocation|0
7385079|NCT01198600|11642606|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7385080|NCT01198600|11642607|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7385081|NCT01198600|11642608|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
7385082|NCT01198600|11642609|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
7385083|NCT01198756|11642630|FG000|Overall Study|Adverse Event|0
7385084|NCT01198756|11642631|FG001|Overall Study|Adverse Event|0
7385085|NCT01198756|11642632|FG002|Overall Study|Adverse Event|0
7385086|NCT01198756|11642633|FG003|Overall Study|Adverse Event|1
7385087|NCT01198756|11642630|FG000|Overall Study|Protocol Violation|0
7385088|NCT01198756|11642631|FG001|Overall Study|Protocol Violation|0
7385089|NCT01198756|11642632|FG002|Overall Study|Protocol Violation|0
7385090|NCT01198756|11642633|FG003|Overall Study|Protocol Violation|2
7385091|NCT01198756|11642630|FG000|Overall Study|Withdrawal by Subject|9
7385092|NCT01198756|11642631|FG001|Overall Study|Withdrawal by Subject|4
7385093|NCT01198756|11642632|FG002|Overall Study|Withdrawal by Subject|7
7385094|NCT01198756|11642633|FG003|Overall Study|Withdrawal by Subject|5
7385095|NCT01198756|11642630|FG000|Overall Study|Lost to Follow-up|29
7385096|NCT01198756|11642631|FG001|Overall Study|Lost to Follow-up|36
7385097|NCT01198756|11642632|FG002|Overall Study|Lost to Follow-up|23
7385098|NCT01198756|11642633|FG003|Overall Study|Lost to Follow-up|18
7385099|NCT01198795|11642654|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
7385100|NCT01198795|11642654|FG000|Overall Study|Withdrawal by Subject|17
7385101|NCT01198795|11642654|FG000|Overall Study|Lost to Follow-up|15
7385102|NCT01198795|11642654|FG000|Overall Study|Adverse Event|9
7385103|NCT01198795|11642654|FG000|Overall Study|Lack of Efficacy|5
7385104|NCT01198795|11642654|FG000|Overall Study|Protocol Violation|2
7385105|NCT01198795|11642654|FG000|Overall Study|Other Reason|4
7385106|NCT01198873|11642660|FG000|Overall Study|Adverse Event|4
7385107|NCT01198873|11642661|FG001|Overall Study|Adverse Event|7
7564844|NCT03297294|11936034|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7564845|NCT03297294|11936035|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7564846|NCT03297294|11936036|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
7385108|NCT01198873|11642660|FG000|Overall Study|Study closure|29
7385109|NCT01198873|11642661|FG001|Overall Study|Study closure|23
7385110|NCT01198873|11642660|FG000|Overall Study|Other than above|4
7564847|NCT03297294|11936032|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
7564848|NCT03297294|11936033|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
7564849|NCT03297294|11936034|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
7457361|NCT01798056|11750861|FG000|Overall Study|Other|0
7457362|NCT01798056|11750862|FG001|Overall Study|Other|2
7457363|NCT01798134|11750870|FG000|Overall Study|Lost to Follow-up|1
7457364|NCT01798134|11750870|FG000|Overall Study|Withdrawal by Subject|3
7457365|NCT01798134|11750870|FG000|Overall Study|Death|2
7564850|NCT03297294|11936035|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
7564851|NCT03297294|11936036|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
7564852|NCT03297294|11936032|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
7564853|NCT03297294|11936033|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
7564854|NCT03297294|11936034|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
7564855|NCT03297294|11936035|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
7564856|NCT03297294|11936036|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
7564857|NCT03297294|11936032|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7564858|NCT03297294|11936033|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7564859|NCT03297294|11936034|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7564860|NCT03297294|11936035|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
7564861|NCT03297294|11936036|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
7564862|NCT03297398|11936051|FG000|Overall Study|Sponsor's decision|6
7564863|NCT03297398|11936052|FG001|Overall Study|Sponsor's decision|9
7564864|NCT03297398|11936053|FG002|Overall Study|Sponsor's decision|7
7564865|NCT03297398|11936051|FG000|Overall Study|Adverse Event|1
7564866|NCT03297398|11936052|FG001|Overall Study|Adverse Event|4
7564867|NCT03297398|11936053|FG002|Overall Study|Adverse Event|4
7564868|NCT03297398|11936051|FG000|Overall Study|Withdrawal by Subject|1
7564869|NCT03297398|11936052|FG001|Overall Study|Withdrawal by Subject|2
7564870|NCT03297398|11936053|FG002|Overall Study|Withdrawal by Subject|2
7564871|NCT03297398|11936051|FG000|Overall Study|Protocol Violation|0
7564872|NCT03297398|11936052|FG001|Overall Study|Protocol Violation|2
7564873|NCT03297398|11936053|FG002|Overall Study|Protocol Violation|0
7564874|NCT03297398|11936051|FG000|Overall Study|Physician Decision|0
7564875|NCT03297398|11936052|FG001|Overall Study|Physician Decision|0
7564876|NCT03297398|11936053|FG002|Overall Study|Physician Decision|1
7564877|NCT03297398|11936051|FG000|Overall Study|Lost to Follow-up|0
7564878|NCT03297398|11936052|FG001|Overall Study|Lost to Follow-up|0
7564879|NCT03297398|11936053|FG002|Overall Study|Lost to Follow-up|1
7564880|NCT03298412|11936101|FG000|Run-in Period|Other, Not Specified|1
7564881|NCT03298412|11936101|FG000|Run-in Period|Disease Progression|1
7564882|NCT03298412|11936101|FG000|Run-in Period|Ineligibility Determined|1
7564883|NCT03298412|11936101|FG000|Run-in Period|Decision by Sponsor|6
7564884|NCT03299101|11936126|FG000|Overall Study|Lost to Follow-up|1
7564885|NCT03299101|11936126|FG000|Overall Study|Withdrawal by Subject|5
7564886|NCT03299101|11936126|FG000|Overall Study|Surgery was changed|3
7329224|NCT00802360|11562425|FG000|Overall Study|Stimulation failure|4
7329225|NCT00802360|11562426|FG001|Overall Study|Stimulation failure|0
7329226|NCT00802360|11562427|FG002|Overall Study|Stimulation failure|3
7329227|NCT00802360|11562428|FG003|Overall Study|Stimulation failure|3
7329228|NCT00802360|11562425|FG000|Overall Study|Inadequate number of oocytes retrieved|0
7329229|NCT00802360|11562426|FG001|Overall Study|Inadequate number of oocytes retrieved|0
7329230|NCT00802360|11562427|FG002|Overall Study|Inadequate number of oocytes retrieved|0
7329231|NCT00802360|11562428|FG003|Overall Study|Inadequate number of oocytes retrieved|1
7329232|NCT00802360|11562425|FG000|Overall Study|Cycle cancelled|0
7329233|NCT00802360|11562426|FG001|Overall Study|Cycle cancelled|1
7564887|NCT03299101|11936126|FG000|Overall Study|Not enough time to complete prehab|1
7329234|NCT00802360|11562427|FG002|Overall Study|Cycle cancelled|1
7329235|NCT00802360|11562428|FG003|Overall Study|Cycle cancelled|1
7329236|NCT00802360|11562425|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7564888|NCT03299244|11936132|FG000|Overall Study|Withdrawal by Subject|34
7564889|NCT03299244|11936133|FG001|Overall Study|Withdrawal by Subject|29
7564890|NCT03299244|11936132|FG000|Overall Study|Decision by Sponsor|4
7564891|NCT03299244|11936133|FG001|Overall Study|Decision by Sponsor|5
7564892|NCT03299244|11936132|FG000|Overall Study|Death|9
7564893|NCT03299244|11936133|FG001|Overall Study|Death|4
7564894|NCT03299686|11936142|FG000|Treatment Epoch|Subject/Guardian Decision|2
7564895|NCT03299686|11936143|FG001|Treatment Epoch|Subject/Guardian Decision|0
7564896|NCT03299686|11936142|FG000|Treatment Epoch|Physician Decision|1
7564897|NCT03299686|11936143|FG001|Treatment Epoch|Physician Decision|0
7564898|NCT03299686|11936142|FG000|Treatment Epoch|Adverse Event|8
7564899|NCT03299686|11936143|FG001|Treatment Epoch|Adverse Event|4
7564900|NCT03299686|11936142|FG000|Follow-up Epoch|Subject/Guardian Decision|0
7564901|NCT03299686|11936143|FG001|Follow-up Epoch|Subject/Guardian Decision|1
7564902|NCT03299881|11936151|FG000|Overall Study|Study Termination|17
7564903|NCT03299881|11936152|FG001|Overall Study|Study Termination|13
7564904|NCT03300050|11936163|FG000|Overall Study|Lost to Follow-up|2
7329237|NCT00802360|11562426|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7457366|NCT01798134|11750870|FG000|Overall Study|Adverse Event|3
7564905|NCT03300050|11936164|FG001|Overall Study|Lost to Follow-up|1
7564906|NCT03300050|11936165|FG002|Overall Study|Lost to Follow-up|0
7564907|NCT03300050|11936166|FG003|Overall Study|Lost to Follow-up|0
7329238|NCT00802360|11562427|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
7564908|NCT03300050|11936167|FG004|Overall Study|Lost to Follow-up|1
7564909|NCT03300050|11936163|FG000|Overall Study|Withdrawal by Subject|1
7457367|NCT01798134|11750870|FG000|Overall Study|Physician Decision|3
7457368|NCT01798134|11750870|FG000|Overall Study|Liver transplant/surgery|4
7457369|NCT01798485|11750942|FG000|Overall Study|Adverse Event|32
7457370|NCT01798485|11750943|FG001|Overall Study|Adverse Event|40
7457371|NCT01798485|11750942|FG000|Overall Study|Withdrawal by Subject|27
7457372|NCT01798485|11750943|FG001|Overall Study|Withdrawal by Subject|31
7457373|NCT01798485|11750942|FG000|Overall Study|Lost to Follow-up|0
7457374|NCT01798485|11750943|FG001|Overall Study|Lost to Follow-up|3
7457375|NCT01798485|11750942|FG000|Overall Study|Physician Decision|14
7457376|NCT01798485|11750943|FG001|Overall Study|Physician Decision|10
7457377|NCT01798485|11750942|FG000|Overall Study|Objective Disease Progression|152
7457378|NCT01798485|11750943|FG001|Overall Study|Objective Disease Progression|106
7457379|NCT01798485|11750942|FG000|Overall Study|Death|25
7457380|NCT01798485|11750943|FG001|Overall Study|Death|22
7457381|NCT01798485|11750942|FG000|Overall Study|Sponsor Decision|61
7457382|NCT01798485|11750943|FG001|Overall Study|Sponsor Decision|54
7457383|NCT01798485|11750942|FG000|Overall Study|Clinical Progression|35
7457384|NCT01798485|11750943|FG001|Overall Study|Clinical Progression|24
7457385|NCT01798706|11750978|FG000|Overall Study|Adverse Event|15
7564910|NCT03300050|11936164|FG001|Overall Study|Withdrawal by Subject|1
7564911|NCT03300050|11936165|FG002|Overall Study|Withdrawal by Subject|1
7564912|NCT03300050|11936166|FG003|Overall Study|Withdrawal by Subject|0
7564913|NCT03300050|11936167|FG004|Overall Study|Withdrawal by Subject|0
7564914|NCT03300050|11936163|FG000|Overall Study|Death|0
7564915|NCT03300050|11936164|FG001|Overall Study|Death|0
7564916|NCT03300050|11936165|FG002|Overall Study|Death|1
7564917|NCT03300050|11936166|FG003|Overall Study|Death|0
7564918|NCT03300050|11936167|FG004|Overall Study|Death|0
7564919|NCT03300050|11936163|FG000|Overall Study|Not Eligible at Randomization|0
7564920|NCT03300050|11936164|FG001|Overall Study|Not Eligible at Randomization|0
7564921|NCT03300050|11936165|FG002|Overall Study|Not Eligible at Randomization|1
7564922|NCT03300050|11936166|FG003|Overall Study|Not Eligible at Randomization|1
7564923|NCT03300050|11936167|FG004|Overall Study|Not Eligible at Randomization|0
7564924|NCT03300570|11936190|FG000|Overall Study|Adverse Event|0
7564925|NCT03300570|11936191|FG001|Overall Study|Adverse Event|1
7564926|NCT03300570|11936190|FG000|Overall Study|Withdrawal by Subject|1
7564927|NCT03300570|11936191|FG001|Overall Study|Withdrawal by Subject|0
7564928|NCT03300570|11936190|FG000|Overall Study|Inadequate bowel prep|1
7564929|NCT03300570|11936191|FG001|Overall Study|Inadequate bowel prep|0
7564930|NCT03301155|11936222|FG000|Overall Study|Сompliance with exclusion criteria|8
7564931|NCT03301155|11936223|FG001|Overall Study|Сompliance with exclusion criteria|7
7564932|NCT03301623|11936270|FG000|Overall Study|Death|3
7329239|NCT00802360|11562428|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
7329240|NCT00802360|11562425|FG000|Overall Study|No positive serum pregnancy|17
7329241|NCT00802360|11562426|FG001|Overall Study|No positive serum pregnancy|20
7329242|NCT00802360|11562427|FG002|Overall Study|No positive serum pregnancy|14
7329243|NCT00802360|11562428|FG003|Overall Study|No positive serum pregnancy|10
7329244|NCT00802360|11562425|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
7329245|NCT00802360|11562426|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
7329246|NCT00802360|11562427|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
7329247|NCT00802360|11562428|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
7329248|NCT00802360|11562425|FG000|Overall Study|Pregnancy loss/miscarriage|0
7329249|NCT00802360|11562426|FG001|Overall Study|Pregnancy loss/miscarriage|2
7329250|NCT00802360|11562427|FG002|Overall Study|Pregnancy loss/miscarriage|0
7329251|NCT00802360|11562428|FG003|Overall Study|Pregnancy loss/miscarriage|3
7329252|NCT00802360|11562425|FG000|Overall Study|Other|2
7329253|NCT00802360|11562426|FG001|Overall Study|Other|3
7329254|NCT00802360|11562427|FG002|Overall Study|Other|6
7329255|NCT00802360|11562428|FG003|Overall Study|Other|3
7329256|NCT00802438|11562449|FG000|Overall Study|Screen Failure|20
7329257|NCT00802438|11562449|FG000|Overall Study|Withdrawal by Subject|7
7329258|NCT00802438|11562449|FG000|Overall Study|Physician Decision|1
7329259|NCT00802464|11562457|FG000|Month 0 - Month 8|Adverse Event|0
7329260|NCT00802464|11562458|FG001|Month 0 - Month 8|Adverse Event|1
7329261|NCT00802464|11562459|FG002|Month 0 - Month 8|Adverse Event|1
7329262|NCT00802464|11562460|FG003|Month 0 - Month 8|Adverse Event|2
7329263|NCT00802464|11562457|FG000|Month 0 - Month 8|Protocol Violation|0
7329264|NCT00802464|11562458|FG001|Month 0 - Month 8|Protocol Violation|0
7329265|NCT00802464|11562459|FG002|Month 0 - Month 8|Protocol Violation|1
7329266|NCT00802464|11562460|FG003|Month 0 - Month 8|Protocol Violation|0
7329267|NCT00802464|11562457|FG000|Month 0 - Month 8|Withdrawal by Subject|0
7457386|NCT01798706|11750979|FG001|Overall Study|Adverse Event|10
7564933|NCT03301623|11936271|FG001|Overall Study|Death|1
7457387|NCT01798706|11750978|FG000|Overall Study|Lack of Efficacy|0
7329268|NCT00802464|11562458|FG001|Month 0 - Month 8|Withdrawal by Subject|1
7329269|NCT00802464|11562459|FG002|Month 0 - Month 8|Withdrawal by Subject|2
7329270|NCT00802464|11562460|FG003|Month 0 - Month 8|Withdrawal by Subject|5
7329271|NCT00802464|11562457|FG000|Month 0 - Month 8|Lost to Follow-up|0
7457388|NCT01798706|11750979|FG001|Overall Study|Lack of Efficacy|2
7564934|NCT03301623|11936270|FG000|Overall Study|Withdrawal by Subject|11
7564935|NCT03301623|11936271|FG001|Overall Study|Withdrawal by Subject|13
7329272|NCT00802464|11562458|FG001|Month 0 - Month 8|Lost to Follow-up|1
7329273|NCT00802464|11562459|FG002|Month 0 - Month 8|Lost to Follow-up|2
7457389|NCT01798706|11750978|FG000|Overall Study|Poor compliance to protocol|1
7457390|NCT01798706|11750979|FG001|Overall Study|Poor compliance to protocol|0
7457391|NCT01798706|11750978|FG000|Overall Study|Other than specified above|5
7457392|NCT01798706|11750979|FG001|Overall Study|Other than specified above|9
7457393|NCT01798849|11750988|FG000|Overall Study|Physician Decision|0
7457394|NCT01798849|11750989|FG001|Overall Study|Physician Decision|0
7457395|NCT01798849|11750990|FG002|Overall Study|Physician Decision|1
7457396|NCT01798927|11751027|FG000|Overall Study|Withdrawal by Subject|1
7457397|NCT01798992|11751040|FG000|Overall Study|Administrative withdrawal|0
7457398|NCT01798992|11751041|FG001|Overall Study|Administrative withdrawal|1
7457399|NCT01798992|11751042|FG002|Overall Study|Administrative withdrawal|0
7457400|NCT01798992|11751043|FG003|Overall Study|Administrative withdrawal|1
7457401|NCT01798992|11751040|FG000|Overall Study|Lost to Follow-up|0
7457402|NCT01798992|11751041|FG001|Overall Study|Lost to Follow-up|1
7457403|NCT01798992|11751042|FG002|Overall Study|Lost to Follow-up|1
7457404|NCT01798992|11751043|FG003|Overall Study|Lost to Follow-up|0
7457405|NCT01798992|11751040|FG000|Overall Study|Insufficient biopsy tissue|0
7457406|NCT01798992|11751041|FG001|Overall Study|Insufficient biopsy tissue|0
7457407|NCT01798992|11751042|FG002|Overall Study|Insufficient biopsy tissue|1
7457408|NCT01798992|11751043|FG003|Overall Study|Insufficient biopsy tissue|0
7457409|NCT01799226|11751073|FG000|Overall Study|Withdrawal by Subject|1
7457410|NCT01799226|11751074|FG001|Overall Study|Withdrawal by Subject|0
7457411|NCT01799226|11751073|FG000|Overall Study|Disqualified at Day 14|1
7457412|NCT01799226|11751074|FG001|Overall Study|Disqualified at Day 14|0
7457413|NCT01799239|11751080|FG000|Period 1 (7 Days)|Lack of Efficacy|1
7457414|NCT01799239|11751081|FG001|Period 1 (7 Days)|Lack of Efficacy|0
7457415|NCT01799239|11751080|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
7457416|NCT01799239|11751081|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
7457417|NCT01799239|11751080|FG000|Period 1 (7 Days)|Protocol Violation|0
7457418|NCT01799239|11751081|FG001|Period 1 (7 Days)|Protocol Violation|1
7457419|NCT01799239|11751080|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
7457420|NCT01799239|11751081|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
7457421|NCT01799239|11751080|FG000|Period 2 (7 Days)|Protocol Violation|1
7457422|NCT01799239|11751081|FG001|Period 2 (7 Days)|Protocol Violation|0
7457423|NCT01799590|11751098|FG000|Overall Study|Adverse Event|13
7457424|NCT01799590|11751099|FG001|Overall Study|Adverse Event|7
7457425|NCT01799590|11751100|FG002|Overall Study|Adverse Event|5
7457426|NCT01799590|11751098|FG000|Overall Study|Pregnancy|2
7457427|NCT01799590|11751099|FG001|Overall Study|Pregnancy|0
7457428|NCT01799590|11751100|FG002|Overall Study|Pregnancy|0
7457429|NCT01799590|11751098|FG000|Overall Study|Lack of Efficacy|3
7457430|NCT01799590|11751099|FG001|Overall Study|Lack of Efficacy|1
7457431|NCT01799590|11751100|FG002|Overall Study|Lack of Efficacy|3
7457432|NCT01799590|11751098|FG000|Overall Study|Participants convenience|4
7457433|NCT01799590|11751099|FG001|Overall Study|Participants convenience|4
7457434|NCT01799590|11751100|FG002|Overall Study|Participants convenience|2
7457435|NCT01799590|11751098|FG000|Overall Study|Aggravation of complications|0
7457436|NCT01799590|11751099|FG001|Overall Study|Aggravation of complications|1
7457437|NCT01799590|11751100|FG002|Overall Study|Aggravation of complications|1
7457438|NCT01799590|11751098|FG000|Overall Study|Using drugs with restricted days of use|0
7457439|NCT01799590|11751099|FG001|Overall Study|Using drugs with restricted days of use|3
7457440|NCT01799590|11751100|FG002|Overall Study|Using drugs with restricted days of use|2
7457441|NCT01799590|11751098|FG000|Overall Study|Use of prohibited concomitant drugs|1
7457442|NCT01799590|11751099|FG001|Overall Study|Use of prohibited concomitant drugs|0
7457443|NCT01799590|11751100|FG002|Overall Study|Use of prohibited concomitant drugs|0
7457444|NCT01799590|11751098|FG000|Overall Study|Other|3
7457445|NCT01799590|11751099|FG001|Overall Study|Other|0
7457446|NCT01799590|11751100|FG002|Overall Study|Other|1
7457447|NCT01799720|11751111|FG000|Overall Study|Withdrawal by Subject|3
7457448|NCT01799720|11751112|FG001|Overall Study|Withdrawal by Subject|0
7457449|NCT01799720|11751113|FG002|Overall Study|Withdrawal by Subject|0
7457450|NCT01799720|11751111|FG000|Overall Study|Protocol Violation|0
7457451|NCT01799720|11751112|FG001|Overall Study|Protocol Violation|1
7457452|NCT01799720|11751113|FG002|Overall Study|Protocol Violation|0
7457453|NCT01799720|11751111|FG000|Overall Study|Pregnancy|0
7457454|NCT01799720|11751112|FG001|Overall Study|Pregnancy|0
7457455|NCT01799720|11751113|FG002|Overall Study|Pregnancy|1
7457456|NCT01799889|11751133|FG000|Overall Study|Adverse Event|4
7457457|NCT01799889|11751134|FG001|Overall Study|Adverse Event|4
7457458|NCT01799889|11751135|FG002|Overall Study|Adverse Event|5
7457459|NCT01799889|11751136|FG003|Overall Study|Adverse Event|1
7457460|NCT01799889|11751137|FG004|Overall Study|Adverse Event|11
7457461|NCT01799889|11751138|FG005|Overall Study|Adverse Event|1
7457462|NCT01799889|11751139|FG006|Overall Study|Adverse Event|5
7457463|NCT01799889|11751140|FG007|Overall Study|Adverse Event|2
7457464|NCT01799889|11751141|FG008|Overall Study|Adverse Event|3
7457465|NCT01799889|11751142|FG009|Overall Study|Adverse Event|1
7457466|NCT01799889|11751143|FG010|Overall Study|Adverse Event|1
7457467|NCT01799889|11751144|FG011|Overall Study|Adverse Event|0
7457468|NCT01799889|11751133|FG000|Overall Study|Death|1
7457469|NCT01799889|11751134|FG001|Overall Study|Death|0
7457470|NCT01799889|11751135|FG002|Overall Study|Death|5
7457471|NCT01799889|11751136|FG003|Overall Study|Death|3
7457472|NCT01799889|11751137|FG004|Overall Study|Death|1
7457473|NCT01799889|11751138|FG005|Overall Study|Death|0
7457474|NCT01799889|11751139|FG006|Overall Study|Death|0
7457475|NCT01799889|11751140|FG007|Overall Study|Death|0
7457476|NCT01799889|11751141|FG008|Overall Study|Death|1
7457477|NCT01799889|11751142|FG009|Overall Study|Death|0
7457478|NCT01799889|11751143|FG010|Overall Study|Death|1
7457479|NCT01799889|11751144|FG011|Overall Study|Death|0
7457480|NCT01799889|11751133|FG000|Overall Study|Lack of Efficacy|1
7457481|NCT01799889|11751134|FG001|Overall Study|Lack of Efficacy|1
7457482|NCT01799889|11751135|FG002|Overall Study|Lack of Efficacy|0
7457483|NCT01799889|11751136|FG003|Overall Study|Lack of Efficacy|1
7457484|NCT01799889|11751137|FG004|Overall Study|Lack of Efficacy|2
7457485|NCT01799889|11751138|FG005|Overall Study|Lack of Efficacy|2
7457486|NCT01799889|11751139|FG006|Overall Study|Lack of Efficacy|0
7457487|NCT01799889|11751140|FG007|Overall Study|Lack of Efficacy|0
7457488|NCT01799889|11751141|FG008|Overall Study|Lack of Efficacy|2
7457489|NCT01799889|11751142|FG009|Overall Study|Lack of Efficacy|0
7457490|NCT01799889|11751143|FG010|Overall Study|Lack of Efficacy|1
7457491|NCT01799889|11751144|FG011|Overall Study|Lack of Efficacy|0
7457492|NCT01799889|11751133|FG000|Overall Study|Lost to Follow-up|0
7457493|NCT01799889|11751134|FG001|Overall Study|Lost to Follow-up|1
7457494|NCT01799889|11751135|FG002|Overall Study|Lost to Follow-up|0
7457495|NCT01799889|11751136|FG003|Overall Study|Lost to Follow-up|0
7457496|NCT01799889|11751137|FG004|Overall Study|Lost to Follow-up|0
7457497|NCT01799889|11751138|FG005|Overall Study|Lost to Follow-up|0
7457498|NCT01799889|11751139|FG006|Overall Study|Lost to Follow-up|0
7457499|NCT01799889|11751140|FG007|Overall Study|Lost to Follow-up|0
7457500|NCT01799889|11751141|FG008|Overall Study|Lost to Follow-up|0
7457501|NCT01799889|11751142|FG009|Overall Study|Lost to Follow-up|0
7457502|NCT01799889|11751143|FG010|Overall Study|Lost to Follow-up|0
7457503|NCT01799889|11751144|FG011|Overall Study|Lost to Follow-up|0
7457504|NCT01799889|11751133|FG000|Overall Study|Physician Decision|3
7457505|NCT01799889|11751134|FG001|Overall Study|Physician Decision|2
7457506|NCT01799889|11751135|FG002|Overall Study|Physician Decision|4
7457507|NCT01799889|11751136|FG003|Overall Study|Physician Decision|4
7457508|NCT01799889|11751137|FG004|Overall Study|Physician Decision|5
7457509|NCT01799889|11751138|FG005|Overall Study|Physician Decision|5
7457510|NCT01799889|11751139|FG006|Overall Study|Physician Decision|5
7457511|NCT01799889|11751140|FG007|Overall Study|Physician Decision|2
7457512|NCT01799889|11751141|FG008|Overall Study|Physician Decision|6
7457513|NCT01799889|11751142|FG009|Overall Study|Physician Decision|0
7457514|NCT01799889|11751143|FG010|Overall Study|Physician Decision|0
7457515|NCT01799889|11751144|FG011|Overall Study|Physician Decision|1
7457516|NCT01799889|11751133|FG000|Overall Study|Progressive Disease|30
7457517|NCT01799889|11751134|FG001|Overall Study|Progressive Disease|26
7457518|NCT01799889|11751135|FG002|Overall Study|Progressive Disease|25
7457519|NCT01799889|11751136|FG003|Overall Study|Progressive Disease|30
7457520|NCT01799889|11751137|FG004|Overall Study|Progressive Disease|23
7457521|NCT01799889|11751138|FG005|Overall Study|Progressive Disease|9
7457522|NCT01799889|11751139|FG006|Overall Study|Progressive Disease|8
7457523|NCT01799889|11751140|FG007|Overall Study|Progressive Disease|13
7457524|NCT01799889|11751141|FG008|Overall Study|Progressive Disease|18
7457525|NCT01799889|11751142|FG009|Overall Study|Progressive Disease|5
7457526|NCT01799889|11751143|FG010|Overall Study|Progressive Disease|3
7457527|NCT01799889|11751144|FG011|Overall Study|Progressive Disease|1
7457528|NCT01799889|11751133|FG000|Overall Study|Specified Criteria for Withdrawal|0
7457529|NCT01799889|11751134|FG001|Overall Study|Specified Criteria for Withdrawal|1
7564936|NCT03301623|11936270|FG000|Overall Study|Lost to Follow-up|3
7564937|NCT03301623|11936271|FG001|Overall Study|Lost to Follow-up|1
7564938|NCT03301649|11936280|FG000|Overall Study|Need alternate therapy due to live lice|17
7564939|NCT03301649|11936281|FG001|Overall Study|Need alternate therapy due to live lice|25
7564940|NCT03301649|11936282|FG002|Overall Study|Need alternate therapy due to live lice|81
7564941|NCT03301649|11936280|FG000|Overall Study|Lost to Follow-up|11
7564942|NCT03301649|11936281|FG001|Overall Study|Lost to Follow-up|11
7564943|NCT03301649|11936282|FG002|Overall Study|Lost to Follow-up|3
7564944|NCT03301649|11936280|FG000|Overall Study|Protocol Violation|0
7564945|NCT03301649|11936281|FG001|Overall Study|Protocol Violation|1
7564946|NCT03301649|11936282|FG002|Overall Study|Protocol Violation|1
7564947|NCT03301649|11936280|FG000|Overall Study|Withdrawal by Subject|10
7564948|NCT03301649|11936281|FG001|Overall Study|Withdrawal by Subject|4
7564949|NCT03301649|11936282|FG002|Overall Study|Withdrawal by Subject|0
7564950|NCT03301649|11936280|FG000|Overall Study|Other than specified|5
7564951|NCT03301649|11936281|FG001|Overall Study|Other than specified|3
7564952|NCT03301649|11936282|FG002|Overall Study|Other than specified|0
7564953|NCT03301714|11936293|FG000|Overall Study|Lost to Follow-up|10
7457530|NCT01799889|11751135|FG002|Overall Study|Specified Criteria for Withdrawal|1
7457531|NCT01799889|11751136|FG003|Overall Study|Specified Criteria for Withdrawal|0
7457532|NCT01799889|11751137|FG004|Overall Study|Specified Criteria for Withdrawal|0
7457533|NCT01799889|11751138|FG005|Overall Study|Specified Criteria for Withdrawal|0
7457534|NCT01799889|11751139|FG006|Overall Study|Specified Criteria for Withdrawal|0
7457535|NCT01799889|11751140|FG007|Overall Study|Specified Criteria for Withdrawal|0
7457536|NCT01799889|11751141|FG008|Overall Study|Specified Criteria for Withdrawal|0
7457537|NCT01799889|11751142|FG009|Overall Study|Specified Criteria for Withdrawal|0
7457538|NCT01799889|11751143|FG010|Overall Study|Specified Criteria for Withdrawal|0
7457539|NCT01799889|11751144|FG011|Overall Study|Specified Criteria for Withdrawal|0
7457540|NCT01799889|11751133|FG000|Overall Study|Study Terminated By Sponsor|1
7457541|NCT01799889|11751134|FG001|Overall Study|Study Terminated By Sponsor|0
7457542|NCT01799889|11751135|FG002|Overall Study|Study Terminated By Sponsor|0
7564954|NCT03301714|11936294|FG001|Overall Study|Lost to Follow-up|4
7564955|NCT03301714|11936295|FG002|Overall Study|Lost to Follow-up|4
7564956|NCT03301714|11936293|FG000|Overall Study|Did not receive allocated intervention|0
7564957|NCT03301714|11936294|FG001|Overall Study|Did not receive allocated intervention|2
7564958|NCT03301714|11936295|FG002|Overall Study|Did not receive allocated intervention|3
7564959|NCT03301740|11936308|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
7564960|NCT03301740|11936309|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
7564961|NCT03301740|11936308|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
7564962|NCT03301740|11936309|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
7564963|NCT03301831|11936324|FG000|Overall Study|Lost to Follow-up|5
7564964|NCT03301831|11936325|FG001|Overall Study|Lost to Follow-up|3
7564965|NCT03301831|11936324|FG000|Overall Study|Protocol Violation|4
7564966|NCT03301831|11936325|FG001|Overall Study|Protocol Violation|0
7564967|NCT03301831|11936324|FG000|Overall Study|Withdrawal by Subject|11
7564968|NCT03301831|11936325|FG001|Overall Study|Withdrawal by Subject|0
7564969|NCT03301844|11936333|FG000|Overall Study|suspected colon cancer|1
7564970|NCT03301844|11936334|FG001|Overall Study|suspected colon cancer|1
7575043|NCT03709654|11958507|FG000|Overall Study|Adverse Event|1
7575044|NCT03709654|11958508|FG001|Overall Study|Adverse Event|0
7575045|NCT03709823|11958527|FG000|Overall Study|Adverse Event|0
7575046|NCT03709823|11958528|FG001|Overall Study|Adverse Event|0
7575047|NCT03709823|11958529|FG002|Overall Study|Adverse Event|1
7575048|NCT03709823|11958530|FG003|Overall Study|Adverse Event|0
7575049|NCT03709823|11958531|FG004|Overall Study|Adverse Event|0
7575050|NCT03709823|11958532|FG005|Overall Study|Adverse Event|0
7575051|NCT03709823|11958527|FG000|Overall Study|Lost to Follow-up|2
7575052|NCT03709823|11958528|FG001|Overall Study|Lost to Follow-up|2
7575053|NCT03709823|11958529|FG002|Overall Study|Lost to Follow-up|2
7575054|NCT03709823|11958530|FG003|Overall Study|Lost to Follow-up|1
7575055|NCT03709823|11958531|FG004|Overall Study|Lost to Follow-up|1
7329274|NCT00802464|11562460|FG003|Month 0 - Month 8|Lost to Follow-up|2
7329275|NCT00802464|11562457|FG000|Month 0 - Month 8|Other|0
7575056|NCT03709823|11958532|FG005|Overall Study|Lost to Follow-up|0
7575057|NCT03709823|11958527|FG000|Overall Study|Withdrawal by Subject|1
7575058|NCT03709823|11958528|FG001|Overall Study|Withdrawal by Subject|3
7575059|NCT03709823|11958529|FG002|Overall Study|Withdrawal by Subject|0
7575060|NCT03709823|11958530|FG003|Overall Study|Withdrawal by Subject|0
7575061|NCT03709823|11958531|FG004|Overall Study|Withdrawal by Subject|0
7575062|NCT03709823|11958532|FG005|Overall Study|Withdrawal by Subject|0
7575063|NCT03709823|11958527|FG000|Overall Study|Other, Not Specified|0
7575064|NCT03709823|11958528|FG001|Overall Study|Other, Not Specified|0
7329276|NCT00802464|11562458|FG001|Month 0 - Month 8|Other|0
7329277|NCT00802464|11562459|FG002|Month 0 - Month 8|Other|1
7329278|NCT00802464|11562460|FG003|Month 0 - Month 8|Other|0
7329279|NCT00802464|11562457|FG000|Month 8 - Month 14|Adverse Event|0
7329280|NCT00802464|11562458|FG001|Month 8 - Month 14|Adverse Event|1
7329281|NCT00802464|11562459|FG002|Month 8 - Month 14|Adverse Event|0
7329282|NCT00802464|11562460|FG003|Month 8 - Month 14|Adverse Event|0
7329283|NCT00802464|11562457|FG000|Month 8 - Month 14|Withdrawal by Subject|1
7329285|NCT00802464|11562459|FG002|Month 8 - Month 14|Withdrawal by Subject|0
7329286|NCT00802464|11562460|FG003|Month 8 - Month 14|Withdrawal by Subject|0
7329287|NCT00802464|11562457|FG000|Month 8 - Month 14|Lost to Follow-up|0
7329288|NCT00802464|11562458|FG001|Month 8 - Month 14|Lost to Follow-up|0
7329289|NCT00802464|11562459|FG002|Month 8 - Month 14|Lost to Follow-up|1
7329290|NCT00802464|11562460|FG003|Month 8 - Month 14|Lost to Follow-up|0
7575065|NCT03709823|11958529|FG002|Overall Study|Other, Not Specified|0
7575066|NCT03709823|11958530|FG003|Overall Study|Other, Not Specified|1
7329291|NCT00802529|11562487|FG000|Overall Study|Lost to Follow-up|0
7457543|NCT01799889|11751136|FG003|Overall Study|Study Terminated By Sponsor|0
7575067|NCT03709823|11958531|FG004|Overall Study|Other, Not Specified|0
7575068|NCT03709823|11958532|FG005|Overall Study|Other, Not Specified|0
7575069|NCT03710083|11958549|FG000|Overall Study|Withdrawal by Subject|2
7575070|NCT03710083|11958549|FG000|Overall Study|Unsuccessful Procedure|1
7575071|NCT03710161|11958555|FG000|Overall Study|Study halted due to COVID pandemic|3
7575072|NCT03710161|11958556|FG001|Overall Study|Study halted due to COVID pandemic|2
7575073|NCT03710590|11958582|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
7575074|NCT03710590|11958583|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
7575484|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7575485|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7575486|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
7575487|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7575488|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
7575489|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7329292|NCT00802529|11562488|FG001|Overall Study|Lost to Follow-up|1
7329293|NCT00802672|11562506|FG000|Overall Study|Lack of fungal pathogen at baseline|56
7329294|NCT00802672|11562507|FG001|Overall Study|Lack of fungal pathogen at baseline|43
7385111|NCT01198873|11642661|FG001|Overall Study|Other than above|2
7457544|NCT01799889|11751137|FG004|Overall Study|Study Terminated By Sponsor|2
7457545|NCT01799889|11751138|FG005|Overall Study|Study Terminated By Sponsor|1
7457546|NCT01799889|11751139|FG006|Overall Study|Study Terminated By Sponsor|0
7457547|NCT01799889|11751140|FG007|Overall Study|Study Terminated By Sponsor|2
7457548|NCT01799889|11751141|FG008|Overall Study|Study Terminated By Sponsor|1
7457549|NCT01799889|11751142|FG009|Overall Study|Study Terminated By Sponsor|1
7457550|NCT01799889|11751143|FG010|Overall Study|Study Terminated By Sponsor|0
7457551|NCT01799889|11751144|FG011|Overall Study|Study Terminated By Sponsor|0
7457552|NCT01799889|11751133|FG000|Overall Study|Withdrawal by Subject|1
7457553|NCT01799889|11751134|FG001|Overall Study|Withdrawal by Subject|6
7457554|NCT01799889|11751135|FG002|Overall Study|Withdrawal by Subject|4
7564971|NCT03302559|11936353|FG000|Overall Study|Adverse Event|2
7564972|NCT03302559|11936353|FG000|Overall Study|Lost to Follow-up|1
7564973|NCT03302559|11936353|FG000|Overall Study|Withdrew Consent|3
7564974|NCT03302936|11936386|FG000|Overall Study|Protocol Violation|3
7564975|NCT03302936|11936387|FG001|Overall Study|Protocol Violation|4
7564976|NCT03302975|11936397|FG000|Overall Study|Lost to Follow-up|4
7564977|NCT03303079|11936404|FG000|Overall Study|Adverse Event|0
7564978|NCT03303079|11936405|FG001|Overall Study|Adverse Event|1
7564979|NCT03303079|11936406|FG002|Overall Study|Adverse Event|3
7564980|NCT03303079|11936404|FG000|Overall Study|Protocol Violation|5
7564981|NCT03303079|11936405|FG001|Overall Study|Protocol Violation|4
7564982|NCT03303079|11936406|FG002|Overall Study|Protocol Violation|7
7564983|NCT03303079|11936404|FG000|Overall Study|Withdrawal by Subject|2
7329295|NCT00802672|11562508|FG002|Overall Study|Lack of fungal pathogen at baseline|25
7329296|NCT00802672|11562506|FG000|Overall Study|Adverse Event|1
7329297|NCT00802672|11562507|FG001|Overall Study|Adverse Event|1
7329298|NCT00802672|11562508|FG002|Overall Study|Adverse Event|1
7329299|NCT00802672|11562506|FG000|Overall Study|Protocol Violation|2
7329300|NCT00802672|11562507|FG001|Overall Study|Protocol Violation|1
7329301|NCT00802672|11562508|FG002|Overall Study|Protocol Violation|1
7329302|NCT00802672|11562506|FG000|Overall Study|Lost to Follow-up|5
7329303|NCT00802672|11562507|FG001|Overall Study|Lost to Follow-up|5
7329304|NCT00802672|11562508|FG002|Overall Study|Lost to Follow-up|3
7329305|NCT00802672|11562506|FG000|Overall Study|Withdrawal by Subject|1
7329306|NCT00802672|11562507|FG001|Overall Study|Withdrawal by Subject|1
7329307|NCT00802672|11562508|FG002|Overall Study|Withdrawal by Subject|2
7329308|NCT00802672|11562506|FG000|Overall Study|other|3
7329309|NCT00802672|11562507|FG001|Overall Study|other|1
7329310|NCT00802672|11562508|FG002|Overall Study|other|2
7329311|NCT00802737|11562528|FG000|Overall Study|Withdrawn due to Disease Progression|9
7329312|NCT00802737|11562529|FG001|Overall Study|Withdrawn due to Disease Progression|3
7329313|NCT00802737|11562530|FG002|Overall Study|Withdrawn due to Disease Progression|0
7329314|NCT00802737|11562528|FG000|Overall Study|Death|6
7329315|NCT00802737|11562529|FG001|Overall Study|Death|5
7329316|NCT00802737|11562530|FG002|Overall Study|Death|1
7329317|NCT00802737|11562528|FG000|Overall Study|Adverse Event|1
7329318|NCT00802737|11562529|FG001|Overall Study|Adverse Event|0
7329319|NCT00802737|11562530|FG002|Overall Study|Adverse Event|0
7329320|NCT00802737|11562528|FG000|Overall Study|Received Prohibited Therapy|1
7329321|NCT00802737|11562529|FG001|Overall Study|Received Prohibited Therapy|0
7329322|NCT00802737|11562530|FG002|Overall Study|Received Prohibited Therapy|0
7329323|NCT00802737|11562528|FG000|Overall Study|Ongoing CLL-Treatment|0
7329324|NCT00802737|11562529|FG001|Overall Study|Ongoing CLL-Treatment|1
7329325|NCT00802737|11562530|FG002|Overall Study|Ongoing CLL-Treatment|0
7329326|NCT00802737|11562528|FG000|Overall Study|Participant too Unwell|0
7329327|NCT00802737|11562529|FG001|Overall Study|Participant too Unwell|2
7329328|NCT00802737|11562530|FG002|Overall Study|Participant too Unwell|0
7329329|NCT00802841|11562541|FG000|Overall Study|Administrative problems|1
7329330|NCT00802841|11562542|FG001|Overall Study|Administrative problems|0
7329331|NCT00802841|11562541|FG000|Overall Study|Lost to Follow-up|2
7329332|NCT00802841|11562542|FG001|Overall Study|Lost to Follow-up|1
7329333|NCT00802841|11562541|FG000|Overall Study|Death|1
7329334|NCT00802841|11562542|FG001|Overall Study|Death|2
7329335|NCT00802841|11562541|FG000|Overall Study|Adverse Event|8
7329336|NCT00802841|11562542|FG001|Overall Study|Adverse Event|2
7329337|NCT00802841|11562541|FG000|Overall Study|Disease progression|7
7329338|NCT00802841|11562542|FG001|Overall Study|Disease progression|3
7329339|NCT00802841|11562541|FG000|Overall Study|Withdrawal by Subject|9
7329340|NCT00802841|11562542|FG001|Overall Study|Withdrawal by Subject|5
7329341|NCT00802841|11562541|FG000|Overall Study|Protocol deviation|2
7329342|NCT00802841|11562542|FG001|Overall Study|Protocol deviation|6
7457555|NCT01799889|11751136|FG003|Overall Study|Withdrawal by Subject|0
7457556|NCT01799889|11751137|FG004|Overall Study|Withdrawal by Subject|5
7564984|NCT03303079|11936405|FG001|Overall Study|Withdrawal by Subject|4
7564985|NCT03303079|11936406|FG002|Overall Study|Withdrawal by Subject|2
7564986|NCT03303079|11936404|FG000|Overall Study|Other than specified|0
7329343|NCT00802841|11562541|FG000|Overall Study|Treatment duration completed|66
7329344|NCT00802841|11562542|FG001|Overall Study|Treatment duration completed|76
7329345|NCT00802867|11562554|FG000|Overall Study|Lost to Follow-up|6
7329346|NCT00802867|11562554|FG000|Overall Study|Protocol Violation|6
7329347|NCT00802867|11562554|FG000|Overall Study|Withdrawal by Subject|1
7329348|NCT00802945|11562578|FG000|Overall Study|Death|27
7329349|NCT00802945|11562579|FG001|Overall Study|Death|23
7564987|NCT03303079|11936405|FG001|Overall Study|Other than specified|2
7457557|NCT01799889|11751138|FG005|Overall Study|Withdrawal by Subject|1
7457558|NCT01799889|11751139|FG006|Overall Study|Withdrawal by Subject|3
7457559|NCT01799889|11751140|FG007|Overall Study|Withdrawal by Subject|1
7457560|NCT01799889|11751141|FG008|Overall Study|Withdrawal by Subject|2
7457561|NCT01799889|11751142|FG009|Overall Study|Withdrawal by Subject|1
7564988|NCT03303079|11936406|FG002|Overall Study|Other than specified|0
7564989|NCT03303092|11936417|FG000|Overall Study|Adverse Event|1
7564990|NCT03303092|11936418|FG001|Overall Study|Adverse Event|0
7564991|NCT03303092|11936419|FG002|Overall Study|Adverse Event|1
7564992|NCT03303092|11936417|FG000|Overall Study|Protocol Violation|1
7564993|NCT03303092|11936418|FG001|Overall Study|Protocol Violation|5
7564994|NCT03303092|11936419|FG002|Overall Study|Protocol Violation|1
7564995|NCT03303092|11936417|FG000|Overall Study|Withdrawal by Subject|1
7564996|NCT03303092|11936418|FG001|Overall Study|Withdrawal by Subject|1
7564997|NCT03303092|11936419|FG002|Overall Study|Withdrawal by Subject|3
7564998|NCT03303105|11936429|FG000|Overall Study|Adverse Event|0
7564999|NCT03303105|11936430|FG001|Overall Study|Adverse Event|2
7565000|NCT03303105|11936429|FG000|Overall Study|Lack of Efficacy|1
7565001|NCT03303105|11936430|FG001|Overall Study|Lack of Efficacy|0
7565002|NCT03303105|11936429|FG000|Overall Study|Protocol Violation|1
7565003|NCT03303105|11936430|FG001|Overall Study|Protocol Violation|0
7565004|NCT03303105|11936429|FG000|Overall Study|Withdrawal by Subject|0
7565005|NCT03303105|11936430|FG001|Overall Study|Withdrawal by Subject|2
7565006|NCT03303417|11936459|FG000|Overall Study|Withdrawal by Subject|1
7565007|NCT03303417|11936460|FG001|Overall Study|Withdrawal by Subject|1
7565008|NCT03303521|11936468|FG000|Overall Study|Withdrawal by Subject|2
7565009|NCT03303521|11936469|FG001|Overall Study|Withdrawal by Subject|0
7565010|NCT03303521|11936468|FG000|Overall Study|Death|1
7565011|NCT03303521|11936469|FG001|Overall Study|Death|0
7565012|NCT03303521|11936468|FG000|Overall Study|Kidney transplantation|0
7565013|NCT03303521|11936469|FG001|Overall Study|Kidney transplantation|1
7565014|NCT03303521|11936468|FG000|Overall Study|Investigational product discontinuation|0
7565015|NCT03303521|11936469|FG001|Overall Study|Investigational product discontinuation|1
7565016|NCT03303521|11936468|FG000|Overall Study|Transferred to non-study dialysis center|1
7565017|NCT03303521|11936469|FG001|Overall Study|Transferred to non-study dialysis center|0
7565018|NCT03303521|11936468|FG000|Overall Study|Non-comliance to study protocol|0
7565019|NCT03303521|11936469|FG001|Overall Study|Non-comliance to study protocol|1
7565020|NCT03303521|11936468|FG000|Overall Study|Adverse Event|1
7565021|NCT03303521|11936469|FG001|Overall Study|Adverse Event|0
7565022|NCT03304184|11936530|FG000|Overall Study|Withdrawal by Subject|1
7565023|NCT03304184|11936531|FG001|Overall Study|Withdrawal by Subject|2
7565024|NCT03304522|11936540|FG000|Overall Study|Adverse Event|0
7565025|NCT03304522|11936541|FG001|Overall Study|Adverse Event|4
7565026|NCT03304522|11936540|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7565027|NCT03304522|11936541|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7565028|NCT03304522|11936540|FG000|Overall Study|Withdrawal of consent (for other reason)|0
7565029|NCT03304522|11936541|FG001|Overall Study|Withdrawal of consent (for other reason)|2
7565030|NCT03304522|11936540|FG000|Overall Study|Other|0
7565031|NCT03304522|11936541|FG001|Overall Study|Other|1
7565032|NCT03304626|11936549|FG000|Overall Study|Adverse Event|1
7565033|NCT03304626|11936550|FG001|Overall Study|Adverse Event|0
7565034|NCT03304626|11936549|FG000|Overall Study|Lack of Efficacy|1
7565035|NCT03304626|11936550|FG001|Overall Study|Lack of Efficacy|1
7565036|NCT03304873|11936559|FG000|Overall Study|Lost to Follow-up|1
7565037|NCT03304873|11936560|FG001|Overall Study|Lost to Follow-up|8
7565038|NCT03305081|11936568|FG000|Overall Study|Lost to Follow-up|10
7565039|NCT03305081|11936569|FG001|Overall Study|Lost to Follow-up|15
7565040|NCT03305419|11936592|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565041|NCT03305419|11936593|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
7565042|NCT03305419|11936594|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565043|NCT03305419|11936595|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565044|NCT03305419|11936596|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565045|NCT03305419|11936597|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565046|NCT03305419|11936598|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565047|NCT03305419|11936599|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
7565048|NCT03305419|11936592|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
7565049|NCT03305419|11936593|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565050|NCT03305419|11936594|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565051|NCT03305419|11936595|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565052|NCT03305419|11936596|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565053|NCT03305419|11936597|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565054|NCT03305419|11936598|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565055|NCT03305419|11936599|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
7565056|NCT03305419|11936592|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
7565057|NCT03305419|11936593|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7457562|NCT01799889|11751143|FG010|Overall Study|Withdrawal by Subject|1
7565058|NCT03305419|11936594|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7457563|NCT01799889|11751144|FG011|Overall Study|Withdrawal by Subject|1
7565059|NCT03305419|11936595|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7565060|NCT03305419|11936596|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7565061|NCT03305419|11936597|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7565062|NCT03305419|11936598|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7565063|NCT03305419|11936599|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
7565064|NCT03305419|11936592|FG000|Part B (14 Days)|Adverse Event|0
7565065|NCT03305419|11936593|FG001|Part B (14 Days)|Adverse Event|0
7565066|NCT03305419|11936594|FG002|Part B (14 Days)|Adverse Event|0
7565067|NCT03305419|11936595|FG003|Part B (14 Days)|Adverse Event|0
7565068|NCT03305419|11936596|FG004|Part B (14 Days)|Adverse Event|1
7565069|NCT03305419|11936597|FG005|Part B (14 Days)|Adverse Event|2
7565070|NCT03305419|11936598|FG006|Part B (14 Days)|Adverse Event|4
7565071|NCT03305419|11936599|FG007|Part B (14 Days)|Adverse Event|0
7565072|NCT03305419|11936592|FG000|Part B (14 Days)|Physician Decision|0
7565073|NCT03305419|11936593|FG001|Part B (14 Days)|Physician Decision|0
7565074|NCT03305419|11936594|FG002|Part B (14 Days)|Physician Decision|0
7565075|NCT03305419|11936595|FG003|Part B (14 Days)|Physician Decision|0
7565076|NCT03305419|11936596|FG004|Part B (14 Days)|Physician Decision|2
7565077|NCT03305419|11936597|FG005|Part B (14 Days)|Physician Decision|8
7565078|NCT03305419|11936598|FG006|Part B (14 Days)|Physician Decision|1
7565079|NCT03305419|11936599|FG007|Part B (14 Days)|Physician Decision|0
7565080|NCT03305575|11936624|FG000|Overall Study|Physician Decision|1
7565081|NCT03305575|11936625|FG001|Overall Study|Physician Decision|0
7565082|NCT03305666|11936637|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
7565083|NCT03305666|11936638|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
7565084|NCT03305731|11936644|FG000|Overall Study|Protocol Violation|1
7565085|NCT03305770|11936650|FG000|Overall Study|Physician Decision - prior to dispense|0
7565086|NCT03305770|11936651|FG001|Overall Study|Physician Decision - prior to dispense|1
7565087|NCT03305770|11936650|FG000|Overall Study|Subject moved|1
7565088|NCT03305770|11936651|FG001|Overall Study|Subject moved|0
7565089|NCT03305809|11936663|FG000|Overall Study|Adverse Event|2
7565090|NCT03305809|11936664|FG001|Overall Study|Adverse Event|2
7565091|NCT03305809|11936665|FG002|Overall Study|Adverse Event|6
7565092|NCT03305809|11936666|FG003|Overall Study|Adverse Event|6
7565093|NCT03305809|11936663|FG000|Overall Study|Death|0
7565094|NCT03305809|11936664|FG001|Overall Study|Death|0
7565095|NCT03305809|11936665|FG002|Overall Study|Death|1
7565096|NCT03305809|11936666|FG003|Overall Study|Death|1
7565097|NCT03305809|11936663|FG000|Overall Study|Lost to Follow-up|1
7565098|NCT03305809|11936664|FG001|Overall Study|Lost to Follow-up|2
7565099|NCT03305809|11936665|FG002|Overall Study|Lost to Follow-up|0
7565100|NCT03305809|11936666|FG003|Overall Study|Lost to Follow-up|0
7565101|NCT03305809|11936663|FG000|Overall Study|Sponsor Decision|1
7565102|NCT03305809|11936664|FG001|Overall Study|Sponsor Decision|0
7565103|NCT03305809|11936665|FG002|Overall Study|Sponsor Decision|1
7565104|NCT03305809|11936666|FG003|Overall Study|Sponsor Decision|8
7565105|NCT03305809|11936663|FG000|Overall Study|Physician Decision|0
7565106|NCT03305809|11936664|FG001|Overall Study|Physician Decision|0
7565107|NCT03305809|11936665|FG002|Overall Study|Physician Decision|2
7565108|NCT03305809|11936666|FG003|Overall Study|Physician Decision|4
7565109|NCT03305809|11936663|FG000|Overall Study|Progressive Disease|0
7565110|NCT03305809|11936664|FG001|Overall Study|Progressive Disease|0
7565111|NCT03305809|11936665|FG002|Overall Study|Progressive Disease|1
7565112|NCT03305809|11936666|FG003|Overall Study|Progressive Disease|0
7565113|NCT03305809|11936663|FG000|Overall Study|Protocol Violation|1
7565114|NCT03305809|11936664|FG001|Overall Study|Protocol Violation|0
7565115|NCT03305809|11936665|FG002|Overall Study|Protocol Violation|2
7565116|NCT03305809|11936666|FG003|Overall Study|Protocol Violation|3
7565117|NCT03305809|11936663|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
7565118|NCT03305809|11936664|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
7565119|NCT03305809|11936665|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
7565120|NCT03305809|11936666|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
7565121|NCT03305809|11936663|FG000|Overall Study|Withdrawal by Subject|2
7565122|NCT03305809|11936664|FG001|Overall Study|Withdrawal by Subject|4
7565123|NCT03305809|11936665|FG002|Overall Study|Withdrawal by Subject|5
7565124|NCT03305809|11936666|FG003|Overall Study|Withdrawal by Subject|2
7565125|NCT03305809|11936663|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
7565126|NCT03305809|11936664|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
7565127|NCT03305809|11936665|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
7565128|NCT03305809|11936666|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
7565129|NCT03306043|11936695|FG000|Overall Study|Adverse Event|1
7565130|NCT03306043|11936695|FG000|Overall Study|Lost to Follow-up|1
7565131|NCT03306043|11936695|FG000|Overall Study|Withdrawal by Subject|2
7565135|NCT03306433|11936728|FG000|Overall Study|Lost to Follow-up|3
7565136|NCT03306433|11936728|FG000|Overall Study|Patient did not have teeth extracted|1
7565137|NCT03306433|11936728|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
7565138|NCT03307174|11936783|FG000|Overall Study|Unplanned ICU Administrion|5
7565139|NCT03307174|11936784|FG001|Overall Study|Unplanned ICU Administrion|3
7565140|NCT03307174|11936783|FG000|Overall Study|Aborted Surgery|1
7565141|NCT03307174|11936784|FG001|Overall Study|Aborted Surgery|2
7565142|NCT03307174|11936783|FG000|Overall Study|Hypotension|6
7565143|NCT03307174|11936784|FG001|Overall Study|Hypotension|0
7565144|NCT03307174|11936783|FG000|Overall Study|Nonfunctional epidural|1
7565145|NCT03307174|11936784|FG001|Overall Study|Nonfunctional epidural|1
7565146|NCT03307174|11936783|FG000|Overall Study|Planned epidural removal|1
7565147|NCT03307174|11936784|FG001|Overall Study|Planned epidural removal|0
7565148|NCT03307174|11936783|FG000|Overall Study|Intrathecal catheter placement|0
7565149|NCT03307174|11936784|FG001|Overall Study|Intrathecal catheter placement|1
7565150|NCT03307252|11936801|FG000|Part 2, Period 1|Treatment not received|0
7565151|NCT03307252|11936802|FG001|Part 2, Period 1|Treatment not received|0
7565152|NCT03307252|11936803|FG002|Part 2, Period 1|Treatment not received|0
7565153|NCT03307252|11936804|FG003|Part 2, Period 1|Treatment not received|0
7565154|NCT03307252|11936805|FG004|Part 2, Period 1|Treatment not received|0
7565155|NCT03307252|11936806|FG005|Part 2, Period 1|Treatment not received|1
7565156|NCT03307252|11936807|FG006|Part 2, Period 1|Treatment not received|0
7565157|NCT03307252|11936808|FG007|Part 2, Period 1|Treatment not received|0
7565158|NCT03307252|11936809|FG008|Part 2, Period 1|Treatment not received|0
7565159|NCT03307252|11936810|FG009|Part 2, Period 1|Treatment not received|0
7565160|NCT03307252|11936811|FG010|Part 2, Period 1|Treatment not received|0
7565161|NCT03307252|11936801|FG000|Part 2, Period 3|Other than listed|0
7565162|NCT03307252|11936802|FG001|Part 2, Period 3|Other than listed|0
7565163|NCT03307252|11936803|FG002|Part 2, Period 3|Other than listed|0
7565164|NCT03307252|11936804|FG003|Part 2, Period 3|Other than listed|0
7565165|NCT03307252|11936805|FG004|Part 2, Period 3|Other than listed|1
7565166|NCT03307252|11936806|FG005|Part 2, Period 3|Other than listed|0
7565167|NCT03307252|11936807|FG006|Part 2, Period 3|Other than listed|0
7565168|NCT03307252|11936808|FG007|Part 2, Period 3|Other than listed|0
7565169|NCT03307252|11936809|FG008|Part 2, Period 3|Other than listed|0
7565170|NCT03307252|11936810|FG009|Part 2, Period 3|Other than listed|0
7565171|NCT03307252|11936811|FG010|Part 2, Period 3|Other than listed|0
7565172|NCT03307252|11936801|FG000|Part 2, Period 4|Other than listed|0
7565173|NCT03307252|11936802|FG001|Part 2, Period 4|Other than listed|0
7565174|NCT03307252|11936803|FG002|Part 2, Period 4|Other than listed|0
7565175|NCT03307252|11936804|FG003|Part 2, Period 4|Other than listed|0
7565176|NCT03307252|11936805|FG004|Part 2, Period 4|Other than listed|0
7565177|NCT03307252|11936806|FG005|Part 2, Period 4|Other than listed|0
7565178|NCT03307252|11936807|FG006|Part 2, Period 4|Other than listed|1
7565179|NCT03307252|11936808|FG007|Part 2, Period 4|Other than listed|0
7565180|NCT03307252|11936809|FG008|Part 2, Period 4|Other than listed|0
7565181|NCT03307252|11936810|FG009|Part 2, Period 4|Other than listed|0
7565182|NCT03307252|11936811|FG010|Part 2, Period 4|Other than listed|0
7565183|NCT03307252|11936801|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565184|NCT03307252|11936802|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565185|NCT03307252|11936803|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565186|NCT03307252|11936804|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565187|NCT03307252|11936805|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565188|NCT03307252|11936806|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565189|NCT03307252|11936807|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565190|NCT03307252|11936808|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565191|NCT03307252|11936809|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565192|NCT03307252|11936810|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
7565193|NCT03307252|11936811|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
7565194|NCT03307837|11936833|FG000|Overall Study|Withdrawal by Subject|0
7565195|NCT03307837|11936834|FG001|Overall Study|Withdrawal by Subject|0
7565196|NCT03307837|11936835|FG002|Overall Study|Withdrawal by Subject|1
7565197|NCT03307837|11936836|FG003|Overall Study|Withdrawal by Subject|0
7565198|NCT03307837|11936837|FG004|Overall Study|Withdrawal by Subject|0
7565199|NCT03307837|11936838|FG005|Overall Study|Withdrawal by Subject|1
7565200|NCT03307837|11936833|FG000|Overall Study|Lost to Follow-up|1
7565201|NCT03307837|11936834|FG001|Overall Study|Lost to Follow-up|1
7565202|NCT03307837|11936835|FG002|Overall Study|Lost to Follow-up|0
7565203|NCT03307837|11936836|FG003|Overall Study|Lost to Follow-up|0
7565204|NCT03307837|11936837|FG004|Overall Study|Lost to Follow-up|0
7565205|NCT03307837|11936838|FG005|Overall Study|Lost to Follow-up|1
7329350|NCT00802945|11562578|FG000|Overall Study|Terminated by sponsor|8
7329351|NCT00802945|11562579|FG001|Overall Study|Terminated by sponsor|12
7329352|NCT00803023|11562609|FG000|Overall Study|Adverse Event|5
7329353|NCT00803023|11562610|FG001|Overall Study|Adverse Event|4
7329354|NCT00803023|11562611|FG002|Overall Study|Adverse Event|8
7329355|NCT00803023|11562612|FG003|Overall Study|Adverse Event|6
7329356|NCT00803023|11562609|FG000|Overall Study|Withdrawal by Subject|0
7329357|NCT00803023|11562610|FG001|Overall Study|Withdrawal by Subject|2
7329358|NCT00803023|11562611|FG002|Overall Study|Withdrawal by Subject|0
7329359|NCT00803023|11562612|FG003|Overall Study|Withdrawal by Subject|0
7329360|NCT00803023|11562609|FG000|Overall Study|Lost to Follow-up|0
7329361|NCT00803023|11562610|FG001|Overall Study|Lost to Follow-up|1
7329362|NCT00803023|11562611|FG002|Overall Study|Lost to Follow-up|2
7329363|NCT00803023|11562612|FG003|Overall Study|Lost to Follow-up|1
7329364|NCT00803023|11562609|FG000|Overall Study|Lack of Efficacy|0
7329365|NCT00803023|11562610|FG001|Overall Study|Lack of Efficacy|1
7329366|NCT00803023|11562611|FG002|Overall Study|Lack of Efficacy|1
7329367|NCT00803023|11562612|FG003|Overall Study|Lack of Efficacy|1
7329368|NCT00803049|11562626|FG000|Overall Study|Adverse Event|21
7329369|NCT00803049|11562627|FG001|Overall Study|Adverse Event|33
7329370|NCT00803049|11562628|FG002|Overall Study|Adverse Event|13
7329371|NCT00803049|11562629|FG003|Overall Study|Adverse Event|27
7329372|NCT00803049|11562626|FG000|Overall Study|Lack of Efficacy|10
7329373|NCT00803049|11562627|FG001|Overall Study|Lack of Efficacy|19
7329374|NCT00803049|11562628|FG002|Overall Study|Lack of Efficacy|6
7329375|NCT00803049|11562629|FG003|Overall Study|Lack of Efficacy|13
7329376|NCT00803049|11562626|FG000|Overall Study|Lost to Follow-up|0
7329377|NCT00803049|11562627|FG001|Overall Study|Lost to Follow-up|2
7329378|NCT00803049|11562628|FG002|Overall Study|Lost to Follow-up|0
7565236|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
7565237|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
7565238|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
7565239|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7565240|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
7565241|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
7565242|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
7565243|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
7565244|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
7565245|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7565246|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
7565247|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
7565248|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
7565249|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7565250|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
7565251|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7565252|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
7565253|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
7565254|NCT03308968|11936934|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
7565255|NCT03308968|11936935|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
7565256|NCT03308968|11936936|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
7565257|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Other than specified|1
7565258|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Other than specified|2
7565259|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Other than specified|1
7329379|NCT00803049|11562629|FG003|Overall Study|Lost to Follow-up|3
7329380|NCT00803049|11562626|FG000|Overall Study|Death|2
7329381|NCT00803049|11562627|FG001|Overall Study|Death|1
7329382|NCT00803049|11562628|FG002|Overall Study|Death|0
7329383|NCT00803049|11562629|FG003|Overall Study|Death|2
7329384|NCT00803049|11562626|FG000|Overall Study|Progressive Disease|6
7329385|NCT00803049|11562627|FG001|Overall Study|Progressive Disease|10
7329386|NCT00803049|11562628|FG002|Overall Study|Progressive Disease|6
7329387|NCT00803049|11562629|FG003|Overall Study|Progressive Disease|6
7329388|NCT00803049|11562626|FG000|Overall Study|Withdrawal by Subject|19
7329389|NCT00803049|11562627|FG001|Overall Study|Withdrawal by Subject|43
7329390|NCT00803049|11562628|FG002|Overall Study|Withdrawal by Subject|16
7329391|NCT00803049|11562629|FG003|Overall Study|Withdrawal by Subject|44
7329392|NCT00803049|11562626|FG000|Overall Study|Protocol Violation|0
7329393|NCT00803049|11562627|FG001|Overall Study|Protocol Violation|1
7329394|NCT00803049|11562628|FG002|Overall Study|Protocol Violation|1
7329395|NCT00803049|11562629|FG003|Overall Study|Protocol Violation|0
7329396|NCT00803049|11562626|FG000|Overall Study|Randomized and Not Treated|0
7329397|NCT00803049|11562627|FG001|Overall Study|Randomized and Not Treated|0
7329398|NCT00803049|11562628|FG002|Overall Study|Randomized and Not Treated|0
7329399|NCT00803049|11562629|FG003|Overall Study|Randomized and Not Treated|2
7329400|NCT00803049|11562626|FG000|Overall Study|Other than Specified Above|3
7329401|NCT00803049|11562627|FG001|Overall Study|Other than Specified Above|9
7329402|NCT00803049|11562628|FG002|Overall Study|Other than Specified Above|2
7329403|NCT00803049|11562629|FG003|Overall Study|Other than Specified Above|5
7329404|NCT00803101|11562658|FG000|Overall Study|Death / Serious Adverse Event|4
7329405|NCT00803101|11562659|FG001|Overall Study|Death / Serious Adverse Event|6
7329406|NCT00803101|11562658|FG000|Overall Study|Withdrawal by Subject|6
7329407|NCT00803101|11562659|FG001|Overall Study|Withdrawal by Subject|4
7329408|NCT00803101|11562658|FG000|Overall Study|Lost to Follow-up|2
7329409|NCT00803101|11562659|FG001|Overall Study|Lost to Follow-up|2
7329410|NCT00803101|11562658|FG000|Overall Study|Protocol Violation|1
7329411|NCT00803101|11562659|FG001|Overall Study|Protocol Violation|7
7329412|NCT00803101|11562658|FG000|Overall Study|Surgery finished outside protocol window|1
7329413|NCT00803101|11562659|FG001|Overall Study|Surgery finished outside protocol window|1
7329414|NCT00803101|11562658|FG000|Overall Study|Patient died outside SAE report period|1
7329415|NCT00803101|11562659|FG001|Overall Study|Patient died outside SAE report period|0
7329416|NCT00803101|11562658|FG000|Overall Study|Patient did not attend scheduled visit|2
7329417|NCT00803101|11562659|FG001|Overall Study|Patient did not attend scheduled visit|1
7329418|NCT00803101|11562658|FG000|Overall Study|Patient did not have surgery|1
7329419|NCT00803101|11562659|FG001|Overall Study|Patient did not have surgery|1
7329420|NCT00803205|11562667|FG000|Overall Study|Adverse Event|7
7329421|NCT00803205|11562668|FG001|Overall Study|Adverse Event|2
7329422|NCT00803205|11562667|FG000|Overall Study|Lost to Follow-up|1
7329423|NCT00803205|11562668|FG001|Overall Study|Lost to Follow-up|0
7329424|NCT00803205|11562667|FG000|Overall Study|Withdrawal by Subject|9
7329425|NCT00803205|11562668|FG001|Overall Study|Withdrawal by Subject|9
7329426|NCT00803205|11562667|FG000|Overall Study|Physician Decision|1
7329427|NCT00803205|11562668|FG001|Overall Study|Physician Decision|0
7329428|NCT00803205|11562667|FG000|Overall Study|Protocol Violation|1
7329429|NCT00803205|11562668|FG001|Overall Study|Protocol Violation|1
7329430|NCT00803205|11562667|FG000|Overall Study|Medical Monitor Decision|1
7329431|NCT00803205|11562668|FG001|Overall Study|Medical Monitor Decision|0
7329432|NCT00803205|11562667|FG000|Overall Study|Acquired a Lung Infection|0
7565260|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
7565261|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
7565262|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
7565263|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7565264|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
7565265|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
7565266|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
7565267|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
7565268|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
7565269|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7565270|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
7565271|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
7565272|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
7565273|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7565274|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
7565275|NCT03308968|11936934|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
7565276|NCT03308968|11936935|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
7565277|NCT03308968|11936936|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
7565278|NCT03309020|11936949|FG000|Overall Study|Death|1
7565279|NCT03309020|11936950|FG001|Overall Study|Death|0
7565280|NCT03309020|11936949|FG000|Overall Study|Did not undergo surgery|2
7565281|NCT03309020|11936950|FG001|Overall Study|Did not undergo surgery|1
7565282|NCT03309202|11936962|FG000|Overall Study|Lost to Follow-up|1
7565283|NCT03309202|11936963|FG001|Overall Study|Lost to Follow-up|0
7565284|NCT03309202|11936964|FG002|Overall Study|Lost to Follow-up|0
7565285|NCT03309202|11936965|FG003|Overall Study|Lost to Follow-up|0
7565286|NCT03309605|11936996|FG000|Overall Study|Adverse Event|0
7565287|NCT03309605|11936997|FG001|Overall Study|Adverse Event|0
7565288|NCT03309605|11936998|FG002|Overall Study|Adverse Event|0
7565289|NCT03309605|11936999|FG003|Overall Study|Adverse Event|1
7565290|NCT03309605|11937000|FG004|Overall Study|Adverse Event|0
7565291|NCT03309605|11937001|FG005|Overall Study|Adverse Event|0
7565292|NCT03309605|11937002|FG006|Overall Study|Adverse Event|2
7565293|NCT03309605|11937003|FG007|Overall Study|Adverse Event|1
7565294|NCT03309605|11936996|FG000|Overall Study|Withdrawal by Subject|0
7565295|NCT03309605|11936997|FG001|Overall Study|Withdrawal by Subject|0
7329433|NCT00803205|11562668|FG001|Overall Study|Acquired a Lung Infection|1
7329434|NCT00803205|11562667|FG000|Overall Study|Sponsor Decision|0
7329435|NCT00803205|11562668|FG001|Overall Study|Sponsor Decision|1
7329436|NCT00803244|11562676|FG000|Overall Study|Adverse Event|1
7329437|NCT00803244|11562677|FG001|Overall Study|Adverse Event|2
7329438|NCT00803244|11562676|FG000|Overall Study|Withdrawal by Subject|2
7329439|NCT00803244|11562677|FG001|Overall Study|Withdrawal by Subject|3
7329440|NCT00803244|11562676|FG000|Overall Study|Any other reason not above-mentioned|4
7329441|NCT00803244|11562677|FG001|Overall Study|Any other reason not above-mentioned|10
7329442|NCT00803270|11562685|FG000|Overall Study|Lost to Follow-up|1
7329443|NCT00803270|11562686|FG001|Overall Study|Lost to Follow-up|2
7329444|NCT00803361|11562694|FG000|Overall Study|Adverse Event|13
7329445|NCT00803361|11562695|FG001|Overall Study|Adverse Event|3
7329446|NCT00803361|11562694|FG000|Overall Study|Lack of Efficacy|4
7329447|NCT00803361|11562695|FG001|Overall Study|Lack of Efficacy|13
7329448|NCT00803361|11562694|FG000|Overall Study|Lost to Follow-up|1
7329449|NCT00803361|11562695|FG001|Overall Study|Lost to Follow-up|2
7329450|NCT00803361|11562694|FG000|Overall Study|Physician Decision|1
7329451|NCT00803361|11562695|FG001|Overall Study|Physician Decision|0
7329452|NCT00803361|11562694|FG000|Overall Study|Protocol Violation|2
7329453|NCT00803361|11562695|FG001|Overall Study|Protocol Violation|4
7329454|NCT00803361|11562694|FG000|Overall Study|Withdrawal by Subject|5
7329455|NCT00803361|11562695|FG001|Overall Study|Withdrawal by Subject|6
7329456|NCT00803452|11562713|FG000|Overall Study|Adverse Event|0
7329457|NCT00803452|11562714|FG001|Overall Study|Adverse Event|2
7329458|NCT00803452|11562713|FG000|Overall Study|Lost to Follow-up|0
7329459|NCT00803452|11562714|FG001|Overall Study|Lost to Follow-up|3
7329460|NCT00803569|11562729|FG000|Overall Study|Progressive Disease|3
7329461|NCT00803569|11562729|FG000|Overall Study|Noncompliance|1
7329462|NCT00803595|11562736|FG000|Overall Study|Adverse Event|3
7329463|NCT00803595|11562737|FG001|Overall Study|Adverse Event|4
7329464|NCT00803595|11562738|FG002|Overall Study|Adverse Event|1
7565296|NCT03309605|11936998|FG002|Overall Study|Withdrawal by Subject|0
7565297|NCT03309605|11936999|FG003|Overall Study|Withdrawal by Subject|0
7565298|NCT03309605|11937000|FG004|Overall Study|Withdrawal by Subject|1
7565299|NCT03309605|11937001|FG005|Overall Study|Withdrawal by Subject|0
7565300|NCT03309605|11937002|FG006|Overall Study|Withdrawal by Subject|1
7329465|NCT00803595|11562736|FG000|Overall Study|Protocol Violation|7
7329466|NCT00803595|11562737|FG001|Overall Study|Protocol Violation|2
7565301|NCT03309605|11937003|FG007|Overall Study|Withdrawal by Subject|1
7565302|NCT03309696|11937023|FG000|Overall Study|Analysis of TEP data could not be completed|0
7565303|NCT03309696|11937024|FG001|Overall Study|Analysis of TEP data could not be completed|5
7565304|NCT03309696|11937025|FG002|Overall Study|Analysis of TEP data could not be completed|0
7329467|NCT00803595|11562738|FG002|Overall Study|Protocol Violation|12
7329468|NCT00803595|11562736|FG000|Overall Study|Withdrawal by Subject|5
7565305|NCT03309696|11937026|FG003|Overall Study|Analysis of TEP data could not be completed|0
7565306|NCT03309943|11937055|FG000|Overall Study|Withdrawal by Subject|0
7565307|NCT03309943|11937056|FG001|Overall Study|Withdrawal by Subject|1
7565308|NCT03309943|11937055|FG000|Overall Study|Inappropriate behavior towards staff|0
7565309|NCT03309943|11937056|FG001|Overall Study|Inappropriate behavior towards staff|1
7565310|NCT03310021|11937082|FG000|Overall Study|Withdrawal by Subject|0
7565311|NCT03310021|11937083|FG001|Overall Study|Withdrawal by Subject|0
7565312|NCT03310021|11937084|FG002|Overall Study|Withdrawal by Subject|0
7565313|NCT03310021|11937085|FG003|Overall Study|Withdrawal by Subject|0
7565314|NCT03310021|11937086|FG004|Overall Study|Withdrawal by Subject|0
7565315|NCT03310021|11937087|FG005|Overall Study|Withdrawal by Subject|0
7565316|NCT03310021|11937088|FG006|Overall Study|Withdrawal by Subject|1
7565317|NCT03310021|11937089|FG007|Overall Study|Withdrawal by Subject|0
7565318|NCT03310021|11937090|FG008|Overall Study|Withdrawal by Subject|0
7565319|NCT03310021|11937091|FG009|Overall Study|Withdrawal by Subject|0
7565320|NCT03310021|11937092|FG010|Overall Study|Withdrawal by Subject|0
7565321|NCT03310021|11937093|FG011|Overall Study|Withdrawal by Subject|0
7565322|NCT03310021|11937094|FG012|Overall Study|Withdrawal by Subject|0
7565323|NCT03310021|11937095|FG013|Overall Study|Withdrawal by Subject|0
7565324|NCT03310021|11937096|FG014|Overall Study|Withdrawal by Subject|0
7565325|NCT03310021|11937097|FG015|Overall Study|Withdrawal by Subject|0
7565326|NCT03310021|11937098|FG016|Overall Study|Withdrawal by Subject|0
7565327|NCT03310021|11937099|FG017|Overall Study|Withdrawal by Subject|0
7565328|NCT03310021|11937100|FG018|Overall Study|Withdrawal by Subject|0
7565329|NCT03310021|11937101|FG019|Overall Study|Withdrawal by Subject|0
7565330|NCT03310021|11937082|FG000|Overall Study|Lost to Follow-up|0
7565331|NCT03310021|11937083|FG001|Overall Study|Lost to Follow-up|0
7565332|NCT03310021|11937084|FG002|Overall Study|Lost to Follow-up|0
7565333|NCT03310021|11937085|FG003|Overall Study|Lost to Follow-up|0
7565334|NCT03310021|11937086|FG004|Overall Study|Lost to Follow-up|0
7565335|NCT03310021|11937087|FG005|Overall Study|Lost to Follow-up|0
7565336|NCT03310021|11937088|FG006|Overall Study|Lost to Follow-up|0
7565337|NCT03310021|11937089|FG007|Overall Study|Lost to Follow-up|0
7565338|NCT03310021|11937090|FG008|Overall Study|Lost to Follow-up|0
7565339|NCT03310021|11937091|FG009|Overall Study|Lost to Follow-up|0
7565340|NCT03310021|11937092|FG010|Overall Study|Lost to Follow-up|1
7565341|NCT03310021|11937093|FG011|Overall Study|Lost to Follow-up|0
7565342|NCT03310021|11937094|FG012|Overall Study|Lost to Follow-up|0
7565343|NCT03310021|11937095|FG013|Overall Study|Lost to Follow-up|0
7565344|NCT03310021|11937096|FG014|Overall Study|Lost to Follow-up|0
7565345|NCT03310021|11937097|FG015|Overall Study|Lost to Follow-up|0
7565346|NCT03310021|11937098|FG016|Overall Study|Lost to Follow-up|0
7565347|NCT03310021|11937099|FG017|Overall Study|Lost to Follow-up|0
7565348|NCT03310021|11937100|FG018|Overall Study|Lost to Follow-up|0
7565349|NCT03310021|11937101|FG019|Overall Study|Lost to Follow-up|0
7565350|NCT03310268|11937146|FG000|Overall Study|(Not specified)|1
7565351|NCT03310268|11937147|FG001|Overall Study|(Not specified)|5
7565352|NCT03310268|11937148|FG002|Overall Study|(Not specified)|0
7565353|NCT03310411|11937156|FG000|Period 1|Adverse Event|0
7565354|NCT03310411|11937157|FG001|Period 1|Adverse Event|0
7565355|NCT03310411|11937158|FG002|Period 1|Adverse Event|0
7565356|NCT03310411|11937159|FG003|Period 1|Adverse Event|1
7565357|NCT03310580|11937194|FG000|Overall Study|Adverse Event|0
7565358|NCT03310580|11937195|FG001|Overall Study|Adverse Event|1
7565359|NCT03310580|11937196|FG002|Overall Study|Adverse Event|0
7565360|NCT03310723|11937207|FG000|Overall Study|Withdrawal by Subject|0
7565361|NCT03310723|11937208|FG001|Overall Study|Withdrawal by Subject|1
7565362|NCT03310723|11937207|FG000|Overall Study|Protocol Violation|0
7565363|NCT03310723|11937208|FG001|Overall Study|Protocol Violation|2
7565364|NCT03310775|11937216|FG000|Overall Study|Lost to Follow-up|2
7565365|NCT03310775|11937217|FG001|Overall Study|Lost to Follow-up|3
7565366|NCT03310775|11937216|FG000|Overall Study|aggravation of depression|0
7565367|NCT03310775|11937217|FG001|Overall Study|aggravation of depression|1
7565368|NCT03310970|11937223|FG000|Overall Study|Withdrawal by Subject|0
7565369|NCT03310970|11937224|FG001|Overall Study|Withdrawal by Subject|1
7565370|NCT03311230|11937235|FG000|Overall Study|Withdrawal by Subject|1
7565371|NCT03311230|11937236|FG001|Overall Study|Withdrawal by Subject|4
7565372|NCT03311230|11937237|FG002|Overall Study|Withdrawal by Subject|2
7565373|NCT03311230|11937238|FG003|Overall Study|Withdrawal by Subject|7
7565374|NCT03311230|11937235|FG000|Overall Study|Unrelated injury|0
7565375|NCT03311230|11937236|FG001|Overall Study|Unrelated injury|1
7565376|NCT03311230|11937237|FG002|Overall Study|Unrelated injury|0
7565377|NCT03311230|11937238|FG003|Overall Study|Unrelated injury|0
7565378|NCT03311373|11937248|FG000|Overall Study|Adverse Event|1
7565379|NCT03311373|11937248|FG000|Overall Study|Protocol Discontinuation Criteria|3
7565380|NCT03311373|11937248|FG000|Overall Study|Lost to Follow-up|1
7565381|NCT03311373|11937248|FG000|Overall Study|Physician Decision|1
7565382|NCT03311373|11937248|FG000|Overall Study|Withdrawal by Subject|3
7565383|NCT03311646|11937258|FG000|Overall Study|Physician Decision|1
7565384|NCT03311646|11937258|FG000|Overall Study|Withdrawal by Subject|5
7565385|NCT03311646|11937258|FG000|Overall Study|Lost to Follow-up|5
7565386|NCT03311646|11937258|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
7565387|NCT03311659|11937263|FG000|Overall Study|Protocol Violation|1
7565388|NCT03311724|11937271|FG000|Overall Study|Physician Decision|0
7565389|NCT03311724|11937272|FG001|Overall Study|Physician Decision|0
7565390|NCT03311724|11937273|FG002|Overall Study|Physician Decision|0
7565391|NCT03311724|11937274|FG003|Overall Study|Physician Decision|1
7565392|NCT03311724|11937271|FG000|Overall Study|Protocol Violation|1
7565393|NCT03311724|11937272|FG001|Overall Study|Protocol Violation|0
7565394|NCT03311724|11937273|FG002|Overall Study|Protocol Violation|1
7565395|NCT03311724|11937274|FG003|Overall Study|Protocol Violation|0
7565396|NCT03311724|11937271|FG000|Overall Study|Withdrawal by Subject|1
7565397|NCT03311724|11937272|FG001|Overall Study|Withdrawal by Subject|1
7565398|NCT03311724|11937273|FG002|Overall Study|Withdrawal by Subject|0
7565399|NCT03311724|11937274|FG003|Overall Study|Withdrawal by Subject|0
7565400|NCT03311724|11937271|FG000|Overall Study|Lost to Follow-up|1
7565401|NCT03311724|11937272|FG001|Overall Study|Lost to Follow-up|0
7565402|NCT03311724|11937273|FG002|Overall Study|Lost to Follow-up|0
7565403|NCT03311724|11937274|FG003|Overall Study|Lost to Follow-up|0
7565404|NCT03311724|11937271|FG000|Overall Study|Sponsor Decision|0
7565405|NCT03311724|11937272|FG001|Overall Study|Sponsor Decision|0
7565406|NCT03311724|11937273|FG002|Overall Study|Sponsor Decision|1
7565407|NCT03311724|11937274|FG003|Overall Study|Sponsor Decision|0
7565408|NCT03311841|11937292|FG000|14-day Wash-out|Adverse Event|0
7565409|NCT03311841|11937293|FG001|14-day Wash-out|Adverse Event|1
7565410|NCT03311841|11937294|FG002|14-day Wash-out|Adverse Event|0
7329469|NCT00803595|11562737|FG001|Overall Study|Withdrawal by Subject|2
7329470|NCT00803595|11562738|FG002|Overall Study|Withdrawal by Subject|3
7329471|NCT00803634|11562748|FG000|Overall Study|Withdrew Consent|1
7329472|NCT00803634|11562749|FG001|Overall Study|Withdrew Consent|0
7329473|NCT00803634|11562748|FG000|Overall Study|Lost to Follow-up|2
7329474|NCT00803634|11562749|FG001|Overall Study|Lost to Follow-up|3
7329475|NCT00803634|11562748|FG000|Overall Study|Death|3
7329476|NCT00803634|11562749|FG001|Overall Study|Death|2
7329477|NCT00803712|11562781|FG000|Overall Study|Noncompliance|3
7329478|NCT00803712|11562782|FG001|Overall Study|Noncompliance|0
7329479|NCT00803712|11562781|FG000|Overall Study|Adverse Event|5
7329480|NCT00803712|11562782|FG001|Overall Study|Adverse Event|0
7329481|NCT00803712|11562781|FG000|Overall Study|Death|8
7329482|NCT00803712|11562782|FG001|Overall Study|Death|7
7329483|NCT00803712|11562781|FG000|Overall Study|Lost to Follow-up|3
7329484|NCT00803712|11562782|FG001|Overall Study|Lost to Follow-up|1
7329485|NCT00803712|11562781|FG000|Overall Study|Withdrawal by Subject|2
7565411|NCT03311841|11937295|FG003|14-day Wash-out|Adverse Event|0
7565412|NCT03311841|11937296|FG004|14-day Wash-out|Adverse Event|0
7565413|NCT03311841|11937292|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
7565414|NCT03311841|11937293|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
7329486|NCT00803712|11562782|FG001|Overall Study|Withdrawal by Subject|4
7329487|NCT00803712|11562781|FG000|Overall Study|"Other in electronic Case Report Form"|0
7329488|NCT00803712|11562782|FG001|Overall Study|"Other in electronic Case Report Form"|1
7329489|NCT00803712|11562781|FG000|Overall Study|Protocol criteria (other)|0
7329490|NCT00803712|11562782|FG001|Overall Study|Protocol criteria (other)|2
7329491|NCT00803712|11562781|FG000|Overall Study|Protocol criteria (renal transplant)|12
7329492|NCT00803712|11562782|FG001|Overall Study|Protocol criteria (renal transplant)|8
7329493|NCT00803712|11562781|FG000|Overall Study|Administrative decision|2
7329494|NCT00803712|11562782|FG001|Overall Study|Administrative decision|3
7329495|NCT00803712|11562781|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
7329496|NCT00803712|11562782|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
7329497|NCT00803738|11562790|FG000|Overall Study|Adverse Event|3
7329498|NCT00803738|11562791|FG001|Overall Study|Adverse Event|5
7329499|NCT00803738|11562790|FG000|Overall Study|Lost to Follow-up|4
7329500|NCT00803738|11562791|FG001|Overall Study|Lost to Follow-up|4
7329501|NCT00803738|11562790|FG000|Overall Study|Protocol Violation|18
7329502|NCT00803738|11562791|FG001|Overall Study|Protocol Violation|10
7329503|NCT00803738|11562790|FG000|Overall Study|Withdrawal by Subject|1
7329504|NCT00803738|11562791|FG001|Overall Study|Withdrawal by Subject|4
7329505|NCT00803738|11562790|FG000|Overall Study|Lack of Efficacy|10
7329506|NCT00803738|11562791|FG001|Overall Study|Lack of Efficacy|16
7329507|NCT00803738|11562790|FG000|Overall Study|Negative Baseline Culture of Candida|56
7329508|NCT00803738|11562791|FG001|Overall Study|Negative Baseline Culture of Candida|63
7329509|NCT00803738|11562790|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
7329510|NCT00803738|11562791|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
7329511|NCT00804141|11562819|FG000|Overall Study|Adverse Event|157
7329512|NCT00804141|11562819|FG000|Overall Study|Death|4
7329513|NCT00804141|11562819|FG000|Overall Study|Failed to return|96
7329514|NCT00804141|11562819|FG000|Overall Study|Investigator request|8
7329515|NCT00804141|11562819|FG000|Overall Study|Protocol Violation|85
7329516|NCT00804141|11562819|FG000|Overall Study|Withdrawal by Subject|131
7329517|NCT00804141|11562819|FG000|Overall Study|Lack of Efficacy|46
7565415|NCT03311841|11937294|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
7565416|NCT03311841|11937295|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
7565417|NCT03311841|11937296|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
7565418|NCT03312114|11937335|FG000|Overall Study|All the five enrolled dropped out of the|5
7565419|NCT03312218|11937342|FG000|Overall Study|Never signed in to access the app|54
7565420|NCT03312218|11937343|FG001|Overall Study|Never signed in to access the app|58
7329518|NCT00804141|11562819|FG000|Overall Study|Other than specified|30
7329519|NCT00804141|11562819|FG000|Overall Study|Enrolled but not treated|6
7565421|NCT03312231|11937354|FG000|Overall Study|Lost to Follow-up|2
7565422|NCT03312231|11937355|FG001|Overall Study|Lost to Follow-up|6
7565423|NCT03312231|11937356|FG002|Overall Study|Lost to Follow-up|1
7565424|NCT03312231|11937357|FG003|Overall Study|Lost to Follow-up|3
7565425|NCT03312231|11937358|FG004|Overall Study|Lost to Follow-up|1
7565426|NCT03312231|11937354|FG000|Overall Study|Withdrawal by Subject|0
7565427|NCT03312231|11937355|FG001|Overall Study|Withdrawal by Subject|3
7565428|NCT03312231|11937356|FG002|Overall Study|Withdrawal by Subject|1
7565429|NCT03312231|11937357|FG003|Overall Study|Withdrawal by Subject|0
7565430|NCT03312231|11937358|FG004|Overall Study|Withdrawal by Subject|0
7565431|NCT03312231|11937354|FG000|Overall Study|Death|0
7565432|NCT03312231|11937355|FG001|Overall Study|Death|1
7565433|NCT03312231|11937356|FG002|Overall Study|Death|1
7565434|NCT03312231|11937357|FG003|Overall Study|Death|0
7565435|NCT03312231|11937358|FG004|Overall Study|Death|0
7565436|NCT03312231|11937354|FG000|Overall Study|Study Vaccination not Received|1
7565437|NCT03312231|11937355|FG001|Overall Study|Study Vaccination not Received|1
7565438|NCT03312231|11937356|FG002|Overall Study|Study Vaccination not Received|1
7565439|NCT03312231|11937357|FG003|Overall Study|Study Vaccination not Received|0
7565440|NCT03312231|11937358|FG004|Overall Study|Study Vaccination not Received|0
7565441|NCT03312543|11937389|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
7565442|NCT03312543|11937390|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
7329520|NCT00804193|11562826|FG000|Overall Study|Lack of baseline fungus|32
7329521|NCT00804193|11562827|FG001|Overall Study|Lack of baseline fungus|31
7329522|NCT00804193|11562828|FG002|Overall Study|Lack of baseline fungus|19
7329523|NCT00804193|11562826|FG000|Overall Study|Adverse Event|0
7329524|NCT00804193|11562827|FG001|Overall Study|Adverse Event|0
7329525|NCT00804193|11562828|FG002|Overall Study|Adverse Event|2
7329526|NCT00804193|11562826|FG000|Overall Study|Lack of Efficacy|1
7329527|NCT00804193|11562827|FG001|Overall Study|Lack of Efficacy|1
7329528|NCT00804193|11562828|FG002|Overall Study|Lack of Efficacy|3
7329529|NCT00804193|11562826|FG000|Overall Study|Protocol Violation|0
7329530|NCT00804193|11562827|FG001|Overall Study|Protocol Violation|8
7329531|NCT00804193|11562828|FG002|Overall Study|Protocol Violation|2
7329532|NCT00804193|11562826|FG000|Overall Study|Lost to Follow-up|3
7329533|NCT00804193|11562827|FG001|Overall Study|Lost to Follow-up|3
7329534|NCT00804193|11562828|FG002|Overall Study|Lost to Follow-up|4
7329535|NCT00804193|11562826|FG000|Overall Study|Withdrawal by Subject|3
7329536|NCT00804193|11562827|FG001|Overall Study|Withdrawal by Subject|1
7329537|NCT00804193|11562828|FG002|Overall Study|Withdrawal by Subject|2
7329538|NCT00804570|11562838|FG000|Overall Study|Adverse Event|14
7329539|NCT00804570|11562839|FG001|Overall Study|Adverse Event|7
7329540|NCT00804570|11562838|FG000|Overall Study|Lack of Efficacy|0
7329541|NCT00804570|11562839|FG001|Overall Study|Lack of Efficacy|1
7329542|NCT00804570|11562838|FG000|Overall Study|Lost to Follow-up|18
7329543|NCT00804570|11562839|FG001|Overall Study|Lost to Follow-up|21
7329544|NCT00804570|11562838|FG000|Overall Study|Entry criteria not met|5
7329545|NCT00804570|11562839|FG001|Overall Study|Entry criteria not met|5
7329546|NCT00804570|11562838|FG000|Overall Study|Protocol Violation|12
7329547|NCT00804570|11562839|FG001|Overall Study|Protocol Violation|16
7329548|NCT00804570|11562838|FG000|Overall Study|Physician Decision|1
7329549|NCT00804570|11562839|FG001|Overall Study|Physician Decision|2
7329550|NCT00804570|11562838|FG000|Overall Study|Sponsor decision|1
7329551|NCT00804570|11562839|FG001|Overall Study|Sponsor decision|4
7565443|NCT03312543|11937389|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
7565444|NCT03312543|11937390|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
7565445|NCT03312543|11937389|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
7565446|NCT03312543|11937390|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
7565447|NCT03312543|11937389|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
7565448|NCT03312543|11937390|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
7565449|NCT03312543|11937389|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
7565450|NCT03312543|11937390|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
7565451|NCT03312543|11937389|FG000|Regression (Week 12 to Week 24)|Death|0
7565452|NCT03312543|11937390|FG001|Regression (Week 12 to Week 24)|Death|1
7565453|NCT03312933|11937400|FG000|Overall Study|Protocol Violation|15
7565454|NCT03312933|11937400|FG000|Overall Study|Lost to Follow-up|36
7565455|NCT03312933|11937400|FG000|Overall Study|Withdrawal by Subject|3
7565456|NCT03313037|11937406|FG000|Overall Study|Protocol Violation|4
7565457|NCT03313037|11937407|FG001|Overall Study|Protocol Violation|1
7565458|NCT03313037|11937406|FG000|Overall Study|Other|1
7329552|NCT00804570|11562838|FG000|Overall Study|Withdrawal by Subject|21
7329553|NCT00804570|11562839|FG001|Overall Study|Withdrawal by Subject|38
7329554|NCT00804687|11562872|FG000|Period 3: Treatment Period|Positive Drug screen|0
7329555|NCT00804687|11562873|FG001|Period 3: Treatment Period|Positive Drug screen|0
7329556|NCT00804687|11562874|FG002|Period 3: Treatment Period|Positive Drug screen|0
7329557|NCT00804687|11562875|FG003|Period 3: Treatment Period|Positive Drug screen|1
7329558|NCT00804687|11562876|FG004|Period 3: Treatment Period|Positive Drug screen|0
7329559|NCT00804687|11562877|FG005|Period 3: Treatment Period|Positive Drug screen|0
7329560|NCT00804687|11562872|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
7565459|NCT03313037|11937407|FG001|Overall Study|Other|1
7329561|NCT00804687|11562873|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
7385112|NCT01198977|11642669|FG000|Overall Study|Lost to Follow-up|1
7565460|NCT03313037|11937406|FG000|Overall Study|Withdrawal by Subject|4
7565461|NCT03313037|11937407|FG001|Overall Study|Withdrawal by Subject|3
7565462|NCT03313037|11937406|FG000|Overall Study|No longer meets eligibility criteria|1
7565463|NCT03313037|11937407|FG001|Overall Study|No longer meets eligibility criteria|7
7565464|NCT03313037|11937406|FG000|Overall Study|Lost to Follow-up|9
7565465|NCT03313037|11937407|FG001|Overall Study|Lost to Follow-up|8
7565466|NCT03313037|11937406|FG000|Overall Study|Randomized but not treated|1
7565467|NCT03313037|11937407|FG001|Overall Study|Randomized but not treated|0
7565468|NCT03313050|11937417|FG000|Stage 2: 12 Months|Adverse Event|0
7565469|NCT03313050|11937418|FG001|Stage 2: 12 Months|Adverse Event|0
7565470|NCT03313050|11937419|FG002|Stage 2: 12 Months|Adverse Event|0
7565471|NCT03313050|11937420|FG003|Stage 2: 12 Months|Adverse Event|1
7565472|NCT03313050|11937417|FG000|Stage 2: 12 Months|Death|0
7565473|NCT03313050|11937418|FG001|Stage 2: 12 Months|Death|0
7565474|NCT03313050|11937419|FG002|Stage 2: 12 Months|Death|3
7565475|NCT03313050|11937420|FG003|Stage 2: 12 Months|Death|0
7565476|NCT03313050|11937417|FG000|Stage 2: 12 Months|Lost to Follow-up|0
7565477|NCT03313050|11937418|FG001|Stage 2: 12 Months|Lost to Follow-up|0
7565478|NCT03313050|11937419|FG002|Stage 2: 12 Months|Lost to Follow-up|1
7565479|NCT03313050|11937420|FG003|Stage 2: 12 Months|Lost to Follow-up|5
7565480|NCT03313050|11937417|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7565481|NCT03313050|11937418|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7565482|NCT03313050|11937419|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
7565483|NCT03313050|11937420|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
7565484|NCT03313050|11937417|FG000|Stage 2: 12 Months|Protocol deviation|0
7565485|NCT03313050|11937418|FG001|Stage 2: 12 Months|Protocol deviation|0
7565486|NCT03313050|11937419|FG002|Stage 2: 12 Months|Protocol deviation|7
7565487|NCT03313050|11937420|FG003|Stage 2: 12 Months|Protocol deviation|7
7565488|NCT03313050|11937417|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
7565489|NCT03313050|11937418|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
7565490|NCT03313050|11937419|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
7565491|NCT03313050|11937420|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
7565492|NCT03313050|11937417|FG000|Stage 2: 12 Months|Other|0
7565493|NCT03313050|11937418|FG001|Stage 2: 12 Months|Other|0
7565494|NCT03313050|11937419|FG002|Stage 2: 12 Months|Other|0
7565495|NCT03313050|11937420|FG003|Stage 2: 12 Months|Other|1
7565496|NCT03313076|11937434|FG000|Overall Study|Withdrawal by Subject|2
7565497|NCT03313076|11937435|FG001|Overall Study|Withdrawal by Subject|0
7565498|NCT03313076|11937436|FG002|Overall Study|Withdrawal by Subject|0
7565499|NCT03313076|11937437|FG003|Overall Study|Withdrawal by Subject|0
7565500|NCT03313076|11937434|FG000|Overall Study|Lost to Follow-up|0
7565501|NCT03313076|11937435|FG001|Overall Study|Lost to Follow-up|2
7565502|NCT03313076|11937436|FG002|Overall Study|Lost to Follow-up|2
7565503|NCT03313076|11937437|FG003|Overall Study|Lost to Follow-up|2
7565504|NCT03313310|11937455|FG000|Phase 2|Lost to Follow-up|4
7565505|NCT03313310|11937456|FG001|Phase 2|Lost to Follow-up|0
7565506|NCT03313310|11937455|FG000|Phase 3|Lost to Follow-up|0
7565507|NCT03313310|11937456|FG001|Phase 3|Lost to Follow-up|1
7565508|NCT03314233|11937462|FG000|Overall Study|No longer eligible at time of delivery|1
7565509|NCT03314519|11937468|FG000|Overall Study|Protocol Violation|3
7565510|NCT03314519|11937469|FG001|Overall Study|Protocol Violation|2
7565511|NCT03314662|11937478|FG000|Overall Study|Withdrawal by Subject|1
7565512|NCT03314662|11937479|FG001|Overall Study|Withdrawal by Subject|1
7565513|NCT03314662|11937480|FG002|Overall Study|Withdrawal by Subject|1
7565514|NCT03314662|11937478|FG000|Overall Study|Lost to Follow-up|5
7565515|NCT03314662|11937479|FG001|Overall Study|Lost to Follow-up|4
7565516|NCT03314662|11937480|FG002|Overall Study|Lost to Follow-up|4
7565517|NCT03314662|11937478|FG000|Overall Study|Death|2
7565518|NCT03314662|11937479|FG001|Overall Study|Death|0
7565519|NCT03314662|11937480|FG002|Overall Study|Death|0
7565522|NCT03315208|11937524|FG000|Overall Study|Lost to Follow-up|11
7565523|NCT03315208|11937525|FG001|Overall Study|Lost to Follow-up|6
7565524|NCT03315208|11937524|FG000|Overall Study|Withdrawal by Subject|2
7565525|NCT03315208|11937525|FG001|Overall Study|Withdrawal by Subject|0
7565526|NCT03315286|11937534|FG000|Overall Study|Lost to Follow-up|0
7565527|NCT03315286|11937535|FG001|Overall Study|Lost to Follow-up|3
7565528|NCT03315286|11937534|FG000|Overall Study|Withdrawal by Subject|1
7565529|NCT03315286|11937535|FG001|Overall Study|Withdrawal by Subject|0
7565530|NCT03315286|11937534|FG000|Overall Study|Protocol Violation|0
7565531|NCT03315286|11937535|FG001|Overall Study|Protocol Violation|1
7565532|NCT03315689|11937560|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
7565533|NCT03315689|11937561|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
7565534|NCT03315689|11937560|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
7565535|NCT03315689|11937561|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
7565536|NCT03315689|11937560|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
7565537|NCT03315689|11937561|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
7575075|NCT03710889|11958589|FG000|Overall Study|Adverse Event|2
7575076|NCT03710889|11958589|FG000|Overall Study|Protocol Deviation|1
7575077|NCT03712280|11958618|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
7575078|NCT03712280|11958619|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
7575079|NCT03712280|11958620|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
7565538|NCT03315793|11937583|FG000|Overall Study|Adverse Event|4
7565539|NCT03315793|11937584|FG001|Overall Study|Adverse Event|2
7565540|NCT03315793|11937583|FG000|Overall Study|Protocol Deviation|1
7565541|NCT03315793|11937584|FG001|Overall Study|Protocol Deviation|0
7565542|NCT03315793|11937583|FG000|Overall Study|Difficult for regular visit|0
7565543|NCT03315793|11937584|FG001|Overall Study|Difficult for regular visit|1
7565544|NCT03316131|11937601|FG000|Treatment Period 2|Protocol deviation|1
7565545|NCT03316131|11937602|FG001|Treatment Period 2|Protocol deviation|0
7565546|NCT03316170|11937610|FG000|Overall Study|Death|1
7565547|NCT03316170|11937611|FG001|Overall Study|Death|0
7565548|NCT03316170|11937610|FG000|Overall Study|Lost to Follow-up|6
7565549|NCT03316170|11937611|FG001|Overall Study|Lost to Follow-up|7
7565550|NCT03316547|11937630|FG000|Overall Study|Death|3
7565551|NCT03316547|11937631|FG001|Overall Study|Death|1
7565552|NCT03316547|11937630|FG000|Overall Study|Lost to Follow-up|6
7565553|NCT03316547|11937631|FG001|Overall Study|Lost to Follow-up|6
7565554|NCT03316547|11937630|FG000|Overall Study|Withdrawal by Subject|3
7565555|NCT03316547|11937631|FG001|Overall Study|Withdrawal by Subject|2
7565556|NCT03316547|11937630|FG000|Overall Study|Transfer to another hospital|6
7565557|NCT03316547|11937631|FG001|Overall Study|Transfer to another hospital|4
7565558|NCT03316911|11937641|FG000|Overall Study|Lost to Follow-up|33
7565559|NCT03316911|11937642|FG001|Overall Study|Lost to Follow-up|29
7565560|NCT03317379|11937691|FG000|Overall Study|Lost to Follow-up|0
7565561|NCT03317379|11937692|FG001|Overall Study|Lost to Follow-up|3
7565562|NCT03317379|11937693|FG002|Overall Study|Lost to Follow-up|2
7565563|NCT03318315|11937717|FG000|Overall Study|Lost to Follow-up|3
7565564|NCT03318315|11937718|FG001|Overall Study|Lost to Follow-up|2
7565565|NCT03318315|11937719|FG002|Overall Study|Lost to Follow-up|1
7565566|NCT03318315|11937717|FG000|Overall Study|Protocol Violation|1
7565567|NCT03318315|11937718|FG001|Overall Study|Protocol Violation|1
7565568|NCT03318315|11937719|FG002|Overall Study|Protocol Violation|1
7565569|NCT03318315|11937717|FG000|Overall Study|Withdrawal by Subject|0
7565570|NCT03318315|11937718|FG001|Overall Study|Withdrawal by Subject|0
7565571|NCT03318315|11937719|FG002|Overall Study|Withdrawal by Subject|2
7565572|NCT03318783|11937741|FG000|Overall Study|Withdrawal by Subject|0
7565573|NCT03318783|11937742|FG001|Overall Study|Withdrawal by Subject|1
7565574|NCT03318783|11937741|FG000|Overall Study|Death|0
7565575|NCT03318783|11937742|FG001|Overall Study|Death|1
7565576|NCT03319212|11937776|FG000|Overall Study|Discontinued as moving out of local area|0
7565577|NCT03319212|11937777|FG001|Overall Study|Discontinued as moving out of local area|1
7565578|NCT03319212|11937776|FG000|Overall Study|Adverse Event|2
7565579|NCT03319212|11937777|FG001|Overall Study|Adverse Event|2
7565580|NCT03319212|11937776|FG000|Overall Study|Withdrawal by Subject|0
7565581|NCT03319212|11937777|FG001|Overall Study|Withdrawal by Subject|1
7565582|NCT03319212|11937776|FG000|Overall Study|Lost to Follow-up|0
7565583|NCT03319212|11937777|FG001|Overall Study|Lost to Follow-up|1
7565584|NCT03319212|11937776|FG000|Overall Study|Physician Decision|1
7565585|NCT03319212|11937777|FG001|Overall Study|Physician Decision|0
7565586|NCT03319719|11937791|FG000|Overall Study|Lost to Follow-up|1
7565587|NCT03319953|11937805|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
7565588|NCT03319953|11937806|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7565589|NCT03319953|11937807|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7565590|NCT03319953|11937808|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
7565591|NCT03319953|11937805|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
7565592|NCT03319953|11937806|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
7565593|NCT03319953|11937807|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
7565594|NCT03319953|11937808|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
7565595|NCT03320057|11937816|FG000|Overall Study|Lost to Follow-up|4
7565596|NCT03320057|11937817|FG001|Overall Study|Lost to Follow-up|17
7565597|NCT03320057|11937816|FG000|Overall Study|Did not take mifepristone or misoprostol|2
7565598|NCT03320057|11937817|FG001|Overall Study|Did not take mifepristone or misoprostol|0
7565599|NCT03320369|11937827|FG000|Overall Study|Adverse Event|1
7565600|NCT03320369|11937827|FG000|Overall Study|Withdrawal by Subject|2
7565609|NCT03320850|11937850|FG000|Overall Study|Lost to Follow-up|0
7565610|NCT03320850|11937851|FG001|Overall Study|Lost to Follow-up|0
7565611|NCT03320850|11937852|FG002|Overall Study|Lost to Follow-up|0
7565612|NCT03320850|11937853|FG003|Overall Study|Lost to Follow-up|0
7565613|NCT03320850|11937854|FG004|Overall Study|Lost to Follow-up|1
7565614|NCT03320850|11937855|FG005|Overall Study|Lost to Follow-up|2
7565615|NCT03320850|11937856|FG006|Overall Study|Lost to Follow-up|2
7565616|NCT03320850|11937857|FG007|Overall Study|Lost to Follow-up|0
7565617|NCT03320850|11937858|FG008|Overall Study|Lost to Follow-up|6
7565618|NCT03320850|11937859|FG009|Overall Study|Lost to Follow-up|4
7565619|NCT03320850|11937850|FG000|Overall Study|Withdrawal by Subject|0
7565620|NCT03320850|11937851|FG001|Overall Study|Withdrawal by Subject|0
7565621|NCT03320850|11937852|FG002|Overall Study|Withdrawal by Subject|0
7565622|NCT03320850|11937853|FG003|Overall Study|Withdrawal by Subject|0
7565623|NCT03320850|11937854|FG004|Overall Study|Withdrawal by Subject|1
7565624|NCT03320850|11937855|FG005|Overall Study|Withdrawal by Subject|2
7565625|NCT03320850|11937856|FG006|Overall Study|Withdrawal by Subject|4
7565626|NCT03320850|11937857|FG007|Overall Study|Withdrawal by Subject|5
7565627|NCT03320850|11937858|FG008|Overall Study|Withdrawal by Subject|2
7565628|NCT03320850|11937859|FG009|Overall Study|Withdrawal by Subject|1
7565629|NCT03320850|11937850|FG000|Overall Study|Lack of Efficacy|0
7565630|NCT03320850|11937851|FG001|Overall Study|Lack of Efficacy|0
7565631|NCT03320850|11937852|FG002|Overall Study|Lack of Efficacy|0
7565632|NCT03320850|11937853|FG003|Overall Study|Lack of Efficacy|1
7565633|NCT03320850|11937854|FG004|Overall Study|Lack of Efficacy|0
7565634|NCT03320850|11937855|FG005|Overall Study|Lack of Efficacy|1
7565635|NCT03320850|11937856|FG006|Overall Study|Lack of Efficacy|0
7565636|NCT03320850|11937857|FG007|Overall Study|Lack of Efficacy|2
7565637|NCT03320850|11937858|FG008|Overall Study|Lack of Efficacy|0
7565638|NCT03320850|11937859|FG009|Overall Study|Lack of Efficacy|3
7565639|NCT03320850|11937850|FG000|Overall Study|Failure to Meet Randomization Criteria|0
7565640|NCT03320850|11937851|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7565641|NCT03320850|11937852|FG002|Overall Study|Failure to Meet Randomization Criteria|0
7565642|NCT03320850|11937853|FG003|Overall Study|Failure to Meet Randomization Criteria|0
7565643|NCT03320850|11937854|FG004|Overall Study|Failure to Meet Randomization Criteria|0
7565644|NCT03320850|11937855|FG005|Overall Study|Failure to Meet Randomization Criteria|1
7565645|NCT03320850|11937856|FG006|Overall Study|Failure to Meet Randomization Criteria|0
7565646|NCT03320850|11937857|FG007|Overall Study|Failure to Meet Randomization Criteria|0
7565647|NCT03320850|11937858|FG008|Overall Study|Failure to Meet Randomization Criteria|0
7565648|NCT03320850|11937859|FG009|Overall Study|Failure to Meet Randomization Criteria|0
7565649|NCT03320850|11937850|FG000|Overall Study|Adverse Event|0
7565650|NCT03320850|11937851|FG001|Overall Study|Adverse Event|0
7329562|NCT00804687|11562874|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
7329563|NCT00804687|11562875|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
7329564|NCT00804687|11562876|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
7329565|NCT00804687|11562877|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
7565651|NCT03320850|11937852|FG002|Overall Study|Adverse Event|0
7565652|NCT03320850|11937853|FG003|Overall Study|Adverse Event|0
7565653|NCT03320850|11937854|FG004|Overall Study|Adverse Event|0
7565654|NCT03320850|11937855|FG005|Overall Study|Adverse Event|2
7565655|NCT03320850|11937856|FG006|Overall Study|Adverse Event|1
7565656|NCT03320850|11937857|FG007|Overall Study|Adverse Event|0
7565657|NCT03320850|11937858|FG008|Overall Study|Adverse Event|2
7565658|NCT03320850|11937859|FG009|Overall Study|Adverse Event|0
7565659|NCT03320850|11937850|FG000|Overall Study|Reason Not Specified|0
7565660|NCT03320850|11937851|FG001|Overall Study|Reason Not Specified|0
7565661|NCT03320850|11937852|FG002|Overall Study|Reason Not Specified|0
7565662|NCT03320850|11937853|FG003|Overall Study|Reason Not Specified|0
7329566|NCT00804687|11562872|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
7329567|NCT00804687|11562873|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
7329568|NCT00804687|11562874|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
7329569|NCT00804687|11562875|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
7329570|NCT00804687|11562876|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
7457564|NCT01799889|11751133|FG000|Overall Study|Non-Compliance With Study Drug|0
7457565|NCT01799889|11751134|FG001|Overall Study|Non-Compliance With Study Drug|0
7457566|NCT01799889|11751135|FG002|Overall Study|Non-Compliance With Study Drug|0
7457567|NCT01799889|11751136|FG003|Overall Study|Non-Compliance With Study Drug|0
7457568|NCT01799889|11751137|FG004|Overall Study|Non-Compliance With Study Drug|0
7457569|NCT01799889|11751138|FG005|Overall Study|Non-Compliance With Study Drug|1
7457570|NCT01799889|11751139|FG006|Overall Study|Non-Compliance With Study Drug|0
7457571|NCT01799889|11751140|FG007|Overall Study|Non-Compliance With Study Drug|0
7457572|NCT01799889|11751141|FG008|Overall Study|Non-Compliance With Study Drug|0
7457573|NCT01799889|11751142|FG009|Overall Study|Non-Compliance With Study Drug|0
7457574|NCT01799889|11751143|FG010|Overall Study|Non-Compliance With Study Drug|0
7457575|NCT01799889|11751144|FG011|Overall Study|Non-Compliance With Study Drug|0
7457576|NCT01799941|11751181|FG000|Overall Study|Adverse Event|34
7565663|NCT03320850|11937854|FG004|Overall Study|Reason Not Specified|0
7565664|NCT03320850|11937855|FG005|Overall Study|Reason Not Specified|1
7565665|NCT03320850|11937856|FG006|Overall Study|Reason Not Specified|0
7565666|NCT03320850|11937857|FG007|Overall Study|Reason Not Specified|0
7565667|NCT03320850|11937858|FG008|Overall Study|Reason Not Specified|0
7565668|NCT03320850|11937859|FG009|Overall Study|Reason Not Specified|1
7565669|NCT03320941|11937891|FG000|Overall Study|subject/guardian decision|0
7565670|NCT03320941|11937892|FG001|Overall Study|subject/guardian decision|0
7565671|NCT03320941|11937893|FG002|Overall Study|subject/guardian decision|0
7565672|NCT03320941|11937894|FG003|Overall Study|subject/guardian decision|1
7565673|NCT03320941|11937895|FG004|Overall Study|subject/guardian decision|0
7565674|NCT03321006|11937909|FG000|Overall Study|Death|1
7565675|NCT03321006|11937910|FG001|Overall Study|Death|0
7565676|NCT03321006|11937909|FG000|Overall Study|Lack of Efficacy|1
7457577|NCT01799941|11751181|FG000|Overall Study|Withdrawal by Subject|21
7565677|NCT03321006|11937910|FG001|Overall Study|Lack of Efficacy|0
7565678|NCT03321396|11937929|FG000|Overall Study|Physician Decision|1
7565679|NCT03321721|11937936|FG000|Overall Study|Lost to Follow-up|4
7565680|NCT03321721|11937937|FG001|Overall Study|Lost to Follow-up|8
7565681|NCT03321721|11937938|FG002|Overall Study|Lost to Follow-up|11
7565682|NCT03322423|11937947|FG000|Period 1|Subject no longer eligible|0
7565683|NCT03322423|11937948|FG001|Period 1|Subject no longer eligible|1
7565684|NCT03322423|11937947|FG000|Period 1|Withdrawal by Subject|0
7565685|NCT03322423|11937948|FG001|Period 1|Withdrawal by Subject|1
7565686|NCT03322423|11937947|FG000|Period 1|Incorrect Lens Dispensed|1
7565687|NCT03322423|11937948|FG001|Period 1|Incorrect Lens Dispensed|0
7565688|NCT03322423|11937947|FG000|Period 1|Unsatisfactory Lens Fitting|1
7565689|NCT03322423|11937948|FG001|Period 1|Unsatisfactory Lens Fitting|0
7565690|NCT03322423|11937947|FG000|Period 2|Dispensed incorrect lens in left eye|0
7565691|NCT03322423|11937948|FG001|Period 2|Dispensed incorrect lens in left eye|1
7565692|NCT03322423|11937947|FG000|Period 2|Protocol Violation|1
7565693|NCT03322423|11937948|FG001|Period 2|Protocol Violation|0
7565694|NCT03322423|11937947|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
7565695|NCT03322423|11937948|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
7565696|NCT03322462|11937954|FG000|Overall Study|Technical difficulties|2
7565697|NCT03322462|11937954|FG000|Overall Study|Other|1
7565698|NCT03322514|11937962|FG000|Overall Study|Withdrawal by Subject|1
7565699|NCT03322514|11937963|FG001|Overall Study|Withdrawal by Subject|1
7565700|NCT03323086|11937989|FG000|Overall Study|Lost to Follow-up|3
7565701|NCT03323086|11937990|FG001|Overall Study|Lost to Follow-up|2
7565702|NCT03323164|11937998|FG000|Overall Study|Poor quality imaging/scans|2
7565703|NCT03323164|11937999|FG001|Overall Study|Poor quality imaging/scans|2
7565704|NCT03324581|11938044|FG000|Overall Study|Adverse Event|18
7565705|NCT03324581|11938045|FG001|Overall Study|Adverse Event|11
7565706|NCT03324581|11938046|FG002|Overall Study|Adverse Event|7
7565707|NCT03324581|11938044|FG000|Overall Study|Lack of Efficacy|0
7565708|NCT03324581|11938045|FG001|Overall Study|Lack of Efficacy|1
7565709|NCT03324581|11938046|FG002|Overall Study|Lack of Efficacy|0
7329571|NCT00804687|11562877|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
7329572|NCT00804687|11562872|FG000|Period 5: Treatment Period|Positive drug test|1
7329573|NCT00804687|11562873|FG001|Period 5: Treatment Period|Positive drug test|0
7329574|NCT00804687|11562874|FG002|Period 5: Treatment Period|Positive drug test|0
7329575|NCT00804687|11562875|FG003|Period 5: Treatment Period|Positive drug test|0
7329576|NCT00804687|11562876|FG004|Period 5: Treatment Period|Positive drug test|0
7329577|NCT00804687|11562877|FG005|Period 5: Treatment Period|Positive drug test|0
7329578|NCT00804843|11562887|FG000|Overall Study|Protocol Violation|1
7329579|NCT00804843|11562888|FG001|Overall Study|Protocol Violation|0
7329580|NCT00804843|11562887|FG000|Overall Study|Adverse Event|8
7329581|NCT00804843|11562888|FG001|Overall Study|Adverse Event|5
7329582|NCT00804843|11562887|FG000|Overall Study|Withdrawal by Subject|1
7329583|NCT00804843|11562888|FG001|Overall Study|Withdrawal by Subject|2
7329584|NCT00804908|11562898|FG000|Overall Study|Other|115
7329585|NCT00804908|11562899|FG001|Overall Study|Other|116
7329586|NCT00804908|11562900|FG002|Overall Study|Other|114
7329587|NCT00804986|11562927|FG000|Overall Study|Adverse Event|0
7329588|NCT00804986|11562928|FG001|Overall Study|Adverse Event|1
7329589|NCT00804986|11562929|FG002|Overall Study|Adverse Event|2
7329590|NCT00804986|11562930|FG003|Overall Study|Adverse Event|1
7565710|NCT03324581|11938044|FG000|Overall Study|Lost to Follow-up|5
7565711|NCT03324581|11938045|FG001|Overall Study|Lost to Follow-up|3
7565712|NCT03324581|11938046|FG002|Overall Study|Lost to Follow-up|6
7565713|NCT03324581|11938044|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7565714|NCT03324581|11938045|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
7565715|NCT03324581|11938046|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
7565716|NCT03324581|11938044|FG000|Overall Study|Physician Decision|0
7329591|NCT00804986|11562931|FG004|Overall Study|Adverse Event|3
7457578|NCT01799941|11751181|FG000|Overall Study|Death|2
7329592|NCT00804986|11562932|FG005|Overall Study|Adverse Event|0
7329593|NCT00804986|11562927|FG000|Overall Study|Lack of Efficacy|0
7565717|NCT03324581|11938045|FG001|Overall Study|Physician Decision|1
7565718|NCT03324581|11938046|FG002|Overall Study|Physician Decision|2
7565719|NCT03324581|11938044|FG000|Overall Study|Protocol Deviation|8
7565720|NCT03324581|11938045|FG001|Overall Study|Protocol Deviation|9
7565721|NCT03324581|11938046|FG002|Overall Study|Protocol Deviation|4
7565722|NCT03324581|11938044|FG000|Overall Study|Withdrawal by Subject|6
7565723|NCT03324581|11938045|FG001|Overall Study|Withdrawal by Subject|8
7565724|NCT03324581|11938046|FG002|Overall Study|Withdrawal by Subject|6
7565725|NCT03324581|11938044|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7565726|NCT03324581|11938045|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
7565727|NCT03324581|11938046|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
7565728|NCT03325010|11938063|FG000|Overall Study|Adverse Event|3
7565729|NCT03325010|11938064|FG001|Overall Study|Adverse Event|8
7565730|NCT03325010|11938063|FG000|Overall Study|Protocol Violation|1
7565731|NCT03325010|11938064|FG001|Overall Study|Protocol Violation|8
7565732|NCT03325010|11938063|FG000|Overall Study|Withdrawal by Subject|1
7565733|NCT03325010|11938064|FG001|Overall Study|Withdrawal by Subject|3
7565734|NCT03325010|11938063|FG000|Overall Study|Lost to Follow-up|1
7565735|NCT03325010|11938064|FG001|Overall Study|Lost to Follow-up|0
7565736|NCT03325010|11938063|FG000|Overall Study|Physician Decision|1
7329594|NCT00804986|11562928|FG001|Overall Study|Lack of Efficacy|0
7329595|NCT00804986|11562929|FG002|Overall Study|Lack of Efficacy|0
7329596|NCT00804986|11562930|FG003|Overall Study|Lack of Efficacy|1
7329597|NCT00804986|11562931|FG004|Overall Study|Lack of Efficacy|0
7329598|NCT00804986|11562932|FG005|Overall Study|Lack of Efficacy|3
7329599|NCT00804986|11562927|FG000|Overall Study|Lost to Follow-up|0
7329600|NCT00804986|11562928|FG001|Overall Study|Lost to Follow-up|0
7329601|NCT00804986|11562929|FG002|Overall Study|Lost to Follow-up|0
7329602|NCT00804986|11562930|FG003|Overall Study|Lost to Follow-up|1
7329603|NCT00804986|11562931|FG004|Overall Study|Lost to Follow-up|1
7329604|NCT00804986|11562932|FG005|Overall Study|Lost to Follow-up|3
7329605|NCT00804986|11562927|FG000|Overall Study|Protocol Violation|0
7329606|NCT00804986|11562928|FG001|Overall Study|Protocol Violation|1
7329607|NCT00804986|11562929|FG002|Overall Study|Protocol Violation|0
7329608|NCT00804986|11562930|FG003|Overall Study|Protocol Violation|1
7329609|NCT00804986|11562931|FG004|Overall Study|Protocol Violation|0
7329610|NCT00804986|11562932|FG005|Overall Study|Protocol Violation|0
7329611|NCT00804986|11562927|FG000|Overall Study|Withdrawal by Subject|0
7329612|NCT00804986|11562928|FG001|Overall Study|Withdrawal by Subject|3
7329613|NCT00804986|11562929|FG002|Overall Study|Withdrawal by Subject|0
7329614|NCT00804986|11562930|FG003|Overall Study|Withdrawal by Subject|3
7329615|NCT00804986|11562931|FG004|Overall Study|Withdrawal by Subject|5
7329616|NCT00804986|11562932|FG005|Overall Study|Withdrawal by Subject|3
7329617|NCT00804986|11562927|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7329618|NCT00804986|11562928|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
7329619|NCT00804986|11562929|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
7329620|NCT00804986|11562930|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
7329621|NCT00804986|11562931|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
7329622|NCT00804986|11562932|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
7329623|NCT00804986|11562927|FG000|Overall Study|Sponsor Decision|0
7329624|NCT00804986|11562928|FG001|Overall Study|Sponsor Decision|1
7329625|NCT00804986|11562929|FG002|Overall Study|Sponsor Decision|0
7329626|NCT00804986|11562930|FG003|Overall Study|Sponsor Decision|0
7329627|NCT00804986|11562931|FG004|Overall Study|Sponsor Decision|0
7329628|NCT00804986|11562932|FG005|Overall Study|Sponsor Decision|0
7329629|NCT00804986|11562927|FG000|Overall Study|Physician Decision|1
7329630|NCT00804986|11562928|FG001|Overall Study|Physician Decision|0
7329631|NCT00804986|11562929|FG002|Overall Study|Physician Decision|0
7329632|NCT00804986|11562930|FG003|Overall Study|Physician Decision|0
7329633|NCT00804986|11562931|FG004|Overall Study|Physician Decision|0
7329634|NCT00804986|11562932|FG005|Overall Study|Physician Decision|0
7329635|NCT00805025|11562963|FG000|Overall Study|Screened but not enrolled/treated|42
7329636|NCT00805025|11562963|FG000|Overall Study|Adverse Event|4
7329637|NCT00805025|11562963|FG000|Overall Study|Withdrawal by Subject|2
7329638|NCT00805025|11562963|FG000|Overall Study|Physician Decision|1
7329639|NCT00805142|11562978|FG000|Titration Period|Adverse Event|3
7329640|NCT00805142|11562979|FG001|Titration Period|Adverse Event|3
7329641|NCT00805142|11562978|FG000|Titration Period|Lack of Efficacy|1
7329642|NCT00805142|11562979|FG001|Titration Period|Lack of Efficacy|1
7329643|NCT00805142|11562978|FG000|Titration Period|Lost to Follow-up|0
7329644|NCT00805142|11562979|FG001|Titration Period|Lost to Follow-up|1
7329645|NCT00805142|11562978|FG000|Titration Period|Disease Progression|2
7329646|NCT00805142|11562979|FG001|Titration Period|Disease Progression|1
7329647|NCT00805142|11562978|FG000|Titration Period|Withdrawal of consent|0
7329648|NCT00805142|11562979|FG001|Titration Period|Withdrawal of consent|1
7329649|NCT00805142|11562978|FG000|Titration Period|Other|0
7329650|NCT00805142|11562979|FG001|Titration Period|Other|3
7565737|NCT03325010|11938064|FG001|Overall Study|Physician Decision|1
7565738|NCT03325010|11938063|FG000|Overall Study|Lack of Efficacy|2
7565739|NCT03325010|11938064|FG001|Overall Study|Lack of Efficacy|0
7329651|NCT00805142|11562978|FG000|Maintenance Period|Adverse Event|0
7329652|NCT00805142|11562979|FG001|Maintenance Period|Adverse Event|1
7329653|NCT00805142|11562978|FG000|Maintenance Period|Other|0
7329654|NCT00805142|11562979|FG001|Maintenance Period|Other|1
7329655|NCT00805194|11562994|FG000|Overall Study|Progressive disease (modified RECIST)|404
7385113|NCT01198977|11642670|FG001|Overall Study|Lost to Follow-up|0
7565740|NCT03325556|11938070|FG000|Open-label Period|Lack of Response in OL period|70
7565741|NCT03325556|11938071|FG001|Open-label Period|Lack of Response in OL period|0
7565742|NCT03325556|11938072|FG002|Open-label Period|Lack of Response in OL period|0
7565743|NCT03325556|11938070|FG000|Open-label Period|Adverse Event|27
7565744|NCT03325556|11938071|FG001|Open-label Period|Adverse Event|0
7565745|NCT03325556|11938072|FG002|Open-label Period|Adverse Event|0
7565746|NCT03325556|11938070|FG000|Open-label Period|Death|1
7565747|NCT03325556|11938071|FG001|Open-label Period|Death|0
7565748|NCT03325556|11938072|FG002|Open-label Period|Death|0
7565749|NCT03325556|11938070|FG000|Open-label Period|Lost to Follow-up|1
7565750|NCT03325556|11938071|FG001|Open-label Period|Lost to Follow-up|0
7565751|NCT03325556|11938072|FG002|Open-label Period|Lost to Follow-up|0
7565752|NCT03325556|11938070|FG000|Open-label Period|Non-compliance with study drug|5
7565753|NCT03325556|11938071|FG001|Open-label Period|Non-compliance with study drug|0
7565754|NCT03325556|11938072|FG002|Open-label Period|Non-compliance with study drug|0
7565755|NCT03325556|11938070|FG000|Open-label Period|Use of prohibited medication|1
7565756|NCT03325556|11938071|FG001|Open-label Period|Use of prohibited medication|0
7565757|NCT03325556|11938072|FG002|Open-label Period|Use of prohibited medication|0
7565758|NCT03325556|11938070|FG000|Open-label Period|Protocol Violation|4
7565759|NCT03325556|11938071|FG001|Open-label Period|Protocol Violation|0
7565760|NCT03325556|11938072|FG002|Open-label Period|Protocol Violation|0
7565761|NCT03325556|11938070|FG000|Open-label Period|Withdrawal by Subject|17
7565762|NCT03325556|11938071|FG001|Open-label Period|Withdrawal by Subject|0
7565763|NCT03325556|11938072|FG002|Open-label Period|Withdrawal by Subject|0
7565764|NCT03325556|11938070|FG000|Open-label Period|Not otherwise specified|8
7565765|NCT03325556|11938071|FG001|Open-label Period|Not otherwise specified|0
7565766|NCT03325556|11938072|FG002|Open-label Period|Not otherwise specified|0
7565767|NCT03325556|11938070|FG000|Open-label Period|Administrative discont. at study termination|41
7565768|NCT03325556|11938071|FG001|Open-label Period|Administrative discont. at study termination|0
7329656|NCT00805194|11562995|FG001|Overall Study|Progressive disease (modified RECIST)|435
7329657|NCT00805194|11562994|FG000|Overall Study|Worsening or AE of underlying disease|64
7329658|NCT00805194|11562995|FG001|Overall Study|Worsening or AE of underlying disease|70
7329659|NCT00805194|11562994|FG000|Overall Study|Other AE|84
7329660|NCT00805194|11562995|FG001|Overall Study|Other AE|73
7329661|NCT00805194|11562994|FG000|Overall Study|Protocol Violation|9
7329662|NCT00805194|11562995|FG001|Overall Study|Protocol Violation|9
7329663|NCT00805194|11562994|FG000|Overall Study|Lost to Follow-up|5
7329664|NCT00805194|11562995|FG001|Overall Study|Lost to Follow-up|5
7329665|NCT00805194|11562994|FG000|Overall Study|Withdrawal by Subject|60
7329666|NCT00805194|11562995|FG001|Overall Study|Withdrawal by Subject|42
7329667|NCT00805194|11562994|FG000|Overall Study|Not treated|3
7329668|NCT00805194|11562995|FG001|Overall Study|Not treated|4
7329669|NCT00805194|11562994|FG000|Overall Study|Reasons other than stated above|20
7329670|NCT00805194|11562995|FG001|Overall Study|Reasons other than stated above|16
7329671|NCT00805207|11563015|FG000|Overall Study|Protocol Violation|0
7329672|NCT00805207|11563016|FG001|Overall Study|Protocol Violation|0
7329673|NCT00805207|11563017|FG002|Overall Study|Protocol Violation|1
7329674|NCT00805207|11563018|FG003|Overall Study|Protocol Violation|0
7329675|NCT00805207|11563019|FG004|Overall Study|Protocol Violation|0
7329676|NCT00805207|11563020|FG005|Overall Study|Protocol Violation|0
7329677|NCT00805207|11563021|FG006|Overall Study|Protocol Violation|0
7329678|NCT00805207|11563022|FG007|Overall Study|Protocol Violation|0
7329679|NCT00805207|11563023|FG008|Overall Study|Protocol Violation|0
7329680|NCT00805207|11563015|FG000|Overall Study|Physician Decision|0
7329681|NCT00805207|11563016|FG001|Overall Study|Physician Decision|1
7329682|NCT00805207|11563017|FG002|Overall Study|Physician Decision|0
7329683|NCT00805207|11563018|FG003|Overall Study|Physician Decision|0
7329684|NCT00805207|11563019|FG004|Overall Study|Physician Decision|0
7329685|NCT00805207|11563020|FG005|Overall Study|Physician Decision|1
7329686|NCT00805207|11563021|FG006|Overall Study|Physician Decision|0
7329687|NCT00805207|11563022|FG007|Overall Study|Physician Decision|0
7329688|NCT00805207|11563023|FG008|Overall Study|Physician Decision|0
7329689|NCT00805207|11563015|FG000|Overall Study|Withdrawal by Subject|0
7329690|NCT00805207|11563016|FG001|Overall Study|Withdrawal by Subject|1
7329691|NCT00805207|11563017|FG002|Overall Study|Withdrawal by Subject|0
7329692|NCT00805207|11563018|FG003|Overall Study|Withdrawal by Subject|0
7329693|NCT00805207|11563019|FG004|Overall Study|Withdrawal by Subject|1
7329694|NCT00805207|11563020|FG005|Overall Study|Withdrawal by Subject|2
7329695|NCT00805207|11563021|FG006|Overall Study|Withdrawal by Subject|0
7565769|NCT03325556|11938072|FG002|Open-label Period|Administrative discont. at study termination|0
7565770|NCT03325556|11938070|FG000|Double-blind Period|Relapse|0
7565771|NCT03325556|11938071|FG001|Double-blind Period|Relapse|15
7565772|NCT03325556|11938072|FG002|Double-blind Period|Relapse|34
7329696|NCT00805207|11563022|FG007|Overall Study|Withdrawal by Subject|0
7329697|NCT00805207|11563023|FG008|Overall Study|Withdrawal by Subject|0
7329698|NCT00805285|11563047|FG000|Overall Study|Lack of Efficacy|1
7329699|NCT00805389|11563056|FG000|Overall Study|Adverse Event|0
7329700|NCT00805389|11563057|FG001|Overall Study|Adverse Event|0
7329701|NCT00805389|11563058|FG002|Overall Study|Adverse Event|1
7329702|NCT00805389|11563059|FG003|Overall Study|Adverse Event|2
7565773|NCT03325556|11938070|FG000|Double-blind Period|Adverse Event|0
7565774|NCT03325556|11938071|FG001|Double-blind Period|Adverse Event|3
7565775|NCT03325556|11938072|FG002|Double-blind Period|Adverse Event|1
7565776|NCT03325556|11938070|FG000|Double-blind Period|Noncompliance with study drug|0
7565777|NCT03325556|11938071|FG001|Double-blind Period|Noncompliance with study drug|0
7565778|NCT03325556|11938072|FG002|Double-blind Period|Noncompliance with study drug|1
7565779|NCT03325556|11938070|FG000|Double-blind Period|Use of prohibited medication|0
7565780|NCT03325556|11938071|FG001|Double-blind Period|Use of prohibited medication|1
7565781|NCT03325556|11938072|FG002|Double-blind Period|Use of prohibited medication|0
7565782|NCT03325556|11938070|FG000|Double-blind Period|Physician Decision|0
7565783|NCT03325556|11938071|FG001|Double-blind Period|Physician Decision|0
7565784|NCT03325556|11938072|FG002|Double-blind Period|Physician Decision|1
7565785|NCT03325556|11938070|FG000|Double-blind Period|Withdrawal by Subject|0
7565786|NCT03325556|11938071|FG001|Double-blind Period|Withdrawal by Subject|6
7565787|NCT03325556|11938072|FG002|Double-blind Period|Withdrawal by Subject|4
7565788|NCT03325556|11938070|FG000|Double-blind Period|Not otherwise specified|0
7565789|NCT03325556|11938071|FG001|Double-blind Period|Not otherwise specified|1
7565790|NCT03325556|11938072|FG002|Double-blind Period|Not otherwise specified|5
7565791|NCT03325556|11938070|FG000|Double-blind Period|Administrative discont. at study termination|0
7565792|NCT03325556|11938071|FG001|Double-blind Period|Administrative discont. at study termination|35
7565793|NCT03325556|11938072|FG002|Double-blind Period|Administrative discont. at study termination|31
7565794|NCT03325673|11938081|FG000|Overall Study|Adverse Event|4
7565795|NCT03325673|11938082|FG001|Overall Study|Adverse Event|0
7329703|NCT00805389|11563060|FG004|Overall Study|Adverse Event|0
7329704|NCT00805389|11563056|FG000|Overall Study|Lost to Follow-up|4
7329705|NCT00805389|11563057|FG001|Overall Study|Lost to Follow-up|3
7329706|NCT00805389|11563058|FG002|Overall Study|Lost to Follow-up|6
7329707|NCT00805389|11563059|FG003|Overall Study|Lost to Follow-up|10
7329708|NCT00805389|11563060|FG004|Overall Study|Lost to Follow-up|9
7329709|NCT00805389|11563056|FG000|Overall Study|Protocol Violation|0
7329710|NCT00805389|11563057|FG001|Overall Study|Protocol Violation|0
7329711|NCT00805389|11563058|FG002|Overall Study|Protocol Violation|1
7329712|NCT00805389|11563059|FG003|Overall Study|Protocol Violation|0
7329713|NCT00805389|11563060|FG004|Overall Study|Protocol Violation|0
7329714|NCT00805389|11563056|FG000|Overall Study|Withdrawal by Subject|3
7329715|NCT00805389|11563057|FG001|Overall Study|Withdrawal by Subject|2
7329716|NCT00805389|11563058|FG002|Overall Study|Withdrawal by Subject|4
7329717|NCT00805389|11563059|FG003|Overall Study|Withdrawal by Subject|5
7329718|NCT00805389|11563060|FG004|Overall Study|Withdrawal by Subject|4
7329719|NCT00805441|11563084|FG000|Overall Study|Adverse Event|5
7329720|NCT00805441|11563085|FG001|Overall Study|Adverse Event|2
7329721|NCT00805441|11563084|FG000|Overall Study|Lack of Efficacy|0
7329722|NCT00805441|11563085|FG001|Overall Study|Lack of Efficacy|2
7565796|NCT03325881|11938101|FG000|Overall Study|Protocol Violation|0
7565797|NCT03325881|11938102|FG001|Overall Study|Protocol Violation|1
7565798|NCT03325881|11938101|FG000|Overall Study|Withdrawal by Subject|0
7565799|NCT03325881|11938102|FG001|Overall Study|Withdrawal by Subject|2
7565800|NCT03325881|11938101|FG000|Overall Study|Lack of Efficacy|2
7565801|NCT03325881|11938102|FG001|Overall Study|Lack of Efficacy|0
7565802|NCT03325881|11938101|FG000|Overall Study|Not treated|1
7565803|NCT03325881|11938102|FG001|Overall Study|Not treated|0
7565804|NCT03325894|11938112|FG000|Overall Study|Adverse Event|2
7565805|NCT03325894|11938113|FG001|Overall Study|Adverse Event|3
7565806|NCT03325894|11938112|FG000|Overall Study|Protocol Violation|1
7565807|NCT03325894|11938113|FG001|Overall Study|Protocol Violation|2
7565808|NCT03325894|11938112|FG000|Overall Study|Withdrawal by Subject|10
7565809|NCT03325894|11938113|FG001|Overall Study|Withdrawal by Subject|6
7565810|NCT03325894|11938112|FG000|Overall Study|Lost to Follow-up|4
7565811|NCT03325894|11938113|FG001|Overall Study|Lost to Follow-up|9
7565812|NCT03325894|11938112|FG000|Overall Study|Lack of Efficacy|8
7565813|NCT03325894|11938113|FG001|Overall Study|Lack of Efficacy|14
7565814|NCT03325894|11938112|FG000|Overall Study|Study Terminated by Sponsor|38
7565815|NCT03325894|11938113|FG001|Overall Study|Study Terminated by Sponsor|43
7565816|NCT03325894|11938112|FG000|Overall Study|Other (Not received Treatment)|1
7565817|NCT03325894|11938113|FG001|Overall Study|Other (Not received Treatment)|0
7565818|NCT03326323|11938122|FG000|Overall Study|Unable to receive ANH protocol|3
7565819|NCT03326518|11938129|FG000|Overall Study|Protocol Violation|1
7565820|NCT03326518|11938130|FG001|Overall Study|Protocol Violation|0
7565821|NCT03326518|11938131|FG002|Overall Study|Protocol Violation|0
7565822|NCT03326518|11938129|FG000|Overall Study|Withdrawal by Subject|1
7565823|NCT03326518|11938130|FG001|Overall Study|Withdrawal by Subject|0
7565824|NCT03326518|11938131|FG002|Overall Study|Withdrawal by Subject|0
7565825|NCT03326518|11938129|FG000|Overall Study|Lost to Follow-up|1
7329723|NCT00805441|11563084|FG000|Overall Study|Protocol Violation|4
7329724|NCT00805441|11563085|FG001|Overall Study|Protocol Violation|8
7329725|NCT00805441|11563084|FG000|Overall Study|Lost to Follow-up|10
7329726|NCT00805441|11563085|FG001|Overall Study|Lost to Follow-up|13
7565826|NCT03326518|11938130|FG001|Overall Study|Lost to Follow-up|0
7565827|NCT03326518|11938131|FG002|Overall Study|Lost to Follow-up|1
7565828|NCT03327220|11938214|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
7565829|NCT03327220|11938215|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
7565830|NCT03327220|11938214|FG000|Overall Study|Investigator Decision|2
7565831|NCT03327220|11938215|FG001|Overall Study|Investigator Decision|0
7565832|NCT03327220|11938214|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
7565833|NCT03327220|11938215|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
7565834|NCT03327220|11938214|FG000|Overall Study|Fungal infection|1
7565835|NCT03327220|11938215|FG001|Overall Study|Fungal infection|0
7565836|NCT03327220|11938214|FG000|Overall Study|Discharged to Rehabilitation|0
7565837|NCT03327220|11938215|FG001|Overall Study|Discharged to Rehabilitation|1
7565838|NCT03327220|11938214|FG000|Overall Study|Missing|1
7565839|NCT03327220|11938215|FG001|Overall Study|Missing|0
7565840|NCT03327402|11938221|FG000|Overall Study|Withdrawal by Subject|1
7565841|NCT03327402|11938221|FG000|Overall Study|Other (Visit Out-Of-Window)|1
7565842|NCT03328182|11938235|FG000|Overall Study|Withdrawal by Subject|1
7565843|NCT03328182|11938235|FG000|Overall Study|Protocol Violation|2
7565844|NCT03328182|11938235|FG000|Overall Study|No Product Evaluated|1
7565845|NCT03328325|11938248|FG000|Overall Study|Lost to Follow-up|4
7565846|NCT03328325|11938248|FG000|Overall Study|Physician Decision|1
7565847|NCT03328325|11938248|FG000|Overall Study|Withdrawal by Subject|3
7565848|NCT03328325|11938248|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
7565849|NCT03328832|11938258|FG000|Overall Study|Lost to Follow-up|0
7565850|NCT03328832|11938259|FG001|Overall Study|Lost to Follow-up|1
7565851|NCT03328897|11938268|FG000|Randomized-treatment Epoch|Adverse Event|4
7565852|NCT03328897|11938269|FG001|Randomized-treatment Epoch|Adverse Event|1
7565853|NCT03328897|11938270|FG002|Randomized-treatment Epoch|Adverse Event|1
7565854|NCT03328897|11938268|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
7565855|NCT03328897|11938269|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
7565856|NCT03328897|11938270|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
7565857|NCT03328897|11938268|FG000|Randomized-treatment Epoch|Pregnancy|3
7565858|NCT03328897|11938269|FG001|Randomized-treatment Epoch|Pregnancy|0
7565859|NCT03328897|11938270|FG002|Randomized-treatment Epoch|Pregnancy|0
7565860|NCT03328897|11938268|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
7565861|NCT03328897|11938269|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
7565862|NCT03328897|11938270|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
7565863|NCT03328897|11938268|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
7565864|NCT03328897|11938269|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
7565865|NCT03328897|11938270|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
7565866|NCT03328897|11938268|FG000|Follow-up Epoch|Adverse Event|4
7565867|NCT03328897|11938269|FG001|Follow-up Epoch|Adverse Event|0
7565868|NCT03328897|11938270|FG002|Follow-up Epoch|Adverse Event|1
7565869|NCT03328897|11938268|FG000|Follow-up Epoch|Lack of Efficacy|1
7565870|NCT03328897|11938269|FG001|Follow-up Epoch|Lack of Efficacy|1
7565871|NCT03328897|11938270|FG002|Follow-up Epoch|Lack of Efficacy|1
7565872|NCT03328897|11938268|FG000|Follow-up Epoch|Lost to Follow-up|0
7565873|NCT03328897|11938269|FG001|Follow-up Epoch|Lost to Follow-up|1
7565874|NCT03328897|11938270|FG002|Follow-up Epoch|Lost to Follow-up|0
7329727|NCT00805441|11563084|FG000|Overall Study|Withdrawal by Subject|15
7329728|NCT00805441|11563085|FG001|Overall Study|Withdrawal by Subject|9
7329729|NCT00805441|11563084|FG000|Overall Study|Physician Decision|0
7329730|NCT00805441|11563085|FG001|Overall Study|Physician Decision|1
7329731|NCT00805441|11563084|FG000|Overall Study|Acute Alcohol Withdrawal|0
7329732|NCT00805441|11563085|FG001|Overall Study|Acute Alcohol Withdrawal|1
7329733|NCT00805467|11563095|FG000|Overall Study|Lack of Efficacy|0
7329734|NCT00805467|11563096|FG001|Overall Study|Lack of Efficacy|8
7329735|NCT00805467|11563097|FG002|Overall Study|Lack of Efficacy|13
7329736|NCT00805467|11563098|FG003|Overall Study|Lack of Efficacy|86
7565875|NCT03328897|11938268|FG000|Follow-up Epoch|Pregnancy|1
7565876|NCT03328897|11938269|FG001|Follow-up Epoch|Pregnancy|0
7565877|NCT03328897|11938270|FG002|Follow-up Epoch|Pregnancy|0
7565878|NCT03328897|11938268|FG000|Follow-up Epoch|Patient/guardian decision|2
7565879|NCT03328897|11938269|FG001|Follow-up Epoch|Patient/guardian decision|1
7565880|NCT03328897|11938270|FG002|Follow-up Epoch|Patient/guardian decision|0
7565881|NCT03329196|11938285|FG000|Overall Study|Adverse Event|10
7565882|NCT03329196|11938286|FG001|Overall Study|Adverse Event|5
7329737|NCT00805467|11563095|FG000|Overall Study|Lost to Follow-up|0
7329738|NCT00805467|11563096|FG001|Overall Study|Lost to Follow-up|1
7329739|NCT00805467|11563097|FG002|Overall Study|Lost to Follow-up|7
7329740|NCT00805467|11563098|FG003|Overall Study|Lost to Follow-up|21
7329741|NCT00805467|11563095|FG000|Overall Study|Withdrawal by Subject|0
7329742|NCT00805467|11563096|FG001|Overall Study|Withdrawal by Subject|6
7329743|NCT00805467|11563097|FG002|Overall Study|Withdrawal by Subject|45
7565883|NCT03329196|11938285|FG000|Overall Study|Physician Decision|2
7565884|NCT03329196|11938286|FG001|Overall Study|Physician Decision|2
7565885|NCT03329196|11938285|FG000|Overall Study|Withdrawal by Subject|11
7565886|NCT03329196|11938286|FG001|Overall Study|Withdrawal by Subject|3
7565887|NCT03329196|11938285|FG000|Overall Study|Hepatic function abnormalities|0
7565888|NCT03329196|11938286|FG001|Overall Study|Hepatic function abnormalities|1
7565889|NCT03329196|11938285|FG000|Overall Study|Conducting rescue therapy before Week 24|2
7565890|NCT03329196|11938286|FG001|Overall Study|Conducting rescue therapy before Week 24|1
7565891|NCT03329196|11938285|FG000|Overall Study|Difficult to control Hb|2
7565892|NCT03329196|11938286|FG001|Overall Study|Difficult to control Hb|3
7565893|NCT03329196|11938285|FG000|Overall Study|Dialysis or renal transplant|13
7329744|NCT00805467|11563098|FG003|Overall Study|Withdrawal by Subject|50
7329745|NCT00805467|11563095|FG000|Overall Study|Protocol Violation|0
7329746|NCT00805467|11563096|FG001|Overall Study|Protocol Violation|3
7329747|NCT00805467|11563097|FG002|Overall Study|Protocol Violation|0
7565894|NCT03329196|11938286|FG001|Overall Study|Dialysis or renal transplant|15
7565895|NCT03329573|11938306|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7565896|NCT03329573|11938307|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
7565897|NCT03329573|11938308|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7565898|NCT03329573|11938309|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
7565899|NCT03329573|11938306|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
7565900|NCT03329573|11938307|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
7565901|NCT03329573|11938308|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7565902|NCT03329573|11938309|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
7565903|NCT03329573|11938306|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
7565904|NCT03329573|11938307|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7565905|NCT03329573|11938308|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7565906|NCT03329573|11938309|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
7565907|NCT03329573|11938306|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7329748|NCT00805467|11563098|FG003|Overall Study|Protocol Violation|5
7329749|NCT00805467|11563095|FG000|Overall Study|Adverse Event|0
7329750|NCT00805467|11563096|FG001|Overall Study|Adverse Event|13
7329751|NCT00805467|11563097|FG002|Overall Study|Adverse Event|26
7329752|NCT00805467|11563098|FG003|Overall Study|Adverse Event|57
7329753|NCT00805467|11563095|FG000|Overall Study|Death|0
7329754|NCT00805467|11563096|FG001|Overall Study|Death|2
7329755|NCT00805467|11563097|FG002|Overall Study|Death|7
7329756|NCT00805467|11563098|FG003|Overall Study|Death|5
7329757|NCT00805467|11563095|FG000|Overall Study|Physician Decision|0
7329758|NCT00805467|11563096|FG001|Overall Study|Physician Decision|1
7329759|NCT00805467|11563097|FG002|Overall Study|Physician Decision|2
7329760|NCT00805467|11563098|FG003|Overall Study|Physician Decision|6
7329761|NCT00805467|11563095|FG000|Overall Study|Not reported|0
7329762|NCT00805467|11563096|FG001|Overall Study|Not reported|0
7329763|NCT00805467|11563097|FG002|Overall Study|Not reported|3
7329764|NCT00805467|11563098|FG003|Overall Study|Not reported|7
7329765|NCT00805480|11563112|FG000|Overall Study|Withdrawal by Subject|13
7329766|NCT00805480|11563113|FG001|Overall Study|Withdrawal by Subject|5
7329767|NCT00805480|11563114|FG002|Overall Study|Withdrawal by Subject|11
7329768|NCT00805480|11563115|FG003|Overall Study|Withdrawal by Subject|5
7329769|NCT00805480|11563112|FG000|Overall Study|Lost to Follow-up|1
7329770|NCT00805480|11563113|FG001|Overall Study|Lost to Follow-up|2
7329771|NCT00805480|11563114|FG002|Overall Study|Lost to Follow-up|0
7329772|NCT00805480|11563115|FG003|Overall Study|Lost to Follow-up|0
7329773|NCT00805480|11563112|FG000|Overall Study|Adverse Event|0
7329774|NCT00805480|11563113|FG001|Overall Study|Adverse Event|0
7329775|NCT00805480|11563114|FG002|Overall Study|Adverse Event|1
7329776|NCT00805480|11563115|FG003|Overall Study|Adverse Event|0
7329777|NCT00805532|11563143|FG000|Overall Study|invalid data|0
7329778|NCT00805532|11563144|FG001|Overall Study|invalid data|1
7329779|NCT00805545|11563154|FG000|Overall Study|Protocol Violation|3
7329780|NCT00805545|11563155|FG001|Overall Study|Protocol Violation|2
7329781|NCT00805545|11563154|FG000|Overall Study|Protocol Violation|3
7329782|NCT00805545|11563155|FG001|Overall Study|Protocol Violation|1
7329783|NCT00805675|11563164|FG000|Overall Study|Adverse Event|0
7329784|NCT00805675|11563165|FG001|Overall Study|Adverse Event|0
7329785|NCT00805675|11563166|FG002|Overall Study|Adverse Event|1
7329786|NCT00805740|11563176|FG000|Overall Study|Death|7
7329787|NCT00805740|11563177|FG001|Overall Study|Death|4
7329788|NCT00805740|11563176|FG000|Overall Study|Withdrawal by Subject|1
7329789|NCT00805740|11563177|FG001|Overall Study|Withdrawal by Subject|0
7329790|NCT00805740|11563176|FG000|Overall Study|Lost to Follow-up|1
7329791|NCT00805740|11563177|FG001|Overall Study|Lost to Follow-up|0
7329792|NCT00805740|11563176|FG000|Overall Study|Randomized, but not treated|2
7329793|NCT00805740|11563177|FG001|Overall Study|Randomized, but not treated|0
7329794|NCT00805766|11563183|FG000|Screening Period|Adverse Event|1
7329795|NCT00805766|11563183|FG000|Screening Period|Lack of Efficacy|2
7329796|NCT00805766|11563183|FG000|Screening Period|Pregnancy|1
7329797|NCT00805766|11563183|FG000|Screening Period|Responder|2
7329798|NCT00805766|11563183|FG000|Increased Dose Period|Adverse Event|4
7329799|NCT00805766|11563183|FG000|Increased Dose Period|Lack of Efficacy|7
7329800|NCT00805766|11563183|FG000|Increased Dose Period|Pregnancy|1
7329801|NCT00805766|11563183|FG000|Increased Dose Period|Withdrawal by Subject|1
7329802|NCT00805792|11563191|FG000|Overall Study|Death|3
7329803|NCT00805792|11563191|FG000|Overall Study|Lost to Follow-up|2
7329804|NCT00805935|11563208|FG000|Overall Study|Stimulation Failure|1
7565908|NCT03329573|11938307|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
7329805|NCT00805935|11563209|FG001|Overall Study|Stimulation Failure|5
7329806|NCT00805935|11563210|FG002|Overall Study|Stimulation Failure|2
7329807|NCT00805935|11563211|FG003|Overall Study|Stimulation Failure|2
7329808|NCT00805935|11563208|FG000|Overall Study|Cycle cancelled|0
7329809|NCT00805935|11563209|FG001|Overall Study|Cycle cancelled|0
7329810|NCT00805935|11563210|FG002|Overall Study|Cycle cancelled|2
7329811|NCT00805935|11563211|FG003|Overall Study|Cycle cancelled|0
7329812|NCT00805935|11563208|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
7329813|NCT00805935|11563209|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
7329814|NCT00805935|11563210|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
7387603|NCT01215227|11646201|FG004|Overall Study|Adverse Event|7
7565909|NCT03329573|11938308|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7565910|NCT03329573|11938309|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
7565911|NCT03329846|11938321|FG000|Overall Study|Disease progression|4
7565912|NCT03329846|11938322|FG001|Overall Study|Disease progression|6
7565913|NCT03329846|11938321|FG000|Overall Study|Study drug toxicity|1
7565914|NCT03329846|11938322|FG001|Overall Study|Study drug toxicity|0
7565915|NCT03329846|11938321|FG000|Overall Study|Participant request to discontinue treatment|0
7565916|NCT03329846|11938322|FG001|Overall Study|Participant request to discontinue treatment|1
7565917|NCT03329846|11938321|FG000|Overall Study|Participant withdrew consent|1
7565918|NCT03329846|11938322|FG001|Overall Study|Participant withdrew consent|0
7565919|NCT03329846|11938321|FG000|Overall Study|Other reasons|2
7565920|NCT03329846|11938322|FG001|Overall Study|Other reasons|2
7565921|NCT03329885|11938334|FG000|Overall Study|Sponsor discontinued the study early|0
7565922|NCT03329885|11938335|FG001|Overall Study|Sponsor discontinued the study early|0
7565923|NCT03329885|11938336|FG002|Overall Study|Sponsor discontinued the study early|0
7565924|NCT03329885|11938337|FG003|Overall Study|Sponsor discontinued the study early|0
7565925|NCT03329885|11938338|FG004|Overall Study|Sponsor discontinued the study early|0
7565926|NCT03329885|11938339|FG005|Overall Study|Sponsor discontinued the study early|0
7565927|NCT03329885|11938340|FG006|Overall Study|Sponsor discontinued the study early|1
7565928|NCT03329885|11938341|FG007|Overall Study|Sponsor discontinued the study early|1
7565929|NCT03329885|11938342|FG008|Overall Study|Sponsor discontinued the study early|0
7565930|NCT03329989|11938375|FG000|Overall Study|Withdrawal by Subject|9
7565931|NCT03329989|11938375|FG000|Overall Study|Lost to Follow-up|8
7565932|NCT03329989|11938375|FG000|Overall Study|Adverse Event|5
7565933|NCT03329989|11938375|FG000|Overall Study|Protocol Violation|1
7565934|NCT03330002|11938379|FG000|Overall Study|Lost to Follow-up|15
7565935|NCT03330002|11938379|FG000|Overall Study|Death|7
7565936|NCT03330119|11938391|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
7565937|NCT03330119|11938392|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
7565938|NCT03330236|11938400|FG000|Overall Study|Death|2
7565939|NCT03330236|11938401|FG001|Overall Study|Death|1
7565940|NCT03330236|11938400|FG000|Overall Study|Withdrawal by Subject|2
7565941|NCT03330236|11938401|FG001|Overall Study|Withdrawal by Subject|4
7565942|NCT03330236|11938400|FG000|Overall Study|Lost to Follow-up|0
7565943|NCT03330236|11938401|FG001|Overall Study|Lost to Follow-up|2
7565944|NCT03330236|11938400|FG000|Overall Study|Physician Decision|2
7565945|NCT03330236|11938401|FG001|Overall Study|Physician Decision|0
7565946|NCT03330236|11938400|FG000|Overall Study|Protocol Violation|4
7565947|NCT03330236|11938401|FG001|Overall Study|Protocol Violation|3
7565948|NCT03330236|11938400|FG000|Overall Study|SedLine malfunction/blinding|19
7565949|NCT03330236|11938401|FG001|Overall Study|SedLine malfunction/blinding|14
7565950|NCT03330236|11938400|FG000|Overall Study|Volatile anesthetics used|11
7565951|NCT03330236|11938401|FG001|Overall Study|Volatile anesthetics used|8
7565952|NCT03330236|11938400|FG000|Overall Study|Surgery aborted/converted to open|60
7565953|NCT03330236|11938401|FG001|Overall Study|Surgery aborted/converted to open|52
7565954|NCT03330288|11938438|FG000|Overall Study|Other reason|1
7565955|NCT03330288|11938439|FG001|Overall Study|Other reason|1
7565956|NCT03330288|11938438|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
7565957|NCT03330288|11938439|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
7565958|NCT03330288|11938438|FG000|Overall Study|Adverse Event|1
7565959|NCT03330288|11938439|FG001|Overall Study|Adverse Event|0
7565960|NCT03330288|11938438|FG000|Overall Study|Withdrawal by Subject|1
7565961|NCT03330288|11938439|FG001|Overall Study|Withdrawal by Subject|0
7565962|NCT03330288|11938438|FG000|Overall Study|Lost to Follow-up|26
7565963|NCT03330288|11938439|FG001|Overall Study|Lost to Follow-up|7
7565964|NCT03331042|11938470|FG000|Overall Study|Protocol Violation|1
7565965|NCT03331042|11938471|FG001|Overall Study|Protocol Violation|0
7565966|NCT03331042|11938472|FG002|Overall Study|Protocol Violation|0
7565967|NCT03331042|11938473|FG003|Overall Study|Protocol Violation|0
7565968|NCT03331042|11938470|FG000|Overall Study|Physician Decision|0
7565969|NCT03331042|11938471|FG001|Overall Study|Physician Decision|0
7565970|NCT03331042|11938472|FG002|Overall Study|Physician Decision|1
7565971|NCT03331042|11938473|FG003|Overall Study|Physician Decision|0
7565972|NCT03331042|11938470|FG000|Overall Study|Lost to Follow-up|0
7565973|NCT03331042|11938471|FG001|Overall Study|Lost to Follow-up|0
7565974|NCT03331042|11938472|FG002|Overall Study|Lost to Follow-up|0
7565975|NCT03331042|11938473|FG003|Overall Study|Lost to Follow-up|1
7565976|NCT03331315|11938500|FG000|Overall Study|Physician Decision|18
7565977|NCT03331315|11938501|FG001|Overall Study|Physician Decision|14
7565978|NCT03331666|11938511|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7565979|NCT03331666|11938512|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
7565980|NCT03332160|11938538|FG000|Overall Study|Withdrawal by Subject|1
7565981|NCT03332160|11938539|FG001|Overall Study|Withdrawal by Subject|1
7565982|NCT03332160|11938538|FG000|Overall Study|Adverse Event|0
7565983|NCT03332160|11938539|FG001|Overall Study|Adverse Event|1
7565984|NCT03332160|11938538|FG000|Overall Study|Developed Exclusion Criteria|0
7565985|NCT03332160|11938539|FG001|Overall Study|Developed Exclusion Criteria|1
7565986|NCT03332160|11938538|FG000|Overall Study|Non-adherence to treatment|0
7565987|NCT03332160|11938539|FG001|Overall Study|Non-adherence to treatment|2
7565988|NCT03332212|11938550|FG000|Overall Study|Not treated|0
7565989|NCT03332212|11938551|FG001|Overall Study|Not treated|1
7565990|NCT03332212|11938552|FG002|Overall Study|Not treated|0
7565991|NCT03332212|11938553|FG003|Overall Study|Not treated|0
7565992|NCT03332212|11938550|FG000|Overall Study|Adverse Event|0
7565993|NCT03332212|11938551|FG001|Overall Study|Adverse Event|0
7565994|NCT03332212|11938552|FG002|Overall Study|Adverse Event|0
7565995|NCT03332212|11938553|FG003|Overall Study|Adverse Event|1
7565996|NCT03332212|11938550|FG000|Overall Study|worsening of disease under study|1
7329815|NCT00805935|11563211|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
7329816|NCT00805935|11563208|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7329817|NCT00805935|11563209|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7329818|NCT00805935|11563210|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
7329819|NCT00805935|11563211|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
7329820|NCT00805935|11563208|FG000|Overall Study|Lost to Follow-up|1
7329821|NCT00805935|11563209|FG001|Overall Study|Lost to Follow-up|0
7329822|NCT00805935|11563210|FG002|Overall Study|Lost to Follow-up|0
7329823|NCT00805935|11563211|FG003|Overall Study|Lost to Follow-up|0
7329824|NCT00805935|11563208|FG000|Overall Study|No positive serum pregnancy|8
7329825|NCT00805935|11563209|FG001|Overall Study|No positive serum pregnancy|7
7329826|NCT00805935|11563210|FG002|Overall Study|No positive serum pregnancy|6
7329827|NCT00805935|11563211|FG003|Overall Study|No positive serum pregnancy|5
7329828|NCT00805935|11563208|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
7329829|NCT00805935|11563209|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
7329830|NCT00805935|11563210|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
7329831|NCT00805935|11563211|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
7329832|NCT00805935|11563208|FG000|Overall Study|Pregnancy loss/miscarriage|2
7329833|NCT00805935|11563209|FG001|Overall Study|Pregnancy loss/miscarriage|0
7329834|NCT00805935|11563210|FG002|Overall Study|Pregnancy loss/miscarriage|0
7329835|NCT00805935|11563211|FG003|Overall Study|Pregnancy loss/miscarriage|0
7329836|NCT00805935|11563208|FG000|Overall Study|Biochemical pregnancy|0
7329837|NCT00805935|11563209|FG001|Overall Study|Biochemical pregnancy|1
7329838|NCT00805935|11563210|FG002|Overall Study|Biochemical pregnancy|0
7329839|NCT00805935|11563211|FG003|Overall Study|Biochemical pregnancy|0
7329840|NCT00805935|11563208|FG000|Overall Study|Chemical pregnancy|0
7329841|NCT00805935|11563209|FG001|Overall Study|Chemical pregnancy|5
7329842|NCT00805935|11563210|FG002|Overall Study|Chemical pregnancy|3
7329843|NCT00805935|11563211|FG003|Overall Study|Chemical pregnancy|2
7329844|NCT00805935|11563208|FG000|Overall Study|Ectopic pregnancy|0
7329845|NCT00805935|11563209|FG001|Overall Study|Ectopic pregnancy|0
7329846|NCT00805935|11563210|FG002|Overall Study|Ectopic pregnancy|1
7329847|NCT00805935|11563211|FG003|Overall Study|Ectopic pregnancy|0
7329848|NCT00805935|11563208|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
7329849|NCT00805935|11563209|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
7329850|NCT00805935|11563210|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
7329851|NCT00805935|11563211|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
7329852|NCT00806026|11563239|FG000|Overall Study|Death|0
7329853|NCT00806026|11563240|FG001|Overall Study|Death|0
7329854|NCT00806026|11563241|FG002|Overall Study|Death|0
7329855|NCT00806026|11563242|FG003|Overall Study|Death|1
7329856|NCT00806026|11563243|FG004|Overall Study|Death|0
7329857|NCT00806026|11563244|FG005|Overall Study|Death|0
7329858|NCT00806026|11563239|FG000|Overall Study|Did not meet entrance criteria|4
7457579|NCT01799941|11751181|FG000|Overall Study|Investigator Decision|4
7329859|NCT00806026|11563240|FG001|Overall Study|Did not meet entrance criteria|1
7329860|NCT00806026|11563241|FG002|Overall Study|Did not meet entrance criteria|2
7329861|NCT00806026|11563242|FG003|Overall Study|Did not meet entrance criteria|1
7329862|NCT00806026|11563243|FG004|Overall Study|Did not meet entrance criteria|0
7565997|NCT03332212|11938551|FG001|Overall Study|worsening of disease under study|1
7565998|NCT03332212|11938552|FG002|Overall Study|worsening of disease under study|0
7565999|NCT03332212|11938553|FG003|Overall Study|worsening of disease under study|0
7329863|NCT00806026|11563244|FG005|Overall Study|Did not meet entrance criteria|0
7329864|NCT00806026|11563239|FG000|Overall Study|Lack of Efficacy|5
7329865|NCT00806026|11563240|FG001|Overall Study|Lack of Efficacy|18
7329866|NCT00806026|11563241|FG002|Overall Study|Lack of Efficacy|13
7329867|NCT00806026|11563242|FG003|Overall Study|Lack of Efficacy|4
7329868|NCT00806026|11563243|FG004|Overall Study|Lack of Efficacy|8
7566000|NCT03332628|11938574|FG000|Overall Study|Physician Decision|2
7566001|NCT03332771|11938583|FG000|Overall Study|Adverse Event|6
7566002|NCT03332771|11938584|FG001|Overall Study|Adverse Event|4
7566003|NCT03332771|11938585|FG002|Overall Study|Adverse Event|1
7566004|NCT03332771|11938586|FG003|Overall Study|Adverse Event|3
7566005|NCT03332771|11938583|FG000|Overall Study|Poor Compliance to Protocol|0
7566006|NCT03332771|11938584|FG001|Overall Study|Poor Compliance to Protocol|1
7566007|NCT03332771|11938585|FG002|Overall Study|Poor Compliance to Protocol|0
7566008|NCT03332771|11938586|FG003|Overall Study|Poor Compliance to Protocol|1
7566009|NCT03332771|11938583|FG000|Overall Study|Lost to Follow-up|2
7566010|NCT03332771|11938584|FG001|Overall Study|Lost to Follow-up|2
7566011|NCT03332771|11938585|FG002|Overall Study|Lost to Follow-up|1
7566012|NCT03332771|11938586|FG003|Overall Study|Lost to Follow-up|2
7566013|NCT03332771|11938583|FG000|Overall Study|At the Participant's own request|20
7566014|NCT03332771|11938584|FG001|Overall Study|At the Participant's own request|26
7566015|NCT03332771|11938585|FG002|Overall Study|At the Participant's own request|14
7566016|NCT03332771|11938586|FG003|Overall Study|At the Participant's own request|23
7566017|NCT03332771|11938583|FG000|Overall Study|Reason Not Specified|6
7566018|NCT03332771|11938584|FG001|Overall Study|Reason Not Specified|18
7566019|NCT03332771|11938585|FG002|Overall Study|Reason Not Specified|16
7566020|NCT03332771|11938586|FG003|Overall Study|Reason Not Specified|19
7575080|NCT03712280|11958621|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
7575081|NCT03712280|11958618|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
7575082|NCT03712280|11958619|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
7575083|NCT03712280|11958620|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
7575084|NCT03712280|11958621|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
7575085|NCT03712280|11958618|FG000|Overall Study|Adverse Event|0
7575086|NCT03712280|11958619|FG001|Overall Study|Adverse Event|0
7575087|NCT03712280|11958620|FG002|Overall Study|Adverse Event|1
7575088|NCT03712280|11958621|FG003|Overall Study|Adverse Event|0
7575089|NCT03712449|11958633|FG000|Overall Study|Withdraw Consent|0
7575090|NCT03712449|11958634|FG001|Overall Study|Withdraw Consent|1
7575091|NCT03712917|11958656|FG000|Overall Study|Pregnancy|0
7575092|NCT03712917|11958657|FG001|Overall Study|Pregnancy|0
7575093|NCT03712917|11958658|FG002|Overall Study|Pregnancy|1
7575094|NCT03712917|11958656|FG000|Overall Study|Adverse Event|0
7575095|NCT03712917|11958657|FG001|Overall Study|Adverse Event|4
7575096|NCT03712917|11958658|FG002|Overall Study|Adverse Event|3
7575097|NCT03712917|11958656|FG000|Overall Study|Lost to Follow-up|9
7575098|NCT03712917|11958657|FG001|Overall Study|Lost to Follow-up|4
7575099|NCT03712917|11958658|FG002|Overall Study|Lost to Follow-up|5
7575100|NCT03712930|11958666|FG000|Overall Study|Death|7
7575101|NCT03712930|11958666|FG000|Overall Study|Physician Decision|1
7575102|NCT03712930|11958666|FG000|Overall Study|Study Terminated by Sponsor|3
7575103|NCT03712930|11958666|FG000|Overall Study|Progressive Disease|2
7575104|NCT03714022|11958681|FG000|Overall Study|Adverse Event|1
7575105|NCT03714022|11958682|FG001|Overall Study|Adverse Event|0
7575106|NCT03714022|11958681|FG000|Overall Study|Consent withdrawal|0
7575107|NCT03714022|11958682|FG001|Overall Study|Consent withdrawal|1
7575108|NCT03714022|11958681|FG000|Overall Study|Lost to Follow-up|3
7575109|NCT03714022|11958682|FG001|Overall Study|Lost to Follow-up|2
7575110|NCT03714672|11958705|FG000|Overall Study|Adverse Event|0
7575111|NCT03714672|11958706|FG001|Overall Study|Adverse Event|0
7575112|NCT03714672|11958707|FG002|Overall Study|Adverse Event|3
7575113|NCT03714672|11958708|FG003|Overall Study|Adverse Event|0
7575114|NCT03714672|11958705|FG000|Overall Study|Physician Decision|0
7575115|NCT03714672|11958706|FG001|Overall Study|Physician Decision|1
7575116|NCT03714672|11958707|FG002|Overall Study|Physician Decision|0
7575117|NCT03714672|11958708|FG003|Overall Study|Physician Decision|0
7575118|NCT03714672|11958705|FG000|Overall Study|Other Reason|1
7575119|NCT03714672|11958706|FG001|Overall Study|Other Reason|2
7575120|NCT03714672|11958707|FG002|Overall Study|Other Reason|1
7575121|NCT03714672|11958708|FG003|Overall Study|Other Reason|1
7575122|NCT03714672|11958705|FG000|Overall Study|Lost to Follow-up|1
7575123|NCT03714672|11958706|FG001|Overall Study|Lost to Follow-up|1
7575124|NCT03714672|11958707|FG002|Overall Study|Lost to Follow-up|0
7575125|NCT03714672|11958708|FG003|Overall Study|Lost to Follow-up|0
7575126|NCT03715530|11958739|FG000|Overall Study|Lost to Follow-up|3
7575127|NCT03715530|11958740|FG001|Overall Study|Lost to Follow-up|1
7575128|NCT03715530|11958741|FG002|Overall Study|Lost to Follow-up|2
7575129|NCT03716024|11958760|FG000|Overall Study|Randomized, not Treated|7
7575130|NCT03716024|11958761|FG001|Overall Study|Randomized, not Treated|8
7575131|NCT03716024|11958760|FG000|Overall Study|Adverse Event|1
7575132|NCT03716024|11958761|FG001|Overall Study|Adverse Event|2
7575133|NCT03716024|11958760|FG000|Overall Study|Treatment Failure|1
7575134|NCT03716024|11958761|FG001|Overall Study|Treatment Failure|0
7575135|NCT03716024|11958760|FG000|Overall Study|Lost to Follow-up|2
7575136|NCT03716024|11958761|FG001|Overall Study|Lost to Follow-up|6
7575137|NCT03716024|11958760|FG000|Overall Study|Withdrawal by Subject|0
7575138|NCT03716024|11958761|FG001|Overall Study|Withdrawal by Subject|1
7575139|NCT03716024|11958760|FG000|Overall Study|Missing Reason|0
7575140|NCT03716024|11958761|FG001|Overall Study|Missing Reason|1
7575141|NCT03716050|11958775|FG000|Overall Study|Lost to Follow-up|0
7575142|NCT03716050|11958776|FG001|Overall Study|Lost to Follow-up|0
7575143|NCT03716050|11958777|FG002|Overall Study|Lost to Follow-up|1
7566021|NCT03332784|11938616|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566022|NCT03332784|11938617|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7566023|NCT03332784|11938618|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566024|NCT03332784|11938619|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566025|NCT03332784|11938620|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566026|NCT03332784|11938621|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566027|NCT03332784|11938622|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566028|NCT03332784|11938623|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566029|NCT03332784|11938624|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566030|NCT03332784|11938625|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566031|NCT03332784|11938626|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566032|NCT03332784|11938627|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566033|NCT03332784|11938628|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566034|NCT03332784|11938629|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566035|NCT03332784|11938630|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
7566036|NCT03332784|11938631|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566037|NCT03332784|11938632|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566038|NCT03332784|11938633|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566039|NCT03332784|11938634|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566040|NCT03332784|11938635|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
7566041|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
7566042|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
7566043|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
7566044|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7566045|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
7566046|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
7566047|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
7566048|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
7566049|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
7566050|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
7566051|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
7566052|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
7566053|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
7566054|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
7566055|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
7566056|NCT03333109|11938696|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7566057|NCT03333109|11938697|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
7566058|NCT03333109|11938698|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
7566059|NCT03333109|11938696|FG000|Safety Follow-up Period|Lost to Follow-up|6
7566060|NCT03333109|11938697|FG001|Safety Follow-up Period|Lost to Follow-up|2
7566061|NCT03333109|11938698|FG002|Safety Follow-up Period|Lost to Follow-up|1
7566062|NCT03333109|11938696|FG000|Safety Follow-up Period|Withdrawal by Subject|7
7566063|NCT03333109|11938697|FG001|Safety Follow-up Period|Withdrawal by Subject|2
7566064|NCT03333109|11938698|FG002|Safety Follow-up Period|Withdrawal by Subject|12
7566065|NCT03333876|11938727|FG000|Screening Period|Screen Failure|4
7566066|NCT03333876|11938727|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
7566067|NCT03333876|11938727|FG000|Mandibular Advancement|Adverse Event|2
7566068|NCT03333876|11938727|FG000|Mandibular Advancement|Product Damage|2
7566069|NCT03333941|11938740|FG000|Overall Study|Lost to Follow-up|10
7566070|NCT03333941|11938740|FG000|Overall Study|Death|2
7566071|NCT03333941|11938740|FG000|Overall Study|Adverse Event|1
7566072|NCT03334175|11938746|FG000|Overall Study|Lost to Follow-up|0
7566073|NCT03334175|11938747|FG001|Overall Study|Lost to Follow-up|1
7566074|NCT03334188|11938755|FG000|Overall Study|Withdrawal by Subject|0
7566075|NCT03334188|11938756|FG001|Overall Study|Withdrawal by Subject|1
7566076|NCT03334188|11938755|FG000|Overall Study|Death|1
7566077|NCT03334188|11938756|FG001|Overall Study|Death|0
7566078|NCT03334188|11938755|FG000|Overall Study|Never had qualifying clinic visit|7
7566079|NCT03334188|11938756|FG001|Overall Study|Never had qualifying clinic visit|7
7566080|NCT03334214|11938765|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7566081|NCT03334214|11938766|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7566082|NCT03334214|11938765|FG000|Overall Study|Withdrawal by Subject|0
7566083|NCT03334214|11938766|FG001|Overall Study|Withdrawal by Subject|1
7566084|NCT03334214|11938765|FG000|Overall Study|Other|1
7566085|NCT03334214|11938766|FG001|Overall Study|Other|0
7566086|NCT03334396|11938781|FG000|Overall Study|Adverse Event|1
7566087|NCT03334396|11938782|FG001|Overall Study|Adverse Event|0
7566088|NCT03334396|11938783|FG002|Overall Study|Adverse Event|1
7566089|NCT03334396|11938784|FG003|Overall Study|Adverse Event|0
7566090|NCT03334396|11938785|FG004|Overall Study|Adverse Event|0
7566091|NCT03334396|11938786|FG005|Overall Study|Adverse Event|0
7566092|NCT03334396|11938787|FG006|Overall Study|Adverse Event|0
7566093|NCT03334396|11938788|FG007|Overall Study|Adverse Event|0
7566094|NCT03334396|11938781|FG000|Overall Study|Lack of Efficacy|10
7566095|NCT03334396|11938782|FG001|Overall Study|Lack of Efficacy|4
7566096|NCT03334396|11938783|FG002|Overall Study|Lack of Efficacy|1
7566097|NCT03334396|11938784|FG003|Overall Study|Lack of Efficacy|3
7566098|NCT03334396|11938785|FG004|Overall Study|Lack of Efficacy|1
7566099|NCT03334396|11938786|FG005|Overall Study|Lack of Efficacy|0
7566100|NCT03334396|11938787|FG006|Overall Study|Lack of Efficacy|0
7566101|NCT03334396|11938788|FG007|Overall Study|Lack of Efficacy|1
7566102|NCT03334396|11938781|FG000|Overall Study|Lost to Follow-up|0
7566103|NCT03334396|11938782|FG001|Overall Study|Lost to Follow-up|0
7566104|NCT03334396|11938783|FG002|Overall Study|Lost to Follow-up|1
7566105|NCT03334396|11938784|FG003|Overall Study|Lost to Follow-up|0
7566106|NCT03334396|11938785|FG004|Overall Study|Lost to Follow-up|0
7566107|NCT03334396|11938786|FG005|Overall Study|Lost to Follow-up|0
7566108|NCT03334396|11938787|FG006|Overall Study|Lost to Follow-up|1
7566109|NCT03334396|11938788|FG007|Overall Study|Lost to Follow-up|0
7566110|NCT03334396|11938781|FG000|Overall Study|Physician Decision|1
7566111|NCT03334396|11938782|FG001|Overall Study|Physician Decision|0
7566112|NCT03334396|11938783|FG002|Overall Study|Physician Decision|0
7566113|NCT03334396|11938784|FG003|Overall Study|Physician Decision|0
7566114|NCT03334396|11938785|FG004|Overall Study|Physician Decision|0
7566115|NCT03334396|11938786|FG005|Overall Study|Physician Decision|0
7566116|NCT03334396|11938787|FG006|Overall Study|Physician Decision|0
7566117|NCT03334396|11938788|FG007|Overall Study|Physician Decision|0
7566118|NCT03334396|11938781|FG000|Overall Study|Withdrawal by Subject|10
7566119|NCT03334396|11938782|FG001|Overall Study|Withdrawal by Subject|5
7566120|NCT03334396|11938783|FG002|Overall Study|Withdrawal by Subject|7
7566121|NCT03334396|11938784|FG003|Overall Study|Withdrawal by Subject|2
7329869|NCT00806026|11563244|FG005|Overall Study|Lack of Efficacy|7
7457580|NCT01799941|11751181|FG000|Overall Study|Lack of Efficacy|3
7457581|NCT01799941|11751181|FG000|Overall Study|Lost to Follow-up|17
7457582|NCT01799941|11751181|FG000|Overall Study|Other|15
7457583|NCT01799993|11751193|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
7457584|NCT01799993|11751194|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
7457585|NCT01799993|11751193|FG000|Overall Study|Death|61
7457586|NCT01799993|11751194|FG001|Overall Study|Death|45
7457587|NCT01799993|11751193|FG000|Overall Study|Withdrawal by Subject|23
7457588|NCT01799993|11751194|FG001|Overall Study|Withdrawal by Subject|24
7457589|NCT01799993|11751193|FG000|Overall Study|Lost to Follow-up|5
7457590|NCT01799993|11751194|FG001|Overall Study|Lost to Follow-up|8
7457591|NCT01799993|11751193|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
7566122|NCT03334396|11938785|FG004|Overall Study|Withdrawal by Subject|2
7566123|NCT03334396|11938786|FG005|Overall Study|Withdrawal by Subject|1
7566124|NCT03334396|11938787|FG006|Overall Study|Withdrawal by Subject|2
7566125|NCT03334396|11938788|FG007|Overall Study|Withdrawal by Subject|0
7566126|NCT03334396|11938781|FG000|Overall Study|Pregnancy|0
7566127|NCT03334396|11938782|FG001|Overall Study|Pregnancy|1
7566128|NCT03334396|11938783|FG002|Overall Study|Pregnancy|0
7566129|NCT03334396|11938784|FG003|Overall Study|Pregnancy|0
7566130|NCT03334396|11938785|FG004|Overall Study|Pregnancy|0
7566131|NCT03334396|11938786|FG005|Overall Study|Pregnancy|0
7566132|NCT03334396|11938787|FG006|Overall Study|Pregnancy|0
7566133|NCT03334396|11938788|FG007|Overall Study|Pregnancy|0
7566134|NCT03334396|11938781|FG000|Overall Study|Ineligible|0
7566135|NCT03334396|11938782|FG001|Overall Study|Ineligible|1
7566136|NCT03334396|11938783|FG002|Overall Study|Ineligible|0
7566137|NCT03334396|11938784|FG003|Overall Study|Ineligible|0
7566138|NCT03334396|11938785|FG004|Overall Study|Ineligible|0
7566139|NCT03334396|11938786|FG005|Overall Study|Ineligible|0
7566140|NCT03334396|11938787|FG006|Overall Study|Ineligible|0
7566141|NCT03334396|11938788|FG007|Overall Study|Ineligible|0
7566142|NCT03334396|11938781|FG000|Overall Study|Started New Job|1
7566143|NCT03334396|11938782|FG001|Overall Study|Started New Job|0
7566144|NCT03334396|11938783|FG002|Overall Study|Started New Job|0
7566145|NCT03334396|11938784|FG003|Overall Study|Started New Job|0
7566146|NCT03334396|11938785|FG004|Overall Study|Started New Job|0
7566147|NCT03334396|11938786|FG005|Overall Study|Started New Job|0
7566148|NCT03334396|11938787|FG006|Overall Study|Started New Job|0
7566149|NCT03334396|11938788|FG007|Overall Study|Started New Job|0
7566150|NCT03334422|11938809|FG000|Overall Study|Adverse Event|1
7566151|NCT03334422|11938810|FG001|Overall Study|Adverse Event|3
7566152|NCT03334422|11938811|FG002|Overall Study|Adverse Event|2
7566153|NCT03334422|11938812|FG003|Overall Study|Adverse Event|2
7566154|NCT03334422|11938809|FG000|Overall Study|Lack of Efficacy|10
7566155|NCT03334422|11938810|FG001|Overall Study|Lack of Efficacy|2
7566156|NCT03334422|11938811|FG002|Overall Study|Lack of Efficacy|7
7566157|NCT03334422|11938812|FG003|Overall Study|Lack of Efficacy|3
7566158|NCT03334422|11938809|FG000|Overall Study|Withdrawal by Subject|8
7566159|NCT03334422|11938810|FG001|Overall Study|Withdrawal by Subject|3
7566160|NCT03334422|11938811|FG002|Overall Study|Withdrawal by Subject|1
7566161|NCT03334422|11938812|FG003|Overall Study|Withdrawal by Subject|0
7566162|NCT03334422|11938809|FG000|Overall Study|Lost to Follow-up|0
7566163|NCT03334422|11938810|FG001|Overall Study|Lost to Follow-up|0
7566164|NCT03334422|11938811|FG002|Overall Study|Lost to Follow-up|0
7457592|NCT01799993|11751194|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
7566165|NCT03334422|11938812|FG003|Overall Study|Lost to Follow-up|1
7566166|NCT03334422|11938809|FG000|Overall Study|Inability to obtain laboratory samples|0
7457593|NCT01799993|11751193|FG000|Overall Study|Protocol driven decision point|0
7566167|NCT03334422|11938810|FG001|Overall Study|Inability to obtain laboratory samples|1
7566168|NCT03334422|11938811|FG002|Overall Study|Inability to obtain laboratory samples|0
7566169|NCT03334422|11938812|FG003|Overall Study|Inability to obtain laboratory samples|0
7566170|NCT03334422|11938809|FG000|Overall Study|Pregnancy|0
7566171|NCT03334422|11938810|FG001|Overall Study|Pregnancy|1
7566172|NCT03334422|11938811|FG002|Overall Study|Pregnancy|0
7566173|NCT03334422|11938812|FG003|Overall Study|Pregnancy|0
7566174|NCT03334448|11938827|FG000|Washout|Personal Reason|0
7566175|NCT03334448|11938828|FG001|Washout|Personal Reason|1
7566176|NCT03334448|11938829|FG002|Washout|Personal Reason|0
7566177|NCT03334448|11938830|FG003|Washout|Personal Reason|0
7566178|NCT03334448|11938827|FG000|Washout|Protocol Violation|0
7566179|NCT03334448|11938828|FG001|Washout|Protocol Violation|0
7566180|NCT03334448|11938829|FG002|Washout|Protocol Violation|0
7566181|NCT03334448|11938830|FG003|Washout|Protocol Violation|1
7566182|NCT03334630|11938838|FG000|Overall Study|Withdrawal by Subject|7
7566183|NCT03334630|11938839|FG001|Overall Study|Withdrawal by Subject|7
7566184|NCT03334630|11938838|FG000|Overall Study|Lost to Follow-up|3
7566185|NCT03334630|11938839|FG001|Overall Study|Lost to Follow-up|1
7566186|NCT03334630|11938838|FG000|Overall Study|Adverse Event|0
7566187|NCT03334630|11938839|FG001|Overall Study|Adverse Event|1
7566188|NCT03334630|11938838|FG000|Overall Study|Physician Decision|1
7566189|NCT03334630|11938839|FG001|Overall Study|Physician Decision|1
7566190|NCT03334630|11938838|FG000|Overall Study|Enrollment closed|2
7566191|NCT03334630|11938839|FG001|Overall Study|Enrollment closed|1
7566192|NCT03334630|11938838|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
7566193|NCT03334630|11938839|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
7566194|NCT03334630|11938838|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
7566195|NCT03334630|11938839|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
7566196|NCT03334695|11938847|FG000|Overall Study|Lost to Follow-up|3
7566197|NCT03334695|11938848|FG001|Overall Study|Lost to Follow-up|3
7566198|NCT03334695|11938847|FG000|Overall Study|Physician Decision|1
7566199|NCT03334695|11938848|FG001|Overall Study|Physician Decision|2
7566200|NCT03334695|11938847|FG000|Overall Study|Protocol Violation|0
7566201|NCT03334695|11938848|FG001|Overall Study|Protocol Violation|1
7566202|NCT03334721|11938858|FG000|Overall Study|Withdrawal by Subject|1
7566203|NCT03334721|11938859|FG001|Overall Study|Withdrawal by Subject|0
7566204|NCT03334721|11938858|FG000|Overall Study|No longer met inclusion/exclusion criter|1
7566205|NCT03334721|11938859|FG001|Overall Study|No longer met inclusion/exclusion criter|0
7566206|NCT03334747|11938891|FG000|Treatment Phase|Technical problems|0
7566207|NCT03334747|11938892|FG001|Treatment Phase|Technical problems|0
7566208|NCT03334747|11938893|FG002|Treatment Phase|Technical problems|0
7566209|NCT03334747|11938894|FG003|Treatment Phase|Technical problems|0
7566210|NCT03334747|11938895|FG004|Treatment Phase|Technical problems|1
7566211|NCT03334747|11938896|FG005|Treatment Phase|Technical problems|0
7566212|NCT03334747|11938897|FG006|Treatment Phase|Technical problems|0
7566213|NCT03334747|11938898|FG007|Treatment Phase|Technical problems|0
7566214|NCT03334747|11938899|FG008|Treatment Phase|Technical problems|0
7566215|NCT03334747|11938891|FG000|Treatment Phase|Subject/guardian decision|1
7566216|NCT03334747|11938892|FG001|Treatment Phase|Subject/guardian decision|0
7566217|NCT03334747|11938893|FG002|Treatment Phase|Subject/guardian decision|0
7566218|NCT03334747|11938894|FG003|Treatment Phase|Subject/guardian decision|0
7566219|NCT03334747|11938895|FG004|Treatment Phase|Subject/guardian decision|0
7566220|NCT03334747|11938896|FG005|Treatment Phase|Subject/guardian decision|1
7566221|NCT03334747|11938897|FG006|Treatment Phase|Subject/guardian decision|0
7566222|NCT03334747|11938898|FG007|Treatment Phase|Subject/guardian decision|0
7566223|NCT03334747|11938899|FG008|Treatment Phase|Subject/guardian decision|0
7566224|NCT03334747|11938891|FG000|Follow-Up Phase|Subject/guardian decision|0
7566225|NCT03334747|11938892|FG001|Follow-Up Phase|Subject/guardian decision|0
7566226|NCT03334747|11938893|FG002|Follow-Up Phase|Subject/guardian decision|0
7566227|NCT03334747|11938894|FG003|Follow-Up Phase|Subject/guardian decision|0
7566228|NCT03334747|11938895|FG004|Follow-Up Phase|Subject/guardian decision|0
7566229|NCT03334747|11938896|FG005|Follow-Up Phase|Subject/guardian decision|0
7566230|NCT03334747|11938897|FG006|Follow-Up Phase|Subject/guardian decision|1
7566231|NCT03334747|11938898|FG007|Follow-Up Phase|Subject/guardian decision|0
7566232|NCT03334747|11938899|FG008|Follow-Up Phase|Subject/guardian decision|1
7566233|NCT03334903|11938941|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
7566234|NCT03334903|11938942|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
7566235|NCT03334903|11938941|FG000|Overall Study|Protocol Violation|1
7566236|NCT03334903|11938942|FG001|Overall Study|Protocol Violation|3
7566237|NCT03334903|11938941|FG000|Overall Study|Surgery postponed|1
7566238|NCT03334903|11938942|FG001|Overall Study|Surgery postponed|0
7566239|NCT03334903|11938941|FG000|Overall Study|Adverse Event|1
7566240|NCT03334903|11938942|FG001|Overall Study|Adverse Event|1
7566241|NCT03334903|11938941|FG000|Overall Study|Withdrawal by Subject|0
7566242|NCT03334903|11938942|FG001|Overall Study|Withdrawal by Subject|1
7566243|NCT03335150|11938950|FG000|Overall Study|Withdrawal by Subject|10
7566244|NCT03335150|11938951|FG001|Overall Study|Withdrawal by Subject|4
7566245|NCT03335150|11938950|FG000|Overall Study|Adverse Event|0
7566246|NCT03335150|11938951|FG001|Overall Study|Adverse Event|1
7566247|NCT03335566|11939027|FG000|Overall Study|Adverse Event|0
7566248|NCT03335566|11939028|FG001|Overall Study|Adverse Event|1
7566249|NCT03335566|11939027|FG000|Overall Study|Lost to Follow-up|1
7566250|NCT03335566|11939028|FG001|Overall Study|Lost to Follow-up|0
7566251|NCT03335566|11939027|FG000|Overall Study|Technical Problems|1
7566252|NCT03335566|11939028|FG001|Overall Study|Technical Problems|0
7566253|NCT03335566|11939027|FG000|Overall Study|Protocol Violation|1
7566254|NCT03335566|11939028|FG001|Overall Study|Protocol Violation|0
7566255|NCT03335566|11939027|FG000|Overall Study|Other than specified above|1
7566256|NCT03335566|11939028|FG001|Overall Study|Other than specified above|2
7566257|NCT03336502|11939057|FG000|Overall Study|Physician Decision|0
7566258|NCT03336502|11939058|FG001|Overall Study|Physician Decision|1
7566259|NCT03336502|11939057|FG000|Overall Study|Prohibited Drugs|1
7566260|NCT03336502|11939058|FG001|Overall Study|Prohibited Drugs|1
7566261|NCT03336502|11939057|FG000|Overall Study|Death|1
7566262|NCT03336502|11939058|FG001|Overall Study|Death|2
7566263|NCT03336502|11939057|FG000|Overall Study|Adverse Event|2
7566264|NCT03336502|11939058|FG001|Overall Study|Adverse Event|5
7566265|NCT03337139|11939079|FG000|Phase I|Withdrawal by Subject|10
7566266|NCT03337139|11939080|FG001|Phase I|Withdrawal by Subject|0
7566267|NCT03337152|11939088|FG000|Overall Study|Physician Decision|1
7566268|NCT03337152|11939089|FG001|Overall Study|Physician Decision|0
7566269|NCT03337152|11939088|FG000|Overall Study|Lost to Follow-up|1
7566270|NCT03337152|11939089|FG001|Overall Study|Lost to Follow-up|3
7566271|NCT03337152|11939088|FG000|Overall Study|Adverse Event|3
7566272|NCT03337152|11939089|FG001|Overall Study|Adverse Event|1
7566273|NCT03337152|11939088|FG000|Overall Study|Stopped drug dosing due to study halt|6
7566274|NCT03337152|11939089|FG001|Overall Study|Stopped drug dosing due to study halt|7
7566275|NCT03337308|11939101|FG000|Overall Study|Adverse Event|2
7566276|NCT03337308|11939102|FG001|Overall Study|Adverse Event|3
7566277|NCT03337308|11939103|FG002|Overall Study|Adverse Event|3
7566278|NCT03337308|11939104|FG003|Overall Study|Adverse Event|1
7566279|NCT03337308|11939101|FG000|Overall Study|Lost to Follow-up|1
7566280|NCT03337308|11939102|FG001|Overall Study|Lost to Follow-up|2
7566281|NCT03337308|11939103|FG002|Overall Study|Lost to Follow-up|0
7566282|NCT03337308|11939104|FG003|Overall Study|Lost to Follow-up|0
7566283|NCT03337308|11939101|FG000|Overall Study|Withdrawal by Subject|2
7566284|NCT03337308|11939102|FG001|Overall Study|Withdrawal by Subject|1
7566285|NCT03337308|11939103|FG002|Overall Study|Withdrawal by Subject|2
7566286|NCT03337308|11939104|FG003|Overall Study|Withdrawal by Subject|1
7566287|NCT03337308|11939101|FG000|Overall Study|Protocol Violation|0
7566288|NCT03337308|11939102|FG001|Overall Study|Protocol Violation|1
7566289|NCT03337308|11939103|FG002|Overall Study|Protocol Violation|0
7566290|NCT03337308|11939104|FG003|Overall Study|Protocol Violation|0
7566291|NCT03337477|11939116|FG000|Overall Study|not categorized into the listed ones|11
7566292|NCT03337477|11939117|FG001|Overall Study|not categorized into the listed ones|9
7566293|NCT03337477|11939116|FG000|Overall Study|Withdrawal by Subject|0
7566294|NCT03337477|11939117|FG001|Overall Study|Withdrawal by Subject|1
7566295|NCT03337477|11939116|FG000|Overall Study|Death|0
7566296|NCT03337477|11939117|FG001|Overall Study|Death|1
7566297|NCT03337477|11939116|FG000|Overall Study|Lost to Follow-up|0
7566298|NCT03337477|11939117|FG001|Overall Study|Lost to Follow-up|2
7329870|NCT00806026|11563239|FG000|Overall Study|Lost to Follow-up|8
7329871|NCT00806026|11563240|FG001|Overall Study|Lost to Follow-up|15
7329872|NCT00806026|11563241|FG002|Overall Study|Lost to Follow-up|8
7329873|NCT00806026|11563242|FG003|Overall Study|Lost to Follow-up|2
7329874|NCT00806026|11563243|FG004|Overall Study|Lost to Follow-up|6
7566299|NCT03337490|11939128|FG000|Overall Study|Withdrawal by Subject|1
7566300|NCT03337490|11939129|FG001|Overall Study|Withdrawal by Subject|0
7566301|NCT03337490|11939130|FG002|Overall Study|Withdrawal by Subject|0
7566302|NCT03337490|11939128|FG000|Overall Study|Lack of Efficacy|10
7566303|NCT03337490|11939129|FG001|Overall Study|Lack of Efficacy|12
7566304|NCT03337490|11939130|FG002|Overall Study|Lack of Efficacy|35
7566305|NCT03337490|11939128|FG000|Overall Study|Physician Decision|0
7566306|NCT03337490|11939129|FG001|Overall Study|Physician Decision|1
7566307|NCT03337490|11939130|FG002|Overall Study|Physician Decision|0
7566308|NCT03337490|11939128|FG000|Overall Study|Lost to Follow-up|0
7566309|NCT03337490|11939129|FG001|Overall Study|Lost to Follow-up|1
7566310|NCT03337490|11939130|FG002|Overall Study|Lost to Follow-up|0
7566311|NCT03337542|11939138|FG000|Overall Study|Withdrew Consent|17
7566312|NCT03337542|11939138|FG000|Overall Study|Allergic Adverse Event|1
7566313|NCT03337542|11939138|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
7566314|NCT03337542|11939138|FG000|Overall Study|Lost to Follow-up|1
7566315|NCT03337542|11939138|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
7566316|NCT03338010|11939145|FG000|Overall Study|Withdrawal by Subject|14
7566317|NCT03338010|11939146|FG001|Overall Study|Withdrawal by Subject|8
7566318|NCT03338010|11939145|FG000|Overall Study|Lost to Follow-up|4
7566319|NCT03338010|11939146|FG001|Overall Study|Lost to Follow-up|2
7329875|NCT00806026|11563244|FG005|Overall Study|Lost to Follow-up|6
7566320|NCT03338010|11939145|FG000|Overall Study|Adverse Event|3
7566321|NCT03338010|11939146|FG001|Overall Study|Adverse Event|2
7566322|NCT03338010|11939145|FG000|Overall Study|Physician Decision|2
7566323|NCT03338010|11939146|FG001|Overall Study|Physician Decision|2
7329876|NCT00806026|11563239|FG000|Overall Study|Withdrawal by Subject|14
7566324|NCT03338010|11939145|FG000|Overall Study|Non-Compliance with Study Drug|0
7329877|NCT00806026|11563240|FG001|Overall Study|Withdrawal by Subject|17
7566325|NCT03338010|11939146|FG001|Overall Study|Non-Compliance with Study Drug|3
7566326|NCT03338010|11939145|FG000|Overall Study|Protocol Violation|0
7566327|NCT03338010|11939146|FG001|Overall Study|Protocol Violation|1
7566328|NCT03338023|11939154|FG000|Overall Study|Withdrawal by Subject|3
7566329|NCT03338023|11939155|FG001|Overall Study|Withdrawal by Subject|4
7566330|NCT03338023|11939154|FG000|Overall Study|Protocol Violation|3
7566331|NCT03338023|11939155|FG001|Overall Study|Protocol Violation|3
7566332|NCT03338023|11939154|FG000|Overall Study|Lost to Follow-up|2
7566333|NCT03338023|11939155|FG001|Overall Study|Lost to Follow-up|1
7566334|NCT03338023|11939154|FG000|Overall Study|Physician Decision|1
7566335|NCT03338023|11939155|FG001|Overall Study|Physician Decision|2
7566336|NCT03338062|11939178|FG000|Overall Study|Alternative Therapy|1
7566337|NCT03338062|11939179|FG001|Overall Study|Alternative Therapy|0
7566338|NCT03338296|11939188|FG000|Overall Study|Adverse Event|0
7566339|NCT03338296|11939189|FG001|Overall Study|Adverse Event|1
7566340|NCT03338296|11939188|FG000|Overall Study|Withdrawal by Subject|14
7566341|NCT03338296|11939189|FG001|Overall Study|Withdrawal by Subject|13
7329878|NCT00806026|11563241|FG002|Overall Study|Withdrawal by Subject|9
7457594|NCT01799993|11751194|FG001|Overall Study|Protocol driven decision point|3
7457595|NCT01799993|11751193|FG000|Overall Study|Protocol Violation|1
7457596|NCT01799993|11751194|FG001|Overall Study|Protocol Violation|1
7457597|NCT01799993|11751193|FG000|Overall Study|Deterioration of general conditions|2
7457598|NCT01799993|11751194|FG001|Overall Study|Deterioration of general conditions|0
7457599|NCT01799993|11751193|FG000|Overall Study|Screen failure|0
7457600|NCT01799993|11751194|FG001|Overall Study|Screen failure|1
7457601|NCT01799993|11751193|FG000|Overall Study|Adverse Event|1
7457602|NCT01799993|11751194|FG001|Overall Study|Adverse Event|0
7457603|NCT01799993|11751193|FG000|Overall Study|Lack of Efficacy|1
7457604|NCT01799993|11751194|FG001|Overall Study|Lack of Efficacy|0
7457605|NCT01799993|11751193|FG000|Overall Study|Recovery|0
7457606|NCT01799993|11751194|FG001|Overall Study|Recovery|1
7457607|NCT01799993|11751193|FG000|Overall Study|Logistical difficulties|1
7457608|NCT01799993|11751194|FG001|Overall Study|Logistical difficulties|0
7457609|NCT01799993|11751193|FG000|Overall Study|Protocol deviation|1
7457610|NCT01799993|11751194|FG001|Overall Study|Protocol deviation|0
7457611|NCT01799993|11751193|FG000|Overall Study|Non-compliance with medical device|1
7457612|NCT01799993|11751194|FG001|Overall Study|Non-compliance with medical device|0
7457613|NCT01799993|11751193|FG000|Overall Study|Withdrawal by parent/guardian|0
7457614|NCT01799993|11751194|FG001|Overall Study|Withdrawal by parent/guardian|1
7457615|NCT01799993|11751193|FG000|Overall Study|Other|1
7457616|NCT01799993|11751194|FG001|Overall Study|Other|0
7457617|NCT01799993|11751193|FG000|Overall Study|Subject didn't return for follow-up|0
7457618|NCT01799993|11751194|FG001|Overall Study|Subject didn't return for follow-up|1
7457619|NCT01800058|11751200|FG000|Overall Study|Lost to Follow-up|1
7457620|NCT01800201|11751207|FG000|Overall Study|Withdrawal by Subject|2
7457621|NCT01800201|11751208|FG001|Overall Study|Withdrawal by Subject|0
7457622|NCT01800201|11751207|FG000|Overall Study|patient privacy concerns|1
7457623|NCT01800201|11751208|FG001|Overall Study|patient privacy concerns|1
7457624|NCT01800201|11751207|FG000|Overall Study|did not want to use device|0
7566342|NCT03338296|11939188|FG000|Overall Study|Lost to Follow-up|10
7566343|NCT03338296|11939189|FG001|Overall Study|Lost to Follow-up|10
7566344|NCT03338296|11939188|FG000|Overall Study|Study Terminated by Sponsor|77
7329879|NCT00806026|11563242|FG003|Overall Study|Withdrawal by Subject|2
7329880|NCT00806026|11563243|FG004|Overall Study|Withdrawal by Subject|5
7329881|NCT00806026|11563244|FG005|Overall Study|Withdrawal by Subject|3
7329882|NCT00806026|11563239|FG000|Overall Study|Other|3
7329883|NCT00806026|11563240|FG001|Overall Study|Other|6
7329884|NCT00806026|11563241|FG002|Overall Study|Other|8
7329885|NCT00806026|11563242|FG003|Overall Study|Other|2
7329886|NCT00806026|11563243|FG004|Overall Study|Other|0
7329887|NCT00806026|11563244|FG005|Overall Study|Other|4
7329888|NCT00806026|11563239|FG000|Overall Study|Protocol Violation|6
7329889|NCT00806026|11563240|FG001|Overall Study|Protocol Violation|9
7329890|NCT00806026|11563241|FG002|Overall Study|Protocol Violation|9
7329891|NCT00806026|11563242|FG003|Overall Study|Protocol Violation|0
7329892|NCT00806026|11563243|FG004|Overall Study|Protocol Violation|2
7329893|NCT00806026|11563244|FG005|Overall Study|Protocol Violation|3
7329894|NCT00806026|11563239|FG000|Overall Study|Adverse Event|52
7329895|NCT00806026|11563240|FG001|Overall Study|Adverse Event|35
7329896|NCT00806026|11563241|FG002|Overall Study|Adverse Event|44
7329897|NCT00806026|11563242|FG003|Overall Study|Adverse Event|17
7329898|NCT00806026|11563243|FG004|Overall Study|Adverse Event|9
7329899|NCT00806026|11563244|FG005|Overall Study|Adverse Event|9
7329900|NCT00806156|11563267|FG000|Overall Study|Death|35
7329901|NCT00806156|11563268|FG001|Overall Study|Death|95
7329902|NCT00806156|11563267|FG000|Overall Study|Did not meet eligibility criteria|1
7329903|NCT00806156|11563268|FG001|Overall Study|Did not meet eligibility criteria|0
7329904|NCT00806156|11563267|FG000|Overall Study|Study terminated by Sponsor|2
7457625|NCT01800201|11751208|FG001|Overall Study|did not want to use device|1
7457626|NCT01800201|11751207|FG000|Overall Study|PI withdrawal, cognitive concerns|0
7457627|NCT01800201|11751208|FG001|Overall Study|PI withdrawal, cognitive concerns|1
7457628|NCT01800903|11751283|FG000|Second Test Period|unable to catheterise|1
7457629|NCT01800903|11751284|FG001|Second Test Period|unable to catheterise|0
7329905|NCT00806156|11563268|FG001|Overall Study|Study terminated by Sponsor|40
7457630|NCT01800903|11751285|FG002|Second Test Period|unable to catheterise|0
7457631|NCT01800903|11751286|FG003|Second Test Period|unable to catheterise|0
7457632|NCT01800903|11751287|FG004|Second Test Period|unable to catheterise|0
7329906|NCT00806156|11563267|FG000|Overall Study|Consent withdrawn by subject|1
7566345|NCT03338296|11939189|FG001|Overall Study|Study Terminated by Sponsor|76
7566346|NCT03338296|11939188|FG000|Overall Study|Other|2
7566347|NCT03338296|11939189|FG001|Overall Study|Other|7
7566348|NCT03338296|11939188|FG000|Overall Study|Missing|0
7566349|NCT03338296|11939189|FG001|Overall Study|Missing|1
7566350|NCT03338400|11939197|FG000|Overall Study|Lost to Follow-up|1
7566351|NCT03338400|11939198|FG001|Overall Study|Lost to Follow-up|2
7566352|NCT03338569|11939231|FG000|Overall Study|Physician Decision|8
7566353|NCT03338569|11939232|FG001|Overall Study|Physician Decision|3
7566354|NCT03338569|11939231|FG000|Overall Study|Withdrawal by Subject|0
7566355|NCT03338569|11939232|FG001|Overall Study|Withdrawal by Subject|1
7566356|NCT03338569|11939231|FG000|Overall Study|Lost to Follow-up|0
7566357|NCT03338569|11939232|FG001|Overall Study|Lost to Follow-up|1
7566358|NCT03338673|11939240|FG000|Overall Study|Lost to Follow-up|1
7566359|NCT03338673|11939241|FG001|Overall Study|Lost to Follow-up|1
7566360|NCT03338855|11939265|FG000|Overall Study|Withdrawn as birth control pill stopped|1
7566361|NCT03338855|11939266|FG001|Overall Study|Withdrawn as birth control pill stopped|0
7566379|NCT03339219|11939299|FG000|Overall Study|Death|12
7566380|NCT03339219|11939299|FG000|Overall Study|Site Terminated by Sponsor|22
7566381|NCT03339219|11939299|FG000|Overall Study|Withdrawal by Subject|1
7566382|NCT03339297|11939305|FG000|Overall Study|Relapse of Hematologic Disease|1
7566383|NCT03339297|11939306|FG001|Overall Study|Relapse of Hematologic Disease|0
7566384|NCT03339297|11939305|FG000|Overall Study|Death|10
7566385|NCT03339297|11939306|FG001|Overall Study|Death|7
7566386|NCT03339297|11939305|FG000|Overall Study|Hepatic Candidosis|1
7566387|NCT03339297|11939306|FG001|Overall Study|Hepatic Candidosis|0
7566388|NCT03339297|11939305|FG000|Overall Study|Adverse Event, Serious Fatal|0
7566389|NCT03339297|11939306|FG001|Overall Study|Adverse Event, Serious Fatal|2
7566390|NCT03339297|11939305|FG000|Overall Study|Consent Withdrawn by Participant|3
7566391|NCT03339297|11939306|FG001|Overall Study|Consent Withdrawn by Participant|3
7566392|NCT03339297|11939305|FG000|Overall Study|Disease Relapse|2
7566393|NCT03339297|11939306|FG001|Overall Study|Disease Relapse|0
7566394|NCT03339297|11939305|FG000|Overall Study|Physician Decision|1
7566395|NCT03339297|11939306|FG001|Overall Study|Physician Decision|1
7566396|NCT03339297|11939305|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
7566397|NCT03339297|11939306|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
7566398|NCT03339297|11939305|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
7566399|NCT03339297|11939306|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
7566400|NCT03339297|11939305|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
7566401|NCT03339297|11939306|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
7566402|NCT03339297|11939305|FG000|Overall Study|Adverse Event, Non-fatal|1
7566403|NCT03339297|11939306|FG001|Overall Study|Adverse Event, Non-fatal|0
7566404|NCT03339297|11939305|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
7566405|NCT03339297|11939306|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
7566406|NCT03339297|11939305|FG000|Overall Study|Patient Was Not Eligible|1
7566407|NCT03339297|11939306|FG001|Overall Study|Patient Was Not Eligible|0
7566408|NCT03339453|11939314|FG000|First Visit of Glucagon Treatment|Adverse Event|0
7566409|NCT03339453|11939315|FG001|First Visit of Glucagon Treatment|Adverse Event|1
7566410|NCT03339583|11939336|FG000|First Intervention (14 Days)|Adverse Event|1
7566411|NCT03339583|11939337|FG001|First Intervention (14 Days)|Adverse Event|0
7566412|NCT03339583|11939336|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
7566413|NCT03339583|11939337|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
7566414|NCT03339583|11939336|FG000|Second Intervention (14 Days)|Adverse Event|0
7566415|NCT03339583|11939337|FG001|Second Intervention (14 Days)|Adverse Event|1
7566416|NCT03339583|11939336|FG000|Follow-up (14 Days)|Physician Decision|6
7566417|NCT03339583|11939337|FG001|Follow-up (14 Days)|Physician Decision|3
7566418|NCT03339713|11939347|FG000|Overall Study|Lost to Follow-up|2
7566419|NCT03339713|11939348|FG001|Overall Study|Lost to Follow-up|1
7566420|NCT03339713|11939347|FG000|Overall Study|Protocol Violation|1
7566421|NCT03339713|11939348|FG001|Overall Study|Protocol Violation|0
7566422|NCT03339713|11939347|FG000|Overall Study|Withdrawal by Subject|1
7566423|NCT03339713|11939348|FG001|Overall Study|Withdrawal by Subject|1
7575144|NCT03716050|11958778|FG003|Overall Study|Lost to Follow-up|0
7575145|NCT03716050|11958779|FG004|Overall Study|Lost to Follow-up|0
7575146|NCT03716050|11958780|FG005|Overall Study|Lost to Follow-up|0
7575147|NCT03716050|11958781|FG006|Overall Study|Lost to Follow-up|0
7575148|NCT03716050|11958782|FG007|Overall Study|Lost to Follow-up|0
7575149|NCT03716050|11958775|FG000|Overall Study|Physician Decision|0
7575150|NCT03716050|11958776|FG001|Overall Study|Physician Decision|0
7575151|NCT03716050|11958777|FG002|Overall Study|Physician Decision|0
7575152|NCT03716050|11958778|FG003|Overall Study|Physician Decision|1
7575153|NCT03716050|11958779|FG004|Overall Study|Physician Decision|0
7575154|NCT03716050|11958780|FG005|Overall Study|Physician Decision|0
7575155|NCT03716050|11958781|FG006|Overall Study|Physician Decision|0
7575156|NCT03716050|11958782|FG007|Overall Study|Physician Decision|0
7575157|NCT03716050|11958775|FG000|Overall Study|Protocol Violation|0
7575158|NCT03716050|11958776|FG001|Overall Study|Protocol Violation|0
7575159|NCT03716050|11958777|FG002|Overall Study|Protocol Violation|0
7575160|NCT03716050|11958778|FG003|Overall Study|Protocol Violation|1
7575161|NCT03716050|11958779|FG004|Overall Study|Protocol Violation|0
7575162|NCT03716050|11958780|FG005|Overall Study|Protocol Violation|0
7575163|NCT03716050|11958781|FG006|Overall Study|Protocol Violation|0
7575164|NCT03716050|11958782|FG007|Overall Study|Protocol Violation|2
7575165|NCT03717012|11958810|FG000|Overall Study|Due to trial termination|1
7575166|NCT03717012|11958811|FG001|Overall Study|Due to trial termination|2
7575167|NCT03717012|11958810|FG000|Overall Study|Protocol Violation|0
7575168|NCT03717012|11958811|FG001|Overall Study|Protocol Violation|2
7575169|NCT03717012|11958810|FG000|Overall Study|Adverse Event|0
7575170|NCT03717012|11958811|FG001|Overall Study|Adverse Event|1
7575171|NCT03717012|11958810|FG000|Overall Study|Lung transplant|0
7575172|NCT03717012|11958811|FG001|Overall Study|Lung transplant|1
7575173|NCT03717064|11958826|FG000|Period 2|Adverse Event|1
7575174|NCT03719586|11958870|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
7575175|NCT03719586|11958871|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
7575490|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
7566424|NCT03339726|11939359|FG000|Overall Study|Withdrawal by Subject|1
7566425|NCT03339726|11939360|FG001|Overall Study|Withdrawal by Subject|0
7566426|NCT03339726|11939361|FG002|Overall Study|Withdrawal by Subject|0
7566427|NCT03339726|11939359|FG000|Overall Study|Lost to Follow-up|0
7566428|NCT03339726|11939360|FG001|Overall Study|Lost to Follow-up|1
7566429|NCT03339726|11939361|FG002|Overall Study|Lost to Follow-up|0
7566430|NCT03339999|11939373|FG000|Overall Study|Adverse Event|1
7566431|NCT03339999|11939374|FG001|Overall Study|Adverse Event|2
7566432|NCT03339999|11939375|FG002|Overall Study|Adverse Event|2
7566433|NCT03339999|11939376|FG003|Overall Study|Adverse Event|1
7566434|NCT03339999|11939373|FG000|Overall Study|Lack of Efficacy|0
7566435|NCT03339999|11939374|FG001|Overall Study|Lack of Efficacy|1
7566436|NCT03339999|11939375|FG002|Overall Study|Lack of Efficacy|0
7566437|NCT03339999|11939376|FG003|Overall Study|Lack of Efficacy|0
7566438|NCT03339999|11939373|FG000|Overall Study|Lost to Follow-up|0
7566439|NCT03339999|11939374|FG001|Overall Study|Lost to Follow-up|0
7566440|NCT03339999|11939375|FG002|Overall Study|Lost to Follow-up|0
7566441|NCT03339999|11939376|FG003|Overall Study|Lost to Follow-up|1
7566442|NCT03339999|11939373|FG000|Overall Study|Study Terminated by Sponsor|6
7566443|NCT03339999|11939374|FG001|Overall Study|Study Terminated by Sponsor|3
7566444|NCT03339999|11939375|FG002|Overall Study|Study Terminated by Sponsor|4
7566445|NCT03339999|11939376|FG003|Overall Study|Study Terminated by Sponsor|3
7566446|NCT03340025|11939391|FG000|Overall Study|Lost to Follow-up|2
7566447|NCT03340025|11939392|FG001|Overall Study|Lost to Follow-up|2
7566448|NCT03340961|11939476|FG000|Overall Study|Adverse Event|1
7566449|NCT03340961|11939477|FG001|Overall Study|Adverse Event|3
7566450|NCT03340961|11939478|FG002|Overall Study|Adverse Event|2
7566451|NCT03340961|11939479|FG003|Overall Study|Adverse Event|4
7566452|NCT03340961|11939476|FG000|Overall Study|Lost to Follow-up|0
7566453|NCT03340961|11939477|FG001|Overall Study|Lost to Follow-up|1
7566454|NCT03340961|11939478|FG002|Overall Study|Lost to Follow-up|0
7566455|NCT03340961|11939479|FG003|Overall Study|Lost to Follow-up|1
7566456|NCT03340961|11939476|FG000|Overall Study|Withdrawal by Subject|3
7566457|NCT03340961|11939477|FG001|Overall Study|Withdrawal by Subject|2
7566458|NCT03340961|11939478|FG002|Overall Study|Withdrawal by Subject|4
7566459|NCT03340961|11939479|FG003|Overall Study|Withdrawal by Subject|7
7566460|NCT03340961|11939476|FG000|Overall Study|Use of prohibited treatment|0
7566461|NCT03340961|11939477|FG001|Overall Study|Use of prohibited treatment|3
7566462|NCT03340961|11939478|FG002|Overall Study|Use of prohibited treatment|2
7566463|NCT03340961|11939479|FG003|Overall Study|Use of prohibited treatment|4
7566464|NCT03340961|11939476|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
7566465|NCT03340961|11939477|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
7566466|NCT03340961|11939478|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
7566467|NCT03340961|11939479|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
7566468|NCT03340961|11939476|FG000|Overall Study|Subject developed an exclusion criterion|0
7566469|NCT03340961|11939477|FG001|Overall Study|Subject developed an exclusion criterion|1
7566470|NCT03340961|11939478|FG002|Overall Study|Subject developed an exclusion criterion|0
7566471|NCT03340961|11939479|FG003|Overall Study|Subject developed an exclusion criterion|0
7566472|NCT03340961|11939476|FG000|Overall Study|Protocol Violation|1
7566473|NCT03340961|11939477|FG001|Overall Study|Protocol Violation|0
7566474|NCT03340961|11939478|FG002|Overall Study|Protocol Violation|1
7566475|NCT03340961|11939479|FG003|Overall Study|Protocol Violation|0
7566476|NCT03340961|11939476|FG000|Overall Study|Adverse Event|1
7566477|NCT03340961|11939477|FG001|Overall Study|Adverse Event|1
7566478|NCT03340961|11939478|FG002|Overall Study|Adverse Event|0
7566479|NCT03340961|11939479|FG003|Overall Study|Adverse Event|0
7566480|NCT03340961|11939476|FG000|Overall Study|Lack of Efficacy|0
7566481|NCT03340961|11939477|FG001|Overall Study|Lack of Efficacy|0
7566482|NCT03340961|11939478|FG002|Overall Study|Lack of Efficacy|0
7566483|NCT03340961|11939479|FG003|Overall Study|Lack of Efficacy|1
7566484|NCT03341273|11939491|FG000|Overall Study|Lost to Follow-up|7
7566485|NCT03341273|11939492|FG001|Overall Study|Lost to Follow-up|7
7566486|NCT03341273|11939491|FG000|Overall Study|Withdrawal by Subject|4
7566487|NCT03341273|11939492|FG001|Overall Study|Withdrawal by Subject|2
7566488|NCT03341273|11939491|FG000|Overall Study|Physician Decision|1
7566489|NCT03341273|11939492|FG001|Overall Study|Physician Decision|0
7566490|NCT03341273|11939491|FG000|Overall Study|Protocol Violation|0
7566491|NCT03341273|11939492|FG001|Overall Study|Protocol Violation|1
7566492|NCT03341273|11939491|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7566493|NCT03341273|11939492|FG001|Overall Study|Enrolled but Treatment Not Administered|1
7566494|NCT03341273|11939491|FG000|Overall Study|Became ineligible after enrollment|1
7566495|NCT03341273|11939492|FG001|Overall Study|Became ineligible after enrollment|0
7566496|NCT03341273|11939491|FG000|Overall Study|Not Eligible at Enrollment|0
7566497|NCT03341273|11939492|FG001|Overall Study|Not Eligible at Enrollment|1
7566498|NCT03341273|11939491|FG000|Overall Study|Participant incarcerated|1
7566499|NCT03341273|11939492|FG001|Overall Study|Participant incarcerated|0
7566500|NCT03341299|11939498|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
7566501|NCT03341299|11939499|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
7566502|NCT03341299|11939500|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
7566503|NCT03341299|11939501|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
7566504|NCT03341312|11939513|FG000|Period 1|Withdrawal by Subject|0
7566505|NCT03341312|11939514|FG001|Period 1|Withdrawal by Subject|1
7566506|NCT03341312|11939515|FG002|Period 1|Withdrawal by Subject|0
7566507|NCT03341312|11939516|FG003|Period 1|Withdrawal by Subject|0
7566508|NCT03341507|11939528|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
7566509|NCT03341533|11939534|FG000|Overall Study|Withdrawal by Subject|1
7566510|NCT03341533|11939535|FG001|Overall Study|Withdrawal by Subject|1
7566511|NCT03341533|11939534|FG000|Overall Study|Not eligible after randomization|2
7566512|NCT03341533|11939535|FG001|Overall Study|Not eligible after randomization|1
7566513|NCT03341637|11939547|FG000|Overall Study|Lost to Follow-up|1
7566514|NCT03341637|11939548|FG001|Overall Study|Lost to Follow-up|0
7566515|NCT03341637|11939547|FG000|Overall Study|Withdrawal by Subject|3
7566516|NCT03341637|11939548|FG001|Overall Study|Withdrawal by Subject|3
7566517|NCT03341637|11939547|FG000|Overall Study|Reason not Specified|1
7566518|NCT03341637|11939548|FG001|Overall Study|Reason not Specified|1
7566519|NCT03341923|11939578|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
7566520|NCT03341923|11939579|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
7329907|NCT00806156|11563268|FG001|Overall Study|Consent withdrawn by subject|3
7329908|NCT00806156|11563267|FG000|Overall Study|Lost to Follow-up|0
7329909|NCT00806156|11563268|FG001|Overall Study|Lost to Follow-up|1
7329910|NCT00806195|11563290|FG000|Overall Study|Death|6
7329911|NCT00806195|11563291|FG001|Overall Study|Death|0
7329912|NCT00806195|11563292|FG002|Overall Study|Death|1
7329913|NCT00806195|11563293|FG003|Overall Study|Death|0
7329914|NCT00806195|11563290|FG000|Overall Study|Adverse Event|25
7329915|NCT00806195|11563291|FG001|Overall Study|Adverse Event|5
7329916|NCT00806195|11563292|FG002|Overall Study|Adverse Event|11
7329917|NCT00806195|11563293|FG003|Overall Study|Adverse Event|2
7329918|NCT00806195|11563290|FG000|Overall Study|Withdrawal by Subject|119
7329919|NCT00806195|11563291|FG001|Overall Study|Withdrawal by Subject|31
7329920|NCT00806195|11563292|FG002|Overall Study|Withdrawal by Subject|76
7329921|NCT00806195|11563293|FG003|Overall Study|Withdrawal by Subject|35
7329922|NCT00806195|11563290|FG000|Overall Study|Lost to Follow-up|217
7329923|NCT00806195|11563291|FG001|Overall Study|Lost to Follow-up|66
7329924|NCT00806195|11563292|FG002|Overall Study|Lost to Follow-up|90
7329925|NCT00806195|11563293|FG003|Overall Study|Lost to Follow-up|34
7329926|NCT00806195|11563290|FG000|Overall Study|Inappropriate Enrollment|0
7329927|NCT00806195|11563291|FG001|Overall Study|Inappropriate Enrollment|1
7329928|NCT00806195|11563292|FG002|Overall Study|Inappropriate Enrollment|0
7329929|NCT00806195|11563293|FG003|Overall Study|Inappropriate Enrollment|0
7329930|NCT00806195|11563290|FG000|Overall Study|Administrative Reason|113
7329931|NCT00806195|11563291|FG001|Overall Study|Administrative Reason|35
7329932|NCT00806195|11563292|FG002|Overall Study|Administrative Reason|66
7329933|NCT00806195|11563293|FG003|Overall Study|Administrative Reason|26
7329934|NCT00806195|11563290|FG000|Overall Study|Protocol Violation|34
7329935|NCT00806195|11563291|FG001|Overall Study|Protocol Violation|24
7329936|NCT00806195|11563292|FG002|Overall Study|Protocol Violation|26
7329937|NCT00806195|11563293|FG003|Overall Study|Protocol Violation|9
7329938|NCT00806260|11563328|FG000|Period 1 (1 Day)|Adverse Event|0
7329939|NCT00806260|11563329|FG001|Period 1 (1 Day)|Adverse Event|0
7566531|NCT03342469|11939607|FG000|Overall Study|Withdrawal by Subject|0
7566532|NCT03342469|11939608|FG001|Overall Study|Withdrawal by Subject|1
7566533|NCT03342469|11939609|FG002|Overall Study|Withdrawal by Subject|0
7566534|NCT03342469|11939610|FG003|Overall Study|Withdrawal by Subject|0
7566535|NCT03342560|11939621|FG000|Overall Study|Lost to Follow-up|2
7566536|NCT03342690|11939629|FG000|Overall Study|Missing Information|9
7566537|NCT03342690|11939629|FG000|Overall Study|Protocol Violation|16
7566538|NCT03342898|11939636|FG000|Overall Study|Adverse Event|3
7566539|NCT03342898|11939637|FG001|Overall Study|Adverse Event|1
7566540|NCT03342898|11939638|FG002|Overall Study|Adverse Event|0
7566541|NCT03342898|11939636|FG000|Overall Study|Lost to Follow-up|44
7566542|NCT03342898|11939637|FG001|Overall Study|Lost to Follow-up|40
7566543|NCT03342898|11939638|FG002|Overall Study|Lost to Follow-up|42
7566544|NCT03342898|11939636|FG000|Overall Study|Withdrawal of Consent|5
7329940|NCT00806260|11563330|FG002|Period 1 (1 Day)|Adverse Event|0
7329941|NCT00806260|11563331|FG003|Period 1 (1 Day)|Adverse Event|0
7566545|NCT03342898|11939637|FG001|Overall Study|Withdrawal of Consent|9
7566546|NCT03342898|11939638|FG002|Overall Study|Withdrawal of Consent|11
7566547|NCT03342898|11939636|FG000|Overall Study|Death|0
7566548|NCT03342898|11939637|FG001|Overall Study|Death|1
7329942|NCT00806260|11563332|FG004|Period 1 (1 Day)|Adverse Event|3
7329943|NCT00806260|11563333|FG005|Period 1 (1 Day)|Adverse Event|0
7329944|NCT00806260|11563328|FG000|Period 2|Adverse Event|0
7329945|NCT00806260|11563329|FG001|Period 2|Adverse Event|0
7329946|NCT00806260|11563330|FG002|Period 2|Adverse Event|0
7566549|NCT03342898|11939638|FG002|Overall Study|Death|1
7566550|NCT03342898|11939636|FG000|Overall Study|Reason not Specified|2
7566551|NCT03342898|11939637|FG001|Overall Study|Reason not Specified|2
7566552|NCT03342898|11939638|FG002|Overall Study|Reason not Specified|0
7566553|NCT03342963|11939650|FG000|Overall Study|Adverse Event|1
7566554|NCT03342963|11939651|FG001|Overall Study|Adverse Event|2
7566555|NCT03342963|11939652|FG002|Overall Study|Adverse Event|0
7566556|NCT03342963|11939653|FG003|Overall Study|Adverse Event|0
7566557|NCT03342963|11939650|FG000|Overall Study|Withdrawal by Subject|1
7566558|NCT03342963|11939651|FG001|Overall Study|Withdrawal by Subject|0
7566559|NCT03342963|11939652|FG002|Overall Study|Withdrawal by Subject|0
7566560|NCT03342963|11939653|FG003|Overall Study|Withdrawal by Subject|0
7566561|NCT03343067|11939666|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
7566562|NCT03343067|11939667|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
7566563|NCT03343067|11939668|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
7566564|NCT03343639|11939687|FG000|Overall Study|Withdrawal by Subject|10
7566565|NCT03343639|11939688|FG001|Overall Study|Withdrawal by Subject|6
7566566|NCT03343639|11939687|FG000|Overall Study|Lost to Follow-up|4
7566567|NCT03343639|11939688|FG001|Overall Study|Lost to Follow-up|5
7566568|NCT03343639|11939687|FG000|Overall Study|Protocol Violation|0
7566569|NCT03343639|11939688|FG001|Overall Study|Protocol Violation|1
7566570|NCT03344172|11939696|FG000|Overall Study|Received <1 dose of treatment|1
7566571|NCT03344172|11939697|FG001|Overall Study|Received <1 dose of treatment|0
7566572|NCT03344640|11939713|FG000|Overall Study|Adverse Event|1
7566573|NCT03344640|11939714|FG001|Overall Study|Adverse Event|0
7566574|NCT03344640|11939713|FG000|Overall Study|Physician Decision|1
7566575|NCT03344640|11939714|FG001|Overall Study|Physician Decision|1
7566576|NCT03344640|11939713|FG000|Overall Study|Withdrawal by Subject|1
7566577|NCT03344640|11939714|FG001|Overall Study|Withdrawal by Subject|2
7566578|NCT03344640|11939713|FG000|Follow-up Epoch|Withdrawal by Subject|0
7566579|NCT03344640|11939714|FG001|Follow-up Epoch|Withdrawal by Subject|2
7566580|NCT03345407|11939757|FG000|Overall Study|Withdrawal by Subject|11
7566581|NCT03345407|11939758|FG001|Overall Study|Withdrawal by Subject|1
7566582|NCT03345407|11939759|FG002|Overall Study|Withdrawal by Subject|5
7566583|NCT03345407|11939760|FG003|Overall Study|Withdrawal by Subject|6
7566584|NCT03345407|11939761|FG004|Overall Study|Withdrawal by Subject|3
7566585|NCT03345407|11939762|FG005|Overall Study|Withdrawal by Subject|6
7566586|NCT03345407|11939763|FG006|Overall Study|Withdrawal by Subject|16
7566587|NCT03345407|11939757|FG000|Overall Study|Physician Decision|3
7566588|NCT03345407|11939758|FG001|Overall Study|Physician Decision|1
7566589|NCT03345407|11939759|FG002|Overall Study|Physician Decision|0
7566590|NCT03345407|11939760|FG003|Overall Study|Physician Decision|0
7566591|NCT03345407|11939761|FG004|Overall Study|Physician Decision|1
7566592|NCT03345407|11939762|FG005|Overall Study|Physician Decision|2
7566593|NCT03345407|11939763|FG006|Overall Study|Physician Decision|3
7566594|NCT03345407|11939757|FG000|Overall Study|Lost to Follow-up|2
7566595|NCT03345407|11939758|FG001|Overall Study|Lost to Follow-up|0
7566596|NCT03345407|11939759|FG002|Overall Study|Lost to Follow-up|1
7566597|NCT03345407|11939760|FG003|Overall Study|Lost to Follow-up|0
7566598|NCT03345407|11939761|FG004|Overall Study|Lost to Follow-up|1
7566599|NCT03345407|11939762|FG005|Overall Study|Lost to Follow-up|2
7566600|NCT03345407|11939763|FG006|Overall Study|Lost to Follow-up|3
7566601|NCT03345407|11939757|FG000|Overall Study|Protocol-defined stopping criteria|9
7566602|NCT03345407|11939758|FG001|Overall Study|Protocol-defined stopping criteria|0
7566603|NCT03345407|11939759|FG002|Overall Study|Protocol-defined stopping criteria|0
7566604|NCT03345407|11939760|FG003|Overall Study|Protocol-defined stopping criteria|0
7566605|NCT03345407|11939761|FG004|Overall Study|Protocol-defined stopping criteria|2
7566606|NCT03345407|11939762|FG005|Overall Study|Protocol-defined stopping criteria|1
7566607|NCT03345407|11939763|FG006|Overall Study|Protocol-defined stopping criteria|1
7566608|NCT03345407|11939757|FG000|Overall Study|Protocol Violation|2
7566609|NCT03345407|11939758|FG001|Overall Study|Protocol Violation|0
7566610|NCT03345407|11939759|FG002|Overall Study|Protocol Violation|0
7566611|NCT03345407|11939760|FG003|Overall Study|Protocol Violation|0
7566612|NCT03345407|11939761|FG004|Overall Study|Protocol Violation|1
7566613|NCT03345407|11939762|FG005|Overall Study|Protocol Violation|0
7566614|NCT03345407|11939763|FG006|Overall Study|Protocol Violation|3
7566615|NCT03345407|11939757|FG000|Overall Study|Lack of Efficacy|1
7566616|NCT03345407|11939758|FG001|Overall Study|Lack of Efficacy|1
7566617|NCT03345407|11939759|FG002|Overall Study|Lack of Efficacy|1
7566618|NCT03345407|11939760|FG003|Overall Study|Lack of Efficacy|1
7566619|NCT03345407|11939761|FG004|Overall Study|Lack of Efficacy|1
7566620|NCT03345407|11939762|FG005|Overall Study|Lack of Efficacy|0
7566621|NCT03345407|11939763|FG006|Overall Study|Lack of Efficacy|3
7566622|NCT03345407|11939757|FG000|Overall Study|Adverse Event|4
7566623|NCT03345407|11939758|FG001|Overall Study|Adverse Event|0
7566624|NCT03345407|11939759|FG002|Overall Study|Adverse Event|5
7566625|NCT03345407|11939760|FG003|Overall Study|Adverse Event|4
7566626|NCT03345407|11939761|FG004|Overall Study|Adverse Event|6
7566627|NCT03345407|11939762|FG005|Overall Study|Adverse Event|5
7566628|NCT03345407|11939763|FG006|Overall Study|Adverse Event|16
7566629|NCT03345472|11939785|FG000|Implant to 3 Months|Withdrawal by Subject|2
7566630|NCT03345472|11939785|FG000|Implant to 3 Months|Physician Decision|1
7566631|NCT03345472|11939785|FG000|Implant to 3 Months|Adverse Event|1
7566632|NCT03345472|11939785|FG000|3 Months to 12 Months|Physician Decision|3
7566633|NCT03345472|11939785|FG000|3 Months to 12 Months|Lost to Follow-up|2
7566634|NCT03345472|11939785|FG000|3 Months to 12 Months|Withdrawal by Subject|1
7566635|NCT03345472|11939785|FG000|3 Months to 12 Months|Adverse Event|1
7566636|NCT03345472|11939785|FG000|3 Months to 12 Months|Death|1
7457633|NCT01800903|11751288|FG005|Second Test Period|unable to catheterise|0
7566637|NCT03345914|11939792|FG000|Overall Study|Transition to another study at week 16|80
7566638|NCT03345914|11939793|FG001|Overall Study|Transition to another study at week 16|86
7566639|NCT03345914|11939794|FG002|Overall Study|Transition to another study at week 16|78
7566640|NCT03345914|11939792|FG000|Overall Study|Transition to OLE during follow-up|37
7566641|NCT03345914|11939793|FG001|Overall Study|Transition to OLE during follow-up|33
7566642|NCT03345914|11939794|FG002|Overall Study|Transition to OLE during follow-up|39
7566643|NCT03345914|11939792|FG000|Overall Study|Physician Decision|0
7566644|NCT03345914|11939793|FG001|Overall Study|Physician Decision|1
7566645|NCT03345914|11939794|FG002|Overall Study|Physician Decision|1
7566646|NCT03345914|11939792|FG000|Overall Study|Withdrawal by Subject|5
7566647|NCT03345914|11939793|FG001|Overall Study|Withdrawal by Subject|1
7566648|NCT03345914|11939794|FG002|Overall Study|Withdrawal by Subject|2
7566649|NCT03345914|11939792|FG000|Overall Study|Other|1
7566650|NCT03345914|11939793|FG001|Overall Study|Other|1
7566651|NCT03345914|11939794|FG002|Overall Study|Other|1
7566652|NCT03345914|11939792|FG000|Overall Study|Ongoing|0
7566653|NCT03345914|11939793|FG001|Overall Study|Ongoing|0
7566654|NCT03345914|11939794|FG002|Overall Study|Ongoing|1
7566655|NCT03345979|11939804|FG000|Overall Study|Withdrawal by Subject|20
7566656|NCT03345979|11939805|FG001|Overall Study|Withdrawal by Subject|31
7566657|NCT03345979|11939804|FG000|Overall Study|Adverse Event|10
7566658|NCT03345979|11939805|FG001|Overall Study|Adverse Event|11
7566659|NCT03345979|11939804|FG000|Overall Study|Lost to Follow-up|8
7566660|NCT03345979|11939805|FG001|Overall Study|Lost to Follow-up|9
7566661|NCT03345979|11939804|FG000|Overall Study|Lack of Efficacy|4
7566662|NCT03345979|11939805|FG001|Overall Study|Lack of Efficacy|2
7566663|NCT03345979|11939804|FG000|Overall Study|Protocol Violation|1
7566664|NCT03345979|11939805|FG001|Overall Study|Protocol Violation|3
7566665|NCT03345979|11939804|FG000|Overall Study|Physician Decision|0
7566666|NCT03345979|11939805|FG001|Overall Study|Physician Decision|2
7566667|NCT03346057|11939815|FG000|Overall Study|Death|1
7566668|NCT03346057|11939816|FG001|Overall Study|Death|2
7566669|NCT03346057|11939817|FG002|Overall Study|Death|0
7566670|NCT03346057|11939818|FG003|Overall Study|Death|0
7566671|NCT03346057|11939815|FG000|Overall Study|Lost to Follow-up|0
7566672|NCT03346057|11939816|FG001|Overall Study|Lost to Follow-up|2
7566673|NCT03346057|11939817|FG002|Overall Study|Lost to Follow-up|1
7566674|NCT03346057|11939818|FG003|Overall Study|Lost to Follow-up|0
7566675|NCT03346057|11939815|FG000|Overall Study|Ineligible For Study - Not Treated|0
7566676|NCT03346057|11939816|FG001|Overall Study|Ineligible For Study - Not Treated|1
7566677|NCT03346057|11939817|FG002|Overall Study|Ineligible For Study - Not Treated|0
7566678|NCT03346057|11939818|FG003|Overall Study|Ineligible For Study - Not Treated|0
7566679|NCT03346057|11939815|FG000|Overall Study|Renal Insufficiency - Not Treated|1
7566680|NCT03346057|11939816|FG001|Overall Study|Renal Insufficiency - Not Treated|0
7566681|NCT03346057|11939817|FG002|Overall Study|Renal Insufficiency - Not Treated|0
7566682|NCT03346057|11939818|FG003|Overall Study|Renal Insufficiency - Not Treated|0
7566683|NCT03346057|11939815|FG000|Overall Study|Physician Decision|3
7566684|NCT03346057|11939816|FG001|Overall Study|Physician Decision|2
7566685|NCT03346057|11939817|FG002|Overall Study|Physician Decision|0
7566686|NCT03346057|11939818|FG003|Overall Study|Physician Decision|2
7566687|NCT03346057|11939815|FG000|Overall Study|Randomization Mistake - Not Treated|1
7566688|NCT03346057|11939816|FG001|Overall Study|Randomization Mistake - Not Treated|1
7566689|NCT03346057|11939817|FG002|Overall Study|Randomization Mistake - Not Treated|0
7566690|NCT03346057|11939818|FG003|Overall Study|Randomization Mistake - Not Treated|0
7566691|NCT03346057|11939815|FG000|Overall Study|Withdrawal by Subject|1
7566692|NCT03346057|11939816|FG001|Overall Study|Withdrawal by Subject|0
7566693|NCT03346057|11939817|FG002|Overall Study|Withdrawal by Subject|0
7566694|NCT03346057|11939818|FG003|Overall Study|Withdrawal by Subject|0
7575176|NCT03719586|11958872|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
7575177|NCT03719586|11958873|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
7575178|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
7575179|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
7575180|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
7575181|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
7575182|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
7575183|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
7575184|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7575185|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7575186|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7575187|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7575188|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
7575189|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
7575190|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7575191|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7575192|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
7566695|NCT03346070|11939833|FG000|Overall Study|Death|0
7566696|NCT03346070|11939834|FG001|Overall Study|Death|0
7566697|NCT03346070|11939835|FG002|Overall Study|Death|0
7566698|NCT03346070|11939836|FG003|Overall Study|Death|0
7566699|NCT03346070|11939837|FG004|Overall Study|Death|1
7566700|NCT03346070|11939833|FG000|Overall Study|Lost to Follow-up|0
7566701|NCT03346070|11939834|FG001|Overall Study|Lost to Follow-up|1
7566702|NCT03346070|11939835|FG002|Overall Study|Lost to Follow-up|2
7566703|NCT03346070|11939836|FG003|Overall Study|Lost to Follow-up|0
7566704|NCT03346070|11939837|FG004|Overall Study|Lost to Follow-up|0
7566705|NCT03346070|11939833|FG000|Overall Study|Physician Decision|0
7566706|NCT03346070|11939834|FG001|Overall Study|Physician Decision|0
7566707|NCT03346070|11939835|FG002|Overall Study|Physician Decision|0
7566708|NCT03346070|11939836|FG003|Overall Study|Physician Decision|1
7566709|NCT03346070|11939837|FG004|Overall Study|Physician Decision|1
7566710|NCT03346070|11939833|FG000|Overall Study|Withdrawal by Subject|1
7566711|NCT03346070|11939834|FG001|Overall Study|Withdrawal by Subject|0
7566712|NCT03346070|11939835|FG002|Overall Study|Withdrawal by Subject|0
7566713|NCT03346070|11939836|FG003|Overall Study|Withdrawal by Subject|1
7566714|NCT03346070|11939837|FG004|Overall Study|Withdrawal by Subject|0
7566715|NCT03346070|11939833|FG000|Overall Study|Study medication not received as planned|2
7566716|NCT03346070|11939834|FG001|Overall Study|Study medication not received as planned|3
7566717|NCT03346070|11939835|FG002|Overall Study|Study medication not received as planned|2
7566718|NCT03346070|11939836|FG003|Overall Study|Study medication not received as planned|3
7566719|NCT03346070|11939837|FG004|Overall Study|Study medication not received as planned|2
7566720|NCT03346070|11939833|FG000|Overall Study|Screen Failure|0
7566721|NCT03346070|11939834|FG001|Overall Study|Screen Failure|0
7566722|NCT03346070|11939835|FG002|Overall Study|Screen Failure|0
7566723|NCT03346070|11939836|FG003|Overall Study|Screen Failure|1
7566724|NCT03346070|11939837|FG004|Overall Study|Screen Failure|1
7566725|NCT03346759|11939862|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
7566726|NCT03346759|11939863|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
7566727|NCT03346759|11939862|FG000|First Menstrual Cycle|Withdrawal by Subject|1
7566728|NCT03346759|11939863|FG001|First Menstrual Cycle|Withdrawal by Subject|0
7566729|NCT03346759|11939862|FG000|Second Menstrual Cycle|Lost to Follow-up|1
7566730|NCT03346759|11939863|FG001|Second Menstrual Cycle|Lost to Follow-up|0
7566731|NCT03347188|11939890|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7566732|NCT03347188|11939891|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
7566733|NCT03347188|11939890|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7566734|NCT03347188|11939891|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
7566735|NCT03347188|11939890|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
7566736|NCT03347188|11939891|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7566737|NCT03347188|11939890|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7566738|NCT03347188|11939891|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
7566739|NCT03347188|11939890|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
7566740|NCT03347188|11939891|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
7566741|NCT03347188|11939890|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
7566742|NCT03347188|11939891|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
7566743|NCT03347188|11939890|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
7566744|NCT03347188|11939891|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
7566745|NCT03347188|11939890|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
7566746|NCT03347188|11939891|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
7566747|NCT03347279|11939899|FG000|Overall Study|Withdrawal by Subject|8
7566748|NCT03347279|11939900|FG001|Overall Study|Withdrawal by Subject|15
7566749|NCT03347279|11939899|FG000|Overall Study|Death|0
7566750|NCT03347279|11939900|FG001|Overall Study|Death|2
7566751|NCT03347279|11939899|FG000|Overall Study|Lost to Follow-up|5
7566752|NCT03347279|11939900|FG001|Overall Study|Lost to Follow-up|2
7566753|NCT03347279|11939899|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
7566754|NCT03347279|11939900|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
7566755|NCT03347695|11939908|FG000|Overall Study|Death|0
7566756|NCT03347695|11939909|FG001|Overall Study|Death|4
7566757|NCT03347695|11939908|FG000|Overall Study|Lost to Follow-up|0
7566758|NCT03347695|11939909|FG001|Overall Study|Lost to Follow-up|1
7566759|NCT03349034|11939928|FG000|Overall Study|catheters dislodged during transport|2
7566760|NCT03349034|11939929|FG001|Overall Study|catheters dislodged during transport|0
7566761|NCT03349034|11939928|FG000|Overall Study|intubated for >48 hrs following surgery|1
7566762|NCT03349034|11939929|FG001|Overall Study|intubated for >48 hrs following surgery|1
7566763|NCT03349034|11939928|FG000|Overall Study|soft tissue flap used|1
7566764|NCT03349034|11939929|FG001|Overall Study|soft tissue flap used|0
7566765|NCT03349034|11939928|FG000|Overall Study|Other|0
7566766|NCT03349034|11939929|FG001|Overall Study|Other|1
7566767|NCT03349060|11939940|FG000|Overall Study|Adverse Event|9
7566768|NCT03349060|11939941|FG001|Overall Study|Adverse Event|9
7566769|NCT03349060|11939942|FG002|Overall Study|Adverse Event|7
7566770|NCT03349060|11939940|FG000|Overall Study|Lack of Efficacy|1
7566771|NCT03349060|11939941|FG001|Overall Study|Lack of Efficacy|0
7566772|NCT03349060|11939942|FG002|Overall Study|Lack of Efficacy|2
7566773|NCT03349060|11939940|FG000|Overall Study|Lost to Follow-up|2
7566774|NCT03349060|11939941|FG001|Overall Study|Lost to Follow-up|1
7566775|NCT03349060|11939942|FG002|Overall Study|Lost to Follow-up|1
7566776|NCT03349060|11939940|FG000|Overall Study|Protocol Violation|2
7566777|NCT03349060|11939941|FG001|Overall Study|Protocol Violation|2
7566778|NCT03349060|11939942|FG002|Overall Study|Protocol Violation|1
7566779|NCT03349060|11939940|FG000|Overall Study|Withdrawal by Subject|5
7566780|NCT03349060|11939941|FG001|Overall Study|Withdrawal by Subject|3
7566781|NCT03349060|11939942|FG002|Overall Study|Withdrawal by Subject|4
7566782|NCT03349060|11939940|FG000|Overall Study|Medication error,no linked adverse event|0
7566783|NCT03349060|11939941|FG001|Overall Study|Medication error,no linked adverse event|0
7566784|NCT03349060|11939942|FG002|Overall Study|Medication error,no linked adverse event|1
7566785|NCT03349060|11939940|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7566786|NCT03349060|11939941|FG001|Overall Study|Withdrawal By Parent/Guardian|1
7566787|NCT03349060|11939942|FG002|Overall Study|Withdrawal By Parent/Guardian|0
7566788|NCT03349060|11939940|FG000|Overall Study|Other|2
7566789|NCT03349060|11939941|FG001|Overall Study|Other|1
7566790|NCT03349060|11939942|FG002|Overall Study|Other|0
7566791|NCT03349099|11939952|FG000|Overall Study|Physician Decision|3
7566792|NCT03349099|11939953|FG001|Overall Study|Physician Decision|4
7566793|NCT03349099|11939952|FG000|Overall Study|Stone migrated from the kidney|1
7566794|NCT03349099|11939953|FG001|Overall Study|Stone migrated from the kidney|0
7566795|NCT03349333|11939959|FG000|Overall Study|Progression of Disease|36
7566796|NCT03349333|11939959|FG000|Overall Study|Adverse Event|11
7566797|NCT03349333|11939959|FG000|Overall Study|Other|6
7566798|NCT03349333|11939959|FG000|Overall Study|Withdrawal by Subject|5
7566799|NCT03349333|11939959|FG000|Overall Study|Conditions interfere with participation|2
7566800|NCT03349333|11939959|FG000|Overall Study|Physician Decision|2
7566801|NCT03349333|11939959|FG000|Overall Study|3-week lapse between pralatrexate doses|1
7566802|NCT03349333|11939959|FG000|Overall Study|Patients in treatment less than 24 month|8
7566803|NCT03349437|11939963|FG000|Screening|Screen Fail|4
7566804|NCT03349437|11939964|FG001|Screening|Screen Fail|0
7566805|NCT03349437|11939965|FG002|Screening|Screen Fail|0
7566806|NCT03349437|11939963|FG000|Screening|Withdrawn|1
7566807|NCT03349437|11939964|FG001|Screening|Withdrawn|0
7566808|NCT03349437|11939965|FG002|Screening|Withdrawn|0
7566809|NCT03349515|11939974|FG000|Overall Study|Lack of Efficacy|2
7566810|NCT03349515|11939975|FG001|Overall Study|Lack of Efficacy|0
7566811|NCT03349515|11939974|FG000|Overall Study|Physician Decision|3
7566812|NCT03349515|11939975|FG001|Overall Study|Physician Decision|1
7566813|NCT03349710|11940017|FG000|Treatment Period|Death|0
7566814|NCT03349710|11940018|FG001|Treatment Period|Death|0
7566815|NCT03349710|11940019|FG002|Treatment Period|Death|1
7566816|NCT03349710|11940020|FG003|Treatment Period|Death|0
7566817|NCT03349710|11940017|FG000|Treatment Period|Disease Progression|0
7566818|NCT03349710|11940018|FG001|Treatment Period|Disease Progression|2
7566819|NCT03349710|11940019|FG002|Treatment Period|Disease Progression|0
7566820|NCT03349710|11940020|FG003|Treatment Period|Disease Progression|1
7566821|NCT03349710|11940017|FG000|Treatment Period|Study Drug Toxicity|1
7566822|NCT03349710|11940018|FG001|Treatment Period|Study Drug Toxicity|0
7566823|NCT03349710|11940019|FG002|Treatment Period|Study Drug Toxicity|1
7566824|NCT03349710|11940020|FG003|Treatment Period|Study Drug Toxicity|1
7566825|NCT03349710|11940017|FG000|Treatment Period|Adverse event unrelated to Study Drug|2
7566826|NCT03349710|11940018|FG001|Treatment Period|Adverse event unrelated to Study Drug|1
7566827|NCT03349710|11940019|FG002|Treatment Period|Adverse event unrelated to Study Drug|1
7566828|NCT03349710|11940020|FG003|Treatment Period|Adverse event unrelated to Study Drug|1
7566829|NCT03349710|11940017|FG000|Treatment Period|admin reason by sponsor|0
7566830|NCT03349710|11940018|FG001|Treatment Period|admin reason by sponsor|7
7566831|NCT03349710|11940019|FG002|Treatment Period|admin reason by sponsor|0
7566832|NCT03349710|11940020|FG003|Treatment Period|admin reason by sponsor|19
7566833|NCT03349710|11940017|FG000|Treatment Period|Other Reason|2
7566834|NCT03349710|11940018|FG001|Treatment Period|Other Reason|0
7566835|NCT03349710|11940019|FG002|Treatment Period|Other Reason|2
7566836|NCT03349710|11940020|FG003|Treatment Period|Other Reason|1
7566837|NCT03349710|11940017|FG000|Treatment Period|completed|6
7566838|NCT03349710|11940018|FG001|Treatment Period|completed|0
7566839|NCT03349710|11940019|FG002|Treatment Period|completed|18
7566840|NCT03349710|11940020|FG003|Treatment Period|completed|1
7566841|NCT03349710|11940017|FG000|Treatment Period|participant request to discontinue|0
7566842|NCT03349710|11940018|FG001|Treatment Period|participant request to discontinue|0
7566843|NCT03349710|11940019|FG002|Treatment Period|participant request to discontinue|4
7566844|NCT03349710|11940020|FG003|Treatment Period|participant request to discontinue|0
7566845|NCT03349710|11940017|FG000|Treatment Period|participant withdrew consent|1
7566846|NCT03349710|11940018|FG001|Treatment Period|participant withdrew consent|0
7566847|NCT03349710|11940019|FG002|Treatment Period|participant withdrew consent|0
7566848|NCT03349710|11940020|FG003|Treatment Period|participant withdrew consent|0
7566849|NCT03350256|11940043|FG000|Overall Study|Inclusion/exclusion violation|4
7566850|NCT03350256|11940043|FG000|Overall Study|Recommended for other therapies|2
7566851|NCT03350256|11940043|FG000|Overall Study|Protocol Violation|3
7566852|NCT03350256|11940043|FG000|Overall Study|Non compliance|2
7566853|NCT03350256|11940043|FG000|Overall Study|Denial by insurance|1
7566854|NCT03350256|11940043|FG000|Overall Study|Adverse Event|2
7566855|NCT03350256|11940043|FG000|Overall Study|Trial failure|12
7566856|NCT03350256|11940043|FG000|Overall Study|Did not proceed to permanent implant|3
7566857|NCT03350256|11940043|FG000|Overall Study|Withdrawal by Subject|3
7566858|NCT03350256|11940043|FG000|Overall Study|Subject moving out of state|1
7566859|NCT03350256|11940043|FG000|Overall Study|Lost to Follow-up|1
7566860|NCT03350256|11940043|FG000|Overall Study|Lack of Efficacy|2
7566861|NCT03350672|11940054|FG000|Overall Study|Withdrawal by Subject|7
7566862|NCT03350672|11940055|FG001|Overall Study|Withdrawal by Subject|0
7566863|NCT03350672|11940056|FG002|Overall Study|Withdrawal by Subject|0
7566864|NCT03351114|11940093|FG000|Overall Study|Withdrawal by Subject|1
7566865|NCT03351231|11940097|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
7566866|NCT03351231|11940097|FG000|Combination Therapy Period|Disease progression|2
7566867|NCT03351231|11940097|FG000|Combination Therapy Period|Study drug toxicity|1
7566868|NCT03351231|11940097|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
7566869|NCT03351231|11940097|FG000|Safety Follow-Up Period|Participant withdrew consent|1
7566870|NCT03351231|11940097|FG000|Safety Follow-Up Period|Other reason|2
7566871|NCT03351335|11940104|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
7566872|NCT03351335|11940105|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
7566873|NCT03351335|11940106|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
7566874|NCT03351478|11940117|FG000|Overall Study|At the subject's own request|11
7566875|NCT03351478|11940118|FG001|Overall Study|At the subject's own request|12
7566876|NCT03351478|11940119|FG002|Overall Study|At the subject's own request|5
7566877|NCT03351478|11940117|FG000|Overall Study|Adverse Event|1
7566878|NCT03351478|11940118|FG001|Overall Study|Adverse Event|2
7566879|NCT03351478|11940119|FG002|Overall Study|Adverse Event|1
7566880|NCT03351478|11940117|FG000|Overall Study|Poor compliance to protocol|1
7566881|NCT03351478|11940118|FG001|Overall Study|Poor compliance to protocol|0
7566882|NCT03351478|11940119|FG002|Overall Study|Poor compliance to protocol|0
7566883|NCT03351478|11940117|FG000|Overall Study|Reason not Specified|1
7566884|NCT03351478|11940118|FG001|Overall Study|Reason not Specified|3
7566885|NCT03351478|11940119|FG002|Overall Study|Reason not Specified|0
7566886|NCT03351478|11940117|FG000|Overall Study|Lost to Follow-up|0
7566887|NCT03351478|11940118|FG001|Overall Study|Lost to Follow-up|0
7566888|NCT03351478|11940119|FG002|Overall Study|Lost to Follow-up|1
7566889|NCT03351608|11940132|FG000|Overall Study|Lost to Follow-up|0
7566890|NCT03351608|11940133|FG001|Overall Study|Lost to Follow-up|1
7566891|NCT03351608|11940134|FG002|Overall Study|Lost to Follow-up|1
7566892|NCT03351608|11940135|FG003|Overall Study|Lost to Follow-up|1
7566893|NCT03351608|11940136|FG004|Overall Study|Lost to Follow-up|1
7566894|NCT03351608|11940132|FG000|Overall Study|Physician Decision|1
7566895|NCT03351608|11940133|FG001|Overall Study|Physician Decision|0
7566896|NCT03351608|11940134|FG002|Overall Study|Physician Decision|0
7566897|NCT03351608|11940135|FG003|Overall Study|Physician Decision|2
7566898|NCT03351608|11940136|FG004|Overall Study|Physician Decision|1
7566899|NCT03351608|11940132|FG000|Overall Study|Randomized by mistake, no treatment given|0
7566900|NCT03351608|11940133|FG001|Overall Study|Randomized by mistake, no treatment given|0
7566901|NCT03351608|11940134|FG002|Overall Study|Randomized by mistake, no treatment given|0
7566902|NCT03351608|11940135|FG003|Overall Study|Randomized by mistake, no treatment given|1
7566903|NCT03351608|11940136|FG004|Overall Study|Randomized by mistake, no treatment given|0
7566904|NCT03351608|11940132|FG000|Overall Study|Withdrawal by parent/guardian|0
7566905|NCT03351608|11940133|FG001|Overall Study|Withdrawal by parent/guardian|0
7566906|NCT03351608|11940134|FG002|Overall Study|Withdrawal by parent/guardian|1
7566907|NCT03351608|11940135|FG003|Overall Study|Withdrawal by parent/guardian|1
7566908|NCT03351608|11940136|FG004|Overall Study|Withdrawal by parent/guardian|0
7566909|NCT03351608|11940132|FG000|Overall Study|Other|0
7566910|NCT03351608|11940133|FG001|Overall Study|Other|1
7566911|NCT03351608|11940134|FG002|Overall Study|Other|1
7566912|NCT03351608|11940135|FG003|Overall Study|Other|3
7566913|NCT03351608|11940136|FG004|Overall Study|Other|0
7566914|NCT03351738|11940192|FG000|Overall Study|Withdrawal by Subject|0
7566915|NCT03351738|11940193|FG001|Overall Study|Withdrawal by Subject|1
7566916|NCT03351738|11940194|FG002|Overall Study|Withdrawal by Subject|0
7566917|NCT03351738|11940195|FG003|Overall Study|Withdrawal by Subject|1
7566918|NCT03351738|11940196|FG004|Overall Study|Withdrawal by Subject|0
7566919|NCT03351738|11940197|FG005|Overall Study|Withdrawal by Subject|0
7566920|NCT03352414|11940235|FG000|Overall Study|Ineligible by operative criteria|12
7566921|NCT03352414|11940236|FG001|Overall Study|Ineligible by operative criteria|10
7566922|NCT03352453|11940246|FG000|Overall Study|Miscellaneous Reasons|1
7566923|NCT03352453|11940247|FG001|Overall Study|Miscellaneous Reasons|2
7566924|NCT03352453|11940246|FG000|Overall Study|Lack of Efficacy|1
7566925|NCT03352453|11940247|FG001|Overall Study|Lack of Efficacy|0
7566926|NCT03352453|11940246|FG000|Overall Study|Withdrawal by Subject|8
7566927|NCT03352453|11940247|FG001|Overall Study|Withdrawal by Subject|14
7566928|NCT03352453|11940246|FG000|Overall Study|Study Terminated by Sponsor|2
7566929|NCT03352453|11940247|FG001|Overall Study|Study Terminated by Sponsor|1
7566930|NCT03352453|11940246|FG000|Overall Study|Protocol Deviation|1
7566931|NCT03352453|11940247|FG001|Overall Study|Protocol Deviation|0
7566932|NCT03352453|11940246|FG000|Overall Study|Lost to Follow-up|7
7566933|NCT03352453|11940247|FG001|Overall Study|Lost to Follow-up|6
7566934|NCT03352453|11940246|FG000|Overall Study|Adverse Event|2
7566935|NCT03352453|11940247|FG001|Overall Study|Adverse Event|9
7566936|NCT03352713|11940262|FG000|Overall Study|Lost to Follow-up|8
7566937|NCT03352713|11940262|FG000|Overall Study|Withdrawn by investigator|5
7566938|NCT03352713|11940262|FG000|Overall Study|Completed 0 EMAs|8
7566939|NCT03352713|11940262|FG000|Overall Study|Device incompatible/stolen|5
7566940|NCT03353220|11940266|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
7566941|NCT03353220|11940267|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
7566942|NCT03353740|11940277|FG000|Overall Study|Images for these participants not viable|52
7566943|NCT03354429|11940301|FG000|Overall Study|Withdrawal by Subject|8
7566944|NCT03354429|11940302|FG001|Overall Study|Withdrawal by Subject|7
7566945|NCT03354429|11940301|FG000|Overall Study|Lost to Follow-up|1
7566946|NCT03354429|11940302|FG001|Overall Study|Lost to Follow-up|0
7566947|NCT03354637|11940320|FG000|Double-blind Period|Protocol Violation|2
7566948|NCT03354637|11940321|FG001|Double-blind Period|Protocol Violation|0
7566949|NCT03354637|11940322|FG002|Double-blind Period|Protocol Violation|0
7566950|NCT03354637|11940320|FG000|Double-blind Period|Adverse Event|1
7566951|NCT03354637|11940321|FG001|Double-blind Period|Adverse Event|2
7566952|NCT03354637|11940322|FG002|Double-blind Period|Adverse Event|0
7566953|NCT03354637|11940320|FG000|Double-blind Period|Lost to Follow-up|3
7566954|NCT03354637|11940321|FG001|Double-blind Period|Lost to Follow-up|4
7566955|NCT03354637|11940322|FG002|Double-blind Period|Lost to Follow-up|3
7566956|NCT03354637|11940320|FG000|Double-blind Period|Withdrawal by Subject|10
7566957|NCT03354637|11940321|FG001|Double-blind Period|Withdrawal by Subject|6
7566958|NCT03354637|11940322|FG002|Double-blind Period|Withdrawal by Subject|4
7566959|NCT03354637|11940320|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
7566960|NCT03354637|11940321|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
7566961|NCT03354637|11940322|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
7566962|NCT03354637|11940320|FG000|Open Label Extension|Adverse Event|0
7566963|NCT03354637|11940321|FG001|Open Label Extension|Adverse Event|0
7566964|NCT03354637|11940322|FG002|Open Label Extension|Adverse Event|1
7566965|NCT03354637|11940320|FG000|Open Label Extension|Lost to Follow-up|0
7566966|NCT03354637|11940321|FG001|Open Label Extension|Lost to Follow-up|0
7566967|NCT03354637|11940322|FG002|Open Label Extension|Lost to Follow-up|2
7566968|NCT03354637|11940320|FG000|Open Label Extension|Withdrawal by Subject|0
7566969|NCT03354637|11940321|FG001|Open Label Extension|Withdrawal by Subject|0
7566970|NCT03354637|11940322|FG002|Open Label Extension|Withdrawal by Subject|5
7566971|NCT03354637|11940320|FG000|Open Label Extension|Study Terminated by Sponsor|0
7566972|NCT03354637|11940321|FG001|Open Label Extension|Study Terminated by Sponsor|0
7566973|NCT03354637|11940322|FG002|Open Label Extension|Study Terminated by Sponsor|17
7566974|NCT03354637|11940320|FG000|Open Label Extension|Subject Noncompliance|0
7566975|NCT03354637|11940321|FG001|Open Label Extension|Subject Noncompliance|0
7566976|NCT03354637|11940322|FG002|Open Label Extension|Subject Noncompliance|1
7566977|NCT03354637|11940320|FG000|Open Label Extension|Lack of Efficacy|0
7566978|NCT03354637|11940321|FG001|Open Label Extension|Lack of Efficacy|0
7566979|NCT03354637|11940322|FG002|Open Label Extension|Lack of Efficacy|1
7566980|NCT03354637|11940320|FG000|Open Label Extension|Physician Decision|0
7566981|NCT03354637|11940321|FG001|Open Label Extension|Physician Decision|0
7566982|NCT03354637|11940322|FG002|Open Label Extension|Physician Decision|1
7566983|NCT03354663|11940331|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
7566984|NCT03354663|11940331|FG000|Enrollment to Catheter Insertion|Adverse Event|1
7566985|NCT03354663|11940331|FG000|Completed 30-day Visit|Withdrawal by Subject|1
7566986|NCT03354663|11940331|FG000|Completed 30-day Visit|Missed Visit|1
7566987|NCT03355326|11940350|FG000|Overall Study|Protocol Violation|3
7566988|NCT03355326|11940351|FG001|Overall Study|Protocol Violation|3
7566989|NCT03355742|11940357|FG000|Overall Study|Lost to Follow-up|4
7566990|NCT03355742|11940357|FG000|Overall Study|Withdrawal by Subject|29
7566991|NCT03355742|11940357|FG000|Overall Study|Physician Decision|6
7566992|NCT03355742|11940357|FG000|Overall Study|Death|55
7566993|NCT03355742|11940357|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
7566994|NCT03356145|11940367|FG000|Overall Study|Withdrawal by Subject|2
7566995|NCT03356145|11940368|FG001|Overall Study|Withdrawal by Subject|1
7566996|NCT03356145|11940367|FG000|Overall Study|Did not meet inclusion criteria|1
7566997|NCT03356145|11940368|FG001|Overall Study|Did not meet inclusion criteria|0
7566998|NCT03356977|11940374|FG000|Overall Study|Lost to Follow-up|3
7566999|NCT03356977|11940374|FG000|Overall Study|Withdrawal by parent/guardian|2
7567000|NCT03357341|11940380|FG000|Overall Study|Withdrawal by Subject|3
7567001|NCT03357341|11940381|FG001|Overall Study|Withdrawal by Subject|6
7567002|NCT03357341|11940380|FG000|Overall Study|Lost to Follow-up|4
7567003|NCT03357341|11940381|FG001|Overall Study|Lost to Follow-up|5
7567004|NCT03357341|11940380|FG000|Overall Study|Death|0
7567005|NCT03357341|11940381|FG001|Overall Study|Death|1
7567006|NCT03357471|11940403|FG000|Overall Study|Adverse Event|1
7567007|NCT03357471|11940404|FG001|Overall Study|Adverse Event|0
7567008|NCT03357471|11940403|FG000|Overall Study|Lost to Follow-up|1
7567009|NCT03357471|11940404|FG001|Overall Study|Lost to Follow-up|0
7567010|NCT03357731|11940419|FG000|Overall Study|Withdrew consent due to personal reasons|0
7567011|NCT03357731|11940420|FG001|Overall Study|Withdrew consent due to personal reasons|0
7567012|NCT03357731|11940421|FG002|Overall Study|Withdrew consent due to personal reasons|0
7567013|NCT03357731|11940422|FG003|Overall Study|Withdrew consent due to personal reasons|0
7567014|NCT03357731|11940423|FG004|Overall Study|Withdrew consent due to personal reasons|1
7567015|NCT03357731|11940424|FG005|Overall Study|Withdrew consent due to personal reasons|0
7567016|NCT03357731|11940419|FG000|Overall Study|Acute bradycardia and hypotension|0
7567017|NCT03357731|11940420|FG001|Overall Study|Acute bradycardia and hypotension|0
7567018|NCT03357731|11940421|FG002|Overall Study|Acute bradycardia and hypotension|0
7567019|NCT03357731|11940422|FG003|Overall Study|Acute bradycardia and hypotension|1
7567020|NCT03357731|11940423|FG004|Overall Study|Acute bradycardia and hypotension|0
7567021|NCT03357731|11940424|FG005|Overall Study|Acute bradycardia and hypotension|0
7567022|NCT03357731|11940419|FG000|Overall Study|Adverse Event|0
7567023|NCT03357731|11940420|FG001|Overall Study|Adverse Event|0
7567024|NCT03357731|11940421|FG002|Overall Study|Adverse Event|0
7567025|NCT03357731|11940422|FG003|Overall Study|Adverse Event|0
7567026|NCT03357731|11940423|FG004|Overall Study|Adverse Event|0
7567027|NCT03357731|11940424|FG005|Overall Study|Adverse Event|1
7567028|NCT03357731|11940419|FG000|Overall Study|Hypotension|0
7567029|NCT03357731|11940420|FG001|Overall Study|Hypotension|0
7567030|NCT03357731|11940421|FG002|Overall Study|Hypotension|1
7567031|NCT03357731|11940422|FG003|Overall Study|Hypotension|1
7567032|NCT03357731|11940423|FG004|Overall Study|Hypotension|0
7567033|NCT03357731|11940424|FG005|Overall Study|Hypotension|0
7567034|NCT03357731|11940419|FG000|Overall Study|Lost to Follow-up|0
7567035|NCT03357731|11940420|FG001|Overall Study|Lost to Follow-up|0
7567036|NCT03357731|11940421|FG002|Overall Study|Lost to Follow-up|0
7567037|NCT03357731|11940422|FG003|Overall Study|Lost to Follow-up|1
7567038|NCT03357731|11940423|FG004|Overall Study|Lost to Follow-up|0
7567039|NCT03357731|11940424|FG005|Overall Study|Lost to Follow-up|0
7567040|NCT03358147|11940437|FG000|Overall Study|Withdrawal by Subject|13
7567041|NCT03358147|11940438|FG001|Overall Study|Withdrawal by Subject|19
7567042|NCT03358147|11940439|FG002|Overall Study|Withdrawal by Subject|16
7567043|NCT03358147|11940440|FG003|Overall Study|Withdrawal by Subject|10
7567044|NCT03358147|11940441|FG004|Overall Study|Withdrawal by Subject|5
7567045|NCT03358147|11940437|FG000|Overall Study|Adverse Event|3
7567046|NCT03358147|11940438|FG001|Overall Study|Adverse Event|9
7567047|NCT03358147|11940439|FG002|Overall Study|Adverse Event|7
7567048|NCT03358147|11940440|FG003|Overall Study|Adverse Event|5
7567049|NCT03358147|11940441|FG004|Overall Study|Adverse Event|2
7567050|NCT03358147|11940437|FG000|Overall Study|Lost to Follow-up|4
7567051|NCT03358147|11940438|FG001|Overall Study|Lost to Follow-up|3
7567052|NCT03358147|11940439|FG002|Overall Study|Lost to Follow-up|7
7567053|NCT03358147|11940440|FG003|Overall Study|Lost to Follow-up|6
7567054|NCT03358147|11940441|FG004|Overall Study|Lost to Follow-up|4
7567055|NCT03358147|11940437|FG000|Overall Study|Major Protocol Deviation|11
7567056|NCT03358147|11940438|FG001|Overall Study|Major Protocol Deviation|3
7567057|NCT03358147|11940439|FG002|Overall Study|Major Protocol Deviation|2
7567058|NCT03358147|11940440|FG003|Overall Study|Major Protocol Deviation|3
7567059|NCT03358147|11940441|FG004|Overall Study|Major Protocol Deviation|1
7567060|NCT03358147|11940437|FG000|Overall Study|Protocol specified criteria|2
7567061|NCT03358147|11940438|FG001|Overall Study|Protocol specified criteria|3
7567062|NCT03358147|11940439|FG002|Overall Study|Protocol specified criteria|0
7567063|NCT03358147|11940440|FG003|Overall Study|Protocol specified criteria|3
7567064|NCT03358147|11940441|FG004|Overall Study|Protocol specified criteria|1
7567065|NCT03358147|11940437|FG000|Overall Study|Physician Decision|1
7567066|NCT03358147|11940438|FG001|Overall Study|Physician Decision|0
7567067|NCT03358147|11940439|FG002|Overall Study|Physician Decision|1
7567068|NCT03358147|11940440|FG003|Overall Study|Physician Decision|6
7567069|NCT03358147|11940441|FG004|Overall Study|Physician Decision|1
7567070|NCT03358147|11940437|FG000|Overall Study|Administrative reasons|0
7567071|NCT03358147|11940438|FG001|Overall Study|Administrative reasons|1
7567072|NCT03358147|11940439|FG002|Overall Study|Administrative reasons|0
7567073|NCT03358147|11940440|FG003|Overall Study|Administrative reasons|3
7567074|NCT03358147|11940441|FG004|Overall Study|Administrative reasons|0
7567075|NCT03358147|11940437|FG000|Overall Study|Lack of Efficacy|0
7567076|NCT03358147|11940438|FG001|Overall Study|Lack of Efficacy|1
7567077|NCT03358147|11940439|FG002|Overall Study|Lack of Efficacy|1
7567078|NCT03358147|11940440|FG003|Overall Study|Lack of Efficacy|0
7567079|NCT03358147|11940441|FG004|Overall Study|Lack of Efficacy|0
7567080|NCT03358238|11940455|FG000|Overall Study|Withdrawal by Subject|0
7567081|NCT03358238|11940456|FG001|Overall Study|Withdrawal by Subject|1
7567082|NCT03358290|11940478|FG000|Overall Study|Study discontinued by Sponsor|0
7567083|NCT03358290|11940479|FG001|Overall Study|Study discontinued by Sponsor|1
7567084|NCT03358290|11940480|FG002|Overall Study|Study discontinued by Sponsor|1
7567085|NCT03358290|11940481|FG003|Overall Study|Study discontinued by Sponsor|0
7567086|NCT03358290|11940482|FG004|Overall Study|Study discontinued by Sponsor|0
7567087|NCT03358290|11940478|FG000|Overall Study|Adverse Event|0
7567088|NCT03358290|11940479|FG001|Overall Study|Adverse Event|0
7567089|NCT03358290|11940480|FG002|Overall Study|Adverse Event|1
7567090|NCT03358290|11940481|FG003|Overall Study|Adverse Event|2
7567091|NCT03358290|11940482|FG004|Overall Study|Adverse Event|0
7567092|NCT03358290|11940478|FG000|Overall Study|Withdrawal by Subject|0
7567093|NCT03358290|11940479|FG001|Overall Study|Withdrawal by Subject|0
7567094|NCT03358290|11940480|FG002|Overall Study|Withdrawal by Subject|0
7567095|NCT03358290|11940481|FG003|Overall Study|Withdrawal by Subject|0
7567096|NCT03358290|11940482|FG004|Overall Study|Withdrawal by Subject|1
7567097|NCT03358329|11940494|FG000|Overall Study|Lost to Follow-up|2
7567098|NCT03358329|11940494|FG000|Overall Study|Withdrawal by Subject|2
7567099|NCT03358407|11940519|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567100|NCT03358407|11940520|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567101|NCT03358407|11940521|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
7567102|NCT03358407|11940522|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567103|NCT03358407|11940523|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567104|NCT03358407|11940524|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567105|NCT03358407|11940525|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567106|NCT03358407|11940526|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567107|NCT03358407|11940527|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567108|NCT03358407|11940528|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
7567109|NCT03358407|11940519|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567110|NCT03358407|11940520|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567111|NCT03358407|11940521|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567112|NCT03358407|11940522|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567113|NCT03358407|11940523|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
7567114|NCT03358407|11940524|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567115|NCT03358407|11940525|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567116|NCT03358407|11940526|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567117|NCT03358407|11940527|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567118|NCT03358407|11940528|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
7567119|NCT03358407|11940519|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567120|NCT03358407|11940520|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567121|NCT03358407|11940521|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567122|NCT03358407|11940522|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567123|NCT03358407|11940523|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567124|NCT03358407|11940524|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
7567125|NCT03358407|11940525|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567126|NCT03358407|11940526|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
7567127|NCT03358407|11940527|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567128|NCT03358407|11940528|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
7567129|NCT03358407|11940519|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567130|NCT03358407|11940520|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567131|NCT03358407|11940521|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567132|NCT03358407|11940522|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567133|NCT03358407|11940523|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567134|NCT03358407|11940524|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7567135|NCT03358407|11940525|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7329947|NCT00806260|11563331|FG003|Period 2|Adverse Event|1
7329948|NCT00806260|11563332|FG004|Period 2|Adverse Event|0
7329949|NCT00806260|11563333|FG005|Period 2|Adverse Event|0
7329950|NCT00806260|11563328|FG000|Period 2|Protocol Violation|1
7329951|NCT00806260|11563329|FG001|Period 2|Protocol Violation|0
7329952|NCT00806260|11563330|FG002|Period 2|Protocol Violation|1
7329953|NCT00806260|11563331|FG003|Period 2|Protocol Violation|0
7329954|NCT00806260|11563332|FG004|Period 2|Protocol Violation|0
7329955|NCT00806260|11563333|FG005|Period 2|Protocol Violation|0
7329956|NCT00806260|11563328|FG000|Period 2|Need to take concomitant medication|1
7329957|NCT00806260|11563329|FG001|Period 2|Need to take concomitant medication|0
7329958|NCT00806260|11563330|FG002|Period 2|Need to take concomitant medication|0
7329959|NCT00806260|11563331|FG003|Period 2|Need to take concomitant medication|0
7329960|NCT00806260|11563332|FG004|Period 2|Need to take concomitant medication|0
7329961|NCT00806260|11563333|FG005|Period 2|Need to take concomitant medication|0
7329962|NCT00806260|11563328|FG000|Period 2|sponsor request|0
7329963|NCT00806260|11563329|FG001|Period 2|sponsor request|0
7329964|NCT00806260|11563330|FG002|Period 2|sponsor request|1
7329965|NCT00806260|11563331|FG003|Period 2|sponsor request|1
7329966|NCT00806260|11563332|FG004|Period 2|sponsor request|0
7329967|NCT00806260|11563333|FG005|Period 2|sponsor request|0
7329968|NCT00806260|11563328|FG000|Period 3|Protocol Violation|0
7329969|NCT00806260|11563329|FG001|Period 3|Protocol Violation|1
7329970|NCT00806260|11563330|FG002|Period 3|Protocol Violation|1
7329971|NCT00806260|11563331|FG003|Period 3|Protocol Violation|0
7329972|NCT00806260|11563332|FG004|Period 3|Protocol Violation|0
7329973|NCT00806260|11563333|FG005|Period 3|Protocol Violation|0
7329974|NCT00806260|11563328|FG000|Period 3|Pregnancy|1
7329975|NCT00806260|11563329|FG001|Period 3|Pregnancy|0
7329976|NCT00806260|11563330|FG002|Period 3|Pregnancy|0
7329977|NCT00806260|11563331|FG003|Period 3|Pregnancy|0
7329978|NCT00806260|11563332|FG004|Period 3|Pregnancy|0
7329979|NCT00806260|11563333|FG005|Period 3|Pregnancy|0
7329980|NCT00806286|11563348|FG000|Overall Study|Adverse Event|5
7329981|NCT00806286|11563349|FG001|Overall Study|Adverse Event|2
7329982|NCT00806286|11563350|FG002|Overall Study|Adverse Event|0
7329983|NCT00806286|11563348|FG000|Overall Study|Disease progression|31
7329984|NCT00806286|11563349|FG001|Overall Study|Disease progression|38
7567136|NCT03358407|11940526|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
7567137|NCT03358407|11940527|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567138|NCT03358407|11940528|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
7567139|NCT03358407|11940519|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567140|NCT03358407|11940520|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567141|NCT03358407|11940521|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567142|NCT03358407|11940522|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567143|NCT03358407|11940523|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567144|NCT03358407|11940524|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7567145|NCT03358407|11940525|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
7329985|NCT00806286|11563350|FG002|Overall Study|Disease progression|1
7329986|NCT00806286|11563348|FG000|Overall Study|Death|1
7329987|NCT00806286|11563349|FG001|Overall Study|Death|6
7329988|NCT00806286|11563350|FG002|Overall Study|Death|0
7567146|NCT03358407|11940526|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567147|NCT03358407|11940527|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567148|NCT03358407|11940528|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
7567149|NCT03358407|11940519|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567150|NCT03358407|11940520|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567151|NCT03358407|11940521|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567152|NCT03358407|11940522|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567153|NCT03358407|11940523|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567154|NCT03358407|11940524|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7567155|NCT03358407|11940525|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
7567156|NCT03358407|11940526|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
7567157|NCT03358407|11940527|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567158|NCT03358407|11940528|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
7567159|NCT03359395|11940567|FG000|First Intervention A / B|Withdrawal by Subject|1
7567160|NCT03359395|11940568|FG001|First Intervention A / B|Withdrawal by Subject|0
7567161|NCT03359395|11940567|FG000|First Intervention A / B|Lost to Follow-up|2
7567162|NCT03359395|11940568|FG001|First Intervention A / B|Lost to Follow-up|3
7567163|NCT03359395|11940567|FG000|Second Intervention B/A|Exclusion criteria|0
7567164|NCT03359395|11940568|FG001|Second Intervention B/A|Exclusion criteria|1
7567165|NCT03359395|11940567|FG000|Second Intervention B/A|Lost to Follow-up|3
7567166|NCT03359395|11940568|FG001|Second Intervention B/A|Lost to Follow-up|2
7567167|NCT03359473|11940578|FG000|Overall Study|Adverse Event|0
7567168|NCT03359473|11940579|FG001|Overall Study|Adverse Event|2
7567169|NCT03359473|11940580|FG002|Overall Study|Adverse Event|5
7567170|NCT03359473|11940581|FG003|Overall Study|Adverse Event|3
7567171|NCT03359473|11940578|FG000|Overall Study|Lost to Follow-up|0
7567172|NCT03359473|11940579|FG001|Overall Study|Lost to Follow-up|1
7567173|NCT03359473|11940580|FG002|Overall Study|Lost to Follow-up|0
7567174|NCT03359473|11940581|FG003|Overall Study|Lost to Follow-up|0
7567175|NCT03359473|11940578|FG000|Overall Study|Physician Decision|0
7567176|NCT03359473|11940579|FG001|Overall Study|Physician Decision|1
7567177|NCT03359473|11940580|FG002|Overall Study|Physician Decision|0
7567178|NCT03359473|11940581|FG003|Overall Study|Physician Decision|1
7567179|NCT03359473|11940578|FG000|Overall Study|Withdrawal by Subject|1
7567180|NCT03359473|11940579|FG001|Overall Study|Withdrawal by Subject|2
7567181|NCT03359473|11940580|FG002|Overall Study|Withdrawal by Subject|1
7567182|NCT03359473|11940581|FG003|Overall Study|Withdrawal by Subject|0
7567183|NCT03359473|11940578|FG000|Overall Study|Protocol-defined stopping criteria|1
7567184|NCT03359473|11940579|FG001|Overall Study|Protocol-defined stopping criteria|0
7567185|NCT03359473|11940580|FG002|Overall Study|Protocol-defined stopping criteria|0
7567186|NCT03359473|11940581|FG003|Overall Study|Protocol-defined stopping criteria|1
7567187|NCT03359590|11940594|FG000|First Intervention|Withdrawal by Subject|1
7567188|NCT03359590|11940595|FG001|First Intervention|Withdrawal by Subject|1
7567189|NCT03359590|11940594|FG000|First Intervention|Protocol Violation|0
7567190|NCT03359590|11940595|FG001|First Intervention|Protocol Violation|1
7567191|NCT03359850|11940612|FG000|PK Phase (Up to Day 8)|Physician Decision|0
7567192|NCT03359850|11940613|FG001|PK Phase (Up to Day 8)|Physician Decision|1
7567193|NCT03359850|11940612|FG000|PK Phase (Up to Day 8)|Adverse Event|1
7567194|NCT03359850|11940613|FG001|PK Phase (Up to Day 8)|Adverse Event|0
7567195|NCT03359850|11940612|FG000|Extension Phase (Up to 28 Months)|Death|2
7567196|NCT03359850|11940613|FG001|Extension Phase (Up to 28 Months)|Death|4
7567197|NCT03359850|11940612|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
7567198|NCT03359850|11940613|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
7567199|NCT03359850|11940612|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
7567200|NCT03359850|11940613|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
7567201|NCT03360071|11940627|FG000|Overall Study|Lost to Follow-up|1
7567202|NCT03360071|11940628|FG001|Overall Study|Lost to Follow-up|0
7567203|NCT03360344|11940656|FG000|Overall Study|Withdrawal by Subject|0
7329989|NCT00806286|11563348|FG000|Overall Study|Lost to Follow-up|0
7329990|NCT00806286|11563349|FG001|Overall Study|Lost to Follow-up|1
7329991|NCT00806286|11563350|FG002|Overall Study|Lost to Follow-up|0
7329992|NCT00806286|11563348|FG000|Overall Study|Withdrawal by Subject|8
7567204|NCT03360344|11940657|FG001|Overall Study|Withdrawal by Subject|1
7567205|NCT03360344|11940658|FG002|Overall Study|Withdrawal by Subject|1
7567206|NCT03360747|11940666|FG000|Overall Study|Voluntary Withdrawal|1
7567207|NCT03361137|11940675|FG000|Overall Study|Reason not specified|1
7567208|NCT03361137|11940676|FG001|Overall Study|Reason not specified|0
7567209|NCT03361137|11940677|FG002|Overall Study|Reason not specified|0
7567210|NCT03361137|11940678|FG003|Overall Study|Reason not specified|0
7567211|NCT03361137|11940679|FG004|Overall Study|Reason not specified|0
7567212|NCT03361176|11940695|FG000|Overall Study|Lost to Follow-up|1
7567213|NCT03361176|11940696|FG001|Overall Study|Lost to Follow-up|2
7567214|NCT03361176|11940695|FG000|Overall Study|Adverse Event|0
7567215|NCT03361176|11940696|FG001|Overall Study|Adverse Event|2
7567216|NCT03361176|11940695|FG000|Overall Study|Withdrawal by Subject|0
7567217|NCT03361176|11940696|FG001|Overall Study|Withdrawal by Subject|1
7567218|NCT03361293|11940704|FG000|Overall Study|Lost to Follow-up|0
7567219|NCT03361293|11940705|FG001|Overall Study|Lost to Follow-up|2
7567220|NCT03361293|11940704|FG000|Overall Study|Withdrawal by Subject|1
7567221|NCT03361293|11940705|FG001|Overall Study|Withdrawal by Subject|3
7567222|NCT03361423|11940713|FG000|Overall Study|Withdrawal by Subject|4
7567223|NCT03361423|11940714|FG001|Overall Study|Withdrawal by Subject|3
7567224|NCT03361423|11940713|FG000|Overall Study|Did not treat|19
7567225|NCT03361423|11940714|FG001|Overall Study|Did not treat|18
7567226|NCT03361423|11940713|FG000|Overall Study|Started >60 minutes from migraine onset|0
7567227|NCT03361423|11940714|FG001|Overall Study|Started >60 minutes from migraine onset|1
7567228|NCT03361423|11940713|FG000|Overall Study|Missing data|4
7567229|NCT03361423|11940714|FG001|Overall Study|Missing data|1
7567230|NCT03361605|11940720|FG000|Overall Study|Analyzable data not available|3
7567231|NCT03363321|11940761|FG000|Overall Study|Withdrawal by Subject|0
7567232|NCT03363321|11940762|FG001|Overall Study|Withdrawal by Subject|1
7567233|NCT03363321|11940763|FG002|Overall Study|Withdrawal by Subject|0
7567234|NCT03363321|11940764|FG003|Overall Study|Withdrawal by Subject|1
7567235|NCT03363321|11940765|FG004|Overall Study|Withdrawal by Subject|0
7567236|NCT03363776|11940781|FG000|Overall Study|Progressive disease|2
7567237|NCT03363776|11940782|FG001|Overall Study|Progressive disease|3
7567238|NCT03363776|11940783|FG002|Overall Study|Progressive disease|1
7567239|NCT03363776|11940781|FG000|Overall Study|Study drug toxicity|0
7567240|NCT03363776|11940782|FG001|Overall Study|Study drug toxicity|0
7567241|NCT03363776|11940783|FG002|Overall Study|Study drug toxicity|1
7567242|NCT03363776|11940781|FG000|Overall Study|Death|1
7567243|NCT03363776|11940782|FG001|Overall Study|Death|0
7567244|NCT03363776|11940783|FG002|Overall Study|Death|0
7567245|NCT03363906|11940823|FG000|Period 1 (Reference or Test)|Adverse Event|1
7567246|NCT03363906|11940824|FG001|Period 1 (Reference or Test)|Adverse Event|2
7567247|NCT03363906|11940823|FG000|Period 2 (Test or Reference)|Adverse Event|2
7567248|NCT03363906|11940824|FG001|Period 2 (Test or Reference)|Adverse Event|0
7567249|NCT03363906|11940823|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
7567250|NCT03363906|11940824|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
7329993|NCT00806286|11563349|FG001|Overall Study|Withdrawal by Subject|3
7329994|NCT00806286|11563350|FG002|Overall Study|Withdrawal by Subject|1
7329995|NCT00806286|11563348|FG000|Overall Study|Physician Decision|2
7329996|NCT00806286|11563349|FG001|Overall Study|Physician Decision|2
7329997|NCT00806286|11563350|FG002|Overall Study|Physician Decision|0
7329998|NCT00806286|11563348|FG000|Overall Study|Due to a variety of reasons|7
7329999|NCT00806286|11563349|FG001|Overall Study|Due to a variety of reasons|2
7330000|NCT00806286|11563350|FG002|Overall Study|Due to a variety of reasons|1
7330001|NCT00806351|11563360|FG000|Overall Study|Death|5
7330002|NCT00806351|11563361|FG001|Overall Study|Death|4
7567251|NCT03363906|11940823|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
7330003|NCT00806442|11563367|FG000|Overall Study|Lost to Follow-up|3
7330004|NCT00806442|11563368|FG001|Overall Study|Lost to Follow-up|2
7330005|NCT00806442|11563367|FG000|Overall Study|Withdrawal by Subject|1
7330006|NCT00806442|11563368|FG001|Overall Study|Withdrawal by Subject|5
7330007|NCT00806494|11563376|FG000|Overall Study|Adverse Event|29
7330008|NCT00806494|11563376|FG000|Overall Study|Lack of Efficacy|6
7330009|NCT00806494|11563376|FG000|Overall Study|Lost to Follow-up|10
7330010|NCT00806494|11563376|FG000|Overall Study|Other|30
7330011|NCT00806494|11563376|FG000|Overall Study|Withdrawal by Subject|5
7330012|NCT00806546|11563381|FG000|Overall Study|Enrolled, not treated|35
7567252|NCT03363906|11940824|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
7567253|NCT03364023|11940830|FG000|Overall Study|Lost to Follow-up|3
7330013|NCT00806546|11563381|FG000|Overall Study|Lost to Follow-up|32
7567254|NCT03364023|11940830|FG000|Overall Study|Death|14
7567255|NCT03364049|11940838|FG000|Overall Study|Death|6
7567256|NCT03364049|11940839|FG001|Overall Study|Death|4
7567257|NCT03364049|11940840|FG002|Overall Study|Death|5
7567258|NCT03364049|11940841|FG003|Overall Study|Death|14
7567259|NCT03364049|11940838|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7567260|NCT03364049|11940839|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
7567261|NCT03364049|11940840|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7567262|NCT03364049|11940841|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
7567263|NCT03364049|11940838|FG000|Overall Study|Withdrawal by Subject|0
7567264|NCT03364049|11940839|FG001|Overall Study|Withdrawal by Subject|1
7567265|NCT03364049|11940840|FG002|Overall Study|Withdrawal by Subject|1
7567266|NCT03364049|11940841|FG003|Overall Study|Withdrawal by Subject|1
7567267|NCT03364192|11940851|FG000|Overall Study|Ineligible|10
7567268|NCT03364192|11940851|FG000|Overall Study|Withdrawal by Subject|5
7567269|NCT03364192|11940851|FG000|Overall Study|Lost to Follow-up|1
7567270|NCT03364309|11940859|FG000|Induction Period|Adverse Event|4
7567271|NCT03364309|11940860|FG001|Induction Period|Adverse Event|0
7567272|NCT03364309|11940861|FG002|Induction Period|Adverse Event|1
7567273|NCT03364309|11940862|FG003|Induction Period|Adverse Event|0
7567274|NCT03364309|11940863|FG004|Induction Period|Adverse Event|0
7567275|NCT03364309|11940864|FG005|Induction Period|Adverse Event|0
7567276|NCT03364309|11940865|FG006|Induction Period|Adverse Event|0
7567277|NCT03364309|11940866|FG007|Induction Period|Adverse Event|0
7567278|NCT03364309|11940867|FG008|Induction Period|Adverse Event|0
7567279|NCT03364309|11940868|FG009|Induction Period|Adverse Event|0
7567280|NCT03364309|11940869|FG010|Induction Period|Adverse Event|0
7567281|NCT03364309|11940870|FG011|Induction Period|Adverse Event|0
7567282|NCT03364309|11940871|FG012|Induction Period|Adverse Event|0
7567283|NCT03364309|11940872|FG013|Induction Period|Adverse Event|0
7567284|NCT03364309|11940873|FG014|Induction Period|Adverse Event|0
7567285|NCT03364309|11940874|FG015|Induction Period|Adverse Event|0
7567286|NCT03364309|11940875|FG016|Induction Period|Adverse Event|0
7567287|NCT03364309|11940876|FG017|Induction Period|Adverse Event|0
7567288|NCT03364309|11940877|FG018|Induction Period|Adverse Event|0
7567289|NCT03364309|11940859|FG000|Induction Period|Withdrawal by Subject|1
7567290|NCT03364309|11940860|FG001|Induction Period|Withdrawal by Subject|3
7567291|NCT03364309|11940861|FG002|Induction Period|Withdrawal by Subject|0
7567292|NCT03364309|11940862|FG003|Induction Period|Withdrawal by Subject|0
7330014|NCT00806546|11563381|FG000|Overall Study|Adverse Event|74
7330015|NCT00806546|11563381|FG000|Overall Study|Withdrawal by Subject|75
7330016|NCT00806546|11563381|FG000|Overall Study|Protocol Violation|49
7330017|NCT00806546|11563381|FG000|Overall Study|Various|42
7330018|NCT00806585|11563390|FG000|Overall Study|Study terminated by Sponsor|0
7330019|NCT00806585|11563391|FG001|Overall Study|Study terminated by Sponsor|0
7330020|NCT00806585|11563392|FG002|Overall Study|Study terminated by Sponsor|1
7330021|NCT00806585|11563393|FG003|Overall Study|Study terminated by Sponsor|2
7330022|NCT00806585|11563394|FG004|Overall Study|Study terminated by Sponsor|0
7330023|NCT00806585|11563390|FG000|Overall Study|Protocol Violation|3
7567293|NCT03364309|11940863|FG004|Induction Period|Withdrawal by Subject|0
7330024|NCT00806585|11563391|FG001|Overall Study|Protocol Violation|1
7330025|NCT00806585|11563392|FG002|Overall Study|Protocol Violation|2
7330026|NCT00806585|11563393|FG003|Overall Study|Protocol Violation|0
7330027|NCT00806585|11563394|FG004|Overall Study|Protocol Violation|0
7330028|NCT00806585|11563390|FG000|Overall Study|Physician Decision|0
7330029|NCT00806585|11563391|FG001|Overall Study|Physician Decision|2
7567294|NCT03364309|11940864|FG005|Induction Period|Withdrawal by Subject|0
7567295|NCT03364309|11940865|FG006|Induction Period|Withdrawal by Subject|0
7567296|NCT03364309|11940866|FG007|Induction Period|Withdrawal by Subject|0
7567297|NCT03364309|11940867|FG008|Induction Period|Withdrawal by Subject|0
7567298|NCT03364309|11940868|FG009|Induction Period|Withdrawal by Subject|0
7567299|NCT03364309|11940869|FG010|Induction Period|Withdrawal by Subject|0
7567300|NCT03364309|11940870|FG011|Induction Period|Withdrawal by Subject|0
7567301|NCT03364309|11940871|FG012|Induction Period|Withdrawal by Subject|0
7567302|NCT03364309|11940872|FG013|Induction Period|Withdrawal by Subject|0
7567303|NCT03364309|11940873|FG014|Induction Period|Withdrawal by Subject|0
7567304|NCT03364309|11940874|FG015|Induction Period|Withdrawal by Subject|0
7567305|NCT03364309|11940875|FG016|Induction Period|Withdrawal by Subject|0
7567306|NCT03364309|11940876|FG017|Induction Period|Withdrawal by Subject|0
7567307|NCT03364309|11940877|FG018|Induction Period|Withdrawal by Subject|0
7567308|NCT03364309|11940859|FG000|Induction Period|Lost to Follow-up|1
7567309|NCT03364309|11940860|FG001|Induction Period|Lost to Follow-up|0
7567310|NCT03364309|11940861|FG002|Induction Period|Lost to Follow-up|0
7567311|NCT03364309|11940862|FG003|Induction Period|Lost to Follow-up|0
7567312|NCT03364309|11940863|FG004|Induction Period|Lost to Follow-up|0
7567313|NCT03364309|11940864|FG005|Induction Period|Lost to Follow-up|0
7567314|NCT03364309|11940865|FG006|Induction Period|Lost to Follow-up|0
7567315|NCT03364309|11940866|FG007|Induction Period|Lost to Follow-up|0
7567316|NCT03364309|11940867|FG008|Induction Period|Lost to Follow-up|0
7567317|NCT03364309|11940868|FG009|Induction Period|Lost to Follow-up|0
7567318|NCT03364309|11940869|FG010|Induction Period|Lost to Follow-up|0
7567319|NCT03364309|11940870|FG011|Induction Period|Lost to Follow-up|0
7567320|NCT03364309|11940871|FG012|Induction Period|Lost to Follow-up|0
7567321|NCT03364309|11940872|FG013|Induction Period|Lost to Follow-up|0
7567322|NCT03364309|11940873|FG014|Induction Period|Lost to Follow-up|0
7567323|NCT03364309|11940874|FG015|Induction Period|Lost to Follow-up|0
7567324|NCT03364309|11940875|FG016|Induction Period|Lost to Follow-up|0
7567325|NCT03364309|11940876|FG017|Induction Period|Lost to Follow-up|0
7567326|NCT03364309|11940877|FG018|Induction Period|Lost to Follow-up|0
7567327|NCT03364309|11940859|FG000|Induction Period|Physician Decision|0
7567328|NCT03364309|11940860|FG001|Induction Period|Physician Decision|1
7567329|NCT03364309|11940861|FG002|Induction Period|Physician Decision|0
7567330|NCT03364309|11940862|FG003|Induction Period|Physician Decision|0
7567331|NCT03364309|11940863|FG004|Induction Period|Physician Decision|0
7567332|NCT03364309|11940864|FG005|Induction Period|Physician Decision|0
7567333|NCT03364309|11940865|FG006|Induction Period|Physician Decision|0
7567334|NCT03364309|11940866|FG007|Induction Period|Physician Decision|0
7567335|NCT03364309|11940867|FG008|Induction Period|Physician Decision|0
7567336|NCT03364309|11940868|FG009|Induction Period|Physician Decision|0
7567337|NCT03364309|11940869|FG010|Induction Period|Physician Decision|0
7567338|NCT03364309|11940870|FG011|Induction Period|Physician Decision|0
7567339|NCT03364309|11940871|FG012|Induction Period|Physician Decision|0
7567340|NCT03364309|11940872|FG013|Induction Period|Physician Decision|0
7567341|NCT03364309|11940873|FG014|Induction Period|Physician Decision|0
7567342|NCT03364309|11940874|FG015|Induction Period|Physician Decision|0
7567343|NCT03364309|11940875|FG016|Induction Period|Physician Decision|0
7567344|NCT03364309|11940876|FG017|Induction Period|Physician Decision|0
7567345|NCT03364309|11940877|FG018|Induction Period|Physician Decision|0
7567346|NCT03364309|11940859|FG000|Maintenance Period|Withdrawal by Subject|0
7567347|NCT03364309|11940860|FG001|Maintenance Period|Withdrawal by Subject|0
7567348|NCT03364309|11940861|FG002|Maintenance Period|Withdrawal by Subject|0
7567349|NCT03364309|11940862|FG003|Maintenance Period|Withdrawal by Subject|1
7567350|NCT03364309|11940863|FG004|Maintenance Period|Withdrawal by Subject|3
7567351|NCT03364309|11940864|FG005|Maintenance Period|Withdrawal by Subject|1
7567352|NCT03364309|11940865|FG006|Maintenance Period|Withdrawal by Subject|3
7567353|NCT03364309|11940866|FG007|Maintenance Period|Withdrawal by Subject|0
7567354|NCT03364309|11940867|FG008|Maintenance Period|Withdrawal by Subject|1
7567355|NCT03364309|11940868|FG009|Maintenance Period|Withdrawal by Subject|1
7567356|NCT03364309|11940869|FG010|Maintenance Period|Withdrawal by Subject|2
7567357|NCT03364309|11940870|FG011|Maintenance Period|Withdrawal by Subject|0
7567358|NCT03364309|11940871|FG012|Maintenance Period|Withdrawal by Subject|0
7567359|NCT03364309|11940872|FG013|Maintenance Period|Withdrawal by Subject|0
7567360|NCT03364309|11940873|FG014|Maintenance Period|Withdrawal by Subject|0
7567361|NCT03364309|11940874|FG015|Maintenance Period|Withdrawal by Subject|0
7567362|NCT03364309|11940875|FG016|Maintenance Period|Withdrawal by Subject|0
7567363|NCT03364309|11940876|FG017|Maintenance Period|Withdrawal by Subject|0
7567364|NCT03364309|11940877|FG018|Maintenance Period|Withdrawal by Subject|0
7567365|NCT03364309|11940859|FG000|Maintenance Period|Adverse Event|0
7567366|NCT03364309|11940860|FG001|Maintenance Period|Adverse Event|0
7567367|NCT03364309|11940861|FG002|Maintenance Period|Adverse Event|0
7567368|NCT03364309|11940862|FG003|Maintenance Period|Adverse Event|0
7567369|NCT03364309|11940863|FG004|Maintenance Period|Adverse Event|2
7567370|NCT03364309|11940864|FG005|Maintenance Period|Adverse Event|0
7567371|NCT03364309|11940865|FG006|Maintenance Period|Adverse Event|3
7567372|NCT03364309|11940866|FG007|Maintenance Period|Adverse Event|0
7567373|NCT03364309|11940867|FG008|Maintenance Period|Adverse Event|1
7567374|NCT03364309|11940868|FG009|Maintenance Period|Adverse Event|0
7567375|NCT03364309|11940869|FG010|Maintenance Period|Adverse Event|2
7330030|NCT00806585|11563392|FG002|Overall Study|Physician Decision|3
7330031|NCT00806585|11563393|FG003|Overall Study|Physician Decision|0
7330032|NCT00806585|11563394|FG004|Overall Study|Physician Decision|1
7330033|NCT00806585|11563390|FG000|Overall Study|Lost to Follow-up|2
7330034|NCT00806585|11563391|FG001|Overall Study|Lost to Follow-up|1
7330035|NCT00806585|11563392|FG002|Overall Study|Lost to Follow-up|2
7330036|NCT00806585|11563393|FG003|Overall Study|Lost to Follow-up|2
7330037|NCT00806585|11563394|FG004|Overall Study|Lost to Follow-up|5
7330038|NCT00806585|11563390|FG000|Overall Study|Lack of Efficacy|1
7330039|NCT00806585|11563391|FG001|Overall Study|Lack of Efficacy|0
7330040|NCT00806585|11563392|FG002|Overall Study|Lack of Efficacy|0
7330041|NCT00806585|11563393|FG003|Overall Study|Lack of Efficacy|0
7330042|NCT00806585|11563394|FG004|Overall Study|Lack of Efficacy|0
7330043|NCT00806585|11563390|FG000|Overall Study|Adverse Event|1
7330044|NCT00806585|11563391|FG001|Overall Study|Adverse Event|5
7330045|NCT00806585|11563392|FG002|Overall Study|Adverse Event|3
7330046|NCT00806585|11563393|FG003|Overall Study|Adverse Event|4
7330047|NCT00806585|11563394|FG004|Overall Study|Adverse Event|2
7330048|NCT00806585|11563390|FG000|Overall Study|Withdrawal by Subject|10
7330049|NCT00806585|11563391|FG001|Overall Study|Withdrawal by Subject|8
7567376|NCT03364309|11940870|FG011|Maintenance Period|Adverse Event|0
7567377|NCT03364309|11940871|FG012|Maintenance Period|Adverse Event|0
7567378|NCT03364309|11940872|FG013|Maintenance Period|Adverse Event|0
7567379|NCT03364309|11940873|FG014|Maintenance Period|Adverse Event|0
7567380|NCT03364309|11940874|FG015|Maintenance Period|Adverse Event|0
7330050|NCT00806585|11563392|FG002|Overall Study|Withdrawal by Subject|9
7330051|NCT00806585|11563393|FG003|Overall Study|Withdrawal by Subject|3
7330052|NCT00806585|11563394|FG004|Overall Study|Withdrawal by Subject|11
7330053|NCT00806585|11563390|FG000|Overall Study|Completion status unknown|15
7567381|NCT03364309|11940875|FG016|Maintenance Period|Adverse Event|0
7330054|NCT00806585|11563391|FG001|Overall Study|Completion status unknown|14
7567382|NCT03364309|11940876|FG017|Maintenance Period|Adverse Event|0
7567383|NCT03364309|11940877|FG018|Maintenance Period|Adverse Event|0
7567384|NCT03364309|11940859|FG000|Maintenance Period|Relapsed|0
7567385|NCT03364309|11940860|FG001|Maintenance Period|Relapsed|0
7567386|NCT03364309|11940861|FG002|Maintenance Period|Relapsed|0
7567387|NCT03364309|11940862|FG003|Maintenance Period|Relapsed|43
7567388|NCT03364309|11940863|FG004|Maintenance Period|Relapsed|7
7567389|NCT03364309|11940864|FG005|Maintenance Period|Relapsed|45
7567390|NCT03364309|11940865|FG006|Maintenance Period|Relapsed|10
7567391|NCT03364309|11940866|FG007|Maintenance Period|Relapsed|2
7567392|NCT03364309|11940867|FG008|Maintenance Period|Relapsed|0
7567393|NCT03364309|11940868|FG009|Maintenance Period|Relapsed|0
7567394|NCT03364309|11940869|FG010|Maintenance Period|Relapsed|0
7567395|NCT03364309|11940870|FG011|Maintenance Period|Relapsed|0
7567396|NCT03364309|11940871|FG012|Maintenance Period|Relapsed|0
7567397|NCT03364309|11940872|FG013|Maintenance Period|Relapsed|0
7567398|NCT03364309|11940873|FG014|Maintenance Period|Relapsed|0
7567399|NCT03364309|11940874|FG015|Maintenance Period|Relapsed|0
7567400|NCT03364309|11940875|FG016|Maintenance Period|Relapsed|0
7567401|NCT03364309|11940876|FG017|Maintenance Period|Relapsed|0
7567402|NCT03364309|11940877|FG018|Maintenance Period|Relapsed|0
7567403|NCT03364309|11940859|FG000|Maintenance Period|Lack of Efficacy|0
7567404|NCT03364309|11940860|FG001|Maintenance Period|Lack of Efficacy|0
7567405|NCT03364309|11940861|FG002|Maintenance Period|Lack of Efficacy|0
7567406|NCT03364309|11940862|FG003|Maintenance Period|Lack of Efficacy|0
7567407|NCT03364309|11940863|FG004|Maintenance Period|Lack of Efficacy|0
7567408|NCT03364309|11940864|FG005|Maintenance Period|Lack of Efficacy|0
7567409|NCT03364309|11940865|FG006|Maintenance Period|Lack of Efficacy|0
7567410|NCT03364309|11940866|FG007|Maintenance Period|Lack of Efficacy|0
7567411|NCT03364309|11940867|FG008|Maintenance Period|Lack of Efficacy|1
7567412|NCT03364309|11940868|FG009|Maintenance Period|Lack of Efficacy|3
7567413|NCT03364309|11940869|FG010|Maintenance Period|Lack of Efficacy|2
7567414|NCT03364309|11940870|FG011|Maintenance Period|Lack of Efficacy|0
7567415|NCT03364309|11940871|FG012|Maintenance Period|Lack of Efficacy|0
7567416|NCT03364309|11940872|FG013|Maintenance Period|Lack of Efficacy|0
7567417|NCT03364309|11940873|FG014|Maintenance Period|Lack of Efficacy|0
7567418|NCT03364309|11940874|FG015|Maintenance Period|Lack of Efficacy|0
7567419|NCT03364309|11940875|FG016|Maintenance Period|Lack of Efficacy|0
7567420|NCT03364309|11940876|FG017|Maintenance Period|Lack of Efficacy|0
7567421|NCT03364309|11940877|FG018|Maintenance Period|Lack of Efficacy|0
7567422|NCT03364309|11940859|FG000|Maintenance Period|Death|0
7567423|NCT03364309|11940860|FG001|Maintenance Period|Death|0
7567424|NCT03364309|11940861|FG002|Maintenance Period|Death|0
7567425|NCT03364309|11940862|FG003|Maintenance Period|Death|0
7567426|NCT03364309|11940863|FG004|Maintenance Period|Death|0
7567427|NCT03364309|11940864|FG005|Maintenance Period|Death|0
7567428|NCT03364309|11940865|FG006|Maintenance Period|Death|0
7567429|NCT03364309|11940866|FG007|Maintenance Period|Death|0
7567430|NCT03364309|11940867|FG008|Maintenance Period|Death|1
7330055|NCT00806585|11563392|FG002|Overall Study|Completion status unknown|12
7330056|NCT00806585|11563393|FG003|Overall Study|Completion status unknown|4
7330057|NCT00806585|11563394|FG004|Overall Study|Completion status unknown|12
7330058|NCT00806624|11563413|FG000|Overall Study|Adverse Event|2
7330059|NCT00806624|11563414|FG001|Overall Study|Adverse Event|8
7330060|NCT00806624|11563415|FG002|Overall Study|Adverse Event|0
7330061|NCT00806624|11563413|FG000|Overall Study|Death|0
7330062|NCT00806624|11563414|FG001|Overall Study|Death|1
7330063|NCT00806624|11563415|FG002|Overall Study|Death|1
7330064|NCT00806624|11563413|FG000|Overall Study|Lost to Follow-up|1
7330065|NCT00806624|11563414|FG001|Overall Study|Lost to Follow-up|0
7330066|NCT00806624|11563415|FG002|Overall Study|Lost to Follow-up|1
7330067|NCT00806624|11563413|FG000|Overall Study|Withdrawal by Subject|6
7330068|NCT00806624|11563414|FG001|Overall Study|Withdrawal by Subject|3
7330069|NCT00806624|11563415|FG002|Overall Study|Withdrawal by Subject|3
7330070|NCT00806624|11563413|FG000|Overall Study|discontinued before start of treatment|0
7330071|NCT00806624|11563414|FG001|Overall Study|discontinued before start of treatment|0
7330072|NCT00806624|11563415|FG002|Overall Study|discontinued before start of treatment|1
7330073|NCT00806819|11563439|FG000|Overall Study|progressive disease (modified RECIST )|217
7330074|NCT00806819|11563440|FG001|Overall Study|progressive disease (modified RECIST )|216
7330075|NCT00806819|11563439|FG000|Overall Study|Worsening or AE of underlying disease|18
7330076|NCT00806819|11563440|FG001|Overall Study|Worsening or AE of underlying disease|25
7567431|NCT03364309|11940868|FG009|Maintenance Period|Death|0
7567432|NCT03364309|11940869|FG010|Maintenance Period|Death|0
7567433|NCT03364309|11940870|FG011|Maintenance Period|Death|0
7567434|NCT03364309|11940871|FG012|Maintenance Period|Death|0
7567435|NCT03364309|11940872|FG013|Maintenance Period|Death|0
7567436|NCT03364309|11940873|FG014|Maintenance Period|Death|0
7567437|NCT03364309|11940874|FG015|Maintenance Period|Death|0
7567438|NCT03364309|11940875|FG016|Maintenance Period|Death|0
7567439|NCT03364309|11940876|FG017|Maintenance Period|Death|0
7567440|NCT03364309|11940877|FG018|Maintenance Period|Death|0
7567441|NCT03364309|11940859|FG000|Maintenance Period|Lost to Follow-up|0
7567442|NCT03364309|11940860|FG001|Maintenance Period|Lost to Follow-up|0
7567443|NCT03364309|11940861|FG002|Maintenance Period|Lost to Follow-up|0
7567444|NCT03364309|11940862|FG003|Maintenance Period|Lost to Follow-up|0
7567445|NCT03364309|11940863|FG004|Maintenance Period|Lost to Follow-up|0
7567446|NCT03364309|11940864|FG005|Maintenance Period|Lost to Follow-up|0
7567447|NCT03364309|11940865|FG006|Maintenance Period|Lost to Follow-up|0
7567448|NCT03364309|11940866|FG007|Maintenance Period|Lost to Follow-up|0
7567449|NCT03364309|11940867|FG008|Maintenance Period|Lost to Follow-up|1
7567450|NCT03364309|11940868|FG009|Maintenance Period|Lost to Follow-up|0
7567451|NCT03364309|11940869|FG010|Maintenance Period|Lost to Follow-up|0
7567452|NCT03364309|11940870|FG011|Maintenance Period|Lost to Follow-up|0
7567453|NCT03364309|11940871|FG012|Maintenance Period|Lost to Follow-up|0
7567454|NCT03364309|11940872|FG013|Maintenance Period|Lost to Follow-up|0
7567455|NCT03364309|11940873|FG014|Maintenance Period|Lost to Follow-up|0
7567456|NCT03364309|11940874|FG015|Maintenance Period|Lost to Follow-up|0
7567457|NCT03364309|11940875|FG016|Maintenance Period|Lost to Follow-up|0
7567458|NCT03364309|11940876|FG017|Maintenance Period|Lost to Follow-up|0
7567459|NCT03364309|11940877|FG018|Maintenance Period|Lost to Follow-up|0
7567460|NCT03364309|11940859|FG000|Maintenance Period|Miscellaneous|0
7567461|NCT03364309|11940860|FG001|Maintenance Period|Miscellaneous|0
7567462|NCT03364309|11940861|FG002|Maintenance Period|Miscellaneous|0
7567463|NCT03364309|11940862|FG003|Maintenance Period|Miscellaneous|0
7567464|NCT03364309|11940863|FG004|Maintenance Period|Miscellaneous|0
7567465|NCT03364309|11940864|FG005|Maintenance Period|Miscellaneous|0
7567466|NCT03364309|11940865|FG006|Maintenance Period|Miscellaneous|0
7567467|NCT03364309|11940866|FG007|Maintenance Period|Miscellaneous|0
7567468|NCT03364309|11940867|FG008|Maintenance Period|Miscellaneous|1
7567469|NCT03364309|11940868|FG009|Maintenance Period|Miscellaneous|0
7567470|NCT03364309|11940869|FG010|Maintenance Period|Miscellaneous|0
7567471|NCT03364309|11940870|FG011|Maintenance Period|Miscellaneous|0
7567472|NCT03364309|11940871|FG012|Maintenance Period|Miscellaneous|0
7567473|NCT03364309|11940872|FG013|Maintenance Period|Miscellaneous|0
7567474|NCT03364309|11940873|FG014|Maintenance Period|Miscellaneous|0
7567475|NCT03364309|11940874|FG015|Maintenance Period|Miscellaneous|0
7567476|NCT03364309|11940875|FG016|Maintenance Period|Miscellaneous|0
7567477|NCT03364309|11940876|FG017|Maintenance Period|Miscellaneous|0
7567478|NCT03364309|11940877|FG018|Maintenance Period|Miscellaneous|0
7567479|NCT03364309|11940859|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567480|NCT03364309|11940860|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567481|NCT03364309|11940861|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567482|NCT03364309|11940862|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567483|NCT03364309|11940863|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567484|NCT03364309|11940864|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567485|NCT03364309|11940865|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567486|NCT03364309|11940866|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567487|NCT03364309|11940867|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567488|NCT03364309|11940868|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567489|NCT03364309|11940869|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567490|NCT03364309|11940870|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567491|NCT03364309|11940871|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567492|NCT03364309|11940872|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7567493|NCT03364309|11940873|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7567494|NCT03364309|11940874|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
7567495|NCT03364309|11940875|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567496|NCT03364309|11940876|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567497|NCT03364309|11940877|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
7567498|NCT03364309|11940859|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
7567499|NCT03364309|11940860|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
7567500|NCT03364309|11940861|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
7567501|NCT03364309|11940862|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
7567502|NCT03364309|11940863|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
7567503|NCT03364309|11940864|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
7567504|NCT03364309|11940865|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
7567505|NCT03364309|11940866|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
7567506|NCT03364309|11940867|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
7330077|NCT00806819|11563439|FG000|Overall Study|Other AE|38
7330078|NCT00806819|11563440|FG001|Overall Study|Other AE|40
7330079|NCT00806819|11563439|FG000|Overall Study|Protocol Violation|9
7330080|NCT00806819|11563440|FG001|Overall Study|Protocol Violation|4
7330081|NCT00806819|11563439|FG000|Overall Study|Lost to Follow-up|1
7457634|NCT01800916|11751294|FG000|Test Period 1 (1 Week)|Convex product user|0
7330082|NCT00806819|11563440|FG001|Overall Study|Lost to Follow-up|0
7330083|NCT00806819|11563439|FG000|Overall Study|Withdrawal by Subject|32
7330084|NCT00806819|11563440|FG001|Overall Study|Withdrawal by Subject|29
7330085|NCT00806819|11563439|FG000|Overall Study|Not treated|6
7330086|NCT00806819|11563440|FG001|Overall Study|Not treated|3
7330087|NCT00806819|11563439|FG000|Overall Study|Reasons other than stated above|25
7457635|NCT01800916|11751295|FG001|Test Period 1 (1 Week)|Convex product user|0
7330088|NCT00806819|11563440|FG001|Overall Study|Reasons other than stated above|41
7330089|NCT00806988|11563449|FG000|Overall Study|Death|15
7330090|NCT00806988|11563450|FG001|Overall Study|Death|16
7457636|NCT01800916|11751296|FG002|Test Period 1 (1 Week)|Convex product user|0
7567507|NCT03364309|11940868|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
7567508|NCT03364309|11940869|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
7567509|NCT03364309|11940870|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
7567510|NCT03364309|11940871|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
7567511|NCT03364309|11940872|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
7567512|NCT03364309|11940873|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
7567513|NCT03364309|11940874|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
7567514|NCT03364309|11940875|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
7567515|NCT03364309|11940876|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
7567516|NCT03364309|11940877|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
7567517|NCT03364309|11940859|FG000|Re-treatment (Maintenance) Period|Relapse|0
7567518|NCT03364309|11940860|FG001|Re-treatment (Maintenance) Period|Relapse|0
7567519|NCT03364309|11940861|FG002|Re-treatment (Maintenance) Period|Relapse|0
7567520|NCT03364309|11940862|FG003|Re-treatment (Maintenance) Period|Relapse|0
7567521|NCT03364309|11940863|FG004|Re-treatment (Maintenance) Period|Relapse|0
7567522|NCT03364309|11940864|FG005|Re-treatment (Maintenance) Period|Relapse|0
7567523|NCT03364309|11940865|FG006|Re-treatment (Maintenance) Period|Relapse|0
7567524|NCT03364309|11940866|FG007|Re-treatment (Maintenance) Period|Relapse|0
7567525|NCT03364309|11940867|FG008|Re-treatment (Maintenance) Period|Relapse|0
7567526|NCT03364309|11940868|FG009|Re-treatment (Maintenance) Period|Relapse|0
7567527|NCT03364309|11940869|FG010|Re-treatment (Maintenance) Period|Relapse|0
7567528|NCT03364309|11940870|FG011|Re-treatment (Maintenance) Period|Relapse|0
7567529|NCT03364309|11940871|FG012|Re-treatment (Maintenance) Period|Relapse|1
7567530|NCT03364309|11940872|FG013|Re-treatment (Maintenance) Period|Relapse|0
7567531|NCT03364309|11940873|FG014|Re-treatment (Maintenance) Period|Relapse|0
7567532|NCT03364309|11940874|FG015|Re-treatment (Maintenance) Period|Relapse|1
7567533|NCT03364309|11940875|FG016|Re-treatment (Maintenance) Period|Relapse|0
7567534|NCT03364309|11940876|FG017|Re-treatment (Maintenance) Period|Relapse|0
7567535|NCT03364309|11940877|FG018|Re-treatment (Maintenance) Period|Relapse|0
7567536|NCT03364309|11940859|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
7567537|NCT03364309|11940860|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
7567538|NCT03364309|11940861|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
7567539|NCT03364309|11940862|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
7567540|NCT03364309|11940863|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7567541|NCT03364309|11940864|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
7567542|NCT03364309|11940865|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
7567543|NCT03364309|11940866|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
7567544|NCT03364309|11940867|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
7567545|NCT03364309|11940868|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
7567546|NCT03364309|11940869|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
7567547|NCT03364309|11940870|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
7567548|NCT03364309|11940871|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
7567549|NCT03364309|11940872|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
7567550|NCT03364309|11940873|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
7567551|NCT03364309|11940874|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
7567552|NCT03364309|11940875|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
7567553|NCT03364309|11940876|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
7567554|NCT03364309|11940877|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
7567555|NCT03364309|11940859|FG000|Post-Treatment Followup Period|Adverse Event|0
7567556|NCT03364309|11940860|FG001|Post-Treatment Followup Period|Adverse Event|0
7567557|NCT03364309|11940861|FG002|Post-Treatment Followup Period|Adverse Event|0
7567558|NCT03364309|11940862|FG003|Post-Treatment Followup Period|Adverse Event|0
7567559|NCT03364309|11940863|FG004|Post-Treatment Followup Period|Adverse Event|0
7567560|NCT03364309|11940864|FG005|Post-Treatment Followup Period|Adverse Event|0
7567561|NCT03364309|11940865|FG006|Post-Treatment Followup Period|Adverse Event|0
7567562|NCT03364309|11940866|FG007|Post-Treatment Followup Period|Adverse Event|0
7567563|NCT03364309|11940867|FG008|Post-Treatment Followup Period|Adverse Event|0
7567564|NCT03364309|11940868|FG009|Post-Treatment Followup Period|Adverse Event|0
7567565|NCT03364309|11940869|FG010|Post-Treatment Followup Period|Adverse Event|0
7567566|NCT03364309|11940870|FG011|Post-Treatment Followup Period|Adverse Event|0
7567567|NCT03364309|11940871|FG012|Post-Treatment Followup Period|Adverse Event|0
7567568|NCT03364309|11940872|FG013|Post-Treatment Followup Period|Adverse Event|0
7567569|NCT03364309|11940873|FG014|Post-Treatment Followup Period|Adverse Event|0
7567570|NCT03364309|11940874|FG015|Post-Treatment Followup Period|Adverse Event|0
7567571|NCT03364309|11940875|FG016|Post-Treatment Followup Period|Adverse Event|2
7567572|NCT03364309|11940876|FG017|Post-Treatment Followup Period|Adverse Event|6
7567573|NCT03364309|11940877|FG018|Post-Treatment Followup Period|Adverse Event|1
7567574|NCT03364309|11940859|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
7567575|NCT03364309|11940860|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
7567576|NCT03364309|11940861|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
7567577|NCT03364309|11940862|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7567578|NCT03364309|11940863|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7567579|NCT03364309|11940864|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
7567580|NCT03364309|11940865|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
7567581|NCT03364309|11940866|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
7330091|NCT00806988|11563449|FG000|Overall Study|Withdrawal by Subject|8
7330092|NCT00806988|11563450|FG001|Overall Study|Withdrawal by Subject|8
7330093|NCT00806988|11563449|FG000|Overall Study|Lost to Follow-up|4
7330094|NCT00806988|11563450|FG001|Overall Study|Lost to Follow-up|19
7330095|NCT00807001|11563461|FG000|Overall Study|Non-compliance|0
7330096|NCT00807001|11563462|FG001|Overall Study|Non-compliance|1
7330097|NCT00807001|11563463|FG002|Overall Study|Non-compliance|0
7330098|NCT00807001|11563464|FG003|Overall Study|Non-compliance|0
7330099|NCT00807001|11563465|FG004|Overall Study|Non-compliance|0
7330100|NCT00807014|11563479|FG000|Overall Study|Participant Considered Disease Cured|13
7330101|NCT00807014|11563480|FG001|Overall Study|Participant Considered Disease Cured|2
7330102|NCT00807014|11563479|FG000|Overall Study|Participant Considered Disease Not Cured|2
7330103|NCT00807014|11563480|FG001|Overall Study|Participant Considered Disease Not Cured|7
7330104|NCT00807014|11563479|FG000|Overall Study|Protocol Violation|2
7330105|NCT00807014|11563480|FG001|Overall Study|Protocol Violation|8
7330106|NCT00807014|11563479|FG000|Overall Study|Adverse Event|0
7330107|NCT00807014|11563480|FG001|Overall Study|Adverse Event|2
7330108|NCT00807014|11563479|FG000|Overall Study|Lost to Follow-up|9
7330109|NCT00807014|11563480|FG001|Overall Study|Lost to Follow-up|7
7330110|NCT00807014|11563479|FG000|Overall Study|Recovery|1
7330111|NCT00807014|11563480|FG001|Overall Study|Recovery|0
7330112|NCT00807014|11563479|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
7330113|NCT00807014|11563480|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
7330114|NCT00807040|11563488|FG000|Overall Study|Death|24
7330115|NCT00807040|11563489|FG001|Overall Study|Death|29
7330116|NCT00807040|11563488|FG000|Overall Study|Withdrawal by Subject|8
7330117|NCT00807040|11563489|FG001|Overall Study|Withdrawal by Subject|6
7330118|NCT00807040|11563488|FG000|Overall Study|Lost to Follow-up|4
7330119|NCT00807040|11563489|FG001|Overall Study|Lost to Follow-up|6
7330120|NCT00807092|11563497|FG000|Overall Study|Adverse Event|0
7330121|NCT00807092|11563498|FG001|Overall Study|Adverse Event|1
7330122|NCT00807092|11563497|FG000|Overall Study|Protocol Violation|0
7330123|NCT00807092|11563498|FG001|Overall Study|Protocol Violation|2
7567582|NCT03364309|11940867|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
7567583|NCT03364309|11940868|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
7567584|NCT03364309|11940869|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
7567585|NCT03364309|11940870|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
7330124|NCT00807092|11563497|FG000|Overall Study|Withdrawal by Subject|1
7330125|NCT00807092|11563498|FG001|Overall Study|Withdrawal by Subject|0
7330126|NCT00807092|11563497|FG000|Overall Study|CGMS data collection failed|0
7330127|NCT00807092|11563498|FG001|Overall Study|CGMS data collection failed|1
7330128|NCT00807144|11563506|FG000|Overall Study|Lost to Follow-up|0
7330129|NCT00807144|11563507|FG001|Overall Study|Lost to Follow-up|1
7330130|NCT00807235|11563528|FG000|Overall Study|Adverse Event|1
7330131|NCT00807235|11563529|FG001|Overall Study|Adverse Event|0
7330132|NCT00807248|11563539|FG000|Overall Study|Adverse Event|1
7330133|NCT00807248|11563540|FG001|Overall Study|Adverse Event|2
7457637|NCT01800916|11751297|FG003|Test Period 1 (1 Week)|Convex product user|1
7457638|NCT01800916|11751298|FG004|Test Period 1 (1 Week)|Convex product user|0
7567586|NCT03364309|11940871|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
7567587|NCT03364309|11940872|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
7567588|NCT03364309|11940873|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
7567589|NCT03364309|11940874|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
7567590|NCT03364309|11940875|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
7567591|NCT03364309|11940876|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
7457639|NCT01800916|11751299|FG005|Test Period 1 (1 Week)|Convex product user|0
7567592|NCT03364309|11940877|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
7567593|NCT03364309|11940859|FG000|Post-Treatment Followup Period|Miscellaneous|0
7567594|NCT03364309|11940860|FG001|Post-Treatment Followup Period|Miscellaneous|0
7567595|NCT03364309|11940861|FG002|Post-Treatment Followup Period|Miscellaneous|0
7567596|NCT03364309|11940862|FG003|Post-Treatment Followup Period|Miscellaneous|0
7567597|NCT03364309|11940863|FG004|Post-Treatment Followup Period|Miscellaneous|0
7567598|NCT03364309|11940864|FG005|Post-Treatment Followup Period|Miscellaneous|0
7567599|NCT03364309|11940865|FG006|Post-Treatment Followup Period|Miscellaneous|0
7567600|NCT03364309|11940866|FG007|Post-Treatment Followup Period|Miscellaneous|0
7567601|NCT03364309|11940867|FG008|Post-Treatment Followup Period|Miscellaneous|0
7567602|NCT03364309|11940868|FG009|Post-Treatment Followup Period|Miscellaneous|0
7567603|NCT03364309|11940869|FG010|Post-Treatment Followup Period|Miscellaneous|0
7567604|NCT03364309|11940870|FG011|Post-Treatment Followup Period|Miscellaneous|0
7567605|NCT03364309|11940871|FG012|Post-Treatment Followup Period|Miscellaneous|0
7567606|NCT03364309|11940872|FG013|Post-Treatment Followup Period|Miscellaneous|0
7567607|NCT03364309|11940873|FG014|Post-Treatment Followup Period|Miscellaneous|0
7567608|NCT03364309|11940874|FG015|Post-Treatment Followup Period|Miscellaneous|0
7567609|NCT03364309|11940875|FG016|Post-Treatment Followup Period|Miscellaneous|0
7567610|NCT03364309|11940876|FG017|Post-Treatment Followup Period|Miscellaneous|4
7330134|NCT00807248|11563541|FG002|Overall Study|Adverse Event|2
7330135|NCT00807248|11563542|FG003|Overall Study|Adverse Event|6
7330136|NCT00807248|11563539|FG000|Overall Study|Lack of Efficacy|14
7330137|NCT00807248|11563540|FG001|Overall Study|Lack of Efficacy|4
7330138|NCT00807248|11563541|FG002|Overall Study|Lack of Efficacy|8
7330139|NCT00807248|11563542|FG003|Overall Study|Lack of Efficacy|3
7330140|NCT00807248|11563539|FG000|Overall Study|Protocol Violation|0
7330141|NCT00807248|11563540|FG001|Overall Study|Protocol Violation|1
7330142|NCT00807248|11563541|FG002|Overall Study|Protocol Violation|1
7330143|NCT00807248|11563542|FG003|Overall Study|Protocol Violation|0
7330144|NCT00807248|11563539|FG000|Overall Study|Withdrawal of Consent|5
7330145|NCT00807248|11563540|FG001|Overall Study|Withdrawal of Consent|5
7330146|NCT00807248|11563541|FG002|Overall Study|Withdrawal of Consent|5
7330147|NCT00807248|11563542|FG003|Overall Study|Withdrawal of Consent|5
7330148|NCT00807248|11563539|FG000|Overall Study|Lost to Follow-up|1
7330149|NCT00807248|11563540|FG001|Overall Study|Lost to Follow-up|0
7330150|NCT00807248|11563541|FG002|Overall Study|Lost to Follow-up|0
7330151|NCT00807248|11563542|FG003|Overall Study|Lost to Follow-up|0
7330152|NCT00807248|11563539|FG000|Overall Study|Other Reason|0
7330153|NCT00807248|11563540|FG001|Overall Study|Other Reason|0
7330154|NCT00807248|11563541|FG002|Overall Study|Other Reason|2
7330155|NCT00807248|11563542|FG003|Overall Study|Other Reason|0
7330156|NCT00807495|11563561|FG000|Overall Study|Adverse Event|6
7330157|NCT00807495|11563562|FG001|Overall Study|Adverse Event|3
7330158|NCT00807495|11563563|FG002|Overall Study|Adverse Event|1
7330159|NCT00807495|11563564|FG003|Overall Study|Adverse Event|1
7330160|NCT00807495|11563565|FG004|Overall Study|Adverse Event|2
7330161|NCT00807495|11563561|FG000|Overall Study|Withdrawal by Patient|2
7330162|NCT00807495|11563562|FG001|Overall Study|Withdrawal by Patient|0
7330163|NCT00807495|11563563|FG002|Overall Study|Withdrawal by Patient|1
7330164|NCT00807495|11563564|FG003|Overall Study|Withdrawal by Patient|0
7330165|NCT00807495|11563565|FG004|Overall Study|Withdrawal by Patient|0
7330166|NCT00807495|11563561|FG000|Overall Study|Reason Not Specified|0
7330167|NCT00807495|11563562|FG001|Overall Study|Reason Not Specified|3
7330168|NCT00807495|11563563|FG002|Overall Study|Reason Not Specified|2
7330169|NCT00807495|11563564|FG003|Overall Study|Reason Not Specified|0
7330170|NCT00807495|11563565|FG004|Overall Study|Reason Not Specified|3
7385114|NCT01199016|11642678|FG000|Overall Study|No longer meets eligibility criteria|4
7385115|NCT01199016|11642678|FG000|Overall Study|Entrance criteria|5
7385116|NCT01199016|11642678|FG000|Overall Study|Protocol Violation|9
7385117|NCT01199016|11642678|FG000|Overall Study|Other|13
7385118|NCT01199016|11642678|FG000|Overall Study|Withdrawal by Subject|21
7385119|NCT01199016|11642678|FG000|Overall Study|Lost to Follow-up|25
7385120|NCT01199042|11642682|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
7385121|NCT01199042|11642682|FG000|At Home (3 Months)|Lost to Follow-up|1
7385122|NCT01199055|11642694|FG000|Overall Study|Death|0
7385123|NCT01199055|11642695|FG001|Overall Study|Death|1
7385124|NCT01199055|11642696|FG002|Overall Study|Death|0
7385125|NCT01199055|11642694|FG000|Overall Study|Physician Decision|0
7385126|NCT01199055|11642695|FG001|Overall Study|Physician Decision|1
7385127|NCT01199055|11642696|FG002|Overall Study|Physician Decision|1
7385128|NCT01199055|11642694|FG000|Overall Study|Progressive disease|2
7385129|NCT01199055|11642695|FG001|Overall Study|Progressive disease|1
7567611|NCT03364309|11940877|FG018|Post-Treatment Followup Period|Miscellaneous|0
7567612|NCT03364335|11940906|FG000|Overall Study|Adverse Event|3
7567613|NCT03364335|11940907|FG001|Overall Study|Adverse Event|4
7567614|NCT03364335|11940908|FG002|Overall Study|Adverse Event|1
7567615|NCT03364335|11940909|FG003|Overall Study|Adverse Event|2
7567616|NCT03364335|11940910|FG004|Overall Study|Adverse Event|0
7567617|NCT03364335|11940906|FG000|Overall Study|Lost to Follow-up|7
7567618|NCT03364335|11940907|FG001|Overall Study|Lost to Follow-up|7
7567619|NCT03364335|11940908|FG002|Overall Study|Lost to Follow-up|10
7567620|NCT03364335|11940909|FG003|Overall Study|Lost to Follow-up|11
7567621|NCT03364335|11940910|FG004|Overall Study|Lost to Follow-up|11
7567622|NCT03364608|11940922|FG000|Overall Study|Withdrawal by Subject|4
7567623|NCT03364608|11940922|FG000|Overall Study|Protocol Violation|2
7567624|NCT03364608|11940922|FG000|Overall Study|Lost to Follow-up|2
7567625|NCT03364738|11940934|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
7567626|NCT03364738|11940934|FG000|Overall Study|Withdrawal by Subject|1
7567627|NCT03364738|11940934|FG000|Overall Study|Adverse Event|1
7567628|NCT03364751|11940943|FG000|Overall Study|Withdrawal by Subject|1
7567629|NCT03364751|11940944|FG001|Overall Study|Withdrawal by Subject|0
7567630|NCT03364751|11940945|FG002|Overall Study|Withdrawal by Subject|0
7567631|NCT03364751|11940946|FG003|Overall Study|Withdrawal by Subject|0
7567632|NCT03364751|11940943|FG000|Overall Study|Lost to Follow-up|0
7385130|NCT01199055|11642696|FG002|Overall Study|Progressive disease|2
7385131|NCT01199055|11642694|FG000|Overall Study|Withdrawal by Subject|0
7385132|NCT01199055|11642695|FG001|Overall Study|Withdrawal by Subject|0
7385133|NCT01199055|11642696|FG002|Overall Study|Withdrawal by Subject|1
7567633|NCT03364751|11940944|FG001|Overall Study|Lost to Follow-up|1
7567634|NCT03364751|11940945|FG002|Overall Study|Lost to Follow-up|0
7567635|NCT03364751|11940946|FG003|Overall Study|Lost to Follow-up|0
7385134|NCT01199068|11642709|FG000|Overall Study|Unacceptable toxicity|0
7385135|NCT01199068|11642710|FG001|Overall Study|Unacceptable toxicity|0
7385136|NCT01199068|11642711|FG002|Overall Study|Unacceptable toxicity|2
7385137|NCT01199068|11642709|FG000|Overall Study|Progressive disease|3
7385138|NCT01199068|11642710|FG001|Overall Study|Progressive disease|3
7567636|NCT03365011|11940962|FG000|Overall Study|Withdrawal by Subject|1
7567637|NCT03365011|11940963|FG001|Overall Study|Withdrawal by Subject|2
7575193|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7575194|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
7575195|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
7575196|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
7575197|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
7575198|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
7575199|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
7575200|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
7575201|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
7575202|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7575203|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7575204|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
7575205|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7575206|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
7575207|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
7575208|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
7575209|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7575210|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
7575211|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
7575212|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
7575213|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
7575214|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7575215|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7575216|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7575217|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7575218|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
7575219|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
7575220|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Other|1
7575221|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Other|0
7575222|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Other|0
7575223|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Other|1
7575224|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Other|2
7575225|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Other|2
7575226|NCT03720470|11958907|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7575227|NCT03720470|11958908|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7575228|NCT03720470|11958909|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7575229|NCT03720470|11958910|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7575230|NCT03720470|11958911|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
7575231|NCT03720470|11958912|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
7575232|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
7575233|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
7575234|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
7575235|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
7575236|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
7575237|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
7575238|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7575239|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7575240|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
7575241|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7575242|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7575243|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
7575244|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7330171|NCT00807573|11563586|FG000|Overall Study|Withdrawal by Subject|1
7330172|NCT00807573|11563586|FG000|Overall Study|Adverse Event|1
7330173|NCT00807599|11563601|FG000|Overall Study|Not treated on protocol study|0
7330174|NCT00807599|11563602|FG001|Overall Study|Not treated on protocol study|0
7330175|NCT00807599|11563603|FG002|Overall Study|Not treated on protocol study|2
7330176|NCT00807599|11563601|FG000|Overall Study|Adverse Event|0
7330177|NCT00807599|11563602|FG001|Overall Study|Adverse Event|0
7330178|NCT00807599|11563603|FG002|Overall Study|Adverse Event|5
7330179|NCT00807599|11563601|FG000|Overall Study|Inadequate response to induction|0
7330180|NCT00807599|11563602|FG001|Overall Study|Inadequate response to induction|0
7330181|NCT00807599|11563603|FG002|Overall Study|Inadequate response to induction|9
7330182|NCT00807599|11563601|FG000|Overall Study|Withdrawal by Subject|0
7330183|NCT00807599|11563602|FG001|Overall Study|Withdrawal by Subject|0
7330184|NCT00807599|11563603|FG002|Overall Study|Withdrawal by Subject|1
7330185|NCT00807742|11563621|FG000|Overall Study|Death|9
7330186|NCT00807742|11563622|FG001|Overall Study|Death|2
7330187|NCT00807742|11563621|FG000|Overall Study|Withdrawal by Subject|2
7567638|NCT03365934|11940986|FG000|Overall Study|Adverse Event|1
7567639|NCT03365934|11940986|FG000|Overall Study|Withdrawal by Subject|1
7567640|NCT03367793|11941016|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7567641|NCT03367793|11941017|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7567642|NCT03367793|11941018|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
7567643|NCT03367793|11941019|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7567644|NCT03367793|11941020|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7567645|NCT03367793|11941021|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
7567646|NCT03368807|11941045|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
7567647|NCT03368807|11941045|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
7567648|NCT03368807|11941045|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
7567649|NCT03368807|11941045|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
7567650|NCT03368859|11941053|FG000|Overall Study|Withdrew Consent|5
7567651|NCT03368859|11941054|FG001|Overall Study|Withdrew Consent|4
7567652|NCT03368859|11941053|FG000|Overall Study|Death|12
7567653|NCT03368859|11941054|FG001|Overall Study|Death|6
7567654|NCT03368859|11941053|FG000|Overall Study|Study terminated by Sponsor|18
7567655|NCT03368859|11941054|FG001|Overall Study|Study terminated by Sponsor|23
7567656|NCT03368859|11941053|FG000|Overall Study|Other|1
7567657|NCT03368859|11941054|FG001|Overall Study|Other|1
7567658|NCT03369236|11941084|FG000|Double-blind Treatment Period|Accidental unblinding|0
7330188|NCT00807742|11563622|FG001|Overall Study|Withdrawal by Subject|1
7330189|NCT00807742|11563621|FG000|Overall Study|Lost to Follow-up|35
7330190|NCT00807742|11563622|FG001|Overall Study|Lost to Follow-up|51
7330191|NCT00807846|11563639|FG000|Overall Study|Adverse Event|5
7330192|NCT00807846|11563640|FG001|Overall Study|Adverse Event|0
7330193|NCT00807846|11563639|FG000|Overall Study|Lack of Efficacy|2
7330194|NCT00807846|11563640|FG001|Overall Study|Lack of Efficacy|0
7330195|NCT00807846|11563639|FG000|Overall Study|Protocol Violation|2
7330196|NCT00807846|11563640|FG001|Overall Study|Protocol Violation|1
7330197|NCT00807846|11563639|FG000|Overall Study|Withdrawal by Subject|2
7330198|NCT00807846|11563640|FG001|Overall Study|Withdrawal by Subject|1
7330199|NCT00807846|11563639|FG000|Overall Study|Other|1
7330200|NCT00807846|11563640|FG001|Overall Study|Other|2
7330201|NCT00807885|11563655|FG000|Overall Study|Lost to Follow-up|0
7330202|NCT00807885|11563656|FG001|Overall Study|Lost to Follow-up|0
7330203|NCT00807885|11563657|FG002|Overall Study|Lost to Follow-up|0
7330204|NCT00807885|11563658|FG003|Overall Study|Lost to Follow-up|0
7457640|NCT01800916|11751300|FG006|Test Period 1 (1 Week)|Convex product user|0
7457641|NCT01800916|11751301|FG007|Test Period 1 (1 Week)|Convex product user|0
7457642|NCT01800916|11751302|FG008|Test Period 1 (1 Week)|Convex product user|0
7457643|NCT01800916|11751294|FG000|Test Period 1 (1 Week)|Adverse Event|0
7457644|NCT01800916|11751295|FG001|Test Period 1 (1 Week)|Adverse Event|0
7457645|NCT01800916|11751296|FG002|Test Period 1 (1 Week)|Adverse Event|0
7457646|NCT01800916|11751297|FG003|Test Period 1 (1 Week)|Adverse Event|0
7457647|NCT01800916|11751298|FG004|Test Period 1 (1 Week)|Adverse Event|1
7457648|NCT01800916|11751299|FG005|Test Period 1 (1 Week)|Adverse Event|0
7457649|NCT01800916|11751300|FG006|Test Period 1 (1 Week)|Adverse Event|0
7457650|NCT01800916|11751301|FG007|Test Period 1 (1 Week)|Adverse Event|0
7457651|NCT01800916|11751302|FG008|Test Period 1 (1 Week)|Adverse Event|0
7457652|NCT01800968|11751314|FG000|Overall Study|Death|23
7457653|NCT01800968|11751315|FG001|Overall Study|Death|16
7457654|NCT01800968|11751314|FG000|Overall Study|Lost to Follow-up|5
7457655|NCT01800968|11751315|FG001|Overall Study|Lost to Follow-up|7
7457656|NCT01800968|11751314|FG000|Overall Study|Withdrawal by Subject|7
7457657|NCT01800968|11751315|FG001|Overall Study|Withdrawal by Subject|9
7457658|NCT01800968|11751314|FG000|Overall Study|Physician Decision|1
7457659|NCT01800968|11751315|FG001|Overall Study|Physician Decision|0
7457660|NCT01801007|11751321|FG000|Overall Study|Adverse Event|2
7457661|NCT01801007|11751321|FG000|Overall Study|Lost to Follow-up|4
7457662|NCT01801007|11751321|FG000|Overall Study|Withdrawal by Subject|5
7457663|NCT01801111|11751325|FG000|Overall Study|Adverse Event|12
7457664|NCT01801111|11751325|FG000|Overall Study|Death|8
7457665|NCT01801111|11751325|FG000|Overall Study|Physician Decision|5
7457666|NCT01801111|11751325|FG000|Overall Study|Other|1
7457667|NCT01801111|11751325|FG000|Overall Study|Withdrawal by Subject|4
7457668|NCT01801111|11751325|FG000|Overall Study|Study Terminated by Sponsor|27
7457669|NCT01801111|11751325|FG000|Overall Study|Progressive Disease|81
7457670|NCT01801280|11751346|FG000|Period 1|Withdrawal by Subject|0
7457671|NCT01801280|11751347|FG001|Period 1|Withdrawal by Subject|1
7457672|NCT01801280|11751348|FG002|Period 1|Withdrawal by Subject|0
7457673|NCT01801280|11751349|FG003|Period 1|Withdrawal by Subject|0
7567659|NCT03369236|11941085|FG001|Double-blind Treatment Period|Accidental unblinding|1
7567660|NCT03369236|11941084|FG000|Open-label Extension Period|Lack of Efficacy|2
7567661|NCT03369236|11941085|FG001|Open-label Extension Period|Lack of Efficacy|1
7567662|NCT03369236|11941084|FG000|Open-label Extension Period|Adverse Event|0
7330205|NCT00807885|11563659|FG004|Overall Study|Lost to Follow-up|0
7457674|NCT01801280|11751346|FG000|Period 2|Withdrawal by Subject|1
7457675|NCT01801280|11751347|FG001|Period 2|Withdrawal by Subject|0
7457676|NCT01801280|11751348|FG002|Period 2|Withdrawal by Subject|0
7457677|NCT01801280|11751349|FG003|Period 2|Withdrawal by Subject|0
7457678|NCT01801280|11751346|FG000|Period 4|Protocol Violation|0
7457679|NCT01801280|11751347|FG001|Period 4|Protocol Violation|0
7457680|NCT01801280|11751348|FG002|Period 4|Protocol Violation|1
7567663|NCT03369236|11941085|FG001|Open-label Extension Period|Adverse Event|1
7567664|NCT03369236|11941084|FG000|Open-label Extension Period|Sponsor decision to close study|3
7567665|NCT03369236|11941085|FG001|Open-label Extension Period|Sponsor decision to close study|4
7567666|NCT03369418|11941114|FG000|Overall Study|Withdrawal by Subject|3
7567667|NCT03369418|11941115|FG001|Overall Study|Withdrawal by Subject|3
7567668|NCT03369704|11941123|FG000|Treatment Epoch|technical problems|1
7567669|NCT03369704|11941124|FG001|Treatment Epoch|technical problems|0
7567670|NCT03369704|11941123|FG000|Treatment Epoch|Protocol Violation|1
7567671|NCT03369704|11941124|FG001|Treatment Epoch|Protocol Violation|0
7567672|NCT03369704|11941123|FG000|Treatment Epoch|Lost to Follow-up|0
7567673|NCT03369704|11941124|FG001|Treatment Epoch|Lost to Follow-up|1
7567674|NCT03369704|11941123|FG000|Treatment Epoch|Lack of Efficacy|0
7567675|NCT03369704|11941124|FG001|Treatment Epoch|Lack of Efficacy|2
7567676|NCT03369704|11941123|FG000|Treatment Epoch|Adverse Event|2
7567677|NCT03369704|11941124|FG001|Treatment Epoch|Adverse Event|0
7567678|NCT03369704|11941123|FG000|Follow-up Epoch|Lost to Follow-up|1
7567679|NCT03369704|11941124|FG001|Follow-up Epoch|Lost to Follow-up|0
7567680|NCT03369951|11941134|FG000|Overall Study|Withdrawal by Subject|3
7567681|NCT03369951|11941134|FG000|Overall Study|Death|1
7567682|NCT03369951|11941134|FG000|Overall Study|Lost to Follow-up|1
7567683|NCT03369951|11941134|FG000|Overall Study|Protocol Violation|1
7567684|NCT03370289|11941151|FG000|Overall Study|Screen Failure|1
7567685|NCT03370289|11941151|FG000|Overall Study|Sample Size Sufficient|4
7567686|NCT03370302|11941161|FG000|Dose Escalation Phase|Other|0
7567687|NCT03370302|11941162|FG001|Dose Escalation Phase|Other|1
7567688|NCT03370302|11941163|FG002|Dose Escalation Phase|Other|1
7567689|NCT03370302|11941164|FG003|Dose Escalation Phase|Other|0
7567690|NCT03370302|11941165|FG004|Dose Escalation Phase|Other|0
7567691|NCT03370302|11941166|FG005|Dose Escalation Phase|Other|0
7567692|NCT03370302|11941161|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7567693|NCT03370302|11941162|FG001|Dose Escalation Phase|Withdrawal by Subject|1
7567694|NCT03370302|11941163|FG002|Dose Escalation Phase|Withdrawal by Subject|2
7567695|NCT03370302|11941164|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7567696|NCT03370302|11941165|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7567697|NCT03370302|11941166|FG005|Dose Escalation Phase|Withdrawal by Subject|2
7567698|NCT03370302|11941161|FG000|Dose Escalation Phase|Adverse Event|1
7567699|NCT03370302|11941162|FG001|Dose Escalation Phase|Adverse Event|0
7567700|NCT03370302|11941163|FG002|Dose Escalation Phase|Adverse Event|2
7567701|NCT03370302|11941164|FG003|Dose Escalation Phase|Adverse Event|0
7567702|NCT03370302|11941165|FG004|Dose Escalation Phase|Adverse Event|0
7330206|NCT00807885|11563660|FG005|Overall Study|Lost to Follow-up|1
7330207|NCT00807885|11563661|FG006|Overall Study|Lost to Follow-up|0
7330208|NCT00807885|11563662|FG007|Overall Study|Lost to Follow-up|0
7330209|NCT00807885|11563663|FG008|Overall Study|Lost to Follow-up|0
7330210|NCT00807937|11563687|FG000|Overall Study|Adverse Event|12
7330211|NCT00807937|11563688|FG001|Overall Study|Adverse Event|12
7330212|NCT00807937|11563689|FG002|Overall Study|Adverse Event|5
7330213|NCT00807937|11563690|FG003|Overall Study|Adverse Event|4
7330214|NCT00807937|11563687|FG000|Overall Study|Protocol Violation|4
7330215|NCT00807937|11563688|FG001|Overall Study|Protocol Violation|5
7330216|NCT00807937|11563689|FG002|Overall Study|Protocol Violation|3
7330217|NCT00807937|11563690|FG003|Overall Study|Protocol Violation|3
7330218|NCT00807937|11563687|FG000|Overall Study|Withdrawal by Subject|5
7330219|NCT00807937|11563688|FG001|Overall Study|Withdrawal by Subject|4
7330220|NCT00807937|11563689|FG002|Overall Study|Withdrawal by Subject|1
7330221|NCT00807937|11563690|FG003|Overall Study|Withdrawal by Subject|4
7330222|NCT00807937|11563687|FG000|Overall Study|Lost to Follow-up|4
7330223|NCT00807937|11563688|FG001|Overall Study|Lost to Follow-up|0
7330224|NCT00807937|11563689|FG002|Overall Study|Lost to Follow-up|2
7330225|NCT00807937|11563690|FG003|Overall Study|Lost to Follow-up|1
7330226|NCT00807937|11563687|FG000|Overall Study|Lack of Efficacy|0
7330227|NCT00807937|11563688|FG001|Overall Study|Lack of Efficacy|0
7330228|NCT00807937|11563689|FG002|Overall Study|Lack of Efficacy|1
7330229|NCT00807937|11563690|FG003|Overall Study|Lack of Efficacy|2
7330230|NCT00807937|11563687|FG000|Overall Study|Intake of prohibited medicine|0
7330231|NCT00807937|11563688|FG001|Overall Study|Intake of prohibited medicine|0
7330232|NCT00807937|11563689|FG002|Overall Study|Intake of prohibited medicine|2
7330233|NCT00807937|11563690|FG003|Overall Study|Intake of prohibited medicine|0
7330234|NCT00807937|11563687|FG000|Overall Study|All other reasons (not provided)|2
7330235|NCT00807937|11563688|FG001|Overall Study|All other reasons (not provided)|4
7330236|NCT00807937|11563689|FG002|Overall Study|All other reasons (not provided)|0
7330237|NCT00807937|11563690|FG003|Overall Study|All other reasons (not provided)|1
7330238|NCT00808015|11563709|FG000|Overall Study|Death|1
7330239|NCT00808015|11563709|FG000|Overall Study|Lack of Efficacy|58
7330240|NCT00808015|11563709|FG000|Overall Study|Lost to Follow-up|76
7330241|NCT00808015|11563709|FG000|Overall Study|Participants not willing to participate|158
7330242|NCT00808015|11563709|FG000|Overall Study|Adverse Event|22
7330243|NCT00808015|11563709|FG000|Overall Study|Other|25
7330244|NCT00808015|11563709|FG000|Overall Study|Enrolled but not treated|4
7330245|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
7567703|NCT03370302|11941166|FG005|Dose Escalation Phase|Adverse Event|0
7330246|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
7330247|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
7567704|NCT03370302|11941161|FG000|Dose Escalation Phase|Progressive Disease|2
7567705|NCT03370302|11941162|FG001|Dose Escalation Phase|Progressive Disease|4
7567706|NCT03370302|11941163|FG002|Dose Escalation Phase|Progressive Disease|2
7567707|NCT03370302|11941164|FG003|Dose Escalation Phase|Progressive Disease|0
7330248|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
7330249|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Other|1
7330250|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Other|0
7330251|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Other|2
7567708|NCT03370302|11941165|FG004|Dose Escalation Phase|Progressive Disease|3
7567709|NCT03370302|11941166|FG005|Dose Escalation Phase|Progressive Disease|1
7330252|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Other|4
7330253|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
7330254|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
7330255|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
7330256|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
7330257|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Adverse Event|0
7330258|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Adverse Event|0
7330259|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Adverse Event|1
7330260|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Adverse Event|2
7330261|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
7330262|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
7330263|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
7330264|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
7330265|NCT00808028|11563717|FG000|Stage 1 (6 Months)|Protocol Violation|0
7330266|NCT00808028|11563718|FG001|Stage 1 (6 Months)|Protocol Violation|0
7330267|NCT00808028|11563719|FG002|Stage 1 (6 Months)|Protocol Violation|0
7330268|NCT00808028|11563720|FG003|Stage 1 (6 Months)|Protocol Violation|1
7330269|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
7330270|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
7330271|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
7330272|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
7330273|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7330274|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7330275|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
7330276|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
7330277|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
7330278|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
7330310|NCT00808067|11563743|FG001|Overall Study|Adverse Event|121
7330279|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
7330280|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
7330281|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
7330282|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
7330283|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
7330284|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
7330285|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7330286|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7330287|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
7330288|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
7330289|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Other|0
7330290|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Other|0
7330291|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Other|1
7330292|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Other|1
7330293|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7330294|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7330295|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
7330296|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
7330297|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Death|0
7330298|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Death|0
7330299|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Death|1
7330300|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Death|0
7330301|NCT00808028|11563717|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7330302|NCT00808028|11563718|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7330303|NCT00808028|11563719|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
7457681|NCT01801280|11751349|FG003|Period 4|Protocol Violation|0
7457682|NCT01801358|11751365|FG000|Overall Study|Adverse Event|0
7567710|NCT03370302|11941161|FG000|Dose Expansion Phase|Progressive Disease|0
7567711|NCT03370302|11941162|FG001|Dose Expansion Phase|Progressive Disease|0
7567712|NCT03370302|11941163|FG002|Dose Expansion Phase|Progressive Disease|0
7567713|NCT03370302|11941164|FG003|Dose Expansion Phase|Progressive Disease|6
7567714|NCT03370302|11941165|FG004|Dose Expansion Phase|Progressive Disease|0
7567715|NCT03370302|11941166|FG005|Dose Expansion Phase|Progressive Disease|0
7567716|NCT03370419|11941184|FG000|Overall Study|Lost to Follow-up|16
7567717|NCT03370471|11941190|FG000|Overall Study|Withdrawal by Subject|6
7567718|NCT03370471|11941191|FG001|Overall Study|Withdrawal by Subject|1
7567719|NCT03370471|11941190|FG000|Overall Study|Unable to access veins for blood draw|0
7567720|NCT03370471|11941191|FG001|Overall Study|Unable to access veins for blood draw|1
7567721|NCT03370471|11941190|FG000|Overall Study|Screen fail|1
7567722|NCT03370471|11941191|FG001|Overall Study|Screen fail|0
7567723|NCT03370770|11941199|FG000|Overall Study|Patient was followed in another hospital center|1
7567724|NCT03370770|11941199|FG000|Overall Study|Progressive Disease|98
7567725|NCT03370770|11941199|FG000|Overall Study|Adverse Event|2
7567726|NCT03370770|11941199|FG000|Overall Study|Death|5
7567727|NCT03371355|11941207|FG000|Overall Study|Investigator judgment|0
7567728|NCT03371355|11941208|FG001|Overall Study|Investigator judgment|0
7567729|NCT03371355|11941209|FG002|Overall Study|Investigator judgment|1
7567730|NCT03371355|11941210|FG003|Overall Study|Investigator judgment|1
7567731|NCT03371355|11941207|FG000|Overall Study|Voluntary withdrawal|1
7567732|NCT03371355|11941208|FG001|Overall Study|Voluntary withdrawal|0
7567733|NCT03371355|11941209|FG002|Overall Study|Voluntary withdrawal|1
7567734|NCT03371355|11941210|FG003|Overall Study|Voluntary withdrawal|2
7567735|NCT03371355|11941207|FG000|Overall Study|Adverse Event|0
7567736|NCT03371355|11941208|FG001|Overall Study|Adverse Event|1
7567737|NCT03371355|11941209|FG002|Overall Study|Adverse Event|2
7567738|NCT03371355|11941210|FG003|Overall Study|Adverse Event|3
7567739|NCT03371355|11941207|FG000|Overall Study|Reason not Specified|0
7567740|NCT03371355|11941208|FG001|Overall Study|Reason not Specified|1
7567741|NCT03371355|11941209|FG002|Overall Study|Reason not Specified|0
7567742|NCT03371355|11941210|FG003|Overall Study|Reason not Specified|1
7567743|NCT03371381|11941224|FG000|Overall Study|Death|5
7567744|NCT03371381|11941224|FG000|Overall Study|Study terminated by sponsor|3
7567745|NCT03371381|11941224|FG000|Overall Study|Other|4
7567746|NCT03371459|11941228|FG000|Washout|Lost to Follow-up|0
7567747|NCT03371459|11941229|FG001|Washout|Lost to Follow-up|1
7567748|NCT03371732|11941237|FG000|Overall Study|Withdrawal by Subject|9
7567749|NCT03371732|11941238|FG001|Overall Study|Withdrawal by Subject|3
7567750|NCT03371732|11941237|FG000|Overall Study|Refusal to continue|3
7567751|NCT03371732|11941238|FG001|Overall Study|Refusal to continue|4
7567752|NCT03372083|11941250|FG000|Overall Study|Adverse Event|3
7567753|NCT03372083|11941250|FG000|Overall Study|Physician Decision|1
7567754|NCT03372083|11941250|FG000|Overall Study|Withdrawal by Subject|1
7567755|NCT03372096|11941254|FG000|Overall Study|Study Closed|8
7567756|NCT03372369|11941263|FG000|Qualification Period|Withdrawal by Subject|16
7330304|NCT00808028|11563720|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
7330305|NCT00808067|11563742|FG000|Overall Study|Major/minor bleed|30
7330306|NCT00808067|11563743|FG001|Overall Study|Major/minor bleed|44
7330307|NCT00808067|11563742|FG000|Overall Study|Outcome event - other|33
7330308|NCT00808067|11563743|FG001|Overall Study|Outcome event - other|25
7330309|NCT00808067|11563742|FG000|Overall Study|Adverse Event|111
7330311|NCT00808067|11563742|FG000|Overall Study|Hospitalization (not including surgery)|18
7330312|NCT00808067|11563743|FG001|Overall Study|Hospitalization (not including surgery)|17
7330313|NCT00808067|11563742|FG000|Overall Study|Hospitalization due to surgery|37
7330314|NCT00808067|11563743|FG001|Overall Study|Hospitalization due to surgery|40
7330315|NCT00808067|11563742|FG000|Overall Study|Reduced creatinine clearance|53
7330316|NCT00808067|11563743|FG001|Overall Study|Reduced creatinine clearance|55
7330317|NCT00808067|11563742|FG000|Overall Study|Elevated LFT results|7
7330318|NCT00808067|11563743|FG001|Overall Study|Elevated LFT results|3
7330319|NCT00808067|11563742|FG000|Overall Study|Patient refused to take study medication|65
7330320|NCT00808067|11563743|FG001|Overall Study|Patient refused to take study medication|76
7330321|NCT00808067|11563742|FG000|Overall Study|Missing|1
7330322|NCT00808067|11563743|FG001|Overall Study|Missing|0
7330323|NCT00808067|11563742|FG000|Overall Study|Death|1
7330324|NCT00808067|11563743|FG001|Overall Study|Death|1
7330325|NCT00808067|11563742|FG000|Overall Study|Procedure|6
7330326|NCT00808067|11563743|FG001|Overall Study|Procedure|7
7330327|NCT00808067|11563742|FG000|Overall Study|Withdrawal by Subject|21
7330328|NCT00808067|11563743|FG001|Overall Study|Withdrawal by Subject|25
7330329|NCT00808067|11563742|FG000|Overall Study|Site closed|4
7330330|NCT00808067|11563743|FG001|Overall Study|Site closed|3
7330331|NCT00808067|11563742|FG000|Overall Study|Physician Decision|47
7330332|NCT00808067|11563743|FG001|Overall Study|Physician Decision|38
7330333|NCT00808067|11563742|FG000|Overall Study|Protocol Violation|3
7330334|NCT00808067|11563743|FG001|Overall Study|Protocol Violation|11
7330335|NCT00808067|11563742|FG000|Overall Study|Patient elected|7
7330336|NCT00808067|11563743|FG001|Overall Study|Patient elected|9
7330337|NCT00808067|11563742|FG000|Overall Study|Site closed for cause|19
7330338|NCT00808067|11563743|FG001|Overall Study|Site closed for cause|19
7330339|NCT00808067|11563742|FG000|Overall Study|Other reason not defined above|5
7330340|NCT00808067|11563743|FG001|Overall Study|Other reason not defined above|5
7330341|NCT00808067|11563742|FG000|Overall Study|Excluded from analysis|13
7567757|NCT03372369|11941264|FG001|Qualification Period|Withdrawal by Subject|13
7567758|NCT03372369|11941263|FG000|Qualification Period|Inconsistent Eligibility Results|10
7567759|NCT03372369|11941264|FG001|Qualification Period|Inconsistent Eligibility Results|9
7567760|NCT03372369|11941263|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
7567761|NCT03372369|11941264|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
7567762|NCT03372551|11941294|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
7567763|NCT03372551|11941295|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
7330342|NCT00808067|11563743|FG001|Overall Study|Excluded from analysis|19
7330343|NCT00808132|11563754|FG000|Overall Study|Adverse Event|34
7330344|NCT00808132|11563755|FG001|Overall Study|Adverse Event|33
7330345|NCT00808132|11563756|FG002|Overall Study|Adverse Event|16
7567764|NCT03372603|11941308|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
7567765|NCT03372603|11941309|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
7567766|NCT03372603|11941308|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
7567767|NCT03372603|11941309|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
7567768|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Adverse Event|7
7567769|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Adverse Event|6
7567770|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Adverse Event|11
7567771|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Adverse Event|15
7567772|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Adverse Event|21
7567773|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
7567774|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
7567775|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
7567776|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
7567777|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
7567778|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Protocol Violation|0
7567779|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Protocol Violation|4
7567780|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Protocol Violation|2
7567781|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Protocol Violation|1
7567782|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Protocol Violation|0
7567783|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
7567784|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
7567785|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
7567786|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
7567787|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
7567788|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
7567789|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
7567790|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
7567791|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
7567792|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
7567793|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
7567794|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
7567795|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
7567796|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
7567797|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
7567798|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
7567799|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
7567800|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
7567801|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
7567802|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
7567803|NCT03373383|11941346|FG000|Treatment Period: Wk0-16|Sponsor decision|0
7567804|NCT03373383|11941347|FG001|Treatment Period: Wk0-16|Sponsor decision|0
7567805|NCT03373383|11941348|FG002|Treatment Period: Wk0-16|Sponsor decision|0
7567806|NCT03373383|11941349|FG003|Treatment Period: Wk0-16|Sponsor decision|1
7567807|NCT03373383|11941350|FG004|Treatment Period: Wk0-16|Sponsor decision|0
7567808|NCT03373383|11941346|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
7567809|NCT03373383|11941347|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7567810|NCT03373383|11941348|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7567811|NCT03373383|11941349|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7567812|NCT03373383|11941350|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
7567813|NCT03374189|11941412|FG000|Overall Study|Lost to Follow-up|1
7567814|NCT03374189|11941413|FG001|Overall Study|Lost to Follow-up|0
7330346|NCT00808132|11563757|FG003|Overall Study|Adverse Event|31
7330347|NCT00808132|11563758|FG004|Overall Study|Adverse Event|33
7330348|NCT00808132|11563754|FG000|Overall Study|Death|0
7330349|NCT00808132|11563755|FG001|Overall Study|Death|0
7330350|NCT00808132|11563756|FG002|Overall Study|Death|0
7330351|NCT00808132|11563757|FG003|Overall Study|Death|0
7330352|NCT00808132|11563758|FG004|Overall Study|Death|1
7330353|NCT00808132|11563754|FG000|Overall Study|Physician Decision|0
7330354|NCT00808132|11563755|FG001|Overall Study|Physician Decision|1
7330355|NCT00808132|11563756|FG002|Overall Study|Physician Decision|0
7330356|NCT00808132|11563757|FG003|Overall Study|Physician Decision|0
7330357|NCT00808132|11563758|FG004|Overall Study|Physician Decision|0
7330358|NCT00808132|11563754|FG000|Overall Study|Lost to Follow-up|8
7330359|NCT00808132|11563755|FG001|Overall Study|Lost to Follow-up|10
7330360|NCT00808132|11563756|FG002|Overall Study|Lost to Follow-up|11
7567815|NCT03374358|11941421|FG000|Overall Study|Withdrawal by Subject|0
7567816|NCT03374358|11941422|FG001|Overall Study|Withdrawal by Subject|2
7567817|NCT03374488|11941430|FG000|Overall Study|Death|13
7567818|NCT03374488|11941431|FG001|Overall Study|Death|13
7567819|NCT03374488|11941430|FG000|Overall Study|Withdrawal by Subject|3
7567820|NCT03374488|11941431|FG001|Overall Study|Withdrawal by Subject|1
7330361|NCT00808132|11563757|FG003|Overall Study|Lost to Follow-up|8
7330362|NCT00808132|11563758|FG004|Overall Study|Lost to Follow-up|9
7330363|NCT00808132|11563754|FG000|Overall Study|Protocol Violation|8
7330364|NCT00808132|11563755|FG001|Overall Study|Protocol Violation|9
7330365|NCT00808132|11563756|FG002|Overall Study|Protocol Violation|4
7330366|NCT00808132|11563757|FG003|Overall Study|Protocol Violation|9
7567821|NCT03374488|11941430|FG000|Overall Study|Physician Decision|3
7567822|NCT03374488|11941431|FG001|Overall Study|Physician Decision|0
7567823|NCT03374995|11941453|FG000|Overall Study|Withdrawal by Subject|0
7567824|NCT03374995|11941454|FG001|Overall Study|Withdrawal by Subject|1
7567825|NCT03376321|11941494|FG000|Overall Study|Other|5
7567826|NCT03376321|11941495|FG001|Overall Study|Other|1
7567827|NCT03376321|11941494|FG000|Overall Study|Withdrawal by Subject|8
7567828|NCT03376321|11941495|FG001|Overall Study|Withdrawal by Subject|14
7567829|NCT03376321|11941494|FG000|Overall Study|Lost to Follow-up|1
7567830|NCT03376321|11941495|FG001|Overall Study|Lost to Follow-up|7
7567831|NCT03376321|11941494|FG000|Overall Study|Death|4
7567832|NCT03376321|11941495|FG001|Overall Study|Death|0
7567833|NCT03376321|11941494|FG000|Overall Study|Randomized, not treated|5
7567834|NCT03376321|11941495|FG001|Overall Study|Randomized, not treated|3
7567835|NCT03376516|11941501|FG000|Overall Study|Not treated|1
7567836|NCT03376516|11941501|FG000|Overall Study|Consent withdrawn|1
7567837|NCT03377556|11941538|FG000|Overall Study|Adverse Event|5
7567838|NCT03377556|11941538|FG000|Overall Study|Refusal unrelated to adverse events|1
7567839|NCT03377556|11941538|FG000|Overall Study|Progression/relapse|38
7567840|NCT03377556|11941538|FG000|Overall Study|Death|3
7567841|NCT03377634|11941544|FG000|Study Period|Adverse Event|1
7567842|NCT03377634|11941545|FG001|Study Period|Adverse Event|0
7567843|NCT03377634|11941544|FG000|Study Period|Withdrawal by Subject|1
7567844|NCT03377634|11941545|FG001|Study Period|Withdrawal by Subject|0
7567845|NCT03378635|11941563|FG000|Overall Study|Adverse Event|1
7567846|NCT03378635|11941564|FG001|Overall Study|Adverse Event|0
7330367|NCT00808132|11563758|FG004|Overall Study|Protocol Violation|5
7330368|NCT00808132|11563754|FG000|Overall Study|Withdrawal by Subject|27
7330369|NCT00808132|11563755|FG001|Overall Study|Withdrawal by Subject|18
7330370|NCT00808132|11563756|FG002|Overall Study|Withdrawal by Subject|2
7330371|NCT00808132|11563757|FG003|Overall Study|Withdrawal by Subject|7
7330372|NCT00808132|11563758|FG004|Overall Study|Withdrawal by Subject|16
7330373|NCT00808132|11563754|FG000|Overall Study|Other|6
7330374|NCT00808132|11563755|FG001|Overall Study|Other|4
7330375|NCT00808132|11563756|FG002|Overall Study|Other|6
7330376|NCT00808132|11563757|FG003|Overall Study|Other|2
7330377|NCT00808132|11563758|FG004|Overall Study|Other|15
7330378|NCT00808132|11563754|FG000|Overall Study|Randomized, but not treated|10
7330379|NCT00808132|11563755|FG001|Overall Study|Randomized, but not treated|7
7330380|NCT00808132|11563756|FG002|Overall Study|Randomized, but not treated|9
7330381|NCT00808132|11563757|FG003|Overall Study|Randomized, but not treated|8
7330382|NCT00808132|11563758|FG004|Overall Study|Randomized, but not treated|9
7330383|NCT00808132|11563754|FG000|Overall Study|Unsatisfactory response|5
7330384|NCT00808132|11563755|FG001|Overall Study|Unsatisfactory response|6
7330385|NCT00808132|11563756|FG002|Overall Study|Unsatisfactory response|6
7330386|NCT00808132|11563757|FG003|Overall Study|Unsatisfactory response|4
7330387|NCT00808132|11563758|FG004|Overall Study|Unsatisfactory response|12
7330388|NCT00808210|11563772|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
7330389|NCT00808210|11563773|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
7330390|NCT00808210|11563772|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
7330391|NCT00808210|11563773|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
7330392|NCT00808210|11563772|FG000|Double-Blind TX Period|Adverse Event|0
7330393|NCT00808210|11563773|FG001|Double-Blind TX Period|Adverse Event|1
7330394|NCT00808210|11563772|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
7330395|NCT00808210|11563773|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
7330396|NCT00808210|11563772|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7330397|NCT00808210|11563773|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
7330398|NCT00808210|11563772|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
7330399|NCT00808210|11563773|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
7330400|NCT00808236|11563781|FG000|Overall Study|Was not resuscitated|50
7330401|NCT00808236|11563782|FG001|Overall Study|Was not resuscitated|56
7330402|NCT00808236|11563781|FG000|Overall Study|Pre-defined exclusion|13
7457683|NCT01801358|11751366|FG001|Overall Study|Adverse Event|2
7567847|NCT03378635|11941565|FG002|Overall Study|Adverse Event|0
7567848|NCT03378635|11941563|FG000|Overall Study|Withdrawal by Subject|1
7567849|NCT03378635|11941564|FG001|Overall Study|Withdrawal by Subject|0
7330403|NCT00808236|11563782|FG001|Overall Study|Pre-defined exclusion|3
7330404|NCT00808236|11563781|FG000|Overall Study|Lost to Follow-up|1
7330405|NCT00808236|11563782|FG001|Overall Study|Lost to Follow-up|1
7330406|NCT00808236|11563781|FG000|Overall Study|Physician Decision|0
7567850|NCT03378635|11941565|FG002|Overall Study|Withdrawal by Subject|0
7567851|NCT03379259|11941598|FG000|Overall Study|Commenced new anti-cancer therapy|1
7567852|NCT03379259|11941599|FG001|Overall Study|Commenced new anti-cancer therapy|0
7330407|NCT00808236|11563782|FG001|Overall Study|Physician Decision|1
7330408|NCT00808236|11563781|FG000|Overall Study|Death|18
7567853|NCT03379259|11941600|FG002|Overall Study|Commenced new anti-cancer therapy|0
7567854|NCT03379259|11941601|FG003|Overall Study|Commenced new anti-cancer therapy|0
7567855|NCT03379259|11941602|FG004|Overall Study|Commenced new anti-cancer therapy|0
7567856|NCT03379259|11941603|FG005|Overall Study|Commenced new anti-cancer therapy|0
7567857|NCT03379259|11941598|FG000|Overall Study|Death|0
7567858|NCT03379259|11941599|FG001|Overall Study|Death|1
7567859|NCT03379259|11941600|FG002|Overall Study|Death|2
7567860|NCT03379259|11941601|FG003|Overall Study|Death|1
7567861|NCT03379259|11941602|FG004|Overall Study|Death|4
7567862|NCT03379259|11941603|FG005|Overall Study|Death|2
7567863|NCT03379259|11941598|FG000|Overall Study|Withdrawal by Subject|0
7567864|NCT03379259|11941599|FG001|Overall Study|Withdrawal by Subject|0
7567865|NCT03379259|11941600|FG002|Overall Study|Withdrawal by Subject|1
7567866|NCT03379259|11941601|FG003|Overall Study|Withdrawal by Subject|0
7567867|NCT03379259|11941602|FG004|Overall Study|Withdrawal by Subject|2
7567868|NCT03379259|11941603|FG005|Overall Study|Withdrawal by Subject|0
7567869|NCT03379259|11941598|FG000|Overall Study|Study terminated by sponsor|0
7567870|NCT03379259|11941599|FG001|Overall Study|Study terminated by sponsor|0
7567871|NCT03379259|11941600|FG002|Overall Study|Study terminated by sponsor|0
7567872|NCT03379259|11941601|FG003|Overall Study|Study terminated by sponsor|1
7567873|NCT03379259|11941602|FG004|Overall Study|Study terminated by sponsor|1
7567874|NCT03379259|11941603|FG005|Overall Study|Study terminated by sponsor|4
7567875|NCT03379259|11941598|FG000|Overall Study|Disease progression|0
7567876|NCT03379259|11941599|FG001|Overall Study|Disease progression|0
7567877|NCT03379259|11941600|FG002|Overall Study|Disease progression|0
7567878|NCT03379259|11941601|FG003|Overall Study|Disease progression|1
7567879|NCT03379259|11941602|FG004|Overall Study|Disease progression|0
7567880|NCT03379259|11941603|FG005|Overall Study|Disease progression|1
7567881|NCT03379259|11941598|FG000|Overall Study|Lost to Follow-up|0
7567882|NCT03379259|11941599|FG001|Overall Study|Lost to Follow-up|0
7567883|NCT03379259|11941600|FG002|Overall Study|Lost to Follow-up|0
7567884|NCT03379259|11941601|FG003|Overall Study|Lost to Follow-up|0
7567885|NCT03379259|11941602|FG004|Overall Study|Lost to Follow-up|1
7567886|NCT03379259|11941603|FG005|Overall Study|Lost to Follow-up|0
7567887|NCT03379259|11941598|FG000|Overall Study|Deteriorating condition|0
7567888|NCT03379259|11941599|FG001|Overall Study|Deteriorating condition|0
7567889|NCT03379259|11941600|FG002|Overall Study|Deteriorating condition|0
7567890|NCT03379259|11941601|FG003|Overall Study|Deteriorating condition|0
7567891|NCT03379259|11941602|FG004|Overall Study|Deteriorating condition|1
7567892|NCT03379259|11941603|FG005|Overall Study|Deteriorating condition|0
7567893|NCT03379376|11941620|FG000|Overall Study|Lost to Follow-up|2
7567894|NCT03379376|11941620|FG000|Overall Study|Did not wish to complete follow up|1
7567895|NCT03379376|11941620|FG000|Overall Study|Overwhelmed, didn't want to continue|1
7567896|NCT03379376|11941620|FG000|Overall Study|Death|1
7567897|NCT03379753|11941673|FG000|Overall Study|Withdrawal by Subject|2
7567898|NCT03379753|11941674|FG001|Overall Study|Withdrawal by Subject|1
7567899|NCT03379753|11941673|FG000|Overall Study|not having correct procedure|1
7567900|NCT03379753|11941674|FG001|Overall Study|not having correct procedure|2
7567901|NCT03379753|11941673|FG000|Overall Study|No primary outcome|12
7567902|NCT03379753|11941674|FG001|Overall Study|No primary outcome|22
7567903|NCT03380091|11941689|FG000|Overall Study|Withdrawal by Subject|2
7567904|NCT03380091|11941690|FG001|Overall Study|Withdrawal by Subject|1
7567905|NCT03380390|11941698|FG000|Overall Study|Adverse Event|3
7567906|NCT03380429|11941707|FG000|Overall Study|Physician Decision|0
7567907|NCT03380429|11941708|FG001|Overall Study|Physician Decision|1
7567908|NCT03380429|11941709|FG002|Overall Study|Physician Decision|0
7567909|NCT03380429|11941710|FG003|Overall Study|Physician Decision|1
7567910|NCT03380429|11941711|FG004|Overall Study|Physician Decision|1
7567911|NCT03380429|11941707|FG000|Overall Study|Withdrawal by Subject|3
7567912|NCT03380429|11941708|FG001|Overall Study|Withdrawal by Subject|3
7567913|NCT03380429|11941709|FG002|Overall Study|Withdrawal by Subject|5
7567914|NCT03380429|11941710|FG003|Overall Study|Withdrawal by Subject|2
7567915|NCT03380429|11941711|FG004|Overall Study|Withdrawal by Subject|1
7567916|NCT03380429|11941707|FG000|Overall Study|Lost to Follow-up|0
7567917|NCT03380429|11941708|FG001|Overall Study|Lost to Follow-up|2
7567918|NCT03380429|11941709|FG002|Overall Study|Lost to Follow-up|4
7567919|NCT03380429|11941710|FG003|Overall Study|Lost to Follow-up|3
7567920|NCT03380429|11941711|FG004|Overall Study|Lost to Follow-up|1
7567921|NCT03380429|11941707|FG000|Overall Study|Protocol Violation|1
7567922|NCT03380429|11941708|FG001|Overall Study|Protocol Violation|0
7567923|NCT03380429|11941709|FG002|Overall Study|Protocol Violation|1
7567924|NCT03380429|11941710|FG003|Overall Study|Protocol Violation|0
7567925|NCT03380429|11941711|FG004|Overall Study|Protocol Violation|1
7567926|NCT03380429|11941707|FG000|Overall Study|Lack of Efficacy|0
7567927|NCT03380429|11941708|FG001|Overall Study|Lack of Efficacy|0
7567928|NCT03380429|11941709|FG002|Overall Study|Lack of Efficacy|0
7567929|NCT03380429|11941710|FG003|Overall Study|Lack of Efficacy|2
7567930|NCT03380429|11941711|FG004|Overall Study|Lack of Efficacy|1
7567931|NCT03380429|11941707|FG000|Overall Study|Adverse Event|1
7567932|NCT03380429|11941708|FG001|Overall Study|Adverse Event|1
7567933|NCT03380429|11941709|FG002|Overall Study|Adverse Event|1
7567934|NCT03380429|11941710|FG003|Overall Study|Adverse Event|2
7567935|NCT03380429|11941711|FG004|Overall Study|Adverse Event|0
7567936|NCT03381196|11941756|FG000|Overall Study|Withdrawal by Subject|7
7567937|NCT03381196|11941757|FG001|Overall Study|Withdrawal by Subject|7
7567938|NCT03381196|11941756|FG000|Overall Study|Other|0
7567939|NCT03381196|11941757|FG001|Overall Study|Other|1
7567940|NCT03381196|11941756|FG000|Overall Study|Lost to Follow-up|5
7567941|NCT03381196|11941757|FG001|Overall Study|Lost to Follow-up|4
7567942|NCT03381196|11941756|FG000|Overall Study|Death|0
7567943|NCT03381196|11941757|FG001|Overall Study|Death|1
7567944|NCT03381196|11941756|FG000|Overall Study|Adverse Event|1
7567945|NCT03381196|11941757|FG001|Overall Study|Adverse Event|0
7567946|NCT03381196|11941756|FG000|Overall Study|Randomized, not treated|3
7567947|NCT03381196|11941757|FG001|Overall Study|Randomized, not treated|6
7567948|NCT03381248|11941765|FG000|Overall Study|Withdrawal by Subject|5
7567949|NCT03381248|11941766|FG001|Overall Study|Withdrawal by Subject|3
7567950|NCT03381248|11941765|FG000|Overall Study|Lost to Follow-up|3
7567951|NCT03381248|11941766|FG001|Overall Study|Lost to Follow-up|2
7567952|NCT03381248|11941765|FG000|Overall Study|Lack of Efficacy|1
7567953|NCT03381248|11941766|FG001|Overall Study|Lack of Efficacy|0
7567954|NCT03381248|11941765|FG000|Overall Study|Adverse Event|2
7567955|NCT03381248|11941766|FG001|Overall Study|Adverse Event|0
7567956|NCT03381248|11941765|FG000|Overall Study|Protocol Violation|2
7567957|NCT03381248|11941766|FG001|Overall Study|Protocol Violation|1
7330409|NCT00808236|11563782|FG001|Overall Study|Death|30
7330410|NCT00808249|11563792|FG000|Overall Study|Adverse Event|4
7330411|NCT00808249|11563793|FG001|Overall Study|Adverse Event|7
7330412|NCT00808249|11563794|FG002|Overall Study|Adverse Event|10
7330413|NCT00808249|11563795|FG003|Overall Study|Adverse Event|6
7330414|NCT00808249|11563792|FG000|Overall Study|Lost to Follow-up|2
7330415|NCT00808249|11563793|FG001|Overall Study|Lost to Follow-up|3
7330416|NCT00808249|11563794|FG002|Overall Study|Lost to Follow-up|3
7330417|NCT00808249|11563795|FG003|Overall Study|Lost to Follow-up|5
7330418|NCT00808249|11563792|FG000|Overall Study|Withdrawal by Subject|4
7330419|NCT00808249|11563793|FG001|Overall Study|Withdrawal by Subject|0
7330420|NCT00808249|11563794|FG002|Overall Study|Withdrawal by Subject|2
7330421|NCT00808249|11563795|FG003|Overall Study|Withdrawal by Subject|4
7330422|NCT00808249|11563792|FG000|Overall Study|Protocol Violation|3
7330423|NCT00808249|11563793|FG001|Overall Study|Protocol Violation|3
7330424|NCT00808249|11563794|FG002|Overall Study|Protocol Violation|3
7330425|NCT00808249|11563795|FG003|Overall Study|Protocol Violation|0
7330426|NCT00808249|11563792|FG000|Overall Study|Lack of Efficacy|1
7330427|NCT00808249|11563793|FG001|Overall Study|Lack of Efficacy|1
7330428|NCT00808249|11563794|FG002|Overall Study|Lack of Efficacy|0
7330429|NCT00808249|11563795|FG003|Overall Study|Lack of Efficacy|0
7330430|NCT00808249|11563792|FG000|Overall Study|study specific discontinuation criteria|1
7330431|NCT00808249|11563793|FG001|Overall Study|study specific discontinuation criteria|0
7330432|NCT00808249|11563794|FG002|Overall Study|study specific discontinuation criteria|1
7330433|NCT00808249|11563795|FG003|Overall Study|study specific discontinuation criteria|0
7330434|NCT00808249|11563792|FG000|Overall Study|All other reasons|2
7330435|NCT00808249|11563793|FG001|Overall Study|All other reasons|1
7330436|NCT00808249|11563794|FG002|Overall Study|All other reasons|3
7330437|NCT00808249|11563795|FG003|Overall Study|All other reasons|1
7330438|NCT00808444|11563829|FG000|Overall Study|Withdrawal by Subject|1
7330439|NCT00808444|11563830|FG001|Overall Study|Withdrawal by Subject|0
7330440|NCT00808444|11563829|FG000|Overall Study|Lost to Follow-up|0
7330441|NCT00808444|11563830|FG001|Overall Study|Lost to Follow-up|1
7330442|NCT00808483|11563851|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7330443|NCT00808483|11563852|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
7330444|NCT00808483|11563851|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
7330445|NCT00808483|11563852|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
7330446|NCT00808483|11563851|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
7330447|NCT00808483|11563852|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
7330448|NCT00808509|11563867|FG000|Randomized Phase|Did not meet eligibility criteria|1
7330449|NCT00808509|11563868|FG001|Randomized Phase|Did not meet eligibility criteria|0
7330450|NCT00808509|11563867|FG000|Randomized Phase|Reduced methotrexate dose|1
7330451|NCT00808509|11563868|FG001|Randomized Phase|Reduced methotrexate dose|2
7330452|NCT00808509|11563867|FG000|Randomized Phase|Patient refused rescue therapy|0
7330453|NCT00808509|11563868|FG001|Randomized Phase|Patient refused rescue therapy|3
7330454|NCT00808639|11563876|FG000|Overall Study|Disease progression before surgery.|1
7330455|NCT00808665|11563882|FG000|Overall Study|Withdrawal by Subject|1
7330456|NCT00808665|11563883|FG001|Overall Study|Withdrawal by Subject|0
7330457|NCT00808665|11563882|FG000|Overall Study|only required minimally invasive surgery|1
7330458|NCT00808665|11563883|FG001|Overall Study|only required minimally invasive surgery|0
7330459|NCT00808665|11563882|FG000|Overall Study|surgery cancelled|1
7330460|NCT00808665|11563883|FG001|Overall Study|surgery cancelled|0
7330461|NCT00808665|11563882|FG000|Overall Study|required an additional procedure|0
7330462|NCT00808665|11563883|FG001|Overall Study|required an additional procedure|1
7330463|NCT00808665|11563882|FG000|Overall Study|Physician Decision|3
7567958|NCT03381339|11941774|FG000|Overall Study|Protocol Violation|4
7567959|NCT03381339|11941775|FG001|Overall Study|Protocol Violation|3
7567960|NCT03381339|11941774|FG000|Overall Study|Lost to Follow-up|0
7567961|NCT03381339|11941775|FG001|Overall Study|Lost to Follow-up|1
7567962|NCT03382262|11941807|FG000|Overall Study|Physician Decision|0
7567963|NCT03382262|11941808|FG001|Overall Study|Physician Decision|0
7567964|NCT03382262|11941809|FG002|Overall Study|Physician Decision|1
7567965|NCT03382262|11941810|FG003|Overall Study|Physician Decision|0
7567966|NCT03382262|11941807|FG000|Overall Study|Withdrawal by Subject|0
7567967|NCT03382262|11941808|FG001|Overall Study|Withdrawal by Subject|0
7567968|NCT03382262|11941809|FG002|Overall Study|Withdrawal by Subject|0
7567969|NCT03382262|11941810|FG003|Overall Study|Withdrawal by Subject|1
7567970|NCT03382418|11941823|FG000|Overall Study|Withdrawal by Subject|1
7567971|NCT03382418|11941824|FG001|Overall Study|Withdrawal by Subject|0
7567972|NCT03382418|11941825|FG002|Overall Study|Withdrawal by Subject|0
7567973|NCT03382418|11941823|FG000|Overall Study|Lost to Follow-up|2
7567974|NCT03382418|11941824|FG001|Overall Study|Lost to Follow-up|3
7567975|NCT03382418|11941825|FG002|Overall Study|Lost to Follow-up|0
7567976|NCT03382821|11941854|FG000|Overall Study|Did not receive allocated intervention.|0
7567977|NCT03382821|11941855|FG001|Overall Study|Did not receive allocated intervention.|3
7567978|NCT03382899|11941868|FG000|Overall Study|Ineligibility Determined|0
7567979|NCT03382899|11941869|FG001|Overall Study|Ineligibility Determined|1
7567980|NCT03382899|11941868|FG000|Overall Study|Lost to Follow-up|0
7567981|NCT03382899|11941869|FG001|Overall Study|Lost to Follow-up|1
7567982|NCT03382899|11941868|FG000|Overall Study|Sponsor's decision|31
7567983|NCT03382899|11941869|FG001|Overall Study|Sponsor's decision|28
7567984|NCT03382899|11941868|FG000|Overall Study|Withdrawal by Subject|0
7567985|NCT03382899|11941869|FG001|Overall Study|Withdrawal by Subject|5
7567986|NCT03382912|11941877|FG000|Overall Study|Physician Decision|0
7567987|NCT03382912|11941878|FG001|Overall Study|Physician Decision|1
7567988|NCT03382912|11941877|FG000|Overall Study|Sponsor Decision|6
7567989|NCT03382912|11941878|FG001|Overall Study|Sponsor Decision|6
7567990|NCT03382912|11941877|FG000|Overall Study|Withdrawal by Subject|0
7567991|NCT03382912|11941878|FG001|Overall Study|Withdrawal by Subject|5
7330464|NCT00808665|11563883|FG001|Overall Study|Physician Decision|1
7330465|NCT00808665|11563882|FG000|Overall Study|Medication stopped by resident|0
7330466|NCT00808665|11563883|FG001|Overall Study|Medication stopped by resident|1
7330467|NCT00808808|11563892|FG000|Overall Study|Vaccinated; survey not completed|131
7330468|NCT00808808|11563893|FG001|Overall Study|Vaccinated; survey not completed|169
7330469|NCT00808808|11563894|FG002|Overall Study|Vaccinated; survey not completed|302
7330470|NCT00808808|11563892|FG000|Overall Study|Employee was not vaccinated.|2686
7330471|NCT00808808|11563893|FG001|Overall Study|Employee was not vaccinated.|2268
7385139|NCT01199068|11642711|FG002|Overall Study|Progressive disease|6
7567992|NCT03383146|11941886|FG000|Overall Study|Screen Failure|1
7567993|NCT03383146|11941887|FG001|Overall Study|Screen Failure|0
7567994|NCT03383146|11941886|FG000|Overall Study|Adverse Event|6
7567995|NCT03383146|11941887|FG001|Overall Study|Adverse Event|18
7567996|NCT03383146|11941886|FG000|Overall Study|Lack of Efficacy|0
7567997|NCT03383146|11941887|FG001|Overall Study|Lack of Efficacy|3
7567998|NCT03383146|11941886|FG000|Overall Study|Withdrawal by Subject|20
7567999|NCT03383146|11941887|FG001|Overall Study|Withdrawal by Subject|36
7568000|NCT03383146|11941886|FG000|Overall Study|Lost to Follow-up|5
7568001|NCT03383146|11941887|FG001|Overall Study|Lost to Follow-up|15
7568002|NCT03383146|11941886|FG000|Overall Study|Death|0
7568003|NCT03383146|11941887|FG001|Overall Study|Death|2
7568004|NCT03383146|11941886|FG000|Overall Study|Physician Decision|0
7568005|NCT03383146|11941887|FG001|Overall Study|Physician Decision|1
7568006|NCT03383146|11941886|FG000|Overall Study|Protocol Deviation|1
7568007|NCT03383146|11941887|FG001|Overall Study|Protocol Deviation|8
7568008|NCT03383146|11941886|FG000|Overall Study|Study Terminated by the Sponsor|48
7568009|NCT03383146|11941887|FG001|Overall Study|Study Terminated by the Sponsor|95
7568010|NCT03383146|11941886|FG000|Overall Study|Reason not Specified|4
7568011|NCT03383146|11941887|FG001|Overall Study|Reason not Specified|6
7568012|NCT03383614|11941949|FG000|Overall Study|Withdrawal by Subject|0
7568013|NCT03383614|11941950|FG001|Overall Study|Withdrawal by Subject|1
7568014|NCT03383614|11941951|FG002|Overall Study|Withdrawal by Subject|0
7568015|NCT03383614|11941952|FG003|Overall Study|Withdrawal by Subject|0
7568016|NCT03383783|11941975|FG000|Overall Study|Withdrawal by Subject|2
7568017|NCT03383887|11941991|FG000|Overall Study|Lost to Follow-up|0
7568018|NCT03383887|11941992|FG001|Overall Study|Lost to Follow-up|1
7575245|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7575246|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7575247|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7575248|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
7575249|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
7575250|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
7575251|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
7575252|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
7575253|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
7575254|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
7575255|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
7575256|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7568019|NCT03384316|11942012|FG000|Overall Study|Screen failure|0
7568020|NCT03384316|11942013|FG001|Overall Study|Screen failure|1
7568021|NCT03384693|11942030|FG000|Overall Study|Adverse Event|3
7568022|NCT03384745|11942040|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7568023|NCT03384745|11942041|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7568024|NCT03384745|11942042|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
7568025|NCT03384745|11942043|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
7568026|NCT03384745|11942044|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7568027|NCT03384745|11942045|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
7568028|NCT03384745|11942040|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7330472|NCT00808808|11563894|FG002|Overall Study|Employee was not vaccinated.|2255
7330473|NCT00809094|11563926|FG000|Overall Study|Lost to Follow-up|0
7330474|NCT00809094|11563927|FG001|Overall Study|Lost to Follow-up|1
7330475|NCT00809133|11563947|FG000|Overall Study|Progressive disease|2
7330476|NCT00809133|11563948|FG001|Overall Study|Progressive disease|5
7330477|NCT00809133|11563949|FG002|Overall Study|Progressive disease|5
7330478|NCT00809133|11563950|FG003|Overall Study|Progressive disease|3
7330479|NCT00809133|11563951|FG004|Overall Study|Progressive disease|4
7330480|NCT00809133|11563952|FG005|Overall Study|Progressive disease|1
7330481|NCT00809133|11563953|FG006|Overall Study|Progressive disease|3
7330482|NCT00809133|11563954|FG007|Overall Study|Progressive disease|3
7330483|NCT00809133|11563955|FG008|Overall Study|Progressive disease|3
7330484|NCT00809133|11563956|FG009|Overall Study|Progressive disease|9
7330485|NCT00809133|11563957|FG010|Overall Study|Progressive disease|5
7330486|NCT00809133|11563958|FG011|Overall Study|Progressive disease|7
7330487|NCT00809133|11563959|FG012|Overall Study|Progressive disease|5
7330488|NCT00809133|11563960|FG013|Overall Study|Progressive disease|4
7330489|NCT00809133|11563947|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
7330490|NCT00809133|11563948|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7330491|NCT00809133|11563949|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
7330492|NCT00809133|11563950|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7330493|NCT00809133|11563951|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
7330494|NCT00809133|11563952|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
7330495|NCT00809133|11563953|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
7330496|NCT00809133|11563954|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
7330497|NCT00809133|11563955|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
7568029|NCT03384745|11942041|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7568030|NCT03384745|11942042|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7568031|NCT03384745|11942043|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
7568032|NCT03384745|11942044|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
7568033|NCT03384745|11942045|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
7568034|NCT03384745|11942040|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7568035|NCT03384745|11942041|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7568036|NCT03384745|11942042|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7568037|NCT03384745|11942043|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7568038|NCT03384745|11942044|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
7568039|NCT03384745|11942045|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
7330498|NCT00809133|11563956|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
7568040|NCT03384745|11942040|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7568041|NCT03384745|11942041|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7568042|NCT03384745|11942042|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
7568043|NCT03384745|11942043|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7568044|NCT03384745|11942044|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7568045|NCT03384745|11942045|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
7568046|NCT03384745|11942040|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
7568047|NCT03384745|11942041|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
7568048|NCT03384745|11942042|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
7568049|NCT03384745|11942043|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
7568050|NCT03384745|11942044|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
7568051|NCT03384745|11942045|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
7568052|NCT03384745|11942040|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7568053|NCT03384745|11942041|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7568054|NCT03384745|11942042|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7568055|NCT03384745|11942043|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7568056|NCT03384745|11942044|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
7568057|NCT03384745|11942045|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
7568058|NCT03384745|11942040|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7568059|NCT03384745|11942041|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7568060|NCT03384745|11942042|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7568061|NCT03384745|11942043|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
7568062|NCT03384745|11942044|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7330499|NCT00809133|11563957|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
7330500|NCT00809133|11563958|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
7568063|NCT03384745|11942045|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
7568064|NCT03384745|11942040|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7568065|NCT03384745|11942041|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7568066|NCT03384745|11942042|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
7568067|NCT03384745|11942043|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7568068|NCT03384745|11942044|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
7568069|NCT03384745|11942045|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
7568070|NCT03384745|11942040|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7568071|NCT03384745|11942041|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7568072|NCT03384745|11942042|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
7568073|NCT03384745|11942043|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7568074|NCT03384745|11942044|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
7568075|NCT03384745|11942045|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
7568076|NCT03384745|11942040|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7568077|NCT03384745|11942041|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7568078|NCT03384745|11942042|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7568079|NCT03384745|11942043|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
7568080|NCT03384745|11942044|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7568081|NCT03384745|11942045|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
7568082|NCT03384745|11942040|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
7568083|NCT03384745|11942041|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
7568084|NCT03384745|11942042|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
7568085|NCT03384745|11942043|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
7568086|NCT03384745|11942044|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
7568087|NCT03384745|11942045|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
7568088|NCT03384940|11942068|FG000|Overall Study|Progressive disease|36
7568089|NCT03384940|11942069|FG001|Overall Study|Progressive disease|11
7568090|NCT03384940|11942070|FG002|Overall Study|Progressive disease|13
7568091|NCT03384940|11942068|FG000|Overall Study|Clinical progression|4
7568092|NCT03384940|11942069|FG001|Overall Study|Clinical progression|0
7568093|NCT03384940|11942070|FG002|Overall Study|Clinical progression|3
7568094|NCT03384940|11942068|FG000|Overall Study|Adverse Event|7
7568095|NCT03384940|11942069|FG001|Overall Study|Adverse Event|1
7568096|NCT03384940|11942070|FG002|Overall Study|Adverse Event|1
7568097|NCT03384940|11942068|FG000|Overall Study|Withdrawal by Subject|3
7568098|NCT03384940|11942069|FG001|Overall Study|Withdrawal by Subject|1
7568099|NCT03384940|11942070|FG002|Overall Study|Withdrawal by Subject|0
7568100|NCT03384940|11942068|FG000|Overall Study|Physician Decision|1
7568101|NCT03384940|11942069|FG001|Overall Study|Physician Decision|1
7568102|NCT03384940|11942070|FG002|Overall Study|Physician Decision|0
7568103|NCT03384940|11942068|FG000|Overall Study|Death|2
7568104|NCT03384940|11942069|FG001|Overall Study|Death|1
7568105|NCT03384940|11942070|FG002|Overall Study|Death|0
7568106|NCT03384940|11942068|FG000|Overall Study|Other|0
7568107|NCT03384940|11942069|FG001|Overall Study|Other|0
7568108|NCT03384940|11942070|FG002|Overall Study|Other|1
7568109|NCT03384966|11942090|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
7568110|NCT03384966|11942091|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
7568111|NCT03384966|11942092|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
7568112|NCT03384966|11942090|FG000|Follow-up Period|Adverse Event|1
7568113|NCT03384966|11942091|FG001|Follow-up Period|Adverse Event|0
7568114|NCT03384966|11942092|FG002|Follow-up Period|Adverse Event|0
7568115|NCT03386032|11942112|FG000|Overall Study|Lack of Efficacy|6
7568116|NCT03386032|11942113|FG001|Overall Study|Lack of Efficacy|2
7568117|NCT03386032|11942114|FG002|Overall Study|Lack of Efficacy|0
7568118|NCT03386032|11942112|FG000|Overall Study|Adverse Event|2
7568119|NCT03386032|11942113|FG001|Overall Study|Adverse Event|2
7568120|NCT03386032|11942114|FG002|Overall Study|Adverse Event|0
7568121|NCT03386032|11942112|FG000|Overall Study|Withdrawal by Subject|1
7568122|NCT03386032|11942113|FG001|Overall Study|Withdrawal by Subject|0
7568123|NCT03386032|11942114|FG002|Overall Study|Withdrawal by Subject|0
7568124|NCT03386032|11942112|FG000|Overall Study|Lost to Follow-up|9
7568125|NCT03386032|11942113|FG001|Overall Study|Lost to Follow-up|3
7568126|NCT03386032|11942114|FG002|Overall Study|Lost to Follow-up|0
7568127|NCT03386344|11942134|FG000|Overall Study|Adverse Event|6
7568128|NCT03386344|11942135|FG001|Overall Study|Adverse Event|3
7568129|NCT03386344|11942136|FG002|Overall Study|Adverse Event|1
7568130|NCT03386344|11942134|FG000|Overall Study|Poor Compliance to Protocol|0
7568131|NCT03386344|11942135|FG001|Overall Study|Poor Compliance to Protocol|1
7568132|NCT03386344|11942136|FG002|Overall Study|Poor Compliance to Protocol|0
7568133|NCT03386344|11942134|FG000|Overall Study|Study Terminated by Sponsor|101
7568134|NCT03386344|11942135|FG001|Overall Study|Study Terminated by Sponsor|102
7568135|NCT03386344|11942136|FG002|Overall Study|Study Terminated by Sponsor|106
7568136|NCT03386344|11942134|FG000|Overall Study|Lost to Follow-up|3
7568137|NCT03386344|11942135|FG001|Overall Study|Lost to Follow-up|2
7568138|NCT03386344|11942136|FG002|Overall Study|Lost to Follow-up|1
7568139|NCT03386344|11942134|FG000|Overall Study|At the Participant's own Request|7
7568140|NCT03386344|11942135|FG001|Overall Study|At the Participant's own Request|7
7568141|NCT03386344|11942136|FG002|Overall Study|At the Participant's own Request|8
7568142|NCT03386344|11942134|FG000|Overall Study|Reason not Specified|0
7568143|NCT03386344|11942135|FG001|Overall Study|Reason not Specified|1
7568144|NCT03386344|11942136|FG002|Overall Study|Reason not Specified|0
7568145|NCT03386435|11942146|FG000|Overall Study|Protocol Violation|5
7568146|NCT03386435|11942147|FG001|Overall Study|Protocol Violation|7
7568147|NCT03386448|11942155|FG000|Overall Study|Adverse Event|0
7568148|NCT03386448|11942156|FG001|Overall Study|Adverse Event|2
7568149|NCT03386474|11942164|FG000|Overall Study|Death|1
7568150|NCT03386474|11942165|FG001|Overall Study|Death|0
7568151|NCT03386474|11942164|FG000|Overall Study|Adverse Event|0
7568152|NCT03386474|11942165|FG001|Overall Study|Adverse Event|1
7568153|NCT03386994|11942179|FG000|Overall Study|Lung transplant|1
7568154|NCT03386994|11942179|FG000|Overall Study|Adverse Event|14
7568155|NCT03386994|11942179|FG000|Overall Study|Lost to Follow-up|4
7568156|NCT03386994|11942179|FG000|Overall Study|Withdrawal by Subject|3
7568157|NCT03386994|11942179|FG000|Overall Study|Death|16
7568158|NCT03387020|11942197|FG000|Overall Study|Adverse Event|0
7568159|NCT03387020|11942198|FG001|Overall Study|Adverse Event|2
7568160|NCT03387020|11942199|FG002|Overall Study|Adverse Event|0
7568161|NCT03387020|11942197|FG000|Overall Study|Withdrawal by Subject|2
7568162|NCT03387020|11942198|FG001|Overall Study|Withdrawal by Subject|0
7568163|NCT03387020|11942199|FG002|Overall Study|Withdrawal by Subject|0
7568164|NCT03387046|11942223|FG000|Overall Study|Adverse Event|1
7568165|NCT03387046|11942224|FG001|Overall Study|Adverse Event|1
7568166|NCT03387462|11942244|FG000|Overall Study|Lost to Follow-up|1
7568167|NCT03387683|11942250|FG000|Overall Study|In receipt of disallowed medication|1
7568168|NCT03387683|11942251|FG001|Overall Study|In receipt of disallowed medication|0
7568169|NCT03387683|11942250|FG000|Overall Study|Did not receive treatment|1
7568170|NCT03387683|11942251|FG001|Overall Study|Did not receive treatment|0
7568171|NCT03388164|11942268|FG000|Overall Study|Withdrawal by Subject|3
7568172|NCT03388164|11942269|FG001|Overall Study|Withdrawal by Subject|1
7568173|NCT03389308|11942302|FG000|Overall Study|Withdrawal by Subject|5
7568174|NCT03389308|11942302|FG000|Overall Study|Lost to Follow-up|3
7568175|NCT03389308|11942302|FG000|Overall Study|Adverse Event|2
7568176|NCT03389308|11942302|FG000|Overall Study|Sponsor Request|2
7568177|NCT03389555|11942308|FG000|Overall Study|Protocol Violation|1
7568178|NCT03389555|11942309|FG001|Overall Study|Protocol Violation|3
7568179|NCT03389555|11942308|FG000|Overall Study|Death|1
7568180|NCT03389555|11942309|FG001|Overall Study|Death|0
7568181|NCT03389893|11942338|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
7568182|NCT03389893|11942339|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
7568183|NCT03389893|11942340|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
7330501|NCT00809133|11563959|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
7330502|NCT00809133|11563960|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
7330503|NCT00809133|11563947|FG000|Overall Study|Other adverse event|1
7330504|NCT00809133|11563948|FG001|Overall Study|Other adverse event|1
7330505|NCT00809133|11563949|FG002|Overall Study|Other adverse event|1
7330506|NCT00809133|11563950|FG003|Overall Study|Other adverse event|0
7330507|NCT00809133|11563951|FG004|Overall Study|Other adverse event|0
7330508|NCT00809133|11563952|FG005|Overall Study|Other adverse event|3
7330509|NCT00809133|11563953|FG006|Overall Study|Other adverse event|2
7330510|NCT00809133|11563954|FG007|Overall Study|Other adverse event|4
7330511|NCT00809133|11563955|FG008|Overall Study|Other adverse event|0
7330512|NCT00809133|11563956|FG009|Overall Study|Other adverse event|0
7330513|NCT00809133|11563957|FG010|Overall Study|Other adverse event|1
7330514|NCT00809133|11563958|FG011|Overall Study|Other adverse event|1
7330515|NCT00809133|11563959|FG012|Overall Study|Other adverse event|0
7330516|NCT00809133|11563960|FG013|Overall Study|Other adverse event|1
7330517|NCT00809133|11563947|FG000|Overall Study|Lost to Follow-up|0
7330518|NCT00809133|11563948|FG001|Overall Study|Lost to Follow-up|0
7330519|NCT00809133|11563949|FG002|Overall Study|Lost to Follow-up|0
7330520|NCT00809133|11563950|FG003|Overall Study|Lost to Follow-up|0
7330521|NCT00809133|11563951|FG004|Overall Study|Lost to Follow-up|0
7330522|NCT00809133|11563952|FG005|Overall Study|Lost to Follow-up|1
7330523|NCT00809133|11563953|FG006|Overall Study|Lost to Follow-up|0
7330524|NCT00809133|11563954|FG007|Overall Study|Lost to Follow-up|0
7330525|NCT00809133|11563955|FG008|Overall Study|Lost to Follow-up|0
7330526|NCT00809133|11563956|FG009|Overall Study|Lost to Follow-up|0
7330527|NCT00809133|11563957|FG010|Overall Study|Lost to Follow-up|0
7330528|NCT00809133|11563958|FG011|Overall Study|Lost to Follow-up|0
7330529|NCT00809133|11563959|FG012|Overall Study|Lost to Follow-up|0
7330530|NCT00809133|11563960|FG013|Overall Study|Lost to Follow-up|0
7330531|NCT00809133|11563947|FG000|Overall Study|Consent withdrawn|0
7330532|NCT00809133|11563948|FG001|Overall Study|Consent withdrawn|0
7330533|NCT00809133|11563949|FG002|Overall Study|Consent withdrawn|0
7330534|NCT00809133|11563950|FG003|Overall Study|Consent withdrawn|0
7330535|NCT00809133|11563951|FG004|Overall Study|Consent withdrawn|1
7330536|NCT00809133|11563952|FG005|Overall Study|Consent withdrawn|0
7330537|NCT00809133|11563953|FG006|Overall Study|Consent withdrawn|0
7330538|NCT00809133|11563954|FG007|Overall Study|Consent withdrawn|0
7330539|NCT00809133|11563955|FG008|Overall Study|Consent withdrawn|0
7330540|NCT00809133|11563956|FG009|Overall Study|Consent withdrawn|0
7330541|NCT00809133|11563957|FG010|Overall Study|Consent withdrawn|0
7330542|NCT00809133|11563958|FG011|Overall Study|Consent withdrawn|0
7330543|NCT00809133|11563959|FG012|Overall Study|Consent withdrawn|0
7330544|NCT00809133|11563960|FG013|Overall Study|Consent withdrawn|0
7330545|NCT00809133|11563947|FG000|Overall Study|Other not mentioned above|0
7330546|NCT00809133|11563948|FG001|Overall Study|Other not mentioned above|1
7330547|NCT00809133|11563949|FG002|Overall Study|Other not mentioned above|0
7330548|NCT00809133|11563950|FG003|Overall Study|Other not mentioned above|0
7330549|NCT00809133|11563951|FG004|Overall Study|Other not mentioned above|0
7330550|NCT00809133|11563952|FG005|Overall Study|Other not mentioned above|1
7330551|NCT00809133|11563953|FG006|Overall Study|Other not mentioned above|0
7330552|NCT00809133|11563954|FG007|Overall Study|Other not mentioned above|0
7330553|NCT00809133|11563955|FG008|Overall Study|Other not mentioned above|0
7330554|NCT00809133|11563956|FG009|Overall Study|Other not mentioned above|0
7330555|NCT00809133|11563957|FG010|Overall Study|Other not mentioned above|0
7330556|NCT00809133|11563958|FG011|Overall Study|Other not mentioned above|0
7330557|NCT00809133|11563959|FG012|Overall Study|Other not mentioned above|0
7330558|NCT00809133|11563960|FG013|Overall Study|Other not mentioned above|0
7330559|NCT00809159|11564016|FG000|Part 1|Adverse Event|1
7330560|NCT00809159|11564017|FG001|Part 1|Adverse Event|1
7568184|NCT03389893|11942341|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
7568185|NCT03389893|11942338|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
7568186|NCT03389893|11942339|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
7568187|NCT03389893|11942340|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
7568188|NCT03389893|11942341|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
7568189|NCT03389893|11942338|FG000|Open Label Extension and Follow-Up|Physician Decision|0
7568190|NCT03389893|11942339|FG001|Open Label Extension and Follow-Up|Physician Decision|0
7568191|NCT03389893|11942340|FG002|Open Label Extension and Follow-Up|Physician Decision|1
7568192|NCT03389893|11942341|FG003|Open Label Extension and Follow-Up|Physician Decision|0
7568193|NCT03389893|11942338|FG000|Open Label Extension and Follow-Up|Participant Moved|0
7568194|NCT03389893|11942339|FG001|Open Label Extension and Follow-Up|Participant Moved|0
7568195|NCT03389893|11942340|FG002|Open Label Extension and Follow-Up|Participant Moved|1
7568196|NCT03389893|11942341|FG003|Open Label Extension and Follow-Up|Participant Moved|0
7568197|NCT03390166|11942358|FG000|Overall Study|Death|0
7568198|NCT03390166|11942359|FG001|Overall Study|Death|1
7568199|NCT03390166|11942358|FG000|Overall Study|Lost to Follow-up|6
7568200|NCT03390166|11942359|FG001|Overall Study|Lost to Follow-up|4
7568201|NCT03390166|11942358|FG000|Overall Study|Physician Decision|2
7568202|NCT03390166|11942359|FG001|Overall Study|Physician Decision|1
7568203|NCT03390166|11942358|FG000|Overall Study|Move from study area|3
7568204|NCT03390166|11942359|FG001|Overall Study|Move from study area|2
7568205|NCT03390166|11942358|FG000|Overall Study|To militarycamp for conscript|1
7330561|NCT00809159|11564018|FG002|Part 1|Adverse Event|0
7330562|NCT00809159|11564019|FG003|Part 1|Adverse Event|0
7330563|NCT00809159|11564020|FG004|Part 1|Adverse Event|0
7330564|NCT00809159|11564021|FG005|Part 1|Adverse Event|0
7330565|NCT00809159|11564016|FG000|Part 1|Lost to Follow-up|1
7330566|NCT00809159|11564017|FG001|Part 1|Lost to Follow-up|0
7568206|NCT03390166|11942359|FG001|Overall Study|To militarycamp for conscript|0
7568207|NCT03390166|11942358|FG000|Overall Study|To drug therapy course|0
7568208|NCT03390166|11942359|FG001|Overall Study|To drug therapy course|1
7568209|NCT03390166|11942358|FG000|Overall Study|Move to work oversea|0
7330567|NCT00809159|11564018|FG002|Part 1|Lost to Follow-up|0
7330568|NCT00809159|11564019|FG003|Part 1|Lost to Follow-up|0
7330569|NCT00809159|11564020|FG004|Part 1|Lost to Follow-up|0
7330570|NCT00809159|11564021|FG005|Part 1|Lost to Follow-up|0
7330571|NCT00809159|11564016|FG000|Part 1|Withdrawal by Subject|3
7330572|NCT00809159|11564017|FG001|Part 1|Withdrawal by Subject|1
7330573|NCT00809159|11564018|FG002|Part 1|Withdrawal by Subject|0
7330574|NCT00809159|11564019|FG003|Part 1|Withdrawal by Subject|0
7330575|NCT00809159|11564020|FG004|Part 1|Withdrawal by Subject|0
7330576|NCT00809159|11564021|FG005|Part 1|Withdrawal by Subject|0
7330577|NCT00809159|11564016|FG000|Part 1|Unsatisfactory therapeutic effect|3
7330578|NCT00809159|11564017|FG001|Part 1|Unsatisfactory therapeutic effect|1
7330579|NCT00809159|11564018|FG002|Part 1|Unsatisfactory therapeutic effect|0
7330580|NCT00809159|11564019|FG003|Part 1|Unsatisfactory therapeutic effect|0
7330581|NCT00809159|11564020|FG004|Part 1|Unsatisfactory therapeutic effect|0
7330582|NCT00809159|11564021|FG005|Part 1|Unsatisfactory therapeutic effect|0
7330583|NCT00809159|11564016|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
7330584|NCT00809159|11564017|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
7330585|NCT00809159|11564018|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
7330586|NCT00809159|11564019|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
7330587|NCT00809159|11564020|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
7330588|NCT00809159|11564021|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
7330589|NCT00809159|11564016|FG000|Part 1 and 2|Administrative problems|0
7330590|NCT00809159|11564017|FG001|Part 1 and 2|Administrative problems|0
7330591|NCT00809159|11564018|FG002|Part 1 and 2|Administrative problems|0
7330592|NCT00809159|11564019|FG003|Part 1 and 2|Administrative problems|1
7330593|NCT00809159|11564020|FG004|Part 1 and 2|Administrative problems|0
7330594|NCT00809159|11564021|FG005|Part 1 and 2|Administrative problems|0
7330595|NCT00809159|11564016|FG000|Part 1 and 2|Adverse Event|0
7330596|NCT00809159|11564017|FG001|Part 1 and 2|Adverse Event|0
7330597|NCT00809159|11564018|FG002|Part 1 and 2|Adverse Event|1
7330598|NCT00809159|11564019|FG003|Part 1 and 2|Adverse Event|0
7330599|NCT00809159|11564020|FG004|Part 1 and 2|Adverse Event|1
7330600|NCT00809159|11564021|FG005|Part 1 and 2|Adverse Event|1
7330601|NCT00809159|11564016|FG000|Part 1 and 2|Lost to Follow-up|0
7330602|NCT00809159|11564017|FG001|Part 1 and 2|Lost to Follow-up|0
7330603|NCT00809159|11564018|FG002|Part 1 and 2|Lost to Follow-up|1
7330604|NCT00809159|11564019|FG003|Part 1 and 2|Lost to Follow-up|1
7330605|NCT00809159|11564020|FG004|Part 1 and 2|Lost to Follow-up|0
7330606|NCT00809159|11564021|FG005|Part 1 and 2|Lost to Follow-up|0
7330607|NCT00809159|11564016|FG000|Part 1 and 2|Withdrawal by Subject|0
7330608|NCT00809159|11564017|FG001|Part 1 and 2|Withdrawal by Subject|0
7330609|NCT00809159|11564018|FG002|Part 1 and 2|Withdrawal by Subject|4
7330610|NCT00809159|11564019|FG003|Part 1 and 2|Withdrawal by Subject|0
7330611|NCT00809159|11564020|FG004|Part 1 and 2|Withdrawal by Subject|0
7330612|NCT00809159|11564021|FG005|Part 1 and 2|Withdrawal by Subject|1
7330613|NCT00809328|11564044|FG000|Overall Study|Lack of Efficacy|18
7330614|NCT00809328|11564044|FG000|Overall Study|Adverse Event|6
7330615|NCT00809328|11564044|FG000|Overall Study|Protocol Violation|3
7330616|NCT00809328|11564044|FG000|Overall Study|Withdrawal by Subject|2
7330617|NCT00809354|11564058|FG000|Overall Study|Adverse Event|32
7330618|NCT00809354|11564059|FG001|Overall Study|Adverse Event|45
7330619|NCT00809354|11564060|FG002|Overall Study|Adverse Event|37
7330620|NCT00809354|11564061|FG003|Overall Study|Adverse Event|53
7330621|NCT00809354|11564062|FG004|Overall Study|Adverse Event|26
7330622|NCT00809354|11564063|FG005|Overall Study|Adverse Event|33
7330623|NCT00809354|11564064|FG006|Overall Study|Adverse Event|44
7330624|NCT00809354|11564065|FG007|Overall Study|Adverse Event|40
7330625|NCT00809354|11564066|FG008|Overall Study|Adverse Event|46
7330626|NCT00809354|11564067|FG009|Overall Study|Adverse Event|26
7330627|NCT00809354|11564058|FG000|Overall Study|Lack of Efficacy|23
7330628|NCT00809354|11564059|FG001|Overall Study|Lack of Efficacy|23
7330629|NCT00809354|11564060|FG002|Overall Study|Lack of Efficacy|22
7330630|NCT00809354|11564061|FG003|Overall Study|Lack of Efficacy|15
7330631|NCT00809354|11564062|FG004|Overall Study|Lack of Efficacy|40
7330632|NCT00809354|11564063|FG005|Overall Study|Lack of Efficacy|19
7330633|NCT00809354|11564064|FG006|Overall Study|Lack of Efficacy|21
7330634|NCT00809354|11564065|FG007|Overall Study|Lack of Efficacy|15
7330635|NCT00809354|11564066|FG008|Overall Study|Lack of Efficacy|18
7330636|NCT00809354|11564067|FG009|Overall Study|Lack of Efficacy|38
7330637|NCT00809354|11564058|FG000|Overall Study|Lost to Follow-up|10
7330638|NCT00809354|11564059|FG001|Overall Study|Lost to Follow-up|11
7330639|NCT00809354|11564060|FG002|Overall Study|Lost to Follow-up|8
7330640|NCT00809354|11564061|FG003|Overall Study|Lost to Follow-up|13
7330641|NCT00809354|11564062|FG004|Overall Study|Lost to Follow-up|6
7330642|NCT00809354|11564063|FG005|Overall Study|Lost to Follow-up|2
7330643|NCT00809354|11564064|FG006|Overall Study|Lost to Follow-up|0
7330644|NCT00809354|11564065|FG007|Overall Study|Lost to Follow-up|5
7330645|NCT00809354|11564066|FG008|Overall Study|Lost to Follow-up|4
7330646|NCT00809354|11564067|FG009|Overall Study|Lost to Follow-up|0
7330647|NCT00809354|11564058|FG000|Overall Study|Protocol Violation|7
7330648|NCT00809354|11564059|FG001|Overall Study|Protocol Violation|14
7330649|NCT00809354|11564060|FG002|Overall Study|Protocol Violation|14
7330650|NCT00809354|11564061|FG003|Overall Study|Protocol Violation|12
7330651|NCT00809354|11564062|FG004|Overall Study|Protocol Violation|14
7330652|NCT00809354|11564063|FG005|Overall Study|Protocol Violation|6
7330653|NCT00809354|11564064|FG006|Overall Study|Protocol Violation|4
7330654|NCT00809354|11564065|FG007|Overall Study|Protocol Violation|6
7330655|NCT00809354|11564066|FG008|Overall Study|Protocol Violation|9
7330656|NCT00809354|11564067|FG009|Overall Study|Protocol Violation|3
7330657|NCT00809354|11564058|FG000|Overall Study|Withdrawal by Subject|32
7330658|NCT00809354|11564059|FG001|Overall Study|Withdrawal by Subject|27
7330659|NCT00809354|11564060|FG002|Overall Study|Withdrawal by Subject|31
7330660|NCT00809354|11564061|FG003|Overall Study|Withdrawal by Subject|33
7330661|NCT00809354|11564062|FG004|Overall Study|Withdrawal by Subject|34
7330662|NCT00809354|11564063|FG005|Overall Study|Withdrawal by Subject|29
7330663|NCT00809354|11564064|FG006|Overall Study|Withdrawal by Subject|27
7330664|NCT00809354|11564065|FG007|Overall Study|Withdrawal by Subject|19
7330665|NCT00809354|11564066|FG008|Overall Study|Withdrawal by Subject|18
7330666|NCT00809354|11564067|FG009|Overall Study|Withdrawal by Subject|20
7330667|NCT00809354|11564058|FG000|Overall Study|Other|10
7330668|NCT00809354|11564059|FG001|Overall Study|Other|2
7330669|NCT00809354|11564060|FG002|Overall Study|Other|7
7330670|NCT00809354|11564061|FG003|Overall Study|Other|10
7330671|NCT00809354|11564062|FG004|Overall Study|Other|5
7330672|NCT00809354|11564063|FG005|Overall Study|Other|3
7330673|NCT00809354|11564064|FG006|Overall Study|Other|2
7330674|NCT00809354|11564065|FG007|Overall Study|Other|3
7330675|NCT00809354|11564066|FG008|Overall Study|Other|4
7330676|NCT00809354|11564067|FG009|Overall Study|Other|3
7330677|NCT00809354|11564058|FG000|Overall Study|Study terminated by sponsor|138
7330678|NCT00809354|11564059|FG001|Overall Study|Study terminated by sponsor|134
7330679|NCT00809354|11564060|FG002|Overall Study|Study terminated by sponsor|129
7330680|NCT00809354|11564061|FG003|Overall Study|Study terminated by sponsor|120
7330681|NCT00809354|11564062|FG004|Overall Study|Study terminated by sponsor|126
7330682|NCT00809354|11564063|FG005|Overall Study|Study terminated by sponsor|133
7330683|NCT00809354|11564064|FG006|Overall Study|Study terminated by sponsor|124
7330684|NCT00809354|11564065|FG007|Overall Study|Study terminated by sponsor|148
7330685|NCT00809354|11564066|FG008|Overall Study|Study terminated by sponsor|127
7330686|NCT00809354|11564067|FG009|Overall Study|Study terminated by sponsor|135
7330687|NCT00809354|11564058|FG000|Overall Study|Withdrawn due to pregnancy|0
7330688|NCT00809354|11564059|FG001|Overall Study|Withdrawn due to pregnancy|1
7330689|NCT00809354|11564060|FG002|Overall Study|Withdrawn due to pregnancy|0
7330690|NCT00809354|11564061|FG003|Overall Study|Withdrawn due to pregnancy|0
7330691|NCT00809354|11564062|FG004|Overall Study|Withdrawn due to pregnancy|0
7330692|NCT00809354|11564063|FG005|Overall Study|Withdrawn due to pregnancy|0
7330693|NCT00809354|11564064|FG006|Overall Study|Withdrawn due to pregnancy|0
7330694|NCT00809354|11564065|FG007|Overall Study|Withdrawn due to pregnancy|0
7330695|NCT00809354|11564066|FG008|Overall Study|Withdrawn due to pregnancy|0
7330696|NCT00809354|11564067|FG009|Overall Study|Withdrawn due to pregnancy|0
7330697|NCT00809354|11564058|FG000|Overall Study|Randomized but not Treated|3
7330698|NCT00809354|11564059|FG001|Overall Study|Randomized but not Treated|1
7330699|NCT00809354|11564060|FG002|Overall Study|Randomized but not Treated|6
7330700|NCT00809354|11564061|FG003|Overall Study|Randomized but not Treated|0
7330701|NCT00809354|11564062|FG004|Overall Study|Randomized but not Treated|5
7330702|NCT00809354|11564063|FG005|Overall Study|Randomized but not Treated|0
7330703|NCT00809354|11564064|FG006|Overall Study|Randomized but not Treated|1
7330704|NCT00809354|11564065|FG007|Overall Study|Randomized but not Treated|1
7330705|NCT00809354|11564066|FG008|Overall Study|Randomized but not Treated|2
7330706|NCT00809354|11564067|FG009|Overall Study|Randomized but not Treated|1
7330707|NCT00809354|11564058|FG000|Overall Study|Death|0
7330708|NCT00809354|11564059|FG001|Overall Study|Death|0
7330709|NCT00809354|11564060|FG002|Overall Study|Death|0
7330710|NCT00809354|11564061|FG003|Overall Study|Death|0
7330711|NCT00809354|11564062|FG004|Overall Study|Death|0
7330712|NCT00809354|11564063|FG005|Overall Study|Death|0
7330713|NCT00809354|11564064|FG006|Overall Study|Death|0
7330714|NCT00809354|11564065|FG007|Overall Study|Death|1
7330715|NCT00809354|11564066|FG008|Overall Study|Death|0
7330716|NCT00809354|11564067|FG009|Overall Study|Death|0
7330717|NCT00809445|11564097|FG000|1 Month Follow-up|Lost contact|1
7330718|NCT00809445|11564098|FG001|1 Month Follow-up|Lost contact|2
7225171|NCT00064701|11434644|FG002|One Year Post-transplant|Withdrawal by Subject|1
7225172|NCT00064701|11434642|FG000|One Year Post-transplant|Lost to Follow-up|1
7225173|NCT00064701|11434643|FG001|One Year Post-transplant|Lost to Follow-up|0
7225174|NCT00064701|11434644|FG002|One Year Post-transplant|Lost to Follow-up|0
7225175|NCT00064701|11434642|FG000|One Year Post-transplant|Converted to rapamycin|1
7568210|NCT03390166|11942359|FG001|Overall Study|Move to work oversea|1
7568211|NCT03390426|11942373|FG000|Overall Study|Protocol Violation|0
7568212|NCT03390426|11942374|FG001|Overall Study|Protocol Violation|1
7568213|NCT03391765|11942407|FG000|Overall Study|Adverse Event|2
7568214|NCT03391765|11942408|FG001|Overall Study|Adverse Event|0
7568215|NCT03391765|11942409|FG002|Overall Study|Adverse Event|0
7568216|NCT03391765|11942410|FG003|Overall Study|Adverse Event|2
7568217|NCT03391765|11942407|FG000|Overall Study|Withdrew consent|5
7568218|NCT03391765|11942408|FG001|Overall Study|Withdrew consent|7
7568219|NCT03391765|11942409|FG002|Overall Study|Withdrew consent|2
7568220|NCT03391765|11942410|FG003|Overall Study|Withdrew consent|5
7568221|NCT03391765|11942407|FG000|Overall Study|Other, not specified|44
7568222|NCT03391765|11942408|FG001|Overall Study|Other, not specified|38
7568223|NCT03391765|11942409|FG002|Overall Study|Other, not specified|21
7568224|NCT03391765|11942410|FG003|Overall Study|Other, not specified|16
7568233|NCT03392194|11942451|FG000|Overall Study|Withdrawal by Subject|1
7568234|NCT03392194|11942452|FG001|Overall Study|Withdrawal by Subject|2
7568235|NCT03392194|11942451|FG000|Overall Study|Conflicts with personal schedule|1
7568236|NCT03392194|11942452|FG001|Overall Study|Conflicts with personal schedule|0
7568237|NCT03393000|11942474|FG000|Overall Study|Death|11
7568238|NCT03393000|11942474|FG000|Overall Study|Withdrawal by Subject|2
7568239|NCT03393000|11942474|FG000|Overall Study|Physician Decision|1
7568240|NCT03393806|11942521|FG000|Overall Study|Physician Decision|1
7568241|NCT03393806|11942522|FG001|Overall Study|Physician Decision|0
7568242|NCT03394391|11942531|FG000|Overall Study|Lost to Follow-up|1
7568243|NCT03394391|11942532|FG001|Overall Study|Lost to Follow-up|2
7568244|NCT03394508|11942540|FG000|Overall Study|Protocol Violation|0
7568245|NCT03394508|11942541|FG001|Overall Study|Protocol Violation|3
7568246|NCT03394508|11942540|FG000|Overall Study|Lost to Follow-up|1
7568247|NCT03394508|11942541|FG001|Overall Study|Lost to Follow-up|0
7568248|NCT03394885|11942555|FG000|Overall Study|Adverse Event|4
7568249|NCT03394885|11942555|FG000|Overall Study|Lack of Efficacy|1
7568250|NCT03394885|11942555|FG000|Overall Study|Physician Decision|1
7330719|NCT00809445|11564099|FG002|1 Month Follow-up|Lost contact|1
7330720|NCT00809445|11564097|FG000|1 Month Follow-up|Withdrew consent|1
7330721|NCT00809445|11564098|FG001|1 Month Follow-up|Withdrew consent|1
7330722|NCT00809445|11564099|FG002|1 Month Follow-up|Withdrew consent|1
7330723|NCT00809445|11564097|FG000|1 Month Follow-up|Death|0
7330724|NCT00809445|11564098|FG001|1 Month Follow-up|Death|1
7330725|NCT00809445|11564099|FG002|1 Month Follow-up|Death|1
7330726|NCT00809445|11564097|FG000|1 Month Follow-up|Incarcerated|0
7330727|NCT00809445|11564098|FG001|1 Month Follow-up|Incarcerated|0
7330728|NCT00809445|11564099|FG002|1 Month Follow-up|Incarcerated|1
7330729|NCT00809445|11564097|FG000|6 Month Follow-up|Lost contact|16
7330730|NCT00809445|11564098|FG001|6 Month Follow-up|Lost contact|14
7330731|NCT00809445|11564099|FG002|6 Month Follow-up|Lost contact|14
7330732|NCT00809445|11564097|FG000|6 Month Follow-up|Death|2
7330733|NCT00809445|11564098|FG001|6 Month Follow-up|Death|1
7330734|NCT00809445|11564099|FG002|6 Month Follow-up|Death|1
7330735|NCT00809445|11564097|FG000|6 Month Follow-up|Incarcerated|6
7330736|NCT00809445|11564098|FG001|6 Month Follow-up|Incarcerated|8
7330737|NCT00809445|11564099|FG002|6 Month Follow-up|Incarcerated|8
7330738|NCT00809445|11564097|FG000|6 Month Follow-up|Withdrew consent|0
7330739|NCT00809445|11564098|FG001|6 Month Follow-up|Withdrew consent|0
7330740|NCT00809445|11564099|FG002|6 Month Follow-up|Withdrew consent|1
7330741|NCT00809471|11564110|FG000|Overall Study|Protocol non-compliance|15
7330742|NCT00809471|11564111|FG001|Overall Study|Protocol non-compliance|15
7330743|NCT00809471|11564112|FG002|Overall Study|Protocol non-compliance|6
7330744|NCT00809471|11564110|FG000|Overall Study|Lost to Follow-up|4
7330745|NCT00809471|11564111|FG001|Overall Study|Lost to Follow-up|2
7330746|NCT00809471|11564112|FG002|Overall Study|Lost to Follow-up|9
7330747|NCT00809471|11564110|FG000|Overall Study|Adverse Event|0
7330748|NCT00809471|11564111|FG001|Overall Study|Adverse Event|2
7330749|NCT00809471|11564112|FG002|Overall Study|Adverse Event|2
7330750|NCT00809471|11564110|FG000|Overall Study|Requirement for restricted medication|1
7330751|NCT00809471|11564111|FG001|Overall Study|Requirement for restricted medication|1
7330752|NCT00809471|11564112|FG002|Overall Study|Requirement for restricted medication|0
7330753|NCT00809614|11564131|FG000|Overall Study|Lack of Efficacy|2
7330754|NCT00809614|11564132|FG001|Overall Study|Lack of Efficacy|3
7330755|NCT00809614|11564131|FG000|Overall Study|Withdrawal by Subject|1
7330756|NCT00809614|11564132|FG001|Overall Study|Withdrawal by Subject|1
7330757|NCT00809757|11564141|FG000|Overall Study|Adverse Event|2
7330758|NCT00809757|11564142|FG001|Overall Study|Adverse Event|3
7330759|NCT00809757|11564143|FG002|Overall Study|Adverse Event|3
7330760|NCT00809757|11564141|FG000|Overall Study|Lost to Follow-up|0
7330761|NCT00809757|11564142|FG001|Overall Study|Lost to Follow-up|0
7330762|NCT00809757|11564143|FG002|Overall Study|Lost to Follow-up|1
7330763|NCT00809757|11564141|FG000|Overall Study|Protocol Violation|1
7330764|NCT00809757|11564142|FG001|Overall Study|Protocol Violation|1
7330765|NCT00809757|11564143|FG002|Overall Study|Protocol Violation|1
7330766|NCT00809757|11564141|FG000|Overall Study|Withdrawal by Subject|2
7330767|NCT00809757|11564142|FG001|Overall Study|Withdrawal by Subject|1
7330768|NCT00809757|11564143|FG002|Overall Study|Withdrawal by Subject|3
7330769|NCT00809757|11564141|FG000|Overall Study|Subject Uncooperative|1
7330770|NCT00809757|11564142|FG001|Overall Study|Subject Uncooperative|0
7330771|NCT00809757|11564143|FG002|Overall Study|Subject Uncooperative|2
7330772|NCT00809757|11564141|FG000|Overall Study|Noncompliance with Medication|0
7330773|NCT00809757|11564142|FG001|Overall Study|Noncompliance with Medication|0
7330774|NCT00809757|11564143|FG002|Overall Study|Noncompliance with Medication|1
7330775|NCT00809783|11564160|FG000|Overall Study|Death|1
7330776|NCT00809783|11564161|FG001|Overall Study|Death|0
7330777|NCT00809783|11564162|FG002|Overall Study|Death|0
7330778|NCT00809783|11564160|FG000|Overall Study|Adverse Event|34
7330779|NCT00809783|11564161|FG001|Overall Study|Adverse Event|52
7330780|NCT00809783|11564162|FG002|Overall Study|Adverse Event|71
7330781|NCT00809783|11564160|FG000|Overall Study|Lack of Efficacy|39
7330782|NCT00809783|11564161|FG001|Overall Study|Lack of Efficacy|52
7330783|NCT00809783|11564162|FG002|Overall Study|Lack of Efficacy|63
7330784|NCT00809783|11564160|FG000|Overall Study|Lost to Follow-up|0
7330785|NCT00809783|11564161|FG001|Overall Study|Lost to Follow-up|3
7330786|NCT00809783|11564162|FG002|Overall Study|Lost to Follow-up|4
7330787|NCT00809783|11564160|FG000|Overall Study|Withdrawal by Subject|47
7330788|NCT00809783|11564161|FG001|Overall Study|Withdrawal by Subject|72
7330789|NCT00809783|11564162|FG002|Overall Study|Withdrawal by Subject|64
7330790|NCT00809783|11564160|FG000|Overall Study|Protocol Violation|2
7330791|NCT00809783|11564161|FG001|Overall Study|Protocol Violation|6
7330792|NCT00809783|11564162|FG002|Overall Study|Protocol Violation|5
7330793|NCT00809783|11564160|FG000|Overall Study|Randomized, but not treated|3
7330794|NCT00809783|11564161|FG001|Overall Study|Randomized, but not treated|0
7330795|NCT00809783|11564162|FG002|Overall Study|Randomized, but not treated|2
7330796|NCT00809783|11564160|FG000|Overall Study|Study Terminated by Sponsor|378
7330797|NCT00809783|11564161|FG001|Overall Study|Study Terminated by Sponsor|626
7330798|NCT00809783|11564162|FG002|Overall Study|Study Terminated by Sponsor|565
7330799|NCT00809783|11564160|FG000|Overall Study|Other|21
7330800|NCT00809783|11564161|FG001|Overall Study|Other|21
7330801|NCT00809783|11564162|FG002|Overall Study|Other|16
7330802|NCT00809835|11564183|FG000|Overall Study|Lost to Follow-up|7
7330803|NCT00809835|11564184|FG001|Overall Study|Lost to Follow-up|6
7330804|NCT00809835|11564185|FG002|Overall Study|Lost to Follow-up|10
7330805|NCT00809835|11564186|FG003|Overall Study|Lost to Follow-up|2
7330806|NCT00809835|11564183|FG000|Overall Study|Withdrawal by Subject|1
7330807|NCT00809835|11564184|FG001|Overall Study|Withdrawal by Subject|1
7330808|NCT00809835|11564185|FG002|Overall Study|Withdrawal by Subject|1
7330809|NCT00809835|11564186|FG003|Overall Study|Withdrawal by Subject|0
7330810|NCT00809926|11564220|FG000|Overall Study|Adverse Event|18
7330811|NCT00809926|11564221|FG001|Overall Study|Adverse Event|10
7330812|NCT00809926|11564220|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7330813|NCT00809926|11564221|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7330814|NCT00809926|11564220|FG000|Overall Study|Patient withdrew consent|8
7330815|NCT00809926|11564221|FG001|Overall Study|Patient withdrew consent|6
7330816|NCT00809926|11564220|FG000|Overall Study|Lost to Follow-up|2
7330817|NCT00809926|11564221|FG001|Overall Study|Lost to Follow-up|1
7330818|NCT00809926|11564220|FG000|Overall Study|Administrative Problems|0
7330819|NCT00809926|11564221|FG001|Overall Study|Administrative Problems|1
7330820|NCT00809926|11564220|FG000|Overall Study|Protocol deviation|0
7330821|NCT00809926|11564221|FG001|Overall Study|Protocol deviation|2
7330822|NCT00809965|11564230|FG000|Overall Study|Death|194
7330823|NCT00809965|11564231|FG001|Overall Study|Death|147
7330824|NCT00809965|11564232|FG002|Overall Study|Death|196
7330825|NCT00809965|11564230|FG000|Overall Study|Lost to Follow-up|17
7330826|NCT00809965|11564231|FG001|Overall Study|Lost to Follow-up|10
7330827|NCT00809965|11564232|FG002|Overall Study|Lost to Follow-up|18
7330828|NCT00809965|11564230|FG000|Overall Study|Withdrawal by Subject|405
7330829|NCT00809965|11564231|FG001|Overall Study|Withdrawal by Subject|448
7330830|NCT00809965|11564232|FG002|Overall Study|Withdrawal by Subject|441
7330831|NCT00809965|11564230|FG000|Overall Study|Other Reason|167
7330832|NCT00809965|11564231|FG001|Overall Study|Other Reason|170
7330833|NCT00809965|11564232|FG002|Overall Study|Other Reason|189
7330834|NCT00810043|11564242|FG000|Overall Study|Withdrawal by Subject|1
7330835|NCT00810043|11564243|FG001|Overall Study|Withdrawal by Subject|0
7330836|NCT00810043|11564244|FG002|Overall Study|Withdrawal by Subject|2
7330837|NCT00810043|11564242|FG000|Overall Study|Lost to Follow-up|1
7330838|NCT00810043|11564243|FG001|Overall Study|Lost to Follow-up|0
7330839|NCT00810043|11564244|FG002|Overall Study|Lost to Follow-up|0
7330840|NCT00810043|11564242|FG000|Overall Study|Physician Decision|0
7330841|NCT00810043|11564243|FG001|Overall Study|Physician Decision|0
7330842|NCT00810043|11564244|FG002|Overall Study|Physician Decision|2
7330843|NCT00810043|11564242|FG000|Overall Study|Death|2
7330844|NCT00810043|11564243|FG001|Overall Study|Death|0
7330845|NCT00810043|11564244|FG002|Overall Study|Death|0
7330846|NCT00810043|11564242|FG000|Overall Study|Unrelated medical problem|0
7330847|NCT00810043|11564243|FG001|Overall Study|Unrelated medical problem|1
7330848|NCT00810043|11564244|FG002|Overall Study|Unrelated medical problem|0
7330849|NCT00810043|11564242|FG000|Overall Study|Non-medical problem|0
7330850|NCT00810043|11564243|FG001|Overall Study|Non-medical problem|0
7568251|NCT03394885|11942555|FG000|Overall Study|Withdrawal by Subject|8
7568252|NCT03394885|11942555|FG000|Overall Study|Alternative Therapy|1
7568253|NCT03394924|11942562|FG000|Overall Study|Adverse Event|0
7330851|NCT00810043|11564244|FG002|Overall Study|Non-medical problem|1
7330852|NCT00810043|11564242|FG000|Overall Study|No longer met enrollment criteria|0
7330853|NCT00810043|11564243|FG001|Overall Study|No longer met enrollment criteria|0
7330854|NCT00810043|11564244|FG002|Overall Study|No longer met enrollment criteria|3
7330855|NCT00810069|11564255|FG000|Lead-in Period I|Adverse Event|43
7330856|NCT00810069|11564256|FG001|Lead-in Period I|Adverse Event|0
7330857|NCT00810069|11564257|FG002|Lead-in Period I|Adverse Event|0
7330858|NCT00810069|11564255|FG000|Lead-in Period I|Lack of Efficacy|1
7330859|NCT00810069|11564256|FG001|Lead-in Period I|Lack of Efficacy|0
7330860|NCT00810069|11564257|FG002|Lead-in Period I|Lack of Efficacy|0
7330861|NCT00810069|11564255|FG000|Lead-in Period I|Lost to Follow-up|19
7568254|NCT03394924|11942563|FG001|Overall Study|Adverse Event|5
7568255|NCT03394924|11942564|FG002|Overall Study|Adverse Event|0
7568256|NCT03394924|11942562|FG000|Overall Study|Withdrawal by Subject|2
7330862|NCT00810069|11564256|FG001|Lead-in Period I|Lost to Follow-up|0
7330863|NCT00810069|11564257|FG002|Lead-in Period I|Lost to Follow-up|0
7330864|NCT00810069|11564255|FG000|Lead-in Period I|Physician Decision|1
7330865|NCT00810069|11564256|FG001|Lead-in Period I|Physician Decision|0
7568257|NCT03394924|11942563|FG001|Overall Study|Withdrawal by Subject|0
7568258|NCT03394924|11942564|FG002|Overall Study|Withdrawal by Subject|0
7568259|NCT03394924|11942562|FG000|Overall Study|Lost to Follow-up|0
7568260|NCT03394924|11942563|FG001|Overall Study|Lost to Follow-up|1
7568261|NCT03394924|11942564|FG002|Overall Study|Lost to Follow-up|0
7568262|NCT03394924|11942562|FG000|Overall Study|Did not meet all inclusion criteria|1
7568263|NCT03394924|11942563|FG001|Overall Study|Did not meet all inclusion criteria|0
7568264|NCT03394924|11942564|FG002|Overall Study|Did not meet all inclusion criteria|0
7330866|NCT00810069|11564257|FG002|Lead-in Period I|Physician Decision|0
7330867|NCT00810069|11564255|FG000|Lead-in Period I|Protocol Violation|1
7330868|NCT00810069|11564256|FG001|Lead-in Period I|Protocol Violation|0
7330869|NCT00810069|11564257|FG002|Lead-in Period I|Protocol Violation|0
7330870|NCT00810069|11564255|FG000|Lead-in Period I|Withdrawal by Subject|46
7330871|NCT00810069|11564256|FG001|Lead-in Period I|Withdrawal by Subject|0
7330872|NCT00810069|11564257|FG002|Lead-in Period I|Withdrawal by Subject|0
7330873|NCT00810069|11564255|FG000|Lead-in Period I|Protocol entry criterion not met|5
7330874|NCT00810069|11564256|FG001|Lead-in Period I|Protocol entry criterion not met|0
7330875|NCT00810069|11564257|FG002|Lead-in Period I|Protocol entry criterion not met|0
7330876|NCT00810069|11564255|FG000|Lead-in Period I|Randomization criteria not met|158
7330877|NCT00810069|11564256|FG001|Lead-in Period I|Randomization criteria not met|0
7330878|NCT00810069|11564257|FG002|Lead-in Period I|Randomization criteria not met|0
7330879|NCT00810069|11564255|FG000|Double-Blind Period II|Adverse Event|0
7330880|NCT00810069|11564256|FG001|Double-Blind Period II|Adverse Event|9
7330881|NCT00810069|11564257|FG002|Double-Blind Period II|Adverse Event|8
7330882|NCT00810069|11564255|FG000|Double-Blind Period II|Lack of Efficacy|0
7330883|NCT00810069|11564256|FG001|Double-Blind Period II|Lack of Efficacy|7
7330884|NCT00810069|11564257|FG002|Double-Blind Period II|Lack of Efficacy|12
7330885|NCT00810069|11564255|FG000|Double-Blind Period II|Lost to Follow-up|0
7330886|NCT00810069|11564256|FG001|Double-Blind Period II|Lost to Follow-up|9
7330887|NCT00810069|11564257|FG002|Double-Blind Period II|Lost to Follow-up|9
7330888|NCT00810069|11564255|FG000|Double-Blind Period II|Physician Decision|0
7330889|NCT00810069|11564256|FG001|Double-Blind Period II|Physician Decision|0
7330890|NCT00810069|11564257|FG002|Double-Blind Period II|Physician Decision|1
7330891|NCT00810069|11564255|FG000|Double-Blind Period II|Withdrawal by Subject|0
7330892|NCT00810069|11564256|FG001|Double-Blind Period II|Withdrawal by Subject|21
7330893|NCT00810069|11564257|FG002|Double-Blind Period II|Withdrawal by Subject|35
7330894|NCT00810069|11564255|FG000|Double-Blind Period II|Protocol entry criterion not met|0
7330895|NCT00810069|11564256|FG001|Double-Blind Period II|Protocol entry criterion not met|0
7330896|NCT00810069|11564257|FG002|Double-Blind Period II|Protocol entry criterion not met|1
7330897|NCT00810069|11564255|FG000|Double-Blind Period II|Clinical relapse|0
7330898|NCT00810069|11564256|FG001|Double-Blind Period II|Clinical relapse|3
7330899|NCT00810069|11564257|FG002|Double-Blind Period II|Clinical relapse|0
7330900|NCT00810069|11564255|FG000|Double-Blind Period II|Protocol Violation|0
7330901|NCT00810069|11564256|FG001|Double-Blind Period II|Protocol Violation|7
7330902|NCT00810069|11564257|FG002|Double-Blind Period II|Protocol Violation|6
7330903|NCT00810082|11564268|FG000|Overall Study|Lost to Follow-up|0
7330904|NCT00810082|11564269|FG001|Overall Study|Lost to Follow-up|4
7330905|NCT00810108|11564281|FG000|Overall Study|Withdrawal by Subject|1
7330906|NCT00810108|11564282|FG001|Overall Study|Withdrawal by Subject|0
7330907|NCT00810199|11564289|FG000|Overall Study|Adverse Event|24
7330908|NCT00810199|11564290|FG001|Overall Study|Adverse Event|26
7330909|NCT00810199|11564289|FG000|Overall Study|Death|4
7330910|NCT00810199|11564290|FG001|Overall Study|Death|6
7330911|NCT00810199|11564289|FG000|Overall Study|Withdrew consent|9
7330912|NCT00810199|11564290|FG001|Overall Study|Withdrew consent|12
7330913|NCT00810199|11564289|FG000|Overall Study|Insufficient therapeutic response|5
7330914|NCT00810199|11564290|FG001|Overall Study|Insufficient therapeutic response|14
7330915|NCT00810199|11564289|FG000|Overall Study|Refused treatment/Did not cooperate|7
7330916|NCT00810199|11564290|FG001|Overall Study|Refused treatment/Did not cooperate|7
7330917|NCT00810199|11564289|FG000|Overall Study|Administrative/Other|5
7330918|NCT00810199|11564290|FG001|Overall Study|Administrative/Other|6
7330919|NCT00810199|11564289|FG000|Overall Study|Protocol Violation|2
7330920|NCT00810199|11564290|FG001|Overall Study|Protocol Violation|6
7330921|NCT00810199|11564289|FG000|Overall Study|Failure to return|1
7330922|NCT00810199|11564290|FG001|Overall Study|Failure to return|4
7330923|NCT00810199|11564289|FG000|Overall Study|Did not receive study drug|2
7330924|NCT00810199|11564290|FG001|Overall Study|Did not receive study drug|1
7330925|NCT00810264|11564302|FG000|Overall Study|Lost to Follow-up|191
7330926|NCT00810264|11564302|FG000|Overall Study|Withdrawal by subject or physician|721
7330927|NCT00810264|11564302|FG000|Overall Study|Death|641
7330928|NCT00810277|11564310|FG000|Overall Study|Adverse Event|1
7330929|NCT00810342|11564324|FG000|Month 1 Follow-up|Lost to Follow-up|4
7330930|NCT00810342|11564325|FG001|Month 1 Follow-up|Lost to Follow-up|2
7330931|NCT00810342|11564324|FG000|Month 1 Follow-up|Pregnancy|1
7330932|NCT00810342|11564325|FG001|Month 1 Follow-up|Pregnancy|0
7330933|NCT00810342|11564324|FG000|6-month Follow-up|Lost to Follow-up|18
7330934|NCT00810342|11564325|FG001|6-month Follow-up|Lost to Follow-up|6
7330935|NCT00810342|11564324|FG000|6-month Follow-up|Pregnancy|6
7330936|NCT00810342|11564325|FG001|6-month Follow-up|Pregnancy|2
7330937|NCT00810342|11564324|FG000|12-month Followup|Pregnancy|9
7330938|NCT00810342|11564325|FG001|12-month Followup|Pregnancy|10
7330939|NCT00810342|11564324|FG000|12-month Followup|Lost to Follow-up|3
7330940|NCT00810342|11564325|FG001|12-month Followup|Lost to Follow-up|1
7330941|NCT00810355|11564336|FG000|Overall Study|Lost to Follow-up|13
7330942|NCT00810355|11564337|FG001|Overall Study|Lost to Follow-up|17
7330943|NCT00810355|11564338|FG002|Overall Study|Lost to Follow-up|11
7330944|NCT00810355|11564336|FG000|Overall Study|Withdrawal by Subject|1
7330945|NCT00810355|11564337|FG001|Overall Study|Withdrawal by Subject|0
7330946|NCT00810355|11564338|FG002|Overall Study|Withdrawal by Subject|0
7330947|NCT00810368|11564348|FG000|Overall Study|Lost to Follow-up|4
7330948|NCT00810368|11564349|FG001|Overall Study|Lost to Follow-up|2
7330949|NCT00810368|11564348|FG000|Overall Study|Lack of Efficacy|2
7330950|NCT00810368|11564349|FG001|Overall Study|Lack of Efficacy|0
7330951|NCT00810394|11564357|FG000|Overall Study|Withdrawal by Subject|3
7330952|NCT00810407|11564361|FG000|Overall Study|Protocol Violation|3
7330953|NCT00810407|11564361|FG000|Overall Study|No Visit After First Day of Treatment|3
7330954|NCT00810511|11564382|FG000|Overall Study|Protocol Violation|0
7330955|NCT00810511|11564383|FG001|Overall Study|Protocol Violation|1
7330956|NCT00810511|11564382|FG000|Overall Study|Lack of Efficacy|9
7330957|NCT00810511|11564383|FG001|Overall Study|Lack of Efficacy|1
7330958|NCT00810511|11564382|FG000|Overall Study|death in the family|0
7330959|NCT00810511|11564383|FG001|Overall Study|death in the family|1
7330960|NCT00810511|11564382|FG000|Overall Study|Lost to Follow-up|1
7330961|NCT00810511|11564383|FG001|Overall Study|Lost to Follow-up|0
7330962|NCT00810511|11564382|FG000|Overall Study|deposits on contact lens|0
7330963|NCT00810511|11564383|FG001|Overall Study|deposits on contact lens|1
7330964|NCT00810602|11564393|FG000|Overall Study|Withdrawal by Subject|8
7330965|NCT00810602|11564394|FG001|Overall Study|Withdrawal by Subject|3
7330966|NCT00810615|11564400|FG000|Overall Study|Withdrawal by Subject|1
7330967|NCT00810615|11564401|FG001|Overall Study|Withdrawal by Subject|1
7330968|NCT00810641|11564422|FG000|Overall Study|Withdrawal by Subject|0
7330969|NCT00810641|11564423|FG001|Overall Study|Withdrawal by Subject|1
7330970|NCT00810641|11564424|FG002|Overall Study|Withdrawal by Subject|2
7330971|NCT00810693|11564435|FG000|Treatment Period|Adverse Event|8
7330972|NCT00810693|11564436|FG001|Treatment Period|Adverse Event|1
7330973|NCT00810693|11564437|FG002|Treatment Period|Adverse Event|7
7330974|NCT00810693|11564435|FG000|Treatment Period|Death|0
7330975|NCT00810693|11564436|FG001|Treatment Period|Death|1
7330976|NCT00810693|11564437|FG002|Treatment Period|Death|2
7330977|NCT00810693|11564435|FG000|Treatment Period|Lack of Efficacy|0
7330978|NCT00810693|11564436|FG001|Treatment Period|Lack of Efficacy|0
7568265|NCT03395353|11942574|FG000|Overall Study|Adverse Event|20
7568266|NCT03395353|11942574|FG000|Overall Study|Protocol Violation|1
7568267|NCT03395353|11942574|FG000|Overall Study|Lack of Efficacy|3
7568268|NCT03395353|11942574|FG000|Overall Study|Withdrawal by Subject|24
7568269|NCT03395353|11942574|FG000|Overall Study|Discontinued visit|1
7225176|NCT00064701|11434643|FG001|One Year Post-transplant|Converted to rapamycin|0
7225177|NCT00064701|11434644|FG002|One Year Post-transplant|Converted to rapamycin|0
7330979|NCT00810693|11564437|FG002|Treatment Period|Lack of Efficacy|1
7330980|NCT00810693|11564435|FG000|Treatment Period|Lost to Follow-up|1
7330981|NCT00810693|11564436|FG001|Treatment Period|Lost to Follow-up|0
7330982|NCT00810693|11564437|FG002|Treatment Period|Lost to Follow-up|0
7568270|NCT03395353|11942574|FG000|Overall Study|Refrain from visit due to COVID-19|1
7568271|NCT03395353|11942574|FG000|Overall Study|Physician Decision|4
7568272|NCT03395353|11942574|FG000|Overall Study|Early termination of overall study|33
7568273|NCT03396835|11942615|FG000|Overall Study|Withdrawn prior to completion|1
7568274|NCT03396835|11942615|FG000|Overall Study|Did not meet criteria for data analysis|1
7568275|NCT03396913|11942621|FG000|Overall Study|Lost to Follow-up|0
7568276|NCT03396913|11942622|FG001|Overall Study|Lost to Follow-up|6
7568277|NCT03397771|11942655|FG000|Overall Study|2 erroneously randomized, never treated|3
7568278|NCT03397771|11942656|FG001|Overall Study|2 erroneously randomized, never treated|1
7568279|NCT03397771|11942655|FG000|Overall Study|Withdrawal by Subject|1
7568280|NCT03397771|11942656|FG001|Overall Study|Withdrawal by Subject|3
7568281|NCT03397771|11942655|FG000|Overall Study|Protocol Violation|2
7568282|NCT03397771|11942656|FG001|Overall Study|Protocol Violation|2
7568283|NCT03397771|11942655|FG000|Overall Study|Adverse Event|2
7568284|NCT03397771|11942656|FG001|Overall Study|Adverse Event|1
7568285|NCT03399786|11942778|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
7568286|NCT03399786|11942779|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7568287|NCT03399786|11942780|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7568288|NCT03399786|11942781|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
7568289|NCT03399786|11942778|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7568290|NCT03399786|11942779|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7568291|NCT03399786|11942780|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
7568292|NCT03399786|11942781|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
7568293|NCT03399786|11942778|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
7568294|NCT03399786|11942779|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
7568295|NCT03399786|11942780|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
7568296|NCT03399786|11942781|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
7568297|NCT03400033|11942791|FG000|Overall Study|Withdrawal by Subject|1
7568298|NCT03400033|11942792|FG001|Overall Study|Withdrawal by Subject|2
7568299|NCT03400787|11942847|FG000|Overall Study|Lost to Follow-up|1
7568300|NCT03400787|11942848|FG001|Overall Study|Lost to Follow-up|0
7568301|NCT03400787|11942847|FG000|Overall Study|Death|1
7568302|NCT03400787|11942848|FG001|Overall Study|Death|0
7568303|NCT03400787|11942847|FG000|Overall Study|Protocol Violation|0
7568304|NCT03400787|11942848|FG001|Overall Study|Protocol Violation|2
7568305|NCT03400787|11942847|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
7568306|NCT03400787|11942848|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
7568307|NCT03400852|11942865|FG000|Blinded Treatment Period|Physician Decision|0
7330983|NCT00810693|11564435|FG000|Treatment Period|Non-compliance|1
7330984|NCT00810693|11564436|FG001|Treatment Period|Non-compliance|0
7330985|NCT00810693|11564437|FG002|Treatment Period|Non-compliance|0
7330986|NCT00810693|11564435|FG000|Treatment Period|Protocol Violation|1
7330987|NCT00810693|11564436|FG001|Treatment Period|Protocol Violation|2
7330988|NCT00810693|11564437|FG002|Treatment Period|Protocol Violation|2
7330989|NCT00810693|11564435|FG000|Treatment Period|Withdrawal by Subject|6
7330990|NCT00810693|11564436|FG001|Treatment Period|Withdrawal by Subject|2
7330991|NCT00810693|11564437|FG002|Treatment Period|Withdrawal by Subject|3
7330992|NCT00810693|11564435|FG000|Treatment Period|Not treated|0
7330993|NCT00810693|11564436|FG001|Treatment Period|Not treated|1
7330994|NCT00810693|11564437|FG002|Treatment Period|Not treated|1
7330995|NCT00810693|11564435|FG000|Follow-up Period (FUP)|Adverse Event|3
7330996|NCT00810693|11564436|FG001|Follow-up Period (FUP)|Adverse Event|1
7330997|NCT00810693|11564437|FG002|Follow-up Period (FUP)|Adverse Event|1
7330998|NCT00810693|11564435|FG000|Follow-up Period (FUP)|Death|2
7330999|NCT00810693|11564436|FG001|Follow-up Period (FUP)|Death|0
7331000|NCT00810693|11564437|FG002|Follow-up Period (FUP)|Death|1
7331001|NCT00810693|11564435|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
7331002|NCT00810693|11564436|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
7331003|NCT00810693|11564437|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
7331004|NCT00810693|11564435|FG000|Follow-up Period (FUP)|Protocol Violation|0
7331005|NCT00810693|11564436|FG001|Follow-up Period (FUP)|Protocol Violation|1
7331006|NCT00810693|11564437|FG002|Follow-up Period (FUP)|Protocol Violation|0
7331007|NCT00810693|11564435|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
7331008|NCT00810693|11564436|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
7331009|NCT00810693|11564437|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
7331010|NCT00810810|11564472|FG000|Overall Study|Withdrawal by Subject|0
7331011|NCT00810810|11564473|FG001|Overall Study|Withdrawal by Subject|8
7331012|NCT00810810|11564474|FG002|Overall Study|Withdrawal by Subject|10
7331013|NCT00810810|11564475|FG003|Overall Study|Withdrawal by Subject|8
7331014|NCT00810810|11564472|FG000|Overall Study|Physician Decision|0
7331015|NCT00810810|11564473|FG001|Overall Study|Physician Decision|3
7331016|NCT00810810|11564474|FG002|Overall Study|Physician Decision|1
7331017|NCT00810810|11564475|FG003|Overall Study|Physician Decision|5
7331018|NCT00810901|11564500|FG000|Overall Study|Lost to Follow-up|88
7331019|NCT00810901|11564501|FG001|Overall Study|Lost to Follow-up|58
7331020|NCT00811018|11564507|FG000|Overall Study|Additional Chronic Treatment|31
7331021|NCT00811018|11564507|FG000|Overall Study|Adverse Event|79
7331022|NCT00811018|11564507|FG000|Overall Study|Death|147
7331023|NCT00811018|11564507|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
7331024|NCT00811018|11564507|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
7331025|NCT00811018|11564507|FG000|Overall Study|Investigator Decision|57
7331026|NCT00811018|11564507|FG000|Overall Study|Lost to Follow-up|19
7331027|NCT00811018|11564507|FG000|Overall Study|Pregnancy|6
7331028|NCT00811018|11564507|FG000|Overall Study|Sponsor Decision|450
7331029|NCT00811018|11564507|FG000|Overall Study|Withdrawal by Subject|70
7331030|NCT00811018|11564507|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
7331031|NCT00811018|11564507|FG000|Overall Study|Other|26
7331032|NCT00811057|11564514|FG000|Overall Study|Protocol Violation|5
7331033|NCT00811057|11564515|FG001|Overall Study|Protocol Violation|10
7331034|NCT00811057|11564516|FG002|Overall Study|Protocol Violation|10
7331035|NCT00811070|11564530|FG000|Overall Study|Death|0
7331036|NCT00811070|11564531|FG001|Overall Study|Death|0
7568308|NCT03400852|11942866|FG001|Blinded Treatment Period|Physician Decision|1
7568309|NCT03400852|11942867|FG002|Blinded Treatment Period|Physician Decision|0
7568310|NCT03400852|11942865|FG000|Blinded Treatment Period|Adverse Event|1
7568311|NCT03400852|11942866|FG001|Blinded Treatment Period|Adverse Event|1
7568312|NCT03400852|11942867|FG002|Blinded Treatment Period|Adverse Event|0
7568313|NCT03400852|11942865|FG000|Blinded Treatment Period|Study terminated by sponsor|8
7568314|NCT03400852|11942866|FG001|Blinded Treatment Period|Study terminated by sponsor|4
7568315|NCT03400852|11942867|FG002|Blinded Treatment Period|Study terminated by sponsor|0
7568316|NCT03400852|11942865|FG000|Open Label Period|Physician Decision|0
7568317|NCT03400852|11942866|FG001|Open Label Period|Physician Decision|0
7331037|NCT00811070|11564532|FG002|Overall Study|Death|0
7331038|NCT00811070|11564533|FG003|Overall Study|Death|2
7331039|NCT00811070|11564534|FG004|Overall Study|Death|5
7331040|NCT00811070|11564535|FG005|Overall Study|Death|0
7331041|NCT00811070|11564530|FG000|Overall Study|Other|1
7331042|NCT00811070|11564531|FG001|Overall Study|Other|0
7568318|NCT03400852|11942867|FG002|Open Label Period|Physician Decision|1
7331043|NCT00811070|11564532|FG002|Overall Study|Other|0
7331044|NCT00811070|11564533|FG003|Overall Study|Other|0
7331045|NCT00811070|11564534|FG004|Overall Study|Other|0
7331046|NCT00811070|11564535|FG005|Overall Study|Other|0
7331047|NCT00811070|11564530|FG000|Overall Study|Withdrawal by Subject|0
7331048|NCT00811070|11564531|FG001|Overall Study|Withdrawal by Subject|1
7331049|NCT00811070|11564532|FG002|Overall Study|Withdrawal by Subject|0
7331050|NCT00811070|11564533|FG003|Overall Study|Withdrawal by Subject|0
7331051|NCT00811070|11564534|FG004|Overall Study|Withdrawal by Subject|0
7331052|NCT00811070|11564535|FG005|Overall Study|Withdrawal by Subject|0
7568319|NCT03400852|11942865|FG000|Open Label Period|Study terminated by sponsor|0
7568320|NCT03400852|11942866|FG001|Open Label Period|Study terminated by sponsor|0
7568321|NCT03400852|11942867|FG002|Open Label Period|Study terminated by sponsor|21
7568322|NCT03401229|11942877|FG000|Overall Study|Lost to Follow-up|2
7568323|NCT03401229|11942878|FG001|Overall Study|Lost to Follow-up|1
7568324|NCT03401229|11942877|FG000|Overall Study|Other|1
7568325|NCT03401229|11942878|FG001|Overall Study|Other|3
7568326|NCT03401229|11942877|FG000|Overall Study|Adverse Event|8
7568327|NCT03401229|11942878|FG001|Overall Study|Adverse Event|6
7568328|NCT03401229|11942877|FG000|Overall Study|Withdrawal by Subject|29
7568329|NCT03401229|11942878|FG001|Overall Study|Withdrawal by Subject|26
7568330|NCT03401229|11942877|FG000|Overall Study|COVID-19|0
7568331|NCT03401229|11942878|FG001|Overall Study|COVID-19|1
7568332|NCT03401450|11942886|FG000|Overall Study|Lost to Follow-up|4
7568333|NCT03401450|11942887|FG001|Overall Study|Lost to Follow-up|6
7568334|NCT03401450|11942886|FG000|Overall Study|Anesthesia plan changed|2
7568335|NCT03401450|11942887|FG001|Overall Study|Anesthesia plan changed|2
7568336|NCT03401450|11942886|FG000|Overall Study|Did not complete medication diary|4
7568337|NCT03401450|11942887|FG001|Overall Study|Did not complete medication diary|2
7568338|NCT03401450|11942886|FG000|Overall Study|post surgery medication change|2
7568339|NCT03401450|11942887|FG001|Overall Study|post surgery medication change|1
7568340|NCT03401450|11942886|FG000|Overall Study|Cancelled surgery|0
7568341|NCT03401450|11942887|FG001|Overall Study|Cancelled surgery|2
7331053|NCT00811070|11564530|FG000|Overall Study|Physician Decision|0
7331054|NCT00811070|11564531|FG001|Overall Study|Physician Decision|0
7331055|NCT00811070|11564532|FG002|Overall Study|Physician Decision|0
7331056|NCT00811070|11564533|FG003|Overall Study|Physician Decision|0
7331057|NCT00811070|11564534|FG004|Overall Study|Physician Decision|0
7331058|NCT00811070|11564535|FG005|Overall Study|Physician Decision|1
7331059|NCT00811135|11564551|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
7331060|NCT00811135|11564551|FG000|Overall Study|Death|3
7331061|NCT00811135|11564551|FG000|Overall Study|Protocol Violation|2
7331062|NCT00811135|11564551|FG000|Overall Study|Violation of Selection Criteria|1
7331063|NCT00811135|11564551|FG000|Overall Study|Refused Treatment|1
7331064|NCT00811135|11564551|FG000|Overall Study|Withdrawal by Subject|3
7331065|NCT00811135|11564551|FG000|Overall Study|Administrative/Other Unspecified|11
7331066|NCT00811135|11564551|FG000|Overall Study|Ongoing|59
7331067|NCT00811174|11564555|FG000|Overall Study|Protocol Violation|2
7331068|NCT00811174|11564555|FG000|Overall Study|Sponsors Decision|1
7331069|NCT00811187|11564561|FG000|Overall Study|Unable to place device / procedure abort|3
7331070|NCT00811187|11564562|FG001|Overall Study|Unable to place device / procedure abort|3
7331071|NCT00811252|11564571|FG000|Overall Study|Adverse Event|6
7331072|NCT00811252|11564572|FG001|Overall Study|Adverse Event|10
7331073|NCT00811252|11564573|FG002|Overall Study|Adverse Event|15
7331074|NCT00811252|11564571|FG000|Overall Study|Lack of Efficacy|7
7331075|NCT00811252|11564572|FG001|Overall Study|Lack of Efficacy|2
7331076|NCT00811252|11564573|FG002|Overall Study|Lack of Efficacy|0
7331077|NCT00811252|11564571|FG000|Overall Study|Protocol Violation|3
7331078|NCT00811252|11564572|FG001|Overall Study|Protocol Violation|3
7331079|NCT00811252|11564573|FG002|Overall Study|Protocol Violation|2
7331080|NCT00811252|11564571|FG000|Overall Study|Withdrawal of Consent|1
7331081|NCT00811252|11564572|FG001|Overall Study|Withdrawal of Consent|2
7331082|NCT00811252|11564573|FG002|Overall Study|Withdrawal of Consent|2
7331083|NCT00811252|11564571|FG000|Overall Study|Lost to Follow-up|0
7331084|NCT00811252|11564572|FG001|Overall Study|Lost to Follow-up|0
7331085|NCT00811252|11564573|FG002|Overall Study|Lost to Follow-up|2
7331086|NCT00811252|11564571|FG000|Overall Study|Administrative or Other Reasons|0
7331087|NCT00811252|11564572|FG001|Overall Study|Administrative or Other Reasons|3
7331088|NCT00811252|11564573|FG002|Overall Study|Administrative or Other Reasons|2
7331089|NCT00811395|11564602|FG000|Extension Treatment|Adverse Event|1
7331090|NCT00811395|11564603|FG001|Extension Treatment|Adverse Event|2
7331091|NCT00811395|11564604|FG002|Extension Treatment|Adverse Event|2
7331092|NCT00811395|11564605|FG003|Extension Treatment|Adverse Event|2
7331093|NCT00811395|11564606|FG004|Extension Treatment|Adverse Event|0
7331094|NCT00811395|11564607|FG005|Extension Treatment|Adverse Event|1
7331095|NCT00811395|11564602|FG000|Extension Treatment|Progressive disease|1
7331096|NCT00811395|11564603|FG001|Extension Treatment|Progressive disease|1
7331097|NCT00811395|11564604|FG002|Extension Treatment|Progressive disease|0
7331098|NCT00811395|11564605|FG003|Extension Treatment|Progressive disease|0
7457684|NCT01801358|11751367|FG002|Overall Study|Adverse Event|1
7457685|NCT01801358|11751368|FG003|Overall Study|Adverse Event|0
7457686|NCT01801358|11751369|FG004|Overall Study|Adverse Event|0
7457687|NCT01801358|11751370|FG005|Overall Study|Adverse Event|1
7457688|NCT01801358|11751365|FG000|Overall Study|Physician Decision|0
7331099|NCT00811395|11564606|FG004|Extension Treatment|Progressive disease|0
7331100|NCT00811395|11564607|FG005|Extension Treatment|Progressive disease|0
7331101|NCT00811395|11564602|FG000|Extension Treatment|Participant did not wish to continue|0
7331102|NCT00811395|11564603|FG001|Extension Treatment|Participant did not wish to continue|3
7225178|NCT00064701|11434642|FG000|One Year Post-transplant|Acute tubular necrosis|1
7225179|NCT00064701|11434643|FG001|One Year Post-transplant|Acute tubular necrosis|0
7225180|NCT00064701|11434644|FG002|One Year Post-transplant|Acute tubular necrosis|0
7331148|NCT00811720|11564713|FG001|All Treated Patients|Non-compliance|14
7225181|NCT00064701|11434642|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
7331103|NCT00811395|11564604|FG002|Extension Treatment|Participant did not wish to continue|0
7331104|NCT00811395|11564605|FG003|Extension Treatment|Participant did not wish to continue|1
7225182|NCT00064701|11434643|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
7331105|NCT00811395|11564606|FG004|Extension Treatment|Participant did not wish to continue|0
7331106|NCT00811395|11564607|FG005|Extension Treatment|Participant did not wish to continue|1
7331107|NCT00811395|11564602|FG000|Extension Treatment|Other than above|0
7331108|NCT00811395|11564603|FG001|Extension Treatment|Other than above|0
7331109|NCT00811395|11564604|FG002|Extension Treatment|Other than above|1
7331110|NCT00811395|11564605|FG003|Extension Treatment|Other than above|0
7331111|NCT00811395|11564606|FG004|Extension Treatment|Other than above|0
7331112|NCT00811395|11564607|FG005|Extension Treatment|Other than above|0
7331113|NCT00811473|11564634|FG000|Overall Study|Adverse Event|3
7331114|NCT00811473|11564635|FG001|Overall Study|Adverse Event|12
7331115|NCT00811473|11564634|FG000|Overall Study|Lost to Follow-up|5
7331116|NCT00811473|11564635|FG001|Overall Study|Lost to Follow-up|1
7331117|NCT00811473|11564634|FG000|Overall Study|Withdrawal by Subject|2
7331118|NCT00811473|11564635|FG001|Overall Study|Withdrawal by Subject|4
7331119|NCT00811473|11564634|FG000|Overall Study|Severe non-compliance to protocol|2
7331120|NCT00811473|11564635|FG001|Overall Study|Severe non-compliance to protocol|4
7331121|NCT00811473|11564634|FG000|Overall Study|Lack of therapeutic response|4
7331122|NCT00811473|11564635|FG001|Overall Study|Lack of therapeutic response|1
7331123|NCT00811473|11564634|FG000|Overall Study|Condition under investigation worsened|1
7331124|NCT00811473|11564635|FG001|Overall Study|Condition under investigation worsened|3
7331125|NCT00811473|11564634|FG000|Overall Study|Other 2|4
7331126|NCT00811473|11564635|FG001|Overall Study|Other 2|1
7331127|NCT00811473|11564634|FG000|Overall Study|Incorrect Enrollment|1
7331128|NCT00811473|11564635|FG001|Overall Study|Incorrect Enrollment|0
7331129|NCT00811473|11564634|FG000|Overall Study|Safety Reasons|1
7331130|NCT00811473|11564635|FG001|Overall Study|Safety Reasons|0
7457689|NCT01801358|11751366|FG001|Overall Study|Physician Decision|0
7457690|NCT01801358|11751367|FG002|Overall Study|Physician Decision|1
7457691|NCT01801358|11751368|FG003|Overall Study|Physician Decision|0
7457692|NCT01801358|11751369|FG004|Overall Study|Physician Decision|0
7457693|NCT01801358|11751370|FG005|Overall Study|Physician Decision|0
7457694|NCT01801358|11751365|FG000|Overall Study|Progressive Disease|6
7457695|NCT01801358|11751366|FG001|Overall Study|Progressive Disease|4
7457696|NCT01801358|11751367|FG002|Overall Study|Progressive Disease|4
7457697|NCT01801358|11751368|FG003|Overall Study|Progressive Disease|5
7457698|NCT01801358|11751369|FG004|Overall Study|Progressive Disease|6
7457699|NCT01801358|11751370|FG005|Overall Study|Progressive Disease|5
7457700|NCT01801358|11751365|FG000|Overall Study|Withdrawal by Subject|0
7457701|NCT01801358|11751366|FG001|Overall Study|Withdrawal by Subject|0
7457702|NCT01801358|11751367|FG002|Overall Study|Withdrawal by Subject|0
7457703|NCT01801358|11751368|FG003|Overall Study|Withdrawal by Subject|1
7457704|NCT01801358|11751369|FG004|Overall Study|Withdrawal by Subject|0
7457705|NCT01801358|11751370|FG005|Overall Study|Withdrawal by Subject|2
7457706|NCT01801436|11751405|FG000|Overall Study|Withdrawal by Subject|3
7457707|NCT01801436|11751405|FG000|Overall Study|Adverse Event|2
7457708|NCT01801436|11751405|FG000|Overall Study|Progressive disease|4
7457709|NCT01801475|11751417|FG000|Overall Study|Withdrawal by Subject|0
7457710|NCT01801475|11751418|FG001|Overall Study|Withdrawal by Subject|0
7457711|NCT01801475|11751419|FG002|Overall Study|Withdrawal by Subject|0
7457712|NCT01801475|11751420|FG003|Overall Study|Withdrawal by Subject|0
7457713|NCT01801475|11751421|FG004|Overall Study|Withdrawal by Subject|1
7457714|NCT01801735|11751430|FG000|Overall Study|Adverse Event|79
7457715|NCT01801735|11751430|FG000|Overall Study|Lack of Efficacy|28
7457716|NCT01801735|11751430|FG000|Overall Study|Withdrawal by Subject|27
7457717|NCT01801735|11751430|FG000|Overall Study|Protocol Violation|25
7457718|NCT01801735|11751430|FG000|Overall Study|Lost to Follow-up|15
7457719|NCT01801735|11751430|FG000|Overall Study|Non-compliance with Trial Drug|13
7457720|NCT01801735|11751430|FG000|Overall Study|Physician Decision|3
7331131|NCT00811577|11564652|FG000|Overall Study|Lost to Follow-up|7
7331132|NCT00811577|11564653|FG001|Overall Study|Lost to Follow-up|1
7457721|NCT01801735|11751430|FG000|Overall Study|Death|1
7457722|NCT01801735|11751430|FG000|Overall Study|Other, including site closure|19
7457723|NCT01801865|11751434|FG000|Overall Study|Patients scanned on another MRI scanner|35
7331133|NCT00811577|11564652|FG000|Overall Study|Withdrawal by Subject|3
7331134|NCT00811577|11564653|FG001|Overall Study|Withdrawal by Subject|0
7331135|NCT00811642|11564702|FG000|Overall Study|Adverse Event|3
7331136|NCT00811642|11564702|FG000|Overall Study|Protocol Violation|1
7331137|NCT00811642|11564702|FG000|Overall Study|Death|2
7331138|NCT00811642|11564702|FG000|Overall Study|Withdrawal by Subject|7
7331139|NCT00811642|11564702|FG000|Overall Study|Cumulative use of antifungal agent|2
7331140|NCT00811655|11564706|FG000|Overall Study|Physician Decision|1
7331141|NCT00811720|11564712|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
7331142|NCT00811720|11564713|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
7331143|NCT00811720|11564712|FG000|All Treated Patients|Adverse Event|20
7331144|NCT00811720|11564713|FG001|All Treated Patients|Adverse Event|62
7331145|NCT00811720|11564712|FG000|All Treated Patients|Lack of Efficacy|22
7331146|NCT00811720|11564713|FG001|All Treated Patients|Lack of Efficacy|18
7331147|NCT00811720|11564712|FG000|All Treated Patients|Non-compliance|0
7331149|NCT00811720|11564712|FG000|All Treated Patients|Protocol Violation|9
7331150|NCT00811720|11564713|FG001|All Treated Patients|Protocol Violation|16
7331151|NCT00811720|11564712|FG000|All Treated Patients|Withdrawal by Subject|28
7568342|NCT03402126|11942902|FG000|Overall Study|Lost to Follow-up|6
7568343|NCT03402126|11942902|FG000|Overall Study|Protocol Violation|10
7568344|NCT03402126|11942902|FG000|Overall Study|Sponsor request/Study termination|29
7331152|NCT00811720|11564713|FG001|All Treated Patients|Withdrawal by Subject|34
7331153|NCT00811720|11564712|FG000|All Treated Patients|Lost to Follow-up|10
7331154|NCT00811720|11564713|FG001|All Treated Patients|Lost to Follow-up|16
7331155|NCT00811720|11564712|FG000|All Treated Patients|Other Reason|7
7331156|NCT00811720|11564713|FG001|All Treated Patients|Other Reason|4
7331157|NCT00811733|11564721|FG000|Overall Study|Investigator Discretion|10
7331158|NCT00811733|11564722|FG001|Overall Study|Investigator Discretion|8
7331159|NCT00811733|11564721|FG000|Overall Study|Withdrawal by Subject|1
7331160|NCT00811733|11564722|FG001|Overall Study|Withdrawal by Subject|2
7331161|NCT00811928|11564740|FG000|Overall Study|AEs and SAEs Including Death|7
7331162|NCT00811928|11564741|FG001|Overall Study|AEs and SAEs Including Death|11
7331163|NCT00811928|11564740|FG000|Overall Study|Withdrawal by Subject|18
7331164|NCT00811928|11564741|FG001|Overall Study|Withdrawal by Subject|12
7457724|NCT01801865|11751434|FG000|Overall Study|Physician Decision|7
7457725|NCT01801917|11751442|FG000|Period 1 - Randomized|Adverse Event|1
7457726|NCT01801917|11751443|FG001|Period 1 - Randomized|Adverse Event|0
7457727|NCT01801917|11751444|FG002|Period 1 - Randomized|Adverse Event|1
7457728|NCT01801917|11751445|FG003|Period 1 - Randomized|Adverse Event|0
7457729|NCT01801930|11751460|FG000|Overall Study|Clear progression of the primary disease is observed|6
7457730|NCT01801930|11751461|FG001|Overall Study|Clear progression of the primary disease is observed|5
7457731|NCT01801930|11751462|FG002|Overall Study|Clear progression of the primary disease is observed|6
7457732|NCT01801930|11751463|FG003|Overall Study|Clear progression of the primary disease is observed|6
7457733|NCT01801930|11751460|FG000|Overall Study|DLT occurs|0
7457734|NCT01801930|11751461|FG001|Overall Study|DLT occurs|1
7457735|NCT01801930|11751462|FG002|Overall Study|DLT occurs|0
7457736|NCT01801930|11751463|FG003|Overall Study|DLT occurs|0
7457737|NCT01801982|11751473|FG000|Overall Study|Lost to Follow-up|1
7457738|NCT01802073|11751479|FG000|Overall Study|Lost to Follow-up|0
7457739|NCT01802073|11751480|FG001|Overall Study|Lost to Follow-up|1
7457740|NCT01802073|11751479|FG000|Overall Study|Non-compliant|4
7457741|NCT01802073|11751480|FG001|Overall Study|Non-compliant|2
7457742|NCT01802073|11751479|FG000|Overall Study|Withdrawal by Subject|1
7457743|NCT01802073|11751480|FG001|Overall Study|Withdrawal by Subject|1
7457744|NCT01802073|11751479|FG000|Overall Study|Physician Decision|0
7457745|NCT01802073|11751480|FG001|Overall Study|Physician Decision|7
7457746|NCT01802216|11751505|FG000|4 Month Visit|Participant did not show to visit|3
7457747|NCT01802216|11751506|FG001|4 Month Visit|Participant did not show to visit|4
7568345|NCT03402126|11942902|FG000|Overall Study|Study product no longer in use|1
7568346|NCT03402126|11942902|FG000|Overall Study|Technical problems|1
7568347|NCT03402126|11942902|FG000|Overall Study|Withdrawal by Subject|6
7568348|NCT03402126|11942902|FG000|Overall Study|Physician Decision|2
7568349|NCT03402126|11942902|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
7568350|NCT03402126|11942902|FG000|Overall Study|Death|4
7568351|NCT03402386|11942919|FG000|Overall Study|Adverse Event|3
7568352|NCT03402386|11942919|FG000|Overall Study|Physician Decision|1
7568353|NCT03402386|11942919|FG000|Overall Study|Difficult to control Hb|2
7568354|NCT03402750|11942938|FG000|Overall Study|Lost to Follow-up|2
7568355|NCT03402750|11942939|FG001|Overall Study|Lost to Follow-up|1
7568356|NCT03402893|11942945|FG000|Overall Study|Withdrawal by Subject|1
7568357|NCT03403036|11942971|FG000|Overall Study|Lack of Efficacy|5
7568358|NCT03403192|11942979|FG000|Overall Study|Lost to Follow-up|1
7568359|NCT03403192|11942980|FG001|Overall Study|Lost to Follow-up|2
7568360|NCT03403192|11942981|FG002|Overall Study|Lost to Follow-up|0
7568361|NCT03403192|11942982|FG003|Overall Study|Lost to Follow-up|0
7225183|NCT00064701|11434644|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
7225184|NCT00064701|11434642|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
7225185|NCT00064701|11434643|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
7225186|NCT00064701|11434644|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
7225187|NCT00064701|11434642|FG000|One Year Post-transplant|Poor absorption|0
7225188|NCT00064701|11434643|FG001|One Year Post-transplant|Poor absorption|1
7225189|NCT00064701|11434644|FG002|One Year Post-transplant|Poor absorption|0
7225190|NCT00064701|11434642|FG000|One Year Post-transplant|Pancreas transplant|0
7225191|NCT00064701|11434643|FG001|One Year Post-transplant|Pancreas transplant|0
7225192|NCT00064701|11434644|FG002|One Year Post-transplant|Pancreas transplant|1
7225193|NCT00064701|11434642|FG000|Clinical Continuation Phase|Adverse Event|12
7225194|NCT00064701|11434643|FG001|Clinical Continuation Phase|Adverse Event|21
7225195|NCT00064701|11434644|FG002|Clinical Continuation Phase|Adverse Event|14
7225196|NCT00064701|11434642|FG000|Clinical Continuation Phase|Non-compliance|8
7225197|NCT00064701|11434643|FG001|Clinical Continuation Phase|Non-compliance|6
7225198|NCT00064701|11434644|FG002|Clinical Continuation Phase|Non-compliance|7
7225199|NCT00064701|11434642|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
7225200|NCT00064701|11434643|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
7331165|NCT00811928|11564740|FG000|Overall Study|Did Not Take Study Drug|3
7331166|NCT00811928|11564741|FG001|Overall Study|Did Not Take Study Drug|0
7331167|NCT00811928|11564740|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
7331168|NCT00811928|11564741|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
7331169|NCT00811928|11564740|FG000|Overall Study|Investigator Decision|2
7568362|NCT03403192|11942979|FG000|Overall Study|Unable to respond|0
7331170|NCT00811928|11564741|FG001|Overall Study|Investigator Decision|1
7331171|NCT00811928|11564740|FG000|Overall Study|Poor Compliance|2
7331172|NCT00811928|11564741|FG001|Overall Study|Poor Compliance|5
7331173|NCT00811941|11564749|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
7331174|NCT00811941|11564750|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
7331175|NCT00811941|11564749|FG000|All Treated Patients|Adverse Event|2
7331176|NCT00811941|11564750|FG001|All Treated Patients|Adverse Event|43
7331177|NCT00811941|11564749|FG000|All Treated Patients|Lack of Efficacy|2
7331178|NCT00811941|11564750|FG001|All Treated Patients|Lack of Efficacy|3
7331179|NCT00811941|11564749|FG000|All Treated Patients|Non-compliance|1
7331180|NCT00811941|11564750|FG001|All Treated Patients|Non-compliance|8
7331181|NCT00811941|11564749|FG000|All Treated Patients|Protocol Violation|5
7331182|NCT00811941|11564750|FG001|All Treated Patients|Protocol Violation|17
7331183|NCT00811941|11564749|FG000|All Treated Patients|Withdrawal by Subject|35
7331184|NCT00811941|11564750|FG001|All Treated Patients|Withdrawal by Subject|94
7331185|NCT00811941|11564749|FG000|All Treated Patients|Lost to Follow-up|3
7331186|NCT00811941|11564750|FG001|All Treated Patients|Lost to Follow-up|12
7331187|NCT00811941|11564749|FG000|All Treated Patients|Other Reason|4
7331188|NCT00811941|11564750|FG001|All Treated Patients|Other Reason|14
7331189|NCT00811954|11564759|FG000|Overall Study|Death|10
7331190|NCT00811954|11564760|FG001|Overall Study|Death|6
7331191|NCT00811954|11564761|FG002|Overall Study|Death|13
7331192|NCT00811954|11564759|FG000|Overall Study|Lost to Follow-up|29
7331193|NCT00811954|11564760|FG001|Overall Study|Lost to Follow-up|23
7331194|NCT00811954|11564761|FG002|Overall Study|Lost to Follow-up|34
7331195|NCT00811954|11564759|FG000|Overall Study|Not able to get to clinic|28
7331196|NCT00811954|11564760|FG001|Overall Study|Not able to get to clinic|35
7331197|NCT00811954|11564761|FG002|Overall Study|Not able to get to clinic|30
7331198|NCT00811954|11564759|FG000|Overall Study|Not willing to adhere to requirements|12
7331199|NCT00811954|11564760|FG001|Overall Study|Not willing to adhere to requirements|2
7331200|NCT00811954|11564761|FG002|Overall Study|Not willing to adhere to requirements|16
7331201|NCT00811954|11564759|FG000|Overall Study|Withdraw consent prior study completion|4
7568363|NCT03403192|11942980|FG001|Overall Study|Unable to respond|1
7568364|NCT03403192|11942981|FG002|Overall Study|Unable to respond|0
7225201|NCT00064701|11434644|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
7331202|NCT00811954|11564760|FG001|Overall Study|Withdraw consent prior study completion|6
7331203|NCT00811954|11564761|FG002|Overall Study|Withdraw consent prior study completion|5
7331204|NCT00811954|11564759|FG000|Overall Study|Site Closure|4
7331205|NCT00811954|11564760|FG001|Overall Study|Site Closure|0
7331206|NCT00811954|11564761|FG002|Overall Study|Site Closure|1
7331207|NCT00811954|11564759|FG000|Overall Study|Severe Debilitation|2
7568365|NCT03403192|11942982|FG003|Overall Study|Unable to respond|0
7568366|NCT03403192|11942979|FG000|Overall Study|Incomplete|3
7568367|NCT03403192|11942980|FG001|Overall Study|Incomplete|1
7568368|NCT03403192|11942981|FG002|Overall Study|Incomplete|3
7568369|NCT03403192|11942982|FG003|Overall Study|Incomplete|6
7568370|NCT03403374|11943057|FG000|Overall Study|Lost to Follow-up|1
7568371|NCT03403400|11943064|FG000|Overall Study|Lost to Follow-up|1
7568372|NCT03403400|11943065|FG001|Overall Study|Lost to Follow-up|0
7568373|NCT03403400|11943066|FG002|Overall Study|Lost to Follow-up|1
7331208|NCT00811954|11564760|FG001|Overall Study|Severe Debilitation|0
7331209|NCT00811954|11564761|FG002|Overall Study|Severe Debilitation|1
7331210|NCT00811954|11564759|FG000|Overall Study|Complete Protocol: No follow-up|0
7331211|NCT00811954|11564760|FG001|Overall Study|Complete Protocol: No follow-up|0
7331212|NCT00811954|11564761|FG002|Overall Study|Complete Protocol: No follow-up|1
7331213|NCT00812097|11564773|FG000|Overall Study|Death|3
7331214|NCT00812097|11564774|FG001|Overall Study|Death|10
7331215|NCT00812097|11564775|FG002|Overall Study|Death|3
7331216|NCT00812097|11564776|FG003|Overall Study|Death|3
7331217|NCT00812097|11564773|FG000|Overall Study|Withdrawal by Subject|14
7331218|NCT00812097|11564774|FG001|Overall Study|Withdrawal by Subject|12
7331219|NCT00812097|11564775|FG002|Overall Study|Withdrawal by Subject|8
7331220|NCT00812097|11564776|FG003|Overall Study|Withdrawal by Subject|2
7331221|NCT00812097|11564773|FG000|Overall Study|Lost to Follow-up|90
7331222|NCT00812097|11564774|FG001|Overall Study|Lost to Follow-up|14
7331223|NCT00812097|11564775|FG002|Overall Study|Lost to Follow-up|17
7331224|NCT00812097|11564776|FG003|Overall Study|Lost to Follow-up|5
7331225|NCT00812097|11564773|FG000|Overall Study|Explantation of study device(s)|27
7331226|NCT00812097|11564774|FG001|Overall Study|Explantation of study device(s)|29
7331227|NCT00812097|11564775|FG002|Overall Study|Explantation of study device(s)|14
7331228|NCT00812097|11564776|FG003|Overall Study|Explantation of study device(s)|20
7331229|NCT00812097|11564773|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
7331230|NCT00812097|11564774|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
7331231|NCT00812097|11564775|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
7331232|NCT00812097|11564776|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
7385140|NCT01199068|11642709|FG000|Overall Study|Withdrawal by Subject|0
7385141|NCT01199068|11642710|FG001|Overall Study|Withdrawal by Subject|0
7385142|NCT01199068|11642711|FG002|Overall Study|Withdrawal by Subject|1
7385143|NCT01199198|11642732|FG000|Overall Study|Adverse Event|3
7385144|NCT01199198|11642733|FG001|Overall Study|Adverse Event|0
7568374|NCT03403400|11943064|FG000|Overall Study|Hospitalization|1
7568375|NCT03403400|11943065|FG001|Overall Study|Hospitalization|0
7568376|NCT03403400|11943066|FG002|Overall Study|Hospitalization|0
7568377|NCT03403400|11943064|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
7568378|NCT03403400|11943065|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
7385145|NCT01199198|11642732|FG000|Overall Study|Lost to Follow-up|1
7385146|NCT01199198|11642733|FG001|Overall Study|Lost to Follow-up|5
7385147|NCT01199198|11642732|FG000|Overall Study|Withdrawal by Subject|1
7385148|NCT01199198|11642733|FG001|Overall Study|Withdrawal by Subject|2
7385149|NCT01199198|11642732|FG000|Overall Study|ICU Transfer|1
7385150|NCT01199198|11642733|FG001|Overall Study|ICU Transfer|2
7385151|NCT01199198|11642732|FG000|Overall Study|Hospice-care transfer|1
7385152|NCT01199198|11642733|FG001|Overall Study|Hospice-care transfer|2
7385153|NCT01199263|11642752|FG000|Overall Study|Ineligible|0
7385154|NCT01199263|11642753|FG001|Overall Study|Ineligible|2
7385155|NCT01199263|11642752|FG000|Overall Study|Never Treated|6
7385156|NCT01199263|11642753|FG001|Overall Study|Never Treated|0
7385157|NCT01199289|11642765|FG000|Overall Study|Ineligibility determined|2
7385158|NCT01199289|11642766|FG001|Overall Study|Ineligibility determined|1
7385159|NCT01199289|11642767|FG002|Overall Study|Ineligibility determined|0
7385160|NCT01199289|11642768|FG003|Overall Study|Ineligibility determined|0
7385161|NCT01199289|11642765|FG000|Overall Study|Protocol Violation|1
7385162|NCT01199289|11642766|FG001|Overall Study|Protocol Violation|0
7385163|NCT01199289|11642767|FG002|Overall Study|Protocol Violation|0
7385164|NCT01199289|11642768|FG003|Overall Study|Protocol Violation|1
7385165|NCT01199289|11642765|FG000|Overall Study|Noncompliance|1
7385166|NCT01199289|11642766|FG001|Overall Study|Noncompliance|0
7385167|NCT01199289|11642767|FG002|Overall Study|Noncompliance|2
7385168|NCT01199289|11642768|FG003|Overall Study|Noncompliance|0
7385169|NCT01199289|11642765|FG000|Overall Study|Adverse Event|0
7385170|NCT01199289|11642766|FG001|Overall Study|Adverse Event|3
7385171|NCT01199289|11642767|FG002|Overall Study|Adverse Event|1
7385172|NCT01199289|11642768|FG003|Overall Study|Adverse Event|4
7385173|NCT01199289|11642765|FG000|Overall Study|Full consent withdrawn|2
7385174|NCT01199289|11642766|FG001|Overall Study|Full consent withdrawn|2
7385175|NCT01199289|11642767|FG002|Overall Study|Full consent withdrawn|2
7385176|NCT01199289|11642768|FG003|Overall Study|Full consent withdrawn|3
7385177|NCT01199289|11642765|FG000|Overall Study|Administrative decision|0
7385178|NCT01199289|11642766|FG001|Overall Study|Administrative decision|0
7385179|NCT01199289|11642767|FG002|Overall Study|Administrative decision|0
7385180|NCT01199289|11642768|FG003|Overall Study|Administrative decision|1
7385181|NCT01199289|11642765|FG000|Overall Study|Lost to Follow-up|0
7385182|NCT01199289|11642766|FG001|Overall Study|Lost to Follow-up|0
7568379|NCT03403400|11943066|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
7385183|NCT01199289|11642767|FG002|Overall Study|Lost to Follow-up|0
7385184|NCT01199289|11642768|FG003|Overall Study|Lost to Follow-up|1
7385185|NCT01199289|11642765|FG000|Overall Study|Protocol-specified criteria|3
7385186|NCT01199289|11642766|FG001|Overall Study|Protocol-specified criteria|0
7385187|NCT01199289|11642767|FG002|Overall Study|Protocol-specified criteria|0
7385188|NCT01199289|11642768|FG003|Overall Study|Protocol-specified criteria|1
7385189|NCT01199289|11642765|FG000|Overall Study|Pregnancy|0
7568380|NCT03403413|11943089|FG000|Overall Study|Lack of Efficacy|2
7331233|NCT00812253|11564792|FG000|Overall Study|Withdrawal by Subject|3
7331234|NCT00812253|11564793|FG001|Overall Study|Withdrawal by Subject|2
7331235|NCT00812253|11564792|FG000|Overall Study|Protocol Violation|1
7331236|NCT00812253|11564793|FG001|Overall Study|Protocol Violation|1
7331237|NCT00812253|11564792|FG000|Overall Study|Lost to Follow-up|2
7331238|NCT00812253|11564793|FG001|Overall Study|Lost to Follow-up|0
7331239|NCT00812331|11564804|FG000|Overall Study|Adverse Event|1
7331240|NCT00812331|11564805|FG001|Overall Study|Adverse Event|0
7331241|NCT00812331|11564806|FG002|Overall Study|Adverse Event|0
7331242|NCT00812331|11564807|FG003|Overall Study|Adverse Event|0
7331243|NCT00812331|11564808|FG004|Overall Study|Adverse Event|0
7331244|NCT00812461|11564818|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
7331245|NCT00812461|11564819|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
7331246|NCT00812461|11564818|FG000|All Treated Patients|Adverse Event|8
7331247|NCT00812461|11564819|FG001|All Treated Patients|Adverse Event|15
7331248|NCT00812461|11564818|FG000|All Treated Patients|Lack of Efficacy|13
7331249|NCT00812461|11564819|FG001|All Treated Patients|Lack of Efficacy|7
7331250|NCT00812461|11564818|FG000|All Treated Patients|Non-compliance|6
7331251|NCT00812461|11564819|FG001|All Treated Patients|Non-compliance|9
7331252|NCT00812461|11564818|FG000|All Treated Patients|Protocol Violation|36
7331253|NCT00812461|11564819|FG001|All Treated Patients|Protocol Violation|27
7331254|NCT00812461|11564818|FG000|All Treated Patients|Withdrawal by Subject|45
7331255|NCT00812461|11564819|FG001|All Treated Patients|Withdrawal by Subject|54
7331256|NCT00812461|11564818|FG000|All Treated Patients|Lost to Follow-up|11
7331257|NCT00812461|11564819|FG001|All Treated Patients|Lost to Follow-up|14
7331258|NCT00812461|11564818|FG000|All Treated Patients|Other Reason|13
7331259|NCT00812461|11564819|FG001|All Treated Patients|Other Reason|21
7331260|NCT00812487|11564827|FG000|Overall Study|Lost to Follow-up|2
7331261|NCT00812487|11564828|FG001|Overall Study|Lost to Follow-up|0
7331262|NCT00812487|11564827|FG000|Overall Study|Withdrawal by Subject|3
7331263|NCT00812487|11564828|FG001|Overall Study|Withdrawal by Subject|2
7331264|NCT00812487|11564827|FG000|Overall Study|Transfer to ICU prior to intervention|1
7331265|NCT00812487|11564828|FG001|Overall Study|Transfer to ICU prior to intervention|0
7331266|NCT00812487|11564827|FG000|Overall Study|Protocol Violation|0
7331267|NCT00812487|11564828|FG001|Overall Study|Protocol Violation|1
7331268|NCT00812565|11564842|FG000|Overall Study|Did Not Receive Study Medication|1
7331269|NCT00812565|11564843|FG001|Overall Study|Did Not Receive Study Medication|1
7331270|NCT00812565|11564844|FG002|Overall Study|Did Not Receive Study Medication|0
7331271|NCT00812565|11564845|FG003|Overall Study|Did Not Receive Study Medication|0
7331272|NCT00812565|11564846|FG004|Overall Study|Did Not Receive Study Medication|0
7331273|NCT00812565|11564847|FG005|Overall Study|Did Not Receive Study Medication|0
7331274|NCT00812565|11564848|FG006|Overall Study|Did Not Receive Study Medication|0
7331275|NCT00812565|11564849|FG007|Overall Study|Did Not Receive Study Medication|0
7331276|NCT00812565|11564842|FG000|Overall Study|Adverse Event|0
7331277|NCT00812565|11564843|FG001|Overall Study|Adverse Event|0
7331278|NCT00812565|11564844|FG002|Overall Study|Adverse Event|0
7331279|NCT00812565|11564845|FG003|Overall Study|Adverse Event|2
7331280|NCT00812565|11564846|FG004|Overall Study|Adverse Event|0
7331281|NCT00812565|11564847|FG005|Overall Study|Adverse Event|0
7331282|NCT00812565|11564848|FG006|Overall Study|Adverse Event|0
7331283|NCT00812565|11564849|FG007|Overall Study|Adverse Event|1
7331284|NCT00812565|11564842|FG000|Overall Study|Did Not Come to Study Visit|1
7331285|NCT00812565|11564843|FG001|Overall Study|Did Not Come to Study Visit|0
7331286|NCT00812565|11564844|FG002|Overall Study|Did Not Come to Study Visit|0
7331287|NCT00812565|11564845|FG003|Overall Study|Did Not Come to Study Visit|0
7331288|NCT00812565|11564846|FG004|Overall Study|Did Not Come to Study Visit|0
7331289|NCT00812565|11564847|FG005|Overall Study|Did Not Come to Study Visit|0
7331290|NCT00812565|11564848|FG006|Overall Study|Did Not Come to Study Visit|0
7331291|NCT00812565|11564849|FG007|Overall Study|Did Not Come to Study Visit|0
7331292|NCT00812565|11564842|FG000|Overall Study|Withdrawal of Consent|1
7331293|NCT00812565|11564843|FG001|Overall Study|Withdrawal of Consent|0
7331294|NCT00812565|11564844|FG002|Overall Study|Withdrawal of Consent|0
7331295|NCT00812565|11564845|FG003|Overall Study|Withdrawal of Consent|0
7331296|NCT00812565|11564846|FG004|Overall Study|Withdrawal of Consent|1
7331297|NCT00812565|11564847|FG005|Overall Study|Withdrawal of Consent|0
7331298|NCT00812565|11564848|FG006|Overall Study|Withdrawal of Consent|0
7331299|NCT00812565|11564849|FG007|Overall Study|Withdrawal of Consent|0
7331300|NCT00812565|11564842|FG000|Overall Study|Reason Not Specified|0
7331301|NCT00812565|11564843|FG001|Overall Study|Reason Not Specified|0
7331302|NCT00812565|11564844|FG002|Overall Study|Reason Not Specified|0
7331303|NCT00812565|11564845|FG003|Overall Study|Reason Not Specified|0
7331304|NCT00812565|11564846|FG004|Overall Study|Reason Not Specified|0
7331305|NCT00812565|11564847|FG005|Overall Study|Reason Not Specified|1
7331306|NCT00812565|11564848|FG006|Overall Study|Reason Not Specified|0
7331307|NCT00812565|11564849|FG007|Overall Study|Reason Not Specified|0
7331308|NCT00812812|11564878|FG000|Overall Study|Adverse Event|2
7331309|NCT00812812|11564879|FG001|Overall Study|Adverse Event|1
7331310|NCT00812812|11564878|FG000|Overall Study|Lack of Efficacy|1
7331311|NCT00812812|11564879|FG001|Overall Study|Lack of Efficacy|0
7331312|NCT00812812|11564878|FG000|Overall Study|Lost to Follow-up|0
7331313|NCT00812812|11564879|FG001|Overall Study|Lost to Follow-up|1
7331314|NCT00812812|11564878|FG000|Overall Study|Withdrawal by Subject|0
7331315|NCT00812812|11564879|FG001|Overall Study|Withdrawal by Subject|2
7331316|NCT00812929|11564913|FG000|Washout Period 1 (7 Days)|Physician Decision|0
7331317|NCT00812929|11564914|FG001|Washout Period 1 (7 Days)|Physician Decision|0
7331318|NCT00812929|11564915|FG002|Washout Period 1 (7 Days)|Physician Decision|1
7331319|NCT00812929|11564916|FG003|Washout Period 1 (7 Days)|Physician Decision|0
7331320|NCT00812929|11564917|FG004|Washout Period 1 (7 Days)|Physician Decision|0
7457748|NCT01802216|11751505|FG000|8 Month Visit|Participant did not show to visit|3
7331321|NCT00812929|11564918|FG005|Washout Period 1 (7 Days)|Physician Decision|0
7331322|NCT00812929|11564919|FG006|Washout Period 1 (7 Days)|Physician Decision|0
7331323|NCT00812929|11564920|FG007|Washout Period 1 (7 Days)|Physician Decision|0
7331324|NCT00812929|11564921|FG008|Washout Period 1 (7 Days)|Physician Decision|0
7331325|NCT00812929|11564922|FG009|Washout Period 1 (7 Days)|Physician Decision|0
7331326|NCT00812929|11564913|FG000|Washout Period 2 (7 Days)|Physician Decision|0
7331327|NCT00812929|11564914|FG001|Washout Period 2 (7 Days)|Physician Decision|0
7331328|NCT00812929|11564915|FG002|Washout Period 2 (7 Days)|Physician Decision|0
7331329|NCT00812929|11564916|FG003|Washout Period 2 (7 Days)|Physician Decision|0
7331330|NCT00812929|11564917|FG004|Washout Period 2 (7 Days)|Physician Decision|0
7331331|NCT00812929|11564918|FG005|Washout Period 2 (7 Days)|Physician Decision|0
7331332|NCT00812929|11564919|FG006|Washout Period 2 (7 Days)|Physician Decision|0
7331333|NCT00812929|11564920|FG007|Washout Period 2 (7 Days)|Physician Decision|0
7331334|NCT00812929|11564921|FG008|Washout Period 2 (7 Days)|Physician Decision|0
7331335|NCT00812929|11564922|FG009|Washout Period 2 (7 Days)|Physician Decision|1
7331336|NCT00812929|11564913|FG000|Washout Period 3 (7 Days)|Adverse Event|0
7331337|NCT00812929|11564914|FG001|Washout Period 3 (7 Days)|Adverse Event|0
7331338|NCT00812929|11564915|FG002|Washout Period 3 (7 Days)|Adverse Event|0
7331339|NCT00812929|11564916|FG003|Washout Period 3 (7 Days)|Adverse Event|0
7331340|NCT00812929|11564917|FG004|Washout Period 3 (7 Days)|Adverse Event|0
7331341|NCT00812929|11564918|FG005|Washout Period 3 (7 Days)|Adverse Event|1
7331342|NCT00812929|11564919|FG006|Washout Period 3 (7 Days)|Adverse Event|0
7331343|NCT00812929|11564920|FG007|Washout Period 3 (7 Days)|Adverse Event|0
7331344|NCT00812929|11564921|FG008|Washout Period 3 (7 Days)|Adverse Event|0
7331345|NCT00812929|11564922|FG009|Washout Period 3 (7 Days)|Adverse Event|0
7331346|NCT00812955|11564943|FG000|Overall Study|Adverse Event|7
7331347|NCT00812955|11564944|FG001|Overall Study|Adverse Event|6
7331348|NCT00812955|11564945|FG002|Overall Study|Adverse Event|3
7331349|NCT00812955|11564946|FG003|Overall Study|Adverse Event|4
7331350|NCT00812955|11564943|FG000|Overall Study|Lost to Follow-up|2
7331351|NCT00812955|11564944|FG001|Overall Study|Lost to Follow-up|1
7331352|NCT00812955|11564945|FG002|Overall Study|Lost to Follow-up|1
7331353|NCT00812955|11564946|FG003|Overall Study|Lost to Follow-up|2
7331354|NCT00812955|11564943|FG000|Overall Study|Withdrawal by Subject|1
7331355|NCT00812955|11564944|FG001|Overall Study|Withdrawal by Subject|0
7331356|NCT00812955|11564945|FG002|Overall Study|Withdrawal by Subject|1
7331357|NCT00812955|11564946|FG003|Overall Study|Withdrawal by Subject|2
7331358|NCT00812955|11564943|FG000|Overall Study|randomized in error|0
7331359|NCT00812955|11564944|FG001|Overall Study|randomized in error|0
7331360|NCT00812955|11564945|FG002|Overall Study|randomized in error|1
7331361|NCT00812955|11564946|FG003|Overall Study|randomized in error|0
7331362|NCT00812968|11564960|FG000|Overall Study|Relapse after erythroid response|6
7331363|NCT00812968|11564960|FG000|Overall Study|Disease progression|1
7331364|NCT00812968|11564960|FG000|Overall Study|No further treatment required|1
7331365|NCT00812968|11564960|FG000|Overall Study|Study closed due to marketing approval|3
7331366|NCT00812981|11564968|FG000|Overall Study|Other|0
7331367|NCT00812981|11564969|FG001|Overall Study|Other|1
7225202|NCT00064701|11434642|FG000|Clinical Continuation Phase|Lost to Follow-up|6
7225203|NCT00064701|11434643|FG001|Clinical Continuation Phase|Lost to Follow-up|3
7225204|NCT00064701|11434644|FG002|Clinical Continuation Phase|Lost to Follow-up|6
7225205|NCT00064701|11434642|FG000|Clinical Continuation Phase|Graft Failure|5
7225206|NCT00064701|11434643|FG001|Clinical Continuation Phase|Graft Failure|5
7225207|NCT00064701|11434644|FG002|Clinical Continuation Phase|Graft Failure|2
7225208|NCT00064701|11434642|FG000|Clinical Continuation Phase|Rejection|1
7225209|NCT00064701|11434643|FG001|Clinical Continuation Phase|Rejection|2
7225210|NCT00064701|11434644|FG002|Clinical Continuation Phase|Rejection|2
7225211|NCT00064701|11434642|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
7225212|NCT00064701|11434643|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
7225213|NCT00064701|11434644|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
7225214|NCT00064701|11434642|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
7225215|NCT00064701|11434643|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
7225216|NCT00064701|11434644|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
7225217|NCT00064701|11434642|FG000|Clinical Continuation Phase|Physician Decision|1
7225218|NCT00064701|11434643|FG001|Clinical Continuation Phase|Physician Decision|3
7225219|NCT00064701|11434644|FG002|Clinical Continuation Phase|Physician Decision|0
7225220|NCT00064701|11434642|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
7225221|NCT00064701|11434643|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
7225222|NCT00064701|11434644|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
7331368|NCT00813098|11564978|FG000|Overall Study|Adverse Event|2
7331369|NCT00813098|11564979|FG001|Overall Study|Adverse Event|4
7331370|NCT00813098|11564980|FG002|Overall Study|Adverse Event|1
7331371|NCT00813098|11564978|FG000|Overall Study|Withdrawal by Subject|0
7331372|NCT00813098|11564979|FG001|Overall Study|Withdrawal by Subject|1
7331373|NCT00813098|11564980|FG002|Overall Study|Withdrawal by Subject|0
7331374|NCT00813098|11564978|FG000|Overall Study|Inability to complete study procedures|1
7331375|NCT00813098|11564979|FG001|Overall Study|Inability to complete study procedures|0
7331376|NCT00813098|11564980|FG002|Overall Study|Inability to complete study procedures|0
7331377|NCT00813098|11564978|FG000|Overall Study|Lost to Follow-up|0
7331378|NCT00813098|11564979|FG001|Overall Study|Lost to Follow-up|1
7331379|NCT00813098|11564980|FG002|Overall Study|Lost to Follow-up|0
7331380|NCT00813098|11564978|FG000|Overall Study|Protocol Violation|0
7331381|NCT00813098|11564979|FG001|Overall Study|Protocol Violation|0
7331382|NCT00813098|11564980|FG002|Overall Study|Protocol Violation|1
7331383|NCT00813098|11564978|FG000|Overall Study|Principal Investigator decision|0
7331384|NCT00813098|11564979|FG001|Overall Study|Principal Investigator decision|1
7331385|NCT00813098|11564980|FG002|Overall Study|Principal Investigator decision|0
7331386|NCT00813098|11564978|FG000|Overall Study|Withdrew Consent|0
7331387|NCT00813098|11564979|FG001|Overall Study|Withdrew Consent|1
7331388|NCT00813098|11564980|FG002|Overall Study|Withdrew Consent|0
7331389|NCT00813124|11564997|FG000|Overall Study|Death|2
7331390|NCT00813124|11564997|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
7331391|NCT00813124|11564997|FG000|Overall Study|Withdrawal by Subject|1
7331392|NCT00813150|11565003|FG000|Treatment Period|Adverse Event|16
7331393|NCT00813150|11565004|FG001|Treatment Period|Adverse Event|15
7331394|NCT00813150|11565003|FG000|Treatment Period|Death|2
7331395|NCT00813150|11565004|FG001|Treatment Period|Death|0
7331396|NCT00813150|11565003|FG000|Treatment Period|Progressive disease|1
7331397|NCT00813150|11565004|FG001|Treatment Period|Progressive disease|0
7331398|NCT00813150|11565003|FG000|Treatment Period|Complete response|0
7331399|NCT00813150|11565004|FG001|Treatment Period|Complete response|1
7331400|NCT00813150|11565003|FG000|Treatment Period|Stable disease|1
7331401|NCT00813150|11565004|FG001|Treatment Period|Stable disease|2
7331402|NCT00813150|11565003|FG000|Treatment Period|Protocol Violation|3
7331403|NCT00813150|11565004|FG001|Treatment Period|Protocol Violation|4
7331404|NCT00813150|11565003|FG000|Treatment Period|Withdrawal by Subject|5
7331405|NCT00813150|11565004|FG001|Treatment Period|Withdrawal by Subject|3
7331406|NCT00813150|11565003|FG000|Treatment Period|Non compliance|0
7331407|NCT00813150|11565004|FG001|Treatment Period|Non compliance|1
7331408|NCT00813150|11565003|FG000|Treatment Period|Reason not specified|3
7331409|NCT00813150|11565004|FG001|Treatment Period|Reason not specified|4
7331410|NCT00813150|11565003|FG000|Treatment Period|Data not available|1
7331411|NCT00813150|11565004|FG001|Treatment Period|Data not available|2
7331412|NCT00813150|11565003|FG000|Long Term Follow-up|Death|0
7331413|NCT00813150|11565004|FG001|Long Term Follow-up|Death|4
7331414|NCT00813150|11565003|FG000|Long Term Follow-up|Other|0
7331415|NCT00813150|11565004|FG001|Long Term Follow-up|Other|3
7331416|NCT00813150|11565003|FG000|Long Term Follow-up|Lost to Follow-up|2
7331417|NCT00813150|11565004|FG001|Long Term Follow-up|Lost to Follow-up|0
7331418|NCT00813150|11565003|FG000|Long Term Follow-up|Progression/Relapse|22
7331419|NCT00813150|11565004|FG001|Long Term Follow-up|Progression/Relapse|24
7331420|NCT00813293|11565023|FG000|Overall Study|Intercurrent illness|1
7331421|NCT00813293|11565024|FG001|Overall Study|Intercurrent illness|0
7331422|NCT00813293|11565023|FG000|Overall Study|Adverse Event|0
7331423|NCT00813293|11565024|FG001|Overall Study|Adverse Event|1
7331424|NCT00813358|11565039|FG000|Overall Study|Death|32
7331425|NCT00813358|11565039|FG000|Overall Study|Lost to Follow-up|12
7331426|NCT00813358|11565039|FG000|Overall Study|other endpoints|5
7331427|NCT00813358|11565039|FG000|Overall Study|Withdrawal by Subject|20
7331428|NCT00813488|11565043|FG000|Titration Period 1|Adverse Event|6
7331429|NCT00813488|11565044|FG001|Titration Period 1|Adverse Event|1
7331430|NCT00813488|11565043|FG000|Titration Period 1|Lack of Efficacy|9
7331431|NCT00813488|11565044|FG001|Titration Period 1|Lack of Efficacy|7
7331432|NCT00813488|11565043|FG000|Titration Period 1|Withdrawal by Subject|2
7331433|NCT00813488|11565044|FG001|Titration Period 1|Withdrawal by Subject|2
7331434|NCT00813488|11565043|FG000|Titration Period 1|Protocol Violation|4
7331435|NCT00813488|11565044|FG001|Titration Period 1|Protocol Violation|3
7331436|NCT00813488|11565043|FG000|Titration Period 1|Non-compliance to study medication|4
7331437|NCT00813488|11565044|FG001|Titration Period 1|Non-compliance to study medication|1
7331438|NCT00813488|11565043|FG000|Titration Period 1|Non-compliance to study procedures|2
7331439|NCT00813488|11565044|FG001|Titration Period 1|Non-compliance to study procedures|2
7331440|NCT00813488|11565043|FG000|Titration Period 1|Technical Difficulties|0
7331441|NCT00813488|11565044|FG001|Titration Period 1|Technical Difficulties|1
7331442|NCT00813488|11565043|FG000|Titration Period 2|Adverse Event|2
7331443|NCT00813488|11565044|FG001|Titration Period 2|Adverse Event|3
7331444|NCT00813488|11565043|FG000|Titration Period 2|Lack of Efficacy|8
7331445|NCT00813488|11565044|FG001|Titration Period 2|Lack of Efficacy|4
7331446|NCT00813488|11565043|FG000|Titration Period 2|Protocol Violation|3
7331447|NCT00813488|11565044|FG001|Titration Period 2|Protocol Violation|2
7331448|NCT00813488|11565043|FG000|Titration Period 2|Lost to Follow-up|1
7331449|NCT00813488|11565044|FG001|Titration Period 2|Lost to Follow-up|0
7331450|NCT00813488|11565043|FG000|Titration Period 2|Non-compliance with study procedures|2
7331451|NCT00813488|11565044|FG001|Titration Period 2|Non-compliance with study procedures|1
7331452|NCT00813488|11565043|FG000|Double-blind Treatment Period 1|Adverse Event|1
7331453|NCT00813488|11565044|FG001|Double-blind Treatment Period 1|Adverse Event|1
7331454|NCT00813488|11565043|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
7331455|NCT00813488|11565044|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
7331456|NCT00813488|11565043|FG000|Double-blind Treatment Period 1|Protocol Violation|0
7331457|NCT00813488|11565044|FG001|Double-blind Treatment Period 1|Protocol Violation|2
7331458|NCT00813488|11565043|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
7331459|NCT00813488|11565044|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
7331460|NCT00813488|11565043|FG000|Double-blind Treatment Period 2|Adverse Event|1
7331461|NCT00813488|11565044|FG001|Double-blind Treatment Period 2|Adverse Event|0
7568381|NCT03403426|11943095|FG000|Overall Study|Death|1
7568382|NCT03403426|11943095|FG000|Overall Study|Lost to Follow-up|2
7575257|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7575258|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
7575259|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7575260|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7575261|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
7575262|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7575263|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
7575264|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
7575265|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7575266|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7575267|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
7575268|NCT03720470|11958907|FG000|Treatment Period: Final 4 Weeks|Other|0
7575269|NCT03720470|11958908|FG001|Treatment Period: Final 4 Weeks|Other|1
7575270|NCT03720470|11958909|FG002|Treatment Period: Final 4 Weeks|Other|0
7331462|NCT00813488|11565043|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
7331463|NCT00813488|11565044|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
7575271|NCT03720470|11958910|FG003|Treatment Period: Final 4 Weeks|Other|2
7331464|NCT00813488|11565043|FG000|Double-blind Treatment Period 2|Protocol Violation|2
7331465|NCT00813488|11565044|FG001|Double-blind Treatment Period 2|Protocol Violation|0
7331466|NCT00813488|11565043|FG000|Double-blind Treatment Period 2|Other|1
7331467|NCT00813488|11565044|FG001|Double-blind Treatment Period 2|Other|0
7568383|NCT03403751|11943197|FG000|Overall Study|Death|5
7568384|NCT03403751|11943198|FG001|Overall Study|Death|6
7568385|NCT03403751|11943197|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
7331468|NCT00813488|11565043|FG000|Open-label Extension|Adverse Event|1
7331469|NCT00813488|11565044|FG001|Open-label Extension|Adverse Event|2
7331470|NCT00813488|11565043|FG000|Open-label Extension|Lack of Efficacy|3
7331471|NCT00813488|11565044|FG001|Open-label Extension|Lack of Efficacy|0
7331472|NCT00813488|11565043|FG000|Open-label Extension|Withdrawal by Subject|0
7331473|NCT00813488|11565044|FG001|Open-label Extension|Withdrawal by Subject|2
7331474|NCT00813488|11565043|FG000|Open-label Extension|Protocol Violation|1
7331475|NCT00813488|11565044|FG001|Open-label Extension|Protocol Violation|2
7331476|NCT00813488|11565043|FG000|Open-label Extension|Non-compliance study medication|4
7331477|NCT00813488|11565044|FG001|Open-label Extension|Non-compliance study medication|0
7331478|NCT00813488|11565043|FG000|Open-label Extension|Non-compliance study procedures|2
7331479|NCT00813488|11565044|FG001|Open-label Extension|Non-compliance study procedures|1
7331480|NCT00813488|11565043|FG000|Open-label Extension|Other|1
7331481|NCT00813488|11565044|FG001|Open-label Extension|Other|0
7331482|NCT00813592|11565054|FG000|Overall Study|Disease assessment was not completed per|2
7331483|NCT00813709|11565062|FG000|Double Blind Period|Adverse Event|4
7331484|NCT00813709|11565063|FG001|Double Blind Period|Adverse Event|1
7331485|NCT00813709|11565064|FG002|Double Blind Period|Adverse Event|4
7331486|NCT00813709|11565065|FG003|Double Blind Period|Adverse Event|0
7331487|NCT00813709|11565066|FG004|Double Blind Period|Adverse Event|0
7331488|NCT00813709|11565067|FG005|Double Blind Period|Adverse Event|0
7568386|NCT03403751|11943198|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
7568387|NCT03404206|11943215|FG000|Overall Study|Withdrawal by Subject|1
7568388|NCT03404206|11943216|FG001|Overall Study|Withdrawal by Subject|1
7568389|NCT03404206|11943217|FG002|Overall Study|Withdrawal by Subject|0
7568390|NCT03404206|11943215|FG000|Overall Study|Lost to Follow-up|3
7568391|NCT03404206|11943216|FG001|Overall Study|Lost to Follow-up|1
7568392|NCT03404206|11943217|FG002|Overall Study|Lost to Follow-up|0
7568393|NCT03404674|11943262|FG000|Overall Study|Inability to Attend Future Visits|0
7568394|NCT03404674|11943263|FG001|Overall Study|Inability to Attend Future Visits|1
7568395|NCT03404674|11943264|FG002|Overall Study|Inability to Attend Future Visits|1
7568396|NCT03404674|11943265|FG003|Overall Study|Inability to Attend Future Visits|0
7331489|NCT00813709|11565062|FG000|Double Blind Period|Lost to Follow-up|3
7331490|NCT00813709|11565063|FG001|Double Blind Period|Lost to Follow-up|2
7331491|NCT00813709|11565064|FG002|Double Blind Period|Lost to Follow-up|2
7331492|NCT00813709|11565065|FG003|Double Blind Period|Lost to Follow-up|0
7331493|NCT00813709|11565066|FG004|Double Blind Period|Lost to Follow-up|0
7331494|NCT00813709|11565067|FG005|Double Blind Period|Lost to Follow-up|0
7331495|NCT00813709|11565062|FG000|Double Blind Period|Switched to open label phase|9
7331496|NCT00813709|11565063|FG001|Double Blind Period|Switched to open label phase|26
7331497|NCT00813709|11565064|FG002|Double Blind Period|Switched to open label phase|18
7331498|NCT00813709|11565065|FG003|Double Blind Period|Switched to open label phase|0
7331499|NCT00813709|11565066|FG004|Double Blind Period|Switched to open label phase|0
7331500|NCT00813709|11565067|FG005|Double Blind Period|Switched to open label phase|0
7331501|NCT00813709|11565062|FG000|Double Blind Period|Randomized but not treated|1
7331502|NCT00813709|11565063|FG001|Double Blind Period|Randomized but not treated|3
7331503|NCT00813709|11565064|FG002|Double Blind Period|Randomized but not treated|1
7331504|NCT00813709|11565065|FG003|Double Blind Period|Randomized but not treated|0
7331505|NCT00813709|11565066|FG004|Double Blind Period|Randomized but not treated|0
7331506|NCT00813709|11565067|FG005|Double Blind Period|Randomized but not treated|0
7331507|NCT00813709|11565062|FG000|Double Blind Period|Other|14
7331508|NCT00813709|11565063|FG001|Double Blind Period|Other|9
7331509|NCT00813709|11565064|FG002|Double Blind Period|Other|6
7331510|NCT00813709|11565065|FG003|Double Blind Period|Other|0
7331511|NCT00813709|11565066|FG004|Double Blind Period|Other|0
7331512|NCT00813709|11565067|FG005|Double Blind Period|Other|0
7331513|NCT00813709|11565062|FG000|Open Label Period|Adverse Event|0
7331514|NCT00813709|11565063|FG001|Open Label Period|Adverse Event|0
7331515|NCT00813709|11565064|FG002|Open Label Period|Adverse Event|0
7331516|NCT00813709|11565065|FG003|Open Label Period|Adverse Event|5
7331517|NCT00813709|11565066|FG004|Open Label Period|Adverse Event|4
7331518|NCT00813709|11565067|FG005|Open Label Period|Adverse Event|3
7331519|NCT00813709|11565062|FG000|Open Label Period|Lack of Efficacy|0
7331520|NCT00813709|11565063|FG001|Open Label Period|Lack of Efficacy|0
7331521|NCT00813709|11565064|FG002|Open Label Period|Lack of Efficacy|0
7331522|NCT00813709|11565065|FG003|Open Label Period|Lack of Efficacy|3
7331523|NCT00813709|11565066|FG004|Open Label Period|Lack of Efficacy|1
7331524|NCT00813709|11565067|FG005|Open Label Period|Lack of Efficacy|1
7331525|NCT00813709|11565062|FG000|Open Label Period|Randomized but not treated|0
7331526|NCT00813709|11565063|FG001|Open Label Period|Randomized but not treated|0
7331527|NCT00813709|11565064|FG002|Open Label Period|Randomized but not treated|0
7331528|NCT00813709|11565065|FG003|Open Label Period|Randomized but not treated|1
7331529|NCT00813709|11565066|FG004|Open Label Period|Randomized but not treated|0
7331530|NCT00813709|11565067|FG005|Open Label Period|Randomized but not treated|1
7331531|NCT00813709|11565062|FG000|Open Label Period|Other|0
7331532|NCT00813709|11565063|FG001|Open Label Period|Other|0
7331533|NCT00813709|11565064|FG002|Open Label Period|Other|0
7331534|NCT00813709|11565065|FG003|Open Label Period|Other|11
7331535|NCT00813709|11565066|FG004|Open Label Period|Other|5
7331536|NCT00813709|11565067|FG005|Open Label Period|Other|6
7331537|NCT00813748|11565098|FG000|Skin Test Substudy|Physician Decision|0
7331538|NCT00813748|11565099|FG001|Skin Test Substudy|Physician Decision|1
7331539|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
7331540|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7331541|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7331542|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
7331543|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7331544|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
7331545|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
7331546|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
7331547|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7331548|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7331549|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
7331550|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
7331551|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7331552|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7331553|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
7331554|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
7331555|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7331556|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7331557|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
7331558|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
7331559|NCT00813761|11565109|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7331560|NCT00813761|11565110|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
7331561|NCT00813761|11565111|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7331562|NCT00813761|11565112|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
7331563|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
7331564|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
7331565|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7331566|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
7331567|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
7331568|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
7331569|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
7331570|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
7331571|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7331572|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7331573|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
7331574|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
7331575|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7331576|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7331577|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
7331578|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
7331579|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
7331580|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
7331581|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
7331582|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
7331583|NCT00813761|11565109|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
7331584|NCT00813761|11565110|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7331585|NCT00813761|11565111|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
7331586|NCT00813761|11565112|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
7331587|NCT00813800|11565128|FG000|Overall Study|Screen Failure after Consent|2
7331588|NCT00813800|11565128|FG000|Overall Study|Adverse Event|1
7331589|NCT00813800|11565128|FG000|Overall Study|Worsening of depression|2
7331590|NCT00813800|11565128|FG000|Overall Study|Physician Decision|1
7331591|NCT00813813|11565134|FG000|Overall Study|Withdrawal by Subject|1
7331592|NCT00813813|11565135|FG001|Overall Study|Withdrawal by Subject|1
7331593|NCT00813813|11565134|FG000|Overall Study|Lost to Follow-up|2
7331594|NCT00813813|11565135|FG001|Overall Study|Lost to Follow-up|7
7331595|NCT00813813|11565134|FG000|Overall Study|Other|0
7331596|NCT00813813|11565135|FG001|Overall Study|Other|1
7331597|NCT00813865|11565141|FG000|Overall Study|Failure to Respond|3
7331598|NCT00813865|11565141|FG000|Overall Study|Lost to Follow-up|3
7331599|NCT00813865|11565141|FG000|Overall Study|Withdrawal by Subject|1
7331600|NCT00813904|11565145|FG000|Overall Study|Death|1
7331601|NCT00813917|11565151|FG000|Overall Study|Adverse Event|0
7331602|NCT00813917|11565152|FG001|Overall Study|Adverse Event|1
7331603|NCT00813917|11565151|FG000|Overall Study|Withdrawal by Subject|3
7331604|NCT00813917|11565152|FG001|Overall Study|Withdrawal by Subject|4
7331605|NCT00813917|11565151|FG000|Overall Study|Lost to Follow-up|3
7331606|NCT00813917|11565152|FG001|Overall Study|Lost to Follow-up|1
7457749|NCT01802216|11751506|FG001|8 Month Visit|Participant did not show to visit|5
7457750|NCT01802216|11751505|FG000|12 Month Visit|Participant did not show to visit|3
7331607|NCT00813943|11565161|FG000|Overall Study|Ongoing at cut-off date|5
7331608|NCT00813943|11565162|FG001|Overall Study|Ongoing at cut-off date|5
7331609|NCT00813943|11565163|FG002|Overall Study|Ongoing at cut-off date|3
7331610|NCT00813995|11565180|FG000|Overall Study|Clinical adverse event|9
7331611|NCT00813995|11565181|FG001|Overall Study|Clinical adverse event|3
7331612|NCT00813995|11565180|FG000|Overall Study|Laboratory adverse event|0
7331613|NCT00813995|11565181|FG001|Overall Study|Laboratory adverse event|2
7331614|NCT00813995|11565180|FG000|Overall Study|Lack of Efficacy|1
7331615|NCT00813995|11565181|FG001|Overall Study|Lack of Efficacy|0
7331616|NCT00813995|11565180|FG000|Overall Study|Lost to Follow-up|4
7331617|NCT00813995|11565181|FG001|Overall Study|Lost to Follow-up|2
7331618|NCT00813995|11565180|FG000|Overall Study|Other reason|2
7331619|NCT00813995|11565181|FG001|Overall Study|Other reason|2
7331620|NCT00813995|11565180|FG000|Overall Study|Protocol Violation|3
7331621|NCT00813995|11565181|FG001|Overall Study|Protocol Violation|2
7331622|NCT00813995|11565180|FG000|Overall Study|Subject moved|4
7331623|NCT00813995|11565181|FG001|Overall Study|Subject moved|0
7331624|NCT00813995|11565180|FG000|Overall Study|Withdrawal by Subject|0
7331625|NCT00813995|11565181|FG001|Overall Study|Withdrawal by Subject|5
7331626|NCT00814164|11565202|FG000|Overall Study|Progression|7
7331627|NCT00814164|11565202|FG000|Overall Study|not stated|7
7331628|NCT00814164|11565202|FG000|Overall Study|Death|5
7331629|NCT00814307|11565235|FG000|Overall Study|Randomized but not treated|1
7331630|NCT00814307|11565236|FG001|Overall Study|Randomized but not treated|0
7331631|NCT00814307|11565237|FG002|Overall Study|Randomized but not treated|0
7331632|NCT00814307|11565238|FG003|Overall Study|Randomized but not treated|0
7331633|NCT00814307|11565235|FG000|Overall Study|Adverse Event|3
7331634|NCT00814307|11565236|FG001|Overall Study|Adverse Event|9
7331635|NCT00814307|11565237|FG002|Overall Study|Adverse Event|3
7331636|NCT00814307|11565238|FG003|Overall Study|Adverse Event|2
7331637|NCT00814307|11565235|FG000|Overall Study|Lack of Efficacy|1
7331638|NCT00814307|11565236|FG001|Overall Study|Lack of Efficacy|1
7331639|NCT00814307|11565237|FG002|Overall Study|Lack of Efficacy|3
7331640|NCT00814307|11565238|FG003|Overall Study|Lack of Efficacy|4
7331641|NCT00814307|11565235|FG000|Overall Study|Other|1
7331642|NCT00814307|11565236|FG001|Overall Study|Other|2
7331643|NCT00814307|11565237|FG002|Overall Study|Other|0
7331644|NCT00814307|11565238|FG003|Overall Study|Other|1
7331645|NCT00814307|11565235|FG000|Overall Study|Protocol Violation|2
7331646|NCT00814307|11565236|FG001|Overall Study|Protocol Violation|8
7331647|NCT00814307|11565237|FG002|Overall Study|Protocol Violation|1
7331648|NCT00814307|11565238|FG003|Overall Study|Protocol Violation|1
7331649|NCT00814307|11565235|FG000|Overall Study|Withdrawal by Subject|4
7331650|NCT00814307|11565236|FG001|Overall Study|Withdrawal by Subject|6
7331651|NCT00814307|11565237|FG002|Overall Study|Withdrawal by Subject|0
7331652|NCT00814307|11565238|FG003|Overall Study|Withdrawal by Subject|2
7331653|NCT00814307|11565235|FG000|Overall Study|Death|0
7331654|NCT00814307|11565236|FG001|Overall Study|Death|1
7331655|NCT00814307|11565237|FG002|Overall Study|Death|0
7331656|NCT00814307|11565238|FG003|Overall Study|Death|0
7331657|NCT00814320|11565252|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
7331658|NCT00814320|11565253|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
7331659|NCT00814320|11565252|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
7331660|NCT00814320|11565253|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
7331661|NCT00814320|11565252|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
7331662|NCT00814320|11565253|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
7331663|NCT00814320|11565252|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
7331664|NCT00814320|11565253|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
7331665|NCT00814320|11565252|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
7331666|NCT00814320|11565253|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
7331667|NCT00814320|11565252|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
7331668|NCT00814320|11565253|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
7331669|NCT00814320|11565252|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
7331670|NCT00814320|11565253|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
7331671|NCT00814320|11565252|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
7457751|NCT01802216|11751506|FG001|12 Month Visit|Participant did not show to visit|4
7331672|NCT00814320|11565253|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
7331673|NCT00814320|11565252|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
7331674|NCT00814320|11565253|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
7331675|NCT00814320|11565252|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
7331676|NCT00814320|11565253|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
7331677|NCT00814346|11565278|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
7331678|NCT00814346|11565279|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
7331679|NCT00814346|11565278|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
7331680|NCT00814346|11565279|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
7331681|NCT00814346|11565278|FG000|Open Phase (17 Months)|Adverse Event|5
7331682|NCT00814346|11565279|FG001|Open Phase (17 Months)|Adverse Event|0
7331683|NCT00814346|11565278|FG000|Open Phase (17 Months)|Consent|2
7331684|NCT00814346|11565279|FG001|Open Phase (17 Months)|Consent|0
7331685|NCT00814346|11565278|FG000|Open Phase (17 Months)|Lost to Follow-up|2
7331686|NCT00814346|11565279|FG001|Open Phase (17 Months)|Lost to Follow-up|0
7331687|NCT00814346|11565278|FG000|Open Phase (17 Months)|Not otherwise specified|1
7331688|NCT00814346|11565279|FG001|Open Phase (17 Months)|Not otherwise specified|0
7331689|NCT00814463|11565298|FG000|Overall Study|Lost to Follow-up|1
7331690|NCT00814489|11565306|FG000|Overall Study|Other|2
7331691|NCT00814489|11565307|FG001|Overall Study|Other|0
7331692|NCT00814489|11565308|FG002|Overall Study|Other|1
7331693|NCT00814502|11565320|FG000|Overall Study|Adverse Event|1
7331694|NCT00814502|11565321|FG001|Overall Study|Adverse Event|0
7331695|NCT00814502|11565320|FG000|Overall Study|Withdrawal by Subject|0
7331696|NCT00814502|11565321|FG001|Overall Study|Withdrawal by Subject|2
7331697|NCT00814580|11565331|FG000|Overall Study|Adverse Event|6
7331698|NCT00814580|11565332|FG001|Overall Study|Adverse Event|15
7331699|NCT00814580|11565331|FG000|Overall Study|Lack of Efficacy|18
7568397|NCT03404674|11943266|FG004|Overall Study|Inability to Attend Future Visits|0
7568398|NCT03404674|11943267|FG005|Overall Study|Inability to Attend Future Visits|0
7568399|NCT03404674|11943262|FG000|Overall Study|Behavioral Problems|0
7568400|NCT03404674|11943263|FG001|Overall Study|Behavioral Problems|0
7568401|NCT03404674|11943264|FG002|Overall Study|Behavioral Problems|1
7568402|NCT03404674|11943265|FG003|Overall Study|Behavioral Problems|0
7568403|NCT03404674|11943266|FG004|Overall Study|Behavioral Problems|0
7568404|NCT03404674|11943267|FG005|Overall Study|Behavioral Problems|0
7568405|NCT03404674|11943262|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
7568406|NCT03404674|11943263|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
7575272|NCT03720470|11958911|FG004|Treatment Period: Final 4 Weeks|Other|1
7331700|NCT00814580|11565332|FG001|Overall Study|Lack of Efficacy|25
7331701|NCT00814580|11565331|FG000|Overall Study|Protocol Violation|2
7331702|NCT00814580|11565332|FG001|Overall Study|Protocol Violation|0
7331703|NCT00814580|11565331|FG000|Overall Study|Withdrawal by Subject|2
7331704|NCT00814580|11565332|FG001|Overall Study|Withdrawal by Subject|2
7331705|NCT00814580|11565331|FG000|Overall Study|Other|1
7331706|NCT00814580|11565332|FG001|Overall Study|Other|3
7331707|NCT00814580|11565331|FG000|Overall Study|Did Not Take Drug|2
7331708|NCT00814580|11565332|FG001|Overall Study|Did Not Take Drug|2
7331709|NCT00814632|11565350|FG000|Overall Study|Lack of Efficacy|2
7331710|NCT00814658|11565356|FG000|Overall Study|Lost to Follow-up|0
7331711|NCT00814658|11565357|FG001|Overall Study|Lost to Follow-up|1
7331712|NCT00814658|11565356|FG000|Overall Study|Physician Decision|1
7331713|NCT00814658|11565357|FG001|Overall Study|Physician Decision|0
7331714|NCT00814658|11565356|FG000|Overall Study|Adverse Event|3
7331715|NCT00814658|11565357|FG001|Overall Study|Adverse Event|3
7331716|NCT00814710|11565396|FG000|Overall Study|Adverse Event|1
7331717|NCT00814710|11565397|FG001|Overall Study|Adverse Event|0
7331718|NCT00814710|11565396|FG000|Overall Study|Lost to Follow-up|7
7331719|NCT00814710|11565397|FG001|Overall Study|Lost to Follow-up|3
7331720|NCT00814801|11565421|FG000|Overall Study|Adverse Event|15
7331721|NCT00814801|11565422|FG001|Overall Study|Adverse Event|16
7331722|NCT00814801|11565423|FG002|Overall Study|Adverse Event|19
7331723|NCT00814801|11565421|FG000|Overall Study|Withdrawal by Subject|9
7331724|NCT00814801|11565422|FG001|Overall Study|Withdrawal by Subject|11
7331725|NCT00814801|11565423|FG002|Overall Study|Withdrawal by Subject|14
7331726|NCT00814801|11565421|FG000|Overall Study|Inappropriate as a subject|1
7331727|NCT00814801|11565422|FG001|Overall Study|Inappropriate as a subject|1
7331728|NCT00814801|11565423|FG002|Overall Study|Inappropriate as a subject|1
7331729|NCT00814801|11565421|FG000|Overall Study|Change of patients for CIBIC plus-J|1
7331730|NCT00814801|11565422|FG001|Overall Study|Change of patients for CIBIC plus-J|1
7331731|NCT00814801|11565423|FG002|Overall Study|Change of patients for CIBIC plus-J|0
7331732|NCT00814801|11565421|FG000|Overall Study|Missing or change of caregiver|6
7331733|NCT00814801|11565422|FG001|Overall Study|Missing or change of caregiver|2
7331734|NCT00814801|11565423|FG002|Overall Study|Missing or change of caregiver|4
7331735|NCT00814801|11565421|FG000|Overall Study|Non-compliance|0
7331736|NCT00814801|11565422|FG001|Overall Study|Non-compliance|1
7331737|NCT00814801|11565423|FG002|Overall Study|Non-compliance|1
7331738|NCT00814801|11565421|FG000|Overall Study|Other|2
7331739|NCT00814801|11565422|FG001|Overall Study|Other|6
7331740|NCT00814801|11565423|FG002|Overall Study|Other|4
7331741|NCT00814879|11565433|FG000|By Week 24|Cancer Diagnosis|1
7331742|NCT00814879|11565434|FG001|By Week 24|Cancer Diagnosis|0
7331743|NCT00814879|11565433|FG000|By Week 24|Incarceration|0
7331744|NCT00814879|11565434|FG001|By Week 24|Incarceration|1
7331745|NCT00814879|11565433|FG000|By Week 48|Lost to Follow-up|2
7331746|NCT00814879|11565434|FG001|By Week 48|Lost to Follow-up|2
7331747|NCT00814879|11565433|FG000|By Week 48|Death|0
7331748|NCT00814879|11565434|FG001|By Week 48|Death|1
7331749|NCT00815191|11565471|FG000|Overall Study|Protocol Violation|1
7331750|NCT00815191|11565472|FG001|Overall Study|Protocol Violation|1
7331751|NCT00815295|11565481|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
7568407|NCT03404674|11943264|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
7568408|NCT03404674|11943265|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
7568409|NCT03404674|11943266|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
7568410|NCT03404674|11943267|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
7568411|NCT03404843|11943284|FG000|Overall Study|Study difficulties unrelated to Tx|4
7568412|NCT03404843|11943285|FG001|Overall Study|Study difficulties unrelated to Tx|1
7568413|NCT03405818|11943313|FG000|Overall Study|Withdrawal by Subject|4
7568414|NCT03405818|11943313|FG000|Overall Study|Lost to Follow-up|4
7568415|NCT03405935|11943317|FG000|Overall Study|Adverse Event|3
7568416|NCT03405935|11943317|FG000|Overall Study|Death|2
7568417|NCT03405935|11943317|FG000|Overall Study|Withdrawal by Subject|1
7568418|NCT03405935|11943317|FG000|Overall Study|Lost to Follow-up|2
7568419|NCT03406260|11943327|FG000|Period 1|Adverse Event|0
7568420|NCT03406260|11943328|FG001|Period 1|Adverse Event|0
7568421|NCT03406260|11943329|FG002|Period 1|Adverse Event|0
7568422|NCT03406260|11943330|FG003|Period 1|Adverse Event|0
7568423|NCT03406260|11943331|FG004|Period 1|Adverse Event|1
7568424|NCT03406260|11943332|FG005|Period 1|Adverse Event|0
7568425|NCT03406962|11943398|FG000|Overall Study|Death|2
7568426|NCT03406962|11943398|FG000|Overall Study|Adverse Event|1
7568427|NCT03407118|11943412|FG000|Period 2|Withdrawal by Subject|1
7568428|NCT03407118|11943413|FG001|Period 2|Withdrawal by Subject|0
7568429|NCT03407170|11943419|FG000|Overall Study|Adverse Event|1
7568430|NCT03407430|11943429|FG000|Washout|Protocol Violation|1
7568431|NCT03407430|11943430|FG001|Washout|Protocol Violation|0
7568432|NCT03407482|11943443|FG000|Overall Study|Adverse Event|12
7568433|NCT03407482|11943443|FG000|Overall Study|Disease Relapse|1
7568434|NCT03407482|11943443|FG000|Overall Study|Lost to Follow-up|1
7568435|NCT03407482|11943443|FG000|Overall Study|Non-Compliance With Study Drug|1
7568436|NCT03407482|11943443|FG000|Overall Study|Pregnancy|2
7331752|NCT00815295|11565482|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
7331753|NCT00815295|11565483|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
7331754|NCT00815308|11565491|FG000|Overall Study|Adverse Event|4
7331755|NCT00815308|11565491|FG000|Overall Study|Withdrawal by Subject|0
7331756|NCT00815308|11565491|FG000|Overall Study|Protocol Violation|6
7331757|NCT00815516|11565521|FG000|Overall Study|Death|3
7331758|NCT00815516|11565522|FG001|Overall Study|Death|1
7331759|NCT00815516|11565521|FG000|Overall Study|Physician Decision|1
7331760|NCT00815516|11565522|FG001|Overall Study|Physician Decision|0
7331761|NCT00815659|11565528|FG000|Overall Study|Adverse Event|9
7331762|NCT00815659|11565528|FG000|Overall Study|Withdrawal by Subject|9
7331763|NCT00815659|11565528|FG000|Overall Study|Lost to Follow-up|4
7331764|NCT00815659|11565528|FG000|Overall Study|Protocol Violation|1
7331765|NCT00815919|11565561|FG000|Overall Study|Unrelated Fungal Infection|1
7331766|NCT00815919|11565561|FG000|Overall Study|AML Relapse|1
7331767|NCT00815919|11565561|FG000|Overall Study|Lack of Efficacy|2
7331768|NCT00816023|11565580|FG000|Overall Study|Lost to Follow-up|1
7331769|NCT00816023|11565581|FG001|Overall Study|Lost to Follow-up|1
7331770|NCT00816023|11565582|FG002|Overall Study|Lost to Follow-up|0
7331771|NCT00816023|11565583|FG003|Overall Study|Lost to Follow-up|0
7331772|NCT00816023|11565580|FG000|Overall Study|Withdrawal by Subject|1
7331773|NCT00816023|11565581|FG001|Overall Study|Withdrawal by Subject|0
7331774|NCT00816023|11565582|FG002|Overall Study|Withdrawal by Subject|0
7331775|NCT00816023|11565583|FG003|Overall Study|Withdrawal by Subject|0
7331776|NCT00816023|11565580|FG000|Overall Study|Physician Decision|0
7331777|NCT00816023|11565581|FG001|Overall Study|Physician Decision|0
7331778|NCT00816023|11565582|FG002|Overall Study|Physician Decision|1
7331779|NCT00816023|11565583|FG003|Overall Study|Physician Decision|0
7331780|NCT00816023|11565580|FG000|Overall Study|assessments complete prior to window|1
7331781|NCT00816023|11565581|FG001|Overall Study|assessments complete prior to window|1
7331782|NCT00816023|11565582|FG002|Overall Study|assessments complete prior to window|2
7331783|NCT00816023|11565583|FG003|Overall Study|assessments complete prior to window|1
7331784|NCT00816023|11565580|FG000|Overall Study|Randomized Not Treated|6
7331785|NCT00816023|11565581|FG001|Overall Study|Randomized Not Treated|4
7331786|NCT00816023|11565582|FG002|Overall Study|Randomized Not Treated|6
7331787|NCT00816023|11565583|FG003|Overall Study|Randomized Not Treated|11
7331788|NCT00816036|11565595|FG000|Overall Study|Death|47
7331789|NCT00816036|11565596|FG001|Overall Study|Death|28
7331790|NCT00816036|11565595|FG000|Overall Study|Lost to Follow-up|75
7568437|NCT03407482|11943443|FG000|Overall Study|Protocol Violation|1
7568438|NCT03407482|11943443|FG000|Overall Study|Study Terminated By Sponsor|106
7568439|NCT03407482|11943443|FG000|Overall Study|Withdrawal by Subject|6
7568440|NCT03407482|11943443|FG000|Overall Study|Data Entry Error|1
7568441|NCT03408483|11943503|FG000|Overall Study|Physician Decision|3
7568442|NCT03408483|11943504|FG001|Overall Study|Physician Decision|3
7568443|NCT03408483|11943503|FG000|Overall Study|Lost to Follow-up|3
7568444|NCT03408483|11943504|FG001|Overall Study|Lost to Follow-up|0
7568445|NCT03408639|11943512|FG000|Overall Study|Death|5
7568446|NCT03408639|11943513|FG001|Overall Study|Death|5
7568447|NCT03408639|11943512|FG000|Overall Study|Lost to Follow-up|1
7568448|NCT03408639|11943513|FG001|Overall Study|Lost to Follow-up|4
7568449|NCT03408639|11943512|FG000|Overall Study|Withdrawal by Subject|2
7568450|NCT03408639|11943513|FG001|Overall Study|Withdrawal by Subject|7
7568451|NCT03408639|11943512|FG000|Overall Study|Physician Decision|3
7568452|NCT03408639|11943513|FG001|Overall Study|Physician Decision|6
7568453|NCT03409107|11943551|FG000|Overall Study|Withdrawal by Subject|4
7568454|NCT03409107|11943552|FG001|Overall Study|Withdrawal by Subject|2
7568455|NCT03409107|11943551|FG000|Overall Study|Physician Decision|1
7568456|NCT03409107|11943552|FG001|Overall Study|Physician Decision|0
7568457|NCT03409107|11943551|FG000|Overall Study|Lost to Follow-up|7
7568458|NCT03409107|11943552|FG001|Overall Study|Lost to Follow-up|2
7568459|NCT03409107|11943551|FG000|Overall Study|Adverse Event|5
7568460|NCT03409107|11943552|FG001|Overall Study|Adverse Event|3
7568461|NCT03410056|11943562|FG000|Overall Study|Decision by Sponsor|0
7568462|NCT03410056|11943563|FG001|Overall Study|Decision by Sponsor|0
7568463|NCT03410056|11943564|FG002|Overall Study|Decision by Sponsor|3
7568464|NCT03410056|11943565|FG003|Overall Study|Decision by Sponsor|0
7568465|NCT03410056|11943566|FG004|Overall Study|Decision by Sponsor|0
7568466|NCT03410056|11943567|FG005|Overall Study|Decision by Sponsor|0
7568467|NCT03410056|11943568|FG006|Overall Study|Decision by Sponsor|0
7568468|NCT03410056|11943562|FG000|Overall Study|Withdrawal by Subject|0
7568469|NCT03410056|11943563|FG001|Overall Study|Withdrawal by Subject|2
7457752|NCT01802320|11751512|FG000|Overall Study|Death|1
7331791|NCT00816036|11565596|FG001|Overall Study|Lost to Follow-up|57
7331792|NCT00816036|11565595|FG000|Overall Study|Withdrawal by Subject|54
7331793|NCT00816036|11565596|FG001|Overall Study|Withdrawal by Subject|23
7331794|NCT00816166|11565622|FG000|Overall Study|Lost to Follow-up|6
7331795|NCT00816166|11565623|FG001|Overall Study|Lost to Follow-up|10
7331796|NCT00816166|11565622|FG000|Overall Study|Death|4
7331797|NCT00816166|11565623|FG001|Overall Study|Death|2
7331798|NCT00816361|11565640|FG000|Overall Study|Withdrawal by Subject|0
7331799|NCT00816361|11565641|FG001|Overall Study|Withdrawal by Subject|0
7331800|NCT00816361|11565642|FG002|Overall Study|Withdrawal by Subject|0
7331801|NCT00816361|11565643|FG003|Overall Study|Withdrawal by Subject|0
7331802|NCT00816361|11565644|FG004|Overall Study|Withdrawal by Subject|1
7331803|NCT00816361|11565645|FG005|Overall Study|Withdrawal by Subject|2
7331804|NCT00816361|11565646|FG006|Overall Study|Withdrawal by Subject|0
7331805|NCT00816361|11565647|FG007|Overall Study|Withdrawal by Subject|2
7331806|NCT00816361|11565648|FG008|Overall Study|Withdrawal by Subject|1
7568470|NCT03410056|11943564|FG002|Overall Study|Withdrawal by Subject|5
7568471|NCT03410056|11943565|FG003|Overall Study|Withdrawal by Subject|5
7568472|NCT03410056|11943566|FG004|Overall Study|Withdrawal by Subject|0
7568473|NCT03410056|11943567|FG005|Overall Study|Withdrawal by Subject|0
7568474|NCT03410056|11943568|FG006|Overall Study|Withdrawal by Subject|0
7568475|NCT03411902|11943612|FG000|Overall Study|Lost to Follow-up|3
7568476|NCT03411902|11943613|FG001|Overall Study|Lost to Follow-up|0
7568477|NCT03412019|11943621|FG000|Overall Study|Withdrawal by Subject|1
7568478|NCT03412019|11943622|FG001|Overall Study|Withdrawal by Subject|1
7568479|NCT03412084|11943630|FG000|Overall Study|Withdrawal by Subject|2
7568480|NCT03412084|11943631|FG001|Overall Study|Withdrawal by Subject|0
7568481|NCT03412084|11943630|FG000|Overall Study|Participant moved|1
7568482|NCT03412084|11943631|FG001|Overall Study|Participant moved|0
7568483|NCT03412084|11943630|FG000|Overall Study|Lost to Follow-up|1
7568484|NCT03412084|11943631|FG001|Overall Study|Lost to Follow-up|1
7568485|NCT03412734|11943639|FG000|Overall Study|Incorrect labeling of samples|2
7568486|NCT03412734|11943640|FG001|Overall Study|Incorrect labeling of samples|0
7568487|NCT03412734|11943639|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
7568488|NCT03412734|11943640|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
7568489|NCT03412929|11943646|FG000|Overall Study|Protocol Violation|3
7331807|NCT00816361|11565640|FG000|Overall Study|Death|4
7331808|NCT00816361|11565641|FG001|Overall Study|Death|3
7331809|NCT00816361|11565642|FG002|Overall Study|Death|3
7331810|NCT00816361|11565643|FG003|Overall Study|Death|3
7331811|NCT00816361|11565644|FG004|Overall Study|Death|1
7331812|NCT00816361|11565645|FG005|Overall Study|Death|1
7331813|NCT00816361|11565646|FG006|Overall Study|Death|3
7331814|NCT00816361|11565647|FG007|Overall Study|Death|7
7331815|NCT00816361|11565648|FG008|Overall Study|Death|8
7331816|NCT00816361|11565640|FG000|Overall Study|Other|0
7331817|NCT00816361|11565641|FG001|Overall Study|Other|0
7331818|NCT00816361|11565642|FG002|Overall Study|Other|0
7331819|NCT00816361|11565643|FG003|Overall Study|Other|0
7331820|NCT00816361|11565644|FG004|Overall Study|Other|0
7331821|NCT00816361|11565645|FG005|Overall Study|Other|0
7331822|NCT00816361|11565646|FG006|Overall Study|Other|0
7331823|NCT00816361|11565647|FG007|Overall Study|Other|0
7331824|NCT00816361|11565648|FG008|Overall Study|Other|1
7331825|NCT00816400|11565678|FG000|Overall Study|Death|2
7331826|NCT00816400|11565679|FG001|Overall Study|Death|3
7331827|NCT00816400|11565680|FG002|Overall Study|Death|3
7331828|NCT00816400|11565681|FG003|Overall Study|Death|3
7331829|NCT00816400|11565682|FG004|Overall Study|Death|2
7331830|NCT00816400|11565683|FG005|Overall Study|Death|3
7331831|NCT00816400|11565684|FG006|Overall Study|Death|2
7331832|NCT00816400|11565685|FG007|Overall Study|Death|5
7331833|NCT00816400|11565686|FG008|Overall Study|Death|6
7331834|NCT00816400|11565678|FG000|Overall Study|In hospice care at the end of the study|0
7331835|NCT00816400|11565679|FG001|Overall Study|In hospice care at the end of the study|0
7331836|NCT00816400|11565680|FG002|Overall Study|In hospice care at the end of the study|2
7331837|NCT00816400|11565681|FG003|Overall Study|In hospice care at the end of the study|0
7331838|NCT00816400|11565682|FG004|Overall Study|In hospice care at the end of the study|0
7331839|NCT00816400|11565683|FG005|Overall Study|In hospice care at the end of the study|0
7331840|NCT00816400|11565684|FG006|Overall Study|In hospice care at the end of the study|0
7331841|NCT00816400|11565685|FG007|Overall Study|In hospice care at the end of the study|0
7331842|NCT00816400|11565686|FG008|Overall Study|In hospice care at the end of the study|0
7331843|NCT00816556|11565710|FG000|Overall Study|Adverse Event|1
7331844|NCT00816556|11565711|FG001|Overall Study|Adverse Event|1
7331845|NCT00816556|11565712|FG002|Overall Study|Adverse Event|1
7331846|NCT00816556|11565710|FG000|Overall Study|Withdrawal by Subject|1
7331847|NCT00816556|11565711|FG001|Overall Study|Withdrawal by Subject|1
7331848|NCT00816556|11565712|FG002|Overall Study|Withdrawal by Subject|1
7331849|NCT00816556|11565710|FG000|Overall Study|Lost to Follow-up|0
7331850|NCT00816556|11565711|FG001|Overall Study|Lost to Follow-up|0
7331851|NCT00816556|11565712|FG002|Overall Study|Lost to Follow-up|1
7331852|NCT00816595|11565722|FG000|Overall Study|Withdrawal by Subject|2
7331853|NCT00816595|11565723|FG001|Overall Study|Withdrawal by Subject|0
7331854|NCT00817063|11565762|FG000|Overall Study|Adverse Event|32
7331855|NCT00817063|11565763|FG001|Overall Study|Adverse Event|13
7331856|NCT00817063|11565762|FG000|Overall Study|Death|1
7331857|NCT00817063|11565763|FG001|Overall Study|Death|1
7331858|NCT00817063|11565762|FG000|Overall Study|Lack of Efficacy|33
7331859|NCT00817063|11565763|FG001|Overall Study|Lack of Efficacy|86
7331860|NCT00817063|11565762|FG000|Overall Study|Failure to Return|13
7331861|NCT00817063|11565763|FG001|Overall Study|Failure to Return|12
7331862|NCT00817063|11565762|FG000|Overall Study|Violation of Selection at Entry|7
7331863|NCT00817063|11565763|FG001|Overall Study|Violation of Selection at Entry|4
7331864|NCT00817063|11565762|FG000|Overall Study|Protocol Violation|3
7331865|NCT00817063|11565763|FG001|Overall Study|Protocol Violation|8
7331866|NCT00817063|11565762|FG000|Overall Study|Withdrawal by Subject|17
7331867|NCT00817063|11565763|FG001|Overall Study|Withdrawal by Subject|37
7331868|NCT00817063|11565762|FG000|Overall Study|Early Improvement|19
7331869|NCT00817063|11565763|FG001|Overall Study|Early Improvement|4
7331870|NCT00817063|11565762|FG000|Overall Study|Administrative|10
7331871|NCT00817063|11565763|FG001|Overall Study|Administrative|4
7331872|NCT00817063|11565762|FG000|Overall Study|Abnormality of Laboratory Test|2
7331873|NCT00817063|11565763|FG001|Overall Study|Abnormality of Laboratory Test|1
7331874|NCT00817089|11565773|FG000|First Alcohol Challenge|Lost to Follow-up|0
7331875|NCT00817089|11565774|FG001|First Alcohol Challenge|Lost to Follow-up|0
7331876|NCT00817089|11565775|FG002|First Alcohol Challenge|Lost to Follow-up|0
7331877|NCT00817089|11565776|FG003|First Alcohol Challenge|Lost to Follow-up|1
7331878|NCT00817089|11565773|FG000|Second Alcohol Challenge|Lost to Follow-up|0
7331879|NCT00817089|11565774|FG001|Second Alcohol Challenge|Lost to Follow-up|1
7331880|NCT00817089|11565775|FG002|Second Alcohol Challenge|Lost to Follow-up|0
7331881|NCT00817089|11565776|FG003|Second Alcohol Challenge|Lost to Follow-up|0
7331882|NCT00817206|11565792|FG000|Overall Study|Adverse Event|10
7331883|NCT00817206|11565793|FG001|Overall Study|Adverse Event|3
7331884|NCT00817206|11565792|FG000|Overall Study|Protocol Violation|0
7331885|NCT00817206|11565793|FG001|Overall Study|Protocol Violation|2
7331886|NCT00817206|11565792|FG000|Overall Study|Lost to Follow-up|0
7331887|NCT00817206|11565793|FG001|Overall Study|Lost to Follow-up|1
7331888|NCT00817206|11565792|FG000|Overall Study|Death|2
7331889|NCT00817206|11565793|FG001|Overall Study|Death|0
7331890|NCT00817206|11565792|FG000|Overall Study|Withdrawal by Subject|7
7331891|NCT00817206|11565793|FG001|Overall Study|Withdrawal by Subject|3
7331892|NCT00817206|11565792|FG000|Overall Study|Physician Decision|2
7331893|NCT00817206|11565793|FG001|Overall Study|Physician Decision|0
7331894|NCT00817336|11565805|FG000|Overall Study|Withdrawal by Subject|1
7331895|NCT00817336|11565806|FG001|Overall Study|Withdrawal by Subject|1
7331896|NCT00817414|11565816|FG000|Overall Study|Adverse Event|1
7331897|NCT00817414|11565817|FG001|Overall Study|Adverse Event|1
7331898|NCT00817414|11565818|FG002|Overall Study|Adverse Event|1
7331899|NCT00817414|11565819|FG003|Overall Study|Adverse Event|0
7331900|NCT00817414|11565820|FG004|Overall Study|Adverse Event|0
7331901|NCT00817414|11565816|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7331902|NCT00817414|11565817|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
7331903|NCT00817414|11565818|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
7331904|NCT00817414|11565819|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
7331905|NCT00817414|11565820|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
7331906|NCT00817414|11565816|FG000|Overall Study|Withdrawal by Subject|1
7331907|NCT00817414|11565817|FG001|Overall Study|Withdrawal by Subject|1
7331908|NCT00817414|11565818|FG002|Overall Study|Withdrawal by Subject|0
7331909|NCT00817414|11565819|FG003|Overall Study|Withdrawal by Subject|0
7331910|NCT00817414|11565820|FG004|Overall Study|Withdrawal by Subject|0
7331911|NCT00817414|11565816|FG000|Overall Study|Lost to Follow-up|0
7331912|NCT00817414|11565817|FG001|Overall Study|Lost to Follow-up|0
7331913|NCT00817414|11565818|FG002|Overall Study|Lost to Follow-up|1
7331914|NCT00817414|11565819|FG003|Overall Study|Lost to Follow-up|1
7331915|NCT00817414|11565820|FG004|Overall Study|Lost to Follow-up|1
7331916|NCT00817414|11565816|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7331917|NCT00817414|11565817|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7331918|NCT00817414|11565818|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7331919|NCT00817414|11565819|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
7331920|NCT00817414|11565820|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
7331921|NCT00817414|11565816|FG000|Overall Study|Protocol Violation|0
7331922|NCT00817414|11565817|FG001|Overall Study|Protocol Violation|0
7331923|NCT00817414|11565818|FG002|Overall Study|Protocol Violation|0
7331924|NCT00817414|11565819|FG003|Overall Study|Protocol Violation|0
7331925|NCT00817414|11565820|FG004|Overall Study|Protocol Violation|1
7331926|NCT00817479|11565839|FG000|Overall Study|Physician Decision|1
7331927|NCT00817479|11565840|FG001|Overall Study|Physician Decision|1
7331928|NCT00817531|11565846|FG000|Overall Study|Adverse Event|1
7331929|NCT00817531|11565846|FG000|Overall Study|Lack of Efficacy|1
7331930|NCT00817635|11565859|FG000|Overall Study|Adverse Event|1
7331931|NCT00817635|11565860|FG001|Overall Study|Adverse Event|0
7331932|NCT00817635|11565861|FG002|Overall Study|Adverse Event|0
7331933|NCT00817635|11565862|FG003|Overall Study|Adverse Event|1
7331934|NCT00817635|11565863|FG004|Overall Study|Adverse Event|1
7331935|NCT00817635|11565859|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7331936|NCT00817635|11565860|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7331937|NCT00817635|11565861|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7331938|NCT00817635|11565862|FG003|Overall Study|Abnormal Laboratory Value(s)|0
7331939|NCT00817635|11565863|FG004|Overall Study|Abnormal Laboratory Value(s)|1
7331940|NCT00817635|11565859|FG000|Overall Study|Withdrawal by Subject|2
7331941|NCT00817635|11565860|FG001|Overall Study|Withdrawal by Subject|1
7331942|NCT00817635|11565861|FG002|Overall Study|Withdrawal by Subject|0
7331943|NCT00817635|11565862|FG003|Overall Study|Withdrawal by Subject|1
7331944|NCT00817635|11565863|FG004|Overall Study|Withdrawal by Subject|2
7331945|NCT00817635|11565859|FG000|Overall Study|Lost to Follow-up|0
7331946|NCT00817635|11565860|FG001|Overall Study|Lost to Follow-up|1
7331947|NCT00817635|11565861|FG002|Overall Study|Lost to Follow-up|0
7331948|NCT00817635|11565862|FG003|Overall Study|Lost to Follow-up|1
7331949|NCT00817635|11565863|FG004|Overall Study|Lost to Follow-up|0
7331950|NCT00817635|11565859|FG000|Overall Study|Administrative Problems|0
7331951|NCT00817635|11565860|FG001|Overall Study|Administrative Problems|0
7331952|NCT00817635|11565861|FG002|Overall Study|Administrative Problems|0
7331953|NCT00817635|11565862|FG003|Overall Study|Administrative Problems|0
7331954|NCT00817635|11565863|FG004|Overall Study|Administrative Problems|1
7331955|NCT00817635|11565859|FG000|Overall Study|Protocol Violation|5
7331956|NCT00817635|11565860|FG001|Overall Study|Protocol Violation|1
7331957|NCT00817635|11565861|FG002|Overall Study|Protocol Violation|3
7331958|NCT00817635|11565862|FG003|Overall Study|Protocol Violation|2
7331959|NCT00817635|11565863|FG004|Overall Study|Protocol Violation|3
7331960|NCT00817778|11565884|FG000|Overall Study|Adverse Event|1
7331961|NCT00817778|11565885|FG001|Overall Study|Adverse Event|0
7331962|NCT00817778|11565884|FG000|Overall Study|Withdrawal by Subject|1
7331963|NCT00817778|11565885|FG001|Overall Study|Withdrawal by Subject|1
7331964|NCT00817778|11565884|FG000|Overall Study|Protocol Violation|0
7331965|NCT00817778|11565885|FG001|Overall Study|Protocol Violation|1
7331966|NCT00817778|11565884|FG000|Overall Study|Study-specific discontinuation criteria|0
7331967|NCT00817778|11565885|FG001|Overall Study|Study-specific discontinuation criteria|1
7331968|NCT00817778|11565884|FG000|Overall Study|Poor venous access|1
7331969|NCT00817778|11565885|FG001|Overall Study|Poor venous access|0
7385190|NCT01199289|11642766|FG001|Overall Study|Pregnancy|1
7385191|NCT01199289|11642767|FG002|Overall Study|Pregnancy|0
7385192|NCT01199289|11642768|FG003|Overall Study|Pregnancy|1
7385193|NCT01199471|11642781|FG000|Overall Study|Protocol Violation|4
7331970|NCT00818168|11565921|FG000|Overall Study|Lack of Efficacy|18
7331971|NCT00818168|11565921|FG000|Overall Study|Pregnancy|2
7331972|NCT00818168|11565921|FG000|Overall Study|Withdrawal by Subject|16
7331973|NCT00818168|11565921|FG000|Overall Study|Lost to Follow-up|7
7331974|NCT00818168|11565921|FG000|Overall Study|Adverse Event|19
7331975|NCT00818168|11565921|FG000|Overall Study|Reason for Non-completion Not reported|6
7331976|NCT00818168|11565921|FG000|Overall Study|Participant Moved|2
7331977|NCT00818207|11565927|FG000|Overall Study|Adverse Event|6
7331978|NCT00818207|11565928|FG001|Overall Study|Adverse Event|0
7331979|NCT00818207|11565927|FG000|Overall Study|Lost to Follow-up|160
7331980|NCT00818207|11565928|FG001|Overall Study|Lost to Follow-up|146
7331981|NCT00818207|11565927|FG000|Overall Study|Multiple reasons|11
7331982|NCT00818207|11565928|FG001|Overall Study|Multiple reasons|12
7331983|NCT00818207|11565927|FG000|Overall Study|Withdrawal by Subject|42
7331984|NCT00818207|11565928|FG001|Overall Study|Withdrawal by Subject|104
7331985|NCT00818207|11565927|FG000|Overall Study|Death|3
7331986|NCT00818207|11565928|FG001|Overall Study|Death|5
7331987|NCT00818246|11565934|FG000|Overall Study|Impossible to match pictures|5
7331988|NCT00818259|11565945|FG000|Part I|Withdrawal by Subject|1
7331989|NCT00818259|11565946|FG001|Part I|Withdrawal by Subject|0
7331990|NCT00818259|11565947|FG002|Part I|Withdrawal by Subject|0
7331991|NCT00818259|11565948|FG003|Part I|Withdrawal by Subject|0
7331992|NCT00818259|11565949|FG004|Part I|Withdrawal by Subject|0
7331993|NCT00818259|11565950|FG005|Part I|Withdrawal by Subject|0
7331994|NCT00818259|11565951|FG006|Part I|Withdrawal by Subject|0
7331995|NCT00818259|11565952|FG007|Part I|Withdrawal by Subject|0
7331996|NCT00818259|11565953|FG008|Part I|Withdrawal by Subject|0
7331997|NCT00818259|11565945|FG000|Part II|Physician Decision|0
7331998|NCT00818259|11565946|FG001|Part II|Physician Decision|0
7331999|NCT00818259|11565947|FG002|Part II|Physician Decision|1
7457753|NCT01802320|11751512|FG000|Overall Study|Withdrawal by Subject|1
7457754|NCT01802333|11751519|FG000|Overall Study|Ineligible|2
7457755|NCT01802333|11751520|FG001|Overall Study|Ineligible|6
7457756|NCT01802333|11751521|FG002|Overall Study|Ineligible|8
7457757|NCT01802333|11751519|FG000|Overall Study|Adverse Event|1
7457758|NCT01802333|11751520|FG001|Overall Study|Adverse Event|8
7457759|NCT01802333|11751521|FG002|Overall Study|Adverse Event|8
7457760|NCT01802333|11751519|FG000|Overall Study|Withdrawal by Subject|6
7457761|NCT01802333|11751520|FG001|Overall Study|Withdrawal by Subject|6
7457762|NCT01802333|11751521|FG002|Overall Study|Withdrawal by Subject|5
7457763|NCT01802333|11751519|FG000|Overall Study|Progression/relapse|1
7457764|NCT01802333|11751520|FG001|Overall Study|Progression/relapse|3
7457765|NCT01802333|11751521|FG002|Overall Study|Progression/relapse|0
7457766|NCT01802333|11751519|FG000|Overall Study|Death|7
7457767|NCT01802333|11751520|FG001|Overall Study|Death|14
7457768|NCT01802333|11751521|FG002|Overall Study|Death|13
7457769|NCT01802333|11751519|FG000|Overall Study|Other - not protocol specified|32
7457770|NCT01802333|11751520|FG001|Overall Study|Other - not protocol specified|22
7457771|NCT01802333|11751521|FG002|Overall Study|Other - not protocol specified|24
7457772|NCT01802333|11751519|FG000|Overall Study|Did not start treatment|0
7457773|NCT01802333|11751520|FG001|Overall Study|Did not start treatment|2
7457774|NCT01802333|11751521|FG002|Overall Study|Did not start treatment|5
7457775|NCT01802385|11751537|FG000|Overall Study|Death|106
7457776|NCT01802385|11751538|FG001|Overall Study|Death|120
7457777|NCT01802411|11751546|FG000|Overall Study|Death|2
7457778|NCT01802411|11751547|FG001|Overall Study|Death|1
7457779|NCT01802411|11751546|FG000|Overall Study|Adverse Event|2
7457780|NCT01802411|11751547|FG001|Overall Study|Adverse Event|7
7457781|NCT01802411|11751546|FG000|Overall Study|Lack of Efficacy|8
7457782|NCT01802411|11751547|FG001|Overall Study|Lack of Efficacy|10
7457783|NCT01802411|11751546|FG000|Overall Study|Withdrawal by Subject|0
7457784|NCT01802411|11751547|FG001|Overall Study|Withdrawal by Subject|2
7457785|NCT01802411|11751546|FG000|Overall Study|Planned pleurodesis as part of the proc|1
7457786|NCT01802411|11751547|FG001|Overall Study|Planned pleurodesis as part of the proc|0
7457787|NCT01802411|11751546|FG000|Overall Study|Surgery aborted after bronchoscopy|1
7457788|NCT01802411|11751547|FG001|Overall Study|Surgery aborted after bronchoscopy|0
7457789|NCT01802411|11751546|FG000|Overall Study|Proc changed to video-asst thorascopic|0
7457790|NCT01802411|11751547|FG001|Overall Study|Proc changed to video-asst thorascopic|1
7457791|NCT01802437|11751555|FG000|Overall Study|Lost to Follow-up|1
7457792|NCT01802437|11751556|FG001|Overall Study|Lost to Follow-up|0
7457793|NCT01802437|11751555|FG000|Overall Study|Withdrawal by Subject|3
7457794|NCT01802437|11751556|FG001|Overall Study|Withdrawal by Subject|4
7457795|NCT01802515|11751565|FG000|Overall Study|Withdrawal by Subject|3
7457796|NCT01802515|11751566|FG001|Overall Study|Withdrawal by Subject|0
7457797|NCT01802515|11751567|FG002|Overall Study|Withdrawal by Subject|0
7457798|NCT01802580|11751586|FG000|Overall Study|Physician Decision|1
7457799|NCT01802580|11751587|FG001|Overall Study|Physician Decision|0
7457800|NCT01802580|11751586|FG000|Overall Study|Protocol Violation|2
7457801|NCT01802580|11751587|FG001|Overall Study|Protocol Violation|0
7457802|NCT01802580|11751586|FG000|Overall Study|Withdrawal by Subject|5
7457803|NCT01802580|11751587|FG001|Overall Study|Withdrawal by Subject|6
7457804|NCT01802580|11751586|FG000|Overall Study|Other|1
7457805|NCT01802580|11751587|FG001|Overall Study|Other|3
7332000|NCT00818259|11565948|FG003|Part II|Physician Decision|0
7332001|NCT00818259|11565949|FG004|Part II|Physician Decision|0
7332002|NCT00818259|11565950|FG005|Part II|Physician Decision|0
7332003|NCT00818259|11565951|FG006|Part II|Physician Decision|0
7332004|NCT00818259|11565952|FG007|Part II|Physician Decision|0
7332005|NCT00818259|11565953|FG008|Part II|Physician Decision|0
7332006|NCT00818259|11565945|FG000|Part II|Lack of Efficacy|0
7332007|NCT00818259|11565946|FG001|Part II|Lack of Efficacy|0
7332008|NCT00818259|11565947|FG002|Part II|Lack of Efficacy|0
7332009|NCT00818259|11565948|FG003|Part II|Lack of Efficacy|1
7332010|NCT00818259|11565949|FG004|Part II|Lack of Efficacy|0
7332011|NCT00818259|11565950|FG005|Part II|Lack of Efficacy|0
7332012|NCT00818259|11565951|FG006|Part II|Lack of Efficacy|0
7332013|NCT00818259|11565952|FG007|Part II|Lack of Efficacy|0
7332014|NCT00818259|11565953|FG008|Part II|Lack of Efficacy|0
7332015|NCT00818259|11565945|FG000|Part II|Not Treated|0
7332016|NCT00818259|11565946|FG001|Part II|Not Treated|0
7332017|NCT00818259|11565947|FG002|Part II|Not Treated|0
7332018|NCT00818259|11565948|FG003|Part II|Not Treated|1
7332019|NCT00818259|11565949|FG004|Part II|Not Treated|0
7332020|NCT00818259|11565950|FG005|Part II|Not Treated|0
7332021|NCT00818259|11565951|FG006|Part II|Not Treated|0
7332022|NCT00818259|11565952|FG007|Part II|Not Treated|0
7332023|NCT00818259|11565953|FG008|Part II|Not Treated|0
7332024|NCT00818259|11565945|FG000|Part IV|Physician Decision|0
7332025|NCT00818259|11565946|FG001|Part IV|Physician Decision|0
7332026|NCT00818259|11565947|FG002|Part IV|Physician Decision|0
7332027|NCT00818259|11565948|FG003|Part IV|Physician Decision|0
7332028|NCT00818259|11565949|FG004|Part IV|Physician Decision|0
7332029|NCT00818259|11565950|FG005|Part IV|Physician Decision|1
7332030|NCT00818259|11565951|FG006|Part IV|Physician Decision|0
7332031|NCT00818259|11565952|FG007|Part IV|Physician Decision|0
7332032|NCT00818259|11565953|FG008|Part IV|Physician Decision|0
7332033|NCT00818259|11565945|FG000|Part V|Adverse Event|0
7332034|NCT00818259|11565946|FG001|Part V|Adverse Event|0
7332035|NCT00818259|11565947|FG002|Part V|Adverse Event|0
7332036|NCT00818259|11565948|FG003|Part V|Adverse Event|0
7332037|NCT00818259|11565949|FG004|Part V|Adverse Event|0
7332038|NCT00818259|11565950|FG005|Part V|Adverse Event|0
7332039|NCT00818259|11565951|FG006|Part V|Adverse Event|0
7332040|NCT00818259|11565952|FG007|Part V|Adverse Event|1
7332041|NCT00818259|11565953|FG008|Part V|Adverse Event|0
7332042|NCT00818389|11565993|FG000|Overall Study|Death|1
7332043|NCT00818389|11565994|FG001|Overall Study|Death|3
7332044|NCT00818389|11565993|FG000|Overall Study|ALS Disease Progression|1
7332045|NCT00818389|11565994|FG001|Overall Study|ALS Disease Progression|0
7332046|NCT00818389|11565993|FG000|Overall Study|Withdrawal by Subject|2
7332047|NCT00818389|11565994|FG001|Overall Study|Withdrawal by Subject|2
7332048|NCT00818389|11565993|FG000|Overall Study|Adverse Event|0
7332049|NCT00818389|11565994|FG001|Overall Study|Adverse Event|1
7332050|NCT00818441|11566002|FG000|Overall Study|Death|69
7332051|NCT00818441|11566003|FG001|Overall Study|Death|26
7332052|NCT00818441|11566002|FG000|Overall Study|Other|5
7332053|NCT00818441|11566003|FG001|Overall Study|Other|0
7332054|NCT00818441|11566002|FG000|Overall Study|Lost to Follow-up|2
7332055|NCT00818441|11566003|FG001|Overall Study|Lost to Follow-up|1
7332056|NCT00818441|11566002|FG000|Overall Study|Withdrawal by Subject|2
7332057|NCT00818441|11566003|FG001|Overall Study|Withdrawal by Subject|0
7332058|NCT00818441|11566002|FG000|Overall Study|Adverse Event|0
7332059|NCT00818441|11566003|FG001|Overall Study|Adverse Event|1
7332060|NCT00818441|11566002|FG000|Overall Study|Study terminated by sponsor|11
7332061|NCT00818441|11566003|FG001|Overall Study|Study terminated by sponsor|2
7332062|NCT00818454|11566010|FG000|Treatment Period 1|Adverse Event|0
7332063|NCT00818454|11566011|FG001|Treatment Period 1|Adverse Event|1
7332064|NCT00818454|11566012|FG002|Treatment Period 1|Adverse Event|0
7332065|NCT00818454|11566013|FG003|Treatment Period 1|Adverse Event|0
7332066|NCT00818454|11566010|FG000|Treatment Period 1|Other|3
7332067|NCT00818454|11566011|FG001|Treatment Period 1|Other|0
7332068|NCT00818454|11566012|FG002|Treatment Period 1|Other|0
7332069|NCT00818454|11566013|FG003|Treatment Period 1|Other|0
7457806|NCT01802580|11751586|FG000|Overall Study|Lack of Efficacy|0
7332070|NCT00818454|11566010|FG000|Washout Period of 1 Week|Adverse Event|1
7332071|NCT00818454|11566011|FG001|Washout Period of 1 Week|Adverse Event|1
7332072|NCT00818454|11566012|FG002|Washout Period of 1 Week|Adverse Event|0
7332073|NCT00818454|11566013|FG003|Washout Period of 1 Week|Adverse Event|0
7332074|NCT00818454|11566010|FG000|Washout Period of 1 Week|Protocol Violation|2
7332075|NCT00818454|11566011|FG001|Washout Period of 1 Week|Protocol Violation|0
7332076|NCT00818454|11566012|FG002|Washout Period of 1 Week|Protocol Violation|0
7332077|NCT00818454|11566013|FG003|Washout Period of 1 Week|Protocol Violation|0
7332078|NCT00818454|11566010|FG000|Washout Period of 1 Week|Other|1
7332079|NCT00818454|11566011|FG001|Washout Period of 1 Week|Other|2
7332080|NCT00818454|11566012|FG002|Washout Period of 1 Week|Other|0
7332081|NCT00818454|11566013|FG003|Washout Period of 1 Week|Other|0
7332082|NCT00818454|11566010|FG000|Treatment Period 2|Other|2
7332083|NCT00818454|11566011|FG001|Treatment Period 2|Other|1
7332084|NCT00818454|11566012|FG002|Treatment Period 2|Other|0
7332085|NCT00818454|11566013|FG003|Treatment Period 2|Other|0
7332086|NCT00818454|11566010|FG000|Treatment Period 3|Adverse Event|0
7332087|NCT00818454|11566011|FG001|Treatment Period 3|Adverse Event|0
7332088|NCT00818454|11566012|FG002|Treatment Period 3|Adverse Event|0
7332089|NCT00818454|11566013|FG003|Treatment Period 3|Adverse Event|1
7332090|NCT00818519|11566025|FG000|Overall Study|Adverse Event|2
7332091|NCT00818519|11566026|FG001|Overall Study|Adverse Event|2
7332092|NCT00818519|11566025|FG000|Overall Study|Lost to Follow-up|4
7332093|NCT00818519|11566026|FG001|Overall Study|Lost to Follow-up|6
7332094|NCT00818519|11566025|FG000|Overall Study|Protocol Violation|2
7332095|NCT00818519|11566026|FG001|Overall Study|Protocol Violation|1
7332096|NCT00818519|11566025|FG000|Overall Study|Pregnancy|0
7332097|NCT00818519|11566026|FG001|Overall Study|Pregnancy|1
7332098|NCT00818519|11566025|FG000|Overall Study|Withdrawal by Subject|4
7332099|NCT00818519|11566026|FG001|Overall Study|Withdrawal by Subject|9
7332100|NCT00818519|11566025|FG000|Overall Study|participant recovered completely|1
7332101|NCT00818519|11566026|FG001|Overall Study|participant recovered completely|0
7332102|NCT00818519|11566025|FG000|Overall Study|participant will leave for long tme|1
7332103|NCT00818519|11566026|FG001|Overall Study|participant will leave for long tme|0
7332104|NCT00818623|11566040|FG000|Overall Study|Adverse Event|1
7332105|NCT00818623|11566041|FG001|Overall Study|Adverse Event|0
7332106|NCT00818623|11566042|FG002|Overall Study|Adverse Event|1
7332107|NCT00818623|11566043|FG003|Overall Study|Adverse Event|0
7332108|NCT00818623|11566044|FG004|Overall Study|Adverse Event|0
7332109|NCT00818623|11566045|FG005|Overall Study|Adverse Event|1
7332110|NCT00818623|11566046|FG006|Overall Study|Adverse Event|0
7332111|NCT00818623|11566047|FG007|Overall Study|Adverse Event|0
7332112|NCT00818623|11566040|FG000|Overall Study|Bad prostate specific antigen response|0
7332113|NCT00818623|11566041|FG001|Overall Study|Bad prostate specific antigen response|3
7332114|NCT00818623|11566042|FG002|Overall Study|Bad prostate specific antigen response|2
7332115|NCT00818623|11566043|FG003|Overall Study|Bad prostate specific antigen response|5
7332116|NCT00818623|11566044|FG004|Overall Study|Bad prostate specific antigen response|0
7332117|NCT00818623|11566045|FG005|Overall Study|Bad prostate specific antigen response|1
7332118|NCT00818623|11566046|FG006|Overall Study|Bad prostate specific antigen response|0
7332119|NCT00818623|11566047|FG007|Overall Study|Bad prostate specific antigen response|0
7332120|NCT00818623|11566040|FG000|Overall Study|Withdrawal by Subject|0
7332121|NCT00818623|11566041|FG001|Overall Study|Withdrawal by Subject|1
7332122|NCT00818623|11566042|FG002|Overall Study|Withdrawal by Subject|1
7332123|NCT00818623|11566043|FG003|Overall Study|Withdrawal by Subject|0
7332124|NCT00818623|11566044|FG004|Overall Study|Withdrawal by Subject|0
7332125|NCT00818623|11566045|FG005|Overall Study|Withdrawal by Subject|1
7332126|NCT00818623|11566046|FG006|Overall Study|Withdrawal by Subject|1
7332127|NCT00818623|11566047|FG007|Overall Study|Withdrawal by Subject|1
7332128|NCT00818623|11566040|FG000|Overall Study|Protocol Violation|1
7332129|NCT00818623|11566041|FG001|Overall Study|Protocol Violation|0
7332130|NCT00818623|11566042|FG002|Overall Study|Protocol Violation|0
7332131|NCT00818623|11566043|FG003|Overall Study|Protocol Violation|0
7332132|NCT00818623|11566044|FG004|Overall Study|Protocol Violation|1
7332133|NCT00818623|11566045|FG005|Overall Study|Protocol Violation|0
7332134|NCT00818623|11566046|FG006|Overall Study|Protocol Violation|1
7332135|NCT00818623|11566047|FG007|Overall Study|Protocol Violation|0
7332136|NCT00818623|11566040|FG000|Overall Study|Need of additional treatment|0
7332137|NCT00818623|11566041|FG001|Overall Study|Need of additional treatment|0
7332138|NCT00818623|11566042|FG002|Overall Study|Need of additional treatment|0
7332139|NCT00818623|11566043|FG003|Overall Study|Need of additional treatment|0
7332140|NCT00818623|11566044|FG004|Overall Study|Need of additional treatment|1
7332141|NCT00818623|11566045|FG005|Overall Study|Need of additional treatment|0
7332142|NCT00818623|11566046|FG006|Overall Study|Need of additional treatment|0
7332143|NCT00818623|11566047|FG007|Overall Study|Need of additional treatment|0
7332144|NCT00818623|11566040|FG000|Overall Study|Lack of trial drug at site|0
7332145|NCT00818623|11566041|FG001|Overall Study|Lack of trial drug at site|0
7332146|NCT00818623|11566042|FG002|Overall Study|Lack of trial drug at site|0
7332147|NCT00818623|11566043|FG003|Overall Study|Lack of trial drug at site|0
7332148|NCT00818623|11566044|FG004|Overall Study|Lack of trial drug at site|2
7332149|NCT00818623|11566045|FG005|Overall Study|Lack of trial drug at site|0
7332150|NCT00818623|11566046|FG006|Overall Study|Lack of trial drug at site|1
7332151|NCT00818623|11566047|FG007|Overall Study|Lack of trial drug at site|0
7332152|NCT00818623|11566040|FG000|Overall Study|Disease progression|0
7332153|NCT00818623|11566041|FG001|Overall Study|Disease progression|0
7332154|NCT00818623|11566042|FG002|Overall Study|Disease progression|0
7332155|NCT00818623|11566043|FG003|Overall Study|Disease progression|0
7332156|NCT00818623|11566044|FG004|Overall Study|Disease progression|0
7332157|NCT00818623|11566045|FG005|Overall Study|Disease progression|0
7332158|NCT00818623|11566046|FG006|Overall Study|Disease progression|1
7332159|NCT00818623|11566047|FG007|Overall Study|Disease progression|0
7332160|NCT00818649|11566065|FG000|Overall Study|Declining performance status|2
7332161|NCT00818649|11566065|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
7332162|NCT00818649|11566065|FG000|Overall Study|Adverse Event|1
7332163|NCT00818662|11566074|FG000|Overall Study|Adverse Event|5
7332164|NCT00818662|11566075|FG001|Overall Study|Adverse Event|14
7332165|NCT00818662|11566076|FG002|Overall Study|Adverse Event|4
7332166|NCT00818662|11566077|FG003|Overall Study|Adverse Event|3
7332167|NCT00818662|11566074|FG000|Overall Study|Withdrawal by Subject|5
7332168|NCT00818662|11566075|FG001|Overall Study|Withdrawal by Subject|4
7332169|NCT00818662|11566076|FG002|Overall Study|Withdrawal by Subject|2
7332170|NCT00818662|11566077|FG003|Overall Study|Withdrawal by Subject|2
7332171|NCT00818662|11566074|FG000|Overall Study|Death|1
7332172|NCT00818662|11566075|FG001|Overall Study|Death|3
7332173|NCT00818662|11566076|FG002|Overall Study|Death|0
7332174|NCT00818662|11566077|FG003|Overall Study|Death|0
7332175|NCT00818662|11566074|FG000|Overall Study|Physician Decision|1
7332176|NCT00818662|11566075|FG001|Overall Study|Physician Decision|0
7332177|NCT00818662|11566076|FG002|Overall Study|Physician Decision|0
7332178|NCT00818662|11566077|FG003|Overall Study|Physician Decision|0
7332179|NCT00818662|11566074|FG000|Overall Study|Lost to Follow-up|0
7332180|NCT00818662|11566075|FG001|Overall Study|Lost to Follow-up|0
7332181|NCT00818662|11566076|FG002|Overall Study|Lost to Follow-up|0
7332182|NCT00818662|11566077|FG003|Overall Study|Lost to Follow-up|1
7332183|NCT00818662|11566074|FG000|Overall Study|Unwilling or Unable to Participate|4
7332184|NCT00818662|11566075|FG001|Overall Study|Unwilling or Unable to Participate|6
7332185|NCT00818662|11566076|FG002|Overall Study|Unwilling or Unable to Participate|2
7332186|NCT00818662|11566077|FG003|Overall Study|Unwilling or Unable to Participate|4
7332187|NCT00818662|11566074|FG000|Overall Study|Protocol Violation|1
7332188|NCT00818662|11566075|FG001|Overall Study|Protocol Violation|1
7332189|NCT00818662|11566076|FG002|Overall Study|Protocol Violation|0
7332190|NCT00818662|11566077|FG003|Overall Study|Protocol Violation|0
7332191|NCT00818662|11566074|FG000|Overall Study|Requires a Prohibited Medication|1
7332192|NCT00818662|11566075|FG001|Overall Study|Requires a Prohibited Medication|0
7332193|NCT00818662|11566076|FG002|Overall Study|Requires a Prohibited Medication|0
7332194|NCT00818662|11566077|FG003|Overall Study|Requires a Prohibited Medication|0
7332195|NCT00818662|11566074|FG000|Overall Study|Safety Risk|1
7332196|NCT00818662|11566075|FG001|Overall Study|Safety Risk|1
7332197|NCT00818662|11566076|FG002|Overall Study|Safety Risk|0
7332198|NCT00818662|11566077|FG003|Overall Study|Safety Risk|1
7332199|NCT00818662|11566074|FG000|Overall Study|Study Partner Unwilling or Unable|3
7332200|NCT00818662|11566075|FG001|Overall Study|Study Partner Unwilling or Unable|2
7332201|NCT00818662|11566076|FG002|Overall Study|Study Partner Unwilling or Unable|1
7332202|NCT00818662|11566077|FG003|Overall Study|Study Partner Unwilling or Unable|1
7332203|NCT00818662|11566074|FG000|Overall Study|Participant's health declined|0
7332204|NCT00818662|11566075|FG001|Overall Study|Participant's health declined|0
7332205|NCT00818662|11566076|FG002|Overall Study|Participant's health declined|0
7332206|NCT00818662|11566077|FG003|Overall Study|Participant's health declined|1
7332207|NCT00818662|11566074|FG000|Overall Study|Caregiver to pursue other treatment|0
7332208|NCT00818662|11566075|FG001|Overall Study|Caregiver to pursue other treatment|1
7332209|NCT00818662|11566076|FG002|Overall Study|Caregiver to pursue other treatment|0
7332210|NCT00818662|11566077|FG003|Overall Study|Caregiver to pursue other treatment|0
7332211|NCT00818662|11566074|FG000|Overall Study|Moving out of state|0
7332212|NCT00818662|11566075|FG001|Overall Study|Moving out of state|0
7332213|NCT00818662|11566076|FG002|Overall Study|Moving out of state|0
7332214|NCT00818662|11566077|FG003|Overall Study|Moving out of state|1
7332215|NCT00818662|11566074|FG000|Overall Study|Declined move to another study site|1
7332216|NCT00818662|11566075|FG001|Overall Study|Declined move to another study site|0
7332217|NCT00818662|11566076|FG002|Overall Study|Declined move to another study site|0
7332218|NCT00818662|11566077|FG003|Overall Study|Declined move to another study site|0
7332219|NCT00818662|11566074|FG000|Overall Study|Change in living situation|0
7332220|NCT00818662|11566075|FG001|Overall Study|Change in living situation|0
7332221|NCT00818662|11566076|FG002|Overall Study|Change in living situation|0
7332222|NCT00818662|11566077|FG003|Overall Study|Change in living situation|1
7332223|NCT00818662|11566074|FG000|Overall Study|Study partner decision|0
7332224|NCT00818662|11566075|FG001|Overall Study|Study partner decision|0
7332225|NCT00818662|11566076|FG002|Overall Study|Study partner decision|0
7332226|NCT00818662|11566077|FG003|Overall Study|Study partner decision|1
7332227|NCT00818662|11566074|FG000|Overall Study|Admitted to long term nursing care|0
7332228|NCT00818662|11566075|FG001|Overall Study|Admitted to long term nursing care|1
7332229|NCT00818662|11566076|FG002|Overall Study|Admitted to long term nursing care|0
7332230|NCT00818662|11566077|FG003|Overall Study|Admitted to long term nursing care|0
7332231|NCT00818753|11566091|FG000|Overall Study|Protocol Violation|1
7332232|NCT00818753|11566092|FG001|Overall Study|Protocol Violation|0
7332233|NCT00818753|11566093|FG002|Overall Study|Protocol Violation|0
7332234|NCT00818753|11566091|FG000|Overall Study|Other reason (not specified)|0
7332235|NCT00818753|11566092|FG001|Overall Study|Other reason (not specified)|0
7332236|NCT00818753|11566093|FG002|Overall Study|Other reason (not specified)|1
7332237|NCT00818753|11566091|FG000|Overall Study|Randomised and not treated|2
7332238|NCT00818753|11566092|FG001|Overall Study|Randomised and not treated|0
7332239|NCT00818753|11566093|FG002|Overall Study|Randomised and not treated|0
7332240|NCT00818766|11566103|FG000|Overall Study|Could not be Contacted on Day 28|11
7332241|NCT00818766|11566104|FG001|Overall Study|Could not be Contacted on Day 28|10
7332242|NCT00818766|11566103|FG000|Overall Study|Death|1
7332243|NCT00818766|11566104|FG001|Overall Study|Death|0
7332244|NCT00818766|11566103|FG000|Overall Study|Did not Receive Allocated Intervention|3
7332245|NCT00818766|11566104|FG001|Overall Study|Did not Receive Allocated Intervention|0
7332246|NCT00818779|11566112|FG000|Overall Study|Protocol Violation|1
7332247|NCT00818779|11566113|FG001|Overall Study|Protocol Violation|0
7332248|NCT00818779|11566112|FG000|Overall Study|Lost to Follow-up|1
7332249|NCT00818779|11566113|FG001|Overall Study|Lost to Follow-up|0
7332250|NCT00818779|11566112|FG000|Overall Study|Adverse Event|4
7332251|NCT00818779|11566113|FG001|Overall Study|Adverse Event|1
7332252|NCT00818883|11566132|FG000|Overall Study|Adverse Event|28
7332253|NCT00818883|11566133|FG001|Overall Study|Adverse Event|19
7332254|NCT00818883|11566132|FG000|Overall Study|Protocol Violation|2
7332255|NCT00818883|11566133|FG001|Overall Study|Protocol Violation|2
7332256|NCT00818883|11566132|FG000|Overall Study|Lost to Follow-up|3
7332257|NCT00818883|11566133|FG001|Overall Study|Lost to Follow-up|2
7332258|NCT00818883|11566132|FG000|Overall Study|Withdrawal by Subject|16
7332259|NCT00818883|11566133|FG001|Overall Study|Withdrawal by Subject|14
7332260|NCT00818883|11566132|FG000|Overall Study|Lack of Efficacy|0
7332261|NCT00818883|11566133|FG001|Overall Study|Lack of Efficacy|2
7332262|NCT00818883|11566132|FG000|Overall Study|Other|2
7332263|NCT00818883|11566133|FG001|Overall Study|Other|7
7332264|NCT00819013|11566147|FG000|Overall Study|Not meeting continuing study eligibility|2
7332265|NCT00819013|11566148|FG001|Overall Study|Not meeting continuing study eligibility|1
7332266|NCT00819013|11566149|FG002|Overall Study|Not meeting continuing study eligibility|2
7332267|NCT00819013|11566150|FG003|Overall Study|Not meeting continuing study eligibility|1
7332268|NCT00819013|11566147|FG000|Overall Study|Adverse Event|0
7332269|NCT00819013|11566148|FG001|Overall Study|Adverse Event|0
7332270|NCT00819013|11566149|FG002|Overall Study|Adverse Event|1
7332271|NCT00819013|11566150|FG003|Overall Study|Adverse Event|0
7332272|NCT00819013|11566147|FG000|Overall Study|Withdrawal by Subject|1
7332273|NCT00819013|11566148|FG001|Overall Study|Withdrawal by Subject|0
7332274|NCT00819013|11566149|FG002|Overall Study|Withdrawal by Subject|1
7332275|NCT00819013|11566150|FG003|Overall Study|Withdrawal by Subject|0
7332276|NCT00819013|11566147|FG000|Overall Study|Lost to Follow-up|0
7332277|NCT00819013|11566148|FG001|Overall Study|Lost to Follow-up|0
7332278|NCT00819013|11566149|FG002|Overall Study|Lost to Follow-up|1
7332279|NCT00819013|11566150|FG003|Overall Study|Lost to Follow-up|2
7332280|NCT00819013|11566147|FG000|Overall Study|Death|0
7332281|NCT00819013|11566148|FG001|Overall Study|Death|0
7332282|NCT00819013|11566149|FG002|Overall Study|Death|0
7332283|NCT00819013|11566150|FG003|Overall Study|Death|1
7332284|NCT00819039|11566163|FG000|Overall Study|Physician Decision|1
7332285|NCT00819039|11566164|FG001|Overall Study|Physician Decision|0
7332286|NCT00819039|11566165|FG002|Overall Study|Physician Decision|1
7332287|NCT00819039|11566163|FG000|Overall Study|Protocol Violation|1
7332288|NCT00819039|11566164|FG001|Overall Study|Protocol Violation|0
7332289|NCT00819039|11566165|FG002|Overall Study|Protocol Violation|0
7332290|NCT00819052|11566177|FG000|Overall Study|Adverse Event|0
7332291|NCT00819052|11566178|FG001|Overall Study|Adverse Event|5
7332292|NCT00819052|11566177|FG000|Overall Study|Protocol Violation|1
7332293|NCT00819052|11566178|FG001|Overall Study|Protocol Violation|2
7332294|NCT00819052|11566177|FG000|Overall Study|Lost to Follow-up|1
7332295|NCT00819052|11566178|FG001|Overall Study|Lost to Follow-up|2
7332296|NCT00819052|11566177|FG000|Overall Study|Withdrawal by Subject|1
7332297|NCT00819052|11566178|FG001|Overall Study|Withdrawal by Subject|2
7332298|NCT00819052|11566177|FG000|Overall Study|Lack of Efficacy|1
7332299|NCT00819052|11566178|FG001|Overall Study|Lack of Efficacy|1
7332300|NCT00819052|11566177|FG000|Overall Study|Pregnancy|1
7332301|NCT00819052|11566178|FG001|Overall Study|Pregnancy|2
7332302|NCT00819052|11566177|FG000|Overall Study|Death or events leading to death|1
7332303|NCT00819052|11566178|FG001|Overall Study|Death or events leading to death|0
7332304|NCT00819091|11566189|FG000|Overall Study|Adverse Event|3
7332305|NCT00819091|11566190|FG001|Overall Study|Adverse Event|5
7332306|NCT00819091|11566189|FG000|Overall Study|Protocol Violation|0
7332307|NCT00819091|11566190|FG001|Overall Study|Protocol Violation|1
7332308|NCT00819091|11566189|FG000|Overall Study|Lost to Follow-up|2
7332309|NCT00819091|11566190|FG001|Overall Study|Lost to Follow-up|0
7332310|NCT00819091|11566189|FG000|Overall Study|Withdrawal by Subject|1
7332311|NCT00819091|11566190|FG001|Overall Study|Withdrawal by Subject|2
7332312|NCT00819091|11566189|FG000|Overall Study|Other|1
7332313|NCT00819091|11566190|FG001|Overall Study|Other|2
7332314|NCT00819156|11566202|FG000|Overall Study|Adverse Event|1
7332315|NCT00819156|11566203|FG001|Overall Study|Adverse Event|4
7332316|NCT00819156|11566204|FG002|Overall Study|Adverse Event|2
7332317|NCT00819156|11566205|FG003|Overall Study|Adverse Event|1
7332318|NCT00819156|11566206|FG004|Overall Study|Adverse Event|2
7332319|NCT00819156|11566207|FG005|Overall Study|Adverse Event|3
7332320|NCT00819156|11566202|FG000|Overall Study|Withdrawal by Subject|0
7332321|NCT00819156|11566203|FG001|Overall Study|Withdrawal by Subject|3
7332322|NCT00819156|11566204|FG002|Overall Study|Withdrawal by Subject|2
7332323|NCT00819156|11566205|FG003|Overall Study|Withdrawal by Subject|0
7332324|NCT00819156|11566206|FG004|Overall Study|Withdrawal by Subject|1
7332325|NCT00819156|11566207|FG005|Overall Study|Withdrawal by Subject|0
7332326|NCT00819156|11566202|FG000|Overall Study|Protocol Violation|1
7332327|NCT00819156|11566203|FG001|Overall Study|Protocol Violation|0
7332328|NCT00819156|11566204|FG002|Overall Study|Protocol Violation|1
7332329|NCT00819156|11566205|FG003|Overall Study|Protocol Violation|0
7332330|NCT00819156|11566206|FG004|Overall Study|Protocol Violation|0
7332331|NCT00819156|11566207|FG005|Overall Study|Protocol Violation|1
7332332|NCT00819156|11566202|FG000|Overall Study|Lost to Follow-up|0
7332333|NCT00819156|11566203|FG001|Overall Study|Lost to Follow-up|1
7332334|NCT00819156|11566204|FG002|Overall Study|Lost to Follow-up|0
7332335|NCT00819156|11566205|FG003|Overall Study|Lost to Follow-up|0
7332336|NCT00819156|11566206|FG004|Overall Study|Lost to Follow-up|0
7332337|NCT00819156|11566207|FG005|Overall Study|Lost to Follow-up|2
7332338|NCT00819156|11566202|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
7332339|NCT00819156|11566203|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
7332340|NCT00819156|11566204|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
7332341|NCT00819156|11566205|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
7332342|NCT00819156|11566206|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
7332343|NCT00819156|11566207|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
7332344|NCT00819156|11566202|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
7332345|NCT00819156|11566203|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7332346|NCT00819156|11566204|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7332347|NCT00819156|11566205|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7332348|NCT00819156|11566206|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
7332349|NCT00819156|11566207|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
7332350|NCT00819156|11566202|FG000|Overall Study|Prostate-specific antigen progression|0
7332351|NCT00819156|11566203|FG001|Overall Study|Prostate-specific antigen progression|0
7332352|NCT00819156|11566204|FG002|Overall Study|Prostate-specific antigen progression|0
7332353|NCT00819156|11566205|FG003|Overall Study|Prostate-specific antigen progression|0
7332354|NCT00819156|11566206|FG004|Overall Study|Prostate-specific antigen progression|1
7332355|NCT00819156|11566207|FG005|Overall Study|Prostate-specific antigen progression|0
7332356|NCT00819234|11566242|FG000|Overall Study|Withdrawal by Subject|8
7332357|NCT00819234|11566243|FG001|Overall Study|Withdrawal by Subject|13
7332358|NCT00819234|11566244|FG002|Overall Study|Withdrawal by Subject|6
7332359|NCT00819234|11566245|FG003|Overall Study|Withdrawal by Subject|3
7332360|NCT00819234|11566246|FG004|Overall Study|Withdrawal by Subject|0
7332361|NCT00819234|11566247|FG005|Overall Study|Withdrawal by Subject|4
7332362|NCT00819234|11566248|FG006|Overall Study|Withdrawal by Subject|4
7332363|NCT00819234|11566249|FG007|Overall Study|Withdrawal by Subject|8
7332364|NCT00819234|11566250|FG008|Overall Study|Withdrawal by Subject|5
7332365|NCT00819234|11566251|FG009|Overall Study|Withdrawal by Subject|3
7332366|NCT00819234|11566242|FG000|Overall Study|Adverse Event|0
7332367|NCT00819234|11566243|FG001|Overall Study|Adverse Event|0
7332368|NCT00819234|11566244|FG002|Overall Study|Adverse Event|1
7332369|NCT00819234|11566245|FG003|Overall Study|Adverse Event|0
7332370|NCT00819234|11566246|FG004|Overall Study|Adverse Event|0
7332371|NCT00819234|11566247|FG005|Overall Study|Adverse Event|2
7332372|NCT00819234|11566248|FG006|Overall Study|Adverse Event|0
7332373|NCT00819234|11566249|FG007|Overall Study|Adverse Event|0
7332374|NCT00819234|11566250|FG008|Overall Study|Adverse Event|0
7332375|NCT00819234|11566251|FG009|Overall Study|Adverse Event|0
7332376|NCT00819234|11566242|FG000|Overall Study|Physician Decision|0
7332377|NCT00819234|11566243|FG001|Overall Study|Physician Decision|0
7332378|NCT00819234|11566244|FG002|Overall Study|Physician Decision|0
7332379|NCT00819234|11566245|FG003|Overall Study|Physician Decision|1
7332380|NCT00819234|11566246|FG004|Overall Study|Physician Decision|0
7332381|NCT00819234|11566247|FG005|Overall Study|Physician Decision|0
7332382|NCT00819234|11566248|FG006|Overall Study|Physician Decision|0
7332383|NCT00819234|11566249|FG007|Overall Study|Physician Decision|0
7332384|NCT00819234|11566250|FG008|Overall Study|Physician Decision|0
7332385|NCT00819234|11566251|FG009|Overall Study|Physician Decision|2
7332386|NCT00819234|11566242|FG000|Overall Study|Protocol Violation|0
7332387|NCT00819234|11566243|FG001|Overall Study|Protocol Violation|0
7332388|NCT00819234|11566244|FG002|Overall Study|Protocol Violation|1
7332389|NCT00819234|11566245|FG003|Overall Study|Protocol Violation|0
7332390|NCT00819234|11566246|FG004|Overall Study|Protocol Violation|0
7332391|NCT00819234|11566247|FG005|Overall Study|Protocol Violation|0
7332392|NCT00819234|11566248|FG006|Overall Study|Protocol Violation|0
7332393|NCT00819234|11566249|FG007|Overall Study|Protocol Violation|0
7332394|NCT00819234|11566250|FG008|Overall Study|Protocol Violation|0
7332395|NCT00819234|11566251|FG009|Overall Study|Protocol Violation|0
7332396|NCT00819234|11566242|FG000|Overall Study|Lost to Follow-up|2
7332397|NCT00819234|11566243|FG001|Overall Study|Lost to Follow-up|2
7332398|NCT00819234|11566244|FG002|Overall Study|Lost to Follow-up|0
7332399|NCT00819234|11566245|FG003|Overall Study|Lost to Follow-up|2
7332400|NCT00819234|11566246|FG004|Overall Study|Lost to Follow-up|1
7332401|NCT00819234|11566247|FG005|Overall Study|Lost to Follow-up|1
7332402|NCT00819234|11566248|FG006|Overall Study|Lost to Follow-up|1
7332403|NCT00819234|11566249|FG007|Overall Study|Lost to Follow-up|1
7332404|NCT00819234|11566250|FG008|Overall Study|Lost to Follow-up|1
7332405|NCT00819234|11566251|FG009|Overall Study|Lost to Follow-up|2
7332406|NCT00819247|11566309|FG000|Overall Study|Adverse Event|0
7332407|NCT00819247|11566310|FG001|Overall Study|Adverse Event|5
7332408|NCT00819247|11566311|FG002|Overall Study|Adverse Event|3
7332409|NCT00819247|11566309|FG000|Overall Study|Insufficient testosterone response|5
7332410|NCT00819247|11566310|FG001|Overall Study|Insufficient testosterone response|8
7332411|NCT00819247|11566311|FG002|Overall Study|Insufficient testosterone response|10
7332412|NCT00819247|11566309|FG000|Overall Study|Withdrawal by Subject|1
7332413|NCT00819247|11566310|FG001|Overall Study|Withdrawal by Subject|0
7332414|NCT00819247|11566311|FG002|Overall Study|Withdrawal by Subject|0
7332415|NCT00819247|11566309|FG000|Overall Study|Protocol Violation|1
7332416|NCT00819247|11566310|FG001|Overall Study|Protocol Violation|0
7332417|NCT00819247|11566311|FG002|Overall Study|Protocol Violation|1
7332418|NCT00819247|11566309|FG000|Overall Study|Mistakenly withdrawn|0
7332419|NCT00819247|11566310|FG001|Overall Study|Mistakenly withdrawn|1
7332420|NCT00819247|11566311|FG002|Overall Study|Mistakenly withdrawn|0
7332421|NCT00819247|11566309|FG000|Overall Study|Bad prostate-specific antigen response|3
7332422|NCT00819247|11566310|FG001|Overall Study|Bad prostate-specific antigen response|2
7332423|NCT00819247|11566311|FG002|Overall Study|Bad prostate-specific antigen response|0
7332424|NCT00819247|11566309|FG000|Overall Study|Other|1
7332425|NCT00819247|11566310|FG001|Overall Study|Other|0
7332426|NCT00819247|11566311|FG002|Overall Study|Other|0
7457807|NCT01802580|11751587|FG001|Overall Study|Lack of Efficacy|2
7457808|NCT01802775|11751606|FG000|Overall Study|Death|0
7457809|NCT01802775|11751607|FG001|Overall Study|Death|3
7457810|NCT01802775|11751606|FG000|Overall Study|Reason not provided|0
7457811|NCT01802775|11751607|FG001|Overall Study|Reason not provided|1
7457812|NCT01802775|11751606|FG000|Overall Study|Physician Decision|1
7457813|NCT01802775|11751607|FG001|Overall Study|Physician Decision|0
7457814|NCT01802775|11751606|FG000|Overall Study|Adverse Event|1
7457815|NCT01802775|11751607|FG001|Overall Study|Adverse Event|1
7457816|NCT01802775|11751606|FG000|Overall Study|Withdrawal by Subject|3
7457817|NCT01802775|11751607|FG001|Overall Study|Withdrawal by Subject|5
7457818|NCT01802775|11751606|FG000|Overall Study|Lost to Follow-up|1
7457819|NCT01802775|11751607|FG001|Overall Study|Lost to Follow-up|2
7457820|NCT01802879|11751613|FG000|Overall Study|Administrative problems|2
7457821|NCT01802879|11751613|FG000|Overall Study|Disease progression|6
7457822|NCT01803269|11751695|FG000|Overall Study|Withdrawal by Subject|3
7457823|NCT01803269|11751696|FG001|Overall Study|Withdrawal by Subject|0
7457824|NCT01803269|11751697|FG002|Overall Study|Withdrawal by Subject|0
7457825|NCT01803282|11751717|FG000|Overall Study|Progressive Disease|4
7457826|NCT01803282|11751718|FG001|Overall Study|Progressive Disease|3
7457827|NCT01803282|11751719|FG002|Overall Study|Progressive Disease|6
7457828|NCT01803282|11751720|FG003|Overall Study|Progressive Disease|22
7457829|NCT01803282|11751721|FG004|Overall Study|Progressive Disease|5
7457830|NCT01803282|11751722|FG005|Overall Study|Progressive Disease|8
7457831|NCT01803282|11751723|FG006|Overall Study|Progressive Disease|23
7457832|NCT01803282|11751724|FG007|Overall Study|Progressive Disease|24
7457833|NCT01803282|11751725|FG008|Overall Study|Progressive Disease|3
7457834|NCT01803282|11751726|FG009|Overall Study|Progressive Disease|29
7457835|NCT01803282|11751727|FG010|Overall Study|Progressive Disease|6
7457836|NCT01803282|11751728|FG011|Overall Study|Progressive Disease|11
7457837|NCT01803282|11751717|FG000|Overall Study|Death|0
7457838|NCT01803282|11751718|FG001|Overall Study|Death|0
7457839|NCT01803282|11751719|FG002|Overall Study|Death|0
7457840|NCT01803282|11751720|FG003|Overall Study|Death|0
7457841|NCT01803282|11751721|FG004|Overall Study|Death|2
7457842|NCT01803282|11751722|FG005|Overall Study|Death|1
7457843|NCT01803282|11751723|FG006|Overall Study|Death|1
7457844|NCT01803282|11751724|FG007|Overall Study|Death|5
7457845|NCT01803282|11751725|FG008|Overall Study|Death|1
7457846|NCT01803282|11751726|FG009|Overall Study|Death|1
7457847|NCT01803282|11751727|FG010|Overall Study|Death|0
7457848|NCT01803282|11751728|FG011|Overall Study|Death|0
7457849|NCT01803282|11751717|FG000|Overall Study|Withdrew Consent|0
7457850|NCT01803282|11751718|FG001|Overall Study|Withdrew Consent|0
7457851|NCT01803282|11751719|FG002|Overall Study|Withdrew Consent|0
7457852|NCT01803282|11751720|FG003|Overall Study|Withdrew Consent|6
7457853|NCT01803282|11751721|FG004|Overall Study|Withdrew Consent|1
7457854|NCT01803282|11751722|FG005|Overall Study|Withdrew Consent|0
7457855|NCT01803282|11751723|FG006|Overall Study|Withdrew Consent|8
7457856|NCT01803282|11751724|FG007|Overall Study|Withdrew Consent|3
7457857|NCT01803282|11751725|FG008|Overall Study|Withdrew Consent|1
7457858|NCT01803282|11751726|FG009|Overall Study|Withdrew Consent|5
7457859|NCT01803282|11751727|FG010|Overall Study|Withdrew Consent|0
7457860|NCT01803282|11751728|FG011|Overall Study|Withdrew Consent|1
7457861|NCT01803282|11751717|FG000|Overall Study|Investigator's Discretion|0
7457862|NCT01803282|11751718|FG001|Overall Study|Investigator's Discretion|0
7332427|NCT00819390|11566338|FG000|Overall Study|Lost to Follow-up|1
7332428|NCT00819390|11566339|FG001|Overall Study|Lost to Follow-up|1
7457863|NCT01803282|11751719|FG002|Overall Study|Investigator's Discretion|0
7457864|NCT01803282|11751720|FG003|Overall Study|Investigator's Discretion|7
7457865|NCT01803282|11751721|FG004|Overall Study|Investigator's Discretion|2
7457866|NCT01803282|11751722|FG005|Overall Study|Investigator's Discretion|1
7457867|NCT01803282|11751723|FG006|Overall Study|Investigator's Discretion|7
7457868|NCT01803282|11751724|FG007|Overall Study|Investigator's Discretion|10
7457869|NCT01803282|11751725|FG008|Overall Study|Investigator's Discretion|6
7457870|NCT01803282|11751726|FG009|Overall Study|Investigator's Discretion|7
7457871|NCT01803282|11751727|FG010|Overall Study|Investigator's Discretion|1
7457872|NCT01803282|11751728|FG011|Overall Study|Investigator's Discretion|0
7457873|NCT01803282|11751717|FG000|Overall Study|Adverse Event|0
7457874|NCT01803282|11751718|FG001|Overall Study|Adverse Event|0
7457875|NCT01803282|11751719|FG002|Overall Study|Adverse Event|0
7457876|NCT01803282|11751720|FG003|Overall Study|Adverse Event|0
7332429|NCT00819390|11566340|FG002|Overall Study|Lost to Follow-up|0
7332430|NCT00819390|11566341|FG003|Overall Study|Lost to Follow-up|0
7332431|NCT00819390|11566338|FG000|Overall Study|Withdrawal by Subject|2
7332432|NCT00819390|11566339|FG001|Overall Study|Withdrawal by Subject|0
7332433|NCT00819390|11566340|FG002|Overall Study|Withdrawal by Subject|0
7332434|NCT00819390|11566341|FG003|Overall Study|Withdrawal by Subject|0
7332435|NCT00819390|11566338|FG000|Overall Study|Adverse Event|0
7332436|NCT00819390|11566339|FG001|Overall Study|Adverse Event|0
7332437|NCT00819390|11566340|FG002|Overall Study|Adverse Event|1
7332438|NCT00819390|11566341|FG003|Overall Study|Adverse Event|0
7332439|NCT00819585|11566375|FG000|Core Study|Adverse Event|2
7332440|NCT00819585|11566376|FG001|Core Study|Adverse Event|1
7332441|NCT00819585|11566377|FG002|Core Study|Adverse Event|1
7332442|NCT00819585|11566378|FG003|Core Study|Adverse Event|4
7332443|NCT00819585|11566379|FG004|Core Study|Adverse Event|1
7332444|NCT00819585|11566380|FG005|Core Study|Adverse Event|0
7332445|NCT00819585|11566381|FG006|Core Study|Adverse Event|2
7332446|NCT00819585|11566382|FG007|Core Study|Adverse Event|0
7332447|NCT00819585|11566383|FG008|Core Study|Adverse Event|0
7332448|NCT00819585|11566384|FG009|Core Study|Adverse Event|0
7332449|NCT00819585|11566385|FG010|Core Study|Adverse Event|0
7332450|NCT00819585|11566375|FG000|Core Study|Abnormal Laboratory Value(s)|2
7332451|NCT00819585|11566376|FG001|Core Study|Abnormal Laboratory Value(s)|0
7332452|NCT00819585|11566377|FG002|Core Study|Abnormal Laboratory Value(s)|0
7332453|NCT00819585|11566378|FG003|Core Study|Abnormal Laboratory Value(s)|0
7332454|NCT00819585|11566379|FG004|Core Study|Abnormal Laboratory Value(s)|0
7332455|NCT00819585|11566380|FG005|Core Study|Abnormal Laboratory Value(s)|0
7332456|NCT00819585|11566381|FG006|Core Study|Abnormal Laboratory Value(s)|0
7332457|NCT00819585|11566382|FG007|Core Study|Abnormal Laboratory Value(s)|0
7332458|NCT00819585|11566383|FG008|Core Study|Abnormal Laboratory Value(s)|0
7332459|NCT00819585|11566384|FG009|Core Study|Abnormal Laboratory Value(s)|0
7332460|NCT00819585|11566385|FG010|Core Study|Abnormal Laboratory Value(s)|0
7332461|NCT00819585|11566375|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
7332462|NCT00819585|11566376|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
7332463|NCT00819585|11566377|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
7332464|NCT00819585|11566378|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
7332465|NCT00819585|11566379|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
7332466|NCT00819585|11566380|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
7332467|NCT00819585|11566381|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
7332468|NCT00819585|11566382|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
7332469|NCT00819585|11566383|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
7332470|NCT00819585|11566384|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
7332471|NCT00819585|11566385|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
7332472|NCT00819585|11566375|FG000|Core Study|Subject No Longer Requires Study Drug|0
7332473|NCT00819585|11566376|FG001|Core Study|Subject No Longer Requires Study Drug|0
7332474|NCT00819585|11566377|FG002|Core Study|Subject No Longer Requires Study Drug|0
7332475|NCT00819585|11566378|FG003|Core Study|Subject No Longer Requires Study Drug|0
7332476|NCT00819585|11566379|FG004|Core Study|Subject No Longer Requires Study Drug|1
7332477|NCT00819585|11566380|FG005|Core Study|Subject No Longer Requires Study Drug|0
7332478|NCT00819585|11566381|FG006|Core Study|Subject No Longer Requires Study Drug|0
7332479|NCT00819585|11566382|FG007|Core Study|Subject No Longer Requires Study Drug|0
7332480|NCT00819585|11566383|FG008|Core Study|Subject No Longer Requires Study Drug|0
7332481|NCT00819585|11566384|FG009|Core Study|Subject No Longer Requires Study Drug|0
7332482|NCT00819585|11566385|FG010|Core Study|Subject No Longer Requires Study Drug|0
7332483|NCT00819585|11566375|FG000|Core Study|Subject Withdrew Consent|0
7332484|NCT00819585|11566376|FG001|Core Study|Subject Withdrew Consent|3
7332485|NCT00819585|11566377|FG002|Core Study|Subject Withdrew Consent|2
7332486|NCT00819585|11566378|FG003|Core Study|Subject Withdrew Consent|1
7332487|NCT00819585|11566379|FG004|Core Study|Subject Withdrew Consent|0
7332488|NCT00819585|11566380|FG005|Core Study|Subject Withdrew Consent|0
7332489|NCT00819585|11566381|FG006|Core Study|Subject Withdrew Consent|3
7332490|NCT00819585|11566382|FG007|Core Study|Subject Withdrew Consent|0
7332491|NCT00819585|11566383|FG008|Core Study|Subject Withdrew Consent|0
7332492|NCT00819585|11566384|FG009|Core Study|Subject Withdrew Consent|0
7332493|NCT00819585|11566385|FG010|Core Study|Subject Withdrew Consent|0
7332494|NCT00819585|11566375|FG000|Core Study|Lost to Follow-up|2
7332495|NCT00819585|11566376|FG001|Core Study|Lost to Follow-up|1
7332496|NCT00819585|11566377|FG002|Core Study|Lost to Follow-up|2
7332497|NCT00819585|11566378|FG003|Core Study|Lost to Follow-up|0
7332498|NCT00819585|11566379|FG004|Core Study|Lost to Follow-up|1
7332499|NCT00819585|11566380|FG005|Core Study|Lost to Follow-up|1
7332500|NCT00819585|11566381|FG006|Core Study|Lost to Follow-up|1
7332501|NCT00819585|11566382|FG007|Core Study|Lost to Follow-up|0
7332502|NCT00819585|11566383|FG008|Core Study|Lost to Follow-up|0
7332503|NCT00819585|11566384|FG009|Core Study|Lost to Follow-up|0
7332504|NCT00819585|11566385|FG010|Core Study|Lost to Follow-up|0
7332505|NCT00819585|11566375|FG000|Core Study|Administrative Problems|0
7332506|NCT00819585|11566376|FG001|Core Study|Administrative Problems|0
7332507|NCT00819585|11566377|FG002|Core Study|Administrative Problems|0
7332508|NCT00819585|11566378|FG003|Core Study|Administrative Problems|0
7332509|NCT00819585|11566379|FG004|Core Study|Administrative Problems|0
7332510|NCT00819585|11566380|FG005|Core Study|Administrative Problems|0
7332511|NCT00819585|11566381|FG006|Core Study|Administrative Problems|2
7332512|NCT00819585|11566382|FG007|Core Study|Administrative Problems|0
7332513|NCT00819585|11566383|FG008|Core Study|Administrative Problems|0
7332514|NCT00819585|11566384|FG009|Core Study|Administrative Problems|0
7332515|NCT00819585|11566385|FG010|Core Study|Administrative Problems|0
7332516|NCT00819585|11566375|FG000|Core Study|Death|0
7332517|NCT00819585|11566376|FG001|Core Study|Death|0
7332518|NCT00819585|11566377|FG002|Core Study|Death|0
7332519|NCT00819585|11566378|FG003|Core Study|Death|0
7332520|NCT00819585|11566379|FG004|Core Study|Death|0
7332521|NCT00819585|11566380|FG005|Core Study|Death|0
7332522|NCT00819585|11566381|FG006|Core Study|Death|1
7332523|NCT00819585|11566382|FG007|Core Study|Death|0
7332524|NCT00819585|11566383|FG008|Core Study|Death|0
7332525|NCT00819585|11566384|FG009|Core Study|Death|0
7332526|NCT00819585|11566385|FG010|Core Study|Death|0
7332527|NCT00819585|11566375|FG000|Core Study|Protocol Violation|0
7332528|NCT00819585|11566376|FG001|Core Study|Protocol Violation|0
7332529|NCT00819585|11566377|FG002|Core Study|Protocol Violation|1
7332530|NCT00819585|11566378|FG003|Core Study|Protocol Violation|0
7332531|NCT00819585|11566379|FG004|Core Study|Protocol Violation|0
7332532|NCT00819585|11566380|FG005|Core Study|Protocol Violation|1
7332533|NCT00819585|11566381|FG006|Core Study|Protocol Violation|3
7332534|NCT00819585|11566382|FG007|Core Study|Protocol Violation|0
7332535|NCT00819585|11566383|FG008|Core Study|Protocol Violation|0
7332536|NCT00819585|11566384|FG009|Core Study|Protocol Violation|0
7332537|NCT00819585|11566385|FG010|Core Study|Protocol Violation|0
7332538|NCT00819585|11566375|FG000|Extension Study|Abnormal Laboratory Value(s)|0
7332539|NCT00819585|11566376|FG001|Extension Study|Abnormal Laboratory Value(s)|0
7332540|NCT00819585|11566377|FG002|Extension Study|Abnormal Laboratory Value(s)|0
7332541|NCT00819585|11566378|FG003|Extension Study|Abnormal Laboratory Value(s)|0
7332542|NCT00819585|11566379|FG004|Extension Study|Abnormal Laboratory Value(s)|0
7332543|NCT00819585|11566380|FG005|Extension Study|Abnormal Laboratory Value(s)|0
7332544|NCT00819585|11566381|FG006|Extension Study|Abnormal Laboratory Value(s)|0
7332545|NCT00819585|11566382|FG007|Extension Study|Abnormal Laboratory Value(s)|0
7332546|NCT00819585|11566383|FG008|Extension Study|Abnormal Laboratory Value(s)|1
7332547|NCT00819585|11566384|FG009|Extension Study|Abnormal Laboratory Value(s)|0
7332548|NCT00819585|11566385|FG010|Extension Study|Abnormal Laboratory Value(s)|0
7332549|NCT00819585|11566375|FG000|Extension Study|Subject Withdrew Consent|0
7332550|NCT00819585|11566376|FG001|Extension Study|Subject Withdrew Consent|0
7332551|NCT00819585|11566377|FG002|Extension Study|Subject Withdrew Consent|0
7332552|NCT00819585|11566378|FG003|Extension Study|Subject Withdrew Consent|0
7332553|NCT00819585|11566379|FG004|Extension Study|Subject Withdrew Consent|0
7332554|NCT00819585|11566380|FG005|Extension Study|Subject Withdrew Consent|0
7332555|NCT00819585|11566381|FG006|Extension Study|Subject Withdrew Consent|0
7332556|NCT00819585|11566382|FG007|Extension Study|Subject Withdrew Consent|0
7332557|NCT00819585|11566383|FG008|Extension Study|Subject Withdrew Consent|3
7332558|NCT00819585|11566384|FG009|Extension Study|Subject Withdrew Consent|0
7332559|NCT00819585|11566385|FG010|Extension Study|Subject Withdrew Consent|1
7332560|NCT00819585|11566375|FG000|Extension Study|Lost to Follow-up|0
7332561|NCT00819585|11566376|FG001|Extension Study|Lost to Follow-up|0
7332562|NCT00819585|11566377|FG002|Extension Study|Lost to Follow-up|0
7332563|NCT00819585|11566378|FG003|Extension Study|Lost to Follow-up|0
7332564|NCT00819585|11566379|FG004|Extension Study|Lost to Follow-up|0
7332565|NCT00819585|11566380|FG005|Extension Study|Lost to Follow-up|0
7332566|NCT00819585|11566381|FG006|Extension Study|Lost to Follow-up|0
7332567|NCT00819585|11566382|FG007|Extension Study|Lost to Follow-up|0
7332568|NCT00819585|11566383|FG008|Extension Study|Lost to Follow-up|2
7332569|NCT00819585|11566384|FG009|Extension Study|Lost to Follow-up|1
7332570|NCT00819585|11566385|FG010|Extension Study|Lost to Follow-up|1
7332571|NCT00819585|11566375|FG000|Extension Study|Death|0
7332572|NCT00819585|11566376|FG001|Extension Study|Death|0
7332573|NCT00819585|11566377|FG002|Extension Study|Death|0
7332574|NCT00819585|11566378|FG003|Extension Study|Death|0
7332575|NCT00819585|11566379|FG004|Extension Study|Death|0
7332576|NCT00819585|11566380|FG005|Extension Study|Death|0
7332577|NCT00819585|11566381|FG006|Extension Study|Death|0
7332578|NCT00819585|11566382|FG007|Extension Study|Death|0
7332579|NCT00819585|11566383|FG008|Extension Study|Death|2
7332580|NCT00819585|11566384|FG009|Extension Study|Death|0
7332581|NCT00819585|11566385|FG010|Extension Study|Death|0
7332582|NCT00819741|11566428|FG000|Overall Study|Adverse Event|5
7332583|NCT00819741|11566429|FG001|Overall Study|Adverse Event|2
7332584|NCT00819741|11566428|FG000|Overall Study|Lack of Efficacy|0
7332585|NCT00819741|11566429|FG001|Overall Study|Lack of Efficacy|2
7332586|NCT00819741|11566428|FG000|Overall Study|Lost to Follow-up|3
7332587|NCT00819741|11566429|FG001|Overall Study|Lost to Follow-up|1
7332588|NCT00819741|11566428|FG000|Overall Study|Protocol Violation|3
7332589|NCT00819741|11566429|FG001|Overall Study|Protocol Violation|4
7332590|NCT00819741|11566428|FG000|Overall Study|Withdrawal by Subject|2
7332591|NCT00819741|11566429|FG001|Overall Study|Withdrawal by Subject|2
7332592|NCT00819741|11566428|FG000|Overall Study|Unclassified|6
7332593|NCT00819741|11566429|FG001|Overall Study|Unclassified|0
7332594|NCT00819741|11566428|FG000|Overall Study|Reasons unknown|3
7332595|NCT00819741|11566429|FG001|Overall Study|Reasons unknown|3
7332596|NCT00819767|11566437|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7332597|NCT00819767|11566438|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7332602|NCT00819910|11566457|FG000|Overall Study|Adverse Event|0
7332603|NCT00819910|11566458|FG001|Overall Study|Adverse Event|0
7332604|NCT00819910|11566459|FG002|Overall Study|Adverse Event|2
7332605|NCT00819910|11566460|FG003|Overall Study|Adverse Event|1
7332606|NCT00819910|11566457|FG000|Overall Study|Withdrawal by Subject|1
7332607|NCT00819910|11566458|FG001|Overall Study|Withdrawal by Subject|1
7332608|NCT00819910|11566459|FG002|Overall Study|Withdrawal by Subject|1
7332609|NCT00819910|11566460|FG003|Overall Study|Withdrawal by Subject|0
7332610|NCT00819910|11566457|FG000|Overall Study|Lost to Follow-up|1
7332611|NCT00819910|11566458|FG001|Overall Study|Lost to Follow-up|0
7332612|NCT00819910|11566459|FG002|Overall Study|Lost to Follow-up|0
7332613|NCT00819910|11566460|FG003|Overall Study|Lost to Follow-up|0
7332614|NCT00820040|11566472|FG000|Overall Study|Death|1
7332615|NCT00820040|11566472|FG000|Overall Study|Sponsor terminated study|1
7332616|NCT00820040|11566472|FG000|Overall Study|Screen failure|1
7332617|NCT00820170|11566481|FG000|Overall Study|Adverse Event|0
7332618|NCT00820170|11566482|FG001|Overall Study|Adverse Event|0
7332619|NCT00820170|11566483|FG002|Overall Study|Adverse Event|0
7332620|NCT00820170|11566484|FG003|Overall Study|Adverse Event|0
7332621|NCT00820170|11566485|FG004|Overall Study|Adverse Event|2
7332622|NCT00820170|11566481|FG000|Overall Study|Progressive Disease|0
7332623|NCT00820170|11566482|FG001|Overall Study|Progressive Disease|0
7332624|NCT00820170|11566483|FG002|Overall Study|Progressive Disease|0
7332625|NCT00820170|11566484|FG003|Overall Study|Progressive Disease|0
7332626|NCT00820170|11566485|FG004|Overall Study|Progressive Disease|2
7332627|NCT00820222|11566504|FG000|Overall Study|Lost to Follow-up|10
7332628|NCT00820222|11566505|FG001|Overall Study|Lost to Follow-up|9
7332629|NCT00820222|11566504|FG000|Overall Study|Withdrawal by Subject|19
7332630|NCT00820222|11566505|FG001|Overall Study|Withdrawal by Subject|21
7332631|NCT00820222|11566504|FG000|Overall Study|Physician Decision|93
7332632|NCT00820222|11566505|FG001|Overall Study|Physician Decision|88
7332633|NCT00820222|11566504|FG000|Overall Study|Sponsor Terminated Study|43
7332634|NCT00820222|11566505|FG001|Overall Study|Sponsor Terminated Study|65
7332635|NCT00820222|11566504|FG000|Overall Study|Unkown|11
7332636|NCT00820222|11566505|FG001|Overall Study|Unkown|7
7332637|NCT00820248|11566526|FG000|Overall Study|No treated|4
7332638|NCT00820248|11566527|FG001|Overall Study|No treated|1
7332639|NCT00820599|11566573|FG000|Overall Study|Death|129
7332640|NCT00820599|11566573|FG000|Overall Study|Withdrawal by Subject|2
7332641|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
7332642|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
7332643|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
7332644|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Death|28
7332645|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Death|0
7332646|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Death|0
7332647|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
7332648|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
7332649|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
7332650|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
7332651|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7332652|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
7332653|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
7225223|NCT00064701|11434642|FG000|Clinical Continuation Phase|Pancreas transplant|1
7332654|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7332655|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
7332656|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
7332657|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
7332658|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
7332659|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
7332660|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7332661|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
7332662|NCT00820755|11566599|FG000|Period 1: Combination Therapy Phase|Other|11
7332663|NCT00820755|11566600|FG001|Period 1: Combination Therapy Phase|Other|0
7332664|NCT00820755|11566601|FG002|Period 1: Combination Therapy Phase|Other|0
7332665|NCT00820755|11566599|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
7332666|NCT00820755|11566600|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7332667|NCT00820755|11566601|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
7385194|NCT01199471|11642781|FG000|Overall Study|Withdrawal by Subject|1
7332668|NCT00820898|11566613|FG000|Overall Study|Inelgible - wrong primary site|1
7332669|NCT00821015|11566623|FG000|Overall Study|Lost to Follow-up|12
7332670|NCT00821093|11566638|FG000|Overall Study|Adverse Event|20
7332671|NCT00821093|11566639|FG001|Overall Study|Adverse Event|12
7332672|NCT00821093|11566638|FG000|Overall Study|Withdrawal by Subject|9
7332673|NCT00821093|11566639|FG001|Overall Study|Withdrawal by Subject|13
7332674|NCT00821093|11566638|FG000|Overall Study|Lost to Follow-up|9
7332675|NCT00821093|11566639|FG001|Overall Study|Lost to Follow-up|3
7332676|NCT00821093|11566638|FG000|Overall Study|Protocol deviation|3
7332677|NCT00821093|11566639|FG001|Overall Study|Protocol deviation|6
7332678|NCT00821093|11566638|FG000|Overall Study|Abnormal laboratory value(s)|2
7332679|NCT00821093|11566639|FG001|Overall Study|Abnormal laboratory value(s)|0
7332680|NCT00821093|11566638|FG000|Overall Study|Lack of Efficacy|2
7332681|NCT00821093|11566639|FG001|Overall Study|Lack of Efficacy|2
7332682|NCT00821093|11566638|FG000|Overall Study|Death|2
7332683|NCT00821093|11566639|FG001|Overall Study|Death|1
7332684|NCT00821093|11566638|FG000|Overall Study|Abnormal test procedure result(s)|1
7332685|NCT00821093|11566639|FG001|Overall Study|Abnormal test procedure result(s)|1
7332686|NCT00821093|11566638|FG000|Overall Study|Administrative problems|1
7332687|NCT00821093|11566639|FG001|Overall Study|Administrative problems|2
7385195|NCT01199471|11642781|FG000|Overall Study|Physician Decision|1
7385196|NCT01199575|11642786|FG000|Overall Study|Withdrawal by Subject|5
7385197|NCT01199601|11642793|FG000|Overall Study|Lost to Follow-up|47
7385198|NCT01199601|11642794|FG001|Overall Study|Lost to Follow-up|66
7385199|NCT01199601|11642793|FG000|Overall Study|Withdrawal by Subject|15
7385200|NCT01199601|11642794|FG001|Overall Study|Withdrawal by Subject|3
7385201|NCT01199601|11642793|FG000|Overall Study|Insecurity prevented staff interviewing.|7
7385202|NCT01199601|11642794|FG001|Overall Study|Insecurity prevented staff interviewing.|9
7385203|NCT01199705|11642800|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
7385204|NCT01199731|11642818|FG000|Overall Study|Adverse Event|0
7385205|NCT01199731|11642819|FG001|Overall Study|Adverse Event|1
7385206|NCT01199731|11642820|FG002|Overall Study|Adverse Event|0
7385207|NCT01199731|11642818|FG000|Overall Study|Study closed/terminated|7
7385208|NCT01199731|11642819|FG001|Overall Study|Study closed/terminated|9
7385209|NCT01199731|11642820|FG002|Overall Study|Study closed/terminated|7
7385210|NCT01199731|11642818|FG000|Overall Study|Lost to Follow-up|0
7385211|NCT01199731|11642819|FG001|Overall Study|Lost to Follow-up|0
7385212|NCT01199731|11642820|FG002|Overall Study|Lost to Follow-up|2
7385213|NCT01199731|11642818|FG000|Overall Study|Physician Decision|0
7385214|NCT01199731|11642819|FG001|Overall Study|Physician Decision|1
7385215|NCT01199731|11642820|FG002|Overall Study|Physician Decision|1
7385216|NCT01199731|11642818|FG000|Overall Study|Withdrawal by Subject|2
7385217|NCT01199731|11642819|FG001|Overall Study|Withdrawal by Subject|0
7385218|NCT01199731|11642820|FG002|Overall Study|Withdrawal by Subject|0
7385219|NCT01199822|11642835|FG000|Overall Study|Investigator discontinued therapy|0
7385220|NCT01199822|11642836|FG001|Overall Study|Investigator discontinued therapy|1
7385221|NCT01199822|11642837|FG002|Overall Study|Investigator discontinued therapy|0
7385222|NCT01199861|11642864|FG000|Overall Study|Administrative problems|1
7385223|NCT01199861|11642865|FG001|Overall Study|Administrative problems|0
7385224|NCT01199861|11642864|FG000|Overall Study|Adverse Event|1
7385225|NCT01199861|11642865|FG001|Overall Study|Adverse Event|0
7385226|NCT01199939|11642880|FG000|Overall Study|Adverse Event|4
7385227|NCT01199939|11642880|FG000|Overall Study|Protocol Violation|3
7385228|NCT01199939|11642880|FG000|Overall Study|Lost to Follow-up|2
7385229|NCT01199939|11642880|FG000|Overall Study|Reached a virologic endpoint|4
7385230|NCT01200069|11642926|FG000|Overall Study|Withdrawal by Subject|0
7385231|NCT01200069|11642927|FG001|Overall Study|Withdrawal by Subject|1
7385232|NCT01200238|11642982|FG000|Overall Study|Adverse Event|2
7385233|NCT01200238|11642983|FG001|Overall Study|Adverse Event|1
7385234|NCT01200238|11642982|FG000|Overall Study|Progressive Disease|5
7385235|NCT01200238|11642983|FG001|Overall Study|Progressive Disease|8
7385236|NCT01200238|11642982|FG000|Overall Study|Withdrawal by Subject|0
7385237|NCT01200238|11642983|FG001|Overall Study|Withdrawal by Subject|1
7385238|NCT01200290|11642989|FG000|Treatment Period|Adverse Event|1
7385239|NCT01200290|11642989|FG000|Post-Treatment Follow-Up Period|Death|2
7385240|NCT01200329|11642993|FG000|Overall Study|Lack of financial coverage|2
7385241|NCT01200329|11642993|FG000|Overall Study|Progressive disease|1
7385242|NCT01200342|11642997|FG000|Overall Study|Disease Progression|1
7385243|NCT01200355|11643003|FG000|Overall Study|Death|7
7385244|NCT01200355|11643004|FG001|Overall Study|Death|2
7385245|NCT01200368|11643013|FG000|Infant Series|Adverse Event|2
7385246|NCT01200368|11643014|FG001|Infant Series|Adverse Event|2
7385247|NCT01200368|11643015|FG002|Infant Series|Adverse Event|3
7385248|NCT01200368|11643013|FG000|Infant Series|Withdrawal by Subject|0
7385249|NCT01200368|11643014|FG001|Infant Series|Withdrawal by Subject|2
7385250|NCT01200368|11643015|FG002|Infant Series|Withdrawal by Subject|2
7385251|NCT01200368|11643013|FG000|Infant Series|Did not meet entrance criteria|0
7385252|NCT01200368|11643014|FG001|Infant Series|Did not meet entrance criteria|1
7385253|NCT01200368|11643015|FG002|Infant Series|Did not meet entrance criteria|0
7385254|NCT01200368|11643013|FG000|Infant Series|Randomized, not vaccinated|0
7385255|NCT01200368|11643014|FG001|Infant Series|Randomized, not vaccinated|1
7385256|NCT01200368|11643015|FG002|Infant Series|Randomized, not vaccinated|1
7385257|NCT01200368|11643013|FG000|Infant Series|Other|1
7332688|NCT04187989|11566669|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6
7332689|NCT04187989|11566670|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8
7332690|NCT04187989|11566669|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
7332691|NCT04187989|11566670|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
7332692|NCT04109118|11566676|FG000|Overall Study|Lost to Follow-up|3
7332695|NCT03846219|11566695|FG000|Overall Study|Withdrawal by Subject|3
7332696|NCT03846219|11566696|FG001|Overall Study|Withdrawal by Subject|2
7332697|NCT03846219|11566697|FG002|Overall Study|Withdrawal by Subject|2
7332698|NCT03846219|11566695|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
7332699|NCT03846219|11566696|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
7332700|NCT03846219|11566697|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
7332701|NCT03846219|11566695|FG000|Overall Study|Physician Decision|0
7332702|NCT03846219|11566696|FG001|Overall Study|Physician Decision|0
7332703|NCT03846219|11566697|FG002|Overall Study|Physician Decision|2
7332704|NCT03606668|11566739|FG000|Overall Study|Screen Failure|1
7332705|NCT03606668|11566739|FG000|Overall Study|Lost to Follow-up|1
7332706|NCT03575897|11566745|FG000|Overall Study|Lost to Follow-up|12
7332707|NCT03575897|11566746|FG001|Overall Study|Lost to Follow-up|13
7332708|NCT03343626|11566760|FG000|Overall Study|Lost to Follow-up|4
7332709|NCT03343626|11566761|FG001|Overall Study|Lost to Follow-up|3
7332710|NCT03343626|11566762|FG002|Overall Study|Lost to Follow-up|2
7332711|NCT03343626|11566763|FG003|Overall Study|Lost to Follow-up|5
7332712|NCT03343626|11566764|FG004|Overall Study|Lost to Follow-up|4
7332713|NCT03343626|11566765|FG005|Overall Study|Lost to Follow-up|4
7332714|NCT03343626|11566766|FG006|Overall Study|Lost to Follow-up|4
7332715|NCT03343626|11566767|FG007|Overall Study|Lost to Follow-up|7
7332716|NCT03343626|11566760|FG000|Overall Study|Withdrawal of Consent|2
7332717|NCT03343626|11566761|FG001|Overall Study|Withdrawal of Consent|1
7332718|NCT03343626|11566762|FG002|Overall Study|Withdrawal of Consent|0
7332719|NCT03343626|11566763|FG003|Overall Study|Withdrawal of Consent|3
7332720|NCT03343626|11566764|FG004|Overall Study|Withdrawal of Consent|3
7332721|NCT03343626|11566765|FG005|Overall Study|Withdrawal of Consent|1
7332722|NCT03343626|11566766|FG006|Overall Study|Withdrawal of Consent|1
7332723|NCT03343626|11566767|FG007|Overall Study|Withdrawal of Consent|2
7332724|NCT03343626|11566760|FG000|Overall Study|Reason not Specified|0
7332725|NCT03343626|11566761|FG001|Overall Study|Reason not Specified|1
7332726|NCT03343626|11566762|FG002|Overall Study|Reason not Specified|0
7332727|NCT03343626|11566763|FG003|Overall Study|Reason not Specified|0
7332728|NCT03343626|11566764|FG004|Overall Study|Reason not Specified|0
7332729|NCT03343626|11566765|FG005|Overall Study|Reason not Specified|0
7332730|NCT03343626|11566766|FG006|Overall Study|Reason not Specified|0
7332731|NCT03343626|11566767|FG007|Overall Study|Reason not Specified|1
7332732|NCT03343626|11566760|FG000|Overall Study|Data Entry Error|0
7332733|NCT03343626|11566761|FG001|Overall Study|Data Entry Error|0
7332734|NCT03343626|11566762|FG002|Overall Study|Data Entry Error|0
7332735|NCT03343626|11566763|FG003|Overall Study|Data Entry Error|0
7332736|NCT03343626|11566764|FG004|Overall Study|Data Entry Error|0
7332737|NCT03343626|11566765|FG005|Overall Study|Data Entry Error|0
7332738|NCT03343626|11566766|FG006|Overall Study|Data Entry Error|0
7332739|NCT03343626|11566767|FG007|Overall Study|Data Entry Error|1
7332740|NCT02807363|11566822|FG000|Dosing Period|Adverse Event|0
7332741|NCT02807363|11566823|FG001|Dosing Period|Adverse Event|1
7332742|NCT02807363|11566824|FG002|Dosing Period|Adverse Event|0
7332743|NCT02807363|11566825|FG003|Dosing Period|Adverse Event|0
7332744|NCT02756403|11566841|FG000|Overall Study|Unable to swallow medication|0
7332745|NCT02756403|11566842|FG001|Overall Study|Unable to swallow medication|1
7332746|NCT02756403|11566843|FG002|Overall Study|Unable to swallow medication|1
7332747|NCT02756403|11566844|FG003|Overall Study|Unable to swallow medication|1
7332748|NCT02756403|11566841|FG000|Overall Study|Did not complete Procedure|0
7332749|NCT02756403|11566842|FG001|Overall Study|Did not complete Procedure|1
7332750|NCT02756403|11566843|FG002|Overall Study|Did not complete Procedure|0
7332751|NCT02756403|11566844|FG003|Overall Study|Did not complete Procedure|0
7332752|NCT02756403|11566841|FG000|Overall Study|Changed Mind About Procedure|0
7332753|NCT02756403|11566842|FG001|Overall Study|Changed Mind About Procedure|0
7332754|NCT02756403|11566843|FG002|Overall Study|Changed Mind About Procedure|1
7332755|NCT02756403|11566844|FG003|Overall Study|Changed Mind About Procedure|0
7332756|NCT02756403|11566841|FG000|Overall Study|Protocol Violation|0
7332757|NCT02756403|11566842|FG001|Overall Study|Protocol Violation|1
7332758|NCT02756403|11566843|FG002|Overall Study|Protocol Violation|0
7332759|NCT02756403|11566844|FG003|Overall Study|Protocol Violation|1
7332760|NCT02751502|11566854|FG000|Overall Study|Lack of funding|4
7332767|NCT01981096|11566895|FG000|Overall Study|Parent illness|1
7332768|NCT01981096|11566896|FG001|Overall Study|Parent illness|0
7332769|NCT01981096|11566895|FG000|Overall Study|Withdrawal by Subject|0
7332770|NCT01981096|11566896|FG001|Overall Study|Withdrawal by Subject|1
7332771|NCT01981096|11566895|FG000|Overall Study|Lost to Follow-up|2
7332772|NCT01981096|11566896|FG001|Overall Study|Lost to Follow-up|0
7332773|NCT01935336|11566906|FG000|Overall Study|Adverse Event|1
7332774|NCT01935336|11566907|FG001|Overall Study|Adverse Event|0
7332775|NCT01935336|11566908|FG002|Overall Study|Adverse Event|0
7332776|NCT01935336|11566909|FG003|Overall Study|Adverse Event|0
7332777|NCT01935336|11566906|FG000|Overall Study|Progressive disease|5
7332778|NCT01935336|11566907|FG001|Overall Study|Progressive disease|3
7332779|NCT01935336|11566908|FG002|Overall Study|Progressive disease|47
7332780|NCT01935336|11566909|FG003|Overall Study|Progressive disease|66
7332781|NCT01712490|11566927|FG000|Overall Study|Ongoing|601
7332782|NCT01712490|11566928|FG001|Overall Study|Ongoing|586
7332783|NCT01712490|11566927|FG000|Overall Study|Other|11
7332784|NCT01712490|11566928|FG001|Overall Study|Other|11
7332785|NCT01712490|11566927|FG000|Overall Study|Withdrawal by Subject|36
7332786|NCT01712490|11566928|FG001|Overall Study|Withdrawal by Subject|44
7332787|NCT01712490|11566927|FG000|Overall Study|Lost to Follow-up|16
7332788|NCT01712490|11566928|FG001|Overall Study|Lost to Follow-up|29
7332789|NCT01702805|11566936|FG000|Overall Study|Data withdrawn prior to hospital discharge|3
7332790|NCT01702805|11566937|FG001|Overall Study|Data withdrawn prior to hospital discharge|7
7332791|NCT01702805|11566936|FG000|Overall Study|Incomplete Follow-up|18
7332792|NCT01702805|11566937|FG001|Overall Study|Incomplete Follow-up|15
7332793|NCT01702805|11566936|FG000|Overall Study|Vital Status Assessment Only|40
7332794|NCT01702805|11566937|FG001|Overall Study|Vital Status Assessment Only|39
7332795|NCT01702805|11566936|FG000|Overall Study|Lost to Follow-up|5
7332796|NCT01702805|11566937|FG001|Overall Study|Lost to Follow-up|5
7332797|NCT01499160|11566943|FG000|Overall Study|Adverse Event|1
7332798|NCT01499160|11566943|FG000|Overall Study|Withdrawal by Subject|1
7332799|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
7332800|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7332801|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
7332802|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
7332803|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
7332804|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
7332805|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
7332806|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
7332807|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
7332808|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
7332809|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
7332810|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
7332811|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
7332812|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
7332813|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
7332814|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
7332815|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
7332816|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
7332817|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
7332818|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
7332819|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
7332820|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
7332821|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
7332822|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
7332892|NCT00821431|11567057|FG000|Overall Study|Adverse Event|6
7332823|NCT01061151|11566985|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
7332824|NCT01061151|11566986|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
7332825|NCT01061151|11566987|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
7332826|NCT01061151|11566988|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
7332827|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7332828|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
7332829|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
7332830|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
7332831|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
7332832|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7332833|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7332834|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
7332835|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
7332836|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
7332837|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
7457877|NCT01803282|11751721|FG004|Overall Study|Adverse Event|0
7457878|NCT01803282|11751722|FG005|Overall Study|Adverse Event|0
7457879|NCT01803282|11751723|FG006|Overall Study|Adverse Event|1
7457880|NCT01803282|11751724|FG007|Overall Study|Adverse Event|2
7457881|NCT01803282|11751725|FG008|Overall Study|Adverse Event|0
7457882|NCT01803282|11751726|FG009|Overall Study|Adverse Event|1
7457883|NCT01803282|11751727|FG010|Overall Study|Adverse Event|0
7457884|NCT01803282|11751728|FG011|Overall Study|Adverse Event|3
7332838|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
7332839|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
7332840|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
7332841|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
7332842|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
7332843|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
7332844|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
7332845|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
7332846|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
7332847|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
7332848|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
7332849|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
7332850|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
7332851|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
7332852|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
7332853|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
7332854|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
7332855|NCT01061151|11566985|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
7332856|NCT01061151|11566986|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
7332857|NCT01061151|11566987|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
7332858|NCT01061151|11566988|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
7332859|NCT00981058|11567010|FG000|Overall Study|Adverse Event|1
7332860|NCT00981058|11567011|FG001|Overall Study|Adverse Event|1
7332861|NCT00981058|11567010|FG000|Overall Study|Progressive Disease|61
7332862|NCT00981058|11567011|FG001|Overall Study|Progressive Disease|49
7332863|NCT00981058|11567010|FG000|Overall Study|Lost to Follow-up|16
7332864|NCT00981058|11567011|FG001|Overall Study|Lost to Follow-up|15
7332865|NCT00981058|11567010|FG000|Overall Study|New Anticancer Therapy|6
7332866|NCT00981058|11567011|FG001|Overall Study|New Anticancer Therapy|6
7332867|NCT00981058|11567010|FG000|Overall Study|Noncompliance|1
7332868|NCT00981058|11567011|FG001|Overall Study|Noncompliance|0
7332869|NCT00981058|11567010|FG000|Overall Study|Radiologist Error|0
7332870|NCT00981058|11567011|FG001|Overall Study|Radiologist Error|1
7332871|NCT00981058|11567010|FG000|Overall Study|Randomization Error|1
7332872|NCT00981058|11567011|FG001|Overall Study|Randomization Error|2
7332873|NCT00981058|11567010|FG000|Overall Study|Withdrawal by Subject|25
7332874|NCT00981058|11567011|FG001|Overall Study|Withdrawal by Subject|23
7332875|NCT00981058|11567010|FG000|Overall Study|On study treatment at conclusion|9
7332876|NCT00981058|11567011|FG001|Overall Study|On study treatment at conclusion|0
7332877|NCT00885495|11567019|FG000|Overall Study|Adverse Event|1
7332878|NCT00885495|11567020|FG001|Overall Study|Adverse Event|2
7332879|NCT00885495|11567019|FG000|Overall Study|Protocol Violation|0
7332880|NCT00885495|11567020|FG001|Overall Study|Protocol Violation|1
7332881|NCT00885495|11567019|FG000|Overall Study|Withdrawal by Subject|1
7332882|NCT00885495|11567020|FG001|Overall Study|Withdrawal by Subject|0
7332883|NCT00084799|11567033|FG000|Overall Study|Disease Progression|1
7332884|NCT00084799|11567034|FG001|Overall Study|Disease Progression|0
7332885|NCT00821236|11567043|FG000|Overall Study|Lost to Follow-up|3
7332886|NCT00821327|11567051|FG000|Overall Study|Adverse Event|13
7332887|NCT00821327|11567051|FG000|Overall Study|Patient Request|1
7332888|NCT00821327|11567051|FG000|Overall Study|Investigator Request|2
7332889|NCT00821327|11567051|FG000|Overall Study|Sponsor Request|1
7332890|NCT00821327|11567051|FG000|Overall Study|Disease Progression|13
7332891|NCT00821327|11567051|FG000|Overall Study|Other/Unknown|5
7332893|NCT00821431|11567058|FG001|Overall Study|Adverse Event|3
7332894|NCT00821431|11567057|FG000|Overall Study|Withdrawal by Subject|5
7332895|NCT00821431|11567058|FG001|Overall Study|Withdrawal by Subject|0
7332896|NCT00821431|11567057|FG000|Overall Study|Lost to Follow-up|1
7332897|NCT00821431|11567058|FG001|Overall Study|Lost to Follow-up|0
7332898|NCT00821431|11567057|FG000|Overall Study|Protocol Violation|3
7332899|NCT00821431|11567058|FG001|Overall Study|Protocol Violation|1
7332900|NCT00821431|11567057|FG000|Overall Study|Physician Decision|0
7332901|NCT00821431|11567058|FG001|Overall Study|Physician Decision|1
7332902|NCT00821509|11567067|FG000|Overall Study|Withdrawal by Subject|12
7568502|NCT03414359|11943679|FG000|Overall Study|Lack of Efficacy|1
7568503|NCT03414359|11943680|FG001|Overall Study|Lack of Efficacy|1
7568504|NCT03414359|11943679|FG000|Overall Study|Protocol Violation|0
7568505|NCT03414359|11943680|FG001|Overall Study|Protocol Violation|1
7568506|NCT03415178|11943695|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
7568507|NCT03415178|11943696|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
7568508|NCT03415178|11943695|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
7332903|NCT00821509|11567068|FG001|Overall Study|Withdrawal by Subject|11
7332904|NCT00821509|11567069|FG002|Overall Study|Withdrawal by Subject|34
7332905|NCT00821678|11567090|FG000|Overall Study|Withdrawal by Subject|8
7332906|NCT00821678|11567091|FG001|Overall Study|Withdrawal by Subject|0
7332907|NCT00821678|11567090|FG000|Overall Study|Lost to Follow-up|13
7332908|NCT00821678|11567091|FG001|Overall Study|Lost to Follow-up|12
7332909|NCT00821678|11567090|FG000|Overall Study|Death|0
7568509|NCT03415178|11943696|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
7332910|NCT00821678|11567091|FG001|Overall Study|Death|2
7332911|NCT00821873|11567123|FG000|Overall Study|Lost to Follow-up|4
7332912|NCT00822172|11567157|FG000|Overall Study|Adverse Event|10
7332913|NCT00822172|11567158|FG001|Overall Study|Adverse Event|12
7332914|NCT00822172|11567157|FG000|Overall Study|Death|1
7332915|NCT00822172|11567158|FG001|Overall Study|Death|0
7332916|NCT00822172|11567157|FG000|Overall Study|Lost to Follow-up|3
7332917|NCT00822172|11567158|FG001|Overall Study|Lost to Follow-up|1
7332918|NCT00822172|11567157|FG000|Overall Study|Withdrawal by Subject|1
7332919|NCT00822172|11567158|FG001|Overall Study|Withdrawal by Subject|4
7332920|NCT00822172|11567157|FG000|Overall Study|site closed|0
7332921|NCT00822172|11567158|FG001|Overall Study|site closed|1
7332922|NCT00822172|11567157|FG000|Overall Study|Other|0
7332923|NCT00822172|11567158|FG001|Overall Study|Other|1
7332924|NCT00822237|11567187|FG000|Dose 1 Vaccination|Not vaccinated|3
7332925|NCT00822237|11567188|FG001|Dose 1 Vaccination|Not vaccinated|0
7332926|NCT00822237|11567187|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
7332927|NCT00822237|11567188|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
7332928|NCT00822237|11567187|FG000|Dose 1 Vaccination|Lost to Follow-up|9
7332929|NCT00822237|11567188|FG001|Dose 1 Vaccination|Lost to Follow-up|12
7332930|NCT00822237|11567187|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
7332931|NCT00822237|11567188|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
7332932|NCT00822237|11567187|FG000|Dose 2 Vaccination|Lost to Follow-up|2
7332933|NCT00822237|11567188|FG001|Dose 2 Vaccination|Lost to Follow-up|9
7332934|NCT00822692|11567256|FG000|Overall Study|Lost to Follow-up|17
7332935|NCT00822692|11567257|FG001|Overall Study|Lost to Follow-up|25
7332936|NCT00822770|11567274|FG000|Overall Study|Not treated|1
7332937|NCT00822770|11567275|FG001|Overall Study|Not treated|0
7332938|NCT00822770|11567274|FG000|Overall Study|Complication/Incomplete treatment|1
7332939|NCT00822770|11567275|FG001|Overall Study|Complication/Incomplete treatment|0
7332940|NCT00822770|11567274|FG000|Overall Study|Death|1
7332941|NCT00822770|11567275|FG001|Overall Study|Death|1
7332942|NCT00822900|11567283|FG000|Overall Study|Withdrawal by Subject|14
7332943|NCT00822900|11567284|FG001|Overall Study|Withdrawal by Subject|14
7332944|NCT00822900|11567283|FG000|Overall Study|Lost to Follow-up|9
7332945|NCT00822900|11567284|FG001|Overall Study|Lost to Follow-up|9
7332946|NCT00822900|11567283|FG000|Overall Study|Death|83
7332947|NCT00822900|11567284|FG001|Overall Study|Death|69
7332948|NCT00822900|11567283|FG000|Overall Study|Became a ward of the state|2
7332949|NCT00822900|11567284|FG001|Overall Study|Became a ward of the state|1
7332950|NCT00822926|11567292|FG000|Second Injection Visit|Lost to Follow-up|1
7332951|NCT00822926|11567293|FG001|Second Injection Visit|Lost to Follow-up|0
7332952|NCT00822926|11567292|FG000|Second Injection Visit|Withdrawal by Subject|0
7332953|NCT00822926|11567293|FG001|Second Injection Visit|Withdrawal by Subject|1
7332954|NCT00823134|11567324|FG000|Overall Study|Invalid measurement|1
7332955|NCT00823199|11567329|FG000|Overall Study|Withdrawal by Subject|2
7332956|NCT00823212|11567336|FG000|Overall Study|Death|8
7332957|NCT00823212|11567337|FG001|Overall Study|Death|10
7332958|NCT00823212|11567336|FG000|Overall Study|Withdrawal by Subject|6
7332959|NCT00823212|11567337|FG001|Overall Study|Withdrawal by Subject|1
7332960|NCT00823212|11567336|FG000|Overall Study|Incarcerated|0
7332961|NCT00823212|11567337|FG001|Overall Study|Incarcerated|1
7332962|NCT00823212|11567336|FG000|Overall Study|Missed 12-month visit|21
7332963|NCT00823212|11567337|FG001|Overall Study|Missed 12-month visit|21
7332964|NCT00823264|11567347|FG000|Overall Study|Protocol Violation|2
7332965|NCT00823264|11567348|FG001|Overall Study|Protocol Violation|0
7332966|NCT00823472|11567370|FG000|Overall Study|Physician Decision|24
7332967|NCT00823472|11567371|FG001|Overall Study|Physician Decision|28
7332968|NCT00823615|11567377|FG000|Period 2|Lost to Follow-up|2
7568510|NCT03416127|11943729|FG000|Overall Study|Withdrawal by Subject|0
7568511|NCT03416127|11943730|FG001|Overall Study|Withdrawal by Subject|1
7568512|NCT03416127|11943731|FG002|Overall Study|Withdrawal by Subject|1
7568513|NCT03417024|11943780|FG000|Overall Study|Study Termination prior to follow-up|11
7568514|NCT03417024|11943780|FG000|Overall Study|Physician Decision|2
7568515|NCT03417141|11943784|FG000|Overall Study|Withdrawal by Subject|1
7568516|NCT03417141|11943784|FG000|Overall Study|Protocol Violation|3
7568517|NCT03417219|11943790|FG000|Overall Study|Lost to Follow-up|0
7568518|NCT03417219|11943791|FG001|Overall Study|Lost to Follow-up|3
7332969|NCT00823615|11567378|FG001|Period 2|Lost to Follow-up|0
7332970|NCT00823615|11567377|FG000|Period 2|Time/Job Conflict|1
7332971|NCT00823615|11567378|FG001|Period 2|Time/Job Conflict|2
7332972|NCT00823719|11567386|FG000|Overall Study|Adverse Event|1
7332973|NCT00823719|11567387|FG001|Overall Study|Adverse Event|2
7332974|NCT00823719|11567386|FG000|Overall Study|Physician Decision|1
7332975|NCT00823719|11567387|FG001|Overall Study|Physician Decision|4
7332976|NCT00823719|11567386|FG000|Overall Study|Withdrawal by Subject|0
7332977|NCT00823719|11567387|FG001|Overall Study|Withdrawal by Subject|1
7332978|NCT00823719|11567386|FG000|Overall Study|Disease Progression|4
7332979|NCT00823719|11567387|FG001|Overall Study|Disease Progression|4
7385258|NCT01200368|11643014|FG001|Infant Series|Other|0
7385259|NCT01200368|11643015|FG002|Infant Series|Other|0
7385260|NCT01200368|11643013|FG000|After Infant Series|Adverse Event|6
7385261|NCT01200368|11643014|FG001|After Infant Series|Adverse Event|6
7385262|NCT01200368|11643015|FG002|After Infant Series|Adverse Event|3
7385263|NCT01200368|11643013|FG000|After Infant Series|Withdrawal by Subject|10
7385264|NCT01200368|11643014|FG001|After Infant Series|Withdrawal by Subject|8
7385265|NCT01200368|11643015|FG002|After Infant Series|Withdrawal by Subject|4
7385266|NCT01200368|11643013|FG000|After Infant Series|Lost to Follow-up|1
7385267|NCT01200368|11643014|FG001|After Infant Series|Lost to Follow-up|0
7385268|NCT01200368|11643015|FG002|After Infant Series|Lost to Follow-up|0
7385269|NCT01200368|11643013|FG000|After Infant Series|Other|1
7385270|NCT01200368|11643014|FG001|After Infant Series|Other|2
7385271|NCT01200368|11643015|FG002|After Infant Series|Other|2
7385272|NCT01200368|11643013|FG000|Toddler Dose|Adverse Event|0
7385273|NCT01200368|11643014|FG001|Toddler Dose|Adverse Event|3
7385274|NCT01200368|11643015|FG002|Toddler Dose|Adverse Event|1
7385275|NCT01200394|11643032|FG000|Overall Study|Adverse Event|0
7385276|NCT01200394|11643033|FG001|Overall Study|Adverse Event|14
7385277|NCT01200394|11643032|FG000|Overall Study|Death|1
7385278|NCT01200394|11643033|FG001|Overall Study|Death|0
7385279|NCT01200394|11643032|FG000|Overall Study|Lost to Follow-up|0
7385280|NCT01200394|11643033|FG001|Overall Study|Lost to Follow-up|1
7385281|NCT01200394|11643032|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7385282|NCT01200394|11643033|FG001|Overall Study|Did Not Meet Entrance Criteria|4
7385283|NCT01200394|11643032|FG000|Overall Study|Protocol Violation|0
7385284|NCT01200394|11643033|FG001|Overall Study|Protocol Violation|3
7385285|NCT01200394|11643032|FG000|Overall Study|Withdrawal by Subject|0
7385286|NCT01200394|11643033|FG001|Overall Study|Withdrawal by Subject|5
7385287|NCT01200394|11643032|FG000|Overall Study|Other|0
7385288|NCT01200394|11643033|FG001|Overall Study|Other|1
7385289|NCT01200407|11643040|FG000|Overall Study|Lost to Follow-up|56
7385290|NCT01200407|11643040|FG000|Overall Study|Adverse Event|3
7385291|NCT01200407|11643040|FG000|Overall Study|Withdrawal by Subject|4
7385292|NCT01200407|11643040|FG000|Overall Study|Other|19
7385293|NCT01200485|11643053|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
7385294|NCT01200485|11643054|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7385295|NCT01200485|11643055|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
7385296|NCT01200485|11643053|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
7385297|NCT01200485|11643054|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7385298|NCT01200485|11643055|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
7385299|NCT01200511|11643066|FG000|Overall Study|Lost to Follow-up|3
7385300|NCT01200511|11643066|FG000|Overall Study|Withdrawal by Subject|1
7385301|NCT01200511|11643066|FG000|Overall Study|Adverse Event|1
7385302|NCT01200524|11643075|FG000|Overall Study|Withdrawal by Subject|1
7385303|NCT01200524|11643076|FG001|Overall Study|Withdrawal by Subject|1
7385304|NCT01200524|11643077|FG002|Overall Study|Withdrawal by Subject|3
7385305|NCT01200524|11643075|FG000|Overall Study|Adverse Event|1
7385306|NCT01200524|11643076|FG001|Overall Study|Adverse Event|0
7385307|NCT01200524|11643077|FG002|Overall Study|Adverse Event|0
7385308|NCT01200524|11643075|FG000|Overall Study|Non availability of study nurse|0
7385309|NCT01200524|11643076|FG001|Overall Study|Non availability of study nurse|0
7385310|NCT01200524|11643077|FG002|Overall Study|Non availability of study nurse|1
7385311|NCT01200589|11643087|FG000|Overall Study|Withdrawal by Subject|13
7385312|NCT01200589|11643088|FG001|Overall Study|Withdrawal by Subject|11
7385313|NCT01200589|11643087|FG000|Overall Study|Physician Decision|2
7385314|NCT01200589|11643088|FG001|Overall Study|Physician Decision|2
7385315|NCT01200589|11643087|FG000|Overall Study|Lost to Follow-up|5
7385316|NCT01200589|11643088|FG001|Overall Study|Lost to Follow-up|4
7385317|NCT01200589|11643087|FG000|Overall Study|Study terminated|170
7385318|NCT01200589|11643088|FG001|Overall Study|Study terminated|172
7387604|NCT01215227|11646202|FG005|Overall Study|Adverse Event|6
7387605|NCT01215227|11646197|FG000|Overall Study|Treatment Failure|8
7387606|NCT01215227|11646198|FG001|Overall Study|Treatment Failure|4
7387607|NCT01215227|11646199|FG002|Overall Study|Treatment Failure|1
7387608|NCT01215227|11646200|FG003|Overall Study|Treatment Failure|5
7387609|NCT01215227|11646201|FG004|Overall Study|Treatment Failure|1
7387610|NCT01215227|11646202|FG005|Overall Study|Treatment Failure|1
7387611|NCT01215227|11646197|FG000|Overall Study|Lost to Follow-up|1
7387612|NCT01215227|11646198|FG001|Overall Study|Lost to Follow-up|4
7387613|NCT01215227|11646199|FG002|Overall Study|Lost to Follow-up|1
7387614|NCT01215227|11646200|FG003|Overall Study|Lost to Follow-up|1
7387615|NCT01215227|11646201|FG004|Overall Study|Lost to Follow-up|1
7387616|NCT01215227|11646202|FG005|Overall Study|Lost to Follow-up|2
7387617|NCT01215227|11646197|FG000|Overall Study|Subject Withdrew Consent|16
7387618|NCT01215227|11646198|FG001|Overall Study|Subject Withdrew Consent|20
7387619|NCT01215227|11646199|FG002|Overall Study|Subject Withdrew Consent|7
7387620|NCT01215227|11646200|FG003|Overall Study|Subject Withdrew Consent|10
7387621|NCT01215227|11646201|FG004|Overall Study|Subject Withdrew Consent|11
7332980|NCT00823823|11567405|FG000|Overall Study|Lost to Follow-up|3
7332981|NCT00823823|11567406|FG001|Overall Study|Lost to Follow-up|1
7332982|NCT00823823|11567405|FG000|Overall Study|Protocol Violation|5
7332983|NCT00823823|11567406|FG001|Overall Study|Protocol Violation|5
7332984|NCT00823836|11567414|FG000|NV and PR/XR Switching Phases|Adverse Event|22
7332985|NCT00823836|11567415|FG001|NV and PR/XR Switching Phases|Adverse Event|21
7332986|NCT00823836|11567414|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
7332987|NCT00823836|11567415|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
7332988|NCT00823836|11567414|FG000|NV and PR/XR Switching Phases|Physician Decision|5
7332989|NCT00823836|11567415|FG001|NV and PR/XR Switching Phases|Physician Decision|2
7332990|NCT00823836|11567414|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
7332991|NCT00823836|11567415|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
7332992|NCT00823836|11567414|FG000|Long-term Phase|Adverse Event|3
7332993|NCT00823836|11567415|FG001|Long-term Phase|Adverse Event|2
7332994|NCT00823836|11567414|FG000|Long-term Phase|Physician Decision|1
7332995|NCT00823836|11567415|FG001|Long-term Phase|Physician Decision|2
7332996|NCT00823836|11567414|FG000|Long-term Phase|Withdrawal by Subject|1
7332997|NCT00823836|11567415|FG001|Long-term Phase|Withdrawal by Subject|1
7332998|NCT00823901|11567426|FG000|Overall Study|Adverse Event|1
7332999|NCT00823901|11567427|FG001|Overall Study|Adverse Event|1
7333000|NCT00823901|11567426|FG000|Overall Study|Lack of Efficacy|1
7333001|NCT00823901|11567427|FG001|Overall Study|Lack of Efficacy|0
7333002|NCT00823901|11567426|FG000|Overall Study|Lost to Follow-up|2
7333003|NCT00823901|11567427|FG001|Overall Study|Lost to Follow-up|1
7333004|NCT00823979|11567440|FG000|Overall Study|Lack of Efficacy|13
7333005|NCT00823979|11567441|FG001|Overall Study|Lack of Efficacy|16
7333006|NCT00823979|11567442|FG002|Overall Study|Lack of Efficacy|9
7333007|NCT00823979|11567440|FG000|Overall Study|Lost to Follow-up|2
7333008|NCT00823979|11567441|FG001|Overall Study|Lost to Follow-up|1
7333009|NCT00823979|11567442|FG002|Overall Study|Lost to Follow-up|0
7333010|NCT00823979|11567440|FG000|Overall Study|Withdrawal by Subject|2
7333011|NCT00823979|11567441|FG001|Overall Study|Withdrawal by Subject|3
7333012|NCT00823979|11567442|FG002|Overall Study|Withdrawal by Subject|2
7333013|NCT00823979|11567440|FG000|Overall Study|Protocol Violation|1
7333014|NCT00823979|11567441|FG001|Overall Study|Protocol Violation|1
7333015|NCT00823979|11567442|FG002|Overall Study|Protocol Violation|0
7333016|NCT00823979|11567440|FG000|Overall Study|Pregnancy|0
7333017|NCT00823979|11567441|FG001|Overall Study|Pregnancy|1
7333018|NCT00823979|11567442|FG002|Overall Study|Pregnancy|0
7333019|NCT00823979|11567440|FG000|Overall Study|Adverse Event|0
7333020|NCT00823979|11567441|FG001|Overall Study|Adverse Event|2
7333021|NCT00823979|11567442|FG002|Overall Study|Adverse Event|4
7333022|NCT00823979|11567440|FG000|Overall Study|Other|2
7333023|NCT00823979|11567441|FG001|Overall Study|Other|0
7333024|NCT00823979|11567442|FG002|Overall Study|Other|1
7333025|NCT00823979|11567440|FG000|Overall Study|Randomized but not Treated|4
7333026|NCT00823979|11567441|FG001|Overall Study|Randomized but not Treated|3
7333027|NCT00823979|11567442|FG002|Overall Study|Randomized but not Treated|1
7333028|NCT00823979|11567440|FG000|Overall Study|Study Terminated by Sponsor|5
7333029|NCT00823979|11567441|FG001|Overall Study|Study Terminated by Sponsor|5
7333030|NCT00823979|11567442|FG002|Overall Study|Study Terminated by Sponsor|7
7333031|NCT00824005|11567452|FG000|Overall Study|Death|0
7333032|NCT00824005|11567453|FG001|Overall Study|Death|1
7333033|NCT00824005|11567452|FG000|Overall Study|Lost to Follow-up|0
7333034|NCT00824005|11567453|FG001|Overall Study|Lost to Follow-up|1
7333035|NCT00824161|11567485|FG000|Overall Study|Withdrawal by Subject|1
7333036|NCT00824161|11567485|FG000|Overall Study|Screen Failure|1
7333037|NCT00824265|11567492|FG000|Treatment Phase|Adverse Event,non-fatal|50
7333038|NCT00824265|11567493|FG001|Treatment Phase|Adverse Event,non-fatal|52
7333039|NCT00824265|11567492|FG000|Treatment Phase|Protocol Violation|1
7333040|NCT00824265|11567493|FG001|Treatment Phase|Protocol Violation|0
7333041|NCT00824265|11567492|FG000|Treatment Phase|Lost to Follow-up|1
7333042|NCT00824265|11567493|FG001|Treatment Phase|Lost to Follow-up|1
7333043|NCT00824265|11567492|FG000|Treatment Phase|Physician Decision|6
7333044|NCT00824265|11567493|FG001|Treatment Phase|Physician Decision|12
7333045|NCT00824265|11567492|FG000|Treatment Phase|Withdrawal by Subject|6
7333046|NCT00824265|11567493|FG001|Treatment Phase|Withdrawal by Subject|15
7225224|NCT00064701|11434643|FG001|Clinical Continuation Phase|Pancreas transplant|0
7333047|NCT00824265|11567492|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
7333048|NCT00824265|11567493|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
7333049|NCT00824265|11567492|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
7333050|NCT00824265|11567493|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
7333051|NCT00824291|11567505|FG000|Overall Study|Adverse Event|15
7333052|NCT00824291|11567506|FG001|Overall Study|Adverse Event|6
7333053|NCT00824291|11567505|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7333054|NCT00824291|11567506|FG001|Overall Study|Discontinuation of Study by Sponsor|2
7333055|NCT00824291|11567505|FG000|Overall Study|Lost to Follow-up|11
7333056|NCT00824291|11567506|FG001|Overall Study|Lost to Follow-up|9
7333057|NCT00824291|11567505|FG000|Overall Study|Non-compliance|1
7333058|NCT00824291|11567506|FG001|Overall Study|Non-compliance|1
7333059|NCT00824291|11567505|FG000|Overall Study|Protocol Violation|4
7333060|NCT00824291|11567506|FG001|Overall Study|Protocol Violation|1
7333061|NCT00824291|11567505|FG000|Overall Study|Withdrawal by Subject|14
7333062|NCT00824291|11567506|FG001|Overall Study|Withdrawal by Subject|8
7333063|NCT00824291|11567505|FG000|Overall Study|Lack of Efficacy|7
7333064|NCT00824291|11567506|FG001|Overall Study|Lack of Efficacy|8
7333065|NCT00824291|11567505|FG000|Overall Study|Participant on prohibited medication|1
7333066|NCT00824291|11567506|FG001|Overall Study|Participant on prohibited medication|0
7333067|NCT00824369|11567518|FG000|Overall Study|Nolonger willing to participate in study|1
7333068|NCT00824369|11567519|FG001|Overall Study|Nolonger willing to participate in study|0
7333069|NCT00824369|11567520|FG002|Overall Study|Nolonger willing to participate in study|1
7333070|NCT00824369|11567521|FG003|Overall Study|Nolonger willing to participate in study|2
7333071|NCT00824369|11567522|FG004|Overall Study|Nolonger willing to participate in study|0
7333072|NCT00824369|11567523|FG005|Overall Study|Nolonger willing to participate in study|1
7333073|NCT00824369|11567518|FG000|Overall Study|Lost to Follow-up|0
7333074|NCT00824369|11567519|FG001|Overall Study|Lost to Follow-up|0
7333075|NCT00824369|11567520|FG002|Overall Study|Lost to Follow-up|0
7333076|NCT00824369|11567521|FG003|Overall Study|Lost to Follow-up|0
7333077|NCT00824369|11567522|FG004|Overall Study|Lost to Follow-up|1
7333078|NCT00824369|11567523|FG005|Overall Study|Lost to Follow-up|0
7333079|NCT00824382|11567541|FG000|Overall Study|Adverse Event|4
7333080|NCT00824382|11567542|FG001|Overall Study|Adverse Event|1
7333081|NCT00824382|11567543|FG002|Overall Study|Adverse Event|1
7333082|NCT00824382|11567544|FG003|Overall Study|Adverse Event|4
7333083|NCT00824382|11567541|FG000|Overall Study|Protocol Violation|1
7333084|NCT00824382|11567542|FG001|Overall Study|Protocol Violation|0
7333085|NCT00824382|11567543|FG002|Overall Study|Protocol Violation|0
7333086|NCT00824382|11567544|FG003|Overall Study|Protocol Violation|1
7333087|NCT00824382|11567541|FG000|Overall Study|Investigator's decision|0
7333088|NCT00824382|11567542|FG001|Overall Study|Investigator's decision|1
7333089|NCT00824382|11567543|FG002|Overall Study|Investigator's decision|2
7333090|NCT00824382|11567544|FG003|Overall Study|Investigator's decision|0
7333091|NCT00824408|11567561|FG000|Run-in Phase|Progressive disease|4
7333092|NCT00824408|11567562|FG001|Run-in Phase|Progressive disease|4
7333093|NCT00824408|11567563|FG002|Run-in Phase|Progressive disease|0
7333094|NCT00824408|11567564|FG003|Run-in Phase|Progressive disease|0
7333095|NCT00824408|11567565|FG004|Run-in Phase|Progressive disease|0
7333096|NCT00824408|11567561|FG000|Run-in Phase|Adverse Event|1
7333097|NCT00824408|11567562|FG001|Run-in Phase|Adverse Event|1
7333098|NCT00824408|11567563|FG002|Run-in Phase|Adverse Event|0
7333099|NCT00824408|11567564|FG003|Run-in Phase|Adverse Event|0
7333100|NCT00824408|11567565|FG004|Run-in Phase|Adverse Event|0
7333101|NCT00824408|11567561|FG000|Run-in Phase|Refused to continue medication|1
7333102|NCT00824408|11567562|FG001|Run-in Phase|Refused to continue medication|0
7333103|NCT00824408|11567563|FG002|Run-in Phase|Refused to continue medication|0
7333104|NCT00824408|11567564|FG003|Run-in Phase|Refused to continue medication|0
7333105|NCT00824408|11567565|FG004|Run-in Phase|Refused to continue medication|0
7333106|NCT00824408|11567561|FG000|Run-in Phase|Other reason not defined above|0
7333107|NCT00824408|11567562|FG001|Run-in Phase|Other reason not defined above|1
7333108|NCT00824408|11567563|FG002|Run-in Phase|Other reason not defined above|0
7333109|NCT00824408|11567564|FG003|Run-in Phase|Other reason not defined above|0
7333110|NCT00824408|11567565|FG004|Run-in Phase|Other reason not defined above|0
7333111|NCT00824408|11567561|FG000|Randomized Phase|Not treated|0
7333112|NCT00824408|11567562|FG001|Randomized Phase|Not treated|0
7333113|NCT00824408|11567563|FG002|Randomized Phase|Not treated|1
7333114|NCT00824408|11567564|FG003|Randomized Phase|Not treated|1
7333115|NCT00824408|11567565|FG004|Randomized Phase|Not treated|1
7333116|NCT00824408|11567561|FG000|Randomized Phase|Progressive disease|0
7333117|NCT00824408|11567562|FG001|Randomized Phase|Progressive disease|0
7333118|NCT00824408|11567563|FG002|Randomized Phase|Progressive disease|25
7333119|NCT00824408|11567564|FG003|Randomized Phase|Progressive disease|36
7333120|NCT00824408|11567565|FG004|Randomized Phase|Progressive disease|34
7333121|NCT00824408|11567561|FG000|Randomized Phase|Adverse Event|0
7333122|NCT00824408|11567562|FG001|Randomized Phase|Adverse Event|0
7333123|NCT00824408|11567563|FG002|Randomized Phase|Adverse Event|4
7333124|NCT00824408|11567564|FG003|Randomized Phase|Adverse Event|5
7333125|NCT00824408|11567565|FG004|Randomized Phase|Adverse Event|5
7225225|NCT00064701|11434644|FG002|Clinical Continuation Phase|Pancreas transplant|0
7225226|NCT00064701|11434642|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7333126|NCT00824408|11567561|FG000|Randomized Phase|Refused to continue medication|0
7333127|NCT00824408|11567562|FG001|Randomized Phase|Refused to continue medication|0
7333128|NCT00824408|11567563|FG002|Randomized Phase|Refused to continue medication|2
7333129|NCT00824408|11567564|FG003|Randomized Phase|Refused to continue medication|2
7333130|NCT00824408|11567565|FG004|Randomized Phase|Refused to continue medication|2
7333131|NCT00824408|11567561|FG000|Randomized Phase|Other reason not defined above|0
7333132|NCT00824408|11567562|FG001|Randomized Phase|Other reason not defined above|0
7333133|NCT00824408|11567563|FG002|Randomized Phase|Other reason not defined above|4
7333134|NCT00824408|11567564|FG003|Randomized Phase|Other reason not defined above|2
7333135|NCT00824408|11567565|FG004|Randomized Phase|Other reason not defined above|4
7333136|NCT00824421|11567586|FG000|Overall Study|Adverse Event|6
7333137|NCT00824421|11567587|FG001|Overall Study|Adverse Event|6
7333138|NCT00824421|11567588|FG002|Overall Study|Adverse Event|6
7333139|NCT00824421|11567586|FG000|Overall Study|Death|0
7333140|NCT00824421|11567587|FG001|Overall Study|Death|1
7333141|NCT00824421|11567588|FG002|Overall Study|Death|0
7333142|NCT00824421|11567586|FG000|Overall Study|Lack of Efficacy|5
7333143|NCT00824421|11567587|FG001|Overall Study|Lack of Efficacy|7
7333144|NCT00824421|11567588|FG002|Overall Study|Lack of Efficacy|4
7333145|NCT00824421|11567586|FG000|Overall Study|Lost to Follow-up|2
7333146|NCT00824421|11567587|FG001|Overall Study|Lost to Follow-up|3
7333147|NCT00824421|11567588|FG002|Overall Study|Lost to Follow-up|0
7333148|NCT00824421|11567586|FG000|Overall Study|Pregnancy|1
7333149|NCT00824421|11567587|FG001|Overall Study|Pregnancy|0
7333150|NCT00824421|11567588|FG002|Overall Study|Pregnancy|1
7333151|NCT00824421|11567586|FG000|Overall Study|Withdrawal by Subject|2
7333152|NCT00824421|11567587|FG001|Overall Study|Withdrawal by Subject|3
7333153|NCT00824421|11567588|FG002|Overall Study|Withdrawal by Subject|3
7333154|NCT00824421|11567586|FG000|Overall Study|Randomized but not Treated|1
7333155|NCT00824421|11567587|FG001|Overall Study|Randomized but not Treated|1
7333156|NCT00824421|11567588|FG002|Overall Study|Randomized but not Treated|0
7333157|NCT00824421|11567586|FG000|Overall Study|Other|0
7333158|NCT00824421|11567587|FG001|Overall Study|Other|1
7333159|NCT00824421|11567588|FG002|Overall Study|Other|0
7333160|NCT00824473|11567637|FG000|Overall Study|Adverse Event|4
7333161|NCT00824473|11567638|FG001|Overall Study|Adverse Event|5
7333162|NCT00824473|11567637|FG000|Overall Study|Lack of Efficacy|2
7333163|NCT00824473|11567638|FG001|Overall Study|Lack of Efficacy|2
7333164|NCT00824473|11567637|FG000|Overall Study|Protocol Violation|2
7333165|NCT00824473|11567638|FG001|Overall Study|Protocol Violation|0
7333166|NCT00824473|11567637|FG000|Overall Study|Non-Compliance|4
7333167|NCT00824473|11567638|FG001|Overall Study|Non-Compliance|2
7333168|NCT00824473|11567637|FG000|Overall Study|Withdrawal by Subject|2
7333169|NCT00824473|11567638|FG001|Overall Study|Withdrawal by Subject|3
7333170|NCT00824473|11567637|FG000|Overall Study|Other|1
7333171|NCT00824473|11567638|FG001|Overall Study|Other|1
7333172|NCT00824564|11567660|FG000|Overall Study|Lost to Follow-up|5
7333173|NCT00824564|11567661|FG001|Overall Study|Lost to Follow-up|7
7333174|NCT00824564|11567660|FG000|Overall Study|Withdrawal by Subject|1
7333175|NCT00824564|11567661|FG001|Overall Study|Withdrawal by Subject|1
7333176|NCT00824564|11567660|FG000|Overall Study|Other|1
7333177|NCT00824564|11567661|FG001|Overall Study|Other|2
7333178|NCT00824564|11567660|FG000|Overall Study|Randomized, but not treated|1
7333179|NCT00824564|11567661|FG001|Overall Study|Randomized, but not treated|0
7333180|NCT00824616|11567669|FG000|Overall Study|Adverse Event|2
7333181|NCT00824616|11567670|FG001|Overall Study|Adverse Event|1
7333182|NCT00824616|11567669|FG000|Overall Study|Creatinine/Creatinine Clearance|0
7333183|NCT00824616|11567670|FG001|Overall Study|Creatinine/Creatinine Clearance|2
7333184|NCT00824616|11567669|FG000|Overall Study|Hyperglycemia|1
7333185|NCT00824616|11567670|FG001|Overall Study|Hyperglycemia|1
7333186|NCT00824616|11567669|FG000|Overall Study|Lack of Efficacy|2
7333187|NCT00824616|11567670|FG001|Overall Study|Lack of Efficacy|1
7333188|NCT00824616|11567669|FG000|Overall Study|Lost to Follow-up|0
7333189|NCT00824616|11567670|FG001|Overall Study|Lost to Follow-up|1
7333190|NCT00824616|11567669|FG000|Overall Study|Withdrawal by Subject|1
7333191|NCT00824616|11567670|FG001|Overall Study|Withdrawal by Subject|1
7333192|NCT00824655|11567678|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
7333193|NCT00824655|11567679|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
7333194|NCT00824655|11567678|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
7333195|NCT00824655|11567679|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
7333196|NCT00824720|11567690|FG000|Overall Study|failed plug insertion|3
7333197|NCT00824720|11567691|FG001|Overall Study|failed plug insertion|1
7333198|NCT00824720|11567692|FG002|Overall Study|failed plug insertion|0
7333199|NCT00824720|11567690|FG000|Overall Study|Protocol Violation|0
7333200|NCT00824720|11567691|FG001|Overall Study|Protocol Violation|0
7333201|NCT00824720|11567692|FG002|Overall Study|Protocol Violation|1
7333202|NCT00824772|11567710|FG000|Overall Study|Withdrawal by Subject|8
7333203|NCT00824850|11567725|FG000|Overall Study|Withdrawal by Subject|0
7333204|NCT00824850|11567726|FG001|Overall Study|Withdrawal by Subject|1
7333205|NCT00824993|11567740|FG000|Overall Study|Withdrawal by Subject|1
7333206|NCT00824993|11567741|FG001|Overall Study|Withdrawal by Subject|1
7333207|NCT00824993|11567740|FG000|Overall Study|Malignancy Relapse|9
7333208|NCT00824993|11567741|FG001|Overall Study|Malignancy Relapse|10
7333209|NCT00824993|11567740|FG000|Overall Study|Rapid Bone Loss|0
7333210|NCT00824993|11567741|FG001|Overall Study|Rapid Bone Loss|1
7333211|NCT00824993|11567740|FG000|Overall Study|Non-Compliant|2
7333212|NCT00824993|11567741|FG001|Overall Study|Non-Compliant|1
7333213|NCT00824993|11567740|FG000|Overall Study|Insurance Issue|2
7333214|NCT00824993|11567741|FG001|Overall Study|Insurance Issue|1
7333215|NCT00824993|11567740|FG000|Overall Study|Death|0
7333216|NCT00824993|11567741|FG001|Overall Study|Death|3
7333217|NCT00825162|11567750|FG000|Overall Study|Withdrawal by Subject|11
7333218|NCT00825162|11567751|FG001|Overall Study|Withdrawal by Subject|13
7333219|NCT00825162|11567752|FG002|Overall Study|Withdrawal by Subject|3
7333220|NCT00825162|11567750|FG000|Overall Study|Lost to Follow-up|9
7333221|NCT00825162|11567751|FG001|Overall Study|Lost to Follow-up|6
7333222|NCT00825162|11567752|FG002|Overall Study|Lost to Follow-up|3
7333223|NCT00825162|11567750|FG000|Overall Study|Physician Decision|2
7333224|NCT00825162|11567751|FG001|Overall Study|Physician Decision|0
7333225|NCT00825162|11567752|FG002|Overall Study|Physician Decision|0
7333226|NCT00825162|11567750|FG000|Overall Study|Move away from the study area|1
7333227|NCT00825162|11567751|FG001|Overall Study|Move away from the study area|0
7333228|NCT00825162|11567752|FG002|Overall Study|Move away from the study area|0
7333229|NCT00825162|11567750|FG000|Overall Study|Unable to attend the study visit|5
7333230|NCT00825162|11567751|FG001|Overall Study|Unable to attend the study visit|2
7333231|NCT00825162|11567752|FG002|Overall Study|Unable to attend the study visit|0
7333232|NCT00825175|11567767|FG000|Overall Study|Withdrawal by Subject|0
7333233|NCT00825175|11567768|FG001|Overall Study|Withdrawal by Subject|5
7333234|NCT00825305|11567785|FG000|Overall Study|Adverse Event|1
7333235|NCT00825305|11567786|FG001|Overall Study|Adverse Event|1
7333236|NCT00825305|11567785|FG000|Overall Study|Withdrawal by Subject|6
7333237|NCT00825305|11567786|FG001|Overall Study|Withdrawal by Subject|12
7333238|NCT00825305|11567785|FG000|Overall Study|Inappropriate inclusion|1
7333239|NCT00825305|11567786|FG001|Overall Study|Inappropriate inclusion|0
7333240|NCT00825305|11567785|FG000|Overall Study|Protocol Violation|9
7333241|NCT00825305|11567786|FG001|Overall Study|Protocol Violation|9
7333242|NCT00825305|11567785|FG000|Overall Study|Can not be classified|0
7333243|NCT00825305|11567786|FG001|Overall Study|Can not be classified|1
7333244|NCT00825682|11567860|FG000|Overall Study|personal reasons/ inconvenience|13
7333245|NCT00825682|11567861|FG001|Overall Study|personal reasons/ inconvenience|5
7333246|NCT00825812|11567888|FG000|Overall Study|Never entered follow up|0
7333247|NCT00825812|11567889|FG001|Overall Study|Never entered follow up|0
7333248|NCT00825812|11567890|FG002|Overall Study|Never entered follow up|0
7333249|NCT00825812|11567891|FG003|Overall Study|Never entered follow up|1
7333250|NCT00825812|11567888|FG000|Overall Study|Adverse Event|0
7333251|NCT00825812|11567889|FG001|Overall Study|Adverse Event|0
7568519|NCT03417505|11943801|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
7333252|NCT00825812|11567890|FG002|Overall Study|Adverse Event|0
7333253|NCT00825812|11567891|FG003|Overall Study|Adverse Event|1
7333254|NCT00825812|11567888|FG000|Overall Study|Subject withdrew consent|0
7333255|NCT00825812|11567889|FG001|Overall Study|Subject withdrew consent|0
7333256|NCT00825812|11567890|FG002|Overall Study|Subject withdrew consent|3
7333257|NCT00825812|11567891|FG003|Overall Study|Subject withdrew consent|2
7333258|NCT00825812|11567888|FG000|Overall Study|Non-compliance with protocol|0
7333259|NCT00825812|11567889|FG001|Overall Study|Non-compliance with protocol|0
7333260|NCT00825812|11567890|FG002|Overall Study|Non-compliance with protocol|0
7333261|NCT00825812|11567891|FG003|Overall Study|Non-compliance with protocol|1
7333262|NCT00825812|11567888|FG000|Overall Study|Administrative|0
7333263|NCT00825812|11567889|FG001|Overall Study|Administrative|1
7333264|NCT00825812|11567890|FG002|Overall Study|Administrative|3
7333265|NCT00825812|11567891|FG003|Overall Study|Administrative|5
7333266|NCT00825825|11567901|FG000|First Medication Period (14 Days)|Adverse Event|1
7333267|NCT00825825|11567902|FG001|First Medication Period (14 Days)|Adverse Event|0
7333268|NCT00825825|11567903|FG002|First Medication Period (14 Days)|Adverse Event|0
7333269|NCT00825825|11567904|FG003|First Medication Period (14 Days)|Adverse Event|0
7333270|NCT00825825|11567905|FG004|First Medication Period (14 Days)|Adverse Event|0
7333271|NCT00825825|11567906|FG005|First Medication Period (14 Days)|Adverse Event|1
7333272|NCT00825825|11567901|FG000|First Medication Period (14 Days)|Physician Decision|2
7333273|NCT00825825|11567902|FG001|First Medication Period (14 Days)|Physician Decision|0
7333274|NCT00825825|11567903|FG002|First Medication Period (14 Days)|Physician Decision|1
7333275|NCT00825825|11567904|FG003|First Medication Period (14 Days)|Physician Decision|0
7333276|NCT00825825|11567905|FG004|First Medication Period (14 Days)|Physician Decision|0
7333277|NCT00825825|11567906|FG005|First Medication Period (14 Days)|Physician Decision|1
7333278|NCT00825825|11567901|FG000|Second Medication Period (14 Days)|Physician Decision|1
7333279|NCT00825825|11567902|FG001|Second Medication Period (14 Days)|Physician Decision|0
7568520|NCT03417505|11943802|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
7568521|NCT03417830|11943852|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1
7568522|NCT03417830|11943853|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0
7568523|NCT03418324|11943890|FG000|Overall Study|Death|0
7568524|NCT03418324|11943891|FG001|Overall Study|Death|1
7568525|NCT03418324|11943890|FG000|Overall Study|Physician Decision|1
7568526|NCT03418324|11943891|FG001|Overall Study|Physician Decision|1
7568527|NCT03418376|11943901|FG000|Overall Study|Musculoskeletal injury|1
7568528|NCT03418376|11943902|FG001|Overall Study|Musculoskeletal injury|2
7568529|NCT03418376|11943903|FG002|Overall Study|Musculoskeletal injury|1
7568530|NCT03418376|11943904|FG003|Overall Study|Musculoskeletal injury|0
7568531|NCT03418376|11943901|FG000|Overall Study|Personal reasons|0
7568532|NCT03418376|11943902|FG001|Overall Study|Personal reasons|2
7568533|NCT03418376|11943903|FG002|Overall Study|Personal reasons|2
7568534|NCT03418376|11943904|FG003|Overall Study|Personal reasons|1
7333280|NCT00825825|11567903|FG002|Second Medication Period (14 Days)|Physician Decision|0
7333281|NCT00825825|11567904|FG003|Second Medication Period (14 Days)|Physician Decision|2
7333282|NCT00825825|11567905|FG004|Second Medication Period (14 Days)|Physician Decision|0
7333283|NCT00825825|11567906|FG005|Second Medication Period (14 Days)|Physician Decision|0
7568535|NCT03418376|11943901|FG000|Overall Study|Exacerbation|0
7568536|NCT03418376|11943902|FG001|Overall Study|Exacerbation|1
7568537|NCT03418376|11943903|FG002|Overall Study|Exacerbation|0
7568538|NCT03418376|11943904|FG003|Overall Study|Exacerbation|0
7568539|NCT03418545|11943916|FG000|Overall Study|Withdrawal by Participant|2
7568540|NCT03418545|11943917|FG001|Overall Study|Withdrawal by Participant|4
7568541|NCT03418545|11943916|FG000|Overall Study|Lost to Follow-up|3
7568542|NCT03418545|11943917|FG001|Overall Study|Lost to Follow-up|5
7568543|NCT03418545|11943916|FG000|Overall Study|Reason Not Specified|0
7568544|NCT03418545|11943917|FG001|Overall Study|Reason Not Specified|1
7568545|NCT03418545|11943916|FG000|Overall Study|Missing Completion Status|0
7568546|NCT03418545|11943917|FG001|Overall Study|Missing Completion Status|1
7568547|NCT03418571|11943928|FG000|Overall Study|Consent withdrawn by legal guardian|1
7568548|NCT03418571|11943929|FG001|Overall Study|Consent withdrawn by legal guardian|0
7568549|NCT03419403|11943964|FG000|Overall Study|Withdrawal by Subject|5
7568550|NCT03419403|11943965|FG001|Overall Study|Withdrawal by Subject|2
7568551|NCT03419403|11943966|FG002|Overall Study|Withdrawal by Subject|5
7568552|NCT03419403|11943967|FG003|Overall Study|Withdrawal by Subject|1
7333284|NCT00825825|11567901|FG000|Second Medication Period (14 Days)|Protocol Violation|1
7333285|NCT00825825|11567902|FG001|Second Medication Period (14 Days)|Protocol Violation|0
7333286|NCT00825825|11567903|FG002|Second Medication Period (14 Days)|Protocol Violation|0
7333287|NCT00825825|11567904|FG003|Second Medication Period (14 Days)|Protocol Violation|0
7333288|NCT00825825|11567905|FG004|Second Medication Period (14 Days)|Protocol Violation|1
7333289|NCT00825825|11567906|FG005|Second Medication Period (14 Days)|Protocol Violation|0
7333290|NCT00825825|11567901|FG000|Third Medication Period (14 Days)|Adverse Event|0
7333291|NCT00825825|11567902|FG001|Third Medication Period (14 Days)|Adverse Event|1
7333292|NCT00825825|11567903|FG002|Third Medication Period (14 Days)|Adverse Event|0
7333293|NCT00825825|11567904|FG003|Third Medication Period (14 Days)|Adverse Event|0
7333294|NCT00825825|11567905|FG004|Third Medication Period (14 Days)|Adverse Event|0
7333295|NCT00825825|11567906|FG005|Third Medication Period (14 Days)|Adverse Event|0
7333296|NCT00825825|11567901|FG000|Third Medication Period (14 Days)|Protocol Violation|0
7333297|NCT00825825|11567902|FG001|Third Medication Period (14 Days)|Protocol Violation|0
7333298|NCT00825825|11567903|FG002|Third Medication Period (14 Days)|Protocol Violation|0
7333299|NCT00825825|11567904|FG003|Third Medication Period (14 Days)|Protocol Violation|0
7333300|NCT00825825|11567905|FG004|Third Medication Period (14 Days)|Protocol Violation|0
7333301|NCT00825825|11567906|FG005|Third Medication Period (14 Days)|Protocol Violation|2
7333302|NCT00825825|11567901|FG000|Third Medication Period (14 Days)|poor data quality|0
7333303|NCT00825825|11567902|FG001|Third Medication Period (14 Days)|poor data quality|1
7333304|NCT00825825|11567903|FG002|Third Medication Period (14 Days)|poor data quality|0
7333305|NCT00825825|11567904|FG003|Third Medication Period (14 Days)|poor data quality|0
7333306|NCT00825825|11567905|FG004|Third Medication Period (14 Days)|poor data quality|0
7333307|NCT00825825|11567906|FG005|Third Medication Period (14 Days)|poor data quality|0
7333308|NCT00825916|11567916|FG000|Overall Study|Lost to Follow-up|4
7333309|NCT00825916|11567917|FG001|Overall Study|Lost to Follow-up|2
7333310|NCT00825916|11567918|FG002|Overall Study|Lost to Follow-up|1
7333311|NCT00825994|11567959|FG000|Overall Study|Withdrawal by Subject|2
7333312|NCT00825994|11567959|FG000|Overall Study|Lost to Follow-up|1
7333313|NCT00825994|11567959|FG000|Overall Study|Protocol Violation|1
7333314|NCT00825994|11567959|FG000|Overall Study|Placebo Responder at V2|1
7333315|NCT00826111|11567977|FG000|Overall Study|Lost to Follow-up|0
7333316|NCT00826111|11567978|FG001|Overall Study|Lost to Follow-up|1
7333317|NCT00826111|11567977|FG000|Overall Study|Protocol Violation|1
7333318|NCT00826111|11567978|FG001|Overall Study|Protocol Violation|0
7333319|NCT00826111|11567977|FG000|Overall Study|Withdrawal by Subject|5
7333320|NCT00826111|11567978|FG001|Overall Study|Withdrawal by Subject|0
7333321|NCT00826111|11567977|FG000|Overall Study|Physician Decision|1
7333322|NCT00826111|11567978|FG001|Overall Study|Physician Decision|1
7333323|NCT00826176|11568004|FG000|Overall Study|Lost to Follow-up|1
7333324|NCT00826176|11568005|FG001|Overall Study|Lost to Follow-up|0
7333325|NCT00826176|11568004|FG000|Overall Study|Subject Withdrew Consent|3
7333326|NCT00826176|11568005|FG001|Overall Study|Subject Withdrew Consent|0
7333327|NCT00826176|11568004|FG000|Overall Study|Administrative|9
7333328|NCT00826176|11568005|FG001|Overall Study|Administrative|0
7333329|NCT00826228|11568020|FG000|Overall Study|Withdrawal by Subject|1
7333330|NCT00826241|11568025|FG000|Overall Study|Withdrawal from Follow-up|1
7333331|NCT00826241|11568025|FG000|Overall Study|Withdrew consent|2
7333332|NCT00826241|11568025|FG000|Overall Study|Death|4
7333333|NCT00826241|11568025|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
7333334|NCT00826241|11568025|FG000|Overall Study|Non-compliance|1
7333335|NCT00826241|11568025|FG000|Overall Study|Progression of disease|1
7333336|NCT00826241|11568025|FG000|Overall Study|Patient refused follow-up|3
7333337|NCT00826241|11568025|FG000|Overall Study|Lost to Follow-up|9
7333338|NCT00826241|11568025|FG000|Overall Study|Could not obtain records|1
7333339|NCT00826241|11568025|FG000|Overall Study|Screen failure|2
7333340|NCT00826241|11568025|FG000|Overall Study|Pt unable to proceed to registration|1
7568553|NCT03419403|11943964|FG000|Overall Study|Progressive disease (per protocol)|0
7333341|NCT00826241|11568025|FG000|Overall Study|Pt opt not to proceed w/trmt|1
7568554|NCT03419403|11943965|FG001|Overall Study|Progressive disease (per protocol)|2
7568555|NCT03419403|11943966|FG002|Overall Study|Progressive disease (per protocol)|2
7568556|NCT03419403|11943967|FG003|Overall Study|Progressive disease (per protocol)|0
7333342|NCT00826267|11568032|FG000|Overall Study|Other Adverse Event|1
7333343|NCT00826267|11568033|FG001|Overall Study|Other Adverse Event|0
7333344|NCT00826267|11568034|FG002|Overall Study|Other Adverse Event|0
7333345|NCT00826280|11568046|FG000|Overall Study|Randomized but drug not received|1
7333346|NCT00826280|11568047|FG001|Overall Study|Randomized but drug not received|0
7333347|NCT00826280|11568048|FG002|Overall Study|Randomized but drug not received|1
7333348|NCT00826280|11568046|FG000|Overall Study|Adverse Event|1
7333349|NCT00826280|11568047|FG001|Overall Study|Adverse Event|3
7333350|NCT00826280|11568048|FG002|Overall Study|Adverse Event|0
7333351|NCT00826280|11568046|FG000|Overall Study|Lost to Follow-up|0
7333352|NCT00826280|11568047|FG001|Overall Study|Lost to Follow-up|1
7333353|NCT00826280|11568048|FG002|Overall Study|Lost to Follow-up|0
7333354|NCT00826280|11568046|FG000|Overall Study|Sponsor discontinued subject or study|1
7333355|NCT00826280|11568047|FG001|Overall Study|Sponsor discontinued subject or study|0
7333356|NCT00826280|11568048|FG002|Overall Study|Sponsor discontinued subject or study|0
7333357|NCT00826280|11568046|FG000|Overall Study|Reversible ischemic defect not present|43
7333358|NCT00826280|11568047|FG001|Overall Study|Reversible ischemic defect not present|40
7333359|NCT00826280|11568048|FG002|Overall Study|Reversible ischemic defect not present|44
7333360|NCT00826280|11568046|FG000|Overall Study|Interpretation Failure|1
7333361|NCT00826280|11568047|FG001|Overall Study|Interpretation Failure|0
7333362|NCT00826280|11568048|FG002|Overall Study|Interpretation Failure|0
7333363|NCT00826280|11568046|FG000|Overall Study|Machine Failure|1
7333364|NCT00826280|11568047|FG001|Overall Study|Machine Failure|1
7333365|NCT00826280|11568048|FG002|Overall Study|Machine Failure|0
7333366|NCT00826280|11568046|FG000|Overall Study|One or more non-interpretable scan|0
7333367|NCT00826280|11568047|FG001|Overall Study|One or more non-interpretable scan|1
7333368|NCT00826280|11568048|FG002|Overall Study|One or more non-interpretable scan|1
7333369|NCT00826449|11568058|FG000|Overall Study|Disease Progression|4
7333370|NCT00826449|11568058|FG000|Overall Study|Withdrawal by Subject|1
7333371|NCT00826514|11568065|FG000|Overall Study|Adverse Event|1
7333372|NCT00826514|11568066|FG001|Overall Study|Adverse Event|1
7333373|NCT00826514|11568065|FG000|Overall Study|Lack of Efficacy|0
7333374|NCT00826514|11568066|FG001|Overall Study|Lack of Efficacy|1
7333375|NCT00826514|11568065|FG000|Overall Study|Withdrawal by Subject|2
7333376|NCT00826514|11568066|FG001|Overall Study|Withdrawal by Subject|3
7333377|NCT00826540|11568072|FG000|Overall Study|ineligible|3
7333378|NCT00826540|11568072|FG000|Overall Study|Withdrawal by Subject|1
7333379|NCT00826618|11568076|FG000|Overall Study|Withdrawal by Subject|1
7333380|NCT00826748|11568083|FG000|Overall Study|Withdrawal by Subject|0
7333381|NCT00826748|11568084|FG001|Overall Study|Withdrawal by Subject|0
7333382|NCT00826748|11568085|FG002|Overall Study|Withdrawal by Subject|2
7333383|NCT00826748|11568083|FG000|Overall Study|Physician Decision|0
7333384|NCT00826748|11568084|FG001|Overall Study|Physician Decision|0
7333385|NCT00826748|11568085|FG002|Overall Study|Physician Decision|1
7333386|NCT00826748|11568083|FG000|Overall Study|Samples Did Not pass QC|0
7333387|NCT00826748|11568084|FG001|Overall Study|Samples Did Not pass QC|0
7333388|NCT00826748|11568085|FG002|Overall Study|Samples Did Not pass QC|1
7333389|NCT00826943|11568097|FG000|Overall Study|Withdrawal by Subject|0
7333390|NCT00826943|11568098|FG001|Overall Study|Withdrawal by Subject|0
7333391|NCT00826943|11568099|FG002|Overall Study|Withdrawal by Subject|0
7333392|NCT00826943|11568100|FG003|Overall Study|Withdrawal by Subject|0
7333393|NCT00826943|11568101|FG004|Overall Study|Withdrawal by Subject|1
7333394|NCT00826943|11568102|FG005|Overall Study|Withdrawal by Subject|0
7333395|NCT00827112|11568125|FG000|Overall Study|Adverse Event|2
7333396|NCT00827112|11568126|FG001|Overall Study|Adverse Event|0
7333397|NCT00827112|11568125|FG000|Overall Study|Lack of Efficacy|2
7333398|NCT00827112|11568126|FG001|Overall Study|Lack of Efficacy|0
7333399|NCT00827112|11568125|FG000|Overall Study|Lost to Follow-up|3
7333400|NCT00827112|11568126|FG001|Overall Study|Lost to Follow-up|2
7333401|NCT00827112|11568125|FG000|Overall Study|Pregnancy|0
7333402|NCT00827112|11568126|FG001|Overall Study|Pregnancy|1
7333403|NCT00827112|11568125|FG000|Overall Study|Protocol Violation|0
7333404|NCT00827112|11568126|FG001|Overall Study|Protocol Violation|2
7333405|NCT00827112|11568125|FG000|Overall Study|Withdrawal by Subject|2
7333406|NCT00827112|11568126|FG001|Overall Study|Withdrawal by Subject|1
7333407|NCT00827112|11568125|FG000|Overall Study|Randomized but not treated|5
7333408|NCT00827112|11568126|FG001|Overall Study|Randomized but not treated|3
7333409|NCT00827112|11568125|FG000|Overall Study|Other|1
7333410|NCT00827112|11568126|FG001|Overall Study|Other|3
7333411|NCT00827242|11568134|FG000|Overall Study|Withdrawal by Subject|2
7333412|NCT00827242|11568135|FG001|Overall Study|Withdrawal by Subject|4
7333413|NCT00827242|11568134|FG000|Overall Study|Protocol Violation|1
7333414|NCT00827242|11568135|FG001|Overall Study|Protocol Violation|3
7333415|NCT00827242|11568134|FG000|Overall Study|Lost to Follow-up|0
7333416|NCT00827242|11568135|FG001|Overall Study|Lost to Follow-up|3
7333417|NCT00827242|11568134|FG000|Overall Study|Adverse Event Excluding Death|2
7333418|NCT00827242|11568135|FG001|Overall Study|Adverse Event Excluding Death|1
7333419|NCT00827242|11568134|FG000|Overall Study|Entry Criteria Not Met|4
7333420|NCT00827242|11568135|FG001|Overall Study|Entry Criteria Not Met|1
7333421|NCT00827242|11568134|FG000|Overall Study|Physician Decision|2
7333422|NCT00827242|11568135|FG001|Overall Study|Physician Decision|0
7333423|NCT00827242|11568134|FG000|Overall Study|Death|1
7333424|NCT00827242|11568135|FG001|Overall Study|Death|0
7333425|NCT00827242|11568134|FG000|Overall Study|Lack of Efficacy|1
7333426|NCT00827242|11568135|FG001|Overall Study|Lack of Efficacy|0
7333427|NCT00827359|11568145|FG000|Overall Study|Progressive Diseas|19
7333428|NCT00827359|11568145|FG000|Overall Study|Unacceptable Toxicity|5
7333429|NCT00827359|11568145|FG000|Overall Study|Ineligible|1
7333430|NCT00827372|11568149|FG000|Overall Study|Adverse Event|5
7333431|NCT00827372|11568149|FG000|Overall Study|Lack of Efficacy|3
7333432|NCT00827502|11568154|FG000|Overall Study|randomized but not treated|11
7333433|NCT00827502|11568154|FG000|Overall Study|Adverse Event|1
7333434|NCT00827502|11568154|FG000|Overall Study|Lost to Follow-up|4
7333435|NCT00827502|11568154|FG000|Overall Study|Withdrawal by Subject|5
7333436|NCT00827541|11568160|FG000|Overall Study|Exitus|1
7333437|NCT00827541|11568161|FG001|Overall Study|Exitus|8
7333438|NCT00827541|11568160|FG000|Overall Study|Other|1
7333439|NCT00827541|11568161|FG001|Overall Study|Other|3
7333440|NCT00827541|11568160|FG000|Overall Study|Pathogen not susceptible|1
7333441|NCT00827541|11568161|FG001|Overall Study|Pathogen not susceptible|0
7333442|NCT00827541|11568160|FG000|Overall Study|Lack of effectiveness|1
7333443|NCT00827541|11568161|FG001|Overall Study|Lack of effectiveness|0
7333444|NCT00827606|11568169|FG000|Overall Study|Protocol Violation|4
7333445|NCT00827606|11568170|FG001|Overall Study|Protocol Violation|3
7333446|NCT00827606|11568169|FG000|Overall Study|Lost to Follow-up|3
7333447|NCT00827606|11568170|FG001|Overall Study|Lost to Follow-up|1
7333448|NCT00827606|11568169|FG000|Overall Study|Withdrawal by Subject|7
7333449|NCT00827606|11568170|FG001|Overall Study|Withdrawal by Subject|6
7333450|NCT00827606|11568169|FG000|Overall Study|Pregnancy|0
7333451|NCT00827606|11568170|FG001|Overall Study|Pregnancy|1
7333452|NCT00827606|11568169|FG000|Overall Study|Other|5
7333453|NCT00827606|11568170|FG001|Overall Study|Other|13
7333454|NCT00827606|11568169|FG000|Overall Study|LDL below 2.59 mmol/L|4
7333455|NCT00827606|11568170|FG001|Overall Study|LDL below 2.59 mmol/L|12
7333456|NCT00827606|11568169|FG000|Overall Study|Adverse Event|4
7333457|NCT00827606|11568170|FG001|Overall Study|Adverse Event|2
7333458|NCT00827632|11568184|FG000|Overall Study|Lost to Follow-up|8
7333459|NCT00827632|11568185|FG001|Overall Study|Lost to Follow-up|12
7333460|NCT00827632|11568184|FG000|Overall Study|Early withdrawal|14
7333461|NCT00827632|11568185|FG001|Overall Study|Early withdrawal|11
7333462|NCT00827775|11568193|FG000|Overall Study|Withdrawal by Subject|0
7333463|NCT00827775|11568194|FG001|Overall Study|Withdrawal by Subject|5
7333464|NCT00827827|11568202|FG000|Overall Study|Lost to Follow-up|3
7333465|NCT00827827|11568203|FG001|Overall Study|Lost to Follow-up|0
7333466|NCT00827827|11568202|FG000|Overall Study|Fall at home- hospitalization|1
7333467|NCT00827827|11568203|FG001|Overall Study|Fall at home- hospitalization|0
7333468|NCT00827827|11568202|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
7333469|NCT00827827|11568203|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
7333470|NCT00827827|11568202|FG000|Overall Study|Gout|1
7333471|NCT00827827|11568203|FG001|Overall Study|Gout|0
7333472|NCT00827827|11568202|FG000|Overall Study|Transportation issues|1
7333473|NCT00827827|11568203|FG001|Overall Study|Transportation issues|0
7333474|NCT00827827|11568202|FG000|Overall Study|Burned with water at home|1
7333475|NCT00827827|11568203|FG001|Overall Study|Burned with water at home|0
7333476|NCT00827918|11568213|FG000|Overall Study|Adverse Event|4
7333477|NCT00827918|11568214|FG001|Overall Study|Adverse Event|0
7333478|NCT00827918|11568215|FG002|Overall Study|Adverse Event|0
7333479|NCT00827918|11568213|FG000|Overall Study|Lack of Efficacy|16
7333480|NCT00827918|11568214|FG001|Overall Study|Lack of Efficacy|4
7333481|NCT00827918|11568215|FG002|Overall Study|Lack of Efficacy|15
7333482|NCT00827918|11568213|FG000|Overall Study|Physician Decision|1
7333483|NCT00827918|11568214|FG001|Overall Study|Physician Decision|0
7333484|NCT00827918|11568215|FG002|Overall Study|Physician Decision|0
7333485|NCT00827918|11568213|FG000|Overall Study|Pregnancy|0
7333486|NCT00827918|11568214|FG001|Overall Study|Pregnancy|1
7333487|NCT00827918|11568215|FG002|Overall Study|Pregnancy|0
7333488|NCT00827918|11568213|FG000|Overall Study|Progressive Disease|1
7333489|NCT00827918|11568214|FG001|Overall Study|Progressive Disease|1
7333490|NCT00827918|11568215|FG002|Overall Study|Progressive Disease|0
7333491|NCT00827918|11568213|FG000|Overall Study|Protocol Violation|0
7333492|NCT00827918|11568214|FG001|Overall Study|Protocol Violation|1
7333493|NCT00827918|11568215|FG002|Overall Study|Protocol Violation|0
7333494|NCT00827918|11568213|FG000|Overall Study|Withdrawal by Subject|6
7333495|NCT00827918|11568214|FG001|Overall Study|Withdrawal by Subject|2
7333496|NCT00827918|11568215|FG002|Overall Study|Withdrawal by Subject|6
7333497|NCT00827931|11568225|FG000|Overall Study|Death|3
7333498|NCT00827931|11568226|FG001|Overall Study|Death|5
7333499|NCT00827931|11568225|FG000|Overall Study|Adverse Event|1
7333500|NCT00827931|11568226|FG001|Overall Study|Adverse Event|0
7333501|NCT00827931|11568225|FG000|Overall Study|Lost to Follow-up|1
7333502|NCT00827931|11568226|FG001|Overall Study|Lost to Follow-up|0
7333503|NCT00827931|11568225|FG000|Overall Study|Withdrawal by Subject|0
7333504|NCT00827931|11568226|FG001|Overall Study|Withdrawal by Subject|1
7333505|NCT00827931|11568225|FG000|Overall Study|Other|1
7333506|NCT00827931|11568226|FG001|Overall Study|Other|0
7333507|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
7333508|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
7333509|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
7333510|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
7333511|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
7385319|NCT01200758|11643096|FG000|Stage I|Death|0
7333512|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
7333513|NCT00828009|11568250|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
7333514|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
7333515|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
7333516|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Death|1
7333517|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
7333518|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
7333519|NCT00828009|11568250|FG000|Step 2 - Maintenance Therapy|Other|1
7333520|NCT00828113|11568284|FG000|Overall Study|Withdrawal by Subject|27
7333521|NCT00828113|11568285|FG001|Overall Study|Withdrawal by Subject|26
7333522|NCT00828113|11568284|FG000|Overall Study|Lost to Follow-up|3
7333523|NCT00828113|11568285|FG001|Overall Study|Lost to Follow-up|5
7333524|NCT00828139|11568295|FG000|Overall Study|Adverse Event|8
7333525|NCT00828139|11568296|FG001|Overall Study|Adverse Event|1
7333526|NCT00828139|11568297|FG002|Overall Study|Adverse Event|10
7333527|NCT00828139|11568298|FG003|Overall Study|Adverse Event|5
7333528|NCT00828139|11568295|FG000|Overall Study|Death|2
7333529|NCT00828139|11568296|FG001|Overall Study|Death|1
7333530|NCT00828139|11568297|FG002|Overall Study|Death|0
7333531|NCT00828139|11568298|FG003|Overall Study|Death|2
7333532|NCT00828139|11568295|FG000|Overall Study|Refusal unrelated to toxicity|3
7333533|NCT00828139|11568296|FG001|Overall Study|Refusal unrelated to toxicity|4
7333534|NCT00828139|11568297|FG002|Overall Study|Refusal unrelated to toxicity|5
7333535|NCT00828139|11568298|FG003|Overall Study|Refusal unrelated to toxicity|3
7333536|NCT00828139|11568295|FG000|Overall Study|Disease Progression|24
7333537|NCT00828139|11568296|FG001|Overall Study|Disease Progression|33
7333538|NCT00828139|11568297|FG002|Overall Study|Disease Progression|35
7333539|NCT00828139|11568298|FG003|Overall Study|Disease Progression|39
7333540|NCT00828139|11568295|FG000|Overall Study|Other|4
7333541|NCT00828139|11568296|FG001|Overall Study|Other|2
7333542|NCT00828139|11568297|FG002|Overall Study|Other|5
7333543|NCT00828139|11568298|FG003|Overall Study|Other|2
7333544|NCT00828204|11568330|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
7333545|NCT00828204|11568331|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
7333546|NCT00828204|11568330|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
7333547|NCT00828204|11568331|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
7333548|NCT00828204|11568330|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
7333549|NCT00828204|11568331|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
7333550|NCT00828204|11568330|FG000|Main Study: After Study Restart|Adverse Event|0
7333551|NCT00828204|11568331|FG001|Main Study: After Study Restart|Adverse Event|2
7333552|NCT00828204|11568330|FG000|Main Study: After Study Restart|Noncompliance|0
7333553|NCT00828204|11568331|FG001|Main Study: After Study Restart|Noncompliance|1
7333554|NCT00828204|11568330|FG000|Extension Study|Lost to Follow-up|0
7333555|NCT00828204|11568331|FG001|Extension Study|Lost to Follow-up|1
7333556|NCT00828204|11568330|FG000|Extension Study|Physician Decision|0
7333557|NCT00828204|11568331|FG001|Extension Study|Physician Decision|2
7333558|NCT00828451|11568365|FG000|Overall Study|Death|2
7333559|NCT00828451|11568365|FG000|Overall Study|Lack of intravenous line|7
7333560|NCT00828451|11568365|FG000|Overall Study|Withdrawal by Subject|1
7333561|NCT00828451|11568365|FG000|Overall Study|Deterioration in clinical status|1
7333562|NCT00828464|11568369|FG000|Overall Study|Withdrawal by Subject|1
7333563|NCT00828516|11568373|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
7333564|NCT00828568|11568389|FG000|Randomized|Withdrawal by Subject|1
7333565|NCT00828568|11568390|FG001|Randomized|Withdrawal by Subject|0
7333566|NCT00828568|11568391|FG002|Randomized|Withdrawal by Subject|2
7333567|NCT00828568|11568389|FG000|Treated - Received at Least One Dose|Adverse Event|11
7333568|NCT00828568|11568390|FG001|Treated - Received at Least One Dose|Adverse Event|8
7333569|NCT00828568|11568391|FG002|Treated - Received at Least One Dose|Adverse Event|1
7333570|NCT00828568|11568389|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
7333571|NCT00828568|11568390|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
7333572|NCT00828568|11568391|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
7333573|NCT00828568|11568389|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
7333574|NCT00828568|11568390|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
7333575|NCT00828568|11568391|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
7333576|NCT00828568|11568389|FG000|Treated - Received at Least One Dose|Protocol Violation|9
7333577|NCT00828568|11568390|FG001|Treated - Received at Least One Dose|Protocol Violation|5
7333578|NCT00828568|11568391|FG002|Treated - Received at Least One Dose|Protocol Violation|3
7333579|NCT00828672|11568402|FG000|Study Treatment|Lost to Follow-up|1
7333580|NCT00828672|11568403|FG001|Study Treatment|Lost to Follow-up|0
7333581|NCT00828672|11568402|FG000|Study Treatment|Adverse Event|0
7333582|NCT00828672|11568403|FG001|Study Treatment|Adverse Event|1
7333583|NCT00828672|11568402|FG000|Study Treatment|Complete response, no surgery|1
7333584|NCT00828672|11568403|FG001|Study Treatment|Complete response, no surgery|1
7333585|NCT00828672|11568402|FG000|Post-surgery (<30 Days)|No central review materials|0
7333586|NCT00828672|11568403|FG001|Post-surgery (<30 Days)|No central review materials|1
7333587|NCT00828711|11568412|FG000|Overall Study|Lost to Follow-up|1
7333588|NCT00828711|11568413|FG001|Overall Study|Lost to Follow-up|0
7333589|NCT00828711|11568414|FG002|Overall Study|Lost to Follow-up|0
7333590|NCT00828750|11568422|FG000|Overall Study|Lack of Efficacy|3
7333591|NCT00828750|11568422|FG000|Overall Study|Normal PC Remained While No Treatment|1
7385320|NCT01200758|11643097|FG001|Stage I|Death|1
7385321|NCT01200758|11643098|FG002|Stage I|Death|0
7385322|NCT01200758|11643099|FG003|Stage I|Death|0
7385323|NCT01200758|11643096|FG000|Stage I|Physician Decision|1
7385324|NCT01200758|11643097|FG001|Stage I|Physician Decision|1
7385325|NCT01200758|11643098|FG002|Stage I|Physician Decision|0
7385326|NCT01200758|11643099|FG003|Stage I|Physician Decision|0
7385327|NCT01200758|11643096|FG000|Stage I|Lack of Efficacy|2
7385328|NCT01200758|11643097|FG001|Stage I|Lack of Efficacy|1
7385329|NCT01200758|11643098|FG002|Stage I|Lack of Efficacy|0
7385330|NCT01200758|11643099|FG003|Stage I|Lack of Efficacy|0
7385331|NCT01200758|11643096|FG000|Stage I|Adverse Event|5
7385332|NCT01200758|11643097|FG001|Stage I|Adverse Event|5
7385333|NCT01200758|11643098|FG002|Stage I|Adverse Event|0
7385334|NCT01200758|11643099|FG003|Stage I|Adverse Event|0
7385335|NCT01200758|11643096|FG000|Stage I|Withdrawal by Subject|1
7385336|NCT01200758|11643097|FG001|Stage I|Withdrawal by Subject|2
7385337|NCT01200758|11643098|FG002|Stage I|Withdrawal by Subject|0
7385338|NCT01200758|11643099|FG003|Stage I|Withdrawal by Subject|0
7385339|NCT01200758|11643096|FG000|Stage I|Disease Progression|9
7385340|NCT01200758|11643097|FG001|Stage I|Disease Progression|7
7385341|NCT01200758|11643098|FG002|Stage I|Disease Progression|0
7385342|NCT01200758|11643099|FG003|Stage I|Disease Progression|0
7385343|NCT01200758|11643096|FG000|Stage 2|Disease Progression|0
7385344|NCT01200758|11643097|FG001|Stage 2|Disease Progression|0
7385345|NCT01200758|11643098|FG002|Stage 2|Disease Progression|16
7385346|NCT01200758|11643099|FG003|Stage 2|Disease Progression|21
7385347|NCT01200758|11643096|FG000|Stage 2|Lack of Efficacy|0
7385348|NCT01200758|11643097|FG001|Stage 2|Lack of Efficacy|0
7385349|NCT01200758|11643098|FG002|Stage 2|Lack of Efficacy|4
7385350|NCT01200758|11643099|FG003|Stage 2|Lack of Efficacy|2
7385351|NCT01200758|11643096|FG000|Stage 2|Physician Decision|0
7385352|NCT01200758|11643097|FG001|Stage 2|Physician Decision|0
7385353|NCT01200758|11643098|FG002|Stage 2|Physician Decision|5
7385354|NCT01200758|11643099|FG003|Stage 2|Physician Decision|7
7385355|NCT01200758|11643096|FG000|Stage 2|Adverse Event|0
7385356|NCT01200758|11643097|FG001|Stage 2|Adverse Event|0
7385357|NCT01200758|11643098|FG002|Stage 2|Adverse Event|5
7385358|NCT01200758|11643099|FG003|Stage 2|Adverse Event|9
7385359|NCT01200758|11643096|FG000|Stage 2|Withdrawal by Subject|0
7385360|NCT01200758|11643097|FG001|Stage 2|Withdrawal by Subject|0
7385361|NCT01200758|11643098|FG002|Stage 2|Withdrawal by Subject|4
7385362|NCT01200758|11643099|FG003|Stage 2|Withdrawal by Subject|1
7385363|NCT01200758|11643096|FG000|Stage 2|Lost to Follow-up|0
7385364|NCT01200758|11643097|FG001|Stage 2|Lost to Follow-up|0
7385365|NCT01200758|11643098|FG002|Stage 2|Lost to Follow-up|3
7385366|NCT01200758|11643099|FG003|Stage 2|Lost to Follow-up|1
7385367|NCT01200758|11643096|FG000|Stage 2|Protocol Violation|0
7385368|NCT01200758|11643097|FG001|Stage 2|Protocol Violation|0
7385369|NCT01200758|11643098|FG002|Stage 2|Protocol Violation|1
7385370|NCT01200758|11643099|FG003|Stage 2|Protocol Violation|4
7385371|NCT01200758|11643096|FG000|Stage 2|Death|0
7385372|NCT01200758|11643097|FG001|Stage 2|Death|0
7385373|NCT01200758|11643098|FG002|Stage 2|Death|3
7385374|NCT01200758|11643099|FG003|Stage 2|Death|5
7385375|NCT01200797|11643111|FG000|Overall Study|symptomatic deterioration|2
7385376|NCT01200797|11643111|FG000|Overall Study|Adverse Event|4
7385377|NCT01200797|11643111|FG000|Overall Study|Disease Progression|13
7385378|NCT01200810|11643118|FG000|Overall Study|Physician Decision|1
7385379|NCT01200810|11643119|FG001|Overall Study|Physician Decision|0
7385380|NCT01200810|11643118|FG000|Overall Study|Withdrawal by Subject|1
7385381|NCT01200810|11643119|FG001|Overall Study|Withdrawal by Subject|2
7385382|NCT01200810|11643118|FG000|Overall Study|Sponsor stopped making study drug|3
7385383|NCT01200810|11643119|FG001|Overall Study|Sponsor stopped making study drug|3
7385384|NCT01200992|11643131|FG000|Overall Study|Study terminated early|35
7385385|NCT01200992|11643132|FG001|Overall Study|Study terminated early|41
7385386|NCT01200992|11643131|FG000|Overall Study|Randomized but not treated|2
7385387|NCT01200992|11643132|FG001|Overall Study|Randomized but not treated|0
7385388|NCT01201265|11643157|FG000|Overall Study|Death|14
7385389|NCT01201265|11643157|FG000|Overall Study|Insufficient Therapeutic Response|3
7385390|NCT01201265|11643157|FG000|Overall Study|Lost to Follow-up|10
7385391|NCT01201265|11643157|FG000|Overall Study|Withdrawal by Subject|7
7385392|NCT01201265|11643157|FG000|Overall Study|Disease Progression|4
7385393|NCT01201317|11643164|FG000|Overall Study|Withdrawal by Subject|5
7385394|NCT01201317|11643165|FG001|Overall Study|Withdrawal by Subject|0
7385395|NCT01201317|11643166|FG002|Overall Study|Withdrawal by Subject|3
7385396|NCT01201317|11643164|FG000|Overall Study|Adverse Event|2
7385397|NCT01201317|11643165|FG001|Overall Study|Adverse Event|2
7385398|NCT01201317|11643166|FG002|Overall Study|Adverse Event|2
7385399|NCT01201317|11643164|FG000|Overall Study|Screen failure|1
7385400|NCT01201317|11643165|FG001|Overall Study|Screen failure|1
7385401|NCT01201317|11643166|FG002|Overall Study|Screen failure|0
7385402|NCT01201317|11643164|FG000|Overall Study|Protocol Violation|0
7385403|NCT01201317|11643165|FG001|Overall Study|Protocol Violation|1
7385404|NCT01201317|11643166|FG002|Overall Study|Protocol Violation|1
7385405|NCT01201317|11643164|FG000|Overall Study|Death|0
7385406|NCT01201317|11643165|FG001|Overall Study|Death|1
7385407|NCT01201317|11643166|FG002|Overall Study|Death|0
7333592|NCT00828945|11568442|FG000|Overall Study|Death|4
7333593|NCT00828945|11568442|FG000|Overall Study|Participant was missing|1
7333594|NCT00828945|11568442|FG000|Overall Study|Other|36
7333595|NCT00828984|11568449|FG000|Overall Study|Adverse Event|2
7333596|NCT00828984|11568450|FG001|Overall Study|Adverse Event|3
7333597|NCT00828984|11568451|FG002|Overall Study|Adverse Event|0
7333598|NCT00828984|11568449|FG000|Overall Study|Lost to Follow-up|5
7333599|NCT00828984|11568450|FG001|Overall Study|Lost to Follow-up|3
7333600|NCT00828984|11568451|FG002|Overall Study|Lost to Follow-up|1
7333601|NCT00828984|11568449|FG000|Overall Study|Withdrawal by Subject|4
7333602|NCT00828984|11568450|FG001|Overall Study|Withdrawal by Subject|4
7333603|NCT00828984|11568451|FG002|Overall Study|Withdrawal by Subject|4
7333604|NCT00828984|11568449|FG000|Overall Study|Ineligable|1
7333605|NCT00828984|11568450|FG001|Overall Study|Ineligable|2
7333606|NCT00828984|11568451|FG002|Overall Study|Ineligable|0
7333607|NCT00828984|11568449|FG000|Overall Study|Medical Contraindication|0
7333608|NCT00828984|11568450|FG001|Overall Study|Medical Contraindication|1
7333609|NCT00828984|11568451|FG002|Overall Study|Medical Contraindication|0
7333610|NCT00828984|11568449|FG000|Overall Study|Noncompliant|1
7333611|NCT00828984|11568450|FG001|Overall Study|Noncompliant|2
7333612|NCT00828984|11568451|FG002|Overall Study|Noncompliant|3
7333613|NCT00828984|11568449|FG000|Overall Study|ConMed|1
7333614|NCT00828984|11568450|FG001|Overall Study|ConMed|1
7333615|NCT00828984|11568451|FG002|Overall Study|ConMed|1
7333616|NCT00829010|11568464|FG000|Overall Study|Adverse Event|1
7333617|NCT00829010|11568465|FG001|Overall Study|Adverse Event|0
7333618|NCT00829010|11568466|FG002|Overall Study|Adverse Event|0
7333619|NCT00829010|11568467|FG003|Overall Study|Adverse Event|0
7333620|NCT00829010|11568468|FG004|Overall Study|Adverse Event|0
7333621|NCT00829010|11568464|FG000|Overall Study|Withdrawal by Subject|0
7333622|NCT00829010|11568465|FG001|Overall Study|Withdrawal by Subject|1
7333623|NCT00829010|11568466|FG002|Overall Study|Withdrawal by Subject|1
7333624|NCT00829010|11568467|FG003|Overall Study|Withdrawal by Subject|0
7333625|NCT00829010|11568468|FG004|Overall Study|Withdrawal by Subject|2
7333626|NCT00829010|11568464|FG000|Overall Study|Lost to Follow-up|1
7333627|NCT00829010|11568465|FG001|Overall Study|Lost to Follow-up|0
7333628|NCT00829010|11568466|FG002|Overall Study|Lost to Follow-up|2
7333629|NCT00829010|11568467|FG003|Overall Study|Lost to Follow-up|0
7333630|NCT00829010|11568468|FG004|Overall Study|Lost to Follow-up|0
7333631|NCT00829010|11568464|FG000|Overall Study|Fatality|5
7333632|NCT00829010|11568465|FG001|Overall Study|Fatality|4
7333633|NCT00829010|11568466|FG002|Overall Study|Fatality|0
7333634|NCT00829010|11568467|FG003|Overall Study|Fatality|3
7333635|NCT00829010|11568468|FG004|Overall Study|Fatality|0
7333636|NCT00829010|11568464|FG000|Overall Study|Migrated/Moved from study area|3
7333637|NCT00829010|11568465|FG001|Overall Study|Migrated/Moved from study area|4
7333638|NCT00829010|11568466|FG002|Overall Study|Migrated/Moved from study area|0
7568557|NCT03419403|11943964|FG000|Overall Study|Other, not specified|6
7568558|NCT03419403|11943965|FG001|Overall Study|Other, not specified|4
7568559|NCT03419403|11943966|FG002|Overall Study|Other, not specified|5
7568560|NCT03419403|11943967|FG003|Overall Study|Other, not specified|1
7568561|NCT03419403|11943964|FG000|Overall Study|Left study due to COVID-19 restrictions|1
7568562|NCT03419403|11943965|FG001|Overall Study|Left study due to COVID-19 restrictions|1
7568563|NCT03419403|11943966|FG002|Overall Study|Left study due to COVID-19 restrictions|0
7568564|NCT03419403|11943967|FG003|Overall Study|Left study due to COVID-19 restrictions|0
7568565|NCT03419598|11943992|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
7568566|NCT03419962|11944007|FG000|Overall Study|Change to other medication|1
7568567|NCT03419962|11944007|FG000|Overall Study|Refusal of continuing with trial drug|1
7568568|NCT03419962|11944007|FG000|Overall Study|Lost to Follow-up|3
7568569|NCT03419962|11944007|FG000|Overall Study|Difficulty in inhaling the doses|1
7568570|NCT03419962|11944007|FG000|Overall Study|Missing completion data|31
7568571|NCT03420300|11944011|FG000|Overall Study|Death|2
7568572|NCT03421379|11944037|FG000|Period 1|Withdrawal by Subject|0
7568573|NCT03421379|11944038|FG001|Period 1|Withdrawal by Subject|1
7568574|NCT03421379|11944037|FG000|Period 1|Physician Decision|1
7568575|NCT03421379|11944038|FG001|Period 1|Physician Decision|1
7568576|NCT03421379|11944037|FG000|Period 1|Did not receive treatment|1
7333639|NCT00829010|11568467|FG003|Overall Study|Migrated/Moved from study area|5
7333640|NCT00829010|11568468|FG004|Overall Study|Migrated/Moved from study area|0
7333641|NCT00829166|11568495|FG000|Overall Study|Death|305
7333642|NCT00829166|11568496|FG001|Overall Study|Death|333
7333643|NCT00829166|11568495|FG000|Overall Study|Lost to Follow-up|5
7333644|NCT00829166|11568496|FG001|Overall Study|Lost to Follow-up|4
7333645|NCT00829166|11568495|FG000|Overall Study|Physician's Decision|4
7333646|NCT00829166|11568496|FG001|Overall Study|Physician's Decision|3
7568577|NCT03421379|11944038|FG001|Period 1|Did not receive treatment|2
7333647|NCT00829166|11568495|FG000|Overall Study|Subject's Decision|41
7333648|NCT00829166|11568496|FG001|Overall Study|Subject's Decision|55
7333649|NCT00829166|11568495|FG000|Overall Study|Sponsor's Decision|137
7333650|NCT00829166|11568496|FG001|Overall Study|Sponsor's Decision|98
7333651|NCT00829166|11568495|FG000|Overall Study|Reason Not Specified|3
7333652|NCT00829166|11568496|FG001|Overall Study|Reason Not Specified|3
7333653|NCT00829179|11568503|FG000|Overall Study|Withdrawal by Subject|1
7333654|NCT00829244|11568509|FG000|Overall Study|Adverse Event|1
7333655|NCT00829244|11568510|FG001|Overall Study|Adverse Event|3
7333656|NCT00829244|11568509|FG000|Overall Study|Protocol Violation|1
7333657|NCT00829244|11568510|FG001|Overall Study|Protocol Violation|0
7333658|NCT00829244|11568509|FG000|Overall Study|Lack of ovarian response to stimulation|9
7333659|NCT00829244|11568510|FG001|Overall Study|Lack of ovarian response to stimulation|5
7333660|NCT00829244|11568509|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
7333661|NCT00829244|11568510|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
7333662|NCT00829244|11568509|FG000|Overall Study|No fertilization|2
7333663|NCT00829244|11568510|FG001|Overall Study|No fertilization|2
7333664|NCT00829244|11568509|FG000|Overall Study|All embryos discarded|0
7333665|NCT00829244|11568510|FG001|Overall Study|All embryos discarded|3
7333666|NCT00829244|11568509|FG000|Overall Study|No embryo cleavage|0
7333667|NCT00829244|11568510|FG001|Overall Study|No embryo cleavage|2
7333668|NCT00829283|11568518|FG000|Overall Study|Lost to Follow-up|7
7333669|NCT00829283|11568519|FG001|Overall Study|Lost to Follow-up|25
7333670|NCT00829296|11568527|FG000|Overall Study|Adverse Event|5
7333671|NCT00829296|11568528|FG001|Overall Study|Adverse Event|4
7333672|NCT00829387|11568536|FG000|Overall Study|Withdrawal by Subject|2
7333673|NCT00829387|11568537|FG001|Overall Study|Withdrawal by Subject|3
7333674|NCT00829387|11568536|FG000|Overall Study|Disqualified by PI|1
7333675|NCT00829387|11568537|FG001|Overall Study|Disqualified by PI|0
7333676|NCT00829413|11568543|FG000|Overall Study|No study drug admimnistered|13
7333677|NCT00829413|11568543|FG000|Overall Study|Training Patients|67
7333678|NCT00829413|11568543|FG000|Overall Study|No truth standard procedure available|9
7333679|NCT00829413|11568543|FG000|Overall Study|Technically inadequate truth standard|2
7333680|NCT00829413|11568543|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
7333681|NCT00829439|11568554|FG000|Overall Study|Adverse Event|0
7333682|NCT00829439|11568555|FG001|Overall Study|Adverse Event|0
7333683|NCT00829439|11568556|FG002|Overall Study|Adverse Event|1
7333684|NCT00829439|11568557|FG003|Overall Study|Adverse Event|0
7333685|NCT00829621|11568563|FG000|Overall Study|Death|1
7333686|NCT00829621|11568564|FG001|Overall Study|Death|0
7333687|NCT00829621|11568563|FG000|Overall Study|Lost to Follow-up|3
7333688|NCT00829621|11568564|FG001|Overall Study|Lost to Follow-up|4
7333689|NCT00829829|11568578|FG000|Overall Study|Protocol Violation|0
7333690|NCT00829829|11568579|FG001|Overall Study|Protocol Violation|3
7333691|NCT00829829|11568580|FG002|Overall Study|Protocol Violation|0
7333692|NCT00829829|11568578|FG000|Overall Study|Adverse Event|4
7333693|NCT00829829|11568579|FG001|Overall Study|Adverse Event|4
7333694|NCT00829829|11568580|FG002|Overall Study|Adverse Event|3
7333695|NCT00829829|11568578|FG000|Overall Study|Withdrawal by Subject|8
7333696|NCT00829829|11568579|FG001|Overall Study|Withdrawal by Subject|4
7333697|NCT00829829|11568580|FG002|Overall Study|Withdrawal by Subject|2
7333698|NCT00829829|11568578|FG000|Overall Study|Decision by the Sponsor|1
7333699|NCT00829829|11568579|FG001|Overall Study|Decision by the Sponsor|0
7333700|NCT00829829|11568580|FG002|Overall Study|Decision by the Sponsor|2
7333701|NCT00829829|11568578|FG000|Overall Study|Lost to Follow-up|7
7333702|NCT00829829|11568579|FG001|Overall Study|Lost to Follow-up|3
7333703|NCT00829829|11568580|FG002|Overall Study|Lost to Follow-up|3
7333704|NCT00829829|11568578|FG000|Overall Study|Other than specified above|2
7333705|NCT00829829|11568579|FG001|Overall Study|Other than specified above|2
7333706|NCT00829829|11568580|FG002|Overall Study|Other than specified above|1
7333707|NCT00829933|11568593|FG000|Overall Study|Adverse Event|2
7333708|NCT00829933|11568594|FG001|Overall Study|Adverse Event|3
7333709|NCT00829933|11568595|FG002|Overall Study|Adverse Event|2
7333710|NCT00829933|11568596|FG003|Overall Study|Adverse Event|1
7333711|NCT00829933|11568593|FG000|Overall Study|Death|0
7333712|NCT00829933|11568594|FG001|Overall Study|Death|0
7333713|NCT00829933|11568595|FG002|Overall Study|Death|1
7333714|NCT00829933|11568596|FG003|Overall Study|Death|1
7333715|NCT00829933|11568593|FG000|Overall Study|Lack of Efficacy|0
7333716|NCT00829933|11568594|FG001|Overall Study|Lack of Efficacy|1
7333717|NCT00829933|11568595|FG002|Overall Study|Lack of Efficacy|0
7333718|NCT00829933|11568596|FG003|Overall Study|Lack of Efficacy|0
7333719|NCT00829933|11568593|FG000|Overall Study|Physician Decision|5
7333720|NCT00829933|11568594|FG001|Overall Study|Physician Decision|7
7333721|NCT00829933|11568595|FG002|Overall Study|Physician Decision|8
7225227|NCT00064701|11434643|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
7333722|NCT00829933|11568596|FG003|Overall Study|Physician Decision|1
7333723|NCT00829933|11568593|FG000|Overall Study|Pregnancy|0
7333724|NCT00829933|11568594|FG001|Overall Study|Pregnancy|0
7333725|NCT00829933|11568595|FG002|Overall Study|Pregnancy|0
7333726|NCT00829933|11568596|FG003|Overall Study|Pregnancy|2
7333727|NCT00829933|11568593|FG000|Overall Study|Protocol Violation|2
7333728|NCT00829933|11568594|FG001|Overall Study|Protocol Violation|1
7333729|NCT00829933|11568595|FG002|Overall Study|Protocol Violation|0
7333730|NCT00829933|11568596|FG003|Overall Study|Protocol Violation|0
7333731|NCT00829933|11568593|FG000|Overall Study|withdrew before treatment started|5
7333732|NCT00829933|11568594|FG001|Overall Study|withdrew before treatment started|1
7333733|NCT00829933|11568595|FG002|Overall Study|withdrew before treatment started|2
7333734|NCT00829933|11568596|FG003|Overall Study|withdrew before treatment started|9
7333735|NCT00830037|11568617|FG000|Overall Study|Withdrawal by Subject|2
7333736|NCT00830037|11568618|FG001|Overall Study|Withdrawal by Subject|3
7333737|NCT00830037|11568617|FG000|Overall Study|Lost to Follow-up|1
7333738|NCT00830037|11568618|FG001|Overall Study|Lost to Follow-up|2
7333739|NCT00830037|11568617|FG000|Overall Study|Active when terminated by DSMB|15
7333740|NCT00830037|11568618|FG001|Overall Study|Active when terminated by DSMB|14
7333741|NCT00830063|11568628|FG000|Overall Study|Adverse Event|7
7333742|NCT00830063|11568629|FG001|Overall Study|Adverse Event|13
7333743|NCT00830063|11568630|FG002|Overall Study|Adverse Event|16
7333744|NCT00830063|11568631|FG003|Overall Study|Adverse Event|13
7333745|NCT00830063|11568628|FG000|Overall Study|Death|1
7333746|NCT00830063|11568629|FG001|Overall Study|Death|0
7333747|NCT00830063|11568630|FG002|Overall Study|Death|0
7333748|NCT00830063|11568631|FG003|Overall Study|Death|0
7333749|NCT00830063|11568628|FG000|Overall Study|Lost to Follow-up|0
7568578|NCT03421431|11944047|FG000|Overall Study|Adverse Event|2
7333750|NCT00830063|11568629|FG001|Overall Study|Lost to Follow-up|0
7333751|NCT00830063|11568630|FG002|Overall Study|Lost to Follow-up|3
7333752|NCT00830063|11568631|FG003|Overall Study|Lost to Follow-up|1
7333753|NCT00830063|11568628|FG000|Overall Study|Preferred Time Entry in Extension Study|119
7333754|NCT00830063|11568629|FG001|Overall Study|Preferred Time Entry in Extension Study|139
7333755|NCT00830063|11568630|FG002|Overall Study|Preferred Time Entry in Extension Study|127
7333756|NCT00830063|11568631|FG003|Overall Study|Preferred Time Entry in Extension Study|126
7333757|NCT00830063|11568628|FG000|Overall Study|Lack of Efficacy|51
7333758|NCT00830063|11568629|FG001|Overall Study|Lack of Efficacy|23
7333759|NCT00830063|11568630|FG002|Overall Study|Lack of Efficacy|25
7333760|NCT00830063|11568631|FG003|Overall Study|Lack of Efficacy|32
7333761|NCT00830063|11568628|FG000|Overall Study|Other|5
7333762|NCT00830063|11568629|FG001|Overall Study|Other|5
7333763|NCT00830063|11568630|FG002|Overall Study|Other|8
7333764|NCT00830063|11568631|FG003|Overall Study|Other|6
7333765|NCT00830063|11568628|FG000|Overall Study|Withdrawal by Subject|16
7333766|NCT00830063|11568629|FG001|Overall Study|Withdrawal by Subject|10
7333767|NCT00830063|11568630|FG002|Overall Study|Withdrawal by Subject|16
7333768|NCT00830063|11568631|FG003|Overall Study|Withdrawal by Subject|13
7333769|NCT00830063|11568628|FG000|Overall Study|Protocol Violation|1
7333770|NCT00830063|11568629|FG001|Overall Study|Protocol Violation|0
7333771|NCT00830063|11568630|FG002|Overall Study|Protocol Violation|3
7333772|NCT00830063|11568631|FG003|Overall Study|Protocol Violation|2
7333773|NCT00830063|11568628|FG000|Overall Study|Randomized But Not Treated|0
7333774|NCT00830063|11568629|FG001|Overall Study|Randomized But Not Treated|2
7333775|NCT00830063|11568630|FG002|Overall Study|Randomized But Not Treated|0
7333776|NCT00830063|11568631|FG003|Overall Study|Randomized But Not Treated|2
7333777|NCT00830115|11568650|FG000|Overall Study|Adverse Event|2
7333778|NCT00830115|11568650|FG000|Overall Study|Improvement/recovery|1
7333779|NCT00830128|11568656|FG000|Overall Study|Adverse Event|5
7333780|NCT00830128|11568656|FG000|Overall Study|Lack of Efficacy|7
7333781|NCT00830128|11568656|FG000|Overall Study|Protocol Violation|1
7333782|NCT00830128|11568656|FG000|Overall Study|Withdrawal by Subject|2
7333783|NCT00830128|11568656|FG000|Overall Study|Family obligation|1
7333784|NCT00830128|11568656|FG000|Overall Study|Relocation|1
7333785|NCT00830128|11568656|FG000|Overall Study|Work obligation|1
7333786|NCT00830128|11568656|FG000|Overall Study|Operating a vehicle|1
7333787|NCT00830167|11568662|FG000|Overall Study|Lack of Efficacy|26
7333788|NCT00830167|11568663|FG001|Overall Study|Lack of Efficacy|10
7333789|NCT00830167|11568662|FG000|Overall Study|Adverse Event|8
7333790|NCT00830167|11568663|FG001|Overall Study|Adverse Event|24
7333791|NCT00830167|11568662|FG000|Overall Study|Not meeting entrance criteria|2
7333792|NCT00830167|11568663|FG001|Overall Study|Not meeting entrance criteria|5
7333793|NCT00830167|11568662|FG000|Overall Study|Withdrawal by Subject|2
7333794|NCT00830167|11568663|FG001|Overall Study|Withdrawal by Subject|0
7333795|NCT00830167|11568662|FG000|Overall Study|Lost to Follow-up|0
7333796|NCT00830167|11568663|FG001|Overall Study|Lost to Follow-up|1
7333797|NCT00830167|11568662|FG000|Overall Study|Protocol Violation|0
7333798|NCT00830167|11568663|FG001|Overall Study|Protocol Violation|1
7333799|NCT00830167|11568662|FG000|Overall Study|Other|2
7333800|NCT00830167|11568663|FG001|Overall Study|Other|2
7333801|NCT00830180|11568669|FG000|Overall Study|Adverse Event|6
7333802|NCT00830180|11568669|FG000|Overall Study|Death|11
7333803|NCT00830180|11568669|FG000|Overall Study|Insufficient clinical response|1
7333804|NCT00830180|11568669|FG000|Overall Study|Withdrawal by Subject|5
7333805|NCT00830180|11568669|FG000|Overall Study|Progressive disease|2
7333806|NCT00830180|11568669|FG000|Overall Study|Other - Unspecified|1
7333807|NCT00830375|11568701|FG000|Overall Study|Lost to Follow-up|1
7333808|NCT00830440|11568711|FG000|Overall Study|Protocol Violation|1
7333809|NCT00830440|11568712|FG001|Overall Study|Protocol Violation|0
7333810|NCT00830440|11568711|FG000|Overall Study|Withdrawal by Subject|1
7333811|NCT00830440|11568712|FG001|Overall Study|Withdrawal by Subject|0
7333812|NCT00830440|11568711|FG000|Overall Study|unsuccessful procedure|4
7333813|NCT00830440|11568712|FG001|Overall Study|unsuccessful procedure|0
7333814|NCT00830440|11568711|FG000|Overall Study|Adverse Event|2
7333815|NCT00830440|11568712|FG001|Overall Study|Adverse Event|0
7333816|NCT00830518|11568721|FG000|Overall Study|Progressive Disease|18
7333817|NCT00830518|11568722|FG001|Overall Study|Progressive Disease|8
7333818|NCT00830518|11568721|FG000|Overall Study|Symptomatic Deterioration|4
7333819|NCT00830518|11568722|FG001|Overall Study|Symptomatic Deterioration|1
7333820|NCT00830518|11568721|FG000|Overall Study|Adverse Event|14
7333821|NCT00830518|11568722|FG001|Overall Study|Adverse Event|1
7333822|NCT00830518|11568721|FG000|Overall Study|Withdrawal by Patient|2
7568579|NCT03421431|11944048|FG001|Overall Study|Adverse Event|1
7333823|NCT00830518|11568722|FG001|Overall Study|Withdrawal by Patient|0
7333824|NCT00830518|11568721|FG000|Overall Study|Reason not Specified|8
7333825|NCT00830518|11568722|FG001|Overall Study|Reason not Specified|1
7333826|NCT00830765|11568744|FG000|Overall Study|Protocol Violation|3
7333827|NCT00830765|11568745|FG001|Overall Study|Protocol Violation|2
7333828|NCT00830804|11568775|FG000|Overall Study|Lost to Follow-up|4
7333829|NCT00830804|11568775|FG000|Overall Study|Death|1
7333830|NCT00830804|11568775|FG000|Overall Study|Unable to get to clinic|7
7333831|NCT00830804|11568775|FG000|Overall Study|Consent withdrawn|2
7333832|NCT00830804|11568775|FG000|Overall Study|Unwilling to adhere to study requirement|1
7333833|NCT00830869|11568792|FG000|Period 1: Part 1|Symptomatic deterioration|0
7333834|NCT00830869|11568793|FG001|Period 1: Part 1|Symptomatic deterioration|0
7333835|NCT00830869|11568794|FG002|Period 1: Part 1|Symptomatic deterioration|0
7333836|NCT00830869|11568795|FG003|Period 1: Part 1|Symptomatic deterioration|1
7333837|NCT00830869|11568796|FG004|Period 1: Part 1|Symptomatic deterioration|0
7333838|NCT00830869|11568797|FG005|Period 1: Part 1|Symptomatic deterioration|1
7333839|NCT00830869|11568798|FG006|Period 1: Part 1|Symptomatic deterioration|1
7333840|NCT00830869|11568799|FG007|Period 1: Part 1|Symptomatic deterioration|0
7333841|NCT00830869|11568800|FG008|Period 1: Part 1|Symptomatic deterioration|0
7333842|NCT00830869|11568801|FG009|Period 1: Part 1|Symptomatic deterioration|0
7333843|NCT00830869|11568802|FG010|Period 1: Part 1|Symptomatic deterioration|0
7333844|NCT00830869|11568803|FG011|Period 1: Part 1|Symptomatic deterioration|0
7333845|NCT00830869|11568792|FG000|Period 1: Part 1|Withdrawal by Subject|0
7333846|NCT00830869|11568793|FG001|Period 1: Part 1|Withdrawal by Subject|1
7333847|NCT00830869|11568794|FG002|Period 1: Part 1|Withdrawal by Subject|0
7333848|NCT00830869|11568795|FG003|Period 1: Part 1|Withdrawal by Subject|0
7333849|NCT00830869|11568796|FG004|Period 1: Part 1|Withdrawal by Subject|0
7333850|NCT00830869|11568797|FG005|Period 1: Part 1|Withdrawal by Subject|0
7333851|NCT00830869|11568798|FG006|Period 1: Part 1|Withdrawal by Subject|0
7333852|NCT00830869|11568799|FG007|Period 1: Part 1|Withdrawal by Subject|0
7333853|NCT00830869|11568800|FG008|Period 1: Part 1|Withdrawal by Subject|0
7333854|NCT00830869|11568801|FG009|Period 1: Part 1|Withdrawal by Subject|0
7333855|NCT00830869|11568802|FG010|Period 1: Part 1|Withdrawal by Subject|0
7333856|NCT00830869|11568803|FG011|Period 1: Part 1|Withdrawal by Subject|0
7333857|NCT00830869|11568792|FG000|Period 1: Part 1|Adverse Event|0
7333858|NCT00830869|11568793|FG001|Period 1: Part 1|Adverse Event|0
7333859|NCT00830869|11568794|FG002|Period 1: Part 1|Adverse Event|0
7333860|NCT00830869|11568795|FG003|Period 1: Part 1|Adverse Event|0
7333861|NCT00830869|11568796|FG004|Period 1: Part 1|Adverse Event|0
7333862|NCT00830869|11568797|FG005|Period 1: Part 1|Adverse Event|1
7333863|NCT00830869|11568798|FG006|Period 1: Part 1|Adverse Event|1
7333864|NCT00830869|11568799|FG007|Period 1: Part 1|Adverse Event|0
7333865|NCT00830869|11568800|FG008|Period 1: Part 1|Adverse Event|0
7333866|NCT00830869|11568801|FG009|Period 1: Part 1|Adverse Event|0
7333867|NCT00830869|11568802|FG010|Period 1: Part 1|Adverse Event|0
7333868|NCT00830869|11568803|FG011|Period 1: Part 1|Adverse Event|0
7333869|NCT00830869|11568792|FG000|Period 1: Part 1|Progressive disease|1
7333870|NCT00830869|11568793|FG001|Period 1: Part 1|Progressive disease|0
7333871|NCT00830869|11568794|FG002|Period 1: Part 1|Progressive disease|1
7333872|NCT00830869|11568795|FG003|Period 1: Part 1|Progressive disease|6
7333873|NCT00830869|11568796|FG004|Period 1: Part 1|Progressive disease|4
7333874|NCT00830869|11568797|FG005|Period 1: Part 1|Progressive disease|4
7333875|NCT00830869|11568798|FG006|Period 1: Part 1|Progressive disease|1
7333876|NCT00830869|11568799|FG007|Period 1: Part 1|Progressive disease|0
7333877|NCT00830869|11568800|FG008|Period 1: Part 1|Progressive disease|0
7333878|NCT00830869|11568801|FG009|Period 1: Part 1|Progressive disease|0
7333879|NCT00830869|11568802|FG010|Period 1: Part 1|Progressive disease|0
7333880|NCT00830869|11568803|FG011|Period 1: Part 1|Progressive disease|0
7333881|NCT00830869|11568792|FG000|Period 2: Part 2|Protocol Violation|0
7333882|NCT00830869|11568793|FG001|Period 2: Part 2|Protocol Violation|0
7333883|NCT00830869|11568794|FG002|Period 2: Part 2|Protocol Violation|0
7333884|NCT00830869|11568795|FG003|Period 2: Part 2|Protocol Violation|0
7333885|NCT00830869|11568796|FG004|Period 2: Part 2|Protocol Violation|0
7333886|NCT00830869|11568797|FG005|Period 2: Part 2|Protocol Violation|0
7333887|NCT00830869|11568798|FG006|Period 2: Part 2|Protocol Violation|0
7333888|NCT00830869|11568799|FG007|Period 2: Part 2|Protocol Violation|1
7333889|NCT00830869|11568800|FG008|Period 2: Part 2|Protocol Violation|0
7333890|NCT00830869|11568801|FG009|Period 2: Part 2|Protocol Violation|1
7333891|NCT00830869|11568802|FG010|Period 2: Part 2|Protocol Violation|0
7333892|NCT00830869|11568803|FG011|Period 2: Part 2|Protocol Violation|0
7333893|NCT00830869|11568792|FG000|Period 2: Part 2|Withdrawal by Subject|0
7333894|NCT00830869|11568793|FG001|Period 2: Part 2|Withdrawal by Subject|0
7333895|NCT00830869|11568794|FG002|Period 2: Part 2|Withdrawal by Subject|0
7333896|NCT00830869|11568795|FG003|Period 2: Part 2|Withdrawal by Subject|0
7333897|NCT00830869|11568796|FG004|Period 2: Part 2|Withdrawal by Subject|0
7333898|NCT00830869|11568797|FG005|Period 2: Part 2|Withdrawal by Subject|0
7333899|NCT00830869|11568798|FG006|Period 2: Part 2|Withdrawal by Subject|0
7333900|NCT00830869|11568799|FG007|Period 2: Part 2|Withdrawal by Subject|1
7333901|NCT00830869|11568800|FG008|Period 2: Part 2|Withdrawal by Subject|2
7333902|NCT00830869|11568801|FG009|Period 2: Part 2|Withdrawal by Subject|1
7333903|NCT00830869|11568802|FG010|Period 2: Part 2|Withdrawal by Subject|0
7333904|NCT00830869|11568803|FG011|Period 2: Part 2|Withdrawal by Subject|1
7333905|NCT00830869|11568792|FG000|Period 2: Part 2|Adverse Event|0
7333906|NCT00830869|11568793|FG001|Period 2: Part 2|Adverse Event|0
7333907|NCT00830869|11568794|FG002|Period 2: Part 2|Adverse Event|0
7333908|NCT00830869|11568795|FG003|Period 2: Part 2|Adverse Event|0
7333909|NCT00830869|11568796|FG004|Period 2: Part 2|Adverse Event|0
7333910|NCT00830869|11568797|FG005|Period 2: Part 2|Adverse Event|0
7333911|NCT00830869|11568798|FG006|Period 2: Part 2|Adverse Event|0
7333912|NCT00830869|11568799|FG007|Period 2: Part 2|Adverse Event|4
7333913|NCT00830869|11568800|FG008|Period 2: Part 2|Adverse Event|3
7333914|NCT00830869|11568801|FG009|Period 2: Part 2|Adverse Event|2
7333915|NCT00830869|11568802|FG010|Period 2: Part 2|Adverse Event|2
7333916|NCT00830869|11568803|FG011|Period 2: Part 2|Adverse Event|0
7333917|NCT00830869|11568792|FG000|Period 2: Part 2|Symptomatic Deterioration|0
7333918|NCT00830869|11568793|FG001|Period 2: Part 2|Symptomatic Deterioration|0
7333919|NCT00830869|11568794|FG002|Period 2: Part 2|Symptomatic Deterioration|0
7333920|NCT00830869|11568795|FG003|Period 2: Part 2|Symptomatic Deterioration|0
7333921|NCT00830869|11568796|FG004|Period 2: Part 2|Symptomatic Deterioration|0
7333922|NCT00830869|11568797|FG005|Period 2: Part 2|Symptomatic Deterioration|0
7333923|NCT00830869|11568798|FG006|Period 2: Part 2|Symptomatic Deterioration|0
7333924|NCT00830869|11568799|FG007|Period 2: Part 2|Symptomatic Deterioration|0
7333925|NCT00830869|11568800|FG008|Period 2: Part 2|Symptomatic Deterioration|6
7333926|NCT00830869|11568801|FG009|Period 2: Part 2|Symptomatic Deterioration|3
7333927|NCT00830869|11568802|FG010|Period 2: Part 2|Symptomatic Deterioration|1
7333928|NCT00830869|11568803|FG011|Period 2: Part 2|Symptomatic Deterioration|4
7333929|NCT00830869|11568792|FG000|Period 2: Part 2|Progressive disease|0
7333930|NCT00830869|11568793|FG001|Period 2: Part 2|Progressive disease|0
7333931|NCT00830869|11568794|FG002|Period 2: Part 2|Progressive disease|0
7333932|NCT00830869|11568795|FG003|Period 2: Part 2|Progressive disease|0
7333933|NCT00830869|11568796|FG004|Period 2: Part 2|Progressive disease|0
7333934|NCT00830869|11568797|FG005|Period 2: Part 2|Progressive disease|0
7333935|NCT00830869|11568798|FG006|Period 2: Part 2|Progressive disease|0
7333936|NCT00830869|11568799|FG007|Period 2: Part 2|Progressive disease|14
7333937|NCT00830869|11568800|FG008|Period 2: Part 2|Progressive disease|11
7333938|NCT00830869|11568801|FG009|Period 2: Part 2|Progressive disease|12
7333939|NCT00830869|11568802|FG010|Period 2: Part 2|Progressive disease|8
7333940|NCT00830869|11568803|FG011|Period 2: Part 2|Progressive disease|15
7333941|NCT00830869|11568792|FG000|Period 2: Part 2|Other|0
7333942|NCT00830869|11568793|FG001|Period 2: Part 2|Other|0
7333943|NCT00830869|11568794|FG002|Period 2: Part 2|Other|0
7333944|NCT00830869|11568795|FG003|Period 2: Part 2|Other|0
7333945|NCT00830869|11568796|FG004|Period 2: Part 2|Other|0
7333946|NCT00830869|11568797|FG005|Period 2: Part 2|Other|0
7333947|NCT00830869|11568798|FG006|Period 2: Part 2|Other|0
7333948|NCT00830869|11568799|FG007|Period 2: Part 2|Other|0
7333949|NCT00830869|11568800|FG008|Period 2: Part 2|Other|0
7333950|NCT00830869|11568801|FG009|Period 2: Part 2|Other|1
7333951|NCT00830869|11568802|FG010|Period 2: Part 2|Other|0
7333952|NCT00830869|11568803|FG011|Period 2: Part 2|Other|0
7333953|NCT00830947|11568832|FG000|Overall Study|Lost to Follow-up|4
7333954|NCT00830947|11568833|FG001|Overall Study|Lost to Follow-up|4
7333955|NCT00830960|11568845|FG000|Overall Study|Death|5
7333956|NCT00830960|11568846|FG001|Overall Study|Death|4
7333957|NCT00830960|11568847|FG002|Overall Study|Death|3
7333958|NCT00830960|11568848|FG003|Overall Study|Death|2
7333959|NCT00830960|11568849|FG004|Overall Study|Death|6
7333960|NCT00830960|11568850|FG005|Overall Study|Death|1
7333961|NCT00830960|11568845|FG000|Overall Study|Lost to Follow-up|1
7333962|NCT00830960|11568846|FG001|Overall Study|Lost to Follow-up|1
7333963|NCT00830960|11568847|FG002|Overall Study|Lost to Follow-up|1
7333964|NCT00830960|11568848|FG003|Overall Study|Lost to Follow-up|0
7333965|NCT00830960|11568849|FG004|Overall Study|Lost to Follow-up|0
7333966|NCT00830960|11568850|FG005|Overall Study|Lost to Follow-up|1
7333967|NCT00830960|11568845|FG000|Overall Study|Withdrawal by Subject|19
7333968|NCT00830960|11568846|FG001|Overall Study|Withdrawal by Subject|19
7333969|NCT00830960|11568847|FG002|Overall Study|Withdrawal by Subject|18
7333970|NCT00830960|11568848|FG003|Overall Study|Withdrawal by Subject|23
7333971|NCT00830960|11568849|FG004|Overall Study|Withdrawal by Subject|16
7333972|NCT00830960|11568850|FG005|Overall Study|Withdrawal by Subject|21
7333973|NCT00830960|11568845|FG000|Overall Study|Sponsor Decision|1
7333974|NCT00830960|11568846|FG001|Overall Study|Sponsor Decision|2
7333975|NCT00830960|11568847|FG002|Overall Study|Sponsor Decision|3
7333976|NCT00830960|11568848|FG003|Overall Study|Sponsor Decision|4
7333977|NCT00830960|11568849|FG004|Overall Study|Sponsor Decision|5
7333978|NCT00830960|11568850|FG005|Overall Study|Sponsor Decision|7
7333979|NCT00830960|11568845|FG000|Overall Study|No study drug received|7
7333980|NCT00830960|11568846|FG001|Overall Study|No study drug received|2
7333981|NCT00830960|11568847|FG002|Overall Study|No study drug received|4
7333982|NCT00830960|11568848|FG003|Overall Study|No study drug received|3
7333983|NCT00830960|11568849|FG004|Overall Study|No study drug received|5
7333984|NCT00830960|11568850|FG005|Overall Study|No study drug received|7
7333985|NCT00831129|11568889|FG000|Overall Study|Adverse Event|0
7333986|NCT00831129|11568890|FG001|Overall Study|Adverse Event|1
7333987|NCT00831129|11568889|FG000|Overall Study|9 lost to follow-up reasons uknown|0
7333988|NCT00831129|11568890|FG001|Overall Study|9 lost to follow-up reasons uknown|9
7333989|NCT00831181|11568896|FG000|Overall Study|Adverse Event|12
7333990|NCT00831233|11568903|FG000|Overall Study|Adverse Event|0
7333991|NCT00831233|11568904|FG001|Overall Study|Adverse Event|1
7333992|NCT00831233|11568903|FG000|Overall Study|Protocol Violation|1
7333993|NCT00831233|11568904|FG001|Overall Study|Protocol Violation|0
7333994|NCT00831233|11568903|FG000|Overall Study|Selection Criteria Not Met|2
7333995|NCT00831233|11568904|FG001|Overall Study|Selection Criteria Not Met|0
7333996|NCT00831311|11568929|FG000|Overall Study|Definitive Contraindication|3
7333997|NCT00831311|11568930|FG001|Overall Study|Definitive Contraindication|3
7333998|NCT00831311|11568929|FG000|Overall Study|Lost to Follow-up|3
7333999|NCT00831311|11568930|FG001|Overall Study|Lost to Follow-up|0
7334000|NCT00831311|11568929|FG000|Overall Study|Physician Decision|0
7334001|NCT00831311|11568930|FG001|Overall Study|Physician Decision|1
7334002|NCT00831311|11568929|FG000|Overall Study|Withdrawal by Subject|6
7334003|NCT00831311|11568930|FG001|Overall Study|Withdrawal by Subject|4
7334004|NCT00831389|11568939|FG000|Overall Study|Withdrawal by Subject|0
7334005|NCT00831389|11568940|FG001|Overall Study|Withdrawal by Subject|1
7334006|NCT00831415|11568946|FG000|Overall Study|Adverse Event|14
7334007|NCT00831415|11568946|FG000|Overall Study|Failed to return|3
7334008|NCT00831415|11568946|FG000|Overall Study|Physician Decision|6
7334009|NCT00831415|11568946|FG000|Overall Study|Lost to Follow-up|9
7334010|NCT00831415|11568946|FG000|Overall Study|Protocol Violation|3
7334011|NCT00831415|11568946|FG000|Overall Study|Withdrawal by Subject|35
7457885|NCT01803282|11751717|FG000|Overall Study|Non-Compliance with Study Drug|0
7457886|NCT01803282|11751718|FG001|Overall Study|Non-Compliance with Study Drug|0
7457887|NCT01803282|11751719|FG002|Overall Study|Non-Compliance with Study Drug|0
7457888|NCT01803282|11751720|FG003|Overall Study|Non-Compliance with Study Drug|1
7457889|NCT01803282|11751721|FG004|Overall Study|Non-Compliance with Study Drug|0
7457890|NCT01803282|11751722|FG005|Overall Study|Non-Compliance with Study Drug|0
7457891|NCT01803282|11751723|FG006|Overall Study|Non-Compliance with Study Drug|0
7457892|NCT01803282|11751724|FG007|Overall Study|Non-Compliance with Study Drug|0
7457893|NCT01803282|11751725|FG008|Overall Study|Non-Compliance with Study Drug|0
7457894|NCT01803282|11751726|FG009|Overall Study|Non-Compliance with Study Drug|0
7457895|NCT01803282|11751727|FG010|Overall Study|Non-Compliance with Study Drug|0
7457896|NCT01803282|11751728|FG011|Overall Study|Non-Compliance with Study Drug|0
7457897|NCT01803282|11751717|FG000|Overall Study|Unknown Reason|0
7457898|NCT01803282|11751718|FG001|Overall Study|Unknown Reason|0
7457899|NCT01803282|11751719|FG002|Overall Study|Unknown Reason|0
7457900|NCT01803282|11751720|FG003|Overall Study|Unknown Reason|0
7457901|NCT01803282|11751721|FG004|Overall Study|Unknown Reason|0
7457902|NCT01803282|11751722|FG005|Overall Study|Unknown Reason|0
7457903|NCT01803282|11751723|FG006|Overall Study|Unknown Reason|0
7457904|NCT01803282|11751724|FG007|Overall Study|Unknown Reason|1
7457905|NCT01803282|11751725|FG008|Overall Study|Unknown Reason|0
7457906|NCT01803282|11751726|FG009|Overall Study|Unknown Reason|0
7457907|NCT01803282|11751727|FG010|Overall Study|Unknown Reason|0
7457908|NCT01803282|11751728|FG011|Overall Study|Unknown Reason|0
7457909|NCT01803282|11751717|FG000|Overall Study|Specified Criteria for Withdrawal|0
7457910|NCT01803282|11751718|FG001|Overall Study|Specified Criteria for Withdrawal|0
7457911|NCT01803282|11751719|FG002|Overall Study|Specified Criteria for Withdrawal|0
7457912|NCT01803282|11751720|FG003|Overall Study|Specified Criteria for Withdrawal|0
7457913|NCT01803282|11751721|FG004|Overall Study|Specified Criteria for Withdrawal|0
7457914|NCT01803282|11751722|FG005|Overall Study|Specified Criteria for Withdrawal|0
7457915|NCT01803282|11751723|FG006|Overall Study|Specified Criteria for Withdrawal|0
7457916|NCT01803282|11751724|FG007|Overall Study|Specified Criteria for Withdrawal|0
7457917|NCT01803282|11751725|FG008|Overall Study|Specified Criteria for Withdrawal|0
7457918|NCT01803282|11751726|FG009|Overall Study|Specified Criteria for Withdrawal|1
7457919|NCT01803282|11751727|FG010|Overall Study|Specified Criteria for Withdrawal|1
7568580|NCT03421431|11944049|FG002|Overall Study|Adverse Event|12
7457920|NCT01803282|11751728|FG011|Overall Study|Specified Criteria for Withdrawal|0
7457921|NCT01803282|11751717|FG000|Overall Study|Enrolled but Never Treated|0
7457922|NCT01803282|11751718|FG001|Overall Study|Enrolled but Never Treated|0
7457923|NCT01803282|11751719|FG002|Overall Study|Enrolled but Never Treated|0
7457924|NCT01803282|11751720|FG003|Overall Study|Enrolled but Never Treated|0
7457925|NCT01803282|11751721|FG004|Overall Study|Enrolled but Never Treated|1
7457926|NCT01803282|11751722|FG005|Overall Study|Enrolled but Never Treated|0
7457927|NCT01803282|11751723|FG006|Overall Study|Enrolled but Never Treated|1
7457928|NCT01803282|11751724|FG007|Overall Study|Enrolled but Never Treated|1
7457929|NCT01803282|11751725|FG008|Overall Study|Enrolled but Never Treated|0
7457930|NCT01803282|11751726|FG009|Overall Study|Enrolled but Never Treated|1
7457931|NCT01803282|11751727|FG010|Overall Study|Enrolled but Never Treated|0
7457932|NCT01803282|11751728|FG011|Overall Study|Enrolled but Never Treated|0
7457933|NCT01803464|11751758|FG000|Overall Study|Incomplete data|0
7457934|NCT01803464|11751759|FG001|Overall Study|Incomplete data|0
7457935|NCT01803464|11751760|FG002|Overall Study|Incomplete data|4
7457936|NCT01803464|11751761|FG003|Overall Study|Incomplete data|0
7457937|NCT01803464|11751758|FG000|Overall Study|Withdrawal by Subject|1
7457938|NCT01803464|11751759|FG001|Overall Study|Withdrawal by Subject|0
7457939|NCT01803464|11751760|FG002|Overall Study|Withdrawal by Subject|0
7457940|NCT01803464|11751761|FG003|Overall Study|Withdrawal by Subject|0
7457941|NCT01803607|11751777|FG000|Overall Study|Adverse Event|5
7568581|NCT03421431|11944047|FG000|Overall Study|Lost to Follow-up|1
7334012|NCT00831415|11568946|FG000|Overall Study|Unsatisfactory response - Efficacy|4
7334013|NCT00831415|11568946|FG000|Overall Study|Death|1
7334014|NCT00831441|11568956|FG000|Randomized|Death|82
7334015|NCT00831441|11568957|FG001|Randomized|Death|81
7334016|NCT00831441|11568956|FG000|Randomized|Adverse Event|248
7334017|NCT00831441|11568957|FG001|Randomized|Adverse Event|321
7334018|NCT00831441|11568956|FG000|Randomized|Emergency procedure|2
7334019|NCT00831441|11568957|FG001|Randomized|Emergency procedure|2
7334020|NCT00831441|11568956|FG000|Randomized|Elective procedure|26
7334021|NCT00831441|11568957|FG001|Randomized|Elective procedure|25
7334022|NCT00831441|11568956|FG000|Randomized|Physician Decision|26
7334023|NCT00831441|11568957|FG001|Randomized|Physician Decision|35
7334024|NCT00831441|11568956|FG000|Randomized|No longer met criteria|13
7334025|NCT00831441|11568957|FG001|Randomized|No longer met criteria|19
7334026|NCT00831441|11568956|FG000|Randomized|Withdrawal by Subject|178
7334027|NCT00831441|11568957|FG001|Randomized|Withdrawal by Subject|212
7334028|NCT00831441|11568956|FG000|Randomized|Lost to Follow-up|26
7334029|NCT00831441|11568957|FG001|Randomized|Lost to Follow-up|35
7334030|NCT00831441|11568956|FG000|Randomized|Administrative reason by sponsor|2780
7334031|NCT00831441|11568957|FG001|Randomized|Administrative reason by sponsor|2671
7334032|NCT00831441|11568956|FG000|Randomized|poor/non-compliance|30
7334033|NCT00831441|11568957|FG001|Randomized|poor/non-compliance|38
7334034|NCT00831441|11568956|FG000|Randomized|non-specified|276
7334035|NCT00831441|11568957|FG001|Randomized|non-specified|266
7334036|NCT00831441|11568956|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
7334037|NCT00831441|11568957|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
7334038|NCT00831441|11568956|FG000|Follow Up (30 Days)|Lost to Follow-up|13
7334039|NCT00831441|11568957|FG001|Follow Up (30 Days)|Lost to Follow-up|27
7334040|NCT00831441|11568956|FG000|Follow Up (30 Days)|Death|63
7334041|NCT00831441|11568957|FG001|Follow Up (30 Days)|Death|86
7334042|NCT00831441|11568956|FG000|Follow Up (30 Days)|non-specified|16
7334043|NCT00831441|11568957|FG001|Follow Up (30 Days)|non-specified|26
7334044|NCT00831441|11568956|FG000|Follow Up (30 Days)|missing end of study status|0
7334045|NCT00831441|11568957|FG001|Follow Up (30 Days)|missing end of study status|1
7334046|NCT00831493|11568968|FG000|Overall Study|Intractable nausea and vomiting|1
7334047|NCT00831701|11568983|FG000|Overall Study|Withdrawal by Subject|2
7334048|NCT00831701|11568984|FG001|Overall Study|Withdrawal by Subject|0
7334049|NCT00831701|11568983|FG000|Overall Study|Stone expulsion before first medication|2
7334050|NCT00831701|11568984|FG001|Overall Study|Stone expulsion before first medication|2
7334051|NCT00831701|11568983|FG000|Overall Study|Lost to Follow-up|1
7334052|NCT00831701|11568984|FG001|Overall Study|Lost to Follow-up|3
7334053|NCT00831779|11569011|FG000|Overall Study|Lost to Follow-up|1
7334054|NCT00831779|11569012|FG001|Overall Study|Lost to Follow-up|0
7334055|NCT00831779|11569011|FG000|Overall Study|No longer met criteria|0
7334056|NCT00831779|11569012|FG001|Overall Study|No longer met criteria|1
7334057|NCT00831792|11569018|FG000|Overall Study|Not Eligible|3
7334058|NCT00831792|11569018|FG000|Overall Study|Adverse Event|1
7334059|NCT00831792|11569018|FG000|Overall Study|Death|1
7334060|NCT00831792|11569018|FG000|Overall Study|Lack of Efficacy|1
7334061|NCT00831844|11569032|FG000|Overall Study|Adverse Event|2
7334062|NCT00831844|11569033|FG001|Overall Study|Adverse Event|0
7334063|NCT00831844|11569034|FG002|Overall Study|Adverse Event|0
7334064|NCT00831844|11569035|FG003|Overall Study|Adverse Event|0
7334065|NCT00831844|11569036|FG004|Overall Study|Adverse Event|1
7334066|NCT00831844|11569037|FG005|Overall Study|Adverse Event|1
7334067|NCT00831844|11569038|FG006|Overall Study|Adverse Event|2
7334068|NCT00831844|11569039|FG007|Overall Study|Adverse Event|0
7334069|NCT00831844|11569040|FG008|Overall Study|Adverse Event|0
7334070|NCT00831844|11569041|FG009|Overall Study|Adverse Event|0
7334071|NCT00831844|11569032|FG000|Overall Study|Death|0
7334072|NCT00831844|11569033|FG001|Overall Study|Death|0
7334073|NCT00831844|11569034|FG002|Overall Study|Death|0
7334074|NCT00831844|11569035|FG003|Overall Study|Death|1
7334075|NCT00831844|11569036|FG004|Overall Study|Death|0
7334076|NCT00831844|11569037|FG005|Overall Study|Death|0
7334077|NCT00831844|11569038|FG006|Overall Study|Death|0
7334078|NCT00831844|11569039|FG007|Overall Study|Death|0
7334079|NCT00831844|11569040|FG008|Overall Study|Death|0
7334080|NCT00831844|11569041|FG009|Overall Study|Death|0
7334081|NCT00831844|11569032|FG000|Overall Study|Lack of Efficacy|8
7334082|NCT00831844|11569033|FG001|Overall Study|Lack of Efficacy|10
7334083|NCT00831844|11569034|FG002|Overall Study|Lack of Efficacy|15
7334084|NCT00831844|11569035|FG003|Overall Study|Lack of Efficacy|8
7334085|NCT00831844|11569036|FG004|Overall Study|Lack of Efficacy|11
7334086|NCT00831844|11569037|FG005|Overall Study|Lack of Efficacy|17
7334087|NCT00831844|11569038|FG006|Overall Study|Lack of Efficacy|8
7334088|NCT00831844|11569039|FG007|Overall Study|Lack of Efficacy|9
7334089|NCT00831844|11569040|FG008|Overall Study|Lack of Efficacy|7
7334090|NCT00831844|11569041|FG009|Overall Study|Lack of Efficacy|0
7334091|NCT00831844|11569032|FG000|Overall Study|Physician Decision|0
7334092|NCT00831844|11569033|FG001|Overall Study|Physician Decision|1
7334093|NCT00831844|11569034|FG002|Overall Study|Physician Decision|3
7334094|NCT00831844|11569035|FG003|Overall Study|Physician Decision|1
7334095|NCT00831844|11569036|FG004|Overall Study|Physician Decision|1
7334096|NCT00831844|11569037|FG005|Overall Study|Physician Decision|1
7334097|NCT00831844|11569038|FG006|Overall Study|Physician Decision|0
7334098|NCT00831844|11569039|FG007|Overall Study|Physician Decision|0
7334099|NCT00831844|11569040|FG008|Overall Study|Physician Decision|1
7334100|NCT00831844|11569041|FG009|Overall Study|Physician Decision|0
7334101|NCT00831844|11569032|FG000|Overall Study|Withdrawal by Subject|0
7334102|NCT00831844|11569033|FG001|Overall Study|Withdrawal by Subject|0
7334103|NCT00831844|11569034|FG002|Overall Study|Withdrawal by Subject|1
7568582|NCT03421431|11944048|FG001|Overall Study|Lost to Follow-up|1
7568583|NCT03421431|11944049|FG002|Overall Study|Lost to Follow-up|1
7568584|NCT03421431|11944047|FG000|Overall Study|Withdrawal by Subject|3
7568585|NCT03421431|11944048|FG001|Overall Study|Withdrawal by Subject|2
7568586|NCT03421431|11944049|FG002|Overall Study|Withdrawal by Subject|1
7568587|NCT03421431|11944047|FG000|Overall Study|Protocol Violation|0
7568588|NCT03421431|11944048|FG001|Overall Study|Protocol Violation|1
7568589|NCT03421431|11944049|FG002|Overall Study|Protocol Violation|0
7568590|NCT03421431|11944047|FG000|Overall Study|Participant met Stopping Rules|0
7568591|NCT03421431|11944048|FG001|Overall Study|Participant met Stopping Rules|1
7568592|NCT03421431|11944049|FG002|Overall Study|Participant met Stopping Rules|0
7568593|NCT03421730|11944059|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568594|NCT03421730|11944060|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
7568595|NCT03421730|11944061|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568596|NCT03421730|11944062|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568597|NCT03421730|11944063|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568598|NCT03421730|11944064|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568599|NCT03421730|11944065|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7334104|NCT00831844|11569035|FG003|Overall Study|Withdrawal by Subject|0
7334105|NCT00831844|11569036|FG004|Overall Study|Withdrawal by Subject|0
7334106|NCT00831844|11569037|FG005|Overall Study|Withdrawal by Subject|0
7334107|NCT00831844|11569038|FG006|Overall Study|Withdrawal by Subject|0
7334108|NCT00831844|11569039|FG007|Overall Study|Withdrawal by Subject|1
7334109|NCT00831844|11569040|FG008|Overall Study|Withdrawal by Subject|1
7334110|NCT00831844|11569041|FG009|Overall Study|Withdrawal by Subject|0
7334111|NCT00831844|11569032|FG000|Overall Study|Ineligible|0
7334112|NCT00831844|11569033|FG001|Overall Study|Ineligible|1
7334113|NCT00831844|11569034|FG002|Overall Study|Ineligible|1
7334114|NCT00831844|11569035|FG003|Overall Study|Ineligible|0
7334115|NCT00831844|11569036|FG004|Overall Study|Ineligible|1
7334116|NCT00831844|11569037|FG005|Overall Study|Ineligible|0
7334117|NCT00831844|11569038|FG006|Overall Study|Ineligible|0
7334118|NCT00831844|11569039|FG007|Overall Study|Ineligible|0
7334119|NCT00831844|11569040|FG008|Overall Study|Ineligible|0
7334120|NCT00831844|11569041|FG009|Overall Study|Ineligible|0
7334121|NCT00832000|11569072|FG000|Overall Study|Adverse Event|2
7334122|NCT00832000|11569073|FG001|Overall Study|Adverse Event|0
7334123|NCT00832000|11569072|FG000|Overall Study|Withdrawal by Subject|1
7334124|NCT00832000|11569073|FG001|Overall Study|Withdrawal by Subject|0
7334125|NCT00832000|11569072|FG000|Overall Study|No calls to IVR in either period|1
7334126|NCT00832000|11569073|FG001|Overall Study|No calls to IVR in either period|1
7334127|NCT00832000|11569072|FG000|Overall Study|No calls to IVR in period 2|2
7334128|NCT00832000|11569073|FG001|Overall Study|No calls to IVR in period 2|0
7334129|NCT00832078|11569108|FG000|Test Day 1-2 Period|Lack of Efficacy|0
7334130|NCT00832078|11569109|FG001|Test Day 1-2 Period|Lack of Efficacy|2
7334131|NCT00832078|11569108|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
7334132|NCT00832078|11569109|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
7334133|NCT00832091|11569117|FG000|Overall Study|Adverse Event|1
7334134|NCT00832091|11569118|FG001|Overall Study|Adverse Event|1
7334135|NCT00832091|11569117|FG000|Overall Study|Protocol Violation|1
7334136|NCT00832091|11569118|FG001|Overall Study|Protocol Violation|0
7334137|NCT00832091|11569117|FG000|Overall Study|Withdrawal by Subject|2
7334138|NCT00832091|11569118|FG001|Overall Study|Withdrawal by Subject|1
7334139|NCT00832091|11569117|FG000|Overall Study|Prohibited Medication|1
7334140|NCT00832091|11569118|FG001|Overall Study|Prohibited Medication|0
7334141|NCT00832117|11569126|FG000|Overall Study|Death|1
7334142|NCT00832117|11569126|FG000|Overall Study|Disease Progression|11
7334143|NCT00832377|11569150|FG000|Overall Study|Protocol Violation|1
7334144|NCT00832416|11569171|FG000|Overall Study|Lack of Efficacy|17
7334145|NCT00832416|11569172|FG001|Overall Study|Lack of Efficacy|15
7334146|NCT00832416|11569173|FG002|Overall Study|Lack of Efficacy|13
7334147|NCT00832416|11569174|FG003|Overall Study|Lack of Efficacy|52
7334148|NCT00832416|11569171|FG000|Overall Study|Withdrawal by Subject|5
7334149|NCT00832416|11569172|FG001|Overall Study|Withdrawal by Subject|7
7334150|NCT00832416|11569173|FG002|Overall Study|Withdrawal by Subject|2
7334151|NCT00832416|11569174|FG003|Overall Study|Withdrawal by Subject|10
7334152|NCT00832416|11569171|FG000|Overall Study|Physician Decision|2
7334153|NCT00832416|11569172|FG001|Overall Study|Physician Decision|12
7334154|NCT00832416|11569173|FG002|Overall Study|Physician Decision|5
7334155|NCT00832416|11569174|FG003|Overall Study|Physician Decision|10
7334156|NCT00832416|11569171|FG000|Overall Study|Administrative|0
7334157|NCT00832416|11569172|FG001|Overall Study|Administrative|0
7334158|NCT00832416|11569173|FG002|Overall Study|Administrative|0
7334159|NCT00832416|11569174|FG003|Overall Study|Administrative|1
7334160|NCT00832416|11569171|FG000|Overall Study|Adverse Event|21
7334161|NCT00832416|11569172|FG001|Overall Study|Adverse Event|19
7334162|NCT00832416|11569173|FG002|Overall Study|Adverse Event|41
7334163|NCT00832416|11569174|FG003|Overall Study|Adverse Event|10
7334164|NCT00832416|11569171|FG000|Overall Study|Death|1
7334165|NCT00832416|11569172|FG001|Overall Study|Death|0
7334166|NCT00832416|11569173|FG002|Overall Study|Death|0
7334167|NCT00832416|11569174|FG003|Overall Study|Death|0
7334168|NCT00832585|11569184|FG000|Overall Study|Withdrawal by Subject|1
7334169|NCT00832585|11569184|FG000|Overall Study|Lost to Follow-up|1
7334170|NCT00832650|11569195|FG000|Overall Study|Randomized but not treated|0
7334171|NCT00832650|11569196|FG001|Overall Study|Randomized but not treated|0
7334172|NCT00832650|11569197|FG002|Overall Study|Randomized but not treated|1
7334173|NCT00832780|11569216|FG000|Overall Study|Death|16
7334174|NCT00832780|11569216|FG000|Overall Study|Lost to Follow-up|4
7334175|NCT00832780|11569216|FG000|Overall Study|no reason given|2
7334176|NCT00832780|11569216|FG000|Overall Study|other complicating condition|2
7334177|NCT00832780|11569216|FG000|Overall Study|Physician Decision|1
7334178|NCT00832819|11569223|FG000|Overall Study|Adverse Event|0
7334179|NCT00832819|11569224|FG001|Overall Study|Adverse Event|1
7334180|NCT00832819|11569225|FG002|Overall Study|Adverse Event|0
7334181|NCT00832819|11569223|FG000|Overall Study|Protocol Violation|0
7334182|NCT00832819|11569224|FG001|Overall Study|Protocol Violation|0
7334183|NCT00832819|11569225|FG002|Overall Study|Protocol Violation|1
7334184|NCT00832975|11569235|FG000|Overall Study|Lost to Follow-up|7
7334185|NCT00832975|11569235|FG000|Overall Study|Protocol Violation|6
7334186|NCT00832975|11569235|FG000|Overall Study|Death|5
7334187|NCT00832975|11569235|FG000|Overall Study|Physician Decision|4
7334188|NCT00832975|11569235|FG000|Overall Study|Withdrawal by Subject|3
7334189|NCT00832975|11569235|FG000|Overall Study|Other reasons|14
7334190|NCT00833027|11569239|FG000|Overall Study|Adverse Event|33
7334191|NCT00833027|11569239|FG000|Overall Study|Death|1
7334192|NCT00833027|11569239|FG000|Overall Study|Lack of Efficacy|12
7334193|NCT00833027|11569239|FG000|Overall Study|Lost to Follow-up|24
7334194|NCT00833027|11569239|FG000|Overall Study|Protocol Violation|115
7334195|NCT00833027|11569239|FG000|Overall Study|Withdrawal by Subject|16
7334196|NCT00833027|11569239|FG000|Overall Study|Missing|10
7334197|NCT00833040|11569243|FG000|Overall Study|Adverse Event|0
7334198|NCT00833040|11569244|FG001|Overall Study|Adverse Event|0
7334199|NCT00833040|11569245|FG002|Overall Study|Adverse Event|0
7334200|NCT00833040|11569246|FG003|Overall Study|Adverse Event|0
7334201|NCT00833040|11569247|FG004|Overall Study|Adverse Event|0
7334202|NCT00833040|11569248|FG005|Overall Study|Adverse Event|1
7334203|NCT00833053|11569255|FG000|Overall Study|Adverse Event|4
7334204|NCT00833053|11569256|FG001|Overall Study|Adverse Event|0
7334205|NCT00833053|11569255|FG000|Overall Study|Treatment Failure|3
7334206|NCT00833053|11569256|FG001|Overall Study|Treatment Failure|1
7334207|NCT00833053|11569255|FG000|Overall Study|Withdrawal by Subject|0
7334208|NCT00833053|11569256|FG001|Overall Study|Withdrawal by Subject|1
7334209|NCT00833053|11569255|FG000|Overall Study|Protocol Violation|2
7334210|NCT00833053|11569256|FG001|Overall Study|Protocol Violation|1
7334211|NCT00833092|11569264|FG000|Overall Study|Withdrawal by Subject|2
7334212|NCT00833092|11569265|FG001|Overall Study|Withdrawal by Subject|3
7334213|NCT00833092|11569264|FG000|Overall Study|Protocol Violation|2
7334214|NCT00833092|11569265|FG001|Overall Study|Protocol Violation|1
7334215|NCT00833092|11569264|FG000|Overall Study|Diarrhea|0
7334216|NCT00833092|11569265|FG001|Overall Study|Diarrhea|2
7334217|NCT00833092|11569264|FG000|Overall Study|constipation|0
7334218|NCT00833092|11569265|FG001|Overall Study|constipation|1
7334219|NCT00833105|11569271|FG000|Overall Study|Withdrawal by Subject|1
7334220|NCT00833105|11569271|FG000|Overall Study|Adverse Event|2
7334221|NCT00833248|11569279|FG000|Overall Study|Adverse Event|3
7334222|NCT00833248|11569280|FG001|Overall Study|Adverse Event|0
7334223|NCT00833248|11569279|FG000|Overall Study|Protocol Violation|1
7334224|NCT00833248|11569280|FG001|Overall Study|Protocol Violation|2
7334225|NCT00833248|11569279|FG000|Overall Study|Withdrawal by Subject|0
7334226|NCT00833248|11569280|FG001|Overall Study|Withdrawal by Subject|1
7334227|NCT00833261|11569286|FG000|Overall Study|Withdrawal by Subject|4
7334228|NCT00833417|11569301|FG000|Overall Study|Adverse Event|5
7334229|NCT00833417|11569302|FG001|Overall Study|Adverse Event|16
7334230|NCT00833417|11569301|FG000|Overall Study|Death|1
7334231|NCT00833417|11569302|FG001|Overall Study|Death|3
7334232|NCT00833417|11569301|FG000|Overall Study|Lost to Follow-up|1
7334233|NCT00833417|11569302|FG001|Overall Study|Lost to Follow-up|2
7334234|NCT00833417|11569301|FG000|Overall Study|Physician Decision to Withdraw Patient|3
7334235|NCT00833417|11569302|FG001|Overall Study|Physician Decision to Withdraw Patient|7
7334236|NCT00833417|11569301|FG000|Overall Study|Patient Decision to Withdraw|4
7334237|NCT00833417|11569302|FG001|Overall Study|Patient Decision to Withdraw|23
7334238|NCT00833417|11569301|FG000|Overall Study|Sponsor Decision to Terminate Study|1
7334239|NCT00833417|11569302|FG001|Overall Study|Sponsor Decision to Terminate Study|2
7334240|NCT00833417|11569301|FG000|Overall Study|Disease Progression|18
7334241|NCT00833417|11569302|FG001|Overall Study|Disease Progression|17
7334242|NCT00833417|11569301|FG000|Overall Study|Reason Not Specified|0
7334243|NCT00833417|11569302|FG001|Overall Study|Reason Not Specified|1
7334244|NCT00833469|11569320|FG000|Overall Study|Withdrawal by Subject|1
7334245|NCT00833469|11569320|FG000|Overall Study|Lost to Follow-up|1
7334246|NCT00833482|11569326|FG000|Days 11-20|Adverse Event|0
7334247|NCT00833482|11569327|FG001|Days 11-20|Adverse Event|2
7334248|NCT00833482|11569328|FG002|Days 11-20|Adverse Event|0
7334249|NCT00833482|11569329|FG003|Days 11-20|Adverse Event|0
7334250|NCT00833482|11569330|FG004|Days 11-20|Adverse Event|0
7334251|NCT00833482|11569331|FG005|Days 11-20|Adverse Event|0
7334252|NCT00833482|11569326|FG000|Days 11-20|Withdrawal by Subject|0
7334253|NCT00833482|11569327|FG001|Days 11-20|Withdrawal by Subject|1
7334254|NCT00833482|11569328|FG002|Days 11-20|Withdrawal by Subject|0
7334255|NCT00833482|11569329|FG003|Days 11-20|Withdrawal by Subject|0
7334256|NCT00833482|11569330|FG004|Days 11-20|Withdrawal by Subject|0
7334257|NCT00833482|11569331|FG005|Days 11-20|Withdrawal by Subject|0
7334258|NCT00833482|11569326|FG000|Days 21-30|Adverse Event|0
7334259|NCT00833482|11569327|FG001|Days 21-30|Adverse Event|0
7334260|NCT00833482|11569328|FG002|Days 21-30|Adverse Event|1
7334261|NCT00833482|11569329|FG003|Days 21-30|Adverse Event|0
7334262|NCT00833482|11569330|FG004|Days 21-30|Adverse Event|0
7334263|NCT00833482|11569331|FG005|Days 21-30|Adverse Event|0
7334264|NCT00833482|11569326|FG000|Days 21-30|Withdrawal by Subject|0
7334265|NCT00833482|11569327|FG001|Days 21-30|Withdrawal by Subject|0
7334266|NCT00833482|11569328|FG002|Days 21-30|Withdrawal by Subject|0
7334267|NCT00833482|11569329|FG003|Days 21-30|Withdrawal by Subject|0
7334268|NCT00833482|11569330|FG004|Days 21-30|Withdrawal by Subject|1
7334269|NCT00833482|11569331|FG005|Days 21-30|Withdrawal by Subject|0
7334270|NCT00833547|11569355|FG000|Overall Study|Withdrawal by Subject|2
7334271|NCT00833547|11569356|FG001|Overall Study|Withdrawal by Subject|2
7334272|NCT00833560|11569362|FG000|Overall Study|Toxicity|13
7334273|NCT00833560|11569362|FG000|Overall Study|Adverse Event|11
7334274|NCT00833560|11569362|FG000|Overall Study|Protocol Violation|6
7334275|NCT00833560|11569362|FG000|Overall Study|Lack of Efficacy|4
7334276|NCT00833560|11569362|FG000|Overall Study|Death|2
7334277|NCT00833560|11569362|FG000|Overall Study|Pregression of other disease|1
7334278|NCT00833560|11569362|FG000|Overall Study|Other|5
7334279|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
7334280|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
7334281|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
7334282|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
7334283|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
7334284|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
7334285|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7334286|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
7334287|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
7334288|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
7334289|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7334290|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
7334291|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7334292|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7334293|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
7334294|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7334295|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
7334296|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
7334297|NCT00833638|11569369|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7334298|NCT00833638|11569370|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
7334299|NCT00833638|11569371|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
7334300|NCT00833638|11569369|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
7334301|NCT00833638|11569370|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
7334302|NCT00833638|11569371|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
7334303|NCT00833638|11569369|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
7334304|NCT00833638|11569370|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
7334305|NCT00833638|11569371|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
7334306|NCT00833690|11569390|FG000|Overall Study|Withdrawal by Subject|1
7334307|NCT00833690|11569391|FG001|Overall Study|Withdrawal by Subject|0
7334308|NCT00833690|11569392|FG002|Overall Study|Withdrawal by Subject|0
7334309|NCT00833690|11569390|FG000|Overall Study|Discontinued study drug|3
7334310|NCT00833690|11569391|FG001|Overall Study|Discontinued study drug|2
7334311|NCT00833690|11569392|FG002|Overall Study|Discontinued study drug|0
7334312|NCT00833703|11569402|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
7334313|NCT00833703|11569403|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
7334314|NCT00833755|11569413|FG000|Overall Study|Physician Decision|4
7334315|NCT00833755|11569414|FG001|Overall Study|Physician Decision|4
7334316|NCT00833755|11569415|FG002|Overall Study|Physician Decision|2
7334317|NCT00833755|11569416|FG003|Overall Study|Physician Decision|6
7334318|NCT00833755|11569413|FG000|Overall Study|Subject had scheduling issues|0
7334319|NCT00833755|11569414|FG001|Overall Study|Subject had scheduling issues|1
7334320|NCT00833755|11569415|FG002|Overall Study|Subject had scheduling issues|0
7334321|NCT00833755|11569416|FG003|Overall Study|Subject had scheduling issues|0
7334322|NCT00833794|11569437|FG000|Open-label Phase|Adverse Event|225
7334323|NCT00833794|11569438|FG001|Open-label Phase|Adverse Event|0
7334324|NCT00833794|11569437|FG000|Open-label Phase|Lack of Efficacy|28
7334325|NCT00833794|11569438|FG001|Open-label Phase|Lack of Efficacy|0
7334326|NCT00833794|11569437|FG000|Open-label Phase|Withdrawal by Subject|48
7334327|NCT00833794|11569438|FG001|Open-label Phase|Withdrawal by Subject|0
7334328|NCT00833794|11569437|FG000|Open-label Phase|Physician Decision|20
7334329|NCT00833794|11569438|FG001|Open-label Phase|Physician Decision|0
7334330|NCT00833794|11569437|FG000|Open-label Phase|Administrative reason|1
7334331|NCT00833794|11569438|FG001|Open-label Phase|Administrative reason|0
7334332|NCT00833794|11569437|FG000|Open-label Phase|Protocol Violation|47
7334333|NCT00833794|11569438|FG001|Open-label Phase|Protocol Violation|0
7334334|NCT00833794|11569437|FG000|Open-label Phase|Did not complete wash-out period|12
7334335|NCT00833794|11569438|FG001|Open-label Phase|Did not complete wash-out period|0
7334336|NCT00833794|11569437|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
7334337|NCT00833794|11569438|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
7334338|NCT00833794|11569437|FG000|Double-blind Phase|Adverse Event|44
7334339|NCT00833794|11569438|FG001|Double-blind Phase|Adverse Event|11
7334340|NCT00833794|11569437|FG000|Double-blind Phase|Lack of Efficacy|34
7334341|NCT00833794|11569438|FG001|Double-blind Phase|Lack of Efficacy|22
7334342|NCT00833794|11569437|FG000|Double-blind Phase|Withdrawal by Subject|23
7334343|NCT00833794|11569438|FG001|Double-blind Phase|Withdrawal by Subject|6
7334344|NCT00833794|11569437|FG000|Double-blind Phase|Physician Decision|4
7334345|NCT00833794|11569438|FG001|Double-blind Phase|Physician Decision|7
7334346|NCT00833794|11569437|FG000|Double-blind Phase|Administrative reason|1
7334347|NCT00833794|11569438|FG001|Double-blind Phase|Administrative reason|3
7334348|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
7334349|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
7334350|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
7334351|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
7334352|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
7334353|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
7334354|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7334355|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
7334356|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7334357|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
7334358|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7334359|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
7334360|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
7334361|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
7334362|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
7334363|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
7334364|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
7334365|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
7334366|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Death|0
7334367|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Death|1
7334368|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Death|2
7334369|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Death|0
7334370|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Death|0
7334371|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Death|0
7334372|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7334373|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334374|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
7334375|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334376|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334377|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334378|NCT00833833|11569452|FG000|Phase 1 (as of 01 April 2011)|Other|1
7334379|NCT00833833|11569453|FG001|Phase 1 (as of 01 April 2011)|Other|3
7334380|NCT00833833|11569454|FG002|Phase 1 (as of 01 April 2011)|Other|0
7334381|NCT00833833|11569455|FG003|Phase 1 (as of 01 April 2011)|Other|1
7334382|NCT00833833|11569456|FG004|Phase 1 (as of 01 April 2011)|Other|0
7334383|NCT00833833|11569457|FG005|Phase 1 (as of 01 April 2011)|Other|0
7334384|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
7334385|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
7334386|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
7334387|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
7334388|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
7334389|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
7334390|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
7334391|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
7334392|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
7334393|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
7334394|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
7334395|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
7334396|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Death|0
7334397|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Death|0
7334398|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Death|0
7334399|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Death|0
7334400|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Death|8
7334401|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Death|9
7334402|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334403|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334404|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334405|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
7334406|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
7334407|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
7334408|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7334409|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7334410|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7334411|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
7334412|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
7334413|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
7334414|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Other|0
7334415|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Other|0
7334416|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Other|0
7334417|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Other|0
7334418|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Other|4
7334419|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Other|3
7334420|NCT00833833|11569452|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7334421|NCT00833833|11569453|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7334422|NCT00833833|11569454|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7334423|NCT00833833|11569455|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7334424|NCT00833833|11569456|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
7334425|NCT00833833|11569457|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
7334426|NCT00833898|11569479|FG000|Overall Study|Withdrawal by Subject|33
7334427|NCT00833898|11569480|FG001|Overall Study|Withdrawal by Subject|27
7334428|NCT00833898|11569479|FG000|Overall Study|Lost to Follow-up|7
7334429|NCT00833898|11569480|FG001|Overall Study|Lost to Follow-up|7
7334430|NCT00833898|11569479|FG000|Overall Study|Patient did not receive transplant|0
7334431|NCT00833898|11569480|FG001|Overall Study|Patient did not receive transplant|2
7385408|NCT01201317|11643164|FG000|Overall Study|Study-specific withdrawal criteria|0
7385409|NCT01201317|11643165|FG001|Overall Study|Study-specific withdrawal criteria|0
7385410|NCT01201317|11643166|FG002|Overall Study|Study-specific withdrawal criteria|1
7385411|NCT01201317|11643164|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
7385412|NCT01201317|11643165|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
7385413|NCT01201317|11643166|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
7385414|NCT01201317|11643164|FG000|Overall Study|Decrease in renal function|0
7385415|NCT01201317|11643165|FG001|Overall Study|Decrease in renal function|1
7385416|NCT01201317|11643166|FG002|Overall Study|Decrease in renal function|0
7385417|NCT01201317|11643164|FG000|Overall Study|Lack of Efficacy|1
7385418|NCT01201317|11643165|FG001|Overall Study|Lack of Efficacy|0
7385419|NCT01201317|11643166|FG002|Overall Study|Lack of Efficacy|0
7385420|NCT01201317|11643164|FG000|Overall Study|Safety, possible history of tuberculosis|0
7385421|NCT01201317|11643165|FG001|Overall Study|Safety, possible history of tuberculosis|0
7385422|NCT01201317|11643166|FG002|Overall Study|Safety, possible history of tuberculosis|1
7385423|NCT01201343|11643174|FG000|Overall Study|Adverse Event|6
7385424|NCT01201343|11643174|FG000|Overall Study|Withdrawal by Subject|5
7385425|NCT01201343|11643174|FG000|Overall Study|Lost to Follow-up|2
7385426|NCT01201343|11643174|FG000|Overall Study|Lack of Efficacy|2
7385427|NCT01201343|11643174|FG000|Overall Study|Participant wrongly included in trial|1
7385428|NCT01201343|11643174|FG000|Overall Study|Randomized, not treated|3
7385429|NCT01201356|11643178|FG000|Overall Study|Adverse Event|170
7385430|NCT01201356|11643178|FG000|Overall Study|Abnormal laboratory value(s)|51
7385431|NCT01201356|11643178|FG000|Overall Study|Abnormal test procedure result(s)|3
7385432|NCT01201356|11643178|FG000|Overall Study|Unsatisfactory therapeutic effect|112
7385433|NCT01201356|11643178|FG000|Overall Study|Condition no longer requires study drug|12
7385434|NCT01201356|11643178|FG000|Overall Study|Withdrawal by Subject|144
7385435|NCT01201356|11643178|FG000|Overall Study|Lost to Follow-up|50
7385436|NCT01201356|11643178|FG000|Overall Study|administrative problems|74
7385437|NCT01201356|11643178|FG000|Overall Study|Death|16
7385438|NCT01201356|11643178|FG000|Overall Study|Protocol Violation|12
7385439|NCT01201759|11643197|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
7385440|NCT01201759|11643198|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
7385441|NCT01201759|11643197|FG000|Visit 3 - Washout|Adverse Event|0
7385442|NCT01201759|11643198|FG001|Visit 3 - Washout|Adverse Event|3
7385443|NCT01201759|11643197|FG000|Visit 3 - Washout|Lost to Follow-up|1
7385444|NCT01201759|11643198|FG001|Visit 3 - Washout|Lost to Follow-up|0
7385445|NCT01201759|11643197|FG000|Visit 4 Crossover|Lost to Follow-up|0
7385446|NCT01201759|11643198|FG001|Visit 4 Crossover|Lost to Follow-up|1
7385447|NCT01201785|11643217|FG000|Overall Study|Lost to Follow-up|16
7385448|NCT01201798|11643223|FG000|Overall Study|Adverse Event|2
7385449|NCT01201798|11643224|FG001|Overall Study|Adverse Event|0
7385450|NCT01201798|11643223|FG000|Overall Study|Lost to Follow-up|3
7385451|NCT01201798|11643224|FG001|Overall Study|Lost to Follow-up|5
7385452|NCT01201798|11643223|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
7334432|NCT00833911|11569486|FG000|Titration|Adverse Event|18
7334433|NCT00833911|11569486|FG000|Titration|Withdrawal by Subject|3
7334434|NCT00833911|11569486|FG000|Maintenance Phase I|Adverse Event|73
7334435|NCT00833911|11569486|FG000|Maintenance Phase I|Withdrawal by Subject|11
7334436|NCT00833911|11569486|FG000|Maintenance Phase I|Physician Decision|10
7334437|NCT00833911|11569486|FG000|Maintenance Phase I|Lack of Efficacy|4
7334438|NCT00833911|11569486|FG000|Maintenance Phase II|Adverse Event|6
7334439|NCT00833911|11569486|FG000|Maintenance Phase II|Physician Decision|2
7334440|NCT00833911|11569486|FG000|Maintenance Phase II|Withdrawal by Subject|1
7334441|NCT00833911|11569486|FG000|Maintenance Phase II|Lack of Efficacy|1
7334442|NCT00833924|11569494|FG000|Overall Study|Death|21
7334443|NCT00833924|11569494|FG000|Overall Study|Conversion|2
7334444|NCT00833924|11569494|FG000|Overall Study|Lost to Follow-up|2
7334445|NCT00833924|11569494|FG000|Overall Study|Withdrawal by Subject|13
7334446|NCT00833924|11569494|FG000|Overall Study|In study follow-up|71
7334447|NCT00833976|11569498|FG000|Overall Study|Withdrawal by Subject|5
7334448|NCT00833976|11569498|FG000|Overall Study|Lost to Follow-up|4
7334449|NCT00833976|11569498|FG000|Overall Study|Did not meet eligibility criteria|41
7334450|NCT00833976|11569498|FG000|Overall Study|Physician Decision|1
7334451|NCT00833989|11569506|FG000|Overall Study|Physician Decision|0
7334452|NCT00833989|11569507|FG001|Overall Study|Physician Decision|0
7334453|NCT00833989|11569508|FG002|Overall Study|Physician Decision|0
7334454|NCT00833989|11569509|FG003|Overall Study|Physician Decision|1
7334455|NCT00833989|11569506|FG000|Overall Study|Withdrawal by Subject|3
7334456|NCT00833989|11569507|FG001|Overall Study|Withdrawal by Subject|0
7334457|NCT00833989|11569508|FG002|Overall Study|Withdrawal by Subject|1
7334458|NCT00833989|11569509|FG003|Overall Study|Withdrawal by Subject|1
7334459|NCT00834041|11569524|FG000|Overall Study|Withdrawal by Subject|1
7334460|NCT00834041|11569525|FG001|Overall Study|Withdrawal by Subject|0
7334461|NCT00834041|11569524|FG000|Overall Study|Lost to Follow-up|0
7334462|NCT00834041|11569525|FG001|Overall Study|Lost to Follow-up|1
7334463|NCT00834080|11569531|FG000|Overall Study|Adverse Event|7
7334464|NCT00834080|11569531|FG000|Overall Study|Lost to Follow-up|7
7334465|NCT00834080|11569531|FG000|Overall Study|Withdrawal by Subject|5
7334466|NCT00834080|11569531|FG000|Overall Study|Other - Pregnancy|1
7334467|NCT00834080|11569531|FG000|Overall Study|Other - False positive tests of the UDS|1
7334468|NCT00834080|11569531|FG000|Overall Study|Physician Decision|1
7334469|NCT00834080|11569531|FG000|Overall Study|Subject Relocated|1
7334470|NCT00834366|11569582|FG000|Treatment Period 1|Adverse Event|1
7334471|NCT00834366|11569583|FG001|Treatment Period 1|Adverse Event|1
7334472|NCT00834834|11569633|FG000|Overall Study|Withdrawal by Subject|4
7334473|NCT00834834|11569634|FG001|Overall Study|Withdrawal by Subject|3
7334474|NCT00834899|11569659|FG000|Overall Study|Withdrawal by Subject|1
7334475|NCT00834899|11569660|FG001|Overall Study|Withdrawal by Subject|1
7334476|NCT00834912|11569672|FG000|Treatment Period 1|Adverse Event|0
7334477|NCT00834912|11569673|FG001|Treatment Period 1|Adverse Event|1
7334478|NCT00834912|11569674|FG002|Treatment Period 1|Adverse Event|0
7334479|NCT00834912|11569675|FG003|Treatment Period 1|Adverse Event|1
7334480|NCT00834912|11569676|FG004|Treatment Period 1|Adverse Event|0
7334481|NCT00834912|11569677|FG005|Treatment Period 1|Adverse Event|0
7334482|NCT00834912|11569672|FG000|Treatment Period 2|Withdrawal by Subject|0
7334483|NCT00834912|11569673|FG001|Treatment Period 2|Withdrawal by Subject|0
7334484|NCT00834912|11569674|FG002|Treatment Period 2|Withdrawal by Subject|1
7334485|NCT00834912|11569675|FG003|Treatment Period 2|Withdrawal by Subject|0
7334486|NCT00834912|11569676|FG004|Treatment Period 2|Withdrawal by Subject|1
7334487|NCT00834912|11569677|FG005|Treatment Period 2|Withdrawal by Subject|0
7334488|NCT00835068|11569696|FG000|Overall Study|Death|1
7334489|NCT00835068|11569697|FG001|Overall Study|Death|0
7334490|NCT00835068|11569696|FG000|Overall Study|Adverse Event|0
7334491|NCT00835068|11569697|FG001|Overall Study|Adverse Event|1
7334492|NCT00835068|11569696|FG000|Overall Study|Other|8
7334493|NCT00835068|11569697|FG001|Overall Study|Other|0
7334494|NCT00835068|11569696|FG000|Overall Study|Withdrawal by Subject|1
7334495|NCT00835068|11569697|FG001|Overall Study|Withdrawal by Subject|0
7334496|NCT00835120|11569703|FG000|Overall Study|Lack of Efficacy|1
7334497|NCT00835120|11569703|FG000|Overall Study|Lost to Follow-up|3
7334498|NCT00835120|11569703|FG000|Overall Study|Adverse Event|2
7334499|NCT00835120|11569703|FG000|Overall Study|Withdrawal by Subject|2
7334500|NCT00835237|11569746|FG000|Overall Study|Lost to Follow-up|4
7334501|NCT00835237|11569747|FG001|Overall Study|Lost to Follow-up|0
7334502|NCT00835237|11569746|FG000|Overall Study|Withdrawal by Subject|2
7334503|NCT00835237|11569747|FG001|Overall Study|Withdrawal by Subject|0
7334504|NCT00835341|11569755|FG000|Overall Study|Lost to Follow-up|3
7334505|NCT00835341|11569756|FG001|Overall Study|Lost to Follow-up|12
7334506|NCT00835380|11569762|FG000|Overall Study|Withdrawal by Subject|2
7334507|NCT00835731|11569781|FG000|Overall Study|Withdrawal by Subject|1
7334508|NCT00835731|11569782|FG001|Overall Study|Withdrawal by Subject|0
7334509|NCT00835731|11569781|FG000|Overall Study|Physician Decision|1
7334510|NCT00835731|11569782|FG001|Overall Study|Physician Decision|1
7334511|NCT00835770|11569790|FG000|Overall Study|MS Relapse|17
7334512|NCT00835770|11569791|FG001|Overall Study|MS Relapse|23
7334513|NCT00835770|11569790|FG000|Overall Study|MS Progression|14
7334514|NCT00835770|11569791|FG001|Overall Study|MS Progression|9
7334515|NCT00835770|11569790|FG000|Overall Study|Adverse Event|113
7334516|NCT00835770|11569791|FG001|Overall Study|Adverse Event|124
7334517|NCT00835770|11569790|FG000|Overall Study|Lost to Follow-up|22
7334518|NCT00835770|11569791|FG001|Overall Study|Lost to Follow-up|19
7334519|NCT00835770|11569790|FG000|Overall Study|Consent Withdrawn|144
7334520|NCT00835770|11569791|FG001|Overall Study|Consent Withdrawn|156
7334521|NCT00835770|11569790|FG000|Overall Study|Investigator Decision|42
7334522|NCT00835770|11569791|FG001|Overall Study|Investigator Decision|42
7334523|NCT00835770|11569790|FG000|Overall Study|Participant Non-Compliance|11
7334524|NCT00835770|11569791|FG001|Overall Study|Participant Non-Compliance|9
7334525|NCT00835770|11569790|FG000|Overall Study|Death|4
7334526|NCT00835770|11569791|FG001|Overall Study|Death|6
7334527|NCT00835770|11569790|FG000|Overall Study|Other|115
7334528|NCT00835770|11569791|FG001|Overall Study|Other|104
7334529|NCT00835770|11569790|FG000|Overall Study|Other|2
7334530|NCT00835770|11569791|FG001|Overall Study|Other|1
7334531|NCT00835978|11569834|FG000|Overall Study|Death|33
7334532|NCT00835978|11569835|FG001|Overall Study|Death|40
7334533|NCT00835978|11569836|FG002|Overall Study|Death|49
7334534|NCT00835978|11569837|FG003|Overall Study|Death|4
7334535|NCT00835978|11569834|FG000|Overall Study|Lost to Follow-up|3
7334536|NCT00835978|11569835|FG001|Overall Study|Lost to Follow-up|4
7334537|NCT00835978|11569836|FG002|Overall Study|Lost to Follow-up|2
7334538|NCT00835978|11569837|FG003|Overall Study|Lost to Follow-up|1
7334539|NCT00835978|11569834|FG000|Overall Study|Other|5
7334540|NCT00835978|11569835|FG001|Overall Study|Other|1
7334541|NCT00835978|11569836|FG002|Overall Study|Other|8
7334542|NCT00835978|11569837|FG003|Overall Study|Other|0
7334543|NCT00835978|11569834|FG000|Overall Study|Objective progression or relapse|2
7334544|NCT00835978|11569835|FG001|Overall Study|Objective progression or relapse|0
7334545|NCT00835978|11569836|FG002|Overall Study|Objective progression or relapse|1
7334546|NCT00835978|11569837|FG003|Overall Study|Objective progression or relapse|0
7334547|NCT00835978|11569834|FG000|Overall Study|Adverse Event|1
7334548|NCT00835978|11569835|FG001|Overall Study|Adverse Event|0
7334549|NCT00835978|11569836|FG002|Overall Study|Adverse Event|1
7334550|NCT00835978|11569837|FG003|Overall Study|Adverse Event|0
7334551|NCT00835978|11569834|FG000|Overall Study|Withdrawal by Subject|0
7334552|NCT00835978|11569835|FG001|Overall Study|Withdrawal by Subject|3
7334553|NCT00835978|11569836|FG002|Overall Study|Withdrawal by Subject|0
7334554|NCT00835978|11569837|FG003|Overall Study|Withdrawal by Subject|5
7334555|NCT00835978|11569834|FG000|Overall Study|Study terminated by sponsor|12
7334556|NCT00835978|11569835|FG001|Overall Study|Study terminated by sponsor|8
7334557|NCT00835978|11569836|FG002|Overall Study|Study terminated by sponsor|30
7334558|NCT00835978|11569837|FG003|Overall Study|Study terminated by sponsor|0
7334559|NCT00836095|11569858|FG000|Overall Study|Physician Decision|0
7334560|NCT00836095|11569859|FG001|Overall Study|Physician Decision|3
7334561|NCT00836186|11569865|FG000|Overall Study|Blood could not be drawn|1
7334562|NCT00836277|11569870|FG000|Overall Study|Not evaluable for response|6
7334563|NCT00836498|11569911|FG000|Overall Study|Adverse Event|1
7334564|NCT00836498|11569912|FG001|Overall Study|Adverse Event|0
7334565|NCT00836498|11569911|FG000|Overall Study|Lost to Follow-up|1
7334566|NCT00836498|11569912|FG001|Overall Study|Lost to Follow-up|0
7334567|NCT00836498|11569911|FG000|Overall Study|Withdrawal by Subject|2
7334568|NCT00836498|11569912|FG001|Overall Study|Withdrawal by Subject|1
7334569|NCT00836589|11569919|FG000|Overall Study|Lost to Follow-up|246
7334570|NCT00836589|11569919|FG000|Overall Study|Death|429
7334571|NCT00836589|11569919|FG000|Overall Study|Withdrawal by Subject or Physician|591
7334572|NCT00836693|11569941|FG000|Overall Study|Adverse Event|4
7334573|NCT00836693|11569942|FG001|Overall Study|Adverse Event|1
7334574|NCT00836693|11569941|FG000|Overall Study|Sponsor Decision|0
7334575|NCT00836693|11569942|FG001|Overall Study|Sponsor Decision|1
7334576|NCT00836693|11569941|FG000|Overall Study|Physician Decision|2
7334577|NCT00836693|11569942|FG001|Overall Study|Physician Decision|0
7334578|NCT00836693|11569941|FG000|Overall Study|Withdrawal by Subject|9
7334579|NCT00836693|11569942|FG001|Overall Study|Withdrawal by Subject|4
7334580|NCT00836693|11569941|FG000|Overall Study|Protocol Violation|1
7334581|NCT00836693|11569942|FG001|Overall Study|Protocol Violation|0
7334582|NCT00836693|11569941|FG000|Overall Study|Lost to Follow-up|1
7334583|NCT00836693|11569942|FG001|Overall Study|Lost to Follow-up|0
7334584|NCT00836745|11569952|FG000|Overall Study|Death|2
7334585|NCT00836745|11569952|FG000|Overall Study|Lost to Follow-up|10
7334586|NCT00836745|11569952|FG000|Overall Study|Adverse Event|3
7334587|NCT00836745|11569952|FG000|Overall Study|Objective progression or relapse|4
7334588|NCT00836745|11569952|FG000|Overall Study|Other|2
7334591|NCT00836875|11569973|FG000|Overall Study|Death|3
7334592|NCT00836875|11569974|FG001|Overall Study|Death|2
7334593|NCT00836875|11569973|FG000|Overall Study|Withdrawal by Subject|0
7334594|NCT00836875|11569974|FG001|Overall Study|Withdrawal by Subject|1
7334595|NCT00836927|11570002|FG000|Overall Study|Progressive disease|2
7334596|NCT00836927|11570003|FG001|Overall Study|Progressive disease|0
7334597|NCT00836927|11570004|FG002|Overall Study|Progressive disease|0
7334598|NCT00836927|11570005|FG003|Overall Study|Progressive disease|1
7334599|NCT00836927|11570006|FG004|Overall Study|Progressive disease|1
7334600|NCT00836927|11570002|FG000|Overall Study|Withdrawal by Subject|1
7334601|NCT00836927|11570003|FG001|Overall Study|Withdrawal by Subject|0
7334602|NCT00836927|11570004|FG002|Overall Study|Withdrawal by Subject|0
7334603|NCT00836927|11570005|FG003|Overall Study|Withdrawal by Subject|0
7334604|NCT00836927|11570006|FG004|Overall Study|Withdrawal by Subject|0
7334605|NCT00836953|11570020|FG000|Overall Study|Withdrawal by Subject|1
7334606|NCT00836953|11570020|FG000|Overall Study|Lost to Follow-up|1
7334611|NCT00837148|11570037|FG000|Overall Study|Adverse Event|1
7334612|NCT00837148|11570037|FG000|Overall Study|Death|1
7334613|NCT00837161|11570041|FG000|Overall Study|refused hysterectomy|2
7334614|NCT00837213|11570051|FG000|Overall Study|Lost to Follow-up|3
7334615|NCT00837213|11570052|FG001|Overall Study|Lost to Follow-up|2
7334616|NCT00837213|11570051|FG000|Overall Study|Withdrawal by Subject|2
7334617|NCT00837213|11570052|FG001|Overall Study|Withdrawal by Subject|2
7334618|NCT00837213|11570051|FG000|Overall Study|not stated|1
7334619|NCT00837213|11570052|FG001|Overall Study|not stated|1
7334620|NCT00837330|11570064|FG000|Overall Study|Lost to Follow-up|1
7568600|NCT03421730|11944066|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568601|NCT03421730|11944067|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568602|NCT03421730|11944068|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568603|NCT03421730|11944069|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568604|NCT03421730|11944070|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
7568605|NCT03421730|11944059|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568606|NCT03421730|11944060|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568607|NCT03421730|11944061|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568608|NCT03421730|11944062|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568609|NCT03421730|11944063|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
7568610|NCT03421730|11944064|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568611|NCT03421730|11944065|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568612|NCT03421730|11944066|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568613|NCT03421730|11944067|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568614|NCT03421730|11944068|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568615|NCT03421730|11944069|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568616|NCT03421730|11944070|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
7568617|NCT03422159|11944095|FG000|Overall Study|Exclusion due to terminal disease|2
7568618|NCT03422159|11944096|FG001|Overall Study|Exclusion due to terminal disease|1
7568619|NCT03422172|11944104|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
7568620|NCT03422172|11944104|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
7568621|NCT03422172|11944104|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
7568622|NCT03422250|11944117|FG000|Intervention|Adverse Event|0
7568623|NCT03422250|11944118|FG001|Intervention|Adverse Event|1
7568624|NCT03422250|11944119|FG002|Intervention|Adverse Event|0
7568625|NCT03422250|11944120|FG003|Intervention|Adverse Event|1
7568626|NCT03422250|11944117|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
7568627|NCT03422250|11944118|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7568628|NCT03422250|11944119|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
7575273|NCT03720470|11958912|FG005|Treatment Period: Final 4 Weeks|Other|0
7334621|NCT00837330|11570065|FG001|Overall Study|Lost to Follow-up|3
7334622|NCT00837434|11570073|FG000|Overall Study|Physician Decision|3
7334623|NCT00837434|11570074|FG001|Overall Study|Physician Decision|0
7334624|NCT00837434|11570073|FG000|Overall Study|Lost to Follow-up|1
7334625|NCT00837434|11570074|FG001|Overall Study|Lost to Follow-up|1
7334626|NCT00837434|11570073|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
7334627|NCT00837434|11570074|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
7334628|NCT00837434|11570073|FG000|Overall Study|Noncompliant|2
7334629|NCT00837434|11570074|FG001|Overall Study|Noncompliant|0
7334630|NCT00837434|11570073|FG000|Overall Study|Baseline assessments not done in time|1
7334631|NCT00837434|11570074|FG001|Overall Study|Baseline assessments not done in time|0
7334632|NCT00837434|11570073|FG000|Overall Study|Unable to obtain study drug|1
7334633|NCT00837434|11570074|FG001|Overall Study|Unable to obtain study drug|0
7334634|NCT00837473|11570085|FG000|Overall Study|Lost to Follow-up|1
7334635|NCT00837473|11570085|FG000|Overall Study|Withdrawal by Subject|2
7334636|NCT00837486|11570091|FG000|Blinded-treatment Phase|Physician Decision|1
7334637|NCT00837486|11570092|FG001|Blinded-treatment Phase|Physician Decision|0
7334638|NCT00837486|11570091|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
7334639|NCT00837486|11570092|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
7334640|NCT00837486|11570091|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
7334641|NCT00837486|11570092|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
7334642|NCT00837486|11570091|FG000|Long-term Follow-up Phase - Open Label|Death|1
7334643|NCT00837486|11570092|FG001|Long-term Follow-up Phase - Open Label|Death|0
7334644|NCT00837577|11570109|FG000|Double-blind Period|Clinical Adverse Event|1
7334645|NCT00837577|11570110|FG001|Double-blind Period|Clinical Adverse Event|0
7334646|NCT00837577|11570109|FG000|Double-blind Period|Withdrawal by Subject|1
7334647|NCT00837577|11570110|FG001|Double-blind Period|Withdrawal by Subject|0
7334648|NCT00837577|11570109|FG000|Open-label Period|Clinical Adverse Event|2
7334649|NCT00837577|11570110|FG001|Open-label Period|Clinical Adverse Event|2
7334650|NCT00837577|11570109|FG000|Open-label Period|Laboratory Adverse Event|0
7334651|NCT00837577|11570110|FG001|Open-label Period|Laboratory Adverse Event|1
7334652|NCT00837577|11570109|FG000|Open-label Period|Lack of Efficacy|4
7334653|NCT00837577|11570110|FG001|Open-label Period|Lack of Efficacy|3
7334654|NCT00837577|11570109|FG000|Open-label Period|Withdrawal by Subject|1
7334655|NCT00837577|11570110|FG001|Open-label Period|Withdrawal by Subject|2
7334656|NCT00837577|11570109|FG000|Open-label Period|Other Reason|1
7334657|NCT00837577|11570110|FG001|Open-label Period|Other Reason|1
7334658|NCT00837616|11570132|FG000|Overall Study|Withdrawal by Subject|0
7334659|NCT00837616|11570133|FG001|Overall Study|Withdrawal by Subject|1
7334660|NCT00837694|11570145|FG000|Overall Study|Lost to Follow-up|2
7334661|NCT00837694|11570146|FG001|Overall Study|Lost to Follow-up|0
7334662|NCT00837694|11570147|FG002|Overall Study|Lost to Follow-up|2
7334663|NCT00837694|11570148|FG003|Overall Study|Lost to Follow-up|1
7334664|NCT00837694|11570149|FG004|Overall Study|Lost to Follow-up|1
7334665|NCT00837694|11570150|FG005|Overall Study|Lost to Follow-up|1
7334666|NCT00837759|11570164|FG000|Overall Study|Protocol Violation|3
7334667|NCT00837759|11570164|FG000|Overall Study|Lost to Follow-up|1
7334668|NCT00837811|11570171|FG000|Overall Study|Adverse Event|4
7334669|NCT00837811|11570172|FG001|Overall Study|Adverse Event|6
7334670|NCT00837811|11570173|FG002|Overall Study|Adverse Event|0
7334671|NCT00837811|11570171|FG000|Overall Study|Death|1
7334672|NCT00837811|11570172|FG001|Overall Study|Death|1
7334673|NCT00837811|11570173|FG002|Overall Study|Death|0
7334674|NCT00837811|11570171|FG000|Overall Study|Lack of Efficacy|0
7334675|NCT00837811|11570172|FG001|Overall Study|Lack of Efficacy|11
7334676|NCT00837811|11570173|FG002|Overall Study|Lack of Efficacy|0
7334677|NCT00837811|11570171|FG000|Overall Study|Lost to Follow-up|1
7334678|NCT00837811|11570172|FG001|Overall Study|Lost to Follow-up|3
7334679|NCT00837811|11570173|FG002|Overall Study|Lost to Follow-up|0
7334680|NCT00837811|11570171|FG000|Overall Study|Physician Decision|0
7334681|NCT00837811|11570172|FG001|Overall Study|Physician Decision|2
7334682|NCT00837811|11570173|FG002|Overall Study|Physician Decision|1
7334683|NCT00837811|11570171|FG000|Overall Study|Withdrawal by Subject|1
7334684|NCT00837811|11570172|FG001|Overall Study|Withdrawal by Subject|9
7334685|NCT00837811|11570173|FG002|Overall Study|Withdrawal by Subject|0
7334686|NCT00837811|11570171|FG000|Overall Study|Sponsor Decision|0
7334687|NCT00837811|11570172|FG001|Overall Study|Sponsor Decision|2
7334688|NCT00837811|11570173|FG002|Overall Study|Sponsor Decision|0
7334689|NCT00837876|11570200|FG000|Overall Study|Death|2
7334690|NCT00837876|11570200|FG000|Overall Study|Adverse Event|7
7334691|NCT00837876|11570200|FG000|Overall Study|Physician Decision|1
7334692|NCT00837876|11570200|FG000|Overall Study|Withdrawal by Subject|3
7334693|NCT00837876|11570200|FG000|Overall Study|disease progression|24
7334694|NCT00837967|11570214|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
7334695|NCT00837967|11570215|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
7334696|NCT00838097|11570236|FG000|Overall Study|Ineligibility determined|6
7334697|NCT00838097|11570236|FG000|Overall Study|Adverse Event|2
7334698|NCT00838097|11570236|FG000|Overall Study|Withdrawal by Subject|3
7334699|NCT00838097|11570236|FG000|Overall Study|Requirement for alternative therapy|2
7334700|NCT00838097|11570236|FG000|Overall Study|Physician Decision|4
7334701|NCT00838097|11570236|FG000|Overall Study|Lost to Follow-up|11
7334702|NCT00838097|11570236|FG000|Overall Study|Death|6
7334703|NCT00838097|11570236|FG000|Overall Study|Protocol-specified criteria|142
7334704|NCT00838110|11570242|FG000|Overall Study|Death|0
7334705|NCT00838110|11570243|FG001|Overall Study|Death|0
7334706|NCT00838110|11570244|FG002|Overall Study|Death|1
7334707|NCT00838110|11570245|FG003|Overall Study|Death|2
7334708|NCT00838110|11570242|FG000|Overall Study|Adverse Event|11
7334709|NCT00838110|11570243|FG001|Overall Study|Adverse Event|10
7334710|NCT00838110|11570244|FG002|Overall Study|Adverse Event|8
7334711|NCT00838110|11570245|FG003|Overall Study|Adverse Event|7
7334712|NCT00838110|11570242|FG000|Overall Study|Withdrawal by Subject|5
7334713|NCT00838110|11570243|FG001|Overall Study|Withdrawal by Subject|6
7334714|NCT00838110|11570244|FG002|Overall Study|Withdrawal by Subject|3
7334715|NCT00838110|11570245|FG003|Overall Study|Withdrawal by Subject|4
7334716|NCT00838110|11570242|FG000|Overall Study|Other|3
7334717|NCT00838110|11570243|FG001|Overall Study|Other|3
7334718|NCT00838110|11570244|FG002|Overall Study|Other|3
7334719|NCT00838110|11570245|FG003|Overall Study|Other|2
7334720|NCT00838110|11570242|FG000|Overall Study|Protocol Violation|0
7334721|NCT00838110|11570243|FG001|Overall Study|Protocol Violation|2
7334722|NCT00838110|11570244|FG002|Overall Study|Protocol Violation|1
7334723|NCT00838110|11570245|FG003|Overall Study|Protocol Violation|1
7334724|NCT00838110|11570242|FG000|Overall Study|Lost to Follow-up|3
7334725|NCT00838110|11570243|FG001|Overall Study|Lost to Follow-up|0
7334726|NCT00838110|11570244|FG002|Overall Study|Lost to Follow-up|0
7334727|NCT00838110|11570245|FG003|Overall Study|Lost to Follow-up|0
7334728|NCT00838110|11570242|FG000|Overall Study|Did not meet eligibility criteria|0
7457942|NCT01803607|11751778|FG001|Overall Study|Adverse Event|3
7334729|NCT00838110|11570243|FG001|Overall Study|Did not meet eligibility criteria|0
7334730|NCT00838110|11570244|FG002|Overall Study|Did not meet eligibility criteria|1
7334731|NCT00838110|11570245|FG003|Overall Study|Did not meet eligibility criteria|2
7334732|NCT00838110|11570242|FG000|Overall Study|Randomized but not treated|0
7334733|NCT00838110|11570243|FG001|Overall Study|Randomized but not treated|1
7334734|NCT00838110|11570244|FG002|Overall Study|Randomized but not treated|0
7334735|NCT00838110|11570245|FG003|Overall Study|Randomized but not treated|0
7334736|NCT00838201|11570274|FG000|Overall Study|Investigator decision, or other reasons|2
7334737|NCT00838201|11570275|FG001|Overall Study|Investigator decision, or other reasons|3
7334738|NCT00838201|11570274|FG000|Overall Study|Noncompliance|0
7334739|NCT00838201|11570275|FG001|Overall Study|Noncompliance|1
7334740|NCT00838201|11570274|FG000|Overall Study|Administrative decision|1
7334741|NCT00838201|11570275|FG001|Overall Study|Administrative decision|2
7334742|NCT00838201|11570274|FG000|Overall Study|Disease progression|3
7334743|NCT00838201|11570275|FG001|Overall Study|Disease progression|3
7334744|NCT00838201|11570274|FG000|Overall Study|Consent withdrawn|16
7334745|NCT00838201|11570275|FG001|Overall Study|Consent withdrawn|19
7334746|NCT00838201|11570274|FG000|Overall Study|Lost to Follow-up|4
7334747|NCT00838201|11570275|FG001|Overall Study|Lost to Follow-up|3
7334748|NCT00838201|11570274|FG000|Overall Study|Adverse Event|5
7334749|NCT00838201|11570275|FG001|Overall Study|Adverse Event|9
7334750|NCT00838201|11570274|FG000|Overall Study|Death|11
7334751|NCT00838201|11570275|FG001|Overall Study|Death|13
7334752|NCT00838331|11570281|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
7334753|NCT00838435|11570285|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
7334754|NCT00838435|11570285|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
7334755|NCT00838435|11570285|FG000|Part 2 (7 Years)|Adverse Event|2
7334756|NCT00838435|11570285|FG000|Part 2 (7 Years)|Lost to Follow-up|2
7334757|NCT00838435|11570285|FG000|Part 2 (7 Years)|Physician Decision|1
7334758|NCT00838435|11570285|FG000|Part 2 (7 Years)|Sponsor Decision|6
7334759|NCT00838435|11570285|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
7334760|NCT00838513|11570292|FG000|Screening Period|Screen Failure|3
7334761|NCT00838513|11570292|FG000|Extension Treatment Period|Death|1
7334762|NCT00838513|11570292|FG000|Post Treatment Period (Patients Who Disc|Death|1
7334763|NCT00838539|11570308|FG000|Overall Study|Disease Progression|2
7334764|NCT00838539|11570309|FG001|Overall Study|Disease Progression|4
7334765|NCT00838539|11570310|FG002|Overall Study|Disease Progression|3
7334766|NCT00838539|11570311|FG003|Overall Study|Disease Progression|2
7334767|NCT00838539|11570312|FG004|Overall Study|Disease Progression|4
7334768|NCT00838539|11570313|FG005|Overall Study|Disease Progression|2
7334769|NCT00838539|11570314|FG006|Overall Study|Disease Progression|3
7334770|NCT00838539|11570315|FG007|Overall Study|Disease Progression|4
7334771|NCT00838539|11570316|FG008|Overall Study|Disease Progression|4
7334772|NCT00838539|11570317|FG009|Overall Study|Disease Progression|5
7334773|NCT00838539|11570318|FG010|Overall Study|Disease Progression|1
7334774|NCT00838539|11570319|FG011|Overall Study|Disease Progression|4
7334775|NCT00838539|11570308|FG000|Overall Study|Adverse Event|1
7334776|NCT00838539|11570309|FG001|Overall Study|Adverse Event|1
7334777|NCT00838539|11570310|FG002|Overall Study|Adverse Event|1
7457943|NCT01803607|11751777|FG000|Overall Study|Lack of Efficacy|0
7457944|NCT01803607|11751778|FG001|Overall Study|Lack of Efficacy|1
7457945|NCT01803607|11751777|FG000|Overall Study|Protocol Violation|3
7457946|NCT01803607|11751778|FG001|Overall Study|Protocol Violation|2
7457947|NCT01803607|11751777|FG000|Overall Study|Study terminated by sponsor|54
7457948|NCT01803607|11751778|FG001|Overall Study|Study terminated by sponsor|56
7457949|NCT01803607|11751777|FG000|Overall Study|Withdrawal by Subject|6
7457950|NCT01803607|11751778|FG001|Overall Study|Withdrawal by Subject|5
7457951|NCT01803646|11751786|FG000|Overall Study|Protocol Violation|1
7457952|NCT01803646|11751787|FG001|Overall Study|Protocol Violation|0
7457953|NCT01803646|11751786|FG000|Overall Study|Adverse Event|1
7457954|NCT01803646|11751787|FG001|Overall Study|Adverse Event|1
7457955|NCT01803646|11751786|FG000|Overall Study|Withdrawal by Subject|9
7457956|NCT01803646|11751787|FG001|Overall Study|Withdrawal by Subject|6
7457957|NCT01803646|11751786|FG000|Overall Study|Randomization error|1
7457958|NCT01803646|11751787|FG001|Overall Study|Randomization error|2
7457959|NCT01803646|11751786|FG000|Overall Study|Lost to Follow-up|5
7457960|NCT01803646|11751787|FG001|Overall Study|Lost to Follow-up|1
7334778|NCT00838539|11570311|FG003|Overall Study|Adverse Event|1
7334779|NCT00838539|11570312|FG004|Overall Study|Adverse Event|2
7334780|NCT00838539|11570313|FG005|Overall Study|Adverse Event|1
7334781|NCT00838539|11570314|FG006|Overall Study|Adverse Event|0
7457961|NCT01803737|11751795|FG000|Overall Study|Lack of Time|1
7457962|NCT01803737|11751796|FG001|Overall Study|Lack of Time|0
7457963|NCT01803737|11751795|FG000|Overall Study|Medical Reason|0
7457964|NCT01803737|11751796|FG001|Overall Study|Medical Reason|1
7457965|NCT01803737|11751795|FG000|Overall Study|Lost to Follow-up|0
7457966|NCT01803737|11751796|FG001|Overall Study|Lost to Follow-up|2
7457967|NCT01803880|11751805|FG000|Overall Study|Adverse Event|1
7457968|NCT01803880|11751806|FG001|Overall Study|Adverse Event|0
7457969|NCT01803880|11751807|FG002|Overall Study|Adverse Event|0
7457970|NCT01803880|11751805|FG000|Overall Study|Withdrawal by Subject|1
7457971|NCT01803880|11751806|FG001|Overall Study|Withdrawal by Subject|1
7457972|NCT01803880|11751807|FG002|Overall Study|Withdrawal by Subject|4
7457973|NCT01803880|11751805|FG000|Overall Study|Physician Decision|0
7457974|NCT01803880|11751806|FG001|Overall Study|Physician Decision|0
7457975|NCT01803880|11751807|FG002|Overall Study|Physician Decision|1
7457976|NCT01803880|11751805|FG000|Overall Study|Unable to return for follow-up visits|0
7334782|NCT00838539|11570315|FG007|Overall Study|Adverse Event|2
7334783|NCT00838539|11570316|FG008|Overall Study|Adverse Event|0
7334784|NCT00838539|11570317|FG009|Overall Study|Adverse Event|1
7334785|NCT00838539|11570318|FG010|Overall Study|Adverse Event|2
7334786|NCT00838539|11570319|FG011|Overall Study|Adverse Event|0
7334787|NCT00838539|11570308|FG000|Overall Study|Withdrawal by Subject|0
7334788|NCT00838539|11570309|FG001|Overall Study|Withdrawal by Subject|1
7334789|NCT00838539|11570310|FG002|Overall Study|Withdrawal by Subject|0
7334790|NCT00838539|11570311|FG003|Overall Study|Withdrawal by Subject|0
7334791|NCT00838539|11570312|FG004|Overall Study|Withdrawal by Subject|0
7334792|NCT00838539|11570313|FG005|Overall Study|Withdrawal by Subject|0
7334793|NCT00838539|11570314|FG006|Overall Study|Withdrawal by Subject|0
7334794|NCT00838539|11570315|FG007|Overall Study|Withdrawal by Subject|0
7334795|NCT00838539|11570316|FG008|Overall Study|Withdrawal by Subject|0
7334796|NCT00838539|11570317|FG009|Overall Study|Withdrawal by Subject|1
7334797|NCT00838539|11570318|FG010|Overall Study|Withdrawal by Subject|2
7334798|NCT00838539|11570319|FG011|Overall Study|Withdrawal by Subject|0
7334799|NCT00838539|11570308|FG000|Overall Study|Death|0
7334800|NCT00838539|11570309|FG001|Overall Study|Death|0
7334801|NCT00838539|11570310|FG002|Overall Study|Death|0
7334802|NCT00838539|11570311|FG003|Overall Study|Death|0
7334803|NCT00838539|11570312|FG004|Overall Study|Death|0
7334804|NCT00838539|11570313|FG005|Overall Study|Death|0
7334805|NCT00838539|11570314|FG006|Overall Study|Death|1
7334806|NCT00838539|11570315|FG007|Overall Study|Death|0
7334807|NCT00838539|11570316|FG008|Overall Study|Death|0
7334808|NCT00838539|11570317|FG009|Overall Study|Death|0
7334809|NCT00838539|11570318|FG010|Overall Study|Death|0
7334810|NCT00838539|11570319|FG011|Overall Study|Death|0
7334811|NCT00838539|11570308|FG000|Overall Study|Physician Decision|0
7334812|NCT00838539|11570309|FG001|Overall Study|Physician Decision|0
7334813|NCT00838539|11570310|FG002|Overall Study|Physician Decision|0
7334814|NCT00838539|11570311|FG003|Overall Study|Physician Decision|0
7334815|NCT00838539|11570312|FG004|Overall Study|Physician Decision|0
7334816|NCT00838539|11570313|FG005|Overall Study|Physician Decision|0
7334817|NCT00838539|11570314|FG006|Overall Study|Physician Decision|0
7334818|NCT00838539|11570315|FG007|Overall Study|Physician Decision|0
7334819|NCT00838539|11570316|FG008|Overall Study|Physician Decision|1
7334820|NCT00838539|11570317|FG009|Overall Study|Physician Decision|0
7334821|NCT00838539|11570318|FG010|Overall Study|Physician Decision|0
7334822|NCT00838539|11570319|FG011|Overall Study|Physician Decision|0
7334823|NCT00838539|11570308|FG000|Overall Study|Clinical Progression|0
7334824|NCT00838539|11570309|FG001|Overall Study|Clinical Progression|0
7334825|NCT00838539|11570310|FG002|Overall Study|Clinical Progression|0
7334826|NCT00838539|11570311|FG003|Overall Study|Clinical Progression|0
7334827|NCT00838539|11570312|FG004|Overall Study|Clinical Progression|0
7334828|NCT00838539|11570313|FG005|Overall Study|Clinical Progression|0
7334829|NCT00838539|11570314|FG006|Overall Study|Clinical Progression|1
7334830|NCT00838539|11570315|FG007|Overall Study|Clinical Progression|0
7334831|NCT00838539|11570316|FG008|Overall Study|Clinical Progression|0
7334832|NCT00838539|11570317|FG009|Overall Study|Clinical Progression|0
7334833|NCT00838539|11570318|FG010|Overall Study|Clinical Progression|0
7334834|NCT00838539|11570319|FG011|Overall Study|Clinical Progression|0
7334835|NCT00838539|11570308|FG000|Overall Study|Symptomatic Deterioration|0
7334836|NCT00838539|11570309|FG001|Overall Study|Symptomatic Deterioration|0
7334837|NCT00838539|11570310|FG002|Overall Study|Symptomatic Deterioration|1
7334838|NCT00838539|11570311|FG003|Overall Study|Symptomatic Deterioration|1
7334839|NCT00838539|11570312|FG004|Overall Study|Symptomatic Deterioration|0
7334840|NCT00838539|11570313|FG005|Overall Study|Symptomatic Deterioration|1
7334841|NCT00838539|11570314|FG006|Overall Study|Symptomatic Deterioration|0
7334842|NCT00838539|11570315|FG007|Overall Study|Symptomatic Deterioration|0
7334843|NCT00838539|11570316|FG008|Overall Study|Symptomatic Deterioration|0
7334844|NCT00838539|11570317|FG009|Overall Study|Symptomatic Deterioration|1
7334845|NCT00838539|11570318|FG010|Overall Study|Symptomatic Deterioration|0
7334846|NCT00838539|11570319|FG011|Overall Study|Symptomatic Deterioration|0
7334847|NCT00838565|11570365|FG000|Overall Study|Withdrawal by Subject|0
7334848|NCT00838565|11570366|FG001|Overall Study|Withdrawal by Subject|0
7334849|NCT00838565|11570367|FG002|Overall Study|Withdrawal by Subject|1
7334850|NCT00838565|11570368|FG003|Overall Study|Withdrawal by Subject|0
7334851|NCT00838565|11570369|FG004|Overall Study|Withdrawal by Subject|0
7334852|NCT00838565|11570370|FG005|Overall Study|Withdrawal by Subject|2
7334853|NCT00838565|11570365|FG000|Overall Study|Other|0
7334854|NCT00838565|11570366|FG001|Overall Study|Other|2
7334855|NCT00838565|11570367|FG002|Overall Study|Other|0
7334856|NCT00838565|11570368|FG003|Overall Study|Other|0
7334857|NCT00838565|11570369|FG004|Overall Study|Other|0
7334858|NCT00838565|11570370|FG005|Overall Study|Other|0
7334859|NCT00838565|11570365|FG000|Overall Study|Randomized but not Treated|0
7334860|NCT00838565|11570366|FG001|Overall Study|Randomized but not Treated|1
7334861|NCT00838565|11570367|FG002|Overall Study|Randomized but not Treated|0
7334862|NCT00838565|11570368|FG003|Overall Study|Randomized but not Treated|0
7334863|NCT00838565|11570369|FG004|Overall Study|Randomized but not Treated|0
7334864|NCT00838565|11570370|FG005|Overall Study|Randomized but not Treated|0
7334865|NCT00838578|11570389|FG000|Overall Study|Protocol Violation|2
7334866|NCT00838682|11570399|FG000|Overall Study|Lost to Follow-up|21
7334867|NCT00838682|11570400|FG001|Overall Study|Lost to Follow-up|14
7334868|NCT00838682|11570399|FG000|Overall Study|detection of exclusion criteria|4
7334869|NCT00838682|11570400|FG001|Overall Study|detection of exclusion criteria|3
7334870|NCT00838682|11570399|FG000|Overall Study|Protocol Violation|0
7334871|NCT00838682|11570400|FG001|Overall Study|Protocol Violation|1
7334872|NCT00838682|11570399|FG000|Overall Study|Withdrawal by Subject|0
7334873|NCT00838682|11570400|FG001|Overall Study|Withdrawal by Subject|1
7334874|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Adverse Event|5
7334875|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Adverse Event|13
7334876|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Adverse Event|17
7334877|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Adverse Event|25
7334878|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
7334879|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
7334880|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
7334881|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
7334882|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Noncompliance|9
7334883|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Noncompliance|13
7334884|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Noncompliance|12
7334885|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Noncompliance|6
7334886|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7334887|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7334888|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7334889|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7334890|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
7334891|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
7334892|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
7334893|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
7334894|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
7334895|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
7334896|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
7334897|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
7334898|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Physician Decision|1
7334899|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Physician Decision|2
7334900|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Physician Decision|1
7334901|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Physician Decision|2
7334902|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
7334903|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7334904|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
7334905|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
7334906|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7334907|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
7334908|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7334909|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
7334910|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7334911|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7334912|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
7334913|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
7334914|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
7334915|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7334916|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7334917|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
7334918|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Pregnancy|0
7334919|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7334920|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Pregnancy|1
7334921|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Pregnancy|0
7334922|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7334923|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7334924|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
7334925|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
7334926|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Site closed|0
7334927|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Site closed|0
7334928|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Site closed|1
7334929|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Site closed|0
7334930|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
7334931|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7334932|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7334933|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
7334934|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7334935|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7334936|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
7334937|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
7334938|NCT00838903|11570419|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
7334939|NCT00838903|11570420|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7334940|NCT00838903|11570421|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7334941|NCT00838903|11570422|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
7334942|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
7334943|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
7334944|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
7334945|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
7334946|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7334947|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
7334948|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
7334949|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
7334950|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
7334951|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
7334952|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7334953|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
7334954|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
7334955|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7334956|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
7334957|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
7334958|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
7334959|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
7334960|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7334961|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
7334962|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
7334963|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
7334964|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
7334965|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
7334966|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
7334967|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7334968|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
7334969|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7334970|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7334971|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
7334972|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7334973|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
7334974|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7334975|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
7334976|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7334977|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
7334978|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7334979|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7334980|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
7334981|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
7334982|NCT00838903|11570419|FG000|Follow-up Period (8 Weeks)|Missing|1
7334983|NCT00838903|11570420|FG001|Follow-up Period (8 Weeks)|Missing|2
7334984|NCT00838903|11570421|FG002|Follow-up Period (8 Weeks)|Missing|1
7334985|NCT00838903|11570422|FG003|Follow-up Period (8 Weeks)|Missing|1
7334986|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Adverse Event|50
7334987|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Adverse Event|11
7334988|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
7334989|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
7334990|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Noncompliance|21
7334991|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Noncompliance|14
7334992|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
7334993|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
7334994|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
7334995|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
7334996|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
7334997|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
7334998|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Physician Decision|6
7334999|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Physician Decision|1
7335000|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
7335001|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
7335002|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Missing|3
7335003|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Missing|1
7335004|NCT00838916|11570434|FG000|Treatment Period (156 Weeks)|Pregnancy|2
7335005|NCT00838916|11570435|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7335006|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
7335007|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
7335008|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
7335009|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
7335010|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
7335011|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
7335012|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7335013|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
7335014|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
7335015|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
7335016|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
7335017|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
7335018|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
7335019|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7335020|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7335021|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
7335022|NCT00838916|11570434|FG000|Follow-up Period (8 Weeks)|Missing|3
7335023|NCT00838916|11570435|FG001|Follow-up Period (8 Weeks)|Missing|0
7335024|NCT00838929|11570444|FG000|Overall Study|Protocol Violation|0
7335025|NCT00838929|11570445|FG001|Overall Study|Protocol Violation|1
7335026|NCT00838929|11570446|FG002|Overall Study|Protocol Violation|0
7335027|NCT00838929|11570444|FG000|Overall Study|Disease progression|0
7335028|NCT00838929|11570445|FG001|Overall Study|Disease progression|2
7335029|NCT00838929|11570446|FG002|Overall Study|Disease progression|1
7335030|NCT00839072|11570452|FG000|First Intervention Period|Withdrawal by Subject|1
7335031|NCT00839072|11570453|FG001|First Intervention Period|Withdrawal by Subject|0
7335032|NCT00839072|11570452|FG000|First Intervention Period|Adverse Event|1
7335033|NCT00839072|11570453|FG001|First Intervention Period|Adverse Event|1
7335034|NCT00839072|11570452|FG000|Second Intervention Period|Withdrawal by Subject|1
7335035|NCT00839072|11570453|FG001|Second Intervention Period|Withdrawal by Subject|0
7335036|NCT00839098|11570462|FG000|Overall Study|Withdrawal by Subject|2
7335037|NCT00839098|11570463|FG001|Overall Study|Withdrawal by Subject|1
7335038|NCT00839098|11570464|FG002|Overall Study|Withdrawal by Subject|7
7335039|NCT00839254|11570489|FG000|Overall Study|Protocol Violation|0
7335040|NCT00839254|11570490|FG001|Overall Study|Protocol Violation|1
7335041|NCT00839254|11570491|FG002|Overall Study|Protocol Violation|1
7335042|NCT00839254|11570492|FG003|Overall Study|Protocol Violation|1
7335043|NCT00839254|11570493|FG004|Overall Study|Protocol Violation|0
7335044|NCT00839254|11570494|FG005|Overall Study|Protocol Violation|0
7335045|NCT00839254|11570495|FG006|Overall Study|Protocol Violation|1
7335046|NCT00839254|11570496|FG007|Overall Study|Protocol Violation|2
7335047|NCT00839254|11570489|FG000|Overall Study|Physician Decision|0
7335048|NCT00839254|11570490|FG001|Overall Study|Physician Decision|1
7335049|NCT00839254|11570491|FG002|Overall Study|Physician Decision|0
7335050|NCT00839254|11570492|FG003|Overall Study|Physician Decision|0
7335051|NCT00839254|11570493|FG004|Overall Study|Physician Decision|0
7335052|NCT00839254|11570494|FG005|Overall Study|Physician Decision|0
7335053|NCT00839254|11570495|FG006|Overall Study|Physician Decision|0
7335054|NCT00839254|11570496|FG007|Overall Study|Physician Decision|1
7335055|NCT00839254|11570489|FG000|Overall Study|Wrong treatment number allocation|0
7335056|NCT00839254|11570490|FG001|Overall Study|Wrong treatment number allocation|1
7457977|NCT01803880|11751806|FG001|Overall Study|Unable to return for follow-up visits|1
7457978|NCT01803880|11751807|FG002|Overall Study|Unable to return for follow-up visits|2
7457979|NCT01803880|11751805|FG000|Overall Study|Lost to Follow-up|1
7457980|NCT01803880|11751806|FG001|Overall Study|Lost to Follow-up|2
7457981|NCT01803880|11751807|FG002|Overall Study|Lost to Follow-up|3
7457982|NCT01803880|11751805|FG000|Overall Study|Protocol Violation|1
7457983|NCT01803880|11751806|FG001|Overall Study|Protocol Violation|0
7457984|NCT01803880|11751807|FG002|Overall Study|Protocol Violation|0
7457985|NCT01803880|11751805|FG000|Overall Study|Early study termination|0
7457986|NCT01803880|11751806|FG001|Overall Study|Early study termination|6
7457987|NCT01803880|11751807|FG002|Overall Study|Early study termination|5
7457988|NCT01803880|11751805|FG000|Overall Study|Incomplete data entry by sites|2
7457989|NCT01803880|11751806|FG001|Overall Study|Incomplete data entry by sites|0
7457990|NCT01803880|11751807|FG002|Overall Study|Incomplete data entry by sites|0
7457991|NCT01804049|11751829|FG000|Overall Study|Adverse Event|2
7457992|NCT01804049|11751830|FG001|Overall Study|Adverse Event|10
7457993|NCT01804049|11751829|FG000|Overall Study|Lost to Follow-up|2
7457994|NCT01804049|11751830|FG001|Overall Study|Lost to Follow-up|1
7457995|NCT01804049|11751829|FG000|Overall Study|Decreased interest/personal|4
7457996|NCT01804049|11751830|FG001|Overall Study|Decreased interest/personal|5
7457997|NCT01804049|11751829|FG000|Overall Study|Other health concerns|2
7457998|NCT01804049|11751830|FG001|Overall Study|Other health concerns|7
7457999|NCT01804049|11751829|FG000|Overall Study|Moved out of area|0
7458000|NCT01804049|11751830|FG001|Overall Study|Moved out of area|7
7458001|NCT01804049|11751829|FG000|Overall Study|other MD recommended|1
7458002|NCT01804049|11751830|FG001|Overall Study|other MD recommended|1
7458003|NCT01804049|11751829|FG000|Overall Study|Enrollment in dual studies|0
7458004|NCT01804049|11751830|FG001|Overall Study|Enrollment in dual studies|1
7458005|NCT01804140|11751873|FG000|Overall Study|No sampling or biopsy procedures done|114
7468227|NCT01908699|11768895|FG001|Overall Study|Withdrawal by Subject|10
7468228|NCT01908699|11768894|FG000|Overall Study|Pregnancy|0
7468229|NCT01908699|11768895|FG001|Overall Study|Pregnancy|1
7468230|NCT01908699|11768894|FG000|Overall Study|Randomized in Error|1
7468231|NCT01908699|11768895|FG001|Overall Study|Randomized in Error|0
7468232|NCT01908699|11768894|FG000|Overall Study|Death|9
7468233|NCT01908699|11768895|FG001|Overall Study|Death|12
7468234|NCT01908699|11768894|FG000|Overall Study|Progressive Disease|30
7335057|NCT00839254|11570491|FG002|Overall Study|Wrong treatment number allocation|0
7335058|NCT00839254|11570492|FG003|Overall Study|Wrong treatment number allocation|0
7335059|NCT00839254|11570493|FG004|Overall Study|Wrong treatment number allocation|0
7335060|NCT00839254|11570494|FG005|Overall Study|Wrong treatment number allocation|1
7335061|NCT00839254|11570495|FG006|Overall Study|Wrong treatment number allocation|0
7335062|NCT00839254|11570496|FG007|Overall Study|Wrong treatment number allocation|0
7335063|NCT00839254|11570489|FG000|Overall Study|Adverse Event|12
7335064|NCT00839254|11570490|FG001|Overall Study|Adverse Event|6
7335065|NCT00839254|11570491|FG002|Overall Study|Adverse Event|3
7335066|NCT00839254|11570492|FG003|Overall Study|Adverse Event|5
7335067|NCT00839254|11570493|FG004|Overall Study|Adverse Event|2
7335068|NCT00839254|11570494|FG005|Overall Study|Adverse Event|1
7335069|NCT00839254|11570495|FG006|Overall Study|Adverse Event|0
7335070|NCT00839254|11570496|FG007|Overall Study|Adverse Event|1
7335071|NCT00839254|11570489|FG000|Overall Study|Withdrawal by Subject|87
7335072|NCT00839254|11570490|FG001|Overall Study|Withdrawal by Subject|53
7335073|NCT00839254|11570491|FG002|Overall Study|Withdrawal by Subject|54
7335074|NCT00839254|11570492|FG003|Overall Study|Withdrawal by Subject|32
7335075|NCT00839254|11570493|FG004|Overall Study|Withdrawal by Subject|27
7335076|NCT00839254|11570494|FG005|Overall Study|Withdrawal by Subject|15
7335077|NCT00839254|11570495|FG006|Overall Study|Withdrawal by Subject|22
7335078|NCT00839254|11570496|FG007|Overall Study|Withdrawal by Subject|9
7335079|NCT00839254|11570489|FG000|Overall Study|Wrong group allocation|0
7335080|NCT00839254|11570490|FG001|Overall Study|Wrong group allocation|0
7335081|NCT00839254|11570491|FG002|Overall Study|Wrong group allocation|0
7335082|NCT00839254|11570492|FG003|Overall Study|Wrong group allocation|0
7335083|NCT00839254|11570493|FG004|Overall Study|Wrong group allocation|0
7335084|NCT00839254|11570494|FG005|Overall Study|Wrong group allocation|0
7335085|NCT00839254|11570495|FG006|Overall Study|Wrong group allocation|1
7335086|NCT00839254|11570496|FG007|Overall Study|Wrong group allocation|0
7335087|NCT00839254|11570489|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
7335088|NCT00839254|11570490|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
7335089|NCT00839254|11570491|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
7335090|NCT00839254|11570492|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
7335091|NCT00839254|11570493|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
7335092|NCT00839254|11570494|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
7335093|NCT00839254|11570495|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
7335094|NCT00839254|11570496|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
7335095|NCT00839254|11570489|FG000|Overall Study|Withdrawn due to non-compliance|2
7335096|NCT00839254|11570490|FG001|Overall Study|Withdrawn due to non-compliance|0
7335097|NCT00839254|11570491|FG002|Overall Study|Withdrawn due to non-compliance|0
7335098|NCT00839254|11570492|FG003|Overall Study|Withdrawn due to non-compliance|0
7335099|NCT00839254|11570493|FG004|Overall Study|Withdrawn due to non-compliance|0
7335100|NCT00839254|11570494|FG005|Overall Study|Withdrawn due to non-compliance|0
7335101|NCT00839254|11570495|FG006|Overall Study|Withdrawn due to non-compliance|0
7335102|NCT00839254|11570496|FG007|Overall Study|Withdrawn due to non-compliance|0
7335103|NCT00839254|11570489|FG000|Overall Study|Lost to Follow-up|51
7568629|NCT03422250|11944120|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
7568630|NCT03422250|11944117|FG000|Follow-up|Withdrawal by Subject|0
7335104|NCT00839254|11570490|FG001|Overall Study|Lost to Follow-up|30
7335105|NCT00839254|11570491|FG002|Overall Study|Lost to Follow-up|32
7335106|NCT00839254|11570492|FG003|Overall Study|Lost to Follow-up|24
7335107|NCT00839254|11570493|FG004|Overall Study|Lost to Follow-up|8
7335108|NCT00839254|11570494|FG005|Overall Study|Lost to Follow-up|8
7335109|NCT00839254|11570495|FG006|Overall Study|Lost to Follow-up|4
7335110|NCT00839254|11570496|FG007|Overall Study|Lost to Follow-up|2
7385453|NCT01201798|11643224|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
7385454|NCT01201798|11643223|FG000|Overall Study|Noncompliance|1
7385455|NCT01201798|11643224|FG001|Overall Study|Noncompliance|0
7385456|NCT01201798|11643223|FG000|Overall Study|Protocol Violation|1
7385457|NCT01201798|11643224|FG001|Overall Study|Protocol Violation|1
7385458|NCT01201798|11643223|FG000|Overall Study|Treatment Failure|1
7385459|NCT01201798|11643224|FG001|Overall Study|Treatment Failure|8
7385460|NCT01201811|11643230|FG000|Overall Study|Adverse Event|6
7385461|NCT01201811|11643230|FG000|Overall Study|Disease progression|3
7385462|NCT01201811|11643230|FG000|Overall Study|Withdrawal by Subject|3
7385463|NCT01201811|11643230|FG000|Overall Study|Death|4
7385464|NCT01201811|11643230|FG000|Overall Study|Treatment Failure|2
7385465|NCT01201811|11643230|FG000|Overall Study|Physician Decision|1
7385466|NCT01201850|11643234|FG000|Overall Study|Tumor progression|4
7385467|NCT01201915|11643254|FG000|Overall Study|Adverse Event|2
7385468|NCT01201915|11643255|FG001|Overall Study|Adverse Event|1
7385469|NCT01201915|11643256|FG002|Overall Study|Adverse Event|1
7385470|NCT01201915|11643254|FG000|Overall Study|Lost to Follow-up|0
7385471|NCT01201915|11643255|FG001|Overall Study|Lost to Follow-up|4
7385472|NCT01201915|11643256|FG002|Overall Study|Lost to Follow-up|0
7385473|NCT01201915|11643254|FG000|Overall Study|Physician Decision|3
7385474|NCT01201915|11643255|FG001|Overall Study|Physician Decision|0
7385475|NCT01201915|11643256|FG002|Overall Study|Physician Decision|0
7385476|NCT01201915|11643254|FG000|Overall Study|Subject Decision|3
7385477|NCT01201915|11643255|FG001|Overall Study|Subject Decision|3
7568631|NCT03422250|11944118|FG001|Follow-up|Withdrawal by Subject|0
7335111|NCT00839306|11570547|FG000|Overall Study|Adverse Event|3
7335112|NCT00839306|11570548|FG001|Overall Study|Adverse Event|5
7335113|NCT00839306|11570547|FG000|Overall Study|Lost to Follow-up|6
7335114|NCT00839306|11570548|FG001|Overall Study|Lost to Follow-up|9
7335115|NCT00839306|11570547|FG000|Overall Study|Withdrawal by Subject|5
7335116|NCT00839306|11570548|FG001|Overall Study|Withdrawal by Subject|7
7335117|NCT00839306|11570547|FG000|Overall Study|Lack of Efficacy|5
7335118|NCT00839306|11570548|FG001|Overall Study|Lack of Efficacy|4
7335119|NCT00839306|11570547|FG000|Overall Study|Other|6
7335120|NCT00839306|11570548|FG001|Overall Study|Other|18
7335121|NCT00839332|11570579|FG000|Phase 1|Disease Progression|38
7335122|NCT00839332|11570580|FG001|Phase 1|Disease Progression|0
7335123|NCT00839332|11570581|FG002|Phase 1|Disease Progression|0
7335124|NCT00839332|11570579|FG000|Phase 1|Adverse Event|6
7335125|NCT00839332|11570580|FG001|Phase 1|Adverse Event|0
7335126|NCT00839332|11570581|FG002|Phase 1|Adverse Event|0
7335127|NCT00839332|11570579|FG000|Phase 1|Withdrawal by Subject|4
7335128|NCT00839332|11570580|FG001|Phase 1|Withdrawal by Subject|0
7335129|NCT00839332|11570581|FG002|Phase 1|Withdrawal by Subject|0
7335130|NCT00839332|11570579|FG000|Phase 1|Physician Decision|2
7335131|NCT00839332|11570580|FG001|Phase 1|Physician Decision|0
7335132|NCT00839332|11570581|FG002|Phase 1|Physician Decision|0
7335133|NCT00839332|11570579|FG000|Phase 2|Protocol Violation|0
7335134|NCT00839332|11570580|FG001|Phase 2|Protocol Violation|1
7335135|NCT00839332|11570581|FG002|Phase 2|Protocol Violation|0
7335136|NCT00839332|11570579|FG000|Phase 2|Disease Progression|0
7335137|NCT00839332|11570580|FG001|Phase 2|Disease Progression|46
7335138|NCT00839332|11570581|FG002|Phase 2|Disease Progression|21
7335139|NCT00839332|11570579|FG000|Phase 2|Adverse Event|0
7335140|NCT00839332|11570580|FG001|Phase 2|Adverse Event|8
7335141|NCT00839332|11570581|FG002|Phase 2|Adverse Event|6
7335142|NCT00839332|11570579|FG000|Phase 2|Death|0
7335143|NCT00839332|11570580|FG001|Phase 2|Death|4
7335144|NCT00839332|11570581|FG002|Phase 2|Death|2
7335145|NCT00839332|11570579|FG000|Phase 2|Withdrawal by Subject|0
7335146|NCT00839332|11570580|FG001|Phase 2|Withdrawal by Subject|5
7335147|NCT00839332|11570581|FG002|Phase 2|Withdrawal by Subject|8
7335148|NCT00839332|11570579|FG000|Phase 2|Physician Decision|0
7335149|NCT00839332|11570580|FG001|Phase 2|Physician Decision|4
7335150|NCT00839332|11570581|FG002|Phase 2|Physician Decision|1
7335151|NCT00839332|11570579|FG000|Phase 2|Lost to Follow-up|0
7335152|NCT00839332|11570580|FG001|Phase 2|Lost to Follow-up|0
7335153|NCT00839332|11570581|FG002|Phase 2|Lost to Follow-up|1
7335154|NCT00839423|11570594|FG000|Overall Study|Adverse Event|4
7335155|NCT00839423|11570595|FG001|Overall Study|Adverse Event|3
7335156|NCT00839423|11570596|FG002|Overall Study|Adverse Event|7
7335157|NCT00839423|11570597|FG003|Overall Study|Adverse Event|16
7335158|NCT00839423|11570594|FG000|Overall Study|Lack of Efficacy|6
7335159|NCT00839423|11570595|FG001|Overall Study|Lack of Efficacy|6
7335160|NCT00839423|11570596|FG002|Overall Study|Lack of Efficacy|3
7335161|NCT00839423|11570597|FG003|Overall Study|Lack of Efficacy|2
7335162|NCT00839423|11570594|FG000|Overall Study|Non-compliance|0
7335163|NCT00839423|11570595|FG001|Overall Study|Non-compliance|0
7335164|NCT00839423|11570596|FG002|Overall Study|Non-compliance|0
7335165|NCT00839423|11570597|FG003|Overall Study|Non-compliance|1
7335166|NCT00839423|11570594|FG000|Overall Study|Protocol Violation|0
7335167|NCT00839423|11570595|FG001|Overall Study|Protocol Violation|1
7335168|NCT00839423|11570596|FG002|Overall Study|Protocol Violation|2
7335169|NCT00839423|11570597|FG003|Overall Study|Protocol Violation|0
7335170|NCT00839423|11570594|FG000|Overall Study|Withdrawal of consent|4
7335171|NCT00839423|11570595|FG001|Overall Study|Withdrawal of consent|0
7335172|NCT00839423|11570596|FG002|Overall Study|Withdrawal of consent|4
7335173|NCT00839423|11570597|FG003|Overall Study|Withdrawal of consent|1
7335174|NCT00839423|11570594|FG000|Overall Study|Lost to Follow-up|1
7335175|NCT00839423|11570595|FG001|Overall Study|Lost to Follow-up|0
7335176|NCT00839423|11570596|FG002|Overall Study|Lost to Follow-up|1
7335177|NCT00839423|11570597|FG003|Overall Study|Lost to Follow-up|0
7335178|NCT00839423|11570594|FG000|Overall Study|Administrative or other reasons|3
7335179|NCT00839423|11570595|FG001|Overall Study|Administrative or other reasons|0
7335180|NCT00839423|11570596|FG002|Overall Study|Administrative or other reasons|1
7335181|NCT00839423|11570597|FG003|Overall Study|Administrative or other reasons|0
7335182|NCT00839436|11570610|FG000|Overall Study|Developed exclusionary condition|1
7335183|NCT00839436|11570611|FG001|Overall Study|Developed exclusionary condition|0
7335184|NCT00839436|11570612|FG002|Overall Study|Developed exclusionary condition|0
7335185|NCT00839436|11570610|FG000|Overall Study|Withdrawal by Subject|0
7335186|NCT00839436|11570611|FG001|Overall Study|Withdrawal by Subject|1
7335187|NCT00839436|11570612|FG002|Overall Study|Withdrawal by Subject|0
7335188|NCT00839436|11570610|FG000|Overall Study|Study drug no longer available|0
7335189|NCT00839436|11570611|FG001|Overall Study|Study drug no longer available|0
7335190|NCT00839436|11570612|FG002|Overall Study|Study drug no longer available|1
7335191|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7335192|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
7335193|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
7335347|NCT00840996|11570783|FG001|Overall Study|Withdrawal by Subject|0
7335194|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
7335195|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
7335196|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
7335197|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
7335198|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
7335199|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
7335200|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
7335201|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
7335202|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7335203|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
7335204|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
7335205|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
7335206|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7335207|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
7335208|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
7335209|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
7335210|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
7335211|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
7335212|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
7335213|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
7335214|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
7335215|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7335216|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
7335217|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
7335218|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7335219|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7335220|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7335221|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
7335222|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
7335223|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
7335224|NCT00839527|11570623|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7335225|NCT00839527|11570624|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
7335226|NCT00839527|11570625|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
7335227|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7335228|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
7335229|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7335230|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7335231|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7335232|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
7335233|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
7335234|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
7335235|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
7335236|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
7335237|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
7335238|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
7335239|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7335240|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
7335241|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7335242|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
7335243|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
7335244|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
7335245|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
7335246|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7335247|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
7335248|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
7335249|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7335250|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
7335251|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7335252|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
7335253|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
7335254|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7335255|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
7458006|NCT01804582|11751892|FG000|Overall Study|Lost to Follow-up|47
7335256|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
7335257|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7335258|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
7335259|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
7335260|NCT00839527|11570623|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
7335261|NCT00839527|11570624|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7335262|NCT00839527|11570625|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
7335263|NCT00839800|11570650|FG000|Overall Study|Adverse Event|8
7335264|NCT00839800|11570651|FG001|Overall Study|Adverse Event|12
7335265|NCT00839800|11570650|FG000|Overall Study|Lost to Follow-up|31
7335266|NCT00839800|11570651|FG001|Overall Study|Lost to Follow-up|26
7335267|NCT00839800|11570650|FG000|Overall Study|Withdrawal by Subject|28
7335268|NCT00839800|11570651|FG001|Overall Study|Withdrawal by Subject|34
7335269|NCT00839800|11570650|FG000|Overall Study|Incorrect Enrolment|3
7335270|NCT00839800|11570651|FG001|Overall Study|Incorrect Enrolment|3
7335271|NCT00839800|11570650|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
7335272|NCT00839800|11570651|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
7335273|NCT00839800|11570650|FG000|Overall Study|Safety Reasons|2
7335274|NCT00839800|11570651|FG001|Overall Study|Safety Reasons|1
7335275|NCT00839800|11570650|FG000|Overall Study|Other|8
7335276|NCT00839800|11570651|FG001|Overall Study|Other|14
7335277|NCT00839800|11570650|FG000|Overall Study|Severe Non-Compliance to Protocol|7
7335278|NCT00839800|11570651|FG001|Overall Study|Severe Non-Compliance to Protocol|7
7335279|NCT00839852|11570657|FG000|Overall Study|Adverse Event|10
7335280|NCT00839852|11570657|FG000|Overall Study|Insufficient Therapeutic Response|3
7335281|NCT00839852|11570657|FG000|Overall Study|Protocol Violation|9
7335282|NCT00839852|11570657|FG000|Overall Study|Withdrawal of Consent|16
7335283|NCT00839852|11570657|FG000|Overall Study|Lost to Follow-up|7
7335284|NCT00839852|11570657|FG000|Overall Study|Lack of Compliance While in Jail|1
7335285|NCT00839852|11570657|FG000|Overall Study|Pregnancy|1
7335286|NCT00839917|11570663|FG000|Overall Study|Lost to Follow-up|1
7335287|NCT00839917|11570664|FG001|Overall Study|Lost to Follow-up|0
7335288|NCT00839917|11570663|FG000|Overall Study|Did not receive vaccine|0
7335289|NCT00839917|11570664|FG001|Overall Study|Did not receive vaccine|1
7335290|NCT00839956|11570670|FG000|Overall Study|Adverse Event|2
7335291|NCT00839956|11570670|FG000|Overall Study|Lack of Efficacy|6
7335292|NCT00839956|11570670|FG000|Overall Study|Physician Decision|1
7335293|NCT00839956|11570670|FG000|Overall Study|Withdrawal by Subject|3
7335294|NCT00840034|11570687|FG000|Acute Treatment Phase|Adverse Event|6
7335295|NCT00840034|11570688|FG001|Acute Treatment Phase|Adverse Event|8
7335296|NCT00840034|11570687|FG000|Acute Treatment Phase|Lack of Efficacy|2
7335297|NCT00840034|11570688|FG001|Acute Treatment Phase|Lack of Efficacy|0
7335298|NCT00840034|11570687|FG000|Acute Treatment Phase|Lost to Follow-up|5
7335299|NCT00840034|11570688|FG001|Acute Treatment Phase|Lost to Follow-up|12
7335300|NCT00840034|11570687|FG000|Acute Treatment Phase|Physician Decision|0
7335301|NCT00840034|11570688|FG001|Acute Treatment Phase|Physician Decision|1
7335302|NCT00840034|11570687|FG000|Acute Treatment Phase|Protocol Violation|2
7335303|NCT00840034|11570688|FG001|Acute Treatment Phase|Protocol Violation|4
7335304|NCT00840034|11570687|FG000|Acute Treatment Phase|Withdrawal by Subject|6
7335305|NCT00840034|11570688|FG001|Acute Treatment Phase|Withdrawal by Subject|11
7335306|NCT00840034|11570687|FG000|Taper Phase|Adverse Event|1
7335307|NCT00840034|11570688|FG001|Taper Phase|Adverse Event|0
7335308|NCT00840034|11570687|FG000|Taper Phase|Lost to Follow-up|1
7335309|NCT00840034|11570688|FG001|Taper Phase|Lost to Follow-up|1
7335310|NCT00840034|11570687|FG000|Taper Phase|Withdrawal by Subject|1
7335311|NCT00840034|11570688|FG001|Taper Phase|Withdrawal by Subject|1
7335312|NCT00840060|11570698|FG000|Overall Study|Withdrawal by Subject|1
7335313|NCT00840060|11570699|FG001|Overall Study|Withdrawal by Subject|0
7335314|NCT00840060|11570698|FG000|Overall Study|Change in emotional/behavioral status|0
7335315|NCT00840060|11570699|FG001|Overall Study|Change in emotional/behavioral status|1
7335316|NCT00840086|11570705|FG000|Overall Study|Adverse Event|1
7335317|NCT00840086|11570705|FG000|Overall Study|Protocol Violation|2
7335318|NCT00840086|11570705|FG000|Overall Study|Lost to Follow-up|1
7335319|NCT00840294|11570714|FG000|Overall Study|Withdrawal by Subject|2
7335320|NCT00840294|11570715|FG001|Overall Study|Withdrawal by Subject|1
7335321|NCT00840294|11570714|FG000|Overall Study|Protocol Violation|1
7335322|NCT00840294|11570715|FG001|Overall Study|Protocol Violation|3
7335323|NCT00840294|11570714|FG000|Overall Study|Illness|0
7335324|NCT00840294|11570715|FG001|Overall Study|Illness|1
7335325|NCT00840450|11570725|FG000|Overall Study|Adverse Event|1
7335326|NCT00840450|11570725|FG000|Overall Study|Lack of Efficacy|2
7335327|NCT00840463|11570731|FG000|Overall Study|Adverse Event|1
7335328|NCT00840463|11570732|FG001|Overall Study|Adverse Event|0
7335329|NCT00840658|11570742|FG000|Overall Study|Death|2
7335330|NCT00840658|11570743|FG001|Overall Study|Death|2
7335331|NCT00840658|11570744|FG002|Overall Study|Death|3
7335332|NCT00840658|11570745|FG003|Overall Study|Death|3
7335333|NCT00840658|11570742|FG000|Overall Study|Lost to Follow-up|3
7335334|NCT00840658|11570743|FG001|Overall Study|Lost to Follow-up|1
7335335|NCT00840658|11570744|FG002|Overall Study|Lost to Follow-up|2
7335336|NCT00840658|11570745|FG003|Overall Study|Lost to Follow-up|1
7335337|NCT00840749|11570761|FG000|Overall Study|Death|1
7335338|NCT00840749|11570762|FG001|Overall Study|Death|2
7335339|NCT00840749|11570761|FG000|Overall Study|not treated on study arm|11
7335340|NCT00840749|11570762|FG001|Overall Study|not treated on study arm|11
7335341|NCT00840749|11570761|FG000|Overall Study|study closed|19
7335342|NCT00840749|11570762|FG001|Overall Study|study closed|14
7335343|NCT00840970|11570768|FG000|Overall Study|Adverse Event|0
7335344|NCT00840970|11570769|FG001|Overall Study|Adverse Event|0
7335345|NCT00840970|11570770|FG002|Overall Study|Adverse Event|1
7335346|NCT00840996|11570782|FG000|Overall Study|Withdrawal by Subject|1
7335348|NCT00841100|11570798|FG000|Phase 1 (28 Days)|Adverse Event|1
7335349|NCT00841100|11570798|FG000|Phase 1 (28 Days)|Participant non-compliance|2
7335350|NCT00841321|11570823|FG000|Overall Study|Lost to Follow-up|1
7335351|NCT00841321|11570824|FG001|Overall Study|Lost to Follow-up|1
7335352|NCT00841321|11570823|FG000|Overall Study|Adverse Event|0
7335353|NCT00841321|11570824|FG001|Overall Study|Adverse Event|2
7335354|NCT00841568|11570848|FG000|Overall Study|Adverse Event|1
7335355|NCT00841568|11570848|FG000|Overall Study|Death|1
7335356|NCT00841568|11570848|FG000|Overall Study|Withdrawal by Subject|2
7335357|NCT00841568|11570848|FG000|Overall Study|Creatinine over the withdrawal criteria|1
7335358|NCT00841672|11570858|FG000|Overall Study|Adverse Event|7
7335359|NCT00841672|11570859|FG001|Overall Study|Adverse Event|16
7335360|NCT00841672|11570858|FG000|Overall Study|Abnormal test procedure result(s)|0
7335361|NCT00841672|11570859|FG001|Overall Study|Abnormal test procedure result(s)|1
7335362|NCT00841672|11570858|FG000|Overall Study|Subject withdrew consent|2
7335363|NCT00841672|11570859|FG001|Overall Study|Subject withdrew consent|4
7335364|NCT00841672|11570858|FG000|Overall Study|Lost to Follow-up|1
7335365|NCT00841672|11570859|FG001|Overall Study|Lost to Follow-up|1
7335366|NCT00841672|11570858|FG000|Overall Study|Administrative problems|9
7335367|NCT00841672|11570859|FG001|Overall Study|Administrative problems|9
7335368|NCT00841672|11570858|FG000|Overall Study|Misrandomized|1
7335369|NCT00841672|11570859|FG001|Overall Study|Misrandomized|0
7335370|NCT00841672|11570858|FG000|Overall Study|Protocol Deviation|0
7335371|NCT00841672|11570859|FG001|Overall Study|Protocol Deviation|1
7335372|NCT00841763|11570867|FG000|Overall Study|Withdrawal by Subject|60
7335373|NCT00841763|11570868|FG001|Overall Study|Withdrawal by Subject|17
7335374|NCT00841763|11570869|FG002|Overall Study|Withdrawal by Subject|4
7335375|NCT00841763|11570870|FG003|Overall Study|Withdrawal by Subject|1
7335376|NCT00841763|11570867|FG000|Overall Study|Adverse Event|9
7335377|NCT00841763|11570868|FG001|Overall Study|Adverse Event|10
7335378|NCT00841763|11570869|FG002|Overall Study|Adverse Event|3
7335379|NCT00841763|11570870|FG003|Overall Study|Adverse Event|2
7335380|NCT00841763|11570867|FG000|Overall Study|Lost to Follow-up|63
7335381|NCT00841763|11570868|FG001|Overall Study|Lost to Follow-up|25
7335382|NCT00841763|11570869|FG002|Overall Study|Lost to Follow-up|0
7335383|NCT00841763|11570870|FG003|Overall Study|Lost to Follow-up|0
7335384|NCT00841763|11570867|FG000|Overall Study|Protocol Violation|20
7335385|NCT00841763|11570868|FG001|Overall Study|Protocol Violation|3
7335386|NCT00841763|11570869|FG002|Overall Study|Protocol Violation|1
7335387|NCT00841763|11570870|FG003|Overall Study|Protocol Violation|0
7335388|NCT00841763|11570867|FG000|Overall Study|Administrative Reasons|3
7335389|NCT00841763|11570868|FG001|Overall Study|Administrative Reasons|1
7335390|NCT00841763|11570869|FG002|Overall Study|Administrative Reasons|0
7335391|NCT00841763|11570870|FG003|Overall Study|Administrative Reasons|0
7335392|NCT00841763|11570867|FG000|Overall Study|Unable to Classify|7
7335393|NCT00841763|11570868|FG001|Overall Study|Unable to Classify|1
7335394|NCT00841763|11570869|FG002|Overall Study|Unable to Classify|0
7335395|NCT00841763|11570870|FG003|Overall Study|Unable to Classify|0
7335396|NCT00841776|11570917|FG000|Overall Study|Lack of Efficacy|0
7335397|NCT00841776|11570918|FG001|Overall Study|Lack of Efficacy|1
7335398|NCT00841776|11570917|FG000|Overall Study|Lost to Follow-up|2
7335399|NCT00841776|11570918|FG001|Overall Study|Lost to Follow-up|1
7335400|NCT00841776|11570917|FG000|Overall Study|Withdrawal by Subject|0
7335401|NCT00841776|11570918|FG001|Overall Study|Withdrawal by Subject|1
7335402|NCT00841906|11570937|FG000|Overall Study|Withdrawal by Subject|2
7335403|NCT00841906|11570938|FG001|Overall Study|Withdrawal by Subject|0
7335404|NCT00842153|11570978|FG000|Overall Study|Adverse Event|0
7335405|NCT00842153|11570979|FG001|Overall Study|Adverse Event|1
7335406|NCT00842153|11570978|FG000|Overall Study|Lost to Follow-up|1
7335407|NCT00842153|11570979|FG001|Overall Study|Lost to Follow-up|2
7568632|NCT03422250|11944119|FG002|Follow-up|Withdrawal by Subject|0
7335408|NCT00842244|11570989|FG000|Overall Study|Death|3
7335409|NCT00842244|11570989|FG000|Overall Study|Withdrawal by Subject|1
7335410|NCT00842244|11570989|FG000|Overall Study|Other|17
7335411|NCT00842257|11570996|FG000|Overall Study|Adverse Event|1
7335412|NCT00842309|11571006|FG000|Overall Study|Withdrawal by Subject|3
7335413|NCT00842309|11571007|FG001|Overall Study|Withdrawal by Subject|1
7335414|NCT00842348|11571021|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
7335415|NCT00842348|11571022|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
7335416|NCT00842348|11571021|FG000|Study 729|Disease progression/death|19
7335417|NCT00842348|11571022|FG001|Study 729|Disease progression/death|30
7568633|NCT03422250|11944120|FG003|Follow-up|Withdrawal by Subject|1
7335418|NCT00842348|11571021|FG000|Study 729|Adverse Event|1
7335419|NCT00842348|11571022|FG001|Study 729|Adverse Event|1
7335420|NCT00842348|11571021|FG000|Study 729|Protocol Violation|1
7335421|NCT00842348|11571022|FG001|Study 729|Protocol Violation|1
7335422|NCT00842348|11571021|FG000|Study 729|Withdrawal by Subject|2
7335423|NCT00842348|11571022|FG001|Study 729|Withdrawal by Subject|4
7335424|NCT00842348|11571021|FG000|Study 729|Due to Sponsor stopping the study|1
7335425|NCT00842348|11571022|FG001|Study 729|Due to Sponsor stopping the study|1
7335426|NCT00842348|11571021|FG000|Study 729|Due to non-availability of IP|0
7335427|NCT00842348|11571022|FG001|Study 729|Due to non-availability of IP|1
7335428|NCT00842348|11571021|FG000|Study 729|Sponsor's decision|1
7335429|NCT00842348|11571022|FG001|Study 729|Sponsor's decision|0
7335430|NCT00842348|11571021|FG000|Study 729|Surgical resection|1
7335431|NCT00842348|11571022|FG001|Study 729|Surgical resection|0
7335432|NCT00842361|11571034|FG000|Overall Study|Protocol Violation|1
7335433|NCT00842361|11571035|FG001|Overall Study|Protocol Violation|0
7335434|NCT00842361|11571034|FG000|Overall Study|Unclassified|0
7335435|NCT00842361|11571035|FG001|Overall Study|Unclassified|2
7335436|NCT00842543|11571045|FG000|Overall Study|Withdrawal by Subject|2
7335437|NCT00842543|11571046|FG001|Overall Study|Withdrawal by Subject|0
7335438|NCT00842543|11571047|FG002|Overall Study|Withdrawal by Subject|3
7335439|NCT00842543|11571048|FG003|Overall Study|Withdrawal by Subject|4
7335440|NCT00842712|11571084|FG000|Safety Run-in Part|Adverse Event|0
7335441|NCT00842712|11571085|FG001|Safety Run-in Part|Adverse Event|1
7335442|NCT00842712|11571086|FG002|Safety Run-in Part|Adverse Event|0
7335443|NCT00842712|11571087|FG003|Safety Run-in Part|Adverse Event|0
7335444|NCT00842712|11571088|FG004|Safety Run-in Part|Adverse Event|0
7335445|NCT00842712|11571089|FG005|Safety Run-in Part|Adverse Event|0
7335446|NCT00842712|11571090|FG006|Safety Run-in Part|Adverse Event|0
7335447|NCT00842712|11571084|FG000|Safety Run-in Part|Progressive disease|3
7335448|NCT00842712|11571085|FG001|Safety Run-in Part|Progressive disease|1
7335449|NCT00842712|11571086|FG002|Safety Run-in Part|Progressive disease|0
7335450|NCT00842712|11571087|FG003|Safety Run-in Part|Progressive disease|1
7335451|NCT00842712|11571088|FG004|Safety Run-in Part|Progressive disease|0
7335452|NCT00842712|11571089|FG005|Safety Run-in Part|Progressive disease|0
7335453|NCT00842712|11571090|FG006|Safety Run-in Part|Progressive disease|0
7335454|NCT00842712|11571084|FG000|Randomized Part|Randomized but not treated|0
7335455|NCT00842712|11571085|FG001|Randomized Part|Randomized but not treated|0
7335456|NCT00842712|11571086|FG002|Randomized Part|Randomized but not treated|0
7335457|NCT00842712|11571087|FG003|Randomized Part|Randomized but not treated|0
7335458|NCT00842712|11571088|FG004|Randomized Part|Randomized but not treated|0
7335459|NCT00842712|11571089|FG005|Randomized Part|Randomized but not treated|1
7335460|NCT00842712|11571090|FG006|Randomized Part|Randomized but not treated|4
7335461|NCT00842712|11571084|FG000|Randomized Part|Ongoing at cut-off date|0
7335462|NCT00842712|11571085|FG001|Randomized Part|Ongoing at cut-off date|0
7335463|NCT00842712|11571086|FG002|Randomized Part|Ongoing at cut-off date|0
7335464|NCT00842712|11571087|FG003|Randomized Part|Ongoing at cut-off date|0
7335465|NCT00842712|11571088|FG004|Randomized Part|Ongoing at cut-off date|0
7335466|NCT00842712|11571089|FG005|Randomized Part|Ongoing at cut-off date|0
7335467|NCT00842712|11571090|FG006|Randomized Part|Ongoing at cut-off date|2
7335468|NCT00842829|11571125|FG000|Dose Titration Period|Adverse Event|11
7335469|NCT00842829|11571126|FG001|Dose Titration Period|Adverse Event|10
7335470|NCT00842829|11571127|FG002|Dose Titration Period|Adverse Event|0
7335471|NCT00842829|11571125|FG000|Dose Titration Period|Lack of Efficacy|4
7335472|NCT00842829|11571126|FG001|Dose Titration Period|Lack of Efficacy|1
7335473|NCT00842829|11571127|FG002|Dose Titration Period|Lack of Efficacy|0
7335474|NCT00842829|11571125|FG000|Dose Titration Period|Unstable persistent cancer pain|1
7335475|NCT00842829|11571126|FG001|Dose Titration Period|Unstable persistent cancer pain|0
7335476|NCT00842829|11571127|FG002|Dose Titration Period|Unstable persistent cancer pain|0
7335477|NCT00842829|11571125|FG000|Dose Titration Period|Withdrawal by Subject|2
7335478|NCT00842829|11571126|FG001|Dose Titration Period|Withdrawal by Subject|6
7335479|NCT00842829|11571127|FG002|Dose Titration Period|Withdrawal by Subject|0
7335480|NCT00842829|11571125|FG000|Dose Titration Period|Other|5
7335481|NCT00842829|11571126|FG001|Dose Titration Period|Other|4
7335482|NCT00842829|11571127|FG002|Dose Titration Period|Other|0
7335483|NCT00842829|11571125|FG000|Dose Titration Period|Non-compliance to study procedures|1
7335484|NCT00842829|11571126|FG001|Dose Titration Period|Non-compliance to study procedures|1
7335485|NCT00842829|11571127|FG002|Dose Titration Period|Non-compliance to study procedures|0
7335486|NCT00842829|11571125|FG000|Dose Titration Period|Non-compliance to study drug|2
7335487|NCT00842829|11571126|FG001|Dose Titration Period|Non-compliance to study drug|1
7335488|NCT00842829|11571127|FG002|Dose Titration Period|Non-compliance to study drug|0
7335489|NCT00842829|11571125|FG000|Treatment Period|Adverse Event|0
7335490|NCT00842829|11571126|FG001|Treatment Period|Adverse Event|0
7335491|NCT00842829|11571127|FG002|Treatment Period|Adverse Event|15
7335492|NCT00842829|11571125|FG000|Treatment Period|Lack of Efficacy|0
7335493|NCT00842829|11571126|FG001|Treatment Period|Lack of Efficacy|0
7335494|NCT00842829|11571127|FG002|Treatment Period|Lack of Efficacy|6
7335495|NCT00842829|11571125|FG000|Treatment Period|Unstable persistent cancer pain|0
7335496|NCT00842829|11571126|FG001|Treatment Period|Unstable persistent cancer pain|0
7335497|NCT00842829|11571127|FG002|Treatment Period|Unstable persistent cancer pain|5
7335498|NCT00842829|11571125|FG000|Treatment Period|Withdrawal by Subject|0
7335499|NCT00842829|11571126|FG001|Treatment Period|Withdrawal by Subject|0
7335500|NCT00842829|11571127|FG002|Treatment Period|Withdrawal by Subject|11
7335501|NCT00842829|11571125|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
7335502|NCT00842829|11571126|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
7335503|NCT00842829|11571127|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
7335504|NCT00842829|11571125|FG000|Treatment Period|Protocol Violation|0
7335505|NCT00842829|11571126|FG001|Treatment Period|Protocol Violation|0
7335506|NCT00842829|11571127|FG002|Treatment Period|Protocol Violation|2
7335507|NCT00842829|11571125|FG000|Treatment Period|Other|0
7335508|NCT00842829|11571126|FG001|Treatment Period|Other|0
7335509|NCT00842829|11571127|FG002|Treatment Period|Other|18
7335510|NCT00842829|11571125|FG000|Treatment Period|Non-compliance to study procedures|0
7335511|NCT00842829|11571126|FG001|Treatment Period|Non-compliance to study procedures|0
7335512|NCT00842829|11571127|FG002|Treatment Period|Non-compliance to study procedures|4
7335513|NCT00842829|11571125|FG000|Treatment Period|Unclear completion status|0
7335514|NCT00842829|11571126|FG001|Treatment Period|Unclear completion status|0
7335515|NCT00842829|11571127|FG002|Treatment Period|Unclear completion status|1
7335516|NCT00842829|11571125|FG000|Continuation Period|Adverse Event|0
7335517|NCT00842829|11571126|FG001|Continuation Period|Adverse Event|0
7335518|NCT00842829|11571127|FG002|Continuation Period|Adverse Event|32
7335519|NCT00842829|11571125|FG000|Continuation Period|Lack of Efficacy|0
7335520|NCT00842829|11571126|FG001|Continuation Period|Lack of Efficacy|0
7335521|NCT00842829|11571127|FG002|Continuation Period|Lack of Efficacy|6
7335522|NCT00842829|11571125|FG000|Continuation Period|Unstable persistent cancer pain|0
7335523|NCT00842829|11571126|FG001|Continuation Period|Unstable persistent cancer pain|0
7335524|NCT00842829|11571127|FG002|Continuation Period|Unstable persistent cancer pain|3
7335525|NCT00842829|11571125|FG000|Continuation Period|Withdrawal by Subject|0
7335526|NCT00842829|11571126|FG001|Continuation Period|Withdrawal by Subject|0
7335527|NCT00842829|11571127|FG002|Continuation Period|Withdrawal by Subject|10
7335528|NCT00842829|11571125|FG000|Continuation Period|Other|0
7335529|NCT00842829|11571126|FG001|Continuation Period|Other|0
7335530|NCT00842829|11571127|FG002|Continuation Period|Other|7
7335531|NCT00842829|11571125|FG000|Continuation Period|Non-compliance to study procedures|0
7335532|NCT00842829|11571126|FG001|Continuation Period|Non-compliance to study procedures|0
7335533|NCT00842829|11571127|FG002|Continuation Period|Non-compliance to study procedures|2
7335534|NCT00842829|11571125|FG000|Continuation Period|Non-compliance to study drug|0
7335535|NCT00842829|11571126|FG001|Continuation Period|Non-compliance to study drug|0
7335536|NCT00842829|11571127|FG002|Continuation Period|Non-compliance to study drug|1
7335537|NCT00842985|11571148|FG000|Screening|Did not meet entrance requirements|27
7335538|NCT00842985|11571148|FG000|First Intervention|Withdrawal by Subject|3
7335539|NCT00842985|11571148|FG000|First Intervention|Protocol Violation|3
7335540|NCT00842985|11571148|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
7335541|NCT00842985|11571148|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
7335542|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
7335543|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
7335544|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7335545|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7335546|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7335547|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
7335548|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
7335549|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
7335550|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7335551|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7335552|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7335553|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
7335554|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
7335555|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
7335556|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7335557|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7335558|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7335559|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
7335560|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
7335561|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
7335562|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
7335563|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
7335564|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
7335565|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
7335566|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
7335567|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
7335568|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
7335569|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
7335570|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
7335571|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
7335572|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
7335573|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
7335574|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
7335575|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
7335576|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
7335577|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
7335578|NCT00843024|11571159|FG000|Single-blind Placebo Run-In Phase|Other|0
7335579|NCT00843024|11571160|FG001|Single-blind Placebo Run-In Phase|Other|1
7335580|NCT00843024|11571161|FG002|Single-blind Placebo Run-In Phase|Other|0
7335581|NCT00843024|11571162|FG003|Single-blind Placebo Run-In Phase|Other|0
7335582|NCT00843024|11571163|FG004|Single-blind Placebo Run-In Phase|Other|0
7335583|NCT00843024|11571164|FG005|Single-blind Placebo Run-In Phase|Other|0
7335662|NCT00843284|11571213|FG000|Overall Study|Death|3
7335584|NCT00843024|11571159|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
7335585|NCT00843024|11571160|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
7335586|NCT00843024|11571161|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
7335587|NCT00843024|11571162|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
7335588|NCT00843024|11571163|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
7335589|NCT00843024|11571164|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
7335590|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7335591|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
7335592|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
7335593|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
7335594|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
7335595|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
7335596|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
7335597|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
7335598|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
7335599|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
7335600|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
7335601|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
7335602|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Protocol Violation|0
7335603|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Protocol Violation|0
7335604|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Protocol Violation|3
7335605|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Protocol Violation|0
7335606|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Protocol Violation|0
7335607|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Protocol Violation|3
7335608|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Physician Decision|0
7335609|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Physician Decision|0
7335610|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Physician Decision|0
7335611|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Physician Decision|3
7335612|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Physician Decision|1
7335613|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Physician Decision|1
7335614|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Adverse Event|0
7335615|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Adverse Event|0
7335616|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Adverse Event|0
7335617|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Adverse Event|0
7335618|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Adverse Event|1
7335619|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Adverse Event|1
7335620|NCT00843024|11571159|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
7335621|NCT00843024|11571160|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
7335622|NCT00843024|11571161|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
7335623|NCT00843024|11571162|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
7335624|NCT00843024|11571163|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
7335625|NCT00843024|11571164|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
7335626|NCT00843115|11571177|FG000|Overall Study|Death|4
7335627|NCT00843115|11571177|FG000|Overall Study|Adverse Event|30
7335628|NCT00843115|11571177|FG000|Overall Study|Lost to Follow-up|4
7335629|NCT00843115|11571177|FG000|Overall Study|Withdrawal by Subject|17
7335630|NCT00843115|11571177|FG000|Overall Study|Family wanted meds stopped|1
7335631|NCT00843115|11571177|FG000|Overall Study|Family does not want continuation|1
7335632|NCT00843115|11571177|FG000|Overall Study|Patient forgot to take meds|1
7335633|NCT00843115|11571177|FG000|Overall Study|Does not meet entrance criteria|1
7335634|NCT00843115|11571177|FG000|Overall Study|Physician Decision|1
7335635|NCT00843115|11571177|FG000|Overall Study|Family discontinued meds|1
7335636|NCT00843115|11571177|FG000|Overall Study|patient took for 2 days then stopped|1
7335637|NCT00843115|11571177|FG000|Overall Study|patient never took the medication|1
7335638|NCT00843115|11571177|FG000|Overall Study|hospitalized due to deterioration|1
7335639|NCT00843115|11571177|FG000|Overall Study|week 12 not done|1
7335640|NCT00843115|11571177|FG000|Overall Study|Syndrome De Glissement|1
7335641|NCT00843167|11571183|FG000|Treatment Period|Adverse Event|1
7335642|NCT00843167|11571184|FG001|Treatment Period|Adverse Event|5
7335643|NCT00843167|11571183|FG000|Treatment Period|Withdrawal by Subject|2
7335644|NCT00843167|11571184|FG001|Treatment Period|Withdrawal by Subject|3
7335645|NCT00843193|11571205|FG000|Overall Study|Adverse Event|2
7335646|NCT00843193|11571206|FG001|Overall Study|Adverse Event|4
7335647|NCT00843193|11571205|FG000|Overall Study|Lack of Efficacy|1
7335648|NCT00843193|11571206|FG001|Overall Study|Lack of Efficacy|1
7335649|NCT00843193|11571205|FG000|Overall Study|Protocol Violation|1
7335650|NCT00843193|11571206|FG001|Overall Study|Protocol Violation|2
7335651|NCT00843193|11571205|FG000|Overall Study|Lost to Follow-up|1
7335652|NCT00843193|11571206|FG001|Overall Study|Lost to Follow-up|0
7335653|NCT00843193|11571205|FG000|Overall Study|Physician Decision|0
7335654|NCT00843193|11571206|FG001|Overall Study|Physician Decision|1
7335655|NCT00843193|11571205|FG000|Overall Study|Withdrawal by Subject|3
7335656|NCT00843193|11571206|FG001|Overall Study|Withdrawal by Subject|3
7335657|NCT00843284|11571213|FG000|Overall Study|Adverse Event|39
7335658|NCT00843284|11571213|FG000|Overall Study|Lack of Efficacy|5
7335659|NCT00843284|11571213|FG000|Overall Study|Lost to Follow-up|11
7335660|NCT00843284|11571213|FG000|Overall Study|Other|10
7335661|NCT00843284|11571213|FG000|Overall Study|Withdrawal by Subject|4
7335663|NCT00843492|11571256|FG000|Overall Study|Adverse Event|0
7335664|NCT00843492|11571257|FG001|Overall Study|Adverse Event|3
7335665|NCT00843492|11571256|FG000|Overall Study|Lost to Follow-up|4
7335666|NCT00843492|11571257|FG001|Overall Study|Lost to Follow-up|4
7335667|NCT00843492|11571256|FG000|Overall Study|Withdrawal by Subject|0
7335668|NCT00843492|11571257|FG001|Overall Study|Withdrawal by Subject|4
7335669|NCT00843492|11571256|FG000|Overall Study|Immobilization Stopped|1
7335670|NCT00843492|11571257|FG001|Overall Study|Immobilization Stopped|0
7335671|NCT00843492|11571256|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7335672|NCT00843492|11571257|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
7335673|NCT00843492|11571256|FG000|Overall Study|Orthopedic Surgery|0
7335674|NCT00843492|11571257|FG001|Overall Study|Orthopedic Surgery|2
7335675|NCT00843492|11571256|FG000|Overall Study|Visit Not Performed|1
7335676|NCT00843492|11571257|FG001|Overall Study|Visit Not Performed|0
7335677|NCT00843492|11571256|FG000|Overall Study|Deep-vein Thrombosis|1
7335678|NCT00843492|11571257|FG001|Overall Study|Deep-vein Thrombosis|0
7335679|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
7335680|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
7335681|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Death|0
7335682|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Death|1
7335683|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
7335684|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
7335685|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
7335686|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
7335687|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
7335688|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
7335689|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
7335690|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
7335691|NCT00843518|11571265|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
7335692|NCT00843518|11571266|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
7335693|NCT00843635|11571296|FG000|Overall Study|Adverse Event|2
7335694|NCT00843635|11571297|FG001|Overall Study|Adverse Event|2
7335695|NCT00843635|11571298|FG002|Overall Study|Adverse Event|0
7335696|NCT00843726|11571321|FG000|Overall Study|Death|1
7335697|NCT00843726|11571322|FG001|Overall Study|Death|0
7335698|NCT00843726|11571321|FG000|Overall Study|Withdrawal by Subject|0
7335699|NCT00843726|11571322|FG001|Overall Study|Withdrawal by Subject|1
7335700|NCT00843778|11571329|FG000|Overall Study|Adverse Event|15
7335701|NCT00843778|11571329|FG000|Overall Study|Lack of Efficacy|14
7335702|NCT00843778|11571329|FG000|Overall Study|Loss of efficacy|2
7335703|NCT00843778|11571329|FG000|Overall Study|Withdrawal by Subject|4
7335704|NCT00843843|11571335|FG000|Overall Study|Physician Decision|1
7335705|NCT00843843|11571336|FG001|Overall Study|Physician Decision|1
7335706|NCT00843843|11571335|FG000|Overall Study|Protocol Violation|1
7335707|NCT00843843|11571336|FG001|Overall Study|Protocol Violation|1
7335708|NCT00843856|11571344|FG000|Overall Study|Lost to Follow-up|1
7335709|NCT00843856|11571345|FG001|Overall Study|Lost to Follow-up|2
7335710|NCT00844194|11571371|FG000|Overall Study|Adverse Event|17
7335711|NCT00844194|11571372|FG001|Overall Study|Adverse Event|5
7335712|NCT00844194|11571371|FG000|Overall Study|Protocol Violation|1
7335713|NCT00844194|11571372|FG001|Overall Study|Protocol Violation|1
7335714|NCT00844194|11571371|FG000|Overall Study|Lost to Follow-up|1
7335715|NCT00844194|11571372|FG001|Overall Study|Lost to Follow-up|1
7335716|NCT00844194|11571371|FG000|Overall Study|Withdrawal by Subject|2
7335717|NCT00844194|11571372|FG001|Overall Study|Withdrawal by Subject|1
7335718|NCT00844194|11571371|FG000|Overall Study|Lack of Efficacy|3
7335719|NCT00844194|11571372|FG001|Overall Study|Lack of Efficacy|0
7335720|NCT00844194|11571371|FG000|Overall Study|Other reason (not specified)|1
7335721|NCT00844194|11571372|FG001|Overall Study|Other reason (not specified)|0
7335722|NCT00844376|11571386|FG000|Period 1: First Intervention|Withdrawal by Subject|1
7335723|NCT00844376|11571387|FG001|Period 1: First Intervention|Withdrawal by Subject|0
7335724|NCT00844415|11571393|FG000|Overall Study|Withdrawal by Subject|1
7335725|NCT00844428|11571398|FG000|Screening Period|Screen Failure|3
7335726|NCT00844428|11571398|FG000|Extension Treatment Period|Death|1
7335727|NCT00844428|11571398|FG000|Post Treatment Period (Patients Who Disc|Death|1
7335728|NCT00844519|11571404|FG000|Overall Study|Withdrawal by Subject|1
7335729|NCT00844519|11571405|FG001|Overall Study|Withdrawal by Subject|1
7335730|NCT00844519|11571404|FG000|Overall Study|Adverse Event|1
7335731|NCT00844519|11571405|FG001|Overall Study|Adverse Event|0
7335732|NCT00844532|11571411|FG000|Overall Study|Death|16
7335733|NCT00844532|11571411|FG000|Overall Study|Withdrawal by Subject|16
7335734|NCT00844532|11571411|FG000|Overall Study|Lost to Follow-up|7
7335735|NCT00844545|11571415|FG000|Treatment Period (26 Weeks)|Adverse Event|1
7335736|NCT00844545|11571415|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
7335737|NCT00844545|11571415|FG000|Extension Treatment Period|Adverse Event|2
7335738|NCT00844545|11571415|FG000|Post Treatment Period|Withdrawal by Subject|1
7335739|NCT00844558|11571422|FG000|Overall Study|Withdrawal by Subject|9
7335740|NCT00844558|11571423|FG001|Overall Study|Withdrawal by Subject|2
7335741|NCT00844558|11571422|FG000|Overall Study|Death|1
7335742|NCT00844558|11571423|FG001|Overall Study|Death|0
7335743|NCT00844558|11571422|FG000|Overall Study|Protocol Violation|1
7335744|NCT00844558|11571423|FG001|Overall Study|Protocol Violation|1
7335745|NCT00844558|11571422|FG000|Overall Study|Lost to Follow-up|0
7335746|NCT00844558|11571423|FG001|Overall Study|Lost to Follow-up|1
7335747|NCT00844558|11571422|FG000|Overall Study|Physician Decision|1
7335748|NCT00844558|11571423|FG001|Overall Study|Physician Decision|0
7335749|NCT00844597|11571440|FG000|Overall Study|Adverse Event|0
7335750|NCT00844597|11571441|FG001|Overall Study|Adverse Event|0
7335751|NCT00844597|11571442|FG002|Overall Study|Adverse Event|0
7335752|NCT00844597|11571443|FG003|Overall Study|Adverse Event|1
7335753|NCT00844597|11571444|FG004|Overall Study|Adverse Event|0
7335754|NCT00844597|11571445|FG005|Overall Study|Adverse Event|0
7335755|NCT00844649|11571463|FG000|Overall Study|Progressive Disease|196
7335756|NCT00844649|11571464|FG001|Overall Study|Progressive Disease|245
7335757|NCT00844649|11571463|FG000|Overall Study|Adverse Event|128
7335758|NCT00844649|11571464|FG001|Overall Study|Adverse Event|73
7335759|NCT00844649|11571463|FG000|Overall Study|Physician Decision|25
7335760|NCT00844649|11571464|FG001|Overall Study|Physician Decision|18
7335761|NCT00844649|11571463|FG000|Overall Study|Protocol Violation|10
7335762|NCT00844649|11571464|FG001|Overall Study|Protocol Violation|6
7335763|NCT00844649|11571463|FG000|Overall Study|Withdrawal by Subject|28
7335764|NCT00844649|11571464|FG001|Overall Study|Withdrawal by Subject|39
7335765|NCT00844649|11571463|FG000|Overall Study|Other|7
7335766|NCT00844649|11571464|FG001|Overall Study|Other|10
7335767|NCT00844649|11571463|FG000|Overall Study|Withdrew prior to starting treatment|11
7335768|NCT00844649|11571464|FG001|Overall Study|Withdrew prior to starting treatment|27
7335769|NCT00844753|11571480|FG000|Overall Study|Lack of Efficacy|1
7335770|NCT00844753|11571481|FG001|Overall Study|Lack of Efficacy|0
7335771|NCT00844753|11571482|FG002|Overall Study|Lack of Efficacy|2
7335772|NCT00844753|11571483|FG003|Overall Study|Lack of Efficacy|2
7335773|NCT00844753|11571480|FG000|Overall Study|Adverse Event|3
7335774|NCT00844753|11571481|FG001|Overall Study|Adverse Event|2
7335775|NCT00844753|11571482|FG002|Overall Study|Adverse Event|5
7335776|NCT00844753|11571483|FG003|Overall Study|Adverse Event|5
7335777|NCT00844753|11571480|FG000|Overall Study|Lost to Follow-up|1
7335778|NCT00844753|11571481|FG001|Overall Study|Lost to Follow-up|1
7335779|NCT00844753|11571482|FG002|Overall Study|Lost to Follow-up|0
7335780|NCT00844753|11571483|FG003|Overall Study|Lost to Follow-up|1
7335781|NCT00844753|11571480|FG000|Overall Study|could not swallow medication|2
7335782|NCT00844753|11571481|FG001|Overall Study|could not swallow medication|0
7335783|NCT00844753|11571482|FG002|Overall Study|could not swallow medication|0
7335784|NCT00844753|11571483|FG003|Overall Study|could not swallow medication|0
7335785|NCT00844753|11571480|FG000|Overall Study|Withdrawal by Subject|1
7335786|NCT00844753|11571481|FG001|Overall Study|Withdrawal by Subject|0
7335787|NCT00844753|11571482|FG002|Overall Study|Withdrawal by Subject|0
7335788|NCT00844753|11571483|FG003|Overall Study|Withdrawal by Subject|3
7335789|NCT00844805|11571493|FG000|Treatment Phase|Adverse Event|5
7335790|NCT00844805|11571494|FG001|Treatment Phase|Adverse Event|1
7335791|NCT00844805|11571495|FG002|Treatment Phase|Adverse Event|0
7335792|NCT00844805|11571496|FG003|Treatment Phase|Adverse Event|0
7335793|NCT00844805|11571493|FG000|Treatment Phase|Withdrawal by Subject|3
7335794|NCT00844805|11571494|FG001|Treatment Phase|Withdrawal by Subject|4
7335795|NCT00844805|11571495|FG002|Treatment Phase|Withdrawal by Subject|0
7335796|NCT00844805|11571496|FG003|Treatment Phase|Withdrawal by Subject|0
7335797|NCT00844805|11571493|FG000|Treatment Phase|Noncompliance With Protocol|1
7335798|NCT00844805|11571494|FG001|Treatment Phase|Noncompliance With Protocol|0
7335799|NCT00844805|11571495|FG002|Treatment Phase|Noncompliance With Protocol|0
7335800|NCT00844805|11571496|FG003|Treatment Phase|Noncompliance With Protocol|0
7335801|NCT00844805|11571493|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
7335802|NCT00844805|11571494|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
7335803|NCT00844805|11571495|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
7335804|NCT00844805|11571496|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
7335805|NCT00844805|11571493|FG000|Follow-Up Phase|Adverse Event|0
7335806|NCT00844805|11571494|FG001|Follow-Up Phase|Adverse Event|0
7335807|NCT00844805|11571495|FG002|Follow-Up Phase|Adverse Event|1
7335808|NCT00844805|11571496|FG003|Follow-Up Phase|Adverse Event|0
7335809|NCT00844805|11571493|FG000|Follow-Up Phase|Withdrawal by Subject|0
7335810|NCT00844805|11571494|FG001|Follow-Up Phase|Withdrawal by Subject|0
7335811|NCT00844805|11571495|FG002|Follow-Up Phase|Withdrawal by Subject|6
7458007|NCT01804582|11751893|FG001|Overall Study|Lost to Follow-up|56
7335812|NCT00844805|11571496|FG003|Follow-Up Phase|Withdrawal by Subject|3
7335813|NCT00844805|11571493|FG000|Follow-Up Phase|Noncompliance With Protocol|0
7335814|NCT00844805|11571494|FG001|Follow-Up Phase|Noncompliance With Protocol|0
7335815|NCT00844805|11571495|FG002|Follow-Up Phase|Noncompliance With Protocol|0
7335816|NCT00844805|11571496|FG003|Follow-Up Phase|Noncompliance With Protocol|1
7335817|NCT00844805|11571493|FG000|Follow-Up Phase|Relapse/Recurrence|0
7335818|NCT00844805|11571494|FG001|Follow-Up Phase|Relapse/Recurrence|0
7335819|NCT00844805|11571495|FG002|Follow-Up Phase|Relapse/Recurrence|2
7225228|NCT00064701|11434644|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
7225229|NCT00064701|11434642|FG000|Clinical Continuation Phase|Discharged to nursing home|0
7225230|NCT00064701|11434643|FG001|Clinical Continuation Phase|Discharged to nursing home|1
7225231|NCT00064701|11434644|FG002|Clinical Continuation Phase|Discharged to nursing home|0
7335820|NCT00844805|11571496|FG003|Follow-Up Phase|Relapse/Recurrence|4
7458008|NCT01804582|11751892|FG000|Overall Study|Physician Decision|2
7458009|NCT01804582|11751893|FG001|Overall Study|Physician Decision|0
7458010|NCT01804673|11751900|FG000|Overall Study|Adverse Event|4
7458011|NCT01804673|11751900|FG000|Overall Study|Withdrawal by Subject|1
7458012|NCT01804673|11751900|FG000|Overall Study|Lack of Efficacy|9
7458013|NCT01804673|11751900|FG000|Overall Study|Change to Oral Therapy|37
7335821|NCT00844805|11571493|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7335822|NCT00844805|11571494|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7335823|NCT00844805|11571495|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
7335824|NCT00844805|11571496|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
7335825|NCT00844831|11571507|FG000|Overall Study|Withdrawal by Subject|4
7335826|NCT00844831|11571507|FG000|Overall Study|Adverse Event|1
7335827|NCT00844831|11571507|FG000|Overall Study|Physician Decision|1
7335828|NCT00844844|11571515|FG000|Treatment Period (26 Weeks)|Adverse Event|1
7335829|NCT00844844|11571515|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
7335830|NCT00844844|11571515|FG000|Extension Treatment Period|Adverse Event|2
7335831|NCT00844844|11571515|FG000|Post Treatment Period|Withdrawal by Subject|1
7335832|NCT00844857|11571521|FG000|Overall Study|Adverse Event|24
7335833|NCT00844857|11571522|FG001|Overall Study|Adverse Event|5
7335834|NCT00844857|11571521|FG000|Overall Study|Sponsor Decision|1
7335835|NCT00844857|11571522|FG001|Overall Study|Sponsor Decision|1
7335836|NCT00844857|11571521|FG000|Overall Study|Physician Decision|2
7335837|NCT00844857|11571522|FG001|Overall Study|Physician Decision|0
7335838|NCT00844857|11571521|FG000|Overall Study|Parent/Caregiver Decision|6
7335839|NCT00844857|11571522|FG001|Overall Study|Parent/Caregiver Decision|2
7335840|NCT00844857|11571521|FG000|Overall Study|Withdrawal by Subject|8
7335841|NCT00844857|11571522|FG001|Overall Study|Withdrawal by Subject|7
7335842|NCT00844857|11571521|FG000|Overall Study|Protocol Violation|6
7335843|NCT00844857|11571522|FG001|Overall Study|Protocol Violation|0
7335844|NCT00844857|11571521|FG000|Overall Study|Lack of Efficacy|5
7335845|NCT00844857|11571522|FG001|Overall Study|Lack of Efficacy|5
7335846|NCT00844857|11571521|FG000|Overall Study|Clinical Relapse|0
7335847|NCT00844857|11571522|FG001|Overall Study|Clinical Relapse|1
7335848|NCT00844857|11571521|FG000|Overall Study|Entry Criteria Not Met|0
7335849|NCT00844857|11571522|FG001|Overall Study|Entry Criteria Not Met|1
7335850|NCT00844857|11571521|FG000|Overall Study|Lost to Follow-up|2
7335851|NCT00844857|11571522|FG001|Overall Study|Lost to Follow-up|3
7335852|NCT00844857|11571521|FG000|Overall Study|Did Not Take Study Drug|3
7335853|NCT00844857|11571522|FG001|Overall Study|Did Not Take Study Drug|1
7335854|NCT00844857|11571521|FG000|Overall Study|Good Clinical Practice Violations|21
7335855|NCT00844857|11571522|FG001|Overall Study|Good Clinical Practice Violations|11
7335856|NCT00844883|11571531|FG000|Overall Study|Bridged to liver transplant|3
7335857|NCT00844883|11571531|FG000|Overall Study|Bridged to resection|1
7335858|NCT00844896|11571537|FG000|Overall Study|Lost to Follow-up|12
7335859|NCT00844896|11571538|FG001|Overall Study|Lost to Follow-up|16
7335860|NCT00844896|11571537|FG000|Overall Study|Parents did not have time to complete|0
7335861|NCT00844896|11571538|FG001|Overall Study|Parents did not have time to complete|1
7335862|NCT00845065|11571577|FG000|Overall Study|Adverse Event|3
7335863|NCT00845065|11571578|FG001|Overall Study|Adverse Event|23
7335864|NCT00845065|11571577|FG000|Overall Study|Lack of Efficacy|43
7335865|NCT00845065|11571578|FG001|Overall Study|Lack of Efficacy|21
7335866|NCT00845065|11571577|FG000|Overall Study|Non-Medical Reasons|1
7335867|NCT00845065|11571578|FG001|Overall Study|Non-Medical Reasons|11
7385478|NCT01201915|11643256|FG002|Overall Study|Subject Decision|5
7385479|NCT01201915|11643254|FG000|Overall Study|Target Lesion Progression|0
7385480|NCT01201915|11643255|FG001|Overall Study|Target Lesion Progression|3
7385481|NCT01201915|11643256|FG002|Overall Study|Target Lesion Progression|0
7385482|NCT01201967|11643266|FG000|Overall Study|Lost to Follow-up|6
7385483|NCT01201967|11643267|FG001|Overall Study|Lost to Follow-up|5
7385484|NCT01202175|11643298|FG000|Overall Study|Lost to Follow-up|2
7385485|NCT01202175|11643298|FG000|Overall Study|Withdrawal by Subject|1
7385486|NCT01202175|11643298|FG000|Overall Study|Adverse Event|2
7385487|NCT01202188|11643308|FG000|Overall Study|Protocol deviation|14
7385488|NCT01202188|11643309|FG001|Overall Study|Protocol deviation|8
7385489|NCT01202188|11643310|FG002|Overall Study|Protocol deviation|12
7385490|NCT01202188|11643311|FG003|Overall Study|Protocol deviation|10
7385491|NCT01202188|11643312|FG004|Overall Study|Protocol deviation|11
7385492|NCT01202188|11643308|FG000|Overall Study|Subject withdrew consent|12
7385493|NCT01202188|11643309|FG001|Overall Study|Subject withdrew consent|13
7385494|NCT01202188|11643310|FG002|Overall Study|Subject withdrew consent|22
7385495|NCT01202188|11643311|FG003|Overall Study|Subject withdrew consent|11
7385496|NCT01202188|11643312|FG004|Overall Study|Subject withdrew consent|13
7385497|NCT01202188|11643308|FG000|Overall Study|Adverse Event|5
7385498|NCT01202188|11643309|FG001|Overall Study|Adverse Event|23
7385499|NCT01202188|11643310|FG002|Overall Study|Adverse Event|13
7385500|NCT01202188|11643311|FG003|Overall Study|Adverse Event|10
7385501|NCT01202188|11643312|FG004|Overall Study|Adverse Event|10
7385502|NCT01202188|11643308|FG000|Overall Study|Administrative problems|3
7385503|NCT01202188|11643309|FG001|Overall Study|Administrative problems|2
7385504|NCT01202188|11643310|FG002|Overall Study|Administrative problems|1
7385505|NCT01202188|11643311|FG003|Overall Study|Administrative problems|1
7385506|NCT01202188|11643312|FG004|Overall Study|Administrative problems|2
7385507|NCT01202188|11643308|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7385508|NCT01202188|11643309|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7385509|NCT01202188|11643310|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7385510|NCT01202188|11643311|FG003|Overall Study|Unsatisfactory therapeutic effect|5
7385511|NCT01202188|11643312|FG004|Overall Study|Unsatisfactory therapeutic effect|8
7385512|NCT01202188|11643308|FG000|Overall Study|Lost to Follow-up|1
7385513|NCT01202188|11643309|FG001|Overall Study|Lost to Follow-up|1
7385514|NCT01202188|11643310|FG002|Overall Study|Lost to Follow-up|0
7385515|NCT01202188|11643311|FG003|Overall Study|Lost to Follow-up|4
7385516|NCT01202188|11643312|FG004|Overall Study|Lost to Follow-up|1
7385517|NCT01202188|11643308|FG000|Overall Study|Death|1
7385518|NCT01202188|11643309|FG001|Overall Study|Death|1
7385519|NCT01202188|11643310|FG002|Overall Study|Death|1
7385520|NCT01202188|11643311|FG003|Overall Study|Death|1
7385521|NCT01202188|11643312|FG004|Overall Study|Death|0
7385522|NCT01202188|11643308|FG000|Overall Study|Abnormal test procedure result (s)|0
7385523|NCT01202188|11643309|FG001|Overall Study|Abnormal test procedure result (s)|0
7385524|NCT01202188|11643310|FG002|Overall Study|Abnormal test procedure result (s)|2
7385525|NCT01202188|11643311|FG003|Overall Study|Abnormal test procedure result (s)|0
7385526|NCT01202188|11643312|FG004|Overall Study|Abnormal test procedure result (s)|0
7385527|NCT01202227|11643330|FG000|Overall Study|Adverse Event|16
7385528|NCT01202227|11643330|FG000|Overall Study|Withdrawal by Subject|2
7385529|NCT01202227|11643330|FG000|Overall Study|Lack of Efficacy|1
7385530|NCT01202279|11643340|FG000|Overall Study|Adverse Event|8
7385531|NCT01202279|11643341|FG001|Overall Study|Adverse Event|6
7385532|NCT01202279|11643340|FG000|Overall Study|Withdrawal by Subject|13
7385533|NCT01202279|11643341|FG001|Overall Study|Withdrawal by Subject|10
7385534|NCT01202279|11643340|FG000|Overall Study|Physician Decision|0
7385535|NCT01202279|11643341|FG001|Overall Study|Physician Decision|1
7385536|NCT01202279|11643340|FG000|Overall Study|Lost to Follow-up|10
7385537|NCT01202279|11643341|FG001|Overall Study|Lost to Follow-up|7
7385538|NCT01202279|11643340|FG000|Overall Study|Protocol Violation|1
7385539|NCT01202279|11643341|FG001|Overall Study|Protocol Violation|1
7385540|NCT01202279|11643340|FG000|Overall Study|study compliance|5
7385541|NCT01202279|11643341|FG001|Overall Study|study compliance|2
7385542|NCT01202409|11643347|FG000|Overall Study|Adverse Event|1
7385543|NCT01202409|11643347|FG000|Overall Study|Ineligible - KRAS mutants|7
7385544|NCT01202591|11643365|FG000|Overall Study|Adverse Event|2
7385545|NCT01202591|11643366|FG001|Overall Study|Adverse Event|1
7385546|NCT01202591|11643367|FG002|Overall Study|Adverse Event|4
7385547|NCT01202591|11643368|FG003|Overall Study|Adverse Event|4
7385548|NCT01202591|11643369|FG004|Overall Study|Adverse Event|0
7385549|NCT01202591|11643370|FG005|Overall Study|Adverse Event|0
7385550|NCT01202591|11643365|FG000|Overall Study|Other reason as per investigator|3
7385551|NCT01202591|11643366|FG001|Overall Study|Other reason as per investigator|4
7385552|NCT01202591|11643367|FG002|Overall Study|Other reason as per investigator|7
7385553|NCT01202591|11643368|FG003|Overall Study|Other reason as per investigator|3
7385554|NCT01202591|11643369|FG004|Overall Study|Other reason as per investigator|1
7335868|NCT00845182|11571598|FG000|Overall Study|Lost to Follow-up|3
7335869|NCT00845182|11571599|FG001|Overall Study|Lost to Follow-up|3
7335870|NCT00845182|11571600|FG002|Overall Study|Lost to Follow-up|4
7335871|NCT00845182|11571598|FG000|Overall Study|Adverse Event|0
7335872|NCT00845182|11571599|FG001|Overall Study|Adverse Event|1
7335873|NCT00845182|11571600|FG002|Overall Study|Adverse Event|1
7335874|NCT00845182|11571598|FG000|Overall Study|Physician Decision|0
7335875|NCT00845182|11571599|FG001|Overall Study|Physician Decision|0
7335876|NCT00845182|11571600|FG002|Overall Study|Physician Decision|1
7335877|NCT00845429|11571624|FG000|Overall Study|Protocol Violation|5
7335878|NCT00845429|11571625|FG001|Overall Study|Protocol Violation|4
7335879|NCT00845429|11571626|FG002|Overall Study|Protocol Violation|7
7335880|NCT00845429|11571624|FG000|Overall Study|Lost to Follow-up|7
7335881|NCT00845429|11571625|FG001|Overall Study|Lost to Follow-up|9
7335882|NCT00845429|11571626|FG002|Overall Study|Lost to Follow-up|10
7335883|NCT00845429|11571624|FG000|Overall Study|Withdrawal by Subject|2
7335884|NCT00845429|11571625|FG001|Overall Study|Withdrawal by Subject|2
7335885|NCT00845429|11571626|FG002|Overall Study|Withdrawal by Subject|2
7335886|NCT00845429|11571624|FG000|Overall Study|Serious adverse event|0
7335887|NCT00845429|11571625|FG001|Overall Study|Serious adverse event|0
7335888|NCT00845429|11571626|FG002|Overall Study|Serious adverse event|1
7335889|NCT00845520|11571655|FG000|Overall Study|Death|1
7335890|NCT00845520|11571656|FG001|Overall Study|Death|2
7335891|NCT00845520|11571657|FG002|Overall Study|Death|0
7335892|NCT00845520|11571655|FG000|Overall Study|Lost to Follow-up|1
7335893|NCT00845520|11571656|FG001|Overall Study|Lost to Follow-up|0
7335894|NCT00845520|11571657|FG002|Overall Study|Lost to Follow-up|0
7335895|NCT00845520|11571655|FG000|Overall Study|Adverse Event|0
7335896|NCT00845520|11571656|FG001|Overall Study|Adverse Event|0
7335897|NCT00845520|11571657|FG002|Overall Study|Adverse Event|1
7335898|NCT00845650|11571677|FG000|Overall Study|Withdrawal by Subject|0
7335899|NCT00845650|11571678|FG001|Overall Study|Withdrawal by Subject|0
7335900|NCT00845650|11571679|FG002|Overall Study|Withdrawal by Subject|0
7335901|NCT00845650|11571680|FG003|Overall Study|Withdrawal by Subject|0
7335902|NCT00845650|11571681|FG004|Overall Study|Withdrawal by Subject|2
7335903|NCT00845650|11571682|FG005|Overall Study|Withdrawal by Subject|0
7335904|NCT00845650|11571677|FG000|Overall Study|Lost to Follow-up|0
7335905|NCT00845650|11571678|FG001|Overall Study|Lost to Follow-up|0
7335906|NCT00845650|11571679|FG002|Overall Study|Lost to Follow-up|3
7335907|NCT00845650|11571680|FG003|Overall Study|Lost to Follow-up|1
7335908|NCT00845650|11571681|FG004|Overall Study|Lost to Follow-up|0
7335909|NCT00845650|11571682|FG005|Overall Study|Lost to Follow-up|1
7335910|NCT00845650|11571677|FG000|Overall Study|Sponsor hold on dosing|0
7335911|NCT00845650|11571678|FG001|Overall Study|Sponsor hold on dosing|0
7335912|NCT00845650|11571679|FG002|Overall Study|Sponsor hold on dosing|0
7335913|NCT00845650|11571680|FG003|Overall Study|Sponsor hold on dosing|0
7335914|NCT00845650|11571681|FG004|Overall Study|Sponsor hold on dosing|1
7335915|NCT00845650|11571682|FG005|Overall Study|Sponsor hold on dosing|1
7335916|NCT00845650|11571677|FG000|Overall Study|Unable to access IV line|1
7335917|NCT00845650|11571678|FG001|Overall Study|Unable to access IV line|0
7335918|NCT00845650|11571679|FG002|Overall Study|Unable to access IV line|0
7335919|NCT00845650|11571680|FG003|Overall Study|Unable to access IV line|0
7335920|NCT00845650|11571681|FG004|Overall Study|Unable to access IV line|0
7335921|NCT00845650|11571682|FG005|Overall Study|Unable to access IV line|0
7335922|NCT00845676|11571707|FG000|Overall Study|Virologic breakthrough at week 20|1
7335923|NCT00845676|11571707|FG000|Overall Study|Adverse Event|1
7335924|NCT00845728|11571714|FG000|Overall Study|Abnormal laboratory value (s)|2
7335925|NCT00845728|11571715|FG001|Overall Study|Abnormal laboratory value (s)|2
7335926|NCT00845728|11571714|FG000|Overall Study|Patient's inability to use the device|4
7335927|NCT00845728|11571715|FG001|Overall Study|Patient's inability to use the device|6
7335928|NCT00845728|11571714|FG000|Overall Study|Abnormal test procedure result (s)|7
7335929|NCT00845728|11571715|FG001|Overall Study|Abnormal test procedure result (s)|2
7335930|NCT00845728|11571714|FG000|Overall Study|Lost to Follow-up|22
7335931|NCT00845728|11571715|FG001|Overall Study|Lost to Follow-up|13
7335932|NCT00845728|11571714|FG000|Overall Study|Death|24
7335933|NCT00845728|11571715|FG001|Overall Study|Death|26
7335934|NCT00845728|11571714|FG000|Overall Study|Administrative Problems|34
7335935|NCT00845728|11571715|FG001|Overall Study|Administrative Problems|26
7335936|NCT00845728|11571714|FG000|Overall Study|Protocol Violation|36
7335937|NCT00845728|11571715|FG001|Overall Study|Protocol Violation|24
7335938|NCT00845728|11571714|FG000|Overall Study|Lack of Efficacy|51
7335939|NCT00845728|11571715|FG001|Overall Study|Lack of Efficacy|39
7335940|NCT00845728|11571714|FG000|Overall Study|Adverse Event|101
7335941|NCT00845728|11571715|FG001|Overall Study|Adverse Event|96
7335942|NCT00845728|11571714|FG000|Overall Study|Withdrawal by Subject|105
7335943|NCT00845728|11571715|FG001|Overall Study|Withdrawal by Subject|108
7335944|NCT00845832|11571724|FG000|Treatment Period|Adverse Event|0
7335945|NCT00845832|11571725|FG001|Treatment Period|Adverse Event|2
7335946|NCT00845832|11571726|FG002|Treatment Period|Adverse Event|0
7335947|NCT00845832|11571724|FG000|Treatment Period|Protocol Violation|1
7335948|NCT00845832|11571725|FG001|Treatment Period|Protocol Violation|1
7335949|NCT00845832|11571726|FG002|Treatment Period|Protocol Violation|0
7335950|NCT00845832|11571724|FG000|Safety Follow-Up|Withdrawal by Subject|1
7335951|NCT00845832|11571725|FG001|Safety Follow-Up|Withdrawal by Subject|0
7335952|NCT00845832|11571726|FG002|Safety Follow-Up|Withdrawal by Subject|0
7335953|NCT00845832|11571724|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
7335954|NCT00845832|11571725|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
7335955|NCT00845832|11571726|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
7335956|NCT00845858|11571737|FG000|Overall Study|Withdrawal by Subject|5
7335957|NCT00845858|11571738|FG001|Overall Study|Withdrawal by Subject|1
7335958|NCT00845858|11571739|FG002|Overall Study|Withdrawal by Subject|1
7335959|NCT00845858|11571737|FG000|Overall Study|Adverse Event|3
7335960|NCT00845858|11571738|FG001|Overall Study|Adverse Event|8
7335961|NCT00845858|11571739|FG002|Overall Study|Adverse Event|4
7335962|NCT00845858|11571737|FG000|Overall Study|Protocol Violation|0
7335963|NCT00845858|11571738|FG001|Overall Study|Protocol Violation|0
7335964|NCT00845858|11571739|FG002|Overall Study|Protocol Violation|1
7335965|NCT00845858|11571737|FG000|Overall Study|not eligible|0
7335966|NCT00845858|11571738|FG001|Overall Study|not eligible|3
7335967|NCT00845858|11571739|FG002|Overall Study|not eligible|2
7335968|NCT00845871|11571750|FG000|Assessment Period|Adverse Event|2
7335969|NCT00845871|11571750|FG000|Assessment Period|Abnormal laboratory values|1
7335970|NCT00845871|11571750|FG000|Assessment Period|Abnormal test procedure results|1
7335971|NCT00845871|11571750|FG000|Assessment Period|Patient withdrew consent|3
7335972|NCT00845897|11571777|FG000|Overall Study|Lost to Follow-up|1
7335973|NCT00845897|11571778|FG001|Overall Study|Lost to Follow-up|1
7335974|NCT00845897|11571779|FG002|Overall Study|Lost to Follow-up|0
7335975|NCT00845897|11571777|FG000|Overall Study|Withdrawal by Subject|0
7335976|NCT00845897|11571778|FG001|Overall Study|Withdrawal by Subject|3
7335977|NCT00845897|11571779|FG002|Overall Study|Withdrawal by Subject|2
7335978|NCT00845897|11571777|FG000|Overall Study|Ulcer did not heal|1
7335979|NCT00845897|11571778|FG001|Overall Study|Ulcer did not heal|0
7335980|NCT00845897|11571779|FG002|Overall Study|Ulcer did not heal|1
7335981|NCT00845897|11571777|FG000|Overall Study|Too ill to participate|0
7335982|NCT00845897|11571778|FG001|Overall Study|Too ill to participate|1
7335983|NCT00845897|11571779|FG002|Overall Study|Too ill to participate|0
7335984|NCT00846027|11571796|FG000|Overall Study|Death|3
7335985|NCT00846027|11571796|FG000|Overall Study|Disease Progression|30
7335986|NCT00846027|11571796|FG000|Overall Study|Toxicity|12
7568634|NCT03422250|11944117|FG000|Follow-up|Adverse Event|0
7568635|NCT03422250|11944118|FG001|Follow-up|Adverse Event|0
7335987|NCT00846027|11571796|FG000|Overall Study|Patient Decision|7
7335988|NCT00846027|11571796|FG000|Overall Study|Investigator Discretion|29
7335989|NCT00846027|11571796|FG000|Overall Study|Protocol Violation|2
7335990|NCT00846027|11571796|FG000|Overall Study|Subject Not Treated|7
7335991|NCT00846040|11571803|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
7335992|NCT00846040|11571804|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
7335993|NCT00846040|11571805|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
7335994|NCT00846040|11571803|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7335995|NCT00846040|11571804|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
7335996|NCT00846040|11571805|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
7335997|NCT00846053|11571816|FG000|Overall Study|Physician Decision|3
7335998|NCT00846053|11571817|FG001|Overall Study|Physician Decision|0
7335999|NCT00846365|11571847|FG000|Overall Study|Adverse Event|20
7336000|NCT00846365|11571848|FG001|Overall Study|Adverse Event|30
7336001|NCT00846365|11571849|FG002|Overall Study|Adverse Event|11
7336002|NCT00846365|11571847|FG000|Overall Study|Protocol Violation|5
7336003|NCT00846365|11571848|FG001|Overall Study|Protocol Violation|4
7336004|NCT00846365|11571849|FG002|Overall Study|Protocol Violation|0
7336005|NCT00846365|11571847|FG000|Overall Study|Lost to Follow-up|8
7336006|NCT00846365|11571848|FG001|Overall Study|Lost to Follow-up|2
7336007|NCT00846365|11571849|FG002|Overall Study|Lost to Follow-up|5
7336008|NCT00846365|11571847|FG000|Overall Study|Withdrawal by Subject|11
7336009|NCT00846365|11571848|FG001|Overall Study|Withdrawal by Subject|11
7336010|NCT00846365|11571849|FG002|Overall Study|Withdrawal by Subject|9
7336011|NCT00846365|11571847|FG000|Overall Study|Pregnancy|1
7336012|NCT00846365|11571848|FG001|Overall Study|Pregnancy|0
7458014|NCT01804673|11751900|FG000|Overall Study|No Further Therapy Required|84
7458015|NCT01804673|11751900|FG000|Overall Study|Use of Prohibited Medication|1
7458016|NCT01804673|11751900|FG000|Overall Study|Other|4
7458017|NCT01804842|11751907|FG000|Overall Study|Adverse Event|1
7458018|NCT01804842|11751908|FG001|Overall Study|Adverse Event|1
7458019|NCT01804842|11751909|FG002|Overall Study|Adverse Event|0
7458020|NCT01804842|11751907|FG000|Overall Study|Lost to Follow-up|1
7568636|NCT03422250|11944119|FG002|Follow-up|Adverse Event|0
7568637|NCT03422250|11944120|FG003|Follow-up|Adverse Event|1
7568638|NCT03423173|11944140|FG000|Overall Study|Randomized but not vaccinated|1
7568639|NCT03423173|11944141|FG001|Overall Study|Randomized but not vaccinated|0
7568640|NCT03423173|11944142|FG002|Overall Study|Randomized but not vaccinated|2
7568641|NCT03423173|11944143|FG003|Overall Study|Randomized but not vaccinated|1
7568642|NCT03423173|11944140|FG000|Overall Study|Adverse Event|1
7568643|NCT03423173|11944141|FG001|Overall Study|Adverse Event|1
7568644|NCT03423173|11944142|FG002|Overall Study|Adverse Event|1
7568645|NCT03423173|11944143|FG003|Overall Study|Adverse Event|1
7568646|NCT03423173|11944140|FG000|Overall Study|Lost to Follow-up|10
7568647|NCT03423173|11944141|FG001|Overall Study|Lost to Follow-up|19
7336013|NCT00846365|11571849|FG002|Overall Study|Pregnancy|0
7336014|NCT00846365|11571847|FG000|Overall Study|Lack of Efficacy|1
7336015|NCT00846365|11571848|FG001|Overall Study|Lack of Efficacy|1
7336016|NCT00846365|11571849|FG002|Overall Study|Lack of Efficacy|2
7336017|NCT00846365|11571847|FG000|Overall Study|Other|9
7336018|NCT00846365|11571848|FG001|Overall Study|Other|1
7336019|NCT00846365|11571849|FG002|Overall Study|Other|6
7336020|NCT00846391|11571860|FG000|Overall Study|Physician Decision|0
7336021|NCT00846391|11571861|FG001|Overall Study|Physician Decision|0
7568648|NCT03423173|11944142|FG002|Overall Study|Lost to Follow-up|17
7568649|NCT03423173|11944143|FG003|Overall Study|Lost to Follow-up|22
7568650|NCT03423173|11944140|FG000|Overall Study|Withdrawal of consent|4
7568651|NCT03423173|11944141|FG001|Overall Study|Withdrawal of consent|10
7336022|NCT00846391|11571862|FG002|Overall Study|Physician Decision|1
7336023|NCT00846391|11571860|FG000|Overall Study|Study Terminated by Sponsor|1
7336024|NCT00846391|11571861|FG001|Overall Study|Study Terminated by Sponsor|2
7336025|NCT00846391|11571862|FG002|Overall Study|Study Terminated by Sponsor|2
7336026|NCT00846495|11571877|FG000|Overall Study|Lost to Follow-up|1
7336027|NCT00846495|11571878|FG001|Overall Study|Lost to Follow-up|0
7336028|NCT00846495|11571877|FG000|Overall Study|Adverse Event|5
7336029|NCT00846495|11571878|FG001|Overall Study|Adverse Event|1
7336030|NCT00846495|11571877|FG000|Overall Study|Lack of Efficacy|1
7336031|NCT00846495|11571878|FG001|Overall Study|Lack of Efficacy|2
7336032|NCT00846495|11571877|FG000|Overall Study|Physician Decision|1
7336033|NCT00846495|11571878|FG001|Overall Study|Physician Decision|0
7336034|NCT00846521|11571884|FG000|Overall Study|Withdrawal by Subject|5
7336035|NCT00846521|11571884|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
7336036|NCT00846521|11571884|FG000|Overall Study|Protocol Violation|1
7336037|NCT00846586|11571908|FG000|Overall Study|Adverse Event|20
7336038|NCT00846586|11571909|FG001|Overall Study|Adverse Event|10
7336039|NCT00846586|11571908|FG000|Overall Study|Subject withdrew consent|8
7336040|NCT00846586|11571909|FG001|Overall Study|Subject withdrew consent|10
7336041|NCT00846586|11571908|FG000|Overall Study|Administrative problems|5
7336042|NCT00846586|11571909|FG001|Overall Study|Administrative problems|4
7336043|NCT00846586|11571908|FG000|Overall Study|Death|2
7336044|NCT00846586|11571909|FG001|Overall Study|Death|0
7336045|NCT00846586|11571908|FG000|Overall Study|Protocol deviation|2
7336046|NCT00846586|11571909|FG001|Overall Study|Protocol deviation|6
7336047|NCT00846586|11571908|FG000|Overall Study|Abnormal test procedure result(s)|1
7336048|NCT00846586|11571909|FG001|Overall Study|Abnormal test procedure result(s)|0
7336049|NCT00846586|11571908|FG000|Overall Study|Lost to Follow-up|1
7336050|NCT00846586|11571909|FG001|Overall Study|Lost to Follow-up|4
7336134|NCT00847561|11572067|FG001|Overall Study|Unable to schedule|1
7336051|NCT00846586|11571908|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7336052|NCT00846586|11571909|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7336053|NCT00846768|11571926|FG000|Overall Study|Adverse Event|0
7336054|NCT00846768|11571927|FG001|Overall Study|Adverse Event|1
7336055|NCT00846768|11571928|FG002|Overall Study|Adverse Event|0
7336056|NCT00846768|11571929|FG003|Overall Study|Adverse Event|0
7336057|NCT00846807|11571939|FG000|Overall Study|Adverse Event|270
7336058|NCT00846807|11571939|FG000|Overall Study|Lost to Follow-up|94
7336059|NCT00846807|11571939|FG000|Overall Study|Withdrawal by Subject|56
7336060|NCT00846807|11571939|FG000|Overall Study|Non compliant with European label|7
7336061|NCT00846807|11571939|FG000|Overall Study|Switch to other anticoagulants|89
7336062|NCT00846807|11571939|FG000|Overall Study|No prescription after hospital discharge|56
7336063|NCT00846807|11571939|FG000|Overall Study|Other|60
7336064|NCT00846846|11571943|FG000|Overall Study|Death|56
7336065|NCT00846846|11571943|FG000|Overall Study|Withdrawal by Subject|19
7336066|NCT00847015|11571947|FG000|Overall Study|Withdrawal by Subject|1
7336067|NCT00847015|11571947|FG000|Overall Study|declined any surgery|1
7336068|NCT00847015|11571947|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
7336069|NCT00847132|11571953|FG000|Overall Study|Death|1
7336070|NCT00847132|11571954|FG001|Overall Study|Death|1
7336071|NCT00847145|11571968|FG000|Overall Study|AE or Death|0
7336072|NCT00847145|11571969|FG001|Overall Study|AE or Death|1
7336073|NCT00847145|11571970|FG002|Overall Study|AE or Death|1
7336074|NCT00847145|11571971|FG003|Overall Study|AE or Death|0
7336075|NCT00847145|11571972|FG004|Overall Study|AE or Death|0
7336076|NCT00847145|11571973|FG005|Overall Study|AE or Death|0
7336077|NCT00847145|11571974|FG006|Overall Study|AE or Death|0
7568652|NCT03423173|11944142|FG002|Overall Study|Withdrawal of consent|4
7336078|NCT00847145|11571975|FG007|Overall Study|AE or Death|0
7336079|NCT00847145|11571968|FG000|Overall Study|Withdrawal by Subject|3
7568653|NCT03423173|11944143|FG003|Overall Study|Withdrawal of consent|5
7336080|NCT00847145|11571969|FG001|Overall Study|Withdrawal by Subject|4
7336081|NCT00847145|11571970|FG002|Overall Study|Withdrawal by Subject|6
7336082|NCT00847145|11571971|FG003|Overall Study|Withdrawal by Subject|1
7336083|NCT00847145|11571972|FG004|Overall Study|Withdrawal by Subject|0
7336084|NCT00847145|11571973|FG005|Overall Study|Withdrawal by Subject|0
7336085|NCT00847145|11571974|FG006|Overall Study|Withdrawal by Subject|1
7336086|NCT00847145|11571975|FG007|Overall Study|Withdrawal by Subject|1
7568654|NCT03423173|11944140|FG000|Overall Study|Death|1
7568655|NCT03423173|11944141|FG001|Overall Study|Death|0
7568656|NCT03423173|11944142|FG002|Overall Study|Death|0
7568657|NCT03423173|11944143|FG003|Overall Study|Death|0
7336087|NCT00847145|11571968|FG000|Overall Study|Lost to Follow-up|3
7458021|NCT01804842|11751908|FG001|Overall Study|Lost to Follow-up|0
7458022|NCT01804842|11751909|FG002|Overall Study|Lost to Follow-up|0
7458023|NCT01804842|11751907|FG000|Overall Study|Non-Compliance|1
7458024|NCT01804842|11751908|FG001|Overall Study|Non-Compliance|1
7458025|NCT01804842|11751909|FG002|Overall Study|Non-Compliance|0
7458026|NCT01804842|11751907|FG000|Overall Study|Personal Reason|0
7568658|NCT03423173|11944140|FG000|Overall Study|Reason not Specified|2
7568659|NCT03423173|11944141|FG001|Overall Study|Reason not Specified|5
7568660|NCT03423173|11944142|FG002|Overall Study|Reason not Specified|3
7568661|NCT03423173|11944143|FG003|Overall Study|Reason not Specified|1
7575274|NCT03720652|11958934|FG000|Overall Study|Withdrawal by Subject|2
7458027|NCT01804842|11751908|FG001|Overall Study|Personal Reason|0
7458028|NCT01804842|11751909|FG002|Overall Study|Personal Reason|1
7458029|NCT01804946|11751930|FG000|Overall Study|Protocol Violation|1
7458030|NCT01804946|11751931|FG001|Overall Study|Protocol Violation|0
7458031|NCT01804946|11751930|FG000|Overall Study|Adverse Event|0
7458032|NCT01804946|11751931|FG001|Overall Study|Adverse Event|1
7458033|NCT01804946|11751930|FG000|Overall Study|Insufficient data available|0
7458034|NCT01804946|11751931|FG001|Overall Study|Insufficient data available|1
7458035|NCT01804946|11751930|FG000|Overall Study|Do not meet inclusion criteria|1
7458036|NCT01804946|11751931|FG001|Overall Study|Do not meet inclusion criteria|2
7458037|NCT01805037|11751956|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
7458038|NCT01805037|11751957|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
7458039|NCT01805037|11751956|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
7458040|NCT01805037|11751957|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
7458041|NCT01805037|11751956|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
7458042|NCT01805037|11751957|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
7458043|NCT01805037|11751956|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
7458044|NCT01805037|11751957|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
7458045|NCT01805037|11751956|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
7458046|NCT01805037|11751957|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
7458047|NCT01805037|11751956|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
7458048|NCT01805037|11751957|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
7458049|NCT01805037|11751956|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
7458050|NCT01805037|11751957|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
7458051|NCT01805037|11751956|FG000|Follow Up (up to 3 Years)|Death|0
7458052|NCT01805037|11751957|FG001|Follow Up (up to 3 Years)|Death|2
7458053|NCT01805037|11751956|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
7458054|NCT01805037|11751957|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
7458055|NCT01805037|11751956|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
7458056|NCT01805037|11751957|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
7458057|NCT01805180|11751979|FG000|Lead-in Donor Phase|screen failure|1
7458058|NCT01805180|11751980|FG001|Lead-in Donor Phase|screen failure|0
7458059|NCT01805180|11751981|FG002|Lead-in Donor Phase|screen failure|0
7458060|NCT01806064|11752083|FG000|Overall Study|Randomized Not Enrolled|0
7458061|NCT01806064|11752084|FG001|Overall Study|Randomized Not Enrolled|0
7458062|NCT01806064|11752085|FG002|Overall Study|Randomized Not Enrolled|0
7458063|NCT01806064|11752086|FG003|Overall Study|Randomized Not Enrolled|1
7458064|NCT01806064|11752087|FG004|Overall Study|Randomized Not Enrolled|2
7458065|NCT01806168|11752106|FG000|Overall Study|Adverse Event|1
7458066|NCT01806168|11752107|FG001|Overall Study|Adverse Event|0
7458067|NCT01806168|11752108|FG002|Overall Study|Adverse Event|0
7458068|NCT01806168|11752106|FG000|Overall Study|Withdrawal by Subject|0
7458069|NCT01806168|11752107|FG001|Overall Study|Withdrawal by Subject|1
7458070|NCT01806168|11752108|FG002|Overall Study|Withdrawal by Subject|2
7458071|NCT01806168|11752106|FG000|Overall Study|Protocol Violation|0
7458072|NCT01806168|11752107|FG001|Overall Study|Protocol Violation|0
7458073|NCT01806168|11752108|FG002|Overall Study|Protocol Violation|1
7458074|NCT01806298|11752129|FG000|Overall Study|Adverse Event|3
7458075|NCT01806298|11752129|FG000|Overall Study|Protocol Non-compliance|1
7458076|NCT01806298|11752129|FG000|Overall Study|Withdrawal by Subject|1
7458077|NCT01806298|11752129|FG000|Overall Study|Other|5
7458078|NCT01806389|11752133|FG000|Overall Study|Withdrawal by Subject|4
7458079|NCT01806506|11752149|FG000|Overall Study|Lost to Follow-up|2
7458080|NCT01806506|11752150|FG001|Overall Study|Lost to Follow-up|1
7458081|NCT01806545|11752158|FG000|Overall Study|Adverse Event|2
7458082|NCT01806545|11752159|FG001|Overall Study|Adverse Event|3
7458083|NCT01806545|11752158|FG000|Overall Study|Lost to Follow-up|1
7458084|NCT01806545|11752159|FG001|Overall Study|Lost to Follow-up|0
7458085|NCT01806545|11752158|FG000|Overall Study|Withdrawal by Subject|3
7575275|NCT03720652|11958935|FG001|Overall Study|Withdrawal by Subject|7
7458086|NCT01806545|11752159|FG001|Overall Study|Withdrawal by Subject|2
7458087|NCT01806584|11752171|FG000|Overall Study|Adverse Event|2
7458088|NCT01806584|11752172|FG001|Overall Study|Adverse Event|1
7458089|NCT01806584|11752171|FG000|Overall Study|Death|1
7458090|NCT01806584|11752172|FG001|Overall Study|Death|0
7458091|NCT01806584|11752171|FG000|Overall Study|Lost to Follow-up|0
7458092|NCT01806584|11752172|FG001|Overall Study|Lost to Follow-up|2
7458093|NCT01806584|11752171|FG000|Overall Study|Study terminated by sponsor|9
7336088|NCT00847145|11571969|FG001|Overall Study|Lost to Follow-up|1
7336089|NCT00847145|11571970|FG002|Overall Study|Lost to Follow-up|1
7336090|NCT00847145|11571971|FG003|Overall Study|Lost to Follow-up|0
7336091|NCT00847145|11571972|FG004|Overall Study|Lost to Follow-up|4
7336092|NCT00847145|11571973|FG005|Overall Study|Lost to Follow-up|4
7336093|NCT00847145|11571974|FG006|Overall Study|Lost to Follow-up|8
7336094|NCT00847145|11571975|FG007|Overall Study|Lost to Follow-up|2
7336095|NCT00847145|11571968|FG000|Overall Study|Inappropriate enrollment|0
7336096|NCT00847145|11571969|FG001|Overall Study|Inappropriate enrollment|0
7336097|NCT00847145|11571970|FG002|Overall Study|Inappropriate enrollment|0
7336098|NCT00847145|11571971|FG003|Overall Study|Inappropriate enrollment|0
7336099|NCT00847145|11571972|FG004|Overall Study|Inappropriate enrollment|1
7336100|NCT00847145|11571973|FG005|Overall Study|Inappropriate enrollment|0
7336101|NCT00847145|11571974|FG006|Overall Study|Inappropriate enrollment|0
7336102|NCT00847145|11571975|FG007|Overall Study|Inappropriate enrollment|0
7336103|NCT00847145|11571968|FG000|Overall Study|Protocol Violation|0
7336104|NCT00847145|11571969|FG001|Overall Study|Protocol Violation|0
7336105|NCT00847145|11571970|FG002|Overall Study|Protocol Violation|3
7336106|NCT00847145|11571971|FG003|Overall Study|Protocol Violation|0
7336107|NCT00847145|11571972|FG004|Overall Study|Protocol Violation|1
7336108|NCT00847145|11571973|FG005|Overall Study|Protocol Violation|0
7336109|NCT00847145|11571974|FG006|Overall Study|Protocol Violation|0
7336110|NCT00847145|11571975|FG007|Overall Study|Protocol Violation|1
7336111|NCT00847197|11572009|FG000|Overall Study|Adverse Event|21
7336112|NCT00847197|11572010|FG001|Overall Study|Adverse Event|3
7336113|NCT00847197|11572009|FG000|Overall Study|Protocol Violation|0
7336114|NCT00847197|11572010|FG001|Overall Study|Protocol Violation|1
7336115|NCT00847197|11572009|FG000|Overall Study|Withdrawal by Subject|3
7336116|NCT00847197|11572010|FG001|Overall Study|Withdrawal by Subject|1
7336117|NCT00847301|11572034|FG000|Overall Study|Adverse Event|35
7336118|NCT00847301|11572034|FG000|Overall Study|Switch to other anticoagulants|16
7336119|NCT00847301|11572034|FG000|Overall Study|Lost to Follow-up|1
7336120|NCT00847301|11572034|FG000|Overall Study|No prescription after hospital discharge|1
7336121|NCT00847301|11572034|FG000|Overall Study|Other reason not defined above|1
7336122|NCT00847379|11572041|FG000|Overall Study|Study terminated by Sponsor|59
7336123|NCT00847379|11572042|FG001|Overall Study|Study terminated by Sponsor|57
7336124|NCT00847379|11572043|FG002|Overall Study|Study terminated by Sponsor|57
7336125|NCT00847535|11572057|FG000|Overall Study|Withdrawal by Subject|2
7336126|NCT00847535|11572058|FG001|Overall Study|Withdrawal by Subject|1
7336127|NCT00847535|11572059|FG002|Overall Study|Withdrawal by Subject|1
7336128|NCT00847535|11572057|FG000|Overall Study|Lost to Follow-up|0
7336129|NCT00847535|11572058|FG001|Overall Study|Lost to Follow-up|1
7336130|NCT00847535|11572059|FG002|Overall Study|Lost to Follow-up|0
7336131|NCT00847561|11572066|FG000|Overall Study|Withdrawal by Subject|4
7336132|NCT00847561|11572067|FG001|Overall Study|Withdrawal by Subject|3
7336133|NCT00847561|11572066|FG000|Overall Study|Unable to schedule|9
7336135|NCT00847613|11572086|FG000|Overall Study|Ongoing at cut-off date|250
7336136|NCT00847613|11572087|FG001|Overall Study|Ongoing at cut-off date|265
7336137|NCT00847613|11572088|FG002|Overall Study|Ongoing at cut-off date|64
7336138|NCT00847613|11572089|FG003|Overall Study|Ongoing at cut-off date|64
7336139|NCT00847613|11572086|FG000|Overall Study|Death|1
7336140|NCT00847613|11572087|FG001|Overall Study|Death|1
7336141|NCT00847613|11572088|FG002|Overall Study|Death|0
7336142|NCT00847613|11572089|FG003|Overall Study|Death|0
7336143|NCT00847613|11572086|FG000|Overall Study|Adverse Event|36
7336144|NCT00847613|11572087|FG001|Overall Study|Adverse Event|26
7336145|NCT00847613|11572088|FG002|Overall Study|Adverse Event|5
7336146|NCT00847613|11572089|FG003|Overall Study|Adverse Event|6
7336147|NCT00847613|11572086|FG000|Overall Study|Lack of Efficacy|7
7336148|NCT00847613|11572087|FG001|Overall Study|Lack of Efficacy|3
7336149|NCT00847613|11572088|FG002|Overall Study|Lack of Efficacy|3
7336150|NCT00847613|11572089|FG003|Overall Study|Lack of Efficacy|1
7336151|NCT00847613|11572086|FG000|Overall Study|Study terminated by Sponsor|1
7336152|NCT00847613|11572087|FG001|Overall Study|Study terminated by Sponsor|0
7336153|NCT00847613|11572088|FG002|Overall Study|Study terminated by Sponsor|2
7336154|NCT00847613|11572089|FG003|Overall Study|Study terminated by Sponsor|1
7336155|NCT00847613|11572086|FG000|Overall Study|Lost to Follow-up|5
7336156|NCT00847613|11572087|FG001|Overall Study|Lost to Follow-up|0
7336157|NCT00847613|11572088|FG002|Overall Study|Lost to Follow-up|0
7336158|NCT00847613|11572089|FG003|Overall Study|Lost to Follow-up|3
7336159|NCT00847613|11572086|FG000|Overall Study|Protocol Violation|6
7336160|NCT00847613|11572087|FG001|Overall Study|Protocol Violation|6
7336161|NCT00847613|11572088|FG002|Overall Study|Protocol Violation|3
7458094|NCT01806584|11752172|FG001|Overall Study|Study terminated by sponsor|14
7336162|NCT00847613|11572089|FG003|Overall Study|Protocol Violation|1
7336163|NCT00847613|11572086|FG000|Overall Study|Pregnancy|1
7336164|NCT00847613|11572087|FG001|Overall Study|Pregnancy|1
7336165|NCT00847613|11572088|FG002|Overall Study|Pregnancy|0
7336166|NCT00847613|11572089|FG003|Overall Study|Pregnancy|0
7336167|NCT00847613|11572086|FG000|Overall Study|Site closure|1
7336168|NCT00847613|11572087|FG001|Overall Study|Site closure|0
7336169|NCT00847613|11572088|FG002|Overall Study|Site closure|0
7336170|NCT00847613|11572089|FG003|Overall Study|Site closure|1
7336171|NCT00847613|11572086|FG000|Overall Study|Withdrawal by Subject|8
7336172|NCT00847613|11572087|FG001|Overall Study|Withdrawal by Subject|11
7336173|NCT00847613|11572088|FG002|Overall Study|Withdrawal by Subject|2
7336174|NCT00847613|11572089|FG003|Overall Study|Withdrawal by Subject|2
7336175|NCT00847613|11572086|FG000|Overall Study|Participant moved|4
7336176|NCT00847613|11572087|FG001|Overall Study|Participant moved|1
7336177|NCT00847613|11572088|FG002|Overall Study|Participant moved|0
7336178|NCT00847613|11572089|FG003|Overall Study|Participant moved|0
7336179|NCT00847613|11572086|FG000|Overall Study|Sponsor request|0
7336180|NCT00847613|11572087|FG001|Overall Study|Sponsor request|1
7336181|NCT00847613|11572088|FG002|Overall Study|Sponsor request|0
7336182|NCT00847613|11572089|FG003|Overall Study|Sponsor request|0
7336183|NCT00847613|11572086|FG000|Overall Study|Randomized, but not treated|0
7336184|NCT00847613|11572087|FG001|Overall Study|Randomized, but not treated|3
7336185|NCT00847613|11572088|FG002|Overall Study|Randomized, but not treated|0
7336186|NCT00847613|11572089|FG003|Overall Study|Randomized, but not treated|0
7336187|NCT00847613|11572086|FG000|Overall Study|Other|1
7336188|NCT00847613|11572087|FG001|Overall Study|Other|1
7336189|NCT00847613|11572088|FG002|Overall Study|Other|2
7336190|NCT00847613|11572089|FG003|Overall Study|Other|0
7336191|NCT00847626|11572117|FG000|Overall Study|Adverse Event|10
7336192|NCT00847626|11572118|FG001|Overall Study|Adverse Event|10
7336193|NCT00847626|11572119|FG002|Overall Study|Adverse Event|6
7336194|NCT00847626|11572120|FG003|Overall Study|Adverse Event|19
7336195|NCT00847626|11572121|FG004|Overall Study|Adverse Event|11
7336196|NCT00847626|11572122|FG005|Overall Study|Adverse Event|22
7336197|NCT00847626|11572123|FG006|Overall Study|Adverse Event|4
7336198|NCT00847626|11572124|FG007|Overall Study|Adverse Event|6
7336199|NCT00847626|11572125|FG008|Overall Study|Adverse Event|3
7336200|NCT00847626|11572126|FG009|Overall Study|Adverse Event|6
7336201|NCT00847626|11572127|FG010|Overall Study|Adverse Event|6
7336202|NCT00847626|11572117|FG000|Overall Study|Protocol Violation|2
7336203|NCT00847626|11572118|FG001|Overall Study|Protocol Violation|1
7336204|NCT00847626|11572119|FG002|Overall Study|Protocol Violation|2
7336205|NCT00847626|11572120|FG003|Overall Study|Protocol Violation|1
7336206|NCT00847626|11572121|FG004|Overall Study|Protocol Violation|1
7336207|NCT00847626|11572122|FG005|Overall Study|Protocol Violation|1
7336208|NCT00847626|11572123|FG006|Overall Study|Protocol Violation|1
7336209|NCT00847626|11572124|FG007|Overall Study|Protocol Violation|1
7336210|NCT00847626|11572125|FG008|Overall Study|Protocol Violation|0
7336211|NCT00847626|11572126|FG009|Overall Study|Protocol Violation|1
7336212|NCT00847626|11572127|FG010|Overall Study|Protocol Violation|1
7336213|NCT00847626|11572117|FG000|Overall Study|Lost to Follow-up|0
7336214|NCT00847626|11572118|FG001|Overall Study|Lost to Follow-up|1
7336215|NCT00847626|11572119|FG002|Overall Study|Lost to Follow-up|1
7336216|NCT00847626|11572120|FG003|Overall Study|Lost to Follow-up|1
7336217|NCT00847626|11572121|FG004|Overall Study|Lost to Follow-up|0
7336218|NCT00847626|11572122|FG005|Overall Study|Lost to Follow-up|3
7336219|NCT00847626|11572123|FG006|Overall Study|Lost to Follow-up|1
7336220|NCT00847626|11572124|FG007|Overall Study|Lost to Follow-up|3
7336221|NCT00847626|11572125|FG008|Overall Study|Lost to Follow-up|1
7336222|NCT00847626|11572126|FG009|Overall Study|Lost to Follow-up|0
7336223|NCT00847626|11572127|FG010|Overall Study|Lost to Follow-up|1
7336224|NCT00847626|11572117|FG000|Overall Study|Withdrawal by Subject|5
7336225|NCT00847626|11572118|FG001|Overall Study|Withdrawal by Subject|5
7336226|NCT00847626|11572119|FG002|Overall Study|Withdrawal by Subject|3
7336227|NCT00847626|11572120|FG003|Overall Study|Withdrawal by Subject|8
7336228|NCT00847626|11572121|FG004|Overall Study|Withdrawal by Subject|12
7336229|NCT00847626|11572122|FG005|Overall Study|Withdrawal by Subject|9
7336230|NCT00847626|11572123|FG006|Overall Study|Withdrawal by Subject|8
7336231|NCT00847626|11572124|FG007|Overall Study|Withdrawal by Subject|4
7336232|NCT00847626|11572125|FG008|Overall Study|Withdrawal by Subject|4
7336233|NCT00847626|11572126|FG009|Overall Study|Withdrawal by Subject|5
7336234|NCT00847626|11572127|FG010|Overall Study|Withdrawal by Subject|2
7336235|NCT00847626|11572117|FG000|Overall Study|Lack of Efficacy|3
7336236|NCT00847626|11572118|FG001|Overall Study|Lack of Efficacy|1
7336237|NCT00847626|11572119|FG002|Overall Study|Lack of Efficacy|0
7336238|NCT00847626|11572120|FG003|Overall Study|Lack of Efficacy|1
7336239|NCT00847626|11572121|FG004|Overall Study|Lack of Efficacy|2
7336240|NCT00847626|11572122|FG005|Overall Study|Lack of Efficacy|0
7336241|NCT00847626|11572123|FG006|Overall Study|Lack of Efficacy|6
7336242|NCT00847626|11572124|FG007|Overall Study|Lack of Efficacy|2
7336243|NCT00847626|11572125|FG008|Overall Study|Lack of Efficacy|5
7336244|NCT00847626|11572126|FG009|Overall Study|Lack of Efficacy|1
7336245|NCT00847626|11572127|FG010|Overall Study|Lack of Efficacy|7
7336246|NCT00847626|11572117|FG000|Overall Study|Other|1
7336247|NCT00847626|11572118|FG001|Overall Study|Other|5
7336248|NCT00847626|11572119|FG002|Overall Study|Other|4
7336249|NCT00847626|11572120|FG003|Overall Study|Other|1
7336250|NCT00847626|11572121|FG004|Overall Study|Other|2
7336251|NCT00847626|11572122|FG005|Overall Study|Other|2
7336252|NCT00847626|11572123|FG006|Overall Study|Other|2
7336253|NCT00847626|11572124|FG007|Overall Study|Other|3
7336254|NCT00847626|11572125|FG008|Overall Study|Other|1
7336255|NCT00847626|11572126|FG009|Overall Study|Other|1
7336256|NCT00847626|11572127|FG010|Overall Study|Other|3
7336257|NCT00847665|11572156|FG000|Overall Study|Withdrawal by Subject|1
7336258|NCT00847665|11572157|FG001|Overall Study|Withdrawal by Subject|0
7336259|NCT00847704|11572163|FG000|Overall Study|Withdrawal by Subject|1
7336261|NCT00847808|11572171|FG000|Overall Study|Adverse Event|7
7336262|NCT00847808|11572171|FG000|Overall Study|Protocol Violation|1
7336263|NCT00847808|11572171|FG000|Overall Study|Lost to Follow-up|1
7336264|NCT00847808|11572171|FG000|Overall Study|Withdrawal by Subject|4
7336265|NCT00847808|11572171|FG000|Overall Study|Participant Reported Lack of Efficacy|1
7336266|NCT00847808|11572171|FG000|Overall Study|Participant Took Excluded Medication|1
7336267|NCT00847886|11572177|FG000|Overall Study|Adverse Event|0
7336268|NCT00847886|11572178|FG001|Overall Study|Adverse Event|1
7336269|NCT00847912|11572186|FG000|Overall Study|Protocol Violation|6
7336270|NCT00847912|11572187|FG001|Overall Study|Protocol Violation|7
7336271|NCT00847912|11572186|FG000|Overall Study|Withdrawal by Subject|3
7336272|NCT00847912|11572187|FG001|Overall Study|Withdrawal by Subject|6
7336273|NCT00848042|11572218|FG000|Overall Study|Death|1
7336274|NCT00848042|11572219|FG001|Overall Study|Death|2
7336275|NCT00848042|11572220|FG002|Overall Study|Death|0
7336276|NCT00848042|11572218|FG000|Overall Study|Other Therapy|3
7336277|NCT00848042|11572219|FG001|Overall Study|Other Therapy|0
7336278|NCT00848042|11572220|FG002|Overall Study|Other Therapy|0
7336279|NCT00848081|11572230|FG000|Overall Study|Adverse Event|6
7336280|NCT00848081|11572231|FG001|Overall Study|Adverse Event|7
7336281|NCT00848081|11572230|FG000|Overall Study|Protocol Violation|8
7336282|NCT00848081|11572231|FG001|Overall Study|Protocol Violation|5
7336283|NCT00848081|11572230|FG000|Overall Study|Lost to Follow-up|1
7336284|NCT00848081|11572231|FG001|Overall Study|Lost to Follow-up|0
7336285|NCT00848081|11572230|FG000|Overall Study|Physician Decision|0
7336286|NCT00848081|11572231|FG001|Overall Study|Physician Decision|3
7336287|NCT00848081|11572230|FG000|Overall Study|Withdrawal by Subject|5
7336288|NCT00848081|11572231|FG001|Overall Study|Withdrawal by Subject|3
7336289|NCT00848107|11572237|FG000|Overall Study|Lost to Follow-up|2
7336290|NCT00848107|11572237|FG000|Overall Study|Withdrawal by Subject|8
7336291|NCT00848107|11572237|FG000|Overall Study|Adverse Event|9
7336292|NCT00848107|11572237|FG000|Overall Study|Death|1
7336293|NCT00848107|11572237|FG000|Overall Study|Pregnancy|1
7336294|NCT00848120|11572241|FG000|Overall Study|Adverse Event|1
7336295|NCT00848198|11572270|FG000|Overall Study|Incomplete Case Report Forms|15
7336296|NCT00848211|11572282|FG000|Overall Study|Protocol Violation|0
7336297|NCT00848211|11572283|FG001|Overall Study|Protocol Violation|1
7336298|NCT00848211|11572284|FG002|Overall Study|Protocol Violation|1
7336299|NCT00848211|11572285|FG003|Overall Study|Protocol Violation|0
7336300|NCT00848211|11572282|FG000|Overall Study|Adverse Event|0
7336301|NCT00848211|11572283|FG001|Overall Study|Adverse Event|0
7336302|NCT00848211|11572284|FG002|Overall Study|Adverse Event|0
7336303|NCT00848211|11572285|FG003|Overall Study|Adverse Event|0
7336304|NCT00848250|11572301|FG000|Overall Study|surgery was completed without cardiopulm|0
7336305|NCT00848250|11572302|FG001|Overall Study|surgery was completed without cardiopulm|1
7336306|NCT00848354|11572311|FG000|Phase 1|Adverse Event|5
7336307|NCT00848354|11572312|FG001|Phase 1|Adverse Event|4
7336308|NCT00848354|11572311|FG000|Phase 1|Discontinuation of study by sponsor|2
7336309|NCT00848354|11572312|FG001|Phase 1|Discontinuation of study by sponsor|1
7336310|NCT00848354|11572311|FG000|Phase 1|Failed to return|0
7336311|NCT00848354|11572312|FG001|Phase 1|Failed to return|1
7336312|NCT00848354|11572311|FG000|Phase 1|Lost to Follow-up|1
7336313|NCT00848354|11572312|FG001|Phase 1|Lost to Follow-up|1
7336314|NCT00848354|11572311|FG000|Phase 1|Unspecified Reason|1
7336315|NCT00848354|11572312|FG001|Phase 1|Unspecified Reason|1
7336316|NCT00848354|11572311|FG000|Phase 1|Protocol Violation|1
7336317|NCT00848354|11572312|FG001|Phase 1|Protocol Violation|1
7336318|NCT00848354|11572311|FG000|Phase 1|Withdrawal by Subject|2
7336319|NCT00848354|11572312|FG001|Phase 1|Withdrawal by Subject|4
7336320|NCT00848354|11572311|FG000|Phase 1|Lack of Efficacy|0
7336321|NCT00848354|11572312|FG001|Phase 1|Lack of Efficacy|1
7336322|NCT00848354|11572311|FG000|Phase 2 Year 1|Adverse Event|7
7336323|NCT00848354|11572312|FG001|Phase 2 Year 1|Adverse Event|2
7336324|NCT00848354|11572311|FG000|Phase 2 Year 1|Death|1
7336325|NCT00848354|11572312|FG001|Phase 2 Year 1|Death|0
7336326|NCT00848354|11572311|FG000|Phase 2 Year 1|Failed to Return|1
7336327|NCT00848354|11572312|FG001|Phase 2 Year 1|Failed to Return|1
7336328|NCT00848354|11572311|FG000|Phase 2 Year 1|Lost to Follow-up|1
7336329|NCT00848354|11572312|FG001|Phase 2 Year 1|Lost to Follow-up|0
7336330|NCT00848354|11572311|FG000|Phase 2 Year 1|Unspecified Reason|3
7336331|NCT00848354|11572312|FG001|Phase 2 Year 1|Unspecified Reason|0
7336332|NCT00848354|11572311|FG000|Phase 2 Year 1|Protocol Violation|4
7336333|NCT00848354|11572312|FG001|Phase 2 Year 1|Protocol Violation|1
7336334|NCT00848354|11572311|FG000|Phase 2 Year 1|Subject Request|1
7336335|NCT00848354|11572312|FG001|Phase 2 Year 1|Subject Request|2
7336336|NCT00848354|11572311|FG000|Phase 2 Year 2|Adverse Event|12
7336337|NCT00848354|11572312|FG001|Phase 2 Year 2|Adverse Event|2
7336338|NCT00848354|11572311|FG000|Phase 2 Year 2|Death|2
7336339|NCT00848354|11572312|FG001|Phase 2 Year 2|Death|0
7336340|NCT00848354|11572311|FG000|Phase 2 Year 2|Failed to return|3
7336341|NCT00848354|11572312|FG001|Phase 2 Year 2|Failed to return|0
7336342|NCT00848354|11572311|FG000|Phase 2 Year 2|Lost to Follow-up|1
7336343|NCT00848354|11572312|FG001|Phase 2 Year 2|Lost to Follow-up|3
7336344|NCT00848354|11572311|FG000|Phase 2 Year 2|Unspecified Reason|1
7336345|NCT00848354|11572312|FG001|Phase 2 Year 2|Unspecified Reason|0
7336346|NCT00848354|11572311|FG000|Phase 2 Year 2|Protocol Violation|1
7336347|NCT00848354|11572312|FG001|Phase 2 Year 2|Protocol Violation|1
7336348|NCT00848354|11572311|FG000|Phase 2 Year 2|Subject Request|1
7336349|NCT00848354|11572312|FG001|Phase 2 Year 2|Subject Request|1
7336350|NCT00848354|11572311|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
7336351|NCT00848354|11572312|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
7336352|NCT00848393|11572336|FG000|Overall Study|Protocol Violation|0
7336353|NCT00848393|11572337|FG001|Overall Study|Protocol Violation|0
7336354|NCT00848393|11572338|FG002|Overall Study|Protocol Violation|1
7336355|NCT00848393|11572336|FG000|Overall Study|surgical complications unrelated to stud|0
7336356|NCT00848393|11572337|FG001|Overall Study|surgical complications unrelated to stud|0
7336357|NCT00848393|11572338|FG002|Overall Study|surgical complications unrelated to stud|2
7336358|NCT00848484|11572352|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
7336359|NCT00848484|11572353|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
7336360|NCT00848484|11572352|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
7336361|NCT00848484|11572353|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
7336362|NCT00848484|11572352|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
7336363|NCT00848484|11572353|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
7336364|NCT00848484|11572352|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
7336365|NCT00848484|11572353|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
7336366|NCT00848484|11572352|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
7336367|NCT00848484|11572353|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
7336368|NCT00848497|11572361|FG000|Overall Study|Screen failure|2
7336369|NCT00848497|11572362|FG001|Overall Study|Screen failure|0
7336370|NCT00848497|11572361|FG000|Overall Study|Withdrawal by Subject|0
7336371|NCT00848497|11572362|FG001|Overall Study|Withdrawal by Subject|1
7336372|NCT00848536|11572389|FG000|Overall Study|Adverse Event|2
7336373|NCT00848536|11572390|FG001|Overall Study|Adverse Event|2
7336374|NCT00848536|11572389|FG000|Overall Study|Withdrawal by Subject|0
7336375|NCT00848536|11572390|FG001|Overall Study|Withdrawal by Subject|1
7336376|NCT00848536|11572389|FG000|Overall Study|Protocol Violation|0
7336377|NCT00848536|11572390|FG001|Overall Study|Protocol Violation|1
7336378|NCT00848536|11572389|FG000|Overall Study|Noncompliance|1
7336379|NCT00848536|11572390|FG001|Overall Study|Noncompliance|0
7336380|NCT00848536|11572389|FG000|Overall Study|Inadequate Control of IOP|1
7336381|NCT00848536|11572390|FG001|Overall Study|Inadequate Control of IOP|1
7336382|NCT00848536|11572389|FG000|Overall Study|Patient Moved|0
7336383|NCT00848536|11572390|FG001|Overall Study|Patient Moved|2
7336384|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
7336385|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
7336386|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
7336387|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
7336388|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7336389|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
7336390|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
7336391|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
7336392|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
7336393|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
7336394|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
7336395|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
7336396|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
7336397|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
7336398|NCT00848549|11572398|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
7336399|NCT00848549|11572399|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
7336400|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
7336401|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
7336402|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
7336403|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
7336404|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
7336405|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
7336406|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7336407|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
7336408|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
7336409|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
7336410|NCT00848549|11572398|FG000|E2090-E044-314 (Extension Study)|Other|5
7336411|NCT00848549|11572399|FG001|E2090-E044-314 (Extension Study)|Other|6
7336412|NCT00848718|11572420|FG000|Overall Study|Adverse Event|2
7336413|NCT00848718|11572421|FG001|Overall Study|Adverse Event|2
7336414|NCT00848718|11572422|FG002|Overall Study|Adverse Event|1
7336415|NCT00848718|11572423|FG003|Overall Study|Adverse Event|1
7336416|NCT00848718|11572424|FG004|Overall Study|Adverse Event|1
7336417|NCT00848718|11572425|FG005|Overall Study|Adverse Event|0
7336418|NCT00848718|11572426|FG006|Overall Study|Adverse Event|0
7336419|NCT00848718|11572427|FG007|Overall Study|Adverse Event|1
7336420|NCT00848718|11572428|FG008|Overall Study|Adverse Event|1
7336421|NCT00848718|11572429|FG009|Overall Study|Adverse Event|0
7336422|NCT00848718|11572430|FG010|Overall Study|Adverse Event|0
7336423|NCT00848718|11572431|FG011|Overall Study|Adverse Event|0
7336424|NCT00848718|11572432|FG012|Overall Study|Adverse Event|2
7336425|NCT00848718|11572420|FG000|Overall Study|Lack of Efficacy|0
7336426|NCT00848718|11572421|FG001|Overall Study|Lack of Efficacy|0
7336427|NCT00848718|11572422|FG002|Overall Study|Lack of Efficacy|1
7336428|NCT00848718|11572423|FG003|Overall Study|Lack of Efficacy|0
7336429|NCT00848718|11572424|FG004|Overall Study|Lack of Efficacy|0
7336430|NCT00848718|11572425|FG005|Overall Study|Lack of Efficacy|0
7336431|NCT00848718|11572426|FG006|Overall Study|Lack of Efficacy|1
7336432|NCT00848718|11572427|FG007|Overall Study|Lack of Efficacy|0
7336433|NCT00848718|11572428|FG008|Overall Study|Lack of Efficacy|0
7336434|NCT00848718|11572429|FG009|Overall Study|Lack of Efficacy|0
7336435|NCT00848718|11572430|FG010|Overall Study|Lack of Efficacy|0
7336436|NCT00848718|11572431|FG011|Overall Study|Lack of Efficacy|0
7336437|NCT00848718|11572432|FG012|Overall Study|Lack of Efficacy|0
7336438|NCT00848718|11572420|FG000|Overall Study|Physician Decision|0
7336439|NCT00848718|11572421|FG001|Overall Study|Physician Decision|1
7336440|NCT00848718|11572422|FG002|Overall Study|Physician Decision|0
7336441|NCT00848718|11572423|FG003|Overall Study|Physician Decision|0
7336442|NCT00848718|11572424|FG004|Overall Study|Physician Decision|1
7336443|NCT00848718|11572425|FG005|Overall Study|Physician Decision|1
7336444|NCT00848718|11572426|FG006|Overall Study|Physician Decision|0
7336445|NCT00848718|11572427|FG007|Overall Study|Physician Decision|0
7336446|NCT00848718|11572428|FG008|Overall Study|Physician Decision|1
7336447|NCT00848718|11572429|FG009|Overall Study|Physician Decision|2
7336448|NCT00848718|11572430|FG010|Overall Study|Physician Decision|0
7336449|NCT00848718|11572431|FG011|Overall Study|Physician Decision|0
7336450|NCT00848718|11572432|FG012|Overall Study|Physician Decision|1
7336451|NCT00848718|11572420|FG000|Overall Study|Progressive disease before treatment|1
7336452|NCT00848718|11572421|FG001|Overall Study|Progressive disease before treatment|5
7336453|NCT00848718|11572422|FG002|Overall Study|Progressive disease before treatment|1
7336454|NCT00848718|11572423|FG003|Overall Study|Progressive disease before treatment|3
7336455|NCT00848718|11572424|FG004|Overall Study|Progressive disease before treatment|4
7336456|NCT00848718|11572425|FG005|Overall Study|Progressive disease before treatment|4
7336457|NCT00848718|11572426|FG006|Overall Study|Progressive disease before treatment|2
7336458|NCT00848718|11572427|FG007|Overall Study|Progressive disease before treatment|1
7336459|NCT00848718|11572428|FG008|Overall Study|Progressive disease before treatment|2
7336460|NCT00848718|11572429|FG009|Overall Study|Progressive disease before treatment|7
7336461|NCT00848718|11572430|FG010|Overall Study|Progressive disease before treatment|3
7336462|NCT00848718|11572431|FG011|Overall Study|Progressive disease before treatment|6
7336463|NCT00848718|11572432|FG012|Overall Study|Progressive disease before treatment|2
7336464|NCT00848718|11572420|FG000|Overall Study|Protocol Violation|0
7336465|NCT00848718|11572421|FG001|Overall Study|Protocol Violation|1
7336466|NCT00848718|11572422|FG002|Overall Study|Protocol Violation|0
7336467|NCT00848718|11572423|FG003|Overall Study|Protocol Violation|0
7336468|NCT00848718|11572424|FG004|Overall Study|Protocol Violation|0
7336469|NCT00848718|11572425|FG005|Overall Study|Protocol Violation|0
7336470|NCT00848718|11572426|FG006|Overall Study|Protocol Violation|0
7336471|NCT00848718|11572427|FG007|Overall Study|Protocol Violation|1
7336472|NCT00848718|11572428|FG008|Overall Study|Protocol Violation|0
7336473|NCT00848718|11572429|FG009|Overall Study|Protocol Violation|0
7336474|NCT00848718|11572430|FG010|Overall Study|Protocol Violation|0
7336475|NCT00848718|11572431|FG011|Overall Study|Protocol Violation|0
7336476|NCT00848718|11572432|FG012|Overall Study|Protocol Violation|1
7336477|NCT00848718|11572420|FG000|Overall Study|Withdrawal by Subject|1
7336478|NCT00848718|11572421|FG001|Overall Study|Withdrawal by Subject|0
7336479|NCT00848718|11572422|FG002|Overall Study|Withdrawal by Subject|0
7336480|NCT00848718|11572423|FG003|Overall Study|Withdrawal by Subject|1
7336481|NCT00848718|11572424|FG004|Overall Study|Withdrawal by Subject|0
7336482|NCT00848718|11572425|FG005|Overall Study|Withdrawal by Subject|0
7336483|NCT00848718|11572426|FG006|Overall Study|Withdrawal by Subject|0
7336484|NCT00848718|11572427|FG007|Overall Study|Withdrawal by Subject|0
7336485|NCT00848718|11572428|FG008|Overall Study|Withdrawal by Subject|0
7336486|NCT00848718|11572429|FG009|Overall Study|Withdrawal by Subject|0
7336487|NCT00848718|11572430|FG010|Overall Study|Withdrawal by Subject|1
7336488|NCT00848718|11572431|FG011|Overall Study|Withdrawal by Subject|0
7336489|NCT00848718|11572432|FG012|Overall Study|Withdrawal by Subject|0
7336490|NCT00848718|11572420|FG000|Overall Study|Progressive disease during treatment|3
7336491|NCT00848718|11572421|FG001|Overall Study|Progressive disease during treatment|0
7336492|NCT00848718|11572422|FG002|Overall Study|Progressive disease during treatment|3
7336493|NCT00848718|11572423|FG003|Overall Study|Progressive disease during treatment|0
7336494|NCT00848718|11572424|FG004|Overall Study|Progressive disease during treatment|0
7336495|NCT00848718|11572425|FG005|Overall Study|Progressive disease during treatment|0
7336496|NCT00848718|11572426|FG006|Overall Study|Progressive disease during treatment|0
7336497|NCT00848718|11572427|FG007|Overall Study|Progressive disease during treatment|2
7336498|NCT00848718|11572428|FG008|Overall Study|Progressive disease during treatment|0
7336499|NCT00848718|11572429|FG009|Overall Study|Progressive disease during treatment|0
7336500|NCT00848718|11572430|FG010|Overall Study|Progressive disease during treatment|0
7336501|NCT00848718|11572431|FG011|Overall Study|Progressive disease during treatment|0
7336502|NCT00848718|11572432|FG012|Overall Study|Progressive disease during treatment|2
7336503|NCT00848926|11572483|FG000|Treatment Period|Progressive disease|45
7336504|NCT00848926|11572483|FG000|Treatment Period|Adverse Event|20
7336505|NCT00848926|11572483|FG000|Treatment Period|Physician Decision|12
7336506|NCT00848926|11572483|FG000|Treatment Period|Withdrawal by Subject|7
7336507|NCT00848926|11572483|FG000|Follow-up Period|Lost to Follow-up|7
7336508|NCT00848926|11572483|FG000|Follow-up Period|Withdrawal by Subject|3
7336509|NCT00848926|11572483|FG000|Follow-up Period|Other|2
7336510|NCT00848965|11572487|FG000|Overall Study|Adverse Event|1
7336511|NCT00848965|11572487|FG000|Overall Study|Withdrawal by Subject|1
7336512|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Adverse Event|5
7336513|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Adverse Event|6
7336514|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Adverse Event|15
7336515|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Noncompliance|3
7336516|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Noncompliance|3
7336517|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Noncompliance|4
7336518|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
7336519|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
7336520|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
7336521|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
7336522|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
7336523|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
7336524|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Physician Decision|0
7336525|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Physician Decision|2
7336526|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Physician Decision|1
7336527|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
7336528|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7336529|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
7336530|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
7336531|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
7336532|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
7336533|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
7336534|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7336535|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
7336536|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
7336537|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7336538|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
7336539|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Pregnancy|1
7336540|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Pregnancy|0
7336541|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Pregnancy|1
7336542|NCT00849017|11572502|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7336543|NCT00849017|11572503|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
7336544|NCT00849017|11572504|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
7336545|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
7336546|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
7336547|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
7336548|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7336549|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
7336550|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
7336551|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
7336552|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7336553|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
7336554|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7336555|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
7336556|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
7336557|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7336558|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
7336559|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
7336560|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
7336561|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
7336562|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
7336563|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
7336564|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7336565|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
7336566|NCT00849017|11572502|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
7336567|NCT00849017|11572503|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7336568|NCT00849017|11572504|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
7336569|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
7336570|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
7336571|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
7336572|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
7336573|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7336574|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
7336575|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
7336576|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
7336577|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
7336578|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
7336579|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7336580|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
7336581|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
7336582|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
7336583|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
7336584|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
7336585|NCT00849056|11572518|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
7336586|NCT00849056|11572519|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
7336587|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
7336588|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
7336589|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
7336590|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
7336591|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
7336592|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
7336593|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
7336594|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
7336595|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7336596|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
7336597|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
7336598|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
7336599|NCT00849056|11572518|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
7336600|NCT00849056|11572519|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
7336601|NCT00849108|11572528|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
7336602|NCT00849108|11572529|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
7336603|NCT00849108|11572528|FG000|Cohort 2 Efficacy|Adverse Event|0
7336604|NCT00849108|11572529|FG001|Cohort 2 Efficacy|Adverse Event|1
7336605|NCT00849108|11572528|FG000|Cohort 2 Efficacy|Other|0
7336606|NCT00849108|11572529|FG001|Cohort 2 Efficacy|Other|9
7336607|NCT00849147|11572546|FG000|Overall Study|Withdrawal by Subject|1
7336608|NCT00849147|11572546|FG000|Overall Study|Protocol Violation|2
7336609|NCT00849147|11572546|FG000|Overall Study|Disease Relapse/Progression|2
7336610|NCT00849186|11572550|FG000|Overall Study|Adverse Event|2
7336611|NCT00849186|11572550|FG000|Overall Study|Withdrawal by Subject|1
7336612|NCT00849186|11572550|FG000|Overall Study|not treated|6
7336613|NCT00849186|11572550|FG000|Overall Study|Other|1
7336614|NCT00849212|11572555|FG000|Overall Study|Lack of Efficacy|1
7336615|NCT00849212|11572555|FG000|Overall Study|Withdrawal by Subject|3
7336616|NCT00849212|11572555|FG000|Overall Study|Adverse Event|2
7336617|NCT00849212|11572555|FG000|Overall Study|Miscellaneous|1
7336618|NCT00849290|11572566|FG000|Overall Study|Adverse Event|3
7336619|NCT00849290|11572566|FG000|Overall Study|Death|14
7336620|NCT00849290|11572566|FG000|Overall Study|Withdrawal by Subject|11
7336621|NCT00849290|11572566|FG000|Overall Study|Lost to Follow-up|2
7336622|NCT00849290|11572566|FG000|Overall Study|Protocol Violation|5
7336623|NCT00849290|11572566|FG000|Overall Study|Disease Progression|20
7336624|NCT00849381|11572570|FG000|Overall Study|Adverse Event|1
7336625|NCT00849381|11572570|FG000|Overall Study|Lost to Follow-up|129
7336626|NCT00849381|11572570|FG000|Overall Study|Protocol Violation|5
7336627|NCT00849381|11572570|FG000|Overall Study|Withdrawal by Subject|6
7336628|NCT00849381|11572570|FG000|Overall Study|Other|4
7336629|NCT00849472|11572574|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
7336630|NCT00849472|11572574|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
7336631|NCT00849472|11572574|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
7336632|NCT00849472|11572574|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
7336633|NCT00849472|11572574|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
7336634|NCT00849472|11572574|FG000|Weekly Paclitaxel|Disease Progression|1
7336635|NCT00849472|11572574|FG000|Weekly Paclitaxel|Adverse Event|11
7336636|NCT00849472|11572574|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
7336637|NCT00849472|11572574|FG000|Weekly Paclitaxel|Physician Decision|3
7336638|NCT00849472|11572574|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
7336639|NCT00849472|11572574|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
7336640|NCT00849472|11572574|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
7336641|NCT00849472|11572574|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
7336642|NCT00849472|11572574|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
7336643|NCT00849472|11572574|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
7336644|NCT00849472|11572574|FG000|Pazopanib Postsurgery Treatment|Moved|1
7387622|NCT01215227|11646202|FG005|Overall Study|Subject Withdrew Consent|8
7336645|NCT00849472|11572574|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
7336646|NCT00849680|11572587|FG000|Overall Study|Adverse Event|0
7336647|NCT00849680|11572588|FG001|Overall Study|Adverse Event|0
7336648|NCT00849680|11572589|FG002|Overall Study|Adverse Event|0
7336649|NCT00849680|11572590|FG003|Overall Study|Adverse Event|0
7336650|NCT00849680|11572591|FG004|Overall Study|Adverse Event|0
7336651|NCT00849680|11572592|FG005|Overall Study|Adverse Event|0
7336652|NCT00849680|11572593|FG006|Overall Study|Adverse Event|2
7336653|NCT00849680|11572594|FG007|Overall Study|Adverse Event|0
7336654|NCT00849680|11572587|FG000|Overall Study|Lost to Follow-up|7
7336655|NCT00849680|11572588|FG001|Overall Study|Lost to Follow-up|3
7225232|NCT00064701|11434642|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
7225233|NCT00064701|11434643|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
7225234|NCT00064701|11434644|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
7225235|NCT00064701|11434642|FG000|Clinical Continuation Phase|Patient opted out|0
7225236|NCT00064701|11434643|FG001|Clinical Continuation Phase|Patient opted out|0
7336656|NCT00849680|11572589|FG002|Overall Study|Lost to Follow-up|12
7336657|NCT00849680|11572590|FG003|Overall Study|Lost to Follow-up|11
7336658|NCT00849680|11572591|FG004|Overall Study|Lost to Follow-up|8
7336659|NCT00849680|11572592|FG005|Overall Study|Lost to Follow-up|11
7336660|NCT00849680|11572593|FG006|Overall Study|Lost to Follow-up|12
7336661|NCT00849680|11572594|FG007|Overall Study|Lost to Follow-up|5
7336662|NCT00849680|11572587|FG000|Overall Study|Subject moved|1
7336663|NCT00849680|11572588|FG001|Overall Study|Subject moved|0
7336664|NCT00849680|11572589|FG002|Overall Study|Subject moved|3
7336665|NCT00849680|11572590|FG003|Overall Study|Subject moved|1
7336666|NCT00849680|11572591|FG004|Overall Study|Subject moved|0
7336667|NCT00849680|11572592|FG005|Overall Study|Subject moved|2
7336668|NCT00849680|11572593|FG006|Overall Study|Subject moved|2
7336669|NCT00849680|11572594|FG007|Overall Study|Subject moved|2
7336670|NCT00849680|11572587|FG000|Overall Study|Withdrawal by Subject|2
7336671|NCT00849680|11572588|FG001|Overall Study|Withdrawal by Subject|0
7336672|NCT00849680|11572589|FG002|Overall Study|Withdrawal by Subject|0
7336673|NCT00849680|11572590|FG003|Overall Study|Withdrawal by Subject|2
7336674|NCT00849680|11572591|FG004|Overall Study|Withdrawal by Subject|2
7336675|NCT00849680|11572592|FG005|Overall Study|Withdrawal by Subject|2
7336676|NCT00849680|11572593|FG006|Overall Study|Withdrawal by Subject|1
7336677|NCT00849680|11572594|FG007|Overall Study|Withdrawal by Subject|1
7336678|NCT00849680|11572587|FG000|Overall Study|Subject unable to comply with protocol|1
7336679|NCT00849680|11572588|FG001|Overall Study|Subject unable to comply with protocol|0
7336680|NCT00849680|11572589|FG002|Overall Study|Subject unable to comply with protocol|0
7336681|NCT00849680|11572590|FG003|Overall Study|Subject unable to comply with protocol|0
7336682|NCT00849680|11572591|FG004|Overall Study|Subject unable to comply with protocol|0
7336683|NCT00849680|11572592|FG005|Overall Study|Subject unable to comply with protocol|0
7336684|NCT00849680|11572593|FG006|Overall Study|Subject unable to comply with protocol|0
7336685|NCT00849680|11572594|FG007|Overall Study|Subject unable to comply with protocol|0
7336686|NCT00849693|11572616|FG000|Acute Treatment Phase|Adverse Event|12
7336687|NCT00849693|11572617|FG001|Acute Treatment Phase|Adverse Event|7
7336688|NCT00849693|11572618|FG002|Acute Treatment Phase|Adverse Event|6
7336689|NCT00849693|11572619|FG003|Acute Treatment Phase|Adverse Event|4
7336690|NCT00849693|11572616|FG000|Acute Treatment Phase|Lost to Follow-up|5
7336691|NCT00849693|11572617|FG001|Acute Treatment Phase|Lost to Follow-up|8
7336692|NCT00849693|11572618|FG002|Acute Treatment Phase|Lost to Follow-up|11
7336693|NCT00849693|11572619|FG003|Acute Treatment Phase|Lost to Follow-up|9
7336694|NCT00849693|11572616|FG000|Acute Treatment Phase|Protocol Violation|1
7336695|NCT00849693|11572617|FG001|Acute Treatment Phase|Protocol Violation|5
7336696|NCT00849693|11572618|FG002|Acute Treatment Phase|Protocol Violation|2
7336697|NCT00849693|11572619|FG003|Acute Treatment Phase|Protocol Violation|6
7336698|NCT00849693|11572616|FG000|Acute Treatment Phase|Withdrawal by Subject|5
7336699|NCT00849693|11572617|FG001|Acute Treatment Phase|Withdrawal by Subject|5
7336700|NCT00849693|11572618|FG002|Acute Treatment Phase|Withdrawal by Subject|3
7336701|NCT00849693|11572619|FG003|Acute Treatment Phase|Withdrawal by Subject|8
7336702|NCT00849693|11572616|FG000|Acute Treatment Phase|Parent or caregiver decision|7
7336703|NCT00849693|11572617|FG001|Acute Treatment Phase|Parent or caregiver decision|6
7336704|NCT00849693|11572618|FG002|Acute Treatment Phase|Parent or caregiver decision|7
7336705|NCT00849693|11572619|FG003|Acute Treatment Phase|Parent or caregiver decision|7
7336706|NCT00849693|11572616|FG000|Acute Treatment Phase|Physician Decision|2
7336707|NCT00849693|11572617|FG001|Acute Treatment Phase|Physician Decision|1
7336708|NCT00849693|11572618|FG002|Acute Treatment Phase|Physician Decision|2
7336709|NCT00849693|11572619|FG003|Acute Treatment Phase|Physician Decision|1
7336710|NCT00849693|11572616|FG000|Acute Treatment Phase|Sponsor decision|0
7336711|NCT00849693|11572617|FG001|Acute Treatment Phase|Sponsor decision|0
7336712|NCT00849693|11572618|FG002|Acute Treatment Phase|Sponsor decision|1
7336713|NCT00849693|11572619|FG003|Acute Treatment Phase|Sponsor decision|0
7336714|NCT00849693|11572616|FG000|Acute Treatment Phase|Lack of Efficacy|1
7336715|NCT00849693|11572617|FG001|Acute Treatment Phase|Lack of Efficacy|3
7336716|NCT00849693|11572618|FG002|Acute Treatment Phase|Lack of Efficacy|1
7336717|NCT00849693|11572619|FG003|Acute Treatment Phase|Lack of Efficacy|2
7336718|NCT00849693|11572616|FG000|Extension Phase|Adverse Event|4
7336719|NCT00849693|11572617|FG001|Extension Phase|Adverse Event|6
7336720|NCT00849693|11572618|FG002|Extension Phase|Adverse Event|3
7336721|NCT00849693|11572619|FG003|Extension Phase|Adverse Event|7
7336722|NCT00849693|11572616|FG000|Extension Phase|Lost to Follow-up|7
7336723|NCT00849693|11572617|FG001|Extension Phase|Lost to Follow-up|5
7336724|NCT00849693|11572618|FG002|Extension Phase|Lost to Follow-up|6
7336725|NCT00849693|11572619|FG003|Extension Phase|Lost to Follow-up|6
7336726|NCT00849693|11572616|FG000|Extension Phase|Protocol Violation|0
7336727|NCT00849693|11572617|FG001|Extension Phase|Protocol Violation|3
7336728|NCT00849693|11572618|FG002|Extension Phase|Protocol Violation|2
7336729|NCT00849693|11572619|FG003|Extension Phase|Protocol Violation|3
7336730|NCT00849693|11572616|FG000|Extension Phase|Withdrawal by Subject|6
7336731|NCT00849693|11572617|FG001|Extension Phase|Withdrawal by Subject|9
7336732|NCT00849693|11572618|FG002|Extension Phase|Withdrawal by Subject|10
7336733|NCT00849693|11572619|FG003|Extension Phase|Withdrawal by Subject|15
7336734|NCT00849693|11572616|FG000|Extension Phase|Parent or caregiver decision|9
7336735|NCT00849693|11572617|FG001|Extension Phase|Parent or caregiver decision|4
7336736|NCT00849693|11572618|FG002|Extension Phase|Parent or caregiver decision|10
7336737|NCT00849693|11572619|FG003|Extension Phase|Parent or caregiver decision|5
7336738|NCT00849693|11572616|FG000|Extension Phase|Physician Decision|1
7336739|NCT00849693|11572617|FG001|Extension Phase|Physician Decision|1
7336740|NCT00849693|11572618|FG002|Extension Phase|Physician Decision|2
7336741|NCT00849693|11572619|FG003|Extension Phase|Physician Decision|0
7336742|NCT00849693|11572616|FG000|Extension Phase|Sponsor decision|1
7336743|NCT00849693|11572617|FG001|Extension Phase|Sponsor decision|0
7336744|NCT00849693|11572618|FG002|Extension Phase|Sponsor decision|0
7336745|NCT00849693|11572619|FG003|Extension Phase|Sponsor decision|1
7336746|NCT00849693|11572616|FG000|Extension Phase|Lack of Efficacy|2
7336747|NCT00849693|11572617|FG001|Extension Phase|Lack of Efficacy|2
7336748|NCT00849693|11572618|FG002|Extension Phase|Lack of Efficacy|2
7336749|NCT00849693|11572619|FG003|Extension Phase|Lack of Efficacy|1
7336750|NCT00849875|11572648|FG000|Overall Study|Death|28
7336751|NCT00849875|11572648|FG000|Overall Study|Ongoing (unknown completion status)|11
7336752|NCT00849875|11572648|FG000|Overall Study|Others|6
7336753|NCT00849875|11572648|FG000|Overall Study|Lost to Follow-up|2
7336754|NCT00849901|11572662|FG000|Acute Treatment Phase|Adverse Event|9
7336755|NCT00849901|11572663|FG001|Acute Treatment Phase|Adverse Event|1
7336756|NCT00849901|11572664|FG002|Acute Treatment Phase|Adverse Event|3
7336757|NCT00849901|11572662|FG000|Acute Treatment Phase|Lost to Follow-up|2
7336758|NCT00849901|11572663|FG001|Acute Treatment Phase|Lost to Follow-up|4
7336759|NCT00849901|11572664|FG002|Acute Treatment Phase|Lost to Follow-up|1
7336760|NCT00849901|11572662|FG000|Acute Treatment Phase|Protocol Violation|0
7336761|NCT00849901|11572663|FG001|Acute Treatment Phase|Protocol Violation|2
7336762|NCT00849901|11572664|FG002|Acute Treatment Phase|Protocol Violation|1
7336763|NCT00849901|11572662|FG000|Acute Treatment Phase|Withdrawal by Subject|4
7336764|NCT00849901|11572663|FG001|Acute Treatment Phase|Withdrawal by Subject|10
7336765|NCT00849901|11572664|FG002|Acute Treatment Phase|Withdrawal by Subject|4
7336766|NCT00849901|11572662|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
7336767|NCT00849901|11572663|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
7336768|NCT00849901|11572664|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
7336769|NCT00849901|11572662|FG000|Acute Treatment Phase|Physician Decision|1
7336770|NCT00849901|11572663|FG001|Acute Treatment Phase|Physician Decision|1
7336771|NCT00849901|11572664|FG002|Acute Treatment Phase|Physician Decision|1
7336772|NCT00849901|11572662|FG000|Acute Treatment Phase|Sponsor Decision|1
7336773|NCT00849901|11572663|FG001|Acute Treatment Phase|Sponsor Decision|0
7336774|NCT00849901|11572664|FG002|Acute Treatment Phase|Sponsor Decision|0
7336775|NCT00849901|11572662|FG000|Acute Treatment Phase|Lack of Efficacy|2
7336776|NCT00849901|11572663|FG001|Acute Treatment Phase|Lack of Efficacy|3
7336777|NCT00849901|11572664|FG002|Acute Treatment Phase|Lack of Efficacy|2
7336778|NCT00849901|11572662|FG000|Extension Phase|Adverse Event|2
7336779|NCT00849901|11572663|FG001|Extension Phase|Adverse Event|8
7336780|NCT00849901|11572664|FG002|Extension Phase|Adverse Event|4
7336781|NCT00849901|11572662|FG000|Extension Phase|Lost to Follow-up|3
7336782|NCT00849901|11572663|FG001|Extension Phase|Lost to Follow-up|0
7336783|NCT00849901|11572664|FG002|Extension Phase|Lost to Follow-up|1
7336784|NCT00849901|11572662|FG000|Extension Phase|Protocol Violation|2
7336785|NCT00849901|11572663|FG001|Extension Phase|Protocol Violation|2
7336786|NCT00849901|11572664|FG002|Extension Phase|Protocol Violation|4
7336787|NCT00849901|11572662|FG000|Extension Phase|Withdrawal by Subject|7
7336788|NCT00849901|11572663|FG001|Extension Phase|Withdrawal by Subject|6
7336789|NCT00849901|11572664|FG002|Extension Phase|Withdrawal by Subject|3
7336790|NCT00849901|11572662|FG000|Extension Phase|Parent or Caregiver Decision|10
7336791|NCT00849901|11572663|FG001|Extension Phase|Parent or Caregiver Decision|4
7336792|NCT00849901|11572664|FG002|Extension Phase|Parent or Caregiver Decision|4
7336793|NCT00849901|11572662|FG000|Extension Phase|Physician Decision|1
7336794|NCT00849901|11572663|FG001|Extension Phase|Physician Decision|2
7336795|NCT00849901|11572664|FG002|Extension Phase|Physician Decision|0
7336796|NCT00849901|11572662|FG000|Extension Phase|Lack of Efficacy|2
7336797|NCT00849901|11572663|FG001|Extension Phase|Lack of Efficacy|4
7336798|NCT00849901|11572664|FG002|Extension Phase|Lack of Efficacy|1
7336799|NCT00849940|11572678|FG000|Overall Study|Physician Decision|4
7336800|NCT00850070|11572688|FG000|Overall Study|Lack of Efficacy|1
7336801|NCT00850070|11572689|FG001|Overall Study|Lack of Efficacy|1
7336802|NCT00850070|11572688|FG000|Overall Study|Adverse Event|2
7336803|NCT00850070|11572689|FG001|Overall Study|Adverse Event|0
7336804|NCT00850135|11572709|FG000|Overall Study|Physician Decision|1
7336805|NCT00850200|11572715|FG000|Overall Study|Physician Decision|2
7336806|NCT00850200|11572715|FG000|Overall Study|Did not recieve treatment|2
7336807|NCT00850200|11572715|FG000|Overall Study|Withdrawal by Subject|1
7385555|NCT01202591|11643370|FG005|Overall Study|Other reason as per investigator|3
7385556|NCT01202591|11643365|FG000|Overall Study|Withdrawal by Subject|0
7385557|NCT01202591|11643366|FG001|Overall Study|Withdrawal by Subject|0
7385558|NCT01202591|11643367|FG002|Overall Study|Withdrawal by Subject|0
7385559|NCT01202591|11643368|FG003|Overall Study|Withdrawal by Subject|0
7385560|NCT01202591|11643369|FG004|Overall Study|Withdrawal by Subject|2
7385561|NCT01202591|11643370|FG005|Overall Study|Withdrawal by Subject|1
7385562|NCT01202591|11643365|FG000|Overall Study|Objective Disease Progression|0
7385563|NCT01202591|11643366|FG001|Overall Study|Objective Disease Progression|0
7385564|NCT01202591|11643367|FG002|Overall Study|Objective Disease Progression|0
7385565|NCT01202591|11643368|FG003|Overall Study|Objective Disease Progression|0
7385566|NCT01202591|11643369|FG004|Overall Study|Objective Disease Progression|2
7385567|NCT01202591|11643370|FG005|Overall Study|Objective Disease Progression|0
7385568|NCT01202747|11643421|FG000|Overall Study|Withdrawal by Subject|1
7385569|NCT01202760|11643428|FG000|Overall Study|Entry Criteria Not Met|0
7385570|NCT01202760|11643429|FG001|Overall Study|Entry Criteria Not Met|3
7385571|NCT01202760|11643430|FG002|Overall Study|Entry Criteria Not Met|1
7385572|NCT01202760|11643428|FG000|Overall Study|Adverse Event|11
7385573|NCT01202760|11643429|FG001|Overall Study|Adverse Event|9
7385574|NCT01202760|11643430|FG002|Overall Study|Adverse Event|10
7385575|NCT01202760|11643428|FG000|Overall Study|Death|2
7385576|NCT01202760|11643429|FG001|Overall Study|Death|1
7385577|NCT01202760|11643430|FG002|Overall Study|Death|0
7385578|NCT01202760|11643428|FG000|Overall Study|Lack of Efficacy|6
7385579|NCT01202760|11643429|FG001|Overall Study|Lack of Efficacy|8
7385580|NCT01202760|11643430|FG002|Overall Study|Lack of Efficacy|7
7385581|NCT01202760|11643428|FG000|Overall Study|Lost to Follow-up|0
7385582|NCT01202760|11643429|FG001|Overall Study|Lost to Follow-up|2
7385583|NCT01202760|11643430|FG002|Overall Study|Lost to Follow-up|1
7385584|NCT01202760|11643428|FG000|Overall Study|Parent / Caregiver Decision|0
7385585|NCT01202760|11643429|FG001|Overall Study|Parent / Caregiver Decision|1
7385586|NCT01202760|11643430|FG002|Overall Study|Parent / Caregiver Decision|0
7385587|NCT01202760|11643428|FG000|Overall Study|Withdrawal by Subject|17
7385588|NCT01202760|11643429|FG001|Overall Study|Withdrawal by Subject|18
7385589|NCT01202760|11643430|FG002|Overall Study|Withdrawal by Subject|14
7385590|NCT01202760|11643428|FG000|Overall Study|Physician Decision|0
7385591|NCT01202760|11643429|FG001|Overall Study|Physician Decision|1
7385592|NCT01202760|11643430|FG002|Overall Study|Physician Decision|0
7385593|NCT01202760|11643428|FG000|Overall Study|Protocol Violation|7
7385594|NCT01202760|11643429|FG001|Overall Study|Protocol Violation|5
7385595|NCT01202760|11643430|FG002|Overall Study|Protocol Violation|2
7336808|NCT00850343|11572726|FG000|Overall Study|Withdrawal by Subject|11
7336809|NCT00850343|11572727|FG001|Overall Study|Withdrawal by Subject|0
7336810|NCT00850343|11572728|FG002|Overall Study|Withdrawal by Subject|3
7336811|NCT00850343|11572729|FG003|Overall Study|Withdrawal by Subject|2
7336812|NCT00850343|11572726|FG000|Overall Study|Adverse Event|15
7336813|NCT00850343|11572727|FG001|Overall Study|Adverse Event|2
7336814|NCT00850343|11572728|FG002|Overall Study|Adverse Event|6
7336815|NCT00850343|11572729|FG003|Overall Study|Adverse Event|6
7336816|NCT00850343|11572726|FG000|Overall Study|Pregnancy|0
7336817|NCT00850343|11572727|FG001|Overall Study|Pregnancy|0
7336818|NCT00850343|11572728|FG002|Overall Study|Pregnancy|0
7336819|NCT00850343|11572729|FG003|Overall Study|Pregnancy|1
7336820|NCT00850343|11572726|FG000|Overall Study|Lack of Efficacy|17
7336821|NCT00850343|11572727|FG001|Overall Study|Lack of Efficacy|0
7336822|NCT00850343|11572728|FG002|Overall Study|Lack of Efficacy|3
7336823|NCT00850343|11572729|FG003|Overall Study|Lack of Efficacy|2
7336824|NCT00850343|11572726|FG000|Overall Study|Non-compliance with Study Procedures|1
7336825|NCT00850343|11572727|FG001|Overall Study|Non-compliance with Study Procedures|0
7336826|NCT00850343|11572728|FG002|Overall Study|Non-compliance with Study Procedures|1
7336827|NCT00850343|11572729|FG003|Overall Study|Non-compliance with Study Procedures|1
7336828|NCT00850343|11572726|FG000|Overall Study|Physician Decision|2
7336829|NCT00850343|11572727|FG001|Overall Study|Physician Decision|1
7336830|NCT00850343|11572728|FG002|Overall Study|Physician Decision|1
7336831|NCT00850343|11572729|FG003|Overall Study|Physician Decision|1
7336832|NCT00850395|11572739|FG000|Overall Study|Death|1
7336833|NCT00850395|11572739|FG000|Overall Study|Adverse Event|1
7336834|NCT00850395|11572739|FG000|Overall Study|Insufficient clinical response|3
7336835|NCT00850395|11572739|FG000|Overall Study|Other|5
7336836|NCT00850460|11572745|FG000|Overall Study|Lost to Follow-up|4
7336837|NCT00850460|11572746|FG001|Overall Study|Lost to Follow-up|4
7336838|NCT00850499|11572758|FG000|Overall Study|Adverse Event|3
7336839|NCT00850499|11572759|FG001|Overall Study|Adverse Event|1
7336840|NCT00850499|11572758|FG000|Overall Study|Lack of Efficacy|0
7336841|NCT00850499|11572759|FG001|Overall Study|Lack of Efficacy|1
7336842|NCT00850538|11572765|FG000|Overall Study|unable/unwilling to complete MRI|13
7336843|NCT00850538|11572765|FG000|Overall Study|specimen missed due to scheduling error|14
7336844|NCT00850538|11572765|FG000|Overall Study|specimen unusable|7
7336845|NCT00850538|11572765|FG000|Overall Study|Withdrawal by Subject|3
7336846|NCT00850538|11572765|FG000|Overall Study|radiology error|2
7336847|NCT00850538|11572765|FG000|Overall Study|Protocol Violation|2
7336848|NCT00850564|11572769|FG000|Overall Study|Withdrawal by Subject|2
7336849|NCT00850759|11572812|FG000|Overall Study|Lost to Follow-up|7
7336850|NCT00850759|11572813|FG001|Overall Study|Lost to Follow-up|5
7336851|NCT00850759|11572814|FG002|Overall Study|Lost to Follow-up|5
7336852|NCT00850759|11572815|FG003|Overall Study|Lost to Follow-up|3
7336853|NCT00850993|11572836|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7336854|NCT00850993|11572837|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7336855|NCT00850993|11572838|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
7336856|NCT00850993|11572839|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
7336857|NCT00851084|11572859|FG000|Overall Study|Randomized but not treated|1
7336858|NCT00851084|11572860|FG001|Overall Study|Randomized but not treated|0
7336859|NCT00851084|11572859|FG000|Overall Study|Adverse Event|26
7336860|NCT00851084|11572860|FG001|Overall Study|Adverse Event|36
7336861|NCT00851084|11572859|FG000|Overall Study|Disease progression|52
7336862|NCT00851084|11572860|FG001|Overall Study|Disease progression|47
7336863|NCT00851084|11572859|FG000|Overall Study|Poor compliance to protocol|1
7336864|NCT00851084|11572860|FG001|Overall Study|Poor compliance to protocol|1
7336865|NCT00851084|11572859|FG000|Overall Study|Physician Decision|13
7336866|NCT00851084|11572860|FG001|Overall Study|Physician Decision|14
7336867|NCT00851084|11572859|FG000|Overall Study|Consent withdrawn|0
7336868|NCT00851084|11572860|FG001|Overall Study|Consent withdrawn|2
7336869|NCT00851084|11572859|FG000|Overall Study|Withdrawal by Subject|11
7336870|NCT00851084|11572860|FG001|Overall Study|Withdrawal by Subject|12
7336871|NCT00851084|11572859|FG000|Overall Study|Metastatic surgery|6
7336872|NCT00851084|11572860|FG001|Overall Study|Metastatic surgery|6
7336873|NCT00851084|11572859|FG000|Overall Study|Other|7
7336874|NCT00851084|11572860|FG001|Overall Study|Other|1
7336875|NCT00851253|11572870|FG000|Overall Study|Disease Progression|1
7336876|NCT00851253|11572871|FG001|Overall Study|Disease Progression|0
7336877|NCT00851318|11572885|FG000|Overall Study|Withdrawal by Subject|7
7336878|NCT00851318|11572886|FG001|Overall Study|Withdrawal by Subject|1
7336879|NCT00851318|11572887|FG002|Overall Study|Withdrawal by Subject|5
7336880|NCT00851318|11572888|FG003|Overall Study|Withdrawal by Subject|3
7336881|NCT00851318|11572885|FG000|Overall Study|Adverse Event|13
7336882|NCT00851318|11572886|FG001|Overall Study|Adverse Event|2
7336883|NCT00851318|11572887|FG002|Overall Study|Adverse Event|9
7336884|NCT00851318|11572888|FG003|Overall Study|Adverse Event|12
7336885|NCT00851318|11572885|FG000|Overall Study|Pregnancy|0
7336886|NCT00851318|11572886|FG001|Overall Study|Pregnancy|0
7336887|NCT00851318|11572887|FG002|Overall Study|Pregnancy|1
7336888|NCT00851318|11572888|FG003|Overall Study|Pregnancy|1
7336889|NCT00851318|11572885|FG000|Overall Study|Lack of Efficacy|8
7336890|NCT00851318|11572886|FG001|Overall Study|Lack of Efficacy|2
7336891|NCT00851318|11572887|FG002|Overall Study|Lack of Efficacy|4
7336892|NCT00851318|11572888|FG003|Overall Study|Lack of Efficacy|2
7336893|NCT00851318|11572885|FG000|Overall Study|Non-compliance with Study Procedures|2
7336894|NCT00851318|11572886|FG001|Overall Study|Non-compliance with Study Procedures|0
7336895|NCT00851318|11572887|FG002|Overall Study|Non-compliance with Study Procedures|1
7336896|NCT00851318|11572888|FG003|Overall Study|Non-compliance with Study Procedures|0
7336897|NCT00851318|11572885|FG000|Overall Study|Physician Decision|0
7336898|NCT00851318|11572886|FG001|Overall Study|Physician Decision|0
7336899|NCT00851318|11572887|FG002|Overall Study|Physician Decision|1
7336900|NCT00851318|11572888|FG003|Overall Study|Physician Decision|1
7336901|NCT00851630|11572918|FG000|Overall Study|Death|2
7336902|NCT00851630|11572919|FG001|Overall Study|Death|1
7336903|NCT00851630|11572918|FG000|Overall Study|Clinical failure|0
7336904|NCT00851630|11572919|FG001|Overall Study|Clinical failure|1
7336905|NCT00851643|11572931|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
7336906|NCT00851643|11572932|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7336907|NCT00851643|11572933|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7336908|NCT00851643|11572934|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7336909|NCT00851643|11572935|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7336910|NCT00851643|11572936|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
7336911|NCT00851643|11572931|FG000|Base Study (Up to 12 Months)|Other|0
7458095|NCT01806584|11752171|FG000|Overall Study|Withdrawal by Subject|1
7458096|NCT01806584|11752172|FG001|Overall Study|Withdrawal by Subject|1
7458097|NCT01806584|11752171|FG000|Overall Study|Other unspecified|1
7458098|NCT01806584|11752172|FG001|Overall Study|Other unspecified|0
7458099|NCT01806597|11752181|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
7458100|NCT01806597|11752182|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
7458101|NCT01806597|11752183|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
7458102|NCT01806597|11752184|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
7458103|NCT01806597|11752185|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
7458104|NCT01806597|11752186|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
7458105|NCT01806597|11752181|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7458106|NCT01806597|11752182|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7458107|NCT01806597|11752183|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7458108|NCT01806597|11752184|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7458109|NCT01806597|11752185|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
7458110|NCT01806597|11752186|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
7458111|NCT01806597|11752181|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
7458112|NCT01806597|11752182|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
7458113|NCT01806597|11752183|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
7458114|NCT01806597|11752184|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
7458115|NCT01806597|11752185|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
7458116|NCT01806597|11752186|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
7458117|NCT01806597|11752181|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
7458118|NCT01806597|11752182|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7458119|NCT01806597|11752183|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7458120|NCT01806597|11752184|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7458121|NCT01806597|11752185|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
7458122|NCT01806597|11752186|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
7458123|NCT01806597|11752181|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
7458124|NCT01806597|11752182|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
7458125|NCT01806597|11752183|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
7458126|NCT01806597|11752184|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
7458127|NCT01806597|11752185|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
7458128|NCT01806597|11752186|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
7458129|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
7458130|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
7458131|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
7458132|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
7458133|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
7458134|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
7458135|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
7458136|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
7458137|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
7458138|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
7458139|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7458140|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
7458141|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
7458142|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7458143|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7458144|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7458145|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7458146|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
7458147|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7458148|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
7336912|NCT00851643|11572932|FG001|Base Study (Up to 12 Months)|Other|0
7336913|NCT00851643|11572933|FG002|Base Study (Up to 12 Months)|Other|0
7336914|NCT00851643|11572934|FG003|Base Study (Up to 12 Months)|Other|0
7336915|NCT00851643|11572935|FG004|Base Study (Up to 12 Months)|Other|0
7336916|NCT00851643|11572936|FG005|Base Study (Up to 12 Months)|Other|1
7336917|NCT00851643|11572931|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7336918|NCT00851643|11572932|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7336919|NCT00851643|11572933|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
7336920|NCT00851643|11572934|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
7336921|NCT00851643|11572935|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
7336922|NCT00851643|11572936|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
7336923|NCT00851643|11572931|FG000|Extension Study (Up to 36 Months)|Moved|0
7336924|NCT00851643|11572932|FG001|Extension Study (Up to 36 Months)|Moved|2
7336925|NCT00851643|11572933|FG002|Extension Study (Up to 36 Months)|Moved|1
7336926|NCT00851643|11572934|FG003|Extension Study (Up to 36 Months)|Moved|1
7336927|NCT00851643|11572935|FG004|Extension Study (Up to 36 Months)|Moved|0
7336928|NCT00851643|11572936|FG005|Extension Study (Up to 36 Months)|Moved|1
7336929|NCT00851721|11572951|FG000|Overall Study|planned surgery|1
7336930|NCT00851721|11572952|FG001|Overall Study|planned surgery|0
7336931|NCT00851721|11572951|FG000|Overall Study|Death|1
7336932|NCT00851721|11572952|FG001|Overall Study|Death|0
7336933|NCT00851721|11572951|FG000|Overall Study|Adverse Event|0
7336934|NCT00851721|11572952|FG001|Overall Study|Adverse Event|1
7336935|NCT00851786|11572966|FG000|Overall Study|Withdrawal by Subject|0
7336936|NCT00851786|11572967|FG001|Overall Study|Withdrawal by Subject|1
7336937|NCT00851786|11572966|FG000|Overall Study|Protocol Violation|0
7336938|NCT00851786|11572967|FG001|Overall Study|Protocol Violation|1
7336939|NCT00851786|11572966|FG000|Overall Study|Lost to Follow-up|1
7336940|NCT00851786|11572967|FG001|Overall Study|Lost to Follow-up|0
7336941|NCT00851786|11572966|FG000|Overall Study|Incarceration|1
7336942|NCT00851786|11572967|FG001|Overall Study|Incarceration|0
7336943|NCT00851786|11572966|FG000|Overall Study|Site Closure|1
7336944|NCT00851786|11572967|FG001|Overall Study|Site Closure|0
7336945|NCT00851786|11572966|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
7336946|NCT00851786|11572967|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
7336947|NCT00851799|11572976|FG000|Overall Study|Death|1
7336948|NCT00851799|11572977|FG001|Overall Study|Death|0
7336949|NCT00851799|11572978|FG002|Overall Study|Death|1
7336950|NCT00851799|11572976|FG000|Overall Study|Lost to Follow-up|5
7336951|NCT00851799|11572977|FG001|Overall Study|Lost to Follow-up|3
7336952|NCT00851799|11572978|FG002|Overall Study|Lost to Follow-up|10
7336953|NCT00851799|11572976|FG000|Overall Study|Not able to get to clinic|8
7336954|NCT00851799|11572977|FG001|Overall Study|Not able to get to clinic|5
7336955|NCT00851799|11572978|FG002|Overall Study|Not able to get to clinic|9
7336956|NCT00851799|11572976|FG000|Overall Study|Not willing to adhere to requirements|1
7336957|NCT00851799|11572977|FG001|Overall Study|Not willing to adhere to requirements|2
7336958|NCT00851799|11572978|FG002|Overall Study|Not willing to adhere to requirements|2
7336959|NCT00851799|11572976|FG000|Overall Study|Withdrew consent prior study completion|1
7336960|NCT00851799|11572977|FG001|Overall Study|Withdrew consent prior study completion|2
7336961|NCT00851799|11572978|FG002|Overall Study|Withdrew consent prior study completion|1
7336962|NCT00851799|11572976|FG000|Overall Study|Severe Debilitation|0
7336963|NCT00851799|11572977|FG001|Overall Study|Severe Debilitation|1
7336964|NCT00851799|11572978|FG002|Overall Study|Severe Debilitation|0
7336965|NCT00851799|11572976|FG000|Overall Study|Completed protocol due to pregnancy|0
7336966|NCT00851799|11572977|FG001|Overall Study|Completed protocol due to pregnancy|0
7336967|NCT00851799|11572978|FG002|Overall Study|Completed protocol due to pregnancy|1
7336968|NCT00851877|11572986|FG000|Phase I-1|Death|1
7336969|NCT00851877|11572987|FG001|Phase I-1|Death|0
7336970|NCT00851877|11572988|FG002|Phase I-1|Death|0
7336971|NCT00851877|11572986|FG000|Phase II|Withdrawal by Subject|0
7336972|NCT00851877|11572987|FG001|Phase II|Withdrawal by Subject|0
7336973|NCT00851877|11572988|FG002|Phase II|Withdrawal by Subject|3
7336974|NCT00851890|11572998|FG000|Overall Study|Lost to Follow-up|0
7336975|NCT00851890|11572999|FG001|Overall Study|Lost to Follow-up|1
7336976|NCT00851890|11573000|FG002|Overall Study|Lost to Follow-up|0
7336977|NCT00851890|11573001|FG003|Overall Study|Lost to Follow-up|1
7336978|NCT00851903|11573011|FG000|Overall Study|Withdrawal by Subject|2
7336979|NCT00852202|11573027|FG000|Overall Study|Adverse Event|2
7336980|NCT00852202|11573028|FG001|Overall Study|Adverse Event|3
7336981|NCT00852202|11573029|FG002|Overall Study|Adverse Event|7
7336982|NCT00852202|11573027|FG000|Overall Study|Lack of Efficacy|4
7336983|NCT00852202|11573028|FG001|Overall Study|Lack of Efficacy|1
7336984|NCT00852202|11573029|FG002|Overall Study|Lack of Efficacy|2
7336985|NCT00852202|11573027|FG000|Overall Study|Protocol Violation|2
7336986|NCT00852202|11573028|FG001|Overall Study|Protocol Violation|2
7336987|NCT00852202|11573029|FG002|Overall Study|Protocol Violation|7
7336988|NCT00852202|11573027|FG000|Overall Study|Withdrawal by Subject|3
7336989|NCT00852202|11573028|FG001|Overall Study|Withdrawal by Subject|1
7336990|NCT00852202|11573029|FG002|Overall Study|Withdrawal by Subject|2
7336991|NCT00852202|11573027|FG000|Overall Study|Lost to Follow-up|5
7336992|NCT00852202|11573028|FG001|Overall Study|Lost to Follow-up|5
7336993|NCT00852202|11573029|FG002|Overall Study|Lost to Follow-up|6
7336994|NCT00852202|11573027|FG000|Overall Study|pregnancy,moving away and surgery|1
7336995|NCT00852202|11573028|FG001|Overall Study|pregnancy,moving away and surgery|0
7336996|NCT00852202|11573029|FG002|Overall Study|pregnancy,moving away and surgery|2
7336997|NCT00852397|11573041|FG000|Overall Study|Adverse Event|4
7336998|NCT00852397|11573042|FG001|Overall Study|Adverse Event|6
7336999|NCT00852397|11573043|FG002|Overall Study|Adverse Event|4
7337000|NCT00852397|11573041|FG000|Overall Study|Death|0
7337001|NCT00852397|11573042|FG001|Overall Study|Death|0
7337002|NCT00852397|11573043|FG002|Overall Study|Death|1
7337003|NCT00852397|11573041|FG000|Overall Study|Withdrawal by Subject|4
7337004|NCT00852397|11573042|FG001|Overall Study|Withdrawal by Subject|1
7337005|NCT00852397|11573043|FG002|Overall Study|Withdrawal by Subject|2
7337006|NCT00852397|11573041|FG000|Overall Study|Study terminated by sponsor|2
7337007|NCT00852397|11573042|FG001|Overall Study|Study terminated by sponsor|1
7337008|NCT00852397|11573043|FG002|Overall Study|Study terminated by sponsor|6
7337009|NCT00852397|11573041|FG000|Overall Study|Difficulty in study site visit|1
7337010|NCT00852397|11573042|FG001|Overall Study|Difficulty in study site visit|0
7337011|NCT00852397|11573043|FG002|Overall Study|Difficulty in study site visit|0
7337012|NCT00852397|11573041|FG000|Overall Study|Protocol Violation|0
7337013|NCT00852397|11573042|FG001|Overall Study|Protocol Violation|0
7337014|NCT00852397|11573043|FG002|Overall Study|Protocol Violation|1
7337015|NCT00852475|11573053|FG000|Overall Study|Lost to Follow-up|3
7337016|NCT00852475|11573054|FG001|Overall Study|Lost to Follow-up|4
7337017|NCT00852540|11573070|FG000|Overall Study|Adverse Event|10
7337018|NCT00852540|11573071|FG001|Overall Study|Adverse Event|3
7337019|NCT00852540|11573070|FG000|Overall Study|Lack of Efficacy|15
7337020|NCT00852540|11573071|FG001|Overall Study|Lack of Efficacy|3
7337021|NCT00852540|11573070|FG000|Overall Study|Protocol Violation|1
7337022|NCT00852540|11573071|FG001|Overall Study|Protocol Violation|2
7337023|NCT00852540|11573070|FG000|Overall Study|Lost to Follow-up|2
7337024|NCT00852540|11573071|FG001|Overall Study|Lost to Follow-up|3
7337025|NCT00852540|11573070|FG000|Overall Study|Investigator Discretion|2
7337026|NCT00852540|11573071|FG001|Overall Study|Investigator Discretion|3
7337027|NCT00852540|11573070|FG000|Overall Study|Withdrawal by Subject|3
7337028|NCT00852540|11573071|FG001|Overall Study|Withdrawal by Subject|1
7337029|NCT00852540|11573070|FG000|Overall Study|Did Not Receive Study Drug|3
7337030|NCT00852540|11573071|FG001|Overall Study|Did Not Receive Study Drug|3
7337031|NCT00852917|11573124|FG000|Overall Study|Adverse Event|13
7337032|NCT00852917|11573125|FG001|Overall Study|Adverse Event|20
7337033|NCT00852917|11573126|FG002|Overall Study|Adverse Event|35
7337034|NCT00852917|11573127|FG003|Overall Study|Adverse Event|17
7337035|NCT00852917|11573124|FG000|Overall Study|Lack of Efficacy|21
7337036|NCT00852917|11573125|FG001|Overall Study|Lack of Efficacy|11
7337037|NCT00852917|11573126|FG002|Overall Study|Lack of Efficacy|11
7337038|NCT00852917|11573127|FG003|Overall Study|Lack of Efficacy|47
7337039|NCT00852917|11573124|FG000|Overall Study|Withdrawal by Subject|4
7337040|NCT00852917|11573125|FG001|Overall Study|Withdrawal by Subject|8
7337041|NCT00852917|11573126|FG002|Overall Study|Withdrawal by Subject|10
7337042|NCT00852917|11573127|FG003|Overall Study|Withdrawal by Subject|9
7337043|NCT00852917|11573124|FG000|Overall Study|Physician Decision|6
7337044|NCT00852917|11573125|FG001|Overall Study|Physician Decision|7
7337045|NCT00852917|11573126|FG002|Overall Study|Physician Decision|2
7337046|NCT00852917|11573127|FG003|Overall Study|Physician Decision|19
7337047|NCT00852917|11573124|FG000|Overall Study|Death|0
7337048|NCT00852917|11573125|FG001|Overall Study|Death|0
7337049|NCT00852917|11573126|FG002|Overall Study|Death|0
7337050|NCT00852917|11573127|FG003|Overall Study|Death|1
7337051|NCT00852930|11573140|FG000|Overall Study|Withdrawal by Subject|1
7337052|NCT00852930|11573141|FG001|Overall Study|Withdrawal by Subject|1
7337053|NCT00852930|11573142|FG002|Overall Study|Withdrawal by Subject|1
7337054|NCT00852930|11573140|FG000|Overall Study|Physician Decision|0
7337055|NCT00852930|11573141|FG001|Overall Study|Physician Decision|0
7337056|NCT00852930|11573142|FG002|Overall Study|Physician Decision|1
7337057|NCT00852969|11573153|FG000|Overall Study|Adverse Event|0
7337058|NCT00852969|11573154|FG001|Overall Study|Adverse Event|1
7337059|NCT00852969|11573153|FG000|Overall Study|Lost to Follow-up|0
7337060|NCT00852969|11573154|FG001|Overall Study|Lost to Follow-up|1
7337061|NCT00852995|11573165|FG000|Overall Study|Adverse Event|1
7337062|NCT00852995|11573166|FG001|Overall Study|Adverse Event|0
7337063|NCT00852995|11573167|FG002|Overall Study|Adverse Event|4
7337064|NCT00852995|11573168|FG003|Overall Study|Adverse Event|0
7337065|NCT00852995|11573169|FG004|Overall Study|Adverse Event|0
7337066|NCT00852995|11573165|FG000|Overall Study|Lost to Follow-up|0
7337067|NCT00852995|11573166|FG001|Overall Study|Lost to Follow-up|1
7337068|NCT00852995|11573167|FG002|Overall Study|Lost to Follow-up|1
7337069|NCT00852995|11573168|FG003|Overall Study|Lost to Follow-up|0
7337070|NCT00852995|11573169|FG004|Overall Study|Lost to Follow-up|0
7337071|NCT00852995|11573165|FG000|Overall Study|Withdrawal by Subject|4
7337072|NCT00852995|11573166|FG001|Overall Study|Withdrawal by Subject|0
7337073|NCT00852995|11573167|FG002|Overall Study|Withdrawal by Subject|0
7337074|NCT00852995|11573168|FG003|Overall Study|Withdrawal by Subject|1
7337075|NCT00852995|11573169|FG004|Overall Study|Withdrawal by Subject|2
7337076|NCT00852995|11573165|FG000|Overall Study|Non-Compliance|0
7337077|NCT00852995|11573166|FG001|Overall Study|Non-Compliance|0
7337078|NCT00852995|11573167|FG002|Overall Study|Non-Compliance|0
7337079|NCT00852995|11573168|FG003|Overall Study|Non-Compliance|2
7337080|NCT00852995|11573169|FG004|Overall Study|Non-Compliance|0
7337081|NCT00852995|11573165|FG000|Overall Study|Progressive Disease|1
7337082|NCT00852995|11573166|FG001|Overall Study|Progressive Disease|0
7337083|NCT00852995|11573167|FG002|Overall Study|Progressive Disease|0
7337084|NCT00852995|11573168|FG003|Overall Study|Progressive Disease|2
7337085|NCT00852995|11573169|FG004|Overall Study|Progressive Disease|1
7337086|NCT00852995|11573165|FG000|Overall Study|Physician Decision|1
7337087|NCT00852995|11573166|FG001|Overall Study|Physician Decision|0
7337088|NCT00852995|11573167|FG002|Overall Study|Physician Decision|0
7337089|NCT00852995|11573168|FG003|Overall Study|Physician Decision|0
7337090|NCT00852995|11573169|FG004|Overall Study|Physician Decision|0
7337091|NCT00852995|11573165|FG000|Overall Study|Protocol Violation|0
7337092|NCT00852995|11573166|FG001|Overall Study|Protocol Violation|0
7337093|NCT00852995|11573167|FG002|Overall Study|Protocol Violation|0
7337094|NCT00852995|11573168|FG003|Overall Study|Protocol Violation|0
7337095|NCT00852995|11573169|FG004|Overall Study|Protocol Violation|1
7337096|NCT00852995|11573165|FG000|Overall Study|Moved Out of Area|1
7337097|NCT00852995|11573166|FG001|Overall Study|Moved Out of Area|0
7568662|NCT03423238|11944164|FG000|Overall Study|Lost to Follow-up|1
7568663|NCT03423238|11944165|FG001|Overall Study|Lost to Follow-up|0
7337098|NCT00852995|11573167|FG002|Overall Study|Moved Out of Area|0
7337099|NCT00852995|11573168|FG003|Overall Study|Moved Out of Area|0
7337100|NCT00852995|11573169|FG004|Overall Study|Moved Out of Area|0
7337101|NCT00853021|11573186|FG000|Overall Study|Adverse Event|2
7337102|NCT00853021|11573186|FG000|Overall Study|Withdrawal by Subject|2
7337103|NCT00853021|11573186|FG000|Overall Study|Death|1
7337104|NCT00853047|11573195|FG000|Core Phase|Participant Request|0
7337105|NCT00853047|11573196|FG001|Core Phase|Participant Request|0
7337106|NCT00853047|11573197|FG002|Core Phase|Participant Request|0
7337107|NCT00853047|11573198|FG003|Core Phase|Participant Request|1
7337108|NCT00853047|11573199|FG004|Core Phase|Participant Request|0
7337109|NCT00853047|11573200|FG005|Core Phase|Participant Request|0
7337110|NCT00853047|11573195|FG000|Open-Label Extension Phase|Participant Request|0
7337111|NCT00853047|11573196|FG001|Open-Label Extension Phase|Participant Request|0
7337112|NCT00853047|11573197|FG002|Open-Label Extension Phase|Participant Request|0
7337113|NCT00853047|11573198|FG003|Open-Label Extension Phase|Participant Request|0
7337114|NCT00853047|11573199|FG004|Open-Label Extension Phase|Participant Request|0
7337115|NCT00853047|11573200|FG005|Open-Label Extension Phase|Participant Request|7
7337116|NCT00853047|11573195|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7337117|NCT00853047|11573196|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7337118|NCT00853047|11573197|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7337119|NCT00853047|11573198|FG003|Open-Label Extension Phase|Lost to Follow-up|0
7337120|NCT00853047|11573199|FG004|Open-Label Extension Phase|Lost to Follow-up|0
7337121|NCT00853047|11573200|FG005|Open-Label Extension Phase|Lost to Follow-up|1
7337122|NCT00853047|11573195|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
7337123|NCT00853047|11573196|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
7337124|NCT00853047|11573197|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
7337125|NCT00853047|11573198|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
7337126|NCT00853047|11573199|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
7337127|NCT00853047|11573200|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
7337128|NCT00853047|11573195|FG000|Open-Label Extension Phase|Investigator Decision|0
7337129|NCT00853047|11573196|FG001|Open-Label Extension Phase|Investigator Decision|0
7337130|NCT00853047|11573197|FG002|Open-Label Extension Phase|Investigator Decision|0
7568664|NCT03423238|11944164|FG000|Overall Study|Withdrawal by Subject|1
7337131|NCT00853047|11573198|FG003|Open-Label Extension Phase|Investigator Decision|0
7337132|NCT00853047|11573199|FG004|Open-Label Extension Phase|Investigator Decision|0
7337133|NCT00853047|11573200|FG005|Open-Label Extension Phase|Investigator Decision|1
7337134|NCT00853047|11573195|FG000|Open-Label Extension Phase|Reason Not Specified|0
7337135|NCT00853047|11573196|FG001|Open-Label Extension Phase|Reason Not Specified|0
7337136|NCT00853047|11573197|FG002|Open-Label Extension Phase|Reason Not Specified|0
7337137|NCT00853047|11573198|FG003|Open-Label Extension Phase|Reason Not Specified|0
7385596|NCT01202760|11643428|FG000|Overall Study|Sponsor Decision|4
7568665|NCT03423238|11944165|FG001|Overall Study|Withdrawal by Subject|0
7568666|NCT03424044|11944181|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568667|NCT03424044|11944182|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568668|NCT03424044|11944183|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
7568669|NCT03424044|11944184|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568670|NCT03424044|11944185|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568671|NCT03424044|11944186|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568672|NCT03424044|11944187|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568673|NCT03424044|11944188|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568674|NCT03424044|11944189|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
7568675|NCT03424044|11944181|FG000|First Intervention (76 Hours)|Adverse Event|0
7568676|NCT03424044|11944182|FG001|First Intervention (76 Hours)|Adverse Event|0
7568677|NCT03424044|11944183|FG002|First Intervention (76 Hours)|Adverse Event|0
7568678|NCT03424044|11944184|FG003|First Intervention (76 Hours)|Adverse Event|0
7568679|NCT03424044|11944185|FG004|First Intervention (76 Hours)|Adverse Event|1
7337138|NCT00853047|11573199|FG004|Open-Label Extension Phase|Reason Not Specified|0
7337139|NCT00853047|11573200|FG005|Open-Label Extension Phase|Reason Not Specified|6
7337140|NCT00853073|11573217|FG000|Overall Study|Withdrawal by Subject|3
7337141|NCT00853073|11573218|FG001|Overall Study|Withdrawal by Subject|2
7337142|NCT00853099|11573227|FG000|Double-blind Period|Adverse Event|7
7337143|NCT00853099|11573228|FG001|Double-blind Period|Adverse Event|9
7337144|NCT00853099|11573229|FG002|Double-blind Period|Adverse Event|13
7337145|NCT00853099|11573230|FG003|Double-blind Period|Adverse Event|0
7337146|NCT00853099|11573227|FG000|Double-blind Period|Withdrawal by Subject|2
7337147|NCT00853099|11573228|FG001|Double-blind Period|Withdrawal by Subject|3
7337148|NCT00853099|11573229|FG002|Double-blind Period|Withdrawal by Subject|0
7337149|NCT00853099|11573230|FG003|Double-blind Period|Withdrawal by Subject|0
7337150|NCT00853099|11573227|FG000|Double-blind Period|Lack of Efficacy|14
7337151|NCT00853099|11573228|FG001|Double-blind Period|Lack of Efficacy|17
7337152|NCT00853099|11573229|FG002|Double-blind Period|Lack of Efficacy|16
7337153|NCT00853099|11573230|FG003|Double-blind Period|Lack of Efficacy|0
7337154|NCT00853099|11573227|FG000|Double-blind Period|Other|0
7337155|NCT00853099|11573228|FG001|Double-blind Period|Other|0
7337156|NCT00853099|11573229|FG002|Double-blind Period|Other|1
7337157|NCT00853099|11573230|FG003|Double-blind Period|Other|0
7337158|NCT00853099|11573227|FG000|Double-blind Period|Mistreated with rescue study drug|0
7337159|NCT00853099|11573228|FG001|Double-blind Period|Mistreated with rescue study drug|0
7337160|NCT00853099|11573229|FG002|Double-blind Period|Mistreated with rescue study drug|1
7337161|NCT00853099|11573230|FG003|Double-blind Period|Mistreated with rescue study drug|0
7337162|NCT00853099|11573227|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
7337163|NCT00853099|11573228|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
7337164|NCT00853099|11573229|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
7337165|NCT00853099|11573230|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
7337166|NCT00853099|11573227|FG000|Double-blind + Open-label Periods|Adverse Event|0
7337167|NCT00853099|11573228|FG001|Double-blind + Open-label Periods|Adverse Event|0
7337168|NCT00853099|11573229|FG002|Double-blind + Open-label Periods|Adverse Event|0
7337169|NCT00853099|11573230|FG003|Double-blind + Open-label Periods|Adverse Event|47
7337170|NCT00853099|11573227|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
7337171|NCT00853099|11573228|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
7337172|NCT00853099|11573229|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
7337173|NCT00853099|11573230|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
7337174|NCT00853099|11573227|FG000|Double-blind + Open-label Periods|Other|0
7337175|NCT00853099|11573228|FG001|Double-blind + Open-label Periods|Other|0
7337176|NCT00853099|11573229|FG002|Double-blind + Open-label Periods|Other|0
7337177|NCT00853099|11573230|FG003|Double-blind + Open-label Periods|Other|6
7337178|NCT00853112|11573247|FG000|Overall Study|Randomized but not treated|0
7337179|NCT00853112|11573248|FG001|Overall Study|Randomized but not treated|1
7337180|NCT00853112|11573249|FG002|Overall Study|Randomized but not treated|0
7337181|NCT00853112|11573250|FG003|Overall Study|Randomized but not treated|2
7337182|NCT00853112|11573251|FG004|Overall Study|Randomized but not treated|0
7337183|NCT00853112|11573252|FG005|Overall Study|Randomized but not treated|0
7337184|NCT00853112|11573253|FG006|Overall Study|Randomized but not treated|1
7337185|NCT00853125|11573269|FG000|Overall Study|Study participant's donor was CMV +|1
7337186|NCT00853151|11573278|FG000|Overall Study|Adverse Event|1
7337187|NCT00853151|11573279|FG001|Overall Study|Adverse Event|4
7337188|NCT00853151|11573280|FG002|Overall Study|Adverse Event|2
7337189|NCT00853151|11573281|FG003|Overall Study|Adverse Event|0
7337190|NCT00853151|11573278|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7337191|NCT00853151|11573279|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7337192|NCT00853151|11573280|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7337193|NCT00853151|11573281|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7337194|NCT00853151|11573278|FG000|Overall Study|Lost to Follow-up|2
7337195|NCT00853151|11573279|FG001|Overall Study|Lost to Follow-up|0
7337196|NCT00853151|11573280|FG002|Overall Study|Lost to Follow-up|3
7337197|NCT00853151|11573281|FG003|Overall Study|Lost to Follow-up|0
7337198|NCT00853151|11573278|FG000|Overall Study|Death|1
7337199|NCT00853151|11573279|FG001|Overall Study|Death|0
7337200|NCT00853151|11573280|FG002|Overall Study|Death|0
7337201|NCT00853151|11573281|FG003|Overall Study|Death|1
7337202|NCT00853151|11573278|FG000|Overall Study|Protocol Violation|0
7337203|NCT00853151|11573279|FG001|Overall Study|Protocol Violation|0
7337204|NCT00853151|11573280|FG002|Overall Study|Protocol Violation|0
7337205|NCT00853151|11573281|FG003|Overall Study|Protocol Violation|1
7337206|NCT00853151|11573278|FG000|Overall Study|Withdrawal by Subject|5
7337207|NCT00853151|11573279|FG001|Overall Study|Withdrawal by Subject|4
7337208|NCT00853151|11573280|FG002|Overall Study|Withdrawal by Subject|2
7337209|NCT00853151|11573281|FG003|Overall Study|Withdrawal by Subject|1
7337210|NCT00853151|11573278|FG000|Overall Study|Physician Decision|0
7337211|NCT00853151|11573279|FG001|Overall Study|Physician Decision|2
7337212|NCT00853151|11573280|FG002|Overall Study|Physician Decision|1
7337213|NCT00853151|11573281|FG003|Overall Study|Physician Decision|0
7337214|NCT00853151|11573278|FG000|Overall Study|Sponsor Decision|0
7337215|NCT00853151|11573279|FG001|Overall Study|Sponsor Decision|3
7337216|NCT00853151|11573280|FG002|Overall Study|Sponsor Decision|0
7337217|NCT00853151|11573281|FG003|Overall Study|Sponsor Decision|0
7337218|NCT00853242|11573301|FG000|Overall Study|Adverse Event|0
7337219|NCT00853242|11573302|FG001|Overall Study|Adverse Event|1
7337220|NCT00853242|11573303|FG002|Overall Study|Adverse Event|1
7337221|NCT00853242|11573304|FG003|Overall Study|Adverse Event|0
7337222|NCT00853242|11573305|FG004|Overall Study|Adverse Event|3
7337223|NCT00853242|11573306|FG005|Overall Study|Adverse Event|1
7337224|NCT00853242|11573307|FG006|Overall Study|Adverse Event|1
7337225|NCT00853242|11573301|FG000|Overall Study|Noncompliant|0
7337226|NCT00853242|11573302|FG001|Overall Study|Noncompliant|0
7337227|NCT00853242|11573303|FG002|Overall Study|Noncompliant|0
7337228|NCT00853242|11573304|FG003|Overall Study|Noncompliant|0
7337229|NCT00853242|11573305|FG004|Overall Study|Noncompliant|1
7337230|NCT00853242|11573306|FG005|Overall Study|Noncompliant|0
7337231|NCT00853242|11573307|FG006|Overall Study|Noncompliant|0
7337232|NCT00853242|11573301|FG000|Overall Study|Withdrawal by Subject|1
7337233|NCT00853242|11573302|FG001|Overall Study|Withdrawal by Subject|2
7337234|NCT00853242|11573303|FG002|Overall Study|Withdrawal by Subject|0
7337235|NCT00853242|11573304|FG003|Overall Study|Withdrawal by Subject|4
7337236|NCT00853242|11573305|FG004|Overall Study|Withdrawal by Subject|0
7337237|NCT00853242|11573306|FG005|Overall Study|Withdrawal by Subject|0
7337238|NCT00853242|11573307|FG006|Overall Study|Withdrawal by Subject|2
7337239|NCT00853242|11573301|FG000|Overall Study|Other|2
7337240|NCT00853242|11573302|FG001|Overall Study|Other|0
7337241|NCT00853242|11573303|FG002|Overall Study|Other|2
7337242|NCT00853242|11573304|FG003|Overall Study|Other|0
7337243|NCT00853242|11573305|FG004|Overall Study|Other|0
7337244|NCT00853242|11573306|FG005|Overall Study|Other|1
7337245|NCT00853242|11573307|FG006|Overall Study|Other|2
7337246|NCT00853372|11573344|FG000|Overall Study|Death|30
7337247|NCT00853372|11573345|FG001|Overall Study|Death|26
7337248|NCT00853372|11573344|FG000|Overall Study|Lost to Follow-up|1
7337249|NCT00853372|11573345|FG001|Overall Study|Lost to Follow-up|2
7337250|NCT00853372|11573344|FG000|Overall Study|Full Consent Withdrawn|1
7337251|NCT00853372|11573345|FG001|Overall Study|Full Consent Withdrawn|1
7337252|NCT00853385|11573356|FG000|Overall Study|Death|0
7337253|NCT00853385|11573357|FG001|Overall Study|Death|0
7337254|NCT00853385|11573358|FG002|Overall Study|Death|0
7568680|NCT03424044|11944186|FG005|First Intervention (76 Hours)|Adverse Event|0
7568681|NCT03424044|11944187|FG006|First Intervention (76 Hours)|Adverse Event|0
7337255|NCT00853385|11573359|FG003|Overall Study|Death|0
7337256|NCT00853385|11573360|FG004|Overall Study|Death|1
7337257|NCT00853385|11573356|FG000|Overall Study|Adverse Event|24
7337258|NCT00853385|11573357|FG001|Overall Study|Adverse Event|24
7337259|NCT00853385|11573358|FG002|Overall Study|Adverse Event|2
7337260|NCT00853385|11573359|FG003|Overall Study|Adverse Event|5
7337261|NCT00853385|11573360|FG004|Overall Study|Adverse Event|22
7337262|NCT00853385|11573356|FG000|Overall Study|Lack of Efficacy|6
7337263|NCT00853385|11573357|FG001|Overall Study|Lack of Efficacy|7
7337264|NCT00853385|11573358|FG002|Overall Study|Lack of Efficacy|3
7337265|NCT00853385|11573359|FG003|Overall Study|Lack of Efficacy|3
7337266|NCT00853385|11573360|FG004|Overall Study|Lack of Efficacy|6
7337267|NCT00853385|11573356|FG000|Overall Study|Lost to Follow-up|2
7337268|NCT00853385|11573357|FG001|Overall Study|Lost to Follow-up|1
7337269|NCT00853385|11573358|FG002|Overall Study|Lost to Follow-up|0
7337270|NCT00853385|11573359|FG003|Overall Study|Lost to Follow-up|0
7337271|NCT00853385|11573360|FG004|Overall Study|Lost to Follow-up|0
7337272|NCT00853385|11573356|FG000|Overall Study|Withdrawal by Subject|4
7337273|NCT00853385|11573357|FG001|Overall Study|Withdrawal by Subject|2
7337274|NCT00853385|11573358|FG002|Overall Study|Withdrawal by Subject|0
7568682|NCT03424044|11944188|FG007|First Intervention (76 Hours)|Adverse Event|0
7568683|NCT03424044|11944189|FG008|First Intervention (76 Hours)|Adverse Event|0
7568684|NCT03424044|11944181|FG000|First Intervention (76 Hours)|device issues|0
7568685|NCT03424044|11944182|FG001|First Intervention (76 Hours)|device issues|0
7568686|NCT03424044|11944183|FG002|First Intervention (76 Hours)|device issues|0
7568687|NCT03424044|11944184|FG003|First Intervention (76 Hours)|device issues|0
7568688|NCT03424044|11944185|FG004|First Intervention (76 Hours)|device issues|0
7568689|NCT03424044|11944186|FG005|First Intervention (76 Hours)|device issues|0
7568690|NCT03424044|11944187|FG006|First Intervention (76 Hours)|device issues|1
7568691|NCT03424044|11944188|FG007|First Intervention (76 Hours)|device issues|1
7568692|NCT03424044|11944189|FG008|First Intervention (76 Hours)|device issues|1
7568693|NCT03424044|11944181|FG000|Third Intervention (76 Hours)|Adverse Event|1
7337275|NCT00853385|11573359|FG003|Overall Study|Withdrawal by Subject|1
7337276|NCT00853385|11573360|FG004|Overall Study|Withdrawal by Subject|1
7337277|NCT00853385|11573356|FG000|Overall Study|Other|18
7337278|NCT00853385|11573357|FG001|Overall Study|Other|9
7337279|NCT00853385|11573358|FG002|Overall Study|Other|4
7337280|NCT00853385|11573359|FG003|Overall Study|Other|4
7337281|NCT00853385|11573360|FG004|Overall Study|Other|12
7337282|NCT00853489|11573384|FG000|Overall Study|Lost to Follow-up|5
7337283|NCT00853489|11573385|FG001|Overall Study|Lost to Follow-up|2
7337284|NCT00853580|11573393|FG000|Overall Study|Lost to Follow-up|3
7337285|NCT00853580|11573394|FG001|Overall Study|Lost to Follow-up|5
7337286|NCT00853580|11573393|FG000|Overall Study|Protocol Violation|2
7337287|NCT00853580|11573394|FG001|Overall Study|Protocol Violation|1
7337288|NCT00853580|11573393|FG000|Overall Study|Withdrawal by Subject|2
7337289|NCT00853580|11573394|FG001|Overall Study|Withdrawal by Subject|8
7337290|NCT00853580|11573393|FG000|Overall Study|Commenced contraindicated therapy|0
7337291|NCT00853580|11573394|FG001|Overall Study|Commenced contraindicated therapy|2
7337292|NCT00853593|11573400|FG000|Overall Study|Subjects did not receive a 4396 lead|12
7337293|NCT00853593|11573400|FG000|Overall Study|Model 4396 lead not attempted|29
7337294|NCT00853593|11573400|FG000|Overall Study|Implant not attempted|4
7337295|NCT00853658|11573432|FG000|Overall Study|Death|713
7337296|NCT00853658|11573433|FG001|Overall Study|Death|768
7337297|NCT00853658|11573434|FG002|Overall Study|Death|753
7337298|NCT00853658|11573432|FG000|Overall Study|Lost to Follow-up|11
7337299|NCT00853658|11573433|FG001|Overall Study|Lost to Follow-up|6
7337300|NCT00853658|11573434|FG002|Overall Study|Lost to Follow-up|11
7337301|NCT00853658|11573432|FG000|Overall Study|H.A. Request|26
7337302|NCT00853658|11573433|FG001|Overall Study|H.A. Request|23
7337303|NCT00853658|11573434|FG002|Overall Study|H.A. Request|19
7337304|NCT00853658|11573432|FG000|Overall Study|IRB request|0
7337305|NCT00853658|11573433|FG001|Overall Study|IRB request|0
7337306|NCT00853658|11573434|FG002|Overall Study|IRB request|2
7337307|NCT00853658|11573432|FG000|Overall Study|Vital Status known (alive) at study end|2
7337308|NCT00853658|11573433|FG001|Overall Study|Vital Status known (alive) at study end|3
7337309|NCT00853658|11573434|FG002|Overall Study|Vital Status known (alive) at study end|3
7337310|NCT00853658|11573432|FG000|Overall Study|Vital Status unknown at study end|1
7337311|NCT00853658|11573433|FG001|Overall Study|Vital Status unknown at study end|1
7337312|NCT00853658|11573434|FG002|Overall Study|Vital Status unknown at study end|0
7337313|NCT00853658|11573432|FG000|Overall Study|Vital Status at study end N/A|8
7337314|NCT00853658|11573433|FG001|Overall Study|Vital Status at study end N/A|10
7337315|NCT00853658|11573434|FG002|Overall Study|Vital Status at study end N/A|10
7337316|NCT00853658|11573432|FG000|Overall Study|Patient's request|21
7337317|NCT00853658|11573433|FG001|Overall Study|Patient's request|17
7337318|NCT00853658|11573434|FG002|Overall Study|Patient's request|11
7337319|NCT00853658|11573432|FG000|Overall Study|Missing study completion information|5
7337320|NCT00853658|11573433|FG001|Overall Study|Missing study completion information|4
7337321|NCT00853658|11573434|FG002|Overall Study|Missing study completion information|6
7337322|NCT00853723|11573449|FG000|Overall Study|Adverse Event|3
7337323|NCT00853723|11573450|FG001|Overall Study|Adverse Event|4
7337324|NCT00853723|11573451|FG002|Overall Study|Adverse Event|1
7337325|NCT00853723|11573449|FG000|Overall Study|Withdrawal by Subject|2
7337326|NCT00853723|11573450|FG001|Overall Study|Withdrawal by Subject|1
7337327|NCT00853723|11573451|FG002|Overall Study|Withdrawal by Subject|0
7337328|NCT00853723|11573449|FG000|Overall Study|Protocol Violation|1
7337329|NCT00853723|11573450|FG001|Overall Study|Protocol Violation|2
7337330|NCT00853723|11573451|FG002|Overall Study|Protocol Violation|1
7337331|NCT00853749|11573464|FG000|Overall Study|Lost to Follow-up|0
7337332|NCT00853749|11573465|FG001|Overall Study|Lost to Follow-up|1
7337333|NCT00853762|11573475|FG000|Overall Study|Premature Termination|16
7337334|NCT00853762|11573476|FG001|Overall Study|Premature Termination|15
7337335|NCT00853762|11573477|FG002|Overall Study|Premature Termination|14
7337336|NCT00853762|11573478|FG003|Overall Study|Premature Termination|21
7337337|NCT00853762|11573475|FG000|Overall Study|Protocol Violation|0
7337338|NCT00853762|11573476|FG001|Overall Study|Protocol Violation|0
7337339|NCT00853762|11573477|FG002|Overall Study|Protocol Violation|0
7337340|NCT00853762|11573478|FG003|Overall Study|Protocol Violation|1
7337341|NCT00853762|11573475|FG000|Overall Study|Withdrawal by Subject|0
7337342|NCT00853762|11573476|FG001|Overall Study|Withdrawal by Subject|0
7337343|NCT00853762|11573477|FG002|Overall Study|Withdrawal by Subject|1
7337344|NCT00853762|11573478|FG003|Overall Study|Withdrawal by Subject|0
7337345|NCT00853762|11573475|FG000|Overall Study|Other|0
7337346|NCT00853762|11573476|FG001|Overall Study|Other|2
7337347|NCT00853762|11573477|FG002|Overall Study|Other|0
7337348|NCT00853762|11573478|FG003|Overall Study|Other|0
7337349|NCT00853762|11573475|FG000|Overall Study|Randomised but not Treated|0
7337350|NCT00853762|11573476|FG001|Overall Study|Randomised but not Treated|2
7337351|NCT00853762|11573477|FG002|Overall Study|Randomised but not Treated|2
7337352|NCT00853762|11573478|FG003|Overall Study|Randomised but not Treated|0
7337353|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Other|4
7337354|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Other|0
7337355|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Adverse Event|9
7337356|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Adverse Event|0
7337357|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
7337358|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
7337359|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
7337360|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
7337361|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
7337362|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
7337363|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
7337364|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
7337365|NCT00853827|11573490|FG000|Single Blind Period (1 Week)|Protocol Violation|12
7337366|NCT00853827|11573491|FG001|Single Blind Period (1 Week)|Protocol Violation|0
7337367|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
7337368|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
7337369|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
7337370|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
7337371|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
7337372|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
7337373|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
7337374|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
7337375|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
7337376|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
7337377|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
7337378|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
7337379|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
7337380|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
7337381|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
7337382|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
7337383|NCT00853827|11573490|FG000|Double Blind Period (103 Weeks)|Death|1
7337384|NCT00853827|11573491|FG001|Double Blind Period (103 Weeks)|Death|6
7337385|NCT00853905|11573507|FG000|Overall Study|Lost to Follow-up|1
7337386|NCT00853905|11573508|FG001|Overall Study|Lost to Follow-up|3
7337387|NCT00853905|11573507|FG000|Overall Study|Withdrawal by Subject|0
7568694|NCT03424044|11944182|FG001|Third Intervention (76 Hours)|Adverse Event|0
7568695|NCT03424044|11944183|FG002|Third Intervention (76 Hours)|Adverse Event|0
7568696|NCT03424044|11944184|FG003|Third Intervention (76 Hours)|Adverse Event|0
7337388|NCT00853905|11573508|FG001|Overall Study|Withdrawal by Subject|1
7337389|NCT00853905|11573507|FG000|Overall Study|never had surgery|1
7337390|NCT00853905|11573508|FG001|Overall Study|never had surgery|0
7568697|NCT03424044|11944185|FG004|Third Intervention (76 Hours)|Adverse Event|0
7568698|NCT03424044|11944186|FG005|Third Intervention (76 Hours)|Adverse Event|0
7568699|NCT03424044|11944187|FG006|Third Intervention (76 Hours)|Adverse Event|1
7568700|NCT03424044|11944188|FG007|Third Intervention (76 Hours)|Adverse Event|0
7568701|NCT03424044|11944189|FG008|Third Intervention (76 Hours)|Adverse Event|0
7568702|NCT03424044|11944181|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
7568703|NCT03424044|11944182|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
7337391|NCT00853957|11573519|FG000|Overall Study|Adverse Event|9
7337392|NCT00853957|11573520|FG001|Overall Study|Adverse Event|3
7337393|NCT00853957|11573519|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7337394|NCT00853957|11573520|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7337395|NCT00853957|11573519|FG000|Overall Study|Subject withdrew consent|4
7337396|NCT00853957|11573520|FG001|Overall Study|Subject withdrew consent|5
7337397|NCT00853957|11573519|FG000|Overall Study|Lost to Follow-up|1
7337398|NCT00853957|11573520|FG001|Overall Study|Lost to Follow-up|6
7337399|NCT00853957|11573519|FG000|Overall Study|Protocol deviation|0
7337400|NCT00853957|11573520|FG001|Overall Study|Protocol deviation|3
7337401|NCT00853970|11573528|FG000|Overall Study|Withdrawal by Subject|2
7337402|NCT00853970|11573529|FG001|Overall Study|Withdrawal by Subject|1
7337403|NCT00853970|11573528|FG000|Overall Study|Cancelled surgery|4
7337404|NCT00853970|11573529|FG001|Overall Study|Cancelled surgery|2
7337405|NCT00854100|11573557|FG000|Overall Study|Inability to complete the study visits|0
7337406|NCT00854100|11573558|FG001|Overall Study|Inability to complete the study visits|0
7337407|NCT00854100|11573559|FG002|Overall Study|Inability to complete the study visits|1
7337408|NCT00854100|11573557|FG000|Overall Study|Lost to Follow-up|2
7337409|NCT00854100|11573558|FG001|Overall Study|Lost to Follow-up|0
7337410|NCT00854100|11573559|FG002|Overall Study|Lost to Follow-up|3
7337411|NCT00854100|11573557|FG000|Overall Study|Withdrawal by Subject|3
7337412|NCT00854100|11573558|FG001|Overall Study|Withdrawal by Subject|1
7337413|NCT00854100|11573559|FG002|Overall Study|Withdrawal by Subject|2
7337414|NCT00854100|11573557|FG000|Overall Study|Protocol Violation|2
7337415|NCT00854100|11573558|FG001|Overall Study|Protocol Violation|4
7337416|NCT00854100|11573559|FG002|Overall Study|Protocol Violation|3
7337417|NCT00854100|11573557|FG000|Overall Study|Adverse Event|2
7337418|NCT00854100|11573558|FG001|Overall Study|Adverse Event|1
7337419|NCT00854100|11573559|FG002|Overall Study|Adverse Event|2
7337420|NCT00854113|11573579|FG000|Overall Study|Adverse Event|0
7337421|NCT00854113|11573580|FG001|Overall Study|Adverse Event|0
7337422|NCT00854113|11573581|FG002|Overall Study|Adverse Event|0
7337423|NCT00854113|11573582|FG003|Overall Study|Adverse Event|0
7337424|NCT00854113|11573583|FG004|Overall Study|Adverse Event|0
7337425|NCT00854113|11573584|FG005|Overall Study|Adverse Event|0
7337426|NCT00854113|11573585|FG006|Overall Study|Adverse Event|0
7337427|NCT00854113|11573586|FG007|Overall Study|Adverse Event|2
7337428|NCT00854113|11573587|FG008|Overall Study|Adverse Event|0
7337429|NCT00854113|11573588|FG009|Overall Study|Adverse Event|0
7337430|NCT00854113|11573589|FG010|Overall Study|Adverse Event|0
7337431|NCT00854113|11573579|FG000|Overall Study|Withdrawal by Subject|0
7337432|NCT00854113|11573580|FG001|Overall Study|Withdrawal by Subject|0
7337433|NCT00854113|11573581|FG002|Overall Study|Withdrawal by Subject|0
7337434|NCT00854113|11573582|FG003|Overall Study|Withdrawal by Subject|0
7337435|NCT00854113|11573583|FG004|Overall Study|Withdrawal by Subject|0
7337436|NCT00854113|11573584|FG005|Overall Study|Withdrawal by Subject|0
7337437|NCT00854113|11573585|FG006|Overall Study|Withdrawal by Subject|0
7337438|NCT00854113|11573586|FG007|Overall Study|Withdrawal by Subject|1
7458149|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7458150|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7458151|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7458152|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
7458153|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
7458154|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7458155|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7458156|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7458157|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7458158|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
7458159|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7458160|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7458161|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7337507|NCT00855062|11573729|FG000|Step1|Early Study Closure|5
7458162|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
7458163|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7458164|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
7458165|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
7458166|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7458167|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
7458168|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
7458169|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7458170|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
7458171|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7458172|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
7468235|NCT01908699|11768895|FG001|Overall Study|Progressive Disease|29
7568704|NCT03424044|11944183|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
7337439|NCT00854113|11573587|FG008|Overall Study|Withdrawal by Subject|1
7337440|NCT00854113|11573588|FG009|Overall Study|Withdrawal by Subject|0
7337441|NCT00854113|11573589|FG010|Overall Study|Withdrawal by Subject|0
7337442|NCT00854308|11573615|FG000|Overall Study|Disease progression|42
7337443|NCT00854308|11573616|FG001|Overall Study|Disease progression|50
7337444|NCT00854308|11573615|FG000|Overall Study|Adverse Event|8
7337445|NCT00854308|11573616|FG001|Overall Study|Adverse Event|3
7337446|NCT00854308|11573615|FG000|Overall Study|Death|2
7337447|NCT00854308|11573616|FG001|Overall Study|Death|5
7337448|NCT00854308|11573615|FG000|Overall Study|Physician Decision|6
7337449|NCT00854308|11573616|FG001|Overall Study|Physician Decision|6
7337450|NCT00854308|11573615|FG000|Overall Study|Withdrawal by Subject|4
7337451|NCT00854308|11573616|FG001|Overall Study|Withdrawal by Subject|2
7337452|NCT00854308|11573615|FG000|Overall Study|Sponsor's decision to terminate study|0
7337453|NCT00854308|11573616|FG001|Overall Study|Sponsor's decision to terminate study|1
7337454|NCT00854360|11573626|FG000|Overall Study|Adverse Event|0
7337455|NCT00854360|11573627|FG001|Overall Study|Adverse Event|1
7337456|NCT00854360|11573628|FG002|Overall Study|Adverse Event|2
7337457|NCT00854360|11573629|FG003|Overall Study|Adverse Event|6
7337458|NCT00854360|11573626|FG000|Overall Study|Withdrawal by Subject|0
7337459|NCT00854360|11573627|FG001|Overall Study|Withdrawal by Subject|0
7337460|NCT00854360|11573628|FG002|Overall Study|Withdrawal by Subject|0
7337461|NCT00854360|11573629|FG003|Overall Study|Withdrawal by Subject|1
7337462|NCT00854360|11573626|FG000|Overall Study|Pregnancy|0
7337463|NCT00854360|11573627|FG001|Overall Study|Pregnancy|1
7337464|NCT00854360|11573628|FG002|Overall Study|Pregnancy|0
7337465|NCT00854360|11573629|FG003|Overall Study|Pregnancy|0
7337466|NCT00854360|11573626|FG000|Overall Study|Lack of Efficacy|2
7337467|NCT00854360|11573627|FG001|Overall Study|Lack of Efficacy|1
7337468|NCT00854360|11573628|FG002|Overall Study|Lack of Efficacy|0
7337469|NCT00854360|11573629|FG003|Overall Study|Lack of Efficacy|0
7337470|NCT00854360|11573626|FG000|Overall Study|Other|0
7337471|NCT00854360|11573627|FG001|Overall Study|Other|0
7337472|NCT00854360|11573628|FG002|Overall Study|Other|0
7337473|NCT00854360|11573629|FG003|Overall Study|Other|3
7337474|NCT00854373|11573641|FG000|Overall Study|Withdrawal by Subject|1
7337475|NCT00854373|11573642|FG001|Overall Study|Withdrawal by Subject|3
7337476|NCT00854373|11573641|FG000|Overall Study|Forgot to take study drug|1
7337477|NCT00854373|11573642|FG001|Overall Study|Forgot to take study drug|1
7337478|NCT00854581|11573648|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
7337479|NCT00854581|11573648|FG000|Induction (Up to Day 21)|Death|1
7337480|NCT00854581|11573648|FG000|Induction (Up to Day 21)|Physician Decision|1
7337481|NCT00854581|11573648|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
7337482|NCT00854607|11573666|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
7337483|NCT00854620|11573677|FG000|Overall Study|Adverse Event|1
7337484|NCT00854724|11573683|FG000|First Intervention|Withdrawal by Subject|1
7337485|NCT00854724|11573684|FG001|First Intervention|Withdrawal by Subject|1
7337486|NCT00854724|11573683|FG000|Washout|Protocol Violation|1
7337487|NCT00854724|11573684|FG001|Washout|Protocol Violation|0
7337488|NCT00854724|11573683|FG000|Washout|Withdrawal by Subject|0
7337489|NCT00854724|11573684|FG001|Washout|Withdrawal by Subject|1
7337490|NCT00854724|11573683|FG000|Second Intervention|Protocol Violation|1
7337491|NCT00854724|11573684|FG001|Second Intervention|Protocol Violation|0
7337492|NCT00854724|11573683|FG000|Second Intervention|Physician Decision|0
7337493|NCT00854724|11573684|FG001|Second Intervention|Physician Decision|1
7337494|NCT00854828|11573694|FG000|Overall Study|Death|1
7337495|NCT00854828|11573695|FG001|Overall Study|Death|0
7337496|NCT00854828|11573696|FG002|Overall Study|Death|0
7337497|NCT00854828|11573697|FG003|Overall Study|Death|0
7337498|NCT00854828|11573694|FG000|Overall Study|Withdrawal by Subject|1
7337499|NCT00854828|11573695|FG001|Overall Study|Withdrawal by Subject|1
7337500|NCT00854828|11573696|FG002|Overall Study|Withdrawal by Subject|0
7337501|NCT00854828|11573697|FG003|Overall Study|Withdrawal by Subject|9
7337502|NCT00854828|11573694|FG000|Overall Study|Missed 24mo visit|1
7337503|NCT00854828|11573695|FG001|Overall Study|Missed 24mo visit|1
7337504|NCT00854828|11573696|FG002|Overall Study|Missed 24mo visit|8
7337505|NCT00854828|11573697|FG003|Overall Study|Missed 24mo visit|8
7337506|NCT00854906|11573707|FG000|Overall Study|One person had no ocular history|1
7337508|NCT00855062|11573730|FG001|Step1|Early Study Closure|7
7337509|NCT00855062|11573729|FG000|Step1|Adverse Event|1
7337510|NCT00855062|11573730|FG001|Step1|Adverse Event|1
7337511|NCT00855062|11573729|FG000|Step1|Protocol Violation|1
7337512|NCT00855062|11573730|FG001|Step1|Protocol Violation|0
7337513|NCT00855062|11573729|FG000|Step1|Pregnancy|1
7337514|NCT00855062|11573730|FG001|Step1|Pregnancy|0
7337515|NCT00855062|11573729|FG000|Step1|Withdrawal by Subject|2
7337516|NCT00855062|11573730|FG001|Step1|Withdrawal by Subject|3
7337517|NCT00855062|11573729|FG000|Step2|Early Study Closure|6
7337518|NCT00855062|11573730|FG001|Step2|Early Study Closure|2
7337519|NCT00855062|11573729|FG000|Step2|Adverse Event|0
7337520|NCT00855062|11573730|FG001|Step2|Adverse Event|3
7337521|NCT00855062|11573729|FG000|Step2|Initiation of antiretroviral therapy/ART|0
7337522|NCT00855062|11573730|FG001|Step2|Initiation of antiretroviral therapy/ART|1
7337523|NCT00855166|11573738|FG000|Overall Study|Adverse Event|0
7337524|NCT00855166|11573739|FG001|Overall Study|Adverse Event|2
7337525|NCT00855166|11573738|FG000|Overall Study|Death|0
7337526|NCT00855166|11573739|FG001|Overall Study|Death|1
7337527|NCT00855166|11573738|FG000|Overall Study|Withdrawal by Subject|1
7337528|NCT00855166|11573739|FG001|Overall Study|Withdrawal by Subject|4
7337529|NCT00855166|11573738|FG000|Overall Study|Poor/non-compliance|2
7337530|NCT00855166|11573739|FG001|Overall Study|Poor/non-compliance|0
7337531|NCT00855166|11573738|FG000|Overall Study|Administrative reasons by sponsor|1
7337532|NCT00855166|11573739|FG001|Overall Study|Administrative reasons by sponsor|0
7337533|NCT00855166|11573738|FG000|Overall Study|Subject no longer meets study criteria|1
7337534|NCT00855166|11573739|FG001|Overall Study|Subject no longer meets study criteria|1
7337535|NCT00855218|11573749|FG000|Overall Study|Adverse Event|43
7337536|NCT00855218|11573750|FG001|Overall Study|Adverse Event|27
7337537|NCT00855218|11573749|FG000|Overall Study|Withdrawal by Subject|10
7337538|NCT00855218|11573750|FG001|Overall Study|Withdrawal by Subject|6
7337539|NCT00855218|11573749|FG000|Overall Study|Physician Decision|18
7337540|NCT00855218|11573750|FG001|Overall Study|Physician Decision|11
7337541|NCT00855218|11573749|FG000|Overall Study|Lost to Follow-up|0
7337542|NCT00855218|11573750|FG001|Overall Study|Lost to Follow-up|1
7337543|NCT00855218|11573749|FG000|Overall Study|Protocol Violation|5
7337544|NCT00855218|11573750|FG001|Overall Study|Protocol Violation|9
7337545|NCT00855218|11573749|FG000|Overall Study|non-compliant with study drug|3
7337546|NCT00855218|11573750|FG001|Overall Study|non-compliant with study drug|1
7337547|NCT00855218|11573749|FG000|Overall Study|patient convenience|2
7337548|NCT00855218|11573750|FG001|Overall Study|patient convenience|0
7337549|NCT00855218|11573749|FG000|Overall Study|technical problems|2
7337550|NCT00855218|11573750|FG001|Overall Study|technical problems|1
7337551|NCT00855218|11573749|FG000|Overall Study|Still treated with study medication|0
7337552|NCT00855218|11573750|FG001|Overall Study|Still treated with study medication|1
7337553|NCT00855218|11573749|FG000|Overall Study|Untreatable disease progression|54
7337554|NCT00855218|11573750|FG001|Overall Study|Untreatable disease progression|67
7337555|NCT00855218|11573749|FG000|Overall Study|Second malignancy|0
7337556|NCT00855218|11573750|FG001|Overall Study|Second malignancy|1
7337557|NCT00855218|11573749|FG000|Overall Study|Progression measurement proven|7
7337558|NCT00855218|11573750|FG001|Overall Study|Progression measurement proven|15
7337559|NCT00855218|11573749|FG000|Overall Study|Clinical endpoint reached|10
7337560|NCT00855218|11573750|FG001|Overall Study|Clinical endpoint reached|13
7337561|NCT00855309|11573758|FG000|Overall Study|patient never recieved drug|1
7337562|NCT00855309|11573759|FG001|Overall Study|patient never recieved drug|0
7337563|NCT00855335|11573770|FG000|Overall Study|Lost to Follow-up|0
7337564|NCT00855335|11573771|FG001|Overall Study|Lost to Follow-up|0
7337565|NCT00855335|11573772|FG002|Overall Study|Lost to Follow-up|3
7337566|NCT00855335|11573773|FG003|Overall Study|Lost to Follow-up|1
7337567|NCT00855335|11573774|FG004|Overall Study|Lost to Follow-up|0
7337568|NCT00855335|11573770|FG000|Overall Study|Withdrawal by Subject|0
7337569|NCT00855335|11573771|FG001|Overall Study|Withdrawal by Subject|0
7337570|NCT00855335|11573772|FG002|Overall Study|Withdrawal by Subject|0
7337571|NCT00855335|11573773|FG003|Overall Study|Withdrawal by Subject|1
7337572|NCT00855335|11573774|FG004|Overall Study|Withdrawal by Subject|0
7337573|NCT00855335|11573770|FG000|Overall Study|Adverse Event|2
7337574|NCT00855335|11573771|FG001|Overall Study|Adverse Event|0
7337575|NCT00855335|11573772|FG002|Overall Study|Adverse Event|0
7337576|NCT00855335|11573773|FG003|Overall Study|Adverse Event|0
7337577|NCT00855335|11573774|FG004|Overall Study|Adverse Event|0
7337578|NCT00855335|11573770|FG000|Overall Study|Physician Decision|1
7337579|NCT00855335|11573771|FG001|Overall Study|Physician Decision|1
7337580|NCT00855335|11573772|FG002|Overall Study|Physician Decision|0
7337581|NCT00855335|11573773|FG003|Overall Study|Physician Decision|0
7337582|NCT00855335|11573774|FG004|Overall Study|Physician Decision|0
7337583|NCT00855335|11573770|FG000|Overall Study|Other|2
7337584|NCT00855335|11573771|FG001|Overall Study|Other|1
7337585|NCT00855335|11573772|FG002|Overall Study|Other|2
7337586|NCT00855335|11573773|FG003|Overall Study|Other|5
7337587|NCT00855335|11573774|FG004|Overall Study|Other|1
7337588|NCT00855439|11573805|FG000|Overall Study|Withdrawal by Subject|2
7337589|NCT00855439|11573806|FG001|Overall Study|Withdrawal by Subject|0
7337590|NCT00855439|11573805|FG000|Overall Study|Pregnancy|1
7337591|NCT00855439|11573806|FG001|Overall Study|Pregnancy|0
7337592|NCT00855465|11573814|FG000|Treatment Period|Adverse Event|4
7337593|NCT00855465|11573815|FG001|Treatment Period|Adverse Event|2
7337594|NCT00855465|11573814|FG000|Treatment Period|Death|2
7337595|NCT00855465|11573815|FG001|Treatment Period|Death|2
7337596|NCT00855465|11573814|FG000|Treatment Period|Lack of Efficacy|2
7337597|NCT00855465|11573815|FG001|Treatment Period|Lack of Efficacy|1
7337598|NCT00855465|11573814|FG000|Treatment Period|Non-compliance|1
7337599|NCT00855465|11573815|FG001|Treatment Period|Non-compliance|0
7337600|NCT00855465|11573814|FG000|Treatment Period|Protocol Violation|2
7337601|NCT00855465|11573815|FG001|Treatment Period|Protocol Violation|0
7337602|NCT00855465|11573814|FG000|Treatment Period|Withdrawal by Subject|2
7337603|NCT00855465|11573815|FG001|Treatment Period|Withdrawal by Subject|0
7337604|NCT00855465|11573814|FG000|Treatment Period|Not treated|1
7337605|NCT00855465|11573815|FG001|Treatment Period|Not treated|0
7337606|NCT00855465|11573814|FG000|Follow-up Period (FUP)|Adverse Event|0
7337607|NCT00855465|11573815|FG001|Follow-up Period (FUP)|Adverse Event|1
7337608|NCT00855465|11573814|FG000|Follow-up Period (FUP)|Death|0
7337609|NCT00855465|11573815|FG001|Follow-up Period (FUP)|Death|1
7337610|NCT00855465|11573814|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
7337611|NCT00855465|11573815|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
7337612|NCT00855465|11573814|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
7337613|NCT00855465|11573815|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
7337614|NCT00855465|11573814|FG000|Follow-up Period (FUP)|Missing|1
7337615|NCT00855465|11573815|FG001|Follow-up Period (FUP)|Missing|0
7337616|NCT00855582|11573824|FG000|Overall Study|Adverse Event|2
7337617|NCT00855582|11573825|FG001|Overall Study|Adverse Event|6
7337618|NCT00855582|11573826|FG002|Overall Study|Adverse Event|3
7337619|NCT00855582|11573824|FG000|Overall Study|Death|1
7337620|NCT00855582|11573825|FG001|Overall Study|Death|0
7337621|NCT00855582|11573826|FG002|Overall Study|Death|0
7337622|NCT00855582|11573824|FG000|Overall Study|Lack of Efficacy|1
7337623|NCT00855582|11573825|FG001|Overall Study|Lack of Efficacy|3
7337624|NCT00855582|11573826|FG002|Overall Study|Lack of Efficacy|8
7337625|NCT00855582|11573824|FG000|Overall Study|Lost to Follow-up|1
7337626|NCT00855582|11573825|FG001|Overall Study|Lost to Follow-up|3
7337627|NCT00855582|11573826|FG002|Overall Study|Lost to Follow-up|1
7337628|NCT00855582|11573824|FG000|Overall Study|Physician Decision|0
7337629|NCT00855582|11573825|FG001|Overall Study|Physician Decision|0
7337630|NCT00855582|11573826|FG002|Overall Study|Physician Decision|1
7337631|NCT00855582|11573824|FG000|Overall Study|Protocol Violation|6
7337632|NCT00855582|11573825|FG001|Overall Study|Protocol Violation|2
7337633|NCT00855582|11573826|FG002|Overall Study|Protocol Violation|6
7337634|NCT00855582|11573824|FG000|Overall Study|Entry Criteria Not Met|8
7337635|NCT00855582|11573825|FG001|Overall Study|Entry Criteria Not Met|6
7337636|NCT00855582|11573826|FG002|Overall Study|Entry Criteria Not Met|3
7337637|NCT00855582|11573824|FG000|Overall Study|Withdrawal by Subject|7
7337638|NCT00855582|11573825|FG001|Overall Study|Withdrawal by Subject|4
7337639|NCT00855582|11573826|FG002|Overall Study|Withdrawal by Subject|8
7337640|NCT00855595|11573839|FG000|Overall Study|Withdrawal by Subject|1
7337641|NCT00855595|11573840|FG001|Overall Study|Withdrawal by Subject|2
7337642|NCT00855595|11573839|FG000|Overall Study|Lost to Follow-up|3
7337643|NCT00855595|11573840|FG001|Overall Study|Lost to Follow-up|3
7337644|NCT00855595|11573839|FG000|Overall Study|Adverse Event|1
7337645|NCT00855595|11573840|FG001|Overall Study|Adverse Event|1
7337646|NCT00855595|11573839|FG000|Overall Study|patient moved out of state|1
7337647|NCT00855595|11573840|FG001|Overall Study|patient moved out of state|0
7337648|NCT00855595|11573839|FG000|Overall Study|patient left country|0
7337649|NCT00855595|11573840|FG001|Overall Study|patient left country|1
7337650|NCT00855738|11573846|FG000|Overall Study|Lost to Follow-up|2
7337651|NCT00855738|11573846|FG000|Overall Study|Adverse Event|1
7337652|NCT00855738|11573846|FG000|Overall Study|Subject Defaulted|1
7337653|NCT00855738|11573846|FG000|Overall Study|Death|1
7337654|NCT00855816|11573854|FG000|Overall Study|Withdrawal by Subject|22
7337655|NCT00855816|11573855|FG001|Overall Study|Withdrawal by Subject|15
7337656|NCT00855816|11573854|FG000|Overall Study|Lost to Follow-up|3
7337657|NCT00855816|11573855|FG001|Overall Study|Lost to Follow-up|5
7337658|NCT00855816|11573854|FG000|Overall Study|Death|1
7337659|NCT00855816|11573855|FG001|Overall Study|Death|0
7337660|NCT00855816|11573854|FG000|Overall Study|Became ineligible|0
7337661|NCT00855816|11573855|FG001|Overall Study|Became ineligible|1
7337662|NCT00855894|11573874|FG000|Overall Study|Death|31
7337663|NCT00855894|11573874|FG000|Overall Study|Patient's decision|1
7337664|NCT00855894|11573874|FG000|Overall Study|Disease progression|1
7337665|NCT00855920|11573881|FG000|Overall Study|Protocol Violation|0
7337666|NCT00855920|11573882|FG001|Overall Study|Protocol Violation|0
7337667|NCT00855920|11573883|FG002|Overall Study|Protocol Violation|2
7337668|NCT00855920|11573881|FG000|Overall Study|Adverse Event|2
7337669|NCT00855920|11573882|FG001|Overall Study|Adverse Event|1
7337670|NCT00855920|11573883|FG002|Overall Study|Adverse Event|1
7337671|NCT00855920|11573881|FG000|Overall Study|Lack of Efficacy|2
7337672|NCT00855920|11573882|FG001|Overall Study|Lack of Efficacy|2
7337673|NCT00855920|11573883|FG002|Overall Study|Lack of Efficacy|2
7337674|NCT00855920|11573881|FG000|Overall Study|Withdrawal by Subject|2
7337675|NCT00855920|11573882|FG001|Overall Study|Withdrawal by Subject|3
7337676|NCT00855920|11573883|FG002|Overall Study|Withdrawal by Subject|2
7337677|NCT00855920|11573881|FG000|Overall Study|Lost to Follow-up|1
7337678|NCT00855920|11573882|FG001|Overall Study|Lost to Follow-up|0
7337679|NCT00855920|11573883|FG002|Overall Study|Lost to Follow-up|2
7337680|NCT00855920|11573881|FG000|Overall Study|Death|0
7337681|NCT00855920|11573882|FG001|Overall Study|Death|1
7337682|NCT00855920|11573883|FG002|Overall Study|Death|0
7337683|NCT00855920|11573881|FG000|Overall Study|Decision by the sponsor|0
7337684|NCT00855920|11573882|FG001|Overall Study|Decision by the sponsor|1
7337685|NCT00855920|11573883|FG002|Overall Study|Decision by the sponsor|1
7337686|NCT00855920|11573881|FG000|Overall Study|Other than specified above|1
7337687|NCT00855920|11573882|FG001|Overall Study|Other than specified above|1
7337688|NCT00855920|11573883|FG002|Overall Study|Other than specified above|1
7337689|NCT00855933|11573893|FG000|Overall Study|Withdrawal by Subject|0
7337690|NCT00855933|11573894|FG001|Overall Study|Withdrawal by Subject|1
7385597|NCT01202760|11643429|FG001|Overall Study|Sponsor Decision|4
7385598|NCT01202760|11643430|FG002|Overall Study|Sponsor Decision|0
7385599|NCT01202773|11643453|FG000|Overall Study|Adverse Event|4
7337691|NCT00855959|11573900|FG000|Overall Study|Adverse Event|2
7337692|NCT00855959|11573900|FG000|Overall Study|Lost to Follow-up|2
7337693|NCT00855959|11573900|FG000|Overall Study|Withdrawal by Subject|3
7337694|NCT00855959|11573900|FG000|Overall Study|Pregnancy|1
7337695|NCT00855959|11573900|FG000|Overall Study|Incorrect enrolment|1
7337696|NCT00856180|11573914|FG000|Overall Study|Adverse Event|4
7337697|NCT00856180|11573914|FG000|Overall Study|Progressive Disease|16
7337698|NCT00856193|11573920|FG000|Period 2|Abnormal test procedure results|0
7337699|NCT00856193|11573921|FG001|Period 2|Abnormal test procedure results|1
7337700|NCT00856193|11573920|FG000|Period 2|Lost to Follow-up|0
7337701|NCT00856193|11573921|FG001|Period 2|Lost to Follow-up|1
7337702|NCT00856206|11573929|FG000|Overall Study|Protocol Violation|6
7337703|NCT00856206|11573930|FG001|Overall Study|Protocol Violation|18
7337704|NCT00856206|11573929|FG000|Overall Study|Adverse Event|10
7337705|NCT00856206|11573930|FG001|Overall Study|Adverse Event|46
7337706|NCT00856206|11573929|FG000|Overall Study|Lack of Efficacy|1
7337707|NCT00856206|11573930|FG001|Overall Study|Lack of Efficacy|2
7337708|NCT00856206|11573929|FG000|Overall Study|Withdrawal by Subject|15
7337709|NCT00856206|11573930|FG001|Overall Study|Withdrawal by Subject|36
7337710|NCT00856206|11573929|FG000|Overall Study|Lost to Follow-up|13
7337711|NCT00856206|11573930|FG001|Overall Study|Lost to Follow-up|39
7337712|NCT00856206|11573929|FG000|Overall Study|Death|2
7337713|NCT00856206|11573930|FG001|Overall Study|Death|2
7337714|NCT00856206|11573929|FG000|Overall Study|Decision by the Sponsor|4
7337715|NCT00856206|11573930|FG001|Overall Study|Decision by the Sponsor|8
7337716|NCT00856206|11573929|FG000|Overall Study|Other than specified above|3
7337717|NCT00856206|11573930|FG001|Overall Study|Other than specified above|10
7337718|NCT00856245|11573951|FG000|Overall Study|Was not transplanted|5
7337719|NCT00856284|11573958|FG000|Overall Study|Hyperglycemic rescue|231
7337720|NCT00856284|11573959|FG001|Overall Study|Hyperglycemic rescue|201
7337721|NCT00856284|11573960|FG002|Overall Study|Hyperglycemic rescue|235
7337722|NCT00856284|11573958|FG000|Overall Study|Adverse Event|60
7337723|NCT00856284|11573959|FG001|Overall Study|Adverse Event|74
7337724|NCT00856284|11573960|FG002|Overall Study|Adverse Event|82
7337725|NCT00856284|11573958|FG000|Overall Study|Major protocol deviation|24
7337726|NCT00856284|11573959|FG001|Overall Study|Major protocol deviation|16
7337727|NCT00856284|11573960|FG002|Overall Study|Major protocol deviation|15
7337728|NCT00856284|11573958|FG000|Overall Study|Lost to Follow-up|20
7337729|NCT00856284|11573959|FG001|Overall Study|Lost to Follow-up|22
7337730|NCT00856284|11573960|FG002|Overall Study|Lost to Follow-up|28
7337731|NCT00856284|11573958|FG000|Overall Study|Voluntary withdrawal|48
7337732|NCT00856284|11573959|FG001|Overall Study|Voluntary withdrawal|52
7337733|NCT00856284|11573960|FG002|Overall Study|Voluntary withdrawal|62
7337734|NCT00856284|11573958|FG000|Overall Study|Pregnancy|1
7337735|NCT00856284|11573959|FG001|Overall Study|Pregnancy|2
7337736|NCT00856284|11573960|FG002|Overall Study|Pregnancy|0
7337737|NCT00856284|11573958|FG000|Overall Study|Investigator discretion|9
7337738|NCT00856284|11573959|FG001|Overall Study|Investigator discretion|8
7337739|NCT00856284|11573960|FG002|Overall Study|Investigator discretion|10
7337740|NCT00856284|11573958|FG000|Overall Study|Other|15
7337741|NCT00856284|11573959|FG001|Overall Study|Other|17
7337742|NCT00856284|11573960|FG002|Overall Study|Other|14
7337743|NCT00856284|11573958|FG000|Overall Study|Randomized in error|0
7337744|NCT00856284|11573959|FG001|Overall Study|Randomized in error|0
7337745|NCT00856284|11573960|FG002|Overall Study|Randomized in error|1
7337746|NCT00856297|11573973|FG000|Overall Study|Unable to classify|2
7337747|NCT00856297|11573974|FG001|Overall Study|Unable to classify|0
7337748|NCT00856297|11573975|FG002|Overall Study|Unable to classify|0
7337749|NCT00856297|11573976|FG003|Overall Study|Unable to classify|0
7337750|NCT00856297|11573977|FG004|Overall Study|Unable to classify|0
7337751|NCT00856323|11573994|FG000|Overall Study|Withdrawal by Subject|2
7337752|NCT00856349|11573998|FG000|Overall Study|Death|418
7337753|NCT00856349|11573998|FG000|Overall Study|Withdrawal by Subject|116
7337754|NCT00856349|11573998|FG000|Overall Study|Lost to Follow-up|91
7337755|NCT00856349|11573998|FG000|Overall Study|Protocol Violation|38
7337756|NCT00856349|11573998|FG000|Overall Study|Physician Decision|13
7337757|NCT00856349|11573998|FG000|Overall Study|Subject relocation|104
7337758|NCT00856349|11573998|FG000|Overall Study|Device explant|33
7337759|NCT00856349|11573998|FG000|Overall Study|Site closure|78
7337760|NCT00856349|11573998|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
7337761|NCT00856375|11574006|FG000|Overall Study|Other|0
7337762|NCT00856375|11574007|FG001|Overall Study|Other|1
7337763|NCT00856375|11574006|FG000|Overall Study|Death|32
7337764|NCT00856375|11574007|FG001|Overall Study|Death|30
7337765|NCT00856375|11574006|FG000|Overall Study|Sponsor Terminated Study|7
7568705|NCT03424044|11944184|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
7568706|NCT03424044|11944185|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
7568707|NCT03424044|11944186|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
7568708|NCT03424044|11944187|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
7568709|NCT03424044|11944188|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
7337766|NCT00856375|11574007|FG001|Overall Study|Sponsor Terminated Study|7
7337767|NCT00856375|11574006|FG000|Overall Study|Withdrawal by Subject|2
7337768|NCT00856375|11574007|FG001|Overall Study|Withdrawal by Subject|1
7337769|NCT00856375|11574006|FG000|Overall Study|Lost to Follow-up|1
7337770|NCT00856375|11574007|FG001|Overall Study|Lost to Follow-up|2
7337771|NCT00856388|11574013|FG000|Overall Study|Other|1
7337772|NCT00856492|11574025|FG000|Overall Study|Ineligible or withdrew consent|1
7337773|NCT00856492|11574026|FG001|Overall Study|Ineligible or withdrew consent|1
7337774|NCT00856492|11574027|FG002|Overall Study|Ineligible or withdrew consent|2
7337775|NCT00856518|11574040|FG000|Overall Study|Lost to Follow-up|4
7337776|NCT00856518|11574041|FG001|Overall Study|Lost to Follow-up|2
7337777|NCT00856544|11574053|FG000|Overall Study|Randomized but not treated|3
7337778|NCT00856544|11574054|FG001|Overall Study|Randomized but not treated|0
7337779|NCT00856544|11574055|FG002|Overall Study|Randomized but not treated|0
7337780|NCT00856544|11574056|FG003|Overall Study|Randomized but not treated|0
7337781|NCT00856544|11574053|FG000|Overall Study|Death|0
7337782|NCT00856544|11574054|FG001|Overall Study|Death|2
7337783|NCT00856544|11574055|FG002|Overall Study|Death|0
7337784|NCT00856544|11574056|FG003|Overall Study|Death|0
7337785|NCT00856544|11574053|FG000|Overall Study|Adverse Event|20
7337786|NCT00856544|11574054|FG001|Overall Study|Adverse Event|29
7337787|NCT00856544|11574055|FG002|Overall Study|Adverse Event|2
7337788|NCT00856544|11574056|FG003|Overall Study|Adverse Event|3
7337789|NCT00856544|11574053|FG000|Overall Study|Lack of Efficacy|16
7337790|NCT00856544|11574054|FG001|Overall Study|Lack of Efficacy|12
7337791|NCT00856544|11574055|FG002|Overall Study|Lack of Efficacy|3
7337792|NCT00856544|11574056|FG003|Overall Study|Lack of Efficacy|3
7337793|NCT00856544|11574053|FG000|Overall Study|Other|9
7337794|NCT00856544|11574054|FG001|Overall Study|Other|16
7337795|NCT00856544|11574055|FG002|Overall Study|Other|1
7337796|NCT00856544|11574056|FG003|Overall Study|Other|6
7337797|NCT00856544|11574053|FG000|Overall Study|Lost to Follow-up|1
7337798|NCT00856544|11574054|FG001|Overall Study|Lost to Follow-up|2
7337799|NCT00856544|11574055|FG002|Overall Study|Lost to Follow-up|2
7337800|NCT00856544|11574056|FG003|Overall Study|Lost to Follow-up|0
7337801|NCT00856544|11574053|FG000|Overall Study|Withdrawal by Subject|8
7337802|NCT00856544|11574054|FG001|Overall Study|Withdrawal by Subject|5
7337803|NCT00856544|11574055|FG002|Overall Study|Withdrawal by Subject|0
7337804|NCT00856544|11574056|FG003|Overall Study|Withdrawal by Subject|1
7337805|NCT00856557|11574080|FG000|Overall Study|No patients with contextual flags|12
7337806|NCT00856557|11574081|FG001|Overall Study|No patients with contextual flags|16
7337807|NCT00856583|11574089|FG000|Overall Study|Lack of Efficacy|389
7337808|NCT00856583|11574090|FG001|Overall Study|Lack of Efficacy|377
7337809|NCT00856583|11574089|FG000|Overall Study|Serious Adverse Event (SAE)|99
7337810|NCT00856583|11574090|FG001|Overall Study|Serious Adverse Event (SAE)|65
7337811|NCT00856583|11574089|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
7337812|NCT00856583|11574090|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
7337813|NCT00856583|11574089|FG000|Overall Study|Non-compliance|305
7337814|NCT00856583|11574090|FG001|Overall Study|Non-compliance|262
7337815|NCT00856583|11574089|FG000|Overall Study|Withdrawal by Subject|1092
7337816|NCT00856583|11574090|FG001|Overall Study|Withdrawal by Subject|919
7337817|NCT00856583|11574089|FG000|Overall Study|Physician Decision|59
7337818|NCT00856583|11574090|FG001|Overall Study|Physician Decision|82
7337819|NCT00856583|11574089|FG000|Overall Study|Pregnancy|14
7337820|NCT00856583|11574090|FG001|Overall Study|Pregnancy|5
7337821|NCT00856583|11574089|FG000|Overall Study|Other|92
7337822|NCT00856583|11574090|FG001|Overall Study|Other|104
7337823|NCT00856583|11574089|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
7337824|NCT00856583|11574090|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
7337825|NCT00856609|11574098|FG000|Overall Study|Adverse Event|1
7337826|NCT00856609|11574099|FG001|Overall Study|Adverse Event|0
7337827|NCT00856635|11574107|FG000|Overall Study|Lost to Follow-up|2
7337828|NCT00856635|11574108|FG001|Overall Study|Lost to Follow-up|5
7337829|NCT00856635|11574107|FG000|Overall Study|Pregnancy|1
7337830|NCT00856635|11574108|FG001|Overall Study|Pregnancy|0
7337831|NCT00856635|11574107|FG000|Overall Study|Withdrawal by Subject|3
7337832|NCT00856635|11574108|FG001|Overall Study|Withdrawal by Subject|1
7337833|NCT00856635|11574107|FG000|Overall Study|Serious Adverse Event|1
7337834|NCT00856635|11574108|FG001|Overall Study|Serious Adverse Event|0
7337835|NCT00856635|11574107|FG000|Overall Study|Other|1
7337836|NCT00856635|11574108|FG001|Overall Study|Other|0
7337837|NCT00856635|11574107|FG000|Overall Study|Discontinued at Randomization|2
7337838|NCT00856635|11574108|FG001|Overall Study|Discontinued at Randomization|2
7337839|NCT00856661|11574118|FG000|Overall Study|Death|15
7337840|NCT00856661|11574119|FG001|Overall Study|Death|18
7337841|NCT00856661|11574118|FG000|Overall Study|Protocol Violation|2
7337842|NCT00856661|11574119|FG001|Overall Study|Protocol Violation|1
7337843|NCT00856661|11574118|FG000|Overall Study|Withdrawal by Subject|1
7337844|NCT00856661|11574119|FG001|Overall Study|Withdrawal by Subject|2
7337845|NCT00856661|11574118|FG000|Overall Study|Lost to Follow-up|1
7337846|NCT00856661|11574119|FG001|Overall Study|Lost to Follow-up|3
7337847|NCT00856661|11574118|FG000|Overall Study|Physician Judgement|8
7337848|NCT00856661|11574119|FG001|Overall Study|Physician Judgement|5
7337849|NCT00856778|11574145|FG000|Overall Study|Adverse Event|7
7337850|NCT00856778|11574145|FG000|Overall Study|Withdrawal by Subject|10
7337851|NCT00856778|11574145|FG000|Overall Study|Study deviation|2
7337852|NCT00856778|11574145|FG000|Overall Study|Lost to Follow-up|5
7337853|NCT00856830|11574157|FG000|Irinotecan & Bendamustine|Death|0
7337854|NCT00856830|11574158|FG001|Irinotecan & Bendamustine|Death|0
7337855|NCT00856830|11574159|FG002|Irinotecan & Bendamustine|Death|0
7337856|NCT00856830|11574160|FG003|Irinotecan & Bendamustine|Death|2
7337857|NCT00856830|11574157|FG000|Irinotecan & Bendamustine|Physician Decision|0
7337858|NCT00856830|11574158|FG001|Irinotecan & Bendamustine|Physician Decision|0
7337859|NCT00856830|11574159|FG002|Irinotecan & Bendamustine|Physician Decision|0
7337860|NCT00856830|11574160|FG003|Irinotecan & Bendamustine|Physician Decision|1
7337861|NCT00856843|11574167|FG000|Overall Study|Withdrawal by Subject|1
7337862|NCT00856843|11574168|FG001|Overall Study|Withdrawal by Subject|5
7337863|NCT00856843|11574167|FG000|Overall Study|Lack of Efficacy|1
7337864|NCT00856843|11574168|FG001|Overall Study|Lack of Efficacy|0
7337865|NCT00856856|11574174|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
7337866|NCT00856856|11574174|FG000|4-year Clinical Follow-up|Missed visit|1
7337867|NCT00856908|11574185|FG000|Overall Study|Lost to Follow-up|1
7337868|NCT00856908|11574186|FG001|Overall Study|Lost to Follow-up|0
7337869|NCT00856973|11574195|FG000|Overall Study|Adverse Event|5
7337870|NCT00856973|11574196|FG001|Overall Study|Adverse Event|5
7337871|NCT00856973|11574197|FG002|Overall Study|Adverse Event|3
7337872|NCT00856973|11574195|FG000|Overall Study|Lost to Follow-up|6
7337873|NCT00856973|11574196|FG001|Overall Study|Lost to Follow-up|3
7337874|NCT00856973|11574197|FG002|Overall Study|Lost to Follow-up|5
7337875|NCT00856973|11574195|FG000|Overall Study|Physician Decision|0
7337876|NCT00856973|11574196|FG001|Overall Study|Physician Decision|3
7337877|NCT00856973|11574197|FG002|Overall Study|Physician Decision|1
7337878|NCT00856973|11574195|FG000|Overall Study|Protocol Violation|1
7337879|NCT00856973|11574196|FG001|Overall Study|Protocol Violation|2
7337880|NCT00856973|11574197|FG002|Overall Study|Protocol Violation|1
7337881|NCT00856973|11574195|FG000|Overall Study|Withdrawal by Subject|13
7337882|NCT00856973|11574196|FG001|Overall Study|Withdrawal by Subject|16
7337883|NCT00856973|11574197|FG002|Overall Study|Withdrawal by Subject|15
7337884|NCT00856973|11574195|FG000|Overall Study|Other|11
7337885|NCT00856973|11574196|FG001|Overall Study|Other|12
7337886|NCT00856973|11574197|FG002|Overall Study|Other|13
7337887|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
7337888|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
7337889|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
7337890|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
7337891|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
7337892|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
7337893|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
7568710|NCT03424044|11944189|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
7568711|NCT03424239|11944223|FG000|Overall Study|Withdrawal by Subject|2
7337894|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
7337895|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
7337896|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
7337897|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7337898|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7337899|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7337900|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
7337901|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
7337902|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7568712|NCT03424265|11944229|FG000|Overall Study|screening failure|1
7568713|NCT03424265|11944230|FG001|Overall Study|screening failure|0
7337903|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7337904|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7568714|NCT03424265|11944229|FG000|Overall Study|Withdrawal by Subject|0
7568715|NCT03424265|11944230|FG001|Overall Study|Withdrawal by Subject|2
7568716|NCT03425188|11944260|FG000|Overall Study|Withdrawal by Subject|1
7568717|NCT03425253|11944265|FG000|Overall Study|Adverse Event|2
7568718|NCT03425253|11944265|FG000|Overall Study|Lost to Follow-up|3
7337905|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
7337906|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
7337907|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7337908|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7337909|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7337910|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
7337911|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
7337912|NCT00856986|11574214|FG000|Run-in Period, Weeks -12-0|Unclassified|0
7337913|NCT00856986|11574215|FG001|Run-in Period, Weeks -12-0|Unclassified|0
7337914|NCT00856986|11574216|FG002|Run-in Period, Weeks -12-0|Unclassified|0
7337915|NCT00856986|11574217|FG003|Run-in Period, Weeks -12-0|Unclassified|24
7337916|NCT00856986|11574218|FG004|Run-in Period, Weeks -12-0|Unclassified|0
7337917|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Adverse Event|6
7337918|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Adverse Event|4
7337919|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Adverse Event|9
7337920|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Adverse Event|0
7337921|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Adverse Event|0
7337922|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Protocol Violation|4
7337923|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Protocol Violation|5
7568719|NCT03425253|11944265|FG000|Overall Study|Withdrew Consent|6
7337924|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Protocol Violation|7
7337925|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Protocol Violation|0
7337926|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Protocol Violation|0
7337927|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
7337928|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
7337929|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
7337930|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
7337931|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
7337932|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
7337933|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
7458173|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7458174|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
7458175|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7458176|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
7458177|NCT01806597|11752181|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
7458178|NCT01806597|11752182|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
7458179|NCT01806597|11752183|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
7458180|NCT01806597|11752184|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
7458181|NCT01806597|11752185|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
7458182|NCT01806597|11752186|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
7458183|NCT01806597|11752181|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7458184|NCT01806597|11752182|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7458185|NCT01806597|11752183|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7458186|NCT01806597|11752184|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7458187|NCT01806597|11752185|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
7458188|NCT01806597|11752186|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
7458189|NCT01806597|11752181|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7458190|NCT01806597|11752182|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7458191|NCT01806597|11752183|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7458192|NCT01806597|11752184|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7458193|NCT01806597|11752185|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
7458194|NCT01806597|11752186|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
7458195|NCT01806597|11752181|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7458196|NCT01806597|11752182|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7458197|NCT01806597|11752183|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7458198|NCT01806597|11752184|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7458199|NCT01806597|11752185|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
7458200|NCT01806597|11752186|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
7458201|NCT01806597|11752181|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7458202|NCT01806597|11752182|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7458203|NCT01806597|11752183|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7458204|NCT01806597|11752184|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7458205|NCT01806597|11752185|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
7337934|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
7337935|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
7337936|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
7337937|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
7337938|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
7337939|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
7337940|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
7337941|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
7337942|NCT00856986|11574214|FG000|Main Period, Weeks 0-26|Unclassified|7
7337943|NCT00856986|11574215|FG001|Main Period, Weeks 0-26|Unclassified|6
7337944|NCT00856986|11574216|FG002|Main Period, Weeks 0-26|Unclassified|7
7337945|NCT00856986|11574217|FG003|Main Period, Weeks 0-26|Unclassified|0
7337946|NCT00856986|11574218|FG004|Main Period, Weeks 0-26|Unclassified|0
7337947|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Adverse Event|3
7337948|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Adverse Event|3
7337949|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Adverse Event|10
7337950|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Adverse Event|0
7337951|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Adverse Event|0
7337952|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
7337953|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
7337954|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
7337955|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
7337956|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
7337957|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
7533024|NCT02679729|11879034|FG008|Overall Study|Lost to Follow-up|0
7337958|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7337959|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
7337960|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7337961|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
7337962|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
7337963|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
7458206|NCT01806597|11752186|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
7458207|NCT01806597|11752181|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7337964|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
7337965|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
7337966|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
7337967|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
7337968|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
7337969|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
7337970|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
7337971|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
7337972|NCT00856986|11574214|FG000|Extension Period, Weeks 26-52|Unclassified|4
7337973|NCT00856986|11574215|FG001|Extension Period, Weeks 26-52|Unclassified|2
7337974|NCT00856986|11574216|FG002|Extension Period, Weeks 26-52|Unclassified|11
7337975|NCT00856986|11574217|FG003|Extension Period, Weeks 26-52|Unclassified|0
7337976|NCT00856986|11574218|FG004|Extension Period, Weeks 26-52|Unclassified|0
7337977|NCT00856999|11574230|FG000|Overall Study|Withdrawal by Subject|5
7337978|NCT00857207|11574237|FG000|Overall Study|Withdrawal by Subject|13
7337979|NCT00857207|11574238|FG001|Overall Study|Withdrawal by Subject|0
7337980|NCT00857207|11574237|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
7337981|NCT00857207|11574238|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
7337982|NCT00857207|11574237|FG000|Overall Study|Subject chose not to participate after signing consent|3
7337983|NCT00857207|11574238|FG001|Overall Study|Subject chose not to participate after signing consent|0
7337984|NCT00857220|11574245|FG000|Overall Study|Adverse Event|35
7337985|NCT00857220|11574245|FG000|Overall Study|Death|1
7337986|NCT00857220|11574245|FG000|Overall Study|Lack of Efficacy|11
7337987|NCT00857220|11574245|FG000|Overall Study|Lost to Follow-up|30
7337988|NCT00857220|11574245|FG000|Overall Study|Physician Decision|4
7337989|NCT00857220|11574245|FG000|Overall Study|Protocol Violation|16
7337990|NCT00857220|11574245|FG000|Overall Study|Withdrawal by Subject|67
7337991|NCT00857220|11574245|FG000|Overall Study|Clinical Hold|6
7337992|NCT00857220|11574245|FG000|Overall Study|Site Closed|5
7337993|NCT00857220|11574245|FG000|Overall Study|Miscellaneous|8
7337994|NCT00857233|11574249|FG000|Overall Study|Adverse Event|24
7337995|NCT00857233|11574249|FG000|Overall Study|Lack of Efficacy|1
7337996|NCT00857233|11574249|FG000|Overall Study|Non-compliance|1
7337997|NCT00857233|11574249|FG000|Overall Study|Withdrawal of Consent|9
7337998|NCT00857233|11574249|FG000|Overall Study|Lost to Follow-up|4
7337999|NCT00857233|11574249|FG000|Overall Study|Nursing Home Placement|14
7338000|NCT00857233|11574249|FG000|Overall Study|Other Reasons|2
7338001|NCT00857246|11574253|FG000|Induction Regimen|Adverse Event|1
7338002|NCT00857246|11574253|FG000|Induction Regimen|disease-related complications|1
7338003|NCT00857246|11574253|FG000|Induction Regimen|Withdrawal by Subject|1
7338004|NCT00857246|11574253|FG000|Surgery (Curative)|disease progression|6
7338005|NCT00857246|11574253|FG000|ChemoRT|Withdrawal by Subject|1
7338006|NCT00857246|11574253|FG000|ChemoRT|Adverse Event|2
7338007|NCT00857259|11574263|FG000|Overall Study|Protocol Violation|1
7338008|NCT00857259|11574264|FG001|Overall Study|Protocol Violation|0
7338009|NCT00857259|11574265|FG002|Overall Study|Protocol Violation|1
7338010|NCT00857311|11574288|FG000|Overall Study|Lost to Follow-up|1
7338011|NCT00857311|11574289|FG001|Overall Study|Lost to Follow-up|0
7338012|NCT00857311|11574290|FG002|Overall Study|Lost to Follow-up|0
7338013|NCT00857311|11574291|FG003|Overall Study|Lost to Follow-up|0
7338014|NCT00857389|11574297|FG000|Overall Study|Did not proceed to transplant|2
7338015|NCT00857415|11574303|FG000|Overall Study|Image acquisition failure|2
7338016|NCT00857415|11574304|FG001|Overall Study|Image acquisition failure|0
7338017|NCT00857415|11574303|FG000|Overall Study|Invalid image or not imaged|3
7338018|NCT00857415|11574304|FG001|Overall Study|Invalid image or not imaged|0
7338019|NCT00857415|11574303|FG000|Overall Study|Subject still living at end of study|110
7338020|NCT00857415|11574304|FG001|Overall Study|Subject still living at end of study|0
7338021|NCT00857415|11574303|FG000|Overall Study|Deceased with no autopsy|2
7338022|NCT00857415|11574304|FG001|Overall Study|Deceased with no autopsy|0
7338023|NCT00857454|11574310|FG000|Overall Study|Withdrawal by Subject|2
7338024|NCT00857454|11574310|FG000|Overall Study|Lost to Follow-up|1
7338025|NCT00857454|11574310|FG000|Overall Study|Adverse Event|2
7338026|NCT00857454|11574310|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
7338027|NCT00857454|11574310|FG000|Overall Study|Total Testosterone <300 ng/dL|8
7338028|NCT00857454|11574310|FG000|Overall Study|MTE09 enrollment criteria not met|6
7338029|NCT00857584|11574366|FG000|Overall Study|Lack of Efficacy|1
7338030|NCT00857584|11574367|FG001|Overall Study|Lack of Efficacy|2
7338031|NCT00857584|11574366|FG000|Overall Study|Adverse Event|2
7338032|NCT00857584|11574367|FG001|Overall Study|Adverse Event|2
7338033|NCT00857584|11574366|FG000|Overall Study|Physician Decision|1
7338034|NCT00857584|11574367|FG001|Overall Study|Physician Decision|1
7338035|NCT00857623|11574375|FG000|Overall Study|Adverse Event|5
7338036|NCT00857623|11574376|FG001|Overall Study|Adverse Event|2
7338037|NCT00857623|11574375|FG000|Overall Study|Study-specific discontinuation criteria|5
7338038|NCT00857623|11574376|FG001|Overall Study|Study-specific discontinuation criteria|3
7338039|NCT00857623|11574375|FG000|Overall Study|Withdrawal by Subject|2
7338040|NCT00857623|11574376|FG001|Overall Study|Withdrawal by Subject|1
7338041|NCT00857623|11574375|FG000|Overall Study|Lack of Efficacy|1
7338042|NCT00857623|11574376|FG001|Overall Study|Lack of Efficacy|1
7338043|NCT00857623|11574375|FG000|Overall Study|Severe non-compliance to protocol|1
7338044|NCT00857623|11574376|FG001|Overall Study|Severe non-compliance to protocol|1
7338045|NCT00857623|11574375|FG000|Overall Study|Intake of prohibited medication|0
7338046|NCT00857623|11574376|FG001|Overall Study|Intake of prohibited medication|1
7338047|NCT00857623|11574375|FG000|Overall Study|Positive for HEP C|0
7338048|NCT00857623|11574376|FG001|Overall Study|Positive for HEP C|1
7338049|NCT00857649|11574384|FG000|Overall Study|Adverse Event|15
7338050|NCT00857649|11574385|FG001|Overall Study|Adverse Event|10
7338051|NCT00857649|11574384|FG000|Overall Study|Non-compliance|1
7338052|NCT00857649|11574385|FG001|Overall Study|Non-compliance|1
7338053|NCT00857649|11574384|FG000|Overall Study|Protocol Violation|2
7338054|NCT00857649|11574385|FG001|Overall Study|Protocol Violation|2
7338055|NCT00857649|11574384|FG000|Overall Study|Withdrawal of Consent|10
7338056|NCT00857649|11574385|FG001|Overall Study|Withdrawal of Consent|7
7338057|NCT00857649|11574384|FG000|Overall Study|Nursing Home Placement|2
7338058|NCT00857649|11574385|FG001|Overall Study|Nursing Home Placement|9
7338059|NCT00857649|11574384|FG000|Overall Study|Other Reasons|1
7338060|NCT00857649|11574385|FG001|Overall Study|Other Reasons|3
7338061|NCT00857766|11574406|FG000|Overall Study|Adverse Event|13
7338062|NCT00857766|11574407|FG001|Overall Study|Adverse Event|12
7338063|NCT00857766|11574406|FG000|Overall Study|Protocol Violation|11
7338064|NCT00857766|11574407|FG001|Overall Study|Protocol Violation|11
7338065|NCT00857766|11574406|FG000|Overall Study|Lost to Follow-up|1
7338066|NCT00857766|11574407|FG001|Overall Study|Lost to Follow-up|0
7338067|NCT00857766|11574406|FG000|Overall Study|Investigator Discretion|2
7338068|NCT00857766|11574407|FG001|Overall Study|Investigator Discretion|3
7338069|NCT00857766|11574406|FG000|Overall Study|Participant Withdrew Consent|4
7338070|NCT00857766|11574407|FG001|Overall Study|Participant Withdrew Consent|4
7338071|NCT00857792|11574413|FG000|Overall Study|inadequate image quality for analysis|12
7338072|NCT00857818|11574419|FG000|Overall Study|Lack of Efficacy|1
7338073|NCT00857818|11574420|FG001|Overall Study|Lack of Efficacy|0
7338074|NCT00857818|11574419|FG000|Overall Study|Adverse Event|3
7338075|NCT00857818|11574420|FG001|Overall Study|Adverse Event|0
7338076|NCT00857818|11574419|FG000|Overall Study|Withdrawal by Subject|0
7338077|NCT00857818|11574420|FG001|Overall Study|Withdrawal by Subject|4
7338078|NCT00857818|11574419|FG000|Overall Study|Sponsor terminated study|6
7338079|NCT00857818|11574420|FG001|Overall Study|Sponsor terminated study|4
7338080|NCT00857818|11574419|FG000|Overall Study|Investigator decision|1
7338081|NCT00857818|11574420|FG001|Overall Study|Investigator decision|0
7338082|NCT00857896|11574438|FG000|Baseline to Week 4|Withdrawal by Subject|1
7338083|NCT00857948|11574447|FG000|Overall Study|Withdrawal by Subject|2
7338084|NCT00857948|11574448|FG001|Overall Study|Withdrawal by Subject|0
7338085|NCT00857948|11574449|FG002|Overall Study|Withdrawal by Subject|0
7338086|NCT00857948|11574450|FG003|Overall Study|Withdrawal by Subject|0
7338087|NCT00857948|11574447|FG000|Overall Study|Protocol Violation|1
7338088|NCT00857948|11574448|FG001|Overall Study|Protocol Violation|0
7338089|NCT00857948|11574449|FG002|Overall Study|Protocol Violation|1
7338090|NCT00857948|11574450|FG003|Overall Study|Protocol Violation|0
7338091|NCT00858117|11574479|FG000|Treatment on Study|Adverse Event|2
7338092|NCT00858117|11574479|FG000|Follow up for 5 Years|Death|4
7338093|NCT00858117|11574479|FG000|Follow up for 5 Years|No further data collected for study|9
7338094|NCT00858143|11574488|FG000|Overall Study|Adverse Event|16
7338095|NCT00858143|11574488|FG000|Overall Study|Lack of Efficacy|4
7338096|NCT00858143|11574488|FG000|Overall Study|Death|7
7338097|NCT00858143|11574488|FG000|Overall Study|Other|23
7338098|NCT00858208|11574492|FG000|Overall Study|Adverse Event|3
7338099|NCT00858208|11574492|FG000|Overall Study|Lost to Follow-up|26
7338100|NCT00858208|11574492|FG000|Overall Study|Participant refused|40
7338101|NCT00858208|11574492|FG000|Overall Study|Other|10
7338102|NCT00858234|11574496|FG000|Overall Study|Adverse Event|6
7338103|NCT00858234|11574496|FG000|Overall Study|Progressive disease|2
7338104|NCT00858234|11574496|FG000|Overall Study|Status unknown|1
7338105|NCT00858247|11574502|FG000|Baseline Assessment|Withdrawal by Subject|1
7338106|NCT00858247|11574503|FG001|Baseline Assessment|Withdrawal by Subject|1
7338107|NCT00858247|11574502|FG000|Baseline Assessment|Poor IV access|1
7338108|NCT00858247|11574503|FG001|Baseline Assessment|Poor IV access|0
7338109|NCT00858247|11574502|FG000|Baseline Assessment|Protocol Violation|0
7338110|NCT00858247|11574503|FG001|Baseline Assessment|Protocol Violation|1
7338111|NCT00858247|11574502|FG000|Week 12 Follow-up|Withdrawal by Subject|0
7338112|NCT00858247|11574503|FG001|Week 12 Follow-up|Withdrawal by Subject|1
7338113|NCT00858364|11574511|FG000|Overall Study|Administrative Decision|3
7338114|NCT00858364|11574512|FG001|Overall Study|Administrative Decision|2
7338115|NCT00858364|11574511|FG000|Overall Study|Adverse Event|5
7338116|NCT00858364|11574512|FG001|Overall Study|Adverse Event|2
7338117|NCT00858364|11574511|FG000|Overall Study|Withdrawal by Subject|44
7338118|NCT00858364|11574512|FG001|Overall Study|Withdrawal by Subject|118
7338119|NCT00858364|11574511|FG000|Overall Study|Ineligibility Determined|1
7338120|NCT00858364|11574512|FG001|Overall Study|Ineligibility Determined|10
7338121|NCT00858364|11574511|FG000|Overall Study|Lost to Follow-up|24
7338122|NCT00858364|11574512|FG001|Overall Study|Lost to Follow-up|54
7338123|NCT00858364|11574511|FG000|Overall Study|Noncompliance|3
7338124|NCT00858364|11574512|FG001|Overall Study|Noncompliance|4
7338125|NCT00858364|11574511|FG000|Overall Study|Protocol Deviation|0
7338126|NCT00858364|11574512|FG001|Overall Study|Protocol Deviation|2
7338127|NCT00858364|11574511|FG000|Overall Study|Other|9
7338128|NCT00858364|11574512|FG001|Overall Study|Other|17
7338129|NCT00858364|11574511|FG000|Overall Study|Missing|1
7338130|NCT00858364|11574512|FG001|Overall Study|Missing|1
7338131|NCT00858364|11574511|FG000|Overall Study|Still on-study|114
7338132|NCT00858364|11574512|FG001|Overall Study|Still on-study|247
7338133|NCT00858403|11574527|FG000|Overall Study|Withdrawal by Subject|1
7338134|NCT00858403|11574527|FG000|Overall Study|Death|3
7338135|NCT00858403|11574527|FG000|Overall Study|Disease Progression|1
7338136|NCT00858442|11574533|FG000|Compression:Start to Finish|Lost to Follow-up|1
7338137|NCT00858442|11574534|FG001|Compression:Start to Finish|Lost to Follow-up|3
7338138|NCT00858637|11574565|FG000|Active Comparison Phase|Adverse Event|14
7338139|NCT00858637|11574566|FG001|Active Comparison Phase|Adverse Event|0
7338140|NCT00858637|11574567|FG002|Active Comparison Phase|Adverse Event|0
7338141|NCT00858637|11574568|FG003|Active Comparison Phase|Adverse Event|9
7338142|NCT00858637|11574569|FG004|Active Comparison Phase|Adverse Event|0
7338143|NCT00858637|11574570|FG005|Active Comparison Phase|Adverse Event|0
7338144|NCT00858637|11574565|FG000|Active Comparison Phase|Death|1
7338145|NCT00858637|11574566|FG001|Active Comparison Phase|Death|0
7338146|NCT00858637|11574567|FG002|Active Comparison Phase|Death|0
7338147|NCT00858637|11574568|FG003|Active Comparison Phase|Death|1
7338148|NCT00858637|11574569|FG004|Active Comparison Phase|Death|0
7338149|NCT00858637|11574570|FG005|Active Comparison Phase|Death|0
7338150|NCT00858637|11574565|FG000|Active Comparison Phase|Physician Decision|1
7338151|NCT00858637|11574566|FG001|Active Comparison Phase|Physician Decision|0
7338152|NCT00858637|11574567|FG002|Active Comparison Phase|Physician Decision|0
7338153|NCT00858637|11574568|FG003|Active Comparison Phase|Physician Decision|1
7338154|NCT00858637|11574569|FG004|Active Comparison Phase|Physician Decision|0
7338155|NCT00858637|11574570|FG005|Active Comparison Phase|Physician Decision|0
7338156|NCT00858637|11574565|FG000|Active Comparison Phase|Withdrawal by Subject|7
7338157|NCT00858637|11574566|FG001|Active Comparison Phase|Withdrawal by Subject|0
7338158|NCT00858637|11574567|FG002|Active Comparison Phase|Withdrawal by Subject|0
7338159|NCT00858637|11574568|FG003|Active Comparison Phase|Withdrawal by Subject|6
7338160|NCT00858637|11574569|FG004|Active Comparison Phase|Withdrawal by Subject|0
7338161|NCT00858637|11574570|FG005|Active Comparison Phase|Withdrawal by Subject|0
7338162|NCT00858637|11574565|FG000|Active Comparison Phase|Other Reasons|1
7338163|NCT00858637|11574566|FG001|Active Comparison Phase|Other Reasons|0
7338164|NCT00858637|11574567|FG002|Active Comparison Phase|Other Reasons|0
7338165|NCT00858637|11574568|FG003|Active Comparison Phase|Other Reasons|1
7338166|NCT00858637|11574569|FG004|Active Comparison Phase|Other Reasons|0
7338167|NCT00858637|11574570|FG005|Active Comparison Phase|Other Reasons|0
7338168|NCT00858637|11574565|FG000|Placebo-controlled Withdrawal Phase|Death|0
7338169|NCT00858637|11574566|FG001|Placebo-controlled Withdrawal Phase|Death|0
7338170|NCT00858637|11574567|FG002|Placebo-controlled Withdrawal Phase|Death|1
7338171|NCT00858637|11574568|FG003|Placebo-controlled Withdrawal Phase|Death|0
7338172|NCT00858637|11574569|FG004|Placebo-controlled Withdrawal Phase|Death|1
7338173|NCT00858637|11574570|FG005|Placebo-controlled Withdrawal Phase|Death|0
7338174|NCT00858637|11574565|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7338175|NCT00858637|11574566|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7338176|NCT00858637|11574567|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7338177|NCT00858637|11574568|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7338178|NCT00858637|11574569|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
7338179|NCT00858637|11574570|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
7338180|NCT00858780|11574584|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
7338181|NCT00858780|11574585|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7338182|NCT00858780|11574586|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7338183|NCT00858780|11574587|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7338184|NCT00858780|11574588|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
7338185|NCT00858780|11574584|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7338186|NCT00858780|11574585|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7338187|NCT00858780|11574586|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
7338188|NCT00858780|11574587|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7338189|NCT00858780|11574588|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
7338190|NCT00858780|11574584|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7338191|NCT00858780|11574585|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7338192|NCT00858780|11574586|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7338193|NCT00858780|11574587|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
7338194|NCT00858780|11574588|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
7338195|NCT00858780|11574584|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7338196|NCT00858780|11574585|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
7338197|NCT00858780|11574586|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7338198|NCT00858780|11574587|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7338199|NCT00858780|11574588|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
7338200|NCT00858780|11574584|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7338201|NCT00858780|11574585|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7338202|NCT00858780|11574586|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7338203|NCT00858780|11574587|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
7338204|NCT00858780|11574588|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
7338205|NCT00858780|11574584|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
7338206|NCT00858780|11574585|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
7338207|NCT00858780|11574586|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
7338208|NCT00858780|11574587|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
7338209|NCT00858780|11574588|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
7338210|NCT00858832|11574600|FG000|Overall Study|became ineligible: delivered vaginally|1
7338211|NCT00858832|11574601|FG001|Overall Study|became ineligible: delivered vaginally|0
7338212|NCT00858832|11574600|FG000|Overall Study|Adverse Event|0
7338213|NCT00858832|11574601|FG001|Overall Study|Adverse Event|1
7338214|NCT00858845|11574609|FG000|Overall Study|Patient underwent heart transplant.|0
7338215|NCT00858845|11574610|FG001|Overall Study|Patient underwent heart transplant.|1
7338216|NCT00858988|11574626|FG000|Analysis|Lactulose unable to be detected in urine|2
7338217|NCT00858988|11574627|FG001|Analysis|Lactulose unable to be detected in urine|1
7338218|NCT00859014|11574633|FG000|Overall Study|Death|4
7338219|NCT00859014|11574633|FG000|Overall Study|Lost to Follow-up|1
7338220|NCT00859222|11574684|FG000|Overall Study|Adverse Event|2
7338221|NCT00859222|11574685|FG001|Overall Study|Adverse Event|3
7338222|NCT00859222|11574686|FG002|Overall Study|Adverse Event|6
7338223|NCT00859222|11574687|FG003|Overall Study|Adverse Event|24
7338224|NCT00859222|11574688|FG004|Overall Study|Adverse Event|15
7338225|NCT00859222|11574684|FG000|Overall Study|DLT|1
7338226|NCT00859222|11574685|FG001|Overall Study|DLT|0
7338227|NCT00859222|11574686|FG002|Overall Study|DLT|0
7338228|NCT00859222|11574687|FG003|Overall Study|DLT|0
7338229|NCT00859222|11574688|FG004|Overall Study|DLT|0
7338230|NCT00859313|11574703|FG000|Overall Study|Lack of Efficacy|2
7338231|NCT00859313|11574703|FG000|Overall Study|Adverse Event|1
7338232|NCT00859313|11574703|FG000|Overall Study|staff error|1
7338233|NCT00859456|11574711|FG000|Overall Study|Adverse Event|3
7338234|NCT00859456|11574711|FG000|Overall Study|Progressive disease|2
7338235|NCT00859456|11574711|FG000|Overall Study|Non-compliance|3
7338236|NCT00859469|11574715|FG000|Overall Study|Adverse Event|2
7338237|NCT00859469|11574715|FG000|Overall Study|Lack of Efficacy|9
7338238|NCT00859469|11574715|FG000|Overall Study|Withdrawal by Subject|1
7338239|NCT00859469|11574715|FG000|Overall Study|Death|16
7338240|NCT00859547|11574732|FG000|Overall Study|Lost to Follow-up|1
7338241|NCT00859547|11574732|FG000|Overall Study|Parent withdrew consent|1
7338242|NCT00859573|11574738|FG000|Overall Study|Withdrawal by Subject|4
7338243|NCT00859573|11574739|FG001|Overall Study|Withdrawal by Subject|1
7338244|NCT00859573|11574738|FG000|Overall Study|Physician Decision|1
7338245|NCT00859573|11574739|FG001|Overall Study|Physician Decision|1
7338246|NCT00859586|11574745|FG000|Overall Study|Donors|4
7338247|NCT00859638|11574751|FG000|Overall Study|Lost to Follow-up|6
7338248|NCT00859638|11574752|FG001|Overall Study|Lost to Follow-up|1
7338249|NCT00859638|11574751|FG000|Overall Study|Withdrawal by Subject|3
7338250|NCT00859638|11574752|FG001|Overall Study|Withdrawal by Subject|2
7338251|NCT00859638|11574751|FG000|Overall Study|Ill health|1
7338252|NCT00859638|11574752|FG001|Overall Study|Ill health|1
7385600|NCT01202773|11643454|FG001|Overall Study|Adverse Event|5
7385601|NCT01202773|11643455|FG002|Overall Study|Adverse Event|5
7385602|NCT01202773|11643453|FG000|Overall Study|Lack of Efficacy|5
7385603|NCT01202773|11643454|FG001|Overall Study|Lack of Efficacy|4
7385604|NCT01202773|11643455|FG002|Overall Study|Lack of Efficacy|9
7385605|NCT01202773|11643453|FG000|Overall Study|Entry Criteria Not Met|2
7385606|NCT01202773|11643454|FG001|Overall Study|Entry Criteria Not Met|0
7385607|NCT01202773|11643455|FG002|Overall Study|Entry Criteria Not Met|1
7385608|NCT01202773|11643453|FG000|Overall Study|Lost to Follow-up|1
7385609|NCT01202773|11643454|FG001|Overall Study|Lost to Follow-up|2
7385610|NCT01202773|11643455|FG002|Overall Study|Lost to Follow-up|2
7385611|NCT01202773|11643453|FG000|Overall Study|Withdrawal by Subject|13
7385612|NCT01202773|11643454|FG001|Overall Study|Withdrawal by Subject|6
7458208|NCT01806597|11752182|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7385613|NCT01202773|11643455|FG002|Overall Study|Withdrawal by Subject|5
7385614|NCT01202773|11643453|FG000|Overall Study|Physician Decision|2
7385615|NCT01202773|11643454|FG001|Overall Study|Physician Decision|0
7338253|NCT00859898|11574775|FG000|Overall Study|Lack of Efficacy|0
7338254|NCT00859898|11574776|FG001|Overall Study|Lack of Efficacy|1
7338255|NCT00859898|11574777|FG002|Overall Study|Lack of Efficacy|1
7338256|NCT00859898|11574775|FG000|Overall Study|Adverse Event|4
7338257|NCT00859898|11574776|FG001|Overall Study|Adverse Event|9
7338258|NCT00859898|11574777|FG002|Overall Study|Adverse Event|8
7338259|NCT00859898|11574775|FG000|Overall Study|Withdrawal by Subject|11
7338260|NCT00859898|11574776|FG001|Overall Study|Withdrawal by Subject|8
7338261|NCT00859898|11574777|FG002|Overall Study|Withdrawal by Subject|11
7338262|NCT00859898|11574775|FG000|Overall Study|Death|0
7338263|NCT00859898|11574776|FG001|Overall Study|Death|0
7338264|NCT00859898|11574777|FG002|Overall Study|Death|1
7338265|NCT00859898|11574775|FG000|Overall Study|Lost to Follow-up|10
7338266|NCT00859898|11574776|FG001|Overall Study|Lost to Follow-up|11
7338267|NCT00859898|11574777|FG002|Overall Study|Lost to Follow-up|5
7338268|NCT00859898|11574775|FG000|Overall Study|poor/non-compliance|2
7338269|NCT00859898|11574776|FG001|Overall Study|poor/non-compliance|0
7338270|NCT00859898|11574777|FG002|Overall Study|poor/non-compliance|0
7338271|NCT00859898|11574775|FG000|Overall Study|No longer meets criteria|0
7338272|NCT00859898|11574776|FG001|Overall Study|No longer meets criteria|1
7338273|NCT00859898|11574777|FG002|Overall Study|No longer meets criteria|0
7338274|NCT00859898|11574775|FG000|Overall Study|non-specified|1
7338275|NCT00859898|11574776|FG001|Overall Study|non-specified|1
7338276|NCT00859898|11574777|FG002|Overall Study|non-specified|1
7338277|NCT00859937|11574788|FG000|Overall Study|Protocol Violation|1
7338278|NCT00859937|11574789|FG001|Overall Study|Protocol Violation|0
7338279|NCT00860028|11574819|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
7338280|NCT00860028|11574820|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
7338281|NCT00860067|11574831|FG000|Overall Study|Lost to Follow-up|46
7338282|NCT00860067|11574832|FG001|Overall Study|Lost to Follow-up|9
7338283|NCT00860067|11574833|FG002|Overall Study|Lost to Follow-up|9
7338284|NCT00860067|11574831|FG000|Overall Study|Withdrawal by Subject|4
7338285|NCT00860067|11574832|FG001|Overall Study|Withdrawal by Subject|0
7338286|NCT00860067|11574833|FG002|Overall Study|Withdrawal by Subject|0
7338287|NCT00860067|11574831|FG000|Overall Study|Pregnancy|1
7338288|NCT00860067|11574832|FG001|Overall Study|Pregnancy|0
7338289|NCT00860067|11574833|FG002|Overall Study|Pregnancy|0
7338290|NCT00860262|11574851|FG000|Overall Study|Adverse Event|9
7338291|NCT00860262|11574852|FG001|Overall Study|Adverse Event|6
7338292|NCT00860262|11574853|FG002|Overall Study|Adverse Event|7
7338293|NCT00860262|11574851|FG000|Overall Study|Protocol Violation|0
7338294|NCT00860262|11574852|FG001|Overall Study|Protocol Violation|1
7338295|NCT00860262|11574853|FG002|Overall Study|Protocol Violation|0
7338296|NCT00860262|11574851|FG000|Overall Study|Lost to Follow-up|2
7338297|NCT00860262|11574852|FG001|Overall Study|Lost to Follow-up|0
7338298|NCT00860262|11574853|FG002|Overall Study|Lost to Follow-up|1
7338299|NCT00860262|11574851|FG000|Overall Study|Withdrawal by Subject|4
7338300|NCT00860262|11574852|FG001|Overall Study|Withdrawal by Subject|8
7338301|NCT00860262|11574853|FG002|Overall Study|Withdrawal by Subject|6
7338302|NCT00860262|11574851|FG000|Overall Study|Lack of Efficacy|0
7338303|NCT00860262|11574852|FG001|Overall Study|Lack of Efficacy|4
7338304|NCT00860262|11574853|FG002|Overall Study|Lack of Efficacy|3
7338305|NCT00860262|11574851|FG000|Overall Study|Other|5
7338306|NCT00860262|11574852|FG001|Overall Study|Other|3
7338307|NCT00860262|11574853|FG002|Overall Study|Other|1
7338308|NCT00860405|11574887|FG000|Overall Study|Main reason: Follow-up data not complete|5
7338309|NCT00860405|11574888|FG001|Overall Study|Main reason: Follow-up data not complete|4
7338310|NCT00860470|11574900|FG000|Overall Study|Death|6
7338311|NCT00860470|11574901|FG001|Overall Study|Death|10
7338312|NCT00860470|11574900|FG000|Overall Study|Moved away|8
7338313|NCT00860470|11574901|FG001|Overall Study|Moved away|10
7338314|NCT00860470|11574900|FG000|Overall Study|Lost to Follow-up|34
7338315|NCT00860470|11574901|FG001|Overall Study|Lost to Follow-up|39
7338316|NCT00860574|11574911|FG000|Overall Study|Death|2
7338317|NCT00860574|11574911|FG000|Overall Study|Relapse|1
7338318|NCT00860743|11574921|FG000|Overall Study|Withdrawal by Subject|3
7338319|NCT00860743|11574922|FG001|Overall Study|Withdrawal by Subject|0
7338320|NCT00860951|11574955|FG000|Overall Study|Withdrawal by Subject|2
7338321|NCT00860951|11574955|FG000|Overall Study|Lost to Follow-up|5
7338322|NCT00861198|11574970|FG000|Overall Study|SpyGlass Failed|5
7338323|NCT00861341|11574978|FG000|Overall Study|Withdrawal by Subject|2
7338324|NCT00861380|11574989|FG000|Overall Study|Withdrawal Information not recorded|8427
7338325|NCT00861380|11574990|FG001|Overall Study|Withdrawal Information not recorded|9112
7338326|NCT00861380|11574991|FG002|Overall Study|Withdrawal Information not recorded|8872
7338327|NCT00861380|11574992|FG003|Overall Study|Withdrawal Information not recorded|3689
7338328|NCT00861380|11574993|FG004|Overall Study|Withdrawal Information not recorded|1812
7338329|NCT00861380|11574994|FG005|Overall Study|Withdrawal Information not recorded|6249
7338330|NCT00861380|11574995|FG006|Overall Study|Withdrawal Information not recorded|3020
7338331|NCT00861471|11575028|FG000|Overall Study|Withdrawal by Subject|1
7338332|NCT00861471|11575028|FG000|Overall Study|Adverse Event|2
7338333|NCT00861471|11575028|FG000|Overall Study|Lack of Efficacy|3
7338334|NCT00861471|11575028|FG000|Overall Study|treatment for lumbar laminectomy|1
7338335|NCT00861471|11575028|FG000|Overall Study|Physician Decision|2
7338336|NCT00861614|11575050|FG000|Overall Study|Disease Progression|182
7338337|NCT00861614|11575051|FG001|Overall Study|Disease Progression|263
7338338|NCT00861614|11575050|FG000|Overall Study|Study Drug Toxicity|79
7338339|NCT00861614|11575051|FG001|Overall Study|Study Drug Toxicity|6
7338340|NCT00861614|11575050|FG000|Overall Study|Death|32
7338341|NCT00861614|11575051|FG001|Overall Study|Death|19
7338342|NCT00861614|11575050|FG000|Overall Study|Adverse Event|27
7458209|NCT01806597|11752183|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7568720|NCT03425253|11944265|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
7568721|NCT03425396|11944275|FG000|Overall Study|Lost to Follow-up|2
7568722|NCT03425396|11944276|FG001|Overall Study|Lost to Follow-up|5
7568723|NCT03425396|11944277|FG002|Overall Study|Lost to Follow-up|2
7568724|NCT03425396|11944278|FG003|Overall Study|Lost to Follow-up|0
7568725|NCT03425396|11944279|FG004|Overall Study|Lost to Follow-up|0
7568726|NCT03425396|11944275|FG000|Overall Study|Withdrawal by Subject|0
7568727|NCT03425396|11944276|FG001|Overall Study|Withdrawal by Subject|1
7568728|NCT03425396|11944277|FG002|Overall Study|Withdrawal by Subject|0
7568729|NCT03425396|11944278|FG003|Overall Study|Withdrawal by Subject|1
7568730|NCT03425396|11944279|FG004|Overall Study|Withdrawal by Subject|0
7468236|NCT01908803|11768920|FG000|Overall Study|Adverse Event|1
7338343|NCT00861614|11575051|FG001|Overall Study|Adverse Event|23
7568731|NCT03425396|11944275|FG000|Overall Study|Other|0
7338344|NCT00861614|11575050|FG000|Overall Study|Withdrawal by Subject|34
7338345|NCT00861614|11575051|FG001|Overall Study|Withdrawal by Subject|35
7338346|NCT00861614|11575050|FG000|Overall Study|Other|17
7338347|NCT00861614|11575051|FG001|Overall Study|Other|22
7338348|NCT00861692|11575057|FG000|Overall Study|Death|6
7338349|NCT00861744|11575065|FG000|Overall Study|Adverse Event|0
7338350|NCT00861744|11575066|FG001|Overall Study|Adverse Event|0
7338351|NCT00861744|11575067|FG002|Overall Study|Adverse Event|0
7338352|NCT00861744|11575068|FG003|Overall Study|Adverse Event|1
7338353|NCT00861744|11575065|FG000|Overall Study|Lost to Follow-up|7
7338354|NCT00861744|11575066|FG001|Overall Study|Lost to Follow-up|19
7338355|NCT00861744|11575067|FG002|Overall Study|Lost to Follow-up|17
7338356|NCT00861744|11575068|FG003|Overall Study|Lost to Follow-up|12
7338357|NCT00861744|11575065|FG000|Overall Study|Withdrawal by Subject|10
7338358|NCT00861744|11575066|FG001|Overall Study|Withdrawal by Subject|6
7338359|NCT00861744|11575067|FG002|Overall Study|Withdrawal by Subject|6
7338360|NCT00861744|11575068|FG003|Overall Study|Withdrawal by Subject|19
7338361|NCT00861744|11575065|FG000|Overall Study|Protocol Violation|0
7338362|NCT00861744|11575066|FG001|Overall Study|Protocol Violation|1
7338363|NCT00861744|11575067|FG002|Overall Study|Protocol Violation|0
7338364|NCT00861744|11575068|FG003|Overall Study|Protocol Violation|0
7338365|NCT00861744|11575065|FG000|Overall Study|Migration from study area|0
7338366|NCT00861744|11575066|FG001|Overall Study|Migration from study area|3
7338367|NCT00861744|11575067|FG002|Overall Study|Migration from study area|1
7338368|NCT00861744|11575068|FG003|Overall Study|Migration from study area|0
7338369|NCT00861744|11575065|FG000|Overall Study|Blood draws|0
7338370|NCT00861744|11575066|FG001|Overall Study|Blood draws|0
7338371|NCT00861744|11575067|FG002|Overall Study|Blood draws|0
7338372|NCT00861744|11575068|FG003|Overall Study|Blood draws|1
7338373|NCT00861757|11575082|FG000|Overall Study|Adverse Event|1
7338374|NCT00861757|11575083|FG001|Overall Study|Adverse Event|5
7338375|NCT00861757|11575084|FG002|Overall Study|Adverse Event|7
7338376|NCT00861757|11575085|FG003|Overall Study|Adverse Event|2
7338377|NCT00861757|11575082|FG000|Overall Study|Entry Criteria Not Met|1
7338378|NCT00861757|11575083|FG001|Overall Study|Entry Criteria Not Met|2
7338379|NCT00861757|11575084|FG002|Overall Study|Entry Criteria Not Met|1
7338380|NCT00861757|11575085|FG003|Overall Study|Entry Criteria Not Met|1
7338381|NCT00861757|11575082|FG000|Overall Study|Lack of Efficacy|3
7338382|NCT00861757|11575083|FG001|Overall Study|Lack of Efficacy|1
7338383|NCT00861757|11575084|FG002|Overall Study|Lack of Efficacy|0
7338384|NCT00861757|11575085|FG003|Overall Study|Lack of Efficacy|1
7338385|NCT00861757|11575082|FG000|Overall Study|Lost to Follow-up|1
7338386|NCT00861757|11575083|FG001|Overall Study|Lost to Follow-up|0
7338387|NCT00861757|11575084|FG002|Overall Study|Lost to Follow-up|1
7338388|NCT00861757|11575085|FG003|Overall Study|Lost to Follow-up|1
7338389|NCT00861757|11575082|FG000|Overall Study|Physician Decision|0
7338390|NCT00861757|11575083|FG001|Overall Study|Physician Decision|0
7338391|NCT00861757|11575084|FG002|Overall Study|Physician Decision|0
7338392|NCT00861757|11575085|FG003|Overall Study|Physician Decision|1
7338393|NCT00861757|11575082|FG000|Overall Study|Protocol Violation|2
7338394|NCT00861757|11575083|FG001|Overall Study|Protocol Violation|2
7338395|NCT00861757|11575084|FG002|Overall Study|Protocol Violation|4
7338396|NCT00861757|11575085|FG003|Overall Study|Protocol Violation|1
7338397|NCT00861757|11575082|FG000|Overall Study|Withdrawal by Subject|1
7338398|NCT00861757|11575083|FG001|Overall Study|Withdrawal by Subject|5
7338399|NCT00861757|11575084|FG002|Overall Study|Withdrawal by Subject|5
7338400|NCT00861757|11575085|FG003|Overall Study|Withdrawal by Subject|2
7338401|NCT00862082|11575105|FG000|Overall Study|Sponsor decision to terminate the study|5
7338402|NCT00862082|11575106|FG001|Overall Study|Sponsor decision to terminate the study|0
7338403|NCT00862082|11575105|FG000|Overall Study|Withdrawal by Subject|0
7338404|NCT00862082|11575106|FG001|Overall Study|Withdrawal by Subject|1
7338405|NCT00862121|11575121|FG000|Overall Study|Adverse Event|1
7338406|NCT00862121|11575122|FG001|Overall Study|Adverse Event|2
7338407|NCT00862121|11575121|FG000|Overall Study|Lack of Efficacy|0
7338408|NCT00862121|11575122|FG001|Overall Study|Lack of Efficacy|3
7338409|NCT00862121|11575121|FG000|Overall Study|Protocol Violation|0
7338410|NCT00862121|11575122|FG001|Overall Study|Protocol Violation|1
7338411|NCT00862121|11575121|FG000|Overall Study|Exclusion criterion violation|0
7338412|NCT00862121|11575122|FG001|Overall Study|Exclusion criterion violation|1
7338413|NCT00862121|11575121|FG000|Overall Study|Incorrect randomisation|0
7338414|NCT00862121|11575122|FG001|Overall Study|Incorrect randomisation|1
7338415|NCT00862134|11575130|FG000|Overall Study|Death|1
7338416|NCT00862134|11575131|FG001|Overall Study|Death|0
7338417|NCT00862134|11575130|FG000|Overall Study|Physician Decision|0
7338418|NCT00862134|11575131|FG001|Overall Study|Physician Decision|1
7338419|NCT00862134|11575130|FG000|Overall Study|Withdrawal by Subject|1
7338420|NCT00862134|11575131|FG001|Overall Study|Withdrawal by Subject|2
7338421|NCT00862134|11575130|FG000|Overall Study|Sponsor terminated study|5
7338422|NCT00862134|11575131|FG001|Overall Study|Sponsor terminated study|7
7338423|NCT00862134|11575130|FG000|Overall Study|Adverse Event|2
7338424|NCT00862134|11575131|FG001|Overall Study|Adverse Event|2
7338425|NCT00862134|11575130|FG000|Overall Study|Withdrew prior to dosing|2
7338426|NCT00862134|11575131|FG001|Overall Study|Withdrew prior to dosing|0
7338427|NCT00862277|11575145|FG000|Overall Study|Protocol Violation|1
7338428|NCT00862277|11575146|FG001|Overall Study|Protocol Violation|2
7338429|NCT00862277|11575147|FG002|Overall Study|Protocol Violation|5
7338430|NCT00862459|11575162|FG000|Overall Study|Lost to Follow-up|1
7338431|NCT00862459|11575163|FG001|Overall Study|Lost to Follow-up|2
7338432|NCT00862459|11575164|FG002|Overall Study|Lost to Follow-up|2
7338433|NCT00862459|11575162|FG000|Overall Study|Protocol Violation|1
7338434|NCT00862459|11575163|FG001|Overall Study|Protocol Violation|0
7338435|NCT00862459|11575164|FG002|Overall Study|Protocol Violation|0
7338436|NCT00862459|11575162|FG000|Overall Study|Withdrawal by Subject|1
7338437|NCT00862459|11575163|FG001|Overall Study|Withdrawal by Subject|1
7338438|NCT00862459|11575164|FG002|Overall Study|Withdrawal by Subject|3
7338439|NCT00862459|11575162|FG000|Overall Study|Adverse Event|0
7338440|NCT00862459|11575163|FG001|Overall Study|Adverse Event|1
7338441|NCT00862459|11575164|FG002|Overall Study|Adverse Event|0
7338442|NCT00862459|11575162|FG000|Overall Study|Personal reasons|1
7338443|NCT00862459|11575163|FG001|Overall Study|Personal reasons|0
7338444|NCT00862459|11575164|FG002|Overall Study|Personal reasons|0
7338445|NCT00862459|11575162|FG000|Overall Study|Operation|1
7338446|NCT00862459|11575163|FG001|Overall Study|Operation|1
7338447|NCT00862459|11575164|FG002|Overall Study|Operation|0
7338448|NCT00862459|11575162|FG000|Overall Study|Intravenous (IV) site problems|1
7338449|NCT00862459|11575163|FG001|Overall Study|Intravenous (IV) site problems|0
7338450|NCT00862459|11575164|FG002|Overall Study|Intravenous (IV) site problems|1
7338451|NCT00862459|11575162|FG000|Overall Study|Unable to hold still for imaging|0
7338452|NCT00862459|11575163|FG001|Overall Study|Unable to hold still for imaging|1
7338453|NCT00862459|11575164|FG002|Overall Study|Unable to hold still for imaging|0
7338454|NCT00862459|11575162|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7338455|NCT00862459|11575163|FG001|Overall Study|Inclusion/exclusion criteria not met|1
7338456|NCT00862459|11575164|FG002|Overall Study|Inclusion/exclusion criteria not met|0
7338457|NCT00862459|11575162|FG000|Overall Study|Administrative problems|0
7338458|NCT00862459|11575163|FG001|Overall Study|Administrative problems|1
7338459|NCT00862459|11575164|FG002|Overall Study|Administrative problems|0
7338460|NCT00862641|11575207|FG000|Overall Study|Randomized, but drug not received|1
7338461|NCT00862641|11575208|FG001|Overall Study|Randomized, but drug not received|4
7338462|NCT00862641|11575209|FG002|Overall Study|Randomized, but drug not received|1
7338463|NCT00862641|11575210|FG003|Overall Study|Randomized, but drug not received|4
7338464|NCT00862654|11575224|FG000|Overall Study|Lack of Efficacy|1
7338465|NCT00862654|11575225|FG001|Overall Study|Lack of Efficacy|0
7338466|NCT00862654|11575226|FG002|Overall Study|Lack of Efficacy|1
7338467|NCT00862654|11575227|FG003|Overall Study|Lack of Efficacy|0
7338468|NCT00862654|11575224|FG000|Overall Study|Lost to Follow-up|1
7338469|NCT00862654|11575225|FG001|Overall Study|Lost to Follow-up|2
7338470|NCT00862654|11575226|FG002|Overall Study|Lost to Follow-up|1
7338471|NCT00862654|11575227|FG003|Overall Study|Lost to Follow-up|3
7338472|NCT00862654|11575224|FG000|Overall Study|Adverse Event|0
7338473|NCT00862654|11575225|FG001|Overall Study|Adverse Event|1
7338474|NCT00862654|11575226|FG002|Overall Study|Adverse Event|1
7338475|NCT00862654|11575227|FG003|Overall Study|Adverse Event|0
7338476|NCT00862654|11575224|FG000|Overall Study|Pregnancy|1
7338477|NCT00862654|11575225|FG001|Overall Study|Pregnancy|1
7338478|NCT00862654|11575226|FG002|Overall Study|Pregnancy|0
7338479|NCT00862654|11575227|FG003|Overall Study|Pregnancy|0
7338480|NCT00862654|11575224|FG000|Overall Study|Withdrawal by Subject|2
7338481|NCT00862654|11575225|FG001|Overall Study|Withdrawal by Subject|2
7338482|NCT00862654|11575226|FG002|Overall Study|Withdrawal by Subject|2
7338483|NCT00862654|11575227|FG003|Overall Study|Withdrawal by Subject|3
7338484|NCT00862654|11575224|FG000|Overall Study|Subject mistake|0
7338485|NCT00862654|11575225|FG001|Overall Study|Subject mistake|1
7338486|NCT00862654|11575226|FG002|Overall Study|Subject mistake|0
7338487|NCT00862654|11575227|FG003|Overall Study|Subject mistake|0
7338488|NCT00862654|11575224|FG000|Overall Study|Familly constraint|0
7338489|NCT00862654|11575225|FG001|Overall Study|Familly constraint|1
7338490|NCT00862654|11575226|FG002|Overall Study|Familly constraint|0
7338491|NCT00862654|11575227|FG003|Overall Study|Familly constraint|0
7338492|NCT00862654|11575224|FG000|Overall Study|Never used study drugs|1
7338493|NCT00862654|11575225|FG001|Overall Study|Never used study drugs|0
7338494|NCT00862654|11575226|FG002|Overall Study|Never used study drugs|0
7338495|NCT00862654|11575227|FG003|Overall Study|Never used study drugs|0
7338496|NCT00862654|11575224|FG000|Overall Study|Included after end of inclusions|0
7338497|NCT00862654|11575225|FG001|Overall Study|Included after end of inclusions|0
7338498|NCT00862654|11575226|FG002|Overall Study|Included after end of inclusions|1
7338499|NCT00862654|11575227|FG003|Overall Study|Included after end of inclusions|0
7338500|NCT00862719|11575241|FG000|Overall Study|Disease Progression|5
7338501|NCT00862719|11575242|FG001|Overall Study|Disease Progression|0
7338502|NCT00862719|11575243|FG002|Overall Study|Disease Progression|1
7338503|NCT00862719|11575244|FG003|Overall Study|Disease Progression|0
7338504|NCT00862719|11575241|FG000|Overall Study|Death|5
7338505|NCT00862719|11575242|FG001|Overall Study|Death|6
7338506|NCT00862719|11575243|FG002|Overall Study|Death|1
7338507|NCT00862719|11575244|FG003|Overall Study|Death|1
7338508|NCT00862719|11575241|FG000|Overall Study|Engraftment failure|0
7338509|NCT00862719|11575242|FG001|Overall Study|Engraftment failure|0
7338510|NCT00862719|11575243|FG002|Overall Study|Engraftment failure|1
7338511|NCT00862719|11575244|FG003|Overall Study|Engraftment failure|0
7338512|NCT00862719|11575241|FG000|Overall Study|Veno-Occlusive Disease|0
7338513|NCT00862719|11575242|FG001|Overall Study|Veno-Occlusive Disease|0
7338514|NCT00862719|11575243|FG002|Overall Study|Veno-Occlusive Disease|1
7338515|NCT00862719|11575244|FG003|Overall Study|Veno-Occlusive Disease|0
7338516|NCT00862823|11575276|FG000|First Intervention|Withdrawal by Subject|1
7338517|NCT00862823|11575277|FG001|First Intervention|Withdrawal by Subject|1
7338518|NCT00862836|11575282|FG000|Overall Study|Withdrawal by Subject|1
7338519|NCT00862849|11575286|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7338520|NCT00862849|11575287|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
7338521|NCT00862849|11575288|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7338522|NCT00862849|11575289|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7338523|NCT00862849|11575290|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7533025|NCT02679729|11879026|FG000|Overall Study|Participant decision|0
7533026|NCT02679729|11879027|FG001|Overall Study|Participant decision|1
7533027|NCT02679729|11879028|FG002|Overall Study|Participant decision|0
7533028|NCT02679729|11879029|FG003|Overall Study|Participant decision|0
7533029|NCT02679729|11879030|FG004|Overall Study|Participant decision|0
7533030|NCT02679729|11879031|FG005|Overall Study|Participant decision|0
7338524|NCT00862849|11575291|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
7338525|NCT00862849|11575286|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
7533031|NCT02679729|11879032|FG006|Overall Study|Participant decision|1
7338526|NCT00862849|11575287|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
7338527|NCT00862849|11575288|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
7338528|NCT00862849|11575289|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
7338529|NCT00862849|11575290|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
7338530|NCT00862849|11575291|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
7338531|NCT00862940|11575301|FG000|Overall Study|Adverse Event|15
7338532|NCT00862940|11575302|FG001|Overall Study|Adverse Event|12
7338533|NCT00862940|11575301|FG000|Overall Study|Lack of Efficacy|1
7338534|NCT00862940|11575302|FG001|Overall Study|Lack of Efficacy|3
7338535|NCT00862940|11575301|FG000|Overall Study|Protocol Violation|2
7338536|NCT00862940|11575302|FG001|Overall Study|Protocol Violation|5
7338537|NCT00862940|11575301|FG000|Overall Study|Withdrawal by Subject|4
7338538|NCT00862940|11575302|FG001|Overall Study|Withdrawal by Subject|6
7338539|NCT00862940|11575301|FG000|Overall Study|Non-compliance|4
7338540|NCT00862940|11575302|FG001|Overall Study|Non-compliance|0
7338541|NCT00862940|11575301|FG000|Overall Study|Lost to Follow-up|0
7338542|NCT00862940|11575302|FG001|Overall Study|Lost to Follow-up|1
7338543|NCT00862940|11575301|FG000|Overall Study|Administrative or other reason(s)|4
7338544|NCT00862940|11575302|FG001|Overall Study|Administrative or other reason(s)|3
7338545|NCT00862979|11575310|FG000|Overall Study|Adverse Event|6
7338546|NCT00862979|11575311|FG001|Overall Study|Adverse Event|3
7338547|NCT00862979|11575310|FG000|Overall Study|Protocol Violation|0
7338548|NCT00862979|11575311|FG001|Overall Study|Protocol Violation|1
7338549|NCT00862979|11575310|FG000|Overall Study|Patient withdrew consent|2
7338550|NCT00862979|11575311|FG001|Overall Study|Patient withdrew consent|1
7338551|NCT00862979|11575310|FG000|Overall Study|Administrative problems|0
7338552|NCT00862979|11575311|FG001|Overall Study|Administrative problems|1
7338553|NCT00862979|11575310|FG000|Overall Study|Death|0
7338554|NCT00862979|11575311|FG001|Overall Study|Death|1
7338555|NCT00862992|11575320|FG000|Overall Study|Adverse Event|2
7338556|NCT00862992|11575321|FG001|Overall Study|Adverse Event|1
7338557|NCT00862992|11575322|FG002|Overall Study|Adverse Event|1
7338558|NCT00862992|11575320|FG000|Overall Study|Physician Decision|1
7338559|NCT00862992|11575321|FG001|Overall Study|Physician Decision|0
7338560|NCT00862992|11575322|FG002|Overall Study|Physician Decision|0
7338561|NCT00862992|11575320|FG000|Overall Study|Withdrawal by Subject|0
7338562|NCT00862992|11575321|FG001|Overall Study|Withdrawal by Subject|0
7338563|NCT00862992|11575322|FG002|Overall Study|Withdrawal by Subject|2
7338564|NCT00863057|11575334|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7338565|NCT00863057|11575335|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7338566|NCT00863057|11575336|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
7338567|NCT00863057|11575337|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
7338568|NCT00863057|11575334|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7338569|NCT00863057|11575335|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
7338570|NCT00863057|11575336|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7338571|NCT00863057|11575337|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
7338572|NCT00863057|11575334|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
7338573|NCT00863057|11575335|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
7338574|NCT00863057|11575336|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
7338575|NCT00863057|11575337|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
7338576|NCT00863057|11575334|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
7338577|NCT00863057|11575335|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
7338578|NCT00863057|11575336|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
7338579|NCT00863057|11575337|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
7338580|NCT00863304|11575395|FG000|Overall Study|Adverse Event|10
7338581|NCT00863304|11575396|FG001|Overall Study|Adverse Event|4
7338582|NCT00863304|11575397|FG002|Overall Study|Adverse Event|14
7338583|NCT00863304|11575398|FG003|Overall Study|Adverse Event|16
7338584|NCT00863304|11575395|FG000|Overall Study|Lost to Follow-up|1
7338585|NCT00863304|11575396|FG001|Overall Study|Lost to Follow-up|5
7338586|NCT00863304|11575397|FG002|Overall Study|Lost to Follow-up|4
7338587|NCT00863304|11575398|FG003|Overall Study|Lost to Follow-up|2
7338588|NCT00863304|11575395|FG000|Overall Study|Lack of Efficacy|57
7338589|NCT00863304|11575396|FG001|Overall Study|Lack of Efficacy|26
7338590|NCT00863304|11575397|FG002|Overall Study|Lack of Efficacy|30
7338591|NCT00863304|11575398|FG003|Overall Study|Lack of Efficacy|28
7338592|NCT00863304|11575395|FG000|Overall Study|Withdrawal by Subject|19
7338593|NCT00863304|11575396|FG001|Overall Study|Withdrawal by Subject|14
7338594|NCT00863304|11575397|FG002|Overall Study|Withdrawal by Subject|20
7338595|NCT00863304|11575398|FG003|Overall Study|Withdrawal by Subject|18
7338596|NCT00863304|11575395|FG000|Overall Study|Other|1
7338597|NCT00863304|11575396|FG001|Overall Study|Other|0
7338598|NCT00863304|11575397|FG002|Overall Study|Other|0
7338599|NCT00863304|11575398|FG003|Overall Study|Other|1
7338600|NCT00863304|11575395|FG000|Overall Study|Protocol Violation|2
7338601|NCT00863304|11575396|FG001|Overall Study|Protocol Violation|6
7338602|NCT00863304|11575397|FG002|Overall Study|Protocol Violation|2
7338603|NCT00863304|11575398|FG003|Overall Study|Protocol Violation|0
7338604|NCT00863304|11575395|FG000|Overall Study|Randomized, but not Treated|3
7338605|NCT00863304|11575396|FG001|Overall Study|Randomized, but not Treated|1
7338606|NCT00863304|11575397|FG002|Overall Study|Randomized, but not Treated|4
7338607|NCT00863304|11575398|FG003|Overall Study|Randomized, but not Treated|1
7338608|NCT00863304|11575395|FG000|Overall Study|Entered extension study|101
7458210|NCT01806597|11752184|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7458211|NCT01806597|11752185|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
7458212|NCT01806597|11752186|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
7458213|NCT01806623|11752200|FG000|Overall Study|Withdrawal by Subject|1
7458214|NCT01806623|11752200|FG000|Overall Study|Adverse Event|1
7458215|NCT01806623|11752200|FG000|Overall Study|Did not meet the inclusion criteria|56
7458216|NCT01806662|11752204|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
7458217|NCT01806662|11752205|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
7458218|NCT01806662|11752204|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
7458219|NCT01806662|11752205|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
7458220|NCT01806662|11752204|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
7458221|NCT01806662|11752205|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
7458222|NCT01806662|11752204|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
7458223|NCT01806662|11752205|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
7458224|NCT01806714|11752238|FG000|Overall Study|No functioning phone number|200
7458225|NCT01806714|11752239|FG001|Overall Study|No functioning phone number|170
7458226|NCT01806740|11752245|FG000|Overall Study|Withdrawal by Subject|4
7458227|NCT01806740|11752245|FG000|Overall Study|Physician Decision|1
7458228|NCT01806740|11752245|FG000|Overall Study|Patient's refusal of treatment|1
7458229|NCT01806779|11752254|FG000|Overall Study|Physician Decision|2
7458230|NCT01806779|11752255|FG001|Overall Study|Physician Decision|0
7458231|NCT01806779|11752256|FG002|Overall Study|Physician Decision|1
7458232|NCT01806779|11752254|FG000|Overall Study|Lack of Efficacy|1
7458233|NCT01806779|11752255|FG001|Overall Study|Lack of Efficacy|1
7458234|NCT01806779|11752256|FG002|Overall Study|Lack of Efficacy|0
7458235|NCT01806779|11752254|FG000|Overall Study|Lost to Follow-up|19
7458236|NCT01806779|11752255|FG001|Overall Study|Lost to Follow-up|20
7458237|NCT01806779|11752256|FG002|Overall Study|Lost to Follow-up|0
7458238|NCT01806779|11752254|FG000|Overall Study|Withdrawal by Subject|20
7458239|NCT01806779|11752255|FG001|Overall Study|Withdrawal by Subject|23
7458240|NCT01806779|11752256|FG002|Overall Study|Withdrawal by Subject|22
7338609|NCT00863304|11575396|FG001|Overall Study|Entered extension study|129
7338610|NCT00863304|11575397|FG002|Overall Study|Entered extension study|113
7338611|NCT00863304|11575398|FG003|Overall Study|Entered extension study|125
7338612|NCT00863317|11575412|FG000|Overall Study|Lost to Follow-up|8
7338613|NCT00863317|11575413|FG001|Overall Study|Lost to Follow-up|9
7338614|NCT00863655|11575444|FG000|Overall Study|Protocol Violation|4
7338615|NCT00863655|11575445|FG001|Overall Study|Protocol Violation|0
7338616|NCT00863655|11575444|FG000|Overall Study|Adverse Event|52
7338617|NCT00863655|11575445|FG001|Overall Study|Adverse Event|8
7338618|NCT00863655|11575444|FG000|Overall Study|Withdrawal by Subject|47
7338619|NCT00863655|11575445|FG001|Overall Study|Withdrawal by Subject|7
7338620|NCT00863655|11575444|FG000|Overall Study|Administrative problems|1
7338621|NCT00863655|11575445|FG001|Overall Study|Administrative problems|0
7338622|NCT00863655|11575444|FG000|Overall Study|Death|7
7338623|NCT00863655|11575445|FG001|Overall Study|Death|1
7338624|NCT00863655|11575444|FG000|Overall Study|New cancer therapy|5
7338625|NCT00863655|11575445|FG001|Overall Study|New cancer therapy|1
7338626|NCT00863655|11575444|FG000|Overall Study|Disease progression|364
7338627|NCT00863655|11575445|FG001|Overall Study|Disease progression|221
7338628|NCT00863655|11575444|FG000|Overall Study|Treatment completed as per protocol|5
7338629|NCT00863655|11575445|FG001|Overall Study|Treatment completed as per protocol|1
7338630|NCT00863681|11575454|FG000|Overall Study|Other|2
7338631|NCT00863681|11575455|FG001|Overall Study|Other|0
7338632|NCT00863681|11575456|FG002|Overall Study|Other|0
7338633|NCT00863681|11575454|FG000|Overall Study|Missing|1
7338634|NCT00863681|11575455|FG001|Overall Study|Missing|0
7338635|NCT00863681|11575456|FG002|Overall Study|Missing|0
7338636|NCT00863681|11575454|FG000|Overall Study|Death|40
7338637|NCT00863681|11575455|FG001|Overall Study|Death|23
7338638|NCT00863681|11575456|FG002|Overall Study|Death|6
7338639|NCT00863681|11575454|FG000|Overall Study|Withdrawal by Subject|12
7338640|NCT00863681|11575455|FG001|Overall Study|Withdrawal by Subject|5
7338641|NCT00863681|11575456|FG002|Overall Study|Withdrawal by Subject|2
7338642|NCT00863681|11575454|FG000|Overall Study|Protocol Violation|2
7338643|NCT00863681|11575455|FG001|Overall Study|Protocol Violation|0
7338644|NCT00863681|11575456|FG002|Overall Study|Protocol Violation|0
7338645|NCT00863681|11575454|FG000|Overall Study|Lost to Follow-up|3
7338646|NCT00863681|11575455|FG001|Overall Study|Lost to Follow-up|0
7338647|NCT00863681|11575456|FG002|Overall Study|Lost to Follow-up|3
7338648|NCT00863681|11575454|FG000|Overall Study|Adverse Event|28
7338649|NCT00863681|11575455|FG001|Overall Study|Adverse Event|10
7338650|NCT00863681|11575456|FG002|Overall Study|Adverse Event|6
7338651|NCT00863681|11575454|FG000|Overall Study|Lack of Efficacy|2
7338652|NCT00863681|11575455|FG001|Overall Study|Lack of Efficacy|2
7338653|NCT00863681|11575456|FG002|Overall Study|Lack of Efficacy|1
7338654|NCT00863681|11575454|FG000|Overall Study|Non-compliance with study drug|1
7338655|NCT00863681|11575455|FG001|Overall Study|Non-compliance with study drug|3
7338656|NCT00863681|11575456|FG002|Overall Study|Non-compliance with study drug|0
7338657|NCT00863707|11575466|FG000|Overall Study|Randomized, but drug not received|4
7338658|NCT00863707|11575467|FG001|Overall Study|Randomized, but drug not received|3
7338659|NCT00863746|11575475|FG000|Treatment|Not treated|4
7338660|NCT00863746|11575476|FG001|Treatment|Not treated|2
7338661|NCT00863746|11575475|FG000|Treatment|Adverse Event|41
7338662|NCT00863746|11575476|FG001|Treatment|Adverse Event|16
7338663|NCT00863746|11575475|FG000|Treatment|non-compliant with study medication|4
7338664|NCT00863746|11575476|FG001|Treatment|non-compliant with study medication|0
7338665|NCT00863746|11575475|FG000|Treatment|Consent withdrawn|15
7338666|NCT00863746|11575476|FG001|Treatment|Consent withdrawn|14
7338667|NCT00863746|11575475|FG000|Treatment|Lost to Follow-up|1
7338668|NCT00863746|11575476|FG001|Treatment|Lost to Follow-up|0
7338669|NCT00863746|11575475|FG000|Treatment|Protocol Violation|5
7338670|NCT00863746|11575476|FG001|Treatment|Protocol Violation|3
7338671|NCT00863746|11575475|FG000|Treatment|Other|1
7338672|NCT00863746|11575476|FG001|Treatment|Other|0
7338673|NCT00863746|11575475|FG000|Survival Follow up|Death|244
7338674|NCT00863746|11575476|FG001|Survival Follow up|Death|271
7338675|NCT00863746|11575475|FG000|Survival Follow up|Lost to Follow-up|2
7338676|NCT00863746|11575476|FG001|Survival Follow up|Lost to Follow-up|1
7338677|NCT00863746|11575475|FG000|Survival Follow up|Consent Withdrawn|7
7338678|NCT00863746|11575476|FG001|Survival Follow up|Consent Withdrawn|8
7338679|NCT00863772|11575485|FG000|Overall Study|Adverse Event|1
7338680|NCT00863772|11575486|FG001|Overall Study|Adverse Event|4
7338681|NCT00863772|11575487|FG002|Overall Study|Adverse Event|0
7338682|NCT00863772|11575485|FG000|Overall Study|Lack of Efficacy|4
7338683|NCT00863772|11575486|FG001|Overall Study|Lack of Efficacy|2
7338684|NCT00863772|11575487|FG002|Overall Study|Lack of Efficacy|4
7338685|NCT00863772|11575485|FG000|Overall Study|Lost to Follow-up|5
7338686|NCT00863772|11575486|FG001|Overall Study|Lost to Follow-up|1
7338687|NCT00863772|11575487|FG002|Overall Study|Lost to Follow-up|1
7338688|NCT00863772|11575485|FG000|Overall Study|Protocol Violation|2
7338689|NCT00863772|11575486|FG001|Overall Study|Protocol Violation|0
7338690|NCT00863772|11575487|FG002|Overall Study|Protocol Violation|2
7338691|NCT00863772|11575485|FG000|Overall Study|Withdrawal by Subject|4
7338692|NCT00863772|11575486|FG001|Overall Study|Withdrawal by Subject|7
7338693|NCT00863772|11575487|FG002|Overall Study|Withdrawal by Subject|5
7338694|NCT00863772|11575485|FG000|Overall Study|Study terminated by sponsor|44
7338695|NCT00863772|11575486|FG001|Overall Study|Study terminated by sponsor|45
7338696|NCT00863772|11575487|FG002|Overall Study|Study terminated by sponsor|36
7338697|NCT00863772|11575485|FG000|Overall Study|Entered extension study|6
7338698|NCT00863772|11575486|FG001|Overall Study|Entered extension study|4
7338699|NCT00863772|11575487|FG002|Overall Study|Entered extension study|9
7338700|NCT00863772|11575485|FG000|Overall Study|Other|1
7338701|NCT00863772|11575486|FG001|Overall Study|Other|2
7338702|NCT00863772|11575487|FG002|Overall Study|Other|4
7338703|NCT00863772|11575485|FG000|Overall Study|Randomized but not Treated|1
7338704|NCT00863772|11575486|FG001|Overall Study|Randomized but not Treated|0
7338705|NCT00863772|11575487|FG002|Overall Study|Randomized but not Treated|0
7338706|NCT00863798|11575498|FG000|Overall Study|Adverse Event|5
7338707|NCT00863798|11575499|FG001|Overall Study|Adverse Event|2
7338708|NCT00863798|11575500|FG002|Overall Study|Adverse Event|4
7338709|NCT00863798|11575498|FG000|Overall Study|Participant failed to return|2
7338710|NCT00863798|11575499|FG001|Overall Study|Participant failed to return|1
7338711|NCT00863798|11575500|FG002|Overall Study|Participant failed to return|0
7338712|NCT00863798|11575498|FG000|Overall Study|Investigator request|1
7338713|NCT00863798|11575499|FG001|Overall Study|Investigator request|2
7338714|NCT00863798|11575500|FG002|Overall Study|Investigator request|1
7338715|NCT00863798|11575498|FG000|Overall Study|Lack of Efficacy|4
7338716|NCT00863798|11575499|FG001|Overall Study|Lack of Efficacy|3
7338717|NCT00863798|11575500|FG002|Overall Study|Lack of Efficacy|6
7338718|NCT00863798|11575498|FG000|Overall Study|Lost to Follow-up|6
7338719|NCT00863798|11575499|FG001|Overall Study|Lost to Follow-up|9
7338720|NCT00863798|11575500|FG002|Overall Study|Lost to Follow-up|5
7338721|NCT00863798|11575498|FG000|Overall Study|Other|2
7338722|NCT00863798|11575499|FG001|Overall Study|Other|3
7338723|NCT00863798|11575500|FG002|Overall Study|Other|1
7338724|NCT00863798|11575498|FG000|Overall Study|Protocol Violation|0
7338725|NCT00863798|11575499|FG001|Overall Study|Protocol Violation|1
7338726|NCT00863798|11575500|FG002|Overall Study|Protocol Violation|1
7338727|NCT00863798|11575498|FG000|Overall Study|Withdrawal by Subject|8
7338728|NCT00863798|11575499|FG001|Overall Study|Withdrawal by Subject|7
7338729|NCT00863798|11575500|FG002|Overall Study|Withdrawal by Subject|4
7338730|NCT00863798|11575498|FG000|Overall Study|Randomized not treated|4
7338731|NCT00863798|11575499|FG001|Overall Study|Randomized not treated|2
7338732|NCT00863798|11575500|FG002|Overall Study|Randomized not treated|3
7338733|NCT00863928|11575510|FG000|Overall Study|Protocol Violation|26
7338734|NCT00863928|11575511|FG001|Overall Study|Protocol Violation|0
7338735|NCT00863928|11575510|FG000|Overall Study|Withdrawal by Subject|3
7338736|NCT00863928|11575511|FG001|Overall Study|Withdrawal by Subject|0
7338737|NCT00863928|11575510|FG000|Overall Study|surgery cancellation|4
7338738|NCT00863928|11575511|FG001|Overall Study|surgery cancellation|0
7338739|NCT00863928|11575510|FG000|Overall Study|medication allergy|3
7338740|NCT00863928|11575511|FG001|Overall Study|medication allergy|0
7338741|NCT00864097|11575538|FG000|Overall Study|Death|0
7338742|NCT00864097|11575539|FG001|Overall Study|Death|1
7338743|NCT00864097|11575540|FG002|Overall Study|Death|0
7338744|NCT00864097|11575541|FG003|Overall Study|Death|0
7338745|NCT00864097|11575538|FG000|Overall Study|Adverse Event|6
7338746|NCT00864097|11575539|FG001|Overall Study|Adverse Event|8
7338747|NCT00864097|11575540|FG002|Overall Study|Adverse Event|11
7338748|NCT00864097|11575541|FG003|Overall Study|Adverse Event|9
7338749|NCT00864097|11575538|FG000|Overall Study|Lack of Efficacy|9
7338750|NCT00864097|11575539|FG001|Overall Study|Lack of Efficacy|3
7338751|NCT00864097|11575540|FG002|Overall Study|Lack of Efficacy|7
7338752|NCT00864097|11575541|FG003|Overall Study|Lack of Efficacy|2
7338753|NCT00864097|11575538|FG000|Overall Study|Lost to Follow-up|0
7338754|NCT00864097|11575539|FG001|Overall Study|Lost to Follow-up|1
7338755|NCT00864097|11575540|FG002|Overall Study|Lost to Follow-up|0
7338756|NCT00864097|11575541|FG003|Overall Study|Lost to Follow-up|1
7338757|NCT00864097|11575538|FG000|Overall Study|Withdrawal by Subject|15
7338758|NCT00864097|11575539|FG001|Overall Study|Withdrawal by Subject|11
7338759|NCT00864097|11575540|FG002|Overall Study|Withdrawal by Subject|11
7338760|NCT00864097|11575541|FG003|Overall Study|Withdrawal by Subject|12
7338761|NCT00864097|11575538|FG000|Overall Study|Protocol Violation|2
7338762|NCT00864097|11575539|FG001|Overall Study|Protocol Violation|1
7338763|NCT00864097|11575540|FG002|Overall Study|Protocol Violation|0
7338764|NCT00864097|11575541|FG003|Overall Study|Protocol Violation|1
7338765|NCT00864097|11575538|FG000|Overall Study|Terminated by sponsor|105
7338766|NCT00864097|11575539|FG001|Overall Study|Terminated by sponsor|112
7338767|NCT00864097|11575540|FG002|Overall Study|Terminated by sponsor|102
7338768|NCT00864097|11575541|FG003|Overall Study|Terminated by sponsor|99
7338769|NCT00864097|11575538|FG000|Overall Study|Randomized but not treated|2
7338770|NCT00864097|11575539|FG001|Overall Study|Randomized but not treated|0
7338771|NCT00864097|11575540|FG002|Overall Study|Randomized but not treated|1
7338772|NCT00864097|11575541|FG003|Overall Study|Randomized but not treated|0
7338773|NCT00864097|11575538|FG000|Overall Study|Other|0
7338774|NCT00864097|11575539|FG001|Overall Study|Other|0
7338775|NCT00864097|11575540|FG002|Overall Study|Other|0
7338776|NCT00864097|11575541|FG003|Overall Study|Other|1
7338777|NCT00864253|11575562|FG000|Overall Study|Adverse Event|56
7338778|NCT00864253|11575563|FG001|Overall Study|Adverse Event|11
7338779|NCT00864253|11575562|FG000|Overall Study|Unrelated Adverse Event|3
7338780|NCT00864253|11575563|FG001|Overall Study|Unrelated Adverse Event|1
7338781|NCT00864253|11575562|FG000|Overall Study|Physician Decision|11
7338782|NCT00864253|11575563|FG001|Overall Study|Physician Decision|15
7338783|NCT00864253|11575562|FG000|Overall Study|Protocol Violation|0
7338784|NCT00864253|11575563|FG001|Overall Study|Protocol Violation|2
7338785|NCT00864253|11575562|FG000|Overall Study|Lost to Follow-up|1
7338786|NCT00864253|11575563|FG001|Overall Study|Lost to Follow-up|1
7338787|NCT00864253|11575562|FG000|Overall Study|Withdrawal by Subject|18
7338788|NCT00864253|11575563|FG001|Overall Study|Withdrawal by Subject|18
7338789|NCT00864253|11575562|FG000|Overall Study|Death|1
7338790|NCT00864253|11575563|FG001|Overall Study|Death|0
7338791|NCT00864253|11575562|FG000|Overall Study|Ongoing|2
7338792|NCT00864253|11575563|FG001|Overall Study|Ongoing|3
7338793|NCT00864253|11575562|FG000|Overall Study|Untreated|7
7338794|NCT00864253|11575563|FG001|Overall Study|Untreated|7
7338795|NCT00864513|11575584|FG000|Overall Study|Withdrawal by Subject|3
7338796|NCT00864682|11575616|FG000|Overall Study|Protocol Violation|2
7338797|NCT00864682|11575617|FG001|Overall Study|Protocol Violation|1
7338798|NCT00864682|11575618|FG002|Overall Study|Protocol Violation|2
7338799|NCT00864721|11575632|FG000|Overall Study|Patient request|11
7338800|NCT00864721|11575632|FG000|Overall Study|Hospitalized|1
7338801|NCT00864721|11575632|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
7338802|NCT00864721|11575632|FG000|Overall Study|Adverse Event|21
7338803|NCT00864851|11575639|FG000|Overall Study|Withdrawal by Subject|0
7338804|NCT00864851|11575640|FG001|Overall Study|Withdrawal by Subject|1
7338805|NCT00864851|11575641|FG002|Overall Study|Withdrawal by Subject|0
7338806|NCT00864851|11575639|FG000|Overall Study|Physician Decision|1
7338807|NCT00864851|11575640|FG001|Overall Study|Physician Decision|0
7338808|NCT00864851|11575641|FG002|Overall Study|Physician Decision|0
7338809|NCT00864851|11575639|FG000|Overall Study|Death|1
7338810|NCT00864851|11575640|FG001|Overall Study|Death|0
7338811|NCT00864851|11575641|FG002|Overall Study|Death|0
7338812|NCT00864851|11575639|FG000|Overall Study|Patient uncooperative|1
7338813|NCT00864851|11575640|FG001|Overall Study|Patient uncooperative|0
7338814|NCT00864851|11575641|FG002|Overall Study|Patient uncooperative|0
7338815|NCT00864916|11575653|FG000|Overall Study|Lost to Follow-up|4
7338816|NCT00864916|11575654|FG001|Overall Study|Lost to Follow-up|4
7338817|NCT00864916|11575653|FG000|Overall Study|Protocol Violation|1
7338818|NCT00864916|11575654|FG001|Overall Study|Protocol Violation|0
7338819|NCT00864916|11575653|FG000|Overall Study|Withdrawal by Subject|1
7338820|NCT00864916|11575654|FG001|Overall Study|Withdrawal by Subject|0
7338821|NCT00865020|11575662|FG000|Overall Study|Withdrawal by Subject|22
7338822|NCT00865020|11575663|FG001|Overall Study|Withdrawal by Subject|16
7338823|NCT00865020|11575662|FG000|Overall Study|Adverse Event|9
7338824|NCT00865020|11575663|FG001|Overall Study|Adverse Event|14
7338825|NCT00865020|11575662|FG000|Overall Study|Abnormal test procedure result(s)|6
7338826|NCT00865020|11575663|FG001|Overall Study|Abnormal test procedure result(s)|8
7338827|NCT00865020|11575662|FG000|Overall Study|Lost to Follow-up|6
7338828|NCT00865020|11575663|FG001|Overall Study|Lost to Follow-up|4
7338829|NCT00865020|11575662|FG000|Overall Study|Protocol deviation|4
7338830|NCT00865020|11575663|FG001|Overall Study|Protocol deviation|1
7338831|NCT00865020|11575662|FG000|Overall Study|Administrative problems|0
7338832|NCT00865020|11575663|FG001|Overall Study|Administrative problems|2
7338833|NCT00865020|11575662|FG000|Overall Study|Abnormal laboratory value(s)|0
7338834|NCT00865020|11575663|FG001|Overall Study|Abnormal laboratory value(s)|1
7338835|NCT00865020|11575662|FG000|Overall Study|Death|0
7338836|NCT00865020|11575663|FG001|Overall Study|Death|1
7338837|NCT00865020|11575662|FG000|Overall Study|Randomized but discontinued|2
7338838|NCT00865020|11575663|FG001|Overall Study|Randomized but discontinued|4
7338839|NCT00865046|11575672|FG000|Overall Study|Lost to Follow-up|1
7338840|NCT00865046|11575673|FG001|Overall Study|Lost to Follow-up|4
7338841|NCT00865046|11575674|FG002|Overall Study|Lost to Follow-up|0
7338842|NCT00865046|11575672|FG000|Overall Study|Death|0
7338843|NCT00865046|11575673|FG001|Overall Study|Death|1
7338844|NCT00865046|11575674|FG002|Overall Study|Death|1
7338845|NCT00865046|11575672|FG000|Overall Study|Withdrawal by Subject|5
7338846|NCT00865046|11575673|FG001|Overall Study|Withdrawal by Subject|0
7338847|NCT00865046|11575674|FG002|Overall Study|Withdrawal by Subject|0
7338848|NCT00865098|11575682|FG000|Overall Study|Progressive disease|1
7338849|NCT00865124|11575689|FG000|Overall Study|Physician Decision|2
7338850|NCT00865124|11575690|FG001|Overall Study|Physician Decision|1
7338851|NCT00865124|11575691|FG002|Overall Study|Physician Decision|0
7338852|NCT00865124|11575689|FG000|Overall Study|Withdrawn consent|2
7338853|NCT00865124|11575690|FG001|Overall Study|Withdrawn consent|0
7338854|NCT00865124|11575691|FG002|Overall Study|Withdrawn consent|0
7338855|NCT00865189|11575701|FG000|Overall Study|Other|1
7338856|NCT00865189|11575702|FG001|Overall Study|Other|2
7338857|NCT00865189|11575701|FG000|Overall Study|Death|4
7338858|NCT00865189|11575702|FG001|Overall Study|Death|11
7338859|NCT00865189|11575701|FG000|Overall Study|Lost to Follow-up|6
7338860|NCT00865189|11575702|FG001|Overall Study|Lost to Follow-up|6
7338861|NCT00865189|11575701|FG000|Overall Study|Withdrawal by Subject|1
7338862|NCT00865189|11575702|FG001|Overall Study|Withdrawal by Subject|0
7338863|NCT00865280|11575720|FG000|Overall Study|Withdrawal by Subject|4
7338864|NCT00865280|11575721|FG001|Overall Study|Withdrawal by Subject|1
7338865|NCT00865280|11575720|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
7338866|NCT00865280|11575721|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
7568732|NCT03425396|11944276|FG001|Overall Study|Other|1
7568733|NCT03425396|11944277|FG002|Overall Study|Other|1
7568734|NCT03425396|11944278|FG003|Overall Study|Other|0
7568735|NCT03425396|11944279|FG004|Overall Study|Other|1
7568736|NCT03426267|11944304|FG000|Overall Study|Physician Decision|1
7568737|NCT03426267|11944305|FG001|Overall Study|Physician Decision|4
7568738|NCT03426267|11944304|FG000|Overall Study|Lost to Follow-up|1
7568739|NCT03426267|11944305|FG001|Overall Study|Lost to Follow-up|0
7568740|NCT03426267|11944304|FG000|Overall Study|Withdrawal by Subject|4
7568741|NCT03426267|11944305|FG001|Overall Study|Withdrawal by Subject|10
7338867|NCT00865280|11575720|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
7338868|NCT00865280|11575721|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
7338869|NCT00865280|11575720|FG000|Overall Study|Exclusion Condition|1
7338870|NCT00865280|11575721|FG001|Overall Study|Exclusion Condition|0
7338871|NCT00865280|11575720|FG000|Overall Study|Adverse Event|0
7338872|NCT00865280|11575721|FG001|Overall Study|Adverse Event|1
7338873|NCT00865306|11575729|FG000|Controlled Trial|Lost to Follow-up|1
7338874|NCT00865306|11575730|FG001|Controlled Trial|Lost to Follow-up|1
7338875|NCT00865306|11575729|FG000|Controlled Trial|Difficulty commuting|2
7338876|NCT00865306|11575730|FG001|Controlled Trial|Difficulty commuting|0
7338877|NCT00865306|11575729|FG000|Controlled Trial|Improved btw baseline and first session|1
7338878|NCT00865306|11575730|FG001|Controlled Trial|Improved btw baseline and first session|0
7568742|NCT03426267|11944304|FG000|Overall Study|Protocol Violation|1
7338879|NCT00865306|11575729|FG000|Controlled Trial|Sought treatment for conduct disorder|1
7338880|NCT00865306|11575730|FG001|Controlled Trial|Sought treatment for conduct disorder|0
7338881|NCT00865306|11575729|FG000|Controlled Trial|Withdrawal by Subject|0
7338882|NCT00865306|11575730|FG001|Controlled Trial|Withdrawal by Subject|1
7338883|NCT00865345|11575736|FG000|Overall Study|Withdrawal by Subject|2
7338884|NCT00865566|11575742|FG000|Overall Study|Death|1
7338885|NCT00865566|11575743|FG001|Overall Study|Death|11
7338886|NCT00865566|11575742|FG000|Overall Study|Lost to Follow-up|314
7338887|NCT00865566|11575743|FG001|Overall Study|Lost to Follow-up|315
7338888|NCT00865566|11575742|FG000|Overall Study|Withdrawal by Subject|45
7338889|NCT00865566|11575743|FG001|Overall Study|Withdrawal by Subject|65
7338890|NCT00865566|11575742|FG000|Overall Study|Physician Decision|0
7338891|NCT00865566|11575743|FG001|Overall Study|Physician Decision|1
7338892|NCT00865566|11575742|FG000|Overall Study|Participant relocated|78
7338893|NCT00865566|11575743|FG001|Overall Study|Participant relocated|107
7338894|NCT00865566|11575742|FG000|Overall Study|Participant unable to adhere|27
7338895|NCT00865566|11575743|FG001|Overall Study|Participant unable to adhere|42
7338896|NCT00865566|11575742|FG000|Overall Study|Other; N=245 due to early study closure|154
7458241|NCT01806896|11752273|FG000|Overall Study|Adverse Event|2
7458242|NCT01806896|11752274|FG001|Overall Study|Adverse Event|0
7338897|NCT00865566|11575743|FG001|Overall Study|Other; N=245 due to early study closure|139
7338898|NCT00865566|11575742|FG000|Overall Study|HIV infection|5
7338899|NCT00865566|11575743|FG001|Overall Study|HIV infection|7
7338900|NCT00865709|11575751|FG000|Treatment|Adverse Event|9
7338901|NCT00865709|11575752|FG001|Treatment|Adverse Event|6
7338902|NCT00865709|11575751|FG000|Treatment|Withdrawal by Subject|10
7338903|NCT00865709|11575752|FG001|Treatment|Withdrawal by Subject|7
7338904|NCT00865709|11575751|FG000|Treatment|Physician Decision|3
7338905|NCT00865709|11575752|FG001|Treatment|Physician Decision|2
7338906|NCT00865709|11575751|FG000|Treatment|Surgery|8
7338907|NCT00865709|11575752|FG001|Treatment|Surgery|3
7338908|NCT00865904|11575765|FG000|Overall Study|Randomized but not Treated|2
7338909|NCT00865904|11575766|FG001|Overall Study|Randomized but not Treated|0
7338910|NCT00865904|11575767|FG002|Overall Study|Randomized but not Treated|0
7338911|NCT00865904|11575768|FG003|Overall Study|Randomized but not Treated|1
7338912|NCT00865904|11575769|FG004|Overall Study|Randomized but not Treated|1
7338913|NCT00866047|11575798|FG000|Treatment Period|Progressive disease|13
7338914|NCT00866047|11575798|FG000|Treatment Period|Adverse Event|16
7338915|NCT00866047|11575798|FG000|Treatment Period|Physician Decision|14
7338916|NCT00866047|11575798|FG000|Treatment Period|Withdrawal by Subject|5
7338917|NCT00866047|11575798|FG000|Follow-up Period|Lost to Follow-up|5
7338918|NCT00866177|11575802|FG000|Overall Study|Withdrawal by Subject|1
7338919|NCT00866177|11575802|FG000|Overall Study|Not Treated|151
7385616|NCT01202773|11643455|FG002|Overall Study|Physician Decision|0
7385617|NCT01202773|11643453|FG000|Overall Study|Protocol Violation|11
7385618|NCT01202773|11643454|FG001|Overall Study|Protocol Violation|6
7385619|NCT01202773|11643455|FG002|Overall Study|Protocol Violation|10
7385620|NCT01202773|11643453|FG000|Overall Study|Sponsor Decision|19
7385621|NCT01202773|11643454|FG001|Overall Study|Sponsor Decision|20
7385622|NCT01202773|11643455|FG002|Overall Study|Sponsor Decision|23
7385623|NCT01202877|11643476|FG000|Overall Study|Disease Progression|0
7385624|NCT01202877|11643477|FG001|Overall Study|Disease Progression|1
7385625|NCT01202877|11643478|FG002|Overall Study|Disease Progression|2
7385626|NCT01202877|11643476|FG000|Overall Study|Adverse Event|0
7385627|NCT01202877|11643477|FG001|Overall Study|Adverse Event|0
7385628|NCT01202877|11643478|FG002|Overall Study|Adverse Event|2
7338920|NCT00866281|11575808|FG000|Overall Study|Adverse Event|1
7338921|NCT00866281|11575809|FG001|Overall Study|Adverse Event|0
7338922|NCT00866281|11575808|FG000|Overall Study|Withdrawal by participants|3
7338923|NCT00866281|11575809|FG001|Overall Study|Withdrawal by participants|0
7338924|NCT00866281|11575808|FG000|Overall Study|Disease progression|3
7338925|NCT00866281|11575809|FG001|Overall Study|Disease progression|11
7338926|NCT00866281|11575808|FG000|Overall Study|New cancer therapy|0
7338927|NCT00866281|11575809|FG001|Overall Study|New cancer therapy|4
7338928|NCT00866294|11575821|FG000|Overall Study|Adverse Event|12
7338929|NCT00866294|11575822|FG001|Overall Study|Adverse Event|13
7338930|NCT00866294|11575823|FG002|Overall Study|Adverse Event|9
7338931|NCT00866294|11575821|FG000|Overall Study|Lack of Efficacy|7
7338932|NCT00866294|11575822|FG001|Overall Study|Lack of Efficacy|1
7338933|NCT00866294|11575823|FG002|Overall Study|Lack of Efficacy|0
7338934|NCT00866294|11575821|FG000|Overall Study|Protocol Violation|2
7338935|NCT00866294|11575822|FG001|Overall Study|Protocol Violation|0
7338936|NCT00866294|11575823|FG002|Overall Study|Protocol Violation|0
7338937|NCT00866294|11575821|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
7338938|NCT00866294|11575822|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7338939|NCT00866294|11575823|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
7338940|NCT00866294|11575821|FG000|Overall Study|Lost to Follow-up|1
7338941|NCT00866294|11575822|FG001|Overall Study|Lost to Follow-up|3
7338942|NCT00866294|11575823|FG002|Overall Study|Lost to Follow-up|0
7338943|NCT00866294|11575821|FG000|Overall Study|Physician Decision|6
7338944|NCT00866294|11575822|FG001|Overall Study|Physician Decision|2
7338945|NCT00866294|11575823|FG002|Overall Study|Physician Decision|1
7338946|NCT00866307|11575839|FG000|Induction|Adverse Event|5
7338947|NCT00866307|11575840|FG001|Induction|Adverse Event|0
7338948|NCT00866307|11575841|FG002|Induction|Adverse Event|0
7338949|NCT00866307|11575839|FG000|Induction|Death|2
7338950|NCT00866307|11575840|FG001|Induction|Death|0
7338951|NCT00866307|11575841|FG002|Induction|Death|0
7338952|NCT00866307|11575839|FG000|Induction|Physician Decision|5
7338953|NCT00866307|11575840|FG001|Induction|Physician Decision|0
7338954|NCT00866307|11575841|FG002|Induction|Physician Decision|0
7338955|NCT00866307|11575839|FG000|Induction|Progressive Disease|1
7338956|NCT00866307|11575840|FG001|Induction|Progressive Disease|0
7338957|NCT00866307|11575841|FG002|Induction|Progressive Disease|0
7338958|NCT00866307|11575839|FG000|Induction|Identification of Patients with Day 29 M|3
7338959|NCT00866307|11575840|FG001|Induction|Identification of Patients with Day 29 M|0
7338960|NCT00866307|11575841|FG002|Induction|Identification of Patients with Day 29 M|0
7338961|NCT00866307|11575839|FG000|Induction|Inadequate cytognetic samples th|1
7338962|NCT00866307|11575840|FG001|Induction|Inadequate cytognetic samples th|0
7338963|NCT00866307|11575841|FG002|Induction|Inadequate cytognetic samples th|0
7338964|NCT00866307|11575839|FG000|Induction|Improper post-induction consent|2
7338965|NCT00866307|11575840|FG001|Induction|Improper post-induction consent|0
7338966|NCT00866307|11575841|FG002|Induction|Improper post-induction consent|0
7338967|NCT00866307|11575839|FG000|Induction|Study was closed at the time|1
7338968|NCT00866307|11575840|FG001|Induction|Study was closed at the time|0
7338969|NCT00866307|11575841|FG002|Induction|Study was closed at the time|0
7338970|NCT00866307|11575839|FG000|Consolidation/Maintenance|Adverse Event|0
7338971|NCT00866307|11575840|FG001|Consolidation/Maintenance|Adverse Event|0
7338972|NCT00866307|11575841|FG002|Consolidation/Maintenance|Adverse Event|8
7338973|NCT00866307|11575839|FG000|Consolidation/Maintenance|Death|0
7338974|NCT00866307|11575840|FG001|Consolidation/Maintenance|Death|0
7338975|NCT00866307|11575841|FG002|Consolidation/Maintenance|Death|1
7338976|NCT00866307|11575839|FG000|Consolidation/Maintenance|Physician Decision|0
7338977|NCT00866307|11575840|FG001|Consolidation/Maintenance|Physician Decision|3
7338978|NCT00866307|11575841|FG002|Consolidation/Maintenance|Physician Decision|2
7338979|NCT00866307|11575839|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
7338980|NCT00866307|11575840|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
7338981|NCT00866307|11575841|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
7338982|NCT00866307|11575839|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7568743|NCT03426267|11944305|FG001|Overall Study|Protocol Violation|3
7338983|NCT00866307|11575840|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
7568744|NCT03426267|11944304|FG000|Overall Study|Adverse Event|9
7568745|NCT03426267|11944305|FG001|Overall Study|Adverse Event|27
7568746|NCT03426267|11944304|FG000|Overall Study|Prohibited Treatment Intake|2
7568747|NCT03426267|11944305|FG001|Overall Study|Prohibited Treatment Intake|3
7568748|NCT03426267|11944304|FG000|Overall Study|Lack of Efficacy|0
7568749|NCT03426267|11944305|FG001|Overall Study|Lack of Efficacy|25
7568750|NCT03426267|11944304|FG000|Overall Study|other|3
7568751|NCT03426267|11944305|FG001|Overall Study|other|0
7568752|NCT03426345|11944313|FG000|Overall Study|Adverse Event|4
7568753|NCT03426345|11944314|FG001|Overall Study|Adverse Event|4
7568754|NCT03426345|11944313|FG000|Overall Study|Lack of Efficacy|1
7568755|NCT03426345|11944314|FG001|Overall Study|Lack of Efficacy|0
7568756|NCT03426345|11944313|FG000|Overall Study|Withdrawal by Subject|5
7568757|NCT03426345|11944314|FG001|Overall Study|Withdrawal by Subject|6
7568758|NCT03426345|11944313|FG000|Overall Study|Lost to Follow-up|3
7568759|NCT03426345|11944314|FG001|Overall Study|Lost to Follow-up|1
7568760|NCT03426345|11944313|FG000|Overall Study|Protocol Deviation|3
7568761|NCT03426345|11944314|FG001|Overall Study|Protocol Deviation|4
7568762|NCT03426345|11944313|FG000|Overall Study|Reason Not Specified|1
7568763|NCT03426345|11944314|FG001|Overall Study|Reason Not Specified|2
7568764|NCT03426345|11944313|FG000|Overall Study|Missing Completion Status|1
7568765|NCT03426345|11944314|FG001|Overall Study|Missing Completion Status|0
7568766|NCT03426436|11944321|FG000|Overall Study|Incorrect lead placement|12
7568767|NCT03426436|11944321|FG000|Overall Study|Withdrawal by Subject|2
7568768|NCT03426436|11944321|FG000|Overall Study|Consent issue|1
7568769|NCT03426436|11944321|FG000|Overall Study|ECGs not saved|4
7568770|NCT03426631|11944325|FG000|Overall Study|Lost to Follow-up|0
7568771|NCT03426631|11944326|FG001|Overall Study|Lost to Follow-up|1
7568772|NCT03426787|11944332|FG000|Overall Study|Withdrawal by Subject|6
7338984|NCT00866307|11575841|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
7338985|NCT00866307|11575839|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
7338986|NCT00866307|11575840|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
7338987|NCT00866307|11575841|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
7338988|NCT00866307|11575839|FG000|Consolidation/Maintenance|Therapy error|0
7338989|NCT00866307|11575840|FG001|Consolidation/Maintenance|Therapy error|1
7338990|NCT00866307|11575841|FG002|Consolidation/Maintenance|Therapy error|0
7338991|NCT00866307|11575839|FG000|Consolidation/Maintenance|Non-compliance|0
7338992|NCT00866307|11575840|FG001|Consolidation/Maintenance|Non-compliance|0
7338993|NCT00866307|11575841|FG002|Consolidation/Maintenance|Non-compliance|1
7338994|NCT00866307|11575839|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
7338995|NCT00866307|11575840|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
7338996|NCT00866307|11575841|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
7338997|NCT00866320|11575847|FG000|Overall Study|Withdrawal by Subject|4
7338998|NCT00866320|11575847|FG000|Overall Study|Death|2
7338999|NCT00866333|11575856|FG000|Overall Study|Withdrawal of consent|0
7339000|NCT00866333|11575857|FG001|Overall Study|Withdrawal of consent|1
7339001|NCT00866333|11575858|FG002|Overall Study|Withdrawal of consent|2
7339002|NCT00866333|11575856|FG000|Overall Study|Reason not Specified|3
7339003|NCT00866333|11575857|FG001|Overall Study|Reason not Specified|1
7458243|NCT01806896|11752273|FG000|Overall Study|Other|1
7339004|NCT00866333|11575858|FG002|Overall Study|Reason not Specified|1
7458244|NCT01806896|11752274|FG001|Overall Study|Other|0
7339005|NCT00866333|11575856|FG000|Overall Study|Study Terminated by Sponsor|2
7339006|NCT00866333|11575857|FG001|Overall Study|Study Terminated by Sponsor|5
7339007|NCT00866333|11575858|FG002|Overall Study|Study Terminated by Sponsor|9
7339008|NCT00866359|11575868|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
7339009|NCT00866359|11575869|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
7339010|NCT00866359|11575870|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
7339011|NCT00866359|11575871|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
7339012|NCT00866359|11575868|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
7339013|NCT00866359|11575869|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7339014|NCT00866359|11575870|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7339015|NCT00866359|11575871|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
7339016|NCT00866359|11575868|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
7339017|NCT00866359|11575869|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7339018|NCT00866359|11575870|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7339019|NCT00866359|11575871|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
7339020|NCT00866359|11575868|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7339021|NCT00866359|11575869|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
7339022|NCT00866359|11575870|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7339023|NCT00866359|11575871|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
7339024|NCT00866359|11575868|FG000|Treatment Phase (Days 1 to 85)|Other|1
7339025|NCT00866359|11575869|FG001|Treatment Phase (Days 1 to 85)|Other|0
7339026|NCT00866359|11575870|FG002|Treatment Phase (Days 1 to 85)|Other|0
7339027|NCT00866359|11575871|FG003|Treatment Phase (Days 1 to 85)|Other|0
7339028|NCT00866359|11575868|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
7339029|NCT00866359|11575869|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
7339030|NCT00866359|11575870|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
7339031|NCT00866359|11575871|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
7339032|NCT00866606|11575898|FG000|Overall Study|Lost to Follow-up|3
7339033|NCT00866606|11575898|FG000|Overall Study|Adverse Event|1
7339034|NCT00866619|11575906|FG000|Overall Study|Adverse Event|112
7339035|NCT00866619|11575907|FG001|Overall Study|Adverse Event|106
7339036|NCT00866619|11575908|FG002|Overall Study|Adverse Event|47
7339037|NCT00866619|11575909|FG003|Overall Study|Adverse Event|44
7339038|NCT00866619|11575906|FG000|Overall Study|Protocol Violation|2
7339039|NCT00866619|11575907|FG001|Overall Study|Protocol Violation|39
7339040|NCT00866619|11575908|FG002|Overall Study|Protocol Violation|2
7339041|NCT00866619|11575909|FG003|Overall Study|Protocol Violation|17
7339042|NCT00866619|11575906|FG000|Overall Study|Withdrawal by Subject|587
7339043|NCT00866619|11575907|FG001|Overall Study|Withdrawal by Subject|295
7339044|NCT00866619|11575908|FG002|Overall Study|Withdrawal by Subject|272
7339045|NCT00866619|11575909|FG003|Overall Study|Withdrawal by Subject|144
7339046|NCT00866619|11575906|FG000|Overall Study|Lost to Follow-up|1145
7339047|NCT00866619|11575907|FG001|Overall Study|Lost to Follow-up|830
7339048|NCT00866619|11575908|FG002|Overall Study|Lost to Follow-up|568
7339049|NCT00866619|11575909|FG003|Overall Study|Lost to Follow-up|425
7339050|NCT00866658|11575946|FG000|Overall Study|Adverse Event|5
7339051|NCT00866658|11575947|FG001|Overall Study|Adverse Event|14
7339052|NCT00866658|11575946|FG000|Overall Study|Lack of Efficacy|2
7339053|NCT00866658|11575947|FG001|Overall Study|Lack of Efficacy|1
7339054|NCT00866658|11575946|FG000|Overall Study|Withdrawal by Subject|1
7339055|NCT00866658|11575947|FG001|Overall Study|Withdrawal by Subject|0
7339056|NCT00866658|11575946|FG000|Overall Study|Protocol Violation|1
7339057|NCT00866658|11575947|FG001|Overall Study|Protocol Violation|1
7339058|NCT00866658|11575946|FG000|Overall Study|Familial and Personal Reasons|4
7339059|NCT00866658|11575947|FG001|Overall Study|Familial and Personal Reasons|5
7339060|NCT00866697|11575955|FG000|Overall Study|Study closed/terminated|156
7339061|NCT00866697|11575956|FG001|Overall Study|Study closed/terminated|138
7339062|NCT00866697|11575955|FG000|Overall Study|Lost to Follow-up|22
7339063|NCT00866697|11575956|FG001|Overall Study|Lost to Follow-up|28
7339064|NCT00866697|11575955|FG000|Overall Study|Physician Decision|3
7339065|NCT00866697|11575956|FG001|Overall Study|Physician Decision|5
7339066|NCT00866697|11575955|FG000|Overall Study|Withdrawal by Subject|33
7339067|NCT00866697|11575956|FG001|Overall Study|Withdrawal by Subject|57
7339068|NCT00866723|11575962|FG000|Overall Study|Withdrawal by Subject|1
7339069|NCT00866723|11575962|FG000|Overall Study|Disease Progression|4
7339070|NCT00866775|11575972|FG000|Overall Study|Adverse Event|5
7339071|NCT00866775|11575973|FG001|Overall Study|Adverse Event|19
7339072|NCT00866775|11575972|FG000|Overall Study|Death|1
7339073|NCT00866775|11575973|FG001|Overall Study|Death|0
7339074|NCT00866775|11575972|FG000|Overall Study|Lost to Follow-up|0
7339075|NCT00866775|11575973|FG001|Overall Study|Lost to Follow-up|4
7339076|NCT00866775|11575972|FG000|Overall Study|Physician Decision|0
7339077|NCT00866775|11575973|FG001|Overall Study|Physician Decision|3
7339078|NCT00866775|11575972|FG000|Overall Study|Protocol Violation|3
7339079|NCT00866775|11575973|FG001|Overall Study|Protocol Violation|4
7339080|NCT00866775|11575972|FG000|Overall Study|Withdrawal by Subject|4
7339081|NCT00866775|11575973|FG001|Overall Study|Withdrawal by Subject|4
7339082|NCT00866775|11575972|FG000|Overall Study|met exit criteria|23
7339083|NCT00866775|11575973|FG001|Overall Study|met exit criteria|17
7339084|NCT00866775|11575972|FG000|Overall Study|discontinued due to communication error|0
7339085|NCT00866775|11575973|FG001|Overall Study|discontinued due to communication error|1
7339086|NCT00866788|11575985|FG000|Overall Study|Adverse Event|0
7339087|NCT00866788|11575986|FG001|Overall Study|Adverse Event|2
7339088|NCT00866788|11575987|FG002|Overall Study|Adverse Event|0
7339089|NCT00866788|11575988|FG003|Overall Study|Adverse Event|1
7339090|NCT00866788|11575985|FG000|Overall Study|Lost to Follow-up|1
7339091|NCT00866788|11575986|FG001|Overall Study|Lost to Follow-up|1
7339092|NCT00866788|11575987|FG002|Overall Study|Lost to Follow-up|0
7339093|NCT00866788|11575988|FG003|Overall Study|Lost to Follow-up|2
7339094|NCT00866788|11575985|FG000|Overall Study|Withdrawal by Subject|2
7339095|NCT00866788|11575986|FG001|Overall Study|Withdrawal by Subject|1
7339096|NCT00866788|11575987|FG002|Overall Study|Withdrawal by Subject|0
7339097|NCT00866788|11575988|FG003|Overall Study|Withdrawal by Subject|1
7339098|NCT00866788|11575985|FG000|Overall Study|Pregnancy|0
7339099|NCT00866788|11575986|FG001|Overall Study|Pregnancy|1
7339100|NCT00866788|11575987|FG002|Overall Study|Pregnancy|0
7339101|NCT00866788|11575988|FG003|Overall Study|Pregnancy|0
7339102|NCT00866788|11575985|FG000|Overall Study|Disease progression|3
7339103|NCT00866788|11575986|FG001|Overall Study|Disease progression|1
7339104|NCT00866788|11575987|FG002|Overall Study|Disease progression|1
7339105|NCT00866788|11575988|FG003|Overall Study|Disease progression|0
7339106|NCT00866788|11575985|FG000|Overall Study|Physician Decision|0
7339107|NCT00866788|11575986|FG001|Overall Study|Physician Decision|0
7339108|NCT00866788|11575987|FG002|Overall Study|Physician Decision|1
7339109|NCT00866788|11575988|FG003|Overall Study|Physician Decision|1
7339110|NCT00866814|11576001|FG000|Overall Study|Lost to Follow-up|12
7339111|NCT00866814|11576001|FG000|Overall Study|Adverse Event|2
7339112|NCT00866814|11576001|FG000|Overall Study|Physician Decision|1
7339113|NCT00866814|11576001|FG000|Overall Study|Death|1
7339114|NCT00866814|11576001|FG000|Overall Study|No longer wished to participate|1
7339115|NCT00866814|11576001|FG000|Overall Study|Unable to meet follow-up requirements|2
7339116|NCT00866814|11576001|FG000|Overall Study|Moved to area without study site|1
7339117|NCT00867009|11576020|FG000|Induction Period|Nonserious Adverse Event|5
7339118|NCT00867009|11576020|FG000|Induction Period|Serious Adverse Event|10
7339119|NCT00867009|11576020|FG000|Induction Period|Death due to serious adverse event|6
7339120|NCT00867009|11576020|FG000|Induction Period|Death due to Study Disease|4
7339121|NCT00867009|11576020|FG000|Induction Period|Protocol Violation|1
7339122|NCT00867009|11576020|FG000|Induction Period|Withdrawal by Subject|8
7339123|NCT00867009|11576020|FG000|Induction Period|Physician Decision|3
7339124|NCT00867009|11576020|FG000|Induction Period|Progressive Disease (PD)|25
7339125|NCT00867009|11576020|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
7339126|NCT00867035|11576026|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
7339127|NCT00867035|11576027|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
7339128|NCT00867035|11576026|FG000|Baseline to 1 Week|Withdrawal by Subject|1
7339129|NCT00867035|11576027|FG001|Baseline to 1 Week|Withdrawal by Subject|0
7339130|NCT00867087|11576033|FG000|Overall Study|Other|1
7339131|NCT00867087|11576033|FG000|Overall Study|Withdrawal by Subject|4
7339132|NCT00867087|11576033|FG000|Overall Study|Death|37
7339133|NCT00867113|11576094|FG000|Treatment Period|Adverse Event|15
7339134|NCT00867113|11576094|FG000|Treatment Period|Death|2
7339135|NCT00867113|11576094|FG000|Treatment Period|Withdrawal by Subject|19
7339136|NCT00867113|11576094|FG000|Treatment Period|Lost to Follow-up|3
7339137|NCT00867113|11576094|FG000|Treatment Period|Administrative problems|1
7339138|NCT00867113|11576094|FG000|Treatment Period|Disease progression/relapse|1
7339139|NCT00867113|11576094|FG000|Treatment Period|Protocol Violation|4
7339140|NCT00867113|11576094|FG000|Post Treatment After Survival Follow-up|Death|1
7339141|NCT00867113|11576094|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
7339142|NCT00867113|11576094|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
7339143|NCT00867113|11576094|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
7339144|NCT00867308|11576130|FG000|Overall Study|Death|1
7339145|NCT00867308|11576131|FG001|Overall Study|Death|0
7339146|NCT00867308|11576130|FG000|Overall Study|Adverse Event|1
7339147|NCT00867308|11576131|FG001|Overall Study|Adverse Event|4
7339148|NCT00867308|11576130|FG000|Overall Study|Lack of Efficacy|6
7339149|NCT00867308|11576131|FG001|Overall Study|Lack of Efficacy|12
7339150|NCT00867308|11576130|FG000|Overall Study|Withdrawal by Subject|1
7339151|NCT00867308|11576131|FG001|Overall Study|Withdrawal by Subject|2
7339152|NCT00867334|11576139|FG000|Overall Study|Withdrawal by Subject|0
7339153|NCT00867334|11576140|FG001|Overall Study|Withdrawal by Subject|1
7339154|NCT00867334|11576139|FG000|Overall Study|Withdrawal by Subject|1
7339155|NCT00867334|11576140|FG001|Overall Study|Withdrawal by Subject|0
7339156|NCT00867334|11576139|FG000|Overall Study|Withdrawal by Subject|1
7339157|NCT00867334|11576140|FG001|Overall Study|Withdrawal by Subject|0
7339158|NCT00867360|11576148|FG000|Overall Study|Withdrawal by Subject|1
7339159|NCT00867360|11576149|FG001|Overall Study|Withdrawal by Subject|0
7339160|NCT00867360|11576148|FG000|Overall Study|Physician Decision|0
7339161|NCT00867360|11576149|FG001|Overall Study|Physician Decision|1
7339162|NCT00867490|11576169|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
7339163|NCT00867490|11576169|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
7339164|NCT00867490|11576169|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
7339165|NCT00867490|11576169|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
7339166|NCT00867490|11576169|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
7339167|NCT00867503|11576176|FG000|Overall Study|Withdrawal by Subject|1
7339168|NCT00867815|11576200|FG000|Overall Study|Lost to Follow-up|1
7339169|NCT00868166|11576232|FG000|Overall Study|Death|58
7339170|NCT00868166|11576233|FG001|Overall Study|Death|65
7339171|NCT00868166|11576232|FG000|Overall Study|Withdrawal by Subject|33
7339172|NCT00868166|11576233|FG001|Overall Study|Withdrawal by Subject|25
7339173|NCT00868166|11576232|FG000|Overall Study|Protocol Violation|1
7339174|NCT00868166|11576233|FG001|Overall Study|Protocol Violation|0
7339175|NCT00868166|11576232|FG000|Overall Study|Lost to Follow-up|1
7339176|NCT00868166|11576233|FG001|Overall Study|Lost to Follow-up|3
7339177|NCT00868166|11576232|FG000|Overall Study|Adverse Event|9
7339178|NCT00868166|11576233|FG001|Overall Study|Adverse Event|10
7339179|NCT00868166|11576232|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
7339180|NCT00868166|11576233|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
7339181|NCT00868166|11576232|FG000|Overall Study|Non-compliance with IMP|1
7339182|NCT00868166|11576233|FG001|Overall Study|Non-compliance with IMP|1
7339183|NCT00868192|11576239|FG000|Overall Study|Ineligible|4
7339184|NCT00868231|11576264|FG000|Treatment Period 1|Adverse Event|0
7339185|NCT00868231|11576265|FG001|Treatment Period 1|Adverse Event|0
7339186|NCT00868231|11576266|FG002|Treatment Period 1|Adverse Event|0
7339187|NCT00868231|11576267|FG003|Treatment Period 1|Adverse Event|0
7339188|NCT00868231|11576268|FG004|Treatment Period 1|Adverse Event|1
7339189|NCT00868231|11576269|FG005|Treatment Period 1|Adverse Event|0
7339190|NCT00868231|11576264|FG000|Treatment Period 2|Adverse Event|1
7339191|NCT00868231|11576265|FG001|Treatment Period 2|Adverse Event|0
7339192|NCT00868231|11576266|FG002|Treatment Period 2|Adverse Event|0
7339193|NCT00868231|11576267|FG003|Treatment Period 2|Adverse Event|0
7339194|NCT00868231|11576268|FG004|Treatment Period 2|Adverse Event|0
7339195|NCT00868231|11576269|FG005|Treatment Period 2|Adverse Event|0
7339196|NCT00868231|11576264|FG000|Treatment Period 3|Adverse Event|0
7339197|NCT00868231|11576265|FG001|Treatment Period 3|Adverse Event|0
7339198|NCT00868231|11576266|FG002|Treatment Period 3|Adverse Event|1
7339199|NCT00868231|11576267|FG003|Treatment Period 3|Adverse Event|0
7339200|NCT00868231|11576268|FG004|Treatment Period 3|Adverse Event|0
7339201|NCT00868231|11576269|FG005|Treatment Period 3|Adverse Event|0
7339202|NCT00868296|11576279|FG000|Overall Study|Adverse Event|0
7339203|NCT00868296|11576280|FG001|Overall Study|Adverse Event|2
7339204|NCT00868296|11576279|FG000|Overall Study|Withdrawal by Subject|0
7339205|NCT00868296|11576280|FG001|Overall Study|Withdrawal by Subject|1
7339206|NCT00868439|11576315|FG000|Overall Study|Adverse Event|4
7339207|NCT00868439|11576316|FG001|Overall Study|Adverse Event|3
7339208|NCT00868439|11576315|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
7339209|NCT00868439|11576316|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
7339210|NCT00868439|11576315|FG000|Overall Study|Death|0
7339211|NCT00868439|11576316|FG001|Overall Study|Death|1
7339212|NCT00868439|11576315|FG000|Overall Study|Protocol Violation|1
7339213|NCT00868439|11576316|FG001|Overall Study|Protocol Violation|1
7339214|NCT00868439|11576315|FG000|Overall Study|Physician Decision|1
7339215|NCT00868439|11576316|FG001|Overall Study|Physician Decision|0
7339216|NCT00868439|11576315|FG000|Overall Study|Withdrawal by Subject|0
7339217|NCT00868439|11576316|FG001|Overall Study|Withdrawal by Subject|1
7339218|NCT00868517|11576335|FG000|Overall Study|Withdrawal by Subject|3
7339219|NCT00868517|11576336|FG001|Overall Study|Withdrawal by Subject|3
7339220|NCT00868517|11576337|FG002|Overall Study|Withdrawal by Subject|2
7339221|NCT00868517|11576335|FG000|Overall Study|Protocol Violation|1
7339222|NCT00868517|11576336|FG001|Overall Study|Protocol Violation|1
7339223|NCT00868517|11576337|FG002|Overall Study|Protocol Violation|0
7339224|NCT00868530|11576345|FG000|Overall Study|Adverse Event|3
7339225|NCT00868530|11576345|FG000|Overall Study|Lost to Follow-up|1
7339226|NCT00868608|11576352|FG000|Overall Study|Withdrawal by Subject|3
7339227|NCT00868608|11576353|FG001|Overall Study|Withdrawal by Subject|1
7339228|NCT00868608|11576354|FG002|Overall Study|Withdrawal by Subject|0
7339229|NCT00868608|11576352|FG000|Overall Study|Lost to Follow-up|3
7339230|NCT00868608|11576353|FG001|Overall Study|Lost to Follow-up|0
7339231|NCT00868608|11576354|FG002|Overall Study|Lost to Follow-up|1
7339232|NCT00868608|11576352|FG000|Overall Study|Death|16
7339233|NCT00868608|11576353|FG001|Overall Study|Death|2
7339234|NCT00868608|11576354|FG002|Overall Study|Death|4
7339235|NCT00868608|11576352|FG000|Overall Study|Other - Unspecified|1
7339236|NCT00868608|11576353|FG001|Overall Study|Other - Unspecified|0
7339237|NCT00868608|11576354|FG002|Overall Study|Other - Unspecified|0
7339238|NCT00868790|11576392|FG000|Period 1|Adverse Event|1
7339239|NCT00868790|11576393|FG001|Period 1|Adverse Event|0
7339240|NCT00868790|11576394|FG002|Period 1|Adverse Event|0
7339241|NCT00868790|11576395|FG003|Period 1|Adverse Event|0
7339242|NCT00868790|11576396|FG004|Period 1|Adverse Event|0
7339243|NCT00868790|11576397|FG005|Period 1|Adverse Event|0
7339244|NCT00868790|11576398|FG006|Period 1|Adverse Event|0
7339245|NCT00868790|11576399|FG007|Period 1|Adverse Event|3
7568773|NCT03426787|11944332|FG000|Overall Study|Lost to Follow-up|7
7568774|NCT03426787|11944332|FG000|Overall Study|Unrelated to intervention death|1
7568775|NCT03426995|11944361|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568776|NCT03426995|11944362|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568777|NCT03426995|11944363|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
7568778|NCT03426995|11944364|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568779|NCT03426995|11944365|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568780|NCT03426995|11944366|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568781|NCT03426995|11944367|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568782|NCT03426995|11944368|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568783|NCT03426995|11944369|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7339246|NCT00868790|11576400|FG008|Period 1|Adverse Event|1
7339247|NCT00868790|11576401|FG009|Period 1|Adverse Event|0
7339248|NCT00868790|11576402|FG010|Period 1|Adverse Event|0
7339249|NCT00868790|11576403|FG011|Period 1|Adverse Event|0
7339250|NCT00868790|11576404|FG012|Period 1|Adverse Event|0
7339251|NCT00868790|11576405|FG013|Period 1|Adverse Event|1
7339252|NCT00868790|11576392|FG000|Period 1|Protocol Violation|1
7339253|NCT00868790|11576393|FG001|Period 1|Protocol Violation|0
7339254|NCT00868790|11576394|FG002|Period 1|Protocol Violation|0
7339255|NCT00868790|11576395|FG003|Period 1|Protocol Violation|0
7339256|NCT00868790|11576396|FG004|Period 1|Protocol Violation|0
7339257|NCT00868790|11576397|FG005|Period 1|Protocol Violation|0
7339258|NCT00868790|11576398|FG006|Period 1|Protocol Violation|0
7339259|NCT00868790|11576399|FG007|Period 1|Protocol Violation|0
7339260|NCT00868790|11576400|FG008|Period 1|Protocol Violation|0
7568784|NCT03426995|11944370|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568785|NCT03426995|11944371|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568786|NCT03426995|11944372|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568787|NCT03426995|11944373|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568788|NCT03426995|11944374|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568789|NCT03426995|11944375|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568790|NCT03426995|11944376|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568791|NCT03426995|11944377|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568792|NCT03426995|11944378|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568793|NCT03426995|11944379|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
7568794|NCT03426995|11944361|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568795|NCT03426995|11944362|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568796|NCT03426995|11944363|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568797|NCT03426995|11944364|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568798|NCT03426995|11944365|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568799|NCT03426995|11944366|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
7568800|NCT03426995|11944367|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568801|NCT03426995|11944368|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568802|NCT03426995|11944369|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568803|NCT03426995|11944370|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568804|NCT03426995|11944371|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568805|NCT03426995|11944372|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568806|NCT03426995|11944373|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568807|NCT03426995|11944374|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568808|NCT03426995|11944375|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568809|NCT03426995|11944376|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568810|NCT03426995|11944377|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568811|NCT03426995|11944378|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568812|NCT03426995|11944379|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
7568813|NCT03426995|11944361|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568814|NCT03426995|11944362|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568815|NCT03426995|11944363|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568816|NCT03426995|11944364|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568817|NCT03426995|11944365|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7568818|NCT03426995|11944366|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
7568819|NCT03426995|11944367|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568820|NCT03426995|11944368|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568821|NCT03426995|11944369|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568822|NCT03426995|11944370|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568823|NCT03426995|11944371|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7339261|NCT00868790|11576401|FG009|Period 1|Protocol Violation|0
7339262|NCT00868790|11576402|FG010|Period 1|Protocol Violation|0
7339263|NCT00868790|11576403|FG011|Period 1|Protocol Violation|0
7339264|NCT00868790|11576404|FG012|Period 1|Protocol Violation|0
7339265|NCT00868790|11576405|FG013|Period 1|Protocol Violation|0
7339266|NCT00868790|11576392|FG000|Period 1|Withdrawal by Subject|0
7339267|NCT00868790|11576393|FG001|Period 1|Withdrawal by Subject|1
7339268|NCT00868790|11576394|FG002|Period 1|Withdrawal by Subject|0
7339269|NCT00868790|11576395|FG003|Period 1|Withdrawal by Subject|0
7339270|NCT00868790|11576396|FG004|Period 1|Withdrawal by Subject|0
7339271|NCT00868790|11576397|FG005|Period 1|Withdrawal by Subject|0
7339272|NCT00868790|11576398|FG006|Period 1|Withdrawal by Subject|0
7339273|NCT00868790|11576399|FG007|Period 1|Withdrawal by Subject|0
7339274|NCT00868790|11576400|FG008|Period 1|Withdrawal by Subject|0
7339275|NCT00868790|11576401|FG009|Period 1|Withdrawal by Subject|0
7339276|NCT00868790|11576402|FG010|Period 1|Withdrawal by Subject|0
7339277|NCT00868790|11576403|FG011|Period 1|Withdrawal by Subject|0
7339278|NCT00868790|11576404|FG012|Period 1|Withdrawal by Subject|0
7339279|NCT00868790|11576405|FG013|Period 1|Withdrawal by Subject|1
7339280|NCT00868790|11576392|FG000|Period 1|Abnormal Triglycerides|0
7339281|NCT00868790|11576393|FG001|Period 1|Abnormal Triglycerides|0
7339282|NCT00868790|11576394|FG002|Period 1|Abnormal Triglycerides|0
7339283|NCT00868790|11576395|FG003|Period 1|Abnormal Triglycerides|0
7339284|NCT00868790|11576396|FG004|Period 1|Abnormal Triglycerides|1
7339285|NCT00868790|11576397|FG005|Period 1|Abnormal Triglycerides|0
7339286|NCT00868790|11576398|FG006|Period 1|Abnormal Triglycerides|0
7339287|NCT00868790|11576399|FG007|Period 1|Abnormal Triglycerides|0
7339288|NCT00868790|11576400|FG008|Period 1|Abnormal Triglycerides|0
7339289|NCT00868790|11576401|FG009|Period 1|Abnormal Triglycerides|0
7339290|NCT00868790|11576402|FG010|Period 1|Abnormal Triglycerides|0
7339291|NCT00868790|11576403|FG011|Period 1|Abnormal Triglycerides|0
7339292|NCT00868790|11576404|FG012|Period 1|Abnormal Triglycerides|0
7339293|NCT00868790|11576405|FG013|Period 1|Abnormal Triglycerides|0
7339294|NCT00868790|11576392|FG000|Period 1|Lost to Follow-up|0
7339295|NCT00868790|11576393|FG001|Period 1|Lost to Follow-up|0
7339296|NCT00868790|11576394|FG002|Period 1|Lost to Follow-up|0
7339297|NCT00868790|11576395|FG003|Period 1|Lost to Follow-up|0
7339298|NCT00868790|11576396|FG004|Period 1|Lost to Follow-up|0
7339299|NCT00868790|11576397|FG005|Period 1|Lost to Follow-up|1
7339300|NCT00868790|11576398|FG006|Period 1|Lost to Follow-up|0
7339301|NCT00868790|11576399|FG007|Period 1|Lost to Follow-up|0
7339302|NCT00868790|11576400|FG008|Period 1|Lost to Follow-up|0
7339303|NCT00868790|11576401|FG009|Period 1|Lost to Follow-up|0
7339304|NCT00868790|11576402|FG010|Period 1|Lost to Follow-up|0
7339305|NCT00868790|11576403|FG011|Period 1|Lost to Follow-up|0
7339306|NCT00868790|11576404|FG012|Period 1|Lost to Follow-up|0
7339307|NCT00868790|11576405|FG013|Period 1|Lost to Follow-up|0
7339308|NCT00868790|11576392|FG000|Period 2|Adverse Event|0
7339309|NCT00868790|11576393|FG001|Period 2|Adverse Event|0
7339310|NCT00868790|11576394|FG002|Period 2|Adverse Event|0
7339311|NCT00868790|11576395|FG003|Period 2|Adverse Event|0
7339312|NCT00868790|11576396|FG004|Period 2|Adverse Event|0
7339313|NCT00868790|11576397|FG005|Period 2|Adverse Event|0
7339314|NCT00868790|11576398|FG006|Period 2|Adverse Event|0
7339315|NCT00868790|11576399|FG007|Period 2|Adverse Event|0
7339316|NCT00868790|11576400|FG008|Period 2|Adverse Event|1
7339317|NCT00868790|11576401|FG009|Period 2|Adverse Event|0
7339318|NCT00868790|11576402|FG010|Period 2|Adverse Event|0
7339319|NCT00868790|11576403|FG011|Period 2|Adverse Event|0
7339320|NCT00868790|11576404|FG012|Period 2|Adverse Event|0
7339321|NCT00868790|11576405|FG013|Period 2|Adverse Event|0
7339322|NCT00868790|11576392|FG000|Period 2|Lost to Follow-up|0
7339323|NCT00868790|11576393|FG001|Period 2|Lost to Follow-up|1
7339324|NCT00868790|11576394|FG002|Period 2|Lost to Follow-up|0
7339325|NCT00868790|11576395|FG003|Period 2|Lost to Follow-up|0
7339326|NCT00868790|11576396|FG004|Period 2|Lost to Follow-up|0
7339327|NCT00868790|11576397|FG005|Period 2|Lost to Follow-up|1
7339328|NCT00868790|11576398|FG006|Period 2|Lost to Follow-up|0
7339329|NCT00868790|11576399|FG007|Period 2|Lost to Follow-up|0
7339330|NCT00868790|11576400|FG008|Period 2|Lost to Follow-up|0
7339331|NCT00868790|11576401|FG009|Period 2|Lost to Follow-up|0
7339332|NCT00868790|11576402|FG010|Period 2|Lost to Follow-up|0
7339333|NCT00868790|11576403|FG011|Period 2|Lost to Follow-up|0
7339334|NCT00868790|11576404|FG012|Period 2|Lost to Follow-up|0
7339335|NCT00868790|11576405|FG013|Period 2|Lost to Follow-up|0
7339336|NCT00868790|11576392|FG000|Period 2|Withdrawal by Subject|0
7339337|NCT00868790|11576393|FG001|Period 2|Withdrawal by Subject|0
7339338|NCT00868790|11576394|FG002|Period 2|Withdrawal by Subject|0
7339339|NCT00868790|11576395|FG003|Period 2|Withdrawal by Subject|0
7339340|NCT00868790|11576396|FG004|Period 2|Withdrawal by Subject|0
7339341|NCT00868790|11576397|FG005|Period 2|Withdrawal by Subject|0
7339342|NCT00868790|11576398|FG006|Period 2|Withdrawal by Subject|0
7339343|NCT00868790|11576399|FG007|Period 2|Withdrawal by Subject|0
7339344|NCT00868790|11576400|FG008|Period 2|Withdrawal by Subject|1
7339345|NCT00868790|11576401|FG009|Period 2|Withdrawal by Subject|0
7339346|NCT00868790|11576402|FG010|Period 2|Withdrawal by Subject|0
7339347|NCT00868790|11576403|FG011|Period 2|Withdrawal by Subject|0
7339348|NCT00868790|11576404|FG012|Period 2|Withdrawal by Subject|0
7339349|NCT00868790|11576405|FG013|Period 2|Withdrawal by Subject|1
7339350|NCT00868790|11576392|FG000|Period 3|Adverse Event|0
7339351|NCT00868790|11576393|FG001|Period 3|Adverse Event|0
7339352|NCT00868790|11576394|FG002|Period 3|Adverse Event|0
7339353|NCT00868790|11576395|FG003|Period 3|Adverse Event|0
7339354|NCT00868790|11576396|FG004|Period 3|Adverse Event|0
7339355|NCT00868790|11576397|FG005|Period 3|Adverse Event|0
7339356|NCT00868790|11576398|FG006|Period 3|Adverse Event|0
7339357|NCT00868790|11576399|FG007|Period 3|Adverse Event|0
7458245|NCT01807065|11752316|FG000|Overall Study|Receive no sip-T due to IV access|1
7458246|NCT01807065|11752317|FG001|Overall Study|Receive no sip-T due to IV access|1
7458247|NCT01807156|11752336|FG000|Overall Study|Physician Decision|1
7458248|NCT01807221|11752346|FG000|Overall Study|Progressive disease|1
7458249|NCT01807221|11752347|FG001|Overall Study|Progressive disease|0
7458250|NCT01807221|11752348|FG002|Overall Study|Progressive disease|1
7458251|NCT01807221|11752349|FG003|Overall Study|Progressive disease|0
7458252|NCT01807221|11752350|FG004|Overall Study|Progressive disease|0
7458253|NCT01807221|11752351|FG005|Overall Study|Progressive disease|0
7458254|NCT01807221|11752346|FG000|Overall Study|Death|7
7458255|NCT01807221|11752347|FG001|Overall Study|Death|9
7458256|NCT01807221|11752348|FG002|Overall Study|Death|4
7458257|NCT01807221|11752349|FG003|Overall Study|Death|2
7458258|NCT01807221|11752350|FG004|Overall Study|Death|1
7458259|NCT01807221|11752351|FG005|Overall Study|Death|6
7458260|NCT01807221|11752346|FG000|Overall Study|Physician Decision|2
7458261|NCT01807221|11752347|FG001|Overall Study|Physician Decision|1
7458262|NCT01807221|11752348|FG002|Overall Study|Physician Decision|0
7458263|NCT01807221|11752349|FG003|Overall Study|Physician Decision|0
7458264|NCT01807221|11752350|FG004|Overall Study|Physician Decision|0
7458265|NCT01807221|11752351|FG005|Overall Study|Physician Decision|0
7458266|NCT01807221|11752346|FG000|Overall Study|Adverse Event|33
7458267|NCT01807221|11752347|FG001|Overall Study|Adverse Event|22
7458268|NCT01807221|11752348|FG002|Overall Study|Adverse Event|26
7458269|NCT01807221|11752349|FG003|Overall Study|Adverse Event|25
7458270|NCT01807221|11752350|FG004|Overall Study|Adverse Event|18
7458271|NCT01807221|11752351|FG005|Overall Study|Adverse Event|21
7339358|NCT00868790|11576400|FG008|Period 3|Adverse Event|0
7339359|NCT00868790|11576401|FG009|Period 3|Adverse Event|1
7339360|NCT00868790|11576402|FG010|Period 3|Adverse Event|0
7339361|NCT00868790|11576403|FG011|Period 3|Adverse Event|0
7339362|NCT00868790|11576404|FG012|Period 3|Adverse Event|0
7339363|NCT00868790|11576405|FG013|Period 3|Adverse Event|0
7339364|NCT00868790|11576392|FG000|Period 3|Protocol Violation|0
7339365|NCT00868790|11576393|FG001|Period 3|Protocol Violation|0
7339366|NCT00868790|11576394|FG002|Period 3|Protocol Violation|0
7339367|NCT00868790|11576395|FG003|Period 3|Protocol Violation|0
7339368|NCT00868790|11576396|FG004|Period 3|Protocol Violation|0
7339369|NCT00868790|11576397|FG005|Period 3|Protocol Violation|0
7339370|NCT00868790|11576398|FG006|Period 3|Protocol Violation|0
7339371|NCT00868790|11576399|FG007|Period 3|Protocol Violation|0
7339372|NCT00868790|11576400|FG008|Period 3|Protocol Violation|0
7458272|NCT01807221|11752346|FG000|Overall Study|Protocol Violation|0
7458273|NCT01807221|11752347|FG001|Overall Study|Protocol Violation|2
7458274|NCT01807221|11752348|FG002|Overall Study|Protocol Violation|1
7458275|NCT01807221|11752349|FG003|Overall Study|Protocol Violation|2
7458276|NCT01807221|11752350|FG004|Overall Study|Protocol Violation|0
7458277|NCT01807221|11752351|FG005|Overall Study|Protocol Violation|1
7458278|NCT01807221|11752346|FG000|Overall Study|Non-compliance|1
7458279|NCT01807221|11752347|FG001|Overall Study|Non-compliance|2
7458280|NCT01807221|11752348|FG002|Overall Study|Non-compliance|0
7458281|NCT01807221|11752349|FG003|Overall Study|Non-compliance|1
7458282|NCT01807221|11752350|FG004|Overall Study|Non-compliance|0
7458283|NCT01807221|11752351|FG005|Overall Study|Non-compliance|0
7458284|NCT01807221|11752346|FG000|Overall Study|Logistical difficulties|0
7458285|NCT01807221|11752347|FG001|Overall Study|Logistical difficulties|1
7458286|NCT01807221|11752348|FG002|Overall Study|Logistical difficulties|0
7458287|NCT01807221|11752349|FG003|Overall Study|Logistical difficulties|0
7458288|NCT01807221|11752350|FG004|Overall Study|Logistical difficulties|1
7458289|NCT01807221|11752351|FG005|Overall Study|Logistical difficulties|0
7458290|NCT01807221|11752346|FG000|Overall Study|Withdrawal by Subject|33
7458291|NCT01807221|11752347|FG001|Overall Study|Withdrawal by Subject|15
7458292|NCT01807221|11752348|FG002|Overall Study|Withdrawal by Subject|8
7458293|NCT01807221|11752349|FG003|Overall Study|Withdrawal by Subject|14
7458294|NCT01807221|11752350|FG004|Overall Study|Withdrawal by Subject|16
7458295|NCT01807221|11752351|FG005|Overall Study|Withdrawal by Subject|13
7458296|NCT01807221|11752346|FG000|Overall Study|Sponsor decision|2
7339373|NCT00868790|11576401|FG009|Period 3|Protocol Violation|0
7339374|NCT00868790|11576402|FG010|Period 3|Protocol Violation|1
7339375|NCT00868790|11576403|FG011|Period 3|Protocol Violation|0
7339376|NCT00868790|11576404|FG012|Period 3|Protocol Violation|0
7339377|NCT00868790|11576405|FG013|Period 3|Protocol Violation|0
7339378|NCT00868790|11576392|FG000|Period 3|Study Terminated by Sponsor|0
7339379|NCT00868790|11576393|FG001|Period 3|Study Terminated by Sponsor|0
7339380|NCT00868790|11576394|FG002|Period 3|Study Terminated by Sponsor|0
7339381|NCT00868790|11576395|FG003|Period 3|Study Terminated by Sponsor|1
7339382|NCT00868790|11576396|FG004|Period 3|Study Terminated by Sponsor|0
7339383|NCT00868790|11576397|FG005|Period 3|Study Terminated by Sponsor|0
7339384|NCT00868790|11576398|FG006|Period 3|Study Terminated by Sponsor|0
7339385|NCT00868790|11576399|FG007|Period 3|Study Terminated by Sponsor|0
7339386|NCT00868790|11576400|FG008|Period 3|Study Terminated by Sponsor|0
7339387|NCT00868790|11576401|FG009|Period 3|Study Terminated by Sponsor|0
7339388|NCT00868790|11576402|FG010|Period 3|Study Terminated by Sponsor|0
7339389|NCT00868790|11576403|FG011|Period 3|Study Terminated by Sponsor|0
7339390|NCT00868790|11576404|FG012|Period 3|Study Terminated by Sponsor|0
7339391|NCT00868790|11576405|FG013|Period 3|Study Terminated by Sponsor|0
7339392|NCT00868790|11576392|FG000|Period 4|Adverse Event|0
7339393|NCT00868790|11576393|FG001|Period 4|Adverse Event|0
7339394|NCT00868790|11576394|FG002|Period 4|Adverse Event|0
7339395|NCT00868790|11576395|FG003|Period 4|Adverse Event|0
7339396|NCT00868790|11576396|FG004|Period 4|Adverse Event|0
7339397|NCT00868790|11576397|FG005|Period 4|Adverse Event|0
7339398|NCT00868790|11576398|FG006|Period 4|Adverse Event|0
7339399|NCT00868790|11576399|FG007|Period 4|Adverse Event|1
7339400|NCT00868790|11576400|FG008|Period 4|Adverse Event|0
7339401|NCT00868790|11576401|FG009|Period 4|Adverse Event|0
7339402|NCT00868790|11576402|FG010|Period 4|Adverse Event|1
7339403|NCT00868790|11576403|FG011|Period 4|Adverse Event|0
7339404|NCT00868790|11576404|FG012|Period 4|Adverse Event|1
7339405|NCT00868790|11576405|FG013|Period 4|Adverse Event|0
7339406|NCT00868790|11576392|FG000|Period 4|Lost to Follow-up|0
7339407|NCT00868790|11576393|FG001|Period 4|Lost to Follow-up|0
7339408|NCT00868790|11576394|FG002|Period 4|Lost to Follow-up|0
7339409|NCT00868790|11576395|FG003|Period 4|Lost to Follow-up|0
7339410|NCT00868790|11576396|FG004|Period 4|Lost to Follow-up|0
7339411|NCT00868790|11576397|FG005|Period 4|Lost to Follow-up|0
7458297|NCT01807221|11752347|FG001|Overall Study|Sponsor decision|0
7458298|NCT01807221|11752348|FG002|Overall Study|Sponsor decision|1
7458299|NCT01807221|11752349|FG003|Overall Study|Sponsor decision|1
7339412|NCT00868790|11576398|FG006|Period 4|Lost to Follow-up|0
7339413|NCT00868790|11576399|FG007|Period 4|Lost to Follow-up|1
7339414|NCT00868790|11576400|FG008|Period 4|Lost to Follow-up|0
7339415|NCT00868790|11576401|FG009|Period 4|Lost to Follow-up|0
7339416|NCT00868790|11576402|FG010|Period 4|Lost to Follow-up|0
7339417|NCT00868790|11576403|FG011|Period 4|Lost to Follow-up|0
7339418|NCT00868790|11576404|FG012|Period 4|Lost to Follow-up|0
7339419|NCT00868790|11576405|FG013|Period 4|Lost to Follow-up|0
7339420|NCT00868790|11576392|FG000|Period 4|Study Terminated by Sponsor|2
7339421|NCT00868790|11576393|FG001|Period 4|Study Terminated by Sponsor|0
7339422|NCT00868790|11576394|FG002|Period 4|Study Terminated by Sponsor|0
7339423|NCT00868790|11576395|FG003|Period 4|Study Terminated by Sponsor|0
7339424|NCT00868790|11576396|FG004|Period 4|Study Terminated by Sponsor|0
7339425|NCT00868790|11576397|FG005|Period 4|Study Terminated by Sponsor|0
7339426|NCT00868790|11576398|FG006|Period 4|Study Terminated by Sponsor|0
7339427|NCT00868790|11576399|FG007|Period 4|Study Terminated by Sponsor|1
7339428|NCT00868790|11576400|FG008|Period 4|Study Terminated by Sponsor|2
7339429|NCT00868790|11576401|FG009|Period 4|Study Terminated by Sponsor|0
7339430|NCT00868790|11576402|FG010|Period 4|Study Terminated by Sponsor|2
7339431|NCT00868790|11576403|FG011|Period 4|Study Terminated by Sponsor|1
7339432|NCT00868790|11576404|FG012|Period 4|Study Terminated by Sponsor|0
7339433|NCT00868790|11576405|FG013|Period 4|Study Terminated by Sponsor|1
7339434|NCT00868790|11576392|FG000|Period 4|Abnormal ALT/AST|0
7339435|NCT00868790|11576393|FG001|Period 4|Abnormal ALT/AST|0
7339436|NCT00868790|11576394|FG002|Period 4|Abnormal ALT/AST|1
7339437|NCT00868790|11576395|FG003|Period 4|Abnormal ALT/AST|0
7339438|NCT00868790|11576396|FG004|Period 4|Abnormal ALT/AST|0
7339439|NCT00868790|11576397|FG005|Period 4|Abnormal ALT/AST|0
7339440|NCT00868790|11576398|FG006|Period 4|Abnormal ALT/AST|0
7339441|NCT00868790|11576399|FG007|Period 4|Abnormal ALT/AST|0
7339442|NCT00868790|11576400|FG008|Period 4|Abnormal ALT/AST|0
7339443|NCT00868790|11576401|FG009|Period 4|Abnormal ALT/AST|0
7339444|NCT00868790|11576402|FG010|Period 4|Abnormal ALT/AST|0
7339445|NCT00868790|11576403|FG011|Period 4|Abnormal ALT/AST|0
7339446|NCT00868790|11576404|FG012|Period 4|Abnormal ALT/AST|0
7339447|NCT00868790|11576405|FG013|Period 4|Abnormal ALT/AST|0
7339448|NCT00868790|11576392|FG000|Post-study|Withdrawal by Subject|0
7339449|NCT00868790|11576393|FG001|Post-study|Withdrawal by Subject|0
7339450|NCT00868790|11576394|FG002|Post-study|Withdrawal by Subject|0
7339451|NCT00868790|11576395|FG003|Post-study|Withdrawal by Subject|0
7339452|NCT00868790|11576396|FG004|Post-study|Withdrawal by Subject|1
7339453|NCT00868790|11576397|FG005|Post-study|Withdrawal by Subject|0
7339454|NCT00868790|11576398|FG006|Post-study|Withdrawal by Subject|0
7339455|NCT00868790|11576399|FG007|Post-study|Withdrawal by Subject|0
7339456|NCT00868790|11576400|FG008|Post-study|Withdrawal by Subject|0
7339457|NCT00868790|11576401|FG009|Post-study|Withdrawal by Subject|0
7339458|NCT00868790|11576402|FG010|Post-study|Withdrawal by Subject|0
7339459|NCT00868790|11576403|FG011|Post-study|Withdrawal by Subject|0
7339460|NCT00868790|11576404|FG012|Post-study|Withdrawal by Subject|0
7339461|NCT00868790|11576405|FG013|Post-study|Withdrawal by Subject|0
7339462|NCT00868790|11576392|FG000|Post-study|Excluded Medication|0
7339463|NCT00868790|11576393|FG001|Post-study|Excluded Medication|0
7339464|NCT00868790|11576394|FG002|Post-study|Excluded Medication|0
7339465|NCT00868790|11576395|FG003|Post-study|Excluded Medication|0
7339466|NCT00868790|11576396|FG004|Post-study|Excluded Medication|0
7339467|NCT00868790|11576397|FG005|Post-study|Excluded Medication|0
7339468|NCT00868790|11576398|FG006|Post-study|Excluded Medication|0
7339469|NCT00868790|11576399|FG007|Post-study|Excluded Medication|2
7339470|NCT00868790|11576400|FG008|Post-study|Excluded Medication|0
7339471|NCT00868790|11576401|FG009|Post-study|Excluded Medication|1
7339472|NCT00868790|11576402|FG010|Post-study|Excluded Medication|0
7339473|NCT00868790|11576403|FG011|Post-study|Excluded Medication|0
7339474|NCT00868790|11576404|FG012|Post-study|Excluded Medication|0
7339475|NCT00868790|11576405|FG013|Post-study|Excluded Medication|0
7339476|NCT00869024|11576427|FG000|Overall Study|Death|2
7339477|NCT00869024|11576428|FG001|Overall Study|Death|3
7339478|NCT00869024|11576427|FG000|Overall Study|Lost to Follow-up|0
7339479|NCT00869024|11576428|FG001|Overall Study|Lost to Follow-up|1
7339480|NCT00869024|11576427|FG000|Overall Study|Protocol Violation|0
7339481|NCT00869024|11576428|FG001|Overall Study|Protocol Violation|1
7339482|NCT00869050|11576434|FG000|Overall Study|Screen Failure|3
7339483|NCT00869089|11576438|FG000|Overall Study|Lost to Follow-up|1
7339484|NCT00869089|11576438|FG000|Overall Study|Withdrawal by Subject|1
7339485|NCT00869089|11576438|FG000|Overall Study|Screen Fail|1
7339486|NCT00869323|11576479|FG000|Maintenance Therapy|concurrent illness|1
7339487|NCT00869362|11576494|FG000|Overall Study|Death|0
7339488|NCT00869362|11576495|FG001|Overall Study|Death|2
7339489|NCT00869362|11576494|FG000|Overall Study|Lost to Follow-up|1
7339490|NCT00869362|11576495|FG001|Overall Study|Lost to Follow-up|3
7339491|NCT00869401|11576516|FG000|Overall Study|Withdrawal by Subject|0
7339492|NCT00869401|11576517|FG001|Overall Study|Withdrawal by Subject|0
7339493|NCT00869401|11576518|FG002|Overall Study|Withdrawal by Subject|0
7339494|NCT00869401|11576519|FG003|Overall Study|Withdrawal by Subject|5
7339495|NCT00869401|11576520|FG004|Overall Study|Withdrawal by Subject|3
7339496|NCT00869440|11576536|FG000|Overall Study|Withdrawal by Subject|1
7339497|NCT00869440|11576537|FG001|Overall Study|Withdrawal by Subject|0
7339498|NCT00869440|11576538|FG002|Overall Study|Withdrawal by Subject|0
7339499|NCT00869440|11576539|FG003|Overall Study|Withdrawal by Subject|0
7339500|NCT00869440|11576536|FG000|Overall Study|Physician Decision|1
7339501|NCT00869440|11576537|FG001|Overall Study|Physician Decision|1
7339502|NCT00869440|11576538|FG002|Overall Study|Physician Decision|0
7568824|NCT03426995|11944372|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568825|NCT03426995|11944373|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568826|NCT03426995|11944374|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568827|NCT03426995|11944375|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568828|NCT03426995|11944376|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7339503|NCT00869440|11576539|FG003|Overall Study|Physician Decision|0
7339504|NCT00869518|11576551|FG000|Overall Study|Lost to Follow-up|1
7339505|NCT00869518|11576552|FG001|Overall Study|Lost to Follow-up|1
7339506|NCT00869557|11576560|FG000|Randomized Phase|Lost to Follow-up|2
7339507|NCT00869557|11576561|FG001|Randomized Phase|Lost to Follow-up|1
7339508|NCT00869557|11576560|FG000|Randomized Phase|Investigator's Discretion|1
7339509|NCT00869557|11576561|FG001|Randomized Phase|Investigator's Discretion|0
7339510|NCT00869557|11576560|FG000|Randomized Phase|Withdrew Consent|0
7339511|NCT00869557|11576561|FG001|Randomized Phase|Withdrew Consent|1
7339512|NCT00869557|11576560|FG000|Extension Phase|Adverse Event|2
7339513|NCT00869557|11576561|FG001|Extension Phase|Adverse Event|2
7339514|NCT00869557|11576560|FG000|Extension Phase|Lack of Efficacy|1
7339515|NCT00869557|11576561|FG001|Extension Phase|Lack of Efficacy|0
7339516|NCT00869557|11576560|FG000|Extension Phase|Lost to Follow-up|3
7339517|NCT00869557|11576561|FG001|Extension Phase|Lost to Follow-up|1
7339518|NCT00869557|11576560|FG000|Extension Phase|Investigator's Discretion|2
7339519|NCT00869557|11576561|FG001|Extension Phase|Investigator's Discretion|0
7339520|NCT00869557|11576560|FG000|Extension Phase|Withdrew Consent|2
7339521|NCT00869557|11576561|FG001|Extension Phase|Withdrew Consent|0
7339522|NCT00869778|11576590|FG000|Overall Study|Adverse Event|2
7339523|NCT00869778|11576591|FG001|Overall Study|Adverse Event|0
7339524|NCT00869778|11576592|FG002|Overall Study|Adverse Event|0
7339525|NCT00869778|11576590|FG000|Overall Study|Withdrawal by Subject|3
7339526|NCT00869778|11576591|FG001|Overall Study|Withdrawal by Subject|4
7339527|NCT00869778|11576592|FG002|Overall Study|Withdrawal by Subject|5
7339528|NCT00869778|11576590|FG000|Overall Study|Pregnancy|1
7339529|NCT00869778|11576591|FG001|Overall Study|Pregnancy|0
7339530|NCT00869778|11576592|FG002|Overall Study|Pregnancy|0
7339531|NCT00869778|11576590|FG000|Overall Study|Protocol Violation|5
7339532|NCT00869778|11576591|FG001|Overall Study|Protocol Violation|3
7339533|NCT00869778|11576592|FG002|Overall Study|Protocol Violation|5
7339534|NCT00869778|11576590|FG000|Overall Study|Unblinding|1
7339535|NCT00869778|11576591|FG001|Overall Study|Unblinding|0
7339536|NCT00869778|11576592|FG002|Overall Study|Unblinding|0
7339537|NCT00869960|11576621|FG000|Overall Study|Lost to Follow-up|2
7339538|NCT00869999|11576625|FG000|Overall Study|Withdrawal by Subject|1
7339539|NCT00869999|11576625|FG000|Overall Study|removed prior to starting therapy|1
7339540|NCT00870103|11576629|FG000|Overall Study|Physician Decision|2
7339541|NCT00870103|11576629|FG000|Overall Study|Lost to Follow-up|2
7339542|NCT00870194|11576635|FG000|Overall Study|Adverse Event|10
7339543|NCT00870194|11576636|FG001|Overall Study|Adverse Event|5
7339544|NCT00870194|11576635|FG000|Overall Study|Lack of Efficacy|0
7339545|NCT00870194|11576636|FG001|Overall Study|Lack of Efficacy|1
7339546|NCT00870194|11576635|FG000|Overall Study|Lost to Follow-up|2
7339547|NCT00870194|11576636|FG001|Overall Study|Lost to Follow-up|0
7339548|NCT00870194|11576635|FG000|Overall Study|Physician Decision|3
7339549|NCT00870194|11576636|FG001|Overall Study|Physician Decision|1
7339550|NCT00870194|11576635|FG000|Overall Study|Protocol Violation|3
7339551|NCT00870194|11576636|FG001|Overall Study|Protocol Violation|3
7339552|NCT00870194|11576635|FG000|Overall Study|Entry Criteria Not Met|1
7339553|NCT00870194|11576636|FG001|Overall Study|Entry Criteria Not Met|2
7339554|NCT00870194|11576635|FG000|Overall Study|Subject Decision|7
7339555|NCT00870194|11576636|FG001|Overall Study|Subject Decision|2
7339556|NCT00870233|11576642|FG000|Overall Study|Withdrawal by Subject|18
7339557|NCT00870233|11576642|FG000|Overall Study|Did not undergo laparotomy|3
7339558|NCT00870233|11576642|FG000|Overall Study|Incompatible internet browser|2
7339559|NCT00870233|11576642|FG000|Overall Study|Death|1
7339560|NCT00870584|11576689|FG000|Overall Study|Adverse Event|3
7339561|NCT00870584|11576690|FG001|Overall Study|Adverse Event|3
7339562|NCT00870584|11576689|FG000|Overall Study|Withdrawal by Subject|6
7339563|NCT00870584|11576690|FG001|Overall Study|Withdrawal by Subject|7
7339564|NCT00870584|11576689|FG000|Overall Study|Lost to Follow-up|5
7568829|NCT03426995|11944377|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568830|NCT03426995|11944378|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7339565|NCT00870584|11576690|FG001|Overall Study|Lost to Follow-up|1
7339566|NCT00870584|11576689|FG000|Overall Study|Protocol Deviation|2
7339567|NCT00870584|11576690|FG001|Overall Study|Protocol Deviation|2
7339568|NCT00870727|11576698|FG000|Overall Study|Lost to Follow-up|0
7339569|NCT00870727|11576699|FG001|Overall Study|Lost to Follow-up|1
7339570|NCT00870727|11576698|FG000|Overall Study|Lack of Efficacy|1
7339571|NCT00870727|11576699|FG001|Overall Study|Lack of Efficacy|3
7339572|NCT00870727|11576698|FG000|Overall Study|Adverse Event|0
7339573|NCT00870727|11576699|FG001|Overall Study|Adverse Event|1
7339574|NCT00870740|11576711|FG000|Overall Study|Adverse Event|2
7339575|NCT00870740|11576712|FG001|Overall Study|Adverse Event|1
7339576|NCT00870740|11576713|FG002|Overall Study|Adverse Event|3
7339577|NCT00870740|11576714|FG003|Overall Study|Adverse Event|2
7339578|NCT00870740|11576715|FG004|Overall Study|Adverse Event|1
7339579|NCT00870740|11576716|FG005|Overall Study|Adverse Event|6
7339580|NCT00870740|11576711|FG000|Overall Study|Consent Withdrawn|6
7339581|NCT00870740|11576712|FG001|Overall Study|Consent Withdrawn|3
7339582|NCT00870740|11576713|FG002|Overall Study|Consent Withdrawn|4
7339583|NCT00870740|11576714|FG003|Overall Study|Consent Withdrawn|6
7339584|NCT00870740|11576715|FG004|Overall Study|Consent Withdrawn|6
7339585|NCT00870740|11576716|FG005|Overall Study|Consent Withdrawn|5
7339586|NCT00870740|11576711|FG000|Overall Study|Investigator Decision|2
7339587|NCT00870740|11576712|FG001|Overall Study|Investigator Decision|0
7339588|NCT00870740|11576713|FG002|Overall Study|Investigator Decision|1
7339589|NCT00870740|11576714|FG003|Overall Study|Investigator Decision|0
7339590|NCT00870740|11576715|FG004|Overall Study|Investigator Decision|0
7339591|NCT00870740|11576716|FG005|Overall Study|Investigator Decision|0
7339592|NCT00870740|11576711|FG000|Overall Study|Subject Non-compliance|0
7339593|NCT00870740|11576712|FG001|Overall Study|Subject Non-compliance|0
7339594|NCT00870740|11576713|FG002|Overall Study|Subject Non-compliance|0
7339595|NCT00870740|11576714|FG003|Overall Study|Subject Non-compliance|0
7339596|NCT00870740|11576715|FG004|Overall Study|Subject Non-compliance|0
7339597|NCT00870740|11576716|FG005|Overall Study|Subject Non-compliance|1
7339598|NCT00870740|11576711|FG000|Overall Study|Death|0
7339599|NCT00870740|11576712|FG001|Overall Study|Death|0
7339600|NCT00870740|11576713|FG002|Overall Study|Death|0
7339601|NCT00870740|11576714|FG003|Overall Study|Death|0
7339602|NCT00870740|11576715|FG004|Overall Study|Death|1
7339603|NCT00870740|11576716|FG005|Overall Study|Death|0
7339604|NCT00870740|11576711|FG000|Overall Study|Other|2
7339605|NCT00870740|11576712|FG001|Overall Study|Other|5
7339606|NCT00870740|11576713|FG002|Overall Study|Other|2
7339607|NCT00870740|11576714|FG003|Overall Study|Other|4
7339608|NCT00870740|11576715|FG004|Overall Study|Other|3
7339609|NCT00870740|11576716|FG005|Overall Study|Other|5
7339610|NCT00870870|11576745|FG000|Overall Study|Withdrawal by Subject|0
7339611|NCT00870870|11576746|FG001|Overall Study|Withdrawal by Subject|1
7339612|NCT00870870|11576747|FG002|Overall Study|Withdrawal by Subject|1
7339613|NCT00870870|11576748|FG003|Overall Study|Withdrawal by Subject|3
7339614|NCT00870870|11576745|FG000|Overall Study|Adverse Event|0
7339615|NCT00870870|11576746|FG001|Overall Study|Adverse Event|0
7339616|NCT00870870|11576747|FG002|Overall Study|Adverse Event|2
7339617|NCT00870870|11576748|FG003|Overall Study|Adverse Event|2
7339618|NCT00871000|11576771|FG000|Overall Study|Withdrawal by Subject|1
7339619|NCT00871000|11576772|FG001|Overall Study|Withdrawal by Subject|0
7339620|NCT00871117|11576780|FG000|Overall Study|Lost to Follow-up|5
7339621|NCT00871117|11576781|FG001|Overall Study|Lost to Follow-up|6
7339622|NCT00871117|11576780|FG000|Overall Study|Other|0
7339623|NCT00871117|11576781|FG001|Overall Study|Other|4
7339624|NCT00871169|11576797|FG000|Overall Study|Protocol Violation|1
7339625|NCT00871169|11576797|FG000|Overall Study|Patient did not receive study treatment|2
7339626|NCT00871234|11576801|FG000|Overall Study|Adverse Event|2
7339627|NCT00871234|11576801|FG000|Overall Study|Lost to Follow-up|3
7339628|NCT00871338|11576820|FG000|Prior to Booster|Withdrawal by Subject|1
7339629|NCT00871338|11576821|FG001|Prior to Booster|Withdrawal by Subject|3
7339630|NCT00871338|11576820|FG000|Prior to Booster|Lost to Follow-up|1
7339631|NCT00871338|11576821|FG001|Prior to Booster|Lost to Follow-up|0
7339632|NCT00871377|11576827|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
7339633|NCT00871377|11576828|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
7339634|NCT00871377|11576829|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
7339635|NCT00871377|11576830|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
7339636|NCT00871377|11576831|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
7339637|NCT00871377|11576832|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
7339638|NCT00871377|11576827|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
7339639|NCT00871377|11576828|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
7339640|NCT00871377|11576829|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
7339641|NCT00871377|11576830|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
7339642|NCT00871377|11576831|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
7339643|NCT00871377|11576832|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
7339644|NCT00871377|11576827|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
7339645|NCT00871377|11576828|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7339646|NCT00871377|11576829|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
7339647|NCT00871377|11576830|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
7339648|NCT00871377|11576831|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
7339649|NCT00871377|11576832|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
7339650|NCT00871377|11576827|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
7339651|NCT00871377|11576828|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7339652|NCT00871377|11576829|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
7339653|NCT00871377|11576830|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
7339654|NCT00871377|11576831|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
7339655|NCT00871377|11576832|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
7339656|NCT00871377|11576827|FG000|Third Intervention (10 Weeks)|Death|0
7339657|NCT00871377|11576828|FG001|Third Intervention (10 Weeks)|Death|0
7339658|NCT00871377|11576829|FG002|Third Intervention (10 Weeks)|Death|0
7339659|NCT00871377|11576830|FG003|Third Intervention (10 Weeks)|Death|1
7339660|NCT00871377|11576831|FG004|Third Intervention (10 Weeks)|Death|0
7339661|NCT00871377|11576832|FG005|Third Intervention (10 Weeks)|Death|0
7339662|NCT00871403|11576843|FG000|Combination Treatment Phase|Randomized but Not Treated|1
7339663|NCT00871403|11576844|FG001|Combination Treatment Phase|Randomized but Not Treated|1
7339664|NCT00871403|11576845|FG002|Combination Treatment Phase|Randomized but Not Treated|1
7339665|NCT00871403|11576843|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
7339666|NCT00871403|11576844|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
7339667|NCT00871403|11576845|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
7339668|NCT00871403|11576843|FG000|Combination Treatment Phase|Adverse Event|0
7339669|NCT00871403|11576844|FG001|Combination Treatment Phase|Adverse Event|17
7339670|NCT00871403|11576845|FG002|Combination Treatment Phase|Adverse Event|2
7339671|NCT00871403|11576843|FG000|Combination Treatment Phase|Disease Progression|0
7339672|NCT00871403|11576844|FG001|Combination Treatment Phase|Disease Progression|8
7339673|NCT00871403|11576845|FG002|Combination Treatment Phase|Disease Progression|5
7339674|NCT00871403|11576843|FG000|Combination Treatment Phase|Withdrawal by Subject|0
7339675|NCT00871403|11576844|FG001|Combination Treatment Phase|Withdrawal by Subject|3
7339676|NCT00871403|11576845|FG002|Combination Treatment Phase|Withdrawal by Subject|1
7339677|NCT00871403|11576843|FG000|Combination Treatment Phase|Physician Decision|0
7339678|NCT00871403|11576844|FG001|Combination Treatment Phase|Physician Decision|1
7339679|NCT00871403|11576845|FG002|Combination Treatment Phase|Physician Decision|3
7339680|NCT00871403|11576843|FG000|Monotherapy Treatment Phase|Disease Progression|0
7339681|NCT00871403|11576844|FG001|Monotherapy Treatment Phase|Disease Progression|9
7339682|NCT00871403|11576845|FG002|Monotherapy Treatment Phase|Disease Progression|1
7339683|NCT00871403|11576843|FG000|Monotherapy Treatment Phase|Adverse Event|0
7339684|NCT00871403|11576844|FG001|Monotherapy Treatment Phase|Adverse Event|4
7339685|NCT00871403|11576845|FG002|Monotherapy Treatment Phase|Adverse Event|0
7339686|NCT00871429|11576852|FG000|Overall Study|Lost to Follow-up|6
7339687|NCT00871429|11576852|FG000|Overall Study|Withdrawal by Subject|17
7339688|NCT00871429|11576852|FG000|Overall Study|Questionnaire not completed|1
7339689|NCT00871494|11576860|FG000|Overall Study|Protocol Violation|5
7339690|NCT00871494|11576860|FG000|Overall Study|Lack of Efficacy|4
7339691|NCT00871494|11576860|FG000|Overall Study|Adverse Event|4
7339692|NCT00871494|11576860|FG000|Overall Study|Lost to Follow-up|1
7339693|NCT00871572|11576868|FG000|Overall Study|Adverse Event|0
7339694|NCT00871572|11576869|FG001|Overall Study|Adverse Event|2
7339695|NCT00871572|11576870|FG002|Overall Study|Adverse Event|0
7339696|NCT00871572|11576871|FG003|Overall Study|Adverse Event|3
7339697|NCT00871572|11576868|FG000|Overall Study|Investigator Decision|0
7339698|NCT00871572|11576869|FG001|Overall Study|Investigator Decision|1
7339699|NCT00871572|11576870|FG002|Overall Study|Investigator Decision|0
7339700|NCT00871572|11576871|FG003|Overall Study|Investigator Decision|1
7339701|NCT00871572|11576868|FG000|Overall Study|Lost to Follow-up|0
7339702|NCT00871572|11576869|FG001|Overall Study|Lost to Follow-up|1
7339703|NCT00871572|11576870|FG002|Overall Study|Lost to Follow-up|0
7339704|NCT00871572|11576871|FG003|Overall Study|Lost to Follow-up|1
7339705|NCT00871572|11576868|FG000|Overall Study|Protocol Violation|0
7339706|NCT00871572|11576869|FG001|Overall Study|Protocol Violation|0
7339707|NCT00871572|11576870|FG002|Overall Study|Protocol Violation|1
7339708|NCT00871572|11576871|FG003|Overall Study|Protocol Violation|1
7339709|NCT00871572|11576868|FG000|Overall Study|Sponsor Decision|1
7339710|NCT00871572|11576869|FG001|Overall Study|Sponsor Decision|0
7339711|NCT00871572|11576870|FG002|Overall Study|Sponsor Decision|0
7339712|NCT00871572|11576871|FG003|Overall Study|Sponsor Decision|0
7339713|NCT00871572|11576868|FG000|Overall Study|Withdrawal by Subject|1
7339714|NCT00871572|11576869|FG001|Overall Study|Withdrawal by Subject|2
7339715|NCT00871572|11576870|FG002|Overall Study|Withdrawal by Subject|3
7339716|NCT00871572|11576871|FG003|Overall Study|Withdrawal by Subject|1
7385629|NCT01202877|11643476|FG000|Overall Study|Withdrawal by Subject|0
7385630|NCT01202877|11643477|FG001|Overall Study|Withdrawal by Subject|0
7385631|NCT01202877|11643478|FG002|Overall Study|Withdrawal by Subject|1
7385632|NCT01202877|11643476|FG000|Overall Study|Death|0
7385633|NCT01202877|11643477|FG001|Overall Study|Death|0
7385634|NCT01202877|11643478|FG002|Overall Study|Death|1
7385635|NCT01202903|11643488|FG000|Overall Study|Administrative Probelms|1
7385636|NCT01202903|11643489|FG001|Overall Study|Administrative Probelms|4
7385637|NCT01202903|11643488|FG000|Overall Study|Protocol Violation|0
7385638|NCT01202903|11643489|FG001|Overall Study|Protocol Violation|1
7385639|NCT01202903|11643488|FG000|Overall Study|Death|1
7385640|NCT01202903|11643489|FG001|Overall Study|Death|0
7385641|NCT01202903|11643488|FG000|Overall Study|Lost to Follow-up|1
7458300|NCT01807221|11752350|FG004|Overall Study|Sponsor decision|0
7385642|NCT01202903|11643489|FG001|Overall Study|Lost to Follow-up|1
7385643|NCT01202903|11643488|FG000|Overall Study|Lack of Efficacy|1
7385644|NCT01202903|11643489|FG001|Overall Study|Lack of Efficacy|3
7385645|NCT01202903|11643488|FG000|Overall Study|Adverse Event|3
7385646|NCT01202903|11643489|FG001|Overall Study|Adverse Event|3
7385647|NCT01202903|11643488|FG000|Overall Study|Withdrawal by Subject|4
7385648|NCT01202903|11643489|FG001|Overall Study|Withdrawal by Subject|4
7339717|NCT00871715|11576899|FG000|Overall Study|Withdrawal by Subject|6
7339718|NCT00871715|11576900|FG001|Overall Study|Withdrawal by Subject|10
7339719|NCT00871715|11576901|FG002|Overall Study|Withdrawal by Subject|15
7339720|NCT00871715|11576899|FG000|Overall Study|Physician Decision|6
7339721|NCT00871715|11576900|FG001|Overall Study|Physician Decision|0
7339722|NCT00871715|11576901|FG002|Overall Study|Physician Decision|2
7568831|NCT03426995|11944379|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
7568832|NCT03426995|11944361|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7339723|NCT00871715|11576899|FG000|Overall Study|Lost to Follow-up|3
7339724|NCT00871715|11576900|FG001|Overall Study|Lost to Follow-up|6
7339725|NCT00871715|11576901|FG002|Overall Study|Lost to Follow-up|9
7339726|NCT00871728|11576910|FG000|Overall Study|Adverse Event|1
7339727|NCT00871728|11576910|FG000|Overall Study|Protocol Violation|7
7339728|NCT00871728|11576910|FG000|Overall Study|Lost to Follow-up|2
7339729|NCT00871728|11576910|FG000|Overall Study|Failed to Visit Hospital|4
7339730|NCT00871728|11576910|FG000|Overall Study|Participant Non-compliance|1
7339731|NCT00871728|11576910|FG000|Overall Study|Withdrawal of Informed Consent|5
7339732|NCT00871741|11576916|FG000|Overall Study|Premature study termination|9
7339733|NCT00871741|11576917|FG001|Overall Study|Premature study termination|7
7339734|NCT00871780|11576923|FG000|Overall Study|Enrolled But Not Treated|6
7339735|NCT00871780|11576923|FG000|Overall Study|Withdrawal by Subject|9
7339736|NCT00871780|11576923|FG000|Overall Study|Adverse Event|6
7339737|NCT00871780|11576923|FG000|Overall Study|Voluntary Discontinuation|4
7339738|NCT00871780|11576923|FG000|Overall Study|Death|1
7339739|NCT00871780|11576923|FG000|Overall Study|Physician Decision|1
7339740|NCT00871858|11576949|FG000|Overall Study|Protocol Violation|3
7339741|NCT00871858|11576950|FG001|Overall Study|Protocol Violation|4
7339742|NCT00871858|11576949|FG000|Overall Study|Adverse Event|1
7339743|NCT00871858|11576950|FG001|Overall Study|Adverse Event|1
7339744|NCT00871858|11576949|FG000|Overall Study|Withdrawal by Subject|1
7339745|NCT00871858|11576950|FG001|Overall Study|Withdrawal by Subject|1
7339746|NCT00871858|11576949|FG000|Overall Study|Lost to Follow-up|0
7339747|NCT00871858|11576950|FG001|Overall Study|Lost to Follow-up|1
7339748|NCT00871871|11576958|FG000|Part I|Adverse Event|0
7339749|NCT00871871|11576959|FG001|Part I|Adverse Event|2
7339750|NCT00871871|11576960|FG002|Part I|Adverse Event|0
7339751|NCT00871871|11576961|FG003|Part I|Adverse Event|0
7339752|NCT00871871|11576958|FG000|Part I|Withdrawal by Subject|3
7339753|NCT00871871|11576959|FG001|Part I|Withdrawal by Subject|0
7339754|NCT00871871|11576960|FG002|Part I|Withdrawal by Subject|0
7339755|NCT00871871|11576961|FG003|Part I|Withdrawal by Subject|0
7339756|NCT00871871|11576958|FG000|Part I|Laboratory abnormality|0
7339757|NCT00871871|11576959|FG001|Part I|Laboratory abnormality|1
7339758|NCT00871871|11576960|FG002|Part I|Laboratory abnormality|0
7339759|NCT00871871|11576961|FG003|Part I|Laboratory abnormality|0
7339760|NCT00871871|11576958|FG000|Part II|Lack of Efficacy|0
7339761|NCT00871871|11576959|FG001|Part II|Lack of Efficacy|0
7339762|NCT00871871|11576960|FG002|Part II|Lack of Efficacy|1
7339763|NCT00871871|11576961|FG003|Part II|Lack of Efficacy|0
7339764|NCT00871871|11576958|FG000|Part II|Withdrawal by Subject|0
7339765|NCT00871871|11576959|FG001|Part II|Withdrawal by Subject|0
7339766|NCT00871871|11576960|FG002|Part II|Withdrawal by Subject|2
7339767|NCT00871871|11576961|FG003|Part II|Withdrawal by Subject|1
7339768|NCT00871871|11576958|FG000|Part II|Adverse Event|0
7339769|NCT00871871|11576959|FG001|Part II|Adverse Event|0
7339770|NCT00871871|11576960|FG002|Part II|Adverse Event|1
7339771|NCT00871871|11576961|FG003|Part II|Adverse Event|2
7339772|NCT00871871|11576958|FG000|Part II|Protocol Violation|0
7339773|NCT00871871|11576959|FG001|Part II|Protocol Violation|0
7339774|NCT00871871|11576960|FG002|Part II|Protocol Violation|0
7339775|NCT00871871|11576961|FG003|Part II|Protocol Violation|1
7339776|NCT00871923|11576971|FG000|Overall Study|Death|1
7339777|NCT00871923|11576971|FG000|Overall Study|Withdrawal by Subject|1
7339778|NCT00871975|11576975|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
7339779|NCT00871975|11576975|FG000|Overall Study|Catheters could not be inserted|1
7339780|NCT00871975|11576975|FG000|Overall Study|Patient unable to void/insufficient vol|13
7339781|NCT00871975|11576975|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
7339782|NCT00872001|11576981|FG000|Overall Study|Adverse Event|34
7458301|NCT01807221|11752351|FG005|Overall Study|Sponsor decision|0
7339783|NCT00872001|11576982|FG001|Overall Study|Adverse Event|23
7339784|NCT00872001|11576981|FG000|Overall Study|Protocol Defined Clinical Event|5
7458302|NCT01807221|11752346|FG000|Overall Study|Lost to Follow-up|1
7339785|NCT00872001|11576982|FG001|Overall Study|Protocol Defined Clinical Event|7
7339786|NCT00872001|11576981|FG000|Overall Study|Lost to Follow-up|13
7339787|NCT00872001|11576982|FG001|Overall Study|Lost to Follow-up|12
7458303|NCT01807221|11752347|FG001|Overall Study|Lost to Follow-up|0
7339788|NCT00872001|11576981|FG000|Overall Study|Withdrawal by Subject|18
7339789|NCT00872001|11576982|FG001|Overall Study|Withdrawal by Subject|30
7339790|NCT00872001|11576981|FG000|Overall Study|Protocol Violation|5
7339791|NCT00872001|11576982|FG001|Overall Study|Protocol Violation|8
7339792|NCT00872001|11576981|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
7339793|NCT00872001|11576982|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
7339794|NCT00872001|11576981|FG000|Overall Study|Administrative|23
7339795|NCT00872001|11576982|FG001|Overall Study|Administrative|15
7339796|NCT00872170|11577005|FG000|Overall Study|Adverse Event|1
7339797|NCT00872170|11577006|FG001|Overall Study|Adverse Event|0
7339798|NCT00872521|11577027|FG000|Completed PAD Induction|Patient choice|0
7339799|NCT00872521|11577028|FG001|Completed PAD Induction|Patient choice|1
7339800|NCT00872521|11577029|FG002|Completed PAD Induction|Patient choice|0
7339801|NCT00872521|11577027|FG000|Completed PAD Induction|Disease progression|0
7339802|NCT00872521|11577028|FG001|Completed PAD Induction|Disease progression|2
7339803|NCT00872521|11577029|FG002|Completed PAD Induction|Disease progression|0
7339804|NCT00872521|11577027|FG000|Completed PAD Induction|Adverse Event|4
7339805|NCT00872521|11577028|FG001|Completed PAD Induction|Adverse Event|0
7339806|NCT00872521|11577029|FG002|Completed PAD Induction|Adverse Event|0
7339807|NCT00872521|11577027|FG000|Completed PAD Induction|Death|1
7339808|NCT00872521|11577028|FG001|Completed PAD Induction|Death|1
7339809|NCT00872521|11577029|FG002|Completed PAD Induction|Death|0
7339810|NCT00872521|11577027|FG000|Primary Endpoint Analysis|Other|1
7339811|NCT00872521|11577028|FG001|Primary Endpoint Analysis|Other|2
7339812|NCT00872521|11577029|FG002|Primary Endpoint Analysis|Other|0
7339813|NCT00872521|11577027|FG000|Primary Endpoint Analysis|Patient choice|0
7339814|NCT00872521|11577028|FG001|Primary Endpoint Analysis|Patient choice|1
7339815|NCT00872521|11577029|FG002|Primary Endpoint Analysis|Patient choice|0
7339816|NCT00872521|11577027|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
7339817|NCT00872521|11577028|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
7339818|NCT00872521|11577029|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
7339819|NCT00872521|11577027|FG000|Primary Endpoint Analysis|Patient response missing|0
7339820|NCT00872521|11577028|FG001|Primary Endpoint Analysis|Patient response missing|0
7339821|NCT00872521|11577029|FG002|Primary Endpoint Analysis|Patient response missing|1
7339822|NCT00872521|11577027|FG000|Completed 3-month Follow up|Other|0
7339823|NCT00872521|11577028|FG001|Completed 3-month Follow up|Other|2
7339824|NCT00872521|11577029|FG002|Completed 3-month Follow up|Other|0
7339825|NCT00872521|11577027|FG000|Completed 3-month Follow up|Physician Decision|0
7339826|NCT00872521|11577028|FG001|Completed 3-month Follow up|Physician Decision|1
7339827|NCT00872521|11577029|FG002|Completed 3-month Follow up|Physician Decision|0
7339828|NCT00872521|11577027|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
7339829|NCT00872521|11577028|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
7339830|NCT00872521|11577029|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
7339831|NCT00872599|11577057|FG000|Second Washout Period|Adverse Event|1
7339832|NCT00872599|11577058|FG001|Second Washout Period|Adverse Event|1
7339833|NCT00872898|11577103|FG000|Part Two - Double Blind|Adverse Event|4
7339834|NCT00872898|11577104|FG001|Part Two - Double Blind|Adverse Event|3
7339835|NCT00872898|11577103|FG000|Part Two - Double Blind|Lack of Efficacy|1
7339836|NCT00872898|11577104|FG001|Part Two - Double Blind|Lack of Efficacy|0
7339837|NCT00872898|11577103|FG000|Part Two - Double Blind|Protocol Violation|1
7339838|NCT00872898|11577104|FG001|Part Two - Double Blind|Protocol Violation|0
7339839|NCT00872898|11577103|FG000|Part Two - Double Blind|Withdrawal by Subject|3
7339840|NCT00872898|11577104|FG001|Part Two - Double Blind|Withdrawal by Subject|1
7339841|NCT00872898|11577103|FG000|Part Two - Double Blind|Lost to Follow-up|0
7339842|NCT00872898|11577104|FG001|Part Two - Double Blind|Lost to Follow-up|2
7339843|NCT00872898|11577103|FG000|Part Two - Double Blind|Other reasons|2
7339844|NCT00872898|11577104|FG001|Part Two - Double Blind|Other reasons|0
7339845|NCT00872989|11577115|FG000|Overall Study|Adverse Event|7
7339846|NCT00872989|11577116|FG001|Overall Study|Adverse Event|15
7339847|NCT00872989|11577115|FG000|Overall Study|Withdrawal by Subject|8
7339848|NCT00872989|11577116|FG001|Overall Study|Withdrawal by Subject|5
7339849|NCT00872989|11577115|FG000|Overall Study|Progression/relapse|47
7339850|NCT00872989|11577116|FG001|Overall Study|Progression/relapse|35
7339851|NCT00872989|11577115|FG000|Overall Study|Not protocol specified|3
7339852|NCT00872989|11577116|FG001|Overall Study|Not protocol specified|8
7339853|NCT00873015|11577132|FG000|Overall Study|Withdrawal by Subject|0
7339854|NCT00873015|11577133|FG001|Overall Study|Withdrawal by Subject|1
7339855|NCT00873015|11577134|FG002|Overall Study|Withdrawal by Subject|0
7339856|NCT00873015|11577135|FG003|Overall Study|Withdrawal by Subject|0
7339857|NCT00873041|11577147|FG000|Core Study|Adverse Event|2
7339858|NCT00873041|11577148|FG001|Core Study|Adverse Event|3
7339859|NCT00873041|11577149|FG002|Core Study|Adverse Event|1
7339860|NCT00873041|11577147|FG000|Core Study|Withdrawal by Subject|1
7339861|NCT00873041|11577148|FG001|Core Study|Withdrawal by Subject|2
7339862|NCT00873041|11577149|FG002|Core Study|Withdrawal by Subject|2
7339863|NCT00873041|11577147|FG000|Core Study|Lost to Follow-up|3
7339864|NCT00873041|11577148|FG001|Core Study|Lost to Follow-up|1
7339865|NCT00873041|11577149|FG002|Core Study|Lost to Follow-up|0
7339866|NCT00873041|11577147|FG000|Core Study|Abnormal laboratory value|0
7339867|NCT00873041|11577148|FG001|Core Study|Abnormal laboratory value|0
7339868|NCT00873041|11577149|FG002|Core Study|Abnormal laboratory value|1
7339869|NCT00873041|11577147|FG000|Core Study|Protocol deviation|1
7458304|NCT01807221|11752348|FG002|Overall Study|Lost to Follow-up|2
7339870|NCT00873041|11577148|FG001|Core Study|Protocol deviation|0
7339871|NCT00873041|11577149|FG002|Core Study|Protocol deviation|1
7339872|NCT00873041|11577147|FG000|Extension Study|Adverse Event|1
7339873|NCT00873041|11577148|FG001|Extension Study|Adverse Event|0
7339874|NCT00873041|11577149|FG002|Extension Study|Adverse Event|1
7339875|NCT00873041|11577147|FG000|Extension Study|Administrative reasons|0
7339876|NCT00873041|11577148|FG001|Extension Study|Administrative reasons|0
7339877|NCT00873041|11577149|FG002|Extension Study|Administrative reasons|1
7339878|NCT00873093|11577169|FG000|Overall Study|Adverse Event|0
7339879|NCT00873093|11577170|FG001|Overall Study|Adverse Event|2
7339880|NCT00873093|11577171|FG002|Overall Study|Adverse Event|0
7339881|NCT00873093|11577172|FG003|Overall Study|Adverse Event|0
7339882|NCT00873093|11577173|FG004|Overall Study|Adverse Event|0
7339883|NCT00873093|11577169|FG000|Overall Study|Death|0
7339884|NCT00873093|11577170|FG001|Overall Study|Death|3
7339885|NCT00873093|11577171|FG002|Overall Study|Death|2
7339886|NCT00873093|11577172|FG003|Overall Study|Death|0
7339887|NCT00873093|11577173|FG004|Overall Study|Death|0
7339888|NCT00873093|11577169|FG000|Overall Study|Physician Decision|0
7339889|NCT00873093|11577170|FG001|Overall Study|Physician Decision|17
7339890|NCT00873093|11577171|FG002|Overall Study|Physician Decision|10
7339891|NCT00873093|11577172|FG003|Overall Study|Physician Decision|10
7339892|NCT00873093|11577173|FG004|Overall Study|Physician Decision|2
7339893|NCT00873093|11577169|FG000|Overall Study|Withdrawal by Subject|1
7339894|NCT00873093|11577170|FG001|Overall Study|Withdrawal by Subject|4
7339895|NCT00873093|11577171|FG002|Overall Study|Withdrawal by Subject|4
7339896|NCT00873093|11577172|FG003|Overall Study|Withdrawal by Subject|0
7339897|NCT00873093|11577173|FG004|Overall Study|Withdrawal by Subject|0
7339898|NCT00873093|11577169|FG000|Overall Study|Ineligible|0
7339899|NCT00873093|11577170|FG001|Overall Study|Ineligible|1
7339900|NCT00873093|11577171|FG002|Overall Study|Ineligible|0
7339901|NCT00873093|11577172|FG003|Overall Study|Ineligible|1
7339902|NCT00873093|11577173|FG004|Overall Study|Ineligible|0
7339903|NCT00873119|11577197|FG000|Overall Study|Patient request|4
7339904|NCT00873119|11577198|FG001|Overall Study|Patient request|2
7339905|NCT00873119|11577197|FG000|Overall Study|Adverse Event|8
7339906|NCT00873119|11577198|FG001|Overall Study|Adverse Event|0
7339907|NCT00873119|11577197|FG000|Overall Study|Progressive disease|26
7339908|NCT00873119|11577198|FG001|Overall Study|Progressive disease|18
7339909|NCT00873119|11577197|FG000|Overall Study|Death|2
7339910|NCT00873119|11577198|FG001|Overall Study|Death|1
7339911|NCT00873119|11577197|FG000|Overall Study|Other|2
7339912|NCT00873119|11577198|FG001|Overall Study|Other|5
7339913|NCT00873119|11577197|FG000|Overall Study|Not treated|2
7339914|NCT00873119|11577198|FG001|Overall Study|Not treated|0
7339915|NCT00873730|11577214|FG000|Overall Study|Protocol Deviation|5
7339916|NCT00873730|11577215|FG001|Overall Study|Protocol Deviation|2
7339917|NCT00873730|11577214|FG000|Overall Study|Adverse Event|0
7339918|NCT00873730|11577215|FG001|Overall Study|Adverse Event|2
7339919|NCT00873730|11577214|FG000|Overall Study|Withdrawal by Subject|0
7339920|NCT00873730|11577215|FG001|Overall Study|Withdrawal by Subject|1
7339921|NCT00873730|11577214|FG000|Overall Study|Sponsor decision|1
7339922|NCT00873730|11577215|FG001|Overall Study|Sponsor decision|0
7339923|NCT00873860|11577238|FG000|Overall Study|Lost to Follow-up|1
7339924|NCT00873860|11577239|FG001|Overall Study|Lost to Follow-up|0
7339925|NCT00873860|11577240|FG002|Overall Study|Lost to Follow-up|0
7339926|NCT00873860|11577241|FG003|Overall Study|Lost to Follow-up|1
7339927|NCT00873860|11577238|FG000|Overall Study|Withdrawal by Subject|1
7339928|NCT00873860|11577239|FG001|Overall Study|Withdrawal by Subject|0
7339929|NCT00873860|11577240|FG002|Overall Study|Withdrawal by Subject|2
7339930|NCT00873860|11577241|FG003|Overall Study|Withdrawal by Subject|0
7339931|NCT00873860|11577238|FG000|Overall Study|Death|1
7339932|NCT00873860|11577239|FG001|Overall Study|Death|0
7339933|NCT00873860|11577240|FG002|Overall Study|Death|0
7339934|NCT00873860|11577241|FG003|Overall Study|Death|0
7339935|NCT00873860|11577238|FG000|Overall Study|Other|1
7339936|NCT00873860|11577239|FG001|Overall Study|Other|0
7339937|NCT00873860|11577240|FG002|Overall Study|Other|1
7339938|NCT00873860|11577241|FG003|Overall Study|Other|0
7339939|NCT00873912|11577273|FG000|Overall Study|Withdrawal by Subject|1
7339940|NCT00873912|11577274|FG001|Overall Study|Withdrawal by Subject|0
7339941|NCT00873912|11577273|FG000|Overall Study|Lost to Follow-up|2
7339942|NCT00873912|11577274|FG001|Overall Study|Lost to Follow-up|0
7339943|NCT00874029|11577280|FG000|Overall Study|Withdrawal by Subject|10
7339944|NCT00874029|11577280|FG000|Overall Study|Pregnancy|4
7339945|NCT00874029|11577280|FG000|Overall Study|Physician Decision|1
7339946|NCT00874029|11577280|FG000|Overall Study|Adverse Event|1
7339947|NCT00874029|11577280|FG000|Overall Study|Lost to Follow-up|5
7339948|NCT00874120|11577300|FG000|First Intervention|Adverse Event|0
7339949|NCT00874120|11577301|FG001|First Intervention|Adverse Event|1
7339950|NCT00874120|11577300|FG000|First Intervention|Withdrawal by Subject|2
7339951|NCT00874120|11577301|FG001|First Intervention|Withdrawal by Subject|0
7339952|NCT00874120|11577300|FG000|First Intervention|Lost to Follow-up|0
7339953|NCT00874120|11577301|FG001|First Intervention|Lost to Follow-up|1
7339954|NCT00874120|11577300|FG000|First Intervention|Protocol Violation|3
7339955|NCT00874120|11577301|FG001|First Intervention|Protocol Violation|0
7458305|NCT01807221|11752349|FG003|Overall Study|Lost to Follow-up|1
7339956|NCT00874120|11577300|FG000|First Intervention|positive drug test|1
7339957|NCT00874120|11577301|FG001|First Intervention|positive drug test|0
7339958|NCT00874120|11577300|FG000|Second Intervention|Withdrawal by Subject|1
7339959|NCT00874120|11577301|FG001|Second Intervention|Withdrawal by Subject|0
7339960|NCT00874120|11577300|FG000|Second Intervention|Protocol Violation|1
7339961|NCT00874120|11577301|FG001|Second Intervention|Protocol Violation|0
7339962|NCT00874237|11577307|FG000|Overall Study|Physician Decision|0
7339963|NCT00874237|11577308|FG001|Overall Study|Physician Decision|1
7339964|NCT00874237|11577309|FG002|Overall Study|Physician Decision|0
7339965|NCT00874237|11577310|FG003|Overall Study|Physician Decision|0
7339966|NCT00874237|11577311|FG004|Overall Study|Physician Decision|0
7339967|NCT00874237|11577312|FG005|Overall Study|Physician Decision|0
7339968|NCT00874237|11577307|FG000|Overall Study|Withdrawal by Subject|0
7339969|NCT00874237|11577308|FG001|Overall Study|Withdrawal by Subject|0
7339970|NCT00874237|11577309|FG002|Overall Study|Withdrawal by Subject|1
7339971|NCT00874237|11577310|FG003|Overall Study|Withdrawal by Subject|0
7568833|NCT03426995|11944362|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568834|NCT03426995|11944363|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568835|NCT03426995|11944364|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568836|NCT03426995|11944365|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568837|NCT03426995|11944366|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568838|NCT03426995|11944367|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568839|NCT03426995|11944368|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568840|NCT03426995|11944369|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568841|NCT03426995|11944370|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568842|NCT03426995|11944371|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
7568843|NCT03426995|11944372|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568844|NCT03426995|11944373|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568845|NCT03426995|11944374|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568846|NCT03426995|11944375|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7575276|NCT03720652|11958934|FG000|Overall Study|Lost to Follow-up|0
7339972|NCT00874237|11577311|FG004|Overall Study|Withdrawal by Subject|0
7339973|NCT00874237|11577312|FG005|Overall Study|Withdrawal by Subject|0
7339974|NCT00874276|11577329|FG000|Overall Study|Withdrawal by Subject|1
7339975|NCT00874276|11577330|FG001|Overall Study|Withdrawal by Subject|1
7339976|NCT00874432|11577342|FG000|Overall Study|Withdrawal by Subject|1
7339977|NCT00874432|11577343|FG001|Overall Study|Withdrawal by Subject|0
7339978|NCT00874432|11577344|FG002|Overall Study|Withdrawal by Subject|0
7339979|NCT00874432|11577345|FG003|Overall Study|Withdrawal by Subject|0
7339980|NCT00874432|11577342|FG000|Overall Study|Physician Decision|1
7339981|NCT00874432|11577343|FG001|Overall Study|Physician Decision|0
7339982|NCT00874432|11577344|FG002|Overall Study|Physician Decision|0
7339983|NCT00874432|11577345|FG003|Overall Study|Physician Decision|0
7339984|NCT00874432|11577342|FG000|Overall Study|Other|1
7339985|NCT00874432|11577343|FG001|Overall Study|Other|2
7339986|NCT00874432|11577344|FG002|Overall Study|Other|8
7339987|NCT00874432|11577345|FG003|Overall Study|Other|3
7339988|NCT00874497|11577359|FG000|Overall Study|Lost to Follow-up|2
7339989|NCT00874497|11577360|FG001|Overall Study|Lost to Follow-up|4
7339990|NCT00874497|11577359|FG000|Overall Study|Adverse Event|9
7339991|NCT00874497|11577360|FG001|Overall Study|Adverse Event|4
7339992|NCT00874497|11577359|FG000|Overall Study|Sponsor Discontinued Trial|7
7339993|NCT00874497|11577360|FG001|Overall Study|Sponsor Discontinued Trial|3
7339994|NCT00874497|11577359|FG000|Overall Study|Met Withdrawal Criteria|4
7339995|NCT00874497|11577360|FG001|Overall Study|Met Withdrawal Criteria|2
7339996|NCT00874497|11577359|FG000|Overall Study|Physician Decision|1
7339997|NCT00874497|11577360|FG001|Overall Study|Physician Decision|1
7339998|NCT00874497|11577359|FG000|Overall Study|Withdrawal by Subject|5
7339999|NCT00874497|11577360|FG001|Overall Study|Withdrawal by Subject|4
7340000|NCT00874549|11577379|FG000|Overall Study|Adverse Event|0
7340001|NCT00874549|11577380|FG001|Overall Study|Adverse Event|0
7340002|NCT00874549|11577381|FG002|Overall Study|Adverse Event|1
7340003|NCT00874549|11577382|FG003|Overall Study|Adverse Event|0
7340004|NCT00874549|11577379|FG000|Overall Study|Protocol Violation|1
7340005|NCT00874549|11577380|FG001|Overall Study|Protocol Violation|0
7340006|NCT00874549|11577381|FG002|Overall Study|Protocol Violation|2
7340007|NCT00874549|11577382|FG003|Overall Study|Protocol Violation|1
7340008|NCT00874549|11577379|FG000|Overall Study|Lost to Follow-up|0
7340009|NCT00874549|11577380|FG001|Overall Study|Lost to Follow-up|0
7340010|NCT00874549|11577381|FG002|Overall Study|Lost to Follow-up|1
7340011|NCT00874549|11577382|FG003|Overall Study|Lost to Follow-up|0
7340012|NCT00874549|11577379|FG000|Overall Study|Withdrawal by Subject|0
7340013|NCT00874549|11577380|FG001|Overall Study|Withdrawal by Subject|1
7340014|NCT00874549|11577381|FG002|Overall Study|Withdrawal by Subject|0
7340015|NCT00874549|11577382|FG003|Overall Study|Withdrawal by Subject|1
7340016|NCT00874731|11577398|FG000|Part 1, Day 1: Placebo|Disease Progression|1
7340017|NCT00874731|11577399|FG001|Part 1, Day 1: Placebo|Disease Progression|0
7340018|NCT00874731|11577400|FG002|Part 1, Day 1: Placebo|Disease Progression|0
7340019|NCT00874731|11577398|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7340020|NCT00874731|11577399|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
7340021|NCT00874731|11577400|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
7340022|NCT00874731|11577398|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7340023|NCT00874731|11577399|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
7340104|NCT00875017|11577465|FG002|Washout|Withdrawal by Subject|0
7340024|NCT00874731|11577400|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
7340025|NCT00874770|11577412|FG000|Overall Study|Lack of Efficacy|2
7340026|NCT00874770|11577413|FG001|Overall Study|Lack of Efficacy|0
7340027|NCT00874770|11577414|FG002|Overall Study|Lack of Efficacy|0
7340028|NCT00874770|11577415|FG003|Overall Study|Lack of Efficacy|2
7340029|NCT00874770|11577412|FG000|Overall Study|Adverse Event|1
7340030|NCT00874770|11577413|FG001|Overall Study|Adverse Event|1
7340031|NCT00874770|11577414|FG002|Overall Study|Adverse Event|4
7340032|NCT00874770|11577415|FG003|Overall Study|Adverse Event|2
7340033|NCT00874770|11577412|FG000|Overall Study|Lost to Follow-up|1
7340034|NCT00874770|11577413|FG001|Overall Study|Lost to Follow-up|0
7340035|NCT00874770|11577414|FG002|Overall Study|Lost to Follow-up|0
7340036|NCT00874770|11577415|FG003|Overall Study|Lost to Follow-up|1
7340037|NCT00874770|11577412|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
7340038|NCT00874770|11577413|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
7340039|NCT00874770|11577414|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
7340040|NCT00874770|11577415|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
7340041|NCT00874822|11577435|FG000|Overall Study|excluded by criteria|8
7340042|NCT00874848|11577441|FG000|Overall Study|Adverse Event|13
7340043|NCT00874848|11577442|FG001|Overall Study|Adverse Event|2
7340044|NCT00874848|11577441|FG000|Overall Study|Progressive neoplastic disease|38
7340045|NCT00874848|11577442|FG001|Overall Study|Progressive neoplastic disease|18
7340046|NCT00874848|11577441|FG000|Overall Study|Withdrawal by Subject|7
7340047|NCT00874848|11577442|FG001|Overall Study|Withdrawal by Subject|4
7340048|NCT00874848|11577441|FG000|Overall Study|Noncompliance|1
7340049|NCT00874848|11577442|FG001|Overall Study|Noncompliance|1
7340050|NCT00874848|11577441|FG000|Overall Study|Failure to comply with protocol|0
7340051|NCT00874848|11577442|FG001|Overall Study|Failure to comply with protocol|1
7340052|NCT00874848|11577441|FG000|Overall Study|Physician Decision|0
7340053|NCT00874848|11577442|FG001|Overall Study|Physician Decision|2
7340054|NCT00875017|11577463|FG000|First Intervention|Withdrawal by Subject|1
7340055|NCT00875017|11577464|FG001|First Intervention|Withdrawal by Subject|0
7340056|NCT00875017|11577465|FG002|First Intervention|Withdrawal by Subject|1
7340057|NCT00875017|11577466|FG003|First Intervention|Withdrawal by Subject|0
7340058|NCT00875017|11577467|FG004|First Intervention|Withdrawal by Subject|0
7340059|NCT00875017|11577468|FG005|First Intervention|Withdrawal by Subject|0
7340060|NCT00875017|11577463|FG000|First Intervention|Adverse Event|0
7340061|NCT00875017|11577464|FG001|First Intervention|Adverse Event|0
7340062|NCT00875017|11577465|FG002|First Intervention|Adverse Event|0
7340063|NCT00875017|11577466|FG003|First Intervention|Adverse Event|1
7340064|NCT00875017|11577467|FG004|First Intervention|Adverse Event|0
7340065|NCT00875017|11577468|FG005|First Intervention|Adverse Event|0
7340066|NCT00875017|11577463|FG000|First Intervention|Problems collecting rectal effluent|1
7340067|NCT00875017|11577464|FG001|First Intervention|Problems collecting rectal effluent|0
7340068|NCT00875017|11577465|FG002|First Intervention|Problems collecting rectal effluent|0
7340069|NCT00875017|11577466|FG003|First Intervention|Problems collecting rectal effluent|0
7340070|NCT00875017|11577467|FG004|First Intervention|Problems collecting rectal effluent|0
7340071|NCT00875017|11577468|FG005|First Intervention|Problems collecting rectal effluent|0
7340072|NCT00875017|11577463|FG000|First Intervention|Intolerance to nasogastric tube|0
7340073|NCT00875017|11577464|FG001|First Intervention|Intolerance to nasogastric tube|0
7340074|NCT00875017|11577465|FG002|First Intervention|Intolerance to nasogastric tube|0
7340075|NCT00875017|11577466|FG003|First Intervention|Intolerance to nasogastric tube|0
7340076|NCT00875017|11577467|FG004|First Intervention|Intolerance to nasogastric tube|1
7340077|NCT00875017|11577468|FG005|First Intervention|Intolerance to nasogastric tube|0
7340078|NCT00875017|11577463|FG000|Washout|Problem collecting rectal effluent|0
7340079|NCT00875017|11577464|FG001|Washout|Problem collecting rectal effluent|0
7340080|NCT00875017|11577465|FG002|Washout|Problem collecting rectal effluent|1
7340081|NCT00875017|11577466|FG003|Washout|Problem collecting rectal effluent|0
7340082|NCT00875017|11577467|FG004|Washout|Problem collecting rectal effluent|0
7340083|NCT00875017|11577468|FG005|Washout|Problem collecting rectal effluent|0
7340084|NCT00875017|11577463|FG000|Second Intervention|Adverse Event|0
7340085|NCT00875017|11577464|FG001|Second Intervention|Adverse Event|0
7340086|NCT00875017|11577465|FG002|Second Intervention|Adverse Event|0
7340087|NCT00875017|11577466|FG003|Second Intervention|Adverse Event|1
7340088|NCT00875017|11577467|FG004|Second Intervention|Adverse Event|0
7340089|NCT00875017|11577468|FG005|Second Intervention|Adverse Event|0
7340090|NCT00875017|11577463|FG000|Washout|Problems collecting rectal effluent|0
7340091|NCT00875017|11577464|FG001|Washout|Problems collecting rectal effluent|1
7340092|NCT00875017|11577465|FG002|Washout|Problems collecting rectal effluent|0
7340093|NCT00875017|11577466|FG003|Washout|Problems collecting rectal effluent|0
7340094|NCT00875017|11577467|FG004|Washout|Problems collecting rectal effluent|0
7340095|NCT00875017|11577468|FG005|Washout|Problems collecting rectal effluent|0
7340096|NCT00875017|11577463|FG000|Third Intervention|Adverse Event|0
7340097|NCT00875017|11577464|FG001|Third Intervention|Adverse Event|1
7340098|NCT00875017|11577465|FG002|Third Intervention|Adverse Event|1
7340099|NCT00875017|11577466|FG003|Third Intervention|Adverse Event|0
7340100|NCT00875017|11577467|FG004|Third Intervention|Adverse Event|0
7340101|NCT00875017|11577468|FG005|Third Intervention|Adverse Event|0
7340102|NCT00875017|11577463|FG000|Washout|Withdrawal by Subject|0
7340103|NCT00875017|11577464|FG001|Washout|Withdrawal by Subject|0
7340105|NCT00875017|11577466|FG003|Washout|Withdrawal by Subject|0
7340106|NCT00875017|11577467|FG004|Washout|Withdrawal by Subject|1
7340107|NCT00875017|11577468|FG005|Washout|Withdrawal by Subject|0
7340108|NCT00875017|11577463|FG000|Fourth Intervention|Inability to comply with fasting|0
7340109|NCT00875017|11577464|FG001|Fourth Intervention|Inability to comply with fasting|0
7340110|NCT00875017|11577465|FG002|Fourth Intervention|Inability to comply with fasting|0
7340111|NCT00875017|11577466|FG003|Fourth Intervention|Inability to comply with fasting|0
7340112|NCT00875017|11577467|FG004|Fourth Intervention|Inability to comply with fasting|0
7340113|NCT00875017|11577468|FG005|Fourth Intervention|Inability to comply with fasting|1
7340114|NCT00875056|11577484|FG000|Overall Study|Adverse Event|6
7340115|NCT00875056|11577485|FG001|Overall Study|Adverse Event|1
7340116|NCT00875056|11577486|FG002|Overall Study|Adverse Event|2
7340117|NCT00875056|11577484|FG000|Overall Study|Progressive Disease|14
7340118|NCT00875056|11577485|FG001|Overall Study|Progressive Disease|8
7340119|NCT00875056|11577486|FG002|Overall Study|Progressive Disease|3
7340120|NCT00875056|11577484|FG000|Overall Study|Withdrawal by Subject|3
7340121|NCT00875056|11577485|FG001|Overall Study|Withdrawal by Subject|0
7340122|NCT00875056|11577486|FG002|Overall Study|Withdrawal by Subject|1
7340123|NCT00875420|11577534|FG000|Overall Study|Adverse Event|0
7340124|NCT00875420|11577535|FG001|Overall Study|Adverse Event|1
7340125|NCT00875420|11577536|FG002|Overall Study|Adverse Event|1
7340126|NCT00875420|11577537|FG003|Overall Study|Adverse Event|0
7340127|NCT00875420|11577538|FG004|Overall Study|Adverse Event|0
7340128|NCT00875420|11577534|FG000|Overall Study|Inability to complete study procedures|1
7340129|NCT00875420|11577535|FG001|Overall Study|Inability to complete study procedures|0
7340130|NCT00875420|11577536|FG002|Overall Study|Inability to complete study procedures|1
7340131|NCT00875420|11577537|FG003|Overall Study|Inability to complete study procedures|1
7340132|NCT00875420|11577538|FG004|Overall Study|Inability to complete study procedures|1
7340133|NCT00875420|11577534|FG000|Overall Study|Lost to Follow-up|1
7340134|NCT00875420|11577535|FG001|Overall Study|Lost to Follow-up|0
7340135|NCT00875420|11577536|FG002|Overall Study|Lost to Follow-up|0
7340136|NCT00875420|11577537|FG003|Overall Study|Lost to Follow-up|0
7340137|NCT00875420|11577538|FG004|Overall Study|Lost to Follow-up|0
7340138|NCT00875420|11577534|FG000|Overall Study|Personal reason|0
7340139|NCT00875420|11577535|FG001|Overall Study|Personal reason|0
7340140|NCT00875420|11577536|FG002|Overall Study|Personal reason|0
7340141|NCT00875420|11577537|FG003|Overall Study|Personal reason|0
7340142|NCT00875420|11577538|FG004|Overall Study|Personal reason|1
7340143|NCT00875420|11577534|FG000|Overall Study|Prohibited medication|0
7340144|NCT00875420|11577535|FG001|Overall Study|Prohibited medication|0
7340145|NCT00875420|11577536|FG002|Overall Study|Prohibited medication|0
7340146|NCT00875420|11577537|FG003|Overall Study|Prohibited medication|1
7340147|NCT00875420|11577538|FG004|Overall Study|Prohibited medication|0
7340148|NCT00875420|11577534|FG000|Overall Study|Sponsor decision|0
7340149|NCT00875420|11577535|FG001|Overall Study|Sponsor decision|1
7340150|NCT00875420|11577536|FG002|Overall Study|Sponsor decision|0
7340151|NCT00875420|11577537|FG003|Overall Study|Sponsor decision|0
7340152|NCT00875420|11577538|FG004|Overall Study|Sponsor decision|0
7340153|NCT00875420|11577534|FG000|Overall Study|Withdrawal by Subject|0
7340154|NCT00875420|11577535|FG001|Overall Study|Withdrawal by Subject|0
7340155|NCT00875420|11577536|FG002|Overall Study|Withdrawal by Subject|1
7340156|NCT00875420|11577537|FG003|Overall Study|Withdrawal by Subject|0
7340157|NCT00875420|11577538|FG004|Overall Study|Withdrawal by Subject|0
7340158|NCT00875433|11577550|FG000|Overall Study|Progressive disease|41
7340159|NCT00875433|11577550|FG000|Overall Study|Other Adverse Event|14
7340160|NCT00875433|11577550|FG000|Overall Study|Withdrawal by Subject|2
7340161|NCT00875433|11577550|FG000|Overall Study|Other|3
7340162|NCT00875485|11577556|FG000|Challenge Dose Epoch|Pregnancy|1
7340163|NCT00875485|11577557|FG001|Challenge Dose Epoch|Pregnancy|0
7340164|NCT00875563|11577574|FG000|Overall Study|Death|4
7340165|NCT00875563|11577574|FG000|Overall Study|Withdrawal by Subject|7
7340166|NCT00875563|11577574|FG000|Overall Study|No long-term (3-5 year) consent|6
7340167|NCT00875563|11577574|FG000|Overall Study|Still be eligible for follow-up|7
7340168|NCT00875615|11577587|FG000|Overall Study|Withdrawal by Subject|1
7340169|NCT00875667|11577606|FG000|Overall Study|Adverse Event|29
7340170|NCT00875667|11577607|FG001|Overall Study|Adverse Event|10
7340171|NCT00875667|11577606|FG000|Overall Study|Withdrawal by Subject|17
7340172|NCT00875667|11577607|FG001|Overall Study|Withdrawal by Subject|5
7340173|NCT00875667|11577606|FG000|Overall Study|Death|7
7340174|NCT00875667|11577607|FG001|Overall Study|Death|2
7340175|NCT00875667|11577606|FG000|Overall Study|Protocol Violation|2
7340176|NCT00875667|11577607|FG001|Overall Study|Protocol Violation|0
7340177|NCT00875667|11577606|FG000|Overall Study|Disease Progression|100
7340178|NCT00875667|11577607|FG001|Overall Study|Disease Progression|49
7340179|NCT00875667|11577606|FG000|Overall Study|Miscellaneous|12
7340180|NCT00875667|11577607|FG001|Overall Study|Miscellaneous|6
7340181|NCT00875667|11577606|FG000|Overall Study|Randomized but no Study Drug Given|3
7340182|NCT00875667|11577607|FG001|Overall Study|Randomized but no Study Drug Given|1
7340183|NCT00875706|11577616|FG000|Overall Study|Withdrawal by Subject|1
7340184|NCT00875706|11577617|FG001|Overall Study|Withdrawal by Subject|0
7340185|NCT00875706|11577618|FG002|Overall Study|Withdrawal by Subject|0
7340186|NCT00875797|11577628|FG000|Overall Study|Protocol Violation|6
7340187|NCT00875797|11577629|FG001|Overall Study|Protocol Violation|3
7340188|NCT00875810|11577638|FG000|Overall Study|Withdrawal by Subject|1
7340189|NCT00875810|11577638|FG000|Overall Study|Physician Decision|3
7340190|NCT00875810|11577638|FG000|Overall Study|Lost to Follow-up|39
7340191|NCT00875810|11577638|FG000|Overall Study|Patient enroled but not implanted|2
7340192|NCT00875810|11577638|FG000|Overall Study|Device explanted|1
7340193|NCT00875979|11577653|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
7340194|NCT00875979|11577654|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
7340195|NCT00875979|11577653|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
7340196|NCT00875979|11577654|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
7340197|NCT00875979|11577653|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
7340198|NCT00875979|11577654|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
7340199|NCT00875979|11577653|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
7340200|NCT00875979|11577654|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
7340201|NCT00875979|11577653|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
7340202|NCT00875979|11577654|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
7340203|NCT00875979|11577653|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
7340204|NCT00875979|11577654|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
7340205|NCT00875979|11577653|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
7340206|NCT00875979|11577654|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
7340207|NCT00875979|11577653|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
7340208|NCT00875979|11577654|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
7340209|NCT00875979|11577653|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
7340210|NCT00875979|11577654|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
7340211|NCT00876018|11577663|FG000|Overall Study|Lost to Follow-up|0
7340212|NCT00876018|11577664|FG001|Overall Study|Lost to Follow-up|1
7340213|NCT00876018|11577665|FG002|Overall Study|Lost to Follow-up|1
7340214|NCT00876018|11577663|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
7340215|NCT00876018|11577664|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
7340216|NCT00876018|11577665|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
7340217|NCT00876187|11577680|FG000|Overall Study|Adverse Event|14
7340218|NCT00876187|11577681|FG001|Overall Study|Adverse Event|12
7340219|NCT00876187|11577682|FG002|Overall Study|Adverse Event|19
7340220|NCT00876187|11577683|FG003|Overall Study|Adverse Event|29
7340221|NCT00876187|11577684|FG004|Overall Study|Adverse Event|10
7340222|NCT00876187|11577680|FG000|Overall Study|Lack of Efficacy|59
7340223|NCT00876187|11577681|FG001|Overall Study|Lack of Efficacy|34
7340224|NCT00876187|11577682|FG002|Overall Study|Lack of Efficacy|45
7340225|NCT00876187|11577683|FG003|Overall Study|Lack of Efficacy|34
7340226|NCT00876187|11577684|FG004|Overall Study|Lack of Efficacy|59
7340227|NCT00876187|11577680|FG000|Overall Study|Lost to Follow-up|9
7340228|NCT00876187|11577681|FG001|Overall Study|Lost to Follow-up|10
7340229|NCT00876187|11577682|FG002|Overall Study|Lost to Follow-up|8
7340230|NCT00876187|11577683|FG003|Overall Study|Lost to Follow-up|8
7340231|NCT00876187|11577684|FG004|Overall Study|Lost to Follow-up|11
7340232|NCT00876187|11577680|FG000|Overall Study|Protocol Violation|6
7340233|NCT00876187|11577681|FG001|Overall Study|Protocol Violation|7
7340234|NCT00876187|11577682|FG002|Overall Study|Protocol Violation|7
7340235|NCT00876187|11577683|FG003|Overall Study|Protocol Violation|6
7340236|NCT00876187|11577684|FG004|Overall Study|Protocol Violation|3
7340237|NCT00876187|11577680|FG000|Overall Study|Withdrawal by Subject|16
7340238|NCT00876187|11577681|FG001|Overall Study|Withdrawal by Subject|26
7340239|NCT00876187|11577682|FG002|Overall Study|Withdrawal by Subject|32
7340240|NCT00876187|11577683|FG003|Overall Study|Withdrawal by Subject|38
7340241|NCT00876187|11577684|FG004|Overall Study|Withdrawal by Subject|37
7340242|NCT00876187|11577680|FG000|Overall Study|Entered extension study|101
7340243|NCT00876187|11577681|FG001|Overall Study|Entered extension study|120
7340244|NCT00876187|11577682|FG002|Overall Study|Entered extension study|156
7340245|NCT00876187|11577683|FG003|Overall Study|Entered extension study|151
7340246|NCT00876187|11577684|FG004|Overall Study|Entered extension study|144
7340247|NCT00876187|11577680|FG000|Overall Study|Randomized but not treated|3
7340248|NCT00876187|11577681|FG001|Overall Study|Randomized but not treated|1
7340249|NCT00876187|11577682|FG002|Overall Study|Randomized but not treated|3
7340250|NCT00876187|11577683|FG003|Overall Study|Randomized but not treated|2
7340251|NCT00876187|11577684|FG004|Overall Study|Randomized but not treated|3
7340252|NCT00876187|11577680|FG000|Overall Study|Other|2
7340253|NCT00876187|11577681|FG001|Overall Study|Other|5
7340254|NCT00876187|11577682|FG002|Overall Study|Other|9
7340255|NCT00876187|11577683|FG003|Overall Study|Other|7
7340256|NCT00876187|11577684|FG004|Overall Study|Other|4
7340257|NCT00876265|11577708|FG000|Overall Study|Miscellaneous reasons|4
7340258|NCT00876265|11577708|FG000|Overall Study|Lost to Follow-up|6
7340259|NCT00876265|11577708|FG000|Overall Study|Withdrawal by Subject|2
7340260|NCT00876343|11577717|FG000|Overall Study|Adverse Event|7
7340261|NCT00876343|11577718|FG001|Overall Study|Adverse Event|8
7340262|NCT00876343|11577719|FG002|Overall Study|Adverse Event|2
7340263|NCT00876343|11577717|FG000|Overall Study|Withdrawal by Subject|4
7340264|NCT00876343|11577718|FG001|Overall Study|Withdrawal by Subject|4
7340265|NCT00876343|11577719|FG002|Overall Study|Withdrawal by Subject|3
7340266|NCT00876343|11577717|FG000|Overall Study|Lack of Efficacy|0
7340267|NCT00876343|11577718|FG001|Overall Study|Lack of Efficacy|0
7340268|NCT00876343|11577719|FG002|Overall Study|Lack of Efficacy|1
7340269|NCT00876343|11577717|FG000|Overall Study|Protocol Violation|4
7340270|NCT00876343|11577718|FG001|Overall Study|Protocol Violation|1
7340271|NCT00876343|11577719|FG002|Overall Study|Protocol Violation|1
7340272|NCT00876343|11577717|FG000|Overall Study|Physician Decision|0
7340273|NCT00876343|11577718|FG001|Overall Study|Physician Decision|1
7340274|NCT00876343|11577719|FG002|Overall Study|Physician Decision|1
7340275|NCT00876343|11577717|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7340276|NCT00876343|11577718|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7340277|NCT00876343|11577719|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
7340278|NCT00876343|11577717|FG000|Overall Study|Change of residence or other commitments|2
7340279|NCT00876343|11577718|FG001|Overall Study|Change of residence or other commitments|2
7340280|NCT00876343|11577719|FG002|Overall Study|Change of residence or other commitments|3
7340281|NCT00876395|11577729|FG000|Overall Study|Untreated|8
7340282|NCT00876395|11577730|FG001|Overall Study|Untreated|1
7340283|NCT00876395|11577729|FG000|Overall Study|Adverse Event|63
7340284|NCT00876395|11577730|FG001|Overall Study|Adverse Event|11
7340285|NCT00876395|11577729|FG000|Overall Study|Abnormal test procedure result(s)|1
7340286|NCT00876395|11577730|FG001|Overall Study|Abnormal test procedure result(s)|0
7340287|NCT00876395|11577729|FG000|Overall Study|Disease progression|259
7340288|NCT00876395|11577730|FG001|Overall Study|Disease progression|162
7340289|NCT00876395|11577729|FG000|Overall Study|New cancer therapy|25
7340290|NCT00876395|11577730|FG001|Overall Study|New cancer therapy|7
7340291|NCT00876395|11577729|FG000|Overall Study|Protocol Violation|5
7340292|NCT00876395|11577730|FG001|Overall Study|Protocol Violation|2
7340293|NCT00876395|11577729|FG000|Overall Study|Withdrawal by Subject|66
7340294|NCT00876395|11577730|FG001|Overall Study|Withdrawal by Subject|33
7340295|NCT00876395|11577729|FG000|Overall Study|Lost to Follow-up|2
7340296|NCT00876395|11577730|FG001|Overall Study|Lost to Follow-up|0
7340297|NCT00876395|11577729|FG000|Overall Study|Administrative problems|39
7340298|NCT00876395|11577730|FG001|Overall Study|Administrative problems|23
7340299|NCT00876395|11577729|FG000|Overall Study|Death|12
7340300|NCT00876395|11577730|FG001|Overall Study|Death|0
7458306|NCT01807221|11752350|FG004|Overall Study|Lost to Follow-up|0
7458307|NCT01807221|11752351|FG005|Overall Study|Lost to Follow-up|0
7458308|NCT01807234|11752371|FG000|Overall Study|Lost to Follow-up|2
7458309|NCT01807234|11752372|FG001|Overall Study|Lost to Follow-up|5
7458310|NCT01807234|11752373|FG002|Overall Study|Lost to Follow-up|1
7458311|NCT01807234|11752374|FG003|Overall Study|Lost to Follow-up|1
7458312|NCT01807234|11752375|FG004|Overall Study|Lost to Follow-up|1
7458313|NCT01807234|11752376|FG005|Overall Study|Lost to Follow-up|2
7458314|NCT01807234|11752371|FG000|Overall Study|Withdrawal by Subject|3
7458315|NCT01807234|11752372|FG001|Overall Study|Withdrawal by Subject|1
7458316|NCT01807234|11752373|FG002|Overall Study|Withdrawal by Subject|1
7458317|NCT01807234|11752374|FG003|Overall Study|Withdrawal by Subject|1
7458318|NCT01807234|11752375|FG004|Overall Study|Withdrawal by Subject|2
7458319|NCT01807234|11752376|FG005|Overall Study|Withdrawal by Subject|1
7458320|NCT01807234|11752371|FG000|Overall Study|Lack of Efficacy|0
7458321|NCT01807234|11752372|FG001|Overall Study|Lack of Efficacy|0
7458322|NCT01807234|11752373|FG002|Overall Study|Lack of Efficacy|0
7458323|NCT01807234|11752374|FG003|Overall Study|Lack of Efficacy|0
7458324|NCT01807234|11752375|FG004|Overall Study|Lack of Efficacy|1
7458325|NCT01807234|11752376|FG005|Overall Study|Lack of Efficacy|1
7458326|NCT01807299|11752390|FG000|Overall Study|Protocol Violation|3
7458327|NCT01807299|11752391|FG001|Overall Study|Protocol Violation|1
7458328|NCT01807299|11752392|FG002|Overall Study|Protocol Violation|0
7458329|NCT01807299|11752393|FG003|Overall Study|Protocol Violation|2
7458330|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7458331|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
7458332|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
7458333|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7458334|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7458335|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7458336|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
7458337|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7340301|NCT00876447|11577743|FG000|Overall Study|Other miscellaneous reasons|3
7340302|NCT00876447|11577744|FG001|Overall Study|Other miscellaneous reasons|8
7340303|NCT00876447|11577743|FG000|Overall Study|Site closure|19
7340304|NCT00876447|11577744|FG001|Overall Study|Site closure|14
7458338|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7458339|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
7458340|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7458341|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7340305|NCT00876447|11577743|FG000|Overall Study|Protocol Violation|9
7458342|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7340306|NCT00876447|11577744|FG001|Overall Study|Protocol Violation|3
7340307|NCT00876447|11577743|FG000|Overall Study|Personal reasons|30
7340308|NCT00876447|11577744|FG001|Overall Study|Personal reasons|28
7340309|NCT00876447|11577743|FG000|Overall Study|Lost to Follow-up|6
7340310|NCT00876447|11577744|FG001|Overall Study|Lost to Follow-up|15
7340311|NCT00876447|11577743|FG000|Overall Study|Pregnancy|4
7340312|NCT00876447|11577744|FG001|Overall Study|Pregnancy|2
7340313|NCT00876447|11577743|FG000|Overall Study|Lack of Efficacy|5
7340314|NCT00876447|11577744|FG001|Overall Study|Lack of Efficacy|3
7340315|NCT00876447|11577743|FG000|Overall Study|Adverse Event|4
7340316|NCT00876447|11577744|FG001|Overall Study|Adverse Event|8
7340317|NCT00876460|11577782|FG000|Combination Therapy Phase|Progressive disease|2
7340318|NCT00876460|11577783|FG001|Combination Therapy Phase|Progressive disease|3
7340319|NCT00876460|11577784|FG002|Combination Therapy Phase|Progressive disease|3
7340320|NCT00876460|11577785|FG003|Combination Therapy Phase|Progressive disease|3
7340321|NCT00876460|11577786|FG004|Combination Therapy Phase|Progressive disease|3
7340322|NCT00876460|11577787|FG005|Combination Therapy Phase|Progressive disease|1
7340323|NCT00876460|11577788|FG006|Combination Therapy Phase|Progressive disease|1
7340324|NCT00876460|11577789|FG007|Combination Therapy Phase|Progressive disease|1
7340325|NCT00876460|11577782|FG000|Combination Therapy Phase|Dose limiting toxicity|0
7340326|NCT00876460|11577783|FG001|Combination Therapy Phase|Dose limiting toxicity|1
7340327|NCT00876460|11577784|FG002|Combination Therapy Phase|Dose limiting toxicity|0
7340328|NCT00876460|11577785|FG003|Combination Therapy Phase|Dose limiting toxicity|1
7340329|NCT00876460|11577786|FG004|Combination Therapy Phase|Dose limiting toxicity|1
7340330|NCT00876460|11577787|FG005|Combination Therapy Phase|Dose limiting toxicity|2
7340331|NCT00876460|11577788|FG006|Combination Therapy Phase|Dose limiting toxicity|2
7340332|NCT00876460|11577789|FG007|Combination Therapy Phase|Dose limiting toxicity|1
7340333|NCT00876460|11577782|FG000|Combination Therapy Phase|Adverse Event|0
7340334|NCT00876460|11577783|FG001|Combination Therapy Phase|Adverse Event|2
7340335|NCT00876460|11577784|FG002|Combination Therapy Phase|Adverse Event|0
7340336|NCT00876460|11577785|FG003|Combination Therapy Phase|Adverse Event|2
7340337|NCT00876460|11577786|FG004|Combination Therapy Phase|Adverse Event|2
7340338|NCT00876460|11577787|FG005|Combination Therapy Phase|Adverse Event|0
7340339|NCT00876460|11577788|FG006|Combination Therapy Phase|Adverse Event|3
7340340|NCT00876460|11577789|FG007|Combination Therapy Phase|Adverse Event|2
7340341|NCT00876460|11577782|FG000|Combination Therapy Phase|Withdrawal by Subject|1
7340342|NCT00876460|11577783|FG001|Combination Therapy Phase|Withdrawal by Subject|1
7340343|NCT00876460|11577784|FG002|Combination Therapy Phase|Withdrawal by Subject|0
7340344|NCT00876460|11577785|FG003|Combination Therapy Phase|Withdrawal by Subject|0
7340345|NCT00876460|11577786|FG004|Combination Therapy Phase|Withdrawal by Subject|1
7340346|NCT00876460|11577787|FG005|Combination Therapy Phase|Withdrawal by Subject|0
7340347|NCT00876460|11577788|FG006|Combination Therapy Phase|Withdrawal by Subject|0
7340348|NCT00876460|11577789|FG007|Combination Therapy Phase|Withdrawal by Subject|0
7340349|NCT00876460|11577782|FG000|Combination Therapy Phase|Other reason not defined above|0
7340350|NCT00876460|11577783|FG001|Combination Therapy Phase|Other reason not defined above|0
7340351|NCT00876460|11577784|FG002|Combination Therapy Phase|Other reason not defined above|0
7340352|NCT00876460|11577785|FG003|Combination Therapy Phase|Other reason not defined above|0
7340353|NCT00876460|11577786|FG004|Combination Therapy Phase|Other reason not defined above|0
7340354|NCT00876460|11577787|FG005|Combination Therapy Phase|Other reason not defined above|0
7340355|NCT00876460|11577788|FG006|Combination Therapy Phase|Other reason not defined above|1
7340356|NCT00876460|11577789|FG007|Combination Therapy Phase|Other reason not defined above|2
7340357|NCT00876460|11577782|FG000|Combination Therapy Phase|Not treated|0
7340358|NCT00876460|11577783|FG001|Combination Therapy Phase|Not treated|0
7340359|NCT00876460|11577784|FG002|Combination Therapy Phase|Not treated|0
7340360|NCT00876460|11577785|FG003|Combination Therapy Phase|Not treated|0
7340361|NCT00876460|11577786|FG004|Combination Therapy Phase|Not treated|0
7340362|NCT00876460|11577787|FG005|Combination Therapy Phase|Not treated|0
7340363|NCT00876460|11577788|FG006|Combination Therapy Phase|Not treated|1
7340364|NCT00876460|11577789|FG007|Combination Therapy Phase|Not treated|0
7340365|NCT00876460|11577782|FG000|Mono Therapy Phase|Progressive disease|0
7340366|NCT00876460|11577783|FG001|Mono Therapy Phase|Progressive disease|0
7340367|NCT00876460|11577784|FG002|Mono Therapy Phase|Progressive disease|0
7340368|NCT00876460|11577785|FG003|Mono Therapy Phase|Progressive disease|0
7340369|NCT00876460|11577786|FG004|Mono Therapy Phase|Progressive disease|2
7340370|NCT00876460|11577787|FG005|Mono Therapy Phase|Progressive disease|0
7340371|NCT00876460|11577788|FG006|Mono Therapy Phase|Progressive disease|1
7340372|NCT00876460|11577789|FG007|Mono Therapy Phase|Progressive disease|3
7340373|NCT00876460|11577782|FG000|Mono Therapy Phase|Withdrawal by Subject|0
7340374|NCT00876460|11577783|FG001|Mono Therapy Phase|Withdrawal by Subject|1
7340375|NCT00876460|11577784|FG002|Mono Therapy Phase|Withdrawal by Subject|0
7340376|NCT00876460|11577785|FG003|Mono Therapy Phase|Withdrawal by Subject|0
7340377|NCT00876460|11577786|FG004|Mono Therapy Phase|Withdrawal by Subject|0
7340378|NCT00876460|11577787|FG005|Mono Therapy Phase|Withdrawal by Subject|0
7340379|NCT00876460|11577788|FG006|Mono Therapy Phase|Withdrawal by Subject|0
7340380|NCT00876460|11577789|FG007|Mono Therapy Phase|Withdrawal by Subject|0
7340381|NCT00876460|11577782|FG000|Mono Therapy Phase|Adverse Event|0
7340382|NCT00876460|11577783|FG001|Mono Therapy Phase|Adverse Event|0
7340383|NCT00876460|11577784|FG002|Mono Therapy Phase|Adverse Event|0
7340384|NCT00876460|11577785|FG003|Mono Therapy Phase|Adverse Event|1
7340385|NCT00876460|11577786|FG004|Mono Therapy Phase|Adverse Event|0
7340386|NCT00876460|11577787|FG005|Mono Therapy Phase|Adverse Event|0
7340387|NCT00876460|11577788|FG006|Mono Therapy Phase|Adverse Event|0
7340388|NCT00876460|11577789|FG007|Mono Therapy Phase|Adverse Event|0
7340389|NCT00876694|11577821|FG000|Overall Study|Adverse Event|10
7340390|NCT00876694|11577822|FG001|Overall Study|Adverse Event|7
7340391|NCT00876694|11577821|FG000|Overall Study|Subject withdrew consent|6
7340392|NCT00876694|11577822|FG001|Overall Study|Subject withdrew consent|4
7340393|NCT00876694|11577821|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7340394|NCT00876694|11577822|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7340395|NCT00876694|11577821|FG000|Overall Study|Abnormal test procedure result(s)|1
7340396|NCT00876694|11577822|FG001|Overall Study|Abnormal test procedure result(s)|0
7340397|NCT00876694|11577821|FG000|Overall Study|Administrative problems|1
7340398|NCT00876694|11577822|FG001|Overall Study|Administrative problems|1
7340399|NCT00876694|11577821|FG000|Overall Study|Death|1
7340400|NCT00876694|11577822|FG001|Overall Study|Death|0
7340401|NCT00876733|11577832|FG000|Overall Study|Adverse Event|34
7340402|NCT00876733|11577833|FG001|Overall Study|Adverse Event|20
7340403|NCT00876733|11577834|FG002|Overall Study|Adverse Event|10
7340404|NCT00876733|11577835|FG003|Overall Study|Adverse Event|3
7340405|NCT00876733|11577832|FG000|Overall Study|Lack of Efficacy|17
7340406|NCT00876733|11577833|FG001|Overall Study|Lack of Efficacy|9
7340407|NCT00876733|11577834|FG002|Overall Study|Lack of Efficacy|10
7340408|NCT00876733|11577835|FG003|Overall Study|Lack of Efficacy|1
7340409|NCT00876733|11577832|FG000|Overall Study|Lost to Follow-up|26
7340410|NCT00876733|11577833|FG001|Overall Study|Lost to Follow-up|10
7340411|NCT00876733|11577834|FG002|Overall Study|Lost to Follow-up|3
7340412|NCT00876733|11577835|FG003|Overall Study|Lost to Follow-up|2
7340413|NCT00876733|11577832|FG000|Overall Study|Data not available|14
7340414|NCT00876733|11577833|FG001|Overall Study|Data not available|3
7340415|NCT00876733|11577834|FG002|Overall Study|Data not available|7
7340416|NCT00876733|11577835|FG003|Overall Study|Data not available|1
7340417|NCT00876928|11577860|FG000|Overall Study|Lost to Follow-up|2
7340418|NCT00876928|11577861|FG001|Overall Study|Lost to Follow-up|5
7340419|NCT00876928|11577860|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
7340420|NCT00876928|11577861|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
7340421|NCT00877006|11577892|FG000|Treatment Period|Death|2
7340422|NCT00877006|11577893|FG001|Treatment Period|Death|1
7340423|NCT00877006|11577892|FG000|Treatment Period|Adverse Event|10
7340424|NCT00877006|11577893|FG001|Treatment Period|Adverse Event|3
7340425|NCT00877006|11577892|FG000|Treatment Period|Withdrawal by Subject|2
7340426|NCT00877006|11577893|FG001|Treatment Period|Withdrawal by Subject|3
7340427|NCT00877006|11577892|FG000|Treatment Period|Protocol Violation|1
7340428|NCT00877006|11577893|FG001|Treatment Period|Protocol Violation|0
7340429|NCT00877006|11577892|FG000|Treatment Period|Lost to Follow-up|0
7340430|NCT00877006|11577893|FG001|Treatment Period|Lost to Follow-up|1
7340431|NCT00877006|11577892|FG000|Treatment Period|Disease Progression|1
7340432|NCT00877006|11577893|FG001|Treatment Period|Disease Progression|2
7340433|NCT00877006|11577892|FG000|Treatment Period|Started New Treatment Regimen|2
7340434|NCT00877006|11577893|FG001|Treatment Period|Started New Treatment Regimen|5
7340435|NCT00877006|11577892|FG000|Treatment Period|Other|4
7340436|NCT00877006|11577893|FG001|Treatment Period|Other|4
7340437|NCT00877006|11577892|FG000|Treatment Period|Randomized but Not Treated|3
7340438|NCT00877006|11577893|FG001|Treatment Period|Randomized but Not Treated|8
7340439|NCT00877006|11577892|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
7340440|NCT00877006|11577893|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
7340441|NCT00877006|11577892|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
7340442|NCT00877006|11577893|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
7340443|NCT00877006|11577892|FG000|Long-Term Follow-up Period|Death|26
7340444|NCT00877006|11577893|FG001|Long-Term Follow-up Period|Death|18
7340445|NCT00877006|11577892|FG000|Long-Term Follow-up Period|Other|7
7340446|NCT00877006|11577893|FG001|Long-Term Follow-up Period|Other|9
7340447|NCT00877032|11577908|FG000|Overall Study|Did not meet entrance criteria|0
7340448|NCT00877032|11577909|FG001|Overall Study|Did not meet entrance criteria|0
7340449|NCT00877032|11577910|FG002|Overall Study|Did not meet entrance criteria|0
7340450|NCT00877032|11577911|FG003|Overall Study|Did not meet entrance criteria|1
7340451|NCT00877032|11577912|FG004|Overall Study|Did not meet entrance criteria|0
7340452|NCT00877032|11577913|FG005|Overall Study|Did not meet entrance criteria|0
7340453|NCT00877032|11577914|FG006|Overall Study|Did not meet entrance criteria|2
7340454|NCT00877383|11577949|FG000|Overall Study|Adverse Event|13
7340455|NCT00877383|11577950|FG001|Overall Study|Adverse Event|14
7340456|NCT00877383|11577949|FG000|Overall Study|Lost to Follow-up|5
7340457|NCT00877383|11577950|FG001|Overall Study|Lost to Follow-up|3
7340458|NCT00877383|11577949|FG000|Overall Study|Subject withdrew consent|3
7340459|NCT00877383|11577950|FG001|Overall Study|Subject withdrew consent|12
7340460|NCT00877383|11577949|FG000|Overall Study|Subject no longer requires study drug|2
7340461|NCT00877383|11577950|FG001|Overall Study|Subject no longer requires study drug|0
7340462|NCT00877383|11577949|FG000|Overall Study|Administrative problems|2
7340463|NCT00877383|11577950|FG001|Overall Study|Administrative problems|0
7340464|NCT00877383|11577949|FG000|Overall Study|Protocol deviation|2
7340465|NCT00877383|11577950|FG001|Overall Study|Protocol deviation|6
7340466|NCT00877383|11577949|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7340467|NCT00877383|11577950|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7340468|NCT00877383|11577949|FG000|Overall Study|Death|1
7340469|NCT00877383|11577950|FG001|Overall Study|Death|2
7340470|NCT00877487|11577985|FG000|Open-label Treatment Phase|Adverse Event|1
7340471|NCT00877487|11577986|FG001|Open-label Treatment Phase|Adverse Event|0
7340472|NCT00877487|11577985|FG000|Open-label Treatment Phase|Protocol Violation|3
7340473|NCT00877487|11577986|FG001|Open-label Treatment Phase|Protocol Violation|0
7340474|NCT00877487|11577985|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
7340475|NCT00877487|11577986|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7340476|NCT00877487|11577985|FG000|Open-label Treatment Phase|Lost to Follow-up|1
7340477|NCT00877487|11577986|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7340478|NCT00877487|11577985|FG000|Open-label Treatment Phase|Out of country for business|1
7340479|NCT00877487|11577986|FG001|Open-label Treatment Phase|Out of country for business|0
7340480|NCT00877487|11577985|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
7340481|NCT00877487|11577986|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
7340482|NCT00877487|11577985|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
7340483|NCT00877487|11577986|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
7340484|NCT00877487|11577985|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
7340485|NCT00877487|11577986|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
7340486|NCT00877487|11577985|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
7340487|NCT00877487|11577986|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
7340488|NCT00877773|11578001|FG000|Overall Study|Disease Progression|44
7340489|NCT00877799|11578010|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
7340490|NCT00877799|11578011|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7340491|NCT00877799|11578012|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
7340492|NCT00877799|11578013|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7340493|NCT00877799|11578014|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
7340494|NCT00877799|11578010|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7340495|NCT00877799|11578011|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
7340496|NCT00877799|11578012|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
7340497|NCT00877799|11578013|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7340498|NCT00877799|11578014|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
7340499|NCT00877799|11578010|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7340500|NCT00877799|11578011|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
7340501|NCT00877799|11578012|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7340502|NCT00877799|11578013|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7340503|NCT00877799|11578014|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
7340504|NCT00877799|11578010|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7340505|NCT00877799|11578011|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7340506|NCT00877799|11578012|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7340507|NCT00877799|11578013|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
7340508|NCT00877799|11578014|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
7340509|NCT00877799|11578010|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7340510|NCT00877799|11578011|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7340511|NCT00877799|11578012|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
7340512|NCT00877799|11578013|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7340513|NCT00877799|11578014|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
7340514|NCT00877890|11578036|FG000|Overall Study|Adverse Event|6
7340515|NCT00877890|11578037|FG001|Overall Study|Adverse Event|6
7340516|NCT00877890|11578036|FG000|Overall Study|Lost to Follow-up|5
7340517|NCT00877890|11578037|FG001|Overall Study|Lost to Follow-up|5
7340518|NCT00877890|11578036|FG000|Overall Study|Protocol Violation|0
7340519|NCT00877890|11578037|FG001|Overall Study|Protocol Violation|1
7340520|NCT00877890|11578036|FG000|Overall Study|Withdrawal of Consent|6
7340521|NCT00877890|11578037|FG001|Overall Study|Withdrawal of Consent|12
7340522|NCT00877890|11578036|FG000|Overall Study|Investigator Decision|0
7340523|NCT00877890|11578037|FG001|Overall Study|Investigator Decision|2
7340524|NCT00877890|11578036|FG000|Overall Study|Loss of Glucose Control|3
7340525|NCT00877890|11578037|FG001|Overall Study|Loss of Glucose Control|4
7340526|NCT00877929|11578049|FG000|Overall Study|Adverse Event|11
7340527|NCT00877929|11578050|FG001|Overall Study|Adverse Event|20
7340528|NCT00877929|11578049|FG000|Overall Study|Protocol Violation|3
7340529|NCT00877929|11578050|FG001|Overall Study|Protocol Violation|3
7340530|NCT00877929|11578049|FG000|Overall Study|Lost to Follow-up|0
7340531|NCT00877929|11578050|FG001|Overall Study|Lost to Follow-up|1
7340532|NCT00877929|11578049|FG000|Overall Study|Withdrawal by Subject|4
7340533|NCT00877929|11578050|FG001|Overall Study|Withdrawal by Subject|4
7340534|NCT00877929|11578049|FG000|Overall Study|Lack of Efficacy|0
7340535|NCT00877929|11578050|FG001|Overall Study|Lack of Efficacy|1
7340536|NCT00877929|11578049|FG000|Overall Study|Other reason (not specified)|2
7458343|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
7458344|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7458345|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7458346|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
7340537|NCT00877929|11578050|FG001|Overall Study|Other reason (not specified)|6
7340538|NCT00878072|11578060|FG000|Overall Study|Withdrew consent|2
7340539|NCT00878189|11578071|FG000|Overall Study|Death|0
7340540|NCT00878189|11578072|FG001|Overall Study|Death|1
7340541|NCT00878189|11578073|FG002|Overall Study|Death|0
7340542|NCT00878189|11578074|FG003|Overall Study|Death|1
7340543|NCT00878189|11578075|FG004|Overall Study|Death|0
7340544|NCT00878189|11578076|FG005|Overall Study|Death|0
7340545|NCT00878189|11578077|FG006|Overall Study|Death|0
7340546|NCT00878189|11578078|FG007|Overall Study|Death|0
7340547|NCT00878189|11578079|FG008|Overall Study|Death|1
7340548|NCT00878189|11578071|FG000|Overall Study|Participant Refused to Follow-up|0
7340549|NCT00878189|11578072|FG001|Overall Study|Participant Refused to Follow-up|0
7340550|NCT00878189|11578073|FG002|Overall Study|Participant Refused to Follow-up|0
7340551|NCT00878189|11578074|FG003|Overall Study|Participant Refused to Follow-up|0
7340552|NCT00878189|11578075|FG004|Overall Study|Participant Refused to Follow-up|0
7340553|NCT00878189|11578076|FG005|Overall Study|Participant Refused to Follow-up|4
7340554|NCT00878189|11578077|FG006|Overall Study|Participant Refused to Follow-up|0
7340555|NCT00878189|11578078|FG007|Overall Study|Participant Refused to Follow-up|0
7340556|NCT00878189|11578079|FG008|Overall Study|Participant Refused to Follow-up|0
7340557|NCT00878189|11578071|FG000|Overall Study|Other|3
7340558|NCT00878189|11578072|FG001|Overall Study|Other|2
7340559|NCT00878189|11578073|FG002|Overall Study|Other|4
7340560|NCT00878189|11578074|FG003|Overall Study|Other|7
7340561|NCT00878189|11578075|FG004|Overall Study|Other|4
7340562|NCT00878189|11578076|FG005|Overall Study|Other|18
7340563|NCT00878189|11578077|FG006|Overall Study|Other|15
7340564|NCT00878189|11578078|FG007|Overall Study|Other|3
7340565|NCT00878189|11578079|FG008|Overall Study|Other|4
7340566|NCT00878189|11578071|FG000|Overall Study|Lost to Follow-up|0
7340567|NCT00878189|11578072|FG001|Overall Study|Lost to Follow-up|0
7340568|NCT00878189|11578073|FG002|Overall Study|Lost to Follow-up|0
7340569|NCT00878189|11578074|FG003|Overall Study|Lost to Follow-up|0
7340570|NCT00878189|11578075|FG004|Overall Study|Lost to Follow-up|0
7340571|NCT00878189|11578076|FG005|Overall Study|Lost to Follow-up|1
7340572|NCT00878189|11578077|FG006|Overall Study|Lost to Follow-up|1
7340573|NCT00878189|11578078|FG007|Overall Study|Lost to Follow-up|0
7340574|NCT00878189|11578079|FG008|Overall Study|Lost to Follow-up|0
7340575|NCT00878189|11578071|FG000|Overall Study|Objection Progression or Relapse|0
7340576|NCT00878189|11578072|FG001|Overall Study|Objection Progression or Relapse|0
7340577|NCT00878189|11578073|FG002|Overall Study|Objection Progression or Relapse|0
7340578|NCT00878189|11578074|FG003|Overall Study|Objection Progression or Relapse|0
7340579|NCT00878189|11578075|FG004|Overall Study|Objection Progression or Relapse|0
7340580|NCT00878189|11578076|FG005|Overall Study|Objection Progression or Relapse|0
7340581|NCT00878189|11578077|FG006|Overall Study|Objection Progression or Relapse|0
7340582|NCT00878189|11578078|FG007|Overall Study|Objection Progression or Relapse|0
7340583|NCT00878189|11578079|FG008|Overall Study|Objection Progression or Relapse|3
7385649|NCT01202955|11643497|FG000|Period 1: 10 Days|Withdrawal by Subject|0
7385650|NCT01202955|11643498|FG001|Period 1: 10 Days|Withdrawal by Subject|2
7385651|NCT01203072|11643525|FG000|Overall Study|Adverse Event|5
7385652|NCT01203072|11643526|FG001|Overall Study|Adverse Event|3
7385653|NCT01203072|11643527|FG002|Overall Study|Adverse Event|2
7385654|NCT01203072|11643528|FG003|Overall Study|Adverse Event|4
7385655|NCT01203072|11643529|FG004|Overall Study|Adverse Event|2
7385656|NCT01203072|11643525|FG000|Overall Study|Lack of Efficacy|1
7385657|NCT01203072|11643526|FG001|Overall Study|Lack of Efficacy|0
7385658|NCT01203072|11643527|FG002|Overall Study|Lack of Efficacy|0
7385659|NCT01203072|11643528|FG003|Overall Study|Lack of Efficacy|0
7385660|NCT01203072|11643529|FG004|Overall Study|Lack of Efficacy|0
7385661|NCT01203072|11643525|FG000|Overall Study|Lost to Follow-up|0
7385662|NCT01203072|11643526|FG001|Overall Study|Lost to Follow-up|1
7385663|NCT01203072|11643527|FG002|Overall Study|Lost to Follow-up|0
7385664|NCT01203072|11643528|FG003|Overall Study|Lost to Follow-up|0
7385665|NCT01203072|11643529|FG004|Overall Study|Lost to Follow-up|0
7385666|NCT01203072|11643525|FG000|Overall Study|Protocol Violation|2
7385667|NCT01203072|11643526|FG001|Overall Study|Protocol Violation|0
7385668|NCT01203072|11643527|FG002|Overall Study|Protocol Violation|0
7385669|NCT01203072|11643528|FG003|Overall Study|Protocol Violation|0
7385670|NCT01203072|11643529|FG004|Overall Study|Protocol Violation|1
7385671|NCT01203072|11643525|FG000|Overall Study|Withdrawal by Subject|2
7385672|NCT01203072|11643526|FG001|Overall Study|Withdrawal by Subject|2
7385673|NCT01203072|11643527|FG002|Overall Study|Withdrawal by Subject|1
7385674|NCT01203072|11643528|FG003|Overall Study|Withdrawal by Subject|2
7385675|NCT01203072|11643529|FG004|Overall Study|Withdrawal by Subject|3
7385676|NCT01203098|11643544|FG000|Overall Study|Adverse Event|3
7385677|NCT01203098|11643545|FG001|Overall Study|Adverse Event|1
7385678|NCT01203098|11643546|FG002|Overall Study|Adverse Event|7
7385679|NCT01203098|11643544|FG000|Overall Study|Lost to Follow-up|0
7385680|NCT01203098|11643545|FG001|Overall Study|Lost to Follow-up|0
7385681|NCT01203098|11643546|FG002|Overall Study|Lost to Follow-up|1
7340584|NCT00878215|11578117|FG000|Overall Study|Determined to be ineligible|0
7340585|NCT00878215|11578118|FG001|Overall Study|Determined to be ineligible|10
7340586|NCT00878215|11578119|FG002|Overall Study|Determined to be ineligible|0
7340587|NCT00878215|11578120|FG003|Overall Study|Determined to be ineligible|0
7340588|NCT00878501|11578151|FG000|Overall Study|Adverse Event|11
7340589|NCT00878501|11578152|FG001|Overall Study|Adverse Event|3
7340590|NCT00878501|11578153|FG002|Overall Study|Adverse Event|3
7340591|NCT00878501|11578151|FG000|Overall Study|Lack of Efficacy|2
7340592|NCT00878501|11578152|FG001|Overall Study|Lack of Efficacy|1
7340593|NCT00878501|11578153|FG002|Overall Study|Lack of Efficacy|0
7340594|NCT00878501|11578151|FG000|Overall Study|Withdrawal by Subject|2
7340595|NCT00878501|11578152|FG001|Overall Study|Withdrawal by Subject|1
7340596|NCT00878501|11578153|FG002|Overall Study|Withdrawal by Subject|2
7340597|NCT00878501|11578151|FG000|Overall Study|Protocol Violation|0
7340598|NCT00878501|11578152|FG001|Overall Study|Protocol Violation|0
7340599|NCT00878501|11578153|FG002|Overall Study|Protocol Violation|1
7340600|NCT00878501|11578151|FG000|Overall Study|Incorrect enrolment|1
7340601|NCT00878501|11578152|FG001|Overall Study|Incorrect enrolment|2
7340602|NCT00878501|11578153|FG002|Overall Study|Incorrect enrolment|0
7340603|NCT00878501|11578151|FG000|Overall Study|Intake of prohibited concom. medication|0
7340604|NCT00878501|11578152|FG001|Overall Study|Intake of prohibited concom. medication|0
7340605|NCT00878501|11578153|FG002|Overall Study|Intake of prohibited concom. medication|1
7340606|NCT00878501|11578151|FG000|Overall Study|Mis-randomisation of patient|1
7340607|NCT00878501|11578152|FG001|Overall Study|Mis-randomisation of patient|0
7340608|NCT00878501|11578153|FG002|Overall Study|Mis-randomisation of patient|0
7340609|NCT00878501|11578151|FG000|Overall Study|Administrative|0
7340610|NCT00878501|11578152|FG001|Overall Study|Administrative|0
7340611|NCT00878501|11578153|FG002|Overall Study|Administrative|1
7340612|NCT00878553|11578165|FG000|Sleep Study|Withdrawal by Subject|2
7340613|NCT00878553|11578166|FG001|Sleep Study|Withdrawal by Subject|0
7340614|NCT00878553|11578167|FG002|Sleep Study|Withdrawal by Subject|0
7340615|NCT00878553|11578168|FG003|Sleep Study|Withdrawal by Subject|0
7340616|NCT00878553|11578169|FG004|Sleep Study|Withdrawal by Subject|0
7340617|NCT00878553|11578165|FG000|Sleep Study|Lost to Follow-up|1
7340618|NCT00878553|11578166|FG001|Sleep Study|Lost to Follow-up|0
7340619|NCT00878553|11578167|FG002|Sleep Study|Lost to Follow-up|0
7340620|NCT00878553|11578168|FG003|Sleep Study|Lost to Follow-up|0
7340621|NCT00878553|11578169|FG004|Sleep Study|Lost to Follow-up|0
7340622|NCT00878553|11578165|FG000|Sleep Study|car accident|1
7340623|NCT00878553|11578166|FG001|Sleep Study|car accident|0
7340624|NCT00878553|11578167|FG002|Sleep Study|car accident|0
7340625|NCT00878553|11578168|FG003|Sleep Study|car accident|0
7340626|NCT00878553|11578169|FG004|Sleep Study|car accident|0
7340627|NCT00878553|11578165|FG000|Sleep Study|family emergency|1
7340628|NCT00878553|11578166|FG001|Sleep Study|family emergency|0
7340629|NCT00878553|11578167|FG002|Sleep Study|family emergency|0
7340630|NCT00878553|11578168|FG003|Sleep Study|family emergency|0
7340631|NCT00878553|11578169|FG004|Sleep Study|family emergency|0
7340632|NCT00878553|11578165|FG000|PK Study|Withdrawal by Subject|0
7340633|NCT00878553|11578166|FG001|PK Study|Withdrawal by Subject|0
7340634|NCT00878553|11578167|FG002|PK Study|Withdrawal by Subject|0
7340635|NCT00878553|11578168|FG003|PK Study|Withdrawal by Subject|1
7340636|NCT00878553|11578169|FG004|PK Study|Withdrawal by Subject|0
7340637|NCT00878709|11578197|FG000|Overall Study|Withdrawal by Subject|197
7340638|NCT00878709|11578198|FG001|Overall Study|Withdrawal by Subject|120
7340639|NCT00878709|11578197|FG000|Overall Study|Lost to Follow-up|35
7340640|NCT00878709|11578198|FG001|Overall Study|Lost to Follow-up|33
7340641|NCT00878709|11578197|FG000|Overall Study|Other Reasons|93
7340642|NCT00878709|11578198|FG001|Overall Study|Other Reasons|84
7340643|NCT00878722|11578213|FG000|Overall Study|Progressive disease|3
7340644|NCT00878722|11578214|FG001|Overall Study|Progressive disease|3
7340645|NCT00878722|11578215|FG002|Overall Study|Progressive disease|3
7340646|NCT00878722|11578216|FG003|Overall Study|Progressive disease|7
7340647|NCT00878722|11578217|FG004|Overall Study|Progressive disease|7
7340648|NCT00878722|11578218|FG005|Overall Study|Progressive disease|1
7340649|NCT00878722|11578219|FG006|Overall Study|Progressive disease|4
7340650|NCT00878722|11578220|FG007|Overall Study|Progressive disease|3
7340651|NCT00878722|11578213|FG000|Overall Study|Death|0
7340652|NCT00878722|11578214|FG001|Overall Study|Death|0
7340653|NCT00878722|11578215|FG002|Overall Study|Death|0
7340654|NCT00878722|11578216|FG003|Overall Study|Death|1
7340655|NCT00878722|11578217|FG004|Overall Study|Death|0
7340656|NCT00878722|11578218|FG005|Overall Study|Death|1
7340657|NCT00878722|11578219|FG006|Overall Study|Death|0
7340658|NCT00878722|11578220|FG007|Overall Study|Death|2
7340659|NCT00878722|11578213|FG000|Overall Study|Adverse Event|0
7340660|NCT00878722|11578214|FG001|Overall Study|Adverse Event|0
7340661|NCT00878722|11578215|FG002|Overall Study|Adverse Event|0
7340662|NCT00878722|11578216|FG003|Overall Study|Adverse Event|0
7340663|NCT00878722|11578217|FG004|Overall Study|Adverse Event|0
7340664|NCT00878722|11578218|FG005|Overall Study|Adverse Event|0
7340665|NCT00878722|11578219|FG006|Overall Study|Adverse Event|2
7340666|NCT00878722|11578220|FG007|Overall Study|Adverse Event|0
7340667|NCT00878722|11578213|FG000|Overall Study|Withdrawal by Subject|0
7340668|NCT00878722|11578214|FG001|Overall Study|Withdrawal by Subject|0
7340669|NCT00878722|11578215|FG002|Overall Study|Withdrawal by Subject|0
7340670|NCT00878722|11578216|FG003|Overall Study|Withdrawal by Subject|0
7340671|NCT00878722|11578217|FG004|Overall Study|Withdrawal by Subject|0
7340672|NCT00878722|11578218|FG005|Overall Study|Withdrawal by Subject|0
7340673|NCT00878722|11578219|FG006|Overall Study|Withdrawal by Subject|0
7340674|NCT00878722|11578220|FG007|Overall Study|Withdrawal by Subject|2
7340675|NCT00878722|11578213|FG000|Overall Study|Relapse|0
7340676|NCT00878722|11578214|FG001|Overall Study|Relapse|0
7340677|NCT00878722|11578215|FG002|Overall Study|Relapse|0
7340678|NCT00878722|11578216|FG003|Overall Study|Relapse|1
7340679|NCT00878722|11578217|FG004|Overall Study|Relapse|0
7340680|NCT00878722|11578218|FG005|Overall Study|Relapse|0
7340681|NCT00878722|11578219|FG006|Overall Study|Relapse|0
7340682|NCT00878722|11578220|FG007|Overall Study|Relapse|0
7340683|NCT00878800|11578246|FG000|Overall Study|Adverse Event|0
7340684|NCT00878800|11578247|FG001|Overall Study|Adverse Event|0
7340685|NCT00878800|11578248|FG002|Overall Study|Adverse Event|2
7340686|NCT00878800|11578249|FG003|Overall Study|Adverse Event|0
7340687|NCT00878800|11578250|FG004|Overall Study|Adverse Event|1
7340688|NCT00878800|11578246|FG000|Overall Study|Progressive disease|1
7340689|NCT00878800|11578247|FG001|Overall Study|Progressive disease|5
7340690|NCT00878800|11578248|FG002|Overall Study|Progressive disease|6
7340691|NCT00878800|11578249|FG003|Overall Study|Progressive disease|5
7340692|NCT00878800|11578250|FG004|Overall Study|Progressive disease|13
7340693|NCT00878800|11578246|FG000|Overall Study|Withdrew consent|1
7340694|NCT00878800|11578247|FG001|Overall Study|Withdrew consent|1
7340695|NCT00878800|11578248|FG002|Overall Study|Withdrew consent|0
7340696|NCT00878800|11578249|FG003|Overall Study|Withdrew consent|1
7340697|NCT00878800|11578250|FG004|Overall Study|Withdrew consent|1
7340698|NCT00878800|11578246|FG000|Overall Study|Death|0
7340699|NCT00878800|11578247|FG001|Overall Study|Death|0
7340700|NCT00878800|11578248|FG002|Overall Study|Death|1
7340701|NCT00878800|11578249|FG003|Overall Study|Death|0
7340702|NCT00878800|11578250|FG004|Overall Study|Death|0
7340703|NCT00878800|11578246|FG000|Overall Study|Other|1
7340704|NCT00878800|11578247|FG001|Overall Study|Other|1
7340705|NCT00878800|11578248|FG002|Overall Study|Other|0
7340706|NCT00878800|11578249|FG003|Overall Study|Other|0
7340707|NCT00878800|11578250|FG004|Overall Study|Other|1
7340708|NCT00878995|11578287|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
7340709|NCT00878995|11578288|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
7340710|NCT00879229|11578321|FG000|Overall Study|Study terminated by Sponsor|13
7340711|NCT00879229|11578322|FG001|Overall Study|Study terminated by Sponsor|12
7340712|NCT00879229|11578321|FG000|Overall Study|Death|4
7340713|NCT00879229|11578322|FG001|Overall Study|Death|2
7340714|NCT00879229|11578321|FG000|Overall Study|Adverse Event|2
7340715|NCT00879229|11578322|FG001|Overall Study|Adverse Event|0
7340716|NCT00879229|11578321|FG000|Overall Study|Withdrawal by Subject|1
7340717|NCT00879229|11578322|FG001|Overall Study|Withdrawal by Subject|0
7340718|NCT00879229|11578321|FG000|Overall Study|Clinical status did not improve|1
7340719|NCT00879229|11578322|FG001|Overall Study|Clinical status did not improve|0
7340720|NCT00879229|11578321|FG000|Overall Study|Other|1
7340721|NCT00879229|11578322|FG001|Overall Study|Other|0
7340722|NCT00879333|11578339|FG000|Overall Study|Adverse Event|94
7340723|NCT00879333|11578340|FG001|Overall Study|Adverse Event|34
7340724|NCT00879333|11578339|FG000|Overall Study|Abnormal Laboratory Value|1
7340725|NCT00879333|11578340|FG001|Overall Study|Abnormal Laboratory Value|0
7340726|NCT00879333|11578339|FG000|Overall Study|Withdrawal by Subject|20
7340727|NCT00879333|11578340|FG001|Overall Study|Withdrawal by Subject|7
7340728|NCT00879333|11578339|FG000|Overall Study|Lost to Follow-up|2
7340729|NCT00879333|11578340|FG001|Overall Study|Lost to Follow-up|1
7340730|NCT00879333|11578339|FG000|Overall Study|Administrative Problems|2
7340731|NCT00879333|11578340|FG001|Overall Study|Administrative Problems|0
7340732|NCT00879333|11578339|FG000|Overall Study|Death|16
7340733|NCT00879333|11578340|FG001|Overall Study|Death|5
7340734|NCT00879333|11578339|FG000|Overall Study|Disease Progression|292
7340735|NCT00879333|11578340|FG001|Overall Study|Disease Progression|169
7340736|NCT00879333|11578339|FG000|Overall Study|Protocol Violation|1
7340737|NCT00879333|11578340|FG001|Overall Study|Protocol Violation|1
7340738|NCT00879398|11578353|FG000|Overall Study|Visit Stop|399
7340739|NCT00879398|11578353|FG000|Overall Study|Lack of Efficacy|64
7340740|NCT00879398|11578353|FG000|Overall Study|Adverse Event|41
7340741|NCT00879398|11578353|FG000|Overall Study|Other Reasons|171
7340742|NCT00879411|11578357|FG000|Overall Study|lost to follow-up (non-AE)|162
7340743|NCT00879437|11578361|FG000|Overall Study|Protocol Violation|0
7340744|NCT00879437|11578362|FG001|Overall Study|Protocol Violation|1
7340745|NCT00879437|11578361|FG000|Overall Study|Death|1
7340746|NCT00879437|11578362|FG001|Overall Study|Death|0
7340747|NCT00879645|11578374|FG000|Overall Study|Adverse Event|1
7340748|NCT00879645|11578375|FG001|Overall Study|Adverse Event|0
7340749|NCT00879645|11578376|FG002|Overall Study|Adverse Event|0
7340750|NCT00879645|11578377|FG003|Overall Study|Adverse Event|0
7340751|NCT00879658|11578394|FG000|Overall Study|Abnormal laboratory value(s)|3
7340752|NCT00879658|11578395|FG001|Overall Study|Abnormal laboratory value(s)|0
7340753|NCT00879658|11578396|FG002|Overall Study|Abnormal laboratory value(s)|0
7340754|NCT00879658|11578397|FG003|Overall Study|Abnormal laboratory value(s)|1
7340755|NCT00879658|11578398|FG004|Overall Study|Abnormal laboratory value(s)|0
7340756|NCT00879658|11578399|FG005|Overall Study|Abnormal laboratory value(s)|0
7340757|NCT00879658|11578400|FG006|Overall Study|Abnormal laboratory value(s)|0
7340758|NCT00879658|11578394|FG000|Overall Study|Administrative problems|2
7340759|NCT00879658|11578395|FG001|Overall Study|Administrative problems|1
7340760|NCT00879658|11578396|FG002|Overall Study|Administrative problems|0
7340761|NCT00879658|11578397|FG003|Overall Study|Administrative problems|1
7340762|NCT00879658|11578398|FG004|Overall Study|Administrative problems|0
7340763|NCT00879658|11578399|FG005|Overall Study|Administrative problems|0
7340764|NCT00879658|11578400|FG006|Overall Study|Administrative problems|0
7340765|NCT00879658|11578394|FG000|Overall Study|Adverse Event|6
7340766|NCT00879658|11578395|FG001|Overall Study|Adverse Event|4
7340767|NCT00879658|11578396|FG002|Overall Study|Adverse Event|3
7340768|NCT00879658|11578397|FG003|Overall Study|Adverse Event|1
7340769|NCT00879658|11578398|FG004|Overall Study|Adverse Event|2
7340770|NCT00879658|11578399|FG005|Overall Study|Adverse Event|0
7340771|NCT00879658|11578400|FG006|Overall Study|Adverse Event|0
7340772|NCT00879658|11578394|FG000|Overall Study|Protocol Violation|1
7340773|NCT00879658|11578395|FG001|Overall Study|Protocol Violation|0
7340774|NCT00879658|11578396|FG002|Overall Study|Protocol Violation|0
7340775|NCT00879658|11578397|FG003|Overall Study|Protocol Violation|0
7340776|NCT00879658|11578398|FG004|Overall Study|Protocol Violation|0
7340777|NCT00879658|11578399|FG005|Overall Study|Protocol Violation|0
7340778|NCT00879658|11578400|FG006|Overall Study|Protocol Violation|0
7340779|NCT00879658|11578394|FG000|Overall Study|Withdrawal by Subject|3
7340780|NCT00879658|11578395|FG001|Overall Study|Withdrawal by Subject|0
7340781|NCT00879658|11578396|FG002|Overall Study|Withdrawal by Subject|2
7340782|NCT00879658|11578397|FG003|Overall Study|Withdrawal by Subject|0
7340783|NCT00879658|11578398|FG004|Overall Study|Withdrawal by Subject|0
7340784|NCT00879658|11578399|FG005|Overall Study|Withdrawal by Subject|1
7340785|NCT00879658|11578400|FG006|Overall Study|Withdrawal by Subject|0
7340786|NCT00879658|11578394|FG000|Overall Study|Lack of Efficacy|0
7340787|NCT00879658|11578395|FG001|Overall Study|Lack of Efficacy|0
7340788|NCT00879658|11578396|FG002|Overall Study|Lack of Efficacy|2
7340789|NCT00879658|11578397|FG003|Overall Study|Lack of Efficacy|0
7340790|NCT00879658|11578398|FG004|Overall Study|Lack of Efficacy|0
7340791|NCT00879658|11578399|FG005|Overall Study|Lack of Efficacy|0
7340792|NCT00879658|11578400|FG006|Overall Study|Lack of Efficacy|0
7340793|NCT00879658|11578394|FG000|Overall Study|misrandomized (never received study med)|0
7340794|NCT00879658|11578395|FG001|Overall Study|misrandomized (never received study med)|0
7340795|NCT00879658|11578396|FG002|Overall Study|misrandomized (never received study med)|0
7340796|NCT00879658|11578397|FG003|Overall Study|misrandomized (never received study med)|1
7340797|NCT00879658|11578398|FG004|Overall Study|misrandomized (never received study med)|0
7340798|NCT00879658|11578399|FG005|Overall Study|misrandomized (never received study med)|0
7340799|NCT00879658|11578400|FG006|Overall Study|misrandomized (never received study med)|0
7340800|NCT00879684|11578422|FG000|Stage 1: Dose Escalation|Adverse Event|1
7340801|NCT00879684|11578423|FG001|Stage 1: Dose Escalation|Adverse Event|0
7340802|NCT00879684|11578424|FG002|Stage 1: Dose Escalation|Adverse Event|0
7340803|NCT00879684|11578425|FG003|Stage 1: Dose Escalation|Adverse Event|0
7340804|NCT00879684|11578426|FG004|Stage 1: Dose Escalation|Adverse Event|0
7340805|NCT00879684|11578427|FG005|Stage 1: Dose Escalation|Adverse Event|0
7340806|NCT00879684|11578428|FG006|Stage 1: Dose Escalation|Adverse Event|0
7340807|NCT00879684|11578422|FG000|Stage 1: Dose Escalation|Progressive Disease|2
7340808|NCT00879684|11578423|FG001|Stage 1: Dose Escalation|Progressive Disease|3
7340809|NCT00879684|11578424|FG002|Stage 1: Dose Escalation|Progressive Disease|0
7340810|NCT00879684|11578425|FG003|Stage 1: Dose Escalation|Progressive Disease|4
7340811|NCT00879684|11578426|FG004|Stage 1: Dose Escalation|Progressive Disease|3
7340812|NCT00879684|11578427|FG005|Stage 1: Dose Escalation|Progressive Disease|3
7340813|NCT00879684|11578428|FG006|Stage 1: Dose Escalation|Progressive Disease|0
7340814|NCT00879684|11578422|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
7340815|NCT00879684|11578423|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
7340816|NCT00879684|11578424|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
7340817|NCT00879684|11578425|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
7340818|NCT00879684|11578426|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
7340819|NCT00879684|11578427|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
7340820|NCT00879684|11578428|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
7340821|NCT00879684|11578422|FG000|Stage 1: Dose Escalation|Death|0
7340822|NCT00879684|11578423|FG001|Stage 1: Dose Escalation|Death|0
7340823|NCT00879684|11578424|FG002|Stage 1: Dose Escalation|Death|1
7340824|NCT00879684|11578425|FG003|Stage 1: Dose Escalation|Death|0
7340825|NCT00879684|11578426|FG004|Stage 1: Dose Escalation|Death|0
7340826|NCT00879684|11578427|FG005|Stage 1: Dose Escalation|Death|0
7340827|NCT00879684|11578428|FG006|Stage 1: Dose Escalation|Death|0
7340828|NCT00879684|11578422|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340829|NCT00879684|11578423|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340830|NCT00879684|11578424|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340831|NCT00879684|11578425|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340832|NCT00879684|11578426|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340833|NCT00879684|11578427|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
7340834|NCT00879684|11578428|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
7340835|NCT00879684|11578422|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
7458347|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7340836|NCT00879684|11578423|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
7340837|NCT00879684|11578424|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
7340838|NCT00879684|11578425|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
7340839|NCT00879684|11578426|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
7340840|NCT00879684|11578427|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
7340841|NCT00879684|11578428|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
7340842|NCT00879684|11578422|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
7340843|NCT00879684|11578423|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
7340844|NCT00879684|11578424|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
7340845|NCT00879684|11578425|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
7340846|NCT00879684|11578426|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
7340847|NCT00879684|11578427|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
7340926|NCT00879996|11578529|FG001|Overall Study|non-compliance|4
7340848|NCT00879684|11578428|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
7340849|NCT00879697|11578449|FG000|Overall Study|Physician Decision|2
7340850|NCT00879697|11578450|FG001|Overall Study|Physician Decision|2
7340851|NCT00879710|11578458|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
7340852|NCT00879710|11578459|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
7340853|NCT00879710|11578460|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
7340854|NCT00879710|11578461|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
7340855|NCT00879710|11578458|FG000|Phase 1 - 6 Weeks|Adverse Event|0
7340856|NCT00879710|11578459|FG001|Phase 1 - 6 Weeks|Adverse Event|0
7340857|NCT00879710|11578460|FG002|Phase 1 - 6 Weeks|Adverse Event|1
7340858|NCT00879710|11578461|FG003|Phase 1 - 6 Weeks|Adverse Event|0
7340859|NCT00879775|11578471|FG000|Overall Study|Lost to Follow-up|2
7340860|NCT00879775|11578472|FG001|Overall Study|Lost to Follow-up|1
7340861|NCT00879814|11578482|FG000|Overall Study|Adverse Event|0
7340862|NCT00879814|11578483|FG001|Overall Study|Adverse Event|1
7340863|NCT00879814|11578484|FG002|Overall Study|Adverse Event|0
7340864|NCT00879814|11578485|FG003|Overall Study|Adverse Event|0
7340865|NCT00879814|11578482|FG000|Overall Study|Lost to Follow-up|1
7340866|NCT00879814|11578483|FG001|Overall Study|Lost to Follow-up|0
7340867|NCT00879814|11578484|FG002|Overall Study|Lost to Follow-up|0
7340868|NCT00879814|11578485|FG003|Overall Study|Lost to Follow-up|2
7340869|NCT00879814|11578482|FG000|Overall Study|Participant Failed to Return|0
7340870|NCT00879814|11578483|FG001|Overall Study|Participant Failed to Return|0
7340871|NCT00879814|11578484|FG002|Overall Study|Participant Failed to Return|0
7340872|NCT00879814|11578485|FG003|Overall Study|Participant Failed to Return|1
7340873|NCT00879814|11578482|FG000|Overall Study|Withdrawal by Subject|3
7340874|NCT00879814|11578483|FG001|Overall Study|Withdrawal by Subject|1
7340875|NCT00879814|11578484|FG002|Overall Study|Withdrawal by Subject|1
7340876|NCT00879814|11578485|FG003|Overall Study|Withdrawal by Subject|2
7340877|NCT00879814|11578482|FG000|Overall Study|Physician Decision|0
7340878|NCT00879814|11578483|FG001|Overall Study|Physician Decision|0
7340879|NCT00879814|11578484|FG002|Overall Study|Physician Decision|1
7340880|NCT00879814|11578485|FG003|Overall Study|Physician Decision|0
7340881|NCT00879814|11578482|FG000|Overall Study|Other|0
7340882|NCT00879814|11578483|FG001|Overall Study|Other|0
7340883|NCT00879814|11578484|FG002|Overall Study|Other|1
7340884|NCT00879814|11578485|FG003|Overall Study|Other|0
7340885|NCT00879879|11578495|FG000|Overall Study|Death|1
7340886|NCT00879879|11578495|FG000|Overall Study|Withdrawal by Subject|1
7340887|NCT00879879|11578495|FG000|Overall Study|Physician Decision|1
7340888|NCT00879970|11578504|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7340889|NCT00879970|11578505|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
7340890|NCT00879970|11578506|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
7340891|NCT00879970|11578507|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7340892|NCT00879970|11578508|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
7340893|NCT00879970|11578504|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
7340894|NCT00879970|11578505|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
7340895|NCT00879970|11578506|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
7340896|NCT00879970|11578507|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
7340897|NCT00879970|11578508|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
7340898|NCT00879970|11578504|FG000|Period 1 TZD Randomization|Death|2
7340899|NCT00879970|11578505|FG001|Period 1 TZD Randomization|Death|1
7340900|NCT00879970|11578506|FG002|Period 1 TZD Randomization|Death|0
7340901|NCT00879970|11578507|FG003|Period 1 TZD Randomization|Death|0
7340902|NCT00879970|11578508|FG004|Period 1 TZD Randomization|Death|0
7340903|NCT00879970|11578504|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
7340904|NCT00879970|11578505|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7340905|NCT00879970|11578506|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
7340906|NCT00879970|11578507|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7340907|NCT00879970|11578508|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
7385682|NCT01203098|11643544|FG000|Overall Study|Physician Decision|2
7340908|NCT00879970|11578504|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7340909|NCT00879970|11578505|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7340910|NCT00879970|11578506|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
7340911|NCT00879970|11578507|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
7340912|NCT00879970|11578508|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
7340913|NCT00879970|11578504|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7340914|NCT00879970|11578505|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7340915|NCT00879970|11578506|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7340916|NCT00879970|11578507|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
7340917|NCT00879970|11578508|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
7340918|NCT00879970|11578504|FG000|Period 2 Vitamin D Randomization|Death|0
7340919|NCT00879970|11578505|FG001|Period 2 Vitamin D Randomization|Death|0
7340920|NCT00879970|11578506|FG002|Period 2 Vitamin D Randomization|Death|0
7340921|NCT00879970|11578507|FG003|Period 2 Vitamin D Randomization|Death|2
7340922|NCT00879970|11578508|FG004|Period 2 Vitamin D Randomization|Death|0
7340923|NCT00879996|11578528|FG000|Overall Study|Lost to Follow-up|7
7340924|NCT00879996|11578529|FG001|Overall Study|Lost to Follow-up|6
7340925|NCT00879996|11578528|FG000|Overall Study|non-compliance|6
7340927|NCT00879996|11578528|FG000|Overall Study|Physician Decision|1
7340928|NCT00879996|11578529|FG001|Overall Study|Physician Decision|2
7340929|NCT00879996|11578528|FG000|Overall Study|psychiatric problem|0
7340930|NCT00879996|11578529|FG001|Overall Study|psychiatric problem|1
7340931|NCT00879996|11578528|FG000|Overall Study|put on parole|1
7340932|NCT00879996|11578529|FG001|Overall Study|put on parole|0
7340933|NCT00880009|11578537|FG000|Overall Study|Study terminated by sponsor|14
7340934|NCT00880009|11578537|FG000|Overall Study|Withdrawal by Subject|1
7340935|NCT00880009|11578537|FG000|Overall Study|Protocol Violation|1
7340936|NCT00880048|11578558|FG000|Overall Study|Adverse Event|2
7340937|NCT00880048|11578559|FG001|Overall Study|Adverse Event|3
7340938|NCT00880048|11578560|FG002|Overall Study|Adverse Event|5
7340939|NCT00880048|11578558|FG000|Overall Study|Lack of Efficacy|1
7340940|NCT00880048|11578559|FG001|Overall Study|Lack of Efficacy|2
7340941|NCT00880048|11578560|FG002|Overall Study|Lack of Efficacy|2
7340942|NCT00880048|11578558|FG000|Overall Study|Protocol Violation|4
7340943|NCT00880048|11578559|FG001|Overall Study|Protocol Violation|6
7340944|NCT00880048|11578560|FG002|Overall Study|Protocol Violation|5
7340945|NCT00880048|11578558|FG000|Overall Study|Lost to Follow-up|6
7340946|NCT00880048|11578559|FG001|Overall Study|Lost to Follow-up|6
7340947|NCT00880048|11578560|FG002|Overall Study|Lost to Follow-up|5
7340948|NCT00880048|11578558|FG000|Overall Study|Physician Decision|1
7340949|NCT00880048|11578559|FG001|Overall Study|Physician Decision|1
7340950|NCT00880048|11578560|FG002|Overall Study|Physician Decision|7
7340951|NCT00880048|11578558|FG000|Overall Study|Withdrawal by Subject|5
7340952|NCT00880048|11578559|FG001|Overall Study|Withdrawal by Subject|8
7340953|NCT00880048|11578560|FG002|Overall Study|Withdrawal by Subject|5
7340954|NCT00880048|11578558|FG000|Overall Study|Study closed/terminated|9
7340955|NCT00880048|11578559|FG001|Overall Study|Study closed/terminated|7
7340956|NCT00880048|11578560|FG002|Overall Study|Study closed/terminated|6
7340957|NCT00880087|11578570|FG000|Overall Study|Lost to Follow-up|0
7340958|NCT00880087|11578571|FG001|Overall Study|Lost to Follow-up|2
7340959|NCT00880100|11578577|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
7340960|NCT00880100|11578577|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
7340961|NCT00880100|11578577|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
7340962|NCT00880165|11578583|FG000|Overall Study|Withdrawal by Subject|27
7340963|NCT00880165|11578584|FG001|Overall Study|Withdrawal by Subject|23
7340964|NCT00880165|11578583|FG000|Overall Study|Not diagnosed with OSA|14
7340965|NCT00880165|11578584|FG001|Overall Study|Not diagnosed with OSA|8
7340966|NCT00880165|11578583|FG000|Overall Study|Required BIPAP or oxygen treatment|12
7340967|NCT00880165|11578584|FG001|Overall Study|Required BIPAP or oxygen treatment|4
7340968|NCT00880165|11578583|FG000|Overall Study|Lost to follow|9
7340969|NCT00880165|11578584|FG001|Overall Study|Lost to follow|15
7340970|NCT00880191|11578592|FG000|Overall Study|Refused further treatment|4
7340971|NCT00880191|11578593|FG001|Overall Study|Refused further treatment|1
7340972|NCT00880191|11578592|FG000|Overall Study|Adverse Event|8
7340973|NCT00880191|11578593|FG001|Overall Study|Adverse Event|6
7340974|NCT00880191|11578592|FG000|Overall Study|Hospitalization/efficacy|1
7340975|NCT00880191|11578593|FG001|Overall Study|Hospitalization/efficacy|1
7533032|NCT02679729|11879033|FG007|Overall Study|Participant decision|0
7340976|NCT00880256|11578603|FG000|Overall Study|Lost to Follow-up|28
7340977|NCT00880269|11578609|FG000|Overall Study|Protocol Violation|1
7340978|NCT00880269|11578610|FG001|Overall Study|Protocol Violation|0
7340979|NCT00880269|11578609|FG000|Overall Study|Disease Progression|13
7340980|NCT00880269|11578610|FG001|Overall Study|Disease Progression|11
7340981|NCT00880269|11578609|FG000|Overall Study|New Cancer Therapy|1
7340982|NCT00880269|11578610|FG001|Overall Study|New Cancer Therapy|0
7340983|NCT00880269|11578609|FG000|Overall Study|Death|4
7340984|NCT00880269|11578610|FG001|Overall Study|Death|2
7340985|NCT00880269|11578609|FG000|Overall Study|Lost to Follow-up|0
7340986|NCT00880269|11578610|FG001|Overall Study|Lost to Follow-up|1
7340987|NCT00880269|11578609|FG000|Overall Study|Withdrawal by Subject|3
7468237|NCT01908803|11768921|FG001|Overall Study|Adverse Event|0
7340988|NCT00880269|11578610|FG001|Overall Study|Withdrawal by Subject|4
7340989|NCT00880269|11578609|FG000|Overall Study|Adverse Event|10
7340990|NCT00880269|11578610|FG001|Overall Study|Adverse Event|9
7340991|NCT00880334|11578618|FG000|Randomized Phase|Physician Decision|1
7340992|NCT00880334|11578619|FG001|Randomized Phase|Physician Decision|0
7340993|NCT00880334|11578618|FG000|Randomized Phase|Withdrawal by Subject|2
7340994|NCT00880334|11578619|FG001|Randomized Phase|Withdrawal by Subject|1
7340995|NCT00880334|11578618|FG000|Randomized Phase|Inadequate Labs|1
7340996|NCT00880334|11578619|FG001|Randomized Phase|Inadequate Labs|1
7340997|NCT00880334|11578618|FG000|Randomized Phase|Brain Metastasis|0
7340998|NCT00880334|11578619|FG001|Randomized Phase|Brain Metastasis|1
7340999|NCT00880334|11578618|FG000|Randomized Phase|Crossover Participants|0
7341000|NCT00880334|11578619|FG001|Randomized Phase|Crossover Participants|37
7341001|NCT00880399|11578637|FG000|Overall Study|Adverse Event|4
7341002|NCT00880399|11578638|FG001|Overall Study|Adverse Event|6
7341003|NCT00880399|11578639|FG002|Overall Study|Adverse Event|5
7341004|NCT00880399|11578637|FG000|Overall Study|Lack of Efficacy|1
7341005|NCT00880399|11578638|FG001|Overall Study|Lack of Efficacy|4
7341006|NCT00880399|11578639|FG002|Overall Study|Lack of Efficacy|2
7341007|NCT00880399|11578637|FG000|Overall Study|Protocol Violation|4
7341008|NCT00880399|11578638|FG001|Overall Study|Protocol Violation|4
7341009|NCT00880399|11578639|FG002|Overall Study|Protocol Violation|6
7341010|NCT00880399|11578637|FG000|Overall Study|Study closed/terminated|3
7341011|NCT00880399|11578638|FG001|Overall Study|Study closed/terminated|7
7341012|NCT00880399|11578639|FG002|Overall Study|Study closed/terminated|4
7341013|NCT00880399|11578637|FG000|Overall Study|Lost to Follow-up|8
7341014|NCT00880399|11578638|FG001|Overall Study|Lost to Follow-up|5
7341015|NCT00880399|11578639|FG002|Overall Study|Lost to Follow-up|3
7341016|NCT00880399|11578637|FG000|Overall Study|Physician Decision|5
7341017|NCT00880399|11578638|FG001|Overall Study|Physician Decision|0
7341018|NCT00880399|11578639|FG002|Overall Study|Physician Decision|3
7341019|NCT00880399|11578637|FG000|Overall Study|Withdrawal by Subject|6
7341020|NCT00880399|11578638|FG001|Overall Study|Withdrawal by Subject|3
7341021|NCT00880399|11578639|FG002|Overall Study|Withdrawal by Subject|3
7341022|NCT00880555|11578661|FG000|Overall Study|Physician Decision|0
7341023|NCT00880555|11578662|FG001|Overall Study|Physician Decision|8
7341024|NCT00880555|11578663|FG002|Overall Study|Physician Decision|0
7341025|NCT00880555|11578664|FG003|Overall Study|Physician Decision|2
7341026|NCT00880555|11578665|FG004|Overall Study|Physician Decision|1
7341027|NCT00880555|11578666|FG005|Overall Study|Physician Decision|0
7341028|NCT00880555|11578661|FG000|Overall Study|Withdrawal by Subject|1
7341029|NCT00880555|11578662|FG001|Overall Study|Withdrawal by Subject|1
7341030|NCT00880555|11578663|FG002|Overall Study|Withdrawal by Subject|0
7341031|NCT00880555|11578664|FG003|Overall Study|Withdrawal by Subject|0
7341032|NCT00880555|11578665|FG004|Overall Study|Withdrawal by Subject|0
7341033|NCT00880555|11578666|FG005|Overall Study|Withdrawal by Subject|0
7341034|NCT00880555|11578661|FG000|Overall Study|Lack of resources (hired rater)|9
7458348|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7458349|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7458350|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
7458351|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
7458352|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458353|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458354|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458355|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458356|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458357|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
7458358|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458359|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458360|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
7458361|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458362|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458363|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458364|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
7458365|NCT01807520|11752410|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
7458366|NCT01807520|11752411|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7341035|NCT00880555|11578662|FG001|Overall Study|Lack of resources (hired rater)|7
7341036|NCT00880555|11578663|FG002|Overall Study|Lack of resources (hired rater)|5
7341037|NCT00880555|11578664|FG003|Overall Study|Lack of resources (hired rater)|0
7341038|NCT00880555|11578665|FG004|Overall Study|Lack of resources (hired rater)|0
7341039|NCT00880555|11578666|FG005|Overall Study|Lack of resources (hired rater)|0
7341040|NCT00880555|11578661|FG000|Overall Study|Death|0
7341041|NCT00880555|11578662|FG001|Overall Study|Death|0
7341042|NCT00880555|11578663|FG002|Overall Study|Death|0
7341043|NCT00880555|11578664|FG003|Overall Study|Death|0
7341044|NCT00880555|11578665|FG004|Overall Study|Death|0
7341045|NCT00880555|11578666|FG005|Overall Study|Death|1
7341046|NCT00880555|11578661|FG000|Overall Study|Lost to Follow-up|0
7341047|NCT00880555|11578662|FG001|Overall Study|Lost to Follow-up|1
7341048|NCT00880555|11578663|FG002|Overall Study|Lost to Follow-up|0
7341049|NCT00880555|11578664|FG003|Overall Study|Lost to Follow-up|0
7341050|NCT00880555|11578665|FG004|Overall Study|Lost to Follow-up|0
7341051|NCT00880555|11578666|FG005|Overall Study|Lost to Follow-up|0
7341052|NCT00880568|11578686|FG000|Overall Study|Disease progression|3
7341053|NCT00880568|11578687|FG001|Overall Study|Disease progression|3
7341054|NCT00880568|11578688|FG002|Overall Study|Disease progression|3
7341055|NCT00880568|11578689|FG003|Overall Study|Disease progression|1
7341056|NCT00880568|11578690|FG004|Overall Study|Disease progression|3
7341057|NCT00880568|11578691|FG005|Overall Study|Disease progression|3
7341058|NCT00880568|11578692|FG006|Overall Study|Disease progression|5
7341059|NCT00880568|11578693|FG007|Overall Study|Disease progression|0
7341060|NCT00880568|11578694|FG008|Overall Study|Disease progression|3
7341061|NCT00880568|11578686|FG000|Overall Study|Adverse Event|0
7341062|NCT00880568|11578687|FG001|Overall Study|Adverse Event|0
7341063|NCT00880568|11578688|FG002|Overall Study|Adverse Event|0
7341064|NCT00880568|11578689|FG003|Overall Study|Adverse Event|0
7341065|NCT00880568|11578690|FG004|Overall Study|Adverse Event|0
7341066|NCT00880568|11578691|FG005|Overall Study|Adverse Event|0
7341067|NCT00880568|11578692|FG006|Overall Study|Adverse Event|1
7341068|NCT00880568|11578693|FG007|Overall Study|Adverse Event|1
7341069|NCT00880568|11578694|FG008|Overall Study|Adverse Event|0
7341070|NCT00880568|11578686|FG000|Overall Study|Withdrawal by Subject|0
7341071|NCT00880568|11578687|FG001|Overall Study|Withdrawal by Subject|0
7341072|NCT00880568|11578688|FG002|Overall Study|Withdrawal by Subject|0
7341073|NCT00880568|11578689|FG003|Overall Study|Withdrawal by Subject|0
7341074|NCT00880568|11578690|FG004|Overall Study|Withdrawal by Subject|0
7341075|NCT00880568|11578691|FG005|Overall Study|Withdrawal by Subject|0
7341076|NCT00880568|11578692|FG006|Overall Study|Withdrawal by Subject|0
7341077|NCT00880568|11578693|FG007|Overall Study|Withdrawal by Subject|1
7341078|NCT00880568|11578694|FG008|Overall Study|Withdrawal by Subject|0
7341079|NCT00880607|11578725|FG000|Overall Study|Physician Decision|2
7341080|NCT00880607|11578726|FG001|Overall Study|Physician Decision|2
7341081|NCT00880607|11578725|FG000|Overall Study|Protocol Violation|2
7341082|NCT00880607|11578726|FG001|Overall Study|Protocol Violation|1
7341083|NCT00880607|11578725|FG000|Overall Study|surgery did not extend past L1 level|3
7341084|NCT00880607|11578726|FG001|Overall Study|surgery did not extend past L1 level|0
7341085|NCT00880620|11578738|FG000|Overall Study|Adverse Event|4
7341086|NCT00880620|11578739|FG001|Overall Study|Adverse Event|5
7341087|NCT00880620|11578740|FG002|Overall Study|Adverse Event|15
7341088|NCT00880620|11578741|FG003|Overall Study|Adverse Event|15
7341089|NCT00880620|11578738|FG000|Overall Study|Death|0
7341090|NCT00880620|11578739|FG001|Overall Study|Death|0
7341091|NCT00880620|11578740|FG002|Overall Study|Death|1
7341092|NCT00880620|11578741|FG003|Overall Study|Death|0
7341093|NCT00880620|11578738|FG000|Overall Study|Lack of Efficacy|12
7341094|NCT00880620|11578739|FG001|Overall Study|Lack of Efficacy|4
7341095|NCT00880620|11578740|FG002|Overall Study|Lack of Efficacy|0
7341096|NCT00880620|11578741|FG003|Overall Study|Lack of Efficacy|1
7341097|NCT00880620|11578738|FG000|Overall Study|Lost to Follow-up|0
7341098|NCT00880620|11578739|FG001|Overall Study|Lost to Follow-up|1
7341099|NCT00880620|11578740|FG002|Overall Study|Lost to Follow-up|1
7341100|NCT00880620|11578741|FG003|Overall Study|Lost to Follow-up|0
7341101|NCT00880620|11578738|FG000|Overall Study|Protocol Violation|0
7341102|NCT00880620|11578739|FG001|Overall Study|Protocol Violation|1
7341103|NCT00880620|11578740|FG002|Overall Study|Protocol Violation|0
7341104|NCT00880620|11578741|FG003|Overall Study|Protocol Violation|2
7341105|NCT00880620|11578738|FG000|Overall Study|Withdrawal by Subject|4
7341106|NCT00880620|11578739|FG001|Overall Study|Withdrawal by Subject|3
7341107|NCT00880620|11578740|FG002|Overall Study|Withdrawal by Subject|1
7341108|NCT00880620|11578741|FG003|Overall Study|Withdrawal by Subject|3
7341109|NCT00880620|11578738|FG000|Overall Study|Noncompliance|0
7341110|NCT00880620|11578739|FG001|Overall Study|Noncompliance|0
7341111|NCT00880620|11578740|FG002|Overall Study|Noncompliance|1
7341112|NCT00880620|11578741|FG003|Overall Study|Noncompliance|1
7341113|NCT00880620|11578738|FG000|Overall Study|Other|1
7341114|NCT00880620|11578739|FG001|Overall Study|Other|1
7341115|NCT00880620|11578740|FG002|Overall Study|Other|2
7341116|NCT00880620|11578741|FG003|Overall Study|Other|2
7341117|NCT00880685|11578755|FG000|Memantine 10mg|Lost to Follow-up|2
7341118|NCT00880685|11578755|FG000|Memantine 20mg|Withdrawal by Subject|1
7341119|NCT00880698|11578766|FG000|Overall Study|Death|0
7341120|NCT00880698|11578767|FG001|Overall Study|Death|0
7341121|NCT00880698|11578768|FG002|Overall Study|Death|1
7341122|NCT00880698|11578769|FG003|Overall Study|Death|2
7341123|NCT00880698|11578766|FG000|Overall Study|Lost to Follow-up|1
7341124|NCT00880698|11578767|FG001|Overall Study|Lost to Follow-up|3
7341125|NCT00880698|11578768|FG002|Overall Study|Lost to Follow-up|0
7341126|NCT00880698|11578769|FG003|Overall Study|Lost to Follow-up|1
7341127|NCT00880750|11578783|FG000|First Intervention|Adverse Event|1
7341128|NCT00880750|11578784|FG001|First Intervention|Adverse Event|0
7385683|NCT01203098|11643545|FG001|Overall Study|Physician Decision|2
7341129|NCT00880750|11578783|FG000|First Intervention|Unable to collect urine|4
7341130|NCT00880750|11578784|FG001|First Intervention|Unable to collect urine|0
7341131|NCT00880750|11578783|FG000|First Intervention|Non-compliance with meals|0
7341132|NCT00880750|11578784|FG001|First Intervention|Non-compliance with meals|1
7341133|NCT00880750|11578783|FG000|First Intervention|Withdrawal by Subject|2
7341134|NCT00880750|11578784|FG001|First Intervention|Withdrawal by Subject|0
7341135|NCT00880750|11578783|FG000|First Intervention|Lost to Follow-up|2
7341136|NCT00880750|11578784|FG001|First Intervention|Lost to Follow-up|0
7341137|NCT00880750|11578783|FG000|Second Intervention|Withdrawal by Subject|2
7341138|NCT00880750|11578784|FG001|Second Intervention|Withdrawal by Subject|2
7341139|NCT00880750|11578783|FG000|Second Intervention|Protocol Violation|1
7341140|NCT00880750|11578784|FG001|Second Intervention|Protocol Violation|0
7341141|NCT00880750|11578783|FG000|Second Intervention|Unable to collect urine|1
7341142|NCT00880750|11578784|FG001|Second Intervention|Unable to collect urine|0
7341143|NCT00880763|11578794|FG000|Extension Period (Part 2)|Adverse Event|0
7341144|NCT00880763|11578795|FG001|Extension Period (Part 2)|Adverse Event|0
7341145|NCT00880763|11578796|FG002|Extension Period (Part 2)|Adverse Event|1
7341146|NCT00880763|11578797|FG003|Extension Period (Part 2)|Adverse Event|1
7341147|NCT00880763|11578794|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
7341148|NCT00880763|11578795|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
7341149|NCT00880763|11578796|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
7341150|NCT00880763|11578797|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
7341151|NCT00880763|11578794|FG000|Extension Period (Part 2)|Physician Decision|0
7341152|NCT00880763|11578795|FG001|Extension Period (Part 2)|Physician Decision|1
7341153|NCT00880763|11578796|FG002|Extension Period (Part 2)|Physician Decision|1
7341154|NCT00880763|11578797|FG003|Extension Period (Part 2)|Physician Decision|0
7341155|NCT00880763|11578794|FG000|Extension Period (Part 2)|Lack of Efficacy|0
7341156|NCT00880763|11578795|FG001|Extension Period (Part 2)|Lack of Efficacy|0
7341157|NCT00880763|11578796|FG002|Extension Period (Part 2)|Lack of Efficacy|0
7341158|NCT00880763|11578797|FG003|Extension Period (Part 2)|Lack of Efficacy|1
7341159|NCT00880906|11578809|FG000|Overall Study|Lost to Follow-up|0
7341160|NCT00880906|11578810|FG001|Overall Study|Lost to Follow-up|1
7341161|NCT00880906|11578809|FG000|Overall Study|Did not meet criteria following patholog|12
7341162|NCT00880906|11578810|FG001|Overall Study|Did not meet criteria following patholog|6
7341163|NCT00881335|11578847|FG000|Overall Study|Lost to Follow-up|3
7341164|NCT00881335|11578848|FG001|Overall Study|Lost to Follow-up|2
7341165|NCT00881361|11578856|FG000|Overall Study|Terminated prior to surgery|27
7341166|NCT00881361|11578857|FG001|Overall Study|Terminated prior to surgery|7
7341167|NCT00881361|11578858|FG002|Overall Study|Terminated prior to surgery|0
7341168|NCT00881361|11578856|FG000|Overall Study|Ineligible|17
7341169|NCT00881361|11578857|FG001|Overall Study|Ineligible|2
7341170|NCT00881361|11578858|FG002|Overall Study|Ineligible|2
7341171|NCT00881504|11578876|FG000|Overall Study|Withdrawal by Subject|1
7341172|NCT00881530|11578886|FG000|Overall Study|Adverse Event|5
7341173|NCT00881530|11578887|FG001|Overall Study|Adverse Event|1
7341174|NCT00881530|11578888|FG002|Overall Study|Adverse Event|1
7341175|NCT00881530|11578889|FG003|Overall Study|Adverse Event|4
7341176|NCT00881530|11578890|FG004|Overall Study|Adverse Event|10
7341177|NCT00881530|11578891|FG005|Overall Study|Adverse Event|2
7341178|NCT00881530|11578886|FG000|Overall Study|Lack of Efficacy|1
7341179|NCT00881530|11578887|FG001|Overall Study|Lack of Efficacy|0
7341180|NCT00881530|11578888|FG002|Overall Study|Lack of Efficacy|0
7341181|NCT00881530|11578889|FG003|Overall Study|Lack of Efficacy|0
7341182|NCT00881530|11578890|FG004|Overall Study|Lack of Efficacy|1
7341183|NCT00881530|11578891|FG005|Overall Study|Lack of Efficacy|1
7341184|NCT00881530|11578886|FG000|Overall Study|Not compliant with the protocol|0
7341185|NCT00881530|11578887|FG001|Overall Study|Not compliant with the protocol|0
7341186|NCT00881530|11578888|FG002|Overall Study|Not compliant with the protocol|0
7341187|NCT00881530|11578889|FG003|Overall Study|Not compliant with the protocol|0
7341188|NCT00881530|11578890|FG004|Overall Study|Not compliant with the protocol|2
7341189|NCT00881530|11578891|FG005|Overall Study|Not compliant with the protocol|0
7341190|NCT00881530|11578886|FG000|Overall Study|Lost to Follow-up|0
7341191|NCT00881530|11578887|FG001|Overall Study|Lost to Follow-up|1
7341192|NCT00881530|11578888|FG002|Overall Study|Lost to Follow-up|1
7341193|NCT00881530|11578889|FG003|Overall Study|Lost to Follow-up|3
7341194|NCT00881530|11578890|FG004|Overall Study|Lost to Follow-up|1
7341195|NCT00881530|11578891|FG005|Overall Study|Lost to Follow-up|0
7458367|NCT01807520|11752412|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7458368|NCT01807520|11752413|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7458369|NCT01807520|11752414|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7458370|NCT01807520|11752415|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7458371|NCT01807520|11752416|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
7458372|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
7458373|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
7458374|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7458375|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7458376|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
7458377|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7458378|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
7341196|NCT00881530|11578886|FG000|Overall Study|Refused to continue medication|7
7341197|NCT00881530|11578887|FG001|Overall Study|Refused to continue medication|2
7341198|NCT00881530|11578888|FG002|Overall Study|Refused to continue medication|1
7341199|NCT00881530|11578889|FG003|Overall Study|Refused to continue medication|2
7341200|NCT00881530|11578890|FG004|Overall Study|Refused to continue medication|0
7341201|NCT00881530|11578891|FG005|Overall Study|Refused to continue medication|0
7341202|NCT00881530|11578886|FG000|Overall Study|Other reason not defined above|1
7341203|NCT00881530|11578887|FG001|Overall Study|Other reason not defined above|1
7341204|NCT00881530|11578888|FG002|Overall Study|Other reason not defined above|2
7341205|NCT00881530|11578889|FG003|Overall Study|Other reason not defined above|0
7341206|NCT00881530|11578890|FG004|Overall Study|Other reason not defined above|0
7341207|NCT00881530|11578891|FG005|Overall Study|Other reason not defined above|2
7341208|NCT00881569|11578907|FG000|Overall Study|Disease progression|1
7341209|NCT00881569|11578908|FG001|Overall Study|Disease progression|1
7341210|NCT00881621|11578914|FG000|Overall Study|Physician Decision|34
7341211|NCT00881712|11578930|FG000|Overall Study|Death|1
7341212|NCT00881712|11578931|FG001|Overall Study|Death|0
7341213|NCT00881712|11578932|FG002|Overall Study|Death|0
7341214|NCT00881712|11578930|FG000|Overall Study|Withdrawal by Subject|1
7341215|NCT00881712|11578931|FG001|Overall Study|Withdrawal by Subject|0
7341216|NCT00881712|11578932|FG002|Overall Study|Withdrawal by Subject|0
7341217|NCT00881751|11578942|FG000|Overall Study|Physician Decision|0
7341218|NCT00881751|11578943|FG001|Overall Study|Physician Decision|1
7341219|NCT00881751|11578942|FG000|Overall Study|Adverse Event|0
7341220|NCT00881751|11578943|FG001|Overall Study|Adverse Event|2
7341221|NCT00881751|11578942|FG000|Overall Study|Withdrawal by Subject|0
7341222|NCT00881751|11578943|FG001|Overall Study|Withdrawal by Subject|2
7341231|NCT00881894|11578960|FG000|Overall Study|Consent withdrawn|0
7341232|NCT00881894|11578961|FG001|Overall Study|Consent withdrawn|1
7341233|NCT00881894|11578960|FG000|Overall Study|Other reasons for premature termination|1
7341234|NCT00881894|11578961|FG001|Overall Study|Other reasons for premature termination|2
7341235|NCT00881959|11578969|FG000|Overall Study|Lost to Follow-up|2
7341236|NCT00881959|11578970|FG001|Overall Study|Lost to Follow-up|4
7341237|NCT00882115|11578980|FG000|Overall Study|Withdrawal by Subject|3
7341238|NCT00882115|11578980|FG000|Overall Study|did not respond to DEP challe|6
7341239|NCT00882362|11578991|FG000|Overall Study|Adverse Event|13
7341240|NCT00882362|11578992|FG001|Overall Study|Adverse Event|10
7341241|NCT00882362|11578991|FG000|Overall Study|Withdrawal by Subject|13
7341242|NCT00882362|11578992|FG001|Overall Study|Withdrawal by Subject|10
7341243|NCT00882362|11578991|FG000|Overall Study|Lack of Efficacy|3
7341244|NCT00882362|11578992|FG001|Overall Study|Lack of Efficacy|0
7341245|NCT00882362|11578991|FG000|Overall Study|Protocol Violation|7
7341246|NCT00882362|11578992|FG001|Overall Study|Protocol Violation|2
7341247|NCT00882362|11578991|FG000|Overall Study|Pregnancy|1
7341248|NCT00882362|11578992|FG001|Overall Study|Pregnancy|0
7341249|NCT00882362|11578991|FG000|Overall Study|Physician Decision|5
7341250|NCT00882362|11578992|FG001|Overall Study|Physician Decision|1
7341251|NCT00882362|11578991|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
7341252|NCT00882362|11578992|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
7341253|NCT00882362|11578991|FG000|Overall Study|change of residence or other commitments|5
7341254|NCT00882362|11578992|FG001|Overall Study|change of residence or other commitments|0
7341255|NCT00882518|11579000|FG000|Overall Study|Adverse Event|9
7341256|NCT00882518|11579001|FG001|Overall Study|Adverse Event|18
7341257|NCT00882518|11579000|FG000|Overall Study|Withdrawal by Subject|9
7341258|NCT00882518|11579001|FG001|Overall Study|Withdrawal by Subject|13
7341259|NCT00882518|11579000|FG000|Overall Study|Lack of Efficacy|12
7341260|NCT00882518|11579001|FG001|Overall Study|Lack of Efficacy|9
7341261|NCT00882518|11579000|FG000|Overall Study|Severe non-compliance to protocol|3
7341262|NCT00882518|11579001|FG001|Overall Study|Severe non-compliance to protocol|1
7341263|NCT00882518|11579000|FG000|Overall Study|Incorrect enrolment|4
7341264|NCT00882518|11579001|FG001|Overall Study|Incorrect enrolment|2
7341265|NCT00882518|11579000|FG000|Overall Study|Central lab closure for National day|1
7341266|NCT00882518|11579001|FG001|Overall Study|Central lab closure for National day|0
7341267|NCT00882518|11579000|FG000|Overall Study|Allocating random number by mistake|0
7341268|NCT00882518|11579001|FG001|Overall Study|Allocating random number by mistake|1
7341269|NCT00882557|11579009|FG000|Overall Study|Withdrawal by Subject|1
7341270|NCT00882557|11579010|FG001|Overall Study|Withdrawal by Subject|0
7341271|NCT00882557|11579009|FG000|Overall Study|Trouble with Vein Access|1
7341272|NCT00882557|11579010|FG001|Overall Study|Trouble with Vein Access|0
7341273|NCT00882557|11579009|FG000|Overall Study|Randomized Not Treated|0
7341274|NCT00882557|11579010|FG001|Overall Study|Randomized Not Treated|1
7341275|NCT00882583|11579018|FG000|Overall Study|Physician Decision|1
7341276|NCT00882583|11579019|FG001|Overall Study|Physician Decision|0
7341277|NCT00882583|11579018|FG000|Overall Study|Adverse Event|0
7341278|NCT00882583|11579019|FG001|Overall Study|Adverse Event|1
7341279|NCT00882713|11579054|FG000|Overall Study|Adverse Event|2
7341280|NCT00882713|11579054|FG000|Overall Study|Death|3
7341281|NCT00882713|11579054|FG000|Overall Study|Administrative reasons|4
7341282|NCT00882713|11579054|FG000|Overall Study|refused treatment/withdrew consent|4
7341283|NCT00882713|11579054|FG000|Overall Study|Blood transfusion|2
7341284|NCT00882713|11579054|FG000|Overall Study|Insufficient therapeutic response|3
7341285|NCT00882713|11579054|FG000|Overall Study|Failure to return|2
7341286|NCT00882713|11579054|FG000|Overall Study|Other - Reasons|2
7341287|NCT00882908|11579068|FG000|Overall Study|Adverse Event|0
7341288|NCT00882908|11579069|FG001|Overall Study|Adverse Event|0
7341289|NCT00882908|11579070|FG002|Overall Study|Adverse Event|1
7341290|NCT00882908|11579071|FG003|Overall Study|Adverse Event|0
7341291|NCT00882908|11579072|FG004|Overall Study|Adverse Event|1
7341292|NCT00882908|11579068|FG000|Overall Study|Lost to Follow-up|3
7341293|NCT00882908|11579069|FG001|Overall Study|Lost to Follow-up|5
7341294|NCT00882908|11579070|FG002|Overall Study|Lost to Follow-up|3
7341295|NCT00882908|11579071|FG003|Overall Study|Lost to Follow-up|1
7341296|NCT00882908|11579072|FG004|Overall Study|Lost to Follow-up|2
7341297|NCT00882908|11579068|FG000|Overall Study|Protocol Violation|0
7341298|NCT00882908|11579069|FG001|Overall Study|Protocol Violation|1
7341299|NCT00882908|11579070|FG002|Overall Study|Protocol Violation|0
7341300|NCT00882908|11579071|FG003|Overall Study|Protocol Violation|0
7341301|NCT00882908|11579072|FG004|Overall Study|Protocol Violation|0
7341302|NCT00882908|11579068|FG000|Overall Study|Withdrawal by Subject|0
7341303|NCT00882908|11579069|FG001|Overall Study|Withdrawal by Subject|0
7341304|NCT00882908|11579070|FG002|Overall Study|Withdrawal by Subject|3
7341305|NCT00882908|11579071|FG003|Overall Study|Withdrawal by Subject|5
7341306|NCT00882908|11579072|FG004|Overall Study|Withdrawal by Subject|2
7341307|NCT00882908|11579068|FG000|Overall Study|Subject reached a virologic endpoint|0
7341308|NCT00882908|11579069|FG001|Overall Study|Subject reached a virologic endpoint|0
7341309|NCT00882908|11579070|FG002|Overall Study|Subject reached a virologic endpoint|0
7341310|NCT00882908|11579071|FG003|Overall Study|Subject reached a virologic endpoint|0
7341311|NCT00882908|11579072|FG004|Overall Study|Subject reached a virologic endpoint|1
7341312|NCT00882908|11579068|FG000|Overall Study|Study terminated in error|0
7341313|NCT00882908|11579069|FG001|Overall Study|Study terminated in error|0
7341314|NCT00882908|11579070|FG002|Overall Study|Study terminated in error|0
7341315|NCT00882908|11579071|FG003|Overall Study|Study terminated in error|1
7341316|NCT00882908|11579072|FG004|Overall Study|Study terminated in error|0
7341317|NCT00882921|11579085|FG000|Overall Study|Death|2
7341318|NCT00882921|11579085|FG000|Overall Study|Other|3
7341319|NCT00882921|11579085|FG000|Overall Study|Lost to Follow-up|2
7341320|NCT00882921|11579085|FG000|Overall Study|Termination By Investigator|3
7341321|NCT00882921|11579085|FG000|Overall Study|Withdrawal Of Consent|1
7341322|NCT00882999|11579097|FG000|Overall Study|Adverse Event|0
7341323|NCT00882999|11579098|FG001|Overall Study|Adverse Event|0
7341324|NCT00882999|11579099|FG002|Overall Study|Adverse Event|0
7341325|NCT00882999|11579100|FG003|Overall Study|Adverse Event|0
7341326|NCT00882999|11579101|FG004|Overall Study|Adverse Event|1
7341327|NCT00882999|11579102|FG005|Overall Study|Adverse Event|0
7341328|NCT00882999|11579103|FG006|Overall Study|Adverse Event|0
7341329|NCT00882999|11579097|FG000|Overall Study|Death|0
7341330|NCT00882999|11579098|FG001|Overall Study|Death|1
7341331|NCT00882999|11579099|FG002|Overall Study|Death|0
7341332|NCT00882999|11579100|FG003|Overall Study|Death|0
7341333|NCT00882999|11579101|FG004|Overall Study|Death|0
7341334|NCT00882999|11579102|FG005|Overall Study|Death|0
7341335|NCT00882999|11579103|FG006|Overall Study|Death|0
7341336|NCT00882999|11579097|FG000|Overall Study|Withdrawal by Subject|7
7341337|NCT00882999|11579098|FG001|Overall Study|Withdrawal by Subject|6
7341338|NCT00882999|11579099|FG002|Overall Study|Withdrawal by Subject|3
7341339|NCT00882999|11579100|FG003|Overall Study|Withdrawal by Subject|3
7341340|NCT00882999|11579101|FG004|Overall Study|Withdrawal by Subject|6
7341341|NCT00882999|11579102|FG005|Overall Study|Withdrawal by Subject|5
7341342|NCT00882999|11579103|FG006|Overall Study|Withdrawal by Subject|5
7341343|NCT00882999|11579097|FG000|Overall Study|Lost to Follow-up|0
7341344|NCT00882999|11579098|FG001|Overall Study|Lost to Follow-up|1
7341345|NCT00882999|11579099|FG002|Overall Study|Lost to Follow-up|1
7341346|NCT00882999|11579100|FG003|Overall Study|Lost to Follow-up|2
7341347|NCT00882999|11579101|FG004|Overall Study|Lost to Follow-up|1
7341348|NCT00882999|11579102|FG005|Overall Study|Lost to Follow-up|1
7341349|NCT00882999|11579103|FG006|Overall Study|Lost to Follow-up|2
7341350|NCT00882999|11579097|FG000|Overall Study|Physician Decision|1
7341351|NCT00882999|11579098|FG001|Overall Study|Physician Decision|0
7341352|NCT00882999|11579099|FG002|Overall Study|Physician Decision|0
7341353|NCT00882999|11579100|FG003|Overall Study|Physician Decision|0
7341354|NCT00882999|11579101|FG004|Overall Study|Physician Decision|0
7341355|NCT00882999|11579102|FG005|Overall Study|Physician Decision|1
7341356|NCT00882999|11579103|FG006|Overall Study|Physician Decision|1
7341357|NCT00883051|11579131|FG000|Overall Study|Lost to Follow-up|0
7341358|NCT00883051|11579132|FG001|Overall Study|Lost to Follow-up|0
7341359|NCT00883051|11579133|FG002|Overall Study|Lost to Follow-up|0
7341360|NCT00883051|11579134|FG003|Overall Study|Lost to Follow-up|0
7341361|NCT00883051|11579135|FG004|Overall Study|Lost to Follow-up|1
7341362|NCT00883051|11579131|FG000|Overall Study|Did not use study medication|24
7341363|NCT00883051|11579132|FG001|Overall Study|Did not use study medication|22
7341364|NCT00883051|11579133|FG002|Overall Study|Did not use study medication|29
7341365|NCT00883051|11579134|FG003|Overall Study|Did not use study medication|29
7341366|NCT00883051|11579135|FG004|Overall Study|Did not use study medication|17
7341367|NCT00883090|11579147|FG000|Overall Study|Sponsor's decision|1
7341368|NCT00883090|11579147|FG000|Overall Study|Withdrawal by Subject|1
7341369|NCT00883116|11579162|FG000|Overall Study|Adverse event unrelated to study drug|5
7341370|NCT00883116|11579163|FG001|Overall Study|Adverse event unrelated to study drug|10
7341371|NCT00883116|11579162|FG000|Overall Study|Death|6
7341372|NCT00883116|11579163|FG001|Overall Study|Death|2
7341373|NCT00883116|11579162|FG000|Overall Study|Disease progression|130
7341374|NCT00883116|11579163|FG001|Overall Study|Disease progression|128
7341375|NCT00883116|11579162|FG000|Overall Study|Lost to Follow-up|0
7341376|NCT00883116|11579163|FG001|Overall Study|Lost to Follow-up|1
7341377|NCT00883116|11579162|FG000|Overall Study|Maximum clinical benefit|13
7341378|NCT00883116|11579163|FG001|Overall Study|Maximum clinical benefit|46
7341379|NCT00883116|11579162|FG000|Overall Study|Not identified|3
7341380|NCT00883116|11579163|FG001|Overall Study|Not identified|6
7341381|NCT00883116|11579162|FG000|Overall Study|Study drug toxicity|36
7341382|NCT00883116|11579163|FG001|Overall Study|Study drug toxicity|16
7341383|NCT00883116|11579162|FG000|Overall Study|Withdrawal by Subject|14
7341384|NCT00883116|11579163|FG001|Overall Study|Withdrawal by Subject|8
7341385|NCT00883116|11579162|FG000|Overall Study|No longer meets study criteria|2
7341386|NCT00883116|11579163|FG001|Overall Study|No longer meets study criteria|2
7341387|NCT00883129|11579173|FG000|Overall Study|Adverse Event|7
7341388|NCT00883129|11579174|FG001|Overall Study|Adverse Event|15
7341389|NCT00883129|11579173|FG000|Overall Study|Withdrawal by Subject|8
7341390|NCT00883129|11579174|FG001|Overall Study|Withdrawal by Subject|9
7341391|NCT00883129|11579173|FG000|Overall Study|Non-compliance|3
7341392|NCT00883129|11579174|FG001|Overall Study|Non-compliance|6
7341393|NCT00883129|11579173|FG000|Overall Study|Lost to Follow-up|1
7341394|NCT00883129|11579174|FG001|Overall Study|Lost to Follow-up|2
7341395|NCT00883129|11579173|FG000|Overall Study|Death|1
7341396|NCT00883129|11579174|FG001|Overall Study|Death|2
7341397|NCT00883129|11579173|FG000|Overall Study|Defined Treatment Failure|0
7341398|NCT00883129|11579174|FG001|Overall Study|Defined Treatment Failure|2
7341399|NCT00883181|11579197|FG000|Overall Study|Hematological Adverse Event|26
7341400|NCT00883181|11579197|FG000|Overall Study|Non-hematological Adverse Event|55
7341401|NCT00883181|11579197|FG000|Overall Study|Disease Progression|94
7341402|NCT00883181|11579197|FG000|Overall Study|Administrative Reason|24
7341403|NCT00883181|11579197|FG000|Overall Study|Withdrawal by Subject|4
7341404|NCT00883181|11579197|FG000|Overall Study|Death|31
7341405|NCT00883181|11579197|FG000|Overall Study|Other|38
7341406|NCT00883181|11579197|FG000|Overall Study|Protocol Deviation|3
7341407|NCT00883181|11579197|FG000|Overall Study|Noncompliance|3
7341408|NCT00883337|11579244|FG000|Core Treatment Period|Adverse Event|9
7341409|NCT00883337|11579245|FG001|Core Treatment Period|Adverse Event|12
7341410|NCT00883337|11579246|FG002|Core Treatment Period|Adverse Event|22
7341411|NCT00883337|11579244|FG000|Core Treatment Period|Lack of Efficacy|7
7341412|NCT00883337|11579245|FG001|Core Treatment Period|Lack of Efficacy|4
7341413|NCT00883337|11579246|FG002|Core Treatment Period|Lack of Efficacy|2
7341414|NCT00883337|11579244|FG000|Core Treatment Period|Lost to Follow-up|1
7341415|NCT00883337|11579245|FG001|Core Treatment Period|Lost to Follow-up|1
7341416|NCT00883337|11579246|FG002|Core Treatment Period|Lost to Follow-up|0
7341417|NCT00883337|11579244|FG000|Core Treatment Period|Withdrawal by Subject|2
7341418|NCT00883337|11579245|FG001|Core Treatment Period|Withdrawal by Subject|2
7341419|NCT00883337|11579246|FG002|Core Treatment Period|Withdrawal by Subject|6
7341420|NCT00883337|11579244|FG000|Core Treatment Period|Wish to be pregnant|1
7341421|NCT00883337|11579245|FG001|Core Treatment Period|Wish to be pregnant|2
7341422|NCT00883337|11579246|FG002|Core Treatment Period|Wish to be pregnant|1
7341423|NCT00883337|11579244|FG000|Core Treatment Period|Poor compliance to protocol|0
7341424|NCT00883337|11579245|FG001|Core Treatment Period|Poor compliance to protocol|0
7341425|NCT00883337|11579246|FG002|Core Treatment Period|Poor compliance to protocol|1
7341426|NCT00883337|11579244|FG000|Core Treatment Period|Other than above|0
7341427|NCT00883337|11579245|FG001|Core Treatment Period|Other than above|1
7341428|NCT00883337|11579246|FG002|Core Treatment Period|Other than above|1
7341429|NCT00883337|11579244|FG000|Extension Treatment Period|Adverse Event|8
7341430|NCT00883337|11579245|FG001|Extension Treatment Period|Adverse Event|5
7341431|NCT00883337|11579246|FG002|Extension Treatment Period|Adverse Event|5
7341432|NCT00883337|11579244|FG000|Extension Treatment Period|Lack of Efficacy|8
7341433|NCT00883337|11579245|FG001|Extension Treatment Period|Lack of Efficacy|8
7341434|NCT00883337|11579246|FG002|Extension Treatment Period|Lack of Efficacy|8
7341435|NCT00883337|11579244|FG000|Extension Treatment Period|Poor compliance to protocol|1
7341436|NCT00883337|11579245|FG001|Extension Treatment Period|Poor compliance to protocol|1
7341437|NCT00883337|11579246|FG002|Extension Treatment Period|Poor compliance to protocol|1
7341438|NCT00883337|11579244|FG000|Extension Treatment Period|Lost to Follow-up|1
7341439|NCT00883337|11579245|FG001|Extension Treatment Period|Lost to Follow-up|0
7341440|NCT00883337|11579246|FG002|Extension Treatment Period|Lost to Follow-up|0
7341441|NCT00883337|11579244|FG000|Extension Treatment Period|Other than above|10
7341442|NCT00883337|11579245|FG001|Extension Treatment Period|Other than above|9
7341443|NCT00883337|11579246|FG002|Extension Treatment Period|Other than above|5
7341444|NCT00883493|11579270|FG000|Overall Study|Adverse Event|11
7341445|NCT00883493|11579271|FG001|Overall Study|Adverse Event|12
7341446|NCT00883493|11579270|FG000|Overall Study|Lack of Efficacy|4
7341447|NCT00883493|11579271|FG001|Overall Study|Lack of Efficacy|3
7341448|NCT00883493|11579270|FG000|Overall Study|Lost to Follow-up|7
7341449|NCT00883493|11579271|FG001|Overall Study|Lost to Follow-up|6
7341450|NCT00883493|11579270|FG000|Overall Study|Withdrawal by Subject|11
7341451|NCT00883493|11579271|FG001|Overall Study|Withdrawal by Subject|20
7341452|NCT00883493|11579270|FG000|Overall Study|Eligibility Criteria not fullfilled|6
7341453|NCT00883493|11579271|FG001|Overall Study|Eligibility Criteria not fullfilled|6
7341454|NCT00883493|11579270|FG000|Overall Study|Study specific disc. criteria|2
7341455|NCT00883493|11579271|FG001|Overall Study|Study specific disc. criteria|0
7341456|NCT00883493|11579270|FG000|Overall Study|Other|5
7341457|NCT00883493|11579271|FG001|Overall Study|Other|3
7341458|NCT00883558|11579277|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
7341459|NCT00883558|11579278|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7341460|NCT00883558|11579279|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
7341461|NCT00883558|11579277|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7341462|NCT00883558|11579278|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
7341463|NCT00883558|11579279|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
7341464|NCT00883558|11579277|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
7341465|NCT00883558|11579278|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7341466|NCT00883558|11579279|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
7341467|NCT00883558|11579277|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7341468|NCT00883558|11579278|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
7341469|NCT00883558|11579279|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
7341470|NCT00883558|11579277|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7341471|NCT00883558|11579278|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
7341472|NCT00883558|11579279|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
7385684|NCT01203098|11643546|FG002|Overall Study|Physician Decision|0
7385685|NCT01203098|11643544|FG000|Overall Study|Withdrawal by Subject|1
7385686|NCT01203098|11643545|FG001|Overall Study|Withdrawal by Subject|1
7385687|NCT01203098|11643546|FG002|Overall Study|Withdrawal by Subject|3
7385688|NCT01203787|11643601|FG000|Overall Study|Death|12
7385689|NCT01203787|11643602|FG001|Overall Study|Death|10
7385690|NCT01203787|11643601|FG000|Overall Study|Withdrawal by Subject|6
7385691|NCT01203787|11643602|FG001|Overall Study|Withdrawal by Subject|2
7385692|NCT01203787|11643601|FG000|Overall Study|Lost to Follow-up|2
7385693|NCT01203787|11643602|FG001|Overall Study|Lost to Follow-up|0
7385694|NCT01203787|11643601|FG000|Overall Study|Adverse Event|11
7385695|NCT01203787|11643602|FG001|Overall Study|Adverse Event|15
7385696|NCT01203852|11643619|FG000|Metoprolol 8 Weeks|Physician Decision|470
7385697|NCT01203852|11643619|FG000|Washout 2 Weeks|Physician Decision|46
7385698|NCT01203878|11643629|FG000|Overall Study|Withdrawal by Subject|0
7385699|NCT01203878|11643630|FG001|Overall Study|Withdrawal by Subject|0
7385700|NCT01203878|11643631|FG002|Overall Study|Withdrawal by Subject|1
7385701|NCT01203878|11643629|FG000|Overall Study|Adverse Event|0
7385702|NCT01203878|11643630|FG001|Overall Study|Adverse Event|0
7385703|NCT01203878|11643631|FG002|Overall Study|Adverse Event|2
7385704|NCT01203917|11643638|FG000|Overall Study|Death|29
7385705|NCT01203917|11643638|FG000|Overall Study|Lost to Follow-up|2
7385706|NCT01203917|11643638|FG000|Overall Study|Withdrawal by Subject|3
7385707|NCT01203917|11643638|FG000|Overall Study|Due to objective disease progression|1
7385708|NCT01203917|11643638|FG000|Overall Study|Due to EGFR M+I patient|1
7385709|NCT01203930|11643644|FG000|Overall Study|Disease Progression|0
7385710|NCT01203930|11643645|FG001|Overall Study|Disease Progression|4
7385711|NCT01203930|11643644|FG000|Overall Study|Death|3
7385712|NCT01203930|11643645|FG001|Overall Study|Death|1
7385713|NCT01203930|11643644|FG000|Overall Study|Withdrew Consent|1
7385714|NCT01203930|11643645|FG001|Overall Study|Withdrew Consent|10
7385715|NCT01203930|11643644|FG000|Overall Study|Investigator Request|0
7385716|NCT01203930|11643645|FG001|Overall Study|Investigator Request|8
7385717|NCT01203930|11643644|FG000|Overall Study|Study Terminated by Sponsor|0
7385718|NCT01203930|11643645|FG001|Overall Study|Study Terminated by Sponsor|12
7385719|NCT01203930|11643644|FG000|Overall Study|Poor tolerance of study drug|0
7385720|NCT01203930|11643645|FG001|Overall Study|Poor tolerance of study drug|1
7385721|NCT01203930|11643644|FG000|Overall Study|Adverse Event|17
7385722|NCT01203930|11643645|FG001|Overall Study|Adverse Event|5
7385723|NCT01203956|11643653|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
7385724|NCT01203956|11643654|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
7385725|NCT01204294|11643676|FG000|Overall Study|Adverse Event|2
7385726|NCT01204294|11643677|FG001|Overall Study|Adverse Event|6
7385727|NCT01204294|11643678|FG002|Overall Study|Adverse Event|0
7385728|NCT01204294|11643679|FG003|Overall Study|Adverse Event|7
7385729|NCT01204294|11643680|FG004|Overall Study|Adverse Event|1
7385730|NCT01204294|11643681|FG005|Overall Study|Adverse Event|4
7385731|NCT01204294|11643682|FG006|Overall Study|Adverse Event|0
7341473|NCT00883688|11579289|FG000|Overall Study|Ineligible|2
7341474|NCT00883740|11579293|FG000|First Intervention|Lost to Follow-up|1
7341475|NCT00883740|11579294|FG001|First Intervention|Lost to Follow-up|0
7341476|NCT00883740|11579293|FG000|First Intervention|No longer willing to participate|2
7341477|NCT00883740|11579294|FG001|First Intervention|No longer willing to participate|0
7341478|NCT00883740|11579293|FG000|First Intervention|Protocol Violation|3
7341479|NCT00883740|11579294|FG001|First Intervention|Protocol Violation|6
7341480|NCT00883740|11579293|FG000|First Intervention|Adverse Event|1
7341481|NCT00883740|11579294|FG001|First Intervention|Adverse Event|2
7341482|NCT00883740|11579293|FG000|Second Intervention|Protocol Violation|1
7341483|NCT00883740|11579294|FG001|Second Intervention|Protocol Violation|0
7341484|NCT00883740|11579293|FG000|Second Intervention|No longer willing to participate|0
7341485|NCT00883740|11579294|FG001|Second Intervention|No longer willing to participate|1
7341486|NCT00883753|11579300|FG000|Overall Study|Adverse Event|37
7341487|NCT00883753|11579300|FG000|Overall Study|Death|2
7341488|NCT00883753|11579300|FG000|Overall Study|Insufficient therapeutic response|16
7341489|NCT00883753|11579300|FG000|Overall Study|Lost to Follow-up|4
7341490|NCT00883753|11579300|FG000|Overall Study|Violation of selection criteria at entry|7
7341491|NCT00883753|11579300|FG000|Overall Study|Protocol Violation|2
7341492|NCT00883753|11579300|FG000|Overall Study|Refused treatment|4
7341493|NCT00883753|11579300|FG000|Overall Study|Withdrew consent|10
7341494|NCT00883753|11579300|FG000|Overall Study|Investigator's decision|17
7341495|NCT00883753|11579300|FG000|Overall Study|Administrative/Other|8
7341496|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
7341497|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
7341498|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Disease progression|75
7341499|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Disease progression|59
7341500|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Adverse Event|16
7341501|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Adverse Event|16
7341502|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Death|2
7341503|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Death|3
7341504|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Refused Treatment|5
7341505|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Refused Treatment|4
7341506|NCT00883779|11579309|FG000|Primary Study Treatment Phase|Other|3
7341507|NCT00883779|11579310|FG001|Primary Study Treatment Phase|Other|0
7341508|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Adverse Event|2
7341509|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Adverse Event|3
7341510|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Death|1
7341511|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Death|3
7341512|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Protocol Violation|0
7341513|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Protocol Violation|1
7341514|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Refused Treatment|3
7341515|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Refused Treatment|0
7341516|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Disease progression|103
7341517|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Disease progression|122
7341518|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Other|3
7341519|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Other|0
7341520|NCT00883779|11579309|FG000|Post-Study Treatment Phase|Ongoing in the study|0
7341521|NCT00883779|11579310|FG001|Post-Study Treatment Phase|Ongoing in the study|6
7341522|NCT00883779|11579309|FG000|Off-study Phase|Death|185
7341523|NCT00883779|11579310|FG001|Off-study Phase|Death|174
7341524|NCT00883779|11579309|FG000|Off-study Phase|Refused treatment|1
7341525|NCT00883779|11579310|FG001|Off-study Phase|Refused treatment|1
7341526|NCT00883779|11579309|FG000|Off-study Phase|Failure to return|5
7341527|NCT00883779|11579310|FG001|Off-study Phase|Failure to return|6
7341528|NCT00883779|11579309|FG000|Off-study Phase|Other|18
7341529|NCT00883779|11579310|FG001|Off-study Phase|Other|21
7341530|NCT00884039|11579318|FG000|Overall Study|Withdrawal by Subject|0
7341531|NCT00884039|11579319|FG001|Overall Study|Withdrawal by Subject|1
7341532|NCT00884039|11579318|FG000|Overall Study|Lack of Efficacy|2
7341533|NCT00884039|11579319|FG001|Overall Study|Lack of Efficacy|0
7341534|NCT00884117|11579341|FG000|Overall Study|Adverse Event|2
7341535|NCT00884117|11579341|FG000|Overall Study|Withdrawal by Subject|89
7341536|NCT00884117|11579341|FG000|Overall Study|Death|3
7341537|NCT00884117|11579341|FG000|Overall Study|Lost to Follow-up|143
7341538|NCT00884117|11579341|FG000|Overall Study|Other|12
7341539|NCT00884221|11579360|FG000|Overall Study|Withdrawal by Subject|0
7341540|NCT00884221|11579361|FG001|Overall Study|Withdrawal by Subject|3
7341541|NCT00884221|11579360|FG000|Overall Study|Adverse Event|6
7341542|NCT00884221|11579361|FG001|Overall Study|Adverse Event|3
7341543|NCT00884221|11579360|FG000|Overall Study|Protocol Violation|16
7341544|NCT00884221|11579361|FG001|Overall Study|Protocol Violation|13
7341545|NCT00884221|11579360|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
7341546|NCT00884221|11579361|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
7341547|NCT00884273|11579371|FG000|Overall Study|Adverse Event|0
7341548|NCT00884273|11579372|FG001|Overall Study|Adverse Event|2
7341549|NCT00884273|11579371|FG000|Overall Study|Protocol Violation|1
7341550|NCT00884273|11579372|FG001|Overall Study|Protocol Violation|3
7341551|NCT00884273|11579371|FG000|Overall Study|Practical reasons|1
7341552|NCT00884273|11579372|FG001|Overall Study|Practical reasons|0
7341553|NCT00884286|11579380|FG000|Overall Study|Progressive disease|21
7341554|NCT00884286|11579381|FG001|Overall Study|Progressive disease|28
7341555|NCT00884286|11579380|FG000|Overall Study|Toxicity|4
7341556|NCT00884286|11579381|FG001|Overall Study|Toxicity|1
7341557|NCT00884286|11579380|FG000|Overall Study|Death|2
7341558|NCT00884286|11579381|FG001|Overall Study|Death|2
7341559|NCT00884286|11579380|FG000|Overall Study|Physician Decision|1
7341560|NCT00884286|11579381|FG001|Overall Study|Physician Decision|0
7341561|NCT00884286|11579380|FG000|Overall Study|Septic shock|1
7341562|NCT00884286|11579381|FG001|Overall Study|Septic shock|0
7341563|NCT00884286|11579380|FG000|Overall Study|Thrombus in right auricle|1
7341564|NCT00884286|11579381|FG001|Overall Study|Thrombus in right auricle|0
7341565|NCT00884286|11579380|FG000|Overall Study|Not treated|2
7341566|NCT00884286|11579381|FG001|Overall Study|Not treated|1
7341567|NCT00884286|11579380|FG000|Overall Study|Comprised lung carcinoma|0
7341568|NCT00884286|11579381|FG001|Overall Study|Comprised lung carcinoma|1
7341569|NCT00884312|11579390|FG000|Overall Study|Non-fatal Progressive Disease|0
7341570|NCT00884312|11579391|FG001|Overall Study|Non-fatal Progressive Disease|8
7341571|NCT00884312|11579390|FG000|Overall Study|Fatal Progressive Disease|0
7341572|NCT00884312|11579391|FG001|Overall Study|Fatal Progressive Disease|1
7341573|NCT00884312|11579390|FG000|Overall Study|Non-fatal Adverse Event|1
7341574|NCT00884312|11579391|FG001|Overall Study|Non-fatal Adverse Event|0
7341575|NCT00884312|11579390|FG000|Overall Study|Fatal Adverse Event|1
7341576|NCT00884312|11579391|FG001|Overall Study|Fatal Adverse Event|4
7341577|NCT00884312|11579390|FG000|Overall Study|Withdrawal by Subject|0
7341578|NCT00884312|11579391|FG001|Overall Study|Withdrawal by Subject|6
7341579|NCT00884312|11579390|FG000|Overall Study|Physician Decision|0
7341580|NCT00884312|11579391|FG001|Overall Study|Physician Decision|1
7341581|NCT00884312|11579390|FG000|Overall Study|Other|0
7341582|NCT00884312|11579391|FG001|Overall Study|Other|4
7341583|NCT00884312|11579390|FG000|Overall Study|Did Not Receive Study Drug|0
7341584|NCT00884312|11579391|FG001|Overall Study|Did Not Receive Study Drug|1
7341585|NCT00884325|11579399|FG000|Overall Study|Lost to Follow-up|1
7341586|NCT00884325|11579400|FG001|Overall Study|Lost to Follow-up|2
7341587|NCT00884325|11579399|FG000|Overall Study|Lack of Efficacy|0
7341588|NCT00884325|11579400|FG001|Overall Study|Lack of Efficacy|1
7341589|NCT00884325|11579399|FG000|Overall Study|Withdrawal by Subject|1
7341590|NCT00884325|11579400|FG001|Overall Study|Withdrawal by Subject|1
7341591|NCT00884325|11579399|FG000|Overall Study|Not provided|1
7341592|NCT00884325|11579400|FG001|Overall Study|Not provided|0
7341593|NCT00884377|11579408|FG000|Overall Study|Withdrawal by Subject|1
7341594|NCT00884377|11579409|FG001|Overall Study|Withdrawal by Subject|0
7341595|NCT00884377|11579408|FG000|Overall Study|Could not confirm diagnosis|1
7341596|NCT00884377|11579409|FG001|Overall Study|Could not confirm diagnosis|0
7341597|NCT00884377|11579408|FG000|Overall Study|Physician Decision|0
7341598|NCT00884377|11579409|FG001|Overall Study|Physician Decision|1
7341599|NCT00884390|11579423|FG000|Overall Study|Adverse Event|0
7341600|NCT00884390|11579424|FG001|Overall Study|Adverse Event|1
7341601|NCT00884390|11579423|FG000|Overall Study|Lost to Follow-up|0
7341602|NCT00884390|11579424|FG001|Overall Study|Lost to Follow-up|1
7341603|NCT00884390|11579423|FG000|Overall Study|Physician Decision|2
7341604|NCT00884390|11579424|FG001|Overall Study|Physician Decision|1
7341605|NCT00884390|11579423|FG000|Overall Study|Protocol Violation|4
7341606|NCT00884390|11579424|FG001|Overall Study|Protocol Violation|1
7341607|NCT00884390|11579423|FG000|Overall Study|Withdrawal by Subject|4
7341608|NCT00884390|11579424|FG001|Overall Study|Withdrawal by Subject|1
7341609|NCT00884390|11579423|FG000|Overall Study|Discontinuation of Study by Sponsor|2
7341610|NCT00884390|11579424|FG001|Overall Study|Discontinuation of Study by Sponsor|2
7341611|NCT00884390|11579423|FG000|Overall Study|Other|11
7341612|NCT00884390|11579424|FG001|Overall Study|Other|1
7341613|NCT00884650|11579459|FG000|Overall Study|Did not return complete pain diaries|7
7341614|NCT00884650|11579460|FG001|Overall Study|Did not return complete pain diaries|7
7341615|NCT00884650|11579459|FG000|Overall Study|Admitted Post-Op|1
7341616|NCT00884650|11579460|FG001|Overall Study|Admitted Post-Op|0
7341617|NCT00884650|11579459|FG000|Overall Study|Femoral Stress Fracture|1
7341618|NCT00884650|11579460|FG001|Overall Study|Femoral Stress Fracture|0
7341619|NCT00884650|11579459|FG000|Overall Study|Pain Pump Complication|0
7341620|NCT00884650|11579460|FG001|Overall Study|Pain Pump Complication|1
7341621|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
7341622|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
7341623|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
7341624|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
7341625|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Death|3
7341626|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Death|0
7341627|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Death|0
7341628|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Death|0
7341629|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
7341630|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
7385732|NCT01204294|11643676|FG000|Overall Study|Protocol Violation|1
7341631|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
7341632|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
7341633|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
7341634|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7341635|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7341636|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
7341637|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
7341638|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
7341639|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
7341640|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
7341641|NCT00884741|11579470|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
7341642|NCT00884741|11579471|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
7341643|NCT00884741|11579472|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
7341644|NCT00884741|11579473|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
7341645|NCT00884741|11579470|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7341646|NCT00884741|11579471|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
7341647|NCT00884741|11579472|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7341648|NCT00884741|11579473|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
7341649|NCT00884741|11579470|FG000|Step 2 Registration: Tissue Analysis|Death|0
7341650|NCT00884741|11579471|FG001|Step 2 Registration: Tissue Analysis|Death|1
7341651|NCT00884741|11579472|FG002|Step 2 Registration: Tissue Analysis|Death|0
7341652|NCT00884741|11579473|FG003|Step 2 Registration: Tissue Analysis|Death|0
7341653|NCT00884741|11579470|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
7341654|NCT00884741|11579471|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
7341655|NCT00884741|11579472|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
7341656|NCT00884741|11579473|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
7341657|NCT00884741|11579470|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
7341658|NCT00884741|11579471|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
7341659|NCT00884741|11579472|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
7341660|NCT00884741|11579473|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
7341661|NCT00884741|11579470|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
7341662|NCT00884741|11579471|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
7341663|NCT00884741|11579472|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
7341664|NCT00884741|11579473|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
7341665|NCT00884741|11579470|FG000|Randomization|Protocol Violation|0
7568847|NCT03426995|11944376|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568848|NCT03426995|11944377|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568849|NCT03426995|11944378|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7341666|NCT00884741|11579471|FG001|Randomization|Protocol Violation|0
7568850|NCT03426995|11944379|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
7568851|NCT03426995|11944361|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568852|NCT03426995|11944362|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568853|NCT03426995|11944363|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568854|NCT03426995|11944364|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568855|NCT03426995|11944365|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568856|NCT03426995|11944366|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568857|NCT03426995|11944367|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568858|NCT03426995|11944368|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
7568859|NCT03426995|11944369|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568860|NCT03426995|11944370|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568861|NCT03426995|11944371|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568862|NCT03426995|11944372|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568863|NCT03426995|11944373|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568864|NCT03426995|11944374|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568865|NCT03426995|11944375|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568866|NCT03426995|11944376|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568867|NCT03426995|11944377|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7341667|NCT00884741|11579472|FG002|Randomization|Protocol Violation|8
7568868|NCT03426995|11944378|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568869|NCT03426995|11944379|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
7568870|NCT03426995|11944361|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568871|NCT03426995|11944362|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568872|NCT03426995|11944363|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568873|NCT03426995|11944364|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568874|NCT03426995|11944365|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568875|NCT03426995|11944366|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568876|NCT03426995|11944367|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568877|NCT03426995|11944368|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568878|NCT03426995|11944369|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568879|NCT03426995|11944370|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568880|NCT03426995|11944371|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568881|NCT03426995|11944372|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568882|NCT03426995|11944373|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568883|NCT03426995|11944374|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568884|NCT03426995|11944375|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
7568885|NCT03426995|11944376|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
7568886|NCT03426995|11944377|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568887|NCT03426995|11944378|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568888|NCT03426995|11944379|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
7568889|NCT03426995|11944361|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568890|NCT03426995|11944362|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568891|NCT03426995|11944363|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568892|NCT03426995|11944364|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568893|NCT03426995|11944365|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568894|NCT03426995|11944366|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568895|NCT03426995|11944367|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568896|NCT03426995|11944368|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568897|NCT03426995|11944369|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568898|NCT03426995|11944370|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568899|NCT03426995|11944371|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568900|NCT03426995|11944372|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568901|NCT03426995|11944373|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568902|NCT03426995|11944374|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568903|NCT03426995|11944375|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
7568904|NCT03426995|11944376|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
7568905|NCT03426995|11944377|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568906|NCT03426995|11944378|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568907|NCT03426995|11944379|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
7568908|NCT03427073|11944434|FG000|Overall Study|Disease Progression|1
7568909|NCT03427073|11944435|FG001|Overall Study|Disease Progression|1
7568910|NCT03427073|11944436|FG002|Overall Study|Disease Progression|1
7568911|NCT03427073|11944437|FG003|Overall Study|Disease Progression|3
7533033|NCT02679729|11879034|FG008|Overall Study|Participant decision|0
7568912|NCT03427073|11944438|FG004|Overall Study|Disease Progression|3
7568913|NCT03427073|11944439|FG005|Overall Study|Disease Progression|4
7568914|NCT03427073|11944440|FG006|Overall Study|Disease Progression|2
7568915|NCT03427073|11944441|FG007|Overall Study|Disease Progression|3
7568916|NCT03427073|11944434|FG000|Overall Study|Physician Decision|0
7568917|NCT03427073|11944435|FG001|Overall Study|Physician Decision|0
7568918|NCT03427073|11944436|FG002|Overall Study|Physician Decision|0
7568919|NCT03427073|11944437|FG003|Overall Study|Physician Decision|0
7568920|NCT03427073|11944438|FG004|Overall Study|Physician Decision|0
7568921|NCT03427073|11944439|FG005|Overall Study|Physician Decision|0
7568922|NCT03427073|11944440|FG006|Overall Study|Physician Decision|1
7568923|NCT03427073|11944441|FG007|Overall Study|Physician Decision|1
7568924|NCT03427268|11944468|FG000|Overall Study|Progressive disease|25
7568925|NCT03427268|11944468|FG000|Overall Study|Never treated|2
7568926|NCT03427268|11944468|FG000|Overall Study|Compassionate use|1
7568927|NCT03427268|11944468|FG000|Overall Study|Withdrawal by Subject|1
7568928|NCT03427268|11944468|FG000|Overall Study|Adverse Event|3
7568929|NCT03427619|11944472|FG000|Overall Study|Physician Decision|3
7568930|NCT03427619|11944472|FG000|Overall Study|Withdrawal by Subject|4
7568931|NCT03427619|11944472|FG000|Overall Study|Lost to Follow-up|5
7568932|NCT03427619|11944472|FG000|Overall Study|Administrative|4
7568933|NCT03427619|11944472|FG000|Overall Study|Other|2
7568934|NCT03427619|11944472|FG000|Overall Study|Unknown or Missing Completion Status|48
7568935|NCT03427892|11944476|FG000|Overall Study|Lost to Follow-up|2
7568936|NCT03428152|11944486|FG000|Overall Study|Physician Decision|4
7568937|NCT03428152|11944487|FG001|Overall Study|Physician Decision|2
7568938|NCT03428152|11944486|FG000|Overall Study|Protocol Violation|3
7568939|NCT03428152|11944487|FG001|Overall Study|Protocol Violation|5
7568940|NCT03428152|11944486|FG000|Overall Study|Lack of Efficacy|0
7568941|NCT03428152|11944487|FG001|Overall Study|Lack of Efficacy|4
7568942|NCT03428360|11944510|FG000|Overall Study|Informed consent withdrawn|5
7568943|NCT03428360|11944510|FG000|Overall Study|Withdrawal by Subject|4
7568944|NCT03428360|11944510|FG000|Overall Study|Lost to Follow-up|5
7568945|NCT03428360|11944510|FG000|Overall Study|Physician Decision|2
7568946|NCT03428360|11944510|FG000|Overall Study|Informed consent withdrawn|5
7568947|NCT03428360|11944510|FG000|Overall Study|Study terminated by sponsor|10
7568948|NCT03428360|11944510|FG000|Overall Study|Non-compliant with study|1
7568949|NCT03428360|11944510|FG000|Overall Study|Non-compliant with study drug|3
7568950|NCT03428360|11944510|FG000|Overall Study|Death|3
7568951|NCT03428360|11944510|FG000|Overall Study|Adverse Event|1
7568952|NCT03428360|11944510|FG000|Overall Study|Not on antiepileptic drug|1
7568953|NCT03428750|11944520|FG000|Overall Study|Withdrawal by Subject|11
7568954|NCT03428750|11944521|FG001|Overall Study|Withdrawal by Subject|10
7568955|NCT03428750|11944520|FG000|Overall Study|Lost to Follow-up|3
7568956|NCT03428750|11944521|FG001|Overall Study|Lost to Follow-up|9
7568957|NCT03428750|11944520|FG000|Overall Study|Adverse Event|9
7568958|NCT03428750|11944521|FG001|Overall Study|Adverse Event|1
7568959|NCT03428750|11944520|FG000|Overall Study|Protocol Violation|1
7568960|NCT03428750|11944521|FG001|Overall Study|Protocol Violation|0
7568961|NCT03428750|11944520|FG000|Overall Study|Administrative|0
7568962|NCT03428750|11944521|FG001|Overall Study|Administrative|1
7568963|NCT03428815|11944552|FG000|Overall Study|Lost to Follow-up|2
7568964|NCT03428815|11944553|FG001|Overall Study|Lost to Follow-up|2
7568965|NCT03428815|11944552|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
7568966|NCT03428815|11944553|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
7568967|NCT03428815|11944552|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
7568968|NCT03428815|11944553|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
7568969|NCT03429556|11944578|FG000|Overall Study|Lost to Follow-up|0
7568970|NCT03429556|11944579|FG001|Overall Study|Lost to Follow-up|1
7568971|NCT03429556|11944580|FG002|Overall Study|Lost to Follow-up|0
7568972|NCT03429556|11944581|FG003|Overall Study|Lost to Follow-up|0
7568973|NCT03430245|11944609|FG000|Overall Study|Withdrawal by Subject|6
7568974|NCT03430245|11944609|FG000|Overall Study|Lost to Follow-up|1
7568975|NCT03430856|11944626|FG000|Overall Study|Adverse Event|0
7568976|NCT03430856|11944627|FG001|Overall Study|Adverse Event|1
7568977|NCT03430856|11944628|FG002|Overall Study|Adverse Event|0
7568978|NCT03430856|11944626|FG000|Overall Study|Rescue criteria|1
7568979|NCT03430856|11944627|FG001|Overall Study|Rescue criteria|1
7568980|NCT03430856|11944628|FG002|Overall Study|Rescue criteria|0
7568981|NCT03430856|11944626|FG000|Overall Study|Voluntary withdrawal of consent|1
7568982|NCT03430856|11944627|FG001|Overall Study|Voluntary withdrawal of consent|1
7568983|NCT03430856|11944628|FG002|Overall Study|Voluntary withdrawal of consent|1
7568984|NCT03430986|11944641|FG000|24-week Control Period|Adverse Event|1
7568985|NCT03430986|11944642|FG001|24-week Control Period|Adverse Event|0
7568986|NCT03430986|11944641|FG000|24-week Control Period|Lost to Follow-up|2
7568987|NCT03430986|11944642|FG001|24-week Control Period|Lost to Follow-up|2
7568988|NCT03430986|11944641|FG000|24-week Control Period|Withdrawal by Participant|5
7568989|NCT03430986|11944642|FG001|24-week Control Period|Withdrawal by Participant|0
7568990|NCT03430986|11944641|FG000|24-week Control Period|Protocol Deviation|0
7568991|NCT03430986|11944642|FG001|24-week Control Period|Protocol Deviation|2
7568992|NCT03430986|11944641|FG000|24-week Post-Control Period|Lost to Follow-up|1
7568993|NCT03430986|11944642|FG001|24-week Post-Control Period|Lost to Follow-up|1
7568994|NCT03430986|11944641|FG000|24-week Post-Control Period|Withdrawal by Participant|0
7568995|NCT03430986|11944642|FG001|24-week Post-Control Period|Withdrawal by Participant|1
7568996|NCT03431337|11944674|FG000|Overall Study|Lost to Follow-up|21
7568997|NCT03431337|11944675|FG001|Overall Study|Lost to Follow-up|19
7568998|NCT03431337|11944674|FG000|Overall Study|Withdrawal by Subject|8
7568999|NCT03431337|11944675|FG001|Overall Study|Withdrawal by Subject|3
7569000|NCT03431441|11944685|FG000|Overall Study|Withdrawal by Subject|2
7569001|NCT03431441|11944685|FG000|Overall Study|Adverse Event|2
7569002|NCT03431441|11944685|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
7569003|NCT03431857|11944689|FG000|Overall Study|Death|6
7569004|NCT03431857|11944689|FG000|Overall Study|Lost to Follow-up|41
7569005|NCT03431857|11944689|FG000|Overall Study|Adverse Event|6
7569006|NCT03431857|11944689|FG000|Overall Study|Withdrawal by Subject|1
7569007|NCT03432390|11944695|FG000|Apnea Period|Protocol Violation|2
7569008|NCT03432390|11944696|FG001|Apnea Period|Protocol Violation|2
7569009|NCT03432533|11944704|FG000|Overall Study|Lost to Follow-up|1
7569010|NCT03432533|11944705|FG001|Overall Study|Lost to Follow-up|2
7569011|NCT03432533|11944704|FG000|Overall Study|Withdrawal by Subject|14
7569012|NCT03432533|11944705|FG001|Overall Study|Withdrawal by Subject|9
7569013|NCT03432858|11944714|FG000|Overall Study|Protocol Violation|2
7569014|NCT03432858|11944715|FG001|Overall Study|Protocol Violation|1
7569015|NCT03432858|11944716|FG002|Overall Study|Protocol Violation|9
7569016|NCT03432858|11944714|FG000|Overall Study|Withdrawal by Subject|0
7569017|NCT03432858|11944715|FG001|Overall Study|Withdrawal by Subject|1
7569018|NCT03432858|11944716|FG002|Overall Study|Withdrawal by Subject|1
7341668|NCT00884741|11579473|FG003|Randomization|Protocol Violation|8
7341669|NCT00884793|11579489|FG000|Overall Study|Withdrawal by Subject|1
7341670|NCT00884832|11579499|FG000|Overall Study|Withdrawal by Subject|0
7341671|NCT00884832|11579500|FG001|Overall Study|Withdrawal by Subject|1
7341672|NCT00884949|11579519|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
7341673|NCT00884949|11579519|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
7341674|NCT00885105|11579552|FG000|Overall Study|Withdrawal by Subject|0
7341675|NCT00885105|11579553|FG001|Overall Study|Withdrawal by Subject|8
7341676|NCT00885105|11579552|FG000|Overall Study|Adverse Event|1
7341677|NCT00885105|11579553|FG001|Overall Study|Adverse Event|0
7341678|NCT00885105|11579552|FG000|Overall Study|Protocol Violation|0
7341679|NCT00885105|11579553|FG001|Overall Study|Protocol Violation|2
7341680|NCT00885118|11579564|FG000|Overall Study|Adverse Event|1
7341681|NCT00885118|11579565|FG001|Overall Study|Adverse Event|0
7341682|NCT00885118|11579566|FG002|Overall Study|Adverse Event|0
7341683|NCT00885118|11579567|FG003|Overall Study|Adverse Event|0
7341684|NCT00885118|11579568|FG004|Overall Study|Adverse Event|0
7341685|NCT00885118|11579564|FG000|Overall Study|Withdrawal by Subject|0
7341686|NCT00885118|11579565|FG001|Overall Study|Withdrawal by Subject|0
7341687|NCT00885118|11579566|FG002|Overall Study|Withdrawal by Subject|0
7341688|NCT00885118|11579567|FG003|Overall Study|Withdrawal by Subject|0
7341689|NCT00885118|11579568|FG004|Overall Study|Withdrawal by Subject|1
7341690|NCT00885118|11579564|FG000|Overall Study|Other reason not defined above|0
7341691|NCT00885118|11579565|FG001|Overall Study|Other reason not defined above|0
7341692|NCT00885118|11579566|FG002|Overall Study|Other reason not defined above|1
7341693|NCT00885118|11579567|FG003|Overall Study|Other reason not defined above|0
7341694|NCT00885118|11579568|FG004|Overall Study|Other reason not defined above|0
7341695|NCT00885170|11579586|FG000|Overall Study|Adverse Event|12
7341696|NCT00885170|11579587|FG001|Overall Study|Adverse Event|4
7341697|NCT00885170|11579586|FG000|Overall Study|Excessive bone loss|6
7341698|NCT00885170|11579587|FG001|Overall Study|Excessive bone loss|3
7341699|NCT00885170|11579586|FG000|Overall Study|Lost to Follow-up|2
7341700|NCT00885170|11579587|FG001|Overall Study|Lost to Follow-up|1
7341701|NCT00885170|11579586|FG000|Overall Study|Physician Decision|2
7341702|NCT00885170|11579587|FG001|Overall Study|Physician Decision|1
7341703|NCT00885170|11579586|FG000|Overall Study|Protocol Violation|3
7341704|NCT00885170|11579587|FG001|Overall Study|Protocol Violation|1
7341705|NCT00885170|11579586|FG000|Overall Study|Withdrawal by Subject|13
7341706|NCT00885170|11579587|FG001|Overall Study|Withdrawal by Subject|13
7341707|NCT00885352|11579595|FG000|Overall Study|Adverse Event|2
7341708|NCT00885352|11579596|FG001|Overall Study|Adverse Event|3
7341709|NCT00885352|11579595|FG000|Overall Study|Lost to Follow-up|2
7341710|NCT00885352|11579596|FG001|Overall Study|Lost to Follow-up|2
7341711|NCT00885352|11579595|FG000|Overall Study|Physician Decision|0
7341712|NCT00885352|11579596|FG001|Overall Study|Physician Decision|3
7341713|NCT00885352|11579595|FG000|Overall Study|Protocol Violation|0
7341714|NCT00885352|11579596|FG001|Overall Study|Protocol Violation|2
7341715|NCT00885352|11579595|FG000|Overall Study|Withdrawal by Subject|1
7341716|NCT00885352|11579596|FG001|Overall Study|Withdrawal by Subject|5
7341717|NCT00885352|11579595|FG000|Overall Study|Contradiction to study medication|0
7341718|NCT00885352|11579596|FG001|Overall Study|Contradiction to study medication|2
7341719|NCT00885352|11579595|FG000|Overall Study|Excluded medication|2
7341720|NCT00885352|11579596|FG001|Overall Study|Excluded medication|2
7341721|NCT00885352|11579595|FG000|Overall Study|Lab abnormalities|1
7341722|NCT00885352|11579596|FG001|Overall Study|Lab abnormalities|1
7341723|NCT00885365|11579604|FG000|4 Weeks ON Treatment|Adverse Event|2
7341724|NCT00885365|11579605|FG001|4 Weeks ON Treatment|Adverse Event|4
7341725|NCT00885365|11579604|FG000|4 Weeks ON Treatment|Protocol Violation|1
7341726|NCT00885365|11579605|FG001|4 Weeks ON Treatment|Protocol Violation|2
7341727|NCT00885365|11579604|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
7569019|NCT03432858|11944714|FG000|Overall Study|Procedure canceled/rescheduled|0
7569020|NCT03432858|11944715|FG001|Overall Study|Procedure canceled/rescheduled|9
7341728|NCT00885365|11579605|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
7341729|NCT00885378|11579613|FG000|Overall Study|Lack of Efficacy|2
7341730|NCT00885378|11579614|FG001|Overall Study|Lack of Efficacy|2
7341731|NCT00885378|11579613|FG000|Overall Study|Withdrawal by Subject|1
7341732|NCT00885378|11579614|FG001|Overall Study|Withdrawal by Subject|2
7341733|NCT00885378|11579613|FG000|Overall Study|Lost to Follow-up|1
7341734|NCT00885378|11579614|FG001|Overall Study|Lost to Follow-up|2
7341735|NCT00885378|11579613|FG000|Overall Study|Poor/Noncompliance|2
7341736|NCT00885378|11579614|FG001|Overall Study|Poor/Noncompliance|2
7341737|NCT00885378|11579613|FG000|Overall Study|Protocol Violation|2
7341738|NCT00885378|11579614|FG001|Overall Study|Protocol Violation|0
7341739|NCT00885482|11579620|FG000|Overall Study|Pregnancy|1
7341740|NCT00885482|11579620|FG000|Overall Study|Lack of Efficacy|1
7341741|NCT00885482|11579620|FG000|Overall Study|Death|1
7569021|NCT03432858|11944716|FG002|Overall Study|Procedure canceled/rescheduled|6
7341742|NCT00885482|11579620|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
7341743|NCT00885534|11579624|FG000|Overall Study|Patient deemed ineligible|1
7341744|NCT00885677|11579638|FG000|Overall Study|Death|40
7341745|NCT00885677|11579639|FG001|Overall Study|Death|34
7341746|NCT00885677|11579638|FG000|Overall Study|Lost to Follow-up|15
7341747|NCT00885677|11579639|FG001|Overall Study|Lost to Follow-up|13
7341748|NCT00885677|11579638|FG000|Overall Study|Protocol Violation|54
7341749|NCT00885677|11579639|FG001|Overall Study|Protocol Violation|54
7341750|NCT00885677|11579638|FG000|Overall Study|premature study closure|41
7341751|NCT00885677|11579639|FG001|Overall Study|premature study closure|44
7341752|NCT00885677|11579638|FG000|Overall Study|device/lead revision or replacement|7
7341753|NCT00885677|11579639|FG001|Overall Study|device/lead revision or replacement|6
7341754|NCT00885677|11579638|FG000|Overall Study|Heart transplantation|1
7341755|NCT00885677|11579639|FG001|Overall Study|Heart transplantation|0
7341756|NCT00885677|11579638|FG000|Overall Study|Inclusion/exclusion not met|25
7341757|NCT00885677|11579639|FG001|Overall Study|Inclusion/exclusion not met|27
7341758|NCT00885703|11579652|FG000|Overall Study|Death|9
7341759|NCT00885703|11579653|FG001|Overall Study|Death|7
7341760|NCT00885703|11579654|FG002|Overall Study|Death|8
7341761|NCT00885703|11579655|FG003|Overall Study|Death|7
7341762|NCT00885703|11579656|FG004|Overall Study|Death|7
7341763|NCT00885703|11579657|FG005|Overall Study|Death|8
7341764|NCT00885703|11579658|FG006|Overall Study|Death|4
7341765|NCT00885703|11579652|FG000|Overall Study|Lost to Follow-up|0
7341766|NCT00885703|11579653|FG001|Overall Study|Lost to Follow-up|0
7341767|NCT00885703|11579654|FG002|Overall Study|Lost to Follow-up|1
7341768|NCT00885703|11579655|FG003|Overall Study|Lost to Follow-up|0
7341769|NCT00885703|11579656|FG004|Overall Study|Lost to Follow-up|0
7341770|NCT00885703|11579657|FG005|Overall Study|Lost to Follow-up|1
7341771|NCT00885703|11579658|FG006|Overall Study|Lost to Follow-up|0
7341772|NCT00885703|11579652|FG000|Overall Study|Withdrawal by Subject|0
7341773|NCT00885703|11579653|FG001|Overall Study|Withdrawal by Subject|0
7341774|NCT00885703|11579654|FG002|Overall Study|Withdrawal by Subject|0
7341775|NCT00885703|11579655|FG003|Overall Study|Withdrawal by Subject|1
7341776|NCT00885703|11579656|FG004|Overall Study|Withdrawal by Subject|3
7341777|NCT00885703|11579657|FG005|Overall Study|Withdrawal by Subject|1
7341778|NCT00885703|11579658|FG006|Overall Study|Withdrawal by Subject|1
7341779|NCT00885703|11579652|FG000|Overall Study|Ineligible (no CM)|1
7341780|NCT00885703|11579653|FG001|Overall Study|Ineligible (no CM)|3
7341781|NCT00885703|11579654|FG002|Overall Study|Ineligible (no CM)|2
7341782|NCT00885703|11579655|FG003|Overall Study|Ineligible (no CM)|1
7341783|NCT00885703|11579656|FG004|Overall Study|Ineligible (no CM)|2
7341784|NCT00885703|11579657|FG005|Overall Study|Ineligible (no CM)|3
7341785|NCT00885703|11579658|FG006|Overall Study|Ineligible (no CM)|1
7341786|NCT00885755|11579685|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
7341787|NCT00885755|11579686|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
7341788|NCT00885755|11579687|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
7341789|NCT00885755|11579685|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
7341790|NCT00885755|11579686|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
7341791|NCT00885755|11579687|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
7341792|NCT00885755|11579685|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
7341793|NCT00885755|11579686|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7341794|NCT00885755|11579687|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
7341795|NCT00885755|11579685|FG000|Part I: Trastuzumab+Taxane|Death|0
7341796|NCT00885755|11579686|FG001|Part I: Trastuzumab+Taxane|Death|0
7341797|NCT00885755|11579687|FG002|Part I: Trastuzumab+Taxane|Death|1
7341798|NCT00885755|11579685|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
7341799|NCT00885755|11579686|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7341800|NCT00885755|11579687|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
7341801|NCT00885846|11579702|FG000|Overall Study|Withdrawal by Subject|2
7341802|NCT00885846|11579703|FG001|Overall Study|Withdrawal by Subject|5
7341803|NCT00885846|11579704|FG002|Overall Study|Withdrawal by Subject|2
7341804|NCT00886015|11579714|FG000|Overall Study|Death|0
7341805|NCT00886015|11579715|FG001|Overall Study|Death|2
7341806|NCT00886119|11579721|FG000|Period 1|Did not meet inclusion criteria|1
7341807|NCT00886119|11579722|FG001|Period 1|Did not meet inclusion criteria|0
7341808|NCT00886288|11579758|FG000|Overall Study|no respect of the 12 weeks period|657
7341809|NCT00886288|11579759|FG001|Overall Study|no respect of the 12 weeks period|227
7341810|NCT00886288|11579758|FG000|Overall Study|Lost to Follow-up|86
7341811|NCT00886288|11579759|FG001|Overall Study|Lost to Follow-up|0
7341812|NCT00886340|11579769|FG000|Overall Study|Withdrawal by Subject|0
7341813|NCT00886340|11579770|FG001|Overall Study|Withdrawal by Subject|7
7341814|NCT00886379|11579781|FG000|Overall Study|Transferred Schools|0
7341815|NCT00886379|11579782|FG001|Overall Study|Transferred Schools|0
7341816|NCT00886379|11579783|FG002|Overall Study|Transferred Schools|2
7341817|NCT00886379|11579784|FG003|Overall Study|Transferred Schools|1
7341818|NCT00886379|11579785|FG004|Overall Study|Transferred Schools|1
7341819|NCT00886379|11579781|FG000|Overall Study|Final blood draw not obtained|3
7341820|NCT00886379|11579782|FG001|Overall Study|Final blood draw not obtained|3
7341821|NCT00886379|11579783|FG002|Overall Study|Final blood draw not obtained|4
7341822|NCT00886379|11579784|FG003|Overall Study|Final blood draw not obtained|2
7341823|NCT00886379|11579785|FG004|Overall Study|Final blood draw not obtained|2
7341824|NCT00886483|11579799|FG000|Overall Study|Lost to Follow-up|0
7341825|NCT00886483|11579800|FG001|Overall Study|Lost to Follow-up|1
7341826|NCT00886483|11579799|FG000|Overall Study|Pursue medications|1
7341827|NCT00886483|11579800|FG001|Overall Study|Pursue medications|2
7341828|NCT00886483|11579799|FG000|Overall Study|Distance to center, poor grades|1
7341829|NCT00886483|11579800|FG001|Overall Study|Distance to center, poor grades|0
7341830|NCT00886587|11579816|FG000|Overall Study|Adverse Event|2
7341831|NCT00886587|11579817|FG001|Overall Study|Adverse Event|1
7341832|NCT00886587|11579816|FG000|Overall Study|Protocol Violation|2
7341833|NCT00886587|11579817|FG001|Overall Study|Protocol Violation|0
7341834|NCT00886587|11579816|FG000|Overall Study|Withdrawal by Subject|0
7341835|NCT00886587|11579817|FG001|Overall Study|Withdrawal by Subject|1
7341836|NCT00886613|11579826|FG000|Overall Study|Protocol deviation (Part B)|1
7341837|NCT00886613|11579827|FG001|Overall Study|Protocol deviation (Part B)|0
7341838|NCT00886613|11579828|FG002|Overall Study|Protocol deviation (Part B)|0
7341839|NCT00886613|11579826|FG000|Overall Study|Lost to follow-up (Part B)|1
7341840|NCT00886613|11579827|FG001|Overall Study|Lost to follow-up (Part B)|0
7341841|NCT00886613|11579828|FG002|Overall Study|Lost to follow-up (Part B)|1
7341842|NCT00886613|11579826|FG000|Overall Study|Subject withdrew consent (Part A)|0
7341843|NCT00886613|11579827|FG001|Overall Study|Subject withdrew consent (Part A)|0
7341844|NCT00886613|11579828|FG002|Overall Study|Subject withdrew consent (Part A)|2
7341845|NCT00886639|11579846|FG000|Overall Study|acute exacerbation|14
7341846|NCT00886639|11579846|FG000|Overall Study|non-compliance|2
7341847|NCT00886743|11579861|FG000|Overall Study|Adverse Event|3
7341848|NCT00886743|11579861|FG000|Overall Study|Other|1
7341849|NCT00886769|11579867|FG000|Overall Study|Unsatisfactory therapeutic effect|6
7341850|NCT00886769|11579868|FG001|Overall Study|Unsatisfactory therapeutic effect|37
7341851|NCT00886795|11579874|FG000|Overall Study|Lack of Efficacy|1
7341852|NCT00886821|11579893|FG000|Stage 2|Adverse Event|0
7341853|NCT00886821|11579894|FG001|Stage 2|Adverse Event|0
7341854|NCT00886821|11579895|FG002|Stage 2|Adverse Event|0
7341855|NCT00886821|11579896|FG003|Stage 2|Adverse Event|0
7341856|NCT00886821|11579897|FG004|Stage 2|Adverse Event|0
7341857|NCT00886821|11579898|FG005|Stage 2|Adverse Event|0
7341858|NCT00886821|11579899|FG006|Stage 2|Adverse Event|0
7341859|NCT00886821|11579900|FG007|Stage 2|Adverse Event|0
7341860|NCT00886821|11579901|FG008|Stage 2|Adverse Event|0
7341861|NCT00886821|11579902|FG009|Stage 2|Adverse Event|0
7341862|NCT00886821|11579903|FG010|Stage 2|Adverse Event|0
7341863|NCT00886821|11579904|FG011|Stage 2|Adverse Event|1
7341864|NCT00886821|11579905|FG012|Stage 2|Adverse Event|3
7341865|NCT00886821|11579906|FG013|Stage 2|Adverse Event|0
7341866|NCT00886821|11579893|FG000|Stage 2|Lost to Follow-up|0
7341867|NCT00886821|11579894|FG001|Stage 2|Lost to Follow-up|0
7341868|NCT00886821|11579895|FG002|Stage 2|Lost to Follow-up|0
7341869|NCT00886821|11579896|FG003|Stage 2|Lost to Follow-up|0
7341870|NCT00886821|11579897|FG004|Stage 2|Lost to Follow-up|0
7341871|NCT00886821|11579898|FG005|Stage 2|Lost to Follow-up|0
7341872|NCT00886821|11579899|FG006|Stage 2|Lost to Follow-up|0
7341873|NCT00886821|11579900|FG007|Stage 2|Lost to Follow-up|0
7341874|NCT00886821|11579901|FG008|Stage 2|Lost to Follow-up|0
7341875|NCT00886821|11579902|FG009|Stage 2|Lost to Follow-up|0
7341876|NCT00886821|11579903|FG010|Stage 2|Lost to Follow-up|0
7341877|NCT00886821|11579904|FG011|Stage 2|Lost to Follow-up|0
7341878|NCT00886821|11579905|FG012|Stage 2|Lost to Follow-up|2
7341879|NCT00886821|11579906|FG013|Stage 2|Lost to Follow-up|1
7341880|NCT00886834|11579952|FG000|Overall Study|Protocol Violation|0
7341881|NCT00886834|11579953|FG001|Overall Study|Protocol Violation|3
7341882|NCT00886938|11579963|FG000|Overall Study|Adverse Event|1
7341883|NCT00886938|11579963|FG000|Overall Study|Withdrawal by Subject|1
7341884|NCT00887068|11579969|FG000|Overall Study|Withdrawal by Subject|2
7341885|NCT00887068|11579970|FG001|Overall Study|Withdrawal by Subject|0
7341886|NCT00887068|11579969|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
7341887|NCT00887068|11579970|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
7341888|NCT00887159|11579979|FG000|Overall Study|Disease progression|6
7341889|NCT00887159|11579980|FG001|Overall Study|Disease progression|39
7341890|NCT00887159|11579981|FG002|Overall Study|Disease progression|33
7341891|NCT00887159|11579979|FG000|Overall Study|Adverse Event|3
7458379|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7458380|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7458381|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7458382|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
7458383|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7341892|NCT00887159|11579980|FG001|Overall Study|Adverse Event|4
7341893|NCT00887159|11579981|FG002|Overall Study|Adverse Event|17
7341894|NCT00887159|11579979|FG000|Overall Study|Death|2
7341895|NCT00887159|11579980|FG001|Overall Study|Death|2
7341896|NCT00887159|11579981|FG002|Overall Study|Death|0
7341897|NCT00887159|11579979|FG000|Overall Study|Withdrawal by Subject|4
7341898|NCT00887159|11579980|FG001|Overall Study|Withdrawal by Subject|4
7341899|NCT00887159|11579981|FG002|Overall Study|Withdrawal by Subject|2
7341900|NCT00887159|11579979|FG000|Overall Study|Alternative therapy|2
7341901|NCT00887159|11579980|FG001|Overall Study|Alternative therapy|0
7341902|NCT00887159|11579981|FG002|Overall Study|Alternative therapy|0
7341903|NCT00887159|11579979|FG000|Overall Study|Physician Decision|1
7341904|NCT00887159|11579980|FG001|Overall Study|Physician Decision|1
7341905|NCT00887159|11579981|FG002|Overall Study|Physician Decision|0
7341906|NCT00887159|11579979|FG000|Overall Study|Sympomatic deterioration|1
7341907|NCT00887159|11579980|FG001|Overall Study|Sympomatic deterioration|0
7341908|NCT00887159|11579981|FG002|Overall Study|Sympomatic deterioration|0
7341909|NCT00887159|11579979|FG000|Overall Study|Treatment delayed|1
7341910|NCT00887159|11579980|FG001|Overall Study|Treatment delayed|1
7341911|NCT00887159|11579981|FG002|Overall Study|Treatment delayed|0
7341912|NCT00887159|11579979|FG000|Overall Study|Pt had PD but was SD when re-measured|0
7341913|NCT00887159|11579980|FG001|Overall Study|Pt had PD but was SD when re-measured|1
7341914|NCT00887159|11579981|FG002|Overall Study|Pt had PD but was SD when re-measured|0
7341915|NCT00887159|11579979|FG000|Overall Study|Received more tx instead of observation|1
7341916|NCT00887159|11579980|FG001|Overall Study|Received more tx instead of observation|0
7341917|NCT00887159|11579981|FG002|Overall Study|Received more tx instead of observation|0
7341918|NCT00887159|11579979|FG000|Overall Study|Ineligible|5
7341919|NCT00887159|11579980|FG001|Overall Study|Ineligible|1
7341920|NCT00887159|11579981|FG002|Overall Study|Ineligible|0
7341921|NCT00887159|11579979|FG000|Overall Study|Never started assigned therapy|3
7341922|NCT00887159|11579980|FG001|Overall Study|Never started assigned therapy|3
7341923|NCT00887159|11579981|FG002|Overall Study|Never started assigned therapy|4
7341924|NCT00887198|11579993|FG000|Randomized Period|Ongoing|42
7341925|NCT00887198|11579994|FG001|Randomized Period|Ongoing|0
7341926|NCT00887198|11579995|FG002|Randomized Period|Ongoing|0
7341927|NCT00887198|11579993|FG000|Randomized Period|Adverse Event|50
7341928|NCT00887198|11579994|FG001|Randomized Period|Adverse Event|33
7341929|NCT00887198|11579995|FG002|Randomized Period|Adverse Event|0
7341930|NCT00887198|11579993|FG000|Randomized Period|Lost to Follow-up|1
7341931|NCT00887198|11579994|FG001|Randomized Period|Lost to Follow-up|0
7341932|NCT00887198|11579995|FG002|Randomized Period|Lost to Follow-up|0
7341933|NCT00887198|11579993|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
7341934|NCT00887198|11579994|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
7341935|NCT00887198|11579995|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
7341936|NCT00887198|11579993|FG000|Randomized Period|Withdrawal by Subject|41
7341937|NCT00887198|11579994|FG001|Randomized Period|Withdrawal by Subject|56
7341938|NCT00887198|11579995|FG002|Randomized Period|Withdrawal by Subject|0
7341939|NCT00887198|11579993|FG000|Randomized Period|Progressive disease|366
7341940|NCT00887198|11579994|FG001|Randomized Period|Progressive disease|370
7341941|NCT00887198|11579995|FG002|Randomized Period|Progressive disease|0
7341942|NCT00887198|11579993|FG000|Randomized Period|Other|42
7341943|NCT00887198|11579994|FG001|Randomized Period|Other|30
7341944|NCT00887198|11579995|FG002|Randomized Period|Other|0
7341945|NCT00887198|11579993|FG000|Randomized Period|Randomized, Not treated|4
7341946|NCT00887198|11579994|FG001|Randomized Period|Randomized, Not treated|2
7341947|NCT00887198|11579995|FG002|Randomized Period|Randomized, Not treated|0
7341948|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7341949|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
7341950|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
7341951|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Ongoing|0
7341952|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Ongoing|0
7341953|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Ongoing|35
7341954|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Adverse Event|0
7341955|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Adverse Event|0
7341956|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Adverse Event|9
7341957|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7341958|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
7341959|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
7341960|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Progressive disease|0
7341961|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Progressive disease|0
7341962|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Progressive disease|20
7341963|NCT00887198|11579993|FG000|Cross Over (Placebo to AA)|Other|0
7341964|NCT00887198|11579994|FG001|Cross Over (Placebo to AA)|Other|0
7341965|NCT00887198|11579995|FG002|Cross Over (Placebo to AA)|Other|19
7341966|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Adverse Event|46
7341967|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Adverse Event|0
7341968|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Adverse Event|0
7341969|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Failed to return|6
7341970|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Failed to return|0
7341971|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Failed to return|0
7341972|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
7341973|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
7341974|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
7341975|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
7341976|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
7341977|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
7341978|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Other|1
7341979|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Other|0
7341980|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Other|0
7341981|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
7341982|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
7341983|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
7341984|NCT00887224|11580006|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
7341985|NCT00887224|11580007|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7341986|NCT00887224|11580008|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
7341987|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
7341988|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
7341989|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
7341990|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Failed to return|3
7341991|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Failed to return|0
7341992|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Failed to return|0
7341993|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
7341994|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7341995|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
7341996|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
7341997|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7341998|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
7341999|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Other|1
7342000|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Other|0
7342001|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Other|0
7342002|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
7342003|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
7342004|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
7342005|NCT00887224|11580006|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
7342006|NCT00887224|11580007|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7342007|NCT00887224|11580008|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
7342008|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
7342009|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
7342010|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
7342011|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
7342012|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
7342013|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
7342014|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
7342015|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
7342016|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
7342017|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
7342018|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7342019|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
7342020|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Other|30
7342021|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Other|0
7342022|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Other|0
7342023|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
7342024|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
7342025|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
7342026|NCT00887224|11580006|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
7342027|NCT00887224|11580007|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7342028|NCT00887224|11580008|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
7342029|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Adverse Event|0
7342030|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Adverse Event|7
7342031|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Adverse Event|2
7342032|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Failed to return|0
7342033|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Failed to return|2
7342034|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Failed to return|2
7342035|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
7342036|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
7342037|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
7342038|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
7342039|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
7342040|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
7342041|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Other|0
7342042|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Other|2
7342043|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Other|0
7342044|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Protocol Violation|0
7342045|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Protocol Violation|8
7342046|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Protocol Violation|5
7342047|NCT00887224|11580006|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
7342048|NCT00887224|11580007|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
7342049|NCT00887224|11580008|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
7342050|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7342051|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
7342052|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
7342053|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
7342054|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
7342055|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
7342056|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7342057|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
7342058|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
7342059|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
7458384|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7458385|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
7458386|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
7458387|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458388|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458389|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458390|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458391|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458392|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
7458393|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458394|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
7458395|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458396|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458397|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458398|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458399|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
7458400|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
7458401|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7458402|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7458403|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
7458404|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7458405|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7458406|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
7458407|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
7458408|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
7458409|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7458410|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7458411|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
7458412|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7458413|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
7458414|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7458415|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7458416|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7458417|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
7458418|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7458419|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7458420|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
7458421|NCT01807520|11752410|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
7458422|NCT01807520|11752411|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
7458423|NCT01807520|11752412|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7458424|NCT01807520|11752413|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7458425|NCT01807520|11752414|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
7458426|NCT01807520|11752415|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7458427|NCT01807520|11752416|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
7458428|NCT01807520|11752410|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458429|NCT01807520|11752411|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458430|NCT01807520|11752412|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458431|NCT01807520|11752413|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458432|NCT01807520|11752414|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458433|NCT01807520|11752415|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
7458434|NCT01807520|11752416|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
7458435|NCT01807520|11752410|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
7458436|NCT01807520|11752411|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
7458437|NCT01807520|11752412|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
7458438|NCT01807520|11752413|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
7458439|NCT01807520|11752414|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
7458440|NCT01807520|11752415|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
7458441|NCT01807520|11752416|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
7458442|NCT01807520|11752410|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7458443|NCT01807520|11752411|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7458444|NCT01807520|11752412|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7458445|NCT01807520|11752413|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7458446|NCT01807520|11752414|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
7458447|NCT01807520|11752415|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
7458448|NCT01807520|11752416|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
7458449|NCT01807598|11752443|FG000|Overall Study|Withdrawal by Subject|4
7458450|NCT01807598|11752443|FG000|Overall Study|Adverse Event|1
7458451|NCT01807598|11752443|FG000|Overall Study|Other Physician Decision|1
7458452|NCT01807650|11752462|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
7342060|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7342061|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
7342062|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Other|0
7342063|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Other|11
7342064|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Other|12
7342065|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
7342066|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
7342067|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
7342068|NCT00887224|11580006|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
7342069|NCT00887224|11580007|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
7342070|NCT00887224|11580008|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
7342071|NCT00887289|11580020|FG000|Overall Study|Lack of Efficacy|14
7342072|NCT00887289|11580020|FG000|Overall Study|Adverse Event|27
7342073|NCT00887289|11580020|FG000|Overall Study|Withdrawal by Subject|26
7342074|NCT00887289|11580020|FG000|Overall Study|Lost to Follow-up|8
7342075|NCT00887289|11580020|FG000|Overall Study|Other|20
7342076|NCT00887341|11580026|FG000|Overall Study|Refused treatment|1
7342077|NCT00887341|11580027|FG001|Overall Study|Refused treatment|0
7342078|NCT00887341|11580026|FG000|Overall Study|Withdrawal by Subject|1
7342079|NCT00887341|11580027|FG001|Overall Study|Withdrawal by Subject|1
7342080|NCT00887341|11580026|FG000|Overall Study|Adverse Event|0
7342081|NCT00887341|11580027|FG001|Overall Study|Adverse Event|1
7342082|NCT00887341|11580026|FG000|Overall Study|Lost to Follow-up|0
7342083|NCT00887341|11580027|FG001|Overall Study|Lost to Follow-up|1
7342084|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
7342085|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
7342086|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7342087|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
7342088|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
7342089|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
7342090|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
7342091|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
7342092|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7342093|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
7342094|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
7342095|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
7342096|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7342097|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
7342098|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
7342099|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
7342100|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
7342101|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
7342102|NCT00887354|11580035|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
7342103|NCT00887354|11580036|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
7342104|NCT00887354|11580035|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
7342105|NCT00887354|11580036|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
7342106|NCT00887354|11580035|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
7342107|NCT00887354|11580036|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
7342108|NCT00887354|11580035|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
7342109|NCT00887354|11580036|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
7342110|NCT00887354|11580035|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
7342111|NCT00887354|11580036|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
7342112|NCT00887354|11580035|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7342113|NCT00887354|11580036|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
7342114|NCT00887432|11580045|FG000|Overall Study|Start Excluded Therapy|3
7342115|NCT00887432|11580046|FG001|Overall Study|Start Excluded Therapy|0
7342116|NCT00887432|11580045|FG000|Overall Study|Did not complete treatment|6
7342117|NCT00887432|11580046|FG001|Overall Study|Did not complete treatment|8
7342118|NCT00887432|11580045|FG000|Overall Study|Protocol Violation|2
7342119|NCT00887432|11580046|FG001|Overall Study|Protocol Violation|3
7342120|NCT00887432|11580045|FG000|Overall Study|Withdrawal by Subject|3
7342121|NCT00887432|11580046|FG001|Overall Study|Withdrawal by Subject|2
7342122|NCT00887432|11580045|FG000|Overall Study|Lost to Follow-up|1
7342123|NCT00887432|11580046|FG001|Overall Study|Lost to Follow-up|0
7342124|NCT00887432|11580045|FG000|Overall Study|No reason provided|0
7342125|NCT00887432|11580046|FG001|Overall Study|No reason provided|1
7342126|NCT00887484|11580072|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
7342127|NCT00887484|11580072|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7342128|NCT00887484|11580072|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
7342129|NCT00887549|11580090|FG000|Induction Therapy|Adverse Event|8
7342130|NCT00887549|11580090|FG000|Induction Therapy|Physician Decision|1
7342131|NCT00887549|11580090|FG000|Induction Therapy|Progressive Disease|13
7342132|NCT00887549|11580090|FG000|Induction Therapy|Death due to Study Disease|4
7342133|NCT00887549|11580090|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
7342134|NCT00887549|11580090|FG000|Maintenance Therapy|Adverse Event|16
7342135|NCT00887549|11580090|FG000|Maintenance Therapy|Physician Decision|1
7342136|NCT00887549|11580090|FG000|Maintenance Therapy|Progressive Disease|25
7342137|NCT00887549|11580090|FG000|Maintenance Therapy|Death due to adverse event|1
7342138|NCT00887588|11580118|FG000|Core Period|Death|1
7342139|NCT00887588|11580119|FG001|Core Period|Death|1
7342140|NCT00887588|11580118|FG000|Core Period|Lost to Follow-up|3
7342141|NCT00887588|11580119|FG001|Core Period|Lost to Follow-up|1
7342142|NCT00887588|11580118|FG000|Core Period|Withdrawal by Subject|6
7342143|NCT00887588|11580119|FG001|Core Period|Withdrawal by Subject|8
7342144|NCT00887588|11580118|FG000|Core Period|Adverse Event|9
7342145|NCT00887588|11580119|FG001|Core Period|Adverse Event|11
7342146|NCT00887588|11580118|FG000|Extension Period|Adverse Event|4
7342147|NCT00887588|11580119|FG001|Extension Period|Adverse Event|4
7342148|NCT00887588|11580118|FG000|Extension Period|Death|0
7342149|NCT00887588|11580119|FG001|Extension Period|Death|1
7342150|NCT00887588|11580118|FG000|Extension Period|Protocol deviation|1
7342151|NCT00887588|11580119|FG001|Extension Period|Protocol deviation|0
7342152|NCT00887588|11580118|FG000|Extension Period|Lost to Follow-up|1
7342153|NCT00887588|11580119|FG001|Extension Period|Lost to Follow-up|0
7342154|NCT00887679|11580133|FG000|Overall Study|Withdrawal by Subject|1
7342155|NCT00887679|11580133|FG000|Overall Study|Lost to Follow-up|4
7342156|NCT00887679|11580133|FG000|Overall Study|Physician Decision|5
7342157|NCT00887744|11580138|FG000|Overall Study|Adverse Event|3
7342158|NCT00887744|11580138|FG000|Overall Study|Death|1
7342159|NCT00887744|11580138|FG000|Overall Study|Lost to Follow-up|3
7342160|NCT00887744|11580138|FG000|Overall Study|Withdrawal by Subject|18
7342161|NCT00887744|11580138|FG000|Overall Study|Various reasons|9
7342162|NCT00887809|11580144|FG000|Overall Study|Patient Not Treated|3
7342163|NCT00887809|11580145|FG001|Overall Study|Patient Not Treated|0
7342164|NCT00887809|11580144|FG000|Overall Study|Death|1
7342165|NCT00887809|11580145|FG001|Overall Study|Death|0
7342166|NCT00887822|11580153|FG000|Overall Study|Insufficient therapeutic response|53
7342167|NCT00887822|11580154|FG001|Overall Study|Insufficient therapeutic response|55
7342168|NCT00887822|11580153|FG000|Overall Study|Adverse Event|14
7342169|NCT00887822|11580154|FG001|Overall Study|Adverse Event|17
7342170|NCT00887822|11580153|FG000|Overall Study|Failure to return|11
7342171|NCT00887822|11580154|FG001|Overall Study|Failure to return|11
7342172|NCT00887822|11580153|FG000|Overall Study|Refused treatment/Did not cooperate|12
7342173|NCT00887822|11580154|FG001|Overall Study|Refused treatment/Did not cooperate|10
7342174|NCT00887822|11580153|FG000|Overall Study|Administrative/Other than specified|5
7342175|NCT00887822|11580154|FG001|Overall Study|Administrative/Other than specified|4
7342176|NCT00887822|11580153|FG000|Overall Study|Death|2
7342177|NCT00887822|11580154|FG001|Overall Study|Death|3
7342178|NCT00887822|11580153|FG000|Overall Study|Protocol Violation|0
7342179|NCT00887822|11580154|FG001|Overall Study|Protocol Violation|1
7342180|NCT00887822|11580153|FG000|Overall Study|Randomized but not treated|0
7342181|NCT00887822|11580154|FG001|Overall Study|Randomized but not treated|1
7342182|NCT00887913|11580160|FG000|Overall Study|Withdrawal by Subject|6
7342183|NCT00887926|11580168|FG000|Overall Study|Withdrawal by Subject|0
7342184|NCT00887926|11580169|FG001|Overall Study|Withdrawal by Subject|1
7342185|NCT00887926|11580170|FG002|Overall Study|Withdrawal by Subject|0
7342186|NCT00887926|11580171|FG003|Overall Study|Withdrawal by Subject|0
7342187|NCT00887978|11580189|FG000|Overall Study|Adverse Event|18
7342188|NCT00887978|11580190|FG001|Overall Study|Adverse Event|5
7342189|NCT00887978|11580189|FG000|Overall Study|Clinical Worsening|4
7342190|NCT00887978|11580190|FG001|Overall Study|Clinical Worsening|4
7342191|NCT00887978|11580189|FG000|Overall Study|Death|2
7342192|NCT00887978|11580190|FG001|Overall Study|Death|3
7342193|NCT00887978|11580189|FG000|Overall Study|Withdrawal by Subject|1
7342194|NCT00887978|11580190|FG001|Overall Study|Withdrawal by Subject|2
7342195|NCT00887978|11580189|FG000|Overall Study|Lost to Follow-up|0
7342196|NCT00887978|11580190|FG001|Overall Study|Lost to Follow-up|1
7342197|NCT00888134|11580196|FG000|Treatment With Study Drug|Withdrawal by Subject|1
7342198|NCT00888134|11580196|FG000|Follow-up|being followed for long-term survival|1
7342199|NCT00888173|11580201|FG000|Overall Study|Wrong Primary|1
7342200|NCT00888173|11580201|FG000|Overall Study|Ineligible: required test not done|1
7342201|NCT00888238|11580205|FG000|Washout Period After Period 2|Adverse Event|0
7342202|NCT00888238|11580206|FG001|Washout Period After Period 2|Adverse Event|0
7342203|NCT00888238|11580207|FG002|Washout Period After Period 2|Adverse Event|1
7342204|NCT00888329|11580215|FG000|Overall Study|Physician Decision|6
7342205|NCT00888329|11580216|FG001|Overall Study|Physician Decision|9
7342206|NCT00888381|11580224|FG000|Overall Study|Lost to Follow-up|0
7342207|NCT00888381|11580225|FG001|Overall Study|Lost to Follow-up|1
7342208|NCT00888433|11580233|FG000|Overall Study|Withdrawal by Subject|1
7342209|NCT00888433|11580234|FG001|Overall Study|Withdrawal by Subject|2
7342210|NCT00888433|11580233|FG000|Overall Study|Missed Visit|2
7342211|NCT00888433|11580234|FG001|Overall Study|Missed Visit|1
7342212|NCT00888615|11580253|FG000|Overall Study|No treatment|2
7385733|NCT01204294|11643677|FG001|Overall Study|Protocol Violation|0
7385734|NCT01204294|11643678|FG002|Overall Study|Protocol Violation|2
7385735|NCT01204294|11643679|FG003|Overall Study|Protocol Violation|1
7385736|NCT01204294|11643680|FG004|Overall Study|Protocol Violation|0
7385737|NCT01204294|11643681|FG005|Overall Study|Protocol Violation|0
7385738|NCT01204294|11643682|FG006|Overall Study|Protocol Violation|0
7385739|NCT01204294|11643676|FG000|Overall Study|Withdrawal by Subject|0
7385740|NCT01204294|11643677|FG001|Overall Study|Withdrawal by Subject|2
7342213|NCT00888654|11580261|FG000|Overall Study|Problems swallowing oral meds.|1
7342214|NCT00888654|11580261|FG000|Overall Study|Not enough oral meds before surgery|3
7342215|NCT00888654|11580261|FG000|Overall Study|Surgery aborted|2
7342216|NCT00888654|11580261|FG000|Overall Study|Withdrawal by Subject|1
7342217|NCT00888654|11580261|FG000|Overall Study|Inelig. due to contraindication of med|1
7342218|NCT00888654|11580261|FG000|Overall Study|Change in surg date|1
7342219|NCT00888654|11580261|FG000|Overall Study|Stopped meds due to headaches|1
7342220|NCT00888849|11580267|FG000|Overall Study|Death|4
7342221|NCT00888849|11580268|FG001|Overall Study|Death|7
7342222|NCT00888849|11580267|FG000|Overall Study|Lost to Follow-up|1
7342223|NCT00888849|11580268|FG001|Overall Study|Lost to Follow-up|2
7342224|NCT00888927|11580278|FG000|Overall Study|Adverse Event|0
7342225|NCT00888927|11580279|FG001|Overall Study|Adverse Event|0
7342226|NCT00888927|11580280|FG002|Overall Study|Adverse Event|0
7342227|NCT00888927|11580281|FG003|Overall Study|Adverse Event|1
7342228|NCT00888927|11580278|FG000|Overall Study|Withdrawal of consent|0
7342229|NCT00888927|11580279|FG001|Overall Study|Withdrawal of consent|0
7342230|NCT00888927|11580280|FG002|Overall Study|Withdrawal of consent|0
7342231|NCT00888927|11580281|FG003|Overall Study|Withdrawal of consent|1
7342232|NCT00888940|11580293|FG000|Overall Study|Adverse Event|12
7342233|NCT00888940|11580294|FG001|Overall Study|Adverse Event|3
7342234|NCT00888940|11580293|FG000|Overall Study|Lost to Follow-up|5
7342235|NCT00888940|11580294|FG001|Overall Study|Lost to Follow-up|5
7342236|NCT00888940|11580293|FG000|Overall Study|Randomized Not Treated|11
7342237|NCT00888940|11580294|FG001|Overall Study|Randomized Not Treated|13
7342238|NCT00889005|11580306|FG000|Overall Study|Lost to Follow-up|4
7342239|NCT00889005|11580307|FG001|Overall Study|Lost to Follow-up|2
7342240|NCT00889005|11580306|FG000|Overall Study|Withdrawal by Subject|4
7342241|NCT00889005|11580307|FG001|Overall Study|Withdrawal by Subject|0
7342242|NCT00889252|11580341|FG000|Overall Study|Adverse Event|2
7342243|NCT00889252|11580342|FG001|Overall Study|Adverse Event|4
7342244|NCT00889252|11580341|FG000|Overall Study|Withdrawal by Subject|3
7342245|NCT00889252|11580342|FG001|Overall Study|Withdrawal by Subject|0
7342246|NCT00889252|11580341|FG000|Overall Study|Protocol Violation|2
7342247|NCT00889252|11580342|FG001|Overall Study|Protocol Violation|0
7342248|NCT00889265|11580348|FG000|Overall Study|Adverse Event|1
7342249|NCT00889265|11580348|FG000|Overall Study|Lost to Follow-up|5
7342250|NCT00889265|11580348|FG000|Overall Study|Protocol Violation|1
7342251|NCT00889603|11580370|FG000|Overall Study|Adverse Event|7
7342252|NCT00889603|11580370|FG000|Overall Study|Death|3
7342253|NCT00889603|11580370|FG000|Overall Study|Lost to Follow-up|19
7342254|NCT00889603|11580370|FG000|Overall Study|No longer willing to participant in stud|4
7342255|NCT00889603|11580370|FG000|Overall Study|Other|4
7342256|NCT00889681|11580374|FG000|Overall Study|Not meeting qualification Criteria|2
7342257|NCT00889681|11580374|FG000|Overall Study|Insurance disapproval|1
7342258|NCT00889707|11580380|FG000|Overall Study|Adverse Event|1
7342259|NCT00889707|11580381|FG001|Overall Study|Adverse Event|0
7342260|NCT00889707|11580380|FG000|Overall Study|Withdrawal by Subject|4
7342261|NCT00889707|11580381|FG001|Overall Study|Withdrawal by Subject|3
7342262|NCT00889707|11580380|FG000|Overall Study|Lost to Follow-up|0
7342263|NCT00889707|11580381|FG001|Overall Study|Lost to Follow-up|2
7342264|NCT00889707|11580380|FG000|Overall Study|Lack of Efficacy|2
7342265|NCT00889707|11580381|FG001|Overall Study|Lack of Efficacy|5
7342266|NCT00889720|11580387|FG000|Overall Study|Withdrawal by Subject|4
7342267|NCT00889720|11580387|FG000|Overall Study|Other|4
7342268|NCT00889863|11580395|FG000|Part I: Open Label|Death|1
7342269|NCT00889863|11580396|FG001|Part I: Open Label|Death|0
7342270|NCT00889863|11580395|FG000|Part I: Open Label|Adverse Event|4
7342271|NCT00889863|11580396|FG001|Part I: Open Label|Adverse Event|0
7342272|NCT00889863|11580395|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
7342273|NCT00889863|11580396|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
7342274|NCT00889863|11580395|FG000|Part II: Randomized Double Blind|Adverse Event|0
7342275|NCT00889863|11580396|FG001|Part II: Randomized Double Blind|Adverse Event|4
7342276|NCT00889863|11580395|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
7342277|NCT00889863|11580396|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
7342278|NCT00889863|11580395|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
7342279|NCT00889863|11580396|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
7342280|NCT00889863|11580395|FG000|Part II: Randomized Double Blind|Protocol deviation|0
7342281|NCT00889863|11580396|FG001|Part II: Randomized Double Blind|Protocol deviation|1
7342282|NCT00890045|11580427|FG000|Overall Study|Death|0
7342283|NCT00890045|11580428|FG001|Overall Study|Death|1
7342284|NCT00890045|11580427|FG000|Overall Study|Did not receive HeRO Graft|0
7342285|NCT00890045|11580428|FG001|Overall Study|Did not receive HeRO Graft|2
7342286|NCT00890045|11580427|FG000|Overall Study|Lost to Follow-up|5
7342287|NCT00890045|11580428|FG001|Overall Study|Lost to Follow-up|7
7342288|NCT00890084|11580434|FG000|Overall Study|Adverse Event|16
7342289|NCT00890084|11580434|FG000|Overall Study|Lost to Follow-up|126
7342290|NCT00890097|11580441|FG000|Overall Study|Adverse Event|21
7342291|NCT00890097|11580442|FG001|Overall Study|Adverse Event|32
7342292|NCT00890097|11580443|FG002|Overall Study|Adverse Event|28
7342293|NCT00890097|11580441|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
7342294|NCT00890097|11580442|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
7342295|NCT00890097|11580443|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
7342296|NCT00890097|11580441|FG000|Overall Study|Withdrew Consent|9
7342297|NCT00890097|11580442|FG001|Overall Study|Withdrew Consent|6
7342298|NCT00890097|11580443|FG002|Overall Study|Withdrew Consent|9
7342299|NCT00890097|11580441|FG000|Overall Study|Lost to Follow-up|5
7342300|NCT00890097|11580442|FG001|Overall Study|Lost to Follow-up|5
7342301|NCT00890097|11580443|FG002|Overall Study|Lost to Follow-up|5
7342302|NCT00890097|11580441|FG000|Overall Study|Noncompliance|0
7342303|NCT00890097|11580442|FG001|Overall Study|Noncompliance|4
7342304|NCT00890097|11580443|FG002|Overall Study|Noncompliance|4
7342305|NCT00890097|11580441|FG000|Overall Study|Sponsor Decision|7
7342306|NCT00890097|11580442|FG001|Overall Study|Sponsor Decision|11
7342307|NCT00890097|11580443|FG002|Overall Study|Sponsor Decision|7
7342308|NCT00890097|11580441|FG000|Overall Study|Did not attend final visit|2
7342309|NCT00890097|11580442|FG001|Overall Study|Did not attend final visit|3
7342310|NCT00890097|11580443|FG002|Overall Study|Did not attend final visit|0
7342311|NCT00890097|11580441|FG000|Overall Study|Subject Decision|3
7342312|NCT00890097|11580442|FG001|Overall Study|Subject Decision|2
7342313|NCT00890097|11580443|FG002|Overall Study|Subject Decision|6
7342314|NCT00890097|11580441|FG000|Overall Study|Randomization Error|2
7342315|NCT00890097|11580442|FG001|Overall Study|Randomization Error|0
7342316|NCT00890097|11580443|FG002|Overall Study|Randomization Error|0
7342317|NCT00890097|11580441|FG000|Overall Study|Failed inclusion criteria|3
7342318|NCT00890097|11580442|FG001|Overall Study|Failed inclusion criteria|4
7342319|NCT00890097|11580443|FG002|Overall Study|Failed inclusion criteria|0
7342320|NCT00890097|11580441|FG000|Overall Study|Transportation|0
7342321|NCT00890097|11580442|FG001|Overall Study|Transportation|2
7342322|NCT00890097|11580443|FG002|Overall Study|Transportation|0
7342323|NCT00890097|11580441|FG000|Overall Study|Subject Moved|0
7342324|NCT00890097|11580442|FG001|Overall Study|Subject Moved|4
7342325|NCT00890097|11580443|FG002|Overall Study|Subject Moved|0
7342326|NCT00890097|11580441|FG000|Overall Study|Protocol Deviation|1
7342327|NCT00890097|11580442|FG001|Overall Study|Protocol Deviation|1
7342328|NCT00890097|11580443|FG002|Overall Study|Protocol Deviation|1
7342329|NCT00890201|11580462|FG000|Overall Study|Protocol Violation|5
7342330|NCT00890201|11580463|FG001|Overall Study|Protocol Violation|56
7342331|NCT00890552|11580481|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
7342332|NCT00890552|11580481|FG000|On-treatment|Early prog disease/ death|10
7342333|NCT00890695|11580504|FG000|Overall Study|Protocol Violation|1
7342334|NCT00890695|11580505|FG001|Overall Study|Protocol Violation|0
7342335|NCT00890825|11580522|FG000|Overall Study|Withdrawal by Subject|1
7342336|NCT00890825|11580523|FG001|Overall Study|Withdrawal by Subject|0
7342337|NCT00890825|11580522|FG000|Overall Study|Alive at data cut off (DCO)|13
7342338|NCT00890825|11580523|FG001|Overall Study|Alive at data cut off (DCO)|14
7342339|NCT00890929|11580533|FG000|Overall Study|Death before treatment|2
7342340|NCT00890929|11580533|FG000|Overall Study|Withdrawal by Subject|3
7342341|NCT00890929|11580533|FG000|Overall Study|Physician Decision|1
7342342|NCT00891020|11580549|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
7342343|NCT00891020|11580550|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
7342344|NCT00891020|11580551|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
7342345|NCT00891020|11580549|FG000|24 Week Treatment Period|Death|0
7342346|NCT00891020|11580550|FG001|24 Week Treatment Period|Death|2
7342347|NCT00891020|11580551|FG002|24 Week Treatment Period|Death|0
7342348|NCT00891020|11580549|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
7342349|NCT00891020|11580550|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
7342350|NCT00891020|11580551|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
7342351|NCT00891020|11580549|FG000|24 Week Treatment Period|Failure to return|4
7342352|NCT00891020|11580550|FG001|24 Week Treatment Period|Failure to return|5
7342353|NCT00891020|11580551|FG002|24 Week Treatment Period|Failure to return|5
7342354|NCT00891020|11580549|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
7342355|NCT00891020|11580550|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
7342356|NCT00891020|11580551|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
7342357|NCT00891020|11580549|FG000|24 Week Treatment Period|Other protocol violation|1
7342358|NCT00891020|11580550|FG001|24 Week Treatment Period|Other protocol violation|1
7342359|NCT00891020|11580551|FG002|24 Week Treatment Period|Other protocol violation|2
7342360|NCT00891020|11580549|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
7342361|NCT00891020|11580550|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
7342362|NCT00891020|11580551|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
7342363|NCT00891020|11580549|FG000|24 Week Treatment Period|Withdrew consent|6
7342364|NCT00891020|11580550|FG001|24 Week Treatment Period|Withdrew consent|3
7342365|NCT00891020|11580551|FG002|24 Week Treatment Period|Withdrew consent|15
7342366|NCT00891020|11580549|FG000|24 Week Treatment Period|Administrative/Other|5
7342367|NCT00891020|11580550|FG001|24 Week Treatment Period|Administrative/Other|6
7342368|NCT00891020|11580551|FG002|24 Week Treatment Period|Administrative/Other|1
7342369|NCT00891020|11580549|FG000|Long-term Extension Period|Adverse Event|1
7342370|NCT00891020|11580550|FG001|Long-term Extension Period|Adverse Event|11
7342371|NCT00891020|11580551|FG002|Long-term Extension Period|Adverse Event|10
7342372|NCT00891020|11580549|FG000|Long-term Extension Period|Death|0
7342373|NCT00891020|11580550|FG001|Long-term Extension Period|Death|0
7342374|NCT00891020|11580551|FG002|Long-term Extension Period|Death|1
7342375|NCT00891020|11580549|FG000|Long-term Extension Period|Insufficient therapeutic response|3
7342376|NCT00891020|11580550|FG001|Long-term Extension Period|Insufficient therapeutic response|2
7342377|NCT00891020|11580551|FG002|Long-term Extension Period|Insufficient therapeutic response|2
7342378|NCT00891020|11580549|FG000|Long-term Extension Period|Protocol Violation|0
7342379|NCT00891020|11580550|FG001|Long-term Extension Period|Protocol Violation|1
7342380|NCT00891020|11580551|FG002|Long-term Extension Period|Protocol Violation|1
7342381|NCT00891020|11580549|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
7342382|NCT00891020|11580550|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
7342383|NCT00891020|11580551|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
7342384|NCT00891020|11580549|FG000|Long-term Extension Period|Failure to return|0
7342385|NCT00891020|11580550|FG001|Long-term Extension Period|Failure to return|2
7342386|NCT00891020|11580551|FG002|Long-term Extension Period|Failure to return|3
7342387|NCT00891020|11580549|FG000|Long-term Extension Period|Administrative|1
7342388|NCT00891020|11580550|FG001|Long-term Extension Period|Administrative|2
7342389|NCT00891020|11580551|FG002|Long-term Extension Period|Administrative|2
7342390|NCT00891046|11580566|FG000|Overall Study|Protocol Violation|1
7342391|NCT00891046|11580567|FG001|Overall Study|Protocol Violation|1
7342392|NCT00891046|11580568|FG002|Overall Study|Protocol Violation|0
7342393|NCT00891046|11580569|FG003|Overall Study|Protocol Violation|0
7342394|NCT00891046|11580570|FG004|Overall Study|Protocol Violation|1
7342395|NCT00891046|11580566|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7342396|NCT00891046|11580567|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7342397|NCT00891046|11580568|FG002|Overall Study|Unsatisfactory therapeutic effect|19
7342398|NCT00891046|11580569|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7342399|NCT00891046|11580570|FG004|Overall Study|Unsatisfactory therapeutic effect|20
7342400|NCT00891046|11580566|FG000|Overall Study|Administrative problems|0
7342401|NCT00891046|11580567|FG001|Overall Study|Administrative problems|0
7342402|NCT00891046|11580568|FG002|Overall Study|Administrative problems|0
7342403|NCT00891046|11580569|FG003|Overall Study|Administrative problems|0
7342404|NCT00891046|11580570|FG004|Overall Study|Administrative problems|1
7342405|NCT00891046|11580566|FG000|Overall Study|Participant no longer required drug|0
7342406|NCT00891046|11580567|FG001|Overall Study|Participant no longer required drug|2
7342407|NCT00891046|11580568|FG002|Overall Study|Participant no longer required drug|0
7342408|NCT00891046|11580569|FG003|Overall Study|Participant no longer required drug|0
7342409|NCT00891046|11580570|FG004|Overall Study|Participant no longer required drug|1
7342410|NCT00891046|11580566|FG000|Overall Study|Adverse Event|4
7342411|NCT00891046|11580567|FG001|Overall Study|Adverse Event|3
7342412|NCT00891046|11580568|FG002|Overall Study|Adverse Event|2
7342413|NCT00891046|11580569|FG003|Overall Study|Adverse Event|0
7342414|NCT00891046|11580570|FG004|Overall Study|Adverse Event|14
7342415|NCT00891046|11580566|FG000|Overall Study|Withdrawal by Subject|2
7342416|NCT00891046|11580567|FG001|Overall Study|Withdrawal by Subject|1
7342417|NCT00891046|11580568|FG002|Overall Study|Withdrawal by Subject|2
7342418|NCT00891046|11580569|FG003|Overall Study|Withdrawal by Subject|1
7342419|NCT00891046|11580570|FG004|Overall Study|Withdrawal by Subject|1
7342420|NCT00891046|11580566|FG000|Overall Study|Lost to Follow-up|0
7342421|NCT00891046|11580567|FG001|Overall Study|Lost to Follow-up|0
7342422|NCT00891046|11580568|FG002|Overall Study|Lost to Follow-up|0
7342423|NCT00891046|11580569|FG003|Overall Study|Lost to Follow-up|0
7342424|NCT00891046|11580570|FG004|Overall Study|Lost to Follow-up|1
7342425|NCT00891202|11580622|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
7342426|NCT00891202|11580623|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
7342427|NCT00891202|11580624|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
7342428|NCT00891202|11580625|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
7342429|NCT00891202|11580622|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7342430|NCT00891202|11580623|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7342431|NCT00891202|11580624|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
7342432|NCT00891202|11580625|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
7342433|NCT00891202|11580622|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7342434|NCT00891202|11580623|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7342435|NCT00891202|11580624|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
7342436|NCT00891202|11580625|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
7342437|NCT00891202|11580622|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7342438|NCT00891202|11580623|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
7342439|NCT00891202|11580624|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
7342440|NCT00891202|11580625|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
7342441|NCT00891228|11580636|FG000|Overall Study|Adverse Event|0
7342442|NCT00891228|11580637|FG001|Overall Study|Adverse Event|2
7342443|NCT00891228|11580638|FG002|Overall Study|Adverse Event|3
7342444|NCT00891228|11580636|FG000|Overall Study|Withdrawal by Subject|2
7342445|NCT00891228|11580637|FG001|Overall Study|Withdrawal by Subject|4
7342446|NCT00891228|11580638|FG002|Overall Study|Withdrawal by Subject|5
7342447|NCT00891228|11580636|FG000|Overall Study|Protocol Violation|3
7342448|NCT00891228|11580637|FG001|Overall Study|Protocol Violation|1
7342449|NCT00891228|11580638|FG002|Overall Study|Protocol Violation|2
7342450|NCT00891228|11580636|FG000|Overall Study|Physician Decision|2
7342451|NCT00891228|11580637|FG001|Overall Study|Physician Decision|1
7342452|NCT00891228|11580638|FG002|Overall Study|Physician Decision|0
7342453|NCT00891228|11580636|FG000|Overall Study|Lost to Follow-up|4
7342454|NCT00891228|11580637|FG001|Overall Study|Lost to Follow-up|4
7342455|NCT00891228|11580638|FG002|Overall Study|Lost to Follow-up|5
7342456|NCT00891228|11580636|FG000|Overall Study|Pregnancy|0
7342457|NCT00891228|11580637|FG001|Overall Study|Pregnancy|1
7342458|NCT00891228|11580638|FG002|Overall Study|Pregnancy|0
7342459|NCT00891293|11580646|FG000|Overall Study|Adverse Event|2
7342460|NCT00891293|11580646|FG000|Overall Study|Protocol Violation|2
7342461|NCT00891293|11580646|FG000|Overall Study|Laboratory abnormality|4
7342462|NCT00891293|11580646|FG000|Overall Study|Lost to Follow-up|7
7342463|NCT00891293|11580646|FG000|Overall Study|Subject withdrew consent|7
7342464|NCT00891293|11580646|FG000|Overall Study|Sponsor termination|62
7342465|NCT00891371|11580659|FG000|Pre-assignment|Inclusion/exclusion|5
7342466|NCT00891371|11580659|FG000|Pre-assignment|Consent withdrawal|1
7342467|NCT00891371|11580659|FG000|Treatment|Lack of Efficacy|5
7342468|NCT00891371|11580659|FG000|Treatment|Adverse Event|2
7342469|NCT00891371|11580659|FG000|Treatment|Death|1
7342470|NCT00891371|11580659|FG000|Treatment|Lost to Follow-up|1
7342471|NCT00891462|11580675|FG000|Overall Study|Withdrawal by Subject|9
7342472|NCT00891462|11580676|FG001|Overall Study|Withdrawal by Subject|6
7342473|NCT00891462|11580677|FG002|Overall Study|Withdrawal by Subject|7
7342474|NCT00891462|11580675|FG000|Overall Study|Adverse Event|7
7342475|NCT00891462|11580676|FG001|Overall Study|Adverse Event|8
7342476|NCT00891462|11580677|FG002|Overall Study|Adverse Event|7
7342477|NCT00891462|11580675|FG000|Overall Study|Lack of Efficacy|10
7342478|NCT00891462|11580676|FG001|Overall Study|Lack of Efficacy|5
7342479|NCT00891462|11580677|FG002|Overall Study|Lack of Efficacy|1
7342480|NCT00891462|11580675|FG000|Overall Study|COPD exacerbation|7
7342481|NCT00891462|11580676|FG001|Overall Study|COPD exacerbation|4
7342482|NCT00891462|11580677|FG002|Overall Study|COPD exacerbation|1
7342483|NCT00891462|11580675|FG000|Overall Study|Other Reason|2
7342484|NCT00891462|11580676|FG001|Overall Study|Other Reason|5
7342485|NCT00891462|11580677|FG002|Overall Study|Other Reason|3
7342486|NCT00891462|11580675|FG000|Overall Study|Protocol Violation|2
7342487|NCT00891462|11580676|FG001|Overall Study|Protocol Violation|1
7342488|NCT00891462|11580677|FG002|Overall Study|Protocol Violation|3
7342489|NCT00891462|11580675|FG000|Overall Study|Inclusion/exclusion criteria|0
7342490|NCT00891462|11580676|FG001|Overall Study|Inclusion/exclusion criteria|2
7342491|NCT00891462|11580677|FG002|Overall Study|Inclusion/exclusion criteria|2
7342492|NCT00891462|11580675|FG000|Overall Study|Lost to Follow-up|0
7342493|NCT00891462|11580676|FG001|Overall Study|Lost to Follow-up|2
7342494|NCT00891462|11580677|FG002|Overall Study|Lost to Follow-up|0
7342495|NCT00891527|11580687|FG000|Overall Study|Withdrawal by Subject|2
7342496|NCT00891618|11580692|FG000|Overall Study|Withdrawal by Subject|1
7342497|NCT00891657|11580698|FG000|Overall Study|Withdrawal by Subject|1
7342498|NCT00891657|11580699|FG001|Overall Study|Withdrawal by Subject|1
7342499|NCT00891735|11580709|FG000|Overall Study|Adverse Event|2
7342500|NCT00891735|11580710|FG001|Overall Study|Adverse Event|0
7342501|NCT00891735|11580711|FG002|Overall Study|Adverse Event|2
7342502|NCT00891735|11580712|FG003|Overall Study|Adverse Event|0
7342503|NCT00891735|11580709|FG000|Overall Study|Death|8
7342504|NCT00891735|11580710|FG001|Overall Study|Death|5
7342505|NCT00891735|11580711|FG002|Overall Study|Death|4
7342506|NCT00891735|11580712|FG003|Overall Study|Death|5
7342507|NCT00891735|11580709|FG000|Overall Study|Lost to Follow-up|2
7342508|NCT00891735|11580710|FG001|Overall Study|Lost to Follow-up|2
7342509|NCT00891735|11580711|FG002|Overall Study|Lost to Follow-up|2
7342510|NCT00891735|11580712|FG003|Overall Study|Lost to Follow-up|2
7342511|NCT00891735|11580709|FG000|Overall Study|Physician's decision to withdraw patient|1
7342512|NCT00891735|11580710|FG001|Overall Study|Physician's decision to withdraw patient|0
7342513|NCT00891735|11580711|FG002|Overall Study|Physician's decision to withdraw patient|0
7342514|NCT00891735|11580712|FG003|Overall Study|Physician's decision to withdraw patient|0
7342515|NCT00891735|11580709|FG000|Overall Study|Patient's decision to withdraw|4
7342516|NCT00891735|11580710|FG001|Overall Study|Patient's decision to withdraw|9
7342517|NCT00891735|11580711|FG002|Overall Study|Patient's decision to withdraw|4
7342518|NCT00891735|11580712|FG003|Overall Study|Patient's decision to withdraw|8
7342519|NCT00891774|11580722|FG000|Overall Study|Lost to Follow-up|5
7342520|NCT00891774|11580722|FG000|Overall Study|Illness (Self/Mother)|3
7342521|NCT00891774|11580722|FG000|Overall Study|Withdrawal by Subject|2
7342522|NCT00891774|11580722|FG000|Overall Study|Protocol Violation|4
7342523|NCT00891813|11580726|FG000|Overall Study|Adverse Event|3
7342524|NCT00891813|11580726|FG000|Overall Study|Withdrawal by Subject|1
7342525|NCT00891813|11580726|FG000|Overall Study|Patient Noncompliance|6
7342526|NCT00891813|11580726|FG000|Overall Study|Protocol Violation|2
7342527|NCT00891839|11580730|FG000|Overall Study|Adverse Event|2
7342528|NCT00891839|11580730|FG000|Overall Study|Withdrawal by Subject|2
7342529|NCT00891839|11580730|FG000|Overall Study|Disease progression|3
7342530|NCT00891930|11580743|FG000|Part 1: Panitumumab +Irinotecan|Death|38
7342531|NCT00891930|11580743|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
7458453|NCT01807650|11752462|FG000|Overall Study|Adverse Event|5
7458454|NCT01807650|11752462|FG000|Overall Study|Other|2
7458455|NCT01807923|11752515|FG000|Overall Study|Adverse Event|2
7342532|NCT00891930|11580743|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
7342533|NCT00891930|11580743|FG000|Part 2: Panitumumab + Ganitumab|Death|30
7385741|NCT01204294|11643678|FG002|Overall Study|Withdrawal by Subject|2
7342534|NCT00891930|11580743|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
7342535|NCT00892008|11580769|FG000|Overall Study|Death|5
7342536|NCT00892008|11580769|FG000|Overall Study|Lack of Efficacy|3
7342537|NCT00892008|11580769|FG000|Overall Study|Lost to Follow-up|142
7342538|NCT00892008|11580769|FG000|Overall Study|Other|378
7342539|NCT00892008|11580769|FG000|Overall Study|Adverse Event|37
7342540|NCT00892047|11580775|FG000|Overall Study|Adverse Event|2
7342541|NCT00892047|11580776|FG001|Overall Study|Adverse Event|2
7342542|NCT00892047|11580775|FG000|Overall Study|subject burden|2
7342543|NCT00892047|11580776|FG001|Overall Study|subject burden|3
7342544|NCT00892047|11580775|FG000|Overall Study|Lack of Efficacy|0
7458456|NCT01807923|11752516|FG001|Overall Study|Adverse Event|1
7458457|NCT01807923|11752517|FG002|Overall Study|Adverse Event|2
7458458|NCT01807923|11752515|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7458459|NCT01807923|11752516|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
7458460|NCT01807923|11752517|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
7458461|NCT01807923|11752515|FG000|Overall Study|Physician Decision|0
7458462|NCT01807923|11752516|FG001|Overall Study|Physician Decision|0
7458463|NCT01807923|11752517|FG002|Overall Study|Physician Decision|1
7458464|NCT01807923|11752515|FG000|Overall Study|Not Eligible (Genotype)|0
7458465|NCT01807923|11752516|FG001|Overall Study|Not Eligible (Genotype)|0
7458466|NCT01807923|11752517|FG002|Overall Study|Not Eligible (Genotype)|1
7458467|NCT01807923|11752515|FG000|Overall Study|Randomized But Not Treated|3
7458468|NCT01807923|11752516|FG001|Overall Study|Randomized But Not Treated|2
7458469|NCT01807923|11752517|FG002|Overall Study|Randomized But Not Treated|5
7458470|NCT01807949|11752530|FG000|Overall Study|Adverse Event|1
7458471|NCT01807949|11752531|FG001|Overall Study|Adverse Event|2
7458472|NCT01807949|11752532|FG002|Overall Study|Adverse Event|2
7458473|NCT01807949|11752530|FG000|Overall Study|Withdrawal by Subject|1
7458474|NCT01807949|11752531|FG001|Overall Study|Withdrawal by Subject|2
7458475|NCT01807949|11752532|FG002|Overall Study|Withdrawal by Subject|2
7458476|NCT01807949|11752530|FG000|Overall Study|Non-Compliance|0
7458477|NCT01807949|11752531|FG001|Overall Study|Non-Compliance|0
7458478|NCT01807949|11752532|FG002|Overall Study|Non-Compliance|1
7458479|NCT01807949|11752530|FG000|Overall Study|Undefined|0
7458480|NCT01807949|11752531|FG001|Overall Study|Undefined|1
7458481|NCT01807949|11752532|FG002|Overall Study|Undefined|2
7458482|NCT01807949|11752530|FG000|Overall Study|Randomized But Not Treated|0
7458483|NCT01807949|11752531|FG001|Overall Study|Randomized But Not Treated|2
7458484|NCT01807949|11752532|FG002|Overall Study|Randomized But Not Treated|2
7458485|NCT01808066|11752542|FG000|Overall Study|Withdrawal by Subject|15
7458486|NCT01808092|11752549|FG000|Overall Study|Death|39
7458487|NCT01808092|11752550|FG001|Overall Study|Death|29
7458488|NCT01808092|11752549|FG000|Overall Study|Lost to Follow-up|3
7458489|NCT01808092|11752550|FG001|Overall Study|Lost to Follow-up|7
7458490|NCT01808092|11752549|FG000|Overall Study|Withdrawal by Subject|9
7458491|NCT01808092|11752550|FG001|Overall Study|Withdrawal by Subject|4
7458492|NCT01808092|11752549|FG000|Overall Study|Other Eligibility criteria|3
7458493|NCT01808092|11752550|FG001|Overall Study|Other Eligibility criteria|5
7458494|NCT01808118|11752556|FG000|Period 1|Adverse Event|15
7458495|NCT01808118|11752557|FG001|Period 1|Adverse Event|0
7458496|NCT01808118|11752558|FG002|Period 1|Adverse Event|0
7458497|NCT01808118|11752556|FG000|Period 1|Withdrew consent|24
7458498|NCT01808118|11752557|FG001|Period 1|Withdrew consent|0
7458499|NCT01808118|11752558|FG002|Period 1|Withdrew consent|0
7458500|NCT01808118|11752556|FG000|Period 1|Lost to Follow-up|9
7458501|NCT01808118|11752557|FG001|Period 1|Lost to Follow-up|0
7458502|NCT01808118|11752558|FG002|Period 1|Lost to Follow-up|0
7458503|NCT01808118|11752556|FG000|Period 1|Did not meet criteria for remission|303
7458504|NCT01808118|11752557|FG001|Period 1|Did not meet criteria for remission|0
7458505|NCT01808118|11752558|FG002|Period 1|Did not meet criteria for remission|0
7458506|NCT01808118|11752556|FG000|Period 1|Enrolled in error|7
7458507|NCT01808118|11752557|FG001|Period 1|Enrolled in error|0
7458508|NCT01808118|11752558|FG002|Period 1|Enrolled in error|0
7458509|NCT01808118|11752556|FG000|Period 1|Did not meet inclusion criteria|3
7458510|NCT01808118|11752557|FG001|Period 1|Did not meet inclusion criteria|0
7458511|NCT01808118|11752558|FG002|Period 1|Did not meet inclusion criteria|0
7458512|NCT01808118|11752556|FG000|Period 1|Non-conformance with inclusion criteria|3
7458513|NCT01808118|11752557|FG001|Period 1|Non-conformance with inclusion criteria|0
7458514|NCT01808118|11752558|FG002|Period 1|Non-conformance with inclusion criteria|0
7458515|NCT01808118|11752556|FG000|Period 1|Investigator decision: site closure|2
7458516|NCT01808118|11752557|FG001|Period 1|Investigator decision: site closure|0
7458517|NCT01808118|11752558|FG002|Period 1|Investigator decision: site closure|0
7458518|NCT01808118|11752556|FG000|Period 1|Non-compliance per sponsor|1
7458519|NCT01808118|11752557|FG001|Period 1|Non-compliance per sponsor|0
7458520|NCT01808118|11752558|FG002|Period 1|Non-compliance per sponsor|0
7342545|NCT00892047|11580776|FG001|Overall Study|Lack of Efficacy|2
7458521|NCT01808118|11752556|FG000|Period 1|Lack of Efficacy|1
7458522|NCT01808118|11752557|FG001|Period 1|Lack of Efficacy|0
7342546|NCT00892099|11580787|FG000|Overall Study|Death|1
7342547|NCT00892099|11580788|FG001|Overall Study|Death|0
7458523|NCT01808118|11752558|FG002|Period 1|Lack of Efficacy|0
7458524|NCT01808118|11752556|FG000|Period 2|Adverse Event|0
7342548|NCT00892099|11580789|FG002|Overall Study|Death|1
7458525|NCT01808118|11752557|FG001|Period 2|Adverse Event|4
7458526|NCT01808118|11752558|FG002|Period 2|Adverse Event|0
7342549|NCT00892099|11580787|FG000|Overall Study|Adverse Event|1
7342550|NCT00892099|11580788|FG001|Overall Study|Adverse Event|0
7342551|NCT00892099|11580789|FG002|Overall Study|Adverse Event|0
7342552|NCT00892099|11580787|FG000|Overall Study|replocated|1
7342553|NCT00892099|11580788|FG001|Overall Study|replocated|0
7342554|NCT00892099|11580789|FG002|Overall Study|replocated|2
7342555|NCT00892099|11580787|FG000|Overall Study|Prolonged hospitalization|1
7342556|NCT00892099|11580788|FG001|Overall Study|Prolonged hospitalization|0
7342557|NCT00892099|11580789|FG002|Overall Study|Prolonged hospitalization|1
7342558|NCT00892099|11580787|FG000|Overall Study|no further details|1
7342559|NCT00892099|11580788|FG001|Overall Study|no further details|0
7342560|NCT00892099|11580789|FG002|Overall Study|no further details|1
7342561|NCT00892099|11580787|FG000|Overall Study|kidney function recovered|0
7342562|NCT00892099|11580788|FG001|Overall Study|kidney function recovered|1
7342563|NCT00892099|11580789|FG002|Overall Study|kidney function recovered|0
7342564|NCT00892099|11580787|FG000|Overall Study|investigator decision|0
7342565|NCT00892099|11580788|FG001|Overall Study|investigator decision|0
7342566|NCT00892099|11580789|FG002|Overall Study|investigator decision|1
7342567|NCT00892099|11580787|FG000|Overall Study|Lost to Follow-up|0
7342568|NCT00892099|11580788|FG001|Overall Study|Lost to Follow-up|0
7342569|NCT00892099|11580789|FG002|Overall Study|Lost to Follow-up|1
7342570|NCT00892151|11580797|FG000|Overall Study|Protocol Violation|1
7342571|NCT00892177|11580804|FG000|Phase II|Ineligible|0
7342572|NCT00892177|11580805|FG001|Phase II|Ineligible|0
7342573|NCT00892177|11580806|FG002|Phase II|Ineligible|0
7342574|NCT00892177|11580807|FG003|Phase II|Ineligible|0
7342575|NCT00892177|11580808|FG004|Phase II|Ineligible|1
7342576|NCT00892177|11580809|FG005|Phase II|Ineligible|1
7342577|NCT00892177|11580804|FG000|Phase II|Withdrawal by Subject|0
7342578|NCT00892177|11580805|FG001|Phase II|Withdrawal by Subject|0
7342579|NCT00892177|11580806|FG002|Phase II|Withdrawal by Subject|0
7342580|NCT00892177|11580807|FG003|Phase II|Withdrawal by Subject|0
7342581|NCT00892177|11580808|FG004|Phase II|Withdrawal by Subject|4
7342582|NCT00892177|11580809|FG005|Phase II|Withdrawal by Subject|1
7342691|NCT00893113|11580965|FG000|Overall Study|Early Termination|1
7385742|NCT01204294|11643679|FG003|Overall Study|Withdrawal by Subject|1
7342647|NCT00892437|11580835|FG000|Randomized Phase|Randomized but not treated|6
7342648|NCT00892437|11580836|FG001|Randomized Phase|Randomized but not treated|0
7342649|NCT00892437|11580835|FG000|Randomized Phase|Adverse Event|2
7342650|NCT00892437|11580836|FG001|Randomized Phase|Adverse Event|2
7342651|NCT00892437|11580835|FG000|Randomized Phase|Lost to Follow-up|1
7342652|NCT00892437|11580836|FG001|Randomized Phase|Lost to Follow-up|3
7342653|NCT00892437|11580835|FG000|Randomized Phase|Investigator's Discretion|1
7342654|NCT00892437|11580836|FG001|Randomized Phase|Investigator's Discretion|0
7342655|NCT00892437|11580835|FG000|Randomized Phase|Withdrew Consent|1
7342656|NCT00892437|11580836|FG001|Randomized Phase|Withdrew Consent|0
7342657|NCT00892437|11580835|FG000|Open-Label Extension Phase|Adverse Event|4
7342658|NCT00892437|11580836|FG001|Open-Label Extension Phase|Adverse Event|2
7342659|NCT00892437|11580835|FG000|Open-Label Extension Phase|Lack of Efficacy|1
7342660|NCT00892437|11580836|FG001|Open-Label Extension Phase|Lack of Efficacy|0
7342661|NCT00892437|11580835|FG000|Open-Label Extension Phase|Lost to Follow-up|3
7342662|NCT00892437|11580836|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7342663|NCT00892437|11580835|FG000|Open-Label Extension Phase|Investigator's Discretion|1
7342664|NCT00892437|11580836|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7342665|NCT00892437|11580835|FG000|Open-Label Extension Phase|Withdrew Consent|3
7342666|NCT00892437|11580836|FG001|Open-Label Extension Phase|Withdrew Consent|1
7342667|NCT00892723|11580873|FG000|Overall Study|Lost to Follow-up|1
7342668|NCT00892723|11580874|FG001|Overall Study|Lost to Follow-up|3
7342669|NCT00892723|11580875|FG002|Overall Study|Lost to Follow-up|1
7342670|NCT00892723|11580873|FG000|Overall Study|Withdrawal by Subject|1
7342671|NCT00892723|11580874|FG001|Overall Study|Withdrawal by Subject|1
7342672|NCT00892723|11580875|FG002|Overall Study|Withdrawal by Subject|1
7342673|NCT00892775|11580918|FG000|Overall Study|Protocol Violation|1
7342674|NCT00892775|11580919|FG001|Overall Study|Protocol Violation|0
7342675|NCT00892775|11580918|FG000|Overall Study|Subject difficulties with blood drawing|1
7342676|NCT00892775|11580919|FG001|Overall Study|Subject difficulties with blood drawing|0
7342677|NCT00892775|11580918|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
7342678|NCT00892775|11580919|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
7342679|NCT00892775|11580918|FG000|Overall Study|Migrated/ moved from study area|1
7342680|NCT00892775|11580919|FG001|Overall Study|Migrated/ moved from study area|0
7342681|NCT00892775|11580918|FG000|Overall Study|Withdrawal by Subject|0
7342682|NCT00892775|11580919|FG001|Overall Study|Withdrawal by Subject|1
7342683|NCT00892775|11580918|FG000|Overall Study|Lost to Follow-up|1
7342684|NCT00892775|11580919|FG001|Overall Study|Lost to Follow-up|0
7342685|NCT00892957|11580927|FG000|Between Postoperative Day 1 and Day 14|Death|0
7342686|NCT00892957|11580928|FG001|Between Postoperative Day 1 and Day 14|Death|2
7342687|NCT00892957|11580927|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
7342688|NCT00892957|11580928|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
7342689|NCT00893113|11580965|FG000|Overall Study|Lost to Follow-up|4
7342690|NCT00893113|11580966|FG001|Overall Study|Lost to Follow-up|8
7342692|NCT00893113|11580966|FG001|Overall Study|Early Termination|1
7342693|NCT00893113|11580965|FG000|Overall Study|Withdrew Consent|8
7342694|NCT00893113|11580966|FG001|Overall Study|Withdrew Consent|7
7342695|NCT00893464|11580989|FG000|Overall Study|Did not complete therapy/experience PD|0
7342696|NCT00893464|11580990|FG001|Overall Study|Did not complete therapy/experience PD|0
7342697|NCT00893464|11580991|FG002|Overall Study|Did not complete therapy/experience PD|0
7342698|NCT00893464|11580992|FG003|Overall Study|Did not complete therapy/experience PD|0
7342699|NCT00893464|11580993|FG004|Overall Study|Did not complete therapy/experience PD|0
7342700|NCT00893464|11580994|FG005|Overall Study|Did not complete therapy/experience PD|0
7342701|NCT00893464|11580995|FG006|Overall Study|Did not complete therapy/experience PD|2
7342702|NCT00893464|11580996|FG007|Overall Study|Did not complete therapy/experience PD|2
7342703|NCT00893737|11581019|FG000|Overall Study|Adverse Event|4
7342704|NCT00893737|11581019|FG000|Overall Study|Withdrawal by Subject|2
7342705|NCT00893737|11581019|FG000|Overall Study|Lost to Follow-up|6
7342706|NCT00893763|11581025|FG000|Overall Study|extubated|110
7342707|NCT00893763|11581026|FG001|Overall Study|extubated|110
7342708|NCT00893971|11581034|FG000|Overall Study|Physician Decision|3
7342709|NCT00894166|11581067|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
7342710|NCT00894166|11581068|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
7342711|NCT00894166|11581069|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
7342712|NCT00894166|11581070|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
7342713|NCT00894166|11581071|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
7342714|NCT00894166|11581072|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
7342715|NCT00894166|11581073|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
7342716|NCT00894166|11581074|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
7342717|NCT00894166|11581067|FG000|Overall Study|Death|0
7342718|NCT00894166|11581068|FG001|Overall Study|Death|0
7342719|NCT00894166|11581069|FG002|Overall Study|Death|0
7342720|NCT00894166|11581070|FG003|Overall Study|Death|1
7342721|NCT00894166|11581071|FG004|Overall Study|Death|0
7342722|NCT00894166|11581072|FG005|Overall Study|Death|0
7342723|NCT00894166|11581073|FG006|Overall Study|Death|0
7342724|NCT00894166|11581074|FG007|Overall Study|Death|0
7342725|NCT00894322|11581100|FG000|Overall Study|Withdrawal by Subject|1
7342726|NCT00894322|11581101|FG001|Overall Study|Withdrawal by Subject|0
7342727|NCT00894322|11581102|FG002|Overall Study|Withdrawal by Subject|0
7342728|NCT00894361|11581114|FG000|Overall Study|deaths and less than 2 years followup|24
7342729|NCT00894361|11581115|FG001|Overall Study|deaths and less than 2 years followup|64
7342730|NCT00894387|11581125|FG000|Overall Study|Adverse Event|44
7342731|NCT00894387|11581126|FG001|Overall Study|Adverse Event|45
7342732|NCT00894387|11581125|FG000|Overall Study|Abnormal Laboratory values|2
7342733|NCT00894387|11581126|FG001|Overall Study|Abnormal Laboratory values|2
7342734|NCT00894387|11581125|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7342735|NCT00894387|11581126|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7342736|NCT00894387|11581125|FG000|Overall Study|Lost to Follow-up|3
7342737|NCT00894387|11581126|FG001|Overall Study|Lost to Follow-up|5
7342738|NCT00894387|11581125|FG000|Overall Study|Administrative problems|2
7342739|NCT00894387|11581126|FG001|Overall Study|Administrative problems|2
7342740|NCT00894387|11581125|FG000|Overall Study|Death|77
7342741|NCT00894387|11581126|FG001|Overall Study|Death|76
7342742|NCT00894387|11581125|FG000|Overall Study|Protocol Deviation|4
7342743|NCT00894387|11581126|FG001|Overall Study|Protocol Deviation|0
7342744|NCT00894387|11581125|FG000|Overall Study|Patient's request|25
7342745|NCT00894387|11581126|FG001|Overall Study|Patient's request|30
7342746|NCT00894387|11581125|FG000|Overall Study|Other (Missing)|5
7342747|NCT00894387|11581126|FG001|Overall Study|Other (Missing)|3
7342748|NCT00894387|11581125|FG000|Overall Study|Mis-randomized|13
7342749|NCT00894387|11581126|FG001|Overall Study|Mis-randomized|9
7342750|NCT00894387|11581125|FG000|Overall Study|GCP non-compliance|0
7342751|NCT00894387|11581126|FG001|Overall Study|GCP non-compliance|2
7342752|NCT00894413|11581134|FG000|Overall Study|Physician Decision|0
7342753|NCT00894413|11581135|FG001|Overall Study|Physician Decision|2
7342754|NCT00894413|11581134|FG000|Overall Study|Adverse Event|0
7342755|NCT00894413|11581135|FG001|Overall Study|Adverse Event|2
7342756|NCT00894413|11581134|FG000|Overall Study|Withdrawal by Subject|0
7342757|NCT00894413|11581135|FG001|Overall Study|Withdrawal by Subject|4
7342758|NCT00894543|11581177|FG000|Baseline to Week 4|No diary or lost or withdrew|3
7342759|NCT00894543|11581178|FG001|Baseline to Week 4|No diary or lost or withdrew|2
7342760|NCT00894543|11581177|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
7342761|NCT00894543|11581178|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
7342762|NCT00894647|11581186|FG000|Overall Study|Adverse Event|5
7342763|NCT00894647|11581187|FG001|Overall Study|Adverse Event|4
7342764|NCT00894647|11581186|FG000|Overall Study|Withdrawal by Subject|4
7342765|NCT00894647|11581187|FG001|Overall Study|Withdrawal by Subject|4
7342766|NCT00894647|11581186|FG000|Overall Study|Lost to Follow-up|0
7342767|NCT00894647|11581187|FG001|Overall Study|Lost to Follow-up|2
7342768|NCT00894647|11581186|FG000|Overall Study|Non-compliance with study procedures|0
7342769|NCT00894647|11581187|FG001|Overall Study|Non-compliance with study procedures|2
7342770|NCT00894647|11581186|FG000|Overall Study|Other, not due to AE|1
7342771|NCT00894647|11581187|FG001|Overall Study|Other, not due to AE|2
7342772|NCT00894686|11581193|FG000|Overall Study|Withdrawal by Subject|50
7342773|NCT00894686|11581193|FG000|Overall Study|Physician Decision|1
7342774|NCT00894686|11581193|FG000|Overall Study|Other|5
7342775|NCT00894803|11581217|FG000|Overall Study|Death|20
7342776|NCT00894803|11581218|FG001|Overall Study|Death|4
7342777|NCT00894803|11581217|FG000|Overall Study|Lost to Follow-up|0
7342778|NCT00894803|11581218|FG001|Overall Study|Lost to Follow-up|1
7342779|NCT00894933|11581224|FG000|Overall Study|Lost to Follow-up|2
7342780|NCT00894933|11581224|FG000|Overall Study|Cancelled Procedure|1
7342781|NCT00894933|11581224|FG000|Overall Study|Did not meeting incl/excl criteria|1
7342782|NCT00895011|11581231|FG000|Overall Study|Withdrawal by Subject|14
7342783|NCT00895011|11581232|FG001|Overall Study|Withdrawal by Subject|7
7342784|NCT00895011|11581233|FG002|Overall Study|Withdrawal by Subject|2
7342785|NCT00895011|11581231|FG000|Overall Study|Lost to Follow-up|5
7342786|NCT00895011|11581232|FG001|Overall Study|Lost to Follow-up|4
7342787|NCT00895011|11581233|FG002|Overall Study|Lost to Follow-up|1
7342788|NCT00895011|11581231|FG000|Overall Study|Protocol Violation|3
7342789|NCT00895011|11581232|FG001|Overall Study|Protocol Violation|1
7342790|NCT00895011|11581233|FG002|Overall Study|Protocol Violation|3
7342791|NCT00895011|11581231|FG000|Overall Study|Adverse Event|1
7342792|NCT00895011|11581232|FG001|Overall Study|Adverse Event|2
7342793|NCT00895011|11581233|FG002|Overall Study|Adverse Event|2
7342794|NCT00895011|11581231|FG000|Overall Study|schedule conflict|1
7342795|NCT00895011|11581232|FG001|Overall Study|schedule conflict|0
7342796|NCT00895011|11581233|FG002|Overall Study|schedule conflict|0
7342797|NCT00895037|11581245|FG000|Overall Study|Death|0
7342798|NCT00895037|11581246|FG001|Overall Study|Death|2
7342799|NCT00895037|11581247|FG002|Overall Study|Death|1
7342800|NCT00895154|11581257|FG000|Overall Study|Lost to Follow-up|1
7342801|NCT00895154|11581258|FG001|Overall Study|Lost to Follow-up|1
7342802|NCT00895154|11581257|FG000|Overall Study|Withdrawal by Subject|0
7342803|NCT00895154|11581258|FG001|Overall Study|Withdrawal by Subject|1
7385743|NCT01204294|11643680|FG004|Overall Study|Withdrawal by Subject|1
7385744|NCT01204294|11643681|FG005|Overall Study|Withdrawal by Subject|1
7385745|NCT01204294|11643682|FG006|Overall Study|Withdrawal by Subject|2
7385746|NCT01204294|11643676|FG000|Overall Study|Lack of Efficacy|0
7385747|NCT01204294|11643677|FG001|Overall Study|Lack of Efficacy|0
7385748|NCT01204294|11643678|FG002|Overall Study|Lack of Efficacy|0
7385749|NCT01204294|11643679|FG003|Overall Study|Lack of Efficacy|2
7385750|NCT01204294|11643680|FG004|Overall Study|Lack of Efficacy|0
7385751|NCT01204294|11643681|FG005|Overall Study|Lack of Efficacy|0
7385752|NCT01204294|11643682|FG006|Overall Study|Lack of Efficacy|0
7385753|NCT01204294|11643676|FG000|Overall Study|Other (house moving)|0
7385754|NCT01204294|11643677|FG001|Overall Study|Other (house moving)|0
7385755|NCT01204294|11643678|FG002|Overall Study|Other (house moving)|1
7385756|NCT01204294|11643679|FG003|Overall Study|Other (house moving)|0
7385757|NCT01204294|11643680|FG004|Overall Study|Other (house moving)|0
7385758|NCT01204294|11643681|FG005|Overall Study|Other (house moving)|0
7385759|NCT01204294|11643682|FG006|Overall Study|Other (house moving)|0
7385760|NCT01204398|11643698|FG000|Overall Study|Adverse Event|1
7385761|NCT01204658|11643706|FG000|Primary Phase|Adverse Event|0
7385762|NCT01204658|11643707|FG001|Primary Phase|Adverse Event|0
7385763|NCT01204658|11643708|FG002|Primary Phase|Adverse Event|1
7385764|NCT01204658|11643709|FG003|Primary Phase|Adverse Event|0
7385765|NCT01204671|11643727|FG000|Overall Study|Adverse Event|4
7385766|NCT01204671|11643728|FG001|Overall Study|Adverse Event|3
7385767|NCT01204671|11643729|FG002|Overall Study|Adverse Event|3
7385768|NCT01204671|11643730|FG003|Overall Study|Adverse Event|3
7385769|NCT01204671|11643731|FG004|Overall Study|Adverse Event|1
7385770|NCT01204671|11643727|FG000|Overall Study|Withdrawal by Subject|2
7385771|NCT01204671|11643728|FG001|Overall Study|Withdrawal by Subject|3
7385772|NCT01204671|11643729|FG002|Overall Study|Withdrawal by Subject|4
7385773|NCT01204671|11643730|FG003|Overall Study|Withdrawal by Subject|5
7385774|NCT01204671|11643731|FG004|Overall Study|Withdrawal by Subject|3
7385775|NCT01204671|11643727|FG000|Overall Study|Lost to Follow-up|7
7385776|NCT01204671|11643728|FG001|Overall Study|Lost to Follow-up|8
7385777|NCT01204671|11643729|FG002|Overall Study|Lost to Follow-up|6
7385778|NCT01204671|11643730|FG003|Overall Study|Lost to Follow-up|4
7385779|NCT01204671|11643731|FG004|Overall Study|Lost to Follow-up|0
7385780|NCT01204671|11643727|FG000|Overall Study|Unknown Completion Status|1
7385781|NCT01204671|11643728|FG001|Overall Study|Unknown Completion Status|1
7385782|NCT01204671|11643729|FG002|Overall Study|Unknown Completion Status|0
7385783|NCT01204671|11643730|FG003|Overall Study|Unknown Completion Status|0
7385784|NCT01204671|11643731|FG004|Overall Study|Unknown Completion Status|0
7385785|NCT01204671|11643727|FG000|Overall Study|Physician Decision|0
7385786|NCT01204671|11643728|FG001|Overall Study|Physician Decision|0
7385787|NCT01204671|11643729|FG002|Overall Study|Physician Decision|0
7385788|NCT01204671|11643730|FG003|Overall Study|Physician Decision|1
7385789|NCT01204671|11643731|FG004|Overall Study|Physician Decision|0
7385790|NCT01204697|11643749|FG000|Overall Study|Death|26
7385791|NCT01204697|11643750|FG001|Overall Study|Death|27
7385792|NCT01204697|11643749|FG000|Overall Study|Lost to Follow-up|3
7385793|NCT01204697|11643750|FG001|Overall Study|Lost to Follow-up|4
7225237|NCT00064701|11434644|FG002|Clinical Continuation Phase|Patient opted out|1
7225238|NCT00064753|11434654|FG000|Overall Study|Death|251
7569022|NCT03432858|11944714|FG000|Overall Study|Required postop mobilization with splinting|0
7385794|NCT01204697|11643749|FG000|Overall Study|Withdrawal by Subject|2
7385795|NCT01204697|11643750|FG001|Overall Study|Withdrawal by Subject|4
7385796|NCT01204697|11643749|FG000|Overall Study|Randomized, but not treated|0
7385797|NCT01204697|11643750|FG001|Overall Study|Randomized, but not treated|1
7385798|NCT01204710|11643758|FG000|Randomization Treatment|Lost to Follow-up|1
7385799|NCT01204710|11643759|FG001|Randomization Treatment|Lost to Follow-up|0
7385800|NCT01204710|11643758|FG000|Randomization Treatment|Withdrawal by Subject|6
7385801|NCT01204710|11643759|FG001|Randomization Treatment|Withdrawal by Subject|5
7385802|NCT01204710|11643758|FG000|Randomization Treatment|Physician Decision|3
7385803|NCT01204710|11643759|FG001|Randomization Treatment|Physician Decision|2
7385804|NCT01204710|11643758|FG000|Randomization Treatment|Entry criteria not met|0
7385805|NCT01204710|11643759|FG001|Randomization Treatment|Entry criteria not met|1
7385806|NCT01204710|11643758|FG000|Randomization Treatment|Adverse Event|4
7385807|NCT01204710|11643759|FG001|Randomization Treatment|Adverse Event|2
7385808|NCT01204710|11643758|FG000|Randomization Treatment|Sponsor Decision|0
7385809|NCT01204710|11643759|FG001|Randomization Treatment|Sponsor Decision|1
7225239|NCT00064753|11434655|FG001|Overall Study|Death|242
7225240|NCT00064753|11434654|FG000|Overall Study|Withdrawal by Subject|198
7225241|NCT00064753|11434655|FG001|Overall Study|Withdrawal by Subject|171
7225242|NCT00064753|11434654|FG000|Overall Study|Lost to Follow-up|225
7225243|NCT00064753|11434655|FG001|Overall Study|Lost to Follow-up|235
7225244|NCT00064792|11434663|FG000|Overall Study|Withdrawal by Subject|2
7225245|NCT00064792|11434664|FG001|Overall Study|Withdrawal by Subject|0
7225246|NCT00064792|11434663|FG000|Overall Study|Adverse Event|3
7225247|NCT00064792|11434664|FG001|Overall Study|Adverse Event|0
7225248|NCT00064987|11434681|FG000|Overall Study|Physician Decision|3
7569023|NCT03432858|11944715|FG001|Overall Study|Required postop mobilization with splinting|0
7569024|NCT03432858|11944716|FG002|Overall Study|Required postop mobilization with splinting|1
7569025|NCT03433482|11944728|FG000|Overall Study|Lost to Follow-up|1
7569026|NCT03433482|11944729|FG001|Overall Study|Lost to Follow-up|0
7569027|NCT03433482|11944730|FG002|Overall Study|Lost to Follow-up|1
7569028|NCT03433482|11944731|FG003|Overall Study|Lost to Follow-up|1
7569029|NCT03433482|11944728|FG000|Overall Study|Withdrawal by Subject|0
7569030|NCT03433482|11944729|FG001|Overall Study|Withdrawal by Subject|0
7569031|NCT03433482|11944730|FG002|Overall Study|Withdrawal by Subject|1
7569032|NCT03433482|11944731|FG003|Overall Study|Withdrawal by Subject|0
7569033|NCT03433482|11944728|FG000|Overall Study|Unknown reason|0
7569034|NCT03433482|11944729|FG001|Overall Study|Unknown reason|0
7342804|NCT00895245|11581305|FG000|Overall Study|Lack of Efficacy|6
7342805|NCT00895310|11581309|FG000|Overall Study|Withdrawal by Subject|1
7342806|NCT00895414|11581313|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
7342807|NCT00895414|11581314|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
7342808|NCT00895414|11581313|FG000|First Intervention (14 Days)|Physician Decision|0
7342809|NCT00895414|11581314|FG001|First Intervention (14 Days)|Physician Decision|1
7342810|NCT00895453|11581323|FG000|Overall Study|Lost to Follow-up|25
7342811|NCT00895453|11581324|FG001|Overall Study|Lost to Follow-up|25
7342812|NCT00895453|11581325|FG002|Overall Study|Lost to Follow-up|23
7342813|NCT00895583|11581344|FG000|Overall Study|Adverse Event|28
7342814|NCT00895583|11581345|FG001|Overall Study|Adverse Event|4
7342815|NCT00895583|11581344|FG000|Overall Study|Death|2
7342816|NCT00895583|11581345|FG001|Overall Study|Death|1
7458527|NCT01808118|11752556|FG000|Period 2|Withdrew consent|0
7458528|NCT01808118|11752557|FG001|Period 2|Withdrew consent|7
7458529|NCT01808118|11752558|FG002|Period 2|Withdrew consent|6
7458530|NCT01808118|11752556|FG000|Period 2|Lost to Follow-up|0
7458531|NCT01808118|11752557|FG001|Period 2|Lost to Follow-up|0
7458532|NCT01808118|11752558|FG002|Period 2|Lost to Follow-up|2
7458533|NCT01808118|11752556|FG000|Period 2|Investigator no longer conducting trials|0
7458534|NCT01808118|11752557|FG001|Period 2|Investigator no longer conducting trials|1
7458535|NCT01808118|11752558|FG002|Period 2|Investigator no longer conducting trials|0
7458536|NCT01808118|11752556|FG000|Period 2|Switched to other therapy|0
7458537|NCT01808118|11752557|FG001|Period 2|Switched to other therapy|1
7458538|NCT01808118|11752558|FG002|Period 2|Switched to other therapy|0
7458539|NCT01808144|11752574|FG000|Overall Study|Death|1
7458540|NCT01808144|11752575|FG001|Overall Study|Death|0
7458541|NCT01808144|11752574|FG000|Overall Study|Withdrawal by Subject|16
7458542|NCT01808144|11752575|FG001|Overall Study|Withdrawal by Subject|23
7458543|NCT01808144|11752574|FG000|Overall Study|Lost to Follow-up|6
7458544|NCT01808144|11752575|FG001|Overall Study|Lost to Follow-up|3
7458545|NCT01808144|11752574|FG000|Overall Study|Protocol Violation|6
7458546|NCT01808144|11752575|FG001|Overall Study|Protocol Violation|6
7458547|NCT01808144|11752574|FG000|Overall Study|Gout flare|0
7458548|NCT01808144|11752575|FG001|Overall Study|Gout flare|1
7458549|NCT01808144|11752574|FG000|Overall Study|Adverse Event|11
7458550|NCT01808144|11752575|FG001|Overall Study|Adverse Event|15
7569035|NCT03433482|11944730|FG002|Overall Study|Unknown reason|2
7569036|NCT03433482|11944731|FG003|Overall Study|Unknown reason|0
7569037|NCT03433677|11944743|FG000|Period 1|Protocol Violation|1
7569038|NCT03433677|11944744|FG001|Period 1|Protocol Violation|0
7569039|NCT03433677|11944743|FG000|Period 2|Withdrawal by Subject|1
7569040|NCT03433677|11944744|FG001|Period 2|Withdrawal by Subject|1
7569041|NCT03433703|11944751|FG000|Overall Study|Study terminated by Sponsor|2
7569042|NCT03433755|11944759|FG000|Overall Study|Lost to Follow-up|1
7569043|NCT03433755|11944760|FG001|Overall Study|Lost to Follow-up|0
7569044|NCT03433755|11944761|FG002|Overall Study|Lost to Follow-up|0
7569045|NCT03433755|11944762|FG003|Overall Study|Lost to Follow-up|0
7569046|NCT03433755|11944759|FG000|Overall Study|Decision by Sponsor|1
7569047|NCT03433755|11944760|FG001|Overall Study|Decision by Sponsor|0
7569048|NCT03433755|11944761|FG002|Overall Study|Decision by Sponsor|0
7569049|NCT03433755|11944762|FG003|Overall Study|Decision by Sponsor|0
7569050|NCT03434249|11944789|FG000|Overall Study|Adverse Event|1
7569051|NCT03434249|11944790|FG001|Overall Study|Adverse Event|0
7569052|NCT03434249|11944789|FG000|Overall Study|Lost to Follow-up|0
7225249|NCT00064987|11434682|FG001|Overall Study|Physician Decision|0
7225250|NCT00065065|11434690|FG000|Overall Study|Adverse Event|3
7458551|NCT01808196|11752581|FG000|Overall Study|Lost to Follow-up|1
7458552|NCT01808209|11752587|FG000|Overall Study|Lost to Follow-up|0
7458553|NCT01808209|11752588|FG001|Overall Study|Lost to Follow-up|1
7342817|NCT00895583|11581344|FG000|Overall Study|Physician Decision|3
7342818|NCT00895583|11581345|FG001|Overall Study|Physician Decision|1
7342819|NCT00895583|11581344|FG000|Overall Study|Lost to Follow-up|1
7569053|NCT03434249|11944790|FG001|Overall Study|Lost to Follow-up|1
7342820|NCT00895583|11581345|FG001|Overall Study|Lost to Follow-up|3
7342821|NCT00895583|11581344|FG000|Overall Study|Protocol Violation|1
7342822|NCT00895583|11581345|FG001|Overall Study|Protocol Violation|0
7342823|NCT00895583|11581344|FG000|Overall Study|Withdrawal by Subject|4
7342824|NCT00895583|11581345|FG001|Overall Study|Withdrawal by Subject|2
7342825|NCT00895583|11581344|FG000|Overall Study|Lack of Efficacy|5
7342826|NCT00895583|11581345|FG001|Overall Study|Lack of Efficacy|0
7342827|NCT00895583|11581344|FG000|Overall Study|Other|0
7342828|NCT00895583|11581345|FG001|Overall Study|Other|1
7342829|NCT00895622|11581354|FG000|Overall Study|Protocol Violation|5
7342830|NCT00895622|11581355|FG001|Overall Study|Protocol Violation|4
7342831|NCT00895622|11581356|FG002|Overall Study|Protocol Violation|4
7342832|NCT00895661|11581372|FG000|Overall Study|Death|1
7342833|NCT00895661|11581372|FG000|Overall Study|reason unknown|2
7342834|NCT00895843|11581414|FG000|Overall Study|Protocol Violation|12
7342835|NCT00895843|11581415|FG001|Overall Study|Protocol Violation|12
7342836|NCT00895895|11581426|FG000|Period 1|Adverse Event|7
7342837|NCT00895895|11581427|FG001|Period 1|Adverse Event|6
7342838|NCT00895895|11581428|FG002|Period 1|Adverse Event|4
7342839|NCT00895895|11581429|FG003|Period 1|Adverse Event|6
7342840|NCT00895895|11581430|FG004|Period 1|Adverse Event|7
7342841|NCT00895895|11581426|FG000|Period 1|Death|0
7342842|NCT00895895|11581427|FG001|Period 1|Death|0
7342843|NCT00895895|11581428|FG002|Period 1|Death|0
7342844|NCT00895895|11581429|FG003|Period 1|Death|0
7342845|NCT00895895|11581430|FG004|Period 1|Death|1
7342846|NCT00895895|11581426|FG000|Period 1|discontinued by sponsor|2
7342847|NCT00895895|11581427|FG001|Period 1|discontinued by sponsor|1
7342848|NCT00895895|11581428|FG002|Period 1|discontinued by sponsor|2
7342849|NCT00895895|11581429|FG003|Period 1|discontinued by sponsor|1
7342850|NCT00895895|11581430|FG004|Period 1|discontinued by sponsor|1
7342851|NCT00895895|11581426|FG000|Period 1|failed to return|0
7342852|NCT00895895|11581427|FG001|Period 1|failed to return|0
7342853|NCT00895895|11581428|FG002|Period 1|failed to return|1
7342854|NCT00895895|11581429|FG003|Period 1|failed to return|0
7342855|NCT00895895|11581430|FG004|Period 1|failed to return|1
7342856|NCT00895895|11581426|FG000|Period 1|investigator request|0
7342857|NCT00895895|11581427|FG001|Period 1|investigator request|1
7342858|NCT00895895|11581428|FG002|Period 1|investigator request|0
7342859|NCT00895895|11581429|FG003|Period 1|investigator request|0
7342860|NCT00895895|11581430|FG004|Period 1|investigator request|0
7342861|NCT00895895|11581426|FG000|Period 1|Lost to Follow-up|2
7342862|NCT00895895|11581427|FG001|Period 1|Lost to Follow-up|1
7342863|NCT00895895|11581428|FG002|Period 1|Lost to Follow-up|3
7342864|NCT00895895|11581429|FG003|Period 1|Lost to Follow-up|2
7342865|NCT00895895|11581430|FG004|Period 1|Lost to Follow-up|3
7342866|NCT00895895|11581426|FG000|Period 1|Other|1
7342867|NCT00895895|11581427|FG001|Period 1|Other|2
7342868|NCT00895895|11581428|FG002|Period 1|Other|1
7342869|NCT00895895|11581429|FG003|Period 1|Other|1
7342870|NCT00895895|11581430|FG004|Period 1|Other|1
7342871|NCT00895895|11581426|FG000|Period 1|Protocol Violation|0
7342872|NCT00895895|11581427|FG001|Period 1|Protocol Violation|1
7342873|NCT00895895|11581428|FG002|Period 1|Protocol Violation|0
7342874|NCT00895895|11581429|FG003|Period 1|Protocol Violation|0
7342875|NCT00895895|11581430|FG004|Period 1|Protocol Violation|0
7342876|NCT00895895|11581426|FG000|Period 1|Withdrawal by Subject|6
7342877|NCT00895895|11581427|FG001|Period 1|Withdrawal by Subject|6
7342878|NCT00895895|11581428|FG002|Period 1|Withdrawal by Subject|8
7342879|NCT00895895|11581429|FG003|Period 1|Withdrawal by Subject|2
7342880|NCT00895895|11581430|FG004|Period 1|Withdrawal by Subject|4
7342881|NCT00895895|11581426|FG000|Period 1|unsatisfactory response-efficacy|2
7342882|NCT00895895|11581427|FG001|Period 1|unsatisfactory response-efficacy|0
7342883|NCT00895895|11581428|FG002|Period 1|unsatisfactory response-efficacy|0
7342884|NCT00895895|11581429|FG003|Period 1|unsatisfactory response-efficacy|0
7342885|NCT00895895|11581430|FG004|Period 1|unsatisfactory response-efficacy|0
7342886|NCT00895895|11581426|FG000|Period 1|randomized and not treated|1
7342887|NCT00895895|11581427|FG001|Period 1|randomized and not treated|3
7342888|NCT00895895|11581428|FG002|Period 1|randomized and not treated|1
7342889|NCT00895895|11581429|FG003|Period 1|randomized and not treated|1
7342890|NCT00895895|11581430|FG004|Period 1|randomized and not treated|2
7342891|NCT00895895|11581426|FG000|After Period 1, Prior to Period 2|Adverse Event|0
7342892|NCT00895895|11581427|FG001|After Period 1, Prior to Period 2|Adverse Event|0
7342893|NCT00895895|11581428|FG002|After Period 1, Prior to Period 2|Adverse Event|1
7342979|NCT00896168|11581529|FG000|Overall Study|Adverse Event|4
7342894|NCT00895895|11581429|FG003|After Period 1, Prior to Period 2|Adverse Event|0
7342895|NCT00895895|11581430|FG004|After Period 1, Prior to Period 2|Adverse Event|0
7342896|NCT00895895|11581426|FG000|After Period 1, Prior to Period 2|Other|0
7342897|NCT00895895|11581427|FG001|After Period 1, Prior to Period 2|Other|0
7342898|NCT00895895|11581428|FG002|After Period 1, Prior to Period 2|Other|1
7342899|NCT00895895|11581429|FG003|After Period 1, Prior to Period 2|Other|0
7342900|NCT00895895|11581430|FG004|After Period 1, Prior to Period 2|Other|0
7342901|NCT00895895|11581426|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
7342902|NCT00895895|11581427|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
7342903|NCT00895895|11581428|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
7342904|NCT00895895|11581429|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
7342905|NCT00895895|11581430|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
7342906|NCT00895895|11581426|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7342907|NCT00895895|11581427|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7342908|NCT00895895|11581428|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7342909|NCT00895895|11581429|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
7342910|NCT00895895|11581430|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
7342911|NCT00895895|11581426|FG000|Period 2|Adverse Event|3
7342912|NCT00895895|11581427|FG001|Period 2|Adverse Event|3
7342913|NCT00895895|11581428|FG002|Period 2|Adverse Event|5
7342914|NCT00895895|11581429|FG003|Period 2|Adverse Event|2
7342915|NCT00895895|11581430|FG004|Period 2|Adverse Event|5
7342916|NCT00895895|11581426|FG000|Period 2|Death|0
7342917|NCT00895895|11581427|FG001|Period 2|Death|0
7342918|NCT00895895|11581428|FG002|Period 2|Death|1
7342919|NCT00895895|11581429|FG003|Period 2|Death|0
7342920|NCT00895895|11581430|FG004|Period 2|Death|0
7342921|NCT00895895|11581426|FG000|Period 2|discontinued by sponsor|44
7342922|NCT00895895|11581427|FG001|Period 2|discontinued by sponsor|44
7342923|NCT00895895|11581428|FG002|Period 2|discontinued by sponsor|38
7342924|NCT00895895|11581429|FG003|Period 2|discontinued by sponsor|46
7342925|NCT00895895|11581430|FG004|Period 2|discontinued by sponsor|37
7342926|NCT00895895|11581426|FG000|Period 2|failed to return|2
7342927|NCT00895895|11581427|FG001|Period 2|failed to return|0
7342928|NCT00895895|11581428|FG002|Period 2|failed to return|0
7342929|NCT00895895|11581429|FG003|Period 2|failed to return|0
7342930|NCT00895895|11581430|FG004|Period 2|failed to return|0
7342931|NCT00895895|11581426|FG000|Period 2|investigator request|2
7342932|NCT00895895|11581427|FG001|Period 2|investigator request|0
7342933|NCT00895895|11581428|FG002|Period 2|investigator request|0
7342934|NCT00895895|11581429|FG003|Period 2|investigator request|0
7342935|NCT00895895|11581430|FG004|Period 2|investigator request|0
7342936|NCT00895895|11581426|FG000|Period 2|Lost to Follow-up|1
7342937|NCT00895895|11581427|FG001|Period 2|Lost to Follow-up|2
7342938|NCT00895895|11581428|FG002|Period 2|Lost to Follow-up|1
7342939|NCT00895895|11581429|FG003|Period 2|Lost to Follow-up|1
7342940|NCT00895895|11581430|FG004|Period 2|Lost to Follow-up|0
7342941|NCT00895895|11581426|FG000|Period 2|Other|1
7342942|NCT00895895|11581427|FG001|Period 2|Other|1
7342943|NCT00895895|11581428|FG002|Period 2|Other|3
7342944|NCT00895895|11581429|FG003|Period 2|Other|1
7342945|NCT00895895|11581430|FG004|Period 2|Other|1
7342946|NCT00895895|11581426|FG000|Period 2|Protocol Violation|1
7342947|NCT00895895|11581427|FG001|Period 2|Protocol Violation|0
7342948|NCT00895895|11581428|FG002|Period 2|Protocol Violation|1
7342949|NCT00895895|11581429|FG003|Period 2|Protocol Violation|1
7342950|NCT00895895|11581430|FG004|Period 2|Protocol Violation|1
7342951|NCT00895895|11581426|FG000|Period 2|Withdrawal by Subject|0
7342952|NCT00895895|11581427|FG001|Period 2|Withdrawal by Subject|2
7342953|NCT00895895|11581428|FG002|Period 2|Withdrawal by Subject|0
7342954|NCT00895895|11581429|FG003|Period 2|Withdrawal by Subject|3
7342955|NCT00895895|11581430|FG004|Period 2|Withdrawal by Subject|5
7342956|NCT00895895|11581426|FG000|Period 2|unsatisfactory response-efficacy|2
7342957|NCT00895895|11581427|FG001|Period 2|unsatisfactory response-efficacy|1
7342958|NCT00895895|11581428|FG002|Period 2|unsatisfactory response-efficacy|0
7342959|NCT00895895|11581429|FG003|Period 2|unsatisfactory response-efficacy|0
7342960|NCT00895895|11581430|FG004|Period 2|unsatisfactory response-efficacy|0
7342961|NCT00895947|11581475|FG000|Overall Study|Adverse Event|3
7342962|NCT00895947|11581476|FG001|Overall Study|Adverse Event|4
7342963|NCT00895947|11581475|FG000|Overall Study|Lost to Follow-up|3
7342964|NCT00895947|11581476|FG001|Overall Study|Lost to Follow-up|4
7342965|NCT00895947|11581475|FG000|Overall Study|Protocol Violation|4
7342966|NCT00895947|11581476|FG001|Overall Study|Protocol Violation|2
7342967|NCT00895947|11581475|FG000|Overall Study|Withdrawal by Subject|2
7342968|NCT00895947|11581476|FG001|Overall Study|Withdrawal by Subject|0
7342969|NCT00896051|11581502|FG000|Overall Study|Adverse Event|2
7342970|NCT00896051|11581503|FG001|Overall Study|Adverse Event|1
7342971|NCT00896051|11581502|FG000|Overall Study|Lost to Follow-up|3
7342972|NCT00896051|11581503|FG001|Overall Study|Lost to Follow-up|2
7342973|NCT00896051|11581502|FG000|Overall Study|Withdrawal by Subject|3
7342974|NCT00896051|11581503|FG001|Overall Study|Withdrawal by Subject|2
7342975|NCT00896051|11581502|FG000|Overall Study|Subject noncompliant|1
7342976|NCT00896051|11581503|FG001|Overall Study|Subject noncompliant|3
7342977|NCT00896051|11581502|FG000|Overall Study|Other|1
7569054|NCT03434249|11944789|FG000|Overall Study|Non-compliance of family|2
7569055|NCT03434249|11944790|FG001|Overall Study|Non-compliance of family|1
7342978|NCT00896051|11581503|FG001|Overall Study|Other|1
7342980|NCT00896168|11581530|FG001|Overall Study|Adverse Event|7
7342981|NCT00896168|11581529|FG000|Overall Study|Treatment failure|8
7342982|NCT00896168|11581530|FG001|Overall Study|Treatment failure|10
7342983|NCT00896168|11581529|FG000|Overall Study|Lost to Follow-up|1
7342984|NCT00896168|11581530|FG001|Overall Study|Lost to Follow-up|1
7342985|NCT00896168|11581529|FG000|Overall Study|Other|1
7342986|NCT00896168|11581530|FG001|Overall Study|Other|1
7342987|NCT00896233|11581540|FG000|Overall Study|Claustrophobia during MRI|1
7342988|NCT00896337|11581554|FG000|Overall Study|Death|7
7342989|NCT00896337|11581554|FG000|Overall Study|Withdrawal by Subject|7
7342990|NCT00896337|11581554|FG000|Overall Study|Lost to Follow-up|11
7342991|NCT00896363|11581566|FG000|Overall Study|Adverse Event|3
7342992|NCT00896363|11581567|FG001|Overall Study|Adverse Event|4
7342993|NCT00896363|11581568|FG002|Overall Study|Adverse Event|2
7342994|NCT00896363|11581566|FG000|Overall Study|Lack of Efficacy|0
7342995|NCT00896363|11581567|FG001|Overall Study|Lack of Efficacy|2
7342996|NCT00896363|11581568|FG002|Overall Study|Lack of Efficacy|1
7342997|NCT00896363|11581566|FG000|Overall Study|Withdrawal by Subject|3
7458554|NCT01808222|11752598|FG000|Overall Study|mpMR scan was not performed|1
7458555|NCT01808248|11752604|FG000|Overall Study|Lack of Efficacy|3
7458556|NCT01808248|11752604|FG000|Overall Study|Withdrawal by Subject|1
7458557|NCT01808248|11752604|FG000|Overall Study|Lost to Follow-up|1
7458558|NCT01808313|11752610|FG000|Overall Study|Adverse Event|5
7458559|NCT01808313|11752610|FG000|Overall Study|Protocol Violation|2
7458560|NCT01808313|11752610|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7458561|NCT01808313|11752610|FG000|Overall Study|Lost to Follow-up|1
7458562|NCT01808313|11752610|FG000|Overall Study|Physician Decision|1
7458563|NCT01808339|11752618|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7537666|NCT02759185|11886790|FG002|Stage 1|Adverse Event|3
7342998|NCT00896363|11581567|FG001|Overall Study|Withdrawal by Subject|5
7342999|NCT00896363|11581568|FG002|Overall Study|Withdrawal by Subject|5
7343000|NCT00896454|11581587|FG000|Overall Study|Death|10
7343001|NCT00896454|11581587|FG000|Overall Study|Adverse Event|8
7343002|NCT00896454|11581587|FG000|Overall Study|Disease Progression|5
7343003|NCT00896454|11581587|FG000|Overall Study|Other|4
7343004|NCT00896454|11581587|FG000|Overall Study|Requirement for alternative therapy|3
7343005|NCT00896454|11581587|FG000|Overall Study|Ongoing in study|2
7343006|NCT00896454|11581587|FG000|Overall Study|Withdrawal by Subject|1
7343007|NCT00896480|11581591|FG000|Overall Study|Disease progression/recurrence|21
7387761|NCT01215942|11646481|FG000|Post-Treatment Follow-Up Period|Death|0
7387762|NCT01215942|11646482|FG001|Post-Treatment Follow-Up Period|Death|1
7387763|NCT01215942|11646481|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7387764|NCT01215942|11646482|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
7387765|NCT01215942|11646481|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
7387766|NCT01215942|11646482|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
7458614|NCT01808612|11752682|FG000|Treatment Period|Lack of Efficacy|1
7387767|NCT01215942|11646481|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
7387768|NCT01215942|11646482|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
7387769|NCT01215942|11646481|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
7387770|NCT01215942|11646482|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
7387771|NCT01215955|11646503|FG000|Overall Study|Adverse Event|1
7387772|NCT01215955|11646504|FG001|Overall Study|Adverse Event|4
7387773|NCT01215955|11646505|FG002|Overall Study|Adverse Event|2
7387774|NCT01215955|11646506|FG003|Overall Study|Adverse Event|3
7387775|NCT01215955|11646503|FG000|Overall Study|Death|2
7387776|NCT01215955|11646504|FG001|Overall Study|Death|0
7387777|NCT01215955|11646505|FG002|Overall Study|Death|1
7387778|NCT01215955|11646506|FG003|Overall Study|Death|3
7387779|NCT01215955|11646503|FG000|Overall Study|Entry Criteria Not Met|1
7458615|NCT01808612|11752683|FG001|Treatment Period|Lack of Efficacy|1
7458616|NCT01808612|11752684|FG002|Treatment Period|Lack of Efficacy|2
7458617|NCT01808612|11752682|FG000|Discontinuation Period|Adverse Event|1
7537667|NCT02759185|11886791|FG003|Stage 1|Adverse Event|0
7343514|NCT00896649|11581675|FG000|Overall Study|Physician Decision|1
7343515|NCT00896649|11581675|FG000|Overall Study|Pregnancy|1
7343516|NCT00896649|11581675|FG000|Overall Study|missing documentation|1
7343517|NCT00896649|11581675|FG000|Overall Study|technical difficulties|2
7343518|NCT00897390|11581689|FG000|Overall Study|Adverse Event|2
7343519|NCT00897390|11581689|FG000|Overall Study|No Longer Met Study Criteria|1
7343520|NCT00897390|11581689|FG000|Overall Study|Personal Reasons|1
7343521|NCT00897390|11581689|FG000|Overall Study|Did not Return for the Clinic Visit|2
7343522|NCT00897715|11581716|FG000|Overall Study|Lost to Follow-up|0
7343523|NCT00897715|11581717|FG001|Overall Study|Lost to Follow-up|1
7343524|NCT00897715|11581716|FG000|Overall Study|Physician Decision|1
7343525|NCT00897715|11581717|FG001|Overall Study|Physician Decision|0
7343526|NCT00897715|11581716|FG000|Overall Study|increased risk of infection|1
7343527|NCT00897715|11581717|FG001|Overall Study|increased risk of infection|0
7343528|NCT00898443|11581733|FG000|Overall Study|Withdrawal by Subject|1
7343529|NCT00898443|11581734|FG001|Overall Study|Withdrawal by Subject|0
7343530|NCT00898807|11581748|FG000|Overall Study|Withdrawal by Subject|5
7343531|NCT00898807|11581749|FG001|Overall Study|Withdrawal by Subject|3
7343532|NCT00898807|11581748|FG000|Overall Study|Family pressure to discontinue|2
7343533|NCT00898807|11581749|FG001|Overall Study|Family pressure to discontinue|2
7343534|NCT00898807|11581748|FG000|Overall Study|Lost to Follow-up|1
7343535|NCT00898807|11581749|FG001|Overall Study|Lost to Follow-up|3
7343536|NCT00898807|11581748|FG000|Overall Study|Death|0
7343537|NCT00898807|11581749|FG001|Overall Study|Death|1
7343538|NCT00899353|11581768|FG000|Overall Study|Adverse Event|2
7343539|NCT00899353|11581768|FG000|Overall Study|Lost to Follow-up|1
7343540|NCT00899353|11581768|FG000|Overall Study|Withdrawal by Subject|2
7343541|NCT00899392|11581791|FG000|Overall Study|Subject didn't finish/partial pilot data|21
7343542|NCT00899392|11581792|FG001|Overall Study|Subject didn't finish/partial pilot data|24
7343543|NCT00899431|11581801|FG000|Overall Study|Physician Decision|1
7343544|NCT00899431|11581802|FG001|Overall Study|Physician Decision|0
7343545|NCT00899431|11581803|FG002|Overall Study|Physician Decision|0
7343546|NCT00899548|11581832|FG000|Overall Study|Physician Decision|3
7343547|NCT00899678|11581856|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
7343548|NCT00899678|11581857|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
7343549|NCT00899678|11581858|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
7343550|NCT00899678|11581856|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
7343551|NCT00899678|11581857|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7343552|NCT00899678|11581858|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
7343553|NCT00899678|11581856|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
7343554|NCT00899678|11581857|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7343555|NCT00899678|11581858|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
7343556|NCT00899678|11581856|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
7343557|NCT00899678|11581857|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
7343558|NCT00899678|11581858|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
7458564|NCT01808339|11752619|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458565|NCT01808339|11752620|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458566|NCT01808339|11752621|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7533050|NCT02680002|11879103|FG000|Overall Study|Lost to Follow-up|5
7533051|NCT02680002|11879104|FG001|Overall Study|Lost to Follow-up|1
7533052|NCT02680002|11879105|FG002|Overall Study|Lost to Follow-up|4
7533053|NCT02680002|11879106|FG003|Overall Study|Lost to Follow-up|2
7533054|NCT02680002|11879107|FG004|Overall Study|Lost to Follow-up|0
7533055|NCT02680002|11879108|FG005|Overall Study|Lost to Follow-up|2
7533056|NCT02680002|11879103|FG000|Overall Study|Physician Decision|5
7533057|NCT02680002|11879104|FG001|Overall Study|Physician Decision|1
7533058|NCT02680002|11879105|FG002|Overall Study|Physician Decision|1
7569056|NCT03434249|11944789|FG000|Overall Study|Difficulties in completing daily diary|2
7458567|NCT01808339|11752622|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
7458568|NCT01808339|11752623|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
7458569|NCT01808339|11752618|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7458570|NCT01808339|11752619|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7458571|NCT01808339|11752620|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7458572|NCT01808339|11752621|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
7458573|NCT01808339|11752622|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7458574|NCT01808339|11752623|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
7458575|NCT01808339|11752618|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458576|NCT01808339|11752619|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458577|NCT01808339|11752620|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
7468238|NCT01908803|11768920|FG000|Overall Study|Physician Decision|0
7569057|NCT03434249|11944790|FG001|Overall Study|Difficulties in completing daily diary|1
7343559|NCT00899678|11581856|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
7343560|NCT00899678|11581857|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
7343561|NCT00899678|11581858|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
7343562|NCT00899678|11581856|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
7569058|NCT03434834|11944800|FG000|Overall Study|unable to swallow OCT probe|16
7569059|NCT03434977|11944806|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
7569060|NCT03434977|11944807|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
7569061|NCT03435055|11944813|FG000|Screening|Physician Decision|2
7569062|NCT03435055|11944813|FG000|Received Intervention|Did not complete nitrous administration|3
7343563|NCT00899678|11581857|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
7343564|NCT00899678|11581858|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
7343565|NCT00899678|11581856|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
7343566|NCT00899678|11581857|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7343567|NCT00899678|11581858|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
7343568|NCT00899678|11581856|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
7343569|NCT00899678|11581857|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
7343570|NCT00899678|11581858|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
7343571|NCT00899678|11581856|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
7343572|NCT00899678|11581857|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
7343573|NCT00899678|11581858|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
7343574|NCT00899847|11581881|FG000|Overall Study|Lack of suitable allogeneic donor|2
7343575|NCT00900029|11581892|FG000|Overall Study|Lost to Follow-up|0
7343576|NCT00900029|11581893|FG001|Overall Study|Lost to Follow-up|2
7343577|NCT00900029|11581894|FG002|Overall Study|Lost to Follow-up|1
7343578|NCT00900029|11581895|FG003|Overall Study|Lost to Follow-up|4
7343579|NCT00900029|11581896|FG004|Overall Study|Lost to Follow-up|4
7343580|NCT00900029|11581892|FG000|Overall Study|Withdrawal by Subject|2
7343581|NCT00900029|11581893|FG001|Overall Study|Withdrawal by Subject|2
7343582|NCT00900029|11581894|FG002|Overall Study|Withdrawal by Subject|1
7343583|NCT00900029|11581895|FG003|Overall Study|Withdrawal by Subject|1
7343584|NCT00900029|11581896|FG004|Overall Study|Withdrawal by Subject|1
7343585|NCT00900029|11581892|FG000|Overall Study|Adverse Event|0
7343586|NCT00900029|11581893|FG001|Overall Study|Adverse Event|0
7343587|NCT00900029|11581894|FG002|Overall Study|Adverse Event|1
7343588|NCT00900029|11581895|FG003|Overall Study|Adverse Event|1
7343589|NCT00900029|11581896|FG004|Overall Study|Adverse Event|1
7343590|NCT00900029|11581892|FG000|Overall Study|Death|1
7343591|NCT00900029|11581893|FG001|Overall Study|Death|0
7343592|NCT00900029|11581894|FG002|Overall Study|Death|0
7343593|NCT00900029|11581895|FG003|Overall Study|Death|1
7458578|NCT01808339|11752621|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458579|NCT01808339|11752622|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458580|NCT01808339|11752623|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
7458581|NCT01808508|11752634|FG000|Overall Study|Lost to Follow-up|1
7458582|NCT01808508|11752635|FG001|Overall Study|Lost to Follow-up|0
7458583|NCT01808508|11752636|FG002|Overall Study|Lost to Follow-up|0
7458584|NCT01808534|11752644|FG000|Overall Study|Disease progression|3
7458585|NCT01808534|11752644|FG000|Overall Study|Physician Decision|1
7458586|NCT01808573|11752672|FG000|Overall Study|Death|212
7458587|NCT01808573|11752673|FG001|Overall Study|Death|240
7458588|NCT01808573|11752672|FG000|Overall Study|Withdrawal by Subject|12
7458589|NCT01808573|11752673|FG001|Overall Study|Withdrawal by Subject|10
7458590|NCT01808573|11752672|FG000|Overall Study|Lost to Follow-up|3
7458591|NCT01808573|11752673|FG001|Overall Study|Lost to Follow-up|0
7458592|NCT01808573|11752672|FG000|Overall Study|Discontinuation of study by sponsor|79
7458593|NCT01808573|11752673|FG001|Overall Study|Discontinuation of study by sponsor|64
7458594|NCT01808573|11752672|FG000|Overall Study|Randomized in Error|1
7458595|NCT01808573|11752673|FG001|Overall Study|Randomized in Error|0
7458596|NCT01808612|11752682|FG000|Treatment Period|Adverse Event|8
7458597|NCT01808612|11752683|FG001|Treatment Period|Adverse Event|4
7458598|NCT01808612|11752684|FG002|Treatment Period|Adverse Event|3
7458599|NCT01808612|11752682|FG000|Treatment Period|Lost to Follow-up|2
7458600|NCT01808612|11752683|FG001|Treatment Period|Lost to Follow-up|2
7458601|NCT01808612|11752684|FG002|Treatment Period|Lost to Follow-up|1
7458602|NCT01808612|11752682|FG000|Treatment Period|Protocol Violation|1
7458603|NCT01808612|11752683|FG001|Treatment Period|Protocol Violation|0
7458604|NCT01808612|11752684|FG002|Treatment Period|Protocol Violation|0
7458605|NCT01808612|11752682|FG000|Treatment Period|Withdrawal by Subject|1
7458606|NCT01808612|11752683|FG001|Treatment Period|Withdrawal by Subject|0
7458607|NCT01808612|11752684|FG002|Treatment Period|Withdrawal by Subject|4
7458608|NCT01808612|11752682|FG000|Treatment Period|Physician Decision|1
7458609|NCT01808612|11752683|FG001|Treatment Period|Physician Decision|0
7458610|NCT01808612|11752684|FG002|Treatment Period|Physician Decision|4
7458611|NCT01808612|11752682|FG000|Treatment Period|Sponsor Decision|1
7458612|NCT01808612|11752683|FG001|Treatment Period|Sponsor Decision|0
7458613|NCT01808612|11752684|FG002|Treatment Period|Sponsor Decision|0
7458618|NCT01808612|11752683|FG001|Discontinuation Period|Adverse Event|0
7458619|NCT01808612|11752684|FG002|Discontinuation Period|Adverse Event|0
7458620|NCT01808612|11752682|FG000|Discontinuation Period|Physician Decision|1
7343594|NCT00900029|11581896|FG004|Overall Study|Death|0
7343595|NCT00900146|11581913|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7343596|NCT00900146|11581914|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
7343597|NCT00900146|11581915|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
7343598|NCT00900146|11581916|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
7343599|NCT00900146|11581917|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
7343600|NCT00900146|11581913|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
7343601|NCT00900146|11581914|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7343602|NCT00900146|11581915|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
7343603|NCT00900146|11581916|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
7343604|NCT00900146|11581917|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
7343605|NCT00900146|11581913|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
7343606|NCT00900146|11581914|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
7343607|NCT00900146|11581915|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
7343608|NCT00900146|11581916|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
7343609|NCT00900146|11581917|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
7343610|NCT00900146|11581913|FG000|Intermediate: Period III|Withdrawal by Subject|0
7343611|NCT00900146|11581914|FG001|Intermediate: Period III|Withdrawal by Subject|1
7343612|NCT00900146|11581915|FG002|Intermediate: Period III|Withdrawal by Subject|0
7343613|NCT00900146|11581916|FG003|Intermediate: Period III|Withdrawal by Subject|0
7343614|NCT00900146|11581917|FG004|Intermediate: Period III|Withdrawal by Subject|3
7343615|NCT00900146|11581913|FG000|Intermediate: Period III|Lost to Follow-up|2
7343616|NCT00900146|11581914|FG001|Intermediate: Period III|Lost to Follow-up|0
7343617|NCT00900146|11581915|FG002|Intermediate: Period III|Lost to Follow-up|0
7343618|NCT00900146|11581916|FG003|Intermediate: Period III|Lost to Follow-up|0
7343619|NCT00900146|11581917|FG004|Intermediate: Period III|Lost to Follow-up|1
7343620|NCT00900146|11581913|FG000|Intermediate: Period III|Administrative problems|85
7343621|NCT00900146|11581914|FG001|Intermediate: Period III|Administrative problems|92
7343622|NCT00900146|11581915|FG002|Intermediate: Period III|Administrative problems|84
7343623|NCT00900146|11581916|FG003|Intermediate: Period III|Administrative problems|90
7343624|NCT00900146|11581917|FG004|Intermediate: Period III|Administrative problems|163
7343625|NCT00900159|11581931|FG000|Second Intervention|disempanelled for inappropriate behavior|1
7343626|NCT00900159|11581932|FG001|Second Intervention|disempanelled for inappropriate behavior|0
7343627|NCT00900562|11581949|FG000|Overall Study|Progressive disease|9
7343628|NCT00900562|11581950|FG001|Overall Study|Progressive disease|5
7343629|NCT00900562|11581949|FG000|Overall Study|Toxicity|1
7343630|NCT00900562|11581950|FG001|Overall Study|Toxicity|0
7343631|NCT00900562|11581949|FG000|Overall Study|Death|1
7343632|NCT00900562|11581950|FG001|Overall Study|Death|1
7343633|NCT00900562|11581949|FG000|Overall Study|Withdrawal by Subject|0
7343634|NCT00900562|11581950|FG001|Overall Study|Withdrawal by Subject|1
7343635|NCT00900562|11581949|FG000|Overall Study|Unrelated adverse event|1
7343636|NCT00900562|11581950|FG001|Overall Study|Unrelated adverse event|0
7343637|NCT00900601|11581957|FG000|Overall Study|Physician Decision|1
7343638|NCT00900627|11581967|FG000|Overall Study|Condition under investigation worsened|4
7343639|NCT00900627|11581968|FG001|Overall Study|Condition under investigation worsened|0
7343640|NCT00900627|11581969|FG002|Overall Study|Condition under investigation worsened|5
7343641|NCT00900627|11581970|FG003|Overall Study|Condition under investigation worsened|3
7343642|NCT00900627|11581971|FG004|Overall Study|Condition under investigation worsened|0
7343643|NCT00900627|11581972|FG005|Overall Study|Condition under investigation worsened|0
7343644|NCT00900627|11581967|FG000|Overall Study|Withdrawal by Subject|1
7343645|NCT00900627|11581968|FG001|Overall Study|Withdrawal by Subject|0
7343646|NCT00900627|11581969|FG002|Overall Study|Withdrawal by Subject|1
7343647|NCT00900627|11581970|FG003|Overall Study|Withdrawal by Subject|0
7343648|NCT00900627|11581971|FG004|Overall Study|Withdrawal by Subject|1
7343649|NCT00900627|11581972|FG005|Overall Study|Withdrawal by Subject|2
7343650|NCT00900627|11581967|FG000|Overall Study|Adverse Event|1
7343651|NCT00900627|11581968|FG001|Overall Study|Adverse Event|2
7343652|NCT00900627|11581969|FG002|Overall Study|Adverse Event|0
7343653|NCT00900627|11581970|FG003|Overall Study|Adverse Event|3
7343654|NCT00900627|11581971|FG004|Overall Study|Adverse Event|0
7343655|NCT00900627|11581972|FG005|Overall Study|Adverse Event|0
7343656|NCT00900627|11581967|FG000|Overall Study|Death|0
7343657|NCT00900627|11581968|FG001|Overall Study|Death|0
7343658|NCT00900627|11581969|FG002|Overall Study|Death|0
7343659|NCT00900627|11581970|FG003|Overall Study|Death|0
7343660|NCT00900627|11581971|FG004|Overall Study|Death|28
7343661|NCT00900627|11581972|FG005|Overall Study|Death|24
7343662|NCT00900731|11581997|FG000|Overall Study|Adverse Event|31
7343663|NCT00900731|11581998|FG001|Overall Study|Adverse Event|27
7343664|NCT00900731|11581997|FG000|Overall Study|Withdrawal by Subject|8
7343665|NCT00900731|11581998|FG001|Overall Study|Withdrawal by Subject|7
7343666|NCT00900731|11581997|FG000|Overall Study|Protocol Deviation|8
7343667|NCT00900731|11581998|FG001|Overall Study|Protocol Deviation|11
7343668|NCT00900731|11581997|FG000|Overall Study|Administrative Problems|5
7343669|NCT00900731|11581998|FG001|Overall Study|Administrative Problems|4
7343670|NCT00900731|11581997|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
7343671|NCT00900731|11581998|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7343672|NCT00900731|11581997|FG000|Overall Study|Abnormal Laboratory Value(s)|2
7343673|NCT00900731|11581998|FG001|Overall Study|Abnormal Laboratory Value(s)|4
7343674|NCT00900731|11581997|FG000|Overall Study|Lost to Follow-up|2
7343675|NCT00900731|11581998|FG001|Overall Study|Lost to Follow-up|3
7343676|NCT00900731|11581997|FG000|Overall Study|Lack of Efficacy|1
7343677|NCT00900731|11581998|FG001|Overall Study|Lack of Efficacy|3
7343678|NCT00900731|11581997|FG000|Overall Study|Death|0
7343679|NCT00900731|11581998|FG001|Overall Study|Death|2
7343680|NCT00900757|11582004|FG000|Overall Study|screen failure|19
7343681|NCT00900796|11582008|FG000|Phase 1|Lacked sufficient information|4
7343682|NCT00900796|11582008|FG000|Phase 1|Missing information at Week 16|7
7343683|NCT00900796|11582008|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
7343684|NCT00900796|11582008|FG000|Phase 2|Lost to Follow-up|5
7343685|NCT00901186|11582029|FG000|Overall Study|Lack of Efficacy|0
7343686|NCT00901186|11582030|FG001|Overall Study|Lack of Efficacy|1
7343687|NCT00901186|11582029|FG000|Overall Study|Abnormal laboratory values|0
7343688|NCT00901186|11582030|FG001|Overall Study|Abnormal laboratory values|1
7343689|NCT00901186|11582029|FG000|Overall Study|Lost to Follow-up|2
7343690|NCT00901186|11582030|FG001|Overall Study|Lost to Follow-up|0
7343691|NCT00901186|11582029|FG000|Overall Study|Adverse Event|2
7343692|NCT00901186|11582030|FG001|Overall Study|Adverse Event|4
7343693|NCT00901186|11582029|FG000|Overall Study|Administration problems|0
7343694|NCT00901186|11582030|FG001|Overall Study|Administration problems|1
7343695|NCT00901186|11582029|FG000|Overall Study|Protocol deviations|5
7343696|NCT00901186|11582030|FG001|Overall Study|Protocol deviations|4
7343697|NCT00901342|11582053|FG000|Overall Study|Adverse Event|1
7343698|NCT00901342|11582053|FG000|Overall Study|Death|4
7343699|NCT00901342|11582053|FG000|Overall Study|Disease progression|1
7343700|NCT00901342|11582053|FG000|Overall Study|Withdrawal by Subject|9
7343701|NCT00901394|11582060|FG000|Overall Study|Physician Decision|1
7343702|NCT00901394|11582061|FG001|Overall Study|Physician Decision|1
7343703|NCT00901394|11582062|FG002|Overall Study|Physician Decision|2
7343704|NCT00901459|11582070|FG000|Overall Study|Withdrawal by Subject|6
7343705|NCT00901485|11582081|FG000|Overall Study|Lack of Efficacy|0
7343706|NCT00901485|11582082|FG001|Overall Study|Lack of Efficacy|2
7343707|NCT00901485|11582081|FG000|Overall Study|Withdrawal by Subject|1
7343708|NCT00901485|11582082|FG001|Overall Study|Withdrawal by Subject|2
7343709|NCT00901576|11582094|FG000|Second Intervention|Withdrawal by Subject|0
7343710|NCT00901576|11582095|FG001|Second Intervention|Withdrawal by Subject|0
7343711|NCT00901576|11582096|FG002|Second Intervention|Withdrawal by Subject|0
7343712|NCT00901576|11582097|FG003|Second Intervention|Withdrawal by Subject|1
7343713|NCT00901576|11582098|FG004|Second Intervention|Withdrawal by Subject|0
7343714|NCT00901576|11582099|FG005|Second Intervention|Withdrawal by Subject|1
7343715|NCT00901576|11582094|FG000|Second Intervention|Physician Decision|1
7343716|NCT00901576|11582095|FG001|Second Intervention|Physician Decision|0
7343717|NCT00901576|11582096|FG002|Second Intervention|Physician Decision|0
7343718|NCT00901576|11582097|FG003|Second Intervention|Physician Decision|0
7343719|NCT00901576|11582098|FG004|Second Intervention|Physician Decision|0
7343720|NCT00901576|11582099|FG005|Second Intervention|Physician Decision|0
7343721|NCT00901628|11582109|FG000|Overall Study|disconnection of catheter|4
7343722|NCT00901628|11582110|FG001|Overall Study|disconnection of catheter|8
7343723|NCT00901628|11582109|FG000|Overall Study|disconnection of drain|0
7343724|NCT00901628|11582110|FG001|Overall Study|disconnection of drain|1
7343725|NCT00901628|11582109|FG000|Overall Study|peroneal nerve palsy|0
7343726|NCT00901628|11582110|FG001|Overall Study|peroneal nerve palsy|1
7343727|NCT00901901|11582118|FG000|Treatment Period|Adverse Event|120
7343728|NCT00901901|11582119|FG001|Treatment Period|Adverse Event|128
7343729|NCT00901901|11582118|FG000|Treatment Period|Withdrawal by Subject|26
7343730|NCT00901901|11582119|FG001|Treatment Period|Withdrawal by Subject|24
7343731|NCT00901901|11582118|FG000|Treatment Period|Physician Decision|2
7343732|NCT00901901|11582119|FG001|Treatment Period|Physician Decision|2
7343733|NCT00901901|11582118|FG000|Treatment Period|Lost to Follow-up|3
7343734|NCT00901901|11582119|FG001|Treatment Period|Lost to Follow-up|5
7343735|NCT00901901|11582118|FG000|Treatment Period|Noncompliance with study medication|4
7343736|NCT00901901|11582119|FG001|Treatment Period|Noncompliance with study medication|1
7343737|NCT00901901|11582118|FG000|Treatment Period|Missing|1
7343738|NCT00901901|11582119|FG001|Treatment Period|Missing|0
7458621|NCT01808612|11752683|FG001|Discontinuation Period|Physician Decision|0
7458622|NCT01808612|11752684|FG002|Discontinuation Period|Physician Decision|0
7458623|NCT01808612|11752682|FG000|Discontinuation Period|Lost to Follow-up|0
7458624|NCT01808612|11752683|FG001|Discontinuation Period|Lost to Follow-up|1
7458625|NCT01808612|11752684|FG002|Discontinuation Period|Lost to Follow-up|0
7458626|NCT01808651|11752698|FG000|Study Period 1|Lost to Follow-up|1
7458627|NCT01808651|11752699|FG001|Study Period 1|Lost to Follow-up|3
7458628|NCT01808651|11752700|FG002|Study Period 1|Lost to Follow-up|0
7458629|NCT01808651|11752698|FG000|Study Period 1|Protocol Violation|1
7458630|NCT01808651|11752699|FG001|Study Period 1|Protocol Violation|0
7458631|NCT01808651|11752700|FG002|Study Period 1|Protocol Violation|1
7458632|NCT01808651|11752698|FG000|Study Period 1|Physician Decision|3
7458633|NCT01808651|11752699|FG001|Study Period 1|Physician Decision|2
7458634|NCT01808651|11752700|FG002|Study Period 1|Physician Decision|0
7458635|NCT01808651|11752698|FG000|Study Period 1|Lack of Efficacy|2
7458636|NCT01808651|11752699|FG001|Study Period 1|Lack of Efficacy|1
7458637|NCT01808651|11752700|FG002|Study Period 1|Lack of Efficacy|0
7343739|NCT00901901|11582118|FG000|Treatment Period|Never treated|0
7343740|NCT00901901|11582119|FG001|Treatment Period|Never treated|3
7343741|NCT00901901|11582118|FG000|Treatment Period|Protocol driven decision point|0
7343742|NCT00901901|11582119|FG001|Treatment Period|Protocol driven decision point|2
7343743|NCT00901901|11582118|FG000|Treatment Period|Study terminated by sponsor|2
7343744|NCT00901901|11582119|FG001|Treatment Period|Study terminated by sponsor|0
7343745|NCT00901901|11582118|FG000|Treatment Period|Protocol Violation|5
7343746|NCT00901901|11582119|FG001|Treatment Period|Protocol Violation|9
7343747|NCT00901901|11582118|FG000|Treatment Period|Switch to commercial drug|1
7343748|NCT00901901|11582119|FG001|Treatment Period|Switch to commercial drug|1
7343749|NCT00901901|11582118|FG000|Treatment Period|Transfer to treatment continuation study|5
7343750|NCT00901901|11582119|FG001|Treatment Period|Transfer to treatment continuation study|2
7343751|NCT00901901|11582118|FG000|Follow-up Period|Death|181
7343752|NCT00901901|11582119|FG001|Follow-up Period|Death|208
7343753|NCT00901901|11582118|FG000|Follow-up Period|Protocol driven decision point|47
7343754|NCT00901901|11582119|FG001|Follow-up Period|Protocol driven decision point|36
7343755|NCT00901901|11582118|FG000|Follow-up Period|Withdrawal by Subject|6
7343756|NCT00901901|11582119|FG001|Follow-up Period|Withdrawal by Subject|9
7343757|NCT00901901|11582118|FG000|Follow-up Period|Lost to Follow-up|12
7343758|NCT00901901|11582119|FG001|Follow-up Period|Lost to Follow-up|8
7343759|NCT00901901|11582118|FG000|Follow-up Period|Missing|94
7343760|NCT00901901|11582119|FG001|Follow-up Period|Missing|80
7343761|NCT00901927|11582127|FG000|Overall Study|Lack of Efficacy|1
7343762|NCT00901927|11582127|FG000|Overall Study|Protocol Violation|3
7343763|NCT00901927|11582127|FG000|Overall Study|Withdrawal by Subject|2
7343764|NCT00902174|11582166|FG000|Overall Study|Adverse Event|27
7343765|NCT00902174|11582167|FG001|Overall Study|Adverse Event|7
7343766|NCT00902174|11582166|FG000|Overall Study|Lack of Efficacy|1
7343767|NCT00902174|11582167|FG001|Overall Study|Lack of Efficacy|5
7343768|NCT00902174|11582166|FG000|Overall Study|Death|2
7343769|NCT00902174|11582167|FG001|Overall Study|Death|2
7343770|NCT00902174|11582166|FG000|Overall Study|Withdrawal by Subject|2
7343771|NCT00902174|11582167|FG001|Overall Study|Withdrawal by Subject|1
7343772|NCT00902174|11582166|FG000|Overall Study|Abnormal labs|1
7343773|NCT00902174|11582167|FG001|Overall Study|Abnormal labs|1
7343774|NCT00902174|11582166|FG000|Overall Study|Protocol Violation|1
7343775|NCT00902174|11582167|FG001|Overall Study|Protocol Violation|1
7343776|NCT00902174|11582166|FG000|Overall Study|Administration problem|0
7343777|NCT00902174|11582167|FG001|Overall Study|Administration problem|1
7343778|NCT00902265|11582180|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
7343779|NCT00902265|11582180|FG000|Overall Study|Adverse Event|2
7343780|NCT00902265|11582180|FG000|Overall Study|Lack of Efficacy|2
7343781|NCT00902265|11582180|FG000|Overall Study|Protocol Violation|1
7343782|NCT00902278|11582189|FG000|Overall Study|Physician Decision|1
7343783|NCT00902278|11582190|FG001|Overall Study|Physician Decision|0
7343784|NCT00902278|11582191|FG002|Overall Study|Physician Decision|2
7343785|NCT00902278|11582192|FG003|Overall Study|Physician Decision|0
7343786|NCT00902278|11582193|FG004|Overall Study|Physician Decision|1
7343787|NCT00902278|11582189|FG000|Overall Study|Lost to Follow-up|3
7343788|NCT00902278|11582190|FG001|Overall Study|Lost to Follow-up|2
7343789|NCT00902278|11582191|FG002|Overall Study|Lost to Follow-up|3
7343790|NCT00902278|11582192|FG003|Overall Study|Lost to Follow-up|0
7343791|NCT00902278|11582193|FG004|Overall Study|Lost to Follow-up|1
7343792|NCT00902304|11582208|FG000|Overall Study|Adverse Event|4
7343793|NCT00902304|11582209|FG001|Overall Study|Adverse Event|10
7343794|NCT00902304|11582210|FG002|Overall Study|Adverse Event|25
7343795|NCT00902304|11582208|FG000|Overall Study|Investigator discretion|3
7343796|NCT00902304|11582209|FG001|Overall Study|Investigator discretion|5
7343797|NCT00902304|11582210|FG002|Overall Study|Investigator discretion|13
7343798|NCT00902304|11582208|FG000|Overall Study|Lost to Follow-up|7
7343799|NCT00902304|11582209|FG001|Overall Study|Lost to Follow-up|7
7343800|NCT00902304|11582210|FG002|Overall Study|Lost to Follow-up|7
7343801|NCT00902304|11582208|FG000|Overall Study|Protocol Violation|9
7343802|NCT00902304|11582209|FG001|Overall Study|Protocol Violation|18
7343803|NCT00902304|11582210|FG002|Overall Study|Protocol Violation|20
7343804|NCT00902304|11582208|FG000|Overall Study|Withdrawal by Subject|32
7343805|NCT00902304|11582209|FG001|Overall Study|Withdrawal by Subject|22
7343806|NCT00902304|11582210|FG002|Overall Study|Withdrawal by Subject|43
7343807|NCT00902304|11582208|FG000|Overall Study|includes pregnancy|3
7343808|NCT00902304|11582209|FG001|Overall Study|includes pregnancy|9
7343809|NCT00902304|11582210|FG002|Overall Study|includes pregnancy|2
7343810|NCT00902330|11582221|FG000|Overall Study|Too overwhelmed by treatment|2
7343811|NCT00902330|11582222|FG001|Overall Study|Too overwhelmed by treatment|5
7343812|NCT00902330|11582221|FG000|Overall Study|Adverse Event|1
7343813|NCT00902330|11582222|FG001|Overall Study|Adverse Event|0
7343814|NCT00902330|11582221|FG000|Overall Study|No post baseline data|1
7343815|NCT00902330|11582222|FG001|Overall Study|No post baseline data|0
7343816|NCT00902486|11582235|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7343817|NCT00902486|11582236|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7343818|NCT00902486|11582237|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
7343819|NCT00902486|11582238|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7343820|NCT00902486|11582239|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
7343821|NCT00902486|11582240|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
7343822|NCT00902486|11582235|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
7343823|NCT00902486|11582236|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7343824|NCT00902486|11582237|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7343825|NCT00902486|11582238|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7343826|NCT00902486|11582239|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
7343827|NCT00902486|11582240|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
7343828|NCT00902486|11582235|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7343829|NCT00902486|11582236|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7343830|NCT00902486|11582237|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7343831|NCT00902486|11582238|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
7343832|NCT00902486|11582239|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7343833|NCT00902486|11582240|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
7343834|NCT00902486|11582235|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7343835|NCT00902486|11582236|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7343836|NCT00902486|11582237|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7343837|NCT00902486|11582238|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
7343838|NCT00902486|11582239|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7343839|NCT00902486|11582240|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
7343840|NCT00902486|11582235|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7343841|NCT00902486|11582236|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7343842|NCT00902486|11582237|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7343843|NCT00902486|11582238|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
7343844|NCT00902486|11582239|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7343845|NCT00902486|11582240|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
7343846|NCT00902486|11582235|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7343847|NCT00902486|11582236|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7343848|NCT00902486|11582237|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7343849|NCT00902486|11582238|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
7343850|NCT00902486|11582239|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
7343851|NCT00902486|11582240|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
7343852|NCT00902486|11582235|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7343853|NCT00902486|11582236|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7343854|NCT00902486|11582237|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7343855|NCT00902486|11582238|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
7343856|NCT00902486|11582239|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7343857|NCT00902486|11582240|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
7343858|NCT00902486|11582235|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7343859|NCT00902486|11582236|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7343860|NCT00902486|11582237|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7458638|NCT01808651|11752698|FG000|Study Period 1|Adverse Event|10
7458639|NCT01808651|11752699|FG001|Study Period 1|Adverse Event|4
7458640|NCT01808651|11752700|FG002|Study Period 1|Adverse Event|1
7458641|NCT01808651|11752698|FG000|Study Period 1|Participant Decision|9
7458642|NCT01808651|11752699|FG001|Study Period 1|Participant Decision|7
7458643|NCT01808651|11752700|FG002|Study Period 1|Participant Decision|3
7458644|NCT01808690|11752713|FG000|Overall Study|Withdrawal by Subject|1
7458645|NCT01808690|11752714|FG001|Overall Study|Withdrawal by Subject|2
7458646|NCT01809132|11752759|FG000|Overall Study|Withdrawal by Subject|0
7458647|NCT01809132|11752760|FG001|Overall Study|Withdrawal by Subject|0
7458648|NCT01809132|11752761|FG002|Overall Study|Withdrawal by Subject|1
7458649|NCT01809197|11752771|FG000|Overall Study|Lost to Follow-up|4
7458650|NCT01809197|11752772|FG001|Overall Study|Lost to Follow-up|2
7458651|NCT01809197|11752771|FG000|Overall Study|Adverse Event|2
7458652|NCT01809197|11752772|FG001|Overall Study|Adverse Event|3
7458653|NCT01809197|11752771|FG000|Overall Study|Failed slit lamp exam|1
7458654|NCT01809197|11752772|FG001|Overall Study|Failed slit lamp exam|0
7458655|NCT01809197|11752771|FG000|Overall Study|Non-Compliance|1
7458656|NCT01809197|11752772|FG001|Overall Study|Non-Compliance|1
7458657|NCT01809197|11752771|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
7458658|NCT01809197|11752772|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
7458659|NCT01809197|11752771|FG000|Overall Study|Withdrawal by Subject|1
7458660|NCT01809197|11752772|FG001|Overall Study|Withdrawal by Subject|1
7458661|NCT01809197|11752771|FG000|Overall Study|Product not available|0
7458662|NCT01809197|11752772|FG001|Overall Study|Product not available|1
7458663|NCT01809210|11752785|FG000|Overall Study|Withdrawal by Subject|0
7458664|NCT01809210|11752786|FG001|Overall Study|Withdrawal by Subject|0
7458665|NCT01809210|11752787|FG002|Overall Study|Withdrawal by Subject|1
7458666|NCT01809210|11752788|FG003|Overall Study|Withdrawal by Subject|1
7458667|NCT01809210|11752789|FG004|Overall Study|Withdrawal by Subject|1
7458668|NCT01809210|11752790|FG005|Overall Study|Withdrawal by Subject|0
7343861|NCT00902486|11582238|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7343862|NCT00902486|11582239|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
7343863|NCT00902486|11582240|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
7343864|NCT00902486|11582235|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7343865|NCT00902486|11582236|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7343866|NCT00902486|11582237|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7343867|NCT00902486|11582238|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
7343868|NCT00902486|11582239|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7343869|NCT00902486|11582240|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
7343870|NCT00902486|11582235|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7343871|NCT00902486|11582236|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7343872|NCT00902486|11582237|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
7343873|NCT00902486|11582238|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7343874|NCT00902486|11582239|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7343875|NCT00902486|11582240|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
7343876|NCT00902486|11582235|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
7343877|NCT00902486|11582236|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
7343878|NCT00902486|11582237|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
7343879|NCT00902486|11582238|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
7343880|NCT00902486|11582239|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
7343881|NCT00902486|11582240|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
7343882|NCT00902538|11582273|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
7343883|NCT00902538|11582274|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7343884|NCT00902538|11582275|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7343885|NCT00902538|11582276|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7343886|NCT00902538|11582277|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7343887|NCT00902538|11582278|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
7343888|NCT00902538|11582273|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
7343889|NCT00902538|11582274|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7343890|NCT00902538|11582275|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7343891|NCT00902538|11582276|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7343892|NCT00902538|11582277|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7343893|NCT00902538|11582278|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
7343894|NCT00902538|11582273|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
7343895|NCT00902538|11582274|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7343896|NCT00902538|11582275|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7343897|NCT00902538|11582276|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7343898|NCT00902538|11582277|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7343899|NCT00902538|11582278|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
7343900|NCT00902538|11582273|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
7343901|NCT00902538|11582274|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7343902|NCT00902538|11582275|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7343903|NCT00902538|11582276|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7343904|NCT00902538|11582277|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7343905|NCT00902538|11582278|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
7343906|NCT00902538|11582273|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
7343907|NCT00902538|11582274|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7343908|NCT00902538|11582275|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7343909|NCT00902538|11582276|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7343910|NCT00902538|11582277|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7343911|NCT00902538|11582278|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
7343912|NCT00902538|11582273|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
7343913|NCT00902538|11582274|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
7343914|NCT00902538|11582275|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
7343915|NCT00902538|11582276|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7343916|NCT00902538|11582277|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7343917|NCT00902538|11582278|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
7343918|NCT00902538|11582273|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7343919|NCT00902538|11582274|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
7343920|NCT00902538|11582275|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
7343921|NCT00902538|11582276|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7343922|NCT00902538|11582277|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7343923|NCT00902538|11582278|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
7343924|NCT00902538|11582273|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
7343925|NCT00902538|11582274|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7343926|NCT00902538|11582275|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
7343927|NCT00902538|11582276|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7343928|NCT00902538|11582277|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7343929|NCT00902538|11582278|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
7343930|NCT00902538|11582273|FG000|2-Randomized Double-blind 3 Treatments|Other|2
7343931|NCT00902538|11582274|FG001|2-Randomized Double-blind 3 Treatments|Other|1
7343932|NCT00902538|11582275|FG002|2-Randomized Double-blind 3 Treatments|Other|0
7343933|NCT00902538|11582276|FG003|2-Randomized Double-blind 3 Treatments|Other|0
7343934|NCT00902538|11582277|FG004|2-Randomized Double-blind 3 Treatments|Other|0
7343935|NCT00902538|11582278|FG005|2-Randomized Double-blind 3 Treatments|Other|0
7343936|NCT00902538|11582273|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7343937|NCT00902538|11582274|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
7343938|NCT00902538|11582275|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
7343939|NCT00902538|11582276|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7343940|NCT00902538|11582277|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7343941|NCT00902538|11582278|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
7343942|NCT00902538|11582273|FG000|3-Single-blind, Single Treatment|Adverse Event|0
7343943|NCT00902538|11582274|FG001|3-Single-blind, Single Treatment|Adverse Event|5
7343944|NCT00902538|11582275|FG002|3-Single-blind, Single Treatment|Adverse Event|0
7343945|NCT00902538|11582276|FG003|3-Single-blind, Single Treatment|Adverse Event|0
7343946|NCT00902538|11582277|FG004|3-Single-blind, Single Treatment|Adverse Event|0
7343947|NCT00902538|11582278|FG005|3-Single-blind, Single Treatment|Adverse Event|0
7343948|NCT00902538|11582273|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
7343949|NCT00902538|11582274|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
7343950|NCT00902538|11582275|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
7343951|NCT00902538|11582276|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
7343952|NCT00902538|11582277|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
7343953|NCT00902538|11582278|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
7343954|NCT00902538|11582273|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7343955|NCT00902538|11582274|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
7343956|NCT00902538|11582275|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7343957|NCT00902538|11582276|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7343958|NCT00902538|11582277|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7343959|NCT00902538|11582278|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
7343960|NCT00902538|11582273|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
7343961|NCT00902538|11582274|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
7343962|NCT00902538|11582275|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
7343963|NCT00902538|11582276|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
7343964|NCT00902538|11582277|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
7343965|NCT00902538|11582278|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
7343966|NCT00902538|11582273|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7343967|NCT00902538|11582274|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7343968|NCT00902538|11582275|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
7343969|NCT00902538|11582276|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
7343970|NCT00902538|11582277|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7343971|NCT00902538|11582278|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
7343972|NCT00902538|11582273|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7343973|NCT00902538|11582274|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7343974|NCT00902538|11582275|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7343975|NCT00902538|11582276|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
7343976|NCT00902538|11582277|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
7343977|NCT00902538|11582278|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
7343978|NCT00902538|11582273|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7343979|NCT00902538|11582274|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7343980|NCT00902538|11582275|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7343981|NCT00902538|11582276|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
7343982|NCT00902538|11582277|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7343983|NCT00902538|11582278|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
7343984|NCT00902564|11582290|FG000|Overall Study|Withdrawal by Subject|2
7343985|NCT00902577|11582294|FG000|Overall Study|Withdrawal by Subject|6
7343986|NCT00902577|11582294|FG000|Overall Study|FMISO production failure|2
7343987|NCT00902746|11582317|FG000|Overall Study|Protocol Violation|7
7343988|NCT00902746|11582317|FG000|Overall Study|Withdrawal by Subject|16
7343989|NCT00902746|11582317|FG000|Overall Study|Adverse Event|8
7343990|NCT00902746|11582317|FG000|Overall Study|Lost to Follow-up|3
7343991|NCT00902746|11582317|FG000|Overall Study|Physician Decision|2
7343992|NCT00902850|11582323|FG000|Overall Study|Physician Decision|2
7343993|NCT00902850|11582324|FG001|Overall Study|Physician Decision|2
7343994|NCT00903032|11582332|FG000|Overall Study|Withdrawal by Subject|5
7343995|NCT00903032|11582333|FG001|Overall Study|Withdrawal by Subject|3
7343996|NCT00903032|11582332|FG000|Overall Study|Lost to Follow-up|2
7458669|NCT01809210|11752791|FG006|Overall Study|Withdrawal by Subject|4
7343997|NCT00903032|11582333|FG001|Overall Study|Lost to Follow-up|2
7343998|NCT00903175|11582345|FG000|Period 1 - First Line|Adverse Event|36
7343999|NCT00903175|11582346|FG001|Period 1 - First Line|Adverse Event|50
7344000|NCT00903175|11582345|FG000|Period 1 - First Line|Abnormal lab value(s)|0
7344001|NCT00903175|11582346|FG001|Period 1 - First Line|Abnormal lab value(s)|1
7344002|NCT00903175|11582345|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
7344003|NCT00903175|11582346|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
7344004|NCT00903175|11582345|FG000|Period 1 - First Line|Protocol Violation|3
7344005|NCT00903175|11582346|FG001|Period 1 - First Line|Protocol Violation|3
7344006|NCT00903175|11582345|FG000|Period 1 - First Line|Withdrawal by Subject|8
7344007|NCT00903175|11582346|FG001|Period 1 - First Line|Withdrawal by Subject|12
7344008|NCT00903175|11582345|FG000|Period 1 - First Line|Administrative problems|12
7344009|NCT00903175|11582346|FG001|Period 1 - First Line|Administrative problems|13
7344010|NCT00903175|11582345|FG000|Period 1 - First Line|Death|17
7344011|NCT00903175|11582346|FG001|Period 1 - First Line|Death|10
7344012|NCT00903175|11582345|FG000|Period 2 - Second Line|Missing|1
7344013|NCT00903175|11582346|FG001|Period 2 - Second Line|Missing|0
7344014|NCT00903175|11582345|FG000|Period 2 - Second Line|Adverse Event|16
7344015|NCT00903175|11582346|FG001|Period 2 - Second Line|Adverse Event|20
7344016|NCT00903175|11582345|FG000|Period 2 - Second Line|Withdrawal by Subject|7
7344017|NCT00903175|11582346|FG001|Period 2 - Second Line|Withdrawal by Subject|5
7344018|NCT00903175|11582345|FG000|Period 2 - Second Line|Lost to Follow-up|1
7344019|NCT00903175|11582346|FG001|Period 2 - Second Line|Lost to Follow-up|0
7344020|NCT00903175|11582345|FG000|Period 2 - Second Line|Administrative problems|19
7344021|NCT00903175|11582346|FG001|Period 2 - Second Line|Administrative problems|9
7344022|NCT00903175|11582345|FG000|Period 2 - Second Line|Death|5
7344023|NCT00903175|11582346|FG001|Period 2 - Second Line|Death|2
7344024|NCT00903201|11582355|FG000|Overall Study|Adverse Event|1
7344025|NCT00903201|11582356|FG001|Overall Study|Adverse Event|4
7344026|NCT00903201|11582357|FG002|Overall Study|Adverse Event|0
7344027|NCT00903201|11582355|FG000|Overall Study|Protocol Violation|2
7344028|NCT00903201|11582356|FG001|Overall Study|Protocol Violation|1
7344029|NCT00903201|11582357|FG002|Overall Study|Protocol Violation|0
7344030|NCT00903201|11582355|FG000|Overall Study|Lost to Follow-up|0
7344031|NCT00903201|11582356|FG001|Overall Study|Lost to Follow-up|1
7344032|NCT00903201|11582357|FG002|Overall Study|Lost to Follow-up|0
7344033|NCT00903201|11582355|FG000|Overall Study|Physician Decision|1
7344034|NCT00903201|11582356|FG001|Overall Study|Physician Decision|0
7344035|NCT00903201|11582357|FG002|Overall Study|Physician Decision|1
7344036|NCT00903201|11582355|FG000|Overall Study|Withdrawal by Subject|1
7344037|NCT00903201|11582356|FG001|Overall Study|Withdrawal by Subject|0
7344038|NCT00903201|11582357|FG002|Overall Study|Withdrawal by Subject|1
7344039|NCT00903331|11582369|FG000|Overall Study|Death|4
7344040|NCT00903331|11582370|FG001|Overall Study|Death|8
7344041|NCT00903331|11582369|FG000|Overall Study|Withdrawal of consent|1
7344042|NCT00903331|11582370|FG001|Overall Study|Withdrawal of consent|8
7344043|NCT00903331|11582369|FG000|Overall Study|Lung transplant|0
7344044|NCT00903331|11582370|FG001|Overall Study|Lung transplant|2
7344045|NCT00903344|11582378|FG000|Overall Study|Pregnancy|2
7344046|NCT00903344|11582379|FG001|Overall Study|Pregnancy|3
7344047|NCT00903344|11582378|FG000|Overall Study|Lost to Follow-up|3
7344048|NCT00903344|11582379|FG001|Overall Study|Lost to Follow-up|0
7344049|NCT00903357|11582385|FG000|First Intervention|Withdrawal by Subject|5
7344050|NCT00903357|11582386|FG001|First Intervention|Withdrawal by Subject|3
7344051|NCT00903357|11582385|FG000|First Intervention|Flu|0
7344052|NCT00903357|11582386|FG001|First Intervention|Flu|1
7344053|NCT00903357|11582385|FG000|Wash Out Period of 2 Weeks|Flu|0
7344054|NCT00903357|11582386|FG001|Wash Out Period of 2 Weeks|Flu|1
7344055|NCT00903357|11582385|FG000|Second Intervention|Lost to Follow-up|1
7344056|NCT00903357|11582386|FG001|Second Intervention|Lost to Follow-up|0
7385810|NCT01204710|11643758|FG000|Randomization Treatment|Worsening of General condition|0
7385811|NCT01204710|11643759|FG001|Randomization Treatment|Worsening of General condition|1
7385812|NCT01204710|11643758|FG000|Randomization Treatment|Moved and Followed for Survival|0
7385813|NCT01204710|11643759|FG001|Randomization Treatment|Moved and Followed for Survival|1
7385814|NCT01204710|11643758|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
7385815|NCT01204710|11643759|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
7385816|NCT01204710|11643758|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
7385817|NCT01204710|11643759|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
7385818|NCT01204710|11643758|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
7385819|NCT01204710|11643759|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
7385820|NCT01204775|11643791|FG000|Overall Study|Poor/non-compliance|0
7385821|NCT01204775|11643792|FG001|Overall Study|Poor/non-compliance|1
7385822|NCT01204775|11643791|FG000|Overall Study|Withdrawal by Subject|1
7385823|NCT01204775|11643792|FG001|Overall Study|Withdrawal by Subject|0
7385824|NCT01204918|11643809|FG000|Overall Study|Withdrawal by Subject|4
7385825|NCT01204918|11643810|FG001|Overall Study|Withdrawal by Subject|10
7385826|NCT01204918|11643811|FG002|Overall Study|Withdrawal by Subject|5
7385827|NCT01205035|11643821|FG000|Overall Study|Withdrawal by Subject|1
7385828|NCT01205035|11643822|FG001|Overall Study|Withdrawal by Subject|0
7385829|NCT01205035|11643821|FG000|Overall Study|Physician Decision|1
7385830|NCT01205035|11643822|FG001|Overall Study|Physician Decision|0
7385831|NCT01205126|11643830|FG000|Titration Phase|Adverse Event|5
7385832|NCT01205126|11643831|FG001|Titration Phase|Adverse Event|3
7385833|NCT01205126|11643830|FG000|Titration Phase|Withdrawal by Subject|5
7385834|NCT01205126|11643831|FG001|Titration Phase|Withdrawal by Subject|5
7344057|NCT00903370|11582398|FG000|Overall Study|Death|13
7344058|NCT00903370|11582399|FG001|Overall Study|Death|10
7344059|NCT00903370|11582398|FG000|Overall Study|Withdrawal by Subject|9
7344060|NCT00903370|11582399|FG001|Overall Study|Withdrawal by Subject|6
7344061|NCT00903370|11582398|FG000|Overall Study|Lost to Follow-up|6
7344062|NCT00903370|11582399|FG001|Overall Study|Lost to Follow-up|8
7344063|NCT00903383|11582409|FG000|Overall Study|Adverse Event|1
7344064|NCT00903383|11582410|FG001|Overall Study|Adverse Event|2
7344065|NCT00903383|11582411|FG002|Overall Study|Adverse Event|3
7344066|NCT00903383|11582412|FG003|Overall Study|Adverse Event|1
7344067|NCT00903383|11582409|FG000|Overall Study|Physician Decision|1
7344068|NCT00903383|11582410|FG001|Overall Study|Physician Decision|2
7344069|NCT00903383|11582411|FG002|Overall Study|Physician Decision|0
7344070|NCT00903383|11582412|FG003|Overall Study|Physician Decision|0
7344071|NCT00903383|11582409|FG000|Overall Study|Lost to Follow-up|0
7344072|NCT00903383|11582410|FG001|Overall Study|Lost to Follow-up|0
7344073|NCT00903383|11582411|FG002|Overall Study|Lost to Follow-up|0
7344074|NCT00903383|11582412|FG003|Overall Study|Lost to Follow-up|1
7344075|NCT00903383|11582409|FG000|Overall Study|Decision of Sponsor|1
7344076|NCT00903383|11582410|FG001|Overall Study|Decision of Sponsor|0
7344077|NCT00903383|11582411|FG002|Overall Study|Decision of Sponsor|0
7344078|NCT00903383|11582412|FG003|Overall Study|Decision of Sponsor|0
7344079|NCT00903383|11582409|FG000|Overall Study|Withdrawal by Subject|4
7344080|NCT00903383|11582410|FG001|Overall Study|Withdrawal by Subject|1
7344081|NCT00903383|11582411|FG002|Overall Study|Withdrawal by Subject|0
7344082|NCT00903383|11582412|FG003|Overall Study|Withdrawal by Subject|2
7344083|NCT00903383|11582409|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
7344084|NCT00903383|11582410|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
7344085|NCT00903383|11582411|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
7344086|NCT00903383|11582412|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
7344087|NCT00903383|11582409|FG000|Overall Study|Patient Decision|0
7344088|NCT00903383|11582410|FG001|Overall Study|Patient Decision|0
7344089|NCT00903383|11582411|FG002|Overall Study|Patient Decision|0
7344090|NCT00903383|11582412|FG003|Overall Study|Patient Decision|1
7344091|NCT00903409|11582424|FG000|Overall Study|Adverse Event|11
7344092|NCT00903409|11582425|FG001|Overall Study|Adverse Event|9
7344093|NCT00903409|11582424|FG000|Overall Study|Non-compliance with Protocol|1
7344094|NCT00903409|11582425|FG001|Overall Study|Non-compliance with Protocol|1
7344095|NCT00903409|11582424|FG000|Overall Study|Laboratory Abnormality|2
7344096|NCT00903409|11582425|FG001|Overall Study|Laboratory Abnormality|0
7344097|NCT00903409|11582424|FG000|Overall Study|Withdrawal by Subject|8
7344098|NCT00903409|11582425|FG001|Overall Study|Withdrawal by Subject|8
7344099|NCT00903409|11582424|FG000|Overall Study|Other|2
7344100|NCT00903409|11582425|FG001|Overall Study|Other|3
7344101|NCT00903409|11582424|FG000|Overall Study|Lost to Follow-up|2
7344102|NCT00903409|11582425|FG001|Overall Study|Lost to Follow-up|6
7344103|NCT00903617|11582444|FG000|Overall Study|Adverse Event|0
7344104|NCT00903617|11582445|FG001|Overall Study|Adverse Event|1
7344105|NCT00903617|11582446|FG002|Overall Study|Adverse Event|1
7344106|NCT00903617|11582447|FG003|Overall Study|Adverse Event|0
7344107|NCT00903617|11582444|FG000|Overall Study|Protocol-defined stopping criteria|0
7344108|NCT00903617|11582445|FG001|Overall Study|Protocol-defined stopping criteria|2
7344109|NCT00903617|11582446|FG002|Overall Study|Protocol-defined stopping criteria|0
7344110|NCT00903617|11582447|FG003|Overall Study|Protocol-defined stopping criteria|0
7344111|NCT00903617|11582444|FG000|Overall Study|Lost to Follow-up|2
7344112|NCT00903617|11582445|FG001|Overall Study|Lost to Follow-up|0
7344113|NCT00903617|11582446|FG002|Overall Study|Lost to Follow-up|1
7344114|NCT00903617|11582447|FG003|Overall Study|Lost to Follow-up|1
7344115|NCT00903617|11582444|FG000|Overall Study|Withdrawal by Subject|1
7344116|NCT00903617|11582445|FG001|Overall Study|Withdrawal by Subject|2
7344117|NCT00903617|11582446|FG002|Overall Study|Withdrawal by Subject|3
7344118|NCT00903617|11582447|FG003|Overall Study|Withdrawal by Subject|0
7344119|NCT00903630|11582461|FG000|Phase 2|Adverse Event|0
7344120|NCT00903630|11582462|FG001|Phase 2|Adverse Event|0
7344121|NCT00903630|11582463|FG002|Phase 2|Adverse Event|1
7344122|NCT00903682|11582475|FG000|Overall Study|Adverse Event|6
7344123|NCT00903682|11582476|FG001|Overall Study|Adverse Event|13
7344124|NCT00903682|11582475|FG000|Overall Study|Lost to Follow-up|1
7344125|NCT00903682|11582476|FG001|Overall Study|Lost to Follow-up|0
7344126|NCT00903682|11582475|FG000|Overall Study|Withdrawal by Subject|5
7344127|NCT00903682|11582476|FG001|Overall Study|Withdrawal by Subject|0
7344128|NCT00903682|11582475|FG000|Overall Study|Pregnancy|0
7344129|NCT00903682|11582476|FG001|Overall Study|Pregnancy|1
7344130|NCT00903682|11582475|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
7344131|NCT00903682|11582476|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
7344132|NCT00903682|11582475|FG000|Overall Study|Subject Non-Compliant|1
7344133|NCT00903682|11582476|FG001|Overall Study|Subject Non-Compliant|0
7344134|NCT00903682|11582475|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
7344135|NCT00903682|11582476|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
7344136|NCT00903682|11582475|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
7344137|NCT00903682|11582476|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
7344138|NCT00903695|11582484|FG000|Overall Study|medical exclusion after 1st testing|1
7344139|NCT00903695|11582485|FG001|Overall Study|medical exclusion after 1st testing|0
7344140|NCT00903695|11582484|FG000|Overall Study|lung cancer|1
7344141|NCT00903695|11582485|FG001|Overall Study|lung cancer|0
7344142|NCT00903760|11582495|FG000|Overall Study|Disease Progression/Death|8
7344143|NCT00903760|11582496|FG001|Overall Study|Disease Progression/Death|6
7344144|NCT00903760|11582495|FG000|Overall Study|Stem Cell Transplant|8
7344145|NCT00903760|11582496|FG001|Overall Study|Stem Cell Transplant|4
7344146|NCT00903760|11582495|FG000|Overall Study|Physician Decision|1
7344147|NCT00903760|11582496|FG001|Overall Study|Physician Decision|2
7344148|NCT00903760|11582495|FG000|Overall Study|Death|0
7344149|NCT00903760|11582496|FG001|Overall Study|Death|1
7344150|NCT00903760|11582495|FG000|Overall Study|Lost to Follow-up|1
7344151|NCT00903760|11582496|FG001|Overall Study|Lost to Follow-up|0
7344152|NCT00903760|11582495|FG000|Overall Study|Withdrawal by Subject|1
7344153|NCT00903760|11582496|FG001|Overall Study|Withdrawal by Subject|2
7344154|NCT00903760|11582495|FG000|Overall Study|Off treatment for long period|0
7344155|NCT00903760|11582496|FG001|Overall Study|Off treatment for long period|1
7344156|NCT00903786|11582502|FG000|Overall Study|Physician Decision|6
7344157|NCT00903786|11582502|FG000|Overall Study|Lack of Efficacy|5
7344158|NCT00903786|11582502|FG000|Overall Study|Reason other than lack of efficacy|4
7344159|NCT00903877|11582507|FG000|Overall Study|Did not meet study criteria|33
7344160|NCT00903877|11582507|FG000|Overall Study|Withdrawal by Subject|3
7344161|NCT00903877|11582507|FG000|Overall Study|Adverse Event|2
7344162|NCT00903877|11582507|FG000|Overall Study|Lost to Follow-up|1
7344163|NCT00903877|11582507|FG000|Overall Study|Participation put on hold|4
7344164|NCT00903929|11582511|FG000|Overall Study|Withdrawal by Subject|0
7344165|NCT00903929|11582512|FG001|Overall Study|Withdrawal by Subject|0
7344166|NCT00903929|11582513|FG002|Overall Study|Withdrawal by Subject|1
7344167|NCT00903929|11582514|FG003|Overall Study|Withdrawal by Subject|2
7344168|NCT00903929|11582511|FG000|Overall Study|Adverse Event|0
7344169|NCT00903929|11582512|FG001|Overall Study|Adverse Event|0
7344170|NCT00903929|11582513|FG002|Overall Study|Adverse Event|0
7344171|NCT00903929|11582514|FG003|Overall Study|Adverse Event|1
7344172|NCT00903968|11582521|FG000|Overall Study|Adverse Event|0
7344173|NCT00903968|11582522|FG001|Overall Study|Adverse Event|0
7344174|NCT00903968|11582523|FG002|Overall Study|Adverse Event|0
7344175|NCT00903968|11582524|FG003|Overall Study|Adverse Event|0
7344176|NCT00903968|11582525|FG004|Overall Study|Adverse Event|0
7344177|NCT00903968|11582526|FG005|Overall Study|Adverse Event|0
7344178|NCT00903968|11582527|FG006|Overall Study|Adverse Event|1
7344179|NCT00903968|11582528|FG007|Overall Study|Adverse Event|8
7344180|NCT00903968|11582521|FG000|Overall Study|DLT|0
7344181|NCT00903968|11582522|FG001|Overall Study|DLT|0
7344182|NCT00903968|11582523|FG002|Overall Study|DLT|0
7344183|NCT00903968|11582524|FG003|Overall Study|DLT|0
7344184|NCT00903968|11582525|FG004|Overall Study|DLT|0
7344185|NCT00903968|11582526|FG005|Overall Study|DLT|0
7344186|NCT00903968|11582527|FG006|Overall Study|DLT|2
7344187|NCT00903968|11582528|FG007|Overall Study|DLT|0
7344188|NCT00903968|11582521|FG000|Overall Study|Withdrawal by Subject|1
7344189|NCT00903968|11582522|FG001|Overall Study|Withdrawal by Subject|0
7344190|NCT00903968|11582523|FG002|Overall Study|Withdrawal by Subject|1
7344191|NCT00903968|11582524|FG003|Overall Study|Withdrawal by Subject|0
7344192|NCT00903968|11582525|FG004|Overall Study|Withdrawal by Subject|1
7344193|NCT00903968|11582526|FG005|Overall Study|Withdrawal by Subject|1
7344194|NCT00903968|11582527|FG006|Overall Study|Withdrawal by Subject|0
7344195|NCT00903968|11582528|FG007|Overall Study|Withdrawal by Subject|4
7344196|NCT00903968|11582521|FG000|Overall Study|Non-Compliance|0
7344197|NCT00903968|11582522|FG001|Overall Study|Non-Compliance|0
7344198|NCT00903968|11582523|FG002|Overall Study|Non-Compliance|0
7344199|NCT00903968|11582524|FG003|Overall Study|Non-Compliance|0
7344200|NCT00903968|11582525|FG004|Overall Study|Non-Compliance|0
7344201|NCT00903968|11582526|FG005|Overall Study|Non-Compliance|1
7344202|NCT00903968|11582527|FG006|Overall Study|Non-Compliance|0
7344203|NCT00903968|11582528|FG007|Overall Study|Non-Compliance|0
7344204|NCT00903968|11582521|FG000|Overall Study|Physician Decision|0
7344205|NCT00903968|11582522|FG001|Overall Study|Physician Decision|0
7344206|NCT00903968|11582523|FG002|Overall Study|Physician Decision|0
7344207|NCT00903968|11582524|FG003|Overall Study|Physician Decision|0
7344208|NCT00903968|11582525|FG004|Overall Study|Physician Decision|0
7344209|NCT00903968|11582526|FG005|Overall Study|Physician Decision|1
7344210|NCT00903968|11582527|FG006|Overall Study|Physician Decision|0
7344211|NCT00903968|11582528|FG007|Overall Study|Physician Decision|0
7344212|NCT00903968|11582521|FG000|Overall Study|Progressive Disease|2
7344213|NCT00903968|11582522|FG001|Overall Study|Progressive Disease|3
7344214|NCT00903968|11582523|FG002|Overall Study|Progressive Disease|2
7344215|NCT00903968|11582524|FG003|Overall Study|Progressive Disease|3
7344216|NCT00903968|11582525|FG004|Overall Study|Progressive Disease|3
7344217|NCT00903968|11582526|FG005|Overall Study|Progressive Disease|3
7344218|NCT00903968|11582527|FG006|Overall Study|Progressive Disease|0
7344219|NCT00903968|11582528|FG007|Overall Study|Progressive Disease|18
7344220|NCT00903968|11582521|FG000|Overall Study|Lack of Efficacy|0
7344221|NCT00903968|11582522|FG001|Overall Study|Lack of Efficacy|0
7344222|NCT00903968|11582523|FG002|Overall Study|Lack of Efficacy|0
7344223|NCT00903968|11582524|FG003|Overall Study|Lack of Efficacy|0
7344224|NCT00903968|11582525|FG004|Overall Study|Lack of Efficacy|0
7344225|NCT00903968|11582526|FG005|Overall Study|Lack of Efficacy|0
7344226|NCT00903968|11582527|FG006|Overall Study|Lack of Efficacy|0
7344227|NCT00903968|11582528|FG007|Overall Study|Lack of Efficacy|3
7344228|NCT00904033|11582564|FG000|Overall Study|Withdrawal by Subject|1
7344229|NCT00904033|11582565|FG001|Overall Study|Withdrawal by Subject|1
7344230|NCT00904033|11582566|FG002|Overall Study|Withdrawal by Subject|0
7344231|NCT00904033|11582567|FG003|Overall Study|Withdrawal by Subject|0
7344232|NCT00904033|11582564|FG000|Overall Study|Physician Decision|0
7344233|NCT00904033|11582565|FG001|Overall Study|Physician Decision|0
7344234|NCT00904033|11582566|FG002|Overall Study|Physician Decision|1
7344235|NCT00904033|11582567|FG003|Overall Study|Physician Decision|0
7344236|NCT00904033|11582564|FG000|Overall Study|Unable to obtain final blood draw|0
7344237|NCT00904033|11582565|FG001|Overall Study|Unable to obtain final blood draw|0
7344238|NCT00904033|11582566|FG002|Overall Study|Unable to obtain final blood draw|0
7344239|NCT00904033|11582567|FG003|Overall Study|Unable to obtain final blood draw|2
7344240|NCT00904150|11582580|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
7344241|NCT00904150|11582581|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
7569087|NCT03435211|11944838|FG000|Overall Study|Unable to achieve minimum desaturation level|1
7569088|NCT03435224|11944842|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
7569089|NCT03435497|11944848|FG000|Overall Study|Lost to Follow-up|1
7569090|NCT03435497|11944849|FG001|Overall Study|Lost to Follow-up|0
7569091|NCT03435497|11944848|FG000|Overall Study|Death|1
7569092|NCT03435497|11944849|FG001|Overall Study|Death|0
7569093|NCT03435497|11944848|FG000|Overall Study|Withdrawal by Subject|0
7344242|NCT00904150|11582580|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
7344243|NCT00904150|11582581|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
7344244|NCT00904215|11582587|FG000|Overall Study|Adverse Event|25
7344245|NCT00904215|11582587|FG000|Overall Study|Protocol Violation|10
7344246|NCT00904215|11582587|FG000|Overall Study|Lost to Follow-up|63
7344247|NCT00904215|11582587|FG000|Overall Study|Withdrawal by Subject|9
7344248|NCT00904215|11582587|FG000|Overall Study|Other|28
7344249|NCT00904371|11582595|FG000|Overall Study|Adverse Event|2
7344250|NCT00904371|11582595|FG000|Overall Study|Lost to Follow-up|4
7344251|NCT00904371|11582595|FG000|Overall Study|Discontinued at target blood pressure|2
7344252|NCT00904371|11582595|FG000|Overall Study|Continued with Tritace|1
7344253|NCT00904670|11582615|FG000|Open Label Phase|Withdrawal by Subject|2
7344254|NCT00904670|11582616|FG001|Open Label Phase|Withdrawal by Subject|0
7344255|NCT00904670|11582615|FG000|Open Label Phase|Adverse Event|2
7344256|NCT00904670|11582616|FG001|Open Label Phase|Adverse Event|0
7344257|NCT00904670|11582615|FG000|Open Label Phase|Lack of Efficacy|1
7344258|NCT00904670|11582616|FG001|Open Label Phase|Lack of Efficacy|0
7344259|NCT00904670|11582615|FG000|Open Label Phase|Lost to Follow-up|1
7344260|NCT00904670|11582616|FG001|Open Label Phase|Lost to Follow-up|0
7344261|NCT00904722|11582624|FG000|Overall Study|Physician Decision|1
7344262|NCT00904748|11582628|FG000|Overall Study|Withdrawal by Subject|1
7344263|NCT00904748|11582629|FG001|Overall Study|Withdrawal by Subject|1
7344264|NCT00904748|11582630|FG002|Overall Study|Withdrawal by Subject|1
7344265|NCT00904748|11582631|FG003|Overall Study|Withdrawal by Subject|2
7344266|NCT00904748|11582632|FG004|Overall Study|Withdrawal by Subject|0
7344267|NCT00904748|11582633|FG005|Overall Study|Withdrawal by Subject|0
7344268|NCT00904748|11582628|FG000|Overall Study|Adverse Event|0
7344269|NCT00904748|11582629|FG001|Overall Study|Adverse Event|0
7344270|NCT00904748|11582630|FG002|Overall Study|Adverse Event|0
7344271|NCT00904748|11582631|FG003|Overall Study|Adverse Event|0
7344272|NCT00904748|11582632|FG004|Overall Study|Adverse Event|1
7344273|NCT00904748|11582633|FG005|Overall Study|Adverse Event|0
7344274|NCT00904839|11582680|FG000|Overall Study|Adverse Event|0
7344275|NCT00904839|11582681|FG001|Overall Study|Adverse Event|5
7344276|NCT00904839|11582682|FG002|Overall Study|Adverse Event|4
7344277|NCT00904839|11582680|FG000|Overall Study|Protocol Violation|0
7344278|NCT00904839|11582681|FG001|Overall Study|Protocol Violation|1
7344279|NCT00904839|11582682|FG002|Overall Study|Protocol Violation|1
7569094|NCT03435497|11944849|FG001|Overall Study|Withdrawal by Subject|4
7344280|NCT00904839|11582680|FG000|Overall Study|Lost to Follow-up|0
7344281|NCT00904839|11582681|FG001|Overall Study|Lost to Follow-up|1
7344282|NCT00904839|11582682|FG002|Overall Study|Lost to Follow-up|2
7569095|NCT03435497|11944848|FG000|Overall Study|Wrong survey administered|0
7569096|NCT03435497|11944849|FG001|Overall Study|Wrong survey administered|2
7569097|NCT03435692|11944879|FG000|Overall Study|Lack of Efficacy|2
7344283|NCT00904839|11582680|FG000|Overall Study|Withdrawal by Subject|0
7344284|NCT00904839|11582681|FG001|Overall Study|Withdrawal by Subject|2
7344285|NCT00904839|11582682|FG002|Overall Study|Withdrawal by Subject|0
7344286|NCT00904839|11582680|FG000|Overall Study|Not treated|1
7344287|NCT00904839|11582681|FG001|Overall Study|Not treated|0
7344288|NCT00904839|11582682|FG002|Overall Study|Not treated|1
7344289|NCT00904839|11582680|FG000|Overall Study|Other than above|0
7344290|NCT00904839|11582681|FG001|Overall Study|Other than above|9
7344291|NCT00904839|11582682|FG002|Overall Study|Other than above|7
7344292|NCT00904917|11582697|FG000|Overall Study|Lost to Follow-up|2
7344293|NCT00904917|11582698|FG001|Overall Study|Lost to Follow-up|2
7344294|NCT00904917|11582699|FG002|Overall Study|Lost to Follow-up|2
7344295|NCT00904917|11582700|FG003|Overall Study|Lost to Follow-up|2
7344296|NCT00904969|11582713|FG000|Overall Study|Lost to Follow-up|4
7344297|NCT00904969|11582713|FG000|Overall Study|Withdrawal by Subject|3
7344298|NCT00904969|11582713|FG000|Overall Study|Additional Treatments|11
7344299|NCT00904969|11582713|FG000|Overall Study|Case Aborted; Subject Exited|1
7344300|NCT00904982|11582736|FG000|Overall Study|Withdrawal by Subject|2
7344301|NCT00904982|11582737|FG001|Overall Study|Withdrawal by Subject|0
7344302|NCT00904982|11582738|FG002|Overall Study|Withdrawal by Subject|0
7344303|NCT00904982|11582739|FG003|Overall Study|Withdrawal by Subject|0
7344304|NCT00905021|11582758|FG000|Overall Study|Adverse Event|2
7344305|NCT00905034|11582763|FG000|Overall Study|Withdrawal by Subject|1
7344306|NCT00905255|11582786|FG000|Overall Study|Adverse Event|7
7458670|NCT01809210|11752785|FG000|Overall Study|Death|1
7458671|NCT01809210|11752786|FG001|Overall Study|Death|1
7458672|NCT01809210|11752787|FG002|Overall Study|Death|2
7458673|NCT01809210|11752788|FG003|Overall Study|Death|0
7458674|NCT01809210|11752789|FG004|Overall Study|Death|1
7458675|NCT01809210|11752790|FG005|Overall Study|Death|3
7533059|NCT02680002|11879106|FG003|Overall Study|Physician Decision|1
7533060|NCT02680002|11879107|FG004|Overall Study|Physician Decision|1
7533061|NCT02680002|11879108|FG005|Overall Study|Physician Decision|1
7533062|NCT02680002|11879103|FG000|Overall Study|Protocol Violation|1
7533063|NCT02680002|11879104|FG001|Overall Study|Protocol Violation|0
7533064|NCT02680002|11879105|FG002|Overall Study|Protocol Violation|1
7533065|NCT02680002|11879106|FG003|Overall Study|Protocol Violation|0
7533066|NCT02680002|11879107|FG004|Overall Study|Protocol Violation|1
7533067|NCT02680002|11879108|FG005|Overall Study|Protocol Violation|2
7533068|NCT02680002|11879103|FG000|Overall Study|Withdrawal by Subject|0
7533069|NCT02680002|11879104|FG001|Overall Study|Withdrawal by Subject|0
7533070|NCT02680002|11879105|FG002|Overall Study|Withdrawal by Subject|1
7533071|NCT02680002|11879106|FG003|Overall Study|Withdrawal by Subject|0
7533072|NCT02680002|11879107|FG004|Overall Study|Withdrawal by Subject|2
7344307|NCT00905255|11582787|FG001|Overall Study|Adverse Event|5
7344308|NCT00905255|11582786|FG000|Overall Study|Withdrawal by Subject|5
7458676|NCT01809210|11752791|FG006|Overall Study|Death|1
7458677|NCT01809262|11752807|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
7458678|NCT01809262|11752808|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
7458679|NCT01809262|11752809|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
7458680|NCT01809262|11752810|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
7458681|NCT01809262|11752811|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
7458682|NCT01809262|11752812|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
7458683|NCT01809262|11752813|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
7458684|NCT01809262|11752814|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
7458685|NCT01809262|11752815|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
7344309|NCT00905255|11582787|FG001|Overall Study|Withdrawal by Subject|4
7344310|NCT00905255|11582786|FG000|Overall Study|Familial and Personal Reasons|1
7344311|NCT00905255|11582787|FG001|Overall Study|Familial and Personal Reasons|0
7344312|NCT00905307|11582817|FG000|Overall Study|Switched to Open Label Rescue|7
7344313|NCT00905307|11582818|FG001|Overall Study|Switched to Open Label Rescue|17
7344314|NCT00905307|11582819|FG002|Overall Study|Switched to Open Label Rescue|11
7344315|NCT00905307|11582820|FG003|Overall Study|Switched to Open Label Rescue|11
7344316|NCT00905307|11582821|FG004|Overall Study|Switched to Open Label Rescue|4
7344317|NCT00905307|11582822|FG005|Overall Study|Switched to Open Label Rescue|15
7344318|NCT00905307|11582817|FG000|Overall Study|Lost to Follow-up|0
7344319|NCT00905307|11582818|FG001|Overall Study|Lost to Follow-up|0
7344320|NCT00905307|11582819|FG002|Overall Study|Lost to Follow-up|0
7344321|NCT00905307|11582820|FG003|Overall Study|Lost to Follow-up|0
7344322|NCT00905307|11582821|FG004|Overall Study|Lost to Follow-up|1
7344323|NCT00905307|11582822|FG005|Overall Study|Lost to Follow-up|1
7344324|NCT00905307|11582817|FG000|Overall Study|Adverse Event|3
7344325|NCT00905307|11582818|FG001|Overall Study|Adverse Event|4
7344326|NCT00905307|11582819|FG002|Overall Study|Adverse Event|5
7344327|NCT00905307|11582820|FG003|Overall Study|Adverse Event|11
7344328|NCT00905307|11582821|FG004|Overall Study|Adverse Event|3
7344329|NCT00905307|11582822|FG005|Overall Study|Adverse Event|5
7344330|NCT00905307|11582817|FG000|Overall Study|Withdrawal by Subject|5
7344331|NCT00905307|11582818|FG001|Overall Study|Withdrawal by Subject|13
7344332|NCT00905307|11582819|FG002|Overall Study|Withdrawal by Subject|15
7344333|NCT00905307|11582820|FG003|Overall Study|Withdrawal by Subject|11
7344334|NCT00905307|11582821|FG004|Overall Study|Withdrawal by Subject|4
7344335|NCT00905307|11582822|FG005|Overall Study|Withdrawal by Subject|13
7344336|NCT00905307|11582817|FG000|Overall Study|Protocol Violation|1
7344337|NCT00905307|11582818|FG001|Overall Study|Protocol Violation|0
7344338|NCT00905307|11582819|FG002|Overall Study|Protocol Violation|1
7344339|NCT00905307|11582820|FG003|Overall Study|Protocol Violation|0
7344340|NCT00905307|11582821|FG004|Overall Study|Protocol Violation|0
7344341|NCT00905307|11582822|FG005|Overall Study|Protocol Violation|0
7344342|NCT00905307|11582817|FG000|Overall Study|Lack of Efficacy|6
7344343|NCT00905307|11582818|FG001|Overall Study|Lack of Efficacy|3
7344344|NCT00905307|11582819|FG002|Overall Study|Lack of Efficacy|5
7344345|NCT00905307|11582820|FG003|Overall Study|Lack of Efficacy|4
7344346|NCT00905307|11582821|FG004|Overall Study|Lack of Efficacy|4
7344347|NCT00905307|11582822|FG005|Overall Study|Lack of Efficacy|8
7344348|NCT00905359|11582851|FG000|Overall Study|Lost to Follow-up|17
7344349|NCT00905359|11582852|FG001|Overall Study|Lost to Follow-up|10
7344350|NCT00905359|11582851|FG000|Overall Study|Death|2
7344351|NCT00905359|11582852|FG001|Overall Study|Death|0
7344352|NCT00905359|11582851|FG000|Overall Study|Withdrawal consent|5
7344353|NCT00905359|11582852|FG001|Overall Study|Withdrawal consent|6
7344354|NCT00905424|11582860|FG000|Overall Study|Lost to Follow-up|3
7344355|NCT00905424|11582861|FG001|Overall Study|Lost to Follow-up|3
7344356|NCT00905424|11582860|FG000|Overall Study|Withdrawal by Subject|1
7344357|NCT00905424|11582861|FG001|Overall Study|Withdrawal by Subject|2
7344358|NCT00905424|11582860|FG000|Overall Study|Adverse Event|4
7344359|NCT00905424|11582861|FG001|Overall Study|Adverse Event|2
7344360|NCT00905424|11582860|FG000|Overall Study|Non-compliance with study medication|2
7344361|NCT00905424|11582861|FG001|Overall Study|Non-compliance with study medication|0
7344362|NCT00905424|11582860|FG000|Overall Study|Sponsor decision|1
7344363|NCT00905424|11582861|FG001|Overall Study|Sponsor decision|0
7344364|NCT00905424|11582860|FG000|Overall Study|Positive urine drug screen|0
7344365|NCT00905424|11582861|FG001|Overall Study|Positive urine drug screen|1
7344366|NCT00905424|11582860|FG000|Overall Study|Non-adherence to visit schedule|0
7344367|NCT00905424|11582861|FG001|Overall Study|Non-adherence to visit schedule|1
7344368|NCT00905437|11582871|FG000|Overall Study|Adverse Event|3
7344369|NCT00905437|11582872|FG001|Overall Study|Adverse Event|2
7344370|NCT00905437|11582871|FG000|Overall Study|Lost to Follow-up|0
7344371|NCT00905437|11582872|FG001|Overall Study|Lost to Follow-up|1
7344372|NCT00905437|11582871|FG000|Overall Study|Withdrawal by Subject|0
7344373|NCT00905437|11582872|FG001|Overall Study|Withdrawal by Subject|1
7344374|NCT00905437|11582871|FG000|Overall Study|Other|5
7344375|NCT00905437|11582872|FG001|Overall Study|Other|6
7344376|NCT00905489|11582911|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
7344377|NCT00905489|11582911|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
7344378|NCT00905489|11582911|FG000|Optional Extension Phase (OEP)|Adverse Event|1
7344379|NCT00905632|11582958|FG000|Overall Study|Adverse Event|0
7344380|NCT00905632|11582959|FG001|Overall Study|Adverse Event|0
7344381|NCT00905632|11582960|FG002|Overall Study|Adverse Event|0
7344382|NCT00905632|11582961|FG003|Overall Study|Adverse Event|0
7344383|NCT00905632|11582962|FG004|Overall Study|Adverse Event|0
7344384|NCT00905632|11582963|FG005|Overall Study|Adverse Event|1
7344385|NCT00905632|11582964|FG006|Overall Study|Adverse Event|4
7344386|NCT00905840|11583000|FG000|Overall Study|Lost to Follow-up|11
7344387|NCT00905840|11583000|FG000|Overall Study|Death|3
7344388|NCT00905840|11583000|FG000|Overall Study|Withdrawal by Subject|1
7344389|NCT00905840|11583000|FG000|Overall Study|Adverse Event|1
7344390|NCT00906087|11583016|FG000|Initial Washout|Withdrawal by Subject|1
7344391|NCT00906087|11583016|FG000|Initial Washout|Physician Decision|1
7344392|NCT00906204|11583043|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
7344393|NCT00906204|11583044|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
7344394|NCT00906204|11583043|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
7344395|NCT00906204|11583044|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
7344396|NCT00906204|11583043|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
7344397|NCT00906204|11583044|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
7344398|NCT00906204|11583043|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7344399|NCT00906204|11583044|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
7344400|NCT00906204|11583043|FG000|Secondary Endpoints (Long-term Safety)|Death|0
7344401|NCT00906204|11583044|FG001|Secondary Endpoints (Long-term Safety)|Death|1
7344402|NCT00906282|11583054|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
7344403|NCT00906282|11583054|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
7344404|NCT00906282|11583054|FG000|Preoperative Chemotherapy|Progressive disease|6
7344405|NCT00906282|11583054|FG000|Preoperative Chemotherapy|Toxicity|1
7344406|NCT00906347|11583061|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
7344407|NCT00906347|11583062|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
7344408|NCT00906347|11583061|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
7344409|NCT00906347|11583062|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
7344410|NCT00906347|11583061|FG000|Received Study Drug|Refused study drug|1
7344411|NCT00906347|11583062|FG001|Received Study Drug|Refused study drug|0
7344412|NCT00906347|11583061|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
7344413|NCT00906347|11583062|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
7344414|NCT00906373|11583070|FG000|Overall Study|Withdrawal by Subject|0
7344415|NCT00906373|11583071|FG001|Overall Study|Withdrawal by Subject|5
7344416|NCT00906373|11583070|FG000|Overall Study|Other|0
7344417|NCT00906373|11583071|FG001|Overall Study|Other|1
7344418|NCT00906373|11583070|FG000|Overall Study|Still on treatment at cutoff date|0
7344419|NCT00906373|11583071|FG001|Overall Study|Still on treatment at cutoff date|2
7344420|NCT00906399|11583081|FG000|Year 1|Randomized But Not Treated|0
7344421|NCT00906399|11583082|FG001|Year 1|Randomized But Not Treated|1
7344422|NCT00906399|11583083|FG002|Year 1|Randomized But Not Treated|3
7344423|NCT00906399|11583084|FG003|Year 1|Randomized But Not Treated|0
7344424|NCT00906399|11583085|FG004|Year 1|Randomized But Not Treated|0
7344425|NCT00906399|11583086|FG005|Year 1|Randomized But Not Treated|0
7344426|NCT00906399|11583087|FG006|Year 1|Randomized But Not Treated|0
7344427|NCT00906399|11583081|FG000|Year 1|Adverse Event|4
7344428|NCT00906399|11583082|FG001|Year 1|Adverse Event|22
7344429|NCT00906399|11583083|FG002|Year 1|Adverse Event|24
7344430|NCT00906399|11583084|FG003|Year 1|Adverse Event|0
7344431|NCT00906399|11583085|FG004|Year 1|Adverse Event|0
7344432|NCT00906399|11583086|FG005|Year 1|Adverse Event|0
7344433|NCT00906399|11583087|FG006|Year 1|Adverse Event|0
7344434|NCT00906399|11583081|FG000|Year 1|Lost to Follow-up|4
7344435|NCT00906399|11583082|FG001|Year 1|Lost to Follow-up|4
7344436|NCT00906399|11583083|FG002|Year 1|Lost to Follow-up|2
7344437|NCT00906399|11583084|FG003|Year 1|Lost to Follow-up|0
7344438|NCT00906399|11583085|FG004|Year 1|Lost to Follow-up|0
7344439|NCT00906399|11583086|FG005|Year 1|Lost to Follow-up|0
7344440|NCT00906399|11583087|FG006|Year 1|Lost to Follow-up|0
7344441|NCT00906399|11583081|FG000|Year 1|Withdrawal by Subject|30
7344442|NCT00906399|11583082|FG001|Year 1|Withdrawal by Subject|32
7344443|NCT00906399|11583083|FG002|Year 1|Withdrawal by Subject|36
7344444|NCT00906399|11583084|FG003|Year 1|Withdrawal by Subject|0
7344445|NCT00906399|11583085|FG004|Year 1|Withdrawal by Subject|0
7344446|NCT00906399|11583086|FG005|Year 1|Withdrawal by Subject|0
7344447|NCT00906399|11583087|FG006|Year 1|Withdrawal by Subject|0
7344448|NCT00906399|11583081|FG000|Year 1|Physician Decision|0
7344449|NCT00906399|11583082|FG001|Year 1|Physician Decision|1
7344450|NCT00906399|11583083|FG002|Year 1|Physician Decision|3
7344451|NCT00906399|11583084|FG003|Year 1|Physician Decision|0
7344452|NCT00906399|11583085|FG004|Year 1|Physician Decision|0
7344453|NCT00906399|11583086|FG005|Year 1|Physician Decision|0
7344454|NCT00906399|11583087|FG006|Year 1|Physician Decision|0
7344455|NCT00906399|11583081|FG000|Year 1|Death|2
7344456|NCT00906399|11583082|FG001|Year 1|Death|1
7344457|NCT00906399|11583083|FG002|Year 1|Death|1
7344458|NCT00906399|11583084|FG003|Year 1|Death|0
7344459|NCT00906399|11583085|FG004|Year 1|Death|0
7344460|NCT00906399|11583086|FG005|Year 1|Death|0
7344461|NCT00906399|11583087|FG006|Year 1|Death|0
7344462|NCT00906399|11583081|FG000|Year 1|Other|4
7344463|NCT00906399|11583082|FG001|Year 1|Other|2
7344464|NCT00906399|11583083|FG002|Year 1|Other|7
7344465|NCT00906399|11583084|FG003|Year 1|Other|0
7344466|NCT00906399|11583085|FG004|Year 1|Other|0
7344467|NCT00906399|11583086|FG005|Year 1|Other|0
7344468|NCT00906399|11583087|FG006|Year 1|Other|0
7344469|NCT00906399|11583081|FG000|Year 2|Adverse Event|0
7344470|NCT00906399|11583082|FG001|Year 2|Adverse Event|0
7344471|NCT00906399|11583083|FG002|Year 2|Adverse Event|0
7344472|NCT00906399|11583084|FG003|Year 2|Adverse Event|9
7344473|NCT00906399|11583085|FG004|Year 2|Adverse Event|8
7344474|NCT00906399|11583086|FG005|Year 2|Adverse Event|11
7344475|NCT00906399|11583087|FG006|Year 2|Adverse Event|6
7344476|NCT00906399|11583081|FG000|Year 2|Lost to Follow-up|0
7344477|NCT00906399|11583082|FG001|Year 2|Lost to Follow-up|0
7344478|NCT00906399|11583083|FG002|Year 2|Lost to Follow-up|0
7344479|NCT00906399|11583084|FG003|Year 2|Lost to Follow-up|1
7344480|NCT00906399|11583085|FG004|Year 2|Lost to Follow-up|4
7344481|NCT00906399|11583086|FG005|Year 2|Lost to Follow-up|2
7344482|NCT00906399|11583087|FG006|Year 2|Lost to Follow-up|4
7344483|NCT00906399|11583081|FG000|Year 2|Withdrawal by Subject|0
7344484|NCT00906399|11583082|FG001|Year 2|Withdrawal by Subject|0
7344485|NCT00906399|11583083|FG002|Year 2|Withdrawal by Subject|0
7344486|NCT00906399|11583084|FG003|Year 2|Withdrawal by Subject|17
7344487|NCT00906399|11583085|FG004|Year 2|Withdrawal by Subject|18
7344488|NCT00906399|11583086|FG005|Year 2|Withdrawal by Subject|27
7344489|NCT00906399|11583087|FG006|Year 2|Withdrawal by Subject|13
7344490|NCT00906399|11583081|FG000|Year 2|Physician Decision|0
7344491|NCT00906399|11583082|FG001|Year 2|Physician Decision|0
7344492|NCT00906399|11583083|FG002|Year 2|Physician Decision|0
7344493|NCT00906399|11583084|FG003|Year 2|Physician Decision|0
7344494|NCT00906399|11583085|FG004|Year 2|Physician Decision|2
7344495|NCT00906399|11583086|FG005|Year 2|Physician Decision|6
7344496|NCT00906399|11583087|FG006|Year 2|Physician Decision|3
7344497|NCT00906399|11583081|FG000|Year 2|Death|0
7344498|NCT00906399|11583082|FG001|Year 2|Death|0
7344499|NCT00906399|11583083|FG002|Year 2|Death|0
7344500|NCT00906399|11583084|FG003|Year 2|Death|1
7344501|NCT00906399|11583085|FG004|Year 2|Death|0
7344502|NCT00906399|11583086|FG005|Year 2|Death|0
7344503|NCT00906399|11583087|FG006|Year 2|Death|3
7344504|NCT00906399|11583081|FG000|Year 2|Other|0
7344505|NCT00906399|11583082|FG001|Year 2|Other|0
7344506|NCT00906399|11583083|FG002|Year 2|Other|0
7344507|NCT00906399|11583084|FG003|Year 2|Other|2
7344508|NCT00906399|11583085|FG004|Year 2|Other|3
7344509|NCT00906399|11583086|FG005|Year 2|Other|1
7344510|NCT00906399|11583087|FG006|Year 2|Other|0
7344511|NCT00906698|11583118|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
7344512|NCT00906698|11583119|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
7344513|NCT00906698|11583120|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
7344514|NCT00906698|11583121|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7344515|NCT00906698|11583122|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
7344516|NCT00906698|11583123|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
7344517|NCT00906698|11583118|FG000|Overall Study|Adverse Event|0
7344518|NCT00906698|11583119|FG001|Overall Study|Adverse Event|0
7344519|NCT00906698|11583120|FG002|Overall Study|Adverse Event|2
7344520|NCT00906698|11583121|FG003|Overall Study|Adverse Event|0
7344521|NCT00906698|11583122|FG004|Overall Study|Adverse Event|4
7344522|NCT00906698|11583123|FG005|Overall Study|Adverse Event|1
7344523|NCT00906698|11583118|FG000|Overall Study|Disease progression|3
7344524|NCT00906698|11583119|FG001|Overall Study|Disease progression|12
7344525|NCT00906698|11583120|FG002|Overall Study|Disease progression|4
7344526|NCT00906698|11583121|FG003|Overall Study|Disease progression|4
7344527|NCT00906698|11583122|FG004|Overall Study|Disease progression|12
7344528|NCT00906698|11583123|FG005|Overall Study|Disease progression|4
7344529|NCT00906698|11583118|FG000|Overall Study|Withdrawal by Subject|0
7344530|NCT00906698|11583119|FG001|Overall Study|Withdrawal by Subject|0
7344531|NCT00906698|11583120|FG002|Overall Study|Withdrawal by Subject|0
7344532|NCT00906698|11583121|FG003|Overall Study|Withdrawal by Subject|0
7344533|NCT00906698|11583122|FG004|Overall Study|Withdrawal by Subject|1
7344534|NCT00906698|11583123|FG005|Overall Study|Withdrawal by Subject|0
7344535|NCT00906698|11583118|FG000|Overall Study|incl. non compliance, lost to follow-up|0
7344536|NCT00906698|11583119|FG001|Overall Study|incl. non compliance, lost to follow-up|1
7344537|NCT00906698|11583120|FG002|Overall Study|incl. non compliance, lost to follow-up|0
7344538|NCT00906698|11583121|FG003|Overall Study|incl. non compliance, lost to follow-up|0
7344539|NCT00906698|11583122|FG004|Overall Study|incl. non compliance, lost to follow-up|0
7344540|NCT00906698|11583123|FG005|Overall Study|incl. non compliance, lost to follow-up|0
7344541|NCT00906945|11583175|FG000|Overall Study|Found to be not eligible|0
7344542|NCT00906945|11583176|FG001|Overall Study|Found to be not eligible|0
7344543|NCT00906945|11583177|FG002|Overall Study|Found to be not eligible|0
7344544|NCT00906945|11583178|FG003|Overall Study|Found to be not eligible|1
7344545|NCT00906945|11583179|FG004|Overall Study|Found to be not eligible|1
7344546|NCT00906945|11583180|FG005|Overall Study|Found to be not eligible|1
7344547|NCT00906945|11583175|FG000|Overall Study|Physician Decision|0
7344548|NCT00906945|11583176|FG001|Overall Study|Physician Decision|0
7344549|NCT00906945|11583177|FG002|Overall Study|Physician Decision|0
7344550|NCT00906945|11583178|FG003|Overall Study|Physician Decision|0
7344551|NCT00906945|11583179|FG004|Overall Study|Physician Decision|0
7344552|NCT00906945|11583180|FG005|Overall Study|Physician Decision|1
7344553|NCT00906971|11583207|FG000|Overall Study|Withdrawal by Subject|8
7344554|NCT00906971|11583208|FG001|Overall Study|Withdrawal by Subject|2
7344555|NCT00906971|11583207|FG000|Overall Study|Lost to Follow-up|0
7344556|NCT00906971|11583208|FG001|Overall Study|Lost to Follow-up|1
7344557|NCT00907153|11583229|FG000|Overall Study|Lost to Follow-up|1
7344558|NCT00907153|11583230|FG001|Overall Study|Lost to Follow-up|1
7344559|NCT00907153|11583229|FG000|Overall Study|Withdrawal by Subject|1
7344560|NCT00907153|11583230|FG001|Overall Study|Withdrawal by Subject|3
7344561|NCT00907257|11583238|FG000|Overall Study|Adverse Event|0
7344562|NCT00907257|11583239|FG001|Overall Study|Adverse Event|4
7344563|NCT00907257|11583238|FG000|Overall Study|Protocol Violation|1
7344564|NCT00907257|11583239|FG001|Overall Study|Protocol Violation|2
7344565|NCT00907257|11583238|FG000|Overall Study|Lost to Follow-up|3
7344566|NCT00907257|11583239|FG001|Overall Study|Lost to Follow-up|3
7344567|NCT00907257|11583238|FG000|Overall Study|Withdrawal by Subject|1
7344568|NCT00907257|11583239|FG001|Overall Study|Withdrawal by Subject|2
7344569|NCT00907257|11583238|FG000|Overall Study|Per IRB-Subject became vulnerable|1
7344570|NCT00907257|11583239|FG001|Overall Study|Per IRB-Subject became vulnerable|0
7344571|NCT00907257|11583238|FG000|Overall Study|Moved|1
7344572|NCT00907257|11583239|FG001|Overall Study|Moved|0
7344573|NCT00907257|11583238|FG000|Overall Study|Personal Reasons|6
7344574|NCT00907257|11583239|FG001|Overall Study|Personal Reasons|1
7458686|NCT01809262|11752816|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
7458687|NCT01809262|11752807|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
7458688|NCT01809262|11752808|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
7458689|NCT01809262|11752809|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
7458690|NCT01809262|11752810|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
7458691|NCT01809262|11752811|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
7458692|NCT01809262|11752812|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
7458693|NCT01809262|11752813|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
7458694|NCT01809262|11752814|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
7458695|NCT01809262|11752815|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
7458696|NCT01809262|11752816|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
7458697|NCT01809314|11752828|FG000|Overall Study|Withdrawal Prior to Treatment|1
7458698|NCT01809314|11752828|FG000|Overall Study|Adverse Event|6
7458699|NCT01809314|11752828|FG000|Overall Study|Insufficient Therapeutic Response|14
7569098|NCT03435692|11944880|FG001|Overall Study|Lack of Efficacy|2
7569099|NCT03435692|11944881|FG002|Overall Study|Lack of Efficacy|0
7569100|NCT03436082|11944904|FG000|Overall Study|Did not undergo procedure|1
7569101|NCT03436082|11944905|FG001|Overall Study|Did not undergo procedure|0
7569102|NCT03436420|11944922|FG000|Overall Study|Lack of Efficacy|3
7569103|NCT03436732|11944928|FG000|Overall Study|Not treated-enrolled in different study|1
7569104|NCT03436732|11944929|FG001|Overall Study|Not treated-enrolled in different study|0
7569105|NCT03436732|11944928|FG000|Overall Study|Off study after cycle 1|1
7569106|NCT03436732|11944929|FG001|Overall Study|Off study after cycle 1|0
7569107|NCT03436732|11944928|FG000|Overall Study|Adverse Event|2
7569108|NCT03436732|11944929|FG001|Overall Study|Adverse Event|0
7569109|NCT03436732|11944928|FG000|Overall Study|Death|0
7569110|NCT03436732|11944929|FG001|Overall Study|Death|1
7569111|NCT03437265|11944965|FG000|Overall Study|Protocol Violation|6
7569112|NCT03437447|11944972|FG000|Treatment Period 1|Withdrawal by Subject|0
7569113|NCT03437447|11944973|FG001|Treatment Period 1|Withdrawal by Subject|0
7458700|NCT01809314|11752828|FG000|Overall Study|Lost to Follow-up|724
7458701|NCT01809327|11752837|FG000|Overall Study|Lost to Follow-up|5
7458702|NCT01809327|11752838|FG001|Overall Study|Lost to Follow-up|2
7458703|NCT01809327|11752839|FG002|Overall Study|Lost to Follow-up|4
7458704|NCT01809327|11752840|FG003|Overall Study|Lost to Follow-up|2
7458705|NCT01809327|11752841|FG004|Overall Study|Lost to Follow-up|3
7458706|NCT01809327|11752837|FG000|Overall Study|Withdrawal by Subject|6
7458707|NCT01809327|11752838|FG001|Overall Study|Withdrawal by Subject|4
7458708|NCT01809327|11752839|FG002|Overall Study|Withdrawal by Subject|4
7458709|NCT01809327|11752840|FG003|Overall Study|Withdrawal by Subject|2
7458710|NCT01809327|11752841|FG004|Overall Study|Withdrawal by Subject|5
7458711|NCT01809327|11752837|FG000|Overall Study|Adverse Event|4
7569114|NCT03437447|11944974|FG002|Treatment Period 1|Withdrawal by Subject|1
7569115|NCT03437512|11944984|FG000|Randomized|Withdrawal by Subject|0
7569116|NCT03437512|11944985|FG001|Randomized|Withdrawal by Subject|2
7344635|NCT00907335|11583288|FG000|Overall Study|Withdrawal by Subject|2
7344636|NCT00907335|11583289|FG001|Overall Study|Withdrawal by Subject|0
7344637|NCT00907335|11583288|FG000|Overall Study|Adverse Event|4
7344638|NCT00907335|11583289|FG001|Overall Study|Adverse Event|1
7344639|NCT00907335|11583288|FG000|Overall Study|Lost to Follow-up|2
7344640|NCT00907335|11583289|FG001|Overall Study|Lost to Follow-up|0
7344641|NCT00907374|11583297|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
7344642|NCT00907374|11583298|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
7344676|NCT00907517|11583336|FG000|Overall Study|Progressive Disease|3
7344677|NCT00907517|11583337|FG001|Overall Study|Progressive Disease|3
7344678|NCT00907517|11583338|FG002|Overall Study|Progressive Disease|4
7344679|NCT00907517|11583339|FG003|Overall Study|Progressive Disease|4
7344680|NCT00907517|11583340|FG004|Overall Study|Progressive Disease|4
7344681|NCT00907517|11583336|FG000|Overall Study|Symptomatic Deterioration|0
7344682|NCT00907517|11583337|FG001|Overall Study|Symptomatic Deterioration|0
7344683|NCT00907517|11583338|FG002|Overall Study|Symptomatic Deterioration|0
7344684|NCT00907517|11583339|FG003|Overall Study|Symptomatic Deterioration|0
7344685|NCT00907517|11583340|FG004|Overall Study|Symptomatic Deterioration|1
7344686|NCT00907621|11583354|FG000|Overall Study|Lost to Follow-up|6
7344687|NCT00907621|11583355|FG001|Overall Study|Lost to Follow-up|3
7344688|NCT00907621|11583354|FG000|Overall Study|intercurrent febrile illness|1
7344689|NCT00907621|11583355|FG001|Overall Study|intercurrent febrile illness|1
7458712|NCT01809327|11752838|FG001|Overall Study|Adverse Event|3
7344690|NCT00907738|11583366|FG000|Overall Study|Adverse Event|2
7344691|NCT00907738|11583367|FG001|Overall Study|Adverse Event|0
7344692|NCT00907738|11583368|FG002|Overall Study|Adverse Event|1
7344693|NCT00907738|11583369|FG003|Overall Study|Adverse Event|0
7344694|NCT00907738|11583370|FG004|Overall Study|Adverse Event|0
7344695|NCT00907738|11583366|FG000|Overall Study|not specified or withdrew consent|3
7344696|NCT00907738|11583367|FG001|Overall Study|not specified or withdrew consent|0
7344697|NCT00907738|11583368|FG002|Overall Study|not specified or withdrew consent|0
7344698|NCT00907738|11583369|FG003|Overall Study|not specified or withdrew consent|0
7344699|NCT00907738|11583370|FG004|Overall Study|not specified or withdrew consent|0
7344700|NCT00907738|11583366|FG000|Overall Study|Disease progression|8
7344701|NCT00907738|11583367|FG001|Overall Study|Disease progression|1
7344702|NCT00907738|11583368|FG002|Overall Study|Disease progression|6
7344703|NCT00907738|11583369|FG003|Overall Study|Disease progression|4
7344704|NCT00907738|11583370|FG004|Overall Study|Disease progression|2
7344705|NCT00907777|11583388|FG000|Overall Study|Withdrawal by Subject|0
7344706|NCT00907777|11583389|FG001|Overall Study|Withdrawal by Subject|1
7344707|NCT00907803|11583398|FG000|Overall Study|Withdrawal of consent - long commute|1
7344708|NCT00907803|11583399|FG001|Overall Study|Withdrawal of consent - long commute|0
7344709|NCT00907803|11583400|FG002|Overall Study|Withdrawal of consent - long commute|0
7344710|NCT00907803|11583398|FG000|Overall Study|Adverse Event|2
7344711|NCT00907803|11583399|FG001|Overall Study|Adverse Event|0
7344712|NCT00907803|11583400|FG002|Overall Study|Adverse Event|0
7344713|NCT00907803|11583398|FG000|Overall Study|Withdrawal by Subject|0
7344714|NCT00907803|11583399|FG001|Overall Study|Withdrawal by Subject|1
7344715|NCT00907803|11583400|FG002|Overall Study|Withdrawal by Subject|0
7344716|NCT00907803|11583398|FG000|Overall Study|Lost to Follow-up|0
7344717|NCT00907803|11583399|FG001|Overall Study|Lost to Follow-up|1
7344718|NCT00907803|11583400|FG002|Overall Study|Lost to Follow-up|0
7344719|NCT00907803|11583398|FG000|Overall Study|Protocol Violation|0
7344720|NCT00907803|11583399|FG001|Overall Study|Protocol Violation|1
7344721|NCT00907803|11583400|FG002|Overall Study|Protocol Violation|0
7344722|NCT00907881|11583408|FG000|Overall Study|Lost to Follow-up|59
7344723|NCT00907881|11583408|FG000|Overall Study|Noncompliance|5
7344724|NCT00907881|11583408|FG000|Overall Study|Withdrawal by Subject|5
7344725|NCT00907881|11583408|FG000|Overall Study|Protocol Violation|1
7344726|NCT00907881|11583408|FG000|Overall Study|Missing discontinuation information|15
7344727|NCT00908011|11583414|FG000|Overall Study|Withdrawal by Subject|2
7344728|NCT00908011|11583415|FG001|Overall Study|Withdrawal by Subject|2
7344729|NCT00908037|11583428|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344730|NCT00908037|11583429|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344731|NCT00908037|11583430|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344732|NCT00908037|11583431|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344733|NCT00908037|11583432|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7344734|NCT00908037|11583433|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344735|NCT00908037|11583434|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
7344736|NCT00908037|11583435|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344737|NCT00908037|11583436|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
7344738|NCT00908037|11583437|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344739|NCT00908037|11583438|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344740|NCT00908037|11583439|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
7344741|NCT00908037|11583428|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344742|NCT00908037|11583429|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344743|NCT00908037|11583430|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344744|NCT00908037|11583431|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344745|NCT00908037|11583432|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
7344746|NCT00908037|11583433|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344747|NCT00908037|11583434|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344748|NCT00908037|11583435|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344749|NCT00908037|11583436|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
7344750|NCT00908037|11583437|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344751|NCT00908037|11583438|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344752|NCT00908037|11583439|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
7344753|NCT00908037|11583428|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344754|NCT00908037|11583429|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344755|NCT00908037|11583430|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344756|NCT00908037|11583431|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7344757|NCT00908037|11583432|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344758|NCT00908037|11583433|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344759|NCT00908037|11583434|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
7344760|NCT00908037|11583435|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344761|NCT00908037|11583436|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344762|NCT00908037|11583437|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344763|NCT00908037|11583438|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344764|NCT00908037|11583439|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
7344765|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344766|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344767|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344768|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344769|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344770|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344771|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344772|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344773|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344774|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344775|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
7344776|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
7344777|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344778|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344779|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344780|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344781|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344782|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344783|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344784|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344785|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344786|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
7344787|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
7344788|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
7344789|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7533077|NCT02680002|11879106|FG003|Overall Study|Missed Visit 8 (Day 201)|1
7344790|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344791|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344792|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344793|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344794|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344795|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344796|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344797|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344798|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
7344799|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344800|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
7344801|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344802|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344803|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344804|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344805|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344806|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344807|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344808|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344809|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344810|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344811|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
7344812|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
7344813|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344814|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344815|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344816|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344817|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344818|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344819|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344820|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344821|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344822|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
7344823|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344824|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
7344825|NCT00908037|11583428|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344826|NCT00908037|11583429|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344827|NCT00908037|11583430|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344828|NCT00908037|11583431|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344829|NCT00908037|11583432|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7385835|NCT01205126|11643830|FG000|Titration Phase|Lost to Follow-up|2
7344830|NCT00908037|11583433|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344831|NCT00908037|11583434|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344832|NCT00908037|11583435|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344833|NCT00908037|11583436|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344834|NCT00908037|11583437|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344835|NCT00908037|11583438|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
7344836|NCT00908037|11583439|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
7344837|NCT00908076|11583493|FG000|Overall Study|Lack of Efficacy|1
7344838|NCT00908076|11583494|FG001|Overall Study|Lack of Efficacy|1
7344839|NCT00908115|11583500|FG000|Overall Study|Other|14
7344840|NCT00908141|11583506|FG000|Overall Study|Withdrawal by Subject|0
7344841|NCT00908141|11583507|FG001|Overall Study|Withdrawal by Subject|1
7344842|NCT00908232|11583513|FG000|Cycle 1 to 4|Death|5
7344843|NCT00908232|11583514|FG001|Cycle 1 to 4|Death|0
7344844|NCT00908232|11583515|FG002|Cycle 1 to 4|Death|0
7344845|NCT00908232|11583516|FG003|Cycle 1 to 4|Death|0
7344846|NCT00908232|11583513|FG000|Cycle 1 to 4|Withdrawal by Subject|4
7344847|NCT00908232|11583514|FG001|Cycle 1 to 4|Withdrawal by Subject|0
7344848|NCT00908232|11583515|FG002|Cycle 1 to 4|Withdrawal by Subject|0
7344849|NCT00908232|11583516|FG003|Cycle 1 to 4|Withdrawal by Subject|0
7344850|NCT00908232|11583513|FG000|Cycle 1 to 4|Progressive Disease|6
7344851|NCT00908232|11583514|FG001|Cycle 1 to 4|Progressive Disease|0
7344852|NCT00908232|11583515|FG002|Cycle 1 to 4|Progressive Disease|0
7344853|NCT00908232|11583516|FG003|Cycle 1 to 4|Progressive Disease|0
7533073|NCT02680002|11879108|FG005|Overall Study|Withdrawal by Subject|2
7533074|NCT02680002|11879103|FG000|Overall Study|Missed Visit 8 (Day 201)|2
7533075|NCT02680002|11879104|FG001|Overall Study|Missed Visit 8 (Day 201)|1
7533076|NCT02680002|11879105|FG002|Overall Study|Missed Visit 8 (Day 201)|3
7533078|NCT02680002|11879107|FG004|Overall Study|Missed Visit 8 (Day 201)|5
7533079|NCT02680002|11879108|FG005|Overall Study|Missed Visit 8 (Day 201)|0
7533080|NCT02680002|11879103|FG000|Overall Study|Other|0
7533081|NCT02680002|11879104|FG001|Overall Study|Other|1
7533082|NCT02680002|11879105|FG002|Overall Study|Other|0
7533083|NCT02680002|11879106|FG003|Overall Study|Other|0
7533084|NCT02680002|11879107|FG004|Overall Study|Other|1
7533085|NCT02680002|11879108|FG005|Overall Study|Other|0
7533086|NCT02680002|11879103|FG000|Overall Study|Adverse Event|0
7533087|NCT02680002|11879104|FG001|Overall Study|Adverse Event|0
7533088|NCT02680002|11879105|FG002|Overall Study|Adverse Event|0
7344854|NCT00908232|11583513|FG000|Cycle 1 to 4|Adverse Event|12
7344855|NCT00908232|11583514|FG001|Cycle 1 to 4|Adverse Event|0
7344856|NCT00908232|11583515|FG002|Cycle 1 to 4|Adverse Event|0
7344857|NCT00908232|11583516|FG003|Cycle 1 to 4|Adverse Event|0
7344858|NCT00908232|11583513|FG000|Cycle 1 to 4|Other|1
7344859|NCT00908232|11583514|FG001|Cycle 1 to 4|Other|0
7344860|NCT00908232|11583515|FG002|Cycle 1 to 4|Other|0
7344861|NCT00908232|11583516|FG003|Cycle 1 to 4|Other|0
7344862|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
7344863|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7344864|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7344865|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
7344866|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
7344867|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7344868|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7344869|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
7344870|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
7344871|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
7344872|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
7344873|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
7344874|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
7344875|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7344876|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
7344877|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
7344878|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
7344879|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
7344880|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7344881|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
7344882|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
7344883|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7344884|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7344885|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
7344886|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
7533089|NCT02680002|11879106|FG003|Overall Study|Adverse Event|0
7533090|NCT02680002|11879107|FG004|Overall Study|Adverse Event|1
7533091|NCT02680002|11879108|FG005|Overall Study|Adverse Event|2
7533092|NCT02680041|11879125|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
7533093|NCT02680041|11879125|FG000|Overall Study|Lost to Follow-up|2
7344887|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
7344888|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
7344889|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
7344890|NCT00908232|11583513|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
7344891|NCT00908232|11583514|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7344892|NCT00908232|11583515|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7344893|NCT00908232|11583516|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
7344894|NCT00908310|11583522|FG000|Overall Study|Death|37
7344895|NCT00908310|11583522|FG000|Overall Study|Withdrawal by Subject|7
7344896|NCT00908310|11583522|FG000|Overall Study|Lost to Follow-up|7
7344897|NCT00908310|11583522|FG000|Overall Study|Screening failure|5
7344898|NCT00908310|11583522|FG000|Overall Study|Other reasons|4
7344899|NCT00908349|11583526|FG000|Overall Study|Adverse Event|10
7344900|NCT00908349|11583526|FG000|Overall Study|Withdrawal by Subject|9
7344901|NCT00908349|11583526|FG000|Overall Study|Physician Decision|5
7344902|NCT00908349|11583526|FG000|Overall Study|Lost to Follow-up|5
7344903|NCT00908349|11583526|FG000|Overall Study|Various|6
7344904|NCT00908375|11583532|FG000|Overall Study|Withdrawal by Subject|2
7344905|NCT00908375|11583533|FG001|Overall Study|Withdrawal by Subject|4
7344906|NCT00908375|11583532|FG000|Overall Study|Lost to Follow-up|8
7344907|NCT00908375|11583533|FG001|Overall Study|Lost to Follow-up|6
7344908|NCT00908544|11583554|FG000|Overall Study|Withdrawal by Subject|2
7344909|NCT00908544|11583555|FG001|Overall Study|Withdrawal by Subject|4
7344910|NCT00908544|11583554|FG000|Overall Study|Lack of Efficacy|0
7344911|NCT00908544|11583555|FG001|Overall Study|Lack of Efficacy|1
7344912|NCT00908544|11583554|FG000|Overall Study|Pregnancy|1
7344913|NCT00908544|11583555|FG001|Overall Study|Pregnancy|0
7344914|NCT00908544|11583554|FG000|Overall Study|Relocation abroad|1
7344915|NCT00908544|11583555|FG001|Overall Study|Relocation abroad|1
7344916|NCT00908544|11583554|FG000|Overall Study|Unable to visit sutdy center|1
7344917|NCT00908544|11583555|FG001|Overall Study|Unable to visit sutdy center|0
7533094|NCT02680639|11879182|FG000|Screening Period|Screen Failure|7
7533095|NCT02680639|11879183|FG001|Screening Period|Screen Failure|0
7533096|NCT02680639|11879184|FG002|Screening Period|Screen Failure|0
7533097|NCT02680665|11879194|FG000|Overall Study|No visit after the first prescription|5
7533098|NCT02680756|11879200|FG000|Overall Study|Adverse Event|10
7533099|NCT02680756|11879201|FG001|Overall Study|Adverse Event|2
7533100|NCT02680756|11879200|FG000|Overall Study|Lost to Follow-up|7
7533101|NCT02680756|11879201|FG001|Overall Study|Lost to Follow-up|6
7533102|NCT02680756|11879200|FG000|Overall Study|Withdrawal by Subject|5
7344918|NCT00908583|11583561|FG000|Phase 1|Withdrawal by Subject|1
7458713|NCT01809327|11752839|FG002|Overall Study|Adverse Event|7
7458714|NCT01809327|11752840|FG003|Overall Study|Adverse Event|4
7458715|NCT01809327|11752841|FG004|Overall Study|Adverse Event|8
7458716|NCT01809327|11752837|FG000|Overall Study|Death|1
7458717|NCT01809327|11752838|FG001|Overall Study|Death|0
7458718|NCT01809327|11752839|FG002|Overall Study|Death|0
7458719|NCT01809327|11752840|FG003|Overall Study|Death|0
7458720|NCT01809327|11752841|FG004|Overall Study|Death|0
7458721|NCT01809327|11752837|FG000|Overall Study|Protocol Violation|0
7344919|NCT00908583|11583561|FG000|Phase 1|Adverse Event|4
7344920|NCT00908583|11583561|FG000|Phase 2|Physician Decision|1
7344921|NCT00908583|11583561|FG000|Phase 2|Adverse Event|1
7344922|NCT00908583|11583561|FG000|Phase 3|Adverse Event|2
7344923|NCT00908583|11583561|FG000|Phase 4|Adverse Event|1
7344924|NCT00908583|11583561|FG000|Phase 4|Physician Decision|1
7344925|NCT00908583|11583561|FG000|Phase 5|Adverse Event|3
7344926|NCT00908596|11583583|FG000|Overall Study|Other reasons|46
7344927|NCT00908596|11583584|FG001|Overall Study|Other reasons|6
7344928|NCT00908596|11583585|FG002|Overall Study|Other reasons|2
7344929|NCT00908596|11583586|FG003|Overall Study|Other reasons|0
7344930|NCT00908596|11583583|FG000|Overall Study|Lost to Follow-up|0
7344931|NCT00908596|11583584|FG001|Overall Study|Lost to Follow-up|1
7344932|NCT00908596|11583585|FG002|Overall Study|Lost to Follow-up|12
7344933|NCT00908596|11583586|FG003|Overall Study|Lost to Follow-up|4
7344934|NCT00908596|11583583|FG000|Overall Study|Death|0
7344935|NCT00908596|11583584|FG001|Overall Study|Death|5
7344936|NCT00908596|11583585|FG002|Overall Study|Death|57
7344937|NCT00908596|11583586|FG003|Overall Study|Death|32
7344938|NCT00908596|11583583|FG000|Overall Study|Protocol Violation|1
7344939|NCT00908596|11583584|FG001|Overall Study|Protocol Violation|0
7344940|NCT00908596|11583585|FG002|Overall Study|Protocol Violation|0
7344941|NCT00908596|11583586|FG003|Overall Study|Protocol Violation|0
7344942|NCT00908596|11583583|FG000|Overall Study|Withdrawal by Subject|0
7344943|NCT00908596|11583584|FG001|Overall Study|Withdrawal by Subject|1
7344944|NCT00908596|11583585|FG002|Overall Study|Withdrawal by Subject|3
7344945|NCT00908596|11583586|FG003|Overall Study|Withdrawal by Subject|1
7458722|NCT01809327|11752838|FG001|Overall Study|Protocol Violation|1
7385836|NCT01205126|11643831|FG001|Titration Phase|Lost to Follow-up|2
7385837|NCT01205126|11643830|FG000|Titration Phase|No stable titration dose|1
7385838|NCT01205126|11643831|FG001|Titration Phase|No stable titration dose|0
7385839|NCT01205126|11643830|FG000|Titration Phase|More than maximum dosage required|2
7458723|NCT01809327|11752839|FG002|Overall Study|Protocol Violation|0
7458724|NCT01809327|11752840|FG003|Overall Study|Protocol Violation|0
7344946|NCT00908895|11583629|FG000|Overall Study|Lost to Follow-up|1
7344947|NCT00908895|11583630|FG001|Overall Study|Lost to Follow-up|3
7344948|NCT00908895|11583629|FG000|Overall Study|algodystrophy|2
7344949|NCT00908895|11583630|FG001|Overall Study|algodystrophy|2
7344950|NCT00908895|11583629|FG000|Overall Study|Adverse Event|1
7344951|NCT00908895|11583630|FG001|Overall Study|Adverse Event|1
7344952|NCT00908960|11583648|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
7344953|NCT00908960|11583649|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
7344954|NCT00908960|11583650|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
7344955|NCT00909038|11583658|FG000|Overall Study|Protocol Violation|187
7344956|NCT00909038|11583658|FG000|Overall Study|Non-evaluable Subjects|230
7344957|NCT00909090|11583668|FG000|Overall Study|Lost to Follow-up|17
7344958|NCT00909090|11583669|FG001|Overall Study|Lost to Follow-up|17
7344959|NCT00909181|11583697|FG000|Overall Study|Lost to Follow-up|39
7344960|NCT00909181|11583698|FG001|Overall Study|Lost to Follow-up|18
7344961|NCT00909181|11583699|FG002|Overall Study|Lost to Follow-up|33
7344962|NCT00909363|11583730|FG000|Overall Study|Withdrawal by Subject|1
7344963|NCT00909363|11583731|FG001|Overall Study|Withdrawal by Subject|0
7344964|NCT00909363|11583732|FG002|Overall Study|Withdrawal by Subject|0
7344965|NCT00909363|11583730|FG000|Overall Study|Lack of Efficacy|1
7344966|NCT00909363|11583731|FG001|Overall Study|Lack of Efficacy|0
7344967|NCT00909363|11583732|FG002|Overall Study|Lack of Efficacy|0
7344968|NCT00909428|11583746|FG000|Overall Study|Lost to Follow-up|13
7344969|NCT00909428|11583747|FG001|Overall Study|Lost to Follow-up|10
7344970|NCT00909428|11583748|FG002|Overall Study|Lost to Follow-up|9
7344971|NCT00909480|11583757|FG000|Overall Study|Adverse Event|5
7344972|NCT00909480|11583758|FG001|Overall Study|Adverse Event|3
7344973|NCT00909480|11583757|FG000|Overall Study|Protocol Violation|6
7344974|NCT00909480|11583758|FG001|Overall Study|Protocol Violation|8
7344975|NCT00909480|11583757|FG000|Overall Study|Withdrawal criteria|9
7344976|NCT00909480|11583758|FG001|Overall Study|Withdrawal criteria|11
7344977|NCT00909480|11583757|FG000|Overall Study|Unclassified|18
7344978|NCT00909480|11583758|FG001|Overall Study|Unclassified|19
7344979|NCT00909532|11583766|FG000|Overall Study|Adverse Event|4
7344980|NCT00909532|11583767|FG001|Overall Study|Adverse Event|1
7344981|NCT00909532|11583766|FG000|Overall Study|Pregnancy|0
7344982|NCT00909532|11583767|FG001|Overall Study|Pregnancy|1
7344983|NCT00909532|11583766|FG000|Overall Study|Prohibited Medication|2
7344984|NCT00909532|11583767|FG001|Overall Study|Prohibited Medication|1
7344985|NCT00909532|11583766|FG000|Overall Study|Withdrawal of Consent|1
7344986|NCT00909532|11583767|FG001|Overall Study|Withdrawal of Consent|1
7344987|NCT00909532|11583766|FG000|Overall Study|Noncompliance with Study Requirements|0
7344988|NCT00909532|11583767|FG001|Overall Study|Noncompliance with Study Requirements|2
7344989|NCT00909532|11583766|FG000|Overall Study|Physician Decision|1
7344990|NCT00909532|11583767|FG001|Overall Study|Physician Decision|0
7344991|NCT00909532|11583766|FG000|Overall Study|Wrong Genotype|1
7344992|NCT00909532|11583767|FG001|Overall Study|Wrong Genotype|0
7344993|NCT00909532|11583766|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
7344994|NCT00909532|11583767|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
7344995|NCT00909727|11583794|FG000|Overall Study|Adverse Event|1
7344996|NCT00909727|11583795|FG001|Overall Study|Adverse Event|0
7344997|NCT00909727|11583794|FG000|Overall Study|Wrong Genotype|1
7344998|NCT00909727|11583795|FG001|Overall Study|Wrong Genotype|0
7344999|NCT00909727|11583794|FG000|Overall Study|Withdrawal of Consent|1
7345000|NCT00909727|11583795|FG001|Overall Study|Withdrawal of Consent|0
7345001|NCT00909727|11583794|FG000|Overall Study|Prohibited Medication|1
7345002|NCT00909727|11583795|FG001|Overall Study|Prohibited Medication|0
7345003|NCT00909779|11583803|FG000|Overall Study|Adverse Event|53
7345004|NCT00909779|11583804|FG001|Overall Study|Adverse Event|55
7345005|NCT00909779|11583803|FG000|Overall Study|Lack of Efficacy|7
7345006|NCT00909779|11583804|FG001|Overall Study|Lack of Efficacy|4
7345007|NCT00909779|11583803|FG000|Overall Study|Lost to Follow-up|19
7345008|NCT00909779|11583804|FG001|Overall Study|Lost to Follow-up|15
7345009|NCT00909779|11583803|FG000|Overall Study|Physician Decision|8
7345010|NCT00909779|11583804|FG001|Overall Study|Physician Decision|2
7345011|NCT00909779|11583803|FG000|Overall Study|Protocol Violation|2
7345012|NCT00909779|11583804|FG001|Overall Study|Protocol Violation|5
7345013|NCT00909779|11583803|FG000|Overall Study|Withdrawal by Subject|116
7345014|NCT00909779|11583804|FG001|Overall Study|Withdrawal by Subject|80
7345015|NCT00909779|11583803|FG000|Overall Study|Site Ceasing Operation|2
7345016|NCT00909779|11583804|FG001|Overall Study|Site Ceasing Operation|2
7345017|NCT00909779|11583803|FG000|Overall Study|Medical Monitor Decision|1
7345018|NCT00909779|11583804|FG001|Overall Study|Medical Monitor Decision|0
7345019|NCT00909779|11583803|FG000|Overall Study|Noncompliance|1
7345020|NCT00909779|11583804|FG001|Overall Study|Noncompliance|1
7345021|NCT00909779|11583803|FG000|Overall Study|Randomized in error|1
7345022|NCT00909779|11583804|FG001|Overall Study|Randomized in error|1
7345023|NCT00909792|11583812|FG000|Period 1|Did not meet inclusion criteria|0
7345024|NCT00909792|11583813|FG001|Period 1|Did not meet inclusion criteria|1
7345025|NCT00909792|11583812|FG000|Period 2|Biomicroscopy|1
7345026|NCT00909792|11583813|FG001|Period 2|Biomicroscopy|0
7345027|NCT00909792|11583812|FG000|Period 2|Lost to Follow-up|0
7345028|NCT00909792|11583813|FG001|Period 2|Lost to Follow-up|1
7345029|NCT00909844|11583819|FG000|Overall Study|Adverse Event|1
7345030|NCT00909844|11583819|FG000|Overall Study|Withdrawal by Subject|1
7345031|NCT00909844|11583819|FG000|Overall Study|Lost to Follow-up|2
7345032|NCT00909857|11583826|FG000|Overall Study|Withdrawal by Subject|6
7345033|NCT00909857|11583827|FG001|Overall Study|Withdrawal by Subject|10
7345034|NCT00909857|11583826|FG000|Overall Study|Adverse Event|5
7345035|NCT00909857|11583827|FG001|Overall Study|Adverse Event|5
7345036|NCT00909857|11583826|FG000|Overall Study|Lost to Follow-up|2
7345037|NCT00909857|11583827|FG001|Overall Study|Lost to Follow-up|5
7345038|NCT00909857|11583826|FG000|Overall Study|Protocol Violation|2
7345039|NCT00909857|11583827|FG001|Overall Study|Protocol Violation|1
7345040|NCT00909857|11583826|FG000|Overall Study|Pregnancy|1
7345041|NCT00909857|11583827|FG001|Overall Study|Pregnancy|0
7345042|NCT00909857|11583826|FG000|Overall Study|Other|1
7345043|NCT00909857|11583827|FG001|Overall Study|Other|0
7345044|NCT00909857|11583826|FG000|Overall Study|Did not receive study medication|19
7345045|NCT00909857|11583827|FG001|Overall Study|Did not receive study medication|24
7345046|NCT00909870|11583835|FG000|Overall Study|Adverse Event|13
7345047|NCT00909870|11583836|FG001|Overall Study|Adverse Event|7
7345048|NCT00909870|11583835|FG000|Overall Study|Protocol Violation|1
7345049|NCT00909870|11583836|FG001|Overall Study|Protocol Violation|2
7345050|NCT00909870|11583835|FG000|Overall Study|Withdrawal by Subject|5
7345051|NCT00909870|11583836|FG001|Overall Study|Withdrawal by Subject|8
7345052|NCT00909870|11583835|FG000|Overall Study|Lost to Follow-up|3
7345053|NCT00909870|11583836|FG001|Overall Study|Lost to Follow-up|3
7345054|NCT00909870|11583835|FG000|Overall Study|Physician Decision|0
7345055|NCT00909870|11583836|FG001|Overall Study|Physician Decision|2
7345056|NCT00909870|11583835|FG000|Overall Study|Other|1
7345057|NCT00909870|11583836|FG001|Overall Study|Other|5
7345058|NCT00910000|11583849|FG000|Overall Study|Adverse Event|0
7345059|NCT00910000|11583850|FG001|Overall Study|Adverse Event|3
7345060|NCT00910000|11583851|FG002|Overall Study|Adverse Event|2
7345061|NCT00910000|11583852|FG003|Overall Study|Adverse Event|2
7345062|NCT00910000|11583853|FG004|Overall Study|Adverse Event|0
7345063|NCT00910000|11583854|FG005|Overall Study|Adverse Event|1
7345064|NCT00910000|11583849|FG000|Overall Study|Withdrawal by Subject|0
7345065|NCT00910000|11583850|FG001|Overall Study|Withdrawal by Subject|0
7345066|NCT00910000|11583851|FG002|Overall Study|Withdrawal by Subject|1
7345067|NCT00910000|11583852|FG003|Overall Study|Withdrawal by Subject|0
7345068|NCT00910000|11583853|FG004|Overall Study|Withdrawal by Subject|1
7345069|NCT00910000|11583854|FG005|Overall Study|Withdrawal by Subject|0
7345070|NCT00910039|11583864|FG000|Overall Study|Physician Decision|1
7345071|NCT00910091|11583871|FG000|Pre-assignment|Withdrawal by Subject|0
7345072|NCT00910091|11583872|FG001|Pre-assignment|Withdrawal by Subject|2
7345073|NCT00910091|11583871|FG000|Treatment and Survival|Withdrawal by Subject|3
7345074|NCT00910091|11583872|FG001|Treatment and Survival|Withdrawal by Subject|4
7345075|NCT00910091|11583871|FG000|Treatment and Survival|Adverse Event|1
7345076|NCT00910091|11583872|FG001|Treatment and Survival|Adverse Event|0
7345077|NCT00910247|11583892|FG000|Overall Study|Adverse Event|15
7345078|NCT00910247|11583892|FG000|Overall Study|Death|2
7345079|NCT00910247|11583892|FG000|Overall Study|Lost to Follow-up|10
7345080|NCT00910247|11583892|FG000|Overall Study|Physician Decision|3
7345081|NCT00910247|11583892|FG000|Overall Study|Protocol Violation|10
7345082|NCT00910247|11583892|FG000|Overall Study|Withdrawal by Subject|25
7345083|NCT00910247|11583892|FG000|Overall Study|Not collected|4
7345084|NCT00910273|11583898|FG000|Overall Study|Lack of Efficacy|6
7345085|NCT00910273|11583899|FG001|Overall Study|Lack of Efficacy|9
7345086|NCT00910273|11583898|FG000|Overall Study|Adverse Event|1
7345087|NCT00910273|11583899|FG001|Overall Study|Adverse Event|1
7345088|NCT00910273|11583898|FG000|Overall Study|Withdrawal by Subject|1
7345089|NCT00910273|11583899|FG001|Overall Study|Withdrawal by Subject|0
7345090|NCT00910273|11583898|FG000|Overall Study|Discontinuation of study by sponsor|8
7345091|NCT00910273|11583899|FG001|Overall Study|Discontinuation of study by sponsor|2
7345092|NCT00910273|11583898|FG000|Overall Study|Protocol Violation|1
7345093|NCT00910273|11583899|FG001|Overall Study|Protocol Violation|0
7345094|NCT00910273|11583898|FG000|Overall Study|Lost to Follow-up|1
7345095|NCT00910273|11583899|FG001|Overall Study|Lost to Follow-up|1
7345096|NCT00910299|11583907|FG000|Overall Study|Withdrawal by Subject|16
7345097|NCT00910299|11583908|FG001|Overall Study|Withdrawal by Subject|13
7345098|NCT00910299|11583907|FG000|Overall Study|Sponsor Decision|58
7345099|NCT00910299|11583908|FG001|Overall Study|Sponsor Decision|60
7345100|NCT00910299|11583907|FG000|Overall Study|Didn't receive any study drug|2
7345101|NCT00910299|11583908|FG001|Overall Study|Didn't receive any study drug|1
7345102|NCT00910429|11583916|FG000|Overall Study|Death|18
7345103|NCT00910429|11583917|FG001|Overall Study|Death|12
7345104|NCT00910429|11583916|FG000|Overall Study|Withdrawal by Subject|3
7345105|NCT00910429|11583917|FG001|Overall Study|Withdrawal by Subject|2
7345106|NCT00910429|11583916|FG000|Overall Study|Protocol Violation|1
7345107|NCT00910429|11583917|FG001|Overall Study|Protocol Violation|0
7345108|NCT00910429|11583916|FG000|Overall Study|Lost to Follow-up|2
7345109|NCT00910429|11583917|FG001|Overall Study|Lost to Follow-up|1
7345110|NCT00910429|11583916|FG000|Overall Study|Adverse Event|10
7345111|NCT00910429|11583917|FG001|Overall Study|Adverse Event|5
7345112|NCT00910429|11583916|FG000|Overall Study|Drug non-compliance|1
7345113|NCT00910429|11583917|FG001|Overall Study|Drug non-compliance|0
7345114|NCT00910429|11583916|FG000|Overall Study|Lack of Efficacy|4
7345115|NCT00910429|11583917|FG001|Overall Study|Lack of Efficacy|1
7345116|NCT00910624|11583945|FG000|Treatment Phase|Adverse Event|2
7345117|NCT00910624|11583946|FG001|Treatment Phase|Adverse Event|6
7345118|NCT00910624|11583947|FG002|Treatment Phase|Adverse Event|6
7345119|NCT00910624|11583948|FG003|Treatment Phase|Adverse Event|0
7345120|NCT00910624|11583945|FG000|Treatment Phase|Treatment Failure|23
7345121|NCT00910624|11583946|FG001|Treatment Phase|Treatment Failure|10
7345122|NCT00910624|11583947|FG002|Treatment Phase|Treatment Failure|0
7345123|NCT00910624|11583948|FG003|Treatment Phase|Treatment Failure|0
7345124|NCT00910624|11583945|FG000|Treatment Phase|Lost to Follow-up|0
7345125|NCT00910624|11583946|FG001|Treatment Phase|Lost to Follow-up|0
7345126|NCT00910624|11583947|FG002|Treatment Phase|Lost to Follow-up|1
7345127|NCT00910624|11583948|FG003|Treatment Phase|Lost to Follow-up|0
7345128|NCT00910624|11583945|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7345129|NCT00910624|11583946|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
7345130|NCT00910624|11583947|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
7345131|NCT00910624|11583948|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
7345132|NCT00910624|11583945|FG000|Treatment Phase|Withdrawal by Subject|2
7345133|NCT00910624|11583946|FG001|Treatment Phase|Withdrawal by Subject|1
7345134|NCT00910624|11583947|FG002|Treatment Phase|Withdrawal by Subject|0
7345135|NCT00910624|11583948|FG003|Treatment Phase|Withdrawal by Subject|0
7345136|NCT00910624|11583945|FG000|Treatment Phase|Non-Compliance With Protocol|0
7345137|NCT00910624|11583946|FG001|Treatment Phase|Non-Compliance With Protocol|1
7345138|NCT00910624|11583947|FG002|Treatment Phase|Non-Compliance With Protocol|1
7345139|NCT00910624|11583948|FG003|Treatment Phase|Non-Compliance With Protocol|0
7345140|NCT00910624|11583945|FG000|Follow-Up Phase|Adverse Event|0
7345141|NCT00910624|11583946|FG001|Follow-Up Phase|Adverse Event|0
7345142|NCT00910624|11583947|FG002|Follow-Up Phase|Adverse Event|1
7345143|NCT00910624|11583948|FG003|Follow-Up Phase|Adverse Event|0
7345144|NCT00910624|11583945|FG000|Follow-Up Phase|Lost to Follow-up|3
7345145|NCT00910624|11583946|FG001|Follow-Up Phase|Lost to Follow-up|1
7345146|NCT00910624|11583947|FG002|Follow-Up Phase|Lost to Follow-up|2
7345147|NCT00910624|11583948|FG003|Follow-Up Phase|Lost to Follow-up|0
7345148|NCT00910624|11583945|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
7345149|NCT00910624|11583946|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
7345150|NCT00910624|11583947|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7345151|NCT00910624|11583948|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
7345152|NCT00910624|11583945|FG000|Follow-Up Phase|Withdrawal by Subject|1
7345153|NCT00910624|11583946|FG001|Follow-Up Phase|Withdrawal by Subject|0
7345154|NCT00910624|11583947|FG002|Follow-Up Phase|Withdrawal by Subject|0
7345155|NCT00910624|11583948|FG003|Follow-Up Phase|Withdrawal by Subject|0
7345156|NCT00910624|11583945|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
7345157|NCT00910624|11583946|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7345158|NCT00910624|11583947|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7345159|NCT00910624|11583948|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
7345160|NCT00910624|11583945|FG000|Follow-Up Phase|Administrative|0
7345161|NCT00910624|11583946|FG001|Follow-Up Phase|Administrative|1
7345162|NCT00910624|11583947|FG002|Follow-Up Phase|Administrative|1
7345163|NCT00910624|11583948|FG003|Follow-Up Phase|Administrative|0
7345164|NCT00910663|11583958|FG000|Period 1|Withdrawal by Subject|0
7345165|NCT00910663|11583959|FG001|Period 1|Withdrawal by Subject|1
7345166|NCT00910689|11583969|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
7345167|NCT00910689|11583970|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
7345168|NCT00910689|11583971|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
7345169|NCT00910689|11583972|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
7345170|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
7345171|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
7345172|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
7345173|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
7345174|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Adverse Event|2
7345175|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Adverse Event|3
7345176|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Adverse Event|2
7345177|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Adverse Event|0
7345178|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Time Demands|1
7345179|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Time Demands|0
7345180|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Time Demands|4
7345181|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Time Demands|8
7345182|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
7345183|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
7345184|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
7345185|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
7345186|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
7345187|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
7345188|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
7345189|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
7345190|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Pregnancy|0
7345191|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Pregnancy|2
7345192|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Pregnancy|0
7345193|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Pregnancy|0
7345194|NCT00910689|11583969|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
7345195|NCT00910689|11583970|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
7345196|NCT00910689|11583971|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
7345197|NCT00910689|11583972|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
7345198|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
7345199|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
7345200|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7575277|NCT03720652|11958935|FG001|Overall Study|Lost to Follow-up|4
7345201|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
7345202|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
7345203|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
7345204|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
7345205|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
7345206|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
7345207|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7345208|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7345209|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
7345210|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7345211|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
7345212|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7345213|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
7345214|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
7345215|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
7345216|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
7345217|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
7345218|NCT00910689|11583969|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
7345219|NCT00910689|11583970|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
7345220|NCT00910689|11583971|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
7345221|NCT00910689|11583972|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
7345222|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
7345223|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
7345224|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
7345225|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
7345226|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
7345227|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
7345228|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
7345229|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
7345230|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
7345231|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
7345232|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
7345233|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
7458725|NCT01809327|11752841|FG004|Overall Study|Protocol Violation|0
7458726|NCT01809327|11752837|FG000|Overall Study|Physician Decision|1
7458727|NCT01809327|11752838|FG001|Overall Study|Physician Decision|1
7345234|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
7345235|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7345236|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
7345237|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
7345238|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
7345239|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
7345240|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
7345241|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
7345242|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7345243|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7345244|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
7345245|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
7345246|NCT00910689|11583969|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
7345247|NCT00910689|11583970|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
7345248|NCT00910689|11583971|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
7345249|NCT00910689|11583972|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
7345250|NCT00910715|11583985|FG000|Overall Study|Lost to Follow-up|22
7345251|NCT00910715|11583986|FG001|Overall Study|Lost to Follow-up|26
7345252|NCT00910715|11583987|FG002|Overall Study|Lost to Follow-up|0
7345253|NCT00910728|11584006|FG000|Overall Study|Lack of Efficacy|2
7458728|NCT01809327|11752839|FG002|Overall Study|Physician Decision|0
7458729|NCT01809327|11752840|FG003|Overall Study|Physician Decision|0
7458730|NCT01809327|11752841|FG004|Overall Study|Physician Decision|0
7458731|NCT01809327|11752837|FG000|Overall Study|Pregnancy|1
7533103|NCT02680756|11879201|FG001|Overall Study|Withdrawal by Subject|5
7533104|NCT02680756|11879200|FG000|Overall Study|Physician Decision|4
7458732|NCT01809327|11752838|FG001|Overall Study|Pregnancy|0
7458733|NCT01809327|11752839|FG002|Overall Study|Pregnancy|0
7458734|NCT01809327|11752840|FG003|Overall Study|Pregnancy|0
7458735|NCT01809327|11752841|FG004|Overall Study|Pregnancy|0
7458736|NCT01809327|11752837|FG000|Overall Study|Other|14
7345254|NCT00910728|11584007|FG001|Overall Study|Lack of Efficacy|3
7345255|NCT00910728|11584008|FG002|Overall Study|Lack of Efficacy|1
7345256|NCT00910728|11584009|FG003|Overall Study|Lack of Efficacy|2
7345257|NCT00910728|11584010|FG004|Overall Study|Lack of Efficacy|1
7345258|NCT00910728|11584011|FG005|Overall Study|Lack of Efficacy|0
7345259|NCT00910728|11584012|FG006|Overall Study|Lack of Efficacy|2
7345260|NCT00910728|11584013|FG007|Overall Study|Lack of Efficacy|2
7458737|NCT01809327|11752838|FG001|Overall Study|Other|15
7458738|NCT01809327|11752839|FG002|Overall Study|Other|7
7458739|NCT01809327|11752840|FG003|Overall Study|Other|4
7458740|NCT01809327|11752841|FG004|Overall Study|Other|9
7458741|NCT01810016|11752877|FG000|Overall Study|Progressive disease|1
7458742|NCT01810016|11752878|FG001|Overall Study|Progressive disease|1
7458743|NCT01810016|11752879|FG002|Overall Study|Progressive disease|0
7458744|NCT01810016|11752877|FG000|Overall Study|Death|0
7458745|NCT01810016|11752878|FG001|Overall Study|Death|0
7458746|NCT01810016|11752879|FG002|Overall Study|Death|1
7458747|NCT01810042|11752887|FG000|Overall Study|Lost to Follow-up|10
7458748|NCT01810263|11752893|FG000|Overall Study|Lost to Follow-up|8
7458749|NCT01810263|11752894|FG001|Overall Study|Lost to Follow-up|7
7458750|NCT01810380|11752912|FG000|Overall Study|Randomised not treated|2
7458751|NCT01810380|11752913|FG001|Overall Study|Randomised not treated|1
7458752|NCT01810380|11752914|FG002|Overall Study|Randomised not treated|1
7458753|NCT01810380|11752912|FG000|Overall Study|Adverse Event|11
7458754|NCT01810380|11752913|FG001|Overall Study|Adverse Event|14
7458755|NCT01810380|11752914|FG002|Overall Study|Adverse Event|4
7458756|NCT01810380|11752912|FG000|Overall Study|Lack of Efficacy|24
7458757|NCT01810380|11752913|FG001|Overall Study|Lack of Efficacy|10
7458758|NCT01810380|11752914|FG002|Overall Study|Lack of Efficacy|11
7458759|NCT01810380|11752912|FG000|Overall Study|Protocol Violation|1
7345261|NCT00910728|11584014|FG008|Overall Study|Lack of Efficacy|2
7345262|NCT00910728|11584006|FG000|Overall Study|Withdrawal by Subject|0
7345263|NCT00910728|11584007|FG001|Overall Study|Withdrawal by Subject|0
7345264|NCT00910728|11584008|FG002|Overall Study|Withdrawal by Subject|0
7345265|NCT00910728|11584009|FG003|Overall Study|Withdrawal by Subject|0
7345266|NCT00910728|11584010|FG004|Overall Study|Withdrawal by Subject|3
7345267|NCT00910728|11584011|FG005|Overall Study|Withdrawal by Subject|1
7345268|NCT00910728|11584012|FG006|Overall Study|Withdrawal by Subject|2
7345269|NCT00910728|11584013|FG007|Overall Study|Withdrawal by Subject|0
7345270|NCT00910728|11584014|FG008|Overall Study|Withdrawal by Subject|0
7345271|NCT00910728|11584006|FG000|Overall Study|(not specified)|2
7345272|NCT00910728|11584007|FG001|Overall Study|(not specified)|0
7345273|NCT00910728|11584008|FG002|Overall Study|(not specified)|1
7345274|NCT00910728|11584009|FG003|Overall Study|(not specified)|0
7345275|NCT00910728|11584010|FG004|Overall Study|(not specified)|1
7345276|NCT00910728|11584011|FG005|Overall Study|(not specified)|0
7345277|NCT00910728|11584012|FG006|Overall Study|(not specified)|0
7345278|NCT00910728|11584013|FG007|Overall Study|(not specified)|0
7345279|NCT00910728|11584014|FG008|Overall Study|(not specified)|0
7345280|NCT00910728|11584006|FG000|Overall Study|Adverse Event|2
7345281|NCT00910728|11584007|FG001|Overall Study|Adverse Event|0
7345282|NCT00910728|11584008|FG002|Overall Study|Adverse Event|1
7345283|NCT00910728|11584009|FG003|Overall Study|Adverse Event|1
7345284|NCT00910728|11584010|FG004|Overall Study|Adverse Event|0
7345285|NCT00910728|11584011|FG005|Overall Study|Adverse Event|0
7345286|NCT00910728|11584012|FG006|Overall Study|Adverse Event|2
7345287|NCT00910728|11584013|FG007|Overall Study|Adverse Event|1
7345288|NCT00910728|11584014|FG008|Overall Study|Adverse Event|1
7345289|NCT00910858|11584046|FG000|Pharmacokinetic Phase|Adverse Event|1
7345290|NCT00910858|11584047|FG001|Pharmacokinetic Phase|Adverse Event|0
7345291|NCT00910858|11584048|FG002|Pharmacokinetic Phase|Adverse Event|0
7345292|NCT00910858|11584046|FG000|Monotherapy Phase|Adverse Event|3
7345293|NCT00910858|11584047|FG001|Monotherapy Phase|Adverse Event|2
7345294|NCT00910858|11584048|FG002|Monotherapy Phase|Adverse Event|0
7345295|NCT00910858|11584046|FG000|Monotherapy Phase|Lack of therapeutic effect|9
7345296|NCT00910858|11584047|FG001|Monotherapy Phase|Lack of therapeutic effect|6
7345297|NCT00910858|11584048|FG002|Monotherapy Phase|Lack of therapeutic effect|4
7345298|NCT00910858|11584046|FG000|Monotherapy Phase|Withdrawal by Subject|1
7345299|NCT00910858|11584047|FG001|Monotherapy Phase|Withdrawal by Subject|3
7345300|NCT00910858|11584048|FG002|Monotherapy Phase|Withdrawal by Subject|1
7345301|NCT00910858|11584046|FG000|Monotherapy Phase|Protocol Violation|1
7345302|NCT00910858|11584047|FG001|Monotherapy Phase|Protocol Violation|0
7345303|NCT00910858|11584048|FG002|Monotherapy Phase|Protocol Violation|0
7345304|NCT00910858|11584046|FG000|Monotherapy Phase|Other|3
7345305|NCT00910858|11584047|FG001|Monotherapy Phase|Other|4
7345306|NCT00910858|11584048|FG002|Monotherapy Phase|Other|2
7458760|NCT01810380|11752913|FG001|Overall Study|Protocol Violation|0
7345307|NCT00910858|11584046|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
7345308|NCT00910858|11584047|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
7345309|NCT00910858|11584048|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
7345310|NCT00910858|11584046|FG000|Combined Treatment Phase|Withdrawal by Subject|0
7345311|NCT00910858|11584047|FG001|Combined Treatment Phase|Withdrawal by Subject|2
7345312|NCT00910858|11584048|FG002|Combined Treatment Phase|Withdrawal by Subject|0
7458761|NCT01810380|11752914|FG002|Overall Study|Protocol Violation|1
7458762|NCT01810380|11752912|FG000|Overall Study|Withdrawal by Subject|6
7345313|NCT00910858|11584046|FG000|Combined Treatment Phase|Protocol Violation|1
7345314|NCT00910858|11584047|FG001|Combined Treatment Phase|Protocol Violation|0
7345315|NCT00910858|11584048|FG002|Combined Treatment Phase|Protocol Violation|0
7345316|NCT00910858|11584046|FG000|Combined Treatment Phase|Other|0
7345317|NCT00910858|11584047|FG001|Combined Treatment Phase|Other|2
7345318|NCT00910858|11584048|FG002|Combined Treatment Phase|Other|1
7345319|NCT00910871|11584064|FG000|Overall Study|Adverse Event|5
7345320|NCT00910871|11584064|FG000|Overall Study|Death|12
7345321|NCT00910871|11584064|FG000|Overall Study|Lost to Follow-up|8
7345322|NCT00910871|11584064|FG000|Overall Study|Protocol Violation|11
7345323|NCT00910871|11584064|FG000|Overall Study|Withdrawal by Subject|12
7345324|NCT00910871|11584064|FG000|Overall Study|Subject didn't meet eligibility criteria|5
7345325|NCT00910871|11584064|FG000|Overall Study|Undefined|1
7345326|NCT00910910|11584070|FG000|Overall Study|Adverse Event|63
7345327|NCT00910910|11584071|FG001|Overall Study|Adverse Event|35
7345328|NCT00910910|11584070|FG000|Overall Study|PD without histologic change|27
7345329|NCT00910910|11584071|FG001|Overall Study|PD without histologic change|23
7569117|NCT03437512|11944984|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
7569118|NCT03437512|11944985|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
7569119|NCT03437577|11945003|FG000|Pre-Randomization|Withdrawal by Subject|0
7569120|NCT03437577|11945004|FG001|Pre-Randomization|Withdrawal by Subject|0
7569121|NCT03437577|11945005|FG002|Pre-Randomization|Withdrawal by Subject|10
7569122|NCT03437577|11945003|FG000|Post-Randomization|Physician Decision|0
7569123|NCT03437577|11945004|FG001|Post-Randomization|Physician Decision|2
7569124|NCT03437577|11945005|FG002|Post-Randomization|Physician Decision|0
7345330|NCT00910910|11584070|FG000|Overall Study|PD with histologic change|0
7345331|NCT00910910|11584071|FG001|Overall Study|PD with histologic change|2
7345332|NCT00910910|11584070|FG000|Overall Study|Withdrawal by Subject|7
7345333|NCT00910910|11584071|FG001|Overall Study|Withdrawal by Subject|5
7345334|NCT00910910|11584070|FG000|Overall Study|Lost to Follow-up|2
7345335|NCT00910910|11584071|FG001|Overall Study|Lost to Follow-up|2
7345336|NCT00910910|11584070|FG000|Overall Study|Death|9
7345337|NCT00910910|11584071|FG001|Overall Study|Death|3
7345338|NCT00910910|11584070|FG000|Overall Study|Protocol Violation|2
7345339|NCT00910910|11584071|FG001|Overall Study|Protocol Violation|2
7345340|NCT00910910|11584070|FG000|Overall Study|Completed 13 cycles of treatment|0
7345341|NCT00910910|11584071|FG001|Overall Study|Completed 13 cycles of treatment|118
7345342|NCT00910910|11584070|FG000|Overall Study|Other|114
7345343|NCT00910910|11584071|FG001|Overall Study|Other|32
7345344|NCT00910910|11584070|FG000|Overall Study|Untreated before cycle 1|1
7345345|NCT00910910|11584071|FG001|Overall Study|Untreated before cycle 1|2
7345346|NCT00910962|11584080|FG000|Overall Study|Adverse Event|5
7345347|NCT00910962|11584081|FG001|Overall Study|Adverse Event|20
7345348|NCT00910962|11584082|FG002|Overall Study|Adverse Event|17
7345349|NCT00910962|11584080|FG000|Overall Study|Protocol Violation|1
7345350|NCT00910962|11584081|FG001|Overall Study|Protocol Violation|3
7345351|NCT00910962|11584082|FG002|Overall Study|Protocol Violation|3
7345352|NCT00910962|11584080|FG000|Overall Study|Lost to Follow-up|0
7345353|NCT00910962|11584081|FG001|Overall Study|Lost to Follow-up|3
7345354|NCT00910962|11584082|FG002|Overall Study|Lost to Follow-up|1
7345355|NCT00910962|11584080|FG000|Overall Study|Physician Decision|0
7345356|NCT00910962|11584081|FG001|Overall Study|Physician Decision|6
7345357|NCT00910962|11584082|FG002|Overall Study|Physician Decision|6
7345358|NCT00910962|11584080|FG000|Overall Study|Withdrawal by Subject|25
7345359|NCT00910962|11584081|FG001|Overall Study|Withdrawal by Subject|32
7345360|NCT00910962|11584082|FG002|Overall Study|Withdrawal by Subject|32
7345361|NCT00910962|11584080|FG000|Overall Study|Reached defined stopping criteria|12
7345362|NCT00910962|11584081|FG001|Overall Study|Reached defined stopping criteria|14
7345363|NCT00910962|11584082|FG002|Overall Study|Reached defined stopping criteria|17
7345364|NCT00910988|11584096|FG000|Overall Study|Lost to Follow-up|2
7345365|NCT00910988|11584097|FG001|Overall Study|Lost to Follow-up|4
7345366|NCT00910988|11584098|FG002|Overall Study|Lost to Follow-up|3
7345367|NCT00910988|11584099|FG003|Overall Study|Lost to Follow-up|0
7345368|NCT00911144|11584127|FG000|Overall Study|Withdrawal by Subject|16
7345369|NCT00911144|11584128|FG001|Overall Study|Withdrawal by Subject|5
7458763|NCT01810380|11752913|FG001|Overall Study|Withdrawal by Subject|0
7458764|NCT01810380|11752914|FG002|Overall Study|Withdrawal by Subject|6
7458765|NCT01810380|11752912|FG000|Overall Study|Administrative or other reasons|11
7458766|NCT01810380|11752913|FG001|Overall Study|Administrative or other reasons|13
7458767|NCT01810380|11752914|FG002|Overall Study|Administrative or other reasons|9
7458768|NCT01810432|11752922|FG000|Washout|Protocol Violation|0
7345370|NCT00911157|11584136|FG000|Overall Study|Adverse Event|4
7345371|NCT00911157|11584137|FG001|Overall Study|Adverse Event|1
7345372|NCT00911157|11584136|FG000|Overall Study|Withdrawal by Subject|1
7345373|NCT00911157|11584137|FG001|Overall Study|Withdrawal by Subject|1
7345374|NCT00911157|11584136|FG000|Overall Study|Need for prohibited drug (heparin)|1
7345375|NCT00911157|11584137|FG001|Overall Study|Need for prohibited drug (heparin)|0
7345376|NCT00911157|11584136|FG000|Overall Study|Need to treat for lung cancer|1
7345377|NCT00911157|11584137|FG001|Overall Study|Need to treat for lung cancer|0
7345378|NCT00911170|11584145|FG000|Treatment Period|Randomized in error|1
7345379|NCT00911170|11584146|FG001|Treatment Period|Randomized in error|1
7345380|NCT00911170|11584145|FG000|Treatment Period|Ineligibility determined|1
7458769|NCT01810432|11752923|FG001|Washout|Protocol Violation|1
7458770|NCT01810432|11752922|FG000|Washout|Adverse Event|1
7458771|NCT01810432|11752923|FG001|Washout|Adverse Event|0
7458772|NCT01810432|11752922|FG000|Period 2|Withdrawal by Subject|2
7458773|NCT01810432|11752923|FG001|Period 2|Withdrawal by Subject|1
7458774|NCT01810432|11752922|FG000|Period 2|Physician Decision|1
7458775|NCT01810432|11752923|FG001|Period 2|Physician Decision|0
7345381|NCT00911170|11584146|FG001|Treatment Period|Ineligibility determined|3
7345382|NCT00911170|11584145|FG000|Treatment Period|Protocol deviation|1
7345383|NCT00911170|11584146|FG001|Treatment Period|Protocol deviation|2
7345384|NCT00911170|11584145|FG000|Treatment Period|Adverse Event|9
7345385|NCT00911170|11584146|FG001|Treatment Period|Adverse Event|10
7345386|NCT00911170|11584145|FG000|Treatment Period|Withdrawal by Subject|4
7345387|NCT00911170|11584146|FG001|Treatment Period|Withdrawal by Subject|4
7345388|NCT00911170|11584145|FG000|Treatment Period|Disease progression|0
7345389|NCT00911170|11584146|FG001|Treatment Period|Disease progression|2
7345390|NCT00911170|11584145|FG000|Treatment Period|Physician Decision|5
7345391|NCT00911170|11584146|FG001|Treatment Period|Physician Decision|5
7345392|NCT00911170|11584145|FG000|Treatment Period|Lost to Follow-up|0
7345393|NCT00911170|11584146|FG001|Treatment Period|Lost to Follow-up|1
7345394|NCT00911170|11584145|FG000|Treatment Period|Death|6
7345395|NCT00911170|11584146|FG001|Treatment Period|Death|9
7345396|NCT00911170|11584145|FG000|Long Term Follow-Up|Continuing in study|274
7345397|NCT00911170|11584146|FG001|Long Term Follow-Up|Continuing in study|269
7345398|NCT00911170|11584145|FG000|Long Term Follow-Up|Withdrawal by Subject|20
7345399|NCT00911170|11584146|FG001|Long Term Follow-Up|Withdrawal by Subject|21
7345400|NCT00911170|11584145|FG000|Long Term Follow-Up|Physician Decision|5
7345401|NCT00911170|11584146|FG001|Long Term Follow-Up|Physician Decision|4
7345402|NCT00911170|11584145|FG000|Long Term Follow-Up|Lost to Follow-up|8
7345403|NCT00911170|11584146|FG001|Long Term Follow-Up|Lost to Follow-up|7
7345404|NCT00911170|11584145|FG000|Long Term Follow-Up|Death|116
7345405|NCT00911170|11584146|FG001|Long Term Follow-Up|Death|121
7345406|NCT00911300|11584154|FG000|Overall Study|Primary Endpoint Component Occurred|1
7345407|NCT00911300|11584155|FG001|Overall Study|Primary Endpoint Component Occurred|2
7345408|NCT00911300|11584154|FG000|Overall Study|Death|1
7345409|NCT00911300|11584155|FG001|Overall Study|Death|0
7345410|NCT00911300|11584154|FG000|Overall Study|Thrombus Persistant in Second TEE|3
7345411|NCT00911300|11584155|FG001|Overall Study|Thrombus Persistant in Second TEE|7
7345412|NCT00911300|11584154|FG000|Overall Study|Adverse Event|14
7345413|NCT00911300|11584155|FG001|Overall Study|Adverse Event|6
7345414|NCT00911300|11584154|FG000|Overall Study|Protocol Violation|3
7345415|NCT00911300|11584155|FG001|Overall Study|Protocol Violation|2
7345416|NCT00911300|11584154|FG000|Overall Study|Consent Withdrawn|4
7345417|NCT00911300|11584155|FG001|Overall Study|Consent Withdrawn|12
7345418|NCT00911300|11584154|FG000|Overall Study|Coronary Angiography Performed|1
7345419|NCT00911300|11584155|FG001|Overall Study|Coronary Angiography Performed|0
7345420|NCT00911300|11584154|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7345421|NCT00911300|11584155|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
7345422|NCT00911300|11584154|FG000|Overall Study|Received Commercial Treatment|1
7345423|NCT00911300|11584155|FG001|Overall Study|Received Commercial Treatment|0
7345424|NCT00911300|11584154|FG000|Overall Study|Recurrent Tachyarrhythmia|1
7345425|NCT00911300|11584155|FG001|Overall Study|Recurrent Tachyarrhythmia|1
7345426|NCT00911300|11584154|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7345427|NCT00911300|11584155|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
7345428|NCT00911300|11584154|FG000|Overall Study|Nurse Unavailable in Participant's City|1
7345429|NCT00911300|11584155|FG001|Overall Study|Nurse Unavailable in Participant's City|0
7345430|NCT00911300|11584154|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
7345431|NCT00911300|11584155|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
7345432|NCT00911300|11584154|FG000|Overall Study|Participant Could Not Stay in Hospital|0
7345433|NCT00911300|11584155|FG001|Overall Study|Participant Could Not Stay in Hospital|1
7345434|NCT00911300|11584154|FG000|Overall Study|Investigator's Decision; New AF Episode|0
7345435|NCT00911300|11584155|FG001|Overall Study|Investigator's Decision; New AF Episode|1
7345436|NCT00911300|11584154|FG000|Overall Study|International Normalized Ratio Too High|0
7345437|NCT00911300|11584155|FG001|Overall Study|International Normalized Ratio Too High|1
7345438|NCT00911300|11584154|FG000|Overall Study|Participant Refused Hospital Consulation|0
7345439|NCT00911300|11584155|FG001|Overall Study|Participant Refused Hospital Consulation|1
7345440|NCT00911300|11584154|FG000|Overall Study|Underlying Disease (Myocarditis)|0
7345441|NCT00911300|11584155|FG001|Overall Study|Underlying Disease (Myocarditis)|1
7345442|NCT00911300|11584154|FG000|Overall Study|Physician Decision|0
7345443|NCT00911300|11584155|FG001|Overall Study|Physician Decision|1
7345444|NCT00911300|11584154|FG000|Overall Study|Treatment Stopped by Mistake|0
7345445|NCT00911300|11584155|FG001|Overall Study|Treatment Stopped by Mistake|1
7345446|NCT00911300|11584154|FG000|Overall Study|Randomized; No Study Medication Received|0
7345447|NCT00911300|11584155|FG001|Overall Study|Randomized; No Study Medication Received|2
7345448|NCT00911508|11584172|FG000|Overall Study|Lost to Follow-up|27
7345449|NCT00911508|11584173|FG001|Overall Study|Lost to Follow-up|18
7345450|NCT00911508|11584172|FG000|Overall Study|Withdrawal by Subject|79
7345451|NCT00911508|11584173|FG001|Overall Study|Withdrawal by Subject|112
7345452|NCT00911534|11584181|FG000|Overall Study|Adverse Event|4
7458776|NCT01810432|11752922|FG000|Period 2|Lost to Follow-up|1
7458777|NCT01810432|11752923|FG001|Period 2|Lost to Follow-up|1
7458778|NCT01810783|11752942|FG000|Overall Study|Adverse Event|32
7458779|NCT01810783|11752942|FG000|Overall Study|Withdrawal by Subject|22
7458780|NCT01810783|11752942|FG000|Overall Study|Lack of Efficacy|12
7458781|NCT01810783|11752942|FG000|Overall Study|Lost to Follow-up|10
7345453|NCT00911534|11584182|FG001|Overall Study|Adverse Event|4
7458782|NCT01810783|11752942|FG000|Overall Study|Protocol Violation|5
7458783|NCT01810783|11752942|FG000|Overall Study|Non-compliance with IMP|4
7458784|NCT01810783|11752942|FG000|Overall Study|Adminstrative or other reason(s)|23
7458785|NCT01810783|11752942|FG000|Overall Study|Enrolled, not treated|1
7458786|NCT01810939|11752946|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
7458787|NCT01810939|11752947|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
7458788|NCT01810939|11752948|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
7458789|NCT01810939|11752946|FG000|Part A Treatment Period|Protocol Violation|2
7458790|NCT01810939|11752947|FG001|Part A Treatment Period|Protocol Violation|0
7458791|NCT01810939|11752948|FG002|Part A Treatment Period|Protocol Violation|0
7458792|NCT01810939|11752946|FG000|Part A Treatment Period|Adverse Event|10
7458793|NCT01810939|11752947|FG001|Part A Treatment Period|Adverse Event|0
7458794|NCT01810939|11752948|FG002|Part A Treatment Period|Adverse Event|0
7458795|NCT01810939|11752946|FG000|Part A Treatment Period|Withdrawal by Subject|5
7458796|NCT01810939|11752947|FG001|Part A Treatment Period|Withdrawal by Subject|0
7458797|NCT01810939|11752948|FG002|Part A Treatment Period|Withdrawal by Subject|0
7458798|NCT01810939|11752946|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
7458799|NCT01810939|11752947|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
7458800|NCT01810939|11752948|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
7458801|NCT01810939|11752946|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
7458802|NCT01810939|11752947|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
7458803|NCT01810939|11752948|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
7458804|NCT01810939|11752946|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
7458805|NCT01810939|11752947|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
7458806|NCT01810939|11752948|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
7458807|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
7458808|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7458809|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
7458810|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7458811|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
7458812|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
7345454|NCT00911534|11584181|FG000|Overall Study|Lost to Follow-up|2
7345455|NCT00911534|11584182|FG001|Overall Study|Lost to Follow-up|4
7345456|NCT00911534|11584181|FG000|Overall Study|Withdrawal by Subject|2
7345457|NCT00911534|11584182|FG001|Overall Study|Withdrawal by Subject|1
7345458|NCT00911534|11584181|FG000|Overall Study|Lack of Efficacy|4
7345459|NCT00911534|11584182|FG001|Overall Study|Lack of Efficacy|1
7345460|NCT00911534|11584181|FG000|Overall Study|Withdrawal of consent|1
7345461|NCT00911534|11584182|FG001|Overall Study|Withdrawal of consent|4
7345462|NCT00911534|11584181|FG000|Overall Study|Other|2
7345463|NCT00911534|11584182|FG001|Overall Study|Other|2
7345464|NCT00911625|11584204|FG000|Overall Study|Lost to Follow-up|7
7345465|NCT00911625|11584205|FG001|Overall Study|Lost to Follow-up|0
7345466|NCT00911768|11584222|FG000|Overall Study|Protocol Violation|5
7345467|NCT00911768|11584223|FG001|Overall Study|Protocol Violation|4
7345468|NCT00911768|11584222|FG000|Overall Study|Withdrawal by Subject|1
7345469|NCT00911768|11584223|FG001|Overall Study|Withdrawal by Subject|0
7345470|NCT00911807|11584232|FG000|Overall Study|Adverse Event|2
7345471|NCT00911807|11584233|FG001|Overall Study|Adverse Event|1
7345472|NCT00911807|11584234|FG002|Overall Study|Adverse Event|5
7345473|NCT00911807|11584232|FG000|Overall Study|Death|0
7345474|NCT00911807|11584233|FG001|Overall Study|Death|0
7345475|NCT00911807|11584234|FG002|Overall Study|Death|1
7345476|NCT00911807|11584232|FG000|Overall Study|Protocol Violation|6
7345477|NCT00911807|11584233|FG001|Overall Study|Protocol Violation|4
7345478|NCT00911807|11584234|FG002|Overall Study|Protocol Violation|9
7345479|NCT00911807|11584232|FG000|Overall Study|Withdrawal by Subject|8
7345480|NCT00911807|11584233|FG001|Overall Study|Withdrawal by Subject|10
7345481|NCT00911807|11584234|FG002|Overall Study|Withdrawal by Subject|7
7345482|NCT00911807|11584232|FG000|Overall Study|Organizational reasons|1
7345483|NCT00911807|11584233|FG001|Overall Study|Organizational reasons|3
7345484|NCT00911807|11584234|FG002|Overall Study|Organizational reasons|1
7345485|NCT00911820|11584244|FG000|Overall Study|RECIST progression|12
7345486|NCT00911820|11584245|FG001|Overall Study|RECIST progression|8
7345487|NCT00911820|11584244|FG000|Overall Study|Adverse Event|8
7345488|NCT00911820|11584245|FG001|Overall Study|Adverse Event|8
7345489|NCT00911820|11584244|FG000|Overall Study|Clinical Progression|7
7345490|NCT00911820|11584245|FG001|Overall Study|Clinical Progression|5
7345491|NCT00911820|11584244|FG000|Overall Study|Physician Decision|5
7345492|NCT00911820|11584245|FG001|Overall Study|Physician Decision|9
7345493|NCT00911820|11584244|FG000|Overall Study|Decline in Performance Status|4
7345494|NCT00911820|11584245|FG001|Overall Study|Decline in Performance Status|2
7458813|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
7458814|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7345495|NCT00911820|11584244|FG000|Overall Study|Withdrawal by Subject|3
7345496|NCT00911820|11584245|FG001|Overall Study|Withdrawal by Subject|4
7345497|NCT00911820|11584244|FG000|Overall Study|Death|1
7345498|NCT00911820|11584245|FG001|Overall Study|Death|2
7345499|NCT00911820|11584244|FG000|Overall Study|Pursue surgery|1
7345500|NCT00911820|11584245|FG001|Overall Study|Pursue surgery|1
7345501|NCT00911820|11584244|FG000|Overall Study|Pursue Radiation|1
7345502|NCT00911820|11584245|FG001|Overall Study|Pursue Radiation|0
7345503|NCT00911820|11584244|FG000|Overall Study|Still on Therapy|2
7345504|NCT00911820|11584245|FG001|Overall Study|Still on Therapy|2
7345505|NCT00911820|11584244|FG000|Overall Study|Pathology Not Confirmed|1
7345506|NCT00911820|11584245|FG001|Overall Study|Pathology Not Confirmed|0
7345507|NCT00911820|11584244|FG000|Overall Study|Withdraw before Receive Treatment|0
7345508|NCT00911820|11584245|FG001|Overall Study|Withdraw before Receive Treatment|2
7345509|NCT00911859|11584254|FG000|Treatment Period|Adverse Event|3
7345510|NCT00911859|11584255|FG001|Treatment Period|Adverse Event|3
7345511|NCT00911859|11584256|FG002|Treatment Period|Adverse Event|7
7345512|NCT00911859|11584254|FG000|Treatment Period|Death|1
7345513|NCT00911859|11584255|FG001|Treatment Period|Death|3
7345514|NCT00911859|11584256|FG002|Treatment Period|Death|5
7345515|NCT00911859|11584254|FG000|Treatment Period|Lack of Efficacy|1
7345516|NCT00911859|11584255|FG001|Treatment Period|Lack of Efficacy|7
7345517|NCT00911859|11584256|FG002|Treatment Period|Lack of Efficacy|5
7345518|NCT00911859|11584254|FG000|Treatment Period|Physician Decision|3
7345519|NCT00911859|11584255|FG001|Treatment Period|Physician Decision|3
7345520|NCT00911859|11584256|FG002|Treatment Period|Physician Decision|3
7345521|NCT00911859|11584254|FG000|Treatment Period|Withdrawal by Subject|0
7345522|NCT00911859|11584255|FG001|Treatment Period|Withdrawal by Subject|4
7569125|NCT03437733|11945013|FG000|Overall Study|Eligibility criteria not met|0
7569126|NCT03437733|11945014|FG001|Overall Study|Eligibility criteria not met|3
7569127|NCT03438006|11945023|FG000|Overall Study|Adverse Event|1
7345523|NCT00911859|11584256|FG002|Treatment Period|Withdrawal by Subject|5
7458815|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
7458816|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Death|0
7458817|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Death|0
7458818|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Death|1
7458819|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7458820|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
7458821|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
7458822|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
7458823|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7458824|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
7345524|NCT00911859|11584254|FG000|Treatment Period|Did not receive study treatment|0
7345525|NCT00911859|11584255|FG001|Treatment Period|Did not receive study treatment|1
7345526|NCT00911859|11584256|FG002|Treatment Period|Did not receive study treatment|0
7345527|NCT00911859|11584254|FG000|Maintainance Period|Lack of Efficacy|0
7345528|NCT00911859|11584255|FG001|Maintainance Period|Lack of Efficacy|0
7345529|NCT00911859|11584256|FG002|Maintainance Period|Lack of Efficacy|9
7345530|NCT00911859|11584254|FG000|Maintainance Period|Physician Decision|0
7345531|NCT00911859|11584255|FG001|Maintainance Period|Physician Decision|0
7345532|NCT00911859|11584256|FG002|Maintainance Period|Physician Decision|9
7345533|NCT00911859|11584254|FG000|Maintainance Period|Withdrawal by Subject|0
7345534|NCT00911859|11584255|FG001|Maintainance Period|Withdrawal by Subject|0
7345535|NCT00911859|11584256|FG002|Maintainance Period|Withdrawal by Subject|3
7345536|NCT00911859|11584254|FG000|Follow-up Period|Death|5
7345537|NCT00911859|11584255|FG001|Follow-up Period|Death|8
7345538|NCT00911859|11584256|FG002|Follow-up Period|Death|10
7345539|NCT00911859|11584254|FG000|Follow-up Period|Lost to Follow-up|1
7345540|NCT00911859|11584255|FG001|Follow-up Period|Lost to Follow-up|1
7345541|NCT00911859|11584256|FG002|Follow-up Period|Lost to Follow-up|0
7345542|NCT00911859|11584254|FG000|Follow-up Period|Withdrawal by Subject|0
7345543|NCT00911859|11584255|FG001|Follow-up Period|Withdrawal by Subject|4
7345544|NCT00911859|11584256|FG002|Follow-up Period|Withdrawal by Subject|4
7345545|NCT00911859|11584254|FG000|Follow-up Period|Study terminated by sponsor|5
7345546|NCT00911859|11584255|FG001|Follow-up Period|Study terminated by sponsor|33
7345547|NCT00911859|11584256|FG002|Follow-up Period|Study terminated by sponsor|27
7345548|NCT00911937|11584270|FG000|Overall Study|Death|1
7345549|NCT00911937|11584271|FG001|Overall Study|Death|0
7345550|NCT00911937|11584270|FG000|Overall Study|Lost to Follow-up|8
7458825|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
7458826|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
7458827|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
7569128|NCT03438006|11945023|FG000|Overall Study|Lost to Follow-up|67
7345551|NCT00911937|11584271|FG001|Overall Study|Lost to Follow-up|5
7345552|NCT00911937|11584270|FG000|Overall Study|Withdrawal by Subject|10
7345553|NCT00911937|11584271|FG001|Overall Study|Withdrawal by Subject|7
7345554|NCT00911937|11584270|FG000|Overall Study|Withdrawn due to pregnancy|1
7345555|NCT00911937|11584271|FG001|Overall Study|Withdrawn due to pregnancy|0
7345556|NCT00911937|11584270|FG000|Overall Study|Adverse Event|11
7345557|NCT00911937|11584271|FG001|Overall Study|Adverse Event|25
7458828|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
7458829|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
7458830|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
7458831|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
7458832|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
7458833|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
7569129|NCT03438006|11945023|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
7345558|NCT00911937|11584270|FG000|Overall Study|Lack of Efficacy|11
7345559|NCT00911937|11584271|FG001|Overall Study|Lack of Efficacy|6
7345560|NCT00911937|11584270|FG000|Overall Study|Did not meet inclusion criteria|9
7345561|NCT00911937|11584271|FG001|Overall Study|Did not meet inclusion criteria|11
7345562|NCT00911937|11584270|FG000|Overall Study|Protocol Violation|14
7345563|NCT00911937|11584271|FG001|Overall Study|Protocol Violation|23
7345564|NCT00911937|11584270|FG000|Overall Study|Randomized but not treated|13
7345565|NCT00911937|11584271|FG001|Overall Study|Randomized but not treated|13
7345566|NCT00911937|11584270|FG000|Overall Study|Other|9
7345567|NCT00911937|11584271|FG001|Overall Study|Other|5
7345568|NCT00911989|11584277|FG000|Overall Study|Adverse Event|1
7345569|NCT00912015|11584290|FG000|Overall Study|Lack of Efficacy|1
7345570|NCT00912015|11584291|FG001|Overall Study|Lack of Efficacy|0
7345571|NCT00912015|11584292|FG002|Overall Study|Lack of Efficacy|0
7345572|NCT00912015|11584293|FG003|Overall Study|Lack of Efficacy|0
7458834|NCT01810939|11752946|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7458835|NCT01810939|11752947|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
7458836|NCT01810939|11752948|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
7468239|NCT01908803|11768921|FG001|Overall Study|Physician Decision|1
7468240|NCT01908803|11768920|FG000|Overall Study|Withdrawal by Subject|1
7468241|NCT01908803|11768921|FG001|Overall Study|Withdrawal by Subject|0
7468242|NCT01908803|11768920|FG000|Overall Study|Randomization Error|1
7468243|NCT01908803|11768921|FG001|Overall Study|Randomization Error|0
7468244|NCT01908803|11768920|FG000|Overall Study|Adverse Event (pre-treatment)|1
7468245|NCT01908803|11768921|FG001|Overall Study|Adverse Event (pre-treatment)|0
7468246|NCT01908816|11768932|FG000|Overall Study|Subject's no longer requires study drug|0
7468247|NCT01908816|11768933|FG001|Overall Study|Subject's no longer requires study drug|0
7468248|NCT01908816|11768934|FG002|Overall Study|Subject's no longer requires study drug|0
7468249|NCT01908816|11768935|FG003|Overall Study|Subject's no longer requires study drug|1
7468250|NCT01908816|11768932|FG000|Overall Study|Protocol deviation|1
7468251|NCT01908816|11768933|FG001|Overall Study|Protocol deviation|2
7468252|NCT01908816|11768934|FG002|Overall Study|Protocol deviation|1
7468253|NCT01908816|11768935|FG003|Overall Study|Protocol deviation|1
7468254|NCT01908816|11768932|FG000|Overall Study|Withdrawal by Subject|0
7468255|NCT01908816|11768933|FG001|Overall Study|Withdrawal by Subject|4
7468256|NCT01908816|11768934|FG002|Overall Study|Withdrawal by Subject|2
7468257|NCT01908816|11768935|FG003|Overall Study|Withdrawal by Subject|2
7468258|NCT01908816|11768932|FG000|Overall Study|Lost to Follow-up|3
7468259|NCT01908816|11768933|FG001|Overall Study|Lost to Follow-up|5
7468260|NCT01908816|11768934|FG002|Overall Study|Lost to Follow-up|4
7468261|NCT01908816|11768935|FG003|Overall Study|Lost to Follow-up|2
7468262|NCT01908816|11768932|FG000|Overall Study|Death|1
7468263|NCT01908816|11768933|FG001|Overall Study|Death|0
7468264|NCT01908816|11768934|FG002|Overall Study|Death|7
7468265|NCT01908816|11768935|FG003|Overall Study|Death|1
7468266|NCT01908816|11768932|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7468267|NCT01908816|11768933|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7468268|NCT01908816|11768934|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7468269|NCT01908816|11768935|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7468270|NCT01908816|11768932|FG000|Overall Study|Early termination|87
7468271|NCT01908816|11768933|FG001|Overall Study|Early termination|60
7468272|NCT01908816|11768934|FG002|Overall Study|Early termination|43
7468273|NCT01908816|11768935|FG003|Overall Study|Early termination|28
7468274|NCT01908829|11768951|FG000|Overall Study|Adverse Event|13
7468275|NCT01908829|11768952|FG001|Overall Study|Adverse Event|11
7468276|NCT01908829|11768953|FG002|Overall Study|Adverse Event|13
7468277|NCT01908829|11768951|FG000|Overall Study|Lost to Follow-up|4
7468278|NCT01908829|11768952|FG001|Overall Study|Lost to Follow-up|2
7468279|NCT01908829|11768953|FG002|Overall Study|Lost to Follow-up|1
7468280|NCT01908829|11768951|FG000|Overall Study|Randomized no double-blind drug received|1
7468281|NCT01908829|11768952|FG001|Overall Study|Randomized no double-blind drug received|0
7468282|NCT01908829|11768953|FG002|Overall Study|Randomized no double-blind drug received|1
7468283|NCT01908829|11768951|FG000|Overall Study|Discontinued (no EoT page)|2
7468284|NCT01908829|11768952|FG001|Overall Study|Discontinued (no EoT page)|0
7468285|NCT01908829|11768953|FG002|Overall Study|Discontinued (no EoT page)|0
7468286|NCT01908829|11768951|FG000|Overall Study|Miscellaneous|0
7468287|NCT01908829|11768952|FG001|Overall Study|Miscellaneous|2
7468288|NCT01908829|11768953|FG002|Overall Study|Miscellaneous|0
7468289|NCT01908829|11768951|FG000|Overall Study|Protocol Violation|2
7468290|NCT01908829|11768952|FG001|Overall Study|Protocol Violation|2
7468291|NCT01908829|11768953|FG002|Overall Study|Protocol Violation|0
7468292|NCT01908829|11768951|FG000|Overall Study|Lack of Efficacy|1
7468293|NCT01908829|11768952|FG001|Overall Study|Lack of Efficacy|3
7569130|NCT03438006|11945023|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
7458837|NCT01811186|11753010|FG000|Overall Study|Adverse Event|54
7458838|NCT01811186|11753011|FG001|Overall Study|Adverse Event|38
7458839|NCT01811186|11753010|FG000|Overall Study|Protocol Violation|5
7458840|NCT01811186|11753011|FG001|Overall Study|Protocol Violation|6
7458841|NCT01811186|11753010|FG000|Overall Study|Withdrawal by Subject|5
7458842|NCT01811186|11753011|FG001|Overall Study|Withdrawal by Subject|10
7458843|NCT01811186|11753010|FG000|Overall Study|Lack of Efficacy|3
7458844|NCT01811186|11753011|FG001|Overall Study|Lack of Efficacy|6
7345573|NCT00912015|11584290|FG000|Overall Study|Withdrawal by Subject|8
7345574|NCT00912015|11584291|FG001|Overall Study|Withdrawal by Subject|8
7345575|NCT00912015|11584292|FG002|Overall Study|Withdrawal by Subject|3
7345576|NCT00912015|11584293|FG003|Overall Study|Withdrawal by Subject|0
7345577|NCT00912015|11584290|FG000|Overall Study|Protocol Violation|1
7345578|NCT00912015|11584291|FG001|Overall Study|Protocol Violation|0
7345579|NCT00912015|11584292|FG002|Overall Study|Protocol Violation|0
7345580|NCT00912015|11584293|FG003|Overall Study|Protocol Violation|1
7345581|NCT00912015|11584290|FG000|Overall Study|Adverse Event|6
7458845|NCT01811186|11753010|FG000|Overall Study|Lost to Follow-up|4
7458846|NCT01811186|11753011|FG001|Overall Study|Lost to Follow-up|2
7458847|NCT01811225|11753025|FG000|Treatment Period 1|Adverse Event|2
7458848|NCT01811225|11753026|FG001|Treatment Period 1|Adverse Event|3
7458849|NCT01811225|11753025|FG000|Treatment Period 1|Lost to Follow-up|12
7458850|NCT01811225|11753026|FG001|Treatment Period 1|Lost to Follow-up|8
7458851|NCT01811225|11753025|FG000|Treatment Period 1|transporation|1
7458852|NCT01811225|11753026|FG001|Treatment Period 1|transporation|0
7458853|NCT01811225|11753025|FG000|Treatment Period 1|unable to remain smoke free overnight|10
7458854|NCT01811225|11753026|FG001|Treatment Period 1|unable to remain smoke free overnight|6
7458855|NCT01811225|11753025|FG000|Treatment Period 2|Lost to Follow-up|1
7458856|NCT01811225|11753026|FG001|Treatment Period 2|Lost to Follow-up|2
7458857|NCT01811225|11753025|FG000|Treatment Period 2|unable to remain smoke free overnight|3
7458858|NCT01811225|11753026|FG001|Treatment Period 2|unable to remain smoke free overnight|4
7458859|NCT01811238|11753032|FG000|Overall Study|Withdrawal by Subject|42
7458860|NCT01811238|11753032|FG000|Overall Study|Adverse Event|25
7458861|NCT01811238|11753032|FG000|Overall Study|Protocol Violation|4
7345582|NCT00912015|11584291|FG001|Overall Study|Adverse Event|0
7345583|NCT00912015|11584292|FG002|Overall Study|Adverse Event|0
7345584|NCT00912015|11584293|FG003|Overall Study|Adverse Event|1
7345585|NCT00912028|11584306|FG000|Overall Study|Lost to Follow-up|2
7345586|NCT00912028|11584307|FG001|Overall Study|Lost to Follow-up|3
7345587|NCT00912028|11584308|FG002|Overall Study|Lost to Follow-up|0
7345588|NCT00912028|11584309|FG003|Overall Study|Lost to Follow-up|1
7345589|NCT00912028|11584310|FG004|Overall Study|Lost to Follow-up|3
7345590|NCT00912028|11584306|FG000|Overall Study|Withdrawal by Subject|3
7345591|NCT00912028|11584307|FG001|Overall Study|Withdrawal by Subject|0
7345592|NCT00912028|11584308|FG002|Overall Study|Withdrawal by Subject|0
7345593|NCT00912028|11584309|FG003|Overall Study|Withdrawal by Subject|0
7345594|NCT00912028|11584310|FG004|Overall Study|Withdrawal by Subject|0
7345595|NCT00912093|11584325|FG000|The Controlled Phase|Death|0
7345596|NCT00912093|11584326|FG001|The Controlled Phase|Death|1
7345597|NCT00912093|11584327|FG002|The Controlled Phase|Death|0
7345598|NCT00912093|11584328|FG003|The Controlled Phase|Death|0
7345599|NCT00912093|11584329|FG004|The Controlled Phase|Death|0
7345600|NCT00912093|11584325|FG000|The Controlled Phase|Medical Condition|0
7345601|NCT00912093|11584326|FG001|The Controlled Phase|Medical Condition|1
7345602|NCT00912093|11584327|FG002|The Controlled Phase|Medical Condition|0
7345603|NCT00912093|11584328|FG003|The Controlled Phase|Medical Condition|0
7345604|NCT00912093|11584329|FG004|The Controlled Phase|Medical Condition|0
7345605|NCT00912093|11584325|FG000|The Controlled Phase|Lost to Follow-up|0
7345606|NCT00912093|11584326|FG001|The Controlled Phase|Lost to Follow-up|0
7345607|NCT00912093|11584327|FG002|The Controlled Phase|Lost to Follow-up|0
7345608|NCT00912093|11584328|FG003|The Controlled Phase|Lost to Follow-up|0
7345609|NCT00912093|11584329|FG004|The Controlled Phase|Lost to Follow-up|1
7345610|NCT00912197|11584339|FG000|Overall Study|Withdrawal by Subject|3
7345611|NCT00912197|11584340|FG001|Overall Study|Withdrawal by Subject|3
7345612|NCT00912288|11584350|FG000|Overall Study|Death|0
7345613|NCT00912288|11584351|FG001|Overall Study|Death|1
7345614|NCT00912288|11584350|FG000|Overall Study|Adverse Event|1
7345615|NCT00912288|11584351|FG001|Overall Study|Adverse Event|1
7345616|NCT00912288|11584350|FG000|Overall Study|Lost to Follow-up|1
7345617|NCT00912288|11584351|FG001|Overall Study|Lost to Follow-up|0
7345618|NCT00912288|11584350|FG000|Overall Study|Protocol Violation|1
7345619|NCT00912288|11584351|FG001|Overall Study|Protocol Violation|0
7345620|NCT00912288|11584350|FG000|Overall Study|Withdrawal by Subject|3
7345621|NCT00912288|11584351|FG001|Overall Study|Withdrawal by Subject|3
7345622|NCT00912288|11584350|FG000|Overall Study|Study terminated by sponsor|34
7345623|NCT00912288|11584351|FG001|Overall Study|Study terminated by sponsor|35
7345624|NCT00912288|11584350|FG000|Overall Study|Other|1
7345625|NCT00912288|11584351|FG001|Overall Study|Other|0
7458862|NCT01811238|11753032|FG000|Overall Study|Lack of Efficacy|4
7458863|NCT01811238|11753032|FG000|Overall Study|subject refused study medication|6
7458864|NCT01811472|11753073|FG000|Overall Study|Adverse Event|1
7345626|NCT00912340|11584373|FG000|Overall Study|Adverse Event|2
7345627|NCT00912340|11584374|FG001|Overall Study|Adverse Event|4
7345628|NCT00912340|11584375|FG002|Overall Study|Adverse Event|0
7345629|NCT00912340|11584373|FG000|Overall Study|Protocol revised to remove arm|0
7345630|NCT00912340|11584374|FG001|Overall Study|Protocol revised to remove arm|0
7345631|NCT00912340|11584375|FG002|Overall Study|Protocol revised to remove arm|4
7345632|NCT00912405|11584383|FG000|Overall Study|Lost to Follow-up|5
7345633|NCT00912509|11584389|FG000|Overall Study|Lost to Follow-up|1
7345634|NCT00912509|11584390|FG001|Overall Study|Lost to Follow-up|0
7345635|NCT00912509|11584389|FG000|Overall Study|Lack of Efficacy|4
7345636|NCT00912509|11584390|FG001|Overall Study|Lack of Efficacy|3
7345637|NCT00912743|11584399|FG000|Overall Study|Adverse Event|3
7345638|NCT00912743|11584400|FG001|Overall Study|Adverse Event|1
7345639|NCT00912743|11584399|FG000|Overall Study|Lack of Efficacy|9
7345640|NCT00912743|11584400|FG001|Overall Study|Lack of Efficacy|18
7345641|NCT00912743|11584399|FG000|Overall Study|Toxicity|0
7345642|NCT00912743|11584400|FG001|Overall Study|Toxicity|1
7345643|NCT00912743|11584399|FG000|Overall Study|End of treatment form was not collected|1
7345644|NCT00912743|11584400|FG001|Overall Study|End of treatment form was not collected|0
7345645|NCT00912782|11584408|FG000|Overall Study|Death|2
7345646|NCT00912782|11584409|FG001|Overall Study|Death|1
7345647|NCT00912782|11584408|FG000|Overall Study|Lost to Follow-up|0
7345648|NCT00912782|11584409|FG001|Overall Study|Lost to Follow-up|1
7345649|NCT00912782|11584408|FG000|Overall Study|Did not receive vascular access type|1
7345650|NCT00912782|11584409|FG001|Overall Study|Did not receive vascular access type|2
7345651|NCT00912782|11584408|FG000|Overall Study|Relocated before study completion|0
7345652|NCT00912782|11584409|FG001|Overall Study|Relocated before study completion|1
7345653|NCT00912808|11584426|FG000|First Intervention (6 Weeks)|Adverse Event|2
7345654|NCT00912808|11584427|FG001|First Intervention (6 Weeks)|Adverse Event|1
7345655|NCT00912808|11584426|FG000|Washout|Withdrawal by Subject|0
7345656|NCT00912808|11584427|FG001|Washout|Withdrawal by Subject|1
7345657|NCT00912808|11584426|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7345658|NCT00912808|11584427|FG001|Second Intervention (6 Weeks)|Adverse Event|1
7345659|NCT00912808|11584426|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7345660|NCT00912808|11584427|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7345661|NCT00912912|11584447|FG000|Overall Study|Withdrawal by Subject|1
7345662|NCT00912912|11584447|FG000|Overall Study|Disease Progression|3
7345663|NCT00912964|11584463|FG000|Overall Study|Eligibility criterion not met|1
7345664|NCT00912964|11584464|FG001|Overall Study|Eligibility criterion not met|1
7345665|NCT00912964|11584465|FG002|Overall Study|Eligibility criterion not met|0
7345666|NCT00912964|11584463|FG000|Overall Study|Adverse Event|15
7345667|NCT00912964|11584464|FG001|Overall Study|Adverse Event|18
7345668|NCT00912964|11584465|FG002|Overall Study|Adverse Event|12
7345669|NCT00912964|11584463|FG000|Overall Study|Lack of Efficacy|11
7345670|NCT00912964|11584464|FG001|Overall Study|Lack of Efficacy|4
7345671|NCT00912964|11584465|FG002|Overall Study|Lack of Efficacy|3
7345672|NCT00912964|11584463|FG000|Overall Study|Withdrawal by Subject|20
7345673|NCT00912964|11584464|FG001|Overall Study|Withdrawal by Subject|12
7345674|NCT00912964|11584465|FG002|Overall Study|Withdrawal by Subject|18
7345675|NCT00912964|11584463|FG000|Overall Study|Lost to Follow-up|4
7345676|NCT00912964|11584464|FG001|Overall Study|Lost to Follow-up|3
7345677|NCT00912964|11584465|FG002|Overall Study|Lost to Follow-up|3
7345678|NCT00912964|11584463|FG000|Overall Study|Protocol Violation|5
7345679|NCT00912964|11584464|FG001|Overall Study|Protocol Violation|3
7345680|NCT00912964|11584465|FG002|Overall Study|Protocol Violation|8
7345681|NCT00912964|11584463|FG000|Overall Study|Taking exclusionary medications|7
7345682|NCT00912964|11584464|FG001|Overall Study|Taking exclusionary medications|4
7345683|NCT00912964|11584465|FG002|Overall Study|Taking exclusionary medications|8
7345684|NCT00912964|11584463|FG000|Overall Study|Medical History|1
7345685|NCT00912964|11584464|FG001|Overall Study|Medical History|0
7345686|NCT00912964|11584465|FG002|Overall Study|Medical History|0
7345687|NCT00912964|11584463|FG000|Overall Study|Non-compliance with study procedures|2
7345688|NCT00912964|11584464|FG001|Overall Study|Non-compliance with study procedures|0
7345689|NCT00912964|11584465|FG002|Overall Study|Non-compliance with study procedures|0
7345690|NCT00912964|11584463|FG000|Overall Study|Violation of exclusion criterion|0
7345691|NCT00912964|11584464|FG001|Overall Study|Violation of exclusion criterion|0
7345692|NCT00912964|11584465|FG002|Overall Study|Violation of exclusion criterion|2
7345693|NCT00912964|11584463|FG000|Overall Study|Randomized but never received study drug|0
7345694|NCT00912964|11584464|FG001|Overall Study|Randomized but never received study drug|1
7345695|NCT00912964|11584465|FG002|Overall Study|Randomized but never received study drug|0
7345696|NCT00913380|11584524|FG000|Clinical Outcomes|Lost to Follow-up|6
7345697|NCT00913380|11584525|FG001|Clinical Outcomes|Lost to Follow-up|6
7345698|NCT00913458|11584531|FG000|Phase 1|Non-Responder|54
7345699|NCT00913458|11584532|FG001|Phase 1|Non-Responder|0
7345700|NCT00913458|11584533|FG002|Phase 1|Non-Responder|0
7345701|NCT00913458|11584534|FG003|Phase 1|Non-Responder|0
7345702|NCT00913458|11584535|FG004|Phase 1|Non-Responder|0
7345703|NCT00913458|11584536|FG005|Phase 1|Non-Responder|0
7345704|NCT00913458|11584537|FG006|Phase 1|Non-Responder|0
7345705|NCT00913458|11584531|FG000|Phase 1|Subject Request|17
7345706|NCT00913458|11584532|FG001|Phase 1|Subject Request|0
7345707|NCT00913458|11584533|FG002|Phase 1|Subject Request|0
7345708|NCT00913458|11584534|FG003|Phase 1|Subject Request|0
7345709|NCT00913458|11584535|FG004|Phase 1|Subject Request|0
7345710|NCT00913458|11584536|FG005|Phase 1|Subject Request|0
7345711|NCT00913458|11584537|FG006|Phase 1|Subject Request|0
7345712|NCT00913458|11584531|FG000|Phase 1|Adverse Event|20
7345713|NCT00913458|11584532|FG001|Phase 1|Adverse Event|0
7345714|NCT00913458|11584533|FG002|Phase 1|Adverse Event|0
7345715|NCT00913458|11584534|FG003|Phase 1|Adverse Event|0
7345716|NCT00913458|11584535|FG004|Phase 1|Adverse Event|0
7345717|NCT00913458|11584536|FG005|Phase 1|Adverse Event|0
7345718|NCT00913458|11584537|FG006|Phase 1|Adverse Event|0
7345719|NCT00913458|11584531|FG000|Phase 1|Lost to Follow-up|2
7345720|NCT00913458|11584532|FG001|Phase 1|Lost to Follow-up|0
7345721|NCT00913458|11584533|FG002|Phase 1|Lost to Follow-up|0
7345722|NCT00913458|11584534|FG003|Phase 1|Lost to Follow-up|0
7345723|NCT00913458|11584535|FG004|Phase 1|Lost to Follow-up|0
7345724|NCT00913458|11584536|FG005|Phase 1|Lost to Follow-up|0
7345725|NCT00913458|11584537|FG006|Phase 1|Lost to Follow-up|0
7345726|NCT00913458|11584531|FG000|Phase 1|Protocol Violation|10
7345727|NCT00913458|11584532|FG001|Phase 1|Protocol Violation|0
7345728|NCT00913458|11584533|FG002|Phase 1|Protocol Violation|0
7345729|NCT00913458|11584534|FG003|Phase 1|Protocol Violation|0
7345730|NCT00913458|11584535|FG004|Phase 1|Protocol Violation|0
7345731|NCT00913458|11584536|FG005|Phase 1|Protocol Violation|0
7345732|NCT00913458|11584537|FG006|Phase 1|Protocol Violation|0
7345733|NCT00913458|11584531|FG000|Phase 1|Sponsor|2
7345734|NCT00913458|11584532|FG001|Phase 1|Sponsor|0
7345735|NCT00913458|11584533|FG002|Phase 1|Sponsor|0
7345736|NCT00913458|11584534|FG003|Phase 1|Sponsor|0
7345737|NCT00913458|11584535|FG004|Phase 1|Sponsor|0
7345738|NCT00913458|11584536|FG005|Phase 1|Sponsor|0
7345739|NCT00913458|11584537|FG006|Phase 1|Sponsor|0
7345740|NCT00913458|11584531|FG000|Phase 1|Unsatisfactory Response per Investigator|7
7345741|NCT00913458|11584532|FG001|Phase 1|Unsatisfactory Response per Investigator|0
7345742|NCT00913458|11584533|FG002|Phase 1|Unsatisfactory Response per Investigator|0
7345743|NCT00913458|11584534|FG003|Phase 1|Unsatisfactory Response per Investigator|0
7345744|NCT00913458|11584535|FG004|Phase 1|Unsatisfactory Response per Investigator|0
7345745|NCT00913458|11584536|FG005|Phase 1|Unsatisfactory Response per Investigator|0
7345746|NCT00913458|11584537|FG006|Phase 1|Unsatisfactory Response per Investigator|0
7345747|NCT00913458|11584531|FG000|Phase 2|Non-Responder|0
7345748|NCT00913458|11584532|FG001|Phase 2|Non-Responder|5
7345749|NCT00913458|11584533|FG002|Phase 2|Non-Responder|7
7345750|NCT00913458|11584534|FG003|Phase 2|Non-Responder|12
7345751|NCT00913458|11584535|FG004|Phase 2|Non-Responder|0
7345752|NCT00913458|11584536|FG005|Phase 2|Non-Responder|0
7345753|NCT00913458|11584537|FG006|Phase 2|Non-Responder|0
7345754|NCT00913458|11584531|FG000|Phase 2|Subject Request|0
7345755|NCT00913458|11584532|FG001|Phase 2|Subject Request|0
7345756|NCT00913458|11584533|FG002|Phase 2|Subject Request|1
7345757|NCT00913458|11584534|FG003|Phase 2|Subject Request|2
7345758|NCT00913458|11584535|FG004|Phase 2|Subject Request|0
7345759|NCT00913458|11584536|FG005|Phase 2|Subject Request|0
7345760|NCT00913458|11584537|FG006|Phase 2|Subject Request|0
7345761|NCT00913458|11584531|FG000|Phase 2|Adverse Event|0
7345762|NCT00913458|11584532|FG001|Phase 2|Adverse Event|3
7345763|NCT00913458|11584533|FG002|Phase 2|Adverse Event|0
7345764|NCT00913458|11584534|FG003|Phase 2|Adverse Event|1
7345765|NCT00913458|11584535|FG004|Phase 2|Adverse Event|0
7345766|NCT00913458|11584536|FG005|Phase 2|Adverse Event|0
7345767|NCT00913458|11584537|FG006|Phase 2|Adverse Event|0
7345768|NCT00913458|11584531|FG000|Phase 2|Lost to Follow-up|0
7345769|NCT00913458|11584532|FG001|Phase 2|Lost to Follow-up|0
7345770|NCT00913458|11584533|FG002|Phase 2|Lost to Follow-up|0
7345771|NCT00913458|11584534|FG003|Phase 2|Lost to Follow-up|1
7345772|NCT00913458|11584535|FG004|Phase 2|Lost to Follow-up|0
7345773|NCT00913458|11584536|FG005|Phase 2|Lost to Follow-up|0
7345774|NCT00913458|11584537|FG006|Phase 2|Lost to Follow-up|0
7345775|NCT00913458|11584531|FG000|Phase 2|Protocol Violation|0
7345776|NCT00913458|11584532|FG001|Phase 2|Protocol Violation|2
7345777|NCT00913458|11584533|FG002|Phase 2|Protocol Violation|0
7345778|NCT00913458|11584534|FG003|Phase 2|Protocol Violation|0
7345779|NCT00913458|11584535|FG004|Phase 2|Protocol Violation|0
7345780|NCT00913458|11584536|FG005|Phase 2|Protocol Violation|0
7345781|NCT00913458|11584537|FG006|Phase 2|Protocol Violation|0
7345782|NCT00913458|11584531|FG000|Phase 2|Unsatisfactory Response per Investigator|0
7345783|NCT00913458|11584532|FG001|Phase 2|Unsatisfactory Response per Investigator|0
7345784|NCT00913458|11584533|FG002|Phase 2|Unsatisfactory Response per Investigator|11
7345785|NCT00913458|11584534|FG003|Phase 2|Unsatisfactory Response per Investigator|17
7345786|NCT00913458|11584535|FG004|Phase 2|Unsatisfactory Response per Investigator|0
7345787|NCT00913458|11584536|FG005|Phase 2|Unsatisfactory Response per Investigator|0
7345788|NCT00913458|11584537|FG006|Phase 2|Unsatisfactory Response per Investigator|0
7345789|NCT00913458|11584531|FG000|Phase 3|Adverse Event|0
7345790|NCT00913458|11584532|FG001|Phase 3|Adverse Event|0
7345791|NCT00913458|11584533|FG002|Phase 3|Adverse Event|0
7345792|NCT00913458|11584534|FG003|Phase 3|Adverse Event|0
7345793|NCT00913458|11584535|FG004|Phase 3|Adverse Event|5
7345794|NCT00913458|11584536|FG005|Phase 3|Adverse Event|4
7345795|NCT00913458|11584537|FG006|Phase 3|Adverse Event|1
7345796|NCT00913458|11584531|FG000|Phase 3|Lost to Follow-up|0
7345797|NCT00913458|11584532|FG001|Phase 3|Lost to Follow-up|0
7345798|NCT00913458|11584533|FG002|Phase 3|Lost to Follow-up|0
7345799|NCT00913458|11584534|FG003|Phase 3|Lost to Follow-up|0
7345800|NCT00913458|11584535|FG004|Phase 3|Lost to Follow-up|2
7345801|NCT00913458|11584536|FG005|Phase 3|Lost to Follow-up|0
7345802|NCT00913458|11584537|FG006|Phase 3|Lost to Follow-up|0
7345803|NCT00913458|11584531|FG000|Phase 3|Non-Responder|0
7345804|NCT00913458|11584532|FG001|Phase 3|Non-Responder|0
7345805|NCT00913458|11584533|FG002|Phase 3|Non-Responder|0
7345806|NCT00913458|11584534|FG003|Phase 3|Non-Responder|0
7345807|NCT00913458|11584535|FG004|Phase 3|Non-Responder|0
7345808|NCT00913458|11584536|FG005|Phase 3|Non-Responder|1
7345809|NCT00913458|11584537|FG006|Phase 3|Non-Responder|3
7345810|NCT00913458|11584531|FG000|Phase 3|Withdrawal by Subject|0
7345811|NCT00913458|11584532|FG001|Phase 3|Withdrawal by Subject|0
7345812|NCT00913458|11584533|FG002|Phase 3|Withdrawal by Subject|0
7345813|NCT00913458|11584534|FG003|Phase 3|Withdrawal by Subject|0
7345814|NCT00913458|11584535|FG004|Phase 3|Withdrawal by Subject|1
7345815|NCT00913458|11584536|FG005|Phase 3|Withdrawal by Subject|2
7345816|NCT00913458|11584537|FG006|Phase 3|Withdrawal by Subject|0
7345817|NCT00913458|11584531|FG000|Phase 3|Unsatisfactory Response per Investigator|0
7345818|NCT00913458|11584532|FG001|Phase 3|Unsatisfactory Response per Investigator|0
7345819|NCT00913458|11584533|FG002|Phase 3|Unsatisfactory Response per Investigator|0
7345820|NCT00913458|11584534|FG003|Phase 3|Unsatisfactory Response per Investigator|0
7345821|NCT00913458|11584535|FG004|Phase 3|Unsatisfactory Response per Investigator|14
7345822|NCT00913458|11584536|FG005|Phase 3|Unsatisfactory Response per Investigator|11
7345823|NCT00913458|11584537|FG006|Phase 3|Unsatisfactory Response per Investigator|4
7345824|NCT00913523|11584566|FG000|Overall Study|Withdrawal by Subject|3
7345825|NCT00913523|11584567|FG001|Overall Study|Withdrawal by Subject|2
7345826|NCT00913523|11584568|FG002|Overall Study|Withdrawal by Subject|2
7345827|NCT00913523|11584566|FG000|Overall Study|Lost to Follow-up|1
7345828|NCT00913523|11584567|FG001|Overall Study|Lost to Follow-up|1
7345829|NCT00913523|11584568|FG002|Overall Study|Lost to Follow-up|1
7345830|NCT00913523|11584566|FG000|Overall Study|Adverse Event|1
7345831|NCT00913523|11584567|FG001|Overall Study|Adverse Event|0
7345832|NCT00913523|11584568|FG002|Overall Study|Adverse Event|0
7345833|NCT00913523|11584566|FG000|Overall Study|Protocol Violation|5
7345834|NCT00913523|11584567|FG001|Overall Study|Protocol Violation|8
7345835|NCT00913523|11584568|FG002|Overall Study|Protocol Violation|8
7345836|NCT00913523|11584566|FG000|Overall Study|Pregnancy|1
7345837|NCT00913523|11584567|FG001|Overall Study|Pregnancy|3
7345838|NCT00913523|11584568|FG002|Overall Study|Pregnancy|0
7345839|NCT00913523|11584566|FG000|Overall Study|Inadequate Number of Tampons Used|7
7345840|NCT00913523|11584567|FG001|Overall Study|Inadequate Number of Tampons Used|2
7345841|NCT00913523|11584568|FG002|Overall Study|Inadequate Number of Tampons Used|3
7345842|NCT00913744|11584595|FG000|Overall Study|Adverse Event|2
7345843|NCT00913744|11584596|FG001|Overall Study|Adverse Event|0
7345844|NCT00913744|11584595|FG000|Overall Study|Withdrawal by Subject|2
7345845|NCT00913744|11584596|FG001|Overall Study|Withdrawal by Subject|1
7345846|NCT00913744|11584595|FG000|Overall Study|Death|1
7345847|NCT00913744|11584596|FG001|Overall Study|Death|0
7345848|NCT00913770|11584605|FG000|Overall Study|Unable to contact|24
7345849|NCT00913770|11584606|FG001|Overall Study|Unable to contact|19
7345850|NCT00913770|11584607|FG002|Overall Study|Unable to contact|13
7345851|NCT00913770|11584605|FG000|Overall Study|Refused|11
7345852|NCT00913770|11584606|FG001|Overall Study|Refused|10
7345853|NCT00913770|11584607|FG002|Overall Study|Refused|8
7345854|NCT00913835|11584617|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
7345855|NCT00913835|11584618|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
7345856|NCT00913835|11584617|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
7345857|NCT00913835|11584618|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
7345858|NCT00913835|11584617|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
7345859|NCT00913835|11584618|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
7345860|NCT00913835|11584617|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7345861|NCT00913835|11584618|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
7345862|NCT00913835|11584617|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
7345863|NCT00913835|11584618|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
7345864|NCT00913978|11584637|FG000|Overall Study|Surgeon choice|1
7345865|NCT00913978|11584638|FG001|Overall Study|Surgeon choice|3
7345866|NCT00914316|11584675|FG000|Phase 1|Physician Decision|4
7345867|NCT00914316|11584676|FG001|Phase 1|Physician Decision|0
7345868|NCT00914316|11584677|FG002|Phase 1|Physician Decision|1
7345869|NCT00914316|11584678|FG003|Phase 1|Physician Decision|2
7345870|NCT00914316|11584675|FG000|Phase 1|Withdrawal by Subject|0
7345871|NCT00914316|11584676|FG001|Phase 1|Withdrawal by Subject|2
7345872|NCT00914316|11584677|FG002|Phase 1|Withdrawal by Subject|4
7345873|NCT00914316|11584678|FG003|Phase 1|Withdrawal by Subject|0
7345874|NCT00914316|11584675|FG000|Phase 1|Adverse Event|1
7345875|NCT00914316|11584676|FG001|Phase 1|Adverse Event|0
7345876|NCT00914316|11584677|FG002|Phase 1|Adverse Event|0
7345877|NCT00914316|11584678|FG003|Phase 1|Adverse Event|0
7345878|NCT00914316|11584675|FG000|Phase 2|Withdrawal by Subject|1
7345879|NCT00914316|11584676|FG001|Phase 2|Withdrawal by Subject|0
7345880|NCT00914316|11584677|FG002|Phase 2|Withdrawal by Subject|1
7345881|NCT00914316|11584678|FG003|Phase 2|Withdrawal by Subject|0
7345882|NCT00914459|11584690|FG000|Overall Study|Protocol Violation|0
7345883|NCT00914459|11584691|FG001|Overall Study|Protocol Violation|1
7345884|NCT00914459|11584690|FG000|Overall Study|Parent/Legal guardian request|1
7345885|NCT00914459|11584691|FG001|Overall Study|Parent/Legal guardian request|0
7385840|NCT01205126|11643831|FG001|Titration Phase|More than maximum dosage required|3
7385841|NCT01205126|11643830|FG000|Titration Phase|Other|8
7385842|NCT01205126|11643831|FG001|Titration Phase|Other|6
7569131|NCT03438383|11945039|FG000|Overall Study|Protocol Violation|9
7569132|NCT03438383|11945040|FG001|Overall Study|Protocol Violation|3
7385843|NCT01205126|11643830|FG000|Between Titration & Maintenance Phase|Other|0
7385844|NCT01205126|11643831|FG001|Between Titration & Maintenance Phase|Other|4
7385845|NCT01205126|11643830|FG000|Maintenance Phase|Adverse Event|3
7385846|NCT01205126|11643831|FG001|Maintenance Phase|Adverse Event|7
7385847|NCT01205126|11643830|FG000|Maintenance Phase|Death|4
7385848|NCT01205126|11643831|FG001|Maintenance Phase|Death|4
7385849|NCT01205126|11643830|FG000|Maintenance Phase|More than the maximum dosage required|5
7385850|NCT01205126|11643831|FG001|Maintenance Phase|More than the maximum dosage required|5
7385851|NCT01205126|11643830|FG000|Maintenance Phase|Prohibited drugs used|1
7385852|NCT01205126|11643831|FG001|Maintenance Phase|Prohibited drugs used|0
7385853|NCT01205126|11643830|FG000|Maintenance Phase|Other|11
7385854|NCT01205126|11643831|FG001|Maintenance Phase|Other|8
7385855|NCT01205126|11643830|FG000|Maintenance Phase|Lost to Follow-up|5
7385856|NCT01205126|11643831|FG001|Maintenance Phase|Lost to Follow-up|5
7385857|NCT01205126|11643830|FG000|Maintenance Phase|Withdrawal by Subject|8
7385858|NCT01205126|11643831|FG001|Maintenance Phase|Withdrawal by Subject|11
7385859|NCT01205152|11643837|FG000|Overall Study|Death|1
7385860|NCT01205165|11643843|FG000|Overall Study|Lost to Follow-up|2
7385861|NCT01205230|11643850|FG000|Overall Study|Adverse Event|4
7385862|NCT01205230|11643851|FG001|Overall Study|Adverse Event|0
7385863|NCT01205230|11643850|FG000|Overall Study|Physician Decision|1
7385864|NCT01205230|11643851|FG001|Overall Study|Physician Decision|0
7385865|NCT01205269|11643862|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
7385866|NCT01205269|11643863|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
7385867|NCT01205269|11643864|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
7385868|NCT01205269|11643865|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
7385869|NCT01205269|11643866|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
7385870|NCT01205269|11643867|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
7385871|NCT01205438|11643882|FG000|Overall Study|Adverse Event|19
7385872|NCT01205438|11643883|FG001|Overall Study|Adverse Event|17
7385873|NCT01205438|11643884|FG002|Overall Study|Adverse Event|24
7385874|NCT01205438|11643882|FG000|Overall Study|Death|1
7385875|NCT01205438|11643883|FG001|Overall Study|Death|1
7385876|NCT01205438|11643884|FG002|Overall Study|Death|3
7385877|NCT01205438|11643882|FG000|Overall Study|Entry Criteria Not Met|16
7385878|NCT01205438|11643883|FG001|Overall Study|Entry Criteria Not Met|15
7385879|NCT01205438|11643884|FG002|Overall Study|Entry Criteria Not Met|13
7385880|NCT01205438|11643882|FG000|Overall Study|Lack of Efficacy|14
7385881|NCT01205438|11643883|FG001|Overall Study|Lack of Efficacy|11
7385882|NCT01205438|11643884|FG002|Overall Study|Lack of Efficacy|14
7385883|NCT01205438|11643882|FG000|Overall Study|Lost to Follow-up|6
7385884|NCT01205438|11643883|FG001|Overall Study|Lost to Follow-up|7
7385885|NCT01205438|11643884|FG002|Overall Study|Lost to Follow-up|8
7385886|NCT01205438|11643882|FG000|Overall Study|Withdrawal by Subject|19
7385887|NCT01205438|11643883|FG001|Overall Study|Withdrawal by Subject|25
7385888|NCT01205438|11643884|FG002|Overall Study|Withdrawal by Subject|19
7385889|NCT01205438|11643882|FG000|Overall Study|Physician Decision|0
7385890|NCT01205438|11643883|FG001|Overall Study|Physician Decision|3
7385891|NCT01205438|11643884|FG002|Overall Study|Physician Decision|2
7385892|NCT01205438|11643882|FG000|Overall Study|Protocol Violation|2
7385893|NCT01205438|11643883|FG001|Overall Study|Protocol Violation|7
7385894|NCT01205438|11643884|FG002|Overall Study|Protocol Violation|4
7385895|NCT01205438|11643882|FG000|Overall Study|Sponsor Decision|0
7385896|NCT01205438|11643883|FG001|Overall Study|Sponsor Decision|1
7385897|NCT01205438|11643884|FG002|Overall Study|Sponsor Decision|1
7385898|NCT01205451|11643897|FG000|Overall Study|Lost to Follow-up|1
7385899|NCT01205451|11643898|FG001|Overall Study|Lost to Follow-up|1
7385900|NCT01205451|11643897|FG000|Overall Study|Withdrawal by Subject|5
7385901|NCT01205451|11643898|FG001|Overall Study|Withdrawal by Subject|9
7385902|NCT01205529|11643913|FG000|Overall Study|Procedure Cancelled|4
7385903|NCT01205529|11643913|FG000|Overall Study|Withdrawal by Subject|2
7385904|NCT01205529|11643913|FG000|Overall Study|Physician Decision|4
7385905|NCT01205529|11643913|FG000|Overall Study|Unstable post op|15
7385906|NCT01205529|11643913|FG000|Overall Study|No longer met criteria|30
7385907|NCT01205581|11643928|FG000|Overall Study|Withdrawal by Subject|1
7385908|NCT01205581|11643929|FG001|Overall Study|Withdrawal by Subject|0
7569139|NCT03438539|11945056|FG000|Overall Study|Lost to Follow-up|8
7569140|NCT03438539|11945057|FG001|Overall Study|Lost to Follow-up|4
7569141|NCT03438539|11945058|FG002|Overall Study|Lost to Follow-up|10
7345886|NCT00914589|11584706|FG000|Overall Study|Adverse Event|1
7345887|NCT00914589|11584707|FG001|Overall Study|Adverse Event|0
7345888|NCT00914589|11584708|FG002|Overall Study|Adverse Event|1
7345889|NCT00914589|11584706|FG000|Overall Study|Protocol Violation|8
7345890|NCT00914589|11584707|FG001|Overall Study|Protocol Violation|6
7345891|NCT00914589|11584708|FG002|Overall Study|Protocol Violation|3
7345892|NCT00914589|11584706|FG000|Overall Study|unclassified|16
7345893|NCT00914589|11584707|FG001|Overall Study|unclassified|9
7345894|NCT00914589|11584708|FG002|Overall Study|unclassified|7
7345895|NCT00914589|11584706|FG000|Overall Study|Death|0
7345896|NCT00914589|11584707|FG001|Overall Study|Death|1
7345897|NCT00914589|11584708|FG002|Overall Study|Death|1
7345898|NCT00914628|11584718|FG000|Overall Study|Death|35
7345899|NCT00914628|11584719|FG001|Overall Study|Death|17
7345900|NCT00914628|11584718|FG000|Overall Study|Medical decision|4
7345901|NCT00914628|11584719|FG001|Overall Study|Medical decision|0
7345902|NCT00914628|11584718|FG000|Overall Study|Protocol Violation|1
7345903|NCT00914628|11584719|FG001|Overall Study|Protocol Violation|0
7345904|NCT00914628|11584718|FG000|Overall Study|Lack of Efficacy|1
7345905|NCT00914628|11584719|FG001|Overall Study|Lack of Efficacy|0
7345906|NCT00914628|11584718|FG000|Overall Study|non-randomized|1
7345907|NCT00914628|11584719|FG001|Overall Study|non-randomized|0
7345908|NCT00914628|11584718|FG000|Overall Study|Relapse|1
7345909|NCT00914628|11584719|FG001|Overall Study|Relapse|2
7345910|NCT00914628|11584718|FG000|Overall Study|Study terminated by Sponsor|14
7345911|NCT00914628|11584719|FG001|Overall Study|Study terminated by Sponsor|8
7345912|NCT00914628|11584718|FG000|Overall Study|Patients who did not receive a single dose|7
7345913|NCT00914628|11584719|FG001|Overall Study|Patients who did not receive a single dose|1
7345914|NCT00914732|11584732|FG000|Overall Study|Lost to Follow-up|6
7345915|NCT00914732|11584733|FG001|Overall Study|Lost to Follow-up|7
7345916|NCT00914732|11584734|FG002|Overall Study|Lost to Follow-up|9
7345917|NCT00914732|11584732|FG000|Overall Study|Withdrawal by Subject|3
7345918|NCT00914732|11584733|FG001|Overall Study|Withdrawal by Subject|0
7345919|NCT00914732|11584734|FG002|Overall Study|Withdrawal by Subject|2
7345920|NCT00914732|11584732|FG000|Overall Study|Adverse Event|1
7345921|NCT00914732|11584733|FG001|Overall Study|Adverse Event|0
7345922|NCT00914732|11584734|FG002|Overall Study|Adverse Event|0
7345923|NCT00914810|11584745|FG000|Overall Study|Withdrawal by Subject|1
7345924|NCT00914810|11584746|FG001|Overall Study|Withdrawal by Subject|0
7345925|NCT00914810|11584745|FG000|Overall Study|Relocated out of state|1
7345926|NCT00914810|11584746|FG001|Overall Study|Relocated out of state|0
7345927|NCT00914810|11584745|FG000|Overall Study|Hospitalized and unable to follow up.|0
7345928|NCT00914810|11584746|FG001|Overall Study|Hospitalized and unable to follow up.|1
7345929|NCT00914849|11584754|FG000|Overall Study|Withdrawal by Subject|1
7345930|NCT00914849|11584755|FG001|Overall Study|Withdrawal by Subject|0
7345931|NCT00914849|11584754|FG000|Overall Study|Not eligible|0
7345932|NCT00914849|11584755|FG001|Overall Study|Not eligible|1
7345933|NCT00914927|11584789|FG000|Overall Study|Adverse Event|0
7345934|NCT00914927|11584790|FG001|Overall Study|Adverse Event|0
7345935|NCT00914927|11584791|FG002|Overall Study|Adverse Event|0
7345936|NCT00914927|11584792|FG003|Overall Study|Adverse Event|0
7345937|NCT00914927|11584793|FG004|Overall Study|Adverse Event|1
7345938|NCT00914927|11584794|FG005|Overall Study|Adverse Event|0
7345939|NCT00914927|11584795|FG006|Overall Study|Adverse Event|0
7345940|NCT00914927|11584789|FG000|Overall Study|Withdrawal by Subject|0
7345941|NCT00914927|11584790|FG001|Overall Study|Withdrawal by Subject|1
7345942|NCT00914927|11584791|FG002|Overall Study|Withdrawal by Subject|0
7345943|NCT00914927|11584792|FG003|Overall Study|Withdrawal by Subject|1
7345944|NCT00914927|11584793|FG004|Overall Study|Withdrawal by Subject|0
7345945|NCT00914927|11584794|FG005|Overall Study|Withdrawal by Subject|0
7345946|NCT00914927|11584795|FG006|Overall Study|Withdrawal by Subject|0
7345947|NCT00914927|11584789|FG000|Overall Study|Lost to Follow-up|0
7345948|NCT00914927|11584790|FG001|Overall Study|Lost to Follow-up|0
7345949|NCT00914927|11584791|FG002|Overall Study|Lost to Follow-up|0
7345950|NCT00914927|11584792|FG003|Overall Study|Lost to Follow-up|1
7345951|NCT00914927|11584793|FG004|Overall Study|Lost to Follow-up|0
7345952|NCT00914927|11584794|FG005|Overall Study|Lost to Follow-up|0
7345953|NCT00914927|11584795|FG006|Overall Study|Lost to Follow-up|0
7345954|NCT00914927|11584789|FG000|Overall Study|Administrative/Other|2
7345955|NCT00914927|11584790|FG001|Overall Study|Administrative/Other|1
7345956|NCT00914927|11584791|FG002|Overall Study|Administrative/Other|0
7345957|NCT00914927|11584792|FG003|Overall Study|Administrative/Other|0
7345958|NCT00914927|11584793|FG004|Overall Study|Administrative/Other|1
7345959|NCT00914927|11584794|FG005|Overall Study|Administrative/Other|0
7345960|NCT00914927|11584795|FG006|Overall Study|Administrative/Other|0
7345961|NCT00914940|11584820|FG000|D0 to D100 Post-transplant|Death|2
7345962|NCT00914940|11584820|FG000|D101 to 2 Years Post-transplant|Death|8
7345963|NCT00914940|11584820|FG000|2 Years to 5 Years Post-transplant|Death|3
7345964|NCT00914966|11584824|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
7345965|NCT00914966|11584824|FG000|Step 1: 1500 Units|Physician Decision|1
7345966|NCT00914966|11584824|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
7345967|NCT00915005|11584835|FG000|Overall Study|Withdrawal by Subject|4
7345968|NCT00915005|11584836|FG001|Overall Study|Withdrawal by Subject|4
7345969|NCT00915005|11584835|FG000|Overall Study|Patient preferred protons therapy|6
7345970|NCT00915005|11584836|FG001|Overall Study|Patient preferred protons therapy|0
7345971|NCT00915005|11584835|FG000|Overall Study|Insurance denial|3
7345972|NCT00915005|11584836|FG001|Overall Study|Insurance denial|15
7345973|NCT00915018|11584844|FG000|Overall Study|Death|75
7345974|NCT00915018|11584845|FG001|Overall Study|Death|70
7345975|NCT00915018|11584844|FG000|Overall Study|Lost to Follow-up|10
7345976|NCT00915018|11584845|FG001|Overall Study|Lost to Follow-up|5
7345977|NCT00915018|11584844|FG000|Overall Study|Withdrawal by Subject|38
7345978|NCT00915018|11584845|FG001|Overall Study|Withdrawal by Subject|27
7345979|NCT00915018|11584844|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
7345980|NCT00915018|11584845|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
7345981|NCT00915278|11584870|FG000|Overall Study|Death|1
7345982|NCT00915278|11584871|FG001|Overall Study|Death|0
7345983|NCT00915278|11584872|FG002|Overall Study|Death|0
7345984|NCT00915278|11584873|FG003|Overall Study|Death|0
7345985|NCT00915278|11584874|FG004|Overall Study|Death|0
7345986|NCT00915278|11584875|FG005|Overall Study|Death|0
7345987|NCT00915278|11584870|FG000|Overall Study|Lost to Follow-up|0
7345988|NCT00915278|11584871|FG001|Overall Study|Lost to Follow-up|1
7345989|NCT00915278|11584872|FG002|Overall Study|Lost to Follow-up|0
7345990|NCT00915278|11584873|FG003|Overall Study|Lost to Follow-up|0
7345991|NCT00915278|11584874|FG004|Overall Study|Lost to Follow-up|0
7345992|NCT00915278|11584875|FG005|Overall Study|Lost to Follow-up|0
7345993|NCT00915278|11584870|FG000|Overall Study|Withdrawal by Subject|0
7345994|NCT00915278|11584871|FG001|Overall Study|Withdrawal by Subject|1
7345995|NCT00915278|11584872|FG002|Overall Study|Withdrawal by Subject|0
7345996|NCT00915278|11584873|FG003|Overall Study|Withdrawal by Subject|0
7345997|NCT00915278|11584874|FG004|Overall Study|Withdrawal by Subject|1
7345998|NCT00915278|11584875|FG005|Overall Study|Withdrawal by Subject|4
7345999|NCT00915278|11584870|FG000|Overall Study|Adverse Event|4
7346000|NCT00915278|11584871|FG001|Overall Study|Adverse Event|1
7346001|NCT00915278|11584872|FG002|Overall Study|Adverse Event|0
7346002|NCT00915278|11584873|FG003|Overall Study|Adverse Event|0
7346003|NCT00915278|11584874|FG004|Overall Study|Adverse Event|0
7346004|NCT00915278|11584875|FG005|Overall Study|Adverse Event|0
7346005|NCT00915278|11584870|FG000|Overall Study|Progressive disease/clinical progression|0
7346006|NCT00915278|11584871|FG001|Overall Study|Progressive disease/clinical progression|0
7346007|NCT00915278|11584872|FG002|Overall Study|Progressive disease/clinical progression|0
7346008|NCT00915278|11584873|FG003|Overall Study|Progressive disease/clinical progression|3
7346009|NCT00915278|11584874|FG004|Overall Study|Progressive disease/clinical progression|1
7346010|NCT00915278|11584875|FG005|Overall Study|Progressive disease/clinical progression|2
7346011|NCT00915278|11584870|FG000|Overall Study|Infusion related AEs|0
7346012|NCT00915278|11584871|FG001|Overall Study|Infusion related AEs|0
7346013|NCT00915278|11584872|FG002|Overall Study|Infusion related AEs|0
7346014|NCT00915278|11584873|FG003|Overall Study|Infusion related AEs|0
7346015|NCT00915278|11584874|FG004|Overall Study|Infusion related AEs|0
7346016|NCT00915278|11584875|FG005|Overall Study|Infusion related AEs|2
7346017|NCT00915278|11584870|FG000|Overall Study|Admission to hospice|0
7346018|NCT00915278|11584871|FG001|Overall Study|Admission to hospice|0
7346019|NCT00915278|11584872|FG002|Overall Study|Admission to hospice|1
7346020|NCT00915278|11584873|FG003|Overall Study|Admission to hospice|0
7346021|NCT00915278|11584874|FG004|Overall Study|Admission to hospice|0
7346022|NCT00915278|11584875|FG005|Overall Study|Admission to hospice|0
7346023|NCT00915343|11584889|FG000|Part B - Open Label Period|Treatment switch|0
7346024|NCT00915343|11584890|FG001|Part B - Open Label Period|Treatment switch|0
7346025|NCT00915343|11584891|FG002|Part B - Open Label Period|Treatment switch|1
7346026|NCT00915343|11584889|FG000|Part B - Open Label Period|Did not attend the last visit|0
7346027|NCT00915343|11584890|FG001|Part B - Open Label Period|Did not attend the last visit|0
7346028|NCT00915343|11584891|FG002|Part B - Open Label Period|Did not attend the last visit|1
7346029|NCT00915356|11584908|FG000|Overall Study|Withdrawal by Subject|1
7346030|NCT00915356|11584909|FG001|Overall Study|Withdrawal by Subject|0
7346031|NCT00915356|11584910|FG002|Overall Study|Withdrawal by Subject|0
7346032|NCT00915356|11584911|FG003|Overall Study|Withdrawal by Subject|0
7346033|NCT00915356|11584912|FG004|Overall Study|Withdrawal by Subject|0
7346034|NCT00915473|11584926|FG000|Screening|Withdrawal by Subject|1
7346035|NCT00915473|11584927|FG001|Screening|Withdrawal by Subject|0
7346036|NCT00915473|11584926|FG000|4-week Follow Up|Lost to Follow-up|1
7346037|NCT00915473|11584927|FG001|4-week Follow Up|Lost to Follow-up|5
7346038|NCT00915525|11584944|FG000|Overall Study|Protocol Violation|9
7346039|NCT00915525|11584945|FG001|Overall Study|Protocol Violation|4
7346040|NCT00915525|11584944|FG000|Overall Study|Withdrawal by Subject|59
7346041|NCT00915525|11584945|FG001|Overall Study|Withdrawal by Subject|21
7346042|NCT00915525|11584944|FG000|Overall Study|Lost to Follow-up|27
7346043|NCT00915525|11584945|FG001|Overall Study|Lost to Follow-up|16
7346044|NCT00915525|11584944|FG000|Overall Study|Pregnancy|2
7346045|NCT00915525|11584945|FG001|Overall Study|Pregnancy|0
7346046|NCT00915525|11584944|FG000|Overall Study|Lack of Efficacy|15
7346047|NCT00915525|11584945|FG001|Overall Study|Lack of Efficacy|32
7346048|NCT00915525|11584944|FG000|Overall Study|Adverse Event|29
7346049|NCT00915525|11584945|FG001|Overall Study|Adverse Event|13
7346050|NCT00915525|11584944|FG000|Overall Study|Missing|12
7346051|NCT00915525|11584945|FG001|Overall Study|Missing|1
7346052|NCT00915525|11584944|FG000|Overall Study|Other Reason|35
7346053|NCT00915525|11584945|FG001|Overall Study|Other Reason|12
7346054|NCT00915525|11584944|FG000|Overall Study|Site Closed|27
7346055|NCT00915525|11584945|FG001|Overall Study|Site Closed|9
7346056|NCT00915525|11584944|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
7346057|NCT00915525|11584945|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
7346058|NCT00915525|11584944|FG000|Overall Study|Study Burden|28
7346059|NCT00915525|11584945|FG001|Overall Study|Study Burden|12
7346060|NCT00915525|11584944|FG000|Overall Study|Non-Compliance|3
7346061|NCT00915525|11584945|FG001|Overall Study|Non-Compliance|1
7346062|NCT00915525|11584944|FG000|Overall Study|Patient Moved|15
7346063|NCT00915525|11584945|FG001|Overall Study|Patient Moved|9
7346064|NCT00915551|11584984|FG000|Overall Study|Withdrawal by Subject|0
7346065|NCT00915551|11584985|FG001|Overall Study|Withdrawal by Subject|1
7346066|NCT00915772|11585031|FG000|Overall Study|Adverse Event|12
7346067|NCT00915772|11585032|FG001|Overall Study|Adverse Event|13
7346068|NCT00915772|11585033|FG002|Overall Study|Adverse Event|11
7346069|NCT00915772|11585031|FG000|Overall Study|Protocol Violation|4
7346070|NCT00915772|11585032|FG001|Overall Study|Protocol Violation|1
7346071|NCT00915772|11585033|FG002|Overall Study|Protocol Violation|2
7346072|NCT00915772|11585031|FG000|Overall Study|Lost to Follow-up|1
7346073|NCT00915772|11585032|FG001|Overall Study|Lost to Follow-up|2
7346074|NCT00915772|11585033|FG002|Overall Study|Lost to Follow-up|2
7346075|NCT00915772|11585031|FG000|Overall Study|Lack of Efficacy|9
7346076|NCT00915772|11585032|FG001|Overall Study|Lack of Efficacy|15
7346077|NCT00915772|11585033|FG002|Overall Study|Lack of Efficacy|3
7346078|NCT00915772|11585031|FG000|Overall Study|Refused to continue trial medication|6
7346079|NCT00915772|11585032|FG001|Overall Study|Refused to continue trial medication|8
7346080|NCT00915772|11585033|FG002|Overall Study|Refused to continue trial medication|4
7346081|NCT00915772|11585031|FG000|Overall Study|Any other reason|4
7346082|NCT00915772|11585032|FG001|Overall Study|Any other reason|7
7346083|NCT00915772|11585033|FG002|Overall Study|Any other reason|7
7346084|NCT00915876|11585071|FG000|Overall Study|Adverse Event|0
7346085|NCT00915876|11585072|FG001|Overall Study|Adverse Event|1
7346086|NCT00916006|11585123|FG000|Overall Study|Adverse Event|1
7346087|NCT00916006|11585124|FG001|Overall Study|Adverse Event|1
7346088|NCT00916006|11585123|FG000|Overall Study|Withdrawal by Subject|2
7346089|NCT00916006|11585124|FG001|Overall Study|Withdrawal by Subject|5
7346090|NCT00916006|11585123|FG000|Overall Study|Protocol Violation|0
7346091|NCT00916006|11585124|FG001|Overall Study|Protocol Violation|1
7346092|NCT00916058|11585144|FG000|Phase 1|Screen Failure|0
7346093|NCT00916058|11585145|FG001|Phase 1|Screen Failure|0
7346094|NCT00916058|11585146|FG002|Phase 1|Screen Failure|0
7346095|NCT00916058|11585147|FG003|Phase 1|Screen Failure|0
7346096|NCT00916058|11585148|FG004|Phase 1|Screen Failure|0
7346097|NCT00916058|11585149|FG005|Phase 1|Screen Failure|1
7346098|NCT00916058|11585150|FG006|Phase 1|Screen Failure|0
7346099|NCT00916058|11585144|FG000|Phase 2|Screen Failure|0
7346100|NCT00916058|11585145|FG001|Phase 2|Screen Failure|0
7346101|NCT00916058|11585146|FG002|Phase 2|Screen Failure|0
7346102|NCT00916058|11585147|FG003|Phase 2|Screen Failure|0
7346103|NCT00916058|11585148|FG004|Phase 2|Screen Failure|0
7346104|NCT00916058|11585149|FG005|Phase 2|Screen Failure|0
7346105|NCT00916058|11585150|FG006|Phase 2|Screen Failure|3
7346106|NCT00916149|11585180|FG000|Overall Study|Lost to Follow-up|3
7346107|NCT00916149|11585181|FG001|Overall Study|Lost to Follow-up|2
7346108|NCT00916149|11585182|FG002|Overall Study|Lost to Follow-up|0
7346109|NCT00916149|11585180|FG000|Overall Study|Unable to place scalp EEG leads|1
7346110|NCT00916149|11585181|FG001|Overall Study|Unable to place scalp EEG leads|0
7346111|NCT00916149|11585182|FG002|Overall Study|Unable to place scalp EEG leads|0
7346112|NCT00916279|11585189|FG000|Overall Study|Death|2
7346113|NCT00916279|11585189|FG000|Overall Study|Lost to Follow-up|2
7346114|NCT00916305|11585198|FG000|Overall Study|Lost to Follow-up|21
7346115|NCT00916305|11585199|FG001|Overall Study|Lost to Follow-up|27
7346116|NCT00916305|11585198|FG000|Overall Study|Withdrawal by Subject|0
7346117|NCT00916305|11585199|FG001|Overall Study|Withdrawal by Subject|1
7346118|NCT00916344|11585205|FG000|Overall Study|Death|2
7346119|NCT00916344|11585205|FG000|Overall Study|ICD upgrade|1
7346120|NCT00916344|11585205|FG000|Overall Study|Drop-out|5
7346121|NCT00916357|11585209|FG000|Period 1|Withdrawal by Subject|1
7346122|NCT00916357|11585210|FG001|Period 1|Withdrawal by Subject|0
7346123|NCT00916357|11585211|FG002|Period 1|Withdrawal by Subject|0
7346124|NCT00916357|11585212|FG003|Period 1|Withdrawal by Subject|0
7346125|NCT00916357|11585213|FG004|Period 1|Withdrawal by Subject|0
7346126|NCT00916357|11585214|FG005|Period 1|Withdrawal by Subject|0
7346127|NCT00916357|11585209|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
7346128|NCT00916357|11585210|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
7346129|NCT00916357|11585211|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
7346130|NCT00916357|11585212|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
7346131|NCT00916357|11585213|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
7346132|NCT00916357|11585214|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
7346133|NCT00916370|11585225|FG000|Overall Study|Death|3
7346134|NCT00916370|11585226|FG001|Overall Study|Death|1
7346135|NCT00916370|11585225|FG000|Overall Study|Withdrawal by Subject|2
7346136|NCT00916370|11585226|FG001|Overall Study|Withdrawal by Subject|0
7346137|NCT00916370|11585225|FG000|Overall Study|Physician Decision|0
7346138|NCT00916370|11585226|FG001|Overall Study|Physician Decision|1
7346139|NCT00916383|11585233|FG000|Overall Study|Adverse Event|1
7346140|NCT00916383|11585233|FG000|Overall Study|Death|1
7346141|NCT00916383|11585233|FG000|Overall Study|Protocol Violation|1
7346142|NCT00916578|11585250|FG000|Overall Study|Physician Decision|2
7346143|NCT00916578|11585250|FG000|Overall Study|Withdrawal by Subject|3
7346144|NCT00916578|11585250|FG000|Overall Study|Insurance Denial|2
7346145|NCT00916617|11585258|FG000|Overall Study|Adverse Event|3
7346146|NCT00916617|11585259|FG001|Overall Study|Adverse Event|2
7346147|NCT00916617|11585260|FG002|Overall Study|Adverse Event|6
7346148|NCT00916617|11585261|FG003|Overall Study|Adverse Event|3
7346149|NCT00916617|11585258|FG000|Overall Study|Withdrawal by Subject|3
7346150|NCT00916617|11585259|FG001|Overall Study|Withdrawal by Subject|2
7346151|NCT00916617|11585260|FG002|Overall Study|Withdrawal by Subject|0
7346152|NCT00916617|11585261|FG003|Overall Study|Withdrawal by Subject|1
7346153|NCT00916617|11585258|FG000|Overall Study|Caregiver Request|3
7346154|NCT00916617|11585259|FG001|Overall Study|Caregiver Request|2
7346155|NCT00916617|11585260|FG002|Overall Study|Caregiver Request|1
7346156|NCT00916617|11585261|FG003|Overall Study|Caregiver Request|0
7346157|NCT00916617|11585258|FG000|Overall Study|Physician Decision|1
7346158|NCT00916617|11585259|FG001|Overall Study|Physician Decision|1
7346159|NCT00916617|11585260|FG002|Overall Study|Physician Decision|0
7346160|NCT00916617|11585261|FG003|Overall Study|Physician Decision|0
7346161|NCT00916617|11585258|FG000|Overall Study|Discontinuation of Study by Sponsor|8
7346162|NCT00916617|11585259|FG001|Overall Study|Discontinuation of Study by Sponsor|13
7346163|NCT00916617|11585260|FG002|Overall Study|Discontinuation of Study by Sponsor|3
7346164|NCT00916617|11585261|FG003|Overall Study|Discontinuation of Study by Sponsor|1
7346165|NCT00916617|11585258|FG000|Overall Study|Lost to Follow-up|2
7346166|NCT00916617|11585259|FG001|Overall Study|Lost to Follow-up|1
7346167|NCT00916617|11585260|FG002|Overall Study|Lost to Follow-up|0
7346168|NCT00916617|11585261|FG003|Overall Study|Lost to Follow-up|0
7346169|NCT00916617|11585258|FG000|Overall Study|Lack of Efficacy|1
7346170|NCT00916617|11585259|FG001|Overall Study|Lack of Efficacy|0
7346171|NCT00916617|11585260|FG002|Overall Study|Lack of Efficacy|0
7346172|NCT00916617|11585261|FG003|Overall Study|Lack of Efficacy|0
7346173|NCT00916617|11585258|FG000|Overall Study|Other|2
7346174|NCT00916617|11585259|FG001|Overall Study|Other|0
7346175|NCT00916617|11585260|FG002|Overall Study|Other|0
7346176|NCT00916617|11585261|FG003|Overall Study|Other|2
7346177|NCT00916721|11585277|FG000|Overall Study|Lost to Follow-up|0
7346178|NCT00916721|11585278|FG001|Overall Study|Lost to Follow-up|1
7346179|NCT00916721|11585277|FG000|Overall Study|Adverse Event|6
7346180|NCT00916721|11585278|FG001|Overall Study|Adverse Event|3
7346181|NCT00916721|11585277|FG000|Overall Study|Withdrawal by Subject|2
7346182|NCT00916721|11585278|FG001|Overall Study|Withdrawal by Subject|2
7346183|NCT00916721|11585277|FG000|Overall Study|Protocol Violation|2
7346184|NCT00916721|11585278|FG001|Overall Study|Protocol Violation|4
7346185|NCT00916929|11585286|FG000|Overall Study|Lost to Follow-up|1
7346186|NCT00916929|11585287|FG001|Overall Study|Lost to Follow-up|3
7346187|NCT00916929|11585286|FG000|Overall Study|Death|5
7346188|NCT00916929|11585287|FG001|Overall Study|Death|10
7346189|NCT00916929|11585286|FG000|Overall Study|Withdrawal by Subject|1
7346190|NCT00916929|11585287|FG001|Overall Study|Withdrawal by Subject|5
7346191|NCT00916929|11585286|FG000|Overall Study|Left ventricular epicardial lead|1
7346192|NCT00916929|11585287|FG001|Overall Study|Left ventricular epicardial lead|2
7346193|NCT00916929|11585286|FG000|Overall Study|Transferred to hospice care|1
7346194|NCT00916929|11585287|FG001|Overall Study|Transferred to hospice care|1
7346195|NCT00916929|11585286|FG000|Overall Study|System explant|1
7346196|NCT00916929|11585287|FG001|Overall Study|System explant|0
7346197|NCT00916929|11585286|FG000|Overall Study|Moved to another state|0
7346198|NCT00916929|11585287|FG001|Overall Study|Moved to another state|1
7346199|NCT00916929|11585286|FG000|Overall Study|Device unable to process impedance data|0
7346200|NCT00916929|11585287|FG001|Overall Study|Device unable to process impedance data|7
7346201|NCT00917124|11585297|FG000|Overall Study|Protocol Violation|4
7346202|NCT00917124|11585298|FG001|Overall Study|Protocol Violation|6
7346203|NCT00917150|11585308|FG000|Overall Study|Adverse Event|12
7346204|NCT00917150|11585309|FG001|Overall Study|Adverse Event|7
7346205|NCT00917150|11585310|FG002|Overall Study|Adverse Event|12
7346206|NCT00917150|11585311|FG003|Overall Study|Adverse Event|11
7346207|NCT00917150|11585308|FG000|Overall Study|Death|1
7346208|NCT00917150|11585309|FG001|Overall Study|Death|4
7346209|NCT00917150|11585310|FG002|Overall Study|Death|3
7346210|NCT00917150|11585311|FG003|Overall Study|Death|2
7346211|NCT00917150|11585308|FG000|Overall Study|Lost to Follow-up|1
7346212|NCT00917150|11585309|FG001|Overall Study|Lost to Follow-up|0
7346213|NCT00917150|11585310|FG002|Overall Study|Lost to Follow-up|4
7346214|NCT00917150|11585311|FG003|Overall Study|Lost to Follow-up|2
7346215|NCT00917150|11585308|FG000|Overall Study|Physician Decision|0
7346216|NCT00917150|11585309|FG001|Overall Study|Physician Decision|2
7346217|NCT00917150|11585310|FG002|Overall Study|Physician Decision|0
7346218|NCT00917150|11585311|FG003|Overall Study|Physician Decision|1
7346219|NCT00917150|11585308|FG000|Overall Study|Protocol Violation|5
7346220|NCT00917150|11585309|FG001|Overall Study|Protocol Violation|5
7569142|NCT03438539|11945059|FG003|Overall Study|Lost to Follow-up|9
7569143|NCT03438539|11945060|FG004|Overall Study|Lost to Follow-up|3
7346221|NCT00917150|11585310|FG002|Overall Study|Protocol Violation|3
7346222|NCT00917150|11585311|FG003|Overall Study|Protocol Violation|5
7346223|NCT00917150|11585308|FG000|Overall Study|Withdrawal by Subject|15
7346224|NCT00917150|11585309|FG001|Overall Study|Withdrawal by Subject|16
7346225|NCT00917150|11585310|FG002|Overall Study|Withdrawal by Subject|18
7346226|NCT00917150|11585311|FG003|Overall Study|Withdrawal by Subject|11
7346227|NCT00917150|11585308|FG000|Overall Study|Other than specified|3
7346228|NCT00917150|11585309|FG001|Overall Study|Other than specified|3
7346229|NCT00917150|11585310|FG002|Overall Study|Other than specified|2
7346230|NCT00917150|11585311|FG003|Overall Study|Other than specified|2
7346231|NCT00917267|11585323|FG000|Overall Study|Adverse Event|15
7346232|NCT00917267|11585324|FG001|Overall Study|Adverse Event|36
7346233|NCT00917267|11585323|FG000|Overall Study|Physician Decision|2
7346234|NCT00917267|11585324|FG001|Overall Study|Physician Decision|4
7346235|NCT00917267|11585323|FG000|Overall Study|Protocol Violation|9
7346236|NCT00917267|11585324|FG001|Overall Study|Protocol Violation|18
7346237|NCT00917267|11585323|FG000|Overall Study|Withdrawal by Subject|5
7346238|NCT00917267|11585324|FG001|Overall Study|Withdrawal by Subject|12
7346239|NCT00917267|11585323|FG000|Overall Study|Lost to follow up|0
7346240|NCT00917267|11585324|FG001|Overall Study|Lost to follow up|2
7346241|NCT00917267|11585323|FG000|Overall Study|Entry Criteria Not Met|1
7346242|NCT00917267|11585324|FG001|Overall Study|Entry Criteria Not Met|0
7346243|NCT00917267|11585323|FG000|Overall Study|Sponsor Decision|5
7346244|NCT00917267|11585324|FG001|Overall Study|Sponsor Decision|5
7346245|NCT00917267|11585323|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7346246|NCT00917267|11585324|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
7346247|NCT00917384|11585336|FG000|Overall Study|Lost to Follow-up|4
7346248|NCT00917384|11585337|FG001|Overall Study|Lost to Follow-up|2
7346249|NCT00917384|11585336|FG000|Overall Study|Withdrawal by Subject|10
7346250|NCT00917384|11585337|FG001|Overall Study|Withdrawal by Subject|2
7346251|NCT00917462|11585343|FG000|Overall Study|Clinical Deterioration|1
7346252|NCT00917501|11585349|FG000|Overall Study|Lost to Follow-up|4
7346253|NCT00917501|11585350|FG001|Overall Study|Lost to Follow-up|1
7346254|NCT00917501|11585349|FG000|Overall Study|Withdrawal by Subject|3
7346255|NCT00917501|11585350|FG001|Overall Study|Withdrawal by Subject|1
7346256|NCT00917501|11585349|FG000|Overall Study|Lack of Efficacy|1
7346257|NCT00917501|11585350|FG001|Overall Study|Lack of Efficacy|2
7346258|NCT00917501|11585349|FG000|Overall Study|trouble swollowing capsules|0
7346259|NCT00917501|11585350|FG001|Overall Study|trouble swollowing capsules|1
7346260|NCT00917553|11585358|FG000|Overall Study|Lost to Follow-up|2
7346261|NCT00917553|11585359|FG001|Overall Study|Lost to Follow-up|1
7346262|NCT00917579|11585365|FG000|Washout >= 2 Weeks|Adverse Event|1
7346263|NCT00917579|11585366|FG001|Washout >= 2 Weeks|Adverse Event|0
7346264|NCT00917579|11585365|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
7346265|NCT00917579|11585366|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
7346266|NCT00917644|11585372|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
7346267|NCT00917644|11585373|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
7346268|NCT00917644|11585372|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
7346269|NCT00917644|11585373|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
7346270|NCT00917644|11585372|FG000|Period 2: Second Intervention|family emergency|1
7346271|NCT00917644|11585373|FG001|Period 2: Second Intervention|family emergency|0
7346272|NCT00917852|11585388|FG000|Overall Study|Death|6
7346273|NCT00918138|11585418|FG000|Overall Study|Subject withdrew consent|1
7346274|NCT00918138|11585419|FG001|Overall Study|Subject withdrew consent|1
7346275|NCT00918138|11585418|FG000|Overall Study|Death|1
7346276|NCT00918138|11585419|FG001|Overall Study|Death|0
7346277|NCT00918203|11585427|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
7346278|NCT00918203|11585428|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
7346355|NCT00918749|11585537|FG002|Overall Study|Adverse Event|1
7346279|NCT00918203|11585429|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
7346280|NCT00918203|11585427|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
7385909|NCT01205581|11643930|FG002|Overall Study|Withdrawal by Subject|0
7569144|NCT03438539|11945061|FG005|Overall Study|Lost to Follow-up|8
7346281|NCT00918203|11585428|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
7346282|NCT00918203|11585429|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
7346283|NCT00918203|11585427|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
7346284|NCT00918203|11585428|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
7346285|NCT00918203|11585429|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
7346286|NCT00918203|11585427|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
7346287|NCT00918203|11585428|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
7346288|NCT00918203|11585429|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
7346289|NCT00918255|11585448|FG000|Overall Study|Adverse Event|1
7346290|NCT00918255|11585449|FG001|Overall Study|Adverse Event|0
7346291|NCT00918255|11585450|FG002|Overall Study|Adverse Event|0
7346292|NCT00918255|11585448|FG000|Overall Study|Withdrawal by Subject|1
7346293|NCT00918255|11585449|FG001|Overall Study|Withdrawal by Subject|0
7346294|NCT00918255|11585450|FG002|Overall Study|Withdrawal by Subject|2
7346295|NCT00918255|11585448|FG000|Overall Study|Lack of Efficacy|1
7346296|NCT00918255|11585449|FG001|Overall Study|Lack of Efficacy|0
7346297|NCT00918255|11585450|FG002|Overall Study|Lack of Efficacy|0
7346298|NCT00918255|11585448|FG000|Overall Study|Lost to Follow-up|1
7346299|NCT00918255|11585449|FG001|Overall Study|Lost to Follow-up|0
7346300|NCT00918255|11585450|FG002|Overall Study|Lost to Follow-up|2
7346301|NCT00918255|11585448|FG000|Overall Study|Exceeded allowed number of interventions|0
7346302|NCT00918255|11585449|FG001|Overall Study|Exceeded allowed number of interventions|0
7346303|NCT00918255|11585450|FG002|Overall Study|Exceeded allowed number of interventions|1
7346304|NCT00918255|11585448|FG000|Overall Study|Non-compliance|1
7346305|NCT00918255|11585449|FG001|Overall Study|Non-compliance|0
7346306|NCT00918255|11585450|FG002|Overall Study|Non-compliance|0
7346307|NCT00918255|11585448|FG000|Overall Study|Investigator discretion|1
7346308|NCT00918255|11585449|FG001|Overall Study|Investigator discretion|0
7346309|NCT00918255|11585450|FG002|Overall Study|Investigator discretion|0
7346310|NCT00918281|11585458|FG000|Overall Study|Physician Decision|29
7346311|NCT00918333|11585467|FG000|Overall Study|Drug not taken per protocol|1
7346312|NCT00918333|11585468|FG001|Overall Study|Drug not taken per protocol|0
7346313|NCT00918333|11585467|FG000|Overall Study|Inadequate amount of drugs provided|1
7346314|NCT00918333|11585468|FG001|Overall Study|Inadequate amount of drugs provided|4
7346315|NCT00918333|11585467|FG000|Overall Study|Ineligible|1
7346316|NCT00918333|11585468|FG001|Overall Study|Ineligible|0
7346317|NCT00918333|11585467|FG000|Overall Study|Withdrawal by Subject|0
7346318|NCT00918333|11585468|FG001|Overall Study|Withdrawal by Subject|1
7346319|NCT00918346|11585477|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
7346320|NCT00918346|11585478|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
7346321|NCT00918385|11585489|FG000|Monotherapy|Adverse Event|1
7346322|NCT00918385|11585490|FG001|Monotherapy|Adverse Event|6
7346323|NCT00918385|11585489|FG000|Monotherapy|Complicating illness|1
7346324|NCT00918385|11585490|FG001|Monotherapy|Complicating illness|0
7346325|NCT00918385|11585489|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
7346326|NCT00918385|11585490|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
7346327|NCT00918385|11585489|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7346328|NCT00918385|11585490|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
7346329|NCT00918385|11585489|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
7346330|NCT00918385|11585490|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
7346331|NCT00918385|11585489|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
7346332|NCT00918385|11585490|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
7346333|NCT00918567|11585500|FG000|Overall Study|Lack of Efficacy|3
7346334|NCT00918567|11585501|FG001|Overall Study|Lack of Efficacy|1
7346335|NCT00918567|11585500|FG000|Overall Study|Withdrawal by Subject|1
7346336|NCT00918567|11585501|FG001|Overall Study|Withdrawal by Subject|1
7346337|NCT00918567|11585500|FG000|Overall Study|Adverse Event|1
7346338|NCT00918567|11585501|FG001|Overall Study|Adverse Event|0
7346339|NCT00918580|11585507|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
7346340|NCT00918580|11585507|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
7346341|NCT00918580|11585507|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
7346342|NCT00918580|11585507|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
7346343|NCT00918580|11585507|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
7346344|NCT00918580|11585507|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
7346345|NCT00918580|11585507|FG000|After 6-month FU to 1-year FU|Failed to Return|2
7346346|NCT00918684|11585518|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
7346347|NCT00918684|11585518|FG000|Treatment Phase|Lack of Efficacy|6
7346348|NCT00918684|11585518|FG000|Treatment Phase|Lost to Follow-up|2
7346349|NCT00918684|11585518|FG000|Treatment Phase|Physician Decision|8
7346350|NCT00918684|11585518|FG000|Treatment Phase|Protocol Violation|1
7346351|NCT00918684|11585518|FG000|Treatment Phase|Withdrawal by Subject|8
7346352|NCT00918736|11585528|FG000|Overall Study|Withdrawal by Subject|4
7346353|NCT00918749|11585535|FG000|Overall Study|Adverse Event|1
7346354|NCT00918749|11585536|FG001|Overall Study|Adverse Event|0
7346356|NCT00918749|11585535|FG000|Overall Study|Lost to Follow-up|0
7346357|NCT00918749|11585536|FG001|Overall Study|Lost to Follow-up|0
7346358|NCT00918749|11585537|FG002|Overall Study|Lost to Follow-up|1
7346359|NCT00918749|11585535|FG000|Overall Study|Withdrawal by Subject|5
7346360|NCT00918749|11585536|FG001|Overall Study|Withdrawal by Subject|3
7346361|NCT00918749|11585537|FG002|Overall Study|Withdrawal by Subject|5
7346362|NCT00918749|11585535|FG000|Overall Study|No Study Medication Taken|1
7346363|NCT00918749|11585536|FG001|Overall Study|No Study Medication Taken|0
7346364|NCT00918749|11585537|FG002|Overall Study|No Study Medication Taken|0
7346365|NCT00918879|11585556|FG000|Overall Study|Withdrawal by Subject|4
7346366|NCT00918879|11585557|FG001|Overall Study|Withdrawal by Subject|4
7346367|NCT00918879|11585556|FG000|Overall Study|Lost to Follow-up|1
7458865|NCT01811472|11753074|FG001|Overall Study|Adverse Event|0
7458866|NCT01811472|11753075|FG002|Overall Study|Adverse Event|4
7458867|NCT01811472|11753073|FG000|Overall Study|Lost to Follow-up|0
7458868|NCT01811472|11753074|FG001|Overall Study|Lost to Follow-up|0
7458869|NCT01811472|11753075|FG002|Overall Study|Lost to Follow-up|1
7458870|NCT01811472|11753073|FG000|Overall Study|Subject/guardian decision|1
7458871|NCT01811472|11753074|FG001|Overall Study|Subject/guardian decision|0
7458872|NCT01811472|11753075|FG002|Overall Study|Subject/guardian decision|0
7458873|NCT01811485|11753087|FG000|Overall Study|Adverse Event|1
7458874|NCT01811485|11753088|FG001|Overall Study|Adverse Event|3
7458875|NCT01811485|11753089|FG002|Overall Study|Adverse Event|2
7458876|NCT01811485|11753087|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7458877|NCT01811485|11753088|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7458878|NCT01811485|11753089|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7458879|NCT01811485|11753087|FG000|Overall Study|Administrative problems|1
7458880|NCT01811485|11753088|FG001|Overall Study|Administrative problems|0
7458881|NCT01811485|11753089|FG002|Overall Study|Administrative problems|0
7458882|NCT01811485|11753087|FG000|Overall Study|Protocol Deviation|0
7458883|NCT01811485|11753088|FG001|Overall Study|Protocol Deviation|1
7458884|NCT01811485|11753089|FG002|Overall Study|Protocol Deviation|0
7458885|NCT01811563|11753102|FG000|Overall Study|Lost to Follow-up|5
7458886|NCT01811563|11753103|FG001|Overall Study|Lost to Follow-up|2
7458887|NCT01811563|11753102|FG000|Overall Study|Incorrect Randomization procedure|0
7458888|NCT01811563|11753103|FG001|Overall Study|Incorrect Randomization procedure|1
7458889|NCT01811706|11753132|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
7458890|NCT01811706|11753133|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
7458891|NCT01811732|11753143|FG000|Overall Study|Lost to Follow-up|24
7458892|NCT01811732|11753144|FG001|Overall Study|Lost to Follow-up|30
7458893|NCT01811732|11753143|FG000|Overall Study|Withdrawal by Subject|16
7458894|NCT01811732|11753144|FG001|Overall Study|Withdrawal by Subject|10
7458895|NCT01811732|11753143|FG000|Overall Study|Adverse Event|3
7458896|NCT01811732|11753144|FG001|Overall Study|Adverse Event|9
7458897|NCT01811732|11753143|FG000|Overall Study|Lack of Efficacy|3
7458898|NCT01811732|11753144|FG001|Overall Study|Lack of Efficacy|1
7458899|NCT01811732|11753143|FG000|Overall Study|Non-compliance with study drug/procedure|3
7458900|NCT01811732|11753144|FG001|Overall Study|Non-compliance with study drug/procedure|3
7458901|NCT01811732|11753143|FG000|Overall Study|Physician Decision|2
7458902|NCT01811732|11753144|FG001|Overall Study|Physician Decision|0
7458903|NCT01811732|11753143|FG000|Overall Study|Death|1
7458904|NCT01811732|11753144|FG001|Overall Study|Death|1
7458905|NCT01811732|11753143|FG000|Overall Study|Insufficient venous access|0
7458906|NCT01811732|11753144|FG001|Overall Study|Insufficient venous access|1
7458907|NCT01811732|11753143|FG000|Overall Study|Protocol Violation|0
7458908|NCT01811732|11753144|FG001|Overall Study|Protocol Violation|1
7458909|NCT01811732|11753143|FG000|Overall Study|Subject incarcerated|1
7458910|NCT01811732|11753144|FG001|Overall Study|Subject incarcerated|2
7458911|NCT01811732|11753143|FG000|Overall Study|Admitted to another facility|1
7458912|NCT01811732|11753144|FG001|Overall Study|Admitted to another facility|0
7533105|NCT02680756|11879201|FG001|Overall Study|Physician Decision|1
7533106|NCT02680756|11879200|FG000|Overall Study|Hb ≤7.5 g/dL|0
7533107|NCT02680756|11879201|FG001|Overall Study|Hb ≤7.5 g/dL|2
7458913|NCT01811732|11753143|FG000|Overall Study|Correct study drug not available on site|1
7458914|NCT01811732|11753144|FG001|Overall Study|Correct study drug not available on site|0
7458915|NCT01811953|11753170|FG000|Overall Study|Adverse Event|0
7458916|NCT01811953|11753171|FG001|Overall Study|Adverse Event|0
7458917|NCT01811953|11753172|FG002|Overall Study|Adverse Event|0
7458918|NCT01811953|11753173|FG003|Overall Study|Adverse Event|1
7458919|NCT01811953|11753174|FG004|Overall Study|Adverse Event|0
7458920|NCT01811953|11753175|FG005|Overall Study|Adverse Event|1
7458921|NCT01811953|11753170|FG000|Overall Study|Protocol Violation|0
7458922|NCT01811953|11753171|FG001|Overall Study|Protocol Violation|0
7458923|NCT01811953|11753172|FG002|Overall Study|Protocol Violation|0
7458924|NCT01811953|11753173|FG003|Overall Study|Protocol Violation|0
7458925|NCT01811953|11753174|FG004|Overall Study|Protocol Violation|1
7458926|NCT01811953|11753175|FG005|Overall Study|Protocol Violation|0
7458927|NCT01812057|11753213|FG000|Overall Study|Protocol Violation|1
7458928|NCT01812057|11753214|FG001|Overall Study|Protocol Violation|0
7458929|NCT01812057|11753213|FG000|Overall Study|Physician Decision|1
7458930|NCT01812057|11753214|FG001|Overall Study|Physician Decision|0
7458931|NCT01812109|11753224|FG000|Overall Study|research personnel delay|16
7458932|NCT01812109|11753224|FG000|Overall Study|NIRS Unattainable|17
7458933|NCT01812655|11753240|FG000|Overall Study|Protocol Violation|1
7458934|NCT01812655|11753241|FG001|Overall Study|Protocol Violation|1
7458935|NCT01812655|11753242|FG002|Overall Study|Protocol Violation|0
7458936|NCT01812707|11753270|FG000|Overall Study|Adverse Event|0
7458937|NCT01812707|11753271|FG001|Overall Study|Adverse Event|0
7346368|NCT00918879|11585557|FG001|Overall Study|Lost to Follow-up|1
7346369|NCT00918879|11585556|FG000|Overall Study|Severe non-compliance to protocol|1
7346370|NCT00918879|11585557|FG001|Overall Study|Severe non-compliance to protocol|1
7346371|NCT00918957|11585569|FG000|Overall Study|Adverse Event|2
7346372|NCT00918957|11585570|FG001|Overall Study|Adverse Event|0
7346373|NCT00918957|11585569|FG000|Overall Study|Withdrawal by Subject|1
7346374|NCT00918957|11585570|FG001|Overall Study|Withdrawal by Subject|0
7346375|NCT00919061|11585580|FG000|Overall Study|Adverse Event|1
7346376|NCT00919061|11585580|FG000|Overall Study|Withdrawal by Subject|1
7346377|NCT00919633|11585635|FG000|Overall Study|Adverse Event|1
7346378|NCT00919633|11585636|FG001|Overall Study|Adverse Event|9
7346379|NCT00919633|11585637|FG002|Overall Study|Adverse Event|12
7346380|NCT00919633|11585638|FG003|Overall Study|Adverse Event|10
7346381|NCT00919633|11585635|FG000|Overall Study|Death|0
7346382|NCT00919633|11585636|FG001|Overall Study|Death|0
7346383|NCT00919633|11585637|FG002|Overall Study|Death|2
7346384|NCT00919633|11585638|FG003|Overall Study|Death|0
7346385|NCT00919633|11585635|FG000|Overall Study|Lack of Efficacy|17
7346386|NCT00919633|11585636|FG001|Overall Study|Lack of Efficacy|3
7346387|NCT00919633|11585637|FG002|Overall Study|Lack of Efficacy|2
7346388|NCT00919633|11585638|FG003|Overall Study|Lack of Efficacy|3
7346389|NCT00919633|11585635|FG000|Overall Study|Withdrawal by Subject|1
7346390|NCT00919633|11585636|FG001|Overall Study|Withdrawal by Subject|2
7346391|NCT00919633|11585637|FG002|Overall Study|Withdrawal by Subject|4
7346392|NCT00919633|11585638|FG003|Overall Study|Withdrawal by Subject|3
7346393|NCT00919633|11585635|FG000|Overall Study|Lost to Follow-up|3
7346394|NCT00919633|11585636|FG001|Overall Study|Lost to Follow-up|1
7346395|NCT00919633|11585637|FG002|Overall Study|Lost to Follow-up|0
7346396|NCT00919633|11585638|FG003|Overall Study|Lost to Follow-up|2
7346397|NCT00919633|11585635|FG000|Overall Study|Withdraw consent post transition to SOC|0
7346398|NCT00919633|11585636|FG001|Overall Study|Withdraw consent post transition to SOC|0
7346399|NCT00919633|11585637|FG002|Overall Study|Withdraw consent post transition to SOC|1
7346400|NCT00919633|11585638|FG003|Overall Study|Withdraw consent post transition to SOC|1
7346401|NCT00919633|11585635|FG000|Overall Study|Protocol Violation|0
7346402|NCT00919633|11585636|FG001|Overall Study|Protocol Violation|0
7346403|NCT00919633|11585637|FG002|Overall Study|Protocol Violation|0
7346404|NCT00919633|11585638|FG003|Overall Study|Protocol Violation|1
7346405|NCT00919633|11585635|FG000|Overall Study|Physician Decision|0
7346406|NCT00919633|11585636|FG001|Overall Study|Physician Decision|0
7346407|NCT00919633|11585637|FG002|Overall Study|Physician Decision|0
7346408|NCT00919633|11585638|FG003|Overall Study|Physician Decision|1
7346409|NCT00919633|11585635|FG000|Overall Study|Request of withdrawal w/o future contact|0
7346410|NCT00919633|11585636|FG001|Overall Study|Request of withdrawal w/o future contact|0
7346411|NCT00919633|11585637|FG002|Overall Study|Request of withdrawal w/o future contact|1
7346412|NCT00919633|11585638|FG003|Overall Study|Request of withdrawal w/o future contact|0
7458938|NCT01812707|11753272|FG002|Overall Study|Adverse Event|0
7458939|NCT01812707|11753273|FG003|Overall Study|Adverse Event|2
7458940|NCT01812707|11753270|FG000|Overall Study|Poor compliance to protocol|1
7458941|NCT01812707|11753271|FG001|Overall Study|Poor compliance to protocol|0
7458942|NCT01812707|11753272|FG002|Overall Study|Poor compliance to protocol|0
7458943|NCT01812707|11753273|FG003|Overall Study|Poor compliance to protocol|0
7458944|NCT01812707|11753270|FG000|Overall Study|Consent withdrawn by participant|1
7458945|NCT01812707|11753271|FG001|Overall Study|Consent withdrawn by participant|0
7458946|NCT01812707|11753272|FG002|Overall Study|Consent withdrawn by participant|0
7458947|NCT01812707|11753273|FG003|Overall Study|Consent withdrawn by participant|0
7458948|NCT01812759|11753287|FG000|Overall Study|Physician Decision|0
7458949|NCT01812759|11753288|FG001|Overall Study|Physician Decision|0
7458950|NCT01812759|11753289|FG002|Overall Study|Physician Decision|1
7458951|NCT01812837|11753300|FG000|Overall Study|Lost to Follow-up|1
7458952|NCT01812837|11753301|FG001|Overall Study|Lost to Follow-up|1
7346413|NCT00919633|11585635|FG000|Overall Study|Viral rebound outside protocol timepoint|0
7346414|NCT00919633|11585636|FG001|Overall Study|Viral rebound outside protocol timepoint|0
7346415|NCT00919633|11585637|FG002|Overall Study|Viral rebound outside protocol timepoint|1
7346416|NCT00919633|11585638|FG003|Overall Study|Viral rebound outside protocol timepoint|0
7346417|NCT00919711|11585650|FG000|Overall Study|Withdrawal by Subject|15
7346418|NCT00919711|11585651|FG001|Overall Study|Withdrawal by Subject|7
7346419|NCT00919711|11585650|FG000|Overall Study|Adverse Event|13
7346420|NCT00919711|11585651|FG001|Overall Study|Adverse Event|3
7346421|NCT00919711|11585650|FG000|Overall Study|Other|1
7346422|NCT00919711|11585651|FG001|Overall Study|Other|2
7346423|NCT00919711|11585650|FG000|Overall Study|Administrative Decision|0
7346424|NCT00919711|11585651|FG001|Overall Study|Administrative Decision|1
7346425|NCT00919711|11585650|FG000|Overall Study|Lost to Follow-up|2
7346426|NCT00919711|11585651|FG001|Overall Study|Lost to Follow-up|0
7346427|NCT00919711|11585650|FG000|Overall Study|Death|1
7346428|NCT00919711|11585651|FG001|Overall Study|Death|0
7346429|NCT00919711|11585650|FG000|Overall Study|Noncompliance|1
7458953|NCT01812837|11753302|FG002|Overall Study|Lost to Follow-up|0
7458954|NCT01812837|11753300|FG000|Overall Study|Protocol Violation|1
7458955|NCT01812837|11753301|FG001|Overall Study|Protocol Violation|0
7458956|NCT01812837|11753302|FG002|Overall Study|Protocol Violation|0
7458957|NCT01813019|11753312|FG000|Overall Study|Adverse Event|0
7458958|NCT01813019|11753313|FG001|Overall Study|Adverse Event|3
7346430|NCT00919711|11585651|FG001|Overall Study|Noncompliance|0
7346431|NCT00919854|11585682|FG000|Overall Study|Adverse Event|1
7346432|NCT00919867|11585692|FG000|First Intervention|Withdrawal by Subject|0
7346433|NCT00919867|11585693|FG001|First Intervention|Withdrawal by Subject|0
7346434|NCT00919867|11585694|FG002|First Intervention|Withdrawal by Subject|1
7346435|NCT00919867|11585695|FG003|First Intervention|Withdrawal by Subject|0
7346436|NCT00919867|11585696|FG004|First Intervention|Withdrawal by Subject|0
7346437|NCT00919867|11585697|FG005|First Intervention|Withdrawal by Subject|0
7346438|NCT00919867|11585692|FG000|First Intervention|Physician Decision|0
7346439|NCT00919867|11585693|FG001|First Intervention|Physician Decision|0
7346440|NCT00919867|11585694|FG002|First Intervention|Physician Decision|0
7346441|NCT00919867|11585695|FG003|First Intervention|Physician Decision|0
7346442|NCT00919867|11585696|FG004|First Intervention|Physician Decision|0
7346443|NCT00919867|11585697|FG005|First Intervention|Physician Decision|1
7346444|NCT00920140|11585727|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
7346445|NCT00920140|11585728|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
7346446|NCT00920140|11585729|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
7346447|NCT00920140|11585730|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
7346448|NCT00920140|11585731|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
7346449|NCT00920140|11585727|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
7346450|NCT00920140|11585728|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
7346451|NCT00920140|11585729|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7346452|NCT00920140|11585730|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7346453|NCT00920140|11585731|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
7346454|NCT00920140|11585727|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7346455|NCT00920140|11585728|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
7346456|NCT00920140|11585729|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7346457|NCT00920140|11585730|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7346458|NCT00920140|11585731|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
7346459|NCT00920140|11585727|FG000|Phase 2|Adverse Event|0
7346460|NCT00920140|11585728|FG001|Phase 2|Adverse Event|0
7346461|NCT00920140|11585729|FG002|Phase 2|Adverse Event|14
7346462|NCT00920140|11585730|FG003|Phase 2|Adverse Event|2
7346463|NCT00920140|11585731|FG004|Phase 2|Adverse Event|3
7346464|NCT00920140|11585727|FG000|Phase 2|Lack of Efficacy|0
7346465|NCT00920140|11585728|FG001|Phase 2|Lack of Efficacy|0
7346466|NCT00920140|11585729|FG002|Phase 2|Lack of Efficacy|29
7346467|NCT00920140|11585730|FG003|Phase 2|Lack of Efficacy|14
7346468|NCT00920140|11585731|FG004|Phase 2|Lack of Efficacy|5
7346469|NCT00920140|11585727|FG000|Phase 2|Lost to Follow-up|0
7346470|NCT00920140|11585728|FG001|Phase 2|Lost to Follow-up|0
7346471|NCT00920140|11585729|FG002|Phase 2|Lost to Follow-up|0
7346472|NCT00920140|11585730|FG003|Phase 2|Lost to Follow-up|1
7346473|NCT00920140|11585731|FG004|Phase 2|Lost to Follow-up|0
7346474|NCT00920140|11585727|FG000|Phase 2|Physician Decision|0
7346475|NCT00920140|11585728|FG001|Phase 2|Physician Decision|0
7346476|NCT00920140|11585729|FG002|Phase 2|Physician Decision|3
7346477|NCT00920140|11585730|FG003|Phase 2|Physician Decision|3
7346478|NCT00920140|11585731|FG004|Phase 2|Physician Decision|2
7346479|NCT00920140|11585727|FG000|Phase 2|Withdrawal by Subject|0
7346480|NCT00920140|11585728|FG001|Phase 2|Withdrawal by Subject|0
7346481|NCT00920140|11585729|FG002|Phase 2|Withdrawal by Subject|4
7346482|NCT00920140|11585730|FG003|Phase 2|Withdrawal by Subject|2
7346483|NCT00920140|11585731|FG004|Phase 2|Withdrawal by Subject|1
7385910|NCT01205581|11643931|FG003|Overall Study|Withdrawal by Subject|0
7385911|NCT01205581|11643932|FG004|Overall Study|Withdrawal by Subject|0
7385912|NCT01205581|11643933|FG005|Overall Study|Withdrawal by Subject|0
7385913|NCT01205685|11643968|FG000|Overall Study|Disease Progression|10
7385914|NCT01205685|11643968|FG000|Overall Study|Withdrawal by Subject|1
7385915|NCT01205776|11643974|FG000|Overall Study|Lost to Follow-up|53
7385916|NCT01205776|11643975|FG001|Overall Study|Lost to Follow-up|61
7385917|NCT01205776|11643974|FG000|Overall Study|Withdrawal by Subject|11
7385918|NCT01205776|11643975|FG001|Overall Study|Withdrawal by Subject|34
7385919|NCT01206140|11643999|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
7385920|NCT01206140|11644000|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
7385921|NCT01206166|11644008|FG000|Overall Study|No evaluable data|2
7385922|NCT01206166|11644009|FG001|Overall Study|No evaluable data|3
7385923|NCT01206322|11644020|FG000|Overall Study|Adverse Event|0
7385924|NCT01206322|11644021|FG001|Overall Study|Adverse Event|0
7385925|NCT01206322|11644022|FG002|Overall Study|Adverse Event|0
7385926|NCT01206322|11644023|FG003|Overall Study|Adverse Event|1
7385927|NCT01206582|11644082|FG000|Overall Study|Withdrew prior to study|1
7385928|NCT01206582|11644083|FG001|Overall Study|Withdrew prior to study|0
7569145|NCT03439072|11945084|FG000|Overall Study|Withdrawal by Subject|2
7569146|NCT03439072|11945085|FG001|Overall Study|Withdrawal by Subject|3
7569147|NCT03439072|11945084|FG000|Overall Study|Physician Decision|0
7569148|NCT03439072|11945085|FG001|Overall Study|Physician Decision|1
7385929|NCT01206582|11644082|FG000|Overall Study|Discontinued intervention before week 8|1
7385930|NCT01206582|11644083|FG001|Overall Study|Discontinued intervention before week 8|2
7385931|NCT01206764|11644133|FG000|Overall Study|Adverse Event|20
7385932|NCT01206764|11644133|FG000|Overall Study|Abnormal laboratory value|2
7385933|NCT01206764|11644133|FG000|Overall Study|Abnormal test procedure result|1
7385934|NCT01206764|11644133|FG000|Overall Study|Patient withdrew consent|5
7385935|NCT01206764|11644133|FG000|Overall Study|Lost to Follow-up|6
7346484|NCT00920218|11585748|FG000|Overall Study|Serious Adverse Event|2
7346485|NCT00920218|11585749|FG001|Overall Study|Serious Adverse Event|0
7346486|NCT00920218|11585750|FG002|Overall Study|Serious Adverse Event|2
7346487|NCT00920218|11585751|FG003|Overall Study|Serious Adverse Event|1
7346488|NCT00920218|11585748|FG000|Overall Study|Withdrawal by Subject|0
7346489|NCT00920218|11585749|FG001|Overall Study|Withdrawal by Subject|3
7346490|NCT00920218|11585750|FG002|Overall Study|Withdrawal by Subject|2
7346491|NCT00920218|11585751|FG003|Overall Study|Withdrawal by Subject|0
7346492|NCT00920218|11585748|FG000|Overall Study|Migrated/moved from study area|0
7346493|NCT00920218|11585749|FG001|Overall Study|Migrated/moved from study area|0
7346494|NCT00920218|11585750|FG002|Overall Study|Migrated/moved from study area|1
7346495|NCT00920218|11585751|FG003|Overall Study|Migrated/moved from study area|0
7346496|NCT00920218|11585748|FG000|Overall Study|Lost to Follow-up|0
7346497|NCT00920218|11585749|FG001|Overall Study|Lost to Follow-up|1
7346498|NCT00920218|11585750|FG002|Overall Study|Lost to Follow-up|0
7346499|NCT00920218|11585751|FG003|Overall Study|Lost to Follow-up|3
7346500|NCT00920218|11585748|FG000|Overall Study|Transplant failed/malignancy recurrence|0
7346501|NCT00920218|11585749|FG001|Overall Study|Transplant failed/malignancy recurrence|1
7346502|NCT00920218|11585750|FG002|Overall Study|Transplant failed/malignancy recurrence|2
7346503|NCT00920218|11585751|FG003|Overall Study|Transplant failed/malignancy recurrence|3
7346504|NCT00920218|11585748|FG000|Overall Study|Other|0
7346505|NCT00920218|11585749|FG001|Overall Study|Other|0
7346506|NCT00920218|11585750|FG002|Overall Study|Other|1
7346507|NCT00920218|11585751|FG003|Overall Study|Other|0
7346508|NCT00920426|11585788|FG000|ITZ111451|Adverse Event|1
7346509|NCT00920426|11585789|FG001|ITZ111451|Adverse Event|0
7346510|NCT00920426|11585790|FG002|ITZ111451|Adverse Event|0
7346511|NCT00920426|11585791|FG003|ITZ111451|Adverse Event|0
7346512|NCT00920556|11585807|FG000|Overall Study|Adverse Event|16
7346513|NCT00920556|11585807|FG000|Overall Study|Physician Decision|7
7346514|NCT00920556|11585807|FG000|Overall Study|Withdrawal by Subject|1
7346515|NCT00920686|11585845|FG000|Overall Study|Lost to Follow-up|2
7346516|NCT00920686|11585846|FG001|Overall Study|Lost to Follow-up|3
7346517|NCT00920686|11585847|FG002|Overall Study|Lost to Follow-up|1
7346518|NCT00920686|11585845|FG000|Overall Study|Study drug dosing criteria not met|17
7346519|NCT00920686|11585846|FG001|Overall Study|Study drug dosing criteria not met|19
7346520|NCT00920686|11585847|FG002|Overall Study|Study drug dosing criteria not met|12
7346521|NCT00920699|11585862|FG000|Overall Study|Withdrawal by Subject|2
7346522|NCT00920699|11585863|FG001|Overall Study|Withdrawal by Subject|0
7346523|NCT00920699|11585864|FG002|Overall Study|Withdrawal by Subject|2
7346524|NCT00920699|11585862|FG000|Overall Study|no longer met eligibility|0
7346525|NCT00920699|11585863|FG001|Overall Study|no longer met eligibility|1
7346526|NCT00920699|11585864|FG002|Overall Study|no longer met eligibility|0
7346527|NCT00920699|11585862|FG000|Overall Study|Lost to Follow-up|0
7346528|NCT00920699|11585863|FG001|Overall Study|Lost to Follow-up|0
7346529|NCT00920699|11585864|FG002|Overall Study|Lost to Follow-up|2
7346530|NCT00920790|11585872|FG000|Overall Study|aggravation of general condition|14
7346531|NCT00920829|11585880|FG000|Allocation|No post randomization data|3
7346532|NCT00920829|11585881|FG001|Allocation|No post randomization data|1
7346533|NCT00920829|11585882|FG002|Allocation|No post randomization data|0
7346534|NCT00920829|11585883|FG003|Allocation|No post randomization data|2
7346535|NCT00920829|11585880|FG000|Available for Analysis|Withdrawal by Subject|6
7346536|NCT00920829|11585881|FG001|Available for Analysis|Withdrawal by Subject|6
7346537|NCT00920829|11585882|FG002|Available for Analysis|Withdrawal by Subject|6
7346538|NCT00920829|11585883|FG003|Available for Analysis|Withdrawal by Subject|10
7346539|NCT00920829|11585880|FG000|Available for Analysis|Required Medical Treatment|0
7346540|NCT00920829|11585881|FG001|Available for Analysis|Required Medical Treatment|1
7346541|NCT00920829|11585882|FG002|Available for Analysis|Required Medical Treatment|2
7346542|NCT00920829|11585883|FG003|Available for Analysis|Required Medical Treatment|0
7346543|NCT00920829|11585880|FG000|Available for Analysis|Adverse Event|1
7346544|NCT00920829|11585881|FG001|Available for Analysis|Adverse Event|2
7346545|NCT00920829|11585882|FG002|Available for Analysis|Adverse Event|1
7346546|NCT00920829|11585883|FG003|Available for Analysis|Adverse Event|0
7346547|NCT00920829|11585880|FG000|Available for Analysis|Death|1
7346548|NCT00920829|11585881|FG001|Available for Analysis|Death|0
7346549|NCT00920829|11585882|FG002|Available for Analysis|Death|0
7346550|NCT00920829|11585883|FG003|Available for Analysis|Death|0
7346551|NCT00920829|11585880|FG000|Available for Analysis|Protocol Violation|0
7346552|NCT00920829|11585881|FG001|Available for Analysis|Protocol Violation|0
7346553|NCT00920829|11585882|FG002|Available for Analysis|Protocol Violation|1
7346554|NCT00920829|11585883|FG003|Available for Analysis|Protocol Violation|0
7346555|NCT00920829|11585880|FG000|Available for Analysis|Required more treatment|0
7346556|NCT00920829|11585881|FG001|Available for Analysis|Required more treatment|2
7346557|NCT00920829|11585882|FG002|Available for Analysis|Required more treatment|0
7346558|NCT00920829|11585883|FG003|Available for Analysis|Required more treatment|1
7346559|NCT00920855|11585896|FG000|Overall Study|Adverse Event|1
7346560|NCT00920855|11585897|FG001|Overall Study|Adverse Event|1
7346561|NCT00920855|11585898|FG002|Overall Study|Adverse Event|4
7346562|NCT00920855|11585896|FG000|Overall Study|Withdrawal by Subject|2
7346563|NCT00920855|11585897|FG001|Overall Study|Withdrawal by Subject|1
7346564|NCT00920855|11585898|FG002|Overall Study|Withdrawal by Subject|6
7346565|NCT00920855|11585896|FG000|Overall Study|Disease progression|2
7346566|NCT00920855|11585897|FG001|Overall Study|Disease progression|1
7346567|NCT00920855|11585898|FG002|Overall Study|Disease progression|10
7346568|NCT00920855|11585896|FG000|Overall Study|Noncompliance to study medication|0
7346569|NCT00920855|11585897|FG001|Overall Study|Noncompliance to study medication|0
7346570|NCT00920855|11585898|FG002|Overall Study|Noncompliance to study medication|1
7346571|NCT00920855|11585896|FG000|Overall Study|Response plateau; started maintenance|0
7346572|NCT00920855|11585897|FG001|Overall Study|Response plateau; started maintenance|0
7346573|NCT00920855|11585898|FG002|Overall Study|Response plateau; started maintenance|1
7346574|NCT00920907|11585909|FG000|Induction Period|Adverse Event|0
7458959|NCT01813019|11753312|FG000|Overall Study|Withdrawal by Subject|3
7458960|NCT01813019|11753313|FG001|Overall Study|Withdrawal by Subject|2
7458961|NCT01813019|11753312|FG000|Overall Study|administrative problems|2
7458962|NCT01813019|11753313|FG001|Overall Study|administrative problems|0
7346575|NCT00920907|11585910|FG001|Induction Period|Adverse Event|2
7346576|NCT00920907|11585909|FG000|Induction Period|Death|1
7458963|NCT01813019|11753312|FG000|Overall Study|Protocol Deviation|2
7458964|NCT01813019|11753313|FG001|Overall Study|Protocol Deviation|1
7346577|NCT00920907|11585910|FG001|Induction Period|Death|1
7346578|NCT00920907|11585909|FG000|Induction Period|Disease Progression|12
7346579|NCT00920907|11585910|FG001|Induction Period|Disease Progression|11
7346580|NCT00920907|11585909|FG000|Induction Period|Study Drug Toxicity|8
7346581|NCT00920907|11585910|FG001|Induction Period|Study Drug Toxicity|6
7346582|NCT00920907|11585909|FG000|Induction Period|No longer meets study criteria|0
7346583|NCT00920907|11585910|FG001|Induction Period|No longer meets study criteria|1
7346584|NCT00920907|11585909|FG000|Induction Period|Withdrawal by Subject|1
7346585|NCT00920907|11585910|FG001|Induction Period|Withdrawal by Subject|1
7346586|NCT00920907|11585909|FG000|Maintenance Period|Disease Progression|3
7346587|NCT00920907|11585910|FG001|Maintenance Period|Disease Progression|7
7346588|NCT00920907|11585909|FG000|Maintenance Period|Administrative (study closure)|7
7346589|NCT00920907|11585910|FG001|Maintenance Period|Administrative (study closure)|2
7346590|NCT00920907|11585909|FG000|Maintenance Period|Study Drug Toxicity|0
7346591|NCT00920907|11585910|FG001|Maintenance Period|Study Drug Toxicity|2
7346592|NCT00920907|11585909|FG000|Maintenance Period|Death|1
7346593|NCT00920907|11585910|FG001|Maintenance Period|Death|1
7346594|NCT00920907|11585909|FG000|Maintenance Period|Withdrawal by Subject|1
7346595|NCT00920907|11585910|FG001|Maintenance Period|Withdrawal by Subject|0
7346596|NCT00920907|11585909|FG000|Maintenance Period|Adverse Event|0
7346597|NCT00920907|11585910|FG001|Maintenance Period|Adverse Event|1
7346598|NCT00921024|11585920|FG000|Overall Study|Lost to Follow-up|2
7346599|NCT00921024|11585921|FG001|Overall Study|Lost to Follow-up|0
7346600|NCT00921024|11585920|FG000|Overall Study|Received concomittant therapy|2
7346601|NCT00921024|11585921|FG001|Overall Study|Received concomittant therapy|0
7346602|NCT00921024|11585920|FG000|Overall Study|Withdrawal by Subject|0
7346603|NCT00921024|11585921|FG001|Overall Study|Withdrawal by Subject|3
7346604|NCT00921557|11585955|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
7346605|NCT00921557|11585956|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7346606|NCT00921557|11585957|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
7346607|NCT00921557|11585955|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
7346608|NCT00921557|11585956|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
7346609|NCT00921557|11585957|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
7346610|NCT00921557|11585955|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7346611|NCT00921557|11585956|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
7346612|NCT00921557|11585957|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
7346613|NCT00921557|11585955|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
7346614|NCT00921557|11585956|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
7346615|NCT00921557|11585957|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
7346616|NCT00921557|11585955|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
7346617|NCT00921557|11585956|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7346618|NCT00921557|11585957|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
7346619|NCT00922116|11586014|FG000|Overall Study|Adverse Event|4
7346620|NCT00922116|11586014|FG000|Overall Study|Death|1
7346621|NCT00922116|11586014|FG000|Overall Study|Lost to Follow-up|1
7346622|NCT00922116|11586014|FG000|Overall Study|Withdrawal by Subject|4
7346623|NCT00922116|11586014|FG000|Overall Study|Other|5
7346624|NCT00922207|11586025|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
7346625|NCT00922207|11586026|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
7346626|NCT00922207|11586027|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
7346627|NCT00922207|11586025|FG000|Overall Study|Insufficient Therapeutic Response|0
7346628|NCT00922207|11586026|FG001|Overall Study|Insufficient Therapeutic Response|0
7346629|NCT00922207|11586027|FG002|Overall Study|Insufficient Therapeutic Response|1
7346630|NCT00922207|11586025|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7346631|NCT00922207|11586026|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7346632|NCT00922207|11586027|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7346633|NCT00922207|11586025|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
7346634|NCT00922207|11586026|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7346635|NCT00922207|11586027|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
7346636|NCT00922207|11586025|FG000|Overall Study|Withdrew Consent|2
7346637|NCT00922207|11586026|FG001|Overall Study|Withdrew Consent|5
7346638|NCT00922207|11586027|FG002|Overall Study|Withdrew Consent|2
7346639|NCT00922207|11586025|FG000|Overall Study|Abnormality of Laboratory Test|0
7346640|NCT00922207|11586026|FG001|Overall Study|Abnormality of Laboratory Test|1
7346641|NCT00922207|11586027|FG002|Overall Study|Abnormality of Laboratory Test|1
7346642|NCT00922272|11586040|FG000|Open-label Phase|Adverse Event|5
7346643|NCT00922272|11586041|FG001|Open-label Phase|Adverse Event|0
7346644|NCT00922272|11586040|FG000|Open-label Phase|Protocol Violation|1
7346645|NCT00922272|11586041|FG001|Open-label Phase|Protocol Violation|0
7346646|NCT00922272|11586040|FG000|Open-label Phase|Withdrawal by Subject|11
7346647|NCT00922272|11586041|FG001|Open-label Phase|Withdrawal by Subject|0
7346648|NCT00922272|11586040|FG000|Open-label Phase|Failure to meet randomization criteria|1
7346649|NCT00922272|11586041|FG001|Open-label Phase|Failure to meet randomization criteria|0
7346650|NCT00922272|11586040|FG000|Open-label Phase|Withdrawal criteria met|5
7346651|NCT00922272|11586041|FG001|Open-label Phase|Withdrawal criteria met|0
7346652|NCT00922272|11586040|FG000|Double-blind Phase|Adverse Event|1
7346653|NCT00922272|11586041|FG001|Double-blind Phase|Adverse Event|1
7346654|NCT00922272|11586040|FG000|Double-blind Phase|Withdrawal by Subject|1
7346655|NCT00922272|11586041|FG001|Double-blind Phase|Withdrawal by Subject|1
7346656|NCT00922272|11586040|FG000|Double-blind Phase|Lost to Follow-up|2
7346657|NCT00922272|11586041|FG001|Double-blind Phase|Lost to Follow-up|1
7346658|NCT00922272|11586040|FG000|Double-blind Phase|Withdrawal criteria met|1
7346659|NCT00922272|11586041|FG001|Double-blind Phase|Withdrawal criteria met|1
7346660|NCT00922272|11586040|FG000|Double-blind Phase|Noncompliance|1
7346661|NCT00922272|11586041|FG001|Double-blind Phase|Noncompliance|1
7346662|NCT00922272|11586040|FG000|Double-blind Phase|Positive urine drug screen|1
7346663|NCT00922272|11586041|FG001|Double-blind Phase|Positive urine drug screen|1
7346664|NCT00922428|11586049|FG000|Overall Study|retrospective/extremely implausible data|2
7346665|NCT00922428|11586049|FG000|Overall Study|no medication use or questionable use|13
7346666|NCT00922441|11586062|FG000|Overall Study|Protocol Violation|0
7346667|NCT00922441|11586063|FG001|Overall Study|Protocol Violation|0
7346668|NCT00922441|11586064|FG002|Overall Study|Protocol Violation|2
7346669|NCT00922441|11586062|FG000|Overall Study|Withdrawal by Subject|0
7346670|NCT00922441|11586063|FG001|Overall Study|Withdrawal by Subject|0
7346671|NCT00922441|11586064|FG002|Overall Study|Withdrawal by Subject|1
7346672|NCT00922480|11586074|FG000|Main Study|Protocol Violation|3
7346673|NCT00922480|11586075|FG001|Main Study|Protocol Violation|6
7346674|NCT00922480|11586074|FG000|Main Study|Adverse Event|6
7346675|NCT00922480|11586075|FG001|Main Study|Adverse Event|7
7346676|NCT00922480|11586074|FG000|Main Study|Lack of Efficacy|3
7346677|NCT00922480|11586075|FG001|Main Study|Lack of Efficacy|0
7346678|NCT00922480|11586074|FG000|Main Study|Withdrawal by Subject|20
7346679|NCT00922480|11586075|FG001|Main Study|Withdrawal by Subject|15
7346680|NCT00922480|11586074|FG000|Main Study|Lost to Follow-up|5
7346681|NCT00922480|11586075|FG001|Main Study|Lost to Follow-up|0
7346682|NCT00922480|11586074|FG000|Main Study|Physician Decision|0
7346683|NCT00922480|11586075|FG001|Main Study|Physician Decision|1
7346684|NCT00922480|11586074|FG000|Extension Study|Protocol Violation|3
7346685|NCT00922480|11586075|FG001|Extension Study|Protocol Violation|0
7346686|NCT00922480|11586074|FG000|Extension Study|Adverse Event|1
7346687|NCT00922480|11586075|FG001|Extension Study|Adverse Event|1
7346688|NCT00922480|11586074|FG000|Extension Study|Withdrawal by Subject|1
7346689|NCT00922480|11586075|FG001|Extension Study|Withdrawal by Subject|1
7346690|NCT00922480|11586074|FG000|Extension Study|Others|0
7346691|NCT00922480|11586075|FG001|Extension Study|Others|1
7346692|NCT00922623|11586083|FG000|Overall Study|Other|4
7346693|NCT00922623|11586083|FG000|Overall Study|Lost to Follow-up|1
7346694|NCT00922636|11586094|FG000|Overall Study|Adverse Event|3
7346695|NCT00922636|11586095|FG001|Overall Study|Adverse Event|3
7346696|NCT00922636|11586096|FG002|Overall Study|Adverse Event|2
7346697|NCT00922636|11586097|FG003|Overall Study|Adverse Event|3
7346698|NCT00922636|11586098|FG004|Overall Study|Adverse Event|2
7346699|NCT00922636|11586094|FG000|Overall Study|Lack of Efficacy|1
7346700|NCT00922636|11586095|FG001|Overall Study|Lack of Efficacy|7
7346701|NCT00922636|11586096|FG002|Overall Study|Lack of Efficacy|3
7346702|NCT00922636|11586097|FG003|Overall Study|Lack of Efficacy|2
7346703|NCT00922636|11586098|FG004|Overall Study|Lack of Efficacy|4
7346704|NCT00922636|11586094|FG000|Overall Study|Sponsor Decision|0
7346705|NCT00922636|11586095|FG001|Overall Study|Sponsor Decision|0
7346706|NCT00922636|11586096|FG002|Overall Study|Sponsor Decision|2
7346707|NCT00922636|11586097|FG003|Overall Study|Sponsor Decision|0
7346708|NCT00922636|11586098|FG004|Overall Study|Sponsor Decision|0
7346709|NCT00922636|11586094|FG000|Overall Study|Withdrawal by Subject|0
7346710|NCT00922636|11586095|FG001|Overall Study|Withdrawal by Subject|0
7346711|NCT00922636|11586096|FG002|Overall Study|Withdrawal by Subject|5
7346712|NCT00922636|11586097|FG003|Overall Study|Withdrawal by Subject|2
7346713|NCT00922636|11586098|FG004|Overall Study|Withdrawal by Subject|4
7346714|NCT00922636|11586094|FG000|Overall Study|Protocol Violation|0
7346715|NCT00922636|11586095|FG001|Overall Study|Protocol Violation|0
7346716|NCT00922636|11586096|FG002|Overall Study|Protocol Violation|2
7346717|NCT00922636|11586097|FG003|Overall Study|Protocol Violation|2
7346718|NCT00922636|11586098|FG004|Overall Study|Protocol Violation|0
7346719|NCT00922636|11586094|FG000|Overall Study|Entry Criteria Not Met|0
7346720|NCT00922636|11586095|FG001|Overall Study|Entry Criteria Not Met|0
7346721|NCT00922636|11586096|FG002|Overall Study|Entry Criteria Not Met|1
7346722|NCT00922636|11586097|FG003|Overall Study|Entry Criteria Not Met|1
7346723|NCT00922636|11586098|FG004|Overall Study|Entry Criteria Not Met|0
7346724|NCT00922636|11586094|FG000|Overall Study|Parent/Caregiver Decision|2
7346725|NCT00922636|11586095|FG001|Overall Study|Parent/Caregiver Decision|4
7346726|NCT00922636|11586096|FG002|Overall Study|Parent/Caregiver Decision|3
7346727|NCT00922636|11586097|FG003|Overall Study|Parent/Caregiver Decision|5
7346728|NCT00922636|11586098|FG004|Overall Study|Parent/Caregiver Decision|2
7346729|NCT00922636|11586094|FG000|Overall Study|Lost to Follow-up|1
7346730|NCT00922636|11586095|FG001|Overall Study|Lost to Follow-up|2
7346731|NCT00922636|11586096|FG002|Overall Study|Lost to Follow-up|2
7346732|NCT00922636|11586097|FG003|Overall Study|Lost to Follow-up|2
7346733|NCT00922636|11586098|FG004|Overall Study|Lost to Follow-up|4
7346734|NCT00922766|11586119|FG000|Overall Study|Death|3
7346735|NCT00922766|11586119|FG000|Overall Study|Withdrawal by Subject|2
7346736|NCT00922766|11586119|FG000|Overall Study|Other|1
7346737|NCT00922766|11586119|FG000|Overall Study|Adverse Event|1
7346738|NCT00922779|11586123|FG000|Overall Study|Adverse Event|67
7346739|NCT00922779|11586123|FG000|Overall Study|Pregnancy|7
7346740|NCT00922779|11586123|FG000|Overall Study|Withdrawal by Subject|308
7346741|NCT00922779|11586123|FG000|Overall Study|Lost to Follow-up|44
7346742|NCT00922779|11586123|FG000|Overall Study|Other|27
7346743|NCT00922779|11586123|FG000|Overall Study|Missing|1874
7346744|NCT00922935|11586134|FG000|Overall Study|Protocol Violation|0
7346745|NCT00922935|11586135|FG001|Overall Study|Protocol Violation|3
7346746|NCT00922935|11586136|FG002|Overall Study|Protocol Violation|0
7346747|NCT00922935|11586134|FG000|Overall Study|Physician Decision|1
7346748|NCT00922935|11586135|FG001|Overall Study|Physician Decision|1
7346749|NCT00922935|11586136|FG002|Overall Study|Physician Decision|0
7346750|NCT00922935|11586134|FG000|Overall Study|Lost to Follow-up|0
7346751|NCT00922935|11586135|FG001|Overall Study|Lost to Follow-up|1
7346752|NCT00922935|11586136|FG002|Overall Study|Lost to Follow-up|0
7346753|NCT00922974|11586147|FG000|Phase II Component|Protocol Violation|2
7346754|NCT00922974|11586148|FG001|Phase II Component|Protocol Violation|0
7346755|NCT00922974|11586147|FG000|Phase II Component|Not evaluable for treatment review|5
7346756|NCT00922974|11586148|FG001|Phase II Component|Not evaluable for treatment review|0
7346757|NCT00922974|11586147|FG000|Phase III Component|Protocol Violation|8
7346758|NCT00922974|11586148|FG001|Phase III Component|Protocol Violation|6
7346759|NCT00922987|11586156|FG000|Overall Study|Insufficient clinical response|1
7346760|NCT00922987|11586156|FG000|Overall Study|Protocol Violation|2
7346761|NCT00922987|11586156|FG000|Overall Study|Adverse Event|1
7346762|NCT00923078|11586163|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7346763|NCT00923078|11586164|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
7346764|NCT00923078|11586165|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
7346765|NCT00923078|11586163|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
7346766|NCT00923078|11586164|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
7346767|NCT00923078|11586165|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
7346768|NCT00923091|11586180|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
7346769|NCT00923091|11586181|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
7346770|NCT00923091|11586182|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
7346771|NCT00923091|11586183|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
7346772|NCT00923091|11586184|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
7346773|NCT00923091|11586185|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
7346774|NCT00923091|11586186|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
7346775|NCT00923091|11586187|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
7346776|NCT00923091|11586188|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7346777|NCT00923091|11586189|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7346778|NCT00923091|11586190|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7346779|NCT00923091|11586191|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7569149|NCT03439137|11945093|FG000|Overall Study|Adverse Event|16
7346780|NCT00923091|11586192|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
7346781|NCT00923091|11586180|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
7346782|NCT00923091|11586181|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7346783|NCT00923091|11586182|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7569150|NCT03439137|11945094|FG001|Overall Study|Adverse Event|12
7569151|NCT03439137|11945093|FG000|Overall Study|Physician Decision|0
7569152|NCT03439137|11945094|FG001|Overall Study|Physician Decision|5
7569153|NCT03439137|11945093|FG000|Overall Study|Withdrawal by Subject|14
7569154|NCT03439137|11945094|FG001|Overall Study|Withdrawal by Subject|4
7346784|NCT00923091|11586183|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
7346785|NCT00923091|11586184|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
7346786|NCT00923091|11586185|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
7346787|NCT00923091|11586186|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7346788|NCT00923091|11586187|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
7346789|NCT00923091|11586188|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7346790|NCT00923091|11586189|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7346791|NCT00923091|11586190|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7346792|NCT00923091|11586191|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7346793|NCT00923091|11586192|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
7346794|NCT00923091|11586180|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7346795|NCT00923091|11586181|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7346796|NCT00923091|11586182|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
7346797|NCT00923091|11586183|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
7346798|NCT00923091|11586184|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7346799|NCT00923091|11586185|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
7346800|NCT00923091|11586186|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
7346801|NCT00923091|11586187|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
7346802|NCT00923091|11586188|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7346803|NCT00923091|11586189|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7346804|NCT00923091|11586190|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7346805|NCT00923091|11586191|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7569155|NCT03439137|11945093|FG000|Overall Study|Conducting rescue therapy|2
7346806|NCT00923091|11586192|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
7346807|NCT00923091|11586180|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346808|NCT00923091|11586181|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346809|NCT00923091|11586182|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346810|NCT00923091|11586183|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346811|NCT00923091|11586184|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346812|NCT00923091|11586185|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
7346813|NCT00923091|11586186|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346814|NCT00923091|11586187|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346815|NCT00923091|11586188|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346816|NCT00923091|11586189|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346817|NCT00923091|11586190|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346818|NCT00923091|11586191|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346819|NCT00923091|11586192|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
7346820|NCT00923091|11586180|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346821|NCT00923091|11586181|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7346822|NCT00923091|11586182|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346823|NCT00923091|11586183|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7346824|NCT00923091|11586184|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346825|NCT00923091|11586185|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
7346826|NCT00923091|11586186|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346827|NCT00923091|11586187|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346828|NCT00923091|11586188|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346829|NCT00923091|11586189|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346830|NCT00923091|11586190|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346831|NCT00923091|11586191|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346832|NCT00923091|11586192|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
7346833|NCT00923091|11586180|FG000|Period III (Single-Blind)|Adverse Event|5
7346834|NCT00923091|11586181|FG001|Period III (Single-Blind)|Adverse Event|0
7346835|NCT00923091|11586182|FG002|Period III (Single-Blind)|Adverse Event|0
7346836|NCT00923091|11586183|FG003|Period III (Single-Blind)|Adverse Event|0
7346837|NCT00923091|11586184|FG004|Period III (Single-Blind)|Adverse Event|0
7346838|NCT00923091|11586185|FG005|Period III (Single-Blind)|Adverse Event|0
7346839|NCT00923091|11586186|FG006|Period III (Single-Blind)|Adverse Event|0
7346840|NCT00923091|11586187|FG007|Period III (Single-Blind)|Adverse Event|0
7346841|NCT00923091|11586188|FG008|Period III (Single-Blind)|Adverse Event|0
7346842|NCT00923091|11586189|FG009|Period III (Single-Blind)|Adverse Event|0
7346843|NCT00923091|11586190|FG010|Period III (Single-Blind)|Adverse Event|0
7346844|NCT00923091|11586191|FG011|Period III (Single-Blind)|Adverse Event|0
7346845|NCT00923091|11586192|FG012|Period III (Single-Blind)|Adverse Event|0
7346846|NCT00923091|11586180|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
7346847|NCT00923091|11586181|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
7346848|NCT00923091|11586182|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
7346849|NCT00923091|11586183|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
7346850|NCT00923091|11586184|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
7346851|NCT00923091|11586185|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
7346852|NCT00923091|11586186|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
7346853|NCT00923091|11586187|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
7346854|NCT00923091|11586188|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
7346855|NCT00923091|11586189|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
7346856|NCT00923091|11586190|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
7346857|NCT00923091|11586191|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
7346858|NCT00923091|11586192|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
7346859|NCT00923091|11586180|FG000|Period III (Single-Blind)|Protocol Violation|3
7346860|NCT00923091|11586181|FG001|Period III (Single-Blind)|Protocol Violation|0
7346861|NCT00923091|11586182|FG002|Period III (Single-Blind)|Protocol Violation|0
7346862|NCT00923091|11586183|FG003|Period III (Single-Blind)|Protocol Violation|0
7346863|NCT00923091|11586184|FG004|Period III (Single-Blind)|Protocol Violation|0
7346864|NCT00923091|11586185|FG005|Period III (Single-Blind)|Protocol Violation|0
7346865|NCT00923091|11586186|FG006|Period III (Single-Blind)|Protocol Violation|0
7346866|NCT00923091|11586187|FG007|Period III (Single-Blind)|Protocol Violation|0
7569156|NCT03439137|11945094|FG001|Overall Study|Conducting rescue therapy|1
7569157|NCT03439137|11945093|FG000|Overall Study|Difficult to control Hb|10
7569158|NCT03439137|11945094|FG001|Overall Study|Difficult to control Hb|2
7346867|NCT00923091|11586188|FG008|Period III (Single-Blind)|Protocol Violation|0
7569159|NCT03439137|11945093|FG000|Overall Study|Initiation of a renal transplant|0
7569160|NCT03439137|11945094|FG001|Overall Study|Initiation of a renal transplant|2
7569161|NCT03439189|11945100|FG000|Overall Study|Protocol Violation|19
7569162|NCT03439189|11945100|FG000|Overall Study|Lack of Efficacy|63
7569163|NCT03440320|11945118|FG000|Overall Study|Withdrawal by Subject|0
7569164|NCT03440320|11945119|FG001|Overall Study|Withdrawal by Subject|1
7346868|NCT00923091|11586189|FG009|Period III (Single-Blind)|Protocol Violation|0
7346869|NCT00923091|11586190|FG010|Period III (Single-Blind)|Protocol Violation|0
7346870|NCT00923091|11586191|FG011|Period III (Single-Blind)|Protocol Violation|0
7346871|NCT00923091|11586192|FG012|Period III (Single-Blind)|Protocol Violation|0
7346872|NCT00923091|11586180|FG000|Period III (Single-Blind)|Lost to Follow-up|2
7346873|NCT00923091|11586181|FG001|Period III (Single-Blind)|Lost to Follow-up|0
7346874|NCT00923091|11586182|FG002|Period III (Single-Blind)|Lost to Follow-up|0
7346875|NCT00923091|11586183|FG003|Period III (Single-Blind)|Lost to Follow-up|0
7346876|NCT00923091|11586184|FG004|Period III (Single-Blind)|Lost to Follow-up|0
7346877|NCT00923091|11586185|FG005|Period III (Single-Blind)|Lost to Follow-up|0
7346878|NCT00923091|11586186|FG006|Period III (Single-Blind)|Lost to Follow-up|0
7346879|NCT00923091|11586187|FG007|Period III (Single-Blind)|Lost to Follow-up|0
7346880|NCT00923091|11586188|FG008|Period III (Single-Blind)|Lost to Follow-up|0
7346881|NCT00923091|11586189|FG009|Period III (Single-Blind)|Lost to Follow-up|0
7346882|NCT00923091|11586190|FG010|Period III (Single-Blind)|Lost to Follow-up|0
7346883|NCT00923091|11586191|FG011|Period III (Single-Blind)|Lost to Follow-up|0
7346884|NCT00923091|11586192|FG012|Period III (Single-Blind)|Lost to Follow-up|0
7346885|NCT00923091|11586180|FG000|Period IV (Double-Blind)|Adverse Event|2
7346886|NCT00923091|11586181|FG001|Period IV (Double-Blind)|Adverse Event|0
7346887|NCT00923091|11586182|FG002|Period IV (Double-Blind)|Adverse Event|0
7346888|NCT00923091|11586183|FG003|Period IV (Double-Blind)|Adverse Event|0
7346889|NCT00923091|11586184|FG004|Period IV (Double-Blind)|Adverse Event|0
7346890|NCT00923091|11586185|FG005|Period IV (Double-Blind)|Adverse Event|0
7346891|NCT00923091|11586186|FG006|Period IV (Double-Blind)|Adverse Event|0
7346892|NCT00923091|11586187|FG007|Period IV (Double-Blind)|Adverse Event|0
7346893|NCT00923091|11586188|FG008|Period IV (Double-Blind)|Adverse Event|0
7346894|NCT00923091|11586189|FG009|Period IV (Double-Blind)|Adverse Event|0
7346895|NCT00923091|11586190|FG010|Period IV (Double-Blind)|Adverse Event|0
7346896|NCT00923091|11586191|FG011|Period IV (Double-Blind)|Adverse Event|0
7346897|NCT00923091|11586192|FG012|Period IV (Double-Blind)|Adverse Event|0
7346898|NCT00923091|11586180|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
7346899|NCT00923091|11586181|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
7346900|NCT00923091|11586182|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
7346901|NCT00923091|11586183|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
7346902|NCT00923091|11586184|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
7346903|NCT00923091|11586185|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
7346904|NCT00923091|11586186|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
7346905|NCT00923091|11586187|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
7346906|NCT00923091|11586188|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
7346907|NCT00923091|11586189|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
7346908|NCT00923091|11586190|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
7346909|NCT00923091|11586191|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
7346910|NCT00923091|11586192|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
7346911|NCT00923091|11586180|FG000|Period IV (Double-Blind)|Protocol Violation|0
7346912|NCT00923091|11586181|FG001|Period IV (Double-Blind)|Protocol Violation|1
7346913|NCT00923091|11586182|FG002|Period IV (Double-Blind)|Protocol Violation|0
7346914|NCT00923091|11586183|FG003|Period IV (Double-Blind)|Protocol Violation|0
7346915|NCT00923091|11586184|FG004|Period IV (Double-Blind)|Protocol Violation|0
7346916|NCT00923091|11586185|FG005|Period IV (Double-Blind)|Protocol Violation|0
7346917|NCT00923091|11586186|FG006|Period IV (Double-Blind)|Protocol Violation|0
7346918|NCT00923091|11586187|FG007|Period IV (Double-Blind)|Protocol Violation|0
7346919|NCT00923091|11586188|FG008|Period IV (Double-Blind)|Protocol Violation|0
7346920|NCT00923091|11586189|FG009|Period IV (Double-Blind)|Protocol Violation|0
7346921|NCT00923091|11586190|FG010|Period IV (Double-Blind)|Protocol Violation|0
7346922|NCT00923091|11586191|FG011|Period IV (Double-Blind)|Protocol Violation|0
7346923|NCT00923091|11586192|FG012|Period IV (Double-Blind)|Protocol Violation|0
7346924|NCT00923091|11586180|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
7346925|NCT00923091|11586181|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
7346926|NCT00923091|11586182|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
7346927|NCT00923091|11586183|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
7346928|NCT00923091|11586184|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
7346929|NCT00923091|11586185|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
7346930|NCT00923091|11586186|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
7346931|NCT00923091|11586187|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
7346932|NCT00923091|11586188|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
7346933|NCT00923091|11586189|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
7346934|NCT00923091|11586190|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
7346935|NCT00923091|11586191|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
7346936|NCT00923091|11586192|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
7346937|NCT00923091|11586180|FG000|Period V (Double -Blind)|Protocol Violation|0
7346938|NCT00923091|11586181|FG001|Period V (Double -Blind)|Protocol Violation|0
7346939|NCT00923091|11586182|FG002|Period V (Double -Blind)|Protocol Violation|0
7346940|NCT00923091|11586183|FG003|Period V (Double -Blind)|Protocol Violation|0
7346941|NCT00923091|11586184|FG004|Period V (Double -Blind)|Protocol Violation|0
7346942|NCT00923091|11586185|FG005|Period V (Double -Blind)|Protocol Violation|0
7346943|NCT00923091|11586186|FG006|Period V (Double -Blind)|Protocol Violation|0
7346944|NCT00923091|11586187|FG007|Period V (Double -Blind)|Protocol Violation|0
7346945|NCT00923091|11586188|FG008|Period V (Double -Blind)|Protocol Violation|0
7346946|NCT00923091|11586189|FG009|Period V (Double -Blind)|Protocol Violation|0
7346947|NCT00923091|11586190|FG010|Period V (Double -Blind)|Protocol Violation|0
7346948|NCT00923091|11586191|FG011|Period V (Double -Blind)|Protocol Violation|0
7346949|NCT00923091|11586192|FG012|Period V (Double -Blind)|Protocol Violation|1
7346950|NCT00923091|11586180|FG000|Period V (Double -Blind)|Lost to Follow-up|0
7346951|NCT00923091|11586181|FG001|Period V (Double -Blind)|Lost to Follow-up|0
7346952|NCT00923091|11586182|FG002|Period V (Double -Blind)|Lost to Follow-up|0
7346953|NCT00923091|11586183|FG003|Period V (Double -Blind)|Lost to Follow-up|0
7346954|NCT00923091|11586184|FG004|Period V (Double -Blind)|Lost to Follow-up|0
7346955|NCT00923091|11586185|FG005|Period V (Double -Blind)|Lost to Follow-up|0
7346956|NCT00923091|11586186|FG006|Period V (Double -Blind)|Lost to Follow-up|0
7346957|NCT00923091|11586187|FG007|Period V (Double -Blind)|Lost to Follow-up|0
7346958|NCT00923091|11586188|FG008|Period V (Double -Blind)|Lost to Follow-up|0
7346959|NCT00923091|11586189|FG009|Period V (Double -Blind)|Lost to Follow-up|0
7346960|NCT00923091|11586190|FG010|Period V (Double -Blind)|Lost to Follow-up|1
7346961|NCT00923091|11586191|FG011|Period V (Double -Blind)|Lost to Follow-up|0
7346962|NCT00923091|11586192|FG012|Period V (Double -Blind)|Lost to Follow-up|0
7346963|NCT00923091|11586180|FG000|Period VI (Open-Label)|Adverse Event|17
7346964|NCT00923091|11586181|FG001|Period VI (Open-Label)|Adverse Event|0
7346965|NCT00923091|11586182|FG002|Period VI (Open-Label)|Adverse Event|4
7346966|NCT00923091|11586183|FG003|Period VI (Open-Label)|Adverse Event|1
7346967|NCT00923091|11586184|FG004|Period VI (Open-Label)|Adverse Event|1
7346968|NCT00923091|11586185|FG005|Period VI (Open-Label)|Adverse Event|0
7346969|NCT00923091|11586186|FG006|Period VI (Open-Label)|Adverse Event|0
7346970|NCT00923091|11586187|FG007|Period VI (Open-Label)|Adverse Event|0
7346971|NCT00923091|11586188|FG008|Period VI (Open-Label)|Adverse Event|0
7346972|NCT00923091|11586189|FG009|Period VI (Open-Label)|Adverse Event|0
7346973|NCT00923091|11586190|FG010|Period VI (Open-Label)|Adverse Event|0
7346974|NCT00923091|11586191|FG011|Period VI (Open-Label)|Adverse Event|0
7346975|NCT00923091|11586192|FG012|Period VI (Open-Label)|Adverse Event|0
7346976|NCT00923091|11586180|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
7346977|NCT00923091|11586181|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
7346978|NCT00923091|11586182|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
7346979|NCT00923091|11586183|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
7346980|NCT00923091|11586184|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
7346981|NCT00923091|11586185|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
7346982|NCT00923091|11586186|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
7346983|NCT00923091|11586187|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
7346984|NCT00923091|11586188|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
7346985|NCT00923091|11586189|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
7346986|NCT00923091|11586190|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
7346987|NCT00923091|11586191|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
7346988|NCT00923091|11586192|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
7346989|NCT00923091|11586180|FG000|Period VI (Open-Label)|Protocol Violation|6
7346990|NCT00923091|11586181|FG001|Period VI (Open-Label)|Protocol Violation|1
7346991|NCT00923091|11586182|FG002|Period VI (Open-Label)|Protocol Violation|3
7346992|NCT00923091|11586183|FG003|Period VI (Open-Label)|Protocol Violation|1
7346993|NCT00923091|11586184|FG004|Period VI (Open-Label)|Protocol Violation|4
7346994|NCT00923091|11586185|FG005|Period VI (Open-Label)|Protocol Violation|0
7346995|NCT00923091|11586186|FG006|Period VI (Open-Label)|Protocol Violation|0
7346996|NCT00923091|11586187|FG007|Period VI (Open-Label)|Protocol Violation|0
7346997|NCT00923091|11586188|FG008|Period VI (Open-Label)|Protocol Violation|0
7346998|NCT00923091|11586189|FG009|Period VI (Open-Label)|Protocol Violation|0
7346999|NCT00923091|11586190|FG010|Period VI (Open-Label)|Protocol Violation|0
7347000|NCT00923091|11586191|FG011|Period VI (Open-Label)|Protocol Violation|0
7347001|NCT00923091|11586192|FG012|Period VI (Open-Label)|Protocol Violation|0
7347002|NCT00923091|11586180|FG000|Period VI (Open-Label)|Lost to Follow-up|1
7347003|NCT00923091|11586181|FG001|Period VI (Open-Label)|Lost to Follow-up|0
7458965|NCT01813058|11753321|FG000|Overall Study|Withdrawal by Subject|5
7458966|NCT01813058|11753322|FG001|Overall Study|Withdrawal by Subject|4
7458967|NCT01813071|11753337|FG000|Overall Study|Protocol Violation|0
7458968|NCT01813071|11753338|FG001|Overall Study|Protocol Violation|0
7458969|NCT01813071|11753339|FG002|Overall Study|Protocol Violation|0
7458970|NCT01813071|11753340|FG003|Overall Study|Protocol Violation|0
7458971|NCT01813071|11753341|FG004|Overall Study|Protocol Violation|1
7458972|NCT01813071|11753342|FG005|Overall Study|Protocol Violation|4
7458973|NCT01813071|11753343|FG006|Overall Study|Protocol Violation|2
7458974|NCT01813071|11753344|FG007|Overall Study|Protocol Violation|4
7458975|NCT01813071|11753345|FG008|Overall Study|Protocol Violation|2
7458976|NCT01813071|11753337|FG000|Overall Study|Withdrawal by Subject|0
7458977|NCT01813071|11753338|FG001|Overall Study|Withdrawal by Subject|0
7347004|NCT00923091|11586182|FG002|Period VI (Open-Label)|Lost to Follow-up|1
7347005|NCT00923091|11586183|FG003|Period VI (Open-Label)|Lost to Follow-up|0
7347006|NCT00923091|11586184|FG004|Period VI (Open-Label)|Lost to Follow-up|0
7347007|NCT00923091|11586185|FG005|Period VI (Open-Label)|Lost to Follow-up|0
7458978|NCT01813071|11753339|FG002|Overall Study|Withdrawal by Subject|0
7458979|NCT01813071|11753340|FG003|Overall Study|Withdrawal by Subject|0
7347008|NCT00923091|11586186|FG006|Period VI (Open-Label)|Lost to Follow-up|0
7347009|NCT00923091|11586187|FG007|Period VI (Open-Label)|Lost to Follow-up|0
7347010|NCT00923091|11586188|FG008|Period VI (Open-Label)|Lost to Follow-up|0
7347011|NCT00923091|11586189|FG009|Period VI (Open-Label)|Lost to Follow-up|0
7347012|NCT00923091|11586190|FG010|Period VI (Open-Label)|Lost to Follow-up|0
7347013|NCT00923091|11586191|FG011|Period VI (Open-Label)|Lost to Follow-up|0
7347014|NCT00923091|11586192|FG012|Period VI (Open-Label)|Lost to Follow-up|0
7347015|NCT00923091|11586180|FG000|Period VI (Open-Label)|Other Reason|0
7347016|NCT00923091|11586181|FG001|Period VI (Open-Label)|Other Reason|0
7347017|NCT00923091|11586182|FG002|Period VI (Open-Label)|Other Reason|0
7347018|NCT00923091|11586183|FG003|Period VI (Open-Label)|Other Reason|1
7347019|NCT00923091|11586184|FG004|Period VI (Open-Label)|Other Reason|1
7347020|NCT00923091|11586185|FG005|Period VI (Open-Label)|Other Reason|0
7347021|NCT00923091|11586186|FG006|Period VI (Open-Label)|Other Reason|0
7347022|NCT00923091|11586187|FG007|Period VI (Open-Label)|Other Reason|0
7347023|NCT00923091|11586188|FG008|Period VI (Open-Label)|Other Reason|0
7347024|NCT00923091|11586189|FG009|Period VI (Open-Label)|Other Reason|0
7347025|NCT00923091|11586190|FG010|Period VI (Open-Label)|Other Reason|0
7347026|NCT00923091|11586191|FG011|Period VI (Open-Label)|Other Reason|0
7347027|NCT00923091|11586192|FG012|Period VI (Open-Label)|Other Reason|0
7347028|NCT00923130|11586226|FG000|Overall Study|Stopped treatment due to progression|17
7347029|NCT00923130|11586226|FG000|Overall Study|Death|1
7347030|NCT00923130|11586226|FG000|Overall Study|Discontinued treatment due to toxicities|3
7347031|NCT00923130|11586226|FG000|Overall Study|Switched to alternative treatment|2
7347032|NCT00923130|11586226|FG000|Overall Study|Refused further treatment|2
7347033|NCT00923156|11586233|FG000|Overall Study|Adverse Event|0
7347034|NCT00923156|11586234|FG001|Overall Study|Adverse Event|2
7347035|NCT00923156|11586235|FG002|Overall Study|Adverse Event|1
7347036|NCT00923156|11586233|FG000|Overall Study|Abnormal laboratory values|0
7347037|NCT00923156|11586234|FG001|Overall Study|Abnormal laboratory values|0
7347038|NCT00923156|11586235|FG002|Overall Study|Abnormal laboratory values|1
7347039|NCT00923156|11586233|FG000|Overall Study|Withdrawal by Subject|0
7347040|NCT00923156|11586234|FG001|Overall Study|Withdrawal by Subject|1
7347041|NCT00923156|11586235|FG002|Overall Study|Withdrawal by Subject|0
7347042|NCT00923156|11586233|FG000|Overall Study|Death|0
7347043|NCT00923156|11586234|FG001|Overall Study|Death|1
7347044|NCT00923156|11586235|FG002|Overall Study|Death|0
7347045|NCT00923156|11586233|FG000|Overall Study|Lack of Efficacy|0
7347046|NCT00923156|11586234|FG001|Overall Study|Lack of Efficacy|0
7347047|NCT00923156|11586235|FG002|Overall Study|Lack of Efficacy|1
7347048|NCT00923195|11586245|FG000|Overall Study|Death|0
7347049|NCT00923195|11586246|FG001|Overall Study|Death|1
7347050|NCT00923260|11586254|FG000|Overall Study|Lost to Follow-up|1
7347051|NCT00923260|11586255|FG001|Overall Study|Lost to Follow-up|1
7347052|NCT00923273|11586266|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7347053|NCT00923273|11586267|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7347054|NCT00923273|11586268|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7347055|NCT00923273|11586269|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
7347056|NCT00923273|11586270|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
7347057|NCT00923273|11586266|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7347058|NCT00923273|11586267|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7347059|NCT00923273|11586268|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7347060|NCT00923273|11586269|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
7347061|NCT00923273|11586270|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
7347062|NCT00923351|11586290|FG000|Overall Study|no apheresis/adequate tumor sample|0
7347063|NCT00923351|11586291|FG001|Overall Study|no apheresis/adequate tumor sample|0
7347064|NCT00923351|11586292|FG002|Overall Study|no apheresis/adequate tumor sample|12
7347065|NCT00923364|11586298|FG000|Overall Study|Death|3
7347066|NCT00923364|11586299|FG001|Overall Study|Death|0
7347067|NCT00923364|11586298|FG000|Overall Study|Did not go to transplant|1
7347068|NCT00923364|11586299|FG001|Overall Study|Did not go to transplant|0
7347069|NCT00923559|11586310|FG000|Overall Study|Lost to Follow-up|2
7347070|NCT00923559|11586311|FG001|Overall Study|Lost to Follow-up|3
7347071|NCT00923845|11586330|FG000|Induction Therapy|Poor performance status|0
7347072|NCT00923845|11586331|FG001|Induction Therapy|Poor performance status|2
7347073|NCT00923936|11586348|FG000|Overall Study|progressive disease on study|2
7347074|NCT00923936|11586349|FG001|Overall Study|progressive disease on study|1
7347075|NCT00923936|11586348|FG000|Overall Study|Adverse Event|2
7347076|NCT00923936|11586349|FG001|Overall Study|Adverse Event|1
7347077|NCT00923936|11586348|FG000|Overall Study|Lost to follow up|2
7569165|NCT03440411|11945131|FG000|Overall Study|Adverse Event|0
7569166|NCT03440411|11945132|FG001|Overall Study|Adverse Event|0
7347078|NCT00923936|11586349|FG001|Overall Study|Lost to follow up|0
7347079|NCT00923936|11586348|FG000|Overall Study|Continuing in follow up period|2
7347080|NCT00923936|11586349|FG001|Overall Study|Continuing in follow up period|1
7347081|NCT00923975|11586361|FG000|Overall Study|Did not meet inclusion criteria|1
7569167|NCT03440411|11945133|FG002|Overall Study|Adverse Event|1
7347082|NCT00924287|11586408|FG000|Overall Study|Death|1
7347083|NCT00924313|11586412|FG000|Overall Study|not imaged due to failed tracer imaging|1
7347084|NCT00924404|11586426|FG000|Overall Study|Lost to Follow-up|6
7347085|NCT00924404|11586427|FG001|Overall Study|Lost to Follow-up|4
7347086|NCT00924443|11586433|FG000|Overall Study|Physician Decision|2
7347087|NCT00924443|11586433|FG000|Overall Study|Protocol Violation|1
7347088|NCT00924469|11586439|FG000|Overall Study|Adverse Event|2
7347089|NCT00924469|11586440|FG001|Overall Study|Adverse Event|0
7347090|NCT00924469|11586439|FG000|Overall Study|Withdrawal by Subject|0
7347091|NCT00924469|11586440|FG001|Overall Study|Withdrawal by Subject|1
7347092|NCT00924469|11586439|FG000|Overall Study|Lost to Follow-up|0
7347093|NCT00924469|11586440|FG001|Overall Study|Lost to Follow-up|1
7347094|NCT00924508|11586451|FG000|Overall Study|Withdrawal by Subject|3
7347095|NCT00924560|11586461|FG000|Overall Study|Did Not Meet Protocol Requirements|4
7347096|NCT00924560|11586462|FG001|Overall Study|Did Not Meet Protocol Requirements|2
7347097|NCT00924560|11586463|FG002|Overall Study|Did Not Meet Protocol Requirements|1
7347098|NCT00924560|11586461|FG000|Overall Study|Non Compliance with the Protocol|20
7347099|NCT00924560|11586462|FG001|Overall Study|Non Compliance with the Protocol|15
7347100|NCT00924560|11586463|FG002|Overall Study|Non Compliance with the Protocol|4
7347101|NCT00924560|11586461|FG000|Overall Study|Physician Decision|2
7347102|NCT00924560|11586462|FG001|Overall Study|Physician Decision|3
7347103|NCT00924560|11586463|FG002|Overall Study|Physician Decision|4
7347104|NCT00924560|11586461|FG000|Overall Study|Withdrawal by Subject|50
7347105|NCT00924560|11586462|FG001|Overall Study|Withdrawal by Subject|44
7347106|NCT00924560|11586463|FG002|Overall Study|Withdrawal by Subject|18
7347107|NCT00924560|11586461|FG000|Overall Study|Adverse Event|39
7347108|NCT00924560|11586462|FG001|Overall Study|Adverse Event|33
7347109|NCT00924560|11586463|FG002|Overall Study|Adverse Event|0
7347110|NCT00924560|11586461|FG000|Overall Study|Pregnancy|5
7347111|NCT00924560|11586462|FG001|Overall Study|Pregnancy|7
7347112|NCT00924560|11586463|FG002|Overall Study|Pregnancy|1
7347113|NCT00924560|11586461|FG000|Overall Study|Lost to Follow-up|78
7347114|NCT00924560|11586462|FG001|Overall Study|Lost to Follow-up|94
7347115|NCT00924560|11586463|FG002|Overall Study|Lost to Follow-up|45
7347116|NCT00924560|11586461|FG000|Overall Study|Miscellaneous Reasons|13
7347117|NCT00924560|11586462|FG001|Overall Study|Miscellaneous Reasons|10
7347118|NCT00924560|11586463|FG002|Overall Study|Miscellaneous Reasons|10
7347119|NCT00924638|11586490|FG000|Overall Study|Death|3
7347120|NCT00924638|11586491|FG001|Overall Study|Death|2
7347121|NCT00924638|11586490|FG000|Overall Study|Lost to Follow-up|1
7347122|NCT00924638|11586491|FG001|Overall Study|Lost to Follow-up|1
7347123|NCT00924638|11586490|FG000|Overall Study|Withdrawal by Subject|5
7347124|NCT00924638|11586491|FG001|Overall Study|Withdrawal by Subject|7
7347125|NCT00924638|11586490|FG000|Overall Study|Physician Decision|3
7347126|NCT00924638|11586491|FG001|Overall Study|Physician Decision|3
7347127|NCT00924651|11586499|FG000|Overall Study|Chemo started too soon|2
7347128|NCT00924651|11586500|FG001|Overall Study|Chemo started too soon|3
7347129|NCT00924651|11586499|FG000|Overall Study|No Reason|3
7347130|NCT00924651|11586500|FG001|Overall Study|No Reason|7
7347131|NCT00924651|11586499|FG000|Overall Study|Overwhelmed|6
7347132|NCT00924651|11586500|FG001|Overall Study|Overwhelmed|6
7347133|NCT00924651|11586499|FG000|Overall Study|Noncompliant|1
7347134|NCT00924651|11586500|FG001|Overall Study|Noncompliant|4
7347135|NCT00924651|11586499|FG000|Overall Study|Medical|1
7347136|NCT00924651|11586500|FG001|Overall Study|Medical|3
7347137|NCT00924651|11586499|FG000|Overall Study|Changed Mind|10
7347138|NCT00924651|11586500|FG001|Overall Study|Changed Mind|1
7347139|NCT00924651|11586499|FG000|Overall Study|Incomplete Form|2
7347140|NCT00924651|11586500|FG001|Overall Study|Incomplete Form|1
7347141|NCT00924664|11586508|FG000|Overall Study|Adverse Event|23
7347142|NCT00924664|11586509|FG001|Overall Study|Adverse Event|39
7347143|NCT00924664|11586508|FG000|Overall Study|Lack of Efficacy|10
7347144|NCT00924664|11586509|FG001|Overall Study|Lack of Efficacy|15
7347145|NCT00924664|11586508|FG000|Overall Study|Lost to Follow-up|10
7347146|NCT00924664|11586509|FG001|Overall Study|Lost to Follow-up|12
7347147|NCT00924664|11586508|FG000|Overall Study|Withdrawal by Subject|47
7347148|NCT00924664|11586509|FG001|Overall Study|Withdrawal by Subject|71
7347149|NCT00924664|11586508|FG000|Overall Study|Protocol Violation|2
7347150|NCT00924664|11586509|FG001|Overall Study|Protocol Violation|5
7347151|NCT00924664|11586508|FG000|Overall Study|Pregnancy|1
7347152|NCT00924664|11586509|FG001|Overall Study|Pregnancy|1
7347153|NCT00924664|11586508|FG000|Overall Study|Death|0
7347154|NCT00924664|11586509|FG001|Overall Study|Death|2
7347155|NCT00924664|11586508|FG000|Overall Study|Study terminated by sponsor|199
7347156|NCT00924664|11586509|FG001|Overall Study|Study terminated by sponsor|330
7347157|NCT00924664|11586508|FG000|Overall Study|Other|29
7347158|NCT00924664|11586509|FG001|Overall Study|Other|52
7347159|NCT00924664|11586508|FG000|Overall Study|Randomized but not Treated|1
7347160|NCT00924664|11586509|FG001|Overall Study|Randomized but not Treated|0
7347161|NCT00924703|11586515|FG000|Overall Study|Withdrawal by Subject|11
7347162|NCT00924703|11586515|FG000|Overall Study|Physician Decision|5
7347163|NCT00924703|11586515|FG000|Overall Study|Lost to Follow-up|3
7347164|NCT00924703|11586515|FG000|Overall Study|Adverse Event|2
7347165|NCT00924703|11586515|FG000|Overall Study|Withdrawal by Sponsor|1
7347166|NCT00924729|11586521|FG000|Overall Study|insufficient volume for analysis|1
7347167|NCT00924729|11586522|FG001|Overall Study|insufficient volume for analysis|0
7347168|NCT00924729|11586521|FG000|Overall Study|Protocol Violation|1
7347169|NCT00924729|11586522|FG001|Overall Study|Protocol Violation|0
7347170|NCT00924781|11586534|FG000|Overall Study|Study terminated by sponsor|12
7347171|NCT00924781|11586535|FG001|Overall Study|Study terminated by sponsor|10
7347172|NCT00924820|11586551|FG000|Overall Study|Death|2
7347173|NCT00924820|11586551|FG000|Overall Study|Ineligible, Screen Failure|5
7347174|NCT00924898|11586566|FG000|Overall Study|Withdrawal by Subject|2
7347175|NCT00924950|11586575|FG000|Overall Study|Lost to Follow-up|2
7347176|NCT00925002|11586585|FG000|Overall Study|Other|1
7347177|NCT00925002|11586586|FG001|Overall Study|Other|4
7347178|NCT00925002|11586587|FG002|Overall Study|Other|0
7347179|NCT00925002|11586585|FG000|Overall Study|Death|1
7347180|NCT00925002|11586586|FG001|Overall Study|Death|1
7347181|NCT00925002|11586587|FG002|Overall Study|Death|5
7347182|NCT00925002|11586585|FG000|Overall Study|Adverse Event|3
7347183|NCT00925002|11586586|FG001|Overall Study|Adverse Event|1
7347184|NCT00925002|11586587|FG002|Overall Study|Adverse Event|2
7347185|NCT00925002|11586585|FG000|Overall Study|Participant withdrew consent|1
7347186|NCT00925002|11586586|FG001|Overall Study|Participant withdrew consent|3
7347187|NCT00925002|11586587|FG002|Overall Study|Participant withdrew consent|3
7347188|NCT00925015|11586599|FG000|Overall Study|Adverse Event|1
7347189|NCT00925015|11586600|FG001|Overall Study|Adverse Event|2
7347190|NCT00925015|11586601|FG002|Overall Study|Adverse Event|1
7347191|NCT00925015|11586599|FG000|Overall Study|Physician Decision|0
7347192|NCT00925015|11586600|FG001|Overall Study|Physician Decision|1
7347193|NCT00925015|11586601|FG002|Overall Study|Physician Decision|0
7347194|NCT00925015|11586599|FG000|Overall Study|Progressive Disease|7
7347195|NCT00925015|11586600|FG001|Overall Study|Progressive Disease|3
7458980|NCT01813071|11753341|FG004|Overall Study|Withdrawal by Subject|0
7458981|NCT01813071|11753342|FG005|Overall Study|Withdrawal by Subject|1
7458982|NCT01813071|11753343|FG006|Overall Study|Withdrawal by Subject|0
7458983|NCT01813071|11753344|FG007|Overall Study|Withdrawal by Subject|0
7458984|NCT01813071|11753345|FG008|Overall Study|Withdrawal by Subject|0
7458985|NCT01813071|11753337|FG000|Overall Study|Adverse Event|0
7458986|NCT01813071|11753338|FG001|Overall Study|Adverse Event|0
7458987|NCT01813071|11753339|FG002|Overall Study|Adverse Event|0
7458988|NCT01813071|11753340|FG003|Overall Study|Adverse Event|0
7458989|NCT01813071|11753341|FG004|Overall Study|Adverse Event|0
7458990|NCT01813071|11753342|FG005|Overall Study|Adverse Event|1
7458991|NCT01813071|11753343|FG006|Overall Study|Adverse Event|0
7458992|NCT01813071|11753344|FG007|Overall Study|Adverse Event|0
7458993|NCT01813071|11753345|FG008|Overall Study|Adverse Event|0
7569168|NCT03440411|11945134|FG003|Overall Study|Adverse Event|0
7569169|NCT03440411|11945131|FG000|Overall Study|PD|2
7458994|NCT01813071|11753337|FG000|Overall Study|Physician Decision|0
7458995|NCT01813071|11753338|FG001|Overall Study|Physician Decision|0
7458996|NCT01813071|11753339|FG002|Overall Study|Physician Decision|0
7458997|NCT01813071|11753340|FG003|Overall Study|Physician Decision|0
7458998|NCT01813071|11753341|FG004|Overall Study|Physician Decision|0
7458999|NCT01813071|11753342|FG005|Overall Study|Physician Decision|0
7459000|NCT01813071|11753343|FG006|Overall Study|Physician Decision|1
7459001|NCT01813071|11753344|FG007|Overall Study|Physician Decision|0
7459002|NCT01813071|11753345|FG008|Overall Study|Physician Decision|0
7459003|NCT01813071|11753337|FG000|Overall Study|Met inc/exc criteria|0
7459004|NCT01813071|11753338|FG001|Overall Study|Met inc/exc criteria|0
7459005|NCT01813071|11753339|FG002|Overall Study|Met inc/exc criteria|0
7459006|NCT01813071|11753340|FG003|Overall Study|Met inc/exc criteria|0
7459007|NCT01813071|11753341|FG004|Overall Study|Met inc/exc criteria|0
7459008|NCT01813071|11753342|FG005|Overall Study|Met inc/exc criteria|1
7459009|NCT01813071|11753343|FG006|Overall Study|Met inc/exc criteria|0
7459010|NCT01813071|11753344|FG007|Overall Study|Met inc/exc criteria|1
7459011|NCT01813071|11753345|FG008|Overall Study|Met inc/exc criteria|1
7459012|NCT01813357|11753412|FG000|Overall Study|Lost to Follow-up|5
7459013|NCT01813357|11753413|FG001|Overall Study|Lost to Follow-up|6
7459014|NCT01813422|11753421|FG000|Overall Study|Withdrawal by Subject|14
7459015|NCT01813422|11753422|FG001|Overall Study|Withdrawal by Subject|8
7459016|NCT01813422|11753421|FG000|Overall Study|Death|2
7459017|NCT01813422|11753422|FG001|Overall Study|Death|3
7459018|NCT01813422|11753421|FG000|Overall Study|Sponsor Decision|2
7459019|NCT01813422|11753422|FG001|Overall Study|Sponsor Decision|1
7459020|NCT01813422|11753421|FG000|Overall Study|Lost to Follow-up|2
7459021|NCT01813422|11753422|FG001|Overall Study|Lost to Follow-up|4
7459022|NCT01813474|11753431|FG000|Overall Study|Withdrawal by Subject|0
7347196|NCT00925015|11586601|FG002|Overall Study|Progressive Disease|4
7347197|NCT00925015|11586599|FG000|Overall Study|Withdrawal by Subject|0
7347198|NCT00925015|11586600|FG001|Overall Study|Withdrawal by Subject|0
7347199|NCT00925015|11586601|FG002|Overall Study|Withdrawal by Subject|1
7347200|NCT00925132|11586639|FG000|Overall Study|Withdrawal by Subject|2
7459023|NCT01813474|11753432|FG001|Overall Study|Withdrawal by Subject|0
7459024|NCT01813474|11753433|FG002|Overall Study|Withdrawal by Subject|1
7459025|NCT01813474|11753431|FG000|Overall Study|Adverse Event|1
7459026|NCT01813474|11753432|FG001|Overall Study|Adverse Event|1
7459027|NCT01813474|11753433|FG002|Overall Study|Adverse Event|0
7459028|NCT01813474|11753431|FG000|Overall Study|Lack of Efficacy|2
7459029|NCT01813474|11753432|FG001|Overall Study|Lack of Efficacy|6
7347201|NCT00925132|11586640|FG001|Overall Study|Withdrawal by Subject|0
7347202|NCT00925132|11586641|FG002|Overall Study|Withdrawal by Subject|0
7347203|NCT00925132|11586642|FG003|Overall Study|Withdrawal by Subject|0
7347204|NCT00925132|11586643|FG004|Overall Study|Withdrawal by Subject|1
7347205|NCT00925132|11586639|FG000|Overall Study|Removed due to disease progression|0
7347206|NCT00925132|11586640|FG001|Overall Study|Removed due to disease progression|0
7347207|NCT00925132|11586641|FG002|Overall Study|Removed due to disease progression|0
7347208|NCT00925132|11586642|FG003|Overall Study|Removed due to disease progression|0
7347209|NCT00925132|11586643|FG004|Overall Study|Removed due to disease progression|4
7347210|NCT00925288|11586651|FG000|Overall Study|Lost to Follow-up|9
7347211|NCT00925288|11586652|FG001|Overall Study|Lost to Follow-up|7
7347212|NCT00925301|11586662|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7347213|NCT00925301|11586663|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
7347214|NCT00925301|11586664|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7347215|NCT00925301|11586665|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
7347216|NCT00925301|11586662|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
7347217|NCT00925301|11586663|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
7347218|NCT00925301|11586664|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
7347219|NCT00925301|11586665|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
7347220|NCT00925301|11586662|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7347221|NCT00925301|11586663|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7347222|NCT00925301|11586664|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
7347223|NCT00925301|11586665|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
7347224|NCT00925301|11586662|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
7347225|NCT00925301|11586663|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
7347226|NCT00925301|11586664|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
7347227|NCT00925301|11586665|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
7347228|NCT00925301|11586662|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7347229|NCT00925301|11586663|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7347230|NCT00925301|11586664|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
7347231|NCT00925301|11586665|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
7347232|NCT00925301|11586662|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
7347233|NCT00925301|11586663|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
7347234|NCT00925301|11586664|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
7347235|NCT00925301|11586665|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
7347236|NCT00925301|11586662|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7347237|NCT00925301|11586663|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7347238|NCT00925301|11586664|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
7347239|NCT00925301|11586665|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
7347240|NCT00925353|11586676|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
7347241|NCT00925522|11586680|FG000|Overall Study|study closed -- business decision|20
7347242|NCT00925587|11586686|FG000|Overall Study|Protocol Specified Criteria|6
7347243|NCT00925587|11586687|FG001|Overall Study|Protocol Specified Criteria|6
7347244|NCT00925587|11586686|FG000|Overall Study|Physician Decision|4
7347245|NCT00925587|11586687|FG001|Overall Study|Physician Decision|1
7347246|NCT00925587|11586686|FG000|Overall Study|Protocol Violation|6
7347247|NCT00925587|11586687|FG001|Overall Study|Protocol Violation|4
7347248|NCT00925587|11586686|FG000|Overall Study|Withdrawal by Subject|9
7347249|NCT00925587|11586687|FG001|Overall Study|Withdrawal by Subject|6
7347250|NCT00925587|11586686|FG000|Overall Study|Death|5
7347251|NCT00925587|11586687|FG001|Overall Study|Death|5
7347252|NCT00925587|11586686|FG000|Overall Study|Adverse Event|6
7347253|NCT00925587|11586687|FG001|Overall Study|Adverse Event|2
7347254|NCT00925587|11586686|FG000|Overall Study|Lost to Follow-up|0
7347255|NCT00925587|11586687|FG001|Overall Study|Lost to Follow-up|1
7347256|NCT00925600|11586695|FG000|Overall Study|Withdrawal by Subject|16
7347257|NCT00925600|11586696|FG001|Overall Study|Withdrawal by Subject|14
7347258|NCT00925600|11586695|FG000|Overall Study|Death|4
7347259|NCT00925600|11586696|FG001|Overall Study|Death|3
7347260|NCT00925600|11586695|FG000|Overall Study|Lost to Follow-up|2
7347261|NCT00925600|11586696|FG001|Overall Study|Lost to Follow-up|2
7347262|NCT00925600|11586695|FG000|Overall Study|Disease Progression|1
7347263|NCT00925600|11586696|FG001|Overall Study|Disease Progression|3
7347264|NCT00925600|11586695|FG000|Overall Study|Administrative Decision|1
7347265|NCT00925600|11586696|FG001|Overall Study|Administrative Decision|1
7347266|NCT00925600|11586695|FG000|Overall Study|Noncompliance|2
7347267|NCT00925600|11586696|FG001|Overall Study|Noncompliance|0
7347268|NCT00925600|11586695|FG000|Overall Study|Ineligibility Determined|2
7347269|NCT00925600|11586696|FG001|Overall Study|Ineligibility Determined|0
7347270|NCT00925600|11586695|FG000|Overall Study|Protocol Deviation|0
7347271|NCT00925600|11586696|FG001|Overall Study|Protocol Deviation|1
7347272|NCT00925600|11586695|FG000|Overall Study|Requirement for Alternative Therapy|0
7347273|NCT00925600|11586696|FG001|Overall Study|Requirement for Alternative Therapy|1
7347274|NCT00925600|11586695|FG000|Overall Study|Other|3
7347275|NCT00925600|11586696|FG001|Overall Study|Other|1
7347276|NCT00925600|11586695|FG000|Overall Study|Adverse Event|1
7347277|NCT00925600|11586696|FG001|Overall Study|Adverse Event|2
7347278|NCT00925704|11586712|FG000|First Intervention|Withdrew consent|0
7347279|NCT00925704|11586713|FG001|First Intervention|Withdrew consent|0
7347280|NCT00925704|11586714|FG002|First Intervention|Withdrew consent|0
7347281|NCT00925704|11586715|FG003|First Intervention|Withdrew consent|1
7347282|NCT00925704|11586716|FG004|First Intervention|Withdrew consent|1
7347283|NCT00925704|11586717|FG005|First Intervention|Withdrew consent|0
7347284|NCT00925704|11586712|FG000|Second Intervention|Withdrawal by Subject|1
7347285|NCT00925704|11586713|FG001|Second Intervention|Withdrawal by Subject|0
7347286|NCT00925704|11586714|FG002|Second Intervention|Withdrawal by Subject|0
7347287|NCT00925704|11586715|FG003|Second Intervention|Withdrawal by Subject|0
7347288|NCT00925704|11586716|FG004|Second Intervention|Withdrawal by Subject|1
7347289|NCT00925704|11586717|FG005|Second Intervention|Withdrawal by Subject|0
7347290|NCT00925704|11586712|FG000|Third Intervention|Withdrew consent|0
7347291|NCT00925704|11586713|FG001|Third Intervention|Withdrew consent|0
7347292|NCT00925704|11586714|FG002|Third Intervention|Withdrew consent|0
7347293|NCT00925704|11586715|FG003|Third Intervention|Withdrew consent|0
7347294|NCT00925704|11586716|FG004|Third Intervention|Withdrew consent|0
7347295|NCT00925704|11586717|FG005|Third Intervention|Withdrew consent|1
7347296|NCT00925769|11586732|FG000|Overall Study|Major toxicity|1
7347297|NCT00925769|11586733|FG001|Overall Study|Major toxicity|0
7347298|NCT00925769|11586734|FG002|Overall Study|Major toxicity|1
7347299|NCT00925769|11586735|FG003|Overall Study|Major toxicity|1
7347300|NCT00925769|11586736|FG004|Overall Study|Major toxicity|0
7347301|NCT00925769|11586737|FG005|Overall Study|Major toxicity|0
7347302|NCT00925769|11586732|FG000|Overall Study|Disease progression|4
7347303|NCT00925769|11586733|FG001|Overall Study|Disease progression|5
7347304|NCT00925769|11586734|FG002|Overall Study|Disease progression|3
7347305|NCT00925769|11586735|FG003|Overall Study|Disease progression|4
7347306|NCT00925769|11586736|FG004|Overall Study|Disease progression|2
7347307|NCT00925769|11586737|FG005|Overall Study|Disease progression|3
7347308|NCT00925769|11586732|FG000|Overall Study|Death|0
7347309|NCT00925769|11586733|FG001|Overall Study|Death|0
7347310|NCT00925769|11586734|FG002|Overall Study|Death|1
7347311|NCT00925769|11586735|FG003|Overall Study|Death|0
7347312|NCT00925769|11586736|FG004|Overall Study|Death|0
7347313|NCT00925769|11586737|FG005|Overall Study|Death|0
7347314|NCT00925769|11586732|FG000|Overall Study|Physician Decision|1
7347315|NCT00925769|11586733|FG001|Overall Study|Physician Decision|0
7347316|NCT00925769|11586734|FG002|Overall Study|Physician Decision|0
7347317|NCT00925769|11586735|FG003|Overall Study|Physician Decision|0
7347318|NCT00925769|11586736|FG004|Overall Study|Physician Decision|0
7347319|NCT00925769|11586737|FG005|Overall Study|Physician Decision|0
7347320|NCT00925769|11586732|FG000|Overall Study|Missing documentation|0
7347321|NCT00925769|11586733|FG001|Overall Study|Missing documentation|1
7347322|NCT00925769|11586734|FG002|Overall Study|Missing documentation|0
7347323|NCT00925769|11586735|FG003|Overall Study|Missing documentation|0
7347324|NCT00925769|11586736|FG004|Overall Study|Missing documentation|0
7347325|NCT00925769|11586737|FG005|Overall Study|Missing documentation|0
7347326|NCT00925769|11586732|FG000|Overall Study|End of study visit not done|0
7347327|NCT00925769|11586733|FG001|Overall Study|End of study visit not done|0
7347328|NCT00925769|11586734|FG002|Overall Study|End of study visit not done|1
7347329|NCT00925769|11586735|FG003|Overall Study|End of study visit not done|0
7347330|NCT00925769|11586736|FG004|Overall Study|End of study visit not done|0
7347331|NCT00925769|11586737|FG005|Overall Study|End of study visit not done|0
7347332|NCT00925769|11586732|FG000|Overall Study|Participant is unable to swallow drug|0
7347333|NCT00925769|11586733|FG001|Overall Study|Participant is unable to swallow drug|0
7347334|NCT00925769|11586734|FG002|Overall Study|Participant is unable to swallow drug|0
7385936|NCT01206764|11644133|FG000|Overall Study|Death|11
7347335|NCT00925769|11586735|FG003|Overall Study|Participant is unable to swallow drug|1
7347336|NCT00925769|11586736|FG004|Overall Study|Participant is unable to swallow drug|0
7347337|NCT00925769|11586737|FG005|Overall Study|Participant is unable to swallow drug|0
7347338|NCT00925769|11586732|FG000|Overall Study|Adverse Event|0
7347339|NCT00925769|11586733|FG001|Overall Study|Adverse Event|0
7347340|NCT00925769|11586734|FG002|Overall Study|Adverse Event|0
7347341|NCT00925769|11586735|FG003|Overall Study|Adverse Event|0
7347342|NCT00925769|11586736|FG004|Overall Study|Adverse Event|1
7347343|NCT00925769|11586737|FG005|Overall Study|Adverse Event|0
7347344|NCT00925899|11586763|FG000|Part 1|Death|1
7347345|NCT00925899|11586764|FG001|Part 1|Death|2
7347346|NCT00925899|11586763|FG000|Part 1|Withdrawal by Subject|10
7347347|NCT00925899|11586764|FG001|Part 1|Withdrawal by Subject|9
7385937|NCT01206764|11644133|FG000|Overall Study|New cancer therapy|2
7385938|NCT01206764|11644133|FG000|Overall Study|Disease progression|88
7385939|NCT01206764|11644133|FG000|Overall Study|Protocol deviation|3
7387623|NCT01215227|11646197|FG000|Overall Study|Non-Compliance With Protocol|2
7387624|NCT01215227|11646198|FG001|Overall Study|Non-Compliance With Protocol|6
7387625|NCT01215227|11646199|FG002|Overall Study|Non-Compliance With Protocol|1
7387626|NCT01215227|11646200|FG003|Overall Study|Non-Compliance With Protocol|0
7387627|NCT01215227|11646201|FG004|Overall Study|Non-Compliance With Protocol|0
7387628|NCT01215227|11646202|FG005|Overall Study|Non-Compliance With Protocol|0
7387629|NCT01215227|11646197|FG000|Overall Study|Administrative|83
7387630|NCT01215227|11646198|FG001|Overall Study|Administrative|73
7387631|NCT01215227|11646199|FG002|Overall Study|Administrative|42
7387632|NCT01215227|11646200|FG003|Overall Study|Administrative|24
7387633|NCT01215227|11646201|FG004|Overall Study|Administrative|28
7387634|NCT01215227|11646202|FG005|Overall Study|Administrative|40
7387635|NCT01215227|11646197|FG000|Overall Study|Missing Status|0
7387636|NCT01215227|11646198|FG001|Overall Study|Missing Status|1
7387637|NCT01215227|11646199|FG002|Overall Study|Missing Status|0
7387638|NCT01215227|11646200|FG003|Overall Study|Missing Status|0
7387639|NCT01215227|11646201|FG004|Overall Study|Missing Status|0
7387640|NCT01215227|11646202|FG005|Overall Study|Missing Status|0
7387641|NCT01215227|11646197|FG000|Overall Study|Randomized but not treated|0
7387642|NCT01215227|11646198|FG001|Overall Study|Randomized but not treated|0
7387643|NCT01215227|11646199|FG002|Overall Study|Randomized but not treated|1
7387644|NCT01215227|11646200|FG003|Overall Study|Randomized but not treated|1
7387645|NCT01215227|11646201|FG004|Overall Study|Randomized but not treated|0
7387646|NCT01215227|11646202|FG005|Overall Study|Randomized but not treated|1
7387647|NCT01215253|11646227|FG000|Overall Study|Withdrawal by Subject|57
7387648|NCT01215253|11646228|FG001|Overall Study|Withdrawal by Subject|35
7387649|NCT01215253|11646227|FG000|Overall Study|Physician Decision|9
7387650|NCT01215253|11646228|FG001|Overall Study|Physician Decision|12
7387651|NCT01215253|11646227|FG000|Overall Study|Lost to Follow-up|6
7387652|NCT01215253|11646228|FG001|Overall Study|Lost to Follow-up|4
7387653|NCT01215253|11646227|FG000|Overall Study|Other|14
7387654|NCT01215253|11646228|FG001|Overall Study|Other|12
7387655|NCT01215357|11646295|FG000|Overall Study|Withdrawal by Subject|3
7387656|NCT01215357|11646295|FG000|Overall Study|Protocol Violation|9
7387657|NCT01215422|11646303|FG000|Overall Study|Relocation|1
7387658|NCT01215422|11646304|FG001|Overall Study|Relocation|0
7387659|NCT01215422|11646305|FG002|Overall Study|Relocation|0
7387660|NCT01215422|11646306|FG003|Overall Study|Relocation|0
7387661|NCT01215422|11646303|FG000|Overall Study|Failed intubations|0
7387662|NCT01215422|11646304|FG001|Overall Study|Failed intubations|0
7387663|NCT01215422|11646305|FG002|Overall Study|Failed intubations|3
7387664|NCT01215422|11646306|FG003|Overall Study|Failed intubations|8
7387665|NCT01215422|11646303|FG000|Overall Study|Did not complete all intubations|7
7387666|NCT01215422|11646304|FG001|Overall Study|Did not complete all intubations|0
7387667|NCT01215422|11646305|FG002|Overall Study|Did not complete all intubations|0
7387668|NCT01215422|11646306|FG003|Overall Study|Did not complete all intubations|0
7387669|NCT01215435|11646330|FG000|Overall Study|Adverse Event|1
7387670|NCT01215435|11646331|FG001|Overall Study|Adverse Event|0
7387671|NCT01215435|11646330|FG000|Overall Study|Protocol Violation|2
7387672|NCT01215435|11646331|FG001|Overall Study|Protocol Violation|0
7387673|NCT01215435|11646330|FG000|Overall Study|Withdrawal Criteria|8
7387674|NCT01215435|11646331|FG001|Overall Study|Withdrawal Criteria|11
7387675|NCT01215435|11646330|FG000|Overall Study|Lost to Follow-up|3
7387676|NCT01215435|11646331|FG001|Overall Study|Lost to Follow-up|0
7387677|NCT01215435|11646330|FG000|Overall Study|Unclassified|5
7387678|NCT01215435|11646331|FG001|Overall Study|Unclassified|5
7387679|NCT01215513|11646337|FG000|Overall Study|Not completed CS42|9
7387680|NCT01215513|11646337|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
7387681|NCT01215513|11646337|FG000|Overall Study|Adverse event (CS42A)|2
7387682|NCT01215513|11646337|FG000|Overall Study|Physician decision (CS42A)|6
7387683|NCT01215513|11646337|FG000|Overall Study|Withdrawal by subject (CS42A)|5
7387684|NCT01215513|11646337|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
7387685|NCT01215721|11646377|FG000|Overall Study|Adverse Event|2
7387686|NCT01215734|11646383|FG000|Overall Study|Death|0
7387687|NCT01215734|11646384|FG001|Overall Study|Death|1
7387688|NCT01215851|11646409|FG000|Treatment Period|Adverse Event|1
7387689|NCT01215851|11646410|FG001|Treatment Period|Adverse Event|1
7347348|NCT00925990|11586786|FG000|Overall Study|Adverse Event|1
7347349|NCT00925990|11586787|FG001|Overall Study|Adverse Event|3
7347350|NCT00925990|11586786|FG000|Overall Study|Withdrawal by Subject|2
7347351|NCT00925990|11586787|FG001|Overall Study|Withdrawal by Subject|2
7347352|NCT00925990|11586786|FG000|Overall Study|Lost to Follow-up|1
7347353|NCT00925990|11586787|FG001|Overall Study|Lost to Follow-up|3
7347354|NCT00925990|11586786|FG000|Overall Study|Physician Decision|1
7347355|NCT00925990|11586787|FG001|Overall Study|Physician Decision|1
7347356|NCT00925990|11586786|FG000|Overall Study|moved out of state, missed medication|0
7347357|NCT00925990|11586787|FG001|Overall Study|moved out of state, missed medication|2
7347358|NCT00926003|11586796|FG000|Post-Training Evaluation|Withdrawal by Subject|1
7347359|NCT00926003|11586797|FG001|Post-Training Evaluation|Withdrawal by Subject|0
7347360|NCT00926003|11586798|FG002|Post-Training Evaluation|Withdrawal by Subject|0
7347361|NCT00926003|11586796|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
7347362|NCT00926003|11586797|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
7347363|NCT00926003|11586798|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
7347364|NCT00926029|11586809|FG000|Overall Study|Lost to Follow-up|2
7347365|NCT00926029|11586810|FG001|Overall Study|Lost to Follow-up|1
7347366|NCT00926029|11586811|FG002|Overall Study|Lost to Follow-up|1
7347367|NCT00926211|11586838|FG000|Overall Study|Lost to Follow-up|1
7347368|NCT00926237|11586843|FG000|Overall Study|Withdrawal by Subject|2
7347369|NCT00926237|11586844|FG001|Overall Study|Withdrawal by Subject|1
7347370|NCT00926289|11586866|FG000|Overall Study|Adverse Event|9
7347371|NCT00926289|11586867|FG001|Overall Study|Adverse Event|11
7347372|NCT00926289|11586866|FG000|Overall Study|Protocol Violation|8
7347373|NCT00926289|11586867|FG001|Overall Study|Protocol Violation|12
7347374|NCT00926289|11586866|FG000|Overall Study|Lost to Follow-up|3
7347375|NCT00926289|11586867|FG001|Overall Study|Lost to Follow-up|6
7347376|NCT00926289|11586866|FG000|Overall Study|Withdrawal by Subject|4
7347377|NCT00926289|11586867|FG001|Overall Study|Withdrawal by Subject|4
7347378|NCT00926289|11586866|FG000|Overall Study|Other|1
7347379|NCT00926289|11586867|FG001|Overall Study|Other|3
7347380|NCT00926328|11586875|FG000|Overall Study|Lost to Follow-up|12
7347381|NCT00926328|11586876|FG001|Overall Study|Lost to Follow-up|14
7347382|NCT00926367|11586884|FG000|Overall Study|Withdrawal by Subject|0
7347383|NCT00926367|11586885|FG001|Overall Study|Withdrawal by Subject|1
7347384|NCT00926367|11586884|FG000|Overall Study|Lost to Follow-up|1
7347385|NCT00926367|11586885|FG001|Overall Study|Lost to Follow-up|0
7347386|NCT00926367|11586884|FG000|Overall Study|Skin Irritation|1
7347387|NCT00926367|11586885|FG001|Overall Study|Skin Irritation|2
7347388|NCT00926393|11586908|FG000|Overall Study|Withdrawal by Subject|1
7347389|NCT00926393|11586909|FG001|Overall Study|Withdrawal by Subject|2
7347390|NCT00926393|11586908|FG000|Overall Study|Adverse Event|1
7347391|NCT00926393|11586909|FG001|Overall Study|Adverse Event|1
7347392|NCT00926536|11586926|FG000|Overall Study|Physician Decision|1
7347393|NCT00926536|11586927|FG001|Overall Study|Physician Decision|2
7347394|NCT00926783|11586944|FG000|Overall Study|Incomplete CFAE Procedures|3
7347395|NCT00926783|11586945|FG001|Overall Study|Incomplete CFAE Procedures|3
7347396|NCT00926796|11586953|FG000|Overall Study|Did not receive randomized treatment|4
7347397|NCT00926796|11586954|FG001|Overall Study|Did not receive randomized treatment|7
7347398|NCT00926796|11586953|FG000|Overall Study|Ineligible, negative for gonorrhea|57
7347399|NCT00926796|11586954|FG001|Overall Study|Ineligible, negative for gonorrhea|60
7347400|NCT00926796|11586953|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
7347401|NCT00926796|11586954|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
7347402|NCT00926796|11586953|FG000|Overall Study|Adverse Event|7
7347403|NCT00926796|11586954|FG001|Overall Study|Adverse Event|14
7347404|NCT00926796|11586953|FG000|Overall Study|Lost to Follow-up|22
7347405|NCT00926796|11586954|FG001|Overall Study|Lost to Follow-up|13
7347406|NCT00926796|11586953|FG000|Overall Study|Protocol Violation|15
7347407|NCT00926796|11586954|FG001|Overall Study|Protocol Violation|11
7347408|NCT00926796|11586953|FG000|Overall Study|Withdrawal by Subject|1
7347409|NCT00926796|11586954|FG001|Overall Study|Withdrawal by Subject|0
7347410|NCT00927069|11586996|FG000|Week 0 to Week 12|Worsening of psoriasis|1
7347411|NCT00927069|11586997|FG001|Week 0 to Week 12|Worsening of psoriasis|1
7347412|NCT00927069|11586998|FG002|Week 0 to Week 12|Worsening of psoriasis|0
7347413|NCT00927069|11586999|FG003|Week 0 to Week 12|Worsening of psoriasis|0
7347414|NCT00927069|11586996|FG000|Week 12 to Week 24|Lack of Efficacy|0
7347415|NCT00927069|11586997|FG001|Week 12 to Week 24|Lack of Efficacy|0
7347416|NCT00927069|11586998|FG002|Week 12 to Week 24|Lack of Efficacy|2
7347417|NCT00927069|11586999|FG003|Week 12 to Week 24|Lack of Efficacy|3
7347418|NCT00927069|11586996|FG000|Week 12 to Week 24|Lost to Follow-up|0
7347419|NCT00927069|11586997|FG001|Week 12 to Week 24|Lost to Follow-up|0
7347420|NCT00927069|11586998|FG002|Week 12 to Week 24|Lost to Follow-up|1
7347421|NCT00927069|11586999|FG003|Week 12 to Week 24|Lost to Follow-up|0
7347422|NCT00927069|11586996|FG000|Week 12 to Week 24|Withdrawal by Subject|1
7347423|NCT00927069|11586997|FG001|Week 12 to Week 24|Withdrawal by Subject|0
7347424|NCT00927069|11586998|FG002|Week 12 to Week 24|Withdrawal by Subject|0
7347425|NCT00927069|11586999|FG003|Week 12 to Week 24|Withdrawal by Subject|0
7347426|NCT00927069|11586996|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
7347427|NCT00927069|11586997|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
7347428|NCT00927069|11586998|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
7347429|NCT00927069|11586999|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
7347430|NCT00927082|11587013|FG000|Overall Study|Lost to Follow-up|9
7347431|NCT00927082|11587014|FG001|Overall Study|Lost to Follow-up|8
7347432|NCT00927082|11587015|FG002|Overall Study|Lost to Follow-up|12
7347433|NCT00927082|11587016|FG003|Overall Study|Lost to Follow-up|16
7347434|NCT00927082|11587013|FG000|Overall Study|Withdrawal by Subject|3
7347435|NCT00927082|11587014|FG001|Overall Study|Withdrawal by Subject|2
7347436|NCT00927082|11587015|FG002|Overall Study|Withdrawal by Subject|7
7347437|NCT00927082|11587016|FG003|Overall Study|Withdrawal by Subject|2
7347438|NCT00927082|11587013|FG000|Overall Study|Death|0
7347439|NCT00927082|11587014|FG001|Overall Study|Death|0
7347440|NCT00927082|11587015|FG002|Overall Study|Death|1
7347441|NCT00927082|11587016|FG003|Overall Study|Death|0
7347442|NCT00927082|11587013|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
7347443|NCT00927082|11587014|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
7347444|NCT00927082|11587015|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
7347445|NCT00927082|11587016|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
7347446|NCT00927095|11587033|FG000|Overall Study|Adverse Event|3
7347447|NCT00927095|11587034|FG001|Overall Study|Adverse Event|1
7347448|NCT00927095|11587035|FG002|Overall Study|Adverse Event|0
7347449|NCT00927095|11587033|FG000|Overall Study|Withdrawal by Subject|2
7347450|NCT00927095|11587034|FG001|Overall Study|Withdrawal by Subject|1
7347451|NCT00927095|11587035|FG002|Overall Study|Withdrawal by Subject|1
7347452|NCT00927095|11587033|FG000|Overall Study|Physician Decision|1
7347453|NCT00927095|11587034|FG001|Overall Study|Physician Decision|2
7347454|NCT00927095|11587035|FG002|Overall Study|Physician Decision|1
7347455|NCT00927186|11587054|FG000|12 Months Primary Study|Adverse Event|5
7347456|NCT00927186|11587055|FG001|12 Months Primary Study|Adverse Event|2
7347457|NCT00927186|11587054|FG000|12 Months Primary Study|Lost to Follow-up|1
7347458|NCT00927186|11587055|FG001|12 Months Primary Study|Lost to Follow-up|0
7347459|NCT00927186|11587054|FG000|12 Months Primary Study|Protocol Violation|0
7347460|NCT00927186|11587055|FG001|12 Months Primary Study|Protocol Violation|1
7347461|NCT00927186|11587054|FG000|12 Months Primary Study|Withdrawal by Subject|1
7347462|NCT00927186|11587055|FG001|12 Months Primary Study|Withdrawal by Subject|1
7347463|NCT00927251|11587064|FG000|Overall Study|Patients not implanted with 4296 lead|8
7347464|NCT00927355|11587081|FG000|Overall Study|Adverse Event|1
7347465|NCT00927355|11587082|FG001|Overall Study|Adverse Event|1
7347466|NCT00927368|11587103|FG000|Overall Study|enrollment in another study|1
7347467|NCT00927368|11587104|FG001|Overall Study|enrollment in another study|1
7347468|NCT00927368|11587105|FG002|Overall Study|enrollment in another study|2
7347469|NCT00927368|11587103|FG000|Overall Study|Lost to Follow-up|4
7347470|NCT00927368|11587104|FG001|Overall Study|Lost to Follow-up|0
7347471|NCT00927368|11587105|FG002|Overall Study|Lost to Follow-up|0
7347472|NCT00927368|11587103|FG000|Overall Study|equipment failure|1
7347473|NCT00927368|11587104|FG001|Overall Study|equipment failure|0
7347474|NCT00927368|11587105|FG002|Overall Study|equipment failure|0
7347475|NCT00927368|11587103|FG000|Overall Study|ineligible post randomization|0
7347476|NCT00927368|11587104|FG001|Overall Study|ineligible post randomization|3
7347477|NCT00927368|11587105|FG002|Overall Study|ineligible post randomization|1
7347478|NCT00927368|11587103|FG000|Overall Study|cancellation of surgery|0
7347479|NCT00927368|11587104|FG001|Overall Study|cancellation of surgery|1
7347480|NCT00927368|11587105|FG002|Overall Study|cancellation of surgery|2
7347481|NCT00927394|11587115|FG000|Overall Study|Adverse Event|14
7347482|NCT00927394|11587116|FG001|Overall Study|Adverse Event|9
7347483|NCT00927394|11587115|FG000|Overall Study|Unsatisfactory therapeutic effect|17
7347484|NCT00927394|11587116|FG001|Overall Study|Unsatisfactory therapeutic effect|23
7347485|NCT00927394|11587115|FG000|Overall Study|Withdrawal by Subject|20
7347486|NCT00927394|11587116|FG001|Overall Study|Withdrawal by Subject|24
7347487|NCT00927394|11587115|FG000|Overall Study|Lost to Follow-up|8
7347488|NCT00927394|11587116|FG001|Overall Study|Lost to Follow-up|14
7347489|NCT00927394|11587115|FG000|Overall Study|Administrative Problem|1
7347490|NCT00927394|11587116|FG001|Overall Study|Administrative Problem|0
7347491|NCT00927394|11587115|FG000|Overall Study|Death|1
7347492|NCT00927394|11587116|FG001|Overall Study|Death|1
7347493|NCT00927394|11587115|FG000|Overall Study|Protocol deviation|16
7347494|NCT00927394|11587116|FG001|Overall Study|Protocol deviation|13
7347495|NCT00927394|11587115|FG000|Overall Study|Randomized in error|0
7347496|NCT00927394|11587116|FG001|Overall Study|Randomized in error|1
7347497|NCT00927472|11587125|FG000|Overall Study|Withdrawal by Subject|10
7347498|NCT00927472|11587126|FG001|Overall Study|Withdrawal by Subject|11
7347499|NCT00927472|11587125|FG000|Overall Study|Lost to Follow-up|1
7347500|NCT00927472|11587126|FG001|Overall Study|Lost to Follow-up|6
7347501|NCT00927472|11587125|FG000|Overall Study|Protocol Violation|0
7347502|NCT00927472|11587126|FG001|Overall Study|Protocol Violation|1
7347503|NCT00927472|11587125|FG000|Overall Study|Post treatment Assessment out of window|0
7347504|NCT00927472|11587126|FG001|Overall Study|Post treatment Assessment out of window|4
7347505|NCT00927485|11587134|FG000|Overall Study|Adverse Event|4
7347506|NCT00927485|11587135|FG001|Overall Study|Adverse Event|2
7347507|NCT00927485|11587134|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
7347508|NCT00927485|11587135|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
7347509|NCT00927563|11587141|FG000|Overall Study|Lost to Follow-up|1
7347510|NCT00927563|11587141|FG000|Overall Study|Withdrawal by Subject|1
7347511|NCT00927589|11587153|FG000|Overall Study|Death|1
7347512|NCT00927589|11587153|FG000|Overall Study|Physician Decision|1
7347513|NCT00927589|11587153|FG000|Overall Study|Withdrawal by Subject|3
7347514|NCT00927589|11587153|FG000|Overall Study|Adverse Event|2
7347515|NCT00927589|11587153|FG000|Overall Study|Disease Progression|8
7347516|NCT00927589|11587153|FG000|Overall Study|Non-compliance|1
7347517|NCT00927758|11587157|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7347518|NCT00927758|11587158|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7347519|NCT00927758|11587159|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7347520|NCT00927758|11587160|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7347521|NCT00927758|11587161|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
7347522|NCT00927758|11587162|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
7347523|NCT00927758|11587157|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7347524|NCT00927758|11587158|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7347525|NCT00927758|11587159|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7347526|NCT00927758|11587160|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7347527|NCT00927758|11587161|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
7347528|NCT00927758|11587162|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
7347529|NCT00927784|11587172|FG000|Overall Study|Death|1
7347530|NCT00927784|11587173|FG001|Overall Study|Death|0
7347531|NCT00927784|11587172|FG000|Overall Study|Withdrawal by Subject|1
7347532|NCT00927784|11587173|FG001|Overall Study|Withdrawal by Subject|0
7347533|NCT00927810|11587183|FG000|Overall Study|Withdrawal by Subject|0
7347534|NCT00927810|11587184|FG001|Overall Study|Withdrawal by Subject|3
7347535|NCT00927810|11587185|FG002|Overall Study|Withdrawal by Subject|0
7347536|NCT00927810|11587186|FG003|Overall Study|Withdrawal by Subject|1
7347537|NCT00927810|11587183|FG000|Overall Study|Lost to Follow-up|0
7347538|NCT00927810|11587184|FG001|Overall Study|Lost to Follow-up|2
7347539|NCT00927810|11587185|FG002|Overall Study|Lost to Follow-up|1
7347540|NCT00927810|11587186|FG003|Overall Study|Lost to Follow-up|1
7347541|NCT00927810|11587183|FG000|Overall Study|Death|0
7347542|NCT00927810|11587184|FG001|Overall Study|Death|2
7347543|NCT00927810|11587185|FG002|Overall Study|Death|0
7347544|NCT00927810|11587186|FG003|Overall Study|Death|0
7347545|NCT00927810|11587183|FG000|Overall Study|Abnormal laboratory value(s)|0
7347546|NCT00927810|11587184|FG001|Overall Study|Abnormal laboratory value(s)|1
7347547|NCT00927810|11587185|FG002|Overall Study|Abnormal laboratory value(s)|0
7347548|NCT00927810|11587186|FG003|Overall Study|Abnormal laboratory value(s)|0
7347549|NCT00927823|11587204|FG000|Continuous Dosing Period|Death|0
7347550|NCT00927823|11587205|FG001|Continuous Dosing Period|Death|0
7347551|NCT00927823|11587206|FG002|Continuous Dosing Period|Death|6
7347552|NCT00927823|11587207|FG003|Continuous Dosing Period|Death|0
7347553|NCT00927823|11587204|FG000|Continuous Dosing Period|Lost to Follow-up|1
7347554|NCT00927823|11587205|FG001|Continuous Dosing Period|Lost to Follow-up|1
7347555|NCT00927823|11587206|FG002|Continuous Dosing Period|Lost to Follow-up|9
7347556|NCT00927823|11587207|FG003|Continuous Dosing Period|Lost to Follow-up|0
7347557|NCT00927823|11587204|FG000|Continuous Dosing Period|Withdrawal by Subject|1
7347558|NCT00927823|11587205|FG001|Continuous Dosing Period|Withdrawal by Subject|0
7347559|NCT00927823|11587206|FG002|Continuous Dosing Period|Withdrawal by Subject|2
7347560|NCT00927823|11587207|FG003|Continuous Dosing Period|Withdrawal by Subject|2
7347561|NCT00927823|11587204|FG000|Continuous Dosing Period|Other|1
7347562|NCT00927823|11587205|FG001|Continuous Dosing Period|Other|2
7347563|NCT00927823|11587206|FG002|Continuous Dosing Period|Other|9
7347564|NCT00927823|11587207|FG003|Continuous Dosing Period|Other|3
7347565|NCT00927862|11587239|FG000|Overall Study|Missing data needed for endpt analyses|27
7347566|NCT00927862|11587240|FG001|Overall Study|Missing data needed for endpt analyses|45
7347567|NCT00927901|11587259|FG000|Treatment Period 1|Subject withdrew consent|0
7347568|NCT00927901|11587260|FG001|Treatment Period 1|Subject withdrew consent|0
7347569|NCT00927901|11587261|FG002|Treatment Period 1|Subject withdrew consent|1
7347570|NCT00927901|11587262|FG003|Treatment Period 1|Subject withdrew consent|0
7347571|NCT00927901|11587259|FG000|Treatment Period 4|Adverse Event|0
7347572|NCT00927901|11587260|FG001|Treatment Period 4|Adverse Event|0
7347573|NCT00927901|11587261|FG002|Treatment Period 4|Adverse Event|0
7347574|NCT00927901|11587262|FG003|Treatment Period 4|Adverse Event|1
7347575|NCT00927901|11587259|FG000|Treatment Period 4|Subject withdrew consent|0
7347576|NCT00927901|11587260|FG001|Treatment Period 4|Subject withdrew consent|0
7347577|NCT00927901|11587261|FG002|Treatment Period 4|Subject withdrew consent|1
7347578|NCT00927901|11587262|FG003|Treatment Period 4|Subject withdrew consent|0
7347579|NCT00927927|11587290|FG000|Overall Study|Withdrawal by Subject|0
7347580|NCT00927927|11587291|FG001|Overall Study|Withdrawal by Subject|0
7347581|NCT00927927|11587292|FG002|Overall Study|Withdrawal by Subject|0
7347582|NCT00927927|11587293|FG003|Overall Study|Withdrawal by Subject|0
7347583|NCT00927927|11587294|FG004|Overall Study|Withdrawal by Subject|0
7347584|NCT00927927|11587295|FG005|Overall Study|Withdrawal by Subject|0
7347585|NCT00927927|11587296|FG006|Overall Study|Withdrawal by Subject|0
7347586|NCT00927927|11587297|FG007|Overall Study|Withdrawal by Subject|2
7347587|NCT00927927|11587298|FG008|Overall Study|Withdrawal by Subject|0
7347588|NCT00927927|11587299|FG009|Overall Study|Withdrawal by Subject|0
7347589|NCT00927927|11587300|FG010|Overall Study|Withdrawal by Subject|0
7347590|NCT00927927|11587301|FG011|Overall Study|Withdrawal by Subject|2
7347591|NCT00927927|11587302|FG012|Overall Study|Withdrawal by Subject|0
7347592|NCT00927927|11587303|FG013|Overall Study|Withdrawal by Subject|0
7347593|NCT00927927|11587304|FG014|Overall Study|Withdrawal by Subject|0
7347594|NCT00927940|11587336|FG000|Overall Study|Death|1
7347595|NCT00928018|11587347|FG000|Overall Study|Withdrawal by Subject|1
7347596|NCT00928018|11587348|FG001|Overall Study|Withdrawal by Subject|0
7347597|NCT00928057|11587360|FG000|Overall Study|Adverse Event|1
7347598|NCT00928057|11587361|FG001|Overall Study|Adverse Event|2
7347599|NCT00928057|11587360|FG000|Overall Study|Withdrawal by Subject|1
7347600|NCT00928057|11587361|FG001|Overall Study|Withdrawal by Subject|0
7347601|NCT00928057|11587360|FG000|Overall Study|Lost to Follow-up|0
7347602|NCT00928057|11587361|FG001|Overall Study|Lost to Follow-up|1
7347603|NCT00928057|11587360|FG000|Overall Study|Protocol Violation|0
7347604|NCT00928057|11587361|FG001|Overall Study|Protocol Violation|1
7347605|NCT00928070|11587379|FG000|Overall Study|Lost to Follow-up|1
7347606|NCT00928070|11587380|FG001|Overall Study|Lost to Follow-up|2
7347607|NCT00928070|11587379|FG000|Overall Study|Withdrawal by Subject|10
7347608|NCT00928070|11587380|FG001|Overall Study|Withdrawal by Subject|3
7347609|NCT00928070|11587379|FG000|Overall Study|Adverse Event|14
7347610|NCT00928070|11587380|FG001|Overall Study|Adverse Event|26
7347611|NCT00928070|11587379|FG000|Overall Study|Lack of Efficacy|9
7347612|NCT00928070|11587380|FG001|Overall Study|Lack of Efficacy|5
7347613|NCT00928070|11587379|FG000|Overall Study|Did not meet entrance criteria|16
7347614|NCT00928070|11587380|FG001|Overall Study|Did not meet entrance criteria|9
7347615|NCT00928070|11587379|FG000|Overall Study|Protocol Violation|6
7347616|NCT00928070|11587380|FG001|Overall Study|Protocol Violation|5
7347617|NCT00928070|11587379|FG000|Overall Study|Randomized but not treated|2
7347618|NCT00928070|11587380|FG001|Overall Study|Randomized but not treated|2
7347619|NCT00928070|11587379|FG000|Overall Study|Other|5
7347620|NCT00928070|11587380|FG001|Overall Study|Other|5
7347621|NCT00928135|11587448|FG000|Overall Study|Withdrawal by Subject|1
7347622|NCT00928135|11587449|FG001|Overall Study|Withdrawal by Subject|0
7347623|NCT00928187|11587462|FG000|Overall Study|Death|1
7347624|NCT00928187|11587463|FG001|Overall Study|Death|2
7347625|NCT00928187|11587464|FG002|Overall Study|Death|3
7347626|NCT00928187|11587462|FG000|Overall Study|Lost to Follow-up|1
7347627|NCT00928187|11587463|FG001|Overall Study|Lost to Follow-up|2
7347628|NCT00928187|11587464|FG002|Overall Study|Lost to Follow-up|1
7347629|NCT00928187|11587462|FG000|Overall Study|Withdrawal by Subject|0
7347630|NCT00928187|11587463|FG001|Overall Study|Withdrawal by Subject|1
7347631|NCT00928187|11587464|FG002|Overall Study|Withdrawal by Subject|1
7347632|NCT00928187|11587462|FG000|Overall Study|Protocol Violation|0
7347633|NCT00928187|11587463|FG001|Overall Study|Protocol Violation|1
7347634|NCT00928187|11587464|FG002|Overall Study|Protocol Violation|0
7347635|NCT00928252|11587476|FG000|Overall Study|Physician Decision|3
7347636|NCT00928408|11587499|FG000|Overall Study|Other|2
7347637|NCT00928408|11587499|FG000|Overall Study|Withdrawal by Subject|4
7347638|NCT00928408|11587499|FG000|Overall Study|Death|5
7347639|NCT00928408|11587499|FG000|Overall Study|Lost to Follow-up|12
7347640|NCT00928434|11587510|FG000|Overall Study|Adverse Event|14
7347641|NCT00928434|11587511|FG001|Overall Study|Adverse Event|5
7347642|NCT00928434|11587512|FG002|Overall Study|Adverse Event|18
7347643|NCT00928434|11587510|FG000|Overall Study|Protocol Violation|5
7347644|NCT00928434|11587511|FG001|Overall Study|Protocol Violation|0
7347645|NCT00928434|11587512|FG002|Overall Study|Protocol Violation|8
7347646|NCT00928434|11587510|FG000|Overall Study|Physician Decision|2
7347647|NCT00928434|11587511|FG001|Overall Study|Physician Decision|0
7347648|NCT00928434|11587512|FG002|Overall Study|Physician Decision|3
7347649|NCT00928434|11587510|FG000|Overall Study|Lost to Follow-up|1
7347650|NCT00928434|11587511|FG001|Overall Study|Lost to Follow-up|0
7347651|NCT00928434|11587512|FG002|Overall Study|Lost to Follow-up|3
7347652|NCT00928434|11587510|FG000|Overall Study|Withdrawal by Subject|5
7347653|NCT00928434|11587511|FG001|Overall Study|Withdrawal by Subject|3
7347654|NCT00928434|11587512|FG002|Overall Study|Withdrawal by Subject|2
7347655|NCT00928434|11587510|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
7347656|NCT00928434|11587511|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
7347657|NCT00928434|11587512|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
7347658|NCT00928434|11587510|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
7347659|NCT00928434|11587511|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7347660|NCT00928434|11587512|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
7347661|NCT00928434|11587510|FG000|Overall Study|Other (not meeting above criteria)|5
7347662|NCT00928434|11587511|FG001|Overall Study|Other (not meeting above criteria)|1
7347663|NCT00928434|11587512|FG002|Overall Study|Other (not meeting above criteria)|2
7347664|NCT00928486|11587528|FG000|Overall Study|Adverse Event|2
7347665|NCT00928486|11587528|FG000|Overall Study|Disease Progression|7
7347666|NCT00928486|11587528|FG000|Overall Study|Withdrawal by Subject|1
7347667|NCT00928512|11587537|FG000|Overall Study|Adverse Event|4
7347668|NCT00928512|11587538|FG001|Overall Study|Adverse Event|3
7347669|NCT00928512|11587539|FG002|Overall Study|Adverse Event|2
7347670|NCT00928512|11587540|FG003|Overall Study|Adverse Event|8
7347671|NCT00928512|11587541|FG004|Overall Study|Adverse Event|6
7347672|NCT00928512|11587537|FG000|Overall Study|Lack of Efficacy|2
7347673|NCT00928512|11587538|FG001|Overall Study|Lack of Efficacy|0
7347674|NCT00928512|11587539|FG002|Overall Study|Lack of Efficacy|4
7347675|NCT00928512|11587540|FG003|Overall Study|Lack of Efficacy|7
7347676|NCT00928512|11587541|FG004|Overall Study|Lack of Efficacy|3
7347677|NCT00928512|11587537|FG000|Overall Study|Protocol Violation|0
7347678|NCT00928512|11587538|FG001|Overall Study|Protocol Violation|1
7347679|NCT00928512|11587539|FG002|Overall Study|Protocol Violation|0
7347680|NCT00928512|11587540|FG003|Overall Study|Protocol Violation|1
7347681|NCT00928512|11587541|FG004|Overall Study|Protocol Violation|3
7347682|NCT00928512|11587537|FG000|Overall Study|Withdrawal by Subject|3
7347683|NCT00928512|11587538|FG001|Overall Study|Withdrawal by Subject|0
7347684|NCT00928512|11587539|FG002|Overall Study|Withdrawal by Subject|3
7347685|NCT00928512|11587540|FG003|Overall Study|Withdrawal by Subject|4
7347686|NCT00928512|11587541|FG004|Overall Study|Withdrawal by Subject|0
7347687|NCT00928512|11587537|FG000|Overall Study|Lost to Follow-up|1
7347688|NCT00928512|11587538|FG001|Overall Study|Lost to Follow-up|1
7347689|NCT00928512|11587539|FG002|Overall Study|Lost to Follow-up|2
7347690|NCT00928512|11587540|FG003|Overall Study|Lost to Follow-up|1
7347691|NCT00928512|11587541|FG004|Overall Study|Lost to Follow-up|3
7347692|NCT00928512|11587537|FG000|Overall Study|Administrative Problems|0
7347693|NCT00928512|11587538|FG001|Overall Study|Administrative Problems|1
7347694|NCT00928512|11587539|FG002|Overall Study|Administrative Problems|0
7347695|NCT00928512|11587540|FG003|Overall Study|Administrative Problems|0
7347696|NCT00928512|11587541|FG004|Overall Study|Administrative Problems|0
7347697|NCT00928564|11587559|FG000|Overall Study|Lost to Follow-up|6
7347698|NCT00928564|11587560|FG001|Overall Study|Lost to Follow-up|0
7347699|NCT00928668|11587573|FG000|Overall Study|Adverse Event|1
7347700|NCT00928668|11587574|FG001|Overall Study|Adverse Event|0
7459030|NCT01813474|11753433|FG002|Overall Study|Lack of Efficacy|9
7459031|NCT01813474|11753431|FG000|Overall Study|Death|0
7459032|NCT01813474|11753432|FG001|Overall Study|Death|0
7459033|NCT01813474|11753433|FG002|Overall Study|Death|1
7459034|NCT01813721|11753442|FG000|Overall Study|Ineligibility determined|63
7459035|NCT01813721|11753442|FG000|Overall Study|Withdrawal by Subject|1
7459036|NCT01813890|11753471|FG000|Overall Study|Adverse Event|0
7459037|NCT01813890|11753472|FG001|Overall Study|Adverse Event|3
7459038|NCT01813890|11753473|FG002|Overall Study|Adverse Event|4
7459039|NCT01813890|11753471|FG000|Overall Study|Lack of Efficacy|9
7459040|NCT01813890|11753472|FG001|Overall Study|Lack of Efficacy|1
7459041|NCT01813890|11753473|FG002|Overall Study|Lack of Efficacy|2
7459042|NCT01814007|11753481|FG000|Overall Study|Withdrawal by Subject|1
7459043|NCT01814046|11753488|FG000|Drug Administration|Death due to complications of RSV|1
7459044|NCT01814046|11753489|FG001|Drug Administration|Death due to complications of RSV|0
7459045|NCT01814046|11753490|FG002|Drug Administration|Death due to complications of RSV|0
7459046|NCT01814072|11753529|FG000|Overall Study|Lost to Follow-up|2
7459047|NCT01814072|11753530|FG001|Overall Study|Lost to Follow-up|2
7459048|NCT01814072|11753531|FG002|Overall Study|Lost to Follow-up|2
7459049|NCT01814072|11753532|FG003|Overall Study|Lost to Follow-up|0
7459050|NCT01814072|11753533|FG004|Overall Study|Lost to Follow-up|2
7459051|NCT01814072|11753534|FG005|Overall Study|Lost to Follow-up|3
7459052|NCT01814072|11753535|FG006|Overall Study|Lost to Follow-up|3
7459053|NCT01814072|11753536|FG007|Overall Study|Lost to Follow-up|1
7459054|NCT01814072|11753537|FG008|Overall Study|Lost to Follow-up|2
7459055|NCT01814072|11753538|FG009|Overall Study|Lost to Follow-up|3
7459056|NCT01814072|11753539|FG010|Overall Study|Lost to Follow-up|1
7347701|NCT00928668|11587575|FG002|Overall Study|Adverse Event|0
7347702|NCT00928668|11587576|FG003|Overall Study|Adverse Event|0
7347703|NCT00928668|11587577|FG004|Overall Study|Adverse Event|0
7347704|NCT00928668|11587573|FG000|Overall Study|Protocol Violation|0
7347705|NCT00928668|11587574|FG001|Overall Study|Protocol Violation|0
7347706|NCT00928668|11587575|FG002|Overall Study|Protocol Violation|0
7459057|NCT01814072|11753540|FG011|Overall Study|Lost to Follow-up|2
7459058|NCT01814072|11753541|FG012|Overall Study|Lost to Follow-up|2
7347707|NCT00928668|11587576|FG003|Overall Study|Protocol Violation|0
7347708|NCT00928668|11587577|FG004|Overall Study|Protocol Violation|1
7347709|NCT00928668|11587573|FG000|Overall Study|Withdrawal by Subject|0
7459059|NCT01814072|11753542|FG013|Overall Study|Lost to Follow-up|1
7459060|NCT01814072|11753543|FG014|Overall Study|Lost to Follow-up|2
7347710|NCT00928668|11587574|FG001|Overall Study|Withdrawal by Subject|1
7347711|NCT00928668|11587575|FG002|Overall Study|Withdrawal by Subject|1
7347712|NCT00928668|11587576|FG003|Overall Study|Withdrawal by Subject|0
7347713|NCT00928668|11587577|FG004|Overall Study|Withdrawal by Subject|0
7347714|NCT00928668|11587573|FG000|Overall Study|Other reasons not listed above|0
7347715|NCT00928668|11587574|FG001|Overall Study|Other reasons not listed above|0
7347716|NCT00928668|11587575|FG002|Overall Study|Other reasons not listed above|0
7347717|NCT00928668|11587576|FG003|Overall Study|Other reasons not listed above|1
7347718|NCT00928668|11587577|FG004|Overall Study|Other reasons not listed above|0
7347719|NCT00928707|11587603|FG000|Overall Study|Protocol Violation|1
7347720|NCT00928707|11587604|FG001|Overall Study|Protocol Violation|0
7347721|NCT00928746|11587626|FG000|Overall Study|Adverse Event|2
7347722|NCT00928746|11587626|FG000|Overall Study|Protocol Violation|1
7347723|NCT00928746|11587626|FG000|Overall Study|Withdrawal by Subject|1
7347724|NCT00928746|11587626|FG000|Overall Study|Other|2
7347725|NCT00928889|11587647|FG000|Overall Study|Lost to Follow-up|3
7347726|NCT00928889|11587648|FG001|Overall Study|Lost to Follow-up|1
7347727|NCT00928889|11587647|FG000|Overall Study|Protocol Violation|0
7347728|NCT00928889|11587648|FG001|Overall Study|Protocol Violation|1
7347729|NCT00928889|11587647|FG000|Overall Study|Adverse Event|1
7347730|NCT00928889|11587648|FG001|Overall Study|Adverse Event|0
7347731|NCT00928889|11587647|FG000|Overall Study|Other|1
7347732|NCT00928889|11587648|FG001|Overall Study|Other|0
7347733|NCT00929110|11587671|FG000|Overall Study|Adverse Event|40
7347734|NCT00929110|11587672|FG001|Overall Study|Adverse Event|29
7347735|NCT00929110|11587673|FG002|Overall Study|Adverse Event|18
7347736|NCT00929110|11587671|FG000|Overall Study|Subject withdrew consent|40
7347737|NCT00929110|11587672|FG001|Overall Study|Subject withdrew consent|23
7347738|NCT00929110|11587673|FG002|Overall Study|Subject withdrew consent|26
7347739|NCT00929110|11587671|FG000|Overall Study|Unsatisfactory therapeutic effect|20
7347740|NCT00929110|11587672|FG001|Overall Study|Unsatisfactory therapeutic effect|9
7347741|NCT00929110|11587673|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7347742|NCT00929110|11587671|FG000|Overall Study|Lost to Follow-up|7
7347743|NCT00929110|11587672|FG001|Overall Study|Lost to Follow-up|7
7347744|NCT00929110|11587673|FG002|Overall Study|Lost to Follow-up|3
7347745|NCT00929110|11587671|FG000|Overall Study|Protocol deviation|5
7347746|NCT00929110|11587672|FG001|Overall Study|Protocol deviation|2
7347747|NCT00929110|11587673|FG002|Overall Study|Protocol deviation|4
7347748|NCT00929110|11587671|FG000|Overall Study|Administrative problems|4
7347749|NCT00929110|11587672|FG001|Overall Study|Administrative problems|1
7347750|NCT00929110|11587673|FG002|Overall Study|Administrative problems|2
7347751|NCT00929110|11587671|FG000|Overall Study|Death|2
7347752|NCT00929110|11587672|FG001|Overall Study|Death|2
7347753|NCT00929110|11587673|FG002|Overall Study|Death|2
7347754|NCT00929110|11587671|FG000|Overall Study|Abnormal laboratory value(s)|0
7347755|NCT00929110|11587672|FG001|Overall Study|Abnormal laboratory value(s)|1
7347756|NCT00929110|11587673|FG002|Overall Study|Abnormal laboratory value(s)|0
7347757|NCT00929110|11587671|FG000|Overall Study|Abnormal test procedure result(s)|0
7347758|NCT00929110|11587672|FG001|Overall Study|Abnormal test procedure result(s)|1
7347759|NCT00929110|11587673|FG002|Overall Study|Abnormal test procedure result(s)|1
7347760|NCT00929110|11587671|FG000|Overall Study|Patient inability to use the device|0
7347761|NCT00929110|11587672|FG001|Overall Study|Patient inability to use the device|1
7347762|NCT00929110|11587673|FG002|Overall Study|Patient inability to use the device|0
7347763|NCT00929162|11587683|FG000|Overall Study|Adverse Event|8
7347764|NCT00929162|11587684|FG001|Overall Study|Adverse Event|5
7347765|NCT00929162|11587683|FG000|Overall Study|Withdrawal by Subject|3
7459061|NCT01814072|11753544|FG015|Overall Study|Lost to Follow-up|1
7459062|NCT01814072|11753545|FG016|Overall Study|Lost to Follow-up|3
7459063|NCT01814072|11753546|FG017|Overall Study|Lost to Follow-up|1
7459064|NCT01814072|11753547|FG018|Overall Study|Lost to Follow-up|3
7459065|NCT01814072|11753548|FG019|Overall Study|Lost to Follow-up|3
7459066|NCT01814072|11753549|FG020|Overall Study|Lost to Follow-up|2
7459067|NCT01814072|11753550|FG021|Overall Study|Lost to Follow-up|1
7459068|NCT01814072|11753551|FG022|Overall Study|Lost to Follow-up|3
7459069|NCT01814072|11753552|FG023|Overall Study|Lost to Follow-up|1
7459070|NCT01814072|11753553|FG024|Overall Study|Lost to Follow-up|4
7459071|NCT01814072|11753554|FG025|Overall Study|Lost to Follow-up|1
7459072|NCT01814072|11753555|FG026|Overall Study|Lost to Follow-up|1
7459073|NCT01814072|11753556|FG027|Overall Study|Lost to Follow-up|2
7459074|NCT01814072|11753557|FG028|Overall Study|Lost to Follow-up|3
7459075|NCT01814072|11753558|FG029|Overall Study|Lost to Follow-up|3
7459076|NCT01814072|11753559|FG030|Overall Study|Lost to Follow-up|2
7459077|NCT01814072|11753560|FG031|Overall Study|Lost to Follow-up|0
7459078|NCT01814072|11753529|FG000|Overall Study|Withdrawal by Subject|2
7459079|NCT01814072|11753530|FG001|Overall Study|Withdrawal by Subject|0
7459080|NCT01814072|11753531|FG002|Overall Study|Withdrawal by Subject|1
7459081|NCT01814072|11753532|FG003|Overall Study|Withdrawal by Subject|0
7459082|NCT01814072|11753533|FG004|Overall Study|Withdrawal by Subject|2
7459083|NCT01814072|11753534|FG005|Overall Study|Withdrawal by Subject|3
7459084|NCT01814072|11753535|FG006|Overall Study|Withdrawal by Subject|1
7459085|NCT01814072|11753536|FG007|Overall Study|Withdrawal by Subject|0
7459086|NCT01814072|11753537|FG008|Overall Study|Withdrawal by Subject|1
7459087|NCT01814072|11753538|FG009|Overall Study|Withdrawal by Subject|2
7459088|NCT01814072|11753539|FG010|Overall Study|Withdrawal by Subject|0
7347766|NCT00929162|11587684|FG001|Overall Study|Withdrawal by Subject|1
7347767|NCT00929162|11587683|FG000|Overall Study|Protocol Violation|32
7347768|NCT00929162|11587684|FG001|Overall Study|Protocol Violation|30
7347769|NCT00929162|11587683|FG000|Overall Study|Other termination reason|5
7347770|NCT00929162|11587684|FG001|Overall Study|Other termination reason|6
7347771|NCT00929201|11587690|FG000|Period 1|Withdrawal by Subject|0
7347772|NCT00929201|11587691|FG001|Period 1|Withdrawal by Subject|1
7347773|NCT00929240|11587698|FG000|Initial Treatment Phase|Adverse Event|31
7347774|NCT00929240|11587699|FG001|Initial Treatment Phase|Adverse Event|0
7347775|NCT00929240|11587700|FG002|Initial Treatment Phase|Adverse Event|0
7347776|NCT00929240|11587698|FG000|Initial Treatment Phase|Disease progression|41
7347777|NCT00929240|11587699|FG001|Initial Treatment Phase|Disease progression|0
7347778|NCT00929240|11587700|FG002|Initial Treatment Phase|Disease progression|0
7347779|NCT00929240|11587698|FG000|Initial Treatment Phase|Withdrawal by Subject|13
7347780|NCT00929240|11587699|FG001|Initial Treatment Phase|Withdrawal by Subject|0
7347781|NCT00929240|11587700|FG002|Initial Treatment Phase|Withdrawal by Subject|0
7347782|NCT00929240|11587698|FG000|Initial Treatment Phase|Protocol Violation|5
7347783|NCT00929240|11587699|FG001|Initial Treatment Phase|Protocol Violation|0
7347784|NCT00929240|11587700|FG002|Initial Treatment Phase|Protocol Violation|0
7347785|NCT00929240|11587698|FG000|Initial Treatment Phase|Death|2
7347786|NCT00929240|11587699|FG001|Initial Treatment Phase|Death|0
7347787|NCT00929240|11587700|FG002|Initial Treatment Phase|Death|0
7347788|NCT00929240|11587698|FG000|Initial Treatment Phase|Health authority/Study termination|3
7347789|NCT00929240|11587699|FG001|Initial Treatment Phase|Health authority/Study termination|0
7347790|NCT00929240|11587700|FG002|Initial Treatment Phase|Health authority/Study termination|0
7347791|NCT00929240|11587698|FG000|Initial Treatment Phase|Physician Decision|4
7347792|NCT00929240|11587699|FG001|Initial Treatment Phase|Physician Decision|0
7347793|NCT00929240|11587700|FG002|Initial Treatment Phase|Physician Decision|0
7347794|NCT00929240|11587698|FG000|Maintenance Phase|Disease progression|0
7347795|NCT00929240|11587699|FG001|Maintenance Phase|Disease progression|73
7347796|NCT00929240|11587700|FG002|Maintenance Phase|Disease progression|60
7347797|NCT00929240|11587698|FG000|Maintenance Phase|Adverse Event|0
7347798|NCT00929240|11587699|FG001|Maintenance Phase|Adverse Event|9
7347799|NCT00929240|11587700|FG002|Maintenance Phase|Adverse Event|12
7347800|NCT00929240|11587698|FG000|Maintenance Phase|Withdrawal by Subject|0
7347801|NCT00929240|11587699|FG001|Maintenance Phase|Withdrawal by Subject|2
7347802|NCT00929240|11587700|FG002|Maintenance Phase|Withdrawal by Subject|6
7347803|NCT00929240|11587698|FG000|Maintenance Phase|Protocol Violation|0
7347804|NCT00929240|11587699|FG001|Maintenance Phase|Protocol Violation|1
7347805|NCT00929240|11587700|FG002|Maintenance Phase|Protocol Violation|0
7347806|NCT00929240|11587698|FG000|Maintenance Phase|Health authority/Study termination|0
7347807|NCT00929240|11587699|FG001|Maintenance Phase|Health authority/Study termination|1
7347808|NCT00929240|11587700|FG002|Maintenance Phase|Health authority/Study termination|2
7347809|NCT00929240|11587698|FG000|Maintenance Phase|Physician Decision|0
7347810|NCT00929240|11587699|FG001|Maintenance Phase|Physician Decision|2
7347811|NCT00929240|11587700|FG002|Maintenance Phase|Physician Decision|1
7347812|NCT00929240|11587698|FG000|Maintenance Phase|Change of treatment|0
7347813|NCT00929240|11587699|FG001|Maintenance Phase|Change of treatment|4
7347814|NCT00929240|11587700|FG002|Maintenance Phase|Change of treatment|0
7347815|NCT00929240|11587698|FG000|Maintenance Phase|Treatment ongoing at study closure|0
7347816|NCT00929240|11587699|FG001|Maintenance Phase|Treatment ongoing at study closure|0
7347817|NCT00929240|11587700|FG002|Maintenance Phase|Treatment ongoing at study closure|10
7347818|NCT00929240|11587698|FG000|Maintenance Phase|Participant not treated|0
7347819|NCT00929240|11587699|FG001|Maintenance Phase|Participant not treated|2
7347820|NCT00929240|11587700|FG002|Maintenance Phase|Participant not treated|0
7347821|NCT00929526|11587765|FG000|Overall Study|Withdrawal by Subject|1
7347822|NCT00929526|11587766|FG001|Overall Study|Withdrawal by Subject|11
7347823|NCT00929526|11587765|FG000|Overall Study|Lost to Follow-up|8
7347824|NCT00929526|11587766|FG001|Overall Study|Lost to Follow-up|12
7347825|NCT00929526|11587765|FG000|Overall Study|Other|8
7347826|NCT00929526|11587766|FG001|Overall Study|Other|6
7347827|NCT00929643|11587781|FG000|Overall Study|Protocol Violation|2
7347828|NCT00929656|11587787|FG000|Overall Study|Lost to Follow-up|0
7347829|NCT00929656|11587788|FG001|Overall Study|Lost to Follow-up|1
7347830|NCT00929669|11587794|FG000|Overall Study|elevated glucose levels|1
7347831|NCT00929695|11587800|FG000|Overall Study|Death|2
7347832|NCT00929695|11587801|FG001|Overall Study|Death|1
7347833|NCT00929695|11587800|FG000|Overall Study|Withdrawal by Subject|0
7347834|NCT00929695|11587801|FG001|Overall Study|Withdrawal by Subject|2
7347835|NCT00929695|11587800|FG000|Overall Study|discharge home|4
7347836|NCT00929695|11587801|FG001|Overall Study|discharge home|3
7347837|NCT00929695|11587800|FG000|Overall Study|incorrect stratification|2
7347838|NCT00929695|11587801|FG001|Overall Study|incorrect stratification|0
7347839|NCT00929708|11587817|FG000|Overall Study|Protocol Violation|2
7347840|NCT00929708|11587818|FG001|Overall Study|Protocol Violation|1
7347841|NCT00929708|11587819|FG002|Overall Study|Protocol Violation|1
7347842|NCT00929708|11587820|FG003|Overall Study|Protocol Violation|1
7347843|NCT00929708|11587821|FG004|Overall Study|Protocol Violation|1
7347844|NCT00929708|11587817|FG000|Overall Study|Withdrawal by Subject|2
7347845|NCT00929708|11587818|FG001|Overall Study|Withdrawal by Subject|0
7347846|NCT00929708|11587819|FG002|Overall Study|Withdrawal by Subject|0
7347847|NCT00929708|11587820|FG003|Overall Study|Withdrawal by Subject|2
7347848|NCT00929708|11587821|FG004|Overall Study|Withdrawal by Subject|1
7347849|NCT00929708|11587817|FG000|Overall Study|Adverse Event|0
7347850|NCT00929708|11587818|FG001|Overall Study|Adverse Event|0
7347851|NCT00929708|11587819|FG002|Overall Study|Adverse Event|0
7347852|NCT00929708|11587820|FG003|Overall Study|Adverse Event|0
7347853|NCT00929708|11587821|FG004|Overall Study|Adverse Event|3
7347854|NCT00929708|11587817|FG000|Overall Study|Physician Decision|0
7347855|NCT00929708|11587818|FG001|Overall Study|Physician Decision|2
7347856|NCT00929708|11587819|FG002|Overall Study|Physician Decision|2
7347857|NCT00929708|11587820|FG003|Overall Study|Physician Decision|2
7347858|NCT00929708|11587821|FG004|Overall Study|Physician Decision|1
7347859|NCT00929708|11587817|FG000|Overall Study|Lost to Follow-up|0
7347860|NCT00929708|11587818|FG001|Overall Study|Lost to Follow-up|0
7347861|NCT00929708|11587819|FG002|Overall Study|Lost to Follow-up|0
7347862|NCT00929708|11587820|FG003|Overall Study|Lost to Follow-up|1
7347863|NCT00929708|11587821|FG004|Overall Study|Lost to Follow-up|0
7347864|NCT00929734|11587835|FG000|Overall Study|Lost to Follow-up|2
7347865|NCT00929734|11587836|FG001|Overall Study|Lost to Follow-up|1
7347866|NCT00929734|11587835|FG000|Overall Study|Withdrawal by Subject|0
7347867|NCT00929734|11587836|FG001|Overall Study|Withdrawal by Subject|2
7347868|NCT00929864|11587871|FG000|Overall Study|Death|1
7347869|NCT00929864|11587872|FG001|Overall Study|Death|1
7347870|NCT00929864|11587871|FG000|Overall Study|Adverse Event|11
7347871|NCT00929864|11587872|FG001|Overall Study|Adverse Event|30
7347872|NCT00929864|11587871|FG000|Overall Study|Lack of Efficacy|19
7347873|NCT00929864|11587872|FG001|Overall Study|Lack of Efficacy|16
7347874|NCT00929864|11587871|FG000|Overall Study|Lost to Follow-up|7
7347875|NCT00929864|11587872|FG001|Overall Study|Lost to Follow-up|12
7347876|NCT00929864|11587871|FG000|Overall Study|Withdrawal by Subject|20
7347877|NCT00929864|11587872|FG001|Overall Study|Withdrawal by Subject|9
7347878|NCT00929864|11587871|FG000|Overall Study|No longer met criteria|2
7347879|NCT00929864|11587872|FG001|Overall Study|No longer met criteria|1
7347880|NCT00929864|11587871|FG000|Overall Study|Poor or non-compliance|3
7347881|NCT00929864|11587872|FG001|Overall Study|Poor or non-compliance|3
7347882|NCT00929864|11587871|FG000|Overall Study|Pregnancy|0
7347883|NCT00929864|11587872|FG001|Overall Study|Pregnancy|3
7347884|NCT00929864|11587871|FG000|Overall Study|Administrative reason by Sponsor|1
7347885|NCT00929864|11587872|FG001|Overall Study|Administrative reason by Sponsor|1
7347886|NCT00929864|11587871|FG000|Overall Study|Non-specified|2
7347887|NCT00929864|11587872|FG001|Overall Study|Non-specified|7
7347888|NCT00929994|11587882|FG000|Overall Study|Withdrawal by Subject|1
7347889|NCT00929994|11587882|FG000|Overall Study|medical issue unrelated to intervention|4
7347890|NCT00929994|11587882|FG000|Overall Study|employment|1
7347891|NCT00930046|11587891|FG000|Overall Study|Wound catheter malfunctioned|1
7347892|NCT00930046|11587892|FG001|Overall Study|Wound catheter malfunctioned|2
7347893|NCT00930059|11587900|FG000|Overall Study|Death|1
7347894|NCT00930059|11587901|FG001|Overall Study|Death|0
7347895|NCT00930059|11587900|FG000|Overall Study|Did not meet entrance criteria|1
7347896|NCT00930059|11587901|FG001|Overall Study|Did not meet entrance criteria|1
7347897|NCT00930059|11587900|FG000|Overall Study|Withdrawal by Subject|3
7347898|NCT00930059|11587901|FG001|Overall Study|Withdrawal by Subject|4
7347899|NCT00930059|11587900|FG000|Overall Study|Other|1
7347900|NCT00930059|11587901|FG001|Overall Study|Other|0
7347901|NCT00930059|11587900|FG000|Overall Study|1 site terminated by sponsor|1
7347902|NCT00930059|11587901|FG001|Overall Study|1 site terminated by sponsor|1
7347903|NCT00930059|11587900|FG000|Overall Study|Adverse Event|1
7347904|NCT00930059|11587901|FG001|Overall Study|Adverse Event|6
7347905|NCT00930176|11587907|FG000|Overall Study|Death|1
7385940|NCT01206777|11644137|FG000|Overall Study|Death|1
7385941|NCT01206777|11644137|FG000|Overall Study|Adverse Event|1
7385942|NCT01206816|11644148|FG000|Overall Study|Protocol Violation|0
7385943|NCT01206816|11644149|FG001|Overall Study|Protocol Violation|0
7385944|NCT01206816|11644150|FG002|Overall Study|Protocol Violation|1
7385945|NCT01206816|11644151|FG003|Overall Study|Protocol Violation|0
7385946|NCT01206816|11644152|FG004|Overall Study|Protocol Violation|0
7385947|NCT01206816|11644153|FG005|Overall Study|Protocol Violation|0
7385948|NCT01206816|11644154|FG006|Overall Study|Protocol Violation|0
7385949|NCT01206816|11644148|FG000|Overall Study|Withdrawal by Subject|0
7385950|NCT01206816|11644149|FG001|Overall Study|Withdrawal by Subject|0
7385951|NCT01206816|11644150|FG002|Overall Study|Withdrawal by Subject|1
7385952|NCT01206816|11644151|FG003|Overall Study|Withdrawal by Subject|0
7385953|NCT01206816|11644152|FG004|Overall Study|Withdrawal by Subject|0
7385954|NCT01206816|11644153|FG005|Overall Study|Withdrawal by Subject|0
7385955|NCT01206816|11644154|FG006|Overall Study|Withdrawal by Subject|0
7385956|NCT01206816|11644148|FG000|Overall Study|Progressive disease|3
7385957|NCT01206816|11644149|FG001|Overall Study|Progressive disease|3
7385958|NCT01206816|11644150|FG002|Overall Study|Progressive disease|13
7385959|NCT01206816|11644151|FG003|Overall Study|Progressive disease|3
7385960|NCT01206816|11644152|FG004|Overall Study|Progressive disease|3
7385961|NCT01206816|11644153|FG005|Overall Study|Progressive disease|16
7385962|NCT01206816|11644154|FG006|Overall Study|Progressive disease|3
7385963|NCT01206816|11644148|FG000|Overall Study|Other AE|0
7385964|NCT01206816|11644149|FG001|Overall Study|Other AE|0
7385965|NCT01206816|11644150|FG002|Overall Study|Other AE|4
7385966|NCT01206816|11644151|FG003|Overall Study|Other AE|0
7347906|NCT00930553|11587920|FG000|Overall Study|Adverse Event|1
7347907|NCT00930553|11587920|FG000|Overall Study|Lack of Efficacy|7
7347908|NCT00930553|11587920|FG000|Overall Study|Physician Decision|39
7347909|NCT00930553|11587920|FG000|Overall Study|Protocol Violation|1
7347910|NCT00930553|11587920|FG000|Overall Study|Pregnancy|1
7347911|NCT00930553|11587920|FG000|Overall Study|Withdrawal by Subject|88
7347912|NCT00930553|11587920|FG000|Overall Study|Lost to Follow-up|25
7347913|NCT00930553|11587920|FG000|Overall Study|Death|9
7347914|NCT00930553|11587920|FG000|Overall Study|Study terminated by sponsor|24
7347915|NCT00930553|11587920|FG000|Overall Study|Other than specified above|28
7347916|NCT00930644|11587942|FG000|Overall Study|Withdrawal by Subject|4
7347917|NCT00930644|11587942|FG000|Overall Study|Physician Decision|2
7347918|NCT00930644|11587942|FG000|Overall Study|Death|1
7347919|NCT00930644|11587942|FG000|Overall Study|Adverse Event|16
7347920|NCT00930761|11587951|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
7347921|NCT00930761|11587952|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
7347922|NCT00930761|11587951|FG000|Overall Study|less than 3 music therapy sessions|0
7347923|NCT00930761|11587952|FG001|Overall Study|less than 3 music therapy sessions|3
7347924|NCT00930774|11587962|FG000|Overall Study|Withdrawal by Subject|1
7347925|NCT00930774|11587963|FG001|Overall Study|Withdrawal by Subject|9
7347926|NCT00930774|11587964|FG002|Overall Study|Withdrawal by Subject|2
7347927|NCT00930774|11587965|FG003|Overall Study|Withdrawal by Subject|0
7347928|NCT00930813|11587978|FG000|Overall Study|Death|4
7347929|NCT00930813|11587979|FG001|Overall Study|Death|5
7347930|NCT00930813|11587978|FG000|Overall Study|Withdrawal by Subject|2
7347931|NCT00930813|11587979|FG001|Overall Study|Withdrawal by Subject|5
7347932|NCT00930813|11587978|FG000|Overall Study|Lost to Follow-up|2
7347933|NCT00930813|11587979|FG001|Overall Study|Lost to Follow-up|4
7347934|NCT00930930|11587989|FG000|Overall Study|Death|1
7347935|NCT00930930|11587990|FG001|Overall Study|Death|0
7347936|NCT00930930|11587989|FG000|Overall Study|Physician Decision|1
7347937|NCT00930930|11587990|FG001|Overall Study|Physician Decision|0
7347938|NCT00930930|11587989|FG000|Overall Study|Adverse Event|13
7347939|NCT00930930|11587990|FG001|Overall Study|Adverse Event|3
7347940|NCT00930930|11587989|FG000|Overall Study|Withdrawal by Subject|3
7347941|NCT00930930|11587990|FG001|Overall Study|Withdrawal by Subject|1
7347942|NCT00930930|11587989|FG000|Overall Study|Disease progression|2
7347943|NCT00930930|11587990|FG001|Overall Study|Disease progression|3
7347944|NCT00930930|11587989|FG000|Overall Study|excessive lapse btw txs, not eligible|0
7347945|NCT00930930|11587990|FG001|Overall Study|excessive lapse btw txs, not eligible|1
7347946|NCT00930930|11587989|FG000|Overall Study|patients not compliant|1
7347947|NCT00930930|11587990|FG001|Overall Study|patients not compliant|1
7347948|NCT00930969|11587996|FG000|Overall Study|Death|5
7347949|NCT00930969|11587996|FG000|Overall Study|Lost to Follow-up|1
7347950|NCT00930969|11587996|FG000|Overall Study|Physician Decision|13
7347951|NCT00930969|11587996|FG000|Overall Study|Withdrawal by Subject|19
7347952|NCT00930982|11588002|FG000|Overall Study|Adverse Event|19
7347953|NCT00930982|11588003|FG001|Overall Study|Adverse Event|23
7347954|NCT00930982|11588002|FG000|Overall Study|Protocol Violation|1
7347955|NCT00930982|11588003|FG001|Overall Study|Protocol Violation|5
7347956|NCT00930982|11588002|FG000|Overall Study|Withdrawal by Subject|1
7347957|NCT00930982|11588003|FG001|Overall Study|Withdrawal by Subject|1
7347959|NCT00931307|11588024|FG000|Overall Study|Lack of Efficacy|12
7347960|NCT00931307|11588024|FG000|Overall Study|Biomicroscopy|1
7347961|NCT00931385|11588037|FG000|Overall Study|Adverse Event|2
7347962|NCT00931385|11588038|FG001|Overall Study|Adverse Event|1
7347963|NCT00931385|11588039|FG002|Overall Study|Adverse Event|0
7347964|NCT00931385|11588040|FG003|Overall Study|Adverse Event|3
7347965|NCT00931385|11588037|FG000|Overall Study|Protocol Violation|0
7347966|NCT00931385|11588038|FG001|Overall Study|Protocol Violation|0
7347967|NCT00931385|11588039|FG002|Overall Study|Protocol Violation|1
7347968|NCT00931385|11588040|FG003|Overall Study|Protocol Violation|0
7347969|NCT00931385|11588037|FG000|Overall Study|Withdrawal by Subject|0
7347970|NCT00931385|11588038|FG001|Overall Study|Withdrawal by Subject|1
7347971|NCT00931385|11588039|FG002|Overall Study|Withdrawal by Subject|0
7347972|NCT00931385|11588040|FG003|Overall Study|Withdrawal by Subject|1
7347973|NCT00931385|11588037|FG000|Overall Study|Lost to Follow-up|0
7347974|NCT00931385|11588038|FG001|Overall Study|Lost to Follow-up|0
7347975|NCT00931385|11588039|FG002|Overall Study|Lost to Follow-up|0
7347976|NCT00931385|11588040|FG003|Overall Study|Lost to Follow-up|1
7347977|NCT00931411|11588056|FG000|First Intervention - 42 Days|Adverse Event|2
7347978|NCT00931411|11588057|FG001|First Intervention - 42 Days|Adverse Event|3
7347979|NCT00931411|11588056|FG000|First Intervention - 42 Days|Lost to Follow-up|2
7347980|NCT00931411|11588057|FG001|First Intervention - 42 Days|Lost to Follow-up|0
7347981|NCT00931411|11588056|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
7347982|NCT00931411|11588057|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
7347983|NCT00931463|11588069|FG000|Overall Study|Death|8
7347984|NCT00931463|11588070|FG001|Overall Study|Death|4
7347985|NCT00931463|11588069|FG000|Overall Study|Withdrawal by Subject|5
7347986|NCT00931463|11588070|FG001|Overall Study|Withdrawal by Subject|0
7347987|NCT00931463|11588069|FG000|Overall Study|Lost to Follow-up|4
7347988|NCT00931463|11588070|FG001|Overall Study|Lost to Follow-up|1
7347989|NCT00931515|11588098|FG000|Overall Study|Lost to Follow-up|2
7347990|NCT00931515|11588099|FG001|Overall Study|Lost to Follow-up|5
7347991|NCT00931528|11588107|FG000|Overall Study|Protocol Violation|9
7347992|NCT00931528|11588108|FG001|Overall Study|Protocol Violation|12
7347993|NCT00931528|11588107|FG000|Overall Study|Withdrawal by Subject|4
7347994|NCT00931528|11588108|FG001|Overall Study|Withdrawal by Subject|12
7347995|NCT00931528|11588107|FG000|Overall Study|Lost to Follow-up|6
7347996|NCT00931528|11588108|FG001|Overall Study|Lost to Follow-up|13
7347997|NCT00931528|11588107|FG000|Overall Study|Assessment outside of Time Frame|22
7347998|NCT00931528|11588108|FG001|Overall Study|Assessment outside of Time Frame|23
7347999|NCT00931632|11588117|FG000|Overall Study|Withdrawal by Subject|2
7348000|NCT00931632|11588118|FG001|Overall Study|Withdrawal by Subject|3
7348001|NCT00931632|11588117|FG000|Overall Study|Adverse Event|19
7348002|NCT00931632|11588118|FG001|Overall Study|Adverse Event|15
7348003|NCT00931710|11588126|FG000|Overall Study|Adverse Event|16
7348004|NCT00931710|11588127|FG001|Overall Study|Adverse Event|10
7348005|NCT00931710|11588126|FG000|Overall Study|Abnormal test procedure results|2
7348006|NCT00931710|11588127|FG001|Overall Study|Abnormal test procedure results|0
7348007|NCT00931710|11588126|FG000|Overall Study|Unsatisfactory therapeutic effects|5
7348008|NCT00931710|11588127|FG001|Overall Study|Unsatisfactory therapeutic effects|12
7348009|NCT00931710|11588126|FG000|Overall Study|Patient withdrew consent|4
7348010|NCT00931710|11588127|FG001|Overall Study|Patient withdrew consent|9
7348011|NCT00931710|11588126|FG000|Overall Study|Lost to Follow-up|6
7348012|NCT00931710|11588127|FG001|Overall Study|Lost to Follow-up|5
7348013|NCT00931710|11588126|FG000|Overall Study|Protocol deviation|1
7348014|NCT00931710|11588127|FG001|Overall Study|Protocol deviation|2
7348015|NCT00931723|11588135|FG000|Overall Study|Withdrawal by Subject|11
7348016|NCT00931723|11588136|FG001|Overall Study|Withdrawal by Subject|13
7348017|NCT00931723|11588135|FG000|Overall Study|Adverse Event|6
7348018|NCT00931723|11588136|FG001|Overall Study|Adverse Event|13
7348019|NCT00931723|11588135|FG000|Overall Study|Lithium found in blood|0
7348020|NCT00931723|11588136|FG001|Overall Study|Lithium found in blood|1
7348021|NCT00931723|11588135|FG000|Overall Study|Condition under investigation worsened|1
7348022|NCT00931723|11588136|FG001|Overall Study|Condition under investigation worsened|2
7348023|NCT00931723|11588135|FG000|Overall Study|Lost to Follow-up|1
7348024|NCT00931723|11588136|FG001|Overall Study|Lost to Follow-up|2
7348025|NCT00931723|11588135|FG000|Overall Study|Study-specific discontinuation criteria|1
7348026|NCT00931723|11588136|FG001|Overall Study|Study-specific discontinuation criteria|1
7348027|NCT00931723|11588135|FG000|Overall Study|Severe non-compliance to protocol|2
7348028|NCT00931723|11588136|FG001|Overall Study|Severe non-compliance to protocol|0
7348029|NCT00931723|11588135|FG000|Overall Study|Safety reasons|0
7348030|NCT00931723|11588136|FG001|Overall Study|Safety reasons|1
7348031|NCT00931723|11588135|FG000|Overall Study|Took prohibited concomitant medication|0
7348032|NCT00931723|11588136|FG001|Overall Study|Took prohibited concomitant medication|1
7348033|NCT00931723|11588135|FG000|Overall Study|Lack or insufficient theraputic response|2
7348034|NCT00931723|11588136|FG001|Overall Study|Lack or insufficient theraputic response|5
7348035|NCT00931723|11588135|FG000|Overall Study|Sponsor decision|1
7348036|NCT00931723|11588136|FG001|Overall Study|Sponsor decision|0
7348037|NCT00931723|11588135|FG000|Overall Study|Late hospital discharge|1
7348038|NCT00931723|11588136|FG001|Overall Study|Late hospital discharge|0
7348039|NCT00931762|11588142|FG000|Overall Study|Abnormal Laboratory Value (s)|2
7348040|NCT00931762|11588142|FG000|Overall Study|Administrative Problems|5
7348041|NCT00931762|11588142|FG000|Overall Study|Death|1
7348042|NCT00931762|11588142|FG000|Overall Study|Disease Progression|3
7348043|NCT00931762|11588142|FG000|Overall Study|Adverse Event (s)|11
7348044|NCT00931762|11588142|FG000|Overall Study|Subject withdrew consent|13
7348045|NCT00931801|11588149|FG000|Overall Study|Adverse Event|0
7348046|NCT00931801|11588150|FG001|Overall Study|Adverse Event|0
7348047|NCT00931801|11588151|FG002|Overall Study|Adverse Event|1
7348048|NCT00931801|11588149|FG000|Overall Study|Lost to Follow-up|0
7348049|NCT00931801|11588150|FG001|Overall Study|Lost to Follow-up|1
7348050|NCT00931801|11588151|FG002|Overall Study|Lost to Follow-up|0
7348051|NCT00931801|11588149|FG000|Overall Study|Withdrawal by Subject|1
7348052|NCT00931801|11588150|FG001|Overall Study|Withdrawal by Subject|0
7348053|NCT00931801|11588151|FG002|Overall Study|Withdrawal by Subject|0
7348054|NCT00931801|11588149|FG000|Overall Study|Confirmed Virologic Failure|0
7348055|NCT00931801|11588150|FG001|Overall Study|Confirmed Virologic Failure|0
7348056|NCT00931801|11588151|FG002|Overall Study|Confirmed Virologic Failure|3
7348057|NCT00931892|11588175|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
7348058|NCT00931892|11588176|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
7348059|NCT00931918|11588224|FG000|Overall Study|Adverse Event|4
7348060|NCT00931918|11588225|FG001|Overall Study|Adverse Event|6
7348061|NCT00931918|11588224|FG000|Overall Study|Progressive Disease|2
7348062|NCT00931918|11588225|FG001|Overall Study|Progressive Disease|1
7348063|NCT00931918|11588224|FG000|Overall Study|Symptomatic Deterioration|1
7348064|NCT00931918|11588225|FG001|Overall Study|Symptomatic Deterioration|0
7348065|NCT00931918|11588224|FG000|Overall Study|Withdrawal by Patient|3
7348066|NCT00931918|11588225|FG001|Overall Study|Withdrawal by Patient|4
7348067|NCT00931918|11588224|FG000|Overall Study|Other Reason not Specified|4
7348068|NCT00931918|11588225|FG001|Overall Study|Other Reason not Specified|4
7348069|NCT00931918|11588224|FG000|Overall Study|Did not receive study drug|3
7348070|NCT00931918|11588225|FG001|Overall Study|Did not receive study drug|2
7348071|NCT00931944|11588231|FG000|Overall Study|Adverse Event|4
7348072|NCT00931944|11588231|FG000|Overall Study|W/D Consent (due to ALS progression))|19
7348073|NCT00931944|11588231|FG000|Overall Study|Withdrawal Consent (due to other)|2
7348074|NCT00931944|11588231|FG000|Overall Study|Death|28
7348075|NCT00931944|11588231|FG000|Overall Study|Other|2
7348076|NCT00932113|11588259|FG000|Overall Study|Lost to Follow-up|1
7348077|NCT00932113|11588260|FG001|Overall Study|Lost to Follow-up|0
7348078|NCT00932126|11588266|FG000|Overall Study|Adverse Event|0
7348079|NCT00932126|11588267|FG001|Overall Study|Adverse Event|0
7348080|NCT00932126|11588268|FG002|Overall Study|Adverse Event|0
7348081|NCT00932126|11588269|FG003|Overall Study|Adverse Event|0
7348082|NCT00932126|11588270|FG004|Overall Study|Adverse Event|0
7348083|NCT00932126|11588271|FG005|Overall Study|Adverse Event|0
7348084|NCT00932126|11588272|FG006|Overall Study|Adverse Event|1
7348085|NCT00932126|11588273|FG007|Overall Study|Adverse Event|2
7348086|NCT00932126|11588266|FG000|Overall Study|Protocol Violation|0
7348087|NCT00932126|11588267|FG001|Overall Study|Protocol Violation|0
7348088|NCT00932126|11588268|FG002|Overall Study|Protocol Violation|0
7348089|NCT00932126|11588269|FG003|Overall Study|Protocol Violation|0
7348090|NCT00932126|11588270|FG004|Overall Study|Protocol Violation|1
7348091|NCT00932126|11588271|FG005|Overall Study|Protocol Violation|0
7348092|NCT00932126|11588272|FG006|Overall Study|Protocol Violation|0
7348093|NCT00932126|11588273|FG007|Overall Study|Protocol Violation|0
7348094|NCT00932126|11588266|FG000|Overall Study|Withdrawal by Subject|0
7569170|NCT03440411|11945132|FG001|Overall Study|PD|1
7569171|NCT03440411|11945133|FG002|Overall Study|PD|1
7348095|NCT00932126|11588267|FG001|Overall Study|Withdrawal by Subject|0
7348096|NCT00932126|11588268|FG002|Overall Study|Withdrawal by Subject|1
7348097|NCT00932126|11588269|FG003|Overall Study|Withdrawal by Subject|0
7348098|NCT00932126|11588270|FG004|Overall Study|Withdrawal by Subject|0
7348099|NCT00932126|11588271|FG005|Overall Study|Withdrawal by Subject|0
7348100|NCT00932126|11588272|FG006|Overall Study|Withdrawal by Subject|0
7348101|NCT00932126|11588273|FG007|Overall Study|Withdrawal by Subject|1
7348102|NCT00932126|11588266|FG000|Overall Study|Objective progression or relapse|3
7348103|NCT00932126|11588267|FG001|Overall Study|Objective progression or relapse|3
7348104|NCT00932126|11588268|FG002|Overall Study|Objective progression or relapse|2
7348105|NCT00932126|11588269|FG003|Overall Study|Objective progression or relapse|3
7348106|NCT00932126|11588270|FG004|Overall Study|Objective progression or relapse|3
7348107|NCT00932126|11588271|FG005|Overall Study|Objective progression or relapse|3
7348108|NCT00932126|11588272|FG006|Overall Study|Objective progression or relapse|3
7348109|NCT00932126|11588273|FG007|Overall Study|Objective progression or relapse|5
7348110|NCT00932126|11588266|FG000|Overall Study|Other|0
7348111|NCT00932126|11588267|FG001|Overall Study|Other|0
7348112|NCT00932126|11588268|FG002|Overall Study|Other|0
7348113|NCT00932126|11588269|FG003|Overall Study|Other|0
7348114|NCT00932126|11588270|FG004|Overall Study|Other|1
7348115|NCT00932126|11588271|FG005|Overall Study|Other|0
7348116|NCT00932126|11588272|FG006|Overall Study|Other|1
7348117|NCT00932126|11588273|FG007|Overall Study|Other|2
7348118|NCT00932165|11588293|FG000|Overall Study|Lost to Follow-up|1
7348119|NCT00932360|11588316|FG000|Washout (One Week)|Withdrawal by Subject|0
7348120|NCT00932360|11588317|FG001|Washout (One Week)|Withdrawal by Subject|0
7348121|NCT00932360|11588318|FG002|Washout (One Week)|Withdrawal by Subject|0
7348122|NCT00932360|11588319|FG003|Washout (One Week)|Withdrawal by Subject|0
7348123|NCT00932360|11588320|FG004|Washout (One Week)|Withdrawal by Subject|2
7348124|NCT00932360|11588321|FG005|Washout (One Week)|Withdrawal by Subject|0
7348125|NCT00932373|11588346|FG000|Overall Study|Progressive disease|3
7348126|NCT00932373|11588347|FG001|Overall Study|Progressive disease|1
7348127|NCT00932373|11588348|FG002|Overall Study|Progressive disease|0
7348128|NCT00932373|11588349|FG003|Overall Study|Progressive disease|0
7348129|NCT00932373|11588350|FG004|Overall Study|Progressive disease|10
7348130|NCT00932373|11588351|FG005|Overall Study|Progressive disease|1
7348131|NCT00932373|11588352|FG006|Overall Study|Progressive disease|0
7348132|NCT00932373|11588353|FG007|Overall Study|Progressive disease|2
7348133|NCT00932373|11588354|FG008|Overall Study|Progressive disease|1
7348134|NCT00932373|11588355|FG009|Overall Study|Progressive disease|9
7348135|NCT00932373|11588356|FG010|Overall Study|Progressive disease|2
7348136|NCT00932373|11588346|FG000|Overall Study|Adverse Event|0
7348137|NCT00932373|11588347|FG001|Overall Study|Adverse Event|0
7348138|NCT00932373|11588348|FG002|Overall Study|Adverse Event|0
7348139|NCT00932373|11588349|FG003|Overall Study|Adverse Event|0
7348140|NCT00932373|11588350|FG004|Overall Study|Adverse Event|2
7348141|NCT00932373|11588351|FG005|Overall Study|Adverse Event|1
7348142|NCT00932373|11588352|FG006|Overall Study|Adverse Event|0
7348143|NCT00932373|11588353|FG007|Overall Study|Adverse Event|1
7348144|NCT00932373|11588354|FG008|Overall Study|Adverse Event|0
7348145|NCT00932373|11588355|FG009|Overall Study|Adverse Event|2
7348146|NCT00932373|11588356|FG010|Overall Study|Adverse Event|1
7348147|NCT00932373|11588346|FG000|Overall Study|Physician Decision|0
7459089|NCT01814072|11753540|FG011|Overall Study|Withdrawal by Subject|0
7348148|NCT00932373|11588347|FG001|Overall Study|Physician Decision|0
7348149|NCT00932373|11588348|FG002|Overall Study|Physician Decision|1
7348150|NCT00932373|11588349|FG003|Overall Study|Physician Decision|0
7348151|NCT00932373|11588350|FG004|Overall Study|Physician Decision|2
7348152|NCT00932373|11588351|FG005|Overall Study|Physician Decision|0
7348153|NCT00932373|11588352|FG006|Overall Study|Physician Decision|0
7348154|NCT00932373|11588353|FG007|Overall Study|Physician Decision|0
7348155|NCT00932373|11588354|FG008|Overall Study|Physician Decision|0
7348156|NCT00932373|11588355|FG009|Overall Study|Physician Decision|1
7348157|NCT00932373|11588356|FG010|Overall Study|Physician Decision|0
7348158|NCT00932373|11588346|FG000|Overall Study|Dose limiting toxicity|0
7348159|NCT00932373|11588347|FG001|Overall Study|Dose limiting toxicity|0
7348160|NCT00932373|11588348|FG002|Overall Study|Dose limiting toxicity|0
7348161|NCT00932373|11588349|FG003|Overall Study|Dose limiting toxicity|0
7348162|NCT00932373|11588350|FG004|Overall Study|Dose limiting toxicity|0
7348163|NCT00932373|11588351|FG005|Overall Study|Dose limiting toxicity|1
7348164|NCT00932373|11588352|FG006|Overall Study|Dose limiting toxicity|0
7348165|NCT00932373|11588353|FG007|Overall Study|Dose limiting toxicity|0
7348166|NCT00932373|11588354|FG008|Overall Study|Dose limiting toxicity|0
7348167|NCT00932373|11588355|FG009|Overall Study|Dose limiting toxicity|0
7348168|NCT00932373|11588356|FG010|Overall Study|Dose limiting toxicity|0
7348169|NCT00932373|11588346|FG000|Overall Study|Withdrawal by Subject|0
7348170|NCT00932373|11588347|FG001|Overall Study|Withdrawal by Subject|0
7348171|NCT00932373|11588348|FG002|Overall Study|Withdrawal by Subject|0
7348172|NCT00932373|11588349|FG003|Overall Study|Withdrawal by Subject|0
7348173|NCT00932373|11588350|FG004|Overall Study|Withdrawal by Subject|0
7348174|NCT00932373|11588351|FG005|Overall Study|Withdrawal by Subject|0
7348175|NCT00932373|11588352|FG006|Overall Study|Withdrawal by Subject|0
7348176|NCT00932373|11588353|FG007|Overall Study|Withdrawal by Subject|0
7348177|NCT00932373|11588354|FG008|Overall Study|Withdrawal by Subject|1
7348178|NCT00932373|11588355|FG009|Overall Study|Withdrawal by Subject|0
7348179|NCT00932373|11588356|FG010|Overall Study|Withdrawal by Subject|0
7348180|NCT00932373|11588346|FG000|Overall Study|Clinical progression|0
7348181|NCT00932373|11588347|FG001|Overall Study|Clinical progression|0
7348182|NCT00932373|11588348|FG002|Overall Study|Clinical progression|0
7348183|NCT00932373|11588349|FG003|Overall Study|Clinical progression|0
7348184|NCT00932373|11588350|FG004|Overall Study|Clinical progression|0
7348185|NCT00932373|11588351|FG005|Overall Study|Clinical progression|0
7348186|NCT00932373|11588352|FG006|Overall Study|Clinical progression|1
7348187|NCT00932373|11588353|FG007|Overall Study|Clinical progression|0
7348188|NCT00932373|11588354|FG008|Overall Study|Clinical progression|0
7348189|NCT00932373|11588355|FG009|Overall Study|Clinical progression|0
7348190|NCT00932373|11588356|FG010|Overall Study|Clinical progression|0
7348191|NCT00932373|11588346|FG000|Overall Study|Lack of Efficacy|0
7348192|NCT00932373|11588347|FG001|Overall Study|Lack of Efficacy|0
7348193|NCT00932373|11588348|FG002|Overall Study|Lack of Efficacy|0
7348194|NCT00932373|11588349|FG003|Overall Study|Lack of Efficacy|0
7348195|NCT00932373|11588350|FG004|Overall Study|Lack of Efficacy|0
7348196|NCT00932373|11588351|FG005|Overall Study|Lack of Efficacy|0
7348197|NCT00932373|11588352|FG006|Overall Study|Lack of Efficacy|0
7348198|NCT00932373|11588353|FG007|Overall Study|Lack of Efficacy|0
7348199|NCT00932373|11588354|FG008|Overall Study|Lack of Efficacy|0
7348200|NCT00932373|11588355|FG009|Overall Study|Lack of Efficacy|1
7348201|NCT00932373|11588356|FG010|Overall Study|Lack of Efficacy|0
7348202|NCT00932425|11588399|FG000|Overall Study|Lost to Follow-up|0
7348203|NCT00932425|11588400|FG001|Overall Study|Lost to Follow-up|1
7348204|NCT00932425|11588399|FG000|Overall Study|Withdrawal by Subject|0
7348205|NCT00932425|11588400|FG001|Overall Study|Withdrawal by Subject|1
7348206|NCT00932451|11588417|FG000|Overall Study|Withdrawal by Subject|69
7348207|NCT00932451|11588417|FG000|Overall Study|Lost to Follow-up|22
7348208|NCT00932451|11588417|FG000|Overall Study|Death|726
7348209|NCT00932451|11588417|FG000|Overall Study|Other reasons|5
7348210|NCT00932646|11588449|FG000|Overall Study|Adverse Event|2
7348211|NCT00932646|11588450|FG001|Overall Study|Adverse Event|1
7348212|NCT00932646|11588451|FG002|Overall Study|Adverse Event|1
7348213|NCT00932646|11588452|FG003|Overall Study|Adverse Event|1
7348214|NCT00932646|11588449|FG000|Overall Study|Lost to Follow-up|2
7348215|NCT00932646|11588450|FG001|Overall Study|Lost to Follow-up|1
7348216|NCT00932646|11588451|FG002|Overall Study|Lost to Follow-up|0
7348217|NCT00932646|11588452|FG003|Overall Study|Lost to Follow-up|0
7348218|NCT00932646|11588449|FG000|Overall Study|Withdrawal by Subject|1
7348219|NCT00932646|11588450|FG001|Overall Study|Withdrawal by Subject|1
7348220|NCT00932646|11588451|FG002|Overall Study|Withdrawal by Subject|3
7348221|NCT00932646|11588452|FG003|Overall Study|Withdrawal by Subject|0
7348222|NCT00932698|11588481|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
7348223|NCT00932698|11588482|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
7348224|NCT00932698|11588483|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
7348225|NCT00932698|11588484|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
7348226|NCT00932698|11588485|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
7348227|NCT00932698|11588486|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
7348228|NCT00932698|11588487|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
7348229|NCT00932698|11588488|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
7348230|NCT00932698|11588489|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
7348231|NCT00932698|11588490|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
7348232|NCT00932698|11588491|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
7348233|NCT00932698|11588481|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348234|NCT00932698|11588482|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7348235|NCT00932698|11588483|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348236|NCT00932698|11588484|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7348237|NCT00932698|11588485|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348238|NCT00932698|11588486|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7348239|NCT00932698|11588487|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
7348240|NCT00932698|11588488|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348241|NCT00932698|11588489|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348242|NCT00932698|11588490|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348243|NCT00932698|11588491|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
7348244|NCT00932698|11588481|FG000|Part 1 (Dose Escalation)|Adverse Event|0
7348245|NCT00932698|11588482|FG001|Part 1 (Dose Escalation)|Adverse Event|0
7348246|NCT00932698|11588483|FG002|Part 1 (Dose Escalation)|Adverse Event|0
7348247|NCT00932698|11588484|FG003|Part 1 (Dose Escalation)|Adverse Event|0
7348248|NCT00932698|11588485|FG004|Part 1 (Dose Escalation)|Adverse Event|0
7348249|NCT00932698|11588486|FG005|Part 1 (Dose Escalation)|Adverse Event|1
7348250|NCT00932698|11588487|FG006|Part 1 (Dose Escalation)|Adverse Event|0
7348251|NCT00932698|11588488|FG007|Part 1 (Dose Escalation)|Adverse Event|0
7348252|NCT00932698|11588489|FG008|Part 1 (Dose Escalation)|Adverse Event|0
7348253|NCT00932698|11588490|FG009|Part 1 (Dose Escalation)|Adverse Event|0
7348254|NCT00932698|11588491|FG010|Part 1 (Dose Escalation)|Adverse Event|0
7348255|NCT00932698|11588481|FG000|Part 1 (Dose Escalation)|Other|0
7348256|NCT00932698|11588482|FG001|Part 1 (Dose Escalation)|Other|0
7348257|NCT00932698|11588483|FG002|Part 1 (Dose Escalation)|Other|1
7348258|NCT00932698|11588484|FG003|Part 1 (Dose Escalation)|Other|0
7348259|NCT00932698|11588485|FG004|Part 1 (Dose Escalation)|Other|0
7348260|NCT00932698|11588486|FG005|Part 1 (Dose Escalation)|Other|0
7348261|NCT00932698|11588487|FG006|Part 1 (Dose Escalation)|Other|1
7348262|NCT00932698|11588488|FG007|Part 1 (Dose Escalation)|Other|0
7348263|NCT00932698|11588489|FG008|Part 1 (Dose Escalation)|Other|0
7348264|NCT00932698|11588490|FG009|Part 1 (Dose Escalation)|Other|0
7348265|NCT00932698|11588491|FG010|Part 1 (Dose Escalation)|Other|0
7348266|NCT00932698|11588481|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
7348267|NCT00932698|11588482|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
7348268|NCT00932698|11588483|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
7348269|NCT00932698|11588484|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
7348270|NCT00932698|11588485|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
7348271|NCT00932698|11588486|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
7348272|NCT00932698|11588487|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
7348273|NCT00932698|11588488|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
7348274|NCT00932698|11588489|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
7348275|NCT00932698|11588490|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
7348276|NCT00932698|11588491|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
7348277|NCT00932698|11588481|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348278|NCT00932698|11588482|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348279|NCT00932698|11588483|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348280|NCT00932698|11588484|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348281|NCT00932698|11588485|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348282|NCT00932698|11588486|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348283|NCT00932698|11588487|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348284|NCT00932698|11588488|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
7348285|NCT00932698|11588489|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
7348286|NCT00932698|11588490|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
7348287|NCT00932698|11588491|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
7348288|NCT00932698|11588481|FG000|Part 2 (Dose Expansion)|Adverse Event|0
7348289|NCT00932698|11588482|FG001|Part 2 (Dose Expansion)|Adverse Event|0
7348290|NCT00932698|11588483|FG002|Part 2 (Dose Expansion)|Adverse Event|0
7348291|NCT00932698|11588484|FG003|Part 2 (Dose Expansion)|Adverse Event|0
7348292|NCT00932698|11588485|FG004|Part 2 (Dose Expansion)|Adverse Event|0
7348293|NCT00932698|11588486|FG005|Part 2 (Dose Expansion)|Adverse Event|0
7348294|NCT00932698|11588487|FG006|Part 2 (Dose Expansion)|Adverse Event|0
7348295|NCT00932698|11588488|FG007|Part 2 (Dose Expansion)|Adverse Event|5
7348296|NCT00932698|11588489|FG008|Part 2 (Dose Expansion)|Adverse Event|1
7348297|NCT00932698|11588490|FG009|Part 2 (Dose Expansion)|Adverse Event|1
7348298|NCT00932698|11588491|FG010|Part 2 (Dose Expansion)|Adverse Event|0
7348299|NCT00932893|11588523|FG000|Overall Study|Death|115
7348300|NCT00932893|11588524|FG001|Overall Study|Death|24
7348301|NCT00932893|11588523|FG000|Overall Study|Lost to Follow-up|8
7348302|NCT00932893|11588524|FG001|Overall Study|Lost to Follow-up|0
7348303|NCT00932893|11588523|FG000|Overall Study|Withdrawal by Subject|5
7348304|NCT00932893|11588524|FG001|Overall Study|Withdrawal by Subject|2
7348305|NCT00932893|11588523|FG000|Overall Study|Other|5
7348306|NCT00932893|11588524|FG001|Overall Study|Other|144
7348307|NCT00933166|11588531|FG000|Overall Study|Lost to Follow-up|4
7348308|NCT00933166|11588531|FG000|Overall Study|Lack of Efficacy|9
7348309|NCT00933166|11588531|FG000|Overall Study|Unavailable|4
7348310|NCT00933166|11588531|FG000|Overall Study|Withdrawal by Subject|1
7348311|NCT00933244|11588538|FG000|Overall Study|Withdrawal by Subject|5
7348312|NCT00933244|11588539|FG001|Overall Study|Withdrawal by Subject|1
7348313|NCT00933244|11588540|FG002|Overall Study|Withdrawal by Subject|3
7348314|NCT00933270|11588548|FG000|Overall Study|Withdrawal by Subject|26
7348315|NCT00933270|11588548|FG000|Overall Study|Insufficient Follow-up|10
7348316|NCT00933270|11588548|FG000|Overall Study|Lost to Follow-up|14
7348317|NCT00933270|11588548|FG000|Overall Study|Adverse Event|1
7348318|NCT00933270|11588548|FG000|Overall Study|Missed Visit|2
7348319|NCT00933270|11588548|FG000|Overall Study|Death|24
7459090|NCT01814072|11753541|FG012|Overall Study|Withdrawal by Subject|1
7459091|NCT01814072|11753542|FG013|Overall Study|Withdrawal by Subject|1
7459092|NCT01814072|11753543|FG014|Overall Study|Withdrawal by Subject|1
7459093|NCT01814072|11753544|FG015|Overall Study|Withdrawal by Subject|1
7459094|NCT01814072|11753545|FG016|Overall Study|Withdrawal by Subject|0
7459095|NCT01814072|11753546|FG017|Overall Study|Withdrawal by Subject|0
7459096|NCT01814072|11753547|FG018|Overall Study|Withdrawal by Subject|0
7459097|NCT01814072|11753548|FG019|Overall Study|Withdrawal by Subject|2
7459098|NCT01814072|11753549|FG020|Overall Study|Withdrawal by Subject|0
7459099|NCT01814072|11753550|FG021|Overall Study|Withdrawal by Subject|0
7459100|NCT01814072|11753551|FG022|Overall Study|Withdrawal by Subject|1
7459101|NCT01814072|11753552|FG023|Overall Study|Withdrawal by Subject|0
7459102|NCT01814072|11753553|FG024|Overall Study|Withdrawal by Subject|2
7459103|NCT01814072|11753554|FG025|Overall Study|Withdrawal by Subject|1
7459104|NCT01814072|11753555|FG026|Overall Study|Withdrawal by Subject|1
7459105|NCT01814072|11753556|FG027|Overall Study|Withdrawal by Subject|2
7459106|NCT01814072|11753557|FG028|Overall Study|Withdrawal by Subject|1
7459107|NCT01814072|11753558|FG029|Overall Study|Withdrawal by Subject|0
7459108|NCT01814072|11753559|FG030|Overall Study|Withdrawal by Subject|0
7459109|NCT01814072|11753560|FG031|Overall Study|Withdrawal by Subject|0
7459110|NCT01814137|11753602|FG000|Overall Study|Adverse Event|0
7459111|NCT01814137|11753603|FG001|Overall Study|Adverse Event|1
7459112|NCT01814137|11753602|FG000|Overall Study|Withdrawal by Subject|2
7459113|NCT01814137|11753603|FG001|Overall Study|Withdrawal by Subject|2
7459114|NCT01814137|11753602|FG000|Overall Study|Physician Decision|1
7459115|NCT01814137|11753603|FG001|Overall Study|Physician Decision|1
7459116|NCT01814137|11753602|FG000|Overall Study|Unclassified|2
7459117|NCT01814137|11753603|FG001|Overall Study|Unclassified|1
7459118|NCT01814332|11753616|FG000|Overall Study|Adverse Event|8
7459119|NCT01814332|11753617|FG001|Overall Study|Adverse Event|3
7459120|NCT01814332|11753616|FG000|Overall Study|Withdrawal by Subject|3
7459121|NCT01814332|11753617|FG001|Overall Study|Withdrawal by Subject|8
7459122|NCT01814332|11753616|FG000|Overall Study|Protocol Violation|0
7459123|NCT01814332|11753617|FG001|Overall Study|Protocol Violation|4
7459124|NCT01814332|11753616|FG000|Overall Study|Lost to Follow-up|5
7459125|NCT01814332|11753617|FG001|Overall Study|Lost to Follow-up|1
7459126|NCT01814371|11753625|FG000|Overall Study|Lost to Follow-up|30
7459127|NCT01814371|11753626|FG001|Overall Study|Lost to Follow-up|27
7459128|NCT01814397|11753635|FG000|Overall Study|Adverse Event|7
7459129|NCT01814397|11753635|FG000|Overall Study|Withdrawal by Subject|7
7459130|NCT01814553|11753641|FG000|Overall Study|PD per clinical progression|6
7459131|NCT01814553|11753642|FG001|Overall Study|PD per clinical progression|8
7459132|NCT01814553|11753641|FG000|Overall Study|Other Adverse Event|4
7459133|NCT01814553|11753642|FG001|Overall Study|Other Adverse Event|5
7459134|NCT01814553|11753641|FG000|Overall Study|Withdrawal by Subject|1
7459135|NCT01814553|11753642|FG001|Overall Study|Withdrawal by Subject|1
7459136|NCT01814553|11753641|FG000|Overall Study|Other than stated|7
7459137|NCT01814553|11753642|FG001|Overall Study|Other than stated|8
7459138|NCT01814670|11753648|FG000|Overall Study|Protocol Violation|12
7459139|NCT01814696|11753654|FG000|Overall Study|Withdrawal by Subject|1
7459140|NCT01814696|11753655|FG001|Overall Study|Withdrawal by Subject|0
7459141|NCT01814696|11753654|FG000|Overall Study|Randomized to wrong group|1
7459142|NCT01814696|11753655|FG001|Overall Study|Randomized to wrong group|0
7459143|NCT01814748|11753663|FG000|Overall Study|Lost to Follow-up|1
7459144|NCT01814748|11753664|FG001|Overall Study|Lost to Follow-up|2
7459145|NCT01814748|11753663|FG000|Overall Study|Study site terminated by sponsor|1
7459146|NCT01814748|11753664|FG001|Overall Study|Study site terminated by sponsor|1
7569172|NCT03440411|11945134|FG003|Overall Study|PD|1
7569173|NCT03440411|11945131|FG000|Overall Study|Withdrawal by Subject|1
7459147|NCT01814748|11753663|FG000|Overall Study|Withdrawal by Subject|6
7459148|NCT01814748|11753664|FG001|Overall Study|Withdrawal by Subject|4
7459149|NCT01814761|11753672|FG000|Overall Study|Other Reasons|1
7459150|NCT01814761|11753673|FG001|Overall Study|Other Reasons|10
7459151|NCT01814761|11753672|FG000|Overall Study|Ocular Adverse Event|6
7459152|NCT01814761|11753673|FG001|Overall Study|Ocular Adverse Event|15
7459153|NCT01814761|11753672|FG000|Overall Study|Lost to Follow-up|1
7459154|NCT01814761|11753673|FG001|Overall Study|Lost to Follow-up|5
7459155|NCT01814800|11753694|FG000|Overall Study|Adverse Event|2
7459156|NCT01814800|11753694|FG000|Overall Study|Pregnancy|1
7459157|NCT01814800|11753694|FG000|Overall Study|Sponsor decision|1
7459158|NCT01814800|11753694|FG000|Overall Study|Subject relocation|1
7459159|NCT01814878|11753713|FG000|Overall Study|Adverse Event|16
7459160|NCT01814878|11753714|FG001|Overall Study|Adverse Event|5
7459161|NCT01814878|11753713|FG000|Overall Study|Withdrawal by Subject|20
7459162|NCT01814878|11753714|FG001|Overall Study|Withdrawal by Subject|16
7459163|NCT01814878|11753713|FG000|Overall Study|Protocol Violation|5
7459164|NCT01814878|11753714|FG001|Overall Study|Protocol Violation|5
7459165|NCT01814878|11753713|FG000|Overall Study|Physician Decision|3
7348320|NCT00933270|11588548|FG000|Overall Study|Moved or would not return|10
7348321|NCT00933335|11588555|FG000|Overall Study|Lost to Follow-up|1
7348322|NCT00933335|11588556|FG001|Overall Study|Lost to Follow-up|3
7348323|NCT00933335|11588555|FG000|Overall Study|Withdrawal by Subject|0
7348324|NCT00933335|11588556|FG001|Overall Study|Withdrawal by Subject|1
7348325|NCT00933335|11588555|FG000|Overall Study|Progressive Disease|0
7348326|NCT00933335|11588556|FG001|Overall Study|Progressive Disease|11
7348327|NCT00933335|11588555|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
7348328|NCT00933335|11588556|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
7348329|NCT00933335|11588555|FG000|Overall Study|Co-morbid Illness|1
7348330|NCT00933335|11588556|FG001|Overall Study|Co-morbid Illness|0
7348331|NCT00933543|11588579|FG000|Overall Study|Adverse Event|2
7348332|NCT00933543|11588580|FG001|Overall Study|Adverse Event|1
7348333|NCT00933543|11588579|FG000|Overall Study|Lost to Follow-up|0
7348334|NCT00933543|11588580|FG001|Overall Study|Lost to Follow-up|1
7348335|NCT00933543|11588579|FG000|Overall Study|Withdrawal by Subject|0
7348336|NCT00933543|11588580|FG001|Overall Study|Withdrawal by Subject|1
7348337|NCT00933543|11588579|FG000|Overall Study|Lack of Efficacy|0
7348338|NCT00933543|11588580|FG001|Overall Study|Lack of Efficacy|3
7348339|NCT00933543|11588579|FG000|Overall Study|Other|1
7348340|NCT00933543|11588580|FG001|Overall Study|Other|1
7348341|NCT00933608|11588588|FG000|Overall Study|Adverse Event|4
7348342|NCT00933608|11588589|FG001|Overall Study|Adverse Event|2
7348343|NCT00933608|11588588|FG000|Overall Study|Physician Decision|1
7348344|NCT00933608|11588589|FG001|Overall Study|Physician Decision|0
7348345|NCT00933686|11588597|FG000|Overall Study|Protocol Violation|0
7348346|NCT00933686|11588598|FG001|Overall Study|Protocol Violation|1
7348347|NCT00933686|11588597|FG000|Overall Study|Lost to Follow-up|2
7348348|NCT00933686|11588598|FG001|Overall Study|Lost to Follow-up|2
7348349|NCT00933686|11588597|FG000|Overall Study|Withdrawal by Subject|6
7348350|NCT00933686|11588598|FG001|Overall Study|Withdrawal by Subject|5
7348351|NCT00933686|11588597|FG000|Overall Study|Adverse Event|1
7348352|NCT00933686|11588598|FG001|Overall Study|Adverse Event|1
7348353|NCT00933686|11588597|FG000|Overall Study|Physician Decision|1
7348354|NCT00933686|11588598|FG001|Overall Study|Physician Decision|0
7348355|NCT00933686|11588597|FG000|Overall Study|Failure to show up at endpoint visits|0
7348356|NCT00933686|11588598|FG001|Overall Study|Failure to show up at endpoint visits|2
7348357|NCT00933933|11588609|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7348358|NCT00933933|11588610|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
7348359|NCT00933933|11588611|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
7348360|NCT00933933|11588609|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7348361|NCT00933933|11588610|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
7348362|NCT00933933|11588611|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
7348363|NCT00934050|11588641|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7348364|NCT00934050|11588642|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7348365|NCT00934050|11588643|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7348366|NCT00934050|11588644|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
7348367|NCT00934050|11588645|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7348368|NCT00934050|11588646|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
7348369|NCT00934050|11588641|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7348370|NCT00934050|11588642|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
7348371|NCT00934050|11588643|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
7348372|NCT00934050|11588644|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
7348373|NCT00934050|11588645|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7348374|NCT00934050|11588646|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
7348375|NCT00934050|11588641|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7348376|NCT00934050|11588642|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7348377|NCT00934050|11588643|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
7348378|NCT00934050|11588644|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7348379|NCT00934050|11588645|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7348380|NCT00934050|11588646|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
7348381|NCT00934050|11588641|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
7348382|NCT00934050|11588642|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
7348383|NCT00934050|11588643|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
7348384|NCT00934050|11588644|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
7348385|NCT00934050|11588645|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
7348386|NCT00934050|11588646|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
7348387|NCT00934050|11588641|FG000|Enrolled After 15 Dec 2009|Death|0
7348388|NCT00934050|11588642|FG001|Enrolled After 15 Dec 2009|Death|0
7348389|NCT00934050|11588643|FG002|Enrolled After 15 Dec 2009|Death|0
7348390|NCT00934050|11588644|FG003|Enrolled After 15 Dec 2009|Death|0
7348391|NCT00934050|11588645|FG004|Enrolled After 15 Dec 2009|Death|0
7348392|NCT00934050|11588646|FG005|Enrolled After 15 Dec 2009|Death|1
7348393|NCT00934050|11588641|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7348394|NCT00934050|11588642|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7348395|NCT00934050|11588643|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7348396|NCT00934050|11588644|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7348397|NCT00934050|11588645|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
7348398|NCT00934050|11588646|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
7348399|NCT00934050|11588641|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7348400|NCT00934050|11588642|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7348401|NCT00934050|11588643|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7348402|NCT00934050|11588644|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
7348403|NCT00934050|11588645|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
7348404|NCT00934050|11588646|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
7348405|NCT00934089|11588658|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
7348406|NCT00934089|11588659|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
7348407|NCT00934089|11588658|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
7348408|NCT00934089|11588659|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
7348409|NCT00934102|11588665|FG000|Period 1, One Night of Wear|Personal Reasons|1
7348410|NCT00934102|11588666|FG001|Period 1, One Night of Wear|Personal Reasons|0
7348411|NCT00934102|11588667|FG002|Period 1, One Night of Wear|Personal Reasons|0
7348412|NCT00934128|11588677|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
7348413|NCT00934128|11588678|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
7348414|NCT00934128|11588677|FG000|First Intervention (2 Hours)|Adverse Event|4
7348415|NCT00934128|11588678|FG001|First Intervention (2 Hours)|Adverse Event|1
7348416|NCT00934128|11588677|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
7348417|NCT00934128|11588678|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
7348418|NCT00934128|11588677|FG000|Washout Period (1 Hour)|Patient preference|1
7348419|NCT00934128|11588678|FG001|Washout Period (1 Hour)|Patient preference|3
7348420|NCT00934128|11588677|FG000|Washout Period (1 Hour)|Pain|1
7348421|NCT00934128|11588678|FG001|Washout Period (1 Hour)|Pain|0
7348422|NCT00934128|11588677|FG000|Washout Period (1 Hour)|Too tired|1
7348423|NCT00934128|11588678|FG001|Washout Period (1 Hour)|Too tired|0
7348424|NCT00934128|11588677|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
7348425|NCT00934128|11588678|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
7348426|NCT00934128|11588677|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
7348427|NCT00934128|11588678|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
7348428|NCT00934362|11588705|FG000|Overall Study|Adverse Event|1
7348429|NCT00934362|11588706|FG001|Overall Study|Adverse Event|0
7348430|NCT00934440|11588721|FG000|Overall Study|Lost to Follow-up|1
7348431|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
7348432|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
7348433|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
7348434|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
7348435|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
7348436|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
7348437|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
7348438|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7348439|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
7348440|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
7348441|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
7348442|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
7348443|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
7348444|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7348445|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
7348446|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7348447|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
7348448|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
7348449|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
7348450|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
7348451|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
7348452|NCT00934544|11588728|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
7348453|NCT00934544|11588729|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
7348454|NCT00934544|11588730|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
7348455|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
7348456|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
7348457|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
7348458|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
7348459|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
7348460|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
7348461|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
7348462|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
7348463|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
7348464|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
7348465|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
7348466|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
7348467|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
7348468|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
7348469|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
7348470|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
7348471|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
7348472|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
7348473|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7348474|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
7348475|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
7348476|NCT00934544|11588728|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
7348477|NCT00934544|11588729|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
7348478|NCT00934544|11588730|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
7348479|NCT00934622|11588760|FG000|Overall Study|Lost to Follow-up|7
7348480|NCT00934622|11588760|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
7348481|NCT00934648|11588801|FG000|Overall Study|Failure to return|8
7348482|NCT00934648|11588801|FG000|Overall Study|Withdrawal by Subject|1
7348483|NCT00934661|11588807|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
7348484|NCT00934661|11588808|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
7348485|NCT00934843|11588816|FG000|Overall Study|Protocol Violation|0
7348486|NCT00934843|11588817|FG001|Overall Study|Protocol Violation|1
7348487|NCT00934856|11588829|FG000|Feasibility Part|Progressive disease|4
7348488|NCT00934856|11588830|FG001|Feasibility Part|Progressive disease|4
7348489|NCT00934856|11588831|FG002|Feasibility Part|Progressive disease|2
7348490|NCT00934856|11588832|FG003|Feasibility Part|Progressive disease|3
7348491|NCT00934856|11588833|FG004|Feasibility Part|Progressive disease|0
7348492|NCT00934856|11588834|FG005|Feasibility Part|Progressive disease|0
7348493|NCT00934856|11588829|FG000|Feasibility Part|Physician Decision|0
7348494|NCT00934856|11588830|FG001|Feasibility Part|Physician Decision|0
7348495|NCT00934856|11588831|FG002|Feasibility Part|Physician Decision|1
7348496|NCT00934856|11588832|FG003|Feasibility Part|Physician Decision|0
7348497|NCT00934856|11588833|FG004|Feasibility Part|Physician Decision|0
7348498|NCT00934856|11588834|FG005|Feasibility Part|Physician Decision|0
7348499|NCT00934856|11588829|FG000|Feasibility Part|Adverse Event|1
7348500|NCT00934856|11588830|FG001|Feasibility Part|Adverse Event|1
7348501|NCT00934856|11588831|FG002|Feasibility Part|Adverse Event|0
7348502|NCT00934856|11588832|FG003|Feasibility Part|Adverse Event|1
7348503|NCT00934856|11588833|FG004|Feasibility Part|Adverse Event|0
7348504|NCT00934856|11588834|FG005|Feasibility Part|Adverse Event|2
7348505|NCT00934856|11588829|FG000|Feasibility Part|Withdrawal by Subject|0
7348506|NCT00934856|11588830|FG001|Feasibility Part|Withdrawal by Subject|0
7348507|NCT00934856|11588831|FG002|Feasibility Part|Withdrawal by Subject|0
7348508|NCT00934856|11588832|FG003|Feasibility Part|Withdrawal by Subject|1
7348509|NCT00934856|11588833|FG004|Feasibility Part|Withdrawal by Subject|0
7348510|NCT00934856|11588834|FG005|Feasibility Part|Withdrawal by Subject|1
7348511|NCT00934856|11588829|FG000|Extension Part|Adverse Event|0
7348512|NCT00934856|11588830|FG001|Extension Part|Adverse Event|0
7348513|NCT00934856|11588831|FG002|Extension Part|Adverse Event|0
7348514|NCT00934856|11588832|FG003|Extension Part|Adverse Event|1
7348515|NCT00934856|11588833|FG004|Extension Part|Adverse Event|4
7348516|NCT00934856|11588834|FG005|Extension Part|Adverse Event|4
7348517|NCT00934856|11588829|FG000|Extension Part|Progressive disease|0
7348518|NCT00934856|11588830|FG001|Extension Part|Progressive disease|0
7348519|NCT00934856|11588831|FG002|Extension Part|Progressive disease|0
7348520|NCT00934856|11588832|FG003|Extension Part|Progressive disease|1
7348521|NCT00934856|11588833|FG004|Extension Part|Progressive disease|0
7348522|NCT00934856|11588834|FG005|Extension Part|Progressive disease|0
7348523|NCT00934856|11588829|FG000|Extension Part|Non-compliance with drug|0
7348524|NCT00934856|11588830|FG001|Extension Part|Non-compliance with drug|0
7348525|NCT00934856|11588831|FG002|Extension Part|Non-compliance with drug|0
7348526|NCT00934856|11588832|FG003|Extension Part|Non-compliance with drug|0
7348527|NCT00934856|11588833|FG004|Extension Part|Non-compliance with drug|0
7348528|NCT00934856|11588834|FG005|Extension Part|Non-compliance with drug|1
7348529|NCT00934947|11588880|FG000|Overall Study|Adverse Event|0
7348530|NCT00934947|11588881|FG001|Overall Study|Adverse Event|2
7348531|NCT00935012|11588889|FG000|Overall Study|Death|19
7348532|NCT00935012|11588889|FG000|Overall Study|Withdrawal by Subject|3
7348533|NCT00935012|11588889|FG000|Overall Study|Other|5
7348534|NCT00935012|11588889|FG000|Overall Study|Adverse Event|2
7348535|NCT00935220|11588902|FG000|Overall Study|Adverse Event|1
7348536|NCT00935220|11588902|FG000|Overall Study|Other reason (not specified)|1
7348537|NCT00935259|11588906|FG000|Period 1|Administrative (scheduling conflict)|1
7348538|NCT00935259|11588907|FG001|Period 1|Administrative (scheduling conflict)|1
7348539|NCT00935272|11588917|FG000|Overall Study|Lost to Follow-up|10
7348540|NCT00935272|11588918|FG001|Overall Study|Lost to Follow-up|3
7348541|NCT00935272|11588917|FG000|Overall Study|Withdrawal by Subject|8
7348542|NCT00935272|11588918|FG001|Overall Study|Withdrawal by Subject|2
7348543|NCT00935272|11588917|FG000|Overall Study|Physician Decision|1
7348544|NCT00935272|11588918|FG001|Overall Study|Physician Decision|0
7348545|NCT00935272|11588917|FG000|Overall Study|Protocol Violation|0
7348546|NCT00935272|11588918|FG001|Overall Study|Protocol Violation|1
7348547|NCT00935493|11588951|FG000|Overall Study|Lost to Follow-up|1
7348548|NCT00935493|11588952|FG001|Overall Study|Lost to Follow-up|1
7348549|NCT00935493|11588953|FG002|Overall Study|Lost to Follow-up|1
7348550|NCT00935493|11588951|FG000|Overall Study|Treatment Discontinued|0
7348551|NCT00935493|11588952|FG001|Overall Study|Treatment Discontinued|1
7348552|NCT00935493|11588953|FG002|Overall Study|Treatment Discontinued|0
7348553|NCT00935532|11588963|FG000|Overall Study|Adverse Event|11
7348554|NCT00935532|11588964|FG001|Overall Study|Adverse Event|6
7348555|NCT00935532|11588963|FG000|Overall Study|Death|1
7348556|NCT00935532|11588964|FG001|Overall Study|Death|0
7348557|NCT00935532|11588963|FG000|Overall Study|Lost to Follow-up|1
7348558|NCT00935532|11588964|FG001|Overall Study|Lost to Follow-up|0
7348559|NCT00935532|11588963|FG000|Overall Study|Physician Decision|1
7348560|NCT00935532|11588964|FG001|Overall Study|Physician Decision|2
7348561|NCT00935532|11588963|FG000|Overall Study|Protocol Violation|2
7348562|NCT00935532|11588964|FG001|Overall Study|Protocol Violation|1
7348563|NCT00935532|11588963|FG000|Overall Study|Subject Decision|2
7348564|NCT00935532|11588964|FG001|Overall Study|Subject Decision|1
7348565|NCT00935532|11588963|FG000|Overall Study|Sponsor Decision|0
7348566|NCT00935532|11588964|FG001|Overall Study|Sponsor Decision|1
7348567|NCT00935532|11588963|FG000|Overall Study|Loss Glucose Control|4
7348568|NCT00935532|11588964|FG001|Overall Study|Loss Glucose Control|0
7348569|NCT00935584|11588972|FG000|Overall Study|Withdrawal by Subject|9
7348570|NCT00935584|11588973|FG001|Overall Study|Withdrawal by Subject|0
7348571|NCT00935584|11588972|FG000|Overall Study|Death|3
7348572|NCT00935584|11588973|FG001|Overall Study|Death|0
7348573|NCT00935584|11588972|FG000|Overall Study|Lost to Follow-up|8
7348574|NCT00935584|11588973|FG001|Overall Study|Lost to Follow-up|0
7348575|NCT00935584|11588972|FG000|Overall Study|No show|9
7348576|NCT00935584|11588973|FG001|Overall Study|No show|0
7348577|NCT00935584|11588972|FG000|Overall Study|Relocated|3
7348578|NCT00935584|11588973|FG001|Overall Study|Relocated|0
7348579|NCT00935584|11588972|FG000|Overall Study|Patient changed provider|3
7348580|NCT00935584|11588973|FG001|Overall Study|Patient changed provider|0
7348581|NCT00935584|11588972|FG000|Overall Study|Provider dropped out of study|14
7348582|NCT00935584|11588973|FG001|Overall Study|Provider dropped out of study|4
7348583|NCT00935701|11588977|FG000|Overall Study|Failure to Transition to Acupuncture|1
7348584|NCT00935818|11589008|FG000|Overall Study|Withdrawal by Subject|45
7348585|NCT00935818|11589009|FG001|Overall Study|Withdrawal by Subject|50
7348586|NCT00935818|11589008|FG000|Overall Study|Lost to Follow-up|40
7348587|NCT00935818|11589009|FG001|Overall Study|Lost to Follow-up|42
7348588|NCT00935818|11589008|FG000|Overall Study|Adverse Event|6
7348589|NCT00935818|11589009|FG001|Overall Study|Adverse Event|7
7348590|NCT00935818|11589008|FG000|Overall Study|Physician Decision|0
7348591|NCT00935818|11589009|FG001|Overall Study|Physician Decision|1
7348592|NCT00935883|11589026|FG000|Treatment Period|Physician Decision|1
7348593|NCT00935883|11589027|FG001|Treatment Period|Physician Decision|0
7348594|NCT00935883|11589026|FG000|Treatment Period|Withdrawal by Subject|0
7348595|NCT00935883|11589027|FG001|Treatment Period|Withdrawal by Subject|2
7348596|NCT00936065|11589036|FG000|Overall Study|Adverse Event|1
7348597|NCT00936065|11589037|FG001|Overall Study|Adverse Event|0
7348598|NCT00936065|11589038|FG002|Overall Study|Adverse Event|1
7348599|NCT00936065|11589036|FG000|Overall Study|Lack of Efficacy|1
7348600|NCT00936065|11589037|FG001|Overall Study|Lack of Efficacy|0
7348601|NCT00936065|11589038|FG002|Overall Study|Lack of Efficacy|1
7348602|NCT00936065|11589036|FG000|Overall Study|Lost to Follow-up|1
7348603|NCT00936065|11589037|FG001|Overall Study|Lost to Follow-up|0
7348604|NCT00936065|11589038|FG002|Overall Study|Lost to Follow-up|0
7348605|NCT00936065|11589036|FG000|Overall Study|Protocol Violation|1
7348606|NCT00936065|11589037|FG001|Overall Study|Protocol Violation|2
7348607|NCT00936065|11589038|FG002|Overall Study|Protocol Violation|1
7348608|NCT00936065|11589036|FG000|Overall Study|Withdrawal by Subject|0
7348609|NCT00936065|11589037|FG001|Overall Study|Withdrawal by Subject|2
7348610|NCT00936065|11589038|FG002|Overall Study|Withdrawal by Subject|4
7348611|NCT00936117|11589046|FG000|Overall Study|Adverse Event|7
7348612|NCT00936117|11589046|FG000|Overall Study|Unable to continue oral medication|3
7348613|NCT00936208|11589053|FG000|Overall Study|Protocol Violation|37
7348614|NCT00936208|11589054|FG001|Overall Study|Protocol Violation|22
7348615|NCT00936221|11589062|FG000|Overall Study|Withdrawal by Subject|1
7348616|NCT00936221|11589063|FG001|Overall Study|Withdrawal by Subject|1
7385967|NCT01206816|11644152|FG004|Overall Study|Other AE|0
7385968|NCT01206816|11644153|FG005|Overall Study|Other AE|3
7385969|NCT01206816|11644154|FG006|Overall Study|Other AE|2
7385970|NCT01206816|11644148|FG000|Overall Study|other than stated above|0
7385971|NCT01206816|11644149|FG001|Overall Study|other than stated above|0
7385972|NCT01206816|11644150|FG002|Overall Study|other than stated above|1
7385973|NCT01206816|11644151|FG003|Overall Study|other than stated above|0
7385974|NCT01206816|11644152|FG004|Overall Study|other than stated above|0
7385975|NCT01206816|11644153|FG005|Overall Study|other than stated above|0
7385976|NCT01206816|11644154|FG006|Overall Study|other than stated above|1
7385977|NCT01207219|11644177|FG000|Overall Study|changed diagnosis during study period|5
7385978|NCT01207219|11644178|FG001|Overall Study|changed diagnosis during study period|3
7385979|NCT01207219|11644179|FG002|Overall Study|changed diagnosis during study period|1
7385980|NCT01207219|11644177|FG000|Overall Study|Lost to Follow-up|6
7385981|NCT01207219|11644178|FG001|Overall Study|Lost to Follow-up|8
7385982|NCT01207219|11644179|FG002|Overall Study|Lost to Follow-up|6
7385983|NCT01207388|11644187|FG000|Overall Study|Death|67
7348617|NCT00936611|11589126|FG000|Overall Study|Progressive Disease|3
7348618|NCT00936611|11589126|FG000|Overall Study|New Systemic Therapy|22
7459166|NCT01814878|11753714|FG001|Overall Study|Physician Decision|1
7459167|NCT01814878|11753713|FG000|Overall Study|Screening failure (drop-out)|0
7459168|NCT01814878|11753714|FG001|Overall Study|Screening failure (drop-out)|3
7459169|NCT01814878|11753713|FG000|Overall Study|Other|2
7459170|NCT01814878|11753714|FG001|Overall Study|Other|0
7459171|NCT01815099|11753726|FG000|Overall Study|Lack of Efficacy|1
7459172|NCT01815099|11753726|FG000|Overall Study|unable to attend study visits|1
7459173|NCT01815138|11753733|FG000|Overall Study|Withdrawal by Subject|0
7459174|NCT01815138|11753734|FG001|Overall Study|Withdrawal by Subject|1
7459175|NCT01815138|11753733|FG000|Overall Study|Physician Decision|8
7459176|NCT01815138|11753734|FG001|Overall Study|Physician Decision|5
7459177|NCT01815424|11753759|FG000|Week 0 to 16|Adverse Event|1
7459178|NCT01815424|11753760|FG001|Week 0 to 16|Adverse Event|3
7459179|NCT01815424|11753761|FG002|Week 0 to 16|Adverse Event|3
7459180|NCT01815424|11753762|FG003|Week 0 to 16|Adverse Event|0
7459181|NCT01815424|11753763|FG004|Week 0 to 16|Adverse Event|0
7459182|NCT01815424|11753759|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
7459183|NCT01815424|11753760|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
7459184|NCT01815424|11753761|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
7459185|NCT01815424|11753762|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
7459186|NCT01815424|11753763|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
7459187|NCT01815424|11753759|FG000|Week 0 to 16|Lost to Follow-up|0
7459188|NCT01815424|11753760|FG001|Week 0 to 16|Lost to Follow-up|1
7459189|NCT01815424|11753761|FG002|Week 0 to 16|Lost to Follow-up|0
7459190|NCT01815424|11753762|FG003|Week 0 to 16|Lost to Follow-up|0
7459191|NCT01815424|11753763|FG004|Week 0 to 16|Lost to Follow-up|0
7459192|NCT01815424|11753759|FG000|Week 0 to 16|Withdrawal by Subject|0
7459193|NCT01815424|11753760|FG001|Week 0 to 16|Withdrawal by Subject|0
7459194|NCT01815424|11753761|FG002|Week 0 to 16|Withdrawal by Subject|1
7459195|NCT01815424|11753762|FG003|Week 0 to 16|Withdrawal by Subject|0
7459196|NCT01815424|11753763|FG004|Week 0 to 16|Withdrawal by Subject|0
7459197|NCT01815424|11753759|FG000|Week 0 to 16|Other|1
7459198|NCT01815424|11753760|FG001|Week 0 to 16|Other|0
7459199|NCT01815424|11753761|FG002|Week 0 to 16|Other|3
7459200|NCT01815424|11753762|FG003|Week 0 to 16|Other|0
7459201|NCT01815424|11753763|FG004|Week 0 to 16|Other|0
7459202|NCT01815424|11753759|FG000|Week 0 to 16|Protocol Violation|1
7459203|NCT01815424|11753760|FG001|Week 0 to 16|Protocol Violation|0
7459204|NCT01815424|11753761|FG002|Week 0 to 16|Protocol Violation|0
7459205|NCT01815424|11753762|FG003|Week 0 to 16|Protocol Violation|0
7459206|NCT01815424|11753763|FG004|Week 0 to 16|Protocol Violation|0
7459207|NCT01815424|11753759|FG000|Week 0 to 16|Insufficient Clinical Response|2
7569174|NCT03440411|11945132|FG001|Overall Study|Withdrawal by Subject|0
7569175|NCT03440411|11945133|FG002|Overall Study|Withdrawal by Subject|0
7569176|NCT03440411|11945134|FG003|Overall Study|Withdrawal by Subject|0
7569177|NCT03440411|11945131|FG000|Overall Study|Closed study by sponsor|0
7569178|NCT03440411|11945132|FG001|Overall Study|Closed study by sponsor|0
7569179|NCT03440411|11945133|FG002|Overall Study|Closed study by sponsor|0
7569180|NCT03440411|11945134|FG003|Overall Study|Closed study by sponsor|1
7569181|NCT03440918|11945178|FG000|Overall Study|Protocol Violation|0
7348619|NCT00936611|11589126|FG000|Overall Study|Lost to Follow-up|1
7459208|NCT01815424|11753760|FG001|Week 0 to 16|Insufficient Clinical Response|0
7459209|NCT01815424|11753761|FG002|Week 0 to 16|Insufficient Clinical Response|4
7459210|NCT01815424|11753762|FG003|Week 0 to 16|Insufficient Clinical Response|0
7459211|NCT01815424|11753763|FG004|Week 0 to 16|Insufficient Clinical Response|0
7459212|NCT01815424|11753759|FG000|Week 16 to 52|Other|0
7459213|NCT01815424|11753760|FG001|Week 16 to 52|Other|1
7459214|NCT01815424|11753761|FG002|Week 16 to 52|Other|0
7459215|NCT01815424|11753762|FG003|Week 16 to 52|Other|0
7569182|NCT03440918|11945179|FG001|Overall Study|Protocol Violation|16
7348620|NCT00936611|11589126|FG000|Overall Study|Withdrawal by Subject|2
7348621|NCT00936611|11589126|FG000|Overall Study|Still on Follow-up|1
7348622|NCT00936611|11589126|FG000|Overall Study|Still on Active Therapy|7
7348623|NCT00936611|11589126|FG000|Overall Study|Ineligible for Study Drug|3
7348624|NCT00936702|11589139|FG000|Overall Study|Disease progression|34
7348625|NCT00936702|11589139|FG000|Overall Study|Adverse Event|8
7348626|NCT00936702|11589139|FG000|Overall Study|Withdrawal by Subject|2
7348627|NCT00936702|11589139|FG000|Overall Study|Alternative Treatment|1
7348628|NCT00936702|11589139|FG000|Overall Study|Other|1
7348629|NCT00936715|11589143|FG000|Overall Study|Investigators Discretion|1
7348630|NCT00936715|11589143|FG000|Overall Study|Protocol Violation|1
7348631|NCT00936715|11589143|FG000|Overall Study|Safety or Tolerability Reasons|4
7348632|NCT00936858|11589151|FG000|Overall Study|Death|3
7348633|NCT00936858|11589151|FG000|Overall Study|Progression|29
7348634|NCT00936858|11589151|FG000|Overall Study|Withdrawal by Subject|5
7348635|NCT00936858|11589151|FG000|Overall Study|Adverse Event|1
7348636|NCT00936858|11589151|FG000|Overall Study|Physician Decision|7
7348637|NCT00936858|11589151|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
7348638|NCT00936858|11589151|FG000|Overall Study|Lost to Follow-up|1
7348639|NCT00936884|11589158|FG000|Double-blind|Withdrawal by Subject|6
7348640|NCT00936884|11589159|FG001|Double-blind|Withdrawal by Subject|4
7348641|NCT00936884|11589160|FG002|Double-blind|Withdrawal by Subject|0
7348642|NCT00936884|11589158|FG000|Double-blind|Death|2
7348643|NCT00936884|11589159|FG001|Double-blind|Death|1
7348644|NCT00936884|11589160|FG002|Double-blind|Death|0
7348645|NCT00936884|11589158|FG000|Double-blind|Lack of Efficacy|1
7348646|NCT00936884|11589159|FG001|Double-blind|Lack of Efficacy|1
7348647|NCT00936884|11589160|FG002|Double-blind|Lack of Efficacy|0
7348648|NCT00936884|11589158|FG000|Double-blind|Adverse Event|1
7348649|NCT00936884|11589159|FG001|Double-blind|Adverse Event|0
7348650|NCT00936884|11589160|FG002|Double-blind|Adverse Event|0
7348651|NCT00936884|11589158|FG000|Double-blind|Physician Decision|1
7348652|NCT00936884|11589159|FG001|Double-blind|Physician Decision|0
7348653|NCT00936884|11589160|FG002|Double-blind|Physician Decision|0
7348654|NCT00936884|11589158|FG000|Double-blind|No post baseline diary entry|1
7348655|NCT00936884|11589159|FG001|Double-blind|No post baseline diary entry|0
7348656|NCT00936884|11589160|FG002|Double-blind|No post baseline diary entry|0
7348657|NCT00936884|11589158|FG000|Double-blind|Did not receive study drug|0
7348658|NCT00936884|11589159|FG001|Double-blind|Did not receive study drug|1
7348659|NCT00936884|11589160|FG002|Double-blind|Did not receive study drug|0
7348660|NCT00936897|11589169|FG000|Overall Study|Withdrawal by Subject|9
7348661|NCT00936897|11589170|FG001|Overall Study|Withdrawal by Subject|19
7348662|NCT00936897|11589169|FG000|Overall Study|Adverse Event|4
7348663|NCT00936897|11589170|FG001|Overall Study|Adverse Event|13
7348664|NCT00936897|11589169|FG000|Overall Study|Other|3
7348665|NCT00936897|11589170|FG001|Overall Study|Other|9
7348666|NCT00936897|11589169|FG000|Overall Study|Lost to Follow-up|1
7348667|NCT00936897|11589170|FG001|Overall Study|Lost to Follow-up|10
7348668|NCT00936897|11589169|FG000|Overall Study|Administrative Decision|1
7348669|NCT00936897|11589170|FG001|Overall Study|Administrative Decision|2
7348670|NCT00936897|11589169|FG000|Overall Study|Protocol Violation|1
7348671|NCT00936897|11589170|FG001|Overall Study|Protocol Violation|1
7348672|NCT00936897|11589169|FG000|Overall Study|Ineligibility Determined|0
7348673|NCT00936897|11589170|FG001|Overall Study|Ineligibility Determined|3
7348674|NCT00936897|11589169|FG000|Overall Study|Noncompliance|0
7348675|NCT00936897|11589170|FG001|Overall Study|Noncompliance|2
7348676|NCT00936897|11589169|FG000|Overall Study|Death|0
7348677|NCT00936897|11589170|FG001|Overall Study|Death|1
7348678|NCT00936910|11589176|FG000|Overall Study|Lack of Efficacy|3
7348679|NCT00936975|11589181|FG000|Overall Study|Withdrawal by Subject|1
7348680|NCT00936975|11589181|FG000|Overall Study|Disease progression|3
7348681|NCT00936975|11589181|FG000|Overall Study|Post-Tx scan uninterpretable|2
7348682|NCT00937040|11589188|FG000|Overall Study|Adverse Event|5
7348683|NCT00937040|11589189|FG001|Overall Study|Adverse Event|8
7348684|NCT00937040|11589188|FG000|Overall Study|Lost to Follow-up|12
7348685|NCT00937040|11589189|FG001|Overall Study|Lost to Follow-up|12
7348686|NCT00937040|11589188|FG000|Overall Study|Protocol Violation|3
7348687|NCT00937040|11589189|FG001|Overall Study|Protocol Violation|0
7459216|NCT01815424|11753763|FG004|Week 16 to 52|Other|0
7459217|NCT01815424|11753759|FG000|Week 16 to 52|Adverse Event|0
7459218|NCT01815424|11753760|FG001|Week 16 to 52|Adverse Event|0
7459219|NCT01815424|11753761|FG002|Week 16 to 52|Adverse Event|0
7459220|NCT01815424|11753762|FG003|Week 16 to 52|Adverse Event|0
7459221|NCT01815424|11753763|FG004|Week 16 to 52|Adverse Event|1
7459222|NCT01815424|11753759|FG000|Week 16 to 52|Insufficient Clinical Response|1
7459223|NCT01815424|11753760|FG001|Week 16 to 52|Insufficient Clinical Response|0
7459224|NCT01815424|11753761|FG002|Week 16 to 52|Insufficient Clinical Response|0
7459225|NCT01815424|11753762|FG003|Week 16 to 52|Insufficient Clinical Response|1
7459226|NCT01815424|11753763|FG004|Week 16 to 52|Insufficient Clinical Response|1
7348688|NCT00937040|11589188|FG000|Overall Study|Withdrawal by Subject|13
7348689|NCT00937040|11589189|FG001|Overall Study|Withdrawal by Subject|7
7348690|NCT00937040|11589188|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
7348691|NCT00937040|11589189|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
7348692|NCT00937040|11589188|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
7348693|NCT00937040|11589189|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
7348694|NCT00937157|11589220|FG000|Overall Study|Pregnancy|1
7348695|NCT00937157|11589220|FG000|Overall Study|Lost to Follow-up|3
7348696|NCT00937326|11589238|FG000|Overall Study|Adverse Event|0
7348697|NCT00937326|11589239|FG001|Overall Study|Adverse Event|3
7348698|NCT00937326|11589240|FG002|Overall Study|Adverse Event|1
7348699|NCT00937326|11589241|FG003|Overall Study|Adverse Event|1
7348700|NCT00937326|11589242|FG004|Overall Study|Adverse Event|2
7348701|NCT00937326|11589238|FG000|Overall Study|Death|0
7348702|NCT00937326|11589239|FG001|Overall Study|Death|0
7348703|NCT00937326|11589240|FG002|Overall Study|Death|1
7348704|NCT00937326|11589241|FG003|Overall Study|Death|0
7348705|NCT00937326|11589242|FG004|Overall Study|Death|0
7348706|NCT00937326|11589238|FG000|Overall Study|Withdrawal by Subject|3
7348707|NCT00937326|11589239|FG001|Overall Study|Withdrawal by Subject|4
7348708|NCT00937326|11589240|FG002|Overall Study|Withdrawal by Subject|1
7348709|NCT00937326|11589241|FG003|Overall Study|Withdrawal by Subject|4
7348710|NCT00937326|11589242|FG004|Overall Study|Withdrawal by Subject|3
7348711|NCT00937326|11589238|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
7348712|NCT00937326|11589239|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
7348713|NCT00937326|11589240|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
7348714|NCT00937326|11589241|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
7348715|NCT00937326|11589242|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
7348716|NCT00937391|11589270|FG000|Stage 2|Withdrawal by Subject|1
7348717|NCT00937404|11589287|FG000|Overall Study|Protocol Violation|1
7348718|NCT00937404|11589287|FG000|Overall Study|Withdrawal by Subject|1
7348719|NCT00937495|11589291|FG000|Overall Study|Protocol Violation|2
7348720|NCT00937521|11589303|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
7348721|NCT00937521|11589304|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
7569183|NCT03440944|11945187|FG000|Overall Study|Physician Decision|1
7569184|NCT03440944|11945188|FG001|Overall Study|Physician Decision|0
7348722|NCT00937521|11589305|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
7348723|NCT00937521|11589306|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
7348724|NCT00937521|11589307|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
7348725|NCT00937521|11589308|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
7348726|NCT00937521|11589309|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
7348727|NCT00937521|11589310|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
7348728|NCT00937521|11589303|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7348729|NCT00937521|11589304|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7348730|NCT00937521|11589305|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
7348731|NCT00937521|11589306|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7348732|NCT00937521|11589307|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7348733|NCT00937521|11589308|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
7348734|NCT00937521|11589309|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
7348735|NCT00937521|11589310|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
7348736|NCT00937521|11589303|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348737|NCT00937521|11589304|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348738|NCT00937521|11589305|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7348739|NCT00937521|11589306|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
7348740|NCT00937521|11589307|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348741|NCT00937521|11589308|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348742|NCT00937521|11589309|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348743|NCT00937521|11589310|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
7348744|NCT00937521|11589303|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7348745|NCT00937521|11589304|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
7348746|NCT00937521|11589305|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7348747|NCT00937521|11589306|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7348748|NCT00937521|11589307|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
7348749|NCT00937521|11589308|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7348750|NCT00937521|11589309|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
7348751|NCT00937521|11589310|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
7348752|NCT00937521|11589303|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7348753|NCT00937521|11589304|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348754|NCT00937521|11589305|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348755|NCT00937521|11589306|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348756|NCT00937521|11589307|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348757|NCT00937521|11589308|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348758|NCT00937521|11589309|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
7348759|NCT00937521|11589310|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
7348760|NCT00937521|11589303|FG000|Booster Phase|Adverse Event|0
7348761|NCT00937521|11589304|FG001|Booster Phase|Adverse Event|0
7569185|NCT03440944|11945187|FG000|Overall Study|No Acceptable Vasculature|0
7569186|NCT03440944|11945188|FG001|Overall Study|No Acceptable Vasculature|1
7348762|NCT00937521|11589305|FG002|Booster Phase|Adverse Event|0
7348763|NCT00937521|11589306|FG003|Booster Phase|Adverse Event|0
7348764|NCT00937521|11589307|FG004|Booster Phase|Adverse Event|0
7348765|NCT00937521|11589308|FG005|Booster Phase|Adverse Event|0
7348766|NCT00937521|11589309|FG006|Booster Phase|Adverse Event|1
7348767|NCT00937521|11589310|FG007|Booster Phase|Adverse Event|0
7348768|NCT00937521|11589303|FG000|Booster Phase|Withdrawal by Subject|1
7348769|NCT00937521|11589304|FG001|Booster Phase|Withdrawal by Subject|0
7348770|NCT00937521|11589305|FG002|Booster Phase|Withdrawal by Subject|0
7348771|NCT00937521|11589306|FG003|Booster Phase|Withdrawal by Subject|1
7348772|NCT00937521|11589307|FG004|Booster Phase|Withdrawal by Subject|0
7348773|NCT00937521|11589308|FG005|Booster Phase|Withdrawal by Subject|0
7348774|NCT00937521|11589309|FG006|Booster Phase|Withdrawal by Subject|0
7348775|NCT00937521|11589310|FG007|Booster Phase|Withdrawal by Subject|2
7348776|NCT00937521|11589303|FG000|Booster Phase|Lost to Follow-up|2
7348777|NCT00937521|11589304|FG001|Booster Phase|Lost to Follow-up|2
7348778|NCT00937521|11589305|FG002|Booster Phase|Lost to Follow-up|4
7348779|NCT00937521|11589306|FG003|Booster Phase|Lost to Follow-up|2
7348780|NCT00937521|11589307|FG004|Booster Phase|Lost to Follow-up|4
7348781|NCT00937521|11589308|FG005|Booster Phase|Lost to Follow-up|4
7348782|NCT00937521|11589309|FG006|Booster Phase|Lost to Follow-up|3
7348783|NCT00937521|11589310|FG007|Booster Phase|Lost to Follow-up|0
7348784|NCT00937521|11589303|FG000|Booster Phase|Administrative Reason|0
7348785|NCT00937521|11589304|FG001|Booster Phase|Administrative Reason|0
7348786|NCT00937521|11589305|FG002|Booster Phase|Administrative Reason|1
7348787|NCT00937521|11589306|FG003|Booster Phase|Administrative Reason|0
7348788|NCT00937521|11589307|FG004|Booster Phase|Administrative Reason|1
7348789|NCT00937521|11589308|FG005|Booster Phase|Administrative Reason|1
7348790|NCT00937521|11589309|FG006|Booster Phase|Administrative Reason|0
7348791|NCT00937521|11589310|FG007|Booster Phase|Administrative Reason|0
7348792|NCT00937521|11589303|FG000|Booster Phase|Protocol Deviation|0
7348793|NCT00937521|11589304|FG001|Booster Phase|Protocol Deviation|0
7348794|NCT00937521|11589305|FG002|Booster Phase|Protocol Deviation|0
7348795|NCT00937521|11589306|FG003|Booster Phase|Protocol Deviation|0
7348796|NCT00937521|11589307|FG004|Booster Phase|Protocol Deviation|0
7348797|NCT00937521|11589308|FG005|Booster Phase|Protocol Deviation|0
7348798|NCT00937521|11589309|FG006|Booster Phase|Protocol Deviation|1
7348799|NCT00937521|11589310|FG007|Booster Phase|Protocol Deviation|0
7348800|NCT00937547|11589346|FG000|Overall Study|misdiagnosis|1
7348801|NCT00937547|11589347|FG001|Overall Study|misdiagnosis|6
7348802|NCT00937547|11589348|FG002|Overall Study|misdiagnosis|7
7348803|NCT00937560|11589356|FG000|Initial Treatment|Death|6
7348804|NCT00937560|11589356|FG000|Initial Treatment|Withdraw consent|3
7348805|NCT00937560|11589356|FG000|Initial Treatment|Adverse Event|1
7348806|NCT00937560|11589356|FG000|Initial Treatment|Lost to Follow-up|1
7348807|NCT00937560|11589356|FG000|Initial Treatment|No end of study page|10
7348808|NCT00937560|11589356|FG000|Maintenance Treatment|Death|12
7348809|NCT00937560|11589356|FG000|Maintenance Treatment|Withdraw consent|5
7348810|NCT00937560|11589356|FG000|Maintenance Treatment|According to protocol|1
7348811|NCT00937768|11589362|FG000|Overall Study|Refused Further Treatment|3
7348812|NCT00937768|11589363|FG001|Overall Study|Refused Further Treatment|2
7348813|NCT00937768|11589362|FG000|Overall Study|Disease Progression|1
7348814|NCT00937768|11589363|FG001|Overall Study|Disease Progression|1
7348815|NCT00937768|11589362|FG000|Overall Study|Alternate Treatment|0
7348816|NCT00937768|11589363|FG001|Overall Study|Alternate Treatment|1
7348817|NCT00937768|11589362|FG000|Overall Study|No Further Funding|4
7348818|NCT00937768|11589363|FG001|Overall Study|No Further Funding|4
7348819|NCT00937833|11589375|FG000|Overall Study|Protocol Violation|1
7348820|NCT00937833|11589376|FG001|Overall Study|Protocol Violation|2
7348821|NCT00937833|11589375|FG000|Overall Study|Procedure delayed; enrollment closed|0
7348822|NCT00937833|11589376|FG001|Overall Study|Procedure delayed; enrollment closed|1
7348823|NCT00937833|11589375|FG000|Overall Study|Lost to Follow-up|10
7348824|NCT00937833|11589376|FG001|Overall Study|Lost to Follow-up|8
7348825|NCT00937833|11589375|FG000|Overall Study|Withdrawal by Subject|4
7348826|NCT00937833|11589376|FG001|Overall Study|Withdrawal by Subject|6
7348827|NCT00937950|11589391|FG000|Overall Study|Withdrawal by Subject|23
7569187|NCT03441789|11945280|FG000|Overall Study|Withdrawal by Subject|1
7569188|NCT03441789|11945281|FG001|Overall Study|Withdrawal by Subject|1
7569189|NCT03441789|11945280|FG000|Overall Study|Adverse Event|0
7569190|NCT03441789|11945281|FG001|Overall Study|Adverse Event|1
7569191|NCT03441789|11945280|FG000|Overall Study|Protocol Violation|0
7348828|NCT00937950|11589391|FG000|Overall Study|Migrated/moved from study area|27
7348829|NCT00937950|11589391|FG000|Overall Study|Lost to Follow-up|144
7348830|NCT00937950|11589391|FG000|Overall Study|Missing confirmed|4
7569192|NCT03441789|11945281|FG001|Overall Study|Protocol Violation|1
7348831|NCT00937950|11589391|FG000|Overall Study|Other|18
7348832|NCT00938015|11589395|FG000|Overall Study|Death|2
7348833|NCT00938015|11589395|FG000|Overall Study|Lost to Follow-up|32
7348834|NCT00938015|11589395|FG000|Overall Study|Adverse Event|32
7348835|NCT00938015|11589395|FG000|Overall Study|Non-responder|52
7348836|NCT00938015|11589395|FG000|Overall Study|Reason not related to Etanercept|29
7348837|NCT00938041|11589399|FG000|Overall Study|Lost to Follow-up|6
7348838|NCT00938041|11589399|FG000|Overall Study|Received Alternative Therapy|1
7348839|NCT00938041|11589399|FG000|Overall Study|Progressive Disease|5
7348840|NCT00938041|11589399|FG000|Overall Study|Death|12
7569193|NCT03441789|11945280|FG000|Overall Study|Lost to Follow-up|0
7569194|NCT03441789|11945281|FG001|Overall Study|Lost to Follow-up|1
7348841|NCT00938041|11589399|FG000|Overall Study|Adrenal Insufficiency|3
7348842|NCT00938327|11589420|FG000|Overall Study|Adverse Event|2
7348843|NCT00938327|11589420|FG000|Overall Study|Protocol Violation|1
7348844|NCT00938327|11589420|FG000|Overall Study|Withdrawal by Subject|4
7348845|NCT00938327|11589420|FG000|Overall Study|Lost to Follow-up|37
7348846|NCT00938327|11589420|FG000|Overall Study|2nd dose received outside of the study|7
7348847|NCT00938327|11589420|FG000|Overall Study|Vaccine not received as out of stock|9
7348848|NCT00938340|11589424|FG000|Overall Study|Withdrawal by Subject|3
7348849|NCT00938340|11589424|FG000|Overall Study|Protocol Violation|1
7348850|NCT00938340|11589424|FG000|Overall Study|Adverse Event|1
7348851|NCT00938366|11589472|FG000|Overall Study|Withdrawal by Subject|1
7348852|NCT00938366|11589473|FG001|Overall Study|Withdrawal by Subject|0
7348853|NCT00938392|11589481|FG000|Overall Study|Adverse Event|0
7348854|NCT00938392|11589482|FG001|Overall Study|Adverse Event|1
7348855|NCT00938392|11589481|FG000|Overall Study|Withdrawal by Subject|0
7348856|NCT00938392|11589482|FG001|Overall Study|Withdrawal by Subject|1
7348857|NCT00938392|11589481|FG000|Overall Study|Lost to Follow-up|2
7348858|NCT00938392|11589482|FG001|Overall Study|Lost to Follow-up|2
7348859|NCT00938431|11589491|FG000|Overall Study|Adverse Event|5
7348860|NCT00938431|11589492|FG001|Overall Study|Adverse Event|8
7348861|NCT00938431|11589493|FG002|Overall Study|Adverse Event|6
7348862|NCT00938431|11589491|FG000|Overall Study|Lack of Efficacy|0
7348863|NCT00938431|11589492|FG001|Overall Study|Lack of Efficacy|1
7348864|NCT00938431|11589493|FG002|Overall Study|Lack of Efficacy|0
7348865|NCT00938431|11589491|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
7348866|NCT00938431|11589492|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
7348867|NCT00938431|11589493|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
7348868|NCT00938431|11589491|FG000|Overall Study|Dosing compliance issue|0
7348869|NCT00938431|11589492|FG001|Overall Study|Dosing compliance issue|0
7348870|NCT00938431|11589493|FG002|Overall Study|Dosing compliance issue|1
7348871|NCT00938431|11589491|FG000|Overall Study|Reached maximum dose early|0
7348872|NCT00938431|11589492|FG001|Overall Study|Reached maximum dose early|0
7348873|NCT00938431|11589493|FG002|Overall Study|Reached maximum dose early|1
7348874|NCT00938470|11589511|FG000|Overall Study|Disease Progression|3
7348875|NCT00938470|11589512|FG001|Overall Study|Disease Progression|0
7348876|NCT00938470|11589511|FG000|Overall Study|Alternate Treatment|1
7348877|NCT00938470|11589512|FG001|Overall Study|Alternate Treatment|0
7348878|NCT00938470|11589511|FG000|Overall Study|Death|3
7348879|NCT00938470|11589512|FG001|Overall Study|Death|2
7348880|NCT00938470|11589511|FG000|Overall Study|Other Reason|0
7348881|NCT00938470|11589512|FG001|Overall Study|Other Reason|1
7348882|NCT00938639|11589529|FG000|Overall Study|Moved away from study area|0
7348883|NCT00938639|11589530|FG001|Overall Study|Moved away from study area|1
7348884|NCT00938639|11589529|FG000|Overall Study|Lost to Follow-up|1
7348885|NCT00938639|11589530|FG001|Overall Study|Lost to Follow-up|2
7348886|NCT00938639|11589529|FG000|Overall Study|Family issues|1
7348887|NCT00938639|11589530|FG001|Overall Study|Family issues|1
7348888|NCT00938639|11589529|FG000|Overall Study|Participant noncompliance|1
7348889|NCT00938639|11589530|FG001|Overall Study|Participant noncompliance|0
7348890|NCT00938717|11589551|FG000|Overall Study|Adverse Event|10
7348891|NCT00938717|11589552|FG001|Overall Study|Adverse Event|41
7348892|NCT00938717|11589551|FG000|Overall Study|Protocol Violation|11
7348893|NCT00938717|11589552|FG001|Overall Study|Protocol Violation|8
7348894|NCT00938717|11589551|FG000|Overall Study|Withdrawal by Subject|26
7348895|NCT00938717|11589552|FG001|Overall Study|Withdrawal by Subject|24
7348896|NCT00938717|11589551|FG000|Overall Study|Lost to Follow-up|13
7348897|NCT00938717|11589552|FG001|Overall Study|Lost to Follow-up|18
7348898|NCT00938717|11589551|FG000|Overall Study|Lack of Efficacy|33
7348899|NCT00938717|11589552|FG001|Overall Study|Lack of Efficacy|15
7348900|NCT00938717|11589551|FG000|Overall Study|Other reason|5
7348901|NCT00938717|11589552|FG001|Overall Study|Other reason|2
7348902|NCT00938860|11589569|FG000|Overall Study|Adverse Event|2
7348903|NCT00938860|11589570|FG001|Overall Study|Adverse Event|1
7348904|NCT00938860|11589569|FG000|Overall Study|Abnormal laboratory values|2
7348905|NCT00938860|11589570|FG001|Overall Study|Abnormal laboratory values|2
7348906|NCT00938860|11589569|FG000|Overall Study|Withdrawal by Subject|11
7348907|NCT00938860|11589570|FG001|Overall Study|Withdrawal by Subject|8
7348908|NCT00938860|11589569|FG000|Overall Study|Lost to Follow-up|4
7348909|NCT00938860|11589570|FG001|Overall Study|Lost to Follow-up|4
7348910|NCT00938860|11589569|FG000|Overall Study|Administration problems|2
7348911|NCT00938860|11589570|FG001|Overall Study|Administration problems|0
7348912|NCT00938860|11589569|FG000|Overall Study|Death|1
7348913|NCT00938860|11589570|FG001|Overall Study|Death|1
7348914|NCT00938860|11589569|FG000|Overall Study|Protocol Violation|3
7348915|NCT00938860|11589570|FG001|Overall Study|Protocol Violation|1
7348916|NCT00938886|11589578|FG000|Overall Study|Death|0
7348917|NCT00938886|11589579|FG001|Overall Study|Death|1
7348918|NCT00938886|11589578|FG000|Overall Study|Withdrawal by Subject|4
7348919|NCT00938886|11589579|FG001|Overall Study|Withdrawal by Subject|7
7348920|NCT00938886|11589578|FG000|Overall Study|Lost to Follow-up|3
7348921|NCT00938886|11589579|FG001|Overall Study|Lost to Follow-up|2
7348922|NCT00938964|11589587|FG000|Overall Study|Death|3
7348923|NCT00938964|11589588|FG001|Overall Study|Death|3
7348924|NCT00938964|11589587|FG000|Overall Study|Lost to Follow-up|2
7348925|NCT00938964|11589588|FG001|Overall Study|Lost to Follow-up|3
7348926|NCT00938964|11589587|FG000|Overall Study|Withdrawal by Subject|22
7348927|NCT00938964|11589588|FG001|Overall Study|Withdrawal by Subject|18
7348928|NCT00938964|11589587|FG000|Overall Study|Found to Meet Exclusion Criteria|3
7348929|NCT00938964|11589588|FG001|Overall Study|Found to Meet Exclusion Criteria|4
7348930|NCT00939003|11589596|FG000|Double-blind Treatment Period|Adverse Event|1
7348931|NCT00939003|11589597|FG001|Double-blind Treatment Period|Adverse Event|1
7348932|NCT00939003|11589596|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7348933|NCT00939003|11589597|FG001|Double-blind Treatment Period|Lack of Efficacy|1
7348934|NCT00939003|11589596|FG000|Double-blind Treatment Period|Pregnancy|0
7348935|NCT00939003|11589597|FG001|Double-blind Treatment Period|Pregnancy|1
7348936|NCT00939003|11589596|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
7348937|NCT00939003|11589597|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
7348938|NCT00939003|11589596|FG000|Open-label Treatment Period|Adverse Event|4
7348939|NCT00939003|11589597|FG001|Open-label Treatment Period|Adverse Event|8
7348940|NCT00939003|11589596|FG000|Open-label Treatment Period|Withdrawal by Subject|14
7348941|NCT00939003|11589597|FG001|Open-label Treatment Period|Withdrawal by Subject|7
7348942|NCT00939003|11589596|FG000|Open-label Treatment Period|Lack of Efficacy|6
7348943|NCT00939003|11589597|FG001|Open-label Treatment Period|Lack of Efficacy|9
7348944|NCT00939003|11589596|FG000|Open-label Treatment Period|Pregnancy|1
7348945|NCT00939003|11589597|FG001|Open-label Treatment Period|Pregnancy|1
7348946|NCT00939003|11589596|FG000|Open-label Treatment Period|Exclusion Criteria|1
7348947|NCT00939003|11589597|FG001|Open-label Treatment Period|Exclusion Criteria|0
7348948|NCT00939003|11589596|FG000|Open-label Treatment Period|Site Closure|3
7348949|NCT00939003|11589597|FG001|Open-label Treatment Period|Site Closure|4
7348950|NCT00939029|11589608|FG000|Overall Study|Withdrawal by Subject|3
7348951|NCT00939029|11589609|FG001|Overall Study|Withdrawal by Subject|7
7348952|NCT00939029|11589608|FG000|Overall Study|Lost to Follow-up|3
7348953|NCT00939029|11589609|FG001|Overall Study|Lost to Follow-up|4
7348954|NCT00939029|11589608|FG000|Overall Study|Adverse Event|0
7348955|NCT00939029|11589609|FG001|Overall Study|Adverse Event|1
7348956|NCT00939055|11589617|FG000|Overall Study|Discontinuation prior to procedure|4
7348957|NCT00939055|11589618|FG001|Overall Study|Discontinuation prior to procedure|0
7348958|NCT00939094|11589627|FG000|Overall Study|Adverse Event|9
7348959|NCT00939094|11589628|FG001|Overall Study|Adverse Event|0
7348960|NCT00939094|11589627|FG000|Overall Study|Withdrawal by Subject|1
7348961|NCT00939094|11589628|FG001|Overall Study|Withdrawal by Subject|6
7348962|NCT00939094|11589627|FG000|Overall Study|Lost to Follow-up|1
7348963|NCT00939094|11589628|FG001|Overall Study|Lost to Follow-up|1
7348964|NCT00939094|11589627|FG000|Overall Study|Eligibility criteria not fulfilled|2
7348965|NCT00939094|11589628|FG001|Overall Study|Eligibility criteria not fulfilled|0
7348966|NCT00939094|11589627|FG000|Overall Study|Severe non-compliance to protocol|0
7348967|NCT00939094|11589628|FG001|Overall Study|Severe non-compliance to protocol|1
7348968|NCT00939094|11589627|FG000|Overall Study|Study stopped by sponsor|0
7348969|NCT00939094|11589628|FG001|Overall Study|Study stopped by sponsor|2
7348970|NCT00939094|11589627|FG000|Overall Study|Abnormal ECG findings|1
7348971|NCT00939094|11589628|FG001|Overall Study|Abnormal ECG findings|0
7348972|NCT00939107|11589636|FG000|Overall Study|Lost to Follow-up|14
7348973|NCT00939107|11589637|FG001|Overall Study|Lost to Follow-up|12
7348974|NCT00939185|11589656|FG000|Overall Study|Adverse Event|3
7348975|NCT00939185|11589656|FG000|Overall Study|Lack of Efficacy|1
7348976|NCT00939185|11589656|FG000|Overall Study|Lost to Follow-up|6
7348977|NCT00939185|11589656|FG000|Overall Study|Other|3
7348978|NCT00939185|11589656|FG000|Overall Study|Withdrawal by Subject|2
7348979|NCT00939185|11589656|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
7348980|NCT00939341|11589677|FG000|Overall Study|Adverse Event|15
7348981|NCT00939341|11589677|FG000|Overall Study|Pregnancy|1
7348982|NCT00939341|11589677|FG000|Overall Study|Lost to Follow-up|23
7348983|NCT00939341|11589677|FG000|Overall Study|Withdrawal by Subject|13
7348984|NCT00939341|11589677|FG000|Overall Study|Protocol Violation|6
7348985|NCT00939341|11589677|FG000|Overall Study|Incorrect enrolment|8
7348986|NCT00939393|11589690|FG000|Overall Study|Withdrawal by Subject|1
7348987|NCT00939393|11589691|FG001|Overall Study|Withdrawal by Subject|0
7348988|NCT00939393|11589690|FG000|Overall Study|Lost to Follow-up|3
7348989|NCT00939393|11589691|FG001|Overall Study|Lost to Follow-up|0
7348990|NCT00939484|11589706|FG000|Overall Study|Progression/Relapse|8
7348991|NCT00939484|11589707|FG001|Overall Study|Progression/Relapse|20
7348992|NCT00939484|11589708|FG002|Overall Study|Progression/Relapse|3
7348993|NCT00939510|11589718|FG000|Overall Study|Withdrawal by Subject|1
7348994|NCT00939523|11589722|FG000|Overall Study|Lack of Efficacy|1
7348995|NCT00939523|11589722|FG000|Overall Study|Physician Decision|2
7348996|NCT00939627|11589744|FG000|Overall Study|Disease Progression|16
7348997|NCT00939627|11589745|FG001|Overall Study|Disease Progression|12
7348998|NCT00939627|11589746|FG002|Overall Study|Disease Progression|0
7348999|NCT00939627|11589744|FG000|Overall Study|Adverse Event|6
7349000|NCT00939627|11589745|FG001|Overall Study|Adverse Event|7
7349001|NCT00939627|11589746|FG002|Overall Study|Adverse Event|0
7349002|NCT00939627|11589744|FG000|Overall Study|Death|0
7349003|NCT00939627|11589745|FG001|Overall Study|Death|2
7349004|NCT00939627|11589746|FG002|Overall Study|Death|0
7349005|NCT00939627|11589744|FG000|Overall Study|Withdrawal by Subject|2
7349006|NCT00939627|11589745|FG001|Overall Study|Withdrawal by Subject|4
7349007|NCT00939627|11589746|FG002|Overall Study|Withdrawal by Subject|0
7349008|NCT00939627|11589744|FG000|Overall Study|Other complicating disease|1
7349009|NCT00939627|11589745|FG001|Overall Study|Other complicating disease|1
7349010|NCT00939627|11589746|FG002|Overall Study|Other complicating disease|0
7349011|NCT00939627|11589744|FG000|Overall Study|Not compliant|2
7349012|NCT00939627|11589745|FG001|Overall Study|Not compliant|0
7349013|NCT00939627|11589746|FG002|Overall Study|Not compliant|0
7349014|NCT00939627|11589744|FG000|Overall Study|No off-tx reason given|0
7349015|NCT00939627|11589745|FG001|Overall Study|No off-tx reason given|2
7349016|NCT00939627|11589746|FG002|Overall Study|No off-tx reason given|0
7349017|NCT00939640|11589752|FG000|Overall Study|Physician Decision|1
7349018|NCT00939692|11589768|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
7349019|NCT00939692|11589769|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
7349020|NCT00939692|11589768|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
7349021|NCT00939692|11589769|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
7349022|NCT00939770|11589799|FG000|Overall Study|Adverse Event|1
7349023|NCT00939770|11589800|FG001|Overall Study|Adverse Event|1
7349024|NCT00939770|11589801|FG002|Overall Study|Adverse Event|0
7349025|NCT00939770|11589802|FG003|Overall Study|Adverse Event|0
7349026|NCT00939770|11589803|FG004|Overall Study|Adverse Event|6
7349027|NCT00939770|11589804|FG005|Overall Study|Adverse Event|2
7349028|NCT00939770|11589805|FG006|Overall Study|Adverse Event|1
7349029|NCT00939770|11589806|FG007|Overall Study|Adverse Event|1
7349030|NCT00939770|11589799|FG000|Overall Study|Lack of Efficacy|4
7349031|NCT00939770|11589800|FG001|Overall Study|Lack of Efficacy|6
7349032|NCT00939770|11589801|FG002|Overall Study|Lack of Efficacy|13
7349033|NCT00939770|11589802|FG003|Overall Study|Lack of Efficacy|9
7349034|NCT00939770|11589803|FG004|Overall Study|Lack of Efficacy|16
7349035|NCT00939770|11589804|FG005|Overall Study|Lack of Efficacy|8
7349036|NCT00939770|11589805|FG006|Overall Study|Lack of Efficacy|11
7349037|NCT00939770|11589806|FG007|Overall Study|Lack of Efficacy|1
7349038|NCT00939770|11589799|FG000|Overall Study|Lost to Follow-up|0
7349039|NCT00939770|11589800|FG001|Overall Study|Lost to Follow-up|0
7349040|NCT00939770|11589801|FG002|Overall Study|Lost to Follow-up|0
7349041|NCT00939770|11589802|FG003|Overall Study|Lost to Follow-up|0
7349042|NCT00939770|11589803|FG004|Overall Study|Lost to Follow-up|1
7349043|NCT00939770|11589804|FG005|Overall Study|Lost to Follow-up|0
7349044|NCT00939770|11589805|FG006|Overall Study|Lost to Follow-up|0
7349045|NCT00939770|11589806|FG007|Overall Study|Lost to Follow-up|0
7349046|NCT00939770|11589799|FG000|Overall Study|Physician Decision|0
7349047|NCT00939770|11589800|FG001|Overall Study|Physician Decision|0
7349048|NCT00939770|11589801|FG002|Overall Study|Physician Decision|2
7349049|NCT00939770|11589802|FG003|Overall Study|Physician Decision|0
7349050|NCT00939770|11589803|FG004|Overall Study|Physician Decision|7
7349051|NCT00939770|11589804|FG005|Overall Study|Physician Decision|1
7459227|NCT01815424|11753759|FG000|Week 16 to 52|Lost to Follow-up|0
7459228|NCT01815424|11753760|FG001|Week 16 to 52|Lost to Follow-up|2
7459229|NCT01815424|11753761|FG002|Week 16 to 52|Lost to Follow-up|0
7459230|NCT01815424|11753762|FG003|Week 16 to 52|Lost to Follow-up|2
7459231|NCT01815424|11753763|FG004|Week 16 to 52|Lost to Follow-up|1
7459232|NCT01815424|11753759|FG000|Week 16 to 52|Withdrawal by Subject|1
7459233|NCT01815424|11753760|FG001|Week 16 to 52|Withdrawal by Subject|2
7459234|NCT01815424|11753761|FG002|Week 16 to 52|Withdrawal by Subject|0
7459235|NCT01815424|11753762|FG003|Week 16 to 52|Withdrawal by Subject|0
7459236|NCT01815424|11753763|FG004|Week 16 to 52|Withdrawal by Subject|0
7459237|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
7459238|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
7468294|NCT01908829|11768953|FG002|Overall Study|Lack of Efficacy|2
7349052|NCT00939770|11589805|FG006|Overall Study|Physician Decision|0
7349053|NCT00939770|11589806|FG007|Overall Study|Physician Decision|6
7349054|NCT00939770|11589799|FG000|Overall Study|Protocol Violation|0
7349055|NCT00939770|11589800|FG001|Overall Study|Protocol Violation|0
7349056|NCT00939770|11589801|FG002|Overall Study|Protocol Violation|0
7349057|NCT00939770|11589802|FG003|Overall Study|Protocol Violation|0
7349058|NCT00939770|11589803|FG004|Overall Study|Protocol Violation|1
7349059|NCT00939770|11589804|FG005|Overall Study|Protocol Violation|0
7349060|NCT00939770|11589805|FG006|Overall Study|Protocol Violation|0
7349061|NCT00939770|11589806|FG007|Overall Study|Protocol Violation|0
7349062|NCT00939770|11589799|FG000|Overall Study|Withdrawal by Subject|0
7349063|NCT00939770|11589800|FG001|Overall Study|Withdrawal by Subject|1
7349064|NCT00939770|11589801|FG002|Overall Study|Withdrawal by Subject|5
7349065|NCT00939770|11589802|FG003|Overall Study|Withdrawal by Subject|2
7349066|NCT00939770|11589803|FG004|Overall Study|Withdrawal by Subject|6
7349067|NCT00939770|11589804|FG005|Overall Study|Withdrawal by Subject|0
7349068|NCT00939770|11589805|FG006|Overall Study|Withdrawal by Subject|2
7349069|NCT00939770|11589806|FG007|Overall Study|Withdrawal by Subject|2
7349070|NCT00939783|11589837|FG000|Overall Study|Death|6
7349071|NCT00939783|11589837|FG000|Overall Study|Adverse Event|39
7349072|NCT00939783|11589837|FG000|Overall Study|Study Terminated by Sponsor|498
7349073|NCT00939783|11589837|FG000|Overall Study|Withdrawal by Subject|78
7349074|NCT00939783|11589837|FG000|Overall Study|Other|16
7349075|NCT00939783|11589837|FG000|Overall Study|Lost to Follow-up|8
7349076|NCT00939783|11589837|FG000|Overall Study|Protocol Violation|3
7349077|NCT00939783|11589837|FG000|Overall Study|Enrolled but not treated|1
7349078|NCT00939809|11589845|FG000|Overall Study|Adverse Event|2
7349079|NCT00939809|11589845|FG000|Overall Study|Death|1
7349080|NCT00939822|11589851|FG000|Overall Study|Lost to Follow-up|1
7349081|NCT00939822|11589852|FG001|Overall Study|Lost to Follow-up|0
7349082|NCT00939822|11589851|FG000|Overall Study|withdrew from study due to busy schedule|1
7349083|NCT00939822|11589852|FG001|Overall Study|withdrew from study due to busy schedule|1
7349084|NCT00939822|11589851|FG000|Overall Study|Mental health issues|0
7349085|NCT00939822|11589852|FG001|Overall Study|Mental health issues|2
7349086|NCT00940017|11589884|FG000|Overall Study|did not meet entrance criteria|3
7349087|NCT00940017|11589884|FG000|Overall Study|Adverse Event|1
7349088|NCT00940108|11589892|FG000|Overall Study|Adverse Event|2
7349089|NCT00940108|11589893|FG001|Overall Study|Adverse Event|4
7349090|NCT00940108|11589894|FG002|Overall Study|Adverse Event|0
7349091|NCT00940108|11589895|FG003|Overall Study|Adverse Event|2
7349092|NCT00940108|11589892|FG000|Overall Study|Withdrew Consent|2
7349093|NCT00940108|11589893|FG001|Overall Study|Withdrew Consent|1
7349094|NCT00940108|11589894|FG002|Overall Study|Withdrew Consent|0
7349095|NCT00940108|11589895|FG003|Overall Study|Withdrew Consent|1
7349096|NCT00940108|11589892|FG000|Overall Study|Dose 2 contraindicated|1
7349097|NCT00940108|11589893|FG001|Overall Study|Dose 2 contraindicated|1
7349098|NCT00940108|11589894|FG002|Overall Study|Dose 2 contraindicated|0
7349099|NCT00940108|11589895|FG003|Overall Study|Dose 2 contraindicated|1
7349100|NCT00940108|11589892|FG000|Overall Study|Declined further vaccination|0
7349101|NCT00940108|11589893|FG001|Overall Study|Declined further vaccination|1
7349102|NCT00940108|11589894|FG002|Overall Study|Declined further vaccination|3
7349103|NCT00940108|11589895|FG003|Overall Study|Declined further vaccination|0
7349104|NCT00940108|11589892|FG000|Overall Study|Refused - pyrexia after Dose 1|0
7349105|NCT00940108|11589893|FG001|Overall Study|Refused - pyrexia after Dose 1|1
7349106|NCT00940108|11589894|FG002|Overall Study|Refused - pyrexia after Dose 1|0
7349107|NCT00940108|11589895|FG003|Overall Study|Refused - pyrexia after Dose 1|0
7349108|NCT00940108|11589892|FG000|Overall Study|Viral illness after Dose 1|0
7349109|NCT00940108|11589893|FG001|Overall Study|Viral illness after Dose 1|1
7349110|NCT00940108|11589894|FG002|Overall Study|Viral illness after Dose 1|0
7349111|NCT00940108|11589895|FG003|Overall Study|Viral illness after Dose 1|0
7349112|NCT00940108|11589892|FG000|Overall Study|Diagnosed with H1N1|0
7349113|NCT00940108|11589893|FG001|Overall Study|Diagnosed with H1N1|0
7349114|NCT00940108|11589894|FG002|Overall Study|Diagnosed with H1N1|0
7349115|NCT00940108|11589895|FG003|Overall Study|Diagnosed with H1N1|1
7349116|NCT00940316|11589925|FG000|Reached First Response at 8 Weeks|Adverse Event|2
7349117|NCT00940316|11589926|FG001|Reached First Response at 8 Weeks|Adverse Event|1
7349118|NCT00940316|11589927|FG002|Reached First Response at 8 Weeks|Adverse Event|0
7349119|NCT00940316|11589925|FG000|Reached First Response at 8 Weeks|Progressive disease|1
7349120|NCT00940316|11589926|FG001|Reached First Response at 8 Weeks|Progressive disease|3
7349121|NCT00940316|11589927|FG002|Reached First Response at 8 Weeks|Progressive disease|0
7349122|NCT00940316|11589925|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
7349123|NCT00940316|11589926|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
7349124|NCT00940316|11589927|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
7349125|NCT00940316|11589925|FG000|Treated After Cycle 5|Adverse Event|0
7349126|NCT00940316|11589926|FG001|Treated After Cycle 5|Adverse Event|0
7349127|NCT00940316|11589927|FG002|Treated After Cycle 5|Adverse Event|1
7349128|NCT00940316|11589925|FG000|Treated After Cycle 5|Progressive disease|0
7349129|NCT00940316|11589926|FG001|Treated After Cycle 5|Progressive disease|1
7349130|NCT00940316|11589927|FG002|Treated After Cycle 5|Progressive disease|0
7349131|NCT00940342|11589946|FG000|Overall Study|Adverse Event|0
7349132|NCT00940342|11589947|FG001|Overall Study|Adverse Event|2
7349133|NCT00940342|11589948|FG002|Overall Study|Adverse Event|1
7349134|NCT00940485|11589969|FG000|Overall Study|HBeAb positive at Baseline|3
7349135|NCT00940485|11589970|FG001|Overall Study|HBeAb positive at Baseline|2
7349136|NCT00940485|11589969|FG000|Overall Study|Lost to Follow-up|2
7349137|NCT00940485|11589970|FG001|Overall Study|Lost to Follow-up|3
7349138|NCT00940485|11589969|FG000|Overall Study|Adverse Event|8
7349139|NCT00940485|11589970|FG001|Overall Study|Adverse Event|0
7349140|NCT00940485|11589969|FG000|Overall Study|Withdrawal by Subject|1
7349141|NCT00940485|11589970|FG001|Overall Study|Withdrawal by Subject|1
7349142|NCT00940485|11589969|FG000|Overall Study|Others|1
7349143|NCT00940485|11589970|FG001|Overall Study|Others|1
7349144|NCT00940602|11590005|FG000|Overall Study|Administrative problems|1
7349145|NCT00940602|11590006|FG001|Overall Study|Administrative problems|1
7349146|NCT00940602|11590005|FG000|Overall Study|Patient/guardian decision|13
7349147|NCT00940602|11590006|FG001|Overall Study|Patient/guardian decision|28
7349148|NCT00940602|11590005|FG000|Overall Study|Physician Decision|8
7349149|NCT00940602|11590006|FG001|Overall Study|Physician Decision|5
7349150|NCT00940602|11590005|FG000|Overall Study|Pregnancy|1
7349151|NCT00940602|11590006|FG001|Overall Study|Pregnancy|0
7349152|NCT00940602|11590005|FG000|Overall Study|Protocol Deviation (untreated)|1
7349153|NCT00940602|11590006|FG001|Overall Study|Protocol Deviation (untreated)|0
7349154|NCT00940602|11590005|FG000|Overall Study|Disease progression|8
7349155|NCT00940602|11590006|FG001|Overall Study|Disease progression|2
7349156|NCT00940602|11590005|FG000|Overall Study|Death|38
7349157|NCT00940602|11590006|FG001|Overall Study|Death|19
7349158|NCT00940602|11590005|FG000|Overall Study|Lost to Follow-up|3
7349159|NCT00940602|11590006|FG001|Overall Study|Lost to Follow-up|1
7349160|NCT00940602|11590005|FG000|Overall Study|Patient withdrew consent|26
7349161|NCT00940602|11590006|FG001|Overall Study|Patient withdrew consent|13
7349162|NCT00940602|11590005|FG000|Overall Study|Adverse Event|7
7349163|NCT00940602|11590006|FG001|Overall Study|Adverse Event|2
7349164|NCT00940602|11590005|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
7349165|NCT00940602|11590006|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
7349166|NCT00940823|11590019|FG000|Overall Study|Death|8
7349167|NCT00940823|11590020|FG001|Overall Study|Death|12
7349168|NCT00940823|11590019|FG000|Overall Study|Lost to Follow-up|27
7349169|NCT00940823|11590020|FG001|Overall Study|Lost to Follow-up|20
7349170|NCT00940875|11590030|FG000|Treatment Phase|Adverse Event|9
7349171|NCT00940875|11590031|FG001|Treatment Phase|Adverse Event|3
7349172|NCT00940875|11590030|FG000|Treatment Phase|Death|3
7349173|NCT00940875|11590031|FG001|Treatment Phase|Death|5
7349174|NCT00940875|11590030|FG000|Treatment Phase|Lack of Efficacy|1
7349175|NCT00940875|11590031|FG001|Treatment Phase|Lack of Efficacy|0
7349176|NCT00940875|11590030|FG000|Treatment Phase|Withdrawal by Subject|3
7349177|NCT00940875|11590031|FG001|Treatment Phase|Withdrawal by Subject|0
7349178|NCT00940875|11590030|FG000|Treatment Phase|Disease progression|9
7349179|NCT00940875|11590031|FG001|Treatment Phase|Disease progression|11
7349180|NCT00940875|11590030|FG000|Treatment Phase|Physician Decision|1
7349181|NCT00940875|11590031|FG001|Treatment Phase|Physician Decision|0
7349182|NCT00940875|11590030|FG000|Post-Study Treatment|Death|0
7349183|NCT00940875|11590031|FG001|Post-Study Treatment|Death|1
7349184|NCT00940875|11590030|FG000|Post-Study Treatment|Disease Progression|0
7349185|NCT00940875|11590031|FG001|Post-Study Treatment|Disease Progression|2
7349186|NCT00940888|11590038|FG000|Overall Study|Unsuccessful Implant|4
7349187|NCT00940888|11590038|FG000|Overall Study|Death|461
7349188|NCT00940888|11590038|FG000|Overall Study|Withdrawn - Non-Death|364
7349189|NCT00940888|11590038|FG000|Overall Study|Lost to Follow-up|6
7349190|NCT00940992|11590060|FG000|Overall Study|Adverse Event|2
7349191|NCT00940992|11590061|FG001|Overall Study|Adverse Event|0
7349192|NCT00940992|11590062|FG002|Overall Study|Adverse Event|1
7349193|NCT00940992|11590060|FG000|Overall Study|subject request|2
7349194|NCT00940992|11590061|FG001|Overall Study|subject request|1
7349195|NCT00940992|11590062|FG002|Overall Study|subject request|0
7349196|NCT00940992|11590060|FG000|Overall Study|Lost to Follow-up|0
7349197|NCT00940992|11590061|FG001|Overall Study|Lost to Follow-up|1
7349198|NCT00940992|11590062|FG002|Overall Study|Lost to Follow-up|1
7385984|NCT01207388|11644187|FG000|Overall Study|Withdrawal by Subject|1
7385985|NCT01207414|11644210|FG000|Overall Study|Adverse Event|25
7385986|NCT01207414|11644211|FG001|Overall Study|Adverse Event|39
7385987|NCT01207414|11644210|FG000|Overall Study|Abnormal test procedure results|0
7385988|NCT01207414|11644211|FG001|Overall Study|Abnormal test procedure results|1
7385989|NCT01207414|11644210|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7385990|NCT01207414|11644211|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7385991|NCT01207414|11644210|FG000|Overall Study|Patient withdrew consent|14
7385992|NCT01207414|11644211|FG001|Overall Study|Patient withdrew consent|11
7385993|NCT01207414|11644210|FG000|Overall Study|Lost to Follow-up|15
7385994|NCT01207414|11644211|FG001|Overall Study|Lost to Follow-up|17
7385995|NCT01207414|11644210|FG000|Overall Study|Administrative problems|1
7385996|NCT01207414|11644211|FG001|Overall Study|Administrative problems|1
7385997|NCT01207414|11644210|FG000|Overall Study|Protocol deviation|12
7385998|NCT01207414|11644211|FG001|Overall Study|Protocol deviation|9
7385999|NCT01207414|11644210|FG000|Overall Study|Randomized in error|1
7386000|NCT01207414|11644211|FG001|Overall Study|Randomized in error|0
7386001|NCT01207427|11644220|FG000|Double-blind Treatment Period|Adverse Event|0
7386002|NCT01207427|11644221|FG001|Double-blind Treatment Period|Adverse Event|1
7386003|NCT01207427|11644222|FG002|Double-blind Treatment Period|Adverse Event|0
7386004|NCT01207427|11644220|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7386005|NCT01207427|11644221|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7386006|NCT01207427|11644222|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7386007|NCT01207427|11644220|FG000|Double-blind Treatment Period|Protocol Violation|2
7386008|NCT01207427|11644221|FG001|Double-blind Treatment Period|Protocol Violation|1
7386009|NCT01207427|11644222|FG002|Double-blind Treatment Period|Protocol Violation|1
7386010|NCT01207427|11644220|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7386011|NCT01207427|11644221|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7386012|NCT01207427|11644222|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7386013|NCT01207440|11644237|FG000|Overall Study|Adverse Event|46
7386014|NCT01207440|11644238|FG001|Overall Study|Adverse Event|11
7386015|NCT01207440|11644239|FG002|Overall Study|Adverse Event|7
7386016|NCT01207440|11644240|FG003|Overall Study|Adverse Event|2
7386017|NCT01207440|11644241|FG004|Overall Study|Adverse Event|6
7386018|NCT01207440|11644242|FG005|Overall Study|Adverse Event|6
7386019|NCT01207440|11644243|FG006|Overall Study|Adverse Event|2
7386020|NCT01207440|11644237|FG000|Overall Study|Death|6
7386021|NCT01207440|11644238|FG001|Overall Study|Death|3
7386022|NCT01207440|11644239|FG002|Overall Study|Death|2
7386023|NCT01207440|11644240|FG003|Overall Study|Death|2
7349199|NCT00941031|11590085|FG000|Induction Period|Lack of Efficacy|2
7349200|NCT00941031|11590086|FG001|Induction Period|Lack of Efficacy|1
7349201|NCT00941031|11590087|FG002|Induction Period|Lack of Efficacy|0
7349202|NCT00941031|11590088|FG003|Induction Period|Lack of Efficacy|5
7459239|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
7459240|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
7459241|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
7459242|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
7459243|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
7459244|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
7459245|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
7459246|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
7459247|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
7459248|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
7459249|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
7459250|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
7459251|NCT01815736|11753814|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
7459252|NCT01815736|11753815|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
7459253|NCT01815736|11753814|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
7459254|NCT01815736|11753815|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
7459255|NCT01815736|11753814|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
7459256|NCT01815736|11753815|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
7459257|NCT01815736|11753814|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
7459258|NCT01815736|11753815|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
7459259|NCT01815736|11753814|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
7459260|NCT01815736|11753815|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
7459261|NCT01815736|11753814|FG000|Extension Treatment Phase- After Week 96|Death|1
7459262|NCT01815736|11753815|FG001|Extension Treatment Phase- After Week 96|Death|0
7459263|NCT01815840|11753825|FG000|Overall Study|Missing|1
7459264|NCT01815840|11753826|FG001|Overall Study|Missing|0
7459265|NCT01815840|11753825|FG000|Overall Study|Withdrew Consent|31
7459266|NCT01815840|11753826|FG001|Overall Study|Withdrew Consent|30
7349203|NCT00941031|11590089|FG004|Induction Period|Lack of Efficacy|0
7349204|NCT00941031|11590090|FG005|Induction Period|Lack of Efficacy|0
7349205|NCT00941031|11590091|FG006|Induction Period|Lack of Efficacy|0
7349206|NCT00941031|11590085|FG000|Induction Period|Withdrawal by Subject|1
7349207|NCT00941031|11590086|FG001|Induction Period|Withdrawal by Subject|2
7349208|NCT00941031|11590087|FG002|Induction Period|Withdrawal by Subject|2
7349209|NCT00941031|11590088|FG003|Induction Period|Withdrawal by Subject|2
7349210|NCT00941031|11590089|FG004|Induction Period|Withdrawal by Subject|0
7349211|NCT00941031|11590090|FG005|Induction Period|Withdrawal by Subject|0
7349212|NCT00941031|11590091|FG006|Induction Period|Withdrawal by Subject|0
7349213|NCT00941031|11590085|FG000|Induction Period|Adminstative Problems|1
7349214|NCT00941031|11590086|FG001|Induction Period|Adminstative Problems|1
7349215|NCT00941031|11590087|FG002|Induction Period|Adminstative Problems|1
7349216|NCT00941031|11590088|FG003|Induction Period|Adminstative Problems|0
7349217|NCT00941031|11590089|FG004|Induction Period|Adminstative Problems|0
7349218|NCT00941031|11590090|FG005|Induction Period|Adminstative Problems|0
7349219|NCT00941031|11590091|FG006|Induction Period|Adminstative Problems|0
7349220|NCT00941031|11590085|FG000|Induction Period|Adverse Event|1
7349221|NCT00941031|11590086|FG001|Induction Period|Adverse Event|0
7349222|NCT00941031|11590087|FG002|Induction Period|Adverse Event|3
7349223|NCT00941031|11590088|FG003|Induction Period|Adverse Event|2
7349224|NCT00941031|11590089|FG004|Induction Period|Adverse Event|0
7349225|NCT00941031|11590090|FG005|Induction Period|Adverse Event|0
7349226|NCT00941031|11590091|FG006|Induction Period|Adverse Event|0
7349227|NCT00941031|11590085|FG000|Maintenance Period|Withdrawal by Subject|0
7349228|NCT00941031|11590086|FG001|Maintenance Period|Withdrawal by Subject|0
7349229|NCT00941031|11590087|FG002|Maintenance Period|Withdrawal by Subject|0
7349230|NCT00941031|11590088|FG003|Maintenance Period|Withdrawal by Subject|0
7349231|NCT00941031|11590089|FG004|Maintenance Period|Withdrawal by Subject|6
7349232|NCT00941031|11590090|FG005|Maintenance Period|Withdrawal by Subject|2
7349233|NCT00941031|11590091|FG006|Maintenance Period|Withdrawal by Subject|13
7349234|NCT00941031|11590085|FG000|Maintenance Period|Administrative Problems|0
7349235|NCT00941031|11590086|FG001|Maintenance Period|Administrative Problems|0
7349236|NCT00941031|11590087|FG002|Maintenance Period|Administrative Problems|0
7349237|NCT00941031|11590088|FG003|Maintenance Period|Administrative Problems|0
7349238|NCT00941031|11590089|FG004|Maintenance Period|Administrative Problems|1
7349239|NCT00941031|11590090|FG005|Maintenance Period|Administrative Problems|0
7349240|NCT00941031|11590091|FG006|Maintenance Period|Administrative Problems|1
7349241|NCT00941031|11590085|FG000|Maintenance Period|Protocol Violation|0
7349242|NCT00941031|11590086|FG001|Maintenance Period|Protocol Violation|0
7349243|NCT00941031|11590087|FG002|Maintenance Period|Protocol Violation|0
7349244|NCT00941031|11590088|FG003|Maintenance Period|Protocol Violation|0
7349245|NCT00941031|11590089|FG004|Maintenance Period|Protocol Violation|0
7349246|NCT00941031|11590090|FG005|Maintenance Period|Protocol Violation|0
7349247|NCT00941031|11590091|FG006|Maintenance Period|Protocol Violation|1
7349248|NCT00941031|11590085|FG000|Maintenance Period|Adverse Event|0
7349249|NCT00941031|11590086|FG001|Maintenance Period|Adverse Event|0
7349250|NCT00941031|11590087|FG002|Maintenance Period|Adverse Event|0
7349251|NCT00941031|11590088|FG003|Maintenance Period|Adverse Event|0
7349252|NCT00941031|11590089|FG004|Maintenance Period|Adverse Event|0
7349253|NCT00941031|11590090|FG005|Maintenance Period|Adverse Event|2
7349254|NCT00941031|11590091|FG006|Maintenance Period|Adverse Event|8
7349255|NCT00941031|11590085|FG000|Maintenance Period|Lost to Follow-up|0
7349256|NCT00941031|11590086|FG001|Maintenance Period|Lost to Follow-up|0
7349257|NCT00941031|11590087|FG002|Maintenance Period|Lost to Follow-up|0
7349258|NCT00941031|11590088|FG003|Maintenance Period|Lost to Follow-up|0
7349259|NCT00941031|11590089|FG004|Maintenance Period|Lost to Follow-up|2
7349260|NCT00941031|11590090|FG005|Maintenance Period|Lost to Follow-up|2
7349261|NCT00941031|11590091|FG006|Maintenance Period|Lost to Follow-up|7
7349262|NCT00941031|11590085|FG000|Maintenance Period|Lack of Efficacy|0
7349263|NCT00941031|11590086|FG001|Maintenance Period|Lack of Efficacy|0
7349264|NCT00941031|11590087|FG002|Maintenance Period|Lack of Efficacy|0
7349265|NCT00941031|11590088|FG003|Maintenance Period|Lack of Efficacy|0
7349266|NCT00941031|11590089|FG004|Maintenance Period|Lack of Efficacy|0
7349267|NCT00941031|11590090|FG005|Maintenance Period|Lack of Efficacy|0
7349268|NCT00941031|11590091|FG006|Maintenance Period|Lack of Efficacy|13
7349269|NCT00941070|11590110|FG000|Overall Study|Patient non-compliant|1
7349270|NCT00941304|11590121|FG000|Overall Study|Lost to Follow-up|1
7349271|NCT00941304|11590122|FG001|Overall Study|Lost to Follow-up|0
7349272|NCT00941304|11590123|FG002|Overall Study|Lost to Follow-up|0
7349273|NCT00941304|11590124|FG003|Overall Study|Lost to Follow-up|0
7349274|NCT00941304|11590125|FG004|Overall Study|Lost to Follow-up|0
7349275|NCT00941330|11590139|FG000|Overall Study|Other|1
7349276|NCT00941330|11590140|FG001|Overall Study|Other|0
7349277|NCT00941330|11590139|FG000|Overall Study|Physician Decision|0
7349278|NCT00941330|11590140|FG001|Overall Study|Physician Decision|2
7349279|NCT00941603|11590152|FG000|Overall Study|Adverse Event|10
7349280|NCT00941603|11590153|FG001|Overall Study|Adverse Event|15
7349281|NCT00941603|11590154|FG002|Overall Study|Adverse Event|5
7349282|NCT00941603|11590155|FG003|Overall Study|Adverse Event|1
7349283|NCT00941603|11590156|FG004|Overall Study|Adverse Event|4
7349284|NCT00941603|11590157|FG005|Overall Study|Adverse Event|0
7349285|NCT00941603|11590152|FG000|Overall Study|Lost to Follow-up|0
7349286|NCT00941603|11590153|FG001|Overall Study|Lost to Follow-up|0
7349287|NCT00941603|11590154|FG002|Overall Study|Lost to Follow-up|0
7349288|NCT00941603|11590155|FG003|Overall Study|Lost to Follow-up|1
7349289|NCT00941603|11590156|FG004|Overall Study|Lost to Follow-up|0
7349290|NCT00941603|11590157|FG005|Overall Study|Lost to Follow-up|2
7349291|NCT00941603|11590152|FG000|Overall Study|Withdrawal by Subject|0
7349292|NCT00941603|11590153|FG001|Overall Study|Withdrawal by Subject|0
7349293|NCT00941603|11590154|FG002|Overall Study|Withdrawal by Subject|0
7349294|NCT00941603|11590155|FG003|Overall Study|Withdrawal by Subject|2
7349295|NCT00941603|11590156|FG004|Overall Study|Withdrawal by Subject|0
7349296|NCT00941603|11590157|FG005|Overall Study|Withdrawal by Subject|1
7349297|NCT00941603|11590152|FG000|Overall Study|Protocol Violation|0
7349298|NCT00941603|11590153|FG001|Overall Study|Protocol Violation|1
7349299|NCT00941603|11590154|FG002|Overall Study|Protocol Violation|0
7349300|NCT00941603|11590155|FG003|Overall Study|Protocol Violation|0
7349301|NCT00941603|11590156|FG004|Overall Study|Protocol Violation|0
7349302|NCT00941603|11590157|FG005|Overall Study|Protocol Violation|0
7349303|NCT00941603|11590152|FG000|Overall Study|Did not meet protocol eligibility|1
7349304|NCT00941603|11590153|FG001|Overall Study|Did not meet protocol eligibility|0
7349305|NCT00941603|11590154|FG002|Overall Study|Did not meet protocol eligibility|0
7349306|NCT00941603|11590155|FG003|Overall Study|Did not meet protocol eligibility|0
7349307|NCT00941603|11590156|FG004|Overall Study|Did not meet protocol eligibility|0
7349308|NCT00941603|11590157|FG005|Overall Study|Did not meet protocol eligibility|0
7349309|NCT00941655|11590173|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
7349310|NCT00941655|11590174|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
7349311|NCT00941655|11590173|FG000|Overall Study|not meet criteria for chemo foll surgery|4
7349312|NCT00941655|11590174|FG001|Overall Study|not meet criteria for chemo foll surgery|0
7349313|NCT00941655|11590173|FG000|Overall Study|progressed while on chemo|0
7349314|NCT00941655|11590174|FG001|Overall Study|progressed while on chemo|2
7349315|NCT00941655|11590173|FG000|Overall Study|refused further treatment|0
7349316|NCT00941655|11590174|FG001|Overall Study|refused further treatment|1
7349317|NCT00941655|11590173|FG000|Overall Study|withdrew consent|0
7349318|NCT00941655|11590174|FG001|Overall Study|withdrew consent|1
7349319|NCT00941655|11590173|FG000|Overall Study|non-compliant|0
7349320|NCT00941655|11590174|FG001|Overall Study|non-compliant|1
7349321|NCT00941720|11590203|FG000|Overall Study|Withdrawal by Subject|1
7349322|NCT00941720|11590203|FG000|Overall Study|Insurance denied participation|11
7349323|NCT00941720|11590203|FG000|Overall Study|ineligible|2
7349324|NCT00941733|11590209|FG000|Overall Study|Death|24
7349325|NCT00941733|11590210|FG001|Overall Study|Death|10
7349326|NCT00941733|11590209|FG000|Overall Study|Withdrawal by Subject|14
7349327|NCT00941733|11590210|FG001|Overall Study|Withdrawal by Subject|6
7569195|NCT03441984|11945289|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569196|NCT03441984|11945290|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7349328|NCT00941733|11590209|FG000|Overall Study|Adverse Event|20
7349329|NCT00941733|11590210|FG001|Overall Study|Adverse Event|4
7349330|NCT00941733|11590209|FG000|Overall Study|Lost to Follow-up|1
7349331|NCT00941733|11590210|FG001|Overall Study|Lost to Follow-up|2
7349332|NCT00941733|11590209|FG000|Overall Study|Protocol Violation|15
7349333|NCT00941733|11590210|FG001|Overall Study|Protocol Violation|6
7349334|NCT00941798|11590218|FG000|Overall Study|Withdrawal by Subject|72
7349335|NCT00941798|11590219|FG001|Overall Study|Withdrawal by Subject|74
7349336|NCT00941798|11590218|FG000|Overall Study|Adverse Event|43
7349337|NCT00941798|11590219|FG001|Overall Study|Adverse Event|23
7349338|NCT00941798|11590218|FG000|Overall Study|Lost to Follow-up|29
7349339|NCT00941798|11590219|FG001|Overall Study|Lost to Follow-up|23
7349340|NCT00941798|11590218|FG000|Overall Study|Protocol Violation|17
7349341|NCT00941798|11590219|FG001|Overall Study|Protocol Violation|20
7349342|NCT00941798|11590218|FG000|Overall Study|Administrative problems|13
7349343|NCT00941798|11590219|FG001|Overall Study|Administrative problems|23
7349344|NCT00941798|11590218|FG000|Overall Study|Lack of Efficacy|10
7349345|NCT00941798|11590219|FG001|Overall Study|Lack of Efficacy|17
7349346|NCT00941798|11590218|FG000|Overall Study|Patient's inability to use device|6
7349347|NCT00941798|11590219|FG001|Overall Study|Patient's inability to use device|1
7349348|NCT00941798|11590218|FG000|Overall Study|Abnormal test procedure results|3
7349349|NCT00941798|11590219|FG001|Overall Study|Abnormal test procedure results|1
7349350|NCT00941798|11590218|FG000|Overall Study|Abnormal laboratory values|1
7349351|NCT00941798|11590219|FG001|Overall Study|Abnormal laboratory values|2
7349352|NCT00941798|11590218|FG000|Overall Study|Death|0
7349353|NCT00941798|11590219|FG001|Overall Study|Death|1
7349354|NCT00941863|11590230|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
7349355|NCT00941863|11590231|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
7349356|NCT00941863|11590232|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
7349357|NCT00941863|11590233|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
7349358|NCT00941863|11590234|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
7349359|NCT00941863|11590230|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
7349360|NCT00941863|11590231|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
7349361|NCT00941863|11590232|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
7349362|NCT00941863|11590233|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
7349363|NCT00941863|11590234|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
7349364|NCT00941863|11590230|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7349365|NCT00941863|11590231|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7349366|NCT00941863|11590232|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
7349367|NCT00941863|11590233|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
7349368|NCT00941863|11590234|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
7349369|NCT00941863|11590230|FG000|Until Primary Completion Date (PCD)|Death|0
7349370|NCT00941863|11590231|FG001|Until Primary Completion Date (PCD)|Death|0
7349371|NCT00941863|11590232|FG002|Until Primary Completion Date (PCD)|Death|1
7349372|NCT00941863|11590233|FG003|Until Primary Completion Date (PCD)|Death|2
7349373|NCT00941863|11590234|FG004|Until Primary Completion Date (PCD)|Death|7
7349374|NCT00941863|11590230|FG000|Until Primary Completion Date (PCD)|Disease progression|6
7349375|NCT00941863|11590231|FG001|Until Primary Completion Date (PCD)|Disease progression|1
7349376|NCT00941863|11590232|FG002|Until Primary Completion Date (PCD)|Disease progression|8
7349377|NCT00941863|11590233|FG003|Until Primary Completion Date (PCD)|Disease progression|14
7349378|NCT00941863|11590234|FG004|Until Primary Completion Date (PCD)|Disease progression|73
7349379|NCT00941863|11590230|FG000|Continued After PCD|Withdrawal by Subject|0
7349380|NCT00941863|11590231|FG001|Continued After PCD|Withdrawal by Subject|0
7349381|NCT00941863|11590232|FG002|Continued After PCD|Withdrawal by Subject|0
7349382|NCT00941863|11590233|FG003|Continued After PCD|Withdrawal by Subject|0
7349383|NCT00941863|11590234|FG004|Continued After PCD|Withdrawal by Subject|1
7349384|NCT00941863|11590230|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
7349385|NCT00941863|11590231|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
7349386|NCT00941863|11590232|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
7349387|NCT00941863|11590233|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
7349388|NCT00941863|11590234|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
7349389|NCT00942084|11590264|FG000|Overall Study|Death|2
7349390|NCT00942162|11590275|FG000|Overall Study|Death|45
7349391|NCT00942162|11590276|FG001|Overall Study|Death|35
7349392|NCT00942162|11590277|FG002|Overall Study|Death|0
7349393|NCT00942162|11590275|FG000|Overall Study|Withdrawal by Subject|7
7349394|NCT00942162|11590276|FG001|Overall Study|Withdrawal by Subject|2
7349395|NCT00942162|11590277|FG002|Overall Study|Withdrawal by Subject|0
7349396|NCT00942162|11590275|FG000|Overall Study|Lost to Follow-up|4
7349397|NCT00942162|11590276|FG001|Overall Study|Lost to Follow-up|0
7349398|NCT00942162|11590277|FG002|Overall Study|Lost to Follow-up|0
7349399|NCT00942162|11590275|FG000|Overall Study|Other|14
7349400|NCT00942162|11590276|FG001|Overall Study|Other|13
7349401|NCT00942162|11590277|FG002|Overall Study|Other|2
7349402|NCT00942175|11590291|FG000|Overall Study|Adverse Event|2
7349403|NCT00942175|11590292|FG001|Overall Study|Adverse Event|1
7349404|NCT00942175|11590293|FG002|Overall Study|Adverse Event|0
7349405|NCT00942175|11590294|FG003|Overall Study|Adverse Event|0
7349406|NCT00942175|11590291|FG000|Overall Study|Protocol Violation|0
7349407|NCT00942175|11590292|FG001|Overall Study|Protocol Violation|1
7349408|NCT00942175|11590293|FG002|Overall Study|Protocol Violation|2
7349409|NCT00942175|11590294|FG003|Overall Study|Protocol Violation|0
7349410|NCT00942175|11590291|FG000|Overall Study|Pregnancy|0
7349411|NCT00942175|11590292|FG001|Overall Study|Pregnancy|0
7349412|NCT00942175|11590293|FG002|Overall Study|Pregnancy|0
7349413|NCT00942175|11590294|FG003|Overall Study|Pregnancy|1
7349414|NCT00942175|11590291|FG000|Overall Study|Elevated Alanine Amino Transferase|0
7349415|NCT00942175|11590292|FG001|Overall Study|Elevated Alanine Amino Transferase|0
7349416|NCT00942175|11590293|FG002|Overall Study|Elevated Alanine Amino Transferase|0
7349417|NCT00942175|11590294|FG003|Overall Study|Elevated Alanine Amino Transferase|1
7349418|NCT00942175|11590291|FG000|Overall Study|Low Platelet Count|0
7349419|NCT00942175|11590292|FG001|Overall Study|Low Platelet Count|2
7349420|NCT00942175|11590293|FG002|Overall Study|Low Platelet Count|0
7349421|NCT00942175|11590294|FG003|Overall Study|Low Platelet Count|0
7349422|NCT00942188|11590316|FG000|Overall Study|Adverse Event|0
7349423|NCT00942188|11590317|FG001|Overall Study|Adverse Event|3
7349424|NCT00942188|11590318|FG002|Overall Study|Adverse Event|2
7349425|NCT00942188|11590319|FG003|Overall Study|Adverse Event|0
7349426|NCT00942188|11590316|FG000|Overall Study|Lack of Efficacy|0
7349427|NCT00942188|11590317|FG001|Overall Study|Lack of Efficacy|0
7349428|NCT00942188|11590318|FG002|Overall Study|Lack of Efficacy|0
7349429|NCT00942188|11590319|FG003|Overall Study|Lack of Efficacy|1
7349430|NCT00942188|11590316|FG000|Overall Study|Protocol Violation|1
7349431|NCT00942188|11590317|FG001|Overall Study|Protocol Violation|1
7349432|NCT00942188|11590318|FG002|Overall Study|Protocol Violation|0
7349433|NCT00942188|11590319|FG003|Overall Study|Protocol Violation|0
7349434|NCT00942188|11590316|FG000|Overall Study|Lost to Follow-up|2
7349435|NCT00942188|11590317|FG001|Overall Study|Lost to Follow-up|1
7349436|NCT00942188|11590318|FG002|Overall Study|Lost to Follow-up|2
7349437|NCT00942188|11590319|FG003|Overall Study|Lost to Follow-up|0
7349438|NCT00942188|11590316|FG000|Overall Study|Withdrawal by Subject|1
7349439|NCT00942188|11590317|FG001|Overall Study|Withdrawal by Subject|3
7349440|NCT00942188|11590318|FG002|Overall Study|Withdrawal by Subject|4
7349441|NCT00942188|11590319|FG003|Overall Study|Withdrawal by Subject|2
7349442|NCT00942188|11590316|FG000|Overall Study|Physician Decision|0
7349443|NCT00942188|11590317|FG001|Overall Study|Physician Decision|0
7349444|NCT00942188|11590318|FG002|Overall Study|Physician Decision|1
7349445|NCT00942188|11590319|FG003|Overall Study|Physician Decision|0
7349446|NCT00942188|11590316|FG000|Overall Study|Sponsor Decision|0
7349447|NCT00942188|11590317|FG001|Overall Study|Sponsor Decision|2
7349448|NCT00942188|11590318|FG002|Overall Study|Sponsor Decision|0
7349449|NCT00942188|11590319|FG003|Overall Study|Sponsor Decision|1
7349450|NCT00942266|11590331|FG000|Overall Study|Withdrawal by Subject|1
7349451|NCT00942266|11590332|FG001|Overall Study|Withdrawal by Subject|0
7349452|NCT00942266|11590331|FG000|Overall Study|Adverse Event|2
7349453|NCT00942266|11590332|FG001|Overall Study|Adverse Event|1
7349454|NCT00942266|11590331|FG000|Overall Study|Disease Progression|38
7349455|NCT00942266|11590332|FG001|Overall Study|Disease Progression|11
7349456|NCT00942266|11590331|FG000|Overall Study|Failure to thrive and pt withdrawal|0
7349457|NCT00942266|11590332|FG001|Overall Study|Failure to thrive and pt withdrawal|1
7349458|NCT00942266|11590331|FG000|Overall Study|Intercurrent illness|0
7349459|NCT00942266|11590332|FG001|Overall Study|Intercurrent illness|1
7349460|NCT00942266|11590331|FG000|Overall Study|Physician Decision|2
7349461|NCT00942266|11590332|FG001|Overall Study|Physician Decision|0
7349462|NCT00942266|11590331|FG000|Overall Study|medical deterioration (pneumonia)|0
7349463|NCT00942266|11590332|FG001|Overall Study|medical deterioration (pneumonia)|1
7349464|NCT00942357|11590381|FG000|Overall Study|Ineligible|37
7349465|NCT00942357|11590382|FG001|Overall Study|Ineligible|40
7349466|NCT00942422|11590388|FG000|Overall Study|Withdrawal by Subject|1
7349467|NCT00942422|11590388|FG000|Overall Study|Death|1
7349468|NCT00942422|11590388|FG000|Overall Study|Progressive diease|1
7349469|NCT00942604|11590433|FG000|Overall Study|Protocol Violation|1
7533108|NCT02680756|11879200|FG000|Overall Study|Blood transfusion for any reason|0
7533109|NCT02680756|11879201|FG001|Overall Study|Blood transfusion for any reason|1
7533110|NCT02680756|11879200|FG000|Overall Study|Death|1
7533111|NCT02680756|11879201|FG001|Overall Study|Death|0
7533112|NCT02680756|11879200|FG000|Overall Study|Protocol Violation|1
7533113|NCT02680756|11879201|FG001|Overall Study|Protocol Violation|0
7533114|NCT02680756|11879200|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
7533115|NCT02680756|11879201|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
7533116|NCT02680756|11879200|FG000|Overall Study|None of above or not recorded|3
7533117|NCT02680756|11879201|FG001|Overall Study|None of above or not recorded|2
7533118|NCT02680834|11879209|FG000|Overall Study|Physician Decision|5
7533119|NCT02680834|11879210|FG001|Overall Study|Physician Decision|2
7533120|NCT02680834|11879209|FG000|Overall Study|Withdrawal by Subject|6
7349470|NCT00942604|11590434|FG001|Overall Study|Protocol Violation|1
7349471|NCT00942604|11590433|FG000|Overall Study|Adverse Event|0
7349472|NCT00942604|11590434|FG001|Overall Study|Adverse Event|1
7349473|NCT00942604|11590433|FG000|Overall Study|Withdrawal by Subject|0
7349474|NCT00942604|11590434|FG001|Overall Study|Withdrawal by Subject|1
7349475|NCT00942604|11590433|FG000|Overall Study|Patient relocation|1
7349476|NCT00942604|11590434|FG001|Overall Study|Patient relocation|1
7349477|NCT00942708|11590440|FG000|Overall Study|Withdrawal by Subject|1
7349478|NCT00942734|11590445|FG000|Overall Study|Adverse Event|2
7349479|NCT00942734|11590445|FG000|Overall Study|Protocol Violation|3
7349480|NCT00942734|11590445|FG000|Overall Study|Disease Progression|2
7349481|NCT00942734|11590445|FG000|Overall Study|Physician Decision|1
7349482|NCT00942968|11590492|FG000|Overall Study|Adverse Event|60
7349483|NCT00942968|11590492|FG000|Overall Study|Death|76
7349484|NCT00942968|11590492|FG000|Overall Study|Protocol Violation|9
7349485|NCT00942968|11590492|FG000|Overall Study|Lost to Follow-up|4
7349486|NCT00942968|11590492|FG000|Overall Study|Withdrawal by Subject|44
7349487|NCT00942968|11590492|FG000|Overall Study|Sponsor request|5
7349488|NCT00942968|11590492|FG000|Overall Study|Physician Decision|11
7349489|NCT00942968|11590492|FG000|Overall Study|Progression of disease|12
7349490|NCT00942968|11590492|FG000|Overall Study|Inferior vena cava filter placement|4
7349491|NCT00942968|11590492|FG000|Overall Study|Pulmonary embolism (PE)|1
7349492|NCT00942968|11590492|FG000|Overall Study|Participant required pancreatic biopsy|1
7349493|NCT00942968|11590492|FG000|Overall Study|Deep vein thrombosis (DVT)|2
7349494|NCT00942994|11590498|FG000|Overall Study|Adverse Event|7
7349495|NCT00942994|11590499|FG001|Overall Study|Adverse Event|4
7349496|NCT00942994|11590498|FG000|Overall Study|Abnormal laboratory value(s)|1
7349497|NCT00942994|11590499|FG001|Overall Study|Abnormal laboratory value(s)|0
7349498|NCT00942994|11590498|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7349499|NCT00942994|11590499|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7349500|NCT00942994|11590498|FG000|Overall Study|Patient withdrew consent|5
7349501|NCT00942994|11590499|FG001|Overall Study|Patient withdrew consent|8
7349502|NCT00942994|11590498|FG000|Overall Study|Lost to Follow-up|1
7349503|NCT00942994|11590499|FG001|Overall Study|Lost to Follow-up|4
7349504|NCT00942994|11590498|FG000|Overall Study|Protocol deviation|1
7349505|NCT00942994|11590499|FG001|Overall Study|Protocol deviation|2
7349506|NCT00943072|11590507|FG000|Overall Study|Adverse Event|0
7349507|NCT00943072|11590508|FG001|Overall Study|Adverse Event|3
7349508|NCT00943072|11590507|FG000|Overall Study|Death|0
7349509|NCT00943072|11590508|FG001|Overall Study|Death|2
7349510|NCT00943072|11590507|FG000|Overall Study|Withdrawal by Subject|3
7349511|NCT00943072|11590508|FG001|Overall Study|Withdrawal by Subject|1
7349512|NCT00943072|11590507|FG000|Overall Study|Protocol Violation|0
7349513|NCT00943072|11590508|FG001|Overall Study|Protocol Violation|1
7349514|NCT00943072|11590507|FG000|Overall Study|Lost to Follow-up|1
7349515|NCT00943072|11590508|FG001|Overall Study|Lost to Follow-up|2
7349516|NCT00943072|11590507|FG000|Overall Study|Lack of Efficacy|0
7569197|NCT03441984|11945291|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
7569198|NCT03441984|11945292|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569199|NCT03441984|11945293|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569200|NCT03441984|11945294|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7575278|NCT03720847|11958943|FG000|Washout|Physician Decision|1
7349517|NCT00943072|11590508|FG001|Overall Study|Lack of Efficacy|4
7349518|NCT00943072|11590507|FG000|Overall Study|Other|1
7349519|NCT00943072|11590508|FG001|Overall Study|Other|1
7349520|NCT00943111|11590527|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
7349521|NCT00943111|11590528|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
7349522|NCT00943111|11590529|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
7349523|NCT00943111|11590527|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7349524|NCT00943111|11590528|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
7533121|NCT02680834|11879210|FG001|Overall Study|Withdrawal by Subject|0
7533122|NCT02680834|11879209|FG000|Overall Study|Lost to Follow-up|0
7533123|NCT02680834|11879210|FG001|Overall Study|Lost to Follow-up|1
7533124|NCT02680847|11879219|FG000|Overall Study|Other|2
7349525|NCT00943111|11590529|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
7349526|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7349527|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
7349528|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
7349529|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Adverse Event|0
7349530|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Adverse Event|0
7349531|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Adverse Event|9
7349532|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7349533|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
7349534|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
7349535|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Pregnancy|0
7349536|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Pregnancy|0
7349537|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Pregnancy|4
7349538|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
7349539|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
7349540|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
7349541|NCT00943111|11590527|FG000|5 Years Long-term Treatment Period|Other than specified above|0
7349542|NCT00943111|11590528|FG001|5 Years Long-term Treatment Period|Other than specified above|0
7349543|NCT00943111|11590529|FG002|5 Years Long-term Treatment Period|Other than specified above|2
7349544|NCT00943124|11590536|FG000|Period 1|Withdrawal by Subject|1
7349545|NCT00943124|11590537|FG001|Period 1|Withdrawal by Subject|1
7349546|NCT00943124|11590536|FG000|Period 1|Did Not Follow Study Procedures|1
7349547|NCT00943124|11590537|FG001|Period 1|Did Not Follow Study Procedures|0
7349548|NCT00943124|11590536|FG000|Period 1|Personal Reasons|0
7349549|NCT00943124|11590537|FG001|Period 1|Personal Reasons|1
7349550|NCT00943306|11590574|FG000|Overall Study|Physician Decision|1
7349551|NCT00943306|11590574|FG000|Overall Study|Death|1
7349552|NCT00943306|11590574|FG000|Overall Study|Sponsor decision due to non-compliance|1
7349553|NCT00943319|11590578|FG000|Overall Study|Death|1
7349554|NCT00943384|11590582|FG000|Overall Study|Dispositioned prior to treatment|23
7349555|NCT00943384|11590582|FG000|Overall Study|Treated off protocol-protocol violation|5
7349556|NCT00943384|11590582|FG000|Overall Study|Lost to Follow-up|16
7349557|NCT00943384|11590582|FG000|Overall Study|Withdrawal by Subject|5
7349558|NCT00943579|11590606|FG000|Overall Study|Adverse Event|4
7349559|NCT00943579|11590607|FG001|Overall Study|Adverse Event|3
7349560|NCT00943579|11590606|FG000|Overall Study|Lack of Efficacy|2
7349561|NCT00943579|11590607|FG001|Overall Study|Lack of Efficacy|2
7349562|NCT00943592|11590616|FG000|Overall Study|Death|3
7349563|NCT00943670|11590629|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
7349564|NCT00943670|11590629|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
7349565|NCT00943670|11590629|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
7349566|NCT00943670|11590629|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
7349567|NCT00943670|11590629|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
7349568|NCT00943670|11590629|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
7349569|NCT00943670|11590629|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
7349570|NCT00943670|11590629|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
7349571|NCT00943670|11590629|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
7349572|NCT00943670|11590629|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
7349573|NCT00943735|11590644|FG000|Overall Study|Adverse Event|12
7349574|NCT00943735|11590644|FG000|Overall Study|Withdrawal by Subject|8
7349575|NCT00943735|11590644|FG000|Overall Study|Death|1
7349576|NCT00943735|11590644|FG000|Overall Study|Other|8
7349577|NCT00943735|11590644|FG000|Overall Study|Other|3
7349578|NCT00943761|11590650|FG000|Overall Study|Lost to Follow-up|2
7349579|NCT00943761|11590651|FG001|Overall Study|Lost to Follow-up|0
7349580|NCT00943761|11590650|FG000|Overall Study|Withdrawal by Subject|2
7349581|NCT00943761|11590651|FG001|Overall Study|Withdrawal by Subject|1
7349582|NCT00943787|11590657|FG000|Overall Study|Physician Decision|4
7349583|NCT00943787|11590657|FG000|Overall Study|Withdrawal by Subject|3
7349584|NCT00943826|11590667|FG000|Concurrent Phase|Adverse Event|50
7349585|NCT00943826|11590668|FG001|Concurrent Phase|Adverse Event|27
7349586|NCT00943826|11590667|FG000|Concurrent Phase|Withdrew consent|3
7349587|NCT00943826|11590668|FG001|Concurrent Phase|Withdrew consent|7
7349588|NCT00943826|11590667|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
7349589|NCT00943826|11590668|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
7349590|NCT00943826|11590667|FG000|Concurrent Phase|Administrative reasons|2
7349591|NCT00943826|11590668|FG001|Concurrent Phase|Administrative reasons|1
7349592|NCT00943826|11590667|FG000|Concurrent Phase|Protocol Violation|1
7349593|NCT00943826|11590668|FG001|Concurrent Phase|Protocol Violation|0
7349594|NCT00943826|11590667|FG000|Maintenance Phase|Adverse Event|31
7349595|NCT00943826|11590668|FG001|Maintenance Phase|Adverse Event|30
7349596|NCT00943826|11590667|FG000|Maintenance Phase|Withdrew consent|2
7349597|NCT00943826|11590668|FG001|Maintenance Phase|Withdrew consent|4
7349598|NCT00943826|11590667|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
7349599|NCT00943826|11590668|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
7349600|NCT00943826|11590667|FG000|Maintenance Phase|Administrative reasons|4
7349601|NCT00943826|11590668|FG001|Maintenance Phase|Administrative reasons|1
7349602|NCT00943826|11590667|FG000|Maintenance Phase|Failure to return|0
7349603|NCT00943826|11590668|FG001|Maintenance Phase|Failure to return|1
7349604|NCT00943826|11590667|FG000|Monotherapy Phase|Adverse Event|42
7349605|NCT00943826|11590668|FG001|Monotherapy Phase|Adverse Event|5
7349606|NCT00943826|11590667|FG000|Monotherapy Phase|Administrative reasons|11
7349607|NCT00943826|11590668|FG001|Monotherapy Phase|Administrative reasons|5
7349608|NCT00943826|11590667|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
7349609|NCT00943826|11590668|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
7349610|NCT00943826|11590667|FG000|Monotherapy Phase|Withdrew Consent|2
7349611|NCT00943826|11590668|FG001|Monotherapy Phase|Withdrew Consent|3
7349612|NCT00943826|11590667|FG000|Monotherapy Phase|Failure to return|2
7349613|NCT00943826|11590668|FG001|Monotherapy Phase|Failure to return|1
7349614|NCT00943826|11590667|FG000|After Primary Overall Survival Analysis|Adverse Event|11
7349615|NCT00943826|11590668|FG001|After Primary Overall Survival Analysis|Adverse Event|0
7349616|NCT00943826|11590667|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
7349617|NCT00943826|11590668|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
7349618|NCT00943826|11590667|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
7349619|NCT00943826|11590668|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
7349620|NCT00943826|11590667|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
7349621|NCT00943826|11590668|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
7349622|NCT00943917|11590711|FG000|Stage I|Adverse Event|1
7349623|NCT00943917|11590712|FG001|Stage I|Adverse Event|2
7349624|NCT00943917|11590713|FG002|Stage I|Adverse Event|2
7349625|NCT00943917|11590714|FG003|Stage I|Adverse Event|0
7349626|NCT00943917|11590715|FG004|Stage I|Adverse Event|0
7349627|NCT00943917|11590716|FG005|Stage I|Adverse Event|0
7349628|NCT00943917|11590717|FG006|Stage I|Adverse Event|0
7349629|NCT00943917|11590718|FG007|Stage I|Adverse Event|0
7349630|NCT00943917|11590719|FG008|Stage I|Adverse Event|0
7349631|NCT00943917|11590720|FG009|Stage I|Adverse Event|0
7349632|NCT00943917|11590721|FG010|Stage I|Adverse Event|0
7349633|NCT00943917|11590722|FG011|Stage I|Adverse Event|0
7349634|NCT00943917|11590723|FG012|Stage I|Adverse Event|0
7349635|NCT00943917|11590724|FG013|Stage I|Adverse Event|0
7349636|NCT00943917|11590725|FG014|Stage I|Adverse Event|0
7349637|NCT00943917|11590711|FG000|Stage I|Lost to Follow-up|0
7349638|NCT00943917|11590712|FG001|Stage I|Lost to Follow-up|0
7349639|NCT00943917|11590713|FG002|Stage I|Lost to Follow-up|1
7349640|NCT00943917|11590714|FG003|Stage I|Lost to Follow-up|0
7349641|NCT00943917|11590715|FG004|Stage I|Lost to Follow-up|0
7349642|NCT00943917|11590716|FG005|Stage I|Lost to Follow-up|0
7349643|NCT00943917|11590717|FG006|Stage I|Lost to Follow-up|0
7349644|NCT00943917|11590718|FG007|Stage I|Lost to Follow-up|0
7349645|NCT00943917|11590719|FG008|Stage I|Lost to Follow-up|0
7349646|NCT00943917|11590720|FG009|Stage I|Lost to Follow-up|0
7349647|NCT00943917|11590721|FG010|Stage I|Lost to Follow-up|0
7349648|NCT00943917|11590722|FG011|Stage I|Lost to Follow-up|0
7349649|NCT00943917|11590723|FG012|Stage I|Lost to Follow-up|0
7349650|NCT00943917|11590724|FG013|Stage I|Lost to Follow-up|0
7349651|NCT00943917|11590725|FG014|Stage I|Lost to Follow-up|0
7349652|NCT00943917|11590711|FG000|Stage I|hyperglycemia|0
7349653|NCT00943917|11590712|FG001|Stage I|hyperglycemia|0
7349654|NCT00943917|11590713|FG002|Stage I|hyperglycemia|1
7349655|NCT00943917|11590714|FG003|Stage I|hyperglycemia|0
7349656|NCT00943917|11590715|FG004|Stage I|hyperglycemia|0
7349657|NCT00943917|11590716|FG005|Stage I|hyperglycemia|0
7349658|NCT00943917|11590717|FG006|Stage I|hyperglycemia|0
7349659|NCT00943917|11590718|FG007|Stage I|hyperglycemia|0
7349660|NCT00943917|11590719|FG008|Stage I|hyperglycemia|0
7349661|NCT00943917|11590720|FG009|Stage I|hyperglycemia|0
7349662|NCT00943917|11590721|FG010|Stage I|hyperglycemia|0
7349663|NCT00943917|11590722|FG011|Stage I|hyperglycemia|0
7349664|NCT00943917|11590723|FG012|Stage I|hyperglycemia|0
7349665|NCT00943917|11590724|FG013|Stage I|hyperglycemia|0
7349666|NCT00943917|11590725|FG014|Stage I|hyperglycemia|0
7349667|NCT00943917|11590711|FG000|Stage I|A1C elevation|1
7349668|NCT00943917|11590712|FG001|Stage I|A1C elevation|0
7349669|NCT00943917|11590713|FG002|Stage I|A1C elevation|0
7349670|NCT00943917|11590714|FG003|Stage I|A1C elevation|0
7349671|NCT00943917|11590715|FG004|Stage I|A1C elevation|0
7349672|NCT00943917|11590716|FG005|Stage I|A1C elevation|0
7349673|NCT00943917|11590717|FG006|Stage I|A1C elevation|0
7459267|NCT01815840|11753825|FG000|Overall Study|Administrative/Other|1
7349674|NCT00943917|11590718|FG007|Stage I|A1C elevation|0
7349675|NCT00943917|11590719|FG008|Stage I|A1C elevation|0
7349676|NCT00943917|11590720|FG009|Stage I|A1C elevation|0
7349677|NCT00943917|11590721|FG010|Stage I|A1C elevation|0
7349678|NCT00943917|11590722|FG011|Stage I|A1C elevation|0
7349679|NCT00943917|11590723|FG012|Stage I|A1C elevation|0
7349680|NCT00943917|11590724|FG013|Stage I|A1C elevation|0
7349681|NCT00943917|11590725|FG014|Stage I|A1C elevation|0
7349682|NCT00943917|11590711|FG000|Stage I|Withdrawal by Subject|2
7349683|NCT00943917|11590712|FG001|Stage I|Withdrawal by Subject|1
7349684|NCT00943917|11590713|FG002|Stage I|Withdrawal by Subject|2
7349685|NCT00943917|11590714|FG003|Stage I|Withdrawal by Subject|0
7349686|NCT00943917|11590715|FG004|Stage I|Withdrawal by Subject|0
7349687|NCT00943917|11590716|FG005|Stage I|Withdrawal by Subject|0
7349688|NCT00943917|11590717|FG006|Stage I|Withdrawal by Subject|0
7349689|NCT00943917|11590718|FG007|Stage I|Withdrawal by Subject|0
7349690|NCT00943917|11590719|FG008|Stage I|Withdrawal by Subject|0
7349691|NCT00943917|11590720|FG009|Stage I|Withdrawal by Subject|0
7349692|NCT00943917|11590721|FG010|Stage I|Withdrawal by Subject|0
7349693|NCT00943917|11590722|FG011|Stage I|Withdrawal by Subject|0
7349694|NCT00943917|11590723|FG012|Stage I|Withdrawal by Subject|0
7349695|NCT00943917|11590724|FG013|Stage I|Withdrawal by Subject|0
7349696|NCT00943917|11590725|FG014|Stage I|Withdrawal by Subject|0
7349697|NCT00943917|11590711|FG000|Stage II|Adverse Event|0
7349698|NCT00943917|11590712|FG001|Stage II|Adverse Event|0
7349699|NCT00943917|11590713|FG002|Stage II|Adverse Event|0
7349700|NCT00943917|11590714|FG003|Stage II|Adverse Event|0
7349701|NCT00943917|11590715|FG004|Stage II|Adverse Event|0
7349702|NCT00943917|11590716|FG005|Stage II|Adverse Event|1
7349703|NCT00943917|11590717|FG006|Stage II|Adverse Event|3
7349704|NCT00943917|11590718|FG007|Stage II|Adverse Event|0
7349705|NCT00943917|11590719|FG008|Stage II|Adverse Event|1
7349706|NCT00943917|11590720|FG009|Stage II|Adverse Event|0
7349707|NCT00943917|11590721|FG010|Stage II|Adverse Event|0
7349708|NCT00943917|11590722|FG011|Stage II|Adverse Event|0
7349709|NCT00943917|11590723|FG012|Stage II|Adverse Event|0
7349710|NCT00943917|11590724|FG013|Stage II|Adverse Event|0
7349711|NCT00943917|11590725|FG014|Stage II|Adverse Event|0
7349712|NCT00943917|11590711|FG000|Stage II|Withdrawal by Subject|0
7349713|NCT00943917|11590712|FG001|Stage II|Withdrawal by Subject|0
7349714|NCT00943917|11590713|FG002|Stage II|Withdrawal by Subject|0
7349715|NCT00943917|11590714|FG003|Stage II|Withdrawal by Subject|0
7349716|NCT00943917|11590715|FG004|Stage II|Withdrawal by Subject|0
7349717|NCT00943917|11590716|FG005|Stage II|Withdrawal by Subject|1
7349718|NCT00943917|11590717|FG006|Stage II|Withdrawal by Subject|0
7349719|NCT00943917|11590718|FG007|Stage II|Withdrawal by Subject|0
7349720|NCT00943917|11590719|FG008|Stage II|Withdrawal by Subject|0
7349721|NCT00943917|11590720|FG009|Stage II|Withdrawal by Subject|0
7349722|NCT00943917|11590721|FG010|Stage II|Withdrawal by Subject|0
7349723|NCT00943917|11590722|FG011|Stage II|Withdrawal by Subject|0
7349724|NCT00943917|11590723|FG012|Stage II|Withdrawal by Subject|0
7349725|NCT00943917|11590724|FG013|Stage II|Withdrawal by Subject|0
7349726|NCT00943917|11590725|FG014|Stage II|Withdrawal by Subject|0
7349727|NCT00943917|11590711|FG000|Stage II|Pregnancy|0
7349728|NCT00943917|11590712|FG001|Stage II|Pregnancy|0
7349729|NCT00943917|11590713|FG002|Stage II|Pregnancy|0
7349730|NCT00943917|11590714|FG003|Stage II|Pregnancy|0
7349731|NCT00943917|11590715|FG004|Stage II|Pregnancy|0
7349732|NCT00943917|11590716|FG005|Stage II|Pregnancy|1
7349733|NCT00943917|11590717|FG006|Stage II|Pregnancy|0
7349734|NCT00943917|11590718|FG007|Stage II|Pregnancy|0
7349735|NCT00943917|11590719|FG008|Stage II|Pregnancy|0
7349736|NCT00943917|11590720|FG009|Stage II|Pregnancy|0
7349737|NCT00943917|11590721|FG010|Stage II|Pregnancy|0
7349738|NCT00943917|11590722|FG011|Stage II|Pregnancy|0
7349739|NCT00943917|11590723|FG012|Stage II|Pregnancy|0
7349740|NCT00943917|11590724|FG013|Stage II|Pregnancy|0
7349741|NCT00943917|11590725|FG014|Stage II|Pregnancy|0
7349742|NCT00943917|11590711|FG000|Stage II Continuation|Adverse Event|0
7349743|NCT00943917|11590712|FG001|Stage II Continuation|Adverse Event|0
7349744|NCT00943917|11590713|FG002|Stage II Continuation|Adverse Event|0
7349745|NCT00943917|11590714|FG003|Stage II Continuation|Adverse Event|0
7349746|NCT00943917|11590715|FG004|Stage II Continuation|Adverse Event|0
7349747|NCT00943917|11590716|FG005|Stage II Continuation|Adverse Event|0
7349748|NCT00943917|11590717|FG006|Stage II Continuation|Adverse Event|0
7349749|NCT00943917|11590718|FG007|Stage II Continuation|Adverse Event|0
7349750|NCT00943917|11590719|FG008|Stage II Continuation|Adverse Event|0
7349751|NCT00943917|11590720|FG009|Stage II Continuation|Adverse Event|0
7349752|NCT00943917|11590721|FG010|Stage II Continuation|Adverse Event|0
7349753|NCT00943917|11590722|FG011|Stage II Continuation|Adverse Event|1
7349754|NCT00943917|11590723|FG012|Stage II Continuation|Adverse Event|2
7349755|NCT00943917|11590724|FG013|Stage II Continuation|Adverse Event|1
7349756|NCT00943917|11590725|FG014|Stage II Continuation|Adverse Event|1
7349757|NCT00943917|11590711|FG000|Stage II Continuation|Withdrawal by Subject|0
7349758|NCT00943917|11590712|FG001|Stage II Continuation|Withdrawal by Subject|0
7349759|NCT00943917|11590713|FG002|Stage II Continuation|Withdrawal by Subject|0
7349760|NCT00943917|11590714|FG003|Stage II Continuation|Withdrawal by Subject|0
7349761|NCT00943917|11590715|FG004|Stage II Continuation|Withdrawal by Subject|0
7349762|NCT00943917|11590716|FG005|Stage II Continuation|Withdrawal by Subject|0
7459268|NCT01815840|11753826|FG001|Overall Study|Administrative/Other|3
7349763|NCT00943917|11590717|FG006|Stage II Continuation|Withdrawal by Subject|0
7349764|NCT00943917|11590718|FG007|Stage II Continuation|Withdrawal by Subject|0
7349765|NCT00943917|11590719|FG008|Stage II Continuation|Withdrawal by Subject|0
7349766|NCT00943917|11590720|FG009|Stage II Continuation|Withdrawal by Subject|0
7349767|NCT00943917|11590721|FG010|Stage II Continuation|Withdrawal by Subject|0
7349768|NCT00943917|11590722|FG011|Stage II Continuation|Withdrawal by Subject|0
7349769|NCT00943917|11590723|FG012|Stage II Continuation|Withdrawal by Subject|0
7349770|NCT00943917|11590724|FG013|Stage II Continuation|Withdrawal by Subject|1
7349771|NCT00943917|11590725|FG014|Stage II Continuation|Withdrawal by Subject|3
7349772|NCT00943917|11590711|FG000|Stage II Continuation|Protocol Violation|0
7349773|NCT00943917|11590712|FG001|Stage II Continuation|Protocol Violation|0
7349774|NCT00943917|11590713|FG002|Stage II Continuation|Protocol Violation|0
7349775|NCT00943917|11590714|FG003|Stage II Continuation|Protocol Violation|0
7349776|NCT00943917|11590715|FG004|Stage II Continuation|Protocol Violation|0
7349777|NCT00943917|11590716|FG005|Stage II Continuation|Protocol Violation|0
7349778|NCT00943917|11590717|FG006|Stage II Continuation|Protocol Violation|0
7349779|NCT00943917|11590718|FG007|Stage II Continuation|Protocol Violation|0
7349780|NCT00943917|11590719|FG008|Stage II Continuation|Protocol Violation|0
7349781|NCT00943917|11590720|FG009|Stage II Continuation|Protocol Violation|1
7349782|NCT00943917|11590721|FG010|Stage II Continuation|Protocol Violation|0
7349783|NCT00943917|11590722|FG011|Stage II Continuation|Protocol Violation|1
7349784|NCT00943917|11590723|FG012|Stage II Continuation|Protocol Violation|0
7349785|NCT00943917|11590724|FG013|Stage II Continuation|Protocol Violation|0
7349786|NCT00943917|11590725|FG014|Stage II Continuation|Protocol Violation|0
7349787|NCT00943917|11590711|FG000|Stage II Continuation|hypoglycemia|0
7349788|NCT00943917|11590712|FG001|Stage II Continuation|hypoglycemia|0
7349789|NCT00943917|11590713|FG002|Stage II Continuation|hypoglycemia|0
7349790|NCT00943917|11590714|FG003|Stage II Continuation|hypoglycemia|0
7349791|NCT00943917|11590715|FG004|Stage II Continuation|hypoglycemia|0
7349792|NCT00943917|11590716|FG005|Stage II Continuation|hypoglycemia|0
7349793|NCT00943917|11590717|FG006|Stage II Continuation|hypoglycemia|0
7349794|NCT00943917|11590718|FG007|Stage II Continuation|hypoglycemia|0
7349795|NCT00943917|11590719|FG008|Stage II Continuation|hypoglycemia|0
7349796|NCT00943917|11590720|FG009|Stage II Continuation|hypoglycemia|0
7349797|NCT00943917|11590721|FG010|Stage II Continuation|hypoglycemia|0
7349798|NCT00943917|11590722|FG011|Stage II Continuation|hypoglycemia|0
7349799|NCT00943917|11590723|FG012|Stage II Continuation|hypoglycemia|1
7349800|NCT00943917|11590724|FG013|Stage II Continuation|hypoglycemia|0
7349801|NCT00943917|11590725|FG014|Stage II Continuation|hypoglycemia|0
7349802|NCT00943917|11590711|FG000|Stage II Continuation|A1C elevation|0
7349803|NCT00943917|11590712|FG001|Stage II Continuation|A1C elevation|0
7349804|NCT00943917|11590713|FG002|Stage II Continuation|A1C elevation|0
7349805|NCT00943917|11590714|FG003|Stage II Continuation|A1C elevation|0
7349806|NCT00943917|11590715|FG004|Stage II Continuation|A1C elevation|0
7349807|NCT00943917|11590716|FG005|Stage II Continuation|A1C elevation|0
7349808|NCT00943917|11590717|FG006|Stage II Continuation|A1C elevation|0
7349809|NCT00943917|11590718|FG007|Stage II Continuation|A1C elevation|0
7349810|NCT00943917|11590719|FG008|Stage II Continuation|A1C elevation|0
7349811|NCT00943917|11590720|FG009|Stage II Continuation|A1C elevation|0
7349812|NCT00943917|11590721|FG010|Stage II Continuation|A1C elevation|0
7349813|NCT00943917|11590722|FG011|Stage II Continuation|A1C elevation|0
7349814|NCT00943917|11590723|FG012|Stage II Continuation|A1C elevation|0
7349815|NCT00943917|11590724|FG013|Stage II Continuation|A1C elevation|1
7349816|NCT00943917|11590725|FG014|Stage II Continuation|A1C elevation|0
7349817|NCT00944034|11590791|FG000|Overall Study|Inappropriate enrollment|0
7349818|NCT00944034|11590792|FG001|Overall Study|Inappropriate enrollment|1
7349819|NCT00944034|11590793|FG002|Overall Study|Inappropriate enrollment|0
7349820|NCT00944034|11590794|FG003|Overall Study|Inappropriate enrollment|1
7349821|NCT00944034|11590795|FG004|Overall Study|Inappropriate enrollment|2
7349822|NCT00944034|11590796|FG005|Overall Study|Inappropriate enrollment|1
7349823|NCT00944034|11590797|FG006|Overall Study|Inappropriate enrollment|0
7349824|NCT00944034|11590798|FG007|Overall Study|Inappropriate enrollment|0
7349825|NCT00944034|11590799|FG008|Overall Study|Inappropriate enrollment|1
7349826|NCT00944034|11590800|FG009|Overall Study|Inappropriate enrollment|1
7349827|NCT00944034|11590801|FG010|Overall Study|Inappropriate enrollment|0
7349828|NCT00944034|11590802|FG011|Overall Study|Inappropriate enrollment|0
7349829|NCT00944034|11590791|FG000|Overall Study|Withdrawal by Subject|3
7349830|NCT00944034|11590792|FG001|Overall Study|Withdrawal by Subject|2
7349831|NCT00944034|11590793|FG002|Overall Study|Withdrawal by Subject|6
7349832|NCT00944034|11590794|FG003|Overall Study|Withdrawal by Subject|2
7349833|NCT00944034|11590795|FG004|Overall Study|Withdrawal by Subject|5
7349834|NCT00944034|11590796|FG005|Overall Study|Withdrawal by Subject|8
7349835|NCT00944034|11590797|FG006|Overall Study|Withdrawal by Subject|2
7349836|NCT00944034|11590798|FG007|Overall Study|Withdrawal by Subject|2
7349837|NCT00944034|11590799|FG008|Overall Study|Withdrawal by Subject|3
7349838|NCT00944034|11590800|FG009|Overall Study|Withdrawal by Subject|4
7349839|NCT00944034|11590801|FG010|Overall Study|Withdrawal by Subject|0
7349840|NCT00944034|11590802|FG011|Overall Study|Withdrawal by Subject|4
7349841|NCT00944034|11590791|FG000|Overall Study|Lost to Follow-up|0
7349842|NCT00944034|11590792|FG001|Overall Study|Lost to Follow-up|4
7349843|NCT00944034|11590793|FG002|Overall Study|Lost to Follow-up|2
7349844|NCT00944034|11590794|FG003|Overall Study|Lost to Follow-up|0
7349845|NCT00944034|11590795|FG004|Overall Study|Lost to Follow-up|5
7349846|NCT00944034|11590796|FG005|Overall Study|Lost to Follow-up|7
7349847|NCT00944034|11590797|FG006|Overall Study|Lost to Follow-up|0
7349848|NCT00944034|11590798|FG007|Overall Study|Lost to Follow-up|1
7349849|NCT00944034|11590799|FG008|Overall Study|Lost to Follow-up|5
7349850|NCT00944034|11590800|FG009|Overall Study|Lost to Follow-up|1
7349851|NCT00944034|11590801|FG010|Overall Study|Lost to Follow-up|1
7349852|NCT00944034|11590802|FG011|Overall Study|Lost to Follow-up|0
7349853|NCT00944034|11590791|FG000|Overall Study|Death|0
7349854|NCT00944034|11590792|FG001|Overall Study|Death|0
7349855|NCT00944034|11590793|FG002|Overall Study|Death|1
7349856|NCT00944034|11590794|FG003|Overall Study|Death|0
7349857|NCT00944034|11590795|FG004|Overall Study|Death|0
7349858|NCT00944034|11590796|FG005|Overall Study|Death|0
7349859|NCT00944034|11590797|FG006|Overall Study|Death|0
7349860|NCT00944034|11590798|FG007|Overall Study|Death|0
7349861|NCT00944034|11590799|FG008|Overall Study|Death|0
7349862|NCT00944034|11590800|FG009|Overall Study|Death|0
7349863|NCT00944034|11590801|FG010|Overall Study|Death|0
7349864|NCT00944034|11590802|FG011|Overall Study|Death|0
7349865|NCT00944034|11590791|FG000|Overall Study|Protocol Violation|2
7349866|NCT00944034|11590792|FG001|Overall Study|Protocol Violation|0
7349867|NCT00944034|11590793|FG002|Overall Study|Protocol Violation|0
7349868|NCT00944034|11590794|FG003|Overall Study|Protocol Violation|1
7349869|NCT00944034|11590795|FG004|Overall Study|Protocol Violation|2
7349870|NCT00944034|11590796|FG005|Overall Study|Protocol Violation|3
7349871|NCT00944034|11590797|FG006|Overall Study|Protocol Violation|0
7349872|NCT00944034|11590798|FG007|Overall Study|Protocol Violation|1
7349873|NCT00944034|11590799|FG008|Overall Study|Protocol Violation|1
7349874|NCT00944034|11590800|FG009|Overall Study|Protocol Violation|4
7349875|NCT00944034|11590801|FG010|Overall Study|Protocol Violation|0
7349876|NCT00944034|11590802|FG011|Overall Study|Protocol Violation|0
7349877|NCT00944034|11590791|FG000|Overall Study|Unable to classify|0
7349878|NCT00944034|11590792|FG001|Overall Study|Unable to classify|0
7349879|NCT00944034|11590793|FG002|Overall Study|Unable to classify|0
7349880|NCT00944034|11590794|FG003|Overall Study|Unable to classify|0
7349881|NCT00944034|11590795|FG004|Overall Study|Unable to classify|0
7349882|NCT00944034|11590796|FG005|Overall Study|Unable to classify|1
7349883|NCT00944034|11590797|FG006|Overall Study|Unable to classify|1
7349884|NCT00944034|11590798|FG007|Overall Study|Unable to classify|1
7349885|NCT00944034|11590799|FG008|Overall Study|Unable to classify|0
7349886|NCT00944034|11590800|FG009|Overall Study|Unable to classify|0
7349887|NCT00944034|11590801|FG010|Overall Study|Unable to classify|0
7349888|NCT00944034|11590802|FG011|Overall Study|Unable to classify|0
7349889|NCT00944034|11590791|FG000|Overall Study|Administrative reason|0
7349890|NCT00944034|11590792|FG001|Overall Study|Administrative reason|0
7349891|NCT00944034|11590793|FG002|Overall Study|Administrative reason|0
7349892|NCT00944034|11590794|FG003|Overall Study|Administrative reason|0
7349893|NCT00944034|11590795|FG004|Overall Study|Administrative reason|0
7349894|NCT00944034|11590796|FG005|Overall Study|Administrative reason|0
7349895|NCT00944034|11590797|FG006|Overall Study|Administrative reason|1
7349896|NCT00944034|11590798|FG007|Overall Study|Administrative reason|0
7349897|NCT00944034|11590799|FG008|Overall Study|Administrative reason|0
7349898|NCT00944034|11590800|FG009|Overall Study|Administrative reason|0
7349899|NCT00944034|11590801|FG010|Overall Study|Administrative reason|0
7349900|NCT00944034|11590802|FG011|Overall Study|Administrative reason|0
7349901|NCT00944125|11590858|FG000|3 to 6 Months|Withdrawal by Subject|0
7349902|NCT00944125|11590859|FG001|3 to 6 Months|Withdrawal by Subject|2
7349903|NCT00944125|11590858|FG000|6 Months to Study Completion|Withdrawal by Subject|0
7349904|NCT00944125|11590859|FG001|6 Months to Study Completion|Withdrawal by Subject|2
7349905|NCT00944645|11590881|FG000|Period 2|Adverse Event|1
7349906|NCT00944645|11590882|FG001|Period 2|Adverse Event|0
7349907|NCT00944645|11590881|FG000|Period 2|Lost to Follow-up|0
7349908|NCT00944645|11590882|FG001|Period 2|Lost to Follow-up|3
7349909|NCT00944645|11590881|FG000|Period 2|Withdrawal by Subject|7
7349910|NCT00944645|11590882|FG001|Period 2|Withdrawal by Subject|6
7349911|NCT00944658|11590890|FG000|Treatment 12 Weeks|Adverse Event|0
7349912|NCT00944658|11590891|FG001|Treatment 12 Weeks|Adverse Event|2
7349913|NCT00944697|11590918|FG000|Overall Study|Withdrawal by Subject|1
7349914|NCT00944697|11590919|FG001|Overall Study|Withdrawal by Subject|1
7349915|NCT00944697|11590918|FG000|Overall Study|Adverse Event|0
7349916|NCT00944697|11590919|FG001|Overall Study|Adverse Event|3
7349917|NCT00944697|11590918|FG000|Overall Study|Administrative|1
7349918|NCT00944697|11590919|FG001|Overall Study|Administrative|1
7349919|NCT00945191|11590970|FG000|Overall Study|Did not achieve a complete response|18
7349920|NCT00945191|11590970|FG000|Overall Study|Participant relocated to another state|1
7349921|NCT00945191|11590970|FG000|Overall Study|Disease progression|3
7349922|NCT00945191|11590970|FG000|Overall Study|Serious adverse event or adverse event|1
7349923|NCT00945191|11590970|FG000|Overall Study|Investigator's discretion|1
7349924|NCT00945243|11590974|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
7349925|NCT00945321|11591025|FG000|Period 1|Adverse Event|0
7349926|NCT00945321|11591026|FG001|Period 1|Adverse Event|0
7349927|NCT00945321|11591027|FG002|Period 1|Adverse Event|0
7349928|NCT00945321|11591028|FG003|Period 1|Adverse Event|0
7459269|NCT01815840|11753825|FG000|Overall Study|Adverse Event|10
7349929|NCT00945321|11591029|FG004|Period 1|Adverse Event|1
7349930|NCT00945321|11591030|FG005|Period 1|Adverse Event|0
7349931|NCT00945321|11591025|FG000|Period 4|Lost to Follow-up|0
7349932|NCT00945321|11591026|FG001|Period 4|Lost to Follow-up|0
7349933|NCT00945321|11591027|FG002|Period 4|Lost to Follow-up|0
7349934|NCT00945321|11591028|FG003|Period 4|Lost to Follow-up|0
7349935|NCT00945321|11591029|FG004|Period 4|Lost to Follow-up|0
7349936|NCT00945321|11591030|FG005|Period 4|Lost to Follow-up|1
7349937|NCT00945477|11591057|FG000|Overall Study|Adverse Event|3
7349938|NCT00945477|11591057|FG000|Overall Study|Lack of Efficacy|2
7349939|NCT00945477|11591057|FG000|Overall Study|Withdrawal by Subject|1
7349940|NCT00945555|11591062|FG000|Overall Study|Referred to another hospital|5
7349941|NCT00945555|11591062|FG000|Overall Study|Worsening condition, intensive care unit|1
7349942|NCT00945555|11591062|FG000|Overall Study|Withdrawal by Subject|2
7349943|NCT00945555|11591062|FG000|Overall Study|Participant continued treatment at home|1
7349944|NCT00945555|11591062|FG000|Overall Study|Death|18
7349945|NCT00945555|11591062|FG000|Overall Study|Other|1
7349946|NCT00945659|11591080|FG000|Overall Study|Lost to Follow-up|7
7349947|NCT00945659|11591081|FG001|Overall Study|Lost to Follow-up|20
7349948|NCT00945659|11591082|FG002|Overall Study|Lost to Follow-up|17
7349949|NCT00945815|11591109|FG000|Overall Study|Death|3
7349950|NCT00945815|11591109|FG000|Overall Study|Not protocol specified|1
7349951|NCT00945815|11591109|FG000|Overall Study|Ineligible|3
7349952|NCT00945815|11591109|FG000|Overall Study|Did not begin protocol therapy|1
7349953|NCT00945893|11591124|FG000|Overall Study|Lost to Follow-up|2
7349954|NCT00945893|11591125|FG001|Overall Study|Lost to Follow-up|8
7349955|NCT00945893|11591124|FG000|Overall Study|Withdrawal of consent|1
7349956|NCT00945893|11591125|FG001|Overall Study|Withdrawal of consent|2
7349957|NCT00945906|11591135|FG000|Overall Study|Withdrawal by Subject|1
7349958|NCT00945906|11591135|FG000|Overall Study|Did not want to return for last visit|2
7349959|NCT00945906|11591135|FG000|Overall Study|Unable to return for last visit|2
7349960|NCT00945906|11591135|FG000|Overall Study|Moved to another country|2
7349961|NCT00945945|11591141|FG000|Overall Study|Adverse Event|15
7349962|NCT00945945|11591142|FG001|Overall Study|Adverse Event|35
7349963|NCT00945945|11591141|FG000|Overall Study|Withdrawal by Subject|7
7349964|NCT00945945|11591142|FG001|Overall Study|Withdrawal by Subject|10
7349965|NCT00945945|11591141|FG000|Overall Study|Lost to Follow-up|4
7349966|NCT00945945|11591142|FG001|Overall Study|Lost to Follow-up|5
7349967|NCT00945945|11591141|FG000|Overall Study|Lack of Efficacy|6
7349968|NCT00945945|11591142|FG001|Overall Study|Lack of Efficacy|2
7349969|NCT00945945|11591141|FG000|Overall Study|Protocol Violation|4
7349970|NCT00945945|11591142|FG001|Overall Study|Protocol Violation|2
7349971|NCT00945945|11591141|FG000|Overall Study|Entry Criteria Not Met|0
7349972|NCT00945945|11591142|FG001|Overall Study|Entry Criteria Not Met|1
7349973|NCT00946088|11591159|FG000|Overall Study|Withdrawal by Subject|0
7349974|NCT00946088|11591160|FG001|Overall Study|Withdrawal by Subject|1
7349975|NCT00946101|11591170|FG000|Overall Study|Lost to Follow-up|2
7349976|NCT00946101|11591171|FG001|Overall Study|Lost to Follow-up|1
7349977|NCT00946101|11591170|FG000|Overall Study|Withdrawal of consent|2
7349978|NCT00946101|11591171|FG001|Overall Study|Withdrawal of consent|0
7349979|NCT00946101|11591170|FG000|Overall Study|Physician Decision|0
7349980|NCT00946101|11591171|FG001|Overall Study|Physician Decision|1
7349981|NCT00946114|11591183|FG000|Overall Study|Death|5
7349982|NCT00946114|11591184|FG001|Overall Study|Death|2
7349983|NCT00946114|11591183|FG000|Overall Study|Other|1
7349984|NCT00946114|11591184|FG001|Overall Study|Other|0
7349985|NCT00946114|11591183|FG000|Overall Study|Withdrawal by Subject|2
7349986|NCT00946114|11591184|FG001|Overall Study|Withdrawal by Subject|0
7349987|NCT00946153|11591195|FG000|Phase 2|Adverse Event|0
7349988|NCT00946153|11591196|FG001|Phase 2|Adverse Event|0
7349989|NCT00946153|11591197|FG002|Phase 2|Adverse Event|0
7349990|NCT00946153|11591198|FG003|Phase 2|Adverse Event|0
7349991|NCT00946153|11591199|FG004|Phase 2|Adverse Event|6
7349992|NCT00946153|11591195|FG000|Phase 2|Need more reduction of dose|0
7349993|NCT00946153|11591196|FG001|Phase 2|Need more reduction of dose|0
7349994|NCT00946153|11591197|FG002|Phase 2|Need more reduction of dose|0
7349995|NCT00946153|11591198|FG003|Phase 2|Need more reduction of dose|0
7349996|NCT00946153|11591199|FG004|Phase 2|Need more reduction of dose|2
7349997|NCT00946153|11591195|FG000|Phase 2|Physician Decision|0
7349998|NCT00946153|11591196|FG001|Phase 2|Physician Decision|0
7349999|NCT00946153|11591197|FG002|Phase 2|Physician Decision|0
7350000|NCT00946153|11591198|FG003|Phase 2|Physician Decision|0
7350001|NCT00946153|11591199|FG004|Phase 2|Physician Decision|1
7350002|NCT00946153|11591195|FG000|Phase 2|14 days washout for recovery due to AE|0
7350003|NCT00946153|11591196|FG001|Phase 2|14 days washout for recovery due to AE|0
7350004|NCT00946153|11591197|FG002|Phase 2|14 days washout for recovery due to AE|0
7350005|NCT00946153|11591198|FG003|Phase 2|14 days washout for recovery due to AE|0
7350006|NCT00946153|11591199|FG004|Phase 2|14 days washout for recovery due to AE|4
7350007|NCT00946192|11591219|FG000|Overall Study|Lost to Follow-up|6
7350008|NCT00946192|11591220|FG001|Overall Study|Lost to Follow-up|11
7350009|NCT00946192|11591221|FG002|Overall Study|Lost to Follow-up|9
7350010|NCT00946192|11591219|FG000|Overall Study|Withdrawal by Subject|10
7350011|NCT00946192|11591220|FG001|Overall Study|Withdrawal by Subject|7
7350012|NCT00946192|11591221|FG002|Overall Study|Withdrawal by Subject|3
7350013|NCT00946192|11591219|FG000|Overall Study|Did not start medication|2
7350014|NCT00946192|11591220|FG001|Overall Study|Did not start medication|0
7350015|NCT00946192|11591221|FG002|Overall Study|Did not start medication|0
7386024|NCT01207440|11644241|FG004|Overall Study|Death|7
7386025|NCT01207440|11644242|FG005|Overall Study|Death|5
7386026|NCT01207440|11644243|FG006|Overall Study|Death|1
7386027|NCT01207440|11644237|FG000|Overall Study|Lack of Efficacy|13
7386028|NCT01207440|11644238|FG001|Overall Study|Lack of Efficacy|2
7386029|NCT01207440|11644239|FG002|Overall Study|Lack of Efficacy|5
7350016|NCT00946296|11591244|FG000|Overall Study|Physician Decision|3
7350017|NCT00946296|11591245|FG001|Overall Study|Physician Decision|0
7350018|NCT00946309|11591253|FG000|Overall Study|Protocol Violation|1
7350019|NCT00946309|11591254|FG001|Overall Study|Protocol Violation|0
7350020|NCT00946309|11591253|FG000|Overall Study|Lost to Follow-up|0
7350021|NCT00946309|11591254|FG001|Overall Study|Lost to Follow-up|1
7350022|NCT00946309|11591253|FG000|Overall Study|Procedure cancelled/discontinued|0
7350023|NCT00946309|11591254|FG001|Overall Study|Procedure cancelled/discontinued|3
7350024|NCT00946322|11591261|FG000|Pre-treatment|participant failure to follow up|1
7350025|NCT00946322|11591261|FG000|Post-treatment|participant failure to follow up|2
7350026|NCT00946530|11591287|FG000|Overall Study|Withdrawal by Subject|0
7350027|NCT00946530|11591288|FG001|Overall Study|Withdrawal by Subject|3
7350028|NCT00946530|11591289|FG002|Overall Study|Withdrawal by Subject|0
7350029|NCT00946530|11591290|FG003|Overall Study|Withdrawal by Subject|3
7350030|NCT00946530|11591287|FG000|Overall Study|Physician Decision|1
7350031|NCT00946530|11591288|FG001|Overall Study|Physician Decision|1
7350032|NCT00946530|11591289|FG002|Overall Study|Physician Decision|1
7350033|NCT00946530|11591290|FG003|Overall Study|Physician Decision|1
7350034|NCT00946647|11591309|FG000|Phase 1 Part|Adverse Event|2
7350035|NCT00946647|11591310|FG001|Phase 1 Part|Adverse Event|5
7350036|NCT00946647|11591311|FG002|Phase 1 Part|Adverse Event|3
7350037|NCT00946647|11591312|FG003|Phase 1 Part|Adverse Event|0
7350038|NCT00946647|11591313|FG004|Phase 1 Part|Adverse Event|0
7350039|NCT00946647|11591309|FG000|Phase 1 Part|Disease progression|3
7350040|NCT00946647|11591310|FG001|Phase 1 Part|Disease progression|6
7459270|NCT01815840|11753826|FG001|Overall Study|Adverse Event|16
7459271|NCT01815840|11753825|FG000|Overall Study|Death|2
7459272|NCT01815840|11753826|FG001|Overall Study|Death|2
7459273|NCT01815840|11753825|FG000|Overall Study|Disease progression|3
7459274|NCT01815840|11753826|FG001|Overall Study|Disease progression|2
7459275|NCT01815840|11753825|FG000|Overall Study|Investigators Decision|2
7459276|NCT01815840|11753826|FG001|Overall Study|Investigators Decision|3
7459277|NCT01815840|11753825|FG000|Overall Study|Lost to Follow-up|3
7459278|NCT01815840|11753826|FG001|Overall Study|Lost to Follow-up|6
7459279|NCT01815840|11753825|FG000|Overall Study|Refused Treatment|5
7459280|NCT01815840|11753826|FG001|Overall Study|Refused Treatment|1
7459281|NCT01815840|11753825|FG000|Overall Study|Sponsor Termination Treatment|1
7459282|NCT01815840|11753826|FG001|Overall Study|Sponsor Termination Treatment|0
7459283|NCT01815918|11753834|FG000|Overall Study|Patient samples not analyzable|3
7459284|NCT01815918|11753835|FG001|Overall Study|Patient samples not analyzable|4
7459285|NCT01815918|11753834|FG000|Overall Study|Lack of Efficacy|15
7459286|NCT01815918|11753835|FG001|Overall Study|Lack of Efficacy|15
7459287|NCT01816048|11753845|FG000|Overall Study|Adverse Event|1
7459288|NCT01816048|11753845|FG000|Overall Study|Death|1
7459289|NCT01816048|11753845|FG000|Overall Study|Withdrawal by Subject|1
7459290|NCT01816048|11753845|FG000|Overall Study|Disease Progression|3
7459291|NCT01816061|11753852|FG000|Overall Study|Lost to Follow-up|13
7459292|NCT01816061|11753853|FG001|Overall Study|Lost to Follow-up|24
7459293|NCT01816074|11753863|FG000|Phase 1|Time commitment issues|0
7459294|NCT01816074|11753864|FG001|Phase 1|Time commitment issues|0
7459295|NCT01816074|11753865|FG002|Phase 1|Time commitment issues|1
7459296|NCT01816074|11753866|FG003|Phase 1|Time commitment issues|0
7569201|NCT03441984|11945295|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569202|NCT03441984|11945296|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569203|NCT03441984|11945297|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7459297|NCT01816074|11753863|FG000|Phase 2|Time commitment Issues|0
7459298|NCT01816074|11753864|FG001|Phase 2|Time commitment Issues|2
7459299|NCT01816074|11753865|FG002|Phase 2|Time commitment Issues|0
7459300|NCT01816074|11753866|FG003|Phase 2|Time commitment Issues|0
7459301|NCT01816074|11753863|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
7459302|NCT01816074|11753864|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
7459303|NCT01816074|11753865|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
7459304|NCT01816074|11753866|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
7459305|NCT01816074|11753863|FG000|Phase 2|Physician Decision|0
7459306|NCT01816074|11753864|FG001|Phase 2|Physician Decision|0
7459307|NCT01816074|11753865|FG002|Phase 2|Physician Decision|0
7459308|NCT01816074|11753866|FG003|Phase 2|Physician Decision|1
7459309|NCT01816074|11753863|FG000|Phase 2|Withdrawal by Subject|1
7459310|NCT01816074|11753864|FG001|Phase 2|Withdrawal by Subject|0
7459311|NCT01816074|11753865|FG002|Phase 2|Withdrawal by Subject|0
7459312|NCT01816074|11753866|FG003|Phase 2|Withdrawal by Subject|0
7459313|NCT01816243|11753894|FG000|Overall Study|Adverse Event|6
7459314|NCT01816243|11753894|FG000|Overall Study|Lost to Follow-up|1
7459315|NCT01816243|11753894|FG000|Overall Study|Lack of Efficacy|1
7459316|NCT01816243|11753894|FG000|Overall Study|Not eligible for the study|1
7569204|NCT03441984|11945298|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7350041|NCT00946647|11591311|FG002|Phase 1 Part|Disease progression|1
7350042|NCT00946647|11591312|FG003|Phase 1 Part|Disease progression|0
7350043|NCT00946647|11591313|FG004|Phase 1 Part|Disease progression|0
7350044|NCT00946647|11591309|FG000|Phase 1 Part|Withdrawal by Subject|1
7350045|NCT00946647|11591310|FG001|Phase 1 Part|Withdrawal by Subject|4
7350046|NCT00946647|11591311|FG002|Phase 1 Part|Withdrawal by Subject|3
7350047|NCT00946647|11591312|FG003|Phase 1 Part|Withdrawal by Subject|0
7350048|NCT00946647|11591313|FG004|Phase 1 Part|Withdrawal by Subject|0
7350049|NCT00946647|11591309|FG000|Phase 1 Part|Abnormal values|0
7350050|NCT00946647|11591310|FG001|Phase 1 Part|Abnormal values|2
7350051|NCT00946647|11591311|FG002|Phase 1 Part|Abnormal values|0
7350052|NCT00946647|11591312|FG003|Phase 1 Part|Abnormal values|0
7350053|NCT00946647|11591313|FG004|Phase 1 Part|Abnormal values|0
7350054|NCT00946647|11591309|FG000|Phase 1 Part|Reason missing|0
7350055|NCT00946647|11591310|FG001|Phase 1 Part|Reason missing|1
7350056|NCT00946647|11591311|FG002|Phase 1 Part|Reason missing|0
7350057|NCT00946647|11591312|FG003|Phase 1 Part|Reason missing|0
7350058|NCT00946647|11591313|FG004|Phase 1 Part|Reason missing|0
7350059|NCT00946647|11591309|FG000|Phase ll Part|Untreated|0
7350060|NCT00946647|11591310|FG001|Phase ll Part|Untreated|0
7350061|NCT00946647|11591311|FG002|Phase ll Part|Untreated|0
7350062|NCT00946647|11591312|FG003|Phase ll Part|Untreated|0
7350063|NCT00946647|11591313|FG004|Phase ll Part|Untreated|2
7350064|NCT00946647|11591309|FG000|Phase ll Part|Adverse Event|0
7350065|NCT00946647|11591310|FG001|Phase ll Part|Adverse Event|0
7350066|NCT00946647|11591311|FG002|Phase ll Part|Adverse Event|0
7350067|NCT00946647|11591312|FG003|Phase ll Part|Adverse Event|10
7350068|NCT00946647|11591313|FG004|Phase ll Part|Adverse Event|6
7350069|NCT00946647|11591309|FG000|Phase ll Part|Withdrawal by Subject|0
7350070|NCT00946647|11591310|FG001|Phase ll Part|Withdrawal by Subject|0
7350071|NCT00946647|11591311|FG002|Phase ll Part|Withdrawal by Subject|0
7350072|NCT00946647|11591312|FG003|Phase ll Part|Withdrawal by Subject|8
7350073|NCT00946647|11591313|FG004|Phase ll Part|Withdrawal by Subject|6
7350074|NCT00946647|11591309|FG000|Phase ll Part|Administrative problems|0
7350075|NCT00946647|11591310|FG001|Phase ll Part|Administrative problems|0
7350076|NCT00946647|11591311|FG002|Phase ll Part|Administrative problems|0
7350077|NCT00946647|11591312|FG003|Phase ll Part|Administrative problems|3
7350078|NCT00946647|11591313|FG004|Phase ll Part|Administrative problems|8
7350079|NCT00946647|11591309|FG000|Phase ll Part|Death|0
7350080|NCT00946647|11591310|FG001|Phase ll Part|Death|0
7350081|NCT00946647|11591311|FG002|Phase ll Part|Death|0
7350082|NCT00946647|11591312|FG003|Phase ll Part|Death|7
7350083|NCT00946647|11591313|FG004|Phase ll Part|Death|4
7350084|NCT00946647|11591309|FG000|Phase ll Part|Disease progression|0
7350085|NCT00946647|11591310|FG001|Phase ll Part|Disease progression|0
7350086|NCT00946647|11591311|FG002|Phase ll Part|Disease progression|0
7350087|NCT00946647|11591312|FG003|Phase ll Part|Disease progression|6
7350088|NCT00946647|11591313|FG004|Phase ll Part|Disease progression|14
7350089|NCT00946647|11591309|FG000|Phase ll Part|Protocol Violation|0
7350090|NCT00946647|11591310|FG001|Phase ll Part|Protocol Violation|0
7350091|NCT00946647|11591311|FG002|Phase ll Part|Protocol Violation|0
7350092|NCT00946647|11591312|FG003|Phase ll Part|Protocol Violation|4
7350093|NCT00946647|11591313|FG004|Phase ll Part|Protocol Violation|2
7350094|NCT00946647|11591309|FG000|Phase ll Part|Subj cond no longer required study drug|0
7350095|NCT00946647|11591310|FG001|Phase ll Part|Subj cond no longer required study drug|0
7350096|NCT00946647|11591311|FG002|Phase ll Part|Subj cond no longer required study drug|0
7350097|NCT00946647|11591312|FG003|Phase ll Part|Subj cond no longer required study drug|2
7350098|NCT00946647|11591313|FG004|Phase ll Part|Subj cond no longer required study drug|0
7350099|NCT00946712|11591328|FG000|Overall Study|Adverse Event|118
7350100|NCT00946712|11591329|FG001|Overall Study|Adverse Event|124
7350101|NCT00946712|11591328|FG000|Overall Study|Disease progression|308
7350102|NCT00946712|11591329|FG001|Overall Study|Disease progression|404
7350103|NCT00946712|11591328|FG000|Overall Study|Death|21
7350104|NCT00946712|11591329|FG001|Overall Study|Death|22
7350105|NCT00946712|11591328|FG000|Overall Study|No treatment given|25
7350106|NCT00946712|11591329|FG001|Overall Study|No treatment given|29
7350107|NCT00946712|11591328|FG000|Overall Study|Other reasons|61
7350108|NCT00946712|11591329|FG001|Overall Study|Other reasons|73
7350109|NCT00946712|11591328|FG000|Overall Study|On Treatment|0
7350110|NCT00946712|11591329|FG001|Overall Study|On Treatment|4
7350111|NCT00946712|11591328|FG000|Overall Study|Ineligible|14
7350112|NCT00946712|11591329|FG001|Overall Study|Ineligible|6
7350113|NCT00946881|11591336|FG000|First Treatment|Withdrawal by Subject|1
7350114|NCT00946881|11591336|FG000|First Treatment|Patient relocated to another state|1
7350115|NCT00946881|11591336|FG000|Retreatment|Withdrawal by Subject|1
7350116|NCT00946920|11591363|FG000|Overall Study|Withdrawal by Subject|28
7350117|NCT00946920|11591364|FG001|Overall Study|Withdrawal by Subject|15
7350118|NCT00946920|11591363|FG000|Overall Study|Lost to Follow-up|2
7350119|NCT00946920|11591364|FG001|Overall Study|Lost to Follow-up|2
7350120|NCT00946920|11591363|FG000|Overall Study|Physician Decision|5
7350121|NCT00946920|11591364|FG001|Overall Study|Physician Decision|2
7350122|NCT00946920|11591363|FG000|Overall Study|Adverse Event|41
7350123|NCT00946920|11591364|FG001|Overall Study|Adverse Event|14
7350124|NCT00946920|11591363|FG000|Overall Study|Protocol Violation|16
7350125|NCT00946920|11591364|FG001|Overall Study|Protocol Violation|8
7350126|NCT00946920|11591363|FG000|Overall Study|Miscellaneous reasons|18
7350127|NCT00946920|11591364|FG001|Overall Study|Miscellaneous reasons|3
7350128|NCT00946998|11591372|FG000|Overall Study|Exited prior to first outcome assessment|5
7350129|NCT00946998|11591373|FG001|Overall Study|Exited prior to first outcome assessment|3
7350130|NCT00947115|11591382|FG000|Overall Study|Missed reporting interval|3
7350131|NCT00947115|11591383|FG001|Overall Study|Missed reporting interval|4
7350132|NCT00947115|11591384|FG002|Overall Study|Missed reporting interval|2
7350133|NCT00947115|11591382|FG000|Overall Study|Physician Decision|0
7350134|NCT00947115|11591383|FG001|Overall Study|Physician Decision|2
7350135|NCT00947115|11591384|FG002|Overall Study|Physician Decision|0
7350136|NCT00947115|11591382|FG000|Overall Study|Death|0
7350137|NCT00947115|11591383|FG001|Overall Study|Death|1
7350138|NCT00947115|11591384|FG002|Overall Study|Death|1
7350139|NCT00947115|11591382|FG000|Overall Study|Migrated from study area|2
7350140|NCT00947115|11591383|FG001|Overall Study|Migrated from study area|0
7350141|NCT00947115|11591384|FG002|Overall Study|Migrated from study area|0
7350142|NCT00947115|11591382|FG000|Overall Study|Withdrawal by Subject|1
7350143|NCT00947115|11591383|FG001|Overall Study|Withdrawal by Subject|3
7350144|NCT00947115|11591384|FG002|Overall Study|Withdrawal by Subject|4
7350145|NCT00947115|11591382|FG000|Overall Study|Lost to Follow-up|11
7350146|NCT00947115|11591383|FG001|Overall Study|Lost to Follow-up|12
7350147|NCT00947115|11591384|FG002|Overall Study|Lost to Follow-up|8
7350148|NCT00947154|11591392|FG000|Overall Study|Lost to Follow-up|1
7350149|NCT00947193|11591401|FG000|Overall Study|Lost to Follow-up|1
7350150|NCT00947193|11591402|FG001|Overall Study|Lost to Follow-up|0
7350151|NCT00947193|11591401|FG000|Overall Study|Withdrawal by Subject|1
7350152|NCT00947193|11591402|FG001|Overall Study|Withdrawal by Subject|0
7350153|NCT00947193|11591401|FG000|Overall Study|Factor VIII >1%|1
7350154|NCT00947193|11591402|FG001|Overall Study|Factor VIII >1%|0
7350155|NCT00947349|11591459|FG000|Triple Treatment Combination Period|Adverse Event|0
7350156|NCT00947349|11591460|FG001|Triple Treatment Combination Period|Adverse Event|1
7350157|NCT00947349|11591461|FG002|Triple Treatment Combination Period|Adverse Event|0
7350158|NCT00947349|11591462|FG003|Triple Treatment Combination Period|Adverse Event|0
7350159|NCT00947349|11591459|FG000|Overall Study Standard of Care|Lack of Efficacy|0
7350160|NCT00947349|11591460|FG001|Overall Study Standard of Care|Lack of Efficacy|0
7350310|NCT00948766|11591740|FG001|Core Study|Death|1
7350161|NCT00947349|11591461|FG002|Overall Study Standard of Care|Lack of Efficacy|1
7350162|NCT00947349|11591462|FG003|Overall Study Standard of Care|Lack of Efficacy|1
7350163|NCT00947349|11591459|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
7350164|NCT00947349|11591460|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
7350165|NCT00947349|11591461|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
7350166|NCT00947349|11591462|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
7350167|NCT00947349|11591459|FG000|Overall Study Standard of Care|Other|0
7350168|NCT00947349|11591460|FG001|Overall Study Standard of Care|Other|0
7350169|NCT00947349|11591461|FG002|Overall Study Standard of Care|Other|0
7350170|NCT00947349|11591462|FG003|Overall Study Standard of Care|Other|1
7350171|NCT00947427|11591492|FG000|Overall Study|Withdrawal by Subject|1
7350172|NCT00947427|11591493|FG001|Overall Study|Withdrawal by Subject|3
7350173|NCT00947427|11591492|FG000|Overall Study|Protocol Violation|0
7350174|NCT00947427|11591493|FG001|Overall Study|Protocol Violation|1
7350175|NCT00947531|11591510|FG000|Overall Study|Withdrawal by Subject|10
7350176|NCT00947531|11591511|FG001|Overall Study|Withdrawal by Subject|7
7350177|NCT00947531|11591510|FG000|Overall Study|Administrative Reason|0
7350178|NCT00947531|11591511|FG001|Overall Study|Administrative Reason|1
7350179|NCT00947531|11591510|FG000|Overall Study|Adverse Event|2
7350180|NCT00947531|11591511|FG001|Overall Study|Adverse Event|2
7350181|NCT00947531|11591510|FG000|Overall Study|Lack of Efficacy|1
7350182|NCT00947531|11591511|FG001|Overall Study|Lack of Efficacy|0
7350183|NCT00947531|11591510|FG000|Overall Study|Other|1
7350184|NCT00947531|11591511|FG001|Overall Study|Other|1
7350185|NCT00947544|11591517|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
7350186|NCT00947544|11591518|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
7350187|NCT00947856|11591557|FG000|Treatment Period|Progressive Disease|33
7350188|NCT00947856|11591558|FG001|Treatment Period|Progressive Disease|12
7350189|NCT00947856|11591557|FG000|Treatment Period|Adverse Event|15
7350190|NCT00947856|11591558|FG001|Treatment Period|Adverse Event|9
7350191|NCT00947856|11591557|FG000|Treatment Period|Physician Decision|14
7350192|NCT00947856|11591558|FG001|Treatment Period|Physician Decision|6
7350193|NCT00947856|11591557|FG000|Treatment Period|Study Stopped by Sponsor|4
7350194|NCT00947856|11591558|FG001|Treatment Period|Study Stopped by Sponsor|4
7350195|NCT00947856|11591557|FG000|Treatment Period|Withdrawal by Subject|12
7350196|NCT00947856|11591558|FG001|Treatment Period|Withdrawal by Subject|1
7350197|NCT00947856|11591557|FG000|Follow-up Period|Study Stopped by Sponsor|40
7350198|NCT00947856|11591558|FG001|Follow-up Period|Study Stopped by Sponsor|20
7350199|NCT00947856|11591557|FG000|Follow-up Period|Re-enrolled for Retreatment|2
7350200|NCT00947856|11591558|FG001|Follow-up Period|Re-enrolled for Retreatment|3
7350201|NCT00947856|11591557|FG000|Follow-up Period|Lost to Follow-up|7
7350202|NCT00947856|11591558|FG001|Follow-up Period|Lost to Follow-up|0
7350203|NCT00947856|11591557|FG000|Follow-up Period|Patient unavailable for site visits|1
7350204|NCT00947856|11591558|FG001|Follow-up Period|Patient unavailable for site visits|0
7350205|NCT00947856|11591557|FG000|Follow-up Period|Withdrawal by Subject|1
7350206|NCT00947856|11591558|FG001|Follow-up Period|Withdrawal by Subject|0
7350207|NCT00947882|11591577|FG000|Overall Study|Adverse Event|0
7350208|NCT00947882|11591578|FG001|Overall Study|Adverse Event|1
7350209|NCT00947882|11591579|FG002|Overall Study|Adverse Event|4
7350210|NCT00947882|11591580|FG003|Overall Study|Adverse Event|4
7350211|NCT00947882|11591577|FG000|Overall Study|Withdrawal by Subject|2
7350212|NCT00947882|11591578|FG001|Overall Study|Withdrawal by Subject|0
7350213|NCT00947882|11591579|FG002|Overall Study|Withdrawal by Subject|8
7350214|NCT00947882|11591580|FG003|Overall Study|Withdrawal by Subject|2
7350215|NCT00947882|11591577|FG000|Overall Study|Protocol Violation|0
7350216|NCT00947882|11591578|FG001|Overall Study|Protocol Violation|0
7350217|NCT00947882|11591579|FG002|Overall Study|Protocol Violation|1
7350218|NCT00947882|11591580|FG003|Overall Study|Protocol Violation|0
7350219|NCT00947882|11591577|FG000|Overall Study|Lost to Follow-up|0
7350220|NCT00947882|11591578|FG001|Overall Study|Lost to Follow-up|2
7350221|NCT00947882|11591579|FG002|Overall Study|Lost to Follow-up|1
7350222|NCT00947882|11591580|FG003|Overall Study|Lost to Follow-up|0
7350223|NCT00947882|11591577|FG000|Overall Study|Other/Unknown|10
7350224|NCT00947882|11591578|FG001|Overall Study|Other/Unknown|13
7569205|NCT03441984|11945299|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569206|NCT03441984|11945300|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
7569207|NCT03442296|11945328|FG000|3 Month Follow-up|Death|3
7569208|NCT03442296|11945329|FG001|3 Month Follow-up|Death|1
7350225|NCT00947882|11591579|FG002|Overall Study|Other/Unknown|3
7350226|NCT00947882|11591580|FG003|Overall Study|Other/Unknown|6
7350227|NCT00947882|11591577|FG000|Overall Study|Trial Terminated by Sponsor|62
7350228|NCT00947882|11591578|FG001|Overall Study|Trial Terminated by Sponsor|61
7350229|NCT00947882|11591579|FG002|Overall Study|Trial Terminated by Sponsor|62
7350230|NCT00947882|11591580|FG003|Overall Study|Trial Terminated by Sponsor|70
7569209|NCT03442296|11945328|FG000|3 Month Follow-up|Lost to Follow-up|1
7569210|NCT03442296|11945329|FG001|3 Month Follow-up|Lost to Follow-up|1
7569211|NCT03442296|11945328|FG000|3 Month Follow-up|Withdrawal by Subject|1
7569212|NCT03442296|11945329|FG001|3 Month Follow-up|Withdrawal by Subject|0
7569213|NCT03442296|11945328|FG000|3 Month Follow-up|Obtained Hearing Aids|0
7569214|NCT03442296|11945329|FG001|3 Month Follow-up|Obtained Hearing Aids|1
7569215|NCT03442296|11945328|FG000|12 Month Follow-up|Incomplete measurement|1
7569216|NCT03442296|11945329|FG001|12 Month Follow-up|Incomplete measurement|1
7569217|NCT03442569|11945335|FG000|Overall Study|Subject was ineligible after enrollment|1
7569218|NCT03442595|11945341|FG000|Overall Study|Lost to Follow-up|94
7569219|NCT03442595|11945342|FG001|Overall Study|Lost to Follow-up|0
7350231|NCT00948025|11591593|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
7350232|NCT00948025|11591594|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
7350233|NCT00948025|11591593|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
7350234|NCT00948025|11591594|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
7350235|NCT00948025|11591593|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7350236|NCT00948025|11591594|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
7350237|NCT00948064|11591604|FG000|Phase I|No treatment received|1
7350238|NCT00948064|11591605|FG001|Phase I|No treatment received|0
7350239|NCT00948064|11591606|FG002|Phase I|No treatment received|0
7350240|NCT00948064|11591604|FG000|Phase II|Physician Decision|0
7350241|NCT00948064|11591605|FG001|Phase II|Physician Decision|0
7350242|NCT00948064|11591606|FG002|Phase II|Physician Decision|1
7350243|NCT00948064|11591604|FG000|Phase II|Withdrawal by Subject|0
7350244|NCT00948064|11591605|FG001|Phase II|Withdrawal by Subject|1
7350245|NCT00948064|11591606|FG002|Phase II|Withdrawal by Subject|0
7350246|NCT00948155|11591630|FG000|First Intervention 21 Days|Lost to Follow-up|2
7350247|NCT00948155|11591631|FG001|First Intervention 21 Days|Lost to Follow-up|2
7350248|NCT00948155|11591630|FG000|Washout 14 Days|Lost to Follow-up|1
7350249|NCT00948155|11591631|FG001|Washout 14 Days|Lost to Follow-up|2
7350250|NCT00948246|11591639|FG000|Overall Study|Lost to Follow-up|11
7350251|NCT00948246|11591639|FG000|Overall Study|Adverse Event|11
7350252|NCT00948246|11591639|FG000|Overall Study|Death|1
7350253|NCT00948246|11591639|FG000|Overall Study|Withdrawal by Subject|1
7350254|NCT00948389|11591657|FG000|Overall Study|Disease Progression/Relapse/Death|3
7350255|NCT00948389|11591658|FG001|Overall Study|Disease Progression/Relapse/Death|3
7350256|NCT00948389|11591659|FG002|Overall Study|Disease Progression/Relapse/Death|7
7350257|NCT00948389|11591660|FG003|Overall Study|Disease Progression/Relapse/Death|8
7350258|NCT00948389|11591661|FG004|Overall Study|Disease Progression/Relapse/Death|1
7350259|NCT00948389|11591657|FG000|Overall Study|Thrombocytopenia, Grade 4|2
7350260|NCT00948389|11591658|FG001|Overall Study|Thrombocytopenia, Grade 4|0
7350261|NCT00948389|11591659|FG002|Overall Study|Thrombocytopenia, Grade 4|0
7350262|NCT00948389|11591660|FG003|Overall Study|Thrombocytopenia, Grade 4|1
7350263|NCT00948389|11591661|FG004|Overall Study|Thrombocytopenia, Grade 4|0
7350264|NCT00948389|11591657|FG000|Overall Study|Both Progression and Toxicity|1
7350265|NCT00948389|11591658|FG001|Overall Study|Both Progression and Toxicity|0
7350266|NCT00948389|11591659|FG002|Overall Study|Both Progression and Toxicity|0
7350267|NCT00948389|11591660|FG003|Overall Study|Both Progression and Toxicity|0
7350268|NCT00948389|11591661|FG004|Overall Study|Both Progression and Toxicity|0
7350269|NCT00948428|11591678|FG000|Overall Study|Withdrawal by Subject|6
7350270|NCT00948428|11591679|FG001|Overall Study|Withdrawal by Subject|12
7350271|NCT00948428|11591680|FG002|Overall Study|Withdrawal by Subject|7
7350272|NCT00948428|11591678|FG000|Overall Study|Adverse Event|6
7350273|NCT00948428|11591679|FG001|Overall Study|Adverse Event|3
7350274|NCT00948428|11591680|FG002|Overall Study|Adverse Event|0
7350275|NCT00948428|11591678|FG000|Overall Study|Lost to Follow-up|2
7575279|NCT03720847|11958944|FG001|Washout|Physician Decision|2
7350276|NCT00948428|11591679|FG001|Overall Study|Lost to Follow-up|1
7350277|NCT00948428|11591680|FG002|Overall Study|Lost to Follow-up|1
7350278|NCT00948428|11591678|FG000|Overall Study|Death|2
7350279|NCT00948428|11591679|FG001|Overall Study|Death|0
7350280|NCT00948428|11591680|FG002|Overall Study|Death|0
7350281|NCT00948428|11591678|FG000|Overall Study|Intercurrent Illness|1
7350282|NCT00948428|11591679|FG001|Overall Study|Intercurrent Illness|0
7350283|NCT00948428|11591680|FG002|Overall Study|Intercurrent Illness|0
7350284|NCT00948428|11591678|FG000|Overall Study|Non-compliance|1
7350285|NCT00948428|11591679|FG001|Overall Study|Non-compliance|2
7350286|NCT00948428|11591680|FG002|Overall Study|Non-compliance|0
7350287|NCT00948441|11591690|FG000|Overall Study|no longer meet inclusion criteria|1
7350288|NCT00948441|11591691|FG001|Overall Study|no longer meet inclusion criteria|4
7350289|NCT00948506|11591701|FG000|Overall Study|Withdrawal by Subject|3
7350290|NCT00948506|11591702|FG001|Overall Study|Withdrawal by Subject|1
7350291|NCT00948675|11591722|FG000|Overall Study|Lost to Follow-up|1
7350292|NCT00948675|11591723|FG001|Overall Study|Lost to Follow-up|0
7350293|NCT00948688|11591729|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
7350294|NCT00948688|11591730|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
7350295|NCT00948688|11591729|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
7350296|NCT00948688|11591730|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
7350297|NCT00948688|11591729|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
7350298|NCT00948688|11591730|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
7350299|NCT00948766|11591739|FG000|Core Study|Adverse Event|73
7350300|NCT00948766|11591740|FG001|Core Study|Adverse Event|51
7350301|NCT00948766|11591739|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
7350302|NCT00948766|11591740|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
7350303|NCT00948766|11591739|FG000|Core Study|Patient Withdrew Consent|27
7350304|NCT00948766|11591740|FG001|Core Study|Patient Withdrew Consent|46
7350305|NCT00948766|11591739|FG000|Core Study|Lost to Follow-up|3
7350306|NCT00948766|11591740|FG001|Core Study|Lost to Follow-up|2
7350307|NCT00948766|11591739|FG000|Core Study|Administrative Problems|2
7350308|NCT00948766|11591740|FG001|Core Study|Administrative Problems|2
7350309|NCT00948766|11591739|FG000|Core Study|Death|1
7350311|NCT00948766|11591739|FG000|Core Study|Protocol Deviation|8
7350312|NCT00948766|11591740|FG001|Core Study|Protocol Deviation|10
7350313|NCT00948766|11591739|FG000|Extension Study|Adverse Event|43
7350314|NCT00948766|11591740|FG001|Extension Study|Adverse Event|0
7350315|NCT00948766|11591739|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
7350316|NCT00948766|11591740|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
7350317|NCT00948766|11591739|FG000|Extension Study|Study Drug No Longer Required|1
7350318|NCT00948766|11591740|FG001|Extension Study|Study Drug No Longer Required|0
7350319|NCT00948766|11591739|FG000|Extension Study|Patient Withdrew Consent|32
7350320|NCT00948766|11591740|FG001|Extension Study|Patient Withdrew Consent|0
7350321|NCT00948766|11591739|FG000|Extension Study|Lost to Follow-up|8
7350322|NCT00948766|11591740|FG001|Extension Study|Lost to Follow-up|0
7350323|NCT00948766|11591739|FG000|Extension Study|Administrative Problems|1
7350324|NCT00948766|11591740|FG001|Extension Study|Administrative Problems|0
7350325|NCT00948766|11591739|FG000|Extension Study|Death|4
7350326|NCT00948766|11591740|FG001|Extension Study|Death|0
7350327|NCT00948818|11591755|FG000|Overall Study|Adverse Event|10
7350328|NCT00948818|11591756|FG001|Overall Study|Adverse Event|32
7350329|NCT00948818|11591755|FG000|Overall Study|Protocol Violation|9
7350330|NCT00948818|11591756|FG001|Overall Study|Protocol Violation|10
7350331|NCT00948818|11591755|FG000|Overall Study|Withdrawal by Subject|25
7350332|NCT00948818|11591756|FG001|Overall Study|Withdrawal by Subject|25
7350333|NCT00948818|11591755|FG000|Overall Study|Lost to Follow-up|10
7350334|NCT00948818|11591756|FG001|Overall Study|Lost to Follow-up|17
7350335|NCT00948818|11591755|FG000|Overall Study|Lack of Efficacy|4
7350336|NCT00948818|11591756|FG001|Overall Study|Lack of Efficacy|5
7350337|NCT00948818|11591755|FG000|Overall Study|Other Reason|4
7350338|NCT00948818|11591756|FG001|Overall Study|Other Reason|5
7350339|NCT00948857|11591767|FG000|Overall Study|Lost to Follow-up|1
7350340|NCT00948857|11591768|FG001|Overall Study|Lost to Follow-up|0
7350341|NCT00948896|11591782|FG000|Randomization to 24 Months of Age|Death|1
7350342|NCT00948896|11591783|FG001|Randomization to 24 Months of Age|Death|0
7350343|NCT00948896|11591784|FG002|Randomization to 24 Months of Age|Death|0
7350344|NCT00948896|11591785|FG003|Randomization to 24 Months of Age|Death|0
7350345|NCT00948896|11591786|FG004|Randomization to 24 Months of Age|Death|2
7350346|NCT00948896|11591787|FG005|Randomization to 24 Months of Age|Death|1
7350347|NCT00948896|11591788|FG006|Randomization to 24 Months of Age|Death|2
7350348|NCT00948896|11591789|FG007|Randomization to 24 Months of Age|Death|1
7350349|NCT00948896|11591782|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
7350350|NCT00948896|11591783|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
7350351|NCT00948896|11591784|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
7350352|NCT00948896|11591785|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
7350353|NCT00948896|11591786|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
7350354|NCT00948896|11591787|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
7350355|NCT00948896|11591788|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
7350356|NCT00948896|11591789|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
7350357|NCT00948896|11591782|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
7350358|NCT00948896|11591783|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
7350359|NCT00948896|11591784|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
7350360|NCT00948896|11591785|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
7350361|NCT00948896|11591786|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
7350362|NCT00948896|11591787|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
7350363|NCT00948896|11591788|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
7350364|NCT00948896|11591789|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
7350365|NCT00948896|11591782|FG000|Randomization to 24 Months of Age|Protocol Violation|0
7350366|NCT00948896|11591783|FG001|Randomization to 24 Months of Age|Protocol Violation|1
7350367|NCT00948896|11591784|FG002|Randomization to 24 Months of Age|Protocol Violation|0
7350368|NCT00948896|11591785|FG003|Randomization to 24 Months of Age|Protocol Violation|1
7350369|NCT00948896|11591786|FG004|Randomization to 24 Months of Age|Protocol Violation|0
7350370|NCT00948896|11591787|FG005|Randomization to 24 Months of Age|Protocol Violation|0
7350371|NCT00948896|11591788|FG006|Randomization to 24 Months of Age|Protocol Violation|1
7350372|NCT00948896|11591789|FG007|Randomization to 24 Months of Age|Protocol Violation|1
7350373|NCT00948896|11591782|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
7350374|NCT00948896|11591783|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
7350375|NCT00948896|11591784|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
7350376|NCT00948896|11591785|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
7350377|NCT00948896|11591786|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
7350378|NCT00948896|11591787|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
7350379|NCT00948896|11591788|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
7350380|NCT00948896|11591789|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
7350381|NCT00948896|11591782|FG000|24 Months of Age to 36 Months of Age|Death|0
7350382|NCT00948896|11591783|FG001|24 Months of Age to 36 Months of Age|Death|2
7350383|NCT00948896|11591784|FG002|24 Months of Age to 36 Months of Age|Death|2
7350384|NCT00948896|11591785|FG003|24 Months of Age to 36 Months of Age|Death|0
7350385|NCT00948896|11591786|FG004|24 Months of Age to 36 Months of Age|Death|0
7350386|NCT00948896|11591787|FG005|24 Months of Age to 36 Months of Age|Death|1
7350387|NCT00948896|11591788|FG006|24 Months of Age to 36 Months of Age|Death|0
7350388|NCT00948896|11591789|FG007|24 Months of Age to 36 Months of Age|Death|0
7350389|NCT00948896|11591782|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7350390|NCT00948896|11591783|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7350391|NCT00948896|11591784|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7350392|NCT00948896|11591785|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
7350393|NCT00948896|11591786|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7350394|NCT00948896|11591787|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7350395|NCT00948896|11591788|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7350396|NCT00948896|11591789|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
7350397|NCT00948896|11591782|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
7350398|NCT00948896|11591783|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7350399|NCT00948896|11591784|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7350400|NCT00948896|11591785|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7350401|NCT00948896|11591786|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
7350402|NCT00948896|11591787|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7350403|NCT00948896|11591788|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7350404|NCT00948896|11591789|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
7350405|NCT00948896|11591782|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350406|NCT00948896|11591783|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350407|NCT00948896|11591784|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
7350408|NCT00948896|11591785|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350409|NCT00948896|11591786|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350410|NCT00948896|11591787|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
7350411|NCT00948896|11591788|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350412|NCT00948896|11591789|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
7350413|NCT00948896|11591782|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350414|NCT00948896|11591783|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350415|NCT00948896|11591784|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350416|NCT00948896|11591785|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
7350417|NCT00948896|11591786|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350418|NCT00948896|11591787|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350419|NCT00948896|11591788|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350420|NCT00948896|11591789|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
7350421|NCT00948922|11591814|FG000|Overall Study|Did not start study treatment|2
7350422|NCT00948922|11591815|FG001|Overall Study|Did not start study treatment|5
7350423|NCT00948922|11591816|FG002|Overall Study|Did not start study treatment|0
7350424|NCT00948922|11591814|FG000|Overall Study|Withdrawal by Subject|0
7350425|NCT00948922|11591815|FG001|Overall Study|Withdrawal by Subject|2
7350426|NCT00948922|11591816|FG002|Overall Study|Withdrawal by Subject|1
7350427|NCT00948922|11591814|FG000|Overall Study|Death|3
7350428|NCT00948922|11591815|FG001|Overall Study|Death|0
7350429|NCT00948922|11591816|FG002|Overall Study|Death|0
7350430|NCT00948922|11591814|FG000|Overall Study|Disease progression|0
7350431|NCT00948922|11591815|FG001|Overall Study|Disease progression|1
7350432|NCT00948922|11591816|FG002|Overall Study|Disease progression|0
7350433|NCT00948922|11591814|FG000|Overall Study|Insurance issues|1
7350434|NCT00948922|11591815|FG001|Overall Study|Insurance issues|0
7350435|NCT00948922|11591816|FG002|Overall Study|Insurance issues|0
7350436|NCT00948922|11591814|FG000|Overall Study|Transplant eligibility issues|2
7350437|NCT00948922|11591815|FG001|Overall Study|Transplant eligibility issues|3
7350438|NCT00948922|11591816|FG002|Overall Study|Transplant eligibility issues|0
7350439|NCT00948922|11591814|FG000|Overall Study|Not evaluable at time of analysis|0
7350440|NCT00948922|11591815|FG001|Overall Study|Not evaluable at time of analysis|3
7350441|NCT00948922|11591816|FG002|Overall Study|Not evaluable at time of analysis|0
7350442|NCT00948974|11591834|FG000|Overall Study|Lost to Follow-up|23
7350443|NCT00948974|11591835|FG001|Overall Study|Lost to Follow-up|20
7350444|NCT00949117|11591852|FG000|Overall Study|Lack of Efficacy|2
7350445|NCT00949117|11591853|FG001|Overall Study|Lack of Efficacy|3
7350446|NCT00949117|11591852|FG000|Overall Study|Protocol Violation|1
7350447|NCT00949117|11591853|FG001|Overall Study|Protocol Violation|1
7350448|NCT00949117|11591852|FG000|Overall Study|Adverse Event|0
7350449|NCT00949117|11591853|FG001|Overall Study|Adverse Event|1
7350450|NCT00949325|11591865|FG000|Overall Study|Adverse Event|0
7350451|NCT00949325|11591866|FG001|Overall Study|Adverse Event|2
7350452|NCT00949325|11591867|FG002|Overall Study|Adverse Event|0
7350453|NCT00949533|11591885|FG000|Overall Study|Lost to Follow-up|0
7350454|NCT00949533|11591886|FG001|Overall Study|Lost to Follow-up|1
7350455|NCT00949650|11591894|FG000|Overall Study|Progressive disease|188
7350456|NCT00949650|11591895|FG001|Overall Study|Progressive disease|19
7350457|NCT00949650|11591894|FG000|Overall Study|Completed 6 courses of chemotherapy|0
7350458|NCT00949650|11591895|FG001|Overall Study|Completed 6 courses of chemotherapy|60
7350459|NCT00949650|11591894|FG000|Overall Study|Other Adverse Event (AE)|28
7350460|NCT00949650|11591895|FG001|Overall Study|Other Adverse Event (AE)|17
7350461|NCT00949650|11591894|FG000|Overall Study|Protocol Violation|1
7350462|NCT00949650|11591895|FG001|Overall Study|Protocol Violation|4
7350463|NCT00949650|11591894|FG000|Overall Study|Refusal to continue medication|7
7350464|NCT00949650|11591895|FG001|Overall Study|Refusal to continue medication|11
7350465|NCT00949650|11591894|FG000|Overall Study|Not treated|1
7350466|NCT00949650|11591895|FG001|Overall Study|Not treated|4
7350467|NCT00949650|11591894|FG000|Overall Study|Other not specified above|5
7350468|NCT00949650|11591895|FG001|Overall Study|Other not specified above|0
7350469|NCT00949702|11591905|FG000|Overall Study|Death|40
7350470|NCT00949702|11591905|FG000|Overall Study|Disease progression|7
7350471|NCT00949702|11591905|FG000|Overall Study|Withdrawal of consent|1
7350472|NCT00949715|11591911|FG000|Overall Study|Physician Decision|1
7350473|NCT00949715|11591912|FG001|Overall Study|Physician Decision|0
7350474|NCT00949715|11591911|FG000|Overall Study|Lost to Follow-up|1
7350475|NCT00949715|11591912|FG001|Overall Study|Lost to Follow-up|0
7350476|NCT00949715|11591911|FG000|Overall Study|Missing 24 month LVEF measurement|2
7350477|NCT00949715|11591912|FG001|Overall Study|Missing 24 month LVEF measurement|0
7350478|NCT00949884|11591920|FG000|Overall Study|Adverse Event|14
7350479|NCT00949884|11591921|FG001|Overall Study|Adverse Event|3
7350480|NCT00949884|11591922|FG002|Overall Study|Adverse Event|12
7350481|NCT00949884|11591920|FG000|Overall Study|Did not meet inclusion/exclusion|2
7350482|NCT00949884|11591921|FG001|Overall Study|Did not meet inclusion/exclusion|1
7350483|NCT00949884|11591922|FG002|Overall Study|Did not meet inclusion/exclusion|3
7350484|NCT00949884|11591920|FG000|Overall Study|Lost to Follow-up|7
7350485|NCT00949884|11591921|FG001|Overall Study|Lost to Follow-up|5
7350486|NCT00949884|11591922|FG002|Overall Study|Lost to Follow-up|5
7350487|NCT00949884|11591920|FG000|Overall Study|Physician Decision|5
7350488|NCT00949884|11591921|FG001|Overall Study|Physician Decision|0
7350489|NCT00949884|11591922|FG002|Overall Study|Physician Decision|6
7350490|NCT00949884|11591920|FG000|Overall Study|Treatment non-compliance|5
7350491|NCT00949884|11591921|FG001|Overall Study|Treatment non-compliance|0
7350492|NCT00949884|11591922|FG002|Overall Study|Treatment non-compliance|8
7350493|NCT00949884|11591920|FG000|Overall Study|Withdrawal by Subject|13
7350494|NCT00949884|11591921|FG001|Overall Study|Withdrawal by Subject|4
7350495|NCT00949884|11591922|FG002|Overall Study|Withdrawal by Subject|16
7350496|NCT00949884|11591920|FG000|Overall Study|Lack of Efficacy|4
7350497|NCT00949884|11591921|FG001|Overall Study|Lack of Efficacy|2
7350498|NCT00949884|11591922|FG002|Overall Study|Lack of Efficacy|7
7350499|NCT00949884|11591920|FG000|Overall Study|Study terminated by sponsor|0
7350500|NCT00949884|11591921|FG001|Overall Study|Study terminated by sponsor|0
7350501|NCT00949884|11591922|FG002|Overall Study|Study terminated by sponsor|1
7350502|NCT00949910|11591931|FG000|Overall Study|Progressive Disease|3750
7350503|NCT00949910|11591931|FG000|Overall Study|Symptomatic Deterioration|1088
7350504|NCT00949910|11591931|FG000|Overall Study|Lost to Follow-up|100
7350505|NCT00949910|11591931|FG000|Overall Study|Study Drug-Related Adverse Event|315
7350506|NCT00949910|11591931|FG000|Overall Study|Participant Refusal|390
7350507|NCT00949910|11591931|FG000|Overall Study|Death Due to Malignant Disease|456
7350508|NCT00949910|11591931|FG000|Overall Study|Death Due to Progression/Deterioration|4
7350509|NCT00949910|11591931|FG000|Overall Study|Death Due to Adverse Event|115
7350510|NCT00949910|11591931|FG000|Overall Study|Death Due to Toxicity|3
7350511|NCT00949910|11591931|FG000|Overall Study|Death from Unknown Cause|5
7350512|NCT00949910|11591931|FG000|Overall Study|Unspecified Progression/Deterioration|13
7350513|NCT00949910|11591931|FG000|Overall Study|Switched to Compassionate/Other Use|174
7350514|NCT00949910|11591931|FG000|Overall Study|Switched to Commercial Treatment|4
7350515|NCT00949910|11591931|FG000|Overall Study|Violation of Eligibility|23
7350516|NCT00949910|11591931|FG000|Overall Study|Logistical Reasons|13
7350517|NCT00949910|11591931|FG000|Overall Study|Non-Compliance|10
7350518|NCT00949910|11591931|FG000|Overall Study|Prolonged Dosing Interruption|4
7350519|NCT00949910|11591931|FG000|Overall Study|Adverse Event|83
7350520|NCT00949910|11591931|FG000|Overall Study|Serious Adverse Event|6
7350521|NCT00949910|11591931|FG000|Overall Study|Physician/Participant Decision|7
7350522|NCT00949910|11591931|FG000|Overall Study|Other|4
7350523|NCT00949910|11591931|FG000|Overall Study|No Data|9
7350524|NCT00949975|11591939|FG000|Overall Study|Voluntary discontinuation|6
7350525|NCT00949975|11591940|FG001|Overall Study|Voluntary discontinuation|5
7350526|NCT00949975|11591941|FG002|Overall Study|Voluntary discontinuation|3
7350527|NCT00949975|11591942|FG003|Overall Study|Voluntary discontinuation|6
7350528|NCT00949975|11591939|FG000|Overall Study|Adverse Event|11
7350529|NCT00949975|11591940|FG001|Overall Study|Adverse Event|11
7350530|NCT00949975|11591941|FG002|Overall Study|Adverse Event|10
7350531|NCT00949975|11591942|FG003|Overall Study|Adverse Event|10
7350532|NCT00949975|11591939|FG000|Overall Study|Safety reason|0
7350533|NCT00949975|11591940|FG001|Overall Study|Safety reason|1
7350534|NCT00949975|11591941|FG002|Overall Study|Safety reason|0
7350535|NCT00949975|11591942|FG003|Overall Study|Safety reason|0
7350536|NCT00949975|11591939|FG000|Overall Study|Study-specific criteria|0
7350537|NCT00949975|11591940|FG001|Overall Study|Study-specific criteria|1
7350538|NCT00949975|11591941|FG002|Overall Study|Study-specific criteria|1
7350539|NCT00949975|11591942|FG003|Overall Study|Study-specific criteria|0
7350540|NCT00949975|11591939|FG000|Overall Study|Incorrect enrolment|5
7350541|NCT00949975|11591940|FG001|Overall Study|Incorrect enrolment|10
7350542|NCT00949975|11591941|FG002|Overall Study|Incorrect enrolment|4
7350543|NCT00949975|11591942|FG003|Overall Study|Incorrect enrolment|7
7350544|NCT00949975|11591939|FG000|Overall Study|Severe non-compliance|3
7350545|NCT00949975|11591940|FG001|Overall Study|Severe non-compliance|1
7350546|NCT00949975|11591941|FG002|Overall Study|Severe non-compliance|0
7350547|NCT00949975|11591942|FG003|Overall Study|Severe non-compliance|2
7350548|NCT00949975|11591939|FG000|Overall Study|Lost to Follow-up|1
7350549|NCT00949975|11591940|FG001|Overall Study|Lost to Follow-up|0
7350550|NCT00949975|11591941|FG002|Overall Study|Lost to Follow-up|1
7350551|NCT00949975|11591942|FG003|Overall Study|Lost to Follow-up|3
7350552|NCT00949975|11591939|FG000|Overall Study|Other|1
7350553|NCT00949975|11591940|FG001|Overall Study|Other|0
7350554|NCT00949975|11591941|FG002|Overall Study|Other|0
7350555|NCT00949975|11591942|FG003|Overall Study|Other|0
7350556|NCT00950170|11591952|FG000|Overall Study|Parent/Legal Guardian Request|1
7350557|NCT00950170|11591952|FG000|Overall Study|Adverse Event|2
7350558|NCT00950170|11591952|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7350559|NCT00950248|11591985|FG000|Year 1: Baseline|Withdrawal by Subject|6
7350560|NCT00950248|11591986|FG001|Year 1: Baseline|Withdrawal by Subject|0
7350561|NCT00950248|11591987|FG002|Year 1: Baseline|Withdrawal by Subject|0
7350562|NCT00950248|11591985|FG000|Year 1: Baseline|worsening of symptoms|2
7350563|NCT00950248|11591986|FG001|Year 1: Baseline|worsening of symptoms|0
7350564|NCT00950248|11591987|FG002|Year 1: Baseline|worsening of symptoms|0
7350565|NCT00950248|11591985|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
7350566|NCT00950248|11591986|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
7350567|NCT00950248|11591987|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
7350568|NCT00950248|11591985|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7350569|NCT00950248|11591986|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
7350570|NCT00950248|11591987|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
7350571|NCT00950248|11591985|FG000|Year 2&3 Treatment Randomization|Death|0
7350572|NCT00950248|11591986|FG001|Year 2&3 Treatment Randomization|Death|0
7350573|NCT00950248|11591987|FG002|Year 2&3 Treatment Randomization|Death|1
7350574|NCT00950248|11591985|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
7350575|NCT00950248|11591986|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
7350576|NCT00950248|11591987|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
7350577|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
7350578|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
7350579|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
7350580|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
7350581|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
7350582|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
7350583|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
7350584|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
7350585|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
7350586|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
7350587|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
7350588|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
7350589|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
7350590|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
7350591|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
7350592|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
7350593|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
7350594|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
7350595|NCT00950300|11591996|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7350596|NCT00950300|11591997|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
7350597|NCT00950300|11591996|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
7350598|NCT00950300|11591997|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
7350599|NCT00950300|11591996|FG000|TFFU Period|Death|4
7350600|NCT00950300|11591997|FG001|TFFU Period|Death|1
7350601|NCT00950300|11591996|FG000|TFFU Period|Refused Treatment|10
7350602|NCT00950300|11591997|FG001|TFFU Period|Refused Treatment|11
7350603|NCT00950300|11591996|FG000|TFFU Period|Failure to Return|16
7350604|NCT00950300|11591997|FG001|TFFU Period|Failure to Return|16
7350605|NCT00950300|11591996|FG000|TFFU Period|Recurrence of Disease|63
7350606|NCT00950300|11591997|FG001|TFFU Period|Recurrence of Disease|72
7350607|NCT00950300|11591996|FG000|TFFU Period|Other|4
7350608|NCT00950300|11591997|FG001|TFFU Period|Other|3
7350609|NCT00950300|11591996|FG000|SFU Period|Death|44
7350610|NCT00950300|11591997|FG001|SFU Period|Death|42
7350611|NCT00950300|11591996|FG000|SFU Period|Lost to Follow-up|30
7350612|NCT00950300|11591997|FG001|SFU Period|Lost to Follow-up|28
7350613|NCT00950300|11591996|FG000|SFU Period|Withdrawal by Subject|4
7350614|NCT00950300|11591997|FG001|SFU Period|Withdrawal by Subject|8
7350615|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350616|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350617|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350618|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
7350619|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350620|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350621|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350622|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350623|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350624|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
7350625|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Adverse Event|0
7350626|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Adverse Event|1
7350627|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Adverse Event|1
7350628|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Adverse Event|1
7350629|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Adverse Event|1
7350630|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Adverse Event|1
7350631|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Adverse Event|0
7350632|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Adverse Event|0
7350633|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Adverse Event|0
7350634|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Adverse Event|0
7350635|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
7350636|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
7350637|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
7350638|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
7350639|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
7350640|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
7350641|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
7350642|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
7350643|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
7350644|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
7350645|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7350646|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7350647|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
7350648|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7350649|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
7350650|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
7350651|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
7350652|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
7350653|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
7350654|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
7350655|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
7350656|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
7350657|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
7350658|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
7350659|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
7350660|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
7350661|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
7350662|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
7350663|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
7350664|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
7350665|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350666|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350667|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350668|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350669|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7350670|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
7350671|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350672|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350673|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350674|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
7350675|NCT00950599|11592030|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
7350676|NCT00950599|11592031|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
7350677|NCT00950599|11592032|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
7350678|NCT00950599|11592033|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
7350679|NCT00950599|11592034|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
7350680|NCT00950599|11592035|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
7350681|NCT00950599|11592036|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
7350682|NCT00950599|11592037|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
7350683|NCT00950599|11592038|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
7350684|NCT00950599|11592039|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
7350685|NCT00950599|11592030|FG000|Follow-Up Period|Adverse Event|0
7350686|NCT00950599|11592031|FG001|Follow-Up Period|Adverse Event|0
7350687|NCT00950599|11592032|FG002|Follow-Up Period|Adverse Event|0
7350688|NCT00950599|11592033|FG003|Follow-Up Period|Adverse Event|0
7350689|NCT00950599|11592034|FG004|Follow-Up Period|Adverse Event|0
7350690|NCT00950599|11592035|FG005|Follow-Up Period|Adverse Event|0
7350691|NCT00950599|11592036|FG006|Follow-Up Period|Adverse Event|0
7350692|NCT00950599|11592037|FG007|Follow-Up Period|Adverse Event|0
7350693|NCT00950599|11592038|FG008|Follow-Up Period|Adverse Event|1
7350694|NCT00950599|11592039|FG009|Follow-Up Period|Adverse Event|0
7350695|NCT00950599|11592030|FG000|Follow-Up Period|Lack of Efficacy|0
7350696|NCT00950599|11592031|FG001|Follow-Up Period|Lack of Efficacy|0
7350697|NCT00950599|11592032|FG002|Follow-Up Period|Lack of Efficacy|0
7350698|NCT00950599|11592033|FG003|Follow-Up Period|Lack of Efficacy|0
7350699|NCT00950599|11592034|FG004|Follow-Up Period|Lack of Efficacy|0
7350700|NCT00950599|11592035|FG005|Follow-Up Period|Lack of Efficacy|0
7350701|NCT00950599|11592036|FG006|Follow-Up Period|Lack of Efficacy|0
7350702|NCT00950599|11592037|FG007|Follow-Up Period|Lack of Efficacy|0
7350703|NCT00950599|11592038|FG008|Follow-Up Period|Lack of Efficacy|3
7350704|NCT00950599|11592039|FG009|Follow-Up Period|Lack of Efficacy|0
7350705|NCT00950599|11592030|FG000|Follow-Up Period|Lost to Follow-up|0
7350706|NCT00950599|11592031|FG001|Follow-Up Period|Lost to Follow-up|0
7350707|NCT00950599|11592032|FG002|Follow-Up Period|Lost to Follow-up|0
7350708|NCT00950599|11592033|FG003|Follow-Up Period|Lost to Follow-up|0
7350709|NCT00950599|11592034|FG004|Follow-Up Period|Lost to Follow-up|0
7350710|NCT00950599|11592035|FG005|Follow-Up Period|Lost to Follow-up|0
7350711|NCT00950599|11592036|FG006|Follow-Up Period|Lost to Follow-up|0
7350712|NCT00950599|11592037|FG007|Follow-Up Period|Lost to Follow-up|0
7350713|NCT00950599|11592038|FG008|Follow-Up Period|Lost to Follow-up|5
7350714|NCT00950599|11592039|FG009|Follow-Up Period|Lost to Follow-up|1
7350715|NCT00950599|11592030|FG000|Follow-Up Period|Physician Decision|0
7350716|NCT00950599|11592031|FG001|Follow-Up Period|Physician Decision|0
7350717|NCT00950599|11592032|FG002|Follow-Up Period|Physician Decision|0
7350718|NCT00950599|11592033|FG003|Follow-Up Period|Physician Decision|0
7350719|NCT00950599|11592034|FG004|Follow-Up Period|Physician Decision|0
7350720|NCT00950599|11592035|FG005|Follow-Up Period|Physician Decision|0
7350721|NCT00950599|11592036|FG006|Follow-Up Period|Physician Decision|0
7350722|NCT00950599|11592037|FG007|Follow-Up Period|Physician Decision|0
7350723|NCT00950599|11592038|FG008|Follow-Up Period|Physician Decision|1
7350724|NCT00950599|11592039|FG009|Follow-Up Period|Physician Decision|0
7350725|NCT00950599|11592030|FG000|Follow-Up Period|Poor/Noncompliance|0
7350726|NCT00950599|11592031|FG001|Follow-Up Period|Poor/Noncompliance|0
7350727|NCT00950599|11592032|FG002|Follow-Up Period|Poor/Noncompliance|0
7350728|NCT00950599|11592033|FG003|Follow-Up Period|Poor/Noncompliance|0
7350729|NCT00950599|11592034|FG004|Follow-Up Period|Poor/Noncompliance|0
7350730|NCT00950599|11592035|FG005|Follow-Up Period|Poor/Noncompliance|0
7350731|NCT00950599|11592036|FG006|Follow-Up Period|Poor/Noncompliance|0
7350732|NCT00950599|11592037|FG007|Follow-Up Period|Poor/Noncompliance|0
7350733|NCT00950599|11592038|FG008|Follow-Up Period|Poor/Noncompliance|1
7350734|NCT00950599|11592039|FG009|Follow-Up Period|Poor/Noncompliance|0
7350735|NCT00950599|11592030|FG000|Follow-Up Period|Subject withdrew Consent|0
7350736|NCT00950599|11592031|FG001|Follow-Up Period|Subject withdrew Consent|0
7350737|NCT00950599|11592032|FG002|Follow-Up Period|Subject withdrew Consent|0
7350738|NCT00950599|11592033|FG003|Follow-Up Period|Subject withdrew Consent|0
7350739|NCT00950599|11592034|FG004|Follow-Up Period|Subject withdrew Consent|0
7350740|NCT00950599|11592035|FG005|Follow-Up Period|Subject withdrew Consent|0
7350741|NCT00950599|11592036|FG006|Follow-Up Period|Subject withdrew Consent|0
7350742|NCT00950599|11592037|FG007|Follow-Up Period|Subject withdrew Consent|0
7350743|NCT00950599|11592038|FG008|Follow-Up Period|Subject withdrew Consent|2
7350744|NCT00950599|11592039|FG009|Follow-Up Period|Subject withdrew Consent|1
7350745|NCT00950651|11592073|FG000|Overall Study|Adverse Event|17
7350746|NCT00950651|11592074|FG001|Overall Study|Adverse Event|20
7350747|NCT00950651|11592073|FG000|Overall Study|Death|1
7350748|NCT00950651|11592074|FG001|Overall Study|Death|0
7350749|NCT00950651|11592073|FG000|Overall Study|Lack of Efficacy|2
7350750|NCT00950651|11592074|FG001|Overall Study|Lack of Efficacy|2
7350751|NCT00950651|11592073|FG000|Overall Study|Protocol Violation|3
7350752|NCT00950651|11592074|FG001|Overall Study|Protocol Violation|4
7350753|NCT00950651|11592073|FG000|Overall Study|Withdrawal by Subject|8
7350754|NCT00950651|11592074|FG001|Overall Study|Withdrawal by Subject|9
7350755|NCT00950664|11592082|FG000|First Intervention|Lost to Follow-up|1
7350756|NCT00950664|11592083|FG001|First Intervention|Lost to Follow-up|3
7350757|NCT00950664|11592082|FG000|First Intervention|Withdrawal by Subject|2
7350758|NCT00950664|11592083|FG001|First Intervention|Withdrawal by Subject|2
7350759|NCT00950742|11592095|FG000|Overall Study|Other Adverse Event|1
7350760|NCT00950742|11592096|FG001|Overall Study|Other Adverse Event|0
7350761|NCT00950742|11592095|FG000|Overall Study|Withdrawal by Subject|3
7350762|NCT00950742|11592096|FG001|Overall Study|Withdrawal by Subject|0
7350763|NCT00950742|11592095|FG000|Overall Study|Progressive Disease|6
7350764|NCT00950742|11592096|FG001|Overall Study|Progressive Disease|2
7350765|NCT00950742|11592095|FG000|Overall Study|Dose limiting toxicity|6
7350766|NCT00950742|11592096|FG001|Overall Study|Dose limiting toxicity|0
7350767|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
7350768|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
7350769|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
7350770|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Death|1
7350771|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
7350772|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
7350773|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
7350774|NCT00950755|11592106|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
7350775|NCT00950755|11592106|FG000|Long-Term Follow-Up|Lost to Follow-up|1
7350776|NCT00950755|11592106|FG000|Long-Term Follow-Up|Death|8
7350777|NCT00950807|11592110|FG000|Treatment Period 1|Lack of Efficacy|1
7350778|NCT00950807|11592111|FG001|Treatment Period 1|Lack of Efficacy|0
7350779|NCT00950807|11592112|FG002|Treatment Period 1|Lack of Efficacy|0
7350780|NCT00950807|11592113|FG003|Treatment Period 1|Lack of Efficacy|0
7350781|NCT00950807|11592114|FG004|Treatment Period 1|Lack of Efficacy|0
7350782|NCT00950807|11592115|FG005|Treatment Period 1|Lack of Efficacy|1
7350783|NCT00950807|11592116|FG006|Treatment Period 1|Lack of Efficacy|0
7350784|NCT00950807|11592117|FG007|Treatment Period 1|Lack of Efficacy|0
7350785|NCT00950807|11592118|FG008|Treatment Period 1|Lack of Efficacy|0
7350786|NCT00950807|11592119|FG009|Treatment Period 1|Lack of Efficacy|0
7350787|NCT00950807|11592110|FG000|Treatment Period 1|Protocol Violation|1
7350788|NCT00950807|11592111|FG001|Treatment Period 1|Protocol Violation|0
7350789|NCT00950807|11592112|FG002|Treatment Period 1|Protocol Violation|0
7350790|NCT00950807|11592113|FG003|Treatment Period 1|Protocol Violation|0
7350791|NCT00950807|11592114|FG004|Treatment Period 1|Protocol Violation|0
7350792|NCT00950807|11592115|FG005|Treatment Period 1|Protocol Violation|0
7350793|NCT00950807|11592116|FG006|Treatment Period 1|Protocol Violation|0
7350794|NCT00950807|11592117|FG007|Treatment Period 1|Protocol Violation|0
7350795|NCT00950807|11592118|FG008|Treatment Period 1|Protocol Violation|0
7350796|NCT00950807|11592119|FG009|Treatment Period 1|Protocol Violation|0
7350797|NCT00950807|11592110|FG000|Treatment Period 1|Lost to Follow-up|0
7350798|NCT00950807|11592111|FG001|Treatment Period 1|Lost to Follow-up|0
7350799|NCT00950807|11592112|FG002|Treatment Period 1|Lost to Follow-up|1
7350800|NCT00950807|11592113|FG003|Treatment Period 1|Lost to Follow-up|0
7350801|NCT00950807|11592114|FG004|Treatment Period 1|Lost to Follow-up|0
7350802|NCT00950807|11592115|FG005|Treatment Period 1|Lost to Follow-up|0
7350803|NCT00950807|11592116|FG006|Treatment Period 1|Lost to Follow-up|0
7350804|NCT00950807|11592117|FG007|Treatment Period 1|Lost to Follow-up|0
7350805|NCT00950807|11592118|FG008|Treatment Period 1|Lost to Follow-up|0
7350806|NCT00950807|11592119|FG009|Treatment Period 1|Lost to Follow-up|0
7350807|NCT00950807|11592110|FG000|Treatment Period 1|Withdrawal by Subject|1
7350808|NCT00950807|11592111|FG001|Treatment Period 1|Withdrawal by Subject|0
7350809|NCT00950807|11592112|FG002|Treatment Period 1|Withdrawal by Subject|0
7350810|NCT00950807|11592113|FG003|Treatment Period 1|Withdrawal by Subject|0
7350811|NCT00950807|11592114|FG004|Treatment Period 1|Withdrawal by Subject|1
7350812|NCT00950807|11592115|FG005|Treatment Period 1|Withdrawal by Subject|0
7350813|NCT00950807|11592116|FG006|Treatment Period 1|Withdrawal by Subject|0
7350814|NCT00950807|11592117|FG007|Treatment Period 1|Withdrawal by Subject|0
7350815|NCT00950807|11592118|FG008|Treatment Period 1|Withdrawal by Subject|1
7350816|NCT00950807|11592119|FG009|Treatment Period 1|Withdrawal by Subject|0
7350817|NCT00950807|11592110|FG000|Treatment Period 1|Adverse Event|0
7350818|NCT00950807|11592111|FG001|Treatment Period 1|Adverse Event|0
7350819|NCT00950807|11592112|FG002|Treatment Period 1|Adverse Event|0
7350820|NCT00950807|11592113|FG003|Treatment Period 1|Adverse Event|0
7350821|NCT00950807|11592114|FG004|Treatment Period 1|Adverse Event|0
7350822|NCT00950807|11592115|FG005|Treatment Period 1|Adverse Event|1
7350823|NCT00950807|11592116|FG006|Treatment Period 1|Adverse Event|0
7350824|NCT00950807|11592117|FG007|Treatment Period 1|Adverse Event|0
7350825|NCT00950807|11592118|FG008|Treatment Period 1|Adverse Event|0
7350826|NCT00950807|11592119|FG009|Treatment Period 1|Adverse Event|0
7350827|NCT00950807|11592110|FG000|Washout Period 1|Lack of Efficacy|0
7350828|NCT00950807|11592111|FG001|Washout Period 1|Lack of Efficacy|0
7350829|NCT00950807|11592112|FG002|Washout Period 1|Lack of Efficacy|0
7350830|NCT00950807|11592113|FG003|Washout Period 1|Lack of Efficacy|0
7350831|NCT00950807|11592114|FG004|Washout Period 1|Lack of Efficacy|0
7350832|NCT00950807|11592115|FG005|Washout Period 1|Lack of Efficacy|0
7350833|NCT00950807|11592116|FG006|Washout Period 1|Lack of Efficacy|1
7350834|NCT00950807|11592117|FG007|Washout Period 1|Lack of Efficacy|0
7350835|NCT00950807|11592118|FG008|Washout Period 1|Lack of Efficacy|0
7350836|NCT00950807|11592119|FG009|Washout Period 1|Lack of Efficacy|0
7350837|NCT00950807|11592110|FG000|Washout Period 1|Withdrawal by Subject|0
7350838|NCT00950807|11592111|FG001|Washout Period 1|Withdrawal by Subject|0
7350839|NCT00950807|11592112|FG002|Washout Period 1|Withdrawal by Subject|0
7350840|NCT00950807|11592113|FG003|Washout Period 1|Withdrawal by Subject|0
7350841|NCT00950807|11592114|FG004|Washout Period 1|Withdrawal by Subject|0
7350842|NCT00950807|11592115|FG005|Washout Period 1|Withdrawal by Subject|0
7350843|NCT00950807|11592116|FG006|Washout Period 1|Withdrawal by Subject|0
7350844|NCT00950807|11592117|FG007|Washout Period 1|Withdrawal by Subject|0
7350845|NCT00950807|11592118|FG008|Washout Period 1|Withdrawal by Subject|1
7350846|NCT00950807|11592119|FG009|Washout Period 1|Withdrawal by Subject|0
7350847|NCT00950807|11592110|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
7350848|NCT00950807|11592111|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
7350849|NCT00950807|11592112|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
7350850|NCT00950807|11592113|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
7350851|NCT00950807|11592114|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
7350852|NCT00950807|11592115|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
7350853|NCT00950807|11592116|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
7350854|NCT00950807|11592117|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
7350855|NCT00950807|11592118|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
7350856|NCT00950807|11592119|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
7350857|NCT00950807|11592110|FG000|Washout Period 1|Adverse Event|2
7350858|NCT00950807|11592111|FG001|Washout Period 1|Adverse Event|0
7350859|NCT00950807|11592112|FG002|Washout Period 1|Adverse Event|0
7350860|NCT00950807|11592113|FG003|Washout Period 1|Adverse Event|1
7350861|NCT00950807|11592114|FG004|Washout Period 1|Adverse Event|1
7350862|NCT00950807|11592115|FG005|Washout Period 1|Adverse Event|0
7350863|NCT00950807|11592116|FG006|Washout Period 1|Adverse Event|0
7350864|NCT00950807|11592117|FG007|Washout Period 1|Adverse Event|0
7350865|NCT00950807|11592118|FG008|Washout Period 1|Adverse Event|0
7350866|NCT00950807|11592119|FG009|Washout Period 1|Adverse Event|0
7350867|NCT00950807|11592110|FG000|Treatment Period 2|Lack of Efficacy|1
7350868|NCT00950807|11592111|FG001|Treatment Period 2|Lack of Efficacy|0
7350869|NCT00950807|11592112|FG002|Treatment Period 2|Lack of Efficacy|0
7350870|NCT00950807|11592113|FG003|Treatment Period 2|Lack of Efficacy|0
7350871|NCT00950807|11592114|FG004|Treatment Period 2|Lack of Efficacy|0
7350872|NCT00950807|11592115|FG005|Treatment Period 2|Lack of Efficacy|0
7350873|NCT00950807|11592116|FG006|Treatment Period 2|Lack of Efficacy|0
7350874|NCT00950807|11592117|FG007|Treatment Period 2|Lack of Efficacy|0
7350875|NCT00950807|11592118|FG008|Treatment Period 2|Lack of Efficacy|0
7350876|NCT00950807|11592119|FG009|Treatment Period 2|Lack of Efficacy|0
7350877|NCT00950807|11592110|FG000|Treatment Period 2|Withdrawal by Subject|0
7350878|NCT00950807|11592111|FG001|Treatment Period 2|Withdrawal by Subject|0
7350879|NCT00950807|11592112|FG002|Treatment Period 2|Withdrawal by Subject|0
7350880|NCT00950807|11592113|FG003|Treatment Period 2|Withdrawal by Subject|0
7350881|NCT00950807|11592114|FG004|Treatment Period 2|Withdrawal by Subject|0
7350882|NCT00950807|11592115|FG005|Treatment Period 2|Withdrawal by Subject|0
7350883|NCT00950807|11592116|FG006|Treatment Period 2|Withdrawal by Subject|1
7350884|NCT00950807|11592117|FG007|Treatment Period 2|Withdrawal by Subject|2
7350885|NCT00950807|11592118|FG008|Treatment Period 2|Withdrawal by Subject|0
7350886|NCT00950807|11592119|FG009|Treatment Period 2|Withdrawal by Subject|0
7350887|NCT00950807|11592110|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
7350888|NCT00950807|11592111|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350889|NCT00950807|11592112|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350890|NCT00950807|11592113|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350891|NCT00950807|11592114|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350892|NCT00950807|11592115|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350893|NCT00950807|11592116|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350894|NCT00950807|11592117|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350895|NCT00950807|11592118|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350896|NCT00950807|11592119|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
7350897|NCT00950807|11592110|FG000|Treatment Period 2|Adverse Event|0
7350898|NCT00950807|11592111|FG001|Treatment Period 2|Adverse Event|1
7350899|NCT00950807|11592112|FG002|Treatment Period 2|Adverse Event|0
7350900|NCT00950807|11592113|FG003|Treatment Period 2|Adverse Event|1
7350901|NCT00950807|11592114|FG004|Treatment Period 2|Adverse Event|0
7350902|NCT00950807|11592115|FG005|Treatment Period 2|Adverse Event|1
7350903|NCT00950807|11592116|FG006|Treatment Period 2|Adverse Event|0
7350904|NCT00950807|11592117|FG007|Treatment Period 2|Adverse Event|1
7350905|NCT00950807|11592118|FG008|Treatment Period 2|Adverse Event|0
7350906|NCT00950807|11592119|FG009|Treatment Period 2|Adverse Event|0
7350907|NCT00950807|11592110|FG000|Washout Period 2|Lack of Efficacy|1
7350908|NCT00950807|11592111|FG001|Washout Period 2|Lack of Efficacy|0
7350909|NCT00950807|11592112|FG002|Washout Period 2|Lack of Efficacy|0
7350910|NCT00950807|11592113|FG003|Washout Period 2|Lack of Efficacy|0
7350911|NCT00950807|11592114|FG004|Washout Period 2|Lack of Efficacy|0
7350912|NCT00950807|11592115|FG005|Washout Period 2|Lack of Efficacy|0
7350913|NCT00950807|11592116|FG006|Washout Period 2|Lack of Efficacy|0
7350914|NCT00950807|11592117|FG007|Washout Period 2|Lack of Efficacy|0
7350915|NCT00950807|11592118|FG008|Washout Period 2|Lack of Efficacy|0
7350916|NCT00950807|11592119|FG009|Washout Period 2|Lack of Efficacy|0
7350917|NCT00950807|11592110|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
7350918|NCT00950807|11592111|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
7350919|NCT00950807|11592112|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
7350920|NCT00950807|11592113|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
7350921|NCT00950807|11592114|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
7350922|NCT00950807|11592115|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
7350923|NCT00950807|11592116|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
7350924|NCT00950807|11592117|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
7350925|NCT00950807|11592118|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
7350926|NCT00950807|11592119|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
7350927|NCT00950807|11592110|FG000|Washout Period 2|Adverse Event|3
7350928|NCT00950807|11592111|FG001|Washout Period 2|Adverse Event|0
7350929|NCT00950807|11592112|FG002|Washout Period 2|Adverse Event|0
7350930|NCT00950807|11592113|FG003|Washout Period 2|Adverse Event|1
7350931|NCT00950807|11592114|FG004|Washout Period 2|Adverse Event|0
7350932|NCT00950807|11592115|FG005|Washout Period 2|Adverse Event|0
7350933|NCT00950807|11592116|FG006|Washout Period 2|Adverse Event|0
7350934|NCT00950807|11592117|FG007|Washout Period 2|Adverse Event|0
7350935|NCT00950807|11592118|FG008|Washout Period 2|Adverse Event|0
7350936|NCT00950807|11592119|FG009|Washout Period 2|Adverse Event|0
7350937|NCT00950807|11592110|FG000|Treatment Period 3|Withdrawal by Subject|0
7350938|NCT00950807|11592111|FG001|Treatment Period 3|Withdrawal by Subject|0
7350939|NCT00950807|11592112|FG002|Treatment Period 3|Withdrawal by Subject|0
7350940|NCT00950807|11592113|FG003|Treatment Period 3|Withdrawal by Subject|0
7350941|NCT00950807|11592114|FG004|Treatment Period 3|Withdrawal by Subject|0
7350942|NCT00950807|11592115|FG005|Treatment Period 3|Withdrawal by Subject|0
7350943|NCT00950807|11592116|FG006|Treatment Period 3|Withdrawal by Subject|0
7350944|NCT00950807|11592117|FG007|Treatment Period 3|Withdrawal by Subject|0
7350945|NCT00950807|11592118|FG008|Treatment Period 3|Withdrawal by Subject|0
7350946|NCT00950807|11592119|FG009|Treatment Period 3|Withdrawal by Subject|1
7569220|NCT03442777|11945365|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
7569221|NCT03442777|11945366|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
7350947|NCT00950807|11592110|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
7459317|NCT01816243|11753894|FG000|Overall Study|Amputation|3
7459318|NCT01816295|11753900|FG000|Double Blind Phase|Adverse Event|11
7569222|NCT03442777|11945367|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
7350948|NCT00950807|11592111|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
7569223|NCT03442829|11945375|FG000|Overall Study|Scheduling clash|3
7569224|NCT03442829|11945376|FG001|Overall Study|Scheduling clash|1
7569225|NCT03442829|11945375|FG000|Overall Study|Illness unrelated to study|1
7569226|NCT03442829|11945376|FG001|Overall Study|Illness unrelated to study|1
7569227|NCT03443024|11945400|FG000|Overall Study|Adverse Event|2
7569228|NCT03443024|11945401|FG001|Overall Study|Adverse Event|4
7350949|NCT00950807|11592112|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350950|NCT00950807|11592113|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350951|NCT00950807|11592114|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350952|NCT00950807|11592115|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350953|NCT00950807|11592116|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
7386030|NCT01207440|11644240|FG003|Overall Study|Lack of Efficacy|1
7386031|NCT01207440|11644241|FG004|Overall Study|Lack of Efficacy|2
7459319|NCT01816295|11753901|FG001|Double Blind Phase|Adverse Event|8
7459320|NCT01816295|11753900|FG000|Double Blind Phase|Entry Criteria Not Met|0
7459321|NCT01816295|11753901|FG001|Double Blind Phase|Entry Criteria Not Met|2
7459322|NCT01816295|11753900|FG000|Double Blind Phase|Lost to Follow-up|3
7459323|NCT01816295|11753901|FG001|Double Blind Phase|Lost to Follow-up|5
7459324|NCT01816295|11753900|FG000|Double Blind Phase|Physician Decision|2
7459325|NCT01816295|11753901|FG001|Double Blind Phase|Physician Decision|2
7459326|NCT01816295|11753900|FG000|Double Blind Phase|Protocol Violation|17
7459327|NCT01816295|11753901|FG001|Double Blind Phase|Protocol Violation|11
7459328|NCT01816295|11753900|FG000|Double Blind Phase|Sponsor Decision|8
7459329|NCT01816295|11753901|FG001|Double Blind Phase|Sponsor Decision|8
7459330|NCT01816295|11753900|FG000|Double Blind Phase|Withdrawal by Subject|22
7459331|NCT01816295|11753901|FG001|Double Blind Phase|Withdrawal by Subject|20
7459332|NCT01816295|11753900|FG000|OLE Phase|Adverse Event|17
7459333|NCT01816295|11753901|FG001|OLE Phase|Adverse Event|15
7459334|NCT01816295|11753900|FG000|OLE Phase|Death|1
7459335|NCT01816295|11753901|FG001|OLE Phase|Death|0
7459336|NCT01816295|11753900|FG000|OLE Phase|Entry Criteria Not Met|3
7459337|NCT01816295|11753901|FG001|OLE Phase|Entry Criteria Not Met|5
7459338|NCT01816295|11753900|FG000|OLE Phase|Lost to Follow-up|5
7459339|NCT01816295|11753901|FG001|OLE Phase|Lost to Follow-up|5
7459340|NCT01816295|11753900|FG000|OLE Phase|Physician Decision|3
7459341|NCT01816295|11753901|FG001|OLE Phase|Physician Decision|1
7459342|NCT01816295|11753900|FG000|OLE Phase|Protocol Violation|4
7459343|NCT01816295|11753901|FG001|OLE Phase|Protocol Violation|4
7459344|NCT01816295|11753900|FG000|OLE Phase|Sponsor Decision|7
7459345|NCT01816295|11753901|FG001|OLE Phase|Sponsor Decision|9
7459346|NCT01816295|11753900|FG000|OLE Phase|Withdrawal by Subject|10
7459347|NCT01816295|11753901|FG001|OLE Phase|Withdrawal by Subject|10
7459348|NCT01816295|11753900|FG000|OLE Phase|Lack of Efficacy|3
7459349|NCT01816295|11753901|FG001|OLE Phase|Lack of Efficacy|7
7459350|NCT01816477|11753925|FG000|Overall Study|Withdrawal by Subject|13
7459351|NCT01816477|11753926|FG001|Overall Study|Withdrawal by Subject|1
7459352|NCT01816477|11753925|FG000|Overall Study|Unable to tolerate catheter placement|3
7459353|NCT01816477|11753926|FG001|Overall Study|Unable to tolerate catheter placement|0
7459354|NCT01816594|11753934|FG000|Overall Study|Local Progress|0
7459355|NCT01816594|11753935|FG001|Overall Study|Local Progress|2
7459356|NCT01816594|11753934|FG000|Overall Study|Adverse Event|9
7459357|NCT01816594|11753935|FG001|Overall Study|Adverse Event|0
7459358|NCT01816594|11753934|FG000|Overall Study|Withdrawal by Subject|1
7459359|NCT01816594|11753935|FG001|Overall Study|Withdrawal by Subject|0
7459360|NCT01816594|11753934|FG000|Overall Study|Physician Decision|1
7459361|NCT01816594|11753935|FG001|Overall Study|Physician Decision|0
7459362|NCT01816685|11753949|FG000|Overall Study|Lost to Follow-up|7
7459363|NCT01816685|11753950|FG001|Overall Study|Lost to Follow-up|9
7459364|NCT01816685|11753949|FG000|Overall Study|Surgery Cancelled|3
7459365|NCT01816685|11753950|FG001|Overall Study|Surgery Cancelled|2
7459366|NCT01816763|11753968|FG000|Overall Study|The main reason for an incomplete survey|4
7459367|NCT01816763|11753969|FG001|Overall Study|The main reason for an incomplete survey|15
7459368|NCT01816763|11753970|FG002|Overall Study|The main reason for an incomplete survey|11
7459369|NCT01816893|11753992|FG000|Washout Period|Withdrawal by Subject|2
7459370|NCT01816893|11753993|FG001|Washout Period|Withdrawal by Subject|0
7459371|NCT01816906|11754001|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
7459372|NCT01816906|11754002|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
7459373|NCT01816906|11754001|FG000|Six Months|Lost to Follow-up|14
7459374|NCT01816906|11754002|FG001|Six Months|Lost to Follow-up|16
7459375|NCT01816906|11754001|FG000|12 Months|Adverse Event|2
7459376|NCT01816906|11754002|FG001|12 Months|Adverse Event|2
7459377|NCT01816906|11754001|FG000|12 Months|Death|0
7459378|NCT01816906|11754002|FG001|12 Months|Death|2
7459379|NCT01816906|11754001|FG000|12 Months|Lost to Follow-up|2
7459380|NCT01816906|11754002|FG001|12 Months|Lost to Follow-up|1
7459381|NCT01816984|11754018|FG000|Overall Study|declining health status|1
7459382|NCT01817075|11754024|FG000|Overall Study|Adverse Event|7
7459383|NCT01817075|11754025|FG001|Overall Study|Adverse Event|5
7459384|NCT01817075|11754024|FG000|Overall Study|Physician Decision|9
7459385|NCT01817075|11754025|FG001|Overall Study|Physician Decision|12
7459386|NCT01817075|11754024|FG000|Overall Study|Withdrawal by Subject|31
7459387|NCT01817075|11754025|FG001|Overall Study|Withdrawal by Subject|15
7459388|NCT01817075|11754024|FG000|Overall Study|Received Sorafenib after enrollment|0
7386032|NCT01207440|11644242|FG005|Overall Study|Lack of Efficacy|3
7386033|NCT01207440|11644243|FG006|Overall Study|Lack of Efficacy|0
7386034|NCT01207440|11644237|FG000|Overall Study|Lost to Follow-up|0
7386035|NCT01207440|11644238|FG001|Overall Study|Lost to Follow-up|0
7386036|NCT01207440|11644239|FG002|Overall Study|Lost to Follow-up|2
7386037|NCT01207440|11644240|FG003|Overall Study|Lost to Follow-up|1
7386038|NCT01207440|11644241|FG004|Overall Study|Lost to Follow-up|0
7350954|NCT00950807|11592117|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
7350955|NCT00950807|11592118|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350956|NCT00950807|11592119|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
7350957|NCT00950807|11592110|FG000|Treatment Period 3|Adverse Event|0
7350958|NCT00950807|11592111|FG001|Treatment Period 3|Adverse Event|0
7350959|NCT00950807|11592112|FG002|Treatment Period 3|Adverse Event|0
7350960|NCT00950807|11592113|FG003|Treatment Period 3|Adverse Event|0
7350961|NCT00950807|11592114|FG004|Treatment Period 3|Adverse Event|0
7350962|NCT00950807|11592115|FG005|Treatment Period 3|Adverse Event|0
7350963|NCT00950807|11592116|FG006|Treatment Period 3|Adverse Event|1
7350964|NCT00950807|11592117|FG007|Treatment Period 3|Adverse Event|0
7350965|NCT00950807|11592118|FG008|Treatment Period 3|Adverse Event|0
7350966|NCT00950807|11592119|FG009|Treatment Period 3|Adverse Event|0
7350967|NCT00950859|11592158|FG000|Overall Study|Adverse Event|3
7350968|NCT00950859|11592159|FG001|Overall Study|Adverse Event|3
7350969|NCT00950859|11592158|FG000|Overall Study|Insufficient Viral Load Response|12
7350970|NCT00950859|11592159|FG001|Overall Study|Insufficient Viral Load Response|3
7350971|NCT00950859|11592158|FG000|Overall Study|Protocol Violation|1
7350972|NCT00950859|11592159|FG001|Overall Study|Protocol Violation|1
7350973|NCT00950859|11592158|FG000|Overall Study|Lost to Follow-up|0
7350974|NCT00950859|11592159|FG001|Overall Study|Lost to Follow-up|3
7350975|NCT00950872|11592165|FG000|Overall Study|Withdrawal by Subject|1
7350976|NCT00950872|11592165|FG000|Overall Study|Did not have surgery|2
7350977|NCT00950911|11592171|FG000|Overall Study|Adverse Event|0
7350978|NCT00950911|11592172|FG001|Overall Study|Adverse Event|2
7350979|NCT00950911|11592171|FG000|Overall Study|Death|4
7350980|NCT00950911|11592172|FG001|Overall Study|Death|6
7350981|NCT00950911|11592171|FG000|Overall Study|Disease progression|2
7350982|NCT00950911|11592172|FG001|Overall Study|Disease progression|2
7350983|NCT00950911|11592171|FG000|Overall Study|Consent withdrawn|1
7350984|NCT00950911|11592172|FG001|Overall Study|Consent withdrawn|3
7350985|NCT00950911|11592171|FG000|Overall Study|Administrative decision|3
7350986|NCT00950911|11592172|FG001|Overall Study|Administrative decision|1
7350987|NCT00950911|11592171|FG000|Overall Study|Ineligibility determined|1
7350988|NCT00950911|11592172|FG001|Overall Study|Ineligibility determined|0
7350989|NCT00950911|11592171|FG000|Overall Study|Noncompliance|1
7350990|NCT00950911|11592172|FG001|Overall Study|Noncompliance|0
7350991|NCT00950911|11592171|FG000|Overall Study|Poor performance status|0
7350992|NCT00950911|11592172|FG001|Overall Study|Poor performance status|1
7350993|NCT00950950|11592180|FG000|Overall Study|Adverse Event|1
7350994|NCT00950950|11592181|FG001|Overall Study|Adverse Event|0
7350995|NCT00950950|11592180|FG000|Overall Study|Withdrawal by Subject|0
7350996|NCT00950950|11592181|FG001|Overall Study|Withdrawal by Subject|1
7350997|NCT00950963|11592190|FG000|Overall Study|Lost to Follow-up|29
7350998|NCT00950963|11592191|FG001|Overall Study|Lost to Follow-up|24
7350999|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Adverse Event|1
7351000|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Adverse Event|1
7351001|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Adverse Event|2
7351002|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Adverse Event|5
7351003|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Adverse Event|0
7351004|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
7351005|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
7351006|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
7351007|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
7351008|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
7351009|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Protocol Violation|1
7351010|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Protocol Violation|1
7351011|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Protocol Violation|1
7351012|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Protocol Violation|0
7351013|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Protocol Violation|0
7351014|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7351015|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7351016|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7351017|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
7351018|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
7351019|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
7351020|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
7351021|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
7351022|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
7351023|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
7351024|NCT00951015|11592201|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
7351025|NCT00951015|11592202|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
7351026|NCT00951015|11592203|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
7351027|NCT00951015|11592204|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
7351028|NCT00951015|11592205|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
7351029|NCT00951015|11592201|FG000|Open-label Phase|Adverse Event|0
7351030|NCT00951015|11592202|FG001|Open-label Phase|Adverse Event|0
7351031|NCT00951015|11592203|FG002|Open-label Phase|Adverse Event|0
7351032|NCT00951015|11592204|FG003|Open-label Phase|Adverse Event|0
7351033|NCT00951015|11592205|FG004|Open-label Phase|Adverse Event|3
7351034|NCT00951015|11592201|FG000|Open-label Phase|Lack of Efficacy|0
7351035|NCT00951015|11592202|FG001|Open-label Phase|Lack of Efficacy|0
7351036|NCT00951015|11592203|FG002|Open-label Phase|Lack of Efficacy|0
7351037|NCT00951015|11592204|FG003|Open-label Phase|Lack of Efficacy|0
7351038|NCT00951015|11592205|FG004|Open-label Phase|Lack of Efficacy|1
7351039|NCT00951015|11592201|FG000|Open-label Phase|Protocol Violation|0
7351040|NCT00951015|11592202|FG001|Open-label Phase|Protocol Violation|0
7351041|NCT00951015|11592203|FG002|Open-label Phase|Protocol Violation|0
7351042|NCT00951015|11592204|FG003|Open-label Phase|Protocol Violation|0
7351043|NCT00951015|11592205|FG004|Open-label Phase|Protocol Violation|12
7351044|NCT00951015|11592201|FG000|Open-label Phase|Lost to Follow-up|0
7351045|NCT00951015|11592202|FG001|Open-label Phase|Lost to Follow-up|0
7351046|NCT00951015|11592203|FG002|Open-label Phase|Lost to Follow-up|0
7351047|NCT00951015|11592204|FG003|Open-label Phase|Lost to Follow-up|0
7351048|NCT00951015|11592205|FG004|Open-label Phase|Lost to Follow-up|12
7351049|NCT00951015|11592201|FG000|Open-label Phase|Withdrawal by Subject|0
7351050|NCT00951015|11592202|FG001|Open-label Phase|Withdrawal by Subject|0
7351051|NCT00951015|11592203|FG002|Open-label Phase|Withdrawal by Subject|0
7351052|NCT00951015|11592204|FG003|Open-label Phase|Withdrawal by Subject|0
7351053|NCT00951015|11592205|FG004|Open-label Phase|Withdrawal by Subject|14
7351054|NCT00951015|11592201|FG000|Open-label Phase|Physician Decision|0
7351055|NCT00951015|11592202|FG001|Open-label Phase|Physician Decision|0
7351056|NCT00951015|11592203|FG002|Open-label Phase|Physician Decision|0
7351057|NCT00951015|11592204|FG003|Open-label Phase|Physician Decision|0
7351058|NCT00951015|11592205|FG004|Open-label Phase|Physician Decision|8
7351059|NCT00951041|11592230|FG000|Overall Study|Withdrawal by Subject|1
7351060|NCT00951041|11592231|FG001|Overall Study|Withdrawal by Subject|1
7351061|NCT00951041|11592230|FG000|Overall Study|Lost to Follow-up|1
7351062|NCT00951041|11592231|FG001|Overall Study|Lost to Follow-up|0
7351063|NCT00951041|11592230|FG000|Overall Study|Other|3
7351064|NCT00951041|11592231|FG001|Overall Study|Other|0
7351073|NCT00951171|11592255|FG000|Overall Study|Adverse Event|2
7351074|NCT00951171|11592256|FG001|Overall Study|Adverse Event|0
7351075|NCT00951275|11592262|FG000|Overall Study|Administrative Reason|1
7351076|NCT00951275|11592262|FG000|Overall Study|Adverse Event|7
7351077|NCT00951275|11592262|FG000|Overall Study|Withdrawal by Subject|4
7351078|NCT00951275|11592262|FG000|Overall Study|Protocol Violation|1
7351079|NCT00951379|11592268|FG000|Overall Study|Adverse Event|4
7569229|NCT03443024|11945402|FG002|Overall Study|Adverse Event|3
7569230|NCT03443024|11945403|FG003|Overall Study|Adverse Event|1
7351080|NCT00951379|11592269|FG001|Overall Study|Adverse Event|1
7351081|NCT00951379|11592268|FG000|Overall Study|Withdrawal by Subject|1
7351082|NCT00951379|11592269|FG001|Overall Study|Withdrawal by Subject|0
7351083|NCT00951379|11592268|FG000|Overall Study|Noncompliance|1
7351084|NCT00951379|11592269|FG001|Overall Study|Noncompliance|0
7351085|NCT00951379|11592268|FG000|Overall Study|Disease Progression|0
7351086|NCT00951379|11592269|FG001|Overall Study|Disease Progression|1
7351087|NCT00951483|11592285|FG000|Overall Study|Physician Decision|4
7351088|NCT00951483|11592286|FG001|Overall Study|Physician Decision|0
7351089|NCT00951483|11592285|FG000|Overall Study|Withdrawal by Subject|15
7351090|NCT00951483|11592286|FG001|Overall Study|Withdrawal by Subject|0
7351091|NCT00951496|11592297|FG000|Overall Study|Did not initiate study treatment|10
7351092|NCT00951496|11592298|FG001|Overall Study|Did not initiate study treatment|8
7351093|NCT00951496|11592299|FG002|Overall Study|Did not initiate study treatment|13
7351094|NCT00951509|11592310|FG000|Overall Study|Withdrawal by Subject|2
7351095|NCT00951665|11592332|FG000|Phase 1b|Adverse Event|2
7351096|NCT00951665|11592333|FG001|Phase 1b|Adverse Event|1
7351097|NCT00951665|11592334|FG002|Phase 1b|Adverse Event|0
7351098|NCT00951665|11592335|FG003|Phase 1b|Adverse Event|1
7351099|NCT00951665|11592336|FG004|Phase 1b|Adverse Event|0
7351100|NCT00951665|11592337|FG005|Phase 1b|Adverse Event|0
7351101|NCT00951665|11592332|FG000|Phase 1b|Death|1
7351102|NCT00951665|11592333|FG001|Phase 1b|Death|0
7569231|NCT03443024|11945400|FG000|Overall Study|Lost to Follow-up|9
7351103|NCT00951665|11592334|FG002|Phase 1b|Death|2
7351104|NCT00951665|11592335|FG003|Phase 1b|Death|0
7351105|NCT00951665|11592336|FG004|Phase 1b|Death|0
7351106|NCT00951665|11592337|FG005|Phase 1b|Death|0
7351107|NCT00951665|11592332|FG000|Phase 1b|Physician Decision|4
7351108|NCT00951665|11592333|FG001|Phase 1b|Physician Decision|0
7351109|NCT00951665|11592334|FG002|Phase 1b|Physician Decision|1
7351110|NCT00951665|11592335|FG003|Phase 1b|Physician Decision|0
7351111|NCT00951665|11592336|FG004|Phase 1b|Physician Decision|0
7351112|NCT00951665|11592337|FG005|Phase 1b|Physician Decision|0
7351113|NCT00951665|11592332|FG000|Phase 1b|Withdrawal by Subject|0
7351114|NCT00951665|11592333|FG001|Phase 1b|Withdrawal by Subject|1
7351115|NCT00951665|11592334|FG002|Phase 1b|Withdrawal by Subject|0
7351116|NCT00951665|11592335|FG003|Phase 1b|Withdrawal by Subject|0
7351117|NCT00951665|11592336|FG004|Phase 1b|Withdrawal by Subject|0
7351118|NCT00951665|11592337|FG005|Phase 1b|Withdrawal by Subject|0
7351119|NCT00951665|11592332|FG000|Phase 1b|Disease Progression|13
7351120|NCT00951665|11592333|FG001|Phase 1b|Disease Progression|2
7351121|NCT00951665|11592334|FG002|Phase 1b|Disease Progression|14
7351122|NCT00951665|11592335|FG003|Phase 1b|Disease Progression|0
7351123|NCT00951665|11592336|FG004|Phase 1b|Disease Progression|0
7351124|NCT00951665|11592337|FG005|Phase 1b|Disease Progression|0
7351125|NCT00951665|11592332|FG000|Phase 1b|Protocol Violation|2
7351126|NCT00951665|11592333|FG001|Phase 1b|Protocol Violation|0
7351127|NCT00951665|11592334|FG002|Phase 1b|Protocol Violation|0
7351128|NCT00951665|11592335|FG003|Phase 1b|Protocol Violation|0
7351129|NCT00951665|11592336|FG004|Phase 1b|Protocol Violation|0
7351130|NCT00951665|11592337|FG005|Phase 1b|Protocol Violation|0
7351131|NCT00951665|11592332|FG000|Phase 2a|Adverse Event|0
7351132|NCT00951665|11592333|FG001|Phase 2a|Adverse Event|0
7351133|NCT00951665|11592334|FG002|Phase 2a|Adverse Event|0
7351134|NCT00951665|11592335|FG003|Phase 2a|Adverse Event|0
7351135|NCT00951665|11592336|FG004|Phase 2a|Adverse Event|2
7351136|NCT00951665|11592337|FG005|Phase 2a|Adverse Event|0
7351137|NCT00951665|11592332|FG000|Phase 2a|Death|0
7351138|NCT00951665|11592333|FG001|Phase 2a|Death|0
7351139|NCT00951665|11592334|FG002|Phase 2a|Death|0
7351140|NCT00951665|11592335|FG003|Phase 2a|Death|0
7351141|NCT00951665|11592336|FG004|Phase 2a|Death|1
7351142|NCT00951665|11592337|FG005|Phase 2a|Death|1
7351143|NCT00951665|11592332|FG000|Phase 2a|Lost to Follow-up|0
7351144|NCT00951665|11592333|FG001|Phase 2a|Lost to Follow-up|0
7351145|NCT00951665|11592334|FG002|Phase 2a|Lost to Follow-up|0
7351146|NCT00951665|11592335|FG003|Phase 2a|Lost to Follow-up|0
7351147|NCT00951665|11592336|FG004|Phase 2a|Lost to Follow-up|1
7351148|NCT00951665|11592337|FG005|Phase 2a|Lost to Follow-up|0
7351149|NCT00951665|11592332|FG000|Phase 2a|Physician Decision|0
7351150|NCT00951665|11592333|FG001|Phase 2a|Physician Decision|0
7351151|NCT00951665|11592334|FG002|Phase 2a|Physician Decision|0
7351152|NCT00951665|11592335|FG003|Phase 2a|Physician Decision|0
7351153|NCT00951665|11592336|FG004|Phase 2a|Physician Decision|0
7351154|NCT00951665|11592337|FG005|Phase 2a|Physician Decision|1
7351155|NCT00951665|11592332|FG000|Phase 2a|Withdrawal by Subject|0
7351156|NCT00951665|11592333|FG001|Phase 2a|Withdrawal by Subject|0
7351157|NCT00951665|11592334|FG002|Phase 2a|Withdrawal by Subject|0
7351158|NCT00951665|11592335|FG003|Phase 2a|Withdrawal by Subject|0
7351159|NCT00951665|11592336|FG004|Phase 2a|Withdrawal by Subject|2
7351160|NCT00951665|11592337|FG005|Phase 2a|Withdrawal by Subject|0
7351161|NCT00951665|11592332|FG000|Phase 2a|Disease Progression|0
7351162|NCT00951665|11592333|FG001|Phase 2a|Disease Progression|0
7351163|NCT00951665|11592334|FG002|Phase 2a|Disease Progression|0
7351164|NCT00951665|11592335|FG003|Phase 2a|Disease Progression|0
7351165|NCT00951665|11592336|FG004|Phase 2a|Disease Progression|6
7351166|NCT00951665|11592337|FG005|Phase 2a|Disease Progression|5
7351167|NCT00951912|11592400|FG000|Overall Study|Lack of Efficacy|1
7351168|NCT00951912|11592401|FG001|Overall Study|Lack of Efficacy|0
7351169|NCT00951912|11592402|FG002|Overall Study|Lack of Efficacy|0
7351170|NCT00951912|11592400|FG000|Overall Study|Adverse Event|0
7351171|NCT00951912|11592401|FG001|Overall Study|Adverse Event|1
7351172|NCT00951912|11592402|FG002|Overall Study|Adverse Event|1
7351173|NCT00951912|11592400|FG000|Overall Study|Lost to Follow-up|2
7351174|NCT00951912|11592401|FG001|Overall Study|Lost to Follow-up|2
7351175|NCT00951912|11592402|FG002|Overall Study|Lost to Follow-up|0
7351176|NCT00951912|11592400|FG000|Overall Study|Physician Decision|1
7351177|NCT00951912|11592401|FG001|Overall Study|Physician Decision|0
7351178|NCT00951912|11592402|FG002|Overall Study|Physician Decision|1
7351179|NCT00951912|11592400|FG000|Overall Study|Withdrawal by Subject|1
7351180|NCT00951912|11592401|FG001|Overall Study|Withdrawal by Subject|1
7351181|NCT00951912|11592402|FG002|Overall Study|Withdrawal by Subject|0
7569232|NCT03443024|11945401|FG001|Overall Study|Lost to Follow-up|9
7569233|NCT03443024|11945402|FG002|Overall Study|Lost to Follow-up|7
7351182|NCT00951912|11592400|FG000|Overall Study|Other:Depression|1
7351183|NCT00951912|11592401|FG001|Overall Study|Other:Depression|0
7351184|NCT00951912|11592402|FG002|Overall Study|Other:Depression|0
7351185|NCT00951912|11592400|FG000|Overall Study|Other: Colon cancer|1
7351186|NCT00951912|11592401|FG001|Overall Study|Other: Colon cancer|0
7351187|NCT00951912|11592402|FG002|Overall Study|Other: Colon cancer|0
7351188|NCT00951912|11592400|FG000|Overall Study|Other: Stroke|0
7351189|NCT00951912|11592401|FG001|Overall Study|Other: Stroke|1
7351190|NCT00951912|11592402|FG002|Overall Study|Other: Stroke|0
7569234|NCT03443024|11945403|FG003|Overall Study|Lost to Follow-up|5
7569235|NCT03443024|11945400|FG000|Overall Study|Withdrawal by Subject|8
7351191|NCT00952068|11592410|FG000|Overall Study|Adverse Event|3
7351192|NCT00952068|11592410|FG000|Overall Study|Withdrawal by Subject|4
7386039|NCT01207440|11644242|FG005|Overall Study|Lost to Follow-up|0
7386040|NCT01207440|11644243|FG006|Overall Study|Lost to Follow-up|0
7386041|NCT01207440|11644237|FG000|Overall Study|Non-compliance with Study Drug|3
7386042|NCT01207440|11644238|FG001|Overall Study|Non-compliance with Study Drug|0
7386043|NCT01207440|11644239|FG002|Overall Study|Non-compliance with Study Drug|1
7386044|NCT01207440|11644240|FG003|Overall Study|Non-compliance with Study Drug|0
7386045|NCT01207440|11644241|FG004|Overall Study|Non-compliance with Study Drug|0
7386046|NCT01207440|11644242|FG005|Overall Study|Non-compliance with Study Drug|0
7386047|NCT01207440|11644243|FG006|Overall Study|Non-compliance with Study Drug|0
7351193|NCT00952276|11592454|FG000|Overall Study|Withdrawal by Subject|1
7351194|NCT00952276|11592455|FG001|Overall Study|Withdrawal by Subject|0
7351195|NCT00952276|11592456|FG002|Overall Study|Withdrawal by Subject|0
7351196|NCT00952276|11592457|FG003|Overall Study|Withdrawal by Subject|1
7351197|NCT00952276|11592458|FG004|Overall Study|Withdrawal by Subject|0
7351198|NCT00952289|11592472|FG000|All Participants|Death|9
7351199|NCT00952289|11592473|FG001|All Participants|Death|9
7351200|NCT00952289|11592472|FG000|All Participants|Adverse Event|8
7351201|NCT00952289|11592473|FG001|All Participants|Adverse Event|8
7351202|NCT00952289|11592472|FG000|All Participants|Disease progression|3
7351203|NCT00952289|11592473|FG001|All Participants|Disease progression|12
7351204|NCT00952289|11592472|FG000|All Participants|Withdrawal by Subject|1
7351205|NCT00952289|11592473|FG001|All Participants|Withdrawal by Subject|10
7351206|NCT00952289|11592472|FG000|All Participants|Data lost during site relocation|0
7351207|NCT00952289|11592473|FG001|All Participants|Data lost during site relocation|1
7351208|NCT00952289|11592472|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
7351209|NCT00952289|11592473|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
7351210|NCT00952289|11592472|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
7351211|NCT00952289|11592473|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
7351212|NCT00952289|11592472|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
7351213|NCT00952289|11592473|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
7351214|NCT00952289|11592472|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
7351215|NCT00952289|11592473|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
7351216|NCT00952289|11592472|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
7351217|NCT00952289|11592473|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
7351218|NCT00952341|11592497|FG000|Cycle 1|Adverse Event|4
7351219|NCT00952341|11592498|FG001|Cycle 1|Adverse Event|1
7351220|NCT00952341|11592497|FG000|Cycle 1|Withdrawal by Subject|3
7351221|NCT00952341|11592498|FG001|Cycle 1|Withdrawal by Subject|8
7351222|NCT00952341|11592497|FG000|Cycle 1|Protocol Violation|2
7351223|NCT00952341|11592498|FG001|Cycle 1|Protocol Violation|1
7351224|NCT00952341|11592497|FG000|Cycle 1|Lost to Follow-up|11
7351225|NCT00952341|11592498|FG001|Cycle 1|Lost to Follow-up|2
7351226|NCT00952341|11592497|FG000|Cycle 1|Physician Decision|0
7351227|NCT00952341|11592498|FG001|Cycle 1|Physician Decision|1
7351228|NCT00952341|11592497|FG000|Cycle 2|Withdrawal by Subject|1
7351229|NCT00952341|11592498|FG001|Cycle 2|Withdrawal by Subject|1
7351230|NCT00952341|11592497|FG000|Cycle 2|Protocol Violation|1
7351231|NCT00952341|11592498|FG001|Cycle 2|Protocol Violation|0
7351232|NCT00952341|11592497|FG000|Cycle 2|Lost to Follow-up|6
7351233|NCT00952341|11592498|FG001|Cycle 2|Lost to Follow-up|9
7351234|NCT00952341|11592497|FG000|Cycle 2|Physician Decision|1
7351235|NCT00952341|11592498|FG001|Cycle 2|Physician Decision|1
7351236|NCT00952341|11592497|FG000|Cycle 2|Progressive Disease|0
7351237|NCT00952341|11592498|FG001|Cycle 2|Progressive Disease|1
7351238|NCT00952367|11592504|FG000|Overall Study|Withdrawal by Subject|2
7351239|NCT00952367|11592504|FG000|Overall Study|Noncoordination|1
7351240|NCT00952367|11592504|FG000|Overall Study|Protocol Violation|3
7351241|NCT00952380|11592513|FG000|Overall Study|Other|0
7351242|NCT00952380|11592514|FG001|Overall Study|Other|0
7351243|NCT00952380|11592515|FG002|Overall Study|Other|0
7351244|NCT00952380|11592516|FG003|Overall Study|Other|0
7351245|NCT00952380|11592517|FG004|Overall Study|Other|1
7351246|NCT00952380|11592513|FG000|Overall Study|Withdrawal by Subject|0
7351247|NCT00952380|11592514|FG001|Overall Study|Withdrawal by Subject|0
7351248|NCT00952380|11592515|FG002|Overall Study|Withdrawal by Subject|1
7351249|NCT00952380|11592516|FG003|Overall Study|Withdrawal by Subject|0
7351250|NCT00952380|11592517|FG004|Overall Study|Withdrawal by Subject|2
7351251|NCT00952380|11592513|FG000|Overall Study|Adverse Event|0
7351252|NCT00952380|11592514|FG001|Overall Study|Adverse Event|1
7351253|NCT00952380|11592515|FG002|Overall Study|Adverse Event|0
7351254|NCT00952380|11592516|FG003|Overall Study|Adverse Event|0
7351255|NCT00952380|11592517|FG004|Overall Study|Adverse Event|3
7569236|NCT03443024|11945401|FG001|Overall Study|Withdrawal by Subject|15
7569237|NCT03443024|11945402|FG002|Overall Study|Withdrawal by Subject|9
7569238|NCT03443024|11945403|FG003|Overall Study|Withdrawal by Subject|23
7569239|NCT03443024|11945400|FG000|Overall Study|Physician Decision|1
7569240|NCT03443024|11945401|FG001|Overall Study|Physician Decision|2
7569241|NCT03443024|11945402|FG002|Overall Study|Physician Decision|0
7569242|NCT03443024|11945403|FG003|Overall Study|Physician Decision|1
7569243|NCT03443024|11945400|FG000|Overall Study|Sponsor Decision|1
7569244|NCT03443024|11945401|FG001|Overall Study|Sponsor Decision|1
7351256|NCT00952380|11592513|FG000|Overall Study|Physician Decision|0
7351257|NCT00952380|11592514|FG001|Overall Study|Physician Decision|0
7351258|NCT00952380|11592515|FG002|Overall Study|Physician Decision|1
7569245|NCT03443024|11945402|FG002|Overall Study|Sponsor Decision|0
7351259|NCT00952380|11592516|FG003|Overall Study|Physician Decision|2
7351260|NCT00952380|11592517|FG004|Overall Study|Physician Decision|0
7351261|NCT00952380|11592513|FG000|Overall Study|Non-compliant to protocol|0
7351262|NCT00952380|11592514|FG001|Overall Study|Non-compliant to protocol|0
7351263|NCT00952380|11592515|FG002|Overall Study|Non-compliant to protocol|0
7351264|NCT00952380|11592516|FG003|Overall Study|Non-compliant to protocol|1
7351265|NCT00952380|11592517|FG004|Overall Study|Non-compliant to protocol|0
7351266|NCT00952419|11592541|FG000|Overall Study|Adverse Event|2
7351267|NCT00952419|11592542|FG001|Overall Study|Adverse Event|0
7351268|NCT00952419|11592543|FG002|Overall Study|Adverse Event|0
7351269|NCT00952419|11592541|FG000|Overall Study|Protocol Violation|3
7351270|NCT00952419|11592542|FG001|Overall Study|Protocol Violation|7
7351271|NCT00952419|11592543|FG002|Overall Study|Protocol Violation|0
7351272|NCT00952419|11592541|FG000|Overall Study|Withdrawal by Subject|1
7351273|NCT00952419|11592542|FG001|Overall Study|Withdrawal by Subject|3
7351274|NCT00952419|11592543|FG002|Overall Study|Withdrawal by Subject|0
7351275|NCT00952484|11592554|FG000|Overall Study|Withdrawal by Subject|0
7351276|NCT00952484|11592555|FG001|Overall Study|Withdrawal by Subject|1
7351277|NCT00952484|11592556|FG002|Overall Study|Withdrawal by Subject|0
7351278|NCT00952523|11592565|FG000|Overall Study|Withdrawal by Subject|7
7351279|NCT00952588|11592573|FG000|Overall Study|Death|28
7351280|NCT00952588|11592574|FG001|Overall Study|Death|13
7351281|NCT00952588|11592573|FG000|Overall Study|Withdrawal by Subject|2
7351282|NCT00952588|11592574|FG001|Overall Study|Withdrawal by Subject|5
7351283|NCT00952588|11592573|FG000|Overall Study|Adverse Event|2
7351284|NCT00952588|11592574|FG001|Overall Study|Adverse Event|3
7351285|NCT00952588|11592573|FG000|Overall Study|Lost to Follow-up|2
7351286|NCT00952588|11592574|FG001|Overall Study|Lost to Follow-up|0
7351287|NCT00952588|11592573|FG000|Overall Study|Physician Decision|0
7351288|NCT00952588|11592574|FG001|Overall Study|Physician Decision|1
7351289|NCT00952588|11592573|FG000|Overall Study|Lack of Efficacy|2
7351290|NCT00952588|11592574|FG001|Overall Study|Lack of Efficacy|2
7351291|NCT00952614|11592580|FG000|Overall Study|Death|3
7351292|NCT00952614|11592580|FG000|Overall Study|Lost to Follow-up|3
7351293|NCT00952614|11592580|FG000|Overall Study|other reason|1
7351294|NCT00952705|11592595|FG000|Overall Study|Lost to Follow-up|24
7351295|NCT00952705|11592596|FG001|Overall Study|Lost to Follow-up|8
7351296|NCT00952705|11592597|FG002|Overall Study|Lost to Follow-up|9
7351297|NCT00952705|11592595|FG000|Overall Study|Withdrawal by Subject|2
7351298|NCT00952705|11592596|FG001|Overall Study|Withdrawal by Subject|1
7351299|NCT00952705|11592597|FG002|Overall Study|Withdrawal by Subject|1
7351300|NCT00952705|11592595|FG000|Overall Study|Death|2
7351301|NCT00952705|11592596|FG001|Overall Study|Death|0
7351302|NCT00952705|11592597|FG002|Overall Study|Death|0
7351303|NCT00952705|11592595|FG000|Overall Study|Incarcerated post dose|5
7351304|NCT00952705|11592596|FG001|Overall Study|Incarcerated post dose|0
7351305|NCT00952705|11592597|FG002|Overall Study|Incarcerated post dose|0
7351306|NCT00952705|11592595|FG000|Overall Study|Exclusion criteria not met pre dose|0
7351307|NCT00952705|11592596|FG001|Overall Study|Exclusion criteria not met pre dose|1
7351308|NCT00952705|11592597|FG002|Overall Study|Exclusion criteria not met pre dose|0
7351309|NCT00952731|11592622|FG000|Overall Study|Drug supply expired|1
7351310|NCT00952731|11592623|FG001|Overall Study|Drug supply expired|0
7351311|NCT00952822|11592629|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7351312|NCT00952822|11592630|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
7351313|NCT00952822|11592631|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7569246|NCT03443024|11945403|FG003|Overall Study|Sponsor Decision|0
7569247|NCT03443024|11945400|FG000|Overall Study|Protocol Deviation|0
7569248|NCT03443024|11945401|FG001|Overall Study|Protocol Deviation|0
7569249|NCT03443024|11945402|FG002|Overall Study|Protocol Deviation|0
7569250|NCT03443024|11945403|FG003|Overall Study|Protocol Deviation|2
7569251|NCT03443414|11945429|FG000|Overall Study|Adverse Event|6
7569252|NCT03443414|11945430|FG001|Overall Study|Adverse Event|0
7569253|NCT03443414|11945431|FG002|Overall Study|Adverse Event|4
7569254|NCT03443414|11945432|FG003|Overall Study|Adverse Event|2
7569255|NCT03443414|11945433|FG004|Overall Study|Adverse Event|3
7569256|NCT03443414|11945429|FG000|Overall Study|Withdrawal by Subject|3
7569257|NCT03443414|11945430|FG001|Overall Study|Withdrawal by Subject|2
7569258|NCT03443414|11945431|FG002|Overall Study|Withdrawal by Subject|2
7569259|NCT03443414|11945432|FG003|Overall Study|Withdrawal by Subject|2
7569260|NCT03443414|11945433|FG004|Overall Study|Withdrawal by Subject|1
7569261|NCT03443414|11945429|FG000|Overall Study|Death|0
7569262|NCT03443414|11945430|FG001|Overall Study|Death|1
7569263|NCT03443414|11945431|FG002|Overall Study|Death|0
7569264|NCT03443414|11945432|FG003|Overall Study|Death|1
7569265|NCT03443414|11945433|FG004|Overall Study|Death|0
7569266|NCT03443414|11945429|FG000|Overall Study|Reason not specified|2
7351314|NCT00952822|11592632|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
7351315|NCT00952822|11592629|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7351316|NCT00952822|11592630|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7351317|NCT00952822|11592631|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
7351318|NCT00952822|11592632|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
7351319|NCT00952848|11592643|FG000|Overall Study|Withdrawal by Subject|4
7351320|NCT00953017|11592651|FG000|Overall Study|DId not show up for colonoscopy|4
7351321|NCT00953017|11592652|FG001|Overall Study|DId not show up for colonoscopy|4
7351322|NCT00953017|11592653|FG002|Overall Study|DId not show up for colonoscopy|5
7351323|NCT00953017|11592654|FG003|Overall Study|DId not show up for colonoscopy|4
7569267|NCT03443414|11945430|FG001|Overall Study|Reason not specified|0
7569268|NCT03443414|11945431|FG002|Overall Study|Reason not specified|0
7569269|NCT03443414|11945432|FG003|Overall Study|Reason not specified|0
7569270|NCT03443414|11945433|FG004|Overall Study|Reason not specified|1
7569271|NCT03443427|11945447|FG000|Overall Study|Adverse Event|2
7351324|NCT00953017|11592651|FG000|Overall Study|Incomplete data|1
7351325|NCT00953017|11592652|FG001|Overall Study|Incomplete data|1
7351326|NCT00953017|11592653|FG002|Overall Study|Incomplete data|0
7351327|NCT00953017|11592654|FG003|Overall Study|Incomplete data|0
7351328|NCT00953017|11592651|FG000|Overall Study|Procedure incomplete due to pain/looping|0
7351329|NCT00953017|11592652|FG001|Overall Study|Procedure incomplete due to pain/looping|1
7351330|NCT00953017|11592653|FG002|Overall Study|Procedure incomplete due to pain/looping|0
7351331|NCT00953017|11592654|FG003|Overall Study|Procedure incomplete due to pain/looping|1
7351332|NCT00953017|11592651|FG000|Overall Study|Brown stool prior to procedure|0
7351333|NCT00953017|11592652|FG001|Overall Study|Brown stool prior to procedure|0
7351334|NCT00953017|11592653|FG002|Overall Study|Brown stool prior to procedure|1
7351335|NCT00953017|11592654|FG003|Overall Study|Brown stool prior to procedure|0
7351336|NCT00953043|11592666|FG000|Overall Study|Withdrawal by Subject|4
7351337|NCT00953043|11592667|FG001|Overall Study|Withdrawal by Subject|0
7351338|NCT00953043|11592666|FG000|Overall Study|Physician Decision|0
7351339|NCT00953043|11592667|FG001|Overall Study|Physician Decision|2
7351340|NCT00953056|11592679|FG000|Overall Study|Withdrew Consent|0
7351341|NCT00953056|11592680|FG001|Overall Study|Withdrew Consent|0
7351342|NCT00953056|11592681|FG002|Overall Study|Withdrew Consent|0
7351343|NCT00953056|11592682|FG003|Overall Study|Withdrew Consent|0
7351344|NCT00953056|11592683|FG004|Overall Study|Withdrew Consent|2
7351345|NCT00953056|11592684|FG005|Overall Study|Withdrew Consent|3
7351346|NCT00953056|11592679|FG000|Overall Study|Serious Adverse Event|0
7351347|NCT00953056|11592680|FG001|Overall Study|Serious Adverse Event|0
7351348|NCT00953056|11592681|FG002|Overall Study|Serious Adverse Event|0
7351349|NCT00953056|11592682|FG003|Overall Study|Serious Adverse Event|0
7351350|NCT00953056|11592683|FG004|Overall Study|Serious Adverse Event|0
7351351|NCT00953056|11592684|FG005|Overall Study|Serious Adverse Event|1
7351352|NCT00953147|11592716|FG000|Overall Study|Adverse Event|8
7351353|NCT00953147|11592717|FG001|Overall Study|Adverse Event|16
7351354|NCT00953147|11592718|FG002|Overall Study|Adverse Event|6
7351355|NCT00953147|11592716|FG000|Overall Study|Protocol Violation|2
7351356|NCT00953147|11592717|FG001|Overall Study|Protocol Violation|8
7351357|NCT00953147|11592718|FG002|Overall Study|Protocol Violation|4
7351358|NCT00953147|11592716|FG000|Overall Study|Withdrawal by Subject|13
7351359|NCT00953147|11592717|FG001|Overall Study|Withdrawal by Subject|15
7351360|NCT00953147|11592718|FG002|Overall Study|Withdrawal by Subject|12
7351361|NCT00953147|11592716|FG000|Overall Study|Lost to Follow-up|8
7351362|NCT00953147|11592717|FG001|Overall Study|Lost to Follow-up|9
7351363|NCT00953147|11592718|FG002|Overall Study|Lost to Follow-up|4
7351364|NCT00953147|11592716|FG000|Overall Study|Physician Decision|2
7351365|NCT00953147|11592717|FG001|Overall Study|Physician Decision|7
7351366|NCT00953147|11592718|FG002|Overall Study|Physician Decision|3
7351367|NCT00953147|11592716|FG000|Overall Study|Other|4
7351368|NCT00953147|11592717|FG001|Overall Study|Other|11
7351369|NCT00953147|11592718|FG002|Overall Study|Other|13
7351370|NCT00953160|11592726|FG000|Overall Study|Lost to Follow-up|23
7351371|NCT00953160|11592726|FG000|Overall Study|Withdrawal by Subject|4
7351372|NCT00953225|11592768|FG000|Overall Study|Withdrawal by Subject|2
7351373|NCT00953225|11592769|FG001|Overall Study|Withdrawal by Subject|0
7351374|NCT00953407|11592787|FG000|Overall Study|Failed inclusion criteria|1
7351375|NCT00953407|11592788|FG001|Overall Study|Failed inclusion criteria|1
7351376|NCT00953407|11592789|FG002|Overall Study|Failed inclusion criteria|1
7351377|NCT00953407|11592790|FG003|Overall Study|Failed inclusion criteria|1
7351378|NCT00953407|11592791|FG004|Overall Study|Failed inclusion criteria|1
7351379|NCT00953407|11592787|FG000|Overall Study|Lost to Follow-up|0
7351380|NCT00953407|11592788|FG001|Overall Study|Lost to Follow-up|0
7351381|NCT00953407|11592789|FG002|Overall Study|Lost to Follow-up|0
7351382|NCT00953407|11592790|FG003|Overall Study|Lost to Follow-up|1
7351383|NCT00953407|11592791|FG004|Overall Study|Lost to Follow-up|0
7351384|NCT00953524|11592807|FG000|Overall Study|Adverse Event|2
7351385|NCT00953524|11592808|FG001|Overall Study|Adverse Event|0
7351386|NCT00953524|11592809|FG002|Overall Study|Adverse Event|1
7351387|NCT00953524|11592810|FG003|Overall Study|Adverse Event|2
7351388|NCT00953524|11592807|FG000|Overall Study|Protocol Violation|18
7351389|NCT00953524|11592808|FG001|Overall Study|Protocol Violation|10
7351390|NCT00953524|11592809|FG002|Overall Study|Protocol Violation|11
7351391|NCT00953524|11592810|FG003|Overall Study|Protocol Violation|6
7351392|NCT00953524|11592807|FG000|Overall Study|Lost to Follow-up|0
7351393|NCT00953524|11592808|FG001|Overall Study|Lost to Follow-up|1
7351394|NCT00953524|11592809|FG002|Overall Study|Lost to Follow-up|1
7351395|NCT00953524|11592810|FG003|Overall Study|Lost to Follow-up|0
7351396|NCT00953524|11592807|FG000|Overall Study|Withdrawal by Subject|2
7351397|NCT00953524|11592808|FG001|Overall Study|Withdrawal by Subject|4
7351398|NCT00953524|11592809|FG002|Overall Study|Withdrawal by Subject|1
7351399|NCT00953524|11592810|FG003|Overall Study|Withdrawal by Subject|0
7351400|NCT00953576|11592822|FG000|Overall Study|Adverse Event|0
7351401|NCT00953576|11592823|FG001|Overall Study|Adverse Event|1
7351402|NCT00953576|11592822|FG000|Overall Study|Ineligible after Consent|2
7351403|NCT00953576|11592823|FG001|Overall Study|Ineligible after Consent|0
7351404|NCT00953667|11592845|FG000|Overall Study|Lost to Follow-up|11
7351405|NCT00953667|11592845|FG000|Overall Study|Physician Decision|35
7351406|NCT00953667|11592845|FG000|Overall Study|Withdrawal by Subject|63
7351407|NCT00953667|11592845|FG000|Overall Study|Adverse Event|10
7351408|NCT00953667|11592845|FG000|Overall Study|poor venous access,unable to draw blood|4
7351409|NCT00953706|11592851|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
7351410|NCT00953706|11592852|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
7351411|NCT00953706|11592853|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7351412|NCT00953706|11592854|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
7351413|NCT00953706|11592851|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7351414|NCT00953706|11592852|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
7351415|NCT00953706|11592853|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7351416|NCT00953706|11592854|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
7351417|NCT00953706|11592851|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7351418|NCT00953706|11592852|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
7351419|NCT00953706|11592853|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7351420|NCT00953706|11592854|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
7351421|NCT00953706|11592851|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7351422|NCT00953706|11592852|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
7351423|NCT00953706|11592853|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7351424|NCT00953706|11592854|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
7351425|NCT00953706|11592851|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7351426|NCT00953706|11592852|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
7351427|NCT00953706|11592853|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7351428|NCT00953706|11592854|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
7533125|NCT02680847|11879220|FG001|Overall Study|Other|0
7533126|NCT02680847|11879221|FG002|Overall Study|Other|0
7533127|NCT02680847|11879219|FG000|Overall Study|No longer met eligibility criteria|2
7533128|NCT02680847|11879220|FG001|Overall Study|No longer met eligibility criteria|2
7533129|NCT02680847|11879221|FG002|Overall Study|No longer met eligibility criteria|0
7533130|NCT02680847|11879219|FG000|Overall Study|Unwilling to participate in study|1
7533131|NCT02680847|11879220|FG001|Overall Study|Unwilling to participate in study|1
7533132|NCT02680847|11879221|FG002|Overall Study|Unwilling to participate in study|0
7533133|NCT02680847|11879219|FG000|Overall Study|Lack of Efficacy|0
7533134|NCT02680847|11879220|FG001|Overall Study|Lack of Efficacy|0
7533135|NCT02680847|11879221|FG002|Overall Study|Lack of Efficacy|2
7533136|NCT02680847|11879219|FG000|Overall Study|Adverse Event|0
7533137|NCT02680847|11879220|FG001|Overall Study|Adverse Event|0
7533138|NCT02680847|11879221|FG002|Overall Study|Adverse Event|1
7533139|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
7533140|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
7533141|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
7533142|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
7533143|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
7533144|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
7533145|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
7533146|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
7533147|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
7533148|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
7533149|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
7533150|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
7533151|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
7533152|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
7533153|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
7533154|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|Other|6
7533155|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|Other|6
7533156|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|Other|7
7533157|NCT02681094|11879232|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
7533158|NCT02681094|11879233|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
7533159|NCT02681094|11879234|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
7533160|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Participant decision|7
7533161|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Participant decision|10
7533162|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Participant decision|9
7533163|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Adverse Event|10
7533164|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Adverse Event|4
7533165|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Adverse Event|1
7533166|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
7533167|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
7533168|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
7533169|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
7533170|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
7533171|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
7537668|NCT02759185|11886792|FG004|Stage 1|Adverse Event|0
7533172|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
7533173|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
7533174|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
7533175|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|Other|6
7533176|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|Other|6
7533177|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|Other|7
7351429|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
7351430|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
7351431|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
7351432|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
7351433|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7351434|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7351435|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
7351436|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
7351437|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7351438|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7351439|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
7351440|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
7351441|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7351442|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
7533178|NCT02681094|11879232|FG000|2 - Enrolled Participants Set|No treatment given|0
7533179|NCT02681094|11879233|FG001|2 - Enrolled Participants Set|No treatment given|1
7351443|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
7351444|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
7351445|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7351446|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
7351447|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
7351448|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
7351449|NCT00953706|11592851|FG000|Part B (96-Week Open-Label Extension)|Other|0
7351450|NCT00953706|11592852|FG001|Part B (96-Week Open-Label Extension)|Other|0
7351451|NCT00953706|11592853|FG002|Part B (96-Week Open-Label Extension)|Other|0
7351452|NCT00953706|11592854|FG003|Part B (96-Week Open-Label Extension)|Other|2
7351453|NCT00953745|11592875|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
7351454|NCT00953745|11592876|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
7351455|NCT00953745|11592875|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
7351456|NCT00953745|11592876|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
7351457|NCT00953745|11592875|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
7351458|NCT00953745|11592876|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
7351459|NCT00953745|11592875|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
7351460|NCT00953745|11592876|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
7351461|NCT00953745|11592875|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
7351462|NCT00953745|11592876|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
7351463|NCT00953745|11592875|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
7351464|NCT00953745|11592876|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
7351465|NCT00953927|11592913|FG000|Overall Study|Lost to Follow-up|61
7351466|NCT00953927|11592914|FG001|Overall Study|Lost to Follow-up|65
7351467|NCT00953927|11592913|FG000|Overall Study|Withdrawal by Subject|36
7351468|NCT00953927|11592914|FG001|Overall Study|Withdrawal by Subject|25
7351469|NCT00953927|11592913|FG000|Overall Study|Death|7
7351470|NCT00953927|11592914|FG001|Overall Study|Death|4
7351471|NCT00953927|11592913|FG000|Overall Study|Other study discontinuation|1
7351472|NCT00953927|11592914|FG001|Overall Study|Other study discontinuation|1
7351473|NCT00954122|11592924|FG000|Overall Study|Withdrawal by Subject|5
7351474|NCT00954122|11592924|FG000|Overall Study|Adverse Event|1
7351475|NCT00954122|11592924|FG000|Overall Study|Safety Reason|1
7351476|NCT00954174|11592933|FG000|Overall Study|Adverse Event|28
7569272|NCT03443427|11945448|FG001|Overall Study|Adverse Event|3
7569273|NCT03443427|11945447|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
7569274|NCT03443427|11945448|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
7569275|NCT03443427|11945447|FG000|Overall Study|Other|4
7569276|NCT03443427|11945448|FG001|Overall Study|Other|6
7569277|NCT03443713|11945457|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7569278|NCT03443713|11945458|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
7569279|NCT03443713|11945459|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
7569280|NCT03444155|11945482|FG000|First Intervention (6 Weeks)|Adverse Event|1
7569281|NCT03444155|11945483|FG001|First Intervention (6 Weeks)|Adverse Event|0
7569282|NCT03444584|11945491|FG000|Overall Study|Withdrawal by Subject|0
7569283|NCT03444584|11945492|FG001|Overall Study|Withdrawal by Subject|1
7569284|NCT03444584|11945491|FG000|Overall Study|Other|0
7569285|NCT03444584|11945492|FG001|Overall Study|Other|1
7569286|NCT03444766|11945499|FG000|Overall Study|Other Reasons|2
7569287|NCT03444766|11945499|FG000|Overall Study|Participant Withdrew Consent|5
7569288|NCT03444766|11945499|FG000|Overall Study|Lost to Follow-up|2
7569289|NCT03444766|11945499|FG000|Overall Study|Death|2
7569290|NCT03444766|11945499|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
7569291|NCT03444766|11945499|FG000|Overall Study|Disease Progression|49
7569292|NCT03445065|11945515|FG000|Overall Study|Withdrawal by Subject|3
7569293|NCT03445065|11945516|FG001|Overall Study|Withdrawal by Subject|6
7569294|NCT03445065|11945517|FG002|Overall Study|Withdrawal by Subject|2
7569295|NCT03445065|11945518|FG003|Overall Study|Withdrawal by Subject|2
7569296|NCT03445065|11945515|FG000|Overall Study|Other|4
7569297|NCT03445065|11945516|FG001|Overall Study|Other|3
7569298|NCT03445065|11945517|FG002|Overall Study|Other|3
7569299|NCT03445065|11945518|FG003|Overall Study|Other|1
7569300|NCT03446781|11945625|FG000|Overall Study|Lost to Follow-up|11
7569301|NCT03446781|11945626|FG001|Overall Study|Lost to Follow-up|5
7569302|NCT03446781|11945625|FG000|Overall Study|Withdrawal by Subject|9
7569303|NCT03446781|11945626|FG001|Overall Study|Withdrawal by Subject|7
7569304|NCT03446781|11945625|FG000|Overall Study|Adverse Event|8
7569305|NCT03446781|11945626|FG001|Overall Study|Adverse Event|2
7569306|NCT03446781|11945625|FG000|Overall Study|Protocol Violation|0
7569307|NCT03446781|11945626|FG001|Overall Study|Protocol Violation|3
7569308|NCT03446885|11945667|FG000|Overall Study|Lost to Follow-up|1
7569309|NCT03446885|11945668|FG001|Overall Study|Lost to Follow-up|0
7569310|NCT03446885|11945667|FG000|Overall Study|Did not complete entire visit|1
7569311|NCT03446885|11945668|FG001|Overall Study|Did not complete entire visit|0
7351477|NCT00954174|11592934|FG001|Overall Study|Adverse Event|23
7569312|NCT03447249|11945687|FG000|Overall Study|Adverse Event|1
7569313|NCT03447249|11945688|FG001|Overall Study|Adverse Event|0
7569314|NCT03447249|11945687|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
7569315|NCT03447249|11945688|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
7351478|NCT00954174|11592935|FG002|Overall Study|Adverse Event|4
7351479|NCT00954174|11592936|FG003|Overall Study|Adverse Event|9
7351480|NCT00954174|11592933|FG000|Overall Study|Death|4
7351481|NCT00954174|11592934|FG001|Overall Study|Death|2
7351482|NCT00954174|11592935|FG002|Overall Study|Death|0
7351483|NCT00954174|11592936|FG003|Overall Study|Death|0
7351484|NCT00954174|11592933|FG000|Overall Study|Lack of Efficacy|32
7351485|NCT00954174|11592934|FG001|Overall Study|Lack of Efficacy|22
7351486|NCT00954174|11592935|FG002|Overall Study|Lack of Efficacy|8
7351487|NCT00954174|11592936|FG003|Overall Study|Lack of Efficacy|6
7351488|NCT00954174|11592933|FG000|Overall Study|Withdrawal by Subject|14
7351489|NCT00954174|11592934|FG001|Overall Study|Withdrawal by Subject|10
7351490|NCT00954174|11592935|FG002|Overall Study|Withdrawal by Subject|4
7351491|NCT00954174|11592936|FG003|Overall Study|Withdrawal by Subject|3
7351492|NCT00954174|11592933|FG000|Overall Study|Medical Reason|4
7351493|NCT00954174|11592934|FG001|Overall Study|Medical Reason|2
7351494|NCT00954174|11592935|FG002|Overall Study|Medical Reason|1
7351495|NCT00954174|11592936|FG003|Overall Study|Medical Reason|0
7351496|NCT00954174|11592933|FG000|Overall Study|Ineligible|40
7351497|NCT00954174|11592934|FG001|Overall Study|Ineligible|47
7351498|NCT00954174|11592935|FG002|Overall Study|Ineligible|7
7351499|NCT00954174|11592936|FG003|Overall Study|Ineligible|4
7351500|NCT00954174|11592933|FG000|Overall Study|Never Treated|4
7351501|NCT00954174|11592934|FG001|Overall Study|Never Treated|17
7351502|NCT00954174|11592935|FG002|Overall Study|Never Treated|0
7351503|NCT00954174|11592936|FG003|Overall Study|Never Treated|3
7351504|NCT00954421|11592958|FG000|Screening|screen failures|3
7351505|NCT00954421|11592958|FG000|6 Months of DBS|Withdrawal by Subject|1
7351506|NCT00954421|11592958|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
7351507|NCT00954447|11592966|FG000|Overall Study|Adverse Event|33
7351508|NCT00954447|11592967|FG001|Overall Study|Adverse Event|25
7351509|NCT00954447|11592966|FG000|Overall Study|Lack of Efficacy|17
7351510|NCT00954447|11592967|FG001|Overall Study|Lack of Efficacy|3
7351511|NCT00954447|11592966|FG000|Overall Study|Protocol Violation|5
7351512|NCT00954447|11592967|FG001|Overall Study|Protocol Violation|7
7351513|NCT00954447|11592966|FG000|Overall Study|Lost to Follow-up|8
7351514|NCT00954447|11592967|FG001|Overall Study|Lost to Follow-up|14
7351515|NCT00954447|11592966|FG000|Overall Study|Withdrawal by Subject|26
7351516|NCT00954447|11592967|FG001|Overall Study|Withdrawal by Subject|21
7351517|NCT00954447|11592966|FG000|Overall Study|Other|21
7351518|NCT00954447|11592967|FG001|Overall Study|Other|18
7351519|NCT00954512|11592979|FG000|Overall Study|Withdrawal by Subject|0
7351520|NCT00954512|11592980|FG001|Overall Study|Withdrawal by Subject|0
7351521|NCT00954512|11592981|FG002|Overall Study|Withdrawal by Subject|0
7351522|NCT00954512|11592982|FG003|Overall Study|Withdrawal by Subject|0
7459389|NCT01817075|11754025|FG001|Overall Study|Received Sorafenib after enrollment|1
7569316|NCT03447249|11945687|FG000|Overall Study|Other|3
7569317|NCT03447249|11945688|FG001|Overall Study|Other|0
7569318|NCT03447353|11945696|FG000|Overall Study|Failure at Screening Visit|2
7569319|NCT03447353|11945696|FG000|Overall Study|Lost to Follow-up|4
7569320|NCT03447353|11945696|FG000|Overall Study|Scheduling Conflicts|3
7569321|NCT03447353|11945696|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
7569322|NCT03447730|11945709|FG000|Overall Study|Adverse Event|0
7351523|NCT00954512|11592983|FG004|Overall Study|Withdrawal by Subject|0
7569323|NCT03447730|11945710|FG001|Overall Study|Adverse Event|2
7569324|NCT03447730|11945711|FG002|Overall Study|Adverse Event|0
7569325|NCT03447821|11945722|FG000|Overall Study|Withdrawal by Subject|1
7569326|NCT03447821|11945723|FG001|Overall Study|Withdrawal by Subject|1
7351524|NCT00954512|11592984|FG005|Overall Study|Withdrawal by Subject|1
7459390|NCT01817075|11754024|FG000|Overall Study|Ineligible|0
7351525|NCT00954512|11592979|FG000|Overall Study|Adverse Event|0
7351526|NCT00954512|11592980|FG001|Overall Study|Adverse Event|0
7351527|NCT00954512|11592981|FG002|Overall Study|Adverse Event|0
7351528|NCT00954512|11592982|FG003|Overall Study|Adverse Event|0
7351529|NCT00954512|11592983|FG004|Overall Study|Adverse Event|1
7351530|NCT00954512|11592984|FG005|Overall Study|Adverse Event|2
7351531|NCT00954512|11592979|FG000|Overall Study|Physician Decision|0
7351532|NCT00954512|11592980|FG001|Overall Study|Physician Decision|1
7351533|NCT00954512|11592981|FG002|Overall Study|Physician Decision|0
7351534|NCT00954512|11592982|FG003|Overall Study|Physician Decision|1
7351535|NCT00954512|11592983|FG004|Overall Study|Physician Decision|0
7351536|NCT00954512|11592984|FG005|Overall Study|Physician Decision|0
7351537|NCT00954512|11592979|FG000|Overall Study|Symptomatic Deterioration|0
7351538|NCT00954512|11592980|FG001|Overall Study|Symptomatic Deterioration|1
7351539|NCT00954512|11592981|FG002|Overall Study|Symptomatic Deterioration|0
7351540|NCT00954512|11592982|FG003|Overall Study|Symptomatic Deterioration|0
7351541|NCT00954512|11592983|FG004|Overall Study|Symptomatic Deterioration|2
7351542|NCT00954512|11592984|FG005|Overall Study|Symptomatic Deterioration|0
7351543|NCT00954512|11592979|FG000|Overall Study|Progression of Disease|2
7351544|NCT00954512|11592980|FG001|Overall Study|Progression of Disease|1
7351545|NCT00954512|11592981|FG002|Overall Study|Progression of Disease|0
7351546|NCT00954512|11592982|FG003|Overall Study|Progression of Disease|1
7351547|NCT00954512|11592983|FG004|Overall Study|Progression of Disease|1
7351548|NCT00954512|11592984|FG005|Overall Study|Progression of Disease|1
7351549|NCT00954538|11592999|FG000|Part III|Withdrawal by Subject|0
7351550|NCT00954538|11593000|FG001|Part III|Withdrawal by Subject|0
7351551|NCT00954538|11593001|FG002|Part III|Withdrawal by Subject|0
7351552|NCT00954538|11593002|FG003|Part III|Withdrawal by Subject|0
7351553|NCT00954538|11593003|FG004|Part III|Withdrawal by Subject|1
7351554|NCT00954538|11593004|FG005|Part III|Withdrawal by Subject|0
7351555|NCT00954707|11593017|FG000|Overall Study|Death|34
7351556|NCT00954707|11593017|FG000|Overall Study|Withdrawal by Subject|100
7351557|NCT00954707|11593017|FG000|Overall Study|Lost to Follow-up|33
7351558|NCT00954733|11593021|FG000|Overall Study|blood gas machine did not work|1
7351559|NCT00954941|11593031|FG000|Overall Study|Received treatment at home|1
7351560|NCT00954941|11593032|FG001|Overall Study|Received treatment at home|0
7351561|NCT00954941|11593031|FG000|Overall Study|Withdrawal by Subject|1
7351562|NCT00954941|11593032|FG001|Overall Study|Withdrawal by Subject|0
7351563|NCT00954941|11593031|FG000|Overall Study|Insurance Denial|2
7351564|NCT00954941|11593032|FG001|Overall Study|Insurance Denial|2
7351565|NCT00954941|11593031|FG000|Overall Study|Physician Decision|2
7351566|NCT00954941|11593032|FG001|Overall Study|Physician Decision|2
7351567|NCT00954941|11593031|FG000|Overall Study|Ineligible|2
7351568|NCT00954941|11593032|FG001|Overall Study|Ineligible|2
7351569|NCT00954941|11593031|FG000|Overall Study|Adverse Event|0
7351570|NCT00954941|11593032|FG001|Overall Study|Adverse Event|1
7351571|NCT00955110|11593062|FG000|Qualification Phase|Did not meet eligibility criteria|24
7351572|NCT00955110|11593062|FG000|Treatment Phase|Adverse Event|2
7351573|NCT00955110|11593062|FG000|Treatment Phase|Administrative reasons|2
7351574|NCT00955110|11593062|FG000|Treatment Phase|Non-compliance with study restrictions|1
7351575|NCT00955110|11593062|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
7351576|NCT00955279|11593118|FG000|Overall Study|Other|0
7351577|NCT00955279|11593119|FG001|Overall Study|Other|0
7351578|NCT00955279|11593120|FG002|Overall Study|Other|3
7351579|NCT00955279|11593118|FG000|Overall Study|Death|1
7351580|NCT00955279|11593119|FG001|Overall Study|Death|1
7351581|NCT00955279|11593120|FG002|Overall Study|Death|1
7533180|NCT02681094|11879234|FG002|2 - Enrolled Participants Set|No treatment given|1
7537669|NCT02759185|11886793|FG005|Stage 1|Adverse Event|0
7537670|NCT02759185|11886794|FG006|Stage 1|Adverse Event|0
7537671|NCT02759185|11886788|FG000|Stage 1|Withdrawal by Subject|1
7537672|NCT02759185|11886789|FG001|Stage 1|Withdrawal by Subject|0
7537673|NCT02759185|11886790|FG002|Stage 1|Withdrawal by Subject|0
7351582|NCT00955279|11593118|FG000|Overall Study|Lost to Follow-up|0
7351583|NCT00955279|11593119|FG001|Overall Study|Lost to Follow-up|3
7351584|NCT00955279|11593120|FG002|Overall Study|Lost to Follow-up|1
7351585|NCT00955279|11593118|FG000|Overall Study|Withdrawal by Subject|2
7351586|NCT00955279|11593119|FG001|Overall Study|Withdrawal by Subject|0
7351587|NCT00955279|11593120|FG002|Overall Study|Withdrawal by Subject|3
7351588|NCT00955305|11593130|FG000|Overall Study|Disease progression|39
7351589|NCT00955305|11593131|FG001|Overall Study|Disease progression|41
7351590|NCT00955305|11593130|FG000|Overall Study|Adverse Event|22
7351591|NCT00955305|11593131|FG001|Overall Study|Adverse Event|22
7351592|NCT00955305|11593130|FG000|Overall Study|Death|2
7351593|NCT00955305|11593131|FG001|Overall Study|Death|1
7537674|NCT02759185|11886791|FG003|Stage 1|Withdrawal by Subject|0
7537675|NCT02759185|11886792|FG004|Stage 1|Withdrawal by Subject|0
7537676|NCT02759185|11886793|FG005|Stage 1|Withdrawal by Subject|0
7537677|NCT02759185|11886794|FG006|Stage 1|Withdrawal by Subject|0
7537678|NCT02759185|11886788|FG000|Stage 2|Adverse Event|0
7537679|NCT02759185|11886789|FG001|Stage 2|Adverse Event|0
7537680|NCT02759185|11886790|FG002|Stage 2|Adverse Event|0
7351594|NCT00955305|11593130|FG000|Overall Study|Withdrawal by Subject|5
7351595|NCT00955305|11593131|FG001|Overall Study|Withdrawal by Subject|4
7351596|NCT00955305|11593130|FG000|Overall Study|Alternative therapy|4
7351597|NCT00955305|11593131|FG001|Overall Study|Alternative therapy|0
7351598|NCT00955305|11593130|FG000|Overall Study|Other complicating disease|2
7351599|NCT00955305|11593131|FG001|Overall Study|Other complicating disease|4
7351600|NCT00955305|11593130|FG000|Overall Study|Physician Decision|1
7351601|NCT00955305|11593131|FG001|Overall Study|Physician Decision|0
7351602|NCT00955305|11593130|FG000|Overall Study|Continued presence of residual disease|0
7351603|NCT00955305|11593131|FG001|Overall Study|Continued presence of residual disease|1
7351604|NCT00955305|11593130|FG000|Overall Study|Functional decline|2
7351605|NCT00955305|11593131|FG001|Overall Study|Functional decline|0
7351606|NCT00955305|11593130|FG000|Overall Study|Maximum response achieved|0
7351607|NCT00955305|11593131|FG001|Overall Study|Maximum response achieved|1
7537681|NCT02759185|11886791|FG003|Stage 2|Adverse Event|0
7537682|NCT02759185|11886792|FG004|Stage 2|Adverse Event|1
7351608|NCT00955305|11593130|FG000|Overall Study|Lost to Follow-up|0
7351609|NCT00955305|11593131|FG001|Overall Study|Lost to Follow-up|1
7351610|NCT00955305|11593130|FG000|Overall Study|No off-treatment reason submitted|1
7351611|NCT00955305|11593131|FG001|Overall Study|No off-treatment reason submitted|0
7351612|NCT00955305|11593130|FG000|Overall Study|Never started protocol treatment|5
7351613|NCT00955305|11593131|FG001|Overall Study|Never started protocol treatment|5
7351614|NCT00955305|11593130|FG000|Overall Study|Ineligible|5
7351615|NCT00955305|11593131|FG001|Overall Study|Ineligible|7
7351616|NCT00955357|11593139|FG000|Titration Phase|Adverse Event|9
7351617|NCT00955357|11593140|FG001|Titration Phase|Adverse Event|46
7351618|NCT00955357|11593139|FG000|Titration Phase|Lack of Efficacy|0
7351619|NCT00955357|11593140|FG001|Titration Phase|Lack of Efficacy|2
7351620|NCT00955357|11593139|FG000|Titration Phase|Protocol Violation|3
7351621|NCT00955357|11593140|FG001|Titration Phase|Protocol Violation|7
7351622|NCT00955357|11593139|FG000|Titration Phase|Lost to Follow-up|1
7351623|NCT00955357|11593140|FG001|Titration Phase|Lost to Follow-up|3
7351624|NCT00955357|11593139|FG000|Titration Phase|Withdrawal by Subject|3
7351625|NCT00955357|11593140|FG001|Titration Phase|Withdrawal by Subject|5
7351626|NCT00955357|11593139|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
7351627|NCT00955357|11593140|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
7351628|NCT00955357|11593139|FG000|Titration Phase|Study medication not tolerated|0
7351629|NCT00955357|11593140|FG001|Titration Phase|Study medication not tolerated|1
7351630|NCT00955357|11593139|FG000|Titration Phase|Non compliance to study procedures|0
7351631|NCT00955357|11593140|FG001|Titration Phase|Non compliance to study procedures|1
7351632|NCT00955357|11593139|FG000|Maintenance Phase|Adverse Event|3
7351633|NCT00955357|11593140|FG001|Maintenance Phase|Adverse Event|23
7351634|NCT00955357|11593139|FG000|Maintenance Phase|Lack of Efficacy|0
7351635|NCT00955357|11593140|FG001|Maintenance Phase|Lack of Efficacy|4
7351636|NCT00955357|11593139|FG000|Maintenance Phase|Protocol Violation|2
7351637|NCT00955357|11593140|FG001|Maintenance Phase|Protocol Violation|6
7351638|NCT00955357|11593139|FG000|Maintenance Phase|Lost to Follow-up|2
7351639|NCT00955357|11593140|FG001|Maintenance Phase|Lost to Follow-up|7
7351640|NCT00955357|11593139|FG000|Maintenance Phase|Withdrawal by Subject|4
7351641|NCT00955357|11593140|FG001|Maintenance Phase|Withdrawal by Subject|4
7351642|NCT00955357|11593139|FG000|Maintenance Phase|Patient moving out of area|0
7351643|NCT00955357|11593140|FG001|Maintenance Phase|Patient moving out of area|1
7351644|NCT00955357|11593139|FG000|Maintenance Phase|Non compliance to study procedures|1
7351645|NCT00955357|11593140|FG001|Maintenance Phase|Non compliance to study procedures|0
7351646|NCT00955409|11593156|FG000|Overall Study|Lack of Efficacy|1
7351647|NCT00955409|11593157|FG001|Overall Study|Lack of Efficacy|0
7351648|NCT00955409|11593158|FG002|Overall Study|Lack of Efficacy|0
7351649|NCT00955409|11593159|FG003|Overall Study|Lack of Efficacy|0
7351650|NCT00955409|11593160|FG004|Overall Study|Lack of Efficacy|0
7351651|NCT00955409|11593161|FG005|Overall Study|Lack of Efficacy|0
7351652|NCT00955409|11593162|FG006|Overall Study|Lack of Efficacy|0
7351653|NCT00955409|11593163|FG007|Overall Study|Lack of Efficacy|0
7351654|NCT00955409|11593164|FG008|Overall Study|Lack of Efficacy|0
7351655|NCT00955409|11593165|FG009|Overall Study|Lack of Efficacy|0
7351656|NCT00955409|11593156|FG000|Overall Study|Withdrawal by Subject|1
7351657|NCT00955409|11593157|FG001|Overall Study|Withdrawal by Subject|0
7351658|NCT00955409|11593158|FG002|Overall Study|Withdrawal by Subject|5
7351659|NCT00955409|11593159|FG003|Overall Study|Withdrawal by Subject|2
7351660|NCT00955409|11593160|FG004|Overall Study|Withdrawal by Subject|0
7351661|NCT00955409|11593161|FG005|Overall Study|Withdrawal by Subject|0
7351662|NCT00955409|11593162|FG006|Overall Study|Withdrawal by Subject|2
7351663|NCT00955409|11593163|FG007|Overall Study|Withdrawal by Subject|0
7351664|NCT00955409|11593164|FG008|Overall Study|Withdrawal by Subject|1
7351665|NCT00955409|11593165|FG009|Overall Study|Withdrawal by Subject|0
7351666|NCT00955409|11593156|FG000|Overall Study|Caregiver Request|2
7351667|NCT00955409|11593157|FG001|Overall Study|Caregiver Request|0
7351668|NCT00955409|11593158|FG002|Overall Study|Caregiver Request|6
7351669|NCT00955409|11593159|FG003|Overall Study|Caregiver Request|5
7351670|NCT00955409|11593160|FG004|Overall Study|Caregiver Request|0
7351671|NCT00955409|11593161|FG005|Overall Study|Caregiver Request|2
7351672|NCT00955409|11593162|FG006|Overall Study|Caregiver Request|3
7351673|NCT00955409|11593163|FG007|Overall Study|Caregiver Request|1
7351674|NCT00955409|11593164|FG008|Overall Study|Caregiver Request|3
7351675|NCT00955409|11593165|FG009|Overall Study|Caregiver Request|0
7351676|NCT00955409|11593156|FG000|Overall Study|Investigator Request|0
7351677|NCT00955409|11593157|FG001|Overall Study|Investigator Request|0
7351678|NCT00955409|11593158|FG002|Overall Study|Investigator Request|1
7351679|NCT00955409|11593159|FG003|Overall Study|Investigator Request|0
7351680|NCT00955409|11593160|FG004|Overall Study|Investigator Request|0
7351681|NCT00955409|11593161|FG005|Overall Study|Investigator Request|0
7351682|NCT00955409|11593162|FG006|Overall Study|Investigator Request|0
7351683|NCT00955409|11593163|FG007|Overall Study|Investigator Request|0
7351684|NCT00955409|11593164|FG008|Overall Study|Investigator Request|0
7351685|NCT00955409|11593165|FG009|Overall Study|Investigator Request|0
7351686|NCT00955409|11593156|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7351687|NCT00955409|11593157|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7351688|NCT00955409|11593158|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7351689|NCT00955409|11593159|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7351690|NCT00955409|11593160|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7351691|NCT00955409|11593161|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7351692|NCT00955409|11593162|FG006|Overall Study|Discontinuation of Study by Sponsor|0
7351693|NCT00955409|11593163|FG007|Overall Study|Discontinuation of Study by Sponsor|1
7351694|NCT00955409|11593164|FG008|Overall Study|Discontinuation of Study by Sponsor|0
7351695|NCT00955409|11593165|FG009|Overall Study|Discontinuation of Study by Sponsor|0
7351696|NCT00955409|11593156|FG000|Overall Study|Lost to Follow-up|0
7351697|NCT00955409|11593157|FG001|Overall Study|Lost to Follow-up|0
7351698|NCT00955409|11593158|FG002|Overall Study|Lost to Follow-up|1
7351699|NCT00955409|11593159|FG003|Overall Study|Lost to Follow-up|0
7351700|NCT00955409|11593160|FG004|Overall Study|Lost to Follow-up|0
7351701|NCT00955409|11593161|FG005|Overall Study|Lost to Follow-up|0
7351702|NCT00955409|11593162|FG006|Overall Study|Lost to Follow-up|1
7351703|NCT00955409|11593163|FG007|Overall Study|Lost to Follow-up|0
7351704|NCT00955409|11593164|FG008|Overall Study|Lost to Follow-up|0
7351705|NCT00955409|11593165|FG009|Overall Study|Lost to Follow-up|0
7351706|NCT00955409|11593156|FG000|Overall Study|Failed to Return|2
7351707|NCT00955409|11593157|FG001|Overall Study|Failed to Return|0
7351708|NCT00955409|11593158|FG002|Overall Study|Failed to Return|0
7569327|NCT03447821|11945724|FG002|Overall Study|Withdrawal by Subject|0
7569328|NCT03447821|11945722|FG000|Overall Study|Lost to Follow-up|0
7569329|NCT03447821|11945723|FG001|Overall Study|Lost to Follow-up|0
7569330|NCT03447821|11945724|FG002|Overall Study|Lost to Follow-up|1
7569331|NCT03448224|11945743|FG000|Overall Study|Provided same answer to every question|1
7569332|NCT03448224|11945744|FG001|Overall Study|Provided same answer to every question|0
7569333|NCT03448406|11945752|FG000|Overall Study|Noncompliance of scheduled visits|1
7569334|NCT03448406|11945753|FG001|Overall Study|Noncompliance of scheduled visits|2
7569335|NCT03448406|11945752|FG000|Overall Study|Withdrawal by Subject|1
7569336|NCT03448406|11945753|FG001|Overall Study|Withdrawal by Subject|2
7569337|NCT03448406|11945752|FG000|Overall Study|Protocol Violation|1
7569338|NCT03448406|11945753|FG001|Overall Study|Protocol Violation|0
7569339|NCT03448406|11945752|FG000|Overall Study|Adverse Event|8
7569340|NCT03448406|11945753|FG001|Overall Study|Adverse Event|9
7569341|NCT03448419|11945761|FG000|Overall Study|Adverse Event|10
7569342|NCT03448419|11945762|FG001|Overall Study|Adverse Event|9
7569343|NCT03448419|11945761|FG000|Overall Study|Lost to Follow-up|0
7569344|NCT03448419|11945762|FG001|Overall Study|Lost to Follow-up|2
7569345|NCT03448419|11945761|FG000|Overall Study|Withdrawal by Subject|3
7569346|NCT03448419|11945762|FG001|Overall Study|Withdrawal by Subject|1
7569347|NCT03448419|11945761|FG000|Overall Study|Not treated|0
7569348|NCT03448419|11945762|FG001|Overall Study|Not treated|1
7569349|NCT03448419|11945761|FG000|Overall Study|Patient did not attend all visits|0
7569350|NCT03448419|11945762|FG001|Overall Study|Patient did not attend all visits|2
7569351|NCT03448419|11945761|FG000|Overall Study|Withdrawn by Sponsor|0
7569352|NCT03448419|11945762|FG001|Overall Study|Withdrawn by Sponsor|1
7569353|NCT03448536|11945772|FG000|Overall Study|Protocol Violation|2
7569354|NCT03448536|11945773|FG001|Overall Study|Protocol Violation|0
7569355|NCT03448536|11945772|FG000|Overall Study|Pregnancy|1
7569356|NCT03448536|11945773|FG001|Overall Study|Pregnancy|0
7569357|NCT03448536|11945772|FG000|Overall Study|Withdrawal by Subject|1
7569358|NCT03448536|11945773|FG001|Overall Study|Withdrawal by Subject|2
7569359|NCT03448536|11945772|FG000|Overall Study|Lost to Follow-up|3
7569360|NCT03448536|11945773|FG001|Overall Study|Lost to Follow-up|2
7569361|NCT03448536|11945772|FG000|Overall Study|Inadequate pain reporter|1
7351709|NCT00955409|11593159|FG003|Overall Study|Failed to Return|0
7351710|NCT00955409|11593160|FG004|Overall Study|Failed to Return|0
7351711|NCT00955409|11593161|FG005|Overall Study|Failed to Return|0
7351712|NCT00955409|11593162|FG006|Overall Study|Failed to Return|0
7351713|NCT00955409|11593163|FG007|Overall Study|Failed to Return|2
7351714|NCT00955409|11593164|FG008|Overall Study|Failed to Return|0
7351715|NCT00955409|11593165|FG009|Overall Study|Failed to Return|0
7351716|NCT00955409|11593156|FG000|Overall Study|Adverse Event (AE)|2
7569362|NCT03448536|11945773|FG001|Overall Study|Inadequate pain reporter|0
7569363|NCT03448536|11945772|FG000|Overall Study|Other|3
7351717|NCT00955409|11593157|FG001|Overall Study|Adverse Event (AE)|0
7459391|NCT01817075|11754025|FG001|Overall Study|Ineligible|2
7459392|NCT01817530|11754055|FG000|Overall Study|Exclusionary Medication Received|0
7459393|NCT01817530|11754056|FG001|Overall Study|Exclusionary Medication Received|0
7459394|NCT01817530|11754057|FG002|Overall Study|Exclusionary Medication Received|0
7459395|NCT01817530|11754058|FG003|Overall Study|Exclusionary Medication Received|0
7459396|NCT01817530|11754059|FG004|Overall Study|Exclusionary Medication Received|1
7459397|NCT01817530|11754060|FG005|Overall Study|Exclusionary Medication Received|0
7459398|NCT01817530|11754061|FG006|Overall Study|Exclusionary Medication Received|0
7459399|NCT01817530|11754062|FG007|Overall Study|Exclusionary Medication Received|0
7459400|NCT01817530|11754055|FG000|Overall Study|Adverse Event|6
7459401|NCT01817530|11754056|FG001|Overall Study|Adverse Event|3
7459402|NCT01817530|11754057|FG002|Overall Study|Adverse Event|2
7459403|NCT01817530|11754058|FG003|Overall Study|Adverse Event|5
7459404|NCT01817530|11754059|FG004|Overall Study|Adverse Event|0
7459405|NCT01817530|11754060|FG005|Overall Study|Adverse Event|10
7459406|NCT01817530|11754061|FG006|Overall Study|Adverse Event|5
7459407|NCT01817530|11754062|FG007|Overall Study|Adverse Event|8
7459408|NCT01817530|11754055|FG000|Overall Study|Subject Noncompliant|3
7459409|NCT01817530|11754056|FG001|Overall Study|Subject Noncompliant|1
7351718|NCT00955409|11593158|FG002|Overall Study|Adverse Event (AE)|0
7351719|NCT00955409|11593159|FG003|Overall Study|Adverse Event (AE)|0
7351720|NCT00955409|11593160|FG004|Overall Study|Adverse Event (AE)|0
7351721|NCT00955409|11593161|FG005|Overall Study|Adverse Event (AE)|1
7351722|NCT00955409|11593162|FG006|Overall Study|Adverse Event (AE)|2
7351723|NCT00955409|11593163|FG007|Overall Study|Adverse Event (AE)|0
7351724|NCT00955409|11593164|FG008|Overall Study|Adverse Event (AE)|2
7351725|NCT00955409|11593165|FG009|Overall Study|Adverse Event (AE)|0
7351726|NCT00955409|11593156|FG000|Overall Study|Reason not Specified|2
7351727|NCT00955409|11593157|FG001|Overall Study|Reason not Specified|1
7351728|NCT00955409|11593158|FG002|Overall Study|Reason not Specified|13
7351729|NCT00955409|11593159|FG003|Overall Study|Reason not Specified|1
7351730|NCT00955409|11593160|FG004|Overall Study|Reason not Specified|2
7351731|NCT00955409|11593161|FG005|Overall Study|Reason not Specified|0
7351732|NCT00955409|11593162|FG006|Overall Study|Reason not Specified|16
7351733|NCT00955409|11593163|FG007|Overall Study|Reason not Specified|0
7351734|NCT00955409|11593164|FG008|Overall Study|Reason not Specified|8
7351735|NCT00955409|11593165|FG009|Overall Study|Reason not Specified|1
7351736|NCT00955474|11593193|FG000|Overall Study|Physician Decision|7
7351737|NCT00955474|11593194|FG001|Overall Study|Physician Decision|5
7351738|NCT00955617|11593234|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
7351739|NCT00955617|11593235|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
7351740|NCT00955617|11593234|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
7351741|NCT00955617|11593235|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
7351742|NCT00955617|11593234|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
7351743|NCT00955617|11593235|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
7351744|NCT00955617|11593234|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
7351745|NCT00955617|11593235|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
7351746|NCT00955682|11593243|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
7351747|NCT00955682|11593244|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
7351748|NCT00955708|11593258|FG000|Overall Study|Death|269
7351749|NCT00955708|11593258|FG000|Overall Study|Lost to Follow-up|72
7351750|NCT00955708|11593258|FG000|Overall Study|Physician Decision|36
7351751|NCT00955708|11593258|FG000|Overall Study|Protocol Violation|134
7351752|NCT00955708|11593258|FG000|Overall Study|Registry Conclusion|186
7351753|NCT00955708|11593258|FG000|Overall Study|Product removed from service|94
7351754|NCT00955708|11593258|FG000|Overall Study|Patient Refused to participate further|116
7351755|NCT00955708|11593258|FG000|Overall Study|Closure of study location|60
7351756|NCT00955708|11593258|FG000|Overall Study|Patient changed care provider/moved|91
7351757|NCT00955721|11593264|FG000|Overall Study|Physician Decision|1
7351758|NCT00955721|11593265|FG001|Overall Study|Physician Decision|0
7351759|NCT00955721|11593264|FG000|Overall Study|Death|1
7351760|NCT00955721|11593265|FG001|Overall Study|Death|0
7351761|NCT00955721|11593264|FG000|Overall Study|Withdrawal by Subject|1
7351762|NCT00955721|11593265|FG001|Overall Study|Withdrawal by Subject|0
7351763|NCT00955825|11593283|FG000|Overall Study|Adverse Event|15
7351764|NCT00955825|11593284|FG001|Overall Study|Adverse Event|2
7351765|NCT00955825|11593283|FG000|Overall Study|Withdrawal by Subject|4
7351766|NCT00955825|11593284|FG001|Overall Study|Withdrawal by Subject|6
7351767|NCT00955825|11593283|FG000|Overall Study|Any other reason not above-mentioned|7
7351768|NCT00955825|11593284|FG001|Overall Study|Any other reason not above-mentioned|9
7351769|NCT00955955|11593323|FG000|Overall Study|Lost to Follow-up|2
7351770|NCT00955955|11593324|FG001|Overall Study|Lost to Follow-up|0
7351771|NCT00955955|11593325|FG002|Overall Study|Lost to Follow-up|0
7351772|NCT00955968|11593341|FG000|Overall Study|Death|2
7351773|NCT00955968|11593342|FG001|Overall Study|Death|4
7351774|NCT00955968|11593341|FG000|Overall Study|Withdrawal by Subject|35
7351775|NCT00955968|11593342|FG001|Overall Study|Withdrawal by Subject|31
7351776|NCT00955968|11593341|FG000|Overall Study|Lost to Follow-up|45
7351777|NCT00955968|11593342|FG001|Overall Study|Lost to Follow-up|39
7569364|NCT03448536|11945773|FG001|Overall Study|Other|0
7351778|NCT00955968|11593341|FG000|Overall Study|Site closed|55
7351779|NCT00955968|11593342|FG001|Overall Study|Site closed|52
7351780|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
7351781|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
7351782|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
7351783|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Death|0
7351784|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Death|0
7351785|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Death|1
7351786|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Protocol Violation|0
7351787|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Protocol Violation|0
7351788|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Protocol Violation|1
7351789|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
7351790|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
7351791|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
7351792|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Administrative problems|0
7351793|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Administrative problems|0
7351794|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Administrative problems|6
7569365|NCT03448536|11945772|FG000|Overall Study|Physician Decision|1
7351795|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Graft loss|0
7351796|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Graft loss|0
7351797|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Graft loss|7
7351798|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
7351799|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
7351800|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
7351801|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
7351802|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
7351803|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
7351804|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Adverse Event|0
7351805|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Adverse Event|0
7351806|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Adverse Event|36
7351807|NCT00956293|11593376|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
7351808|NCT00956293|11593377|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
7351809|NCT00956293|11593378|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
7351810|NCT00956293|11593376|FG000|Main Period (Randomization)|Abnormal laboratory value|0
7351811|NCT00956293|11593377|FG001|Main Period (Randomization)|Abnormal laboratory value|2
7351812|NCT00956293|11593378|FG002|Main Period (Randomization)|Abnormal laboratory value|0
7351813|NCT00956293|11593376|FG000|Main Period (Randomization)|Lack of Efficacy|1
7351814|NCT00956293|11593377|FG001|Main Period (Randomization)|Lack of Efficacy|10
7351815|NCT00956293|11593378|FG002|Main Period (Randomization)|Lack of Efficacy|0
7351816|NCT00956293|11593376|FG000|Main Period (Randomization)|Adverse Event|0
7351817|NCT00956293|11593377|FG001|Main Period (Randomization)|Adverse Event|15
7351818|NCT00956293|11593378|FG002|Main Period (Randomization)|Adverse Event|0
7351819|NCT00956293|11593376|FG000|Follow-up Period|Follow-up period was terminated.|20
7351820|NCT00956293|11593377|FG001|Follow-up Period|Follow-up period was terminated.|32
7351821|NCT00956293|11593378|FG002|Follow-up Period|Follow-up period was terminated.|0
7351822|NCT00956592|11593403|FG000|Overall Study|Protocol Violation|1
7351823|NCT00956592|11593404|FG001|Overall Study|Protocol Violation|3
7351824|NCT00956813|11593443|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
7351825|NCT00956813|11593444|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
7351826|NCT00956813|11593443|FG000|Flaxseed and Placebo|Ineligible|3
7351827|NCT00956813|11593444|FG001|Flaxseed and Placebo|Ineligible|1
7351828|NCT00956839|11593454|FG000|Overall Study|Lost to Follow-up|3
7351829|NCT00956839|11593455|FG001|Overall Study|Lost to Follow-up|0
7351830|NCT00956839|11593456|FG002|Overall Study|Lost to Follow-up|3
7351831|NCT00956943|11593477|FG000|Overall Study|Lost to Follow-up|9
7351832|NCT00956943|11593478|FG001|Overall Study|Lost to Follow-up|10
7351833|NCT00957008|11593488|FG000|Overall Study|Withdrawal by Subject|13
7351834|NCT00957008|11593489|FG001|Overall Study|Withdrawal by Subject|10
7351835|NCT00957008|11593490|FG002|Overall Study|Withdrawal by Subject|12
7351836|NCT00957008|11593491|FG003|Overall Study|Withdrawal by Subject|16
7351837|NCT00957008|11593488|FG000|Overall Study|Lost to Follow-up|3
7351838|NCT00957008|11593489|FG001|Overall Study|Lost to Follow-up|1
7351839|NCT00957008|11593490|FG002|Overall Study|Lost to Follow-up|3
7351840|NCT00957008|11593491|FG003|Overall Study|Lost to Follow-up|4
7351841|NCT00957008|11593488|FG000|Overall Study|Physician Decision|1
7351842|NCT00957008|11593489|FG001|Overall Study|Physician Decision|0
7351843|NCT00957008|11593490|FG002|Overall Study|Physician Decision|1
7351844|NCT00957008|11593491|FG003|Overall Study|Physician Decision|1
7351845|NCT00957008|11593488|FG000|Overall Study|Relocated; Family conflict|4
7351846|NCT00957008|11593489|FG001|Overall Study|Relocated; Family conflict|1
7351847|NCT00957008|11593490|FG002|Overall Study|Relocated; Family conflict|1
7351848|NCT00957008|11593491|FG003|Overall Study|Relocated; Family conflict|3
7351849|NCT00957021|11593505|FG000|Overall Study|Death|5
7351850|NCT00957021|11593505|FG000|Overall Study|Lost to Follow-up|8
7351851|NCT00957021|11593505|FG000|Overall Study|Withdrawal by Subject|34
7351852|NCT00957021|11593505|FG000|Overall Study|No 2 yr ROM data|35
7351853|NCT00957021|11593505|FG000|Overall Study|Revised study component by 2 yr visit|8
7351854|NCT00957021|11593505|FG000|Overall Study|Site Termination by the 2 yr visit|16
7351855|NCT00957021|11593505|FG000|Overall Study|Surgery Cancelled|9
7351856|NCT00957021|11593505|FG000|Overall Study|Termination due to language issue|2
7351857|NCT00957229|11593538|FG000|Study Start|Adverse Event|0
7351858|NCT00957229|11593539|FG001|Study Start|Adverse Event|3
7351859|NCT00957229|11593538|FG000|Study Start|Disease Progression|1
7351860|NCT00957229|11593539|FG001|Study Start|Disease Progression|0
7351861|NCT00957229|11593538|FG000|Reallocated to or Continued Vismodegib|Death|1
7351862|NCT00957229|11593539|FG001|Reallocated to or Continued Vismodegib|Death|1
7351863|NCT00957229|11593538|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
7351864|NCT00957229|11593539|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
7351865|NCT00957268|11593561|FG000|Overall Study|Voluntary Withdrawal|0
7569366|NCT03448536|11945773|FG001|Overall Study|Physician Decision|0
7569367|NCT03449030|11945789|FG000|Overall Study|Withdrawal by Subject|0
7569368|NCT03449030|11945790|FG001|Overall Study|Withdrawal by Subject|0
7569369|NCT03449030|11945791|FG002|Overall Study|Withdrawal by Subject|0
7351866|NCT00957268|11593562|FG001|Overall Study|Voluntary Withdrawal|0
7351867|NCT00957268|11593563|FG002|Overall Study|Voluntary Withdrawal|1
7351868|NCT00957268|11593564|FG003|Overall Study|Voluntary Withdrawal|0
7351869|NCT00957268|11593565|FG004|Overall Study|Voluntary Withdrawal|0
7351870|NCT00957372|11593593|FG000|PART I|Lost to Follow-up|0
7351871|NCT00957372|11593594|FG001|PART I|Lost to Follow-up|0
7351872|NCT00957372|11593595|FG002|PART I|Lost to Follow-up|1
7351873|NCT00957372|11593596|FG003|PART I|Lost to Follow-up|0
7351874|NCT00957372|11593593|FG000|PART II|Withdrawal by Subject|0
7351875|NCT00957372|11593594|FG001|PART II|Withdrawal by Subject|0
7351876|NCT00957372|11593595|FG002|PART II|Withdrawal by Subject|0
7351877|NCT00957372|11593596|FG003|PART II|Withdrawal by Subject|8
7351878|NCT00957372|11593593|FG000|PART II|Physician Decision|0
7351879|NCT00957372|11593594|FG001|PART II|Physician Decision|0
7351880|NCT00957372|11593595|FG002|PART II|Physician Decision|0
7351881|NCT00957372|11593596|FG003|PART II|Physician Decision|1
7351882|NCT00957372|11593593|FG000|PART II|Pregnancy|0
7351883|NCT00957372|11593594|FG001|PART II|Pregnancy|0
7351884|NCT00957372|11593595|FG002|PART II|Pregnancy|0
7351885|NCT00957372|11593596|FG003|PART II|Pregnancy|1
7351886|NCT00957372|11593593|FG000|PART II|Not Know|0
7351887|NCT00957372|11593594|FG001|PART II|Not Know|0
7351888|NCT00957372|11593595|FG002|PART II|Not Know|0
7351889|NCT00957372|11593596|FG003|PART II|Not Know|20
7351890|NCT00957372|11593593|FG000|PART II|Adverse Event|0
7351891|NCT00957372|11593594|FG001|PART II|Adverse Event|0
7351892|NCT00957372|11593595|FG002|PART II|Adverse Event|0
7351893|NCT00957372|11593596|FG003|PART II|Adverse Event|10
7351894|NCT00957372|11593593|FG000|PART II|Patient non-compliance|0
7351895|NCT00957372|11593594|FG001|PART II|Patient non-compliance|0
7351896|NCT00957372|11593595|FG002|PART II|Patient non-compliance|0
7351897|NCT00957372|11593596|FG003|PART II|Patient non-compliance|4
7351898|NCT00957424|11593612|FG000|Overall Study|Lost to Follow-up|19
7351899|NCT00957424|11593612|FG000|Overall Study|Protocol Violation|3
7351900|NCT00957424|11593612|FG000|Overall Study|Withdrawal by Subject|1
7351901|NCT00957528|11593619|FG000|Overall Study|Protocol Violation|0
7351902|NCT00957528|11593620|FG001|Overall Study|Protocol Violation|1
7351903|NCT00957528|11593621|FG002|Overall Study|Protocol Violation|0
7351904|NCT00957528|11593619|FG000|Overall Study|Withdrawal by Subject|0
7351905|NCT00957528|11593620|FG001|Overall Study|Withdrawal by Subject|0
7351906|NCT00957528|11593621|FG002|Overall Study|Withdrawal by Subject|1
7351907|NCT00957580|11593632|FG000|Overall Study|Ongoing at data cut-off|0
7351908|NCT00957580|11593633|FG001|Overall Study|Ongoing at data cut-off|1
7351909|NCT00957580|11593634|FG002|Overall Study|Ongoing at data cut-off|0
7351910|NCT00957580|11593632|FG000|Overall Study|Enrolled but not treated|0
7351911|NCT00957580|11593633|FG001|Overall Study|Enrolled but not treated|1
7351912|NCT00957580|11593634|FG002|Overall Study|Enrolled but not treated|0
7351913|NCT00957658|11593666|FG000|Overall Study|Death|1
7351914|NCT00957658|11593666|FG000|Overall Study|Lost to Follow-up|4
7351915|NCT00957658|11593666|FG000|Overall Study|Withdrawal by Subject|12
7351916|NCT00957658|11593666|FG000|Overall Study|Revision|1
7351917|NCT00957658|11593666|FG000|Overall Study|Incomplete 2 yr data|28
7351918|NCT00957658|11593666|FG000|Overall Study|Site termination|10
7351919|NCT00957658|11593666|FG000|Overall Study|unwilling/unable to return|2
7351920|NCT00957658|11593666|FG000|Overall Study|surgery cancelled|2
7351921|NCT00957658|11593666|FG000|Overall Study|Protocol Violation|5
7569370|NCT03449030|11945792|FG003|Overall Study|Withdrawal by Subject|1
7569371|NCT03449030|11945793|FG004|Overall Study|Withdrawal by Subject|1
7569372|NCT03449030|11945794|FG005|Overall Study|Withdrawal by Subject|1
7569373|NCT03449030|11945795|FG006|Overall Study|Withdrawal by Subject|1
7351922|NCT00957723|11593695|FG000|Overall Study|Death|3
7351923|NCT00957723|11593695|FG000|Overall Study|Revision/ Removal of Study Implant|3
7351924|NCT00957723|11593695|FG000|Overall Study|Lost to Follow-up|8
7351925|NCT00957723|11593695|FG000|Overall Study|Withdrawal by Subject|24
7351926|NCT00957723|11593695|FG000|Overall Study|Investigative Site Terminated|61
7351927|NCT00957723|11593695|FG000|Overall Study|Intercurrent Illness|2
7351928|NCT00957723|11593695|FG000|Overall Study|2yr ROM Data Not Evaluable|12
7351929|NCT00957801|11593705|FG000|Overall Study|Withdrawal by Subject|0
7351930|NCT00957801|11593706|FG001|Overall Study|Withdrawal by Subject|0
7351931|NCT00957801|11593707|FG002|Overall Study|Withdrawal by Subject|0
7351932|NCT00957801|11593708|FG003|Overall Study|Withdrawal by Subject|1
7351933|NCT00957853|11593721|FG000|Overall Study|Withdrawal by Subject|1
7351934|NCT00957853|11593722|FG001|Overall Study|Withdrawal by Subject|0
7351935|NCT00957853|11593723|FG002|Overall Study|Withdrawal by Subject|0
7351936|NCT00957905|11593733|FG000|Part B|Not Treated|0
7351937|NCT00957905|11593734|FG001|Part B|Not Treated|1
7351938|NCT00957905|11593733|FG000|Part B|Physician Decision|0
7351939|NCT00957905|11593734|FG001|Part B|Physician Decision|1
7351940|NCT00957905|11593733|FG000|Part B|Death|0
7351941|NCT00957905|11593734|FG001|Part B|Death|1
7351942|NCT00957905|11593733|FG000|Part B|Protocol Violation|0
7351943|NCT00957905|11593734|FG001|Part B|Protocol Violation|1
7351944|NCT00957931|11593740|FG000|Overall Study|Death|4
7569374|NCT03449030|11945796|FG007|Overall Study|Withdrawal by Subject|2
7569375|NCT03449030|11945797|FG008|Overall Study|Withdrawal by Subject|0
7569376|NCT03449030|11945798|FG009|Overall Study|Withdrawal by Subject|0
7569377|NCT03449030|11945789|FG000|Overall Study|Symptomatic Deterioration|0
7569378|NCT03449030|11945790|FG001|Overall Study|Symptomatic Deterioration|1
7569379|NCT03449030|11945791|FG002|Overall Study|Symptomatic Deterioration|0
7569380|NCT03449030|11945792|FG003|Overall Study|Symptomatic Deterioration|0
7569381|NCT03449030|11945793|FG004|Overall Study|Symptomatic Deterioration|0
7569382|NCT03449030|11945794|FG005|Overall Study|Symptomatic Deterioration|1
7569383|NCT03449030|11945795|FG006|Overall Study|Symptomatic Deterioration|1
7569384|NCT03449030|11945796|FG007|Overall Study|Symptomatic Deterioration|0
7569385|NCT03449030|11945797|FG008|Overall Study|Symptomatic Deterioration|2
7569386|NCT03449030|11945798|FG009|Overall Study|Symptomatic Deterioration|0
7569387|NCT03449030|11945789|FG000|Overall Study|Progressive Disease|1
7569388|NCT03449030|11945790|FG001|Overall Study|Progressive Disease|0
7351945|NCT00957944|11593746|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
7351946|NCT00957944|11593747|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
7351947|NCT00957996|11593755|FG000|Overall Study|Death|4
7351948|NCT00957996|11593756|FG001|Overall Study|Death|10
7351949|NCT00957996|11593755|FG000|Overall Study|Lost to Follow-up|4
7351950|NCT00957996|11593756|FG001|Overall Study|Lost to Follow-up|7
7351951|NCT00957996|11593755|FG000|Overall Study|Withdrawal by Subject|9
7351952|NCT00957996|11593756|FG001|Overall Study|Withdrawal by Subject|2
7569389|NCT03449030|11945791|FG002|Overall Study|Progressive Disease|1
7569390|NCT03449030|11945792|FG003|Overall Study|Progressive Disease|4
7569391|NCT03449030|11945793|FG004|Overall Study|Progressive Disease|5
7351953|NCT00957996|11593755|FG000|Overall Study|Adverse Event|2
7351954|NCT00957996|11593756|FG001|Overall Study|Adverse Event|1
7351955|NCT00957996|11593755|FG000|Overall Study|Physician Decision|1
7351956|NCT00957996|11593756|FG001|Overall Study|Physician Decision|1
7351957|NCT00957996|11593755|FG000|Overall Study|Influenza-related complication|0
7351958|NCT00957996|11593756|FG001|Overall Study|Influenza-related complication|1
7351959|NCT00957996|11593755|FG000|Overall Study|Missing|1
7351960|NCT00957996|11593756|FG001|Overall Study|Missing|0
7351961|NCT00957996|11593755|FG000|Overall Study|Noncompliance; Protocol Deviations|5
7351962|NCT00957996|11593756|FG001|Overall Study|Noncompliance; Protocol Deviations|6
7351963|NCT00958009|11593764|FG000|Overall Study|Adverse Event|1
7351964|NCT00958009|11593764|FG000|Overall Study|Subject found device difficult to use|1
7351965|NCT00958074|11593779|FG000|Overall Study|Withdrawal by Subject|0
7351966|NCT00958074|11593780|FG001|Overall Study|Withdrawal by Subject|1
7351967|NCT00958126|11593794|FG000|Overall Study|Serious Adverse Event|0
7351968|NCT00958126|11593795|FG001|Overall Study|Serious Adverse Event|2
7351969|NCT00958126|11593796|FG002|Overall Study|Serious Adverse Event|0
7351970|NCT00958126|11593797|FG003|Overall Study|Serious Adverse Event|0
7351971|NCT00958126|11593798|FG004|Overall Study|Serious Adverse Event|0
7351972|NCT00958126|11593799|FG005|Overall Study|Serious Adverse Event|0
7351973|NCT00958126|11593800|FG006|Overall Study|Serious Adverse Event|1
7351974|NCT00958126|11593801|FG007|Overall Study|Serious Adverse Event|0
7351975|NCT00958126|11593794|FG000|Overall Study|Withdrawal by Subject|0
7351976|NCT00958126|11593795|FG001|Overall Study|Withdrawal by Subject|2
7351977|NCT00958126|11593796|FG002|Overall Study|Withdrawal by Subject|0
7351978|NCT00958126|11593797|FG003|Overall Study|Withdrawal by Subject|0
7351979|NCT00958126|11593798|FG004|Overall Study|Withdrawal by Subject|0
7351980|NCT00958126|11593799|FG005|Overall Study|Withdrawal by Subject|0
7225251|NCT00065065|11434691|FG001|Overall Study|Adverse Event|2
7225252|NCT00065065|11434690|FG000|Overall Study|Withdrawal by Subject|1
7225253|NCT00065065|11434691|FG001|Overall Study|Withdrawal by Subject|5
7225254|NCT00065065|11434690|FG000|Overall Study|Lack of Efficacy|4
7225255|NCT00065065|11434691|FG001|Overall Study|Lack of Efficacy|11
7225256|NCT00065065|11434690|FG000|Overall Study|Other|2
7225257|NCT00065065|11434691|FG001|Overall Study|Other|2
7225258|NCT00065156|11434699|FG000|Overall Study|Adverse Event|37
7225259|NCT00065156|11434699|FG000|Overall Study|Lack of Efficacy|52
7225260|NCT00065156|11434699|FG000|Overall Study|Withdrawal by Subject|8
7351981|NCT00958126|11593800|FG006|Overall Study|Withdrawal by Subject|0
7351982|NCT00958126|11593801|FG007|Overall Study|Withdrawal by Subject|0
7351983|NCT00958126|11593794|FG000|Overall Study|Moved away from study area|0
7351984|NCT00958126|11593795|FG001|Overall Study|Moved away from study area|0
7351985|NCT00958126|11593796|FG002|Overall Study|Moved away from study area|1
7351986|NCT00958126|11593797|FG003|Overall Study|Moved away from study area|1
7351987|NCT00958126|11593798|FG004|Overall Study|Moved away from study area|0
7351988|NCT00958126|11593799|FG005|Overall Study|Moved away from study area|0
7351989|NCT00958126|11593800|FG006|Overall Study|Moved away from study area|0
7351990|NCT00958126|11593801|FG007|Overall Study|Moved away from study area|0
7351991|NCT00958126|11593794|FG000|Overall Study|Lost to Follow-up|1
7351992|NCT00958126|11593795|FG001|Overall Study|Lost to Follow-up|5
7351993|NCT00958126|11593796|FG002|Overall Study|Lost to Follow-up|9
7351994|NCT00958126|11593797|FG003|Overall Study|Lost to Follow-up|8
7351995|NCT00958126|11593798|FG004|Overall Study|Lost to Follow-up|0
7351996|NCT00958126|11593799|FG005|Overall Study|Lost to Follow-up|0
7351997|NCT00958126|11593800|FG006|Overall Study|Lost to Follow-up|0
7351998|NCT00958126|11593801|FG007|Overall Study|Lost to Follow-up|0
7351999|NCT00958126|11593794|FG000|Overall Study|Sponsor/Investigator decision|0
7352000|NCT00958126|11593795|FG001|Overall Study|Sponsor/Investigator decision|0
7352001|NCT00958126|11593796|FG002|Overall Study|Sponsor/Investigator decision|0
7352002|NCT00958126|11593797|FG003|Overall Study|Sponsor/Investigator decision|1
7352003|NCT00958126|11593798|FG004|Overall Study|Sponsor/Investigator decision|0
7352004|NCT00958126|11593799|FG005|Overall Study|Sponsor/Investigator decision|0
7352005|NCT00958126|11593800|FG006|Overall Study|Sponsor/Investigator decision|0
7352006|NCT00958126|11593801|FG007|Overall Study|Sponsor/Investigator decision|0
7352007|NCT00958126|11593794|FG000|Overall Study|Other Reason|0
7352008|NCT00958126|11593795|FG001|Overall Study|Other Reason|0
7352009|NCT00958126|11593796|FG002|Overall Study|Other Reason|0
7352010|NCT00958126|11593797|FG003|Overall Study|Other Reason|1
7352011|NCT00958126|11593798|FG004|Overall Study|Other Reason|0
7352012|NCT00958126|11593799|FG005|Overall Study|Other Reason|1
7352013|NCT00958126|11593800|FG006|Overall Study|Other Reason|0
7352014|NCT00958126|11593801|FG007|Overall Study|Other Reason|0
7352015|NCT00958165|11593823|FG000|Overall Study|Lost to Follow-up|5
7352016|NCT00958165|11593823|FG000|Overall Study|Not eligible|9
7352017|NCT00958191|11593827|FG000|Overall Study|Death|4
7352018|NCT00958191|11593827|FG000|Overall Study|Lost to Follow-up|5
7352019|NCT00958191|11593827|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
7352020|NCT00958191|11593827|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
7352021|NCT00958191|11593827|FG000|Overall Study|Revision of study device|4
7352022|NCT00958191|11593827|FG000|Overall Study|Site termination|11
7352023|NCT00958191|11593827|FG000|Overall Study|No 5 yr x-rays|56
7352024|NCT00958217|11593835|FG000|Overall Study|Death|2
7352025|NCT00958217|11593836|FG001|Overall Study|Death|1
7352026|NCT00958217|11593835|FG000|Overall Study|Withdrawal by Subject|4
7352027|NCT00958217|11593836|FG001|Overall Study|Withdrawal by Subject|3
7352028|NCT00958217|11593835|FG000|Overall Study|Lost to Follow-up|17
7352029|NCT00958217|11593836|FG001|Overall Study|Lost to Follow-up|19
7352030|NCT00958217|11593835|FG000|Overall Study|Moved out of area|1
7352031|NCT00958217|11593836|FG001|Overall Study|Moved out of area|1
7352032|NCT00958217|11593835|FG000|Overall Study|Inpatient hospitalization|0
7352033|NCT00958217|11593836|FG001|Overall Study|Inpatient hospitalization|1
7352034|NCT00958243|11593849|FG000|Overall Study|Withdrawal by Subject|0
7352035|NCT00958243|11593850|FG001|Overall Study|Withdrawal by Subject|1
7352036|NCT00958243|11593851|FG002|Overall Study|Withdrawal by Subject|3
7352037|NCT00958243|11593852|FG003|Overall Study|Withdrawal by Subject|1
7352038|NCT00958243|11593853|FG004|Overall Study|Withdrawal by Subject|1
7352039|NCT00958243|11593854|FG005|Overall Study|Withdrawal by Subject|5
7352040|NCT00958243|11593849|FG000|Overall Study|Lost to Follow-up|2
7352041|NCT00958243|11593850|FG001|Overall Study|Lost to Follow-up|5
7352042|NCT00958243|11593851|FG002|Overall Study|Lost to Follow-up|11
7352043|NCT00958243|11593852|FG003|Overall Study|Lost to Follow-up|2
7352044|NCT00958243|11593853|FG004|Overall Study|Lost to Follow-up|8
7352045|NCT00958243|11593854|FG005|Overall Study|Lost to Follow-up|5
7352046|NCT00958256|11593874|FG000|Overall Study|Adverse Event|3
7352047|NCT00958360|11593915|FG000|Overall Study|Withdrawal by Subject|3
7352048|NCT00958360|11593916|FG001|Overall Study|Withdrawal by Subject|1
7352049|NCT00958360|11593915|FG000|Overall Study|Death|6
7352050|NCT00958360|11593916|FG001|Overall Study|Death|7
7352051|NCT00958360|11593915|FG000|Overall Study|Physician Decision|2
7352052|NCT00958360|11593916|FG001|Overall Study|Physician Decision|1
7352053|NCT00958360|11593915|FG000|Overall Study|Lost to Follow-up|0
7352054|NCT00958360|11593916|FG001|Overall Study|Lost to Follow-up|1
7352055|NCT00958412|11593922|FG000|Overall Study|Study prematurely terminated|18
7352056|NCT00958438|11593929|FG000|Overall Study|Protocol Violation|3
7352057|NCT00958438|11593930|FG001|Overall Study|Protocol Violation|2
7352058|NCT00958438|11593931|FG002|Overall Study|Protocol Violation|2
7352059|NCT00958438|11593929|FG000|Overall Study|Withdrawal by Subject|4
7352060|NCT00958438|11593930|FG001|Overall Study|Withdrawal by Subject|2
7352061|NCT00958438|11593931|FG002|Overall Study|Withdrawal by Subject|1
7352062|NCT00958438|11593929|FG000|Overall Study|Adverse Event|0
7352063|NCT00958438|11593930|FG001|Overall Study|Adverse Event|3
7352064|NCT00958438|11593931|FG002|Overall Study|Adverse Event|0
7352065|NCT00958438|11593929|FG000|Overall Study|Physician Decision|1
7352066|NCT00958438|11593930|FG001|Overall Study|Physician Decision|0
7352067|NCT00958438|11593931|FG002|Overall Study|Physician Decision|1
7352068|NCT00958438|11593929|FG000|Overall Study|Other than specified above|2
7352069|NCT00958438|11593930|FG001|Overall Study|Other than specified above|3
7352070|NCT00958438|11593931|FG002|Overall Study|Other than specified above|2
7352071|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
7352072|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7352073|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7352074|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
7352075|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
7352076|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7352077|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7352078|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
7352079|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
7352080|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7352081|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7352082|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
7352083|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
7352084|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7352085|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7352086|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
7352087|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
7352088|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7352089|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7352090|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
7352091|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
7352092|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7459410|NCT01817530|11754057|FG002|Overall Study|Subject Noncompliant|0
7459411|NCT01817530|11754058|FG003|Overall Study|Subject Noncompliant|4
7459412|NCT01817530|11754059|FG004|Overall Study|Subject Noncompliant|0
7459413|NCT01817530|11754060|FG005|Overall Study|Subject Noncompliant|1
7459414|NCT01817530|11754061|FG006|Overall Study|Subject Noncompliant|1
7459415|NCT01817530|11754062|FG007|Overall Study|Subject Noncompliant|1
7459416|NCT01817530|11754055|FG000|Overall Study|Lack of Efficacy|1
7459417|NCT01817530|11754056|FG001|Overall Study|Lack of Efficacy|0
7459418|NCT01817530|11754057|FG002|Overall Study|Lack of Efficacy|0
7459419|NCT01817530|11754058|FG003|Overall Study|Lack of Efficacy|0
7459420|NCT01817530|11754059|FG004|Overall Study|Lack of Efficacy|0
7459421|NCT01817530|11754060|FG005|Overall Study|Lack of Efficacy|1
7459422|NCT01817530|11754061|FG006|Overall Study|Lack of Efficacy|0
7459423|NCT01817530|11754062|FG007|Overall Study|Lack of Efficacy|1
7459424|NCT01817530|11754055|FG000|Overall Study|Pregnancy|0
7459425|NCT01817530|11754056|FG001|Overall Study|Pregnancy|0
7459426|NCT01817530|11754057|FG002|Overall Study|Pregnancy|0
7459427|NCT01817530|11754058|FG003|Overall Study|Pregnancy|0
7459428|NCT01817530|11754059|FG004|Overall Study|Pregnancy|0
7459429|NCT01817530|11754060|FG005|Overall Study|Pregnancy|1
7459430|NCT01817530|11754061|FG006|Overall Study|Pregnancy|0
7459431|NCT01817530|11754062|FG007|Overall Study|Pregnancy|0
7459432|NCT01817530|11754055|FG000|Overall Study|Other|0
7459433|NCT01817530|11754056|FG001|Overall Study|Other|1
7459434|NCT01817530|11754057|FG002|Overall Study|Other|0
7459435|NCT01817530|11754058|FG003|Overall Study|Other|0
7459436|NCT01817530|11754059|FG004|Overall Study|Other|1
7459437|NCT01817530|11754060|FG005|Overall Study|Other|0
7459438|NCT01817530|11754061|FG006|Overall Study|Other|5
7459439|NCT01817530|11754062|FG007|Overall Study|Other|0
7459440|NCT01817530|11754055|FG000|Overall Study|Surgery or Invasive Intervention|1
7459441|NCT01817530|11754056|FG001|Overall Study|Surgery or Invasive Intervention|0
7459442|NCT01817530|11754057|FG002|Overall Study|Surgery or Invasive Intervention|0
7459443|NCT01817530|11754058|FG003|Overall Study|Surgery or Invasive Intervention|0
7459444|NCT01817530|11754059|FG004|Overall Study|Surgery or Invasive Intervention|1
7459445|NCT01817530|11754060|FG005|Overall Study|Surgery or Invasive Intervention|1
7569392|NCT03449030|11945794|FG005|Overall Study|Progressive Disease|3
7459446|NCT01817530|11754061|FG006|Overall Study|Surgery or Invasive Intervention|1
7459447|NCT01817530|11754062|FG007|Overall Study|Surgery or Invasive Intervention|0
7459448|NCT01817530|11754055|FG000|Overall Study|Consent Withdrawn by Subject|3
7459449|NCT01817530|11754056|FG001|Overall Study|Consent Withdrawn by Subject|4
7459450|NCT01817530|11754057|FG002|Overall Study|Consent Withdrawn by Subject|7
7459451|NCT01817530|11754058|FG003|Overall Study|Consent Withdrawn by Subject|3
7459452|NCT01817530|11754059|FG004|Overall Study|Consent Withdrawn by Subject|5
7459453|NCT01817530|11754060|FG005|Overall Study|Consent Withdrawn by Subject|3
7459454|NCT01817530|11754061|FG006|Overall Study|Consent Withdrawn by Subject|3
7459455|NCT01817530|11754062|FG007|Overall Study|Consent Withdrawn by Subject|10
7459456|NCT01817530|11754055|FG000|Overall Study|Lost to Follow-up|1
7459457|NCT01817530|11754056|FG001|Overall Study|Lost to Follow-up|4
7459458|NCT01817530|11754057|FG002|Overall Study|Lost to Follow-up|2
7459459|NCT01817530|11754058|FG003|Overall Study|Lost to Follow-up|1
7459460|NCT01817530|11754059|FG004|Overall Study|Lost to Follow-up|3
7569393|NCT03449030|11945795|FG006|Overall Study|Progressive Disease|0
7352093|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7352094|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
7352095|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
7352096|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7352097|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7352098|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
7352099|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
7352100|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7352101|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7352102|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
7352103|NCT00958568|11593962|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
7352104|NCT00958568|11593963|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7352105|NCT00958568|11593964|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7352106|NCT00958568|11593965|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
7352107|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7352108|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
7352109|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7352110|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
7352111|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7352112|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
7352113|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7352114|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
7352115|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7352116|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
7352117|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7352118|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
7352119|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7352120|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
7352121|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7352122|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
7352123|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7352124|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
7352125|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7352126|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
7352127|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7352128|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
7352129|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7352130|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
7352131|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7352132|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
7352133|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7352134|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
7352135|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7352136|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
7352137|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7352138|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
7352139|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7352140|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
7352141|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7352142|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
7352143|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7352144|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
7352145|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7352146|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
7352147|NCT00958568|11593962|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7352148|NCT00958568|11593963|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
7352149|NCT00958568|11593964|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7352150|NCT00958568|11593965|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
7352151|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7352152|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
7352153|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
7569394|NCT03449030|11945796|FG007|Overall Study|Progressive Disease|1
7569395|NCT03449030|11945797|FG008|Overall Study|Progressive Disease|1
7569396|NCT03449030|11945798|FG009|Overall Study|Progressive Disease|1
7569397|NCT03449030|11945789|FG000|Overall Study|Adverse Event|0
7569398|NCT03449030|11945790|FG001|Overall Study|Adverse Event|0
7569399|NCT03449030|11945791|FG002|Overall Study|Adverse Event|0
7352394|NCT00960206|11594365|FG002|Overall Study|Revision of study component|2
7352154|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
7352155|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7352156|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
7352157|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
7352158|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
7352159|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7352160|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
7352161|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
7352162|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
7352163|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7352164|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
7352165|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
7352166|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
7352167|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7352168|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
7352169|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
7352170|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
7352171|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7352172|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
7352173|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
7352174|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
7352175|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7352176|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
7352177|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
7352178|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
7352179|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7352180|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7352181|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
7352182|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
7352183|NCT00958568|11593962|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7352184|NCT00958568|11593963|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7352185|NCT00958568|11593964|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
7352186|NCT00958568|11593965|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
7352187|NCT00958711|11593994|FG000|Overall Study|Withdrawal by Subject|0
7352188|NCT00958711|11593995|FG001|Overall Study|Withdrawal by Subject|4
7352189|NCT00958711|11593994|FG000|Overall Study|Physician Decision|5
7352190|NCT00958711|11593995|FG001|Overall Study|Physician Decision|7
7352191|NCT00958711|11593994|FG000|Overall Study|Lost to Follow-up|4
7352192|NCT00958711|11593995|FG001|Overall Study|Lost to Follow-up|1
7352193|NCT00958711|11593994|FG000|Overall Study|Other|2
7352194|NCT00958711|11593995|FG001|Overall Study|Other|5
7352195|NCT00958711|11593994|FG000|Overall Study|Death|1
7352196|NCT00958711|11593995|FG001|Overall Study|Death|2
7352197|NCT00958711|11593994|FG000|Overall Study|Adverse Event|1
7352198|NCT00958711|11593995|FG001|Overall Study|Adverse Event|2
7352199|NCT00958724|11594001|FG000|Overall Study|Disease Progression|6
7352200|NCT00958776|11594007|FG000|Overall Study|Adverse Event|0
7352201|NCT00958776|11594008|FG001|Overall Study|Adverse Event|1
7352202|NCT00958776|11594007|FG000|Overall Study|Physician Decision|1
7352203|NCT00958776|11594008|FG001|Overall Study|Physician Decision|0
7352204|NCT00958776|11594007|FG000|Overall Study|Lost to Follow-up|2
7352205|NCT00958776|11594008|FG001|Overall Study|Lost to Follow-up|6
7352206|NCT00958776|11594007|FG000|Overall Study|Withdrawal by Subject|7
7569400|NCT03449030|11945792|FG003|Overall Study|Adverse Event|0
7569401|NCT03449030|11945793|FG004|Overall Study|Adverse Event|0
7569402|NCT03449030|11945794|FG005|Overall Study|Adverse Event|2
7569403|NCT03449030|11945795|FG006|Overall Study|Adverse Event|0
7569404|NCT03449030|11945796|FG007|Overall Study|Adverse Event|0
7569405|NCT03449030|11945797|FG008|Overall Study|Adverse Event|0
7352207|NCT00958776|11594008|FG001|Overall Study|Withdrawal by Subject|16
7352208|NCT00958776|11594007|FG000|Overall Study|Protocol Violation|1
7352209|NCT00958776|11594008|FG001|Overall Study|Protocol Violation|1
7352210|NCT00958776|11594007|FG000|Overall Study|Death|2
7352211|NCT00958776|11594008|FG001|Overall Study|Death|1
7352212|NCT00958776|11594007|FG000|Overall Study|Noncompliance; Protocol Deviations|2
7352213|NCT00958776|11594008|FG001|Overall Study|Noncompliance; Protocol Deviations|3
7352214|NCT00958776|11594007|FG000|Overall Study|Missing|1
7352215|NCT00958776|11594008|FG001|Overall Study|Missing|1
7352216|NCT00958789|11594015|FG000|Overall Study|Death|5
7352217|NCT00958789|11594015|FG000|Overall Study|Lost to Follow-up|14
7352218|NCT00958789|11594015|FG000|Overall Study|Withdrawal by Subject|17
7352219|NCT00958789|11594015|FG000|Overall Study|No 2 yr. Knee Society Score data|4
7352220|NCT00958789|11594015|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
7352221|NCT00958789|11594015|FG000|Overall Study|Subject terminated|2
7352222|NCT00958789|11594015|FG000|Overall Study|Revision|7
7352223|NCT00958828|11594024|FG000|Period 1, 1 Week of Wear|Randomization break|0
7352224|NCT00958828|11594025|FG001|Period 1, 1 Week of Wear|Randomization break|1
7352225|NCT00958828|11594024|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
7352226|NCT00958828|11594025|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
7352227|NCT00958841|11594031|FG000|Overall Study|Abnormal laboratory value(s)|1
7352228|NCT00958841|11594031|FG000|Overall Study|Abnormal test procedure result(s)|3
7352229|NCT00958841|11594031|FG000|Overall Study|Administrative problems|1
7352230|NCT00958841|11594031|FG000|Overall Study|Adverse Event|8
7352231|NCT00958841|11594031|FG000|Overall Study|New cancer therapy|5
7352232|NCT00958841|11594031|FG000|Overall Study|Withdrawal by Subject|1
7352233|NCT00958841|11594031|FG000|Overall Study|Unsatisfactory therapeutic effect|22
7352234|NCT00958841|11594031|FG000|Overall Study|Completed M6/did not enter extension|27
7352235|NCT00958841|11594031|FG000|Overall Study|Discontinued prior to M*|28
7352236|NCT00958880|11594047|FG000|Overall Study|Lost to Follow-up|2
7352237|NCT00958880|11594048|FG001|Overall Study|Lost to Follow-up|2
7352238|NCT00959049|11594074|FG000|Overall Study|Adverse Event|1
7352239|NCT00959049|11594075|FG001|Overall Study|Adverse Event|0
7352240|NCT00959049|11594076|FG002|Overall Study|Adverse Event|0
7352241|NCT00959049|11594077|FG003|Overall Study|Adverse Event|0
7352242|NCT00959049|11594078|FG004|Overall Study|Adverse Event|0
7352243|NCT00959049|11594079|FG005|Overall Study|Adverse Event|0
7352244|NCT00959049|11594074|FG000|Overall Study|Lost to Follow-up|17
7352245|NCT00959049|11594075|FG001|Overall Study|Lost to Follow-up|5
7352246|NCT00959049|11594076|FG002|Overall Study|Lost to Follow-up|1
7352247|NCT00959049|11594077|FG003|Overall Study|Lost to Follow-up|10
7352248|NCT00959049|11594078|FG004|Overall Study|Lost to Follow-up|9
7352249|NCT00959049|11594079|FG005|Overall Study|Lost to Follow-up|1
7352250|NCT00959049|11594074|FG000|Overall Study|Contraindicated medication|0
7352251|NCT00959049|11594075|FG001|Overall Study|Contraindicated medication|0
7352252|NCT00959049|11594076|FG002|Overall Study|Contraindicated medication|0
7352253|NCT00959049|11594077|FG003|Overall Study|Contraindicated medication|1
7352254|NCT00959049|11594078|FG004|Overall Study|Contraindicated medication|0
7352255|NCT00959049|11594079|FG005|Overall Study|Contraindicated medication|0
7352256|NCT00959049|11594074|FG000|Overall Study|Withdrawal by Subject|0
7352257|NCT00959049|11594075|FG001|Overall Study|Withdrawal by Subject|2
7352258|NCT00959049|11594076|FG002|Overall Study|Withdrawal by Subject|0
7352259|NCT00959049|11594077|FG003|Overall Study|Withdrawal by Subject|0
7352260|NCT00959049|11594078|FG004|Overall Study|Withdrawal by Subject|0
7352261|NCT00959049|11594079|FG005|Overall Study|Withdrawal by Subject|0
7352262|NCT00959192|11594117|FG000|Overall Study|Adverse Event|1
7352263|NCT00959192|11594118|FG001|Overall Study|Adverse Event|1
7352264|NCT00959192|11594119|FG002|Overall Study|Adverse Event|1
7352265|NCT00959192|11594120|FG003|Overall Study|Adverse Event|0
7352266|NCT00959192|11594117|FG000|Overall Study|Investigator Request|1
7352267|NCT00959192|11594118|FG001|Overall Study|Investigator Request|0
7352268|NCT00959192|11594119|FG002|Overall Study|Investigator Request|0
7352269|NCT00959192|11594120|FG003|Overall Study|Investigator Request|0
7352270|NCT00959192|11594117|FG000|Overall Study|Caregiver Request|0
7352271|NCT00959192|11594118|FG001|Overall Study|Caregiver Request|0
7352272|NCT00959192|11594119|FG002|Overall Study|Caregiver Request|2
7352273|NCT00959192|11594120|FG003|Overall Study|Caregiver Request|1
7352274|NCT00959374|11594131|FG000|Overall Study|Withdrawal by Subject|2
7352275|NCT00959374|11594131|FG000|Overall Study|Lost to Follow-up|14
7352276|NCT00959374|11594131|FG000|Overall Study|Death|1
7352277|NCT00959374|11594131|FG000|Overall Study|Protocol Violation|1
7352278|NCT00959374|11594131|FG000|Overall Study|Implant Removed/Not Replaced|4
7352279|NCT00959374|11594131|FG000|Overall Study|Physician Decision|1
7352280|NCT00959647|11594139|FG000|Overall Study|Adverse Event|2
7352281|NCT00959647|11594139|FG000|Overall Study|Progressive disease|6
7352282|NCT00959647|11594139|FG000|Overall Study|Study terminated by sponsor|4
7352283|NCT00959647|11594139|FG000|Overall Study|Withdrawal by Subject|7
7352284|NCT00959699|11594162|FG000|Treatment Period|Adverse Event|3
7352285|NCT00959699|11594163|FG001|Treatment Period|Adverse Event|13
7352286|NCT00959699|11594162|FG000|Treatment Period|Lack of Efficacy|15
7352287|NCT00959699|11594163|FG001|Treatment Period|Lack of Efficacy|6
7352288|NCT00959699|11594162|FG000|Treatment Period|Lost to Follow-up|0
7352289|NCT00959699|11594163|FG001|Treatment Period|Lost to Follow-up|1
7352290|NCT00959699|11594162|FG000|Treatment Period|Withdrawal by Subject|1
7352291|NCT00959699|11594163|FG001|Treatment Period|Withdrawal by Subject|3
7352292|NCT00959699|11594162|FG000|Treatment Period|Non-Compliance with Protocol|0
7352293|NCT00959699|11594163|FG001|Treatment Period|Non-Compliance with Protocol|1
7352294|NCT00959699|11594162|FG000|Treatment Period|Did not receive treatment|0
7352295|NCT00959699|11594163|FG001|Treatment Period|Did not receive treatment|1
7352296|NCT00959699|11594162|FG000|Treatment Period|Futility/crossover to boceprevir|4
7352297|NCT00959699|11594163|FG001|Treatment Period|Futility/crossover to boceprevir|0
7352298|NCT00959699|11594162|FG000|Follow-up Period|Lost to Follow-up|3
7352299|NCT00959699|11594163|FG001|Follow-up Period|Lost to Follow-up|2
7352300|NCT00959699|11594162|FG000|Follow-up Period|Withdrawal by Subject|3
7352301|NCT00959699|11594163|FG001|Follow-up Period|Withdrawal by Subject|4
7352302|NCT00959751|11594172|FG000|Overall Study|Lost to Follow-up|2
7352303|NCT00959751|11594173|FG001|Overall Study|Lost to Follow-up|3
7352304|NCT00959751|11594172|FG000|Overall Study|Consent Withdrawn|0
7352305|NCT00959751|11594173|FG001|Overall Study|Consent Withdrawn|1
7352306|NCT00959751|11594172|FG000|Overall Study|Non-compliance to Study Procedures|0
7352307|NCT00959751|11594173|FG001|Overall Study|Non-compliance to Study Procedures|1
7352308|NCT00959751|11594172|FG000|Overall Study|No migraine headache without aura|7
7352309|NCT00959751|11594173|FG001|Overall Study|No migraine headache without aura|7
7352310|NCT00959894|11594199|FG000|Overall Study|Lost to Follow-up|10
7352311|NCT00959894|11594199|FG000|Overall Study|Adverse Event|3
7352312|NCT00959894|11594199|FG000|Overall Study|Withdrawal by Subject|1
7352313|NCT00959894|11594199|FG000|Overall Study|Need for contraindicated medication|1
7352314|NCT00959894|11594199|FG000|Overall Study|Subject moved out of town|1
7352315|NCT00959907|11594206|FG000|Overall Study|Protocol Violation|0
7352316|NCT00959907|11594207|FG001|Overall Study|Protocol Violation|1
7352317|NCT00959907|11594206|FG000|Overall Study|Adverse Event|1
7352318|NCT00959907|11594207|FG001|Overall Study|Adverse Event|0
7352319|NCT00959907|11594206|FG000|Overall Study|Withdrawal by Subject|2
7352320|NCT00959907|11594207|FG001|Overall Study|Withdrawal by Subject|0
7352321|NCT00959946|11594232|FG000|Overall Study|Adverse Event|0
7352322|NCT00959946|11594233|FG001|Overall Study|Adverse Event|0
7352323|NCT00959946|11594234|FG002|Overall Study|Adverse Event|2
7352324|NCT00959946|11594235|FG003|Overall Study|Adverse Event|1
7352325|NCT00959946|11594236|FG004|Overall Study|Adverse Event|0
7352326|NCT00959946|11594237|FG005|Overall Study|Adverse Event|1
7352327|NCT00959946|11594238|FG006|Overall Study|Adverse Event|0
7352328|NCT00959946|11594239|FG007|Overall Study|Adverse Event|0
7352329|NCT00959946|11594232|FG000|Overall Study|Death|0
7352330|NCT00959946|11594233|FG001|Overall Study|Death|0
7352331|NCT00959946|11594234|FG002|Overall Study|Death|0
7352332|NCT00959946|11594235|FG003|Overall Study|Death|0
7352333|NCT00959946|11594236|FG004|Overall Study|Death|0
7352334|NCT00959946|11594237|FG005|Overall Study|Death|1
7352335|NCT00959946|11594238|FG006|Overall Study|Death|0
7352336|NCT00959946|11594239|FG007|Overall Study|Death|0
7352337|NCT00959946|11594232|FG000|Overall Study|Disease Progression|2
7352338|NCT00959946|11594233|FG001|Overall Study|Disease Progression|4
7352339|NCT00959946|11594234|FG002|Overall Study|Disease Progression|2
7352340|NCT00959946|11594235|FG003|Overall Study|Disease Progression|4
7352341|NCT00959946|11594236|FG004|Overall Study|Disease Progression|4
7352342|NCT00959946|11594237|FG005|Overall Study|Disease Progression|6
7352343|NCT00959946|11594238|FG006|Overall Study|Disease Progression|2
7352344|NCT00959946|11594239|FG007|Overall Study|Disease Progression|2
7352345|NCT00959946|11594232|FG000|Overall Study|Withdrawal by Subject|0
7352346|NCT00959946|11594233|FG001|Overall Study|Withdrawal by Subject|0
7352347|NCT00959946|11594234|FG002|Overall Study|Withdrawal by Subject|0
7352348|NCT00959946|11594235|FG003|Overall Study|Withdrawal by Subject|0
7352349|NCT00959946|11594236|FG004|Overall Study|Withdrawal by Subject|0
7352350|NCT00959946|11594237|FG005|Overall Study|Withdrawal by Subject|1
7352351|NCT00959946|11594238|FG006|Overall Study|Withdrawal by Subject|0
7352352|NCT00959946|11594239|FG007|Overall Study|Withdrawal by Subject|0
7352353|NCT00960011|11594281|FG000|Overall Study|Death|5
7352354|NCT00960011|11594282|FG001|Overall Study|Death|0
7352355|NCT00960011|11594281|FG000|Overall Study|Lost to Follow-up|6
7352356|NCT00960011|11594282|FG001|Overall Study|Lost to Follow-up|2
7352357|NCT00960063|11594325|FG000|Overall Study|Adverse Event|1
7352358|NCT00960063|11594326|FG001|Overall Study|Adverse Event|0
7352359|NCT00960063|11594327|FG002|Overall Study|Adverse Event|0
7352360|NCT00960063|11594325|FG000|Overall Study|Progression of Disease|0
7352361|NCT00960063|11594326|FG001|Overall Study|Progression of Disease|0
7352362|NCT00960063|11594327|FG002|Overall Study|Progression of Disease|3
7352363|NCT00960076|11594337|FG000|Overall Study|Adverse Event|1
7352364|NCT00960076|11594338|FG001|Overall Study|Adverse Event|7
7352365|NCT00960076|11594337|FG000|Overall Study|No longer met study criteria|1
7352366|NCT00960076|11594338|FG001|Overall Study|No longer met study criteria|5
7352367|NCT00960076|11594337|FG000|Overall Study|Withdrawal by Subject|1
7352368|NCT00960076|11594338|FG001|Overall Study|Withdrawal by Subject|2
7352369|NCT00960076|11594337|FG000|Overall Study|Lost to Follow-up|3
7352370|NCT00960076|11594338|FG001|Overall Study|Lost to Follow-up|3
7352371|NCT00960076|11594337|FG000|Overall Study|Severe non-compliance to protocol|1
7352372|NCT00960076|11594338|FG001|Overall Study|Severe non-compliance to protocol|2
7352373|NCT00960076|11594337|FG000|Overall Study|Hyperglycemia|1
7352374|NCT00960076|11594338|FG001|Overall Study|Hyperglycemia|5
7352375|NCT00960076|11594337|FG000|Overall Study|Did not attend the termination visit|0
7352376|NCT00960076|11594338|FG001|Overall Study|Did not attend the termination visit|1
7352377|NCT00960115|11594346|FG000|Overall Study|Ongoing treatment at data cut-off date|19
7352378|NCT00960115|11594347|FG001|Overall Study|Ongoing treatment at data cut-off date|15
7352379|NCT00960193|11594353|FG000|14 Day Washout Period|Withdrawal by Subject|1
7352380|NCT00960206|11594363|FG000|Overall Study|Death|7
7352381|NCT00960206|11594364|FG001|Overall Study|Death|4
7352382|NCT00960206|11594365|FG002|Overall Study|Death|1
7352383|NCT00960206|11594363|FG000|Overall Study|Unwilling/Unable to return|1
7352384|NCT00960206|11594364|FG001|Overall Study|Unwilling/Unable to return|2
7352385|NCT00960206|11594365|FG002|Overall Study|Unwilling/Unable to return|0
7352386|NCT00960206|11594363|FG000|Overall Study|Lost to Follow-up|8
7352387|NCT00960206|11594364|FG001|Overall Study|Lost to Follow-up|14
7352388|NCT00960206|11594365|FG002|Overall Study|Lost to Follow-up|8
7352389|NCT00960206|11594363|FG000|Overall Study|Withdrawal by Subject|2
7352390|NCT00960206|11594364|FG001|Overall Study|Withdrawal by Subject|4
7352391|NCT00960206|11594365|FG002|Overall Study|Withdrawal by Subject|0
7352392|NCT00960206|11594363|FG000|Overall Study|Revision of study component|2
7352393|NCT00960206|11594364|FG001|Overall Study|Revision of study component|2
7352395|NCT00960206|11594363|FG000|Overall Study|Missing 10 year data|20
7533181|NCT02681510|11879256|FG000|Overall Study|Withdrawal by Subject|1
7533182|NCT02681510|11879256|FG000|Overall Study|Lost to Follow-up|9
7533183|NCT02681523|11879260|FG000|Overall Study|Adverse Event|1
7533184|NCT02681523|11879260|FG000|Overall Study|Patient Non-compliance|1
7533185|NCT02682264|11879310|FG000|Overall Study|Withdrawal by Subject|56
7533186|NCT02682264|11879311|FG001|Overall Study|Withdrawal by Subject|45
7533187|NCT02682264|11879310|FG000|Overall Study|Lost to Follow-up|49
7533188|NCT02682264|11879311|FG001|Overall Study|Lost to Follow-up|41
7533189|NCT02682264|11879310|FG000|Overall Study|Lack of Efficacy|14
7533190|NCT02682264|11879311|FG001|Overall Study|Lack of Efficacy|16
7533191|NCT02682264|11879310|FG000|Overall Study|Withdrawal by Parent|6
7533192|NCT02682264|11879311|FG001|Overall Study|Withdrawal by Parent|7
7533193|NCT02682264|11879310|FG000|Overall Study|Adverse Event|9
7533194|NCT02682264|11879311|FG001|Overall Study|Adverse Event|0
7533195|NCT02682264|11879310|FG000|Overall Study|Noncompliance with study drug|1
7533196|NCT02682264|11879311|FG001|Overall Study|Noncompliance with study drug|4
7533197|NCT02682264|11879310|FG000|Overall Study|Pregnancy|1
7533198|NCT02682264|11879311|FG001|Overall Study|Pregnancy|2
7533199|NCT02682264|11879310|FG000|Overall Study|Recovery|1
7533200|NCT02682264|11879311|FG001|Overall Study|Recovery|2
7533201|NCT02682264|11879310|FG000|Overall Study|Progressive Disease|1
7533202|NCT02682264|11879311|FG001|Overall Study|Progressive Disease|0
7533203|NCT02682264|11879310|FG000|Overall Study|Technical Problems|0
7533204|NCT02682264|11879311|FG001|Overall Study|Technical Problems|1
7533205|NCT02682264|11879310|FG000|Overall Study|Moved abroad and unable to continue|0
7569406|NCT03449030|11945798|FG009|Overall Study|Adverse Event|0
7569407|NCT03449030|11945789|FG000|Overall Study|Death|0
7569408|NCT03449030|11945790|FG001|Overall Study|Death|0
7352396|NCT00960206|11594364|FG001|Overall Study|Missing 10 year data|1
7352397|NCT00960206|11594365|FG002|Overall Study|Missing 10 year data|1
7352398|NCT00960323|11594374|FG000|Atorvastatin Alone|Withdrawal by Subject|1
7352399|NCT00960375|11594384|FG000|Overall Study|Lost to Follow-up|20
7352400|NCT00960375|11594385|FG001|Overall Study|Lost to Follow-up|22
7352401|NCT00960440|11594395|FG000|Overall Study|Death|0
7352402|NCT00960440|11594396|FG001|Overall Study|Death|0
7352403|NCT00960440|11594397|FG002|Overall Study|Death|0
7352404|NCT00960440|11594398|FG003|Overall Study|Death|1
7352405|NCT00960440|11594395|FG000|Overall Study|Adverse Event|12
7352406|NCT00960440|11594396|FG001|Overall Study|Adverse Event|12
7533206|NCT02682264|11879311|FG001|Overall Study|Moved abroad and unable to continue|3
7533207|NCT02682264|11879310|FG000|Overall Study|Stopped test article application|0
7569409|NCT03449030|11945791|FG002|Overall Study|Death|0
7569410|NCT03449030|11945792|FG003|Overall Study|Death|0
7352407|NCT00960440|11594397|FG002|Overall Study|Adverse Event|4
7352408|NCT00960440|11594398|FG003|Overall Study|Adverse Event|4
7352409|NCT00960440|11594395|FG000|Overall Study|Lack of Efficacy|2
7352410|NCT00960440|11594396|FG001|Overall Study|Lack of Efficacy|5
7352411|NCT00960440|11594397|FG002|Overall Study|Lack of Efficacy|3
7352412|NCT00960440|11594398|FG003|Overall Study|Lack of Efficacy|8
7352413|NCT00960440|11594395|FG000|Overall Study|Protocol Violation|2
7352414|NCT00960440|11594396|FG001|Overall Study|Protocol Violation|8
7352415|NCT00960440|11594397|FG002|Overall Study|Protocol Violation|3
7352416|NCT00960440|11594398|FG003|Overall Study|Protocol Violation|4
7352417|NCT00960440|11594395|FG000|Overall Study|Withdrawal by Subject|9
7352418|NCT00960440|11594396|FG001|Overall Study|Withdrawal by Subject|5
7352419|NCT00960440|11594397|FG002|Overall Study|Withdrawal by Subject|2
7352420|NCT00960440|11594398|FG003|Overall Study|Withdrawal by Subject|1
7352421|NCT00960440|11594395|FG000|Overall Study|Other|1
7352422|NCT00960440|11594396|FG001|Overall Study|Other|1
7352423|NCT00960440|11594397|FG002|Overall Study|Other|1
7537683|NCT02759185|11886793|FG005|Stage 2|Adverse Event|2
7569411|NCT03449030|11945793|FG004|Overall Study|Death|1
7569412|NCT03449030|11945794|FG005|Overall Study|Death|0
7569413|NCT03449030|11945795|FG006|Overall Study|Death|0
7569414|NCT03449030|11945796|FG007|Overall Study|Death|0
7352424|NCT00960440|11594398|FG003|Overall Study|Other|0
7352425|NCT00960531|11594433|FG000|Overall Study|Lack of Efficacy|1
7352426|NCT00960531|11594434|FG001|Overall Study|Lack of Efficacy|0
7352427|NCT00960531|11594435|FG002|Overall Study|Lack of Efficacy|0
7352428|NCT00960531|11594436|FG003|Overall Study|Lack of Efficacy|0
7352429|NCT00960531|11594437|FG004|Overall Study|Lack of Efficacy|0
7352430|NCT00960531|11594438|FG005|Overall Study|Lack of Efficacy|0
7352431|NCT00960531|11594439|FG006|Overall Study|Lack of Efficacy|0
7352432|NCT00960531|11594440|FG007|Overall Study|Lack of Efficacy|0
7352433|NCT00960531|11594441|FG008|Overall Study|Lack of Efficacy|0
7352434|NCT00960531|11594442|FG009|Overall Study|Lack of Efficacy|0
7352435|NCT00960531|11594433|FG000|Overall Study|Withdrawal by Subject|1
7352436|NCT00960531|11594434|FG001|Overall Study|Withdrawal by Subject|0
7352437|NCT00960531|11594435|FG002|Overall Study|Withdrawal by Subject|5
7352438|NCT00960531|11594436|FG003|Overall Study|Withdrawal by Subject|2
7352439|NCT00960531|11594437|FG004|Overall Study|Withdrawal by Subject|0
7352440|NCT00960531|11594438|FG005|Overall Study|Withdrawal by Subject|0
7352441|NCT00960531|11594439|FG006|Overall Study|Withdrawal by Subject|2
7352442|NCT00960531|11594440|FG007|Overall Study|Withdrawal by Subject|0
7352443|NCT00960531|11594441|FG008|Overall Study|Withdrawal by Subject|1
7352444|NCT00960531|11594442|FG009|Overall Study|Withdrawal by Subject|0
7352445|NCT00960531|11594433|FG000|Overall Study|Caregiver Request|2
7352446|NCT00960531|11594434|FG001|Overall Study|Caregiver Request|0
7352447|NCT00960531|11594435|FG002|Overall Study|Caregiver Request|6
7352448|NCT00960531|11594436|FG003|Overall Study|Caregiver Request|5
7352449|NCT00960531|11594437|FG004|Overall Study|Caregiver Request|0
7569415|NCT03449030|11945797|FG008|Overall Study|Death|0
7569416|NCT03449030|11945798|FG009|Overall Study|Death|0
7569417|NCT03449134|11945824|FG000|52-Week Treatment Period|Death|2
7569418|NCT03449134|11945825|FG001|52-Week Treatment Period|Death|1
7569419|NCT03449134|11945826|FG002|52-Week Treatment Period|Death|0
7569420|NCT03449134|11945824|FG000|52-Week Treatment Period|Lost to Follow-up|2
7569421|NCT03449134|11945825|FG001|52-Week Treatment Period|Lost to Follow-up|1
7569422|NCT03449134|11945826|FG002|52-Week Treatment Period|Lost to Follow-up|1
7569423|NCT03449134|11945824|FG000|52-Week Treatment Period|Physician Decision|2
7569424|NCT03449134|11945825|FG001|52-Week Treatment Period|Physician Decision|3
7569425|NCT03449134|11945826|FG002|52-Week Treatment Period|Physician Decision|3
7569426|NCT03449134|11945824|FG000|52-Week Treatment Period|Screen Failure|1
7569427|NCT03449134|11945825|FG001|52-Week Treatment Period|Screen Failure|0
7569428|NCT03449134|11945826|FG002|52-Week Treatment Period|Screen Failure|1
7569429|NCT03449134|11945824|FG000|52-Week Treatment Period|Withdrawal by Subject|37
7569430|NCT03449134|11945825|FG001|52-Week Treatment Period|Withdrawal by Subject|39
7569431|NCT03449134|11945826|FG002|52-Week Treatment Period|Withdrawal by Subject|55
7569432|NCT03449134|11945824|FG000|52-Week Treatment Period|Site Closure|1
7569433|NCT03449134|11945825|FG001|52-Week Treatment Period|Site Closure|0
7569434|NCT03449134|11945826|FG002|52-Week Treatment Period|Site Closure|0
7569435|NCT03449147|11945840|FG000|52-week Treatment Period|Death|0
7569436|NCT03449147|11945841|FG001|52-week Treatment Period|Death|1
7569437|NCT03449147|11945842|FG002|52-week Treatment Period|Death|0
7569438|NCT03449147|11945840|FG000|52-week Treatment Period|Lost to Follow-up|6
7569439|NCT03449147|11945841|FG001|52-week Treatment Period|Lost to Follow-up|2
7569440|NCT03449147|11945842|FG002|52-week Treatment Period|Lost to Follow-up|5
7569441|NCT03449147|11945840|FG000|52-week Treatment Period|Other|0
7569442|NCT03449147|11945841|FG001|52-week Treatment Period|Other|1
7352450|NCT00960531|11594438|FG005|Overall Study|Caregiver Request|2
7352451|NCT00960531|11594439|FG006|Overall Study|Caregiver Request|3
7352452|NCT00960531|11594440|FG007|Overall Study|Caregiver Request|1
7352453|NCT00960531|11594441|FG008|Overall Study|Caregiver Request|3
7352454|NCT00960531|11594442|FG009|Overall Study|Caregiver Request|0
7352455|NCT00960531|11594433|FG000|Overall Study|Investigator Request|0
7352456|NCT00960531|11594434|FG001|Overall Study|Investigator Request|0
7352457|NCT00960531|11594435|FG002|Overall Study|Investigator Request|1
7352458|NCT00960531|11594436|FG003|Overall Study|Investigator Request|0
7352459|NCT00960531|11594437|FG004|Overall Study|Investigator Request|0
7352460|NCT00960531|11594438|FG005|Overall Study|Investigator Request|0
7352461|NCT00960531|11594439|FG006|Overall Study|Investigator Request|0
7352462|NCT00960531|11594440|FG007|Overall Study|Investigator Request|0
7352463|NCT00960531|11594441|FG008|Overall Study|Investigator Request|0
7352464|NCT00960531|11594442|FG009|Overall Study|Investigator Request|0
7352465|NCT00960531|11594433|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7352466|NCT00960531|11594434|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7352467|NCT00960531|11594435|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7352468|NCT00960531|11594436|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7352469|NCT00960531|11594437|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7352470|NCT00960531|11594438|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7352471|NCT00960531|11594439|FG006|Overall Study|Discontinuation of Study by Sponsor|0
7352472|NCT00960531|11594440|FG007|Overall Study|Discontinuation of Study by Sponsor|1
7352473|NCT00960531|11594441|FG008|Overall Study|Discontinuation of Study by Sponsor|0
7352474|NCT00960531|11594442|FG009|Overall Study|Discontinuation of Study by Sponsor|0
7352475|NCT00960531|11594433|FG000|Overall Study|Lost to Follow-up|0
7352476|NCT00960531|11594434|FG001|Overall Study|Lost to Follow-up|0
7352477|NCT00960531|11594435|FG002|Overall Study|Lost to Follow-up|1
7352478|NCT00960531|11594436|FG003|Overall Study|Lost to Follow-up|0
7352479|NCT00960531|11594437|FG004|Overall Study|Lost to Follow-up|0
7352480|NCT00960531|11594438|FG005|Overall Study|Lost to Follow-up|0
7352481|NCT00960531|11594439|FG006|Overall Study|Lost to Follow-up|1
7352482|NCT00960531|11594440|FG007|Overall Study|Lost to Follow-up|0
7352483|NCT00960531|11594441|FG008|Overall Study|Lost to Follow-up|0
7352484|NCT00960531|11594442|FG009|Overall Study|Lost to Follow-up|0
7352485|NCT00960531|11594433|FG000|Overall Study|Failed to Return|2
7352486|NCT00960531|11594434|FG001|Overall Study|Failed to Return|0
7352487|NCT00960531|11594435|FG002|Overall Study|Failed to Return|0
7352488|NCT00960531|11594436|FG003|Overall Study|Failed to Return|0
7352489|NCT00960531|11594437|FG004|Overall Study|Failed to Return|0
7352490|NCT00960531|11594438|FG005|Overall Study|Failed to Return|0
7352491|NCT00960531|11594439|FG006|Overall Study|Failed to Return|0
7352492|NCT00960531|11594440|FG007|Overall Study|Failed to Return|2
7352493|NCT00960531|11594441|FG008|Overall Study|Failed to Return|0
7352494|NCT00960531|11594442|FG009|Overall Study|Failed to Return|0
7352495|NCT00960531|11594433|FG000|Overall Study|Adverse Event (AE)|2
7352496|NCT00960531|11594434|FG001|Overall Study|Adverse Event (AE)|0
7352497|NCT00960531|11594435|FG002|Overall Study|Adverse Event (AE)|0
7352498|NCT00960531|11594436|FG003|Overall Study|Adverse Event (AE)|0
7352499|NCT00960531|11594437|FG004|Overall Study|Adverse Event (AE)|0
7352500|NCT00960531|11594438|FG005|Overall Study|Adverse Event (AE)|1
7352501|NCT00960531|11594439|FG006|Overall Study|Adverse Event (AE)|2
7352502|NCT00960531|11594440|FG007|Overall Study|Adverse Event (AE)|0
7352503|NCT00960531|11594441|FG008|Overall Study|Adverse Event (AE)|2
7352504|NCT00960531|11594442|FG009|Overall Study|Adverse Event (AE)|0
7352505|NCT00960531|11594433|FG000|Overall Study|Reason not Specified|2
7352506|NCT00960531|11594434|FG001|Overall Study|Reason not Specified|1
7352507|NCT00960531|11594435|FG002|Overall Study|Reason not Specified|13
7352508|NCT00960531|11594436|FG003|Overall Study|Reason not Specified|1
7352509|NCT00960531|11594437|FG004|Overall Study|Reason not Specified|2
7352510|NCT00960531|11594438|FG005|Overall Study|Reason not Specified|0
7352511|NCT00960531|11594439|FG006|Overall Study|Reason not Specified|16
7352512|NCT00960531|11594440|FG007|Overall Study|Reason not Specified|0
7352513|NCT00960531|11594441|FG008|Overall Study|Reason not Specified|8
7352514|NCT00960531|11594442|FG009|Overall Study|Reason not Specified|1
7352515|NCT00960570|11594468|FG000|21 Day Washout Period|Adverse Event|1
7352516|NCT00960570|11594468|FG000|21 Day Washout Period|Withdrawal by Subject|1
7352517|NCT00960570|11594468|FG000|1 Day Period Between Dosing|Adverse Event|2
7352518|NCT00960570|11594468|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
7352519|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
7352520|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7352521|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
7352522|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
7352523|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7352524|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
7352525|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
7352526|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7352527|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
7352528|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
7352529|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7352530|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
7352531|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
7352532|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7352533|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
7352534|NCT00960661|11594486|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
7352535|NCT00960661|11594487|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7352536|NCT00960661|11594488|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
7352537|NCT00960661|11594486|FG000|Interventional Phase|Adverse Event|0
7352538|NCT00960661|11594487|FG001|Interventional Phase|Adverse Event|17
7352539|NCT00960661|11594488|FG002|Interventional Phase|Adverse Event|8
7352540|NCT00960661|11594486|FG000|Interventional Phase|Death|0
7352541|NCT00960661|11594487|FG001|Interventional Phase|Death|1
7352542|NCT00960661|11594488|FG002|Interventional Phase|Death|0
7352543|NCT00960661|11594486|FG000|Interventional Phase|Lost to Follow-up|0
7352544|NCT00960661|11594487|FG001|Interventional Phase|Lost to Follow-up|0
7352545|NCT00960661|11594488|FG002|Interventional Phase|Lost to Follow-up|2
7352546|NCT00960661|11594486|FG000|Interventional Phase|entry criteria not met|0
7352547|NCT00960661|11594487|FG001|Interventional Phase|entry criteria not met|3
7352548|NCT00960661|11594488|FG002|Interventional Phase|entry criteria not met|0
7352549|NCT00960661|11594486|FG000|Interventional Phase|Protocol Violation|0
7352550|NCT00960661|11594487|FG001|Interventional Phase|Protocol Violation|7
7352551|NCT00960661|11594488|FG002|Interventional Phase|Protocol Violation|2
7352552|NCT00960661|11594486|FG000|Interventional Phase|Withdrawal by Subject|0
7352553|NCT00960661|11594487|FG001|Interventional Phase|Withdrawal by Subject|18
7352554|NCT00960661|11594488|FG002|Interventional Phase|Withdrawal by Subject|29
7352555|NCT00960661|11594486|FG000|Interventional Phase|Physician Decision|0
7352556|NCT00960661|11594487|FG001|Interventional Phase|Physician Decision|3
7352557|NCT00960661|11594488|FG002|Interventional Phase|Physician Decision|5
7352558|NCT00960661|11594486|FG000|Interventional Phase|sponsor decision|0
7352559|NCT00960661|11594487|FG001|Interventional Phase|sponsor decision|1
7352560|NCT00960661|11594488|FG002|Interventional Phase|sponsor decision|0
7352561|NCT00960661|11594486|FG000|Interventional Phase|Lack of Efficacy|0
7352562|NCT00960661|11594487|FG001|Interventional Phase|Lack of Efficacy|2
7352563|NCT00960661|11594488|FG002|Interventional Phase|Lack of Efficacy|0
7352564|NCT00960687|11594494|FG000|Washout Period of 7 Days|Adverse Event|3
7352565|NCT00960687|11594495|FG001|Washout Period of 7 Days|Adverse Event|2
7352566|NCT00960687|11594494|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7352567|NCT00960687|11594495|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7352568|NCT00960804|11594513|FG000|Overall Study|Adverse Event|1
7352569|NCT00960804|11594514|FG001|Overall Study|Adverse Event|0
7352570|NCT00960804|11594515|FG002|Overall Study|Adverse Event|0
7352571|NCT00960804|11594513|FG000|Overall Study|Withdrawal by Subject|1
7352572|NCT00960804|11594514|FG001|Overall Study|Withdrawal by Subject|0
7352573|NCT00960804|11594515|FG002|Overall Study|Withdrawal by Subject|0
7352574|NCT00960804|11594513|FG000|Overall Study|Study terminated by the sponsor|5
7352575|NCT00960804|11594514|FG001|Overall Study|Study terminated by the sponsor|4
7352576|NCT00960804|11594515|FG002|Overall Study|Study terminated by the sponsor|10
7352577|NCT00960843|11594525|FG000|Overall Study|Lost to Follow-up|2
7352578|NCT00960843|11594526|FG001|Overall Study|Lost to Follow-up|0
7352579|NCT00960843|11594525|FG000|Overall Study|Protocol Violation|0
7352580|NCT00960843|11594526|FG001|Overall Study|Protocol Violation|4
7352581|NCT00960843|11594525|FG000|Overall Study|Repeated needle dislodgment|0
7352582|NCT00960843|11594526|FG001|Overall Study|Repeated needle dislodgment|1
7352583|NCT00960856|11594532|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7352584|NCT00960856|11594533|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
7352585|NCT00960856|11594534|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
7352586|NCT00960856|11594535|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
7352587|NCT00960856|11594532|FG000|Washout Period of 7 Days|Adverse Event|0
7352588|NCT00960856|11594533|FG001|Washout Period of 7 Days|Adverse Event|0
7352589|NCT00960856|11594534|FG002|Washout Period of 7 Days|Adverse Event|1
7352590|NCT00960856|11594535|FG003|Washout Period of 7 Days|Adverse Event|0
7352591|NCT00960869|11594547|FG000|Overall Study|Adverse Event|17
7352592|NCT00960869|11594548|FG001|Overall Study|Adverse Event|26
7352593|NCT00960869|11594547|FG000|Overall Study|Withdrawal by Subject|16
7352594|NCT00960869|11594548|FG001|Overall Study|Withdrawal by Subject|14
7352595|NCT00960869|11594547|FG000|Overall Study|Lost to Follow-up|1
7352596|NCT00960869|11594548|FG001|Overall Study|Lost to Follow-up|4
7352597|NCT00960869|11594547|FG000|Overall Study|Misc|19
7352598|NCT00960869|11594548|FG001|Overall Study|Misc|18
7352599|NCT00960934|11594560|FG000|Overall Study|Adverse Event|2
7352600|NCT00960934|11594561|FG001|Overall Study|Adverse Event|3
7352601|NCT00960934|11594562|FG002|Overall Study|Adverse Event|3
7352602|NCT00960934|11594563|FG003|Overall Study|Adverse Event|2
7352603|NCT00960934|11594564|FG004|Overall Study|Adverse Event|4
7352604|NCT00960934|11594565|FG005|Overall Study|Adverse Event|3
7352605|NCT00960934|11594560|FG000|Overall Study|Lack of Efficacy|1
7352606|NCT00960934|11594561|FG001|Overall Study|Lack of Efficacy|0
7352607|NCT00960934|11594562|FG002|Overall Study|Lack of Efficacy|0
7352608|NCT00960934|11594563|FG003|Overall Study|Lack of Efficacy|0
7352609|NCT00960934|11594564|FG004|Overall Study|Lack of Efficacy|0
7352610|NCT00960934|11594565|FG005|Overall Study|Lack of Efficacy|0
7352611|NCT00960934|11594560|FG000|Overall Study|Lost to Follow-up|0
7352612|NCT00960934|11594561|FG001|Overall Study|Lost to Follow-up|1
7352613|NCT00960934|11594562|FG002|Overall Study|Lost to Follow-up|0
7352614|NCT00960934|11594563|FG003|Overall Study|Lost to Follow-up|0
7352615|NCT00960934|11594564|FG004|Overall Study|Lost to Follow-up|0
7352616|NCT00960934|11594565|FG005|Overall Study|Lost to Follow-up|0
7352617|NCT00960934|11594560|FG000|Overall Study|Other|2
7352618|NCT00960934|11594561|FG001|Overall Study|Other|1
7352619|NCT00960934|11594562|FG002|Overall Study|Other|5
7352620|NCT00960934|11594563|FG003|Overall Study|Other|4
7352621|NCT00960934|11594564|FG004|Overall Study|Other|2
7352622|NCT00960934|11594565|FG005|Overall Study|Other|2
7352623|NCT00960934|11594560|FG000|Overall Study|Physician Decision|0
7352624|NCT00960934|11594561|FG001|Overall Study|Physician Decision|1
7352625|NCT00960934|11594562|FG002|Overall Study|Physician Decision|0
7352626|NCT00960934|11594563|FG003|Overall Study|Physician Decision|0
7352627|NCT00960934|11594564|FG004|Overall Study|Physician Decision|0
7352628|NCT00960934|11594565|FG005|Overall Study|Physician Decision|0
7352629|NCT00960934|11594560|FG000|Overall Study|Progressive Disease|1
7352630|NCT00960934|11594561|FG001|Overall Study|Progressive Disease|1
7352631|NCT00960934|11594562|FG002|Overall Study|Progressive Disease|0
7352632|NCT00960934|11594563|FG003|Overall Study|Progressive Disease|0
7352633|NCT00960934|11594564|FG004|Overall Study|Progressive Disease|1
7352634|NCT00960934|11594565|FG005|Overall Study|Progressive Disease|1
7352635|NCT00960934|11594560|FG000|Overall Study|Protocol Violation|3
7352636|NCT00960934|11594561|FG001|Overall Study|Protocol Violation|4
7352637|NCT00960934|11594562|FG002|Overall Study|Protocol Violation|0
7352638|NCT00960934|11594563|FG003|Overall Study|Protocol Violation|3
7352639|NCT00960934|11594564|FG004|Overall Study|Protocol Violation|3
7352640|NCT00960934|11594565|FG005|Overall Study|Protocol Violation|2
7352641|NCT00960934|11594560|FG000|Overall Study|Withdrawal by Subject|5
7352642|NCT00960934|11594561|FG001|Overall Study|Withdrawal by Subject|6
7352643|NCT00960934|11594562|FG002|Overall Study|Withdrawal by Subject|4
7352644|NCT00960934|11594563|FG003|Overall Study|Withdrawal by Subject|5
7352645|NCT00960934|11594564|FG004|Overall Study|Withdrawal by Subject|5
7352646|NCT00960934|11594565|FG005|Overall Study|Withdrawal by Subject|7
7352647|NCT00960934|11594560|FG000|Overall Study|Study Terminated by Sponsor|50
7352648|NCT00960934|11594561|FG001|Overall Study|Study Terminated by Sponsor|46
7352649|NCT00960934|11594562|FG002|Overall Study|Study Terminated by Sponsor|52
7352650|NCT00960934|11594563|FG003|Overall Study|Study Terminated by Sponsor|50
7352651|NCT00960934|11594564|FG004|Overall Study|Study Terminated by Sponsor|49
7352652|NCT00960934|11594565|FG005|Overall Study|Study Terminated by Sponsor|49
7352653|NCT00960986|11594583|FG000|Period 1 (Screening and Washout)|Adverse Event|1
7352654|NCT00960986|11594584|FG001|Period 1 (Screening and Washout)|Adverse Event|2
7352655|NCT00960986|11594585|FG002|Period 1 (Screening and Washout)|Adverse Event|1
7352656|NCT00960986|11594586|FG003|Period 1 (Screening and Washout)|Adverse Event|1
7352657|NCT00960986|11594583|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
7352658|NCT00960986|11594584|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
7352659|NCT00960986|11594585|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
7352660|NCT00960986|11594586|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
7352661|NCT00960986|11594583|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
7352662|NCT00960986|11594584|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
7352663|NCT00960986|11594585|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
7352664|NCT00960986|11594586|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
7352665|NCT00960986|11594583|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7352666|NCT00960986|11594584|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
7352667|NCT00960986|11594585|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7352668|NCT00960986|11594586|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
7352669|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
7352670|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
7352671|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
7352672|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
7352673|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Death|0
7352674|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Death|0
7352675|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Death|1
7352676|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Death|0
7352677|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7352678|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7352679|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
7352680|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
7352681|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
7352682|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
7352683|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
7352684|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
7352685|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7352686|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7352687|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
7352688|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
7352689|NCT00960986|11594583|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7352690|NCT00960986|11594584|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
7352691|NCT00960986|11594585|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
7352692|NCT00960986|11594586|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
7352693|NCT00960999|11594598|FG000|Overall Study|Withdrawal by Subject|1
7352694|NCT00960999|11594599|FG001|Overall Study|Withdrawal by Subject|0
7459461|NCT01817530|11754060|FG005|Overall Study|Lost to Follow-up|2
7352695|NCT00960999|11594598|FG000|Overall Study|Protocol Violation|5
7352696|NCT00960999|11594599|FG001|Overall Study|Protocol Violation|2
7352697|NCT00960999|11594598|FG000|Overall Study|RT dose constraints not met|2
7352698|NCT00960999|11594599|FG001|Overall Study|RT dose constraints not met|0
7352699|NCT00961116|11594614|FG000|Washout Period of 7 Days|Adverse Event|1
7352700|NCT00961116|11594615|FG001|Washout Period of 7 Days|Adverse Event|1
7352701|NCT00961116|11594614|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
7352702|NCT00961116|11594615|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7352703|NCT00961116|11594614|FG000|Washout Period of 7 Days|Protocol Violation|0
7352704|NCT00961116|11594615|FG001|Washout Period of 7 Days|Protocol Violation|1
7352705|NCT00961181|11594622|FG000|Overall Study|Death|2
7352706|NCT00961181|11594622|FG000|Overall Study|Withdrawal by Subject|2
7352707|NCT00961181|11594622|FG000|Overall Study|Lost to Follow-up|1
7352708|NCT00961220|11594626|FG000|Overall Study|Adverse Event|3
7352709|NCT00961220|11594626|FG000|Overall Study|Lack of Efficacy|1
7352710|NCT00961220|11594626|FG000|Overall Study|No IV access for O6BG|1
7352711|NCT00961220|11594626|FG000|Overall Study|O6BG no longer supplied|1
7352712|NCT00961220|11594626|FG000|Overall Study|Complete Response prior to 12 courses|1
7352713|NCT00961259|11594643|FG000|Washout Period of 7 Days|due to concomitant medication used|0
7352714|NCT00961259|11594644|FG001|Washout Period of 7 Days|due to concomitant medication used|1
7352715|NCT00961259|11594645|FG002|Washout Period of 7 Days|due to concomitant medication used|0
7352716|NCT00961298|11594654|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
7352717|NCT00961298|11594654|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
7352718|NCT00961298|11594654|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
7352719|NCT00961350|11594664|FG000|Overall Study|Adverse Event|18
7352720|NCT00961350|11594665|FG001|Overall Study|Adverse Event|33
7352721|NCT00961350|11594664|FG000|Overall Study|Withdrawal by Subject|10
7352722|NCT00961350|11594665|FG001|Overall Study|Withdrawal by Subject|10
7352723|NCT00961350|11594664|FG000|Overall Study|Lost to Follow-up|3
7352724|NCT00961350|11594665|FG001|Overall Study|Lost to Follow-up|3
7352725|NCT00961350|11594664|FG000|Overall Study|Misc|16
7352726|NCT00961350|11594665|FG001|Overall Study|Misc|21
7352727|NCT00961415|11594682|FG000|Induction Treatment Phase|Withdrawal by Subject|11
7352728|NCT00961415|11594683|FG001|Induction Treatment Phase|Withdrawal by Subject|0
7352729|NCT00961415|11594684|FG002|Induction Treatment Phase|Withdrawal by Subject|0
7352730|NCT00961415|11594682|FG000|Induction Treatment Phase|Death|77
7352731|NCT00961415|11594683|FG001|Induction Treatment Phase|Death|0
7352732|NCT00961415|11594684|FG002|Induction Treatment Phase|Death|0
7352733|NCT00961415|11594682|FG000|Induction Treatment Phase|Protocol Violation|1
7352734|NCT00961415|11594683|FG001|Induction Treatment Phase|Protocol Violation|0
7352735|NCT00961415|11594684|FG002|Induction Treatment Phase|Protocol Violation|0
7352736|NCT00961415|11594682|FG000|Induction Treatment Phase|Physician Decision|2
7352737|NCT00961415|11594683|FG001|Induction Treatment Phase|Physician Decision|0
7352738|NCT00961415|11594684|FG002|Induction Treatment Phase|Physician Decision|0
7352739|NCT00961415|11594682|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
7352740|NCT00961415|11594683|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7352741|NCT00961415|11594684|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
7352742|NCT00961415|11594682|FG000|Induction Treatment Phase|Other Reason|5
7352743|NCT00961415|11594683|FG001|Induction Treatment Phase|Other Reason|0
7352744|NCT00961415|11594684|FG002|Induction Treatment Phase|Other Reason|0
7352745|NCT00961415|11594682|FG000|Maintenance Treatment Phase|Death|0
7352746|NCT00961415|11594683|FG001|Maintenance Treatment Phase|Death|42
7352747|NCT00961415|11594684|FG002|Maintenance Treatment Phase|Death|34
7352748|NCT00961415|11594682|FG000|Maintenance Treatment Phase|Investigators decision|0
7352749|NCT00961415|11594683|FG001|Maintenance Treatment Phase|Investigators decision|2
7352750|NCT00961415|11594684|FG002|Maintenance Treatment Phase|Investigators decision|0
7352751|NCT00961415|11594682|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
7352752|NCT00961415|11594683|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
7352753|NCT00961415|11594684|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
7352754|NCT00961415|11594682|FG000|Maintenance Treatment Phase|Other reason|0
7352755|NCT00961415|11594683|FG001|Maintenance Treatment Phase|Other reason|1
7352756|NCT00961415|11594684|FG002|Maintenance Treatment Phase|Other reason|3
7352757|NCT00961571|11594711|FG000|Overall Study|Physician Decision|39
7352758|NCT00961636|11594718|FG000|Overall Study|Adverse Event|35
7352759|NCT00961636|11594719|FG001|Overall Study|Adverse Event|54
7352760|NCT00961636|11594720|FG002|Overall Study|Adverse Event|13
7352761|NCT00961636|11594718|FG000|Overall Study|Flushing Symptoms|29
7352762|NCT00961636|11594719|FG001|Overall Study|Flushing Symptoms|46
7352763|NCT00961636|11594720|FG002|Overall Study|Flushing Symptoms|3
7352764|NCT00961636|11594718|FG000|Overall Study|Lost to Follow-up|2
7533208|NCT02682264|11879311|FG001|Overall Study|Stopped test article application|1
7533209|NCT02682602|11879362|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
7533210|NCT02682602|11879363|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
7533211|NCT02682602|11879362|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
7533212|NCT02682602|11879363|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
7533213|NCT02682784|11879377|FG000|Overall Study|Withdrawal by Subject|0
7533214|NCT02682784|11879378|FG001|Overall Study|Withdrawal by Subject|2
7569443|NCT03449147|11945842|FG002|52-week Treatment Period|Other|2
7569444|NCT03449147|11945840|FG000|52-week Treatment Period|Physician Decision|1
7352765|NCT00961636|11594719|FG001|Overall Study|Lost to Follow-up|3
7533215|NCT02682784|11879379|FG002|Overall Study|Withdrawal by Subject|1
7352766|NCT00961636|11594720|FG002|Overall Study|Lost to Follow-up|1
7352767|NCT00961636|11594718|FG000|Overall Study|Physician Decision|3
7533216|NCT02682784|11879380|FG003|Overall Study|Withdrawal by Subject|2
7533217|NCT02682784|11879377|FG000|Overall Study|Physician Decision|1
7533218|NCT02682784|11879378|FG001|Overall Study|Physician Decision|0
7533219|NCT02682784|11879379|FG002|Overall Study|Physician Decision|1
7533220|NCT02682784|11879380|FG003|Overall Study|Physician Decision|1
7533221|NCT02682823|11879395|FG000|Overall Study|Withdrawal by Subject|0
7533222|NCT02682823|11879396|FG001|Overall Study|Withdrawal by Subject|0
7533223|NCT02682823|11879397|FG002|Overall Study|Withdrawal by Subject|1
7533224|NCT02682823|11879398|FG003|Overall Study|Withdrawal by Subject|0
7569445|NCT03449147|11945841|FG001|52-week Treatment Period|Physician Decision|0
7569446|NCT03449147|11945842|FG002|52-week Treatment Period|Physician Decision|3
7352768|NCT00961636|11594719|FG001|Overall Study|Physician Decision|1
7352769|NCT00961636|11594720|FG002|Overall Study|Physician Decision|1
7352770|NCT00961636|11594718|FG000|Overall Study|Protocol Violation|9
7352771|NCT00961636|11594719|FG001|Overall Study|Protocol Violation|5
7352772|NCT00961636|11594720|FG002|Overall Study|Protocol Violation|1
7352773|NCT00961636|11594718|FG000|Overall Study|Withdrawal by Subject|29
7352774|NCT00961636|11594719|FG001|Overall Study|Withdrawal by Subject|22
7352775|NCT00961636|11594720|FG002|Overall Study|Withdrawal by Subject|13
7352776|NCT00961649|11594732|FG000|Overall Study|Adverse Event|4
7352777|NCT00961649|11594733|FG001|Overall Study|Adverse Event|0
7352778|NCT00961649|11594734|FG002|Overall Study|Adverse Event|0
7352779|NCT00961649|11594735|FG003|Overall Study|Adverse Event|2
7352780|NCT00961649|11594732|FG000|Overall Study|Inadequate control of IOP|0
7352781|NCT00961649|11594733|FG001|Overall Study|Inadequate control of IOP|0
7352782|NCT00961649|11594734|FG002|Overall Study|Inadequate control of IOP|0
7352783|NCT00961649|11594735|FG003|Overall Study|Inadequate control of IOP|1
7352784|NCT00961649|11594732|FG000|Overall Study|Patient has travel plans during holidays|0
7352785|NCT00961649|11594733|FG001|Overall Study|Patient has travel plans during holidays|0
7352786|NCT00961649|11594734|FG002|Overall Study|Patient has travel plans during holidays|1
7352787|NCT00961649|11594735|FG003|Overall Study|Patient has travel plans during holidays|0
7352788|NCT00961649|11594732|FG000|Overall Study|Patient left to Mexico-family emergency|1
7352789|NCT00961649|11594733|FG001|Overall Study|Patient left to Mexico-family emergency|0
7352790|NCT00961649|11594734|FG002|Overall Study|Patient left to Mexico-family emergency|0
7352791|NCT00961649|11594735|FG003|Overall Study|Patient left to Mexico-family emergency|0
7352792|NCT00961649|11594732|FG000|Overall Study|Study terminated by sponsor|4
7352793|NCT00961649|11594733|FG001|Overall Study|Study terminated by sponsor|4
7352794|NCT00961649|11594734|FG002|Overall Study|Study terminated by sponsor|4
7352795|NCT00961649|11594735|FG003|Overall Study|Study terminated by sponsor|1
7352796|NCT00961896|11594761|FG000|Overall Study|Abnormal laboratory value|0
7352797|NCT00961896|11594762|FG001|Overall Study|Abnormal laboratory value|0
7352798|NCT00961896|11594763|FG002|Overall Study|Abnormal laboratory value|1
7352799|NCT00961961|11594778|FG000|Phase I|Withdrawal by Subject|7
7352800|NCT00961961|11594779|FG001|Phase I|Withdrawal by Subject|0
7352801|NCT00961961|11594780|FG002|Phase I|Withdrawal by Subject|0
7352802|NCT00961961|11594781|FG003|Phase I|Withdrawal by Subject|0
7352803|NCT00961961|11594778|FG000|Phase I|Lost to Follow-up|10
7352804|NCT00961961|11594779|FG001|Phase I|Lost to Follow-up|0
7352805|NCT00961961|11594780|FG002|Phase I|Lost to Follow-up|0
7352806|NCT00961961|11594781|FG003|Phase I|Lost to Follow-up|0
7352807|NCT00961961|11594778|FG000|Phase I|Lack of Efficacy|94
7352808|NCT00961961|11594779|FG001|Phase I|Lack of Efficacy|0
7352809|NCT00961961|11594780|FG002|Phase I|Lack of Efficacy|0
7352810|NCT00961961|11594781|FG003|Phase I|Lack of Efficacy|0
7352811|NCT00961961|11594778|FG000|Phase I|Adverse Event|7
7352812|NCT00961961|11594779|FG001|Phase I|Adverse Event|0
7352813|NCT00961961|11594780|FG002|Phase I|Adverse Event|0
7352814|NCT00961961|11594781|FG003|Phase I|Adverse Event|0
7352815|NCT00961961|11594778|FG000|Phase I|Physician Decision|8
7352816|NCT00961961|11594779|FG001|Phase I|Physician Decision|0
7352817|NCT00961961|11594780|FG002|Phase I|Physician Decision|0
7352818|NCT00961961|11594781|FG003|Phase I|Physician Decision|0
7352819|NCT00961961|11594778|FG000|Phase II|Lost to Follow-up|0
7352820|NCT00961961|11594779|FG001|Phase II|Lost to Follow-up|0
7352821|NCT00961961|11594780|FG002|Phase II|Lost to Follow-up|10
7352822|NCT00961961|11594781|FG003|Phase II|Lost to Follow-up|7
7352823|NCT00961961|11594778|FG000|Phase II|Adverse Event|0
7352824|NCT00961961|11594779|FG001|Phase II|Adverse Event|0
7352825|NCT00961961|11594780|FG002|Phase II|Adverse Event|0
7352826|NCT00961961|11594781|FG003|Phase II|Adverse Event|1
7352827|NCT00961961|11594778|FG000|Phase II|Physician Decision|0
7352828|NCT00961961|11594779|FG001|Phase II|Physician Decision|0
7352829|NCT00961961|11594780|FG002|Phase II|Physician Decision|1
7352830|NCT00961961|11594781|FG003|Phase II|Physician Decision|0
7352831|NCT00961961|11594778|FG000|Phase II|Withdrawal by Subject|0
7352832|NCT00961961|11594779|FG001|Phase II|Withdrawal by Subject|0
7352833|NCT00961961|11594780|FG002|Phase II|Withdrawal by Subject|1
7352834|NCT00961961|11594781|FG003|Phase II|Withdrawal by Subject|0
7386048|NCT01207440|11644237|FG000|Overall Study|Physician Decision|6
7386049|NCT01207440|11644238|FG001|Overall Study|Physician Decision|5
7386050|NCT01207440|11644239|FG002|Overall Study|Physician Decision|5
7386051|NCT01207440|11644240|FG003|Overall Study|Physician Decision|0
7386052|NCT01207440|11644241|FG004|Overall Study|Physician Decision|1
7386053|NCT01207440|11644242|FG005|Overall Study|Physician Decision|0
7386054|NCT01207440|11644243|FG006|Overall Study|Physician Decision|0
7386055|NCT01207440|11644237|FG000|Overall Study|Progressive Disease|19
7352835|NCT00962013|11594808|FG000|Overall Study|Did not have surgery|1
7352836|NCT00962013|11594808|FG000|Overall Study|Death|8
7352837|NCT00962013|11594808|FG000|Overall Study|Lost to Follow-up|12
7352838|NCT00962013|11594808|FG000|Overall Study|Unable/Unwilling to return|6
7352839|NCT00962013|11594808|FG000|Overall Study|Withdrawal by Subject|8
7352840|NCT00962013|11594808|FG000|Overall Study|Removal of study device|3
7352841|NCT00962013|11594808|FG000|Overall Study|Site Termination|24
7352842|NCT00962013|11594808|FG000|Overall Study|No 5 year evaluation|6
7352843|NCT00962091|11594850|FG000|Overall Study|Withdrawal by Subject|1
7352844|NCT00962091|11594851|FG001|Overall Study|Withdrawal by Subject|2
7352845|NCT00962091|11594852|FG002|Overall Study|Withdrawal by Subject|1
7352846|NCT00962091|11594853|FG003|Overall Study|Withdrawal by Subject|1
7352847|NCT00962091|11594854|FG004|Overall Study|Withdrawal by Subject|0
7352848|NCT00962091|11594855|FG005|Overall Study|Withdrawal by Subject|1
7352849|NCT00962091|11594856|FG006|Overall Study|Withdrawal by Subject|0
7352850|NCT00962091|11594850|FG000|Overall Study|Adverse Event|0
7352851|NCT00962091|11594851|FG001|Overall Study|Adverse Event|0
7352852|NCT00962091|11594852|FG002|Overall Study|Adverse Event|0
7352853|NCT00962091|11594853|FG003|Overall Study|Adverse Event|0
7352854|NCT00962091|11594854|FG004|Overall Study|Adverse Event|0
7352855|NCT00962091|11594855|FG005|Overall Study|Adverse Event|0
7352856|NCT00962091|11594856|FG006|Overall Study|Adverse Event|1
7352857|NCT00962104|11594882|FG000|Overall Study|Adverse Event|10
7352858|NCT00962104|11594883|FG001|Overall Study|Adverse Event|3
7352859|NCT00962104|11594882|FG000|Overall Study|Entry Criteria Not Met|1
7352860|NCT00962104|11594883|FG001|Overall Study|Entry Criteria Not Met|2
7352861|NCT00962104|11594882|FG000|Overall Study|Lack of Efficacy|0
7352862|NCT00962104|11594883|FG001|Overall Study|Lack of Efficacy|1
7352863|NCT00962104|11594882|FG000|Overall Study|Lost to Follow-up|10
7352864|NCT00962104|11594883|FG001|Overall Study|Lost to Follow-up|4
7352865|NCT00962104|11594882|FG000|Overall Study|Physician Decision|1
7352866|NCT00962104|11594883|FG001|Overall Study|Physician Decision|0
7352867|NCT00962104|11594882|FG000|Overall Study|Protocol Violation|6
7352868|NCT00962104|11594883|FG001|Overall Study|Protocol Violation|8
7352869|NCT00962104|11594882|FG000|Overall Study|Sponsor Decision|0
7352870|NCT00962104|11594883|FG001|Overall Study|Sponsor Decision|1
7352871|NCT00962104|11594882|FG000|Overall Study|Withdrawal by Subject|10
7352872|NCT00962104|11594883|FG001|Overall Study|Withdrawal by Subject|6
7352873|NCT00962104|11594882|FG000|Overall Study|Other|2
7352874|NCT00962104|11594883|FG001|Overall Study|Other|0
7352875|NCT00962208|11594891|FG000|Overall Study|Could not achieve good vision|9
7352876|NCT00962208|11594892|FG001|Overall Study|Could not achieve good vision|0
7352877|NCT00962208|11594891|FG000|Overall Study|Contraindicated to continue study|5
7352878|NCT00962208|11594892|FG001|Overall Study|Contraindicated to continue study|1
7352879|NCT00962208|11594891|FG000|Overall Study|Lost to Follow-up|0
7352880|NCT00962208|11594892|FG001|Overall Study|Lost to Follow-up|9
7352881|NCT00962247|11594898|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
7352882|NCT00962247|11594898|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
7352883|NCT00962390|11594908|FG000|Overall Study|Adverse Event|0
7352884|NCT00962390|11594909|FG001|Overall Study|Adverse Event|0
7352885|NCT00962390|11594910|FG002|Overall Study|Adverse Event|3
7352886|NCT00962390|11594911|FG003|Overall Study|Adverse Event|1
7352887|NCT00962390|11594908|FG000|Overall Study|Lost to Follow-up|2
7352888|NCT00962390|11594909|FG001|Overall Study|Lost to Follow-up|2
7352889|NCT00962390|11594910|FG002|Overall Study|Lost to Follow-up|0
7352890|NCT00962390|11594911|FG003|Overall Study|Lost to Follow-up|0
7352891|NCT00962390|11594908|FG000|Overall Study|Protocol Violation|1
7352892|NCT00962390|11594909|FG001|Overall Study|Protocol Violation|0
7352893|NCT00962390|11594910|FG002|Overall Study|Protocol Violation|0
7352894|NCT00962390|11594911|FG003|Overall Study|Protocol Violation|0
7352895|NCT00962390|11594908|FG000|Overall Study|Withdrawal by Subject|1
7352896|NCT00962390|11594909|FG001|Overall Study|Withdrawal by Subject|1
7352897|NCT00962390|11594910|FG002|Overall Study|Withdrawal by Subject|1
7352898|NCT00962390|11594911|FG003|Overall Study|Withdrawal by Subject|0
7352899|NCT00962585|11594925|FG000|Overall Study|Adverse Event|0
7352900|NCT00962585|11594926|FG001|Overall Study|Adverse Event|2
7352901|NCT00962585|11594927|FG002|Overall Study|Adverse Event|1
7352902|NCT00962585|11594928|FG003|Overall Study|Adverse Event|0
7352903|NCT00962585|11594925|FG000|Overall Study|Lost to Follow-up|3
7352904|NCT00962585|11594926|FG001|Overall Study|Lost to Follow-up|0
7352905|NCT00962585|11594927|FG002|Overall Study|Lost to Follow-up|1
7352906|NCT00962585|11594928|FG003|Overall Study|Lost to Follow-up|0
7352907|NCT00962585|11594925|FG000|Overall Study|Protocol Violation|0
7352908|NCT00962585|11594926|FG001|Overall Study|Protocol Violation|0
7352909|NCT00962585|11594927|FG002|Overall Study|Protocol Violation|1
7352910|NCT00962585|11594928|FG003|Overall Study|Protocol Violation|0
7352911|NCT00962585|11594925|FG000|Overall Study|Withdrawal by Subject|1
7352912|NCT00962585|11594926|FG001|Overall Study|Withdrawal by Subject|0
7352913|NCT00962585|11594927|FG002|Overall Study|Withdrawal by Subject|0
7352914|NCT00962585|11594928|FG003|Overall Study|Withdrawal by Subject|0
7352915|NCT00962585|11594925|FG000|Overall Study|Withdrew Consent|2
7352916|NCT00962585|11594926|FG001|Overall Study|Withdrew Consent|0
7352917|NCT00962585|11594927|FG002|Overall Study|Withdrew Consent|0
7352918|NCT00962585|11594928|FG003|Overall Study|Withdrew Consent|0
7352919|NCT00962650|11594949|FG000|Overall Study|Transgastric DP was not completed|2
7352920|NCT00962741|11594953|FG000|Overall Study|Failed to return|3
7352921|NCT00962741|11594953|FG000|Overall Study|Lost to Follow-up|2
7352922|NCT00962741|11594953|FG000|Overall Study|Withdrawal by Subject|1
7352923|NCT00962741|11594953|FG000|Overall Study|Lack of Efficacy|1
7352924|NCT00962741|11594953|FG000|Overall Study|drug ineffective+prohibited drug taken|1
7352925|NCT00962780|11594972|FG000|Overall Study|Death|0
7352926|NCT00962780|11594973|FG001|Overall Study|Death|1
7352927|NCT00962780|11594972|FG000|Overall Study|Protocol Violation|9
7352928|NCT00962780|11594973|FG001|Overall Study|Protocol Violation|4
7352929|NCT00962780|11594972|FG000|Overall Study|Withdrawal by Subject|1
7352930|NCT00962780|11594973|FG001|Overall Study|Withdrawal by Subject|8
7352931|NCT00962780|11594972|FG000|Overall Study|Other|0
7352932|NCT00962780|11594973|FG001|Overall Study|Other|1
7352933|NCT00963235|11595045|FG000|Overall Study|Withdrawal by Subject|22
7352934|NCT00963235|11595045|FG000|Overall Study|Lost to Follow-up|14
7352935|NCT00963235|11595045|FG000|Overall Study|Failed to return|9
7352936|NCT00963235|11595045|FG000|Overall Study|Protocol Violation|7
7352937|NCT00963235|11595045|FG000|Overall Study|Adverse Event|5
7352938|NCT00963235|11595045|FG000|Overall Study|Physician Decision|2
7352939|NCT00963235|11595045|FG000|Overall Study|Other|1
7352940|NCT00963547|11595083|FG000|Overall Study|Adverse Event|0
7352941|NCT00963547|11595084|FG001|Overall Study|Adverse Event|1
7352942|NCT00963547|11595085|FG002|Overall Study|Adverse Event|0
7352943|NCT00963547|11595086|FG003|Overall Study|Adverse Event|1
7352944|NCT00963547|11595087|FG004|Overall Study|Adverse Event|0
7352945|NCT00963547|11595088|FG005|Overall Study|Adverse Event|0
7352946|NCT00963547|11595089|FG006|Overall Study|Adverse Event|0
7352947|NCT00963547|11595083|FG000|Overall Study|Physician Decision|1
7352948|NCT00963547|11595084|FG001|Overall Study|Physician Decision|1
7352949|NCT00963547|11595085|FG002|Overall Study|Physician Decision|0
7352950|NCT00963547|11595086|FG003|Overall Study|Physician Decision|0
7352951|NCT00963547|11595087|FG004|Overall Study|Physician Decision|0
7352952|NCT00963547|11595088|FG005|Overall Study|Physician Decision|0
7352953|NCT00963547|11595089|FG006|Overall Study|Physician Decision|0
7352954|NCT00963547|11595083|FG000|Overall Study|Progressive Disease|3
7352955|NCT00963547|11595084|FG001|Overall Study|Progressive Disease|8
7352956|NCT00963547|11595085|FG002|Overall Study|Progressive Disease|9
7352957|NCT00963547|11595086|FG003|Overall Study|Progressive Disease|5
7352958|NCT00963547|11595087|FG004|Overall Study|Progressive Disease|0
7352959|NCT00963547|11595088|FG005|Overall Study|Progressive Disease|0
7352960|NCT00963547|11595089|FG006|Overall Study|Progressive Disease|0
7352961|NCT00963547|11595083|FG000|Overall Study|Withdrawal by Subject|0
7352962|NCT00963547|11595084|FG001|Overall Study|Withdrawal by Subject|0
7352963|NCT00963547|11595085|FG002|Overall Study|Withdrawal by Subject|3
7352964|NCT00963547|11595086|FG003|Overall Study|Withdrawal by Subject|0
7352965|NCT00963547|11595087|FG004|Overall Study|Withdrawal by Subject|0
7352966|NCT00963547|11595088|FG005|Overall Study|Withdrawal by Subject|0
7459462|NCT01817530|11754061|FG006|Overall Study|Lost to Follow-up|8
7459463|NCT01817530|11754062|FG007|Overall Study|Lost to Follow-up|4
7459464|NCT01817582|11754083|FG000|Overall Study|Withdrawal by Subject|0
7459465|NCT01817582|11754084|FG001|Overall Study|Withdrawal by Subject|1
7459466|NCT01817582|11754085|FG002|Overall Study|Withdrawal by Subject|0
7459467|NCT01817582|11754083|FG000|Overall Study|Participant revealed masked treatment|1
7459468|NCT01817582|11754084|FG001|Overall Study|Participant revealed masked treatment|0
7459469|NCT01817582|11754085|FG002|Overall Study|Participant revealed masked treatment|0
7459470|NCT01817582|11754083|FG000|Overall Study|Randomized but exclusion criteria met|1
7459471|NCT01817582|11754084|FG001|Overall Study|Randomized but exclusion criteria met|0
7459472|NCT01817582|11754085|FG002|Overall Study|Randomized but exclusion criteria met|0
7459473|NCT01817725|11754102|FG000|Overall Study|Withdrawal by Subject|1
7352967|NCT00963547|11595089|FG006|Overall Study|Withdrawal by Subject|0
7352968|NCT00963547|11595083|FG000|Overall Study|Reason Unknown|0
7352969|NCT00963547|11595084|FG001|Overall Study|Reason Unknown|1
7352970|NCT00963547|11595085|FG002|Overall Study|Reason Unknown|0
7352971|NCT00963547|11595086|FG003|Overall Study|Reason Unknown|0
7352972|NCT00963547|11595087|FG004|Overall Study|Reason Unknown|0
7352973|NCT00963547|11595088|FG005|Overall Study|Reason Unknown|0
7352974|NCT00963547|11595089|FG006|Overall Study|Reason Unknown|0
7352975|NCT00963807|11595133|FG000|Overall Study|Physician Decision|2
7352976|NCT00963807|11595133|FG000|Overall Study|Reaction to study chemotherapy regimen|1
7352977|NCT00963807|11595133|FG000|Overall Study|Disease progression|15
7352978|NCT00963820|11595139|FG000|Dose Escalation Phase|Progressive Disease|3
7352979|NCT00963820|11595140|FG001|Dose Escalation Phase|Progressive Disease|3
7352980|NCT00963820|11595141|FG002|Dose Escalation Phase|Progressive Disease|3
7352981|NCT00963820|11595142|FG003|Dose Escalation Phase|Progressive Disease|3
7352982|NCT00963820|11595143|FG004|Dose Escalation Phase|Progressive Disease|4
7352983|NCT00963820|11595144|FG005|Dose Escalation Phase|Progressive Disease|3
7352984|NCT00963820|11595145|FG006|Dose Escalation Phase|Progressive Disease|3
7352985|NCT00963820|11595146|FG007|Dose Escalation Phase|Progressive Disease|2
7352986|NCT00963820|11595147|FG008|Dose Escalation Phase|Progressive Disease|0
7352987|NCT00963820|11595148|FG009|Dose Escalation Phase|Progressive Disease|0
7352988|NCT00963820|11595149|FG010|Dose Escalation Phase|Progressive Disease|0
7352989|NCT00963820|11595150|FG011|Dose Escalation Phase|Progressive Disease|0
7352990|NCT00963820|11595139|FG000|Dose Escalation Phase|Adverse Event|0
7352991|NCT00963820|11595140|FG001|Dose Escalation Phase|Adverse Event|0
7352992|NCT00963820|11595141|FG002|Dose Escalation Phase|Adverse Event|0
7352993|NCT00963820|11595142|FG003|Dose Escalation Phase|Adverse Event|0
7352994|NCT00963820|11595143|FG004|Dose Escalation Phase|Adverse Event|0
7352995|NCT00963820|11595144|FG005|Dose Escalation Phase|Adverse Event|0
7352996|NCT00963820|11595145|FG006|Dose Escalation Phase|Adverse Event|3
7352997|NCT00963820|11595146|FG007|Dose Escalation Phase|Adverse Event|1
7352998|NCT00963820|11595147|FG008|Dose Escalation Phase|Adverse Event|0
7352999|NCT00963820|11595148|FG009|Dose Escalation Phase|Adverse Event|0
7353000|NCT00963820|11595149|FG010|Dose Escalation Phase|Adverse Event|0
7353001|NCT00963820|11595150|FG011|Dose Escalation Phase|Adverse Event|0
7353002|NCT00963820|11595139|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7353003|NCT00963820|11595140|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7353004|NCT00963820|11595141|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7353005|NCT00963820|11595142|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7353006|NCT00963820|11595143|FG004|Dose Escalation Phase|Withdrawal by Subject|0
7353007|NCT00963820|11595144|FG005|Dose Escalation Phase|Withdrawal by Subject|0
7353008|NCT00963820|11595145|FG006|Dose Escalation Phase|Withdrawal by Subject|1
7353009|NCT00963820|11595146|FG007|Dose Escalation Phase|Withdrawal by Subject|2
7353010|NCT00963820|11595147|FG008|Dose Escalation Phase|Withdrawal by Subject|0
7353011|NCT00963820|11595148|FG009|Dose Escalation Phase|Withdrawal by Subject|0
7353012|NCT00963820|11595149|FG010|Dose Escalation Phase|Withdrawal by Subject|0
7353013|NCT00963820|11595150|FG011|Dose Escalation Phase|Withdrawal by Subject|0
7353014|NCT00963820|11595139|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353015|NCT00963820|11595140|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353016|NCT00963820|11595141|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353017|NCT00963820|11595142|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353018|NCT00963820|11595143|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353019|NCT00963820|11595144|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353020|NCT00963820|11595145|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7353021|NCT00963820|11595146|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353022|NCT00963820|11595147|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353023|NCT00963820|11595148|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353024|NCT00963820|11595149|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353025|NCT00963820|11595150|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7353026|NCT00963820|11595139|FG000|Expansion Phase|Progressive Disease|0
7353027|NCT00963820|11595140|FG001|Expansion Phase|Progressive Disease|0
7353028|NCT00963820|11595141|FG002|Expansion Phase|Progressive Disease|0
7353029|NCT00963820|11595142|FG003|Expansion Phase|Progressive Disease|0
7353030|NCT00963820|11595143|FG004|Expansion Phase|Progressive Disease|0
7353031|NCT00963820|11595144|FG005|Expansion Phase|Progressive Disease|0
7353032|NCT00963820|11595145|FG006|Expansion Phase|Progressive Disease|0
7353033|NCT00963820|11595146|FG007|Expansion Phase|Progressive Disease|0
7353034|NCT00963820|11595147|FG008|Expansion Phase|Progressive Disease|8
7353035|NCT00963820|11595148|FG009|Expansion Phase|Progressive Disease|6
7353036|NCT00963820|11595149|FG010|Expansion Phase|Progressive Disease|4
7353037|NCT00963820|11595150|FG011|Expansion Phase|Progressive Disease|2
7353038|NCT00963820|11595139|FG000|Expansion Phase|Adverse Event|0
7353039|NCT00963820|11595140|FG001|Expansion Phase|Adverse Event|0
7353040|NCT00963820|11595141|FG002|Expansion Phase|Adverse Event|0
7353041|NCT00963820|11595142|FG003|Expansion Phase|Adverse Event|0
7353042|NCT00963820|11595143|FG004|Expansion Phase|Adverse Event|0
7353043|NCT00963820|11595144|FG005|Expansion Phase|Adverse Event|0
7353044|NCT00963820|11595145|FG006|Expansion Phase|Adverse Event|0
7353045|NCT00963820|11595146|FG007|Expansion Phase|Adverse Event|0
7353046|NCT00963820|11595147|FG008|Expansion Phase|Adverse Event|1
7353047|NCT00963820|11595148|FG009|Expansion Phase|Adverse Event|3
7353048|NCT00963820|11595149|FG010|Expansion Phase|Adverse Event|0
7353049|NCT00963820|11595150|FG011|Expansion Phase|Adverse Event|0
7353050|NCT00963820|11595139|FG000|Expansion Phase|Withdrawal by Subject|0
7353051|NCT00963820|11595140|FG001|Expansion Phase|Withdrawal by Subject|0
7353052|NCT00963820|11595141|FG002|Expansion Phase|Withdrawal by Subject|0
7353053|NCT00963820|11595142|FG003|Expansion Phase|Withdrawal by Subject|0
7353054|NCT00963820|11595143|FG004|Expansion Phase|Withdrawal by Subject|0
7353055|NCT00963820|11595144|FG005|Expansion Phase|Withdrawal by Subject|0
7353056|NCT00963820|11595145|FG006|Expansion Phase|Withdrawal by Subject|0
7353057|NCT00963820|11595146|FG007|Expansion Phase|Withdrawal by Subject|0
7353058|NCT00963820|11595147|FG008|Expansion Phase|Withdrawal by Subject|1
7353059|NCT00963820|11595148|FG009|Expansion Phase|Withdrawal by Subject|0
7353060|NCT00963820|11595149|FG010|Expansion Phase|Withdrawal by Subject|1
7353061|NCT00963820|11595150|FG011|Expansion Phase|Withdrawal by Subject|1
7353062|NCT00963820|11595139|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353063|NCT00963820|11595140|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353064|NCT00963820|11595141|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353065|NCT00963820|11595142|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353066|NCT00963820|11595143|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353067|NCT00963820|11595144|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353068|NCT00963820|11595145|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353069|NCT00963820|11595146|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353070|NCT00963820|11595147|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353071|NCT00963820|11595148|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353072|NCT00963820|11595149|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
7353073|NCT00963820|11595150|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
7353074|NCT00963924|11595186|FG000|Overall Study|Adverse Event|1
7353075|NCT00963924|11595187|FG001|Overall Study|Adverse Event|0
7353076|NCT00963924|11595186|FG000|Overall Study|Withdrawal by Subject|0
7353077|NCT00963924|11595187|FG001|Overall Study|Withdrawal by Subject|1
7353078|NCT00963924|11595186|FG000|Overall Study|Changed antipsychotic|0
7353079|NCT00963924|11595187|FG001|Overall Study|Changed antipsychotic|1
7353080|NCT00963924|11595186|FG000|Overall Study|Lost to Follow-up|0
7459474|NCT01817764|11754108|FG000|Overall Study|Adverse Event|7
7459475|NCT01817764|11754109|FG001|Overall Study|Adverse Event|10
7459476|NCT01817764|11754108|FG000|Overall Study|Lack of Efficacy|9
7459477|NCT01817764|11754109|FG001|Overall Study|Lack of Efficacy|7
7459478|NCT01817764|11754108|FG000|Overall Study|Protocol Violation|7
7459479|NCT01817764|11754109|FG001|Overall Study|Protocol Violation|5
7459480|NCT01817764|11754108|FG000|Overall Study|Lost to Follow-up|1
7459481|NCT01817764|11754109|FG001|Overall Study|Lost to Follow-up|4
7459482|NCT01817764|11754108|FG000|Overall Study|Withdrawal by Subject|10
7459483|NCT01817764|11754109|FG001|Overall Study|Withdrawal by Subject|12
7459484|NCT01817777|11754117|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
7459485|NCT01817777|11754118|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
7459486|NCT01817777|11754119|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
7459487|NCT01817777|11754117|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
7459488|NCT01817777|11754118|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
7459489|NCT01817777|11754119|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
7459490|NCT01817777|11754117|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7459491|NCT01817777|11754118|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
7459492|NCT01817777|11754119|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
7459493|NCT01817777|11754117|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
7459494|NCT01817777|11754118|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
7459495|NCT01817777|11754119|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
7353081|NCT00963924|11595187|FG001|Overall Study|Lost to Follow-up|1
7353082|NCT00963937|11595198|FG000|Overall Study|Protocol Violation|1
7353083|NCT00963937|11595199|FG001|Overall Study|Protocol Violation|1
7569447|NCT03449147|11945840|FG000|52-week Treatment Period|Screen Failure|1
7569448|NCT03449147|11945841|FG001|52-week Treatment Period|Screen Failure|2
7569449|NCT03449147|11945842|FG002|52-week Treatment Period|Screen Failure|0
7569450|NCT03449147|11945840|FG000|52-week Treatment Period|Withdrawal by Subject|46
7569451|NCT03449147|11945841|FG001|52-week Treatment Period|Withdrawal by Subject|68
7569452|NCT03449147|11945842|FG002|52-week Treatment Period|Withdrawal by Subject|74
7569453|NCT03449147|11945840|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
7569454|NCT03449147|11945841|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7569455|NCT03449147|11945842|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
7569456|NCT03449147|11945840|FG000|12-Week Off-Treatment Durability Period|Other|0
7353084|NCT00963937|11595200|FG002|Overall Study|Protocol Violation|0
7353085|NCT00963937|11595198|FG000|Overall Study|Physician Decision|18
7353086|NCT00963937|11595199|FG001|Overall Study|Physician Decision|10
7353087|NCT00963937|11595200|FG002|Overall Study|Physician Decision|4
7353088|NCT00964028|11595217|FG000|Overall Study|Withdrawal by Subject|0
7353089|NCT00964028|11595218|FG001|Overall Study|Withdrawal by Subject|1
7353090|NCT00964158|11595231|FG000|Overall Study|Lost to Follow-up|0
7353091|NCT00964158|11595232|FG001|Overall Study|Lost to Follow-up|1
7353092|NCT00964158|11595233|FG002|Overall Study|Lost to Follow-up|2
7353093|NCT00964158|11595231|FG000|Overall Study|Withdrawal by Subject|0
7353094|NCT00964158|11595232|FG001|Overall Study|Withdrawal by Subject|0
7353095|NCT00964158|11595233|FG002|Overall Study|Withdrawal by Subject|6
7353096|NCT00964223|11595244|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
7353097|NCT00964366|11595260|FG000|Overall Study|Did not qualify at Day 1|1
7353098|NCT00964366|11595261|FG001|Overall Study|Did not qualify at Day 1|0
7353099|NCT00964366|11595260|FG000|Overall Study|Withdrawal by Subject|0
7353100|NCT00964366|11595261|FG001|Overall Study|Withdrawal by Subject|1
7353101|NCT00964392|11595269|FG000|Overall Study|Withdrawal by Subject|4
7353102|NCT00964392|11595270|FG001|Overall Study|Withdrawal by Subject|6
7353103|NCT00964392|11595269|FG000|Overall Study|Lost to Follow-up|4
7353104|NCT00964392|11595270|FG001|Overall Study|Lost to Follow-up|10
7353105|NCT00964392|11595269|FG000|Overall Study|Early Termination, non-study arrhythmia|1
7353106|NCT00964392|11595270|FG001|Overall Study|Early Termination, non-study arrhythmia|6
7353107|NCT00964392|11595269|FG000|Overall Study|Not completed|44
7353108|NCT00964392|11595270|FG001|Overall Study|Not completed|168
7353109|NCT00964678|11595315|FG000|Overall Study|Physician Decision|4
7353110|NCT00964743|11595320|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
7353111|NCT00964782|11595326|FG000|Overall Study|Lost to Follow-up|1
7353112|NCT00964782|11595327|FG001|Overall Study|Lost to Follow-up|0
7353113|NCT00964795|11595335|FG000|Overall Study|Withdrawal by Subject|79
7353114|NCT00964795|11595335|FG000|Overall Study|Adverse Event|12
7353115|NCT00964795|11595335|FG000|Overall Study|Death|14
7353116|NCT00964795|11595335|FG000|Overall Study|Lost to Follow-up|7
7353117|NCT00964795|11595335|FG000|Overall Study|Termination of Study by Sponsor|169
7533225|NCT02682823|11879399|FG004|Overall Study|Withdrawal by Subject|1
7533226|NCT02682823|11879395|FG000|Overall Study|Protocol Deviation|0
7353118|NCT00964795|11595335|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
7353119|NCT00964795|11595335|FG000|Overall Study|Other|23
7533227|NCT02682823|11879396|FG001|Overall Study|Protocol Deviation|1
7533228|NCT02682823|11879397|FG002|Overall Study|Protocol Deviation|0
7533229|NCT02682823|11879398|FG003|Overall Study|Protocol Deviation|0
7533230|NCT02682823|11879399|FG004|Overall Study|Protocol Deviation|0
7533231|NCT02682823|11879395|FG000|Overall Study|Adverse Event|0
7533232|NCT02682823|11879396|FG001|Overall Study|Adverse Event|0
7353120|NCT00964860|11595342|FG000|Overall Study|Withdrawal by Subject|0
7353121|NCT00964860|11595343|FG001|Overall Study|Withdrawal by Subject|1
7353122|NCT00964886|11595353|FG000|Overall Study|Lost to Follow-up|2
7353123|NCT00964886|11595354|FG001|Overall Study|Lost to Follow-up|2
7353124|NCT00964886|11595355|FG002|Overall Study|Lost to Follow-up|6
7353125|NCT00964886|11595356|FG003|Overall Study|Lost to Follow-up|4
7353126|NCT00964886|11595353|FG000|Overall Study|Withdrawal by Subject|6
7353127|NCT00964886|11595354|FG001|Overall Study|Withdrawal by Subject|2
7353128|NCT00964886|11595355|FG002|Overall Study|Withdrawal by Subject|5
7353129|NCT00964886|11595356|FG003|Overall Study|Withdrawal by Subject|3
7353130|NCT00964886|11595353|FG000|Overall Study|Adverse Event|3
7353131|NCT00964886|11595354|FG001|Overall Study|Adverse Event|1
7353132|NCT00964886|11595355|FG002|Overall Study|Adverse Event|5
7353133|NCT00964886|11595356|FG003|Overall Study|Adverse Event|2
7353134|NCT00964886|11595353|FG000|Overall Study|Protocol Violation|0
7353135|NCT00964886|11595354|FG001|Overall Study|Protocol Violation|2
7353136|NCT00964886|11595355|FG002|Overall Study|Protocol Violation|0
7353137|NCT00964886|11595356|FG003|Overall Study|Protocol Violation|0
7353138|NCT00965081|11595372|FG000|Overall Study|Adverse Event|14
7353139|NCT00965081|11595373|FG001|Overall Study|Adverse Event|9
7353140|NCT00965081|11595372|FG000|Overall Study|Lack of Efficacy|2
7353141|NCT00965081|11595373|FG001|Overall Study|Lack of Efficacy|5
7353142|NCT00965081|11595372|FG000|Overall Study|Lost to Follow-up|4
7353143|NCT00965081|11595373|FG001|Overall Study|Lost to Follow-up|5
7353144|NCT00965081|11595372|FG000|Overall Study|Physician Decision|2
7353145|NCT00965081|11595373|FG001|Overall Study|Physician Decision|0
7353146|NCT00965081|11595372|FG000|Overall Study|Protocol Violation|2
7353147|NCT00965081|11595373|FG001|Overall Study|Protocol Violation|5
7353148|NCT00965081|11595372|FG000|Overall Study|Sponsor Decision|1
7353149|NCT00965081|11595373|FG001|Overall Study|Sponsor Decision|0
7353150|NCT00965081|11595372|FG000|Overall Study|Withdrawal by Subject|4
7353151|NCT00965081|11595373|FG001|Overall Study|Withdrawal by Subject|7
7353152|NCT00965081|11595372|FG000|Overall Study|Switched to Rescue Arm|5
7353153|NCT00965081|11595373|FG001|Overall Study|Switched to Rescue Arm|12
7353154|NCT00965094|11595382|FG000|Overall Study|Adverse Event|5
7353155|NCT00965094|11595383|FG001|Overall Study|Adverse Event|0
7353156|NCT00965094|11595382|FG000|Overall Study|Lost to Follow-up|0
7353157|NCT00965094|11595383|FG001|Overall Study|Lost to Follow-up|1
7353158|NCT00965185|11595392|FG000|Overall Study|Lost to Follow-up|2
7353159|NCT00965185|11595393|FG001|Overall Study|Lost to Follow-up|0
7353160|NCT00965185|11595392|FG000|Overall Study|Withdrawal by Subject|0
7353161|NCT00965185|11595393|FG001|Overall Study|Withdrawal by Subject|1
7353162|NCT00965263|11595419|FG000|Overall Study|Physician Decision|2
7533233|NCT02682823|11879397|FG002|Overall Study|Adverse Event|0
7533234|NCT02682823|11879398|FG003|Overall Study|Adverse Event|1
7533235|NCT02682823|11879399|FG004|Overall Study|Adverse Event|0
7533236|NCT02683109|11879417|FG000|Overall Study|Adverse Event|1
7533237|NCT02683109|11879418|FG001|Overall Study|Adverse Event|0
7533238|NCT02683187|11879434|FG000|Overall Study|Failed IV access|3
7533239|NCT02683187|11879434|FG000|Overall Study|Withdrawal by Subject|5
7353163|NCT00965263|11595420|FG001|Overall Study|Physician Decision|0
7353164|NCT00965263|11595419|FG000|Overall Study|Family emergency|0
7353165|NCT00965263|11595420|FG001|Overall Study|Family emergency|1
7353166|NCT00965263|11595419|FG000|Overall Study|Protocol Violation|0
7353167|NCT00965263|11595420|FG001|Overall Study|Protocol Violation|2
7353168|NCT00965341|11595446|FG000|Overall Study|Withdrew consent|1
7353169|NCT00965341|11595447|FG001|Overall Study|Withdrew consent|5
7353170|NCT00965341|11595446|FG000|Overall Study|Lost to Follow-up|1
7353171|NCT00965341|11595447|FG001|Overall Study|Lost to Follow-up|0
7353172|NCT00965341|11595446|FG000|Overall Study|Transportation issues|4
7353173|NCT00965341|11595447|FG001|Overall Study|Transportation issues|3
7353174|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Adverse Event|33
7353175|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
7353176|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Protocol Violation|21
7353177|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
7353178|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Physician Decision|6
7353179|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Sponsor Decision|5
7353180|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
7353181|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
7353182|NCT00965419|11595453|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
7353183|NCT00965419|11595453|FG000|Follow-up Phase|Adverse Event|9
7353184|NCT00965419|11595453|FG000|Follow-up Phase|Protocol Violation|4
7353185|NCT00965419|11595453|FG000|Follow-up Phase|Withdrawal by Subject|8
7353186|NCT00965419|11595453|FG000|Follow-up Phase|Physician Decision|4
7353187|NCT00965419|11595453|FG000|Follow-up Phase|Parent/Caregiver Decision|9
7353188|NCT00965419|11595453|FG000|Follow-up Phase|Lack of Efficacy|28
7353189|NCT00965458|11595460|FG000|Overall Study|Adverse Event|1
7353190|NCT00965458|11595461|FG001|Overall Study|Adverse Event|0
7569457|NCT03449147|11945841|FG001|12-Week Off-Treatment Durability Period|Other|1
7569458|NCT03449147|11945842|FG002|12-Week Off-Treatment Durability Period|Other|0
7353191|NCT00965458|11595460|FG000|Overall Study|Lost to Follow-up|1
7353192|NCT00965458|11595461|FG001|Overall Study|Lost to Follow-up|3
7353193|NCT00965458|11595460|FG000|Overall Study|Withdrawal by Subject|0
7353194|NCT00965458|11595461|FG001|Overall Study|Withdrawal by Subject|1
7353195|NCT00965484|11595469|FG000|Overall Study|Protocol Violation|1
7353196|NCT00965484|11595469|FG000|Overall Study|Withdrawal by Subject|1
7353197|NCT00965497|11595473|FG000|Overall Study|Physician Decision|1
7353198|NCT00965523|11595477|FG000|Study 221|Progressive Disease|4
7353199|NCT00965523|11595477|FG000|Study 221|Physician Decision|3
7353200|NCT00965523|11595477|FG000|Study 224|Progressive Disease|5
7353201|NCT00965523|11595477|FG000|Study 224|Physician Decision|1
7353202|NCT00965562|11595484|FG000|Overall Study|Lost to Follow-up|1
7353203|NCT00965562|11595485|FG001|Overall Study|Lost to Follow-up|2
7353204|NCT00965562|11595486|FG002|Overall Study|Lost to Follow-up|3
7353205|NCT00965562|11595484|FG000|Overall Study|Withdrawal by Subject|2
7353206|NCT00965562|11595485|FG001|Overall Study|Withdrawal by Subject|2
7353207|NCT00965562|11595486|FG002|Overall Study|Withdrawal by Subject|0
7353208|NCT00965575|11595497|FG000|Overall Study|subject unwillingness to swallow study c|1
7353209|NCT00965575|11595498|FG001|Overall Study|subject unwillingness to swallow study c|0
7353210|NCT00965718|11595506|FG000|Overall Study|Withdrawal by Subject|4
7353211|NCT00965731|11595512|FG000|Overall Study|Death|0
7353212|NCT00965731|11595513|FG001|Overall Study|Death|4
7353213|NCT00965731|11595512|FG000|Overall Study|Withdrawal by Subject|0
7353214|NCT00965731|11595513|FG001|Overall Study|Withdrawal by Subject|1
7353215|NCT00965731|11595512|FG000|Overall Study|Other|7
7353216|NCT00965731|11595513|FG001|Overall Study|Other|15
7353217|NCT00965848|11595524|FG000|Overall Study|Protocol Violation|3
7353218|NCT00965848|11595525|FG001|Overall Study|Protocol Violation|0
7353219|NCT00965848|11595526|FG002|Overall Study|Protocol Violation|1
7353220|NCT00965848|11595524|FG000|Overall Study|Death|11
7353221|NCT00965848|11595525|FG001|Overall Study|Death|1
7353222|NCT00965848|11595526|FG002|Overall Study|Death|5
7353223|NCT00965848|11595524|FG000|Overall Study|Lost to Follow-up|0
7353224|NCT00965848|11595525|FG001|Overall Study|Lost to Follow-up|0
7353225|NCT00965848|11595526|FG002|Overall Study|Lost to Follow-up|1
7353226|NCT00965848|11595524|FG000|Overall Study|Withdrawal by Subject|1
7353227|NCT00965848|11595525|FG001|Overall Study|Withdrawal by Subject|0
7353228|NCT00965848|11595526|FG002|Overall Study|Withdrawal by Subject|0
7353229|NCT00965848|11595524|FG000|Overall Study|Indeterminate Clinical Outcome|2
7353230|NCT00965848|11595525|FG001|Overall Study|Indeterminate Clinical Outcome|0
7353231|NCT00965848|11595526|FG002|Overall Study|Indeterminate Clinical Outcome|1
7353232|NCT00965848|11595524|FG000|Overall Study|Not Clinically Evaluable|7
7353233|NCT00965848|11595525|FG001|Overall Study|Not Clinically Evaluable|1
7353234|NCT00965848|11595526|FG002|Overall Study|Not Clinically Evaluable|1
7353235|NCT00965848|11595524|FG000|Overall Study|Other|5
7353236|NCT00965848|11595525|FG001|Overall Study|Other|0
7353237|NCT00965848|11595526|FG002|Overall Study|Other|1
7353238|NCT00966264|11595570|FG000|Overall Study|Lost to Follow-up|4
7353239|NCT00966264|11595571|FG001|Overall Study|Lost to Follow-up|3
7353240|NCT00966277|11595579|FG000|Overall Study|Withdrawal by Subject|3
7353241|NCT00966277|11595580|FG001|Overall Study|Withdrawal by Subject|0
7353242|NCT00966277|11595579|FG000|Overall Study|Ineligible|1
7353243|NCT00966277|11595580|FG001|Overall Study|Ineligible|3
7353244|NCT00966277|11595579|FG000|Overall Study|Treatment Plan Changed|0
7353245|NCT00966277|11595580|FG001|Overall Study|Treatment Plan Changed|1
7353246|NCT00966355|11595589|FG000|Overall Study|non-variceal bleeding on endoscopy|68
7353247|NCT00966355|11595590|FG001|Overall Study|non-variceal bleeding on endoscopy|70
7353248|NCT00966355|11595591|FG002|Overall Study|non-variceal bleeding on endoscopy|71
7353249|NCT00966355|11595589|FG000|Overall Study|newly diagnosed advanced HCC|11
7353250|NCT00966355|11595590|FG001|Overall Study|newly diagnosed advanced HCC|12
7353251|NCT00966355|11595591|FG002|Overall Study|newly diagnosed advanced HCC|10
7353252|NCT00966355|11595589|FG000|Overall Study|Lost to Follow-up|5
7353253|NCT00966355|11595590|FG001|Overall Study|Lost to Follow-up|4
7353254|NCT00966355|11595591|FG002|Overall Study|Lost to Follow-up|3
7353255|NCT00966693|11595647|FG000|Overall Study|Adverse Event|0
7353256|NCT00966693|11595648|FG001|Overall Study|Adverse Event|0
7353257|NCT00966693|11595649|FG002|Overall Study|Adverse Event|1
7353258|NCT00966693|11595650|FG003|Overall Study|Adverse Event|2
7353259|NCT00966693|11595647|FG000|Overall Study|Death|0
7353260|NCT00966693|11595648|FG001|Overall Study|Death|0
7353261|NCT00966693|11595649|FG002|Overall Study|Death|1
7353262|NCT00966693|11595650|FG003|Overall Study|Death|0
7353263|NCT00966693|11595647|FG000|Overall Study|Withdrawal by Subject|1
7353264|NCT00966693|11595648|FG001|Overall Study|Withdrawal by Subject|0
7353265|NCT00966693|11595649|FG002|Overall Study|Withdrawal by Subject|0
7353266|NCT00966693|11595650|FG003|Overall Study|Withdrawal by Subject|5
7353267|NCT00966693|11595647|FG000|Overall Study|Disease Progression|0
7353268|NCT00966693|11595648|FG001|Overall Study|Disease Progression|0
7353269|NCT00966693|11595649|FG002|Overall Study|Disease Progression|1
7353270|NCT00966693|11595650|FG003|Overall Study|Disease Progression|16
7353271|NCT00966719|11595662|FG000|Overall Study|Lost to Follow-up|6
7353272|NCT00966719|11595663|FG001|Overall Study|Lost to Follow-up|11
7353273|NCT00966875|11595695|FG000|Part A|Adverse Event|2
7353274|NCT00966875|11595696|FG001|Part A|Adverse Event|1
7353275|NCT00966875|11595697|FG002|Part A|Adverse Event|0
7353276|NCT00966875|11595698|FG003|Part A|Adverse Event|1
7353277|NCT00966875|11595699|FG004|Part A|Adverse Event|0
7353278|NCT00966875|11595700|FG005|Part A|Adverse Event|1
7353279|NCT00966875|11595701|FG006|Part A|Adverse Event|0
7353280|NCT00966875|11595702|FG007|Part A|Adverse Event|3
7353281|NCT00966875|11595703|FG008|Part A|Adverse Event|3
7353282|NCT00966875|11595695|FG000|Part A|Entry Criteria|0
7353283|NCT00966875|11595696|FG001|Part A|Entry Criteria|0
7353284|NCT00966875|11595697|FG002|Part A|Entry Criteria|0
7353285|NCT00966875|11595698|FG003|Part A|Entry Criteria|0
7353286|NCT00966875|11595699|FG004|Part A|Entry Criteria|0
7353287|NCT00966875|11595700|FG005|Part A|Entry Criteria|2
7353288|NCT00966875|11595701|FG006|Part A|Entry Criteria|0
7353289|NCT00966875|11595702|FG007|Part A|Entry Criteria|0
7353290|NCT00966875|11595703|FG008|Part A|Entry Criteria|0
7353291|NCT00966875|11595695|FG000|Part A|Lack of Efficacy|0
7353292|NCT00966875|11595696|FG001|Part A|Lack of Efficacy|1
7353293|NCT00966875|11595697|FG002|Part A|Lack of Efficacy|0
7353294|NCT00966875|11595698|FG003|Part A|Lack of Efficacy|0
7353295|NCT00966875|11595699|FG004|Part A|Lack of Efficacy|0
7353296|NCT00966875|11595700|FG005|Part A|Lack of Efficacy|0
7353297|NCT00966875|11595701|FG006|Part A|Lack of Efficacy|4
7353298|NCT00966875|11595702|FG007|Part A|Lack of Efficacy|0
7353299|NCT00966875|11595703|FG008|Part A|Lack of Efficacy|0
7353300|NCT00966875|11595695|FG000|Part A|Lost to Follow-up|2
7353301|NCT00966875|11595696|FG001|Part A|Lost to Follow-up|0
7353302|NCT00966875|11595697|FG002|Part A|Lost to Follow-up|0
7353303|NCT00966875|11595698|FG003|Part A|Lost to Follow-up|0
7353304|NCT00966875|11595699|FG004|Part A|Lost to Follow-up|0
7353305|NCT00966875|11595700|FG005|Part A|Lost to Follow-up|1
7353306|NCT00966875|11595701|FG006|Part A|Lost to Follow-up|0
7353307|NCT00966875|11595702|FG007|Part A|Lost to Follow-up|0
7353308|NCT00966875|11595703|FG008|Part A|Lost to Follow-up|0
7353309|NCT00966875|11595695|FG000|Part A|Parent/Caregiver Decision|0
7353310|NCT00966875|11595696|FG001|Part A|Parent/Caregiver Decision|0
7353311|NCT00966875|11595697|FG002|Part A|Parent/Caregiver Decision|0
7353312|NCT00966875|11595698|FG003|Part A|Parent/Caregiver Decision|1
7353313|NCT00966875|11595699|FG004|Part A|Parent/Caregiver Decision|0
7353314|NCT00966875|11595700|FG005|Part A|Parent/Caregiver Decision|0
7353315|NCT00966875|11595701|FG006|Part A|Parent/Caregiver Decision|0
7353316|NCT00966875|11595702|FG007|Part A|Parent/Caregiver Decision|0
7353317|NCT00966875|11595703|FG008|Part A|Parent/Caregiver Decision|0
7459496|NCT01817777|11754117|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
7459497|NCT01817777|11754118|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
7353318|NCT00966875|11595695|FG000|Part A|Physician Decision|0
7353319|NCT00966875|11595696|FG001|Part A|Physician Decision|0
7353320|NCT00966875|11595697|FG002|Part A|Physician Decision|0
7353321|NCT00966875|11595698|FG003|Part A|Physician Decision|0
7353322|NCT00966875|11595699|FG004|Part A|Physician Decision|1
7353323|NCT00966875|11595700|FG005|Part A|Physician Decision|0
7353324|NCT00966875|11595701|FG006|Part A|Physician Decision|1
7353325|NCT00966875|11595702|FG007|Part A|Physician Decision|0
7353326|NCT00966875|11595703|FG008|Part A|Physician Decision|2
7353327|NCT00966875|11595695|FG000|Part A|Sponsor Decision|0
7353328|NCT00966875|11595696|FG001|Part A|Sponsor Decision|0
7353329|NCT00966875|11595697|FG002|Part A|Sponsor Decision|1
7353330|NCT00966875|11595698|FG003|Part A|Sponsor Decision|0
7353331|NCT00966875|11595699|FG004|Part A|Sponsor Decision|1
7353332|NCT00966875|11595700|FG005|Part A|Sponsor Decision|0
7353333|NCT00966875|11595701|FG006|Part A|Sponsor Decision|0
7353334|NCT00966875|11595702|FG007|Part A|Sponsor Decision|2
7353335|NCT00966875|11595703|FG008|Part A|Sponsor Decision|1
7353336|NCT00966875|11595695|FG000|Part A|Withdrawal by Subject|2
7353337|NCT00966875|11595696|FG001|Part A|Withdrawal by Subject|2
7353338|NCT00966875|11595697|FG002|Part A|Withdrawal by Subject|1
7353339|NCT00966875|11595698|FG003|Part A|Withdrawal by Subject|1
7353340|NCT00966875|11595699|FG004|Part A|Withdrawal by Subject|3
7353341|NCT00966875|11595700|FG005|Part A|Withdrawal by Subject|0
7353342|NCT00966875|11595701|FG006|Part A|Withdrawal by Subject|5
7353343|NCT00966875|11595702|FG007|Part A|Withdrawal by Subject|1
7353344|NCT00966875|11595703|FG008|Part A|Withdrawal by Subject|1
7353345|NCT00966875|11595695|FG000|Part A|Protocol Violation|0
7353346|NCT00966875|11595696|FG001|Part A|Protocol Violation|0
7353347|NCT00966875|11595697|FG002|Part A|Protocol Violation|0
7353348|NCT00966875|11595698|FG003|Part A|Protocol Violation|0
7353349|NCT00966875|11595699|FG004|Part A|Protocol Violation|0
7353350|NCT00966875|11595700|FG005|Part A|Protocol Violation|0
7353351|NCT00966875|11595701|FG006|Part A|Protocol Violation|2
7353352|NCT00966875|11595702|FG007|Part A|Protocol Violation|1
7353353|NCT00966875|11595703|FG008|Part A|Protocol Violation|1
7353354|NCT00966875|11595695|FG000|Part B|Adverse Event|0
7353355|NCT00966875|11595696|FG001|Part B|Adverse Event|1
7353356|NCT00966875|11595697|FG002|Part B|Adverse Event|1
7353357|NCT00966875|11595698|FG003|Part B|Adverse Event|0
7353358|NCT00966875|11595699|FG004|Part B|Adverse Event|1
7353359|NCT00966875|11595700|FG005|Part B|Adverse Event|0
7353360|NCT00966875|11595701|FG006|Part B|Adverse Event|5
7353361|NCT00966875|11595702|FG007|Part B|Adverse Event|2
7353362|NCT00966875|11595703|FG008|Part B|Adverse Event|2
7353363|NCT00966875|11595695|FG000|Part B|Death|0
7353364|NCT00966875|11595696|FG001|Part B|Death|0
7353365|NCT00966875|11595697|FG002|Part B|Death|1
7353366|NCT00966875|11595698|FG003|Part B|Death|0
7353367|NCT00966875|11595699|FG004|Part B|Death|0
7353368|NCT00966875|11595700|FG005|Part B|Death|0
7353369|NCT00966875|11595701|FG006|Part B|Death|0
7353370|NCT00966875|11595702|FG007|Part B|Death|1
7353371|NCT00966875|11595703|FG008|Part B|Death|0
7353372|NCT00966875|11595695|FG000|Part B|Lack of Efficacy|2
7353373|NCT00966875|11595696|FG001|Part B|Lack of Efficacy|1
7353374|NCT00966875|11595697|FG002|Part B|Lack of Efficacy|1
7353375|NCT00966875|11595698|FG003|Part B|Lack of Efficacy|1
7353376|NCT00966875|11595699|FG004|Part B|Lack of Efficacy|2
7353377|NCT00966875|11595700|FG005|Part B|Lack of Efficacy|3
7353378|NCT00966875|11595701|FG006|Part B|Lack of Efficacy|12
7353379|NCT00966875|11595702|FG007|Part B|Lack of Efficacy|9
7353380|NCT00966875|11595703|FG008|Part B|Lack of Efficacy|6
7353381|NCT00966875|11595695|FG000|Part B|Lost to Follow-up|0
7353382|NCT00966875|11595696|FG001|Part B|Lost to Follow-up|0
7353383|NCT00966875|11595697|FG002|Part B|Lost to Follow-up|0
7353384|NCT00966875|11595698|FG003|Part B|Lost to Follow-up|1
7353385|NCT00966875|11595699|FG004|Part B|Lost to Follow-up|0
7353386|NCT00966875|11595700|FG005|Part B|Lost to Follow-up|0
7353387|NCT00966875|11595701|FG006|Part B|Lost to Follow-up|0
7353388|NCT00966875|11595702|FG007|Part B|Lost to Follow-up|0
7353389|NCT00966875|11595703|FG008|Part B|Lost to Follow-up|1
7353390|NCT00966875|11595695|FG000|Part B|Physician Decision|0
7353391|NCT00966875|11595696|FG001|Part B|Physician Decision|0
7353392|NCT00966875|11595697|FG002|Part B|Physician Decision|1
7353393|NCT00966875|11595698|FG003|Part B|Physician Decision|0
7353394|NCT00966875|11595699|FG004|Part B|Physician Decision|2
7353395|NCT00966875|11595700|FG005|Part B|Physician Decision|1
7353396|NCT00966875|11595701|FG006|Part B|Physician Decision|0
7353397|NCT00966875|11595702|FG007|Part B|Physician Decision|0
7353398|NCT00966875|11595703|FG008|Part B|Physician Decision|2
7353399|NCT00966875|11595695|FG000|Part B|Sponsor Decision|1
7353400|NCT00966875|11595696|FG001|Part B|Sponsor Decision|0
7353401|NCT00966875|11595697|FG002|Part B|Sponsor Decision|0
7353402|NCT00966875|11595698|FG003|Part B|Sponsor Decision|0
7353403|NCT00966875|11595699|FG004|Part B|Sponsor Decision|0
7353404|NCT00966875|11595700|FG005|Part B|Sponsor Decision|1
7353405|NCT00966875|11595701|FG006|Part B|Sponsor Decision|0
7353406|NCT00966875|11595702|FG007|Part B|Sponsor Decision|2
7353407|NCT00966875|11595703|FG008|Part B|Sponsor Decision|1
7353408|NCT00966875|11595695|FG000|Part B|Withdrawal by Subject|2
7353409|NCT00966875|11595696|FG001|Part B|Withdrawal by Subject|1
7353410|NCT00966875|11595697|FG002|Part B|Withdrawal by Subject|2
7353411|NCT00966875|11595698|FG003|Part B|Withdrawal by Subject|1
7353412|NCT00966875|11595699|FG004|Part B|Withdrawal by Subject|2
7353413|NCT00966875|11595700|FG005|Part B|Withdrawal by Subject|1
7353414|NCT00966875|11595701|FG006|Part B|Withdrawal by Subject|4
7353415|NCT00966875|11595702|FG007|Part B|Withdrawal by Subject|5
7353416|NCT00966875|11595703|FG008|Part B|Withdrawal by Subject|5
7353417|NCT00966875|11595695|FG000|Part B|Entry Criteria|0
7353418|NCT00966875|11595696|FG001|Part B|Entry Criteria|0
7353419|NCT00966875|11595697|FG002|Part B|Entry Criteria|0
7353420|NCT00966875|11595698|FG003|Part B|Entry Criteria|0
7353421|NCT00966875|11595699|FG004|Part B|Entry Criteria|0
7353422|NCT00966875|11595700|FG005|Part B|Entry Criteria|0
7353423|NCT00966875|11595701|FG006|Part B|Entry Criteria|1
7353424|NCT00966875|11595702|FG007|Part B|Entry Criteria|0
7353425|NCT00966875|11595703|FG008|Part B|Entry Criteria|1
7353426|NCT00966940|11595778|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
7353427|NCT00966940|11595779|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
7353428|NCT00966940|11595778|FG000|Period 1, First 6 Weeks|Protocol Violation|1
7353429|NCT00966940|11595779|FG001|Period 1, First 6 Weeks|Protocol Violation|0
7353430|NCT00967005|11595787|FG000|Overall Study|Lost to Follow-up|7
7353431|NCT00967005|11595788|FG001|Overall Study|Lost to Follow-up|10
7353432|NCT00967018|11595794|FG000|Overall Study|Adverse Event|2
7353433|NCT00967018|11595794|FG000|Overall Study|Physician Decision|7
7353434|NCT00967018|11595794|FG000|Overall Study|Lost to Follow-up|2
7353435|NCT00967018|11595794|FG000|Overall Study|Withdrawal by Subject|1
7353436|NCT00967018|11595794|FG000|Overall Study|Miscellaneous Reasons|9
7353437|NCT00967226|11595804|FG000|Overall Study|Adverse Event|0
7353438|NCT00967226|11595805|FG001|Overall Study|Adverse Event|5
7353439|NCT00967226|11595804|FG000|Overall Study|Protocol Violation|2
7353440|NCT00967226|11595805|FG001|Overall Study|Protocol Violation|0
7353441|NCT00967226|11595804|FG000|Overall Study|Physician Decision|0
7353442|NCT00967226|11595805|FG001|Overall Study|Physician Decision|1
7353443|NCT00967330|11595837|FG000|Overall Study|Protocol Violation|3
7353444|NCT00967330|11595838|FG001|Overall Study|Protocol Violation|4
7353445|NCT00967330|11595837|FG000|Overall Study|Regular|10
7353446|NCT00967330|11595838|FG001|Overall Study|Regular|3
7353447|NCT00967330|11595837|FG000|Overall Study|Withdrawal by Subject|6
7353448|NCT00967330|11595838|FG001|Overall Study|Withdrawal by Subject|0
7353449|NCT00967330|11595837|FG000|Overall Study|Lost to Follow-up|1
7353450|NCT00967330|11595838|FG001|Overall Study|Lost to Follow-up|1
7353451|NCT00967330|11595837|FG000|Overall Study|Death|102
7353452|NCT00967330|11595838|FG001|Overall Study|Death|51
7353453|NCT00967330|11595837|FG000|Overall Study|Severe protocol deviation|0
7353454|NCT00967330|11595838|FG001|Overall Study|Severe protocol deviation|1
7353455|NCT00967343|11595844|FG000|Overall Study|Study termination by sponsor|12
7353456|NCT00967343|11595844|FG000|Overall Study|Death|24
7353457|NCT00967343|11595844|FG000|Overall Study|Relapse|1
7353458|NCT00967343|11595844|FG000|Overall Study|Lost to Follow-up|1
7353459|NCT00967499|11595872|FG000|Overall Study|Adverse Event|0
7353460|NCT00967499|11595873|FG001|Overall Study|Adverse Event|1
7353461|NCT00967499|11595872|FG000|Overall Study|Protocol Violation|1
7353462|NCT00967499|11595873|FG001|Overall Study|Protocol Violation|0
7353463|NCT00967499|11595872|FG000|Overall Study|Sponsor Decision|1
7353464|NCT00967499|11595873|FG001|Overall Study|Sponsor Decision|0
7353465|NCT00967499|11595872|FG000|Overall Study|Randomized but not treated|63
7353466|NCT00967499|11595873|FG001|Overall Study|Randomized but not treated|59
7353467|NCT00967616|11595890|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
7353468|NCT00967616|11595891|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
7353469|NCT00967616|11595890|FG000|Overall Study|Death|0
7353470|NCT00967616|11595891|FG001|Overall Study|Death|3
7353471|NCT00967616|11595890|FG000|Overall Study|Withdrawal by Subject|8
7353472|NCT00967616|11595891|FG001|Overall Study|Withdrawal by Subject|4
7353473|NCT00967616|11595890|FG000|Overall Study|Progressive Disease|31
7353474|NCT00967616|11595891|FG001|Overall Study|Progressive Disease|18
7353475|NCT00967616|11595890|FG000|Overall Study|Other|8
7353476|NCT00967616|11595891|FG001|Overall Study|Other|8
7353477|NCT00967616|11595890|FG000|Overall Study|Protocol Violation|1
7353478|NCT00967616|11595891|FG001|Overall Study|Protocol Violation|0
7569459|NCT03449446|11945890|FG000|Overall Study|Randomized but Never Treated|0
7569460|NCT03449446|11945891|FG001|Overall Study|Randomized but Never Treated|0
7569461|NCT03449446|11945892|FG002|Overall Study|Randomized but Never Treated|1
7353479|NCT00967668|11595900|FG000|Overall Study|Withdrawal by Subject|13
7353480|NCT00967668|11595901|FG001|Overall Study|Withdrawal by Subject|8
7353481|NCT00967668|11595902|FG002|Overall Study|Withdrawal by Subject|8
7353482|NCT00967668|11595900|FG000|Overall Study|Death|0
7353483|NCT00967668|11595901|FG001|Overall Study|Death|2
7353484|NCT00967668|11595902|FG002|Overall Study|Death|4
7353485|NCT00967668|11595900|FG000|Overall Study|Removed due to behavior|1
7353486|NCT00967668|11595901|FG001|Overall Study|Removed due to behavior|1
7353487|NCT00967668|11595902|FG002|Overall Study|Removed due to behavior|2
7353488|NCT00967668|11595900|FG000|Overall Study|Refused Year 2|11
7353489|NCT00967668|11595901|FG001|Overall Study|Refused Year 2|6
7353490|NCT00967668|11595902|FG002|Overall Study|Refused Year 2|4
7353491|NCT00967668|11595900|FG000|Overall Study|Lost to follow-up at 12-mo|27
7353492|NCT00967668|11595901|FG001|Overall Study|Lost to follow-up at 12-mo|29
7353493|NCT00967668|11595902|FG002|Overall Study|Lost to follow-up at 12-mo|26
7353494|NCT00967668|11595900|FG000|Overall Study|Lost to Follow-up|15
7353495|NCT00967668|11595901|FG001|Overall Study|Lost to Follow-up|9
7353496|NCT00967668|11595902|FG002|Overall Study|Lost to Follow-up|16
7353497|NCT00967668|11595900|FG000|Overall Study|Refused 12-mo assessment|3
7353498|NCT00967668|11595901|FG001|Overall Study|Refused 12-mo assessment|1
7353499|NCT00967668|11595902|FG002|Overall Study|Refused 12-mo assessment|9
7353500|NCT00967668|11595900|FG000|Overall Study|Pregnancy|1
7353501|NCT00967668|11595901|FG001|Overall Study|Pregnancy|0
7353502|NCT00967668|11595902|FG002|Overall Study|Pregnancy|0
7353503|NCT00967694|11595913|FG000|Overall Study|Withdrawal by Subject|6
7353504|NCT00967798|11595919|FG000|Overall Study|Withdrawal by Subject|5
7353505|NCT00967798|11595920|FG001|Overall Study|Withdrawal by Subject|2
7353506|NCT00967798|11595919|FG000|Overall Study|Lost to Follow-up|4
7353507|NCT00967798|11595920|FG001|Overall Study|Lost to Follow-up|1
7386056|NCT01207440|11644238|FG001|Overall Study|Progressive Disease|10
7386057|NCT01207440|11644239|FG002|Overall Study|Progressive Disease|19
7386058|NCT01207440|11644240|FG003|Overall Study|Progressive Disease|7
7386059|NCT01207440|11644241|FG004|Overall Study|Progressive Disease|23
7386060|NCT01207440|11644242|FG005|Overall Study|Progressive Disease|27
7386061|NCT01207440|11644243|FG006|Overall Study|Progressive Disease|0
7353508|NCT00968253|11595962|FG000|Overall Study|Death|0
7353509|NCT00968253|11595963|FG001|Overall Study|Death|0
7353510|NCT00968253|11595964|FG002|Overall Study|Death|2
7353511|NCT00968253|11595962|FG000|Overall Study|Withdrawal by Subject|0
7353512|NCT00968253|11595963|FG001|Overall Study|Withdrawal by Subject|0
7353513|NCT00968253|11595964|FG002|Overall Study|Withdrawal by Subject|1
7353514|NCT00968253|11595962|FG000|Overall Study|Disease Progression|0
7353515|NCT00968253|11595963|FG001|Overall Study|Disease Progression|3
7353516|NCT00968253|11595964|FG002|Overall Study|Disease Progression|3
7353517|NCT00968253|11595962|FG000|Overall Study|Adverse Event|0
7353518|NCT00968253|11595963|FG001|Overall Study|Adverse Event|0
7353519|NCT00968253|11595964|FG002|Overall Study|Adverse Event|1
7353520|NCT00968526|11595984|FG000|Overall Study|Adverse Event|2
7353521|NCT00968526|11595985|FG001|Overall Study|Adverse Event|0
7353522|NCT00968526|11595984|FG000|Overall Study|Migrated/moved from study area|1
7353523|NCT00968526|11595985|FG001|Overall Study|Migrated/moved from study area|0
7353524|NCT00968539|11596002|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
7353525|NCT00968539|11596003|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
7353526|NCT00968617|11596010|FG000|Overall Study|Study terminated by sponsor|6
7353527|NCT00968669|11596018|FG000|Overall Study|Lost to Follow-up|5
7353528|NCT00968669|11596019|FG001|Overall Study|Lost to Follow-up|2
7353529|NCT00968669|11596020|FG002|Overall Study|Lost to Follow-up|1
7353530|NCT00968669|11596021|FG003|Overall Study|Lost to Follow-up|4
7353531|NCT00968669|11596018|FG000|Overall Study|Withdrawal by Subject|9
7353532|NCT00968669|11596019|FG001|Overall Study|Withdrawal by Subject|7
7353533|NCT00968669|11596020|FG002|Overall Study|Withdrawal by Subject|5
7353534|NCT00968669|11596021|FG003|Overall Study|Withdrawal by Subject|3
7353535|NCT00968669|11596018|FG000|Overall Study|Pregnancy|0
7353536|NCT00968669|11596019|FG001|Overall Study|Pregnancy|0
7353537|NCT00968669|11596020|FG002|Overall Study|Pregnancy|2
7353538|NCT00968669|11596021|FG003|Overall Study|Pregnancy|0
7353539|NCT00968669|11596018|FG000|Overall Study|AE|1
7353540|NCT00968669|11596019|FG001|Overall Study|AE|0
7353541|NCT00968669|11596020|FG002|Overall Study|AE|0
7353542|NCT00968669|11596021|FG003|Overall Study|AE|0
7353543|NCT00968669|11596018|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7353544|NCT00968669|11596019|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7353545|NCT00968669|11596020|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
7353546|NCT00968669|11596021|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
7353547|NCT00968669|11596018|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
7353548|NCT00968669|11596019|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7353549|NCT00968669|11596020|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7353550|NCT00968669|11596021|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
7353551|NCT00968669|11596018|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
7353552|NCT00968669|11596019|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7353553|NCT00968669|11596020|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7353554|NCT00968669|11596021|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
7353555|NCT00968669|11596018|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7353556|NCT00968669|11596019|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7353557|NCT00968669|11596020|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
7353558|NCT00968669|11596021|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
7353559|NCT00968669|11596018|FG000|Overall Study|EARLY WITHDRAWAL|0
7353560|NCT00968669|11596019|FG001|Overall Study|EARLY WITHDRAWAL|1
7353561|NCT00968669|11596020|FG002|Overall Study|EARLY WITHDRAWAL|0
7353562|NCT00968669|11596021|FG003|Overall Study|EARLY WITHDRAWAL|0
7353563|NCT00968669|11596018|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
7353564|NCT00968669|11596019|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
7353565|NCT00968669|11596020|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
7353566|NCT00968669|11596021|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
7353567|NCT00968669|11596018|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
7353568|NCT00968669|11596019|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7353569|NCT00968669|11596020|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7353570|NCT00968669|11596021|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
7353571|NCT00968669|11596018|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7353572|NCT00968669|11596019|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
7353573|NCT00968669|11596020|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7353574|NCT00968669|11596021|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
7353575|NCT00968669|11596018|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7353576|NCT00968669|11596019|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
7353577|NCT00968669|11596020|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7353578|NCT00968669|11596021|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
7353579|NCT00968669|11596018|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7353580|NCT00968669|11596019|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
7353581|NCT00968669|11596020|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7353582|NCT00968669|11596021|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
7353583|NCT00968669|11596018|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7353584|NCT00968669|11596019|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
7353585|NCT00968669|11596020|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7353586|NCT00968669|11596021|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
7353587|NCT00968669|11596018|FG000|Overall Study|SPONSOR DECISION|0
7353588|NCT00968669|11596019|FG001|Overall Study|SPONSOR DECISION|1
7353589|NCT00968669|11596020|FG002|Overall Study|SPONSOR DECISION|0
7353590|NCT00968669|11596021|FG003|Overall Study|SPONSOR DECISION|0
7353591|NCT00968669|11596018|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7353592|NCT00968669|11596019|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7353593|NCT00968669|11596020|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
7353594|NCT00968669|11596021|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
7353595|NCT00968669|11596018|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7353596|NCT00968669|11596019|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
7353597|NCT00968669|11596020|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7353598|NCT00968669|11596021|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
7353599|NCT00968669|11596018|FG000|Overall Study|SUBJECT INCARCERATED|0
7353600|NCT00968669|11596019|FG001|Overall Study|SUBJECT INCARCERATED|1
7353601|NCT00968669|11596020|FG002|Overall Study|SUBJECT INCARCERATED|0
7353602|NCT00968669|11596021|FG003|Overall Study|SUBJECT INCARCERATED|0
7353603|NCT00968669|11596018|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7353604|NCT00968669|11596019|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
7353605|NCT00968669|11596020|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7353606|NCT00968669|11596021|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
7353607|NCT00968669|11596018|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7353608|NCT00968669|11596019|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7353609|NCT00968669|11596020|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
7353610|NCT00968669|11596021|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
7353611|NCT00968708|11596033|FG000|Overall Study|Adverse Event|169
7353612|NCT00968708|11596034|FG001|Overall Study|Adverse Event|150
7353613|NCT00968708|11596033|FG000|Overall Study|Major Protocol Deviation|0
7353614|NCT00968708|11596034|FG001|Overall Study|Major Protocol Deviation|1
7353615|NCT00968708|11596033|FG000|Overall Study|Lost to Follow-up|19
7353616|NCT00968708|11596034|FG001|Overall Study|Lost to Follow-up|11
7353617|NCT00968708|11596033|FG000|Overall Study|Voluntary Withdrawal|104
7353618|NCT00968708|11596034|FG001|Overall Study|Voluntary Withdrawal|101
7353619|NCT00968708|11596033|FG000|Overall Study|Investigator Discretion|0
7353620|NCT00968708|11596034|FG001|Overall Study|Investigator Discretion|1
7353621|NCT00968708|11596033|FG000|Overall Study|Other|26
7353622|NCT00968708|11596034|FG001|Overall Study|Other|34
7353623|NCT00968799|11596040|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
7353624|NCT00968812|11596047|FG000|Overall Study|Adverse Event|30
7353625|NCT00968812|11596048|FG001|Overall Study|Adverse Event|46
7353626|NCT00968812|11596049|FG002|Overall Study|Adverse Event|33
7353627|NCT00968812|11596047|FG000|Overall Study|Death|2
7353628|NCT00968812|11596048|FG001|Overall Study|Death|2
7353629|NCT00968812|11596049|FG002|Overall Study|Death|1
7353630|NCT00968812|11596047|FG000|Overall Study|Lack of Efficacy|9
7353631|NCT00968812|11596048|FG001|Overall Study|Lack of Efficacy|7
7353632|NCT00968812|11596049|FG002|Overall Study|Lack of Efficacy|16
7353633|NCT00968812|11596047|FG000|Overall Study|Lost to Follow-up|17
7353634|NCT00968812|11596048|FG001|Overall Study|Lost to Follow-up|12
7353635|NCT00968812|11596049|FG002|Overall Study|Lost to Follow-up|11
7353636|NCT00968812|11596047|FG000|Overall Study|Physician Decision|8
7353637|NCT00968812|11596048|FG001|Overall Study|Physician Decision|5
7353638|NCT00968812|11596049|FG002|Overall Study|Physician Decision|9
7353639|NCT00968812|11596047|FG000|Overall Study|Protocol Violation|7
7353640|NCT00968812|11596048|FG001|Overall Study|Protocol Violation|4
7353641|NCT00968812|11596049|FG002|Overall Study|Protocol Violation|3
7353642|NCT00968812|11596047|FG000|Overall Study|Withdrawal by Subject|17
7353643|NCT00968812|11596048|FG001|Overall Study|Withdrawal by Subject|23
7353644|NCT00968812|11596049|FG002|Overall Study|Withdrawal by Subject|25
7353645|NCT00968812|11596047|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
7353646|NCT00968812|11596048|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
7353647|NCT00968812|11596049|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
7353648|NCT00968812|11596047|FG000|Overall Study|Noncompliance with study drug|4
7353649|NCT00968812|11596048|FG001|Overall Study|Noncompliance with study drug|1
7353650|NCT00968812|11596049|FG002|Overall Study|Noncompliance with study drug|6
7353651|NCT00968812|11596047|FG000|Overall Study|Unable to take rescue therapy|12
7353652|NCT00968812|11596048|FG001|Overall Study|Unable to take rescue therapy|12
7353653|NCT00968812|11596049|FG002|Overall Study|Unable to take rescue therapy|17
7353654|NCT00968812|11596047|FG000|Overall Study|Other|25
7353655|NCT00968812|11596048|FG001|Overall Study|Other|37
7353656|NCT00968812|11596049|FG002|Overall Study|Other|40
7353657|NCT00968968|11596080|FG000|Overall Study|Study closed/terminated|10
7353658|NCT00968968|11596081|FG001|Overall Study|Study closed/terminated|10
7353659|NCT00968968|11596080|FG000|Overall Study|Protocol defined stopping criteria|3
7353660|NCT00968968|11596081|FG001|Overall Study|Protocol defined stopping criteria|1
7353661|NCT00968968|11596080|FG000|Overall Study|Withdrawal by Subject|2
7353662|NCT00968968|11596081|FG001|Overall Study|Withdrawal by Subject|0
7353663|NCT00968968|11596080|FG000|Overall Study|Physician Decision|1
7353664|NCT00968968|11596081|FG001|Overall Study|Physician Decision|2
7353665|NCT00968968|11596080|FG000|Overall Study|Lost to Follow-up|0
7353666|NCT00968968|11596081|FG001|Overall Study|Lost to Follow-up|1
7468295|NCT01908829|11768951|FG000|Overall Study|Withdrawal by Subject|26
7353667|NCT00968981|11596091|FG000|Overall Study|Adverse Event|2
7353668|NCT00968981|11596092|FG001|Overall Study|Adverse Event|0
7353669|NCT00968981|11596093|FG002|Overall Study|Adverse Event|0
7353670|NCT00968981|11596091|FG000|Overall Study|Disease Progression|14
7353671|NCT00968981|11596092|FG001|Overall Study|Disease Progression|16
7353672|NCT00968981|11596093|FG002|Overall Study|Disease Progression|13
7353673|NCT00968981|11596091|FG000|Overall Study|Lost to Follow-up|0
7353674|NCT00968981|11596092|FG001|Overall Study|Lost to Follow-up|0
7353675|NCT00968981|11596093|FG002|Overall Study|Lost to Follow-up|1
7353676|NCT00968981|11596091|FG000|Overall Study|Physician Decision|5
7353677|NCT00968981|11596092|FG001|Overall Study|Physician Decision|3
7353678|NCT00968981|11596093|FG002|Overall Study|Physician Decision|5
7353679|NCT00968981|11596091|FG000|Overall Study|Withdrawal by Subject|1
7353680|NCT00968981|11596092|FG001|Overall Study|Withdrawal by Subject|3
7353681|NCT00968981|11596093|FG002|Overall Study|Withdrawal by Subject|3
7353682|NCT00969124|11596102|FG000|Overall Study|Protocol Violation|2
7353683|NCT00969124|11596102|FG000|Overall Study|Inadequate bowel preparation|15
7353684|NCT00969124|11596102|FG000|Overall Study|Inability to reach cecum|9
7353685|NCT00969124|11596102|FG000|Overall Study|Previously unrecognized disease|3
7353686|NCT00969124|11596102|FG000|Overall Study|Technical error|1
7353687|NCT00969150|11596109|FG000|Overall Study|Adverse Event|4
7353688|NCT00969150|11596110|FG001|Overall Study|Adverse Event|14
7353689|NCT00969150|11596109|FG000|Overall Study|Lack of Efficacy|1
7353690|NCT00969150|11596110|FG001|Overall Study|Lack of Efficacy|1
7353691|NCT00969150|11596109|FG000|Overall Study|Protocol Violation|9
7353692|NCT00969150|11596110|FG001|Overall Study|Protocol Violation|12
7353693|NCT00969150|11596109|FG000|Overall Study|Withdrawal by Subject|13
7353694|NCT00969150|11596110|FG001|Overall Study|Withdrawal by Subject|9
7353695|NCT00969150|11596109|FG000|Overall Study|Lost to Follow-up|5
7353696|NCT00969150|11596110|FG001|Overall Study|Lost to Follow-up|4
7353697|NCT00969150|11596109|FG000|Overall Study|Other reasons|1
7353698|NCT00969150|11596110|FG001|Overall Study|Other reasons|0
7353699|NCT00969228|11596118|FG000|Overall Study|Adverse Event|1
7569462|NCT03449446|11945893|FG003|Overall Study|Randomized but Never Treated|1
7569463|NCT03449446|11945894|FG004|Overall Study|Randomized but Never Treated|1
7569464|NCT03449446|11945895|FG005|Overall Study|Randomized but Never Treated|0
7353700|NCT00969228|11596119|FG001|Overall Study|Adverse Event|0
7353701|NCT00969228|11596118|FG000|Overall Study|Withdrawal by Subject|4
7353702|NCT00969228|11596119|FG001|Overall Study|Withdrawal by Subject|0
7353703|NCT00969228|11596118|FG000|Overall Study|Porcine circovirus detection in vaccine|38
7353704|NCT00969228|11596119|FG001|Overall Study|Porcine circovirus detection in vaccine|14
7353705|NCT00969280|11596127|FG000|Overall Study|Protocol Violation|2
7353706|NCT00969280|11596128|FG001|Overall Study|Protocol Violation|1
7353707|NCT00969280|11596127|FG000|Overall Study|Withdrawal by Subject|0
7353708|NCT00969280|11596128|FG001|Overall Study|Withdrawal by Subject|1
7353709|NCT00969280|11596127|FG000|Overall Study|infection of influenza A(H1N1)|0
7353710|NCT00969280|11596128|FG001|Overall Study|infection of influenza A(H1N1)|1
7353711|NCT00969332|11596134|FG000|Overall Study|Physician Decision|8
7353712|NCT00969332|11596134|FG000|Overall Study|Withdrawal by Subject|3
7353713|NCT00969436|11596142|FG000|Overall Study|Protocol Violation|1
7353714|NCT00969436|11596143|FG001|Overall Study|Protocol Violation|3
7353715|NCT00969436|11596144|FG002|Overall Study|Protocol Violation|0
7353716|NCT00969436|11596142|FG000|Overall Study|Migrated/moved from study area|12
7353717|NCT00969436|11596143|FG001|Overall Study|Migrated/moved from study area|10
7353718|NCT00969436|11596144|FG002|Overall Study|Migrated/moved from study area|2
7353719|NCT00969436|11596142|FG000|Overall Study|Father - serious health problem|0
7353720|NCT00969436|11596143|FG001|Overall Study|Father - serious health problem|0
7353721|NCT00969436|11596144|FG002|Overall Study|Father - serious health problem|1
7353722|NCT00969436|11596142|FG000|Overall Study|Parents personal problem|0
7353723|NCT00969436|11596143|FG001|Overall Study|Parents personal problem|0
7353724|NCT00969436|11596144|FG002|Overall Study|Parents personal problem|1
7353725|NCT00969436|11596142|FG000|Overall Study|Subject eliminated (other vaccine)|1
7353726|NCT00969436|11596143|FG001|Overall Study|Subject eliminated (other vaccine)|0
7353727|NCT00969436|11596144|FG002|Overall Study|Subject eliminated (other vaccine)|0
7353728|NCT00969436|11596142|FG000|Overall Study|Withdrawal by Subject|3
7353729|NCT00969436|11596143|FG001|Overall Study|Withdrawal by Subject|0
7353730|NCT00969436|11596144|FG002|Overall Study|Withdrawal by Subject|2
7353731|NCT00969436|11596142|FG000|Overall Study|Lost to Follow-up|8
7353732|NCT00969436|11596143|FG001|Overall Study|Lost to Follow-up|8
7353733|NCT00969436|11596144|FG002|Overall Study|Lost to Follow-up|5
7353734|NCT00969540|11596158|FG000|Overall Study|Lost to Follow-up|1
7353735|NCT00969540|11596159|FG001|Overall Study|Lost to Follow-up|1
7353736|NCT00969553|11596186|FG000|Overall Study|Progressive disease (PD)|2
7353737|NCT00969553|11596187|FG001|Overall Study|Progressive disease (PD)|2
7353738|NCT00969553|11596188|FG002|Overall Study|Progressive disease (PD)|6
7353739|NCT00969553|11596189|FG003|Overall Study|Progressive disease (PD)|9
7353740|NCT00969553|11596190|FG004|Overall Study|Progressive disease (PD)|2
7353741|NCT00969553|11596191|FG005|Overall Study|Progressive disease (PD)|4
7569465|NCT03449446|11945896|FG006|Overall Study|Randomized but Never Treated|0
7353742|NCT00969553|11596192|FG006|Overall Study|Progressive disease (PD)|2
7353743|NCT00969553|11596193|FG007|Overall Study|Progressive disease (PD)|12
7353744|NCT00969553|11596194|FG008|Overall Study|Progressive disease (PD)|3
7353745|NCT00969553|11596186|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
7353746|NCT00969553|11596187|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
7353747|NCT00969553|11596188|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
7353748|NCT00969553|11596189|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
7353749|NCT00969553|11596190|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
7353750|NCT00969553|11596191|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
7353751|NCT00969553|11596192|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
7353752|NCT00969553|11596193|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
7353753|NCT00969553|11596194|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
7353754|NCT00969553|11596186|FG000|Overall Study|Other Adverse Event|0
7353755|NCT00969553|11596187|FG001|Overall Study|Other Adverse Event|0
7353756|NCT00969553|11596188|FG002|Overall Study|Other Adverse Event|0
7353757|NCT00969553|11596189|FG003|Overall Study|Other Adverse Event|1
7353758|NCT00969553|11596190|FG004|Overall Study|Other Adverse Event|0
7353759|NCT00969553|11596191|FG005|Overall Study|Other Adverse Event|0
7353760|NCT00969553|11596192|FG006|Overall Study|Other Adverse Event|1
7353761|NCT00969553|11596193|FG007|Overall Study|Other Adverse Event|0
7353762|NCT00969553|11596194|FG008|Overall Study|Other Adverse Event|0
7353763|NCT00969553|11596186|FG000|Overall Study|Refused cont. medication|1
7353764|NCT00969553|11596187|FG001|Overall Study|Refused cont. medication|1
7353765|NCT00969553|11596188|FG002|Overall Study|Refused cont. medication|0
7353766|NCT00969553|11596189|FG003|Overall Study|Refused cont. medication|2
7353767|NCT00969553|11596190|FG004|Overall Study|Refused cont. medication|0
7353768|NCT00969553|11596191|FG005|Overall Study|Refused cont. medication|0
7353769|NCT00969553|11596192|FG006|Overall Study|Refused cont. medication|0
7353770|NCT00969553|11596193|FG007|Overall Study|Refused cont. medication|1
7353771|NCT00969553|11596194|FG008|Overall Study|Refused cont. medication|0
7353772|NCT00969553|11596186|FG000|Overall Study|Not specified above|0
7353773|NCT00969553|11596187|FG001|Overall Study|Not specified above|0
7353774|NCT00969553|11596188|FG002|Overall Study|Not specified above|0
7353775|NCT00969553|11596189|FG003|Overall Study|Not specified above|4
7353776|NCT00969553|11596190|FG004|Overall Study|Not specified above|0
7353777|NCT00969553|11596191|FG005|Overall Study|Not specified above|0
7353778|NCT00969553|11596192|FG006|Overall Study|Not specified above|1
7353779|NCT00969553|11596193|FG007|Overall Study|Not specified above|1
7353780|NCT00969553|11596194|FG008|Overall Study|Not specified above|0
7353781|NCT00969618|11596222|FG000|Overall Study|Adverse Event|29
7353782|NCT00969618|11596222|FG000|Overall Study|Entry Criteria Not Met|3
7353783|NCT00969618|11596222|FG000|Overall Study|Lack of Efficacy|2
7353784|NCT00969618|11596222|FG000|Overall Study|Lost to Follow-up|7
7353785|NCT00969618|11596222|FG000|Overall Study|Physician Decision|1
7353786|NCT00969618|11596222|FG000|Overall Study|Protocol Violation|9
7353787|NCT00969618|11596222|FG000|Overall Study|Withdrawal by Subject|27
7353788|NCT00969709|11596230|FG000|Overall Study|Adverse Event|3
7353789|NCT00969709|11596231|FG001|Overall Study|Adverse Event|13
7353790|NCT00969709|11596232|FG002|Overall Study|Adverse Event|26
7353791|NCT00969709|11596233|FG003|Overall Study|Adverse Event|12
7353792|NCT00969709|11596230|FG000|Overall Study|Lack of Efficacy|7
7353793|NCT00969709|11596231|FG001|Overall Study|Lack of Efficacy|4
7353794|NCT00969709|11596232|FG002|Overall Study|Lack of Efficacy|1
7353795|NCT00969709|11596233|FG003|Overall Study|Lack of Efficacy|3
7353796|NCT00969709|11596230|FG000|Overall Study|Protocol Violation|9
7353797|NCT00969709|11596231|FG001|Overall Study|Protocol Violation|5
7353798|NCT00969709|11596232|FG002|Overall Study|Protocol Violation|9
7353799|NCT00969709|11596233|FG003|Overall Study|Protocol Violation|10
7353800|NCT00969709|11596230|FG000|Overall Study|Withdrawal by Subject|9
7353801|NCT00969709|11596231|FG001|Overall Study|Withdrawal by Subject|12
7353802|NCT00969709|11596232|FG002|Overall Study|Withdrawal by Subject|11
7353803|NCT00969709|11596233|FG003|Overall Study|Withdrawal by Subject|23
7353804|NCT00969709|11596230|FG000|Overall Study|Lost to Follow-up|10
7353805|NCT00969709|11596231|FG001|Overall Study|Lost to Follow-up|14
7353806|NCT00969709|11596232|FG002|Overall Study|Lost to Follow-up|8
7353807|NCT00969709|11596233|FG003|Overall Study|Lost to Follow-up|15
7353808|NCT00969709|11596230|FG000|Overall Study|Other reasons|0
7353809|NCT00969709|11596231|FG001|Overall Study|Other reasons|0
7353810|NCT00969709|11596232|FG002|Overall Study|Other reasons|3
7353811|NCT00969709|11596233|FG003|Overall Study|Other reasons|0
7353812|NCT00969761|11596259|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7353813|NCT00969761|11596260|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353814|NCT00969761|11596261|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353815|NCT00969761|11596262|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7353816|NCT00969761|11596263|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353817|NCT00969761|11596264|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353818|NCT00969761|11596265|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353819|NCT00969761|11596266|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353820|NCT00969761|11596267|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7353821|NCT00969761|11596268|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
7353822|NCT00969761|11596269|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353823|NCT00969761|11596270|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
7353824|NCT00969761|11596259|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353825|NCT00969761|11596260|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353826|NCT00969761|11596261|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
7353827|NCT00969761|11596262|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353828|NCT00969761|11596263|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353829|NCT00969761|11596264|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353830|NCT00969761|11596265|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353831|NCT00969761|11596266|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353832|NCT00969761|11596267|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353833|NCT00969761|11596268|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353834|NCT00969761|11596269|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353835|NCT00969761|11596270|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
7353836|NCT00969761|11596259|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353837|NCT00969761|11596260|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353838|NCT00969761|11596261|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
7353839|NCT00969761|11596262|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353840|NCT00969761|11596263|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353841|NCT00969761|11596264|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353842|NCT00969761|11596265|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353843|NCT00969761|11596266|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353844|NCT00969761|11596267|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353845|NCT00969761|11596268|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353846|NCT00969761|11596269|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353847|NCT00969761|11596270|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
7353848|NCT00969761|11596259|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353849|NCT00969761|11596260|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353850|NCT00969761|11596261|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353851|NCT00969761|11596262|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353852|NCT00969761|11596263|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353853|NCT00969761|11596264|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353854|NCT00969761|11596265|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353855|NCT00969761|11596266|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353856|NCT00969761|11596267|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
7353857|NCT00969761|11596268|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353858|NCT00969761|11596269|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353859|NCT00969761|11596270|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
7353860|NCT00969761|11596259|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7353861|NCT00969761|11596260|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7353862|NCT00969761|11596261|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
7353863|NCT00969761|11596262|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7353864|NCT00969761|11596263|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7459498|NCT01817777|11754119|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
7468296|NCT01908829|11768952|FG001|Overall Study|Withdrawal by Subject|29
7468297|NCT01908829|11768953|FG002|Overall Study|Withdrawal by Subject|22
7468298|NCT01908907|11768972|FG000|Overall Study|Physician Decision|1
7468299|NCT01908907|11768973|FG001|Overall Study|Physician Decision|0
7468300|NCT01908907|11768972|FG000|Overall Study|Protocol Violation|1
7468301|NCT01908907|11768973|FG001|Overall Study|Protocol Violation|0
7468302|NCT01909336|11769025|FG000|Overall Study|Lost to Follow-up|4
7468303|NCT01909336|11769026|FG001|Overall Study|Lost to Follow-up|2
7468304|NCT01909336|11769027|FG002|Overall Study|Lost to Follow-up|2
7468305|NCT01909336|11769025|FG000|Overall Study|Physician Decision|0
7468306|NCT01909336|11769026|FG001|Overall Study|Physician Decision|1
7468307|NCT01909336|11769027|FG002|Overall Study|Physician Decision|1
7468308|NCT01909466|11769035|FG000|Overall Study|Lost to Follow-up|5
7468309|NCT01909466|11769036|FG001|Overall Study|Lost to Follow-up|7
7468310|NCT01909466|11769035|FG000|Overall Study|Adverse Event|3
7468311|NCT01909466|11769036|FG001|Overall Study|Adverse Event|4
7468312|NCT01909466|11769035|FG000|Overall Study|Met Withdrawal Criteria|0
7468313|NCT01909466|11769036|FG001|Overall Study|Met Withdrawal Criteria|3
7468314|NCT01909466|11769035|FG000|Overall Study|Physician Decision|2
7468315|NCT01909466|11769036|FG001|Overall Study|Physician Decision|0
7468316|NCT01909466|11769035|FG000|Overall Study|Withdrawal by Subject|11
7468317|NCT01909466|11769036|FG001|Overall Study|Withdrawal by Subject|9
7468318|NCT01909466|11769035|FG000|Overall Study|Lack of Efficacy|1
7468319|NCT01909466|11769036|FG001|Overall Study|Lack of Efficacy|0
7468320|NCT01909674|11769042|FG000|Overall Study|Withdrawal by Subject|5
7468321|NCT01909674|11769043|FG001|Overall Study|Withdrawal by Subject|2
7468322|NCT01909778|11769074|FG000|Overall Study|failed screening|1
7468323|NCT01909791|11769083|FG000|Overall Study|Death|9
7468324|NCT01909791|11769084|FG001|Overall Study|Death|8
7468325|NCT01909791|11769085|FG002|Overall Study|Death|4
7468326|NCT01909791|11769083|FG000|Overall Study|Withdrawal by Subject|5
7468327|NCT01909791|11769084|FG001|Overall Study|Withdrawal by Subject|9
7468328|NCT01909791|11769085|FG002|Overall Study|Withdrawal by Subject|13
7468329|NCT01909791|11769083|FG000|Overall Study|Lost to Follow-up|5
7353865|NCT00969761|11596264|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7353866|NCT00969761|11596265|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7353867|NCT00969761|11596266|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
7353868|NCT00969761|11596267|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
7353869|NCT00969761|11596268|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
7353870|NCT00969761|11596269|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7569466|NCT03449446|11945890|FG000|Overall Study|Unknown Reason|33
7569467|NCT03449446|11945891|FG001|Overall Study|Unknown Reason|1
7569468|NCT03449446|11945892|FG002|Overall Study|Unknown Reason|1
7569469|NCT03449446|11945893|FG003|Overall Study|Unknown Reason|1
7569470|NCT03449446|11945894|FG004|Overall Study|Unknown Reason|2
7569471|NCT03449446|11945895|FG005|Overall Study|Unknown Reason|2
7569472|NCT03449446|11945896|FG006|Overall Study|Unknown Reason|0
7353871|NCT00969761|11596270|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
7353872|NCT00969761|11596259|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353873|NCT00969761|11596260|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353874|NCT00969761|11596261|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353875|NCT00969761|11596262|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7353876|NCT00969761|11596263|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
7353877|NCT00969761|11596264|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353878|NCT00969761|11596265|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353879|NCT00969761|11596266|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353880|NCT00969761|11596267|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
7353881|NCT00969761|11596268|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353882|NCT00969761|11596269|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353883|NCT00969761|11596270|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
7353884|NCT00970268|11596335|FG000|Overall Study|Withdrawal by Subject|12
7353885|NCT00970268|11596336|FG001|Overall Study|Withdrawal by Subject|19
7353886|NCT00970268|11596335|FG000|Overall Study|Adverse Event|15
7353887|NCT00970268|11596336|FG001|Overall Study|Adverse Event|12
7353888|NCT00970268|11596335|FG000|Overall Study|Lack of Efficacy|3
7353889|NCT00970268|11596336|FG001|Overall Study|Lack of Efficacy|6
7353890|NCT00970268|11596335|FG000|Overall Study|Protocol Violation|4
7353891|NCT00970268|11596336|FG001|Overall Study|Protocol Violation|7
7353892|NCT00970268|11596335|FG000|Overall Study|Other Reason|3
7353893|NCT00970268|11596336|FG001|Overall Study|Other Reason|1
7353894|NCT00970268|11596335|FG000|Overall Study|COPD Exacerbation|4
7353895|NCT00970268|11596336|FG001|Overall Study|COPD Exacerbation|2
7353896|NCT00970268|11596335|FG000|Overall Study|Lost to Follow-up|1
7353897|NCT00970268|11596336|FG001|Overall Study|Lost to Follow-up|2
7353898|NCT00970268|11596335|FG000|Overall Study|Inclusion/Exclusion Criteria|1
7353899|NCT00970268|11596336|FG001|Overall Study|Inclusion/Exclusion Criteria|0
7353900|NCT00970281|11596350|FG000|Overall Study|Lack of Efficacy|1
7353901|NCT00970281|11596351|FG001|Overall Study|Lack of Efficacy|14
7353902|NCT00970281|11596350|FG000|Overall Study|Withdrawal by Subject|0
7353903|NCT00970281|11596351|FG001|Overall Study|Withdrawal by Subject|1
7353904|NCT00970281|11596350|FG000|Overall Study|Physician Decision|1
7353905|NCT00970281|11596351|FG001|Overall Study|Physician Decision|1
7353906|NCT00970294|11596357|FG000|Overall Study|Physician Decision|4
7353907|NCT00970294|11596357|FG000|Overall Study|Withdrawal by Subject|1
7353908|NCT00970307|11596364|FG000|Overall Study|Serious Adverse Event|1
7353909|NCT00970307|11596365|FG001|Overall Study|Serious Adverse Event|0
7353910|NCT00970307|11596366|FG002|Overall Study|Serious Adverse Event|0
7353911|NCT00970307|11596364|FG000|Overall Study|Withdrawal by Subject|2
7353912|NCT00970307|11596365|FG001|Overall Study|Withdrawal by Subject|3
7353913|NCT00970307|11596366|FG002|Overall Study|Withdrawal by Subject|2
7353914|NCT00970359|11596395|FG000|Overall Study|Not Treated|4
7353915|NCT00970489|11596401|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
7353916|NCT00970489|11596402|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
7353917|NCT00970502|11596408|FG000|Overall Study|Withdrawal by Subject|1
7353918|NCT00970593|11596423|FG000|Overall Study|Adverse Event|1
7353919|NCT00970593|11596424|FG001|Overall Study|Adverse Event|1
7353920|NCT00970593|11596425|FG002|Overall Study|Adverse Event|0
7353921|NCT00970593|11596426|FG003|Overall Study|Adverse Event|0
7353922|NCT00970593|11596427|FG004|Overall Study|Adverse Event|0
7353923|NCT00970593|11596428|FG005|Overall Study|Adverse Event|0
7353924|NCT00970593|11596429|FG006|Overall Study|Adverse Event|0
7353925|NCT00970593|11596423|FG000|Overall Study|Discontinuation of study by sponsor|0
7353926|NCT00970593|11596424|FG001|Overall Study|Discontinuation of study by sponsor|0
7353927|NCT00970593|11596425|FG002|Overall Study|Discontinuation of study by sponsor|5
7353928|NCT00970593|11596426|FG003|Overall Study|Discontinuation of study by sponsor|0
7353929|NCT00970593|11596427|FG004|Overall Study|Discontinuation of study by sponsor|0
7353930|NCT00970593|11596428|FG005|Overall Study|Discontinuation of study by sponsor|0
7353931|NCT00970593|11596429|FG006|Overall Study|Discontinuation of study by sponsor|2
7353932|NCT00970593|11596423|FG000|Overall Study|Withdrawal by Subject|0
7353933|NCT00970593|11596424|FG001|Overall Study|Withdrawal by Subject|0
7353934|NCT00970593|11596425|FG002|Overall Study|Withdrawal by Subject|1
7569473|NCT03449446|11945890|FG000|Overall Study|Withdrew Consent|1
7569474|NCT03449446|11945891|FG001|Overall Study|Withdrew Consent|3
7569475|NCT03449446|11945892|FG002|Overall Study|Withdrew Consent|1
7353935|NCT00970593|11596426|FG003|Overall Study|Withdrawal by Subject|0
7353936|NCT00970593|11596427|FG004|Overall Study|Withdrawal by Subject|0
7353937|NCT00970593|11596428|FG005|Overall Study|Withdrawal by Subject|0
7353938|NCT00970593|11596429|FG006|Overall Study|Withdrawal by Subject|0
7353939|NCT00970632|11596452|FG000|Overall Study|Adverse Event|2
7353940|NCT00970632|11596453|FG001|Overall Study|Adverse Event|2
7353941|NCT00970632|11596454|FG002|Overall Study|Adverse Event|1
7353942|NCT00970632|11596452|FG000|Overall Study|Lack of Efficacy|3
7353943|NCT00970632|11596453|FG001|Overall Study|Lack of Efficacy|0
7353944|NCT00970632|11596454|FG002|Overall Study|Lack of Efficacy|0
7353945|NCT00970632|11596452|FG000|Overall Study|Lost to Follow-up|3
7353946|NCT00970632|11596453|FG001|Overall Study|Lost to Follow-up|0
7353947|NCT00970632|11596454|FG002|Overall Study|Lost to Follow-up|2
7353948|NCT00970632|11596452|FG000|Overall Study|Protocol Violation|8
7353949|NCT00970632|11596453|FG001|Overall Study|Protocol Violation|5
7353950|NCT00970632|11596454|FG002|Overall Study|Protocol Violation|8
7353951|NCT00970632|11596452|FG000|Overall Study|Withdrawal by Subject|7
7353952|NCT00970632|11596453|FG001|Overall Study|Withdrawal by Subject|6
7353953|NCT00970632|11596454|FG002|Overall Study|Withdrawal by Subject|4
7353954|NCT00970632|11596452|FG000|Overall Study|Entry criteria not met|0
7353955|NCT00970632|11596453|FG001|Overall Study|Entry criteria not met|2
7353956|NCT00970632|11596454|FG002|Overall Study|Entry criteria not met|2
7353957|NCT00970632|11596452|FG000|Overall Study|Sponsor decision|1
7353958|NCT00970632|11596453|FG001|Overall Study|Sponsor decision|0
7353959|NCT00970632|11596454|FG002|Overall Study|Sponsor decision|1
7353963|NCT00970944|11596486|FG000|Overall Study|Death|1
7353964|NCT00970944|11596487|FG001|Overall Study|Death|0
7353965|NCT00970944|11596486|FG000|Overall Study|Physician Decision|0
7353966|NCT00970944|11596487|FG001|Overall Study|Physician Decision|2
7353967|NCT00971048|11596498|FG000|Overall Study|Protocol Violation|1
7353968|NCT00971048|11596499|FG001|Overall Study|Protocol Violation|2
7353969|NCT00971048|11596500|FG002|Overall Study|Protocol Violation|0
7353970|NCT00971048|11596501|FG003|Overall Study|Protocol Violation|1
7353971|NCT00971048|11596498|FG000|Overall Study|Adverse Event|0
7353972|NCT00971048|11596499|FG001|Overall Study|Adverse Event|0
7353973|NCT00971048|11596500|FG002|Overall Study|Adverse Event|1
7353974|NCT00971048|11596501|FG003|Overall Study|Adverse Event|0
7353975|NCT00971048|11596498|FG000|Overall Study|Physician Decision|0
7353976|NCT00971048|11596499|FG001|Overall Study|Physician Decision|0
7353977|NCT00971048|11596500|FG002|Overall Study|Physician Decision|0
7353978|NCT00971048|11596501|FG003|Overall Study|Physician Decision|1
7353979|NCT00971178|11596516|FG000|Overall Study|Lost to Follow-up|2
7353980|NCT00971178|11596517|FG001|Overall Study|Lost to Follow-up|2
7353981|NCT00971178|11596518|FG002|Overall Study|Lost to Follow-up|2
7353982|NCT00971204|11596526|FG000|Overall Study|Did not meet all criteria-not treated|14
7353983|NCT00971204|11596526|FG000|Overall Study|Lost to Follow-up|10
7353984|NCT00971243|11596535|FG000|Double Blind Period|Adverse Event|2
7353985|NCT00971243|11596536|FG001|Double Blind Period|Adverse Event|3
7353986|NCT00971243|11596537|FG002|Double Blind Period|Adverse Event|2
7353987|NCT00971243|11596538|FG003|Double Blind Period|Adverse Event|2
7353988|NCT00971243|11596539|FG004|Double Blind Period|Adverse Event|3
7353989|NCT00971243|11596535|FG000|Double Blind Period|Lost to Follow-up|0
7353990|NCT00971243|11596536|FG001|Double Blind Period|Lost to Follow-up|1
7353991|NCT00971243|11596537|FG002|Double Blind Period|Lost to Follow-up|1
7353992|NCT00971243|11596538|FG003|Double Blind Period|Lost to Follow-up|0
7353993|NCT00971243|11596539|FG004|Double Blind Period|Lost to Follow-up|1
7353994|NCT00971243|11596535|FG000|Double Blind Period|Physician Decision|10
7353995|NCT00971243|11596536|FG001|Double Blind Period|Physician Decision|6
7353996|NCT00971243|11596537|FG002|Double Blind Period|Physician Decision|7
7353997|NCT00971243|11596538|FG003|Double Blind Period|Physician Decision|6
7353998|NCT00971243|11596539|FG004|Double Blind Period|Physician Decision|7
7353999|NCT00971243|11596535|FG000|Double Blind Period|Protocol Violation|2
7354000|NCT00971243|11596536|FG001|Double Blind Period|Protocol Violation|0
7354001|NCT00971243|11596537|FG002|Double Blind Period|Protocol Violation|3
7354002|NCT00971243|11596538|FG003|Double Blind Period|Protocol Violation|2
7354003|NCT00971243|11596539|FG004|Double Blind Period|Protocol Violation|2
7354004|NCT00971243|11596535|FG000|Double Blind Period|Withdrawal by Subject|4
7354005|NCT00971243|11596536|FG001|Double Blind Period|Withdrawal by Subject|1
7354006|NCT00971243|11596537|FG002|Double Blind Period|Withdrawal by Subject|4
7459499|NCT01817790|11754127|FG000|Overall Study|Adverse Event|0
7354007|NCT00971243|11596538|FG003|Double Blind Period|Withdrawal by Subject|4
7354008|NCT00971243|11596539|FG004|Double Blind Period|Withdrawal by Subject|4
7354009|NCT00971243|11596535|FG000|Double Blind Period|Other reasons|1
7354010|NCT00971243|11596536|FG001|Double Blind Period|Other reasons|0
7354011|NCT00971243|11596537|FG002|Double Blind Period|Other reasons|2
7354012|NCT00971243|11596538|FG003|Double Blind Period|Other reasons|0
7354013|NCT00971243|11596539|FG004|Double Blind Period|Other reasons|1
7354014|NCT00971243|11596535|FG000|Open-label Period|Adverse Event|1
7354015|NCT00971243|11596536|FG001|Open-label Period|Adverse Event|0
7354016|NCT00971243|11596537|FG002|Open-label Period|Adverse Event|1
7354017|NCT00971243|11596538|FG003|Open-label Period|Adverse Event|1
7354018|NCT00971243|11596539|FG004|Open-label Period|Adverse Event|0
7354019|NCT00971243|11596535|FG000|Open-label Period|Physician Decision|5
7354020|NCT00971243|11596536|FG001|Open-label Period|Physician Decision|9
7354021|NCT00971243|11596537|FG002|Open-label Period|Physician Decision|3
7354022|NCT00971243|11596538|FG003|Open-label Period|Physician Decision|7
7354023|NCT00971243|11596539|FG004|Open-label Period|Physician Decision|2
7354024|NCT00971243|11596535|FG000|Open-label Period|Protocol Violation|1
7354025|NCT00971243|11596536|FG001|Open-label Period|Protocol Violation|1
7354026|NCT00971243|11596537|FG002|Open-label Period|Protocol Violation|1
7354027|NCT00971243|11596538|FG003|Open-label Period|Protocol Violation|0
7354028|NCT00971243|11596539|FG004|Open-label Period|Protocol Violation|1
7354029|NCT00971243|11596535|FG000|Open-label Period|Withdrawal by Subject|1
7354030|NCT00971243|11596536|FG001|Open-label Period|Withdrawal by Subject|0
7354031|NCT00971243|11596537|FG002|Open-label Period|Withdrawal by Subject|0
7354032|NCT00971243|11596538|FG003|Open-label Period|Withdrawal by Subject|2
7354033|NCT00971243|11596539|FG004|Open-label Period|Withdrawal by Subject|1
7354034|NCT00971243|11596535|FG000|Open-label Period|Other reason|0
7354035|NCT00971243|11596536|FG001|Open-label Period|Other reason|0
7354036|NCT00971243|11596537|FG002|Open-label Period|Other reason|0
7354037|NCT00971243|11596538|FG003|Open-label Period|Other reason|0
7354038|NCT00971243|11596539|FG004|Open-label Period|Other reason|2
7354039|NCT00971321|11596566|FG000|Up to Month 7|Withdrawal by Subject|1
7354040|NCT00971321|11596567|FG001|Up to Month 7|Withdrawal by Subject|0
7354041|NCT00971321|11596566|FG000|Up to Month 7|Migrated/moved from study area|3
7354042|NCT00971321|11596567|FG001|Up to Month 7|Migrated/moved from study area|2
7354043|NCT00971321|11596566|FG000|Up to Month 11-12|Withdrawal by Subject|2
7354044|NCT00971321|11596567|FG001|Up to Month 11-12|Withdrawal by Subject|1
7354045|NCT00971321|11596566|FG000|Up to Month 11-12|Migrated/moved from study area|2
7354046|NCT00971321|11596567|FG001|Up to Month 11-12|Migrated/moved from study area|2
7354047|NCT00971321|11596566|FG000|Up to Month 11-12|Lost to Follow-up|1
7354048|NCT00971321|11596567|FG001|Up to Month 11-12|Lost to Follow-up|0
7354049|NCT00971425|11596575|FG000|Overall Study|Adverse Event|1
7354050|NCT00971425|11596576|FG001|Overall Study|Adverse Event|1
7354051|NCT00971425|11596575|FG000|Overall Study|Withdrawal by Subject|0
7354052|NCT00971425|11596576|FG001|Overall Study|Withdrawal by Subject|1
7354053|NCT00971932|11596627|FG000|Overall Study|Withdrawal by Subject|1
7354054|NCT00971932|11596627|FG000|Overall Study|Investigator's decision|2
7354055|NCT00971932|11596627|FG000|Overall Study|Ongoing|4
7354056|NCT00971945|11596631|FG000|Overall Study|Progressive Disease|3
7354057|NCT00971945|11596631|FG000|Overall Study|Change in treatment policy|1
7354058|NCT00971945|11596631|FG000|Overall Study|Other reasons|2
7354059|NCT00971997|11596635|FG000|Overall Study|Adverse Event|2
7354060|NCT00971997|11596635|FG000|Overall Study|Death|1
7354061|NCT00971997|11596635|FG000|Overall Study|Protocol Violation|4
7354062|NCT00971997|11596635|FG000|Overall Study|Withdrawal by Subject|5
7354063|NCT00971997|11596635|FG000|Overall Study|Physician Decision|7
7354064|NCT00972153|11596649|FG000|Overall Study|Equipment malfunction during case|0
7354065|NCT00972153|11596650|FG001|Overall Study|Equipment malfunction during case|1
7354066|NCT00972153|11596651|FG002|Overall Study|Equipment malfunction during case|0
7354067|NCT00972244|11596668|FG000|Overall Study|Incorrect Enrolment|1
7354068|NCT00972244|11596669|FG001|Overall Study|Incorrect Enrolment|0
7354069|NCT00972244|11596670|FG002|Overall Study|Incorrect Enrolment|0
7354070|NCT00972244|11596671|FG003|Overall Study|Incorrect Enrolment|0
7354071|NCT00972244|11596672|FG004|Overall Study|Incorrect Enrolment|0
7354072|NCT00972244|11596668|FG000|Overall Study|Adverse Event|0
7354073|NCT00972244|11596669|FG001|Overall Study|Adverse Event|1
7354074|NCT00972244|11596670|FG002|Overall Study|Adverse Event|1
7354075|NCT00972244|11596671|FG003|Overall Study|Adverse Event|0
7354076|NCT00972244|11596672|FG004|Overall Study|Adverse Event|0
7354077|NCT00972244|11596668|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
7354078|NCT00972244|11596669|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
7354079|NCT00972244|11596670|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
7354080|NCT00972244|11596671|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
7354081|NCT00972244|11596672|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
7354082|NCT00972244|11596668|FG000|Overall Study|Withdrawal by Subject|1
7354083|NCT00972244|11596669|FG001|Overall Study|Withdrawal by Subject|2
7354084|NCT00972244|11596670|FG002|Overall Study|Withdrawal by Subject|1
7354085|NCT00972244|11596671|FG003|Overall Study|Withdrawal by Subject|0
7354086|NCT00972244|11596672|FG004|Overall Study|Withdrawal by Subject|1
7533240|NCT02683525|11879459|FG000|Overall Study|Lost to Follow-up|1
7533241|NCT02683525|11879459|FG000|Overall Study|Physician Decision|1
7533242|NCT02683525|11879459|FG000|Overall Study|Disease Progression|6
7533243|NCT02683668|11879478|FG000|Period 2|Withdrawal by Subject|0
7533244|NCT02683668|11879479|FG001|Period 2|Withdrawal by Subject|1
7533245|NCT02683668|11879480|FG002|Period 2|Withdrawal by Subject|0
7533246|NCT02683746|11879497|FG000|Overall Study|Adverse Event|3
7354087|NCT00972244|11596668|FG000|Overall Study|Safety|0
7354088|NCT00972244|11596669|FG001|Overall Study|Safety|0
7354089|NCT00972244|11596670|FG002|Overall Study|Safety|0
7354090|NCT00972244|11596671|FG003|Overall Study|Safety|0
7354091|NCT00972244|11596672|FG004|Overall Study|Safety|1
7354092|NCT00972244|11596668|FG000|Overall Study|Death|1
7533247|NCT02683746|11879498|FG001|Overall Study|Adverse Event|2
7533248|NCT02683746|11879497|FG000|Overall Study|Lost to Follow-up|5
7533249|NCT02683746|11879498|FG001|Overall Study|Lost to Follow-up|6
7533250|NCT02683746|11879497|FG000|Overall Study|Withdrawal by Subject|6
7533251|NCT02683746|11879498|FG001|Overall Study|Withdrawal by Subject|5
7533252|NCT02683746|11879497|FG000|Overall Study|Physician Decision|2
7533253|NCT02683746|11879498|FG001|Overall Study|Physician Decision|1
7533254|NCT02683785|11879517|FG000|Overall Study|Withdrawal by Subject|1
7533255|NCT02683785|11879518|FG001|Overall Study|Withdrawal by Subject|1
7533256|NCT02683785|11879517|FG000|Overall Study|Lost to Follow-up|0
7533257|NCT02683785|11879518|FG001|Overall Study|Lost to Follow-up|1
7533258|NCT02683785|11879517|FG000|Overall Study|Adverse Event|0
7533259|NCT02683785|11879518|FG001|Overall Study|Adverse Event|2
7533260|NCT02683876|11879528|FG000|Overall Study|samples damaged during shipping|2
7533261|NCT02683876|11879529|FG001|Overall Study|samples damaged during shipping|0
7533262|NCT02683941|11879548|FG000|Double-blind Phase|Adverse Event|0
7533263|NCT02683941|11879549|FG001|Double-blind Phase|Adverse Event|1
7354093|NCT00972244|11596669|FG001|Overall Study|Death|0
7354094|NCT00972244|11596670|FG002|Overall Study|Death|0
7354095|NCT00972244|11596671|FG003|Overall Study|Death|0
7354096|NCT00972244|11596672|FG004|Overall Study|Death|0
7354097|NCT00972244|11596668|FG000|Overall Study|Various|0
7354098|NCT00972244|11596669|FG001|Overall Study|Various|0
7354099|NCT00972244|11596670|FG002|Overall Study|Various|0
7354100|NCT00972244|11596671|FG003|Overall Study|Various|0
7354101|NCT00972244|11596672|FG004|Overall Study|Various|2
7354102|NCT00972283|11596686|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
7354103|NCT00972283|11596687|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
7354104|NCT00972283|11596686|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
7354105|NCT00972283|11596687|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
7354106|NCT00972283|11596686|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
7354107|NCT00972283|11596687|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
7354108|NCT00972283|11596686|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
7354109|NCT00972283|11596687|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
7354110|NCT00972283|11596686|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
7459500|NCT01817790|11754128|FG001|Overall Study|Adverse Event|2
7459501|NCT01817790|11754127|FG000|Overall Study|Lost to Follow-up|0
7459502|NCT01817790|11754128|FG001|Overall Study|Lost to Follow-up|1
7459503|NCT01817790|11754127|FG000|Overall Study|Protocol Violation|2
7459504|NCT01817790|11754128|FG001|Overall Study|Protocol Violation|1
7459505|NCT01817790|11754127|FG000|Overall Study|Withdrawal by Subject|1
7459506|NCT01817790|11754128|FG001|Overall Study|Withdrawal by Subject|3
7459507|NCT01817790|11754127|FG000|Overall Study|Other: Could not attend appointment|1
7459508|NCT01817790|11754128|FG001|Overall Study|Other: Could not attend appointment|1
7459509|NCT01817959|11754170|FG000|Overall Study|Graft loss|1
7459510|NCT01817959|11754171|FG001|Overall Study|Graft loss|1
7459511|NCT01817959|11754170|FG000|Overall Study|forbidden medication|1
7459512|NCT01817959|11754171|FG001|Overall Study|forbidden medication|1
7459513|NCT01817959|11754170|FG000|Overall Study|Adverse Event|1
7459514|NCT01817959|11754171|FG001|Overall Study|Adverse Event|0
7459515|NCT01817959|11754170|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7459516|NCT01817959|11754171|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
7459517|NCT01818141|11754188|FG000|Overall Study|Withdrawal by Subject|2
7459518|NCT01818141|11754189|FG001|Overall Study|Withdrawal by Subject|0
7459519|NCT01818141|11754188|FG000|Overall Study|No baseline C.diff colonies|1
7459520|NCT01818141|11754189|FG001|Overall Study|No baseline C.diff colonies|1
7459521|NCT01818141|11754188|FG000|Overall Study|Lost to Follow-up|0
7459522|NCT01818141|11754189|FG001|Overall Study|Lost to Follow-up|2
7459523|NCT01818258|11754211|FG000|Overall Study|Death|3
7459524|NCT01818258|11754212|FG001|Overall Study|Death|0
7459525|NCT01818258|11754211|FG000|Overall Study|Withdrawal by Subject|0
7459526|NCT01818258|11754212|FG001|Overall Study|Withdrawal by Subject|1
7459527|NCT01818258|11754211|FG000|Overall Study|Lost to Follow-up|0
7459528|NCT01818258|11754212|FG001|Overall Study|Lost to Follow-up|1
7459529|NCT01818258|11754211|FG000|Overall Study|Unable to Travel to Clinic|0
7459530|NCT01818258|11754212|FG001|Overall Study|Unable to Travel to Clinic|1
7459531|NCT01818284|11754221|FG000|Overall Study|Not eligible due to White Blood Counts|4
7459532|NCT01818284|11754222|FG001|Overall Study|Not eligible due to White Blood Counts|4
7459533|NCT01818284|11754221|FG000|Overall Study|Death|0
7459534|NCT01818284|11754222|FG001|Overall Study|Death|2
7459535|NCT01818297|11754229|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
7459536|NCT01818297|11754230|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
7459537|NCT01818297|11754229|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
7459538|NCT01818297|11754230|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
7459539|NCT01818297|11754229|FG000|Open Label Phase (3-12 Months)|Early study closure|17
7459540|NCT01818297|11754230|FG001|Open Label Phase (3-12 Months)|Early study closure|10
7459541|NCT01818336|11754236|FG000|Overall Study|Declined retest visit|0
7533264|NCT02683941|11879548|FG000|Double-blind Phase|Withdrawal by Subject|4
7533265|NCT02683941|11879549|FG001|Double-blind Phase|Withdrawal by Subject|2
7459542|NCT01818336|11754237|FG001|Overall Study|Declined retest visit|11
7459543|NCT01818336|11754236|FG000|Overall Study|Lost to Follow-up|0
7459544|NCT01818336|11754237|FG001|Overall Study|Lost to Follow-up|1
7459545|NCT01818492|11754263|FG000|Overall Study|Adverse Event|2
7459546|NCT01818492|11754263|FG000|Overall Study|Death|3
7459547|NCT01818492|11754263|FG000|Overall Study|Withdrawal by Subject|1
7354111|NCT00972283|11596687|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
7354112|NCT00972283|11596686|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
7354113|NCT00972283|11596687|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
7354114|NCT00972283|11596686|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7354115|NCT00972283|11596687|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
7354116|NCT00972283|11596686|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
7354117|NCT00972283|11596687|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
7354118|NCT00972283|11596686|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
7354119|NCT00972283|11596687|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
7354120|NCT00972283|11596686|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
7354121|NCT00972283|11596687|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
7354122|NCT00972322|11596695|FG000|Overall Study|Adverse Event|2
7354123|NCT00972322|11596696|FG001|Overall Study|Adverse Event|1
7354124|NCT00972322|11596695|FG000|Overall Study|Positive drug screen|0
7354125|NCT00972322|11596696|FG001|Overall Study|Positive drug screen|1
7354126|NCT00972322|11596695|FG000|Overall Study|Lost to Follow-up|0
7354127|NCT00972322|11596696|FG001|Overall Study|Lost to Follow-up|1
7354128|NCT00972322|11596695|FG000|Overall Study|Consistently high glucose values|1
7354129|NCT00972322|11596696|FG001|Overall Study|Consistently high glucose values|0
7354130|NCT00972504|11596728|FG000|Overall Study|Adverse Event|2
7354131|NCT00972504|11596728|FG000|Overall Study|Investigator discretion|1
7354132|NCT00972517|11596738|FG000|Overall Study|Adverse Event|0
7354133|NCT00972517|11596739|FG001|Overall Study|Adverse Event|0
7354134|NCT00972517|11596740|FG002|Overall Study|Adverse Event|0
7354135|NCT00972517|11596741|FG003|Overall Study|Adverse Event|1
7354136|NCT00972517|11596742|FG004|Overall Study|Adverse Event|0
7354137|NCT00972517|11596743|FG005|Overall Study|Adverse Event|0
7354138|NCT00972517|11596738|FG000|Overall Study|Withdrawal by Subject|0
7354139|NCT00972517|11596739|FG001|Overall Study|Withdrawal by Subject|1
7354140|NCT00972517|11596740|FG002|Overall Study|Withdrawal by Subject|0
7354141|NCT00972517|11596741|FG003|Overall Study|Withdrawal by Subject|2
7354142|NCT00972517|11596742|FG004|Overall Study|Withdrawal by Subject|1
7354143|NCT00972517|11596743|FG005|Overall Study|Withdrawal by Subject|0
7354144|NCT00972543|11596774|FG000|Overall Study|Adverse Event|1
7354145|NCT00972543|11596775|FG001|Overall Study|Adverse Event|0
7354146|NCT00972543|11596774|FG000|Overall Study|Early study termination by sponsor|4
7354147|NCT00972543|11596775|FG001|Overall Study|Early study termination by sponsor|1
7354148|NCT00972595|11596781|FG000|Period 1|Adverse Event|1
7354149|NCT00972595|11596782|FG001|Period 1|Adverse Event|0
7354150|NCT00972777|11596808|FG000|Overall Study|Adverse Event|3
7354151|NCT00972777|11596809|FG001|Overall Study|Adverse Event|2
7354152|NCT00972777|11596808|FG000|Overall Study|Lost to Follow-up|0
7354153|NCT00972777|11596809|FG001|Overall Study|Lost to Follow-up|4
7354154|NCT00972777|11596808|FG000|Overall Study|Withdrawal by Subject|4
7354155|NCT00972777|11596809|FG001|Overall Study|Withdrawal by Subject|5
7354156|NCT00972777|11596808|FG000|Overall Study|Physician Decision|4
7354157|NCT00972777|11596809|FG001|Overall Study|Physician Decision|0
7354158|NCT00972777|11596808|FG000|Overall Study|Protocol Violation|0
7354159|NCT00972777|11596809|FG001|Overall Study|Protocol Violation|2
7354160|NCT00972777|11596808|FG000|Overall Study|Screening Failure|2
7354161|NCT00972777|11596809|FG001|Overall Study|Screening Failure|1
7354162|NCT00972777|11596808|FG000|Overall Study|Missed visit|1
7354163|NCT00972777|11596809|FG001|Overall Study|Missed visit|0
7354164|NCT00972816|11596823|FG000|Overall Study|Adverse Event|0
7354165|NCT00972816|11596824|FG001|Overall Study|Adverse Event|0
7354166|NCT00972816|11596825|FG002|Overall Study|Adverse Event|1
7354167|NCT00972816|11596826|FG003|Overall Study|Adverse Event|0
7354168|NCT00972816|11596827|FG004|Overall Study|Adverse Event|0
7354169|NCT00972816|11596828|FG005|Overall Study|Adverse Event|0
7354170|NCT00972816|11596829|FG006|Overall Study|Adverse Event|0
7354171|NCT00972816|11596830|FG007|Overall Study|Adverse Event|0
7354172|NCT00972816|11596823|FG000|Overall Study|Withdrawal by Subject|4
7354173|NCT00972816|11596824|FG001|Overall Study|Withdrawal by Subject|2
7354174|NCT00972816|11596825|FG002|Overall Study|Withdrawal by Subject|1
7354175|NCT00972816|11596826|FG003|Overall Study|Withdrawal by Subject|3
7354176|NCT00972816|11596827|FG004|Overall Study|Withdrawal by Subject|0
7354177|NCT00972816|11596828|FG005|Overall Study|Withdrawal by Subject|1
7354178|NCT00972816|11596829|FG006|Overall Study|Withdrawal by Subject|1
7354179|NCT00972816|11596830|FG007|Overall Study|Withdrawal by Subject|2
7354180|NCT00972816|11596823|FG000|Overall Study|Lost to Follow-up|11
7354181|NCT00972816|11596824|FG001|Overall Study|Lost to Follow-up|9
7354182|NCT00972816|11596825|FG002|Overall Study|Lost to Follow-up|7
7354183|NCT00972816|11596826|FG003|Overall Study|Lost to Follow-up|5
7354184|NCT00972816|11596827|FG004|Overall Study|Lost to Follow-up|11
7354185|NCT00972816|11596828|FG005|Overall Study|Lost to Follow-up|10
7354186|NCT00972816|11596829|FG006|Overall Study|Lost to Follow-up|7
7354187|NCT00972816|11596830|FG007|Overall Study|Lost to Follow-up|7
7354188|NCT00972816|11596823|FG000|Overall Study|Inappropriate enrolment|0
7354189|NCT00972816|11596824|FG001|Overall Study|Inappropriate enrolment|0
7354190|NCT00972816|11596825|FG002|Overall Study|Inappropriate enrolment|0
7354191|NCT00972816|11596826|FG003|Overall Study|Inappropriate enrolment|0
7354192|NCT00972816|11596827|FG004|Overall Study|Inappropriate enrolment|0
7354193|NCT00972816|11596828|FG005|Overall Study|Inappropriate enrolment|0
7354194|NCT00972816|11596829|FG006|Overall Study|Inappropriate enrolment|2
7354195|NCT00972816|11596830|FG007|Overall Study|Inappropriate enrolment|0
7354196|NCT00972816|11596823|FG000|Overall Study|Unable to classify|2
7354197|NCT00972816|11596824|FG001|Overall Study|Unable to classify|0
7354198|NCT00972816|11596825|FG002|Overall Study|Unable to classify|0
7354199|NCT00972816|11596826|FG003|Overall Study|Unable to classify|0
7354200|NCT00972816|11596827|FG004|Overall Study|Unable to classify|1
7354201|NCT00972816|11596828|FG005|Overall Study|Unable to classify|0
7354202|NCT00972816|11596829|FG006|Overall Study|Unable to classify|0
7354203|NCT00972816|11596830|FG007|Overall Study|Unable to classify|0
7354204|NCT00973102|11596854|FG000|Overall Study|Protocol Violation|1
7354205|NCT00973102|11596855|FG001|Overall Study|Protocol Violation|0
7354206|NCT00973102|11596854|FG000|Overall Study|Prisoner|0
7354207|NCT00973102|11596855|FG001|Overall Study|Prisoner|1
7354208|NCT00973349|11596877|FG000|Overall Study|Adverse Event|0
7354209|NCT00973349|11596878|FG001|Overall Study|Adverse Event|0
7354210|NCT00973349|11596879|FG002|Overall Study|Adverse Event|0
7354211|NCT00973349|11596880|FG003|Overall Study|Adverse Event|0
7354212|NCT00973349|11596881|FG004|Overall Study|Adverse Event|1
7354213|NCT00973349|11596882|FG005|Overall Study|Adverse Event|0
7354214|NCT00973349|11596883|FG006|Overall Study|Adverse Event|0
7354215|NCT00973349|11596884|FG007|Overall Study|Adverse Event|0
7354216|NCT00973349|11596885|FG008|Overall Study|Adverse Event|1
7354217|NCT00973349|11596886|FG009|Overall Study|Adverse Event|0
7354218|NCT00973349|11596887|FG010|Overall Study|Adverse Event|0
7354219|NCT00973349|11596888|FG011|Overall Study|Adverse Event|0
7354220|NCT00973349|11596889|FG012|Overall Study|Adverse Event|0
7354221|NCT00973349|11596890|FG013|Overall Study|Adverse Event|0
7354222|NCT00973349|11596891|FG014|Overall Study|Adverse Event|1
7354223|NCT00973349|11596892|FG015|Overall Study|Adverse Event|0
7354224|NCT00973349|11596877|FG000|Overall Study|Withdrawal by Subject|1
7354225|NCT00973349|11596878|FG001|Overall Study|Withdrawal by Subject|2
7354226|NCT00973349|11596879|FG002|Overall Study|Withdrawal by Subject|2
7354227|NCT00973349|11596880|FG003|Overall Study|Withdrawal by Subject|3
7354228|NCT00973349|11596881|FG004|Overall Study|Withdrawal by Subject|2
7354229|NCT00973349|11596882|FG005|Overall Study|Withdrawal by Subject|0
7354230|NCT00973349|11596883|FG006|Overall Study|Withdrawal by Subject|2
7354231|NCT00973349|11596884|FG007|Overall Study|Withdrawal by Subject|2
7354232|NCT00973349|11596885|FG008|Overall Study|Withdrawal by Subject|0
7354233|NCT00973349|11596886|FG009|Overall Study|Withdrawal by Subject|2
7354234|NCT00973349|11596887|FG010|Overall Study|Withdrawal by Subject|0
7354235|NCT00973349|11596888|FG011|Overall Study|Withdrawal by Subject|1
7354236|NCT00973349|11596889|FG012|Overall Study|Withdrawal by Subject|0
7354237|NCT00973349|11596890|FG013|Overall Study|Withdrawal by Subject|0
7354238|NCT00973349|11596891|FG014|Overall Study|Withdrawal by Subject|0
7354239|NCT00973349|11596892|FG015|Overall Study|Withdrawal by Subject|0
7354240|NCT00973349|11596877|FG000|Overall Study|Lost to Follow-up|3
7354241|NCT00973349|11596878|FG001|Overall Study|Lost to Follow-up|1
7354242|NCT00973349|11596879|FG002|Overall Study|Lost to Follow-up|2
7354243|NCT00973349|11596880|FG003|Overall Study|Lost to Follow-up|2
7354244|NCT00973349|11596881|FG004|Overall Study|Lost to Follow-up|1
7354245|NCT00973349|11596882|FG005|Overall Study|Lost to Follow-up|3
7354246|NCT00973349|11596883|FG006|Overall Study|Lost to Follow-up|0
7354247|NCT00973349|11596884|FG007|Overall Study|Lost to Follow-up|1
7354248|NCT00973349|11596885|FG008|Overall Study|Lost to Follow-up|2
7354249|NCT00973349|11596886|FG009|Overall Study|Lost to Follow-up|1
7354250|NCT00973349|11596887|FG010|Overall Study|Lost to Follow-up|0
7354251|NCT00973349|11596888|FG011|Overall Study|Lost to Follow-up|1
7354252|NCT00973349|11596889|FG012|Overall Study|Lost to Follow-up|0
7354253|NCT00973349|11596890|FG013|Overall Study|Lost to Follow-up|0
7354254|NCT00973349|11596891|FG014|Overall Study|Lost to Follow-up|0
7354255|NCT00973349|11596892|FG015|Overall Study|Lost to Follow-up|1
7354256|NCT00973349|11596877|FG000|Overall Study|Inappropriate enrolment|0
7354257|NCT00973349|11596878|FG001|Overall Study|Inappropriate enrolment|0
7354258|NCT00973349|11596879|FG002|Overall Study|Inappropriate enrolment|1
7354259|NCT00973349|11596880|FG003|Overall Study|Inappropriate enrolment|0
7354260|NCT00973349|11596881|FG004|Overall Study|Inappropriate enrolment|0
7354261|NCT00973349|11596882|FG005|Overall Study|Inappropriate enrolment|0
7354262|NCT00973349|11596883|FG006|Overall Study|Inappropriate enrolment|0
7354263|NCT00973349|11596884|FG007|Overall Study|Inappropriate enrolment|0
7354264|NCT00973349|11596885|FG008|Overall Study|Inappropriate enrolment|0
7354265|NCT00973349|11596886|FG009|Overall Study|Inappropriate enrolment|2
7354266|NCT00973349|11596887|FG010|Overall Study|Inappropriate enrolment|0
7354267|NCT00973349|11596888|FG011|Overall Study|Inappropriate enrolment|0
7354268|NCT00973349|11596889|FG012|Overall Study|Inappropriate enrolment|1
7354269|NCT00973349|11596890|FG013|Overall Study|Inappropriate enrolment|0
7354270|NCT00973349|11596891|FG014|Overall Study|Inappropriate enrolment|1
7354271|NCT00973349|11596892|FG015|Overall Study|Inappropriate enrolment|1
7354272|NCT00973349|11596877|FG000|Overall Study|Protocol Violation|0
7354273|NCT00973349|11596878|FG001|Overall Study|Protocol Violation|0
7354274|NCT00973349|11596879|FG002|Overall Study|Protocol Violation|0
7354275|NCT00973349|11596880|FG003|Overall Study|Protocol Violation|0
7354276|NCT00973349|11596881|FG004|Overall Study|Protocol Violation|0
7354277|NCT00973349|11596882|FG005|Overall Study|Protocol Violation|0
7354278|NCT00973349|11596883|FG006|Overall Study|Protocol Violation|0
7354279|NCT00973349|11596884|FG007|Overall Study|Protocol Violation|0
7354280|NCT00973349|11596885|FG008|Overall Study|Protocol Violation|1
7354281|NCT00973349|11596886|FG009|Overall Study|Protocol Violation|0
7354282|NCT00973349|11596887|FG010|Overall Study|Protocol Violation|0
7354283|NCT00973349|11596888|FG011|Overall Study|Protocol Violation|0
7354284|NCT00973349|11596889|FG012|Overall Study|Protocol Violation|0
7354285|NCT00973349|11596890|FG013|Overall Study|Protocol Violation|0
7354286|NCT00973349|11596891|FG014|Overall Study|Protocol Violation|0
7354287|NCT00973349|11596892|FG015|Overall Study|Protocol Violation|0
7354288|NCT00973349|11596877|FG000|Overall Study|Unable to classify|0
7354289|NCT00973349|11596878|FG001|Overall Study|Unable to classify|0
7354290|NCT00973349|11596879|FG002|Overall Study|Unable to classify|0
7354291|NCT00973349|11596880|FG003|Overall Study|Unable to classify|0
7354292|NCT00973349|11596881|FG004|Overall Study|Unable to classify|1
7354293|NCT00973349|11596882|FG005|Overall Study|Unable to classify|1
7354294|NCT00973349|11596883|FG006|Overall Study|Unable to classify|0
7354295|NCT00973349|11596884|FG007|Overall Study|Unable to classify|0
7354296|NCT00973349|11596885|FG008|Overall Study|Unable to classify|0
7354297|NCT00973349|11596886|FG009|Overall Study|Unable to classify|1
7354298|NCT00973349|11596887|FG010|Overall Study|Unable to classify|0
7354299|NCT00973349|11596888|FG011|Overall Study|Unable to classify|0
7354300|NCT00973349|11596889|FG012|Overall Study|Unable to classify|0
7354301|NCT00973349|11596890|FG013|Overall Study|Unable to classify|0
7354302|NCT00973349|11596891|FG014|Overall Study|Unable to classify|0
7354303|NCT00973349|11596892|FG015|Overall Study|Unable to classify|0
7354304|NCT00973362|11596920|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
7354305|NCT00973362|11596921|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
7354306|NCT00973362|11596920|FG000|Baseline Evaluation|No colposcopy visit|62
7354307|NCT00973362|11596921|FG001|Baseline Evaluation|No colposcopy visit|0
7354308|NCT00973362|11596920|FG000|Baseline Evaluation|Inevaluable|686
7354309|NCT00973362|11596921|FG001|Baseline Evaluation|Inevaluable|223
7354310|NCT00973362|11596920|FG000|3-Year Follow-up|Lost to Follow-up|17
7354311|NCT00973362|11596921|FG001|3-Year Follow-up|Lost to Follow-up|0
7354312|NCT00973479|11596932|FG000|Overall Study|Lost to Follow-up|0
7354313|NCT00973479|11596933|FG001|Overall Study|Lost to Follow-up|3
7354314|NCT00973479|11596932|FG000|Overall Study|Death|2
7354315|NCT00973479|11596933|FG001|Overall Study|Death|2
7354316|NCT00973479|11596932|FG000|Overall Study|Withdrawal by Subject|15
7354317|NCT00973479|11596933|FG001|Overall Study|Withdrawal by Subject|16
7354318|NCT00973479|11596932|FG000|Overall Study|Lack of Efficacy|5
7354319|NCT00973479|11596933|FG001|Overall Study|Lack of Efficacy|7
7354320|NCT00973479|11596932|FG000|Overall Study|Adverse Event|12
7354321|NCT00973479|11596933|FG001|Overall Study|Adverse Event|32
7354322|NCT00973479|11596932|FG000|Overall Study|Protocol Violation|2
7354323|NCT00973479|11596933|FG001|Overall Study|Protocol Violation|2
7354324|NCT00973479|11596932|FG000|Overall Study|Other|1
7354325|NCT00973479|11596933|FG001|Overall Study|Other|7
7354326|NCT00973622|11596943|FG000|Overall Study|did not attend MRI|14
7354327|NCT00973622|11596944|FG001|Overall Study|did not attend MRI|3
7354328|NCT00973622|11596943|FG000|Overall Study|did not pass MRI screen|6
7354329|NCT00973622|11596944|FG001|Overall Study|did not pass MRI screen|0
7354330|NCT00973622|11596943|FG000|Overall Study|did not complete rTMS sessions|11
7354331|NCT00973622|11596944|FG001|Overall Study|did not complete rTMS sessions|2
7354332|NCT00973674|11596952|FG000|Overall Study|Protocol Violation|2
7354333|NCT00973674|11596953|FG001|Overall Study|Protocol Violation|0
7354334|NCT00973700|11596965|FG000|Overall Study|Withdrawal by Subject|2
7354335|NCT00973700|11596966|FG001|Overall Study|Withdrawal by Subject|2
7354336|NCT00973700|11596967|FG002|Overall Study|Withdrawal by Subject|8
7354337|NCT00973700|11596968|FG003|Overall Study|Withdrawal by Subject|4
7354338|NCT00973700|11596969|FG004|Overall Study|Withdrawal by Subject|4
7354339|NCT00973700|11596965|FG000|Overall Study|Lost to Follow-up|5
7354340|NCT00973700|11596966|FG001|Overall Study|Lost to Follow-up|0
7354341|NCT00973700|11596967|FG002|Overall Study|Lost to Follow-up|1
7354342|NCT00973700|11596968|FG003|Overall Study|Lost to Follow-up|8
7354343|NCT00973700|11596969|FG004|Overall Study|Lost to Follow-up|5
7354344|NCT00973700|11596965|FG000|Overall Study|Inappropriate enrolment|0
7354345|NCT00973700|11596966|FG001|Overall Study|Inappropriate enrolment|0
7354346|NCT00973700|11596967|FG002|Overall Study|Inappropriate enrolment|0
7354347|NCT00973700|11596968|FG003|Overall Study|Inappropriate enrolment|4
7354348|NCT00973700|11596969|FG004|Overall Study|Inappropriate enrolment|0
7354349|NCT00973700|11596965|FG000|Overall Study|Unable to Classify|0
7354350|NCT00973700|11596966|FG001|Overall Study|Unable to Classify|0
7354351|NCT00973700|11596967|FG002|Overall Study|Unable to Classify|1
7354352|NCT00973700|11596968|FG003|Overall Study|Unable to Classify|2
7354353|NCT00973700|11596969|FG004|Overall Study|Unable to Classify|1
7354354|NCT00973765|11597006|FG000|Overall Study|Lost to Follow-up|8
7354355|NCT00973765|11597007|FG001|Overall Study|Lost to Follow-up|14
7354356|NCT00973921|11597013|FG000|Overall Study|IVUS results were not available|9
7354357|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
7354358|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
7354359|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
7354360|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
7354361|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
7354362|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
7354363|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
7354364|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
7354365|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7354366|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
7354367|NCT00973973|11597019|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7354368|NCT00973973|11597020|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
7354369|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
7354370|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
7354371|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
7354372|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
7354373|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
7354374|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
7354375|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
7354376|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
7354377|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
7354378|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
7354379|NCT00973973|11597019|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
7354380|NCT00973973|11597020|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
7354381|NCT00974090|11597039|FG000|Period 1: Double Blind Period|Adverse Event|2
7354382|NCT00974090|11597040|FG001|Period 1: Double Blind Period|Adverse Event|1
7354383|NCT00974090|11597039|FG000|Period 1: Double Blind Period|Physician Decision|1
7354384|NCT00974090|11597040|FG001|Period 1: Double Blind Period|Physician Decision|0
7354385|NCT00974090|11597039|FG000|Period 2: Open-label Period|Adverse Event|4
7354386|NCT00974090|11597040|FG001|Period 2: Open-label Period|Adverse Event|6
7354387|NCT00974090|11597039|FG000|Period 2: Open-label Period|Lack of Efficacy|3
7354388|NCT00974090|11597040|FG001|Period 2: Open-label Period|Lack of Efficacy|1
7354389|NCT00974090|11597039|FG000|Period 2: Open-label Period|Physician Decision|0
7354390|NCT00974090|11597040|FG001|Period 2: Open-label Period|Physician Decision|3
7354391|NCT00974090|11597039|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
7354392|NCT00974090|11597040|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
7354393|NCT00974220|11597059|FG000|Treatment Period 1|Adverse Event|2
7354394|NCT00974220|11597060|FG001|Treatment Period 1|Adverse Event|1
7354395|NCT00974220|11597059|FG000|Treatment Period 1|noncompliant subjects|0
7354396|NCT00974220|11597060|FG001|Treatment Period 1|noncompliant subjects|1
7386062|NCT01207440|11644237|FG000|Overall Study|Protocol Violation|2
7386063|NCT01207440|11644238|FG001|Overall Study|Protocol Violation|0
7386064|NCT01207440|11644239|FG002|Overall Study|Protocol Violation|0
7386065|NCT01207440|11644240|FG003|Overall Study|Protocol Violation|0
7386066|NCT01207440|11644241|FG004|Overall Study|Protocol Violation|0
7386067|NCT01207440|11644242|FG005|Overall Study|Protocol Violation|0
7386068|NCT01207440|11644243|FG006|Overall Study|Protocol Violation|0
7386069|NCT01207440|11644237|FG000|Overall Study|Site Terminated by Sponsor|69
7386070|NCT01207440|11644238|FG001|Overall Study|Site Terminated by Sponsor|19
7386071|NCT01207440|11644239|FG002|Overall Study|Site Terminated by Sponsor|12
7386072|NCT01207440|11644240|FG003|Overall Study|Site Terminated by Sponsor|2
7386073|NCT01207440|11644241|FG004|Overall Study|Site Terminated by Sponsor|3
7386074|NCT01207440|11644242|FG005|Overall Study|Site Terminated by Sponsor|0
7386075|NCT01207440|11644243|FG006|Overall Study|Site Terminated by Sponsor|2
7386076|NCT01207440|11644237|FG000|Overall Study|Withdrawal by Subject|29
7386077|NCT01207440|11644238|FG001|Overall Study|Withdrawal by Subject|4
7386078|NCT01207440|11644239|FG002|Overall Study|Withdrawal by Subject|5
7386079|NCT01207440|11644240|FG003|Overall Study|Withdrawal by Subject|3
7386080|NCT01207440|11644241|FG004|Overall Study|Withdrawal by Subject|2
7386081|NCT01207440|11644242|FG005|Overall Study|Withdrawal by Subject|2
7386082|NCT01207440|11644243|FG006|Overall Study|Withdrawal by Subject|0
7386083|NCT01207440|11644237|FG000|Overall Study|Reason Not Specified|10
7386084|NCT01207440|11644238|FG001|Overall Study|Reason Not Specified|10
7386085|NCT01207440|11644239|FG002|Overall Study|Reason Not Specified|7
7386086|NCT01207440|11644240|FG003|Overall Study|Reason Not Specified|0
7386087|NCT01207440|11644241|FG004|Overall Study|Reason Not Specified|4
7386088|NCT01207440|11644242|FG005|Overall Study|Reason Not Specified|3
7386089|NCT01207440|11644243|FG006|Overall Study|Reason Not Specified|0
7386090|NCT01207453|11644267|FG000|First Intervention|Adverse Event|2
7386091|NCT01207453|11644268|FG001|First Intervention|Adverse Event|1
7386092|NCT01207453|11644267|FG000|Washout|Adverse Event|1
7386093|NCT01207453|11644268|FG001|Washout|Adverse Event|0
7386094|NCT01207453|11644267|FG000|Washout|Lost to Follow-up|1
7386095|NCT01207453|11644268|FG001|Washout|Lost to Follow-up|0
7386096|NCT01207453|11644267|FG000|2nd Intervention|Adverse Event|1
7386097|NCT01207453|11644268|FG001|2nd Intervention|Adverse Event|2
7386098|NCT01207453|11644267|FG000|2nd Intervention|Lost to Follow-up|1
7386099|NCT01207453|11644268|FG001|2nd Intervention|Lost to Follow-up|0
7386100|NCT01207583|11644298|FG000|Overall Study|Withdrawal by Subject|0
7386101|NCT01207583|11644299|FG001|Overall Study|Withdrawal by Subject|3
7386102|NCT01207583|11644300|FG002|Overall Study|Withdrawal by Subject|1
7386103|NCT01207583|11644298|FG000|Overall Study|Participant failed to return|1
7354397|NCT00974233|11597066|FG000|Induction Chemoimmunotherapy|Death|2
7354398|NCT00974233|11597066|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
7569476|NCT03449446|11945893|FG003|Overall Study|Withdrew Consent|4
7569477|NCT03449446|11945894|FG004|Overall Study|Withdrew Consent|4
7569478|NCT03449446|11945895|FG005|Overall Study|Withdrew Consent|4
7569479|NCT03449446|11945896|FG006|Overall Study|Withdrew Consent|1
7569480|NCT03449446|11945890|FG000|Overall Study|Adverse Event|1
7569481|NCT03449446|11945891|FG001|Overall Study|Adverse Event|2
7569482|NCT03449446|11945892|FG002|Overall Study|Adverse Event|1
7354399|NCT00974233|11597066|FG000|Induction Chemoimmunotherapy|Adverse Event|7
7354400|NCT00974233|11597066|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
7354401|NCT00974233|11597066|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
7354402|NCT00974233|11597066|FG000|Maintenance Lenalidomide|Adverse Event|8
7354403|NCT00974259|11597085|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
7354404|NCT00974259|11597086|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
7354405|NCT00974311|11597094|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
7354406|NCT00974311|11597095|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
7354407|NCT00974311|11597094|FG000|DB Phase (up to 24 Months)|Death|561
7354408|NCT00974311|11597095|FG001|DB Phase (up to 24 Months)|Death|298
7354409|NCT00974311|11597094|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
7354410|NCT00974311|11597095|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
7354411|NCT00974311|11597094|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
7354412|NCT00974311|11597095|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
7354413|NCT00974311|11597094|FG000|DB Phase (up to 24 Months)|Other|1
7354414|NCT00974311|11597095|FG001|DB Phase (up to 24 Months)|Other|0
7354415|NCT00974311|11597094|FG000|OLE Phase (up to 77 Months)|Death|14
7354416|NCT00974311|11597095|FG001|OLE Phase (up to 77 Months)|Death|21
7354417|NCT00974311|11597094|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
7354418|NCT00974311|11597095|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
7354419|NCT00974311|11597094|FG000|OLE Phase (up to 77 Months)|Other|15
7354420|NCT00974311|11597095|FG001|OLE Phase (up to 77 Months)|Other|2
7354421|NCT00974311|11597094|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
7354422|NCT00974311|11597095|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
7354423|NCT00974675|11597168|FG000|Overall Study|Adverse Event|2
7354424|NCT00974675|11597169|FG001|Overall Study|Adverse Event|1
7354425|NCT00974675|11597170|FG002|Overall Study|Adverse Event|1
7354426|NCT00974675|11597171|FG003|Overall Study|Adverse Event|1
7354427|NCT00974675|11597168|FG000|Overall Study|Physician Decision|0
7354428|NCT00974675|11597169|FG001|Overall Study|Physician Decision|0
7354429|NCT00974675|11597170|FG002|Overall Study|Physician Decision|1
7354430|NCT00974675|11597171|FG003|Overall Study|Physician Decision|0
7354431|NCT00974675|11597168|FG000|Overall Study|Participant on holiday; unable to attend|0
7354432|NCT00974675|11597169|FG001|Overall Study|Participant on holiday; unable to attend|0
7354433|NCT00974675|11597170|FG002|Overall Study|Participant on holiday; unable to attend|0
7354434|NCT00974675|11597171|FG003|Overall Study|Participant on holiday; unable to attend|1
7354435|NCT00974974|11597192|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
7354436|NCT00974974|11597193|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
7354437|NCT00974974|11597192|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
7354438|NCT00974974|11597193|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
7354439|NCT00974974|11597192|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
7354440|NCT00974974|11597193|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
7354441|NCT00974974|11597192|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
7354442|NCT00974974|11597193|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
7354443|NCT00974974|11597192|FG000|IR CD-LD Dose Adjustment|Various|0
7354444|NCT00974974|11597193|FG001|IR CD-LD Dose Adjustment|Various|9
7354445|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Adverse Event|23
7354446|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Adverse Event|0
7354447|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Death|2
7354448|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Death|0
7354449|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
7354450|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
7354451|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
7354452|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
7354453|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Various|3
7354454|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Various|0
7354455|NCT00974974|11597192|FG000|IPX066 Dose Conversion|Protocol Violation|4
7354456|NCT00974974|11597193|FG001|IPX066 Dose Conversion|Protocol Violation|0
7354457|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
7354458|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
7354459|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
7354460|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
7354461|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
7354462|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
7354463|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7354464|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
7354465|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
7354466|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
7569483|NCT03449446|11945893|FG003|Overall Study|Adverse Event|0
7354467|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
7354468|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
7354469|NCT00974974|11597192|FG000|Maintenance - Double Blind Treatment|Various|4
7354470|NCT00974974|11597193|FG001|Maintenance - Double Blind Treatment|Various|0
7354471|NCT00975000|11597201|FG000|Overall Study|Other|1
7354472|NCT00975000|11597202|FG001|Overall Study|Other|0
7354473|NCT00975000|11597201|FG000|Overall Study|Adverse Event|1
7354474|NCT00975000|11597202|FG001|Overall Study|Adverse Event|1
7354475|NCT00975000|11597201|FG000|Overall Study|Withdrawal by Subject|2
7354476|NCT00975000|11597202|FG001|Overall Study|Withdrawal by Subject|2
7354477|NCT00975000|11597201|FG000|Overall Study|Lost to Follow-up|0
7354478|NCT00975000|11597202|FG001|Overall Study|Lost to Follow-up|1
7354479|NCT00975000|11597201|FG000|Overall Study|Protocol-specified Criteria|1
7354480|NCT00975000|11597202|FG001|Overall Study|Protocol-specified Criteria|0
7354481|NCT00975000|11597201|FG000|Overall Study|Non-compliance|0
7354482|NCT00975000|11597202|FG001|Overall Study|Non-compliance|1
7354483|NCT00975130|11597208|FG000|Study Part 1|Adverse Event|150
7354484|NCT00975130|11597209|FG001|Study Part 1|Adverse Event|0
7354485|NCT00975130|11597210|FG002|Study Part 1|Adverse Event|0
7354486|NCT00975130|11597208|FG000|Study Part 1|Lost to Follow-up|19
7354487|NCT00975130|11597209|FG001|Study Part 1|Lost to Follow-up|0
7354488|NCT00975130|11597210|FG002|Study Part 1|Lost to Follow-up|0
7354489|NCT00975130|11597208|FG000|Study Part 1|Withdrawal by Subject|61
7354490|NCT00975130|11597209|FG001|Study Part 1|Withdrawal by Subject|0
7354491|NCT00975130|11597210|FG002|Study Part 1|Withdrawal by Subject|0
7354492|NCT00975130|11597208|FG000|Study Part 1|Protocol Violation|13
7354493|NCT00975130|11597209|FG001|Study Part 1|Protocol Violation|0
7354494|NCT00975130|11597210|FG002|Study Part 1|Protocol Violation|0
7354495|NCT00975130|11597208|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
7354496|NCT00975130|11597209|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
7354497|NCT00975130|11597210|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
7354498|NCT00975130|11597208|FG000|Study Part 1|Administrative|4
7354499|NCT00975130|11597209|FG001|Study Part 1|Administrative|0
7354500|NCT00975130|11597210|FG002|Study Part 1|Administrative|0
7354501|NCT00975130|11597208|FG000|Study Part 1|Withdrew Consent|24
7354502|NCT00975130|11597209|FG001|Study Part 1|Withdrew Consent|0
7354503|NCT00975130|11597210|FG002|Study Part 1|Withdrew Consent|0
7354504|NCT00975130|11597208|FG000|Study Part 2|Adverse Event|0
7354505|NCT00975130|11597209|FG001|Study Part 2|Adverse Event|14
7354506|NCT00975130|11597210|FG002|Study Part 2|Adverse Event|7
7354507|NCT00975130|11597208|FG000|Study Part 2|Lost to Follow-up|0
7354508|NCT00975130|11597209|FG001|Study Part 2|Lost to Follow-up|0
7354509|NCT00975130|11597210|FG002|Study Part 2|Lost to Follow-up|1
7354510|NCT00975130|11597208|FG000|Study Part 2|Withdrawal by Subject|0
7354511|NCT00975130|11597209|FG001|Study Part 2|Withdrawal by Subject|13
7354512|NCT00975130|11597210|FG002|Study Part 2|Withdrawal by Subject|5
7354513|NCT00975130|11597208|FG000|Study Part 2|Withdrew Consent|0
7354514|NCT00975130|11597209|FG001|Study Part 2|Withdrew Consent|6
7354515|NCT00975130|11597210|FG002|Study Part 2|Withdrew Consent|2
7354516|NCT00975130|11597208|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
7354517|NCT00975130|11597209|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
7354518|NCT00975130|11597210|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
7354519|NCT00975130|11597208|FG000|Study Part 2|Administrative|0
7354520|NCT00975130|11597209|FG001|Study Part 2|Administrative|1
7354521|NCT00975130|11597210|FG002|Study Part 2|Administrative|0
7354522|NCT00975130|11597208|FG000|Study Part 2|Protocol Violation|0
7354523|NCT00975130|11597209|FG001|Study Part 2|Protocol Violation|0
7354524|NCT00975130|11597210|FG002|Study Part 2|Protocol Violation|1
7354525|NCT00975143|11597225|FG000|Overall Study|Adverse Event|19
7354526|NCT00975143|11597226|FG001|Overall Study|Adverse Event|15
7354527|NCT00975143|11597225|FG000|Overall Study|Withdrawal by Subject|15
7354528|NCT00975143|11597226|FG001|Overall Study|Withdrawal by Subject|15
7354529|NCT00975143|11597225|FG000|Overall Study|Lost to Follow-up|20
7354530|NCT00975143|11597226|FG001|Overall Study|Lost to Follow-up|16
7354531|NCT00975143|11597225|FG000|Overall Study|Non-compliance|5
7354532|NCT00975143|11597226|FG001|Overall Study|Non-compliance|8
7354533|NCT00975143|11597225|FG000|Overall Study|Physician Decision|1
7354534|NCT00975143|11597226|FG001|Overall Study|Physician Decision|2
7354535|NCT00975143|11597225|FG000|Overall Study|Details not available|10
7354536|NCT00975143|11597226|FG001|Overall Study|Details not available|4
7354537|NCT00975156|11597234|FG000|Overall Study|Protocol Violation|0
7354538|NCT00975156|11597235|FG001|Overall Study|Protocol Violation|1
7354539|NCT00975195|11597247|FG000|Overall Study|Adverse Event|108
7354540|NCT00975195|11597248|FG001|Overall Study|Adverse Event|101
7354541|NCT00975195|11597247|FG000|Overall Study|Lack of Efficacy|6
7354542|NCT00975195|11597248|FG001|Overall Study|Lack of Efficacy|6
7354543|NCT00975195|11597247|FG000|Overall Study|Protocol Violation|27
7354544|NCT00975195|11597248|FG001|Overall Study|Protocol Violation|23
7354545|NCT00975195|11597247|FG000|Overall Study|Lost to Follow-up|9
7354546|NCT00975195|11597248|FG001|Overall Study|Lost to Follow-up|7
7354547|NCT00975195|11597247|FG000|Overall Study|Withdrawal by Subject|48
7354548|NCT00975195|11597248|FG001|Overall Study|Withdrawal by Subject|61
7354549|NCT00975195|11597247|FG000|Overall Study|Other reason not defined above|29
7354550|NCT00975195|11597248|FG001|Overall Study|Other reason not defined above|33
7354551|NCT00975195|11597247|FG000|Overall Study|Not treated|1
7354552|NCT00975195|11597248|FG001|Overall Study|Not treated|2
7354553|NCT00975221|11597256|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
7354554|NCT00975221|11597257|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
7354555|NCT00975221|11597256|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
7354556|NCT00975221|11597257|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
7354557|NCT00975221|11597256|FG000|Titration Phase (Weeks 1-12)|Other|0
7354558|NCT00975221|11597257|FG001|Titration Phase (Weeks 1-12)|Other|1
7354559|NCT00975221|11597256|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
7354560|NCT00975221|11597257|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
7354561|NCT00975221|11597256|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7354562|NCT00975221|11597257|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
7354563|NCT00975221|11597256|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
7354564|NCT00975221|11597257|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
7354565|NCT00975286|11597267|FG000|Overall Study|Adverse Event|9
7354566|NCT00975286|11597268|FG001|Overall Study|Adverse Event|19
7354567|NCT00975286|11597267|FG000|Overall Study|Protocol Violation|1
7354568|NCT00975286|11597268|FG001|Overall Study|Protocol Violation|2
7354569|NCT00975286|11597267|FG000|Overall Study|Withdrawal by Subject|0
7354570|NCT00975286|11597268|FG001|Overall Study|Withdrawal by Subject|2
7354571|NCT00975286|11597267|FG000|Overall Study|Familial and Personal Reasons|2
7354572|NCT00975286|11597268|FG001|Overall Study|Familial and Personal Reasons|2
7354573|NCT00975286|11597267|FG000|Overall Study|Poor Compliance to Protocol|0
7354574|NCT00975286|11597268|FG001|Overall Study|Poor Compliance to Protocol|2
7354575|NCT00975286|11597267|FG000|Overall Study|Sponsor Decision|0
7354576|NCT00975286|11597268|FG001|Overall Study|Sponsor Decision|2
7354577|NCT00975416|11597276|FG000|Overall Study|early discharge from tx|3
7354578|NCT00975416|11597277|FG001|Overall Study|early discharge from tx|5
7354579|NCT00975481|11597284|FG000|Second Intervention Period|Adverse Event|2
7354580|NCT00975481|11597285|FG001|Second Intervention Period|Adverse Event|1
7354581|NCT00975481|11597286|FG002|Second Intervention Period|Adverse Event|0
7354582|NCT00975481|11597287|FG003|Second Intervention Period|Adverse Event|0
7354583|NCT00975481|11597288|FG004|Second Intervention Period|Adverse Event|0
7354584|NCT00975481|11597289|FG005|Second Intervention Period|Adverse Event|0
7354585|NCT00975481|11597284|FG000|Second Intervention Period|Withdrawal by Subject|0
7354586|NCT00975481|11597285|FG001|Second Intervention Period|Withdrawal by Subject|0
7354587|NCT00975481|11597286|FG002|Second Intervention Period|Withdrawal by Subject|1
7354588|NCT00975481|11597287|FG003|Second Intervention Period|Withdrawal by Subject|0
7354589|NCT00975481|11597288|FG004|Second Intervention Period|Withdrawal by Subject|0
7354590|NCT00975481|11597289|FG005|Second Intervention Period|Withdrawal by Subject|0
7354591|NCT00975481|11597284|FG000|Fourth Intervention Period|Withdrawal by Subject|0
7354592|NCT00975481|11597285|FG001|Fourth Intervention Period|Withdrawal by Subject|0
7354593|NCT00975481|11597286|FG002|Fourth Intervention Period|Withdrawal by Subject|1
7354594|NCT00975481|11597287|FG003|Fourth Intervention Period|Withdrawal by Subject|1
7354595|NCT00975481|11597288|FG004|Fourth Intervention Period|Withdrawal by Subject|0
7354596|NCT00975481|11597289|FG005|Fourth Intervention Period|Withdrawal by Subject|0
7354597|NCT00975481|11597284|FG000|Fifth Intervention Period|Withdrawal by Subject|0
7354598|NCT00975481|11597285|FG001|Fifth Intervention Period|Withdrawal by Subject|0
7354599|NCT00975481|11597286|FG002|Fifth Intervention Period|Withdrawal by Subject|0
7354600|NCT00975481|11597287|FG003|Fifth Intervention Period|Withdrawal by Subject|0
7354601|NCT00975481|11597288|FG004|Fifth Intervention Period|Withdrawal by Subject|1
7354602|NCT00975481|11597289|FG005|Fifth Intervention Period|Withdrawal by Subject|0
7354603|NCT00975507|11597309|FG000|Overall Study|Adverse Event|1
7354604|NCT00975507|11597310|FG001|Overall Study|Adverse Event|0
7354605|NCT00975507|11597309|FG000|Overall Study|Lost to Follow-up|7
7354606|NCT00975507|11597310|FG001|Overall Study|Lost to Follow-up|1
7354607|NCT00975507|11597309|FG000|Overall Study|Protocol Violation|2
7354608|NCT00975507|11597310|FG001|Overall Study|Protocol Violation|0
7354609|NCT00975507|11597309|FG000|Overall Study|Withdrawal by Subject|10
7354610|NCT00975507|11597310|FG001|Overall Study|Withdrawal by Subject|3
7354611|NCT00975585|11597320|FG000|Overall Study|Adverse Event|0
7354612|NCT00975585|11597321|FG001|Overall Study|Adverse Event|4
7354613|NCT00975585|11597320|FG000|Overall Study|Lost to Follow-up|3
7354614|NCT00975585|11597321|FG001|Overall Study|Lost to Follow-up|5
7569484|NCT03449446|11945894|FG004|Overall Study|Adverse Event|0
7569485|NCT03449446|11945895|FG005|Overall Study|Adverse Event|2
7354615|NCT00975585|11597320|FG000|Overall Study|Withdrawal by Subject|2
7354616|NCT00975585|11597321|FG001|Overall Study|Withdrawal by Subject|1
7354617|NCT00975585|11597320|FG000|Overall Study|Lens issue|2
7354618|NCT00975585|11597321|FG001|Overall Study|Lens issue|2
7354619|NCT00975676|11597365|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
7354620|NCT00975676|11597366|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
7354621|NCT00975689|11597379|FG000|Overall Study|Adverse Event|0
7354622|NCT00975689|11597380|FG001|Overall Study|Adverse Event|3
7354623|NCT00975689|11597379|FG000|Overall Study|Withdrawal by Subject|1
7354624|NCT00975689|11597380|FG001|Overall Study|Withdrawal by Subject|0
7354625|NCT00975689|11597379|FG000|Overall Study|Physician Decision|1
7354626|NCT00975689|11597380|FG001|Overall Study|Physician Decision|0
7354627|NCT00975715|11597388|FG000|Titration Period|Adverse Event|6
7468330|NCT01909791|11769084|FG001|Overall Study|Lost to Follow-up|11
7354628|NCT00975715|11597389|FG001|Titration Period|Adverse Event|0
7354629|NCT00975715|11597388|FG000|Titration Period|Protocol Violation|1
7354630|NCT00975715|11597389|FG001|Titration Period|Protocol Violation|0
7354631|NCT00975715|11597388|FG000|Maintenance Period|Adverse Event|2
7354632|NCT00975715|11597389|FG001|Maintenance Period|Adverse Event|1
7354633|NCT00975780|11597397|FG000|Follow Up|Death|88
7354634|NCT00975780|11597398|FG001|Follow Up|Death|122
7354635|NCT00975780|11597397|FG000|Follow Up|Facility Withdrawal|7
7354636|NCT00975780|11597398|FG001|Follow Up|Facility Withdrawal|23
7354637|NCT00975780|11597397|FG000|Follow Up|Discharged from Facility|7
7354638|NCT00975780|11597398|FG001|Follow Up|Discharged from Facility|12
7354639|NCT00975806|11597407|FG000|Overall Study|Adverse Event|2
7354640|NCT00975806|11597408|FG001|Overall Study|Adverse Event|1
7354641|NCT00975806|11597409|FG002|Overall Study|Adverse Event|2
7354642|NCT00975806|11597407|FG000|Overall Study|Disease Progression|1
7354643|NCT00975806|11597408|FG001|Overall Study|Disease Progression|5
7354644|NCT00975806|11597409|FG002|Overall Study|Disease Progression|1
7354645|NCT00975806|11597407|FG000|Overall Study|Withdrawal by Subject|1
7354646|NCT00975806|11597408|FG001|Overall Study|Withdrawal by Subject|0
7354647|NCT00975806|11597409|FG002|Overall Study|Withdrawal by Subject|0
7354648|NCT00975806|11597407|FG000|Overall Study|Death|0
7354649|NCT00975806|11597408|FG001|Overall Study|Death|1
7354650|NCT00975806|11597409|FG002|Overall Study|Death|0
7354651|NCT00975806|11597407|FG000|Overall Study|Physician decision and disease related|1
7354652|NCT00975806|11597408|FG001|Overall Study|Physician decision and disease related|0
7354653|NCT00975806|11597409|FG002|Overall Study|Physician decision and disease related|1
7354654|NCT00975884|11597421|FG000|Overall Study|Adverse Event|1
7354655|NCT00975884|11597422|FG001|Overall Study|Adverse Event|0
7354656|NCT00975884|11597421|FG000|Overall Study|Lost to Follow-up|5
7354657|NCT00975884|11597422|FG001|Overall Study|Lost to Follow-up|3
7354658|NCT00975884|11597421|FG000|Overall Study|Withdrawal by Subject|9
7354659|NCT00975884|11597422|FG001|Overall Study|Withdrawal by Subject|9
7354660|NCT00975884|11597421|FG000|Overall Study|Other|1
7354661|NCT00975884|11597422|FG001|Overall Study|Other|3
7354662|NCT00975923|11597440|FG000|Overall Study|Withdrawal by Subject|0
7459548|NCT01818492|11754263|FG000|Overall Study|Additional therapy when not allowed PP|4
7459549|NCT01818531|11754295|FG000|Overall Study|Withdrawn for case delay after block|1
7459550|NCT01818531|11754296|FG001|Overall Study|Withdrawn for case delay after block|0
7459551|NCT01818531|11754295|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
7459552|NCT01818531|11754296|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
7459553|NCT01818531|11754295|FG000|Overall Study|Withdrawn for failure to place block|0
7459554|NCT01818531|11754296|FG001|Overall Study|Withdrawn for failure to place block|1
7459555|NCT01818596|11754304|FG000|Overall Study|Enrolled but Not Treated|4
7459556|NCT01818596|11754305|FG001|Overall Study|Enrolled but Not Treated|0
7459557|NCT01818596|11754304|FG000|Overall Study|Adverse Event|7
7459558|NCT01818596|11754305|FG001|Overall Study|Adverse Event|0
7459559|NCT01818596|11754304|FG000|Overall Study|Death|3
7459560|NCT01818596|11754305|FG001|Overall Study|Death|0
7459561|NCT01818596|11754304|FG000|Overall Study|Investigator's Discretion|4
7459562|NCT01818596|11754305|FG001|Overall Study|Investigator's Discretion|0
7459563|NCT01818596|11754304|FG000|Overall Study|Protocol Violation|1
7459564|NCT01818596|11754305|FG001|Overall Study|Protocol Violation|0
7459565|NCT01818596|11754304|FG000|Overall Study|Withdrew Consent|5
7459566|NCT01818596|11754305|FG001|Overall Study|Withdrew Consent|0
7459567|NCT01818596|11754304|FG000|Overall Study|Lost to Follow-up|7
7459568|NCT01818596|11754305|FG001|Overall Study|Lost to Follow-up|0
7459569|NCT01818700|11754312|FG000|Overall Study|Adverse Event|67
7459570|NCT01818700|11754312|FG000|Overall Study|Lack of Efficacy|2
7459571|NCT01818700|11754312|FG000|Overall Study|Lost to Follow-up|5
7459572|NCT01818700|11754312|FG000|Overall Study|Withdrawal by Subject|27
7459573|NCT01818700|11754312|FG000|Overall Study|Protocol Violation|2
7459574|NCT01818700|11754312|FG000|Overall Study|Other|1
7459575|NCT01818726|11754320|FG000|Overall Study|Administrative reasons|5
7459576|NCT01818726|11754321|FG001|Overall Study|Administrative reasons|1
7459577|NCT01818726|11754320|FG000|Overall Study|Withdrawal by Subject|0
7459578|NCT01818726|11754321|FG001|Overall Study|Withdrawal by Subject|1
7459579|NCT01818726|11754320|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
7533266|NCT02683941|11879548|FG000|Double-blind Phase|Lost to Follow-up|1
7533267|NCT02683941|11879549|FG001|Double-blind Phase|Lost to Follow-up|0
7533268|NCT02683941|11879548|FG000|Double-blind Phase|Disease Progression|5
7533269|NCT02683941|11879549|FG001|Double-blind Phase|Disease Progression|2
7533270|NCT02683941|11879548|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7533271|NCT02683941|11879549|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
7533272|NCT02683941|11879548|FG000|Open-label Treatment Phase|Disease Progression|1
7533273|NCT02683941|11879549|FG001|Open-label Treatment Phase|Disease Progression|2
7533274|NCT02683941|11879548|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
7537684|NCT02759185|11886794|FG006|Stage 2|Adverse Event|0
7354663|NCT00975923|11597441|FG001|Overall Study|Withdrawal by Subject|1
7459580|NCT01818726|11754321|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
7459581|NCT01818752|11754334|FG000|Overall Study|Adverse Event|64
7354664|NCT00975975|11597448|FG000|Overall Study|Death|6
7354665|NCT00976027|11597454|FG000|Overall Study|Serious Adverse Event|36
7354666|NCT00976027|11597455|FG001|Overall Study|Serious Adverse Event|17
7354667|NCT00976027|11597454|FG000|Overall Study|Adverse Event|0
7354668|NCT00976027|11597455|FG001|Overall Study|Adverse Event|2
7354669|NCT00976027|11597454|FG000|Overall Study|Protocol Violation|60
7354670|NCT00976027|11597455|FG001|Overall Study|Protocol Violation|27
7354671|NCT00976027|11597454|FG000|Overall Study|Lost to Follow-up|208
7354672|NCT00976027|11597455|FG001|Overall Study|Lost to Follow-up|103
7354673|NCT00976027|11597454|FG000|Overall Study|Withdrawal by Subject|107
7354674|NCT00976027|11597455|FG001|Overall Study|Withdrawal by Subject|66
7354675|NCT00976209|11597467|FG000|Treatment Period 1|Protocol Violation|1
7354676|NCT00976209|11597468|FG001|Treatment Period 1|Protocol Violation|0
7354677|NCT00976209|11597467|FG000|Treatment Period 1|Lost to Follow-up|2
7354678|NCT00976209|11597468|FG001|Treatment Period 1|Lost to Follow-up|0
7354679|NCT00976209|11597467|FG000|Treatment Period 1|Other|0
7354680|NCT00976209|11597468|FG001|Treatment Period 1|Other|1
7354681|NCT00976209|11597467|FG000|Wash-out Period|Adverse Event|1
7354682|NCT00976209|11597468|FG001|Wash-out Period|Adverse Event|2
7354683|NCT00976209|11597467|FG000|Wash-out Period|Lost to Follow-up|1
7354684|NCT00976209|11597468|FG001|Wash-out Period|Lost to Follow-up|0
7354685|NCT00976209|11597467|FG000|Wash-out Period|Protocol Violation|1
7354686|NCT00976209|11597468|FG001|Wash-out Period|Protocol Violation|0
7354687|NCT00976209|11597467|FG000|Wash-out Period|Other|1
7354688|NCT00976209|11597468|FG001|Wash-out Period|Other|0
7354689|NCT00976209|11597467|FG000|Treatment Period 2|Withdrawal by Subject|0
7354690|NCT00976209|11597468|FG001|Treatment Period 2|Withdrawal by Subject|1
7354691|NCT00976209|11597467|FG000|Treatment Period 2|Lost to Follow-up|0
7354692|NCT00976209|11597468|FG001|Treatment Period 2|Lost to Follow-up|1
7354693|NCT00976274|11597480|FG000|Overall Study|Lost to Follow-up|5
7354694|NCT00976274|11597481|FG001|Overall Study|Lost to Follow-up|5
7354695|NCT00976274|11597480|FG000|Overall Study|Withdrawal by Subject|1
7354696|NCT00976274|11597481|FG001|Overall Study|Withdrawal by Subject|1
7354697|NCT00976274|11597480|FG000|Overall Study|Physician Decision|1
7354698|NCT00976274|11597481|FG001|Overall Study|Physician Decision|2
7354699|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Adverse Event|16
7354700|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Adverse Event|2
7354701|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
7354702|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
7354703|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Noncompliance|4
7354704|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Noncompliance|4
7354705|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
7354706|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
7354707|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
7354708|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
7354709|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Physician Decision|1
7354710|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Physician Decision|1
7354711|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
7354712|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
7354713|NCT00976391|11597502|FG000|Treatment Period (52 Weeks)|Pregnancy|1
7354714|NCT00976391|11597503|FG001|Treatment Period (52 Weeks)|Pregnancy|0
7354715|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
7354716|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
7354717|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
7354718|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
7354719|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
7354720|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
7354721|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
7354722|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
7354723|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
7354724|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
7354725|NCT00976391|11597502|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
7354726|NCT00976391|11597503|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
7354727|NCT00976456|11597522|FG000|Overall Study|Adverse Event|17
7354728|NCT00976456|11597523|FG001|Overall Study|Adverse Event|22
7354729|NCT00976456|11597522|FG000|Overall Study|Death|7
7354730|NCT00976456|11597523|FG001|Overall Study|Death|9
7354731|NCT00976456|11597522|FG000|Overall Study|Lack of Efficacy|5
7354732|NCT00976456|11597523|FG001|Overall Study|Lack of Efficacy|2
7354733|NCT00976456|11597522|FG000|Overall Study|Withdrawal by Subject|3
7354734|NCT00976456|11597523|FG001|Overall Study|Withdrawal by Subject|1
7354735|NCT00976456|11597522|FG000|Overall Study|screening failure, unknown|11
7354736|NCT00976456|11597523|FG001|Overall Study|screening failure, unknown|4
7354737|NCT00976482|11597529|FG000|Overall Study|Death|208
7354738|NCT00976482|11597529|FG000|Overall Study|Withdrawal by Subject|45
7354739|NCT00976482|11597529|FG000|Overall Study|Center terminated|1
7354740|NCT00976482|11597529|FG000|Overall Study|Protocol Violation|5
7354741|NCT00976495|11597536|FG000|Overall Study|Withdrawal by Subject|0
7354742|NCT00976495|11597537|FG001|Overall Study|Withdrawal by Subject|1
7354743|NCT00976495|11597538|FG002|Overall Study|Withdrawal by Subject|0
7354744|NCT00976508|11597548|FG000|Overall Study|Death|7
7354745|NCT00976508|11597549|FG001|Overall Study|Death|1
7354746|NCT00976508|11597548|FG000|Overall Study|Lost to Follow-up|1
7354747|NCT00976508|11597549|FG001|Overall Study|Lost to Follow-up|0
7354748|NCT00976508|11597548|FG000|Overall Study|Withdrawal by Subject|1
7354749|NCT00976508|11597549|FG001|Overall Study|Withdrawal by Subject|0
7354750|NCT00976508|11597548|FG000|Overall Study|Disease Progression|4
7354751|NCT00976508|11597549|FG001|Overall Study|Disease Progression|4
7354752|NCT00976508|11597548|FG000|Overall Study|Subject Enrolled in Hospice|1
7354753|NCT00976508|11597549|FG001|Overall Study|Subject Enrolled in Hospice|0
7354754|NCT00976508|11597548|FG000|Overall Study|Terminated by the Sponsor|0
7354755|NCT00976508|11597549|FG001|Overall Study|Terminated by the Sponsor|1
7354756|NCT00976560|11597578|FG000|Overall Study|Adverse Event|5
7354757|NCT00976560|11597579|FG001|Overall Study|Adverse Event|5
7354758|NCT00976560|11597578|FG000|Overall Study|Lack of Efficacy|3
7354759|NCT00976560|11597579|FG001|Overall Study|Lack of Efficacy|5
7354760|NCT00976560|11597578|FG000|Overall Study|Protocol Violation|1
7354761|NCT00976560|11597579|FG001|Overall Study|Protocol Violation|0
7354762|NCT00976560|11597578|FG000|Overall Study|Lost to Follow-up|1
7354763|NCT00976560|11597579|FG001|Overall Study|Lost to Follow-up|0
7354764|NCT00976560|11597578|FG000|Overall Study|Physician Decision|2
7354765|NCT00976560|11597579|FG001|Overall Study|Physician Decision|0
7354766|NCT00976560|11597578|FG000|Overall Study|Withdrawal by Subject|2
7354767|NCT00976560|11597579|FG001|Overall Study|Withdrawal by Subject|3
7354768|NCT00976573|11597587|FG000|Overall Study|Ineligible|0
7354769|NCT00976573|11597588|FG001|Overall Study|Ineligible|1
7354770|NCT00976573|11597587|FG000|Overall Study|Cancel prior to receiving treatment|4
7354771|NCT00976573|11597588|FG001|Overall Study|Cancel prior to receiving treatment|2
7354772|NCT00976677|11597614|FG000|Overall Study|Adverse Event|1
7354773|NCT00976677|11597615|FG001|Overall Study|Adverse Event|0
7354774|NCT00976677|11597614|FG000|Overall Study|Withdrawal by Subject|0
7354775|NCT00976677|11597615|FG001|Overall Study|Withdrawal by Subject|2
7354776|NCT00976677|11597614|FG000|Overall Study|Disease progression|1
7354777|NCT00976677|11597615|FG001|Overall Study|Disease progression|1
7354778|NCT00976677|11597614|FG000|Overall Study|Trial unblinded|2
7354779|NCT00976677|11597615|FG001|Overall Study|Trial unblinded|2
7354780|NCT00976677|11597614|FG000|Overall Study|Unknown/Missing|1
7354781|NCT00976677|11597615|FG001|Overall Study|Unknown/Missing|0
7354782|NCT00976703|11597623|FG000|Overall Study|Physician Decision|1
7354783|NCT00976703|11597624|FG001|Overall Study|Physician Decision|1
7354784|NCT00976703|11597623|FG000|Overall Study|ineligible for study|2
7354785|NCT00976703|11597624|FG001|Overall Study|ineligible for study|2
7354786|NCT00976716|11597630|FG000|Overall Study|Adverse Event|1
7354787|NCT00976820|11597639|FG000|Overall Study|Lost to Follow-up|5
7354788|NCT00976820|11597640|FG001|Overall Study|Lost to Follow-up|16
7354789|NCT00976820|11597641|FG002|Overall Study|Lost to Follow-up|2
7354790|NCT00976820|11597642|FG003|Overall Study|Lost to Follow-up|3
7354791|NCT00976820|11597639|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
7354792|NCT00976820|11597640|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
7354793|NCT00976820|11597641|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
7354794|NCT00976820|11597642|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
7354795|NCT00976820|11597639|FG000|Overall Study|Withdrawal by Subject|2
7354796|NCT00976820|11597640|FG001|Overall Study|Withdrawal by Subject|4
7354797|NCT00976820|11597641|FG002|Overall Study|Withdrawal by Subject|1
7354798|NCT00976820|11597642|FG003|Overall Study|Withdrawal by Subject|4
7354799|NCT00976898|11597693|FG000|Overall Study|Protocol Violation|1
7354800|NCT00976898|11597693|FG000|Overall Study|Adverse Event|1
7354801|NCT00976898|11597693|FG000|Overall Study|Physician Decision|1
7354802|NCT00976898|11597693|FG000|Overall Study|Liver Transplant|1
7354803|NCT00976898|11597693|FG000|Overall Study|Progressive Disease|1
7354804|NCT00976937|11597699|FG000|Overall Study|Adverse Event|4
7354805|NCT00976937|11597700|FG001|Overall Study|Adverse Event|5
7354806|NCT00976937|11597699|FG000|Overall Study|Lost to Follow-up|2
7354807|NCT00976937|11597700|FG001|Overall Study|Lost to Follow-up|1
7354808|NCT00976937|11597699|FG000|Overall Study|Withdrawal by Subject|5
7354809|NCT00976937|11597700|FG001|Overall Study|Withdrawal by Subject|3
7354810|NCT00976937|11597699|FG000|Overall Study|Poor compliance to protocol|3
7354811|NCT00976937|11597700|FG001|Overall Study|Poor compliance to protocol|0
7354812|NCT00976937|11597699|FG000|Overall Study|Personal and Familial Reason|2
7354813|NCT00976937|11597700|FG001|Overall Study|Personal and Familial Reason|2
7354814|NCT00976950|11597706|FG000|Overall Study|Adverse Event|3
7354815|NCT00976950|11597706|FG000|Overall Study|Events with no relationship to Aptivus|3
7354816|NCT00976989|11597713|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7354817|NCT00976989|11597714|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7354818|NCT00976989|11597715|FG002|Overall Study|Violation of Selection Criteria at Entry|1
7354819|NCT00976989|11597713|FG000|Overall Study|Death|5
7354820|NCT00976989|11597714|FG001|Overall Study|Death|7
7354821|NCT00976989|11597715|FG002|Overall Study|Death|10
7354822|NCT00976989|11597713|FG000|Overall Study|Refused Treatment|4
7354823|NCT00976989|11597714|FG001|Overall Study|Refused Treatment|3
7354824|NCT00976989|11597715|FG002|Overall Study|Refused Treatment|5
7354825|NCT00976989|11597713|FG000|Overall Study|Failure to Return|2
7354826|NCT00976989|11597714|FG001|Overall Study|Failure to Return|1
7354827|NCT00976989|11597715|FG002|Overall Study|Failure to Return|0
7354828|NCT00976989|11597713|FG000|Overall Study|Recurrence of Disease|0
7354829|NCT00976989|11597714|FG001|Overall Study|Recurrence of Disease|1
7354830|NCT00976989|11597715|FG002|Overall Study|Recurrence of Disease|0
7354831|NCT00976989|11597713|FG000|Overall Study|Other|1
7354832|NCT00976989|11597714|FG001|Overall Study|Other|0
7354833|NCT00976989|11597715|FG002|Overall Study|Other|1
7354834|NCT00977080|11597727|FG000|Overall Study|Adverse Event|2
7354835|NCT00977080|11597728|FG001|Overall Study|Adverse Event|7
7354836|NCT00977080|11597729|FG002|Overall Study|Adverse Event|7
7354837|NCT00977080|11597730|FG003|Overall Study|Adverse Event|7
7354838|NCT00977080|11597727|FG000|Overall Study|Withdrawal by Subject|1
7354839|NCT00977080|11597728|FG001|Overall Study|Withdrawal by Subject|5
7354840|NCT00977080|11597729|FG002|Overall Study|Withdrawal by Subject|1
7354841|NCT00977080|11597730|FG003|Overall Study|Withdrawal by Subject|5
7354842|NCT00977080|11597727|FG000|Overall Study|Protocol Violation|7
7354843|NCT00977080|11597728|FG001|Overall Study|Protocol Violation|3
7354844|NCT00977080|11597729|FG002|Overall Study|Protocol Violation|4
7354845|NCT00977080|11597730|FG003|Overall Study|Protocol Violation|3
7354846|NCT00977080|11597727|FG000|Overall Study|Noncompliance|0
7354847|NCT00977080|11597728|FG001|Overall Study|Noncompliance|2
7354848|NCT00977080|11597729|FG002|Overall Study|Noncompliance|1
7354849|NCT00977080|11597730|FG003|Overall Study|Noncompliance|0
7354850|NCT00977080|11597727|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7354851|NCT00977080|11597728|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7354852|NCT00977080|11597729|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
7354853|NCT00977080|11597730|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
7354854|NCT00977080|11597727|FG000|Overall Study|Required kidney transplantation|1
7354855|NCT00977080|11597728|FG001|Overall Study|Required kidney transplantation|3
7354856|NCT00977080|11597729|FG002|Overall Study|Required kidney transplantation|3
7354857|NCT00977080|11597730|FG003|Overall Study|Required kidney transplantation|1
7354858|NCT00977080|11597727|FG000|Overall Study|Travel for family reasons|1
7354859|NCT00977080|11597728|FG001|Overall Study|Travel for family reasons|0
7354860|NCT00977080|11597729|FG002|Overall Study|Travel for family reasons|0
7354861|NCT00977080|11597730|FG003|Overall Study|Travel for family reasons|0
7354862|NCT00977106|11597742|FG000|Overall Study|Adverse Event|5
7354863|NCT00977106|11597743|FG001|Overall Study|Adverse Event|6
7354864|NCT00977106|11597742|FG000|Overall Study|Withdrawal by Subject|2
7354865|NCT00977106|11597743|FG001|Overall Study|Withdrawal by Subject|2
7354866|NCT00977106|11597742|FG000|Overall Study|Lack of Efficacy|2
7354867|NCT00977106|11597743|FG001|Overall Study|Lack of Efficacy|2
7354868|NCT00977106|11597742|FG000|Overall Study|Protocol Violation|0
7354869|NCT00977106|11597743|FG001|Overall Study|Protocol Violation|1
7354870|NCT00977106|11597742|FG000|Overall Study|Other|1
7354871|NCT00977106|11597743|FG001|Overall Study|Other|0
7354872|NCT00977197|11597773|FG000|Overall Study|Withdrawal by Subject|3
7354873|NCT00977197|11597774|FG001|Overall Study|Withdrawal by Subject|4
7354874|NCT00977197|11597773|FG000|Overall Study|Adverse Event|3
7354875|NCT00977197|11597774|FG001|Overall Study|Adverse Event|1
7354876|NCT00977197|11597773|FG000|Overall Study|Lack of Efficacy|1
7354877|NCT00977197|11597774|FG001|Overall Study|Lack of Efficacy|0
7354878|NCT00977197|11597773|FG000|Overall Study|Lost to Follow-up|1
7354879|NCT00977197|11597774|FG001|Overall Study|Lost to Follow-up|3
7354880|NCT00977197|11597773|FG000|Overall Study|Nonadherence|1
7354881|NCT00977197|11597774|FG001|Overall Study|Nonadherence|1
7354882|NCT00977314|11597782|FG000|Overall Study|Withdrawal by Subject|1
7354883|NCT00977314|11597783|FG001|Overall Study|Withdrawal by Subject|0
7354884|NCT00977314|11597782|FG000|Overall Study|Physician Decision|1
7354885|NCT00977314|11597783|FG001|Overall Study|Physician Decision|0
7354886|NCT00977379|11597791|FG000|Overall Study|Withdrawal by Subject|1
7354887|NCT00977379|11597792|FG001|Overall Study|Withdrawal by Subject|1
7354888|NCT00977379|11597791|FG000|Overall Study|Death|7
7354889|NCT00977379|11597792|FG001|Overall Study|Death|9
7354890|NCT00977379|11597791|FG000|Overall Study|Premature Study Termination|4
7354891|NCT00977379|11597792|FG001|Overall Study|Premature Study Termination|0
7354892|NCT00977379|11597791|FG000|Overall Study|Participant Moving House|0
7354893|NCT00977379|11597792|FG001|Overall Study|Participant Moving House|1
7354894|NCT00977379|11597791|FG000|Overall Study|Randomization Error|0
7354895|NCT00977379|11597792|FG001|Overall Study|Randomization Error|1
7354896|NCT00977431|11597803|FG000|Overall Study|Other than listed|1
7354897|NCT00977431|11597804|FG001|Overall Study|Other than listed|0
7354898|NCT00977431|11597805|FG002|Overall Study|Other than listed|0
7354899|NCT00977431|11597806|FG003|Overall Study|Other than listed|0
7354900|NCT00977431|11597807|FG004|Overall Study|Other than listed|2
7354901|NCT00977431|11597803|FG000|Overall Study|Protocol Violation|0
7354902|NCT00977431|11597804|FG001|Overall Study|Protocol Violation|0
7354903|NCT00977431|11597805|FG002|Overall Study|Protocol Violation|1
7354904|NCT00977431|11597806|FG003|Overall Study|Protocol Violation|0
7354905|NCT00977431|11597807|FG004|Overall Study|Protocol Violation|0
7354906|NCT00977431|11597803|FG000|Overall Study|Adverse Event|3
7354907|NCT00977431|11597804|FG001|Overall Study|Adverse Event|0
7354908|NCT00977431|11597805|FG002|Overall Study|Adverse Event|4
7354909|NCT00977431|11597806|FG003|Overall Study|Adverse Event|0
7354910|NCT00977431|11597807|FG004|Overall Study|Adverse Event|6
7354911|NCT00977431|11597803|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
7354912|NCT00977431|11597804|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
7354913|NCT00977431|11597805|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
7354914|NCT00977431|11597806|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7354915|NCT00977431|11597807|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
7354916|NCT00977431|11597803|FG000|Overall Study|Progressive disease|2
7354917|NCT00977431|11597804|FG001|Overall Study|Progressive disease|6
7354918|NCT00977431|11597805|FG002|Overall Study|Progressive disease|1
7354919|NCT00977431|11597806|FG003|Overall Study|Progressive disease|3
7354920|NCT00977431|11597807|FG004|Overall Study|Progressive disease|5
7354921|NCT00977470|11597825|FG000|Overall Study|Lack of Efficacy|32
7354922|NCT00977470|11597826|FG001|Overall Study|Lack of Efficacy|30
7354923|NCT00977470|11597825|FG000|Overall Study|Physician Decision|2
7354924|NCT00977470|11597826|FG001|Overall Study|Physician Decision|0
7354925|NCT00977470|11597825|FG000|Overall Study|Adverse Event|1
7354926|NCT00977470|11597826|FG001|Overall Study|Adverse Event|2
7354927|NCT00977470|11597825|FG000|Overall Study|Protocol Violation|1
7354928|NCT00977470|11597826|FG001|Overall Study|Protocol Violation|0
7354929|NCT00977470|11597825|FG000|Overall Study|Withdrawal by Subject|0
7354930|NCT00977470|11597826|FG001|Overall Study|Withdrawal by Subject|2
7354931|NCT00977470|11597825|FG000|Overall Study|Death|0
7354932|NCT00977470|11597826|FG001|Overall Study|Death|2
7354933|NCT00977470|11597825|FG000|Overall Study|clinical decline|0
7354934|NCT00977470|11597826|FG001|Overall Study|clinical decline|1
7354935|NCT00977470|11597825|FG000|Overall Study|prolonged recovery post-surgery|0
7354936|NCT00977470|11597826|FG001|Overall Study|prolonged recovery post-surgery|1
7354937|NCT00977470|11597825|FG000|Overall Study|Still on-study|2
7354938|NCT00977470|11597826|FG001|Overall Study|Still on-study|0
7354939|NCT00977548|11597832|FG000|Overall Study|Ineligible|4
7354940|NCT00977548|11597832|FG000|Overall Study|Adverse Event|8
7354941|NCT00977548|11597832|FG000|Overall Study|Withdrawal by Subject|1
7354942|NCT00977561|11597838|FG000|Overall Study|Death|3
7354943|NCT00977561|11597839|FG001|Overall Study|Death|2
7354944|NCT00977561|11597838|FG000|Overall Study|Study terminated|0
7354945|NCT00977561|11597839|FG001|Overall Study|Study terminated|2
7354946|NCT00977561|11597838|FG000|Overall Study|Other|2
7354947|NCT00977561|11597839|FG001|Overall Study|Other|0
7354948|NCT00977613|11597847|FG000|Overall Study|Lost to Follow-up|16
7354949|NCT00977665|11597853|FG000|Overall Study|Withdrawal by Subject|1
7354950|NCT00977665|11597854|FG001|Overall Study|Withdrawal by Subject|3
7354951|NCT00977665|11597853|FG000|Overall Study|Physician Decision|2
7354952|NCT00977665|11597854|FG001|Overall Study|Physician Decision|1
7354953|NCT00977665|11597853|FG000|Overall Study|Sponsor requested withdrawal|0
7354954|NCT00977665|11597854|FG001|Overall Study|Sponsor requested withdrawal|1
7354955|NCT00977665|11597853|FG000|Overall Study|Lost to Follow-up|1
7354956|NCT00977665|11597854|FG001|Overall Study|Lost to Follow-up|0
7354957|NCT00977665|11597853|FG000|Overall Study|Death|3
7354958|NCT00977665|11597854|FG001|Overall Study|Death|2
7354959|NCT00977665|11597853|FG000|Overall Study|Adverse Event|14
7354960|NCT00977665|11597854|FG001|Overall Study|Adverse Event|7
7569486|NCT03449446|11945896|FG006|Overall Study|Adverse Event|0
7354961|NCT00977665|11597853|FG000|Overall Study|Treatment failure|0
7354962|NCT00977665|11597854|FG001|Overall Study|Treatment failure|1
7354963|NCT00977938|11597886|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
7354964|NCT00977938|11597887|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
7354965|NCT00977938|11597888|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
7354966|NCT00977938|11597889|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
7354967|NCT00977938|11597886|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
7354968|NCT00977938|11597887|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
7354969|NCT00977938|11597888|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
7354970|NCT00977938|11597889|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
7354971|NCT00977938|11597886|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
7354972|NCT00977938|11597887|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
7354973|NCT00977938|11597888|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
7354974|NCT00977938|11597889|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
7354975|NCT00977938|11597886|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
7354976|NCT00977938|11597887|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
7354977|NCT00977938|11597888|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
7354978|NCT00977938|11597889|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
7354979|NCT00977938|11597886|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
7354980|NCT00977938|11597887|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
7354981|NCT00977938|11597888|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
7459582|NCT01818752|11754335|FG001|Overall Study|Adverse Event|74
7354982|NCT00977938|11597889|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
7354983|NCT00977938|11597886|FG000|Observation (30-33 mo. Post Procedure)|Other|8
7354984|NCT00977938|11597887|FG001|Observation (30-33 mo. Post Procedure)|Other|4
7354985|NCT00977938|11597888|FG002|Observation (30-33 mo. Post Procedure)|Other|0
7354986|NCT00977938|11597889|FG003|Observation (30-33 mo. Post Procedure)|Other|0
7354987|NCT00978029|11597904|FG000|Overall Study|Adverse Event|1
7354988|NCT00978029|11597905|FG001|Overall Study|Adverse Event|2
7354989|NCT00978029|11597906|FG002|Overall Study|Adverse Event|5
7354990|NCT00978029|11597904|FG000|Overall Study|Withdrawal by Subject|0
7354991|NCT00978029|11597905|FG001|Overall Study|Withdrawal by Subject|0
7354992|NCT00978029|11597906|FG002|Overall Study|Withdrawal by Subject|1
7354993|NCT00978029|11597904|FG000|Overall Study|Protocol Violation|0
7569487|NCT03449446|11945890|FG000|Overall Study|Lost to Follow-up|0
7354994|NCT00978029|11597905|FG001|Overall Study|Protocol Violation|1
7354995|NCT00978029|11597906|FG002|Overall Study|Protocol Violation|0
7354996|NCT00978042|11597916|FG000|Initial Treatment Period|Treated in Error|0
7354997|NCT00978042|11597917|FG001|Initial Treatment Period|Treated in Error|3
7354998|NCT00978042|11597916|FG000|Initial Treatment Period|Ineligibility|1
7354999|NCT00978042|11597917|FG001|Initial Treatment Period|Ineligibility|0
7355000|NCT00978042|11597916|FG000|Initial Treatment Period|Lost to Follow-up|21
7355001|NCT00978042|11597917|FG001|Initial Treatment Period|Lost to Follow-up|3
7355002|NCT00978042|11597916|FG000|Initial Treatment Period|Adverse Event|2
7355003|NCT00978042|11597917|FG001|Initial Treatment Period|Adverse Event|0
7355004|NCT00978042|11597916|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
7355005|NCT00978042|11597917|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
7355006|NCT00978042|11597916|FG000|Initial Treatment Period|Consent withdrawn|22
7355007|NCT00978042|11597917|FG001|Initial Treatment Period|Consent withdrawn|9
7355008|NCT00978042|11597916|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
7355009|NCT00978042|11597917|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
7355010|NCT00978068|11597925|FG000|Overall Study|Were Awaiting Initiation of ART|2
7355011|NCT00978068|11597926|FG001|Overall Study|Were Awaiting Initiation of ART|2
7355012|NCT00978068|11597925|FG000|Overall Study|Death|1
7355013|NCT00978068|11597926|FG001|Overall Study|Death|2
7355014|NCT00978068|11597925|FG000|Overall Study|Lost to Follow-up|1
7355015|NCT00978068|11597926|FG001|Overall Study|Lost to Follow-up|2
7355016|NCT00978068|11597925|FG000|Overall Study|Physician Decision|0
7355017|NCT00978068|11597926|FG001|Overall Study|Physician Decision|1
7355018|NCT00978068|11597925|FG000|Overall Study|Unable to Comply with Study|0
7355019|NCT00978068|11597926|FG001|Overall Study|Unable to Comply with Study|2
7355020|NCT00978120|11597940|FG000|Overall Study|Death|0
7355021|NCT00978120|11597941|FG001|Overall Study|Death|0
7355022|NCT00978120|11597942|FG002|Overall Study|Death|0
7355023|NCT00978120|11597943|FG003|Overall Study|Death|1
7355024|NCT00978120|11597940|FG000|Overall Study|Lost to Follow-up|0
7355025|NCT00978120|11597941|FG001|Overall Study|Lost to Follow-up|0
7355026|NCT00978120|11597942|FG002|Overall Study|Lost to Follow-up|3
7355027|NCT00978120|11597943|FG003|Overall Study|Lost to Follow-up|0
7355028|NCT00978120|11597940|FG000|Overall Study|Withdrawal by Subject|2
7355029|NCT00978120|11597941|FG001|Overall Study|Withdrawal by Subject|0
7355030|NCT00978120|11597942|FG002|Overall Study|Withdrawal by Subject|0
7355031|NCT00978120|11597943|FG003|Overall Study|Withdrawal by Subject|0
7355032|NCT00978120|11597940|FG000|Overall Study|Moved out of state|0
7355033|NCT00978120|11597941|FG001|Overall Study|Moved out of state|0
7355034|NCT00978120|11597942|FG002|Overall Study|Moved out of state|0
7459583|NCT01818752|11754334|FG000|Overall Study|Death|14
7459584|NCT01818752|11754335|FG001|Overall Study|Death|18
7459585|NCT01818752|11754334|FG000|Overall Study|Non-compliance|16
7459586|NCT01818752|11754335|FG001|Overall Study|Non-compliance|20
7459587|NCT01818752|11754334|FG000|Overall Study|Withdrawal by Subject|15
7459588|NCT01818752|11754335|FG001|Overall Study|Withdrawal by Subject|14
7459589|NCT01818752|11754334|FG000|Overall Study|Physician Decision|9
7459590|NCT01818752|11754335|FG001|Overall Study|Physician Decision|8
7459591|NCT01818752|11754334|FG000|Overall Study|Disease Progression|54
7459592|NCT01818752|11754335|FG001|Overall Study|Disease Progression|48
7459593|NCT01818752|11754334|FG000|Overall Study|Other|7
7459594|NCT01818752|11754335|FG001|Overall Study|Other|8
7459595|NCT01818752|11754334|FG000|Overall Study|Continuing Treatment|1
7459596|NCT01818752|11754335|FG001|Overall Study|Continuing Treatment|4
7459597|NCT01818752|11754334|FG000|Overall Study|Randomized but not Dosed|7
7459598|NCT01818752|11754335|FG001|Overall Study|Randomized but not Dosed|4
7459599|NCT01818765|11754341|FG000|Overall Study|Death|2
7459600|NCT01819129|11754357|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
7459601|NCT01819129|11754358|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
7459602|NCT01819129|11754357|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
7459603|NCT01819129|11754358|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
7459604|NCT01819129|11754357|FG000|Overall Study|Other, Subject moved out of the country|0
7459605|NCT01819129|11754358|FG001|Overall Study|Other, Subject moved out of the country|1
7459606|NCT01819129|11754357|FG000|Overall Study|Withdrawal by Subject|15
7459607|NCT01819129|11754358|FG001|Overall Study|Withdrawal by Subject|15
7459608|NCT01819129|11754357|FG000|Overall Study|Lost to Follow-up|5
7459609|NCT01819129|11754358|FG001|Overall Study|Lost to Follow-up|2
7459610|NCT01819129|11754357|FG000|Overall Study|Lack of Efficacy|0
7459611|NCT01819129|11754358|FG001|Overall Study|Lack of Efficacy|1
7459612|NCT01819129|11754357|FG000|Overall Study|Adverse Event|1
7459613|NCT01819129|11754358|FG001|Overall Study|Adverse Event|4
7459614|NCT01819129|11754357|FG000|Overall Study|Death|1
7459615|NCT01819129|11754358|FG001|Overall Study|Death|1
7459616|NCT01819129|11754357|FG000|Overall Study|Withdrawal Criteria|20
7459617|NCT01819129|11754358|FG001|Overall Study|Withdrawal Criteria|15
7459618|NCT01819194|11754364|FG000|Overall Study|Loss of study articles|2
7459619|NCT01819272|11754378|FG000|Overall Study|Adverse Event|1
7459620|NCT01819272|11754379|FG001|Overall Study|Adverse Event|0
7459621|NCT01819272|11754380|FG002|Overall Study|Adverse Event|0
7459622|NCT01819272|11754381|FG003|Overall Study|Adverse Event|2
7459623|NCT01819272|11754382|FG004|Overall Study|Adverse Event|0
7459624|NCT01819272|11754383|FG005|Overall Study|Adverse Event|0
7355035|NCT00978120|11597943|FG003|Overall Study|Moved out of state|1
7355036|NCT00978250|11597961|FG000|Overall Study|Late determination of ineligibility|0
7355037|NCT00978250|11597962|FG001|Overall Study|Late determination of ineligibility|1
7355038|NCT00978250|11597963|FG002|Overall Study|Late determination of ineligibility|0
7355039|NCT00978250|11597964|FG003|Overall Study|Late determination of ineligibility|1
7355040|NCT00978341|11597976|FG000|Washout Period of 2 Weeks|Adverse Event|1
7355041|NCT00978341|11597977|FG001|Washout Period of 2 Weeks|Adverse Event|0
7355042|NCT00978380|11597984|FG000|Overall Study|Protocol Violation|2
7355043|NCT00978380|11597984|FG000|Overall Study|Withdrawal criteria|9
7355044|NCT00978380|11597984|FG000|Overall Study|Unclassified|8
7355045|NCT00978432|11597992|FG000|Overall Study|Withdrawal by Subject|0
7355046|NCT00978432|11597993|FG001|Overall Study|Withdrawal by Subject|0
7355047|NCT00978432|11597994|FG002|Overall Study|Withdrawal by Subject|1
7355048|NCT00978432|11597992|FG000|Overall Study|Lack of Efficacy|1
7355049|NCT00978432|11597993|FG001|Overall Study|Lack of Efficacy|1
7355050|NCT00978432|11597994|FG002|Overall Study|Lack of Efficacy|3
7355051|NCT00978432|11597992|FG000|Overall Study|Adverse Event|2
7355052|NCT00978432|11597993|FG001|Overall Study|Adverse Event|0
7355053|NCT00978432|11597994|FG002|Overall Study|Adverse Event|1
7355054|NCT00978627|11598017|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
7355055|NCT00978627|11598018|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
7355056|NCT00978627|11598017|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
7355057|NCT00978627|11598018|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
7355058|NCT00978627|11598017|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
7355059|NCT00978627|11598018|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
7355060|NCT00978627|11598017|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
7355061|NCT00978627|11598018|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
7355062|NCT00978627|11598017|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
7355063|NCT00978627|11598018|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
7355064|NCT00978627|11598017|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
7355065|NCT00978627|11598018|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
7355066|NCT00978627|11598017|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
7355067|NCT00978627|11598018|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
7355068|NCT00978627|11598017|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
7355069|NCT00978627|11598018|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
7355070|NCT00978627|11598017|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
7355071|NCT00978627|11598018|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
7355072|NCT00978731|11598028|FG000|Overall Study|Death|4
7355073|NCT00978731|11598029|FG001|Overall Study|Death|1
7355074|NCT00978731|11598030|FG002|Overall Study|Death|1
7355075|NCT00978731|11598031|FG003|Overall Study|Death|0
7355076|NCT00978731|11598028|FG000|Overall Study|Lost to Follow-up|0
7355077|NCT00978731|11598029|FG001|Overall Study|Lost to Follow-up|0
7355078|NCT00978731|11598030|FG002|Overall Study|Lost to Follow-up|0
7355079|NCT00978731|11598031|FG003|Overall Study|Lost to Follow-up|1
7355080|NCT00978731|11598028|FG000|Overall Study|Adverse Event|5
7355081|NCT00978731|11598029|FG001|Overall Study|Adverse Event|2
7355082|NCT00978731|11598030|FG002|Overall Study|Adverse Event|0
7355083|NCT00978731|11598031|FG003|Overall Study|Adverse Event|0
7355084|NCT00978731|11598028|FG000|Overall Study|Participant's request|1
7355085|NCT00978731|11598029|FG001|Overall Study|Participant's request|0
7355086|NCT00978731|11598030|FG002|Overall Study|Participant's request|0
7355087|NCT00978731|11598031|FG003|Overall Study|Participant's request|0
7355088|NCT00978731|11598028|FG000|Overall Study|Administrative reason|3
7355089|NCT00978731|11598029|FG001|Overall Study|Administrative reason|3
7355090|NCT00978731|11598030|FG002|Overall Study|Administrative reason|1
7355091|NCT00978731|11598031|FG003|Overall Study|Administrative reason|0
7355092|NCT00978731|11598028|FG000|Overall Study|Deterioration without progression|0
7355093|NCT00978731|11598029|FG001|Overall Study|Deterioration without progression|1
7355094|NCT00978731|11598030|FG002|Overall Study|Deterioration without progression|0
7355095|NCT00978731|11598031|FG003|Overall Study|Deterioration without progression|0
7355096|NCT00978731|11598028|FG000|Overall Study|Disease progression/relapse|5
7355097|NCT00978731|11598029|FG001|Overall Study|Disease progression/relapse|4
7355098|NCT00978731|11598030|FG002|Overall Study|Disease progression/relapse|2
7355099|NCT00978731|11598031|FG003|Overall Study|Disease progression/relapse|2
7355100|NCT00978731|11598028|FG000|Overall Study|Study closure|3
7355101|NCT00978731|11598029|FG001|Overall Study|Study closure|4
7355102|NCT00978731|11598030|FG002|Overall Study|Study closure|1
7355103|NCT00978731|11598031|FG003|Overall Study|Study closure|1
7355104|NCT00978731|11598028|FG000|Overall Study|No response|1
7355105|NCT00978731|11598029|FG001|Overall Study|No response|0
7355106|NCT00978731|11598030|FG002|Overall Study|No response|0
7355107|NCT00978731|11598031|FG003|Overall Study|No response|0
7355108|NCT00978757|11598047|FG000|Overall Study|Physician Decision|1
7355109|NCT00978757|11598048|FG001|Overall Study|Physician Decision|3
7355110|NCT00979134|11598085|FG000|Overall Study|Disease progression|18
7355111|NCT00979134|11598086|FG001|Overall Study|Disease progression|2
7355112|NCT00979134|11598087|FG002|Overall Study|Disease progression|5
7355113|NCT00979134|11598085|FG000|Overall Study|Adverse Event|0
7355114|NCT00979134|11598086|FG001|Overall Study|Adverse Event|0
7355115|NCT00979134|11598087|FG002|Overall Study|Adverse Event|2
7355116|NCT00979134|11598085|FG000|Overall Study|Withdrawal by Subject|1
7355117|NCT00979134|11598086|FG001|Overall Study|Withdrawal by Subject|1
7355118|NCT00979134|11598087|FG002|Overall Study|Withdrawal by Subject|2
7355119|NCT00979134|11598085|FG000|Overall Study|Lost to Follow-up|2
7355120|NCT00979134|11598086|FG001|Overall Study|Lost to Follow-up|2
7355121|NCT00979134|11598087|FG002|Overall Study|Lost to Follow-up|0
7355122|NCT00979134|11598085|FG000|Overall Study|Death|4
7355123|NCT00979134|11598086|FG001|Overall Study|Death|0
7355124|NCT00979134|11598087|FG002|Overall Study|Death|26
7355125|NCT00979134|11598085|FG000|Overall Study|Other|8
7355126|NCT00979134|11598086|FG001|Overall Study|Other|1
7355127|NCT00979134|11598087|FG002|Overall Study|Other|5
7355128|NCT00979407|11598115|FG000|Overall Study|Withdrawal by Subject|3
7355129|NCT00979407|11598116|FG001|Overall Study|Withdrawal by Subject|4
7355130|NCT00979407|11598115|FG000|Overall Study|Lost to Follow-up|3
7355131|NCT00979407|11598116|FG001|Overall Study|Lost to Follow-up|3
7355132|NCT00979420|11598128|FG000|Overall Study|Adverse Event|1
7355133|NCT00979420|11598129|FG001|Overall Study|Adverse Event|0
7355134|NCT00979420|11598130|FG002|Overall Study|Adverse Event|0
7355135|NCT00979420|11598131|FG003|Overall Study|Adverse Event|0
7355136|NCT00979420|11598128|FG000|Overall Study|Lack of Efficacy|3
7355137|NCT00979420|11598129|FG001|Overall Study|Lack of Efficacy|0
7355138|NCT00979420|11598130|FG002|Overall Study|Lack of Efficacy|1
7355139|NCT00979420|11598131|FG003|Overall Study|Lack of Efficacy|1
7355140|NCT00979420|11598128|FG000|Overall Study|Other reasons not related to Viramune|3
7355141|NCT00979420|11598129|FG001|Overall Study|Other reasons not related to Viramune|0
7355142|NCT00979420|11598130|FG002|Overall Study|Other reasons not related to Viramune|0
7355143|NCT00979420|11598131|FG003|Overall Study|Other reasons not related to Viramune|1
7355144|NCT00979576|11598151|FG000|Combination Treatment Phase|Progressive disease|3
7355145|NCT00979576|11598152|FG001|Combination Treatment Phase|Progressive disease|1
7355146|NCT00979576|11598153|FG002|Combination Treatment Phase|Progressive disease|5
7355147|NCT00979576|11598151|FG000|Combination Treatment Phase|Dose limiting toxicity|0
7355148|NCT00979576|11598152|FG001|Combination Treatment Phase|Dose limiting toxicity|3
7355149|NCT00979576|11598153|FG002|Combination Treatment Phase|Dose limiting toxicity|2
7355150|NCT00979576|11598151|FG000|Combination Treatment Phase|Adverse Event|0
7355151|NCT00979576|11598152|FG001|Combination Treatment Phase|Adverse Event|2
7355152|NCT00979576|11598153|FG002|Combination Treatment Phase|Adverse Event|2
7355153|NCT00979576|11598151|FG000|Combination Followed by Monotherapy|Progressive Disease|0
7355154|NCT00979576|11598152|FG001|Combination Followed by Monotherapy|Progressive Disease|2
7355155|NCT00979576|11598153|FG002|Combination Followed by Monotherapy|Progressive Disease|1
7355156|NCT00979602|11598164|FG000|Overall Study|Serious Adverse Event|5
7355157|NCT00979602|11598165|FG001|Overall Study|Serious Adverse Event|3
7355158|NCT00979602|11598164|FG000|Overall Study|Protocol Violation|3
7355159|NCT00979602|11598165|FG001|Overall Study|Protocol Violation|0
7355160|NCT00979602|11598164|FG000|Overall Study|Withdrawal by Subject|31
7355161|NCT00979602|11598165|FG001|Overall Study|Withdrawal by Subject|25
7355162|NCT00979602|11598164|FG000|Overall Study|Lost to Follow-up|100
7355163|NCT00979602|11598165|FG001|Overall Study|Lost to Follow-up|96
7355164|NCT00979602|11598164|FG000|Overall Study|Migrated/moved from study area|3
7355165|NCT00979602|11598165|FG001|Overall Study|Migrated/moved from study area|6
7355166|NCT00979602|11598164|FG000|Overall Study|Others|3
7355167|NCT00979602|11598165|FG001|Overall Study|Others|3
7386104|NCT01207583|11644299|FG001|Overall Study|Participant failed to return|0
7386105|NCT01207583|11644300|FG002|Overall Study|Participant failed to return|0
7386106|NCT01207583|11644298|FG000|Overall Study|Lost to Follow-up|0
7386107|NCT01207583|11644299|FG001|Overall Study|Lost to Follow-up|2
7386108|NCT01207583|11644300|FG002|Overall Study|Lost to Follow-up|0
7386109|NCT01207596|11644321|FG000|Overall Study|Physician Decision|4
7386110|NCT01207596|11644321|FG000|Overall Study|Lack of Efficacy|1
7386111|NCT01207596|11644321|FG000|Overall Study|Adverse Event|3
7386112|NCT01207596|11644321|FG000|Overall Study|Withdrawal by Subject|1
7386113|NCT01207687|11644329|FG000|Overall Study|Adverse Event|1
7386114|NCT01207687|11644329|FG000|Overall Study|Withdrawal by Subject|1
7386115|NCT01208038|11644374|FG000|Overall Study|Withdrawal by Subject|1
7386116|NCT01208051|11644383|FG000|Total Enrollment|Withdrawal by Subject|0
7386117|NCT01208051|11644384|FG001|Total Enrollment|Withdrawal by Subject|1
7533275|NCT02683941|11879549|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
7386118|NCT01208051|11644385|FG002|Total Enrollment|Withdrawal by Subject|0
7386119|NCT01208051|11644386|FG003|Total Enrollment|Withdrawal by Subject|0
7386120|NCT01208051|11644387|FG004|Total Enrollment|Withdrawal by Subject|2
7386121|NCT01208051|11644383|FG000|Total Enrollment|Brain metastases|0
7386122|NCT01208051|11644384|FG001|Total Enrollment|Brain metastases|0
7386123|NCT01208051|11644385|FG002|Total Enrollment|Brain metastases|1
7355168|NCT00979628|11598195|FG000|Overall Study|received regimen < 24 hours|7
7355169|NCT00979628|11598196|FG001|Overall Study|received regimen < 24 hours|6
7355170|NCT00979628|11598197|FG002|Overall Study|received regimen < 24 hours|5
7355171|NCT00979628|11598195|FG000|Overall Study|received steroids|1
7355172|NCT00979628|11598196|FG001|Overall Study|received steroids|1
7355173|NCT00979628|11598197|FG002|Overall Study|received steroids|0
7355174|NCT00979628|11598195|FG000|Overall Study|transferred to ICU|1
7355175|NCT00979628|11598196|FG001|Overall Study|transferred to ICU|2
7355176|NCT00979628|11598197|FG002|Overall Study|transferred to ICU|1
7355177|NCT00979654|11598208|FG000|Overall Study|Lost to Follow-up|1
7355178|NCT00979654|11598208|FG000|Overall Study|Withdrawal by Subject|22
7355179|NCT00979654|11598208|FG000|Overall Study|Death|1
7355180|NCT00979654|11598208|FG000|Overall Study|Lack of Efficacy|6
7355181|NCT00979654|11598208|FG000|Overall Study|Adverse Event|1
7355182|NCT00979654|11598208|FG000|Overall Study|Adverse Event of Diverticulitis|1
7355183|NCT00979654|11598208|FG000|Overall Study|Per Principal Investigator's Discretion|1
7355184|NCT00979654|11598208|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
7355185|NCT00979654|11598208|FG000|Overall Study|Serious Adverse Event|1
7355186|NCT00979654|11598208|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
7355187|NCT00979953|11598262|FG000|Overall Study|Adverse Event|5
7355188|NCT00979953|11598263|FG001|Overall Study|Adverse Event|2
7355189|NCT00979953|11598264|FG002|Overall Study|Adverse Event|17
7355190|NCT00979953|11598265|FG003|Overall Study|Adverse Event|4
7355191|NCT00979953|11598262|FG000|Overall Study|Lack of Efficacy|1
7355192|NCT00979953|11598263|FG001|Overall Study|Lack of Efficacy|2
7355193|NCT00979953|11598264|FG002|Overall Study|Lack of Efficacy|0
7355194|NCT00979953|11598265|FG003|Overall Study|Lack of Efficacy|0
7355195|NCT00979953|11598262|FG000|Overall Study|Lost to Follow-up|1
7355196|NCT00979953|11598263|FG001|Overall Study|Lost to Follow-up|1
7355197|NCT00979953|11598264|FG002|Overall Study|Lost to Follow-up|1
7355198|NCT00979953|11598265|FG003|Overall Study|Lost to Follow-up|0
7355199|NCT00979953|11598262|FG000|Overall Study|Withdrawal by Subject|0
7355200|NCT00979953|11598263|FG001|Overall Study|Withdrawal by Subject|0
7355201|NCT00979953|11598264|FG002|Overall Study|Withdrawal by Subject|2
7355202|NCT00979953|11598265|FG003|Overall Study|Withdrawal by Subject|1
7355203|NCT00979953|11598262|FG000|Overall Study|Protocol Violation|1
7355204|NCT00979953|11598263|FG001|Overall Study|Protocol Violation|0
7355205|NCT00979953|11598264|FG002|Overall Study|Protocol Violation|2
7355206|NCT00979953|11598265|FG003|Overall Study|Protocol Violation|2
7355207|NCT00979992|11598275|FG000|Overall Study|Ineligible - inadequate pathology|1
7355208|NCT00979992|11598275|FG000|Overall Study|Ineligible - wrong cell type|2
7355209|NCT00979992|11598275|FG000|Overall Study|Refused - Never Treated|2
7355210|NCT00980005|11598281|FG000|Overall Study|Withdrawal by Subject|6
7355211|NCT00980005|11598282|FG001|Overall Study|Withdrawal by Subject|17
7355212|NCT00980005|11598281|FG000|Overall Study|Lost to Follow-up|37
7355213|NCT00980005|11598282|FG001|Overall Study|Lost to Follow-up|43
7355214|NCT00980005|11598281|FG000|Overall Study|Other|4
7355215|NCT00980005|11598282|FG001|Overall Study|Other|3
7355216|NCT00980018|11598292|FG000|Overall Study|Adverse Event|8
7355217|NCT00980018|11598292|FG000|Overall Study|Patient withdrew consent|3
7355218|NCT00980018|11598292|FG000|Overall Study|Lost to Follow-up|1
7355219|NCT00980044|11598299|FG000|Overall Study|Withdrawal by Subject|5
7355220|NCT00980044|11598300|FG001|Overall Study|Withdrawal by Subject|7
7355221|NCT00980044|11598301|FG002|Overall Study|Withdrawal by Subject|3
7355222|NCT00980044|11598299|FG000|Overall Study|Protocol Violation|0
7355223|NCT00980044|11598300|FG001|Overall Study|Protocol Violation|0
7355224|NCT00980044|11598301|FG002|Overall Study|Protocol Violation|2
7355225|NCT00980057|11598314|FG000|Overall Study|Death|13
7355226|NCT00980057|11598315|FG001|Overall Study|Death|3
7355227|NCT00980057|11598314|FG000|Overall Study|Adverse Event|0
7355228|NCT00980057|11598315|FG001|Overall Study|Adverse Event|1
7355229|NCT00980057|11598314|FG000|Overall Study|Physician Decision|4
7355230|NCT00980057|11598315|FG001|Overall Study|Physician Decision|0
7569488|NCT03449446|11945891|FG001|Overall Study|Lost to Follow-up|0
7355231|NCT00980057|11598314|FG000|Overall Study|Lost to Follow-up|1
7355232|NCT00980057|11598315|FG001|Overall Study|Lost to Follow-up|0
7355233|NCT00980057|11598314|FG000|Overall Study|Withdrawal by Subject|1
7355234|NCT00980057|11598315|FG001|Overall Study|Withdrawal by Subject|1
7355235|NCT00980148|11598324|FG000|Overall Study|Discharged from facility|89
7355236|NCT00980148|11598325|FG001|Overall Study|Discharged from facility|96
7355237|NCT00980148|11598324|FG000|Overall Study|Received other antichlamydia treatment|20
7355238|NCT00980148|11598325|FG001|Overall Study|Received other antichlamydia treatment|14
7355239|NCT00980148|11598324|FG000|Overall Study|Negative for chlamydia at enrollment|12
7355240|NCT00980148|11598325|FG001|Overall Study|Negative for chlamydia at enrollment|9
7355241|NCT00980148|11598324|FG000|Overall Study|Various other reasons|8
7355242|NCT00980148|11598325|FG001|Overall Study|Various other reasons|9
7355243|NCT00980174|11598333|FG000|Overall Study|Withdrawal by Subject|1
7355244|NCT00980174|11598334|FG001|Overall Study|Withdrawal by Subject|4
7355245|NCT00980174|11598333|FG000|Overall Study|Adverse Event|0
7355246|NCT00980174|11598334|FG001|Overall Study|Adverse Event|3
7355247|NCT00980174|11598333|FG000|Overall Study|Ineligibility determined|2
7355248|NCT00980174|11598334|FG001|Overall Study|Ineligibility determined|1
7355249|NCT00980174|11598333|FG000|Overall Study|Death|1
7355250|NCT00980174|11598334|FG001|Overall Study|Death|1
7355251|NCT00980174|11598333|FG000|Overall Study|Other|0
7355252|NCT00980174|11598334|FG001|Overall Study|Other|1
7355253|NCT00980200|11598340|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
7355254|NCT00980200|11598341|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
7355255|NCT00980200|11598342|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
7355256|NCT00980200|11598343|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
7355257|NCT00980200|11598344|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
7355258|NCT00980200|11598340|FG000|7-day Treatment Period 3|Lack of Efficacy|0
7355259|NCT00980200|11598341|FG001|7-day Treatment Period 3|Lack of Efficacy|1
7355260|NCT00980200|11598342|FG002|7-day Treatment Period 3|Lack of Efficacy|0
7355261|NCT00980200|11598343|FG003|7-day Treatment Period 3|Lack of Efficacy|0
7355262|NCT00980200|11598344|FG004|7-day Treatment Period 3|Lack of Efficacy|1
7355263|NCT00980330|11598372|FG000|Overall Study|Adverse Event|0
7355264|NCT00980330|11598373|FG001|Overall Study|Adverse Event|0
7355265|NCT00980330|11598374|FG002|Overall Study|Adverse Event|0
7355266|NCT00980330|11598375|FG003|Overall Study|Adverse Event|1
7355267|NCT00980330|11598376|FG004|Overall Study|Adverse Event|0
7355268|NCT00980330|11598377|FG005|Overall Study|Adverse Event|0
7355269|NCT00980330|11598378|FG006|Overall Study|Adverse Event|0
7355270|NCT00980330|11598372|FG000|Overall Study|Lost to Follow-up|1
7355271|NCT00980330|11598373|FG001|Overall Study|Lost to Follow-up|1
7355272|NCT00980330|11598374|FG002|Overall Study|Lost to Follow-up|4
7355273|NCT00980330|11598375|FG003|Overall Study|Lost to Follow-up|2
7355274|NCT00980330|11598376|FG004|Overall Study|Lost to Follow-up|1
7355275|NCT00980330|11598377|FG005|Overall Study|Lost to Follow-up|1
7355276|NCT00980330|11598378|FG006|Overall Study|Lost to Follow-up|2
7355277|NCT00980330|11598372|FG000|Overall Study|Withdrawal by Subject|2
7355278|NCT00980330|11598373|FG001|Overall Study|Withdrawal by Subject|4
7355279|NCT00980330|11598374|FG002|Overall Study|Withdrawal by Subject|4
7355280|NCT00980330|11598375|FG003|Overall Study|Withdrawal by Subject|1
7355281|NCT00980330|11598376|FG004|Overall Study|Withdrawal by Subject|3
7355282|NCT00980330|11598377|FG005|Overall Study|Withdrawal by Subject|2
7355283|NCT00980330|11598378|FG006|Overall Study|Withdrawal by Subject|5
7355284|NCT00980330|11598372|FG000|Overall Study|(not specified)|2
7355285|NCT00980330|11598373|FG001|Overall Study|(not specified)|0
7355286|NCT00980330|11598374|FG002|Overall Study|(not specified)|0
7355287|NCT00980330|11598375|FG003|Overall Study|(not specified)|1
7355288|NCT00980330|11598376|FG004|Overall Study|(not specified)|1
7355289|NCT00980330|11598377|FG005|Overall Study|(not specified)|1
7355290|NCT00980330|11598378|FG006|Overall Study|(not specified)|0
7355291|NCT00980343|11598397|FG000|Overall Study|no tumor at surgery - treatment effect|1
7355292|NCT00980343|11598398|FG001|Overall Study|no tumor at surgery - treatment effect|3
7355293|NCT00980655|11598430|FG000|Overall Study|Adverse Event|13
7355294|NCT00980655|11598431|FG001|Overall Study|Adverse Event|31
7355295|NCT00980655|11598430|FG000|Overall Study|Death|0
7355296|NCT00980655|11598431|FG001|Overall Study|Death|7
7355297|NCT00980655|11598430|FG000|Overall Study|Protocol Violation|2
7355298|NCT00980655|11598431|FG001|Overall Study|Protocol Violation|7
7355299|NCT00980655|11598430|FG000|Overall Study|Withdrawal by Subject|0
7355300|NCT00980655|11598431|FG001|Overall Study|Withdrawal by Subject|4
7355301|NCT00980655|11598430|FG000|Overall Study|Lost to Follow-up|0
7355302|NCT00980655|11598431|FG001|Overall Study|Lost to Follow-up|1
7355303|NCT00980655|11598430|FG000|Overall Study|Parent/legal guardian request|1
7355304|NCT00980655|11598431|FG001|Overall Study|Parent/legal guardian request|0
7355305|NCT00980655|11598430|FG000|Overall Study|Other|0
7355306|NCT00980655|11598431|FG001|Overall Study|Other|1
7355307|NCT00980798|11598484|FG000|Overall Study|Adverse Event|7
7355308|NCT00980798|11598485|FG001|Overall Study|Adverse Event|36
7355309|NCT00980798|11598484|FG000|Overall Study|Lack of Efficacy|16
7355310|NCT00980798|11598485|FG001|Overall Study|Lack of Efficacy|5
7355311|NCT00980798|11598484|FG000|Overall Study|Lost to Follow-up|0
7355312|NCT00980798|11598485|FG001|Overall Study|Lost to Follow-up|1
7355313|NCT00980798|11598484|FG000|Overall Study|Physician Decision|2
7355314|NCT00980798|11598485|FG001|Overall Study|Physician Decision|1
7355315|NCT00980798|11598484|FG000|Overall Study|Withdrawal by Subject|8
7355316|NCT00980798|11598485|FG001|Overall Study|Withdrawal by Subject|11
7355317|NCT00980798|11598484|FG000|Overall Study|Other|0
7355318|NCT00980798|11598485|FG001|Overall Study|Other|1
7355319|NCT00980980|11598494|FG000|Overall Study|Withdrawal by Hospital|0
7355320|NCT00980980|11598495|FG001|Overall Study|Withdrawal by Hospital|1
7355321|NCT00980980|11598496|FG002|Overall Study|Withdrawal by Hospital|0
7355322|NCT00981019|11598507|FG000|Overall Study|Did not respond|65
7355323|NCT00981019|11598507|FG000|Overall Study|Did not match target population|94
7355324|NCT00981019|11598507|FG000|Overall Study|Inadvertent exclusion|239
7355325|NCT00981019|11598507|FG000|Overall Study|Hit the survey after closure|79
7355326|NCT00981084|11598522|FG000|Post Intervention (Data Analysis)|poor effort|1
7355327|NCT00981084|11598523|FG001|Post Intervention (Data Analysis)|poor effort|1
7355328|NCT00981084|11598522|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
7355329|NCT00981084|11598523|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
7355330|NCT00981149|11598533|FG000|Overall Study|Lost to Follow-up|1
7355331|NCT00981149|11598534|FG001|Overall Study|Lost to Follow-up|2
7355332|NCT00981149|11598533|FG000|Overall Study|Withdrawal by Subject|1
7355333|NCT00981149|11598534|FG001|Overall Study|Withdrawal by Subject|1
7355334|NCT00981175|11598543|FG000|Primary Dose Vaccination|Adverse Event|1
7355335|NCT00981175|11598544|FG001|Primary Dose Vaccination|Adverse Event|0
7355336|NCT00981175|11598543|FG000|Primary Dose Vaccination|Protocol Violation|0
7355337|NCT00981175|11598544|FG001|Primary Dose Vaccination|Protocol Violation|1
7355338|NCT00981175|11598543|FG000|Primary Dose Vaccination|Lost to Follow-up|2
7355339|NCT00981175|11598544|FG001|Primary Dose Vaccination|Lost to Follow-up|1
7355340|NCT00981175|11598543|FG000|Booster Dose Vaccination|Lost to Follow-up|2
7355341|NCT00981175|11598544|FG001|Booster Dose Vaccination|Lost to Follow-up|3
7355342|NCT00981292|11598606|FG000|Day 1|Protocol Violation|1
7355343|NCT00981292|11598607|FG001|Day 1|Protocol Violation|0
7355344|NCT00981292|11598608|FG002|Day 1|Protocol Violation|0
7355345|NCT00981292|11598609|FG003|Day 1|Protocol Violation|0
7355346|NCT00981292|11598610|FG004|Day 1|Protocol Violation|0
7355347|NCT00981292|11598611|FG005|Day 1|Protocol Violation|2
7355348|NCT00981292|11598606|FG000|Day 2|Protocol Violation|2
7355349|NCT00981292|11598607|FG001|Day 2|Protocol Violation|0
7355350|NCT00981292|11598608|FG002|Day 2|Protocol Violation|0
7355351|NCT00981292|11598609|FG003|Day 2|Protocol Violation|0
7355352|NCT00981292|11598610|FG004|Day 2|Protocol Violation|0
7355353|NCT00981292|11598611|FG005|Day 2|Protocol Violation|0
7355354|NCT00981292|11598606|FG000|Day 3|Protocol Violation|0
7355355|NCT00981292|11598607|FG001|Day 3|Protocol Violation|0
7355356|NCT00981292|11598608|FG002|Day 3|Protocol Violation|0
7355357|NCT00981292|11598609|FG003|Day 3|Protocol Violation|0
7355358|NCT00981292|11598610|FG004|Day 3|Protocol Violation|0
7355359|NCT00981292|11598611|FG005|Day 3|Protocol Violation|1
7355360|NCT00981409|11598634|FG000|Overall Study|Adverse Event|4
7355361|NCT00981409|11598635|FG001|Overall Study|Adverse Event|0
7355362|NCT00981409|11598634|FG000|Overall Study|Protocol Violation|0
7355363|NCT00981409|11598635|FG001|Overall Study|Protocol Violation|1
7355364|NCT00981409|11598634|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
7355365|NCT00981409|11598635|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
7355366|NCT00981461|11598656|FG000|Overall Study|Lost to Follow-up|5
7355367|NCT00981461|11598657|FG001|Overall Study|Lost to Follow-up|2
7355368|NCT00981526|11598676|FG000|Overall Study|Withdrawal by Subject|0
7355369|NCT00981526|11598677|FG001|Overall Study|Withdrawal by Subject|2
7355370|NCT00981526|11598676|FG000|Overall Study|Physician Decision|4
7569489|NCT03449446|11945892|FG002|Overall Study|Lost to Follow-up|2
7569490|NCT03449446|11945893|FG003|Overall Study|Lost to Follow-up|1
7569491|NCT03449446|11945894|FG004|Overall Study|Lost to Follow-up|3
7355371|NCT00981526|11598677|FG001|Overall Study|Physician Decision|4
7355372|NCT00981578|11598685|FG000|Overall Study|Death|1
7355373|NCT00981578|11598685|FG000|Overall Study|Withdrawal by Subject|2
7355374|NCT00981682|11598715|FG000|Overall Study|Adverse Event|48
7355375|NCT00981682|11598715|FG000|Overall Study|Withdrawal by Subject|52
7355376|NCT00981682|11598715|FG000|Overall Study|Lost to Follow-up|14
7355377|NCT00981682|11598715|FG000|Overall Study|Lack of Efficacy|13
7355378|NCT00981682|11598715|FG000|Overall Study|Protocol Violation|6
7355379|NCT00981682|11598715|FG000|Overall Study|administrative|9
7355380|NCT00981747|11598719|FG000|Losartan|Withdrawal by Subject|1
7355381|NCT00981747|11598719|FG000|Losartan|Death|1
7355382|NCT00981747|11598719|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
7355383|NCT00981799|11598733|FG000|Overall Study|Adverse Event|1
7355384|NCT00981799|11598734|FG001|Overall Study|Adverse Event|1
7355385|NCT00981799|11598735|FG002|Overall Study|Adverse Event|0
7355386|NCT00981799|11598736|FG003|Overall Study|Adverse Event|0
7355387|NCT00982020|11598779|FG000|Overall Study|Adverse Event|19
7355388|NCT00982020|11598780|FG001|Overall Study|Adverse Event|15
7355389|NCT00982020|11598779|FG000|Overall Study|Withdrawal by Subject|11
7355390|NCT00982020|11598780|FG001|Overall Study|Withdrawal by Subject|14
7355391|NCT00982020|11598779|FG000|Overall Study|Lost to Follow-up|5
7355392|NCT00982020|11598780|FG001|Overall Study|Lost to Follow-up|11
7355393|NCT00982020|11598779|FG000|Overall Study|Lack of Efficacy|10
7355394|NCT00982020|11598780|FG001|Overall Study|Lack of Efficacy|4
7355395|NCT00982020|11598779|FG000|Overall Study|Parent/Caregiver Decision|5
7355396|NCT00982020|11598780|FG001|Overall Study|Parent/Caregiver Decision|5
7355397|NCT00982020|11598779|FG000|Overall Study|Treatment Non-compliance|3
7355398|NCT00982020|11598780|FG001|Overall Study|Treatment Non-compliance|6
7355399|NCT00982020|11598779|FG000|Overall Study|Physician Decision|2
7355400|NCT00982020|11598780|FG001|Overall Study|Physician Decision|5
7355401|NCT00982020|11598779|FG000|Overall Study|Entry Criteria Not Met|2
7355402|NCT00982020|11598780|FG001|Overall Study|Entry Criteria Not Met|1
7355403|NCT00982020|11598779|FG000|Overall Study|Protocol Violation|0
7355404|NCT00982020|11598780|FG001|Overall Study|Protocol Violation|2
7355405|NCT00982020|11598779|FG000|Overall Study|Clinical Relapse|0
7355406|NCT00982020|11598780|FG001|Overall Study|Clinical Relapse|1
7355407|NCT00982137|11598813|FG000|Overall Study|Lost to Follow-up|0
7355408|NCT00982137|11598814|FG001|Overall Study|Lost to Follow-up|0
7355409|NCT00982137|11598815|FG002|Overall Study|Lost to Follow-up|0
7355410|NCT00982137|11598816|FG003|Overall Study|Lost to Follow-up|1
7569492|NCT03449446|11945895|FG005|Overall Study|Lost to Follow-up|0
7355411|NCT00982137|11598813|FG000|Overall Study|Withdrawal by Subject|0
7355412|NCT00982137|11598814|FG001|Overall Study|Withdrawal by Subject|1
7355413|NCT00982137|11598815|FG002|Overall Study|Withdrawal by Subject|0
7355414|NCT00982137|11598816|FG003|Overall Study|Withdrawal by Subject|0
7355415|NCT00982228|11598854|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
7355416|NCT00982228|11598855|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
7355492|NCT00982488|11598916|FG000|Overall Study|Lost to Follow-up|1
7355417|NCT00982228|11598854|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
7355418|NCT00982228|11598855|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
7355419|NCT00982228|11598854|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
7355420|NCT00982228|11598855|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
7355421|NCT00982228|11598854|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
7355422|NCT00982228|11598855|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
7355423|NCT00982228|11598854|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
7355424|NCT00982228|11598855|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
7355425|NCT00982228|11598854|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
7355426|NCT00982228|11598855|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
7355427|NCT00982228|11598854|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
7355428|NCT00982228|11598855|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
7355429|NCT00982228|11598854|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
7355430|NCT00982228|11598855|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
7355431|NCT00982228|11598854|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
7355432|NCT00982228|11598855|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
7355433|NCT00982228|11598854|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
7355434|NCT00982228|11598855|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
7355435|NCT00982280|11598861|FG000|Observation Period|Not eligible to be dosed|19
7355436|NCT00982280|11598861|FG000|Titration and Optimal Dose Period|Adverse Event|5
7355437|NCT00982280|11598861|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
7355438|NCT00982280|11598861|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
7355439|NCT00982280|11598861|FG000|Maintenance Period|Adverse Event|1
7355440|NCT00982319|11598868|FG000|Overall Study|Surgery date change|1
7355441|NCT00982319|11598869|FG001|Overall Study|Surgery date change|0
7355442|NCT00982319|11598868|FG000|Overall Study|Preop values out of acceptable range|1
7355443|NCT00982319|11598869|FG001|Overall Study|Preop values out of acceptable range|1
7355444|NCT00982319|11598868|FG000|Overall Study|Pregnancy|0
7355445|NCT00982319|11598869|FG001|Overall Study|Pregnancy|1
7355446|NCT00982410|11598893|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
7355447|NCT00982410|11598894|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
7355448|NCT00982410|11598893|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
7355449|NCT00982410|11598894|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
7355450|NCT00982410|11598893|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
7355451|NCT00982410|11598894|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
7355452|NCT00982410|11598893|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
7355453|NCT00982410|11598894|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
7355454|NCT00982410|11598893|FG000|6-month Follow-up Assessment|participant no transportation|1
7355455|NCT00982410|11598894|FG001|6-month Follow-up Assessment|participant no transportation|0
7355456|NCT00982410|11598893|FG000|6-month Follow-up Assessment|incarceration|0
7355457|NCT00982410|11598894|FG001|6-month Follow-up Assessment|incarceration|2
7355458|NCT00982410|11598893|FG000|6-month Follow-up Assessment|patent surgery|0
7355459|NCT00982410|11598894|FG001|6-month Follow-up Assessment|patent surgery|1
7355460|NCT00982410|11598893|FG000|6-month Follow-up Assessment|scheduled, no-show|0
7355461|NCT00982410|11598894|FG001|6-month Follow-up Assessment|scheduled, no-show|1
7355462|NCT00982410|11598893|FG000|12-month Follow-up Assessment|Death|0
7355463|NCT00982410|11598894|FG001|12-month Follow-up Assessment|Death|2
7355464|NCT00982410|11598893|FG000|12-month Follow-up Assessment|could not reach to schedule|6
7355465|NCT00982410|11598894|FG001|12-month Follow-up Assessment|could not reach to schedule|5
7355466|NCT00982410|11598893|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
7355467|NCT00982410|11598894|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
7355468|NCT00982410|11598893|FG000|12-month Follow-up Assessment|incarceration|2
7355469|NCT00982410|11598894|FG001|12-month Follow-up Assessment|incarceration|1
7355470|NCT00982410|11598893|FG000|12-month Follow-up Assessment|scheduled, no-show|1
7355471|NCT00982410|11598894|FG001|12-month Follow-up Assessment|scheduled, no-show|0
7355472|NCT00982488|11598916|FG000|Overall Study|Administrative reason by sponsor|81
7355473|NCT00982488|11598917|FG001|Overall Study|Administrative reason by sponsor|3
7355474|NCT00982488|11598918|FG002|Overall Study|Administrative reason by sponsor|11
7355475|NCT00982488|11598919|FG003|Overall Study|Administrative reason by sponsor|0
7355476|NCT00982488|11598920|FG004|Overall Study|Administrative reason by sponsor|0
7355477|NCT00982488|11598916|FG000|Overall Study|Adverse event unrelated to study drug|5
7355478|NCT00982488|11598917|FG001|Overall Study|Adverse event unrelated to study drug|1
7355479|NCT00982488|11598918|FG002|Overall Study|Adverse event unrelated to study drug|0
7355480|NCT00982488|11598919|FG003|Overall Study|Adverse event unrelated to study drug|0
7355481|NCT00982488|11598920|FG004|Overall Study|Adverse event unrelated to study drug|0
7355482|NCT00982488|11598916|FG000|Overall Study|Death|11
7355483|NCT00982488|11598917|FG001|Overall Study|Death|0
7355484|NCT00982488|11598918|FG002|Overall Study|Death|2
7355485|NCT00982488|11598919|FG003|Overall Study|Death|0
7355486|NCT00982488|11598920|FG004|Overall Study|Death|0
7355487|NCT00982488|11598916|FG000|Overall Study|Disease progression|30
7355488|NCT00982488|11598917|FG001|Overall Study|Disease progression|5
7355489|NCT00982488|11598918|FG002|Overall Study|Disease progression|10
7355490|NCT00982488|11598919|FG003|Overall Study|Disease progression|1
7355491|NCT00982488|11598920|FG004|Overall Study|Disease progression|1
7355493|NCT00982488|11598917|FG001|Overall Study|Lost to Follow-up|0
7355494|NCT00982488|11598918|FG002|Overall Study|Lost to Follow-up|0
7355495|NCT00982488|11598919|FG003|Overall Study|Lost to Follow-up|0
7355496|NCT00982488|11598920|FG004|Overall Study|Lost to Follow-up|0
7355497|NCT00982488|11598916|FG000|Overall Study|Maximum clinical benefit|1
7355498|NCT00982488|11598917|FG001|Overall Study|Maximum clinical benefit|1
7355499|NCT00982488|11598918|FG002|Overall Study|Maximum clinical benefit|1
7355500|NCT00982488|11598919|FG003|Overall Study|Maximum clinical benefit|0
7355501|NCT00982488|11598920|FG004|Overall Study|Maximum clinical benefit|0
7355502|NCT00982488|11598916|FG000|Overall Study|Other|15
7355503|NCT00982488|11598917|FG001|Overall Study|Other|1
7355504|NCT00982488|11598918|FG002|Overall Study|Other|3
7355505|NCT00982488|11598919|FG003|Overall Study|Other|1
7355506|NCT00982488|11598920|FG004|Overall Study|Other|0
7355507|NCT00982488|11598916|FG000|Overall Study|Poor compliance/noncompliance|0
7355508|NCT00982488|11598917|FG001|Overall Study|Poor compliance/noncompliance|1
7355509|NCT00982488|11598918|FG002|Overall Study|Poor compliance/noncompliance|0
7355510|NCT00982488|11598919|FG003|Overall Study|Poor compliance/noncompliance|0
7355511|NCT00982488|11598920|FG004|Overall Study|Poor compliance/noncompliance|0
7355512|NCT00982488|11598916|FG000|Overall Study|Stem cell transplant|2
7355513|NCT00982488|11598917|FG001|Overall Study|Stem cell transplant|0
7355514|NCT00982488|11598918|FG002|Overall Study|Stem cell transplant|0
7355515|NCT00982488|11598919|FG003|Overall Study|Stem cell transplant|1
7355516|NCT00982488|11598920|FG004|Overall Study|Stem cell transplant|0
7355517|NCT00982488|11598916|FG000|Overall Study|Study drug toxicity|34
7355518|NCT00982488|11598917|FG001|Overall Study|Study drug toxicity|1
7355519|NCT00982488|11598918|FG002|Overall Study|Study drug toxicity|6
7355520|NCT00982488|11598919|FG003|Overall Study|Study drug toxicity|0
7355521|NCT00982488|11598920|FG004|Overall Study|Study drug toxicity|0
7355522|NCT00982488|11598916|FG000|Overall Study|Withdrawal by Subject|5
7355523|NCT00982488|11598917|FG001|Overall Study|Withdrawal by Subject|1
7355524|NCT00982488|11598918|FG002|Overall Study|Withdrawal by Subject|1
7355525|NCT00982488|11598919|FG003|Overall Study|Withdrawal by Subject|0
7355526|NCT00982488|11598920|FG004|Overall Study|Withdrawal by Subject|0
7355527|NCT00982644|11598952|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
7355528|NCT00982644|11598953|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
7355529|NCT00982644|11598952|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
7355530|NCT00982644|11598953|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
7355531|NCT00982644|11598952|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
7355532|NCT00982644|11598953|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
7355533|NCT00982644|11598952|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
7355534|NCT00982644|11598953|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
7355535|NCT00982644|11598952|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
7355536|NCT00982644|11598953|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
7355537|NCT00982644|11598952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
7355538|NCT00982644|11598953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
7355539|NCT00982644|11598952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
7355540|NCT00982644|11598953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
7355541|NCT00982644|11598952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
7355542|NCT00982644|11598953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
7355543|NCT00982644|11598952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
7355544|NCT00982644|11598953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
7355545|NCT00982644|11598952|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
7355546|NCT00982644|11598953|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
7355547|NCT00982657|11598963|FG000|Overall Study|Death|1
7355548|NCT00982657|11598964|FG001|Overall Study|Death|0
7355549|NCT00982657|11598965|FG002|Overall Study|Death|1
7355550|NCT00982657|11598966|FG003|Overall Study|Death|1
7355551|NCT00982657|11598963|FG000|Overall Study|Withdrawal by Subject|0
7355552|NCT00982657|11598964|FG001|Overall Study|Withdrawal by Subject|0
7355553|NCT00982657|11598965|FG002|Overall Study|Withdrawal by Subject|1
7355554|NCT00982657|11598966|FG003|Overall Study|Withdrawal by Subject|3
7355555|NCT00982657|11598963|FG000|Overall Study|Other|0
7355556|NCT00982657|11598964|FG001|Overall Study|Other|0
7355557|NCT00982657|11598965|FG002|Overall Study|Other|0
7355558|NCT00982657|11598966|FG003|Overall Study|Other|4
7355559|NCT00982657|11598963|FG000|Overall Study|On going at date of cut-off|0
7355560|NCT00982657|11598964|FG001|Overall Study|On going at date of cut-off|0
7355561|NCT00982657|11598965|FG002|Overall Study|On going at date of cut-off|0
7355562|NCT00982657|11598966|FG003|Overall Study|On going at date of cut-off|1
7355563|NCT00982735|11598986|FG000|Overall Study|Lost to Follow-up|6
7355564|NCT00982735|11598986|FG000|Overall Study|Patient ineligible for trial|224
7355565|NCT00982878|11599044|FG000|Overall Study|Physician Decision|1
7355566|NCT00982930|11599048|FG000|Overall Study|Adverse Event|1
7355567|NCT00982930|11599048|FG000|Overall Study|Withdrawal by Subject|1
7355568|NCT00982930|11599048|FG000|Overall Study|Administrative Problems|2
7355569|NCT00983073|11599052|FG000|Titration and Optimal Dose Period|Adverse Event|19
7386124|NCT01208051|11644386|FG003|Total Enrollment|Brain metastases|0
7355570|NCT00983073|11599052|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
7355571|NCT00983073|11599052|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
7355572|NCT00983073|11599052|FG000|Titration and Optimal Dose Period|Non-Compliance|1
7355573|NCT00983073|11599052|FG000|Titration and Optimal Dose Period|Other reason|4
7355574|NCT00983073|11599052|FG000|Maintenance Period|Adverse Event|5
7355575|NCT00983073|11599052|FG000|Maintenance Period|Withdrawal by Subject|2
7355576|NCT00983073|11599052|FG000|Maintenance Period|Lack of Efficacy|2
7355577|NCT00983073|11599052|FG000|Maintenance Period|Other Reason|7
7355578|NCT00983294|11599080|FG000|14 Day Washout Period|Withdrawal by Subject|2
7355579|NCT00983294|11599080|FG000|Colchicine With Azithromycin|Adverse Event|1
7355580|NCT00983372|11599099|FG000|14 Day Washout Period|Withdrawal by Subject|1
7355581|NCT00983372|11599099|FG000|Diltiazem ER Alone|missed diltiazem dose|2
7355582|NCT00983372|11599099|FG000|Diltiazem ER Alone|Adverse Event|1
7355583|NCT00983385|11599106|FG000|Observation Period|Not eligible to be dosed|20
7355584|NCT00983385|11599106|FG000|Observation Period|Not Evaluable due to Non Compliance|12
7355585|NCT00983476|11599128|FG000|Overall Study|Did not receive intervention|17
7355586|NCT00983476|11599129|FG001|Overall Study|Did not receive intervention|22
7355587|NCT00983476|11599130|FG002|Overall Study|Did not receive intervention|0
7355588|NCT00983515|11599157|FG000|Ritonavir Alone|liver panel out of range|6
7355589|NCT00983515|11599157|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
7355590|NCT00983528|11599164|FG000|Overall Study|Death|4
7355591|NCT00983528|11599164|FG000|Overall Study|Lost to Follow-up|1
7355592|NCT00983528|11599164|FG000|Overall Study|Study Terminated|1
7355593|NCT00983580|11599174|FG000|Overall Study|Cancel Prior to treatment|1
7355594|NCT00983580|11599175|FG001|Overall Study|Cancel Prior to treatment|3
7355595|NCT00983580|11599174|FG000|Overall Study|Protocol Violation|1
7355596|NCT00983580|11599175|FG001|Overall Study|Protocol Violation|1
7355597|NCT00983580|11599174|FG000|Overall Study|Ineligible|3
7355598|NCT00983580|11599175|FG001|Overall Study|Ineligible|0
7355599|NCT00983619|11599194|FG000|Overall Study|Lost to Follow-up|0
7355600|NCT00983619|11599195|FG001|Overall Study|Lost to Follow-up|1
7355601|NCT00983619|11599196|FG002|Overall Study|Lost to Follow-up|0
7355602|NCT00983619|11599197|FG003|Overall Study|Lost to Follow-up|0
7355603|NCT00983619|11599198|FG004|Overall Study|Lost to Follow-up|0
7355604|NCT00983619|11599199|FG005|Overall Study|Lost to Follow-up|2
7355605|NCT00983619|11599200|FG006|Overall Study|Lost to Follow-up|0
7355606|NCT00983619|11599201|FG007|Overall Study|Lost to Follow-up|0
7355607|NCT00983619|11599202|FG008|Overall Study|Lost to Follow-up|0
7355608|NCT00983619|11599203|FG009|Overall Study|Lost to Follow-up|0
7355609|NCT00983619|11599204|FG010|Overall Study|Lost to Follow-up|0
7355610|NCT00983619|11599205|FG011|Overall Study|Lost to Follow-up|2
7569493|NCT03449446|11945896|FG006|Overall Study|Lost to Follow-up|0
7569494|NCT03449446|11945890|FG000|Overall Study|Investigator's Discretion|0
7569495|NCT03449446|11945891|FG001|Overall Study|Investigator's Discretion|1
7569496|NCT03449446|11945892|FG002|Overall Study|Investigator's Discretion|1
7569497|NCT03449446|11945893|FG003|Overall Study|Investigator's Discretion|2
7569498|NCT03449446|11945894|FG004|Overall Study|Investigator's Discretion|0
7569499|NCT03449446|11945895|FG005|Overall Study|Investigator's Discretion|0
7569500|NCT03449446|11945896|FG006|Overall Study|Investigator's Discretion|0
7569501|NCT03449446|11945890|FG000|Overall Study|Non Compliance with Study Drug|1
7569502|NCT03449446|11945891|FG001|Overall Study|Non Compliance with Study Drug|0
7569503|NCT03449446|11945892|FG002|Overall Study|Non Compliance with Study Drug|0
7355611|NCT00983619|11599194|FG000|Overall Study|Withdrawal by Subject|2
7355612|NCT00983619|11599195|FG001|Overall Study|Withdrawal by Subject|1
7355613|NCT00983619|11599196|FG002|Overall Study|Withdrawal by Subject|1
7355614|NCT00983619|11599197|FG003|Overall Study|Withdrawal by Subject|3
7355615|NCT00983619|11599198|FG004|Overall Study|Withdrawal by Subject|1
7355616|NCT00983619|11599199|FG005|Overall Study|Withdrawal by Subject|23
7355617|NCT00983619|11599200|FG006|Overall Study|Withdrawal by Subject|0
7355618|NCT00983619|11599201|FG007|Overall Study|Withdrawal by Subject|0
7355619|NCT00983619|11599202|FG008|Overall Study|Withdrawal by Subject|0
7355620|NCT00983619|11599203|FG009|Overall Study|Withdrawal by Subject|0
7355621|NCT00983619|11599204|FG010|Overall Study|Withdrawal by Subject|1
7355622|NCT00983619|11599205|FG011|Overall Study|Withdrawal by Subject|1
7355623|NCT00983619|11599194|FG000|Overall Study|Death|0
7355624|NCT00983619|11599195|FG001|Overall Study|Death|2
7355625|NCT00983619|11599196|FG002|Overall Study|Death|2
7355626|NCT00983619|11599197|FG003|Overall Study|Death|1
7355627|NCT00983619|11599198|FG004|Overall Study|Death|2
7355628|NCT00983619|11599199|FG005|Overall Study|Death|30
7355629|NCT00983619|11599200|FG006|Overall Study|Death|1
7355630|NCT00983619|11599201|FG007|Overall Study|Death|0
7355631|NCT00983619|11599202|FG008|Overall Study|Death|1
7355632|NCT00983619|11599203|FG009|Overall Study|Death|2
7355633|NCT00983619|11599204|FG010|Overall Study|Death|9
7569504|NCT03449446|11945893|FG003|Overall Study|Non Compliance with Study Drug|0
7355634|NCT00983619|11599205|FG011|Overall Study|Death|8
7355635|NCT00983619|11599194|FG000|Overall Study|Other|1
7355636|NCT00983619|11599195|FG001|Overall Study|Other|0
7355637|NCT00983619|11599196|FG002|Overall Study|Other|0
7355638|NCT00983619|11599197|FG003|Overall Study|Other|1
7355639|NCT00983619|11599198|FG004|Overall Study|Other|0
7355640|NCT00983619|11599199|FG005|Overall Study|Other|12
7355641|NCT00983619|11599200|FG006|Overall Study|Other|2
7355642|NCT00983619|11599201|FG007|Overall Study|Other|2
7355643|NCT00983619|11599202|FG008|Overall Study|Other|0
7355644|NCT00983619|11599203|FG009|Overall Study|Other|1
7355645|NCT00983619|11599204|FG010|Overall Study|Other|1
7355646|NCT00983619|11599205|FG011|Overall Study|Other|0
7355647|NCT00983749|11599253|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
7355648|NCT00983749|11599254|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
7355649|NCT00983827|11599264|FG000|Overall Study|Withdrawal by Subject|1
7355650|NCT00983853|11599274|FG000|Overall Study|Lost to Follow-up|1
7355651|NCT00983853|11599275|FG001|Overall Study|Lost to Follow-up|1
7355652|NCT00983853|11599276|FG002|Overall Study|Lost to Follow-up|2
7355653|NCT00983853|11599277|FG003|Overall Study|Lost to Follow-up|2
7355654|NCT00983853|11599278|FG004|Overall Study|Lost to Follow-up|2
7355655|NCT00983853|11599279|FG005|Overall Study|Lost to Follow-up|1
7355656|NCT00983853|11599274|FG000|Overall Study|Withdrawal by Subject|0
7355657|NCT00983853|11599275|FG001|Overall Study|Withdrawal by Subject|0
7355658|NCT00983853|11599276|FG002|Overall Study|Withdrawal by Subject|1
7355659|NCT00983853|11599277|FG003|Overall Study|Withdrawal by Subject|0
7355660|NCT00983853|11599278|FG004|Overall Study|Withdrawal by Subject|1
7355661|NCT00983853|11599279|FG005|Overall Study|Withdrawal by Subject|0
7355662|NCT00983853|11599274|FG000|Overall Study|Unable to come to study follow-up visits|0
7355663|NCT00983853|11599275|FG001|Overall Study|Unable to come to study follow-up visits|1
7355664|NCT00983853|11599276|FG002|Overall Study|Unable to come to study follow-up visits|0
7355665|NCT00983853|11599277|FG003|Overall Study|Unable to come to study follow-up visits|0
7355666|NCT00983853|11599278|FG004|Overall Study|Unable to come to study follow-up visits|0
7355667|NCT00983853|11599279|FG005|Overall Study|Unable to come to study follow-up visits|0
7355668|NCT00983892|11599297|FG000|Overall Study|Withdrawal by Subject|10
7355669|NCT00983892|11599298|FG001|Overall Study|Withdrawal by Subject|12
7355670|NCT00983905|11599304|FG000|Theophylline Alone|Adverse Event|1
7355671|NCT00983905|11599304|FG000|Colchicine Alone|Adverse Event|2
7355672|NCT00983918|11599315|FG000|Overall Study|conversion to open cholecystectomy|0
7355673|NCT00983918|11599316|FG001|Overall Study|conversion to open cholecystectomy|2
7355674|NCT00983918|11599317|FG002|Overall Study|conversion to open cholecystectomy|2
7355675|NCT00983918|11599318|FG003|Overall Study|conversion to open cholecystectomy|2
7355676|NCT00983931|11599328|FG000|14 Day Washout Period|Physician Decision|1
7355677|NCT00983957|11599334|FG000|Overall Study|Adverse Event|1
7355678|NCT00983957|11599334|FG000|Overall Study|Personal Reasons|1
7355679|NCT00984009|11599358|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
7386125|NCT01208051|11644387|FG004|Total Enrollment|Brain metastases|0
7386126|NCT01208103|11644403|FG000|Overall Study|Adverse Event|1
7386127|NCT01208103|11644403|FG000|Overall Study|Withdrawal by Subject|1
7386128|NCT01208233|11644423|FG000|Overall Study|Adverse Event|0
7386129|NCT01208233|11644424|FG001|Overall Study|Adverse Event|1
7386130|NCT01208233|11644425|FG002|Overall Study|Adverse Event|2
7386131|NCT01208233|11644426|FG003|Overall Study|Adverse Event|0
7386132|NCT01208233|11644427|FG004|Overall Study|Adverse Event|3
7386133|NCT01208233|11644428|FG005|Overall Study|Adverse Event|5
7386134|NCT01208233|11644423|FG000|Overall Study|Death|0
7386135|NCT01208233|11644424|FG001|Overall Study|Death|0
7386136|NCT01208233|11644425|FG002|Overall Study|Death|0
7386137|NCT01208233|11644426|FG003|Overall Study|Death|0
7386138|NCT01208233|11644427|FG004|Overall Study|Death|3
7386139|NCT01208233|11644428|FG005|Overall Study|Death|5
7386140|NCT01208233|11644423|FG000|Overall Study|Did not meet entrance criteria|2
7386141|NCT01208233|11644424|FG001|Overall Study|Did not meet entrance criteria|1
7386142|NCT01208233|11644425|FG002|Overall Study|Did not meet entrance criteria|1
7386143|NCT01208233|11644426|FG003|Overall Study|Did not meet entrance criteria|0
7386144|NCT01208233|11644427|FG004|Overall Study|Did not meet entrance criteria|1
7386145|NCT01208233|11644428|FG005|Overall Study|Did not meet entrance criteria|0
7386146|NCT01208233|11644423|FG000|Overall Study|Medication error without adverse event|0
7386147|NCT01208233|11644424|FG001|Overall Study|Medication error without adverse event|0
7386148|NCT01208233|11644425|FG002|Overall Study|Medication error without adverse event|0
7386149|NCT01208233|11644426|FG003|Overall Study|Medication error without adverse event|0
7386150|NCT01208233|11644427|FG004|Overall Study|Medication error without adverse event|0
7386151|NCT01208233|11644428|FG005|Overall Study|Medication error without adverse event|1
7386152|NCT01208233|11644423|FG000|Overall Study|Study terminated by sponsor|0
7386153|NCT01208233|11644424|FG001|Overall Study|Study terminated by sponsor|0
7386154|NCT01208233|11644425|FG002|Overall Study|Study terminated by sponsor|0
7386155|NCT01208233|11644426|FG003|Overall Study|Study terminated by sponsor|0
7386156|NCT01208233|11644427|FG004|Overall Study|Study terminated by sponsor|10
7386157|NCT01208233|11644428|FG005|Overall Study|Study terminated by sponsor|7
7386158|NCT01208233|11644423|FG000|Overall Study|Protocol Violation|0
7386159|NCT01208233|11644424|FG001|Overall Study|Protocol Violation|0
7386160|NCT01208233|11644425|FG002|Overall Study|Protocol Violation|0
7386161|NCT01208233|11644426|FG003|Overall Study|Protocol Violation|0
7386162|NCT01208233|11644427|FG004|Overall Study|Protocol Violation|3
7386163|NCT01208233|11644428|FG005|Overall Study|Protocol Violation|0
7386164|NCT01208233|11644423|FG000|Overall Study|Other|2
7386165|NCT01208233|11644424|FG001|Overall Study|Other|1
7386166|NCT01208233|11644425|FG002|Overall Study|Other|0
7386167|NCT01208233|11644426|FG003|Overall Study|Other|0
7386168|NCT01208233|11644427|FG004|Overall Study|Other|0
7386169|NCT01208233|11644428|FG005|Overall Study|Other|1
7355680|NCT00984022|11599367|FG000|Overall Study|Lost to Follow-up|10
7355681|NCT00984022|11599368|FG001|Overall Study|Lost to Follow-up|14
7355682|NCT00984061|11599374|FG000|Clarithromycin Alone|Protocol Violation|1
7355683|NCT00984126|11599385|FG000|Overall Study|Protocol Violation|0
7355684|NCT00984126|11599386|FG001|Overall Study|Protocol Violation|0
7355685|NCT00984126|11599387|FG002|Overall Study|Protocol Violation|1
7355686|NCT00984126|11599388|FG003|Overall Study|Protocol Violation|2
7355687|NCT00984126|11599385|FG000|Overall Study|Adverse Event|0
7355688|NCT00984126|11599386|FG001|Overall Study|Adverse Event|0
7355689|NCT00984126|11599387|FG002|Overall Study|Adverse Event|0
7355690|NCT00984126|11599388|FG003|Overall Study|Adverse Event|2
7355691|NCT00984126|11599385|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
7355692|NCT00984126|11599386|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
7355693|NCT00984126|11599387|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
7355694|NCT00984126|11599388|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
7355695|NCT00984126|11599385|FG000|Overall Study|Withdrawal criteria|0
7355696|NCT00984126|11599386|FG001|Overall Study|Withdrawal criteria|1
7355697|NCT00984126|11599387|FG002|Overall Study|Withdrawal criteria|3
7355698|NCT00984126|11599388|FG003|Overall Study|Withdrawal criteria|9
7355699|NCT00984165|11599415|FG000|Overall Study|Death on study|2
7355700|NCT00984165|11599416|FG001|Overall Study|Death on study|0
7355701|NCT00984165|11599417|FG002|Overall Study|Death on study|0
7355702|NCT00984165|11599418|FG003|Overall Study|Death on study|0
7355703|NCT00984165|11599415|FG000|Overall Study|Disease progression on study|5
7355704|NCT00984165|11599416|FG001|Overall Study|Disease progression on study|1
7355705|NCT00984165|11599417|FG002|Overall Study|Disease progression on study|0
7355706|NCT00984165|11599418|FG003|Overall Study|Disease progression on study|0
7355707|NCT00984165|11599415|FG000|Overall Study|Death of recipient|0
7355708|NCT00984165|11599416|FG001|Overall Study|Death of recipient|0
7355709|NCT00984165|11599417|FG002|Overall Study|Death of recipient|0
7355710|NCT00984165|11599418|FG003|Overall Study|Death of recipient|1
7355711|NCT00984165|11599415|FG000|Overall Study|New protocol|0
7355712|NCT00984165|11599416|FG001|Overall Study|New protocol|0
7355713|NCT00984165|11599417|FG002|Overall Study|New protocol|0
7355714|NCT00984165|11599418|FG003|Overall Study|New protocol|1
7355715|NCT00984165|11599415|FG000|Overall Study|P+/donor pair removed from protocol|0
7355716|NCT00984165|11599416|FG001|Overall Study|P+/donor pair removed from protocol|0
7355717|NCT00984165|11599417|FG002|Overall Study|P+/donor pair removed from protocol|0
7355718|NCT00984165|11599418|FG003|Overall Study|P+/donor pair removed from protocol|1
7355719|NCT00984165|11599415|FG000|Overall Study|removed with a pair recipient|0
7355720|NCT00984165|11599416|FG001|Overall Study|removed with a pair recipient|0
7355721|NCT00984165|11599417|FG002|Overall Study|removed with a pair recipient|0
7355722|NCT00984165|11599418|FG003|Overall Study|removed with a pair recipient|1
7355723|NCT00984204|11599429|FG000|Overall Study|Death|1
7355724|NCT00984204|11599429|FG000|Overall Study|Lost to Follow-up|4
7355725|NCT00984204|11599429|FG000|Overall Study|Lack of Efficacy|10
7355726|NCT00984256|11599435|FG000|Overall Study|Withdrawal by Subject|0
7355727|NCT00984256|11599436|FG001|Overall Study|Withdrawal by Subject|1
7355728|NCT00984282|11599453|FG000|Double Blind Treatment|Adverse Event|40
7355729|NCT00984282|11599454|FG001|Double Blind Treatment|Adverse Event|6
7355730|NCT00984282|11599453|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
7355731|NCT00984282|11599454|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
7355732|NCT00984282|11599453|FG000|Double Blind Treatment|Physician Decision|1
7355733|NCT00984282|11599454|FG001|Double Blind Treatment|Physician Decision|2
7355734|NCT00984282|11599453|FG000|Double Blind Treatment|Noncompliance with study medication|3
7355735|NCT00984282|11599454|FG001|Double Blind Treatment|Noncompliance with study medication|0
7355736|NCT00984282|11599453|FG000|Double Blind Treatment|Progression by clinical judgment|2
7355737|NCT00984282|11599454|FG001|Double Blind Treatment|Progression by clinical judgment|0
7355738|NCT00984282|11599453|FG000|Double Blind Treatment|Withdrawal by Subject|13
7355739|NCT00984282|11599454|FG001|Double Blind Treatment|Withdrawal by Subject|18
7355740|NCT00984282|11599453|FG000|Double Blind Treatment|Lost to Follow-up|3
7355741|NCT00984282|11599454|FG001|Double Blind Treatment|Lost to Follow-up|0
7355742|NCT00984282|11599453|FG000|Double Blind Treatment|Death|8
7355743|NCT00984282|11599454|FG001|Double Blind Treatment|Death|4
7355744|NCT00984282|11599453|FG000|Double Blind Treatment|Not treated|0
7355745|NCT00984282|11599454|FG001|Double Blind Treatment|Not treated|1
7355746|NCT00984282|11599453|FG000|Double Blind Treatment|Switched to commercial drug|6
7355747|NCT00984282|11599454|FG001|Double Blind Treatment|Switched to commercial drug|1
7355748|NCT00984282|11599453|FG000|Double Blind Treatment|protocol driven decision point|1
7355749|NCT00984282|11599454|FG001|Double Blind Treatment|protocol driven decision point|1
7355750|NCT00984282|11599453|FG000|Double Blind Treatment|Radiological and clinical progression|0
7355751|NCT00984282|11599454|FG001|Double Blind Treatment|Radiological and clinical progression|1
7355752|NCT00984282|11599453|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
7355753|NCT00984282|11599454|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
7355754|NCT00984282|11599453|FG000|Open-label Treatment|Adverse Event|20
7355755|NCT00984282|11599454|FG001|Open-label Treatment|Adverse Event|30
7355756|NCT00984282|11599453|FG000|Open-label Treatment|Withdrawal by Subject|6
7355757|NCT00984282|11599454|FG001|Open-label Treatment|Withdrawal by Subject|21
7355758|NCT00984282|11599453|FG000|Open-label Treatment|Death|7
7355759|NCT00984282|11599454|FG001|Open-label Treatment|Death|15
7355760|NCT00984282|11599453|FG000|Open-label Treatment|Progression, recurrence or relapse|40
7355761|NCT00984282|11599454|FG001|Open-label Treatment|Progression, recurrence or relapse|82
7355762|NCT00984282|11599453|FG000|Open-label Treatment|Lost to Follow-up|1
7355763|NCT00984282|11599454|FG001|Open-label Treatment|Lost to Follow-up|1
7355764|NCT00984282|11599453|FG000|Open-label Treatment|Patient convenience|1
7355765|NCT00984282|11599454|FG001|Open-label Treatment|Patient convenience|0
7355766|NCT00984282|11599453|FG000|Open-label Treatment|Non-compliant with study medication|1
7355767|NCT00984282|11599454|FG001|Open-label Treatment|Non-compliant with study medication|0
7355768|NCT00984282|11599453|FG000|Open-label Treatment|Target lesion removed|0
7355769|NCT00984282|11599454|FG001|Open-label Treatment|Target lesion removed|1
7355770|NCT00984282|11599453|FG000|Open-label Treatment|Protocol driven decision point|1
7355771|NCT00984282|11599454|FG001|Open-label Treatment|Protocol driven decision point|1
7355772|NCT00984282|11599453|FG000|Open-label Treatment|Transferred to treat. continuation study|2
7355773|NCT00984282|11599454|FG001|Open-label Treatment|Transferred to treat. continuation study|3
7355774|NCT00984282|11599453|FG000|Open-label Treatment|Switched to commercial drug|6
7355775|NCT00984282|11599454|FG001|Open-label Treatment|Switched to commercial drug|7
7355776|NCT00984282|11599453|FG000|Open-label Treatment|Physician Decision|1
7355777|NCT00984282|11599454|FG001|Open-label Treatment|Physician Decision|0
7355778|NCT00984282|11599453|FG000|Long Term Follow-up|Withdrawal by Subject|8
7355779|NCT00984282|11599454|FG001|Long Term Follow-up|Withdrawal by Subject|14
7355780|NCT00984282|11599453|FG000|Long Term Follow-up|Death|27
7355781|NCT00984282|11599454|FG001|Long Term Follow-up|Death|68
7355782|NCT00984282|11599453|FG000|Long Term Follow-up|Lost to Follow-up|3
7355783|NCT00984282|11599454|FG001|Long Term Follow-up|Lost to Follow-up|6
7355784|NCT00984282|11599453|FG000|Long Term Follow-up|Protocol driven decision point|25
7355785|NCT00984282|11599454|FG001|Long Term Follow-up|Protocol driven decision point|26
7355786|NCT00984282|11599453|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
7355787|NCT00984282|11599454|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
7355788|NCT00984282|11599453|FG000|Long Term Follow-up|Switched to commercial drug|4
7355789|NCT00984282|11599454|FG001|Long Term Follow-up|Switched to commercial drug|2
7355790|NCT00984282|11599453|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
7355791|NCT00984282|11599454|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
7355792|NCT00984295|11599465|FG000|Overall Study|Lost to Follow-up|31
7355793|NCT00984295|11599466|FG001|Overall Study|Lost to Follow-up|12
7355794|NCT00984295|11599467|FG002|Overall Study|Lost to Follow-up|13
7355795|NCT00984295|11599465|FG000|Overall Study|Protocol Violation|2
7355796|NCT00984295|11599466|FG001|Overall Study|Protocol Violation|1
7355797|NCT00984295|11599467|FG002|Overall Study|Protocol Violation|4
7355798|NCT00984295|11599465|FG000|Overall Study|Withdrawal by Subject|18
7355799|NCT00984295|11599466|FG001|Overall Study|Withdrawal by Subject|9
7355800|NCT00984295|11599467|FG002|Overall Study|Withdrawal by Subject|12
7355801|NCT00984295|11599465|FG000|Overall Study|CAE - discontinued test vaccine|0
7355802|NCT00984295|11599466|FG001|Overall Study|CAE - discontinued test vaccine|1
7355803|NCT00984295|11599467|FG002|Overall Study|CAE - discontinued test vaccine|3
7355804|NCT00984295|11599465|FG000|Overall Study|Missed one or more blood samplings|3
7355805|NCT00984295|11599466|FG001|Overall Study|Missed one or more blood samplings|7
7355806|NCT00984295|11599467|FG002|Overall Study|Missed one or more blood samplings|2
7355807|NCT00984295|11599465|FG000|Overall Study|Incomplete safety follow-up|11
7355808|NCT00984295|11599466|FG001|Overall Study|Incomplete safety follow-up|2
7355809|NCT00984295|11599467|FG002|Overall Study|Incomplete safety follow-up|3
7355810|NCT00984542|11599505|FG000|Overall Study|disease progression|19
7355811|NCT00984542|11599505|FG000|Overall Study|toxicity|7
7355812|NCT00984542|11599505|FG000|Overall Study|Death|7
7355813|NCT00984542|11599505|FG000|Overall Study|complicating disease|3
7355814|NCT00984542|11599505|FG000|Overall Study|Withdrawal by Subject|3
7355815|NCT00984542|11599505|FG000|Overall Study|clinical deterioration|2
7355816|NCT00984568|11599512|FG000|Overall Study|Withdrawal by Subject|1
7355817|NCT00984568|11599513|FG001|Overall Study|Withdrawal by Subject|2
7355818|NCT00984568|11599512|FG000|Overall Study|Lack of Efficacy|2
7355819|NCT00984568|11599513|FG001|Overall Study|Lack of Efficacy|0
7355820|NCT00984568|11599512|FG000|Overall Study|Adverse Event|2
7355821|NCT00984568|11599513|FG001|Overall Study|Adverse Event|0
7355822|NCT00984568|11599512|FG000|Overall Study|Did Not Meet Randomization Criteria|1
7355823|NCT00984568|11599513|FG001|Overall Study|Did Not Meet Randomization Criteria|0
7355824|NCT00984568|11599512|FG000|Overall Study|Lost to Follow-up|0
7355825|NCT00984568|11599513|FG001|Overall Study|Lost to Follow-up|1
7355826|NCT00984568|11599512|FG000|Overall Study|Opportunistic Infection|1
7355827|NCT00984568|11599513|FG001|Overall Study|Opportunistic Infection|0
7355828|NCT00984568|11599512|FG000|Overall Study|Unknown Reason|1
7355829|NCT00984568|11599513|FG001|Overall Study|Unknown Reason|3
7355830|NCT00984594|11599521|FG000|Overall Study|Lost to Follow-up|1
7355831|NCT00984594|11599522|FG001|Overall Study|Lost to Follow-up|0
7355832|NCT00984594|11599521|FG000|Overall Study|Withdrawal by Subject|0
7355833|NCT00984594|11599522|FG001|Overall Study|Withdrawal by Subject|1
7355834|NCT00984620|11599532|FG000|Overall Study|Adverse Event|5
7355835|NCT00984620|11599533|FG001|Overall Study|Adverse Event|5
7355836|NCT00984620|11599532|FG000|Overall Study|Lost to Follow-up|1
7355837|NCT00984620|11599533|FG001|Overall Study|Lost to Follow-up|1
7355838|NCT00984620|11599532|FG000|Overall Study|Withdrawal by Subject|0
7355839|NCT00984620|11599533|FG001|Overall Study|Withdrawal by Subject|2
7355840|NCT00984620|11599532|FG000|Overall Study|reason other than listed above|0
7355841|NCT00984620|11599533|FG001|Overall Study|reason other than listed above|4
7355842|NCT00984659|11599545|FG000|2-week Run-in Period|Adverse Event|8
7355843|NCT00984659|11599546|FG001|2-week Run-in Period|Adverse Event|0
7355844|NCT00984659|11599547|FG002|2-week Run-in Period|Adverse Event|0
7355845|NCT00984659|11599548|FG003|2-week Run-in Period|Adverse Event|0
7355846|NCT00984659|11599545|FG000|2-week Run-in Period|Protocol Violation|5
7355847|NCT00984659|11599546|FG001|2-week Run-in Period|Protocol Violation|0
7355848|NCT00984659|11599547|FG002|2-week Run-in Period|Protocol Violation|0
7355849|NCT00984659|11599548|FG003|2-week Run-in Period|Protocol Violation|0
7355850|NCT00984659|11599545|FG000|2-week Run-in Period|Study Closed/Terminated|2
7355851|NCT00984659|11599546|FG001|2-week Run-in Period|Study Closed/Terminated|0
7355852|NCT00984659|11599547|FG002|2-week Run-in Period|Study Closed/Terminated|0
7355853|NCT00984659|11599548|FG003|2-week Run-in Period|Study Closed/Terminated|0
7355854|NCT00984659|11599545|FG000|2-week Run-in Period|Lost to Follow-up|3
7355855|NCT00984659|11599546|FG001|2-week Run-in Period|Lost to Follow-up|0
7355856|NCT00984659|11599547|FG002|2-week Run-in Period|Lost to Follow-up|0
7355857|NCT00984659|11599548|FG003|2-week Run-in Period|Lost to Follow-up|0
7355858|NCT00984659|11599545|FG000|2-week Run-in Period|Physician Decision|10
7355859|NCT00984659|11599546|FG001|2-week Run-in Period|Physician Decision|0
7355860|NCT00984659|11599547|FG002|2-week Run-in Period|Physician Decision|0
7355861|NCT00984659|11599548|FG003|2-week Run-in Period|Physician Decision|0
7355862|NCT00984659|11599545|FG000|2-week Run-in Period|Withdrawal by Subject|10
7355863|NCT00984659|11599546|FG001|2-week Run-in Period|Withdrawal by Subject|0
7355864|NCT00984659|11599547|FG002|2-week Run-in Period|Withdrawal by Subject|0
7355865|NCT00984659|11599548|FG003|2-week Run-in Period|Withdrawal by Subject|0
7355866|NCT00984659|11599545|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
7355867|NCT00984659|11599546|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7355868|NCT00984659|11599547|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7355869|NCT00984659|11599548|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7355870|NCT00984659|11599545|FG000|6-week Double-blind Treatment Period|Adverse Event|0
7355871|NCT00984659|11599546|FG001|6-week Double-blind Treatment Period|Adverse Event|3
7355872|NCT00984659|11599547|FG002|6-week Double-blind Treatment Period|Adverse Event|3
7459625|NCT01819272|11754378|FG000|Overall Study|Lost to Follow-up|3
7459626|NCT01819272|11754379|FG001|Overall Study|Lost to Follow-up|0
7459627|NCT01819272|11754380|FG002|Overall Study|Lost to Follow-up|1
7459628|NCT01819272|11754381|FG003|Overall Study|Lost to Follow-up|0
7459629|NCT01819272|11754382|FG004|Overall Study|Lost to Follow-up|0
7459630|NCT01819272|11754383|FG005|Overall Study|Lost to Follow-up|3
7459631|NCT01819272|11754378|FG000|Overall Study|Protocol Violation|0
7459632|NCT01819272|11754379|FG001|Overall Study|Protocol Violation|0
7459633|NCT01819272|11754380|FG002|Overall Study|Protocol Violation|0
7459634|NCT01819272|11754381|FG003|Overall Study|Protocol Violation|1
7459635|NCT01819272|11754382|FG004|Overall Study|Protocol Violation|2
7459636|NCT01819272|11754383|FG005|Overall Study|Protocol Violation|3
7459637|NCT01819272|11754378|FG000|Overall Study|Physician Decision|0
7459638|NCT01819272|11754379|FG001|Overall Study|Physician Decision|1
7459639|NCT01819272|11754380|FG002|Overall Study|Physician Decision|0
7459640|NCT01819272|11754381|FG003|Overall Study|Physician Decision|0
7459641|NCT01819272|11754382|FG004|Overall Study|Physician Decision|0
7459642|NCT01819272|11754383|FG005|Overall Study|Physician Decision|0
7459643|NCT01819272|11754378|FG000|Overall Study|Withdrawal of Consent|0
7459644|NCT01819272|11754379|FG001|Overall Study|Withdrawal of Consent|1
7459645|NCT01819272|11754380|FG002|Overall Study|Withdrawal of Consent|2
7459646|NCT01819272|11754381|FG003|Overall Study|Withdrawal of Consent|1
7459647|NCT01819272|11754382|FG004|Overall Study|Withdrawal of Consent|0
7459648|NCT01819272|11754383|FG005|Overall Study|Withdrawal of Consent|1
7459649|NCT01819272|11754378|FG000|Overall Study|Loss of Glucose Control|2
7459650|NCT01819272|11754379|FG001|Overall Study|Loss of Glucose Control|1
7459651|NCT01819272|11754380|FG002|Overall Study|Loss of Glucose Control|0
7355873|NCT00984659|11599548|FG003|6-week Double-blind Treatment Period|Adverse Event|7
7355874|NCT00984659|11599545|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
7355875|NCT00984659|11599546|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
7355876|NCT00984659|11599547|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
7355877|NCT00984659|11599548|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
7355878|NCT00984659|11599545|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
7355879|NCT00984659|11599546|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
7355880|NCT00984659|11599547|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
7355881|NCT00984659|11599548|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
7355882|NCT00984659|11599545|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7459652|NCT01819272|11754381|FG003|Overall Study|Loss of Glucose Control|1
7459653|NCT01819272|11754382|FG004|Overall Study|Loss of Glucose Control|2
7459654|NCT01819272|11754383|FG005|Overall Study|Loss of Glucose Control|0
7459655|NCT01819506|11754425|FG000|Overall Study|Physician Decision|5
7459656|NCT01819506|11754426|FG001|Overall Study|Physician Decision|2
7459657|NCT01819506|11754425|FG000|Overall Study|Withdrawal by Subject|3
7459658|NCT01819506|11754426|FG001|Overall Study|Withdrawal by Subject|3
7355883|NCT00984659|11599546|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7355884|NCT00984659|11599547|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
7355885|NCT00984659|11599548|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
7355968|NCT00985153|11599650|FG002|Overall Study|Incomplete Safety Follow-up|4
7355886|NCT00984659|11599545|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
7355887|NCT00984659|11599546|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7355888|NCT00984659|11599547|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
7355889|NCT00984659|11599548|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
7355890|NCT00984867|11599570|FG000|Overall Study|Adverse Event|3
7355891|NCT00984867|11599571|FG001|Overall Study|Adverse Event|7
7355892|NCT00984867|11599570|FG000|Overall Study|Death|1
7355893|NCT00984867|11599571|FG001|Overall Study|Death|0
7355894|NCT00984867|11599570|FG000|Overall Study|Withdrawal by Subject|13
7355895|NCT00984867|11599571|FG001|Overall Study|Withdrawal by Subject|4
7355896|NCT00984867|11599570|FG000|Overall Study|Lost to Follow-up|3
7355897|NCT00984867|11599571|FG001|Overall Study|Lost to Follow-up|4
7355898|NCT00984867|11599570|FG000|Overall Study|Poor/non-compliance|0
7355899|NCT00984867|11599571|FG001|Overall Study|Poor/non-compliance|1
7355900|NCT00984867|11599570|FG000|Overall Study|Subject no longer meets study criteria|1
7355901|NCT00984867|11599571|FG001|Overall Study|Subject no longer meets study criteria|1
7355902|NCT00984867|11599570|FG000|Overall Study|site closing|1
7355903|NCT00984867|11599571|FG001|Overall Study|site closing|0
7355904|NCT00984867|11599570|FG000|Overall Study|lack of efficacy and subject compliance|1
7355905|NCT00984867|11599571|FG001|Overall Study|lack of efficacy and subject compliance|0
7355906|NCT00985088|11599596|FG000|Overall Study|Serious Adverse Event|1
7355907|NCT00985088|11599597|FG001|Overall Study|Serious Adverse Event|1
7355908|NCT00985088|11599598|FG002|Overall Study|Serious Adverse Event|0
7355909|NCT00985088|11599599|FG003|Overall Study|Serious Adverse Event|0
7355910|NCT00985088|11599600|FG004|Overall Study|Serious Adverse Event|0
7355911|NCT00985088|11599601|FG005|Overall Study|Serious Adverse Event|0
7355912|NCT00985088|11599602|FG006|Overall Study|Serious Adverse Event|0
7355913|NCT00985088|11599603|FG007|Overall Study|Serious Adverse Event|1
7355914|NCT00985088|11599596|FG000|Overall Study|Adverse Event|0
7355915|NCT00985088|11599597|FG001|Overall Study|Adverse Event|0
7355916|NCT00985088|11599598|FG002|Overall Study|Adverse Event|1
7355917|NCT00985088|11599599|FG003|Overall Study|Adverse Event|0
7355918|NCT00985088|11599600|FG004|Overall Study|Adverse Event|0
7355919|NCT00985088|11599601|FG005|Overall Study|Adverse Event|0
7355920|NCT00985088|11599602|FG006|Overall Study|Adverse Event|0
7355921|NCT00985088|11599603|FG007|Overall Study|Adverse Event|0
7355922|NCT00985088|11599596|FG000|Overall Study|Withdrawal by Subject|4
7355923|NCT00985088|11599597|FG001|Overall Study|Withdrawal by Subject|0
7355924|NCT00985088|11599598|FG002|Overall Study|Withdrawal by Subject|0
7355925|NCT00985088|11599599|FG003|Overall Study|Withdrawal by Subject|1
7355926|NCT00985088|11599600|FG004|Overall Study|Withdrawal by Subject|3
7355927|NCT00985088|11599601|FG005|Overall Study|Withdrawal by Subject|2
7355928|NCT00985088|11599602|FG006|Overall Study|Withdrawal by Subject|1
7355929|NCT00985088|11599603|FG007|Overall Study|Withdrawal by Subject|2
7355930|NCT00985088|11599596|FG000|Overall Study|Migrated/moved from study area|0
7355931|NCT00985088|11599597|FG001|Overall Study|Migrated/moved from study area|0
7355932|NCT00985088|11599598|FG002|Overall Study|Migrated/moved from study area|1
7355933|NCT00985088|11599599|FG003|Overall Study|Migrated/moved from study area|0
7355934|NCT00985088|11599600|FG004|Overall Study|Migrated/moved from study area|0
7355935|NCT00985088|11599601|FG005|Overall Study|Migrated/moved from study area|0
7355936|NCT00985088|11599602|FG006|Overall Study|Migrated/moved from study area|0
7355937|NCT00985088|11599603|FG007|Overall Study|Migrated/moved from study area|1
7355938|NCT00985088|11599596|FG000|Overall Study|Lost to Follow-up|6
7355939|NCT00985088|11599597|FG001|Overall Study|Lost to Follow-up|1
7355940|NCT00985088|11599598|FG002|Overall Study|Lost to Follow-up|2
7355941|NCT00985088|11599599|FG003|Overall Study|Lost to Follow-up|6
7355942|NCT00985088|11599600|FG004|Overall Study|Lost to Follow-up|6
7355943|NCT00985088|11599601|FG005|Overall Study|Lost to Follow-up|5
7355944|NCT00985088|11599602|FG006|Overall Study|Lost to Follow-up|3
7355945|NCT00985088|11599603|FG007|Overall Study|Lost to Follow-up|2
7355946|NCT00985114|11599633|FG000|Overall Study|Adverse Event|1
7355947|NCT00985114|11599634|FG001|Overall Study|Adverse Event|0
7355948|NCT00985114|11599633|FG000|Overall Study|Withdrawal by Subject|0
7355949|NCT00985114|11599634|FG001|Overall Study|Withdrawal by Subject|2
7355950|NCT00985153|11599648|FG000|Overall Study|Lost to Follow-up|16
7355951|NCT00985153|11599649|FG001|Overall Study|Lost to Follow-up|19
7355952|NCT00985153|11599650|FG002|Overall Study|Lost to Follow-up|17
7355953|NCT00985153|11599651|FG003|Overall Study|Lost to Follow-up|20
7355954|NCT00985153|11599648|FG000|Overall Study|Protocol Violation|3
7355955|NCT00985153|11599649|FG001|Overall Study|Protocol Violation|2
7355956|NCT00985153|11599650|FG002|Overall Study|Protocol Violation|4
7355957|NCT00985153|11599651|FG003|Overall Study|Protocol Violation|3
7355958|NCT00985153|11599648|FG000|Overall Study|Withdrawal by Subject|6
7355959|NCT00985153|11599649|FG001|Overall Study|Withdrawal by Subject|11
7355960|NCT00985153|11599650|FG002|Overall Study|Withdrawal by Subject|11
7355961|NCT00985153|11599651|FG003|Overall Study|Withdrawal by Subject|10
7355962|NCT00985153|11599648|FG000|Overall Study|Missed One or More Bleeds|7
7355963|NCT00985153|11599649|FG001|Overall Study|Missed One or More Bleeds|7
7355964|NCT00985153|11599650|FG002|Overall Study|Missed One or More Bleeds|8
7355965|NCT00985153|11599651|FG003|Overall Study|Missed One or More Bleeds|10
7355966|NCT00985153|11599648|FG000|Overall Study|Incomplete Safety Follow-up|3
7355967|NCT00985153|11599649|FG001|Overall Study|Incomplete Safety Follow-up|5
7355969|NCT00985153|11599651|FG003|Overall Study|Incomplete Safety Follow-up|4
7355970|NCT00985166|11599664|FG000|Overall Study|Lost to Follow-up|3
7355971|NCT00985166|11599665|FG001|Overall Study|Lost to Follow-up|2
7355972|NCT00985166|11599666|FG002|Overall Study|Lost to Follow-up|2
7355973|NCT00985166|11599664|FG000|Overall Study|Withdrawal by Subject|3
7355974|NCT00985166|11599665|FG001|Overall Study|Withdrawal by Subject|2
7355975|NCT00985166|11599666|FG002|Overall Study|Withdrawal by Subject|0
7355976|NCT00985166|11599664|FG000|Overall Study|Test not done|2
7355977|NCT00985166|11599665|FG001|Overall Study|Test not done|0
7355978|NCT00985166|11599666|FG002|Overall Study|Test not done|4
7355979|NCT00985166|11599664|FG000|Overall Study|Other|1
7355980|NCT00985166|11599665|FG001|Overall Study|Other|0
7355981|NCT00985166|11599666|FG002|Overall Study|Other|1
7355982|NCT00985192|11599676|FG000|Overall Study|Withdrawal by Subject|1
7355983|NCT00985192|11599676|FG000|Overall Study|Disease Progression|1
7355984|NCT00985192|11599676|FG000|Overall Study|Determined to be Ineligible During Trial|2
7355985|NCT00985231|11599682|FG000|Overall Study|ineligible|1
7355986|NCT00985231|11599683|FG001|Overall Study|ineligible|0
7355987|NCT00985231|11599682|FG000|Overall Study|Protocol Violation|1
7355988|NCT00985231|11599683|FG001|Overall Study|Protocol Violation|0
7355989|NCT00985231|11599682|FG000|Overall Study|Withdrawal by Subject|1
7355990|NCT00985231|11599683|FG001|Overall Study|Withdrawal by Subject|0
7355991|NCT00985231|11599682|FG000|Overall Study|Lost to Follow-up|0
7355992|NCT00985231|11599683|FG001|Overall Study|Lost to Follow-up|1
7355993|NCT00985231|11599682|FG000|Overall Study|Study related symptoms & complaints|0
7355994|NCT00985231|11599683|FG001|Overall Study|Study related symptoms & complaints|2
7355995|NCT00985426|11599695|FG000|Overall Study|Adverse Event|0
7355996|NCT00985426|11599696|FG001|Overall Study|Adverse Event|1
7355997|NCT00985426|11599695|FG000|Overall Study|Subject Non-Compliance|3
7355998|NCT00985426|11599696|FG001|Overall Study|Subject Non-Compliance|3
7355999|NCT00985426|11599695|FG000|Overall Study|Withdrawal by Subject|12
7356000|NCT00985426|11599696|FG001|Overall Study|Withdrawal by Subject|16
7356001|NCT00985426|11599695|FG000|Overall Study|Lost to Follow-up|8
7356002|NCT00985426|11599696|FG001|Overall Study|Lost to Follow-up|10
7356003|NCT00985426|11599695|FG000|Overall Study|Death|7
7356004|NCT00985426|11599696|FG001|Overall Study|Death|3
7356005|NCT00985426|11599695|FG000|Overall Study|Protocol Violation|2
7356006|NCT00985426|11599696|FG001|Overall Study|Protocol Violation|0
7356007|NCT00985426|11599695|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7356008|NCT00985426|11599696|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
7356009|NCT00985439|11599706|FG000|Overall Study|Adverse Event|0
7356010|NCT00985439|11599707|FG001|Overall Study|Adverse Event|0
7356011|NCT00985439|11599708|FG002|Overall Study|Adverse Event|1
7569505|NCT03449446|11945894|FG004|Overall Study|Non Compliance with Study Drug|0
7569506|NCT03449446|11945895|FG005|Overall Study|Non Compliance with Study Drug|0
7569507|NCT03449446|11945896|FG006|Overall Study|Non Compliance with Study Drug|0
7569508|NCT03449446|11945890|FG000|Overall Study|Protocol Violation|0
7569509|NCT03449446|11945891|FG001|Overall Study|Protocol Violation|0
7569510|NCT03449446|11945892|FG002|Overall Study|Protocol Violation|0
7356012|NCT00985439|11599709|FG003|Overall Study|Adverse Event|0
7356013|NCT00985465|11599721|FG000|Overall Study|Withdrawal by Subject|1
7356014|NCT00985465|11599722|FG001|Overall Study|Withdrawal by Subject|2
7356015|NCT00985465|11599721|FG000|Overall Study|Considered to be part of the other group|0
7356016|NCT00985465|11599722|FG001|Overall Study|Considered to be part of the other group|1
7356017|NCT00985491|11599729|FG000|Overall Study|Adverse Event|8
7356018|NCT00985491|11599729|FG000|Overall Study|device migration|7
7356019|NCT00985491|11599729|FG000|Overall Study|Withdrawal by Subject|1
7356020|NCT00985491|11599729|FG000|Overall Study|implant failure|3
7356021|NCT00985504|11599736|FG000|Acute Treatment Period|Adverse Event|3
7356022|NCT00985504|11599737|FG001|Acute Treatment Period|Adverse Event|4
7356023|NCT00985504|11599736|FG000|Acute Treatment Period|Entry Criteria Not Met|1
7356024|NCT00985504|11599737|FG001|Acute Treatment Period|Entry Criteria Not Met|2
7356025|NCT00985504|11599736|FG000|Acute Treatment Period|Protocol Violation|2
7356026|NCT00985504|11599737|FG001|Acute Treatment Period|Protocol Violation|0
7356027|NCT00985504|11599736|FG000|Acute Treatment Period|Sponsor Decision|0
7356028|NCT00985504|11599737|FG001|Acute Treatment Period|Sponsor Decision|1
7356029|NCT00985504|11599736|FG000|Acute Treatment Period|Withdrawal by Subject|9
7356030|NCT00985504|11599737|FG001|Acute Treatment Period|Withdrawal by Subject|5
7356031|NCT00985504|11599736|FG000|Optimization Period|Adverse Event|7
7356032|NCT00985504|11599737|FG001|Optimization Period|Adverse Event|9
7356033|NCT00985504|11599736|FG000|Optimization Period|Death|0
7356034|NCT00985504|11599737|FG001|Optimization Period|Death|1
7356035|NCT00985504|11599736|FG000|Optimization Period|Lack of Efficacy|5
7356036|NCT00985504|11599737|FG001|Optimization Period|Lack of Efficacy|3
7356037|NCT00985504|11599736|FG000|Optimization Period|Lost to Follow-up|0
7356038|NCT00985504|11599737|FG001|Optimization Period|Lost to Follow-up|1
7356039|NCT00985504|11599736|FG000|Optimization Period|Physician Decision|1
7569511|NCT03449446|11945893|FG003|Overall Study|Protocol Violation|0
7356040|NCT00985504|11599737|FG001|Optimization Period|Physician Decision|0
7356041|NCT00985504|11599736|FG000|Optimization Period|Protocol Violation|3
7356042|NCT00985504|11599737|FG001|Optimization Period|Protocol Violation|1
7356043|NCT00985504|11599736|FG000|Optimization Period|Withdrawal by Subject|10
7356044|NCT00985504|11599737|FG001|Optimization Period|Withdrawal by Subject|8
7356045|NCT00985621|11599771|FG000|Overall Study|Adverse Event|2
7356046|NCT00985621|11599772|FG001|Overall Study|Adverse Event|3
7356047|NCT00985621|11599773|FG002|Overall Study|Adverse Event|4
7356048|NCT00985621|11599774|FG003|Overall Study|Adverse Event|16
7356049|NCT00985621|11599771|FG000|Overall Study|Lack of Efficacy|10
7356050|NCT00985621|11599772|FG001|Overall Study|Lack of Efficacy|6
7356051|NCT00985621|11599773|FG002|Overall Study|Lack of Efficacy|5
7356052|NCT00985621|11599774|FG003|Overall Study|Lack of Efficacy|12
7356053|NCT00985621|11599771|FG000|Overall Study|Lost to Follow-up|2
7356054|NCT00985621|11599772|FG001|Overall Study|Lost to Follow-up|3
7356055|NCT00985621|11599773|FG002|Overall Study|Lost to Follow-up|4
7356056|NCT00985621|11599774|FG003|Overall Study|Lost to Follow-up|4
7459659|NCT01819727|11754438|FG000|Overall Study|Adverse Event|8
7459660|NCT01819727|11754439|FG001|Overall Study|Adverse Event|9
7459661|NCT01819727|11754438|FG000|Overall Study|Death|1
7459662|NCT01819727|11754439|FG001|Overall Study|Death|0
7459663|NCT01819727|11754438|FG000|Overall Study|Lost to Follow-up|1
7459664|NCT01819727|11754439|FG001|Overall Study|Lost to Follow-up|1
7459665|NCT01819727|11754438|FG000|Overall Study|Physician Decision|3
7459666|NCT01819727|11754439|FG001|Overall Study|Physician Decision|2
7459667|NCT01819727|11754438|FG000|Overall Study|Pregnancy|1
7459668|NCT01819727|11754439|FG001|Overall Study|Pregnancy|0
7459669|NCT01819727|11754438|FG000|Overall Study|Protocol Violation|0
7459670|NCT01819727|11754439|FG001|Overall Study|Protocol Violation|2
7459671|NCT01819727|11754438|FG000|Overall Study|Study Terminated by Sponsor|0
7459672|NCT01819727|11754439|FG001|Overall Study|Study Terminated by Sponsor|1
7459673|NCT01819727|11754438|FG000|Overall Study|Withdrawal by Subject|6
7459674|NCT01819727|11754439|FG001|Overall Study|Withdrawal by Subject|11
7459675|NCT01819727|11754438|FG000|Overall Study|Unable to demostrate ability self-inject|0
7459676|NCT01819727|11754439|FG001|Overall Study|Unable to demostrate ability self-inject|1
7459677|NCT01819727|11754438|FG000|Overall Study|Quit due to lack of health benifits|0
7459678|NCT01819727|11754439|FG001|Overall Study|Quit due to lack of health benifits|1
7459679|NCT01820260|11754488|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459680|NCT01820260|11754489|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459681|NCT01820260|11754490|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459682|NCT01820260|11754491|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459683|NCT01820260|11754492|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459684|NCT01820260|11754493|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459685|NCT01820260|11754494|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
7459686|NCT01820260|11754495|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459687|NCT01820260|11754496|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459688|NCT01820260|11754497|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459689|NCT01820260|11754498|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459690|NCT01820260|11754499|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459691|NCT01820260|11754500|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459692|NCT01820260|11754501|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
7459693|NCT01820260|11754488|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
7459694|NCT01820260|11754489|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
7459695|NCT01820260|11754490|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
7459696|NCT01820260|11754491|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
7459697|NCT01820260|11754492|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
7459698|NCT01820260|11754493|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
7459699|NCT01820260|11754494|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
7459700|NCT01820260|11754495|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
7459701|NCT01820260|11754496|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
7459702|NCT01820260|11754497|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
7459703|NCT01820260|11754498|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
7459704|NCT01820260|11754499|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
7569512|NCT03449446|11945894|FG004|Overall Study|Protocol Violation|1
7569513|NCT03449446|11945895|FG005|Overall Study|Protocol Violation|1
7569514|NCT03449446|11945896|FG006|Overall Study|Protocol Violation|0
7569515|NCT03449446|11945890|FG000|Overall Study|Death|0
7459705|NCT01820260|11754500|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
7459706|NCT01820260|11754501|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
7459707|NCT01820364|11754537|FG000|Part I: LGX818|Death|1
7459708|NCT01820364|11754538|FG001|Part I: LGX818|Death|0
7459709|NCT01820364|11754537|FG000|Part I: LGX818|Administrative Problems|3
7459710|NCT01820364|11754538|FG001|Part I: LGX818|Administrative Problems|0
7459711|NCT01820364|11754537|FG000|Part I: LGX818|Adverse Event|6
7459712|NCT01820364|11754538|FG001|Part I: LGX818|Adverse Event|0
7459713|NCT01820364|11754537|FG000|Part I: LGX818|Disease Progression|4
7569516|NCT03449446|11945891|FG001|Overall Study|Death|0
7356057|NCT00985621|11599771|FG000|Overall Study|Study Terminated by Sponsor|89
7356058|NCT00985621|11599772|FG001|Overall Study|Study Terminated by Sponsor|108
7356059|NCT00985621|11599773|FG002|Overall Study|Study Terminated by Sponsor|99
7356060|NCT00985621|11599774|FG003|Overall Study|Study Terminated by Sponsor|92
7356061|NCT00985621|11599771|FG000|Overall Study|Protocol Violation|1
7356062|NCT00985621|11599772|FG001|Overall Study|Protocol Violation|1
7356063|NCT00985621|11599773|FG002|Overall Study|Protocol Violation|1
7356064|NCT00985621|11599774|FG003|Overall Study|Protocol Violation|0
7356065|NCT00985621|11599771|FG000|Overall Study|Withdrawal by Subject|8
7356066|NCT00985621|11599772|FG001|Overall Study|Withdrawal by Subject|10
7356067|NCT00985621|11599773|FG002|Overall Study|Withdrawal by Subject|8
7356068|NCT00985621|11599774|FG003|Overall Study|Withdrawal by Subject|12
7356069|NCT00985621|11599771|FG000|Overall Study|Other|1
7356070|NCT00985621|11599772|FG001|Overall Study|Other|0
7356071|NCT00985621|11599773|FG002|Overall Study|Other|0
7356072|NCT00985621|11599774|FG003|Overall Study|Other|0
7356073|NCT00985621|11599771|FG000|Overall Study|Randomized but not Treated|1
7356074|NCT00985621|11599772|FG001|Overall Study|Randomized but not Treated|0
7356075|NCT00985621|11599773|FG002|Overall Study|Randomized but not Treated|2
7356076|NCT00985621|11599774|FG003|Overall Study|Randomized but not Treated|1
7356077|NCT00985673|11599792|FG000|Overall Study|Lost to Follow-up|6
7356078|NCT00985673|11599793|FG001|Overall Study|Lost to Follow-up|7
7356079|NCT00985673|11599794|FG002|Overall Study|Lost to Follow-up|6
7356080|NCT00985673|11599795|FG003|Overall Study|Lost to Follow-up|10
7356081|NCT00985673|11599796|FG004|Overall Study|Lost to Follow-up|5
7356082|NCT00985673|11599797|FG005|Overall Study|Lost to Follow-up|3
7356083|NCT00985673|11599792|FG000|Overall Study|Withdrawal by Subject|0
7356084|NCT00985673|11599793|FG001|Overall Study|Withdrawal by Subject|4
7356085|NCT00985673|11599794|FG002|Overall Study|Withdrawal by Subject|5
7356086|NCT00985673|11599795|FG003|Overall Study|Withdrawal by Subject|2
7356087|NCT00985673|11599796|FG004|Overall Study|Withdrawal by Subject|2
7356088|NCT00985673|11599797|FG005|Overall Study|Withdrawal by Subject|3
7356089|NCT00985673|11599792|FG000|Overall Study|Other|1
7356090|NCT00985673|11599793|FG001|Overall Study|Other|0
7356091|NCT00985673|11599794|FG002|Overall Study|Other|1
7356092|NCT00985673|11599795|FG003|Overall Study|Other|0
7356093|NCT00985673|11599796|FG004|Overall Study|Other|1
7356094|NCT00985673|11599797|FG005|Overall Study|Other|0
7356095|NCT00985686|11599816|FG000|Overall Study|Lost to Follow-up|1
7356096|NCT00985686|11599817|FG001|Overall Study|Lost to Follow-up|1
7356097|NCT00985686|11599818|FG002|Overall Study|Lost to Follow-up|0
7356098|NCT00985686|11599819|FG003|Overall Study|Lost to Follow-up|2
7356099|NCT00985712|11599829|FG000|Overall Study|Adverse Event|0
7356100|NCT00985712|11599830|FG001|Overall Study|Adverse Event|1
7356101|NCT00985712|11599829|FG000|Overall Study|Lost to Follow-up|2
7356102|NCT00985712|11599830|FG001|Overall Study|Lost to Follow-up|2
7356103|NCT00985712|11599829|FG000|Overall Study|Protocol Violation|0
7356104|NCT00985712|11599830|FG001|Overall Study|Protocol Violation|1
7356105|NCT00985712|11599829|FG000|Overall Study|Withdrawal by Subject|4
7356106|NCT00985712|11599830|FG001|Overall Study|Withdrawal by Subject|1
7356107|NCT00985712|11599829|FG000|Overall Study|Sponsor decision|0
7356108|NCT00985712|11599830|FG001|Overall Study|Sponsor decision|2
7356109|NCT00985725|11599838|FG000|Overall Study|Adverse Event|4
7356110|NCT00985725|11599839|FG001|Overall Study|Adverse Event|1
7356111|NCT00985725|11599838|FG000|Overall Study|Protocol Violation|1
7356112|NCT00985725|11599839|FG001|Overall Study|Protocol Violation|3
7356113|NCT00985725|11599838|FG000|Overall Study|Withdrawal by Subject|4
7356114|NCT00985725|11599839|FG001|Overall Study|Withdrawal by Subject|4
7356115|NCT00985725|11599838|FG000|Overall Study|Lost to Follow-up|1
7569517|NCT03449446|11945892|FG002|Overall Study|Death|0
7356116|NCT00985725|11599839|FG001|Overall Study|Lost to Follow-up|1
7356117|NCT00985725|11599838|FG000|Overall Study|Lack of Efficacy|0
7356118|NCT00985725|11599839|FG001|Overall Study|Lack of Efficacy|1
7356119|NCT00985725|11599838|FG000|Overall Study|Non-compliance|1
7356120|NCT00985725|11599839|FG001|Overall Study|Non-compliance|2
7356121|NCT00985725|11599838|FG000|Overall Study|Out-of-window visits|0
7356122|NCT00985725|11599839|FG001|Overall Study|Out-of-window visits|1
7356123|NCT00985751|11599850|FG000|Overall Study|Adverse Event|0
7356124|NCT00985751|11599851|FG001|Overall Study|Adverse Event|0
7356125|NCT00985751|11599852|FG002|Overall Study|Adverse Event|0
7356126|NCT00985751|11599853|FG003|Overall Study|Adverse Event|0
7356127|NCT00985751|11599854|FG004|Overall Study|Adverse Event|1
7356128|NCT00985790|11599871|FG000|Overall Study|Withdrawal by Subject|1
7356129|NCT00985790|11599872|FG001|Overall Study|Withdrawal by Subject|1
7356130|NCT00985790|11599871|FG000|Overall Study|Lost to Follow-up|6
7356131|NCT00985790|11599872|FG001|Overall Study|Lost to Follow-up|7
7356132|NCT00985946|11599892|FG000|Overall Study|Lost to Follow-up|6
7356133|NCT00985946|11599892|FG000|Overall Study|Withdrawal by Subject|1
7356134|NCT00985959|11599899|FG000|Overall Study|Adverse Event|0
7356135|NCT00985959|11599900|FG001|Overall Study|Adverse Event|0
7356136|NCT00985959|11599901|FG002|Overall Study|Adverse Event|19
7356137|NCT00985959|11599899|FG000|Overall Study|Withdrawal by Subject|0
7356138|NCT00985959|11599900|FG001|Overall Study|Withdrawal by Subject|0
7356139|NCT00985959|11599901|FG002|Overall Study|Withdrawal by Subject|8
7356140|NCT00985959|11599899|FG000|Overall Study|Progressive disease|1
7356141|NCT00985959|11599900|FG001|Overall Study|Progressive disease|2
7356142|NCT00985959|11599901|FG002|Overall Study|Progressive disease|8
7569518|NCT03449446|11945893|FG003|Overall Study|Death|0
7356143|NCT00985959|11599899|FG000|Overall Study|Unrecovered toxicity|0
7356144|NCT00985959|11599900|FG001|Overall Study|Unrecovered toxicity|0
7356145|NCT00985959|11599901|FG002|Overall Study|Unrecovered toxicity|7
7356146|NCT00985959|11599899|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
7356147|NCT00985959|11599900|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
7356148|NCT00985959|11599901|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
7356149|NCT00985959|11599899|FG000|Overall Study|Complete response observed over 2 cycles|0
7356150|NCT00985959|11599900|FG001|Overall Study|Complete response observed over 2 cycles|1
7356151|NCT00985959|11599901|FG002|Overall Study|Complete response observed over 2 cycles|4
7356152|NCT00985959|11599899|FG000|Overall Study|Other|0
7356153|NCT00985959|11599900|FG001|Overall Study|Other|0
7356154|NCT00985959|11599901|FG002|Overall Study|Other|11
7356155|NCT00985985|11599919|FG000|Overall Study|Adverse Event|4
7356156|NCT00985985|11599920|FG001|Overall Study|Adverse Event|2
7356157|NCT00985985|11599921|FG002|Overall Study|Adverse Event|2
7356158|NCT00985985|11599922|FG003|Overall Study|Adverse Event|2
7356159|NCT00985985|11599919|FG000|Overall Study|Lost to Follow-up|4
7356160|NCT00985985|11599920|FG001|Overall Study|Lost to Follow-up|11
7356161|NCT00985985|11599921|FG002|Overall Study|Lost to Follow-up|2
7356162|NCT00985985|11599922|FG003|Overall Study|Lost to Follow-up|3
7356163|NCT00985985|11599919|FG000|Overall Study|Protocol Violation|1
7356164|NCT00985985|11599920|FG001|Overall Study|Protocol Violation|2
7356165|NCT00985985|11599921|FG002|Overall Study|Protocol Violation|0
7356166|NCT00985985|11599922|FG003|Overall Study|Protocol Violation|1
7356167|NCT00985985|11599919|FG000|Overall Study|Lack of Efficacy|5
7356168|NCT00985985|11599920|FG001|Overall Study|Lack of Efficacy|6
7356169|NCT00985985|11599921|FG002|Overall Study|Lack of Efficacy|1
7356170|NCT00985985|11599922|FG003|Overall Study|Lack of Efficacy|3
7356171|NCT00985985|11599919|FG000|Overall Study|Withdrawal by Subject|4
7356172|NCT00985985|11599920|FG001|Overall Study|Withdrawal by Subject|2
7356173|NCT00985985|11599921|FG002|Overall Study|Withdrawal by Subject|2
7356174|NCT00985985|11599922|FG003|Overall Study|Withdrawal by Subject|2
7356175|NCT00985985|11599919|FG000|Overall Study|Other Reason|6
7356176|NCT00985985|11599920|FG001|Overall Study|Other Reason|1
7356177|NCT00985985|11599921|FG002|Overall Study|Other Reason|4
7356178|NCT00985985|11599922|FG003|Overall Study|Other Reason|2
7356179|NCT00986102|11599941|FG000|Overall Study|Lost to Follow-up|0
7356180|NCT00986102|11599942|FG001|Overall Study|Lost to Follow-up|1
7356181|NCT00986102|11599943|FG002|Overall Study|Lost to Follow-up|0
7356182|NCT00986102|11599944|FG003|Overall Study|Lost to Follow-up|1
7356183|NCT00986102|11599941|FG000|Overall Study|Withdrawal by Subject|1
7356184|NCT00986102|11599942|FG001|Overall Study|Withdrawal by Subject|1
7356185|NCT00986102|11599943|FG002|Overall Study|Withdrawal by Subject|0
7356186|NCT00986102|11599944|FG003|Overall Study|Withdrawal by Subject|0
7356187|NCT00986154|11599956|FG000|Overall Study|Death|136
7356188|NCT00986154|11599957|FG001|Overall Study|Death|127
7356189|NCT00986154|11599956|FG000|Overall Study|Lost to Follow-up|7
7356190|NCT00986154|11599957|FG001|Overall Study|Lost to Follow-up|4
7356191|NCT00986154|11599956|FG000|Overall Study|Withdrawal by Subject|32
7356192|NCT00986154|11599957|FG001|Overall Study|Withdrawal by Subject|33
7356193|NCT00986154|11599956|FG000|Overall Study|investigator/subject decide not continue|6
7356194|NCT00986154|11599957|FG001|Overall Study|investigator/subject decide not continue|3
7356195|NCT00986154|11599956|FG000|Overall Study|never received study drug|25
7356196|NCT00986154|11599957|FG001|Overall Study|never received study drug|27
7356197|NCT00986180|11599965|FG000|Overall Study|Adverse Event|21
7356198|NCT00986180|11599966|FG001|Overall Study|Adverse Event|23
7356199|NCT00986180|11599965|FG000|Overall Study|Lack of Efficacy|4
7356200|NCT00986180|11599966|FG001|Overall Study|Lack of Efficacy|3
7356201|NCT00986180|11599965|FG000|Overall Study|Lost to Follow-up|5
7356202|NCT00986180|11599966|FG001|Overall Study|Lost to Follow-up|7
7356203|NCT00986180|11599965|FG000|Overall Study|Physician Decision|1
7356204|NCT00986180|11599966|FG001|Overall Study|Physician Decision|3
7356205|NCT00986180|11599965|FG000|Overall Study|Protocol Violation|2
7356206|NCT00986180|11599966|FG001|Overall Study|Protocol Violation|0
7356207|NCT00986180|11599965|FG000|Overall Study|Withdrawal by Subject|1
7356208|NCT00986180|11599966|FG001|Overall Study|Withdrawal by Subject|9
7356209|NCT00986180|11599965|FG000|Overall Study|Miscellanies|10
7356210|NCT00986180|11599966|FG001|Overall Study|Miscellanies|11
7356211|NCT00986232|11599976|FG000|Overall Study|Adverse Event|1
7356212|NCT00986232|11599977|FG001|Overall Study|Adverse Event|2
7356213|NCT00986232|11599978|FG002|Overall Study|Adverse Event|3
7356214|NCT00986232|11599979|FG003|Overall Study|Adverse Event|0
7356215|NCT00986232|11599976|FG000|Overall Study|Lost to Follow-up|19
7356216|NCT00986232|11599977|FG001|Overall Study|Lost to Follow-up|12
7356217|NCT00986232|11599978|FG002|Overall Study|Lost to Follow-up|12
7356218|NCT00986232|11599979|FG003|Overall Study|Lost to Follow-up|7
7356219|NCT00986232|11599976|FG000|Overall Study|Protocol Violation|2
7356220|NCT00986232|11599977|FG001|Overall Study|Protocol Violation|3
7356221|NCT00986232|11599978|FG002|Overall Study|Protocol Violation|0
7356222|NCT00986232|11599979|FG003|Overall Study|Protocol Violation|1
7356223|NCT00986232|11599976|FG000|Overall Study|Withdrawal by Subject|13
7356224|NCT00986232|11599977|FG001|Overall Study|Withdrawal by Subject|16
7356225|NCT00986232|11599978|FG002|Overall Study|Withdrawal by Subject|12
7356226|NCT00986232|11599979|FG003|Overall Study|Withdrawal by Subject|3
7356227|NCT00986232|11599976|FG000|Overall Study|Missed one or more bleeds|13
7356228|NCT00986232|11599977|FG001|Overall Study|Missed one or more bleeds|10
7356229|NCT00986232|11599978|FG002|Overall Study|Missed one or more bleeds|6
7356230|NCT00986232|11599979|FG003|Overall Study|Missed one or more bleeds|7
7356231|NCT00986232|11599976|FG000|Overall Study|Incomplete safety follow-up|3
7356232|NCT00986232|11599977|FG001|Overall Study|Incomplete safety follow-up|7
7356233|NCT00986232|11599978|FG002|Overall Study|Incomplete safety follow-up|2
7356234|NCT00986232|11599979|FG003|Overall Study|Incomplete safety follow-up|2
7356235|NCT00986245|11599995|FG000|First Intervention|Poor compliance|8
7356236|NCT00986245|11599996|FG001|First Intervention|Poor compliance|4
7356237|NCT00986245|11599995|FG000|First Intervention|Lack of Efficacy|1
7356238|NCT00986245|11599996|FG001|First Intervention|Lack of Efficacy|2
7356239|NCT00986245|11599995|FG000|First Intervention|Withdrawal by Subject|0
7356240|NCT00986245|11599996|FG001|First Intervention|Withdrawal by Subject|1
7569519|NCT03449446|11945894|FG004|Overall Study|Death|1
7569520|NCT03449446|11945895|FG005|Overall Study|Death|0
7356241|NCT00986245|11599995|FG000|First Intervention|Protocol Violation|0
7356242|NCT00986245|11599996|FG001|First Intervention|Protocol Violation|1
7356243|NCT00986245|11599995|FG000|First Intervention|Out of indication|1
7356244|NCT00986245|11599996|FG001|First Intervention|Out of indication|0
7356245|NCT00986245|11599995|FG000|Second Intervention|Poor compliance|1
7356246|NCT00986245|11599996|FG001|Second Intervention|Poor compliance|0
7356247|NCT00986245|11599995|FG000|Second Intervention|Lost to Follow-up|1
7356248|NCT00986245|11599996|FG001|Second Intervention|Lost to Follow-up|0
7356249|NCT00986245|11599995|FG000|Second Intervention|Protocol Violation|0
7356250|NCT00986245|11599996|FG001|Second Intervention|Protocol Violation|1
7356251|NCT00986258|11600007|FG000|Observation Period|Not eligible to be dosed|11
7356252|NCT00986258|11600007|FG000|Titration and Optimal Dose Period|Adverse Event|15
7356253|NCT00986258|11600007|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
7356254|NCT00986258|11600007|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
7459714|NCT01820364|11754538|FG001|Part I: LGX818|Disease Progression|0
7459715|NCT01820364|11754537|FG000|Part II: LGX818 + MEK162|Study Termination|0
7459716|NCT01820364|11754538|FG001|Part II: LGX818 + MEK162|Study Termination|1
7459717|NCT01820559|11754560|FG000|Overall Study|Adverse Event|4
7459718|NCT01820559|11754561|FG001|Overall Study|Adverse Event|6
7459719|NCT01820559|11754562|FG002|Overall Study|Adverse Event|13
7459720|NCT01820559|11754560|FG000|Overall Study|Withdrawal by Subject|1
7459721|NCT01820559|11754561|FG001|Overall Study|Withdrawal by Subject|2
7459722|NCT01820559|11754562|FG002|Overall Study|Withdrawal by Subject|5
7459723|NCT01820559|11754560|FG000|Overall Study|Protocol Violation|2
7459724|NCT01820559|11754561|FG001|Overall Study|Protocol Violation|1
7459725|NCT01820559|11754562|FG002|Overall Study|Protocol Violation|3
7356255|NCT00986258|11600007|FG000|Titration and Optimal Dose Period|Non-Compliance|1
7356256|NCT00986258|11600007|FG000|Titration and Optimal Dose Period|Other|1
7356257|NCT00986258|11600007|FG000|Maintenance Period|Adverse Event|5
7356258|NCT00986258|11600007|FG000|Maintenance Period|Lack of Efficacy|2
7356259|NCT00986258|11600007|FG000|Maintenance Period|Withdrawal by Subject|2
7356260|NCT00986349|11600021|FG000|Overall Study|Unsuccessful implant procedure|3
7356261|NCT00986349|11600021|FG000|Overall Study|Adverse Event|2
7356262|NCT00986349|11600021|FG000|Overall Study|Physician Decision|1
7356263|NCT00986349|11600021|FG000|Overall Study|device migration|1
7356264|NCT00986362|11600036|FG000|Overall Study|Death|2
7356265|NCT00986362|11600037|FG001|Overall Study|Death|0
7356266|NCT00986362|11600036|FG000|Overall Study|Lost to Follow-up|0
7356267|NCT00986362|11600037|FG001|Overall Study|Lost to Follow-up|1
7356268|NCT00986427|11600057|FG000|Overall Study|Lost to Follow-up|2
7356269|NCT00986427|11600058|FG001|Overall Study|Lost to Follow-up|0
7356270|NCT00986427|11600057|FG000|Overall Study|Lack of Efficacy|1
7356271|NCT00986427|11600058|FG001|Overall Study|Lack of Efficacy|0
7356272|NCT00986427|11600057|FG000|Overall Study|Withdrawal by Subject|1
7356273|NCT00986427|11600058|FG001|Overall Study|Withdrawal by Subject|0
7356274|NCT00986440|11600070|FG000|Overall Study|Progressive disease|27
7356275|NCT00986440|11600071|FG001|Overall Study|Progressive disease|37
7356276|NCT00986440|11600070|FG000|Overall Study|Serious adverse event or adverse event|9
7356277|NCT00986440|11600071|FG001|Overall Study|Serious adverse event or adverse event|2
7569521|NCT03449446|11945896|FG006|Overall Study|Death|0
7356278|NCT00986440|11600070|FG000|Overall Study|Withdrawal by Subject|1
7459726|NCT01820559|11754560|FG000|Overall Study|Subject's non-compliance|1
7356279|NCT00986440|11600071|FG001|Overall Study|Withdrawal by Subject|2
7356280|NCT00986440|11600070|FG000|Overall Study|Screen failure (not dosed)|4
7356281|NCT00986440|11600071|FG001|Overall Study|Screen failure (not dosed)|2
7356282|NCT00986479|11600085|FG000|Period 1|Improved mood|1
7356283|NCT00986479|11600086|FG001|Period 1|Improved mood|0
7356284|NCT00986479|11600085|FG000|Period 1|Administrative reasons|1
7356285|NCT00986479|11600086|FG001|Period 1|Administrative reasons|0
7356286|NCT00986570|11600102|FG000|Overall Study|Lost to Follow-up|6
7356287|NCT00986570|11600102|FG000|Overall Study|Potential bias for objective assessment|1
7356288|NCT00986674|11600119|FG000|Overall Study|Lack of Efficacy|28
7356289|NCT00986674|11600120|FG001|Overall Study|Lack of Efficacy|25
7356290|NCT00986674|11600121|FG002|Overall Study|Lack of Efficacy|23
7356291|NCT00986674|11600119|FG000|Overall Study|Adverse Event|4
7356292|NCT00986674|11600120|FG001|Overall Study|Adverse Event|8
7356293|NCT00986674|11600121|FG002|Overall Study|Adverse Event|9
7356294|NCT00986674|11600119|FG000|Overall Study|Death|5
7356295|NCT00986674|11600120|FG001|Overall Study|Death|0
7356296|NCT00986674|11600121|FG002|Overall Study|Death|4
7356297|NCT00986674|11600119|FG000|Overall Study|Withdrawal by Subject|6
7356298|NCT00986674|11600120|FG001|Overall Study|Withdrawal by Subject|2
7356299|NCT00986674|11600121|FG002|Overall Study|Withdrawal by Subject|1
7356300|NCT00986674|11600119|FG000|Overall Study|alternative therapy|0
7356301|NCT00986674|11600120|FG001|Overall Study|alternative therapy|0
7356302|NCT00986674|11600121|FG002|Overall Study|alternative therapy|1
7356303|NCT00986674|11600119|FG000|Overall Study|not start protocol therapy|4
7356304|NCT00986674|11600120|FG001|Overall Study|not start protocol therapy|3
7356305|NCT00986674|11600121|FG002|Overall Study|not start protocol therapy|1
7356306|NCT00986674|11600119|FG000|Overall Study|unknown/not specify|0
7356307|NCT00986674|11600120|FG001|Overall Study|unknown/not specify|7
7356308|NCT00986674|11600121|FG002|Overall Study|unknown/not specify|9
7356309|NCT00986830|11600129|FG000|Overall Study|Death|1
7356310|NCT00986830|11600129|FG000|Overall Study|Lost to Follow-up|1
7356311|NCT00986830|11600129|FG000|Overall Study|Lack of Efficacy|1
7356312|NCT00986830|11600129|FG000|Overall Study|Unable to access sinus with device|5
7356313|NCT00986921|11600144|FG000|Overall Study|Physician Decision|1
7356314|NCT00986921|11600145|FG001|Overall Study|Physician Decision|0
7356315|NCT00986973|11600154|FG000|Overall Study|Withdrawn by study team|1
7356316|NCT00986986|11600161|FG000|Overall Study|Lost to Follow-up|0
7569522|NCT03449979|11945916|FG000|Overall Study|Technical difficulty|0
7569523|NCT03449979|11945917|FG001|Overall Study|Technical difficulty|0
7356317|NCT00986986|11600162|FG001|Overall Study|Lost to Follow-up|1
7356318|NCT00987337|11600172|FG000|Overall Study|Adverse Event|10
7356319|NCT00987337|11600173|FG001|Overall Study|Adverse Event|9
7356320|NCT00987337|11600174|FG002|Overall Study|Adverse Event|8
7356321|NCT00987337|11600172|FG000|Overall Study|Insufficient Virologic Response|10
7356322|NCT00987337|11600173|FG001|Overall Study|Insufficient Virologic Response|7
7356323|NCT00987337|11600174|FG002|Overall Study|Insufficient Virologic Response|12
7356324|NCT00987337|11600172|FG000|Overall Study|Virologic Breakthrough|2
7356325|NCT00987337|11600173|FG001|Overall Study|Virologic Breakthrough|2
7356326|NCT00987337|11600174|FG002|Overall Study|Virologic Breakthrough|8
7356327|NCT00987337|11600172|FG000|Overall Study|Lost to Follow-up|10
7356328|NCT00987337|11600173|FG001|Overall Study|Lost to Follow-up|6
7356329|NCT00987337|11600174|FG002|Overall Study|Lost to Follow-up|2
7356330|NCT00987337|11600172|FG000|Overall Study|Withdrawal by Subject|6
7356331|NCT00987337|11600173|FG001|Overall Study|Withdrawal by Subject|9
7356332|NCT00987337|11600174|FG002|Overall Study|Withdrawal by Subject|9
7356333|NCT00987337|11600172|FG000|Overall Study|Other|0
7356334|NCT00987337|11600173|FG001|Overall Study|Other|2
7356335|NCT00987337|11600174|FG002|Overall Study|Other|5
7356336|NCT00987337|11600172|FG000|Overall Study|Protocol Violation|1
7356337|NCT00987337|11600173|FG001|Overall Study|Protocol Violation|0
7356338|NCT00987337|11600174|FG002|Overall Study|Protocol Violation|2
7356339|NCT00987337|11600172|FG000|Overall Study|Participant Relapsed|18
7356340|NCT00987337|11600173|FG001|Overall Study|Participant Relapsed|20
7356341|NCT00987337|11600174|FG002|Overall Study|Participant Relapsed|5
7356342|NCT00987389|11600186|FG000|Overall Study|Ineligible|0
7356343|NCT00987389|11600187|FG001|Overall Study|Ineligible|3
7356344|NCT00987389|11600188|FG002|Overall Study|Ineligible|0
7356345|NCT00987389|11600189|FG003|Overall Study|Ineligible|0
7356346|NCT00987389|11600186|FG000|Overall Study|Lost to Follow-up|4
7356347|NCT00987389|11600187|FG001|Overall Study|Lost to Follow-up|1
7356348|NCT00987389|11600188|FG002|Overall Study|Lost to Follow-up|3
7356349|NCT00987389|11600189|FG003|Overall Study|Lost to Follow-up|1
7356350|NCT00987389|11600186|FG000|Overall Study|Withdrawal by Subject|4
7356351|NCT00987389|11600187|FG001|Overall Study|Withdrawal by Subject|3
7356352|NCT00987389|11600188|FG002|Overall Study|Withdrawal by Subject|2
7356353|NCT00987389|11600189|FG003|Overall Study|Withdrawal by Subject|1
7356354|NCT00987389|11600186|FG000|Overall Study|Withdrawn from Treatment|0
7569524|NCT03449979|11945918|FG002|Overall Study|Technical difficulty|0
7356355|NCT00987389|11600187|FG001|Overall Study|Withdrawn from Treatment|1
7356356|NCT00987389|11600188|FG002|Overall Study|Withdrawn from Treatment|0
7356357|NCT00987389|11600189|FG003|Overall Study|Withdrawn from Treatment|0
7356358|NCT00987389|11600186|FG000|Overall Study|Multiple different reasons|1
7356359|NCT00987389|11600187|FG001|Overall Study|Multiple different reasons|0
7356360|NCT00987389|11600188|FG002|Overall Study|Multiple different reasons|3
7356361|NCT00987389|11600189|FG003|Overall Study|Multiple different reasons|1
7356362|NCT00987402|11600199|FG000|Overall Study|Insufficient data entry|86
7356363|NCT00987402|11600200|FG001|Overall Study|Insufficient data entry|98
7356364|NCT00987467|11600215|FG000|Overall Study|Lost to Follow-up|2
7356365|NCT00987623|11600234|FG000|Overall Study|Lost to Follow-up|2
7356366|NCT00987623|11600235|FG001|Overall Study|Lost to Follow-up|1
7356367|NCT00987623|11600234|FG000|Overall Study|Time/job conflict|2
7356368|NCT00987623|11600235|FG001|Overall Study|Time/job conflict|0
7356369|NCT00987623|11600234|FG000|Overall Study|Discomfort|1
7356370|NCT00987623|11600235|FG001|Overall Study|Discomfort|0
7356371|NCT00987623|11600234|FG000|Overall Study|Biomicroscopy|0
7569525|NCT03449979|11945919|FG003|Overall Study|Technical difficulty|1
7569526|NCT03450070|11945929|FG000|Overall Study|Withdrawal by Subject|8
7569527|NCT03451071|11945960|FG000|First Vaccine|Withdrawal by Subject|1
7569528|NCT03451071|11945960|FG000|Second Vaccine|Lost to Follow-up|19
7569529|NCT03451071|11945960|FG000|Third Vaccine|Lost to Follow-up|22
7569530|NCT03451071|11945960|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
7356372|NCT00987623|11600235|FG001|Overall Study|Biomicroscopy|1
7356373|NCT00987623|11600234|FG000|Overall Study|Influenza|0
7356374|NCT00987623|11600235|FG001|Overall Study|Influenza|1
7356375|NCT00987831|11600253|FG000|Overall Study|Never flared in 12 months|1
7356376|NCT00987831|11600254|FG001|Overall Study|Never flared in 12 months|0
7356377|NCT00987831|11600255|FG002|Overall Study|Never flared in 12 months|0
7356378|NCT00987831|11600253|FG000|Overall Study|Lost to Follow-up|0
7356379|NCT00987831|11600254|FG001|Overall Study|Lost to Follow-up|3
7356380|NCT00987831|11600255|FG002|Overall Study|Lost to Follow-up|0
7356381|NCT00987935|11600273|FG000|Overall Study|Progressive disease|3
7356382|NCT00987935|11600274|FG001|Overall Study|Progressive disease|2
7356383|NCT00987935|11600275|FG002|Overall Study|Progressive disease|3
7356384|NCT00987935|11600276|FG003|Overall Study|Progressive disease|2
7356385|NCT00987935|11600277|FG004|Overall Study|Progressive disease|5
7356386|NCT00987935|11600278|FG005|Overall Study|Progressive disease|3
7356387|NCT00987935|11600279|FG006|Overall Study|Progressive disease|9
7356388|NCT00987935|11600280|FG007|Overall Study|Progressive disease|48
7356389|NCT00987935|11600281|FG008|Overall Study|Progressive disease|23
7356390|NCT00987935|11600273|FG000|Overall Study|Adverse Event|0
7356391|NCT00987935|11600274|FG001|Overall Study|Adverse Event|1
7356392|NCT00987935|11600275|FG002|Overall Study|Adverse Event|0
7356393|NCT00987935|11600276|FG003|Overall Study|Adverse Event|1
7356394|NCT00987935|11600277|FG004|Overall Study|Adverse Event|1
7356395|NCT00987935|11600278|FG005|Overall Study|Adverse Event|0
7356396|NCT00987935|11600279|FG006|Overall Study|Adverse Event|2
7356397|NCT00987935|11600280|FG007|Overall Study|Adverse Event|10
7356398|NCT00987935|11600281|FG008|Overall Study|Adverse Event|6
7356399|NCT00987935|11600273|FG000|Overall Study|Refused to continue taking trial med.|1
7356400|NCT00987935|11600274|FG001|Overall Study|Refused to continue taking trial med.|0
7356401|NCT00987935|11600275|FG002|Overall Study|Refused to continue taking trial med.|0
7356402|NCT00987935|11600276|FG003|Overall Study|Refused to continue taking trial med.|0
7356403|NCT00987935|11600277|FG004|Overall Study|Refused to continue taking trial med.|1
7356404|NCT00987935|11600278|FG005|Overall Study|Refused to continue taking trial med.|0
7356405|NCT00987935|11600279|FG006|Overall Study|Refused to continue taking trial med.|4
7356406|NCT00987935|11600280|FG007|Overall Study|Refused to continue taking trial med.|4
7356407|NCT00987935|11600281|FG008|Overall Study|Refused to continue taking trial med.|2
7356408|NCT00987935|11600273|FG000|Overall Study|Reason other than those specified above|0
7356409|NCT00987935|11600274|FG001|Overall Study|Reason other than those specified above|0
7356410|NCT00987935|11600275|FG002|Overall Study|Reason other than those specified above|0
7356411|NCT00987935|11600276|FG003|Overall Study|Reason other than those specified above|0
7356412|NCT00987935|11600277|FG004|Overall Study|Reason other than those specified above|0
7356413|NCT00987935|11600278|FG005|Overall Study|Reason other than those specified above|0
7356414|NCT00987935|11600279|FG006|Overall Study|Reason other than those specified above|0
7356415|NCT00987935|11600280|FG007|Overall Study|Reason other than those specified above|0
7356416|NCT00987935|11600281|FG008|Overall Study|Reason other than those specified above|1
7356417|NCT00988065|11600348|FG000|Overall Study|Adverse Event|4
7569531|NCT03451084|11945968|FG000|Overall Study|Withdrawal by Subject|2
7569532|NCT03451084|11945969|FG001|Overall Study|Withdrawal by Subject|1
7356418|NCT00988065|11600349|FG001|Overall Study|Adverse Event|10
7356419|NCT00988065|11600350|FG002|Overall Study|Adverse Event|2
7356420|NCT00988065|11600348|FG000|Overall Study|Lost to Follow-up|1
7356421|NCT00988065|11600349|FG001|Overall Study|Lost to Follow-up|2
7356422|NCT00988065|11600350|FG002|Overall Study|Lost to Follow-up|2
7356423|NCT00988065|11600348|FG000|Overall Study|Subject withdrew consent|3
7569533|NCT03451084|11945970|FG002|Overall Study|Withdrawal by Subject|2
7356424|NCT00988065|11600349|FG001|Overall Study|Subject withdrew consent|5
7356425|NCT00988065|11600350|FG002|Overall Study|Subject withdrew consent|2
7356426|NCT00988065|11600348|FG000|Overall Study|Noncompliance with protocol|5
7356427|NCT00988065|11600349|FG001|Overall Study|Noncompliance with protocol|6
7356428|NCT00988065|11600350|FG002|Overall Study|Noncompliance with protocol|9
7356429|NCT00988091|11600360|FG000|Double-blind Period|Withdrawal by Subject|15
7356430|NCT00988091|11600361|FG001|Double-blind Period|Withdrawal by Subject|13
7569534|NCT03451084|11945971|FG003|Overall Study|Withdrawal by Subject|1
7569535|NCT03451084|11945968|FG000|Overall Study|Disease recurrence|0
7569536|NCT03451084|11945969|FG001|Overall Study|Disease recurrence|2
7356431|NCT00988091|11600360|FG000|Double-blind Period|Lost to Follow-up|12
7356432|NCT00988091|11600361|FG001|Double-blind Period|Lost to Follow-up|14
7356433|NCT00988091|11600360|FG000|Double-blind Period|Other|8
7356434|NCT00988091|11600361|FG001|Double-blind Period|Other|8
7356435|NCT00988091|11600360|FG000|Double-blind Period|Adverse Event|6
7356436|NCT00988091|11600361|FG001|Double-blind Period|Adverse Event|9
7356437|NCT00988091|11600360|FG000|Double-blind Period|Use of exclusionary medication|2
7356438|NCT00988091|11600361|FG001|Double-blind Period|Use of exclusionary medication|3
7356439|NCT00988091|11600360|FG000|Open-label Period|Adverse Event|4
7356440|NCT00988091|11600361|FG001|Open-label Period|Adverse Event|7
7356441|NCT00988091|11600360|FG000|Open-label Period|Use of exclusionary medication|1
7356442|NCT00988091|11600361|FG001|Open-label Period|Use of exclusionary medication|1
7356443|NCT00988091|11600360|FG000|Open-label Period|Protocol Violation|1
7356444|NCT00988091|11600361|FG001|Open-label Period|Protocol Violation|1
7356445|NCT00988091|11600360|FG000|Open-label Period|Withdrawal by Subject|10
7356446|NCT00988091|11600361|FG001|Open-label Period|Withdrawal by Subject|16
7356447|NCT00988091|11600360|FG000|Open-label Period|Lost to Follow-up|3
7356448|NCT00988091|11600361|FG001|Open-label Period|Lost to Follow-up|5
7356449|NCT00988091|11600360|FG000|Open-label Period|Other|2
7356450|NCT00988091|11600361|FG001|Open-label Period|Other|3
7356451|NCT00988117|11600368|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
7356452|NCT00988117|11600368|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
7356453|NCT00988169|11600395|FG000|Overall Study|Withdrawal by Subject|1
7356454|NCT00988208|11600401|FG000|Overall Study|Adverse Event|71
7356455|NCT00988208|11600402|FG001|Overall Study|Adverse Event|122
7356456|NCT00988208|11600401|FG000|Overall Study|Disease Progression|103
7356457|NCT00988208|11600402|FG001|Overall Study|Disease Progression|89
7356458|NCT00988208|11600401|FG000|Overall Study|Withdrawal by Subject|50
7356459|NCT00988208|11600402|FG001|Overall Study|Withdrawal by Subject|57
7356460|NCT00988208|11600401|FG000|Overall Study|Death|9
7356461|NCT00988208|11600402|FG001|Overall Study|Death|15
7356462|NCT00988208|11600401|FG000|Overall Study|Lost to Follow-up|2
7356463|NCT00988208|11600402|FG001|Overall Study|Lost to Follow-up|3
7356464|NCT00988208|11600401|FG000|Overall Study|Protocol Violation|9
7356465|NCT00988208|11600402|FG001|Overall Study|Protocol Violation|2
7356466|NCT00988208|11600401|FG000|Overall Study|Sponsor Decision|102
7356467|NCT00988208|11600402|FG001|Overall Study|Sponsor Decision|78
7356468|NCT00988208|11600401|FG000|Overall Study|Clinical Progression|17
7356469|NCT00988208|11600402|FG001|Overall Study|Clinical Progression|16
7356470|NCT00988208|11600401|FG000|Overall Study|Biochemical Progression|21
7356471|NCT00988208|11600402|FG001|Overall Study|Biochemical Progression|7
7356472|NCT00988208|11600401|FG000|Overall Study|Clinical Deterioration|7
7356473|NCT00988208|11600402|FG001|Overall Study|Clinical Deterioration|14
7356474|NCT00988208|11600401|FG000|Overall Study|Subject Decision/Investigator Discretion|32
7356475|NCT00988208|11600402|FG001|Overall Study|Subject Decision/Investigator Discretion|32
7356476|NCT00988208|11600401|FG000|Overall Study|Other|8
7356477|NCT00988208|11600402|FG001|Overall Study|Other|3
7356478|NCT00988221|11600411|FG000|Part I|Adverse Event|0
7356479|NCT00988221|11600412|FG001|Part I|Adverse Event|1
7356480|NCT00988221|11600413|FG002|Part I|Adverse Event|2
7356481|NCT00988221|11600414|FG003|Part I|Adverse Event|0
7356482|NCT00988221|11600411|FG000|Part I|Insufficient Therapeutic Response|4
7356483|NCT00988221|11600412|FG001|Part I|Insufficient Therapeutic Response|6
7356484|NCT00988221|11600413|FG002|Part I|Insufficient Therapeutic Response|5
7356485|NCT00988221|11600414|FG003|Part I|Insufficient Therapeutic Response|0
7356486|NCT00988221|11600411|FG000|Part I|Refused Treatment|0
7459727|NCT01820559|11754561|FG001|Overall Study|Subject's non-compliance|0
7459728|NCT01820559|11754562|FG002|Overall Study|Subject's non-compliance|2
7459729|NCT01820559|11754560|FG000|Overall Study|Lost to Follow-up|3
7459730|NCT01820559|11754561|FG001|Overall Study|Lost to Follow-up|2
7356487|NCT00988221|11600412|FG001|Part I|Refused Treatment|2
7356488|NCT00988221|11600413|FG002|Part I|Refused Treatment|1
7356489|NCT00988221|11600414|FG003|Part I|Refused Treatment|0
7356490|NCT00988221|11600411|FG000|Part I|Lost to Follow-up|0
7356491|NCT00988221|11600412|FG001|Part I|Lost to Follow-up|1
7356492|NCT00988221|11600413|FG002|Part I|Lost to Follow-up|0
7356493|NCT00988221|11600414|FG003|Part I|Lost to Follow-up|0
7356494|NCT00988221|11600411|FG000|Part II|Adverse Event|1
7356495|NCT00988221|11600412|FG001|Part II|Adverse Event|0
7356496|NCT00988221|11600413|FG002|Part II|Adverse Event|0
7356497|NCT00988221|11600414|FG003|Part II|Adverse Event|1
7356498|NCT00988221|11600411|FG000|Part II|Withdrawal by Subject|0
7356499|NCT00988221|11600412|FG001|Part II|Withdrawal by Subject|0
7356500|NCT00988221|11600413|FG002|Part II|Withdrawal by Subject|2
7356501|NCT00988221|11600414|FG003|Part II|Withdrawal by Subject|2
7356502|NCT00988221|11600411|FG000|Part II|Reason not Specified|0
7356503|NCT00988221|11600412|FG001|Part II|Reason not Specified|0
7356504|NCT00988221|11600413|FG002|Part II|Reason not Specified|1
7356505|NCT00988221|11600414|FG003|Part II|Reason not Specified|0
7356506|NCT00988221|11600411|FG000|Part III|Adverse Event|1
7356507|NCT00988221|11600412|FG001|Part III|Adverse Event|0
7356508|NCT00988221|11600413|FG002|Part III|Adverse Event|1
7356509|NCT00988221|11600414|FG003|Part III|Adverse Event|0
7356510|NCT00988221|11600411|FG000|Part III|Insufficient Therapeutic Response|0
7356511|NCT00988221|11600412|FG001|Part III|Insufficient Therapeutic Response|1
7356512|NCT00988221|11600413|FG002|Part III|Insufficient Therapeutic Response|1
7356513|NCT00988221|11600414|FG003|Part III|Insufficient Therapeutic Response|0
7356514|NCT00988221|11600411|FG000|Part III|Refused Treatment|0
7356515|NCT00988221|11600412|FG001|Part III|Refused Treatment|0
7356516|NCT00988221|11600413|FG002|Part III|Refused Treatment|1
7356517|NCT00988221|11600414|FG003|Part III|Refused Treatment|0
7356518|NCT00988351|11600452|FG000|Overall Study|Withdrawal by Subject|8
7356519|NCT00988351|11600453|FG001|Overall Study|Withdrawal by Subject|0
7356520|NCT00988351|11600452|FG000|Overall Study|Lost to Follow-up|6
7356521|NCT00988351|11600453|FG001|Overall Study|Lost to Follow-up|9
7356522|NCT00988351|11600452|FG000|Overall Study|not using CPAP|5
7356523|NCT00988351|11600453|FG001|Overall Study|not using CPAP|3
7356524|NCT00988429|11600462|FG000|Overall Study|Adverse Event|9
7356525|NCT00988429|11600463|FG001|Overall Study|Adverse Event|21
7356526|NCT00988429|11600464|FG002|Overall Study|Adverse Event|45
7356527|NCT00988429|11600462|FG000|Overall Study|Lack of Efficacy|0
7356528|NCT00988429|11600463|FG001|Overall Study|Lack of Efficacy|0
7356529|NCT00988429|11600464|FG002|Overall Study|Lack of Efficacy|1
7356530|NCT00988429|11600462|FG000|Overall Study|Non-Compliance with Study Drug|5
7356531|NCT00988429|11600463|FG001|Overall Study|Non-Compliance with Study Drug|1
7356532|NCT00988429|11600464|FG002|Overall Study|Non-Compliance with Study Drug|3
7356533|NCT00988429|11600462|FG000|Overall Study|Physician Decision|1
7356534|NCT00988429|11600463|FG001|Overall Study|Physician Decision|0
7356535|NCT00988429|11600464|FG002|Overall Study|Physician Decision|3
7356536|NCT00988429|11600462|FG000|Overall Study|Pregnancy|2
7356537|NCT00988429|11600463|FG001|Overall Study|Pregnancy|1
7356538|NCT00988429|11600464|FG002|Overall Study|Pregnancy|0
7356539|NCT00988429|11600462|FG000|Overall Study|Protocol Violation|4
7356540|NCT00988429|11600463|FG001|Overall Study|Protocol Violation|3
7356541|NCT00988429|11600464|FG002|Overall Study|Protocol Violation|3
7356542|NCT00988429|11600462|FG000|Overall Study|Withdrawal by Subject|7
7356543|NCT00988429|11600463|FG001|Overall Study|Withdrawal by Subject|7
7356544|NCT00988429|11600464|FG002|Overall Study|Withdrawal by Subject|12
7356545|NCT00988429|11600462|FG000|Overall Study|Administrative Reasons|1
7356546|NCT00988429|11600463|FG001|Overall Study|Administrative Reasons|2
7356547|NCT00988429|11600464|FG002|Overall Study|Administrative Reasons|1
7356548|NCT00988429|11600462|FG000|Overall Study|other reasons|8
7356549|NCT00988429|11600463|FG001|Overall Study|other reasons|8
7356550|NCT00988429|11600464|FG002|Overall Study|other reasons|1
7356551|NCT00988442|11600475|FG000|Overall Study|Death|1
7356552|NCT00988442|11600476|FG001|Overall Study|Death|2
7356553|NCT00988442|11600475|FG000|Overall Study|Lost to Follow-up|0
7356554|NCT00988442|11600476|FG001|Overall Study|Lost to Follow-up|1
7356555|NCT00988442|11600475|FG000|Overall Study|Early Study Closure|29
7356556|NCT00988442|11600476|FG001|Overall Study|Early Study Closure|25
7356557|NCT00988533|11600485|FG000|Overall Study|Lost to Follow-up|3
7356558|NCT00988559|11600493|FG000|Overall Study|Withdrawal by Subject|1
7356559|NCT00988559|11600494|FG001|Overall Study|Withdrawal by Subject|1
7356560|NCT00988559|11600495|FG002|Overall Study|Withdrawal by Subject|0
7356561|NCT00988559|11600496|FG003|Overall Study|Withdrawal by Subject|1
7356562|NCT00988559|11600493|FG000|Overall Study|Pregnancy|0
7356563|NCT00988559|11600494|FG001|Overall Study|Pregnancy|1
7356564|NCT00988559|11600495|FG002|Overall Study|Pregnancy|1
7356565|NCT00988559|11600496|FG003|Overall Study|Pregnancy|0
7356566|NCT00988559|11600493|FG000|Overall Study|Lost to Follow-up|0
7356567|NCT00988559|11600494|FG001|Overall Study|Lost to Follow-up|0
7356568|NCT00988559|11600495|FG002|Overall Study|Lost to Follow-up|1
7356569|NCT00988559|11600496|FG003|Overall Study|Lost to Follow-up|0
7356570|NCT00988598|11600508|FG000|Overall Study|Withdrawal by Subject|2
7356571|NCT00988598|11600509|FG001|Overall Study|Withdrawal by Subject|0
7386170|NCT01208233|11644423|FG000|Overall Study|Withdrawal by Subject|1
7386171|NCT01208233|11644424|FG001|Overall Study|Withdrawal by Subject|0
7386172|NCT01208233|11644425|FG002|Overall Study|Withdrawal by Subject|1
7459731|NCT01820559|11754562|FG002|Overall Study|Lost to Follow-up|2
7459732|NCT01820559|11754560|FG000|Overall Study|At sponsor request|0
7386173|NCT01208233|11644426|FG003|Overall Study|Withdrawal by Subject|1
7386174|NCT01208233|11644427|FG004|Overall Study|Withdrawal by Subject|4
7386175|NCT01208233|11644428|FG005|Overall Study|Withdrawal by Subject|2
7386176|NCT01208324|11644452|FG000|Post-randomization of Patch|Withdrawal by Subject|1
7386177|NCT01208324|11644453|FG001|Post-randomization of Patch|Withdrawal by Subject|0
7386178|NCT01208324|11644454|FG002|Post-randomization of Patch|Withdrawal by Subject|0
7386179|NCT01208324|11644455|FG003|Post-randomization of Patch|Withdrawal by Subject|0
7386180|NCT01208337|11644465|FG000|Overall Study|Death|3
7386181|NCT01208402|11644471|FG000|Overall Study|Withdrawal by Subject|1
7386182|NCT01208402|11644472|FG001|Overall Study|Withdrawal by Subject|0
7386183|NCT01208415|11644478|FG000|Overall Study|Death|1
7386184|NCT01208415|11644478|FG000|Overall Study|Lost to Follow-up|2
7386185|NCT01208415|11644478|FG000|Overall Study|Withdrawal by Subject|3
7386186|NCT01208415|11644478|FG000|Overall Study|Device not placed|1
7386187|NCT01208415|11644478|FG000|Overall Study|Still be eligible for follow-up|33
7356578|NCT00988858|11600531|FG000|Overall Study|Adverse Event|7
7356579|NCT00988858|11600531|FG000|Overall Study|Death|1
7356580|NCT00988858|11600531|FG000|Overall Study|Physician Decision|1
7356581|NCT00988858|11600531|FG000|Overall Study|Sponsor Decision|1
7356582|NCT00988884|11600537|FG000|Overall Study|Adverse Event|0
7356583|NCT00988884|11600538|FG001|Overall Study|Adverse Event|1
7356584|NCT00988884|11600537|FG000|Overall Study|Lost to Follow-up|20
7356585|NCT00988884|11600538|FG001|Overall Study|Lost to Follow-up|16
7356586|NCT00988884|11600537|FG000|Overall Study|Protocol Violation|0
7356587|NCT00988884|11600538|FG001|Overall Study|Protocol Violation|1
7356588|NCT00988884|11600537|FG000|Overall Study|Withdrawal by Subject|15
7356589|NCT00988884|11600538|FG001|Overall Study|Withdrawal by Subject|18
7356590|NCT00989092|11600563|FG000|Overall Study|Physician Decision|9
7356591|NCT00989092|11600564|FG001|Overall Study|Physician Decision|6
7356592|NCT00989092|11600563|FG000|Overall Study|Adverse Event|20
7356593|NCT00989092|11600564|FG001|Overall Study|Adverse Event|1
7356594|NCT00989092|11600563|FG000|Overall Study|Chemotherapy initiated|12
7356595|NCT00989092|11600564|FG001|Overall Study|Chemotherapy initiated|4
7356596|NCT00989092|11600563|FG000|Overall Study|Withdrawal by Subject|17
7356597|NCT00989092|11600564|FG001|Overall Study|Withdrawal by Subject|9
7356598|NCT00989092|11600563|FG000|Overall Study|Death|14
7356599|NCT00989092|11600564|FG001|Overall Study|Death|2
7356600|NCT00989092|11600563|FG000|Overall Study|Ineligibility determined|3
7356601|NCT00989092|11600564|FG001|Overall Study|Ineligibility determined|3
7356602|NCT00989092|11600563|FG000|Overall Study|Lost to Follow-up|6
7356603|NCT00989092|11600564|FG001|Overall Study|Lost to Follow-up|2
7356604|NCT00989092|11600563|FG000|Overall Study|Other|3
7356605|NCT00989092|11600564|FG001|Overall Study|Other|1
7356606|NCT00989092|11600563|FG000|Overall Study|Protocol deviation|2
7356607|NCT00989092|11600564|FG001|Overall Study|Protocol deviation|0
7356608|NCT00989092|11600563|FG000|Overall Study|Erythropoietin therapy initiated|2
7356609|NCT00989092|11600564|FG001|Overall Study|Erythropoietin therapy initiated|0
7356610|NCT00989092|11600563|FG000|Overall Study|Did not receive study drug|2
7356611|NCT00989092|11600564|FG001|Overall Study|Did not receive study drug|0
7356612|NCT00989196|11600582|FG000|Treatment Period|Lost to Follow-up|1
7356613|NCT00989196|11600583|FG001|Treatment Period|Lost to Follow-up|0
7356614|NCT00989235|11600591|FG000|Overall Study|Death|0
7356615|NCT00989235|11600592|FG001|Overall Study|Death|1
7356616|NCT00989235|11600591|FG000|Overall Study|Adverse Event|0
7356617|NCT00989235|11600592|FG001|Overall Study|Adverse Event|1
7356618|NCT00989235|11600591|FG000|Overall Study|Lack of Efficacy|1
7356619|NCT00989235|11600592|FG001|Overall Study|Lack of Efficacy|0
7356620|NCT00989235|11600591|FG000|Overall Study|Withdrawal of Consent|1
7356621|NCT00989235|11600592|FG001|Overall Study|Withdrawal of Consent|1
7356622|NCT00989235|11600591|FG000|Overall Study|Desire to Become Pregnant|1
7356623|NCT00989235|11600592|FG001|Overall Study|Desire to Become Pregnant|0
7356624|NCT00989235|11600591|FG000|Overall Study|Randomized by Mistake|0
7356625|NCT00989235|11600592|FG001|Overall Study|Randomized by Mistake|2
7459733|NCT01820559|11754561|FG001|Overall Study|At sponsor request|0
7459734|NCT01820559|11754562|FG002|Overall Study|At sponsor request|1
7459735|NCT01820559|11754560|FG000|Overall Study|Lack of Efficacy|3
7459736|NCT01820559|11754561|FG001|Overall Study|Lack of Efficacy|2
7459737|NCT01820559|11754562|FG002|Overall Study|Lack of Efficacy|3
7459738|NCT01820572|11754572|FG000|Randomization|Not Treated|2
7459739|NCT01820572|11754573|FG001|Randomization|Not Treated|1
7459740|NCT01820572|11754572|FG000|Treatment Period|Adverse Event|12
7459741|NCT01820572|11754573|FG001|Treatment Period|Adverse Event|7
7459742|NCT01820572|11754572|FG000|Treatment Period|Death|3
7459743|NCT01820572|11754573|FG001|Treatment Period|Death|3
7459744|NCT01820572|11754572|FG000|Treatment Period|Lack of Efficacy|1
7459745|NCT01820572|11754573|FG001|Treatment Period|Lack of Efficacy|0
7459746|NCT01820572|11754572|FG000|Treatment Period|poor/non compliance|0
7459747|NCT01820572|11754573|FG001|Treatment Period|poor/non compliance|3
7459748|NCT01820572|11754572|FG000|Treatment Period|request to discontinue|6
7459749|NCT01820572|11754573|FG001|Treatment Period|request to discontinue|11
7459750|NCT01820572|11754572|FG000|Treatment Period|No longer meets study criteria|3
7459751|NCT01820572|11754573|FG001|Treatment Period|No longer meets study criteria|10
7459752|NCT01820572|11754572|FG000|Treatment Period|withdrew consent|1
7459753|NCT01820572|11754573|FG001|Treatment Period|withdrew consent|2
7459754|NCT01820585|11754583|FG000|Overall Study|Adverse Event|9
7459755|NCT01820585|11754584|FG001|Overall Study|Adverse Event|13
7356626|NCT00989235|11600591|FG000|Overall Study|Lost to Follow-up|0
7356627|NCT00989235|11600592|FG001|Overall Study|Lost to Follow-up|1
7356628|NCT00989261|11600603|FG000|Overall Study|Still in follow up|12
7356629|NCT00989261|11600604|FG001|Overall Study|Still in follow up|21
7356630|NCT00989261|11600603|FG000|Overall Study|Withdrawal by Subject|0
7356631|NCT00989261|11600604|FG001|Overall Study|Withdrawal by Subject|1
7459756|NCT01820585|11754585|FG002|Overall Study|Adverse Event|23
7459757|NCT01820585|11754586|FG003|Overall Study|Adverse Event|34
7356632|NCT00989261|11600603|FG000|Overall Study|Lost to Follow-up|3
7356633|NCT00989261|11600604|FG001|Overall Study|Lost to Follow-up|0
7356634|NCT00989287|11600612|FG000|Overall Study|Adverse Event|1
7356635|NCT00989287|11600613|FG001|Overall Study|Adverse Event|0
7356636|NCT00989287|11600612|FG000|Overall Study|Lost to Follow-up|0
7356637|NCT00989287|11600613|FG001|Overall Study|Lost to Follow-up|1
7356638|NCT00989573|11600635|FG000|Overall Study|Adverse Event|8
7356639|NCT00989573|11600636|FG001|Overall Study|Adverse Event|12
7356640|NCT00989573|11600637|FG002|Overall Study|Adverse Event|4
7356641|NCT00989573|11600635|FG000|Overall Study|Physician Decision|0
7356642|NCT00989573|11600636|FG001|Overall Study|Physician Decision|2
7356643|NCT00989573|11600637|FG002|Overall Study|Physician Decision|0
7356644|NCT00989573|11600635|FG000|Overall Study|Protocol Violation|1
7356645|NCT00989573|11600636|FG001|Overall Study|Protocol Violation|1
7356646|NCT00989573|11600637|FG002|Overall Study|Protocol Violation|1
7356647|NCT00989573|11600635|FG000|Overall Study|Withdrawal by Subject|4
7356648|NCT00989573|11600636|FG001|Overall Study|Withdrawal by Subject|7
7356649|NCT00989573|11600637|FG002|Overall Study|Withdrawal by Subject|3
7356650|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
7356651|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
7356652|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
7356653|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Death|1
7356654|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
7356655|NCT00989664|11600661|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
7356656|NCT00989664|11600661|FG000|Long-Term Follow-Up|Death|3
7356657|NCT00989781|11600677|FG000|Ovarian Response to hCG|Lost to Follow-up|3
7356658|NCT00989781|11600678|FG001|Ovarian Response to hCG|Lost to Follow-up|2
7356659|NCT00989833|11600688|FG000|Overall Study|Lost to Follow-up|0
7356660|NCT00989833|11600689|FG001|Overall Study|Lost to Follow-up|1
7356661|NCT00989833|11600690|FG002|Overall Study|Lost to Follow-up|0
7356662|NCT00989833|11600688|FG000|Overall Study|Protocol Violation|1
7356663|NCT00989833|11600689|FG001|Overall Study|Protocol Violation|2
7356664|NCT00989833|11600690|FG002|Overall Study|Protocol Violation|1
7356665|NCT00989833|11600688|FG000|Overall Study|Withdrawal by Subject|0
7356666|NCT00989833|11600689|FG001|Overall Study|Withdrawal by Subject|0
7356667|NCT00989833|11600690|FG002|Overall Study|Withdrawal by Subject|1
7356668|NCT00989833|11600688|FG000|Overall Study|Incorrectly randomized|1
7356669|NCT00989833|11600689|FG001|Overall Study|Incorrectly randomized|0
7356670|NCT00989833|11600690|FG002|Overall Study|Incorrectly randomized|0
7356671|NCT00989950|11600706|FG000|Randomized Phase|Protocol Violation|1
7356672|NCT00989950|11600707|FG001|Randomized Phase|Protocol Violation|0
7356673|NCT00989950|11600708|FG002|Randomized Phase|Protocol Violation|0
7356674|NCT00989950|11600709|FG003|Randomized Phase|Protocol Violation|0
7356675|NCT00989950|11600706|FG000|Randomized Phase|Adverse Event|0
7356676|NCT00989950|11600707|FG001|Randomized Phase|Adverse Event|1
7356677|NCT00989950|11600708|FG002|Randomized Phase|Adverse Event|0
7356678|NCT00989950|11600709|FG003|Randomized Phase|Adverse Event|0
7356679|NCT00989963|11600722|FG000|Overall Study|Adverse Event|1
7356680|NCT00989963|11600723|FG001|Overall Study|Adverse Event|1
7356681|NCT00989963|11600724|FG002|Overall Study|Adverse Event|1
7356682|NCT00990093|11600745|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
7356683|NCT00990093|11600746|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
7356684|NCT00990093|11600745|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
7356685|NCT00990093|11600746|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
7356686|NCT00990093|11600745|FG000|Test Period 1 (1-14 Days)|Other|1
7356687|NCT00990093|11600746|FG001|Test Period 1 (1-14 Days)|Other|0
7356688|NCT00990093|11600745|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
7356689|NCT00990093|11600746|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
7356690|NCT00990093|11600745|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
7356691|NCT00990093|11600746|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
7356692|NCT00990093|11600745|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
7356693|NCT00990093|11600746|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
7356694|NCT00990093|11600745|FG000|Test Period 2 (15-28 Days)|Other|0
7356695|NCT00990093|11600746|FG001|Test Period 2 (15-28 Days)|Other|1
7356696|NCT00990106|11600754|FG000|Overall Study|"too busy to continue"|1
7356697|NCT00990106|11600755|FG001|Overall Study|"too busy to continue"|2
7356698|NCT00990106|11600754|FG000|Overall Study|Lost to Follow-up|1
7356699|NCT00990106|11600755|FG001|Overall Study|Lost to Follow-up|3
7356700|NCT00990106|11600754|FG000|Overall Study|Withdrawal by Subject|2
7356701|NCT00990106|11600755|FG001|Overall Study|Withdrawal by Subject|1
7356702|NCT00990106|11600754|FG000|Overall Study|opted for open label prazosin|1
7356703|NCT00990106|11600755|FG001|Overall Study|opted for open label prazosin|1
7356704|NCT00990106|11600754|FG000|Overall Study|relocation/deployment|4
7356705|NCT00990106|11600755|FG001|Overall Study|relocation/deployment|1
7356706|NCT00990106|11600754|FG000|Overall Study|started exclusionary medication|0
7356707|NCT00990106|11600755|FG001|Overall Study|started exclusionary medication|1
7356708|NCT00990106|11600754|FG000|Overall Study|planned major surgery|0
7356709|NCT00990106|11600755|FG001|Overall Study|planned major surgery|1
7356710|NCT00990106|11600754|FG000|Overall Study|scheduling conflicts|0
7356711|NCT00990106|11600755|FG001|Overall Study|scheduling conflicts|2
7356712|NCT00990184|11600761|FG000|Overall Study|Physician Decision|1
7356713|NCT00990249|11600776|FG000|Overall Study|Disease Progression|8
7356714|NCT00990249|11600776|FG000|Overall Study|Non-Compliance|1
7356715|NCT00990249|11600776|FG000|Overall Study|Death|2
7356716|NCT00990249|11600776|FG000|Overall Study|Not treated|2
7356717|NCT00990314|11600789|FG000|Overall Study|Death|2
7356718|NCT00990314|11600789|FG000|Overall Study|Adverse Event|2
7356719|NCT00990314|11600789|FG000|Overall Study|Withdrawal by Subject|3
7356720|NCT00990314|11600789|FG000|Overall Study|Non-Compliance|1
7356721|NCT00990314|11600789|FG000|Overall Study|Physician Decision|3
7356722|NCT00990314|11600789|FG000|Overall Study|Lack of Efficacy|1
7356723|NCT00990340|11600795|FG000|First 14-day Treatment|Not Compliant|2
7356724|NCT00990340|11600796|FG001|First 14-day Treatment|Not Compliant|1
7356725|NCT00990340|11600795|FG000|First 14-day Treatment|Lost to Follow-up|2
7356726|NCT00990340|11600796|FG001|First 14-day Treatment|Lost to Follow-up|1
7356727|NCT00990340|11600795|FG000|First 14-day Treatment|Protocol Violation|2
7356728|NCT00990340|11600796|FG001|First 14-day Treatment|Protocol Violation|2
7356729|NCT00990652|11600824|FG000|Pre-surgical Bortezomib|Adverse Event|1
7356730|NCT00990652|11600824|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
7356731|NCT00990665|11600829|FG000|Overall Study|Unsuccessful Implant|8
7356732|NCT00990665|11600829|FG000|Overall Study|Death|29
7356733|NCT00990665|11600829|FG000|Overall Study|Heart Transplant|1
7356734|NCT00990665|11600829|FG000|Overall Study|Withdrawal by Subject|6
7356735|NCT00990665|11600829|FG000|Overall Study|Lost to Follow-up|1
7356736|NCT00990665|11600829|FG000|Overall Study|System Explant|3
7356737|NCT00990704|11600837|FG000|Overall Study|Adverse Event|1
7356738|NCT00990704|11600838|FG001|Overall Study|Adverse Event|1
7356739|NCT00990704|11600837|FG000|Overall Study|Physician Decision|0
7356740|NCT00990704|11600838|FG001|Overall Study|Physician Decision|1
7356741|NCT00990821|11600871|FG000|Overall Study|Withdrawal by Subject|0
7356742|NCT00990821|11600872|FG001|Overall Study|Withdrawal by Subject|2
7356743|NCT00990821|11600873|FG002|Overall Study|Withdrawal by Subject|0
7356744|NCT00990821|11600874|FG003|Overall Study|Withdrawal by Subject|0
7356745|NCT00990821|11600875|FG004|Overall Study|Withdrawal by Subject|3
7356746|NCT00990821|11600876|FG005|Overall Study|Withdrawal by Subject|3
7356747|NCT00990821|11600877|FG006|Overall Study|Withdrawal by Subject|1
7356748|NCT00990821|11600878|FG007|Overall Study|Withdrawal by Subject|0
7356749|NCT00990821|11600879|FG008|Overall Study|Withdrawal by Subject|0
7356750|NCT00990821|11600880|FG009|Overall Study|Withdrawal by Subject|1
7356751|NCT00990821|11600881|FG010|Overall Study|Withdrawal by Subject|3
7356752|NCT00990821|11600882|FG011|Overall Study|Withdrawal by Subject|5
7356753|NCT00990821|11600883|FG012|Overall Study|Withdrawal by Subject|2
7356754|NCT00990821|11600884|FG013|Overall Study|Withdrawal by Subject|1
7356755|NCT00991276|11600960|FG000|First Intervention Period|Adverse Event|0
7356756|NCT00991276|11600961|FG001|First Intervention Period|Adverse Event|1
7356757|NCT00991276|11600962|FG002|First Intervention Period|Adverse Event|0
7356758|NCT00991276|11600963|FG003|First Intervention Period|Adverse Event|1
7356759|NCT00991276|11600964|FG004|First Intervention Period|Adverse Event|0
7356760|NCT00991276|11600965|FG005|First Intervention Period|Adverse Event|0
7356761|NCT00991276|11600960|FG000|First Intervention Period|Protocol Violation|0
7569537|NCT03451084|11945970|FG002|Overall Study|Disease recurrence|0
7356762|NCT00991276|11600961|FG001|First Intervention Period|Protocol Violation|0
7356763|NCT00991276|11600962|FG002|First Intervention Period|Protocol Violation|0
7356764|NCT00991276|11600963|FG003|First Intervention Period|Protocol Violation|0
7356765|NCT00991276|11600964|FG004|First Intervention Period|Protocol Violation|2
7356766|NCT00991276|11600965|FG005|First Intervention Period|Protocol Violation|0
7356767|NCT00991276|11600960|FG000|First Intervention Period|Insufficient clinical response|0
7356768|NCT00991276|11600961|FG001|First Intervention Period|Insufficient clinical response|0
7356769|NCT00991276|11600962|FG002|First Intervention Period|Insufficient clinical response|0
7356770|NCT00991276|11600963|FG003|First Intervention Period|Insufficient clinical response|0
7356771|NCT00991276|11600964|FG004|First Intervention Period|Insufficient clinical response|1
7356772|NCT00991276|11600965|FG005|First Intervention Period|Insufficient clinical response|0
7356773|NCT00991276|11600960|FG000|First Intervention Period|Other|0
7356774|NCT00991276|11600961|FG001|First Intervention Period|Other|0
7356775|NCT00991276|11600962|FG002|First Intervention Period|Other|0
7356776|NCT00991276|11600963|FG003|First Intervention Period|Other|1
7356777|NCT00991276|11600964|FG004|First Intervention Period|Other|1
7356778|NCT00991276|11600965|FG005|First Intervention Period|Other|0
7356779|NCT00991276|11600960|FG000|First Intervention Period|Withdrawal by Subject|0
7356780|NCT00991276|11600961|FG001|First Intervention Period|Withdrawal by Subject|1
7356781|NCT00991276|11600962|FG002|First Intervention Period|Withdrawal by Subject|0
7356782|NCT00991276|11600963|FG003|First Intervention Period|Withdrawal by Subject|1
7569538|NCT03451084|11945971|FG003|Overall Study|Disease recurrence|0
7356783|NCT00991276|11600964|FG004|First Intervention Period|Withdrawal by Subject|0
7356784|NCT00991276|11600965|FG005|First Intervention Period|Withdrawal by Subject|1
7356785|NCT00991276|11600960|FG000|First Intervention Period|Lost to Follow-up|0
7356786|NCT00991276|11600961|FG001|First Intervention Period|Lost to Follow-up|1
7356787|NCT00991276|11600962|FG002|First Intervention Period|Lost to Follow-up|0
7356788|NCT00991276|11600963|FG003|First Intervention Period|Lost to Follow-up|1
7356789|NCT00991276|11600964|FG004|First Intervention Period|Lost to Follow-up|0
7356790|NCT00991276|11600965|FG005|First Intervention Period|Lost to Follow-up|0
7569539|NCT03451084|11945968|FG000|Overall Study|Lack of Efficacy|0
7569540|NCT03451084|11945969|FG001|Overall Study|Lack of Efficacy|3
7356791|NCT00991276|11600960|FG000|Second Intervention Period|Adverse Event|0
7356792|NCT00991276|11600961|FG001|Second Intervention Period|Adverse Event|2
7356793|NCT00991276|11600962|FG002|Second Intervention Period|Adverse Event|0
7356794|NCT00991276|11600963|FG003|Second Intervention Period|Adverse Event|1
7356795|NCT00991276|11600964|FG004|Second Intervention Period|Adverse Event|1
7356796|NCT00991276|11600965|FG005|Second Intervention Period|Adverse Event|0
7356797|NCT00991276|11600960|FG000|Second Intervention Period|Protocol Violation|1
7356798|NCT00991276|11600961|FG001|Second Intervention Period|Protocol Violation|0
7356799|NCT00991276|11600962|FG002|Second Intervention Period|Protocol Violation|0
7356800|NCT00991276|11600963|FG003|Second Intervention Period|Protocol Violation|0
7356801|NCT00991276|11600964|FG004|Second Intervention Period|Protocol Violation|0
7356802|NCT00991276|11600965|FG005|Second Intervention Period|Protocol Violation|0
7356803|NCT00991276|11600960|FG000|Second Intervention Period|Other|0
7356804|NCT00991276|11600961|FG001|Second Intervention Period|Other|0
7356805|NCT00991276|11600962|FG002|Second Intervention Period|Other|0
7356806|NCT00991276|11600963|FG003|Second Intervention Period|Other|1
7356807|NCT00991276|11600964|FG004|Second Intervention Period|Other|0
7356808|NCT00991276|11600965|FG005|Second Intervention Period|Other|1
7356809|NCT00991276|11600960|FG000|Third Intervention Period|Protocol Violation|1
7356810|NCT00991276|11600961|FG001|Third Intervention Period|Protocol Violation|0
7356811|NCT00991276|11600962|FG002|Third Intervention Period|Protocol Violation|0
7356812|NCT00991276|11600963|FG003|Third Intervention Period|Protocol Violation|0
7356813|NCT00991276|11600964|FG004|Third Intervention Period|Protocol Violation|0
7356814|NCT00991276|11600965|FG005|Third Intervention Period|Protocol Violation|0
7356815|NCT00991276|11600960|FG000|Third Intervention Period|Other|0
7356816|NCT00991276|11600961|FG001|Third Intervention Period|Other|0
7356817|NCT00991276|11600962|FG002|Third Intervention Period|Other|0
7356818|NCT00991276|11600963|FG003|Third Intervention Period|Other|0
7356819|NCT00991276|11600964|FG004|Third Intervention Period|Other|0
7356820|NCT00991276|11600965|FG005|Third Intervention Period|Other|1
7356821|NCT00991276|11600960|FG000|Third Intervention Period|Adverse Event|0
7356822|NCT00991276|11600961|FG001|Third Intervention Period|Adverse Event|0
7356823|NCT00991276|11600962|FG002|Third Intervention Period|Adverse Event|1
7356824|NCT00991276|11600963|FG003|Third Intervention Period|Adverse Event|0
7356825|NCT00991276|11600964|FG004|Third Intervention Period|Adverse Event|0
7356826|NCT00991276|11600965|FG005|Third Intervention Period|Adverse Event|0
7356827|NCT00991276|11600960|FG000|Third Intervention Period|Withdrawal by Subject|0
7356828|NCT00991276|11600961|FG001|Third Intervention Period|Withdrawal by Subject|0
7356829|NCT00991276|11600962|FG002|Third Intervention Period|Withdrawal by Subject|0
7356830|NCT00991276|11600963|FG003|Third Intervention Period|Withdrawal by Subject|1
7356831|NCT00991276|11600964|FG004|Third Intervention Period|Withdrawal by Subject|0
7356832|NCT00991276|11600965|FG005|Third Intervention Period|Withdrawal by Subject|0
7356833|NCT00991289|11600974|FG000|Overall Study|Adverse Event|1
7356834|NCT00991289|11600974|FG000|Overall Study|Physician Decision|2
7356835|NCT00991289|11600974|FG000|Overall Study|Withdrawal by Subject|3
7356836|NCT00991289|11600974|FG000|Overall Study|Lost to Follow-up|4
7356837|NCT00991289|11600974|FG000|Overall Study|Protocol Violation|2
7356838|NCT00991302|11600980|FG000|Overall Study|Death|0
7356839|NCT00991302|11600981|FG001|Overall Study|Death|1
7356840|NCT00991302|11600980|FG000|Overall Study|Lost to Follow-up|14
7356841|NCT00991302|11600981|FG001|Overall Study|Lost to Follow-up|12
7356842|NCT00991341|11600989|FG000|Overall Study|no surgery w/in 30 days of randomization|11
7356843|NCT00991341|11600990|FG001|Overall Study|no surgery w/in 30 days of randomization|18
7356844|NCT00991341|11600989|FG000|Overall Study|Death|3
7356845|NCT00991341|11600990|FG001|Overall Study|Death|0
7356846|NCT00991341|11600989|FG000|Overall Study|no RBCs received 96hrs after randomized|186
7356847|NCT00991341|11600990|FG001|Overall Study|no RBCs received 96hrs after randomized|155
7356848|NCT00991341|11600989|FG000|Overall Study|Physician Decision|1
7356849|NCT00991341|11600990|FG001|Overall Study|Physician Decision|2
7356850|NCT00991341|11600989|FG000|Overall Study|Withdrawal by Subject|3
7356851|NCT00991341|11600990|FG001|Overall Study|Withdrawal by Subject|4
7356852|NCT00991406|11600996|FG000|Overall Study|One participant did not respond to FES.|1
7356853|NCT00991510|11601015|FG000|Period I (Days 1-14)|Adverse Event|1
7356854|NCT00991510|11601016|FG001|Period I (Days 1-14)|Adverse Event|0
7356855|NCT00991510|11601015|FG000|Period III (Days 29-112)|Adverse Event|1
7356856|NCT00991510|11601016|FG001|Period III (Days 29-112)|Adverse Event|1
7356857|NCT00991939|11601039|FG000|Overall Study|Lost to Follow-up|0
7356858|NCT00991939|11601040|FG001|Overall Study|Lost to Follow-up|1
7356859|NCT00991939|11601039|FG000|Overall Study|Withdrawal by Subject|1
7356860|NCT00991939|11601040|FG001|Overall Study|Withdrawal by Subject|0
7356861|NCT00991939|11601039|FG000|Overall Study|Entire study terminated|4
7356862|NCT00991939|11601040|FG001|Overall Study|Entire study terminated|1
7356863|NCT00991952|11601050|FG000|Overall Study|Adverse Event|0
7356864|NCT00991952|11601051|FG001|Overall Study|Adverse Event|1
7356865|NCT00992017|11601057|FG000|Overall Study|Lost to Follow-up|2
7356866|NCT00992017|11601057|FG000|Overall Study|Withdrawal by Subject|2
7356867|NCT00992017|11601057|FG000|Overall Study|Unable to get to clinic|5
7356868|NCT00992017|11601057|FG000|Overall Study|Not adhere to study requirements|1
7356869|NCT00992056|11601068|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
7356870|NCT00992056|11601069|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
7356871|NCT00992056|11601068|FG000|Washout Period (2 Weeks)|Physician Decision|1
7356872|NCT00992056|11601069|FG001|Washout Period (2 Weeks)|Physician Decision|0
7356873|NCT00992108|11601077|FG000|Overall Study|Lost to Follow-up|0
7356874|NCT00992108|11601078|FG001|Overall Study|Lost to Follow-up|1
7356875|NCT00992186|11601084|FG000|Overall Study|Withdrawal by Subject|2
7356876|NCT00992186|11601084|FG000|Overall Study|Protocol Violation|1
7356877|NCT00992186|11601084|FG000|Overall Study|Physician Decision|1
7356878|NCT00992186|11601084|FG000|Overall Study|Adverse Event|9
7356879|NCT00992186|11601084|FG000|Overall Study|Progressive Disease|30
7356880|NCT00992186|11601084|FG000|Overall Study|Refusal To Receive Study Agent|3
7356881|NCT00992225|11601089|FG000|Overall Study|Entry Criteria Not Met|8
7356882|NCT00992225|11601089|FG000|Overall Study|Adverse Event|2
7356883|NCT00992394|11601137|FG000|Overall Study|Lack of Efficacy|6
7356884|NCT00992394|11601138|FG001|Overall Study|Lack of Efficacy|3
7459758|NCT01820585|11754583|FG000|Overall Study|Lack of Efficacy|9
7459759|NCT01820585|11754584|FG001|Overall Study|Lack of Efficacy|7
7459760|NCT01820585|11754585|FG002|Overall Study|Lack of Efficacy|5
7459761|NCT01820585|11754586|FG003|Overall Study|Lack of Efficacy|1
7459762|NCT01820585|11754583|FG000|Overall Study|Withdrawal by Subject|3
7459763|NCT01820585|11754584|FG001|Overall Study|Withdrawal by Subject|7
7459764|NCT01820585|11754585|FG002|Overall Study|Withdrawal by Subject|3
7459765|NCT01820585|11754586|FG003|Overall Study|Withdrawal by Subject|8
7459766|NCT01820585|11754583|FG000|Overall Study|Lost to Follow-up|3
7459767|NCT01820585|11754584|FG001|Overall Study|Lost to Follow-up|3
7459768|NCT01820585|11754585|FG002|Overall Study|Lost to Follow-up|0
7459769|NCT01820585|11754586|FG003|Overall Study|Lost to Follow-up|3
7459770|NCT01820585|11754583|FG000|Overall Study|Protocol Violation|3
7459771|NCT01820585|11754584|FG001|Overall Study|Protocol Violation|1
7459772|NCT01820585|11754585|FG002|Overall Study|Protocol Violation|1
7459773|NCT01820585|11754586|FG003|Overall Study|Protocol Violation|1
7459774|NCT01820585|11754583|FG000|Overall Study|Subject non-compliance|0
7459775|NCT01820585|11754584|FG001|Overall Study|Subject non-compliance|0
7459776|NCT01820585|11754585|FG002|Overall Study|Subject non-compliance|1
7459777|NCT01820585|11754586|FG003|Overall Study|Subject non-compliance|2
7459778|NCT01820585|11754583|FG000|Overall Study|at sponsor request|0
7459779|NCT01820585|11754584|FG001|Overall Study|at sponsor request|0
7459780|NCT01820585|11754585|FG002|Overall Study|at sponsor request|1
7459781|NCT01820585|11754586|FG003|Overall Study|at sponsor request|0
7459782|NCT01820585|11754583|FG000|Overall Study|Pregnancy|0
7459783|NCT01820585|11754584|FG001|Overall Study|Pregnancy|1
7569541|NCT03451084|11945970|FG002|Overall Study|Lack of Efficacy|0
7356885|NCT00992394|11601137|FG000|Overall Study|Adverse Event|4
7459784|NCT01820585|11754585|FG002|Overall Study|Pregnancy|0
7459785|NCT01820585|11754586|FG003|Overall Study|Pregnancy|0
7459786|NCT01820637|11754596|FG000|Overall Study|Death|2
7459787|NCT01820637|11754596|FG000|Overall Study|Withdrawal by Subject|1
7459788|NCT01821118|11754610|FG000|Overall Study|Death|0
7459789|NCT01821118|11754611|FG001|Overall Study|Death|1
7459790|NCT01821391|11754665|FG000|Overall Study|Adverse Event|1
7459791|NCT01821391|11754666|FG001|Overall Study|Adverse Event|0
7459792|NCT01821560|11754689|FG000|Overall Study|Lost to Follow-up|5
7459793|NCT01821560|11754690|FG001|Overall Study|Lost to Follow-up|5
7459794|NCT01821560|11754689|FG000|Overall Study|Withdrawal by Subject|1
7459795|NCT01821560|11754690|FG001|Overall Study|Withdrawal by Subject|1
7459796|NCT01821560|11754689|FG000|Overall Study|Protocol Violation|0
7459797|NCT01821560|11754690|FG001|Overall Study|Protocol Violation|1
7459798|NCT01821625|11754696|FG000|Overall Study|Withdrawal by Subject|2
7459799|NCT01821625|11754696|FG000|Overall Study|Lack of Efficacy|2
7459800|NCT01821625|11754696|FG000|Overall Study|Adverse Event|1
7459801|NCT01821625|11754696|FG000|Overall Study|Medical contraindication|1
7459802|NCT01821729|11754700|FG000|Overall Study|Withdrawal by Subject|1
7459803|NCT01821807|11754706|FG000|Overall Study|Lost to Follow-up|3
7459804|NCT01821807|11754707|FG001|Overall Study|Lost to Follow-up|1
7459805|NCT01821937|11754715|FG000|Overall Study|Adverse Event|0
7459806|NCT01821937|11754716|FG001|Overall Study|Adverse Event|3
7459807|NCT01822132|11754730|FG000|Overall Study|Lost to Follow-up|4
7459808|NCT01822132|11754731|FG001|Overall Study|Lost to Follow-up|2
7459809|NCT01822223|11754749|FG000|Overall Study|Death|0
7459810|NCT01822223|11754750|FG001|Overall Study|Death|1
7459811|NCT01822353|11754771|FG000|Overall Study|Adverse Event|1
7459812|NCT01822353|11754772|FG001|Overall Study|Adverse Event|3
7459813|NCT01822353|11754773|FG002|Overall Study|Adverse Event|1
7459814|NCT01822353|11754771|FG000|Overall Study|Pregnancy|0
7459815|NCT01822353|11754772|FG001|Overall Study|Pregnancy|1
7459816|NCT01822353|11754773|FG002|Overall Study|Pregnancy|0
7459817|NCT01822353|11754771|FG000|Overall Study|Withdrawal by Subject|3
7459818|NCT01822353|11754772|FG001|Overall Study|Withdrawal by Subject|1
7459819|NCT01822353|11754773|FG002|Overall Study|Withdrawal by Subject|0
7459820|NCT01822366|11754788|FG000|Overall Study|Lost to Follow-up|5
7459821|NCT01822366|11754789|FG001|Overall Study|Lost to Follow-up|1
7459822|NCT01822366|11754790|FG002|Overall Study|Lost to Follow-up|5
7356886|NCT00992394|11601138|FG001|Overall Study|Adverse Event|5
7356887|NCT00992394|11601137|FG000|Overall Study|Withdrawal by Subject|8
7459823|NCT01822366|11754791|FG003|Overall Study|Lost to Follow-up|1
7459824|NCT01822366|11754788|FG000|Overall Study|Withdrawal by Subject|0
7459825|NCT01822366|11754789|FG001|Overall Study|Withdrawal by Subject|6
7459826|NCT01822366|11754790|FG002|Overall Study|Withdrawal by Subject|0
7459827|NCT01822366|11754791|FG003|Overall Study|Withdrawal by Subject|6
7356888|NCT00992394|11601138|FG001|Overall Study|Withdrawal by Subject|2
7356889|NCT00992394|11601137|FG000|Overall Study|Physician Decision|1
7356890|NCT00992394|11601138|FG001|Overall Study|Physician Decision|0
7356891|NCT00992394|11601137|FG000|Overall Study|Protocol Violation|2
7356892|NCT00992394|11601138|FG001|Overall Study|Protocol Violation|4
7356893|NCT00992394|11601137|FG000|Overall Study|Lost to Follow-up|2
7356894|NCT00992394|11601138|FG001|Overall Study|Lost to Follow-up|0
7356895|NCT00992394|11601137|FG000|Overall Study|Other event|1
7356896|NCT00992394|11601138|FG001|Overall Study|Other event|0
7356897|NCT00992407|11601146|FG000|Overall Study|Protocol Violation|2
7356898|NCT00992407|11601147|FG001|Overall Study|Protocol Violation|1
7356899|NCT00992407|11601146|FG000|Overall Study|Lost to Follow-up|3
7356900|NCT00992407|11601147|FG001|Overall Study|Lost to Follow-up|3
7356901|NCT00992407|11601146|FG000|Overall Study|Adverse Event|3
7356902|NCT00992407|11601147|FG001|Overall Study|Adverse Event|2
7356903|NCT00992407|11601146|FG000|Overall Study|protocol Violation & Adverse events|2
7356904|NCT00992407|11601147|FG001|Overall Study|protocol Violation & Adverse events|4
7356905|NCT00992407|11601146|FG000|Overall Study|Other|2
7356906|NCT00992407|11601147|FG001|Overall Study|Other|0
7356907|NCT00992407|11601146|FG000|Overall Study|Loss of follow-up & Adverse events|2
7356908|NCT00992407|11601147|FG001|Overall Study|Loss of follow-up & Adverse events|1
7356909|NCT00992407|11601146|FG000|Overall Study|Study medication not administered|17
7356910|NCT00992407|11601147|FG001|Overall Study|Study medication not administered|13
7356911|NCT00992446|11601165|FG000|Overall Study|Disease Progression|1
7356912|NCT00992446|11601165|FG000|Overall Study|Withdrawal by Subject|2
7356913|NCT00992446|11601165|FG000|Overall Study|Maintenance Therapy Screen Fail|5
7356914|NCT00992459|11601171|FG000|Overall Study|Withdrawal by Subject|0
7356915|NCT00992459|11601172|FG001|Overall Study|Withdrawal by Subject|1
7356916|NCT00992459|11601171|FG000|Overall Study|Adverse Event|1
7356917|NCT00992459|11601172|FG001|Overall Study|Adverse Event|0
7356918|NCT00992511|11601182|FG000|Overall Study|Migrated/moved from study area|1
7356919|NCT00992511|11601183|FG001|Overall Study|Migrated/moved from study area|0
7356920|NCT00992511|11601184|FG002|Overall Study|Migrated/moved from study area|1
7356921|NCT00992511|11601185|FG003|Overall Study|Migrated/moved from study area|2
7356922|NCT00992511|11601182|FG000|Overall Study|Lost to Follow-up|1
7356923|NCT00992511|11601183|FG001|Overall Study|Lost to Follow-up|0
7356924|NCT00992511|11601184|FG002|Overall Study|Lost to Follow-up|0
7356925|NCT00992511|11601185|FG003|Overall Study|Lost to Follow-up|2
7356926|NCT00992511|11601182|FG000|Overall Study|Withdrawal by Subject|0
7356927|NCT00992511|11601183|FG001|Overall Study|Withdrawal by Subject|0
7356928|NCT00992511|11601184|FG002|Overall Study|Withdrawal by Subject|1
7356929|NCT00992511|11601185|FG003|Overall Study|Withdrawal by Subject|1
7356930|NCT00992589|11601195|FG000|Open-Label Phase|Adverse Event|4
7356931|NCT00992589|11601196|FG001|Open-Label Phase|Adverse Event|0
7356932|NCT00992589|11601197|FG002|Open-Label Phase|Adverse Event|0
7356933|NCT00992589|11601198|FG003|Open-Label Phase|Adverse Event|0
7356934|NCT00992589|11601195|FG000|Open-Label Phase|Withdrawal by Subject|20
7356935|NCT00992589|11601196|FG001|Open-Label Phase|Withdrawal by Subject|0
7356936|NCT00992589|11601197|FG002|Open-Label Phase|Withdrawal by Subject|0
7356937|NCT00992589|11601198|FG003|Open-Label Phase|Withdrawal by Subject|0
7356938|NCT00992589|11601195|FG000|Open-Label Phase|Lost to Follow-up|1
7356939|NCT00992589|11601196|FG001|Open-Label Phase|Lost to Follow-up|0
7356940|NCT00992589|11601197|FG002|Open-Label Phase|Lost to Follow-up|0
7356941|NCT00992589|11601198|FG003|Open-Label Phase|Lost to Follow-up|0
7356942|NCT00992589|11601195|FG000|Open-Label Phase|Protocol Violation|3
7356943|NCT00992589|11601196|FG001|Open-Label Phase|Protocol Violation|0
7356944|NCT00992589|11601197|FG002|Open-Label Phase|Protocol Violation|0
7356945|NCT00992589|11601198|FG003|Open-Label Phase|Protocol Violation|0
7356946|NCT00992589|11601195|FG000|Open-Label Phase|Physician Decision|4
7356947|NCT00992589|11601196|FG001|Open-Label Phase|Physician Decision|0
7356948|NCT00992589|11601197|FG002|Open-Label Phase|Physician Decision|0
7356949|NCT00992589|11601198|FG003|Open-Label Phase|Physician Decision|0
7356950|NCT00992589|11601195|FG000|Open-Label Phase|Other|45
7356951|NCT00992589|11601196|FG001|Open-Label Phase|Other|0
7356952|NCT00992589|11601197|FG002|Open-Label Phase|Other|0
7356953|NCT00992589|11601198|FG003|Open-Label Phase|Other|0
7356954|NCT00992589|11601195|FG000|Double-Blind Phase|Adverse Event|0
7356955|NCT00992589|11601196|FG001|Double-Blind Phase|Adverse Event|6
7356956|NCT00992589|11601197|FG002|Double-Blind Phase|Adverse Event|2
7356957|NCT00992589|11601198|FG003|Double-Blind Phase|Adverse Event|3
7356958|NCT00992589|11601195|FG000|Double-Blind Phase|Withdrawal by Subject|0
7356959|NCT00992589|11601196|FG001|Double-Blind Phase|Withdrawal by Subject|6
7356960|NCT00992589|11601197|FG002|Double-Blind Phase|Withdrawal by Subject|5
7356961|NCT00992589|11601198|FG003|Double-Blind Phase|Withdrawal by Subject|2
7356962|NCT00992589|11601195|FG000|Double-Blind Phase|Lost to Follow-up|0
7356963|NCT00992589|11601196|FG001|Double-Blind Phase|Lost to Follow-up|0
7356964|NCT00992589|11601197|FG002|Double-Blind Phase|Lost to Follow-up|0
7356965|NCT00992589|11601198|FG003|Double-Blind Phase|Lost to Follow-up|2
7356966|NCT00992589|11601195|FG000|Double-Blind Phase|Other|0
7356967|NCT00992589|11601196|FG001|Double-Blind Phase|Other|1
7356968|NCT00992589|11601197|FG002|Double-Blind Phase|Other|6
7356969|NCT00992589|11601198|FG003|Double-Blind Phase|Other|3
7356970|NCT00992784|11601236|FG000|Overall Study|Adverse Event|2
7356971|NCT00992784|11601237|FG001|Overall Study|Adverse Event|1
7356972|NCT00992784|11601238|FG002|Overall Study|Adverse Event|0
7356973|NCT00992784|11601236|FG000|Overall Study|Withdrawal by Subject|1
7356974|NCT00992784|11601237|FG001|Overall Study|Withdrawal by Subject|1
7356975|NCT00992784|11601238|FG002|Overall Study|Withdrawal by Subject|1
7356976|NCT00992836|11601246|FG000|Overall Study|Lost to Follow-up|1
7356977|NCT00992836|11601246|FG000|Overall Study|Withdrawal by Subject|2
7356978|NCT00992836|11601246|FG000|Overall Study|Protocol Violation|2
7356979|NCT00992992|11601265|FG000|Overall Study|Lost to Follow-up|3
7356980|NCT00992992|11601265|FG000|Overall Study|Death|16
7356981|NCT00992992|11601265|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
7356982|NCT00992992|11601265|FG000|Overall Study|Sponsor Closed the Study|4
7356983|NCT00993031|11601271|FG000|Overall Study|Death|0
7356984|NCT00993031|11601272|FG001|Overall Study|Death|1
7356985|NCT00993031|11601271|FG000|Overall Study|Physician Decision|0
7356986|NCT00993031|11601272|FG001|Overall Study|Physician Decision|2
7356987|NCT00993031|11601271|FG000|Overall Study|Withdrawal by Subject|3
7356988|NCT00993031|11601272|FG001|Overall Study|Withdrawal by Subject|3
7356989|NCT00993031|11601271|FG000|Overall Study|Lost to Follow-up|19
7356990|NCT00993031|11601272|FG001|Overall Study|Lost to Follow-up|13
7356991|NCT00993044|11601282|FG000|Irinotecan 50 mg|Physician Decision|1
7356992|NCT00993148|11601287|FG000|Overall Study|Lost to Follow-up|2
7356993|NCT00993148|11601287|FG000|Overall Study|never initiated treatment|1
7356994|NCT00993265|11601326|FG000|Overall Study|Adverse Event|1
7356995|NCT00993265|11601327|FG001|Overall Study|Adverse Event|0
7356996|NCT00993265|11601326|FG000|Overall Study|Changed dose of concomitant drug|2
7356997|NCT00993265|11601327|FG001|Overall Study|Changed dose of concomitant drug|0
7356998|NCT00993265|11601326|FG000|Overall Study|Non-compliant with study medication|1
7356999|NCT00993265|11601327|FG001|Overall Study|Non-compliant with study medication|0
7357000|NCT00993291|11601333|FG000|Overall Study|Withdrawal by Subject|1
7357001|NCT00993317|11601339|FG000|Overall Study|Adverse Event|2
7357002|NCT00993317|11601340|FG001|Overall Study|Adverse Event|4
7357003|NCT00993317|11601339|FG000|Overall Study|Lack of Efficacy|18
7357004|NCT00993317|11601340|FG001|Overall Study|Lack of Efficacy|18
7357005|NCT00993317|11601339|FG000|Overall Study|Withdrawal by Subject|0
7357006|NCT00993317|11601340|FG001|Overall Study|Withdrawal by Subject|2
7357007|NCT00993317|11601339|FG000|Overall Study|Investigator's opinion|0
7357008|NCT00993317|11601340|FG001|Overall Study|Investigator's opinion|1
7357009|NCT00993317|11601339|FG000|Overall Study|Early study termination at the site|1
7357010|NCT00993317|11601340|FG001|Overall Study|Early study termination at the site|0
7357011|NCT00993421|11601353|FG000|Overall Study|Adverse Event|2
7357012|NCT00993421|11601354|FG001|Overall Study|Adverse Event|7
7357013|NCT00993421|11601355|FG002|Overall Study|Adverse Event|6
7357014|NCT00993421|11601356|FG003|Overall Study|Adverse Event|9
7357015|NCT00993421|11601357|FG004|Overall Study|Adverse Event|5
7357016|NCT00993421|11601358|FG005|Overall Study|Adverse Event|7
7357017|NCT00993421|11601359|FG006|Overall Study|Adverse Event|1
7357018|NCT00993421|11601353|FG000|Overall Study|Sponsor Decision|36
7357019|NCT00993421|11601354|FG001|Overall Study|Sponsor Decision|31
7357020|NCT00993421|11601355|FG002|Overall Study|Sponsor Decision|28
7357021|NCT00993421|11601356|FG003|Overall Study|Sponsor Decision|30
7357022|NCT00993421|11601357|FG004|Overall Study|Sponsor Decision|38
7357023|NCT00993421|11601358|FG005|Overall Study|Sponsor Decision|30
7357024|NCT00993421|11601359|FG006|Overall Study|Sponsor Decision|29
7357025|NCT00993421|11601353|FG000|Overall Study|Lost to Follow-up|3
7357026|NCT00993421|11601354|FG001|Overall Study|Lost to Follow-up|5
7357027|NCT00993421|11601355|FG002|Overall Study|Lost to Follow-up|5
7357028|NCT00993421|11601356|FG003|Overall Study|Lost to Follow-up|0
7357029|NCT00993421|11601357|FG004|Overall Study|Lost to Follow-up|0
7459828|NCT01822366|11754788|FG000|Overall Study|Partial Intervention Completion|0
7459829|NCT01822366|11754789|FG001|Overall Study|Partial Intervention Completion|15
7459830|NCT01822366|11754790|FG002|Overall Study|Partial Intervention Completion|0
7459831|NCT01822366|11754791|FG003|Overall Study|Partial Intervention Completion|15
7459832|NCT01822496|11754832|FG000|Overall Study|Protocol Violation|2
7459833|NCT01822496|11754833|FG001|Overall Study|Protocol Violation|2
7459834|NCT01822496|11754834|FG002|Overall Study|Protocol Violation|0
7459835|NCT01822496|11754835|FG003|Overall Study|Protocol Violation|1
7459836|NCT01822496|11754832|FG000|Overall Study|Withdrawal by Subject|0
7459837|NCT01822496|11754833|FG001|Overall Study|Withdrawal by Subject|0
7459838|NCT01822496|11754834|FG002|Overall Study|Withdrawal by Subject|0
7459839|NCT01822496|11754835|FG003|Overall Study|Withdrawal by Subject|3
7459840|NCT01822535|11754847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
7459841|NCT01822535|11754848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
7459842|NCT01822535|11754847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
7459843|NCT01822535|11754848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
7459844|NCT01822535|11754847|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
7459845|NCT01822535|11754848|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
7459846|NCT01822561|11754866|FG000|Overall Study|Withdrawal by Subject|2
7459847|NCT01822587|11754890|FG000|Overall Study|Lost to Follow-up|7
7459848|NCT01822587|11754891|FG001|Overall Study|Lost to Follow-up|9
7357030|NCT00993421|11601358|FG005|Overall Study|Lost to Follow-up|0
7357031|NCT00993421|11601359|FG006|Overall Study|Lost to Follow-up|6
7357032|NCT00993421|11601353|FG000|Overall Study|Withdrawal by Subject|3
7357033|NCT00993421|11601354|FG001|Overall Study|Withdrawal by Subject|2
7357034|NCT00993421|11601355|FG002|Overall Study|Withdrawal by Subject|3
7357035|NCT00993421|11601356|FG003|Overall Study|Withdrawal by Subject|3
7357036|NCT00993421|11601357|FG004|Overall Study|Withdrawal by Subject|3
7357037|NCT00993421|11601358|FG005|Overall Study|Withdrawal by Subject|5
7357038|NCT00993421|11601359|FG006|Overall Study|Withdrawal by Subject|3
7357039|NCT00993421|11601353|FG000|Overall Study|Death|0
7357040|NCT00993421|11601354|FG001|Overall Study|Death|0
7357041|NCT00993421|11601355|FG002|Overall Study|Death|0
7357042|NCT00993421|11601356|FG003|Overall Study|Death|0
7357043|NCT00993421|11601357|FG004|Overall Study|Death|0
7357044|NCT00993421|11601358|FG005|Overall Study|Death|0
7357045|NCT00993421|11601359|FG006|Overall Study|Death|1
7357046|NCT00993421|11601353|FG000|Overall Study|Entry Criteria Exclusion|0
7357047|NCT00993421|11601354|FG001|Overall Study|Entry Criteria Exclusion|0
7357048|NCT00993421|11601355|FG002|Overall Study|Entry Criteria Exclusion|1
7357049|NCT00993421|11601356|FG003|Overall Study|Entry Criteria Exclusion|3
7357050|NCT00993421|11601357|FG004|Overall Study|Entry Criteria Exclusion|0
7357051|NCT00993421|11601358|FG005|Overall Study|Entry Criteria Exclusion|1
7357052|NCT00993421|11601359|FG006|Overall Study|Entry Criteria Exclusion|0
7357053|NCT00993421|11601353|FG000|Overall Study|Physician Decision|0
7357054|NCT00993421|11601354|FG001|Overall Study|Physician Decision|0
7357055|NCT00993421|11601355|FG002|Overall Study|Physician Decision|0
7357056|NCT00993421|11601356|FG003|Overall Study|Physician Decision|0
7357057|NCT00993421|11601357|FG004|Overall Study|Physician Decision|0
7357058|NCT00993421|11601358|FG005|Overall Study|Physician Decision|1
7357059|NCT00993421|11601359|FG006|Overall Study|Physician Decision|1
7357060|NCT00993421|11601353|FG000|Overall Study|Protocol Violation|0
7357061|NCT00993421|11601354|FG001|Overall Study|Protocol Violation|0
7357062|NCT00993421|11601355|FG002|Overall Study|Protocol Violation|0
7357063|NCT00993421|11601356|FG003|Overall Study|Protocol Violation|0
7357064|NCT00993421|11601357|FG004|Overall Study|Protocol Violation|0
7357065|NCT00993421|11601358|FG005|Overall Study|Protocol Violation|2
7357066|NCT00993421|11601359|FG006|Overall Study|Protocol Violation|1
7357067|NCT00993473|11601377|FG000|Overall Study|Adverse Event|0
7357068|NCT00993473|11601378|FG001|Overall Study|Adverse Event|2
7357069|NCT00993473|11601377|FG000|Overall Study|Protocol Violation|1
7357070|NCT00993473|11601378|FG001|Overall Study|Protocol Violation|2
7357071|NCT00993473|11601377|FG000|Overall Study|Lost to Follow-up|1
7357072|NCT00993473|11601378|FG001|Overall Study|Lost to Follow-up|0
7357073|NCT00993473|11601377|FG000|Overall Study|Withdrawal by Subject|1
7357074|NCT00993473|11601378|FG001|Overall Study|Withdrawal by Subject|5
7357075|NCT00993473|11601377|FG000|Overall Study|Technical problem with CGM device|0
7357076|NCT00993473|11601378|FG001|Overall Study|Technical problem with CGM device|1
7357077|NCT00993473|11601377|FG000|Overall Study|Family event|1
7357078|NCT00993473|11601378|FG001|Overall Study|Family event|0
7357079|NCT00993499|11601390|FG000|Run-in Period (8 Days)|Adverse Event|0
7357080|NCT00993499|11601391|FG001|Run-in Period (8 Days)|Adverse Event|1
7357081|NCT00993499|11601392|FG002|Run-in Period (8 Days)|Adverse Event|0
7357082|NCT00993499|11601393|FG003|Run-in Period (8 Days)|Adverse Event|0
7357083|NCT00993499|11601394|FG004|Run-in Period (8 Days)|Adverse Event|0
7357084|NCT00993499|11601395|FG005|Run-in Period (8 Days)|Adverse Event|0
7357085|NCT00993499|11601390|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
7357086|NCT00993499|11601391|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7357087|NCT00993499|11601392|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7459849|NCT01822587|11754892|FG002|Overall Study|Lost to Follow-up|12
7459850|NCT01822587|11754890|FG000|Overall Study|Physician Decision|9
7459851|NCT01822587|11754891|FG001|Overall Study|Physician Decision|6
7459852|NCT01822587|11754892|FG002|Overall Study|Physician Decision|6
7459853|NCT01822665|11754900|FG000|Overall Study|Adverse Event|3
7459854|NCT01822665|11754900|FG000|Overall Study|Other Reason|5
7459855|NCT01822678|11754921|FG000|Overall Study|Withdrawal by Subject|5
7459856|NCT01822678|11754922|FG001|Overall Study|Withdrawal by Subject|4
7459857|NCT01822678|11754923|FG002|Overall Study|Withdrawal by Subject|4
7459858|NCT01822678|11754921|FG000|Overall Study|Adverse Event|4
7459859|NCT01822678|11754922|FG001|Overall Study|Adverse Event|3
7459860|NCT01822678|11754923|FG002|Overall Study|Adverse Event|1
7459861|NCT01822678|11754921|FG000|Overall Study|Lack of Efficacy|3
7459862|NCT01822678|11754922|FG001|Overall Study|Lack of Efficacy|6
7459863|NCT01822678|11754923|FG002|Overall Study|Lack of Efficacy|5
7459864|NCT01822678|11754921|FG000|Overall Study|Lost to Follow-up|0
7459865|NCT01822678|11754922|FG001|Overall Study|Lost to Follow-up|2
7459866|NCT01822678|11754923|FG002|Overall Study|Lost to Follow-up|1
7459867|NCT01822691|11754931|FG000|Overall Study|Withdrawal by Subject|2
7357088|NCT00993499|11601393|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7357089|NCT00993499|11601394|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7357090|NCT00993499|11601395|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
7459868|NCT01822756|11754940|FG000|Overall Study|Adverse Event|0
7459869|NCT01822756|11754941|FG001|Overall Study|Adverse Event|0
7459870|NCT01822756|11754942|FG002|Overall Study|Adverse Event|0
7459871|NCT01822756|11754943|FG003|Overall Study|Adverse Event|2
7459872|NCT01822756|11754944|FG004|Overall Study|Adverse Event|0
7357091|NCT00993499|11601390|FG000|Run-in Period (8 Days)|Consent withdrawn|0
7357092|NCT00993499|11601391|FG001|Run-in Period (8 Days)|Consent withdrawn|1
7357093|NCT00993499|11601392|FG002|Run-in Period (8 Days)|Consent withdrawn|0
7357094|NCT00993499|11601393|FG003|Run-in Period (8 Days)|Consent withdrawn|0
7357095|NCT00993499|11601394|FG004|Run-in Period (8 Days)|Consent withdrawn|0
7357096|NCT00993499|11601395|FG005|Run-in Period (8 Days)|Consent withdrawn|0
7357097|NCT00993499|11601390|FG000|Run-in Period (8 Days)|Progressive disease|0
7357098|NCT00993499|11601391|FG001|Run-in Period (8 Days)|Progressive disease|1
7357099|NCT00993499|11601392|FG002|Run-in Period (8 Days)|Progressive disease|1
7357100|NCT00993499|11601393|FG003|Run-in Period (8 Days)|Progressive disease|0
7357101|NCT00993499|11601394|FG004|Run-in Period (8 Days)|Progressive disease|0
7357102|NCT00993499|11601395|FG005|Run-in Period (8 Days)|Progressive disease|0
7357103|NCT00993499|11601390|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
7357104|NCT00993499|11601391|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
7357105|NCT00993499|11601392|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
7357106|NCT00993499|11601393|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
7357107|NCT00993499|11601394|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
7357108|NCT00993499|11601395|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
7357109|NCT00993499|11601390|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7357110|NCT00993499|11601391|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
7357111|NCT00993499|11601392|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7357112|NCT00993499|11601393|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7357113|NCT00993499|11601394|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7357114|NCT00993499|11601395|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
7357115|NCT00993499|11601390|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7357116|NCT00993499|11601391|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7357117|NCT00993499|11601392|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7357118|NCT00993499|11601393|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
7357119|NCT00993499|11601394|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7357120|NCT00993499|11601395|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
7357121|NCT00993499|11601390|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7357122|NCT00993499|11601391|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7357123|NCT00993499|11601392|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
7357124|NCT00993499|11601393|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7357125|NCT00993499|11601394|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7357126|NCT00993499|11601395|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
7357127|NCT00993499|11601390|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
7357128|NCT00993499|11601391|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
7357129|NCT00993499|11601392|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
7357130|NCT00993499|11601393|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
7357131|NCT00993499|11601394|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
7357132|NCT00993499|11601395|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
7357133|NCT00993499|11601390|FG000|Discontinued After Starting Course 3|Progressive Disease|6
7357134|NCT00993499|11601391|FG001|Discontinued After Starting Course 3|Progressive Disease|4
7357135|NCT00993499|11601392|FG002|Discontinued After Starting Course 3|Progressive Disease|3
7357136|NCT00993499|11601393|FG003|Discontinued After Starting Course 3|Progressive Disease|1
7357137|NCT00993499|11601394|FG004|Discontinued After Starting Course 3|Progressive Disease|3
7357138|NCT00993499|11601395|FG005|Discontinued After Starting Course 3|Progressive Disease|3
7357139|NCT00993499|11601390|FG000|Discontinued After Starting Course 3|DLT|1
7357140|NCT00993499|11601391|FG001|Discontinued After Starting Course 3|DLT|0
7357141|NCT00993499|11601392|FG002|Discontinued After Starting Course 3|DLT|2
7357142|NCT00993499|11601393|FG003|Discontinued After Starting Course 3|DLT|1
7357143|NCT00993499|11601394|FG004|Discontinued After Starting Course 3|DLT|0
7357144|NCT00993499|11601395|FG005|Discontinued After Starting Course 3|DLT|0
7357145|NCT00993499|11601390|FG000|Discontinued After Starting Course 3|Other adverse event|1
7357146|NCT00993499|11601391|FG001|Discontinued After Starting Course 3|Other adverse event|0
7357147|NCT00993499|11601392|FG002|Discontinued After Starting Course 3|Other adverse event|1
7357148|NCT00993499|11601393|FG003|Discontinued After Starting Course 3|Other adverse event|0
7357149|NCT00993499|11601394|FG004|Discontinued After Starting Course 3|Other adverse event|0
7357150|NCT00993499|11601395|FG005|Discontinued After Starting Course 3|Other adverse event|0
7357151|NCT00993616|11601409|FG000|Overall Study|No tumor at entry|1
7357152|NCT00993616|11601409|FG000|Overall Study|Never treated|1
7357153|NCT00993668|11601437|FG000|Single-Blind Period|Adverse Event|1
7357154|NCT00993668|11601438|FG001|Single-Blind Period|Adverse Event|1
7357155|NCT00993668|11601437|FG000|Single-Blind Period|Lack of Efficacy|0
7357156|NCT00993668|11601438|FG001|Single-Blind Period|Lack of Efficacy|1
7357157|NCT00993668|11601437|FG000|Single-Blind Period|Lost to Follow-up|3
7357158|NCT00993668|11601438|FG001|Single-Blind Period|Lost to Follow-up|1
7357159|NCT00993668|11601437|FG000|Open-Label Period|Adverse Event|9
7357160|NCT00993668|11601438|FG001|Open-Label Period|Adverse Event|8
7533276|NCT02683941|11879548|FG000|Open-label Treatment Phase|Other|1
7357161|NCT00993668|11601437|FG000|Open-Label Period|Lack of Efficacy|4
7357162|NCT00993668|11601438|FG001|Open-Label Period|Lack of Efficacy|3
7357163|NCT00993668|11601437|FG000|Open-Label Period|Withdrawal by Subject|4
7357164|NCT00993668|11601438|FG001|Open-Label Period|Withdrawal by Subject|3
7357165|NCT00993668|11601437|FG000|Open-Label Period|Lost to Follow-up|6
7357166|NCT00993668|11601438|FG001|Open-Label Period|Lost to Follow-up|1
7357167|NCT00993915|11601471|FG000|Overall Study|Insufficient clinical response|3
7357168|NCT00993915|11601471|FG000|Overall Study|Withdrawal by Subject|2
7357169|NCT00993915|11601471|FG000|Overall Study|Other|1
7357170|NCT00993915|11601471|FG000|Overall Study|Ongoing|3
7357171|NCT00993928|11601477|FG000|Overall Study|Withdrawal by Subject|4
7357172|NCT00993928|11601478|FG001|Overall Study|Withdrawal by Subject|7
7357173|NCT00993928|11601477|FG000|Overall Study|ineligible|1
7357174|NCT00993928|11601478|FG001|Overall Study|ineligible|0
7357175|NCT00993954|11601490|FG000|Overall Study|Protocol Violation|21
7357176|NCT00993954|11601491|FG001|Overall Study|Protocol Violation|2
7357177|NCT00993967|11601497|FG000|Overall Study|Adverse Event|8
7357178|NCT00993967|11601497|FG000|Overall Study|Death|1
7357179|NCT00993967|11601497|FG000|Overall Study|Lost to Follow-up|14
7357180|NCT00993967|11601497|FG000|Overall Study|Withdrawal by Subject|36
7357181|NCT00993967|11601497|FG000|Overall Study|Protocol Violation|2
7357182|NCT00994110|11601503|FG000|Overall Study|Withdrawal by Subject|9
7357183|NCT00994110|11601504|FG001|Overall Study|Withdrawal by Subject|9
7357184|NCT00994110|11601503|FG000|Overall Study|Not Treated|4
7357185|NCT00994110|11601504|FG001|Overall Study|Not Treated|8
7357186|NCT00994110|11601503|FG000|Overall Study|Adverse Event|1
7357187|NCT00994110|11601504|FG001|Overall Study|Adverse Event|0
7357188|NCT00994110|11601503|FG000|Overall Study|Patient not resected|41
7357189|NCT00994110|11601504|FG001|Overall Study|Patient not resected|52
7357190|NCT00994110|11601503|FG000|Overall Study|Pt not eligible|10
7357191|NCT00994110|11601504|FG001|Overall Study|Pt not eligible|5
7357192|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7357193|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
7357194|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7357195|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
7357196|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7357197|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7357198|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
7357199|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
7357200|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
7357201|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7357202|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7357203|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
7357204|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7357205|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
7569542|NCT03451084|11945971|FG003|Overall Study|Lack of Efficacy|1
7569543|NCT03451084|11945968|FG000|Overall Study|Death|1
7569544|NCT03451084|11945969|FG001|Overall Study|Death|0
7569545|NCT03451084|11945970|FG002|Overall Study|Death|2
7569546|NCT03451084|11945971|FG003|Overall Study|Death|0
7569547|NCT03451084|11945968|FG000|Overall Study|Physician Decision|0
7569548|NCT03451084|11945969|FG001|Overall Study|Physician Decision|0
7569549|NCT03451084|11945970|FG002|Overall Study|Physician Decision|2
7569550|NCT03451084|11945971|FG003|Overall Study|Physician Decision|2
7569551|NCT03451084|11945968|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
7569552|NCT03451084|11945969|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7569553|NCT03451084|11945970|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
7569554|NCT03451084|11945971|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
7569555|NCT03451721|11945981|FG000|Overall Study|Death|1
7569556|NCT03451773|11945987|FG000|Overall Study|Death on study|1
7569557|NCT03451773|11945988|FG001|Overall Study|Death on study|5
7357206|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
7357207|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
7357208|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7357209|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7357210|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
7357211|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
7357212|NCT00994214|11601545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
7357213|NCT00994214|11601546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
7357214|NCT00994214|11601547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7357215|NCT00994214|11601548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
7357216|NCT00994240|11601578|FG000|Overall Study|Lost to Follow-up|3
7357217|NCT00994240|11601579|FG001|Overall Study|Lost to Follow-up|2
7357218|NCT00994240|11601578|FG000|Overall Study|Withdrawal by Subject|1
7569558|NCT03451773|11945987|FG000|Overall Study|Death during follow-up period|0
7569559|NCT03451773|11945988|FG001|Overall Study|Death during follow-up period|1
7569560|NCT03452189|11946012|FG000|First Intervention (3 Months)|Adverse Event|1
7357219|NCT00994240|11601579|FG001|Overall Study|Withdrawal by Subject|0
7357220|NCT00994240|11601578|FG000|Overall Study|study termination|2
7357221|NCT00994240|11601579|FG001|Overall Study|study termination|3
7357222|NCT00994279|11601587|FG000|Overall Study|Withdrawal by Subject|2
7357223|NCT00994279|11601588|FG001|Overall Study|Withdrawal by Subject|2
7357224|NCT00994279|11601587|FG000|Overall Study|Toxicity|1
7357225|NCT00994279|11601588|FG001|Overall Study|Toxicity|0
7357226|NCT00994279|11601587|FG000|Overall Study|Multiple reasons|1
7357227|NCT00994279|11601588|FG001|Overall Study|Multiple reasons|3
7357228|NCT00994422|11601609|FG000|Overall Study|Lost to Follow-up|7
7357229|NCT00994422|11601610|FG001|Overall Study|Lost to Follow-up|1
7357230|NCT00994448|11601620|FG000|Overall Study|Adverse Event|1
7357231|NCT00994448|11601621|FG001|Overall Study|Adverse Event|0
7357232|NCT00994448|11601620|FG000|Overall Study|Lost to Follow-up|5
7357233|NCT00994448|11601621|FG001|Overall Study|Lost to Follow-up|1
7357234|NCT00994448|11601620|FG000|Overall Study|Withdrawal by Subject|1
7357235|NCT00994448|11601621|FG001|Overall Study|Withdrawal by Subject|1
7357236|NCT00994448|11601620|FG000|Overall Study|Physician Decision|1
7357237|NCT00994448|11601621|FG001|Overall Study|Physician Decision|0
7386188|NCT01208870|11644484|FG000|Overall Study|Lost to Follow-up|2
7386189|NCT01208870|11644485|FG001|Overall Study|Lost to Follow-up|8
7386190|NCT01208961|11644502|FG000|High-Fat Period III|Protocol Violation|1
7386191|NCT01208961|11644503|FG001|High-Fat Period III|Protocol Violation|0
7386192|NCT01209078|11644510|FG000|Overall Study|Adverse Event|5
7386193|NCT01209078|11644511|FG001|Overall Study|Adverse Event|0
7386194|NCT01209078|11644510|FG000|Overall Study|Lost to Follow-up|4
7386195|NCT01209078|11644511|FG001|Overall Study|Lost to Follow-up|0
7386196|NCT01209078|11644510|FG000|Overall Study|Physician Decision|5
7386197|NCT01209078|11644511|FG001|Overall Study|Physician Decision|2
7386198|NCT01209078|11644510|FG000|Overall Study|Withdrawal by Subject|2
7386199|NCT01209078|11644511|FG001|Overall Study|Withdrawal by Subject|1
7386200|NCT01209143|11644521|FG000|Overall Study|Adverse Event|2
7386201|NCT01209143|11644522|FG001|Overall Study|Adverse Event|1
7386202|NCT01209143|11644521|FG000|Overall Study|Death|0
7386203|NCT01209143|11644522|FG001|Overall Study|Death|1
7386204|NCT01209143|11644521|FG000|Overall Study|Physician Decision|3
7386205|NCT01209143|11644522|FG001|Overall Study|Physician Decision|1
7386206|NCT01209143|11644521|FG000|Overall Study|Lost to Follow-up|1
7386207|NCT01209143|11644522|FG001|Overall Study|Lost to Follow-up|0
7386208|NCT01209143|11644521|FG000|Overall Study|Withdrawal by Subject|2
7386209|NCT01209143|11644522|FG001|Overall Study|Withdrawal by Subject|1
7386210|NCT01209143|11644521|FG000|Overall Study|Disease progression|11
7386211|NCT01209143|11644522|FG001|Overall Study|Disease progression|16
7386212|NCT01209286|11644574|FG000|Overall Study|Adverse Event|4
7386213|NCT01209286|11644575|FG001|Overall Study|Adverse Event|3
7386214|NCT01209286|11644576|FG002|Overall Study|Adverse Event|1
7386215|NCT01209286|11644574|FG000|Overall Study|Hematological Relapse After Remission|0
7386216|NCT01209286|11644575|FG001|Overall Study|Hematological Relapse After Remission|1
7386217|NCT01209286|11644576|FG002|Overall Study|Hematological Relapse After Remission|1
7386218|NCT01209286|11644574|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
7386219|NCT01209286|11644575|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
7386220|NCT01209286|11644576|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
7386221|NCT01209286|11644574|FG000|Overall Study|Physician Decision|0
7386222|NCT01209286|11644575|FG001|Overall Study|Physician Decision|2
7386223|NCT01209286|11644576|FG002|Overall Study|Physician Decision|0
7386224|NCT01209286|11644574|FG000|Overall Study|Other|0
7569561|NCT03452189|11946013|FG001|First Intervention (3 Months)|Adverse Event|0
7569562|NCT03452189|11946012|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
7386225|NCT01209286|11644575|FG001|Overall Study|Other|1
7386226|NCT01209286|11644576|FG002|Overall Study|Other|0
7386227|NCT01209325|11644593|FG000|Overall Study|Lost to Follow-up|24
7386228|NCT01209325|11644593|FG000|Overall Study|Adverse Event|1
7386229|NCT01209325|11644593|FG000|Overall Study|Relocated|3
7386230|NCT01209325|11644593|FG000|Overall Study|Refusal after starting therapy|8
7386231|NCT01209325|11644593|FG000|Overall Study|Protocol Violation|4
7386232|NCT01209325|11644593|FG000|Overall Study|Refusal prior to therapy|1
7386233|NCT01209325|11644593|FG000|Overall Study|Incarceration|2
7386234|NCT01209598|11644625|FG000|Overall Study|Withdrawal by Subject|1
7386235|NCT01209598|11644626|FG001|Overall Study|Withdrawal by Subject|0
7386236|NCT01209624|11644633|FG000|Overall Study|Death|2
7386237|NCT01209624|11644633|FG000|Overall Study|Adverse Event|13
7386238|NCT01209624|11644633|FG000|Overall Study|Lack of Efficacy|17
7386239|NCT01209624|11644633|FG000|Overall Study|Lost to Follow-up|290
7386240|NCT01209624|11644633|FG000|Overall Study|Other|4
7386241|NCT01209689|11644639|FG000|Overall Study|Insufficient Therapeutic Response|7
7386242|NCT01209689|11644640|FG001|Overall Study|Insufficient Therapeutic Response|2
7386243|NCT01209689|11644639|FG000|Overall Study|Refused Treatment|8
7386244|NCT01209689|11644640|FG001|Overall Study|Refused Treatment|3
7386245|NCT01209689|11644639|FG000|Overall Study|Adverse Event|4
7386246|NCT01209689|11644640|FG001|Overall Study|Adverse Event|0
7386247|NCT01209689|11644639|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7357238|NCT00994461|11601630|FG000|Overall Study|Adverse Event|2
7357239|NCT00994461|11601631|FG001|Overall Study|Adverse Event|1
7357240|NCT00994461|11601632|FG002|Overall Study|Adverse Event|0
7357241|NCT00994643|11601647|FG000|Overall Study|Withdrawal by Subject|1
7357242|NCT00994682|11601653|FG000|Double Bilnd|Withdrawal by Subject|5
7357243|NCT00994682|11601654|FG001|Double Bilnd|Withdrawal by Subject|6
7357244|NCT00994682|11601653|FG000|Double Bilnd|Lost to Follow-up|3
7357245|NCT00994682|11601654|FG001|Double Bilnd|Lost to Follow-up|3
7357246|NCT00994682|11601653|FG000|Double Bilnd|Adverse Event|1
7357247|NCT00994682|11601654|FG001|Double Bilnd|Adverse Event|0
7357248|NCT00994682|11601653|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
7357249|NCT00994682|11601654|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
7357250|NCT00994682|11601653|FG000|Pioglitazone Open Label|Lost to Follow-up|3
7357251|NCT00994682|11601654|FG001|Pioglitazone Open Label|Lost to Follow-up|2
7357252|NCT00994682|11601653|FG000|Pioglitazone Open Label|Physician Decision|6
7357253|NCT00994682|11601654|FG001|Pioglitazone Open Label|Physician Decision|1
7357254|NCT00994890|11601685|FG000|Overall Study|Adverse Event|13
7357255|NCT00994890|11601686|FG001|Overall Study|Adverse Event|9
7357256|NCT00994890|11601687|FG002|Overall Study|Adverse Event|11
7357257|NCT00994890|11601685|FG000|Overall Study|Lack of Efficacy|0
7357258|NCT00994890|11601686|FG001|Overall Study|Lack of Efficacy|0
7357259|NCT00994890|11601687|FG002|Overall Study|Lack of Efficacy|1
7357260|NCT00994890|11601685|FG000|Overall Study|Lost to Follow-up|6
7357261|NCT00994890|11601686|FG001|Overall Study|Lost to Follow-up|1
7357262|NCT00994890|11601687|FG002|Overall Study|Lost to Follow-up|3
7357263|NCT00994890|11601685|FG000|Overall Study|No longer willing to participate|8
7357264|NCT00994890|11601686|FG001|Overall Study|No longer willing to participate|5
7357265|NCT00994890|11601687|FG002|Overall Study|No longer willing to participate|13
7357266|NCT00994890|11601685|FG000|Overall Study|Protocol Violation|2
7357267|NCT00994890|11601686|FG001|Overall Study|Protocol Violation|4
7357268|NCT00994890|11601687|FG002|Overall Study|Protocol Violation|0
7357269|NCT00994890|11601685|FG000|Overall Study|Study terminated by sponsor|199
7357270|NCT00994890|11601686|FG001|Overall Study|Study terminated by sponsor|201
7357271|NCT00994890|11601687|FG002|Overall Study|Study terminated by sponsor|197
7357272|NCT00994890|11601685|FG000|Overall Study|Randomized, but not treated|1
7357273|NCT00994890|11601686|FG001|Overall Study|Randomized, but not treated|0
7357274|NCT00994890|11601687|FG002|Overall Study|Randomized, but not treated|0
7357275|NCT00994890|11601685|FG000|Overall Study|Other|2
7357276|NCT00994890|11601686|FG001|Overall Study|Other|2
7357277|NCT00994890|11601687|FG002|Overall Study|Other|1
7357278|NCT00995007|11601702|FG000|Overall Study|Withdrew consent|1
7357279|NCT00995007|11601703|FG001|Overall Study|Withdrew consent|0
7357280|NCT00995007|11601702|FG000|Overall Study|Refused further treatment|8
7357281|NCT00995007|11601703|FG001|Overall Study|Refused further treatment|2
7357282|NCT00995007|11601702|FG000|Overall Study|Toxicity|8
7357283|NCT00995007|11601703|FG001|Overall Study|Toxicity|0
7357284|NCT00995020|11601720|FG000|Overall Study|margin analysis not performed|2
7357285|NCT00995020|11601721|FG001|Overall Study|margin analysis not performed|5
7357286|NCT00995020|11601720|FG000|Overall Study|specimen fragmentation, thermal damage|1
7357287|NCT00995020|11601721|FG001|Overall Study|specimen fragmentation, thermal damage|2
7357288|NCT00995085|11601738|FG000|Overall Study|Withdrawal by Subject|5
7357289|NCT00995345|11601752|FG000|Overall Study|Withdrawal by Subject|4
7357290|NCT00995345|11601753|FG001|Overall Study|Withdrawal by Subject|2
7357291|NCT00995345|11601754|FG002|Overall Study|Withdrawal by Subject|1
7357292|NCT00995345|11601755|FG003|Overall Study|Withdrawal by Subject|3
7357293|NCT00995345|11601756|FG004|Overall Study|Withdrawal by Subject|1
7357294|NCT00995345|11601752|FG000|Overall Study|Adverse Event|3
7357295|NCT00995345|11601753|FG001|Overall Study|Adverse Event|1
7357296|NCT00995345|11601754|FG002|Overall Study|Adverse Event|2
7357297|NCT00995345|11601755|FG003|Overall Study|Adverse Event|0
7357298|NCT00995345|11601756|FG004|Overall Study|Adverse Event|1
7357299|NCT00995345|11601752|FG000|Overall Study|Lost to Follow-up|2
7357300|NCT00995345|11601753|FG001|Overall Study|Lost to Follow-up|2
7357301|NCT00995345|11601754|FG002|Overall Study|Lost to Follow-up|2
7357302|NCT00995345|11601755|FG003|Overall Study|Lost to Follow-up|1
7357303|NCT00995345|11601756|FG004|Overall Study|Lost to Follow-up|0
7357304|NCT00995345|11601752|FG000|Overall Study|all other reasons combined|2
7357305|NCT00995345|11601753|FG001|Overall Study|all other reasons combined|2
7357306|NCT00995345|11601754|FG002|Overall Study|all other reasons combined|2
7357307|NCT00995345|11601755|FG003|Overall Study|all other reasons combined|1
7357308|NCT00995345|11601756|FG004|Overall Study|all other reasons combined|3
7357309|NCT00995371|11601770|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7357310|NCT00995371|11601771|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
7357311|NCT00995410|11601779|FG000|Overall Study|Adverse Event|51
7357312|NCT00995410|11601779|FG000|Overall Study|Withdrawal by Subject|7
7357313|NCT00995410|11601779|FG000|Overall Study|Lost to Follow-up|2
7357314|NCT00995410|11601779|FG000|Overall Study|Misc|28
7357315|NCT00995436|11601786|FG000|Overall Study|Withdrawal by Subject|2
7357316|NCT00995436|11601787|FG001|Overall Study|Withdrawal by Subject|5
7357317|NCT00995436|11601788|FG002|Overall Study|Withdrawal by Subject|0
7357318|NCT00995488|11601818|FG000|Overall Study|Withdrawal by Subject|1
7357319|NCT00995553|11601857|FG000|Overall Study|Withdrawal by Subject|2
7357320|NCT00995553|11601858|FG001|Overall Study|Withdrawal by Subject|6
7357321|NCT00995566|11601864|FG000|Overall Study|Adverse Event|2
7357322|NCT00995566|11601864|FG000|Overall Study|Early study termination|52
7357323|NCT00995670|11601871|FG000|Overall Study|Failed arterial cannulation|1
7357324|NCT00995670|11601872|FG001|Overall Study|Failed arterial cannulation|0
7357325|NCT00995670|11601873|FG002|Overall Study|Failed arterial cannulation|3
7357326|NCT00995709|11601884|FG000|Overall Study|Adverse Event|4
7357327|NCT00995709|11601885|FG001|Overall Study|Adverse Event|2
7357328|NCT00995709|11601886|FG002|Overall Study|Adverse Event|0
7357329|NCT00995709|11601884|FG000|Overall Study|Lack of Efficacy|0
7357330|NCT00995709|11601885|FG001|Overall Study|Lack of Efficacy|1
7357331|NCT00995709|11601886|FG002|Overall Study|Lack of Efficacy|4
7357332|NCT00995709|11601884|FG000|Overall Study|Withdrawal by Subject|0
7357333|NCT00995709|11601885|FG001|Overall Study|Withdrawal by Subject|4
7357334|NCT00995709|11601886|FG002|Overall Study|Withdrawal by Subject|1
7357335|NCT00995709|11601884|FG000|Overall Study|Lost to Follow-up|1
7357336|NCT00995709|11601885|FG001|Overall Study|Lost to Follow-up|0
7357337|NCT00995709|11601886|FG002|Overall Study|Lost to Follow-up|0
7357338|NCT00995709|11601884|FG000|Overall Study|Death|0
7357339|NCT00995709|11601885|FG001|Overall Study|Death|1
7357340|NCT00995709|11601886|FG002|Overall Study|Death|0
7357341|NCT00995709|11601884|FG000|Overall Study|Protocol Violation|2
7357342|NCT00995709|11601885|FG001|Overall Study|Protocol Violation|1
7357343|NCT00995709|11601886|FG002|Overall Study|Protocol Violation|0
7357344|NCT00995774|11601909|FG000|Training Period 2|Withdrawal by Subject|2
7357345|NCT00995774|11601910|FG001|Training Period 2|Withdrawal by Subject|0
7357346|NCT00995865|11601919|FG000|Overall Study|Protocol Violation|2
7357347|NCT00995865|11601920|FG001|Overall Study|Protocol Violation|0
7357348|NCT00995865|11601921|FG002|Overall Study|Protocol Violation|0
7357349|NCT00995865|11601919|FG000|Overall Study|Lost to Follow-up|0
7357350|NCT00995865|11601920|FG001|Overall Study|Lost to Follow-up|0
7357351|NCT00995865|11601921|FG002|Overall Study|Lost to Follow-up|1
7357352|NCT00995930|11601952|FG000|Overall Study|Protocol deviation|2
7357353|NCT00995930|11601953|FG001|Overall Study|Protocol deviation|5
7357354|NCT00995930|11601952|FG000|Overall Study|Death|0
7357355|NCT00995930|11601953|FG001|Overall Study|Death|1
7357356|NCT00995930|11601952|FG000|Overall Study|Administrative problems|4
7357357|NCT00995930|11601953|FG001|Overall Study|Administrative problems|2
7357358|NCT00995930|11601952|FG000|Overall Study|Lost to Follow-up|1
7357359|NCT00995930|11601953|FG001|Overall Study|Lost to Follow-up|2
7357360|NCT00995930|11601952|FG000|Overall Study|Withdrawal by Subject|3
7357361|NCT00995930|11601953|FG001|Overall Study|Withdrawal by Subject|4
7357362|NCT00995930|11601952|FG000|Overall Study|Adverse Event|11
7357363|NCT00995930|11601953|FG001|Overall Study|Adverse Event|14
7357364|NCT00996034|11601960|FG000|Overall Study|Lost to Follow-up|2
7357365|NCT00996034|11601960|FG000|Overall Study|withdrawn by PI|1
7357366|NCT00996125|11601966|FG000|Overall Study|Adverse Event|0
7357367|NCT00996125|11601967|FG001|Overall Study|Adverse Event|2
7357368|NCT00996125|11601966|FG000|Overall Study|Lost to Follow-up|1
7357369|NCT00996125|11601967|FG001|Overall Study|Lost to Follow-up|6
7357370|NCT00996125|11601966|FG000|Overall Study|Withdrawal by Subject|4
7357371|NCT00996125|11601967|FG001|Overall Study|Withdrawal by Subject|3
7357372|NCT00996203|11601982|FG000|Overall Study|Adverse Event|3
7357373|NCT00996203|11601982|FG000|Overall Study|Lost to Follow-up|1
7357374|NCT00996203|11601982|FG000|Overall Study|Lack of Efficacy|1
7357375|NCT00996203|11601982|FG000|Overall Study|Protocol Violation|2
7357376|NCT00996216|11601987|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
7357377|NCT00996216|11601987|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
7357378|NCT00996216|11601987|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
7357379|NCT00996281|11601994|FG000|Overall Study|Adverse Event|75
7357380|NCT00996281|11601995|FG001|Overall Study|Adverse Event|37
7357381|NCT00996281|11601994|FG000|Overall Study|Major Protocol Deviation|6
7357382|NCT00996281|11601995|FG001|Overall Study|Major Protocol Deviation|7
7357383|NCT00996281|11601994|FG000|Overall Study|Lost to Follow-up|14
7357384|NCT00996281|11601995|FG001|Overall Study|Lost to Follow-up|16
7357385|NCT00996281|11601994|FG000|Overall Study|Withdrawal by Subject|31
7357386|NCT00996281|11601995|FG001|Overall Study|Withdrawal by Subject|20
7357387|NCT00996281|11601994|FG000|Overall Study|Lack of Efficacy|0
7357388|NCT00996281|11601995|FG001|Overall Study|Lack of Efficacy|2
7357389|NCT00996281|11601994|FG000|Overall Study|Other|5
7357390|NCT00996281|11601995|FG001|Overall Study|Other|7
7357391|NCT00996307|11602005|FG000|Overall Study|Adverse Event|0
7459873|NCT01822756|11754940|FG000|Overall Study|Disease progression|11
7357392|NCT00996307|11602006|FG001|Overall Study|Adverse Event|1
7357393|NCT00996307|11602007|FG002|Overall Study|Adverse Event|0
7357394|NCT00996307|11602008|FG003|Overall Study|Adverse Event|0
7357395|NCT00996307|11602005|FG000|Overall Study|Withdrawal by Subject|3
7357396|NCT00996307|11602006|FG001|Overall Study|Withdrawal by Subject|2
7357397|NCT00996307|11602007|FG002|Overall Study|Withdrawal by Subject|5
7357398|NCT00996307|11602008|FG003|Overall Study|Withdrawal by Subject|5
7357399|NCT00996307|11602005|FG000|Overall Study|Lost to Follow-up|13
7357400|NCT00996307|11602006|FG001|Overall Study|Lost to Follow-up|13
7357401|NCT00996307|11602007|FG002|Overall Study|Lost to Follow-up|7
7357402|NCT00996307|11602008|FG003|Overall Study|Lost to Follow-up|15
7357403|NCT00996307|11602005|FG000|Overall Study|Administrative reason|0
7357404|NCT00996307|11602006|FG001|Overall Study|Administrative reason|1
7459874|NCT01822756|11754941|FG001|Overall Study|Disease progression|1
7357405|NCT00996307|11602007|FG002|Overall Study|Administrative reason|0
7357406|NCT00996307|11602008|FG003|Overall Study|Administrative reason|0
7357407|NCT00996307|11602005|FG000|Overall Study|Unable to classify|4
7357408|NCT00996307|11602006|FG001|Overall Study|Unable to classify|0
7357409|NCT00996307|11602007|FG002|Overall Study|Unable to classify|2
7357410|NCT00996307|11602008|FG003|Overall Study|Unable to classify|1
7357411|NCT00996437|11602060|FG000|Overall Study|Death|1
7357412|NCT00996437|11602061|FG001|Overall Study|Death|0
7357413|NCT00996437|11602060|FG000|Overall Study|Dropped|2
7357414|NCT00996437|11602061|FG001|Overall Study|Dropped|2
7357415|NCT00996437|11602060|FG000|Overall Study|Missed|2
7357416|NCT00996437|11602061|FG001|Overall Study|Missed|5
7357417|NCT00996476|11602072|FG000|Overall Study|Withdrawal by Subject|1
7357418|NCT00996476|11602073|FG001|Overall Study|Withdrawal by Subject|2
7357419|NCT00996476|11602074|FG002|Overall Study|Withdrawal by Subject|1
7357420|NCT00996476|11602075|FG003|Overall Study|Withdrawal by Subject|0
7357421|NCT00996476|11602076|FG004|Overall Study|Withdrawal by Subject|1
7357422|NCT00996476|11602072|FG000|Overall Study|Adverse Event|0
7357423|NCT00996476|11602073|FG001|Overall Study|Adverse Event|1
7357424|NCT00996476|11602074|FG002|Overall Study|Adverse Event|0
7357425|NCT00996476|11602075|FG003|Overall Study|Adverse Event|0
7357426|NCT00996476|11602076|FG004|Overall Study|Adverse Event|1
7357427|NCT00996489|11602093|FG000|Overall Study|Device failure|45
7357428|NCT00996489|11602093|FG000|Overall Study|Discontinued|116
7357429|NCT00996580|11602097|FG000|Overall Study|Adverse Event|466
7357430|NCT00996580|11602097|FG000|Overall Study|Lost to Follow-up|480
7357431|NCT00996580|11602097|FG000|Overall Study|Noncompliance with the protocol|137
7357432|NCT00996580|11602097|FG000|Overall Study|Physician Decision|5
7357433|NCT00996580|11602097|FG000|Overall Study|Pregnancy|68
7357434|NCT00996580|11602097|FG000|Overall Study|Protocol Violation|16
7357435|NCT00996580|11602097|FG000|Overall Study|Sponsor requested participant withdrawal|35
7357436|NCT00996580|11602097|FG000|Overall Study|Withdrawal by Subject|217
7357437|NCT00996580|11602097|FG000|Overall Study|Other|29
7357438|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
7357439|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
7357440|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
7357441|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Death|1
7357442|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
7357443|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
7357444|NCT00996593|11602104|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
7357445|NCT00996593|11602104|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
7357446|NCT00996593|11602104|FG000|Long-Term Follow-Up|Site Closed|1
7357447|NCT00996606|11602108|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
7357448|NCT00996606|11602108|FG000|Overall Study|Insufficient Therapeutic Response|2
7357449|NCT00996606|11602108|FG000|Overall Study|Protocol Violation|1
7357450|NCT00996606|11602108|FG000|Overall Study|Withdrawal by Subject|3
7357451|NCT00996632|11602114|FG000|Overall Study|Physician Decision|0
7357452|NCT00996632|11602115|FG001|Overall Study|Physician Decision|0
7357453|NCT00996658|11602123|FG000|Overall Study|Adverse Event|2
7357454|NCT00996658|11602124|FG001|Overall Study|Adverse Event|5
7357455|NCT00996658|11602123|FG000|Overall Study|Protocol Violation|0
7357456|NCT00996658|11602124|FG001|Overall Study|Protocol Violation|1
7357457|NCT00996658|11602123|FG000|Overall Study|Lost to Follow-up|2
7357458|NCT00996658|11602124|FG001|Overall Study|Lost to Follow-up|5
7357459|NCT00996658|11602123|FG000|Overall Study|Non-compliance issues|3
7357460|NCT00996658|11602124|FG001|Overall Study|Non-compliance issues|3
7357461|NCT00996658|11602123|FG000|Overall Study|Other|9
7357462|NCT00996658|11602124|FG001|Overall Study|Other|7
7357463|NCT00996736|11602132|FG000|Overall Study|Death|1
7357464|NCT00996736|11602133|FG001|Overall Study|Death|1
7357465|NCT00996736|11602132|FG000|Overall Study|Lost to Follow-up|15
7357466|NCT00996736|11602133|FG001|Overall Study|Lost to Follow-up|14
7357467|NCT00996736|11602132|FG000|Overall Study|Visit not within 3-month window|5
7357468|NCT00996736|11602133|FG001|Overall Study|Visit not within 3-month window|3
7357469|NCT00996801|11602154|FG000|Overall Study|Adverse Event|6
7357470|NCT00996801|11602155|FG001|Overall Study|Adverse Event|4
7357471|NCT00996801|11602156|FG002|Overall Study|Adverse Event|12
7357472|NCT00996801|11602157|FG003|Overall Study|Adverse Event|17
7357473|NCT00996801|11602158|FG004|Overall Study|Adverse Event|31
7357474|NCT00996801|11602159|FG005|Overall Study|Adverse Event|3
7357475|NCT00996801|11602154|FG000|Overall Study|Lack of Efficacy|3
7357476|NCT00996801|11602155|FG001|Overall Study|Lack of Efficacy|0
7357477|NCT00996801|11602156|FG002|Overall Study|Lack of Efficacy|1
7357478|NCT00996801|11602157|FG003|Overall Study|Lack of Efficacy|3
7357479|NCT00996801|11602158|FG004|Overall Study|Lack of Efficacy|0
7357480|NCT00996801|11602159|FG005|Overall Study|Lack of Efficacy|1
7357481|NCT00996801|11602154|FG000|Overall Study|Lost to Follow-up|0
7357482|NCT00996801|11602155|FG001|Overall Study|Lost to Follow-up|0
7357483|NCT00996801|11602156|FG002|Overall Study|Lost to Follow-up|0
7357484|NCT00996801|11602157|FG003|Overall Study|Lost to Follow-up|3
7357485|NCT00996801|11602158|FG004|Overall Study|Lost to Follow-up|3
7357486|NCT00996801|11602159|FG005|Overall Study|Lost to Follow-up|2
7357487|NCT00996801|11602154|FG000|Overall Study|Physician Decision|0
7357488|NCT00996801|11602155|FG001|Overall Study|Physician Decision|0
7357489|NCT00996801|11602156|FG002|Overall Study|Physician Decision|0
7357490|NCT00996801|11602157|FG003|Overall Study|Physician Decision|1
7357491|NCT00996801|11602158|FG004|Overall Study|Physician Decision|0
7357492|NCT00996801|11602159|FG005|Overall Study|Physician Decision|0
7357493|NCT00996801|11602154|FG000|Overall Study|Progressive Disease|0
7357494|NCT00996801|11602155|FG001|Overall Study|Progressive Disease|1
7357495|NCT00996801|11602156|FG002|Overall Study|Progressive Disease|0
7357496|NCT00996801|11602157|FG003|Overall Study|Progressive Disease|0
7357497|NCT00996801|11602158|FG004|Overall Study|Progressive Disease|0
7357498|NCT00996801|11602159|FG005|Overall Study|Progressive Disease|0
7357499|NCT00996801|11602154|FG000|Overall Study|Protocol Violation|3
7357500|NCT00996801|11602155|FG001|Overall Study|Protocol Violation|4
7357501|NCT00996801|11602156|FG002|Overall Study|Protocol Violation|1
7357502|NCT00996801|11602157|FG003|Overall Study|Protocol Violation|2
7357503|NCT00996801|11602158|FG004|Overall Study|Protocol Violation|3
7357504|NCT00996801|11602159|FG005|Overall Study|Protocol Violation|4
7357505|NCT00996801|11602154|FG000|Overall Study|Study Terminated by Sponsor|0
7357506|NCT00996801|11602155|FG001|Overall Study|Study Terminated by Sponsor|1
7357507|NCT00996801|11602156|FG002|Overall Study|Study Terminated by Sponsor|0
7357508|NCT00996801|11602157|FG003|Overall Study|Study Terminated by Sponsor|0
7357509|NCT00996801|11602158|FG004|Overall Study|Study Terminated by Sponsor|46
7357510|NCT00996801|11602159|FG005|Overall Study|Study Terminated by Sponsor|0
7357511|NCT00996801|11602154|FG000|Overall Study|Withdrawal by Subject|8
7357512|NCT00996801|11602155|FG001|Overall Study|Withdrawal by Subject|6
7357513|NCT00996801|11602156|FG002|Overall Study|Withdrawal by Subject|9
7357514|NCT00996801|11602157|FG003|Overall Study|Withdrawal by Subject|5
7357515|NCT00996801|11602158|FG004|Overall Study|Withdrawal by Subject|5
7357516|NCT00996801|11602159|FG005|Overall Study|Withdrawal by Subject|9
7357517|NCT00996840|11602180|FG000|Overall Study|Adverse Event|0
7357518|NCT00996840|11602181|FG001|Overall Study|Adverse Event|1
7357519|NCT00996840|11602182|FG002|Overall Study|Adverse Event|0
7357520|NCT00996840|11602183|FG003|Overall Study|Adverse Event|0
7357521|NCT00996840|11602184|FG004|Overall Study|Adverse Event|0
7357522|NCT00996840|11602180|FG000|Overall Study|Physician Decision|0
7357523|NCT00996840|11602181|FG001|Overall Study|Physician Decision|0
7357524|NCT00996840|11602182|FG002|Overall Study|Physician Decision|1
7357525|NCT00996840|11602183|FG003|Overall Study|Physician Decision|1
7357526|NCT00996840|11602184|FG004|Overall Study|Physician Decision|2
7357527|NCT00996840|11602180|FG000|Overall Study|Withdrawal by Subject|1
7357528|NCT00996840|11602181|FG001|Overall Study|Withdrawal by Subject|1
7357529|NCT00996840|11602182|FG002|Overall Study|Withdrawal by Subject|0
7357530|NCT00996840|11602183|FG003|Overall Study|Withdrawal by Subject|0
7357531|NCT00996840|11602184|FG004|Overall Study|Withdrawal by Subject|0
7357532|NCT00996892|11602200|FG000|Dose-Escalation Stage 1|Adverse Event|0
7357533|NCT00996892|11602201|FG001|Dose-Escalation Stage 1|Adverse Event|0
7357534|NCT00996892|11602202|FG002|Dose-Escalation Stage 1|Adverse Event|0
7357535|NCT00996892|11602203|FG003|Dose-Escalation Stage 1|Adverse Event|2
7357536|NCT00996892|11602204|FG004|Dose-Escalation Stage 1|Adverse Event|0
7357537|NCT00996892|11602205|FG005|Dose-Escalation Stage 1|Adverse Event|0
7357538|NCT00996892|11602206|FG006|Dose-Escalation Stage 1|Adverse Event|1
7357539|NCT00996892|11602207|FG007|Dose-Escalation Stage 1|Adverse Event|0
7357540|NCT00996892|11602208|FG008|Dose-Escalation Stage 1|Adverse Event|0
7357541|NCT00996892|11602209|FG009|Dose-Escalation Stage 1|Adverse Event|0
7357542|NCT00996892|11602210|FG010|Dose-Escalation Stage 1|Adverse Event|0
7357543|NCT00996892|11602211|FG011|Dose-Escalation Stage 1|Adverse Event|0
7357544|NCT00996892|11602212|FG012|Dose-Escalation Stage 1|Adverse Event|0
7357545|NCT00996892|11602213|FG013|Dose-Escalation Stage 1|Adverse Event|0
7357546|NCT00996892|11602214|FG014|Dose-Escalation Stage 1|Adverse Event|0
7357547|NCT00996892|11602215|FG015|Dose-Escalation Stage 1|Adverse Event|0
7357548|NCT00996892|11602216|FG016|Dose-Escalation Stage 1|Adverse Event|0
7357549|NCT00996892|11602217|FG017|Dose-Escalation Stage 1|Adverse Event|0
7357550|NCT00996892|11602218|FG018|Dose-Escalation Stage 1|Adverse Event|0
7357551|NCT00996892|11602219|FG019|Dose-Escalation Stage 1|Adverse Event|0
7357552|NCT00996892|11602200|FG000|Dose-Escalation Stage 1|Death|1
7357553|NCT00996892|11602201|FG001|Dose-Escalation Stage 1|Death|0
7357554|NCT00996892|11602202|FG002|Dose-Escalation Stage 1|Death|0
7357555|NCT00996892|11602203|FG003|Dose-Escalation Stage 1|Death|0
7357556|NCT00996892|11602204|FG004|Dose-Escalation Stage 1|Death|0
7357557|NCT00996892|11602205|FG005|Dose-Escalation Stage 1|Death|1
7357558|NCT00996892|11602206|FG006|Dose-Escalation Stage 1|Death|0
7357559|NCT00996892|11602207|FG007|Dose-Escalation Stage 1|Death|0
7357560|NCT00996892|11602208|FG008|Dose-Escalation Stage 1|Death|0
7357561|NCT00996892|11602209|FG009|Dose-Escalation Stage 1|Death|0
7357562|NCT00996892|11602210|FG010|Dose-Escalation Stage 1|Death|0
7357563|NCT00996892|11602211|FG011|Dose-Escalation Stage 1|Death|0
7357564|NCT00996892|11602212|FG012|Dose-Escalation Stage 1|Death|0
7357565|NCT00996892|11602213|FG013|Dose-Escalation Stage 1|Death|0
7357566|NCT00996892|11602214|FG014|Dose-Escalation Stage 1|Death|0
7357567|NCT00996892|11602215|FG015|Dose-Escalation Stage 1|Death|0
7357568|NCT00996892|11602216|FG016|Dose-Escalation Stage 1|Death|0
7357569|NCT00996892|11602217|FG017|Dose-Escalation Stage 1|Death|0
7357570|NCT00996892|11602218|FG018|Dose-Escalation Stage 1|Death|0
7357571|NCT00996892|11602219|FG019|Dose-Escalation Stage 1|Death|0
7357572|NCT00996892|11602200|FG000|Dose-Escalation Stage 1|Physician Decision|1
7357573|NCT00996892|11602201|FG001|Dose-Escalation Stage 1|Physician Decision|0
7357574|NCT00996892|11602202|FG002|Dose-Escalation Stage 1|Physician Decision|0
7357575|NCT00996892|11602203|FG003|Dose-Escalation Stage 1|Physician Decision|1
7357576|NCT00996892|11602204|FG004|Dose-Escalation Stage 1|Physician Decision|0
7357577|NCT00996892|11602205|FG005|Dose-Escalation Stage 1|Physician Decision|1
7357578|NCT00996892|11602206|FG006|Dose-Escalation Stage 1|Physician Decision|2
7357579|NCT00996892|11602207|FG007|Dose-Escalation Stage 1|Physician Decision|0
7357580|NCT00996892|11602208|FG008|Dose-Escalation Stage 1|Physician Decision|0
7357581|NCT00996892|11602209|FG009|Dose-Escalation Stage 1|Physician Decision|0
7357582|NCT00996892|11602210|FG010|Dose-Escalation Stage 1|Physician Decision|0
7357583|NCT00996892|11602211|FG011|Dose-Escalation Stage 1|Physician Decision|0
7357584|NCT00996892|11602212|FG012|Dose-Escalation Stage 1|Physician Decision|0
7357585|NCT00996892|11602213|FG013|Dose-Escalation Stage 1|Physician Decision|0
7357586|NCT00996892|11602214|FG014|Dose-Escalation Stage 1|Physician Decision|0
7357587|NCT00996892|11602215|FG015|Dose-Escalation Stage 1|Physician Decision|0
7357588|NCT00996892|11602216|FG016|Dose-Escalation Stage 1|Physician Decision|0
7357589|NCT00996892|11602217|FG017|Dose-Escalation Stage 1|Physician Decision|0
7357590|NCT00996892|11602218|FG018|Dose-Escalation Stage 1|Physician Decision|0
7357591|NCT00996892|11602219|FG019|Dose-Escalation Stage 1|Physician Decision|0
7357592|NCT00996892|11602200|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357593|NCT00996892|11602201|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
7357594|NCT00996892|11602202|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357595|NCT00996892|11602203|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
7357596|NCT00996892|11602204|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
7357597|NCT00996892|11602205|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
7357598|NCT00996892|11602206|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
7357599|NCT00996892|11602207|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357600|NCT00996892|11602208|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357601|NCT00996892|11602209|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357602|NCT00996892|11602210|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357603|NCT00996892|11602211|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357604|NCT00996892|11602212|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357605|NCT00996892|11602213|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357606|NCT00996892|11602214|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357607|NCT00996892|11602215|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357608|NCT00996892|11602216|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357609|NCT00996892|11602217|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357610|NCT00996892|11602218|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357611|NCT00996892|11602219|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
7357612|NCT00996892|11602200|FG000|Dose-Escalation Stage 1|Disease Progression|2
7357613|NCT00996892|11602201|FG001|Dose-Escalation Stage 1|Disease Progression|2
7357614|NCT00996892|11602202|FG002|Dose-Escalation Stage 1|Disease Progression|3
7357615|NCT00996892|11602203|FG003|Dose-Escalation Stage 1|Disease Progression|4
7357616|NCT00996892|11602204|FG004|Dose-Escalation Stage 1|Disease Progression|10
7357617|NCT00996892|11602205|FG005|Dose-Escalation Stage 1|Disease Progression|7
7357618|NCT00996892|11602206|FG006|Dose-Escalation Stage 1|Disease Progression|0
7357619|NCT00996892|11602207|FG007|Dose-Escalation Stage 1|Disease Progression|0
7357620|NCT00996892|11602208|FG008|Dose-Escalation Stage 1|Disease Progression|0
7357621|NCT00996892|11602209|FG009|Dose-Escalation Stage 1|Disease Progression|0
7357622|NCT00996892|11602210|FG010|Dose-Escalation Stage 1|Disease Progression|0
7357623|NCT00996892|11602211|FG011|Dose-Escalation Stage 1|Disease Progression|0
7357624|NCT00996892|11602212|FG012|Dose-Escalation Stage 1|Disease Progression|0
7357625|NCT00996892|11602213|FG013|Dose-Escalation Stage 1|Disease Progression|0
7357626|NCT00996892|11602214|FG014|Dose-Escalation Stage 1|Disease Progression|0
7357627|NCT00996892|11602215|FG015|Dose-Escalation Stage 1|Disease Progression|0
7357628|NCT00996892|11602216|FG016|Dose-Escalation Stage 1|Disease Progression|0
7357629|NCT00996892|11602217|FG017|Dose-Escalation Stage 1|Disease Progression|0
7357630|NCT00996892|11602218|FG018|Dose-Escalation Stage 1|Disease Progression|0
7357631|NCT00996892|11602219|FG019|Dose-Escalation Stage 1|Disease Progression|0
7357632|NCT00996892|11602200|FG000|Dose-Escalation Stage 1A|Adverse Event|0
7357633|NCT00996892|11602201|FG001|Dose-Escalation Stage 1A|Adverse Event|0
7357634|NCT00996892|11602202|FG002|Dose-Escalation Stage 1A|Adverse Event|0
7357635|NCT00996892|11602203|FG003|Dose-Escalation Stage 1A|Adverse Event|0
7357636|NCT00996892|11602204|FG004|Dose-Escalation Stage 1A|Adverse Event|0
7357637|NCT00996892|11602205|FG005|Dose-Escalation Stage 1A|Adverse Event|0
7357638|NCT00996892|11602206|FG006|Dose-Escalation Stage 1A|Adverse Event|0
7357639|NCT00996892|11602207|FG007|Dose-Escalation Stage 1A|Adverse Event|0
7357640|NCT00996892|11602208|FG008|Dose-Escalation Stage 1A|Adverse Event|0
7357641|NCT00996892|11602209|FG009|Dose-Escalation Stage 1A|Adverse Event|0
7357642|NCT00996892|11602210|FG010|Dose-Escalation Stage 1A|Adverse Event|1
7357643|NCT00996892|11602211|FG011|Dose-Escalation Stage 1A|Adverse Event|0
7357644|NCT00996892|11602212|FG012|Dose-Escalation Stage 1A|Adverse Event|0
7569563|NCT03452189|11946013|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
7569564|NCT03452527|11946030|FG000|Overall Study|Withdrawal by Subject|1
7569565|NCT03452527|11946031|FG001|Overall Study|Withdrawal by Subject|1
7569566|NCT03452527|11946030|FG000|Overall Study|Study Terminated|2
7569567|NCT03452527|11946031|FG001|Overall Study|Study Terminated|3
7569568|NCT03452943|11946039|FG000|Titration Period (7 Weeks)|Adverse Event|1
7569569|NCT03452943|11946040|FG001|Titration Period (7 Weeks)|Adverse Event|1
7569570|NCT03452943|11946039|FG000|Titration Period (7 Weeks)|Protocol Violation|0
7569571|NCT03452943|11946040|FG001|Titration Period (7 Weeks)|Protocol Violation|1
7569572|NCT03452943|11946039|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
7569573|NCT03452943|11946040|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
7569574|NCT03452943|11946039|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
7357645|NCT00996892|11602213|FG013|Dose-Escalation Stage 1A|Adverse Event|1
7357646|NCT00996892|11602214|FG014|Dose-Escalation Stage 1A|Adverse Event|0
7357647|NCT00996892|11602215|FG015|Dose-Escalation Stage 1A|Adverse Event|0
7357648|NCT00996892|11602216|FG016|Dose-Escalation Stage 1A|Adverse Event|0
7357649|NCT00996892|11602217|FG017|Dose-Escalation Stage 1A|Adverse Event|0
7357650|NCT00996892|11602218|FG018|Dose-Escalation Stage 1A|Adverse Event|0
7357651|NCT00996892|11602219|FG019|Dose-Escalation Stage 1A|Adverse Event|0
7357652|NCT00996892|11602200|FG000|Dose-Escalation Stage 1A|Death|0
7357653|NCT00996892|11602201|FG001|Dose-Escalation Stage 1A|Death|0
7357654|NCT00996892|11602202|FG002|Dose-Escalation Stage 1A|Death|0
7357655|NCT00996892|11602203|FG003|Dose-Escalation Stage 1A|Death|0
7357656|NCT00996892|11602204|FG004|Dose-Escalation Stage 1A|Death|0
7357657|NCT00996892|11602205|FG005|Dose-Escalation Stage 1A|Death|0
7357658|NCT00996892|11602206|FG006|Dose-Escalation Stage 1A|Death|0
7357659|NCT00996892|11602207|FG007|Dose-Escalation Stage 1A|Death|0
7357660|NCT00996892|11602208|FG008|Dose-Escalation Stage 1A|Death|0
7357661|NCT00996892|11602209|FG009|Dose-Escalation Stage 1A|Death|2
7357662|NCT00996892|11602210|FG010|Dose-Escalation Stage 1A|Death|0
7357663|NCT00996892|11602211|FG011|Dose-Escalation Stage 1A|Death|1
7357664|NCT00996892|11602212|FG012|Dose-Escalation Stage 1A|Death|1
7357665|NCT00996892|11602213|FG013|Dose-Escalation Stage 1A|Death|0
7357666|NCT00996892|11602214|FG014|Dose-Escalation Stage 1A|Death|0
7357667|NCT00996892|11602215|FG015|Dose-Escalation Stage 1A|Death|0
7357668|NCT00996892|11602216|FG016|Dose-Escalation Stage 1A|Death|0
7357669|NCT00996892|11602217|FG017|Dose-Escalation Stage 1A|Death|0
7357670|NCT00996892|11602218|FG018|Dose-Escalation Stage 1A|Death|0
7357671|NCT00996892|11602219|FG019|Dose-Escalation Stage 1A|Death|0
7357672|NCT00996892|11602200|FG000|Dose-Escalation Stage 1A|Physician Decision|0
7357673|NCT00996892|11602201|FG001|Dose-Escalation Stage 1A|Physician Decision|0
7357674|NCT00996892|11602202|FG002|Dose-Escalation Stage 1A|Physician Decision|0
7357675|NCT00996892|11602203|FG003|Dose-Escalation Stage 1A|Physician Decision|0
7357676|NCT00996892|11602204|FG004|Dose-Escalation Stage 1A|Physician Decision|0
7357677|NCT00996892|11602205|FG005|Dose-Escalation Stage 1A|Physician Decision|0
7357678|NCT00996892|11602206|FG006|Dose-Escalation Stage 1A|Physician Decision|0
7357679|NCT00996892|11602207|FG007|Dose-Escalation Stage 1A|Physician Decision|1
7357680|NCT00996892|11602208|FG008|Dose-Escalation Stage 1A|Physician Decision|0
7357681|NCT00996892|11602209|FG009|Dose-Escalation Stage 1A|Physician Decision|0
7357682|NCT00996892|11602210|FG010|Dose-Escalation Stage 1A|Physician Decision|0
7357683|NCT00996892|11602211|FG011|Dose-Escalation Stage 1A|Physician Decision|0
7357684|NCT00996892|11602212|FG012|Dose-Escalation Stage 1A|Physician Decision|0
7357685|NCT00996892|11602213|FG013|Dose-Escalation Stage 1A|Physician Decision|0
7357686|NCT00996892|11602214|FG014|Dose-Escalation Stage 1A|Physician Decision|0
7357687|NCT00996892|11602215|FG015|Dose-Escalation Stage 1A|Physician Decision|0
7357688|NCT00996892|11602216|FG016|Dose-Escalation Stage 1A|Physician Decision|0
7357689|NCT00996892|11602217|FG017|Dose-Escalation Stage 1A|Physician Decision|0
7357690|NCT00996892|11602218|FG018|Dose-Escalation Stage 1A|Physician Decision|0
7357691|NCT00996892|11602219|FG019|Dose-Escalation Stage 1A|Physician Decision|0
7357692|NCT00996892|11602200|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357693|NCT00996892|11602201|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357694|NCT00996892|11602202|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357695|NCT00996892|11602203|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357696|NCT00996892|11602204|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357697|NCT00996892|11602205|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357698|NCT00996892|11602206|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357699|NCT00996892|11602207|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357700|NCT00996892|11602208|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357701|NCT00996892|11602209|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7357702|NCT00996892|11602210|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7357703|NCT00996892|11602211|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7357704|NCT00996892|11602212|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
7357705|NCT00996892|11602213|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357706|NCT00996892|11602214|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357707|NCT00996892|11602215|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357708|NCT00996892|11602216|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357709|NCT00996892|11602217|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357710|NCT00996892|11602218|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357711|NCT00996892|11602219|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
7357712|NCT00996892|11602200|FG000|Dose-Escalation Stage 1A|Disease Progression|0
7357713|NCT00996892|11602201|FG001|Dose-Escalation Stage 1A|Disease Progression|0
7357714|NCT00996892|11602202|FG002|Dose-Escalation Stage 1A|Disease Progression|0
7569575|NCT03452943|11946040|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
7357715|NCT00996892|11602203|FG003|Dose-Escalation Stage 1A|Disease Progression|0
7357716|NCT00996892|11602204|FG004|Dose-Escalation Stage 1A|Disease Progression|0
7357717|NCT00996892|11602205|FG005|Dose-Escalation Stage 1A|Disease Progression|0
7357718|NCT00996892|11602206|FG006|Dose-Escalation Stage 1A|Disease Progression|0
7357719|NCT00996892|11602207|FG007|Dose-Escalation Stage 1A|Disease Progression|2
7357720|NCT00996892|11602208|FG008|Dose-Escalation Stage 1A|Disease Progression|3
7357721|NCT00996892|11602209|FG009|Dose-Escalation Stage 1A|Disease Progression|1
7357722|NCT00996892|11602210|FG010|Dose-Escalation Stage 1A|Disease Progression|5
7357723|NCT00996892|11602211|FG011|Dose-Escalation Stage 1A|Disease Progression|7
7357724|NCT00996892|11602212|FG012|Dose-Escalation Stage 1A|Disease Progression|6
7357725|NCT00996892|11602213|FG013|Dose-Escalation Stage 1A|Disease Progression|4
7357726|NCT00996892|11602214|FG014|Dose-Escalation Stage 1A|Disease Progression|0
7357727|NCT00996892|11602215|FG015|Dose-Escalation Stage 1A|Disease Progression|0
7569576|NCT03452943|11946039|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
7569577|NCT03452943|11946040|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
7569578|NCT03452943|11946039|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
7569579|NCT03452943|11946040|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
7569580|NCT03453151|11946067|FG000|Overall Study|Withdrawal by Subject|1
7569581|NCT03453151|11946067|FG000|Overall Study|Physician Decision|3
7569582|NCT03454412|11946099|FG000|Baseline Assesment|Physician Decision|12
7569583|NCT03455543|11946141|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
7569584|NCT03455543|11946142|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
7357728|NCT00996892|11602216|FG016|Dose-Escalation Stage 1A|Disease Progression|0
7357729|NCT00996892|11602217|FG017|Dose-Escalation Stage 1A|Disease Progression|0
7357730|NCT00996892|11602218|FG018|Dose-Escalation Stage 1A|Disease Progression|0
7357731|NCT00996892|11602219|FG019|Dose-Escalation Stage 1A|Disease Progression|0
7357732|NCT00996892|11602200|FG000|Dose-Escalation Stage 1B|Physician Decision|0
7357733|NCT00996892|11602201|FG001|Dose-Escalation Stage 1B|Physician Decision|0
7357734|NCT00996892|11602202|FG002|Dose-Escalation Stage 1B|Physician Decision|0
7357735|NCT00996892|11602203|FG003|Dose-Escalation Stage 1B|Physician Decision|0
7357736|NCT00996892|11602204|FG004|Dose-Escalation Stage 1B|Physician Decision|0
7357737|NCT00996892|11602205|FG005|Dose-Escalation Stage 1B|Physician Decision|0
7357738|NCT00996892|11602206|FG006|Dose-Escalation Stage 1B|Physician Decision|0
7357739|NCT00996892|11602207|FG007|Dose-Escalation Stage 1B|Physician Decision|0
7357740|NCT00996892|11602208|FG008|Dose-Escalation Stage 1B|Physician Decision|0
7357741|NCT00996892|11602209|FG009|Dose-Escalation Stage 1B|Physician Decision|0
7357742|NCT00996892|11602210|FG010|Dose-Escalation Stage 1B|Physician Decision|0
7357743|NCT00996892|11602211|FG011|Dose-Escalation Stage 1B|Physician Decision|0
7357744|NCT00996892|11602212|FG012|Dose-Escalation Stage 1B|Physician Decision|0
7357745|NCT00996892|11602213|FG013|Dose-Escalation Stage 1B|Physician Decision|0
7357746|NCT00996892|11602214|FG014|Dose-Escalation Stage 1B|Physician Decision|0
7357747|NCT00996892|11602215|FG015|Dose-Escalation Stage 1B|Physician Decision|0
7357748|NCT00996892|11602216|FG016|Dose-Escalation Stage 1B|Physician Decision|0
7357749|NCT00996892|11602217|FG017|Dose-Escalation Stage 1B|Physician Decision|2
7357750|NCT00996892|11602218|FG018|Dose-Escalation Stage 1B|Physician Decision|0
7357751|NCT00996892|11602219|FG019|Dose-Escalation Stage 1B|Physician Decision|0
7357752|NCT00996892|11602200|FG000|Dose-Escalation Stage 1B|Disease Progression|0
7357753|NCT00996892|11602201|FG001|Dose-Escalation Stage 1B|Disease Progression|0
7357754|NCT00996892|11602202|FG002|Dose-Escalation Stage 1B|Disease Progression|0
7357755|NCT00996892|11602203|FG003|Dose-Escalation Stage 1B|Disease Progression|0
7357756|NCT00996892|11602204|FG004|Dose-Escalation Stage 1B|Disease Progression|0
7357757|NCT00996892|11602205|FG005|Dose-Escalation Stage 1B|Disease Progression|0
7357758|NCT00996892|11602206|FG006|Dose-Escalation Stage 1B|Disease Progression|0
7357759|NCT00996892|11602207|FG007|Dose-Escalation Stage 1B|Disease Progression|0
7357760|NCT00996892|11602208|FG008|Dose-Escalation Stage 1B|Disease Progression|0
7357761|NCT00996892|11602209|FG009|Dose-Escalation Stage 1B|Disease Progression|0
7357762|NCT00996892|11602210|FG010|Dose-Escalation Stage 1B|Disease Progression|0
7357763|NCT00996892|11602211|FG011|Dose-Escalation Stage 1B|Disease Progression|0
7357764|NCT00996892|11602212|FG012|Dose-Escalation Stage 1B|Disease Progression|0
7357765|NCT00996892|11602213|FG013|Dose-Escalation Stage 1B|Disease Progression|0
7357766|NCT00996892|11602214|FG014|Dose-Escalation Stage 1B|Disease Progression|4
7357767|NCT00996892|11602215|FG015|Dose-Escalation Stage 1B|Disease Progression|3
7357768|NCT00996892|11602216|FG016|Dose-Escalation Stage 1B|Disease Progression|3
7357769|NCT00996892|11602217|FG017|Dose-Escalation Stage 1B|Disease Progression|3
7357770|NCT00996892|11602218|FG018|Dose-Escalation Stage 1B|Disease Progression|0
7357771|NCT00996892|11602219|FG019|Dose-Escalation Stage 1B|Disease Progression|0
7357772|NCT00996892|11602200|FG000|Expansion Stage 2|Adverse Event|0
7357773|NCT00996892|11602201|FG001|Expansion Stage 2|Adverse Event|0
7357774|NCT00996892|11602202|FG002|Expansion Stage 2|Adverse Event|0
7357775|NCT00996892|11602203|FG003|Expansion Stage 2|Adverse Event|0
7357776|NCT00996892|11602204|FG004|Expansion Stage 2|Adverse Event|0
7357777|NCT00996892|11602205|FG005|Expansion Stage 2|Adverse Event|0
7357778|NCT00996892|11602206|FG006|Expansion Stage 2|Adverse Event|0
7357779|NCT00996892|11602207|FG007|Expansion Stage 2|Adverse Event|0
7357780|NCT00996892|11602208|FG008|Expansion Stage 2|Adverse Event|0
7569585|NCT03455543|11946143|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
7357781|NCT00996892|11602209|FG009|Expansion Stage 2|Adverse Event|0
7357782|NCT00996892|11602210|FG010|Expansion Stage 2|Adverse Event|0
7357783|NCT00996892|11602211|FG011|Expansion Stage 2|Adverse Event|0
7357784|NCT00996892|11602212|FG012|Expansion Stage 2|Adverse Event|0
7357785|NCT00996892|11602213|FG013|Expansion Stage 2|Adverse Event|0
7357786|NCT00996892|11602214|FG014|Expansion Stage 2|Adverse Event|0
7357787|NCT00996892|11602215|FG015|Expansion Stage 2|Adverse Event|0
7357788|NCT00996892|11602216|FG016|Expansion Stage 2|Adverse Event|0
7357789|NCT00996892|11602217|FG017|Expansion Stage 2|Adverse Event|0
7357790|NCT00996892|11602218|FG018|Expansion Stage 2|Adverse Event|3
7357791|NCT00996892|11602219|FG019|Expansion Stage 2|Adverse Event|0
7357792|NCT00996892|11602200|FG000|Expansion Stage 2|Death|0
7357793|NCT00996892|11602201|FG001|Expansion Stage 2|Death|0
7357794|NCT00996892|11602202|FG002|Expansion Stage 2|Death|0
7357795|NCT00996892|11602203|FG003|Expansion Stage 2|Death|0
7357796|NCT00996892|11602204|FG004|Expansion Stage 2|Death|0
7357797|NCT00996892|11602205|FG005|Expansion Stage 2|Death|0
7357798|NCT00996892|11602206|FG006|Expansion Stage 2|Death|0
7357799|NCT00996892|11602207|FG007|Expansion Stage 2|Death|0
7357800|NCT00996892|11602208|FG008|Expansion Stage 2|Death|0
7357801|NCT00996892|11602209|FG009|Expansion Stage 2|Death|0
7357802|NCT00996892|11602210|FG010|Expansion Stage 2|Death|0
7357803|NCT00996892|11602211|FG011|Expansion Stage 2|Death|0
7357804|NCT00996892|11602212|FG012|Expansion Stage 2|Death|0
7357805|NCT00996892|11602213|FG013|Expansion Stage 2|Death|0
7357806|NCT00996892|11602214|FG014|Expansion Stage 2|Death|0
7357807|NCT00996892|11602215|FG015|Expansion Stage 2|Death|0
7357808|NCT00996892|11602216|FG016|Expansion Stage 2|Death|0
7357809|NCT00996892|11602217|FG017|Expansion Stage 2|Death|0
7357810|NCT00996892|11602218|FG018|Expansion Stage 2|Death|2
7357811|NCT00996892|11602219|FG019|Expansion Stage 2|Death|0
7357812|NCT00996892|11602200|FG000|Expansion Stage 2|Physician Decision|0
7357813|NCT00996892|11602201|FG001|Expansion Stage 2|Physician Decision|0
7357814|NCT00996892|11602202|FG002|Expansion Stage 2|Physician Decision|0
7357815|NCT00996892|11602203|FG003|Expansion Stage 2|Physician Decision|0
7357816|NCT00996892|11602204|FG004|Expansion Stage 2|Physician Decision|0
7357817|NCT00996892|11602205|FG005|Expansion Stage 2|Physician Decision|0
7357818|NCT00996892|11602206|FG006|Expansion Stage 2|Physician Decision|0
7357819|NCT00996892|11602207|FG007|Expansion Stage 2|Physician Decision|0
7357820|NCT00996892|11602208|FG008|Expansion Stage 2|Physician Decision|0
7357821|NCT00996892|11602209|FG009|Expansion Stage 2|Physician Decision|0
7357822|NCT00996892|11602210|FG010|Expansion Stage 2|Physician Decision|0
7357823|NCT00996892|11602211|FG011|Expansion Stage 2|Physician Decision|0
7357824|NCT00996892|11602212|FG012|Expansion Stage 2|Physician Decision|0
7357825|NCT00996892|11602213|FG013|Expansion Stage 2|Physician Decision|0
7357826|NCT00996892|11602214|FG014|Expansion Stage 2|Physician Decision|0
7357827|NCT00996892|11602215|FG015|Expansion Stage 2|Physician Decision|0
7357828|NCT00996892|11602216|FG016|Expansion Stage 2|Physician Decision|0
7357829|NCT00996892|11602217|FG017|Expansion Stage 2|Physician Decision|0
7357830|NCT00996892|11602218|FG018|Expansion Stage 2|Physician Decision|1
7357831|NCT00996892|11602219|FG019|Expansion Stage 2|Physician Decision|0
7357832|NCT00996892|11602200|FG000|Expansion Stage 2|Withdrawal by Subject|0
7357833|NCT00996892|11602201|FG001|Expansion Stage 2|Withdrawal by Subject|0
7357834|NCT00996892|11602202|FG002|Expansion Stage 2|Withdrawal by Subject|0
7357835|NCT00996892|11602203|FG003|Expansion Stage 2|Withdrawal by Subject|0
7357836|NCT00996892|11602204|FG004|Expansion Stage 2|Withdrawal by Subject|0
7357837|NCT00996892|11602205|FG005|Expansion Stage 2|Withdrawal by Subject|0
7357838|NCT00996892|11602206|FG006|Expansion Stage 2|Withdrawal by Subject|0
7357839|NCT00996892|11602207|FG007|Expansion Stage 2|Withdrawal by Subject|0
7357840|NCT00996892|11602208|FG008|Expansion Stage 2|Withdrawal by Subject|0
7357841|NCT00996892|11602209|FG009|Expansion Stage 2|Withdrawal by Subject|0
7357842|NCT00996892|11602210|FG010|Expansion Stage 2|Withdrawal by Subject|0
7357843|NCT00996892|11602211|FG011|Expansion Stage 2|Withdrawal by Subject|0
7459875|NCT01822756|11754942|FG002|Overall Study|Disease progression|7
7459876|NCT01822756|11754943|FG003|Overall Study|Disease progression|2
7459877|NCT01822756|11754944|FG004|Overall Study|Disease progression|6
7459878|NCT01822756|11754940|FG000|Overall Study|Death|2
7459879|NCT01822756|11754941|FG001|Overall Study|Death|2
7459880|NCT01822756|11754942|FG002|Overall Study|Death|1
7459881|NCT01822756|11754943|FG003|Overall Study|Death|0
7459882|NCT01822756|11754944|FG004|Overall Study|Death|0
7459883|NCT01822756|11754940|FG000|Overall Study|Lost to Follow-up|1
7459884|NCT01822756|11754941|FG001|Overall Study|Lost to Follow-up|0
7459885|NCT01822756|11754942|FG002|Overall Study|Lost to Follow-up|1
7459886|NCT01822756|11754943|FG003|Overall Study|Lost to Follow-up|0
7459887|NCT01822756|11754944|FG004|Overall Study|Lost to Follow-up|1
7459888|NCT01822756|11754940|FG000|Overall Study|Physician Decision|0
7459889|NCT01822756|11754941|FG001|Overall Study|Physician Decision|1
7459890|NCT01822756|11754942|FG002|Overall Study|Physician Decision|0
7459891|NCT01822756|11754943|FG003|Overall Study|Physician Decision|0
7459892|NCT01822756|11754944|FG004|Overall Study|Physician Decision|0
7357844|NCT00996892|11602212|FG012|Expansion Stage 2|Withdrawal by Subject|0
7357845|NCT00996892|11602213|FG013|Expansion Stage 2|Withdrawal by Subject|0
7357846|NCT00996892|11602214|FG014|Expansion Stage 2|Withdrawal by Subject|0
7357847|NCT00996892|11602215|FG015|Expansion Stage 2|Withdrawal by Subject|0
7459893|NCT01822756|11754940|FG000|Overall Study|disease progression & patient preference|2
7459894|NCT01822756|11754941|FG001|Overall Study|disease progression & patient preference|0
7357848|NCT00996892|11602216|FG016|Expansion Stage 2|Withdrawal by Subject|0
7357849|NCT00996892|11602217|FG017|Expansion Stage 2|Withdrawal by Subject|0
7357850|NCT00996892|11602218|FG018|Expansion Stage 2|Withdrawal by Subject|1
7357851|NCT00996892|11602219|FG019|Expansion Stage 2|Withdrawal by Subject|0
7357852|NCT00996892|11602200|FG000|Expansion Stage 2|Disease Progression|0
7357853|NCT00996892|11602201|FG001|Expansion Stage 2|Disease Progression|0
7357854|NCT00996892|11602202|FG002|Expansion Stage 2|Disease Progression|0
7357855|NCT00996892|11602203|FG003|Expansion Stage 2|Disease Progression|0
7357856|NCT00996892|11602204|FG004|Expansion Stage 2|Disease Progression|0
7357857|NCT00996892|11602205|FG005|Expansion Stage 2|Disease Progression|0
7357858|NCT00996892|11602206|FG006|Expansion Stage 2|Disease Progression|0
7357859|NCT00996892|11602207|FG007|Expansion Stage 2|Disease Progression|0
7357860|NCT00996892|11602208|FG008|Expansion Stage 2|Disease Progression|0
7357861|NCT00996892|11602209|FG009|Expansion Stage 2|Disease Progression|0
7357862|NCT00996892|11602210|FG010|Expansion Stage 2|Disease Progression|0
7357863|NCT00996892|11602211|FG011|Expansion Stage 2|Disease Progression|0
7357864|NCT00996892|11602212|FG012|Expansion Stage 2|Disease Progression|0
7357865|NCT00996892|11602213|FG013|Expansion Stage 2|Disease Progression|0
7357866|NCT00996892|11602214|FG014|Expansion Stage 2|Disease Progression|0
7357867|NCT00996892|11602215|FG015|Expansion Stage 2|Disease Progression|0
7357868|NCT00996892|11602216|FG016|Expansion Stage 2|Disease Progression|0
7357869|NCT00996892|11602217|FG017|Expansion Stage 2|Disease Progression|0
7357870|NCT00996892|11602218|FG018|Expansion Stage 2|Disease Progression|28
7357871|NCT00996892|11602219|FG019|Expansion Stage 2|Disease Progression|0
7357872|NCT00996892|11602200|FG000|Expansion Stage 2A|Adverse Event|0
7357873|NCT00996892|11602201|FG001|Expansion Stage 2A|Adverse Event|0
7357874|NCT00996892|11602202|FG002|Expansion Stage 2A|Adverse Event|0
7357875|NCT00996892|11602203|FG003|Expansion Stage 2A|Adverse Event|0
7357876|NCT00996892|11602204|FG004|Expansion Stage 2A|Adverse Event|0
7357877|NCT00996892|11602205|FG005|Expansion Stage 2A|Adverse Event|0
7357878|NCT00996892|11602206|FG006|Expansion Stage 2A|Adverse Event|0
7357879|NCT00996892|11602207|FG007|Expansion Stage 2A|Adverse Event|0
7357880|NCT00996892|11602208|FG008|Expansion Stage 2A|Adverse Event|0
7357881|NCT00996892|11602209|FG009|Expansion Stage 2A|Adverse Event|0
7357882|NCT00996892|11602210|FG010|Expansion Stage 2A|Adverse Event|0
7357883|NCT00996892|11602211|FG011|Expansion Stage 2A|Adverse Event|0
7357884|NCT00996892|11602212|FG012|Expansion Stage 2A|Adverse Event|0
7357885|NCT00996892|11602213|FG013|Expansion Stage 2A|Adverse Event|0
7357886|NCT00996892|11602214|FG014|Expansion Stage 2A|Adverse Event|0
7357887|NCT00996892|11602215|FG015|Expansion Stage 2A|Adverse Event|0
7357888|NCT00996892|11602216|FG016|Expansion Stage 2A|Adverse Event|0
7357889|NCT00996892|11602217|FG017|Expansion Stage 2A|Adverse Event|0
7357890|NCT00996892|11602218|FG018|Expansion Stage 2A|Adverse Event|0
7357891|NCT00996892|11602219|FG019|Expansion Stage 2A|Adverse Event|8
7357892|NCT00996892|11602200|FG000|Expansion Stage 2A|Physician Decision|0
7357893|NCT00996892|11602201|FG001|Expansion Stage 2A|Physician Decision|0
7357894|NCT00996892|11602202|FG002|Expansion Stage 2A|Physician Decision|0
7357895|NCT00996892|11602203|FG003|Expansion Stage 2A|Physician Decision|0
7357896|NCT00996892|11602204|FG004|Expansion Stage 2A|Physician Decision|0
7357897|NCT00996892|11602205|FG005|Expansion Stage 2A|Physician Decision|0
7357898|NCT00996892|11602206|FG006|Expansion Stage 2A|Physician Decision|0
7357899|NCT00996892|11602207|FG007|Expansion Stage 2A|Physician Decision|0
7357900|NCT00996892|11602208|FG008|Expansion Stage 2A|Physician Decision|0
7357901|NCT00996892|11602209|FG009|Expansion Stage 2A|Physician Decision|0
7357902|NCT00996892|11602210|FG010|Expansion Stage 2A|Physician Decision|0
7357903|NCT00996892|11602211|FG011|Expansion Stage 2A|Physician Decision|0
7357904|NCT00996892|11602212|FG012|Expansion Stage 2A|Physician Decision|0
7357905|NCT00996892|11602213|FG013|Expansion Stage 2A|Physician Decision|0
7357906|NCT00996892|11602214|FG014|Expansion Stage 2A|Physician Decision|0
7357907|NCT00996892|11602215|FG015|Expansion Stage 2A|Physician Decision|0
7357908|NCT00996892|11602216|FG016|Expansion Stage 2A|Physician Decision|0
7357909|NCT00996892|11602217|FG017|Expansion Stage 2A|Physician Decision|0
7357910|NCT00996892|11602218|FG018|Expansion Stage 2A|Physician Decision|0
7357911|NCT00996892|11602219|FG019|Expansion Stage 2A|Physician Decision|2
7357912|NCT00996892|11602200|FG000|Expansion Stage 2A|Withdrawal by Subject|0
7357913|NCT00996892|11602201|FG001|Expansion Stage 2A|Withdrawal by Subject|0
7357914|NCT00996892|11602202|FG002|Expansion Stage 2A|Withdrawal by Subject|0
7357915|NCT00996892|11602203|FG003|Expansion Stage 2A|Withdrawal by Subject|0
7357916|NCT00996892|11602204|FG004|Expansion Stage 2A|Withdrawal by Subject|0
7357917|NCT00996892|11602205|FG005|Expansion Stage 2A|Withdrawal by Subject|0
7357918|NCT00996892|11602206|FG006|Expansion Stage 2A|Withdrawal by Subject|0
7357919|NCT00996892|11602207|FG007|Expansion Stage 2A|Withdrawal by Subject|0
7357920|NCT00996892|11602208|FG008|Expansion Stage 2A|Withdrawal by Subject|0
7357921|NCT00996892|11602209|FG009|Expansion Stage 2A|Withdrawal by Subject|0
7357922|NCT00996892|11602210|FG010|Expansion Stage 2A|Withdrawal by Subject|0
7357923|NCT00996892|11602211|FG011|Expansion Stage 2A|Withdrawal by Subject|0
7357924|NCT00996892|11602212|FG012|Expansion Stage 2A|Withdrawal by Subject|0
7357925|NCT00996892|11602213|FG013|Expansion Stage 2A|Withdrawal by Subject|0
7357926|NCT00996892|11602214|FG014|Expansion Stage 2A|Withdrawal by Subject|0
7357927|NCT00996892|11602215|FG015|Expansion Stage 2A|Withdrawal by Subject|0
7357928|NCT00996892|11602216|FG016|Expansion Stage 2A|Withdrawal by Subject|0
7357929|NCT00996892|11602217|FG017|Expansion Stage 2A|Withdrawal by Subject|0
7357930|NCT00996892|11602218|FG018|Expansion Stage 2A|Withdrawal by Subject|0
7357931|NCT00996892|11602219|FG019|Expansion Stage 2A|Withdrawal by Subject|4
7357932|NCT00996892|11602200|FG000|Expansion Stage 2A|Disease Progression|0
7357933|NCT00996892|11602201|FG001|Expansion Stage 2A|Disease Progression|0
7357934|NCT00996892|11602202|FG002|Expansion Stage 2A|Disease Progression|0
7357935|NCT00996892|11602203|FG003|Expansion Stage 2A|Disease Progression|0
7357936|NCT00996892|11602204|FG004|Expansion Stage 2A|Disease Progression|0
7357937|NCT00996892|11602205|FG005|Expansion Stage 2A|Disease Progression|0
7357938|NCT00996892|11602206|FG006|Expansion Stage 2A|Disease Progression|0
7357939|NCT00996892|11602207|FG007|Expansion Stage 2A|Disease Progression|0
7357940|NCT00996892|11602208|FG008|Expansion Stage 2A|Disease Progression|0
7357941|NCT00996892|11602209|FG009|Expansion Stage 2A|Disease Progression|0
7357942|NCT00996892|11602210|FG010|Expansion Stage 2A|Disease Progression|0
7357943|NCT00996892|11602211|FG011|Expansion Stage 2A|Disease Progression|0
7357944|NCT00996892|11602212|FG012|Expansion Stage 2A|Disease Progression|0
7357945|NCT00996892|11602213|FG013|Expansion Stage 2A|Disease Progression|0
7357946|NCT00996892|11602214|FG014|Expansion Stage 2A|Disease Progression|0
7357947|NCT00996892|11602215|FG015|Expansion Stage 2A|Disease Progression|0
7357948|NCT00996892|11602216|FG016|Expansion Stage 2A|Disease Progression|0
7357949|NCT00996892|11602217|FG017|Expansion Stage 2A|Disease Progression|0
7357950|NCT00996892|11602218|FG018|Expansion Stage 2A|Disease Progression|0
7357951|NCT00996892|11602219|FG019|Expansion Stage 2A|Disease Progression|31
7357952|NCT00996918|11602285|FG000|Overall Study|Lack of Efficacy|1
7357953|NCT00996918|11602286|FG001|Overall Study|Lack of Efficacy|1
7357954|NCT00996918|11602287|FG002|Overall Study|Lack of Efficacy|2
7357955|NCT00996918|11602288|FG003|Overall Study|Lack of Efficacy|2
7357956|NCT00996918|11602289|FG004|Overall Study|Lack of Efficacy|0
7357957|NCT00996918|11602285|FG000|Overall Study|Adverse Event|2
7357958|NCT00996918|11602286|FG001|Overall Study|Adverse Event|5
7357959|NCT00996918|11602287|FG002|Overall Study|Adverse Event|2
7357960|NCT00996918|11602288|FG003|Overall Study|Adverse Event|6
7357961|NCT00996918|11602289|FG004|Overall Study|Adverse Event|0
7357962|NCT00996918|11602285|FG000|Overall Study|Withdrawal by Subject|1
7357963|NCT00996918|11602286|FG001|Overall Study|Withdrawal by Subject|4
7357964|NCT00996918|11602287|FG002|Overall Study|Withdrawal by Subject|3
7357965|NCT00996918|11602288|FG003|Overall Study|Withdrawal by Subject|3
7357966|NCT00996918|11602289|FG004|Overall Study|Withdrawal by Subject|2
7357967|NCT00996918|11602285|FG000|Overall Study|Physician Decision|1
7357968|NCT00996918|11602286|FG001|Overall Study|Physician Decision|0
7357969|NCT00996918|11602287|FG002|Overall Study|Physician Decision|0
7357970|NCT00996918|11602288|FG003|Overall Study|Physician Decision|0
7357971|NCT00996918|11602289|FG004|Overall Study|Physician Decision|0
7357972|NCT00996918|11602285|FG000|Overall Study|Discontinuation of Study by Sponsor|31
7357973|NCT00996918|11602286|FG001|Overall Study|Discontinuation of Study by Sponsor|54
7357974|NCT00996918|11602287|FG002|Overall Study|Discontinuation of Study by Sponsor|30
7357975|NCT00996918|11602288|FG003|Overall Study|Discontinuation of Study by Sponsor|45
7357976|NCT00996918|11602289|FG004|Overall Study|Discontinuation of Study by Sponsor|2
7357977|NCT00996918|11602285|FG000|Overall Study|Loss of Caregiver|0
7357978|NCT00996918|11602286|FG001|Overall Study|Loss of Caregiver|1
7357979|NCT00996918|11602287|FG002|Overall Study|Loss of Caregiver|0
7357980|NCT00996918|11602288|FG003|Overall Study|Loss of Caregiver|0
7357981|NCT00996918|11602289|FG004|Overall Study|Loss of Caregiver|0
7357982|NCT00996918|11602285|FG000|Overall Study|Other|3
7357983|NCT00996918|11602286|FG001|Overall Study|Other|1
7357984|NCT00996918|11602287|FG002|Overall Study|Other|0
7357985|NCT00996918|11602288|FG003|Overall Study|Other|0
7357986|NCT00996918|11602289|FG004|Overall Study|Other|0
7357987|NCT00996944|11602308|FG000|Double-blind Treatment Period|Adverse Event|2
7357988|NCT00996944|11602309|FG001|Double-blind Treatment Period|Adverse Event|1
7357989|NCT00996944|11602308|FG000|Double-blind Treatment Period|Protocol Violation|1
7357990|NCT00996944|11602309|FG001|Double-blind Treatment Period|Protocol Violation|0
7357991|NCT00996944|11602308|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
7357992|NCT00996944|11602309|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
7357993|NCT00996944|11602308|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7357994|NCT00996944|11602309|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7357995|NCT00996944|11602308|FG000|Long-term Treatment Period|Study Closed/Terminated|12
7357996|NCT00996944|11602309|FG001|Long-term Treatment Period|Study Closed/Terminated|5
7357997|NCT00996996|11602317|FG000|Overall Study|Progressive Disease|10
7357998|NCT00996996|11602317|FG000|Overall Study|Non-compliance|8
7357999|NCT00996996|11602317|FG000|Overall Study|Lost to Follow-up|9
7358000|NCT00996996|11602317|FG000|Overall Study|Death|5
7358001|NCT00996996|11602317|FG000|Overall Study|Did Not Receive Study Medications|1
7358002|NCT00997035|11602323|FG000|3-week Followup Visit|Lost to Follow-up|9
7358003|NCT00997035|11602324|FG001|3-week Followup Visit|Lost to Follow-up|6
7358004|NCT00997035|11602323|FG000|3-month Follow-up Visit|Lost to Follow-up|12
7358005|NCT00997035|11602324|FG001|3-month Follow-up Visit|Lost to Follow-up|6
7358006|NCT00997126|11602351|FG000|Overall Study|Physician Decision|7
7358007|NCT00997126|11602352|FG001|Overall Study|Physician Decision|11
7358008|NCT00997243|11602377|FG000|Overall Study|Early termination of study by sponsor|7
7358009|NCT00997321|11602383|FG000|Overall Study|did not undergo sedation after enrollmen|0
7358010|NCT00997321|11602384|FG001|Overall Study|did not undergo sedation after enrollmen|3
7358011|NCT00997334|11602396|FG000|Overall Study|still on therapy|12
7358012|NCT00997334|11602396|FG000|Overall Study|Adverse Event|3
7358013|NCT00997334|11602396|FG000|Overall Study|Patient non-compliance|1
7358014|NCT00997334|11602396|FG000|Overall Study|Withdrawal by Subject|3
7358015|NCT00997334|11602396|FG000|Overall Study|Death|2
7358016|NCT00997334|11602396|FG000|Overall Study|Urgent Palliative Care|2
7358017|NCT00997334|11602396|FG000|Overall Study|No lesion amenable|1
7358018|NCT00997334|11602396|FG000|Overall Study|Ineligible|1
7358019|NCT00997373|11602402|FG000|Overall Study|Withdrawal by Subject|5
7358020|NCT00997373|11602403|FG001|Overall Study|Withdrawal by Subject|0
7358021|NCT00997373|11602402|FG000|Overall Study|wrong tumor type|4
7358022|NCT00997373|11602403|FG001|Overall Study|wrong tumor type|0
7358023|NCT00997373|11602402|FG000|Overall Study|could not have hysterectomy|6
7358024|NCT00997373|11602403|FG001|Overall Study|could not have hysterectomy|0
7358025|NCT00997438|11602417|FG000|Overall Study|Blood draw difficulty|2
7358026|NCT00997438|11602418|FG001|Overall Study|Blood draw difficulty|0
7358027|NCT00997438|11602419|FG002|Overall Study|Blood draw difficulty|1
7358028|NCT00997438|11602417|FG000|Overall Study|Withdrawal by Subject|1
7358029|NCT00997438|11602418|FG001|Overall Study|Withdrawal by Subject|1
7358030|NCT00997438|11602419|FG002|Overall Study|Withdrawal by Subject|0
7358031|NCT00997438|11602417|FG000|Overall Study|Exclusion criteria at visit 1|2
7358032|NCT00997438|11602418|FG001|Overall Study|Exclusion criteria at visit 1|2
7358033|NCT00997438|11602419|FG002|Overall Study|Exclusion criteria at visit 1|3
7358034|NCT00997503|11602428|FG000|Overall Study|Death|53
7358035|NCT00997503|11602428|FG000|Overall Study|Withdrawal by Subject|76
7358036|NCT00997503|11602428|FG000|Overall Study|Lost to Follow-up|33
7358037|NCT00997503|11602428|FG000|Overall Study|Adverse Event|3
7358038|NCT00997503|11602428|FG000|Overall Study|Physician Decision|10
7358039|NCT00997503|11602428|FG000|Overall Study|Missed 12-month follow-up|85
7358040|NCT00997503|11602428|FG000|Overall Study|Other reason|13
7358041|NCT00997893|11602486|FG000|Overall Study|Adverse Event|1
7358042|NCT00997893|11602487|FG001|Overall Study|Adverse Event|0
7358043|NCT00997893|11602488|FG002|Overall Study|Adverse Event|0
7358044|NCT00997893|11602486|FG000|Overall Study|Unable to meet study timelines|1
7358045|NCT00997893|11602487|FG001|Overall Study|Unable to meet study timelines|0
7358046|NCT00997893|11602488|FG002|Overall Study|Unable to meet study timelines|0
7358047|NCT00997893|11602486|FG000|Overall Study|Pain/pain meds during Visit 4|0
7358048|NCT00997893|11602487|FG001|Overall Study|Pain/pain meds during Visit 4|1
7358049|NCT00997893|11602488|FG002|Overall Study|Pain/pain meds during Visit 4|0
7358050|NCT00997984|11602504|FG000|Overall Study|Adverse Event|1
7358051|NCT00997984|11602505|FG001|Overall Study|Adverse Event|8
7358052|NCT00997984|11602506|FG002|Overall Study|Adverse Event|8
7358053|NCT00997984|11602504|FG000|Overall Study|Protocol Violation|1
7358054|NCT00997984|11602505|FG001|Overall Study|Protocol Violation|3
7358055|NCT00997984|11602506|FG002|Overall Study|Protocol Violation|0
7358056|NCT00997984|11602504|FG000|Overall Study|Withdrawal by Subject|6
7358057|NCT00997984|11602505|FG001|Overall Study|Withdrawal by Subject|9
7358058|NCT00997984|11602506|FG002|Overall Study|Withdrawal by Subject|5
7358059|NCT00997984|11602504|FG000|Overall Study|Lost to Follow-up|8
7358060|NCT00997984|11602505|FG001|Overall Study|Lost to Follow-up|5
7358061|NCT00997984|11602506|FG002|Overall Study|Lost to Follow-up|4
7358062|NCT00997984|11602504|FG000|Overall Study|Lack of Efficacy|20
7358063|NCT00997984|11602505|FG001|Overall Study|Lack of Efficacy|6
7358064|NCT00997984|11602506|FG002|Overall Study|Lack of Efficacy|3
7358065|NCT00997984|11602504|FG000|Overall Study|Met exclusion criteria|1
7358066|NCT00997984|11602505|FG001|Overall Study|Met exclusion criteria|0
7358067|NCT00997984|11602506|FG002|Overall Study|Met exclusion criteria|0
7358068|NCT00997984|11602504|FG000|Overall Study|non-compliance|0
7358069|NCT00997984|11602505|FG001|Overall Study|non-compliance|2
7358070|NCT00997984|11602506|FG002|Overall Study|non-compliance|3
7358071|NCT00997984|11602504|FG000|Overall Study|Wrong medication dispensed|0
7358072|NCT00997984|11602505|FG001|Overall Study|Wrong medication dispensed|1
7358073|NCT00997984|11602506|FG002|Overall Study|Wrong medication dispensed|0
7358074|NCT00997984|11602504|FG000|Overall Study|Suicidal ideation|0
7358075|NCT00997984|11602505|FG001|Overall Study|Suicidal ideation|0
7358076|NCT00997984|11602506|FG002|Overall Study|Suicidal ideation|1
7358077|NCT00997984|11602504|FG000|Overall Study|Work schedule|0
7358078|NCT00997984|11602505|FG001|Overall Study|Work schedule|0
7358079|NCT00997984|11602506|FG002|Overall Study|Work schedule|2
7358080|NCT00998296|11602549|FG000|Overall Study|Progressive disease|0
7358081|NCT00998296|11602550|FG001|Overall Study|Progressive disease|1
7358082|NCT00998296|11602551|FG002|Overall Study|Progressive disease|0
7358083|NCT00998296|11602552|FG003|Overall Study|Progressive disease|0
7358084|NCT00998296|11602553|FG004|Overall Study|Progressive disease|0
7358085|NCT00998296|11602554|FG005|Overall Study|Progressive disease|0
7358086|NCT00998296|11602555|FG006|Overall Study|Progressive disease|1
7358087|NCT00998296|11602556|FG007|Overall Study|Progressive disease|0
7358088|NCT00998296|11602557|FG008|Overall Study|Progressive disease|0
7358089|NCT00998296|11602558|FG009|Overall Study|Progressive disease|14
7358090|NCT00998296|11602559|FG010|Overall Study|Progressive disease|5
7358091|NCT00998296|11602549|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
7358092|NCT00998296|11602550|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
7358093|NCT00998296|11602551|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
7358094|NCT00998296|11602552|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
7358095|NCT00998296|11602553|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
7358096|NCT00998296|11602554|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
7358097|NCT00998296|11602555|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
7358098|NCT00998296|11602556|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
7358099|NCT00998296|11602557|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
7358100|NCT00998296|11602558|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
7358101|NCT00998296|11602559|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
7358102|NCT00998296|11602549|FG000|Overall Study|Other adverse event|0
7358103|NCT00998296|11602550|FG001|Overall Study|Other adverse event|0
7358104|NCT00998296|11602551|FG002|Overall Study|Other adverse event|0
7358105|NCT00998296|11602552|FG003|Overall Study|Other adverse event|0
7358106|NCT00998296|11602553|FG004|Overall Study|Other adverse event|1
7358107|NCT00998296|11602554|FG005|Overall Study|Other adverse event|0
7358108|NCT00998296|11602555|FG006|Overall Study|Other adverse event|0
7358109|NCT00998296|11602556|FG007|Overall Study|Other adverse event|0
7358110|NCT00998296|11602557|FG008|Overall Study|Other adverse event|0
7358111|NCT00998296|11602558|FG009|Overall Study|Other adverse event|1
7358112|NCT00998296|11602559|FG010|Overall Study|Other adverse event|2
7358113|NCT00998296|11602549|FG000|Overall Study|Refused to continue taking trial med.|0
7358114|NCT00998296|11602550|FG001|Overall Study|Refused to continue taking trial med.|0
7358115|NCT00998296|11602551|FG002|Overall Study|Refused to continue taking trial med.|0
7358116|NCT00998296|11602552|FG003|Overall Study|Refused to continue taking trial med.|0
7358117|NCT00998296|11602553|FG004|Overall Study|Refused to continue taking trial med.|0
7358118|NCT00998296|11602554|FG005|Overall Study|Refused to continue taking trial med.|0
7358119|NCT00998296|11602555|FG006|Overall Study|Refused to continue taking trial med.|0
7358120|NCT00998296|11602556|FG007|Overall Study|Refused to continue taking trial med.|0
7358121|NCT00998296|11602557|FG008|Overall Study|Refused to continue taking trial med.|0
7358122|NCT00998296|11602558|FG009|Overall Study|Refused to continue taking trial med.|2
7358123|NCT00998296|11602559|FG010|Overall Study|Refused to continue taking trial med.|0
7358124|NCT00998296|11602549|FG000|Overall Study|Reason other than those specified above|0
7358125|NCT00998296|11602550|FG001|Overall Study|Reason other than those specified above|0
7358126|NCT00998296|11602551|FG002|Overall Study|Reason other than those specified above|0
7358127|NCT00998296|11602552|FG003|Overall Study|Reason other than those specified above|0
7358128|NCT00998296|11602553|FG004|Overall Study|Reason other than those specified above|0
7358129|NCT00998296|11602554|FG005|Overall Study|Reason other than those specified above|0
7358130|NCT00998296|11602555|FG006|Overall Study|Reason other than those specified above|0
7358131|NCT00998296|11602556|FG007|Overall Study|Reason other than those specified above|0
7386274|NCT01209780|11644675|FG001|Overall Study|Inappropriate enrollment|2
7358132|NCT00998296|11602557|FG008|Overall Study|Reason other than those specified above|0
7358133|NCT00998296|11602558|FG009|Overall Study|Reason other than those specified above|1
7358134|NCT00998296|11602559|FG010|Overall Study|Reason other than those specified above|0
7358135|NCT00998309|11602588|FG000|Overall Study|Protocol Violation|4
7358136|NCT00998335|11602642|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
7358137|NCT00998335|11602643|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
7358138|NCT00998400|11602668|FG000|Overall Study|Lack of interest/motivation|1
7358139|NCT00998400|11602669|FG001|Overall Study|Lack of interest/motivation|2
7358140|NCT00998400|11602668|FG000|Overall Study|Logistical problems|1
7358141|NCT00998400|11602669|FG001|Overall Study|Logistical problems|0
7358142|NCT00998764|11602712|FG000|Overall Study|Lack of Efficacy|3
7358143|NCT00998764|11602713|FG001|Overall Study|Lack of Efficacy|6
7358144|NCT00998764|11602712|FG000|Overall Study|Adverse Event|17
7358145|NCT00998764|11602713|FG001|Overall Study|Adverse Event|12
7358146|NCT00998764|11602712|FG000|Overall Study|Withdrawal by Subject|19
7358147|NCT00998764|11602713|FG001|Overall Study|Withdrawal by Subject|25
7358148|NCT00998764|11602712|FG000|Overall Study|Physician Decision|3
7358149|NCT00998764|11602713|FG001|Overall Study|Physician Decision|3
7358150|NCT00998764|11602712|FG000|Overall Study|Death|3
7358151|NCT00998764|11602713|FG001|Overall Study|Death|1
7358152|NCT00998764|11602712|FG000|Overall Study|Discontinuation of Study by Sponsor|164
7358153|NCT00998764|11602713|FG001|Overall Study|Discontinuation of Study by Sponsor|217
7358154|NCT00998764|11602712|FG000|Overall Study|Protocol Violation|0
7358155|NCT00998764|11602713|FG001|Overall Study|Protocol Violation|1
7358156|NCT00998764|11602712|FG000|Overall Study|Failed to Return|1
7358157|NCT00998764|11602713|FG001|Overall Study|Failed to Return|1
7358158|NCT00998764|11602712|FG000|Overall Study|Lost to Follow-up|1
7358159|NCT00998764|11602713|FG001|Overall Study|Lost to Follow-up|1
7358160|NCT00998764|11602712|FG000|Overall Study|Loss of Caregiver|0
7358161|NCT00998764|11602713|FG001|Overall Study|Loss of Caregiver|3
7358162|NCT00998764|11602712|FG000|Overall Study|Other|4
7358163|NCT00998764|11602713|FG001|Overall Study|Other|4
7358164|NCT00998764|11602712|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
7387690|NCT01215851|11646411|FG002|Treatment Period|Adverse Event|1
7358165|NCT00998764|11602713|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
7358166|NCT00998790|11602721|FG000|Overall Study|Withdrawal by Subject|21
7358167|NCT00998881|11602731|FG000|Overall Study|Adverse Event|2
7358168|NCT00998881|11602732|FG001|Overall Study|Adverse Event|2
7358169|NCT00998881|11602731|FG000|Overall Study|Lack of Efficacy|1
7358170|NCT00998881|11602732|FG001|Overall Study|Lack of Efficacy|0
7358171|NCT00998881|11602731|FG000|Overall Study|Physician Decision|3
7358172|NCT00998881|11602732|FG001|Overall Study|Physician Decision|0
7358173|NCT00998881|11602731|FG000|Overall Study|Withdrawal by Subject|1
7358174|NCT00998881|11602732|FG001|Overall Study|Withdrawal by Subject|0
7358175|NCT00998881|11602731|FG000|Overall Study|Personal matter|1
7358176|NCT00998881|11602732|FG001|Overall Study|Personal matter|0
7358177|NCT00998946|11602738|FG000|Overall Study|Lost to Follow-up|1
7358178|NCT00998946|11602738|FG000|Overall Study|Withdrawal by Subject|1
7569586|NCT03455543|11946141|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
7358179|NCT00998946|11602738|FG000|Overall Study|Death|2
7358180|NCT00998946|11602738|FG000|Overall Study|Reason Unspecified|3
7358181|NCT00998946|11602738|FG000|Overall Study|Enrolled but not Dosed|2
7358182|NCT00998985|11602756|FG000|Overall Study|Withdrawal by Subject|0
7358183|NCT00998985|11602757|FG001|Overall Study|Withdrawal by Subject|0
7358184|NCT00998985|11602758|FG002|Overall Study|Withdrawal by Subject|0
7358185|NCT00998985|11602759|FG003|Overall Study|Withdrawal by Subject|0
7358186|NCT00998985|11602760|FG004|Overall Study|Withdrawal by Subject|0
7358187|NCT00998985|11602761|FG005|Overall Study|Withdrawal by Subject|0
7358188|NCT00998985|11602762|FG006|Overall Study|Withdrawal by Subject|0
7358189|NCT00998985|11602763|FG007|Overall Study|Withdrawal by Subject|0
7358190|NCT00998985|11602764|FG008|Overall Study|Withdrawal by Subject|1
7358191|NCT00998985|11602765|FG009|Overall Study|Withdrawal by Subject|0
7358192|NCT00998985|11602766|FG010|Overall Study|Withdrawal by Subject|0
7358193|NCT00998985|11602767|FG011|Overall Study|Withdrawal by Subject|0
7358194|NCT00998985|11602768|FG012|Overall Study|Withdrawal by Subject|0
7358195|NCT00998985|11602769|FG013|Overall Study|Withdrawal by Subject|0
7358196|NCT00998985|11602756|FG000|Overall Study|Protocol Violation|0
7358197|NCT00998985|11602757|FG001|Overall Study|Protocol Violation|0
7358198|NCT00998985|11602758|FG002|Overall Study|Protocol Violation|0
7358199|NCT00998985|11602759|FG003|Overall Study|Protocol Violation|0
7358200|NCT00998985|11602760|FG004|Overall Study|Protocol Violation|0
7358201|NCT00998985|11602761|FG005|Overall Study|Protocol Violation|1
7358202|NCT00998985|11602762|FG006|Overall Study|Protocol Violation|0
7358203|NCT00998985|11602763|FG007|Overall Study|Protocol Violation|0
7358204|NCT00998985|11602764|FG008|Overall Study|Protocol Violation|0
7358205|NCT00998985|11602765|FG009|Overall Study|Protocol Violation|0
7358206|NCT00998985|11602766|FG010|Overall Study|Protocol Violation|0
7358207|NCT00998985|11602767|FG011|Overall Study|Protocol Violation|0
7358208|NCT00998985|11602768|FG012|Overall Study|Protocol Violation|0
7358209|NCT00998985|11602769|FG013|Overall Study|Protocol Violation|0
7358210|NCT00999167|11602894|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
7358211|NCT00999167|11602895|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7358212|NCT00999167|11602896|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
7358213|NCT00999167|11602894|FG000|Part A: Open Label Safety run-in|Adverse Event|3
7358214|NCT00999167|11602895|FG001|Part A: Open Label Safety run-in|Adverse Event|0
7358215|NCT00999167|11602896|FG002|Part A: Open Label Safety run-in|Adverse Event|0
7459895|NCT01822756|11754942|FG002|Overall Study|disease progression & patient preference|1
7459896|NCT01822756|11754943|FG003|Overall Study|disease progression & patient preference|0
7459897|NCT01822756|11754944|FG004|Overall Study|disease progression & patient preference|0
7459898|NCT01822821|11754958|FG000|Overall Study|Eligible surgery cancelled|1
7459899|NCT01822821|11754959|FG001|Overall Study|Eligible surgery cancelled|1
7459900|NCT01822821|11754958|FG000|Overall Study|Other reasons|1
7459901|NCT01822821|11754959|FG001|Overall Study|Other reasons|0
7459902|NCT01822899|11754971|FG000|Overall Study|Adverse Event|6
7459903|NCT01822899|11754972|FG001|Overall Study|Adverse Event|5
7459904|NCT01822899|11754971|FG000|Overall Study|Lack of Efficacy|6
7459905|NCT01822899|11754972|FG001|Overall Study|Lack of Efficacy|3
7459906|NCT01822899|11754971|FG000|Overall Study|Protocol Violation|6
7459907|NCT01822899|11754972|FG001|Overall Study|Protocol Violation|3
7459908|NCT01822899|11754971|FG000|Overall Study|Lost to Follow-up|1
7459909|NCT01822899|11754972|FG001|Overall Study|Lost to Follow-up|0
7459910|NCT01822899|11754971|FG000|Overall Study|Withdrawal by Subject|5
7459911|NCT01822899|11754972|FG001|Overall Study|Withdrawal by Subject|7
7459912|NCT01822925|11754982|FG000|Overall Study|Adverse Event|1
7459913|NCT01822925|11754983|FG001|Overall Study|Adverse Event|1
7459914|NCT01822925|11754984|FG002|Overall Study|Adverse Event|1
7459915|NCT01822925|11754985|FG003|Overall Study|Adverse Event|1
7459916|NCT01822925|11754982|FG000|Overall Study|Lost to Follow-up|0
7459917|NCT01822925|11754983|FG001|Overall Study|Lost to Follow-up|1
7358216|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
7358217|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
7459918|NCT01822925|11754984|FG002|Overall Study|Lost to Follow-up|0
7459919|NCT01822925|11754985|FG003|Overall Study|Lost to Follow-up|0
7459920|NCT01822925|11754982|FG000|Overall Study|Protocol Violation|1
7459921|NCT01822925|11754983|FG001|Overall Study|Protocol Violation|0
7358218|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
7358219|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
7358220|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
7358221|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
7358222|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
7358223|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
7358224|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
7358225|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
7358226|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
7358227|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
7358228|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
7358229|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
7358230|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
7358231|NCT00999167|11602894|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7358232|NCT00999167|11602895|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
7358233|NCT00999167|11602896|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
7358234|NCT00999466|11602909|FG000|Main Part|Withdrawal by Subject|0
7358235|NCT00999466|11602910|FG001|Main Part|Withdrawal by Subject|0
7358236|NCT00999466|11602911|FG002|Main Part|Withdrawal by Subject|2
7358237|NCT00999466|11602909|FG000|Main Part|Adverse Event|0
7358238|NCT00999466|11602910|FG001|Main Part|Adverse Event|4
7358239|NCT00999466|11602911|FG002|Main Part|Adverse Event|2
7386248|NCT01209689|11644640|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7386249|NCT01209689|11644639|FG000|Overall Study|Failure to Return|3
7386250|NCT01209689|11644640|FG001|Overall Study|Failure to Return|0
7386251|NCT01209689|11644639|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
7386252|NCT01209689|11644640|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
7386253|NCT01209780|11644674|FG000|Overall Study|Adverse Event|0
7386254|NCT01209780|11644675|FG001|Overall Study|Adverse Event|1
7386255|NCT01209780|11644676|FG002|Overall Study|Adverse Event|0
7386256|NCT01209780|11644677|FG003|Overall Study|Adverse Event|0
7386257|NCT01209780|11644678|FG004|Overall Study|Adverse Event|0
7386258|NCT01209780|11644674|FG000|Overall Study|Withdrawal by Subject|9
7386259|NCT01209780|11644675|FG001|Overall Study|Withdrawal by Subject|2
7386260|NCT01209780|11644676|FG002|Overall Study|Withdrawal by Subject|1
7386261|NCT01209780|11644677|FG003|Overall Study|Withdrawal by Subject|1
7386262|NCT01209780|11644678|FG004|Overall Study|Withdrawal by Subject|0
7386263|NCT01209780|11644674|FG000|Overall Study|Lost to Follow-up|17
7386264|NCT01209780|11644675|FG001|Overall Study|Lost to Follow-up|12
7386265|NCT01209780|11644676|FG002|Overall Study|Lost to Follow-up|3
7386266|NCT01209780|11644677|FG003|Overall Study|Lost to Follow-up|9
7386267|NCT01209780|11644678|FG004|Overall Study|Lost to Follow-up|4
7386268|NCT01209780|11644674|FG000|Overall Study|Protocol Violation|0
7386269|NCT01209780|11644675|FG001|Overall Study|Protocol Violation|1
7386270|NCT01209780|11644676|FG002|Overall Study|Protocol Violation|0
7386271|NCT01209780|11644677|FG003|Overall Study|Protocol Violation|0
7386272|NCT01209780|11644678|FG004|Overall Study|Protocol Violation|0
7386273|NCT01209780|11644674|FG000|Overall Study|Inappropriate enrollment|0
7386275|NCT01209780|11644676|FG002|Overall Study|Inappropriate enrollment|0
7386276|NCT01209780|11644677|FG003|Overall Study|Inappropriate enrollment|0
7386277|NCT01209780|11644678|FG004|Overall Study|Inappropriate enrollment|1
7386278|NCT01209832|11644691|FG000|Period 1|Sponsor Decision and was not dosed|1
7386279|NCT01209832|11644691|FG000|Period 2|Sponsor Decision|1
7386281|NCT01210001|11644709|FG000|Overall Study|Not treated|1
7386282|NCT01210001|11644710|FG001|Overall Study|Not treated|0
7386283|NCT01210001|11644711|FG002|Overall Study|Not treated|0
7386284|NCT01210001|11644709|FG000|Overall Study|Adverse Event|4
7386285|NCT01210001|11644710|FG001|Overall Study|Adverse Event|2
7386286|NCT01210001|11644711|FG002|Overall Study|Adverse Event|5
7386287|NCT01210001|11644709|FG000|Overall Study|Non compliant with protocol|2
7386288|NCT01210001|11644710|FG001|Overall Study|Non compliant with protocol|2
7386289|NCT01210001|11644711|FG002|Overall Study|Non compliant with protocol|3
7386290|NCT01210001|11644709|FG000|Overall Study|Lost to Follow-up|4
7386291|NCT01210001|11644710|FG001|Overall Study|Lost to Follow-up|3
7386292|NCT01210001|11644711|FG002|Overall Study|Lost to Follow-up|2
7386293|NCT01210001|11644709|FG000|Overall Study|Patient refusal to continue,not due toAE|6
7386294|NCT01210001|11644710|FG001|Overall Study|Patient refusal to continue,not due toAE|2
7386295|NCT01210001|11644711|FG002|Overall Study|Patient refusal to continue,not due toAE|1
7386296|NCT01210001|11644709|FG000|Overall Study|Other reason not defined above|2
7386297|NCT01210001|11644710|FG001|Overall Study|Other reason not defined above|2
7386298|NCT01210001|11644711|FG002|Overall Study|Other reason not defined above|1
7386299|NCT01210118|11644730|FG000|Overall Study|Lost to Follow-up|1
7386300|NCT01210118|11644731|FG001|Overall Study|Lost to Follow-up|1
7386301|NCT01210118|11644730|FG000|Overall Study|Protocol Violation|1
7386302|NCT01210118|11644731|FG001|Overall Study|Protocol Violation|1
7386303|NCT01210118|11644730|FG000|Overall Study|Spontaneous abortion|1
7386304|NCT01210118|11644731|FG001|Overall Study|Spontaneous abortion|3
7386305|NCT01210144|11644742|FG000|Overall Study|Lack of ovarian response|1
7358240|NCT00999518|11602924|FG000|Overall Study|Adverse Event|1
7358241|NCT00999518|11602925|FG001|Overall Study|Adverse Event|6
7358242|NCT00999518|11602926|FG002|Overall Study|Adverse Event|3
7358243|NCT00999518|11602927|FG003|Overall Study|Adverse Event|1
7358244|NCT00999518|11602928|FG004|Overall Study|Adverse Event|2
7358245|NCT00999518|11602924|FG000|Overall Study|Lack of Efficacy|2
7358246|NCT00999518|11602925|FG001|Overall Study|Lack of Efficacy|0
7358247|NCT00999518|11602926|FG002|Overall Study|Lack of Efficacy|0
7358248|NCT00999518|11602927|FG003|Overall Study|Lack of Efficacy|2
7358249|NCT00999518|11602928|FG004|Overall Study|Lack of Efficacy|2
7358250|NCT00999518|11602924|FG000|Overall Study|Lost to Follow-up|0
7358251|NCT00999518|11602925|FG001|Overall Study|Lost to Follow-up|0
7358252|NCT00999518|11602926|FG002|Overall Study|Lost to Follow-up|0
7358253|NCT00999518|11602927|FG003|Overall Study|Lost to Follow-up|4
7358254|NCT00999518|11602928|FG004|Overall Study|Lost to Follow-up|1
7358255|NCT00999518|11602924|FG000|Overall Study|Did not meet entrance criteria|0
7358256|NCT00999518|11602925|FG001|Overall Study|Did not meet entrance criteria|0
7358257|NCT00999518|11602926|FG002|Overall Study|Did not meet entrance criteria|0
7358258|NCT00999518|11602927|FG003|Overall Study|Did not meet entrance criteria|0
7358259|NCT00999518|11602928|FG004|Overall Study|Did not meet entrance criteria|1
7358260|NCT00999518|11602924|FG000|Overall Study|Study terminated by sponsor|10
7358261|NCT00999518|11602925|FG001|Overall Study|Study terminated by sponsor|6
7358262|NCT00999518|11602926|FG002|Overall Study|Study terminated by sponsor|5
7358263|NCT00999518|11602927|FG003|Overall Study|Study terminated by sponsor|5
7358264|NCT00999518|11602928|FG004|Overall Study|Study terminated by sponsor|9
7358265|NCT00999518|11602924|FG000|Overall Study|Pregnancy|0
7358266|NCT00999518|11602925|FG001|Overall Study|Pregnancy|0
7358267|NCT00999518|11602926|FG002|Overall Study|Pregnancy|1
7358268|NCT00999518|11602927|FG003|Overall Study|Pregnancy|0
7358269|NCT00999518|11602928|FG004|Overall Study|Pregnancy|0
7358270|NCT00999518|11602924|FG000|Overall Study|Protocol Violation|0
7358271|NCT00999518|11602925|FG001|Overall Study|Protocol Violation|1
7358272|NCT00999518|11602926|FG002|Overall Study|Protocol Violation|0
7358273|NCT00999518|11602927|FG003|Overall Study|Protocol Violation|0
7358274|NCT00999518|11602928|FG004|Overall Study|Protocol Violation|2
7358275|NCT00999518|11602924|FG000|Overall Study|Withdrawal by Subject|5
7358276|NCT00999518|11602925|FG001|Overall Study|Withdrawal by Subject|4
7358277|NCT00999518|11602926|FG002|Overall Study|Withdrawal by Subject|10
7358278|NCT00999518|11602927|FG003|Overall Study|Withdrawal by Subject|6
7358279|NCT00999518|11602928|FG004|Overall Study|Withdrawal by Subject|1
7358280|NCT00999518|11602924|FG000|Overall Study|Other|5
7358281|NCT00999518|11602925|FG001|Overall Study|Other|7
7358282|NCT00999518|11602926|FG002|Overall Study|Other|1
7358283|NCT00999518|11602927|FG003|Overall Study|Other|4
7358284|NCT00999518|11602928|FG004|Overall Study|Other|5
7358285|NCT00999518|11602924|FG000|Overall Study|Randomized but not Treated|1
7358286|NCT00999518|11602925|FG001|Overall Study|Randomized but not Treated|1
7358287|NCT00999518|11602926|FG002|Overall Study|Randomized but not Treated|2
7358288|NCT00999518|11602927|FG003|Overall Study|Randomized but not Treated|0
7358289|NCT00999518|11602928|FG004|Overall Study|Randomized but not Treated|1
7358290|NCT00999544|11602944|FG000|Overall Study|Withdrawal by Subject|1
7358291|NCT00999596|11602977|FG000|Overall Study|Statistical population not required|101
7358292|NCT00999661|11602982|FG000|Overall Study|Lost to Follow-up|59
7358293|NCT00999661|11602982|FG000|Overall Study|Adverse Event|1
7358294|NCT00999661|11602982|FG000|Overall Study|Withdrawal by Subject|1
7358295|NCT00999661|11602982|FG000|Overall Study|Not meeting eligibility criteria|9
7358296|NCT00999687|11602986|FG000|First Intervention|Withdrawal by Subject|1
7358297|NCT00999687|11602986|FG000|Second Intervention|Withdrawal by Subject|2
7358298|NCT00999687|11602986|FG000|Second Intervention|Lack of Efficacy|1
7358299|NCT00999713|11602994|FG000|Overall Study|Physician Decision|2
7358300|NCT00999713|11602995|FG001|Overall Study|Physician Decision|0
7358301|NCT00999908|11603010|FG000|Treatment Period 1|Subject withdrew consent|2
7358302|NCT00999908|11603011|FG001|Treatment Period 1|Subject withdrew consent|0
7358303|NCT00999908|11603012|FG002|Treatment Period 1|Subject withdrew consent|0
7358304|NCT00999908|11603010|FG000|Treatment Period 2|Protocol Violation|1
7358305|NCT00999908|11603011|FG001|Treatment Period 2|Protocol Violation|0
7358306|NCT00999908|11603012|FG002|Treatment Period 2|Protocol Violation|0
7358307|NCT00999921|11603022|FG000|Overall Study|Lost to Follow-up|10
7358308|NCT00999921|11603023|FG001|Overall Study|Lost to Follow-up|19
7358309|NCT01000025|11603034|FG000|Overall Study|Adverse Event|43
7358310|NCT01000025|11603035|FG001|Overall Study|Adverse Event|2
7358311|NCT01000025|11603034|FG000|Overall Study|Withdrawal by Subject|13
7358312|NCT01000025|11603035|FG001|Overall Study|Withdrawal by Subject|8
7358313|NCT01000025|11603034|FG000|Overall Study|Death|23
7358314|NCT01000025|11603035|FG001|Overall Study|Death|13
7358315|NCT01000025|11603034|FG000|Overall Study|Lack of Efficacy|363
7358316|NCT01000025|11603035|FG001|Overall Study|Lack of Efficacy|208
7358317|NCT01000025|11603034|FG000|Overall Study|Intercurrent Illness|26
7358318|NCT01000025|11603035|FG001|Overall Study|Intercurrent Illness|7
7358319|NCT01000051|11603043|FG000|Overall Study|Withdrawal by Subject|1
7358320|NCT01000051|11603044|FG001|Overall Study|Withdrawal by Subject|1
7358321|NCT01000051|11603043|FG000|Overall Study|Disease Progression|1
7358322|NCT01000051|11603044|FG001|Overall Study|Disease Progression|0
7358323|NCT01000051|11603043|FG000|Overall Study|Serious noncompliance|1
7358324|NCT01000051|11603044|FG001|Overall Study|Serious noncompliance|0
7358325|NCT01000064|11603050|FG000|Overall Study|Withdrawal by Subject|1
7358326|NCT01000064|11603051|FG001|Overall Study|Withdrawal by Subject|1
7358327|NCT01000155|11603060|FG000|Overall Study|Withdrawal by Subject|1
7358328|NCT01000155|11603060|FG000|Overall Study|Adverse Event|1
7358329|NCT01000311|11603082|FG000|Overall Study|Adverse Event|2
7358330|NCT01000311|11603083|FG001|Overall Study|Adverse Event|5
7358331|NCT01000311|11603082|FG000|Overall Study|Withdrawal by Subject|16
7358332|NCT01000311|11603083|FG001|Overall Study|Withdrawal by Subject|24
7358333|NCT01000311|11603082|FG000|Overall Study|Lost to Follow-up|15
7358334|NCT01000311|11603083|FG001|Overall Study|Lost to Follow-up|24
7358335|NCT01000311|11603082|FG000|Overall Study|Protocol Violation|1
7358336|NCT01000311|11603083|FG001|Overall Study|Protocol Violation|2
7358337|NCT01000311|11603082|FG000|Overall Study|Inappropriate enrollment|2
7358338|NCT01000311|11603083|FG001|Overall Study|Inappropriate enrollment|0
7358339|NCT01000311|11603082|FG000|Overall Study|Administrative reason|9
7358340|NCT01000311|11603083|FG001|Overall Study|Administrative reason|15
7358341|NCT01000337|11603096|FG000|Overall Study|Lost to Follow-up|4
7358342|NCT01000337|11603097|FG001|Overall Study|Lost to Follow-up|3
7358343|NCT01000376|11603105|FG000|Cycle 1 Day 1|Adverse Event|1
7358344|NCT01000376|11603106|FG001|Cycle 1 Day 1|Adverse Event|0
7358345|NCT01000376|11603105|FG000|Cycle 1 Day 1|Progressive Disease|1
7358346|NCT01000376|11603106|FG001|Cycle 1 Day 1|Progressive Disease|0
7358347|NCT01000480|11603112|FG000|Induction Phase|Adverse Event|2
7358348|NCT01000480|11603112|FG000|Induction Phase|Lost to Follow-up|1
7358349|NCT01000480|11603112|FG000|Induction Phase|Physician Decision|1
7358350|NCT01000480|11603112|FG000|Induction Phase|Entry Criteria Not Met|3
7358351|NCT01000480|11603112|FG000|Concurrent Therapy Phase|Adverse Event|4
7358352|NCT01000480|11603112|FG000|Concurrent Therapy Phase|Protocol Violation|2
7358353|NCT01000480|11603112|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
7358354|NCT01000480|11603112|FG000|Concurrent Therapy Phase|Physician Decision|1
7358355|NCT01000493|11603118|FG000|Overall Study|Adverse Event|3
7358356|NCT01000493|11603119|FG001|Overall Study|Adverse Event|6
7358357|NCT01000493|11603118|FG000|Overall Study|Lack of Efficacy|1
7358358|NCT01000493|11603119|FG001|Overall Study|Lack of Efficacy|1
7358359|NCT01000493|11603118|FG000|Overall Study|Protocol Violation|1
7358360|NCT01000493|11603119|FG001|Overall Study|Protocol Violation|8
7358361|NCT01000493|11603118|FG000|Overall Study|Study closed/terminated|25
7358362|NCT01000493|11603119|FG001|Overall Study|Study closed/terminated|23
7358363|NCT01000493|11603118|FG000|Overall Study|Lost to Follow-up|5
7358364|NCT01000493|11603119|FG001|Overall Study|Lost to Follow-up|9
7358365|NCT01000493|11603118|FG000|Overall Study|Physician Decision|1
7358366|NCT01000493|11603119|FG001|Overall Study|Physician Decision|1
7358367|NCT01000493|11603118|FG000|Overall Study|Withdrawal by Subject|3
7358368|NCT01000493|11603119|FG001|Overall Study|Withdrawal by Subject|7
7358369|NCT01000506|11603129|FG000|Overall Study|Adverse Event|6
7358370|NCT01000506|11603130|FG001|Overall Study|Adverse Event|5
7358371|NCT01000506|11603131|FG002|Overall Study|Adverse Event|8
7358372|NCT01000506|11603132|FG003|Overall Study|Adverse Event|9
7358373|NCT01000506|11603129|FG000|Overall Study|Lack of Efficacy|8
7358374|NCT01000506|11603130|FG001|Overall Study|Lack of Efficacy|6
7358375|NCT01000506|11603131|FG002|Overall Study|Lack of Efficacy|4
7358376|NCT01000506|11603132|FG003|Overall Study|Lack of Efficacy|4
7358377|NCT01000506|11603129|FG000|Overall Study|Protocol Violation|1
7358378|NCT01000506|11603130|FG001|Overall Study|Protocol Violation|1
7358379|NCT01000506|11603131|FG002|Overall Study|Protocol Violation|0
7358380|NCT01000506|11603132|FG003|Overall Study|Protocol Violation|0
7358381|NCT01000506|11603129|FG000|Overall Study|Lost to Follow-up|1
7358382|NCT01000506|11603130|FG001|Overall Study|Lost to Follow-up|1
7358383|NCT01000506|11603131|FG002|Overall Study|Lost to Follow-up|4
7358384|NCT01000506|11603132|FG003|Overall Study|Lost to Follow-up|0
7358385|NCT01000506|11603129|FG000|Overall Study|Physician Decision|1
7358386|NCT01000506|11603130|FG001|Overall Study|Physician Decision|3
7358387|NCT01000506|11603131|FG002|Overall Study|Physician Decision|3
7358388|NCT01000506|11603132|FG003|Overall Study|Physician Decision|3
7358389|NCT01000506|11603129|FG000|Overall Study|Withdrawal by Subject|11
7358390|NCT01000506|11603130|FG001|Overall Study|Withdrawal by Subject|8
7358391|NCT01000506|11603131|FG002|Overall Study|Withdrawal by Subject|2
7358392|NCT01000506|11603132|FG003|Overall Study|Withdrawal by Subject|7
7358393|NCT01000610|11603142|FG000|Overall Study|Adverse Event|1
7358394|NCT01000610|11603142|FG000|Overall Study|Lost to Follow-up|4
7358395|NCT01000610|11603142|FG000|Overall Study|Treatment failure|1
7358396|NCT01000636|11603146|FG000|Overall Study|Withdrawal by Subject|1
7358397|NCT01000636|11603146|FG000|Overall Study|Adverse Event|1
7358398|NCT01000649|11603154|FG000|Overall Study|Adverse Event|5
7358399|NCT01000649|11603155|FG001|Overall Study|Adverse Event|1
7358400|NCT01000649|11603156|FG002|Overall Study|Adverse Event|2
7358401|NCT01000649|11603157|FG003|Overall Study|Adverse Event|4
7358402|NCT01000649|11603154|FG000|Overall Study|Lost to Follow-up|0
7358403|NCT01000649|11603155|FG001|Overall Study|Lost to Follow-up|2
7358404|NCT01000649|11603156|FG002|Overall Study|Lost to Follow-up|0
7358405|NCT01000649|11603157|FG003|Overall Study|Lost to Follow-up|2
7358406|NCT01000727|11603179|FG000|Overall Study|Lost to Follow-up|41
7358407|NCT01000727|11603180|FG001|Overall Study|Lost to Follow-up|43
7358408|NCT01000727|11603179|FG000|Overall Study|Withdrawal by Subject|111
7358409|NCT01000727|11603180|FG001|Overall Study|Withdrawal by Subject|109
7358410|NCT01000727|11603179|FG000|Overall Study|Study closed/terminated|23
7358411|NCT01000727|11603180|FG001|Overall Study|Study closed/terminated|24
7358412|NCT01000805|11603190|FG000|Overall Study|Adverse Event|21
7358413|NCT01000805|11603191|FG001|Overall Study|Adverse Event|9
7358414|NCT01000805|11603190|FG000|Overall Study|Lack of Efficacy|5
7358415|NCT01000805|11603191|FG001|Overall Study|Lack of Efficacy|16
7358416|NCT01000805|11603190|FG000|Overall Study|Lost to Follow-up|16
7358417|NCT01000805|11603191|FG001|Overall Study|Lost to Follow-up|21
7358418|NCT01000805|11603190|FG000|Overall Study|Physician Decision|0
7358419|NCT01000805|11603191|FG001|Overall Study|Physician Decision|1
7358420|NCT01000805|11603190|FG000|Overall Study|Protocol Violation|12
7358421|NCT01000805|11603191|FG001|Overall Study|Protocol Violation|8
7358422|NCT01000805|11603190|FG000|Overall Study|Withdrawal by Subject|16
7358423|NCT01000805|11603191|FG001|Overall Study|Withdrawal by Subject|6
7358424|NCT01000805|11603190|FG000|Overall Study|Sponsor Decision|0
7358425|NCT01000805|11603191|FG001|Overall Study|Sponsor Decision|1
7358426|NCT01000961|11603207|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
7358427|NCT01000961|11603208|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7358428|NCT01000961|11603207|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
7358429|NCT01000961|11603208|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
7358430|NCT01000974|11603219|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
7358431|NCT01000974|11603220|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
7358432|NCT01000974|11603221|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
7358433|NCT01000974|11603219|FG000|Primary Vaccination Phase|Lost to Follow-up|171
7358434|NCT01000974|11603220|FG001|Primary Vaccination Phase|Lost to Follow-up|19
7358435|NCT01000974|11603221|FG002|Primary Vaccination Phase|Lost to Follow-up|26
7358436|NCT01000974|11603219|FG000|Primary Vaccination Phase|Protocol Violation|40
7358437|NCT01000974|11603220|FG001|Primary Vaccination Phase|Protocol Violation|3
7358438|NCT01000974|11603221|FG002|Primary Vaccination Phase|Protocol Violation|2
7358439|NCT01000974|11603219|FG000|Primary Vaccination Phase|Adverse Event|14
7358440|NCT01000974|11603220|FG001|Primary Vaccination Phase|Adverse Event|2
7358441|NCT01000974|11603221|FG002|Primary Vaccination Phase|Adverse Event|2
7358442|NCT01000974|11603219|FG000|Primary Vaccination Phase|Other|4
7358443|NCT01000974|11603220|FG001|Primary Vaccination Phase|Other|9
7358444|NCT01000974|11603221|FG002|Primary Vaccination Phase|Other|12
7358445|NCT01000974|11603219|FG000|Booster Vaccination Phase|Protocol Violation|0
7358446|NCT01000974|11603220|FG001|Booster Vaccination Phase|Protocol Violation|0
7358447|NCT01000974|11603221|FG002|Booster Vaccination Phase|Protocol Violation|2
7358448|NCT01000974|11603219|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
7358449|NCT01000974|11603220|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
7358450|NCT01000974|11603221|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
7358451|NCT01000974|11603219|FG000|Booster Vaccination Phase|Lost to Follow-up|40
7358452|NCT01000974|11603220|FG001|Booster Vaccination Phase|Lost to Follow-up|5
7358453|NCT01000974|11603221|FG002|Booster Vaccination Phase|Lost to Follow-up|7
7358454|NCT01000974|11603219|FG000|Booster Vaccination Phase|Other|24
7358455|NCT01000974|11603220|FG001|Booster Vaccination Phase|Other|6
7358456|NCT01000974|11603221|FG002|Booster Vaccination Phase|Other|4
7358457|NCT01001104|11603267|FG000|Overall Study|Adverse Event|2
7358458|NCT01001104|11603268|FG001|Overall Study|Adverse Event|1
7358459|NCT01001104|11603269|FG002|Overall Study|Adverse Event|0
7358460|NCT01001104|11603270|FG003|Overall Study|Adverse Event|0
7358461|NCT01001104|11603267|FG000|Overall Study|Lost to Follow-up|0
7358462|NCT01001104|11603268|FG001|Overall Study|Lost to Follow-up|0
7569587|NCT03455543|11946142|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
7569588|NCT03455543|11946143|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
7569589|NCT03455543|11946141|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
7569590|NCT03455543|11946142|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7569591|NCT03455543|11946143|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
7569592|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7569593|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
7569594|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
7569595|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7358463|NCT01001104|11603269|FG002|Overall Study|Lost to Follow-up|1
7358464|NCT01001104|11603270|FG003|Overall Study|Lost to Follow-up|0
7358465|NCT01001104|11603267|FG000|Overall Study|Entry Criteria Not Met|0
7358466|NCT01001104|11603268|FG001|Overall Study|Entry Criteria Not Met|0
7358467|NCT01001104|11603269|FG002|Overall Study|Entry Criteria Not Met|0
7358468|NCT01001104|11603270|FG003|Overall Study|Entry Criteria Not Met|1
7358469|NCT01001104|11603267|FG000|Overall Study|Withdrawal by Subject|0
7358470|NCT01001104|11603268|FG001|Overall Study|Withdrawal by Subject|0
7358471|NCT01001104|11603269|FG002|Overall Study|Withdrawal by Subject|0
7358472|NCT01001104|11603270|FG003|Overall Study|Withdrawal by Subject|2
7358473|NCT01001169|11603285|FG000|Overall Study|Withdrawal by Subject|2
7358474|NCT01001169|11603286|FG001|Overall Study|Withdrawal by Subject|1
7358475|NCT01001208|11603319|FG000|Overall Study|Adverse Event|10
7358476|NCT01001208|11603320|FG001|Overall Study|Adverse Event|5
7358477|NCT01001208|11603319|FG000|Overall Study|Lost to Follow-up|5
7358478|NCT01001208|11603320|FG001|Overall Study|Lost to Follow-up|9
7358479|NCT01001208|11603319|FG000|Overall Study|Physician Decision|1
7358480|NCT01001208|11603320|FG001|Overall Study|Physician Decision|0
7358481|NCT01001208|11603319|FG000|Overall Study|Withdrawal by Subject|4
7569596|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
7569597|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
7569598|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7569599|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
7569600|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
7569601|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7569602|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
7569603|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
7569604|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7569605|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
7569606|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
7569607|NCT03455543|11946141|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7569608|NCT03455543|11946142|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
7569609|NCT03455543|11946143|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
7569610|NCT03456856|11946160|FG000|Overall Study|Lost to Follow-up|2
7569611|NCT03456856|11946160|FG000|Overall Study|Withdrawal by Subject|1
7569612|NCT03456960|11946170|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7569613|NCT03456960|11946171|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7569614|NCT03456960|11946172|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7569615|NCT03456960|11946173|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
7569616|NCT03456960|11946174|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7569617|NCT03456960|11946175|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7569618|NCT03456960|11946170|FG000|Period 2 (1 Day)|Adverse Event|1
7569619|NCT03456960|11946171|FG001|Period 2 (1 Day)|Adverse Event|0
7569620|NCT03456960|11946172|FG002|Period 2 (1 Day)|Adverse Event|0
7569621|NCT03456960|11946173|FG003|Period 2 (1 Day)|Adverse Event|1
7569622|NCT03456960|11946174|FG004|Period 2 (1 Day)|Adverse Event|0
7569623|NCT03456960|11946175|FG005|Period 2 (1 Day)|Adverse Event|0
7569624|NCT03457103|11946193|FG000|Overall Study|illness/hospitalization|4
7569625|NCT03457103|11946194|FG001|Overall Study|illness/hospitalization|2
7569626|NCT03457103|11946193|FG000|Overall Study|Lost to Follow-up|2
7569627|NCT03457103|11946194|FG001|Overall Study|Lost to Follow-up|1
7569628|NCT03457103|11946193|FG000|Overall Study|Withdrawal by Subject|1
7569629|NCT03457103|11946194|FG001|Overall Study|Withdrawal by Subject|2
7569630|NCT03457103|11946193|FG000|Overall Study|financial/ insurance issues|1
7358482|NCT01001208|11603320|FG001|Overall Study|Withdrawal by Subject|5
7358483|NCT01001208|11603319|FG000|Overall Study|Ineligibility Determined|4
7358484|NCT01001208|11603320|FG001|Overall Study|Ineligibility Determined|2
7358485|NCT01001208|11603319|FG000|Overall Study|Noncompliance|4
7358486|NCT01001208|11603320|FG001|Overall Study|Noncompliance|7
7358487|NCT01001208|11603319|FG000|Overall Study|Disease Progression|0
7358488|NCT01001208|11603320|FG001|Overall Study|Disease Progression|3
7358489|NCT01001208|11603319|FG000|Overall Study|Other|0
7358490|NCT01001208|11603320|FG001|Overall Study|Other|2
7358491|NCT01001221|11603330|FG000|Overall Study|Adverse Event|1
7358492|NCT01001221|11603331|FG001|Overall Study|Adverse Event|2
7358493|NCT01001221|11603332|FG002|Overall Study|Adverse Event|0
7358494|NCT01001221|11603333|FG003|Overall Study|Adverse Event|2
7358495|NCT01001221|11603334|FG004|Overall Study|Adverse Event|0
7358496|NCT01001221|11603330|FG000|Overall Study|Disease progression|3
7358497|NCT01001221|11603331|FG001|Overall Study|Disease progression|2
7358498|NCT01001221|11603332|FG002|Overall Study|Disease progression|2
7358499|NCT01001221|11603333|FG003|Overall Study|Disease progression|4
7358500|NCT01001221|11603334|FG004|Overall Study|Disease progression|0
7358501|NCT01001221|11603330|FG000|Overall Study|Other|1
7358502|NCT01001221|11603331|FG001|Overall Study|Other|1
7358503|NCT01001221|11603332|FG002|Overall Study|Other|0
7358504|NCT01001221|11603333|FG003|Overall Study|Other|0
7358505|NCT01001221|11603334|FG004|Overall Study|Other|0
7358506|NCT01001221|11603330|FG000|Overall Study|Not treated; protocol exclusion|0
7358507|NCT01001221|11603331|FG001|Overall Study|Not treated; protocol exclusion|0
7358508|NCT01001221|11603332|FG002|Overall Study|Not treated; protocol exclusion|1
7358509|NCT01001221|11603333|FG003|Overall Study|Not treated; protocol exclusion|0
7358510|NCT01001221|11603334|FG004|Overall Study|Not treated; protocol exclusion|0
7358511|NCT01001299|11603345|FG000|Overall Study|Insufficient Therapeutic Response|20
7358512|NCT01001299|11603345|FG000|Overall Study|Adverse event or Intercurrent Illness|1
7358513|NCT01001299|11603345|FG000|Overall Study|Death|1
7358514|NCT01001299|11603345|FG000|Overall Study|Began Taking Commercially Available Drug|2
7358515|NCT01001299|11603345|FG000|Overall Study|Withdrew Consent|1
7358516|NCT01001325|11603351|FG000|Overall Study|Lost to Follow-up|16
7358517|NCT01001325|11603352|FG001|Overall Study|Lost to Follow-up|10
7358518|NCT01001325|11603351|FG000|Overall Study|Protocol Violation|2
7358519|NCT01001325|11603352|FG001|Overall Study|Protocol Violation|0
7569631|NCT03457103|11946194|FG001|Overall Study|financial/ insurance issues|1
7569632|NCT03457636|11946209|FG000|Overall Study|Lost to Follow-up|2
7358528|NCT01001429|11603378|FG000|Overall Study|surgery cancelled|0
7358529|NCT01001429|11603379|FG001|Overall Study|surgery cancelled|1
7358530|NCT01001494|11603449|FG000|Overall Study|Adverse Event|8
7358531|NCT01001494|11603450|FG001|Overall Study|Adverse Event|4
7358532|NCT01001494|11603451|FG002|Overall Study|Adverse Event|6
7358533|NCT01001494|11603449|FG000|Overall Study|Protocol Violation|0
7358534|NCT01001494|11603450|FG001|Overall Study|Protocol Violation|1
7358535|NCT01001494|11603451|FG002|Overall Study|Protocol Violation|1
7358536|NCT01001494|11603449|FG000|Overall Study|Lost to Follow-up|2
7358537|NCT01001494|11603450|FG001|Overall Study|Lost to Follow-up|0
7358538|NCT01001494|11603451|FG002|Overall Study|Lost to Follow-up|1
7358539|NCT01001494|11603449|FG000|Overall Study|Withdrawal by Subject|9
7358540|NCT01001494|11603450|FG001|Overall Study|Withdrawal by Subject|7
7358541|NCT01001494|11603451|FG002|Overall Study|Withdrawal by Subject|17
7358542|NCT01001494|11603449|FG000|Overall Study|COPD exacerbation|3
7358543|NCT01001494|11603450|FG001|Overall Study|COPD exacerbation|4
7358544|NCT01001494|11603451|FG002|Overall Study|COPD exacerbation|5
7358545|NCT01001494|11603449|FG000|Overall Study|Lack of Efficacy|2
7358546|NCT01001494|11603450|FG001|Overall Study|Lack of Efficacy|0
7358547|NCT01001494|11603451|FG002|Overall Study|Lack of Efficacy|8
7358548|NCT01001494|11603449|FG000|Overall Study|Other|0
7358549|NCT01001494|11603450|FG001|Overall Study|Other|1
7358550|NCT01001494|11603451|FG002|Overall Study|Other|3
7358551|NCT01001520|11603459|FG000|Medication Period 1|Withdrawal by Subject|2
7358552|NCT01001520|11603460|FG001|Medication Period 1|Withdrawal by Subject|2
7358553|NCT01001520|11603459|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
7358554|NCT01001520|11603460|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
7358555|NCT01001520|11603459|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
7358556|NCT01001520|11603460|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
7358557|NCT01001520|11603459|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
7358558|NCT01001520|11603460|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
7358559|NCT01001520|11603459|FG000|Washout Period|Withdrawal by Subject|2
7358560|NCT01001520|11603460|FG001|Washout Period|Withdrawal by Subject|1
7358561|NCT01001520|11603459|FG000|Medication Period 2|Withdrawal by Subject|0
7358562|NCT01001520|11603460|FG001|Medication Period 2|Withdrawal by Subject|3
7358563|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
7358564|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7358565|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
7358566|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
7358567|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
7358568|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
7358569|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
7358570|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7358571|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
7358572|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
7358573|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7358574|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
7358575|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
7358576|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7358577|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
7358578|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
7358579|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7358580|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
7358581|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
7358582|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
7358583|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
7358584|NCT01001572|11603489|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
7358585|NCT01001572|11603490|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7358586|NCT01001572|11603491|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
7358587|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Adverse Event|0
7358588|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Adverse Event|2
7358589|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Adverse Event|2
7358590|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
7358591|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
7358592|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
7358593|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7358594|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
7358595|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
7358596|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7358597|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7386306|NCT01210144|11644743|FG001|Overall Study|Lack of ovarian response|0
7358598|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
7358599|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Protocol deviation|0
7358600|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Protocol deviation|0
7358601|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Protocol deviation|1
7358602|NCT01001572|11603489|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
7358603|NCT01001572|11603490|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7358604|NCT01001572|11603491|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7358605|NCT01001598|11603497|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
7358606|NCT01001598|11603497|FG000|Overall Study|Adverse Event|1
7358607|NCT01001702|11603501|FG000|Overall Study|Lost to Follow-up|7
7358608|NCT01001702|11603501|FG000|Overall Study|Adverse Event|7
7358609|NCT01001702|11603501|FG000|Overall Study|Sponsor Discontinued Study|4
7358610|NCT01001702|11603501|FG000|Overall Study|Subject met Withdrawal Criteria|22
7358611|NCT01001702|11603501|FG000|Overall Study|Investigator withdrew Subject|10
7358612|NCT01001702|11603501|FG000|Overall Study|Withdrawal by Subject|19
7358613|NCT01001702|11603501|FG000|Overall Study|Lack of Efficacy per Investigator|3
7358614|NCT01001767|11603507|FG000|Overall Study|no baseline study performed|1
7358615|NCT01001767|11603508|FG001|Overall Study|no baseline study performed|0
7358616|NCT01001767|11603507|FG000|Overall Study|Protocol Violation|1
7358617|NCT01001767|11603508|FG001|Overall Study|Protocol Violation|0
7358618|NCT01001767|11603507|FG000|Overall Study|Lost to Follow-up|1
7358619|NCT01001767|11603508|FG001|Overall Study|Lost to Follow-up|0
7358620|NCT01001767|11603507|FG000|Overall Study|Physician Decision|1
7358621|NCT01001767|11603508|FG001|Overall Study|Physician Decision|0
7358622|NCT01001832|11603529|FG000|Short-term Period|Adverse Event|2
7358623|NCT01001832|11603530|FG001|Short-term Period|Adverse Event|3
7358624|NCT01001832|11603529|FG000|Long-term Period|Adverse Event|2
7358625|NCT01001832|11603530|FG001|Long-term Period|Adverse Event|1
7358626|NCT01001832|11603529|FG000|Long-term Period|Withdrawal by Subject|1
7358627|NCT01001832|11603530|FG001|Long-term Period|Withdrawal by Subject|0
7358628|NCT01001832|11603529|FG000|Long-term Period|Lack of Efficacy|0
7358629|NCT01001832|11603530|FG001|Long-term Period|Lack of Efficacy|2
7358630|NCT01001832|11603529|FG000|Long-term Period|Other|1
7358631|NCT01001832|11603530|FG001|Long-term Period|Other|2
7358632|NCT01001832|11603529|FG000|Follow-up Period|Withdrawal by Subject|1
7358633|NCT01001832|11603530|FG001|Follow-up Period|Withdrawal by Subject|0
7358634|NCT01001832|11603529|FG000|Follow-up Period|Follow-up no longer required /protocol|15
7358635|NCT01001832|11603530|FG001|Follow-up Period|Follow-up no longer required /protocol|20
7358636|NCT01001832|11603529|FG000|Follow-up Period|Other|2
7358637|NCT01001832|11603530|FG001|Follow-up Period|Other|1
7358638|NCT01001910|11603539|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
7358639|NCT01001988|11603552|FG000|Overall Study|Protocol Violation|84
7358640|NCT01001988|11603552|FG000|Overall Study|Withdrawal by Subject|18
7358641|NCT01001988|11603552|FG000|Overall Study|Lost to Follow-up|15
7358642|NCT01002105|11603558|FG000|Overall Study|Lost to Follow-up|10
7459922|NCT01822925|11754984|FG002|Overall Study|Protocol Violation|0
7459923|NCT01822925|11754985|FG003|Overall Study|Protocol Violation|1
7459924|NCT01822925|11754982|FG000|Overall Study|Withdrawal by Subject|2
7459925|NCT01822925|11754983|FG001|Overall Study|Withdrawal by Subject|0
7459926|NCT01822925|11754984|FG002|Overall Study|Withdrawal by Subject|2
7459927|NCT01822925|11754985|FG003|Overall Study|Withdrawal by Subject|2
7459928|NCT01822925|11754982|FG000|Overall Study|Taking prohibited medication|2
7459929|NCT01822925|11754983|FG001|Overall Study|Taking prohibited medication|0
7459930|NCT01822925|11754984|FG002|Overall Study|Taking prohibited medication|0
7459931|NCT01822925|11754985|FG003|Overall Study|Taking prohibited medication|1
7459932|NCT01823107|11754995|FG000|Overall Study|Withdrawal by Subject|1
7459933|NCT01823146|11755001|FG000|Overall Study|Withdrawal by Subject|0
7459934|NCT01823146|11755002|FG001|Overall Study|Withdrawal by Subject|1
7459935|NCT01823146|11755001|FG000|Overall Study|Lost to Follow-up|2
7459936|NCT01823146|11755002|FG001|Overall Study|Lost to Follow-up|1
7459937|NCT01823224|11755010|FG000|Overall Study|Lost to Follow-up|5
7459938|NCT01823224|11755011|FG001|Overall Study|Lost to Follow-up|6
7459939|NCT01823224|11755010|FG000|Overall Study|didn't qualify|1
7459940|NCT01823224|11755011|FG001|Overall Study|didn't qualify|2
7459941|NCT01823224|11755010|FG000|Overall Study|pharmacy error|0
7459942|NCT01823224|11755011|FG001|Overall Study|pharmacy error|1
7459943|NCT01823224|11755010|FG000|Overall Study|missed med dose|0
7459944|NCT01823224|11755011|FG001|Overall Study|missed med dose|1
7459945|NCT01823224|11755010|FG000|Overall Study|Withdrawal by Subject|0
7459946|NCT01823224|11755011|FG001|Overall Study|Withdrawal by Subject|1
7459947|NCT01823289|11755019|FG000|Overall Study|Lost to Follow-up|5
7459948|NCT01823289|11755019|FG000|Overall Study|Adverse Event|5
7459949|NCT01823289|11755019|FG000|Overall Study|Lack of Efficacy|1
7459950|NCT01823289|11755019|FG000|Overall Study|Physician Decision|9
7459951|NCT01823289|11755019|FG000|Overall Study|Administered contraindicated medicine|1
7459952|NCT01823289|11755019|FG000|Overall Study|Transaminase increased more than 3 times|1
7459953|NCT01823289|11755019|FG000|Overall Study|Drug affected efficacy and safety|1
7459954|NCT01823289|11755019|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
7459955|NCT01823328|11755025|FG000|Overall Study|Withdrawal by Subject|8
7459956|NCT01823328|11755026|FG001|Overall Study|Withdrawal by Subject|6
7533277|NCT02683941|11879549|FG001|Open-label Treatment Phase|Other|0
7459957|NCT01823341|11755032|FG000|Overall Study|Failed run-in|7
7358643|NCT01002105|11603559|FG001|Overall Study|Lost to Follow-up|16
7358644|NCT01002105|11603558|FG000|Overall Study|non compliance|5
7358645|NCT01002105|11603559|FG001|Overall Study|non compliance|3
7358646|NCT01002105|11603558|FG000|Overall Study|condition worsened|4
7358647|NCT01002105|11603559|FG001|Overall Study|condition worsened|2
7358648|NCT01002339|11603584|FG000|Overall Study|Withdrawal by Subject|0
7358649|NCT01002339|11603585|FG001|Overall Study|Withdrawal by Subject|1
7358650|NCT01002339|11603586|FG002|Overall Study|Withdrawal by Subject|0
7358651|NCT01002339|11603584|FG000|Overall Study|Incorrect treatment assignment|0
7358652|NCT01002339|11603585|FG001|Overall Study|Incorrect treatment assignment|0
7358653|NCT01002339|11603586|FG002|Overall Study|Incorrect treatment assignment|1
7358654|NCT01002339|11603584|FG000|Overall Study|Protocol Violation|0
7358655|NCT01002339|11603585|FG001|Overall Study|Protocol Violation|0
7358656|NCT01002339|11603586|FG002|Overall Study|Protocol Violation|2
7358657|NCT01002339|11603584|FG000|Overall Study|Lung cancer detected before transplant|0
7358658|NCT01002339|11603585|FG001|Overall Study|Lung cancer detected before transplant|0
7358659|NCT01002339|11603586|FG002|Overall Study|Lung cancer detected before transplant|1
7358660|NCT01002339|11603584|FG000|Overall Study|Randomized. Not transplanted|0
7358661|NCT01002339|11603585|FG001|Overall Study|Randomized. Not transplanted|0
7358662|NCT01002339|11603586|FG002|Overall Study|Randomized. Not transplanted|1
7358663|NCT01002482|11603607|FG000|Overall Study|Withdrawal by Subject|14
7358664|NCT01002482|11603608|FG001|Overall Study|Withdrawal by Subject|21
7358665|NCT01002482|11603607|FG000|Overall Study|Included twice|1
7358666|NCT01002482|11603608|FG001|Overall Study|Included twice|0
7358667|NCT01002547|11603617|FG000|Overall Study|Withdrawal by Subject|4
7358668|NCT01002547|11603618|FG001|Overall Study|Withdrawal by Subject|0
7358669|NCT01002547|11603619|FG002|Overall Study|Withdrawal by Subject|5
7358670|NCT01002547|11603617|FG000|Overall Study|Lost to Follow-up|2
7358671|NCT01002547|11603618|FG001|Overall Study|Lost to Follow-up|1
7358672|NCT01002547|11603619|FG002|Overall Study|Lost to Follow-up|1
7358673|NCT01002547|11603617|FG000|Overall Study|Physician Decision|1
7358674|NCT01002547|11603618|FG001|Overall Study|Physician Decision|0
7358675|NCT01002547|11603619|FG002|Overall Study|Physician Decision|0
7358676|NCT01002547|11603617|FG000|Overall Study|Death|0
7358677|NCT01002547|11603618|FG001|Overall Study|Death|2
7358678|NCT01002547|11603619|FG002|Overall Study|Death|2
7358679|NCT01002547|11603617|FG000|Overall Study|Adverse Event|1
7358680|NCT01002547|11603618|FG001|Overall Study|Adverse Event|0
7358681|NCT01002547|11603619|FG002|Overall Study|Adverse Event|0
7358682|NCT01002573|11603629|FG000|Overall Study|Subject did not receive at least 1 dose|11
7358683|NCT01002573|11603630|FG001|Overall Study|Subject did not receive at least 1 dose|7
7358684|NCT01002742|11603638|FG000|Overall Study|Determined to be ineligible|0
7358685|NCT01002742|11603639|FG001|Overall Study|Determined to be ineligible|1
7358686|NCT01002989|11603649|FG000|Overall Study|exclusion criteria, no consent|5
7358687|NCT01003184|11603698|FG000|Overall Study|Adverse Event|12
7358688|NCT01003184|11603699|FG001|Overall Study|Adverse Event|5
7358689|NCT01003184|11603698|FG000|Overall Study|Lost to Follow-up|1
7358690|NCT01003184|11603699|FG001|Overall Study|Lost to Follow-up|0
7358691|NCT01003184|11603698|FG000|Overall Study|Loss of glucose control|1
7358692|NCT01003184|11603699|FG001|Overall Study|Loss of glucose control|1
7358693|NCT01003184|11603698|FG000|Overall Study|Protocol Violation|3
7358694|NCT01003184|11603699|FG001|Overall Study|Protocol Violation|0
7358695|NCT01003184|11603698|FG000|Overall Study|Withdrawal by Subject|1
7358696|NCT01003184|11603699|FG001|Overall Study|Withdrawal by Subject|6
7358697|NCT01003184|11603698|FG000|Overall Study|Physician Decision|1
7358698|NCT01003184|11603699|FG001|Overall Study|Physician Decision|0
7358699|NCT01003210|11603707|FG000|Overall Study|Lost to Follow-up|1
7358700|NCT01003210|11603708|FG001|Overall Study|Lost to Follow-up|3
7358701|NCT01003249|11603714|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
7358702|NCT01003249|11603715|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
7358703|NCT01003249|11603714|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
7358704|NCT01003249|11603715|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
7358705|NCT01003249|11603714|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7358706|NCT01003249|11603715|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7358707|NCT01003249|11603714|FG000|Second Intervention (4 Weeks)|Adverse Event|1
7358708|NCT01003249|11603715|FG001|Second Intervention (4 Weeks)|Adverse Event|0
7358709|NCT01003639|11603761|FG000|Overall Study|Lost to Follow-up|6
7358710|NCT01003639|11603762|FG001|Overall Study|Lost to Follow-up|9
7358711|NCT01003639|11603761|FG000|Overall Study|Withdrawal by Subject|9
7358712|NCT01003639|11603762|FG001|Overall Study|Withdrawal by Subject|5
7358713|NCT01003639|11603761|FG000|Overall Study|Lack of Efficacy|1
7358714|NCT01003639|11603762|FG001|Overall Study|Lack of Efficacy|6
7358715|NCT01003639|11603761|FG000|Overall Study|Adverse Event|0
7358716|NCT01003639|11603762|FG001|Overall Study|Adverse Event|1
7358717|NCT01003639|11603761|FG000|Overall Study|Protocol Violation|0
7358718|NCT01003639|11603762|FG001|Overall Study|Protocol Violation|1
7358719|NCT01003639|11603761|FG000|Overall Study|Physician Decision|1
7358720|NCT01003639|11603762|FG001|Overall Study|Physician Decision|0
7358721|NCT01003886|11603772|FG000|Overall Study|Lack of Efficacy|5
7358722|NCT01003886|11603772|FG000|Overall Study|Lost to Follow-up|169
7358723|NCT01003886|11603772|FG000|Overall Study|Withdrawal by Subject|39
7358724|NCT01003886|11603772|FG000|Overall Study|Other|14
7358725|NCT01003886|11603772|FG000|Overall Study|Adverse Event|3
7358726|NCT01003899|11603776|FG000|Overall Study|Other Adverse Event|8
7358727|NCT01003899|11603776|FG000|Overall Study|Not entered|4
7358728|NCT01003899|11603776|FG000|Overall Study|Not treated|1
7358729|NCT01003899|11603776|FG000|Overall Study|Progressive disease|34
7358730|NCT01003990|11603787|FG000|Overall Study|Adverse Event|8
7358731|NCT01003990|11603788|FG001|Overall Study|Adverse Event|5
7358732|NCT01003990|11603789|FG002|Overall Study|Adverse Event|11
7358733|NCT01003990|11603787|FG000|Overall Study|Death|0
7358734|NCT01003990|11603788|FG001|Overall Study|Death|8
7358735|NCT01003990|11603789|FG002|Overall Study|Death|1
7358736|NCT01003990|11603787|FG000|Overall Study|Lack of Efficacy|10
7358737|NCT01003990|11603788|FG001|Overall Study|Lack of Efficacy|2
7358738|NCT01003990|11603789|FG002|Overall Study|Lack of Efficacy|3
7358739|NCT01003990|11603787|FG000|Overall Study|Lost to Follow-up|30
7358740|NCT01003990|11603788|FG001|Overall Study|Lost to Follow-up|12
7358741|NCT01003990|11603789|FG002|Overall Study|Lost to Follow-up|7
7358742|NCT01003990|11603787|FG000|Overall Study|Reasons Not Identified|14
7358743|NCT01003990|11603788|FG001|Overall Study|Reasons Not Identified|13
7358744|NCT01003990|11603789|FG002|Overall Study|Reasons Not Identified|8
7358745|NCT01003990|11603787|FG000|Overall Study|Poor/Non-compliance|4
7358746|NCT01003990|11603788|FG001|Overall Study|Poor/Non-compliance|3
7358747|NCT01003990|11603789|FG002|Overall Study|Poor/Non-compliance|2
7358748|NCT01003990|11603787|FG000|Overall Study|Pregnancy|10
7358749|NCT01003990|11603788|FG001|Overall Study|Pregnancy|2
7358750|NCT01003990|11603789|FG002|Overall Study|Pregnancy|4
7358751|NCT01003990|11603787|FG000|Overall Study|No Longer Met Study Criteria|4
7358752|NCT01003990|11603788|FG001|Overall Study|No Longer Met Study Criteria|1
7358753|NCT01003990|11603789|FG002|Overall Study|No Longer Met Study Criteria|0
7358754|NCT01003990|11603787|FG000|Overall Study|Subject Withdrew Consent|12
7358755|NCT01003990|11603788|FG001|Overall Study|Subject Withdrew Consent|5
7358756|NCT01003990|11603789|FG002|Overall Study|Subject Withdrew Consent|7
7358757|NCT01004003|11603806|FG000|Overall Study|Progressive disease|2
7358758|NCT01004003|11603807|FG001|Overall Study|Progressive disease|1
7358759|NCT01004003|11603808|FG002|Overall Study|Progressive disease|1
7358760|NCT01004003|11603809|FG003|Overall Study|Progressive disease|0
7358761|NCT01004003|11603810|FG004|Overall Study|Progressive disease|2
7358762|NCT01004003|11603811|FG005|Overall Study|Progressive disease|1
7358763|NCT01004003|11603812|FG006|Overall Study|Progressive disease|1
7358764|NCT01004003|11603813|FG007|Overall Study|Progressive disease|39
7358765|NCT01004003|11603814|FG008|Overall Study|Progressive disease|22
7358766|NCT01004003|11603806|FG000|Overall Study|Adverse Event|4
7358767|NCT01004003|11603807|FG001|Overall Study|Adverse Event|2
7358768|NCT01004003|11603808|FG002|Overall Study|Adverse Event|3
7358769|NCT01004003|11603809|FG003|Overall Study|Adverse Event|3
7358770|NCT01004003|11603810|FG004|Overall Study|Adverse Event|2
7358771|NCT01004003|11603811|FG005|Overall Study|Adverse Event|2
7358772|NCT01004003|11603812|FG006|Overall Study|Adverse Event|7
7358773|NCT01004003|11603813|FG007|Overall Study|Adverse Event|21
7358774|NCT01004003|11603814|FG008|Overall Study|Adverse Event|6
7358775|NCT01004003|11603806|FG000|Overall Study|Refused to continue taking trial med.|0
7358776|NCT01004003|11603807|FG001|Overall Study|Refused to continue taking trial med.|0
7358777|NCT01004003|11603808|FG002|Overall Study|Refused to continue taking trial med.|0
7358778|NCT01004003|11603809|FG003|Overall Study|Refused to continue taking trial med.|0
7358779|NCT01004003|11603810|FG004|Overall Study|Refused to continue taking trial med.|0
7459972|NCT01823536|11755061|FG000|Overall Study|Withdrawal by Subject|1
7358780|NCT01004003|11603811|FG005|Overall Study|Refused to continue taking trial med.|0
7358781|NCT01004003|11603812|FG006|Overall Study|Refused to continue taking trial med.|0
7358782|NCT01004003|11603813|FG007|Overall Study|Refused to continue taking trial med.|0
7358783|NCT01004003|11603814|FG008|Overall Study|Refused to continue taking trial med.|2
7358784|NCT01004003|11603806|FG000|Overall Study|Other|0
7358785|NCT01004003|11603807|FG001|Overall Study|Other|0
7358786|NCT01004003|11603808|FG002|Overall Study|Other|0
7358787|NCT01004003|11603809|FG003|Overall Study|Other|0
7358788|NCT01004003|11603810|FG004|Overall Study|Other|0
7358789|NCT01004003|11603811|FG005|Overall Study|Other|1
7358790|NCT01004003|11603812|FG006|Overall Study|Other|0
7358791|NCT01004003|11603813|FG007|Overall Study|Other|0
7358792|NCT01004003|11603814|FG008|Overall Study|Other|0
7358793|NCT01004146|11603875|FG000|Overall Study|Withdrawal by Subject|4
7358794|NCT01004146|11603876|FG001|Overall Study|Withdrawal by Subject|5
7358795|NCT01004159|11603882|FG000|Overall Study|Adverse Event|2
7358796|NCT01004159|11603882|FG000|Overall Study|Disease Progression|18
7358797|NCT01004172|11603886|FG000|Overall Study|Progressive Disease in CNS Only|16
7358798|NCT01004172|11603886|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
7358799|NCT01004172|11603886|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
7358800|NCT01004172|11603886|FG000|Overall Study|Adverse Event|1
7358801|NCT01004172|11603886|FG000|Overall Study|Physician Decision|1
7358802|NCT01004172|11603886|FG000|Overall Study|Symptomatic Deterioration|2
7358803|NCT01004185|11603893|FG000|Overall Study|Adverse Event|1
7358804|NCT01004185|11603894|FG001|Overall Study|Adverse Event|1
7358805|NCT01004185|11603893|FG000|Overall Study|Lost to Follow-up|0
7358806|NCT01004185|11603894|FG001|Overall Study|Lost to Follow-up|1
7358807|NCT01004185|11603893|FG000|Overall Study|Lack of Efficacy|2
7358808|NCT01004185|11603894|FG001|Overall Study|Lack of Efficacy|1
7358809|NCT01004185|11603893|FG000|Overall Study|Sponsor Terminated Study|4
7358810|NCT01004185|11603894|FG001|Overall Study|Sponsor Terminated Study|5
7358811|NCT01004185|11603893|FG000|Overall Study|Withdrawal by Subject|2
7358812|NCT01004185|11603894|FG001|Overall Study|Withdrawal by Subject|1
7358813|NCT01004250|11603900|FG000|Induction Therapy Period|Adverse Event|10
7358814|NCT01004250|11603900|FG000|Induction Therapy Period|Entry Criteria Not Met|1
7358815|NCT01004250|11603900|FG000|Induction Therapy Period|Withdrawal by Subject|2
7358816|NCT01004250|11603900|FG000|Induction Therapy Period|Physician Decision|2
7358817|NCT01004250|11603900|FG000|Maintenance Therapy Period|Adverse Event|15
7358818|NCT01004250|11603900|FG000|Maintenance Therapy Period|Lost to Follow-up|1
7358819|NCT01004250|11603900|FG000|Maintenance Therapy Period|Protocol Violation|1
7358820|NCT01004250|11603900|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
7358821|NCT01004250|11603900|FG000|Maintenance Therapy Period|Physician Decision|4
7358822|NCT01004250|11603900|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
7358823|NCT01004406|11603918|FG000|Overall Study|Withdrawal by Subject|2
7358824|NCT01004406|11603919|FG001|Overall Study|Withdrawal by Subject|0
7358825|NCT01004406|11603918|FG000|Overall Study|Lost to Follow-up|1
7358826|NCT01004406|11603919|FG001|Overall Study|Lost to Follow-up|0
7358827|NCT01004432|11603925|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
7358828|NCT01004432|11603926|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7358829|NCT01004432|11603927|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7358830|NCT01004432|11603928|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7358831|NCT01004432|11603929|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
7358832|NCT01004432|11603925|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
7358833|NCT01004432|11603926|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7358834|NCT01004432|11603927|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7358835|NCT01004432|11603928|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7358836|NCT01004432|11603929|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
7358837|NCT01004432|11603925|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
7358838|NCT01004432|11603926|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7358839|NCT01004432|11603927|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7358840|NCT01004432|11603928|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7358841|NCT01004432|11603929|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
7358842|NCT01004432|11603925|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
7358843|NCT01004432|11603926|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7358844|NCT01004432|11603927|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7358845|NCT01004432|11603928|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7358846|NCT01004432|11603929|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
7358847|NCT01004432|11603925|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
7358848|NCT01004432|11603926|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7358849|NCT01004432|11603927|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7358850|NCT01004432|11603928|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7358851|NCT01004432|11603929|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
7358852|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7358853|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
7358854|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
7358855|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
7358856|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
7358857|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7358858|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7358859|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
7358860|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
7358861|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
7358862|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7358863|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
7358864|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
7358865|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
7358866|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
7358867|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7358868|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7358869|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7358870|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
7358871|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
7358872|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7358873|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
7358874|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
7358875|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
7358876|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
7358877|NCT01004432|11603925|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7358878|NCT01004432|11603926|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7358879|NCT01004432|11603927|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
7358880|NCT01004432|11603928|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
7358881|NCT01004432|11603929|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
7358882|NCT01004432|11603925|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
7358883|NCT01004432|11603926|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
7358884|NCT01004432|11603927|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
7358885|NCT01004432|11603928|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
7358886|NCT01004432|11603929|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
7358887|NCT01004432|11603925|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7358888|NCT01004432|11603926|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7358889|NCT01004432|11603927|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7358890|NCT01004432|11603928|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
7358891|NCT01004432|11603929|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
7358892|NCT01004432|11603925|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7358893|NCT01004432|11603926|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7358894|NCT01004432|11603927|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7358895|NCT01004432|11603928|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
7358896|NCT01004432|11603929|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
7358897|NCT01004432|11603925|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7358898|NCT01004432|11603926|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7358899|NCT01004432|11603927|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7358900|NCT01004432|11603928|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
7358901|NCT01004432|11603929|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
7358902|NCT01004614|11603947|FG000|Washout|Withdrawal by Subject|0
7358903|NCT01004614|11603948|FG001|Washout|Withdrawal by Subject|1
7358904|NCT01004614|11603949|FG002|Washout|Withdrawal by Subject|0
7358905|NCT01004614|11603950|FG003|Washout|Withdrawal by Subject|0
7386307|NCT01210144|11644742|FG000|Overall Study|No fertilization|1
7386308|NCT01210144|11644743|FG001|Overall Study|No fertilization|0
7386309|NCT01210144|11644742|FG000|Overall Study|No transfer|1
7386310|NCT01210144|11644743|FG001|Overall Study|No transfer|0
7386311|NCT01210222|11644771|FG000|Overall Study|Ineligible|2
7386312|NCT01210222|11644771|FG000|Overall Study|Never treated|1
7386313|NCT01210352|11644790|FG000|Overall Study|Adverse Event|0
7386314|NCT01210352|11644791|FG001|Overall Study|Adverse Event|0
7386315|NCT01210352|11644792|FG002|Overall Study|Adverse Event|0
7386316|NCT01210352|11644793|FG003|Overall Study|Adverse Event|0
7386317|NCT01210352|11644794|FG004|Overall Study|Adverse Event|0
7386318|NCT01210352|11644795|FG005|Overall Study|Adverse Event|0
7386319|NCT01210352|11644796|FG006|Overall Study|Adverse Event|0
7459958|NCT01823341|11755032|FG000|Overall Study|Withdrawal by Subject|7
7459959|NCT01823341|11755032|FG000|Overall Study|Adverse Event|1
7459960|NCT01823536|11755061|FG000|Overall Study|Lost to Follow-up|1
7459961|NCT01823536|11755062|FG001|Overall Study|Lost to Follow-up|0
7459962|NCT01823536|11755063|FG002|Overall Study|Lost to Follow-up|0
7459963|NCT01823536|11755064|FG003|Overall Study|Lost to Follow-up|1
7459964|NCT01823536|11755065|FG004|Overall Study|Lost to Follow-up|1
7459965|NCT01823536|11755066|FG005|Overall Study|Lost to Follow-up|0
7459966|NCT01823536|11755061|FG000|Overall Study|Protocol Violation|0
7459967|NCT01823536|11755062|FG001|Overall Study|Protocol Violation|1
7459968|NCT01823536|11755063|FG002|Overall Study|Protocol Violation|0
7459969|NCT01823536|11755064|FG003|Overall Study|Protocol Violation|0
7459970|NCT01823536|11755065|FG004|Overall Study|Protocol Violation|0
7459971|NCT01823536|11755066|FG005|Overall Study|Protocol Violation|0
7459973|NCT01823536|11755062|FG001|Overall Study|Withdrawal by Subject|1
7459974|NCT01823536|11755063|FG002|Overall Study|Withdrawal by Subject|0
7459975|NCT01823536|11755064|FG003|Overall Study|Withdrawal by Subject|0
7459976|NCT01823536|11755065|FG004|Overall Study|Withdrawal by Subject|0
7459977|NCT01823536|11755066|FG005|Overall Study|Withdrawal by Subject|0
7459978|NCT01823536|11755061|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
7459979|NCT01823536|11755062|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
7459980|NCT01823536|11755063|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
7459981|NCT01823536|11755064|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
7459982|NCT01823536|11755065|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
7459983|NCT01823536|11755066|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
7459984|NCT01823536|11755061|FG000|Overall Study|Met exclusion criterion No 6|0
7459985|NCT01823536|11755062|FG001|Overall Study|Met exclusion criterion No 6|0
7459986|NCT01823536|11755063|FG002|Overall Study|Met exclusion criterion No 6|0
7459987|NCT01823536|11755064|FG003|Overall Study|Met exclusion criterion No 6|1
7459988|NCT01823536|11755065|FG004|Overall Study|Met exclusion criterion No 6|0
7459989|NCT01823536|11755066|FG005|Overall Study|Met exclusion criterion No 6|0
7459990|NCT01823536|11755061|FG000|Overall Study|Subject moved out of the state|0
7459991|NCT01823536|11755062|FG001|Overall Study|Subject moved out of the state|0
7386320|NCT01210352|11644797|FG007|Overall Study|Adverse Event|2
7386321|NCT01210352|11644798|FG008|Overall Study|Adverse Event|1
7386322|NCT01210352|11644790|FG000|Overall Study|Lack of Efficacy|0
7386323|NCT01210352|11644791|FG001|Overall Study|Lack of Efficacy|0
7386324|NCT01210352|11644792|FG002|Overall Study|Lack of Efficacy|0
7386325|NCT01210352|11644793|FG003|Overall Study|Lack of Efficacy|0
7386326|NCT01210352|11644794|FG004|Overall Study|Lack of Efficacy|0
7358906|NCT01004822|11604007|FG000|Overall Study|Objective progression or relapse|3
7358907|NCT01004822|11604008|FG001|Overall Study|Objective progression or relapse|3
7358908|NCT01004822|11604009|FG002|Overall Study|Objective progression or relapse|0
7358909|NCT01004822|11604010|FG003|Overall Study|Objective progression or relapse|1
7358910|NCT01004822|11604011|FG004|Overall Study|Objective progression or relapse|2
7358911|NCT01004822|11604012|FG005|Overall Study|Objective progression or relapse|2
7358912|NCT01004822|11604013|FG006|Overall Study|Objective progression or relapse|1
7358913|NCT01004822|11604014|FG007|Overall Study|Objective progression or relapse|4
7358914|NCT01004822|11604007|FG000|Overall Study|Global deterioration of health status|0
7358915|NCT01004822|11604008|FG001|Overall Study|Global deterioration of health status|0
7358916|NCT01004822|11604009|FG002|Overall Study|Global deterioration of health status|0
7358917|NCT01004822|11604010|FG003|Overall Study|Global deterioration of health status|1
7358918|NCT01004822|11604011|FG004|Overall Study|Global deterioration of health status|0
7358919|NCT01004822|11604012|FG005|Overall Study|Global deterioration of health status|0
7358920|NCT01004822|11604013|FG006|Overall Study|Global deterioration of health status|1
7358921|NCT01004822|11604014|FG007|Overall Study|Global deterioration of health status|0
7358922|NCT01004822|11604007|FG000|Overall Study|No longer willing to continue|0
7358923|NCT01004822|11604008|FG001|Overall Study|No longer willing to continue|0
7358924|NCT01004822|11604009|FG002|Overall Study|No longer willing to continue|0
7358925|NCT01004822|11604010|FG003|Overall Study|No longer willing to continue|1
7358926|NCT01004822|11604011|FG004|Overall Study|No longer willing to continue|2
7358927|NCT01004822|11604012|FG005|Overall Study|No longer willing to continue|1
7358928|NCT01004822|11604013|FG006|Overall Study|No longer willing to continue|1
7358929|NCT01004822|11604014|FG007|Overall Study|No longer willing to continue|0
7358930|NCT01004822|11604007|FG000|Overall Study|Adverse Event|0
7358931|NCT01004822|11604008|FG001|Overall Study|Adverse Event|0
7358932|NCT01004822|11604009|FG002|Overall Study|Adverse Event|0
7358933|NCT01004822|11604010|FG003|Overall Study|Adverse Event|0
7358934|NCT01004822|11604011|FG004|Overall Study|Adverse Event|0
7358935|NCT01004822|11604012|FG005|Overall Study|Adverse Event|0
7358936|NCT01004822|11604013|FG006|Overall Study|Adverse Event|1
7358937|NCT01004822|11604014|FG007|Overall Study|Adverse Event|1
7358938|NCT01004822|11604007|FG000|Overall Study|Other|0
7358939|NCT01004822|11604008|FG001|Overall Study|Other|0
7358940|NCT01004822|11604009|FG002|Overall Study|Other|4
7358941|NCT01004822|11604010|FG003|Overall Study|Other|1
7358942|NCT01004822|11604011|FG004|Overall Study|Other|0
7358943|NCT01004822|11604012|FG005|Overall Study|Other|1
7358944|NCT01004822|11604013|FG006|Overall Study|Other|0
7358945|NCT01004822|11604014|FG007|Overall Study|Other|0
7358946|NCT01004848|11604036|FG000|Overall Study|Lost to Follow-up|55
7358947|NCT01004848|11604037|FG001|Overall Study|Lost to Follow-up|45
7358948|NCT01005251|11604060|FG000|Overall Study|Withdrawal by Subject|2
7358949|NCT01005251|11604061|FG001|Overall Study|Withdrawal by Subject|5
7358950|NCT01005251|11604062|FG002|Overall Study|Withdrawal by Subject|3
7358951|NCT01005251|11604063|FG003|Overall Study|Withdrawal by Subject|4
7358952|NCT01005251|11604064|FG004|Overall Study|Withdrawal by Subject|9
7358953|NCT01005251|11604060|FG000|Overall Study|Eligibility criteria not fulfilled|4
7358954|NCT01005251|11604061|FG001|Overall Study|Eligibility criteria not fulfilled|0
7358955|NCT01005251|11604062|FG002|Overall Study|Eligibility criteria not fulfilled|4
7358956|NCT01005251|11604063|FG003|Overall Study|Eligibility criteria not fulfilled|1
7358957|NCT01005251|11604064|FG004|Overall Study|Eligibility criteria not fulfilled|0
7358958|NCT01005251|11604060|FG000|Overall Study|Adverse Event|2
7358959|NCT01005251|11604061|FG001|Overall Study|Adverse Event|6
7358960|NCT01005251|11604062|FG002|Overall Study|Adverse Event|8
7358961|NCT01005251|11604063|FG003|Overall Study|Adverse Event|5
7358962|NCT01005251|11604064|FG004|Overall Study|Adverse Event|4
7358963|NCT01005251|11604060|FG000|Overall Study|Protocol Violation|1
7358964|NCT01005251|11604061|FG001|Overall Study|Protocol Violation|0
7358965|NCT01005251|11604062|FG002|Overall Study|Protocol Violation|0
7358966|NCT01005251|11604063|FG003|Overall Study|Protocol Violation|0
7358967|NCT01005251|11604064|FG004|Overall Study|Protocol Violation|2
7358968|NCT01005251|11604060|FG000|Overall Study|Developed study-specific withdrawal crit|2
7358969|NCT01005251|11604061|FG001|Overall Study|Developed study-specific withdrawal crit|0
7358970|NCT01005251|11604062|FG002|Overall Study|Developed study-specific withdrawal crit|3
7358971|NCT01005251|11604063|FG003|Overall Study|Developed study-specific withdrawal crit|0
7358972|NCT01005251|11604064|FG004|Overall Study|Developed study-specific withdrawal crit|1
7459992|NCT01823536|11755063|FG002|Overall Study|Subject moved out of the state|0
7459993|NCT01823536|11755064|FG003|Overall Study|Subject moved out of the state|0
7358973|NCT01005251|11604060|FG000|Overall Study|Lost to Follow-up|1
7358974|NCT01005251|11604061|FG001|Overall Study|Lost to Follow-up|4
7358975|NCT01005251|11604062|FG002|Overall Study|Lost to Follow-up|2
7358976|NCT01005251|11604063|FG003|Overall Study|Lost to Follow-up|0
7358977|NCT01005251|11604064|FG004|Overall Study|Lost to Follow-up|0
7358978|NCT01005251|11604060|FG000|Overall Study|Physician Decision|0
7358979|NCT01005251|11604061|FG001|Overall Study|Physician Decision|0
7358980|NCT01005251|11604062|FG002|Overall Study|Physician Decision|0
7358981|NCT01005251|11604063|FG003|Overall Study|Physician Decision|0
7358982|NCT01005251|11604064|FG004|Overall Study|Physician Decision|2
7358983|NCT01005251|11604060|FG000|Overall Study|Patient moved|1
7358984|NCT01005251|11604061|FG001|Overall Study|Patient moved|0
7358985|NCT01005251|11604062|FG002|Overall Study|Patient moved|0
7358986|NCT01005251|11604063|FG003|Overall Study|Patient moved|0
7358987|NCT01005251|11604064|FG004|Overall Study|Patient moved|0
7358988|NCT01005251|11604060|FG000|Overall Study|Wrong drug dispensed|0
7358989|NCT01005251|11604061|FG001|Overall Study|Wrong drug dispensed|1
7358990|NCT01005251|11604062|FG002|Overall Study|Wrong drug dispensed|0
7358991|NCT01005251|11604063|FG003|Overall Study|Wrong drug dispensed|0
7358992|NCT01005251|11604064|FG004|Overall Study|Wrong drug dispensed|0
7358993|NCT01005251|11604060|FG000|Overall Study|Randomized in error|0
7358994|NCT01005251|11604061|FG001|Overall Study|Randomized in error|0
7358995|NCT01005251|11604062|FG002|Overall Study|Randomized in error|1
7358996|NCT01005251|11604063|FG003|Overall Study|Randomized in error|1
7358997|NCT01005251|11604064|FG004|Overall Study|Randomized in error|0
7358998|NCT01005251|11604060|FG000|Overall Study|Lack of Efficacy|0
7358999|NCT01005251|11604061|FG001|Overall Study|Lack of Efficacy|0
7359000|NCT01005251|11604062|FG002|Overall Study|Lack of Efficacy|1
7359001|NCT01005251|11604063|FG003|Overall Study|Lack of Efficacy|1
7359002|NCT01005251|11604064|FG004|Overall Study|Lack of Efficacy|0
7359003|NCT01005316|11604088|FG000|Overall Study|Adverse Event|0
7359004|NCT01005316|11604089|FG001|Overall Study|Adverse Event|0
7359005|NCT01005316|11604090|FG002|Overall Study|Adverse Event|0
7359006|NCT01005316|11604091|FG003|Overall Study|Adverse Event|1
7359007|NCT01005316|11604088|FG000|Overall Study|Death|20
7359008|NCT01005316|11604089|FG001|Overall Study|Death|5
7359009|NCT01005316|11604090|FG002|Overall Study|Death|1
7359010|NCT01005316|11604091|FG003|Overall Study|Death|15
7359011|NCT01005316|11604088|FG000|Overall Study|Study Termination|5
7359012|NCT01005316|11604089|FG001|Overall Study|Study Termination|63
7359013|NCT01005316|11604090|FG002|Overall Study|Study Termination|9
7359014|NCT01005316|11604091|FG003|Overall Study|Study Termination|85
7359015|NCT01005316|11604088|FG000|Overall Study|Lost to Follow-up|1
7359016|NCT01005316|11604089|FG001|Overall Study|Lost to Follow-up|3
7359017|NCT01005316|11604090|FG002|Overall Study|Lost to Follow-up|0
7359018|NCT01005316|11604091|FG003|Overall Study|Lost to Follow-up|2
7359019|NCT01005316|11604088|FG000|Overall Study|Physician Decision|6
7359020|NCT01005316|11604089|FG001|Overall Study|Physician Decision|0
7359021|NCT01005316|11604090|FG002|Overall Study|Physician Decision|0
7359022|NCT01005316|11604091|FG003|Overall Study|Physician Decision|0
7359023|NCT01005316|11604088|FG000|Overall Study|Sponsor Decision|6
7359024|NCT01005316|11604089|FG001|Overall Study|Sponsor Decision|3
7359025|NCT01005316|11604090|FG002|Overall Study|Sponsor Decision|0
7359026|NCT01005316|11604091|FG003|Overall Study|Sponsor Decision|0
7359027|NCT01005316|11604088|FG000|Overall Study|Withdrawal by Subject|1
7359028|NCT01005316|11604089|FG001|Overall Study|Withdrawal by Subject|1
7359029|NCT01005316|11604090|FG002|Overall Study|Withdrawal by Subject|0
7359030|NCT01005316|11604091|FG003|Overall Study|Withdrawal by Subject|2
7359031|NCT01005316|11604088|FG000|Overall Study|Consented to Another Study|2
7359032|NCT01005316|11604089|FG001|Overall Study|Consented to Another Study|0
7359033|NCT01005316|11604090|FG002|Overall Study|Consented to Another Study|0
7359034|NCT01005316|11604091|FG003|Overall Study|Consented to Another Study|0
7359035|NCT01005316|11604088|FG000|Overall Study|Delisted|8
7359036|NCT01005316|11604089|FG001|Overall Study|Delisted|0
7359037|NCT01005316|11604090|FG002|Overall Study|Delisted|0
7359038|NCT01005316|11604091|FG003|Overall Study|Delisted|0
7359039|NCT01005316|11604088|FG000|Overall Study|Transferred Care|1
7359040|NCT01005316|11604089|FG001|Overall Study|Transferred Care|0
7359041|NCT01005316|11604090|FG002|Overall Study|Transferred Care|1
7359042|NCT01005316|11604091|FG003|Overall Study|Transferred Care|3
7359043|NCT01005316|11604088|FG000|Overall Study|Retransplanted|0
7359044|NCT01005316|11604089|FG001|Overall Study|Retransplanted|1
7359045|NCT01005316|11604090|FG002|Overall Study|Retransplanted|0
7359046|NCT01005316|11604091|FG003|Overall Study|Retransplanted|0
7359047|NCT01005329|11604102|FG000|Overall Study|Ineligible or received no protocol trt.|4
7359048|NCT01005602|11604147|FG000|Overall Study|Excluded due to unreliable clinical data|1
7359049|NCT01005602|11604148|FG001|Overall Study|Excluded due to unreliable clinical data|0
7359050|NCT01005680|11604163|FG000|Overall Study|Lost to Follow-up|4
7359051|NCT01005680|11604164|FG001|Overall Study|Lost to Follow-up|6
7359052|NCT01005680|11604163|FG000|Overall Study|Withdrawal by Subject|1
7359053|NCT01005680|11604164|FG001|Overall Study|Withdrawal by Subject|4
7359054|NCT01005680|11604163|FG000|Overall Study|Physician Decision|1
7359055|NCT01005680|11604164|FG001|Overall Study|Physician Decision|1
7359056|NCT01005719|11604180|FG000|Period 1|Adverse Event|0
7359057|NCT01005719|11604181|FG001|Period 1|Adverse Event|0
7359058|NCT01005719|11604182|FG002|Period 1|Adverse Event|0
7359059|NCT01005719|11604183|FG003|Period 1|Adverse Event|1
7359060|NCT01005719|11604184|FG004|Period 1|Adverse Event|0
7359061|NCT01005719|11604185|FG005|Period 1|Adverse Event|0
7359062|NCT01005719|11604180|FG000|Period 1|Delay in completing study procedures|0
7359063|NCT01005719|11604181|FG001|Period 1|Delay in completing study procedures|0
7359064|NCT01005719|11604182|FG002|Period 1|Delay in completing study procedures|0
7359065|NCT01005719|11604183|FG003|Period 1|Delay in completing study procedures|0
7359066|NCT01005719|11604184|FG004|Period 1|Delay in completing study procedures|0
7359067|NCT01005719|11604185|FG005|Period 1|Delay in completing study procedures|1
7359068|NCT01005719|11604180|FG000|Period 2|Adverse Event|0
7359069|NCT01005719|11604181|FG001|Period 2|Adverse Event|0
7359070|NCT01005719|11604182|FG002|Period 2|Adverse Event|0
7359071|NCT01005719|11604183|FG003|Period 2|Adverse Event|0
7359072|NCT01005719|11604184|FG004|Period 2|Adverse Event|1
7359073|NCT01005719|11604185|FG005|Period 2|Adverse Event|1
7359074|NCT01005732|11604194|FG000|Overall Study|Lost to Follow-up|10
7359075|NCT01005732|11604194|FG000|Overall Study|Death|1
7359076|NCT01005875|11604211|FG000|Overall Study|Death|3
7359077|NCT01005901|11604228|FG000|Overall Study|Withdrawal by Subject|38
7359078|NCT01005901|11604229|FG001|Overall Study|Withdrawal by Subject|14
7359079|NCT01005901|11604228|FG000|Overall Study|Adverse Event|30
7359080|NCT01005901|11604229|FG001|Overall Study|Adverse Event|16
7359081|NCT01005901|11604228|FG000|Overall Study|Administrative problems|21
7359082|NCT01005901|11604229|FG001|Overall Study|Administrative problems|13
7359083|NCT01005901|11604228|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7359084|NCT01005901|11604229|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7359085|NCT01005901|11604228|FG000|Overall Study|Protocol Violation|4
7359086|NCT01005901|11604229|FG001|Overall Study|Protocol Violation|3
7359087|NCT01005901|11604228|FG000|Overall Study|Death|2
7359088|NCT01005901|11604229|FG001|Overall Study|Death|3
7359089|NCT01005901|11604228|FG000|Overall Study|Lost to Follow-up|1
7359090|NCT01005901|11604229|FG001|Overall Study|Lost to Follow-up|2
7359091|NCT01005901|11604228|FG000|Overall Study|Patient's inability to use the device|1
7359092|NCT01005901|11604229|FG001|Overall Study|Patient's inability to use the device|1
7359093|NCT01005901|11604228|FG000|Overall Study|No longer requires study drug|0
7359094|NCT01005901|11604229|FG001|Overall Study|No longer requires study drug|1
7359095|NCT01005966|11604235|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7359096|NCT01005966|11604236|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7359097|NCT01005966|11604237|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
7359098|NCT01005966|11604238|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
7359099|NCT01005966|11604239|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
7359100|NCT01005966|11604235|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
7359101|NCT01005966|11604236|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
7359102|NCT01005966|11604237|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
7359103|NCT01005966|11604238|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
7359104|NCT01005966|11604239|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
7359105|NCT01005966|11604235|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7359106|NCT01005966|11604236|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7359107|NCT01005966|11604237|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7359108|NCT01005966|11604238|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
7359109|NCT01005966|11604239|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
7359110|NCT01005966|11604235|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
7359111|NCT01005966|11604236|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
7359112|NCT01005966|11604237|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
7359113|NCT01005966|11604238|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
7359114|NCT01005966|11604239|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
7359115|NCT01005966|11604235|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
7359116|NCT01005966|11604236|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
7359117|NCT01005966|11604237|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
7359118|NCT01005966|11604238|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
7359119|NCT01005966|11604239|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
7359120|NCT01005966|11604235|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7359121|NCT01005966|11604236|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7359122|NCT01005966|11604237|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
7359123|NCT01005966|11604238|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7359124|NCT01005966|11604239|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
7359125|NCT01005966|11604235|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
7359126|NCT01005966|11604236|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
7359127|NCT01005966|11604237|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
7359128|NCT01005966|11604238|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
7359129|NCT01005966|11604239|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
7359130|NCT01005966|11604235|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
7359131|NCT01005966|11604236|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
7359132|NCT01005966|11604237|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
7359133|NCT01005966|11604238|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
7359134|NCT01005966|11604239|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
7359135|NCT01005966|11604235|FG000|Treatment Period 4 (14 Days)|Other Reason|0
7359136|NCT01005966|11604236|FG001|Treatment Period 4 (14 Days)|Other Reason|0
7359137|NCT01005966|11604237|FG002|Treatment Period 4 (14 Days)|Other Reason|0
7359138|NCT01005966|11604238|FG003|Treatment Period 4 (14 Days)|Other Reason|0
7359139|NCT01005966|11604239|FG004|Treatment Period 4 (14 Days)|Other Reason|1
7359140|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
7359141|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
7359142|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Protocol Violation|1
7359143|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Protocol Violation|1
7359144|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Pregnancy|0
7359145|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Pregnancy|1
7359146|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
7359147|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
7386327|NCT01210352|11644795|FG005|Overall Study|Lack of Efficacy|0
7359148|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
7359149|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
7359150|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
7359151|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
7359152|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Other|3
7359153|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Other|0
7359154|NCT01006122|11604256|FG000|First Double-blind Intervention Period|Adverse Event|0
7359155|NCT01006122|11604257|FG001|First Double-blind Intervention Period|Adverse Event|4
7359156|NCT01006122|11604256|FG000|Second Double-blind Intervention Period|Adverse Event|1
7359157|NCT01006122|11604257|FG001|Second Double-blind Intervention Period|Adverse Event|1
7359158|NCT01006122|11604256|FG000|Second Double-blind Intervention Period|Protocol Violation|1
7359159|NCT01006122|11604257|FG001|Second Double-blind Intervention Period|Protocol Violation|0
7359160|NCT01006122|11604256|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
7359161|NCT01006122|11604257|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
7359162|NCT01006122|11604256|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
7359163|NCT01006122|11604257|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
7359164|NCT01006122|11604256|FG000|Second Double-blind Intervention Period|Death|0
7359165|NCT01006122|11604257|FG001|Second Double-blind Intervention Period|Death|1
7359166|NCT01006135|11604263|FG000|Overall Study|Adverse Event|22
7359167|NCT01006135|11604263|FG000|Overall Study|Protocol Violation|14
7359168|NCT01006135|11604263|FG000|Overall Study|Lost to Follow-up|32
7359169|NCT01006135|11604263|FG000|Overall Study|Other|72
7359170|NCT01006291|11604283|FG000|Overall Study|Adverse Event|2
7359171|NCT01006291|11604284|FG001|Overall Study|Adverse Event|1
7359172|NCT01006291|11604285|FG002|Overall Study|Adverse Event|2
7359173|NCT01006291|11604283|FG000|Overall Study|Lack of Efficacy|2
7359174|NCT01006291|11604284|FG001|Overall Study|Lack of Efficacy|2
7359175|NCT01006291|11604285|FG002|Overall Study|Lack of Efficacy|1
7359176|NCT01006291|11604283|FG000|Overall Study|Protocol Violation|3
7359177|NCT01006291|11604284|FG001|Overall Study|Protocol Violation|3
7359178|NCT01006291|11604285|FG002|Overall Study|Protocol Violation|3
7359179|NCT01006291|11604283|FG000|Overall Study|Withdrawal criteria|5
7359180|NCT01006291|11604284|FG001|Overall Study|Withdrawal criteria|4
7359181|NCT01006291|11604285|FG002|Overall Study|Withdrawal criteria|4
7359182|NCT01006291|11604283|FG000|Overall Study|Other|14
7359183|NCT01006291|11604284|FG001|Overall Study|Other|14
7359184|NCT01006291|11604285|FG002|Overall Study|Other|17
7359185|NCT01006356|11604293|FG000|Overall Study|Adverse Event|6
7359186|NCT01006356|11604293|FG000|Overall Study|Physician Decision|1
7359187|NCT01006356|11604293|FG000|Overall Study|Paticipants did not cooperate|6
7359188|NCT01006356|11604293|FG000|Overall Study|Withdrawal by Subject|1
7359189|NCT01006356|11604293|FG000|Overall Study|Choice by participants|2
7359190|NCT01006356|11604293|FG000|Overall Study|Protocol Violation|3
7359191|NCT01006356|11604293|FG000|Overall Study|Other|23
7359192|NCT01006590|11604316|FG000|Overall Study|Adverse Event|2
7359193|NCT01006590|11604317|FG001|Overall Study|Adverse Event|3
7359194|NCT01006590|11604316|FG000|Overall Study|Death|1
7359195|NCT01006590|11604317|FG001|Overall Study|Death|1
7359196|NCT01006590|11604316|FG000|Overall Study|Lost to Follow-up|1
7359197|NCT01006590|11604317|FG001|Overall Study|Lost to Follow-up|1
7359198|NCT01006590|11604316|FG000|Overall Study|Protocol Violation|1
7359199|NCT01006590|11604317|FG001|Overall Study|Protocol Violation|0
7359200|NCT01006590|11604316|FG000|Overall Study|Withdrawal by Subject|4
7359201|NCT01006590|11604317|FG001|Overall Study|Withdrawal by Subject|2
7359202|NCT01006590|11604316|FG000|Overall Study|Study specific discontinuation criteria|16
7359203|NCT01006590|11604317|FG001|Overall Study|Study specific discontinuation criteria|23
7359204|NCT01006590|11604316|FG000|Overall Study|Other|3
7359205|NCT01006590|11604317|FG001|Overall Study|Other|2
7359206|NCT01006603|11604325|FG000|Overall Study|Withdrawal by Subject|17
7359207|NCT01006603|11604326|FG001|Overall Study|Withdrawal by Subject|19
7359208|NCT01006603|11604325|FG000|Overall Study|Lost to Follow-up|0
7359209|NCT01006603|11604326|FG001|Overall Study|Lost to Follow-up|1
7359210|NCT01006603|11604325|FG000|Overall Study|Safety reason|1
7359211|NCT01006603|11604326|FG001|Overall Study|Safety reason|1
7359212|NCT01006603|11604325|FG000|Overall Study|Protocol Violation|1
7359213|NCT01006603|11604326|FG001|Overall Study|Protocol Violation|3
7359214|NCT01006603|11604325|FG000|Overall Study|Incorrect enrolment|0
7359215|NCT01006603|11604326|FG001|Overall Study|Incorrect enrolment|2
7359216|NCT01006603|11604325|FG000|Overall Study|Adverse Event|15
7359217|NCT01006603|11604326|FG001|Overall Study|Adverse Event|7
7359218|NCT01006603|11604325|FG000|Overall Study|Death|1
7359219|NCT01006603|11604326|FG001|Overall Study|Death|1
7359220|NCT01006603|11604325|FG000|Overall Study|Study specific discontinuation criteria|33
7359221|NCT01006603|11604326|FG001|Overall Study|Study specific discontinuation criteria|34
7359222|NCT01006603|11604325|FG000|Overall Study|Other|3
7359223|NCT01006603|11604326|FG001|Overall Study|Other|7
7359224|NCT01006616|11604336|FG000|Period 1 (6 Months)|Adverse Event|10
7359225|NCT01006616|11604337|FG001|Period 1 (6 Months)|Adverse Event|31
7359226|NCT01006616|11604338|FG002|Period 1 (6 Months)|Adverse Event|37
7359227|NCT01006616|11604339|FG003|Period 1 (6 Months)|Adverse Event|9
7359228|NCT01006616|11604336|FG000|Period 1 (6 Months)|Lack of Efficacy|3
7359229|NCT01006616|11604337|FG001|Period 1 (6 Months)|Lack of Efficacy|4
7359230|NCT01006616|11604338|FG002|Period 1 (6 Months)|Lack of Efficacy|0
7359231|NCT01006616|11604339|FG003|Period 1 (6 Months)|Lack of Efficacy|4
7359232|NCT01006616|11604336|FG000|Period 1 (6 Months)|Lost to Follow-up|0
7359233|NCT01006616|11604337|FG001|Period 1 (6 Months)|Lost to Follow-up|0
7359234|NCT01006616|11604338|FG002|Period 1 (6 Months)|Lost to Follow-up|1
7359235|NCT01006616|11604339|FG003|Period 1 (6 Months)|Lost to Follow-up|0
7359236|NCT01006616|11604336|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
7359237|NCT01006616|11604337|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
7359238|NCT01006616|11604338|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
7359239|NCT01006616|11604339|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
7359240|NCT01006616|11604336|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
7359241|NCT01006616|11604337|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
7359242|NCT01006616|11604338|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
7359243|NCT01006616|11604339|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
7359244|NCT01006616|11604336|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
7359245|NCT01006616|11604337|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
7359246|NCT01006616|11604338|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
7359247|NCT01006616|11604339|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
7359248|NCT01006616|11604336|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7359249|NCT01006616|11604337|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
7359250|NCT01006616|11604338|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7359251|NCT01006616|11604339|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
7359252|NCT01006616|11604336|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
7359253|NCT01006616|11604337|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
7359254|NCT01006616|11604338|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
7359255|NCT01006616|11604339|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
7359256|NCT01006616|11604336|FG000|Period 1 (6 Months)|Not Treated|0
7359257|NCT01006616|11604337|FG001|Period 1 (6 Months)|Not Treated|0
7359258|NCT01006616|11604338|FG002|Period 1 (6 Months)|Not Treated|1
7359259|NCT01006616|11604339|FG003|Period 1 (6 Months)|Not Treated|1
7359260|NCT01006616|11604336|FG000|Period 2 (18 Months)|Adverse Event|6
7359261|NCT01006616|11604337|FG001|Period 2 (18 Months)|Adverse Event|6
7359262|NCT01006616|11604338|FG002|Period 2 (18 Months)|Adverse Event|6
7359263|NCT01006616|11604339|FG003|Period 2 (18 Months)|Adverse Event|4
7359264|NCT01006616|11604336|FG000|Period 2 (18 Months)|Lack of Efficacy|0
7359265|NCT01006616|11604337|FG001|Period 2 (18 Months)|Lack of Efficacy|0
7359266|NCT01006616|11604338|FG002|Period 2 (18 Months)|Lack of Efficacy|1
7359267|NCT01006616|11604339|FG003|Period 2 (18 Months)|Lack of Efficacy|2
7359268|NCT01006616|11604336|FG000|Period 2 (18 Months)|Lost to Follow-up|2
7359269|NCT01006616|11604337|FG001|Period 2 (18 Months)|Lost to Follow-up|0
7359270|NCT01006616|11604338|FG002|Period 2 (18 Months)|Lost to Follow-up|0
7359271|NCT01006616|11604339|FG003|Period 2 (18 Months)|Lost to Follow-up|0
7359272|NCT01006616|11604336|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7359273|NCT01006616|11604337|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
7359274|NCT01006616|11604338|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
7359275|NCT01006616|11604339|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
7359276|NCT01006616|11604336|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
7359277|NCT01006616|11604337|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
7359278|NCT01006616|11604338|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
7359279|NCT01006616|11604339|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
7359280|NCT01006616|11604336|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
7359281|NCT01006616|11604337|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
7359282|NCT01006616|11604338|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
7359283|NCT01006616|11604339|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
7359284|NCT01006616|11604336|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
7359285|NCT01006616|11604337|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
7359286|NCT01006616|11604338|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
7359287|NCT01006616|11604339|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
7359288|NCT01006616|11604336|FG000|Period 2 (18 Months)|Study Terminated|63
7359289|NCT01006616|11604337|FG001|Period 2 (18 Months)|Study Terminated|46
7359290|NCT01006616|11604338|FG002|Period 2 (18 Months)|Study Terminated|44
7359291|NCT01006616|11604339|FG003|Period 2 (18 Months)|Study Terminated|70
7359292|NCT01006629|11604349|FG000|Overall Study|Adverse Event|1
7359293|NCT01006629|11604349|FG000|Overall Study|Parent refused to continue participation|1
7359294|NCT01006629|11604349|FG000|Overall Study|Parent unable to perform site visit|4
7359295|NCT01006707|11604362|FG000|Study Session 1|Lost to Follow-up|2
7359296|NCT01006707|11604363|FG001|Study Session 1|Lost to Follow-up|0
7359297|NCT01006707|11604364|FG002|Study Session 1|Lost to Follow-up|0
7359298|NCT01006707|11604362|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
7359299|NCT01006707|11604363|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
7359300|NCT01006707|11604364|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
7359301|NCT01006889|11604372|FG000|Overall Study|Withdrawal by Subject|3
7359302|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
7359303|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
7359304|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
7359305|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
7359306|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Death|13
7359307|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Death|12
7359308|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Progression|257
7359309|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Progression|218
7359310|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
7359311|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
7359312|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
7359313|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
7359314|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
7359315|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
7359316|NCT01006980|11604390|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
7359317|NCT01006980|11604391|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
7359318|NCT01006980|11604390|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
7359319|NCT01006980|11604391|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
7359320|NCT01006980|11604390|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
7359321|NCT01006980|11604391|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
7359322|NCT01006980|11604390|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
7359323|NCT01006980|11604391|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
7359324|NCT01006980|11604390|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
7359325|NCT01006980|11604391|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
7359326|NCT01006980|11604390|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
7359327|NCT01006980|11604391|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
7359328|NCT01007032|11604402|FG000|Overall Study|On Study Treatment at Cut-off Date|0
7359329|NCT01007032|11604403|FG001|Overall Study|On Study Treatment at Cut-off Date|1
7359330|NCT01007032|11604404|FG002|Overall Study|On Study Treatment at Cut-off Date|1
7359331|NCT01007032|11604405|FG003|Overall Study|On Study Treatment at Cut-off Date|0
7359332|NCT01007032|11604402|FG000|Overall Study|Withdrawal by Subject|0
7359333|NCT01007032|11604403|FG001|Overall Study|Withdrawal by Subject|0
7359334|NCT01007032|11604404|FG002|Overall Study|Withdrawal by Subject|0
7359335|NCT01007032|11604405|FG003|Overall Study|Withdrawal by Subject|1
7359336|NCT01007123|11604444|FG000|Overall Study|Adverse Event|3
7359337|NCT01007123|11604445|FG001|Overall Study|Adverse Event|4
7359338|NCT01007123|11604446|FG002|Overall Study|Adverse Event|7
7359339|NCT01007123|11604447|FG003|Overall Study|Adverse Event|1
7359340|NCT01007123|11604444|FG000|Overall Study|Lack of Efficacy|1
7359341|NCT01007123|11604445|FG001|Overall Study|Lack of Efficacy|0
7359342|NCT01007123|11604446|FG002|Overall Study|Lack of Efficacy|1
7359343|NCT01007123|11604447|FG003|Overall Study|Lack of Efficacy|4
7359344|NCT01007123|11604444|FG000|Overall Study|Protocol Violation|1
7359345|NCT01007123|11604445|FG001|Overall Study|Protocol Violation|1
7359346|NCT01007123|11604446|FG002|Overall Study|Protocol Violation|2
7359347|NCT01007123|11604447|FG003|Overall Study|Protocol Violation|1
7359348|NCT01007123|11604444|FG000|Overall Study|Withdrawal by Subject|1
7359349|NCT01007123|11604445|FG001|Overall Study|Withdrawal by Subject|0
7359350|NCT01007123|11604446|FG002|Overall Study|Withdrawal by Subject|1
7359351|NCT01007123|11604447|FG003|Overall Study|Withdrawal by Subject|0
7359352|NCT01007123|11604444|FG000|Overall Study|Lost to Follow-up|0
7359353|NCT01007123|11604445|FG001|Overall Study|Lost to Follow-up|1
7359354|NCT01007123|11604446|FG002|Overall Study|Lost to Follow-up|0
7359355|NCT01007123|11604447|FG003|Overall Study|Lost to Follow-up|0
7359356|NCT01007149|11604480|FG000|Overall Study|Administrative problems|0
7359357|NCT01007149|11604481|FG001|Overall Study|Administrative problems|1
7359358|NCT01007253|11604487|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
7359359|NCT01007253|11604488|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
7359360|NCT01007253|11604489|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
7359361|NCT01007253|11604490|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
7359362|NCT01007396|11604500|FG000|Overall Study|Lost to Follow-up|47
7359363|NCT01007435|11604508|FG000|Overall Study|Adverse Event|16
7359364|NCT01007435|11604509|FG001|Overall Study|Adverse Event|25
7359365|NCT01007435|11604510|FG002|Overall Study|Adverse Event|47
7359366|NCT01007435|11604511|FG003|Overall Study|Adverse Event|31
7359367|NCT01007435|11604508|FG000|Overall Study|Death|2
7359368|NCT01007435|11604509|FG001|Overall Study|Death|4
7359369|NCT01007435|11604510|FG002|Overall Study|Death|2
7359370|NCT01007435|11604511|FG003|Overall Study|Death|1
7359371|NCT01007435|11604508|FG000|Overall Study|Insufficient Therapeutic Response|21
7359372|NCT01007435|11604509|FG001|Overall Study|Insufficient Therapeutic Response|7
7359373|NCT01007435|11604510|FG002|Overall Study|Insufficient Therapeutic Response|2
7359374|NCT01007435|11604511|FG003|Overall Study|Insufficient Therapeutic Response|9
7359375|NCT01007435|11604508|FG000|Overall Study|Violation of Selection Criteria at Entry|3
7359376|NCT01007435|11604509|FG001|Overall Study|Violation of Selection Criteria at Entry|5
7359377|NCT01007435|11604510|FG002|Overall Study|Violation of Selection Criteria at Entry|2
7359378|NCT01007435|11604511|FG003|Overall Study|Violation of Selection Criteria at Entry|0
7359379|NCT01007435|11604508|FG000|Overall Study|Other Protocol Violation|2
7359380|NCT01007435|11604509|FG001|Overall Study|Other Protocol Violation|0
7359381|NCT01007435|11604510|FG002|Overall Study|Other Protocol Violation|1
7359382|NCT01007435|11604511|FG003|Overall Study|Other Protocol Violation|0
7359383|NCT01007435|11604508|FG000|Overall Study|Refused Treatment|13
7359384|NCT01007435|11604509|FG001|Overall Study|Refused Treatment|13
7359385|NCT01007435|11604510|FG002|Overall Study|Refused Treatment|5
7359386|NCT01007435|11604511|FG003|Overall Study|Refused Treatment|8
7359387|NCT01007435|11604508|FG000|Overall Study|Failure to Return|5
7359388|NCT01007435|11604509|FG001|Overall Study|Failure to Return|4
7359389|NCT01007435|11604510|FG002|Overall Study|Failure to Return|3
7359390|NCT01007435|11604511|FG003|Overall Study|Failure to Return|6
7359391|NCT01007435|11604508|FG000|Overall Study|Reason not Specified|1
7359392|NCT01007435|11604509|FG001|Overall Study|Reason not Specified|1
7359393|NCT01007435|11604510|FG002|Overall Study|Reason not Specified|2
7359394|NCT01007435|11604511|FG003|Overall Study|Reason not Specified|1
7359395|NCT01007448|11604523|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
7359396|NCT01007448|11604524|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
7359397|NCT01007448|11604523|FG000|Overall Study|Staph Skin Infection Flare|1
7359398|NCT01007448|11604524|FG001|Overall Study|Staph Skin Infection Flare|0
7359399|NCT01007448|11604523|FG000|Overall Study|Participant Leaving the Country|1
7359400|NCT01007448|11604524|FG001|Overall Study|Participant Leaving the Country|0
7359401|NCT01007448|11604523|FG000|Overall Study|Participant Given Prohibited Medication|1
7359402|NCT01007448|11604524|FG001|Overall Study|Participant Given Prohibited Medication|0
7359403|NCT01007448|11604523|FG000|Overall Study|Progressive Disease|1
7359404|NCT01007448|11604524|FG001|Overall Study|Progressive Disease|2
7359405|NCT01007448|11604523|FG000|Overall Study|Lack of Efficacy|2
7359406|NCT01007448|11604524|FG001|Overall Study|Lack of Efficacy|0
7359407|NCT01007448|11604523|FG000|Overall Study|Withdrawal by Subject|2
7359408|NCT01007448|11604524|FG001|Overall Study|Withdrawal by Subject|3
7359409|NCT01007448|11604523|FG000|Overall Study|Adverse Event|1
7359410|NCT01007448|11604524|FG001|Overall Study|Adverse Event|4
7359411|NCT01007552|11604534|FG000|Overall Study|Withdrawal by Subject|1
7359412|NCT01007812|11604560|FG000|Period 1, One Week|Lost to Follow-up|0
7359413|NCT01007812|11604561|FG001|Period 1, One Week|Lost to Follow-up|1
7359414|NCT01007812|11604560|FG000|Period 1, One Week|Discomfort|1
7359415|NCT01007812|11604561|FG001|Period 1, One Week|Discomfort|0
7359416|NCT01007838|11604571|FG000|Overall Study|Withdrawal by Subject|1
7359417|NCT01007838|11604572|FG001|Overall Study|Withdrawal by Subject|0
7359418|NCT01007838|11604573|FG002|Overall Study|Withdrawal by Subject|0
7359419|NCT01007838|11604574|FG003|Overall Study|Withdrawal by Subject|0
7359420|NCT01007838|11604571|FG000|Overall Study|Physician Decision|1
7359421|NCT01007838|11604572|FG001|Overall Study|Physician Decision|0
7359422|NCT01007838|11604573|FG002|Overall Study|Physician Decision|0
7359423|NCT01007838|11604574|FG003|Overall Study|Physician Decision|0
7359424|NCT01007838|11604571|FG000|Overall Study|Started home haemodialysis|1
7359425|NCT01007838|11604572|FG001|Overall Study|Started home haemodialysis|0
7359426|NCT01007838|11604573|FG002|Overall Study|Started home haemodialysis|0
7359427|NCT01007838|11604574|FG003|Overall Study|Started home haemodialysis|0
7359428|NCT01007916|11604584|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
7359429|NCT01007916|11604585|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
7359430|NCT01007916|11604584|FG000|Period 2, 4 Weeks of Wear|Relocation|1
7359431|NCT01007916|11604585|FG001|Period 2, 4 Weeks of Wear|Relocation|0
7359432|NCT01007942|11604593|FG000|Overall Study|Adverse Event|29
7359433|NCT01007942|11604594|FG001|Overall Study|Adverse Event|14
7359434|NCT01007942|11604593|FG000|Overall Study|Abnormal test procedure|0
7359435|NCT01007942|11604594|FG001|Overall Study|Abnormal test procedure|1
7359436|NCT01007942|11604593|FG000|Overall Study|Disease progression|217
7359437|NCT01007942|11604594|FG001|Overall Study|Disease progression|242
7359438|NCT01007942|11604593|FG000|Overall Study|New cancer therapy|5
7359439|NCT01007942|11604594|FG001|Overall Study|New cancer therapy|1
7359440|NCT01007942|11604593|FG000|Overall Study|Protocol Violation|1
7359441|NCT01007942|11604594|FG001|Overall Study|Protocol Violation|1
7359442|NCT01007942|11604593|FG000|Overall Study|Withdrawal by Subject|19
7359443|NCT01007942|11604594|FG001|Overall Study|Withdrawal by Subject|14
7459994|NCT01823536|11755065|FG004|Overall Study|Subject moved out of the state|1
7459995|NCT01823536|11755066|FG005|Overall Study|Subject moved out of the state|0
7459996|NCT01823679|11755117|FG000|Overall Study|Death|1
7459997|NCT01823835|11755137|FG000|Overall Study|Adverse Event|0
7459998|NCT01823835|11755138|FG001|Overall Study|Adverse Event|0
7569633|NCT03457727|11946217|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7569634|NCT03457727|11946218|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7569635|NCT03457727|11946219|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
7569636|NCT03457727|11946220|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
7569637|NCT03458702|11946256|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
7569638|NCT03458702|11946257|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
7569639|NCT03458702|11946256|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
7569640|NCT03458702|11946257|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
7569641|NCT03459040|11946267|FG000|Overall Study|Death|8
7359444|NCT01007942|11604593|FG000|Overall Study|Lost to Follow-up|1
7359445|NCT01007942|11604594|FG001|Overall Study|Lost to Follow-up|0
7359446|NCT01007942|11604593|FG000|Overall Study|Administrative problems|2
7359447|NCT01007942|11604594|FG001|Overall Study|Administrative problems|0
7359448|NCT01007942|11604593|FG000|Overall Study|Death|3
7359449|NCT01007942|11604594|FG001|Overall Study|Death|2
7359450|NCT01007942|11604593|FG000|Overall Study|Patients untreated|4
7459999|NCT01823835|11755139|FG002|Overall Study|Adverse Event|0
7460000|NCT01823835|11755140|FG003|Overall Study|Adverse Event|0
7359451|NCT01007942|11604594|FG001|Overall Study|Patients untreated|3
7359452|NCT01008150|11604635|FG000|Overall Study|did not receive study drug|1
7359453|NCT01008150|11604636|FG001|Overall Study|did not receive study drug|1
7359454|NCT01008150|11604637|FG002|Overall Study|did not receive study drug|1
7359455|NCT01008150|11604638|FG003|Overall Study|did not receive study drug|0
7359456|NCT01008410|11604673|FG000|Overall Study|Adverse Event|13
7359457|NCT01008410|11604674|FG001|Overall Study|Adverse Event|7
7359458|NCT01008410|11604673|FG000|Overall Study|Withdrawal by Subject|6
7359459|NCT01008410|11604674|FG001|Overall Study|Withdrawal by Subject|2
7359460|NCT01008410|11604673|FG000|Overall Study|Lost to Follow-up|1
7359461|NCT01008410|11604674|FG001|Overall Study|Lost to Follow-up|0
7359462|NCT01008410|11604673|FG000|Overall Study|Noncompliance|1
7359463|NCT01008410|11604674|FG001|Overall Study|Noncompliance|0
7359464|NCT01008410|11604673|FG000|Overall Study|Low Cortisol|2
7569642|NCT03459040|11946267|FG000|Overall Study|Withdrawal by Subject|1
7569643|NCT03459196|11946279|FG000|Overall Study|Subject didn't receive study catheter|2
7569644|NCT03461146|11946340|FG000|Overall Study|Adverse Event|2
7569645|NCT03461146|11946340|FG000|Overall Study|Physician Decision|1
7359465|NCT01008410|11604674|FG001|Overall Study|Low Cortisol|0
7359466|NCT01008410|11604673|FG000|Overall Study|Lack of Efficacy|2
7359467|NCT01008410|11604674|FG001|Overall Study|Lack of Efficacy|6
7359468|NCT01008410|11604673|FG000|Overall Study|Met Exclusion Criterion|0
7359469|NCT01008410|11604674|FG001|Overall Study|Met Exclusion Criterion|1
7359470|NCT01008423|11604682|FG000|Overall Study|Adverse Event|13
7359471|NCT01008423|11604683|FG001|Overall Study|Adverse Event|6
7359472|NCT01008423|11604682|FG000|Overall Study|Withdrawal by Subject|4
7359473|NCT01008423|11604683|FG001|Overall Study|Withdrawal by Subject|7
7359474|NCT01008423|11604682|FG000|Overall Study|Lost to Follow-up|0
7359475|NCT01008423|11604683|FG001|Overall Study|Lost to Follow-up|2
7359476|NCT01008423|11604682|FG000|Overall Study|Low Cortisol|0
7460001|NCT01823835|11755141|FG004|Overall Study|Adverse Event|1
7460002|NCT01823835|11755142|FG005|Overall Study|Adverse Event|0
7460003|NCT01823835|11755143|FG006|Overall Study|Adverse Event|1
7460004|NCT01823835|11755144|FG007|Overall Study|Adverse Event|0
7460005|NCT01823835|11755145|FG008|Overall Study|Adverse Event|0
7460006|NCT01823835|11755146|FG009|Overall Study|Adverse Event|0
7460007|NCT01823835|11755147|FG010|Overall Study|Adverse Event|1
7460008|NCT01823835|11755148|FG011|Overall Study|Adverse Event|2
7460009|NCT01823835|11755149|FG012|Overall Study|Adverse Event|0
7460010|NCT01823835|11755150|FG013|Overall Study|Adverse Event|0
7460011|NCT01823835|11755151|FG014|Overall Study|Adverse Event|0
7460012|NCT01823835|11755137|FG000|Overall Study|Physician Decision|0
7460013|NCT01823835|11755138|FG001|Overall Study|Physician Decision|0
7460014|NCT01823835|11755139|FG002|Overall Study|Physician Decision|0
7460015|NCT01823835|11755140|FG003|Overall Study|Physician Decision|0
7460016|NCT01823835|11755141|FG004|Overall Study|Physician Decision|0
7460017|NCT01823835|11755142|FG005|Overall Study|Physician Decision|0
7460018|NCT01823835|11755143|FG006|Overall Study|Physician Decision|0
7460019|NCT01823835|11755144|FG007|Overall Study|Physician Decision|0
7460020|NCT01823835|11755145|FG008|Overall Study|Physician Decision|0
7460021|NCT01823835|11755146|FG009|Overall Study|Physician Decision|0
7460022|NCT01823835|11755147|FG010|Overall Study|Physician Decision|0
7460023|NCT01823835|11755148|FG011|Overall Study|Physician Decision|2
7460024|NCT01823835|11755149|FG012|Overall Study|Physician Decision|0
7460025|NCT01823835|11755150|FG013|Overall Study|Physician Decision|0
7460026|NCT01823835|11755151|FG014|Overall Study|Physician Decision|0
7460027|NCT01823835|11755137|FG000|Overall Study|Progressive Disease|3
7460028|NCT01823835|11755138|FG001|Overall Study|Progressive Disease|4
7460029|NCT01823835|11755139|FG002|Overall Study|Progressive Disease|3
7460030|NCT01823835|11755140|FG003|Overall Study|Progressive Disease|6
7460031|NCT01823835|11755141|FG004|Overall Study|Progressive Disease|4
7460032|NCT01823835|11755142|FG005|Overall Study|Progressive Disease|6
7460033|NCT01823835|11755143|FG006|Overall Study|Progressive Disease|5
7460034|NCT01823835|11755144|FG007|Overall Study|Progressive Disease|3
7460035|NCT01823835|11755145|FG008|Overall Study|Progressive Disease|3
7460036|NCT01823835|11755146|FG009|Overall Study|Progressive Disease|18
7460037|NCT01823835|11755147|FG010|Overall Study|Progressive Disease|8
7460038|NCT01823835|11755148|FG011|Overall Study|Progressive Disease|46
7460039|NCT01823835|11755149|FG012|Overall Study|Progressive Disease|18
7460040|NCT01823835|11755150|FG013|Overall Study|Progressive Disease|4
7460041|NCT01823835|11755151|FG014|Overall Study|Progressive Disease|6
7460042|NCT01823835|11755137|FG000|Overall Study|Study Termination|0
7460043|NCT01823835|11755138|FG001|Overall Study|Study Termination|0
7460044|NCT01823835|11755139|FG002|Overall Study|Study Termination|0
7460045|NCT01823835|11755140|FG003|Overall Study|Study Termination|0
7460046|NCT01823835|11755141|FG004|Overall Study|Study Termination|1
7460047|NCT01823835|11755142|FG005|Overall Study|Study Termination|0
7359477|NCT01008423|11604683|FG001|Overall Study|Low Cortisol|1
7359478|NCT01008423|11604682|FG000|Overall Study|Lack of Efficacy|0
7359479|NCT01008423|11604683|FG001|Overall Study|Lack of Efficacy|5
7460048|NCT01823835|11755143|FG006|Overall Study|Study Termination|0
7460049|NCT01823835|11755144|FG007|Overall Study|Study Termination|0
7460050|NCT01823835|11755145|FG008|Overall Study|Study Termination|0
7460051|NCT01823835|11755146|FG009|Overall Study|Study Termination|0
7460052|NCT01823835|11755147|FG010|Overall Study|Study Termination|0
7460053|NCT01823835|11755148|FG011|Overall Study|Study Termination|1
7460054|NCT01823835|11755149|FG012|Overall Study|Study Termination|0
7359480|NCT01008423|11604682|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
7359481|NCT01008423|11604683|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
7359482|NCT01008423|11604682|FG000|Overall Study|Personal Conflict|1
7359483|NCT01008423|11604683|FG001|Overall Study|Personal Conflict|0
7359484|NCT01008423|11604682|FG000|Overall Study|Other|0
7359485|NCT01008423|11604683|FG001|Overall Study|Other|1
7359486|NCT01008449|11604691|FG000|Overall Study|Lost to Follow-up|29
7359487|NCT01008449|11604692|FG001|Overall Study|Lost to Follow-up|19
7359488|NCT01008475|11604709|FG000|Overall Study|Ongoing treatment at data cut-off date|0
7359489|NCT01008475|11604710|FG001|Overall Study|Ongoing treatment at data cut-off date|0
7359490|NCT01008475|11604711|FG002|Overall Study|Ongoing treatment at data cut-off date|0
7359491|NCT01008475|11604712|FG003|Overall Study|Ongoing treatment at data cut-off date|0
7359492|NCT01008475|11604713|FG004|Overall Study|Ongoing treatment at data cut-off date|5
7359493|NCT01008475|11604714|FG005|Overall Study|Ongoing treatment at data cut-off date|6
7359494|NCT01008475|11604715|FG006|Overall Study|Ongoing treatment at data cut-off date|4
7359495|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Physician Decision|2
7359496|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Physician Decision|0
7359497|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Physician Decision|0
7359498|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Adverse Event|33
7359499|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Adverse Event|0
7359500|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Adverse Event|0
7359501|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
7359502|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
7359503|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
7359504|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
7359505|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
7359506|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
7359507|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
7359508|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7359509|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7359510|NCT01008553|11604731|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
7359511|NCT01008553|11604732|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
7359512|NCT01008553|11604733|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
7359513|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
7359514|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
7359515|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
7359516|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
7359517|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
7359518|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
7359519|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7359520|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7359521|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7359522|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7359523|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
7359524|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
7359525|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7359526|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
7359527|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
7359528|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7359529|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
7359530|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
7359531|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7359532|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7359533|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7359534|NCT01008553|11604731|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7359535|NCT01008553|11604732|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
7359536|NCT01008553|11604733|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
7359537|NCT01008618|11604754|FG000|Period 1 (Titration Period)|Physician Decision|2
7359538|NCT01008618|11604755|FG001|Period 1 (Titration Period)|Physician Decision|0
7359539|NCT01008618|11604756|FG002|Period 1 (Titration Period)|Physician Decision|0
7359540|NCT01008618|11604754|FG000|Period 1 (Titration Period)|Adverse Event|33
7359541|NCT01008618|11604755|FG001|Period 1 (Titration Period)|Adverse Event|0
7359542|NCT01008618|11604756|FG002|Period 1 (Titration Period)|Adverse Event|0
7359543|NCT01008618|11604754|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
7359544|NCT01008618|11604755|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
7359545|NCT01008618|11604756|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
7359546|NCT01008618|11604754|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
7359547|NCT01008618|11604755|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7359548|NCT01008618|11604756|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
7359549|NCT01008618|11604754|FG000|Period 1 (Titration Period)|Aggravated symptom|2
7359550|NCT01008618|11604755|FG001|Period 1 (Titration Period)|Aggravated symptom|0
7359551|NCT01008618|11604756|FG002|Period 1 (Titration Period)|Aggravated symptom|0
7359552|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
7359553|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
7359554|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
7359555|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
7359556|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
7359557|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
7359558|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
7359559|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
7359560|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
7359561|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7359562|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
7359563|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
7359564|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7359565|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
7359566|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
7359567|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
7359568|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
7359569|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
7359570|NCT01008618|11604754|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7359571|NCT01008618|11604755|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
7359572|NCT01008618|11604756|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
7359573|NCT01008696|11604767|FG000|Overall Study|Participant's evasion of hospital visit|5
7359574|NCT01008696|11604768|FG001|Overall Study|Participant's evasion of hospital visit|4
7359575|NCT01008696|11604767|FG000|Overall Study|Withdrawal by Subject|2
7359576|NCT01008696|11604768|FG001|Overall Study|Withdrawal by Subject|4
7359577|NCT01008696|11604767|FG000|Overall Study|Physician Decision|5
7359578|NCT01008696|11604768|FG001|Overall Study|Physician Decision|1
7359579|NCT01008696|11604767|FG000|Overall Study|Adverse Event|1
7359580|NCT01008696|11604768|FG001|Overall Study|Adverse Event|0
7359581|NCT01008696|11604767|FG000|Overall Study|Participants' non-cooperation|2
7359582|NCT01008696|11604768|FG001|Overall Study|Participants' non-cooperation|3
7359583|NCT01008696|11604767|FG000|Overall Study|Other|2
7359584|NCT01008696|11604768|FG001|Overall Study|Other|3
7359585|NCT01008696|11604767|FG000|Overall Study|Other|0
7359586|NCT01008696|11604768|FG001|Overall Study|Other|2
7359587|NCT01008748|11604784|FG000|Overall Study|Lost to Follow-up|80
7359588|NCT01008748|11604784|FG000|Overall Study|Other|1
7359589|NCT01008904|11604788|FG000|Overall Study|Lost to Follow-up|1
7359590|NCT01008904|11604788|FG000|Overall Study|Adverse Event|2
7359591|NCT01008904|11604788|FG000|Overall Study|unexpected unrelated surgery|1
7359592|NCT01008943|11604792|FG000|Overall Study|Withdrawal by Subject|1
7569646|NCT03461757|11946346|FG000|Overall Study|Adverse Event|1
7359593|NCT01008995|11604802|FG000|Controlled Period|Adverse Event|1
7359594|NCT01008995|11604803|FG001|Controlled Period|Adverse Event|2
7359595|NCT01008995|11604804|FG002|Controlled Period|Adverse Event|0
7359596|NCT01008995|11604805|FG003|Controlled Period|Adverse Event|0
7359597|NCT01008995|11604802|FG000|Controlled Period|Other|2
7359598|NCT01008995|11604803|FG001|Controlled Period|Other|1
7359599|NCT01008995|11604804|FG002|Controlled Period|Other|0
7359600|NCT01008995|11604805|FG003|Controlled Period|Other|0
7359601|NCT01008995|11604802|FG000|After Controlled Period|Adverse Event|0
7359602|NCT01008995|11604803|FG001|After Controlled Period|Adverse Event|0
7359603|NCT01008995|11604804|FG002|After Controlled Period|Adverse Event|1
7359604|NCT01008995|11604805|FG003|After Controlled Period|Adverse Event|1
7359605|NCT01008995|11604802|FG000|After Controlled Period|Other|0
7359606|NCT01008995|11604803|FG001|After Controlled Period|Other|0
7359607|NCT01008995|11604804|FG002|After Controlled Period|Other|1
7359608|NCT01008995|11604805|FG003|After Controlled Period|Other|0
7359609|NCT01009034|11604813|FG000|Overall Study|Lost to Follow-up|2
7359610|NCT01009034|11604813|FG000|Overall Study|Withdrawal by Subject|2
7359611|NCT01009047|11604819|FG000|Overall Study|Adverse Event|5
7359612|NCT01009047|11604820|FG001|Overall Study|Adverse Event|0
7359613|NCT01009047|11604819|FG000|Overall Study|Lost to Follow-up|0
7359614|NCT01009047|11604820|FG001|Overall Study|Lost to Follow-up|2
7359615|NCT01009047|11604819|FG000|Overall Study|Lack of Efficacy|4
7359616|NCT01009047|11604820|FG001|Overall Study|Lack of Efficacy|11
7359617|NCT01009047|11604819|FG000|Overall Study|Withdrawal by consent|16
7359618|NCT01009047|11604820|FG001|Overall Study|Withdrawal by consent|11
7359619|NCT01009047|11604819|FG000|Overall Study|Other|3
7359620|NCT01009047|11604820|FG001|Overall Study|Other|2
7359621|NCT01009060|11604828|FG000|Overall Study|Adverse Event|1
7359622|NCT01009060|11604829|FG001|Overall Study|Adverse Event|2
7569647|NCT03461757|11946347|FG001|Overall Study|Adverse Event|0
7359623|NCT01009060|11604828|FG000|Overall Study|Protocol Violation|0
7359624|NCT01009060|11604829|FG001|Overall Study|Protocol Violation|1
7359625|NCT01009060|11604828|FG000|Overall Study|Lost to Follow-up|1
7359626|NCT01009060|11604829|FG001|Overall Study|Lost to Follow-up|0
7359627|NCT01009060|11604828|FG000|Overall Study|Physician Decision|1
7359628|NCT01009060|11604829|FG001|Overall Study|Physician Decision|1
7359629|NCT01009060|11604828|FG000|Overall Study|Withdrawal by Subject|1
7359630|NCT01009060|11604829|FG001|Overall Study|Withdrawal by Subject|1
7359631|NCT01009086|11604842|FG000|Overall Study|Lack of Efficacy|16
7359632|NCT01009086|11604843|FG001|Overall Study|Lack of Efficacy|15
7359633|NCT01009086|11604844|FG002|Overall Study|Lack of Efficacy|9
7359634|NCT01009086|11604842|FG000|Overall Study|Lost to Follow-up|4
7359635|NCT01009086|11604843|FG001|Overall Study|Lost to Follow-up|5
7359636|NCT01009086|11604844|FG002|Overall Study|Lost to Follow-up|3
7359637|NCT01009086|11604842|FG000|Overall Study|Adverse Event|12
7359638|NCT01009086|11604843|FG001|Overall Study|Adverse Event|11
7359639|NCT01009086|11604844|FG002|Overall Study|Adverse Event|8
7359640|NCT01009086|11604842|FG000|Overall Study|Withdrawal by Subject|9
7359641|NCT01009086|11604843|FG001|Overall Study|Withdrawal by Subject|11
7359642|NCT01009086|11604844|FG002|Overall Study|Withdrawal by Subject|13
7359643|NCT01009086|11604842|FG000|Overall Study|Other|3
7359644|NCT01009086|11604843|FG001|Overall Study|Other|5
7359645|NCT01009086|11604844|FG002|Overall Study|Other|1
7359646|NCT01009099|11604859|FG000|Overall Study|Lost to Follow-up|1
7359647|NCT01009099|11604860|FG001|Overall Study|Lost to Follow-up|0
7359648|NCT01009099|11604859|FG000|Overall Study|Physician Decision|3
7359649|NCT01009099|11604860|FG001|Overall Study|Physician Decision|2
7359650|NCT01009099|11604859|FG000|Overall Study|Withdrawal by Subject|1
7359651|NCT01009099|11604860|FG001|Overall Study|Withdrawal by Subject|1
7359652|NCT01009099|11604859|FG000|Overall Study|Death|0
7359653|NCT01009099|11604860|FG001|Overall Study|Death|1
7359654|NCT01009203|11604875|FG000|Overall Study|Withdrawal by Subject|1
7359655|NCT01009203|11604875|FG000|Overall Study|Adverse Event|5
7359656|NCT01009203|11604875|FG000|Overall Study|Treatment-unrelated death|1
7359657|NCT01009281|11604879|FG000|Overall Study|Administrative problems|7
7359658|NCT01009346|11604896|FG000|Overall Study|Adverse Event|4
7359659|NCT01009463|11604905|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
7359660|NCT01009463|11604906|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7359661|NCT01009463|11604907|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7359662|NCT01009463|11604908|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7359663|NCT01009463|11604909|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7359664|NCT01009463|11604905|FG000|4-week, Open-label Run-In Period|Adverse Event|10
7359665|NCT01009463|11604906|FG001|4-week, Open-label Run-In Period|Adverse Event|0
7359666|NCT01009463|11604907|FG002|4-week, Open-label Run-In Period|Adverse Event|0
7359667|NCT01009463|11604908|FG003|4-week, Open-label Run-In Period|Adverse Event|0
7359668|NCT01009463|11604909|FG004|4-week, Open-label Run-In Period|Adverse Event|0
7359669|NCT01009463|11604905|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
7359670|NCT01009463|11604906|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
7359671|NCT01009463|11604907|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
7359672|NCT01009463|11604908|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
7359673|NCT01009463|11604909|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
7359674|NCT01009463|11604905|FG000|4-week, Open-label Run-In Period|Physician Decision|10
7359675|NCT01009463|11604906|FG001|4-week, Open-label Run-In Period|Physician Decision|0
7359676|NCT01009463|11604907|FG002|4-week, Open-label Run-In Period|Physician Decision|0
7359677|NCT01009463|11604908|FG003|4-week, Open-label Run-In Period|Physician Decision|0
7359678|NCT01009463|11604909|FG004|4-week, Open-label Run-In Period|Physician Decision|0
7359679|NCT01009463|11604905|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
7359680|NCT01009463|11604906|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7359681|NCT01009463|11604907|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7359682|NCT01009463|11604908|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7359683|NCT01009463|11604909|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7359684|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
7359685|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
7359686|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
7359687|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
7359688|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
7359689|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7359690|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
7359691|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
7359692|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
7359693|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7359694|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7359695|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
7359696|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7359697|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
7359698|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
7359699|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
7359700|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
7359701|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
7460055|NCT01823835|11755150|FG013|Overall Study|Study Termination|0
7359702|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
7359703|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
7359704|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7359705|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7359706|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
7359707|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7359708|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
7359709|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7359710|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
7359711|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7359712|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7359713|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7359714|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7359715|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
7359716|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
7359717|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7359718|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
7359719|NCT01009463|11604905|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
7359720|NCT01009463|11604906|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
7359721|NCT01009463|11604907|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
7359722|NCT01009463|11604908|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
7359723|NCT01009463|11604909|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
7359724|NCT01009515|11604920|FG000|Overall Study|Withdrawal by Subject|3
7359725|NCT01009554|11604926|FG000|Overall Study|Adverse Event|1
7359726|NCT01009554|11604927|FG001|Overall Study|Adverse Event|1
7460056|NCT01823835|11755151|FG014|Overall Study|Study Termination|0
7460057|NCT01823835|11755137|FG000|Overall Study|Withdrawal by Subject|0
7460058|NCT01823835|11755138|FG001|Overall Study|Withdrawal by Subject|0
7460059|NCT01823835|11755139|FG002|Overall Study|Withdrawal by Subject|1
7460060|NCT01823835|11755140|FG003|Overall Study|Withdrawal by Subject|0
7460061|NCT01823835|11755141|FG004|Overall Study|Withdrawal by Subject|0
7460062|NCT01823835|11755142|FG005|Overall Study|Withdrawal by Subject|0
7460063|NCT01823835|11755143|FG006|Overall Study|Withdrawal by Subject|0
7460064|NCT01823835|11755144|FG007|Overall Study|Withdrawal by Subject|0
7460065|NCT01823835|11755145|FG008|Overall Study|Withdrawal by Subject|0
7460066|NCT01823835|11755146|FG009|Overall Study|Withdrawal by Subject|1
7460067|NCT01823835|11755147|FG010|Overall Study|Withdrawal by Subject|1
7460068|NCT01823835|11755148|FG011|Overall Study|Withdrawal by Subject|2
7460069|NCT01823835|11755149|FG012|Overall Study|Withdrawal by Subject|1
7460070|NCT01823835|11755150|FG013|Overall Study|Withdrawal by Subject|0
7460071|NCT01823835|11755151|FG014|Overall Study|Withdrawal by Subject|0
7460072|NCT01823991|11755202|FG000|Overall Study|Withdrawal by Subject|8
7460073|NCT01823991|11755203|FG001|Overall Study|Withdrawal by Subject|5
7460074|NCT01824290|11755232|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
7460075|NCT01824290|11755233|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
7460076|NCT01824290|11755234|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
7460077|NCT01824290|11755235|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
7460078|NCT01824290|11755232|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
7460079|NCT01824290|11755233|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
7460080|NCT01824290|11755234|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
7460081|NCT01824290|11755235|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
7460082|NCT01824290|11755232|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7460083|NCT01824290|11755233|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
7460084|NCT01824290|11755234|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7460085|NCT01824290|11755235|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
7460086|NCT01824290|11755232|FG000|Period 2: Open-Label Treatment|Adverse Event|0
7460087|NCT01824290|11755233|FG001|Period 2: Open-Label Treatment|Adverse Event|0
7460088|NCT01824290|11755234|FG002|Period 2: Open-Label Treatment|Adverse Event|0
7460089|NCT01824290|11755235|FG003|Period 2: Open-Label Treatment|Adverse Event|1
7460090|NCT01824290|11755232|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7460091|NCT01824290|11755233|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
7460092|NCT01824290|11755234|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7460093|NCT01824290|11755235|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
7460094|NCT01824290|11755232|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7460095|NCT01824290|11755233|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
7460096|NCT01824290|11755234|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
7460097|NCT01824290|11755235|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
7460098|NCT01824303|11755249|FG000|Randomized Study|Withdrawal by Subject|1
7460099|NCT01824303|11755250|FG001|Randomized Study|Withdrawal by Subject|1
7460100|NCT01824303|11755249|FG000|Randomized Study|Other Miscellaneous Reasons|1
7460101|NCT01824303|11755250|FG001|Randomized Study|Other Miscellaneous Reasons|0
7569648|NCT03461757|11946346|FG000|Overall Study|Lost to Follow-up|13
7359727|NCT01009554|11604926|FG000|Overall Study|Withdrawal by Subject|1
7359728|NCT01009554|11604927|FG001|Overall Study|Withdrawal by Subject|3
7359729|NCT01009554|11604926|FG000|Overall Study|Noncompliant with Study Product|0
7359730|NCT01009554|11604927|FG001|Overall Study|Noncompliant with Study Product|3
7569649|NCT03461757|11946347|FG001|Overall Study|Lost to Follow-up|7
7359731|NCT01009580|11604935|FG000|Overall Study|Adverse Event|4
7359732|NCT01009580|11604936|FG001|Overall Study|Adverse Event|4
7359733|NCT01009580|11604935|FG000|Overall Study|Lack of Efficacy|0
7359734|NCT01009580|11604936|FG001|Overall Study|Lack of Efficacy|1
7359735|NCT01009580|11604935|FG000|Overall Study|Protocol Violation|2
7359736|NCT01009580|11604936|FG001|Overall Study|Protocol Violation|3
7359737|NCT01009580|11604935|FG000|Overall Study|Withdrawal Criteria|4
7359738|NCT01009580|11604936|FG001|Overall Study|Withdrawal Criteria|6
7359739|NCT01009580|11604935|FG000|Overall Study|Unclassified|17
7359740|NCT01009580|11604936|FG001|Overall Study|Unclassified|21
7359741|NCT01009645|11604955|FG000|Overall Study|Lost to Follow-up|2
7359742|NCT01009645|11604956|FG001|Overall Study|Lost to Follow-up|8
7359743|NCT01009645|11604957|FG002|Overall Study|Lost to Follow-up|4
7359744|NCT01009645|11604958|FG003|Overall Study|Lost to Follow-up|5
7359745|NCT01009814|11604984|FG000|Overall Study|No longer met study criteria|1
7359746|NCT01009814|11604985|FG001|Overall Study|No longer met study criteria|1
7359747|NCT01009814|11604986|FG002|Overall Study|No longer met study criteria|0
7359748|NCT01009814|11604987|FG003|Overall Study|No longer met study criteria|0
7359749|NCT01009814|11604988|FG004|Overall Study|No longer met study criteria|0
7359750|NCT01009840|11605004|FG000|Overall Study|Lost to Follow-up|1
7359751|NCT01009840|11605004|FG000|Overall Study|Adverse Event|4
7359752|NCT01009840|11605004|FG000|Overall Study|Subject Met Withdrawal Criteria|7
7359753|NCT01009840|11605004|FG000|Overall Study|Subject was Withdrawn by Investigator|1
7359754|NCT01009840|11605004|FG000|Overall Study|Subject Withdrew Consent to Participate|1
7359755|NCT01009983|11605021|FG000|Overall Study|necessary scans not completed|1
7386328|NCT01210352|11644796|FG006|Overall Study|Lack of Efficacy|1
7386329|NCT01210352|11644797|FG007|Overall Study|Lack of Efficacy|0
7386330|NCT01210352|11644798|FG008|Overall Study|Lack of Efficacy|0
7386331|NCT01210352|11644790|FG000|Overall Study|Physician Decision|0
7386332|NCT01210352|11644791|FG001|Overall Study|Physician Decision|0
7386333|NCT01210352|11644792|FG002|Overall Study|Physician Decision|0
7386334|NCT01210352|11644793|FG003|Overall Study|Physician Decision|0
7386335|NCT01210352|11644794|FG004|Overall Study|Physician Decision|0
7386336|NCT01210352|11644795|FG005|Overall Study|Physician Decision|0
7386337|NCT01210352|11644796|FG006|Overall Study|Physician Decision|0
7386338|NCT01210352|11644797|FG007|Overall Study|Physician Decision|1
7386339|NCT01210352|11644798|FG008|Overall Study|Physician Decision|2
7386340|NCT01210352|11644790|FG000|Overall Study|Withdrawal by Subject|0
7386341|NCT01210352|11644791|FG001|Overall Study|Withdrawal by Subject|0
7386342|NCT01210352|11644792|FG002|Overall Study|Withdrawal by Subject|1
7386343|NCT01210352|11644793|FG003|Overall Study|Withdrawal by Subject|0
7386344|NCT01210352|11644794|FG004|Overall Study|Withdrawal by Subject|0
7386345|NCT01210352|11644795|FG005|Overall Study|Withdrawal by Subject|0
7386346|NCT01210352|11644796|FG006|Overall Study|Withdrawal by Subject|1
7386347|NCT01210352|11644797|FG007|Overall Study|Withdrawal by Subject|0
7386348|NCT01210352|11644798|FG008|Overall Study|Withdrawal by Subject|1
7386349|NCT01210352|11644790|FG000|Overall Study|Patient Discharged Early|0
7386350|NCT01210352|11644791|FG001|Overall Study|Patient Discharged Early|0
7386351|NCT01210352|11644792|FG002|Overall Study|Patient Discharged Early|1
7386352|NCT01210352|11644793|FG003|Overall Study|Patient Discharged Early|0
7386353|NCT01210352|11644794|FG004|Overall Study|Patient Discharged Early|0
7386354|NCT01210352|11644795|FG005|Overall Study|Patient Discharged Early|0
7386355|NCT01210352|11644796|FG006|Overall Study|Patient Discharged Early|0
7386356|NCT01210352|11644797|FG007|Overall Study|Patient Discharged Early|0
7386357|NCT01210352|11644798|FG008|Overall Study|Patient Discharged Early|0
7386358|NCT01210443|11644903|FG000|Overall Study|Study terminated by sponsor|2
7386359|NCT01210495|11644911|FG000|Overall Study|Participant Refused Further Follow-Up|1
7386360|NCT01210495|11644912|FG001|Overall Study|Participant Refused Further Follow-Up|0
7386361|NCT01210495|11644913|FG002|Overall Study|Participant Refused Further Follow-Up|11
7386362|NCT01210495|11644914|FG003|Overall Study|Participant Refused Further Follow-Up|2
7386363|NCT01210495|11644911|FG000|Overall Study|Death|14
7386364|NCT01210495|11644912|FG001|Overall Study|Death|7
7386365|NCT01210495|11644913|FG002|Overall Study|Death|112
7386366|NCT01210495|11644914|FG003|Overall Study|Death|54
7386367|NCT01210495|11644911|FG000|Overall Study|Study Terminated by Sponsor|0
7386368|NCT01210495|11644912|FG001|Overall Study|Study Terminated by Sponsor|0
7386369|NCT01210495|11644913|FG002|Overall Study|Study Terminated by Sponsor|4
7386370|NCT01210495|11644914|FG003|Overall Study|Study Terminated by Sponsor|11
7359756|NCT01010061|11605040|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
7359757|NCT01010061|11605041|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
7359758|NCT01010061|11605040|FG000|Overall Study|Disease Progression|2
7359759|NCT01010061|11605041|FG001|Overall Study|Disease Progression|8
7359760|NCT01010061|11605040|FG000|Overall Study|Withdrew Consent|5
7359761|NCT01010061|11605041|FG001|Overall Study|Withdrew Consent|1
7359762|NCT01010061|11605040|FG000|Overall Study|Death|3
7359763|NCT01010061|11605041|FG001|Overall Study|Death|6
7359764|NCT01010061|11605040|FG000|Overall Study|Administrative/Other|0
7359765|NCT01010061|11605041|FG001|Overall Study|Administrative/Other|1
7359766|NCT01010061|11605040|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
7359767|NCT01010061|11605041|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
7359768|NCT01010061|11605040|FG000|Overall Study|Insufficient Therapeutic Response|1
7359769|NCT01010061|11605041|FG001|Overall Study|Insufficient Therapeutic Response|5
7359770|NCT01010061|11605040|FG000|Overall Study|Violation of Selection Criteria|0
7359771|NCT01010061|11605041|FG001|Overall Study|Violation of Selection Criteria|1
7359772|NCT01010061|11605040|FG000|Overall Study|Did Not Receive Treatment|2
7359773|NCT01010061|11605041|FG001|Overall Study|Did Not Receive Treatment|2
7359774|NCT01010126|11605055|FG000|Overall Study|Withdrawal by Subject|1
7359775|NCT01010126|11605056|FG001|Overall Study|Withdrawal by Subject|0
7359776|NCT01010126|11605057|FG002|Overall Study|Withdrawal by Subject|1
7359777|NCT01010126|11605058|FG003|Overall Study|Withdrawal by Subject|0
7359778|NCT01010126|11605059|FG004|Overall Study|Withdrawal by Subject|3
7359779|NCT01010126|11605060|FG005|Overall Study|Withdrawal by Subject|0
7359780|NCT01010204|11605076|FG000|Overall Study|Lost to Follow-up|2
7359781|NCT01010204|11605077|FG001|Overall Study|Lost to Follow-up|2
7359782|NCT01010204|11605076|FG000|Overall Study|Adverse Event|1
7359783|NCT01010204|11605077|FG001|Overall Study|Adverse Event|3
7359784|NCT01010204|11605076|FG000|Overall Study|Withdrawal by Subject|2
7359785|NCT01010204|11605077|FG001|Overall Study|Withdrawal by Subject|3
7359786|NCT01010204|11605076|FG000|Overall Study|psychiatric hospitalization|2
7359787|NCT01010204|11605077|FG001|Overall Study|psychiatric hospitalization|1
7359788|NCT01010217|11605088|FG000|Overall Study|Lost to Follow-up|4
7359789|NCT01010217|11605089|FG001|Overall Study|Lost to Follow-up|5
7359790|NCT01010217|11605090|FG002|Overall Study|Lost to Follow-up|1
7359791|NCT01010217|11605091|FG003|Overall Study|Lost to Follow-up|0
7359792|NCT01010217|11605092|FG004|Overall Study|Lost to Follow-up|0
7359793|NCT01010217|11605088|FG000|Overall Study|Withdrawal by Subject|1
7359794|NCT01010217|11605089|FG001|Overall Study|Withdrawal by Subject|0
7359795|NCT01010217|11605090|FG002|Overall Study|Withdrawal by Subject|0
7359796|NCT01010217|11605091|FG003|Overall Study|Withdrawal by Subject|0
7359797|NCT01010217|11605092|FG004|Overall Study|Withdrawal by Subject|0
7359798|NCT01010217|11605088|FG000|Overall Study|Physician Decision|0
7359799|NCT01010217|11605089|FG001|Overall Study|Physician Decision|0
7359800|NCT01010217|11605090|FG002|Overall Study|Physician Decision|0
7359801|NCT01010217|11605091|FG003|Overall Study|Physician Decision|6
7359802|NCT01010217|11605092|FG004|Overall Study|Physician Decision|3
7359803|NCT01010230|11605106|FG000|Overall Study|Withdrawal by Subject|6
7359804|NCT01010230|11605107|FG001|Overall Study|Withdrawal by Subject|5
7359805|NCT01010230|11605106|FG000|Overall Study|Lost to Follow-up|4
7359806|NCT01010230|11605107|FG001|Overall Study|Lost to Follow-up|2
7359807|NCT01010503|11605139|FG000|Overall Study|Adverse Event|1
7359808|NCT01010503|11605139|FG000|Overall Study|Death|1
7359809|NCT01010633|11605161|FG000|Overall Study|Adverse Event|1
7359810|NCT01010633|11605162|FG001|Overall Study|Adverse Event|1
7359811|NCT01010633|11605161|FG000|Overall Study|Protocol Violation|1
7359812|NCT01010633|11605162|FG001|Overall Study|Protocol Violation|2
7359813|NCT01010633|11605161|FG000|Overall Study|Withdrawal by Subject|2
7359814|NCT01010633|11605162|FG001|Overall Study|Withdrawal by Subject|1
7359815|NCT01010633|11605161|FG000|Overall Study|Investigator decision|0
7359816|NCT01010633|11605162|FG001|Overall Study|Investigator decision|1
7359817|NCT01010750|11605174|FG000|Second Intervention|Adverse Event|0
7359818|NCT01010750|11605175|FG001|Second Intervention|Adverse Event|1
7359819|NCT01010750|11605176|FG002|Second Intervention|Adverse Event|0
7359820|NCT01010750|11605177|FG003|Second Intervention|Adverse Event|0
7359821|NCT01010750|11605178|FG004|Second Intervention|Adverse Event|0
7359822|NCT01010750|11605179|FG005|Second Intervention|Adverse Event|0
7359823|NCT01010776|11605196|FG000|Main Phase|Withdrawal by Subject|14
7359824|NCT01010776|11605196|FG000|Main Phase|Lack of Efficacy|8
7359825|NCT01010776|11605196|FG000|Main Phase|Adverse Event|7
7359826|NCT01010776|11605196|FG000|Main Phase|Lost to Follow-up|6
7359827|NCT01010776|11605196|FG000|Main Phase|Non-compliance to study medication|5
7359828|NCT01010776|11605196|FG000|Main Phase|Selection failure|2
7359829|NCT01010776|11605196|FG000|Main Phase|Inform consent withdrawal|1
7359830|NCT01010776|11605196|FG000|Main Phase|Other|1
7359831|NCT01010776|11605196|FG000|Main Phase|Did not received study medication|5
7359832|NCT01010776|11605196|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
7359833|NCT01010776|11605196|FG000|Extension Phase|Other|3
7359834|NCT01010867|11605215|FG000|Overall Study|< 50% adherence to probiotic|1
7359835|NCT01010971|11605255|FG000|Overall Study|Adverse Event|2
7359836|NCT01010971|11605256|FG001|Overall Study|Adverse Event|4
7359837|NCT01010971|11605257|FG002|Overall Study|Adverse Event|3
7359838|NCT01010971|11605255|FG000|Overall Study|Withdrawal by Subject|0
7359839|NCT01010971|11605256|FG001|Overall Study|Withdrawal by Subject|2
7359840|NCT01010971|11605257|FG002|Overall Study|Withdrawal by Subject|5
7359841|NCT01010971|11605255|FG000|Overall Study|Lost to Follow-up|0
7359842|NCT01010971|11605256|FG001|Overall Study|Lost to Follow-up|2
7359843|NCT01010971|11605257|FG002|Overall Study|Lost to Follow-up|3
7359844|NCT01010971|11605255|FG000|Overall Study|Other|1
7359845|NCT01010971|11605256|FG001|Overall Study|Other|0
7359846|NCT01010971|11605257|FG002|Overall Study|Other|2
7359847|NCT01011049|11605274|FG000|Overall Study|Protocol Violation|0
7359848|NCT01011049|11605275|FG001|Overall Study|Protocol Violation|0
7359849|NCT01011049|11605276|FG002|Overall Study|Protocol Violation|2
7359850|NCT01011049|11605277|FG003|Overall Study|Protocol Violation|0
7359851|NCT01011049|11605274|FG000|Overall Study|Lost to Follow-up|1
7359852|NCT01011049|11605275|FG001|Overall Study|Lost to Follow-up|2
7359853|NCT01011049|11605276|FG002|Overall Study|Lost to Follow-up|1
7359854|NCT01011049|11605277|FG003|Overall Study|Lost to Follow-up|0
7359855|NCT01011049|11605274|FG000|Overall Study|Withdrawal by Subject|0
7359856|NCT01011049|11605275|FG001|Overall Study|Withdrawal by Subject|0
7359857|NCT01011049|11605276|FG002|Overall Study|Withdrawal by Subject|1
7359858|NCT01011049|11605277|FG003|Overall Study|Withdrawal by Subject|0
7359859|NCT01011153|11605294|FG000|Overall Study|Less than 78 cases completed|8
7359860|NCT01011153|11605295|FG001|Overall Study|Less than 78 cases completed|11
7359861|NCT01011153|11605296|FG002|Overall Study|Less than 78 cases completed|9
7359862|NCT01011283|11605342|FG000|Overall Study|Adverse Event|4
7359863|NCT01011283|11605343|FG001|Overall Study|Adverse Event|2
7359864|NCT01011283|11605342|FG000|Overall Study|Progressive Disease|0
7359865|NCT01011283|11605343|FG001|Overall Study|Progressive Disease|2
7359866|NCT01011283|11605342|FG000|Overall Study|Terminated by Sponsor|5
7359867|NCT01011283|11605343|FG001|Overall Study|Terminated by Sponsor|5
7359868|NCT01011283|11605342|FG000|Overall Study|Other|2
7359869|NCT01011283|11605343|FG001|Overall Study|Other|2
7359870|NCT01011309|11605352|FG000|Overall Study|Adverse Event|2
7359871|NCT01011309|11605353|FG001|Overall Study|Adverse Event|1
7359872|NCT01011309|11605354|FG002|Overall Study|Adverse Event|2
7359873|NCT01011309|11605352|FG000|Overall Study|Lack of Efficacy|0
7359874|NCT01011309|11605353|FG001|Overall Study|Lack of Efficacy|1
7359875|NCT01011309|11605354|FG002|Overall Study|Lack of Efficacy|0
7359876|NCT01011309|11605352|FG000|Overall Study|Protocol Violation|0
7359877|NCT01011309|11605353|FG001|Overall Study|Protocol Violation|1
7359878|NCT01011309|11605354|FG002|Overall Study|Protocol Violation|3
7359879|NCT01011335|11605366|FG000|Overall Study|Lost to Follow-up|0
7359880|NCT01011335|11605367|FG001|Overall Study|Lost to Follow-up|0
7359881|NCT01011335|11605368|FG002|Overall Study|Lost to Follow-up|1
7359882|NCT01011335|11605369|FG003|Overall Study|Lost to Follow-up|1
7359883|NCT01011335|11605370|FG004|Overall Study|Lost to Follow-up|1
7359884|NCT01011335|11605371|FG005|Overall Study|Lost to Follow-up|1
7359885|NCT01011335|11605372|FG006|Overall Study|Lost to Follow-up|2
7359886|NCT01011335|11605373|FG007|Overall Study|Lost to Follow-up|2
7359887|NCT01011335|11605374|FG008|Overall Study|Lost to Follow-up|1
7359888|NCT01011335|11605375|FG009|Overall Study|Lost to Follow-up|0
7359889|NCT01011335|11605376|FG010|Overall Study|Lost to Follow-up|0
7569650|NCT03461757|11946346|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
7569651|NCT03461757|11946347|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
7569652|NCT03461757|11946346|FG000|Overall Study|Non-compliance with study treatment|0
7569653|NCT03461757|11946347|FG001|Overall Study|Non-compliance with study treatment|1
7569654|NCT03461757|11946346|FG000|Overall Study|Pregnancy|2
7569655|NCT03461757|11946347|FG001|Overall Study|Pregnancy|0
7569656|NCT03461757|11946346|FG000|Overall Study|Protocol Violation|1
7569657|NCT03461757|11946347|FG001|Overall Study|Protocol Violation|1
7569658|NCT03461757|11946346|FG000|Overall Study|Withdrawal by Subject|7
7569659|NCT03461757|11946347|FG001|Overall Study|Withdrawal by Subject|7
7569660|NCT03461757|11946346|FG000|Overall Study|Other Reasons|1
7569661|NCT03461757|11946347|FG001|Overall Study|Other Reasons|4
7569662|NCT03462082|11946362|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
7569663|NCT03462082|11946363|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
7569664|NCT03462082|11946364|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
7569665|NCT03462082|11946365|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
7359890|NCT01011335|11605377|FG011|Overall Study|Lost to Follow-up|1
7359891|NCT01011335|11605378|FG012|Overall Study|Lost to Follow-up|2
7359892|NCT01011335|11605366|FG000|Overall Study|Protocol Violation|0
7359893|NCT01011335|11605367|FG001|Overall Study|Protocol Violation|1
7359894|NCT01011335|11605368|FG002|Overall Study|Protocol Violation|0
7359895|NCT01011335|11605369|FG003|Overall Study|Protocol Violation|0
7359896|NCT01011335|11605370|FG004|Overall Study|Protocol Violation|0
7359897|NCT01011335|11605371|FG005|Overall Study|Protocol Violation|0
7359898|NCT01011335|11605372|FG006|Overall Study|Protocol Violation|0
7359899|NCT01011335|11605373|FG007|Overall Study|Protocol Violation|0
7359900|NCT01011335|11605374|FG008|Overall Study|Protocol Violation|0
7359901|NCT01011335|11605375|FG009|Overall Study|Protocol Violation|0
7359902|NCT01011335|11605376|FG010|Overall Study|Protocol Violation|0
7359903|NCT01011335|11605377|FG011|Overall Study|Protocol Violation|0
7359904|NCT01011335|11605378|FG012|Overall Study|Protocol Violation|0
7359905|NCT01011335|11605366|FG000|Overall Study|Moved/deployed or no booster|1
7569666|NCT03462082|11946366|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
7569667|NCT03462082|11946367|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
7359906|NCT01011335|11605367|FG001|Overall Study|Moved/deployed or no booster|0
7359907|NCT01011335|11605368|FG002|Overall Study|Moved/deployed or no booster|0
7359908|NCT01011335|11605369|FG003|Overall Study|Moved/deployed or no booster|1
7359909|NCT01011335|11605370|FG004|Overall Study|Moved/deployed or no booster|0
7359910|NCT01011335|11605371|FG005|Overall Study|Moved/deployed or no booster|0
7359911|NCT01011335|11605372|FG006|Overall Study|Moved/deployed or no booster|1
7359912|NCT01011335|11605373|FG007|Overall Study|Moved/deployed or no booster|0
7359913|NCT01011335|11605374|FG008|Overall Study|Moved/deployed or no booster|1
7359914|NCT01011335|11605375|FG009|Overall Study|Moved/deployed or no booster|0
7359915|NCT01011335|11605376|FG010|Overall Study|Moved/deployed or no booster|2
7359916|NCT01011335|11605377|FG011|Overall Study|Moved/deployed or no booster|0
7359917|NCT01011335|11605378|FG012|Overall Study|Moved/deployed or no booster|0
7359918|NCT01011335|11605366|FG000|Overall Study|Adverse Event|0
7359919|NCT01011335|11605367|FG001|Overall Study|Adverse Event|0
7359920|NCT01011335|11605368|FG002|Overall Study|Adverse Event|0
7359921|NCT01011335|11605369|FG003|Overall Study|Adverse Event|0
7359922|NCT01011335|11605370|FG004|Overall Study|Adverse Event|0
7359923|NCT01011335|11605371|FG005|Overall Study|Adverse Event|0
7359924|NCT01011335|11605372|FG006|Overall Study|Adverse Event|0
7359925|NCT01011335|11605373|FG007|Overall Study|Adverse Event|0
7359926|NCT01011335|11605374|FG008|Overall Study|Adverse Event|0
7359927|NCT01011335|11605375|FG009|Overall Study|Adverse Event|0
7359928|NCT01011335|11605376|FG010|Overall Study|Adverse Event|4
7359929|NCT01011335|11605377|FG011|Overall Study|Adverse Event|0
7359930|NCT01011335|11605378|FG012|Overall Study|Adverse Event|1
7359931|NCT01011387|11605415|FG000|Overall Study|Withdrawal by Subject|3
7359932|NCT01011387|11605415|FG000|Overall Study|Adverse Event|2
7359933|NCT01011387|11605415|FG000|Overall Study|Protocol Violation|1
7359934|NCT01011439|11605435|FG000|Overall Study|Death|37
7359935|NCT01011439|11605435|FG000|Overall Study|Lost to Follow-up|4
7359936|NCT01011439|11605435|FG000|Overall Study|Withdrawal by Subject|1
7359937|NCT01011439|11605435|FG000|Overall Study|Sponsor's decision|15
7359938|NCT01011465|11605448|FG000|Overall Study|Withdrawal by Subject|2
7359939|NCT01011465|11605449|FG001|Overall Study|Withdrawal by Subject|1
7359940|NCT01011465|11605450|FG002|Overall Study|Withdrawal by Subject|0
7359941|NCT01011465|11605451|FG003|Overall Study|Withdrawal by Subject|0
7359942|NCT01011465|11605452|FG004|Overall Study|Withdrawal by Subject|1
7359943|NCT01011465|11605453|FG005|Overall Study|Withdrawal by Subject|0
7359944|NCT01011465|11605454|FG006|Overall Study|Withdrawal by Subject|1
7359945|NCT01011465|11605455|FG007|Overall Study|Withdrawal by Subject|0
7359946|NCT01011556|11605475|FG000|Overall Study|Adverse Event|1
7359947|NCT01011556|11605476|FG001|Overall Study|Adverse Event|3
7359948|NCT01011556|11605477|FG002|Overall Study|Adverse Event|2
7359949|NCT01011556|11605478|FG003|Overall Study|Adverse Event|1
7359950|NCT01011556|11605475|FG000|Overall Study|Lost to Follow-up|1
7359951|NCT01011556|11605476|FG001|Overall Study|Lost to Follow-up|0
7359952|NCT01011556|11605477|FG002|Overall Study|Lost to Follow-up|0
7359953|NCT01011556|11605478|FG003|Overall Study|Lost to Follow-up|0
7359954|NCT01011556|11605475|FG000|Overall Study|Physician Decision|1
7359955|NCT01011556|11605476|FG001|Overall Study|Physician Decision|0
7359956|NCT01011556|11605477|FG002|Overall Study|Physician Decision|0
7359957|NCT01011556|11605478|FG003|Overall Study|Physician Decision|1
7359958|NCT01011556|11605475|FG000|Overall Study|Protocol Violation|0
7359959|NCT01011556|11605476|FG001|Overall Study|Protocol Violation|1
7359960|NCT01011556|11605477|FG002|Overall Study|Protocol Violation|0
7359961|NCT01011556|11605478|FG003|Overall Study|Protocol Violation|0
7359962|NCT01011556|11605475|FG000|Overall Study|Withdrawal by Subject|1
7359963|NCT01011556|11605476|FG001|Overall Study|Withdrawal by Subject|2
7359964|NCT01011556|11605477|FG002|Overall Study|Withdrawal by Subject|4
7359965|NCT01011556|11605478|FG003|Overall Study|Withdrawal by Subject|4
7359966|NCT01011556|11605475|FG000|Overall Study|Sponsor decision|0
7359967|NCT01011556|11605476|FG001|Overall Study|Sponsor decision|1
7359968|NCT01011556|11605477|FG002|Overall Study|Sponsor decision|1
7359969|NCT01011556|11605478|FG003|Overall Study|Sponsor decision|2
7359970|NCT01011556|11605475|FG000|Overall Study|Inclusion/exclusion criteria not met|2
7359971|NCT01011556|11605476|FG001|Overall Study|Inclusion/exclusion criteria not met|1
7359972|NCT01011556|11605477|FG002|Overall Study|Inclusion/exclusion criteria not met|3
7359973|NCT01011556|11605478|FG003|Overall Study|Inclusion/exclusion criteria not met|5
7359974|NCT01011673|11605493|FG000|Randomized|Secondary headache|2
7359975|NCT01011673|11605494|FG001|Randomized|Secondary headache|1
7359976|NCT01011673|11605493|FG000|24 Hour Follow-up|Lost to Follow-up|3
7359977|NCT01011673|11605494|FG001|24 Hour Follow-up|Lost to Follow-up|3
7359978|NCT01011738|11605503|FG000|Overall Study|Death|12
7359979|NCT01011738|11605504|FG001|Overall Study|Death|3
7359980|NCT01011738|11605505|FG002|Overall Study|Death|0
7359981|NCT01011738|11605503|FG000|Overall Study|Unknown reasons|312
7359982|NCT01011738|11605504|FG001|Overall Study|Unknown reasons|291
7359983|NCT01011738|11605505|FG002|Overall Study|Unknown reasons|17
7359984|NCT01011868|11605537|FG000|After Week 18 Follow-up|Adverse Event|8
7359985|NCT01011868|11605538|FG001|After Week 18 Follow-up|Adverse Event|6
7359986|NCT01011868|11605539|FG002|After Week 18 Follow-up|Adverse Event|13
7359987|NCT01011868|11605537|FG000|After Week 18 Follow-up|Lack of Efficacy|1
7359988|NCT01011868|11605538|FG001|After Week 18 Follow-up|Lack of Efficacy|0
7359989|NCT01011868|11605539|FG002|After Week 18 Follow-up|Lack of Efficacy|0
7359990|NCT01011868|11605537|FG000|After Week 18 Follow-up|Protocol Violation|1
7359991|NCT01011868|11605538|FG001|After Week 18 Follow-up|Protocol Violation|1
7359992|NCT01011868|11605539|FG002|After Week 18 Follow-up|Protocol Violation|1
7359993|NCT01011868|11605537|FG000|After Week 18 Follow-up|Lost to Follow-up|5
7359994|NCT01011868|11605538|FG001|After Week 18 Follow-up|Lost to Follow-up|3
7359995|NCT01011868|11605539|FG002|After Week 18 Follow-up|Lost to Follow-up|0
7359996|NCT01011868|11605537|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
7359997|NCT01011868|11605538|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
7359998|NCT01011868|11605539|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
7359999|NCT01011868|11605537|FG000|After Week 18 Follow-up|Other reason not defined above|2
7360000|NCT01011868|11605538|FG001|After Week 18 Follow-up|Other reason not defined above|3
7360001|NCT01011868|11605539|FG002|After Week 18 Follow-up|Other reason not defined above|12
7360002|NCT01011868|11605537|FG000|After Week 78 Follow-up|Adverse Event|14
7360003|NCT01011868|11605538|FG001|After Week 78 Follow-up|Adverse Event|18
7360004|NCT01011868|11605539|FG002|After Week 78 Follow-up|Adverse Event|21
7360005|NCT01011868|11605537|FG000|After Week 78 Follow-up|Lack of Efficacy|4
7360006|NCT01011868|11605538|FG001|After Week 78 Follow-up|Lack of Efficacy|0
7360007|NCT01011868|11605539|FG002|After Week 78 Follow-up|Lack of Efficacy|0
7360008|NCT01011868|11605537|FG000|After Week 78 Follow-up|Protocol Violation|9
7360009|NCT01011868|11605538|FG001|After Week 78 Follow-up|Protocol Violation|1
7360010|NCT01011868|11605539|FG002|After Week 78 Follow-up|Protocol Violation|2
7360011|NCT01011868|11605537|FG000|After Week 78 Follow-up|Lost to Follow-up|11
7360012|NCT01011868|11605538|FG001|After Week 78 Follow-up|Lost to Follow-up|6
7360013|NCT01011868|11605539|FG002|After Week 78 Follow-up|Lost to Follow-up|4
7360014|NCT01011868|11605537|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
7360015|NCT01011868|11605538|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
7360016|NCT01011868|11605539|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
7360017|NCT01011868|11605537|FG000|After Week 78 Follow-up|Other reason not defined above|5
7360018|NCT01011868|11605538|FG001|After Week 78 Follow-up|Other reason not defined above|5
7360019|NCT01011868|11605539|FG002|After Week 78 Follow-up|Other reason not defined above|16
7360020|NCT01011907|11605553|FG000|Overall Study|Withdrawal by Subject|13
7360021|NCT01011907|11605554|FG001|Overall Study|Withdrawal by Subject|11
7360022|NCT01011907|11605553|FG000|Overall Study|Adverse Event|1
7360023|NCT01011907|11605554|FG001|Overall Study|Adverse Event|4
7360024|NCT01011933|11605560|FG000|Overall Study|Wrong cell type|1
7569668|NCT03462082|11946368|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
7569669|NCT03462082|11946369|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
7569670|NCT03462576|11946382|FG000|Overall Study|Protocol Violation|5
7569671|NCT03462576|11946383|FG001|Overall Study|Protocol Violation|11
7569672|NCT03462576|11946384|FG002|Overall Study|Protocol Violation|7
7569673|NCT03462576|11946382|FG000|Overall Study|Device Malfunction|0
7569674|NCT03462576|11946383|FG001|Overall Study|Device Malfunction|0
7569675|NCT03462576|11946384|FG002|Overall Study|Device Malfunction|1
7569676|NCT03462680|11946394|FG000|Overall Study|Withdrawal by Subject|3
7569677|NCT03462680|11946395|FG001|Overall Study|Withdrawal by Subject|5
7360025|NCT01011933|11605560|FG000|Overall Study|Improper pre-protocol Rx|1
7360026|NCT01011933|11605560|FG000|Overall Study|Inadequate pathology|1
7360027|NCT01011933|11605560|FG000|Overall Study|Never treated|1
7360028|NCT01011946|11605570|FG000|Overall Study|Transferred to another hospital|2
7360029|NCT01011946|11605570|FG000|Overall Study|No pathological lab value|1
7360030|NCT01012037|11605577|FG000|Overall Study|Adverse Event|0
7360031|NCT01012037|11605578|FG001|Overall Study|Adverse Event|8
7360032|NCT01012037|11605579|FG002|Overall Study|Adverse Event|3
7360033|NCT01012037|11605577|FG000|Overall Study|Protocol Violation|0
7360034|NCT01012037|11605578|FG001|Overall Study|Protocol Violation|3
7360035|NCT01012037|11605579|FG002|Overall Study|Protocol Violation|5
7360036|NCT01012037|11605577|FG000|Overall Study|Withdrawal by Subject|0
7360037|NCT01012037|11605578|FG001|Overall Study|Withdrawal by Subject|4
7360038|NCT01012037|11605579|FG002|Overall Study|Withdrawal by Subject|1
7360039|NCT01012037|11605577|FG000|Overall Study|Other reason (not specified)|1
7360040|NCT01012037|11605578|FG001|Overall Study|Other reason (not specified)|1
7360041|NCT01012037|11605579|FG002|Overall Study|Other reason (not specified)|1
7360042|NCT01012219|11605595|FG000|Period 1|Withdrawal by Subject|1
7360043|NCT01012219|11605595|FG000|Period 2|Withdrawal by Subject|1
7360044|NCT01012258|11605617|FG000|Overall Study|Death|14
7360045|NCT01012258|11605617|FG000|Overall Study|Lost to Follow-up|1
7360046|NCT01012258|11605617|FG000|Overall Study|Adverse Event|1
7360047|NCT01012258|11605617|FG000|Overall Study|Progressive Disease (PD)|18
7360048|NCT01012258|11605617|FG000|Overall Study|Symptomatic Deterioration|1
7360049|NCT01012258|11605617|FG000|Overall Study|Another Anti-cancer Drug Received|1
7360050|NCT01012258|11605617|FG000|Overall Study|Another Tumor Discovered|1
7360051|NCT01012258|11605617|FG000|Overall Study|Ongoing|29
7360052|NCT01012323|11605631|FG000|Overall Study|Investigator Judgment|1
7360053|NCT01012440|11605668|FG000|Overall Study|Withdrawal by Subject|2
7360054|NCT01012622|11605676|FG000|Overall Study|Withdrawal by Subject|6
7360055|NCT01012622|11605676|FG000|Overall Study|Lost to Follow-up|5
7360056|NCT01012622|11605676|FG000|Overall Study|Adverse Event|7
7360057|NCT01012622|11605676|FG000|Overall Study|non-compliance with the drug|9
7360058|NCT01012622|11605676|FG000|Overall Study|Other|1
7360059|NCT01012622|11605676|FG000|Overall Study|screening failure|1
7360060|NCT01012622|11605676|FG000|Overall Study|withdrawal of consent by a parent|2
7360061|NCT01012713|11605694|FG000|Overall Study|Lack of Efficacy|3
7360062|NCT01012739|11605699|FG000|Treatment Period 1|Adverse Event|0
7360063|NCT01012739|11605700|FG001|Treatment Period 1|Adverse Event|0
7360064|NCT01012739|11605701|FG002|Treatment Period 1|Adverse Event|0
7360065|NCT01012739|11605702|FG003|Treatment Period 1|Adverse Event|1
7360066|NCT01012739|11605699|FG000|Treatment Period 2|Abnormal test procedure results|0
7360067|NCT01012739|11605700|FG001|Treatment Period 2|Abnormal test procedure results|0
7360068|NCT01012739|11605701|FG002|Treatment Period 2|Abnormal test procedure results|0
7360069|NCT01012739|11605702|FG003|Treatment Period 2|Abnormal test procedure results|1
7360070|NCT01012765|11605713|FG000|Treatment Period 1|Adverse Event|1
7360071|NCT01012765|11605714|FG001|Treatment Period 1|Adverse Event|0
7360072|NCT01012765|11605715|FG002|Treatment Period 1|Adverse Event|1
7360073|NCT01012765|11605716|FG003|Treatment Period 1|Adverse Event|0
7360074|NCT01012765|11605717|FG004|Treatment Period 1|Adverse Event|0
7360075|NCT01012765|11605718|FG005|Treatment Period 1|Adverse Event|0
7360076|NCT01012765|11605713|FG000|Treatment Period 1|Withdrawal by Subject|2
7360077|NCT01012765|11605714|FG001|Treatment Period 1|Withdrawal by Subject|0
7360078|NCT01012765|11605715|FG002|Treatment Period 1|Withdrawal by Subject|0
7360079|NCT01012765|11605716|FG003|Treatment Period 1|Withdrawal by Subject|0
7360080|NCT01012765|11605717|FG004|Treatment Period 1|Withdrawal by Subject|0
7360081|NCT01012765|11605718|FG005|Treatment Period 1|Withdrawal by Subject|0
7360082|NCT01012765|11605713|FG000|Treatment Period 1|Administrative problems|0
7360083|NCT01012765|11605714|FG001|Treatment Period 1|Administrative problems|0
7360084|NCT01012765|11605715|FG002|Treatment Period 1|Administrative problems|1
7360085|NCT01012765|11605716|FG003|Treatment Period 1|Administrative problems|1
7360086|NCT01012765|11605717|FG004|Treatment Period 1|Administrative problems|1
7360087|NCT01012765|11605718|FG005|Treatment Period 1|Administrative problems|0
7360088|NCT01012765|11605713|FG000|Treatment Period 1|Protocol Violation|0
7360089|NCT01012765|11605714|FG001|Treatment Period 1|Protocol Violation|0
7360090|NCT01012765|11605715|FG002|Treatment Period 1|Protocol Violation|0
7360091|NCT01012765|11605716|FG003|Treatment Period 1|Protocol Violation|2
7360092|NCT01012765|11605717|FG004|Treatment Period 1|Protocol Violation|1
7360093|NCT01012765|11605718|FG005|Treatment Period 1|Protocol Violation|0
7360094|NCT01012765|11605713|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
7360095|NCT01012765|11605714|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
7360096|NCT01012765|11605715|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
7360097|NCT01012765|11605716|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
7360098|NCT01012765|11605717|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
7360099|NCT01012765|11605718|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
7360100|NCT01012765|11605713|FG000|Treatment Period 2|Withdrawal by Subject|1
7360101|NCT01012765|11605714|FG001|Treatment Period 2|Withdrawal by Subject|0
7360102|NCT01012765|11605715|FG002|Treatment Period 2|Withdrawal by Subject|1
7360103|NCT01012765|11605716|FG003|Treatment Period 2|Withdrawal by Subject|0
7360104|NCT01012765|11605717|FG004|Treatment Period 2|Withdrawal by Subject|1
7360105|NCT01012765|11605718|FG005|Treatment Period 2|Withdrawal by Subject|0
7360106|NCT01012765|11605713|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
7360107|NCT01012765|11605714|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
7360108|NCT01012765|11605715|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
7360109|NCT01012765|11605716|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
7360110|NCT01012765|11605717|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
7360111|NCT01012765|11605718|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
7360112|NCT01012765|11605713|FG000|Treatment Period 2|Adverse Event|0
7360113|NCT01012765|11605714|FG001|Treatment Period 2|Adverse Event|1
7360114|NCT01012765|11605715|FG002|Treatment Period 2|Adverse Event|1
7360115|NCT01012765|11605716|FG003|Treatment Period 2|Adverse Event|0
7360116|NCT01012765|11605717|FG004|Treatment Period 2|Adverse Event|0
7360117|NCT01012765|11605718|FG005|Treatment Period 2|Adverse Event|0
7360118|NCT01012765|11605713|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
7360119|NCT01012765|11605714|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
7360120|NCT01012765|11605715|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
7360121|NCT01012765|11605716|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
7360122|NCT01012765|11605717|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
7360123|NCT01012765|11605718|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
7360124|NCT01012947|11605740|FG000|Overall Study|Lost to Follow-up|131
7360125|NCT01012947|11605741|FG001|Overall Study|Lost to Follow-up|135
7360126|NCT01012947|11605742|FG002|Overall Study|Lost to Follow-up|130
7360127|NCT01012947|11605743|FG003|Overall Study|Lost to Follow-up|118
7360128|NCT01012947|11605744|FG004|Overall Study|Lost to Follow-up|142
7360129|NCT01012973|11605758|FG000|Overall Study|Adverse Event|5
7360130|NCT01012973|11605759|FG001|Overall Study|Adverse Event|5
7360131|NCT01012973|11605758|FG000|Overall Study|Lack of Efficacy|0
7360132|NCT01012973|11605759|FG001|Overall Study|Lack of Efficacy|5
7360133|NCT01012973|11605758|FG000|Overall Study|Lost to Follow-up|1
7360134|NCT01012973|11605759|FG001|Overall Study|Lost to Follow-up|0
7360135|NCT01012973|11605758|FG000|Overall Study|(Overseas travel - indefinite period)|1
7360136|NCT01012973|11605759|FG001|Overall Study|(Overseas travel - indefinite period)|0
7360137|NCT01012973|11605758|FG000|Overall Study|Increase in vis. acuity, never injected|0
7360138|NCT01012973|11605759|FG001|Overall Study|Increase in vis. acuity, never injected|1
7360139|NCT01012973|11605758|FG000|Overall Study|Protocol Violation|5
7360140|NCT01012973|11605759|FG001|Overall Study|Protocol Violation|2
7360141|NCT01012973|11605758|FG000|Overall Study|Withdrawal by Subject|4
7360142|NCT01012973|11605759|FG001|Overall Study|Withdrawal by Subject|6
7360143|NCT01012999|11605769|FG000|Overall Study|Protocol Violation|1
7360144|NCT01013207|11605786|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
7360145|NCT01013285|11605792|FG000|Overall Study|Death|48
7360146|NCT01013285|11605793|FG001|Overall Study|Death|89
7360147|NCT01013350|11605800|FG000|Overall Study|Lost to Follow-up|15
7360148|NCT01013350|11605801|FG001|Overall Study|Lost to Follow-up|95
7360149|NCT01013350|11605800|FG000|Overall Study|Adverse Event|0
7360150|NCT01013350|11605801|FG001|Overall Study|Adverse Event|1
7360151|NCT01013350|11605800|FG000|Overall Study|Physician Decision|4
7360152|NCT01013350|11605801|FG001|Overall Study|Physician Decision|20
7360153|NCT01013350|11605800|FG000|Overall Study|Withdrawal by Subject|15
7360154|NCT01013350|11605801|FG001|Overall Study|Withdrawal by Subject|38
7360155|NCT01013350|11605800|FG000|Overall Study|Death|3
7360156|NCT01013350|11605801|FG001|Overall Study|Death|5
7360157|NCT01013350|11605800|FG000|Overall Study|Participant entered interventional study|0
7360158|NCT01013350|11605801|FG001|Overall Study|Participant entered interventional study|8
7360159|NCT01013350|11605800|FG000|Overall Study|Other|1
7360160|NCT01013350|11605801|FG001|Overall Study|Other|25
7360161|NCT01013597|11605808|FG000|Overall Study|Withdrawal by Subject|1
7360162|NCT01013740|11605814|FG000|Overall Study|Lost to Follow-up|3
7360163|NCT01013740|11605815|FG001|Overall Study|Lost to Follow-up|5
7360164|NCT01013740|11605814|FG000|Overall Study|Physician Decision|2
7360165|NCT01013740|11605815|FG001|Overall Study|Physician Decision|0
7360166|NCT01013740|11605814|FG000|Overall Study|Withdrawal by Subject|2
7360167|NCT01013740|11605815|FG001|Overall Study|Withdrawal by Subject|10
7360168|NCT01013740|11605814|FG000|Overall Study|study close / terminated : done in error|2
7360169|NCT01013740|11605815|FG001|Overall Study|study close / terminated : done in error|1
7360170|NCT01013740|11605814|FG000|Overall Study|Missing|2
7360171|NCT01013740|11605815|FG001|Overall Study|Missing|1
7360172|NCT01013740|11605814|FG000|Overall Study|Ongoing: Study records not completed|0
7360173|NCT01013740|11605815|FG001|Overall Study|Ongoing: Study records not completed|2
7360174|NCT01013753|11605823|FG000|Overall Study|Adverse Event|8
7360175|NCT01013753|11605823|FG000|Overall Study|Protocol Violation|3
7360176|NCT01013753|11605823|FG000|Overall Study|Lost to Follow-up|1
7360177|NCT01013753|11605823|FG000|Overall Study|Withdrawal by Subject|2
7360178|NCT01013753|11605823|FG000|Overall Study|Other|2
7360179|NCT01013792|11605839|FG000|Overall Study|Study suspended|2
7360180|NCT01013792|11605840|FG001|Overall Study|Study suspended|1
7360181|NCT01013792|11605839|FG000|Overall Study|Adverse Event|0
7360182|NCT01013792|11605840|FG001|Overall Study|Adverse Event|3
7360183|NCT01013792|11605839|FG000|Overall Study|Lost to Follow-up|0
7360184|NCT01013792|11605840|FG001|Overall Study|Lost to Follow-up|1
7360185|NCT01013870|11605861|FG000|Overall Study|Lost to Follow-up|1
7360186|NCT01013870|11605862|FG001|Overall Study|Lost to Follow-up|3
7360187|NCT01013883|11605870|FG000|Overall Study|Lost to Follow-up|2
7360188|NCT01013883|11605871|FG001|Overall Study|Lost to Follow-up|2
7360189|NCT01013961|11605879|FG000|Overall Study|Adverse Event|2
7360190|NCT01013961|11605880|FG001|Overall Study|Adverse Event|2
7360191|NCT01013961|11605879|FG000|Overall Study|Withdrawal by Subject|1
7360192|NCT01013961|11605880|FG001|Overall Study|Withdrawal by Subject|0
7360193|NCT01013961|11605879|FG000|Overall Study|Physician Decision|0
7569678|NCT03463031|11946423|FG000|Overall Study|Withdrawal by Subject|4
7569679|NCT03463031|11946424|FG001|Overall Study|Withdrawal by Subject|2
7360194|NCT01013961|11605880|FG001|Overall Study|Physician Decision|1
7360195|NCT01014013|11605888|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
7360196|NCT01014013|11605889|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
7360197|NCT01014013|11605888|FG000|Overall Study|Clinical adverse experience|4
7360198|NCT01014013|11605889|FG001|Overall Study|Clinical adverse experience|2
7360199|NCT01014013|11605888|FG000|Overall Study|Laboratory adverse experience|1
7360200|NCT01014013|11605889|FG001|Overall Study|Laboratory adverse experience|1
7360201|NCT01014013|11605888|FG000|Overall Study|Protocol Violation|1
7360202|NCT01014013|11605889|FG001|Overall Study|Protocol Violation|3
7360203|NCT01014013|11605888|FG000|Overall Study|Withdrawal by Subject|7
7569680|NCT03463031|11946423|FG000|Overall Study|Investigator/Sponsor Decision|0
7360204|NCT01014013|11605889|FG001|Overall Study|Withdrawal by Subject|4
7360205|NCT01014013|11605888|FG000|Overall Study|Clinical/microbiologic failure|1
7360206|NCT01014013|11605889|FG001|Overall Study|Clinical/microbiologic failure|2
7360207|NCT01014013|11605888|FG000|Overall Study|Pathogen culture = no growth|26
7360208|NCT01014013|11605889|FG001|Overall Study|Pathogen culture = no growth|34
7360209|NCT01014013|11605888|FG000|Overall Study|Negative urine culture|2
7360210|NCT01014013|11605889|FG001|Overall Study|Negative urine culture|0
7360211|NCT01014013|11605888|FG000|Overall Study|Pathogen resistant|7
7360212|NCT01014013|11605889|FG001|Overall Study|Pathogen resistant|4
7360213|NCT01014013|11605888|FG000|Overall Study|Physician Decision|0
7360214|NCT01014013|11605889|FG001|Overall Study|Physician Decision|1
7360215|NCT01014013|11605888|FG000|Overall Study|Another antibiotic therapy required|0
7360216|NCT01014013|11605889|FG001|Overall Study|Another antibiotic therapy required|1
7360217|NCT01014013|11605888|FG000|Overall Study|Appendectomy|1
7360218|NCT01014013|11605889|FG001|Overall Study|Appendectomy|0
7360219|NCT01014013|11605888|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
7360220|NCT01014013|11605889|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
7360221|NCT01014143|11605934|FG000|Second Intervention|Lost to Follow-up|2
7360222|NCT01014143|11605935|FG001|Second Intervention|Lost to Follow-up|0
7360223|NCT01014143|11605936|FG002|Second Intervention|Lost to Follow-up|0
7360224|NCT01014208|11605955|FG000|Overall Study|Lost to Follow-up|2
7360225|NCT01014208|11605956|FG001|Overall Study|Lost to Follow-up|5
7360226|NCT01014208|11605955|FG000|Overall Study|Participant Withdrew Consent|12
7360227|NCT01014208|11605956|FG001|Overall Study|Participant Withdrew Consent|12
7360228|NCT01014208|11605955|FG000|Overall Study|Did Not Receive Study Drug|2
7360229|NCT01014208|11605956|FG001|Overall Study|Did Not Receive Study Drug|0
7360230|NCT01014208|11605955|FG000|Overall Study|Study Closed/terminated|78
7360231|NCT01014208|11605956|FG001|Overall Study|Study Closed/terminated|83
7360232|NCT01014442|11605981|FG000|Overall Study|Adverse Event|0
7360233|NCT01014442|11605982|FG001|Overall Study|Adverse Event|8
7360234|NCT01014442|11605981|FG000|Overall Study|Withdrawal by Subject|4
7360235|NCT01014442|11605982|FG001|Overall Study|Withdrawal by Subject|4
7360236|NCT01014442|11605981|FG000|Overall Study|Protocol Violation|2
7569681|NCT03463031|11946424|FG001|Overall Study|Investigator/Sponsor Decision|1
7569682|NCT03463031|11946423|FG000|Overall Study|Lost to Follow-up|1
7569683|NCT03463031|11946424|FG001|Overall Study|Lost to Follow-up|1
7569684|NCT03463031|11946423|FG000|Overall Study|Adverse Event|4
7569685|NCT03463031|11946424|FG001|Overall Study|Adverse Event|1
7360237|NCT01014442|11605982|FG001|Overall Study|Protocol Violation|5
7360238|NCT01014442|11605981|FG000|Overall Study|Lack of Compliance|0
7360239|NCT01014442|11605982|FG001|Overall Study|Lack of Compliance|1
7360240|NCT01014442|11605981|FG000|Overall Study|Unspecified Reason|1
7360241|NCT01014442|11605982|FG001|Overall Study|Unspecified Reason|1
7360242|NCT01014533|11606003|FG000|Overall Study|Protocol Violation|3
7360243|NCT01014533|11606004|FG001|Overall Study|Protocol Violation|2
7360244|NCT01014533|11606003|FG000|Overall Study|Withdrawal by Subject|2
7360245|NCT01014533|11606004|FG001|Overall Study|Withdrawal by Subject|0
7360246|NCT01014533|11606003|FG000|Overall Study|unable to come to appointment|0
7360247|NCT01014533|11606004|FG001|Overall Study|unable to come to appointment|3
7360248|NCT01014585|11606015|FG000|Overall Study|Adverse Event|0
7360249|NCT01014585|11606016|FG001|Overall Study|Adverse Event|2
7360250|NCT01014585|11606017|FG002|Overall Study|Adverse Event|0
7360251|NCT01014585|11606018|FG003|Overall Study|Adverse Event|3
7360252|NCT01014585|11606015|FG000|Overall Study|Withdrawal by Subject|2
7360253|NCT01014585|11606016|FG001|Overall Study|Withdrawal by Subject|0
7360254|NCT01014585|11606017|FG002|Overall Study|Withdrawal by Subject|1
7360255|NCT01014585|11606018|FG003|Overall Study|Withdrawal by Subject|3
7360256|NCT01014585|11606015|FG000|Overall Study|Lost to Follow-up|0
7360257|NCT01014585|11606016|FG001|Overall Study|Lost to Follow-up|0
7360258|NCT01014585|11606017|FG002|Overall Study|Lost to Follow-up|0
7360259|NCT01014585|11606018|FG003|Overall Study|Lost to Follow-up|2
7360260|NCT01014585|11606015|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
7360261|NCT01014585|11606016|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
7360262|NCT01014585|11606017|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7360263|NCT01014585|11606018|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
7360264|NCT01014624|11606030|FG000|Overall Study|Adverse Event|0
7360265|NCT01014624|11606031|FG001|Overall Study|Adverse Event|1
7360266|NCT01014624|11606030|FG000|Overall Study|Protocol Violation|1
7360267|NCT01014624|11606031|FG001|Overall Study|Protocol Violation|0
7360268|NCT01014624|11606030|FG000|Overall Study|Withdrawal by Subject|1
7360269|NCT01014624|11606031|FG001|Overall Study|Withdrawal by Subject|0
7360270|NCT01014689|11606041|FG000|Overall Study|Lack of Efficacy|0
7360271|NCT01014689|11606042|FG001|Overall Study|Lack of Efficacy|1
7360272|NCT01014689|11606041|FG000|Overall Study|Adverse Event|3
7360273|NCT01014689|11606042|FG001|Overall Study|Adverse Event|0
7360274|NCT01014689|11606041|FG000|Overall Study|Withdrawal by Subject|5
7360275|NCT01014689|11606042|FG001|Overall Study|Withdrawal by Subject|4
7360276|NCT01014689|11606041|FG000|Overall Study|Protocol Violation|1
7360277|NCT01014689|11606042|FG001|Overall Study|Protocol Violation|1
7360278|NCT01014689|11606041|FG000|Overall Study|Lost to Follow-up|3
7360279|NCT01014689|11606042|FG001|Overall Study|Lost to Follow-up|7
7360280|NCT01014689|11606041|FG000|Overall Study|Pregnancy|1
7360281|NCT01014689|11606042|FG001|Overall Study|Pregnancy|0
7360282|NCT01014910|11606074|FG000|Overall Study|Withdrawal by Subject|0
7360283|NCT01014910|11606075|FG001|Overall Study|Withdrawal by Subject|2
7569686|NCT03463031|11946423|FG000|Overall Study|Use of prohibited medication by subject|1
7360284|NCT01014975|11606152|FG000|Overall Study|Withdrawal by Subject|1
7360285|NCT01014975|11606153|FG001|Overall Study|Withdrawal by Subject|0
7360286|NCT01014975|11606154|FG002|Overall Study|Withdrawal by Subject|1
7360287|NCT01014975|11606152|FG000|Overall Study|Death|3
7360288|NCT01014975|11606153|FG001|Overall Study|Death|3
7360289|NCT01014975|11606154|FG002|Overall Study|Death|4
7360290|NCT01014975|11606152|FG000|Overall Study|Lost to Follow-up|0
7360291|NCT01014975|11606153|FG001|Overall Study|Lost to Follow-up|0
7360292|NCT01014975|11606154|FG002|Overall Study|Lost to Follow-up|1
7360293|NCT01014988|11606168|FG000|Overall Study|Adverse Event|20
7360294|NCT01014988|11606169|FG001|Overall Study|Adverse Event|0
7360295|NCT01014988|11606170|FG002|Overall Study|Adverse Event|1
7360296|NCT01014988|11606171|FG003|Overall Study|Adverse Event|0
7360297|NCT01014988|11606172|FG004|Overall Study|Adverse Event|1
7360298|NCT01014988|11606173|FG005|Overall Study|Adverse Event|3
7360299|NCT01014988|11606168|FG000|Overall Study|Lost to Follow-up|1
7360300|NCT01014988|11606169|FG001|Overall Study|Lost to Follow-up|0
7360301|NCT01014988|11606170|FG002|Overall Study|Lost to Follow-up|1
7360302|NCT01014988|11606171|FG003|Overall Study|Lost to Follow-up|0
7360303|NCT01014988|11606172|FG004|Overall Study|Lost to Follow-up|0
7360304|NCT01014988|11606173|FG005|Overall Study|Lost to Follow-up|0
7360305|NCT01014988|11606168|FG000|Overall Study|Physician Decision|1
7360306|NCT01014988|11606169|FG001|Overall Study|Physician Decision|0
7360307|NCT01014988|11606170|FG002|Overall Study|Physician Decision|0
7360308|NCT01014988|11606171|FG003|Overall Study|Physician Decision|0
7360309|NCT01014988|11606172|FG004|Overall Study|Physician Decision|0
7360310|NCT01014988|11606173|FG005|Overall Study|Physician Decision|0
7360311|NCT01014988|11606168|FG000|Overall Study|Withdrawal by Subject|1
7360312|NCT01014988|11606169|FG001|Overall Study|Withdrawal by Subject|0
7360313|NCT01014988|11606170|FG002|Overall Study|Withdrawal by Subject|0
7360314|NCT01014988|11606171|FG003|Overall Study|Withdrawal by Subject|0
7360315|NCT01014988|11606172|FG004|Overall Study|Withdrawal by Subject|0
7360316|NCT01014988|11606173|FG005|Overall Study|Withdrawal by Subject|0
7360317|NCT01015118|11606197|FG000|Overall Study|Protocol Violation|5
7360318|NCT01015118|11606198|FG001|Overall Study|Protocol Violation|6
7360319|NCT01015118|11606197|FG000|Overall Study|Withdrawal by Subject|103
7360320|NCT01015118|11606198|FG001|Overall Study|Withdrawal by Subject|27
7360321|NCT01015118|11606197|FG000|Overall Study|Other Adverse Event (AE)|141
7360322|NCT01015118|11606198|FG001|Overall Study|Other Adverse Event (AE)|33
7360323|NCT01015118|11606197|FG000|Overall Study|Worsening or AE of underlying disease|5
7360324|NCT01015118|11606198|FG001|Overall Study|Worsening or AE of underlying disease|4
7360325|NCT01015118|11606197|FG000|Overall Study|Progressive disease|364
7360326|NCT01015118|11606198|FG001|Overall Study|Progressive disease|229
7360327|NCT01015118|11606197|FG000|Overall Study|Not treated|9
7360328|NCT01015118|11606198|FG001|Overall Study|Not treated|5
7360329|NCT01015118|11606197|FG000|Overall Study|Other than stated above|42
7360330|NCT01015118|11606198|FG001|Overall Study|Other than stated above|23
7360331|NCT01015131|11606204|FG000|Overall Study|Physician Decision|1
7360332|NCT01015131|11606204|FG000|Overall Study|Protocol Violation|1
7360333|NCT01015131|11606204|FG000|Overall Study|Withdrawal by Subject|2
7360334|NCT01015131|11606204|FG000|Overall Study|Other Protocol Specified Criteria|4
7386371|NCT01210495|11644911|FG000|Overall Study|Lost to Follow-up|0
7386372|NCT01210495|11644912|FG001|Overall Study|Lost to Follow-up|0
7386373|NCT01210495|11644913|FG002|Overall Study|Lost to Follow-up|1
7386374|NCT01210495|11644914|FG003|Overall Study|Lost to Follow-up|1
7386375|NCT01210495|11644911|FG000|Overall Study|Other unspecified|0
7386376|NCT01210495|11644912|FG001|Overall Study|Other unspecified|0
7386377|NCT01210495|11644913|FG002|Overall Study|Other unspecified|6
7386378|NCT01210495|11644914|FG003|Overall Study|Other unspecified|0
7386379|NCT01210651|11644949|FG000|Overall Study|Lost to Follow-up|1
7386380|NCT01210651|11644950|FG001|Overall Study|Lost to Follow-up|1
7386381|NCT01210651|11644949|FG000|Overall Study|schedule conflicts|1
7386382|NCT01210651|11644950|FG001|Overall Study|schedule conflicts|5
7386383|NCT01210651|11644949|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
7386384|NCT01210651|11644950|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
7386385|NCT01210651|11644949|FG000|Overall Study|Withdrawal by Subject|1
7386386|NCT01210651|11644950|FG001|Overall Study|Withdrawal by Subject|1
7386387|NCT01210651|11644949|FG000|Overall Study|Injury outside study|2
7386388|NCT01210651|11644950|FG001|Overall Study|Injury outside study|0
7386389|NCT01210664|11644960|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7386390|NCT01210664|11644961|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7386391|NCT01210664|11644962|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
7386392|NCT01210664|11644963|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
7386393|NCT01210664|11644960|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7386394|NCT01210664|11644961|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7386395|NCT01210664|11644962|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
7386396|NCT01210664|11644963|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
7386397|NCT01210664|11644960|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7386398|NCT01210664|11644961|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7386399|NCT01210664|11644962|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
7386400|NCT01210664|11644963|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
7386401|NCT01210690|11644973|FG000|Overall Study|Adverse Event|7
7386402|NCT01210690|11644973|FG000|Overall Study|Lack of Efficacy|12
7386403|NCT01210690|11644973|FG000|Overall Study|Lost to Follow-up|3
7386404|NCT01210690|11644973|FG000|Overall Study|Disease Remission|1
7386405|NCT01210690|11644973|FG000|Overall Study|Withdrawal by Subject|1
7360335|NCT01015287|11606216|FG000|Overall Study|Death|21
7360336|NCT01015287|11606217|FG001|Overall Study|Death|16
7360337|NCT01015287|11606216|FG000|Overall Study|Adverse Event|1
7360338|NCT01015287|11606217|FG001|Overall Study|Adverse Event|0
7360339|NCT01015287|11606216|FG000|Overall Study|Sponsor Decision|3
7360340|NCT01015287|11606217|FG001|Overall Study|Sponsor Decision|7
7360341|NCT01015287|11606216|FG000|Overall Study|Physician Decision|19
7360342|NCT01015287|11606217|FG001|Overall Study|Physician Decision|21
7360343|NCT01015287|11606216|FG000|Overall Study|Withdrawal by Subject|14
7460102|NCT01824342|11755260|FG000|Overall Study|Withdrawal by Subject|0
7460103|NCT01824342|11755261|FG001|Overall Study|Withdrawal by Subject|3
7460104|NCT01824342|11755260|FG000|Overall Study|Adverse Event|1
7460105|NCT01824342|11755261|FG001|Overall Study|Adverse Event|1
7460106|NCT01824342|11755260|FG000|Overall Study|Disease Progression|1
7460107|NCT01824342|11755261|FG001|Overall Study|Disease Progression|1
7460108|NCT01824342|11755260|FG000|Overall Study|Physician Decision|5
7460109|NCT01824342|11755261|FG001|Overall Study|Physician Decision|0
7460110|NCT01824342|11755260|FG000|Overall Study|Death|2
7460111|NCT01824342|11755261|FG001|Overall Study|Death|0
7468331|NCT01909791|11769085|FG002|Overall Study|Lost to Follow-up|10
7468332|NCT01909791|11769083|FG000|Overall Study|Missed Visit|2
7468333|NCT01909791|11769084|FG001|Overall Study|Missed Visit|0
7468334|NCT01909791|11769085|FG002|Overall Study|Missed Visit|1
7468335|NCT01909804|11769110|FG000|Overall Study|Randomized but Never Treated|0
7468336|NCT01909804|11769111|FG001|Overall Study|Randomized but Never Treated|0
7468337|NCT01909804|11769112|FG002|Overall Study|Randomized but Never Treated|0
7468338|NCT01909804|11769113|FG003|Overall Study|Randomized but Never Treated|0
7468339|NCT01909804|11769114|FG004|Overall Study|Randomized but Never Treated|0
7468340|NCT01909804|11769115|FG005|Overall Study|Randomized but Never Treated|0
7468341|NCT01909804|11769116|FG006|Overall Study|Randomized but Never Treated|1
7468342|NCT01909804|11769117|FG007|Overall Study|Randomized but Never Treated|0
7468343|NCT01909804|11769118|FG008|Overall Study|Randomized but Never Treated|0
7468344|NCT01909804|11769119|FG009|Overall Study|Randomized but Never Treated|0
7468345|NCT01909804|11769120|FG010|Overall Study|Randomized but Never Treated|0
7468346|NCT01909804|11769121|FG011|Overall Study|Randomized but Never Treated|1
7468347|NCT01909804|11769110|FG000|Overall Study|Death|0
7569687|NCT03463031|11946424|FG001|Overall Study|Use of prohibited medication by subject|0
7569688|NCT03464383|11946466|FG000|Overall Study|Lost to Follow-up|1
7569689|NCT03464383|11946467|FG001|Overall Study|Lost to Follow-up|0
7569690|NCT03464383|11946468|FG002|Overall Study|Lost to Follow-up|0
7569691|NCT03464383|11946466|FG000|Overall Study|Withdrawal by Subject|0
7569692|NCT03464383|11946467|FG001|Overall Study|Withdrawal by Subject|1
7468348|NCT01909804|11769111|FG001|Overall Study|Death|0
7468349|NCT01909804|11769112|FG002|Overall Study|Death|0
7468350|NCT01909804|11769113|FG003|Overall Study|Death|0
7468351|NCT01909804|11769114|FG004|Overall Study|Death|0
7468352|NCT01909804|11769115|FG005|Overall Study|Death|0
7468353|NCT01909804|11769116|FG006|Overall Study|Death|0
7468354|NCT01909804|11769117|FG007|Overall Study|Death|0
7468355|NCT01909804|11769118|FG008|Overall Study|Death|0
7468356|NCT01909804|11769119|FG009|Overall Study|Death|0
7468357|NCT01909804|11769120|FG010|Overall Study|Death|1
7468358|NCT01909804|11769121|FG011|Overall Study|Death|0
7468359|NCT01909804|11769110|FG000|Overall Study|Lack of Efficacy|4
7468360|NCT01909804|11769111|FG001|Overall Study|Lack of Efficacy|1
7468361|NCT01909804|11769112|FG002|Overall Study|Lack of Efficacy|0
7468362|NCT01909804|11769113|FG003|Overall Study|Lack of Efficacy|0
7468363|NCT01909804|11769114|FG004|Overall Study|Lack of Efficacy|7
7468364|NCT01909804|11769115|FG005|Overall Study|Lack of Efficacy|3
7468365|NCT01909804|11769116|FG006|Overall Study|Lack of Efficacy|1
7468366|NCT01909804|11769117|FG007|Overall Study|Lack of Efficacy|1
7468367|NCT01909804|11769118|FG008|Overall Study|Lack of Efficacy|0
7468368|NCT01909804|11769119|FG009|Overall Study|Lack of Efficacy|1
7468369|NCT01909804|11769120|FG010|Overall Study|Lack of Efficacy|0
7468370|NCT01909804|11769121|FG011|Overall Study|Lack of Efficacy|1
7569693|NCT03464383|11946468|FG002|Overall Study|Withdrawal by Subject|0
7468371|NCT01909804|11769110|FG000|Overall Study|Withdrew Consent|0
7468372|NCT01909804|11769111|FG001|Overall Study|Withdrew Consent|0
7468373|NCT01909804|11769112|FG002|Overall Study|Withdrew Consent|0
7468374|NCT01909804|11769113|FG003|Overall Study|Withdrew Consent|0
7468375|NCT01909804|11769114|FG004|Overall Study|Withdrew Consent|1
7468376|NCT01909804|11769115|FG005|Overall Study|Withdrew Consent|1
7468377|NCT01909804|11769116|FG006|Overall Study|Withdrew Consent|0
7468378|NCT01909804|11769117|FG007|Overall Study|Withdrew Consent|0
7468379|NCT01909804|11769118|FG008|Overall Study|Withdrew Consent|0
7468380|NCT01909804|11769119|FG009|Overall Study|Withdrew Consent|0
7468381|NCT01909804|11769120|FG010|Overall Study|Withdrew Consent|0
7468382|NCT01909804|11769121|FG011|Overall Study|Withdrew Consent|0
7468383|NCT01909804|11769110|FG000|Overall Study|Protocol Violation|0
7468384|NCT01909804|11769111|FG001|Overall Study|Protocol Violation|0
7468385|NCT01909804|11769112|FG002|Overall Study|Protocol Violation|0
7468386|NCT01909804|11769113|FG003|Overall Study|Protocol Violation|0
7468387|NCT01909804|11769114|FG004|Overall Study|Protocol Violation|0
7468388|NCT01909804|11769115|FG005|Overall Study|Protocol Violation|0
7468389|NCT01909804|11769116|FG006|Overall Study|Protocol Violation|0
7569694|NCT03464422|11946477|FG000|Overall Study|Lost to Follow-up|2
7468390|NCT01909804|11769117|FG007|Overall Study|Protocol Violation|0
7360344|NCT01015287|11606217|FG001|Overall Study|Withdrawal by Subject|19
7360345|NCT01015287|11606216|FG000|Overall Study|Entry Criteria not Met|11
7360346|NCT01015287|11606217|FG001|Overall Study|Entry Criteria not Met|14
7360347|NCT01015287|11606216|FG000|Overall Study|Lost to Follow-up|2
7360348|NCT01015287|11606217|FG001|Overall Study|Lost to Follow-up|1
7569695|NCT03464422|11946477|FG000|Overall Study|Withdrawal by Subject|2
7569696|NCT03465436|11946487|FG000|Period 1|Protocol Violation|0
7569697|NCT03465436|11946488|FG001|Period 1|Protocol Violation|0
7569698|NCT03465436|11946489|FG002|Period 1|Protocol Violation|1
7569699|NCT03465436|11946490|FG003|Period 1|Protocol Violation|0
7569700|NCT03465436|11946487|FG000|Period 2|Protocol Violation|0
7569701|NCT03465436|11946488|FG001|Period 2|Protocol Violation|1
7569702|NCT03465436|11946489|FG002|Period 2|Protocol Violation|0
7569703|NCT03465436|11946490|FG003|Period 2|Protocol Violation|0
7569704|NCT03465436|11946487|FG000|Period 3|Protocol Violation|1
7360349|NCT01015287|11606216|FG000|Overall Study|Protocol Violation|1
7360350|NCT01015287|11606217|FG001|Overall Study|Protocol Violation|1
7360351|NCT01015560|11606255|FG000|Overall Study|Adverse Event|1
7360352|NCT01015560|11606255|FG000|Overall Study|Not protocol specified|1
7360353|NCT01015560|11606255|FG000|Overall Study|Withdrawal by Subject|1
7360354|NCT01015612|11606268|FG000|Overall Study|Death|113
7360355|NCT01015612|11606268|FG000|Overall Study|Withdrawal by Subject|40
7360356|NCT01015638|11606274|FG000|Overall Study|Withdrawal by Subject|1
7360357|NCT01015638|11606275|FG001|Overall Study|Withdrawal by Subject|0
7360358|NCT01015677|11606284|FG000|Overall Study|Adverse Event|0
7360359|NCT01015677|11606285|FG001|Overall Study|Adverse Event|1
7360360|NCT01015677|11606286|FG002|Overall Study|Adverse Event|0
7360361|NCT01015677|11606284|FG000|Overall Study|Lack of Efficacy|0
7360362|NCT01015677|11606285|FG001|Overall Study|Lack of Efficacy|1
7360363|NCT01015677|11606286|FG002|Overall Study|Lack of Efficacy|0
7360364|NCT01015677|11606284|FG000|Overall Study|Protocol Violation|0
7360365|NCT01015677|11606285|FG001|Overall Study|Protocol Violation|1
7360366|NCT01015677|11606286|FG002|Overall Study|Protocol Violation|0
7360367|NCT01015677|11606284|FG000|Overall Study|Withdrawal by Subject|1
7360368|NCT01015677|11606285|FG001|Overall Study|Withdrawal by Subject|1
7360369|NCT01015677|11606286|FG002|Overall Study|Withdrawal by Subject|0
7360370|NCT01015703|11606299|FG000|Overall Study|Withdrawal by Subject|0
7569705|NCT03465436|11946488|FG001|Period 3|Protocol Violation|1
7360371|NCT01015703|11606300|FG001|Overall Study|Withdrawal by Subject|1
7360372|NCT01015703|11606301|FG002|Overall Study|Withdrawal by Subject|0
7360373|NCT01015703|11606302|FG003|Overall Study|Withdrawal by Subject|0
7360374|NCT01015703|11606303|FG004|Overall Study|Withdrawal by Subject|0
7360375|NCT01015703|11606299|FG000|Overall Study|Adverse Event|1
7360376|NCT01015703|11606300|FG001|Overall Study|Adverse Event|0
7360377|NCT01015703|11606301|FG002|Overall Study|Adverse Event|0
7360378|NCT01015703|11606302|FG003|Overall Study|Adverse Event|0
7360379|NCT01015703|11606303|FG004|Overall Study|Adverse Event|0
7360380|NCT01015703|11606299|FG000|Overall Study|Protocol Violation|1
7360381|NCT01015703|11606300|FG001|Overall Study|Protocol Violation|0
7360382|NCT01015703|11606301|FG002|Overall Study|Protocol Violation|0
7360383|NCT01015703|11606302|FG003|Overall Study|Protocol Violation|0
7360384|NCT01015703|11606303|FG004|Overall Study|Protocol Violation|0
7360385|NCT01015768|11606315|FG000|Overall Study|Some subject data unuseable|4
7360386|NCT01015768|11606316|FG001|Overall Study|Some subject data unuseable|4
7360387|NCT01015820|11606348|FG000|Overall Study|Suboptimal measurements|1
7360388|NCT01015820|11606349|FG001|Overall Study|Suboptimal measurements|0
7360389|NCT01016015|11606360|FG000|Overall Study|Not Treated|3
7360390|NCT01016015|11606360|FG000|Overall Study|Withdrawal by Subject|1
7360391|NCT01016015|11606360|FG000|Overall Study|Adverse Event|15
7360392|NCT01016067|11606366|FG000|Overall Study|Lost to Follow-up|1
7360393|NCT01016067|11606367|FG001|Overall Study|Lost to Follow-up|2
7360394|NCT01016067|11606366|FG000|Overall Study|Physician Decision|1
7360395|NCT01016067|11606367|FG001|Overall Study|Physician Decision|1
7360396|NCT01016067|11606366|FG000|Overall Study|Withdrew due to Relocation|0
7360397|NCT01016067|11606367|FG001|Overall Study|Withdrew due to Relocation|1
7360398|NCT01016132|11606382|FG000|Overall Study|Discomfort|1
7360399|NCT01016262|11606389|FG000|Double-blind Phase|Adverse Event|0
7360400|NCT01016262|11606390|FG001|Double-blind Phase|Adverse Event|0
7360401|NCT01016262|11606391|FG002|Double-blind Phase|Adverse Event|1
7360402|NCT01016262|11606392|FG003|Double-blind Phase|Adverse Event|0
7360403|NCT01016262|11606393|FG004|Double-blind Phase|Adverse Event|0
7360404|NCT01016262|11606394|FG005|Double-blind Phase|Adverse Event|0
7360405|NCT01016262|11606389|FG000|Double-blind Phase|Lack of Efficacy|1
7360406|NCT01016262|11606390|FG001|Double-blind Phase|Lack of Efficacy|0
7360407|NCT01016262|11606391|FG002|Double-blind Phase|Lack of Efficacy|5
7360408|NCT01016262|11606392|FG003|Double-blind Phase|Lack of Efficacy|0
7360409|NCT01016262|11606393|FG004|Double-blind Phase|Lack of Efficacy|0
7360410|NCT01016262|11606394|FG005|Double-blind Phase|Lack of Efficacy|0
7360411|NCT01016262|11606389|FG000|Double-blind Phase|Disease Progression|0
7360412|NCT01016262|11606390|FG001|Double-blind Phase|Disease Progression|1
7360413|NCT01016262|11606391|FG002|Double-blind Phase|Disease Progression|2
7360414|NCT01016262|11606392|FG003|Double-blind Phase|Disease Progression|0
7360415|NCT01016262|11606393|FG004|Double-blind Phase|Disease Progression|0
7569706|NCT03465436|11946489|FG002|Period 3|Protocol Violation|0
7569707|NCT03465436|11946490|FG003|Period 3|Protocol Violation|0
7360416|NCT01016262|11606394|FG005|Double-blind Phase|Disease Progression|0
7360417|NCT01016262|11606389|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
7360418|NCT01016262|11606390|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
7360419|NCT01016262|11606391|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
7360420|NCT01016262|11606392|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
7360421|NCT01016262|11606393|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
7360422|NCT01016262|11606394|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
7360423|NCT01016262|11606389|FG000|Open-Label Phase|Adverse Event|0
7360424|NCT01016262|11606390|FG001|Open-Label Phase|Adverse Event|0
7360425|NCT01016262|11606391|FG002|Open-Label Phase|Adverse Event|0
7360426|NCT01016262|11606392|FG003|Open-Label Phase|Adverse Event|1
7360427|NCT01016262|11606393|FG004|Open-Label Phase|Adverse Event|0
7360428|NCT01016262|11606394|FG005|Open-Label Phase|Adverse Event|0
7360429|NCT01016262|11606389|FG000|Open-Label Phase|Lost to Follow-up|0
7360430|NCT01016262|11606390|FG001|Open-Label Phase|Lost to Follow-up|0
7360431|NCT01016262|11606391|FG002|Open-Label Phase|Lost to Follow-up|0
7360432|NCT01016262|11606392|FG003|Open-Label Phase|Lost to Follow-up|0
7360433|NCT01016262|11606393|FG004|Open-Label Phase|Lost to Follow-up|1
7360434|NCT01016262|11606394|FG005|Open-Label Phase|Lost to Follow-up|0
7360435|NCT01016262|11606389|FG000|Open-Label Phase|Lack of Efficacy|0
7360436|NCT01016262|11606390|FG001|Open-Label Phase|Lack of Efficacy|0
7360437|NCT01016262|11606391|FG002|Open-Label Phase|Lack of Efficacy|0
7360438|NCT01016262|11606392|FG003|Open-Label Phase|Lack of Efficacy|1
7360439|NCT01016262|11606393|FG004|Open-Label Phase|Lack of Efficacy|0
7360440|NCT01016262|11606394|FG005|Open-Label Phase|Lack of Efficacy|0
7360441|NCT01016262|11606389|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
7360442|NCT01016262|11606390|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
7360443|NCT01016262|11606391|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
7360444|NCT01016262|11606392|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
7360445|NCT01016262|11606393|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
7360446|NCT01016262|11606394|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
7360447|NCT01016600|11606463|FG000|Overall Study|Did not start treatment|1
7360448|NCT01016600|11606464|FG001|Overall Study|Did not start treatment|0
7360449|NCT01016600|11606465|FG002|Overall Study|Did not start treatment|0
7360450|NCT01016600|11606466|FG003|Overall Study|Did not start treatment|0
7360451|NCT01016912|11606561|FG000|End of Treatment Period|Lack of Efficacy|0
7360452|NCT01016912|11606562|FG001|End of Treatment Period|Lack of Efficacy|1
7360453|NCT01016912|11606563|FG002|End of Treatment Period|Lack of Efficacy|0
7360454|NCT01016912|11606564|FG003|End of Treatment Period|Lack of Efficacy|4
7360455|NCT01016912|11606565|FG004|End of Treatment Period|Lack of Efficacy|4
7360456|NCT01016912|11606561|FG000|End of Treatment Period|Adverse Event|0
7360457|NCT01016912|11606562|FG001|End of Treatment Period|Adverse Event|1
7360458|NCT01016912|11606563|FG002|End of Treatment Period|Adverse Event|1
7360459|NCT01016912|11606564|FG003|End of Treatment Period|Adverse Event|0
7360460|NCT01016912|11606565|FG004|End of Treatment Period|Adverse Event|0
7360461|NCT01016912|11606561|FG000|End of Treatment Period|Completed double-blind period only|0
7360462|NCT01016912|11606562|FG001|End of Treatment Period|Completed double-blind period only|1
7360463|NCT01016912|11606563|FG002|End of Treatment Period|Completed double-blind period only|0
7360464|NCT01016912|11606564|FG003|End of Treatment Period|Completed double-blind period only|0
7360465|NCT01016912|11606565|FG004|End of Treatment Period|Completed double-blind period only|0
7360466|NCT01016912|11606561|FG000|Follow-up Period|Other reason|0
7360467|NCT01016912|11606562|FG001|Follow-up Period|Other reason|0
7360468|NCT01016912|11606563|FG002|Follow-up Period|Other reason|1
7360469|NCT01016912|11606564|FG003|Follow-up Period|Other reason|1
7360470|NCT01016912|11606565|FG004|Follow-up Period|Other reason|0
7360471|NCT01016964|11606604|FG000|Overall Study|Lost to Follow-up|3
7360472|NCT01016964|11606605|FG001|Overall Study|Lost to Follow-up|3
7360473|NCT01016977|11606613|FG000|Overall Study|Lost to Follow-up|1
7360474|NCT01016977|11606614|FG001|Overall Study|Lost to Follow-up|0
7360475|NCT01016977|11606613|FG000|Overall Study|Withdrawal by Subject|2
7360476|NCT01016977|11606614|FG001|Overall Study|Withdrawal by Subject|2
7360477|NCT01017029|11606631|FG000|Overall Study|Lost to Follow-up|1
7360478|NCT01017029|11606632|FG001|Overall Study|Lost to Follow-up|0
7360479|NCT01017029|11606631|FG000|Overall Study|Administrative problem|0
7360480|NCT01017029|11606632|FG001|Overall Study|Administrative problem|1
7360481|NCT01017029|11606631|FG000|Overall Study|Death|3
7360482|NCT01017029|11606632|FG001|Overall Study|Death|1
7360483|NCT01017120|11606649|FG000|Overall Study|Adverse Event|9
7360484|NCT01017120|11606650|FG001|Overall Study|Adverse Event|0
7360485|NCT01017120|11606649|FG000|Overall Study|Lost to Follow-up|13
7360486|NCT01017120|11606650|FG001|Overall Study|Lost to Follow-up|11
7360487|NCT01017120|11606649|FG000|Overall Study|Lack of Efficacy|1
7360488|NCT01017120|11606650|FG001|Overall Study|Lack of Efficacy|0
7360489|NCT01017120|11606649|FG000|Overall Study|Withdrawal by Subject|39
7360490|NCT01017120|11606650|FG001|Overall Study|Withdrawal by Subject|21
7360491|NCT01017120|11606649|FG000|Overall Study|Pregnancy|1
7360492|NCT01017120|11606650|FG001|Overall Study|Pregnancy|1
7360493|NCT01017120|11606649|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7360494|NCT01017120|11606650|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7360495|NCT01017120|11606649|FG000|Overall Study|Relocated Out of Town|0
7360496|NCT01017120|11606650|FG001|Overall Study|Relocated Out of Town|2
7360497|NCT01017120|11606649|FG000|Overall Study|Protocol Violation|1
7360498|NCT01017120|11606650|FG001|Overall Study|Protocol Violation|0
7360499|NCT01017120|11606649|FG000|Overall Study|Parent Unable to Provide Transportation|1
7360500|NCT01017120|11606650|FG001|Overall Study|Parent Unable to Provide Transportation|0
7360501|NCT01017146|11606658|FG000|Overall Study|Adverse Event|11
7360502|NCT01017146|11606659|FG001|Overall Study|Adverse Event|1
7360503|NCT01017146|11606658|FG000|Overall Study|Lost to Follow-up|14
7360504|NCT01017146|11606659|FG001|Overall Study|Lost to Follow-up|14
7360505|NCT01017146|11606658|FG000|Overall Study|Noncompliance with Study Product|1
7360506|NCT01017146|11606659|FG001|Overall Study|Noncompliance with Study Product|1
7360507|NCT01017146|11606658|FG000|Overall Study|Withdrawal by Subject|32
7360508|NCT01017146|11606659|FG001|Overall Study|Withdrawal by Subject|16
7360509|NCT01017146|11606658|FG000|Overall Study|Relocation|0
7360510|NCT01017146|11606659|FG001|Overall Study|Relocation|4
7360511|NCT01017146|11606658|FG000|Overall Study|Pregnancy|2
7360512|NCT01017146|11606659|FG001|Overall Study|Pregnancy|1
7360513|NCT01017146|11606658|FG000|Overall Study|Protocol Violation|2
7360514|NCT01017146|11606659|FG001|Overall Study|Protocol Violation|0
7360515|NCT01017146|11606658|FG000|Overall Study|Took Excluded Medication|2
7360516|NCT01017146|11606659|FG001|Overall Study|Took Excluded Medication|0
7360517|NCT01017146|11606658|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7360518|NCT01017146|11606659|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
7360519|NCT01017146|11606658|FG000|Overall Study|Change in Work Situation|1
7360520|NCT01017146|11606659|FG001|Overall Study|Change in Work Situation|0
7360521|NCT01017549|11606697|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
7360522|NCT01017549|11606697|FG000|One-year Follow-up|Lost to Follow-up|2
7360523|NCT01017549|11606697|FG000|One-year Follow-up|Withdrawal by Subject|5
7360524|NCT01017549|11606697|FG000|5 Year Follow-up|Lost to Follow-up|9
7360525|NCT01017549|11606697|FG000|5 Year Follow-up|Mastectomy|3
7360526|NCT01017575|11606706|FG000|Overall Study|Lack of Efficacy|0
7360527|NCT01017575|11606707|FG001|Overall Study|Lack of Efficacy|1
7360528|NCT01017575|11606708|FG002|Overall Study|Lack of Efficacy|0
7360529|NCT01017575|11606709|FG003|Overall Study|Lack of Efficacy|1
7360530|NCT01017575|11606710|FG004|Overall Study|Lack of Efficacy|1
7360531|NCT01017575|11606706|FG000|Overall Study|Adverse Event|0
7360532|NCT01017575|11606707|FG001|Overall Study|Adverse Event|1
7360533|NCT01017575|11606708|FG002|Overall Study|Adverse Event|0
7360534|NCT01017575|11606709|FG003|Overall Study|Adverse Event|0
7360535|NCT01017575|11606710|FG004|Overall Study|Adverse Event|2
7360536|NCT01017575|11606706|FG000|Overall Study|Withdrawal by Subject|1
7360537|NCT01017575|11606707|FG001|Overall Study|Withdrawal by Subject|0
7360538|NCT01017575|11606708|FG002|Overall Study|Withdrawal by Subject|0
7360539|NCT01017575|11606709|FG003|Overall Study|Withdrawal by Subject|0
7360540|NCT01017575|11606710|FG004|Overall Study|Withdrawal by Subject|0
7360541|NCT01017601|11606724|FG000|Overall Study|Disease Progression|12
7360542|NCT01017601|11606725|FG001|Overall Study|Disease Progression|12
7360543|NCT01017601|11606724|FG000|Overall Study|Withdrawal by Subject|0
7360544|NCT01017601|11606725|FG001|Overall Study|Withdrawal by Subject|1
7360545|NCT01017731|11606735|FG000|Overall Study|Lost to Follow-up|2
7360546|NCT01017731|11606735|FG000|Overall Study|Withdrawal by Subject|3
7360547|NCT01017731|11606735|FG000|Overall Study|Physician Decision|2
7360548|NCT01017731|11606735|FG000|Overall Study|Adverse Event|1
7360549|NCT01017874|11606742|FG000|Overall Study|Withdrawal by Subject|23
7360550|NCT01017874|11606743|FG001|Overall Study|Withdrawal by Subject|20
7360551|NCT01017874|11606742|FG000|Overall Study|Sponsor decision|3
7360552|NCT01017874|11606743|FG001|Overall Study|Sponsor decision|1
7360553|NCT01017874|11606742|FG000|Overall Study|Lost to Follow-up|3
7360554|NCT01017874|11606743|FG001|Overall Study|Lost to Follow-up|2
7360555|NCT01017874|11606742|FG000|Overall Study|Physician Decision|1
7360556|NCT01017874|11606743|FG001|Overall Study|Physician Decision|3
7360557|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
7360558|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7360559|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7360560|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7360561|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
7360562|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Adverse Event|23
7360563|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Adverse Event|0
7360564|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Adverse Event|0
7360565|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Adverse Event|0
7360566|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Adverse Event|0
7360567|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
7360568|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7360569|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7360570|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7360571|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
7360572|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
7360573|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
7360574|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
7360575|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
7360576|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
7360577|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Physician Decision|10
7360578|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Physician Decision|0
7360579|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Physician Decision|0
7360580|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Physician Decision|0
7360581|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Physician Decision|0
7360582|NCT01017952|11606753|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
7360583|NCT01017952|11606754|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7360584|NCT01017952|11606755|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7360585|NCT01017952|11606756|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7360586|NCT01017952|11606757|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
7360587|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
7360588|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
7360589|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
7360590|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
7360591|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
7360592|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
7360593|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
7360594|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
7360595|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7360596|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
7360597|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
7360598|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
7360599|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7360600|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
7360601|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
7360602|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
7360603|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
7360604|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
7360605|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
7360606|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
7360607|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7360608|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7360609|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7360610|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
7360611|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7360612|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7360613|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7360614|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
7360615|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7360616|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
7360617|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
7360618|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7360619|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
7360620|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
7360621|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
7360622|NCT01017952|11606753|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
7360623|NCT01017952|11606754|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
7360624|NCT01017952|11606755|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
7360625|NCT01017952|11606756|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
7360626|NCT01017952|11606757|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
7360627|NCT01018030|11606770|FG000|Overall Study|Adverse Event|10
7360628|NCT01018030|11606771|FG001|Overall Study|Adverse Event|5
7360629|NCT01018030|11606772|FG002|Overall Study|Adverse Event|5
7360630|NCT01018030|11606770|FG000|Overall Study|Withdrawal by Subject|2
7360631|NCT01018030|11606771|FG001|Overall Study|Withdrawal by Subject|2
7360632|NCT01018030|11606772|FG002|Overall Study|Withdrawal by Subject|4
7360633|NCT01018030|11606770|FG000|Overall Study|Lost to Follow-up|2
7360634|NCT01018030|11606771|FG001|Overall Study|Lost to Follow-up|0
7360635|NCT01018030|11606772|FG002|Overall Study|Lost to Follow-up|3
7360636|NCT01018030|11606770|FG000|Overall Study|Protocol Violation|2
7360637|NCT01018030|11606771|FG001|Overall Study|Protocol Violation|1
7360638|NCT01018030|11606772|FG002|Overall Study|Protocol Violation|0
7360639|NCT01018030|11606770|FG000|Overall Study|Physician Decision|1
7360640|NCT01018030|11606771|FG001|Overall Study|Physician Decision|0
7360641|NCT01018030|11606772|FG002|Overall Study|Physician Decision|1
7360642|NCT01018030|11606770|FG000|Overall Study|Lack of Efficacy|1
7360643|NCT01018030|11606771|FG001|Overall Study|Lack of Efficacy|0
7360644|NCT01018030|11606772|FG002|Overall Study|Lack of Efficacy|0
7360645|NCT01018030|11606770|FG000|Overall Study|Did Not Receive Study Drug|1
7360646|NCT01018030|11606771|FG001|Overall Study|Did Not Receive Study Drug|3
7360647|NCT01018030|11606772|FG002|Overall Study|Did Not Receive Study Drug|0
7360648|NCT01018186|11606835|FG000|2-week Run-in Period|Protocol Violation|1
7360649|NCT01018186|11606836|FG001|2-week Run-in Period|Protocol Violation|0
7360650|NCT01018186|11606837|FG002|2-week Run-in Period|Protocol Violation|0
7360651|NCT01018186|11606838|FG003|2-week Run-in Period|Protocol Violation|0
7360652|NCT01018186|11606835|FG000|2-week Run-in Period|Lost to Follow-up|2
7360653|NCT01018186|11606836|FG001|2-week Run-in Period|Lost to Follow-up|0
7360654|NCT01018186|11606837|FG002|2-week Run-in Period|Lost to Follow-up|0
7360655|NCT01018186|11606838|FG003|2-week Run-in Period|Lost to Follow-up|0
7360656|NCT01018186|11606835|FG000|2-week Run-in Period|Physician Decision|3
7360657|NCT01018186|11606836|FG001|2-week Run-in Period|Physician Decision|0
7360658|NCT01018186|11606837|FG002|2-week Run-in Period|Physician Decision|0
7360659|NCT01018186|11606838|FG003|2-week Run-in Period|Physician Decision|0
7360660|NCT01018186|11606835|FG000|2-week Run-in Period|Withdrawal by Subject|11
7360661|NCT01018186|11606836|FG001|2-week Run-in Period|Withdrawal by Subject|0
7360662|NCT01018186|11606837|FG002|2-week Run-in Period|Withdrawal by Subject|0
7360663|NCT01018186|11606838|FG003|2-week Run-in Period|Withdrawal by Subject|0
7360664|NCT01018186|11606835|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
7360665|NCT01018186|11606836|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7360666|NCT01018186|11606837|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7360667|NCT01018186|11606838|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
7360668|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Adverse Event|0
7360669|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Adverse Event|5
7360670|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Adverse Event|3
7360671|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Adverse Event|6
7360672|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
7360673|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
7360674|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
7360675|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
7360676|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
7360677|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
7360678|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
7360679|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
7360680|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
7360681|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
7360682|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
7360683|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
7360684|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
7360685|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
7360686|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
7360687|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
7360688|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Physician Decision|0
7360689|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Physician Decision|1
7360690|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Physician Decision|0
7360691|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Physician Decision|3
7360692|NCT01018186|11606835|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7360693|NCT01018186|11606836|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
7360694|NCT01018186|11606837|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
7360695|NCT01018186|11606838|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
7360696|NCT01018264|11606852|FG000|Overall Study|Withdrawal by Subject|1
7360697|NCT01018264|11606853|FG001|Overall Study|Withdrawal by Subject|0
7360698|NCT01018264|11606852|FG000|Overall Study|Lost to Follow-up|0
7360699|NCT01018264|11606853|FG001|Overall Study|Lost to Follow-up|1
7360700|NCT01018394|11606861|FG000|Overall Study|Withdrawal by Subject|5
7360701|NCT01018394|11606862|FG001|Overall Study|Withdrawal by Subject|5
7360702|NCT01018394|11606861|FG000|Overall Study|Lost to Follow-up|4
7360703|NCT01018394|11606862|FG001|Overall Study|Lost to Follow-up|3
7360704|NCT01018511|11606898|FG000|Overall Study|Not fulfilling eligibility criteria|6
7360705|NCT01018511|11606899|FG001|Overall Study|Not fulfilling eligibility criteria|7
7360706|NCT01018511|11606900|FG002|Overall Study|Not fulfilling eligibility criteria|7
7360707|NCT01018511|11606901|FG003|Overall Study|Not fulfilling eligibility criteria|3
7360708|NCT01018511|11606898|FG000|Overall Study|Adverse Event|5
7360709|NCT01018511|11606899|FG001|Overall Study|Adverse Event|9
7360710|NCT01018511|11606900|FG002|Overall Study|Adverse Event|13
7360711|NCT01018511|11606901|FG003|Overall Study|Adverse Event|10
7360712|NCT01018511|11606898|FG000|Overall Study|Lack of Efficacy|4
7360713|NCT01018511|11606899|FG001|Overall Study|Lack of Efficacy|1
7360714|NCT01018511|11606900|FG002|Overall Study|Lack of Efficacy|1
7360715|NCT01018511|11606901|FG003|Overall Study|Lack of Efficacy|2
7360716|NCT01018511|11606898|FG000|Overall Study|Withdrawal by Subject|6
7360717|NCT01018511|11606899|FG001|Overall Study|Withdrawal by Subject|5
7360718|NCT01018511|11606900|FG002|Overall Study|Withdrawal by Subject|11
7360719|NCT01018511|11606901|FG003|Overall Study|Withdrawal by Subject|9
7360720|NCT01018511|11606898|FG000|Overall Study|Lost to Follow-up|0
7360721|NCT01018511|11606899|FG001|Overall Study|Lost to Follow-up|0
7360722|NCT01018511|11606900|FG002|Overall Study|Lost to Follow-up|1
7360723|NCT01018511|11606901|FG003|Overall Study|Lost to Follow-up|0
7360724|NCT01018511|11606898|FG000|Overall Study|Protocol Violation|5
7360725|NCT01018511|11606899|FG001|Overall Study|Protocol Violation|8
7360726|NCT01018511|11606900|FG002|Overall Study|Protocol Violation|7
7360727|NCT01018511|11606901|FG003|Overall Study|Protocol Violation|9
7360728|NCT01018511|11606898|FG000|Overall Study|Miscellaneous|0
7360729|NCT01018511|11606899|FG001|Overall Study|Miscellaneous|2
7360730|NCT01018511|11606900|FG002|Overall Study|Miscellaneous|0
7360731|NCT01018511|11606901|FG003|Overall Study|Miscellaneous|0
7360732|NCT01018680|11606919|FG000|Overall Study|Adverse Event|23
7360733|NCT01018680|11606920|FG001|Overall Study|Adverse Event|40
7360734|NCT01018680|11606919|FG000|Overall Study|Withdrawal by Subject|10
7360735|NCT01018680|11606920|FG001|Overall Study|Withdrawal by Subject|10
7360736|NCT01018680|11606919|FG000|Overall Study|Protocol Violation|5
7360737|NCT01018680|11606920|FG001|Overall Study|Protocol Violation|8
7360738|NCT01018680|11606919|FG000|Overall Study|Sponsor Decision|6
7360739|NCT01018680|11606920|FG001|Overall Study|Sponsor Decision|7
7360740|NCT01018680|11606919|FG000|Overall Study|Lack of Efficacy|8
7360741|NCT01018680|11606920|FG001|Overall Study|Lack of Efficacy|2
7360742|NCT01018680|11606919|FG000|Overall Study|Lost to Follow-up|5
7360743|NCT01018680|11606920|FG001|Overall Study|Lost to Follow-up|3
7360744|NCT01018680|11606919|FG000|Overall Study|Entry Criteria Not Met|1
7360745|NCT01018680|11606920|FG001|Overall Study|Entry Criteria Not Met|4
7360746|NCT01018680|11606919|FG000|Overall Study|Physician Decision|3
7360747|NCT01018680|11606920|FG001|Overall Study|Physician Decision|1
7360748|NCT01018732|11606929|FG000|Overall Study|Lost to Follow-up|0
7360749|NCT01018732|11606930|FG001|Overall Study|Lost to Follow-up|0
7360750|NCT01018732|11606931|FG002|Overall Study|Lost to Follow-up|3
7360751|NCT01018732|11606929|FG000|Overall Study|Protocol Violation|1
7360752|NCT01018732|11606930|FG001|Overall Study|Protocol Violation|1
7360753|NCT01018732|11606931|FG002|Overall Study|Protocol Violation|0
7360754|NCT01018732|11606929|FG000|Overall Study|Inappropriate Enrollment|0
7360755|NCT01018732|11606930|FG001|Overall Study|Inappropriate Enrollment|1
7360756|NCT01018732|11606931|FG002|Overall Study|Inappropriate Enrollment|0
7360757|NCT01018732|11606929|FG000|Overall Study|Unable to Classify|0
7360758|NCT01018732|11606930|FG001|Overall Study|Unable to Classify|0
7360759|NCT01018732|11606931|FG002|Overall Study|Unable to Classify|1
7360760|NCT01018862|11606942|FG000|Overall Study|Adverse Event|2
7360761|NCT01018862|11606943|FG001|Overall Study|Adverse Event|0
7360762|NCT01018862|11606944|FG002|Overall Study|Adverse Event|6
7360763|NCT01018862|11606942|FG000|Overall Study|Lack of Efficacy|1
7360764|NCT01018862|11606943|FG001|Overall Study|Lack of Efficacy|0
7360765|NCT01018862|11606944|FG002|Overall Study|Lack of Efficacy|2
7360766|NCT01018862|11606942|FG000|Overall Study|Lost to Follow-up|3
7360767|NCT01018862|11606943|FG001|Overall Study|Lost to Follow-up|1
7360768|NCT01018862|11606944|FG002|Overall Study|Lost to Follow-up|0
7360769|NCT01018862|11606942|FG000|Overall Study|Protocol Violation|1
7360770|NCT01018862|11606943|FG001|Overall Study|Protocol Violation|3
7360771|NCT01018862|11606944|FG002|Overall Study|Protocol Violation|3
7360772|NCT01018862|11606942|FG000|Overall Study|Withdrawal by Subject|1
7360773|NCT01018862|11606943|FG001|Overall Study|Withdrawal by Subject|2
7360774|NCT01018862|11606944|FG002|Overall Study|Withdrawal by Subject|1
7360775|NCT01018862|11606942|FG000|Overall Study|administrative problems|5
7360776|NCT01018862|11606943|FG001|Overall Study|administrative problems|4
7360777|NCT01018862|11606944|FG002|Overall Study|administrative problems|4
7360778|NCT01018953|11606952|FG000|Overall Study|Adverse Event|2
7360779|NCT01018953|11606952|FG000|Overall Study|Withdrawal by Subject|1
7360780|NCT01018953|11606952|FG000|Overall Study|Study termination by sponsor|5
7360781|NCT01018979|11606959|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
7360782|NCT01018979|11606960|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
7360783|NCT01018979|11606959|FG000|Overall Study|Not received at least one dose|0
7360784|NCT01018979|11606960|FG001|Overall Study|Not received at least one dose|1
7360785|NCT01018992|11606971|FG000|Overall Study|Adverse Event|8
7360786|NCT01018992|11606972|FG001|Overall Study|Adverse Event|3
7360787|NCT01018992|11606971|FG000|Overall Study|Withdrawal by Subject|3
7360788|NCT01018992|11606972|FG001|Overall Study|Withdrawal by Subject|8
7360789|NCT01018992|11606971|FG000|Overall Study|Protocol Violation|0
7360790|NCT01018992|11606972|FG001|Overall Study|Protocol Violation|4
7360791|NCT01018992|11606971|FG000|Overall Study|Lost to Follow-up|5
7360792|NCT01018992|11606972|FG001|Overall Study|Lost to Follow-up|1
7360793|NCT01019135|11606981|FG000|Overall Study|Did not receive allocated intervention|12
7360794|NCT01019135|11606982|FG001|Overall Study|Did not receive allocated intervention|6
7360795|NCT01019135|11606983|FG002|Overall Study|Did not receive allocated intervention|25
7360796|NCT01019135|11606981|FG000|Overall Study|Did not attend CR|8
7360797|NCT01019135|11606982|FG001|Overall Study|Did not attend CR|13
7460112|NCT01824355|11755267|FG000|Overall Study|Adverse Event|2
7360798|NCT01019135|11606983|FG002|Overall Study|Did not attend CR|6
7360799|NCT01019252|11606993|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
7360800|NCT01019252|11606994|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
7360801|NCT01019252|11606993|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
7360802|NCT01019252|11606994|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
7360803|NCT01019252|11606993|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
7360804|NCT01019252|11606994|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
7360805|NCT01019252|11606993|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
7360806|NCT01019252|11606994|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
7360807|NCT01019317|11607000|FG000|Overall Study|Not Eligible|4
7360808|NCT01019369|11607006|FG000|Overall Study|Lost to Follow-up|10
7360809|NCT01019369|11607007|FG001|Overall Study|Lost to Follow-up|6
7360810|NCT01019369|11607006|FG000|Overall Study|Withdrawal by Subject|0
7360811|NCT01019369|11607007|FG001|Overall Study|Withdrawal by Subject|1
7360812|NCT01019486|11607017|FG000|Overall Study|Withdrawal by Subject|1
7360813|NCT01019486|11607018|FG001|Overall Study|Withdrawal by Subject|1
7360814|NCT01019486|11607019|FG002|Overall Study|Withdrawal by Subject|1
7360815|NCT01019694|11607031|FG000|Overall Study|Adverse Event|12
7360816|NCT01019694|11607032|FG001|Overall Study|Adverse Event|16
7360817|NCT01019694|11607033|FG002|Overall Study|Adverse Event|19
7360818|NCT01019694|11607031|FG000|Overall Study|Protocol Violation|2
7360819|NCT01019694|11607032|FG001|Overall Study|Protocol Violation|6
7360820|NCT01019694|11607033|FG002|Overall Study|Protocol Violation|4
7360821|NCT01019694|11607031|FG000|Overall Study|Lost to Follow-up|5
7360822|NCT01019694|11607032|FG001|Overall Study|Lost to Follow-up|3
7360823|NCT01019694|11607033|FG002|Overall Study|Lost to Follow-up|3
7360824|NCT01019694|11607031|FG000|Overall Study|Withdrawal by Subject|4
7360825|NCT01019694|11607032|FG001|Overall Study|Withdrawal by Subject|6
7360826|NCT01019694|11607033|FG002|Overall Study|Withdrawal by Subject|12
7360827|NCT01019694|11607031|FG000|Overall Study|Not treated|0
7360828|NCT01019694|11607032|FG001|Overall Study|Not treated|2
7360829|NCT01019694|11607033|FG002|Overall Study|Not treated|3
7360830|NCT01019694|11607031|FG000|Overall Study|Other reason (not specified)|1
7360831|NCT01019694|11607032|FG001|Overall Study|Other reason (not specified)|5
7360832|NCT01019694|11607033|FG002|Overall Study|Other reason (not specified)|6
7360833|NCT01020019|11607072|FG000|Overall Study|Lost to Follow-up|21
7360834|NCT01020019|11607073|FG001|Overall Study|Lost to Follow-up|18
7360835|NCT01020019|11607072|FG000|Overall Study|Adverse Event|1
7360836|NCT01020019|11607073|FG001|Overall Study|Adverse Event|5
7360837|NCT01020019|11607072|FG000|Overall Study|not interested in treatment|4
7360838|NCT01020019|11607073|FG001|Overall Study|not interested in treatment|4
7360839|NCT01020019|11607072|FG000|Overall Study|moving|0
7360840|NCT01020019|11607073|FG001|Overall Study|moving|2
7360841|NCT01020123|11607086|FG000|Main Period|Withdrawal by Subject|6
7360842|NCT01020123|11607087|FG001|Main Period|Withdrawal by Subject|5
7360843|NCT01020123|11607088|FG002|Main Period|Withdrawal by Subject|3
7360844|NCT01020123|11607089|FG003|Main Period|Withdrawal by Subject|1
7360845|NCT01020123|11607090|FG004|Main Period|Withdrawal by Subject|6
7360846|NCT01020123|11607091|FG005|Main Period|Withdrawal by Subject|3
7360847|NCT01020123|11607092|FG006|Main Period|Withdrawal by Subject|2
7360848|NCT01020123|11607086|FG000|Main Period|Eligibility Criteria not fullfilled|0
7360849|NCT01020123|11607087|FG001|Main Period|Eligibility Criteria not fullfilled|1
7360850|NCT01020123|11607088|FG002|Main Period|Eligibility Criteria not fullfilled|0
7360851|NCT01020123|11607089|FG003|Main Period|Eligibility Criteria not fullfilled|0
7360852|NCT01020123|11607090|FG004|Main Period|Eligibility Criteria not fullfilled|1
7360853|NCT01020123|11607091|FG005|Main Period|Eligibility Criteria not fullfilled|0
7360854|NCT01020123|11607092|FG006|Main Period|Eligibility Criteria not fullfilled|0
7360855|NCT01020123|11607086|FG000|Main Period|Adverse Event|5
7360856|NCT01020123|11607087|FG001|Main Period|Adverse Event|2
7360857|NCT01020123|11607088|FG002|Main Period|Adverse Event|2
7360858|NCT01020123|11607089|FG003|Main Period|Adverse Event|1
7360859|NCT01020123|11607090|FG004|Main Period|Adverse Event|1
7360860|NCT01020123|11607091|FG005|Main Period|Adverse Event|2
7360861|NCT01020123|11607092|FG006|Main Period|Adverse Event|1
7360862|NCT01020123|11607086|FG000|Main Period|Protocol Violation|4
7360863|NCT01020123|11607087|FG001|Main Period|Protocol Violation|4
7360864|NCT01020123|11607088|FG002|Main Period|Protocol Violation|2
7360865|NCT01020123|11607089|FG003|Main Period|Protocol Violation|5
7360866|NCT01020123|11607090|FG004|Main Period|Protocol Violation|2
7360867|NCT01020123|11607091|FG005|Main Period|Protocol Violation|3
7360868|NCT01020123|11607092|FG006|Main Period|Protocol Violation|2
7360869|NCT01020123|11607086|FG000|Main Period|Lost to Follow-up|0
7360870|NCT01020123|11607087|FG001|Main Period|Lost to Follow-up|2
7360871|NCT01020123|11607088|FG002|Main Period|Lost to Follow-up|0
7360872|NCT01020123|11607089|FG003|Main Period|Lost to Follow-up|0
7360873|NCT01020123|11607090|FG004|Main Period|Lost to Follow-up|0
7360874|NCT01020123|11607091|FG005|Main Period|Lost to Follow-up|0
7360875|NCT01020123|11607092|FG006|Main Period|Lost to Follow-up|0
7360876|NCT01020123|11607086|FG000|Main Period|Unclasified|2
7360877|NCT01020123|11607087|FG001|Main Period|Unclasified|0
7360878|NCT01020123|11607088|FG002|Main Period|Unclasified|1
7360879|NCT01020123|11607089|FG003|Main Period|Unclasified|0
7360880|NCT01020123|11607090|FG004|Main Period|Unclasified|1
7360881|NCT01020123|11607091|FG005|Main Period|Unclasified|3
7360882|NCT01020123|11607092|FG006|Main Period|Unclasified|6
7360883|NCT01020123|11607086|FG000|Extention Period|Withdrawal by Subject|2
7360884|NCT01020123|11607087|FG001|Extention Period|Withdrawal by Subject|1
7360885|NCT01020123|11607088|FG002|Extention Period|Withdrawal by Subject|1
7360886|NCT01020123|11607089|FG003|Extention Period|Withdrawal by Subject|0
7360887|NCT01020123|11607090|FG004|Extention Period|Withdrawal by Subject|0
7360888|NCT01020123|11607091|FG005|Extention Period|Withdrawal by Subject|0
7360889|NCT01020123|11607092|FG006|Extention Period|Withdrawal by Subject|0
7360890|NCT01020123|11607086|FG000|Extention Period|Adverse Event|0
7360891|NCT01020123|11607087|FG001|Extention Period|Adverse Event|0
7360892|NCT01020123|11607088|FG002|Extention Period|Adverse Event|0
7360893|NCT01020123|11607089|FG003|Extention Period|Adverse Event|1
7360894|NCT01020123|11607090|FG004|Extention Period|Adverse Event|0
7360895|NCT01020123|11607091|FG005|Extention Period|Adverse Event|0
7360896|NCT01020123|11607092|FG006|Extention Period|Adverse Event|0
7360897|NCT01020123|11607086|FG000|Extention Period|Protocol Violation|1
7360898|NCT01020123|11607087|FG001|Extention Period|Protocol Violation|1
7360899|NCT01020123|11607088|FG002|Extention Period|Protocol Violation|1
7360900|NCT01020123|11607089|FG003|Extention Period|Protocol Violation|0
7360901|NCT01020123|11607090|FG004|Extention Period|Protocol Violation|0
7360902|NCT01020123|11607091|FG005|Extention Period|Protocol Violation|0
7360903|NCT01020123|11607092|FG006|Extention Period|Protocol Violation|1
7360904|NCT01020123|11607086|FG000|Extention Period|Lost to Follow-up|0
7360905|NCT01020123|11607087|FG001|Extention Period|Lost to Follow-up|0
7360906|NCT01020123|11607088|FG002|Extention Period|Lost to Follow-up|0
7360907|NCT01020123|11607089|FG003|Extention Period|Lost to Follow-up|0
7360908|NCT01020123|11607090|FG004|Extention Period|Lost to Follow-up|0
7360909|NCT01020123|11607091|FG005|Extention Period|Lost to Follow-up|2
7360910|NCT01020123|11607092|FG006|Extention Period|Lost to Follow-up|0
7360911|NCT01020305|11607109|FG000|Overall Study|Adverse Event|2
7360912|NCT01020435|11607115|FG000|Overall Study|Lost to Follow-up|0
7360913|NCT01020435|11607116|FG001|Overall Study|Lost to Follow-up|1
7360914|NCT01020448|11607123|FG000|Pre-assignment|Adverse Event|6
7360915|NCT01020448|11607123|FG000|Pre-assignment|Withdrawal by Subject|5
7360916|NCT01020448|11607123|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
7360917|NCT01020448|11607123|FG000|Treatment|Adverse Event|11
7360918|NCT01020448|11607123|FG000|Treatment|Consent Withdrawn|3
7360919|NCT01020448|11607123|FG000|Treatment|Disease Progression|2
7360920|NCT01020448|11607123|FG000|Treatment|Lack of Efficacy|8
7360921|NCT01020448|11607123|FG000|Treatment|Lost to Follow-up|2
7360922|NCT01020474|11607130|FG000|Overall Study|Adverse Event|4
7360923|NCT01020474|11607131|FG001|Overall Study|Adverse Event|4
7360924|NCT01020474|11607130|FG000|Overall Study|Protocol Violation|0
7360925|NCT01020474|11607131|FG001|Overall Study|Protocol Violation|2
7360926|NCT01020474|11607130|FG000|Overall Study|Withdrawal by Subject|5
7360927|NCT01020474|11607131|FG001|Overall Study|Withdrawal by Subject|7
7360928|NCT01020474|11607130|FG000|Overall Study|Other Reasons|1
7360929|NCT01020474|11607131|FG001|Overall Study|Other Reasons|1
7360930|NCT01020474|11607130|FG000|Overall Study|Insufficient Clinical Response|0
7360931|NCT01020474|11607131|FG001|Overall Study|Insufficient Clinical Response|3
7360932|NCT01020487|11607140|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
7360933|NCT01020487|11607141|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
7360934|NCT01020487|11607142|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
7360935|NCT01020487|11607140|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7360936|NCT01020487|11607141|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
7360937|NCT01020487|11607142|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
7360938|NCT01020487|11607140|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7360939|NCT01020487|11607141|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
7360940|NCT01020487|11607142|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
7360941|NCT01020487|11607140|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
7360942|NCT01020487|11607141|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
7360943|NCT01020487|11607142|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
7360944|NCT01020487|11607140|FG000|Part 2 Open-label Period|Adverse Event|0
7360945|NCT01020487|11607141|FG001|Part 2 Open-label Period|Adverse Event|4
7360946|NCT01020487|11607142|FG002|Part 2 Open-label Period|Adverse Event|1
7360947|NCT01020526|11607152|FG000|Overall Study|Withdrawal by Subject|5
7360948|NCT01020526|11607152|FG000|Overall Study|Other reasons|3
7360949|NCT01020526|11607152|FG000|Overall Study|Insufficient clinical response|3
7360950|NCT01020526|11607152|FG000|Overall Study|Lost to Follow-up|1
7360951|NCT01020526|11607152|FG000|Overall Study|Adverse Event|2
7360952|NCT01020747|11607167|FG000|Overall Study|Withdrawal by Subject|1
7360953|NCT01020773|11607174|FG000|Overall Study|Withdrawal by Subject|4
7360954|NCT01020773|11607175|FG001|Overall Study|Withdrawal by Subject|3
7360955|NCT01020786|11607181|FG000|Induction Period|Entry Criteria Not Met|2
7360956|NCT01020786|11607181|FG000|Induction Period|Adverse Event|10
7360957|NCT01020786|11607181|FG000|Induction Period|Progressive Disease|31
7360958|NCT01020786|11607181|FG000|Induction Period|Investigator Decision|3
7360959|NCT01020786|11607181|FG000|Induction Period|Withdrawal by Subject|3
7360960|NCT01020786|11607181|FG000|Maintenance Period|Adverse Event|8
7360961|NCT01020786|11607181|FG000|Maintenance Period|Progressive Disease|43
7360962|NCT01020786|11607181|FG000|Maintenance Period|Withdrawal by Subject|8
7360963|NCT01020786|11607181|FG000|Maintenance Period|Sponsor Decision|1
7360964|NCT01020799|11607189|FG000|Overall Study|Adverse Event|4
7360965|NCT01020799|11607190|FG001|Overall Study|Adverse Event|3
7360966|NCT01020799|11607191|FG002|Overall Study|Adverse Event|2
7360967|NCT01020799|11607189|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
7360968|NCT01020799|11607190|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
7360969|NCT01020799|11607191|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
7360970|NCT01020799|11607189|FG000|Overall Study|Protocol Violation|3
7360971|NCT01020799|11607190|FG001|Overall Study|Protocol Violation|2
7360972|NCT01020799|11607191|FG002|Overall Study|Protocol Violation|0
7360973|NCT01020799|11607189|FG000|Overall Study|Withdrawal by Subject|2
7360974|NCT01020799|11607190|FG001|Overall Study|Withdrawal by Subject|2
7360975|NCT01020799|11607191|FG002|Overall Study|Withdrawal by Subject|3
7360976|NCT01020799|11607189|FG000|Overall Study|Lost to Follow-up|6
7360977|NCT01020799|11607190|FG001|Overall Study|Lost to Follow-up|4
7360978|NCT01020799|11607191|FG002|Overall Study|Lost to Follow-up|2
7360979|NCT01020812|11607199|FG000|Overall Study|Physician Decision|1
7360980|NCT01020812|11607199|FG000|Overall Study|Withdrawal by Subject|1
7360981|NCT01020812|11607199|FG000|Overall Study|Protocol Violation|1
7360982|NCT01020838|11607203|FG000|Overall Study|Death|90
7360983|NCT01020838|11607203|FG000|Overall Study|Adverse Event|1
7360984|NCT01020838|11607203|FG000|Overall Study|Withdrawal by Subject|9
7360985|NCT01020838|11607203|FG000|Overall Study|Lost to Follow-up|6
7360986|NCT01020838|11607203|FG000|Overall Study|Most common: Study ended by sponsor|77
7360987|NCT01020877|11607218|FG000|Second Intervention|Withdrawal by Subject|1
7360988|NCT01020877|11607219|FG001|Second Intervention|Withdrawal by Subject|0
7360989|NCT01020981|11607227|FG000|Overall Study|Did not return mailed survey|74
7360990|NCT01020981|11607228|FG001|Overall Study|Did not return mailed survey|58
7360991|NCT01020981|11607227|FG000|Overall Study|Survey returned undeliverable|8
7360992|NCT01020981|11607228|FG001|Overall Study|Survey returned undeliverable|32
7360993|NCT01020981|11607227|FG000|Overall Study|Participant declined to complete survey|2
7360994|NCT01020981|11607228|FG001|Overall Study|Participant declined to complete survey|0
7360995|NCT01021007|11607238|FG000|Overall Study|Lost to Follow-up|1
7360996|NCT01021007|11607239|FG001|Overall Study|Lost to Follow-up|1
7360997|NCT01021007|11607238|FG000|Overall Study|Adverse Event|1
7360998|NCT01021007|11607239|FG001|Overall Study|Adverse Event|3
7360999|NCT01021020|11607245|FG000|Period I|Protocol Violation|1
7361000|NCT01021020|11607245|FG000|Period I|Withdrawal by Subject|1
7361001|NCT01021020|11607245|FG000|14 Day Washout Period A|Physician Decision|1
7361002|NCT01021137|11607265|FG000|Overall Study|Lost to Follow-up|9
7361003|NCT01021137|11607266|FG001|Overall Study|Lost to Follow-up|4
7361004|NCT01021137|11607267|FG002|Overall Study|Lost to Follow-up|2
7361005|NCT01021137|11607268|FG003|Overall Study|Lost to Follow-up|6
7361006|NCT01021137|11607265|FG000|Overall Study|Withdrawal by Subject|1
7361007|NCT01021137|11607266|FG001|Overall Study|Withdrawal by Subject|0
7361008|NCT01021137|11607267|FG002|Overall Study|Withdrawal by Subject|0
7361009|NCT01021137|11607268|FG003|Overall Study|Withdrawal by Subject|3
7361010|NCT01021215|11607281|FG000|Overall Study|Lost to Follow-up|3
7361011|NCT01021215|11607282|FG001|Overall Study|Lost to Follow-up|0
7386406|NCT01210690|11644973|FG000|Overall Study|Patient refused to swallow|1
7386407|NCT01210690|11644973|FG000|Overall Study|Patient could not take glucose|1
7386408|NCT01210807|11644987|FG000|Overall Study|Lost to Follow-up|1
7386409|NCT01210807|11644988|FG001|Overall Study|Lost to Follow-up|2
7386410|NCT01210807|11644987|FG000|Overall Study|Not implanted bilaterally|2
7386411|NCT01210807|11644988|FG001|Overall Study|Not implanted bilaterally|1
7386412|NCT01211145|11645018|FG000|Overall Study|Reason not specified|3
7386413|NCT01211145|11645019|FG001|Overall Study|Reason not specified|2
7386414|NCT01211145|11645020|FG002|Overall Study|Reason not specified|2
7386415|NCT01211145|11645021|FG003|Overall Study|Reason not specified|1
7386416|NCT01211145|11645018|FG000|Overall Study|Lost to Follow-up|3
7386417|NCT01211145|11645019|FG001|Overall Study|Lost to Follow-up|2
7386418|NCT01211145|11645020|FG002|Overall Study|Lost to Follow-up|1
7386419|NCT01211145|11645021|FG003|Overall Study|Lost to Follow-up|2
7386420|NCT01211145|11645018|FG000|Overall Study|Study-specific withdrawal criteria|1
7386421|NCT01211145|11645019|FG001|Overall Study|Study-specific withdrawal criteria|0
7386422|NCT01211145|11645020|FG002|Overall Study|Study-specific withdrawal criteria|0
7386423|NCT01211145|11645021|FG003|Overall Study|Study-specific withdrawal criteria|0
7386424|NCT01211145|11645018|FG000|Overall Study|Severe noncompliance to protocol|1
7386425|NCT01211145|11645019|FG001|Overall Study|Severe noncompliance to protocol|0
7386426|NCT01211145|11645020|FG002|Overall Study|Severe noncompliance to protocol|0
7386427|NCT01211145|11645021|FG003|Overall Study|Severe noncompliance to protocol|0
7386428|NCT01211145|11645018|FG000|Overall Study|Eligibility criteria not fulfilled|16
7386429|NCT01211145|11645019|FG001|Overall Study|Eligibility criteria not fulfilled|12
7386430|NCT01211145|11645020|FG002|Overall Study|Eligibility criteria not fulfilled|10
7386431|NCT01211145|11645021|FG003|Overall Study|Eligibility criteria not fulfilled|15
7386432|NCT01211145|11645018|FG000|Overall Study|Patient decision|2
7386433|NCT01211145|11645019|FG001|Overall Study|Patient decision|1
7386434|NCT01211145|11645020|FG002|Overall Study|Patient decision|0
7386435|NCT01211145|11645021|FG003|Overall Study|Patient decision|2
7386436|NCT01211184|11645034|FG000|Overall Study|Withdrawal by Subject|0
7386437|NCT01211184|11645035|FG001|Overall Study|Withdrawal by Subject|2
7386438|NCT01211184|11645036|FG002|Overall Study|Withdrawal by Subject|1
7386439|NCT01211197|11645047|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7386440|NCT01211197|11645048|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7386441|NCT01211197|11645049|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7386442|NCT01211197|11645050|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7386443|NCT01211197|11645051|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7386444|NCT01211197|11645052|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7386445|NCT01211197|11645047|FG000|Washout Period 2 (7 Days)|Adverse Event|1
7386446|NCT01211197|11645048|FG001|Washout Period 2 (7 Days)|Adverse Event|0
7361014|NCT04102501|11607299|FG000|Overall Study|Withdrawal by Subject|7
7361015|NCT04102501|11607300|FG001|Overall Study|Withdrawal by Subject|9
7361016|NCT04102501|11607299|FG000|Overall Study|Adverse Event|1
7361017|NCT04102501|11607300|FG001|Overall Study|Adverse Event|3
7361018|NCT03398356|11607343|FG000|Before Treatment|Lost to Follow-up|1
7361019|NCT03398356|11607344|FG001|Before Treatment|Lost to Follow-up|2
7361020|NCT03398356|11607345|FG002|Before Treatment|Lost to Follow-up|0
7361021|NCT03398356|11607343|FG000|Before Treatment|drug intolerance|2
7361022|NCT03398356|11607344|FG001|Before Treatment|drug intolerance|1
7361023|NCT03398356|11607345|FG002|Before Treatment|drug intolerance|0
7361024|NCT03398356|11607343|FG000|Before Treatment|Withdrawal by Subject|0
7361025|NCT03398356|11607344|FG001|Before Treatment|Withdrawal by Subject|5
7361026|NCT03398356|11607345|FG002|Before Treatment|Withdrawal by Subject|0
7361027|NCT03398356|11607343|FG000|Before Treatment|Physician Decision|0
7361028|NCT03398356|11607344|FG001|Before Treatment|Physician Decision|0
7361029|NCT03398356|11607345|FG002|Before Treatment|Physician Decision|11
7361030|NCT03398356|11607343|FG000|After 6 Weeks of Treatment|Physician Decision|0
7361031|NCT03398356|11607344|FG001|After 6 Weeks of Treatment|Physician Decision|2
7361032|NCT03398356|11607345|FG002|After 6 Weeks of Treatment|Physician Decision|0
7361033|NCT03365791|11607353|FG000|Overall Study|Adverse Event|5
7361034|NCT03365791|11607353|FG000|Overall Study|Death|1
7361035|NCT03365791|11607353|FG000|Overall Study|Lost to Follow-up|1
7361036|NCT03365791|11607353|FG000|Overall Study|Physician Decision|9
7361037|NCT03365791|11607353|FG000|Overall Study|Progressive disease|51
7361038|NCT03365791|11607353|FG000|Overall Study|Subject/guardian decision|5
7361041|NCT02819440|11607380|FG000|Overall Study|Adverse Event|3
7361042|NCT02819440|11607381|FG001|Overall Study|Adverse Event|1
7361043|NCT02819440|11607380|FG000|Overall Study|Lost to Follow-up|1
7361044|NCT02819440|11607381|FG001|Overall Study|Lost to Follow-up|3
7361045|NCT02819440|11607380|FG000|Overall Study|Withdrawal by Subject|9
7361046|NCT02819440|11607381|FG001|Overall Study|Withdrawal by Subject|8
7361047|NCT02782741|11607389|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
7361048|NCT02782741|11607390|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
7361049|NCT02782741|11607389|FG000|Blinded Treatment Period: up to Week 49|Other|0
7361050|NCT02782741|11607390|FG001|Blinded Treatment Period: up to Week 49|Other|1
7361051|NCT02782741|11607389|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
7361052|NCT02782741|11607390|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
7361053|NCT02782741|11607389|FG000|Open-label Long-term: Week 50 to 145|Other|1
7361054|NCT02782741|11607390|FG001|Open-label Long-term: Week 50 to 145|Other|0
7361055|NCT02782741|11607389|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
7361056|NCT02782741|11607390|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
7361057|NCT02647359|11607402|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0
7361058|NCT02647359|11607403|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1
7361059|NCT02647359|11607402|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4
7361060|NCT02647359|11607403|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0
7361061|NCT02647359|11607402|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2
7361062|NCT02647359|11607403|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1
7361063|NCT02647359|11607402|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8
7361064|NCT02647359|11607403|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3
7361065|NCT02647359|11607402|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1
7361066|NCT02647359|11607403|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0
7361067|NCT02647359|11607402|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7
7361068|NCT02647359|11607403|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4
7361069|NCT02485691|11607415|FG000|Overall Study|Adverse Event|25
7361070|NCT02485691|11607416|FG001|Overall Study|Adverse Event|11
7361071|NCT02485691|11607415|FG000|Overall Study|Poor compliance to protocol|0
7361072|NCT02485691|11607416|FG001|Overall Study|Poor compliance to protocol|1
7361073|NCT02485691|11607415|FG000|Overall Study|Disease progression|57
7361074|NCT02485691|11607416|FG001|Overall Study|Disease progression|92
7361075|NCT02485691|11607415|FG000|Overall Study|Investigator's decision|23
7361076|NCT02485691|11607416|FG001|Overall Study|Investigator's decision|5
7361077|NCT02485691|11607415|FG000|Overall Study|Participant's request|13
7361078|NCT02485691|11607416|FG001|Overall Study|Participant's request|6
7361079|NCT02485691|11607415|FG000|Overall Study|Other reason|8
7361080|NCT02485691|11607416|FG001|Overall Study|Other reason|9
7361081|NCT02485691|11607415|FG000|Overall Study|Randomized and not treated|3
7361082|NCT02485691|11607416|FG001|Overall Study|Randomized and not treated|2
7361083|NCT02201251|11607425|FG000|Overall Study|Adverse Event|1
7361084|NCT02201251|11607426|FG001|Overall Study|Adverse Event|1
7361085|NCT02201251|11607425|FG000|Overall Study|Protocol Violation|1
7361086|NCT02201251|11607426|FG001|Overall Study|Protocol Violation|0
7361087|NCT02201251|11607425|FG000|Overall Study|Noncompliance with Study Drug|0
7361088|NCT02201251|11607426|FG001|Overall Study|Noncompliance with Study Drug|1
7361089|NCT02201251|11607425|FG000|Overall Study|Withdrawal by Subject|2
7361090|NCT02201251|11607426|FG001|Overall Study|Withdrawal by Subject|1
7361091|NCT01021293|11607469|FG000|Overall Study|Serious Adverse Event|2
7361092|NCT01021293|11607470|FG001|Overall Study|Serious Adverse Event|1
7361093|NCT01021293|11607469|FG000|Overall Study|Adverse Event|2
7361094|NCT01021293|11607470|FG001|Overall Study|Adverse Event|1
7361095|NCT01021293|11607469|FG000|Overall Study|Withdrawal by Subject|1
7361096|NCT01021293|11607470|FG001|Overall Study|Withdrawal by Subject|3
7361097|NCT01021293|11607469|FG000|Overall Study|Migrated/moved from study area|6
7361098|NCT01021293|11607470|FG001|Overall Study|Migrated/moved from study area|18
7361099|NCT01021293|11607469|FG000|Overall Study|Lost to Follow-up|1
7361100|NCT01021293|11607470|FG001|Overall Study|Lost to Follow-up|1
7361101|NCT01021332|11607494|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
7361102|NCT01021332|11607494|FG000|Overall Study|Adverse Event|43
7361103|NCT01021332|11607494|FG000|Overall Study|Lack of Efficacy|19
7361104|NCT01021332|11607494|FG000|Overall Study|Withdrawal of Consent|23
7361105|NCT01021332|11607494|FG000|Overall Study|Lost to Follow-up|4
7361106|NCT01021332|11607494|FG000|Overall Study|Protocol Violation|9
7361107|NCT01021332|11607494|FG000|Overall Study|Miscellaneous|3
7361108|NCT01021423|11607502|FG000|Overall Study|Study terminated|4
7361109|NCT01021423|11607503|FG001|Overall Study|Study terminated|5
7361110|NCT01021553|11607512|FG000|Overall Study|Adverse Event|1
7361111|NCT01021553|11607513|FG001|Overall Study|Adverse Event|0
7361112|NCT01021553|11607514|FG002|Overall Study|Adverse Event|0
7361113|NCT01021553|11607512|FG000|Overall Study|Lack of Efficacy|2
7361114|NCT01021553|11607513|FG001|Overall Study|Lack of Efficacy|2
7361115|NCT01021553|11607514|FG002|Overall Study|Lack of Efficacy|0
7361116|NCT01021553|11607512|FG000|Overall Study|Protocol Violation|0
7361117|NCT01021553|11607513|FG001|Overall Study|Protocol Violation|2
7361118|NCT01021553|11607514|FG002|Overall Study|Protocol Violation|2
7361119|NCT01021553|11607512|FG000|Overall Study|Lost to Follow-up|0
7361120|NCT01021553|11607513|FG001|Overall Study|Lost to Follow-up|0
7361121|NCT01021553|11607514|FG002|Overall Study|Lost to Follow-up|1
7361122|NCT01021553|11607512|FG000|Overall Study|Withdrawal by Subject|1
7361123|NCT01021553|11607513|FG001|Overall Study|Withdrawal by Subject|1
7460113|NCT01824355|11755267|FG000|Overall Study|unevaluable reference method results per|1
7460114|NCT01824394|11755274|FG000|Overall Study|Early Termination|1
7460115|NCT01824394|11755275|FG001|Overall Study|Early Termination|1
7460116|NCT01824394|11755276|FG002|Overall Study|Early Termination|3
7460117|NCT01824394|11755274|FG000|Overall Study|Withdrawn due to Study Termination|91
7460118|NCT01824394|11755275|FG001|Overall Study|Withdrawn due to Study Termination|83
7460119|NCT01824394|11755276|FG002|Overall Study|Withdrawn due to Study Termination|41
7460120|NCT01824394|11755274|FG000|Overall Study|Lost to Follow-up|0
7460121|NCT01824394|11755275|FG001|Overall Study|Lost to Follow-up|9
7460122|NCT01824394|11755276|FG002|Overall Study|Lost to Follow-up|3
7460123|NCT01824394|11755274|FG000|Overall Study|Death|3
7460124|NCT01824394|11755275|FG001|Overall Study|Death|2
7460125|NCT01824394|11755276|FG002|Overall Study|Death|4
7460126|NCT01824394|11755274|FG000|Overall Study|Discontinued Subjects|1
7460127|NCT01824394|11755275|FG001|Overall Study|Discontinued Subjects|1
7460128|NCT01824394|11755276|FG002|Overall Study|Discontinued Subjects|2
7460129|NCT01824394|11755274|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
7460130|NCT01824394|11755275|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
7460131|NCT01824394|11755276|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
7460132|NCT01824472|11755291|FG000|Overall Study|Lost to Follow-up|0
7460133|NCT01824472|11755292|FG001|Overall Study|Lost to Follow-up|0
7460134|NCT01824472|11755293|FG002|Overall Study|Lost to Follow-up|1
7460135|NCT01824472|11755291|FG000|Overall Study|Withdrawal by Subject|1
7460136|NCT01824472|11755292|FG001|Overall Study|Withdrawal by Subject|5
7460137|NCT01824472|11755293|FG002|Overall Study|Withdrawal by Subject|3
7460138|NCT01824472|11755291|FG000|Overall Study|Ineligible post randomization&screening|0
7460139|NCT01824472|11755292|FG001|Overall Study|Ineligible post randomization&screening|2
7460140|NCT01824472|11755293|FG002|Overall Study|Ineligible post randomization&screening|0
7460141|NCT01824498|11755307|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
7460142|NCT01824498|11755308|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
7460143|NCT01824498|11755309|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
7460144|NCT01824498|11755310|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
7460145|NCT01824498|11755311|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
7460146|NCT01824498|11755312|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
7460147|NCT01824576|11755320|FG000|Overall Study|Device deficiency|2
7460148|NCT01824602|11755345|FG000|Overall Study|Withdrawal by Subject|0
7460149|NCT01824602|11755346|FG001|Overall Study|Withdrawal by Subject|0
7361124|NCT01021553|11607514|FG002|Overall Study|Withdrawal by Subject|0
7361125|NCT01021683|11607536|FG000|Overall Study|Lack of Efficacy|12
7361126|NCT01021683|11607536|FG000|Overall Study|Recovery of neutrophil count|51
7361127|NCT01021683|11607536|FG000|Overall Study|Other|8
7386447|NCT01211197|11645049|FG002|Washout Period 2 (7 Days)|Adverse Event|0
7386448|NCT01211197|11645050|FG003|Washout Period 2 (7 Days)|Adverse Event|0
7386449|NCT01211197|11645051|FG004|Washout Period 2 (7 Days)|Adverse Event|0
7386450|NCT01211197|11645052|FG005|Washout Period 2 (7 Days)|Adverse Event|0
7386451|NCT01211262|11645062|FG000|Overall Study|Progressive Disease|18
7386452|NCT01211262|11645063|FG001|Overall Study|Progressive Disease|9
7386453|NCT01211262|11645062|FG000|Overall Study|Adverse Event|4
7386454|NCT01211262|11645063|FG001|Overall Study|Adverse Event|0
7386455|NCT01211262|11645062|FG000|Overall Study|Withdrawal of Consent|1
7386456|NCT01211262|11645063|FG001|Overall Study|Withdrawal of Consent|0
7361128|NCT01021748|11607549|FG000|Overall Study|Adverse Event|2
7361129|NCT01021748|11607550|FG001|Overall Study|Adverse Event|1
7361130|NCT01021748|11607551|FG002|Overall Study|Adverse Event|2
7361131|NCT01021748|11607552|FG003|Overall Study|Adverse Event|0
7361132|NCT01021748|11607553|FG004|Overall Study|Adverse Event|2
7361133|NCT01021748|11607554|FG005|Overall Study|Adverse Event|0
7361134|NCT01021748|11607555|FG006|Overall Study|Adverse Event|1
7361135|NCT01021748|11607556|FG007|Overall Study|Adverse Event|0
7361136|NCT01021748|11607557|FG008|Overall Study|Adverse Event|7
7361137|NCT01021748|11607549|FG000|Overall Study|Physician Decision|1
7361138|NCT01021748|11607550|FG001|Overall Study|Physician Decision|0
7361139|NCT01021748|11607551|FG002|Overall Study|Physician Decision|1
7361140|NCT01021748|11607552|FG003|Overall Study|Physician Decision|1
7361141|NCT01021748|11607553|FG004|Overall Study|Physician Decision|0
7361142|NCT01021748|11607554|FG005|Overall Study|Physician Decision|0
7361143|NCT01021748|11607555|FG006|Overall Study|Physician Decision|1
7361144|NCT01021748|11607556|FG007|Overall Study|Physician Decision|1
7361145|NCT01021748|11607557|FG008|Overall Study|Physician Decision|2
7361146|NCT01021748|11607549|FG000|Overall Study|Progressive Disease|3
7361147|NCT01021748|11607550|FG001|Overall Study|Progressive Disease|3
7361148|NCT01021748|11607551|FG002|Overall Study|Progressive Disease|4
7361149|NCT01021748|11607552|FG003|Overall Study|Progressive Disease|6
7361150|NCT01021748|11607553|FG004|Overall Study|Progressive Disease|7
7361151|NCT01021748|11607554|FG005|Overall Study|Progressive Disease|3
7361152|NCT01021748|11607555|FG006|Overall Study|Progressive Disease|0
7361153|NCT01021748|11607556|FG007|Overall Study|Progressive Disease|5
7361154|NCT01021748|11607557|FG008|Overall Study|Progressive Disease|6
7361155|NCT01021748|11607549|FG000|Overall Study|Withdrawal by Subject|0
7361156|NCT01021748|11607550|FG001|Overall Study|Withdrawal by Subject|0
7361157|NCT01021748|11607551|FG002|Overall Study|Withdrawal by Subject|0
7361158|NCT01021748|11607552|FG003|Overall Study|Withdrawal by Subject|0
7361159|NCT01021748|11607553|FG004|Overall Study|Withdrawal by Subject|0
7361160|NCT01021748|11607554|FG005|Overall Study|Withdrawal by Subject|0
7361161|NCT01021748|11607555|FG006|Overall Study|Withdrawal by Subject|1
7361162|NCT01021748|11607556|FG007|Overall Study|Withdrawal by Subject|0
7361163|NCT01021748|11607557|FG008|Overall Study|Withdrawal by Subject|1
7361164|NCT01021748|11607549|FG000|Overall Study|Not Treated|0
7361165|NCT01021748|11607550|FG001|Overall Study|Not Treated|1
7361166|NCT01021748|11607551|FG002|Overall Study|Not Treated|0
7361167|NCT01021748|11607552|FG003|Overall Study|Not Treated|0
7361168|NCT01021748|11607553|FG004|Overall Study|Not Treated|0
7361169|NCT01021748|11607554|FG005|Overall Study|Not Treated|0
7361170|NCT01021748|11607555|FG006|Overall Study|Not Treated|0
7361171|NCT01021748|11607556|FG007|Overall Study|Not Treated|0
7361172|NCT01021748|11607557|FG008|Overall Study|Not Treated|0
7361173|NCT01021813|11607592|FG000|DB Treatment Phase|Adverse Event|60
7361174|NCT01021813|11607593|FG001|DB Treatment Phase|Adverse Event|22
7361175|NCT01021813|11607594|FG002|DB Treatment Phase|Adverse Event|0
7361176|NCT01021813|11607595|FG003|DB Treatment Phase|Adverse Event|0
7361177|NCT01021813|11607596|FG004|DB Treatment Phase|Adverse Event|0
7361178|NCT01021813|11607592|FG000|DB Treatment Phase|Lack of Efficacy|44
7361179|NCT01021813|11607593|FG001|DB Treatment Phase|Lack of Efficacy|28
7361180|NCT01021813|11607594|FG002|DB Treatment Phase|Lack of Efficacy|0
7361181|NCT01021813|11607595|FG003|DB Treatment Phase|Lack of Efficacy|0
7361182|NCT01021813|11607596|FG004|DB Treatment Phase|Lack of Efficacy|0
7361183|NCT01021813|11607592|FG000|DB Treatment Phase|Lost to Follow-up|14
7361184|NCT01021813|11607593|FG001|DB Treatment Phase|Lost to Follow-up|12
7361185|NCT01021813|11607594|FG002|DB Treatment Phase|Lost to Follow-up|0
7361186|NCT01021813|11607595|FG003|DB Treatment Phase|Lost to Follow-up|0
7361187|NCT01021813|11607596|FG004|DB Treatment Phase|Lost to Follow-up|0
7361188|NCT01021813|11607592|FG000|DB Treatment Phase|Physician Decision|17
7361189|NCT01021813|11607593|FG001|DB Treatment Phase|Physician Decision|8
7361190|NCT01021813|11607594|FG002|DB Treatment Phase|Physician Decision|0
7361191|NCT01021813|11607595|FG003|DB Treatment Phase|Physician Decision|0
7361192|NCT01021813|11607596|FG004|DB Treatment Phase|Physician Decision|0
7361193|NCT01021813|11607592|FG000|DB Treatment Phase|Pregnancy|1
7361194|NCT01021813|11607593|FG001|DB Treatment Phase|Pregnancy|0
7361195|NCT01021813|11607594|FG002|DB Treatment Phase|Pregnancy|0
7361196|NCT01021813|11607595|FG003|DB Treatment Phase|Pregnancy|0
7361197|NCT01021813|11607596|FG004|DB Treatment Phase|Pregnancy|0
7361198|NCT01021813|11607592|FG000|DB Treatment Phase|Protocol Violation|4
7361199|NCT01021813|11607593|FG001|DB Treatment Phase|Protocol Violation|3
7361200|NCT01021813|11607594|FG002|DB Treatment Phase|Protocol Violation|0
7361201|NCT01021813|11607595|FG003|DB Treatment Phase|Protocol Violation|0
7361202|NCT01021813|11607596|FG004|DB Treatment Phase|Protocol Violation|0
7361203|NCT01021813|11607592|FG000|DB Treatment Phase|Withdrawal by Subject|60
7361204|NCT01021813|11607593|FG001|DB Treatment Phase|Withdrawal by Subject|24
7361205|NCT01021813|11607594|FG002|DB Treatment Phase|Withdrawal by Subject|0
7361206|NCT01021813|11607595|FG003|DB Treatment Phase|Withdrawal by Subject|0
7361207|NCT01021813|11607596|FG004|DB Treatment Phase|Withdrawal by Subject|0
7361208|NCT01021813|11607592|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
7361209|NCT01021813|11607593|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
7361210|NCT01021813|11607594|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
7361211|NCT01021813|11607595|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
7361212|NCT01021813|11607596|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
7361213|NCT01021813|11607592|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7361214|NCT01021813|11607593|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7361215|NCT01021813|11607594|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7361216|NCT01021813|11607595|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
7361217|NCT01021813|11607596|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
7361218|NCT01021813|11607592|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7361219|NCT01021813|11607593|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7361220|NCT01021813|11607594|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7361221|NCT01021813|11607595|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
7361222|NCT01021813|11607596|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
7361223|NCT01021813|11607592|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
7361224|NCT01021813|11607593|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
7361225|NCT01021813|11607594|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
7361226|NCT01021813|11607595|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
7361227|NCT01021813|11607596|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
7361228|NCT01021813|11607592|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7361229|NCT01021813|11607593|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
7361230|NCT01021813|11607594|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7361231|NCT01021813|11607595|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
7361232|NCT01021813|11607596|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
7361233|NCT01021852|11607621|FG000|Treatment Period 1|Adverse Event|3
7361234|NCT01021852|11607622|FG001|Treatment Period 1|Adverse Event|1
7361235|NCT01021852|11607623|FG002|Treatment Period 1|Adverse Event|1
7361236|NCT01021852|11607624|FG003|Treatment Period 1|Adverse Event|0
7361237|NCT01021852|11607625|FG004|Treatment Period 1|Adverse Event|2
7361238|NCT01021852|11607626|FG005|Treatment Period 1|Adverse Event|2
7361239|NCT01021852|11607627|FG006|Treatment Period 1|Adverse Event|0
7361240|NCT01021852|11607628|FG007|Treatment Period 1|Adverse Event|0
7361241|NCT01021852|11607621|FG000|Treatment Period 1|Pregnancy|0
7361242|NCT01021852|11607622|FG001|Treatment Period 1|Pregnancy|0
7361243|NCT01021852|11607623|FG002|Treatment Period 1|Pregnancy|1
7361244|NCT01021852|11607624|FG003|Treatment Period 1|Pregnancy|0
7361245|NCT01021852|11607625|FG004|Treatment Period 1|Pregnancy|0
7361246|NCT01021852|11607626|FG005|Treatment Period 1|Pregnancy|0
7361247|NCT01021852|11607627|FG006|Treatment Period 1|Pregnancy|0
7361248|NCT01021852|11607628|FG007|Treatment Period 1|Pregnancy|0
7361249|NCT01021852|11607621|FG000|Treatment Period 1|Withdrawal by Subject|0
7361250|NCT01021852|11607622|FG001|Treatment Period 1|Withdrawal by Subject|0
7361251|NCT01021852|11607623|FG002|Treatment Period 1|Withdrawal by Subject|0
7361252|NCT01021852|11607624|FG003|Treatment Period 1|Withdrawal by Subject|0
7361253|NCT01021852|11607625|FG004|Treatment Period 1|Withdrawal by Subject|1
7361254|NCT01021852|11607626|FG005|Treatment Period 1|Withdrawal by Subject|0
7361255|NCT01021852|11607627|FG006|Treatment Period 1|Withdrawal by Subject|0
7361256|NCT01021852|11607628|FG007|Treatment Period 1|Withdrawal by Subject|1
7361257|NCT01021852|11607621|FG000|Treatment Period 1|Not Treated|0
7361258|NCT01021852|11607622|FG001|Treatment Period 1|Not Treated|0
7361259|NCT01021852|11607623|FG002|Treatment Period 1|Not Treated|0
7361260|NCT01021852|11607624|FG003|Treatment Period 1|Not Treated|2
7361261|NCT01021852|11607625|FG004|Treatment Period 1|Not Treated|0
7361262|NCT01021852|11607626|FG005|Treatment Period 1|Not Treated|0
7361263|NCT01021852|11607627|FG006|Treatment Period 1|Not Treated|0
7361264|NCT01021852|11607628|FG007|Treatment Period 1|Not Treated|0
7361265|NCT01021852|11607621|FG000|Washout Period-Placebo|Adverse Event|0
7361266|NCT01021852|11607622|FG001|Washout Period-Placebo|Adverse Event|0
7361267|NCT01021852|11607623|FG002|Washout Period-Placebo|Adverse Event|0
7361268|NCT01021852|11607624|FG003|Washout Period-Placebo|Adverse Event|1
7361269|NCT01021852|11607625|FG004|Washout Period-Placebo|Adverse Event|0
7361270|NCT01021852|11607626|FG005|Washout Period-Placebo|Adverse Event|1
7361271|NCT01021852|11607627|FG006|Washout Period-Placebo|Adverse Event|0
7361272|NCT01021852|11607628|FG007|Washout Period-Placebo|Adverse Event|0
7361273|NCT01021852|11607621|FG000|Washout Period-Placebo|Lost to Follow-up|0
7361274|NCT01021852|11607622|FG001|Washout Period-Placebo|Lost to Follow-up|0
7361275|NCT01021852|11607623|FG002|Washout Period-Placebo|Lost to Follow-up|0
7361276|NCT01021852|11607624|FG003|Washout Period-Placebo|Lost to Follow-up|0
7361277|NCT01021852|11607625|FG004|Washout Period-Placebo|Lost to Follow-up|1
7361278|NCT01021852|11607626|FG005|Washout Period-Placebo|Lost to Follow-up|0
7361279|NCT01021852|11607627|FG006|Washout Period-Placebo|Lost to Follow-up|0
7361280|NCT01021852|11607628|FG007|Washout Period-Placebo|Lost to Follow-up|0
7361281|NCT01021852|11607621|FG000|Washout Period-Placebo|Protocol Violation|0
7569708|NCT03465436|11946487|FG000|Period 4|Protocol Violation|0
7569709|NCT03465436|11946488|FG001|Period 4|Protocol Violation|0
7569710|NCT03465436|11946489|FG002|Period 4|Protocol Violation|1
7569711|NCT03465436|11946490|FG003|Period 4|Protocol Violation|0
7361282|NCT01021852|11607622|FG001|Washout Period-Placebo|Protocol Violation|0
7361283|NCT01021852|11607623|FG002|Washout Period-Placebo|Protocol Violation|0
7361284|NCT01021852|11607624|FG003|Washout Period-Placebo|Protocol Violation|0
7361285|NCT01021852|11607625|FG004|Washout Period-Placebo|Protocol Violation|0
7361286|NCT01021852|11607626|FG005|Washout Period-Placebo|Protocol Violation|0
7361287|NCT01021852|11607627|FG006|Washout Period-Placebo|Protocol Violation|1
7569712|NCT03465709|11946502|FG000|Overall Study|Study/Site Terminated by Sponsor|14
7361288|NCT01021852|11607628|FG007|Washout Period-Placebo|Protocol Violation|0
7361289|NCT01021852|11607621|FG000|Washout Period-No Drug|Adverse Event|1
7361290|NCT01021852|11607622|FG001|Washout Period-No Drug|Adverse Event|0
7361291|NCT01021852|11607623|FG002|Washout Period-No Drug|Adverse Event|0
7361292|NCT01021852|11607624|FG003|Washout Period-No Drug|Adverse Event|0
7361293|NCT01021852|11607625|FG004|Washout Period-No Drug|Adverse Event|0
7361294|NCT01021852|11607626|FG005|Washout Period-No Drug|Adverse Event|1
7361295|NCT01021852|11607627|FG006|Washout Period-No Drug|Adverse Event|0
7361296|NCT01021852|11607628|FG007|Washout Period-No Drug|Adverse Event|0
7361297|NCT01021852|11607621|FG000|Treatment Period 2|Adverse Event|0
7361298|NCT01021852|11607622|FG001|Treatment Period 2|Adverse Event|1
7361299|NCT01021852|11607623|FG002|Treatment Period 2|Adverse Event|0
7361300|NCT01021852|11607624|FG003|Treatment Period 2|Adverse Event|0
7361301|NCT01021852|11607625|FG004|Treatment Period 2|Adverse Event|1
7361302|NCT01021852|11607626|FG005|Treatment Period 2|Adverse Event|0
7361303|NCT01021852|11607627|FG006|Treatment Period 2|Adverse Event|1
7361304|NCT01021852|11607628|FG007|Treatment Period 2|Adverse Event|0
7361305|NCT01021852|11607621|FG000|Treatment Period 2|Lack of Efficacy|0
7361306|NCT01021852|11607622|FG001|Treatment Period 2|Lack of Efficacy|0
7361307|NCT01021852|11607623|FG002|Treatment Period 2|Lack of Efficacy|0
7361308|NCT01021852|11607624|FG003|Treatment Period 2|Lack of Efficacy|0
7361309|NCT01021852|11607625|FG004|Treatment Period 2|Lack of Efficacy|0
7361310|NCT01021852|11607626|FG005|Treatment Period 2|Lack of Efficacy|1
7361311|NCT01021852|11607627|FG006|Treatment Period 2|Lack of Efficacy|0
7361312|NCT01021852|11607628|FG007|Treatment Period 2|Lack of Efficacy|0
7361313|NCT01021852|11607621|FG000|Treatment Period 2|Physician Decision|0
7361314|NCT01021852|11607622|FG001|Treatment Period 2|Physician Decision|0
7361315|NCT01021852|11607623|FG002|Treatment Period 2|Physician Decision|1
7361316|NCT01021852|11607624|FG003|Treatment Period 2|Physician Decision|0
7361317|NCT01021852|11607625|FG004|Treatment Period 2|Physician Decision|0
7361318|NCT01021852|11607626|FG005|Treatment Period 2|Physician Decision|0
7361319|NCT01021852|11607627|FG006|Treatment Period 2|Physician Decision|0
7361320|NCT01021852|11607628|FG007|Treatment Period 2|Physician Decision|0
7361321|NCT01021852|11607621|FG000|Treatment Period 2|Protocol Violation|0
7361322|NCT01021852|11607622|FG001|Treatment Period 2|Protocol Violation|0
7361323|NCT01021852|11607623|FG002|Treatment Period 2|Protocol Violation|0
7361324|NCT01021852|11607624|FG003|Treatment Period 2|Protocol Violation|0
7361325|NCT01021852|11607625|FG004|Treatment Period 2|Protocol Violation|1
7361326|NCT01021852|11607626|FG005|Treatment Period 2|Protocol Violation|0
7361327|NCT01021852|11607627|FG006|Treatment Period 2|Protocol Violation|1
7361328|NCT01021852|11607628|FG007|Treatment Period 2|Protocol Violation|0
7361329|NCT01021852|11607621|FG000|Treatment Period 2|Withdrawal by Subject|0
7361330|NCT01021852|11607622|FG001|Treatment Period 2|Withdrawal by Subject|0
7361331|NCT01021852|11607623|FG002|Treatment Period 2|Withdrawal by Subject|0
7361332|NCT01021852|11607624|FG003|Treatment Period 2|Withdrawal by Subject|0
7361333|NCT01021852|11607625|FG004|Treatment Period 2|Withdrawal by Subject|0
7361334|NCT01021852|11607626|FG005|Treatment Period 2|Withdrawal by Subject|0
7361335|NCT01021852|11607627|FG006|Treatment Period 2|Withdrawal by Subject|1
7361336|NCT01021852|11607628|FG007|Treatment Period 2|Withdrawal by Subject|2
7361337|NCT01021878|11607644|FG000|Overall Study|Lost to Follow-up|4
7361338|NCT01021878|11607645|FG001|Overall Study|Lost to Follow-up|3
7361339|NCT01021878|11607644|FG000|Overall Study|Death|0
7361340|NCT01021878|11607645|FG001|Overall Study|Death|1
7361341|NCT01021878|11607644|FG000|Overall Study|Adverse Event|6
7361342|NCT01021878|11607645|FG001|Overall Study|Adverse Event|5
7361343|NCT01021878|11607644|FG000|Overall Study|Transplantation|6
7361344|NCT01021878|11607645|FG001|Overall Study|Transplantation|1
7361345|NCT01022112|11607686|FG000|Overall Study|Adverse Event|1
7361346|NCT01022112|11607687|FG001|Overall Study|Adverse Event|2
7361347|NCT01022112|11607688|FG002|Overall Study|Adverse Event|0
7361348|NCT01022112|11607689|FG003|Overall Study|Adverse Event|1
7361349|NCT01022112|11607690|FG004|Overall Study|Adverse Event|0
7361350|NCT01022112|11607686|FG000|Overall Study|Lack of Efficacy|1
7361351|NCT01022112|11607687|FG001|Overall Study|Lack of Efficacy|0
7361352|NCT01022112|11607688|FG002|Overall Study|Lack of Efficacy|0
7361353|NCT01022112|11607689|FG003|Overall Study|Lack of Efficacy|0
7361354|NCT01022112|11607690|FG004|Overall Study|Lack of Efficacy|1
7361355|NCT01022112|11607686|FG000|Overall Study|Physician Decision|0
7361356|NCT01022112|11607687|FG001|Overall Study|Physician Decision|0
7361357|NCT01022112|11607688|FG002|Overall Study|Physician Decision|1
7361358|NCT01022112|11607689|FG003|Overall Study|Physician Decision|0
7361359|NCT01022112|11607690|FG004|Overall Study|Physician Decision|1
7361360|NCT01022112|11607686|FG000|Overall Study|Withdrawal by Subject|0
7361361|NCT01022112|11607687|FG001|Overall Study|Withdrawal by Subject|1
7361362|NCT01022112|11607688|FG002|Overall Study|Withdrawal by Subject|2
7361363|NCT01022112|11607689|FG003|Overall Study|Withdrawal by Subject|2
7361364|NCT01022112|11607690|FG004|Overall Study|Withdrawal by Subject|1
7361365|NCT01022112|11607686|FG000|Overall Study|Fasting plasma glucose level increased|1
7361366|NCT01022112|11607687|FG001|Overall Study|Fasting plasma glucose level increased|0
7361367|NCT01022112|11607688|FG002|Overall Study|Fasting plasma glucose level increased|0
7361368|NCT01022112|11607689|FG003|Overall Study|Fasting plasma glucose level increased|0
7361369|NCT01022112|11607690|FG004|Overall Study|Fasting plasma glucose level increased|7
7361370|NCT01022203|11607708|FG000|Post Treatment Assessment|Withdrawal by Subject|12
7361371|NCT01022203|11607709|FG001|Post Treatment Assessment|Withdrawal by Subject|12
7361372|NCT01022203|11607708|FG000|Post Treatment Assessment|Physician Decision|2
7361373|NCT01022203|11607709|FG001|Post Treatment Assessment|Physician Decision|0
7361374|NCT01022203|11607708|FG000|Post Treatment Assessment|Adverse Event|0
7361375|NCT01022203|11607709|FG001|Post Treatment Assessment|Adverse Event|2
7361376|NCT01022203|11607708|FG000|Follow-Up Assessment|Lost to Follow-up|2
7361377|NCT01022203|11607709|FG001|Follow-Up Assessment|Lost to Follow-up|2
7361378|NCT01022424|11607745|FG000|Overall Study|Adverse Event|1
7361379|NCT01022424|11607745|FG000|Overall Study|Physician Decision|1
7361380|NCT01022424|11607745|FG000|Overall Study|eGFR under the withdrawal criteria|2
7361381|NCT01022502|11607753|FG000|Overall Study|Adverse Event|1
7361382|NCT01022502|11607753|FG000|Overall Study|employment related reasons|1
7361383|NCT01022502|11607753|FG000|Overall Study|Withdrawal by Subject|1
7361384|NCT01022580|11607770|FG000|Overall Study|Death|18
7361385|NCT01022580|11607771|FG001|Overall Study|Death|22
7361386|NCT01022762|11607785|FG000|Overall Study|Adverse Event|3
7361387|NCT01022762|11607786|FG001|Overall Study|Adverse Event|1
7361388|NCT01022762|11607785|FG000|Overall Study|Lack of Efficacy|0
7361389|NCT01022762|11607786|FG001|Overall Study|Lack of Efficacy|1
7361390|NCT01022762|11607785|FG000|Overall Study|Protocol Violation|7
7361391|NCT01022762|11607786|FG001|Overall Study|Protocol Violation|6
7361392|NCT01022762|11607785|FG000|Overall Study|Unclassified|12
7361393|NCT01022762|11607786|FG001|Overall Study|Unclassified|20
7361394|NCT01022853|11607797|FG000|Overall Study|Progressive disease|2
7361395|NCT01022853|11607798|FG001|Overall Study|Progressive disease|3
7361396|NCT01022853|11607799|FG002|Overall Study|Progressive disease|11
7361397|NCT01022853|11607800|FG003|Overall Study|Progressive disease|7
7361398|NCT01022853|11607801|FG004|Overall Study|Progressive disease|1
7361399|NCT01022853|11607797|FG000|Overall Study|Dose-limiting toxicity|0
7361400|NCT01022853|11607798|FG001|Overall Study|Dose-limiting toxicity|0
7361401|NCT01022853|11607799|FG002|Overall Study|Dose-limiting toxicity|0
7361402|NCT01022853|11607800|FG003|Overall Study|Dose-limiting toxicity|0
7361403|NCT01022853|11607801|FG004|Overall Study|Dose-limiting toxicity|1
7361404|NCT01022853|11607797|FG000|Overall Study|Withdrawal by Subject|0
7361405|NCT01022853|11607798|FG001|Overall Study|Withdrawal by Subject|1
7361406|NCT01022853|11607799|FG002|Overall Study|Withdrawal by Subject|1
7361407|NCT01022853|11607800|FG003|Overall Study|Withdrawal by Subject|1
7361408|NCT01022853|11607801|FG004|Overall Study|Withdrawal by Subject|0
7361409|NCT01022853|11607797|FG000|Overall Study|Other not stated above|1
7361410|NCT01022853|11607798|FG001|Overall Study|Other not stated above|0
7361411|NCT01022853|11607799|FG002|Overall Study|Other not stated above|1
7361412|NCT01022853|11607800|FG003|Overall Study|Other not stated above|0
7361413|NCT01022853|11607801|FG004|Overall Study|Other not stated above|0
7361414|NCT01022996|11607816|FG000|Overall Study|Adverse Event|14
7361415|NCT01022996|11607816|FG000|Overall Study|Withdrawal by Subject|3
7361416|NCT01022996|11607816|FG000|Overall Study|Lost to Follow-up|1
7361417|NCT01022996|11607816|FG000|Overall Study|Administrative problems|6
7361418|NCT01022996|11607816|FG000|Overall Study|Disease Progression|32
7361419|NCT01022996|11607816|FG000|Overall Study|Protocol Violation|1
7361420|NCT01023022|11607820|FG000|Overall Study|Death|5
7361421|NCT01023022|11607820|FG000|Overall Study|Lost to Follow-up|7
7361422|NCT01023022|11607820|FG000|Overall Study|due to technical issues|2
7361423|NCT01023035|11607827|FG000|Treatment Period|Adverse Event|27
7361424|NCT01023035|11607828|FG001|Treatment Period|Adverse Event|32
7361425|NCT01023035|11607829|FG002|Treatment Period|Adverse Event|50
7361426|NCT01023035|11607827|FG000|Treatment Period|Non-Medical Reasons|19
7361427|NCT01023035|11607828|FG001|Treatment Period|Non-Medical Reasons|22
7361428|NCT01023035|11607829|FG002|Treatment Period|Non-Medical Reasons|44
7361429|NCT01023035|11607827|FG000|Treatment Period|Treatment Failure|26
7361430|NCT01023035|11607828|FG001|Treatment Period|Treatment Failure|31
7361431|NCT01023035|11607829|FG002|Treatment Period|Treatment Failure|24
7361432|NCT01023035|11607827|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
7361433|NCT01023035|11607828|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
7361434|NCT01023035|11607829|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
7361435|NCT01023035|11607827|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
7361436|NCT01023035|11607828|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
7361437|NCT01023035|11607829|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
7361438|NCT01023061|11607839|FG000|Overall Study|Withdrawal prior to treatment|2
7361439|NCT01023217|11607875|FG000|Overall Study|Withdrawal by Subject|1
7361440|NCT01023217|11607876|FG001|Overall Study|Withdrawal by Subject|0
7361441|NCT01023256|11607886|FG000|Overall Study|Protocol Violation|2
7361442|NCT01023256|11607887|FG001|Overall Study|Protocol Violation|3
7361443|NCT01023256|11607888|FG002|Overall Study|Protocol Violation|0
7361444|NCT01023256|11607889|FG003|Overall Study|Protocol Violation|0
7361445|NCT01023256|11607886|FG000|Overall Study|Randomized but not treated|1
7361446|NCT01023256|11607887|FG001|Overall Study|Randomized but not treated|0
7361447|NCT01023256|11607888|FG002|Overall Study|Randomized but not treated|1
7361448|NCT01023256|11607889|FG003|Overall Study|Randomized but not treated|0
7361449|NCT01023256|11607886|FG000|Overall Study|Other|1
7361450|NCT01023256|11607887|FG001|Overall Study|Other|0
7361451|NCT01023256|11607888|FG002|Overall Study|Other|0
7361452|NCT01023256|11607889|FG003|Overall Study|Other|2
7361453|NCT01023256|11607886|FG000|Overall Study|Adverse Event|0
7361454|NCT01023256|11607887|FG001|Overall Study|Adverse Event|0
7361455|NCT01023256|11607888|FG002|Overall Study|Adverse Event|0
7361456|NCT01023256|11607889|FG003|Overall Study|Adverse Event|1
7361457|NCT01023256|11607886|FG000|Overall Study|Withdrawal by Subject|0
7361458|NCT01023256|11607887|FG001|Overall Study|Withdrawal by Subject|0
7361459|NCT01023256|11607888|FG002|Overall Study|Withdrawal by Subject|0
7361460|NCT01023256|11607889|FG003|Overall Study|Withdrawal by Subject|2
7361461|NCT01023269|11607902|FG000|Overall Study|early termination of the study|2
7361462|NCT01023269|11607903|FG001|Overall Study|early termination of the study|0
7361463|NCT01023308|11607909|FG000|Overall Study|Abnormal test proceedure results|3
7361464|NCT01023308|11607910|FG001|Overall Study|Abnormal test proceedure results|8
7361465|NCT01023308|11607909|FG000|Overall Study|Administrative problems|2
7361466|NCT01023308|11607910|FG001|Overall Study|Administrative problems|1
7361467|NCT01023308|11607909|FG000|Overall Study|Adverse Event|130
7361468|NCT01023308|11607910|FG001|Overall Study|Adverse Event|66
7361469|NCT01023308|11607909|FG000|Overall Study|Death|21
7361470|NCT01023308|11607910|FG001|Overall Study|Death|17
7361471|NCT01023308|11607909|FG000|Overall Study|Disease progression|82
7361472|NCT01023308|11607910|FG001|Overall Study|Disease progression|153
7361473|NCT01023308|11607909|FG000|Overall Study|New Cancer therapy|4
7361474|NCT01023308|11607910|FG001|Overall Study|New Cancer therapy|7
7361475|NCT01023308|11607909|FG000|Overall Study|Protocol Violation|3
7361476|NCT01023308|11607910|FG001|Overall Study|Protocol Violation|4
7361477|NCT01023308|11607909|FG000|Overall Study|Untreated|5
7361478|NCT01023308|11607910|FG001|Overall Study|Untreated|5
7361479|NCT01023308|11607909|FG000|Overall Study|Lost to Follow-up|1
7361480|NCT01023308|11607910|FG001|Overall Study|Lost to Follow-up|0
7361481|NCT01023308|11607909|FG000|Overall Study|Withdrawal by Subject|34
7361482|NCT01023308|11607910|FG001|Overall Study|Withdrawal by Subject|18
7361483|NCT01023516|11607927|FG000|Overall Study|Voluntary discontinuation|7
7361484|NCT01023516|11607928|FG001|Overall Study|Voluntary discontinuation|5
7361485|NCT01023516|11607927|FG000|Overall Study|Adverse Event|9
7361486|NCT01023516|11607928|FG001|Overall Study|Adverse Event|6
7361487|NCT01023516|11607927|FG000|Overall Study|Safety reason|0
7361488|NCT01023516|11607928|FG001|Overall Study|Safety reason|3
7361489|NCT01023516|11607927|FG000|Overall Study|Study-specific criteria|4
7361490|NCT01023516|11607928|FG001|Overall Study|Study-specific criteria|2
7361491|NCT01023516|11607927|FG000|Overall Study|Incorrect enrolment|4
7361492|NCT01023516|11607928|FG001|Overall Study|Incorrect enrolment|2
7361493|NCT01023581|11607954|FG000|Overall Study|Adverse Event|4
7361494|NCT01023581|11607955|FG001|Overall Study|Adverse Event|4
7361495|NCT01023581|11607956|FG002|Overall Study|Adverse Event|7
7361496|NCT01023581|11607957|FG003|Overall Study|Adverse Event|3
7361497|NCT01023581|11607958|FG004|Overall Study|Adverse Event|2
7361498|NCT01023581|11607959|FG005|Overall Study|Adverse Event|5
7361499|NCT01023581|11607960|FG006|Overall Study|Adverse Event|11
7361500|NCT01023581|11607954|FG000|Overall Study|Major protocol deviation|2
7361501|NCT01023581|11607955|FG001|Overall Study|Major protocol deviation|0
7361502|NCT01023581|11607956|FG002|Overall Study|Major protocol deviation|3
7361503|NCT01023581|11607957|FG003|Overall Study|Major protocol deviation|0
7361504|NCT01023581|11607958|FG004|Overall Study|Major protocol deviation|0
7361505|NCT01023581|11607959|FG005|Overall Study|Major protocol deviation|0
7361506|NCT01023581|11607960|FG006|Overall Study|Major protocol deviation|0
7361507|NCT01023581|11607954|FG000|Overall Study|Lost to Follow-up|4
7460150|NCT01824602|11755347|FG002|Overall Study|Withdrawal by Subject|1
7460151|NCT01824602|11755348|FG003|Overall Study|Withdrawal by Subject|2
7460152|NCT01824602|11755345|FG000|Overall Study|Patient non-compliance|0
7460153|NCT01824602|11755346|FG001|Overall Study|Patient non-compliance|0
7460154|NCT01824602|11755347|FG002|Overall Study|Patient non-compliance|1
7460155|NCT01824602|11755348|FG003|Overall Study|Patient non-compliance|0
7569713|NCT03465709|11946502|FG000|Overall Study|Withdrawal by Subject|3
7569714|NCT03465722|11946510|FG000|End of Treatment|Patient Refused Treatment|3
7569715|NCT03465722|11946511|FG001|End of Treatment|Patient Refused Treatment|1
7460156|NCT01824602|11755345|FG000|Overall Study|Adverse Event|1
7460157|NCT01824602|11755346|FG001|Overall Study|Adverse Event|0
7460158|NCT01824602|11755347|FG002|Overall Study|Adverse Event|2
7460159|NCT01824602|11755348|FG003|Overall Study|Adverse Event|2
7460160|NCT01824602|11755345|FG000|Overall Study|Treatment failure|0
7460161|NCT01824602|11755346|FG001|Overall Study|Treatment failure|0
7361508|NCT01023581|11607955|FG001|Overall Study|Lost to Follow-up|8
7361509|NCT01023581|11607956|FG002|Overall Study|Lost to Follow-up|7
7361510|NCT01023581|11607957|FG003|Overall Study|Lost to Follow-up|2
7361511|NCT01023581|11607958|FG004|Overall Study|Lost to Follow-up|5
7361512|NCT01023581|11607959|FG005|Overall Study|Lost to Follow-up|2
7361513|NCT01023581|11607960|FG006|Overall Study|Lost to Follow-up|2
7361514|NCT01023581|11607954|FG000|Overall Study|Withdrawal by Subject|13
7361515|NCT01023581|11607955|FG001|Overall Study|Withdrawal by Subject|8
7361516|NCT01023581|11607956|FG002|Overall Study|Withdrawal by Subject|16
7361517|NCT01023581|11607957|FG003|Overall Study|Withdrawal by Subject|10
7361518|NCT01023581|11607958|FG004|Overall Study|Withdrawal by Subject|6
7361519|NCT01023581|11607959|FG005|Overall Study|Withdrawal by Subject|8
7361520|NCT01023581|11607960|FG006|Overall Study|Withdrawal by Subject|5
7361521|NCT01023581|11607954|FG000|Overall Study|Pregnancy|0
7361522|NCT01023581|11607955|FG001|Overall Study|Pregnancy|0
7361523|NCT01023581|11607956|FG002|Overall Study|Pregnancy|0
7361524|NCT01023581|11607957|FG003|Overall Study|Pregnancy|2
7361525|NCT01023581|11607958|FG004|Overall Study|Pregnancy|0
7361526|NCT01023581|11607959|FG005|Overall Study|Pregnancy|1
7361527|NCT01023581|11607960|FG006|Overall Study|Pregnancy|0
7361528|NCT01023581|11607954|FG000|Overall Study|Lack of Efficacy|9
7361529|NCT01023581|11607955|FG001|Overall Study|Lack of Efficacy|3
7361530|NCT01023581|11607956|FG002|Overall Study|Lack of Efficacy|6
7361531|NCT01023581|11607957|FG003|Overall Study|Lack of Efficacy|2
7361532|NCT01023581|11607958|FG004|Overall Study|Lack of Efficacy|1
7361533|NCT01023581|11607959|FG005|Overall Study|Lack of Efficacy|2
7361534|NCT01023581|11607960|FG006|Overall Study|Lack of Efficacy|1
7361535|NCT01023581|11607954|FG000|Overall Study|Physician Decision|2
7361536|NCT01023581|11607955|FG001|Overall Study|Physician Decision|0
7361537|NCT01023581|11607956|FG002|Overall Study|Physician Decision|2
7361538|NCT01023581|11607957|FG003|Overall Study|Physician Decision|1
7361539|NCT01023581|11607958|FG004|Overall Study|Physician Decision|1
7361540|NCT01023581|11607959|FG005|Overall Study|Physician Decision|1
7361541|NCT01023581|11607960|FG006|Overall Study|Physician Decision|1
7361542|NCT01023581|11607954|FG000|Overall Study|Other|1
7361543|NCT01023581|11607955|FG001|Overall Study|Other|0
7361544|NCT01023581|11607956|FG002|Overall Study|Other|1
7361545|NCT01023581|11607957|FG003|Overall Study|Other|0
7361546|NCT01023581|11607958|FG004|Overall Study|Other|1
7361547|NCT01023581|11607959|FG005|Overall Study|Other|0
7361548|NCT01023581|11607960|FG006|Overall Study|Other|0
7361549|NCT01023659|11607979|FG000|Overall Study|Lost to Follow-up|73
7361550|NCT01023659|11607980|FG001|Overall Study|Lost to Follow-up|228
7361551|NCT01023659|11607981|FG002|Overall Study|Lost to Follow-up|99
7361552|NCT01023672|11607990|FG000|Overall Study|Worsening disease|2
7361553|NCT01023672|11607990|FG000|Overall Study|Death|1
7361554|NCT01023789|11608012|FG000|3 - Year Visit|Death|29
7361555|NCT01023789|11608012|FG000|3 - Year Visit|Withdrawal of consent|1
7361556|NCT01023789|11608012|FG000|3 - Year Visit|Lost to Follow-up|13
7361557|NCT01023815|11608020|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
7361558|NCT01023815|11608021|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7361559|NCT01023815|11608022|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7361560|NCT01023815|11608023|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
7361561|NCT01023815|11608020|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7361562|NCT01023815|11608021|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
7361563|NCT01023815|11608022|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7569716|NCT03465722|11946510|FG000|End of Treatment|Withdrawal by Subject|6
7569717|NCT03465722|11946511|FG001|End of Treatment|Withdrawal by Subject|1
7569718|NCT03465722|11946510|FG000|End of Treatment|Adverse Event|30
7569719|NCT03465722|11946511|FG001|End of Treatment|Adverse Event|23
7569720|NCT03465722|11946510|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
7569721|NCT03465722|11946511|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
7569722|NCT03465722|11946510|FG000|End of Treatment|Clinical Progression|17
7569723|NCT03465722|11946511|FG001|End of Treatment|Clinical Progression|5
7569724|NCT03465722|11946510|FG000|End of Treatment|Physician Decision|4
7569725|NCT03465722|11946511|FG001|End of Treatment|Physician Decision|5
7361564|NCT01023815|11608023|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
7361565|NCT01023815|11608020|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7361566|NCT01023815|11608021|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7361567|NCT01023815|11608022|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
7361568|NCT01023815|11608023|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
7361569|NCT01023815|11608020|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
7361570|NCT01023815|11608021|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
7361571|NCT01023815|11608022|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
7569726|NCT03465722|11946510|FG000|End of Treatment|Lost to Follow-up|3
7361572|NCT01023815|11608023|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
7361573|NCT01023815|11608020|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7361574|NCT01023815|11608021|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
7569727|NCT03465722|11946511|FG001|End of Treatment|Lost to Follow-up|1
7361575|NCT01023815|11608022|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7361576|NCT01023815|11608023|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
7361577|NCT01023958|11608043|FG000|Overall Study|Progressive disease|48
7361578|NCT01023958|11608043|FG000|Overall Study|Other adverse event|1
7361579|NCT01023958|11608043|FG000|Overall Study|Refused to continue medication|1
7361580|NCT01024036|11608058|FG000|Blinded Treatment|Adverse Event|1
7361581|NCT01024036|11608059|FG001|Blinded Treatment|Adverse Event|1
7361582|NCT01024036|11608058|FG000|Blinded Treatment|Lack of Efficacy|16
7361583|NCT01024036|11608059|FG001|Blinded Treatment|Lack of Efficacy|14
7361584|NCT01024036|11608058|FG000|Blinded Treatment|Physician Decision|1
7361585|NCT01024036|11608059|FG001|Blinded Treatment|Physician Decision|0
7361586|NCT01024036|11608058|FG000|Blinded Treatment|Death|0
7361587|NCT01024036|11608059|FG001|Blinded Treatment|Death|2
7361588|NCT01024036|11608058|FG000|Blinded Treatment|Withdrawal by Subject|4
7361589|NCT01024036|11608059|FG001|Blinded Treatment|Withdrawal by Subject|3
7361590|NCT01024036|11608058|FG000|Unblinded Treatment|Adverse Event|0
7361591|NCT01024036|11608059|FG001|Unblinded Treatment|Adverse Event|1
7361592|NCT01024036|11608058|FG000|Unblinded Treatment|Lack of Efficacy|0
7361593|NCT01024036|11608059|FG001|Unblinded Treatment|Lack of Efficacy|2
7361594|NCT01024036|11608058|FG000|Follow-Up Period|Lost to Follow-up|1
7361595|NCT01024036|11608059|FG001|Follow-Up Period|Lost to Follow-up|1
7361596|NCT01024036|11608058|FG000|Follow-Up Period|Withdrawal by Subject|0
7361597|NCT01024036|11608059|FG001|Follow-Up Period|Withdrawal by Subject|1
7361598|NCT01024036|11608058|FG000|Follow-Up Period|Adverse Event|4
7361599|NCT01024036|11608059|FG001|Follow-Up Period|Adverse Event|1
7361600|NCT01024231|11608075|FG000|Overall Study|Other Reasons|1
7361601|NCT01024231|11608076|FG001|Overall Study|Other Reasons|2
7361602|NCT01024231|11608077|FG002|Overall Study|Other Reasons|0
7361603|NCT01024231|11608078|FG003|Overall Study|Other Reasons|0
7361604|NCT01024231|11608079|FG004|Overall Study|Other Reasons|2
7361605|NCT01024231|11608080|FG005|Overall Study|Other Reasons|0
7361606|NCT01024231|11608081|FG006|Overall Study|Other Reasons|1
7361607|NCT01024231|11608075|FG000|Overall Study|Maximum Clinical Benefit|1
7361608|NCT01024231|11608076|FG001|Overall Study|Maximum Clinical Benefit|2
7361609|NCT01024231|11608077|FG002|Overall Study|Maximum Clinical Benefit|0
7361610|NCT01024231|11608078|FG003|Overall Study|Maximum Clinical Benefit|1
7361611|NCT01024231|11608079|FG004|Overall Study|Maximum Clinical Benefit|1
7361612|NCT01024231|11608080|FG005|Overall Study|Maximum Clinical Benefit|0
7361613|NCT01024231|11608081|FG006|Overall Study|Maximum Clinical Benefit|0
7361614|NCT01024231|11608075|FG000|Overall Study|Disease Progression|3
7361615|NCT01024231|11608076|FG001|Overall Study|Disease Progression|1
7361616|NCT01024231|11608077|FG002|Overall Study|Disease Progression|3
7361617|NCT01024231|11608078|FG003|Overall Study|Disease Progression|0
7361618|NCT01024231|11608079|FG004|Overall Study|Disease Progression|4
7361619|NCT01024231|11608080|FG005|Overall Study|Disease Progression|11
7361620|NCT01024231|11608081|FG006|Overall Study|Disease Progression|6
7361621|NCT01024231|11608075|FG000|Overall Study|AE unrelated to Study Drug|0
7361622|NCT01024231|11608076|FG001|Overall Study|AE unrelated to Study Drug|1
7361623|NCT01024231|11608077|FG002|Overall Study|AE unrelated to Study Drug|0
7361624|NCT01024231|11608078|FG003|Overall Study|AE unrelated to Study Drug|0
7361625|NCT01024231|11608079|FG004|Overall Study|AE unrelated to Study Drug|0
7361626|NCT01024231|11608080|FG005|Overall Study|AE unrelated to Study Drug|0
7361627|NCT01024231|11608081|FG006|Overall Study|AE unrelated to Study Drug|0
7361628|NCT01024231|11608075|FG000|Overall Study|No longer meets criteria|0
7361629|NCT01024231|11608076|FG001|Overall Study|No longer meets criteria|0
7361630|NCT01024231|11608077|FG002|Overall Study|No longer meets criteria|0
7361631|NCT01024231|11608078|FG003|Overall Study|No longer meets criteria|0
7361632|NCT01024231|11608079|FG004|Overall Study|No longer meets criteria|1
7361633|NCT01024231|11608080|FG005|Overall Study|No longer meets criteria|0
7361634|NCT01024231|11608081|FG006|Overall Study|No longer meets criteria|1
7361635|NCT01024231|11608075|FG000|Overall Study|Study Drug Toxicity|1
7361636|NCT01024231|11608076|FG001|Overall Study|Study Drug Toxicity|6
7361637|NCT01024231|11608077|FG002|Overall Study|Study Drug Toxicity|6
7361638|NCT01024231|11608078|FG003|Overall Study|Study Drug Toxicity|4
7361639|NCT01024231|11608079|FG004|Overall Study|Study Drug Toxicity|2
7361640|NCT01024231|11608080|FG005|Overall Study|Study Drug Toxicity|0
7361641|NCT01024231|11608081|FG006|Overall Study|Study Drug Toxicity|7
7361642|NCT01024231|11608075|FG000|Overall Study|Death|6
7361643|NCT01024231|11608076|FG001|Overall Study|Death|2
7361644|NCT01024231|11608077|FG002|Overall Study|Death|1
7361645|NCT01024231|11608078|FG003|Overall Study|Death|0
7361646|NCT01024231|11608079|FG004|Overall Study|Death|4
7361647|NCT01024231|11608080|FG005|Overall Study|Death|3
7361648|NCT01024231|11608081|FG006|Overall Study|Death|5
7361649|NCT01024231|11608075|FG000|Overall Study|Lost to Follow-up|0
7361650|NCT01024231|11608076|FG001|Overall Study|Lost to Follow-up|0
7361651|NCT01024231|11608077|FG002|Overall Study|Lost to Follow-up|0
7361652|NCT01024231|11608078|FG003|Overall Study|Lost to Follow-up|0
7361653|NCT01024231|11608079|FG004|Overall Study|Lost to Follow-up|0
7361654|NCT01024231|11608080|FG005|Overall Study|Lost to Follow-up|0
7361655|NCT01024231|11608081|FG006|Overall Study|Lost to Follow-up|1
7361656|NCT01024231|11608075|FG000|Overall Study|Withdrew Consent|0
7361657|NCT01024231|11608076|FG001|Overall Study|Withdrew Consent|1
7361658|NCT01024231|11608077|FG002|Overall Study|Withdrew Consent|0
7361659|NCT01024231|11608078|FG003|Overall Study|Withdrew Consent|0
7361660|NCT01024231|11608079|FG004|Overall Study|Withdrew Consent|0
7361661|NCT01024231|11608080|FG005|Overall Study|Withdrew Consent|0
7361662|NCT01024231|11608081|FG006|Overall Study|Withdrew Consent|0
7361663|NCT01024231|11608075|FG000|Overall Study|Continuing on Treatment|0
7361664|NCT01024231|11608076|FG001|Overall Study|Continuing on Treatment|0
7361665|NCT01024231|11608077|FG002|Overall Study|Continuing on Treatment|0
7361666|NCT01024231|11608078|FG003|Overall Study|Continuing on Treatment|0
7361667|NCT01024231|11608079|FG004|Overall Study|Continuing on Treatment|3
7361668|NCT01024231|11608080|FG005|Overall Study|Continuing on Treatment|2
7361669|NCT01024231|11608081|FG006|Overall Study|Continuing on Treatment|0
7361670|NCT01024244|11608107|FG000|Overall Study|Adverse Event|1
7361671|NCT01024244|11608108|FG001|Overall Study|Adverse Event|2
7361672|NCT01024244|11608109|FG002|Overall Study|Adverse Event|0
7361673|NCT01024244|11608110|FG003|Overall Study|Adverse Event|1
7361674|NCT01024244|11608111|FG004|Overall Study|Adverse Event|2
7361675|NCT01024244|11608107|FG000|Overall Study|Entry Criteria Not Met|0
7361676|NCT01024244|11608108|FG001|Overall Study|Entry Criteria Not Met|1
7361677|NCT01024244|11608109|FG002|Overall Study|Entry Criteria Not Met|0
7361678|NCT01024244|11608110|FG003|Overall Study|Entry Criteria Not Met|0
7361679|NCT01024244|11608111|FG004|Overall Study|Entry Criteria Not Met|0
7361680|NCT01024244|11608107|FG000|Overall Study|Lack of Efficacy|1
7361681|NCT01024244|11608108|FG001|Overall Study|Lack of Efficacy|0
7361682|NCT01024244|11608109|FG002|Overall Study|Lack of Efficacy|0
7361683|NCT01024244|11608110|FG003|Overall Study|Lack of Efficacy|0
7361684|NCT01024244|11608111|FG004|Overall Study|Lack of Efficacy|0
7361685|NCT01024244|11608107|FG000|Overall Study|Protocol Violation|1
7361686|NCT01024244|11608108|FG001|Overall Study|Protocol Violation|0
7361687|NCT01024244|11608109|FG002|Overall Study|Protocol Violation|0
7361688|NCT01024244|11608110|FG003|Overall Study|Protocol Violation|0
7361689|NCT01024244|11608111|FG004|Overall Study|Protocol Violation|2
7361690|NCT01024244|11608107|FG000|Overall Study|Sponsor Decision|14
7361691|NCT01024244|11608108|FG001|Overall Study|Sponsor Decision|7
7361692|NCT01024244|11608109|FG002|Overall Study|Sponsor Decision|14
7361693|NCT01024244|11608110|FG003|Overall Study|Sponsor Decision|12
7361694|NCT01024244|11608111|FG004|Overall Study|Sponsor Decision|10
7361695|NCT01024244|11608107|FG000|Overall Study|Withdrawal by Subject|0
7361696|NCT01024244|11608108|FG001|Overall Study|Withdrawal by Subject|1
7361697|NCT01024244|11608109|FG002|Overall Study|Withdrawal by Subject|0
7361698|NCT01024244|11608110|FG003|Overall Study|Withdrawal by Subject|0
7361699|NCT01024244|11608111|FG004|Overall Study|Withdrawal by Subject|0
7361700|NCT01024309|11608129|FG000|Overall Study|Physician Decision|4
7361701|NCT01024309|11608130|FG001|Overall Study|Physician Decision|0
7361702|NCT01024309|11608129|FG000|Overall Study|Withdrawal by Subject|4
7361703|NCT01024309|11608130|FG001|Overall Study|Withdrawal by Subject|4
7361704|NCT01024387|11608145|FG000|Overall Study|Radiographic Progression|29
7361705|NCT01024387|11608145|FG000|Overall Study|Symptomatic Progression|10
7361706|NCT01024387|11608145|FG000|Overall Study|Physician Decision|5
7361707|NCT01024387|11608145|FG000|Overall Study|Withdrawal by Subject|5
7361708|NCT01024387|11608145|FG000|Overall Study|Death|2
7361709|NCT01024387|11608145|FG000|Overall Study|Prolonged Treatment Delay|1
7361710|NCT01024387|11608145|FG000|Overall Study|Adverse Event|3
7361711|NCT01024387|11608145|FG000|Overall Study|Other|5
7361712|NCT01024465|11608149|FG000|Overall Study|Adverse Event|2
7361713|NCT01024465|11608149|FG000|Overall Study|Physician Decision|1
7569728|NCT03465722|11946510|FG000|End of Treatment|Administrative/Other|6
7569729|NCT03465722|11946511|FG001|End of Treatment|Administrative/Other|3
7569730|NCT03465722|11946510|FG000|End of Treatment|Treatment Ongoing|68
7569731|NCT03465722|11946511|FG001|End of Treatment|Treatment Ongoing|94
7569732|NCT03465722|11946510|FG000|End of Treatment|Randomized But Not Treated|1
7569733|NCT03465722|11946511|FG001|End of Treatment|Randomized But Not Treated|2
7569734|NCT03465722|11946510|FG000|End of Study|Withdrawal by Subject|17
7569735|NCT03465722|11946511|FG001|End of Study|Withdrawal by Subject|7
7569736|NCT03465722|11946510|FG000|End of Study|Death|57
7569737|NCT03465722|11946511|FG001|End of Study|Death|57
7361714|NCT01024751|11608192|FG000|Enrolled Participants|Ineligible at baseline|3
7361715|NCT01024751|11608193|FG001|Enrolled Participants|Ineligible at baseline|4
7361716|NCT01024751|11608192|FG000|Eligible Participants|Withdrawal by Subject|0
7361717|NCT01024751|11608193|FG001|Eligible Participants|Withdrawal by Subject|1
7361718|NCT01024751|11608192|FG000|Eligible Participants|Lost to Follow-up|0
7361719|NCT01024751|11608193|FG001|Eligible Participants|Lost to Follow-up|1
7361720|NCT01024751|11608192|FG000|Eligible Participants|Ineligible|0
7361721|NCT01024751|11608193|FG001|Eligible Participants|Ineligible|1
7361722|NCT01024855|11608199|FG000|Overall Study|Inclusion/exclusion criteria|1
7361723|NCT01024920|11608206|FG000|Overall Study|Progressive disease|47
7361724|NCT01024920|11608207|FG001|Overall Study|Progressive disease|25
7361725|NCT01024920|11608206|FG000|Overall Study|Adverse Event|8
7361726|NCT01024920|11608207|FG001|Overall Study|Adverse Event|4
7361727|NCT01024920|11608206|FG000|Overall Study|Lost to Follow-up|0
7361728|NCT01024920|11608207|FG001|Overall Study|Lost to Follow-up|1
7361729|NCT01024920|11608206|FG000|Overall Study|Patient refusal to continue|4
7361730|NCT01024920|11608207|FG001|Overall Study|Patient refusal to continue|0
7361731|NCT01024920|11608206|FG000|Overall Study|Other than listed|5
7361732|NCT01024920|11608207|FG001|Overall Study|Other than listed|1
7361733|NCT01024920|11608206|FG000|Overall Study|Not treated|3
7361734|NCT01024920|11608207|FG001|Overall Study|Not treated|0
7361735|NCT01024920|11608206|FG000|Overall Study|Protocol Violation|0
7361736|NCT01024920|11608207|FG001|Overall Study|Protocol Violation|1
7361737|NCT01024946|11608213|FG000|Overall Study|Screen Failure|3
7361738|NCT01024946|11608213|FG000|Overall Study|Withdrawal by Subject|1
7361739|NCT01024946|11608213|FG000|Overall Study|Adverse Event|1
7361740|NCT01024959|11608217|FG000|Overall Study|ineligible|12
7361741|NCT01024959|11608217|FG000|Overall Study|results not evaluable|12
7361742|NCT01024959|11608217|FG000|Overall Study|missing results required for analysis|17
7361743|NCT01025037|11608236|FG000|Overall Study|Adverse Event|3
7361744|NCT01025037|11608236|FG000|Overall Study|Lost to Follow-up|7
7361745|NCT01025037|11608236|FG000|Overall Study|Withdrawal by Subject|1
7361746|NCT01025154|11608244|FG000|Overall Study|Lost to Follow-up|1
7361747|NCT01025154|11608244|FG000|Overall Study|Withdrawal by Subject|1
7361748|NCT01025193|11608248|FG000|Overall Study|Protocol Violation|1
7361749|NCT01025193|11608248|FG000|Overall Study|Adverse Event|3
7361750|NCT01025232|11608258|FG000|Overall Study|Study drug no longer available|3
7361751|NCT01025232|11608259|FG001|Overall Study|Study drug no longer available|6
7361752|NCT01025284|11608268|FG000|Overall Study|Investigator Decision|0
7361753|NCT01025284|11608269|FG001|Overall Study|Investigator Decision|1
7361754|NCT01025284|11608270|FG002|Overall Study|Investigator Decision|0
7361755|NCT01025284|11608268|FG000|Overall Study|Withdrawal by Subject|0
7361756|NCT01025284|11608269|FG001|Overall Study|Withdrawal by Subject|1
7361757|NCT01025284|11608270|FG002|Overall Study|Withdrawal by Subject|0
7361758|NCT01025336|11608285|FG000|Overall Study|Protocol Violation|0
7361759|NCT01025336|11608286|FG001|Overall Study|Protocol Violation|0
7361760|NCT01025336|11608287|FG002|Overall Study|Protocol Violation|0
7361761|NCT01025336|11608288|FG003|Overall Study|Protocol Violation|2
7361762|NCT01025336|11608289|FG004|Overall Study|Protocol Violation|0
7361763|NCT01025635|11608323|FG000|Overall Study|Withdrawal by Subject|6
7361764|NCT01025635|11608324|FG001|Overall Study|Withdrawal by Subject|7
7361765|NCT01025635|11608323|FG000|Overall Study|Protocol Violation|4
7361766|NCT01025635|11608324|FG001|Overall Study|Protocol Violation|2
7361767|NCT01025635|11608323|FG000|Overall Study|Lack of Efficacy|0
7361768|NCT01025635|11608324|FG001|Overall Study|Lack of Efficacy|1
7361769|NCT01025635|11608323|FG000|Overall Study|Lost to Follow-up|9
7361770|NCT01025635|11608324|FG001|Overall Study|Lost to Follow-up|13
7361771|NCT01025635|11608323|FG000|Overall Study|Reason not known|4
7361772|NCT01025635|11608324|FG001|Overall Study|Reason not known|2
7361773|NCT01025752|11608332|FG000|Overall Study|Lost to Follow-up|7
7361774|NCT01025752|11608333|FG001|Overall Study|Lost to Follow-up|10
7361775|NCT01025752|11608332|FG000|Overall Study|Physician Decision|1
7361776|NCT01025752|11608333|FG001|Overall Study|Physician Decision|3
7361777|NCT01025817|11608408|FG000|Completed Study Medication|Adverse Event|66
7361778|NCT01025817|11608409|FG001|Completed Study Medication|Adverse Event|39
7361779|NCT01025817|11608408|FG000|Completed Study Medication|Protocol Deviation|9
7361780|NCT01025817|11608409|FG001|Completed Study Medication|Protocol Deviation|8
7361781|NCT01025817|11608408|FG000|Completed Study Medication|Withdrawal by Subject|8
7361782|NCT01025817|11608409|FG001|Completed Study Medication|Withdrawal by Subject|9
7361783|NCT01025817|11608408|FG000|Completed Study Medication|Administrative problems|7
7361784|NCT01025817|11608409|FG001|Completed Study Medication|Administrative problems|5
7361785|NCT01025817|11608408|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
7361786|NCT01025817|11608409|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
7361787|NCT01025817|11608408|FG000|Completed Study Medication|Abnormal test procedure|4
7361788|NCT01025817|11608409|FG001|Completed Study Medication|Abnormal test procedure|0
7361789|NCT01025817|11608408|FG000|Completed Study Medication|Graft loss|2
7361790|NCT01025817|11608409|FG001|Completed Study Medication|Graft loss|5
7361791|NCT01025817|11608408|FG000|Completed Study Medication|Death|2
7361792|NCT01025817|11608409|FG001|Completed Study Medication|Death|2
7361793|NCT01025817|11608408|FG000|Completed Study Medication|Abnormal lab values|0
7361794|NCT01025817|11608409|FG001|Completed Study Medication|Abnormal lab values|2
7361795|NCT01025817|11608408|FG000|Completed Study Medication|Subject no longer required study drug|0
7361796|NCT01025817|11608409|FG001|Completed Study Medication|Subject no longer required study drug|1
7361797|NCT01025817|11608408|FG000|Completed Study Medication|Lost to Follow-up|0
7361798|NCT01025817|11608409|FG001|Completed Study Medication|Lost to Follow-up|1
7361799|NCT01025817|11608408|FG000|Completed Study|Withdrawal by Subject|8
7361800|NCT01025817|11608409|FG001|Completed Study|Withdrawal by Subject|16
7361801|NCT01025817|11608408|FG000|Completed Study|Death|6
7361802|NCT01025817|11608409|FG001|Completed Study|Death|5
7361803|NCT01025817|11608408|FG000|Completed Study|Missing|2
7361804|NCT01025817|11608409|FG001|Completed Study|Missing|0
7361805|NCT01025817|11608408|FG000|Completed Study|Lost to Follow-up|0
7361806|NCT01025817|11608409|FG001|Completed Study|Lost to Follow-up|1
7361807|NCT01025843|11608437|FG000|Washout 4|Withdrawal by Subject|0
7361808|NCT01025843|11608438|FG001|Washout 4|Withdrawal by Subject|0
7361809|NCT01025843|11608439|FG002|Washout 4|Withdrawal by Subject|1
7361810|NCT01025843|11608440|FG003|Washout 4|Withdrawal by Subject|1
7361811|NCT01025843|11608441|FG004|Washout 4|Withdrawal by Subject|0
7361812|NCT01025843|11608442|FG005|Washout 4|Withdrawal by Subject|0
7361813|NCT01025843|11608443|FG006|Washout 4|Withdrawal by Subject|0
7361814|NCT01025843|11608444|FG007|Washout 4|Withdrawal by Subject|0
7361815|NCT01025843|11608445|FG008|Washout 4|Withdrawal by Subject|0
7361816|NCT01025843|11608446|FG009|Washout 4|Withdrawal by Subject|0
7361817|NCT01026038|11608481|FG000|Overall Study|Lost to Follow-up|1
7361818|NCT01026038|11608482|FG001|Overall Study|Lost to Follow-up|1
7361819|NCT01026038|11608483|FG002|Overall Study|Lost to Follow-up|0
7361820|NCT01026103|11608491|FG000|Overall Study|Physician Decision|1
7361821|NCT01026103|11608491|FG000|Overall Study|did not receive study device bc of error|1
7361822|NCT01026142|11608497|FG000|Overall Study|Death|136
7361823|NCT01026142|11608498|FG001|Overall Study|Death|134
7361824|NCT01026142|11608497|FG000|Overall Study|Withdrew consent or lost to follow-up|36
7361825|NCT01026142|11608498|FG001|Overall Study|Withdrew consent or lost to follow-up|29
7361826|NCT01026194|11608519|FG000|Period 1：Double Blind Period|Adverse Event|2
7361827|NCT01026194|11608520|FG001|Period 1：Double Blind Period|Adverse Event|1
7361828|NCT01026194|11608519|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
7361829|NCT01026194|11608520|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
7361830|NCT01026194|11608519|FG000|Period 1：Double Blind Period|Physician Decision|0
7361831|NCT01026194|11608520|FG001|Period 1：Double Blind Period|Physician Decision|4
7361832|NCT01026194|11608519|FG000|Period 2：Open-label Period|Adverse Event|4
7361833|NCT01026194|11608520|FG001|Period 2：Open-label Period|Adverse Event|5
7361834|NCT01026194|11608519|FG000|Period 2：Open-label Period|Physician Decision|3
7361835|NCT01026194|11608520|FG001|Period 2：Open-label Period|Physician Decision|1
7361836|NCT01026194|11608519|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
7361837|NCT01026194|11608520|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
7361838|NCT01026324|11608531|FG000|Follow up/Survival|Withdrawal by Subject|1
7361839|NCT01026324|11608532|FG001|Follow up/Survival|Withdrawal by Subject|0
7361840|NCT01026324|11608533|FG002|Follow up/Survival|Withdrawal by Subject|0
7361841|NCT01026389|11608544|FG000|Overall Study|Withdrawal by Subject|1
7361842|NCT01026389|11608545|FG001|Overall Study|Withdrawal by Subject|3
7361843|NCT01026389|11608544|FG000|Overall Study|change of treatment, patient moved|4
7361844|NCT01026389|11608545|FG001|Overall Study|change of treatment, patient moved|2
7361845|NCT01026454|11608625|FG000|Second Intervention|Pregnancy|1
7361846|NCT01026454|11608626|FG001|Second Intervention|Pregnancy|1
7361847|NCT01026493|11608640|FG000|Overall Study|Protocol Violation|0
7361848|NCT01026493|11608641|FG001|Overall Study|Protocol Violation|1
7361849|NCT01026493|11608642|FG002|Overall Study|Protocol Violation|0
7361850|NCT01026493|11608643|FG003|Overall Study|Protocol Violation|0
7361851|NCT01026493|11608644|FG004|Overall Study|Protocol Violation|2
7361852|NCT01026493|11608645|FG005|Overall Study|Protocol Violation|3
7361853|NCT01026493|11608646|FG006|Overall Study|Protocol Violation|4
7361854|NCT01026493|11608647|FG007|Overall Study|Protocol Violation|1
7361855|NCT01026792|11608679|FG000|Overall Study|Protocol Violation|1
7361856|NCT01026818|11608690|FG000|Screening Period|Entry Criteria Not Met|105
7361857|NCT01026818|11608691|FG001|Screening Period|Entry Criteria Not Met|0
7361858|NCT01026818|11608692|FG002|Screening Period|Entry Criteria Not Met|0
7361859|NCT01026818|11608693|FG003|Screening Period|Entry Criteria Not Met|0
7361860|NCT01026818|11608690|FG000|Screening Period|Withdrawal by Subject|49
7361861|NCT01026818|11608691|FG001|Screening Period|Withdrawal by Subject|0
7361862|NCT01026818|11608692|FG002|Screening Period|Withdrawal by Subject|0
7361863|NCT01026818|11608693|FG003|Screening Period|Withdrawal by Subject|0
7361864|NCT01026818|11608690|FG000|Screening Period|Protocol Deviation|3
7361865|NCT01026818|11608691|FG001|Screening Period|Protocol Deviation|0
7361866|NCT01026818|11608692|FG002|Screening Period|Protocol Deviation|0
7361867|NCT01026818|11608693|FG003|Screening Period|Protocol Deviation|0
7361868|NCT01026818|11608690|FG000|Screening Period|Adverse Event|2
7361869|NCT01026818|11608691|FG001|Screening Period|Adverse Event|0
7361870|NCT01026818|11608692|FG002|Screening Period|Adverse Event|0
7361871|NCT01026818|11608693|FG003|Screening Period|Adverse Event|0
7361872|NCT01026818|11608690|FG000|Screening Period|Physician Decision|1
7361873|NCT01026818|11608691|FG001|Screening Period|Physician Decision|0
7361874|NCT01026818|11608692|FG002|Screening Period|Physician Decision|0
7361875|NCT01026818|11608693|FG003|Screening Period|Physician Decision|0
7361876|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
7361877|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
7361878|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
7361879|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
7361880|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
7361881|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
7361882|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7361883|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
7361884|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
7361885|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
7361886|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
7361887|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
7361888|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7361889|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
7361890|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
7361891|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
7361892|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
7361893|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
7361894|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
7361895|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
7361896|NCT01026818|11608690|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7361897|NCT01026818|11608691|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
7361898|NCT01026818|11608692|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
7361899|NCT01026818|11608693|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
7361900|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
7361901|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7361902|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
7361903|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
7361904|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
7361905|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7361906|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
7361907|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
7361908|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7361909|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
7361910|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7361911|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
7361912|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7361913|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
7361914|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
7361915|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
7361916|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7361917|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7361918|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
7361919|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
7361920|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7361921|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
7361922|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7361923|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
7361924|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7361925|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
7361926|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
7361927|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
7361928|NCT01026818|11608690|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
7361929|NCT01026818|11608691|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
7361930|NCT01026818|11608692|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
7361931|NCT01026818|11608693|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
7361932|NCT01026818|11608690|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7361933|NCT01026818|11608691|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
7361934|NCT01026818|11608692|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7361935|NCT01026818|11608693|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
7361936|NCT01026818|11608690|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7361937|NCT01026818|11608691|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
7361938|NCT01026818|11608692|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7361939|NCT01026818|11608693|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
7361940|NCT01026818|11608690|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
7361941|NCT01026818|11608691|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7361942|NCT01026818|11608692|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
7361943|NCT01026818|11608693|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
7361944|NCT01026818|11608690|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
7361945|NCT01026818|11608691|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7361946|NCT01026818|11608692|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
7361947|NCT01026818|11608693|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
7361948|NCT01026818|11608690|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7361949|NCT01026818|11608691|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
7361950|NCT01026818|11608692|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
7361951|NCT01026818|11608693|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
7361952|NCT01026831|11608707|FG000|Overall Study|Adverse Event|4
7361953|NCT01026831|11608708|FG001|Overall Study|Adverse Event|3
7361954|NCT01026831|11608707|FG000|Overall Study|Lost to Follow-up|2
7361955|NCT01026831|11608708|FG001|Overall Study|Lost to Follow-up|0
7361956|NCT01026831|11608707|FG000|Overall Study|Physician Decision|1
7361957|NCT01026831|11608708|FG001|Overall Study|Physician Decision|1
7361958|NCT01026831|11608707|FG000|Overall Study|Protocol Violation|0
7361959|NCT01026831|11608708|FG001|Overall Study|Protocol Violation|2
7361960|NCT01026831|11608707|FG000|Overall Study|Withdrawal by Subject|7
7361961|NCT01026831|11608708|FG001|Overall Study|Withdrawal by Subject|5
7361962|NCT01026948|11608732|FG000|Overall Study|Physician Decision|8
7361963|NCT01026974|11608741|FG000|Overall Study|Withdrawal by Subject|0
7361964|NCT01026974|11608742|FG001|Overall Study|Withdrawal by Subject|1
7361965|NCT01026974|11608743|FG002|Overall Study|Withdrawal by Subject|7
7361966|NCT01026974|11608744|FG003|Overall Study|Withdrawal by Subject|2
7361967|NCT01026974|11608741|FG000|Overall Study|Lost to Follow-up|1
7361968|NCT01026974|11608742|FG001|Overall Study|Lost to Follow-up|1
7361969|NCT01026974|11608743|FG002|Overall Study|Lost to Follow-up|4
7361970|NCT01026974|11608744|FG003|Overall Study|Lost to Follow-up|0
7361971|NCT01026974|11608741|FG000|Overall Study|Adverse Event|0
7361972|NCT01026974|11608742|FG001|Overall Study|Adverse Event|0
7361973|NCT01026974|11608743|FG002|Overall Study|Adverse Event|0
7361974|NCT01026974|11608744|FG003|Overall Study|Adverse Event|1
7361975|NCT01026974|11608741|FG000|Overall Study|Inappropriate enrollment|0
7361976|NCT01026974|11608742|FG001|Overall Study|Inappropriate enrollment|0
7361977|NCT01026974|11608743|FG002|Overall Study|Inappropriate enrollment|1
7361978|NCT01026974|11608744|FG003|Overall Study|Inappropriate enrollment|0
7361979|NCT01027273|11608774|FG000|Overall Study|Lost to Follow-up|57
7361980|NCT01027273|11608775|FG001|Overall Study|Lost to Follow-up|31
7361981|NCT01027273|11608774|FG000|Overall Study|Death|2
7361982|NCT01027273|11608775|FG001|Overall Study|Death|2
7361983|NCT01027286|11608783|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
7361984|NCT01027286|11608784|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
7361985|NCT01027286|11608783|FG000|Overall Study|Lost to Follow-up|0
7361986|NCT01027286|11608784|FG001|Overall Study|Lost to Follow-up|1
7361987|NCT01027351|11608796|FG000|Overall Study|Withdrawal by Subject|1
7361988|NCT01027351|11608797|FG001|Overall Study|Withdrawal by Subject|0
7361989|NCT01027351|11608798|FG002|Overall Study|Withdrawal by Subject|1
7361990|NCT01027351|11608799|FG003|Overall Study|Withdrawal by Subject|0
7361991|NCT01027351|11608800|FG004|Overall Study|Withdrawal by Subject|3
7361992|NCT01027351|11608801|FG005|Overall Study|Withdrawal by Subject|5
7361993|NCT01027351|11608796|FG000|Overall Study|Lost to Follow-up|1
7361994|NCT01027351|11608797|FG001|Overall Study|Lost to Follow-up|1
7361995|NCT01027351|11608798|FG002|Overall Study|Lost to Follow-up|0
7361996|NCT01027351|11608799|FG003|Overall Study|Lost to Follow-up|1
7361997|NCT01027351|11608800|FG004|Overall Study|Lost to Follow-up|6
7361998|NCT01027351|11608801|FG005|Overall Study|Lost to Follow-up|0
7361999|NCT01027351|11608796|FG000|Overall Study|Inappropriate enrollment|0
7362000|NCT01027351|11608797|FG001|Overall Study|Inappropriate enrollment|0
7362001|NCT01027351|11608798|FG002|Overall Study|Inappropriate enrollment|0
7362002|NCT01027351|11608799|FG003|Overall Study|Inappropriate enrollment|0
7362003|NCT01027351|11608800|FG004|Overall Study|Inappropriate enrollment|1
7362004|NCT01027351|11608801|FG005|Overall Study|Inappropriate enrollment|0
7362005|NCT01027351|11608796|FG000|Overall Study|Protocol Violation|1
7362006|NCT01027351|11608797|FG001|Overall Study|Protocol Violation|0
7362007|NCT01027351|11608798|FG002|Overall Study|Protocol Violation|0
7362008|NCT01027351|11608799|FG003|Overall Study|Protocol Violation|1
7362009|NCT01027351|11608800|FG004|Overall Study|Protocol Violation|1
7362010|NCT01027351|11608801|FG005|Overall Study|Protocol Violation|0
7386457|NCT01211262|11645062|FG000|Overall Study|Other|0
7386458|NCT01211262|11645063|FG001|Overall Study|Other|1
7386459|NCT01211288|11645074|FG000|Overall Study|Lost to Follow-up|1
7386460|NCT01211288|11645075|FG001|Overall Study|Lost to Follow-up|1
7386461|NCT01211483|11645096|FG000|Phase 1b|Death|6
7386462|NCT01211483|11645097|FG001|Phase 1b|Death|0
7386463|NCT01211483|11645098|FG002|Phase 1b|Death|0
7386464|NCT01211483|11645099|FG003|Phase 1b|Death|0
7386465|NCT01211483|11645096|FG000|Phase 1b|Withdrawal by Subject|1
7386466|NCT01211483|11645097|FG001|Phase 1b|Withdrawal by Subject|0
7386467|NCT01211483|11645098|FG002|Phase 1b|Withdrawal by Subject|0
7386468|NCT01211483|11645099|FG003|Phase 1b|Withdrawal by Subject|0
7386469|NCT01211483|11645096|FG000|Phase 2|Lost to Follow-up|0
7386470|NCT01211483|11645097|FG001|Phase 2|Lost to Follow-up|1
7386471|NCT01211483|11645098|FG002|Phase 2|Lost to Follow-up|1
7386472|NCT01211483|11645099|FG003|Phase 2|Lost to Follow-up|2
7386473|NCT01211483|11645096|FG000|Phase 2|Death|0
7386474|NCT01211483|11645097|FG001|Phase 2|Death|64
7386475|NCT01211483|11645098|FG002|Phase 2|Death|53
7386476|NCT01211483|11645099|FG003|Phase 2|Death|53
7386477|NCT01211483|11645096|FG000|Phase 2|Withdrawal by Subject|0
7386478|NCT01211483|11645097|FG001|Phase 2|Withdrawal by Subject|1
7386479|NCT01211483|11645098|FG002|Phase 2|Withdrawal by Subject|10
7386480|NCT01211483|11645099|FG003|Phase 2|Withdrawal by Subject|5
7386481|NCT01211483|11645096|FG000|Phase 2|Study terminated by Sponsor|0
7386482|NCT01211483|11645097|FG001|Phase 2|Study terminated by Sponsor|6
7386483|NCT01211483|11645098|FG002|Phase 2|Study terminated by Sponsor|8
7386484|NCT01211483|11645099|FG003|Phase 2|Study terminated by Sponsor|11
7362011|NCT01027364|11608826|FG000|Overall Study|Adverse Event|1
7362012|NCT01027364|11608827|FG001|Overall Study|Adverse Event|0
7362013|NCT01027364|11608828|FG002|Overall Study|Adverse Event|1
7362014|NCT01027364|11608829|FG003|Overall Study|Adverse Event|0
7362015|NCT01027364|11608826|FG000|Overall Study|Lost to Follow-up|1
7362016|NCT01027364|11608827|FG001|Overall Study|Lost to Follow-up|0
7362017|NCT01027364|11608828|FG002|Overall Study|Lost to Follow-up|0
7362018|NCT01027364|11608829|FG003|Overall Study|Lost to Follow-up|0
7362019|NCT01027364|11608826|FG000|Overall Study|Protocol Violation|1
7362020|NCT01027364|11608827|FG001|Overall Study|Protocol Violation|0
7362021|NCT01027364|11608828|FG002|Overall Study|Protocol Violation|0
7362022|NCT01027364|11608829|FG003|Overall Study|Protocol Violation|1
7362023|NCT01027364|11608826|FG000|Overall Study|Withdrawal by Subject|1
7362024|NCT01027364|11608827|FG001|Overall Study|Withdrawal by Subject|2
7362025|NCT01027364|11608828|FG002|Overall Study|Withdrawal by Subject|0
7362026|NCT01027364|11608829|FG003|Overall Study|Withdrawal by Subject|0
7362027|NCT01027416|11608857|FG000|Overall Study|Withdrawal by Subject|0
7362028|NCT01027416|11608858|FG001|Overall Study|Withdrawal by Subject|1
7362029|NCT01027416|11608857|FG000|Overall Study|Physician Decision|1
7362030|NCT01027416|11608858|FG001|Overall Study|Physician Decision|4
7362031|NCT01027650|11608899|FG000|Overall Study|Personal Reasons|0
7362032|NCT01027650|11608900|FG001|Overall Study|Personal Reasons|0
7362033|NCT01027650|11608901|FG002|Overall Study|Personal Reasons|0
7362034|NCT01027650|11608902|FG003|Overall Study|Personal Reasons|0
7362035|NCT01027650|11608903|FG004|Overall Study|Personal Reasons|2
7362036|NCT01027650|11608904|FG005|Overall Study|Personal Reasons|1
7362037|NCT01027650|11608905|FG006|Overall Study|Personal Reasons|0
7362038|NCT01027650|11608906|FG007|Overall Study|Personal Reasons|0
7362039|NCT01027650|11608899|FG000|Overall Study|Lost to Follow-up|0
7362040|NCT01027650|11608900|FG001|Overall Study|Lost to Follow-up|0
7362041|NCT01027650|11608901|FG002|Overall Study|Lost to Follow-up|0
7362042|NCT01027650|11608902|FG003|Overall Study|Lost to Follow-up|0
7362043|NCT01027650|11608903|FG004|Overall Study|Lost to Follow-up|0
7362044|NCT01027650|11608904|FG005|Overall Study|Lost to Follow-up|0
7362045|NCT01027650|11608905|FG006|Overall Study|Lost to Follow-up|1
7362046|NCT01027650|11608906|FG007|Overall Study|Lost to Follow-up|0
7362047|NCT01027650|11608899|FG000|Overall Study|Lack of Efficacy|0
7362048|NCT01027650|11608900|FG001|Overall Study|Lack of Efficacy|0
7362049|NCT01027650|11608901|FG002|Overall Study|Lack of Efficacy|0
7362050|NCT01027650|11608902|FG003|Overall Study|Lack of Efficacy|0
7362051|NCT01027650|11608903|FG004|Overall Study|Lack of Efficacy|0
7362052|NCT01027650|11608904|FG005|Overall Study|Lack of Efficacy|1
7362053|NCT01027650|11608905|FG006|Overall Study|Lack of Efficacy|0
7362054|NCT01027650|11608906|FG007|Overall Study|Lack of Efficacy|0
7362055|NCT01027754|11608926|FG000|Overall Study|withdrew/lost to follow-up after interve|2
7362056|NCT01027754|11608927|FG001|Overall Study|withdrew/lost to follow-up after interve|3
7362057|NCT01027754|11608926|FG000|Overall Study|Withdrawal by Subject|0
7362058|NCT01027754|11608927|FG001|Overall Study|Withdrawal by Subject|5
7362059|NCT01027845|11608972|FG000|Primary Vaccination Phase|Serious Adverse Event|2
7362060|NCT01027845|11608973|FG001|Primary Vaccination Phase|Serious Adverse Event|0
7362061|NCT01027845|11608974|FG002|Primary Vaccination Phase|Serious Adverse Event|0
7362062|NCT01027845|11608975|FG003|Primary Vaccination Phase|Serious Adverse Event|0
7362063|NCT01027845|11608972|FG000|Primary Vaccination Phase|Adverse Event|1
7362064|NCT01027845|11608973|FG001|Primary Vaccination Phase|Adverse Event|0
7362065|NCT01027845|11608974|FG002|Primary Vaccination Phase|Adverse Event|0
7362066|NCT01027845|11608975|FG003|Primary Vaccination Phase|Adverse Event|0
7362067|NCT01027845|11608972|FG000|Primary Vaccination Phase|Protocol Violation|1
7362068|NCT01027845|11608973|FG001|Primary Vaccination Phase|Protocol Violation|0
7362069|NCT01027845|11608974|FG002|Primary Vaccination Phase|Protocol Violation|0
7362070|NCT01027845|11608975|FG003|Primary Vaccination Phase|Protocol Violation|0
7362071|NCT01027845|11608972|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
7362072|NCT01027845|11608973|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
7362073|NCT01027845|11608974|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
7362074|NCT01027845|11608975|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
7362075|NCT01027845|11608972|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
7362076|NCT01027845|11608973|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7362077|NCT01027845|11608974|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
7362078|NCT01027845|11608975|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
7362079|NCT01027845|11608972|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
7362080|NCT01027845|11608973|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
7362081|NCT01027845|11608974|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
7362082|NCT01027845|11608975|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
7362083|NCT01027871|11608987|FG000|Overall Study|Physician Decision|1
7362084|NCT01027871|11608988|FG001|Overall Study|Physician Decision|5
7362085|NCT01027871|11608989|FG002|Overall Study|Physician Decision|0
7362086|NCT01027871|11608987|FG000|Overall Study|Protocol Violation|0
7362087|NCT01027871|11608988|FG001|Overall Study|Protocol Violation|2
7362088|NCT01027871|11608989|FG002|Overall Study|Protocol Violation|2
7362089|NCT01027871|11608987|FG000|Overall Study|Withdrawal by Subject|1
7362090|NCT01027871|11608988|FG001|Overall Study|Withdrawal by Subject|2
7362091|NCT01027871|11608989|FG002|Overall Study|Withdrawal by Subject|2
7362092|NCT01027871|11608987|FG000|Overall Study|Adverse Event|0
7362093|NCT01027871|11608988|FG001|Overall Study|Adverse Event|2
7362094|NCT01027871|11608989|FG002|Overall Study|Adverse Event|2
7362095|NCT01027871|11608987|FG000|Overall Study|Sponsor Decision|0
7362096|NCT01027871|11608988|FG001|Overall Study|Sponsor Decision|2
7362097|NCT01027871|11608989|FG002|Overall Study|Sponsor Decision|0
7362098|NCT01027871|11608987|FG000|Overall Study|Discontinued Prior to Treatment|0
7362099|NCT01027871|11608988|FG001|Overall Study|Discontinued Prior to Treatment|0
7362100|NCT01027871|11608989|FG002|Overall Study|Discontinued Prior to Treatment|1
7362101|NCT01027884|11609004|FG000|Overall Study|Adverse Event|2
7362102|NCT01027884|11609005|FG001|Overall Study|Adverse Event|1
7362103|NCT01027884|11609004|FG000|Overall Study|Protocol Violation|1
7362104|NCT01027884|11609005|FG001|Overall Study|Protocol Violation|0
7362105|NCT01027884|11609004|FG000|Overall Study|Non-compliance|1
7362106|NCT01027884|11609005|FG001|Overall Study|Non-compliance|1
7362107|NCT01027884|11609004|FG000|Overall Study|Withdrawal by Subject|0
7362108|NCT01027884|11609005|FG001|Overall Study|Withdrawal by Subject|1
7362109|NCT01027884|11609004|FG000|Overall Study|Lost to Follow-up|0
7362110|NCT01027884|11609005|FG001|Overall Study|Lost to Follow-up|1
7362111|NCT01027884|11609004|FG000|Overall Study|Spinal fixation surgery|0
7362112|NCT01027884|11609005|FG001|Overall Study|Spinal fixation surgery|3
7362113|NCT01027897|11609013|FG000|Overall Study|Protocol Violation|1
7362114|NCT01027897|11609013|FG000|Overall Study|Withdrawal by Subject|1
7362115|NCT01027949|11609028|FG000|Overall Study|Death|174
7362116|NCT01027949|11609028|FG000|Overall Study|Progressive Disease|163
7362117|NCT01027949|11609028|FG000|Overall Study|Adverse Event|172
7362118|NCT01027949|11609028|FG000|Overall Study|Withdrawal by Subject|113
7362119|NCT01027949|11609028|FG000|Overall Study|Lost to Follow-up|17
7362120|NCT01027949|11609028|FG000|Overall Study|Protocol Violation|13
7362121|NCT01027949|11609028|FG000|Overall Study|PI Decision|8
7362122|NCT01027949|11609028|FG000|Overall Study|Limited Study Drug Effectiveness|7
7362123|NCT01027949|11609028|FG000|Overall Study|Non-compliance with Study Procedures|7
7362124|NCT01027949|11609028|FG000|Overall Study|Lung Transplant|5
7362125|NCT01027949|11609028|FG000|Overall Study|Unable to Tolerate Study Drug|2
7362126|NCT01027949|11609028|FG000|Overall Study|Use of Excluded Medication|2
7362127|NCT01027949|11609028|FG000|Overall Study|Patient Self-discontinuation|1
7362128|NCT01027949|11609028|FG000|Overall Study|Pregnancy|1
7362129|NCT01027949|11609028|FG000|Overall Study|Surgery|1
7362130|NCT01028014|11609038|FG000|Overall Study|Lost to Follow-up|1
7362131|NCT01028014|11609039|FG001|Overall Study|Lost to Follow-up|2
7362132|NCT01028014|11609040|FG002|Overall Study|Lost to Follow-up|0
7362133|NCT01028014|11609041|FG003|Overall Study|Lost to Follow-up|1
7362134|NCT01028014|11609042|FG004|Overall Study|Lost to Follow-up|1
7362135|NCT01028014|11609043|FG005|Overall Study|Lost to Follow-up|2
7362136|NCT01028027|11609059|FG000|Overall Study|Lost to Follow-up|4
7362137|NCT01028027|11609060|FG001|Overall Study|Lost to Follow-up|1
7362138|NCT01028027|11609059|FG000|Overall Study|Withdrawal by Subject|5
7362139|NCT01028027|11609060|FG001|Overall Study|Withdrawal by Subject|3
7362140|NCT01028027|11609059|FG000|Overall Study|Adverse Event|4
7362141|NCT01028027|11609060|FG001|Overall Study|Adverse Event|7
7362142|NCT01028027|11609059|FG000|Overall Study|Protocol Violation|3
7362143|NCT01028027|11609060|FG001|Overall Study|Protocol Violation|1
7362144|NCT01028027|11609059|FG000|Overall Study|Lack of Efficacy|0
7362145|NCT01028027|11609060|FG001|Overall Study|Lack of Efficacy|1
7362146|NCT01028053|11609066|FG000|Overall Study|Screen Failure|113
7362147|NCT01028053|11609066|FG000|Overall Study|Patient Request|11
7362148|NCT01028053|11609066|FG000|Overall Study|Protocol Violation|1
7362149|NCT01028053|11609066|FG000|Overall Study|Physician Decision|2
7362150|NCT01028053|11609066|FG000|Overall Study|Technical Problem|1
7362151|NCT01028053|11609066|FG000|Overall Study|Terminated by Sponsor|1
7362152|NCT01028053|11609066|FG000|Overall Study|Various reasons|4
7362153|NCT01028222|11609091|FG000|Overall Study|Protocol deviation|1
7362154|NCT01028222|11609092|FG001|Overall Study|Protocol deviation|0
7362155|NCT01028222|11609091|FG000|Overall Study|Disease progression|33
7362156|NCT01028222|11609092|FG001|Overall Study|Disease progression|9
7362157|NCT01028222|11609091|FG000|Overall Study|Administrative problems|1
7362158|NCT01028222|11609092|FG001|Overall Study|Administrative problems|1
7362159|NCT01028222|11609091|FG000|Overall Study|Lost to Follow-up|0
7362160|NCT01028222|11609092|FG001|Overall Study|Lost to Follow-up|1
7362161|NCT01028222|11609091|FG000|Overall Study|Withdrawal by Subject|1
7362162|NCT01028222|11609092|FG001|Overall Study|Withdrawal by Subject|0
7362163|NCT01028222|11609091|FG000|Overall Study|Crossover to nilotinib w/out progression|0
7362164|NCT01028222|11609092|FG001|Overall Study|Crossover to nilotinib w/out progression|2
7362165|NCT01028222|11609091|FG000|Overall Study|Adverse Event|2
7362166|NCT01028222|11609092|FG001|Overall Study|Adverse Event|0
7362167|NCT01028352|11609099|FG000|Overall Study|Ineligible due to baseline average pain|5
7362168|NCT01028352|11609099|FG000|Overall Study|Withdrawal by Subject|1
7362169|NCT01028378|11609103|FG000|Overall Study|Lost to Follow-up|12
7362170|NCT01028378|11609103|FG000|Overall Study|Withdrawal by Subject|1
7362171|NCT01028378|11609103|FG000|Overall Study|Adminstrative Reasons|4
7362172|NCT01028391|11609109|FG000|Overall Study|Adverse Event|4
7362173|NCT01028391|11609110|FG001|Overall Study|Adverse Event|0
7362174|NCT01028391|11609109|FG000|Overall Study|Lack of Efficacy|0
7362175|NCT01028391|11609110|FG001|Overall Study|Lack of Efficacy|2
7362176|NCT01028391|11609109|FG000|Overall Study|Lost to Follow-up|3
7362177|NCT01028391|11609110|FG001|Overall Study|Lost to Follow-up|4
7362178|NCT01028391|11609109|FG000|Overall Study|Physician Decision|0
7362179|NCT01028391|11609110|FG001|Overall Study|Physician Decision|1
7362180|NCT01028391|11609109|FG000|Overall Study|Withdrawal by Subject|6
7362181|NCT01028391|11609110|FG001|Overall Study|Withdrawal by Subject|3
7362182|NCT01028391|11609109|FG000|Overall Study|Needed excluded medication|1
7362183|NCT01028391|11609110|FG001|Overall Study|Needed excluded medication|1
7362184|NCT01028560|11609118|FG000|Overall Study|Lack of Efficacy|3
7362185|NCT01028560|11609119|FG001|Overall Study|Lack of Efficacy|6
7362186|NCT01028560|11609118|FG000|Overall Study|Withdrawal by Subject|7
7362187|NCT01028560|11609119|FG001|Overall Study|Withdrawal by Subject|12
7362188|NCT01028651|11609126|FG000|Overall Study|Death|2
7362189|NCT01028651|11609126|FG000|Overall Study|Adverse Event|1
7362190|NCT01029262|11609167|FG000|Overall Study|Adverse Event|9
7362191|NCT01029262|11609168|FG001|Overall Study|Adverse Event|52
7362192|NCT01029262|11609167|FG000|Overall Study|Lack of therapeutic effect|57
7362193|NCT01029262|11609168|FG001|Overall Study|Lack of therapeutic effect|76
7362194|NCT01029262|11609167|FG000|Overall Study|Withdrawal by Subject|10
7362195|NCT01029262|11609168|FG001|Overall Study|Withdrawal by Subject|17
7362196|NCT01029262|11609167|FG000|Overall Study|Protocol Violation|2
7362197|NCT01029262|11609168|FG001|Overall Study|Protocol Violation|3
7362198|NCT01029262|11609167|FG000|Overall Study|Miscellaneous|1
7362199|NCT01029262|11609168|FG001|Overall Study|Miscellaneous|9
7362200|NCT01029262|11609167|FG000|Overall Study|Death|0
7362201|NCT01029262|11609168|FG001|Overall Study|Death|3
7362202|NCT01029340|11609184|FG000|Part B Treatment Period|Withdrawal by Subject|0
7362203|NCT01029340|11609185|FG001|Part B Treatment Period|Withdrawal by Subject|0
7362204|NCT01029340|11609186|FG002|Part B Treatment Period|Withdrawal by Subject|1
7362205|NCT01029340|11609187|FG003|Part B Treatment Period|Withdrawal by Subject|0
7362206|NCT01029340|11609188|FG004|Part B Treatment Period|Withdrawal by Subject|0
7362207|NCT01029340|11609189|FG005|Part B Treatment Period|Withdrawal by Subject|0
7362208|NCT01029340|11609184|FG000|Part B Treatment Period|Protocol Violation|0
7362209|NCT01029340|11609185|FG001|Part B Treatment Period|Protocol Violation|0
7362210|NCT01029340|11609186|FG002|Part B Treatment Period|Protocol Violation|1
7362211|NCT01029340|11609187|FG003|Part B Treatment Period|Protocol Violation|0
7362212|NCT01029340|11609188|FG004|Part B Treatment Period|Protocol Violation|0
7362213|NCT01029340|11609189|FG005|Part B Treatment Period|Protocol Violation|0
7362214|NCT01029340|11609184|FG000|Extension Period|Adverse Event|0
7362215|NCT01029340|11609185|FG001|Extension Period|Adverse Event|0
7362216|NCT01029340|11609186|FG002|Extension Period|Adverse Event|0
7362217|NCT01029340|11609187|FG003|Extension Period|Adverse Event|0
7362218|NCT01029340|11609188|FG004|Extension Period|Adverse Event|0
7362219|NCT01029340|11609189|FG005|Extension Period|Adverse Event|1
7362220|NCT01029340|11609184|FG000|Extension Period|starting another study|0
7362221|NCT01029340|11609185|FG001|Extension Period|starting another study|0
7362222|NCT01029340|11609186|FG002|Extension Period|starting another study|0
7362223|NCT01029340|11609187|FG003|Extension Period|starting another study|0
7362224|NCT01029340|11609188|FG004|Extension Period|starting another study|0
7362225|NCT01029340|11609189|FG005|Extension Period|starting another study|8
7362226|NCT01029340|11609184|FG000|Extension Period|non-compliance|0
7362227|NCT01029340|11609185|FG001|Extension Period|non-compliance|0
7362228|NCT01029340|11609186|FG002|Extension Period|non-compliance|0
7362229|NCT01029340|11609187|FG003|Extension Period|non-compliance|0
7362230|NCT01029340|11609188|FG004|Extension Period|non-compliance|0
7362231|NCT01029340|11609189|FG005|Extension Period|non-compliance|1
7362232|NCT01029340|11609184|FG000|Extension Period|Withdrawal by Subject|0
7362233|NCT01029340|11609185|FG001|Extension Period|Withdrawal by Subject|0
7362234|NCT01029340|11609186|FG002|Extension Period|Withdrawal by Subject|0
7362235|NCT01029340|11609187|FG003|Extension Period|Withdrawal by Subject|0
7362236|NCT01029340|11609188|FG004|Extension Period|Withdrawal by Subject|0
7362237|NCT01029340|11609189|FG005|Extension Period|Withdrawal by Subject|1
7362238|NCT01029340|11609184|FG000|Extension Period|Physician Decision|0
7362239|NCT01029340|11609185|FG001|Extension Period|Physician Decision|0
7362240|NCT01029340|11609186|FG002|Extension Period|Physician Decision|0
7362241|NCT01029340|11609187|FG003|Extension Period|Physician Decision|0
7362242|NCT01029340|11609188|FG004|Extension Period|Physician Decision|0
7362243|NCT01029340|11609189|FG005|Extension Period|Physician Decision|1
7362244|NCT01029353|11609206|FG000|Overall Study|Lost to Follow-up|4
7362245|NCT01029353|11609207|FG001|Overall Study|Lost to Follow-up|5
7362246|NCT01029353|11609208|FG002|Overall Study|Lost to Follow-up|5
7362247|NCT01029353|11609209|FG003|Overall Study|Lost to Follow-up|4
7362248|NCT01029353|11609206|FG000|Overall Study|Consent Withdrawn|2
7362249|NCT01029353|11609207|FG001|Overall Study|Consent Withdrawn|0
7362250|NCT01029353|11609208|FG002|Overall Study|Consent Withdrawn|0
7362251|NCT01029353|11609209|FG003|Overall Study|Consent Withdrawn|0
7362252|NCT01029353|11609206|FG000|Overall Study|Primary Outcome Indeterminate|1
7362253|NCT01029353|11609207|FG001|Overall Study|Primary Outcome Indeterminate|3
7362254|NCT01029353|11609208|FG002|Overall Study|Primary Outcome Indeterminate|2
7362255|NCT01029353|11609209|FG003|Overall Study|Primary Outcome Indeterminate|0
7362256|NCT01029366|11609221|FG000|Overall Study|Withdrawal by Subject|1
7362257|NCT01029366|11609222|FG001|Overall Study|Withdrawal by Subject|0
7362258|NCT01029366|11609221|FG000|Overall Study|Death|1
7362259|NCT01029366|11609222|FG001|Overall Study|Death|1
7362260|NCT01029366|11609221|FG000|Overall Study|disease progression|2
7362261|NCT01029366|11609222|FG001|Overall Study|disease progression|0
7362262|NCT01029366|11609221|FG000|Overall Study|manufacturing failure|0
7362263|NCT01029366|11609222|FG001|Overall Study|manufacturing failure|1
7362264|NCT01029392|11609231|FG000|Overall Study|Withdrawal by Subject|18
7362265|NCT01029392|11609232|FG001|Overall Study|Withdrawal by Subject|11
7362266|NCT01029392|11609231|FG000|Overall Study|Physician Decision|2
7362267|NCT01029392|11609232|FG001|Overall Study|Physician Decision|0
7362268|NCT01029405|11609244|FG000|Overall Study|Withdrawal by Subject|0
7362269|NCT01029405|11609245|FG001|Overall Study|Withdrawal by Subject|1
7362270|NCT01029405|11609246|FG002|Overall Study|Withdrawal by Subject|2
7362271|NCT01029405|11609247|FG003|Overall Study|Withdrawal by Subject|0
7362272|NCT01029405|11609244|FG000|Overall Study|Protocol Violation|0
7362273|NCT01029405|11609245|FG001|Overall Study|Protocol Violation|0
7362274|NCT01029405|11609246|FG002|Overall Study|Protocol Violation|0
7362275|NCT01029405|11609247|FG003|Overall Study|Protocol Violation|1
7362276|NCT01029405|11609244|FG000|Overall Study|Adverse Event|0
7362277|NCT01029405|11609245|FG001|Overall Study|Adverse Event|0
7362278|NCT01029405|11609246|FG002|Overall Study|Adverse Event|1
7362279|NCT01029405|11609247|FG003|Overall Study|Adverse Event|1
7362280|NCT01029405|11609244|FG000|Overall Study|Lost to Follow-up|2
7362281|NCT01029405|11609245|FG001|Overall Study|Lost to Follow-up|1
7362282|NCT01029405|11609246|FG002|Overall Study|Lost to Follow-up|1
7362283|NCT01029405|11609247|FG003|Overall Study|Lost to Follow-up|2
7362284|NCT01029405|11609244|FG000|Overall Study|Other|0
7362285|NCT01029405|11609245|FG001|Overall Study|Other|1
7362286|NCT01029405|11609246|FG002|Overall Study|Other|0
7362287|NCT01029405|11609247|FG003|Overall Study|Other|1
7362288|NCT01029535|11609257|FG000|Overall Study|Lost to Follow-up|24
7362289|NCT01029535|11609257|FG000|Overall Study|Protocol Violation|2
7362290|NCT01029535|11609257|FG000|Overall Study|Participant Withdrew Consent|2
7362291|NCT01029535|11609257|FG000|Overall Study|Adverse Event|1
7362292|NCT01029535|11609257|FG000|Overall Study|Use of Another Treatment|1
7362293|NCT01029535|11609257|FG000|Overall Study|Death|1
7362294|NCT01029652|11609268|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
7362295|NCT01029652|11609269|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
7362296|NCT01029652|11609268|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
7362297|NCT01029652|11609269|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
7362298|NCT01029652|11609268|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
7362299|NCT01029652|11609269|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
7362300|NCT01029652|11609268|FG000|Core Study (0-12 Weeks)|Administrative problems|2
7362301|NCT01029652|11609269|FG001|Core Study (0-12 Weeks)|Administrative problems|1
7362302|NCT01029652|11609268|FG000|Core Study (0-12 Weeks)|Death|0
7362303|NCT01029652|11609269|FG001|Core Study (0-12 Weeks)|Death|1
7362304|NCT01029652|11609268|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
7362305|NCT01029652|11609269|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
7362306|NCT01029652|11609268|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
7362307|NCT01029652|11609269|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
7362308|NCT01029652|11609268|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
7362309|NCT01029652|11609269|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
7362310|NCT01029652|11609268|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
7362311|NCT01029652|11609269|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
7362312|NCT01029652|11609268|FG000|Extension Study 2 (25-72 Weeks)|Death|1
7362313|NCT01029652|11609269|FG001|Extension Study 2 (25-72 Weeks)|Death|1
7362314|NCT01029652|11609268|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
7362315|NCT01029652|11609269|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
7362316|NCT01029652|11609268|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
7362317|NCT01029652|11609269|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
7362318|NCT01029691|11609296|FG000|Continued APAP to Delivery|Death|0
7362319|NCT01029691|11609297|FG001|Continued APAP to Delivery|Death|0
7362320|NCT01029691|11609298|FG002|Continued APAP to Delivery|Death|1
7362321|NCT01029704|11609316|FG000|Overall Study|Adverse Event|0
7362322|NCT01029704|11609317|FG001|Overall Study|Adverse Event|0
7362323|NCT01029704|11609318|FG002|Overall Study|Adverse Event|0
7362324|NCT01029704|11609319|FG003|Overall Study|Adverse Event|0
7362325|NCT01029704|11609320|FG004|Overall Study|Adverse Event|0
7362326|NCT01029704|11609321|FG005|Overall Study|Adverse Event|0
7362327|NCT01029704|11609322|FG006|Overall Study|Adverse Event|1
7362328|NCT01029704|11609323|FG007|Overall Study|Adverse Event|1
7362329|NCT01029704|11609324|FG008|Overall Study|Adverse Event|0
7362330|NCT01029704|11609316|FG000|Overall Study|Withdrawal by Subject|0
7362331|NCT01029704|11609317|FG001|Overall Study|Withdrawal by Subject|0
7362332|NCT01029704|11609318|FG002|Overall Study|Withdrawal by Subject|0
7362333|NCT01029704|11609319|FG003|Overall Study|Withdrawal by Subject|0
7362334|NCT01029704|11609320|FG004|Overall Study|Withdrawal by Subject|2
7362335|NCT01029704|11609321|FG005|Overall Study|Withdrawal by Subject|1
7362336|NCT01029704|11609322|FG006|Overall Study|Withdrawal by Subject|1
7362337|NCT01029704|11609323|FG007|Overall Study|Withdrawal by Subject|1
7362338|NCT01029704|11609324|FG008|Overall Study|Withdrawal by Subject|0
7362339|NCT01029704|11609316|FG000|Overall Study|Lost to Follow-up|0
7362340|NCT01029704|11609317|FG001|Overall Study|Lost to Follow-up|0
7362341|NCT01029704|11609318|FG002|Overall Study|Lost to Follow-up|0
7362342|NCT01029704|11609319|FG003|Overall Study|Lost to Follow-up|0
7362343|NCT01029704|11609320|FG004|Overall Study|Lost to Follow-up|0
7362344|NCT01029704|11609321|FG005|Overall Study|Lost to Follow-up|0
7362345|NCT01029704|11609322|FG006|Overall Study|Lost to Follow-up|1
7362346|NCT01029704|11609323|FG007|Overall Study|Lost to Follow-up|1
7362347|NCT01029704|11609324|FG008|Overall Study|Lost to Follow-up|1
7362348|NCT01029704|11609316|FG000|Overall Study|Lack of Efficacy|0
7362349|NCT01029704|11609317|FG001|Overall Study|Lack of Efficacy|0
7362350|NCT01029704|11609318|FG002|Overall Study|Lack of Efficacy|0
7362351|NCT01029704|11609319|FG003|Overall Study|Lack of Efficacy|0
7362352|NCT01029704|11609320|FG004|Overall Study|Lack of Efficacy|2
7362353|NCT01029704|11609321|FG005|Overall Study|Lack of Efficacy|3
7362354|NCT01029704|11609322|FG006|Overall Study|Lack of Efficacy|1
7362355|NCT01029704|11609323|FG007|Overall Study|Lack of Efficacy|2
7362356|NCT01029704|11609324|FG008|Overall Study|Lack of Efficacy|0
7362357|NCT01029704|11609316|FG000|Overall Study|Withdrawn due to major protocol violation|0
7362358|NCT01029704|11609317|FG001|Overall Study|Withdrawn due to major protocol violation|0
7362359|NCT01029704|11609318|FG002|Overall Study|Withdrawn due to major protocol violation|0
7362360|NCT01029704|11609319|FG003|Overall Study|Withdrawn due to major protocol violation|0
7460162|NCT01824602|11755347|FG002|Overall Study|Treatment failure|0
7460163|NCT01824602|11755348|FG003|Overall Study|Treatment failure|1
7460164|NCT01824693|11755361|FG000|Overall Study|Death|0
7460165|NCT01824693|11755362|FG001|Overall Study|Death|1
7460166|NCT01824693|11755363|FG002|Overall Study|Death|0
7460167|NCT01824693|11755361|FG000|Overall Study|Physician Decision|1
7460168|NCT01824693|11755362|FG001|Overall Study|Physician Decision|1
7460169|NCT01824693|11755363|FG002|Overall Study|Physician Decision|1
7460170|NCT01824693|11755361|FG000|Overall Study|Withdrawal by Subject|0
7460171|NCT01824693|11755362|FG001|Overall Study|Withdrawal by Subject|0
7460172|NCT01824693|11755363|FG002|Overall Study|Withdrawal by Subject|1
7460173|NCT01824693|11755361|FG000|Overall Study|Progressive Disease|0
7460174|NCT01824693|11755362|FG001|Overall Study|Progressive Disease|5
7460175|NCT01824693|11755363|FG002|Overall Study|Progressive Disease|0
7460176|NCT01824693|11755361|FG000|Overall Study|Ineligible|0
7460177|NCT01824693|11755362|FG001|Overall Study|Ineligible|0
7460178|NCT01824693|11755363|FG002|Overall Study|Ineligible|3
7460179|NCT01824693|11755361|FG000|Overall Study|No Transplant Planned|0
7460180|NCT01824693|11755362|FG001|Overall Study|No Transplant Planned|0
7460181|NCT01824693|11755363|FG002|Overall Study|No Transplant Planned|10
7460182|NCT01824823|11755372|FG000|Overall Study|Lack of Efficacy|1
7460183|NCT01824823|11755373|FG001|Overall Study|Lack of Efficacy|1
7460184|NCT01824823|11755372|FG000|Overall Study|Off-treatment reason not submitted|1
7460185|NCT01824823|11755373|FG001|Overall Study|Off-treatment reason not submitted|0
7460186|NCT01824979|11755388|FG000|Overall Study|Withdrawal by Subject|5
7460187|NCT01824979|11755389|FG001|Overall Study|Withdrawal by Subject|0
7460188|NCT01824979|11755388|FG000|Overall Study|Physician Decision|2
7460189|NCT01824979|11755389|FG001|Overall Study|Physician Decision|0
7460190|NCT01824979|11755388|FG000|Overall Study|Protocol Violation|6
7460191|NCT01824979|11755389|FG001|Overall Study|Protocol Violation|13
7460192|NCT01825200|11755422|FG000|Overall Study|Lost to Follow-up|5
7460193|NCT01825200|11755423|FG001|Overall Study|Lost to Follow-up|6
7460194|NCT01825200|11755422|FG000|Overall Study|Withdrawal by Subject|0
7460195|NCT01825200|11755423|FG001|Overall Study|Withdrawal by Subject|1
7460196|NCT01825577|11755455|FG000|Overall Study|Physician Decision|2
7460197|NCT01825577|11755455|FG000|Overall Study|Withdrawal by Subject|1
7460198|NCT01825577|11755455|FG000|Overall Study|Withdrawn by family members|2
7460199|NCT01825577|11755455|FG000|Overall Study|Lack of Efficacy|3
7460200|NCT01825785|11755475|FG000|Overall Study|Adverse Event|0
7460201|NCT01825785|11755476|FG001|Overall Study|Adverse Event|0
7460202|NCT01825785|11755477|FG002|Overall Study|Adverse Event|0
7460203|NCT01825785|11755478|FG003|Overall Study|Adverse Event|0
7460204|NCT01825785|11755479|FG004|Overall Study|Adverse Event|1
7460205|NCT01825785|11755480|FG005|Overall Study|Adverse Event|0
7460206|NCT01825785|11755481|FG006|Overall Study|Adverse Event|0
7460207|NCT01825785|11755475|FG000|Overall Study|Withdrawal by Subject|0
7460208|NCT01825785|11755476|FG001|Overall Study|Withdrawal by Subject|0
7460209|NCT01825785|11755477|FG002|Overall Study|Withdrawal by Subject|0
7460210|NCT01825785|11755478|FG003|Overall Study|Withdrawal by Subject|0
7460211|NCT01825785|11755479|FG004|Overall Study|Withdrawal by Subject|1
7460212|NCT01825785|11755480|FG005|Overall Study|Withdrawal by Subject|1
7460213|NCT01825785|11755481|FG006|Overall Study|Withdrawal by Subject|0
7460214|NCT01825798|11755505|FG000|Overall Study|Adverse Event|1
7460215|NCT01825798|11755506|FG001|Overall Study|Adverse Event|5
7460216|NCT01825798|11755505|FG000|Overall Study|Lost to Follow-up|1
7460217|NCT01825798|11755506|FG001|Overall Study|Lost to Follow-up|0
7460218|NCT01825837|11755516|FG000|PART I|Withdrawal by Subject|0
7460219|NCT01825837|11755517|FG001|PART I|Withdrawal by Subject|0
7460220|NCT01825837|11755518|FG002|PART I|Withdrawal by Subject|0
7460221|NCT01825837|11755519|FG003|PART I|Withdrawal by Subject|6
7460222|NCT01825837|11755516|FG000|PART I|Patient non-compliance|0
7460223|NCT01825837|11755517|FG001|PART I|Patient non-compliance|0
7460224|NCT01825837|11755518|FG002|PART I|Patient non-compliance|0
7460225|NCT01825837|11755519|FG003|PART I|Patient non-compliance|1
7460226|NCT01825837|11755516|FG000|PART I|Treatment failure|0
7460227|NCT01825837|11755517|FG001|PART I|Treatment failure|0
7460228|NCT01825837|11755518|FG002|PART I|Treatment failure|0
7460229|NCT01825837|11755519|FG003|PART I|Treatment failure|7
7362361|NCT01029704|11609320|FG004|Overall Study|Withdrawn due to major protocol violation|1
7362362|NCT01029704|11609321|FG005|Overall Study|Withdrawn due to major protocol violation|0
7362363|NCT01029704|11609322|FG006|Overall Study|Withdrawn due to major protocol violation|0
7362364|NCT01029704|11609323|FG007|Overall Study|Withdrawn due to major protocol violation|1
7362365|NCT01029704|11609324|FG008|Overall Study|Withdrawn due to major protocol violation|0
7362366|NCT01029782|11609350|FG000|Overall Study|Lost to Follow-up|2
7362367|NCT01029782|11609351|FG001|Overall Study|Lost to Follow-up|2
7362368|NCT01029782|11609350|FG000|Overall Study|Diagnosis changed|1
7362369|NCT01029782|11609351|FG001|Overall Study|Diagnosis changed|1
7362370|NCT01029782|11609350|FG000|Overall Study|Adverse Event|0
7362371|NCT01029782|11609351|FG001|Overall Study|Adverse Event|1
7362372|NCT01029782|11609350|FG000|Overall Study|Physician Decision|0
7362373|NCT01029782|11609351|FG001|Overall Study|Physician Decision|1
7362374|NCT01029782|11609350|FG000|Overall Study|Protocol Violation|0
7362375|NCT01029782|11609351|FG001|Overall Study|Protocol Violation|2
7362376|NCT01029782|11609350|FG000|Overall Study|Withdrawal by Subject|0
7362377|NCT01029782|11609351|FG001|Overall Study|Withdrawal by Subject|1
7362378|NCT01029795|11609359|FG000|Overall Study|Entry Criteria Not Met|2
7362379|NCT01029795|11609360|FG001|Overall Study|Entry Criteria Not Met|1
7362380|NCT01029795|11609359|FG000|Overall Study|Physician Decision|2
7362381|NCT01029795|11609360|FG001|Overall Study|Physician Decision|1
7362382|NCT01029795|11609359|FG000|Overall Study|Sponsor Decision|11
7362383|NCT01029795|11609360|FG001|Overall Study|Sponsor Decision|17
7362384|NCT01029795|11609359|FG000|Overall Study|Withdrawal by Subject|1
7362385|NCT01029795|11609360|FG001|Overall Study|Withdrawal by Subject|3
7362386|NCT01029886|11609368|FG000|Overall Study|Adverse Event|12
7362387|NCT01029886|11609369|FG001|Overall Study|Adverse Event|25
7362388|NCT01029886|11609368|FG000|Overall Study|Lost to Follow-up|1
7362389|NCT01029886|11609369|FG001|Overall Study|Lost to Follow-up|0
7362390|NCT01029886|11609368|FG000|Overall Study|Physician Decision|2
7362391|NCT01029886|11609369|FG001|Overall Study|Physician Decision|6
7362392|NCT01029886|11609368|FG000|Overall Study|Protocol Violation|17
7362393|NCT01029886|11609369|FG001|Overall Study|Protocol Violation|5
7362394|NCT01029886|11609368|FG000|Overall Study|Withdrawal by Subject|8
7362395|NCT01029886|11609369|FG001|Overall Study|Withdrawal by Subject|18
7362396|NCT01029886|11609368|FG000|Overall Study|Entry Criteria Not Met|13
7362397|NCT01029886|11609369|FG001|Overall Study|Entry Criteria Not Met|5
7362398|NCT01029886|11609368|FG000|Overall Study|Sponsor Decision|1
7362399|NCT01029886|11609369|FG001|Overall Study|Sponsor Decision|0
7362400|NCT01029886|11609368|FG000|Overall Study|Loss Glucose Control|7
7362401|NCT01029886|11609369|FG001|Overall Study|Loss Glucose Control|1
7362402|NCT01029925|11609388|FG000|Completion of Cycle 1 (28 Days)|Death|2
7362403|NCT01029925|11609388|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
7362404|NCT01029925|11609388|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
7362405|NCT01030133|11609394|FG000|Overall Study|failed to experience pain at level 7/10|2
7362406|NCT01030133|11609395|FG001|Overall Study|failed to experience pain at level 7/10|2
7362407|NCT01030458|11609436|FG000|Overall Study|Lost to Follow-up|9
7362408|NCT01030458|11609437|FG001|Overall Study|Lost to Follow-up|10
7362409|NCT01030458|11609436|FG000|Overall Study|Withdrawal by Subject|2
7362410|NCT01030458|11609437|FG001|Overall Study|Withdrawal by Subject|3
7362411|NCT01030458|11609436|FG000|Overall Study|Logistical reasons|9
7362412|NCT01030458|11609437|FG001|Overall Study|Logistical reasons|5
7362413|NCT01030458|11609436|FG000|Overall Study|Moved or changed job|6
7362414|NCT01030458|11609437|FG001|Overall Study|Moved or changed job|13
7362415|NCT01030458|11609436|FG000|Overall Study|Side effect of medication|1
7362416|NCT01030458|11609437|FG001|Overall Study|Side effect of medication|1
7362417|NCT01030523|11609445|FG000|Overall Study|Death|1
7362418|NCT01030523|11609446|FG001|Overall Study|Death|0
7362419|NCT01030523|11609445|FG000|Overall Study|Lost to Follow-up|4
7362420|NCT01030523|11609446|FG001|Overall Study|Lost to Follow-up|4
7362421|NCT01030523|11609445|FG000|Overall Study|Implant failure|1
7362422|NCT01030523|11609446|FG001|Overall Study|Implant failure|0
7362423|NCT01030523|11609445|FG000|Overall Study|Withdrawal by Subject|0
7362424|NCT01030523|11609446|FG001|Overall Study|Withdrawal by Subject|1
7362425|NCT01030536|11609457|FG000|Overall Study|Withdrawal by Subject|0
7362426|NCT01030536|11609458|FG001|Overall Study|Withdrawal by Subject|0
7362427|NCT01030536|11609459|FG002|Overall Study|Withdrawal by Subject|1
7362428|NCT01030536|11609460|FG003|Overall Study|Withdrawal by Subject|0
7362429|NCT01030536|11609461|FG004|Overall Study|Withdrawal by Subject|0
7362430|NCT01030536|11609457|FG000|Overall Study|undefined|1
7569738|NCT03465722|11946510|FG000|End of Study|Lost to Follow-up|5
7569739|NCT03465722|11946511|FG001|End of Study|Lost to Follow-up|2
7569740|NCT03465722|11946510|FG000|End of Study|Administrative/Other|4
7569741|NCT03465722|11946511|FG001|End of Study|Administrative/Other|2
7362431|NCT01030536|11609458|FG001|Overall Study|undefined|0
7362432|NCT01030536|11609459|FG002|Overall Study|undefined|1
7362433|NCT01030536|11609460|FG003|Overall Study|undefined|1
7362434|NCT01030536|11609461|FG004|Overall Study|undefined|0
7362435|NCT01030536|11609457|FG000|Overall Study|Adverse Event|0
7362436|NCT01030536|11609458|FG001|Overall Study|Adverse Event|3
7362437|NCT01030536|11609459|FG002|Overall Study|Adverse Event|1
7362438|NCT01030536|11609460|FG003|Overall Study|Adverse Event|0
7362439|NCT01030536|11609461|FG004|Overall Study|Adverse Event|1
7362440|NCT01030536|11609457|FG000|Overall Study|Progressive disease|6
7362441|NCT01030536|11609458|FG001|Overall Study|Progressive disease|2
7362442|NCT01030536|11609459|FG002|Overall Study|Progressive disease|3
7362443|NCT01030536|11609460|FG003|Overall Study|Progressive disease|2
7362444|NCT01030536|11609461|FG004|Overall Study|Progressive disease|0
7362445|NCT01030536|11609457|FG000|Overall Study|Death|0
7362446|NCT01030536|11609458|FG001|Overall Study|Death|1
7362447|NCT01030536|11609459|FG002|Overall Study|Death|0
7362448|NCT01030536|11609460|FG003|Overall Study|Death|0
7362449|NCT01030536|11609461|FG004|Overall Study|Death|0
7362450|NCT01030666|11609489|FG000|Overall Study|Lost to Follow-up|3
7362451|NCT01030666|11609490|FG001|Overall Study|Lost to Follow-up|2
7362452|NCT01030718|11609500|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
7362453|NCT01030718|11609501|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
7362454|NCT01030718|11609502|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
7362455|NCT01030718|11609500|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
7362456|NCT01030718|11609501|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
7362457|NCT01030718|11609502|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
7362458|NCT01030718|11609500|FG000|Studies CA180-031 and -036 Combined|Death|0
7362459|NCT01030718|11609501|FG001|Studies CA180-031 and -036 Combined|Death|1
7362460|NCT01030718|11609502|FG002|Studies CA180-031 and -036 Combined|Death|0
7362461|NCT01030718|11609500|FG000|Studies CA180-031 and -036 Combined|other reasons|0
7362462|NCT01030718|11609501|FG001|Studies CA180-031 and -036 Combined|other reasons|2
7362463|NCT01030718|11609502|FG002|Studies CA180-031 and -036 Combined|other reasons|0
7362464|NCT01030718|11609500|FG000|Study CA180-036 Only|insufficient effect|1
7362465|NCT01030718|11609501|FG001|Study CA180-036 Only|insufficient effect|1
7362466|NCT01030718|11609502|FG002|Study CA180-036 Only|insufficient effect|5
7362467|NCT01030718|11609500|FG000|Study CA180-036 Only|Adverse Event|2
7362468|NCT01030718|11609501|FG001|Study CA180-036 Only|Adverse Event|3
7362469|NCT01030718|11609502|FG002|Study CA180-036 Only|Adverse Event|0
7362470|NCT01030718|11609500|FG000|Study CA180-036 Only|Death|0
7362471|NCT01030718|11609501|FG001|Study CA180-036 Only|Death|1
7362472|NCT01030718|11609502|FG002|Study CA180-036 Only|Death|0
7362473|NCT01030718|11609500|FG000|Study CA180-036 Only|Other Reasons|0
7362474|NCT01030718|11609501|FG001|Study CA180-036 Only|Other Reasons|2
7362475|NCT01030718|11609502|FG002|Study CA180-036 Only|Other Reasons|0
7362476|NCT01030822|11609532|FG000|Overall Study|Moved/migrated from study area|6
7362477|NCT01030822|11609533|FG001|Overall Study|Moved/migrated from study area|7
7362478|NCT01030822|11609534|FG002|Overall Study|Moved/migrated from study area|3
7362479|NCT01030822|11609532|FG000|Overall Study|Withdrawal by Subject|16
7362480|NCT01030822|11609533|FG001|Overall Study|Withdrawal by Subject|13
7362481|NCT01030822|11609534|FG002|Overall Study|Withdrawal by Subject|16
7362482|NCT01030822|11609532|FG000|Overall Study|Lost to Follow-up|9
7362483|NCT01030822|11609533|FG001|Overall Study|Lost to Follow-up|4
7362484|NCT01030822|11609534|FG002|Overall Study|Lost to Follow-up|7
7362485|NCT01030874|11609554|FG000|Overall Study|Withdrawal by Subject|1
7362486|NCT01030874|11609555|FG001|Overall Study|Withdrawal by Subject|0
7362487|NCT01030874|11609554|FG000|Overall Study|Discharged in first 2 weeks|17
7362488|NCT01030874|11609555|FG001|Overall Study|Discharged in first 2 weeks|16
7362489|NCT01030952|11609563|FG000|Overall Study|Protocol Violation|0
7362490|NCT01030952|11609564|FG001|Overall Study|Protocol Violation|1
7362491|NCT01030952|11609563|FG000|Overall Study|Informed consent withdrawal|1
7362492|NCT01030952|11609564|FG001|Overall Study|Informed consent withdrawal|0
7362493|NCT01030952|11609563|FG000|Overall Study|Lost to Follow-up|0
7362494|NCT01030952|11609564|FG001|Overall Study|Lost to Follow-up|1
7569742|NCT03465722|11946510|FG000|End of Study|On Treatment or in Follow Up|157
7362495|NCT01030952|11609563|FG000|Overall Study|Unexplained|1
7460230|NCT01825837|11755516|FG000|PART I|reason unspecified|0
7460231|NCT01825837|11755517|FG001|PART I|reason unspecified|0
7460232|NCT01825837|11755518|FG002|PART I|reason unspecified|0
7460233|NCT01825837|11755519|FG003|PART I|reason unspecified|3
7460234|NCT01825837|11755516|FG000|PART II|Withdrawal by Subject|3
7460235|NCT01825837|11755517|FG001|PART II|Withdrawal by Subject|3
7460236|NCT01825837|11755518|FG002|PART II|Withdrawal by Subject|7
7460237|NCT01825837|11755519|FG003|PART II|Withdrawal by Subject|0
7460238|NCT01825837|11755516|FG000|PART II|Patient non-compliance|5
7460239|NCT01825837|11755517|FG001|PART II|Patient non-compliance|2
7460240|NCT01825837|11755518|FG002|PART II|Patient non-compliance|4
7460241|NCT01825837|11755519|FG003|PART II|Patient non-compliance|0
7460242|NCT01825837|11755516|FG000|PART II|Adverse Event|3
7460243|NCT01825837|11755517|FG001|PART II|Adverse Event|3
7460244|NCT01825837|11755518|FG002|PART II|Adverse Event|1
7460245|NCT01825837|11755519|FG003|PART II|Adverse Event|0
7460246|NCT01825837|11755516|FG000|PART II|Treatment failure|6
7460247|NCT01825837|11755517|FG001|PART II|Treatment failure|4
7460248|NCT01825837|11755518|FG002|PART II|Treatment failure|5
7460249|NCT01825837|11755519|FG003|PART II|Treatment failure|0
7460250|NCT01825837|11755516|FG000|PART II|reason unspecified|2
7460251|NCT01825837|11755517|FG001|PART II|reason unspecified|2
7460252|NCT01825837|11755518|FG002|PART II|reason unspecified|2
7460253|NCT01825837|11755519|FG003|PART II|reason unspecified|0
7460254|NCT01825876|11755527|FG000|Period 2|Withdrawal by Subject|0
7460255|NCT01825876|11755528|FG001|Period 2|Withdrawal by Subject|1
7460256|NCT01825941|11755548|FG000|Overall Study|Lost to Follow-up|4
7460257|NCT01825941|11755549|FG001|Overall Study|Lost to Follow-up|1
7460258|NCT01826201|11755555|FG000|Overall Study|Non compliance with protocol|4
7460259|NCT01826214|11755563|FG000|Overall Study|Adverse Event|7
7460260|NCT01826214|11755564|FG001|Overall Study|Adverse Event|6
7460261|NCT01826214|11755563|FG000|Overall Study|Death|3
7460262|NCT01826214|11755564|FG001|Overall Study|Death|1
7460263|NCT01826214|11755563|FG000|Overall Study|Lost to Follow-up|1
7460264|NCT01826214|11755564|FG001|Overall Study|Lost to Follow-up|0
7460265|NCT01826214|11755563|FG000|Overall Study|Physician Decision|0
7460266|NCT01826214|11755564|FG001|Overall Study|Physician Decision|2
7460267|NCT01826214|11755563|FG000|Overall Study|Progressive disease|22
7460268|NCT01826214|11755564|FG001|Overall Study|Progressive disease|21
7460269|NCT01826214|11755563|FG000|Overall Study|Study terminated by Sponsor|0
7460270|NCT01826214|11755564|FG001|Overall Study|Study terminated by Sponsor|1
7460271|NCT01826214|11755563|FG000|Overall Study|Subject/guardian decision|2
7460272|NCT01826214|11755564|FG001|Overall Study|Subject/guardian decision|3
7460273|NCT01826370|11755574|FG000|Overall Study|Protocol Violation|6
7460274|NCT01826370|11755574|FG000|Overall Study|Lost to Follow-up|12
7460275|NCT01826370|11755574|FG000|Overall Study|Other reason not defined above|2
7460276|NCT01826422|11755580|FG000|Overall Study|Withdrawal by Subject|1
7460277|NCT01826422|11755581|FG001|Overall Study|Withdrawal by Subject|3
7460278|NCT01826448|11755589|FG000|Overall Study|Adverse Event|1
7460279|NCT01826448|11755590|FG001|Overall Study|Adverse Event|3
7460280|NCT01826448|11755589|FG000|Overall Study|Disease progression|2
7460281|NCT01826448|11755590|FG001|Overall Study|Disease progression|4
7460282|NCT01826448|11755589|FG000|Overall Study|Withdrawal by Subject|1
7460283|NCT01826448|11755590|FG001|Overall Study|Withdrawal by Subject|0
7460284|NCT01826448|11755589|FG000|Overall Study|Physician Decision|0
7460285|NCT01826448|11755590|FG001|Overall Study|Physician Decision|1
7460286|NCT01826448|11755589|FG000|Overall Study|2 active cancers|0
7460287|NCT01826448|11755590|FG001|Overall Study|2 active cancers|1
7460288|NCT01826487|11755598|FG000|Overall Study|Adverse Event|1
7460289|NCT01826487|11755599|FG001|Overall Study|Adverse Event|1
7460290|NCT01826487|11755598|FG000|Overall Study|Lost to Follow-up|1
7460291|NCT01826487|11755599|FG001|Overall Study|Lost to Follow-up|0
7460292|NCT01826487|11755598|FG000|Overall Study|Withdrawal by Subject|1
7460293|NCT01826487|11755599|FG001|Overall Study|Withdrawal by Subject|3
7460294|NCT01826487|11755598|FG000|Overall Study|Protocol Violation|1
7460295|NCT01826487|11755599|FG001|Overall Study|Protocol Violation|1
7460296|NCT01826604|11755620|FG000|Overall Study|Lost to Follow-up|8
7460297|NCT01826604|11755621|FG001|Overall Study|Lost to Follow-up|9
7460298|NCT01826825|11755640|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
7460299|NCT01826825|11755641|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
7460300|NCT01826981|11755673|FG000|Overall Study|Lack of Efficacy|0
7460301|NCT01826981|11755674|FG001|Overall Study|Lack of Efficacy|1
7460302|NCT01826981|11755675|FG002|Overall Study|Lack of Efficacy|0
7460303|NCT01826981|11755676|FG003|Overall Study|Lack of Efficacy|0
7460304|NCT01826981|11755677|FG004|Overall Study|Lack of Efficacy|5
7460305|NCT01826981|11755678|FG005|Overall Study|Lack of Efficacy|0
7460306|NCT01826981|11755679|FG006|Overall Study|Lack of Efficacy|0
7362496|NCT01030952|11609564|FG001|Overall Study|Unexplained|1
7460307|NCT01826981|11755680|FG007|Overall Study|Lack of Efficacy|8
7460308|NCT01826981|11755681|FG008|Overall Study|Lack of Efficacy|7
7460309|NCT01826981|11755682|FG009|Overall Study|Lack of Efficacy|0
7460310|NCT01826981|11755683|FG010|Overall Study|Lack of Efficacy|1
7460311|NCT01826981|11755684|FG011|Overall Study|Lack of Efficacy|0
7460312|NCT01826981|11755685|FG012|Overall Study|Lack of Efficacy|0
7460313|NCT01826981|11755686|FG013|Overall Study|Lack of Efficacy|3
7460314|NCT01826981|11755687|FG014|Overall Study|Lack of Efficacy|0
7362497|NCT01030965|11609576|FG000|Overall Study|Lack of Efficacy|3
7362498|NCT01030965|11609577|FG001|Overall Study|Lack of Efficacy|2
7362499|NCT01030965|11609578|FG002|Overall Study|Lack of Efficacy|0
7362500|NCT01030965|11609579|FG003|Overall Study|Lack of Efficacy|3
7362501|NCT01030965|11609576|FG000|Overall Study|Protocol Violation|1
7362502|NCT01030965|11609577|FG001|Overall Study|Protocol Violation|1
7362503|NCT01030965|11609578|FG002|Overall Study|Protocol Violation|1
7362504|NCT01030965|11609579|FG003|Overall Study|Protocol Violation|1
7362505|NCT01030965|11609576|FG000|Overall Study|Adverse Event|0
7362506|NCT01030965|11609577|FG001|Overall Study|Adverse Event|1
7362507|NCT01030965|11609578|FG002|Overall Study|Adverse Event|2
7362508|NCT01030965|11609579|FG003|Overall Study|Adverse Event|1
7362509|NCT01030965|11609576|FG000|Overall Study|Protocol-defined Stopping Criteria|0
7362510|NCT01030965|11609577|FG001|Overall Study|Protocol-defined Stopping Criteria|1
7362511|NCT01030965|11609578|FG002|Overall Study|Protocol-defined Stopping Criteria|1
7362512|NCT01030965|11609579|FG003|Overall Study|Protocol-defined Stopping Criteria|0
7362513|NCT01030965|11609576|FG000|Overall Study|Withdrawal by Subject|0
7362514|NCT01030965|11609577|FG001|Overall Study|Withdrawal by Subject|1
7362515|NCT01030965|11609578|FG002|Overall Study|Withdrawal by Subject|0
7362516|NCT01030965|11609579|FG003|Overall Study|Withdrawal by Subject|2
7362517|NCT01031004|11609591|FG000|Overall Study|Protocol Violation|0
7362518|NCT01031004|11609592|FG001|Overall Study|Protocol Violation|1
7362519|NCT01031004|11609591|FG000|Overall Study|Lost to Follow-up|1
7362520|NCT01031004|11609592|FG001|Overall Study|Lost to Follow-up|0
7362521|NCT01031069|11609606|FG000|Overall Study|Serious Adverse Event|0
7362522|NCT01031069|11609607|FG001|Overall Study|Serious Adverse Event|1
7362523|NCT01031069|11609608|FG002|Overall Study|Serious Adverse Event|0
7362524|NCT01031069|11609609|FG003|Overall Study|Serious Adverse Event|0
7362525|NCT01031069|11609606|FG000|Overall Study|Withdrawal by Subject|2
7362526|NCT01031069|11609607|FG001|Overall Study|Withdrawal by Subject|3
7362527|NCT01031069|11609608|FG002|Overall Study|Withdrawal by Subject|18
7362528|NCT01031069|11609609|FG003|Overall Study|Withdrawal by Subject|18
7362529|NCT01031069|11609606|FG000|Overall Study|Migrated/moved from study area|1
7362530|NCT01031069|11609607|FG001|Overall Study|Migrated/moved from study area|2
7362531|NCT01031069|11609608|FG002|Overall Study|Migrated/moved from study area|1
7362532|NCT01031069|11609609|FG003|Overall Study|Migrated/moved from study area|1
7362533|NCT01031069|11609606|FG000|Overall Study|Lost to Follow-up|9
7362534|NCT01031069|11609607|FG001|Overall Study|Lost to Follow-up|5
7362535|NCT01031069|11609608|FG002|Overall Study|Lost to Follow-up|21
7362536|NCT01031069|11609609|FG003|Overall Study|Lost to Follow-up|15
7362537|NCT01031069|11609606|FG000|Overall Study|Other|0
7362538|NCT01031069|11609607|FG001|Overall Study|Other|0
7362539|NCT01031069|11609608|FG002|Overall Study|Other|1
7362540|NCT01031069|11609609|FG003|Overall Study|Other|0
7362541|NCT01031381|11609639|FG000|Overall Study|Physician Decision|3
7362542|NCT01031381|11609639|FG000|Overall Study|Withdrawal by Subject|6
7362543|NCT01031446|11609648|FG000|Overall Study|Disease Progression|38
7362544|NCT01031446|11609648|FG000|Overall Study|Adverse Event|9
7362545|NCT01031446|11609648|FG000|Overall Study|Physician Decision|4
7362546|NCT01031446|11609648|FG000|Overall Study|Withdrawal by Subject|3
7362547|NCT01031446|11609648|FG000|Overall Study|Still on treatment|1
7362548|NCT01031537|11609667|FG000|Overall Study|medical reasons not related to study|3
7362549|NCT01031537|11609667|FG000|Overall Study|Lack of Efficacy|1
7362550|NCT01031537|11609667|FG000|Overall Study|retired from NIH, met exclusion criteria|1
7362551|NCT01031537|11609667|FG000|Overall Study|moved, met exclusion criteria|10
7362552|NCT01031537|11609667|FG000|Overall Study|Withdrawal by Subject|5
7362553|NCT01031537|11609667|FG000|Overall Study|PI removal, no longer met eligibility|12
7362554|NCT01031680|11609673|FG000|Overall Study|Adverse Event|8
7362555|NCT01031680|11609674|FG001|Overall Study|Adverse Event|3
7362556|NCT01031680|11609673|FG000|Overall Study|Lost to Follow-up|2
7362557|NCT01031680|11609674|FG001|Overall Study|Lost to Follow-up|10
7362558|NCT01031680|11609673|FG000|Overall Study|Withdrawal by Subject|12
7362559|NCT01031680|11609674|FG001|Overall Study|Withdrawal by Subject|16
7362560|NCT01031680|11609673|FG000|Overall Study|Death|2
7362561|NCT01031680|11609674|FG001|Overall Study|Death|1
7362562|NCT01031680|11609673|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
7362563|NCT01031680|11609674|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
7362564|NCT01031680|11609673|FG000|Overall Study|Poor/Non-compliance|5
7362565|NCT01031680|11609674|FG001|Overall Study|Poor/Non-compliance|6
7362566|NCT01031680|11609673|FG000|Overall Study|Safety|1
7362567|NCT01031680|11609674|FG001|Overall Study|Safety|0
7362568|NCT01031680|11609673|FG000|Overall Study|Incorrect Enrolment|1
7362569|NCT01031680|11609674|FG001|Overall Study|Incorrect Enrolment|2
7362570|NCT01031680|11609673|FG000|Overall Study|Administrative Reason by Sponsor|0
7362571|NCT01031680|11609674|FG001|Overall Study|Administrative Reason by Sponsor|1
7362572|NCT01031680|11609673|FG000|Overall Study|Various|0
7362573|NCT01031680|11609674|FG001|Overall Study|Various|2
7362574|NCT01031706|11609682|FG000|Overall Study|Adverse Event|1
7362575|NCT01031706|11609683|FG001|Overall Study|Adverse Event|0
7362576|NCT01031706|11609682|FG000|Overall Study|Withdrawal by Subject|1
7362577|NCT01031706|11609683|FG001|Overall Study|Withdrawal by Subject|1
7362578|NCT01031836|11609701|FG000|Stage I|Adverse Event|1
7362579|NCT01031836|11609702|FG001|Stage I|Adverse Event|1
7362580|NCT01031836|11609703|FG002|Stage I|Adverse Event|0
7362581|NCT01031836|11609704|FG003|Stage I|Adverse Event|0
7362582|NCT01031836|11609705|FG004|Stage I|Adverse Event|0
7362583|NCT01031836|11609706|FG005|Stage I|Adverse Event|0
7362584|NCT01031836|11609701|FG000|Stage I|Other|0
7362585|NCT01031836|11609702|FG001|Stage I|Other|1
7362586|NCT01031836|11609703|FG002|Stage I|Other|0
7362587|NCT01031836|11609704|FG003|Stage I|Other|0
7362588|NCT01031836|11609705|FG004|Stage I|Other|0
7362589|NCT01031836|11609706|FG005|Stage I|Other|1
7362590|NCT01031836|11609701|FG000|Stage II|Adverse Event|0
7362591|NCT01031836|11609702|FG001|Stage II|Adverse Event|0
7362592|NCT01031836|11609703|FG002|Stage II|Adverse Event|2
7362593|NCT01031836|11609704|FG003|Stage II|Adverse Event|2
7362594|NCT01031836|11609705|FG004|Stage II|Adverse Event|1
7362595|NCT01031836|11609706|FG005|Stage II|Adverse Event|1
7362596|NCT01031836|11609701|FG000|Stage II|Other|2
7362597|NCT01031836|11609702|FG001|Stage II|Other|0
7362598|NCT01031836|11609703|FG002|Stage II|Other|0
7362599|NCT01031836|11609704|FG003|Stage II|Other|1
7362600|NCT01031836|11609705|FG004|Stage II|Other|1
7362601|NCT01031836|11609706|FG005|Stage II|Other|0
7362602|NCT01031979|11609736|FG000|Overall Study|Lost to Follow-up|5
7362603|NCT01031979|11609737|FG001|Overall Study|Lost to Follow-up|4
7362604|NCT01032018|11609745|FG000|Overall Study|Lost to Follow-up|6
7362605|NCT01032018|11609746|FG001|Overall Study|Lost to Follow-up|5
7362606|NCT01032018|11609745|FG000|Overall Study|Death|0
7362607|NCT01032018|11609746|FG001|Overall Study|Death|1
7362608|NCT01032044|11609754|FG000|Overall Study|Protocol Violation|14
7362609|NCT01032044|11609755|FG001|Overall Study|Protocol Violation|8
7362610|NCT01032044|11609754|FG000|Overall Study|Adverse Event|0
7362611|NCT01032044|11609755|FG001|Overall Study|Adverse Event|1
7362612|NCT01032044|11609754|FG000|Overall Study|Lost to Follow-up|11
7362613|NCT01032044|11609755|FG001|Overall Study|Lost to Follow-up|11
7362614|NCT01032070|11609763|FG000|Overall Study|Disease progression|13
7362615|NCT01032070|11609764|FG001|Overall Study|Disease progression|8
7362616|NCT01032070|11609763|FG000|Overall Study|Medical or ethical reasons|0
7362617|NCT01032070|11609764|FG001|Overall Study|Medical or ethical reasons|2
7362618|NCT01032070|11609763|FG000|Overall Study|Withdrawal by Subject|0
7362619|NCT01032070|11609764|FG001|Overall Study|Withdrawal by Subject|2
7362620|NCT01032174|11609797|FG000|Overall Study|Adverse Event|0
7362621|NCT01032174|11609798|FG001|Overall Study|Adverse Event|1
7362622|NCT01032200|11609806|FG000|Overall Study|Death|1
7362623|NCT01032200|11609807|FG001|Overall Study|Death|1
7362624|NCT01032200|11609806|FG000|Overall Study|Withdrawal by Subject|1
7362625|NCT01032200|11609807|FG001|Overall Study|Withdrawal by Subject|3
7362626|NCT01032200|11609806|FG000|Overall Study|Toxicity|0
7362627|NCT01032200|11609807|FG001|Overall Study|Toxicity|2
7362628|NCT01032200|11609806|FG000|Overall Study|Progression|1
7362629|NCT01032200|11609807|FG001|Overall Study|Progression|0
7362630|NCT01032200|11609806|FG000|Overall Study|Multiple|1
7362631|NCT01032200|11609807|FG001|Overall Study|Multiple|1
7362632|NCT01032239|11609815|FG000|Overall Study|Lost to Follow-up|3
7362633|NCT01032239|11609816|FG001|Overall Study|Lost to Follow-up|2
7362634|NCT01032239|11609815|FG000|Overall Study|Withdrawal by Subject|2
7362635|NCT01032239|11609816|FG001|Overall Study|Withdrawal by Subject|3
7362636|NCT01032239|11609815|FG000|Overall Study|Death|1
7362637|NCT01032239|11609816|FG001|Overall Study|Death|0
7362638|NCT01032239|11609815|FG000|Overall Study|Protocol Violation|1
7362639|NCT01032239|11609816|FG001|Overall Study|Protocol Violation|0
7362640|NCT01032291|11609825|FG000|Safety Lead-in|Adverse Event|1
7362641|NCT01032291|11609826|FG001|Safety Lead-in|Adverse Event|0
7362642|NCT01032291|11609827|FG002|Safety Lead-in|Adverse Event|0
7362643|NCT01032291|11609825|FG000|Safety Lead-in|Death|1
7362644|NCT01032291|11609826|FG001|Safety Lead-in|Death|0
7362645|NCT01032291|11609827|FG002|Safety Lead-in|Death|0
7362646|NCT01032291|11609825|FG000|Proof of Concept|Adverse Event|0
7362647|NCT01032291|11609826|FG001|Proof of Concept|Adverse Event|5
7362648|NCT01032291|11609827|FG002|Proof of Concept|Adverse Event|1
7362649|NCT01032291|11609825|FG000|Proof of Concept|Death|0
7362650|NCT01032291|11609826|FG001|Proof of Concept|Death|1
7362651|NCT01032291|11609827|FG002|Proof of Concept|Death|2
7362652|NCT01032291|11609825|FG000|Proof of Concept|Lack of Efficacy|0
7362653|NCT01032291|11609826|FG001|Proof of Concept|Lack of Efficacy|1
7362654|NCT01032291|11609827|FG002|Proof of Concept|Lack of Efficacy|0
7362655|NCT01032291|11609825|FG000|Proof of Concept|Never Received Study Drug|0
7362656|NCT01032291|11609826|FG001|Proof of Concept|Never Received Study Drug|1
7362657|NCT01032291|11609827|FG002|Proof of Concept|Never Received Study Drug|0
7362658|NCT01032382|11609865|FG000|Overall Study|Disease dissemination|1
7362659|NCT01032382|11609866|FG001|Overall Study|Disease dissemination|1
7362660|NCT01032382|11609865|FG000|Overall Study|Treatment failure|3
7362661|NCT01032382|11609866|FG001|Overall Study|Treatment failure|1
7362662|NCT01032382|11609865|FG000|Overall Study|Index lesion relapse|1
7362663|NCT01032382|11609866|FG001|Overall Study|Index lesion relapse|3
7362664|NCT01032629|11609881|FG000|Overall Study|Closed Site|21
7362665|NCT01032629|11609882|FG001|Overall Study|Closed Site|18
7362666|NCT01032629|11609883|FG002|Overall Study|Closed Site|16
7362667|NCT01032629|11609881|FG000|Overall Study|Withdrawal by Subject|50
7362668|NCT01032629|11609882|FG001|Overall Study|Withdrawal by Subject|36
7362669|NCT01032629|11609883|FG002|Overall Study|Withdrawal by Subject|35
7362670|NCT01032629|11609881|FG000|Overall Study|Lost to Follow-up|74
7362671|NCT01032629|11609882|FG001|Overall Study|Lost to Follow-up|47
7362672|NCT01032629|11609883|FG002|Overall Study|Lost to Follow-up|37
7362673|NCT01032837|11609924|FG000|Overall Study|Adverse event/internal illness|0
7362674|NCT01032837|11609925|FG001|Overall Study|Adverse event/internal illness|1
7362675|NCT01032837|11609926|FG002|Overall Study|Adverse event/internal illness|0
7362676|NCT01032837|11609927|FG003|Overall Study|Adverse event/internal illness|1
7362677|NCT01032837|11609924|FG000|Overall Study|Withdrew consent|0
7362678|NCT01032837|11609925|FG001|Overall Study|Withdrew consent|2
7362679|NCT01032837|11609926|FG002|Overall Study|Withdrew consent|0
7362680|NCT01032837|11609927|FG003|Overall Study|Withdrew consent|1
7362681|NCT01032837|11609924|FG000|Overall Study|Failed to return|0
7362682|NCT01032837|11609925|FG001|Overall Study|Failed to return|0
7362683|NCT01032837|11609926|FG002|Overall Study|Failed to return|1
7362684|NCT01032837|11609927|FG003|Overall Study|Failed to return|0
7362685|NCT01032837|11609924|FG000|Overall Study|Refused treatment|0
7362686|NCT01032837|11609925|FG001|Overall Study|Refused treatment|0
7362687|NCT01032837|11609926|FG002|Overall Study|Refused treatment|0
7362688|NCT01032837|11609927|FG003|Overall Study|Refused treatment|1
7362689|NCT01032889|11609944|FG000|Overall Study|Adverse Event|2
7362690|NCT01032889|11609945|FG001|Overall Study|Adverse Event|2
7362691|NCT01032889|11609946|FG002|Overall Study|Adverse Event|0
7362692|NCT01032889|11609944|FG000|Overall Study|Withdrawal of Consent|1
7362693|NCT01032889|11609945|FG001|Overall Study|Withdrawal of Consent|2
7362694|NCT01032889|11609946|FG002|Overall Study|Withdrawal of Consent|1
7362695|NCT01032889|11609944|FG000|Overall Study|Patient Request|0
7362696|NCT01032889|11609945|FG001|Overall Study|Patient Request|1
7362697|NCT01032889|11609946|FG002|Overall Study|Patient Request|0
7362698|NCT01032889|11609944|FG000|Overall Study|Lost to Follow-up|1
7362699|NCT01032889|11609945|FG001|Overall Study|Lost to Follow-up|1
7362700|NCT01032889|11609946|FG002|Overall Study|Lost to Follow-up|0
7362701|NCT01032889|11609944|FG000|Overall Study|Lack of Submental Fat|2
7362702|NCT01032889|11609945|FG001|Overall Study|Lack of Submental Fat|8
7362703|NCT01032889|11609946|FG002|Overall Study|Lack of Submental Fat|1
7362704|NCT01032889|11609944|FG000|Overall Study|Miscellaneous Reasons|2
7362705|NCT01032889|11609945|FG001|Overall Study|Miscellaneous Reasons|1
7362706|NCT01032889|11609946|FG002|Overall Study|Miscellaneous Reasons|1
7362707|NCT01032915|11609958|FG000|Overall Study|Adverse Event|2
7362708|NCT01032915|11609959|FG001|Overall Study|Adverse Event|2
7362709|NCT01032915|11609960|FG002|Overall Study|Adverse Event|1
7362710|NCT01032915|11609961|FG003|Overall Study|Adverse Event|1
7362711|NCT01032915|11609958|FG000|Overall Study|Abnormal test procedure result|0
7362712|NCT01032915|11609959|FG001|Overall Study|Abnormal test procedure result|0
7362713|NCT01032915|11609960|FG002|Overall Study|Abnormal test procedure result|1
7362714|NCT01032915|11609961|FG003|Overall Study|Abnormal test procedure result|0
7362715|NCT01032915|11609958|FG000|Overall Study|Withdrawal by Subject|0
7362716|NCT01032915|11609959|FG001|Overall Study|Withdrawal by Subject|3
7569743|NCT03465722|11946511|FG001|End of Study|On Treatment or in Follow Up|168
7569744|NCT03465878|11946519|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7569745|NCT03465878|11946520|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
7362717|NCT01032915|11609960|FG002|Overall Study|Withdrawal by Subject|1
7362718|NCT01032915|11609961|FG003|Overall Study|Withdrawal by Subject|1
7362719|NCT01032915|11609958|FG000|Overall Study|Administrative reasons|5
7362720|NCT01032915|11609959|FG001|Overall Study|Administrative reasons|6
7362721|NCT01032915|11609960|FG002|Overall Study|Administrative reasons|4
7362722|NCT01032915|11609961|FG003|Overall Study|Administrative reasons|4
7362723|NCT01032915|11609958|FG000|Overall Study|Protocol Violation|1
7362724|NCT01032915|11609959|FG001|Overall Study|Protocol Violation|0
7362725|NCT01032915|11609960|FG002|Overall Study|Protocol Violation|0
7362726|NCT01032915|11609961|FG003|Overall Study|Protocol Violation|1
7386485|NCT01211522|11645116|FG000|Overall Study|Withdrawal by Subject|3
7386486|NCT01211522|11645117|FG001|Overall Study|Withdrawal by Subject|7
7386487|NCT01211522|11645118|FG002|Overall Study|Withdrawal by Subject|5
7386488|NCT01211535|11645128|FG000|Overall Study|Adverse Event|0
7386489|NCT01211535|11645129|FG001|Overall Study|Adverse Event|1
7386490|NCT01211613|11645149|FG000|Overall Study|Lost to Follow-up|2
7386491|NCT01211613|11645150|FG001|Overall Study|Lost to Follow-up|2
7386492|NCT01211613|11645151|FG002|Overall Study|Lost to Follow-up|2
7386493|NCT01211613|11645149|FG000|Overall Study|Withdrawal by Subject|1
7386494|NCT01211613|11645150|FG001|Overall Study|Withdrawal by Subject|0
7386495|NCT01211613|11645151|FG002|Overall Study|Withdrawal by Subject|0
7386496|NCT01211665|11645161|FG000|Overall Study|Withdrawal by Subject|1
7386497|NCT01211665|11645162|FG001|Overall Study|Withdrawal by Subject|0
7386498|NCT01211665|11645161|FG000|Overall Study|Death|1
7386499|NCT01211665|11645162|FG001|Overall Study|Death|0
7386500|NCT01211769|11645181|FG000|Overall Study|Lost to Follow-up|7
7386501|NCT01211769|11645182|FG001|Overall Study|Lost to Follow-up|9
7386502|NCT01211769|11645183|FG002|Overall Study|Lost to Follow-up|5
7386503|NCT01211769|11645184|FG003|Overall Study|Lost to Follow-up|9
7386504|NCT01211769|11645181|FG000|Overall Study|Physician Decision|2
7569746|NCT03465878|11946521|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7386505|NCT01211769|11645182|FG001|Overall Study|Physician Decision|0
7386506|NCT01211769|11645183|FG002|Overall Study|Physician Decision|2
7386507|NCT01211769|11645184|FG003|Overall Study|Physician Decision|1
7386508|NCT01211769|11645181|FG000|Overall Study|Adverse Event|0
7386509|NCT01211769|11645182|FG001|Overall Study|Adverse Event|1
7386510|NCT01211769|11645183|FG002|Overall Study|Adverse Event|1
7362727|NCT01033019|11610003|FG000|Overall Study|Withdrawal by Subject|1
7362728|NCT01033019|11610004|FG001|Overall Study|Withdrawal by Subject|0
7569747|NCT03465878|11946522|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
7569748|NCT03465878|11946519|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7569749|NCT03465878|11946520|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7569750|NCT03465878|11946521|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
7569751|NCT03465878|11946522|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
7569752|NCT03465878|11946519|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
7569753|NCT03465878|11946520|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
7569754|NCT03465878|11946521|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
7569755|NCT03465878|11946522|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
7569756|NCT03465904|11946550|FG000|Overall Study|Withdrawal by Subject|9
7362729|NCT01033071|11610014|FG000|Overall Study|Adverse Event|28
7362730|NCT01033071|11610015|FG001|Overall Study|Adverse Event|51
7362731|NCT01033071|11610016|FG002|Overall Study|Adverse Event|26
7569757|NCT03465904|11946551|FG001|Overall Study|Withdrawal by Subject|5
7362732|NCT01033071|11610014|FG000|Overall Study|Protocol Violation|0
7362733|NCT01033071|11610015|FG001|Overall Study|Protocol Violation|2
7362734|NCT01033071|11610016|FG002|Overall Study|Protocol Violation|1
7362735|NCT01033071|11610014|FG000|Overall Study|Lost to Follow-up|4
7362736|NCT01033071|11610015|FG001|Overall Study|Lost to Follow-up|5
7362737|NCT01033071|11610016|FG002|Overall Study|Lost to Follow-up|5
7362738|NCT01033071|11610014|FG000|Overall Study|Withdrawal by Subject|17
7362739|NCT01033071|11610015|FG001|Overall Study|Withdrawal by Subject|14
7362740|NCT01033071|11610016|FG002|Overall Study|Withdrawal by Subject|11
7362741|NCT01033071|11610014|FG000|Overall Study|Lack of Efficacy|0
7362742|NCT01033071|11610015|FG001|Overall Study|Lack of Efficacy|1
7362743|NCT01033071|11610016|FG002|Overall Study|Lack of Efficacy|1
7362744|NCT01033071|11610014|FG000|Overall Study|Other|6
7362745|NCT01033071|11610015|FG001|Overall Study|Other|4
7362746|NCT01033071|11610016|FG002|Overall Study|Other|3
7362747|NCT01033136|11610026|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
7362748|NCT01033136|11610027|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
7362749|NCT01033240|11610049|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
7362750|NCT01033240|11610050|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
7362751|NCT01033240|11610051|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
7362752|NCT01033240|11610049|FG000|Overall Study|Death|2
7362753|NCT01033240|11610050|FG001|Overall Study|Death|0
7362754|NCT01033240|11610051|FG002|Overall Study|Death|0
7362755|NCT01033240|11610049|FG000|Overall Study|Withdrew Consent|2
7362756|NCT01033240|11610050|FG001|Overall Study|Withdrew Consent|9
7362757|NCT01033240|11610051|FG002|Overall Study|Withdrew Consent|2
7362758|NCT01033240|11610049|FG000|Overall Study|Disease Progression|35
7362759|NCT01033240|11610050|FG001|Overall Study|Disease Progression|32
7362760|NCT01033240|11610051|FG002|Overall Study|Disease Progression|41
7362761|NCT01033240|11610049|FG000|Overall Study|Investigator Discretion|0
7362762|NCT01033240|11610050|FG001|Overall Study|Investigator Discretion|0
7362763|NCT01033240|11610051|FG002|Overall Study|Investigator Discretion|2
7362764|NCT01033240|11610049|FG000|Overall Study|Other|0
7362765|NCT01033240|11610050|FG001|Overall Study|Other|1
7362766|NCT01033240|11610051|FG002|Overall Study|Other|2
7362767|NCT01033448|11610089|FG000|Overall Study|Withdrawal by Subject|4
7362768|NCT01033448|11610089|FG000|Overall Study|Positive HCV-RNA at week 48|1
7362769|NCT01033448|11610089|FG000|Overall Study|Lost to Follow-up|3
7362770|NCT01033448|11610089|FG000|Overall Study|Withdrew due to other reasons|3
7362771|NCT01033448|11610089|FG000|Overall Study|Unknown disposition|1
7362772|NCT01033487|11610095|FG000|Fourth Intervention Period|Adverse Event|0
7362773|NCT01033487|11610096|FG001|Fourth Intervention Period|Adverse Event|0
7362774|NCT01033487|11610097|FG002|Fourth Intervention Period|Adverse Event|0
7362775|NCT01033487|11610098|FG003|Fourth Intervention Period|Adverse Event|0
7362776|NCT01033487|11610099|FG004|Fourth Intervention Period|Adverse Event|0
7362777|NCT01033487|11610100|FG005|Fourth Intervention Period|Adverse Event|0
7362778|NCT01033487|11610101|FG006|Fourth Intervention Period|Adverse Event|0
7362779|NCT01033487|11610102|FG007|Fourth Intervention Period|Adverse Event|0
7362780|NCT01033487|11610103|FG008|Fourth Intervention Period|Adverse Event|1
7362781|NCT01033487|11610104|FG009|Fourth Intervention Period|Adverse Event|0
7362782|NCT01033643|11610127|FG000|Overall Study|Withdrew Consent|0
7362783|NCT01033643|11610128|FG001|Overall Study|Withdrew Consent|3
7362784|NCT01033643|11610129|FG002|Overall Study|Withdrew Consent|0
7362785|NCT01033643|11610130|FG003|Overall Study|Withdrew Consent|0
7362786|NCT01033643|11610131|FG004|Overall Study|Withdrew Consent|0
7362787|NCT01033643|11610132|FG005|Overall Study|Withdrew Consent|1
7569758|NCT03465904|11946550|FG000|Overall Study|Lost to Follow-up|10
7569759|NCT03465904|11946551|FG001|Overall Study|Lost to Follow-up|9
7362788|NCT01033734|11610146|FG000|Overall Study|Withdrawal by Subject|1
7362789|NCT01033747|11610161|FG000|Overall Study|Adverse Event|9
7362790|NCT01033747|11610162|FG001|Overall Study|Adverse Event|4
7362791|NCT01033747|11610161|FG000|Overall Study|Abnormal Laboratory Value|1
7362792|NCT01033747|11610162|FG001|Overall Study|Abnormal Laboratory Value|0
7362793|NCT01033747|11610161|FG000|Overall Study|Abnormal test procedure|0
7362794|NCT01033747|11610162|FG001|Overall Study|Abnormal test procedure|1
7362795|NCT01033747|11610161|FG000|Overall Study|Unsatisfactory therapeutic effect|14
7362796|NCT01033747|11610162|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7362797|NCT01033747|11610161|FG000|Overall Study|Protocol Violation|1
7362798|NCT01033747|11610162|FG001|Overall Study|Protocol Violation|0
7362799|NCT01033747|11610161|FG000|Overall Study|Withdrawal by Subject|9
7362800|NCT01033747|11610162|FG001|Overall Study|Withdrawal by Subject|6
7362801|NCT01033747|11610161|FG000|Overall Study|Stopped at end of prolongation visit 1|1
7362802|NCT01033747|11610162|FG001|Overall Study|Stopped at end of prolongation visit 1|0
7362803|NCT01033747|11610161|FG000|Overall Study|Stopped at end of Extension 1|2
7362804|NCT01033747|11610162|FG001|Overall Study|Stopped at end of Extension 1|0
7362805|NCT01033825|11610179|FG000|Overall Study|Withdrawal by Subject|2
7362806|NCT01033825|11610180|FG001|Overall Study|Withdrawal by Subject|3
7362807|NCT01033825|11610181|FG002|Overall Study|Withdrawal by Subject|2
7362808|NCT01033825|11610182|FG003|Overall Study|Withdrawal by Subject|1
7362809|NCT01033825|11610183|FG004|Overall Study|Withdrawal by Subject|1
7362810|NCT01033825|11610184|FG005|Overall Study|Withdrawal by Subject|0
7362811|NCT01033825|11610185|FG006|Overall Study|Withdrawal by Subject|0
7362812|NCT01033825|11610179|FG000|Overall Study|Adverse Event|0
7362813|NCT01033825|11610180|FG001|Overall Study|Adverse Event|0
7362814|NCT01033825|11610181|FG002|Overall Study|Adverse Event|0
7362815|NCT01033825|11610182|FG003|Overall Study|Adverse Event|1
7362816|NCT01033825|11610183|FG004|Overall Study|Adverse Event|0
7362817|NCT01033825|11610184|FG005|Overall Study|Adverse Event|0
7362818|NCT01033825|11610185|FG006|Overall Study|Adverse Event|0
7362819|NCT01033825|11610179|FG000|Overall Study|Protocol Violation|1
7362820|NCT01033825|11610180|FG001|Overall Study|Protocol Violation|0
7362821|NCT01033825|11610181|FG002|Overall Study|Protocol Violation|0
7362822|NCT01033825|11610182|FG003|Overall Study|Protocol Violation|0
7362823|NCT01033825|11610183|FG004|Overall Study|Protocol Violation|0
7362824|NCT01033825|11610184|FG005|Overall Study|Protocol Violation|0
7362825|NCT01033825|11610185|FG006|Overall Study|Protocol Violation|0
7362826|NCT01033825|11610179|FG000|Overall Study|Other|0
7362827|NCT01033825|11610180|FG001|Overall Study|Other|0
7362828|NCT01033825|11610181|FG002|Overall Study|Other|0
7362829|NCT01033825|11610182|FG003|Overall Study|Other|0
7362830|NCT01033825|11610183|FG004|Overall Study|Other|1
7362831|NCT01033825|11610184|FG005|Overall Study|Other|0
7362832|NCT01033825|11610185|FG006|Overall Study|Other|0
7362833|NCT01033851|11610205|FG000|Overall Study|Withdrawal by Subject|3
7362834|NCT01033851|11610206|FG001|Overall Study|Withdrawal by Subject|7
7362835|NCT01033942|11610224|FG000|Overall Study|Withdrawal by Subject|1
7362836|NCT01033942|11610225|FG001|Overall Study|Withdrawal by Subject|1
7362837|NCT01033942|11610226|FG002|Overall Study|Withdrawal by Subject|1
7362838|NCT01033942|11610224|FG000|Overall Study|Lost to Follow-up|1
7362839|NCT01033942|11610225|FG001|Overall Study|Lost to Follow-up|0
7362840|NCT01033942|11610226|FG002|Overall Study|Lost to Follow-up|0
7362841|NCT01033942|11610224|FG000|Overall Study|Enrolled in Extension Study|0
7362842|NCT01033942|11610225|FG001|Overall Study|Enrolled in Extension Study|3
7362843|NCT01033942|11610226|FG002|Overall Study|Enrolled in Extension Study|0
7362844|NCT01034137|11610243|FG000|Overall Study|Adverse Event|9
7362845|NCT01034137|11610244|FG001|Overall Study|Adverse Event|10
7362846|NCT01034137|11610245|FG002|Overall Study|Adverse Event|8
7362847|NCT01034137|11610243|FG000|Overall Study|Withdrawal by Subject|4
7362848|NCT01034137|11610244|FG001|Overall Study|Withdrawal by Subject|3
7362849|NCT01034137|11610245|FG002|Overall Study|Withdrawal by Subject|3
7362850|NCT01034137|11610243|FG000|Overall Study|Lack of Efficacy|9
7362851|NCT01034137|11610244|FG001|Overall Study|Lack of Efficacy|4
7362852|NCT01034137|11610245|FG002|Overall Study|Lack of Efficacy|13
7362853|NCT01034137|11610243|FG000|Overall Study|Protocol Violation|2
7362854|NCT01034137|11610244|FG001|Overall Study|Protocol Violation|2
7362855|NCT01034137|11610245|FG002|Overall Study|Protocol Violation|1
7362856|NCT01034137|11610243|FG000|Overall Study|Refused treatment or did not cooperate|2
7362857|NCT01034137|11610244|FG001|Overall Study|Refused treatment or did not cooperate|0
7362858|NCT01034137|11610245|FG002|Overall Study|Refused treatment or did not cooperate|1
7362859|NCT01034137|11610243|FG000|Overall Study|Administrative or other|2
7362860|NCT01034137|11610244|FG001|Overall Study|Administrative or other|3
7362861|NCT01034137|11610245|FG002|Overall Study|Administrative or other|4
7362862|NCT01034163|11610256|FG000|Overall Study|Treatment completed as per protocol|8
7362863|NCT01034163|11610257|FG001|Overall Study|Treatment completed as per protocol|7
7362864|NCT01034163|11610256|FG000|Overall Study|Withdrawal by Subject|8
7362865|NCT01034163|11610257|FG001|Overall Study|Withdrawal by Subject|2
7362866|NCT01034163|11610256|FG000|Overall Study|Protocol deviation|1
7362867|NCT01034163|11610257|FG001|Overall Study|Protocol deviation|0
7362868|NCT01034163|11610256|FG000|Overall Study|Disease progression|3
7362869|NCT01034163|11610257|FG001|Overall Study|Disease progression|4
7362870|NCT01034163|11610256|FG000|Overall Study|Adverse Event|6
7362871|NCT01034163|11610257|FG001|Overall Study|Adverse Event|0
7362872|NCT01034163|11610256|FG000|Overall Study|Administrative problems|0
7362873|NCT01034163|11610257|FG001|Overall Study|Administrative problems|1
7362874|NCT01034163|11610256|FG000|Overall Study|Abnormal laboratory value|1
7362875|NCT01034163|11610257|FG001|Overall Study|Abnormal laboratory value|0
7362876|NCT01034176|11610265|FG000|Overall Study|Physician Decision|2
7362877|NCT01034176|11610266|FG001|Overall Study|Physician Decision|0
7362878|NCT01034176|11610265|FG000|Overall Study|Withdrawal by Subject|0
7362879|NCT01034176|11610266|FG001|Overall Study|Withdrawal by Subject|1
7362880|NCT01034176|11610265|FG000|Overall Study|Lost to Follow-up|0
7362881|NCT01034176|11610266|FG001|Overall Study|Lost to Follow-up|1
7362882|NCT01034358|11610272|FG000|Overall Study|Withdrawal by Subject|1
7362883|NCT01034358|11610272|FG000|Overall Study|Protocol Violation|1
7362884|NCT01034397|11610278|FG000|Overall Study|Lack of compliance|0
7362885|NCT01034397|11610279|FG001|Overall Study|Lack of compliance|1
7362886|NCT01034397|11610278|FG000|Overall Study|Lack of Efficacy|3
7362887|NCT01034397|11610279|FG001|Overall Study|Lack of Efficacy|0
7362888|NCT01034397|11610278|FG000|Overall Study|Adverse Event|4
7362889|NCT01034397|11610279|FG001|Overall Study|Adverse Event|0
7362890|NCT01034397|11610278|FG000|Overall Study|Other|0
7362891|NCT01034397|11610279|FG001|Overall Study|Other|1
7362892|NCT01034462|11610296|FG000|Overall Study|Adverse Event|7
7362893|NCT01034462|11610297|FG001|Overall Study|Adverse Event|17
7362894|NCT01034462|11610296|FG000|Overall Study|Lack of Efficacy|4
7362895|NCT01034462|11610297|FG001|Overall Study|Lack of Efficacy|4
7362896|NCT01034462|11610296|FG000|Overall Study|Protocol Violation|10
7362897|NCT01034462|11610297|FG001|Overall Study|Protocol Violation|7
7460315|NCT01826981|11755673|FG000|Overall Study|Lost to Follow-up|0
7460316|NCT01826981|11755674|FG001|Overall Study|Lost to Follow-up|0
7460317|NCT01826981|11755675|FG002|Overall Study|Lost to Follow-up|0
7460318|NCT01826981|11755676|FG003|Overall Study|Lost to Follow-up|0
7460319|NCT01826981|11755677|FG004|Overall Study|Lost to Follow-up|1
7460320|NCT01826981|11755678|FG005|Overall Study|Lost to Follow-up|1
7460321|NCT01826981|11755679|FG006|Overall Study|Lost to Follow-up|0
7460322|NCT01826981|11755680|FG007|Overall Study|Lost to Follow-up|1
7460323|NCT01826981|11755681|FG008|Overall Study|Lost to Follow-up|0
7460324|NCT01826981|11755682|FG009|Overall Study|Lost to Follow-up|1
7460325|NCT01826981|11755683|FG010|Overall Study|Lost to Follow-up|1
7460326|NCT01826981|11755684|FG011|Overall Study|Lost to Follow-up|1
7460327|NCT01826981|11755685|FG012|Overall Study|Lost to Follow-up|1
7460328|NCT01826981|11755686|FG013|Overall Study|Lost to Follow-up|0
7460329|NCT01826981|11755687|FG014|Overall Study|Lost to Follow-up|0
7460330|NCT01826981|11755673|FG000|Overall Study|Withdrew Consent|0
7460331|NCT01826981|11755674|FG001|Overall Study|Withdrew Consent|0
7460332|NCT01826981|11755675|FG002|Overall Study|Withdrew Consent|0
7460333|NCT01826981|11755676|FG003|Overall Study|Withdrew Consent|0
7460334|NCT01826981|11755677|FG004|Overall Study|Withdrew Consent|0
7460335|NCT01826981|11755678|FG005|Overall Study|Withdrew Consent|0
7460336|NCT01826981|11755679|FG006|Overall Study|Withdrew Consent|1
7460337|NCT01826981|11755680|FG007|Overall Study|Withdrew Consent|1
7460338|NCT01826981|11755681|FG008|Overall Study|Withdrew Consent|0
7460339|NCT01826981|11755682|FG009|Overall Study|Withdrew Consent|0
7460340|NCT01826981|11755683|FG010|Overall Study|Withdrew Consent|0
7460341|NCT01826981|11755684|FG011|Overall Study|Withdrew Consent|1
7460342|NCT01826981|11755685|FG012|Overall Study|Withdrew Consent|0
7460343|NCT01826981|11755686|FG013|Overall Study|Withdrew Consent|1
7460344|NCT01826981|11755687|FG014|Overall Study|Withdrew Consent|0
7460345|NCT01826981|11755673|FG000|Overall Study|Adverse Event|0
7460346|NCT01826981|11755674|FG001|Overall Study|Adverse Event|0
7460347|NCT01826981|11755675|FG002|Overall Study|Adverse Event|0
7460348|NCT01826981|11755676|FG003|Overall Study|Adverse Event|0
7460349|NCT01826981|11755677|FG004|Overall Study|Adverse Event|1
7460350|NCT01826981|11755678|FG005|Overall Study|Adverse Event|0
7460351|NCT01826981|11755679|FG006|Overall Study|Adverse Event|0
7460352|NCT01826981|11755680|FG007|Overall Study|Adverse Event|0
7460353|NCT01826981|11755681|FG008|Overall Study|Adverse Event|0
7460354|NCT01826981|11755682|FG009|Overall Study|Adverse Event|0
7460355|NCT01826981|11755683|FG010|Overall Study|Adverse Event|0
7460356|NCT01826981|11755684|FG011|Overall Study|Adverse Event|0
7460357|NCT01826981|11755685|FG012|Overall Study|Adverse Event|0
7460358|NCT01826981|11755686|FG013|Overall Study|Adverse Event|0
7460359|NCT01826981|11755687|FG014|Overall Study|Adverse Event|0
7460360|NCT01826981|11755673|FG000|Overall Study|Upper G-I Haemorrhage|0
7460361|NCT01826981|11755674|FG001|Overall Study|Upper G-I Haemorrhage|0
7460362|NCT01826981|11755675|FG002|Overall Study|Upper G-I Haemorrhage|0
7460363|NCT01826981|11755676|FG003|Overall Study|Upper G-I Haemorrhage|0
7460364|NCT01826981|11755677|FG004|Overall Study|Upper G-I Haemorrhage|0
7460365|NCT01826981|11755678|FG005|Overall Study|Upper G-I Haemorrhage|0
7460366|NCT01826981|11755679|FG006|Overall Study|Upper G-I Haemorrhage|0
7460367|NCT01826981|11755680|FG007|Overall Study|Upper G-I Haemorrhage|0
7460368|NCT01826981|11755681|FG008|Overall Study|Upper G-I Haemorrhage|0
7460369|NCT01826981|11755682|FG009|Overall Study|Upper G-I Haemorrhage|0
7460370|NCT01826981|11755683|FG010|Overall Study|Upper G-I Haemorrhage|0
7460371|NCT01826981|11755684|FG011|Overall Study|Upper G-I Haemorrhage|0
7362898|NCT01034462|11610296|FG000|Overall Study|Withdrawal by Subject|9
7362899|NCT01034462|11610297|FG001|Overall Study|Withdrawal by Subject|8
7362900|NCT01034462|11610296|FG000|Overall Study|Lost to Follow-up|14
7362901|NCT01034462|11610297|FG001|Overall Study|Lost to Follow-up|16
7460372|NCT01826981|11755685|FG012|Overall Study|Upper G-I Haemorrhage|0
7460373|NCT01826981|11755686|FG013|Overall Study|Upper G-I Haemorrhage|1
7460374|NCT01826981|11755687|FG014|Overall Study|Upper G-I Haemorrhage|0
7460375|NCT01826981|11755673|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
7362902|NCT01034462|11610296|FG000|Overall Study|Other reasons|1
7362903|NCT01034462|11610297|FG001|Overall Study|Other reasons|2
7460376|NCT01826981|11755674|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
7362904|NCT01034540|11610316|FG000|Overall Study|Adverse Event|0
7362905|NCT01034540|11610317|FG001|Overall Study|Adverse Event|1
7569760|NCT03465904|11946550|FG000|Overall Study|Protocol Violation|8
7569761|NCT03465904|11946551|FG001|Overall Study|Protocol Violation|5
7569762|NCT03465904|11946550|FG000|Overall Study|Ineligible for mITT analysis|62
7569763|NCT03465904|11946551|FG001|Overall Study|Ineligible for mITT analysis|47
7569764|NCT03466060|11946586|FG000|Period 1|Test Lens Damage|0
7569765|NCT03466060|11946587|FG001|Period 1|Test Lens Damage|2
7569766|NCT03466060|11946588|FG002|Period 1|Test Lens Damage|0
7569767|NCT03466060|11946589|FG003|Period 1|Test Lens Damage|0
7569768|NCT03466060|11946590|FG004|Period 1|Test Lens Damage|0
7362915|NCT01034657|11610373|FG000|Core Phase|Withdrawal by Subject|1
7362916|NCT01034657|11610374|FG001|Core Phase|Withdrawal by Subject|0
7362917|NCT01034657|11610375|FG002|Core Phase|Withdrawal by Subject|0
7362918|NCT01034657|11610373|FG000|Core Phase|Lack of Efficacy|2
7362919|NCT01034657|11610374|FG001|Core Phase|Lack of Efficacy|0
7362920|NCT01034657|11610375|FG002|Core Phase|Lack of Efficacy|0
7362921|NCT01034657|11610373|FG000|Core Phase|Abnormal laboratory value|1
7362922|NCT01034657|11610374|FG001|Core Phase|Abnormal laboratory value|0
7362923|NCT01034657|11610375|FG002|Core Phase|Abnormal laboratory value|0
7362924|NCT01034657|11610373|FG000|Core Phase|Adverse Event|8
7362925|NCT01034657|11610374|FG001|Core Phase|Adverse Event|0
7362926|NCT01034657|11610375|FG002|Core Phase|Adverse Event|0
7362927|NCT01034657|11610373|FG000|Core Phase|Protocol Violation|2
7362928|NCT01034657|11610374|FG001|Core Phase|Protocol Violation|0
7362929|NCT01034657|11610375|FG002|Core Phase|Protocol Violation|0
7362930|NCT01034657|11610373|FG000|Randomized Phase|Withdrawal by Subject|0
7362931|NCT01034657|11610374|FG001|Randomized Phase|Withdrawal by Subject|2
7362932|NCT01034657|11610375|FG002|Randomized Phase|Withdrawal by Subject|0
7362933|NCT01034657|11610373|FG000|Randomized Phase|Lack of Efficacy|5
7362934|NCT01034657|11610374|FG001|Randomized Phase|Lack of Efficacy|1
7362935|NCT01034657|11610375|FG002|Randomized Phase|Lack of Efficacy|0
7362936|NCT01034657|11610373|FG000|Randomized Phase|Abnormal laboratory value|0
7362937|NCT01034657|11610374|FG001|Randomized Phase|Abnormal laboratory value|1
7362938|NCT01034657|11610375|FG002|Randomized Phase|Abnormal laboratory value|0
7362939|NCT01034657|11610373|FG000|Randomized Phase|Adverse Event|0
7362940|NCT01034657|11610374|FG001|Randomized Phase|Adverse Event|2
7362941|NCT01034657|11610375|FG002|Randomized Phase|Adverse Event|1
7362942|NCT01034709|11610387|FG000|Overall Study|Protocol Violation|9
7362943|NCT01034709|11610388|FG001|Overall Study|Protocol Violation|16
7362944|NCT01035060|11610405|FG000|Overall Study|Lost to Follow-up|0
7362945|NCT01035060|11610406|FG001|Overall Study|Lost to Follow-up|7
7362946|NCT01035060|11610405|FG000|Overall Study|Did not quality after 2nd screening|14
7362947|NCT01035060|11610406|FG001|Overall Study|Did not quality after 2nd screening|1
7362948|NCT01035060|11610405|FG000|Overall Study|Withdrawal by Subject|8
7362949|NCT01035060|11610406|FG001|Overall Study|Withdrawal by Subject|6
7362950|NCT01035060|11610405|FG000|Overall Study|Physician Decision|2
7362951|NCT01035060|11610406|FG001|Overall Study|Physician Decision|0
7362952|NCT01035138|11610425|FG000|Overall Study|Adverse Event|4
7362953|NCT01035138|11610426|FG001|Overall Study|Adverse Event|0
7362954|NCT01035138|11610427|FG002|Overall Study|Adverse Event|2
7362955|NCT01035138|11610425|FG000|Overall Study|Caregiver Decision|2
7362956|NCT01035138|11610426|FG001|Overall Study|Caregiver Decision|0
7362957|NCT01035138|11610427|FG002|Overall Study|Caregiver Decision|1
7362958|NCT01035138|11610425|FG000|Overall Study|Withdrawal by Subject|1
7362959|NCT01035138|11610426|FG001|Overall Study|Withdrawal by Subject|0
7362960|NCT01035138|11610427|FG002|Overall Study|Withdrawal by Subject|0
7362961|NCT01035138|11610425|FG000|Overall Study|Physician Decision|0
7362962|NCT01035138|11610426|FG001|Overall Study|Physician Decision|0
7362963|NCT01035138|11610427|FG002|Overall Study|Physician Decision|1
7362964|NCT01035138|11610425|FG000|Overall Study|Sponsor Decision|66
7362965|NCT01035138|11610426|FG001|Overall Study|Sponsor Decision|60
7362966|NCT01035138|11610427|FG002|Overall Study|Sponsor Decision|42
7362967|NCT01035138|11610425|FG000|Overall Study|Lost to Follow-up|0
7362968|NCT01035138|11610426|FG001|Overall Study|Lost to Follow-up|0
7362969|NCT01035138|11610427|FG002|Overall Study|Lost to Follow-up|1
7362970|NCT01035229|11610448|FG000|Overall Study|Adverse Event|61
7362971|NCT01035229|11610449|FG001|Overall Study|Adverse Event|14
7362972|NCT01035229|11610448|FG000|Overall Study|Withdrawal by Subject|20
7362973|NCT01035229|11610449|FG001|Overall Study|Withdrawal by Subject|7
7362974|NCT01035229|11610448|FG000|Overall Study|Lost to Follow-up|1
7362975|NCT01035229|11610449|FG001|Overall Study|Lost to Follow-up|0
7362976|NCT01035229|11610448|FG000|Overall Study|Administrative problems|1
7362977|NCT01035229|11610449|FG001|Overall Study|Administrative problems|1
7362978|NCT01035229|11610448|FG000|Overall Study|Death|13
7362979|NCT01035229|11610449|FG001|Overall Study|Death|5
7362980|NCT01035229|11610448|FG000|Overall Study|New cancer therapy|2
7362981|NCT01035229|11610449|FG001|Overall Study|New cancer therapy|0
7362982|NCT01035229|11610448|FG000|Overall Study|Protocol Violation|0
7362983|NCT01035229|11610449|FG001|Overall Study|Protocol Violation|2
7362984|NCT01035229|11610448|FG000|Overall Study|Sponsor's decision to end study|3
7362985|NCT01035229|11610449|FG001|Overall Study|Sponsor's decision to end study|3
7362986|NCT01035229|11610448|FG000|Overall Study|Disease Progression|261
7362987|NCT01035229|11610449|FG001|Overall Study|Disease Progression|152
7362988|NCT01035255|11610459|FG000|Overall Study|Death|724
7569769|NCT03466060|11946591|FG005|Period 1|Test Lens Damage|0
7362989|NCT01035255|11610460|FG001|Overall Study|Death|844
7362990|NCT01035255|11610459|FG000|Overall Study|Lost to Follow-up|2
7362991|NCT01035255|11610460|FG001|Overall Study|Lost to Follow-up|5
7362992|NCT01035255|11610459|FG000|Overall Study|patient's request|15
7362993|NCT01035255|11610460|FG001|Overall Study|patient's request|13
7362994|NCT01035463|11610481|FG000|Overall Study|Adverse Event|0
7362995|NCT01035463|11610482|FG001|Overall Study|Adverse Event|0
7362996|NCT01035463|11610483|FG002|Overall Study|Adverse Event|4
7362997|NCT01035463|11610484|FG003|Overall Study|Adverse Event|1
7362998|NCT01035463|11610485|FG004|Overall Study|Adverse Event|5
7362999|NCT01035463|11610486|FG005|Overall Study|Adverse Event|7
7363000|NCT01035463|11610481|FG000|Overall Study|Withdrawal by Subject|0
7363001|NCT01035463|11610482|FG001|Overall Study|Withdrawal by Subject|2
7363002|NCT01035463|11610483|FG002|Overall Study|Withdrawal by Subject|1
7363003|NCT01035463|11610484|FG003|Overall Study|Withdrawal by Subject|0
7363004|NCT01035463|11610485|FG004|Overall Study|Withdrawal by Subject|1
7363005|NCT01035463|11610486|FG005|Overall Study|Withdrawal by Subject|4
7363006|NCT01035463|11610481|FG000|Overall Study|Disease progression|0
7363007|NCT01035463|11610482|FG001|Overall Study|Disease progression|0
7363008|NCT01035463|11610483|FG002|Overall Study|Disease progression|0
7363009|NCT01035463|11610484|FG003|Overall Study|Disease progression|0
7363010|NCT01035463|11610485|FG004|Overall Study|Disease progression|0
7363011|NCT01035463|11610486|FG005|Overall Study|Disease progression|3
7363012|NCT01035463|11610481|FG000|Overall Study|Other Malignancy|0
7363013|NCT01035463|11610482|FG001|Overall Study|Other Malignancy|0
7363014|NCT01035463|11610483|FG002|Overall Study|Other Malignancy|0
7363015|NCT01035463|11610484|FG003|Overall Study|Other Malignancy|0
7363016|NCT01035463|11610485|FG004|Overall Study|Other Malignancy|0
7363017|NCT01035463|11610486|FG005|Overall Study|Other Malignancy|2
7363018|NCT01035463|11610481|FG000|Overall Study|Other|0
7363019|NCT01035463|11610482|FG001|Overall Study|Other|0
7363020|NCT01035463|11610483|FG002|Overall Study|Other|0
7363021|NCT01035463|11610484|FG003|Overall Study|Other|1
7363022|NCT01035463|11610485|FG004|Overall Study|Other|0
7363023|NCT01035463|11610486|FG005|Overall Study|Other|2
7363024|NCT01035606|11610496|FG000|Overall Study|change in health, job demands,family|3
7363025|NCT01035606|11610497|FG001|Overall Study|change in health, job demands,family|3
7363026|NCT01035606|11610498|FG002|Overall Study|change in health, job demands,family|4
7363027|NCT01035905|11610554|FG000|Overall Study|Lack of Efficacy|1
7363028|NCT01035905|11610555|FG001|Overall Study|Lack of Efficacy|1
7363029|NCT01036022|11610577|FG000|Overall Study|Adverse Event|1
7363030|NCT01036022|11610578|FG001|Overall Study|Adverse Event|3
7363031|NCT01036022|11610579|FG002|Overall Study|Adverse Event|2
7363032|NCT01036022|11610580|FG003|Overall Study|Adverse Event|1
7363033|NCT01036022|11610581|FG004|Overall Study|Adverse Event|0
7363034|NCT01036022|11610582|FG005|Overall Study|Adverse Event|2
7363035|NCT01036022|11610577|FG000|Overall Study|Lack of Efficacy|1
7363036|NCT01036022|11610578|FG001|Overall Study|Lack of Efficacy|1
7533278|NCT02683941|11879548|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
7569770|NCT03466060|11946586|FG000|Period 1|Withdrawal by Subject|0
7569771|NCT03466060|11946587|FG001|Period 1|Withdrawal by Subject|0
7569772|NCT03466060|11946588|FG002|Period 1|Withdrawal by Subject|2
7569773|NCT03466060|11946589|FG003|Period 1|Withdrawal by Subject|0
7569774|NCT03466060|11946590|FG004|Period 1|Withdrawal by Subject|0
7569775|NCT03466060|11946591|FG005|Period 1|Withdrawal by Subject|0
7569776|NCT03466060|11946586|FG000|Period 1|Lost to Follow-up|0
7569777|NCT03466060|11946587|FG001|Period 1|Lost to Follow-up|0
7569778|NCT03466060|11946588|FG002|Period 1|Lost to Follow-up|0
7569779|NCT03466060|11946589|FG003|Period 1|Lost to Follow-up|1
7569780|NCT03466060|11946590|FG004|Period 1|Lost to Follow-up|0
7363037|NCT01036022|11610579|FG002|Overall Study|Lack of Efficacy|1
7363038|NCT01036022|11610580|FG003|Overall Study|Lack of Efficacy|0
7363039|NCT01036022|11610581|FG004|Overall Study|Lack of Efficacy|1
7363040|NCT01036022|11610582|FG005|Overall Study|Lack of Efficacy|1
7363041|NCT01036022|11610577|FG000|Overall Study|Physician Decision|0
7363042|NCT01036022|11610578|FG001|Overall Study|Physician Decision|0
7363043|NCT01036022|11610579|FG002|Overall Study|Physician Decision|1
7363044|NCT01036022|11610580|FG003|Overall Study|Physician Decision|0
7363045|NCT01036022|11610581|FG004|Overall Study|Physician Decision|0
7363046|NCT01036022|11610582|FG005|Overall Study|Physician Decision|0
7533279|NCT02683941|11879549|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
7533280|NCT02683941|11879548|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
7533281|NCT02683941|11879549|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
7533282|NCT02683941|11879548|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
7533283|NCT02683941|11879549|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
7533284|NCT02683941|11879548|FG000|Open-label Follow-up Phase|Other|8
7533285|NCT02683941|11879549|FG001|Open-label Follow-up Phase|Other|1
7533286|NCT02684097|11879570|FG000|Overall Study|Lack of Efficacy|13
7533287|NCT02684097|11879571|FG001|Overall Study|Lack of Efficacy|6
7533288|NCT02684279|11879596|FG000|Overall Study|Adverse Event|87
7569781|NCT03466060|11946591|FG005|Period 1|Lost to Follow-up|0
7363047|NCT01036022|11610577|FG000|Overall Study|Withdrawal by Subject|0
7363048|NCT01036022|11610578|FG001|Overall Study|Withdrawal by Subject|0
7363049|NCT01036022|11610579|FG002|Overall Study|Withdrawal by Subject|0
7363050|NCT01036022|11610580|FG003|Overall Study|Withdrawal by Subject|1
7569782|NCT03466060|11946586|FG000|Period 1|Grade 2 Conjunctivitis|0
7569783|NCT03466060|11946587|FG001|Period 1|Grade 2 Conjunctivitis|0
7569784|NCT03466060|11946588|FG002|Period 1|Grade 2 Conjunctivitis|1
7569785|NCT03466060|11946589|FG003|Period 1|Grade 2 Conjunctivitis|0
7569786|NCT03466060|11946590|FG004|Period 1|Grade 2 Conjunctivitis|0
7569787|NCT03466060|11946591|FG005|Period 1|Grade 2 Conjunctivitis|0
7569788|NCT03466060|11946586|FG000|Period 2|Lens Handling Difficulties|0
7569789|NCT03466060|11946587|FG001|Period 2|Lens Handling Difficulties|0
7569790|NCT03466060|11946588|FG002|Period 2|Lens Handling Difficulties|1
7569791|NCT03466060|11946589|FG003|Period 2|Lens Handling Difficulties|0
7569792|NCT03466060|11946590|FG004|Period 2|Lens Handling Difficulties|0
7569793|NCT03466060|11946591|FG005|Period 2|Lens Handling Difficulties|0
7569794|NCT03466073|11946611|FG000|Overall Study|Death|1
7569795|NCT03466073|11946612|FG001|Overall Study|Death|0
7569796|NCT03466073|11946613|FG002|Overall Study|Death|0
7363051|NCT01036022|11610581|FG004|Overall Study|Withdrawal by Subject|2
7363052|NCT01036022|11610582|FG005|Overall Study|Withdrawal by Subject|0
7363053|NCT01036165|11610604|FG000|Overall Study|Adverse Event|6
7363054|NCT01036165|11610604|FG000|Overall Study|Lost to Follow-up|2
7363055|NCT01036165|11610604|FG000|Overall Study|Withdrawal by Subject|3
7363056|NCT01036165|11610604|FG000|Overall Study|Device Related Issues|3
7363057|NCT01036165|11610604|FG000|Overall Study|Problems finding proper area to inject|1
7363058|NCT01036321|11610610|FG000|Overall Study|Ineligible after randomization|0
7363059|NCT01036321|11610611|FG001|Overall Study|Ineligible after randomization|1
7363060|NCT01036321|11610610|FG000|Overall Study|Withdrawal by Subject|3
7363061|NCT01036321|11610611|FG001|Overall Study|Withdrawal by Subject|2
7363062|NCT01036321|11610610|FG000|Overall Study|Adverse Event|2
7363063|NCT01036321|11610611|FG001|Overall Study|Adverse Event|1
7363064|NCT01036438|11610619|FG000|Overall Study|Adverse Event|7
7363065|NCT01036438|11610620|FG001|Overall Study|Adverse Event|8
7363066|NCT01036438|11610619|FG000|Overall Study|Death|0
7363067|NCT01036438|11610620|FG001|Overall Study|Death|1
7363068|NCT01036438|11610619|FG000|Overall Study|No effect of study treatment|3
7363069|NCT01036438|11610620|FG001|Overall Study|No effect of study treatment|1
7363070|NCT01036529|11610637|FG000|Overall Study|Adverse Event|0
7363071|NCT01036529|11610638|FG001|Overall Study|Adverse Event|1
7363072|NCT01036529|11610637|FG000|Overall Study|Lost to Follow-up|0
7363073|NCT01036529|11610638|FG001|Overall Study|Lost to Follow-up|1
7363074|NCT01036529|11610637|FG000|Overall Study|Physician Decision|1
7363075|NCT01036529|11610638|FG001|Overall Study|Physician Decision|0
7363076|NCT01036529|11610637|FG000|Overall Study|Withdrawal by Subject|1
7363077|NCT01036529|11610638|FG001|Overall Study|Withdrawal by Subject|1
7363078|NCT01036529|11610637|FG000|Overall Study|Sponsor study termination|11
7363079|NCT01036529|11610638|FG001|Overall Study|Sponsor study termination|12
7363080|NCT01036594|11610644|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
7363081|NCT01036594|11610645|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
7363082|NCT01036594|11610644|FG000|First Treatment Regimen|Withdrawal by Subject|1
7363083|NCT01036594|11610645|FG001|First Treatment Regimen|Withdrawal by Subject|0
7363084|NCT01036594|11610644|FG000|Week 12 Evaluation|Adverse Event|5
7363085|NCT01036594|11610645|FG001|Week 12 Evaluation|Adverse Event|0
7363086|NCT01036594|11610644|FG000|Week 12 Evaluation|Physician Decision|1
7363087|NCT01036594|11610645|FG001|Week 12 Evaluation|Physician Decision|0
7363088|NCT01036594|11610644|FG000|Treatment Regiments Post Week 12|Physician Decision|1
7363089|NCT01036594|11610645|FG001|Treatment Regiments Post Week 12|Physician Decision|1
7363090|NCT01036594|11610644|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
7363091|NCT01036594|11610645|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
7363092|NCT01036594|11610644|FG000|Treatment Regiments Post Week 12|Adverse Event|0
7363093|NCT01036594|11610645|FG001|Treatment Regiments Post Week 12|Adverse Event|1
7363094|NCT01036594|11610644|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
7363095|NCT01036594|11610645|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
7363096|NCT01036594|11610644|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
7363097|NCT01036594|11610645|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
7363098|NCT01036724|11610653|FG000|Overall Study|Adverse Event|1
7363099|NCT01036724|11610654|FG001|Overall Study|Adverse Event|2
7363100|NCT01036724|11610653|FG000|Overall Study|Lack of Efficacy|1
7363101|NCT01036724|11610654|FG001|Overall Study|Lack of Efficacy|1
7363102|NCT01036724|11610653|FG000|Overall Study|Protocol Violation|4
7363103|NCT01036724|11610654|FG001|Overall Study|Protocol Violation|5
7363104|NCT01036763|11610660|FG000|Overall Study|Adverse Event|25
7363105|NCT01036763|11610660|FG000|Overall Study|Lost to Follow-up|28
7363106|NCT01036763|11610660|FG000|Overall Study|Other reason (not specified)|40
7363107|NCT01037088|11610674|FG000|Overall Study|Withdrawal by Subject|3
7363108|NCT01037114|11610683|FG000|Year 20|Others|1
7569797|NCT03466073|11946614|FG003|Overall Study|Death|0
7363109|NCT01037127|11610689|FG000|Overall Study|Lost to Follow-up|2
7363110|NCT01037127|11610690|FG001|Overall Study|Lost to Follow-up|4
7569798|NCT03466073|11946615|FG004|Overall Study|Death|0
7569799|NCT03466073|11946616|FG005|Overall Study|Death|1
7569800|NCT03466086|11946637|FG000|Period 1|Sponsor decision due to study timeline|1
7569801|NCT03466086|11946638|FG001|Period 1|Sponsor decision due to study timeline|0
7569802|NCT03466086|11946637|FG000|Period 1|Withdrawal by Subject|1
7569803|NCT03466086|11946638|FG001|Period 1|Withdrawal by Subject|0
7569804|NCT03466099|11946647|FG000|Overall Study|Adverse Event|1
7363111|NCT01037127|11610689|FG000|Overall Study|Physician Decision|1
7363112|NCT01037127|11610690|FG001|Overall Study|Physician Decision|0
7363113|NCT01037127|11610689|FG000|Overall Study|Study Closed Terminated|2
7363114|NCT01037127|11610690|FG001|Overall Study|Study Closed Terminated|17
7363115|NCT01037218|11610721|FG000|Overall Study|Adverse Event|4
7363116|NCT01037218|11610722|FG001|Overall Study|Adverse Event|2
7363117|NCT01037218|11610723|FG002|Overall Study|Adverse Event|2
7363118|NCT01037218|11610724|FG003|Overall Study|Adverse Event|1
7363119|NCT01037218|11610721|FG000|Overall Study|Lack of Efficacy|0
7363120|NCT01037218|11610722|FG001|Overall Study|Lack of Efficacy|2
7363121|NCT01037218|11610723|FG002|Overall Study|Lack of Efficacy|1
7363122|NCT01037218|11610724|FG003|Overall Study|Lack of Efficacy|5
7363123|NCT01037218|11610721|FG000|Overall Study|Lost to Follow-up|3
7363124|NCT01037218|11610722|FG001|Overall Study|Lost to Follow-up|5
7363125|NCT01037218|11610723|FG002|Overall Study|Lost to Follow-up|4
7363126|NCT01037218|11610724|FG003|Overall Study|Lost to Follow-up|2
7363127|NCT01037218|11610721|FG000|Overall Study|Withdrawal by Subject|6
7363128|NCT01037218|11610722|FG001|Overall Study|Withdrawal by Subject|7
7363129|NCT01037218|11610723|FG002|Overall Study|Withdrawal by Subject|7
7363130|NCT01037218|11610724|FG003|Overall Study|Withdrawal by Subject|4
7363131|NCT01037218|11610721|FG000|Overall Study|Partner Withdrew Consent|0
7363132|NCT01037218|11610722|FG001|Overall Study|Partner Withdrew Consent|3
7363133|NCT01037218|11610723|FG002|Overall Study|Partner Withdrew Consent|2
7363134|NCT01037218|11610724|FG003|Overall Study|Partner Withdrew Consent|1
7363135|NCT01037218|11610721|FG000|Overall Study|Protocol Violation|0
7363136|NCT01037218|11610722|FG001|Overall Study|Protocol Violation|0
7569805|NCT03466099|11946648|FG001|Overall Study|Adverse Event|1
7569806|NCT03466099|11946649|FG002|Overall Study|Adverse Event|1
7569807|NCT03466099|11946647|FG000|Overall Study|Withdrawal by Subject|2
7569808|NCT03466099|11946648|FG001|Overall Study|Withdrawal by Subject|3
7569809|NCT03466099|11946649|FG002|Overall Study|Withdrawal by Subject|1
7363137|NCT01037218|11610723|FG002|Overall Study|Protocol Violation|2
7363138|NCT01037218|11610724|FG003|Overall Study|Protocol Violation|2
7363139|NCT01037218|11610721|FG000|Overall Study|Various|3
7363140|NCT01037218|11610722|FG001|Overall Study|Various|2
7363141|NCT01037218|11610723|FG002|Overall Study|Various|3
7363142|NCT01037218|11610724|FG003|Overall Study|Various|1
7363143|NCT01037244|11610738|FG000|Overall Study|Adverse Event|3
7363144|NCT01037244|11610739|FG001|Overall Study|Adverse Event|2
7363145|NCT01037244|11610740|FG002|Overall Study|Adverse Event|6
7363146|NCT01037244|11610741|FG003|Overall Study|Adverse Event|3
7363147|NCT01037244|11610738|FG000|Overall Study|Lack of Efficacy|1
7363148|NCT01037244|11610739|FG001|Overall Study|Lack of Efficacy|1
7363149|NCT01037244|11610740|FG002|Overall Study|Lack of Efficacy|0
7363150|NCT01037244|11610741|FG003|Overall Study|Lack of Efficacy|1
7363151|NCT01037244|11610738|FG000|Overall Study|Lost to Follow-up|3
7363152|NCT01037244|11610739|FG001|Overall Study|Lost to Follow-up|3
7363153|NCT01037244|11610740|FG002|Overall Study|Lost to Follow-up|4
7363154|NCT01037244|11610741|FG003|Overall Study|Lost to Follow-up|4
7363155|NCT01037244|11610738|FG000|Overall Study|Withdrawal by Subject|1
7363156|NCT01037244|11610739|FG001|Overall Study|Withdrawal by Subject|5
7363157|NCT01037244|11610740|FG002|Overall Study|Withdrawal by Subject|3
7363158|NCT01037244|11610741|FG003|Overall Study|Withdrawal by Subject|5
7363159|NCT01037244|11610738|FG000|Overall Study|Partner Withdrew Consent|2
7363160|NCT01037244|11610739|FG001|Overall Study|Partner Withdrew Consent|1
7363161|NCT01037244|11610740|FG002|Overall Study|Partner Withdrew Consent|0
7363162|NCT01037244|11610741|FG003|Overall Study|Partner Withdrew Consent|0
7363163|NCT01037244|11610738|FG000|Overall Study|Various|3
7363164|NCT01037244|11610739|FG001|Overall Study|Various|2
7363165|NCT01037244|11610740|FG002|Overall Study|Various|1
7363166|NCT01037244|11610741|FG003|Overall Study|Various|1
7363167|NCT01037413|11610788|FG000|Part A: Skin Testing|Adverse Event|1
7363168|NCT01037413|11610789|FG001|Part A: Skin Testing|Adverse Event|0
7363169|NCT01037413|11610788|FG000|Part A: Skin Testing|Protocol Violation|1
7363170|NCT01037413|11610789|FG001|Part A: Skin Testing|Protocol Violation|0
7363171|NCT01037413|11610788|FG000|Part B: Scar Revision|Withdrawal by Subject|0
7363172|NCT01037413|11610789|FG001|Part B: Scar Revision|Withdrawal by Subject|1
7363173|NCT01037413|11610788|FG000|Part B: Scar Revision|Assigned But Not Treated|0
7363174|NCT01037413|11610789|FG001|Part B: Scar Revision|Assigned But Not Treated|1
7363175|NCT01037985|11610878|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
7363176|NCT01037985|11610879|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
7363177|NCT01037985|11610878|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
7363178|NCT01037985|11610879|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
7363179|NCT01037985|11610878|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
7363180|NCT01037985|11610879|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
7363181|NCT01037985|11610878|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
7363182|NCT01037985|11610879|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
7363183|NCT01038128|11610889|FG000|Overall Study|Lack of Efficacy|1
7363184|NCT01038128|11610889|FG000|Overall Study|Lost to Follow-up|1
7363185|NCT01038128|11610889|FG000|Overall Study|Withdrawal by Subject|2
7363186|NCT01038297|11610898|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
7569810|NCT03466099|11946647|FG000|Overall Study|Use of rescue medication|8
7569811|NCT03466099|11946648|FG001|Overall Study|Use of rescue medication|9
7363187|NCT01038297|11610899|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7363188|NCT01038297|11610900|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
7363189|NCT01038323|11610920|FG000|Overall Study|Withdrawal by Subject|3
7363190|NCT01038323|11610921|FG001|Overall Study|Withdrawal by Subject|2
7363191|NCT01038323|11610922|FG002|Overall Study|Withdrawal by Subject|4
7363192|NCT01038427|11610951|FG000|Overall Study|Lost to follow up|1
7363193|NCT01038427|11610952|FG001|Overall Study|Lost to follow up|1
7363194|NCT01038427|11610953|FG002|Overall Study|Lost to follow up|0
7363195|NCT01038427|11610951|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7363196|NCT01038427|11610952|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
7363197|NCT01038427|11610953|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
7363198|NCT01038427|11610951|FG000|Overall Study|Withdrew consent|0
7363199|NCT01038427|11610952|FG001|Overall Study|Withdrew consent|0
7363200|NCT01038427|11610953|FG002|Overall Study|Withdrew consent|1
7363201|NCT01038427|11610951|FG000|Overall Study|Adverse Event|2
7363202|NCT01038427|11610952|FG001|Overall Study|Adverse Event|2
7363203|NCT01038427|11610953|FG002|Overall Study|Adverse Event|1
7363204|NCT01038427|11610951|FG000|Overall Study|Enrolled in error|0
7363205|NCT01038427|11610952|FG001|Overall Study|Enrolled in error|1
7363206|NCT01038427|11610953|FG002|Overall Study|Enrolled in error|1
7363207|NCT01038427|11610951|FG000|Overall Study|Other|0
7363208|NCT01038427|11610952|FG001|Overall Study|Other|2
7363209|NCT01038427|11610953|FG002|Overall Study|Other|0
7363210|NCT01038609|11610979|FG000|Overall Study|Adverse Event|0
7363211|NCT01038609|11610980|FG001|Overall Study|Adverse Event|0
7363212|NCT01038609|11610981|FG002|Overall Study|Adverse Event|1
7363213|NCT01038609|11610982|FG003|Overall Study|Adverse Event|0
7363214|NCT01038609|11610983|FG004|Overall Study|Adverse Event|0
7363215|NCT01038609|11610979|FG000|Overall Study|Dosing Error|0
7363216|NCT01038609|11610980|FG001|Overall Study|Dosing Error|0
7363217|NCT01038609|11610981|FG002|Overall Study|Dosing Error|0
7363218|NCT01038609|11610982|FG003|Overall Study|Dosing Error|1
7363219|NCT01038609|11610983|FG004|Overall Study|Dosing Error|1
7363220|NCT01038609|11610979|FG000|Overall Study|Death in the Family|1
7363221|NCT01038609|11610980|FG001|Overall Study|Death in the Family|0
7363222|NCT01038609|11610981|FG002|Overall Study|Death in the Family|0
7363223|NCT01038609|11610982|FG003|Overall Study|Death in the Family|0
7363224|NCT01038609|11610983|FG004|Overall Study|Death in the Family|0
7363225|NCT01038609|11610979|FG000|Overall Study|Refusal of Blood Draws|0
7363226|NCT01038609|11610980|FG001|Overall Study|Refusal of Blood Draws|1
7363227|NCT01038609|11610981|FG002|Overall Study|Refusal of Blood Draws|0
7363228|NCT01038609|11610982|FG003|Overall Study|Refusal of Blood Draws|0
7363229|NCT01038609|11610983|FG004|Overall Study|Refusal of Blood Draws|0
7363230|NCT01038635|11611004|FG000|Overall Study|Disease Progression|2
7363231|NCT01038635|11611005|FG001|Overall Study|Disease Progression|0
7363232|NCT01038635|11611006|FG002|Overall Study|Disease Progression|0
7363233|NCT01038635|11611007|FG003|Overall Study|Disease Progression|0
7363234|NCT01038635|11611008|FG004|Overall Study|Disease Progression|0
7363235|NCT01038635|11611009|FG005|Overall Study|Disease Progression|0
7363236|NCT01038635|11611010|FG006|Overall Study|Disease Progression|1
7363237|NCT01038635|11611011|FG007|Overall Study|Disease Progression|4
7363238|NCT01038635|11611012|FG008|Overall Study|Disease Progression|0
7363239|NCT01038635|11611004|FG000|Overall Study|Death|0
7363240|NCT01038635|11611005|FG001|Overall Study|Death|0
7363241|NCT01038635|11611006|FG002|Overall Study|Death|0
7363242|NCT01038635|11611007|FG003|Overall Study|Death|0
7363243|NCT01038635|11611008|FG004|Overall Study|Death|1
7363244|NCT01038635|11611009|FG005|Overall Study|Death|0
7363245|NCT01038635|11611010|FG006|Overall Study|Death|1
7363246|NCT01038635|11611011|FG007|Overall Study|Death|1
7363247|NCT01038635|11611012|FG008|Overall Study|Death|2
7363248|NCT01038687|11611036|FG000|Overall Study|Adverse Event|0
7363249|NCT01038687|11611037|FG001|Overall Study|Adverse Event|2
7363250|NCT01038687|11611038|FG002|Overall Study|Adverse Event|1
7363251|NCT01038713|11611049|FG000|Overall Study|Patient to hospice|1
7363252|NCT01038713|11611050|FG001|Overall Study|Patient to hospice|1
7363253|NCT01038713|11611051|FG002|Overall Study|Patient to hospice|1
7363254|NCT01038713|11611049|FG000|Overall Study|Lost to Follow-up|3
7363255|NCT01038713|11611050|FG001|Overall Study|Lost to Follow-up|0
7363256|NCT01038713|11611051|FG002|Overall Study|Lost to Follow-up|0
7363257|NCT01038713|11611049|FG000|Overall Study|Neuroendocrine Tumor|0
7363258|NCT01038713|11611050|FG001|Overall Study|Neuroendocrine Tumor|1
7363259|NCT01038713|11611051|FG002|Overall Study|Neuroendocrine Tumor|0
7363260|NCT01038713|11611049|FG000|Overall Study|died from PEP|0
7363261|NCT01038713|11611050|FG001|Overall Study|died from PEP|1
7363262|NCT01038713|11611051|FG002|Overall Study|died from PEP|0
7363263|NCT01038713|11611049|FG000|Overall Study|Autoimmune Pancreatitis|1
7363264|NCT01038713|11611050|FG001|Overall Study|Autoimmune Pancreatitis|0
7363265|NCT01038713|11611051|FG002|Overall Study|Autoimmune Pancreatitis|0
7363266|NCT01038856|11611059|FG000|Overall Study|Adverse Event|2
7363267|NCT01038869|11611065|FG000|Overall Study|Withdrawal by Subject|1
7363268|NCT01038869|11611065|FG000|Overall Study|Lost to Follow-up|6
7363269|NCT01038921|11611075|FG000|Overall Study|Withdrawal by Subject|1
7363270|NCT01038921|11611076|FG001|Overall Study|Withdrawal by Subject|0
7363271|NCT01038921|11611075|FG000|Overall Study|Physician Decision|1
7363272|NCT01038921|11611076|FG001|Overall Study|Physician Decision|0
7363273|NCT01039376|11611088|FG000|Overall Study|Lost to Follow-up|5
7363274|NCT01039376|11611089|FG001|Overall Study|Lost to Follow-up|12
7363275|NCT01039376|11611088|FG000|Overall Study|Physician Decision|15
7363276|NCT01039376|11611089|FG001|Overall Study|Physician Decision|10
7363277|NCT01039376|11611088|FG000|Overall Study|Withdrawal by Subject|20
7363278|NCT01039376|11611089|FG001|Overall Study|Withdrawal by Subject|32
7363279|NCT01039376|11611088|FG000|Overall Study|Study terminated by Sponsor|90
7363280|NCT01039376|11611089|FG001|Overall Study|Study terminated by Sponsor|72
7363281|NCT01039428|11611098|FG000|Overall Study|Protocol Violation|1
7363282|NCT01039428|11611099|FG001|Overall Study|Protocol Violation|0
7363283|NCT01039428|11611098|FG000|Overall Study|Withdrawal by Subject|1
7363284|NCT01039428|11611099|FG001|Overall Study|Withdrawal by Subject|0
7363285|NCT01039519|11611116|FG000|Treatment|Progressive disease|20
7363286|NCT01039519|11611116|FG000|Treatment|Treatment failure|2
7363287|NCT01039519|11611116|FG000|Treatment|Adverse Event|3
7363288|NCT01039519|11611116|FG000|Treatment|Physician Decision|2
7363289|NCT01039519|11611116|FG000|Survival Follow-up|Death|23
7363290|NCT01039519|11611116|FG000|Survival Follow-up|Sponsor decision|4
7363291|NCT01039584|11611123|FG000|Overall Study|Withdrawal by Subject|4
7363292|NCT01039584|11611124|FG001|Overall Study|Withdrawal by Subject|2
7363293|NCT01039584|11611125|FG002|Overall Study|Withdrawal by Subject|1
7363294|NCT01039584|11611123|FG000|Overall Study|Protocol Violation|10
7363295|NCT01039584|11611124|FG001|Overall Study|Protocol Violation|4
7363296|NCT01039584|11611125|FG002|Overall Study|Protocol Violation|6
7363297|NCT01039584|11611123|FG000|Overall Study|Lost to Follow-up|5
7363298|NCT01039584|11611124|FG001|Overall Study|Lost to Follow-up|3
7363299|NCT01039584|11611125|FG002|Overall Study|Lost to Follow-up|4
7363300|NCT01039584|11611123|FG000|Overall Study|Negative Baseline culture for Candida|59
7363301|NCT01039584|11611124|FG001|Overall Study|Negative Baseline culture for Candida|59
7363302|NCT01039584|11611125|FG002|Overall Study|Negative Baseline culture for Candida|24
7363303|NCT01039584|11611123|FG000|Overall Study|Lack of Efficacy|7
7363304|NCT01039584|11611124|FG001|Overall Study|Lack of Efficacy|6
7363305|NCT01039584|11611125|FG002|Overall Study|Lack of Efficacy|10
7363306|NCT01039584|11611123|FG000|Overall Study|other|1
7363307|NCT01039584|11611124|FG001|Overall Study|other|3
7363308|NCT01039584|11611125|FG002|Overall Study|other|1
7363309|NCT01039584|11611123|FG000|Overall Study|Pap smear with significant pathology|10
7363310|NCT01039584|11611124|FG001|Overall Study|Pap smear with significant pathology|10
7363311|NCT01039584|11611125|FG002|Overall Study|Pap smear with significant pathology|3
7363312|NCT01039584|11611123|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
7363313|NCT01039584|11611124|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
7363314|NCT01039584|11611125|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
7363315|NCT01039675|11611135|FG000|Overall Study|Adverse Event|0
7363316|NCT01039675|11611136|FG001|Overall Study|Adverse Event|2
7363317|NCT01039675|11611135|FG000|Overall Study|Lack of Efficacy|0
7363318|NCT01039675|11611136|FG001|Overall Study|Lack of Efficacy|2
7363319|NCT01039675|11611135|FG000|Overall Study|Withdrawal by Subject|0
7363320|NCT01039675|11611136|FG001|Overall Study|Withdrawal by Subject|1
7363321|NCT01039675|11611135|FG000|Overall Study|Lost to Follow-up|0
7363322|NCT01039675|11611136|FG001|Overall Study|Lost to Follow-up|1
7363323|NCT01039675|11611135|FG000|Overall Study|Physician Decision|0
7363324|NCT01039675|11611136|FG001|Overall Study|Physician Decision|1
7363325|NCT01039688|11611145|FG000|Overall Study|Adverse Event|38
7363326|NCT01039688|11611146|FG001|Overall Study|Adverse Event|39
7363327|NCT01039688|11611147|FG002|Overall Study|Adverse Event|24
7363328|NCT01039688|11611145|FG000|Overall Study|Lack of Efficacy|20
7363329|NCT01039688|11611146|FG001|Overall Study|Lack of Efficacy|11
7363330|NCT01039688|11611147|FG002|Overall Study|Lack of Efficacy|26
7363331|NCT01039688|11611145|FG000|Overall Study|Lost to Follow-up|11
7363332|NCT01039688|11611146|FG001|Overall Study|Lost to Follow-up|9
7363333|NCT01039688|11611147|FG002|Overall Study|Lost to Follow-up|5
7363334|NCT01039688|11611145|FG000|Overall Study|Other|13
7363335|NCT01039688|11611146|FG001|Overall Study|Other|25
7363336|NCT01039688|11611147|FG002|Overall Study|Other|12
7363337|NCT01039688|11611145|FG000|Overall Study|Withdrawal by Subject|23
7363338|NCT01039688|11611146|FG001|Overall Study|Withdrawal by Subject|27
7363339|NCT01039688|11611147|FG002|Overall Study|Withdrawal by Subject|13
7363340|NCT01039688|11611145|FG000|Overall Study|Death|2
7363341|NCT01039688|11611146|FG001|Overall Study|Death|0
7363342|NCT01039688|11611147|FG002|Overall Study|Death|0
7363343|NCT01040130|11611171|FG000|Overall Study|Adverse Event|1
7363344|NCT01040130|11611172|FG001|Overall Study|Adverse Event|1
7363345|NCT01040130|11611173|FG002|Overall Study|Adverse Event|0
7363346|NCT01040130|11611174|FG003|Overall Study|Adverse Event|5
7363347|NCT01040130|11611175|FG004|Overall Study|Adverse Event|0
7363348|NCT01040130|11611176|FG005|Overall Study|Adverse Event|3
7363349|NCT01040130|11611171|FG000|Overall Study|Protocol Violation|0
7363350|NCT01040130|11611172|FG001|Overall Study|Protocol Violation|0
7363351|NCT01040130|11611173|FG002|Overall Study|Protocol Violation|2
7363352|NCT01040130|11611174|FG003|Overall Study|Protocol Violation|0
7363353|NCT01040130|11611175|FG004|Overall Study|Protocol Violation|0
7363354|NCT01040130|11611176|FG005|Overall Study|Protocol Violation|0
7363355|NCT01040130|11611171|FG000|Overall Study|Withdrawal by Subject|0
7363356|NCT01040130|11611172|FG001|Overall Study|Withdrawal by Subject|2
7363357|NCT01040130|11611173|FG002|Overall Study|Withdrawal by Subject|0
7363358|NCT01040130|11611174|FG003|Overall Study|Withdrawal by Subject|0
7363359|NCT01040130|11611175|FG004|Overall Study|Withdrawal by Subject|0
7363360|NCT01040130|11611176|FG005|Overall Study|Withdrawal by Subject|1
7363361|NCT01040130|11611171|FG000|Overall Study|Other reasons not listed above|2
7363362|NCT01040130|11611172|FG001|Overall Study|Other reasons not listed above|0
7363363|NCT01040130|11611173|FG002|Overall Study|Other reasons not listed above|0
7363364|NCT01040130|11611174|FG003|Overall Study|Other reasons not listed above|0
7363365|NCT01040130|11611175|FG004|Overall Study|Other reasons not listed above|0
7363366|NCT01040130|11611176|FG005|Overall Study|Other reasons not listed above|0
7363367|NCT01040169|11611188|FG000|Overall Study|Lost to Follow-up|3
7363368|NCT01040169|11611189|FG001|Overall Study|Lost to Follow-up|8
7386511|NCT01211769|11645184|FG003|Overall Study|Adverse Event|1
7386512|NCT01212094|11645211|FG000|Year 1: Baseline Monitoring|Study terminated|7
7386513|NCT01212094|11645212|FG001|Year 1: Baseline Monitoring|Study terminated|0
7386514|NCT01212094|11645213|FG002|Year 1: Baseline Monitoring|Study terminated|0
7386515|NCT01212094|11645211|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
7386516|NCT01212094|11645212|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7386517|NCT01212094|11645213|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
7386518|NCT01212094|11645211|FG000|Year 1: Baseline Monitoring|Started on DMT|2
7386519|NCT01212094|11645212|FG001|Year 1: Baseline Monitoring|Started on DMT|0
7386520|NCT01212094|11645213|FG002|Year 1: Baseline Monitoring|Started on DMT|0
7386521|NCT01212094|11645211|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
7386522|NCT01212094|11645212|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
7386523|NCT01212094|11645213|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
7386524|NCT01212094|11645211|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7386525|NCT01212094|11645212|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
7386526|NCT01212094|11645213|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
7386527|NCT01212094|11645211|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
7386528|NCT01212094|11645212|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
7386529|NCT01212094|11645213|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
7386530|NCT01212159|11645287|FG000|Overall Study|Withdrawal by Subject|12
7386531|NCT01212159|11645288|FG001|Overall Study|Withdrawal by Subject|12
7386532|NCT01212185|11645305|FG000|Overall Study|Protocol Violation|2
7386533|NCT01212185|11645306|FG001|Overall Study|Protocol Violation|1
7386534|NCT01212588|11645352|FG000|Overall Study|Physician Decision|0
7386535|NCT01212588|11645353|FG001|Overall Study|Physician Decision|1
7386536|NCT01212588|11645352|FG000|Overall Study|Protocol Violation|1
7386537|NCT01212588|11645353|FG001|Overall Study|Protocol Violation|1
7386538|NCT01212744|11645363|FG000|Overall Study|Withdrawal by Subject|1
7386539|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7386540|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7386541|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7386542|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386543|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386544|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386545|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386546|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386547|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386548|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7386549|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7386550|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7386551|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386552|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386553|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386554|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386555|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386556|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386557|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
7386558|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
7386559|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7386560|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386561|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386562|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386563|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386564|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386565|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386566|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
7386567|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386568|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7386569|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386570|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386571|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7363369|NCT01040260|11611215|FG000|Overall Study|Withdrawal by Subject|12
7363370|NCT01040260|11611216|FG001|Overall Study|Withdrawal by Subject|6
7363371|NCT01040260|11611215|FG000|Overall Study|Lost to Follow-up|3
7363372|NCT01040260|11611216|FG001|Overall Study|Lost to Follow-up|5
7363373|NCT01040351|11611224|FG000|Overall Study|poor ovarian response|1
7363374|NCT01040351|11611225|FG001|Overall Study|poor ovarian response|2
7363375|NCT01040403|11611231|FG000|Overall Study|Adverse Event|10
7363376|NCT01040403|11611231|FG000|Overall Study|Protocol Violation|2
7363377|NCT01040403|11611231|FG000|Overall Study|Lost to Follow-up|1
7363378|NCT01040403|11611231|FG000|Overall Study|Not treated|1
7363379|NCT01040403|11611231|FG000|Overall Study|Other reason not defined above|6
7363380|NCT01040689|11611250|FG000|Overall Study|Adverse Event|0
7363381|NCT01040689|11611251|FG001|Overall Study|Adverse Event|0
7363382|NCT01040689|11611252|FG002|Overall Study|Adverse Event|2
7363383|NCT01040689|11611253|FG003|Overall Study|Adverse Event|4
7363384|NCT01040689|11611250|FG000|Overall Study|Lack of Efficacy|0
7363385|NCT01040689|11611251|FG001|Overall Study|Lack of Efficacy|0
7363386|NCT01040689|11611252|FG002|Overall Study|Lack of Efficacy|1
7363387|NCT01040689|11611253|FG003|Overall Study|Lack of Efficacy|0
7363388|NCT01040689|11611250|FG000|Overall Study|Lost to Follow-up|1
7363389|NCT01040689|11611251|FG001|Overall Study|Lost to Follow-up|0
7363390|NCT01040689|11611252|FG002|Overall Study|Lost to Follow-up|0
7363391|NCT01040689|11611253|FG003|Overall Study|Lost to Follow-up|0
7363392|NCT01040689|11611250|FG000|Overall Study|Withdrawal by Subject|2
7363393|NCT01040689|11611251|FG001|Overall Study|Withdrawal by Subject|1
7363394|NCT01040689|11611252|FG002|Overall Study|Withdrawal by Subject|1
7363395|NCT01040689|11611253|FG003|Overall Study|Withdrawal by Subject|0
7363396|NCT01040689|11611250|FG000|Overall Study|Other reasons not listed above|0
7363397|NCT01040689|11611251|FG001|Overall Study|Other reasons not listed above|1
7363398|NCT01040689|11611252|FG002|Overall Study|Other reasons not listed above|0
7363399|NCT01040689|11611253|FG003|Overall Study|Other reasons not listed above|0
7363400|NCT01040728|11611268|FG000|Overall Study|Adverse Event|4
7363401|NCT01040728|11611269|FG001|Overall Study|Adverse Event|8
7363402|NCT01040728|11611270|FG002|Overall Study|Adverse Event|0
7363403|NCT01040728|11611271|FG003|Overall Study|Adverse Event|4
7363404|NCT01040728|11611268|FG000|Overall Study|Withdrawal by Subject|0
7363405|NCT01040728|11611269|FG001|Overall Study|Withdrawal by Subject|1
7363406|NCT01040728|11611270|FG002|Overall Study|Withdrawal by Subject|1
7363407|NCT01040728|11611271|FG003|Overall Study|Withdrawal by Subject|0
7363408|NCT01040728|11611268|FG000|Overall Study|Protocol Violation|0
7363409|NCT01040728|11611269|FG001|Overall Study|Protocol Violation|0
7363410|NCT01040728|11611270|FG002|Overall Study|Protocol Violation|0
7363411|NCT01040728|11611271|FG003|Overall Study|Protocol Violation|1
7363412|NCT01040728|11611268|FG000|Overall Study|Lack of Efficacy|0
7363413|NCT01040728|11611269|FG001|Overall Study|Lack of Efficacy|1
7363414|NCT01040728|11611270|FG002|Overall Study|Lack of Efficacy|0
7363415|NCT01040728|11611271|FG003|Overall Study|Lack of Efficacy|1
7363416|NCT01040728|11611268|FG000|Overall Study|Other reasons not listed above|0
7363417|NCT01040728|11611269|FG001|Overall Study|Other reasons not listed above|1
7363418|NCT01040728|11611270|FG002|Overall Study|Other reasons not listed above|0
7363419|NCT01040728|11611271|FG003|Overall Study|Other reasons not listed above|0
7363420|NCT01040780|11611289|FG000|Overall Study|Protocol Violation|1
7363421|NCT01040780|11611290|FG001|Overall Study|Protocol Violation|3
7363422|NCT01040793|11611299|FG000|Overall Study|Adverse Event|5
7363423|NCT01040793|11611300|FG001|Overall Study|Adverse Event|3
7363424|NCT01040793|11611301|FG002|Overall Study|Adverse Event|0
7460377|NCT01826981|11755675|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
7460378|NCT01826981|11755676|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
7460379|NCT01826981|11755677|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
7460380|NCT01826981|11755678|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
7460381|NCT01826981|11755679|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
7460382|NCT01826981|11755680|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
7460383|NCT01826981|11755681|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
7460384|NCT01826981|11755682|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
7460385|NCT01826981|11755683|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
7460386|NCT01826981|11755684|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
7460387|NCT01826981|11755685|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
7460388|NCT01826981|11755686|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
7460389|NCT01826981|11755687|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
7460390|NCT01827046|11755725|FG000|Overall Study|Lost to Follow-up|1
7460391|NCT01827046|11755726|FG001|Overall Study|Lost to Follow-up|5
7460392|NCT01827046|11755725|FG000|Overall Study|Withdrawal by Subject|0
7460393|NCT01827046|11755726|FG001|Overall Study|Withdrawal by Subject|4
7460394|NCT01827163|11755732|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
7460395|NCT01827163|11755732|FG000|Overall Study|Adverse Event|9
7460396|NCT01827254|11755736|FG000|Overall Study|Death|10
7533289|NCT02684279|11879596|FG000|Overall Study|Lack of Efficacy|4
7460397|NCT01827254|11755736|FG000|Overall Study|Case report form not completed|4
7460398|NCT01827254|11755736|FG000|Overall Study|Invalidated centre|3
7460399|NCT01827254|11755736|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
7460400|NCT01827254|11755736|FG000|Overall Study|Did not complete re-challenge|1
7460401|NCT01827254|11755736|FG000|Overall Study|Disease progression|36
7363425|NCT01040793|11611302|FG003|Overall Study|Adverse Event|2
7363426|NCT01040793|11611303|FG004|Overall Study|Adverse Event|2
7363427|NCT01040793|11611304|FG005|Overall Study|Adverse Event|1
7363428|NCT01040793|11611299|FG000|Overall Study|Protocol Violation|1
7363429|NCT01040793|11611300|FG001|Overall Study|Protocol Violation|1
7363430|NCT01040793|11611301|FG002|Overall Study|Protocol Violation|1
7363431|NCT01040793|11611302|FG003|Overall Study|Protocol Violation|0
7363432|NCT01040793|11611303|FG004|Overall Study|Protocol Violation|1
7363433|NCT01040793|11611304|FG005|Overall Study|Protocol Violation|0
7363434|NCT01040793|11611299|FG000|Overall Study|Lost to Follow-up|0
7363435|NCT01040793|11611300|FG001|Overall Study|Lost to Follow-up|1
7363436|NCT01040793|11611301|FG002|Overall Study|Lost to Follow-up|1
7363437|NCT01040793|11611302|FG003|Overall Study|Lost to Follow-up|0
7363438|NCT01040793|11611303|FG004|Overall Study|Lost to Follow-up|0
7363439|NCT01040793|11611304|FG005|Overall Study|Lost to Follow-up|0
7363440|NCT01040793|11611299|FG000|Overall Study|Withdrawal by Subject|0
7363441|NCT01040793|11611300|FG001|Overall Study|Withdrawal by Subject|0
7363442|NCT01040793|11611301|FG002|Overall Study|Withdrawal by Subject|0
7363443|NCT01040793|11611302|FG003|Overall Study|Withdrawal by Subject|2
7363444|NCT01040793|11611303|FG004|Overall Study|Withdrawal by Subject|0
7363445|NCT01040793|11611304|FG005|Overall Study|Withdrawal by Subject|0
7363446|NCT01040793|11611299|FG000|Overall Study|Other reasons not listed above|0
7363447|NCT01040793|11611300|FG001|Overall Study|Other reasons not listed above|0
7363448|NCT01040793|11611301|FG002|Overall Study|Other reasons not listed above|1
7363449|NCT01040793|11611302|FG003|Overall Study|Other reasons not listed above|0
7363450|NCT01040793|11611303|FG004|Overall Study|Other reasons not listed above|1
7363451|NCT01040793|11611304|FG005|Overall Study|Other reasons not listed above|0
7363452|NCT01040832|11611325|FG000|Overall Study|Adverse Event|4
7363453|NCT01040832|11611326|FG001|Overall Study|Adverse Event|5
7363454|NCT01040832|11611325|FG000|Overall Study|Death|4
7363455|NCT01040832|11611326|FG001|Overall Study|Death|6
7363456|NCT01040832|11611325|FG000|Overall Study|Withdrawal by Subject|2
7363457|NCT01040832|11611326|FG001|Overall Study|Withdrawal by Subject|3
7363458|NCT01040832|11611325|FG000|Overall Study|Progressive disease|32
7363459|NCT01040832|11611326|FG001|Overall Study|Progressive disease|17
7363460|NCT01040832|11611325|FG000|Overall Study|Symptomatic deterioration|2
7363461|NCT01040832|11611326|FG001|Overall Study|Symptomatic deterioration|5
7363462|NCT01040832|11611325|FG000|Overall Study|Other|2
7363463|NCT01040832|11611326|FG001|Overall Study|Other|1
7363464|NCT01040845|11611334|FG000|Overall Study|Withdrawal by Subject|1
7363465|NCT01040845|11611335|FG001|Overall Study|Withdrawal by Subject|1
7363466|NCT01040845|11611334|FG000|Overall Study|Physician Decision|1
7363467|NCT01040845|11611335|FG001|Overall Study|Physician Decision|0
7363468|NCT01040871|11611357|FG000|Overall Study|Adverse Event|6
7363469|NCT01040871|11611358|FG001|Overall Study|Adverse Event|2
7363470|NCT01040871|11611357|FG000|Overall Study|Withdrawal by Subject|2
7363471|NCT01040871|11611358|FG001|Overall Study|Withdrawal by Subject|0
7363472|NCT01040871|11611357|FG000|Overall Study|Death|1
7363473|NCT01040871|11611358|FG001|Overall Study|Death|3
7363474|NCT01040871|11611357|FG000|Overall Study|Lack of Efficacy|1
7363475|NCT01040871|11611358|FG001|Overall Study|Lack of Efficacy|1
7363476|NCT01040871|11611357|FG000|Overall Study|drug supply issue|1
7363477|NCT01040871|11611358|FG001|Overall Study|drug supply issue|0
7363478|NCT01040871|11611357|FG000|Overall Study|Randomized and Not Treated|2
7363479|NCT01040871|11611358|FG001|Overall Study|Randomized and Not Treated|1
7363480|NCT01041287|11611390|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7363481|NCT01041287|11611391|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
7363482|NCT01041287|11611390|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
7363483|NCT01041287|11611391|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
7363484|NCT01041404|11611399|FG000|Overall Study|Adverse Event|45
7363485|NCT01041404|11611400|FG001|Overall Study|Adverse Event|35
7363486|NCT01041404|11611399|FG000|Overall Study|Lack of Efficacy|200
7363487|NCT01041404|11611400|FG001|Overall Study|Lack of Efficacy|210
7363488|NCT01041404|11611399|FG000|Overall Study|Violation of Selection Criteria|0
7363489|NCT01041404|11611400|FG001|Overall Study|Violation of Selection Criteria|1
7363490|NCT01041404|11611399|FG000|Overall Study|Protocol Violation|4
7363491|NCT01041404|11611400|FG001|Overall Study|Protocol Violation|0
7363492|NCT01041404|11611399|FG000|Overall Study|Withdrawal by Subject|29
7363493|NCT01041404|11611400|FG001|Overall Study|Withdrawal by Subject|23
7363494|NCT01041404|11611399|FG000|Overall Study|Failure to Return|1
7363495|NCT01041404|11611400|FG001|Overall Study|Failure to Return|2
7363496|NCT01041404|11611399|FG000|Overall Study|Other|11
7363497|NCT01041404|11611400|FG001|Overall Study|Other|23
7363498|NCT01041417|11611411|FG000|Overall Study|Adverse Event|5
7363499|NCT01041417|11611412|FG001|Overall Study|Adverse Event|2
7363500|NCT01041417|11611411|FG000|Overall Study|Lost to Follow-up|1
7363501|NCT01041417|11611412|FG001|Overall Study|Lost to Follow-up|1
7363502|NCT01041417|11611411|FG000|Overall Study|Death|1
7363503|NCT01041417|11611412|FG001|Overall Study|Death|0
7363504|NCT01041495|11611422|FG000|Overall Study|Withdrawal by Subject|2
7363505|NCT01041495|11611423|FG001|Overall Study|Withdrawal by Subject|5
7363506|NCT01041495|11611422|FG000|Overall Study|Adverse Event|2
7363507|NCT01041495|11611423|FG001|Overall Study|Adverse Event|1
7363508|NCT01041495|11611422|FG000|Overall Study|Lost to Follow-up|0
7363509|NCT01041495|11611423|FG001|Overall Study|Lost to Follow-up|1
7363510|NCT01041573|11611442|FG000|Overall Study|Withdrawal by Subject|2
7363511|NCT01041573|11611443|FG001|Overall Study|Withdrawal by Subject|5
7363512|NCT01041573|11611444|FG002|Overall Study|Withdrawal by Subject|2
7363513|NCT01041573|11611445|FG003|Overall Study|Withdrawal by Subject|0
7363514|NCT01041573|11611442|FG000|Overall Study|Death|1
7363515|NCT01041573|11611443|FG001|Overall Study|Death|0
7363516|NCT01041573|11611444|FG002|Overall Study|Death|0
7363517|NCT01041573|11611445|FG003|Overall Study|Death|0
7363518|NCT01041573|11611442|FG000|Overall Study|Lost to Follow-up|0
7363519|NCT01041573|11611443|FG001|Overall Study|Lost to Follow-up|1
7363520|NCT01041573|11611444|FG002|Overall Study|Lost to Follow-up|2
7363521|NCT01041573|11611445|FG003|Overall Study|Lost to Follow-up|1
7363522|NCT01041573|11611442|FG000|Overall Study|Adverse Event|0
7363523|NCT01041573|11611443|FG001|Overall Study|Adverse Event|2
7363524|NCT01041573|11611444|FG002|Overall Study|Adverse Event|0
7363525|NCT01041573|11611445|FG003|Overall Study|Adverse Event|0
7363526|NCT01041573|11611442|FG000|Overall Study|relocation|1
7363527|NCT01041573|11611443|FG001|Overall Study|relocation|4
7363528|NCT01041573|11611444|FG002|Overall Study|relocation|3
7363529|NCT01041573|11611445|FG003|Overall Study|relocation|1
7363530|NCT01041573|11611442|FG000|Overall Study|further blood extraction|0
7363531|NCT01041573|11611443|FG001|Overall Study|further blood extraction|1
7363532|NCT01041573|11611444|FG002|Overall Study|further blood extraction|0
7363533|NCT01041573|11611445|FG003|Overall Study|further blood extraction|0
7363534|NCT01041573|11611442|FG000|Overall Study|positive to anti-HCV|1
7363535|NCT01041573|11611443|FG001|Overall Study|positive to anti-HCV|0
7363536|NCT01041573|11611444|FG002|Overall Study|positive to anti-HCV|0
7363537|NCT01041573|11611445|FG003|Overall Study|positive to anti-HCV|0
7363538|NCT01041638|11611464|FG000|Overall Study|Adverse Event|4
7363539|NCT01041638|11611464|FG000|Overall Study|Death|1
7363540|NCT01041638|11611464|FG000|Overall Study|Lack of Efficacy|7
7363541|NCT01041638|11611464|FG000|Overall Study|Physician Decision|4
7363542|NCT01041638|11611464|FG000|Overall Study|Withdrawal by Subject|11
7363543|NCT01041859|11611487|FG000|Open-Label Titration|Adverse Event|69
7363544|NCT01041859|11611488|FG001|Open-Label Titration|Adverse Event|0
7363545|NCT01041859|11611489|FG002|Open-Label Titration|Adverse Event|0
7363546|NCT01041859|11611487|FG000|Open-Label Titration|Lack of Efficacy|3
7363547|NCT01041859|11611488|FG001|Open-Label Titration|Lack of Efficacy|0
7363548|NCT01041859|11611489|FG002|Open-Label Titration|Lack of Efficacy|0
7363549|NCT01041859|11611487|FG000|Open-Label Titration|Lost to Follow-up|1
7363550|NCT01041859|11611488|FG001|Open-Label Titration|Lost to Follow-up|0
7363551|NCT01041859|11611489|FG002|Open-Label Titration|Lost to Follow-up|0
7363552|NCT01041859|11611487|FG000|Open-Label Titration|Physician Decision|1
7363553|NCT01041859|11611488|FG001|Open-Label Titration|Physician Decision|0
7363554|NCT01041859|11611489|FG002|Open-Label Titration|Physician Decision|0
7363555|NCT01041859|11611487|FG000|Open-Label Titration|Protocol Violation|1
7363556|NCT01041859|11611488|FG001|Open-Label Titration|Protocol Violation|0
7363557|NCT01041859|11611489|FG002|Open-Label Titration|Protocol Violation|0
7363558|NCT01041859|11611487|FG000|Open-Label Titration|Other|7
7363559|NCT01041859|11611488|FG001|Open-Label Titration|Other|0
7363560|NCT01041859|11611489|FG002|Open-Label Titration|Other|0
7363561|NCT01041859|11611487|FG000|Open-Label Titration|Noncompliance With Study Drug|8
7363562|NCT01041859|11611488|FG001|Open-Label Titration|Noncompliance With Study Drug|0
7363563|NCT01041859|11611489|FG002|Open-Label Titration|Noncompliance With Study Drug|0
7363564|NCT01041859|11611487|FG000|Open-Label Titration|Withdrawal by Subject|11
7363565|NCT01041859|11611488|FG001|Open-Label Titration|Withdrawal by Subject|0
7363566|NCT01041859|11611489|FG002|Open-Label Titration|Withdrawal by Subject|0
7363567|NCT01041859|11611487|FG000|Double-Blind Maintenance|Adverse Event|0
7363568|NCT01041859|11611488|FG001|Double-Blind Maintenance|Adverse Event|23
7363569|NCT01041859|11611489|FG002|Double-Blind Maintenance|Adverse Event|13
7363570|NCT01041859|11611487|FG000|Double-Blind Maintenance|Lack of Efficacy|0
7363571|NCT01041859|11611488|FG001|Double-Blind Maintenance|Lack of Efficacy|3
7363572|NCT01041859|11611489|FG002|Double-Blind Maintenance|Lack of Efficacy|11
7363573|NCT01041859|11611487|FG000|Double-Blind Maintenance|Lost to Follow-up|0
7363574|NCT01041859|11611488|FG001|Double-Blind Maintenance|Lost to Follow-up|1
7363575|NCT01041859|11611489|FG002|Double-Blind Maintenance|Lost to Follow-up|0
7363576|NCT01041859|11611487|FG000|Double-Blind Maintenance|Physician Decision|0
7363577|NCT01041859|11611488|FG001|Double-Blind Maintenance|Physician Decision|2
7363578|NCT01041859|11611489|FG002|Double-Blind Maintenance|Physician Decision|1
7460402|NCT01827254|11755736|FG000|Overall Study|Intolerance to treatment|4
7460403|NCT01827267|11755746|FG000|Overall Study|Did not receive study drug|1
7460404|NCT01827267|11755747|FG001|Overall Study|Did not receive study drug|1
7460405|NCT01827267|11755746|FG000|Overall Study|Physician Decision|1
7460406|NCT01827267|11755747|FG001|Overall Study|Physician Decision|0
7460407|NCT01827267|11755746|FG000|Overall Study|Disease Progression|1
7460408|NCT01827267|11755747|FG001|Overall Study|Disease Progression|1
7460409|NCT01827267|11755746|FG000|Overall Study|Sponsor Discontinued Study|2
7460410|NCT01827267|11755747|FG001|Overall Study|Sponsor Discontinued Study|8
7460411|NCT01827267|11755746|FG000|Overall Study|Still on study|0
7460412|NCT01827267|11755747|FG001|Overall Study|Still on study|2
7460413|NCT01827319|11755763|FG000|Overall Study|Lost to Follow-up|3
7363579|NCT01041859|11611487|FG000|Double-Blind Maintenance|Protocol Violation|0
7363580|NCT01041859|11611488|FG001|Double-Blind Maintenance|Protocol Violation|1
7363581|NCT01041859|11611489|FG002|Double-Blind Maintenance|Protocol Violation|3
7363582|NCT01041859|11611487|FG000|Double-Blind Maintenance|Other|0
7363583|NCT01041859|11611488|FG001|Double-Blind Maintenance|Other|6
7363584|NCT01041859|11611489|FG002|Double-Blind Maintenance|Other|2
7363585|NCT01041859|11611487|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
7363586|NCT01041859|11611488|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
7363587|NCT01041859|11611489|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
7363588|NCT01041859|11611487|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
7363589|NCT01041859|11611488|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
7363590|NCT01041859|11611489|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
7363591|NCT01041976|11611498|FG000|Overall Study|Withdrawal by Subject|3
7363592|NCT01041976|11611499|FG001|Overall Study|Withdrawal by Subject|0
7363593|NCT01041976|11611498|FG000|Overall Study|Incarceration|2
7363594|NCT01041976|11611499|FG001|Overall Study|Incarceration|0
7363595|NCT01041976|11611498|FG000|Overall Study|Death|0
7363596|NCT01041976|11611499|FG001|Overall Study|Death|4
7363597|NCT01042093|11611509|FG000|Overall Study|Protocol Violation|2
7363598|NCT01042093|11611510|FG001|Overall Study|Protocol Violation|2
7363599|NCT01042093|11611511|FG002|Overall Study|Protocol Violation|2
7363600|NCT01042093|11611512|FG003|Overall Study|Protocol Violation|3
7363601|NCT01042093|11611509|FG000|Overall Study|Withdrawal by Subject|0
7363602|NCT01042093|11611510|FG001|Overall Study|Withdrawal by Subject|0
7363603|NCT01042093|11611511|FG002|Overall Study|Withdrawal by Subject|0
7363604|NCT01042093|11611512|FG003|Overall Study|Withdrawal by Subject|1
7363605|NCT01042158|11611534|FG000|Overall Study|Physician Decision|1
7363606|NCT01042236|11611538|FG000|Treatment Period 1|Adverse Event|0
7363607|NCT01042236|11611539|FG001|Treatment Period 1|Adverse Event|1
7363608|NCT01042236|11611540|FG002|Treatment Period 1|Adverse Event|0
7363609|NCT01042236|11611541|FG003|Treatment Period 1|Adverse Event|0
7363610|NCT01042236|11611542|FG004|Treatment Period 1|Adverse Event|1
7363611|NCT01042236|11611543|FG005|Treatment Period 1|Adverse Event|0
7363612|NCT01042236|11611538|FG000|Treatment Period 3|Adverse Event|0
7363613|NCT01042236|11611539|FG001|Treatment Period 3|Adverse Event|0
7363614|NCT01042236|11611540|FG002|Treatment Period 3|Adverse Event|0
7363615|NCT01042236|11611541|FG003|Treatment Period 3|Adverse Event|1
7363616|NCT01042236|11611542|FG004|Treatment Period 3|Adverse Event|0
7363617|NCT01042236|11611543|FG005|Treatment Period 3|Adverse Event|0
7363618|NCT01042236|11611538|FG000|Treatment Period 3|Protocol Violation|0
7363619|NCT01042236|11611539|FG001|Treatment Period 3|Protocol Violation|0
7363620|NCT01042236|11611540|FG002|Treatment Period 3|Protocol Violation|0
7363621|NCT01042236|11611541|FG003|Treatment Period 3|Protocol Violation|1
7363622|NCT01042236|11611542|FG004|Treatment Period 3|Protocol Violation|0
7363623|NCT01042236|11611543|FG005|Treatment Period 3|Protocol Violation|0
7363624|NCT01042392|11611568|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
7363625|NCT01042392|11611569|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7363626|NCT01042392|11611570|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
7363627|NCT01042392|11611571|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
7363628|NCT01042392|11611568|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
7363629|NCT01042392|11611569|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7363630|NCT01042392|11611570|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7363631|NCT01042392|11611571|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
7363632|NCT01042392|11611568|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
7363633|NCT01042392|11611569|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7363634|NCT01042392|11611570|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
7363635|NCT01042392|11611571|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
7363636|NCT01042392|11611568|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7363637|NCT01042392|11611569|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7363707|NCT01043705|11611776|FG000|Overall Study|Death|28
7363638|NCT01042392|11611570|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
7363639|NCT01042392|11611571|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
7363640|NCT01042392|11611568|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
7363641|NCT01042392|11611569|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7363642|NCT01042392|11611570|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7363643|NCT01042392|11611571|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
7363644|NCT01042392|11611568|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7363645|NCT01042392|11611569|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7363646|NCT01042392|11611570|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
7363647|NCT01042392|11611571|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
7363648|NCT01042392|11611568|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
7363649|NCT01042392|11611569|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7363650|NCT01042392|11611570|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7363651|NCT01042392|11611571|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
7363652|NCT01042392|11611568|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7363653|NCT01042392|11611569|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7363654|NCT01042392|11611570|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
7363655|NCT01042392|11611571|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
7363656|NCT01042392|11611568|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
7363657|NCT01042392|11611569|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7363658|NCT01042392|11611570|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7363659|NCT01042392|11611571|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
7363660|NCT01042535|11611600|FG000|Overall Study|disease progression prior to treatment|3
7363661|NCT01042535|11611600|FG000|Overall Study|disease progression during treatment|3
7363662|NCT01042535|11611600|FG000|Overall Study|complications from other disease|2
7363663|NCT01042600|11611606|FG000|Overall Study|Ineligible|1
7363664|NCT01042600|11611607|FG001|Overall Study|Ineligible|0
7363665|NCT01042678|11611626|FG000|Overall Study|Physician Decision|1
7363666|NCT01042678|11611627|FG001|Overall Study|Physician Decision|0
7363667|NCT01042678|11611628|FG002|Overall Study|Physician Decision|0
7363668|NCT01042678|11611629|FG003|Overall Study|Physician Decision|0
7363669|NCT01042678|11611630|FG004|Overall Study|Physician Decision|0
7363670|NCT01042678|11611631|FG005|Overall Study|Physician Decision|0
7363671|NCT01042938|11611645|FG000|Overall Study|Withdrawal by Subject|1
7363672|NCT01042938|11611646|FG001|Overall Study|Withdrawal by Subject|1
7363673|NCT01042938|11611645|FG000|Overall Study|Protocol Violation|1
7363674|NCT01042938|11611646|FG001|Overall Study|Protocol Violation|1
7363675|NCT01042938|11611645|FG000|Overall Study|Ineligible: RTOG study conflict|1
7363676|NCT01042938|11611646|FG001|Overall Study|Ineligible: RTOG study conflict|0
7363677|NCT01042977|11611656|FG000|Overall Study|Adverse Event|4
7363678|NCT01042977|11611657|FG001|Overall Study|Adverse Event|12
7363679|NCT01042977|11611656|FG000|Overall Study|Death|2
7363680|NCT01042977|11611657|FG001|Overall Study|Death|1
7363681|NCT01042977|11611656|FG000|Overall Study|Withdrawal by Subject|8
7363682|NCT01042977|11611657|FG001|Overall Study|Withdrawal by Subject|16
7363683|NCT01042977|11611656|FG000|Overall Study|Lost to Follow-up|0
7363684|NCT01042977|11611657|FG001|Overall Study|Lost to Follow-up|2
7363685|NCT01042977|11611656|FG000|Overall Study|Poor/non-compliance|3
7363686|NCT01042977|11611657|FG001|Overall Study|Poor/non-compliance|4
7363687|NCT01042977|11611656|FG000|Overall Study|Subject no longer meets study criteria|15
7363688|NCT01042977|11611657|FG001|Overall Study|Subject no longer meets study criteria|13
7363689|NCT01042977|11611656|FG000|Overall Study|Incorrect enrollment|6
7363690|NCT01042977|11611657|FG001|Overall Study|Incorrect enrollment|4
7363691|NCT01042977|11611656|FG000|Overall Study|Safety|0
7363692|NCT01042977|11611657|FG001|Overall Study|Safety|2
7363693|NCT01042977|11611656|FG000|Overall Study|Administrative reason by sponsor|0
7363694|NCT01042977|11611657|FG001|Overall Study|Administrative reason by sponsor|1
7363695|NCT01042977|11611656|FG000|Overall Study|Various|3
7363696|NCT01042977|11611657|FG001|Overall Study|Various|0
7569812|NCT03466099|11946649|FG002|Overall Study|Use of rescue medication|13
7569813|NCT03466099|11946647|FG000|Overall Study|Rescued without meeting criteria|4
7569814|NCT03466099|11946648|FG001|Overall Study|Rescued without meeting criteria|1
7569815|NCT03466099|11946649|FG002|Overall Study|Rescued without meeting criteria|1
7569816|NCT03466099|11946647|FG000|Overall Study|Subject compliance|2
7569817|NCT03466099|11946648|FG001|Overall Study|Subject compliance|0
7569818|NCT03466099|11946649|FG002|Overall Study|Subject compliance|0
7363697|NCT01043185|11611706|FG000|Period 6 - Third Washout Period|Protocol Violation|0
7363698|NCT01043185|11611707|FG001|Period 6 - Third Washout Period|Protocol Violation|0
7363699|NCT01043185|11611708|FG002|Period 6 - Third Washout Period|Protocol Violation|0
7363700|NCT01043185|11611709|FG003|Period 6 - Third Washout Period|Protocol Violation|0
7363701|NCT01043185|11611710|FG004|Period 6 - Third Washout Period|Protocol Violation|0
7363702|NCT01043185|11611711|FG005|Period 6 - Third Washout Period|Protocol Violation|0
7363703|NCT01043185|11611712|FG006|Period 6 - Third Washout Period|Protocol Violation|0
7363704|NCT01043185|11611713|FG007|Period 6 - Third Washout Period|Protocol Violation|0
7363705|NCT01043185|11611714|FG008|Period 6 - Third Washout Period|Protocol Violation|1
7363706|NCT01043185|11611715|FG009|Period 6 - Third Washout Period|Protocol Violation|0
7363708|NCT01043705|11611777|FG001|Overall Study|Death|60
7363709|NCT01043705|11611778|FG002|Overall Study|Death|26
7363710|NCT01043705|11611776|FG000|Overall Study|Lost to Follow-up|27
7363711|NCT01043705|11611777|FG001|Overall Study|Lost to Follow-up|12
7363712|NCT01043705|11611778|FG002|Overall Study|Lost to Follow-up|0
7363713|NCT01043705|11611776|FG000|Overall Study|Multiple Reasons|4
7363714|NCT01043705|11611777|FG001|Overall Study|Multiple Reasons|7
7363715|NCT01043705|11611778|FG002|Overall Study|Multiple Reasons|0
7363716|NCT01043705|11611776|FG000|Overall Study|Protocol Violation|2
7363717|NCT01043705|11611777|FG001|Overall Study|Protocol Violation|1
7363718|NCT01043705|11611778|FG002|Overall Study|Protocol Violation|0
7363719|NCT01043705|11611776|FG000|Overall Study|Withdrawal by Subject|8
7363720|NCT01043705|11611777|FG001|Overall Study|Withdrawal by Subject|6
7363721|NCT01043705|11611778|FG002|Overall Study|Withdrawal by Subject|0
7363722|NCT01043705|11611776|FG000|Overall Study|Site Closure|8
7569819|NCT03466099|11946647|FG000|Overall Study|Worsening disease|0
7569820|NCT03466099|11946648|FG001|Overall Study|Worsening disease|0
7569821|NCT03466099|11946649|FG002|Overall Study|Worsening disease|1
7569822|NCT03467217|11946673|FG000|Overall Study|Trial stopped early|5
7363723|NCT01043705|11611777|FG001|Overall Study|Site Closure|0
7363724|NCT01043705|11611778|FG002|Overall Study|Site Closure|0
7363725|NCT01043705|11611776|FG000|Overall Study|Subsequent Procedure|9
7363726|NCT01043705|11611777|FG001|Overall Study|Subsequent Procedure|24
7363727|NCT01043705|11611778|FG002|Overall Study|Subsequent Procedure|29
7363728|NCT01043705|11611776|FG000|Overall Study|Adverse Event|0
7363729|NCT01043705|11611777|FG001|Overall Study|Adverse Event|2
7363730|NCT01043705|11611778|FG002|Overall Study|Adverse Event|0
7363731|NCT01043705|11611776|FG000|Overall Study|Screen Fail|21
7363732|NCT01043705|11611777|FG001|Overall Study|Screen Fail|0
7363733|NCT01043705|11611778|FG002|Overall Study|Screen Fail|0
7363734|NCT01043705|11611776|FG000|Overall Study|Other|0
7363735|NCT01043705|11611777|FG001|Overall Study|Other|19
7363736|NCT01043705|11611778|FG002|Overall Study|Other|25
7363737|NCT01043874|11611786|FG000|Overall Study|Adverse Event|3
7363738|NCT01043874|11611786|FG000|Overall Study|Withdrawal by Subject|1
7363739|NCT01043874|11611786|FG000|Overall Study|Lack of Efficacy|1
7363740|NCT01043874|11611786|FG000|Overall Study|Administrative Problems|1
7363741|NCT01044290|11611845|FG000|Follow-up 1|Death|3
7363742|NCT01044290|11611846|FG001|Follow-up 1|Death|3
7363743|NCT01044290|11611847|FG002|Follow-up 1|Death|1
7363744|NCT01044290|11611845|FG000|Follow-up 1|Withdrawal by Subject|2
7363745|NCT01044290|11611846|FG001|Follow-up 1|Withdrawal by Subject|2
7363746|NCT01044290|11611847|FG002|Follow-up 1|Withdrawal by Subject|0
7363747|NCT01044290|11611845|FG000|Follow-Up 2|Death|0
7363748|NCT01044290|11611846|FG001|Follow-Up 2|Death|1
7363749|NCT01044290|11611847|FG002|Follow-Up 2|Death|1
7363750|NCT01044290|11611845|FG000|Follow-Up 2|Withdrawal by Subject|0
7363751|NCT01044290|11611846|FG001|Follow-Up 2|Withdrawal by Subject|1
7363752|NCT01044290|11611847|FG002|Follow-Up 2|Withdrawal by Subject|1
7363753|NCT01044303|11611865|FG000|Overall Study|Lost to Follow-up|2
7363754|NCT01044433|11611872|FG000|Overall Study|Lost to Follow-up|3
7569823|NCT03467217|11946674|FG001|Overall Study|Trial stopped early|2
7569824|NCT03467217|11946673|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
7363755|NCT01044433|11611872|FG000|Overall Study|Withdrawal by Subject|3
7363756|NCT01044459|11611879|FG000|Overall Study|Withdrawal by Subject|21
7363757|NCT01044459|11611880|FG001|Overall Study|Withdrawal by Subject|28
7363758|NCT01044459|11611879|FG000|Overall Study|Terminated by Sponsor|22
7363759|NCT01044459|11611880|FG001|Overall Study|Terminated by Sponsor|21
7363760|NCT01044459|11611879|FG000|Overall Study|Adverse Event|22
7363761|NCT01044459|11611880|FG001|Overall Study|Adverse Event|20
7363762|NCT01044459|11611879|FG000|Overall Study|Lack of Efficacy|23
7363763|NCT01044459|11611880|FG001|Overall Study|Lack of Efficacy|12
7363764|NCT01044459|11611879|FG000|Overall Study|Protocol Violation|11
7363765|NCT01044459|11611880|FG001|Overall Study|Protocol Violation|16
7363766|NCT01044459|11611879|FG000|Overall Study|Other Reason|7
7363767|NCT01044459|11611880|FG001|Overall Study|Other Reason|14
7363768|NCT01044459|11611879|FG000|Overall Study|COPD exacerbation|9
7363769|NCT01044459|11611880|FG001|Overall Study|COPD exacerbation|8
7363770|NCT01044459|11611879|FG000|Overall Study|Lost to Follow-up|18
7363771|NCT01044459|11611880|FG001|Overall Study|Lost to Follow-up|12
7363772|NCT01044498|11611888|FG000|Overall Study|Withdrew consent|1
7363773|NCT01044498|11611889|FG001|Overall Study|Withdrew consent|1
7363774|NCT01044498|11611888|FG000|Overall Study|Adverse Event|1
7363775|NCT01044498|11611889|FG001|Overall Study|Adverse Event|1
7363776|NCT01044498|11611888|FG000|Overall Study|Other|1
7363777|NCT01044498|11611889|FG001|Overall Study|Other|0
7363778|NCT01044732|11611973|FG000|Overall Study|Lost to Follow-up|2
7363779|NCT01044732|11611974|FG001|Overall Study|Lost to Follow-up|1
7363780|NCT01044732|11611973|FG000|Overall Study|Physician Decision|5
7363781|NCT01044732|11611974|FG001|Overall Study|Physician Decision|3
7363782|NCT01044732|11611973|FG000|Overall Study|Protocol Violation|11
7363783|NCT01044732|11611974|FG001|Overall Study|Protocol Violation|12
7363784|NCT01044732|11611973|FG000|Overall Study|Withdrawal by Subject|0
7363785|NCT01044732|11611974|FG001|Overall Study|Withdrawal by Subject|1
7363786|NCT01044732|11611973|FG000|Overall Study|Inadequate bowel preparation|11
7363787|NCT01044732|11611974|FG001|Overall Study|Inadequate bowel preparation|17
7363788|NCT01044732|11611973|FG000|Overall Study|Inability to reach cecum|5
7363789|NCT01044732|11611974|FG001|Overall Study|Inability to reach cecum|2
7363790|NCT01044732|11611973|FG000|Overall Study|Technical error or malfunction|15
7363791|NCT01044732|11611974|FG001|Overall Study|Technical error or malfunction|14
7363792|NCT01044745|11611982|FG000|Overall Study|Ineiligible|2
7363793|NCT01045096|11612064|FG000|Overall Study|Withdrawal by Subject|2
7363794|NCT01045096|11612065|FG001|Overall Study|Withdrawal by Subject|0
7363795|NCT01045096|11612066|FG002|Overall Study|Withdrawal by Subject|0
7569825|NCT03467217|11946674|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
7569826|NCT03467217|11946673|FG000|Overall Study|Lost to Follow-up|0
7569827|NCT03467217|11946674|FG001|Overall Study|Lost to Follow-up|2
7569828|NCT03467425|11946705|FG000|Overall Study|Adverse Event|9
7569829|NCT03467425|11946706|FG001|Overall Study|Adverse Event|9
7569830|NCT03467425|11946705|FG000|Overall Study|Lack of Efficacy|3
7569831|NCT03467425|11946706|FG001|Overall Study|Lack of Efficacy|1
7569832|NCT03467425|11946705|FG000|Overall Study|Protocol Violation|0
7569833|NCT03467425|11946706|FG001|Overall Study|Protocol Violation|1
7569834|NCT03467425|11946705|FG000|Overall Study|Lost to Follow-up|18
7363796|NCT01045096|11612064|FG000|Overall Study|Other|1
7363797|NCT01045096|11612065|FG001|Overall Study|Other|0
7363798|NCT01045096|11612066|FG002|Overall Study|Other|0
7363799|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
7363800|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
7363801|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
7363802|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
7363803|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
7569835|NCT03467425|11946706|FG001|Overall Study|Lost to Follow-up|25
7363804|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
7363805|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
7363806|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
7363807|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
7363808|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
7363809|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
7363810|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
7363811|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7363812|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7363813|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
7363814|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7363815|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
7363816|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
7363817|NCT01045161|11612090|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7363818|NCT01045161|11612091|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
7363819|NCT01045161|11612092|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
7363820|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
7363821|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
7363822|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
7363823|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7363824|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
7363825|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
7363826|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
7363827|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7363828|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
7363829|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7363830|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
7363831|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
7363832|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
7363833|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
7363834|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
7363835|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7363836|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
7363837|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
7363838|NCT01045161|11612090|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
7363839|NCT01045161|11612091|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
7363840|NCT01045161|11612092|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
7363841|NCT01045421|11612132|FG000|Phase 1|Progressive Disease|0
7363842|NCT01045421|11612133|FG001|Phase 1|Progressive Disease|0
7363843|NCT01045421|11612134|FG002|Phase 1|Progressive Disease|0
7363844|NCT01045421|11612135|FG003|Phase 1|Progressive Disease|0
7363845|NCT01045421|11612136|FG004|Phase 1|Progressive Disease|1
7363846|NCT01045421|11612137|FG005|Phase 1|Progressive Disease|0
7363847|NCT01045421|11612138|FG006|Phase 1|Progressive Disease|0
7363848|NCT01045421|11612139|FG007|Phase 1|Progressive Disease|0
7363849|NCT01045421|11612140|FG008|Phase 1|Progressive Disease|0
7363850|NCT01045421|11612141|FG009|Phase 1|Progressive Disease|0
7363851|NCT01045421|11612142|FG010|Phase 1|Progressive Disease|0
7363852|NCT01045421|11612132|FG000|Phase 1|Withdrawal by Subject|0
7363853|NCT01045421|11612133|FG001|Phase 1|Withdrawal by Subject|0
7363854|NCT01045421|11612134|FG002|Phase 1|Withdrawal by Subject|0
7363855|NCT01045421|11612135|FG003|Phase 1|Withdrawal by Subject|1
7363856|NCT01045421|11612136|FG004|Phase 1|Withdrawal by Subject|0
7363857|NCT01045421|11612137|FG005|Phase 1|Withdrawal by Subject|0
7363858|NCT01045421|11612138|FG006|Phase 1|Withdrawal by Subject|0
7363859|NCT01045421|11612139|FG007|Phase 1|Withdrawal by Subject|0
7363860|NCT01045421|11612140|FG008|Phase 1|Withdrawal by Subject|0
7460414|NCT01827332|11755769|FG000|Overall Study|Lost to Follow-up|2
7569836|NCT03467425|11946705|FG000|Overall Study|Physician Decision|2
7569837|NCT03467425|11946706|FG001|Overall Study|Physician Decision|1
7569838|NCT03467425|11946705|FG000|Overall Study|Withdrawal by Subject|15
7569839|NCT03467425|11946706|FG001|Overall Study|Withdrawal by Subject|17
7363861|NCT01045421|11612141|FG009|Phase 1|Withdrawal by Subject|0
7363862|NCT01045421|11612142|FG010|Phase 1|Withdrawal by Subject|0
7363863|NCT01045421|11612132|FG000|Phase 2|Progressive Disease|0
7363864|NCT01045421|11612133|FG001|Phase 2|Progressive Disease|0
7363865|NCT01045421|11612134|FG002|Phase 2|Progressive Disease|0
7363866|NCT01045421|11612135|FG003|Phase 2|Progressive Disease|0
7363867|NCT01045421|11612136|FG004|Phase 2|Progressive Disease|0
7363868|NCT01045421|11612137|FG005|Phase 2|Progressive Disease|0
7363869|NCT01045421|11612138|FG006|Phase 2|Progressive Disease|0
7363870|NCT01045421|11612139|FG007|Phase 2|Progressive Disease|1
7363871|NCT01045421|11612140|FG008|Phase 2|Progressive Disease|1
7363872|NCT01045421|11612141|FG009|Phase 2|Progressive Disease|1
7363873|NCT01045421|11612142|FG010|Phase 2|Progressive Disease|1
7363874|NCT01045421|11612132|FG000|Phase 2|Death|0
7363875|NCT01045421|11612133|FG001|Phase 2|Death|0
7363876|NCT01045421|11612134|FG002|Phase 2|Death|0
7363877|NCT01045421|11612135|FG003|Phase 2|Death|0
7363878|NCT01045421|11612136|FG004|Phase 2|Death|0
7363879|NCT01045421|11612137|FG005|Phase 2|Death|0
7363880|NCT01045421|11612138|FG006|Phase 2|Death|0
7363881|NCT01045421|11612139|FG007|Phase 2|Death|1
7363882|NCT01045421|11612140|FG008|Phase 2|Death|1
7363883|NCT01045421|11612141|FG009|Phase 2|Death|2
7363884|NCT01045421|11612142|FG010|Phase 2|Death|0
7363885|NCT01045421|11612132|FG000|Phase 2|Other|0
7363886|NCT01045421|11612133|FG001|Phase 2|Other|0
7363887|NCT01045421|11612134|FG002|Phase 2|Other|0
7363888|NCT01045421|11612135|FG003|Phase 2|Other|0
7363889|NCT01045421|11612136|FG004|Phase 2|Other|0
7363890|NCT01045421|11612137|FG005|Phase 2|Other|0
7363891|NCT01045421|11612138|FG006|Phase 2|Other|0
7363892|NCT01045421|11612139|FG007|Phase 2|Other|3
7363893|NCT01045421|11612140|FG008|Phase 2|Other|0
7363894|NCT01045421|11612141|FG009|Phase 2|Other|0
7363895|NCT01045421|11612142|FG010|Phase 2|Other|1
7363896|NCT01045447|11612165|FG000|Overall Study|Adverse Event|0
7363897|NCT01045447|11612166|FG001|Overall Study|Adverse Event|1
7363898|NCT01045447|11612165|FG000|Overall Study|Lack of Efficacy|3
7363899|NCT01045447|11612166|FG001|Overall Study|Lack of Efficacy|1
7363900|NCT01045447|11612165|FG000|Overall Study|Protocol Violation|6
7363901|NCT01045447|11612166|FG001|Overall Study|Protocol Violation|3
7363902|NCT01045447|11612165|FG000|Overall Study|Withdrawal Criteria|10
7363903|NCT01045447|11612166|FG001|Overall Study|Withdrawal Criteria|10
7363904|NCT01045447|11612165|FG000|Overall Study|Unclassified|17
7363905|NCT01045447|11612166|FG001|Overall Study|Unclassified|13
7363906|NCT01045460|11612174|FG000|Overall Study|Physician Decision|3
7363907|NCT01045460|11612175|FG001|Overall Study|Physician Decision|2
7363908|NCT01045460|11612174|FG000|Overall Study|Lost to Follow-up|0
7363909|NCT01045460|11612175|FG001|Overall Study|Lost to Follow-up|1
7363910|NCT01045460|11612174|FG000|Overall Study|Lack of Efficacy|3
7363911|NCT01045460|11612175|FG001|Overall Study|Lack of Efficacy|0
7363912|NCT01045707|11612194|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
7363913|NCT01045707|11612195|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
7363914|NCT01045707|11612194|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
7363915|NCT01045707|11612195|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
7363916|NCT01045707|11612194|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
7363917|NCT01045707|11612195|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
7363918|NCT01045707|11612194|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
7363919|NCT01045707|11612195|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
7363920|NCT01045707|11612194|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
7363921|NCT01045707|11612195|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
7363922|NCT01045707|11612194|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7363923|NCT01045707|11612195|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
7363924|NCT01045707|11612194|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
7569840|NCT03467763|11946728|FG000|Overall Study|Lost to Follow-up|1
7569841|NCT03467763|11946728|FG000|Overall Study|Protocol Violation|2
7569842|NCT03467945|11946738|FG000|Treatment Period 2|Withdrawal by Subject|0
7569843|NCT03467945|11946739|FG001|Treatment Period 2|Withdrawal by Subject|1
7569844|NCT03467945|11946740|FG002|Treatment Period 2|Withdrawal by Subject|0
7569845|NCT03467945|11946741|FG003|Treatment Period 2|Withdrawal by Subject|0
7569846|NCT03467945|11946738|FG000|Treatment Period 3|Withdrawal by Subject|1
7569847|NCT03467945|11946739|FG001|Treatment Period 3|Withdrawal by Subject|0
7569848|NCT03467945|11946740|FG002|Treatment Period 3|Withdrawal by Subject|2
7569849|NCT03467945|11946741|FG003|Treatment Period 3|Withdrawal by Subject|1
7569850|NCT03467971|11946754|FG000|Treatment Period 2|Withdrawal by Subject|0
7569851|NCT03467971|11946755|FG001|Treatment Period 2|Withdrawal by Subject|1
7363925|NCT01045707|11612195|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
7363926|NCT01045707|11612194|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
7363927|NCT01045707|11612195|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
7363928|NCT01045707|11612194|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
7363929|NCT01045707|11612195|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
7363930|NCT01045798|11612203|FG000|Overall Study|Changed to Open-Label Caspofungin|1
7363931|NCT01045798|11612204|FG001|Overall Study|Changed to Open-Label Caspofungin|0
7363932|NCT01045798|11612203|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
7363933|NCT01045798|11612204|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
7363934|NCT01045798|11612203|FG000|Overall Study|Changed to Other Antifungal Therapy|1
7363935|NCT01045798|11612204|FG001|Overall Study|Changed to Other Antifungal Therapy|2
7363936|NCT01045798|11612203|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
7363937|NCT01045798|11612204|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
7363938|NCT01045967|11612212|FG000|Second Intervention|Protocol Violation|0
7363939|NCT01045967|11612213|FG001|Second Intervention|Protocol Violation|1
7363940|NCT01045993|11612223|FG000|Overall Study|Treated-later found eligibility not met|0
7363941|NCT01045993|11612224|FG001|Overall Study|Treated-later found eligibility not met|1
7363942|NCT01045993|11612225|FG002|Overall Study|Treated-later found eligibility not met|0
7363943|NCT01045993|11612226|FG003|Overall Study|Treated-later found eligibility not met|0
7363944|NCT01046084|11612238|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
7363945|NCT01046084|11612239|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
7363946|NCT01046110|11612247|FG000|Overall Study|Adverse Event|9
7363947|NCT01046110|11612248|FG001|Overall Study|Adverse Event|2
7363948|NCT01046110|11612247|FG000|Overall Study|Lack of Efficacy|0
7363949|NCT01046110|11612248|FG001|Overall Study|Lack of Efficacy|1
7363950|NCT01046110|11612247|FG000|Overall Study|Protocol Violation|7
7363951|NCT01046110|11612248|FG001|Overall Study|Protocol Violation|12
7363952|NCT01046110|11612247|FG000|Overall Study|Withdrawal Criteria|3
7363953|NCT01046110|11612248|FG001|Overall Study|Withdrawal Criteria|5
7363954|NCT01046110|11612247|FG000|Overall Study|Unclassified|36
7363955|NCT01046110|11612248|FG001|Overall Study|Unclassified|35
7363956|NCT01046136|11612256|FG000|Overall Study|Withdrawal by Subject|0
7363957|NCT01046136|11612257|FG001|Overall Study|Withdrawal by Subject|4
7363958|NCT01046136|11612256|FG000|Overall Study|Physician Decision|1
7363959|NCT01046136|11612257|FG001|Overall Study|Physician Decision|1
7363960|NCT01046136|11612256|FG000|Overall Study|Lost to Follow-up|3
7363961|NCT01046136|11612257|FG001|Overall Study|Lost to Follow-up|3
7363962|NCT01046253|11612267|FG000|Second Intervention|Adverse Event|0
7363963|NCT01046253|11612268|FG001|Second Intervention|Adverse Event|1
7363964|NCT01046253|11612267|FG000|Second Intervention|Protocol Violation|0
7363965|NCT01046253|11612268|FG001|Second Intervention|Protocol Violation|1
7363969|NCT01046643|11612292|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
7363970|NCT01046643|11612293|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
7363971|NCT01046643|11612294|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
7363972|NCT01046643|11612295|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
7386572|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386573|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386574|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7386575|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7386576|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7386577|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7386578|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386579|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386580|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386581|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386582|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386583|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386584|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386585|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7386586|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7363973|NCT01046682|11612316|FG000|Overall Study|Adverse Event|2
7363974|NCT01046682|11612317|FG001|Overall Study|Adverse Event|0
7363975|NCT01046695|11612325|FG000|Overall Study|Subject had a pacemaker|0
7363976|NCT01046695|11612326|FG001|Overall Study|Subject had a pacemaker|1
7363977|NCT01046695|11612325|FG000|Overall Study|TENS interfered with the cardiac monitor|0
7363978|NCT01046695|11612326|FG001|Overall Study|TENS interfered with the cardiac monitor|1
7363979|NCT01046877|11612332|FG000|Overall Study|Exited voluntarily before tube extrusion|7
7363980|NCT01046877|11612332|FG000|Overall Study|Exited voluntarily after tube extrusion|11
7363981|NCT01046903|11612336|FG000|Overall Study|Lost to Follow-up|16
7363982|NCT01046903|11612336|FG000|Overall Study|Adverse Event|4
7363983|NCT01046903|11612336|FG000|Overall Study|Withdrawal by Subject|3
7363984|NCT01046903|11612336|FG000|Overall Study|Other|5
7363985|NCT01047007|11612344|FG000|Overall Study|Adverse Event|0
7363986|NCT01047007|11612345|FG001|Overall Study|Adverse Event|2
7363987|NCT01047007|11612346|FG002|Overall Study|Adverse Event|1
7363988|NCT01047007|11612347|FG003|Overall Study|Adverse Event|0
7363989|NCT01047007|11612344|FG000|Overall Study|Progressive Disease|2
7363990|NCT01047007|11612345|FG001|Overall Study|Progressive Disease|4
7363991|NCT01047007|11612346|FG002|Overall Study|Progressive Disease|1
7363992|NCT01047007|11612347|FG003|Overall Study|Progressive Disease|0
7363993|NCT01047293|11612373|FG000|Overall Study|DLT criteria not fulfilled|1
7363994|NCT01047293|11612374|FG001|Overall Study|DLT criteria not fulfilled|1
7363995|NCT01047293|11612375|FG002|Overall Study|DLT criteria not fulfilled|0
7363996|NCT01047293|11612376|FG003|Overall Study|DLT criteria not fulfilled|0
7363997|NCT01047306|11612385|FG000|Overall Study|Withdrawal by Subject|2
7363998|NCT01047306|11612386|FG001|Overall Study|Withdrawal by Subject|0
7363999|NCT01047306|11612385|FG000|Overall Study|Lost to Follow-up|1
7364000|NCT01047306|11612386|FG001|Overall Study|Lost to Follow-up|0
7364001|NCT01047332|11612396|FG000|Overall Study|SEMS Obstruction|11
7364002|NCT01047332|11612397|FG001|Overall Study|SEMS Obstruction|20
7364003|NCT01047332|11612396|FG000|Overall Study|Died Unobstructed|38
7364004|NCT01047332|11612397|FG001|Overall Study|Died Unobstructed|41
7364005|NCT01047332|11612396|FG000|Overall Study|Lost to Follow-up|8
7364006|NCT01047332|11612397|FG001|Overall Study|Lost to Follow-up|3
7364007|NCT01047345|11612405|FG000|Base Study|Adverse Event|3
7364008|NCT01047345|11612406|FG001|Base Study|Adverse Event|0
7364009|NCT01047345|11612407|FG002|Base Study|Adverse Event|0
7364010|NCT01047345|11612405|FG000|Base Study|Lost to Follow-up|4
7364011|NCT01047345|11612406|FG001|Base Study|Lost to Follow-up|1
7364012|NCT01047345|11612407|FG002|Base Study|Lost to Follow-up|0
7364013|NCT01047345|11612405|FG000|Base Study|Protocol Violation|3
7364014|NCT01047345|11612406|FG001|Base Study|Protocol Violation|1
7364015|NCT01047345|11612407|FG002|Base Study|Protocol Violation|0
7364016|NCT01047345|11612405|FG000|Base Study|Withdrawal by Subject|12
7364017|NCT01047345|11612406|FG001|Base Study|Withdrawal by Subject|4
7364018|NCT01047345|11612407|FG002|Base Study|Withdrawal by Subject|0
7364019|NCT01047345|11612405|FG000|Extension|Withdrawal by Subject|0
7364020|NCT01047345|11612406|FG001|Extension|Withdrawal by Subject|0
7364021|NCT01047345|11612407|FG002|Extension|Withdrawal by Subject|1
7364022|NCT01047345|11612405|FG000|Extension|Lost to Follow-up|0
7364023|NCT01047345|11612406|FG001|Extension|Lost to Follow-up|0
7364024|NCT01047345|11612407|FG002|Extension|Lost to Follow-up|5
7364025|NCT01047436|11612422|FG000|Overall Study|Protocol Violation|1
7364026|NCT01047436|11612423|FG001|Overall Study|Protocol Violation|0
7364027|NCT01047553|11612454|FG000|Overall Study|Adverse Event|10
7364028|NCT01047553|11612455|FG001|Overall Study|Adverse Event|5
7364029|NCT01047553|11612454|FG000|Overall Study|Withdrawal by Subject|4
7364030|NCT01047553|11612455|FG001|Overall Study|Withdrawal by Subject|2
7364031|NCT01047553|11612454|FG000|Overall Study|Development of Study-Specific Withdrawal|1
7364032|NCT01047553|11612455|FG001|Overall Study|Development of Study-Specific Withdrawal|1
7364033|NCT01047553|11612454|FG000|Overall Study|Lost to Follow-up|1
7364034|NCT01047553|11612455|FG001|Overall Study|Lost to Follow-up|0
7364035|NCT01047553|11612454|FG000|Overall Study|Sever Non-Compliance to Protocol|1
7364036|NCT01047553|11612455|FG001|Overall Study|Sever Non-Compliance to Protocol|0
7364037|NCT01047553|11612454|FG000|Overall Study|PI's decision|0
7364038|NCT01047553|11612455|FG001|Overall Study|PI's decision|1
7364039|NCT01048099|11612488|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
7364040|NCT01048099|11612488|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
7364041|NCT01048242|11612496|FG000|Overall Study|See study flow chart|4
7364042|NCT01048242|11612497|FG001|Overall Study|See study flow chart|2
7364043|NCT01048333|11612503|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7364044|NCT01048333|11612504|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
7364045|NCT01048333|11612505|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7364046|NCT01048333|11612506|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7364047|NCT01048333|11612507|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7364048|NCT01048333|11612508|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
7364049|NCT01048502|11612530|FG000|Overall Study|Lost to Follow-up|2
7364050|NCT01048502|11612531|FG001|Overall Study|Lost to Follow-up|0
7364051|NCT01048502|11612532|FG002|Overall Study|Lost to Follow-up|0
7364052|NCT01048502|11612533|FG003|Overall Study|Lost to Follow-up|0
7364053|NCT01048502|11612530|FG000|Overall Study|Adverse Event|1
7364054|NCT01048502|11612531|FG001|Overall Study|Adverse Event|0
7364055|NCT01048502|11612532|FG002|Overall Study|Adverse Event|0
7364056|NCT01048502|11612533|FG003|Overall Study|Adverse Event|0
7364057|NCT01048502|11612530|FG000|Overall Study|Withdrawal by Subject|1
7364058|NCT01048502|11612531|FG001|Overall Study|Withdrawal by Subject|4
7364059|NCT01048502|11612532|FG002|Overall Study|Withdrawal by Subject|5
7364060|NCT01048502|11612533|FG003|Overall Study|Withdrawal by Subject|3
7364061|NCT01048502|11612530|FG000|Overall Study|Physician Decision|0
7364062|NCT01048502|11612531|FG001|Overall Study|Physician Decision|3
7364063|NCT01048502|11612532|FG002|Overall Study|Physician Decision|0
7364064|NCT01048502|11612533|FG003|Overall Study|Physician Decision|1
7364065|NCT01048541|11612544|FG000|Overall Study|Withdrawal by Subject|1
7364066|NCT01048541|11612545|FG001|Overall Study|Withdrawal by Subject|0
7364067|NCT01048671|11612593|FG000|Overall Study|Protocol Violation|0
7364068|NCT01048671|11612594|FG001|Overall Study|Protocol Violation|1
7364069|NCT01048671|11612595|FG002|Overall Study|Protocol Violation|1
7364070|NCT01048788|11612610|FG000|Overall Study|Adverse Event|5
7364071|NCT01048788|11612611|FG001|Overall Study|Adverse Event|1
7364072|NCT01048788|11612612|FG002|Overall Study|Adverse Event|1
7364073|NCT01048788|11612610|FG000|Overall Study|Lack of Efficacy|0
7364074|NCT01048788|11612611|FG001|Overall Study|Lack of Efficacy|0
7364075|NCT01048788|11612612|FG002|Overall Study|Lack of Efficacy|1
7364076|NCT01048788|11612610|FG000|Overall Study|Withdrawal by Subject|0
7364077|NCT01048788|11612611|FG001|Overall Study|Withdrawal by Subject|1
7364078|NCT01048788|11612612|FG002|Overall Study|Withdrawal by Subject|0
7364079|NCT01048866|11612622|FG000|Overall Study|Adverse Event|1
7364080|NCT01048866|11612623|FG001|Overall Study|Adverse Event|0
7364081|NCT01048866|11612622|FG000|Overall Study|Protocol Violation|1
7364082|NCT01048866|11612623|FG001|Overall Study|Protocol Violation|0
7364083|NCT01048866|11612622|FG000|Overall Study|Physician Decision|1
7364084|NCT01048866|11612623|FG001|Overall Study|Physician Decision|0
7364085|NCT01048866|11612622|FG000|Overall Study|Withdrawal by Subject|0
7364086|NCT01048866|11612623|FG001|Overall Study|Withdrawal by Subject|2
7364087|NCT01048866|11612622|FG000|Overall Study|Lost to Follow-up|0
7364088|NCT01048866|11612623|FG001|Overall Study|Lost to Follow-up|2
7364089|NCT01048866|11612622|FG000|Overall Study|Other|1
7364090|NCT01048866|11612623|FG001|Overall Study|Other|1
7364091|NCT01048944|11612650|FG000|Overall Study|Protocol Violation|8
7364092|NCT01048944|11612651|FG001|Overall Study|Protocol Violation|10
7364093|NCT01048944|11612652|FG002|Overall Study|Protocol Violation|10
7364094|NCT01048944|11612653|FG003|Overall Study|Protocol Violation|2
7364095|NCT01049009|11612665|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7364096|NCT01049009|11612666|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
7364097|NCT01049009|11612665|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
7364098|NCT01049009|11612666|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
7364099|NCT01049009|11612665|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
7364100|NCT01049009|11612666|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
7364101|NCT01049009|11612665|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
7364102|NCT01049009|11612666|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
7364103|NCT01049217|11612674|FG000|Overall Study|Adverse Event|2
7364104|NCT01049217|11612675|FG001|Overall Study|Adverse Event|1
7364105|NCT01049217|11612674|FG000|Overall Study|Lack of Efficacy|1
7364106|NCT01049217|11612675|FG001|Overall Study|Lack of Efficacy|1
7364107|NCT01049217|11612674|FG000|Overall Study|Lost to Follow-up|3
7364108|NCT01049217|11612675|FG001|Overall Study|Lost to Follow-up|8
7364109|NCT01049217|11612674|FG000|Overall Study|Withdrawal by Subject|4
7364110|NCT01049217|11612675|FG001|Overall Study|Withdrawal by Subject|3
7364111|NCT01049217|11612674|FG000|Overall Study|Protocol Violation|1
7364112|NCT01049217|11612675|FG001|Overall Study|Protocol Violation|3
7364113|NCT01049217|11612674|FG000|Overall Study|Pregnancy|1
7364114|NCT01049217|11612675|FG001|Overall Study|Pregnancy|0
7364115|NCT01049217|11612674|FG000|Overall Study|Study Terminated by Sponsor|43
7364116|NCT01049217|11612675|FG001|Overall Study|Study Terminated by Sponsor|43
7364117|NCT01049217|11612674|FG000|Overall Study|Other|1
7364118|NCT01049217|11612675|FG001|Overall Study|Other|2
7364119|NCT01049217|11612674|FG000|Overall Study|Randomized but not Treated|0
7364120|NCT01049217|11612675|FG001|Overall Study|Randomized but not Treated|2
7364121|NCT01049308|11612686|FG000|Pill Counts|Withdrawal by Subject|83
7364122|NCT01049334|11612695|FG000|Overall Study|Withdrawal by Subject|5
7364123|NCT01049334|11612696|FG001|Overall Study|Withdrawal by Subject|3
7364124|NCT01049334|11612695|FG000|Overall Study|Adverse Event|2
7364125|NCT01049334|11612696|FG001|Overall Study|Adverse Event|3
7364126|NCT01049334|11612695|FG000|Overall Study|Physician Decision|2
7364127|NCT01049334|11612696|FG001|Overall Study|Physician Decision|0
7364128|NCT01049334|11612695|FG000|Overall Study|Protocol Violation|0
7364129|NCT01049334|11612696|FG001|Overall Study|Protocol Violation|1
7364130|NCT01049360|11612702|FG000|Period 1|Adverse Event|0
7364131|NCT01049360|11612703|FG001|Period 1|Adverse Event|1
7364132|NCT01049360|11612704|FG002|Period 1|Adverse Event|0
7364133|NCT01049360|11612705|FG003|Period 1|Adverse Event|1
7364134|NCT01049360|11612706|FG004|Period 1|Adverse Event|0
7364135|NCT01049360|11612707|FG005|Period 1|Adverse Event|0
7364136|NCT01049360|11612708|FG006|Period 1|Adverse Event|0
7364137|NCT01049360|11612709|FG007|Period 1|Adverse Event|1
7364138|NCT01049360|11612710|FG008|Period 1|Adverse Event|0
7364139|NCT01049360|11612711|FG009|Period 1|Adverse Event|0
7364140|NCT01049360|11612712|FG010|Period 1|Adverse Event|0
7364141|NCT01049360|11612713|FG011|Period 1|Adverse Event|0
7364142|NCT01049360|11612714|FG012|Period 1|Adverse Event|1
7364143|NCT01049360|11612715|FG013|Period 1|Adverse Event|1
7364144|NCT01049360|11612716|FG014|Period 1|Adverse Event|0
7364145|NCT01049360|11612717|FG015|Period 1|Adverse Event|0
7364146|NCT01049360|11612718|FG016|Period 1|Adverse Event|1
7364147|NCT01049360|11612719|FG017|Period 1|Adverse Event|0
7364148|NCT01049360|11612720|FG018|Period 1|Adverse Event|1
7364149|NCT01049360|11612721|FG019|Period 1|Adverse Event|0
7364150|NCT01049360|11612702|FG000|Period 1|Did not meet inc/exc criteria|0
7364151|NCT01049360|11612703|FG001|Period 1|Did not meet inc/exc criteria|0
7364152|NCT01049360|11612704|FG002|Period 1|Did not meet inc/exc criteria|0
7364153|NCT01049360|11612705|FG003|Period 1|Did not meet inc/exc criteria|0
7364154|NCT01049360|11612706|FG004|Period 1|Did not meet inc/exc criteria|0
7364155|NCT01049360|11612707|FG005|Period 1|Did not meet inc/exc criteria|0
7364156|NCT01049360|11612708|FG006|Period 1|Did not meet inc/exc criteria|0
7364157|NCT01049360|11612709|FG007|Period 1|Did not meet inc/exc criteria|1
7364158|NCT01049360|11612710|FG008|Period 1|Did not meet inc/exc criteria|1
7364159|NCT01049360|11612711|FG009|Period 1|Did not meet inc/exc criteria|0
7364160|NCT01049360|11612712|FG010|Period 1|Did not meet inc/exc criteria|0
7364161|NCT01049360|11612713|FG011|Period 1|Did not meet inc/exc criteria|0
7364162|NCT01049360|11612714|FG012|Period 1|Did not meet inc/exc criteria|0
7364163|NCT01049360|11612715|FG013|Period 1|Did not meet inc/exc criteria|0
7364164|NCT01049360|11612716|FG014|Period 1|Did not meet inc/exc criteria|0
7364165|NCT01049360|11612717|FG015|Period 1|Did not meet inc/exc criteria|0
7364166|NCT01049360|11612718|FG016|Period 1|Did not meet inc/exc criteria|0
7364167|NCT01049360|11612719|FG017|Period 1|Did not meet inc/exc criteria|0
7364168|NCT01049360|11612720|FG018|Period 1|Did not meet inc/exc criteria|0
7364169|NCT01049360|11612721|FG019|Period 1|Did not meet inc/exc criteria|0
7364170|NCT01049360|11612702|FG000|Period 1|Withdrawal by Subject|0
7364171|NCT01049360|11612703|FG001|Period 1|Withdrawal by Subject|0
7364172|NCT01049360|11612704|FG002|Period 1|Withdrawal by Subject|0
7364173|NCT01049360|11612705|FG003|Period 1|Withdrawal by Subject|0
7364174|NCT01049360|11612706|FG004|Period 1|Withdrawal by Subject|0
7364175|NCT01049360|11612707|FG005|Period 1|Withdrawal by Subject|0
7364176|NCT01049360|11612708|FG006|Period 1|Withdrawal by Subject|0
7364177|NCT01049360|11612709|FG007|Period 1|Withdrawal by Subject|0
7364178|NCT01049360|11612710|FG008|Period 1|Withdrawal by Subject|1
7364179|NCT01049360|11612711|FG009|Period 1|Withdrawal by Subject|0
7364180|NCT01049360|11612712|FG010|Period 1|Withdrawal by Subject|1
7364181|NCT01049360|11612713|FG011|Period 1|Withdrawal by Subject|0
7364182|NCT01049360|11612714|FG012|Period 1|Withdrawal by Subject|1
7364183|NCT01049360|11612715|FG013|Period 1|Withdrawal by Subject|0
7364184|NCT01049360|11612716|FG014|Period 1|Withdrawal by Subject|0
7364185|NCT01049360|11612717|FG015|Period 1|Withdrawal by Subject|0
7364186|NCT01049360|11612718|FG016|Period 1|Withdrawal by Subject|0
7364187|NCT01049360|11612719|FG017|Period 1|Withdrawal by Subject|0
7364188|NCT01049360|11612720|FG018|Period 1|Withdrawal by Subject|0
7364189|NCT01049360|11612721|FG019|Period 1|Withdrawal by Subject|0
7364190|NCT01049360|11612702|FG000|Period 2|Protocol Violation|0
7364191|NCT01049360|11612703|FG001|Period 2|Protocol Violation|0
7364192|NCT01049360|11612704|FG002|Period 2|Protocol Violation|0
7364193|NCT01049360|11612705|FG003|Period 2|Protocol Violation|1
7364194|NCT01049360|11612706|FG004|Period 2|Protocol Violation|0
7364195|NCT01049360|11612707|FG005|Period 2|Protocol Violation|0
7364196|NCT01049360|11612708|FG006|Period 2|Protocol Violation|0
7364197|NCT01049360|11612709|FG007|Period 2|Protocol Violation|0
7364198|NCT01049360|11612710|FG008|Period 2|Protocol Violation|0
7364199|NCT01049360|11612711|FG009|Period 2|Protocol Violation|0
7364200|NCT01049360|11612712|FG010|Period 2|Protocol Violation|0
7364201|NCT01049360|11612713|FG011|Period 2|Protocol Violation|0
7364202|NCT01049360|11612714|FG012|Period 2|Protocol Violation|0
7364203|NCT01049360|11612715|FG013|Period 2|Protocol Violation|0
7364204|NCT01049360|11612716|FG014|Period 2|Protocol Violation|1
7364205|NCT01049360|11612717|FG015|Period 2|Protocol Violation|1
7364206|NCT01049360|11612718|FG016|Period 2|Protocol Violation|0
7364207|NCT01049360|11612719|FG017|Period 2|Protocol Violation|0
7364208|NCT01049360|11612720|FG018|Period 2|Protocol Violation|0
7364209|NCT01049360|11612721|FG019|Period 2|Protocol Violation|0
7364210|NCT01049360|11612702|FG000|Period 2|Adverse Event|0
7364211|NCT01049360|11612703|FG001|Period 2|Adverse Event|1
7364212|NCT01049360|11612704|FG002|Period 2|Adverse Event|0
7364213|NCT01049360|11612705|FG003|Period 2|Adverse Event|0
7364214|NCT01049360|11612706|FG004|Period 2|Adverse Event|0
7364215|NCT01049360|11612707|FG005|Period 2|Adverse Event|0
7364216|NCT01049360|11612708|FG006|Period 2|Adverse Event|0
7364217|NCT01049360|11612709|FG007|Period 2|Adverse Event|0
7364218|NCT01049360|11612710|FG008|Period 2|Adverse Event|1
7364219|NCT01049360|11612711|FG009|Period 2|Adverse Event|0
7364220|NCT01049360|11612712|FG010|Period 2|Adverse Event|0
7364221|NCT01049360|11612713|FG011|Period 2|Adverse Event|0
7364222|NCT01049360|11612714|FG012|Period 2|Adverse Event|0
7364223|NCT01049360|11612715|FG013|Period 2|Adverse Event|0
7364224|NCT01049360|11612716|FG014|Period 2|Adverse Event|0
7364225|NCT01049360|11612717|FG015|Period 2|Adverse Event|0
7364226|NCT01049360|11612718|FG016|Period 2|Adverse Event|0
7364227|NCT01049360|11612719|FG017|Period 2|Adverse Event|0
7364228|NCT01049360|11612720|FG018|Period 2|Adverse Event|0
7364229|NCT01049360|11612721|FG019|Period 2|Adverse Event|1
7364230|NCT01049360|11612702|FG000|Period 2|Withdrawal by Subject|0
7364231|NCT01049360|11612703|FG001|Period 2|Withdrawal by Subject|0
7364232|NCT01049360|11612704|FG002|Period 2|Withdrawal by Subject|0
7364233|NCT01049360|11612705|FG003|Period 2|Withdrawal by Subject|1
7364234|NCT01049360|11612706|FG004|Period 2|Withdrawal by Subject|0
7364235|NCT01049360|11612707|FG005|Period 2|Withdrawal by Subject|0
7364236|NCT01049360|11612708|FG006|Period 2|Withdrawal by Subject|0
7364237|NCT01049360|11612709|FG007|Period 2|Withdrawal by Subject|0
7364238|NCT01049360|11612710|FG008|Period 2|Withdrawal by Subject|0
7364239|NCT01049360|11612711|FG009|Period 2|Withdrawal by Subject|0
7364240|NCT01049360|11612712|FG010|Period 2|Withdrawal by Subject|0
7364241|NCT01049360|11612713|FG011|Period 2|Withdrawal by Subject|0
7364242|NCT01049360|11612714|FG012|Period 2|Withdrawal by Subject|0
7364243|NCT01049360|11612715|FG013|Period 2|Withdrawal by Subject|0
7364244|NCT01049360|11612716|FG014|Period 2|Withdrawal by Subject|1
7364245|NCT01049360|11612717|FG015|Period 2|Withdrawal by Subject|0
7364246|NCT01049360|11612718|FG016|Period 2|Withdrawal by Subject|0
7364247|NCT01049360|11612719|FG017|Period 2|Withdrawal by Subject|0
7364248|NCT01049360|11612720|FG018|Period 2|Withdrawal by Subject|0
7364249|NCT01049360|11612721|FG019|Period 2|Withdrawal by Subject|1
7364250|NCT01049360|11612702|FG000|Period 2|Lack of Efficacy|0
7364251|NCT01049360|11612703|FG001|Period 2|Lack of Efficacy|0
7364252|NCT01049360|11612704|FG002|Period 2|Lack of Efficacy|0
7364253|NCT01049360|11612705|FG003|Period 2|Lack of Efficacy|0
7364254|NCT01049360|11612706|FG004|Period 2|Lack of Efficacy|0
7364255|NCT01049360|11612707|FG005|Period 2|Lack of Efficacy|1
7364256|NCT01049360|11612708|FG006|Period 2|Lack of Efficacy|0
7364257|NCT01049360|11612709|FG007|Period 2|Lack of Efficacy|0
7364258|NCT01049360|11612710|FG008|Period 2|Lack of Efficacy|0
7364259|NCT01049360|11612711|FG009|Period 2|Lack of Efficacy|0
7364260|NCT01049360|11612712|FG010|Period 2|Lack of Efficacy|0
7364261|NCT01049360|11612713|FG011|Period 2|Lack of Efficacy|0
7364262|NCT01049360|11612714|FG012|Period 2|Lack of Efficacy|0
7364263|NCT01049360|11612715|FG013|Period 2|Lack of Efficacy|0
7364264|NCT01049360|11612716|FG014|Period 2|Lack of Efficacy|0
7364265|NCT01049360|11612717|FG015|Period 2|Lack of Efficacy|0
7364266|NCT01049360|11612718|FG016|Period 2|Lack of Efficacy|0
7364267|NCT01049360|11612719|FG017|Period 2|Lack of Efficacy|0
7364268|NCT01049360|11612720|FG018|Period 2|Lack of Efficacy|0
7364269|NCT01049360|11612721|FG019|Period 2|Lack of Efficacy|0
7364270|NCT01049360|11612702|FG000|Period 4|Protocol Violation|0
7364271|NCT01049360|11612703|FG001|Period 4|Protocol Violation|0
7364272|NCT01049360|11612704|FG002|Period 4|Protocol Violation|0
7364273|NCT01049360|11612705|FG003|Period 4|Protocol Violation|0
7364274|NCT01049360|11612706|FG004|Period 4|Protocol Violation|0
7364275|NCT01049360|11612707|FG005|Period 4|Protocol Violation|0
7364276|NCT01049360|11612708|FG006|Period 4|Protocol Violation|0
7364277|NCT01049360|11612709|FG007|Period 4|Protocol Violation|0
7364278|NCT01049360|11612710|FG008|Period 4|Protocol Violation|0
7364279|NCT01049360|11612711|FG009|Period 4|Protocol Violation|0
7364280|NCT01049360|11612712|FG010|Period 4|Protocol Violation|0
7364281|NCT01049360|11612713|FG011|Period 4|Protocol Violation|0
7460415|NCT01827332|11755770|FG001|Overall Study|Lost to Follow-up|1
7460416|NCT01827371|11755789|FG000|Overall Study|Adverse Event|0
7460417|NCT01827371|11755790|FG001|Overall Study|Adverse Event|0
7460418|NCT01827371|11755791|FG002|Overall Study|Adverse Event|4
7460419|NCT01827371|11755792|FG003|Overall Study|Adverse Event|2
7569852|NCT03468543|11946773|FG000|Overall Study|Protocol stopping rules met|3
7569853|NCT03468855|11946788|FG000|Overall Study|Adverse Event|2
7569854|NCT03468855|11946788|FG000|Overall Study|Lost to Follow-up|5
7569855|NCT03468855|11946788|FG000|Overall Study|Withdrawal by Subject|3
7569856|NCT03468855|11946788|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
7569857|NCT03469336|11946810|FG000|Overall Study|Adverse Event|1
7569858|NCT03469349|11946822|FG000|Overall Study|Withdrawal by Subject|1
7569859|NCT03469349|11946823|FG001|Overall Study|Withdrawal by Subject|3
7569860|NCT03469349|11946822|FG000|Overall Study|Progressive Disease|0
7569861|NCT03469349|11946823|FG001|Overall Study|Progressive Disease|1
7569862|NCT03469349|11946822|FG000|Overall Study|Lost to Follow-up|2
7364282|NCT01049360|11612714|FG012|Period 4|Protocol Violation|0
7460420|NCT01827371|11755789|FG000|Overall Study|Lost to Follow-up|0
7460421|NCT01827371|11755790|FG001|Overall Study|Lost to Follow-up|2
7460422|NCT01827371|11755791|FG002|Overall Study|Lost to Follow-up|0
7460423|NCT01827371|11755792|FG003|Overall Study|Lost to Follow-up|4
7460424|NCT01827371|11755789|FG000|Overall Study|Protocol Violation|1
7460425|NCT01827371|11755790|FG001|Overall Study|Protocol Violation|0
7460426|NCT01827371|11755791|FG002|Overall Study|Protocol Violation|0
7460427|NCT01827371|11755792|FG003|Overall Study|Protocol Violation|0
7364283|NCT01049360|11612715|FG013|Period 4|Protocol Violation|0
7364284|NCT01049360|11612716|FG014|Period 4|Protocol Violation|0
7364285|NCT01049360|11612717|FG015|Period 4|Protocol Violation|0
7364286|NCT01049360|11612718|FG016|Period 4|Protocol Violation|0
7460428|NCT01827371|11755789|FG000|Overall Study|Withdrawal by Subject|1
7569863|NCT03469349|11946823|FG001|Overall Study|Lost to Follow-up|2
7569864|NCT03469349|11946822|FG000|Overall Study|Adverse Event|2
7569865|NCT03469349|11946823|FG001|Overall Study|Adverse Event|4
7569866|NCT03470194|11946835|FG000|Overall Study|Lost to Follow-up|11
7569867|NCT03470194|11946836|FG001|Overall Study|Lost to Follow-up|17
7569868|NCT03470545|11946848|FG000|Overall Study|Death|0
7569869|NCT03470545|11946849|FG001|Overall Study|Death|1
7569870|NCT03470545|11946848|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
7569871|NCT03470545|11946849|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
7569872|NCT03470545|11946848|FG000|Overall Study|Adverse Event|2
7569873|NCT03470545|11946849|FG001|Overall Study|Adverse Event|0
7569874|NCT03470545|11946848|FG000|Overall Study|Withdrawal by Subject|1
7569875|NCT03470545|11946849|FG001|Overall Study|Withdrawal by Subject|1
7569876|NCT03470545|11946848|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
7569877|NCT03470545|11946849|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
7569878|NCT03471078|11946872|FG000|Overall Study|Withdrawal by Subject|9
7569879|NCT03471078|11946873|FG001|Overall Study|Withdrawal by Subject|1
7569880|NCT03471078|11946872|FG000|Overall Study|Adverse Event|4
7569881|NCT03471078|11946873|FG001|Overall Study|Adverse Event|1
7569882|NCT03471078|11946872|FG000|Overall Study|Physician Decision|3
7569883|NCT03471078|11946873|FG001|Overall Study|Physician Decision|2
7569884|NCT03471078|11946872|FG000|Overall Study|Death|2
7569885|NCT03471078|11946873|FG001|Overall Study|Death|0
7569886|NCT03471078|11946872|FG000|Overall Study|Other|3
7569887|NCT03471078|11946873|FG001|Overall Study|Other|2
7569888|NCT03471871|11946890|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7569889|NCT03471871|11946891|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7569890|NCT03471871|11946892|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
7569891|NCT03471871|11946893|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7569892|NCT03471871|11946894|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
7569893|NCT03471871|11946890|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7569894|NCT03471871|11946891|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7569895|NCT03471871|11946892|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
7569896|NCT03471871|11946893|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7569897|NCT03471871|11946894|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
7569898|NCT03471871|11946890|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7569899|NCT03471871|11946891|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7569900|NCT03471871|11946892|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7569901|NCT03471871|11946893|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
7569902|NCT03471871|11946894|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
7569903|NCT03471871|11946890|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7569904|NCT03471871|11946891|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7569905|NCT03471871|11946892|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7569906|NCT03471871|11946893|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
7569907|NCT03471871|11946894|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
7569908|NCT03471871|11946890|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7569909|NCT03471871|11946891|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7569910|NCT03471871|11946892|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7569911|NCT03471871|11946893|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
7569912|NCT03471871|11946894|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
7569913|NCT03472014|11946915|FG000|Overall Study|Lost to Follow-up|4
7569914|NCT03472326|11946930|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7569915|NCT03472326|11946931|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
7569916|NCT03472326|11946932|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
7569917|NCT03472326|11946933|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
7569918|NCT03472326|11946930|FG000|Part 2: Combination Therapy|Pregnancy|0
7569919|NCT03472326|11946931|FG001|Part 2: Combination Therapy|Pregnancy|0
7569920|NCT03472326|11946932|FG002|Part 2: Combination Therapy|Pregnancy|0
7569921|NCT03472326|11946933|FG003|Part 2: Combination Therapy|Pregnancy|1
7569922|NCT03472534|11946951|FG000|Overall Study|Withdrawal by Subject|9
7569923|NCT03472534|11946951|FG000|Overall Study|Adverse Event|2
7569924|NCT03472547|11946955|FG000|Overall Study|Withdrawal by Subject|30
7569925|NCT03473197|11946967|FG000|Overall Study|Adverse Event|4
7569926|NCT03473197|11946967|FG000|Overall Study|Lost to Follow-up|1
7569927|NCT03473197|11946967|FG000|Overall Study|Withdrawal by Subject|5
7569928|NCT03473236|11946981|FG000|Overall Study|Withdrawal by Subject|0
7569929|NCT03473236|11946982|FG001|Overall Study|Withdrawal by Subject|0
7569930|NCT03473236|11946983|FG002|Overall Study|Withdrawal by Subject|0
7569931|NCT03473236|11946984|FG003|Overall Study|Withdrawal by Subject|0
7569932|NCT03473236|11946985|FG004|Overall Study|Withdrawal by Subject|0
7569933|NCT03473236|11946986|FG005|Overall Study|Withdrawal by Subject|1
7569934|NCT03473236|11946987|FG006|Overall Study|Withdrawal by Subject|0
7569935|NCT03473236|11946988|FG007|Overall Study|Withdrawal by Subject|0
7569936|NCT03473236|11946989|FG008|Overall Study|Withdrawal by Subject|1
7364287|NCT01049360|11612719|FG017|Period 4|Protocol Violation|1
7364288|NCT01049360|11612720|FG018|Period 4|Protocol Violation|0
7364289|NCT01049360|11612721|FG019|Period 4|Protocol Violation|0
7364290|NCT01049360|11612702|FG000|Period 4|Withdrawal by Subject|0
7364291|NCT01049360|11612703|FG001|Period 4|Withdrawal by Subject|0
7364292|NCT01049360|11612704|FG002|Period 4|Withdrawal by Subject|0
7364293|NCT01049360|11612705|FG003|Period 4|Withdrawal by Subject|1
7364294|NCT01049360|11612706|FG004|Period 4|Withdrawal by Subject|0
7364295|NCT01049360|11612707|FG005|Period 4|Withdrawal by Subject|0
7364296|NCT01049360|11612708|FG006|Period 4|Withdrawal by Subject|0
7364297|NCT01049360|11612709|FG007|Period 4|Withdrawal by Subject|0
7364298|NCT01049360|11612710|FG008|Period 4|Withdrawal by Subject|0
7364299|NCT01049360|11612711|FG009|Period 4|Withdrawal by Subject|0
7364300|NCT01049360|11612712|FG010|Period 4|Withdrawal by Subject|0
7364301|NCT01049360|11612713|FG011|Period 4|Withdrawal by Subject|0
7364302|NCT01049360|11612714|FG012|Period 4|Withdrawal by Subject|0
7364303|NCT01049360|11612715|FG013|Period 4|Withdrawal by Subject|0
7364304|NCT01049360|11612716|FG014|Period 4|Withdrawal by Subject|0
7364305|NCT01049360|11612717|FG015|Period 4|Withdrawal by Subject|0
7364306|NCT01049360|11612718|FG016|Period 4|Withdrawal by Subject|0
7364307|NCT01049360|11612719|FG017|Period 4|Withdrawal by Subject|0
7364308|NCT01049360|11612720|FG018|Period 4|Withdrawal by Subject|0
7364309|NCT01049360|11612721|FG019|Period 4|Withdrawal by Subject|0
7364310|NCT01049373|11612735|FG000|Overall Study|Protocol Violation|9
7364311|NCT01049373|11612736|FG001|Overall Study|Protocol Violation|9
7364312|NCT01049373|11612735|FG000|Overall Study|Withdrawal by Subject|8
7364313|NCT01049373|11612736|FG001|Overall Study|Withdrawal by Subject|5
7364314|NCT01049373|11612735|FG000|Overall Study|Adverse Event|3
7364315|NCT01049373|11612736|FG001|Overall Study|Adverse Event|3
7364316|NCT01049373|11612735|FG000|Overall Study|Lost to Follow-up|9
7364317|NCT01049373|11612736|FG001|Overall Study|Lost to Follow-up|4
7364318|NCT01049373|11612735|FG000|Overall Study|no evaluable study values|9
7364319|NCT01049373|11612736|FG001|Overall Study|no evaluable study values|21
7364320|NCT01049373|11612735|FG000|Overall Study|Other|1
7364321|NCT01049373|11612736|FG001|Overall Study|Other|1
7364322|NCT01049373|11612735|FG000|Overall Study|Non-cooperation|0
7364323|NCT01049373|11612736|FG001|Overall Study|Non-cooperation|1
7364324|NCT01049412|11612746|FG000|Period I|Withdrawal by Subject|4
7364325|NCT01049412|11612747|FG001|Period I|Withdrawal by Subject|6
7364326|NCT01049412|11612746|FG000|Period I|Lost to Follow-up|2
7364327|NCT01049412|11612747|FG001|Period I|Lost to Follow-up|2
7364328|NCT01049412|11612746|FG000|Period I|Physician Decision|0
7364329|NCT01049412|11612747|FG001|Period I|Physician Decision|3
7364330|NCT01049412|11612746|FG000|Period I|Protocol Violation|1
7364331|NCT01049412|11612747|FG001|Period I|Protocol Violation|2
7364332|NCT01049412|11612746|FG000|Period I|Adverse Event|1
7364333|NCT01049412|11612747|FG001|Period I|Adverse Event|0
7364334|NCT01049412|11612746|FG000|Period II|Withdrawal by Subject|2
7364335|NCT01049412|11612747|FG001|Period II|Withdrawal by Subject|3
7364336|NCT01049412|11612746|FG000|Period II|Adverse Event|1
7364337|NCT01049412|11612747|FG001|Period II|Adverse Event|0
7364338|NCT01049412|11612746|FG000|Period II|Lost to Follow-up|1
7364339|NCT01049412|11612747|FG001|Period II|Lost to Follow-up|0
7364340|NCT01049503|11612761|FG000|Overall Study|Lost to Follow-up|11
7364341|NCT01049503|11612762|FG001|Overall Study|Lost to Follow-up|12
7364342|NCT01049503|11612763|FG002|Overall Study|Lost to Follow-up|24
7364343|NCT01049503|11612764|FG003|Overall Study|Lost to Follow-up|26
7364344|NCT01049503|11612765|FG004|Overall Study|Lost to Follow-up|27
7364345|NCT01049503|11612766|FG005|Overall Study|Lost to Follow-up|8
7364346|NCT01049581|11612791|FG000|Overall Study|Lost to Follow-up|2
7364347|NCT01049581|11612792|FG001|Overall Study|Lost to Follow-up|1
7364348|NCT01049919|11612816|FG000|Overall Study|Met study endpoint (major amputation, death)|36
7364349|NCT01049919|11612817|FG001|Overall Study|Met study endpoint (major amputation, death)|16
7364350|NCT01049919|11612816|FG000|Overall Study|Withdrawal by Subject|5
7364351|NCT01049919|11612817|FG001|Overall Study|Withdrawal by Subject|0
7364352|NCT01049919|11612816|FG000|Overall Study|Lost to Follow-up|6
7364353|NCT01049919|11612817|FG001|Overall Study|Lost to Follow-up|1
7364354|NCT01049919|11612816|FG000|Overall Study|Physician Decision|2
7364355|NCT01049919|11612817|FG001|Overall Study|Physician Decision|0
7364356|NCT01049919|11612816|FG000|Overall Study|Received 2nd treatment via compassionate use|1
7364357|NCT01049919|11612817|FG001|Overall Study|Received 2nd treatment via compassionate use|0
7364358|NCT01049919|11612816|FG000|Overall Study|Early study termination by sponsor.|2
7364359|NCT01049919|11612817|FG001|Overall Study|Early study termination by sponsor.|0
7364360|NCT01049984|11612846|FG000|Overall Study|Withdrawal by Subject|1
7364361|NCT01049984|11612847|FG001|Overall Study|Withdrawal by Subject|5
7364362|NCT01049984|11612846|FG000|Overall Study|Protocol Violation|3
7364363|NCT01049984|11612847|FG001|Overall Study|Protocol Violation|4
7364364|NCT01049984|11612846|FG000|Overall Study|Lost to Follow-up|2
7364365|NCT01049984|11612847|FG001|Overall Study|Lost to Follow-up|1
7364366|NCT01049984|11612846|FG000|Overall Study|Adverse Event|13
7364367|NCT01049984|11612847|FG001|Overall Study|Adverse Event|7
7364368|NCT01049984|11612846|FG000|Overall Study|Treatment failure|0
7364369|NCT01049984|11612847|FG001|Overall Study|Treatment failure|2
7364370|NCT01050062|11612855|FG000|Overall Study|Adverse Event|75
7364371|NCT01050062|11612856|FG001|Overall Study|Adverse Event|22
7364372|NCT01050062|11612855|FG000|Overall Study|Lost to Follow-up|83
7364373|NCT01050062|11612856|FG001|Overall Study|Lost to Follow-up|35
7364374|NCT01050062|11612855|FG000|Overall Study|Lack of Efficacy|22
7364375|NCT01050062|11612856|FG001|Overall Study|Lack of Efficacy|35
7364376|NCT01050062|11612855|FG000|Overall Study|Physician Decision|74
7364377|NCT01050062|11612856|FG001|Overall Study|Physician Decision|9
7364378|NCT01050062|11612855|FG000|Overall Study|Others|17
7364379|NCT01050062|11612856|FG001|Overall Study|Others|11
7569937|NCT03473236|11946990|FG009|Overall Study|Withdrawal by Subject|0
7569938|NCT03473301|11947023|FG000|Overall Study|Protocol Violation|4
7569939|NCT03473301|11947024|FG001|Overall Study|Protocol Violation|0
7569940|NCT03473301|11947025|FG002|Overall Study|Protocol Violation|0
7569941|NCT03473301|11947023|FG000|Overall Study|Withdrawal by Subject|0
7569942|NCT03473301|11947024|FG001|Overall Study|Withdrawal by Subject|1
7569943|NCT03473301|11947025|FG002|Overall Study|Withdrawal by Subject|0
7569944|NCT03473301|11947023|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
7569945|NCT03473301|11947024|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
7569946|NCT03473301|11947025|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
7569947|NCT03473808|11947044|FG000|Overall Study|Withdrawal by Subject|1
7569948|NCT03474081|11947054|FG000|Overall Study|Adverse Event|6
7569949|NCT03474081|11947055|FG001|Overall Study|Adverse Event|3
7569950|NCT03474081|11947054|FG000|Overall Study|Lost to Follow-up|2
7569951|NCT03474081|11947055|FG001|Overall Study|Lost to Follow-up|1
7569952|NCT03474081|11947054|FG000|Overall Study|Physician Decision|3
7569953|NCT03474081|11947055|FG001|Overall Study|Physician Decision|2
7569954|NCT03474081|11947054|FG000|Overall Study|Withdrawal by Subject|5
7569955|NCT03474081|11947055|FG001|Overall Study|Withdrawal by Subject|7
7569956|NCT03474081|11947054|FG000|Overall Study|Investigator site closed|1
7569957|NCT03474081|11947055|FG001|Overall Study|Investigator site closed|0
7364380|NCT01050205|11612875|FG000|Overall Study|Lost to Follow-up|7
7364381|NCT01050205|11612876|FG001|Overall Study|Lost to Follow-up|1
7364382|NCT01050205|11612875|FG000|Overall Study|Withdrawal by Subject|1
7364383|NCT01050205|11612876|FG001|Overall Study|Withdrawal by Subject|1
7364384|NCT01050205|11612875|FG000|Overall Study|Relocated from area|1
7364385|NCT01050205|11612876|FG001|Overall Study|Relocated from area|2
7364386|NCT01050205|11612875|FG000|Overall Study|Discontinued Intervention|2
7364387|NCT01050205|11612876|FG001|Overall Study|Discontinued Intervention|0
7364388|NCT01050257|11612894|FG000|Overall Study|Adverse Event|4
7364389|NCT01050257|11612895|FG001|Overall Study|Adverse Event|4
7364390|NCT01050257|11612896|FG002|Overall Study|Adverse Event|2
7364391|NCT01050257|11612894|FG000|Overall Study|Admin/Other (did not switch to oral)|6
7364392|NCT01050257|11612895|FG001|Overall Study|Admin/Other (did not switch to oral)|2
7364393|NCT01050257|11612896|FG002|Overall Study|Admin/Other (did not switch to oral)|2
7364394|NCT01050257|11612894|FG000|Overall Study|Withdrawal by Subject|0
7364395|NCT01050257|11612895|FG001|Overall Study|Withdrawal by Subject|3
7364396|NCT01050257|11612896|FG002|Overall Study|Withdrawal by Subject|0
7364397|NCT01050257|11612894|FG000|Overall Study|No reason specified|0
7364398|NCT01050257|11612895|FG001|Overall Study|No reason specified|0
7364399|NCT01050257|11612896|FG002|Overall Study|No reason specified|2
7364400|NCT01050257|11612894|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
7364401|NCT01050257|11612895|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
7364402|NCT01050257|11612896|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
7364403|NCT01050257|11612894|FG000|Overall Study|Violation criteria|0
7364404|NCT01050257|11612895|FG001|Overall Study|Violation criteria|1
7364405|NCT01050257|11612896|FG002|Overall Study|Violation criteria|0
7364406|NCT01050257|11612894|FG000|Overall Study|Failure to return|0
7364407|NCT01050257|11612895|FG001|Overall Study|Failure to return|2
7364408|NCT01050257|11612896|FG002|Overall Study|Failure to return|0
7364409|NCT01050257|11612894|FG000|Overall Study|Death|0
7364410|NCT01050257|11612895|FG001|Overall Study|Death|0
7364411|NCT01050257|11612896|FG002|Overall Study|Death|1
7364412|NCT01050530|11612906|FG000|Overall Study|Adverse Event|6
7364413|NCT01050530|11612907|FG001|Overall Study|Adverse Event|3
7364414|NCT01050530|11612906|FG000|Overall Study|Lack of Efficacy|1
7364415|NCT01050530|11612907|FG001|Overall Study|Lack of Efficacy|4
7364416|NCT01050530|11612906|FG000|Overall Study|Withdrawal by Subject|0
7364417|NCT01050530|11612907|FG001|Overall Study|Withdrawal by Subject|3
7364418|NCT01050530|11612906|FG000|Overall Study|Protocol Violation|1
7364419|NCT01050530|11612907|FG001|Overall Study|Protocol Violation|0
7364420|NCT01050543|11612915|FG000|Overall Study|Withdrawal by Subject|0
7364421|NCT01050543|11612916|FG001|Overall Study|Withdrawal by Subject|2
7364422|NCT01050543|11612915|FG000|Overall Study|Protocol Violation|0
7364423|NCT01050543|11612916|FG001|Overall Study|Protocol Violation|1
7364424|NCT01050543|11612915|FG000|Overall Study|Administrative|4
7364425|NCT01050543|11612916|FG001|Overall Study|Administrative|1
7364426|NCT01050569|11612925|FG000|Overall Study|Lost to Follow-up|20
7569962|NCT03475316|11947095|FG000|6 Month Intervention|Adverse Event|2
7364427|NCT01050569|11612926|FG001|Overall Study|Lost to Follow-up|14
7364428|NCT01050569|11612927|FG002|Overall Study|Lost to Follow-up|16
7364429|NCT01050569|11612925|FG000|Overall Study|Withdrawal by Subject|9
7364430|NCT01050569|11612926|FG001|Overall Study|Withdrawal by Subject|3
7364431|NCT01050569|11612927|FG002|Overall Study|Withdrawal by Subject|11
7364432|NCT01050569|11612925|FG000|Overall Study|Lack of Efficacy|5
7364433|NCT01050569|11612926|FG001|Overall Study|Lack of Efficacy|4
7364434|NCT01050569|11612927|FG002|Overall Study|Lack of Efficacy|3
7364435|NCT01050569|11612925|FG000|Overall Study|Adverse Event|1
7364436|NCT01050569|11612926|FG001|Overall Study|Adverse Event|0
7364437|NCT01050569|11612927|FG002|Overall Study|Adverse Event|0
7364438|NCT01050569|11612925|FG000|Overall Study|Physician Decision|3
7364439|NCT01050569|11612926|FG001|Overall Study|Physician Decision|3
7364440|NCT01050569|11612927|FG002|Overall Study|Physician Decision|3
7364441|NCT01050634|11612948|FG000|Overall Study|Enrolled, but Not Treated|56
7364442|NCT01050634|11612948|FG000|Overall Study|Death|2
7364443|NCT01050634|11612948|FG000|Overall Study|Adverse Event|42
7364444|NCT01050634|11612948|FG000|Overall Study|Lost to Follow-up|2
7364445|NCT01050634|11612948|FG000|Overall Study|Other|21
7364446|NCT01050634|11612948|FG000|Overall Study|Ongoing at Date of Cut-Off|5
7364447|NCT01050673|11612972|FG000|Overall Study|Physician Decision|4
7364448|NCT01050673|11612973|FG001|Overall Study|Physician Decision|5
7364449|NCT01050764|11612979|FG000|Overall Study|Death, before HSCT|1
7364450|NCT01050764|11612979|FG000|Overall Study|Donor mobilization failure, death|1
7364451|NCT01050764|11612979|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
7364452|NCT01050790|11612983|FG000|Overall Study|Adverse Event|1
7364453|NCT01050816|11612988|FG000|Overall Study|Lost to Follow-up|2
7364454|NCT01050816|11612988|FG000|Overall Study|patient's refusal|2
7364455|NCT01050998|11613006|FG000|Overall Study|Adverse Event|1
7364456|NCT01050998|11613007|FG001|Overall Study|Adverse Event|0
7364457|NCT01050998|11613008|FG002|Overall Study|Adverse Event|1
7364458|NCT01050998|11613009|FG003|Overall Study|Adverse Event|0
7364459|NCT01050998|11613010|FG004|Overall Study|Adverse Event|2
7364460|NCT01050998|11613006|FG000|Overall Study|Withdrawal by Subject|0
7364461|NCT01050998|11613007|FG001|Overall Study|Withdrawal by Subject|0
7364462|NCT01050998|11613008|FG002|Overall Study|Withdrawal by Subject|0
7364463|NCT01050998|11613009|FG003|Overall Study|Withdrawal by Subject|1
7364464|NCT01050998|11613010|FG004|Overall Study|Withdrawal by Subject|3
7364465|NCT01050998|11613006|FG000|Overall Study|Other|3
7364466|NCT01050998|11613007|FG001|Overall Study|Other|2
7364467|NCT01050998|11613008|FG002|Overall Study|Other|1
7364468|NCT01050998|11613009|FG003|Overall Study|Other|1
7364469|NCT01050998|11613010|FG004|Overall Study|Other|5
7364470|NCT01050998|11613006|FG000|Overall Study|Data integrity issues|0
7364471|NCT01050998|11613007|FG001|Overall Study|Data integrity issues|0
7364472|NCT01050998|11613008|FG002|Overall Study|Data integrity issues|1
7364473|NCT01050998|11613009|FG003|Overall Study|Data integrity issues|1
7364474|NCT01050998|11613010|FG004|Overall Study|Data integrity issues|4
7364475|NCT01051063|11613028|FG000|Overall Study|Death|2
7364476|NCT01051063|11613029|FG001|Overall Study|Death|2
7364477|NCT01051063|11613028|FG000|Overall Study|Withdrawal by Subject|1
7364478|NCT01051063|11613029|FG001|Overall Study|Withdrawal by Subject|1
7364479|NCT01051063|11613028|FG000|Overall Study|Termination of the study|5
7364480|NCT01051063|11613029|FG001|Overall Study|Termination of the study|0
7364481|NCT01051063|11613028|FG000|Overall Study|Moved from the study site area|1
7364482|NCT01051063|11613029|FG001|Overall Study|Moved from the study site area|0
7364483|NCT01051063|11613028|FG000|Overall Study|Other|1
7364484|NCT01051063|11613029|FG001|Overall Study|Other|0
7364485|NCT01051063|11613028|FG000|Overall Study|Lost to Follow-up|0
7364486|NCT01051063|11613029|FG001|Overall Study|Lost to Follow-up|1
7364487|NCT01051323|11613042|FG000|Overall Study|Discontinuation of treatment|103
7364488|NCT01051323|11613042|FG000|Overall Study|Transplantation|28
7364489|NCT01051323|11613042|FG000|Overall Study|Dialysis dependency|22
7364490|NCT01051323|11613042|FG000|Overall Study|Withdrawal by Subject|13
7364491|NCT01051323|11613042|FG000|Overall Study|Lost to Follow-up|31
7364492|NCT01051323|11613042|FG000|Overall Study|Death|129
7364493|NCT01051323|11613042|FG000|Overall Study|Hospitalization|28
7364494|NCT01051323|11613042|FG000|Overall Study|Other|148
7364495|NCT01051323|11613042|FG000|Overall Study|Missing|37
7364496|NCT01051349|11613050|FG000|Overall Study|Adverse Event|88
7364497|NCT01051349|11613050|FG000|Overall Study|Consent Withdrawn|54
7364498|NCT01051349|11613050|FG000|Overall Study|Investigator Decision|6
7364499|NCT01051349|11613050|FG000|Overall Study|Lost to Follow-up|6
7364500|NCT01051349|11613050|FG000|Overall Study|Subject non-compliance|7
7364501|NCT01051349|11613050|FG000|Overall Study|Reason not Specified|12
7364502|NCT01051466|11613068|FG000|Overall Study|Adverse Event|1
7364503|NCT01051466|11613069|FG001|Overall Study|Adverse Event|0
7364504|NCT01051466|11613068|FG000|Overall Study|Lost to Follow-up|1
7364505|NCT01051466|11613069|FG001|Overall Study|Lost to Follow-up|1
7364506|NCT01051466|11613068|FG000|Overall Study|Withdrawal by Subject|5
7364507|NCT01051466|11613069|FG001|Overall Study|Withdrawal by Subject|1
7364508|NCT01051466|11613068|FG000|Overall Study|Entry Criteria Not Met|0
7364509|NCT01051466|11613069|FG001|Overall Study|Entry Criteria Not Met|3
7364510|NCT01051466|11613068|FG000|Overall Study|Physician Decision|1
7364511|NCT01051466|11613069|FG001|Overall Study|Physician Decision|0
7364512|NCT01051557|11613095|FG000|Overall Study|Physician Decision|1
7364513|NCT01051557|11613096|FG001|Overall Study|Physician Decision|0
7364514|NCT01051557|11613097|FG002|Overall Study|Physician Decision|0
7364515|NCT01051557|11613098|FG003|Overall Study|Physician Decision|0
7364516|NCT01051557|11613099|FG004|Overall Study|Physician Decision|0
7364517|NCT01051557|11613100|FG005|Overall Study|Physician Decision|0
7364518|NCT01051557|11613101|FG006|Overall Study|Physician Decision|0
7364519|NCT01051557|11613095|FG000|Overall Study|disease progression|3
7364520|NCT01051557|11613096|FG001|Overall Study|disease progression|3
7364521|NCT01051557|11613097|FG002|Overall Study|disease progression|5
7364522|NCT01051557|11613098|FG003|Overall Study|disease progression|2
7364523|NCT01051557|11613099|FG004|Overall Study|disease progression|4
7364524|NCT01051557|11613100|FG005|Overall Study|disease progression|3
7364525|NCT01051557|11613101|FG006|Overall Study|disease progression|1
7364526|NCT01051557|11613095|FG000|Overall Study|Withdrawal by Subject|0
7364527|NCT01051557|11613096|FG001|Overall Study|Withdrawal by Subject|0
7364528|NCT01051557|11613097|FG002|Overall Study|Withdrawal by Subject|1
7364529|NCT01051557|11613098|FG003|Overall Study|Withdrawal by Subject|0
7364530|NCT01051557|11613099|FG004|Overall Study|Withdrawal by Subject|2
7364531|NCT01051557|11613100|FG005|Overall Study|Withdrawal by Subject|0
7364532|NCT01051557|11613101|FG006|Overall Study|Withdrawal by Subject|1
7364533|NCT01051557|11613095|FG000|Overall Study|Adverse Event|0
7364534|NCT01051557|11613096|FG001|Overall Study|Adverse Event|0
7364535|NCT01051557|11613097|FG002|Overall Study|Adverse Event|0
7364536|NCT01051557|11613098|FG003|Overall Study|Adverse Event|1
7364537|NCT01051557|11613099|FG004|Overall Study|Adverse Event|1
7364538|NCT01051557|11613100|FG005|Overall Study|Adverse Event|3
7364539|NCT01051557|11613101|FG006|Overall Study|Adverse Event|4
7364540|NCT01051661|11613132|FG000|Overall Study|Adverse Event|1
7364541|NCT01051661|11613133|FG001|Overall Study|Adverse Event|1
7364542|NCT01051661|11613134|FG002|Overall Study|Adverse Event|1
7364543|NCT01051661|11613135|FG003|Overall Study|Adverse Event|1
7364544|NCT01051661|11613136|FG004|Overall Study|Adverse Event|0
7364545|NCT01051661|11613137|FG005|Overall Study|Adverse Event|0
7364546|NCT01051661|11613132|FG000|Overall Study|Lost to Follow-up|13
7364547|NCT01051661|11613133|FG001|Overall Study|Lost to Follow-up|22
7364548|NCT01051661|11613134|FG002|Overall Study|Lost to Follow-up|15
7364549|NCT01051661|11613135|FG003|Overall Study|Lost to Follow-up|17
7364550|NCT01051661|11613136|FG004|Overall Study|Lost to Follow-up|10
7364551|NCT01051661|11613137|FG005|Overall Study|Lost to Follow-up|24
7364552|NCT01051661|11613132|FG000|Overall Study|Migrated/moved from study area|1
7364553|NCT01051661|11613133|FG001|Overall Study|Migrated/moved from study area|6
7364554|NCT01051661|11613134|FG002|Overall Study|Migrated/moved from study area|6
7364555|NCT01051661|11613135|FG003|Overall Study|Migrated/moved from study area|8
7364556|NCT01051661|11613136|FG004|Overall Study|Migrated/moved from study area|7
7364557|NCT01051661|11613137|FG005|Overall Study|Migrated/moved from study area|3
7364558|NCT01051661|11613132|FG000|Overall Study|Refused blood sampling|0
7364559|NCT01051661|11613133|FG001|Overall Study|Refused blood sampling|0
7364560|NCT01051661|11613134|FG002|Overall Study|Refused blood sampling|0
7364561|NCT01051661|11613135|FG003|Overall Study|Refused blood sampling|0
7364562|NCT01051661|11613136|FG004|Overall Study|Refused blood sampling|0
7364563|NCT01051661|11613137|FG005|Overall Study|Refused blood sampling|1
7364564|NCT01051661|11613132|FG000|Overall Study|Data not reliable|1
7364565|NCT01051661|11613133|FG001|Overall Study|Data not reliable|0
7364566|NCT01051661|11613134|FG002|Overall Study|Data not reliable|0
7364567|NCT01051661|11613135|FG003|Overall Study|Data not reliable|0
7364568|NCT01051661|11613136|FG004|Overall Study|Data not reliable|0
7364569|NCT01051661|11613137|FG005|Overall Study|Data not reliable|1
7364570|NCT01051661|11613132|FG000|Overall Study|Unable to attend visit(s)|2
7364571|NCT01051661|11613133|FG001|Overall Study|Unable to attend visit(s)|4
7364572|NCT01051661|11613134|FG002|Overall Study|Unable to attend visit(s)|2
7364573|NCT01051661|11613135|FG003|Overall Study|Unable to attend visit(s)|1
7364574|NCT01051661|11613136|FG004|Overall Study|Unable to attend visit(s)|3
7364575|NCT01051661|11613137|FG005|Overall Study|Unable to attend visit(s)|2
7364576|NCT01051661|11613132|FG000|Overall Study|Consent not received from both parents|0
7364577|NCT01051661|11613133|FG001|Overall Study|Consent not received from both parents|0
7364578|NCT01051661|11613134|FG002|Overall Study|Consent not received from both parents|0
7364579|NCT01051661|11613135|FG003|Overall Study|Consent not received from both parents|0
7364580|NCT01051661|11613136|FG004|Overall Study|Consent not received from both parents|0
7364581|NCT01051661|11613137|FG005|Overall Study|Consent not received from both parents|1
7364582|NCT01051661|11613132|FG000|Overall Study|Failure to comply with protocol|0
7364583|NCT01051661|11613133|FG001|Overall Study|Failure to comply with protocol|0
7364584|NCT01051661|11613134|FG002|Overall Study|Failure to comply with protocol|2
7364585|NCT01051661|11613135|FG003|Overall Study|Failure to comply with protocol|0
7364586|NCT01051661|11613136|FG004|Overall Study|Failure to comply with protocol|0
7364587|NCT01051661|11613137|FG005|Overall Study|Failure to comply with protocol|0
7364588|NCT01051661|11613132|FG000|Overall Study|Subject lost legal representation|0
7364589|NCT01051661|11613133|FG001|Overall Study|Subject lost legal representation|0
7364590|NCT01051661|11613134|FG002|Overall Study|Subject lost legal representation|0
7364591|NCT01051661|11613135|FG003|Overall Study|Subject lost legal representation|0
7364592|NCT01051661|11613136|FG004|Overall Study|Subject lost legal representation|1
7364593|NCT01051661|11613137|FG005|Overall Study|Subject lost legal representation|0
7364594|NCT01051661|11613132|FG000|Overall Study|Protocol Violation|0
7364595|NCT01051661|11613133|FG001|Overall Study|Protocol Violation|0
7364596|NCT01051661|11613134|FG002|Overall Study|Protocol Violation|0
7364597|NCT01051661|11613135|FG003|Overall Study|Protocol Violation|1
7364598|NCT01051661|11613136|FG004|Overall Study|Protocol Violation|2
7364599|NCT01051661|11613137|FG005|Overall Study|Protocol Violation|1
7533290|NCT02684279|11879596|FG000|Overall Study|Lost to Follow-up|61
7533291|NCT02684279|11879596|FG000|Overall Study|Protocol Violation|6
7533292|NCT02684279|11879596|FG000|Overall Study|Pregnancy|8
7533293|NCT02684279|11879596|FG000|Overall Study|Withdrawal by Subject|92
7533294|NCT02684279|11879596|FG000|Overall Study|non-compliance with study drug|9
7533295|NCT02684279|11879596|FG000|Overall Study|non compliance with study visits|2
7533296|NCT02684279|11879596|FG000|Overall Study|subject to have surgery|1
7533297|NCT02684279|11879596|FG000|Overall Study|family emergency|1
7533298|NCT02684279|11879596|FG000|Overall Study|Site closures|7
7533299|NCT02684279|11879596|FG000|Overall Study|Physician Decision|1
7533300|NCT02684344|11879602|FG000|Overall Study|Withdrawal by Subject|0
7533301|NCT02684344|11879603|FG001|Overall Study|Withdrawal by Subject|1
7533302|NCT02684357|11879612|FG000|Part A|Adverse Event (Worsening of Disease)|1
7533303|NCT02684357|11879613|FG001|Part A|Adverse Event (Worsening of Disease)|0
7364600|NCT01051661|11613132|FG000|Overall Study|Withdrawal by Subject|16
7364601|NCT01051661|11613133|FG001|Overall Study|Withdrawal by Subject|30
7364602|NCT01051661|11613134|FG002|Overall Study|Withdrawal by Subject|13
7364603|NCT01051661|11613135|FG003|Overall Study|Withdrawal by Subject|28
7364604|NCT01051661|11613136|FG004|Overall Study|Withdrawal by Subject|12
7364605|NCT01051661|11613137|FG005|Overall Study|Withdrawal by Subject|34
7364606|NCT01051739|11613174|FG000|Overall Study|Death|3
7364607|NCT01051739|11613175|FG001|Overall Study|Death|3
7364608|NCT01051739|11613174|FG000|Overall Study|Withdrawal by Subject|25
7364609|NCT01051739|11613175|FG001|Overall Study|Withdrawal by Subject|10
7364610|NCT01051791|11613190|FG000|Overall Study|Failed screening|3
7364611|NCT01051791|11613190|FG000|Overall Study|Withdrawal by Subject|1
7364612|NCT01051817|11613197|FG000|Overall Study|Adverse Event|0
7364613|NCT01051817|11613198|FG001|Overall Study|Adverse Event|2
7364614|NCT01051817|11613197|FG000|Overall Study|Abnormal Test Proceedure reults|0
7364615|NCT01051817|11613198|FG001|Overall Study|Abnormal Test Proceedure reults|1
7364616|NCT01051817|11613197|FG000|Overall Study|Withdrawal by Subject|3
7364617|NCT01051817|11613198|FG001|Overall Study|Withdrawal by Subject|5
7364618|NCT01051817|11613197|FG000|Overall Study|Protocol Violation|0
7364619|NCT01051817|11613198|FG001|Overall Study|Protocol Violation|1
7364620|NCT01051856|11613206|FG000|Overall Study|Withdrawal by Subject|1
7364621|NCT01051856|11613207|FG001|Overall Study|Withdrawal by Subject|0
7364622|NCT01051960|11613213|FG000|Overall Study|Adverse Event|1
7364623|NCT01051986|11613219|FG000|Overall Study|Death|1
7364624|NCT01051986|11613220|FG001|Overall Study|Death|0
7364625|NCT01051986|11613219|FG000|Overall Study|Withdrawal by Subject|2
7364626|NCT01051986|11613220|FG001|Overall Study|Withdrawal by Subject|1
7364627|NCT01051986|11613219|FG000|Overall Study|Protocol Violation|2
7364628|NCT01051986|11613220|FG001|Overall Study|Protocol Violation|3
7364629|NCT01052012|11613232|FG000|Overall Study|Not treated|2
7364630|NCT01052012|11613233|FG001|Overall Study|Not treated|5
7364631|NCT01052012|11613234|FG002|Overall Study|Not treated|0
7364632|NCT01052012|11613235|FG003|Overall Study|Not treated|0
7364633|NCT01052012|11613236|FG004|Overall Study|Not treated|11
7364634|NCT01052012|11613237|FG005|Overall Study|Not treated|8
7364635|NCT01052012|11613232|FG000|Overall Study|Adverse Event|1
7364636|NCT01052012|11613233|FG001|Overall Study|Adverse Event|0
7364637|NCT01052012|11613234|FG002|Overall Study|Adverse Event|0
7364638|NCT01052012|11613235|FG003|Overall Study|Adverse Event|1
7364639|NCT01052012|11613236|FG004|Overall Study|Adverse Event|0
7364640|NCT01052012|11613237|FG005|Overall Study|Adverse Event|0
7364641|NCT01052012|11613232|FG000|Overall Study|Lost to Follow-up|0
7364642|NCT01052012|11613233|FG001|Overall Study|Lost to Follow-up|0
7364643|NCT01052012|11613234|FG002|Overall Study|Lost to Follow-up|0
7364644|NCT01052012|11613235|FG003|Overall Study|Lost to Follow-up|0
7364645|NCT01052012|11613236|FG004|Overall Study|Lost to Follow-up|1
7364646|NCT01052012|11613237|FG005|Overall Study|Lost to Follow-up|0
7364647|NCT01052012|11613232|FG000|Overall Study|Withdrawal by Subject|1
7364648|NCT01052012|11613233|FG001|Overall Study|Withdrawal by Subject|1
7364649|NCT01052012|11613234|FG002|Overall Study|Withdrawal by Subject|0
7364650|NCT01052012|11613235|FG003|Overall Study|Withdrawal by Subject|0
7364651|NCT01052012|11613236|FG004|Overall Study|Withdrawal by Subject|3
7364652|NCT01052012|11613237|FG005|Overall Study|Withdrawal by Subject|1
7364653|NCT01052012|11613232|FG000|Overall Study|Physician Decision|0
7364654|NCT01052012|11613233|FG001|Overall Study|Physician Decision|0
7533304|NCT02684357|11879614|FG002|Part A|Adverse Event (Worsening of Disease)|0
7364655|NCT01052012|11613234|FG002|Overall Study|Physician Decision|0
7364656|NCT01052012|11613235|FG003|Overall Study|Physician Decision|0
7364657|NCT01052012|11613236|FG004|Overall Study|Physician Decision|0
7364658|NCT01052012|11613237|FG005|Overall Study|Physician Decision|1
7364659|NCT01052012|11613232|FG000|Overall Study|Other|0
7364660|NCT01052012|11613233|FG001|Overall Study|Other|0
7364661|NCT01052012|11613234|FG002|Overall Study|Other|0
7364662|NCT01052012|11613235|FG003|Overall Study|Other|0
7364663|NCT01052012|11613236|FG004|Overall Study|Other|1
7364664|NCT01052012|11613237|FG005|Overall Study|Other|0
7364665|NCT01052038|11613254|FG000|Overall Study|Lost to Follow-up|2
7364666|NCT01052038|11613255|FG001|Overall Study|Lost to Follow-up|3
7364667|NCT01052038|11613256|FG002|Overall Study|Lost to Follow-up|1
7364668|NCT01052038|11613254|FG000|Overall Study|Protocol Violation|2
7364669|NCT01052038|11613255|FG001|Overall Study|Protocol Violation|3
7364670|NCT01052038|11613256|FG002|Overall Study|Protocol Violation|3
7364671|NCT01052077|11613266|FG000|Phase A|Lost to Follow-up|22
7364672|NCT01052077|11613267|FG001|Phase A|Lost to Follow-up|0
7364673|NCT01052077|11613268|FG002|Phase A|Lost to Follow-up|0
7364674|NCT01052077|11613269|FG003|Phase A|Lost to Follow-up|0
7364675|NCT01052077|11613266|FG000|Phase A|Adverse Event|32
7364676|NCT01052077|11613267|FG001|Phase A|Adverse Event|0
7364677|NCT01052077|11613268|FG002|Phase A|Adverse Event|0
7364678|NCT01052077|11613269|FG003|Phase A|Adverse Event|0
7364679|NCT01052077|11613266|FG000|Phase A|Met Withdrawal Criteria|26
7364680|NCT01052077|11613267|FG001|Phase A|Met Withdrawal Criteria|0
7364681|NCT01052077|11613268|FG002|Phase A|Met Withdrawal Criteria|0
7364682|NCT01052077|11613269|FG003|Phase A|Met Withdrawal Criteria|0
7364683|NCT01052077|11613266|FG000|Phase A|Physician Decision|10
7364684|NCT01052077|11613267|FG001|Phase A|Physician Decision|0
7364685|NCT01052077|11613268|FG002|Phase A|Physician Decision|0
7364686|NCT01052077|11613269|FG003|Phase A|Physician Decision|0
7364687|NCT01052077|11613266|FG000|Phase A|Withdrawal by Subject|29
7364688|NCT01052077|11613267|FG001|Phase A|Withdrawal by Subject|0
7364689|NCT01052077|11613268|FG002|Phase A|Withdrawal by Subject|0
7364690|NCT01052077|11613269|FG003|Phase A|Withdrawal by Subject|0
7364691|NCT01052077|11613266|FG000|Phase A|Protocol Deviation|27
7364692|NCT01052077|11613267|FG001|Phase A|Protocol Deviation|0
7364693|NCT01052077|11613268|FG002|Phase A|Protocol Deviation|0
7364694|NCT01052077|11613269|FG003|Phase A|Protocol Deviation|0
7364695|NCT01052077|11613266|FG000|Phase B|Lost to Follow-up|0
7364696|NCT01052077|11613267|FG001|Phase B|Lost to Follow-up|2
7364697|NCT01052077|11613268|FG002|Phase B|Lost to Follow-up|3
7364698|NCT01052077|11613269|FG003|Phase B|Lost to Follow-up|0
7364699|NCT01052077|11613266|FG000|Phase B|Adverse Event|0
7364700|NCT01052077|11613267|FG001|Phase B|Adverse Event|9
7364701|NCT01052077|11613268|FG002|Phase B|Adverse Event|2
7364702|NCT01052077|11613269|FG003|Phase B|Adverse Event|0
7364703|NCT01052077|11613266|FG000|Phase B|Met Withdrawal Criteria|0
7364704|NCT01052077|11613267|FG001|Phase B|Met Withdrawal Criteria|2
7364705|NCT01052077|11613268|FG002|Phase B|Met Withdrawal Criteria|1
7364706|NCT01052077|11613269|FG003|Phase B|Met Withdrawal Criteria|0
7460429|NCT01827371|11755790|FG001|Overall Study|Withdrawal by Subject|2
7460430|NCT01827371|11755791|FG002|Overall Study|Withdrawal by Subject|2
7460431|NCT01827371|11755792|FG003|Overall Study|Withdrawal by Subject|3
7460432|NCT01827371|11755789|FG000|Overall Study|Physician Decision|0
7460433|NCT01827371|11755790|FG001|Overall Study|Physician Decision|1
7460434|NCT01827371|11755791|FG002|Overall Study|Physician Decision|0
7460435|NCT01827371|11755792|FG003|Overall Study|Physician Decision|1
7460436|NCT01827371|11755789|FG000|Overall Study|Temporary study halt to vaccinations|11
7460437|NCT01827371|11755790|FG001|Overall Study|Temporary study halt to vaccinations|2
7460438|NCT01827371|11755791|FG002|Overall Study|Temporary study halt to vaccinations|5
7460439|NCT01827371|11755792|FG003|Overall Study|Temporary study halt to vaccinations|13
7460440|NCT01827592|11755834|FG000|Overall Study|Adverse Event|11
7460441|NCT01827592|11755835|FG001|Overall Study|Adverse Event|9
7460442|NCT01827592|11755836|FG002|Overall Study|Adverse Event|2
7460443|NCT01827592|11755834|FG000|Overall Study|Physician Decision|0
7460444|NCT01827592|11755835|FG001|Overall Study|Physician Decision|2
7460445|NCT01827592|11755836|FG002|Overall Study|Physician Decision|1
7460446|NCT01827592|11755834|FG000|Overall Study|Protocol Violation|2
7460447|NCT01827592|11755835|FG001|Overall Study|Protocol Violation|1
7460448|NCT01827592|11755836|FG002|Overall Study|Protocol Violation|0
7460449|NCT01827592|11755834|FG000|Overall Study|Lost to Follow-up|1
7460450|NCT01827592|11755835|FG001|Overall Study|Lost to Follow-up|2
7460451|NCT01827592|11755836|FG002|Overall Study|Lost to Follow-up|2
7460452|NCT01827592|11755834|FG000|Overall Study|Withdrawal by Subject|12
7460453|NCT01827592|11755835|FG001|Overall Study|Withdrawal by Subject|11
7460454|NCT01827592|11755836|FG002|Overall Study|Withdrawal by Subject|11
7460455|NCT01827592|11755834|FG000|Overall Study|Patient's substantial non-compliance|1
7460456|NCT01827592|11755835|FG001|Overall Study|Patient's substantial non-compliance|1
7460457|NCT01827592|11755836|FG002|Overall Study|Patient's substantial non-compliance|6
7460458|NCT01827592|11755834|FG000|Overall Study|Trial terminated by Sponsor|47
7364707|NCT01052077|11613266|FG000|Phase B|Physician Decision|0
7364708|NCT01052077|11613267|FG001|Phase B|Physician Decision|1
7364709|NCT01052077|11613268|FG002|Phase B|Physician Decision|1
7364710|NCT01052077|11613269|FG003|Phase B|Physician Decision|0
7364711|NCT01052077|11613266|FG000|Phase B|Withdrawal by Subject|0
7364712|NCT01052077|11613267|FG001|Phase B|Withdrawal by Subject|0
7364713|NCT01052077|11613268|FG002|Phase B|Withdrawal by Subject|5
7364714|NCT01052077|11613269|FG003|Phase B|Withdrawal by Subject|0
7364715|NCT01052077|11613266|FG000|Phase B|Protocol Deviation|0
7364716|NCT01052077|11613267|FG001|Phase B|Protocol Deviation|3
7460459|NCT01827592|11755835|FG001|Overall Study|Trial terminated by Sponsor|53
7460460|NCT01827592|11755836|FG002|Overall Study|Trial terminated by Sponsor|51
7364717|NCT01052077|11613268|FG002|Phase B|Protocol Deviation|4
7364718|NCT01052077|11613269|FG003|Phase B|Protocol Deviation|0
7460461|NCT01827592|11755834|FG000|Overall Study|Others|0
7460462|NCT01827592|11755835|FG001|Overall Study|Others|1
7364719|NCT01052077|11613266|FG000|Phase B|Lack of Efficacy|0
7364720|NCT01052077|11613267|FG001|Phase B|Lack of Efficacy|1
7364721|NCT01052077|11613268|FG002|Phase B|Lack of Efficacy|0
7364722|NCT01052077|11613269|FG003|Phase B|Lack of Efficacy|0
7364723|NCT01052077|11613266|FG000|Phase A+|Lost to Follow-up|0
7364724|NCT01052077|11613267|FG001|Phase A+|Lost to Follow-up|0
7364725|NCT01052077|11613268|FG002|Phase A+|Lost to Follow-up|0
7364726|NCT01052077|11613269|FG003|Phase A+|Lost to Follow-up|8
7364727|NCT01052077|11613266|FG000|Phase A+|Adverse Event|0
7364728|NCT01052077|11613267|FG001|Phase A+|Adverse Event|0
7364729|NCT01052077|11613268|FG002|Phase A+|Adverse Event|0
7364730|NCT01052077|11613269|FG003|Phase A+|Adverse Event|4
7364731|NCT01052077|11613266|FG000|Phase A+|Met Withdrawal Criteria|0
7364732|NCT01052077|11613267|FG001|Phase A+|Met Withdrawal Criteria|0
7364733|NCT01052077|11613268|FG002|Phase A+|Met Withdrawal Criteria|0
7364734|NCT01052077|11613269|FG003|Phase A+|Met Withdrawal Criteria|2
7364735|NCT01052077|11613266|FG000|Phase A+|Withdrawal by Subject|0
7364736|NCT01052077|11613267|FG001|Phase A+|Withdrawal by Subject|0
7364737|NCT01052077|11613268|FG002|Phase A+|Withdrawal by Subject|0
7364738|NCT01052077|11613269|FG003|Phase A+|Withdrawal by Subject|7
7364755|NCT01052116|11613287|FG000|Overall Study|Lost to Follow-up|11
7364756|NCT01052116|11613288|FG001|Overall Study|Lost to Follow-up|17
7364757|NCT01052116|11613287|FG000|Overall Study|Withdrawal by Subject|3
7364758|NCT01052116|11613288|FG001|Overall Study|Withdrawal by Subject|6
7364759|NCT01052116|11613287|FG000|Overall Study|Spirometry not performed|0
7364760|NCT01052116|11613288|FG001|Overall Study|Spirometry not performed|4
7364761|NCT01052272|11613307|FG000|Overall Study|Death|0
7364762|NCT01052272|11613308|FG001|Overall Study|Death|0
7364763|NCT01052272|11613309|FG002|Overall Study|Death|1
7364764|NCT01052272|11613310|FG003|Overall Study|Death|1
7364765|NCT01052272|11613307|FG000|Overall Study|Physician Decision|0
7364766|NCT01052272|11613308|FG001|Overall Study|Physician Decision|1
7364767|NCT01052272|11613309|FG002|Overall Study|Physician Decision|0
7364768|NCT01052272|11613310|FG003|Overall Study|Physician Decision|0
7364769|NCT01052272|11613307|FG000|Overall Study|patient refuses follow-up|5
7364770|NCT01052272|11613308|FG001|Overall Study|patient refuses follow-up|4
7364771|NCT01052272|11613309|FG002|Overall Study|patient refuses follow-up|2
7364772|NCT01052272|11613310|FG003|Overall Study|patient refuses follow-up|4
7364773|NCT01052272|11613307|FG000|Overall Study|Withdrawal by Subject|0
7364774|NCT01052272|11613308|FG001|Overall Study|Withdrawal by Subject|2
7364775|NCT01052272|11613309|FG002|Overall Study|Withdrawal by Subject|3
7364776|NCT01052272|11613310|FG003|Overall Study|Withdrawal by Subject|2
7364777|NCT01052272|11613307|FG000|Overall Study|placed in long-term care|0
7364778|NCT01052272|11613308|FG001|Overall Study|placed in long-term care|0
7364779|NCT01052272|11613309|FG002|Overall Study|placed in long-term care|1
7364780|NCT01052272|11613310|FG003|Overall Study|placed in long-term care|0
7364781|NCT01052272|11613307|FG000|Overall Study|decline in health|0
7364782|NCT01052272|11613308|FG001|Overall Study|decline in health|0
7364783|NCT01052272|11613309|FG002|Overall Study|decline in health|1
7364784|NCT01052272|11613310|FG003|Overall Study|decline in health|0
7364785|NCT01052428|11613322|FG000|Overall Study|Death|1
7364786|NCT01052428|11613323|FG001|Overall Study|Death|0
7364787|NCT01052428|11613322|FG000|Overall Study|Withdrawal by Subject|0
7364788|NCT01052428|11613323|FG001|Overall Study|Withdrawal by Subject|1
7364789|NCT01052480|11613331|FG000|Overall Study|Lost to Follow-up|3
7364790|NCT01052480|11613332|FG001|Overall Study|Lost to Follow-up|3
7364791|NCT01052480|11613331|FG000|Overall Study|Protocol Violation|1
7364792|NCT01052480|11613332|FG001|Overall Study|Protocol Violation|0
7364793|NCT01052480|11613331|FG000|Overall Study|Withdrawal by Subject|3
7364794|NCT01052480|11613332|FG001|Overall Study|Withdrawal by Subject|7
7364795|NCT01052480|11613331|FG000|Overall Study|Physician Decision|0
7364796|NCT01052480|11613332|FG001|Overall Study|Physician Decision|2
7364797|NCT01052480|11613331|FG000|Overall Study|Death|1
7364798|NCT01052480|11613332|FG001|Overall Study|Death|5
7364799|NCT01052493|11613338|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
7364800|NCT01052493|11613339|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7364801|NCT01052493|11613340|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
7364802|NCT01052662|11613377|FG000|Overall Study|Lost to Follow-up|15
7364803|NCT01052662|11613378|FG001|Overall Study|Lost to Follow-up|13
7364804|NCT01052662|11613379|FG002|Overall Study|Lost to Follow-up|18
7364805|NCT01052662|11613377|FG000|Overall Study|Withdrawal by Subject|3
7364806|NCT01052662|11613378|FG001|Overall Study|Withdrawal by Subject|2
7364807|NCT01052662|11613379|FG002|Overall Study|Withdrawal by Subject|1
7364808|NCT01052662|11613377|FG000|Overall Study|Pharmacy issue|1
7364809|NCT01052662|11613378|FG001|Overall Study|Pharmacy issue|3
7364810|NCT01052662|11613379|FG002|Overall Study|Pharmacy issue|3
7364811|NCT01052662|11613377|FG000|Overall Study|Adverse Event|1
7364812|NCT01052662|11613378|FG001|Overall Study|Adverse Event|1
7364813|NCT01052662|11613379|FG002|Overall Study|Adverse Event|0
7364814|NCT01052662|11613377|FG000|Overall Study|Legal Problem|2
7364815|NCT01052662|11613378|FG001|Overall Study|Legal Problem|0
7364816|NCT01052662|11613379|FG002|Overall Study|Legal Problem|0
7364817|NCT01052662|11613377|FG000|Overall Study|Administrative|0
7364818|NCT01052662|11613378|FG001|Overall Study|Administrative|3
7364819|NCT01052662|11613379|FG002|Overall Study|Administrative|0
7364820|NCT01052714|11613398|FG000|Overall Study|Adverse Event|6
7364821|NCT01052714|11613399|FG001|Overall Study|Adverse Event|3
7364822|NCT01052714|11613400|FG002|Overall Study|Adverse Event|0
7364823|NCT01052714|11613398|FG000|Overall Study|Death|1
7364824|NCT01052714|11613399|FG001|Overall Study|Death|2
7364825|NCT01052714|11613400|FG002|Overall Study|Death|0
7364826|NCT01052714|11613398|FG000|Overall Study|Lost to Follow-up|2
7364827|NCT01052714|11613399|FG001|Overall Study|Lost to Follow-up|3
7364828|NCT01052714|11613400|FG002|Overall Study|Lost to Follow-up|0
7364829|NCT01052714|11613398|FG000|Overall Study|Physician Decision|9
7364830|NCT01052714|11613399|FG001|Overall Study|Physician Decision|9
7364831|NCT01052714|11613400|FG002|Overall Study|Physician Decision|1
7364832|NCT01052714|11613398|FG000|Overall Study|Withdrawal by Subject|7
7364833|NCT01052714|11613399|FG001|Overall Study|Withdrawal by Subject|12
7364834|NCT01052714|11613400|FG002|Overall Study|Withdrawal by Subject|1
7386587|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7460481|NCT01828567|11755992|FG001|Overall Study|Lost to Follow-up|9
7386588|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386589|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386590|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386591|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386592|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386593|NCT01212757|11645372|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
7386594|NCT01212757|11645373|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
7386595|NCT01212757|11645374|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386596|NCT01212757|11645375|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386597|NCT01212757|11645376|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386598|NCT01212757|11645377|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386599|NCT01212757|11645378|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386600|NCT01212757|11645379|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386601|NCT01212757|11645380|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
7386602|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7386603|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7386604|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
7386605|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
7386606|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7386607|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
7386608|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7386609|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7386610|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
7386611|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7386612|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
7386613|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
7386614|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
7386615|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7386616|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
7386617|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7386618|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7386619|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
7386620|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386621|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386622|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
7386623|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386624|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386625|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386626|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7460463|NCT01827592|11755836|FG002|Overall Study|Others|3
7386627|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386628|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
7386629|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7460464|NCT01827670|11755846|FG000|Overall Study|Withdrawal of Consent|3
7364835|NCT01052779|11613408|FG000|Overall Study|Adverse Event|1
7364836|NCT01052779|11613409|FG001|Overall Study|Adverse Event|4
7364837|NCT01052779|11613408|FG000|Overall Study|Withdrawal by Subject|1
7364838|NCT01052779|11613409|FG001|Overall Study|Withdrawal by Subject|2
7364839|NCT01052779|11613408|FG000|Overall Study|Other-Protocol Violation|1
7364840|NCT01052779|11613409|FG001|Overall Study|Other-Protocol Violation|1
7364841|NCT01052779|11613408|FG000|Overall Study|Other-Surgery|0
7364842|NCT01052779|11613409|FG001|Overall Study|Other-Surgery|2
7364843|NCT01052779|11613408|FG000|Overall Study|Other-Missed Week 5 Visit|2
7364844|NCT01052779|11613409|FG001|Overall Study|Other-Missed Week 5 Visit|0
7364845|NCT01052844|11613426|FG000|Overall Study|Adverse Event|0
7364846|NCT01052844|11613427|FG001|Overall Study|Adverse Event|1
7364847|NCT01053247|11613588|FG000|Overall Study|Withdrawal by Subject|9
7364848|NCT01053247|11613589|FG001|Overall Study|Withdrawal by Subject|4
7364849|NCT01053247|11613590|FG002|Overall Study|Withdrawal by Subject|15
7364850|NCT01053247|11613588|FG000|Overall Study|Lack of Efficacy|1
7364851|NCT01053247|11613589|FG001|Overall Study|Lack of Efficacy|0
7364852|NCT01053247|11613590|FG002|Overall Study|Lack of Efficacy|1
7364853|NCT01053247|11613588|FG000|Overall Study|Protocol Violation|2
7364854|NCT01053247|11613589|FG001|Overall Study|Protocol Violation|1
7364855|NCT01053247|11613590|FG002|Overall Study|Protocol Violation|2
7364856|NCT01053247|11613588|FG000|Overall Study|Lost to Follow-up|8
7364857|NCT01053247|11613589|FG001|Overall Study|Lost to Follow-up|5
7364858|NCT01053247|11613590|FG002|Overall Study|Lost to Follow-up|7
7364859|NCT01053247|11613588|FG000|Overall Study|Adverse Event|0
7364860|NCT01053247|11613589|FG001|Overall Study|Adverse Event|9
7364861|NCT01053247|11613590|FG002|Overall Study|Adverse Event|3
7364862|NCT01053429|11613616|FG000|Overall Study|Adverse Event|64
7364863|NCT01053429|11613616|FG000|Overall Study|Other|309
7364864|NCT01053663|11613632|FG000|Overall Study|Death|2
7364865|NCT01053663|11613632|FG000|Overall Study|Lost to Follow-up|1
7364866|NCT01053663|11613632|FG000|Overall Study|Poor IV Access|1
7364867|NCT01053663|11613632|FG000|Overall Study|Transferred to Another Hospital|1
7364868|NCT01053663|11613632|FG000|Overall Study|Negative Influenza Diagnosis|1
7364869|NCT01053741|11613644|FG000|2nd Study Intervention|Physician Decision|0
7364870|NCT01053741|11613645|FG001|2nd Study Intervention|Physician Decision|1
7364871|NCT01053962|11613671|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7364872|NCT01053962|11613672|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7364873|NCT01053962|11613673|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
7364874|NCT01053962|11613674|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
7364875|NCT01053962|11613675|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
7364876|NCT01053962|11613671|FG000|Pretreatment Period|Venipuncture Failure|0
7364877|NCT01053962|11613672|FG001|Pretreatment Period|Venipuncture Failure|0
7364878|NCT01053962|11613673|FG002|Pretreatment Period|Venipuncture Failure|1
7364879|NCT01053962|11613674|FG003|Pretreatment Period|Venipuncture Failure|0
7364880|NCT01053962|11613675|FG004|Pretreatment Period|Venipuncture Failure|0
7364881|NCT01053962|11613671|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
7364882|NCT01053962|11613672|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
7364883|NCT01053962|11613673|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
7364884|NCT01053962|11613674|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
7364885|NCT01053962|11613675|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
7364886|NCT01053962|11613671|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
7364887|NCT01053962|11613672|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
7364888|NCT01053962|11613673|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
7364889|NCT01053962|11613674|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
7364890|NCT01053962|11613675|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
7364891|NCT01053962|11613671|FG000|Treatment Period|Lack of Efficacy|0
7364892|NCT01053962|11613672|FG001|Treatment Period|Lack of Efficacy|0
7364893|NCT01053962|11613673|FG002|Treatment Period|Lack of Efficacy|0
7364894|NCT01053962|11613674|FG003|Treatment Period|Lack of Efficacy|0
7364895|NCT01053962|11613675|FG004|Treatment Period|Lack of Efficacy|1
7364896|NCT01053962|11613671|FG000|Treatment Period|Adverse Event|0
7364897|NCT01053962|11613672|FG001|Treatment Period|Adverse Event|0
7364898|NCT01053962|11613673|FG002|Treatment Period|Adverse Event|0
7364899|NCT01053962|11613674|FG003|Treatment Period|Adverse Event|0
7364900|NCT01053962|11613675|FG004|Treatment Period|Adverse Event|1
7364901|NCT01053962|11613671|FG000|Treatment Period|Withdrawal by Subject|0
7364902|NCT01053962|11613672|FG001|Treatment Period|Withdrawal by Subject|0
7364903|NCT01053962|11613673|FG002|Treatment Period|Withdrawal by Subject|0
7364904|NCT01053962|11613674|FG003|Treatment Period|Withdrawal by Subject|0
7364905|NCT01053962|11613675|FG004|Treatment Period|Withdrawal by Subject|1
7364906|NCT01053962|11613671|FG000|Treatment Period|Noncompliance with protocol|1
7364907|NCT01053962|11613672|FG001|Treatment Period|Noncompliance with protocol|0
7364908|NCT01053962|11613673|FG002|Treatment Period|Noncompliance with protocol|0
7364909|NCT01053962|11613674|FG003|Treatment Period|Noncompliance with protocol|0
7364910|NCT01053962|11613675|FG004|Treatment Period|Noncompliance with protocol|0
7364911|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
7364912|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7364913|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7364914|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7364915|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7364916|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7364917|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
7364918|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7364919|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7364920|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7364921|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7364922|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7364923|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
7364924|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7364925|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7364926|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7460465|NCT01827670|11755847|FG001|Overall Study|Withdrawal of Consent|2
7460466|NCT01827670|11755846|FG000|Overall Study|Lost to Follow-up|0
7460467|NCT01827670|11755847|FG001|Overall Study|Lost to Follow-up|1
7460468|NCT01827839|11755870|FG000|Overall Study|Adverse Event|1
7460469|NCT01827839|11755870|FG000|Overall Study|Consent Withdrawal|2
7460470|NCT01827943|11755894|FG000|Overall Study|Protocol Violation|8
7460471|NCT01827943|11755894|FG000|Overall Study|Never treated because of an rapid progression|1
7460472|NCT01828034|11755902|FG000|Overall Study|Withdrawal by Subject|0
7460473|NCT01828034|11755903|FG001|Overall Study|Withdrawal by Subject|0
7460474|NCT01828034|11755904|FG002|Overall Study|Withdrawal by Subject|0
7460475|NCT01828034|11755905|FG003|Overall Study|Withdrawal by Subject|1
7460476|NCT01828073|11755914|FG000|Overall Study|Lost to Follow-up|1
7460477|NCT01828073|11755915|FG001|Overall Study|Lost to Follow-up|2
7460478|NCT01828281|11755959|FG000|Overall Study|Withdrawal by Subject|1
7460479|NCT01828281|11755960|FG001|Overall Study|Withdrawal by Subject|0
7460480|NCT01828567|11755991|FG000|Overall Study|Lost to Follow-up|27
7460482|NCT01828567|11755991|FG000|Overall Study|Excluded - did not meet criteria|4
7460483|NCT01828567|11755992|FG001|Overall Study|Excluded - did not meet criteria|1
7460484|NCT01829048|11756028|FG000|Overall Study|Withdrawal by Subject|0
7460485|NCT01829048|11756029|FG001|Overall Study|Withdrawal by Subject|0
7460486|NCT01829048|11756030|FG002|Overall Study|Withdrawal by Subject|0
7460487|NCT01829048|11756031|FG003|Overall Study|Withdrawal by Subject|2
7460488|NCT01829048|11756032|FG004|Overall Study|Withdrawal by Subject|0
7460489|NCT01829113|11756047|FG000|Overall Study|Disease Progression|37
7460490|NCT01829113|11756048|FG001|Overall Study|Disease Progression|48
7460491|NCT01829113|11756047|FG000|Overall Study|Adverse Event|14
7460492|NCT01829113|11756048|FG001|Overall Study|Adverse Event|10
7460493|NCT01829113|11756047|FG000|Overall Study|Withdrawal by Subject|17
7460494|NCT01829113|11756048|FG001|Overall Study|Withdrawal by Subject|10
7460495|NCT01829113|11756047|FG000|Overall Study|Death|4
7460496|NCT01829113|11756048|FG001|Overall Study|Death|6
7460497|NCT01829113|11756047|FG000|Overall Study|Sponsor Decision|1
7460498|NCT01829113|11756048|FG001|Overall Study|Sponsor Decision|1
7460499|NCT01829113|11756047|FG000|Overall Study|No Study Treatment Received|3
7460500|NCT01829113|11756048|FG001|Overall Study|No Study Treatment Received|2
7460501|NCT01829113|11756047|FG000|Overall Study|Physician Decision|1
7460502|NCT01829113|11756048|FG001|Overall Study|Physician Decision|1
7460503|NCT01829165|11756058|FG000|Overall Study|Did not complete intervention|2
7460504|NCT01829165|11756059|FG001|Overall Study|Did not complete intervention|0
7460505|NCT01829191|11756067|FG000|Overall Study|Relocation|0
7460506|NCT01829191|11756068|FG001|Overall Study|Relocation|1
7460507|NCT01829191|11756067|FG000|Overall Study|Lens discomfort|0
7460508|NCT01829191|11756068|FG001|Overall Study|Lens discomfort|3
7460509|NCT01829191|11756067|FG000|Overall Study|Lens handling difficulty|1
7460510|NCT01829191|11756068|FG001|Overall Study|Lens handling difficulty|4
7460511|NCT01829191|11756067|FG000|Overall Study|Protocol Violation|4
7460512|NCT01829191|11756068|FG001|Overall Study|Protocol Violation|1
7460513|NCT01829191|11756067|FG000|Overall Study|Withdrawal by Subject|2
7460514|NCT01829191|11756068|FG001|Overall Study|Withdrawal by Subject|3
7460515|NCT01829191|11756067|FG000|Overall Study|Lost to Follow-up|0
7460516|NCT01829191|11756068|FG001|Overall Study|Lost to Follow-up|1
7460517|NCT01829191|11756067|FG000|Overall Study|Subject was fit for ortho - k|0
7460518|NCT01829191|11756068|FG001|Overall Study|Subject was fit for ortho - k|1
7460519|NCT01829230|11756079|FG000|Overall Study|Protocol Violation|0
7460520|NCT01829230|11756080|FG001|Overall Study|Protocol Violation|2
7460521|NCT01829230|11756079|FG000|Overall Study|Withdrawal by Subject|0
7460522|NCT01829230|11756080|FG001|Overall Study|Withdrawal by Subject|1
7460523|NCT01829230|11756079|FG000|Overall Study|Lost to Follow-up|1
7460524|NCT01829230|11756080|FG001|Overall Study|Lost to Follow-up|1
7460525|NCT01829243|11756086|FG000|First Intervention|Screen Failure|4
7460526|NCT01829243|11756087|FG001|First Intervention|Screen Failure|2
7460527|NCT01829295|11756097|FG000|6-12 Months|Did not want to switch antimetabolites|0
7460528|NCT01829295|11756098|FG001|6-12 Months|Did not want to switch antimetabolites|0
7460529|NCT01829295|11756099|FG002|6-12 Months|Did not want to switch antimetabolites|9
7460530|NCT01829295|11756100|FG003|6-12 Months|Did not want to switch antimetabolites|11
7460531|NCT01829295|11756097|FG000|6-12 Months|Adverse Event|0
7364927|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7364928|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7364929|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
7364930|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7364931|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7364932|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7364933|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
7364934|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
7364935|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
7364936|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7364937|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7364938|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7364939|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
7364940|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
7364941|NCT01053988|11613697|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7364942|NCT01053988|11613698|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7364943|NCT01053988|11613699|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7364944|NCT01053988|11613700|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7364945|NCT01053988|11613701|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7364946|NCT01053988|11613702|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7364947|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7364948|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
7364949|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
7364950|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
7364951|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
7364952|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
7364953|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7364954|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7364955|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7364956|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
7364957|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7364958|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7364959|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7364960|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
7364961|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
7364962|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
7364963|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
7364964|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7364965|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7364966|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
7364967|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
7364968|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7364969|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
7364970|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
7364971|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
7364972|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
7364973|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
7364974|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
7364975|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
7364976|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
7364977|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7364978|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
7364979|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7364980|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7364981|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7364982|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7364983|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7364984|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
7364985|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
7364986|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
7364987|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
7364988|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
7364989|NCT01053988|11613697|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7364990|NCT01053988|11613698|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
7364991|NCT01053988|11613699|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7364992|NCT01053988|11613700|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7364993|NCT01053988|11613701|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
7364994|NCT01053988|11613702|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7364995|NCT01054144|11613718|FG000|Overall Study|Death|2
7364996|NCT01054170|11613727|FG000|Overall Study|Protocol Violation|1
7364997|NCT01054170|11613728|FG001|Overall Study|Protocol Violation|0
7364998|NCT01054170|11613727|FG000|Overall Study|Withdrawal by Subject|3
7364999|NCT01054170|11613728|FG001|Overall Study|Withdrawal by Subject|2
7365000|NCT01054170|11613727|FG000|Overall Study|Adverse Event|0
7365001|NCT01054170|11613728|FG001|Overall Study|Adverse Event|4
7365002|NCT01054222|11613752|FG000|Overall Study|Lack of Efficacy|1
7365003|NCT01054222|11613752|FG000|Overall Study|Lost to Follow-up|4
7365004|NCT01054222|11613752|FG000|Overall Study|Withdrawal by Subject|6
7365005|NCT01054300|11613758|FG000|Period 1|Adverse Event|1
7365006|NCT01054300|11613759|FG001|Period 1|Adverse Event|0
7365007|NCT01054300|11613760|FG002|Period 1|Adverse Event|0
7365008|NCT01054300|11613761|FG003|Period 1|Adverse Event|0
7365009|NCT01054300|11613758|FG000|Period 2|Withdrawal by Subject|0
7365010|NCT01054300|11613759|FG001|Period 2|Withdrawal by Subject|0
7365011|NCT01054300|11613760|FG002|Period 2|Withdrawal by Subject|1
7365012|NCT01054300|11613761|FG003|Period 2|Withdrawal by Subject|0
7365013|NCT01054443|11613799|FG000|Overall Study|Withdrawal by Subject|0
7365014|NCT01054443|11613800|FG001|Overall Study|Withdrawal by Subject|0
7365015|NCT01054443|11613801|FG002|Overall Study|Withdrawal by Subject|0
7365016|NCT01054443|11613802|FG003|Overall Study|Withdrawal by Subject|1
7365017|NCT01054456|11613815|FG000|Overall Study|Other|1
7365018|NCT01054560|11613821|FG000|Overall Study|Death|10
7365019|NCT01054560|11613822|FG001|Overall Study|Death|21
7365020|NCT01054560|11613821|FG000|Overall Study|Lost to Follow-up|2
7365021|NCT01054560|11613822|FG001|Overall Study|Lost to Follow-up|5
7365022|NCT01054560|11613821|FG000|Overall Study|Withdrawal by Subject|0
7365023|NCT01054560|11613822|FG001|Overall Study|Withdrawal by Subject|2
7365024|NCT01054560|11613821|FG000|Overall Study|Physician Decision|1
7365025|NCT01054560|11613822|FG001|Overall Study|Physician Decision|0
7365026|NCT01054573|11613834|FG000|Overall Study|Adverse Event|1
7365027|NCT01054573|11613835|FG001|Overall Study|Adverse Event|0
7365028|NCT01054573|11613836|FG002|Overall Study|Adverse Event|1
7365029|NCT01054573|11613837|FG003|Overall Study|Adverse Event|1
7365030|NCT01054573|11613834|FG000|Overall Study|Lost to Follow-up|0
7365031|NCT01054573|11613835|FG001|Overall Study|Lost to Follow-up|2
7365032|NCT01054573|11613836|FG002|Overall Study|Lost to Follow-up|0
7365033|NCT01054573|11613837|FG003|Overall Study|Lost to Follow-up|0
7365034|NCT01054573|11613834|FG000|Overall Study|Withdrawal by Subject|0
7365035|NCT01054573|11613835|FG001|Overall Study|Withdrawal by Subject|2
7365036|NCT01054573|11613836|FG002|Overall Study|Withdrawal by Subject|2
7365037|NCT01054573|11613837|FG003|Overall Study|Withdrawal by Subject|1
7365038|NCT01054599|11613885|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
7365039|NCT01054599|11613886|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
7365040|NCT01054599|11613885|FG000|Overall Study|Protocol Violation|1
7365041|NCT01054599|11613886|FG001|Overall Study|Protocol Violation|0
7365042|NCT01054599|11613885|FG000|Overall Study|Spells/seizure-like episodes|1
7365043|NCT01054599|11613886|FG001|Overall Study|Spells/seizure-like episodes|1
7365044|NCT01054599|11613885|FG000|Overall Study|Timing/scheduling difficulties|1
7365045|NCT01054599|11613886|FG001|Overall Study|Timing/scheduling difficulties|1
7365046|NCT01054599|11613885|FG000|Overall Study|Visual impairment, WTAR <80|0
7365047|NCT01054599|11613886|FG001|Overall Study|Visual impairment, WTAR <80|1
7365048|NCT01054599|11613885|FG000|Overall Study|Lost to Follow-up|0
7365049|NCT01054599|11613886|FG001|Overall Study|Lost to Follow-up|2
7365050|NCT01054599|11613885|FG000|Overall Study|Adverse Event|0
7365051|NCT01054599|11613886|FG001|Overall Study|Adverse Event|1
7365052|NCT01054599|11613885|FG000|Overall Study|Withdrawal by Subject|0
7365053|NCT01054599|11613886|FG001|Overall Study|Withdrawal by Subject|1
7365054|NCT01054729|11613913|FG000|Overall Study|Randomized but Not Treated|0
7365055|NCT01054729|11613914|FG001|Overall Study|Randomized but Not Treated|1
7365056|NCT01054729|11613915|FG002|Overall Study|Randomized but Not Treated|0
7365057|NCT01054729|11613916|FG003|Overall Study|Randomized but Not Treated|0
7365058|NCT01054729|11613913|FG000|Overall Study|Adverse Event|1
7365059|NCT01054729|11613914|FG001|Overall Study|Adverse Event|1
7365060|NCT01054729|11613915|FG002|Overall Study|Adverse Event|2
7365061|NCT01054729|11613916|FG003|Overall Study|Adverse Event|1
7365062|NCT01054729|11613913|FG000|Overall Study|Withdrawal by Subject|1
7365063|NCT01054729|11613914|FG001|Overall Study|Withdrawal by Subject|0
7365064|NCT01054729|11613915|FG002|Overall Study|Withdrawal by Subject|1
7365065|NCT01054729|11613916|FG003|Overall Study|Withdrawal by Subject|0
7365066|NCT01054729|11613913|FG000|Overall Study|Lost to Follow-up|0
7365067|NCT01054729|11613914|FG001|Overall Study|Lost to Follow-up|1
7365068|NCT01054729|11613915|FG002|Overall Study|Lost to Follow-up|0
7365069|NCT01054729|11613916|FG003|Overall Study|Lost to Follow-up|0
7365070|NCT01054729|11613913|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
7365071|NCT01054729|11613914|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
7365072|NCT01054729|11613915|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
7365073|NCT01054729|11613916|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
7365074|NCT01054729|11613913|FG000|Overall Study|Non-responder|1
7365075|NCT01054729|11613914|FG001|Overall Study|Non-responder|0
7365076|NCT01054729|11613915|FG002|Overall Study|Non-responder|1
7365077|NCT01054729|11613916|FG003|Overall Study|Non-responder|1
7365078|NCT01054729|11613913|FG000|Overall Study|PEG/RBV Non-responder|1
7365079|NCT01054729|11613914|FG001|Overall Study|PEG/RBV Non-responder|0
7365080|NCT01054729|11613915|FG002|Overall Study|PEG/RBV Non-responder|1
7569963|NCT03475316|11947096|FG001|6 Month Intervention|Adverse Event|1
7569964|NCT03475316|11947095|FG000|6 Month Intervention|Withdrawal by Subject|2
7569965|NCT03475316|11947096|FG001|6 Month Intervention|Withdrawal by Subject|0
7365081|NCT01054729|11613916|FG003|Overall Study|PEG/RBV Non-responder|0
7365082|NCT01054729|11613913|FG000|Overall Study|Personal/Obligations|0
7365083|NCT01054729|11613914|FG001|Overall Study|Personal/Obligations|1
7365084|NCT01054729|11613915|FG002|Overall Study|Personal/Obligations|0
7365085|NCT01054729|11613916|FG003|Overall Study|Personal/Obligations|0
7365086|NCT01054729|11613913|FG000|Overall Study|Subject moved|0
7365087|NCT01054729|11613914|FG001|Overall Study|Subject moved|0
7365088|NCT01054729|11613915|FG002|Overall Study|Subject moved|1
7365089|NCT01054729|11613916|FG003|Overall Study|Subject moved|0
7365090|NCT01054729|11613913|FG000|Overall Study|Lack of Efficacy|0
7365091|NCT01054729|11613914|FG001|Overall Study|Lack of Efficacy|0
7365092|NCT01054729|11613915|FG002|Overall Study|Lack of Efficacy|0
7365093|NCT01054729|11613916|FG003|Overall Study|Lack of Efficacy|1
7365094|NCT01054820|11613939|FG000|Overall Study|Withdrawal by Subject|2
7365095|NCT01054846|11613945|FG000|Overall Study|Lost to Follow-up|76
7365096|NCT01054846|11613946|FG001|Overall Study|Lost to Follow-up|17
7365097|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
7365098|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7365099|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7365100|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7365101|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7365102|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7365103|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
7460532|NCT01829295|11756098|FG001|6-12 Months|Adverse Event|0
7460533|NCT01829295|11756099|FG002|6-12 Months|Adverse Event|3
7460534|NCT01829295|11756100|FG003|6-12 Months|Adverse Event|2
7460535|NCT01829295|11756097|FG000|6-12 Months|Lost to Follow-up|2
7460536|NCT01829295|11756098|FG001|6-12 Months|Lost to Follow-up|0
7460537|NCT01829295|11756099|FG002|6-12 Months|Lost to Follow-up|0
7460538|NCT01829295|11756100|FG003|6-12 Months|Lost to Follow-up|0
7460539|NCT01829295|11756097|FG000|6-12 Months|Withdrawal by Subject|2
7460540|NCT01829295|11756098|FG001|6-12 Months|Withdrawal by Subject|2
7460541|NCT01829295|11756099|FG002|6-12 Months|Withdrawal by Subject|0
7460542|NCT01829295|11756100|FG003|6-12 Months|Withdrawal by Subject|0
7460543|NCT01829347|11756112|FG000|VTI-210|Death|5
7460544|NCT01829347|11756113|FG001|VTI-210|Death|3
7460545|NCT01829347|11756112|FG000|VTI-210|Withdrawal by Subject|1
7460546|NCT01829347|11756113|FG001|VTI-210|Withdrawal by Subject|0
7460547|NCT01829347|11756112|FG000|VTI-210E|Death|2
7460548|NCT01829347|11756113|FG001|VTI-210E|Death|1
7460549|NCT01829347|11756112|FG000|VTI-210E|Study terminated prematurely|1
7460550|NCT01829347|11756113|FG001|VTI-210E|Study terminated prematurely|5
7460551|NCT01829360|11756123|FG000|Overall Study|Protocol Violation|0
7460552|NCT01829360|11756124|FG001|Overall Study|Protocol Violation|0
7460553|NCT01829360|11756125|FG002|Overall Study|Protocol Violation|1
7460554|NCT01829360|11756126|FG003|Overall Study|Protocol Violation|0
7460555|NCT01829425|11756153|FG000|Overall Study|Withdrawal by Subject|4
7460556|NCT01829425|11756154|FG001|Overall Study|Withdrawal by Subject|3
7460557|NCT01829425|11756153|FG000|Overall Study|Lost to Follow-up|2
7460558|NCT01829425|11756154|FG001|Overall Study|Lost to Follow-up|1
7460559|NCT01829464|11756163|FG000|Overall Study|Adverse Event|1
7460560|NCT01829464|11756164|FG001|Overall Study|Adverse Event|0
7460561|NCT01829464|11756165|FG002|Overall Study|Adverse Event|0
7460562|NCT01829464|11756163|FG000|Overall Study|Lost to Follow-up|0
7460563|NCT01829464|11756164|FG001|Overall Study|Lost to Follow-up|0
7460564|NCT01829464|11756165|FG002|Overall Study|Lost to Follow-up|1
7460565|NCT01829464|11756163|FG000|Overall Study|Withdrawal by Subject|2
7460566|NCT01829464|11756164|FG001|Overall Study|Withdrawal by Subject|0
7460567|NCT01829464|11756165|FG002|Overall Study|Withdrawal by Subject|0
7460568|NCT01829464|11756163|FG000|Overall Study|Study terminated by sponsor|25
7460569|NCT01829464|11756164|FG001|Overall Study|Study terminated by sponsor|28
7460570|NCT01829464|11756165|FG002|Overall Study|Study terminated by sponsor|25
7460571|NCT01829464|11756163|FG000|Overall Study|Lack of Efficacy|0
7460572|NCT01829464|11756164|FG001|Overall Study|Lack of Efficacy|1
7460573|NCT01829464|11756165|FG002|Overall Study|Lack of Efficacy|0
7365104|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
7365105|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
7460574|NCT01830127|11756198|FG000|Overall Study|Adverse Event|1
7460575|NCT01830127|11756199|FG001|Overall Study|Adverse Event|6
7460576|NCT01830127|11756198|FG000|Overall Study|Lack of Efficacy|3
7460577|NCT01830127|11756199|FG001|Overall Study|Lack of Efficacy|0
7460578|NCT01830127|11756198|FG000|Overall Study|Withdrawal by Subject|1
7460579|NCT01830127|11756199|FG001|Overall Study|Withdrawal by Subject|1
7460580|NCT01830127|11756198|FG000|Overall Study|Other reason not defined above|0
7569966|NCT03475316|11947095|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
7365106|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
7365107|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
7365108|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
7365109|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
7365110|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
7365111|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
7365112|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365113|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365114|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365115|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365116|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365117|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
7365118|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
7365119|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365120|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365121|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365122|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365123|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365124|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
7365125|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
7365126|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
7365127|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
7365128|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
7365129|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
7365130|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
7365131|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
7365132|NCT01054885|11613957|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
7365133|NCT01054885|11613958|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365134|NCT01054885|11613959|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365135|NCT01054885|11613960|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365136|NCT01054885|11613961|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365137|NCT01054885|11613962|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365138|NCT01054885|11613963|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
7365139|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
7365140|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
7365141|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
7365142|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
7365143|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
7365144|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
7365145|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
7365146|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7365147|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7365148|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
7365149|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7365150|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7365151|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
7365152|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
7365153|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
7365154|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
7365155|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
7365156|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
7365157|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
7365158|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7365159|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
7365160|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
7365161|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
7365162|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
7365163|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
7365164|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
7365165|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
7365166|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
7365167|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
7365168|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7365169|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7365170|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7365171|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
7365172|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
7365173|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
7365174|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7365175|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7365176|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7365177|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7365178|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7365179|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
7365180|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
7365181|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7365182|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
7365183|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7365184|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7365185|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
7365186|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
7365187|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
7365188|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
7365189|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
7365190|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
7365191|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
7365192|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
7365193|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
7365194|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
7365195|NCT01054885|11613957|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
7365196|NCT01054885|11613958|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
7365197|NCT01054885|11613959|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7365198|NCT01054885|11613960|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
7365199|NCT01054885|11613961|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
7365200|NCT01054885|11613962|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
7365276|NCT01055457|11614082|FG005|Overall Study|Subject Ineligible|0
7365201|NCT01054885|11613963|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
7365202|NCT01054976|11613984|FG000|Overall Study|Adverse Event|16
7365203|NCT01054976|11613984|FG000|Overall Study|Uncooperative participations to study|7
7365204|NCT01054976|11613984|FG000|Overall Study|Withdrawal by Subject|4
7365205|NCT01054976|11613984|FG000|Overall Study|Other|8
7365206|NCT01055028|11613990|FG000|Screening|Screen Failure|1
7365207|NCT01055028|11613991|FG001|Screening|Screen Failure|1
7365208|NCT01055028|11613990|FG000|Treatment Cycles 1 to 3|Adverse Event|0
7365209|NCT01055028|11613991|FG001|Treatment Cycles 1 to 3|Adverse Event|1
7365210|NCT01055028|11613990|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7365211|NCT01055028|11613991|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
7365212|NCT01055028|11613990|FG000|Inter-treatment Period|Did not start Cycle 4|0
7365213|NCT01055028|11613991|FG001|Inter-treatment Period|Did not start Cycle 4|3
7365214|NCT01055132|11614007|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
7365215|NCT01055132|11614008|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
7365216|NCT01055132|11614007|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
7365217|NCT01055132|11614008|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
7365218|NCT01055197|11614033|FG000|Overall Study|Protocol Violation|7
7365219|NCT01055197|11614034|FG001|Overall Study|Protocol Violation|2
7365220|NCT01055197|11614033|FG000|Overall Study|Withdrawal by Subject|2
7365221|NCT01055197|11614034|FG001|Overall Study|Withdrawal by Subject|0
7365222|NCT01055262|11614053|FG000|Overall Study|Adverse Event|5
7365223|NCT01055262|11614053|FG000|Overall Study|Protocol Violation|3
7365224|NCT01055262|11614053|FG000|Overall Study|Uncooperativeness|1
7365225|NCT01055314|11614059|FG000|Overall Study|Adverse Event|7
7365226|NCT01055314|11614060|FG001|Overall Study|Adverse Event|4
7365227|NCT01055314|11614059|FG000|Overall Study|Death|2
7365228|NCT01055314|11614060|FG001|Overall Study|Death|1
7365229|NCT01055314|11614059|FG000|Overall Study|Lack of Efficacy|11
7365230|NCT01055314|11614060|FG001|Overall Study|Lack of Efficacy|19
7365231|NCT01055314|11614059|FG000|Overall Study|Physician Decision|10
7365232|NCT01055314|11614060|FG001|Overall Study|Physician Decision|5
7365233|NCT01055314|11614059|FG000|Overall Study|Withdrawal by Subject|1
7365234|NCT01055314|11614060|FG001|Overall Study|Withdrawal by Subject|0
7365235|NCT01055314|11614059|FG000|Overall Study|Ineligible|3
7365236|NCT01055314|11614060|FG001|Overall Study|Ineligible|5
7365237|NCT01055314|11614059|FG000|Overall Study|Refusal of further protocol therapy|10
7460581|NCT01830127|11756199|FG001|Overall Study|Other reason not defined above|2
7460582|NCT01830543|11756245|FG000|Overall Study|Subject Decision|19
7460583|NCT01830543|11756246|FG001|Overall Study|Subject Decision|21
7460584|NCT01830543|11756247|FG002|Overall Study|Subject Decision|57
7460585|NCT01830543|11756245|FG000|Overall Study|Adverse Event|91
7460586|NCT01830543|11756246|FG001|Overall Study|Adverse Event|77
7460587|NCT01830543|11756247|FG002|Overall Study|Adverse Event|76
7460588|NCT01830543|11756245|FG000|Overall Study|Death|20
7460589|NCT01830543|11756246|FG001|Overall Study|Death|22
7460590|NCT01830543|11756247|FG002|Overall Study|Death|22
7365238|NCT01055314|11614060|FG001|Overall Study|Refusal of further protocol therapy|4
7365239|NCT01055314|11614059|FG000|Overall Study|No treatment|1
7365240|NCT01055314|11614060|FG001|Overall Study|No treatment|0
7365241|NCT01055457|11614077|FG000|Overall Study|Lost to Follow-up|0
7365242|NCT01055457|11614078|FG001|Overall Study|Lost to Follow-up|1
7365243|NCT01055457|11614079|FG002|Overall Study|Lost to Follow-up|0
7365244|NCT01055457|11614080|FG003|Overall Study|Lost to Follow-up|0
7365245|NCT01055457|11614081|FG004|Overall Study|Lost to Follow-up|0
7365246|NCT01055457|11614082|FG005|Overall Study|Lost to Follow-up|1
7365247|NCT01055457|11614083|FG006|Overall Study|Lost to Follow-up|0
7365248|NCT01055457|11614084|FG007|Overall Study|Lost to Follow-up|0
7365249|NCT01055457|11614085|FG008|Overall Study|Lost to Follow-up|0
7365250|NCT01055457|11614086|FG009|Overall Study|Lost to Follow-up|0
7365251|NCT01055457|11614077|FG000|Overall Study|Protocol Violation|0
7365252|NCT01055457|11614078|FG001|Overall Study|Protocol Violation|0
7365253|NCT01055457|11614079|FG002|Overall Study|Protocol Violation|1
7365254|NCT01055457|11614080|FG003|Overall Study|Protocol Violation|1
7365255|NCT01055457|11614081|FG004|Overall Study|Protocol Violation|1
7365256|NCT01055457|11614082|FG005|Overall Study|Protocol Violation|2
7365257|NCT01055457|11614083|FG006|Overall Study|Protocol Violation|1
7365258|NCT01055457|11614084|FG007|Overall Study|Protocol Violation|0
7365259|NCT01055457|11614085|FG008|Overall Study|Protocol Violation|0
7365260|NCT01055457|11614086|FG009|Overall Study|Protocol Violation|1
7365261|NCT01055457|11614077|FG000|Overall Study|Subject Disinterest|0
7365262|NCT01055457|11614078|FG001|Overall Study|Subject Disinterest|0
7365263|NCT01055457|11614079|FG002|Overall Study|Subject Disinterest|0
7365264|NCT01055457|11614080|FG003|Overall Study|Subject Disinterest|0
7365265|NCT01055457|11614081|FG004|Overall Study|Subject Disinterest|0
7365266|NCT01055457|11614082|FG005|Overall Study|Subject Disinterest|0
7365267|NCT01055457|11614083|FG006|Overall Study|Subject Disinterest|0
7365268|NCT01055457|11614084|FG007|Overall Study|Subject Disinterest|1
7365269|NCT01055457|11614085|FG008|Overall Study|Subject Disinterest|0
7365270|NCT01055457|11614086|FG009|Overall Study|Subject Disinterest|0
7365271|NCT01055457|11614077|FG000|Overall Study|Subject Ineligible|1
7365272|NCT01055457|11614078|FG001|Overall Study|Subject Ineligible|0
7365273|NCT01055457|11614079|FG002|Overall Study|Subject Ineligible|1
7365274|NCT01055457|11614080|FG003|Overall Study|Subject Ineligible|0
7365275|NCT01055457|11614081|FG004|Overall Study|Subject Ineligible|1
7365277|NCT01055457|11614083|FG006|Overall Study|Subject Ineligible|0
7365278|NCT01055457|11614084|FG007|Overall Study|Subject Ineligible|0
7365279|NCT01055457|11614085|FG008|Overall Study|Subject Ineligible|0
7365280|NCT01055457|11614086|FG009|Overall Study|Subject Ineligible|0
7365281|NCT01055457|11614077|FG000|Overall Study|Discomfort|0
7365282|NCT01055457|11614078|FG001|Overall Study|Discomfort|0
7365283|NCT01055457|11614079|FG002|Overall Study|Discomfort|0
7365284|NCT01055457|11614080|FG003|Overall Study|Discomfort|0
7365285|NCT01055457|11614081|FG004|Overall Study|Discomfort|1
7365286|NCT01055457|11614082|FG005|Overall Study|Discomfort|0
7365287|NCT01055457|11614083|FG006|Overall Study|Discomfort|0
7365288|NCT01055457|11614084|FG007|Overall Study|Discomfort|0
7365289|NCT01055457|11614085|FG008|Overall Study|Discomfort|0
7365290|NCT01055457|11614086|FG009|Overall Study|Discomfort|0
7365291|NCT01055457|11614077|FG000|Overall Study|Pregnancy|0
7365292|NCT01055457|11614078|FG001|Overall Study|Pregnancy|0
7365293|NCT01055457|11614079|FG002|Overall Study|Pregnancy|0
7365294|NCT01055457|11614080|FG003|Overall Study|Pregnancy|1
7365295|NCT01055457|11614081|FG004|Overall Study|Pregnancy|0
7365296|NCT01055457|11614082|FG005|Overall Study|Pregnancy|0
7365297|NCT01055457|11614083|FG006|Overall Study|Pregnancy|0
7365298|NCT01055457|11614084|FG007|Overall Study|Pregnancy|0
7365299|NCT01055457|11614085|FG008|Overall Study|Pregnancy|0
7365300|NCT01055457|11614086|FG009|Overall Study|Pregnancy|0
7365301|NCT01055457|11614077|FG000|Overall Study|Adverse Event|0
7365302|NCT01055457|11614078|FG001|Overall Study|Adverse Event|0
7365303|NCT01055457|11614079|FG002|Overall Study|Adverse Event|0
7365304|NCT01055457|11614080|FG003|Overall Study|Adverse Event|1
7365305|NCT01055457|11614081|FG004|Overall Study|Adverse Event|0
7365306|NCT01055457|11614082|FG005|Overall Study|Adverse Event|0
7365307|NCT01055457|11614083|FG006|Overall Study|Adverse Event|0
7365308|NCT01055457|11614084|FG007|Overall Study|Adverse Event|0
7365309|NCT01055457|11614085|FG008|Overall Study|Adverse Event|0
7365310|NCT01055457|11614086|FG009|Overall Study|Adverse Event|0
7365311|NCT01055496|11614110|FG000|Overall Study|Withdrawal by Subject|2
7365312|NCT01055496|11614111|FG001|Overall Study|Withdrawal by Subject|4
7365313|NCT01055496|11614110|FG000|Overall Study|Death|13
7365314|NCT01055496|11614111|FG001|Overall Study|Death|23
7365315|NCT01055496|11614110|FG000|Overall Study|Lost to Follow-up|0
7365316|NCT01055496|11614111|FG001|Overall Study|Lost to Follow-up|2
7365317|NCT01055496|11614110|FG000|Overall Study|Other - Unspecified|0
7365318|NCT01055496|11614111|FG001|Overall Study|Other - Unspecified|1
7365319|NCT01055613|11614140|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
7365320|NCT01055613|11614141|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7365321|NCT01055613|11614140|FG000|Overall Study|Unacceptable lens fit|1
7365322|NCT01055613|11614141|FG001|Overall Study|Unacceptable lens fit|0
7365323|NCT01055613|11614140|FG000|Overall Study|Discomfort|2
7365324|NCT01055613|11614141|FG001|Overall Study|Discomfort|1
7365325|NCT01055613|11614140|FG000|Overall Study|Lost to Follow-up|1
7365326|NCT01055613|11614141|FG001|Overall Study|Lost to Follow-up|1
7365327|NCT01055613|11614140|FG000|Overall Study|Protocol Violation|1
7365328|NCT01055613|11614141|FG001|Overall Study|Protocol Violation|1
7365329|NCT01055613|11614140|FG000|Overall Study|Subject Disinterest|1
7365330|NCT01055613|11614141|FG001|Overall Study|Subject Disinterest|1
7365331|NCT01055639|11614149|FG000|Overall Study|Adverse Event|0
7365332|NCT01055639|11614150|FG001|Overall Study|Adverse Event|1
7365333|NCT01055639|11614149|FG000|Overall Study|Lack of Efficacy|0
7365334|NCT01055639|11614150|FG001|Overall Study|Lack of Efficacy|1
7365335|NCT01055639|11614149|FG000|Overall Study|Lost to Follow-up|8
7365336|NCT01055639|11614150|FG001|Overall Study|Lost to Follow-up|11
7365337|NCT01055639|11614149|FG000|Overall Study|Protocol Violation|5
7365338|NCT01055639|11614150|FG001|Overall Study|Protocol Violation|5
7365339|NCT01055639|11614149|FG000|Overall Study|Withdrawal by Subject|8
7365340|NCT01055639|11614150|FG001|Overall Study|Withdrawal by Subject|11
7365341|NCT01055834|11614194|FG000|Treatment Period I|Adverse Event|1
7365342|NCT01055834|11614195|FG001|Treatment Period I|Adverse Event|0
7365343|NCT01055886|11614206|FG000|Overall Study|Withdrawal by Subject|4
7365344|NCT01055886|11614207|FG001|Overall Study|Withdrawal by Subject|9
7365345|NCT01055886|11614206|FG000|Overall Study|Lost to Follow-up|1
7365346|NCT01055886|11614207|FG001|Overall Study|Lost to Follow-up|1
7365347|NCT01055886|11614206|FG000|Overall Study|Withdrawal by PI|0
7365348|NCT01055886|11614207|FG001|Overall Study|Withdrawal by PI|1
7365349|NCT01056107|11614226|FG000|Overall Study|Withdrawal by Subject|0
7365350|NCT01056107|11614227|FG001|Overall Study|Withdrawal by Subject|1
7365351|NCT01056107|11614228|FG002|Overall Study|Withdrawal by Subject|3
7365352|NCT01056107|11614229|FG003|Overall Study|Withdrawal by Subject|0
7365353|NCT01056263|11614250|FG000|Overall Study|Adverse Event|12
7365354|NCT01056263|11614250|FG000|Overall Study|Death|1
7365355|NCT01056263|11614250|FG000|Overall Study|Withdrawal by Subject|1
7365356|NCT01056263|11614250|FG000|Overall Study|Lack of Efficacy|29
7365357|NCT01056263|11614250|FG000|Overall Study|Progressive disease|2
7365358|NCT01056263|11614250|FG000|Overall Study|Neoplasm progression|1
7365359|NCT01056263|11614250|FG000|Overall Study|Objective progression or relapse|1
7365360|NCT01056263|11614250|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
7365361|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Toxicity|2
7365362|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Toxicity|1
7365363|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
7365364|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
7365365|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
7365366|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
7365367|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
7365368|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
7460591|NCT01830543|11756245|FG000|Overall Study|Protocol Violation|3
7460592|NCT01830543|11756246|FG001|Overall Study|Protocol Violation|7
7460593|NCT01830543|11756247|FG002|Overall Study|Protocol Violation|7
7365369|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
7365370|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
7365371|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Death|3
7365372|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Death|1
7365373|NCT01056276|11614256|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
7365374|NCT01056276|11614257|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
7365375|NCT01056276|11614256|FG000|Maintenance Therapy|Toxicity|0
7365376|NCT01056276|11614257|FG001|Maintenance Therapy|Toxicity|2
7365377|NCT01056276|11614256|FG000|Maintenance Therapy|Progressive Disease|0
7365378|NCT01056276|11614257|FG001|Maintenance Therapy|Progressive Disease|9
7365379|NCT01056276|11614256|FG000|Maintenance Therapy|Physician Decision|0
7365380|NCT01056276|11614257|FG001|Maintenance Therapy|Physician Decision|1
7460594|NCT01830543|11756245|FG000|Overall Study|Physician Decision|11
7365381|NCT01056276|11614256|FG000|Maintenance Therapy|Withdrawal by Subject|0
7365382|NCT01056276|11614257|FG001|Maintenance Therapy|Withdrawal by Subject|1
7365383|NCT01056276|11614256|FG000|Maintenance Therapy|Intercurrent Illness|0
7365384|NCT01056276|11614257|FG001|Maintenance Therapy|Intercurrent Illness|1
7365385|NCT01056276|11614256|FG000|Maintenance Therapy|Continuing maintenance therapy|0
7365386|NCT01056276|11614257|FG001|Maintenance Therapy|Continuing maintenance therapy|14
7365387|NCT01056289|11614268|FG000|Open-label Phase|Adverse Event|29
7365388|NCT01056289|11614269|FG001|Open-label Phase|Adverse Event|0
7365389|NCT01056289|11614270|FG002|Open-label Phase|Adverse Event|0
7365390|NCT01056289|11614271|FG003|Open-label Phase|Adverse Event|0
7365391|NCT01056289|11614268|FG000|Open-label Phase|Lost to Follow-up|30
7365392|NCT01056289|11614269|FG001|Open-label Phase|Lost to Follow-up|0
7365393|NCT01056289|11614270|FG002|Open-label Phase|Lost to Follow-up|0
7365394|NCT01056289|11614271|FG003|Open-label Phase|Lost to Follow-up|0
7365395|NCT01056289|11614268|FG000|Open-label Phase|Other|9
7365396|NCT01056289|11614269|FG001|Open-label Phase|Other|0
7365397|NCT01056289|11614270|FG002|Open-label Phase|Other|0
7365398|NCT01056289|11614271|FG003|Open-label Phase|Other|0
7365399|NCT01056289|11614268|FG000|Open-label Phase|Protocol Violation|6
7365400|NCT01056289|11614269|FG001|Open-label Phase|Protocol Violation|0
7365401|NCT01056289|11614270|FG002|Open-label Phase|Protocol Violation|0
7365402|NCT01056289|11614271|FG003|Open-label Phase|Protocol Violation|0
7365403|NCT01056289|11614268|FG000|Open-label Phase|Withdrawal by Subject|26
7365404|NCT01056289|11614269|FG001|Open-label Phase|Withdrawal by Subject|0
7365405|NCT01056289|11614270|FG002|Open-label Phase|Withdrawal by Subject|0
7365406|NCT01056289|11614271|FG003|Open-label Phase|Withdrawal by Subject|0
7365407|NCT01056289|11614268|FG000|Open-label Phase|Lack of Efficacy|18
7365408|NCT01056289|11614269|FG001|Open-label Phase|Lack of Efficacy|0
7365409|NCT01056289|11614270|FG002|Open-label Phase|Lack of Efficacy|0
7365410|NCT01056289|11614271|FG003|Open-label Phase|Lack of Efficacy|0
7365411|NCT01056289|11614268|FG000|Open-label Phase|Not randomized to Double-blind phase|1
7365412|NCT01056289|11614269|FG001|Open-label Phase|Not randomized to Double-blind phase|0
7365413|NCT01056289|11614270|FG002|Open-label Phase|Not randomized to Double-blind phase|0
7365414|NCT01056289|11614271|FG003|Open-label Phase|Not randomized to Double-blind phase|0
7365415|NCT01056289|11614268|FG000|Double-blind Phase|Adverse Event|0
7365416|NCT01056289|11614269|FG001|Double-blind Phase|Adverse Event|1
7365417|NCT01056289|11614270|FG002|Double-blind Phase|Adverse Event|2
7365418|NCT01056289|11614271|FG003|Double-blind Phase|Adverse Event|1
7365419|NCT01056289|11614268|FG000|Double-blind Phase|Lost to Follow-up|0
7365420|NCT01056289|11614269|FG001|Double-blind Phase|Lost to Follow-up|2
7365421|NCT01056289|11614270|FG002|Double-blind Phase|Lost to Follow-up|2
7365422|NCT01056289|11614271|FG003|Double-blind Phase|Lost to Follow-up|2
7365423|NCT01056289|11614268|FG000|Double-blind Phase|Other|0
7365424|NCT01056289|11614269|FG001|Double-blind Phase|Other|0
7365425|NCT01056289|11614270|FG002|Double-blind Phase|Other|1
7365426|NCT01056289|11614271|FG003|Double-blind Phase|Other|2
7365427|NCT01056289|11614268|FG000|Double-blind Phase|Protocol Violation|0
7365428|NCT01056289|11614269|FG001|Double-blind Phase|Protocol Violation|0
7365429|NCT01056289|11614270|FG002|Double-blind Phase|Protocol Violation|1
7365430|NCT01056289|11614271|FG003|Double-blind Phase|Protocol Violation|1
7365431|NCT01056289|11614268|FG000|Double-blind Phase|Withdrawal by Subject|0
7365432|NCT01056289|11614269|FG001|Double-blind Phase|Withdrawal by Subject|0
7365433|NCT01056289|11614270|FG002|Double-blind Phase|Withdrawal by Subject|4
7365434|NCT01056289|11614271|FG003|Double-blind Phase|Withdrawal by Subject|2
7365435|NCT01056289|11614268|FG000|Double-blind Phase|Discontinuation symptom|0
7365436|NCT01056289|11614269|FG001|Double-blind Phase|Discontinuation symptom|1
7365437|NCT01056289|11614270|FG002|Double-blind Phase|Discontinuation symptom|2
7365438|NCT01056289|11614271|FG003|Double-blind Phase|Discontinuation symptom|2
7365439|NCT01056289|11614268|FG000|Double-blind Phase|Physician Decision|0
7365440|NCT01056289|11614269|FG001|Double-blind Phase|Physician Decision|0
7365441|NCT01056289|11614270|FG002|Double-blind Phase|Physician Decision|1
7365442|NCT01056289|11614271|FG003|Double-blind Phase|Physician Decision|0
7365443|NCT01056341|11614303|FG000|Overall Study|Treatment Intolerance|0
7365444|NCT01056341|11614304|FG001|Overall Study|Treatment Intolerance|2
7365445|NCT01056341|11614305|FG002|Overall Study|Treatment Intolerance|0
7365446|NCT01056341|11614306|FG003|Overall Study|Treatment Intolerance|2
7365447|NCT01056341|11614307|FG004|Overall Study|Treatment Intolerance|0
7365448|NCT01056341|11614303|FG000|Overall Study|Lack of Efficacy|32
7365449|NCT01056341|11614304|FG001|Overall Study|Lack of Efficacy|30
7365450|NCT01056341|11614305|FG002|Overall Study|Lack of Efficacy|7
7365451|NCT01056341|11614306|FG003|Overall Study|Lack of Efficacy|25
7365452|NCT01056341|11614307|FG004|Overall Study|Lack of Efficacy|9
7365453|NCT01056341|11614303|FG000|Overall Study|Other reasons|4
7365454|NCT01056341|11614304|FG001|Overall Study|Other reasons|4
7365455|NCT01056341|11614305|FG002|Overall Study|Other reasons|8
7365456|NCT01056341|11614306|FG003|Overall Study|Other reasons|9
7365457|NCT01056341|11614307|FG004|Overall Study|Other reasons|5
7365458|NCT01056380|11614327|FG000|Overall Study|Lost to Follow-up|2
7365459|NCT01056380|11614328|FG001|Overall Study|Lost to Follow-up|3
7365460|NCT01056484|11614338|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
7365461|NCT01056484|11614339|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
7365462|NCT01056484|11614338|FG000|Randomized Controlled Trial|Physician Decision|1
7365463|NCT01056484|11614339|FG001|Randomized Controlled Trial|Physician Decision|0
7365464|NCT01056484|11614338|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
7365465|NCT01056484|11614339|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
7365466|NCT01056510|11614348|FG000|Overall Study|Dropout Before Start of Treatment|1
7365467|NCT01056510|11614349|FG001|Overall Study|Dropout Before Start of Treatment|1
7365468|NCT01056510|11614348|FG000|Overall Study|Withdrawal by Subject|4
7365469|NCT01056510|11614349|FG001|Overall Study|Withdrawal by Subject|2
7365470|NCT01056510|11614348|FG000|Overall Study|Death|29
7365471|NCT01056510|11614349|FG001|Overall Study|Death|34
7365472|NCT01056510|11614348|FG000|Overall Study|Noncompliance|1
7365473|NCT01056510|11614349|FG001|Overall Study|Noncompliance|3
7365474|NCT01056510|11614348|FG000|Overall Study|Physician Decision|4
7365475|NCT01056510|11614349|FG001|Overall Study|Physician Decision|5
7365476|NCT01056510|11614348|FG000|Overall Study|Lost to Follow-up|5
7365477|NCT01056510|11614349|FG001|Overall Study|Lost to Follow-up|6
7365478|NCT01056510|11614348|FG000|Overall Study|Other|10
7365479|NCT01056510|11614349|FG001|Overall Study|Other|12
7365480|NCT01056510|11614348|FG000|Overall Study|Missing|0
7365481|NCT01056510|11614349|FG001|Overall Study|Missing|1
7365482|NCT01056523|11614355|FG000|Overall Study|Death|1
7365483|NCT01056523|11614356|FG001|Overall Study|Death|0
7365484|NCT01056523|11614357|FG002|Overall Study|Death|2
7365485|NCT01056523|11614358|FG003|Overall Study|Death|3
7365486|NCT01056523|11614359|FG004|Overall Study|Death|0
7365487|NCT01056523|11614360|FG005|Overall Study|Death|0
7365488|NCT01056523|11614361|FG006|Overall Study|Death|1
7365489|NCT01056536|11614369|FG000|Overall Study|Lost to Follow-up|202
7365490|NCT01056536|11614370|FG001|Overall Study|Lost to Follow-up|116
7365491|NCT01056536|11614371|FG002|Overall Study|Lost to Follow-up|248
7365492|NCT01056640|11614385|FG000|Overall Study|Withdrawal by Subject|11
7365493|NCT01056640|11614386|FG001|Overall Study|Withdrawal by Subject|8
7365494|NCT01056640|11614385|FG000|Overall Study|Death|15
7365495|NCT01056640|11614386|FG001|Overall Study|Death|4
7365496|NCT01056653|11614395|FG000|Overall Study|Lost to Follow-up|0
7365497|NCT01056653|11614396|FG001|Overall Study|Lost to Follow-up|0
7365498|NCT01056653|11614397|FG002|Overall Study|Lost to Follow-up|2
7365499|NCT01056718|11614406|FG000|Overall Study|Withdrawal by Subject|2
7365500|NCT01056718|11614406|FG000|Overall Study|Ischemia on baseline stress test|1
7365501|NCT01056822|11614413|FG000|Overall Study|Adverse Event|0
7365502|NCT01056822|11614414|FG001|Overall Study|Adverse Event|1
7365503|NCT01056822|11614413|FG000|Overall Study|Protocol Violation|6
7365504|NCT01056822|11614414|FG001|Overall Study|Protocol Violation|5
7365505|NCT01056822|11614413|FG000|Overall Study|Withdrawal by Subject|1
7365506|NCT01056822|11614414|FG001|Overall Study|Withdrawal by Subject|1
7365507|NCT01056822|11614413|FG000|Overall Study|Lost to Follow-up|1
7365508|NCT01056822|11614414|FG001|Overall Study|Lost to Follow-up|0
7365509|NCT01057251|11614449|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
7365510|NCT01057251|11614450|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
7365511|NCT01057251|11614449|FG000|Overall Study|Adverse Event|4
7365512|NCT01057251|11614450|FG001|Overall Study|Adverse Event|2
7365513|NCT01057251|11614449|FG000|Overall Study|Lack of Efficacy|2
7365514|NCT01057251|11614450|FG001|Overall Study|Lack of Efficacy|11
7365515|NCT01057251|11614449|FG000|Overall Study|Protocol Violation|6
7365516|NCT01057251|11614450|FG001|Overall Study|Protocol Violation|2
7365517|NCT01057251|11614449|FG000|Overall Study|Withdrawal by Subject|4
7365518|NCT01057251|11614450|FG001|Overall Study|Withdrawal by Subject|5
7365519|NCT01057251|11614449|FG000|Overall Study|Lost to Follow-up|7
7365520|NCT01057251|11614450|FG001|Overall Study|Lost to Follow-up|6
7365521|NCT01057251|11614449|FG000|Overall Study|Other Reason|1
7365522|NCT01057251|11614450|FG001|Overall Study|Other Reason|1
7365523|NCT01057394|11614477|FG000|Overall Study|Not eligible|0
7365524|NCT01057394|11614478|FG001|Overall Study|Not eligible|2
7365525|NCT01057433|11614482|FG000|Overall Study|Adverse Event|1
7365526|NCT01057589|11614486|FG000|Overall Study|Disease Progression|35
7365527|NCT01057589|11614486|FG000|Overall Study|Adverse Event|10
7365528|NCT01057589|11614486|FG000|Overall Study|Physician Decision|8
7365529|NCT01057589|11614486|FG000|Overall Study|Withdrawal by Subject|3
7365530|NCT01057589|11614486|FG000|Overall Study|Sponsor Decision|1
7365531|NCT01057589|11614486|FG000|Overall Study|Death|8
7365532|NCT01057589|11614486|FG000|Overall Study|Lost to Follow-up|1
7365533|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
7365534|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7365535|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
7365536|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
7365537|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7365538|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
7365539|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
7365540|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7365541|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
7365542|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
7365543|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7365544|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
7365545|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
7365546|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7387691|NCT01215851|11646412|FG003|Treatment Period|Adverse Event|3
7365547|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
7365548|NCT01057693|11614490|FG000|Single-Blind Phase (Up to Week 6)|Other|2
7365549|NCT01057693|11614491|FG001|Single-Blind Phase (Up to Week 6)|Other|0
7365550|NCT01057693|11614492|FG002|Single-Blind Phase (Up to Week 6)|Other|0
7365551|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
7365552|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
7365553|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
7365554|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
7365555|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7365556|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
7365557|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
7365558|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7365559|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
7365560|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
7365561|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
7365562|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
7365563|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
7365564|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7365565|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
7365566|NCT01057693|11614490|FG000|Between Single-Blind and Double-Blind|Other|6
7365567|NCT01057693|11614491|FG001|Between Single-Blind and Double-Blind|Other|0
7365568|NCT01057693|11614492|FG002|Between Single-Blind and Double-Blind|Other|0
7365569|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
7365570|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
7365571|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
7365572|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
7365573|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
7365574|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
7365575|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
7365576|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
7365577|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
7365578|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7365579|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
7365580|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
7365581|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
7365582|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
7365583|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
7365584|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
7365585|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
7365586|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
7365587|NCT01057693|11614490|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7365588|NCT01057693|11614491|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
7365589|NCT01057693|11614492|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
7365590|NCT01057810|11614502|FG000|Overall Study|Disease progression|156
7365591|NCT01057810|11614503|FG001|Overall Study|Disease progression|197
7365592|NCT01057810|11614502|FG000|Overall Study|Study drug toxicity|5
7365593|NCT01057810|11614503|FG001|Overall Study|Study drug toxicity|114
7365594|NCT01057810|11614502|FG000|Overall Study|Adverse event unrelated to study drug|13
7365595|NCT01057810|11614503|FG001|Overall Study|Adverse event unrelated to study drug|29
7365596|NCT01057810|11614502|FG000|Overall Study|Withdrawal by Subject|10
7365597|NCT01057810|11614503|FG001|Overall Study|Withdrawal by Subject|25
7365598|NCT01057810|11614502|FG000|Overall Study|Death|2
7365599|NCT01057810|11614503|FG001|Overall Study|Death|12
7365600|NCT01057810|11614502|FG000|Overall Study|Maximum clinical benefit|5
7365601|NCT01057810|11614503|FG001|Overall Study|Maximum clinical benefit|5
7365602|NCT01057810|11614502|FG000|Overall Study|Poor/non-compliance|0
7365603|NCT01057810|11614503|FG001|Overall Study|Poor/non-compliance|1
7365604|NCT01057810|11614502|FG000|Overall Study|No longer met study criteria|0
7365605|NCT01057810|11614503|FG001|Overall Study|No longer met study criteria|1
7365606|NCT01057810|11614502|FG000|Overall Study|Other|7
7365607|NCT01057810|11614503|FG001|Overall Study|Other|14
7365608|NCT01057862|11614511|FG000|Overall Study|Withdrawal by Subject|1
7365609|NCT01057862|11614512|FG001|Overall Study|Withdrawal by Subject|2
7365610|NCT01058005|11614541|FG000|Overall Study|Adverse Event|0
7365611|NCT01058005|11614542|FG001|Overall Study|Adverse Event|2
7365612|NCT01058005|11614543|FG002|Overall Study|Adverse Event|1
7365613|NCT01058005|11614541|FG000|Overall Study|Physician Decision|2
7365614|NCT01058005|11614542|FG001|Overall Study|Physician Decision|2
7365615|NCT01058005|11614543|FG002|Overall Study|Physician Decision|0
7365616|NCT01058005|11614541|FG000|Overall Study|Withdrawal by Subject|4
7365617|NCT01058005|11614542|FG001|Overall Study|Withdrawal by Subject|5
7365618|NCT01058005|11614543|FG002|Overall Study|Withdrawal by Subject|11
7365619|NCT01058005|11614541|FG000|Overall Study|Withdrawn Due to Study Termination|27
7365620|NCT01058005|11614542|FG001|Overall Study|Withdrawn Due to Study Termination|13
7365621|NCT01058005|11614543|FG002|Overall Study|Withdrawn Due to Study Termination|7
7365622|NCT01058005|11614541|FG000|Overall Study|Reason Missing|5
7365623|NCT01058005|11614542|FG001|Overall Study|Reason Missing|3
7365624|NCT01058005|11614543|FG002|Overall Study|Reason Missing|1
7365625|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Adverse Event|11
7365626|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Adverse Event|15
7365627|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
7365628|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
7365629|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Protocol Violation|2
7365630|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Protocol Violation|1
7365631|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
7365632|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
7365633|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7365634|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7365635|NCT01058096|11614558|FG000|Double-blind Treatment Phase|Other Unspecified|2
7365636|NCT01058096|11614559|FG001|Double-blind Treatment Phase|Other Unspecified|0
7365637|NCT01058265|11614571|FG000|Overall Study|Lost to Follow-up|11
7365638|NCT01058265|11614572|FG001|Overall Study|Lost to Follow-up|12
7365639|NCT01058304|11614580|FG000|Overall Study|Withdrawal by Subject|8
7365640|NCT01058304|11614581|FG001|Overall Study|Withdrawal by Subject|5
7365641|NCT01058304|11614580|FG000|Overall Study|Lost to Follow-up|13
7365642|NCT01058304|11614581|FG001|Overall Study|Lost to Follow-up|16
7365643|NCT01058304|11614580|FG000|Overall Study|Developed exclusion criterion|6
7365644|NCT01058304|11614581|FG001|Overall Study|Developed exclusion criterion|12
7386630|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7386631|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
7386632|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7386633|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
7386634|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
7386635|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7386636|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7386637|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7386638|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386639|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7386640|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386641|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386642|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7386643|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386644|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386645|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386646|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7386647|NCT01212757|11645372|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386648|NCT01212757|11645373|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
7386649|NCT01212757|11645374|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
7386650|NCT01212757|11645375|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386651|NCT01212757|11645376|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386652|NCT01212757|11645377|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386653|NCT01212757|11645378|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386654|NCT01212757|11645379|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386655|NCT01212757|11645380|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
7386656|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386657|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386658|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386659|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386660|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386661|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386662|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386663|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
7386664|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
7386665|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
7386666|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
7386667|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
7386668|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
7386669|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
7386670|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
7386671|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
7460595|NCT01830543|11756246|FG001|Overall Study|Physician Decision|5
7386672|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
7386673|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
7386674|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386675|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7365645|NCT01058356|11614587|FG000|Overall Study|Adverse Event|5
7365646|NCT01058356|11614587|FG000|Overall Study|Administration of contraindicated drugs|12
7365647|NCT01058356|11614587|FG000|Overall Study|Withdrawal by Subject|21
7365648|NCT01058356|11614587|FG000|Overall Study|Lost to Follow-up|4
7365649|NCT01058395|11614593|FG000|Overall Study|Death|2
7365650|NCT01058395|11614594|FG001|Overall Study|Death|1
7365651|NCT01058395|11614593|FG000|Overall Study|Lost to Follow-up|1
7365652|NCT01058395|11614594|FG001|Overall Study|Lost to Follow-up|0
7365653|NCT01058421|11614602|FG000|1 Month Outcomes|Death|10
7365654|NCT01058421|11614603|FG001|1 Month Outcomes|Death|6
7365655|NCT01058421|11614602|FG000|1 Month Outcomes|Lost to Follow-up|8
7365656|NCT01058421|11614603|FG001|1 Month Outcomes|Lost to Follow-up|7
7460596|NCT01830543|11756247|FG002|Overall Study|Physician Decision|12
7460597|NCT01830543|11756245|FG000|Overall Study|Withdrawal by consent|3
7365657|NCT01058421|11614602|FG000|1 Month Outcomes|Remained in Hospital|5
7365658|NCT01058421|11614603|FG001|1 Month Outcomes|Remained in Hospital|12
7365659|NCT01058421|11614602|FG000|1 Month Outcomes|Remained in Other Facility|16
7365660|NCT01058421|11614603|FG001|1 Month Outcomes|Remained in Other Facility|17
7365661|NCT01058421|11614602|FG000|3 Month Outcomes|Death|3
7365662|NCT01058421|11614603|FG001|3 Month Outcomes|Death|5
7365663|NCT01058421|11614602|FG000|3 Month Outcomes|Lost to Follow-up|12
7365664|NCT01058421|11614603|FG001|3 Month Outcomes|Lost to Follow-up|11
7365665|NCT01058421|11614602|FG000|3 Month Outcomes|Remained in Hospital|0
7365666|NCT01058421|11614603|FG001|3 Month Outcomes|Remained in Hospital|2
7365667|NCT01058421|11614602|FG000|3 Month Outcomes|Remained in Other Facility|5
7365668|NCT01058421|11614603|FG001|3 Month Outcomes|Remained in Other Facility|8
7365669|NCT01058421|11614602|FG000|6 Month Outcomes|Death|2
7365670|NCT01058421|11614603|FG001|6 Month Outcomes|Death|2
7365671|NCT01058421|11614602|FG000|6 Month Outcomes|Lost to Follow-up|16
7365672|NCT01058421|11614603|FG001|6 Month Outcomes|Lost to Follow-up|21
7365673|NCT01058421|11614602|FG000|6 Month Outcomes|Remained in Other Facility|1
7365674|NCT01058421|11614603|FG001|6 Month Outcomes|Remained in Other Facility|3
7365675|NCT01058655|11614613|FG000|Overall Study|Withdrawal by Subject|1
7365676|NCT01058655|11614614|FG001|Overall Study|Withdrawal by Subject|0
7365677|NCT01058655|11614615|FG002|Overall Study|Withdrawal by Subject|3
7365678|NCT01058655|11614616|FG003|Overall Study|Withdrawal by Subject|4
7365679|NCT01058655|11614613|FG000|Overall Study|Prolonged Treatment Delay|0
7365680|NCT01058655|11614614|FG001|Overall Study|Prolonged Treatment Delay|0
7365681|NCT01058655|11614615|FG002|Overall Study|Prolonged Treatment Delay|0
7365682|NCT01058655|11614616|FG003|Overall Study|Prolonged Treatment Delay|2
7365683|NCT01058655|11614613|FG000|Overall Study|Symptomatic Deterioration|0
7365684|NCT01058655|11614614|FG001|Overall Study|Symptomatic Deterioration|0
7365685|NCT01058655|11614615|FG002|Overall Study|Symptomatic Deterioration|0
7365686|NCT01058655|11614616|FG003|Overall Study|Symptomatic Deterioration|1
7365687|NCT01058655|11614613|FG000|Overall Study|Clinical Progression (non-RECIST)|1
7365688|NCT01058655|11614614|FG001|Overall Study|Clinical Progression (non-RECIST)|0
7365689|NCT01058655|11614615|FG002|Overall Study|Clinical Progression (non-RECIST)|0
7365690|NCT01058655|11614616|FG003|Overall Study|Clinical Progression (non-RECIST)|7
7365691|NCT01058655|11614613|FG000|Overall Study|Death|0
7365692|NCT01058655|11614614|FG001|Overall Study|Death|1
7365693|NCT01058655|11614615|FG002|Overall Study|Death|1
7365694|NCT01058655|11614616|FG003|Overall Study|Death|0
7365695|NCT01058655|11614613|FG000|Overall Study|Disease Progression|1
7365696|NCT01058655|11614614|FG001|Overall Study|Disease Progression|2
7365697|NCT01058655|11614615|FG002|Overall Study|Disease Progression|4
7365698|NCT01058655|11614616|FG003|Overall Study|Disease Progression|24
7365699|NCT01058655|11614613|FG000|Overall Study|Other|0
7365700|NCT01058655|11614614|FG001|Overall Study|Other|0
7365701|NCT01058655|11614615|FG002|Overall Study|Other|0
7365702|NCT01058655|11614616|FG003|Overall Study|Other|4
7365703|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Adverse Event|8
7365704|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Adverse Event|15
7365705|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Adverse Event|25
7365706|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
7365707|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
7365708|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
7365793|NCT01059539|11614812|FG000|Overall Study|Lost to Follow-up|42
7365709|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Protocol Violation|1
7365710|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Protocol Violation|1
7365711|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Protocol Violation|2
7365712|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
7365713|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
7365714|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
7365715|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
7365716|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
7365717|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
7365718|NCT01058668|11614630|FG000|Double-blind Treatment Phase|Other Unspecified|1
7365719|NCT01058668|11614631|FG001|Double-blind Treatment Phase|Other Unspecified|1
7365720|NCT01058668|11614632|FG002|Double-blind Treatment Phase|Other Unspecified|0
7365721|NCT01058707|11614647|FG000|Overall Study|Disease Progression|15
7365722|NCT01058707|11614648|FG001|Overall Study|Disease Progression|20
7365723|NCT01058707|11614649|FG002|Overall Study|Disease Progression|20
7365724|NCT01058707|11614650|FG003|Overall Study|Disease Progression|15
7365725|NCT01058707|11614651|FG004|Overall Study|Disease Progression|23
7365726|NCT01058707|11614652|FG005|Overall Study|Disease Progression|10
7365727|NCT01058707|11614653|FG006|Overall Study|Disease Progression|12
7365728|NCT01058707|11614647|FG000|Overall Study|Adverse Event|11
7365729|NCT01058707|11614648|FG001|Overall Study|Adverse Event|4
7365730|NCT01058707|11614649|FG002|Overall Study|Adverse Event|7
7365731|NCT01058707|11614650|FG003|Overall Study|Adverse Event|6
7365732|NCT01058707|11614651|FG004|Overall Study|Adverse Event|7
7365733|NCT01058707|11614652|FG005|Overall Study|Adverse Event|3
7365734|NCT01058707|11614653|FG006|Overall Study|Adverse Event|1
7365735|NCT01058707|11614647|FG000|Overall Study|Subject Decision|5
7365736|NCT01058707|11614648|FG001|Overall Study|Subject Decision|3
7365737|NCT01058707|11614649|FG002|Overall Study|Subject Decision|3
7365738|NCT01058707|11614650|FG003|Overall Study|Subject Decision|1
7365739|NCT01058707|11614651|FG004|Overall Study|Subject Decision|2
7365740|NCT01058707|11614652|FG005|Overall Study|Subject Decision|3
7365741|NCT01058707|11614653|FG006|Overall Study|Subject Decision|6
7365742|NCT01058707|11614647|FG000|Overall Study|Lost to Follow-up|0
7365743|NCT01058707|11614648|FG001|Overall Study|Lost to Follow-up|0
7365744|NCT01058707|11614649|FG002|Overall Study|Lost to Follow-up|1
7365745|NCT01058707|11614650|FG003|Overall Study|Lost to Follow-up|0
7365746|NCT01058707|11614651|FG004|Overall Study|Lost to Follow-up|0
7365747|NCT01058707|11614652|FG005|Overall Study|Lost to Follow-up|0
7365748|NCT01058707|11614653|FG006|Overall Study|Lost to Follow-up|0
7365749|NCT01058707|11614647|FG000|Overall Study|Reason Not Specified|0
7365750|NCT01058707|11614648|FG001|Overall Study|Reason Not Specified|3
7365751|NCT01058707|11614649|FG002|Overall Study|Reason Not Specified|2
7365752|NCT01058707|11614650|FG003|Overall Study|Reason Not Specified|0
7365753|NCT01058707|11614651|FG004|Overall Study|Reason Not Specified|7
7365754|NCT01058707|11614652|FG005|Overall Study|Reason Not Specified|1
7365755|NCT01058707|11614653|FG006|Overall Study|Reason Not Specified|7
7365756|NCT01058863|11614691|FG000|Overall Study|Lost to Follow-up|1
7365757|NCT01058863|11614691|FG000|Overall Study|Withdrawal by Subject|1
7365758|NCT01058863|11614691|FG000|Overall Study|Sponsor requested withdrawal|1
7365759|NCT01058863|11614691|FG000|Overall Study|Randomized in error|1
7365760|NCT01059175|11614719|FG000|Overall Study|Death|17
7365761|NCT01059175|11614720|FG001|Overall Study|Death|17
7365762|NCT01059175|11614719|FG000|Overall Study|Adverse Event|4
7365763|NCT01059175|11614720|FG001|Overall Study|Adverse Event|2
7365764|NCT01059175|11614719|FG000|Overall Study|Lost to Follow-up|0
7365765|NCT01059175|11614720|FG001|Overall Study|Lost to Follow-up|1
7365766|NCT01059318|11614730|FG000|Core Study (26 Week)|Adverse Event|3
7365767|NCT01059318|11614730|FG000|Core Study (26 Week)|Withdrawal by Subject|1
7365768|NCT01059318|11614730|FG000|Extension (36 Week)|Adverse Event|3
7365769|NCT01059344|11614739|FG000|Overall Study|Adverse Event|12
7365770|NCT01059344|11614740|FG001|Overall Study|Adverse Event|30
7365771|NCT01059344|11614739|FG000|Overall Study|Withdrawal by Subject|6
7365772|NCT01059344|11614740|FG001|Overall Study|Withdrawal by Subject|9
7365773|NCT01059344|11614739|FG000|Overall Study|Lost to Follow-up|1
7365774|NCT01059344|11614740|FG001|Overall Study|Lost to Follow-up|1
7365775|NCT01059344|11614739|FG000|Overall Study|Other|3
7365776|NCT01059344|11614740|FG001|Overall Study|Other|6
7365777|NCT01059526|11614805|FG000|Overall Study|Patient enrolled but not treated|20
7365778|NCT01059526|11614806|FG001|Overall Study|Patient enrolled but not treated|17
7365779|NCT01059526|11614805|FG000|Overall Study|Adverse Event|2
7365780|NCT01059526|11614806|FG001|Overall Study|Adverse Event|2
7365781|NCT01059526|11614805|FG000|Overall Study|Protocol Violation|0
7365782|NCT01059526|11614806|FG001|Overall Study|Protocol Violation|1
7365783|NCT01059526|11614805|FG000|Overall Study|Withdrawal by Subject|3
7365784|NCT01059526|11614806|FG001|Overall Study|Withdrawal by Subject|1
7365785|NCT01059526|11614805|FG000|Overall Study|Lost to Follow-up|4
7365786|NCT01059526|11614806|FG001|Overall Study|Lost to Follow-up|1
7365787|NCT01059526|11614805|FG000|Overall Study|Patient found to be dermatographic|1
7365788|NCT01059526|11614806|FG001|Overall Study|Patient found to be dermatographic|0
7365789|NCT01059539|11614812|FG000|Overall Study|Adverse Event|66
7365790|NCT01059539|11614812|FG000|Overall Study|Insufficient Therapeutic Response|26
7365791|NCT01059539|11614812|FG000|Overall Study|Protocol Violation|55
7365792|NCT01059539|11614812|FG000|Overall Study|Withdrawal of Consent|80
7365794|NCT01059539|11614812|FG000|Overall Study|Reason Not Specified|2
7365795|NCT01059565|11614818|FG000|24-Week Randomized Phase|Randomized but not treated|1
7365796|NCT01059565|11614819|FG001|24-Week Randomized Phase|Randomized but not treated|0
7365797|NCT01059565|11614818|FG000|24-Week Randomized Phase|Adverse Event|5
7365798|NCT01059565|11614819|FG001|24-Week Randomized Phase|Adverse Event|0
7365799|NCT01059565|11614818|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
7460598|NCT01830543|11756246|FG001|Overall Study|Withdrawal by consent|3
7460599|NCT01830543|11756247|FG002|Overall Study|Withdrawal by consent|3
7460600|NCT01830543|11756245|FG000|Overall Study|Other|12
7460601|NCT01830543|11756246|FG001|Overall Study|Other|17
7460602|NCT01830543|11756247|FG002|Overall Study|Other|37
7460603|NCT01830595|11756255|FG000|First Period|Withdrawal by Subject|1
7460604|NCT01830595|11756256|FG001|First Period|Withdrawal by Subject|3
7460605|NCT01830595|11756255|FG000|Washout|Withdrawal by Subject|2
7460606|NCT01830595|11756256|FG001|Washout|Withdrawal by Subject|2
7460607|NCT01830816|11756283|FG000|Overall Study|Progressive Disease|12
7460608|NCT01830816|11756284|FG001|Overall Study|Progressive Disease|7
7460609|NCT01830816|11756285|FG002|Overall Study|Progressive Disease|7
7460610|NCT01830816|11756283|FG000|Overall Study|Adverse Event|3
7460611|NCT01830816|11756284|FG001|Overall Study|Adverse Event|4
7460612|NCT01830816|11756285|FG002|Overall Study|Adverse Event|0
7460613|NCT01830816|11756283|FG000|Overall Study|Study Terminated by Sponsor|1
7460614|NCT01830816|11756284|FG001|Overall Study|Study Terminated by Sponsor|1
7460615|NCT01830816|11756285|FG002|Overall Study|Study Terminated by Sponsor|0
7460616|NCT01830816|11756283|FG000|Overall Study|Withdrawal by Subject|1
7460617|NCT01830816|11756284|FG001|Overall Study|Withdrawal by Subject|1
7460618|NCT01830816|11756285|FG002|Overall Study|Withdrawal by Subject|0
7460619|NCT01830816|11756283|FG000|Overall Study|Lost to Follow-up|0
7460620|NCT01830816|11756284|FG001|Overall Study|Lost to Follow-up|1
7460621|NCT01830816|11756285|FG002|Overall Study|Lost to Follow-up|0
7460622|NCT01830816|11756283|FG000|Overall Study|Symptomatic Deterioration|1
7460623|NCT01830816|11756284|FG001|Overall Study|Symptomatic Deterioration|0
7460624|NCT01830816|11756285|FG002|Overall Study|Symptomatic Deterioration|0
7460625|NCT01830816|11756283|FG000|Overall Study|Reason not Specified|2
7460626|NCT01830816|11756284|FG001|Overall Study|Reason not Specified|0
7460627|NCT01830816|11756285|FG002|Overall Study|Reason not Specified|0
7460628|NCT01830855|11756309|FG000|Overall Study|Other|7
7460629|NCT01830855|11756310|FG001|Overall Study|Other|1
7460630|NCT01830855|11756311|FG002|Overall Study|Other|4
7460631|NCT01830855|11756312|FG003|Overall Study|Other|4
7460632|NCT01830855|11756309|FG000|Overall Study|Medication error without associated AE|1
7460633|NCT01830855|11756310|FG001|Overall Study|Medication error without associated AE|0
7460634|NCT01830855|11756311|FG002|Overall Study|Medication error without associated AE|0
7460635|NCT01830855|11756312|FG003|Overall Study|Medication error without associated AE|1
7460636|NCT01830855|11756309|FG000|Overall Study|Pregnancy|3
7460637|NCT01830855|11756310|FG001|Overall Study|Pregnancy|1
7460638|NCT01830855|11756311|FG002|Overall Study|Pregnancy|2
7460639|NCT01830855|11756312|FG003|Overall Study|Pregnancy|1
7460640|NCT01830855|11756309|FG000|Overall Study|No longer meets eligibility criteria|11
7460641|NCT01830855|11756310|FG001|Overall Study|No longer meets eligibility criteria|2
7460642|NCT01830855|11756311|FG002|Overall Study|No longer meets eligibility criteria|3
7365800|NCT01059565|11614819|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
7569967|NCT03475316|11947096|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
7569968|NCT03475316|11947095|FG000|9 Months|Study stopped due to COVID pandemic|3
7365801|NCT01059565|11614818|FG000|24-Week Randomized Phase|Lost to Follow-up|0
7365802|NCT01059565|11614819|FG001|24-Week Randomized Phase|Lost to Follow-up|1
7365803|NCT01059565|11614818|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
7365804|NCT01059565|11614819|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
7365805|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Adverse Event|2
7365806|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Adverse Event|0
7365807|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
7365808|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
7365809|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
7365810|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
7365811|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Subject noncompliance|1
7365812|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Subject noncompliance|0
7365813|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
7365814|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
7365815|NCT01059565|11614818|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
7365816|NCT01059565|11614819|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
7365817|NCT01059617|11614831|FG000|Overall Study|Other|7
7365818|NCT01059617|11614832|FG001|Overall Study|Other|1
7365819|NCT01059617|11614833|FG002|Overall Study|Other|8
7365820|NCT01059617|11614834|FG003|Overall Study|Other|6
7365821|NCT01059630|11614854|FG000|Overall Study|Death|100
7365822|NCT01059630|11614855|FG001|Overall Study|Death|84
7365823|NCT01059630|11614854|FG000|Overall Study|Lost to Follow-up|4
7365824|NCT01059630|11614855|FG001|Overall Study|Lost to Follow-up|1
7365825|NCT01059630|11614854|FG000|Overall Study|Physician Decision|2
7365826|NCT01059630|11614855|FG001|Overall Study|Physician Decision|4
7365827|NCT01059630|11614854|FG000|Overall Study|Withdrawal by Subject|21
7365828|NCT01059630|11614855|FG001|Overall Study|Withdrawal by Subject|14
7365829|NCT01059643|11614861|FG000|Overall Study|Adverse Event|3
7365830|NCT01059643|11614861|FG000|Overall Study|Withdrawal by Subject|2
7365831|NCT01059643|11614861|FG000|Overall Study|Physician Decision|1
7365832|NCT01059773|11614889|FG000|Overall Study|Adverse Event|2
7365833|NCT01059773|11614890|FG001|Overall Study|Adverse Event|2
7365834|NCT01059773|11614889|FG000|Overall Study|Withdrawal by Subject|1
7365835|NCT01059773|11614890|FG001|Overall Study|Withdrawal by Subject|5
7365836|NCT01059773|11614889|FG000|Overall Study|Lost to Follow-up|1
7365837|NCT01059773|11614890|FG001|Overall Study|Lost to Follow-up|1
7365838|NCT01059773|11614889|FG000|Overall Study|Pregnancy|1
7365839|NCT01059773|11614890|FG001|Overall Study|Pregnancy|1
7365840|NCT01059773|11614889|FG000|Overall Study|Protocol Violation|6
7365841|NCT01059773|11614890|FG001|Overall Study|Protocol Violation|2
7365842|NCT01059773|11614889|FG000|Overall Study|Physician Decision|5
7365843|NCT01059773|11614890|FG001|Overall Study|Physician Decision|4
7365844|NCT01059773|11614889|FG000|Overall Study|Lack of Efficacy|3
7365845|NCT01059773|11614890|FG001|Overall Study|Lack of Efficacy|3
7365846|NCT01059773|11614889|FG000|Overall Study|Death|0
7365847|NCT01059773|11614890|FG001|Overall Study|Death|1
7365848|NCT01059773|11614889|FG000|Overall Study|Malignancy including squamous cell skin|0
7365849|NCT01059773|11614890|FG001|Overall Study|Malignancy including squamous cell skin|1
7365850|NCT01059773|11614889|FG000|Overall Study|Ineligible follow TB screening criteria|0
7365851|NCT01059773|11614890|FG001|Overall Study|Ineligible follow TB screening criteria|1
7365852|NCT01059773|11614889|FG000|Overall Study|Other|1
7365853|NCT01059773|11614890|FG001|Overall Study|Other|3
7365854|NCT01059799|11614903|FG000|Overall Study|Adverse Event|2
7365855|NCT01059799|11614904|FG001|Overall Study|Adverse Event|3
7365856|NCT01059799|11614903|FG000|Overall Study|Lack of Efficacy|1
7365857|NCT01059799|11614904|FG001|Overall Study|Lack of Efficacy|0
7365858|NCT01059799|11614903|FG000|Overall Study|Protocol Violation|3
7365859|NCT01059799|11614904|FG001|Overall Study|Protocol Violation|2
7365860|NCT01059799|11614903|FG000|Overall Study|Withdrawal criteria|13
7365861|NCT01059799|11614904|FG001|Overall Study|Withdrawal criteria|2
7365862|NCT01059799|11614903|FG000|Overall Study|Other|12
7365863|NCT01059799|11614904|FG001|Overall Study|Other|3
7365864|NCT01059812|11614912|FG000|Overall Study|Adverse Event|9
7365865|NCT01059812|11614913|FG001|Overall Study|Adverse Event|5
7365866|NCT01059812|11614912|FG000|Overall Study|Lack of Efficacy|2
7365867|NCT01059812|11614913|FG001|Overall Study|Lack of Efficacy|2
7365868|NCT01059812|11614912|FG000|Overall Study|Protocol Violation|3
7365869|NCT01059812|11614913|FG001|Overall Study|Protocol Violation|1
7365870|NCT01059812|11614912|FG000|Overall Study|Withdrawal Criteria|9
7365871|NCT01059812|11614913|FG001|Overall Study|Withdrawal Criteria|4
7365872|NCT01059812|11614912|FG000|Overall Study|Unclassified|14
7365873|NCT01059812|11614913|FG001|Overall Study|Unclassified|4
7365874|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365875|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365876|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365877|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365878|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365879|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
7365880|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
7365881|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365882|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365883|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365884|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365885|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365886|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
7365887|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
7365888|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
7365889|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
7365890|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
7365891|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
7365892|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
7365893|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
7365894|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
7365895|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
7365896|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
7365897|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
7365898|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
7365899|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
7365900|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
7365901|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
7365902|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Other reason not specified|0
7365903|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Other reason not specified|0
7365904|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Other reason not specified|0
7365905|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Other reason not specified|0
7365906|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Other reason not specified|0
7365907|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Other reason not specified|0
7365908|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Other reason not specified|7
7365909|NCT01059825|11614925|FG000|Enrolled, Run-in Period|Protocol Violation|0
7365910|NCT01059825|11614926|FG001|Enrolled, Run-in Period|Protocol Violation|0
7365911|NCT01059825|11614927|FG002|Enrolled, Run-in Period|Protocol Violation|0
7365912|NCT01059825|11614928|FG003|Enrolled, Run-in Period|Protocol Violation|0
7365913|NCT01059825|11614929|FG004|Enrolled, Run-in Period|Protocol Violation|0
7365914|NCT01059825|11614930|FG005|Enrolled, Run-in Period|Protocol Violation|0
7365915|NCT01059825|11614931|FG006|Enrolled, Run-in Period|Protocol Violation|5
7365916|NCT01059825|11614925|FG000|Treatment Period|Lost to Follow-up|2
7365917|NCT01059825|11614926|FG001|Treatment Period|Lost to Follow-up|1
7365918|NCT01059825|11614927|FG002|Treatment Period|Lost to Follow-up|0
7365919|NCT01059825|11614928|FG003|Treatment Period|Lost to Follow-up|1
7365920|NCT01059825|11614929|FG004|Treatment Period|Lost to Follow-up|2
7365921|NCT01059825|11614930|FG005|Treatment Period|Lost to Follow-up|0
7365922|NCT01059825|11614931|FG006|Treatment Period|Lost to Follow-up|0
7365923|NCT01059825|11614925|FG000|Treatment Period|Withdrawal by Subject|3
7365924|NCT01059825|11614926|FG001|Treatment Period|Withdrawal by Subject|0
7365925|NCT01059825|11614927|FG002|Treatment Period|Withdrawal by Subject|1
7365926|NCT01059825|11614928|FG003|Treatment Period|Withdrawal by Subject|5
7365927|NCT01059825|11614929|FG004|Treatment Period|Withdrawal by Subject|4
7365928|NCT01059825|11614930|FG005|Treatment Period|Withdrawal by Subject|1
7365929|NCT01059825|11614931|FG006|Treatment Period|Withdrawal by Subject|0
7365930|NCT01059825|11614925|FG000|Treatment Period|Other reason not specified|1
7365931|NCT01059825|11614926|FG001|Treatment Period|Other reason not specified|2
7365932|NCT01059825|11614927|FG002|Treatment Period|Other reason not specified|1
7365933|NCT01059825|11614928|FG003|Treatment Period|Other reason not specified|2
7365934|NCT01059825|11614929|FG004|Treatment Period|Other reason not specified|0
7365935|NCT01059825|11614930|FG005|Treatment Period|Other reason not specified|0
7365936|NCT01059825|11614931|FG006|Treatment Period|Other reason not specified|0
7365937|NCT01059825|11614925|FG000|Treatment Period|Protocol Violation|0
7365938|NCT01059825|11614926|FG001|Treatment Period|Protocol Violation|0
7365939|NCT01059825|11614927|FG002|Treatment Period|Protocol Violation|1
7365940|NCT01059825|11614928|FG003|Treatment Period|Protocol Violation|1
7365941|NCT01059825|11614929|FG004|Treatment Period|Protocol Violation|1
7365942|NCT01059825|11614930|FG005|Treatment Period|Protocol Violation|1
7365943|NCT01059825|11614931|FG006|Treatment Period|Protocol Violation|0
7365944|NCT01059825|11614925|FG000|Treatment Period|Adverse event related to study drug|1
7365945|NCT01059825|11614926|FG001|Treatment Period|Adverse event related to study drug|0
7365946|NCT01059825|11614927|FG002|Treatment Period|Adverse event related to study drug|1
7365947|NCT01059825|11614928|FG003|Treatment Period|Adverse event related to study drug|1
7365948|NCT01059825|11614929|FG004|Treatment Period|Adverse event related to study drug|0
7365949|NCT01059825|11614930|FG005|Treatment Period|Adverse event related to study drug|0
7365950|NCT01059825|11614931|FG006|Treatment Period|Adverse event related to study drug|0
7365951|NCT01059825|11614925|FG000|Treatment Period|Insufficient clinical response|3
7365952|NCT01059825|11614926|FG001|Treatment Period|Insufficient clinical response|0
7365953|NCT01059825|11614927|FG002|Treatment Period|Insufficient clinical response|0
7365954|NCT01059825|11614928|FG003|Treatment Period|Insufficient clinical response|0
7365955|NCT01059825|11614929|FG004|Treatment Period|Insufficient clinical response|0
7365956|NCT01059825|11614930|FG005|Treatment Period|Insufficient clinical response|0
7365957|NCT01059825|11614931|FG006|Treatment Period|Insufficient clinical response|0
7460643|NCT01830855|11756312|FG003|Overall Study|No longer meets eligibility criteria|5
7460644|NCT01830855|11756309|FG000|Overall Study|Adverse Event|11
7460645|NCT01830855|11756310|FG001|Overall Study|Adverse Event|5
7460646|NCT01830855|11756311|FG002|Overall Study|Adverse Event|6
7460647|NCT01830855|11756312|FG003|Overall Study|Adverse Event|3
7460648|NCT01830855|11756309|FG000|Overall Study|Protocol deviation|10
7460649|NCT01830855|11756310|FG001|Overall Study|Protocol deviation|5
7460650|NCT01830855|11756311|FG002|Overall Study|Protocol deviation|6
7460651|NCT01830855|11756312|FG003|Overall Study|Protocol deviation|6
7460652|NCT01830855|11756309|FG000|Overall Study|Withdrawal by Subject|33
7460653|NCT01830855|11756310|FG001|Overall Study|Withdrawal by Subject|14
7460654|NCT01830855|11756311|FG002|Overall Study|Withdrawal by Subject|10
7460655|NCT01830855|11756312|FG003|Overall Study|Withdrawal by Subject|12
7460656|NCT01830855|11756309|FG000|Overall Study|No longer willing to participate|32
7460657|NCT01830855|11756310|FG001|Overall Study|No longer willing to participate|13
7460658|NCT01830855|11756311|FG002|Overall Study|No longer willing to participate|12
7460659|NCT01830855|11756312|FG003|Overall Study|No longer willing to participate|17
7460660|NCT01830855|11756309|FG000|Overall Study|Lost to Follow-up|47
7460661|NCT01830855|11756310|FG001|Overall Study|Lost to Follow-up|20
7460662|NCT01830855|11756311|FG002|Overall Study|Lost to Follow-up|23
7460663|NCT01830855|11756312|FG003|Overall Study|Lost to Follow-up|33
7460664|NCT01830881|11756329|FG000|Overall Study|Changed decision to have an abortion|0
7460665|NCT01830881|11756330|FG001|Overall Study|Changed decision to have an abortion|1
7460666|NCT01830920|11756343|FG000|Overall Study|Adverse Event|1
7460667|NCT01830920|11756344|FG001|Overall Study|Adverse Event|0
7460668|NCT01830920|11756345|FG002|Overall Study|Adverse Event|1
7460669|NCT01830920|11756346|FG003|Overall Study|Adverse Event|0
7460670|NCT01830920|11756347|FG004|Overall Study|Adverse Event|0
7460671|NCT01830920|11756343|FG000|Overall Study|Withdrawal by Subject|2
7460672|NCT01830920|11756344|FG001|Overall Study|Withdrawal by Subject|2
7460673|NCT01830920|11756345|FG002|Overall Study|Withdrawal by Subject|1
7460674|NCT01830920|11756346|FG003|Overall Study|Withdrawal by Subject|7
7460675|NCT01830920|11756347|FG004|Overall Study|Withdrawal by Subject|1
7460676|NCT01830920|11756343|FG000|Overall Study|Death|3
7460677|NCT01830920|11756344|FG001|Overall Study|Death|3
7460678|NCT01830920|11756345|FG002|Overall Study|Death|5
7460679|NCT01830920|11756346|FG003|Overall Study|Death|4
7460680|NCT01830920|11756347|FG004|Overall Study|Death|4
7460681|NCT01830920|11756343|FG000|Overall Study|Other|15
7460682|NCT01830920|11756344|FG001|Overall Study|Other|1
7460683|NCT01830920|11756345|FG002|Overall Study|Other|1
7460684|NCT01830920|11756346|FG003|Overall Study|Other|5
7460685|NCT01830920|11756347|FG004|Overall Study|Other|3
7460686|NCT01830972|11756370|FG000|Part II|Withdrawal by Subject|2
7460687|NCT01830972|11756371|FG001|Part II|Withdrawal by Subject|2
7460688|NCT01830972|11756370|FG000|Part III|Withdrawal by Subject|1
7460689|NCT01830972|11756371|FG001|Part III|Withdrawal by Subject|0
7460690|NCT01830972|11756370|FG000|Part III|Noncompliance|1
7460691|NCT01830972|11756371|FG001|Part III|Noncompliance|0
7460692|NCT01830972|11756370|FG000|Part IV|Withdrawal by Subject|2
7460693|NCT01830972|11756371|FG001|Part IV|Withdrawal by Subject|1
7460694|NCT01830972|11756370|FG000|Part IV|Non-Compliance|1
7460695|NCT01830972|11756371|FG001|Part IV|Non-Compliance|0
7460696|NCT01831089|11756393|FG000|Cohort I: Dose Level 1|Progressive disease|3
7460697|NCT01831089|11756394|FG001|Cohort I: Dose Level 1|Progressive disease|0
7460698|NCT01831089|11756395|FG002|Cohort I: Dose Level 1|Progressive disease|0
7460699|NCT01831089|11756396|FG003|Cohort I: Dose Level 1|Progressive disease|0
7460700|NCT01831089|11756397|FG004|Cohort I: Dose Level 1|Progressive disease|0
7460701|NCT01831089|11756398|FG005|Cohort I: Dose Level 1|Progressive disease|0
7460702|NCT01831089|11756393|FG000|Cohort II: Dose Level 2|Progressive disease|0
7460703|NCT01831089|11756394|FG001|Cohort II: Dose Level 2|Progressive disease|2
7460704|NCT01831089|11756395|FG002|Cohort II: Dose Level 2|Progressive disease|0
7365958|NCT01059825|11614925|FG000|Treatment Period|Adverse event not related to study drug|0
7365959|NCT01059825|11614926|FG001|Treatment Period|Adverse event not related to study drug|1
7365960|NCT01059825|11614927|FG002|Treatment Period|Adverse event not related to study drug|2
7365961|NCT01059825|11614928|FG003|Treatment Period|Adverse event not related to study drug|1
7365962|NCT01059825|11614929|FG004|Treatment Period|Adverse event not related to study drug|1
7365963|NCT01059825|11614930|FG005|Treatment Period|Adverse event not related to study drug|1
7365964|NCT01059825|11614931|FG006|Treatment Period|Adverse event not related to study drug|0
7365965|NCT01059864|11614964|FG000|Open-Label Run-In Phase|Adverse Event|7
7365966|NCT01059864|11614965|FG001|Open-Label Run-In Phase|Adverse Event|0
7365967|NCT01059864|11614966|FG002|Open-Label Run-In Phase|Adverse Event|0
7365968|NCT01059864|11614964|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
7365969|NCT01059864|11614965|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
7365970|NCT01059864|11614966|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
7365971|NCT01059864|11614964|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
7365972|NCT01059864|11614965|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
7365973|NCT01059864|11614966|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
7365974|NCT01059864|11614964|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
7365975|NCT01059864|11614965|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
7365976|NCT01059864|11614966|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
7460705|NCT01831089|11756396|FG003|Cohort II: Dose Level 2|Progressive disease|0
7460706|NCT01831089|11756397|FG004|Cohort II: Dose Level 2|Progressive disease|0
7460707|NCT01831089|11756398|FG005|Cohort II: Dose Level 2|Progressive disease|0
7460708|NCT01831089|11756393|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
7460709|NCT01831089|11756394|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
7460710|NCT01831089|11756395|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
7460711|NCT01831089|11756396|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
7460712|NCT01831089|11756397|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
7460713|NCT01831089|11756398|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
7460714|NCT01831089|11756393|FG000|Cohort III: Dose Level 3|Progressive disease|0
7460715|NCT01831089|11756394|FG001|Cohort III: Dose Level 3|Progressive disease|0
7569969|NCT03475316|11947096|FG001|9 Months|Study stopped due to COVID pandemic|4
7569970|NCT03475875|11947102|FG000|Period 1|Lost to Follow-up|1
7569971|NCT03475875|11947103|FG001|Period 1|Lost to Follow-up|0
7569972|NCT03475875|11947102|FG000|Period 1|Adverse Event|2
7569973|NCT03475875|11947103|FG001|Period 1|Adverse Event|1
7569974|NCT03475875|11947102|FG000|Period 2|Adverse Event|3
7569975|NCT03475875|11947103|FG001|Period 2|Adverse Event|0
7569976|NCT03475875|11947102|FG000|Period 2|Protocol Violation|0
7569977|NCT03475875|11947103|FG001|Period 2|Protocol Violation|1
7569981|NCT03477838|11947180|FG000|Overall Study|Lost to Follow-up|14
7569982|NCT03478371|11947198|FG000|Overall Study|non-compliance|1
7569983|NCT03478371|11947198|FG000|Overall Study|Lost to Follow-up|4
7569984|NCT03478644|11947210|FG000|Phase 2|Withdrawal by Subject|2
7569985|NCT03478644|11947211|FG001|Phase 2|Withdrawal by Subject|1
7569986|NCT03478644|11947210|FG000|Phase 2|Lost to Follow-up|1
7569987|NCT03478644|11947211|FG001|Phase 2|Lost to Follow-up|0
7569988|NCT03478657|11947219|FG000|Overall Study|Withdrawal by Subject|0
7569989|NCT03478657|11947220|FG001|Overall Study|Withdrawal by Subject|1
7569990|NCT03478683|11947228|FG000|Overall Study|Adverse Event|5
7569991|NCT03478683|11947229|FG001|Overall Study|Adverse Event|3
7569992|NCT03478683|11947228|FG000|Overall Study|Lost to Follow-up|0
7569993|NCT03478683|11947229|FG001|Overall Study|Lost to Follow-up|5
7569994|NCT03478683|11947228|FG000|Overall Study|Physician Decision|1
7569995|NCT03478683|11947229|FG001|Overall Study|Physician Decision|3
7569996|NCT03478683|11947228|FG000|Overall Study|Withdrawal by Subject|7
7569997|NCT03478683|11947229|FG001|Overall Study|Withdrawal by Subject|7
7569998|NCT03478696|11947237|FG000|Overall Study|Adverse Event|1
7569999|NCT03478696|11947238|FG001|Overall Study|Adverse Event|5
7570000|NCT03478696|11947237|FG000|Overall Study|Lost to Follow-up|1
7570001|NCT03478696|11947238|FG001|Overall Study|Lost to Follow-up|0
7570002|NCT03478696|11947237|FG000|Overall Study|Physician Decision|6
7570003|NCT03478696|11947238|FG001|Overall Study|Physician Decision|3
7570004|NCT03478696|11947237|FG000|Overall Study|Withdrawal by Subject|9
7570005|NCT03478696|11947238|FG001|Overall Study|Withdrawal by Subject|4
7570006|NCT03478787|11947246|FG000|Overall Study|Adverse Event|5
7570007|NCT03478787|11947247|FG001|Overall Study|Adverse Event|1
7570008|NCT03478787|11947246|FG000|Overall Study|Protocol Violation|3
7570009|NCT03478787|11947247|FG001|Overall Study|Protocol Violation|0
7365977|NCT01059864|11614964|FG000|Open-Label Run-In Phase|Protocol Violation|2
7365978|NCT01059864|11614965|FG001|Open-Label Run-In Phase|Protocol Violation|0
7570010|NCT03478787|11947246|FG000|Overall Study|Lack of Efficacy|7
7570011|NCT03478787|11947247|FG001|Overall Study|Lack of Efficacy|1
7570012|NCT03478787|11947246|FG000|Overall Study|Lost to Follow-up|9
7570013|NCT03478787|11947247|FG001|Overall Study|Lost to Follow-up|5
7570014|NCT03478787|11947246|FG000|Overall Study|Withdrawal by Subject|2
7570015|NCT03478787|11947247|FG001|Overall Study|Withdrawal by Subject|6
7570016|NCT03478787|11947246|FG000|Overall Study|Other, Not Specified|3
7570017|NCT03478787|11947247|FG001|Overall Study|Other, Not Specified|0
7570018|NCT03478891|11947256|FG000|Overall Study|Enrolled, but product never administered|0
7570019|NCT03478891|11947257|FG001|Overall Study|Enrolled, but product never administered|0
7365979|NCT01059864|11614966|FG002|Open-Label Run-In Phase|Protocol Violation|0
7365980|NCT01059864|11614964|FG000|Double-Blind Treatment Phase|Adverse Event|0
7365981|NCT01059864|11614965|FG001|Double-Blind Treatment Phase|Adverse Event|3
7365982|NCT01059864|11614966|FG002|Double-Blind Treatment Phase|Adverse Event|3
7365983|NCT01059903|11614984|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
7365984|NCT01059903|11614985|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
7365985|NCT01060007|11615017|FG000|Overall Study|Withdrawal by Subject|1
7365986|NCT01060007|11615017|FG000|Overall Study|Inevaluable for response at surgery|3
7365987|NCT01060059|11615031|FG000|Overall Study|Adverse Event|1
7365988|NCT01060059|11615032|FG001|Overall Study|Adverse Event|1
7365989|NCT01060059|11615031|FG000|Overall Study|Death|2
7365990|NCT01060059|11615032|FG001|Overall Study|Death|3
7365991|NCT01060059|11615031|FG000|Overall Study|Lost to Follow-up|18
7365992|NCT01060059|11615032|FG001|Overall Study|Lost to Follow-up|34
7365993|NCT01060059|11615031|FG000|Overall Study|entry criteria not met|4
7365994|NCT01060059|11615032|FG001|Overall Study|entry criteria not met|3
7365995|NCT01060059|11615031|FG000|Overall Study|Withdrawal by Subject|35
7365996|NCT01060059|11615032|FG001|Overall Study|Withdrawal by Subject|23
7365997|NCT01060059|11615031|FG000|Overall Study|lack of glycemic control|2
7365998|NCT01060059|11615032|FG001|Overall Study|lack of glycemic control|1
7365999|NCT01060059|11615031|FG000|Overall Study|lack of compliance|5
7366000|NCT01060059|11615032|FG001|Overall Study|lack of compliance|2
7366001|NCT01060072|11615042|FG000|Overall Study|Adverse Event|1
7366002|NCT01060072|11615043|FG001|Overall Study|Adverse Event|1
7366003|NCT01060072|11615042|FG000|Overall Study|Physician Decision|0
7366004|NCT01060072|11615043|FG001|Overall Study|Physician Decision|2
7366005|NCT01060072|11615042|FG000|Overall Study|Protocol Violation|0
7366006|NCT01060072|11615043|FG001|Overall Study|Protocol Violation|1
7366007|NCT01060072|11615042|FG000|Overall Study|Acute cholecystitis|1
7366008|NCT01060072|11615043|FG001|Overall Study|Acute cholecystitis|0
7366009|NCT01060072|11615042|FG000|Overall Study|Excluded Medications|0
7366010|NCT01060072|11615043|FG001|Overall Study|Excluded Medications|1
7366011|NCT01060111|11615065|FG000|Overall Study|Adverse Event|9
7366012|NCT01060111|11615066|FG001|Overall Study|Adverse Event|5
7366013|NCT01060111|11615067|FG002|Overall Study|Adverse Event|18
7366014|NCT01060111|11615065|FG000|Overall Study|Lack of Efficacy|2
7366015|NCT01060111|11615066|FG001|Overall Study|Lack of Efficacy|1
7366016|NCT01060111|11615067|FG002|Overall Study|Lack of Efficacy|0
7366017|NCT01060111|11615065|FG000|Overall Study|Inappropriate participant|5
7366018|NCT01060111|11615066|FG001|Overall Study|Inappropriate participant|4
7366019|NCT01060111|11615067|FG002|Overall Study|Inappropriate participant|5
7366020|NCT01060111|11615065|FG000|Overall Study|Participants' evasion for hospital visit|0
7570020|NCT03478891|11947258|FG002|Overall Study|Enrolled, but product never administered|1
7570021|NCT03478891|11947256|FG000|Overall Study|Moved from area|0
7570022|NCT03478891|11947257|FG001|Overall Study|Moved from area|0
7570023|NCT03478891|11947258|FG002|Overall Study|Moved from area|1
7570024|NCT03478891|11947256|FG000|Overall Study|Lost to Follow-up|1
7570025|NCT03478891|11947257|FG001|Overall Study|Lost to Follow-up|0
7570026|NCT03478891|11947258|FG002|Overall Study|Lost to Follow-up|1
7570027|NCT03478969|11947284|FG000|Overall Study|Withdrawal by Subject|4
7570028|NCT03478969|11947285|FG001|Overall Study|Withdrawal by Subject|7
7570029|NCT03478969|11947286|FG002|Overall Study|Withdrawal by Subject|6
7570030|NCT03478969|11947284|FG000|Overall Study|Adverse Event|2
7570031|NCT03478969|11947285|FG001|Overall Study|Adverse Event|0
7570032|NCT03478969|11947286|FG002|Overall Study|Adverse Event|1
7570033|NCT03478969|11947284|FG000|Overall Study|Pregnancy|1
7570034|NCT03478969|11947285|FG001|Overall Study|Pregnancy|0
7366021|NCT01060111|11615066|FG001|Overall Study|Participants' evasion for hospital visit|3
7366022|NCT01060111|11615067|FG002|Overall Study|Participants' evasion for hospital visit|2
7366023|NCT01060111|11615065|FG000|Overall Study|Participants' non-cooperation|8
7366024|NCT01060111|11615066|FG001|Overall Study|Participants' non-cooperation|6
7366025|NCT01060111|11615067|FG002|Overall Study|Participants' non-cooperation|6
7366026|NCT01060111|11615065|FG000|Overall Study|Adverse event and insufficient effect|0
7366027|NCT01060111|11615066|FG001|Overall Study|Adverse event and insufficient effect|1
7366028|NCT01060111|11615067|FG002|Overall Study|Adverse event and insufficient effect|0
7366029|NCT01060111|11615065|FG000|Overall Study|Participants' non-cooperation|1
7366030|NCT01060111|11615066|FG001|Overall Study|Participants' non-cooperation|0
7366031|NCT01060111|11615067|FG002|Overall Study|Participants' non-cooperation|0
7366032|NCT01060111|11615065|FG000|Overall Study|Other|2
7366033|NCT01060111|11615066|FG001|Overall Study|Other|3
7366034|NCT01060111|11615067|FG002|Overall Study|Other|4
7366035|NCT01060124|11615078|FG000|Overall Study|Other|16
7366036|NCT01060124|11615078|FG000|Overall Study|Adverse Event|14
7366037|NCT01060124|11615078|FG000|Overall Study|Withdrawal by Subject|7
7366038|NCT01060150|11615082|FG000|Overall Study|Adverse Event|6
7366039|NCT01060150|11615082|FG000|Overall Study|Lost to Follow-up|1
7366040|NCT01060150|11615082|FG000|Overall Study|Protocol Violation|6
7570035|NCT03478969|11947286|FG002|Overall Study|Pregnancy|0
7570036|NCT03478969|11947284|FG000|Overall Study|Personal Reasons|1
7570037|NCT03478969|11947285|FG001|Overall Study|Personal Reasons|0
7570038|NCT03478969|11947286|FG002|Overall Study|Personal Reasons|1
7366041|NCT01060150|11615082|FG000|Overall Study|Withdrawal by Subject|8
7366042|NCT01060150|11615082|FG000|Overall Study|Enrolled, but not treated|2
7366043|NCT01060384|11615090|FG000|Overall Study|Withdrawal by Subject|0
7366044|NCT01060384|11615091|FG001|Overall Study|Withdrawal by Subject|1
7366045|NCT01060384|11615092|FG002|Overall Study|Withdrawal by Subject|0
7366046|NCT01060384|11615093|FG003|Overall Study|Withdrawal by Subject|0
7366047|NCT01060384|11615094|FG004|Overall Study|Withdrawal by Subject|0
7366048|NCT01060384|11615090|FG000|Overall Study|Death|0
7570039|NCT03478969|11947284|FG000|Overall Study|Covid-19|1
7570040|NCT03478969|11947285|FG001|Overall Study|Covid-19|4
7570041|NCT03478969|11947286|FG002|Overall Study|Covid-19|3
7570042|NCT03478969|11947284|FG000|Overall Study|Multiple Reasons|0
7570043|NCT03478969|11947285|FG001|Overall Study|Multiple Reasons|1
7570044|NCT03478969|11947286|FG002|Overall Study|Multiple Reasons|1
7570045|NCT03478969|11947284|FG000|Overall Study|Eligibility Criteria|0
7570046|NCT03478969|11947285|FG001|Overall Study|Eligibility Criteria|0
7570047|NCT03478969|11947286|FG002|Overall Study|Eligibility Criteria|5
7570048|NCT03478969|11947284|FG000|Overall Study|Lost to Follow-up|0
7570049|NCT03478969|11947285|FG001|Overall Study|Lost to Follow-up|0
7570050|NCT03478969|11947286|FG002|Overall Study|Lost to Follow-up|1
7570051|NCT03479216|11947315|FG000|Overall Study|Withdrawal by Subject|3
7366049|NCT01060384|11615091|FG001|Overall Study|Death|0
7366050|NCT01060384|11615092|FG002|Overall Study|Death|0
7366051|NCT01060384|11615093|FG003|Overall Study|Death|0
7366052|NCT01060384|11615094|FG004|Overall Study|Death|1
7366053|NCT01060384|11615090|FG000|Overall Study|Intercurrent illness|0
7366054|NCT01060384|11615091|FG001|Overall Study|Intercurrent illness|0
7366055|NCT01060384|11615092|FG002|Overall Study|Intercurrent illness|0
7366056|NCT01060384|11615093|FG003|Overall Study|Intercurrent illness|0
7366057|NCT01060384|11615094|FG004|Overall Study|Intercurrent illness|1
7366058|NCT01060540|11615105|FG000|Overall Study|Withdrawal by Subject|10
7366059|NCT01060540|11615106|FG001|Overall Study|Withdrawal by Subject|20
7366060|NCT01060540|11615105|FG000|Overall Study|Lost to Follow-up|52
7366061|NCT01060540|11615106|FG001|Overall Study|Lost to Follow-up|43
7366062|NCT01060540|11615105|FG000|Overall Study|Death|2
7366063|NCT01060540|11615106|FG001|Overall Study|Death|1
7366064|NCT01060540|11615105|FG000|Overall Study|Physician Decision|0
7366065|NCT01060540|11615106|FG001|Overall Study|Physician Decision|1
7366066|NCT01060553|11615114|FG000|Overall Study|Lost to Follow-up|3
7366067|NCT01060553|11615115|FG001|Overall Study|Lost to Follow-up|5
7366068|NCT01060553|11615114|FG000|Overall Study|Withdrawal by Subject|5
7366069|NCT01060553|11615115|FG001|Overall Study|Withdrawal by Subject|5
7366070|NCT01060553|11615114|FG000|Overall Study|Lack of Efficacy|1
7366071|NCT01060553|11615115|FG001|Overall Study|Lack of Efficacy|0
7366072|NCT01060670|11615131|FG000|Run In|screen failure|0
7366073|NCT01060670|11615132|FG001|Run In|screen failure|238
7366074|NCT01061008|11615142|FG000|Overall Study|Badiocephalic fistula failed|3
7366075|NCT01061008|11615143|FG001|Overall Study|Badiocephalic fistula failed|2
7366076|NCT01061008|11615142|FG000|Overall Study|Death|1
7366077|NCT01061008|11615143|FG001|Overall Study|Death|0
7366078|NCT01061008|11615142|FG000|Overall Study|Withdrawal by Subject|1
7366079|NCT01061008|11615143|FG001|Overall Study|Withdrawal by Subject|3
7366080|NCT01061008|11615142|FG000|Overall Study|Unable to exercise following surgery|1
7366081|NCT01061008|11615143|FG001|Overall Study|Unable to exercise following surgery|0
7366082|NCT01061008|11615142|FG000|Overall Study|Adverse Event|0
7366083|NCT01061008|11615143|FG001|Overall Study|Adverse Event|1
7366084|NCT01061177|11615153|FG000|Overall Study|Adverse Event|117
7366085|NCT01061177|11615153|FG000|Overall Study|Withdrawal by Subject|27
7366086|NCT01061177|11615153|FG000|Overall Study|Disease progression|17
7366087|NCT01061177|11615153|FG000|Overall Study|Protocol Violation|11
7366088|NCT01061177|11615153|FG000|Overall Study|Lost to Follow-up|9
7366089|NCT01061177|11615153|FG000|Overall Study|New cancer therapy|9
7366090|NCT01061177|11615153|FG000|Overall Study|Abnormal laboratory values|6
7366091|NCT01061177|11615153|FG000|Overall Study|Abnormal test procedure results|4
7366092|NCT01061177|11615153|FG000|Overall Study|Administratie problems|4
7366093|NCT01061177|11615153|FG000|Overall Study|Death|4
7366094|NCT01061333|11615157|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
7366095|NCT01061333|11615158|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
7366096|NCT01061359|11615169|FG000|Overall Study|Death|32
7366097|NCT01061359|11615169|FG000|Overall Study|Lost to Follow-up|1072
7366098|NCT01061359|11615169|FG000|Overall Study|Relapse|187
7366099|NCT01061359|11615169|FG000|Overall Study|Secondary neoplasm|11
7366100|NCT01061385|11615175|FG000|Overall Study|Lost to Follow-up|1
7366101|NCT01061385|11615176|FG001|Overall Study|Lost to Follow-up|0
7366102|NCT01061385|11615175|FG000|Overall Study|subject decision not related to AE|0
7366103|NCT01061385|11615176|FG001|Overall Study|subject decision not related to AE|1
7366104|NCT01061567|11615196|FG000|Overall Study|Adverse Event|32
7366105|NCT01061567|11615196|FG000|Overall Study|Death|2
7366106|NCT01061567|11615196|FG000|Overall Study|Lack of Efficacy|3
7366107|NCT01061567|11615196|FG000|Overall Study|Lost to Follow-up|24
7366108|NCT01061567|11615196|FG000|Overall Study|Protocol Violation|1
7366109|NCT01061567|11615196|FG000|Overall Study|Withdrawal by Subject|11
7366110|NCT01061567|11615196|FG000|Overall Study|Other reason than stated above|3
7366111|NCT01061606|11615200|FG000|Overall Study|Adverse Event|1
7570052|NCT03479216|11947316|FG001|Overall Study|Withdrawal by Subject|2
7366112|NCT01061606|11615200|FG000|Overall Study|Death|1
7366113|NCT01061606|11615200|FG000|Overall Study|Disease Progression|4
7366114|NCT01061606|11615200|FG000|Overall Study|alternative therapy|2
7366115|NCT01061671|11615206|FG000|Overall Study|Withdrawal by Subject|16
7366116|NCT01061671|11615207|FG001|Overall Study|Withdrawal by Subject|20
7366117|NCT01061671|11615206|FG000|Overall Study|Lost to Follow-up|3
7366118|NCT01061671|11615207|FG001|Overall Study|Lost to Follow-up|5
7366119|NCT01061671|11615206|FG000|Overall Study|Death|28
7366120|NCT01061671|11615207|FG001|Overall Study|Death|30
7366121|NCT01061710|11615213|FG000|Overall Study|Protocol Violation|14
7366122|NCT01061723|11615223|FG000|Overall Study|Adverse Event|0
7366123|NCT01061723|11615224|FG001|Overall Study|Adverse Event|2
7366124|NCT01061723|11615225|FG002|Overall Study|Adverse Event|5
7366125|NCT01061723|11615226|FG003|Overall Study|Adverse Event|5
7366126|NCT01061723|11615227|FG004|Overall Study|Adverse Event|2
7366127|NCT01061723|11615228|FG005|Overall Study|Adverse Event|6
7366128|NCT01061723|11615223|FG000|Overall Study|Lack of Efficacy|2
7366129|NCT01061723|11615224|FG001|Overall Study|Lack of Efficacy|3
7366130|NCT01061723|11615225|FG002|Overall Study|Lack of Efficacy|4
7366131|NCT01061723|11615226|FG003|Overall Study|Lack of Efficacy|2
7366132|NCT01061723|11615227|FG004|Overall Study|Lack of Efficacy|1
7366133|NCT01061723|11615228|FG005|Overall Study|Lack of Efficacy|1
7366134|NCT01061723|11615223|FG000|Overall Study|Randomized but not treated|0
7366135|NCT01061723|11615224|FG001|Overall Study|Randomized but not treated|0
7366136|NCT01061723|11615225|FG002|Overall Study|Randomized but not treated|0
7366137|NCT01061723|11615226|FG003|Overall Study|Randomized but not treated|0
7366138|NCT01061723|11615227|FG004|Overall Study|Randomized but not treated|0
7366139|NCT01061723|11615228|FG005|Overall Study|Randomized but not treated|1
7366140|NCT01061723|11615223|FG000|Overall Study|Other than specified above|2
7366141|NCT01061723|11615224|FG001|Overall Study|Other than specified above|1
7366142|NCT01061723|11615225|FG002|Overall Study|Other than specified above|1
7366143|NCT01061723|11615226|FG003|Overall Study|Other than specified above|1
7366144|NCT01061723|11615227|FG004|Overall Study|Other than specified above|0
7366145|NCT01061723|11615228|FG005|Overall Study|Other than specified above|1
7366146|NCT01061736|11615257|FG000|Overall Study|Dose regimen not selected|0
7366147|NCT01061736|11615258|FG001|Overall Study|Dose regimen not selected|0
7366148|NCT01061736|11615259|FG002|Overall Study|Dose regimen not selected|0
7366149|NCT01061736|11615260|FG003|Overall Study|Dose regimen not selected|0
7366150|NCT01061736|11615261|FG004|Overall Study|Dose regimen not selected|0
7366151|NCT01061736|11615262|FG005|Overall Study|Dose regimen not selected|0
7366152|NCT01061736|11615263|FG006|Overall Study|Dose regimen not selected|79
7366153|NCT01061736|11615264|FG007|Overall Study|Dose regimen not selected|0
7366154|NCT01061736|11615265|FG008|Overall Study|Dose regimen not selected|0
7366155|NCT01061736|11615266|FG009|Overall Study|Dose regimen not selected|0
7366156|NCT01061736|11615257|FG000|Overall Study|Adverse Event|13
7366157|NCT01061736|11615258|FG001|Overall Study|Adverse Event|1
7366158|NCT01061736|11615259|FG002|Overall Study|Adverse Event|3
7366159|NCT01061736|11615260|FG003|Overall Study|Adverse Event|2
7366160|NCT01061736|11615261|FG004|Overall Study|Adverse Event|4
7366161|NCT01061736|11615262|FG005|Overall Study|Adverse Event|1
7366162|NCT01061736|11615263|FG006|Overall Study|Adverse Event|4
7366163|NCT01061736|11615264|FG007|Overall Study|Adverse Event|63
7366164|NCT01061736|11615265|FG008|Overall Study|Adverse Event|67
7366165|NCT01061736|11615266|FG009|Overall Study|Adverse Event|34
7366166|NCT01061736|11615257|FG000|Overall Study|Lack of Efficacy|0
7366167|NCT01061736|11615258|FG001|Overall Study|Lack of Efficacy|2
7366168|NCT01061736|11615259|FG002|Overall Study|Lack of Efficacy|1
7366169|NCT01061736|11615260|FG003|Overall Study|Lack of Efficacy|1
7366170|NCT01061736|11615261|FG004|Overall Study|Lack of Efficacy|1
7366171|NCT01061736|11615262|FG005|Overall Study|Lack of Efficacy|2
7366172|NCT01061736|11615263|FG006|Overall Study|Lack of Efficacy|1
7366173|NCT01061736|11615264|FG007|Overall Study|Lack of Efficacy|9
7366174|NCT01061736|11615265|FG008|Overall Study|Lack of Efficacy|9
7366175|NCT01061736|11615266|FG009|Overall Study|Lack of Efficacy|10
7366176|NCT01061736|11615257|FG000|Overall Study|Poor compliance to protocol|0
7366177|NCT01061736|11615258|FG001|Overall Study|Poor compliance to protocol|0
7366178|NCT01061736|11615259|FG002|Overall Study|Poor compliance to protocol|0
7366179|NCT01061736|11615260|FG003|Overall Study|Poor compliance to protocol|0
7366180|NCT01061736|11615261|FG004|Overall Study|Poor compliance to protocol|0
7366181|NCT01061736|11615262|FG005|Overall Study|Poor compliance to protocol|0
7366182|NCT01061736|11615263|FG006|Overall Study|Poor compliance to protocol|0
7366183|NCT01061736|11615264|FG007|Overall Study|Poor compliance to protocol|2
7366184|NCT01061736|11615265|FG008|Overall Study|Poor compliance to protocol|5
7366185|NCT01061736|11615266|FG009|Overall Study|Poor compliance to protocol|9
7366186|NCT01061736|11615257|FG000|Overall Study|Not treated|0
7366187|NCT01061736|11615258|FG001|Overall Study|Not treated|0
7366188|NCT01061736|11615259|FG002|Overall Study|Not treated|0
7366189|NCT01061736|11615260|FG003|Overall Study|Not treated|0
7366190|NCT01061736|11615261|FG004|Overall Study|Not treated|1
7366191|NCT01061736|11615262|FG005|Overall Study|Not treated|0
7366192|NCT01061736|11615263|FG006|Overall Study|Not treated|0
7366193|NCT01061736|11615264|FG007|Overall Study|Not treated|2
7366194|NCT01061736|11615265|FG008|Overall Study|Not treated|1
7366195|NCT01061736|11615266|FG009|Overall Study|Not treated|0
7366196|NCT01061736|11615257|FG000|Overall Study|Other than specified above|0
7366197|NCT01061736|11615258|FG001|Overall Study|Other than specified above|1
7366198|NCT01061736|11615259|FG002|Overall Study|Other than specified above|2
7366199|NCT01061736|11615260|FG003|Overall Study|Other than specified above|0
7366200|NCT01061736|11615261|FG004|Overall Study|Other than specified above|1
7366201|NCT01061736|11615262|FG005|Overall Study|Other than specified above|0
7366202|NCT01061736|11615263|FG006|Overall Study|Other than specified above|0
7366203|NCT01061736|11615264|FG007|Overall Study|Other than specified above|18
7366204|NCT01061736|11615265|FG008|Overall Study|Other than specified above|15
7366205|NCT01061736|11615266|FG009|Overall Study|Other than specified above|21
7366206|NCT01061775|11615291|FG000|Overall Study|Physician Decision|2
7366207|NCT01061775|11615291|FG000|Overall Study|Lost to Follow-up|1
7366208|NCT01061866|11615296|FG000|Overall Study|Adverse Event|2
7366209|NCT01062061|11615317|FG000|Overall Study|Enrolled more than once|2
7366210|NCT01062061|11615317|FG000|Overall Study|Investigated before study start|13
7366211|NCT01062061|11615317|FG000|Overall Study|Outside chief indications|10
7366212|NCT01062061|11615317|FG000|Overall Study|Failed to meet inclusion criteria|2
7366213|NCT01062113|11615332|FG000|Overall Study|Adverse Event|1
7366214|NCT01062113|11615333|FG001|Overall Study|Adverse Event|0
7366215|NCT01062113|11615334|FG002|Overall Study|Adverse Event|0
7366216|NCT01062113|11615332|FG000|Overall Study|Lack of Efficacy|38
7366217|NCT01062113|11615333|FG001|Overall Study|Lack of Efficacy|22
7366218|NCT01062113|11615334|FG002|Overall Study|Lack of Efficacy|31
7366219|NCT01062113|11615332|FG000|Overall Study|Withdrawal by Subject|1
7366220|NCT01062113|11615333|FG001|Overall Study|Withdrawal by Subject|0
7366221|NCT01062113|11615334|FG002|Overall Study|Withdrawal by Subject|0
7366222|NCT01062126|11615342|FG000|Overall Study|Death|209
7366223|NCT01062126|11615342|FG000|Overall Study|All Withdrawals|324
7366224|NCT01062256|11615357|FG000|Overall Study|Adverse Event|1
7366225|NCT01062256|11615358|FG001|Overall Study|Adverse Event|0
7366226|NCT01062256|11615359|FG002|Overall Study|Adverse Event|0
7366227|NCT01062256|11615357|FG000|Overall Study|Withdrawal by Subject|1
7366228|NCT01062256|11615358|FG001|Overall Study|Withdrawal by Subject|1
7366229|NCT01062256|11615359|FG002|Overall Study|Withdrawal by Subject|1
7366230|NCT01062256|11615357|FG000|Overall Study|Ineligible|1
7366231|NCT01062256|11615358|FG001|Overall Study|Ineligible|4
7366232|NCT01062256|11615359|FG002|Overall Study|Ineligible|3
7366233|NCT01062256|11615357|FG000|Overall Study|Administrative|0
7366234|NCT01062256|11615358|FG001|Overall Study|Administrative|2
7366235|NCT01062256|11615359|FG002|Overall Study|Administrative|0
7366236|NCT01062555|11615386|FG000|Phase 1|Death|10
7366237|NCT01062555|11615387|FG001|Phase 1|Death|17
7366238|NCT01062555|11615388|FG002|Phase 1|Death|0
7366239|NCT01062555|11615389|FG003|Phase 1|Death|0
7366240|NCT01062555|11615386|FG000|Phase 1|Graft Failure|12
7366241|NCT01062555|11615387|FG001|Phase 1|Graft Failure|8
7366242|NCT01062555|11615388|FG002|Phase 1|Graft Failure|0
7366243|NCT01062555|11615389|FG003|Phase 1|Graft Failure|0
7366244|NCT01062555|11615386|FG000|Phase 1|Withdrawal by Subject|1
7366245|NCT01062555|11615387|FG001|Phase 1|Withdrawal by Subject|1
7366246|NCT01062555|11615388|FG002|Phase 1|Withdrawal by Subject|0
7366247|NCT01062555|11615389|FG003|Phase 1|Withdrawal by Subject|0
7366248|NCT01062555|11615386|FG000|Phase 2|Death|0
7366249|NCT01062555|11615387|FG001|Phase 2|Death|0
7366250|NCT01062555|11615388|FG002|Phase 2|Death|8
7366251|NCT01062555|11615389|FG003|Phase 2|Death|3
7366252|NCT01062555|11615386|FG000|Phase 2|Graft failure|0
7366253|NCT01062555|11615387|FG001|Phase 2|Graft failure|0
7366254|NCT01062555|11615388|FG002|Phase 2|Graft failure|7
7366255|NCT01062555|11615389|FG003|Phase 2|Graft failure|4
7366256|NCT01062555|11615386|FG000|Phase 2|Withdrawal by Subject|0
7366257|NCT01062555|11615387|FG001|Phase 2|Withdrawal by Subject|0
7366258|NCT01062555|11615388|FG002|Phase 2|Withdrawal by Subject|0
7366259|NCT01062555|11615389|FG003|Phase 2|Withdrawal by Subject|7
7366260|NCT01062555|11615386|FG000|Phase 2|Protocol Violation|0
7366261|NCT01062555|11615387|FG001|Phase 2|Protocol Violation|0
7366262|NCT01062555|11615388|FG002|Phase 2|Protocol Violation|0
7366263|NCT01062555|11615389|FG003|Phase 2|Protocol Violation|3
7366264|NCT01062555|11615386|FG000|Phase 2|Physician Decision|0
7366265|NCT01062555|11615387|FG001|Phase 2|Physician Decision|0
7366266|NCT01062555|11615388|FG002|Phase 2|Physician Decision|0
7366267|NCT01062555|11615389|FG003|Phase 2|Physician Decision|17
7366268|NCT01062763|11615415|FG000|Overall Study|Adverse Event|3
7366269|NCT01062763|11615416|FG001|Overall Study|Adverse Event|4
7366270|NCT01062841|11615424|FG000|Overall Study|Indwelling Device Removed|41
7366271|NCT01062841|11615425|FG001|Overall Study|Indwelling Device Removed|48
7366272|NCT01062841|11615424|FG000|Overall Study|Death|3
7366273|NCT01062841|11615425|FG001|Overall Study|Death|5
7366274|NCT01062841|11615424|FG000|Overall Study|Withdrawal by Subject|2
7366275|NCT01062841|11615425|FG001|Overall Study|Withdrawal by Subject|0
7366276|NCT01062841|11615424|FG000|Overall Study|Withdrawal by Study|3
7366277|NCT01062841|11615425|FG001|Overall Study|Withdrawal by Study|0
7366278|NCT01062971|11615442|FG000|Overall Study|Protocol Violation|1
7366279|NCT01062971|11615443|FG001|Overall Study|Protocol Violation|3
7366280|NCT01062971|11615442|FG000|Overall Study|Lost to Follow-up|3
7366281|NCT01062971|11615443|FG001|Overall Study|Lost to Follow-up|4
7366282|NCT01063036|11615449|FG000|Participants Treated With Study Drug|Adverse Event|1
7366283|NCT01063036|11615449|FG000|Participants Treated With Study Drug|Protocol Violation|1
7366284|NCT01063036|11615449|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
7366285|NCT01063036|11615449|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
7366286|NCT01063036|11615449|FG000|Participants Treated With Study Drug|Pregnancy|1
7366287|NCT01063036|11615449|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
7366288|NCT01063036|11615449|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
7366289|NCT01063036|11615449|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
7366290|NCT01063062|11615468|FG000|Overall Study|Patient withdrew consent|0
7366291|NCT01063062|11615469|FG001|Overall Study|Patient withdrew consent|1
7366292|NCT01063062|11615468|FG000|Overall Study|Adverse Event|2
7366293|NCT01063062|11615469|FG001|Overall Study|Adverse Event|4
7366294|NCT01063062|11615468|FG000|Overall Study|Protocol Violation|5
7366295|NCT01063062|11615469|FG001|Overall Study|Protocol Violation|4
7366296|NCT01063062|11615468|FG000|Overall Study|Investigator's request|1
7366297|NCT01063062|11615469|FG001|Overall Study|Investigator's request|0
7366298|NCT01063062|11615468|FG000|Overall Study|Lost to Follow-up|0
7366299|NCT01063062|11615469|FG001|Overall Study|Lost to Follow-up|2
7366300|NCT01063062|11615468|FG000|Overall Study|Miscellaneous reason|0
7366301|NCT01063062|11615469|FG001|Overall Study|Miscellaneous reason|1
7366302|NCT01063153|11615491|FG000|Overall Study|Found Ineligible During Screening|2
7366303|NCT01063153|11615492|FG001|Overall Study|Found Ineligible During Screening|0
7366304|NCT01063153|11615491|FG000|Overall Study|Lost to Follow-up|0
7366305|NCT01063153|11615492|FG001|Overall Study|Lost to Follow-up|7
7366306|NCT01063153|11615491|FG000|Overall Study|Withdrawal by Subject|0
7366307|NCT01063153|11615492|FG001|Overall Study|Withdrawal by Subject|1
7366308|NCT01063153|11615491|FG000|Overall Study|Physician Decision|0
7366309|NCT01063153|11615492|FG001|Overall Study|Physician Decision|4
7366310|NCT01063283|11615504|FG000|Cycle 1|Adverse Event|2
7366311|NCT01063283|11615505|FG001|Cycle 1|Adverse Event|0
7366312|NCT01063283|11615506|FG002|Cycle 1|Adverse Event|0
7366313|NCT01063283|11615504|FG000|Cycle 1|Technical failure in data collection|1
7366314|NCT01063283|11615505|FG001|Cycle 1|Technical failure in data collection|0
7366315|NCT01063283|11615506|FG002|Cycle 1|Technical failure in data collection|0
7366316|NCT01063348|11615514|FG000|Overall Study|Lost to Follow-up|3
7366317|NCT01063348|11615515|FG001|Overall Study|Lost to Follow-up|10
7366318|NCT01063595|11615521|FG000|Enrolled in Study and Randomized|Reason not Specified|1
7366319|NCT01063595|11615522|FG001|Enrolled in Study and Randomized|Reason not Specified|0
7366320|NCT01063595|11615521|FG000|Enrolled in Study and Randomized|Adverse Event|0
7366321|NCT01063595|11615522|FG001|Enrolled in Study and Randomized|Adverse Event|1
7366322|NCT01063595|11615521|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
7366323|NCT01063595|11615522|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
7366324|NCT01063595|11615521|FG000|First Intervention|Adverse Event|1
7366325|NCT01063595|11615522|FG001|First Intervention|Adverse Event|4
7366326|NCT01063595|11615521|FG000|First Intervention|Withdrawal by Subject|1
7366327|NCT01063595|11615522|FG001|First Intervention|Withdrawal by Subject|0
7366328|NCT01063595|11615521|FG000|First Intervention|Reason not Specified|0
7366329|NCT01063595|11615522|FG001|First Intervention|Reason not Specified|1
7366330|NCT01063764|11615533|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
7366331|NCT01063764|11615533|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
7366332|NCT01063764|11615533|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
7366333|NCT01063764|11615533|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
7366334|NCT01063764|11615533|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
7366335|NCT01063764|11615533|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
7366336|NCT01063764|11615533|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
7366337|NCT01063855|11615556|FG000|Overall Study|Adverse Event|4
7366338|NCT01063855|11615557|FG001|Overall Study|Adverse Event|4
7366339|NCT01063855|11615556|FG000|Overall Study|Death|0
7366340|NCT01063855|11615557|FG001|Overall Study|Death|1
7366341|NCT01063855|11615556|FG000|Overall Study|Lost to Follow-up|8
7366342|NCT01063855|11615557|FG001|Overall Study|Lost to Follow-up|4
7366343|NCT01063855|11615556|FG000|Overall Study|Pregnancy|1
7366344|NCT01063855|11615557|FG001|Overall Study|Pregnancy|0
7366345|NCT01063855|11615556|FG000|Overall Study|Lack of Efficacy|0
7366346|NCT01063855|11615557|FG001|Overall Study|Lack of Efficacy|1
7366347|NCT01063855|11615556|FG000|Overall Study|Withdrawal by Subject|11
7366348|NCT01063855|11615557|FG001|Overall Study|Withdrawal by Subject|8
7366349|NCT01063855|11615556|FG000|Overall Study|Reason not specified|13
7366350|NCT01063855|11615557|FG001|Overall Study|Reason not specified|11
7366351|NCT01063868|11615569|FG000|Overall Study|Adverse Event|9
7366352|NCT01063868|11615570|FG001|Overall Study|Adverse Event|7
7366353|NCT01063868|11615569|FG000|Overall Study|Withdrawal by Subject|3
7366354|NCT01063868|11615570|FG001|Overall Study|Withdrawal by Subject|1
7366355|NCT01063868|11615569|FG000|Overall Study|Study Terminated By Sponsor|23
7366356|NCT01063868|11615570|FG001|Overall Study|Study Terminated By Sponsor|4
7366357|NCT01063881|11615579|FG000|Overall Study|Adverse Event|12
7366358|NCT01063881|11615580|FG001|Overall Study|Adverse Event|2
7366359|NCT01063881|11615581|FG002|Overall Study|Adverse Event|0
7366360|NCT01063881|11615579|FG000|Overall Study|Lost to Follow-up|13
7366361|NCT01063881|11615580|FG001|Overall Study|Lost to Follow-up|7
7366362|NCT01063881|11615581|FG002|Overall Study|Lost to Follow-up|1
7366363|NCT01063881|11615579|FG000|Overall Study|Withdrawal by Subject|25
7366364|NCT01063881|11615580|FG001|Overall Study|Withdrawal by Subject|1
7366365|NCT01063881|11615581|FG002|Overall Study|Withdrawal by Subject|0
7366366|NCT01063881|11615579|FG000|Overall Study|Reason for not completed not specified|5
7366367|NCT01063881|11615580|FG001|Overall Study|Reason for not completed not specified|1
7366368|NCT01063881|11615581|FG002|Overall Study|Reason for not completed not specified|0
7366369|NCT01063972|11615621|FG000|Overall Study|Death|12
7366370|NCT01063972|11615622|FG001|Overall Study|Death|11
7366371|NCT01063972|11615621|FG000|Overall Study|Incarcerated|2
7366372|NCT01063972|11615622|FG001|Overall Study|Incarcerated|1
7366373|NCT01064167|11615635|FG000|Overall Study|Protocol Violation|14
7366374|NCT01064167|11615636|FG001|Overall Study|Protocol Violation|15
7366375|NCT01064297|11615655|FG000|Overall Study|Lost to Follow-up|791
7366376|NCT01064297|11615656|FG001|Overall Study|Lost to Follow-up|48
7366377|NCT01064297|11615657|FG002|Overall Study|Lost to Follow-up|133
7366378|NCT01064310|11615674|FG000|Period 1|Adverse Event|7
7366379|NCT01064310|11615675|FG001|Period 1|Adverse Event|10
7366380|NCT01064310|11615676|FG002|Period 1|Adverse Event|0
7366381|NCT01064310|11615674|FG000|Period 1|Physician Decision|1
7366382|NCT01064310|11615675|FG001|Period 1|Physician Decision|0
7366383|NCT01064310|11615676|FG002|Period 1|Physician Decision|0
7366384|NCT01064310|11615674|FG000|Period 1|Withdrawal by Subject|2
7366385|NCT01064310|11615675|FG001|Period 1|Withdrawal by Subject|2
7366386|NCT01064310|11615676|FG002|Period 1|Withdrawal by Subject|0
7366387|NCT01064310|11615674|FG000|Period 1|Lack of Efficacy|3
7366388|NCT01064310|11615675|FG001|Period 1|Lack of Efficacy|5
7570053|NCT03479216|11947315|FG000|Overall Study|Physician Decision|2
7366389|NCT01064310|11615676|FG002|Period 1|Lack of Efficacy|0
7366390|NCT01064310|11615674|FG000|Period 1|Entered Open-label Period|1
7366391|NCT01064310|11615675|FG001|Period 1|Entered Open-label Period|1
7366392|NCT01064310|11615676|FG002|Period 1|Entered Open-label Period|0
7366393|NCT01064310|11615674|FG000|Period 2|Adverse Event|2
7366394|NCT01064310|11615675|FG001|Period 2|Adverse Event|1
7366395|NCT01064310|11615676|FG002|Period 2|Adverse Event|0
7366396|NCT01064310|11615674|FG000|Period 2|Physician Decision|0
7366397|NCT01064310|11615675|FG001|Period 2|Physician Decision|1
7366398|NCT01064310|11615676|FG002|Period 2|Physician Decision|0
7366399|NCT01064310|11615674|FG000|Period 2|Entered Open-label Period|1
7366400|NCT01064310|11615675|FG001|Period 2|Entered Open-label Period|0
7366401|NCT01064310|11615676|FG002|Period 2|Entered Open-label Period|0
7366402|NCT01064310|11615674|FG000|Period 2|Lack of Efficacy|1
7366403|NCT01064310|11615675|FG001|Period 2|Lack of Efficacy|4
7366404|NCT01064310|11615676|FG002|Period 2|Lack of Efficacy|0
7366405|NCT01064310|11615674|FG000|Open Label Pazopinib|Withdrawal by Subject|0
7366406|NCT01064310|11615675|FG001|Open Label Pazopinib|Withdrawal by Subject|0
7366407|NCT01064310|11615676|FG002|Open Label Pazopinib|Withdrawal by Subject|1
7366408|NCT01064310|11615674|FG000|Open Label Pazopinib|Adverse Event|0
7366409|NCT01064310|11615675|FG001|Open Label Pazopinib|Adverse Event|0
7366410|NCT01064310|11615676|FG002|Open Label Pazopinib|Adverse Event|12
7366411|NCT01064310|11615674|FG000|Open Label Pazopinib|Lack of Efficacy|0
7366412|NCT01064310|11615675|FG001|Open Label Pazopinib|Lack of Efficacy|0
7366413|NCT01064310|11615676|FG002|Open Label Pazopinib|Lack of Efficacy|51
7366414|NCT01064310|11615674|FG000|Open Label Pazopinib|Physician Decision|0
7366415|NCT01064310|11615675|FG001|Open Label Pazopinib|Physician Decision|0
7366416|NCT01064310|11615676|FG002|Open Label Pazopinib|Physician Decision|20
7386676|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
7386677|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386678|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386679|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386680|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386681|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
7386682|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
7386683|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7386684|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
7386685|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
7386686|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7386687|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7386688|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7386689|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
7386690|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
7386691|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
7386692|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386693|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386694|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
7386695|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386696|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386697|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386698|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386699|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386700|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
7386701|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
7386702|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
7386703|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
7386704|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
7386705|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
7570054|NCT03479216|11947316|FG001|Overall Study|Physician Decision|3
7570055|NCT03480009|11947334|FG000|Overall Study|Lost to Follow-up|4
7570056|NCT03480009|11947335|FG001|Overall Study|Lost to Follow-up|5
7570057|NCT03480009|11947336|FG002|Overall Study|Lost to Follow-up|4
7570058|NCT03480009|11947337|FG003|Overall Study|Lost to Follow-up|0
7570059|NCT03480022|11947352|FG000|Overall Study|Pregnancy|2
7570060|NCT03480022|11947353|FG001|Overall Study|Pregnancy|0
7570061|NCT03480022|11947352|FG000|Overall Study|Adverse Event|6
7570062|NCT03480022|11947353|FG001|Overall Study|Adverse Event|0
7570063|NCT03480022|11947352|FG000|Overall Study|Lack of Efficacy|0
7570064|NCT03480022|11947353|FG001|Overall Study|Lack of Efficacy|2
7570065|NCT03480022|11947352|FG000|Overall Study|Physician Decision|0
7570066|NCT03480022|11947353|FG001|Overall Study|Physician Decision|1
7570067|NCT03480022|11947352|FG000|Overall Study|Withdrawal by Subject|2
7570068|NCT03480022|11947353|FG001|Overall Study|Withdrawal by Subject|0
7570069|NCT03480022|11947352|FG000|Overall Study|Medication concerns|1
7570070|NCT03480022|11947353|FG001|Overall Study|Medication concerns|0
7570071|NCT03480022|11947352|FG000|Overall Study|Family member COVID exposure|0
7570072|NCT03480022|11947353|FG001|Overall Study|Family member COVID exposure|1
7570073|NCT03480152|11947370|FG000|Phase I|Signed consent. Died before treatment.|1
7570074|NCT03480152|11947371|FG001|Phase I|Signed consent. Died before treatment.|0
7570075|NCT03480152|11947372|FG002|Phase I|Signed consent. Died before treatment.|0
7570076|NCT03480243|11947380|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
7570077|NCT03480243|11947380|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
7570078|NCT03480425|11947393|FG000|Overall Study|Force transducer technical failure|1
7570079|NCT03480750|11947409|FG000|Overall Study|Withdrawal by Subject|0
7570080|NCT03480750|11947410|FG001|Overall Study|Withdrawal by Subject|1
7570081|NCT03480750|11947411|FG002|Overall Study|Withdrawal by Subject|0
7570082|NCT03480750|11947412|FG003|Overall Study|Withdrawal by Subject|0
7570083|NCT03480750|11947413|FG004|Overall Study|Withdrawal by Subject|0
7570084|NCT03480750|11947414|FG005|Overall Study|Withdrawal by Subject|0
7570085|NCT03480750|11947409|FG000|Overall Study|The interruption in Trientine shippment|0
7570086|NCT03480750|11947410|FG001|Overall Study|The interruption in Trientine shippment|0
7570087|NCT03480750|11947411|FG002|Overall Study|The interruption in Trientine shippment|0
7570088|NCT03480750|11947412|FG003|Overall Study|The interruption in Trientine shippment|0
7570089|NCT03480750|11947413|FG004|Overall Study|The interruption in Trientine shippment|0
7570090|NCT03480750|11947414|FG005|Overall Study|The interruption in Trientine shippment|1
7570091|NCT03480763|11947439|FG000|Overall Study|Withdrawal by Subject|18
7570092|NCT03480763|11947440|FG001|Overall Study|Withdrawal by Subject|10
7570093|NCT03480763|11947439|FG000|Overall Study|Lost to Follow-up|4
7570094|NCT03480763|11947440|FG001|Overall Study|Lost to Follow-up|7
7570095|NCT03480763|11947439|FG000|Overall Study|non-study pneumococcal vaccine|1
7570096|NCT03480763|11947440|FG001|Overall Study|non-study pneumococcal vaccine|0
7570097|NCT03480763|11947439|FG000|Overall Study|oncological treatment|0
7570098|NCT03480763|11947440|FG001|Overall Study|oncological treatment|2
7570099|NCT03480763|11947439|FG000|Overall Study|pain with vaccination|1
7570100|NCT03480763|11947440|FG001|Overall Study|pain with vaccination|0
7570101|NCT03480841|11947452|FG000|Overall Study|Lost to Follow-up|2
7570102|NCT03480932|11947472|FG000|Overall Study|Death|1
7570103|NCT03480932|11947473|FG001|Overall Study|Death|1
7570104|NCT03480932|11947474|FG002|Overall Study|Death|0
7570105|NCT03480932|11947472|FG000|Overall Study|Lost to Follow-up|0
7570106|NCT03480932|11947473|FG001|Overall Study|Lost to Follow-up|2
7570107|NCT03480932|11947474|FG002|Overall Study|Lost to Follow-up|3
7570108|NCT03480932|11947472|FG000|Overall Study|Incarcerated|2
7570109|NCT03480932|11947473|FG001|Overall Study|Incarcerated|2
7570110|NCT03480932|11947474|FG002|Overall Study|Incarcerated|2
7570111|NCT03481309|11947497|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
7570112|NCT03481309|11947498|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
7570113|NCT03481309|11947499|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
7570114|NCT03481309|11947500|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
7570115|NCT03481309|11947501|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
7570116|NCT03481309|11947502|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
7570117|NCT03481725|11947521|FG000|Overall Study|Withdrawal by Subject|1
7570118|NCT03481725|11947522|FG001|Overall Study|Withdrawal by Subject|0
7570119|NCT03481816|11947532|FG000|Starting Dose|Refused further vaccines after 1 dose|1
7570120|NCT03481816|11947533|FG001|Starting Dose|Refused further vaccines after 1 dose|0
7570121|NCT03481816|11947532|FG000|Dose Expansion|Off treatment due to progressive disease|0
7570122|NCT03481816|11947533|FG001|Dose Expansion|Off treatment due to progressive disease|5
7460716|NCT01831089|11756395|FG002|Cohort III: Dose Level 3|Progressive disease|3
7460717|NCT01831089|11756396|FG003|Cohort III: Dose Level 3|Progressive disease|0
7460718|NCT01831089|11756397|FG004|Cohort III: Dose Level 3|Progressive disease|0
7460719|NCT01831089|11756398|FG005|Cohort III: Dose Level 3|Progressive disease|0
7460720|NCT01831089|11756393|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
7460721|NCT01831089|11756394|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
7460722|NCT01831089|11756395|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
7460723|NCT01831089|11756396|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
7460724|NCT01831089|11756397|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
7460725|NCT01831089|11756398|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
7460726|NCT01831089|11756393|FG000|Cohort III: Dose Level 3|Adverse Event|0
7460727|NCT01831089|11756394|FG001|Cohort III: Dose Level 3|Adverse Event|0
7460728|NCT01831089|11756395|FG002|Cohort III: Dose Level 3|Adverse Event|1
7460729|NCT01831089|11756396|FG003|Cohort III: Dose Level 3|Adverse Event|0
7460730|NCT01831089|11756397|FG004|Cohort III: Dose Level 3|Adverse Event|0
7460731|NCT01831089|11756398|FG005|Cohort III: Dose Level 3|Adverse Event|0
7460732|NCT01831089|11756393|FG000|Cohort III: Dose Level 3|Global end of study|0
7460733|NCT01831089|11756394|FG001|Cohort III: Dose Level 3|Global end of study|0
7460734|NCT01831089|11756395|FG002|Cohort III: Dose Level 3|Global end of study|1
7460735|NCT01831089|11756396|FG003|Cohort III: Dose Level 3|Global end of study|0
7460736|NCT01831089|11756397|FG004|Cohort III: Dose Level 3|Global end of study|0
7460737|NCT01831089|11756398|FG005|Cohort III: Dose Level 3|Global end of study|0
7460738|NCT01831089|11756393|FG000|Cohort IV: Dose Level 4|Progressive disease|0
7460739|NCT01831089|11756394|FG001|Cohort IV: Dose Level 4|Progressive disease|0
7460740|NCT01831089|11756395|FG002|Cohort IV: Dose Level 4|Progressive disease|0
7460741|NCT01831089|11756396|FG003|Cohort IV: Dose Level 4|Progressive disease|6
7460742|NCT01831089|11756397|FG004|Cohort IV: Dose Level 4|Progressive disease|0
7460743|NCT01831089|11756398|FG005|Cohort IV: Dose Level 4|Progressive disease|0
7460744|NCT01831089|11756393|FG000|Cohort V: Dose Level 5|Progressive disease|0
7460745|NCT01831089|11756394|FG001|Cohort V: Dose Level 5|Progressive disease|0
7460746|NCT01831089|11756395|FG002|Cohort V: Dose Level 5|Progressive disease|0
7460747|NCT01831089|11756396|FG003|Cohort V: Dose Level 5|Progressive disease|0
7460748|NCT01831089|11756397|FG004|Cohort V: Dose Level 5|Progressive disease|30
7460749|NCT01831089|11756398|FG005|Cohort V: Dose Level 5|Progressive disease|0
7460750|NCT01831089|11756393|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
7460751|NCT01831089|11756394|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
7460752|NCT01831089|11756395|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
7460753|NCT01831089|11756396|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
7460754|NCT01831089|11756397|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
7460755|NCT01831089|11756398|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
7460756|NCT01831089|11756393|FG000|Cohort V: Dose Level 5|Death|0
7460757|NCT01831089|11756394|FG001|Cohort V: Dose Level 5|Death|0
7460758|NCT01831089|11756395|FG002|Cohort V: Dose Level 5|Death|0
7460759|NCT01831089|11756396|FG003|Cohort V: Dose Level 5|Death|0
7460760|NCT01831089|11756397|FG004|Cohort V: Dose Level 5|Death|1
7460761|NCT01831089|11756398|FG005|Cohort V: Dose Level 5|Death|0
7460762|NCT01831089|11756393|FG000|Cohort V: Dose Level 5|Global end of study|0
7460763|NCT01831089|11756394|FG001|Cohort V: Dose Level 5|Global end of study|0
7460764|NCT01831089|11756395|FG002|Cohort V: Dose Level 5|Global end of study|0
7460765|NCT01831089|11756396|FG003|Cohort V: Dose Level 5|Global end of study|0
7460766|NCT01831089|11756397|FG004|Cohort V: Dose Level 5|Global end of study|2
7460767|NCT01831089|11756398|FG005|Cohort V: Dose Level 5|Global end of study|0
7460768|NCT01831089|11756393|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
7460769|NCT01831089|11756394|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
7460770|NCT01831089|11756395|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
7460771|NCT01831089|11756396|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
7460772|NCT01831089|11756397|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
7570123|NCT03481816|11947532|FG000|Dose Expansion|Withdrawal by Subject|0
7570124|NCT03481816|11947533|FG001|Dose Expansion|Withdrawal by Subject|2
7570125|NCT03481816|11947532|FG000|Dose Expansion|Physician Decision|0
7570126|NCT03481816|11947533|FG001|Dose Expansion|Physician Decision|5
7570127|NCT03482011|11947543|FG000|Induction Period (16 Weeks)|Adverse Event|1
7570128|NCT03482011|11947544|FG001|Induction Period (16 Weeks)|Adverse Event|3
7570129|NCT03482011|11947545|FG002|Induction Period (16 Weeks)|Adverse Event|0
7570130|NCT03482011|11947546|FG003|Induction Period (16 Weeks)|Adverse Event|0
7570131|NCT03482011|11947547|FG004|Induction Period (16 Weeks)|Adverse Event|0
7570132|NCT03482011|11947548|FG005|Induction Period (16 Weeks)|Adverse Event|0
7570133|NCT03482011|11947549|FG006|Induction Period (16 Weeks)|Adverse Event|0
7570134|NCT03482011|11947550|FG007|Induction Period (16 Weeks)|Adverse Event|0
7570135|NCT03482011|11947543|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
7570136|NCT03482011|11947544|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
7570137|NCT03482011|11947545|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
7570138|NCT03482011|11947546|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
7570139|NCT03482011|11947547|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
7570140|NCT03482011|11947548|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
7570141|NCT03482011|11947549|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
7570142|NCT03482011|11947550|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
7570143|NCT03482011|11947543|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
7570144|NCT03482011|11947544|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
7570145|NCT03482011|11947545|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
7570146|NCT03482011|11947546|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
7570147|NCT03482011|11947547|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
7570148|NCT03482011|11947548|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
7570149|NCT03482011|11947549|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
7570150|NCT03482011|11947550|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
7570151|NCT03482011|11947543|FG000|Induction Period (16 Weeks)|Screen Failure|0
7570152|NCT03482011|11947544|FG001|Induction Period (16 Weeks)|Screen Failure|1
7570153|NCT03482011|11947545|FG002|Induction Period (16 Weeks)|Screen Failure|0
7570154|NCT03482011|11947546|FG003|Induction Period (16 Weeks)|Screen Failure|0
7570155|NCT03482011|11947547|FG004|Induction Period (16 Weeks)|Screen Failure|0
7570156|NCT03482011|11947548|FG005|Induction Period (16 Weeks)|Screen Failure|0
7570157|NCT03482011|11947549|FG006|Induction Period (16 Weeks)|Screen Failure|0
7570158|NCT03482011|11947550|FG007|Induction Period (16 Weeks)|Screen Failure|0
7570159|NCT03482011|11947543|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7570160|NCT03482011|11947544|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
7570161|NCT03482011|11947545|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7570162|NCT03482011|11947546|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7570163|NCT03482011|11947547|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7570164|NCT03482011|11947548|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7460773|NCT01831089|11756398|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
7460774|NCT01831089|11756393|FG000|Cohort B: Arm B|Progressive disease|0
7460775|NCT01831089|11756394|FG001|Cohort B: Arm B|Progressive disease|0
7460776|NCT01831089|11756395|FG002|Cohort B: Arm B|Progressive disease|0
7460777|NCT01831089|11756396|FG003|Cohort B: Arm B|Progressive disease|0
7460778|NCT01831089|11756397|FG004|Cohort B: Arm B|Progressive disease|0
7460779|NCT01831089|11756398|FG005|Cohort B: Arm B|Progressive disease|8
7460780|NCT01831089|11756393|FG000|Cohort B: Arm B|Physician Decision|0
7460781|NCT01831089|11756394|FG001|Cohort B: Arm B|Physician Decision|0
7460782|NCT01831089|11756395|FG002|Cohort B: Arm B|Physician Decision|0
7570165|NCT03482011|11947549|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7570166|NCT03482011|11947550|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7570167|NCT03482011|11947543|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
7570168|NCT03482011|11947544|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
7570169|NCT03482011|11947545|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
7570170|NCT03482011|11947546|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
7570171|NCT03482011|11947547|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
7570172|NCT03482011|11947548|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
7570173|NCT03482011|11947549|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
7570174|NCT03482011|11947550|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
7570175|NCT03482011|11947543|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7570176|NCT03482011|11947544|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7570177|NCT03482011|11947545|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7570178|NCT03482011|11947546|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
7570179|NCT03482011|11947547|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7570180|NCT03482011|11947548|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
7570181|NCT03482011|11947549|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
7570182|NCT03482011|11947550|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
7570183|NCT03482011|11947543|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7570184|NCT03482011|11947544|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7570185|NCT03482011|11947545|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7570186|NCT03482011|11947546|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7460783|NCT01831089|11756396|FG003|Cohort B: Arm B|Physician Decision|0
7570187|NCT03482011|11947547|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
7570188|NCT03482011|11947548|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7570189|NCT03482011|11947549|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7570190|NCT03482011|11947550|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7570191|NCT03482011|11947543|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
7570192|NCT03482011|11947544|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
7570193|NCT03482011|11947545|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
7570194|NCT03482011|11947546|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
7570195|NCT03482011|11947547|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
7570196|NCT03482011|11947548|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
7570197|NCT03482011|11947549|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
7570198|NCT03482011|11947550|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
7570199|NCT03482011|11947543|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7570200|NCT03482011|11947544|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7570201|NCT03482011|11947545|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7570202|NCT03482011|11947546|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7570203|NCT03482011|11947547|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7570204|NCT03482011|11947548|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
7570205|NCT03482011|11947549|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7570206|NCT03482011|11947550|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7570207|NCT03482011|11947543|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7570208|NCT03482011|11947544|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7570209|NCT03482011|11947545|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7570210|NCT03482011|11947546|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
7570211|NCT03482011|11947547|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
7570212|NCT03482011|11947548|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7570213|NCT03482011|11947549|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
7570214|NCT03482011|11947550|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
7570215|NCT03482011|11947543|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
7570216|NCT03482011|11947544|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
7570217|NCT03482011|11947545|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
7570218|NCT03482011|11947546|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
7570219|NCT03482011|11947547|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
7570220|NCT03482011|11947548|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
7570221|NCT03482011|11947549|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
7570222|NCT03482011|11947550|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
7570223|NCT03482011|11947543|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7570224|NCT03482011|11947544|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7570225|NCT03482011|11947545|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
7570226|NCT03482011|11947546|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
7570227|NCT03482011|11947547|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7570228|NCT03482011|11947548|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7570229|NCT03482011|11947549|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
7570230|NCT03482011|11947550|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
7570231|NCT03482011|11947543|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
7570232|NCT03482011|11947544|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
7570233|NCT03482011|11947545|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
7570234|NCT03482011|11947546|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
7386706|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
7386707|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
7386708|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
7386709|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
7386710|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7386711|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
7386712|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
7386713|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7386714|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7386715|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7386716|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
7386717|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
7386718|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
7386719|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386720|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386721|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
7386722|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386723|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386724|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386725|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386726|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386727|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
7386728|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7386729|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
7386730|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7570235|NCT03482011|11947547|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
7570236|NCT03482011|11947548|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
7366616|NCT01064401|11615921|FG000|Overall Study|Adverse Event|47
7366617|NCT01064401|11615922|FG001|Overall Study|Adverse Event|56
7366618|NCT01064401|11615921|FG000|Overall Study|Lack of Efficacy|46
7366619|NCT01064401|11615922|FG001|Overall Study|Lack of Efficacy|23
7366620|NCT01064401|11615921|FG000|Overall Study|Lost to Follow-up|12
7366621|NCT01064401|11615922|FG001|Overall Study|Lost to Follow-up|9
7366622|NCT01064401|11615921|FG000|Overall Study|Consent Withdrawn|98
7366623|NCT01064401|11615922|FG001|Overall Study|Consent Withdrawn|80
7366624|NCT01064401|11615921|FG000|Overall Study|Investigator Decision|4
7366625|NCT01064401|11615922|FG001|Overall Study|Investigator Decision|6
7366626|NCT01064401|11615921|FG000|Overall Study|Death|4
7366627|NCT01064401|11615922|FG001|Overall Study|Death|0
7366628|NCT01064401|11615921|FG000|Overall Study|Pregnancy|4
7366629|NCT01064401|11615922|FG001|Overall Study|Pregnancy|7
7366630|NCT01064401|11615921|FG000|Overall Study|Noncompliance|7
7366631|NCT01064401|11615922|FG001|Overall Study|Noncompliance|8
7366632|NCT01064401|11615921|FG000|Overall Study|Site Closure|4
7366633|NCT01064401|11615922|FG001|Overall Study|Site Closure|5
7366634|NCT01064401|11615921|FG000|Overall Study|Other|2
7366635|NCT01064401|11615922|FG001|Overall Study|Other|1
7366636|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Adverse Event|4
7366637|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Adverse Event|4
7366638|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Adverse Event|2
7366639|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Death|0
7366640|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Death|1
7366641|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Death|0
7366642|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
7366643|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
7366644|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
7366645|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7366646|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7366647|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
7366648|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7366649|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7366650|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7366651|NCT01064414|11615932|FG000|Core Period: Baseline to Week 26|Other|4
7366652|NCT01064414|11615933|FG001|Core Period: Baseline to Week 26|Other|7
7366653|NCT01064414|11615934|FG002|Core Period: Baseline to Week 26|Other|2
7366654|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
7366655|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7366656|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
7366657|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Death|0
7366658|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Death|1
7366659|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Death|0
7366660|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7570237|NCT03482011|11947549|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
7570238|NCT03482011|11947550|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
7570239|NCT03482011|11947543|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7570240|NCT03482011|11947544|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7570241|NCT03482011|11947545|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7570242|NCT03482011|11947546|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7570243|NCT03482011|11947547|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7366661|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7366662|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7366663|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
7366664|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
7366665|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
7366666|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7366667|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7366668|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7366669|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7366670|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7366671|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7366672|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
7366673|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7366674|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
7366675|NCT01064414|11615932|FG000|Extension Period: Week 26 to Week 52|Other|5
7366676|NCT01064414|11615933|FG001|Extension Period: Week 26 to Week 52|Other|2
7366759|NCT01064947|11616050|FG000|Overall Study|negative culture|41
7366677|NCT01064414|11615934|FG002|Extension Period: Week 26 to Week 52|Other|1
7366678|NCT01064531|11615947|FG000|Overall Study|Lost to Follow-up|0
7366679|NCT01064531|11615948|FG001|Overall Study|Lost to Follow-up|2
7366680|NCT01064531|11615947|FG000|Overall Study|Physician Decision|0
7570244|NCT03482011|11947548|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7366681|NCT01064531|11615948|FG001|Overall Study|Physician Decision|1
7366682|NCT01064531|11615947|FG000|Overall Study|Withdrawal by Subject|2
7366683|NCT01064531|11615948|FG001|Overall Study|Withdrawal by Subject|2
7366684|NCT01064531|11615947|FG000|Overall Study|Revision due to femoral stem loosening|1
7366685|NCT01064531|11615948|FG001|Overall Study|Revision due to femoral stem loosening|0
7366686|NCT01064531|11615947|FG000|Overall Study|Revision due to dislocation|0
7366687|NCT01064531|11615948|FG001|Overall Study|Revision due to dislocation|1
7366688|NCT01064531|11615947|FG000|Overall Study|Death|0
7366689|NCT01064531|11615948|FG001|Overall Study|Death|1
7366690|NCT01064622|11615957|FG000|Randomized Phase II|Withdrawal by Subject|2
7366691|NCT01064622|11615958|FG001|Randomized Phase II|Withdrawal by Subject|2
7366692|NCT01064622|11615957|FG000|Randomized Phase II|Protocol Violation|0
7366693|NCT01064622|11615958|FG001|Randomized Phase II|Protocol Violation|1
7366694|NCT01064687|11615971|FG000|Overall Study|Adverse Event|9
7366695|NCT01064687|11615972|FG001|Overall Study|Adverse Event|4
7366696|NCT01064687|11615973|FG002|Overall Study|Adverse Event|10
7366697|NCT01064687|11615974|FG003|Overall Study|Adverse Event|3
7366698|NCT01064687|11615971|FG000|Overall Study|Death|1
7366699|NCT01064687|11615972|FG001|Overall Study|Death|1
7366700|NCT01064687|11615973|FG002|Overall Study|Death|0
7366701|NCT01064687|11615974|FG003|Overall Study|Death|0
7366702|NCT01064687|11615971|FG000|Overall Study|Entry Criteria Not Met|3
7366703|NCT01064687|11615972|FG001|Overall Study|Entry Criteria Not Met|0
7366704|NCT01064687|11615973|FG002|Overall Study|Entry Criteria Not Met|0
7366705|NCT01064687|11615974|FG003|Overall Study|Entry Criteria Not Met|0
7366706|NCT01064687|11615971|FG000|Overall Study|Lack of Efficacy|1
7366707|NCT01064687|11615972|FG001|Overall Study|Lack of Efficacy|0
7366708|NCT01064687|11615973|FG002|Overall Study|Lack of Efficacy|2
7366709|NCT01064687|11615974|FG003|Overall Study|Lack of Efficacy|3
7366710|NCT01064687|11615971|FG000|Overall Study|Lost to Follow-up|7
7366711|NCT01064687|11615972|FG001|Overall Study|Lost to Follow-up|10
7366712|NCT01064687|11615973|FG002|Overall Study|Lost to Follow-up|13
7366713|NCT01064687|11615974|FG003|Overall Study|Lost to Follow-up|5
7366714|NCT01064687|11615971|FG000|Overall Study|Physician Decision|2
7366715|NCT01064687|11615972|FG001|Overall Study|Physician Decision|2
7366716|NCT01064687|11615973|FG002|Overall Study|Physician Decision|0
7366717|NCT01064687|11615974|FG003|Overall Study|Physician Decision|0
7366718|NCT01064687|11615971|FG000|Overall Study|Protocol Violation|1
7366719|NCT01064687|11615972|FG001|Overall Study|Protocol Violation|1
7366720|NCT01064687|11615973|FG002|Overall Study|Protocol Violation|0
7366721|NCT01064687|11615974|FG003|Overall Study|Protocol Violation|1
7366722|NCT01064687|11615971|FG000|Overall Study|Sponsor Decision|0
7366723|NCT01064687|11615972|FG001|Overall Study|Sponsor Decision|0
7366724|NCT01064687|11615973|FG002|Overall Study|Sponsor Decision|3
7366725|NCT01064687|11615974|FG003|Overall Study|Sponsor Decision|0
7366726|NCT01064687|11615971|FG000|Overall Study|Withdrawal by Subject|9
7366727|NCT01064687|11615972|FG001|Overall Study|Withdrawal by Subject|7
7366728|NCT01064687|11615973|FG002|Overall Study|Withdrawal by Subject|12
7366729|NCT01064687|11615974|FG003|Overall Study|Withdrawal by Subject|5
7366730|NCT01064687|11615971|FG000|Overall Study|Treatment Noncompliance|1
7366731|NCT01064687|11615972|FG001|Overall Study|Treatment Noncompliance|1
7366732|NCT01064687|11615973|FG002|Overall Study|Treatment Noncompliance|1
7366733|NCT01064687|11615974|FG003|Overall Study|Treatment Noncompliance|0
7366734|NCT01064739|11616004|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
7366735|NCT01064856|11616027|FG000|Double-blind (DB) Period|Adverse Event|1
7366736|NCT01064856|11616028|FG001|Double-blind (DB) Period|Adverse Event|0
7366737|NCT01064856|11616029|FG002|Double-blind (DB) Period|Adverse Event|0
7366738|NCT01064856|11616030|FG003|Double-blind (DB) Period|Adverse Event|0
7366739|NCT01064856|11616027|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
7366740|NCT01064856|11616028|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
7366741|NCT01064856|11616029|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
7366742|NCT01064856|11616030|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
7366743|NCT01064856|11616027|FG000|Open-label (OL) Period|Adverse Event|0
7366744|NCT01064856|11616028|FG001|Open-label (OL) Period|Adverse Event|0
7366745|NCT01064856|11616029|FG002|Open-label (OL) Period|Adverse Event|12
7366746|NCT01064856|11616030|FG003|Open-label (OL) Period|Adverse Event|6
7366747|NCT01064856|11616027|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
7366748|NCT01064856|11616028|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
7366749|NCT01064856|11616029|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
7366750|NCT01064856|11616030|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
7366751|NCT01064856|11616027|FG000|Open-label (OL) Period|Lost to Follow-up|0
7366752|NCT01064856|11616028|FG001|Open-label (OL) Period|Lost to Follow-up|0
7366753|NCT01064856|11616029|FG002|Open-label (OL) Period|Lost to Follow-up|2
7366754|NCT01064856|11616030|FG003|Open-label (OL) Period|Lost to Follow-up|1
7366755|NCT01064856|11616027|FG000|Open-label (OL) Period|Other|0
7366756|NCT01064856|11616028|FG001|Open-label (OL) Period|Other|0
7366757|NCT01064856|11616029|FG002|Open-label (OL) Period|Other|7
7366758|NCT01064856|11616030|FG003|Open-label (OL) Period|Other|7
7366760|NCT01065350|11616060|FG000|Overall Study|Received incorrect drug allocation|0
7366761|NCT01065350|11616061|FG001|Overall Study|Received incorrect drug allocation|1
7366762|NCT01065597|11616109|FG000|Overall Study|Adverse Event|1
7366763|NCT01065766|11616120|FG000|Overall Study|Assessed before the contracted date|1
7366764|NCT01065766|11616120|FG000|Overall Study|Contraindication to administration|6
7366765|NCT01065766|11616120|FG000|Overall Study|Violated dosage/administration|25
7366766|NCT01065844|11616124|FG000|Overall Study|Adverse Event|5
7366767|NCT01066000|11616128|FG000|Overall Study|Protocol Violation|4
7366768|NCT01066000|11616128|FG000|Overall Study|Death|3
7366769|NCT01066000|11616128|FG000|Overall Study|Withdrawal by Subject|1
7366770|NCT01066000|11616128|FG000|Overall Study|Adverse Event|1
7366771|NCT01066039|11616138|FG000|Overall Study|Adverse Event|6
7366772|NCT01066039|11616138|FG000|Overall Study|Withdrawal by Subject|17
7366773|NCT01066039|11616138|FG000|Overall Study|Protocol Violation|2
7366774|NCT01066039|11616138|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
7366775|NCT01066039|11616138|FG000|Overall Study|Investigator's Request|1
7366776|NCT01066039|11616138|FG000|Overall Study|Dropout due to Insulin Administration|1
7366777|NCT01066039|11616138|FG000|Overall Study|Additional Antihypertensive Required|4
7366778|NCT01066039|11616138|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
7366779|NCT01066039|11616138|FG000|Overall Study|Failure to Control Blood Pressure|1
7366780|NCT01066039|11616138|FG000|Overall Study|Drug/Dose Adjustment Required|1
7366781|NCT01066052|11616144|FG000|Overall Study|Enrolled But Not Treated|3
7366782|NCT01066052|11616145|FG001|Overall Study|Enrolled But Not Treated|0
7366783|NCT01066104|11616152|FG000|Overall Study|Adverse Event|1
7366784|NCT01066104|11616153|FG001|Overall Study|Adverse Event|1
7366785|NCT01066104|11616152|FG000|Overall Study|Protocol Violation|1
7366786|NCT01066104|11616153|FG001|Overall Study|Protocol Violation|0
7366787|NCT01066143|11616159|FG000|Overall Study|ineligible for the study|8
7366788|NCT01066156|11616163|FG000|Overall Study|ineligible|2
7366789|NCT01066156|11616163|FG000|Overall Study|Lost to Follow-up|7
7366790|NCT01066156|11616163|FG000|Overall Study|Withdrawal by Subject|1
7366791|NCT01066546|11616189|FG000|Overall Study|Study terminated by sponsor|5
7366792|NCT01066585|11616195|FG000|Overall Study|Protocol Violation|1
7366793|NCT01066585|11616196|FG001|Overall Study|Protocol Violation|0
7366794|NCT01066585|11616195|FG000|Overall Study|Withdrawal by Subject|0
7366795|NCT01066585|11616196|FG001|Overall Study|Withdrawal by Subject|3
7366796|NCT01066780|11616215|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7366797|NCT01066780|11616216|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
7366798|NCT01066793|11616226|FG000|Overall Study|Death|4
7366799|NCT01066793|11616227|FG001|Overall Study|Death|1
7366800|NCT01066793|11616228|FG002|Overall Study|Death|1
7366801|NCT01066793|11616229|FG003|Overall Study|Death|0
7366802|NCT01066793|11616230|FG004|Overall Study|Death|0
7366803|NCT01066793|11616231|FG005|Overall Study|Death|0
7366804|NCT01066793|11616226|FG000|Overall Study|Lack of Efficacy|2
7366805|NCT01066793|11616227|FG001|Overall Study|Lack of Efficacy|1
7366806|NCT01066793|11616228|FG002|Overall Study|Lack of Efficacy|0
7366807|NCT01066793|11616229|FG003|Overall Study|Lack of Efficacy|0
7366808|NCT01066793|11616230|FG004|Overall Study|Lack of Efficacy|0
7366809|NCT01066793|11616231|FG005|Overall Study|Lack of Efficacy|0
7366810|NCT01066793|11616226|FG000|Overall Study|Lost to Follow-up|180
7366811|NCT01066793|11616227|FG001|Overall Study|Lost to Follow-up|39
7366812|NCT01066793|11616228|FG002|Overall Study|Lost to Follow-up|82
7366813|NCT01066793|11616229|FG003|Overall Study|Lost to Follow-up|16
7366814|NCT01066793|11616230|FG004|Overall Study|Lost to Follow-up|0
7366815|NCT01066793|11616231|FG005|Overall Study|Lost to Follow-up|1
7366816|NCT01066793|11616226|FG000|Overall Study|Physician Decision|3
7366817|NCT01066793|11616227|FG001|Overall Study|Physician Decision|0
7366818|NCT01066793|11616228|FG002|Overall Study|Physician Decision|0
7366819|NCT01066793|11616229|FG003|Overall Study|Physician Decision|0
7366820|NCT01066793|11616230|FG004|Overall Study|Physician Decision|0
7366821|NCT01066793|11616231|FG005|Overall Study|Physician Decision|0
7460784|NCT01831089|11756397|FG004|Cohort B: Arm B|Physician Decision|0
7460785|NCT01831089|11756398|FG005|Cohort B: Arm B|Physician Decision|2
7460786|NCT01831089|11756393|FG000|Cohort B: Arm B|Never treated|0
7460787|NCT01831089|11756394|FG001|Cohort B: Arm B|Never treated|0
7460788|NCT01831089|11756395|FG002|Cohort B: Arm B|Never treated|0
7366822|NCT01066793|11616226|FG000|Overall Study|Protocol Violation|3
7366823|NCT01066793|11616227|FG001|Overall Study|Protocol Violation|2
7366824|NCT01066793|11616228|FG002|Overall Study|Protocol Violation|2
7366825|NCT01066793|11616229|FG003|Overall Study|Protocol Violation|0
7366826|NCT01066793|11616230|FG004|Overall Study|Protocol Violation|0
7366827|NCT01066793|11616231|FG005|Overall Study|Protocol Violation|0
7366828|NCT01066793|11616226|FG000|Overall Study|Withdrawal by Subject|7
7366829|NCT01066793|11616227|FG001|Overall Study|Withdrawal by Subject|4
7366830|NCT01066793|11616228|FG002|Overall Study|Withdrawal by Subject|1
7460789|NCT01831089|11756396|FG003|Cohort B: Arm B|Never treated|0
7460790|NCT01831089|11756397|FG004|Cohort B: Arm B|Never treated|0
7366831|NCT01066793|11616229|FG003|Overall Study|Withdrawal by Subject|0
7366832|NCT01066793|11616230|FG004|Overall Study|Withdrawal by Subject|0
7366833|NCT01066793|11616231|FG005|Overall Study|Withdrawal by Subject|0
7366834|NCT01066793|11616226|FG000|Overall Study|Early Termination|3
7366835|NCT01066793|11616227|FG001|Overall Study|Early Termination|0
7366836|NCT01066793|11616228|FG002|Overall Study|Early Termination|0
7366837|NCT01066793|11616229|FG003|Overall Study|Early Termination|0
7366838|NCT01066793|11616230|FG004|Overall Study|Early Termination|0
7366839|NCT01066793|11616231|FG005|Overall Study|Early Termination|0
7366840|NCT01066793|11616226|FG000|Overall Study|Lab test not done|7
7366841|NCT01066793|11616227|FG001|Overall Study|Lab test not done|0
7366842|NCT01066793|11616228|FG002|Overall Study|Lab test not done|0
7366843|NCT01066793|11616229|FG003|Overall Study|Lab test not done|1
7366844|NCT01066793|11616230|FG004|Overall Study|Lab test not done|0
7366845|NCT01066793|11616231|FG005|Overall Study|Lab test not done|0
7366846|NCT01066793|11616226|FG000|Overall Study|Miscellaneous|4
7366847|NCT01066793|11616227|FG001|Overall Study|Miscellaneous|5
7366848|NCT01066793|11616228|FG002|Overall Study|Miscellaneous|6
7366849|NCT01066793|11616229|FG003|Overall Study|Miscellaneous|0
7366850|NCT01066793|11616230|FG004|Overall Study|Miscellaneous|0
7366851|NCT01066793|11616231|FG005|Overall Study|Miscellaneous|0
7366852|NCT01066793|11616226|FG000|Overall Study|Non-responders|104
7366853|NCT01066793|11616227|FG001|Overall Study|Non-responders|5
7366854|NCT01066793|11616228|FG002|Overall Study|Non-responders|11
7366855|NCT01066793|11616229|FG003|Overall Study|Non-responders|25
7366856|NCT01066793|11616230|FG004|Overall Study|Non-responders|0
7366857|NCT01066793|11616231|FG005|Overall Study|Non-responders|0
7366858|NCT01066793|11616226|FG000|Overall Study|Other|15
7366859|NCT01066793|11616227|FG001|Overall Study|Other|5
7366860|NCT01066793|11616228|FG002|Overall Study|Other|6
7366861|NCT01066793|11616229|FG003|Overall Study|Other|2
7366862|NCT01066793|11616230|FG004|Overall Study|Other|0
7366863|NCT01066793|11616231|FG005|Overall Study|Other|0
7366864|NCT01066793|11616226|FG000|Overall Study|Relapse|20
7366865|NCT01066793|11616227|FG001|Overall Study|Relapse|8
7366866|NCT01066793|11616228|FG002|Overall Study|Relapse|2
7366867|NCT01066793|11616229|FG003|Overall Study|Relapse|3
7366868|NCT01066793|11616230|FG004|Overall Study|Relapse|0
7366869|NCT01066793|11616231|FG005|Overall Study|Relapse|0
7366870|NCT01066793|11616226|FG000|Overall Study|Result Not Available|1
7366871|NCT01066793|11616227|FG001|Overall Study|Result Not Available|0
7366872|NCT01066793|11616228|FG002|Overall Study|Result Not Available|0
7366873|NCT01066793|11616229|FG003|Overall Study|Result Not Available|0
7366874|NCT01066793|11616230|FG004|Overall Study|Result Not Available|0
7366875|NCT01066793|11616231|FG005|Overall Study|Result Not Available|0
7366876|NCT01066793|11616226|FG000|Overall Study|Treatment Interrupted|1
7366877|NCT01066793|11616227|FG001|Overall Study|Treatment Interrupted|1
7366878|NCT01066793|11616228|FG002|Overall Study|Treatment Interrupted|0
7366879|NCT01066793|11616229|FG003|Overall Study|Treatment Interrupted|0
7366880|NCT01066793|11616230|FG004|Overall Study|Treatment Interrupted|0
7366881|NCT01066793|11616231|FG005|Overall Study|Treatment Interrupted|0
7366882|NCT01066793|11616226|FG000|Overall Study|Treatment Never Started|18
7366883|NCT01066793|11616227|FG001|Overall Study|Treatment Never Started|5
7366884|NCT01066793|11616228|FG002|Overall Study|Treatment Never Started|4
7366885|NCT01066793|11616229|FG003|Overall Study|Treatment Never Started|1
7366886|NCT01066793|11616230|FG004|Overall Study|Treatment Never Started|0
7366887|NCT01066793|11616231|FG005|Overall Study|Treatment Never Started|0
7366888|NCT01066793|11616226|FG000|Overall Study|Treatment Stopped|2
7366889|NCT01066793|11616227|FG001|Overall Study|Treatment Stopped|1
7366890|NCT01066793|11616228|FG002|Overall Study|Treatment Stopped|0
7366891|NCT01066793|11616229|FG003|Overall Study|Treatment Stopped|1
7366892|NCT01066793|11616230|FG004|Overall Study|Treatment Stopped|0
7366893|NCT01066793|11616231|FG005|Overall Study|Treatment Stopped|0
7366894|NCT01066819|11616252|FG000|Overall Study|Adverse Event|18
7366895|NCT01066819|11616253|FG001|Overall Study|Adverse Event|1
7366896|NCT01066819|11616254|FG002|Overall Study|Adverse Event|6
7366897|NCT01066819|11616255|FG003|Overall Study|Adverse Event|0
7366898|NCT01066819|11616256|FG004|Overall Study|Adverse Event|0
7366899|NCT01066819|11616257|FG005|Overall Study|Adverse Event|0
7366900|NCT01066819|11616252|FG000|Overall Study|Death|5
7366901|NCT01066819|11616253|FG001|Overall Study|Death|0
7366902|NCT01066819|11616254|FG002|Overall Study|Death|1
7366903|NCT01066819|11616255|FG003|Overall Study|Death|0
7366904|NCT01066819|11616256|FG004|Overall Study|Death|0
7366905|NCT01066819|11616257|FG005|Overall Study|Death|0
7366906|NCT01066819|11616252|FG000|Overall Study|Lack of Efficacy|22
7366907|NCT01066819|11616253|FG001|Overall Study|Lack of Efficacy|1
7366908|NCT01066819|11616254|FG002|Overall Study|Lack of Efficacy|2
7366909|NCT01066819|11616255|FG003|Overall Study|Lack of Efficacy|1
7366910|NCT01066819|11616256|FG004|Overall Study|Lack of Efficacy|0
7460791|NCT01831089|11756398|FG005|Cohort B: Arm B|Never treated|2
7366911|NCT01066819|11616257|FG005|Overall Study|Lack of Efficacy|0
7366912|NCT01066819|11616252|FG000|Overall Study|Physician Decision|6
7366913|NCT01066819|11616253|FG001|Overall Study|Physician Decision|2
7366914|NCT01066819|11616254|FG002|Overall Study|Physician Decision|3
7366915|NCT01066819|11616255|FG003|Overall Study|Physician Decision|0
7366916|NCT01066819|11616256|FG004|Overall Study|Physician Decision|0
7366917|NCT01066819|11616257|FG005|Overall Study|Physician Decision|0
7366918|NCT01066819|11616252|FG000|Overall Study|Protocol Violation|12
7366919|NCT01066819|11616253|FG001|Overall Study|Protocol Violation|6
7366920|NCT01066819|11616254|FG002|Overall Study|Protocol Violation|0
7366921|NCT01066819|11616255|FG003|Overall Study|Protocol Violation|0
7366922|NCT01066819|11616256|FG004|Overall Study|Protocol Violation|0
7366923|NCT01066819|11616257|FG005|Overall Study|Protocol Violation|0
7366924|NCT01066819|11616252|FG000|Overall Study|Withdrawal by Subject|29
7366925|NCT01066819|11616253|FG001|Overall Study|Withdrawal by Subject|11
7366926|NCT01066819|11616254|FG002|Overall Study|Withdrawal by Subject|6
7366927|NCT01066819|11616255|FG003|Overall Study|Withdrawal by Subject|0
7366928|NCT01066819|11616256|FG004|Overall Study|Withdrawal by Subject|0
7366929|NCT01066819|11616257|FG005|Overall Study|Withdrawal by Subject|0
7366930|NCT01066819|11616252|FG000|Overall Study|Administrative|6
7366931|NCT01066819|11616253|FG001|Overall Study|Administrative|4
7366932|NCT01066819|11616254|FG002|Overall Study|Administrative|2
7366933|NCT01066819|11616255|FG003|Overall Study|Administrative|0
7366934|NCT01066819|11616256|FG004|Overall Study|Administrative|0
7366935|NCT01066819|11616257|FG005|Overall Study|Administrative|0
7366936|NCT01066819|11616252|FG000|Overall Study|Not met inclusion/exclusion criteria|1
7366937|NCT01066819|11616253|FG001|Overall Study|Not met inclusion/exclusion criteria|0
7366938|NCT01066819|11616254|FG002|Overall Study|Not met inclusion/exclusion criteria|0
7366939|NCT01066819|11616255|FG003|Overall Study|Not met inclusion/exclusion criteria|0
7366940|NCT01066819|11616256|FG004|Overall Study|Not met inclusion/exclusion criteria|0
7570245|NCT03482011|11947549|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
7570246|NCT03482011|11947550|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
7570247|NCT03482453|11947587|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570248|NCT03482453|11947588|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570249|NCT03482453|11947589|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570250|NCT03482453|11947590|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570251|NCT03482453|11947591|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570252|NCT03482453|11947592|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570253|NCT03482453|11947593|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570254|NCT03482453|11947594|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570255|NCT03482453|11947595|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570256|NCT03482453|11947596|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7366941|NCT01066819|11616257|FG005|Overall Study|Not met inclusion/exclusion criteria|0
7366942|NCT01066819|11616252|FG000|Overall Study|Early termination|2
7366943|NCT01066819|11616253|FG001|Overall Study|Early termination|0
7366944|NCT01066819|11616254|FG002|Overall Study|Early termination|0
7366945|NCT01066819|11616255|FG003|Overall Study|Early termination|0
7366946|NCT01066819|11616256|FG004|Overall Study|Early termination|0
7366947|NCT01066819|11616257|FG005|Overall Study|Early termination|0
7366948|NCT01066819|11616252|FG000|Overall Study|Failed to return|298
7366949|NCT01066819|11616253|FG001|Overall Study|Failed to return|107
7366950|NCT01066819|11616254|FG002|Overall Study|Failed to return|68
7366951|NCT01066819|11616255|FG003|Overall Study|Failed to return|7
7366952|NCT01066819|11616256|FG004|Overall Study|Failed to return|2
7366953|NCT01066819|11616257|FG005|Overall Study|Failed to return|3
7366954|NCT01066819|11616252|FG000|Overall Study|Lab test not done|9
7366955|NCT01066819|11616253|FG001|Overall Study|Lab test not done|0
7366956|NCT01066819|11616254|FG002|Overall Study|Lab test not done|2
7366957|NCT01066819|11616255|FG003|Overall Study|Lab test not done|1
7366958|NCT01066819|11616256|FG004|Overall Study|Lab test not done|0
7366959|NCT01066819|11616257|FG005|Overall Study|Lab test not done|0
7366960|NCT01066819|11616252|FG000|Overall Study|Miscellaneous|28
7366961|NCT01066819|11616253|FG001|Overall Study|Miscellaneous|10
7366962|NCT01066819|11616254|FG002|Overall Study|Miscellaneous|18
7366963|NCT01066819|11616255|FG003|Overall Study|Miscellaneous|1
7366964|NCT01066819|11616256|FG004|Overall Study|Miscellaneous|0
7366965|NCT01066819|11616257|FG005|Overall Study|Miscellaneous|0
7366966|NCT01066819|11616252|FG000|Overall Study|Non responders|123
7366967|NCT01066819|11616253|FG001|Overall Study|Non responders|2
7366968|NCT01066819|11616254|FG002|Overall Study|Non responders|7
7366969|NCT01066819|11616255|FG003|Overall Study|Non responders|2
7366970|NCT01066819|11616256|FG004|Overall Study|Non responders|0
7366971|NCT01066819|11616257|FG005|Overall Study|Non responders|1
7366972|NCT01066819|11616252|FG000|Overall Study|Not categorised|9
7366973|NCT01066819|11616253|FG001|Overall Study|Not categorised|2
7366974|NCT01066819|11616254|FG002|Overall Study|Not categorised|6
7366975|NCT01066819|11616255|FG003|Overall Study|Not categorised|1
7366976|NCT01066819|11616256|FG004|Overall Study|Not categorised|0
7366977|NCT01066819|11616257|FG005|Overall Study|Not categorised|0
7366978|NCT01066819|11616252|FG000|Overall Study|Relapse|16
7366979|NCT01066819|11616253|FG001|Overall Study|Relapse|4
7366980|NCT01066819|11616254|FG002|Overall Study|Relapse|3
7366981|NCT01066819|11616255|FG003|Overall Study|Relapse|0
7366982|NCT01066819|11616256|FG004|Overall Study|Relapse|0
7366983|NCT01066819|11616257|FG005|Overall Study|Relapse|0
7366984|NCT01066819|11616252|FG000|Overall Study|Results not available|1
7366985|NCT01066819|11616253|FG001|Overall Study|Results not available|0
7366986|NCT01066819|11616254|FG002|Overall Study|Results not available|0
7366987|NCT01066819|11616255|FG003|Overall Study|Results not available|0
7366988|NCT01066819|11616256|FG004|Overall Study|Results not available|0
7366989|NCT01066819|11616257|FG005|Overall Study|Results not available|0
7366990|NCT01066819|11616252|FG000|Overall Study|Screen failure|1
7366991|NCT01066819|11616253|FG001|Overall Study|Screen failure|0
7366992|NCT01066819|11616254|FG002|Overall Study|Screen failure|0
7366993|NCT01066819|11616255|FG003|Overall Study|Screen failure|0
7366994|NCT01066819|11616256|FG004|Overall Study|Screen failure|0
7366995|NCT01066819|11616257|FG005|Overall Study|Screen failure|0
7366996|NCT01066819|11616252|FG000|Overall Study|Spontaneous cure|1
7366997|NCT01066819|11616253|FG001|Overall Study|Spontaneous cure|0
7366998|NCT01066819|11616254|FG002|Overall Study|Spontaneous cure|0
7366999|NCT01066819|11616255|FG003|Overall Study|Spontaneous cure|0
7367000|NCT01066819|11616256|FG004|Overall Study|Spontaneous cure|0
7367001|NCT01066819|11616257|FG005|Overall Study|Spontaneous cure|0
7367002|NCT01066819|11616252|FG000|Overall Study|Treatment never started|85
7367003|NCT01066819|11616253|FG001|Overall Study|Treatment never started|19
7367004|NCT01066819|11616254|FG002|Overall Study|Treatment never started|19
7367005|NCT01066819|11616255|FG003|Overall Study|Treatment never started|3
7367006|NCT01066819|11616256|FG004|Overall Study|Treatment never started|2
7367007|NCT01066819|11616257|FG005|Overall Study|Treatment never started|2
7367008|NCT01066819|11616252|FG000|Overall Study|Treatment stopped|12
7367009|NCT01066819|11616253|FG001|Overall Study|Treatment stopped|1
7367010|NCT01066819|11616254|FG002|Overall Study|Treatment stopped|2
7367011|NCT01066819|11616255|FG003|Overall Study|Treatment stopped|1
7367012|NCT01066819|11616256|FG004|Overall Study|Treatment stopped|0
7367013|NCT01066819|11616257|FG005|Overall Study|Treatment stopped|0
7367014|NCT01066819|11616252|FG000|Overall Study|Other|5
7367015|NCT01066819|11616253|FG001|Overall Study|Other|1
7367016|NCT01066819|11616254|FG002|Overall Study|Other|1
7367017|NCT01066819|11616255|FG003|Overall Study|Other|0
7367018|NCT01066819|11616256|FG004|Overall Study|Other|0
7367019|NCT01066819|11616257|FG005|Overall Study|Other|0
7367020|NCT01066871|11616273|FG000|Overall Study|Lost to Follow-up|0
7367021|NCT01066871|11616274|FG001|Overall Study|Lost to Follow-up|2
7367022|NCT01066871|11616275|FG002|Overall Study|Lost to Follow-up|2
7367023|NCT01066871|11616276|FG003|Overall Study|Lost to Follow-up|0
7367024|NCT01066871|11616273|FG000|Overall Study|Protocol Violation|1
7367025|NCT01066871|11616274|FG001|Overall Study|Protocol Violation|0
7367026|NCT01066871|11616275|FG002|Overall Study|Protocol Violation|3
7367027|NCT01066871|11616276|FG003|Overall Study|Protocol Violation|2
7367028|NCT01066871|11616273|FG000|Overall Study|Lack of Efficacy|0
7367029|NCT01066871|11616274|FG001|Overall Study|Lack of Efficacy|0
7367030|NCT01066871|11616275|FG002|Overall Study|Lack of Efficacy|0
7367031|NCT01066871|11616276|FG003|Overall Study|Lack of Efficacy|1
7367032|NCT01066871|11616273|FG000|Overall Study|Withdrawal by Subject|3
7367033|NCT01066871|11616274|FG001|Overall Study|Withdrawal by Subject|1
7367034|NCT01066871|11616275|FG002|Overall Study|Withdrawal by Subject|0
7367035|NCT01066871|11616276|FG003|Overall Study|Withdrawal by Subject|0
7367036|NCT01066871|11616273|FG000|Overall Study|Other|0
7367037|NCT01066871|11616274|FG001|Overall Study|Other|2
7367038|NCT01066871|11616275|FG002|Overall Study|Other|1
7367039|NCT01066871|11616276|FG003|Overall Study|Other|2
7367040|NCT01066897|11616293|FG000|Overall Study|Withdrawal by Subject|1
7367041|NCT01066897|11616294|FG001|Overall Study|Withdrawal by Subject|0
7367042|NCT01066897|11616293|FG000|Overall Study|stopped study after developing the flu.|1
7367043|NCT01066897|11616294|FG001|Overall Study|stopped study after developing the flu.|0
7367044|NCT01066923|11616305|FG000|Overall Study|Withdrawal by Subject|3
7367045|NCT01066923|11616306|FG001|Overall Study|Withdrawal by Subject|3
7367046|NCT01066923|11616307|FG002|Overall Study|Withdrawal by Subject|8
7367047|NCT01066923|11616308|FG003|Overall Study|Withdrawal by Subject|8
7367048|NCT01066936|11616318|FG000|Overall Study|Death|2
7367049|NCT01066936|11616318|FG000|Overall Study|Device revised/removed|1
7367050|NCT01066936|11616318|FG000|Overall Study|Lost to Follow-up|3
7367051|NCT01066936|11616318|FG000|Overall Study|Withdrawal by Subject|4
7367052|NCT01067105|11616324|FG000|Overall Study|Adverse Event|14
7367053|NCT01067105|11616324|FG000|Overall Study|Protocol Violation|48
7367054|NCT01067105|11616324|FG000|Overall Study|Withdrawal by Subject|36
7367055|NCT01067105|11616324|FG000|Overall Study|Lost to Follow-up|6
7367056|NCT01067105|11616324|FG000|Overall Study|Physician Decision|6
7367057|NCT01067105|11616324|FG000|Overall Study|Other|31
7367058|NCT01067326|11616330|FG000|Overall Study|Adverse Event|0
7367059|NCT01067326|11616331|FG001|Overall Study|Adverse Event|2
7367060|NCT01067326|11616330|FG000|Overall Study|Withdrawal by Subject|1
7367061|NCT01067326|11616331|FG001|Overall Study|Withdrawal by Subject|0
7367062|NCT01067326|11616330|FG000|Overall Study|Early Study Termination|1
7367063|NCT01067326|11616331|FG001|Overall Study|Early Study Termination|1
7367064|NCT01067339|11616339|FG000|Overall Study|Withdrawal by Subject|6
7367065|NCT01067339|11616340|FG001|Overall Study|Withdrawal by Subject|5
7367066|NCT01067352|11616349|FG000|Overall Study|Withdrawal by Subject|1
7367067|NCT01067352|11616350|FG001|Overall Study|Withdrawal by Subject|2
7367068|NCT01067352|11616351|FG002|Overall Study|Withdrawal by Subject|1
7367069|NCT01067352|11616349|FG000|Overall Study|Physician Decision|0
7367070|NCT01067352|11616350|FG001|Overall Study|Physician Decision|1
7367071|NCT01067352|11616351|FG002|Overall Study|Physician Decision|0
7367072|NCT01067469|11616372|FG000|Overall Study|Withdrawal by Subject|0
7367073|NCT01067469|11616373|FG001|Overall Study|Withdrawal by Subject|1
7367074|NCT01067469|11616372|FG000|Overall Study|Disease Progression|0
7367075|NCT01067469|11616373|FG001|Overall Study|Disease Progression|1
7367076|NCT01067508|11616381|FG000|Overall Study|Physician Decision|0
7367077|NCT01067508|11616382|FG001|Overall Study|Physician Decision|1
7367078|NCT01067508|11616381|FG000|Overall Study|Withdrawal by Subject|0
7367079|NCT01067508|11616382|FG001|Overall Study|Withdrawal by Subject|1
7367080|NCT01067846|11616431|FG000|Overall Study|Lost to Follow-up|17
7367081|NCT01067846|11616432|FG001|Overall Study|Lost to Follow-up|19
7367082|NCT01067846|11616431|FG000|Overall Study|Withdrawal by Subject|1
7367083|NCT01067846|11616432|FG001|Overall Study|Withdrawal by Subject|0
7367084|NCT01067846|11616431|FG000|Overall Study|participation in other tx study|1
7367085|NCT01067846|11616432|FG001|Overall Study|participation in other tx study|0
7367086|NCT01067976|11616438|FG000|Overall Study|Study drug never administered|20
7367087|NCT01067976|11616438|FG000|Overall Study|Study prematurely discontinued|2
7367088|NCT01068158|11616458|FG000|Overall Study|Withdrawal by Subject|1
7367089|NCT01068158|11616459|FG001|Overall Study|Withdrawal by Subject|2
7367090|NCT01068158|11616458|FG000|Overall Study|Lost to Follow-up|7
7367091|NCT01068158|11616459|FG001|Overall Study|Lost to Follow-up|0
7367092|NCT01068158|11616458|FG000|Overall Study|Protocol Violation|0
7367093|NCT01068158|11616459|FG001|Overall Study|Protocol Violation|2
7367094|NCT01068262|11616469|FG000|Overall Study|Adverse Event|2
7367095|NCT01068262|11616470|FG001|Overall Study|Adverse Event|0
7367096|NCT01068262|11616471|FG002|Overall Study|Adverse Event|1
7367097|NCT01068262|11616472|FG003|Overall Study|Adverse Event|0
7367098|NCT01068262|11616469|FG000|Overall Study|Protocol Violation|1
7367099|NCT01068262|11616470|FG001|Overall Study|Protocol Violation|0
7367100|NCT01068262|11616471|FG002|Overall Study|Protocol Violation|0
7367101|NCT01068262|11616472|FG003|Overall Study|Protocol Violation|0
7367102|NCT01068262|11616469|FG000|Overall Study|Withdrawal by Subject|0
7367103|NCT01068262|11616470|FG001|Overall Study|Withdrawal by Subject|1
7367104|NCT01068262|11616471|FG002|Overall Study|Withdrawal by Subject|0
7367105|NCT01068262|11616472|FG003|Overall Study|Withdrawal by Subject|0
7367106|NCT01068418|11616485|FG000|Overall Study|Physician Decision|12
7367107|NCT01068509|11616492|FG000|Overall Study|Death|0
7367108|NCT01068509|11616493|FG001|Overall Study|Death|0
7367109|NCT01068509|11616494|FG002|Overall Study|Death|1
7367110|NCT01068509|11616492|FG000|Overall Study|Disease Progression|5
7367111|NCT01068509|11616493|FG001|Overall Study|Disease Progression|20
7367112|NCT01068509|11616494|FG002|Overall Study|Disease Progression|18
7367113|NCT01068509|11616492|FG000|Overall Study|Lost to Follow-up|1
7367114|NCT01068509|11616493|FG001|Overall Study|Lost to Follow-up|0
7367115|NCT01068509|11616494|FG002|Overall Study|Lost to Follow-up|0
7367116|NCT01068509|11616492|FG000|Overall Study|Withdrew Consent|0
7367117|NCT01068509|11616493|FG001|Overall Study|Withdrew Consent|1
7367118|NCT01068509|11616494|FG002|Overall Study|Withdrew Consent|2
7367119|NCT01068509|11616492|FG000|Overall Study|Reason Not Specified|0
7367120|NCT01068509|11616493|FG001|Overall Study|Reason Not Specified|1
7367121|NCT01068509|11616494|FG002|Overall Study|Reason Not Specified|0
7367122|NCT01068600|11616513|FG000|Overall Study|Withdrawal by Subject|5
7367123|NCT01068600|11616514|FG001|Overall Study|Withdrawal by Subject|6
7367124|NCT01068600|11616513|FG000|Overall Study|Adverse Event|3
7367125|NCT01068600|11616514|FG001|Overall Study|Adverse Event|3
7367126|NCT01068600|11616513|FG000|Overall Study|Abnormal laboratory value(s)|1
7367127|NCT01068600|11616514|FG001|Overall Study|Abnormal laboratory value(s)|0
7367128|NCT01068600|11616513|FG000|Overall Study|Lost to Follow-up|1
7367129|NCT01068600|11616514|FG001|Overall Study|Lost to Follow-up|2
7367130|NCT01068600|11616513|FG000|Overall Study|Protocol deviation|1
7367131|NCT01068600|11616514|FG001|Overall Study|Protocol deviation|1
7367132|NCT01068600|11616513|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7367133|NCT01068600|11616514|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7367134|NCT01068600|11616513|FG000|Overall Study|Administrative problems|0
7367135|NCT01068600|11616514|FG001|Overall Study|Administrative problems|1
7367136|NCT01068626|11616522|FG000|Overall Study|Adverse Event|3
7367137|NCT01068626|11616523|FG001|Overall Study|Adverse Event|0
7367138|NCT01068626|11616522|FG000|Overall Study|Withdrawal by Subject|0
7367139|NCT01068626|11616523|FG001|Overall Study|Withdrawal by Subject|2
7367140|NCT01068652|11616531|FG000|Overall Study|Adverse Event|4
7367141|NCT01068652|11616532|FG001|Overall Study|Adverse Event|0
7367142|NCT01068652|11616531|FG000|Overall Study|Lack of Efficacy|0
7367143|NCT01068652|11616532|FG001|Overall Study|Lack of Efficacy|2
7367144|NCT01068652|11616531|FG000|Overall Study|Lost to Follow-up|2
7367145|NCT01068652|11616532|FG001|Overall Study|Lost to Follow-up|1
7367146|NCT01068652|11616531|FG000|Overall Study|Protocol Violation|3
7367147|NCT01068652|11616532|FG001|Overall Study|Protocol Violation|6
7367148|NCT01068652|11616531|FG000|Overall Study|Withdrawal criteria|1
7367149|NCT01068652|11616532|FG001|Overall Study|Withdrawal criteria|2
7367150|NCT01068652|11616531|FG000|Overall Study|Patient was not eligible|1
7367151|NCT01068652|11616532|FG001|Overall Study|Patient was not eligible|0
7367152|NCT01068652|11616531|FG000|Overall Study|Unclassified|7
7367153|NCT01068652|11616532|FG001|Overall Study|Unclassified|4
7367154|NCT01068665|11616540|FG000|Overall Study|Adverse Event|5
7367155|NCT01068665|11616541|FG001|Overall Study|Adverse Event|4
7367156|NCT01068665|11616540|FG000|Overall Study|Lack of Efficacy|0
7367157|NCT01068665|11616541|FG001|Overall Study|Lack of Efficacy|2
7367158|NCT01068665|11616540|FG000|Overall Study|Protocol Violation|5
7367159|NCT01068665|11616541|FG001|Overall Study|Protocol Violation|2
7367160|NCT01068665|11616540|FG000|Overall Study|Withdrawal Criteria|3
7367161|NCT01068665|11616541|FG001|Overall Study|Withdrawal Criteria|9
7367162|NCT01068665|11616540|FG000|Overall Study|Other|17
7367163|NCT01068665|11616541|FG001|Overall Study|Other|12
7367164|NCT01068678|11616549|FG000|Overall Study|Lack of Efficacy|3
7367165|NCT01068678|11616550|FG001|Overall Study|Lack of Efficacy|2
7367166|NCT01068678|11616549|FG000|Overall Study|Protocol Violation|5
7367167|NCT01068678|11616550|FG001|Overall Study|Protocol Violation|1
7367168|NCT01068678|11616549|FG000|Overall Study|Withdrawal criteria|12
7367169|NCT01068678|11616550|FG001|Overall Study|Withdrawal criteria|6
7367170|NCT01068678|11616549|FG000|Overall Study|Unclassified|18
7367171|NCT01068678|11616550|FG001|Overall Study|Unclassified|15
7367172|NCT01068717|11616556|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
7367173|NCT01068717|11616557|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7367174|NCT01068717|11616558|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7367175|NCT01068717|11616559|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
7367176|NCT01068730|11616573|FG000|Period 3|Personal reason|1
7367177|NCT01068730|11616574|FG001|Period 3|Personal reason|0
7367178|NCT01068730|11616575|FG002|Period 3|Personal reason|0
7367179|NCT01068730|11616576|FG003|Period 3|Personal reason|0
7367180|NCT01068730|11616573|FG000|Period 4|Family emergency|0
7367181|NCT01068730|11616574|FG001|Period 4|Family emergency|1
7367182|NCT01068730|11616575|FG002|Period 4|Family emergency|0
7367183|NCT01068730|11616576|FG003|Period 4|Family emergency|0
7367184|NCT01068743|11616593|FG000|Period 3|Adverse Event|0
7367185|NCT01068743|11616594|FG001|Period 3|Adverse Event|1
7367186|NCT01068743|11616595|FG002|Period 3|Adverse Event|0
7367187|NCT01068743|11616596|FG003|Period 3|Adverse Event|0
7367188|NCT01068769|11616609|FG000|Overall Study|Ineligible|1
7367189|NCT01068860|11616632|FG000|Overall Study|Withdrawal by Subject|0
7367190|NCT01068860|11616633|FG001|Overall Study|Withdrawal by Subject|0
7367191|NCT01068860|11616634|FG002|Overall Study|Withdrawal by Subject|0
7367192|NCT01068860|11616635|FG003|Overall Study|Withdrawal by Subject|0
7367193|NCT01068860|11616636|FG004|Overall Study|Withdrawal by Subject|0
7367194|NCT01068860|11616637|FG005|Overall Study|Withdrawal by Subject|2
7367195|NCT01068860|11616638|FG006|Overall Study|Withdrawal by Subject|0
7367196|NCT01068860|11616639|FG007|Overall Study|Withdrawal by Subject|0
7367197|NCT01068860|11616640|FG008|Overall Study|Withdrawal by Subject|0
7367198|NCT01068860|11616641|FG009|Overall Study|Withdrawal by Subject|3
7367199|NCT01068860|11616632|FG000|Overall Study|Administrative problems; misrandomized|0
7367200|NCT01068860|11616633|FG001|Overall Study|Administrative problems; misrandomized|0
7460792|NCT01831089|11756393|FG000|Cohort B: Arm B|Adverse Event|0
7460793|NCT01831089|11756394|FG001|Cohort B: Arm B|Adverse Event|0
7460794|NCT01831089|11756395|FG002|Cohort B: Arm B|Adverse Event|0
7460795|NCT01831089|11756396|FG003|Cohort B: Arm B|Adverse Event|0
7460796|NCT01831089|11756397|FG004|Cohort B: Arm B|Adverse Event|0
7460797|NCT01831089|11756398|FG005|Cohort B: Arm B|Adverse Event|1
7460798|NCT01831089|11756393|FG000|Cohort B: Arm B|Global end of study|0
7460799|NCT01831089|11756394|FG001|Cohort B: Arm B|Global end of study|0
7460800|NCT01831089|11756395|FG002|Cohort B: Arm B|Global end of study|0
7460801|NCT01831089|11756396|FG003|Cohort B: Arm B|Global end of study|0
7460802|NCT01831089|11756397|FG004|Cohort B: Arm B|Global end of study|0
7460803|NCT01831089|11756398|FG005|Cohort B: Arm B|Global end of study|1
7468391|NCT01909804|11769118|FG008|Overall Study|Protocol Violation|0
7468392|NCT01909804|11769119|FG009|Overall Study|Protocol Violation|0
7468393|NCT01909804|11769120|FG010|Overall Study|Protocol Violation|0
7468394|NCT01909804|11769121|FG011|Overall Study|Protocol Violation|1
7468395|NCT01909973|11769145|FG000|Overall Study|Lost to Follow-up|1
7468396|NCT01909973|11769146|FG001|Overall Study|Lost to Follow-up|0
7468397|NCT01910116|11769158|FG000|Overall Study|Adverse Event|0
7468398|NCT01910116|11769159|FG001|Overall Study|Adverse Event|3
7468399|NCT01910116|11769158|FG000|Overall Study|Lack of Efficacy|3
7367201|NCT01068860|11616634|FG002|Overall Study|Administrative problems; misrandomized|0
7468400|NCT01910116|11769159|FG001|Overall Study|Lack of Efficacy|4
7468401|NCT01910116|11769158|FG000|Overall Study|Lost to Follow-up|1
7468402|NCT01910116|11769159|FG001|Overall Study|Lost to Follow-up|0
7468403|NCT01910116|11769158|FG000|Overall Study|Protocol Violation|1
7468404|NCT01910116|11769159|FG001|Overall Study|Protocol Violation|2
7468405|NCT01910116|11769158|FG000|Overall Study|Withdrawal by Subject|8
7468406|NCT01910116|11769159|FG001|Overall Study|Withdrawal by Subject|3
7468407|NCT01910116|11769158|FG000|Overall Study|uncertain allocation|1
7533305|NCT02684357|11879615|FG003|Part A|Adverse Event (Worsening of Disease)|0
7533306|NCT02684357|11879616|FG004|Part A|Adverse Event (Worsening of Disease)|0
7367202|NCT01068860|11616635|FG003|Overall Study|Administrative problems; misrandomized|1
7468408|NCT01910116|11769159|FG001|Overall Study|uncertain allocation|3
7468409|NCT01910116|11769158|FG000|Overall Study|incomplete data|0
7468410|NCT01910116|11769159|FG001|Overall Study|incomplete data|1
7468411|NCT01910129|11769167|FG000|Randomized Phase 2|Withdrawal by Subject|2
7367203|NCT01068860|11616636|FG004|Overall Study|Administrative problems; misrandomized|0
7367204|NCT01068860|11616637|FG005|Overall Study|Administrative problems; misrandomized|0
7367205|NCT01068860|11616638|FG006|Overall Study|Administrative problems; misrandomized|0
7367206|NCT01068860|11616639|FG007|Overall Study|Administrative problems; misrandomized|0
7367207|NCT01068860|11616640|FG008|Overall Study|Administrative problems; misrandomized|0
7367208|NCT01068860|11616641|FG009|Overall Study|Administrative problems; misrandomized|1
7367209|NCT01068860|11616632|FG000|Overall Study|Lost to Follow-up|0
7367210|NCT01068860|11616633|FG001|Overall Study|Lost to Follow-up|1
7367211|NCT01068860|11616634|FG002|Overall Study|Lost to Follow-up|0
7367212|NCT01068860|11616635|FG003|Overall Study|Lost to Follow-up|0
7367213|NCT01068860|11616636|FG004|Overall Study|Lost to Follow-up|0
7367214|NCT01068860|11616637|FG005|Overall Study|Lost to Follow-up|0
7367215|NCT01068860|11616638|FG006|Overall Study|Lost to Follow-up|0
7367216|NCT01068860|11616639|FG007|Overall Study|Lost to Follow-up|0
7367217|NCT01068860|11616640|FG008|Overall Study|Lost to Follow-up|0
7367218|NCT01068860|11616641|FG009|Overall Study|Lost to Follow-up|0
7367219|NCT01068912|11616670|FG000|Overall Study|Adverse Event|2
7367220|NCT01068912|11616671|FG001|Overall Study|Adverse Event|3
7367221|NCT01068912|11616672|FG002|Overall Study|Adverse Event|2
7367222|NCT01068912|11616670|FG000|Overall Study|Withdrawal by Subject|5
7367223|NCT01068912|11616671|FG001|Overall Study|Withdrawal by Subject|6
7367224|NCT01068912|11616672|FG002|Overall Study|Withdrawal by Subject|6
7367225|NCT01068912|11616670|FG000|Overall Study|Lost to Follow-up|3
7367226|NCT01068912|11616671|FG001|Overall Study|Lost to Follow-up|7
7367227|NCT01068912|11616672|FG002|Overall Study|Lost to Follow-up|3
7367228|NCT01068912|11616670|FG000|Overall Study|Protocol Violation|0
7367229|NCT01068912|11616671|FG001|Overall Study|Protocol Violation|2
7367230|NCT01068912|11616672|FG002|Overall Study|Protocol Violation|0
7367231|NCT01068912|11616670|FG000|Overall Study|aggravation influenza|1
7367232|NCT01068912|11616671|FG001|Overall Study|aggravation influenza|1
7367233|NCT01068912|11616672|FG002|Overall Study|aggravation influenza|1
7367234|NCT01068912|11616670|FG000|Overall Study|other underlying illness|0
7367235|NCT01068912|11616671|FG001|Overall Study|other underlying illness|3
7367236|NCT01068912|11616672|FG002|Overall Study|other underlying illness|3
7367237|NCT01069172|11616704|FG000|Overall Study|Withdrawal by Subject|1
7367238|NCT01069172|11616705|FG001|Overall Study|Withdrawal by Subject|0
7367239|NCT01069289|11616723|FG000|Overall Study|Withdrawal by Subject|15
7367240|NCT01069289|11616724|FG001|Overall Study|Withdrawal by Subject|26
7367241|NCT01069289|11616723|FG000|Overall Study|Adverse Event|21
7367242|NCT01069289|11616724|FG001|Overall Study|Adverse Event|28
7367243|NCT01069289|11616723|FG000|Overall Study|Eligibility criteria not fulfilled|2
7367244|NCT01069289|11616724|FG001|Overall Study|Eligibility criteria not fulfilled|0
7367245|NCT01069289|11616723|FG000|Overall Study|Severe non-compliance to protocol|3
7367246|NCT01069289|11616724|FG001|Overall Study|Severe non-compliance to protocol|2
7367247|NCT01069289|11616723|FG000|Overall Study|Due to deteriorating health condition|1
7367248|NCT01069289|11616724|FG001|Overall Study|Due to deteriorating health condition|0
7367249|NCT01069341|11616751|FG000|Overall Study|Lost to Follow-up|1
7367250|NCT01069419|11616763|FG000|Overall Study|Adverse Event|233
7367251|NCT01069419|11616763|FG000|Overall Study|Lack of Efficacy|332
7367252|NCT01069419|11616763|FG000|Overall Study|Lost to Follow-up|49
7367253|NCT01069419|11616763|FG000|Overall Study|Remission of disease|11
7367254|NCT01069419|11616763|FG000|Overall Study|Withdrawal by Subject|34
7367255|NCT01069419|11616763|FG000|Overall Study|Other Reason|43
7367256|NCT01069419|11616763|FG000|Overall Study|Missing termination information|13
7367257|NCT01069484|11616769|FG000|Overall Study|Death-in-near-family|1
7367258|NCT01069484|11616770|FG001|Overall Study|Death-in-near-family|0
7367259|NCT01069484|11616769|FG000|Overall Study|No specific reason|8
7367260|NCT01069484|11616770|FG001|Overall Study|No specific reason|2
7367261|NCT01069484|11616769|FG000|Overall Study|Illness mother or child|3
7367262|NCT01069484|11616770|FG001|Overall Study|Illness mother or child|1
7367263|NCT01069523|11616788|FG000|Overall Study|Withdrawal by Subject|4
7367264|NCT01069523|11616789|FG001|Overall Study|Withdrawal by Subject|7
7367265|NCT01069627|11616806|FG000|Overall Study|Disease progression|7
7367266|NCT01069627|11616806|FG000|Overall Study|Adverse Event|12
7367267|NCT01069627|11616806|FG000|Overall Study|Protocol Violation|1
7367268|NCT01069705|11616810|FG000|Overall Study|Adverse Event|1
7367269|NCT01069705|11616810|FG000|Overall Study|Withdrawal by Subject|2
7367270|NCT01069900|11616816|FG000|Overall Study|Technical problems|0
7367271|NCT01069900|11616817|FG001|Overall Study|Technical problems|1
7367272|NCT01069900|11616816|FG000|Overall Study|Lost to Follow-up|7
7367273|NCT01069900|11616817|FG001|Overall Study|Lost to Follow-up|1
7367274|NCT01069900|11616816|FG000|Overall Study|Withdrawal by Subject|6
7367275|NCT01069900|11616817|FG001|Overall Study|Withdrawal by Subject|1
7367276|NCT01069900|11616816|FG000|Overall Study|Protocol Violation|4
7367277|NCT01069900|11616817|FG001|Overall Study|Protocol Violation|1
7367278|NCT01069900|11616816|FG000|Overall Study|Insufficient Therapeutic effect|1
7367279|NCT01069900|11616817|FG001|Overall Study|Insufficient Therapeutic effect|0
7367280|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Adverse Event|17
7367281|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Adverse Event|22
7367282|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
7367283|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
7367284|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
7387692|NCT01215851|11646413|FG004|Treatment Period|Adverse Event|0
7460804|NCT01831258|11756439|FG000|Overall Study|Withdrawal by Subject|2
7460805|NCT01831258|11756440|FG001|Overall Study|Withdrawal by Subject|1
7460806|NCT01831258|11756439|FG000|Overall Study|Lost to Follow-up|3
7460807|NCT01831258|11756440|FG001|Overall Study|Lost to Follow-up|2
7460808|NCT01831427|11756459|FG000|Overall Study|Adverse Event|0
7460809|NCT01831427|11756460|FG001|Overall Study|Adverse Event|1
7460810|NCT01831427|11756461|FG002|Overall Study|Adverse Event|0
7460811|NCT01831427|11756462|FG003|Overall Study|Adverse Event|0
7460812|NCT01831427|11756463|FG004|Overall Study|Adverse Event|0
7460813|NCT01831427|11756464|FG005|Overall Study|Adverse Event|1
7460814|NCT01831427|11756465|FG006|Overall Study|Adverse Event|0
7460815|NCT01831427|11756466|FG007|Overall Study|Adverse Event|1
7460816|NCT01831427|11756467|FG008|Overall Study|Adverse Event|0
7460817|NCT01831427|11756468|FG009|Overall Study|Adverse Event|0
7460818|NCT01831427|11756469|FG010|Overall Study|Adverse Event|2
7460819|NCT01831427|11756459|FG000|Overall Study|Investigator's Discretion|0
7460820|NCT01831427|11756460|FG001|Overall Study|Investigator's Discretion|0
7460821|NCT01831427|11756461|FG002|Overall Study|Investigator's Discretion|0
7460822|NCT01831427|11756462|FG003|Overall Study|Investigator's Discretion|1
7460823|NCT01831427|11756463|FG004|Overall Study|Investigator's Discretion|0
7460824|NCT01831427|11756464|FG005|Overall Study|Investigator's Discretion|0
7460825|NCT01831427|11756465|FG006|Overall Study|Investigator's Discretion|0
7460826|NCT01831427|11756466|FG007|Overall Study|Investigator's Discretion|0
7460827|NCT01831427|11756467|FG008|Overall Study|Investigator's Discretion|0
7460828|NCT01831427|11756468|FG009|Overall Study|Investigator's Discretion|0
7460829|NCT01831427|11756469|FG010|Overall Study|Investigator's Discretion|0
7460830|NCT01831427|11756459|FG000|Overall Study|Withdrew Consent|0
7460831|NCT01831427|11756460|FG001|Overall Study|Withdrew Consent|0
7460832|NCT01831427|11756461|FG002|Overall Study|Withdrew Consent|0
7460833|NCT01831427|11756462|FG003|Overall Study|Withdrew Consent|0
7460834|NCT01831427|11756463|FG004|Overall Study|Withdrew Consent|0
7460835|NCT01831427|11756464|FG005|Overall Study|Withdrew Consent|0
7460836|NCT01831427|11756465|FG006|Overall Study|Withdrew Consent|2
7460837|NCT01831427|11756466|FG007|Overall Study|Withdrew Consent|0
7460838|NCT01831427|11756467|FG008|Overall Study|Withdrew Consent|0
7460839|NCT01831427|11756468|FG009|Overall Study|Withdrew Consent|1
7460840|NCT01831427|11756469|FG010|Overall Study|Withdrew Consent|1
7460841|NCT01831466|11756516|FG000|Overall Study|Protocol Violation|1
7460842|NCT01831466|11756517|FG001|Overall Study|Protocol Violation|1
7460843|NCT01831466|11756518|FG002|Overall Study|Protocol Violation|2
7460844|NCT01831466|11756519|FG003|Overall Study|Protocol Violation|0
7460845|NCT01831466|11756520|FG004|Overall Study|Protocol Violation|0
7460846|NCT01831466|11756521|FG005|Overall Study|Protocol Violation|1
7460847|NCT01831466|11756522|FG006|Overall Study|Protocol Violation|0
7460848|NCT01831466|11756523|FG007|Overall Study|Protocol Violation|0
7460849|NCT01831466|11756524|FG008|Overall Study|Protocol Violation|0
7460850|NCT01831466|11756525|FG009|Overall Study|Protocol Violation|0
7460851|NCT01831466|11756526|FG010|Overall Study|Protocol Violation|0
7460852|NCT01831466|11756527|FG011|Overall Study|Protocol Violation|0
7387693|NCT01215851|11646414|FG005|Treatment Period|Adverse Event|1
7387694|NCT01215851|11646409|FG000|Follow up Period|Lost to Follow-up|0
7387695|NCT01215851|11646410|FG001|Follow up Period|Lost to Follow-up|0
7387696|NCT01215851|11646411|FG002|Follow up Period|Lost to Follow-up|0
7387697|NCT01215851|11646412|FG003|Follow up Period|Lost to Follow-up|0
7387698|NCT01215851|11646413|FG004|Follow up Period|Lost to Follow-up|0
7387699|NCT01215851|11646414|FG005|Follow up Period|Lost to Follow-up|1
7387700|NCT01215916|11646438|FG000|Overall Study|Progressive Disease|0
7367285|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
7367286|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Protocol Violation|0
7367287|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Protocol Violation|1
7367288|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
7367289|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
7367290|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
7367291|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
7367292|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
7367293|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
7367294|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
7367295|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
7367296|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Physician Decision|0
7367297|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Physician Decision|2
7367298|NCT01069939|11616825|FG000|Randomised and Included in the Analyses|Removal|1
7367299|NCT01069939|11616826|FG001|Randomised and Included in the Analyses|Removal|0
7367300|NCT01070043|11616834|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
7367301|NCT01070043|11616835|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
7367302|NCT01070043|11616836|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
7367303|NCT01070043|11616834|FG000|Double-Blind Treatment|Adverse Event|0
7367304|NCT01070043|11616835|FG001|Double-Blind Treatment|Adverse Event|0
7367305|NCT01070043|11616836|FG002|Double-Blind Treatment|Adverse Event|2
7367306|NCT01070303|11616865|FG000|Overall Study|Adverse Event|39
7367307|NCT01070303|11616865|FG000|Overall Study|Withdrawal by Subject|20
7367308|NCT01070303|11616865|FG000|Overall Study|Lost to Follow-up|9
7367309|NCT01070303|11616865|FG000|Overall Study|Protocol Violation|0
7367310|NCT01070303|11616865|FG000|Overall Study|Lack of Efficacy|2
7367311|NCT01070303|11616865|FG000|Overall Study|Administrative Reason|1
7367312|NCT01070303|11616865|FG000|Overall Study|Other|18
7367313|NCT01070316|11616875|FG000|Extension Phase|Lack of Efficacy|3
7367314|NCT01070316|11616875|FG000|Extension Phase|Withdrawal by Subject|1
7367315|NCT01070329|11616881|FG000|Overall Study|Adverse Event|13
7367316|NCT01070329|11616882|FG001|Overall Study|Adverse Event|10
7367317|NCT01070329|11616881|FG000|Overall Study|Lost to Follow-up|22
7367318|NCT01070329|11616882|FG001|Overall Study|Lost to Follow-up|12
7367319|NCT01070329|11616881|FG000|Overall Study|Withdrawal by Subject|9
7367320|NCT01070329|11616882|FG001|Overall Study|Withdrawal by Subject|11
7367321|NCT01070329|11616881|FG000|Overall Study|Protocol Violation|3
7367322|NCT01070329|11616882|FG001|Overall Study|Protocol Violation|8
7367323|NCT01070329|11616881|FG000|Overall Study|Lack of Efficacy|2
7367324|NCT01070329|11616882|FG001|Overall Study|Lack of Efficacy|6
7367325|NCT01070329|11616881|FG000|Overall Study|Physician Decision|2
7367326|NCT01070329|11616882|FG001|Overall Study|Physician Decision|1
7367327|NCT01070329|11616881|FG000|Overall Study|Entry Criteria Not Met|1
7367328|NCT01070329|11616882|FG001|Overall Study|Entry Criteria Not Met|0
7367329|NCT01070329|11616881|FG000|Overall Study|Sponsor Decision|0
7367330|NCT01070329|11616882|FG001|Overall Study|Sponsor Decision|1
7367331|NCT01070381|11616888|FG000|Period 2, 1 Week of Wear|Handling|0
7367332|NCT01070381|11616889|FG001|Period 2, 1 Week of Wear|Handling|1
7367333|NCT01070381|11616888|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
7367334|NCT01070381|11616889|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
7367335|NCT01070394|11616895|FG000|Overall Study|Adverse Event|6
7367336|NCT01070394|11616895|FG000|Overall Study|Withdrawal by Subject|1
7367337|NCT01070550|11616907|FG000|Overall Study|Adverse Event|43
7367338|NCT01070550|11616908|FG001|Overall Study|Adverse Event|1
7367339|NCT01070550|11616909|FG002|Overall Study|Adverse Event|3
7367340|NCT01070550|11616910|FG003|Overall Study|Adverse Event|0
7367341|NCT01070550|11616911|FG004|Overall Study|Adverse Event|0
7367342|NCT01070550|11616912|FG005|Overall Study|Adverse Event|0
7367343|NCT01070550|11616907|FG000|Overall Study|Death|20
7367344|NCT01070550|11616908|FG001|Overall Study|Death|4
7367345|NCT01070550|11616909|FG002|Overall Study|Death|3
7367346|NCT01070550|11616910|FG003|Overall Study|Death|0
7367347|NCT01070550|11616911|FG004|Overall Study|Death|0
7367348|NCT01070550|11616912|FG005|Overall Study|Death|0
7367349|NCT01070550|11616907|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
7367350|NCT01070550|11616908|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
7367351|NCT01070550|11616909|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
7367352|NCT01070550|11616910|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
7367353|NCT01070550|11616911|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
7367354|NCT01070550|11616912|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
7533307|NCT02684357|11879617|FG005|Part A|Adverse Event (Worsening of Disease)|0
7367355|NCT01070550|11616907|FG000|Overall Study|Early termination|3
7367356|NCT01070550|11616908|FG001|Overall Study|Early termination|0
7367357|NCT01070550|11616909|FG002|Overall Study|Early termination|0
7367358|NCT01070550|11616910|FG003|Overall Study|Early termination|0
7367359|NCT01070550|11616911|FG004|Overall Study|Early termination|0
7367360|NCT01070550|11616912|FG005|Overall Study|Early termination|0
7533308|NCT02684357|11879612|FG000|Part A|Lost to Follow-up|0
7367361|NCT01070550|11616907|FG000|Overall Study|Failed to return|450
7367362|NCT01070550|11616908|FG001|Overall Study|Failed to return|33
7367363|NCT01070550|11616909|FG002|Overall Study|Failed to return|144
7367364|NCT01070550|11616910|FG003|Overall Study|Failed to return|40
7367365|NCT01070550|11616911|FG004|Overall Study|Failed to return|1
7367366|NCT01070550|11616912|FG005|Overall Study|Failed to return|2
7367367|NCT01070550|11616907|FG000|Overall Study|Incomplete treatment|2
7367368|NCT01070550|11616908|FG001|Overall Study|Incomplete treatment|0
7367369|NCT01070550|11616909|FG002|Overall Study|Incomplete treatment|0
7367370|NCT01070550|11616910|FG003|Overall Study|Incomplete treatment|0
7367371|NCT01070550|11616911|FG004|Overall Study|Incomplete treatment|0
7367372|NCT01070550|11616912|FG005|Overall Study|Incomplete treatment|0
7367373|NCT01070550|11616907|FG000|Overall Study|Lab test not done|22
7367374|NCT01070550|11616908|FG001|Overall Study|Lab test not done|3
7367375|NCT01070550|11616909|FG002|Overall Study|Lab test not done|4
7367376|NCT01070550|11616910|FG003|Overall Study|Lab test not done|1
7367377|NCT01070550|11616911|FG004|Overall Study|Lab test not done|0
7367378|NCT01070550|11616912|FG005|Overall Study|Lab test not done|1
7367379|NCT01070550|11616907|FG000|Overall Study|Lack of Efficacy|65
7367380|NCT01070550|11616908|FG001|Overall Study|Lack of Efficacy|1
7367381|NCT01070550|11616909|FG002|Overall Study|Lack of Efficacy|5
7367382|NCT01070550|11616910|FG003|Overall Study|Lack of Efficacy|5
7367383|NCT01070550|11616911|FG004|Overall Study|Lack of Efficacy|0
7367384|NCT01070550|11616912|FG005|Overall Study|Lack of Efficacy|1
7367385|NCT01070550|11616907|FG000|Overall Study|Miscellaneous|12
7367386|NCT01070550|11616908|FG001|Overall Study|Miscellaneous|2
7367387|NCT01070550|11616909|FG002|Overall Study|Miscellaneous|3
7367388|NCT01070550|11616910|FG003|Overall Study|Miscellaneous|1
7367389|NCT01070550|11616911|FG004|Overall Study|Miscellaneous|0
7367390|NCT01070550|11616912|FG005|Overall Study|Miscellaneous|0
7367391|NCT01070550|11616907|FG000|Overall Study|New treatment started|3
7367392|NCT01070550|11616908|FG001|Overall Study|New treatment started|1
7367393|NCT01070550|11616909|FG002|Overall Study|New treatment started|0
7367394|NCT01070550|11616910|FG003|Overall Study|New treatment started|2
7367395|NCT01070550|11616911|FG004|Overall Study|New treatment started|0
7367396|NCT01070550|11616912|FG005|Overall Study|New treatment started|0
7367397|NCT01070550|11616907|FG000|Overall Study|Non-responders|493
7367398|NCT01070550|11616908|FG001|Overall Study|Non-responders|4
7367399|NCT01070550|11616909|FG002|Overall Study|Non-responders|21
7367400|NCT01070550|11616910|FG003|Overall Study|Non-responders|20
7367401|NCT01070550|11616911|FG004|Overall Study|Non-responders|0
7367402|NCT01070550|11616912|FG005|Overall Study|Non-responders|2
7367403|NCT01070550|11616907|FG000|Overall Study|Not categorized|33
7367404|NCT01070550|11616908|FG001|Overall Study|Not categorized|2
7367405|NCT01070550|11616909|FG002|Overall Study|Not categorized|6
7367406|NCT01070550|11616910|FG003|Overall Study|Not categorized|1
7367407|NCT01070550|11616911|FG004|Overall Study|Not categorized|0
7367408|NCT01070550|11616912|FG005|Overall Study|Not categorized|1
7367409|NCT01070550|11616907|FG000|Overall Study|Protocol Violation|15
7367410|NCT01070550|11616908|FG001|Overall Study|Protocol Violation|1
7367411|NCT01070550|11616909|FG002|Overall Study|Protocol Violation|1
7367412|NCT01070550|11616910|FG003|Overall Study|Protocol Violation|1
7367413|NCT01070550|11616911|FG004|Overall Study|Protocol Violation|0
7367414|NCT01070550|11616912|FG005|Overall Study|Protocol Violation|0
7367415|NCT01070550|11616907|FG000|Overall Study|Relapse|44
7367416|NCT01070550|11616908|FG001|Overall Study|Relapse|5
7367417|NCT01070550|11616909|FG002|Overall Study|Relapse|14
7570257|NCT03482453|11947597|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
7570258|NCT03482453|11947598|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
7570259|NCT03482635|11947652|FG000|Overall Study|Lack of Efficacy|0
7570260|NCT03482635|11947653|FG001|Overall Study|Lack of Efficacy|0
7570261|NCT03482635|11947654|FG002|Overall Study|Lack of Efficacy|1
7570262|NCT03482635|11947655|FG003|Overall Study|Lack of Efficacy|3
7570263|NCT03482635|11947652|FG000|Overall Study|Adverse Event|2
7570264|NCT03482635|11947653|FG001|Overall Study|Adverse Event|2
7570265|NCT03482635|11947654|FG002|Overall Study|Adverse Event|0
7570266|NCT03482635|11947655|FG003|Overall Study|Adverse Event|3
7570267|NCT03482635|11947652|FG000|Overall Study|Withdrawal by Subject|2
7570268|NCT03482635|11947653|FG001|Overall Study|Withdrawal by Subject|1
7570269|NCT03482635|11947654|FG002|Overall Study|Withdrawal by Subject|0
7367418|NCT01070550|11616910|FG003|Overall Study|Relapse|4
7367419|NCT01070550|11616911|FG004|Overall Study|Relapse|0
7367420|NCT01070550|11616912|FG005|Overall Study|Relapse|0
7367421|NCT01070550|11616907|FG000|Overall Study|Result not available|3
7367422|NCT01070550|11616908|FG001|Overall Study|Result not available|1
7367423|NCT01070550|11616909|FG002|Overall Study|Result not available|3
7367424|NCT01070550|11616910|FG003|Overall Study|Result not available|0
7367425|NCT01070550|11616911|FG004|Overall Study|Result not available|0
7367426|NCT01070550|11616912|FG005|Overall Study|Result not available|0
7570270|NCT03482635|11947655|FG003|Overall Study|Withdrawal by Subject|1
7367427|NCT01070550|11616907|FG000|Overall Study|Screen failure|1
7367428|NCT01070550|11616908|FG001|Overall Study|Screen failure|0
7367429|NCT01070550|11616909|FG002|Overall Study|Screen failure|0
7367430|NCT01070550|11616910|FG003|Overall Study|Screen failure|0
7367431|NCT01070550|11616911|FG004|Overall Study|Screen failure|0
7367432|NCT01070550|11616912|FG005|Overall Study|Screen failure|0
7367433|NCT01070550|11616907|FG000|Overall Study|Sponsor decision|1
7367434|NCT01070550|11616908|FG001|Overall Study|Sponsor decision|0
7367435|NCT01070550|11616909|FG002|Overall Study|Sponsor decision|0
7367436|NCT01070550|11616910|FG003|Overall Study|Sponsor decision|0
7367437|NCT01070550|11616911|FG004|Overall Study|Sponsor decision|0
7367438|NCT01070550|11616912|FG005|Overall Study|Sponsor decision|0
7367439|NCT01070550|11616907|FG000|Overall Study|Treatment duration shortened|1
7367440|NCT01070550|11616908|FG001|Overall Study|Treatment duration shortened|0
7367441|NCT01070550|11616909|FG002|Overall Study|Treatment duration shortened|0
7367442|NCT01070550|11616910|FG003|Overall Study|Treatment duration shortened|0
7367443|NCT01070550|11616911|FG004|Overall Study|Treatment duration shortened|0
7367444|NCT01070550|11616912|FG005|Overall Study|Treatment duration shortened|0
7367445|NCT01070550|11616907|FG000|Overall Study|Treatment interrupted|7
7367446|NCT01070550|11616908|FG001|Overall Study|Treatment interrupted|0
7367447|NCT01070550|11616909|FG002|Overall Study|Treatment interrupted|1
7367448|NCT01070550|11616910|FG003|Overall Study|Treatment interrupted|1
7367449|NCT01070550|11616911|FG004|Overall Study|Treatment interrupted|0
7367450|NCT01070550|11616912|FG005|Overall Study|Treatment interrupted|0
7367451|NCT01070550|11616907|FG000|Overall Study|Treatment not started|14
7367452|NCT01070550|11616908|FG001|Overall Study|Treatment not started|2
7367453|NCT01070550|11616909|FG002|Overall Study|Treatment not started|4
7367454|NCT01070550|11616910|FG003|Overall Study|Treatment not started|0
7367455|NCT01070550|11616911|FG004|Overall Study|Treatment not started|0
7367456|NCT01070550|11616912|FG005|Overall Study|Treatment not started|0
7367457|NCT01070550|11616907|FG000|Overall Study|Treatment restarted|0
7367458|NCT01070550|11616908|FG001|Overall Study|Treatment restarted|1
7367459|NCT01070550|11616909|FG002|Overall Study|Treatment restarted|0
7367460|NCT01070550|11616910|FG003|Overall Study|Treatment restarted|0
7367461|NCT01070550|11616911|FG004|Overall Study|Treatment restarted|0
7367462|NCT01070550|11616912|FG005|Overall Study|Treatment restarted|0
7367463|NCT01070550|11616907|FG000|Overall Study|Treatment stopped|3
7367464|NCT01070550|11616908|FG001|Overall Study|Treatment stopped|0
7367465|NCT01070550|11616909|FG002|Overall Study|Treatment stopped|0
7367466|NCT01070550|11616910|FG003|Overall Study|Treatment stopped|0
7367467|NCT01070550|11616911|FG004|Overall Study|Treatment stopped|0
7367468|NCT01070550|11616912|FG005|Overall Study|Treatment stopped|0
7367469|NCT01070550|11616907|FG000|Overall Study|Treatment unavailable|1
7367470|NCT01070550|11616908|FG001|Overall Study|Treatment unavailable|0
7367471|NCT01070550|11616909|FG002|Overall Study|Treatment unavailable|0
7367472|NCT01070550|11616910|FG003|Overall Study|Treatment unavailable|0
7367473|NCT01070550|11616911|FG004|Overall Study|Treatment unavailable|0
7367474|NCT01070550|11616912|FG005|Overall Study|Treatment unavailable|0
7367475|NCT01070550|11616907|FG000|Overall Study|Treatment was stopped early|7
7367476|NCT01070550|11616908|FG001|Overall Study|Treatment was stopped early|0
7367477|NCT01070550|11616909|FG002|Overall Study|Treatment was stopped early|0
7367478|NCT01070550|11616910|FG003|Overall Study|Treatment was stopped early|0
7367479|NCT01070550|11616911|FG004|Overall Study|Treatment was stopped early|0
7367480|NCT01070550|11616912|FG005|Overall Study|Treatment was stopped early|0
7367481|NCT01070550|11616907|FG000|Overall Study|Other|5
7367482|NCT01070550|11616908|FG001|Overall Study|Other|0
7367483|NCT01070550|11616909|FG002|Overall Study|Other|0
7367484|NCT01070550|11616910|FG003|Overall Study|Other|1
7367485|NCT01070550|11616911|FG004|Overall Study|Other|0
7367486|NCT01070550|11616912|FG005|Overall Study|Other|0
7367487|NCT01070550|11616907|FG000|Overall Study|Withdrawal by Subject|35
7367488|NCT01070550|11616908|FG001|Overall Study|Withdrawal by Subject|0
7367489|NCT01070550|11616909|FG002|Overall Study|Withdrawal by Subject|3
7367490|NCT01070550|11616910|FG003|Overall Study|Withdrawal by Subject|0
7367491|NCT01070550|11616911|FG004|Overall Study|Withdrawal by Subject|0
7367492|NCT01070550|11616912|FG005|Overall Study|Withdrawal by Subject|0
7367493|NCT01070771|11616936|FG000|Overall Study|Adverse Event|2
7367494|NCT01070771|11616936|FG000|Overall Study|Protocol Violation|1
7386731|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7386732|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7386733|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7386734|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
7386735|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7386736|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
7386737|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386738|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386739|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386740|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386741|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386742|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386743|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386744|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
7386745|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
7386746|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386747|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
7386748|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386749|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7387701|NCT01215916|11646439|FG001|Overall Study|Progressive Disease|2
7367495|NCT01070784|11616943|FG000|Overall Study|Withdrawal by Subject|6
7367496|NCT01070784|11616944|FG001|Overall Study|Withdrawal by Subject|9
7367497|NCT01070784|11616943|FG000|Overall Study|Adverse Event|14
7570271|NCT03482635|11947652|FG000|Overall Study|Withdrawn by Principle Investigator|1
7367498|NCT01070784|11616944|FG001|Overall Study|Adverse Event|9
7367499|NCT01070888|11616963|FG000|First Intervention (14 Days)|Adverse Event|0
7367500|NCT01070888|11616964|FG001|First Intervention (14 Days)|Adverse Event|1
7367501|NCT01070888|11616963|FG000|First Intervention (14 Days)|Lost to Follow-up|0
7367502|NCT01070888|11616964|FG001|First Intervention (14 Days)|Lost to Follow-up|1
7367503|NCT01070888|11616963|FG000|Washout (14 Days)|Physician Decision|1
7367504|NCT01070888|11616964|FG001|Washout (14 Days)|Physician Decision|0
7367505|NCT01070979|11616973|FG000|Overall Study|Adverse Event|2
7367506|NCT01070979|11616974|FG001|Overall Study|Adverse Event|3
7367507|NCT01070979|11616975|FG002|Overall Study|Adverse Event|3
7367508|NCT01070979|11616973|FG000|Overall Study|Lost to Follow-up|2
7367509|NCT01070979|11616974|FG001|Overall Study|Lost to Follow-up|1
7367510|NCT01070979|11616975|FG002|Overall Study|Lost to Follow-up|1
7367511|NCT01070979|11616973|FG000|Overall Study|Protocol Violation|0
7367512|NCT01070979|11616974|FG001|Overall Study|Protocol Violation|2
7367513|NCT01070979|11616975|FG002|Overall Study|Protocol Violation|6
7367514|NCT01070979|11616973|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
7367515|NCT01070979|11616974|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
7367516|NCT01070979|11616975|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
7367517|NCT01070979|11616973|FG000|Overall Study|Withdrawal by Subject|3
7367518|NCT01070979|11616974|FG001|Overall Study|Withdrawal by Subject|1
7367519|NCT01070979|11616975|FG002|Overall Study|Withdrawal by Subject|1
7367520|NCT01070979|11616973|FG000|Overall Study|No study drug taken|0
7367521|NCT01070979|11616974|FG001|Overall Study|No study drug taken|1
7367522|NCT01070979|11616975|FG002|Overall Study|No study drug taken|0
7367523|NCT01071070|11616997|FG000|Overall Study|Adverse Event|0
7367524|NCT01071070|11616998|FG001|Overall Study|Adverse Event|3
7367525|NCT01071070|11616997|FG000|Overall Study|Withdrawal by Subject|1
7367526|NCT01071070|11616998|FG001|Overall Study|Withdrawal by Subject|0
7367527|NCT01071070|11616997|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
7367528|NCT01071070|11616998|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
7367529|NCT01071070|11616997|FG000|Overall Study|Hypercalcemia|1
7367530|NCT01071070|11616998|FG001|Overall Study|Hypercalcemia|0
7367531|NCT01071083|11617009|FG000|Overall Study|Adverse Event|1
7367532|NCT01071083|11617010|FG001|Overall Study|Adverse Event|0
7367533|NCT01071083|11617011|FG002|Overall Study|Adverse Event|1
7367534|NCT01071083|11617012|FG003|Overall Study|Adverse Event|0
7367535|NCT01071083|11617013|FG004|Overall Study|Adverse Event|1
7367536|NCT01071083|11617009|FG000|Overall Study|Withdrawal by Subject|3
7367537|NCT01071083|11617010|FG001|Overall Study|Withdrawal by Subject|0
7367538|NCT01071083|11617011|FG002|Overall Study|Withdrawal by Subject|2
7367539|NCT01071083|11617012|FG003|Overall Study|Withdrawal by Subject|0
7367540|NCT01071083|11617013|FG004|Overall Study|Withdrawal by Subject|3
7367541|NCT01071083|11617009|FG000|Overall Study|Physician Decision|1
7367542|NCT01071083|11617010|FG001|Overall Study|Physician Decision|0
7367543|NCT01071083|11617011|FG002|Overall Study|Physician Decision|0
7367544|NCT01071083|11617012|FG003|Overall Study|Physician Decision|1
7367545|NCT01071083|11617013|FG004|Overall Study|Physician Decision|1
7367546|NCT01071083|11617009|FG000|Overall Study|Early Rescue|1
7367547|NCT01071083|11617010|FG001|Overall Study|Early Rescue|0
7367548|NCT01071083|11617011|FG002|Overall Study|Early Rescue|0
7367549|NCT01071083|11617012|FG003|Overall Study|Early Rescue|0
7367550|NCT01071083|11617013|FG004|Overall Study|Early Rescue|1
7367551|NCT01071083|11617009|FG000|Overall Study|Subject Moved|0
7367552|NCT01071083|11617010|FG001|Overall Study|Subject Moved|1
7367553|NCT01071083|11617011|FG002|Overall Study|Subject Moved|0
7367554|NCT01071083|11617012|FG003|Overall Study|Subject Moved|0
7367555|NCT01071083|11617013|FG004|Overall Study|Subject Moved|0
7367556|NCT01071083|11617009|FG000|Overall Study|Images Not Usable (Motion)|0
7367557|NCT01071083|11617010|FG001|Overall Study|Images Not Usable (Motion)|1
7367558|NCT01071083|11617011|FG002|Overall Study|Images Not Usable (Motion)|0
7367559|NCT01071083|11617012|FG003|Overall Study|Images Not Usable (Motion)|0
7367560|NCT01071083|11617013|FG004|Overall Study|Images Not Usable (Motion)|0
7367561|NCT01071083|11617009|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
7367562|NCT01071083|11617010|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7367563|NCT01071083|11617011|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
7367564|NCT01071083|11617012|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
7367565|NCT01071083|11617013|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
7367566|NCT01071083|11617009|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
7367567|NCT01071083|11617010|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
7367568|NCT01071083|11617011|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
7367569|NCT01071083|11617012|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
7367570|NCT01071083|11617013|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
7367571|NCT01071083|11617009|FG000|Overall Study|Subject Refused to Continue|1
7367572|NCT01071083|11617010|FG001|Overall Study|Subject Refused to Continue|0
7367573|NCT01071083|11617011|FG002|Overall Study|Subject Refused to Continue|0
7367574|NCT01071083|11617012|FG003|Overall Study|Subject Refused to Continue|0
7367575|NCT01071083|11617013|FG004|Overall Study|Subject Refused to Continue|0
7367576|NCT01071096|11617025|FG000|First Intervention (90 Days)|Lost to Follow-up|1
7367577|NCT01071096|11617026|FG001|First Intervention (90 Days)|Lost to Follow-up|0
7367578|NCT01071200|11617045|FG000|Overall Study|Lack of ovarian response|1
7367579|NCT01071200|11617046|FG001|Overall Study|Lack of ovarian response|1
7367580|NCT01071200|11617045|FG000|Overall Study|No fertilization|4
7367581|NCT01071200|11617046|FG001|Overall Study|No fertilization|0
7367582|NCT01071200|11617045|FG000|Overall Study|No oocytes retrieved|1
7367583|NCT01071200|11617046|FG001|Overall Study|No oocytes retrieved|1
7367584|NCT01071200|11617045|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
7367585|NCT01071200|11617046|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
7367586|NCT01071200|11617045|FG000|Overall Study|No viable embryos|0
7367587|NCT01071200|11617046|FG001|Overall Study|No viable embryos|1
7367588|NCT01071252|11617057|FG000|Overall Study|unsatisfactory therapeutic effect|4
7367589|NCT01071252|11617058|FG001|Overall Study|unsatisfactory therapeutic effect|6
7367590|NCT01071252|11617059|FG002|Overall Study|unsatisfactory therapeutic effect|2
7367591|NCT01071252|11617060|FG003|Overall Study|unsatisfactory therapeutic effect|0
7367592|NCT01071252|11617061|FG004|Overall Study|unsatisfactory therapeutic effect|6
7367593|NCT01071252|11617057|FG000|Overall Study|Withdrawal by Subject|8
7367594|NCT01071252|11617058|FG001|Overall Study|Withdrawal by Subject|2
7367595|NCT01071252|11617059|FG002|Overall Study|Withdrawal by Subject|1
7367596|NCT01071252|11617060|FG003|Overall Study|Withdrawal by Subject|2
7367597|NCT01071252|11617061|FG004|Overall Study|Withdrawal by Subject|3
7367598|NCT01071252|11617057|FG000|Overall Study|administrative problems|1
7367599|NCT01071252|11617058|FG001|Overall Study|administrative problems|1
7367600|NCT01071252|11617059|FG002|Overall Study|administrative problems|0
7367601|NCT01071252|11617060|FG003|Overall Study|administrative problems|2
7367602|NCT01071252|11617061|FG004|Overall Study|administrative problems|1
7367603|NCT01071252|11617057|FG000|Overall Study|Lost to Follow-up|1
7367604|NCT01071252|11617058|FG001|Overall Study|Lost to Follow-up|0
7367605|NCT01071252|11617059|FG002|Overall Study|Lost to Follow-up|1
7367606|NCT01071252|11617060|FG003|Overall Study|Lost to Follow-up|2
7367607|NCT01071252|11617061|FG004|Overall Study|Lost to Follow-up|0
7367608|NCT01071252|11617057|FG000|Overall Study|Adverse Event|1
7367609|NCT01071252|11617058|FG001|Overall Study|Adverse Event|1
7367610|NCT01071252|11617059|FG002|Overall Study|Adverse Event|0
7367611|NCT01071252|11617060|FG003|Overall Study|Adverse Event|1
7367612|NCT01071252|11617061|FG004|Overall Study|Adverse Event|0
7460853|NCT01831466|11756516|FG000|Overall Study|Other|2
7460854|NCT01831466|11756517|FG001|Overall Study|Other|3
7460855|NCT01831466|11756518|FG002|Overall Study|Other|2
7460856|NCT01831466|11756519|FG003|Overall Study|Other|2
7460857|NCT01831466|11756520|FG004|Overall Study|Other|2
7367613|NCT01071252|11617057|FG000|Overall Study|Death|0
7367614|NCT01071252|11617058|FG001|Overall Study|Death|0
7367615|NCT01071252|11617059|FG002|Overall Study|Death|0
7367616|NCT01071252|11617060|FG003|Overall Study|Death|0
7367617|NCT01071252|11617061|FG004|Overall Study|Death|1
7367618|NCT01071278|11617073|FG000|Overall Study|Premature Discontinuation|254
7367619|NCT01071278|11617073|FG000|Overall Study|Completion Status Unknown|459
7367620|NCT01071317|11617081|FG000|Overall Study|Lost to Follow-up|2
7367621|NCT01071317|11617082|FG001|Overall Study|Lost to Follow-up|2
7367622|NCT01071395|11617099|FG000|Overall Study|Withdrawal by Subject|2
7367623|NCT01071395|11617100|FG001|Overall Study|Withdrawal by Subject|1
7367624|NCT01071395|11617099|FG000|Overall Study|Adverse Event|3
7367625|NCT01071395|11617100|FG001|Overall Study|Adverse Event|1
7367626|NCT01071512|11617106|FG000|Overall Study|Adverse Event|1
7367627|NCT01071512|11617106|FG000|Overall Study|Development of antibodies to drug|2
7367628|NCT01071512|11617106|FG000|Overall Study|positive anti-JC virus antibody test|2
7367629|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
7367630|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Lack of tolerability|14
7367631|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Patient requirement|20
7367632|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Death|5
7367633|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Change of therapy|6
7367634|NCT01071798|11617114|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
7367635|NCT01071798|11617114|FG000|Subpopulation Who Received Two Cycles|Remission|1
7367636|NCT01071798|11617114|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
7367637|NCT01071798|11617114|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
7367638|NCT01071798|11617114|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
7367639|NCT01071915|11617128|FG000|Overall Study|Adverse Event|3
7460858|NCT01831466|11756521|FG005|Overall Study|Other|1
7367640|NCT01071915|11617128|FG000|Overall Study|Physician Decision|2
7367641|NCT01071915|11617128|FG000|Overall Study|Withdrawal by Subject|2
7367642|NCT01071915|11617128|FG000|Overall Study|Miscellaneous Reasons|2
7367643|NCT01071954|11617132|FG000|Overall Study|Noncompliance|4
7367644|NCT01071954|11617132|FG000|Overall Study|Adverse Event|1
7367645|NCT01071954|11617132|FG000|Overall Study|Withdrawal by Subject|11
7367646|NCT01071954|11617132|FG000|Overall Study|Requirement for Alternative Therapy|5
7367647|NCT01071954|11617132|FG000|Overall Study|Administrative Decision|5
7460859|NCT01831466|11756522|FG006|Overall Study|Other|0
7367648|NCT01071954|11617132|FG000|Overall Study|Protocol Specified Criteria|1
7367649|NCT01072149|11617176|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367650|NCT01072149|11617177|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367651|NCT01072149|11617178|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7367652|NCT01072149|11617179|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367653|NCT01072149|11617180|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367654|NCT01072149|11617181|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367655|NCT01072149|11617182|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367656|NCT01072149|11617183|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367657|NCT01072149|11617184|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367658|NCT01072149|11617185|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367659|NCT01072149|11617186|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367660|NCT01072149|11617187|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367661|NCT01072149|11617188|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367662|NCT01072149|11617189|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367663|NCT01072149|11617190|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367664|NCT01072149|11617191|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367665|NCT01072149|11617192|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367666|NCT01072149|11617193|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7367667|NCT01072149|11617176|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
7367668|NCT01072149|11617177|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
7367669|NCT01072149|11617178|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
7367670|NCT01072149|11617179|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
7367671|NCT01072149|11617180|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
7367672|NCT01072149|11617181|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
7367673|NCT01072149|11617182|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
7367674|NCT01072149|11617183|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
7367675|NCT01072149|11617184|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
7367676|NCT01072149|11617185|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
7367677|NCT01072149|11617186|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
7367678|NCT01072149|11617187|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
7367679|NCT01072149|11617188|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
7367680|NCT01072149|11617189|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
7367681|NCT01072149|11617190|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
7367682|NCT01072149|11617191|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
7367683|NCT01072149|11617192|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
7367684|NCT01072149|11617193|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
7367685|NCT01072149|11617176|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367686|NCT01072149|11617177|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367687|NCT01072149|11617178|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367688|NCT01072149|11617179|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367689|NCT01072149|11617180|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367690|NCT01072149|11617181|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367691|NCT01072149|11617182|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367692|NCT01072149|11617183|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367693|NCT01072149|11617184|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367694|NCT01072149|11617185|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367695|NCT01072149|11617186|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
7367696|NCT01072149|11617187|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367697|NCT01072149|11617188|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367698|NCT01072149|11617189|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367699|NCT01072149|11617190|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367700|NCT01072149|11617191|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367701|NCT01072149|11617192|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367702|NCT01072149|11617193|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
7367703|NCT01072149|11617176|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367704|NCT01072149|11617177|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
7367705|NCT01072149|11617178|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367706|NCT01072149|11617179|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367707|NCT01072149|11617180|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367708|NCT01072149|11617181|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367709|NCT01072149|11617182|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367710|NCT01072149|11617183|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367711|NCT01072149|11617184|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367712|NCT01072149|11617185|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367713|NCT01072149|11617186|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367714|NCT01072149|11617187|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367715|NCT01072149|11617188|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367716|NCT01072149|11617189|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367717|NCT01072149|11617190|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367718|NCT01072149|11617191|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367719|NCT01072149|11617192|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367720|NCT01072149|11617193|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
7367721|NCT01072149|11617176|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367722|NCT01072149|11617177|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367723|NCT01072149|11617178|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7367724|NCT01072149|11617179|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367725|NCT01072149|11617180|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367726|NCT01072149|11617181|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367727|NCT01072149|11617182|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367728|NCT01072149|11617183|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367729|NCT01072149|11617184|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367730|NCT01072149|11617185|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367731|NCT01072149|11617186|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367732|NCT01072149|11617187|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367733|NCT01072149|11617188|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367734|NCT01072149|11617189|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367735|NCT01072149|11617190|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367736|NCT01072149|11617191|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367737|NCT01072149|11617192|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367738|NCT01072149|11617193|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7367739|NCT01072149|11617176|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
7367740|NCT01072149|11617177|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
7367741|NCT01072149|11617178|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
7367742|NCT01072149|11617179|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
7367743|NCT01072149|11617180|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
7367744|NCT01072149|11617181|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
7367745|NCT01072149|11617182|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
7367746|NCT01072149|11617183|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
7367747|NCT01072149|11617184|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
7367748|NCT01072149|11617185|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
7367749|NCT01072149|11617186|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
7367750|NCT01072149|11617187|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
7367751|NCT01072149|11617188|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
7367752|NCT01072149|11617189|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
7367753|NCT01072149|11617190|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
7367754|NCT01072149|11617191|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
7367755|NCT01072149|11617192|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
7367756|NCT01072149|11617193|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
7367757|NCT01072149|11617176|FG000|Washout Period 2 (14 Days)|Physician Decision|1
7367758|NCT01072149|11617177|FG001|Washout Period 2 (14 Days)|Physician Decision|0
7367759|NCT01072149|11617178|FG002|Washout Period 2 (14 Days)|Physician Decision|0
7367760|NCT01072149|11617179|FG003|Washout Period 2 (14 Days)|Physician Decision|0
7367761|NCT01072149|11617180|FG004|Washout Period 2 (14 Days)|Physician Decision|0
7367762|NCT01072149|11617181|FG005|Washout Period 2 (14 Days)|Physician Decision|0
7367763|NCT01072149|11617182|FG006|Washout Period 2 (14 Days)|Physician Decision|0
7367764|NCT01072149|11617183|FG007|Washout Period 2 (14 Days)|Physician Decision|0
7367765|NCT01072149|11617184|FG008|Washout Period 2 (14 Days)|Physician Decision|0
7367766|NCT01072149|11617185|FG009|Washout Period 2 (14 Days)|Physician Decision|0
7367767|NCT01072149|11617186|FG010|Washout Period 2 (14 Days)|Physician Decision|0
7367768|NCT01072149|11617187|FG011|Washout Period 2 (14 Days)|Physician Decision|0
7367769|NCT01072149|11617188|FG012|Washout Period 2 (14 Days)|Physician Decision|0
7367770|NCT01072149|11617189|FG013|Washout Period 2 (14 Days)|Physician Decision|0
7367771|NCT01072149|11617190|FG014|Washout Period 2 (14 Days)|Physician Decision|0
7367772|NCT01072149|11617191|FG015|Washout Period 2 (14 Days)|Physician Decision|0
7367773|NCT01072149|11617192|FG016|Washout Period 2 (14 Days)|Physician Decision|0
7367774|NCT01072149|11617193|FG017|Washout Period 2 (14 Days)|Physician Decision|0
7367775|NCT01072149|11617176|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367776|NCT01072149|11617177|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367777|NCT01072149|11617178|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367778|NCT01072149|11617179|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367779|NCT01072149|11617180|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367780|NCT01072149|11617181|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367781|NCT01072149|11617182|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367782|NCT01072149|11617183|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367783|NCT01072149|11617184|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367784|NCT01072149|11617185|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367785|NCT01072149|11617186|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367786|NCT01072149|11617187|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367787|NCT01072149|11617188|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367788|NCT01072149|11617189|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7387702|NCT01215916|11646440|FG002|Overall Study|Progressive Disease|1
7367789|NCT01072149|11617190|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367790|NCT01072149|11617191|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
7367791|NCT01072149|11617192|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367792|NCT01072149|11617193|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
7367793|NCT01072149|11617176|FG000|Washout Period 2 (14 Days)|Adverse Event|0
7367794|NCT01072149|11617177|FG001|Washout Period 2 (14 Days)|Adverse Event|0
7367795|NCT01072149|11617178|FG002|Washout Period 2 (14 Days)|Adverse Event|0
7367796|NCT01072149|11617179|FG003|Washout Period 2 (14 Days)|Adverse Event|0
7367797|NCT01072149|11617180|FG004|Washout Period 2 (14 Days)|Adverse Event|0
7367798|NCT01072149|11617181|FG005|Washout Period 2 (14 Days)|Adverse Event|0
7367799|NCT01072149|11617182|FG006|Washout Period 2 (14 Days)|Adverse Event|0
7367800|NCT01072149|11617183|FG007|Washout Period 2 (14 Days)|Adverse Event|0
7367801|NCT01072149|11617184|FG008|Washout Period 2 (14 Days)|Adverse Event|0
7367802|NCT01072149|11617185|FG009|Washout Period 2 (14 Days)|Adverse Event|0
7367803|NCT01072149|11617186|FG010|Washout Period 2 (14 Days)|Adverse Event|0
7367804|NCT01072149|11617187|FG011|Washout Period 2 (14 Days)|Adverse Event|0
7367805|NCT01072149|11617188|FG012|Washout Period 2 (14 Days)|Adverse Event|0
7367806|NCT01072149|11617189|FG013|Washout Period 2 (14 Days)|Adverse Event|0
7367807|NCT01072149|11617190|FG014|Washout Period 2 (14 Days)|Adverse Event|0
7367808|NCT01072149|11617191|FG015|Washout Period 2 (14 Days)|Adverse Event|1
7367809|NCT01072149|11617192|FG016|Washout Period 2 (14 Days)|Adverse Event|0
7367810|NCT01072149|11617193|FG017|Washout Period 2 (14 Days)|Adverse Event|0
7367811|NCT01072149|11617176|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367812|NCT01072149|11617177|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367813|NCT01072149|11617178|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367814|NCT01072149|11617179|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367815|NCT01072149|11617180|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
7570272|NCT03482635|11947653|FG001|Overall Study|Withdrawn by Principle Investigator|0
7570273|NCT03482635|11947654|FG002|Overall Study|Withdrawn by Principle Investigator|0
7570274|NCT03482635|11947655|FG003|Overall Study|Withdrawn by Principle Investigator|0
7570275|NCT03482635|11947652|FG000|Overall Study|Not treated|0
7570276|NCT03482635|11947653|FG001|Overall Study|Not treated|0
7570277|NCT03482635|11947654|FG002|Overall Study|Not treated|0
7570278|NCT03482635|11947655|FG003|Overall Study|Not treated|1
7570279|NCT03482882|11947674|FG000|Overall Study|Adverse Event|3
7570280|NCT03482882|11947674|FG000|Overall Study|Lost to Follow-up|1
7570281|NCT03482882|11947674|FG000|Overall Study|Protocol Violation|2
7570282|NCT03482882|11947674|FG000|Overall Study|Not further specified|1
7570283|NCT03483623|11947693|FG000|Overall Study|43 complete sets achieved|1
7570284|NCT03483961|11947736|FG000|Overall Study|Lost to Follow-up|7
7570285|NCT03483961|11947737|FG001|Overall Study|Lost to Follow-up|6
7570286|NCT03483961|11947738|FG002|Overall Study|Lost to Follow-up|6
7570287|NCT03483961|11947739|FG003|Overall Study|Lost to Follow-up|6
7570288|NCT03483961|11947740|FG004|Overall Study|Lost to Follow-up|6
7570289|NCT03483961|11947741|FG005|Overall Study|Lost to Follow-up|4
7367816|NCT01072149|11617181|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367817|NCT01072149|11617182|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367818|NCT01072149|11617183|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367819|NCT01072149|11617184|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367820|NCT01072149|11617185|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367821|NCT01072149|11617186|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367822|NCT01072149|11617187|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367823|NCT01072149|11617188|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
7367824|NCT01072149|11617189|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367825|NCT01072149|11617190|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367826|NCT01072149|11617191|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367827|NCT01072149|11617192|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367828|NCT01072149|11617193|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
7367829|NCT01072149|11617176|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367830|NCT01072149|11617177|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7570290|NCT03483961|11947742|FG006|Overall Study|Lost to Follow-up|4
7570291|NCT03483961|11947743|FG007|Overall Study|Lost to Follow-up|11
7367831|NCT01072149|11617178|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7367832|NCT01072149|11617179|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367833|NCT01072149|11617180|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367834|NCT01072149|11617181|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367835|NCT01072149|11617182|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367836|NCT01072149|11617183|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7570292|NCT03483961|11947744|FG008|Overall Study|Lost to Follow-up|1
7570293|NCT03483961|11947745|FG009|Overall Study|Lost to Follow-up|0
7570294|NCT03483961|11947736|FG000|Overall Study|Withdrawal by Subject|3
7570295|NCT03483961|11947737|FG001|Overall Study|Withdrawal by Subject|4
7570296|NCT03483961|11947738|FG002|Overall Study|Withdrawal by Subject|5
7367837|NCT01072149|11617184|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367838|NCT01072149|11617185|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367839|NCT01072149|11617186|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367840|NCT01072149|11617187|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367841|NCT01072149|11617188|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367842|NCT01072149|11617189|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
7367843|NCT01072149|11617190|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367844|NCT01072149|11617191|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367845|NCT01072149|11617192|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367846|NCT01072149|11617193|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
7367847|NCT01072201|11617214|FG000|Overall Study|Lost to Follow-up|0
7367848|NCT01072201|11617215|FG001|Overall Study|Lost to Follow-up|1
7367849|NCT01072344|11617236|FG000|Overall Study|Relasped-reached end point|7
7367850|NCT01072344|11617237|FG001|Overall Study|Relasped-reached end point|12
7367851|NCT01072344|11617236|FG000|Overall Study|Protocol Violation|1
7367852|NCT01072344|11617237|FG001|Overall Study|Protocol Violation|2
7367853|NCT01072344|11617236|FG000|Overall Study|Lost to Follow-up|3
7367854|NCT01072344|11617237|FG001|Overall Study|Lost to Follow-up|4
7367855|NCT01072357|11617245|FG000|Overall Study|Lost to Follow-up|0
7367856|NCT01072357|11617246|FG001|Overall Study|Lost to Follow-up|1
7367857|NCT01072396|11617254|FG000|Period One|Adverse Event|1
7367858|NCT01072396|11617255|FG001|Period One|Adverse Event|1
7367859|NCT01072396|11617254|FG000|Period One|Protocol Violation|2
7367860|NCT01072396|11617255|FG001|Period One|Protocol Violation|1
7367861|NCT01072396|11617254|FG000|Period One|Withdrawal by Subject|2
7367862|NCT01072396|11617255|FG001|Period One|Withdrawal by Subject|0
7367863|NCT01072396|11617254|FG000|Washout Period|Missing termination information|0
7367864|NCT01072396|11617255|FG001|Washout Period|Missing termination information|1
7367865|NCT01072396|11617254|FG000|Period Two|Adverse Event|0
7367866|NCT01072396|11617255|FG001|Period Two|Adverse Event|3
7367867|NCT01072396|11617254|FG000|Period Two|Lost to Follow-up|1
7367868|NCT01072396|11617255|FG001|Period Two|Lost to Follow-up|0
7367869|NCT01072448|11617267|FG000|Overall Study|Adverse Event|9
7367870|NCT01072448|11617268|FG001|Overall Study|Adverse Event|10
7367871|NCT01072448|11617267|FG000|Overall Study|Subject withdrew consent|4
7367872|NCT01072448|11617268|FG001|Overall Study|Subject withdrew consent|9
7367873|NCT01072448|11617267|FG000|Overall Study|Protocol deviation|3
7367874|NCT01072448|11617268|FG001|Overall Study|Protocol deviation|4
7367875|NCT01072448|11617267|FG000|Overall Study|Abnormal test procedure result(s)|1
7367876|NCT01072448|11617268|FG001|Overall Study|Abnormal test procedure result(s)|0
7367877|NCT01072448|11617267|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7367878|NCT01072448|11617268|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7367879|NCT01072448|11617267|FG000|Overall Study|Lost to Follow-up|1
7367880|NCT01072448|11617268|FG001|Overall Study|Lost to Follow-up|1
7367881|NCT01072448|11617267|FG000|Overall Study|Abnormal laboratory value(s)|0
7367882|NCT01072448|11617268|FG001|Overall Study|Abnormal laboratory value(s)|1
7367883|NCT01072448|11617267|FG000|Overall Study|Death|0
7367884|NCT01072448|11617268|FG001|Overall Study|Death|2
7367885|NCT01072500|11617276|FG000|Overall Study|Death|2
7367886|NCT01072500|11617277|FG001|Overall Study|Death|2
7367887|NCT01072500|11617276|FG000|Overall Study|Lost to Follow-up|5
7367888|NCT01072500|11617277|FG001|Overall Study|Lost to Follow-up|2
7367889|NCT01072500|11617276|FG000|Overall Study|Withdrawal by Subject|17
7367890|NCT01072500|11617277|FG001|Overall Study|Withdrawal by Subject|10
7367891|NCT01072539|11617285|FG000|Overall Study|Treated prior to the Site Initiation|1
7367892|NCT01072539|11617285|FG000|Overall Study|Protocol Violation|2
7367893|NCT01072630|11617297|FG000|Overall Study|Adverse Event|11
7367894|NCT01072630|11617298|FG001|Overall Study|Adverse Event|19
7367895|NCT01072630|11617299|FG002|Overall Study|Adverse Event|2
7367896|NCT01072630|11617297|FG000|Overall Study|Lack of Efficacy|10
7367897|NCT01072630|11617298|FG001|Overall Study|Lack of Efficacy|10
7367898|NCT01072630|11617299|FG002|Overall Study|Lack of Efficacy|1
7367899|NCT01072630|11617297|FG000|Overall Study|Withdrawal by Subject|8
7367900|NCT01072630|11617298|FG001|Overall Study|Withdrawal by Subject|7
7367901|NCT01072630|11617299|FG002|Overall Study|Withdrawal by Subject|2
7367902|NCT01072630|11617297|FG000|Overall Study|Protocol Violation|10
7367903|NCT01072630|11617298|FG001|Overall Study|Protocol Violation|8
7367904|NCT01072630|11617299|FG002|Overall Study|Protocol Violation|4
7367905|NCT01072630|11617297|FG000|Overall Study|Lost to Follow-up|11
7367906|NCT01072630|11617298|FG001|Overall Study|Lost to Follow-up|11
7367907|NCT01072630|11617299|FG002|Overall Study|Lost to Follow-up|1
7367908|NCT01072630|11617297|FG000|Overall Study|Noncompliance with study medication|1
7367909|NCT01072630|11617298|FG001|Overall Study|Noncompliance with study medication|1
7367910|NCT01072630|11617299|FG002|Overall Study|Noncompliance with study medication|1
7367911|NCT01072630|11617297|FG000|Overall Study|Noncompliance with study procedures|1
7367912|NCT01072630|11617298|FG001|Overall Study|Noncompliance with study procedures|2
7367913|NCT01072630|11617299|FG002|Overall Study|Noncompliance with study procedures|1
7367914|NCT01072630|11617297|FG000|Overall Study|Other|3
7367915|NCT01072630|11617298|FG001|Overall Study|Other|2
7367916|NCT01072630|11617299|FG002|Overall Study|Other|1
7367917|NCT01072877|11617359|FG000|Overall Study|Lost to Follow-up|1
7367918|NCT01072877|11617360|FG001|Overall Study|Lost to Follow-up|1
7367919|NCT01072877|11617361|FG002|Overall Study|Lost to Follow-up|0
7367920|NCT01072877|11617362|FG003|Overall Study|Lost to Follow-up|2
7367921|NCT01072877|11617363|FG004|Overall Study|Lost to Follow-up|0
7367922|NCT01072929|11617380|FG000|Overall Study|Adverse Event|8
7367923|NCT01072929|11617381|FG001|Overall Study|Adverse Event|11
7367924|NCT01072929|11617382|FG002|Overall Study|Adverse Event|2
7367925|NCT01072929|11617380|FG000|Overall Study|Lack of Efficacy|7
7367926|NCT01072929|11617381|FG001|Overall Study|Lack of Efficacy|4
7367927|NCT01072929|11617382|FG002|Overall Study|Lack of Efficacy|0
7367928|NCT01072929|11617380|FG000|Overall Study|Withdrawal by Subject|7
7367929|NCT01072929|11617381|FG001|Overall Study|Withdrawal by Subject|15
7367930|NCT01072929|11617382|FG002|Overall Study|Withdrawal by Subject|3
7367931|NCT01072929|11617380|FG000|Overall Study|Protocol Violation|13
7367932|NCT01072929|11617381|FG001|Overall Study|Protocol Violation|11
7367933|NCT01072929|11617382|FG002|Overall Study|Protocol Violation|2
7367934|NCT01072929|11617380|FG000|Overall Study|Lost to Follow-up|8
7367935|NCT01072929|11617381|FG001|Overall Study|Lost to Follow-up|4
7367936|NCT01072929|11617382|FG002|Overall Study|Lost to Follow-up|1
7367937|NCT01072929|11617380|FG000|Overall Study|Noncompliance with study medication|0
7367938|NCT01072929|11617381|FG001|Overall Study|Noncompliance with study medication|3
7367939|NCT01072929|11617382|FG002|Overall Study|Noncompliance with study medication|0
7367940|NCT01072929|11617380|FG000|Overall Study|Noncompliance with study procedures|1
7367941|NCT01072929|11617381|FG001|Overall Study|Noncompliance with study procedures|0
7367942|NCT01072929|11617382|FG002|Overall Study|Noncompliance with study procedures|1
7367943|NCT01072929|11617380|FG000|Overall Study|Other|0
7367944|NCT01072929|11617381|FG001|Overall Study|Other|3
7367945|NCT01072929|11617382|FG002|Overall Study|Other|0
7367946|NCT01073020|11617395|FG000|Overall Study|Withdrawal by Subject|6
7367947|NCT01073020|11617396|FG001|Overall Study|Withdrawal by Subject|4
7367948|NCT01073020|11617397|FG002|Overall Study|Withdrawal by Subject|1
7367949|NCT01073020|11617398|FG003|Overall Study|Withdrawal by Subject|2
7367950|NCT01073020|11617395|FG000|Overall Study|Physician Decision|1
7367951|NCT01073020|11617396|FG001|Overall Study|Physician Decision|0
7367952|NCT01073020|11617397|FG002|Overall Study|Physician Decision|2
7367953|NCT01073020|11617398|FG003|Overall Study|Physician Decision|0
7367954|NCT01073020|11617395|FG000|Overall Study|Death|0
7367955|NCT01073020|11617396|FG001|Overall Study|Death|1
7367956|NCT01073020|11617397|FG002|Overall Study|Death|0
7367957|NCT01073020|11617398|FG003|Overall Study|Death|0
7367958|NCT01073163|11617408|FG000|Overall Study|Adverse Event|1
7367959|NCT01073163|11617408|FG000|Overall Study|Disease Progression|1
7367960|NCT01073163|11617408|FG000|Overall Study|Early termination|1
7367961|NCT01073267|11617416|FG000|Overall Study|Disease Progression|3
7367962|NCT01073293|11617422|FG000|Overall Study|Lost to Follow-up|0
7367963|NCT01073293|11617423|FG001|Overall Study|Lost to Follow-up|1
7367964|NCT01073293|11617422|FG000|Overall Study|Withdrawal by Subject|5
7570297|NCT03483961|11947739|FG003|Overall Study|Withdrawal by Subject|3
7367965|NCT01073293|11617423|FG001|Overall Study|Withdrawal by Subject|10
7367966|NCT01073462|11617433|FG000|Overall Study|Death|14
7367967|NCT01073462|11617433|FG000|Overall Study|Kidney transplant|10
7367968|NCT01073462|11617433|FG000|Overall Study|Low parathyroid hormone levels|8
7367969|NCT01073462|11617433|FG000|Overall Study|Serious adverse event|2
7367970|NCT01073462|11617433|FG000|Overall Study|Lost to Follow-up|7
7367971|NCT01073566|11617439|FG000|Period 2 (6 Weeks)|Adverse Event|1
7367972|NCT01073566|11617440|FG001|Period 2 (6 Weeks)|Adverse Event|0
7367973|NCT01073605|11617449|FG000|Overall Study|Ongoing at Cutoff Date|1
7367974|NCT01073605|11617450|FG001|Overall Study|Ongoing at Cutoff Date|1
7367975|NCT01073605|11617451|FG002|Overall Study|Ongoing at Cutoff Date|0
7367976|NCT01073605|11617449|FG000|Overall Study|Adverse Event|2
7367977|NCT01073605|11617450|FG001|Overall Study|Adverse Event|1
7367978|NCT01073605|11617451|FG002|Overall Study|Adverse Event|0
7367979|NCT01073605|11617449|FG000|Overall Study|Lost to Follow-up|3
7367980|NCT01073605|11617450|FG001|Overall Study|Lost to Follow-up|4
7367981|NCT01073605|11617451|FG002|Overall Study|Lost to Follow-up|9
7367982|NCT01073605|11617449|FG000|Overall Study|Other|25
7367983|NCT01073605|11617450|FG001|Overall Study|Other|21
7367984|NCT01073605|11617451|FG002|Overall Study|Other|29
7367985|NCT01073605|11617449|FG000|Overall Study|Withdrawal by Subject|31
7367986|NCT01073605|11617450|FG001|Overall Study|Withdrawal by Subject|39
7367987|NCT01073605|11617451|FG002|Overall Study|Withdrawal by Subject|22
7367988|NCT01073605|11617449|FG000|Overall Study|Randomized But Not Treated|0
7367989|NCT01073605|11617450|FG001|Overall Study|Randomized But Not Treated|1
7367990|NCT01073605|11617451|FG002|Overall Study|Randomized But Not Treated|1
7367991|NCT01073618|11617459|FG000|Overall Study|Death|208
7367992|NCT01073618|11617459|FG000|Overall Study|Adverse Event|19
7367993|NCT01073618|11617459|FG000|Overall Study|Other|80
7367994|NCT01073631|11617463|FG000|Overall Study|Death|82
7367995|NCT01073631|11617463|FG000|Overall Study|Adverse Event|24
7367996|NCT01073631|11617463|FG000|Overall Study|Other|63
7367997|NCT01073865|11617478|FG000|Overall Study|Reasons other than below|19
7367998|NCT01073865|11617479|FG001|Overall Study|Reasons other than below|31
7367999|NCT01073865|11617478|FG000|Overall Study|Lost to Follow-up|1
7368000|NCT01073865|11617479|FG001|Overall Study|Lost to Follow-up|1
7368001|NCT01073865|11617478|FG000|Overall Study|Death|3
7368002|NCT01073865|11617479|FG001|Overall Study|Death|2
7368003|NCT01073865|11617478|FG000|Overall Study|Withdrawal by Subject|5
7368004|NCT01073865|11617479|FG001|Overall Study|Withdrawal by Subject|5
7368005|NCT01073930|11617487|FG000|Overall Study|Withdrawal by Subject|3
7368006|NCT01073930|11617488|FG001|Overall Study|Withdrawal by Subject|2
7368007|NCT01073930|11617487|FG000|Overall Study|Lost to Follow-up|0
7368008|NCT01073930|11617488|FG001|Overall Study|Lost to Follow-up|1
7368009|NCT01073930|11617487|FG000|Overall Study|Adverse Event|0
7368010|NCT01073930|11617488|FG001|Overall Study|Adverse Event|1
7368011|NCT01073930|11617487|FG000|Overall Study|Noncompliance with study drug|0
7368012|NCT01073930|11617488|FG001|Overall Study|Noncompliance with study drug|1
7368013|NCT01073930|11617487|FG000|Overall Study|Inadequate prep; unable to do procedure|0
7368014|NCT01073930|11617488|FG001|Overall Study|Inadequate prep; unable to do procedure|1
7368015|NCT01073943|11617496|FG000|Overall Study|Withdrawal by Subject|8
7368016|NCT01073943|11617497|FG001|Overall Study|Withdrawal by Subject|2
7368017|NCT01073943|11617496|FG000|Overall Study|Protocol Violation|2
7368018|NCT01073943|11617497|FG001|Overall Study|Protocol Violation|1
7368019|NCT01073943|11617496|FG000|Overall Study|Adverse Event|1
7368020|NCT01073943|11617497|FG001|Overall Study|Adverse Event|1
7368021|NCT01073943|11617496|FG000|Overall Study|Lost to Follow-up|0
7570298|NCT03483961|11947740|FG004|Overall Study|Withdrawal by Subject|4
7368022|NCT01073943|11617497|FG001|Overall Study|Lost to Follow-up|2
7368023|NCT01073943|11617496|FG000|Overall Study|Power outage; colonoscopy not done|1
7368024|NCT01073943|11617497|FG001|Overall Study|Power outage; colonoscopy not done|0
7368025|NCT01073943|11617496|FG000|Overall Study|Subject forgot|0
7368026|NCT01073943|11617497|FG001|Overall Study|Subject forgot|1
7368027|NCT01073943|11617496|FG000|Overall Study|Unable to return for follow-up|0
7368028|NCT01073943|11617497|FG001|Overall Study|Unable to return for follow-up|1
7368029|NCT01073943|11617496|FG000|Overall Study|Could not tolerate prep|1
7368030|NCT01073943|11617497|FG001|Overall Study|Could not tolerate prep|0
7368031|NCT01074008|11617512|FG000|Overall Study|Adverse Event|0
7368032|NCT01074008|11617513|FG001|Overall Study|Adverse Event|1
7368033|NCT01074008|11617514|FG002|Overall Study|Adverse Event|0
7368034|NCT01074008|11617515|FG003|Overall Study|Adverse Event|0
7368035|NCT01074008|11617516|FG004|Overall Study|Adverse Event|0
7368036|NCT01074008|11617517|FG005|Overall Study|Adverse Event|0
7368037|NCT01074008|11617518|FG006|Overall Study|Adverse Event|0
7570299|NCT03483961|11947741|FG005|Overall Study|Withdrawal by Subject|2
7570300|NCT03483961|11947742|FG006|Overall Study|Withdrawal by Subject|1
7570301|NCT03483961|11947743|FG007|Overall Study|Withdrawal by Subject|2
7570302|NCT03483961|11947744|FG008|Overall Study|Withdrawal by Subject|1
7368038|NCT01074008|11617519|FG007|Overall Study|Adverse Event|0
7368039|NCT01074008|11617520|FG008|Overall Study|Adverse Event|0
7368040|NCT01074008|11617512|FG000|Overall Study|Withdrawal by Subject|1
7368041|NCT01074008|11617513|FG001|Overall Study|Withdrawal by Subject|1
7368042|NCT01074008|11617514|FG002|Overall Study|Withdrawal by Subject|1
7368043|NCT01074008|11617515|FG003|Overall Study|Withdrawal by Subject|0
7368044|NCT01074008|11617516|FG004|Overall Study|Withdrawal by Subject|1
7368045|NCT01074008|11617517|FG005|Overall Study|Withdrawal by Subject|0
7368046|NCT01074008|11617518|FG006|Overall Study|Withdrawal by Subject|0
7368047|NCT01074008|11617519|FG007|Overall Study|Withdrawal by Subject|0
7368048|NCT01074008|11617520|FG008|Overall Study|Withdrawal by Subject|0
7368049|NCT01074008|11617512|FG000|Overall Study|Lost to Follow-up|0
7368050|NCT01074008|11617513|FG001|Overall Study|Lost to Follow-up|1
7368051|NCT01074008|11617514|FG002|Overall Study|Lost to Follow-up|1
7368052|NCT01074008|11617515|FG003|Overall Study|Lost to Follow-up|1
7368053|NCT01074008|11617516|FG004|Overall Study|Lost to Follow-up|1
7368054|NCT01074008|11617517|FG005|Overall Study|Lost to Follow-up|0
7368055|NCT01074008|11617518|FG006|Overall Study|Lost to Follow-up|1
7368056|NCT01074008|11617519|FG007|Overall Study|Lost to Follow-up|0
7368057|NCT01074008|11617520|FG008|Overall Study|Lost to Follow-up|4
7368058|NCT01074047|11617556|FG000|Treatment Phase|Adverse Event|89
7368059|NCT01074047|11617557|FG001|Treatment Phase|Adverse Event|66
7368060|NCT01074047|11617556|FG000|Treatment Phase|Disease Progression|16
7368061|NCT01074047|11617557|FG001|Treatment Phase|Disease Progression|21
7533309|NCT02684357|11879613|FG001|Part A|Lost to Follow-up|2
7368062|NCT01074047|11617556|FG000|Treatment Phase|Withdrawal by Subject|27
7368063|NCT01074047|11617557|FG001|Treatment Phase|Withdrawal by Subject|48
7368064|NCT01074047|11617556|FG000|Treatment Phase|Death|53
7368065|NCT01074047|11617557|FG001|Treatment Phase|Death|58
7368066|NCT01074047|11617556|FG000|Treatment Phase|Lost to Follow-up|0
7368067|NCT01074047|11617557|FG001|Treatment Phase|Lost to Follow-up|1
7368068|NCT01074047|11617556|FG000|Treatment Phase|Protocol Violation|0
7368069|NCT01074047|11617557|FG001|Treatment Phase|Protocol Violation|1
7368070|NCT01074047|11617556|FG000|Treatment Phase|Miscellaneous|32
7368071|NCT01074047|11617557|FG001|Treatment Phase|Miscellaneous|39
7533310|NCT02684357|11879614|FG002|Part A|Lost to Follow-up|2
7368072|NCT01074047|11617556|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
7368073|NCT01074047|11617557|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
7368074|NCT01074047|11617556|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
7368075|NCT01074047|11617557|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
7368076|NCT01074047|11617556|FG000|Survival Follow-Up Phase|Death|116
7368077|NCT01074047|11617557|FG001|Survival Follow-Up Phase|Death|124
7368078|NCT01074047|11617556|FG000|Survival Follow-Up Phase|Alive at study closure|1
7368079|NCT01074047|11617557|FG001|Survival Follow-Up Phase|Alive at study closure|3
7368080|NCT01074047|11617556|FG000|Extension Phase|Physician Decision|1
7368081|NCT01074047|11617557|FG001|Extension Phase|Physician Decision|0
7368082|NCT01074047|11617556|FG000|Extension Phase|Adverse Event|5
7368083|NCT01074047|11617557|FG001|Extension Phase|Adverse Event|0
7368084|NCT01074047|11617556|FG000|Extension Phase|Disease Progression|9
7368085|NCT01074047|11617557|FG001|Extension Phase|Disease Progression|0
7368086|NCT01074047|11617556|FG000|Extension Phase|Withdrawal by Subject|2
7368087|NCT01074047|11617557|FG001|Extension Phase|Withdrawal by Subject|0
7368088|NCT01074047|11617556|FG000|Extension Phase|Death|5
7368089|NCT01074047|11617557|FG001|Extension Phase|Death|0
7368090|NCT01074216|11617608|FG000|Overall Study|Physician Decision|1
7368091|NCT01074216|11617608|FG000|Overall Study|Not Treated|12
7368092|NCT01074229|11617615|FG000|Overall Study|Lost to Follow-up|1
7368093|NCT01074229|11617616|FG001|Overall Study|Lost to Follow-up|0
7368094|NCT01074229|11617617|FG002|Overall Study|Lost to Follow-up|0
7368095|NCT01074229|11617615|FG000|Overall Study|Change to open surgical procedure|1
7368096|NCT01074229|11617616|FG001|Overall Study|Change to open surgical procedure|3
7460860|NCT01831466|11756523|FG007|Overall Study|Other|0
7460861|NCT01831466|11756524|FG008|Overall Study|Other|0
7460862|NCT01831466|11756525|FG009|Overall Study|Other|0
7460863|NCT01831466|11756526|FG010|Overall Study|Other|0
7460864|NCT01831466|11756527|FG011|Overall Study|Other|0
7460865|NCT01831466|11756516|FG000|Overall Study|Non-compliance with study treatment|2
7460866|NCT01831466|11756517|FG001|Overall Study|Non-compliance with study treatment|1
7460867|NCT01831466|11756518|FG002|Overall Study|Non-compliance with study treatment|1
7460868|NCT01831466|11756519|FG003|Overall Study|Non-compliance with study treatment|0
7460869|NCT01831466|11756520|FG004|Overall Study|Non-compliance with study treatment|0
7460870|NCT01831466|11756521|FG005|Overall Study|Non-compliance with study treatment|1
7460871|NCT01831466|11756522|FG006|Overall Study|Non-compliance with study treatment|0
7460872|NCT01831466|11756523|FG007|Overall Study|Non-compliance with study treatment|0
7460873|NCT01831466|11756524|FG008|Overall Study|Non-compliance with study treatment|0
7460874|NCT01831466|11756525|FG009|Overall Study|Non-compliance with study treatment|0
7460875|NCT01831466|11756526|FG010|Overall Study|Non-compliance with study treatment|0
7460876|NCT01831466|11756527|FG011|Overall Study|Non-compliance with study treatment|0
7460877|NCT01831466|11756516|FG000|Overall Study|Death|0
7460878|NCT01831466|11756517|FG001|Overall Study|Death|1
7460879|NCT01831466|11756518|FG002|Overall Study|Death|0
7460880|NCT01831466|11756519|FG003|Overall Study|Death|0
7460881|NCT01831466|11756520|FG004|Overall Study|Death|0
7460882|NCT01831466|11756521|FG005|Overall Study|Death|0
7460883|NCT01831466|11756522|FG006|Overall Study|Death|0
7460884|NCT01831466|11756523|FG007|Overall Study|Death|0
7460885|NCT01831466|11756524|FG008|Overall Study|Death|0
7460886|NCT01831466|11756525|FG009|Overall Study|Death|0
7460887|NCT01831466|11756526|FG010|Overall Study|Death|0
7460888|NCT01831466|11756527|FG011|Overall Study|Death|0
7460889|NCT01831466|11756516|FG000|Overall Study|Withdrawal by Subject|6
7460890|NCT01831466|11756517|FG001|Overall Study|Withdrawal by Subject|3
7460891|NCT01831466|11756518|FG002|Overall Study|Withdrawal by Subject|3
7460892|NCT01831466|11756519|FG003|Overall Study|Withdrawal by Subject|3
7460893|NCT01831466|11756520|FG004|Overall Study|Withdrawal by Subject|3
7460894|NCT01831466|11756521|FG005|Overall Study|Withdrawal by Subject|5
7460895|NCT01831466|11756522|FG006|Overall Study|Withdrawal by Subject|0
7460896|NCT01831466|11756523|FG007|Overall Study|Withdrawal by Subject|0
7460897|NCT01831466|11756524|FG008|Overall Study|Withdrawal by Subject|0
7460898|NCT01831466|11756525|FG009|Overall Study|Withdrawal by Subject|1
7460899|NCT01831466|11756526|FG010|Overall Study|Withdrawal by Subject|0
7460900|NCT01831466|11756527|FG011|Overall Study|Withdrawal by Subject|1
7460901|NCT01831466|11756516|FG000|Overall Study|Lost to Follow-up|0
7460902|NCT01831466|11756517|FG001|Overall Study|Lost to Follow-up|1
7460903|NCT01831466|11756518|FG002|Overall Study|Lost to Follow-up|4
7460904|NCT01831466|11756519|FG003|Overall Study|Lost to Follow-up|2
7460905|NCT01831466|11756520|FG004|Overall Study|Lost to Follow-up|0
7460906|NCT01831466|11756521|FG005|Overall Study|Lost to Follow-up|3
7460907|NCT01831466|11756522|FG006|Overall Study|Lost to Follow-up|0
7460908|NCT01831466|11756523|FG007|Overall Study|Lost to Follow-up|0
7460909|NCT01831466|11756524|FG008|Overall Study|Lost to Follow-up|0
7460910|NCT01831466|11756525|FG009|Overall Study|Lost to Follow-up|1
7460911|NCT01831466|11756526|FG010|Overall Study|Lost to Follow-up|0
7460912|NCT01831466|11756527|FG011|Overall Study|Lost to Follow-up|1
7460913|NCT01831466|11756516|FG000|Overall Study|Lack of Efficacy|5
7460914|NCT01831466|11756517|FG001|Overall Study|Lack of Efficacy|8
7460915|NCT01831466|11756518|FG002|Overall Study|Lack of Efficacy|7
7460916|NCT01831466|11756519|FG003|Overall Study|Lack of Efficacy|6
7460917|NCT01831466|11756520|FG004|Overall Study|Lack of Efficacy|9
7460918|NCT01831466|11756521|FG005|Overall Study|Lack of Efficacy|8
7460919|NCT01831466|11756522|FG006|Overall Study|Lack of Efficacy|1
7368097|NCT01074229|11617617|FG002|Overall Study|Change to open surgical procedure|4
7368098|NCT01074242|11617627|FG000|Overall Study|Case report before date of contract|40
7368099|NCT01074242|11617627|FG000|Overall Study|Lost to Follow-up|1
7368100|NCT01074242|11617627|FG000|Overall Study|Case report unclear|6
7368101|NCT01074242|11617627|FG000|Overall Study|Violation of vaccine dose or dosage|351
7368102|NCT01074242|11617627|FG000|Overall Study|Duplicate Case Report Form|5
7368103|NCT01074255|11617631|FG000|Overall Study|Did not receive EMEND|2
7368104|NCT01074268|11617637|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
7368105|NCT01074268|11617638|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
7368106|NCT01074268|11617637|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
7368107|NCT01074268|11617638|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
7368108|NCT01074268|11617637|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
7368109|NCT01074268|11617638|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
7368110|NCT01074268|11617637|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
7368111|NCT01074268|11617638|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
7368112|NCT01074268|11617637|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
7368113|NCT01074268|11617638|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
7368114|NCT01074268|11617637|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7368115|NCT01074268|11617638|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
7368116|NCT01074268|11617637|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
7368117|NCT01074268|11617638|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
7368118|NCT01074268|11617637|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7368119|NCT01074268|11617638|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
7368120|NCT01074268|11617637|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
7368121|NCT01074268|11617638|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
7368122|NCT01074307|11617646|FG000|Overall Study|No primary endpoint evaluation|14
7368123|NCT01074307|11617647|FG001|Overall Study|No primary endpoint evaluation|6
7368124|NCT01074307|11617646|FG000|Overall Study|Exclusion criterion|0
7368125|NCT01074307|11617647|FG001|Overall Study|Exclusion criterion|1
7368126|NCT01074307|11617646|FG000|Overall Study|Protocol Violation|8
7368127|NCT01074307|11617647|FG001|Overall Study|Protocol Violation|5
7368128|NCT01074450|11617655|FG000|First Intervention|Emesis in Dosing Interval|0
7368129|NCT01074450|11617656|FG001|First Intervention|Emesis in Dosing Interval|2
7368130|NCT01074450|11617655|FG000|Second Intervention|Protocol Violation|1
7368131|NCT01074450|11617656|FG001|Second Intervention|Protocol Violation|0
7368132|NCT01074450|11617655|FG000|Second Intervention|Physician Decision|0
7368133|NCT01074450|11617656|FG001|Second Intervention|Physician Decision|1
7368134|NCT01074554|11617673|FG000|Overall Study|Adverse Event|3
7368135|NCT01074554|11617674|FG001|Overall Study|Adverse Event|3
7368136|NCT01074554|11617673|FG000|Overall Study|Lost to Follow-up|0
7368137|NCT01074554|11617674|FG001|Overall Study|Lost to Follow-up|1
7368138|NCT01074658|11617680|FG000|Overall Study|No implant attempted|19
7368139|NCT01074931|11617684|FG000|Overall Study|Economic reasons|1
7368140|NCT01074931|11617684|FG000|Overall Study|Death|5
7368141|NCT01074944|11617692|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
7368142|NCT01074944|11617693|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7368143|NCT01074944|11617694|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7368144|NCT01074944|11617695|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7368145|NCT01074944|11617696|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
7368146|NCT01074944|11617692|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
7368147|NCT01074944|11617693|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7368148|NCT01074944|11617694|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7368149|NCT01074944|11617695|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7368150|NCT01074944|11617696|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
7368151|NCT01074944|11617692|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
7368152|NCT01074944|11617693|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7368153|NCT01074944|11617694|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7368154|NCT01074944|11617695|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7368155|NCT01074944|11617696|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
7368156|NCT01074944|11617692|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
7368157|NCT01074944|11617693|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7368158|NCT01074944|11617694|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7368159|NCT01074944|11617695|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7368160|NCT01074944|11617696|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
7368161|NCT01074944|11617692|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7368162|NCT01074944|11617693|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
7368163|NCT01074944|11617694|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
7368164|NCT01074944|11617695|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7368165|NCT01074944|11617696|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
7368166|NCT01074944|11617692|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7368167|NCT01074944|11617693|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
7368168|NCT01074944|11617694|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
7368169|NCT01074944|11617695|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7368170|NCT01074944|11617696|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
7368171|NCT01074944|11617692|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7368172|NCT01074944|11617693|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7368173|NCT01074944|11617694|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
7368174|NCT01074944|11617695|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7368175|NCT01074944|11617696|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
7368176|NCT01074944|11617692|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7368177|NCT01074944|11617693|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
7368178|NCT01074944|11617694|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7368179|NCT01074944|11617695|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7368180|NCT01074944|11617696|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
7368181|NCT01074944|11617692|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7368182|NCT01074944|11617693|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7368183|NCT01074944|11617694|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
7368184|NCT01074944|11617695|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7368185|NCT01074944|11617696|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
7368186|NCT01074944|11617692|FG000|Long Term Treatment|Adverse Event|0
7460920|NCT01831466|11756523|FG007|Overall Study|Lack of Efficacy|1
7460921|NCT01831466|11756524|FG008|Overall Study|Lack of Efficacy|2
7368187|NCT01074944|11617693|FG001|Long Term Treatment|Adverse Event|0
7368188|NCT01074944|11617694|FG002|Long Term Treatment|Adverse Event|0
7368189|NCT01074944|11617695|FG003|Long Term Treatment|Adverse Event|3
7368190|NCT01074944|11617696|FG004|Long Term Treatment|Adverse Event|0
7368191|NCT01074944|11617692|FG000|Long Term Treatment|Lost to Follow-up|0
7460922|NCT01831466|11756525|FG009|Overall Study|Lack of Efficacy|2
7460923|NCT01831466|11756526|FG010|Overall Study|Lack of Efficacy|2
7460924|NCT01831466|11756527|FG011|Overall Study|Lack of Efficacy|0
7460925|NCT01831466|11756516|FG000|Overall Study|Adverse Event|0
7460926|NCT01831466|11756517|FG001|Overall Study|Adverse Event|0
7460927|NCT01831466|11756518|FG002|Overall Study|Adverse Event|4
7460928|NCT01831466|11756519|FG003|Overall Study|Adverse Event|6
7460929|NCT01831466|11756520|FG004|Overall Study|Adverse Event|3
7460930|NCT01831466|11756521|FG005|Overall Study|Adverse Event|7
7460931|NCT01831466|11756522|FG006|Overall Study|Adverse Event|0
7460932|NCT01831466|11756523|FG007|Overall Study|Adverse Event|1
7460933|NCT01831466|11756524|FG008|Overall Study|Adverse Event|1
7460934|NCT01831466|11756525|FG009|Overall Study|Adverse Event|1
7460935|NCT01831466|11756526|FG010|Overall Study|Adverse Event|0
7460936|NCT01831466|11756527|FG011|Overall Study|Adverse Event|2
7460937|NCT01831544|11756547|FG000|Overall Study|Death|1
7460938|NCT01831544|11756547|FG000|Overall Study|Still on original MVAD device|2
7460939|NCT01831726|11756551|FG000|Overall Study|Adverse Event|16
7460940|NCT01831726|11756551|FG000|Overall Study|Death|7
7460941|NCT01831726|11756551|FG000|Overall Study|Disease Progression|49
7460942|NCT01831726|11756551|FG000|Overall Study|Physician Decision|1
7460943|NCT01831726|11756551|FG000|Overall Study|Subject/guardian decision|7
7460944|NCT01831765|11756558|FG000|Overall Study|Lack of Efficacy|1
7460945|NCT01831765|11756559|FG001|Overall Study|Lack of Efficacy|0
7460946|NCT01831765|11756560|FG002|Overall Study|Lack of Efficacy|0
7368192|NCT01074944|11617693|FG001|Long Term Treatment|Lost to Follow-up|0
7368193|NCT01074944|11617694|FG002|Long Term Treatment|Lost to Follow-up|0
7460947|NCT01831765|11756558|FG000|Overall Study|Other, sponsor withdrew subject|0
7460948|NCT01831765|11756559|FG001|Overall Study|Other, sponsor withdrew subject|1
7460949|NCT01831765|11756560|FG002|Overall Study|Other, sponsor withdrew subject|0
7368194|NCT01074944|11617695|FG003|Long Term Treatment|Lost to Follow-up|2
7368195|NCT01074944|11617696|FG004|Long Term Treatment|Lost to Follow-up|0
7368196|NCT01074944|11617692|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7368197|NCT01074944|11617693|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7368198|NCT01074944|11617694|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7368199|NCT01074944|11617695|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
7368200|NCT01074944|11617696|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
7368201|NCT01074944|11617692|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
7368202|NCT01074944|11617693|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
7368203|NCT01074944|11617694|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
7368204|NCT01074944|11617695|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
7368205|NCT01074944|11617696|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
7368206|NCT01074944|11617692|FG000|Long Term Treatment|Withdrawal by Subject|0
7368207|NCT01074944|11617693|FG001|Long Term Treatment|Withdrawal by Subject|0
7368208|NCT01074944|11617694|FG002|Long Term Treatment|Withdrawal by Subject|0
7368209|NCT01074944|11617695|FG003|Long Term Treatment|Withdrawal by Subject|2
7368210|NCT01074944|11617696|FG004|Long Term Treatment|Withdrawal by Subject|0
7368211|NCT01074944|11617692|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
7368212|NCT01074944|11617693|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
7368213|NCT01074944|11617694|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
7368214|NCT01074944|11617695|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
7368215|NCT01074944|11617696|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
7368216|NCT01074944|11617692|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7368217|NCT01074944|11617693|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7460950|NCT01831765|11756558|FG000|Overall Study|Pregnancy|1
7570303|NCT03483961|11947745|FG009|Overall Study|Withdrawal by Subject|0
7570304|NCT03483961|11947736|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
7570305|NCT03483961|11947737|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570306|NCT03483961|11947738|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570307|NCT03483961|11947739|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570308|NCT03483961|11947740|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570309|NCT03483961|11947741|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7368218|NCT01074944|11617694|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7460951|NCT01831765|11756559|FG001|Overall Study|Pregnancy|1
7368219|NCT01074944|11617695|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
7368220|NCT01074944|11617696|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
7368221|NCT01075048|11617707|FG000|Overall Study|Death|4
7368222|NCT01075048|11617708|FG001|Overall Study|Death|17
7368223|NCT01075048|11617709|FG002|Overall Study|Death|12
7368224|NCT01075048|11617707|FG000|Overall Study|Start of other or new therapy|4
7368225|NCT01075048|11617708|FG001|Overall Study|Start of other or new therapy|36
7368226|NCT01075048|11617709|FG002|Overall Study|Start of other or new therapy|46
7368227|NCT01075048|11617707|FG000|Overall Study|Withdrawal by Subject|1
7368228|NCT01075048|11617708|FG001|Overall Study|Withdrawal by Subject|6
7368229|NCT01075048|11617709|FG002|Overall Study|Withdrawal by Subject|3
7368230|NCT01075048|11617707|FG000|Overall Study|Lost to Follow-up|0
7368231|NCT01075048|11617708|FG001|Overall Study|Lost to Follow-up|1
7368232|NCT01075048|11617709|FG002|Overall Study|Lost to Follow-up|1
7368233|NCT01075074|11617723|FG000|Overall Study|Surgeon changed to open incisional case|1
7368234|NCT01075074|11617724|FG001|Overall Study|Surgeon changed to open incisional case|2
7368235|NCT01075074|11617725|FG002|Overall Study|Surgeon changed to open incisional case|2
7368236|NCT01075100|11617748|FG000|Overall Study|Adverse Event|15
7368237|NCT01075100|11617749|FG001|Overall Study|Adverse Event|18
7368238|NCT01075100|11617748|FG000|Overall Study|Patient Request|4
7368239|NCT01075100|11617749|FG001|Overall Study|Patient Request|4
7368240|NCT01075100|11617748|FG000|Overall Study|Investigator Request|2
7368241|NCT01075100|11617749|FG001|Overall Study|Investigator Request|1
7368242|NCT01075100|11617748|FG000|Overall Study|Disease Progression|25
7368243|NCT01075100|11617749|FG001|Overall Study|Disease Progression|29
7368244|NCT01075100|11617748|FG000|Overall Study|Other|3
7368245|NCT01075100|11617749|FG001|Overall Study|Other|1
7368246|NCT01075152|11617759|FG000|Overall Study|Withdrawal by Subject|1
7368247|NCT01075152|11617760|FG001|Overall Study|Withdrawal by Subject|0
7368248|NCT01075178|11617770|FG000|Subject Matching|eligible but not matched|130
7368249|NCT01075178|11617771|FG001|Subject Matching|eligible but not matched|403
7368250|NCT01075178|11617770|FG000|Subject Chart Review|died before chart review period|0
7368251|NCT01075178|11617771|FG001|Subject Chart Review|died before chart review period|2
7368252|NCT01075178|11617770|FG000|Subject Chart Review|no data collected due to site closure|3
7368253|NCT01075178|11617771|FG001|Subject Chart Review|no data collected due to site closure|4
7368254|NCT01075178|11617770|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
7368255|NCT01075178|11617771|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
7368256|NCT01075191|11617777|FG000|Overall Study|Death|1
7368257|NCT01075191|11617777|FG000|Overall Study|Intensification|3
7368258|NCT01075191|11617777|FG000|Overall Study|Co-morbidities|1
7368259|NCT01075191|11617777|FG000|Overall Study|Adverse Event|4
7368260|NCT01075191|11617777|FG000|Overall Study|Noncompliance|3
7368261|NCT01075191|11617777|FG000|Overall Study|Therapy Break|3
7368262|NCT01075191|11617777|FG000|Overall Study|Patient's Wish|2
7368263|NCT01075191|11617777|FG000|Overall Study|Unknown Reasons|1
7368264|NCT01075217|11617787|FG000|Overall Study|Adverse Event|1
7368265|NCT01075217|11617788|FG001|Overall Study|Adverse Event|1
7368266|NCT01075217|11617787|FG000|Overall Study|Physician Decision|1
7368267|NCT01075217|11617788|FG001|Overall Study|Physician Decision|0
7368268|NCT01075243|11617805|FG000|Overall Study|Lost to Follow-up|5
7368269|NCT01075243|11617806|FG001|Overall Study|Lost to Follow-up|2
7368270|NCT01075243|11617807|FG002|Overall Study|Lost to Follow-up|0
7368271|NCT01075243|11617805|FG000|Overall Study|Withdrawal by Subject|1
7368272|NCT01075243|11617806|FG001|Overall Study|Withdrawal by Subject|1
7368273|NCT01075243|11617807|FG002|Overall Study|Withdrawal by Subject|0
7368274|NCT01075256|11617820|FG000|Overall Study|Withdrawal by Subject|1
7368275|NCT01075256|11617821|FG001|Overall Study|Withdrawal by Subject|0
7368276|NCT01075256|11617822|FG002|Overall Study|Withdrawal by Subject|0
7368277|NCT01075282|11617838|FG000|Overall Study|Withdrawal by Subject|11
7368278|NCT01075282|11617839|FG001|Overall Study|Withdrawal by Subject|7
7368279|NCT01075282|11617840|FG002|Overall Study|Withdrawal by Subject|11
7368280|NCT01075282|11617838|FG000|Overall Study|Adverse Event|9
7368281|NCT01075282|11617839|FG001|Overall Study|Adverse Event|8
7460952|NCT01831765|11756560|FG002|Overall Study|Pregnancy|2
7368282|NCT01075282|11617840|FG002|Overall Study|Adverse Event|5
7368283|NCT01075282|11617838|FG000|Overall Study|Entry Criteria Not Met|3
7368284|NCT01075282|11617839|FG001|Overall Study|Entry Criteria Not Met|2
7368285|NCT01075282|11617840|FG002|Overall Study|Entry Criteria Not Met|0
7368286|NCT01075282|11617838|FG000|Overall Study|Lost to Follow-up|3
7368287|NCT01075282|11617839|FG001|Overall Study|Lost to Follow-up|3
7368288|NCT01075282|11617840|FG002|Overall Study|Lost to Follow-up|3
7368289|NCT01075282|11617838|FG000|Overall Study|Physician Decision|3
7368290|NCT01075282|11617839|FG001|Overall Study|Physician Decision|3
7368291|NCT01075282|11617840|FG002|Overall Study|Physician Decision|3
7368292|NCT01075282|11617838|FG000|Overall Study|Lack of Efficacy|1
7368293|NCT01075282|11617839|FG001|Overall Study|Lack of Efficacy|1
7368294|NCT01075282|11617840|FG002|Overall Study|Lack of Efficacy|0
7368295|NCT01075282|11617838|FG000|Overall Study|Treatment Non-compliance|1
7368296|NCT01075282|11617839|FG001|Overall Study|Treatment Non-compliance|2
7368297|NCT01075282|11617840|FG002|Overall Study|Treatment Non-compliance|2
7368298|NCT01075282|11617838|FG000|Overall Study|Protocol Violation|0
7368299|NCT01075282|11617839|FG001|Overall Study|Protocol Violation|2
7368300|NCT01075282|11617840|FG002|Overall Study|Protocol Violation|1
7368301|NCT01075282|11617838|FG000|Overall Study|Death|0
7368302|NCT01075282|11617839|FG001|Overall Study|Death|1
7368303|NCT01075282|11617840|FG002|Overall Study|Death|2
7368304|NCT01075321|11617849|FG000|Overall Study|Withdrawal by Subject|0
7368305|NCT01075321|11617850|FG001|Overall Study|Withdrawal by Subject|0
7368306|NCT01075321|11617851|FG002|Overall Study|Withdrawal by Subject|1
7368307|NCT01075321|11617852|FG003|Overall Study|Withdrawal by Subject|1
7368308|NCT01075321|11617849|FG000|Overall Study|Protocol Violation|0
7368309|NCT01075321|11617850|FG001|Overall Study|Protocol Violation|0
7368310|NCT01075321|11617851|FG002|Overall Study|Protocol Violation|1
7368311|NCT01075321|11617852|FG003|Overall Study|Protocol Violation|0
7368312|NCT01075321|11617849|FG000|Overall Study|Treatment Incomplete due to progression|1
7368313|NCT01075321|11617850|FG001|Overall Study|Treatment Incomplete due to progression|0
7368314|NCT01075321|11617851|FG002|Overall Study|Treatment Incomplete due to progression|0
7368315|NCT01075321|11617852|FG003|Overall Study|Treatment Incomplete due to progression|0
7368316|NCT01075321|11617849|FG000|Overall Study|Ineligible (miscalculated lab value)|0
7368317|NCT01075321|11617850|FG001|Overall Study|Ineligible (miscalculated lab value)|0
7368318|NCT01075321|11617851|FG002|Overall Study|Ineligible (miscalculated lab value)|0
7368319|NCT01075321|11617852|FG003|Overall Study|Ineligible (miscalculated lab value)|1
7368320|NCT01075412|11617879|FG000|Overall Study|Withdrawal by Subject|0
7368321|NCT01075412|11617880|FG001|Overall Study|Withdrawal by Subject|1
7368322|NCT01075516|11617887|FG000|Overall Study|Death|5
7368323|NCT01075516|11617888|FG001|Overall Study|Death|9
7368324|NCT01075516|11617887|FG000|Overall Study|Lost to Follow-up|10
7368325|NCT01075516|11617888|FG001|Overall Study|Lost to Follow-up|2
7368326|NCT01075516|11617887|FG000|Overall Study|Withdrawal by Subject|3
7368327|NCT01075516|11617888|FG001|Overall Study|Withdrawal by Subject|5
7368328|NCT01075646|11617898|FG000|Overall Study|Lost to Follow-up|4
7368329|NCT01075646|11617899|FG001|Overall Study|Lost to Follow-up|3
7368330|NCT01075646|11617900|FG002|Overall Study|Lost to Follow-up|1
7368331|NCT01075646|11617901|FG003|Overall Study|Lost to Follow-up|2
7368332|NCT01075685|11617913|FG000|Overall Study|Protocol Violation|9
7368333|NCT01075685|11617914|FG001|Overall Study|Protocol Violation|1
7368334|NCT01075685|11617913|FG000|Overall Study|Withdrawal by Subject|20
7368335|NCT01075685|11617914|FG001|Overall Study|Withdrawal by Subject|5
7368336|NCT01075685|11617913|FG000|Overall Study|Lost to Follow-up|563
7368337|NCT01075685|11617914|FG001|Overall Study|Lost to Follow-up|220
7368338|NCT01075763|11617922|FG000|Overall Study|Lost to Follow-up|2
7368339|NCT01075763|11617923|FG001|Overall Study|Lost to Follow-up|1
7368340|NCT01075763|11617922|FG000|Overall Study|Lack of Efficacy|0
7368341|NCT01075763|11617923|FG001|Overall Study|Lack of Efficacy|1
7368342|NCT01075763|11617922|FG000|Overall Study|Withdrawal by Subject|2
7368343|NCT01075763|11617923|FG001|Overall Study|Withdrawal by Subject|2
7368344|NCT01075815|11617931|FG000|Overall Study|Withdrawal before r-hCG administration|6
7368345|NCT01075815|11617932|FG001|Overall Study|Withdrawal before r-hCG administration|1
7368346|NCT01075815|11617931|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7368347|NCT01075815|11617932|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
7368348|NCT01075815|11617931|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
7368349|NCT01075815|11617932|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
7368350|NCT01075958|11617938|FG000|Overall Study|Blood sample could not be obtained|44
7368351|NCT01075984|11617951|FG000|Treatment Phase|Adverse Event|0
7368352|NCT01075984|11617952|FG001|Treatment Phase|Adverse Event|1
7368353|NCT01075984|11617953|FG002|Treatment Phase|Adverse Event|3
7368354|NCT01075984|11617954|FG003|Treatment Phase|Adverse Event|7
7368355|NCT01075984|11617955|FG004|Treatment Phase|Adverse Event|35
7368356|NCT01075984|11617951|FG000|Treatment Phase|Protocol Violation|0
7368357|NCT01075984|11617952|FG001|Treatment Phase|Protocol Violation|0
7368358|NCT01075984|11617953|FG002|Treatment Phase|Protocol Violation|1
7368359|NCT01075984|11617954|FG003|Treatment Phase|Protocol Violation|0
7368360|NCT01075984|11617955|FG004|Treatment Phase|Protocol Violation|3
7368361|NCT01075984|11617951|FG000|Treatment Phase|Withdrawal by Subject|0
7368362|NCT01075984|11617952|FG001|Treatment Phase|Withdrawal by Subject|0
7368363|NCT01075984|11617953|FG002|Treatment Phase|Withdrawal by Subject|2
7368364|NCT01075984|11617954|FG003|Treatment Phase|Withdrawal by Subject|0
7368365|NCT01075984|11617955|FG004|Treatment Phase|Withdrawal by Subject|15
7368366|NCT01075984|11617951|FG000|Treatment Phase|Treatment Failure|0
7368367|NCT01075984|11617952|FG001|Treatment Phase|Treatment Failure|0
7368368|NCT01075984|11617953|FG002|Treatment Phase|Treatment Failure|1
7368369|NCT01075984|11617954|FG003|Treatment Phase|Treatment Failure|0
7368370|NCT01075984|11617955|FG004|Treatment Phase|Treatment Failure|5
7368371|NCT01075984|11617951|FG000|Treatment Phase|Progression of disease|0
7368372|NCT01075984|11617952|FG001|Treatment Phase|Progression of disease|0
7368373|NCT01075984|11617953|FG002|Treatment Phase|Progression of disease|0
7368374|NCT01075984|11617954|FG003|Treatment Phase|Progression of disease|0
7368375|NCT01075984|11617955|FG004|Treatment Phase|Progression of disease|2
7368376|NCT01075984|11617951|FG000|Follow-up Phase|Protocol Violation|0
7368377|NCT01075984|11617952|FG001|Follow-up Phase|Protocol Violation|0
7368378|NCT01075984|11617953|FG002|Follow-up Phase|Protocol Violation|1
7368379|NCT01075984|11617954|FG003|Follow-up Phase|Protocol Violation|0
7368380|NCT01075984|11617955|FG004|Follow-up Phase|Protocol Violation|3
7368381|NCT01075984|11617951|FG000|Follow-up Phase|Adverse Event|0
7368382|NCT01075984|11617952|FG001|Follow-up Phase|Adverse Event|0
7368383|NCT01075984|11617953|FG002|Follow-up Phase|Adverse Event|0
7225261|NCT00065156|11434699|FG000|Overall Study|Lost to Follow-up|1
7225262|NCT00065156|11434699|FG000|Overall Study|Death|11
7225263|NCT00065156|11434699|FG000|Overall Study|Study Closed by Sponsor|2
7225264|NCT00065156|11434699|FG000|Overall Study|Disease Progression|7
7368384|NCT01075984|11617954|FG003|Follow-up Phase|Adverse Event|2
7368385|NCT01075984|11617955|FG004|Follow-up Phase|Adverse Event|27
7368386|NCT01075984|11617951|FG000|Follow-up Phase|Administrative|0
7368387|NCT01075984|11617952|FG001|Follow-up Phase|Administrative|0
7368388|NCT01075984|11617953|FG002|Follow-up Phase|Administrative|0
7368389|NCT01075984|11617954|FG003|Follow-up Phase|Administrative|0
7368390|NCT01075984|11617955|FG004|Follow-up Phase|Administrative|1
7368391|NCT01075984|11617951|FG000|Follow-up Phase|Withdrawal by Subject|0
7368392|NCT01075984|11617952|FG001|Follow-up Phase|Withdrawal by Subject|0
7368393|NCT01075984|11617953|FG002|Follow-up Phase|Withdrawal by Subject|0
7368394|NCT01075984|11617954|FG003|Follow-up Phase|Withdrawal by Subject|0
7368395|NCT01075984|11617955|FG004|Follow-up Phase|Withdrawal by Subject|10
7368396|NCT01075984|11617951|FG000|Follow-up Phase|Progression of disease|0
7368397|NCT01075984|11617952|FG001|Follow-up Phase|Progression of disease|0
7368398|NCT01075984|11617953|FG002|Follow-up Phase|Progression of disease|0
7368399|NCT01075984|11617954|FG003|Follow-up Phase|Progression of disease|0
7368400|NCT01075984|11617955|FG004|Follow-up Phase|Progression of disease|2
7368401|NCT01075984|11617951|FG000|Follow-up Phase|Treatment failure|0
7368402|NCT01075984|11617952|FG001|Follow-up Phase|Treatment failure|0
7368403|NCT01075984|11617953|FG002|Follow-up Phase|Treatment failure|0
7368404|NCT01075984|11617954|FG003|Follow-up Phase|Treatment failure|0
7368405|NCT01075984|11617955|FG004|Follow-up Phase|Treatment failure|4
7368406|NCT01076010|11617970|FG000|Overall Study|Death|15
7368407|NCT01076010|11617971|FG001|Overall Study|Death|1
7368408|NCT01076010|11617972|FG002|Overall Study|Death|0
7368409|NCT01076010|11617970|FG000|Overall Study|Adverse Event|7
7368410|NCT01076010|11617971|FG001|Overall Study|Adverse Event|2
7368411|NCT01076010|11617972|FG002|Overall Study|Adverse Event|0
7368412|NCT01076010|11617970|FG000|Overall Study|Progressive disease|90
7368413|NCT01076010|11617971|FG001|Overall Study|Progressive disease|30
7368414|NCT01076010|11617972|FG002|Overall Study|Progressive disease|1
7368415|NCT01076010|11617970|FG000|Overall Study|Lack of Efficacy|4
7368416|NCT01076010|11617971|FG001|Overall Study|Lack of Efficacy|0
7368417|NCT01076010|11617972|FG002|Overall Study|Lack of Efficacy|0
7368418|NCT01076010|11617970|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
7368419|NCT01076010|11617971|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
7368420|NCT01076010|11617972|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
7368421|NCT01076010|11617970|FG000|Overall Study|Significant Surgical Procedure|0
7368422|NCT01076010|11617971|FG001|Overall Study|Significant Surgical Procedure|1
7368423|NCT01076010|11617972|FG002|Overall Study|Significant Surgical Procedure|0
7368424|NCT01076010|11617970|FG000|Overall Study|Protocol Violation|0
7368425|NCT01076010|11617971|FG001|Overall Study|Protocol Violation|1
7368426|NCT01076010|11617972|FG002|Overall Study|Protocol Violation|0
7368427|NCT01076010|11617970|FG000|Overall Study|Noncompliance|1
7368428|NCT01076010|11617971|FG001|Overall Study|Noncompliance|1
7368429|NCT01076010|11617972|FG002|Overall Study|Noncompliance|0
7368430|NCT01076010|11617970|FG000|Overall Study|Withdrawal by Subject|3
7368431|NCT01076010|11617971|FG001|Overall Study|Withdrawal by Subject|0
7368432|NCT01076010|11617972|FG002|Overall Study|Withdrawal by Subject|1
7368433|NCT01076010|11617970|FG000|Overall Study|Other|5
7368434|NCT01076010|11617971|FG001|Overall Study|Other|2
7368435|NCT01076010|11617972|FG002|Overall Study|Other|0
7368436|NCT01076036|11617980|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
7386750|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386751|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386752|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386753|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7368437|NCT01076075|11618001|FG000|Overall Study|Adverse Event|3
7368438|NCT01076075|11618002|FG001|Overall Study|Adverse Event|9
7368439|NCT01076075|11618001|FG000|Overall Study|Lack of Efficacy|5
7368440|NCT01076075|11618002|FG001|Overall Study|Lack of Efficacy|4
7570310|NCT03483961|11947742|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570311|NCT03483961|11947743|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570312|NCT03483961|11947744|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7368441|NCT01076075|11618001|FG000|Overall Study|Lost to Follow-up|6
7368442|NCT01076075|11618002|FG001|Overall Study|Lost to Follow-up|5
7368443|NCT01076075|11618001|FG000|Overall Study|other|19
7368444|NCT01076075|11618002|FG001|Overall Study|other|9
7368445|NCT01076075|11618001|FG000|Overall Study|Protocol Violation|0
7368446|NCT01076075|11618002|FG001|Overall Study|Protocol Violation|1
7368447|NCT01076075|11618001|FG000|Overall Study|Withdrawal by Subject|8
7368448|NCT01076075|11618002|FG001|Overall Study|Withdrawal by Subject|19
7368449|NCT01076088|11618017|FG000|Overall Study|Adverse Event|1
7368450|NCT01076088|11618018|FG001|Overall Study|Adverse Event|6
7368451|NCT01076088|11618019|FG002|Overall Study|Adverse Event|3
7368452|NCT01076088|11618020|FG003|Overall Study|Adverse Event|2
7368453|NCT01076088|11618021|FG004|Overall Study|Adverse Event|3
7368454|NCT01076088|11618022|FG005|Overall Study|Adverse Event|3
7368455|NCT01076088|11618017|FG000|Overall Study|Lost to Follow-up|1
7368456|NCT01076088|11618018|FG001|Overall Study|Lost to Follow-up|1
7368457|NCT01076088|11618019|FG002|Overall Study|Lost to Follow-up|0
7368458|NCT01076088|11618020|FG003|Overall Study|Lost to Follow-up|1
7368459|NCT01076088|11618021|FG004|Overall Study|Lost to Follow-up|1
7368460|NCT01076088|11618022|FG005|Overall Study|Lost to Follow-up|2
7368461|NCT01076088|11618017|FG000|Overall Study|Non-compliance with study drug|0
7368462|NCT01076088|11618018|FG001|Overall Study|Non-compliance with study drug|0
7368463|NCT01076088|11618019|FG002|Overall Study|Non-compliance with study drug|0
7368464|NCT01076088|11618020|FG003|Overall Study|Non-compliance with study drug|1
7368465|NCT01076088|11618021|FG004|Overall Study|Non-compliance with study drug|0
7368466|NCT01076088|11618022|FG005|Overall Study|Non-compliance with study drug|0
7368467|NCT01076088|11618017|FG000|Overall Study|Physician Decision|1
7368468|NCT01076088|11618018|FG001|Overall Study|Physician Decision|3
7368469|NCT01076088|11618019|FG002|Overall Study|Physician Decision|0
7368470|NCT01076088|11618020|FG003|Overall Study|Physician Decision|1
7368471|NCT01076088|11618021|FG004|Overall Study|Physician Decision|1
7570313|NCT03483961|11947745|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
7570314|NCT03483961|11947736|FG000|Overall Study|Adverse Event|0
7570315|NCT03483961|11947737|FG001|Overall Study|Adverse Event|0
7570316|NCT03483961|11947738|FG002|Overall Study|Adverse Event|1
7368472|NCT01076088|11618022|FG005|Overall Study|Physician Decision|0
7368473|NCT01076088|11618017|FG000|Overall Study|Withdrawal by Subject|8
7368474|NCT01076088|11618018|FG001|Overall Study|Withdrawal by Subject|8
7368475|NCT01076088|11618019|FG002|Overall Study|Withdrawal by Subject|14
7368476|NCT01076088|11618020|FG003|Overall Study|Withdrawal by Subject|10
7368477|NCT01076088|11618021|FG004|Overall Study|Withdrawal by Subject|11
7368478|NCT01076088|11618022|FG005|Overall Study|Withdrawal by Subject|17
7368479|NCT01076088|11618017|FG000|Overall Study|Other protocol specified criteria|0
7368480|NCT01076088|11618018|FG001|Overall Study|Other protocol specified criteria|0
7368481|NCT01076088|11618019|FG002|Overall Study|Other protocol specified criteria|0
7368482|NCT01076088|11618020|FG003|Overall Study|Other protocol specified criteria|0
7368483|NCT01076088|11618021|FG004|Overall Study|Other protocol specified criteria|0
7368484|NCT01076088|11618022|FG005|Overall Study|Other protocol specified criteria|1
7368485|NCT01076153|11618037|FG000|Overall Study|Symptoms improved/resolved|10
7368486|NCT01076153|11618037|FG000|Overall Study|Adverse Event|1
7368487|NCT01076166|11618045|FG000|Overall Study|Adverse Event|3
7368488|NCT01076166|11618045|FG000|Overall Study|Symptoms improved/resolved|6
7368489|NCT01076179|11618052|FG000|Overall Study|Withdrawal by Subject|1
7368490|NCT01076192|11618057|FG000|Overall Study|Other|197
7368491|NCT01076205|11618062|FG000|Overall Study|Adverse Drug Reaction|299
7368492|NCT01076205|11618062|FG000|Overall Study|Lack of Effectiveness|1423
7368493|NCT01076205|11618062|FG000|Overall Study|Other Reason|1075
7368494|NCT01076205|11618062|FG000|Overall Study|Unknown Reason|71
7368495|NCT01076205|11618062|FG000|Overall Study|Lost to Follow-up|3151
7368496|NCT01076335|11618128|FG000|Overall Study|Withdrawal by Subject|3
7368497|NCT01076335|11618128|FG000|Overall Study|Withdrawal without treatment|1
7368498|NCT01076361|11618136|FG000|Overall Study|22 leads were excluded from analysis|21
7368499|NCT01076400|11618140|FG000|Overall Study|Adverse Event|2
7368500|NCT01076400|11618141|FG001|Overall Study|Adverse Event|0
7368501|NCT01076400|11618142|FG002|Overall Study|Adverse Event|0
7368502|NCT01076400|11618140|FG000|Overall Study|Progressive Disease|5
7570317|NCT03483961|11947739|FG003|Overall Study|Adverse Event|0
7570318|NCT03483961|11947740|FG004|Overall Study|Adverse Event|0
7570319|NCT03483961|11947741|FG005|Overall Study|Adverse Event|0
7368503|NCT01076400|11618141|FG001|Overall Study|Progressive Disease|0
7368504|NCT01076400|11618142|FG002|Overall Study|Progressive Disease|0
7368505|NCT01076543|11618165|FG000|Overall Study|Withdrawal by Subject|2
7368506|NCT01076543|11618166|FG001|Overall Study|Withdrawal by Subject|0
7368507|NCT01076543|11618167|FG002|Overall Study|Withdrawal by Subject|0
7368508|NCT01076543|11618168|FG003|Overall Study|Withdrawal by Subject|0
7368509|NCT01076543|11618169|FG004|Overall Study|Withdrawal by Subject|0
7570320|NCT03483961|11947742|FG006|Overall Study|Adverse Event|0
7570321|NCT03483961|11947743|FG007|Overall Study|Adverse Event|0
7570322|NCT03483961|11947744|FG008|Overall Study|Adverse Event|0
7570323|NCT03483961|11947745|FG009|Overall Study|Adverse Event|0
7570324|NCT03484273|11947766|FG000|Overall Study|Equipment Malfunction|1
7570325|NCT03484273|11947766|FG000|Overall Study|Data excluded from analysis|1
7570326|NCT03484429|11947780|FG000|Overall Study|Withdrawal by Subject|1
7570327|NCT03484429|11947781|FG001|Overall Study|Withdrawal by Subject|0
7570328|NCT03484429|11947780|FG000|Overall Study|Adverse Event|2
7570329|NCT03484429|11947781|FG001|Overall Study|Adverse Event|0
7570330|NCT03485222|11947789|FG000|Overall Study|Death|0
7570331|NCT03485222|11947790|FG001|Overall Study|Death|1
7570332|NCT03485222|11947789|FG000|Overall Study|Lost to Follow-up|2
7570333|NCT03485222|11947790|FG001|Overall Study|Lost to Follow-up|1
7570334|NCT03485495|11947798|FG000|Overall Study|Non-compliance with inclusion criteria|1
7570335|NCT03485495|11947799|FG001|Overall Study|Non-compliance with inclusion criteria|0
7570336|NCT03486392|11947814|FG000|Overall Study|Lost to Follow-up|0
7570337|NCT03486392|11947815|FG001|Overall Study|Lost to Follow-up|0
7570338|NCT03486392|11947816|FG002|Overall Study|Lost to Follow-up|8
7570339|NCT03486392|11947817|FG003|Overall Study|Lost to Follow-up|5
7570340|NCT03486392|11947818|FG004|Overall Study|Lost to Follow-up|2
7570341|NCT03486392|11947814|FG000|Overall Study|Withdrawal by Subject|3
7570342|NCT03486392|11947815|FG001|Overall Study|Withdrawal by Subject|0
7570343|NCT03486392|11947816|FG002|Overall Study|Withdrawal by Subject|6
7570344|NCT03486392|11947817|FG003|Overall Study|Withdrawal by Subject|4
7570345|NCT03486392|11947818|FG004|Overall Study|Withdrawal by Subject|1
7570346|NCT03486392|11947814|FG000|Overall Study|Death|0
7570347|NCT03486392|11947815|FG001|Overall Study|Death|0
7570348|NCT03486392|11947816|FG002|Overall Study|Death|0
7570349|NCT03486392|11947817|FG003|Overall Study|Death|0
7570350|NCT03486392|11947818|FG004|Overall Study|Death|1
7570351|NCT03486834|11947833|FG000|Overall Study|Withdrawal by Subject|46
7570352|NCT03486834|11947834|FG001|Overall Study|Withdrawal by Subject|46
7570353|NCT03486834|11947835|FG002|Overall Study|Withdrawal by Subject|52
7570354|NCT03486834|11947833|FG000|Overall Study|Adverse Event|8
7570355|NCT03486834|11947834|FG001|Overall Study|Adverse Event|7
7570356|NCT03486834|11947835|FG002|Overall Study|Adverse Event|0
7570357|NCT03486834|11947833|FG000|Overall Study|Lost to Follow-up|41
7570358|NCT03486834|11947834|FG001|Overall Study|Lost to Follow-up|24
7570359|NCT03486834|11947835|FG002|Overall Study|Lost to Follow-up|39
7570360|NCT03486834|11947833|FG000|Overall Study|Non-compliance with Study Drug|2
7570361|NCT03486834|11947834|FG001|Overall Study|Non-compliance with Study Drug|2
7570362|NCT03486834|11947835|FG002|Overall Study|Non-compliance with Study Drug|0
7570363|NCT03486834|11947833|FG000|Overall Study|Physician Decision|5
7570364|NCT03486834|11947834|FG001|Overall Study|Physician Decision|2
7570365|NCT03486834|11947835|FG002|Overall Study|Physician Decision|3
7570366|NCT03486834|11947833|FG000|Overall Study|Pregnancy|10
7570367|NCT03486834|11947834|FG001|Overall Study|Pregnancy|12
7570368|NCT03486834|11947835|FG002|Overall Study|Pregnancy|12
7570369|NCT03486834|11947833|FG000|Overall Study|Protocol Deviation|2
7570370|NCT03486834|11947834|FG001|Overall Study|Protocol Deviation|3
7570371|NCT03486834|11947835|FG002|Overall Study|Protocol Deviation|3
7570372|NCT03486834|11947833|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7570373|NCT03486834|11947834|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7570374|NCT03486834|11947835|FG002|Overall Study|Withdrawal by Parent/Guardian|2
7570375|NCT03486834|11947833|FG000|Overall Study|Randomized but not treated|4
7570376|NCT03486834|11947834|FG001|Overall Study|Randomized but not treated|4
7570377|NCT03486834|11947835|FG002|Overall Study|Randomized but not treated|1
7570378|NCT03487445|11947930|FG000|Randomization|Not treated for administrative reasons|1
7570379|NCT03487445|11947931|FG001|Randomization|Not treated for administrative reasons|0
7570380|NCT03487549|11947939|FG000|Overall Study|Protocol Violation|0
7570381|NCT03487549|11947940|FG001|Overall Study|Protocol Violation|1
7570382|NCT03487549|11947939|FG000|Overall Study|Lost to Follow-up|2
7570383|NCT03487549|11947940|FG001|Overall Study|Lost to Follow-up|1
7570384|NCT03487549|11947939|FG000|Overall Study|Withdrawal by Subject|2
7570385|NCT03487549|11947940|FG001|Overall Study|Withdrawal by Subject|0
7570386|NCT03487848|11947959|FG000|Overall Study|Lost to Follow-up|1
7570387|NCT03488108|11947965|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
7570388|NCT03488108|11947966|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
7570389|NCT03488108|11947965|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
7570390|NCT03488108|11947966|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
7570391|NCT03488225|11947974|FG000|Overall Study|Off Protocol Therapy|2
7570392|NCT03488225|11947974|FG000|Overall Study|Stem Cell Transplant|2
7570393|NCT03488238|11947978|FG000|Overall Study|Equipment malfunction|1
7570394|NCT03488238|11947978|FG000|Overall Study|Adverse Event|1
7570395|NCT03488927|11947998|FG000|Overall Study|Withdrawal by Subject|44
7570396|NCT03488927|11947999|FG001|Overall Study|Withdrawal by Subject|118
7570397|NCT03488927|11948000|FG002|Overall Study|Withdrawal by Subject|217
7570398|NCT03489304|11948008|FG000|Overall Study|Lost to Follow-up|4
7570399|NCT03489343|11948019|FG000|Overall Study|Documented progressive disease|1
7368510|NCT01076543|11618170|FG005|Overall Study|Withdrawal by Subject|0
7368511|NCT01076647|11618187|FG000|Overall Study|Adverse Event|4
7368512|NCT01076647|11618188|FG001|Overall Study|Adverse Event|1
7368513|NCT01076647|11618187|FG000|Overall Study|Lack of Efficacy|0
7368514|NCT01076647|11618188|FG001|Overall Study|Lack of Efficacy|1
7368515|NCT01076647|11618187|FG000|Overall Study|Protocol Violation|7
7368516|NCT01076647|11618188|FG001|Overall Study|Protocol Violation|9
7368517|NCT01076647|11618187|FG000|Overall Study|Withdrawal criteria|2
7368518|NCT01076647|11618188|FG001|Overall Study|Withdrawal criteria|2
7368519|NCT01076647|11618187|FG000|Overall Study|Unclassified|12
7368520|NCT01076647|11618188|FG001|Overall Study|Unclassified|12
7368521|NCT01076959|11618211|FG000|Overall Study|Adverse Event|767
7368522|NCT01076959|11618211|FG000|Overall Study|Lack of Efficacy|849
7368523|NCT01076959|11618211|FG000|Overall Study|Non-compliance|274
7368524|NCT01076959|11618211|FG000|Overall Study|Lost to Follow-up|241
7368525|NCT01076959|11618211|FG000|Overall Study|Other|119
7368526|NCT01077024|11618250|FG000|Overall Study|Lost to Follow-up|20
7368527|NCT01077024|11618251|FG001|Overall Study|Lost to Follow-up|14
7368528|NCT01077024|11618250|FG000|Overall Study|Withdrawal by Subject|0
7368529|NCT01077024|11618251|FG001|Overall Study|Withdrawal by Subject|2
7368530|NCT01077024|11618250|FG000|Overall Study|Incarcerated|7
7368531|NCT01077024|11618251|FG001|Overall Study|Incarcerated|8
7368532|NCT01077024|11618250|FG000|Overall Study|Other|4
7368533|NCT01077024|11618251|FG001|Overall Study|Other|4
7368534|NCT01077050|11618257|FG000|Overall Study|Subjects signed ICF could not be located|1
7368535|NCT01077050|11618257|FG000|Overall Study|Screen failure|8
7368536|NCT01077063|11618263|FG000|Overall Study|Adverse Event|3
7368537|NCT01077063|11618264|FG001|Overall Study|Adverse Event|0
7368538|NCT01077063|11618263|FG000|Overall Study|Death|1
7368539|NCT01077063|11618264|FG001|Overall Study|Death|1
7368540|NCT01077063|11618263|FG000|Overall Study|Withdrawal by Subject|0
7368541|NCT01077063|11618264|FG001|Overall Study|Withdrawal by Subject|2
7368542|NCT01077076|11618270|FG000|First Intervention|Withdrawal by Subject|1
7368543|NCT01077076|11618271|FG001|First Intervention|Withdrawal by Subject|0
7368544|NCT01077076|11618272|FG002|First Intervention|Withdrawal by Subject|0
7368545|NCT01077076|11618273|FG003|First Intervention|Withdrawal by Subject|0
7368546|NCT01077076|11618274|FG004|First Intervention|Withdrawal by Subject|0
7368547|NCT01077076|11618275|FG005|First Intervention|Withdrawal by Subject|0
7368548|NCT01077076|11618270|FG000|Third Intervention|Death in the participant's family|0
7368549|NCT01077076|11618271|FG001|Third Intervention|Death in the participant's family|0
7368550|NCT01077076|11618272|FG002|Third Intervention|Death in the participant's family|0
7368551|NCT01077076|11618273|FG003|Third Intervention|Death in the participant's family|0
7368552|NCT01077076|11618274|FG004|Third Intervention|Death in the participant's family|0
7368553|NCT01077076|11618275|FG005|Third Intervention|Death in the participant's family|1
7368554|NCT01077128|11618283|FG000|Overall Study|Adverse Event|8
7368555|NCT01077128|11618283|FG000|Overall Study|Lack of Efficacy|1
7368556|NCT01077128|11618283|FG000|Overall Study|Disease exacerbation|1
7368557|NCT01077128|11618283|FG000|Overall Study|Adverse event and consent withdrawal|1
7368558|NCT01077128|11618283|FG000|Overall Study|Adverse event and disease exacerbation|1
7368559|NCT01077128|11618283|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
7570400|NCT03489343|11948020|FG001|Overall Study|Documented progressive disease|0
7570401|NCT03489343|11948021|FG002|Overall Study|Documented progressive disease|3
7570402|NCT03489343|11948022|FG003|Overall Study|Documented progressive disease|1
7570403|NCT03489343|11948023|FG004|Overall Study|Documented progressive disease|3
7570404|NCT03489343|11948024|FG005|Overall Study|Documented progressive disease|5
7570405|NCT03489343|11948025|FG006|Overall Study|Documented progressive disease|4
7570406|NCT03489343|11948019|FG000|Overall Study|Adverse Event|0
7368560|NCT01077128|11618283|FG000|Overall Study|Other|54
7570407|NCT03489343|11948020|FG001|Overall Study|Adverse Event|1
7570408|NCT03489343|11948021|FG002|Overall Study|Adverse Event|0
7368561|NCT01077154|11618339|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
7368562|NCT01077154|11618340|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
7368563|NCT01077154|11618339|FG000|Overall Study|Withdrawal by Subject|369
7368564|NCT01077154|11618340|FG001|Overall Study|Withdrawal by Subject|385
7368565|NCT01077154|11618339|FG000|Overall Study|Death|215
7368566|NCT01077154|11618340|FG001|Overall Study|Death|214
7368567|NCT01077154|11618339|FG000|Overall Study|Lost to Follow-up|43
7368568|NCT01077154|11618340|FG001|Overall Study|Lost to Follow-up|35
7368569|NCT01077154|11618339|FG000|Overall Study|Noncompliance|22
7368570|NCT01077154|11618340|FG001|Overall Study|Noncompliance|20
7368571|NCT01077154|11618339|FG000|Overall Study|Disease Progression|18
7368572|NCT01077154|11618340|FG001|Overall Study|Disease Progression|20
7368573|NCT01077154|11618339|FG000|Overall Study|Ineligibility Determined|10
7570409|NCT03489343|11948022|FG003|Overall Study|Adverse Event|0
7368574|NCT01077154|11618340|FG001|Overall Study|Ineligibility Determined|14
7368575|NCT01077154|11618339|FG000|Overall Study|Other|14
7368576|NCT01077154|11618340|FG001|Overall Study|Other|11
7368577|NCT01077154|11618339|FG000|Overall Study|Adverse Event|9
7368578|NCT01077154|11618340|FG001|Overall Study|Adverse Event|9
7368579|NCT01077154|11618339|FG000|Overall Study|Administrative Decision|1
7368580|NCT01077154|11618340|FG001|Overall Study|Administrative Decision|6
7368581|NCT01077154|11618339|FG000|Overall Study|Protocol Deviation|1
7368582|NCT01077154|11618340|FG001|Overall Study|Protocol Deviation|0
7368583|NCT01077193|11618346|FG000|Overall Study|Lost to Follow-up|1
7368584|NCT01077193|11618346|FG000|Overall Study|Withdrawal by Subject|2
7368585|NCT01077193|11618346|FG000|Overall Study|Lack of Efficacy|1
7368586|NCT01077193|11618346|FG000|Overall Study|Study Terminated by Sponsor|40
7368587|NCT01077258|11618350|FG000|Overall Study|Lost to Follow-up|1390
7368588|NCT01077258|11618350|FG000|Overall Study|Adverse drug reaction|218
7368589|NCT01077258|11618350|FG000|Overall Study|Lack of Efficacy|663
7368590|NCT01077258|11618350|FG000|Overall Study|Clinical remission|37
7368591|NCT01077258|11618350|FG000|Overall Study|Other reasons|260
7368592|NCT01077271|11618367|FG000|Overall Study|Parental desire|8
7368593|NCT01077271|11618367|FG000|Overall Study|Screen failure, did not take palivizumab|4
7368594|NCT01077271|11618367|FG000|Overall Study|Noncompliance|2
7368595|NCT01077271|11618367|FG000|Overall Study|Quota used up (insurance reimb issue)|2
7368596|NCT01077271|11618367|FG000|Overall Study|Changed doctors|2
7368597|NCT01077271|11618367|FG000|Overall Study|Parents thought too many injections|2
7368598|NCT01077271|11618367|FG000|Overall Study|End of RSV season nearly reached|1
7368599|NCT01077271|11618367|FG000|Overall Study|Mother unconvinced of the necessity|1
7368600|NCT01077284|11618382|FG000|Overall Study|Adverse Event|2
7368601|NCT01077284|11618383|FG001|Overall Study|Adverse Event|0
7368602|NCT01077284|11618384|FG002|Overall Study|Adverse Event|1
7368603|NCT01077284|11618382|FG000|Overall Study|Lost to Follow-up|1
7368604|NCT01077284|11618383|FG001|Overall Study|Lost to Follow-up|2
7368605|NCT01077284|11618384|FG002|Overall Study|Lost to Follow-up|0
7368606|NCT01077284|11618382|FG000|Overall Study|Withdrawal by Subject|2
7368607|NCT01077284|11618383|FG001|Overall Study|Withdrawal by Subject|3
7368608|NCT01077284|11618384|FG002|Overall Study|Withdrawal by Subject|1
7368609|NCT01077284|11618382|FG000|Overall Study|Other|0
7368610|NCT01077284|11618383|FG001|Overall Study|Other|0
7368611|NCT01077284|11618384|FG002|Overall Study|Other|1
7368612|NCT01077323|11618409|FG000|Overall Study|<9 months enroll before drug dispensed|11226
7368613|NCT01077323|11618410|FG001|Overall Study|<9 months enroll before drug dispensed|263954
7368614|NCT01077323|11618411|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
7368615|NCT01077323|11618409|FG000|Overall Study|Dispensing of drug in baseline period|0
7368616|NCT01077323|11618410|FG001|Overall Study|Dispensing of drug in baseline period|120229
7368617|NCT01077323|11618411|FG002|Overall Study|Dispensing of drug in baseline period|256446
7368618|NCT01077323|11618409|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
7368619|NCT01077323|11618410|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
7368620|NCT01077323|11618411|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
7368621|NCT01077362|11618422|FG000|Overall Study|Lack of Efficacy|13
7368622|NCT01077362|11618423|FG001|Overall Study|Lack of Efficacy|8
7368623|NCT01077362|11618424|FG002|Overall Study|Lack of Efficacy|10
7368624|NCT01077362|11618422|FG000|Overall Study|Lost to Follow-up|1
7368625|NCT01077362|11618423|FG001|Overall Study|Lost to Follow-up|0
7368626|NCT01077362|11618424|FG002|Overall Study|Lost to Follow-up|3
7368627|NCT01077362|11618422|FG000|Overall Study|Adverse Event|12
7368628|NCT01077362|11618423|FG001|Overall Study|Adverse Event|7
7368629|NCT01077362|11618424|FG002|Overall Study|Adverse Event|4
7368630|NCT01077362|11618422|FG000|Overall Study|Withdrawal by Subject|5
7368631|NCT01077362|11618423|FG001|Overall Study|Withdrawal by Subject|3
7368632|NCT01077362|11618424|FG002|Overall Study|Withdrawal by Subject|5
7368633|NCT01077362|11618422|FG000|Overall Study|Other|0
7368634|NCT01077362|11618423|FG001|Overall Study|Other|1
7368635|NCT01077362|11618424|FG002|Overall Study|Other|2
7368636|NCT01077375|11618439|FG000|Overall Study|Adverse Event|2
7368637|NCT01077375|11618440|FG001|Overall Study|Adverse Event|15
7368638|NCT01077375|11618439|FG000|Overall Study|Lack of Efficacy|6
7368639|NCT01077375|11618440|FG001|Overall Study|Lack of Efficacy|8
7368640|NCT01077375|11618439|FG000|Overall Study|Withdrawal by Subject|0
7368641|NCT01077375|11618440|FG001|Overall Study|Withdrawal by Subject|6
7368642|NCT01077375|11618439|FG000|Overall Study|Lost to Follow-up|2
7368643|NCT01077375|11618440|FG001|Overall Study|Lost to Follow-up|5
7368644|NCT01077375|11618439|FG000|Overall Study|Other Reason|0
7368645|NCT01077375|11618440|FG001|Overall Study|Other Reason|1
7368646|NCT01077518|11618459|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
7368647|NCT01077518|11618460|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
7368648|NCT01077518|11618461|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
7368649|NCT01077518|11618459|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
7368650|NCT01077518|11618460|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
7368651|NCT01077518|11618461|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
7368652|NCT01077518|11618459|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
7368653|NCT01077518|11618460|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
7368654|NCT01077518|11618461|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
7368655|NCT01077518|11618459|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
7368656|NCT01077518|11618460|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
7368657|NCT01077518|11618461|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
7368658|NCT01077518|11618459|FG000|Optional Ofa Phase|Physician Decision|0
7368659|NCT01077518|11618460|FG001|Optional Ofa Phase|Physician Decision|0
7368660|NCT01077518|11618461|FG002|Optional Ofa Phase|Physician Decision|1
7368661|NCT01077518|11618459|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
7368662|NCT01077518|11618460|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
7368663|NCT01077518|11618461|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
7368664|NCT01077518|11618459|FG000|Optional Ofa Phase|Withdrawal by Subject|0
7368665|NCT01077518|11618460|FG001|Optional Ofa Phase|Withdrawal by Subject|0
7368666|NCT01077518|11618461|FG002|Optional Ofa Phase|Withdrawal by Subject|3
7368667|NCT01077544|11618472|FG000|Overall Study|New Cancer Therapy|3
7368668|NCT01077544|11618473|FG001|Overall Study|New Cancer Therapy|3
7368669|NCT01077544|11618472|FG000|Overall Study|Adverse Event|0
7368670|NCT01077544|11618473|FG001|Overall Study|Adverse Event|1
7368671|NCT01077544|11618472|FG000|Overall Study|Disease Progression|0
7368672|NCT01077544|11618473|FG001|Overall Study|Disease Progression|1
7368673|NCT01077622|11618523|FG000|Overall Study|Physician Decision|2
7368674|NCT01077622|11618523|FG000|Overall Study|Withdrawal by Subject|1
7368675|NCT01077713|11618529|FG000|Overall Study|Withdrawal by Subject|1
7368676|NCT01077713|11618530|FG001|Overall Study|Withdrawal by Subject|2
7368677|NCT01077713|11618529|FG000|Overall Study|Progressive Disease (PD)|0
7368678|NCT01077713|11618530|FG001|Overall Study|Progressive Disease (PD)|1
7368679|NCT01077713|11618529|FG000|Overall Study|Death|28
7368680|NCT01077713|11618530|FG001|Overall Study|Death|29
7368681|NCT01077713|11618529|FG000|Overall Study|Lost to Follow-up|1
7368682|NCT01077713|11618530|FG001|Overall Study|Lost to Follow-up|1
7368683|NCT01077713|11618529|FG000|Overall Study|Adverse Event|2
7368684|NCT01077713|11618530|FG001|Overall Study|Adverse Event|1
7368685|NCT01077713|11618529|FG000|Overall Study|Other|4
7368686|NCT01077713|11618530|FG001|Overall Study|Other|2
7368687|NCT01077739|11618538|FG000|Overall Study|Premature withdrawal|1
7368688|NCT01077739|11618539|FG001|Overall Study|Premature withdrawal|3
7368689|NCT01077739|11618538|FG000|Overall Study|Withdrawal by Subject|1
7368690|NCT01077739|11618539|FG001|Overall Study|Withdrawal by Subject|0
7368691|NCT01077739|11618538|FG000|Overall Study|Death|0
7368692|NCT01077739|11618539|FG001|Overall Study|Death|3
7368693|NCT01077739|11618538|FG000|Overall Study|Unacceptable toxicity|1
7368694|NCT01077739|11618539|FG001|Overall Study|Unacceptable toxicity|2
7368695|NCT01077739|11618538|FG000|Overall Study|Other|2
7368696|NCT01077739|11618539|FG001|Overall Study|Other|2
7368697|NCT01077804|11618545|FG000|Overall Study|Unreachable|102
7368698|NCT01077804|11618545|FG000|Overall Study|Refused to continue|79
7368699|NCT01077804|11618545|FG000|Overall Study|Other|18
7368700|NCT01077960|11618604|FG000|Overall Study|Adverse Event|6
7368701|NCT01077960|11618604|FG000|Overall Study|Protocol Violation|3
7368702|NCT01077960|11618604|FG000|Overall Study|Lost to Follow-up|5
7368703|NCT01077960|11618604|FG000|Overall Study|Subject decision|1
7368704|NCT01077960|11618604|FG000|Overall Study|Reason unspecified|1
7368705|NCT01078090|11618623|FG000|Overall Study|Lost to Follow-up|2363
7368706|NCT01078090|11618623|FG000|Overall Study|Adverse drug reaction (ADR)|453
7368707|NCT01078090|11618623|FG000|Overall Study|Lack of Efficacy|1193
7368708|NCT01078090|11618623|FG000|Overall Study|ADR and lack of efficacy|61
7368709|NCT01078090|11618623|FG000|Overall Study|Other|523
7368710|NCT01078116|11618641|FG000|Overall Study|Lost to Follow-up|17
7368711|NCT01078116|11618641|FG000|Overall Study|Adverse Event|5
7368712|NCT01078116|11618641|FG000|Overall Study|Withdrawal by Subject|8
7368713|NCT01078116|11618641|FG000|Overall Study|Lack of effectiveness|15
7368714|NCT01078116|11618641|FG000|Overall Study|Case report form not completed|3
7368715|NCT01078155|11618645|FG000|Overall Study|Adverse Event|7
7368716|NCT01078155|11618645|FG000|Overall Study|Lack of Efficacy|16
7368717|NCT01078155|11618645|FG000|Overall Study|Participant's Decision|6
7368718|NCT01078155|11618645|FG000|Overall Study|Lost to Follow-up|15
7368719|NCT01078168|11618651|FG000|Overall Study|Physician Decision|0
7368720|NCT01078168|11618652|FG001|Overall Study|Physician Decision|1
7368721|NCT01078298|11618711|FG000|Overall Study|Lost to Follow-up|12
7368722|NCT01078298|11618712|FG001|Overall Study|Lost to Follow-up|13
7368723|NCT01078298|11618711|FG000|Overall Study|Withdrawal by Subject|31
7368724|NCT01078298|11618712|FG001|Overall Study|Withdrawal by Subject|33
7368725|NCT01078298|11618711|FG000|Overall Study|Protocol Violation|6
7368726|NCT01078298|11618712|FG001|Overall Study|Protocol Violation|6
7368727|NCT01078298|11618711|FG000|Overall Study|Adverse Event|6
7368728|NCT01078298|11618712|FG001|Overall Study|Adverse Event|5
7368729|NCT01078298|11618711|FG000|Overall Study|Death|2
7368730|NCT01078298|11618712|FG001|Overall Study|Death|0
7368731|NCT01078298|11618711|FG000|Overall Study|Did not meet entrance criteria|0
7368732|NCT01078298|11618712|FG001|Overall Study|Did not meet entrance criteria|1
7368733|NCT01078298|11618711|FG000|Overall Study|Other|24
7368734|NCT01078298|11618712|FG001|Overall Study|Other|32
7368735|NCT01078389|11618751|FG000|Overall Study|Adverse Event|10
7368736|NCT01078389|11618752|FG001|Overall Study|Adverse Event|6
7368737|NCT01078389|11618751|FG000|Overall Study|Major Protocol Deviation|2
7368738|NCT01078389|11618752|FG001|Overall Study|Major Protocol Deviation|0
7368739|NCT01078389|11618751|FG000|Overall Study|Lost to Follow-up|23
7368740|NCT01078389|11618752|FG001|Overall Study|Lost to Follow-up|23
7368741|NCT01078389|11618751|FG000|Overall Study|Voluntary Withdrawal|20
7368742|NCT01078389|11618752|FG001|Overall Study|Voluntary Withdrawal|36
7368743|NCT01078389|11618751|FG000|Overall Study|Other|9
7368744|NCT01078389|11618752|FG001|Overall Study|Other|2
7368745|NCT01078441|11618775|FG000|Overall Study|Withdrawal by Subject|1
7368746|NCT01078545|11618779|FG000|Overall Study|Lost to Follow-up|13
7368747|NCT01078545|11618779|FG000|Overall Study|Physician Decision|6
7368748|NCT01078545|11618779|FG000|Overall Study|Withdrawal by Subject|3
7368749|NCT01078545|11618779|FG000|Overall Study|Death|3
7368750|NCT01078545|11618779|FG000|Overall Study|Participant moved to another physician|1
7368751|NCT01078571|11618796|FG000|Overall Study|Adverse Event|36
7368752|NCT01078571|11618796|FG000|Overall Study|Lack of effectiveness|36
7368753|NCT01078571|11618796|FG000|Overall Study|Reason not reported|21
7368754|NCT01078571|11618796|FG000|Overall Study|Withdrawal by Subject|12
7368755|NCT01078571|11618796|FG000|Overall Study|Lost to Follow-up|8
7368756|NCT01078571|11618796|FG000|Overall Study|Protocol Violation|2
7570410|NCT03489343|11948023|FG004|Overall Study|Adverse Event|0
7570411|NCT03489343|11948024|FG005|Overall Study|Adverse Event|1
7570412|NCT03489343|11948025|FG006|Overall Study|Adverse Event|0
7570413|NCT03489343|11948019|FG000|Overall Study|Withdrawal by Subject|0
7570414|NCT03489343|11948020|FG001|Overall Study|Withdrawal by Subject|0
7570415|NCT03489343|11948021|FG002|Overall Study|Withdrawal by Subject|0
7570416|NCT03489343|11948022|FG003|Overall Study|Withdrawal by Subject|1
7570417|NCT03489343|11948023|FG004|Overall Study|Withdrawal by Subject|0
7570418|NCT03489343|11948024|FG005|Overall Study|Withdrawal by Subject|1
7570419|NCT03489343|11948025|FG006|Overall Study|Withdrawal by Subject|1
7570420|NCT03489343|11948019|FG000|Overall Study|Clinical progression|0
7570421|NCT03489343|11948020|FG001|Overall Study|Clinical progression|0
7570422|NCT03489343|11948021|FG002|Overall Study|Clinical progression|0
7368757|NCT01078584|11618805|FG000|Overall Study|Final Status Unknown|1073
7368758|NCT01078584|11618805|FG000|Overall Study|Lost to Follow-up|670
7368759|NCT01078584|11618805|FG000|Overall Study|Non-serious Adverse Event|577
7570423|NCT03489343|11948022|FG003|Overall Study|Clinical progression|1
7368760|NCT01078584|11618805|FG000|Overall Study|Withdrawal of Consent|244
7368761|NCT01078584|11618805|FG000|Overall Study|Physician Withdrew from Study|90
7570424|NCT03489343|11948023|FG004|Overall Study|Clinical progression|0
7570425|NCT03489343|11948024|FG005|Overall Study|Clinical progression|0
7368762|NCT01078584|11618805|FG000|Overall Study|Non-compliance|67
7368763|NCT01078584|11618805|FG000|Overall Study|Blood Pressure Controlled|49
7368764|NCT01078584|11618805|FG000|Overall Study|Physician Switched Medication|26
7368765|NCT01078584|11618805|FG000|Overall Study|Physician Discontinued Patient|12
7368766|NCT01078584|11618805|FG000|Overall Study|Lack of Efficacy|98
7368767|NCT01078584|11618805|FG000|Overall Study|Protocol Violation|75
7368768|NCT01078584|11618805|FG000|Overall Study|Serious Adverse Event|27
7368769|NCT01078584|11618805|FG000|Overall Study|Multiple Reasons|2
7368770|NCT01078623|11618822|FG000|Treatment Period 1|Adverse Event|1
7368771|NCT01078623|11618823|FG001|Treatment Period 1|Adverse Event|1
7368772|NCT01078623|11618824|FG002|Treatment Period 1|Adverse Event|1
7368773|NCT01078623|11618825|FG003|Treatment Period 1|Adverse Event|0
7368774|NCT01078623|11618826|FG004|Treatment Period 1|Adverse Event|0
7368775|NCT01078623|11618827|FG005|Treatment Period 1|Adverse Event|0
7368776|NCT01078623|11618828|FG006|Treatment Period 1|Adverse Event|1
7368777|NCT01078623|11618829|FG007|Treatment Period 1|Adverse Event|0
7368778|NCT01078623|11618830|FG008|Treatment Period 1|Adverse Event|1
7368779|NCT01078623|11618831|FG009|Treatment Period 1|Adverse Event|1
7570426|NCT03489343|11948025|FG006|Overall Study|Clinical progression|1
7368780|NCT01078623|11618832|FG010|Treatment Period 1|Adverse Event|0
7368781|NCT01078623|11618833|FG011|Treatment Period 1|Adverse Event|0
7460953|NCT01831765|11756558|FG000|Overall Study|Death|0
7570427|NCT03489369|11948045|FG000|Overall Study|Documented Progressive Disease|3
7570428|NCT03489369|11948046|FG001|Overall Study|Documented Progressive Disease|2
7570429|NCT03489369|11948047|FG002|Overall Study|Documented Progressive Disease|3
7570430|NCT03489369|11948048|FG003|Overall Study|Documented Progressive Disease|6
7570431|NCT03489369|11948045|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
7570432|NCT03489369|11948046|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
7570433|NCT03489369|11948047|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
7570434|NCT03489369|11948048|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
7570435|NCT03489551|11948058|FG000|Overall Study|Withdrawal by Subject|2
7368782|NCT01078623|11618834|FG012|Treatment Period 1|Adverse Event|0
7368783|NCT01078623|11618835|FG013|Treatment Period 1|Adverse Event|0
7368784|NCT01078623|11618836|FG014|Treatment Period 1|Adverse Event|0
7368785|NCT01078623|11618837|FG015|Treatment Period 1|Adverse Event|0
7368786|NCT01078623|11618838|FG016|Treatment Period 1|Adverse Event|0
7368787|NCT01078623|11618839|FG017|Treatment Period 1|Adverse Event|0
7368788|NCT01078623|11618840|FG018|Treatment Period 1|Adverse Event|0
7368789|NCT01078623|11618841|FG019|Treatment Period 1|Adverse Event|0
7368790|NCT01078623|11618822|FG000|Treatment Period 1|Withdrawal by Subject|0
7368791|NCT01078623|11618823|FG001|Treatment Period 1|Withdrawal by Subject|0
7368792|NCT01078623|11618824|FG002|Treatment Period 1|Withdrawal by Subject|0
7368793|NCT01078623|11618825|FG003|Treatment Period 1|Withdrawal by Subject|0
7368794|NCT01078623|11618826|FG004|Treatment Period 1|Withdrawal by Subject|0
7368795|NCT01078623|11618827|FG005|Treatment Period 1|Withdrawal by Subject|0
7368796|NCT01078623|11618828|FG006|Treatment Period 1|Withdrawal by Subject|0
7368797|NCT01078623|11618829|FG007|Treatment Period 1|Withdrawal by Subject|1
7368798|NCT01078623|11618830|FG008|Treatment Period 1|Withdrawal by Subject|0
7368799|NCT01078623|11618831|FG009|Treatment Period 1|Withdrawal by Subject|0
7368800|NCT01078623|11618832|FG010|Treatment Period 1|Withdrawal by Subject|1
7368801|NCT01078623|11618833|FG011|Treatment Period 1|Withdrawal by Subject|0
7368802|NCT01078623|11618834|FG012|Treatment Period 1|Withdrawal by Subject|0
7368803|NCT01078623|11618835|FG013|Treatment Period 1|Withdrawal by Subject|0
7368804|NCT01078623|11618836|FG014|Treatment Period 1|Withdrawal by Subject|0
7368805|NCT01078623|11618837|FG015|Treatment Period 1|Withdrawal by Subject|0
7368806|NCT01078623|11618838|FG016|Treatment Period 1|Withdrawal by Subject|0
7368807|NCT01078623|11618839|FG017|Treatment Period 1|Withdrawal by Subject|0
7368808|NCT01078623|11618840|FG018|Treatment Period 1|Withdrawal by Subject|0
7368809|NCT01078623|11618841|FG019|Treatment Period 1|Withdrawal by Subject|0
7368810|NCT01078623|11618822|FG000|Treatment Period 1|Protocol Violation|0
7368811|NCT01078623|11618823|FG001|Treatment Period 1|Protocol Violation|0
7368812|NCT01078623|11618824|FG002|Treatment Period 1|Protocol Violation|0
7368813|NCT01078623|11618825|FG003|Treatment Period 1|Protocol Violation|0
7368814|NCT01078623|11618826|FG004|Treatment Period 1|Protocol Violation|0
7368815|NCT01078623|11618827|FG005|Treatment Period 1|Protocol Violation|1
7368816|NCT01078623|11618828|FG006|Treatment Period 1|Protocol Violation|0
7368817|NCT01078623|11618829|FG007|Treatment Period 1|Protocol Violation|0
7368818|NCT01078623|11618830|FG008|Treatment Period 1|Protocol Violation|0
7368819|NCT01078623|11618831|FG009|Treatment Period 1|Protocol Violation|0
7368820|NCT01078623|11618832|FG010|Treatment Period 1|Protocol Violation|0
7368821|NCT01078623|11618833|FG011|Treatment Period 1|Protocol Violation|0
7368822|NCT01078623|11618834|FG012|Treatment Period 1|Protocol Violation|0
7368823|NCT01078623|11618835|FG013|Treatment Period 1|Protocol Violation|0
7368824|NCT01078623|11618836|FG014|Treatment Period 1|Protocol Violation|0
7368825|NCT01078623|11618837|FG015|Treatment Period 1|Protocol Violation|0
7368826|NCT01078623|11618838|FG016|Treatment Period 1|Protocol Violation|0
7368827|NCT01078623|11618839|FG017|Treatment Period 1|Protocol Violation|0
7368828|NCT01078623|11618840|FG018|Treatment Period 1|Protocol Violation|0
7368829|NCT01078623|11618841|FG019|Treatment Period 1|Protocol Violation|0
7368830|NCT01078623|11618822|FG000|Treatment Period 2|Adverse Event|0
7368831|NCT01078623|11618823|FG001|Treatment Period 2|Adverse Event|0
7368832|NCT01078623|11618824|FG002|Treatment Period 2|Adverse Event|0
7368833|NCT01078623|11618825|FG003|Treatment Period 2|Adverse Event|0
7368834|NCT01078623|11618826|FG004|Treatment Period 2|Adverse Event|0
7368835|NCT01078623|11618827|FG005|Treatment Period 2|Adverse Event|0
7368836|NCT01078623|11618828|FG006|Treatment Period 2|Adverse Event|1
7368837|NCT01078623|11618829|FG007|Treatment Period 2|Adverse Event|0
7368838|NCT01078623|11618830|FG008|Treatment Period 2|Adverse Event|0
7368839|NCT01078623|11618831|FG009|Treatment Period 2|Adverse Event|0
7368840|NCT01078623|11618832|FG010|Treatment Period 2|Adverse Event|0
7368841|NCT01078623|11618833|FG011|Treatment Period 2|Adverse Event|0
7368842|NCT01078623|11618834|FG012|Treatment Period 2|Adverse Event|0
7368843|NCT01078623|11618835|FG013|Treatment Period 2|Adverse Event|0
7368844|NCT01078623|11618836|FG014|Treatment Period 2|Adverse Event|0
7368845|NCT01078623|11618837|FG015|Treatment Period 2|Adverse Event|0
7368846|NCT01078623|11618838|FG016|Treatment Period 2|Adverse Event|0
7368847|NCT01078623|11618839|FG017|Treatment Period 2|Adverse Event|0
7368848|NCT01078623|11618840|FG018|Treatment Period 2|Adverse Event|1
7368849|NCT01078623|11618841|FG019|Treatment Period 2|Adverse Event|0
7368850|NCT01078623|11618822|FG000|Treatment Period 2|Withdrawal by Subject|0
7368851|NCT01078623|11618823|FG001|Treatment Period 2|Withdrawal by Subject|0
7368852|NCT01078623|11618824|FG002|Treatment Period 2|Withdrawal by Subject|0
7368853|NCT01078623|11618825|FG003|Treatment Period 2|Withdrawal by Subject|0
7368854|NCT01078623|11618826|FG004|Treatment Period 2|Withdrawal by Subject|0
7368855|NCT01078623|11618827|FG005|Treatment Period 2|Withdrawal by Subject|1
7368856|NCT01078623|11618828|FG006|Treatment Period 2|Withdrawal by Subject|0
7368857|NCT01078623|11618829|FG007|Treatment Period 2|Withdrawal by Subject|0
7368858|NCT01078623|11618830|FG008|Treatment Period 2|Withdrawal by Subject|0
7368859|NCT01078623|11618831|FG009|Treatment Period 2|Withdrawal by Subject|0
7368860|NCT01078623|11618832|FG010|Treatment Period 2|Withdrawal by Subject|0
7368861|NCT01078623|11618833|FG011|Treatment Period 2|Withdrawal by Subject|0
7368862|NCT01078623|11618834|FG012|Treatment Period 2|Withdrawal by Subject|0
7368863|NCT01078623|11618835|FG013|Treatment Period 2|Withdrawal by Subject|0
7368864|NCT01078623|11618836|FG014|Treatment Period 2|Withdrawal by Subject|0
7368865|NCT01078623|11618837|FG015|Treatment Period 2|Withdrawal by Subject|0
7368866|NCT01078623|11618838|FG016|Treatment Period 2|Withdrawal by Subject|0
7368867|NCT01078623|11618839|FG017|Treatment Period 2|Withdrawal by Subject|0
7368868|NCT01078623|11618840|FG018|Treatment Period 2|Withdrawal by Subject|0
7368869|NCT01078623|11618841|FG019|Treatment Period 2|Withdrawal by Subject|0
7368870|NCT01078623|11618822|FG000|Treatment Period 3|Adverse Event|0
7368871|NCT01078623|11618823|FG001|Treatment Period 3|Adverse Event|0
7368872|NCT01078623|11618824|FG002|Treatment Period 3|Adverse Event|0
7368873|NCT01078623|11618825|FG003|Treatment Period 3|Adverse Event|0
7368874|NCT01078623|11618826|FG004|Treatment Period 3|Adverse Event|1
7368875|NCT01078623|11618827|FG005|Treatment Period 3|Adverse Event|0
7368876|NCT01078623|11618828|FG006|Treatment Period 3|Adverse Event|0
7368877|NCT01078623|11618829|FG007|Treatment Period 3|Adverse Event|0
7368878|NCT01078623|11618830|FG008|Treatment Period 3|Adverse Event|0
7368879|NCT01078623|11618831|FG009|Treatment Period 3|Adverse Event|0
7368880|NCT01078623|11618832|FG010|Treatment Period 3|Adverse Event|0
7368881|NCT01078623|11618833|FG011|Treatment Period 3|Adverse Event|0
7368882|NCT01078623|11618834|FG012|Treatment Period 3|Adverse Event|0
7368883|NCT01078623|11618835|FG013|Treatment Period 3|Adverse Event|1
7368884|NCT01078623|11618836|FG014|Treatment Period 3|Adverse Event|0
7368885|NCT01078623|11618837|FG015|Treatment Period 3|Adverse Event|0
7368886|NCT01078623|11618838|FG016|Treatment Period 3|Adverse Event|0
7368887|NCT01078623|11618839|FG017|Treatment Period 3|Adverse Event|0
7368888|NCT01078623|11618840|FG018|Treatment Period 3|Adverse Event|0
7368889|NCT01078623|11618841|FG019|Treatment Period 3|Adverse Event|0
7368890|NCT01078623|11618822|FG000|Treatment Period 4|Adverse Event|0
7368891|NCT01078623|11618823|FG001|Treatment Period 4|Adverse Event|0
7368892|NCT01078623|11618824|FG002|Treatment Period 4|Adverse Event|1
7368893|NCT01078623|11618825|FG003|Treatment Period 4|Adverse Event|0
7368894|NCT01078623|11618826|FG004|Treatment Period 4|Adverse Event|0
7368895|NCT01078623|11618827|FG005|Treatment Period 4|Adverse Event|0
7368896|NCT01078623|11618828|FG006|Treatment Period 4|Adverse Event|0
7368897|NCT01078623|11618829|FG007|Treatment Period 4|Adverse Event|0
7368898|NCT01078623|11618830|FG008|Treatment Period 4|Adverse Event|0
7368899|NCT01078623|11618831|FG009|Treatment Period 4|Adverse Event|0
7368900|NCT01078623|11618832|FG010|Treatment Period 4|Adverse Event|0
7368901|NCT01078623|11618833|FG011|Treatment Period 4|Adverse Event|0
7368902|NCT01078623|11618834|FG012|Treatment Period 4|Adverse Event|0
7368903|NCT01078623|11618835|FG013|Treatment Period 4|Adverse Event|0
7368904|NCT01078623|11618836|FG014|Treatment Period 4|Adverse Event|0
7368905|NCT01078623|11618837|FG015|Treatment Period 4|Adverse Event|0
7368906|NCT01078623|11618838|FG016|Treatment Period 4|Adverse Event|0
7368907|NCT01078623|11618839|FG017|Treatment Period 4|Adverse Event|0
7368908|NCT01078623|11618840|FG018|Treatment Period 4|Adverse Event|0
7368909|NCT01078623|11618841|FG019|Treatment Period 4|Adverse Event|0
7368910|NCT01078623|11618822|FG000|Treatment Period 4|Withdrawal by Subject|0
7570436|NCT03489720|11948064|FG000|Overall Study|Withdrawal by Subject|2
7570437|NCT03489720|11948065|FG001|Overall Study|Withdrawal by Subject|0
7570438|NCT03489863|11948086|FG000|Overall Study|Withdrawal by Subject|0
7368911|NCT01078623|11618823|FG001|Treatment Period 4|Withdrawal by Subject|0
7368912|NCT01078623|11618824|FG002|Treatment Period 4|Withdrawal by Subject|0
7368913|NCT01078623|11618825|FG003|Treatment Period 4|Withdrawal by Subject|0
7570439|NCT03489863|11948087|FG001|Overall Study|Withdrawal by Subject|1
7570440|NCT03490032|11948104|FG000|Overall Study|family issue (child custody)|1
7570441|NCT03490032|11948105|FG001|Overall Study|family issue (child custody)|0
7570442|NCT03490032|11948106|FG002|Overall Study|family issue (child custody)|0
7368914|NCT01078623|11618826|FG004|Treatment Period 4|Withdrawal by Subject|0
7368915|NCT01078623|11618827|FG005|Treatment Period 4|Withdrawal by Subject|0
7368916|NCT01078623|11618828|FG006|Treatment Period 4|Withdrawal by Subject|0
7368917|NCT01078623|11618829|FG007|Treatment Period 4|Withdrawal by Subject|0
7368918|NCT01078623|11618830|FG008|Treatment Period 4|Withdrawal by Subject|0
7368919|NCT01078623|11618831|FG009|Treatment Period 4|Withdrawal by Subject|0
7368920|NCT01078623|11618832|FG010|Treatment Period 4|Withdrawal by Subject|0
7368921|NCT01078623|11618833|FG011|Treatment Period 4|Withdrawal by Subject|0
7368922|NCT01078623|11618834|FG012|Treatment Period 4|Withdrawal by Subject|0
7368923|NCT01078623|11618835|FG013|Treatment Period 4|Withdrawal by Subject|0
7368924|NCT01078623|11618836|FG014|Treatment Period 4|Withdrawal by Subject|0
7368925|NCT01078623|11618837|FG015|Treatment Period 4|Withdrawal by Subject|1
7368926|NCT01078623|11618838|FG016|Treatment Period 4|Withdrawal by Subject|0
7368927|NCT01078623|11618839|FG017|Treatment Period 4|Withdrawal by Subject|0
7368928|NCT01078623|11618840|FG018|Treatment Period 4|Withdrawal by Subject|0
7368929|NCT01078623|11618841|FG019|Treatment Period 4|Withdrawal by Subject|0
7368930|NCT01078675|11618855|FG000|Overall Study|Withdrawal by Subject|7
7368931|NCT01078675|11618856|FG001|Overall Study|Withdrawal by Subject|3
7368932|NCT01078675|11618855|FG000|Overall Study|Protocol Violation|56
7368933|NCT01078675|11618856|FG001|Overall Study|Protocol Violation|0
7368934|NCT01078675|11618855|FG000|Overall Study|Provided in CRF for specific reasons|2
7368935|NCT01078675|11618856|FG001|Overall Study|Provided in CRF for specific reasons|3
7368936|NCT01078675|11618855|FG000|Overall Study|Adverse Event|3
7368937|NCT01078675|11618856|FG001|Overall Study|Adverse Event|0
7368938|NCT01078805|11618871|FG000|Overall Study|Clinically significant abnormal lab|5
7368939|NCT01078805|11618871|FG000|Overall Study|Death|134
7368940|NCT01078805|11618871|FG000|Overall Study|Lost to Follow-up|676
7368941|NCT01078805|11618871|FG000|Overall Study|Physician Decision|169
7368942|NCT01078805|11618871|FG000|Overall Study|Serious adverse event|26
7368943|NCT01078805|11618871|FG000|Overall Study|Sponsor decision|46
7368944|NCT01078805|11618871|FG000|Overall Study|Withdrawal by Subject|739
7368945|NCT01078805|11618871|FG000|Overall Study|Other|173
7368946|NCT01078805|11618871|FG000|Overall Study|Didn't take study drug|82
7368947|NCT01078922|11618896|FG000|Overall Study|Adverse Event|1
7368948|NCT01078974|11618901|FG000|Overall Study|Adverse Event|3
7368949|NCT01079130|11618911|FG000|Overall Study|Adverse Event|1
7368950|NCT01079130|11618912|FG001|Overall Study|Adverse Event|1
7368951|NCT01079130|11618913|FG002|Overall Study|Adverse Event|0
7368952|NCT01079130|11618914|FG003|Overall Study|Adverse Event|1
7368953|NCT01079130|11618915|FG004|Overall Study|Adverse Event|5
7368954|NCT01079130|11618916|FG005|Overall Study|Adverse Event|1
7368955|NCT01079130|11618911|FG000|Overall Study|Administrative problems|1
7368956|NCT01079130|11618912|FG001|Overall Study|Administrative problems|3
7368957|NCT01079130|11618913|FG002|Overall Study|Administrative problems|0
7368958|NCT01079130|11618914|FG003|Overall Study|Administrative problems|0
7368959|NCT01079130|11618915|FG004|Overall Study|Administrative problems|0
7368960|NCT01079130|11618916|FG005|Overall Study|Administrative problems|1
7368961|NCT01079130|11618911|FG000|Overall Study|Withdrawal by Subject|0
7368962|NCT01079130|11618912|FG001|Overall Study|Withdrawal by Subject|1
7368963|NCT01079130|11618913|FG002|Overall Study|Withdrawal by Subject|0
7368964|NCT01079130|11618914|FG003|Overall Study|Withdrawal by Subject|0
7368965|NCT01079130|11618915|FG004|Overall Study|Withdrawal by Subject|1
7368966|NCT01079130|11618916|FG005|Overall Study|Withdrawal by Subject|3
7368967|NCT01079130|11618911|FG000|Overall Study|Protocol deviation|0
7368968|NCT01079130|11618912|FG001|Overall Study|Protocol deviation|2
7368969|NCT01079130|11618913|FG002|Overall Study|Protocol deviation|1
7368970|NCT01079130|11618914|FG003|Overall Study|Protocol deviation|2
7368971|NCT01079130|11618915|FG004|Overall Study|Protocol deviation|0
7368972|NCT01079130|11618916|FG005|Overall Study|Protocol deviation|0
7368973|NCT01079130|11618911|FG000|Overall Study|Abnormal test procedure result(s)|0
7368974|NCT01079130|11618912|FG001|Overall Study|Abnormal test procedure result(s)|0
7368975|NCT01079130|11618913|FG002|Overall Study|Abnormal test procedure result(s)|0
7368976|NCT01079130|11618914|FG003|Overall Study|Abnormal test procedure result(s)|0
7368977|NCT01079130|11618915|FG004|Overall Study|Abnormal test procedure result(s)|1
7368978|NCT01079130|11618916|FG005|Overall Study|Abnormal test procedure result(s)|0
7368979|NCT01079130|11618911|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7368980|NCT01079130|11618912|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7368981|NCT01079130|11618913|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7368982|NCT01079130|11618914|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7368983|NCT01079130|11618915|FG004|Overall Study|Unsatisfactory therapeutic effect|0
7368984|NCT01079130|11618916|FG005|Overall Study|Unsatisfactory therapeutic effect|0
7368985|NCT01079130|11618911|FG000|Overall Study|Lost to Follow-up|0
7460954|NCT01831765|11756559|FG001|Overall Study|Death|1
7460955|NCT01831765|11756560|FG002|Overall Study|Death|1
7460956|NCT01831765|11756558|FG000|Overall Study|Other, site closed|1
7460957|NCT01831765|11756559|FG001|Overall Study|Other, site closed|1
7460958|NCT01831765|11756560|FG002|Overall Study|Other, site closed|0
7460959|NCT01831765|11756558|FG000|Overall Study|Adverse Event|5
7460960|NCT01831765|11756559|FG001|Overall Study|Adverse Event|3
7460961|NCT01831765|11756560|FG002|Overall Study|Adverse Event|3
7460962|NCT01831765|11756558|FG000|Overall Study|Withdrawal by Subject|22
7460963|NCT01831765|11756559|FG001|Overall Study|Withdrawal by Subject|7
7460964|NCT01831765|11756560|FG002|Overall Study|Withdrawal by Subject|17
7460965|NCT01831765|11756558|FG000|Overall Study|Withdrawal criteria|12
7460966|NCT01831765|11756559|FG001|Overall Study|Withdrawal criteria|10
7460967|NCT01831765|11756560|FG002|Overall Study|Withdrawal criteria|16
7460968|NCT01831765|11756558|FG000|Overall Study|Lost to Follow-up|2
7460969|NCT01831765|11756559|FG001|Overall Study|Lost to Follow-up|3
7460970|NCT01831765|11756560|FG002|Overall Study|Lost to Follow-up|3
7460971|NCT01831791|11756570|FG000|Overall Study|Withdrawal by Subject|10
7460972|NCT01831804|11756583|FG000|Overall Study|Adverse Event|0
7460973|NCT01831804|11756584|FG001|Overall Study|Adverse Event|0
7460974|NCT01831804|11756585|FG002|Overall Study|Adverse Event|0
7460975|NCT01831804|11756586|FG003|Overall Study|Adverse Event|0
7460976|NCT01831804|11756587|FG004|Overall Study|Adverse Event|0
7460977|NCT01831804|11756588|FG005|Overall Study|Adverse Event|0
7460978|NCT01831804|11756589|FG006|Overall Study|Adverse Event|1
7460979|NCT01831804|11756590|FG007|Overall Study|Adverse Event|0
7460980|NCT01831804|11756591|FG008|Overall Study|Adverse Event|1
7460981|NCT01831804|11756583|FG000|Overall Study|Protocol Violation|0
7460982|NCT01831804|11756584|FG001|Overall Study|Protocol Violation|0
7460983|NCT01831804|11756585|FG002|Overall Study|Protocol Violation|2
7460984|NCT01831804|11756586|FG003|Overall Study|Protocol Violation|0
7460985|NCT01831804|11756587|FG004|Overall Study|Protocol Violation|0
7460986|NCT01831804|11756588|FG005|Overall Study|Protocol Violation|0
7460987|NCT01831804|11756589|FG006|Overall Study|Protocol Violation|0
7460988|NCT01831804|11756590|FG007|Overall Study|Protocol Violation|0
7460989|NCT01831804|11756591|FG008|Overall Study|Protocol Violation|0
7460990|NCT01831804|11756583|FG000|Overall Study|Protocol defined stopping criteria|1
7460991|NCT01831804|11756584|FG001|Overall Study|Protocol defined stopping criteria|1
7460992|NCT01831804|11756585|FG002|Overall Study|Protocol defined stopping criteria|3
7460993|NCT01831804|11756586|FG003|Overall Study|Protocol defined stopping criteria|0
7460994|NCT01831804|11756587|FG004|Overall Study|Protocol defined stopping criteria|1
7460995|NCT01831804|11756588|FG005|Overall Study|Protocol defined stopping criteria|0
7460996|NCT01831804|11756589|FG006|Overall Study|Protocol defined stopping criteria|0
7460997|NCT01831804|11756590|FG007|Overall Study|Protocol defined stopping criteria|0
7460998|NCT01831804|11756591|FG008|Overall Study|Protocol defined stopping criteria|0
7460999|NCT01831804|11756583|FG000|Overall Study|Lost to Follow-up|0
7461000|NCT01831804|11756584|FG001|Overall Study|Lost to Follow-up|0
7461001|NCT01831804|11756585|FG002|Overall Study|Lost to Follow-up|1
7461002|NCT01831804|11756586|FG003|Overall Study|Lost to Follow-up|0
7461003|NCT01831804|11756587|FG004|Overall Study|Lost to Follow-up|0
7461004|NCT01831804|11756588|FG005|Overall Study|Lost to Follow-up|0
7461005|NCT01831804|11756589|FG006|Overall Study|Lost to Follow-up|0
7461006|NCT01831804|11756590|FG007|Overall Study|Lost to Follow-up|0
7461007|NCT01831804|11756591|FG008|Overall Study|Lost to Follow-up|1
7461008|NCT01831804|11756583|FG000|Overall Study|Investigator discretion|0
7461009|NCT01831804|11756584|FG001|Overall Study|Investigator discretion|0
7461010|NCT01831804|11756585|FG002|Overall Study|Investigator discretion|0
7461011|NCT01831804|11756586|FG003|Overall Study|Investigator discretion|0
7461012|NCT01831804|11756587|FG004|Overall Study|Investigator discretion|1
7461013|NCT01831804|11756588|FG005|Overall Study|Investigator discretion|0
7461014|NCT01831804|11756589|FG006|Overall Study|Investigator discretion|0
7461015|NCT01831804|11756590|FG007|Overall Study|Investigator discretion|1
7461016|NCT01831804|11756591|FG008|Overall Study|Investigator discretion|0
7461017|NCT01831804|11756583|FG000|Overall Study|Withdrew Consent|0
7461018|NCT01831804|11756584|FG001|Overall Study|Withdrew Consent|1
7461019|NCT01831804|11756585|FG002|Overall Study|Withdrew Consent|0
7368986|NCT01079130|11618912|FG001|Overall Study|Lost to Follow-up|0
7368987|NCT01079130|11618913|FG002|Overall Study|Lost to Follow-up|0
7368988|NCT01079130|11618914|FG003|Overall Study|Lost to Follow-up|0
7368989|NCT01079130|11618915|FG004|Overall Study|Lost to Follow-up|1
7368990|NCT01079130|11618916|FG005|Overall Study|Lost to Follow-up|0
7368991|NCT01079182|11618951|FG000|Overall Study|Lost to Follow-up|1634
7368992|NCT01079182|11618951|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
7368993|NCT01079182|11618951|FG000|Overall Study|Lack of Efficacy|514
7368994|NCT01079182|11618951|FG000|Overall Study|ADR and Lack of Effectiveness|39
7368995|NCT01079182|11618951|FG000|Overall Study|Reasons not Evaluated|271
7368996|NCT01079195|11618955|FG000|Overall Study|No Documentation of Tarka Therapy|739
7368997|NCT01079195|11618955|FG000|Overall Study|No Documentation Available|437
7461020|NCT01831804|11756586|FG003|Overall Study|Withdrew Consent|0
7570443|NCT03490981|11948139|FG000|Overall Study|Lost to Follow-up|1
7461021|NCT01831804|11756587|FG004|Overall Study|Withdrew Consent|0
7461022|NCT01831804|11756588|FG005|Overall Study|Withdrew Consent|0
7461023|NCT01831804|11756589|FG006|Overall Study|Withdrew Consent|0
7461024|NCT01831804|11756590|FG007|Overall Study|Withdrew Consent|2
7461025|NCT01831804|11756591|FG008|Overall Study|Withdrew Consent|0
7461026|NCT01831817|11756624|FG000|Overall Study|Lost to Follow-up|1
7461027|NCT01831817|11756625|FG001|Overall Study|Lost to Follow-up|0
7461028|NCT01831817|11756626|FG002|Overall Study|Lost to Follow-up|0
7461029|NCT01831817|11756627|FG003|Overall Study|Lost to Follow-up|0
7461030|NCT01831817|11756624|FG000|Overall Study|Withdrawl of Consent|3
7461031|NCT01831817|11756625|FG001|Overall Study|Withdrawl of Consent|0
7461032|NCT01831817|11756626|FG002|Overall Study|Withdrawl of Consent|0
7461033|NCT01831817|11756627|FG003|Overall Study|Withdrawl of Consent|0
7461034|NCT01831856|11756639|FG000|Overall Study|Adverse Event|5
7461035|NCT01831856|11756640|FG001|Overall Study|Adverse Event|8
7461036|NCT01831856|11756639|FG000|Overall Study|Lack of Efficacy|13
7461037|NCT01831856|11756640|FG001|Overall Study|Lack of Efficacy|11
7461038|NCT01831856|11756639|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
7461039|NCT01831856|11756640|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
7461040|NCT01832038|11756677|FG000|Overall Study|Death|5
7461041|NCT01832038|11756677|FG000|Overall Study|Adverse Event|50
7461042|NCT01832038|11756677|FG000|Overall Study|Lack of Efficacy|81
7461043|NCT01832038|11756677|FG000|Overall Study|Protocol Violation|7
7461044|NCT01832038|11756677|FG000|Overall Study|Lost to Follow-up|10
7461045|NCT01832038|11756677|FG000|Overall Study|Withdrawal by Subject|49
7461046|NCT01832038|11756677|FG000|Overall Study|Visit non-compliance|2
7461047|NCT01832038|11756677|FG000|Overall Study|Subject refused to return visit|2
7461048|NCT01832038|11756677|FG000|Overall Study|Not convenient to come back to site|2
7461049|NCT01832038|11756677|FG000|Overall Study|Participant was asked to quit|5
7461050|NCT01832038|11756677|FG000|Overall Study|Back home|1
7461051|NCT01832038|11756677|FG000|Overall Study|Pregnancy|1
7461052|NCT01832038|11756677|FG000|Overall Study|Low compliance|3
7461053|NCT01832038|11756677|FG000|Overall Study|Prohibit procedure|2
7461054|NCT01832038|11756677|FG000|Overall Study|Not possible to visit the hospital|1
7461055|NCT01832038|11756677|FG000|Overall Study|Changes of implementation system|3
7461056|NCT01832038|11756677|FG000|Overall Study|Plan to pregnancy|7
7461057|NCT01832038|11756677|FG000|Overall Study|Bad mood and has suicidal thought|1
7461058|NCT01832038|11756677|FG000|Overall Study|Prohibited concomitant medication|1
7461059|NCT01832038|11756677|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
7461060|NCT01832038|11756677|FG000|Overall Study|Subject considered the efficacy was poor|1
7461061|NCT01832155|11756713|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
7461062|NCT01832155|11756714|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
7461063|NCT01832155|11756713|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
7461064|NCT01832155|11756714|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
7461065|NCT01832480|11756737|FG000|Overall Study|Lost to Follow-up|33
7461066|NCT01832480|11756738|FG001|Overall Study|Lost to Follow-up|30
7461067|NCT01832480|11756737|FG000|Overall Study|Withdrawal by Subject|0
7461068|NCT01832480|11756738|FG001|Overall Study|Withdrawal by Subject|2
7461069|NCT01832480|11756737|FG000|Overall Study|post randomization ineligible|8
7461070|NCT01832480|11756738|FG001|Overall Study|post randomization ineligible|10
7461071|NCT01832493|11756744|FG000|Overall Study|Physician Decision|2
7461072|NCT01832493|11756744|FG000|Overall Study|Protocol Violation|4
7461073|NCT01832493|11756744|FG000|Overall Study|Unable to place LV lead|2
7461074|NCT01832532|11756768|FG000|Overall Study|Withdrawal by Subject|5
7461075|NCT01832532|11756769|FG001|Overall Study|Withdrawal by Subject|2
7461076|NCT01832727|11756788|FG000|Overall Study|Adverse Event|4
7461077|NCT01832727|11756789|FG001|Overall Study|Adverse Event|6
7461078|NCT01832727|11756790|FG002|Overall Study|Adverse Event|1
7461079|NCT01832727|11756791|FG003|Overall Study|Adverse Event|0
7570444|NCT03490981|11948140|FG001|Overall Study|Lost to Follow-up|2
7461080|NCT01832727|11756792|FG004|Overall Study|Adverse Event|1
7461081|NCT01832727|11756793|FG005|Overall Study|Adverse Event|1
7461082|NCT01832727|11756794|FG006|Overall Study|Adverse Event|2
7461083|NCT01832727|11756795|FG007|Overall Study|Adverse Event|1
7461084|NCT01832727|11756796|FG008|Overall Study|Adverse Event|9
7461085|NCT01832727|11756788|FG000|Overall Study|Disease progression|3
7368998|NCT01079195|11618955|FG000|Overall Study|Adverse Event|157
7368999|NCT01079195|11618955|FG000|Overall Study|Reason Unknown|39
7369000|NCT01079195|11618955|FG000|Overall Study|Withdrawal by Subject|18
7369001|NCT01079195|11618955|FG000|Overall Study|Financial Reasons|15
7369002|NCT01079195|11618955|FG000|Overall Study|Lack of Effectiveness|12
7369003|NCT01079195|11618955|FG000|Overall Study|Physician Decision|4
7369004|NCT01079195|11618955|FG000|Overall Study|Improved Status of Participant|4
7369005|NCT01079195|11618955|FG000|Overall Study|No Follow-up Documentation Available|4
7369006|NCT01079195|11618955|FG000|Overall Study|Non-compliance|2
7386754|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
7386755|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386756|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386757|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
7386758|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386759|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386760|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386761|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386762|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
7386763|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
7386764|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386765|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
7386766|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386767|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386768|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386769|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386770|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386771|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
7386772|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
7386773|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
7386774|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
7386775|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
7386776|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
7386777|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
7386778|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
7386779|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
7386780|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
7386781|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
7386782|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7386783|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7386784|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
7386785|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7386786|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7386787|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7386788|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
7386789|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7386790|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
7386791|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7386792|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
7386793|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
7386794|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7386795|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7386796|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7386797|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
7386798|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
7386799|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
7386800|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Death|0
7386801|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Death|0
7386802|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Death|1
7386803|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Death|0
7386804|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Death|0
7386805|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Death|0
7386806|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Death|0
7386807|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Death|0
7386808|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Death|1
7386809|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386810|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386811|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386812|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386813|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386814|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386815|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386816|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
7386817|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
7386818|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7386819|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7386820|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
7386821|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7386822|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7369007|NCT01079234|11618962|FG000|Main: Week 0 to 26|Adverse Event|5
7369008|NCT01079234|11618963|FG001|Main: Week 0 to 26|Adverse Event|4
7369009|NCT01079234|11618964|FG002|Main: Week 0 to 26|Adverse Event|1
7369010|NCT01079234|11618965|FG003|Main: Week 0 to 26|Adverse Event|0
7369011|NCT01079234|11618962|FG000|Main: Week 0 to 26|Lack of Efficacy|2
7369012|NCT01079234|11618963|FG001|Main: Week 0 to 26|Lack of Efficacy|1
7369013|NCT01079234|11618964|FG002|Main: Week 0 to 26|Lack of Efficacy|1
7369014|NCT01079234|11618965|FG003|Main: Week 0 to 26|Lack of Efficacy|0
7369015|NCT01079234|11618962|FG000|Main: Week 0 to 26|Protocol Violation|6
7369016|NCT01079234|11618963|FG001|Main: Week 0 to 26|Protocol Violation|2
7369017|NCT01079234|11618964|FG002|Main: Week 0 to 26|Protocol Violation|4
7369018|NCT01079234|11618965|FG003|Main: Week 0 to 26|Protocol Violation|0
7369019|NCT01079234|11618962|FG000|Main: Week 0 to 26|Withdrawal criteria|6
7369020|NCT01079234|11618963|FG001|Main: Week 0 to 26|Withdrawal criteria|6
7369021|NCT01079234|11618964|FG002|Main: Week 0 to 26|Withdrawal criteria|2
7369022|NCT01079234|11618965|FG003|Main: Week 0 to 26|Withdrawal criteria|0
7369023|NCT01079234|11618962|FG000|Main: Week 0 to 26|Unclassified|7
7369024|NCT01079234|11618963|FG001|Main: Week 0 to 26|Unclassified|13
7369025|NCT01079234|11618964|FG002|Main: Week 0 to 26|Unclassified|4
7369026|NCT01079234|11618965|FG003|Main: Week 0 to 26|Unclassified|0
7369027|NCT01079234|11618962|FG000|Extension: Week 27 to 52|Adverse Event|0
7369028|NCT01079234|11618963|FG001|Extension: Week 27 to 52|Adverse Event|0
7369029|NCT01079234|11618964|FG002|Extension: Week 27 to 52|Adverse Event|1
7369030|NCT01079234|11618965|FG003|Extension: Week 27 to 52|Adverse Event|0
7369031|NCT01079234|11618962|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
7369032|NCT01079234|11618963|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
7369033|NCT01079234|11618964|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
7369034|NCT01079234|11618965|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
7369035|NCT01079234|11618962|FG000|Extension: Week 27 to 52|Protocol Violation|0
7369036|NCT01079234|11618963|FG001|Extension: Week 27 to 52|Protocol Violation|0
7369037|NCT01079234|11618964|FG002|Extension: Week 27 to 52|Protocol Violation|2
7369038|NCT01079234|11618965|FG003|Extension: Week 27 to 52|Protocol Violation|5
7369039|NCT01079234|11618962|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
7369040|NCT01079234|11618963|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
7369041|NCT01079234|11618964|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
7369042|NCT01079234|11618965|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
7369043|NCT01079234|11618962|FG000|Extension: Week 27 to 52|Unclassified|0
7369044|NCT01079234|11618963|FG001|Extension: Week 27 to 52|Unclassified|0
7369045|NCT01079234|11618964|FG002|Extension: Week 27 to 52|Unclassified|4
7369046|NCT01079234|11618965|FG003|Extension: Week 27 to 52|Unclassified|7
7369047|NCT01079663|11619000|FG000|Overall Study|Adverse Event|0
7369048|NCT01079663|11619001|FG001|Overall Study|Adverse Event|2
7369049|NCT01079663|11619000|FG000|Overall Study|Protocol Violation|0
7369050|NCT01079663|11619001|FG001|Overall Study|Protocol Violation|2
7369051|NCT01079741|11619012|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7369052|NCT01079741|11619013|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
7369053|NCT01079741|11619014|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7369054|NCT01079741|11619015|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7369055|NCT01079741|11619016|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
7369056|NCT01079741|11619012|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7369057|NCT01079741|11619013|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7369058|NCT01079741|11619014|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7369059|NCT01079741|11619015|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
7369060|NCT01079741|11619016|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
7369061|NCT01079806|11619030|FG000|Day 1 to Week 96|Adverse Event|0
7369062|NCT01079806|11619031|FG001|Day 1 to Week 96|Adverse Event|3
7369063|NCT01079806|11619030|FG000|Day 1 to Week 96|Withdrawal by Subject|3
7369064|NCT01079806|11619031|FG001|Day 1 to Week 96|Withdrawal by Subject|2
7369065|NCT01079806|11619030|FG000|Day 1 to Week 96|Pregnancy|0
7369066|NCT01079806|11619031|FG001|Day 1 to Week 96|Pregnancy|1
7369067|NCT01079806|11619030|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
7369068|NCT01079806|11619031|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
7369069|NCT01079806|11619030|FG000|Day 1 to Week 96|Lost to Follow-up|1
7369070|NCT01079806|11619031|FG001|Day 1 to Week 96|Lost to Follow-up|0
7369071|NCT01079806|11619030|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
7369072|NCT01079806|11619031|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
7369073|NCT01079806|11619030|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
7369074|NCT01079806|11619031|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
7369075|NCT01079806|11619030|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
7369076|NCT01079806|11619031|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
7369077|NCT01079806|11619030|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
7369078|NCT01079806|11619031|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
7369079|NCT01079806|11619030|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7369080|NCT01079806|11619031|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
7369081|NCT01079832|11619039|FG000|Overall Study|Withdrawal by Subject|1
7369082|NCT01079936|11619047|FG000|Phase I: MTD|First Remission Status|2
7369083|NCT01079936|11619048|FG001|Phase I: MTD|First Remission Status|0
7369084|NCT01079936|11619049|FG002|Phase I: MTD|First Remission Status|0
7369085|NCT01079936|11619050|FG003|Phase I: MTD|First Remission Status|0
7369086|NCT01079936|11619051|FG004|Phase I: MTD|First Remission Status|0
7369087|NCT01079936|11619047|FG000|Phase I: MTD|No Stem Cell Transplantation|2
7369088|NCT01079936|11619048|FG001|Phase I: MTD|No Stem Cell Transplantation|0
7369089|NCT01079936|11619049|FG002|Phase I: MTD|No Stem Cell Transplantation|0
7369090|NCT01079936|11619050|FG003|Phase I: MTD|No Stem Cell Transplantation|0
7369091|NCT01079936|11619051|FG004|Phase I: MTD|No Stem Cell Transplantation|0
7369092|NCT01079936|11619047|FG000|Phase II|Adverse Event|0
7369093|NCT01079936|11619048|FG001|Phase II|Adverse Event|0
7369094|NCT01079936|11619049|FG002|Phase II|Adverse Event|1
7369095|NCT01079936|11619050|FG003|Phase II|Adverse Event|0
7369096|NCT01079936|11619051|FG004|Phase II|Adverse Event|0
7369097|NCT01079936|11619047|FG000|Phase II|Insurance Issue|0
7369098|NCT01079936|11619048|FG001|Phase II|Insurance Issue|0
7369099|NCT01079936|11619049|FG002|Phase II|Insurance Issue|0
7369100|NCT01079936|11619050|FG003|Phase II|Insurance Issue|0
7369101|NCT01079936|11619051|FG004|Phase II|Insurance Issue|1
7369102|NCT01079949|11619064|FG000|Overall Study|Withdrawal before r-hCG administration|2
7369103|NCT01079949|11619065|FG001|Overall Study|Withdrawal before r-hCG administration|3
7369104|NCT01079949|11619064|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
7369105|NCT01079949|11619065|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
7369106|NCT01079949|11619064|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
7369107|NCT01079949|11619065|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
7369108|NCT01079949|11619064|FG000|Overall Study|Randomized but not treated|1
7369109|NCT01079949|11619065|FG001|Overall Study|Randomized but not treated|0
7369110|NCT01079962|11619073|FG000|Overall Study|Adverse Event|2
7369111|NCT01079962|11619074|FG001|Overall Study|Adverse Event|2
7369112|NCT01079962|11619073|FG000|Overall Study|Withdrawal by Subject|5
7369113|NCT01079962|11619074|FG001|Overall Study|Withdrawal by Subject|7
7369114|NCT01079962|11619073|FG000|Overall Study|Protocol Violation|2
7369115|NCT01079962|11619074|FG001|Overall Study|Protocol Violation|2
7369116|NCT01079962|11619073|FG000|Overall Study|No blood pressure (BP) control|3
7369117|NCT01079962|11619074|FG001|Overall Study|No blood pressure (BP) control|0
7369118|NCT01079962|11619073|FG000|Overall Study|Inclusion/exclusion criteria|1
7369119|NCT01079962|11619074|FG001|Overall Study|Inclusion/exclusion criteria|3
7369120|NCT01079962|11619073|FG000|Overall Study|Participant not returning for next visit|1
7369121|NCT01079962|11619074|FG001|Overall Study|Participant not returning for next visit|0
7369122|NCT01079962|11619073|FG000|Overall Study|Due to arrhythmia/bradycardia|1
7369123|NCT01079962|11619074|FG001|Overall Study|Due to arrhythmia/bradycardia|1
7369124|NCT01079988|11619085|FG000|Overall Study|Lost to Follow-up|0
7369125|NCT01079988|11619086|FG001|Overall Study|Lost to Follow-up|0
7369126|NCT01079988|11619087|FG002|Overall Study|Lost to Follow-up|0
7369127|NCT01079988|11619088|FG003|Overall Study|Lost to Follow-up|1
7369128|NCT01079988|11619089|FG004|Overall Study|Lost to Follow-up|0
7369129|NCT01079988|11619085|FG000|Overall Study|Lack of Efficacy|1
7369130|NCT01079988|11619086|FG001|Overall Study|Lack of Efficacy|0
7369131|NCT01079988|11619087|FG002|Overall Study|Lack of Efficacy|0
7369132|NCT01079988|11619088|FG003|Overall Study|Lack of Efficacy|0
7369133|NCT01079988|11619089|FG004|Overall Study|Lack of Efficacy|0
7369134|NCT01079988|11619085|FG000|Overall Study|Other|0
7369135|NCT01079988|11619086|FG001|Overall Study|Other|0
7369136|NCT01079988|11619087|FG002|Overall Study|Other|0
7369137|NCT01079988|11619088|FG003|Overall Study|Other|2
7369138|NCT01079988|11619089|FG004|Overall Study|Other|1
7369139|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7369140|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
7369141|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
7369142|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
7369143|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
7369144|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
7369145|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
7369146|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
7369147|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Death|1
7369148|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Death|0
7369149|NCT01080131|11619114|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
7369150|NCT01080131|11619115|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
7369151|NCT01080131|11619114|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
7369152|NCT01080131|11619115|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
7369153|NCT01080131|11619114|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
7369154|NCT01080131|11619115|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
7369155|NCT01080131|11619114|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
7369156|NCT01080131|11619115|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
7369157|NCT01080131|11619114|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
7369158|NCT01080131|11619115|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
7369159|NCT01080131|11619114|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
7369160|NCT01080131|11619115|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
7369161|NCT01080131|11619114|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
7369162|NCT01080131|11619115|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
7369163|NCT01080131|11619114|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
7369164|NCT01080131|11619115|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
7369165|NCT01080300|11619178|FG000|Overall Study|Adverse Event|49
7369166|NCT01080300|11619179|FG001|Overall Study|Adverse Event|35
7369167|NCT01080300|11619178|FG000|Overall Study|Lack of Efficacy|12
7369168|NCT01080300|11619179|FG001|Overall Study|Lack of Efficacy|15
7369169|NCT01080300|11619178|FG000|Overall Study|Protocol Violation|7
7369170|NCT01080300|11619179|FG001|Overall Study|Protocol Violation|13
7369171|NCT01080300|11619178|FG000|Overall Study|Lost to Follow-up|10
7369172|NCT01080300|11619179|FG001|Overall Study|Lost to Follow-up|6
7369173|NCT01080300|11619178|FG000|Overall Study|Death|0
7369174|NCT01080300|11619179|FG001|Overall Study|Death|1
7369175|NCT01080300|11619178|FG000|Overall Study|Withdrawal by Subject|12
7369176|NCT01080300|11619179|FG001|Overall Study|Withdrawal by Subject|28
7369177|NCT01080300|11619178|FG000|Overall Study|Reasons not specified|4
7369178|NCT01080300|11619179|FG001|Overall Study|Reasons not specified|6
7369179|NCT01080326|11619187|FG000|Overall Study|Patient deterioration prior to procedure|3
7369180|NCT01080326|11619187|FG000|Overall Study|Surgeon decision|1
7369183|NCT01080625|11619203|FG000|Overall Study|Physician Decision|0
7369184|NCT01080625|11619204|FG001|Overall Study|Physician Decision|2
7369185|NCT01080625|11619205|FG002|Overall Study|Physician Decision|1
7386823|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7386824|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
7386825|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7386826|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
7386827|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386828|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
7386829|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
7386830|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386831|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386832|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386833|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386834|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
7386835|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
7386836|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7386837|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7386838|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7386839|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7386840|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7386841|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7386842|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
7386843|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
7386844|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
7386845|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386846|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
7386847|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386848|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386849|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386850|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386851|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386852|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386853|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
7386854|NCT01212757|11645372|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386855|NCT01212757|11645373|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7386856|NCT01212757|11645374|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
7386857|NCT01212757|11645375|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386858|NCT01212757|11645376|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386859|NCT01212757|11645377|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386860|NCT01212757|11645378|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386861|NCT01212757|11645379|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386862|NCT01212757|11645380|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
7386863|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7386864|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
7386865|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
7386866|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386867|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386868|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386869|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386870|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386871|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7386872|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7386873|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
7386874|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
7386875|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7369186|NCT01080716|11619230|FG000|Part 1|Physician Decision|1
7369187|NCT01080716|11619231|FG001|Part 1|Physician Decision|0
7369188|NCT01080716|11619232|FG002|Part 1|Physician Decision|0
7369189|NCT01080716|11619233|FG003|Part 1|Physician Decision|0
7369190|NCT01080807|11619266|FG000|Overall Study|Adverse Event|9
7369191|NCT01080807|11619267|FG001|Overall Study|Adverse Event|1
7369192|NCT01080807|11619266|FG000|Overall Study|Lack of Efficacy|0
7369193|NCT01080807|11619267|FG001|Overall Study|Lack of Efficacy|1
7369194|NCT01080807|11619266|FG000|Overall Study|Withdrawal by Subject|7
7369195|NCT01080807|11619267|FG001|Overall Study|Withdrawal by Subject|2
7369196|NCT01080807|11619266|FG000|Overall Study|Protocol Violation|7
7369197|NCT01080807|11619267|FG001|Overall Study|Protocol Violation|6
7369198|NCT01080807|11619266|FG000|Overall Study|Lost to Follow-up|6
7369199|NCT01080807|11619267|FG001|Overall Study|Lost to Follow-up|4
7369200|NCT01080807|11619266|FG000|Overall Study|Noncompliance with drug administration|1
7369201|NCT01080807|11619267|FG001|Overall Study|Noncompliance with drug administration|1
7369202|NCT01080807|11619266|FG000|Overall Study|Noncompliance to study procedures|1
7369203|NCT01080807|11619267|FG001|Overall Study|Noncompliance to study procedures|1
7369204|NCT01080807|11619266|FG000|Overall Study|Began working day shift|0
7369205|NCT01080807|11619267|FG001|Overall Study|Began working day shift|2
7369206|NCT01080807|11619266|FG000|Overall Study|Laid off or terminated from job|1
7369207|NCT01080807|11619267|FG001|Overall Study|Laid off or terminated from job|2
7369208|NCT01080807|11619266|FG000|Overall Study|Stopped working consistent night shifts|0
7570445|NCT03491150|11948148|FG000|Overall Study|Adverse Event|1
7570446|NCT03491150|11948149|FG001|Overall Study|Adverse Event|0
7570447|NCT03491150|11948148|FG000|Overall Study|Study Terminated by Sponsor|74
7570448|NCT03491150|11948149|FG001|Overall Study|Study Terminated by Sponsor|70
7369209|NCT01080807|11619267|FG001|Overall Study|Stopped working consistent night shifts|1
7570449|NCT03491150|11948148|FG000|Overall Study|Other|0
7570450|NCT03491150|11948149|FG001|Overall Study|Other|1
7570451|NCT03491150|11948148|FG000|Overall Study|Withdrawal by Subject|1
7570452|NCT03491150|11948149|FG001|Overall Study|Withdrawal by Subject|2
7570453|NCT03491553|11948165|FG000|Main Study (Up to Week 48)|Adverse Event|0
7570454|NCT03491553|11948166|FG001|Main Study (Up to Week 48)|Adverse Event|0
7570455|NCT03491553|11948167|FG002|Main Study (Up to Week 48)|Adverse Event|0
7570456|NCT03491553|11948168|FG003|Main Study (Up to Week 48)|Adverse Event|1
7570457|NCT03491553|11948169|FG004|Main Study (Up to Week 48)|Adverse Event|0
7570458|NCT03491553|11948170|FG005|Main Study (Up to Week 48)|Adverse Event|0
7570459|NCT03491553|11948165|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
7570460|NCT03491553|11948166|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
7570461|NCT03491553|11948167|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
7570462|NCT03491553|11948168|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
7369210|NCT01080807|11619266|FG000|Overall Study|Work schedule changing|1
7369211|NCT01080807|11619267|FG001|Overall Study|Work schedule changing|1
7369212|NCT01080807|11619266|FG000|Overall Study|Work schedule and travel|0
7369213|NCT01080807|11619267|FG001|Overall Study|Work schedule and travel|1
7369214|NCT01080807|11619266|FG000|Overall Study|Switched to first shift|1
7369215|NCT01080807|11619267|FG001|Overall Study|Switched to first shift|0
7369216|NCT01080807|11619266|FG000|Overall Study|Moved away without notifying center|1
7369217|NCT01080807|11619267|FG001|Overall Study|Moved away without notifying center|0
7369218|NCT01081132|11619302|FG000|Overall Study|Lack of Efficacy|25
7369219|NCT01081132|11619303|FG001|Overall Study|Lack of Efficacy|9
7369220|NCT01081132|11619302|FG000|Overall Study|Withdrawal by Subject|13
7369221|NCT01081132|11619303|FG001|Overall Study|Withdrawal by Subject|16
7369222|NCT01081132|11619302|FG000|Overall Study|Lost to Follow-up|4
7369223|NCT01081132|11619303|FG001|Overall Study|Lost to Follow-up|11
7369224|NCT01081132|11619302|FG000|Overall Study|Adverse Event|3
7369225|NCT01081132|11619303|FG001|Overall Study|Adverse Event|9
7369226|NCT01081132|11619302|FG000|Overall Study|Non Compliance|4
7369227|NCT01081132|11619303|FG001|Overall Study|Non Compliance|2
7369228|NCT01081132|11619302|FG000|Overall Study|Lack Of Compliance|0
7570463|NCT03491553|11948169|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
7570464|NCT03491553|11948170|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
7570465|NCT03492281|11948219|FG000|Overall Study|Withdrawal by Subject|21
7369229|NCT01081132|11619303|FG001|Overall Study|Lack Of Compliance|1
7369230|NCT01081132|11619302|FG000|Overall Study|Missed Visits|1
7369231|NCT01081132|11619303|FG001|Overall Study|Missed Visits|1
7369232|NCT01081132|11619302|FG000|Overall Study|Stopped Taking Meds|2
7369233|NCT01081132|11619303|FG001|Overall Study|Stopped Taking Meds|0
7369234|NCT01081132|11619302|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
7369235|NCT01081132|11619303|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
7369236|NCT01081132|11619302|FG000|Overall Study|Declined Taper Phase|0
7369237|NCT01081132|11619303|FG001|Overall Study|Declined Taper Phase|1
7369238|NCT01081132|11619302|FG000|Overall Study|Protocol Violation|3
7570466|NCT03492281|11948220|FG001|Overall Study|Withdrawal by Subject|14
7369239|NCT01081132|11619303|FG001|Overall Study|Protocol Violation|1
7369240|NCT01081145|11619309|FG000|Open-Label Phase|Lack of Efficacy|56
7369241|NCT01081145|11619310|FG001|Open-Label Phase|Lack of Efficacy|0
7369242|NCT01081145|11619309|FG000|Open-Label Phase|Response criteria not met|46
7369243|NCT01081145|11619310|FG001|Open-Label Phase|Response criteria not met|0
7369244|NCT01081145|11619309|FG000|Open-Label Phase|Adverse Event|42
7369245|NCT01081145|11619310|FG001|Open-Label Phase|Adverse Event|0
7369246|NCT01081145|11619309|FG000|Open-Label Phase|Withdrawal by Subject|41
7369247|NCT01081145|11619310|FG001|Open-Label Phase|Withdrawal by Subject|0
7369248|NCT01081145|11619309|FG000|Open-Label Phase|Other|12
7369249|NCT01081145|11619310|FG001|Open-Label Phase|Other|0
7369250|NCT01081145|11619309|FG000|Open-Label Phase|Lost to Follow-up|11
7369251|NCT01081145|11619310|FG001|Open-Label Phase|Lost to Follow-up|0
7369252|NCT01081145|11619309|FG000|Open-Label Phase|Protocol Violation|4
7369253|NCT01081145|11619310|FG001|Open-Label Phase|Protocol Violation|0
7369254|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
7369255|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
7369256|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
7369257|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
7369258|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
7369259|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
7369260|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
7369261|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
7369262|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
7369263|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
7369264|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
7369265|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
7369266|NCT01081145|11619309|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
7369267|NCT01081145|11619310|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
7369268|NCT01081249|11619318|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
7369269|NCT01081249|11619319|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
7369270|NCT01081301|11619325|FG000|Overall Study|Bereaved|3
7369271|NCT01081301|11619325|FG000|Overall Study|Too busy|5
7369272|NCT01081301|11619325|FG000|Overall Study|Patient too ill|2
7369273|NCT01081301|11619325|FG000|Overall Study|Lost to Follow-up|4
7369274|NCT01081626|11619348|FG000|Overall Study|Dosing error|1
7369275|NCT01081626|11619349|FG001|Overall Study|Dosing error|1
7369276|NCT01081626|11619348|FG000|Overall Study|Missing Estradiol|25
7369277|NCT01081626|11619349|FG001|Overall Study|Missing Estradiol|28
7369278|NCT01081626|11619348|FG000|Overall Study|Low antral follicle count|1
7369279|NCT01081626|11619349|FG001|Overall Study|Low antral follicle count|0
7369280|NCT01081626|11619348|FG000|Overall Study|Overstimulation|0
7369281|NCT01081626|11619349|FG001|Overall Study|Overstimulation|1
7369282|NCT01081626|11619348|FG000|Overall Study|Lost to Follow-up|0
7369283|NCT01081626|11619349|FG001|Overall Study|Lost to Follow-up|1
7369284|NCT01081626|11619348|FG000|Overall Study|Other|33
7369285|NCT01081626|11619349|FG001|Overall Study|Other|30
7369286|NCT01081665|11619355|FG000|Overall Study|Death|41
7369287|NCT01081665|11619355|FG000|Overall Study|Lost to Follow-up|18
7369288|NCT01081665|11619355|FG000|Overall Study|Withdrawal by Subject|17
7369289|NCT01081665|11619355|FG000|Overall Study|Change of dialysis unit|10
7369290|NCT01081665|11619355|FG000|Overall Study|Regulation of iPTH|5
7369291|NCT01081665|11619355|FG000|Overall Study|Change in renal replacement therapy|2
7369292|NCT01081665|11619355|FG000|Overall Study|Adverse Event|1
7369293|NCT01081665|11619355|FG000|Overall Study|Lack of Efficacy|1
7369326|NCT01081769|11619378|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
7369327|NCT01081769|11619379|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
7369328|NCT01081769|11619378|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7369329|NCT01081769|11619379|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
7369330|NCT01081769|11619378|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
7369331|NCT01081769|11619379|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
7369332|NCT01081769|11619378|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
7369333|NCT01081769|11619379|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
7369334|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Adverse Event|14
7369335|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Adverse Event|11
7369336|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Death|1
7369337|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Death|1
7369338|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
7369339|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
7369340|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
7369341|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
7369342|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Pregnancy|1
7369343|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Pregnancy|0
7369344|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
7369345|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
7369346|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
7369347|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
7369348|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Other|0
7369349|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Other|1
7369350|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Ineligibility|3
7369351|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Ineligibility|4
7369352|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
7369353|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
7369354|NCT01081769|11619378|FG000|CORE Intent-To-Treat|Patient Moved|2
7369355|NCT01081769|11619379|FG001|CORE Intent-To-Treat|Patient Moved|2
7369356|NCT01081795|11619388|FG000|Overall Study|Adverse Event|18
7369357|NCT01081795|11619389|FG001|Overall Study|Adverse Event|23
7369358|NCT01081795|11619390|FG002|Overall Study|Adverse Event|6
7369359|NCT01081795|11619388|FG000|Overall Study|Lack of Efficacy|7
7369360|NCT01081795|11619389|FG001|Overall Study|Lack of Efficacy|5
7369361|NCT01081795|11619390|FG002|Overall Study|Lack of Efficacy|19
7369362|NCT01081795|11619388|FG000|Overall Study|Subject's schedule|1
7369363|NCT01081795|11619389|FG001|Overall Study|Subject's schedule|1
7369364|NCT01081795|11619390|FG002|Overall Study|Subject's schedule|2
7369365|NCT01081795|11619388|FG000|Overall Study|Revocation of informed consent|2
7369366|NCT01081795|11619389|FG001|Overall Study|Revocation of informed consent|0
7369367|NCT01081795|11619390|FG002|Overall Study|Revocation of informed consent|0
7369368|NCT01081795|11619388|FG000|Overall Study|Ineligible for participation|1
7369369|NCT01081795|11619389|FG001|Overall Study|Ineligible for participation|0
7369370|NCT01081795|11619390|FG002|Overall Study|Ineligible for participation|0
7369371|NCT01081795|11619388|FG000|Overall Study|Use of a prohibited concomitant drug|1
7369372|NCT01081795|11619389|FG001|Overall Study|Use of a prohibited concomitant drug|1
7369373|NCT01081795|11619390|FG002|Overall Study|Use of a prohibited concomitant drug|1
7369374|NCT01081795|11619388|FG000|Overall Study|Using drug with restricted days of use|2
7369375|NCT01081795|11619389|FG001|Overall Study|Using drug with restricted days of use|3
7369376|NCT01081795|11619390|FG002|Overall Study|Using drug with restricted days of use|2
7369377|NCT01081795|11619388|FG000|Overall Study|Other|1
7369378|NCT01081795|11619389|FG001|Overall Study|Other|2
7369379|NCT01081795|11619390|FG002|Overall Study|Other|0
7369380|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Pregnancy|1
7369381|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Pregnancy|0
7369382|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Pregnancy|0
7369383|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Pregnancy|0
7369384|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Pregnancy|0
7369385|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Adverse Event|2
7369386|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Adverse Event|5
7369387|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Adverse Event|3
7369388|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Adverse Event|1
7369389|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Adverse Event|1
7369390|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Death|1
7369391|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Death|0
7369392|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Death|0
7369393|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Death|0
7369394|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Death|0
7369395|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
7369396|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
7369397|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
7369398|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
7369399|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
7369400|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
7369401|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
7369402|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7369403|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
7369404|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
7369405|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7369406|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7369407|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7369408|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7369409|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7369410|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7369411|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
7369412|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7369413|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
7369414|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7369415|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7369416|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7369417|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7369418|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7369419|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7369420|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Other|4
7369421|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Other|4
7369422|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Other|3
7369423|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Other|1
7369424|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Other|0
7369425|NCT01081834|11619403|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
7369426|NCT01081834|11619404|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7369427|NCT01081834|11619405|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7369428|NCT01081834|11619406|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7369429|NCT01081834|11619407|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7369430|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7369431|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
7369432|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
7369433|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
7369434|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
7369435|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Death|1
7369436|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Death|0
7369437|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Death|0
7369438|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Death|0
7369439|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Death|0
7369440|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7369441|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
7369442|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7369443|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7369444|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7369445|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
7369446|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7369447|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7369448|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
7369449|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
7369450|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7369451|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7369452|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7369453|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7369454|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7369455|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7369456|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7369457|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7369458|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7369459|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7369460|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7369461|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7369462|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7369463|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7369464|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
7369465|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Other|4
7369466|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Other|5
7369467|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Other|4
7369468|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Other|0
7369469|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Other|0
7369470|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
7369471|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
7369472|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7369473|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7369474|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
7369475|NCT01081834|11619403|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
7369476|NCT01081834|11619404|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
7369477|NCT01081834|11619405|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
7369478|NCT01081834|11619406|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
7369479|NCT01081834|11619407|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
7369480|NCT01081873|11619426|FG000|Overall Study|Death|86
7369481|NCT01081873|11619426|FG000|Overall Study|Withdrawal by Subject|10
7369482|NCT01081873|11619426|FG000|Overall Study|Lost to Follow-up|142
7369483|NCT01081873|11619426|FG000|Overall Study|Progression of prostate cancer|13
7369484|NCT01081873|11619426|FG000|Overall Study|Other|47
7369485|NCT01081912|11619455|FG000|Conversion/Titration|Adverse Event|47
7369486|NCT01081912|11619456|FG001|Conversion/Titration|Adverse Event|0
7369487|NCT01081912|11619457|FG002|Conversion/Titration|Adverse Event|0
7369488|NCT01081912|11619455|FG000|Conversion/Titration|Lack of Efficacy|17
7369489|NCT01081912|11619456|FG001|Conversion/Titration|Lack of Efficacy|0
7369490|NCT01081912|11619457|FG002|Conversion/Titration|Lack of Efficacy|0
7369491|NCT01081912|11619455|FG000|Conversion/Titration|Lost to Follow-up|5
7369492|NCT01081912|11619456|FG001|Conversion/Titration|Lost to Follow-up|0
7369493|NCT01081912|11619457|FG002|Conversion/Titration|Lost to Follow-up|0
7369494|NCT01081912|11619455|FG000|Conversion/Titration|Physician Decision|2
7369495|NCT01081912|11619456|FG001|Conversion/Titration|Physician Decision|0
7369496|NCT01081912|11619457|FG002|Conversion/Titration|Physician Decision|0
7369497|NCT01081912|11619455|FG000|Conversion/Titration|Protocol Violation|67
7369498|NCT01081912|11619456|FG001|Conversion/Titration|Protocol Violation|0
7369499|NCT01081912|11619457|FG002|Conversion/Titration|Protocol Violation|0
7369500|NCT01081912|11619455|FG000|Conversion/Titration|Withdrawal by Subject|23
7369501|NCT01081912|11619456|FG001|Conversion/Titration|Withdrawal by Subject|0
7369502|NCT01081912|11619457|FG002|Conversion/Titration|Withdrawal by Subject|0
7369503|NCT01081912|11619455|FG000|Conversion/Titration|Non-Compliance|47
7369504|NCT01081912|11619456|FG001|Conversion/Titration|Non-Compliance|0
7369505|NCT01081912|11619457|FG002|Conversion/Titration|Non-Compliance|0
7369506|NCT01081912|11619455|FG000|Maintenance Treatment|Adverse Event|0
7369507|NCT01081912|11619456|FG001|Maintenance Treatment|Adverse Event|2
7369508|NCT01081912|11619457|FG002|Maintenance Treatment|Adverse Event|12
7369509|NCT01081912|11619455|FG000|Maintenance Treatment|Lack of Efficacy|0
7369510|NCT01081912|11619456|FG001|Maintenance Treatment|Lack of Efficacy|14
7369511|NCT01081912|11619457|FG002|Maintenance Treatment|Lack of Efficacy|64
7369512|NCT01081912|11619455|FG000|Maintenance Treatment|Lost to Follow-up|0
7369513|NCT01081912|11619456|FG001|Maintenance Treatment|Lost to Follow-up|1
7369514|NCT01081912|11619457|FG002|Maintenance Treatment|Lost to Follow-up|0
7369515|NCT01081912|11619455|FG000|Maintenance Treatment|Physician Decision|0
7369516|NCT01081912|11619456|FG001|Maintenance Treatment|Physician Decision|0
7369517|NCT01081912|11619457|FG002|Maintenance Treatment|Physician Decision|1
7369518|NCT01081912|11619455|FG000|Maintenance Treatment|Protocol Violation|0
7369519|NCT01081912|11619456|FG001|Maintenance Treatment|Protocol Violation|1
7369520|NCT01081912|11619457|FG002|Maintenance Treatment|Protocol Violation|2
7369521|NCT01081912|11619455|FG000|Maintenance Treatment|Withdrawal by Subject|0
7369522|NCT01081912|11619456|FG001|Maintenance Treatment|Withdrawal by Subject|5
7369523|NCT01081912|11619457|FG002|Maintenance Treatment|Withdrawal by Subject|5
7369524|NCT01081912|11619455|FG000|Maintenance Treatment|Non-Compliance|0
7369525|NCT01081912|11619456|FG001|Maintenance Treatment|Non-Compliance|4
7369526|NCT01081912|11619457|FG002|Maintenance Treatment|Non-Compliance|7
7369527|NCT01081912|11619455|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
7369528|NCT01081912|11619456|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
7369529|NCT01081912|11619457|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
7369530|NCT01082081|11619467|FG000|Overall Study|Lost to Follow-up|0
7369531|NCT01082081|11619468|FG001|Overall Study|Lost to Follow-up|0
7369532|NCT01082081|11619469|FG002|Overall Study|Lost to Follow-up|1
7369533|NCT01082081|11619467|FG000|Overall Study|Withdrawal by Subject|0
7369534|NCT01082081|11619468|FG001|Overall Study|Withdrawal by Subject|0
7369535|NCT01082081|11619469|FG002|Overall Study|Withdrawal by Subject|1
7369536|NCT01082081|11619467|FG000|Overall Study|Other Reason|0
7369537|NCT01082081|11619468|FG001|Overall Study|Other Reason|1
7369538|NCT01082081|11619469|FG002|Overall Study|Other Reason|0
7369539|NCT01082328|11619482|FG000|Overall Study|Adverse Event|1
7369540|NCT01082367|11619488|FG000|Double-blind Period|Administrative problems|0
7369541|NCT01082367|11619489|FG001|Double-blind Period|Administrative problems|1
7369542|NCT01082367|11619488|FG000|Double-blind Period|Lack of Efficacy|5
7369543|NCT01082367|11619489|FG001|Double-blind Period|Lack of Efficacy|11
7369544|NCT01082367|11619488|FG000|Double-blind Period|Adverse Event|0
7369545|NCT01082367|11619489|FG001|Double-blind Period|Adverse Event|1
7369546|NCT01082367|11619488|FG000|Follow-up (F-U) Period|Administrative problems|1
7369547|NCT01082367|11619489|FG001|Follow-up (F-U) Period|Administrative problems|0
7369548|NCT01082367|11619488|FG000|Follow-up (F-U) Period|Abnormal lab values|1
7369549|NCT01082367|11619489|FG001|Follow-up (F-U) Period|Abnormal lab values|0
7369550|NCT01082367|11619488|FG000|Follow-up (F-U) Period|Adverse Event|0
7369551|NCT01082367|11619489|FG001|Follow-up (F-U) Period|Adverse Event|1
7369552|NCT01082614|11619518|FG000|Overall Study|Adverse Event|1
7369553|NCT01082614|11619519|FG001|Overall Study|Adverse Event|4
7369554|NCT01082614|11619518|FG000|Overall Study|Equipment Malfunction|0
7369555|NCT01082614|11619519|FG001|Overall Study|Equipment Malfunction|1
7369556|NCT01082614|11619518|FG000|Overall Study|Physician Decision|2
7369557|NCT01082614|11619519|FG001|Overall Study|Physician Decision|0
7369558|NCT01082640|11619528|FG000|Overall Study|Adverse Event|9
7369559|NCT01082640|11619529|FG001|Overall Study|Adverse Event|5
7369560|NCT01082640|11619530|FG002|Overall Study|Adverse Event|3
7369561|NCT01082640|11619528|FG000|Overall Study|Withdrawal by Subject|3
7369562|NCT01082640|11619529|FG001|Overall Study|Withdrawal by Subject|3
7369563|NCT01082640|11619530|FG002|Overall Study|Withdrawal by Subject|2
7369564|NCT01082640|11619528|FG000|Overall Study|Major protocol deviation|3
7369565|NCT01082640|11619529|FG001|Overall Study|Major protocol deviation|3
7369566|NCT01082640|11619530|FG002|Overall Study|Major protocol deviation|0
7369567|NCT01082640|11619528|FG000|Overall Study|Lost to Follow-up|0
7369568|NCT01082640|11619529|FG001|Overall Study|Lost to Follow-up|3
7369569|NCT01082640|11619530|FG002|Overall Study|Lost to Follow-up|0
7369570|NCT01082640|11619528|FG000|Overall Study|Other|2
7369571|NCT01082640|11619529|FG001|Overall Study|Other|1
7369572|NCT01082640|11619530|FG002|Overall Study|Other|3
7369573|NCT01082874|11619545|FG000|Overall Study|Lost to Follow-up|10
7369574|NCT01082874|11619546|FG001|Overall Study|Lost to Follow-up|10
7369575|NCT01082874|11619547|FG002|Overall Study|Lost to Follow-up|6
7369576|NCT01082874|11619548|FG003|Overall Study|Lost to Follow-up|10
7369577|NCT01082874|11619545|FG000|Overall Study|Withdrawal by Subject|1
7369578|NCT01082874|11619546|FG001|Overall Study|Withdrawal by Subject|2
7369579|NCT01082874|11619547|FG002|Overall Study|Withdrawal by Subject|5
7369580|NCT01082874|11619548|FG003|Overall Study|Withdrawal by Subject|3
7369581|NCT01082965|11619573|FG000|Overall Study|Protocol Violation|0
7369582|NCT01082965|11619574|FG001|Overall Study|Protocol Violation|1
7369583|NCT01082965|11619573|FG000|Overall Study|Other|1
7369584|NCT01082965|11619574|FG001|Overall Study|Other|1
7369585|NCT01083121|11619580|FG000|Overall Study|Use of Humira outside the approved label|81
7369586|NCT01083160|11619588|FG000|Overall Study|Adverse Event|1
7369587|NCT01083173|11619592|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7369588|NCT01083173|11619593|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7369589|NCT01083173|11619592|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
7369590|NCT01083173|11619593|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
7369591|NCT01083173|11619592|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
7369592|NCT01083173|11619593|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
7369593|NCT01083173|11619592|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
7369594|NCT01083173|11619593|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
7369595|NCT01083173|11619592|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
7369596|NCT01083173|11619593|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
7369597|NCT01083173|11619592|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
7369598|NCT01083173|11619593|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
7369599|NCT01083173|11619592|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
7369600|NCT01083173|11619593|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
7369601|NCT01083173|11619592|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
7369602|NCT01083173|11619593|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
7369603|NCT01083173|11619592|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
7369604|NCT01083173|11619593|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
7369605|NCT01083173|11619592|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
7369606|NCT01083173|11619593|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
7369607|NCT01083173|11619592|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
7369608|NCT01083173|11619593|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
7369609|NCT01083186|11619602|FG000|Overall Study|Lost to Follow-up|48
7369610|NCT01083186|11619602|FG000|Overall Study|Consent Withdrawal|7
7369611|NCT01083186|11619602|FG000|Overall Study|Death|3
7369612|NCT01083186|11619602|FG000|Overall Study|Adverse Event|3
7369613|NCT01083186|11619602|FG000|Overall Study|Lack of Efficacy|2
7369614|NCT01083186|11619602|FG000|Overall Study|Hemodialysis Initiation|28
7369615|NCT01083186|11619602|FG000|Overall Study|Administrative Reasons|2
7369616|NCT01083186|11619602|FG000|Overall Study|Non-compliance to Study Treatment|1
7369617|NCT01083316|11619631|FG000|Overall Study|Adverse Event|2
7369618|NCT01083316|11619631|FG000|Overall Study|Withdrawal by Subject|1
7369619|NCT01083485|11619651|FG000|Overall Study|Adverse Event|0
7369620|NCT01083485|11619652|FG001|Overall Study|Adverse Event|1
7369621|NCT01083485|11619651|FG000|Overall Study|Protocol Violation|1
7570467|NCT03492281|11948221|FG002|Overall Study|Withdrawal by Subject|13
7570468|NCT03492281|11948219|FG000|Overall Study|Lost to Follow-up|14
7369622|NCT01083485|11619652|FG001|Overall Study|Protocol Violation|0
7369623|NCT01083485|11619651|FG000|Overall Study|Withdrawal by Subject|5
7369624|NCT01083485|11619652|FG001|Overall Study|Withdrawal by Subject|2
7369625|NCT01083485|11619651|FG000|Overall Study|Other|1
7369626|NCT01083485|11619652|FG001|Overall Study|Other|0
7369627|NCT01083576|11619662|FG000|Overall Study|Treatment Failure|6
7369628|NCT01083576|11619663|FG001|Overall Study|Treatment Failure|1
7369629|NCT01083602|11619670|FG000|Overall Study|Adverse Event|11
7369630|NCT01083602|11619670|FG000|Overall Study|New Cancer Therapy|2
7369631|NCT01083602|11619670|FG000|Overall Study|Death|1
7369632|NCT01083602|11619670|FG000|Overall Study|Withdrawal by Subject|5
7369633|NCT01083602|11619670|FG000|Overall Study|Lack of Efficacy|36
7369634|NCT01083641|11619683|FG000|Overall Study|Withdrawal by Subject|2
7369635|NCT01083680|11619700|FG000|Overall Study|Lost to Follow-up|2758
7369636|NCT01083680|11619700|FG000|Overall Study|Withdrawal by Subject|1086
7369637|NCT01083693|11619707|FG000|Overall Study|Adverse Event|1
7369638|NCT01083693|11619708|FG001|Overall Study|Adverse Event|1
7369639|NCT01083693|11619709|FG002|Overall Study|Adverse Event|0
7369640|NCT01083693|11619707|FG000|Overall Study|Lost to Follow-up|2
7369641|NCT01083693|11619708|FG001|Overall Study|Lost to Follow-up|0
7369642|NCT01083693|11619709|FG002|Overall Study|Lost to Follow-up|2
7369643|NCT01083693|11619707|FG000|Overall Study|Lack of effectiveness|13
7369644|NCT01083693|11619708|FG001|Overall Study|Lack of effectiveness|2
7369645|NCT01083693|11619709|FG002|Overall Study|Lack of effectiveness|2
7369646|NCT01083693|11619707|FG000|Overall Study|Patient Moved|0
7369647|NCT01083693|11619708|FG001|Overall Study|Patient Moved|1
7369648|NCT01083693|11619709|FG002|Overall Study|Patient Moved|0
7369649|NCT01083693|11619707|FG000|Overall Study|Complete remission|0
7369650|NCT01083693|11619708|FG001|Overall Study|Complete remission|1
7369651|NCT01083693|11619709|FG002|Overall Study|Complete remission|0
7369652|NCT01083693|11619707|FG000|Overall Study|Other medical condition/surgery|1
7369653|NCT01083693|11619708|FG001|Overall Study|Other medical condition/surgery|1
7369654|NCT01083693|11619709|FG002|Overall Study|Other medical condition/surgery|0
7369655|NCT01083693|11619707|FG000|Overall Study|Withdrawal by Subject|3
7369656|NCT01083693|11619708|FG001|Overall Study|Withdrawal by Subject|0
7369657|NCT01083693|11619709|FG002|Overall Study|Withdrawal by Subject|2
7369658|NCT01083693|11619707|FG000|Overall Study|Reason unknown|0
7369659|NCT01083693|11619708|FG001|Overall Study|Reason unknown|0
7369660|NCT01083693|11619709|FG002|Overall Study|Reason unknown|1
7369661|NCT01083810|11619748|FG000|Overall Study|Lost to Follow-up|23
7369662|NCT01083810|11619749|FG001|Overall Study|Lost to Follow-up|11
7369663|NCT01083810|11619750|FG002|Overall Study|Lost to Follow-up|4
7369664|NCT01083810|11619748|FG000|Overall Study|Adverse Event|15
7369665|NCT01083810|11619749|FG001|Overall Study|Adverse Event|11
7369666|NCT01083810|11619750|FG002|Overall Study|Adverse Event|4
7369667|NCT01083810|11619748|FG000|Overall Study|Withdrawal by Subject|7
7369668|NCT01083810|11619749|FG001|Overall Study|Withdrawal by Subject|2
7369669|NCT01083810|11619750|FG002|Overall Study|Withdrawal by Subject|4
7369670|NCT01083810|11619748|FG000|Overall Study|Reason not reported|6
7369671|NCT01083810|11619749|FG001|Overall Study|Reason not reported|1
7369672|NCT01083810|11619750|FG002|Overall Study|Reason not reported|1
7369673|NCT01083810|11619748|FG000|Overall Study|Non-compliance|4
7369674|NCT01083810|11619749|FG001|Overall Study|Non-compliance|7
7369675|NCT01083810|11619750|FG002|Overall Study|Non-compliance|2
7369676|NCT01083810|11619748|FG000|Overall Study|Simplification|4
7570469|NCT03492281|11948220|FG001|Overall Study|Lost to Follow-up|15
7570470|NCT03492281|11948221|FG002|Overall Study|Lost to Follow-up|10
7570471|NCT03492281|11948219|FG000|Overall Study|Adverse Event|6
7570472|NCT03492281|11948220|FG001|Overall Study|Adverse Event|8
7570473|NCT03492281|11948221|FG002|Overall Study|Adverse Event|13
7570474|NCT03492281|11948219|FG000|Overall Study|Lack of Efficacy|3
7570475|NCT03492281|11948220|FG001|Overall Study|Lack of Efficacy|0
7570476|NCT03492281|11948221|FG002|Overall Study|Lack of Efficacy|1
7570477|NCT03492281|11948219|FG000|Overall Study|Physician Decision|1
7369677|NCT01083810|11619749|FG001|Overall Study|Simplification|1
7369678|NCT01083810|11619750|FG002|Overall Study|Simplification|0
7369679|NCT01083810|11619748|FG000|Overall Study|Death|2
7369680|NCT01083810|11619749|FG001|Overall Study|Death|2
7369681|NCT01083810|11619750|FG002|Overall Study|Death|3
7369682|NCT01083810|11619748|FG000|Overall Study|Co-morbidities|1
7570478|NCT03492281|11948220|FG001|Overall Study|Physician Decision|0
7570479|NCT03492281|11948221|FG002|Overall Study|Physician Decision|3
7570480|NCT03492281|11948219|FG000|Overall Study|Protocol Violation|0
7570481|NCT03492281|11948220|FG001|Overall Study|Protocol Violation|2
7369683|NCT01083810|11619749|FG001|Overall Study|Co-morbidities|0
7369684|NCT01083810|11619750|FG002|Overall Study|Co-morbidities|0
7369685|NCT01083810|11619748|FG000|Overall Study|Participation in study|1
7369686|NCT01083810|11619749|FG001|Overall Study|Participation in study|0
7369687|NCT01083810|11619750|FG002|Overall Study|Participation in study|0
7570482|NCT03492281|11948221|FG002|Overall Study|Protocol Violation|1
7369688|NCT01083810|11619748|FG000|Overall Study|Therapy break|1
7369689|NCT01083810|11619749|FG001|Overall Study|Therapy break|2
7369690|NCT01083810|11619750|FG002|Overall Study|Therapy break|2
7369691|NCT01083810|11619748|FG000|Overall Study|Virologic failure|1
7369692|NCT01083810|11619749|FG001|Overall Study|Virologic failure|8
7369693|NCT01083810|11619750|FG002|Overall Study|Virologic failure|0
7369694|NCT01084005|11619787|FG000|Overall Study|Adverse Event|1
7369695|NCT01084005|11619788|FG001|Overall Study|Adverse Event|8
7369696|NCT01084005|11619787|FG000|Overall Study|Protocol Violation|3
7369697|NCT01084005|11619788|FG001|Overall Study|Protocol Violation|7
7369698|NCT01084005|11619787|FG000|Overall Study|Withdrawal by Subject|1
7369699|NCT01084005|11619788|FG001|Overall Study|Withdrawal by Subject|1
7369700|NCT01084083|11619794|FG000|Overall Study|Adverse Event|5
7369701|NCT01084083|11619794|FG000|Overall Study|Death|1
7369702|NCT01084083|11619794|FG000|Overall Study|Withdrawal by Subject|2
7369703|NCT01084083|11619794|FG000|Overall Study|Complicating disease|1
7369704|NCT01084083|11619794|FG000|Overall Study|Other|2
7369705|NCT01084083|11619794|FG000|Overall Study|Never started assigned therapy|1
7369706|NCT01084135|11619803|FG000|20 Week|Physician Decision|0
7369707|NCT01084135|11619804|FG001|20 Week|Physician Decision|1
7369708|NCT01084174|11619825|FG000|Overall Study|gastrointestinal symptoms|1
7369709|NCT01084174|11619826|FG001|Overall Study|gastrointestinal symptoms|1
7369710|NCT01084174|11619825|FG000|Overall Study|Eosinophilic esophagitis|0
7369711|NCT01084174|11619826|FG001|Overall Study|Eosinophilic esophagitis|1
7369712|NCT01084174|11619825|FG000|Overall Study|Anaphylaxis|0
7369713|NCT01084174|11619826|FG001|Overall Study|Anaphylaxis|1
7369714|NCT01084174|11619825|FG000|Overall Study|Participant noncompliance|0
7369715|NCT01084174|11619826|FG001|Overall Study|Participant noncompliance|1
7369716|NCT01084239|11619834|FG000|28-Day Follow-up|Lost to Follow-up|4
7369717|NCT01084239|11619835|FG001|28-Day Follow-up|Lost to Follow-up|9
7369718|NCT01084538|11619879|FG000|Overall Study|Drug not available|30
7369719|NCT01084538|11619879|FG000|Overall Study|Adverse Event|9
7369720|NCT01084538|11619879|FG000|Overall Study|Kidney transplant|6
7369721|NCT01084538|11619879|FG000|Overall Study|Serious Adverse Event|3
7369722|NCT01084538|11619879|FG000|Overall Study|Lack of effectiveness|2
7369723|NCT01084538|11619879|FG000|Overall Study|Patient noncompliance|2
7369724|NCT01084538|11619879|FG000|Overall Study|Hyperphosphatemia|2
7369725|NCT01084538|11619879|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
7369726|NCT01084538|11619879|FG000|Overall Study|Change of residence|2
7369727|NCT01084538|11619879|FG000|Overall Study|Over-suppression of parathyroid gland|2
7369728|NCT01084538|11619879|FG000|Overall Study|Reason unknown|8
7369729|NCT01084551|11619886|FG000|Overall Study|Adverse Event|2
7369730|NCT01084551|11619887|FG001|Overall Study|Adverse Event|9
7369731|NCT01084551|11619888|FG002|Overall Study|Adverse Event|4
7369732|NCT01084551|11619886|FG000|Overall Study|Lack of Efficacy|2
7369733|NCT01084551|11619887|FG001|Overall Study|Lack of Efficacy|0
7369734|NCT01084551|11619888|FG002|Overall Study|Lack of Efficacy|1
7369735|NCT01084551|11619886|FG000|Overall Study|Withdrawal by Subject|2
7369736|NCT01084551|11619887|FG001|Overall Study|Withdrawal by Subject|1
7369737|NCT01084551|11619888|FG002|Overall Study|Withdrawal by Subject|0
7369738|NCT01084551|11619886|FG000|Overall Study|Protocol Violation|2
7369739|NCT01084551|11619887|FG001|Overall Study|Protocol Violation|4
7369740|NCT01084551|11619888|FG002|Overall Study|Protocol Violation|0
7369741|NCT01084551|11619886|FG000|Overall Study|Lost to Follow-up|0
7369742|NCT01084551|11619887|FG001|Overall Study|Lost to Follow-up|0
7369743|NCT01084551|11619888|FG002|Overall Study|Lost to Follow-up|3
7369744|NCT01084551|11619886|FG000|Overall Study|Physician Decision|1
7369745|NCT01084551|11619887|FG001|Overall Study|Physician Decision|0
7369746|NCT01084551|11619888|FG002|Overall Study|Physician Decision|0
7369747|NCT01084603|11619896|FG000|Baseline|Withdrawal by Subject|2
7369748|NCT01084603|11619896|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
7369749|NCT01084603|11619896|FG000|Nicorette® Gum|Withdrawal by Subject|1
7369750|NCT01084603|11619896|FG000|Oral Nicotine 1|Withdrawal by Subject|1
7369751|NCT01084603|11619896|FG000|Washout Period 4|Adverse Event|1
7369752|NCT01084655|11619912|FG000|Overall Study|Radiographic disease progression|3
7369753|NCT01084655|11619913|FG001|Overall Study|Radiographic disease progression|2
7369754|NCT01084655|11619914|FG002|Overall Study|Radiographic disease progression|8
7369755|NCT01084655|11619912|FG000|Overall Study|Withdrawal by Subject|1
7369756|NCT01084655|11619913|FG001|Overall Study|Withdrawal by Subject|0
7369757|NCT01084655|11619914|FG002|Overall Study|Withdrawal by Subject|4
7369758|NCT01084655|11619912|FG000|Overall Study|Adverse Event|2
7369759|NCT01084655|11619913|FG001|Overall Study|Adverse Event|1
7369760|NCT01084655|11619914|FG002|Overall Study|Adverse Event|2
7369761|NCT01084655|11619912|FG000|Overall Study|Other|0
7369762|NCT01084655|11619913|FG001|Overall Study|Other|3
7369763|NCT01084655|11619914|FG002|Overall Study|Other|2
7369764|NCT01084655|11619912|FG000|Overall Study|Symptomatic deterioration|0
7369765|NCT01084655|11619913|FG001|Overall Study|Symptomatic deterioration|0
7369766|NCT01084655|11619914|FG002|Overall Study|Symptomatic deterioration|2
7369767|NCT01084655|11619912|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
7369768|NCT01084655|11619913|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
7369769|NCT01084655|11619914|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
7369770|NCT01084668|11619926|FG000|Overall Study|Lack of Efficacy|5
7369771|NCT01084668|11619926|FG000|Overall Study|Withdrawal by Subject|2
7369772|NCT01084668|11619926|FG000|Overall Study|Pregnancy|1
7369773|NCT01084668|11619926|FG000|Overall Study|Non-compliance|1
7369774|NCT01084694|11619934|FG000|Overall Study|Withdrawal by Subject|2
7369775|NCT01084694|11619935|FG001|Overall Study|Withdrawal by Subject|1
7369776|NCT01084694|11619934|FG000|Overall Study|Death|2
7369777|NCT01084694|11619935|FG001|Overall Study|Death|12
7369778|NCT01084694|11619934|FG000|Overall Study|eligibility not maintained|2
7369779|NCT01084694|11619935|FG001|Overall Study|eligibility not maintained|7
7369780|NCT01084707|11619949|FG000|Overall Study|Withdrawal by Subject|6
7369781|NCT01084772|11619967|FG000|Baseline|Withdrawal by Subject|7
7369782|NCT01084772|11619968|FG001|Baseline|Withdrawal by Subject|6
7369783|NCT01084772|11619967|FG000|3 Months|Death|1
7369784|NCT01084772|11619968|FG001|3 Months|Death|0
7369785|NCT01084772|11619967|FG000|3 Months|Study Termination|2
7369786|NCT01084772|11619968|FG001|3 Months|Study Termination|2
7369787|NCT01084772|11619967|FG000|1 Year|Withdrawal by Subject|0
7369788|NCT01084772|11619968|FG001|1 Year|Withdrawal by Subject|1
7369789|NCT01084772|11619967|FG000|1 Year|Lost to Follow-up|3
7369790|NCT01084772|11619968|FG001|1 Year|Lost to Follow-up|0
7369791|NCT01084772|11619967|FG000|1 Year|Study Termination|0
7369792|NCT01084772|11619968|FG001|1 Year|Study Termination|7
7369793|NCT01084772|11619967|FG000|2 Years|Withdrawal by Subject|1
7369794|NCT01084772|11619968|FG001|2 Years|Withdrawal by Subject|0
7369795|NCT01084772|11619967|FG000|2 Years|Lost to Follow-up|5
7369796|NCT01084772|11619968|FG001|2 Years|Lost to Follow-up|2
7369797|NCT01084772|11619967|FG000|2 Years|Study Termination|3
7369798|NCT01084772|11619968|FG001|2 Years|Study Termination|2
7461086|NCT01832727|11756789|FG001|Overall Study|Disease progression|0
7461087|NCT01832727|11756790|FG002|Overall Study|Disease progression|2
7461088|NCT01832727|11756791|FG003|Overall Study|Disease progression|1
7461089|NCT01832727|11756792|FG004|Overall Study|Disease progression|3
7461090|NCT01832727|11756793|FG005|Overall Study|Disease progression|3
7461091|NCT01832727|11756794|FG006|Overall Study|Disease progression|6
7461092|NCT01832727|11756795|FG007|Overall Study|Disease progression|2
7461093|NCT01832727|11756796|FG008|Overall Study|Disease progression|7
7461094|NCT01832727|11756788|FG000|Overall Study|Lost to Follow-up|0
7461095|NCT01832727|11756789|FG001|Overall Study|Lost to Follow-up|0
7461096|NCT01832727|11756790|FG002|Overall Study|Lost to Follow-up|0
7461097|NCT01832727|11756791|FG003|Overall Study|Lost to Follow-up|1
7461098|NCT01832727|11756792|FG004|Overall Study|Lost to Follow-up|0
7461099|NCT01832727|11756793|FG005|Overall Study|Lost to Follow-up|0
7461100|NCT01832727|11756794|FG006|Overall Study|Lost to Follow-up|0
7461101|NCT01832727|11756795|FG007|Overall Study|Lost to Follow-up|0
7461102|NCT01832727|11756796|FG008|Overall Study|Lost to Follow-up|0
7461103|NCT01832727|11756788|FG000|Overall Study|Physician Decision|1
7461104|NCT01832727|11756789|FG001|Overall Study|Physician Decision|0
7461105|NCT01832727|11756790|FG002|Overall Study|Physician Decision|0
7461106|NCT01832727|11756791|FG003|Overall Study|Physician Decision|1
7461107|NCT01832727|11756792|FG004|Overall Study|Physician Decision|0
7461108|NCT01832727|11756793|FG005|Overall Study|Physician Decision|1
7461109|NCT01832727|11756794|FG006|Overall Study|Physician Decision|0
7461110|NCT01832727|11756795|FG007|Overall Study|Physician Decision|0
7461111|NCT01832727|11756796|FG008|Overall Study|Physician Decision|0
7461112|NCT01832727|11756788|FG000|Overall Study|Withdrawal by Subject|1
7461113|NCT01832727|11756789|FG001|Overall Study|Withdrawal by Subject|1
7461114|NCT01832727|11756790|FG002|Overall Study|Withdrawal by Subject|0
7461115|NCT01832727|11756791|FG003|Overall Study|Withdrawal by Subject|1
7461116|NCT01832727|11756792|FG004|Overall Study|Withdrawal by Subject|0
7461117|NCT01832727|11756793|FG005|Overall Study|Withdrawal by Subject|1
7461118|NCT01832727|11756794|FG006|Overall Study|Withdrawal by Subject|0
7461119|NCT01832727|11756795|FG007|Overall Study|Withdrawal by Subject|2
7461120|NCT01832727|11756796|FG008|Overall Study|Withdrawal by Subject|1
7461121|NCT01832727|11756788|FG000|Overall Study|Study terminated by sponsor|0
7461122|NCT01832727|11756789|FG001|Overall Study|Study terminated by sponsor|0
7461123|NCT01832727|11756790|FG002|Overall Study|Study terminated by sponsor|0
7461124|NCT01832727|11756791|FG003|Overall Study|Study terminated by sponsor|0
7461125|NCT01832727|11756792|FG004|Overall Study|Study terminated by sponsor|0
7461126|NCT01832727|11756793|FG005|Overall Study|Study terminated by sponsor|0
7461127|NCT01832727|11756794|FG006|Overall Study|Study terminated by sponsor|0
7461128|NCT01832727|11756795|FG007|Overall Study|Study terminated by sponsor|1
7461129|NCT01832727|11756796|FG008|Overall Study|Study terminated by sponsor|1
7369799|NCT01085045|11619983|FG000|Part A|Withdrawal by Subject|4
7369800|NCT01085045|11619983|FG000|Part A|Adverse Event|6
7461130|NCT01832766|11756839|FG000|Washout|Lost to Follow-up|0
7461131|NCT01832766|11756840|FG001|Washout|Lost to Follow-up|1
7461132|NCT01832818|11756846|FG000|Overall Study|Lost to Follow-up|6
7461133|NCT01833065|11756878|FG000|Overall Study|Adverse Event|6
7461134|NCT01833065|11756879|FG001|Overall Study|Adverse Event|1
7461135|NCT01833065|11756880|FG002|Overall Study|Adverse Event|0
7461136|NCT01833065|11756881|FG003|Overall Study|Adverse Event|2
7369801|NCT01085045|11619983|FG000|Part A|Protocol Violation|1
7369802|NCT01085045|11619983|FG000|Part A|Protocol Specified Criteria|7
7369803|NCT01085045|11619983|FG000|Part B|Withdrawal by Subject|2
7369804|NCT01085045|11619983|FG000|Part B|Protocol Specified Criteria|6
7369805|NCT01085045|11619983|FG000|Part B|Lost to Follow-up|1
7461137|NCT01833065|11756882|FG004|Overall Study|Adverse Event|3
7369806|NCT01085045|11619983|FG000|Part B|Adverse Event|6
7461138|NCT01833065|11756878|FG000|Overall Study|Protocol Violation|1
7369807|NCT01085136|11620003|FG000|Part A|Other Adverse event|223
7369808|NCT01085136|11620004|FG001|Part A|Other Adverse event|0
7369809|NCT01085136|11620005|FG002|Part A|Other Adverse event|0
7369810|NCT01085136|11620003|FG000|Part A|Protocol Violation|3
7369811|NCT01085136|11620004|FG001|Part A|Protocol Violation|0
7369812|NCT01085136|11620005|FG002|Part A|Protocol Violation|0
7369813|NCT01085136|11620003|FG000|Part A|Lost to Follow-up|3
7369814|NCT01085136|11620004|FG001|Part A|Lost to Follow-up|0
7369815|NCT01085136|11620005|FG002|Part A|Lost to Follow-up|0
7369816|NCT01085136|11620003|FG000|Part A|Refusal to continue trial medication|64
7369817|NCT01085136|11620004|FG001|Part A|Refusal to continue trial medication|0
7369818|NCT01085136|11620005|FG002|Part A|Refusal to continue trial medication|0
7369819|NCT01085136|11620003|FG000|Part A|Other reason not defined above|30
7369820|NCT01085136|11620004|FG001|Part A|Other reason not defined above|0
7369821|NCT01085136|11620005|FG002|Part A|Other reason not defined above|0
7369822|NCT01085136|11620003|FG000|Part B|Other AE|0
7369823|NCT01085136|11620004|FG001|Part B|Other AE|29
7369824|NCT01085136|11620005|FG002|Part B|Other AE|8
7369825|NCT01085136|11620003|FG000|Part B|Refusal to continue trial medication|0
7369826|NCT01085136|11620004|FG001|Part B|Refusal to continue trial medication|12
7369827|NCT01085136|11620005|FG002|Part B|Refusal to continue trial medication|7
7369828|NCT01085136|11620003|FG000|Part B|Not treated|0
7369829|NCT01085136|11620004|FG001|Part B|Not treated|4
7369830|NCT01085136|11620005|FG002|Part B|Not treated|8
7369831|NCT01085136|11620003|FG000|Part B|Other reason not defined above|0
7369832|NCT01085136|11620004|FG001|Part B|Other reason not defined above|6
7369833|NCT01085136|11620005|FG002|Part B|Other reason not defined above|3
7369834|NCT01085201|11620020|FG000|Overall Study|Scheduling conflict|1
7369835|NCT01085201|11620021|FG001|Overall Study|Scheduling conflict|0
7369836|NCT01085201|11620022|FG002|Overall Study|Scheduling conflict|1
7369837|NCT01085201|11620023|FG003|Overall Study|Scheduling conflict|0
7369838|NCT01085201|11620024|FG004|Overall Study|Scheduling conflict|0
7369839|NCT01085201|11620020|FG000|Overall Study|Unknown- no study drug|2
7369840|NCT01085201|11620021|FG001|Overall Study|Unknown- no study drug|0
7369841|NCT01085201|11620022|FG002|Overall Study|Unknown- no study drug|0
7369842|NCT01085201|11620023|FG003|Overall Study|Unknown- no study drug|0
7369843|NCT01085201|11620024|FG004|Overall Study|Unknown- no study drug|0
7369844|NCT01085201|11620020|FG000|Overall Study|Fond ineligible after consent|0
7369845|NCT01085201|11620021|FG001|Overall Study|Fond ineligible after consent|1
7369846|NCT01085201|11620022|FG002|Overall Study|Fond ineligible after consent|1
7369847|NCT01085201|11620023|FG003|Overall Study|Fond ineligible after consent|0
7369848|NCT01085201|11620024|FG004|Overall Study|Fond ineligible after consent|0
7369849|NCT01085214|11620041|FG000|Overall Study|Alternate treatment required|1
7369850|NCT01085357|11620073|FG000|Overall Study|Adverse Event|1
7369851|NCT01085357|11620074|FG001|Overall Study|Adverse Event|1
7369852|NCT01085357|11620073|FG000|Overall Study|Subject Decision|4
7369853|NCT01085357|11620074|FG001|Overall Study|Subject Decision|3
7369854|NCT01085357|11620073|FG000|Overall Study|Investigator Decision|1
7369855|NCT01085357|11620074|FG001|Overall Study|Investigator Decision|1
7369856|NCT01085357|11620073|FG000|Overall Study|Death|11
7369857|NCT01085357|11620074|FG001|Overall Study|Death|1
7369858|NCT01085357|11620073|FG000|Overall Study|Lost to Follow-up|2
7369859|NCT01085357|11620074|FG001|Overall Study|Lost to Follow-up|0
7369860|NCT01085591|11620105|FG000|Overall Study|Adverse Event|0
7369861|NCT01085591|11620106|FG001|Overall Study|Adverse Event|1
7369862|NCT01085591|11620107|FG002|Overall Study|Adverse Event|3
7369863|NCT01085591|11620105|FG000|Overall Study|Physician Decision|1
7369864|NCT01085591|11620106|FG001|Overall Study|Physician Decision|0
7369865|NCT01085591|11620107|FG002|Overall Study|Physician Decision|1
7369866|NCT01085591|11620105|FG000|Overall Study|Withdrawal by Subject|0
7369867|NCT01085591|11620106|FG001|Overall Study|Withdrawal by Subject|2
7369868|NCT01085591|11620107|FG002|Overall Study|Withdrawal by Subject|1
7369869|NCT01085591|11620105|FG000|Overall Study|Lost to Follow-up|0
7369870|NCT01085591|11620106|FG001|Overall Study|Lost to Follow-up|1
7369871|NCT01085591|11620107|FG002|Overall Study|Lost to Follow-up|1
7369872|NCT01085591|11620105|FG000|Overall Study|Protocol Violation|1
7369873|NCT01085591|11620106|FG001|Overall Study|Protocol Violation|1
7369874|NCT01085591|11620107|FG002|Overall Study|Protocol Violation|1
7369875|NCT01085591|11620105|FG000|Overall Study|Other|0
7369876|NCT01085591|11620106|FG001|Overall Study|Other|1
7369877|NCT01085591|11620107|FG002|Overall Study|Other|0
7369878|NCT01085591|11620105|FG000|Overall Study|Not Properly Consented|1
7369879|NCT01085591|11620106|FG001|Overall Study|Not Properly Consented|0
7369880|NCT01085591|11620107|FG002|Overall Study|Not Properly Consented|0
7369881|NCT01085630|11620118|FG000|Overall Study|Insufficient data|1
7369882|NCT01085630|11620119|FG001|Overall Study|Insufficient data|0
7369883|NCT01085630|11620118|FG000|Overall Study|Ineligible|3
7369884|NCT01085630|11620119|FG001|Overall Study|Ineligible|0
7461139|NCT01833065|11756879|FG001|Overall Study|Protocol Violation|0
7461140|NCT01833065|11756880|FG002|Overall Study|Protocol Violation|0
7461141|NCT01833065|11756881|FG003|Overall Study|Protocol Violation|0
7461142|NCT01833065|11756882|FG004|Overall Study|Protocol Violation|2
7461143|NCT01833065|11756878|FG000|Overall Study|Lost to Follow-up|1
7461144|NCT01833065|11756879|FG001|Overall Study|Lost to Follow-up|0
7461145|NCT01833065|11756880|FG002|Overall Study|Lost to Follow-up|0
7461146|NCT01833065|11756881|FG003|Overall Study|Lost to Follow-up|0
7369885|NCT01085682|11620127|FG000|Overall Study|Withdrawal by Subject|25
7369886|NCT01085682|11620128|FG001|Overall Study|Withdrawal by Subject|25
7369887|NCT01085734|11620136|FG000|Overall Study|Adverse Event|0
7369888|NCT01085734|11620137|FG001|Overall Study|Adverse Event|2
7369889|NCT01085734|11620136|FG000|Overall Study|Death|1
7369890|NCT01085734|11620137|FG001|Overall Study|Death|0
7369891|NCT01085734|11620136|FG000|Overall Study|Lost to Follow-up|0
7369892|NCT01085734|11620137|FG001|Overall Study|Lost to Follow-up|1
7369893|NCT01085734|11620136|FG000|Overall Study|Withdrawal by Subject|0
7369894|NCT01085734|11620137|FG001|Overall Study|Withdrawal by Subject|1
7369895|NCT01085812|11620170|FG000|Open-Label Period|Adverse Event|0
7369896|NCT01085812|11620171|FG001|Open-Label Period|Adverse Event|80
7369897|NCT01085812|11620170|FG000|Open-Label Period|Lack of Efficacy|0
7369898|NCT01085812|11620171|FG001|Open-Label Period|Lack of Efficacy|26
7369899|NCT01085812|11620170|FG000|Open-Label Period|Protocol Violation|0
7369900|NCT01085812|11620171|FG001|Open-Label Period|Protocol Violation|39
7369901|NCT01085812|11620170|FG000|Open-Label Period|Withdrawal by Subject|0
7369902|NCT01085812|11620171|FG001|Open-Label Period|Withdrawal by Subject|53
7369903|NCT01085812|11620170|FG000|Open-Label Period|Lost to Follow-up|0
7369904|NCT01085812|11620171|FG001|Open-Label Period|Lost to Follow-up|42
7369905|NCT01085812|11620170|FG000|Double-Blind Period|Adverse Event|3
7369906|NCT01085812|11620171|FG001|Double-Blind Period|Adverse Event|8
7369907|NCT01085812|11620170|FG000|Double-Blind Period|Protocol Violation|2
7369908|NCT01085812|11620171|FG001|Double-Blind Period|Protocol Violation|7
7369909|NCT01085812|11620170|FG000|Double-Blind Period|Withdrawal by Subject|11
7369910|NCT01085812|11620171|FG001|Double-Blind Period|Withdrawal by Subject|24
7369911|NCT01085812|11620170|FG000|Double-Blind Period|Lost to Follow-up|5
7369912|NCT01085812|11620171|FG001|Double-Blind Period|Lost to Follow-up|17
7369913|NCT01085812|11620170|FG000|Double-Blind Period|Other Reasons|0
7369914|NCT01085812|11620171|FG001|Double-Blind Period|Other Reasons|2
7369915|NCT01085812|11620170|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
7369916|NCT01085812|11620171|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
7369917|NCT01085812|11620170|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
7369918|NCT01085812|11620171|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
7369919|NCT01085812|11620170|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
7369920|NCT01085812|11620171|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
7369921|NCT01085812|11620170|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
7369922|NCT01085812|11620171|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
7369923|NCT01085812|11620170|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
7369924|NCT01085812|11620171|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
7369925|NCT01086033|11620219|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
7369926|NCT01086033|11620219|FG000|Overall Study|Lost to Follow-up|86
7369927|NCT01086033|11620219|FG000|Overall Study|Adverse Event|42
7369928|NCT01086033|11620219|FG000|Overall Study|Withdrawal by Subject|41
7369929|NCT01086033|11620219|FG000|Overall Study|Other|14
7369930|NCT01086033|11620219|FG000|Overall Study|Other|13
7369931|NCT01086033|11620219|FG000|Overall Study|AE and Withdrew Consent|5
7369932|NCT01086033|11620219|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
7369933|NCT01086033|11620219|FG000|Overall Study|Withdrew consent and Other Reason|4
7369934|NCT01086033|11620219|FG000|Overall Study|AE and Lack of Efficacy|4
7369935|NCT01086033|11620219|FG000|Overall Study|Death|1
7369936|NCT01086033|11620219|FG000|Overall Study|AE and Lost to Follow-up|1
7369937|NCT01086033|11620219|FG000|Overall Study|AE and Other Reason|1
7369938|NCT01086033|11620219|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
7369939|NCT01086150|11620229|FG000|Overall Study|Withdrawal by Subject|0
7369940|NCT01086150|11620230|FG001|Overall Study|Withdrawal by Subject|4
7369941|NCT01086150|11620231|FG002|Overall Study|Withdrawal by Subject|1
7369942|NCT01086150|11620229|FG000|Overall Study|Lost to Follow-up|0
7369943|NCT01086150|11620230|FG001|Overall Study|Lost to Follow-up|1
7369944|NCT01086150|11620231|FG002|Overall Study|Lost to Follow-up|0
7369945|NCT01086150|11620229|FG000|Overall Study|Screen Failure|0
7369946|NCT01086150|11620230|FG001|Overall Study|Screen Failure|1
7369947|NCT01086150|11620231|FG002|Overall Study|Screen Failure|0
7369948|NCT01086215|11620243|FG000|Overall Study|Death|14
7369949|NCT01086215|11620244|FG001|Overall Study|Death|8
7369950|NCT01086215|11620245|FG002|Overall Study|Death|8
7369951|NCT01086215|11620246|FG003|Overall Study|Death|1
7369952|NCT01086215|11620243|FG000|Overall Study|Lost to Follow-up|22
7369953|NCT01086215|11620244|FG001|Overall Study|Lost to Follow-up|39
7369954|NCT01086215|11620245|FG002|Overall Study|Lost to Follow-up|18
7369955|NCT01086215|11620246|FG003|Overall Study|Lost to Follow-up|2
7369956|NCT01086358|11620260|FG000|First Intervention|Lost to Follow-up|9
7369957|NCT01086358|11620261|FG001|First Intervention|Lost to Follow-up|4
7369958|NCT01086358|11620260|FG000|First Intervention|Withdrawal by Subject|0
7369959|NCT01086358|11620261|FG001|First Intervention|Withdrawal by Subject|1
7369960|NCT01086358|11620260|FG000|Second Intervention|Lost to Follow-up|4
7369961|NCT01086358|11620261|FG001|Second Intervention|Lost to Follow-up|4
7369962|NCT01086384|11620269|FG000|2-week Run-in Period|Adverse Event|1
7369963|NCT01086384|11620270|FG001|2-week Run-in Period|Adverse Event|0
7369964|NCT01086384|11620271|FG002|2-week Run-in Period|Adverse Event|0
7369965|NCT01086384|11620269|FG000|2-week Run-in Period|Protocol Violation|1
7369966|NCT01086384|11620270|FG001|2-week Run-in Period|Protocol Violation|0
7369967|NCT01086384|11620271|FG002|2-week Run-in Period|Protocol Violation|0
7369968|NCT01086384|11620269|FG000|2-week Run-in Period|Lost to Follow-up|1
7369969|NCT01086384|11620270|FG001|2-week Run-in Period|Lost to Follow-up|0
7369970|NCT01086384|11620271|FG002|2-week Run-in Period|Lost to Follow-up|0
7369971|NCT01086384|11620269|FG000|2-week Run-in Period|Physician Decision|6
7369972|NCT01086384|11620270|FG001|2-week Run-in Period|Physician Decision|0
7369973|NCT01086384|11620271|FG002|2-week Run-in Period|Physician Decision|0
7369974|NCT01086384|11620269|FG000|2-week Run-in Period|Withdrawal by Subject|19
7369975|NCT01086384|11620270|FG001|2-week Run-in Period|Withdrawal by Subject|0
7369976|NCT01086384|11620271|FG002|2-week Run-in Period|Withdrawal by Subject|0
7369977|NCT01086384|11620269|FG000|2-week Run-in Period|Study Closed/Terminated|42
7369978|NCT01086384|11620270|FG001|2-week Run-in Period|Study Closed/Terminated|0
7369979|NCT01086384|11620271|FG002|2-week Run-in Period|Study Closed/Terminated|0
7369980|NCT01086384|11620269|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
7369981|NCT01086384|11620270|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
7369982|NCT01086384|11620271|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
7369983|NCT01086384|11620269|FG000|2-week Run-in Period|Randomized in Error|1
7369984|NCT01086384|11620270|FG001|2-week Run-in Period|Randomized in Error|0
7369985|NCT01086384|11620271|FG002|2-week Run-in Period|Randomized in Error|0
7369986|NCT01086384|11620269|FG000|Treatment Period|Withdrawal by Subject|0
7369987|NCT01086384|11620270|FG001|Treatment Period|Withdrawal by Subject|53
7369988|NCT01086384|11620271|FG002|Treatment Period|Withdrawal by Subject|55
7369989|NCT01086384|11620269|FG000|Treatment Period|Protocol Violation|0
7369990|NCT01086384|11620270|FG001|Treatment Period|Protocol Violation|26
7369991|NCT01086384|11620271|FG002|Treatment Period|Protocol Violation|17
7369992|NCT01086384|11620269|FG000|Treatment Period|Lack of Efficacy|0
7369993|NCT01086384|11620270|FG001|Treatment Period|Lack of Efficacy|22
7369994|NCT01086384|11620271|FG002|Treatment Period|Lack of Efficacy|13
7369995|NCT01086384|11620269|FG000|Treatment Period|Adverse Event|0
7369996|NCT01086384|11620270|FG001|Treatment Period|Adverse Event|19
7369997|NCT01086384|11620271|FG002|Treatment Period|Adverse Event|15
7369998|NCT01086384|11620269|FG000|Treatment Period|Lost to Follow-up|0
7369999|NCT01086384|11620270|FG001|Treatment Period|Lost to Follow-up|11
7370000|NCT01086384|11620271|FG002|Treatment Period|Lost to Follow-up|9
7370001|NCT01086384|11620269|FG000|Treatment Period|Physician Decision|0
7370002|NCT01086384|11620270|FG001|Treatment Period|Physician Decision|9
7370003|NCT01086384|11620271|FG002|Treatment Period|Physician Decision|6
7370004|NCT01086384|11620269|FG000|Treatment Period|Study Closed/Terminated|0
7370005|NCT01086384|11620270|FG001|Treatment Period|Study Closed/Terminated|7
7370006|NCT01086384|11620271|FG002|Treatment Period|Study Closed/Terminated|8
7370007|NCT01086384|11620269|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
7370008|NCT01086384|11620270|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
7370009|NCT01086384|11620271|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
7370010|NCT01086384|11620269|FG000|Treatment Period|Received Treatment in Error|0
7370011|NCT01086384|11620270|FG001|Treatment Period|Received Treatment in Error|1
7370012|NCT01086384|11620271|FG002|Treatment Period|Received Treatment in Error|0
7386876|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386877|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386878|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386879|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386880|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7386881|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
7386882|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7386883|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7386884|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386885|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386886|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386887|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386888|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386889|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7386890|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7386891|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386892|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
7386893|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386894|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386895|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386896|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386897|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386898|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7386899|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386900|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386901|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7386902|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7370013|NCT01086410|11620281|FG000|Overall Study|Adverse Event|1
7370014|NCT01086410|11620282|FG001|Overall Study|Adverse Event|0
7370015|NCT01086410|11620283|FG002|Overall Study|Adverse Event|0
7370016|NCT01086410|11620284|FG003|Overall Study|Adverse Event|2
7370017|NCT01086410|11620281|FG000|Overall Study|Lack of Efficacy|1
7370018|NCT01086410|11620282|FG001|Overall Study|Lack of Efficacy|1
7370019|NCT01086410|11620283|FG002|Overall Study|Lack of Efficacy|0
7370020|NCT01086410|11620284|FG003|Overall Study|Lack of Efficacy|0
7370021|NCT01086410|11620281|FG000|Overall Study|Protocol Violation|1
7370022|NCT01086410|11620282|FG001|Overall Study|Protocol Violation|1
7370023|NCT01086410|11620283|FG002|Overall Study|Protocol Violation|0
7370024|NCT01086410|11620284|FG003|Overall Study|Protocol Violation|0
7370025|NCT01086410|11620281|FG000|Overall Study|Lost to Follow-up|0
7370026|NCT01086410|11620282|FG001|Overall Study|Lost to Follow-up|0
7370027|NCT01086410|11620283|FG002|Overall Study|Lost to Follow-up|1
7370028|NCT01086410|11620284|FG003|Overall Study|Lost to Follow-up|0
7370029|NCT01086423|11620297|FG000|Overall Study|Protocol Violation|0
7370030|NCT01086423|11620298|FG001|Overall Study|Protocol Violation|0
7370031|NCT01086423|11620299|FG002|Overall Study|Protocol Violation|1
7370032|NCT01086423|11620297|FG000|Overall Study|Migrated/moved from study area|2
7370033|NCT01086423|11620298|FG001|Overall Study|Migrated/moved from study area|0
7370034|NCT01086423|11620299|FG002|Overall Study|Migrated/moved from study area|4
7370035|NCT01086423|11620297|FG000|Overall Study|Adverse event, fatal|1
7370036|NCT01086423|11620298|FG001|Overall Study|Adverse event, fatal|1
7370037|NCT01086423|11620299|FG002|Overall Study|Adverse event, fatal|0
7370038|NCT01086423|11620297|FG000|Overall Study|Adverse event, non-fatal|2
7370039|NCT01086423|11620298|FG001|Overall Study|Adverse event, non-fatal|1
7370040|NCT01086423|11620299|FG002|Overall Study|Adverse event, non-fatal|0
7370041|NCT01086423|11620297|FG000|Overall Study|Withdrawal by Subject|5
7370042|NCT01086423|11620298|FG001|Overall Study|Withdrawal by Subject|1
7370043|NCT01086423|11620299|FG002|Overall Study|Withdrawal by Subject|3
7370044|NCT01086423|11620297|FG000|Overall Study|Lost to Follow-up|0
7370045|NCT01086423|11620298|FG001|Overall Study|Lost to Follow-up|0
7370046|NCT01086423|11620299|FG002|Overall Study|Lost to Follow-up|1
7370047|NCT01086540|11620318|FG000|Overall Study|Death|3
7370048|NCT01086540|11620319|FG001|Overall Study|Death|1
7370049|NCT01086540|11620318|FG000|Overall Study|Physician Decision|2
7370050|NCT01086540|11620319|FG001|Overall Study|Physician Decision|1
7370051|NCT01086540|11620318|FG000|Overall Study|Addition of new therapy for PAH|1
7370052|NCT01086540|11620319|FG001|Overall Study|Addition of new therapy for PAH|0
7370053|NCT01086969|11620366|FG000|Overall Study|Withdrawal by Subject|1
7370054|NCT01086969|11620367|FG001|Overall Study|Withdrawal by Subject|2
7370055|NCT01086969|11620368|FG002|Overall Study|Withdrawal by Subject|0
7370056|NCT01087489|11620376|FG000|Overall Study|enrolled in another VA study|0
7370057|NCT01087489|11620377|FG001|Overall Study|enrolled in another VA study|1
7370058|NCT01087489|11620376|FG000|Overall Study|Death|0
7370059|NCT01087489|11620377|FG001|Overall Study|Death|1
7370060|NCT01087489|11620376|FG000|Overall Study|unable to survey by telephone|0
7370061|NCT01087489|11620377|FG001|Overall Study|unable to survey by telephone|1
7370062|NCT01087502|11620385|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
7370063|NCT01087502|11620386|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
7370064|NCT01087502|11620385|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
7370065|NCT01087502|11620386|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
7370066|NCT01087502|11620385|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7370067|NCT01087502|11620386|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
7370068|NCT01087502|11620385|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
7370069|NCT01087502|11620386|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
7370070|NCT01087502|11620385|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
7370071|NCT01087502|11620386|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
7370072|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
7370073|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
7370074|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
7370075|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
7370076|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
7370077|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
7370078|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
7370079|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
7370080|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
7370081|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
7370082|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
7370083|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
7370084|NCT01087502|11620385|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
7370085|NCT01087502|11620386|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
7370086|NCT01087528|11620394|FG000|Overall Study|Withdrawal by Subject|1
7370087|NCT01087528|11620394|FG000|Overall Study|Incomplete CE procedure|6
7370088|NCT01087723|11620411|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
7370089|NCT01087723|11620412|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
7370090|NCT01087723|11620411|FG000|Overall Study|Withdrawal by Subject|10
7370091|NCT01087723|11620412|FG001|Overall Study|Withdrawal by Subject|13
7370092|NCT01087723|11620411|FG000|Overall Study|Physician Decision|2
7370093|NCT01087723|11620412|FG001|Overall Study|Physician Decision|0
7370094|NCT01087723|11620411|FG000|Overall Study|Lost to Follow-up|1
7370095|NCT01087723|11620412|FG001|Overall Study|Lost to Follow-up|4
7370096|NCT01087723|11620411|FG000|Overall Study|Reason Not Specified|1
7370097|NCT01087723|11620412|FG001|Overall Study|Reason Not Specified|2
7370098|NCT01087736|11620420|FG000|Overall Study|Lost to Follow-up|1
7370099|NCT01087736|11620421|FG001|Overall Study|Lost to Follow-up|0
7370100|NCT01087736|11620420|FG000|Overall Study|Death|0
7370101|NCT01087736|11620421|FG001|Overall Study|Death|1
7370102|NCT01087736|11620420|FG000|Overall Study|Withdrawal by Subject|0
7370103|NCT01087736|11620421|FG001|Overall Study|Withdrawal by Subject|1
7370104|NCT01087762|11620430|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
7370105|NCT01087762|11620431|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7370106|NCT01087762|11620432|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
7370107|NCT01087762|11620433|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7370108|NCT01087762|11620434|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
7370109|NCT01087762|11620430|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
7370110|NCT01087762|11620431|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7370111|NCT01087762|11620432|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
7370112|NCT01087762|11620433|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7370113|NCT01087762|11620434|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
7370114|NCT01087762|11620430|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7370115|NCT01087762|11620431|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
7370116|NCT01087762|11620432|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
7370117|NCT01087762|11620433|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7370118|NCT01087762|11620434|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
7370119|NCT01087762|11620430|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7370120|NCT01087762|11620431|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
7370121|NCT01087762|11620432|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
7370122|NCT01087762|11620433|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7370123|NCT01087762|11620434|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
7370124|NCT01087762|11620430|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7370125|NCT01087762|11620431|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
7370126|NCT01087762|11620432|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
7370127|NCT01087762|11620433|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7370128|NCT01087762|11620434|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
7370129|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7370130|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7370131|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
7370132|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
7370133|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
7370134|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7370135|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7370136|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
7370137|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7370138|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
7370139|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7370140|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7370141|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
7370142|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
7370143|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
7370144|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7370145|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7370146|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
7370147|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
7370148|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
7370149|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|Other|0
7370150|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|Other|0
7570483|NCT03492281|11948219|FG000|Overall Study|Withdrawn Due to Sponsor|1
7370151|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|Other|0
7370152|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|Other|2
7370153|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|Other|4
7370154|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7370155|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7370156|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
7370157|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
7370158|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
7370159|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7370160|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7370161|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
7370162|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
7370163|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
7387703|NCT01215916|11646441|FG003|Overall Study|Progressive Disease|2
7370164|NCT01087762|11620430|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7370165|NCT01087762|11620431|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7370166|NCT01087762|11620432|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
7370167|NCT01087762|11620433|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
7370168|NCT01087762|11620434|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
7370169|NCT01087775|11620444|FG000|Overall Study|failed inclusion criteria|2
7370170|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
7370171|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
7370172|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
7370173|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Protocol Violation|0
7370174|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Protocol Violation|1
7370175|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Protocol Violation|0
7370176|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
7370177|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
7370178|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
7370179|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
7370180|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
7370181|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
7370182|NCT01087788|11620452|FG000|24-weeks Double-blind Period|AE, serious fatal|0
7370183|NCT01087788|11620453|FG001|24-weeks Double-blind Period|AE, serious fatal|1
7370184|NCT01087788|11620454|FG002|24-weeks Double-blind Period|AE, serious fatal|1
7370185|NCT01087788|11620452|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
7370186|NCT01087788|11620453|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
7370187|NCT01087788|11620454|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
7370188|NCT01087788|11620452|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7370189|NCT01087788|11620453|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
7370190|NCT01087788|11620454|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
7370191|NCT01087788|11620452|FG000|24-weeks Double-blind Period|AE, unknown type|0
7370192|NCT01087788|11620453|FG001|24-weeks Double-blind Period|AE, unknown type|0
7370193|NCT01087788|11620454|FG002|24-weeks Double-blind Period|AE, unknown type|1
7370194|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
7370195|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7370196|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
7370197|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7370198|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
7370199|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
7370200|NCT01087788|11620452|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
7370201|NCT01087788|11620453|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
7370202|NCT01087788|11620454|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
7370203|NCT01087788|11620452|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7370204|NCT01087788|11620453|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
7370205|NCT01087788|11620454|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
7370206|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
7370207|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
7370208|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
7370209|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
7370210|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
7370211|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
7370212|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
7370213|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
7370214|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
7370215|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
7370216|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
7370217|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
7370218|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
7370219|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
7370220|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
7370221|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
7370222|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7370223|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
7370224|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
7370225|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7370226|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
7370227|NCT01087788|11620452|FG000|24-weeks Dose-blind Period|Patient moved|0
7370228|NCT01087788|11620453|FG001|24-weeks Dose-blind Period|Patient moved|0
7370229|NCT01087788|11620454|FG002|24-weeks Dose-blind Period|Patient moved|1
7370230|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
7370231|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
7370232|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
7370233|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Protocol Violation|2
7370234|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Protocol Violation|1
7370235|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Protocol Violation|0
7370236|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
7370237|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
7570484|NCT03492281|11948220|FG001|Overall Study|Withdrawn Due to Sponsor|0
7370238|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
7370239|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
7370240|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
7370241|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
7370242|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
7370243|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
7370244|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
7370245|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
7370246|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
7370247|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
7370248|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
7370249|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7370250|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
7370251|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7370252|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
7370253|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
7370254|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
7370255|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
7370256|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
7370257|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Sponsor request|1
7370258|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Sponsor request|0
7370259|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Sponsor request|0
7370260|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
7370261|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
7370262|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
7370263|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|No participation in study extension|0
7370264|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|No participation in study extension|0
7370265|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|No participation in study extension|1
7370266|NCT01087788|11620452|FG000|Open-Label Period (OL-P)|Personal reasons|0
7370267|NCT01087788|11620453|FG001|Open-Label Period (OL-P)|Personal reasons|0
7370268|NCT01087788|11620454|FG002|Open-Label Period (OL-P)|Personal reasons|1
7370269|NCT01087814|11620474|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
7370270|NCT01087814|11620475|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
7370271|NCT01087814|11620474|FG000|Second Intervention (5 Days)|Physician Decision|1
7370272|NCT01087814|11620475|FG001|Second Intervention (5 Days)|Physician Decision|0
7370273|NCT01087905|11620489|FG000|Overall Study|Lost to Follow-up|24
7370274|NCT01087905|11620490|FG001|Overall Study|Lost to Follow-up|28
7370275|NCT01087905|11620491|FG002|Overall Study|Lost to Follow-up|18
7370276|NCT01087905|11620492|FG003|Overall Study|Lost to Follow-up|31
7370277|NCT01087905|11620493|FG004|Overall Study|Lost to Follow-up|27
7370278|NCT01087905|11620494|FG005|Overall Study|Lost to Follow-up|25
7370279|NCT01087905|11620495|FG006|Overall Study|Lost to Follow-up|20
7570485|NCT03492281|11948221|FG002|Overall Study|Withdrawn Due to Sponsor|1
7570486|NCT03492281|11948219|FG000|Overall Study|Death|0
7570487|NCT03492281|11948220|FG001|Overall Study|Death|0
7570488|NCT03492281|11948221|FG002|Overall Study|Death|1
7570489|NCT03492281|11948219|FG000|Overall Study|Captured as Other in Database|8
7370280|NCT01087905|11620496|FG007|Overall Study|Lost to Follow-up|24
7370281|NCT01087905|11620489|FG000|Overall Study|Withdrawal by Subject|5
7370282|NCT01087905|11620490|FG001|Overall Study|Withdrawal by Subject|4
7370283|NCT01087905|11620491|FG002|Overall Study|Withdrawal by Subject|4
7370284|NCT01087905|11620492|FG003|Overall Study|Withdrawal by Subject|5
7370285|NCT01087905|11620493|FG004|Overall Study|Withdrawal by Subject|4
7370286|NCT01087905|11620494|FG005|Overall Study|Withdrawal by Subject|3
7370287|NCT01087905|11620495|FG006|Overall Study|Withdrawal by Subject|3
7370288|NCT01087905|11620496|FG007|Overall Study|Withdrawal by Subject|5
7370289|NCT01087944|11620534|FG000|Period 1 (Week 1-3)|Adverse Event|1
7370290|NCT01087944|11620535|FG001|Period 1 (Week 1-3)|Adverse Event|0
7370291|NCT01087944|11620534|FG000|Period 2 (Week 4-6)|Adverse Event|0
7370292|NCT01087944|11620535|FG001|Period 2 (Week 4-6)|Adverse Event|2
7370293|NCT01087957|11620543|FG000|Overall Study|Death|2
7370294|NCT01087957|11620544|FG001|Overall Study|Death|2
7370295|NCT01087957|11620543|FG000|Overall Study|Lost to Follow-up|3
7370296|NCT01087957|11620544|FG001|Overall Study|Lost to Follow-up|4
7370297|NCT01087957|11620543|FG000|Overall Study|Protocol Violation|13
7370298|NCT01087957|11620544|FG001|Overall Study|Protocol Violation|25
7370299|NCT01087957|11620543|FG000|Overall Study|Withdrawal by Subject|18
7370300|NCT01087957|11620544|FG001|Overall Study|Withdrawal by Subject|15
7370301|NCT01087957|11620543|FG000|Overall Study|Physician Decision|5
7370302|NCT01087957|11620544|FG001|Overall Study|Physician Decision|9
7370303|NCT01087970|11620550|FG000|Overall Study|Protocol Violation|2
7370304|NCT01088048|11620574|FG000|Overall Study|Adverse Event|7
7370305|NCT01088048|11620575|FG001|Overall Study|Adverse Event|9
7370306|NCT01088048|11620576|FG002|Overall Study|Adverse Event|7
7370307|NCT01088048|11620577|FG003|Overall Study|Adverse Event|5
7370308|NCT01088048|11620578|FG004|Overall Study|Adverse Event|6
7370309|NCT01088048|11620579|FG005|Overall Study|Adverse Event|3
7370310|NCT01088048|11620580|FG006|Overall Study|Adverse Event|3
7370311|NCT01088048|11620581|FG007|Overall Study|Adverse Event|0
7370312|NCT01088048|11620582|FG008|Overall Study|Adverse Event|2
7370313|NCT01088048|11620583|FG009|Overall Study|Adverse Event|2
7370314|NCT01088048|11620574|FG000|Overall Study|Withdrew Consent|1
7370315|NCT01088048|11620575|FG001|Overall Study|Withdrew Consent|1
7370316|NCT01088048|11620576|FG002|Overall Study|Withdrew Consent|1
7370317|NCT01088048|11620577|FG003|Overall Study|Withdrew Consent|1
7370318|NCT01088048|11620578|FG004|Overall Study|Withdrew Consent|2
7370319|NCT01088048|11620579|FG005|Overall Study|Withdrew Consent|1
7370320|NCT01088048|11620580|FG006|Overall Study|Withdrew Consent|0
7370321|NCT01088048|11620581|FG007|Overall Study|Withdrew Consent|2
7370322|NCT01088048|11620582|FG008|Overall Study|Withdrew Consent|2
7370323|NCT01088048|11620583|FG009|Overall Study|Withdrew Consent|1
7370324|NCT01088048|11620574|FG000|Overall Study|Concomitant Medication Prohibited|1
7370325|NCT01088048|11620575|FG001|Overall Study|Concomitant Medication Prohibited|0
7370326|NCT01088048|11620576|FG002|Overall Study|Concomitant Medication Prohibited|0
7370327|NCT01088048|11620577|FG003|Overall Study|Concomitant Medication Prohibited|0
7370328|NCT01088048|11620578|FG004|Overall Study|Concomitant Medication Prohibited|0
7370329|NCT01088048|11620579|FG005|Overall Study|Concomitant Medication Prohibited|0
7370330|NCT01088048|11620580|FG006|Overall Study|Concomitant Medication Prohibited|0
7370331|NCT01088048|11620581|FG007|Overall Study|Concomitant Medication Prohibited|0
7370332|NCT01088048|11620582|FG008|Overall Study|Concomitant Medication Prohibited|0
7370333|NCT01088048|11620583|FG009|Overall Study|Concomitant Medication Prohibited|0
7370334|NCT01088048|11620574|FG000|Overall Study|Investigator Request|2
7370335|NCT01088048|11620575|FG001|Overall Study|Investigator Request|2
7370336|NCT01088048|11620576|FG002|Overall Study|Investigator Request|0
7370337|NCT01088048|11620577|FG003|Overall Study|Investigator Request|0
7370338|NCT01088048|11620578|FG004|Overall Study|Investigator Request|3
7370339|NCT01088048|11620579|FG005|Overall Study|Investigator Request|1
7370340|NCT01088048|11620580|FG006|Overall Study|Investigator Request|1
7370341|NCT01088048|11620581|FG007|Overall Study|Investigator Request|0
7370342|NCT01088048|11620582|FG008|Overall Study|Investigator Request|0
7370343|NCT01088048|11620583|FG009|Overall Study|Investigator Request|0
7370344|NCT01088048|11620574|FG000|Overall Study|Patient Non-compliance|0
7370345|NCT01088048|11620575|FG001|Overall Study|Patient Non-compliance|1
7370346|NCT01088048|11620576|FG002|Overall Study|Patient Non-compliance|0
7370347|NCT01088048|11620577|FG003|Overall Study|Patient Non-compliance|0
7370348|NCT01088048|11620578|FG004|Overall Study|Patient Non-compliance|0
7370349|NCT01088048|11620579|FG005|Overall Study|Patient Non-compliance|0
7370350|NCT01088048|11620580|FG006|Overall Study|Patient Non-compliance|0
7370351|NCT01088048|11620581|FG007|Overall Study|Patient Non-compliance|0
7370352|NCT01088048|11620582|FG008|Overall Study|Patient Non-compliance|0
7370353|NCT01088048|11620583|FG009|Overall Study|Patient Non-compliance|0
7370354|NCT01088048|11620574|FG000|Overall Study|Disease Progression|7
7370355|NCT01088048|11620575|FG001|Overall Study|Disease Progression|4
7370356|NCT01088048|11620576|FG002|Overall Study|Disease Progression|3
7370357|NCT01088048|11620577|FG003|Overall Study|Disease Progression|5
7370358|NCT01088048|11620578|FG004|Overall Study|Disease Progression|3
7370359|NCT01088048|11620579|FG005|Overall Study|Disease Progression|3
7370360|NCT01088048|11620580|FG006|Overall Study|Disease Progression|2
7370361|NCT01088048|11620581|FG007|Overall Study|Disease Progression|1
7370362|NCT01088048|11620582|FG008|Overall Study|Disease Progression|0
7370363|NCT01088048|11620583|FG009|Overall Study|Disease Progression|0
7370364|NCT01088048|11620574|FG000|Overall Study|Death|1
7370365|NCT01088048|11620575|FG001|Overall Study|Death|5
7370366|NCT01088048|11620576|FG002|Overall Study|Death|3
7370367|NCT01088048|11620577|FG003|Overall Study|Death|3
7370368|NCT01088048|11620578|FG004|Overall Study|Death|1
7370369|NCT01088048|11620579|FG005|Overall Study|Death|3
7370370|NCT01088048|11620580|FG006|Overall Study|Death|0
7370371|NCT01088048|11620581|FG007|Overall Study|Death|0
7370372|NCT01088048|11620582|FG008|Overall Study|Death|3
7370373|NCT01088048|11620583|FG009|Overall Study|Death|1
7370374|NCT01088048|11620574|FG000|Overall Study|Other|3
7370375|NCT01088048|11620575|FG001|Overall Study|Other|5
7370376|NCT01088048|11620576|FG002|Overall Study|Other|0
7370377|NCT01088048|11620577|FG003|Overall Study|Other|0
7370378|NCT01088048|11620578|FG004|Overall Study|Other|2
7370379|NCT01088048|11620579|FG005|Overall Study|Other|0
7370380|NCT01088048|11620580|FG006|Overall Study|Other|0
7370381|NCT01088048|11620581|FG007|Overall Study|Other|2
7370382|NCT01088048|11620582|FG008|Overall Study|Other|0
7370383|NCT01088048|11620583|FG009|Overall Study|Other|0
7370384|NCT01088243|11620618|FG000|Overall Study|Adverse Event|1
7370385|NCT01088243|11620619|FG001|Overall Study|Adverse Event|0
7370386|NCT01088399|11620632|FG000|Overall Study|Adverse Event|211
7370387|NCT01088399|11620633|FG001|Overall Study|Adverse Event|16
7370388|NCT01088399|11620634|FG002|Overall Study|Adverse Event|0
7370389|NCT01088399|11620632|FG000|Overall Study|Death|204
7370390|NCT01088399|11620633|FG001|Overall Study|Death|45
7370391|NCT01088399|11620634|FG002|Overall Study|Death|0
7370392|NCT01088399|11620632|FG000|Overall Study|Lack of Efficacy|298
7370393|NCT01088399|11620633|FG001|Overall Study|Lack of Efficacy|7
7370394|NCT01088399|11620634|FG002|Overall Study|Lack of Efficacy|5
7370395|NCT01088399|11620632|FG000|Overall Study|Lost to Follow-up|1070
7370396|NCT01088399|11620633|FG001|Overall Study|Lost to Follow-up|278
7370397|NCT01088399|11620634|FG002|Overall Study|Lost to Follow-up|58
7370398|NCT01088399|11620632|FG000|Overall Study|Physician Decision|531
7370399|NCT01088399|11620633|FG001|Overall Study|Physician Decision|88
7370400|NCT01088399|11620634|FG002|Overall Study|Physician Decision|16
7370401|NCT01088399|11620632|FG000|Overall Study|Withdrawal by Subject|544
7370402|NCT01088399|11620633|FG001|Overall Study|Withdrawal by Subject|195
7370403|NCT01088399|11620634|FG002|Overall Study|Withdrawal by Subject|33
7370404|NCT01088399|11620632|FG000|Overall Study|Change to or start of somatropin therapy|234
7370405|NCT01088399|11620633|FG001|Overall Study|Change to or start of somatropin therapy|17
7370406|NCT01088399|11620634|FG002|Overall Study|Change to or start of somatropin therapy|12
7370407|NCT01088399|11620632|FG000|Overall Study|Sponsor decision|1573
7370408|NCT01088399|11620633|FG001|Overall Study|Sponsor decision|298
7370409|NCT01088399|11620634|FG002|Overall Study|Sponsor decision|7
7370410|NCT01088399|11620632|FG000|Overall Study|Protocol Violation|10
7370411|NCT01088399|11620633|FG001|Overall Study|Protocol Violation|1
7370412|NCT01088399|11620634|FG002|Overall Study|Protocol Violation|0
7370413|NCT01088399|11620632|FG000|Overall Study|Enrollment criteria not met|48
7370414|NCT01088399|11620633|FG001|Overall Study|Enrollment criteria not met|119
7370415|NCT01088399|11620634|FG002|Overall Study|Enrollment criteria not met|70
7370416|NCT01088399|11620632|FG000|Overall Study|Study summary visit not completed|2398
7370417|NCT01088399|11620633|FG001|Overall Study|Study summary visit not completed|283
7370418|NCT01088399|11620634|FG002|Overall Study|Study summary visit not completed|80
7370419|NCT01088412|11620645|FG000|Overall Study|Adverse Event|38
7370420|NCT01088412|11620646|FG001|Overall Study|Adverse Event|0
7370421|NCT01088412|11620647|FG002|Overall Study|Adverse Event|0
7370422|NCT01088412|11620645|FG000|Overall Study|Death|42
7370423|NCT01088412|11620646|FG001|Overall Study|Death|6
7370424|NCT01088412|11620647|FG002|Overall Study|Death|0
7370425|NCT01088412|11620645|FG000|Overall Study|Other Reason per Case Report Form|2089
7370426|NCT01088412|11620646|FG001|Overall Study|Other Reason per Case Report Form|103
7370427|NCT01088412|11620647|FG002|Overall Study|Other Reason per Case Report Form|9
7370428|NCT01088412|11620645|FG000|Overall Study|Withdrawal by Subject|1761
7370429|NCT01088412|11620646|FG001|Overall Study|Withdrawal by Subject|25
7370430|NCT01088412|11620647|FG002|Overall Study|Withdrawal by Subject|1
7370431|NCT01088412|11620645|FG000|Overall Study|Received Another GH Product|79
7370432|NCT01088412|11620646|FG001|Overall Study|Received Another GH Product|0
7370433|NCT01088412|11620647|FG002|Overall Study|Received Another GH Product|0
7370434|NCT01088412|11620645|FG000|Overall Study|Participant Moved|601
7370435|NCT01088412|11620646|FG001|Overall Study|Participant Moved|21
7370436|NCT01088412|11620647|FG002|Overall Study|Participant Moved|2
7370437|NCT01088412|11620645|FG000|Overall Study|Physician Decision|1041
7370438|NCT01088412|11620646|FG001|Overall Study|Physician Decision|8
7370439|NCT01088412|11620647|FG002|Overall Study|Physician Decision|4
7370440|NCT01088412|11620645|FG000|Overall Study|Sponsor Decision|4467
7370441|NCT01088412|11620646|FG001|Overall Study|Sponsor Decision|79
7370442|NCT01088412|11620647|FG002|Overall Study|Sponsor Decision|23
7370443|NCT01088412|11620645|FG000|Overall Study|Third Party Required to Change Brand|487
7370444|NCT01088412|11620646|FG001|Overall Study|Third Party Required to Change Brand|0
7370445|NCT01088412|11620647|FG002|Overall Study|Third Party Required to Change Brand|0
7370446|NCT01088412|11620645|FG000|Overall Study|Lost to Follow-up|3052
7370447|NCT01088412|11620646|FG001|Overall Study|Lost to Follow-up|130
7370448|NCT01088412|11620647|FG002|Overall Study|Lost to Follow-up|11
7370449|NCT01088412|11620645|FG000|Overall Study|Study Summary Not Completed|4360
7370450|NCT01088412|11620646|FG001|Overall Study|Study Summary Not Completed|64
7370451|NCT01088412|11620647|FG002|Overall Study|Study Summary Not Completed|22
7370452|NCT01088438|11620660|FG000|Overall Study|Withdrawal by Subject|11
7370453|NCT01088438|11620661|FG001|Overall Study|Withdrawal by Subject|6
7370454|NCT01088438|11620660|FG000|Overall Study|Lost to Follow-up|18
7370455|NCT01088438|11620661|FG001|Overall Study|Lost to Follow-up|30
7370456|NCT01088503|11620683|FG000|Overall Study|Withdrawal by Subject|118
7370457|NCT01088503|11620684|FG001|Overall Study|Withdrawal by Subject|327
7370458|NCT01088503|11620685|FG002|Overall Study|Withdrawal by Subject|10
7370459|NCT01088503|11620683|FG000|Overall Study|Death|64
7370460|NCT01088503|11620684|FG001|Overall Study|Death|358
7370461|NCT01088503|11620685|FG002|Overall Study|Death|7
7370462|NCT01088529|11620693|FG000|Overall Study|Did not receive study treatment|0
7370463|NCT01088529|11620694|FG001|Overall Study|Did not receive study treatment|1
7370464|NCT01088984|11620730|FG000|Phase 1|Death|2
7370465|NCT01088984|11620731|FG001|Phase 1|Death|1
7370466|NCT01088984|11620730|FG000|Phase 1|Disease Progression|2
7370467|NCT01088984|11620731|FG001|Phase 1|Disease Progression|4
7370468|NCT01088984|11620730|FG000|Phase 1|Other|1
7370469|NCT01088984|11620731|FG001|Phase 1|Other|1
7370470|NCT01088984|11620730|FG000|Phase 2|Death|0
7370471|NCT01088984|11620731|FG001|Phase 2|Death|5
7370472|NCT01088984|11620730|FG000|Phase 2|Withdrawal by Subject|0
7370473|NCT01088984|11620731|FG001|Phase 2|Withdrawal by Subject|1
7370474|NCT01088984|11620730|FG000|Phase 2|DIsease Progression|0
7370475|NCT01088984|11620731|FG001|Phase 2|DIsease Progression|25
7370476|NCT01088984|11620730|FG000|Phase 2|Other|0
7370477|NCT01088984|11620731|FG001|Phase 2|Other|1
7370478|NCT01088997|11620742|FG000|Overall Study|Physician Decision|1
7370479|NCT01088997|11620743|FG001|Overall Study|Physician Decision|1
7370480|NCT01088997|11620742|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
7370481|NCT01088997|11620743|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
7370482|NCT01088997|11620742|FG000|Overall Study|Excluded prior to receiving drug|1
7370483|NCT01088997|11620743|FG001|Overall Study|Excluded prior to receiving drug|1
7370484|NCT01089023|11620752|FG000|Overall Study|Lost to Follow-up|3
7370485|NCT01089023|11620752|FG000|Overall Study|Adverse Event|1
7370486|NCT01089023|11620752|FG000|Overall Study|Withdrawal by Subject|1
7370487|NCT01089023|11620752|FG000|Overall Study|Protocol Violation|1
7370488|NCT01089023|11620752|FG000|Overall Study|Lack of Efficacy|1
7370489|NCT01089127|11620782|FG000|Overall Study|Adverse Event|5
7370490|NCT01089127|11620783|FG001|Overall Study|Adverse Event|1
7370491|NCT01089127|11620784|FG002|Overall Study|Adverse Event|1
7370492|NCT01089127|11620785|FG003|Overall Study|Adverse Event|0
7370493|NCT01089127|11620786|FG004|Overall Study|Adverse Event|0
7370494|NCT01089127|11620787|FG005|Overall Study|Adverse Event|1
7370495|NCT01089127|11620782|FG000|Overall Study|Subject withdrew consent|0
7370496|NCT01089127|11620783|FG001|Overall Study|Subject withdrew consent|1
7370497|NCT01089127|11620784|FG002|Overall Study|Subject withdrew consent|1
7370498|NCT01089127|11620785|FG003|Overall Study|Subject withdrew consent|1
7461147|NCT01833065|11756882|FG004|Overall Study|Lost to Follow-up|3
7461148|NCT01833065|11756878|FG000|Overall Study|Withdrawal by Subject|6
7461149|NCT01833065|11756879|FG001|Overall Study|Withdrawal by Subject|2
7461150|NCT01833065|11756880|FG002|Overall Study|Withdrawal by Subject|4
7461151|NCT01833065|11756881|FG003|Overall Study|Withdrawal by Subject|3
7461152|NCT01833065|11756882|FG004|Overall Study|Withdrawal by Subject|11
7461153|NCT01833065|11756878|FG000|Overall Study|Subject's substantial non-compliance|0
7461154|NCT01833065|11756879|FG001|Overall Study|Subject's substantial non-compliance|1
7461155|NCT01833065|11756880|FG002|Overall Study|Subject's substantial non-compliance|0
7461156|NCT01833065|11756881|FG003|Overall Study|Subject's substantial non-compliance|0
7461157|NCT01833065|11756882|FG004|Overall Study|Subject's substantial non-compliance|0
7461158|NCT01833065|11756878|FG000|Overall Study|Trial terminated by sponsor|8
7461159|NCT01833065|11756879|FG001|Overall Study|Trial terminated by sponsor|8
7461160|NCT01833065|11756880|FG002|Overall Study|Trial terminated by sponsor|7
7461161|NCT01833065|11756881|FG003|Overall Study|Trial terminated by sponsor|3
7461162|NCT01833065|11756882|FG004|Overall Study|Trial terminated by sponsor|13
7461163|NCT01833065|11756878|FG000|Overall Study|Others|2
7461164|NCT01833065|11756879|FG001|Overall Study|Others|1
7461165|NCT01833065|11756880|FG002|Overall Study|Others|1
7461166|NCT01833065|11756881|FG003|Overall Study|Others|1
7461167|NCT01833065|11756882|FG004|Overall Study|Others|4
7461168|NCT01833143|11756914|FG000|Overall Study|Not Treated|1
7461169|NCT01833169|11756918|FG000|Overall Study|Disease Progression|99
7461170|NCT01833169|11756918|FG000|Overall Study|Adverse Event|33
7461171|NCT01833169|11756918|FG000|Overall Study|Withdrawal by Subject|9
7461172|NCT01833169|11756918|FG000|Overall Study|Death|3
7461173|NCT01833169|11756918|FG000|Overall Study|Physician Decision|2
7461174|NCT01833455|11756933|FG000|Overall Study|Withdrawal by Subject|1
7461175|NCT01833455|11756934|FG001|Overall Study|Withdrawal by Subject|0
7461176|NCT01833494|11756965|FG000|Overall Study|Adverse Event|24
7461177|NCT01833494|11756965|FG000|Overall Study|Physician Decision|6
7461178|NCT01833494|11756965|FG000|Overall Study|Withdrawal by Subject|6
7461179|NCT01833494|11756965|FG000|Overall Study|Decrease in serum phosphorus|4
7461180|NCT01833494|11756965|FG000|Overall Study|Decrease in serum calcium|4
7461181|NCT01833494|11756965|FG000|Overall Study|Increase in serum ferritin|1
7461182|NCT01833520|11756971|FG000|Overall Study|Lack of Efficacy|3
7461183|NCT01833520|11756972|FG001|Overall Study|Lack of Efficacy|3
7461184|NCT01833520|11756973|FG002|Overall Study|Lack of Efficacy|8
7461185|NCT01833520|11756974|FG003|Overall Study|Lack of Efficacy|3
7461186|NCT01833533|11756988|FG000|Overall Study|Adverse Event|0
7461187|NCT01833533|11756989|FG001|Overall Study|Adverse Event|1
7461188|NCT01833533|11756988|FG000|Overall Study|Lost to Follow-up|4
7461189|NCT01833533|11756989|FG001|Overall Study|Lost to Follow-up|9
7461190|NCT01833533|11756988|FG000|Overall Study|To Enter an Extension Study|0
7461191|NCT01833533|11756989|FG001|Overall Study|To Enter an Extension Study|4
7461192|NCT01833533|11756988|FG000|Overall Study|Other|2
7461193|NCT01833533|11756989|FG001|Overall Study|Other|7
7461194|NCT01833832|11757030|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
7461195|NCT01833897|11757038|FG000|Overall Study|Lack of Efficacy|1
7461196|NCT01834222|11757072|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
7461197|NCT01834274|11757087|FG000|Overall Study|Study Termination|41
7461198|NCT01834274|11757088|FG001|Overall Study|Study Termination|38
7461199|NCT01834274|11757087|FG000|Overall Study|Withdrawal by Subject|1
7461200|NCT01834274|11757088|FG001|Overall Study|Withdrawal by Subject|1
7461201|NCT01834274|11757087|FG000|Overall Study|Lost to Follow-up|3
7461202|NCT01834274|11757088|FG001|Overall Study|Lost to Follow-up|1
7461203|NCT01834274|11757087|FG000|Overall Study|Other|2
7461204|NCT01834274|11757088|FG001|Overall Study|Other|1
7461205|NCT01834586|11757112|FG000|Overall Study|Adverse Event|1
7461206|NCT01834729|11757135|FG000|Overall Study|Did not return bowel diaries|0
7461207|NCT01834729|11757136|FG001|Overall Study|Did not return bowel diaries|0
7461208|NCT01834729|11757137|FG002|Overall Study|Did not return bowel diaries|3
7461209|NCT01834729|11757138|FG003|Overall Study|Did not return bowel diaries|0
7370499|NCT01089127|11620786|FG004|Overall Study|Subject withdrew consent|0
7370500|NCT01089127|11620787|FG005|Overall Study|Subject withdrew consent|2
7370501|NCT01089127|11620782|FG000|Overall Study|Abnormal test procedure result(s)|2
7370502|NCT01089127|11620783|FG001|Overall Study|Abnormal test procedure result(s)|1
7370503|NCT01089127|11620784|FG002|Overall Study|Abnormal test procedure result(s)|0
7370504|NCT01089127|11620785|FG003|Overall Study|Abnormal test procedure result(s)|0
7370505|NCT01089127|11620786|FG004|Overall Study|Abnormal test procedure result(s)|0
7370506|NCT01089127|11620787|FG005|Overall Study|Abnormal test procedure result(s)|0
7370507|NCT01089127|11620782|FG000|Overall Study|Lost to Follow-up|1
7370508|NCT01089127|11620783|FG001|Overall Study|Lost to Follow-up|1
7370509|NCT01089127|11620784|FG002|Overall Study|Lost to Follow-up|0
7370510|NCT01089127|11620785|FG003|Overall Study|Lost to Follow-up|0
7370511|NCT01089127|11620786|FG004|Overall Study|Lost to Follow-up|1
7370512|NCT01089127|11620787|FG005|Overall Study|Lost to Follow-up|0
7370513|NCT01089127|11620782|FG000|Overall Study|Protocol deviation|0
7370514|NCT01089127|11620783|FG001|Overall Study|Protocol deviation|1
7370515|NCT01089127|11620784|FG002|Overall Study|Protocol deviation|0
7370516|NCT01089127|11620785|FG003|Overall Study|Protocol deviation|0
7370517|NCT01089127|11620786|FG004|Overall Study|Protocol deviation|1
7370518|NCT01089127|11620787|FG005|Overall Study|Protocol deviation|0
7370519|NCT01089361|11620820|FG000|Overall Study|Death|1
7370520|NCT01089361|11620821|FG001|Overall Study|Death|0
7370521|NCT01089413|11620832|FG000|Overall Study|Lost to Follow-up|1
7370522|NCT01089413|11620832|FG000|Overall Study|Progressive Disease|93
7370523|NCT01089413|11620832|FG000|Overall Study|Participant Withdrew Consent|1
7370524|NCT01089413|11620832|FG000|Overall Study|Unacceptable Toxicity|12
7370525|NCT01089413|11620832|FG000|Overall Study|Death|10
7370526|NCT01089413|11620832|FG000|Overall Study|Metastasectomy|13
7370527|NCT01089413|11620832|FG000|Overall Study|Other|71
7370528|NCT01089504|11620844|FG000|Overall Study|Lost to Follow-up|1
7370529|NCT01089504|11620845|FG001|Overall Study|Lost to Follow-up|1
7370530|NCT01089504|11620844|FG000|Overall Study|Withdrawal by Subject|2
7370531|NCT01089504|11620845|FG001|Overall Study|Withdrawal by Subject|0
7370532|NCT01089543|11620868|FG000|Overall Study|Withdrawal by Subject|2
7370533|NCT01089543|11620869|FG001|Overall Study|Withdrawal by Subject|3
7370534|NCT01089543|11620870|FG002|Overall Study|Withdrawal by Subject|3
7370535|NCT01089543|11620871|FG003|Overall Study|Withdrawal by Subject|1
7370536|NCT01089543|11620868|FG000|Overall Study|Physician Decision|1
7370537|NCT01089543|11620869|FG001|Overall Study|Physician Decision|0
7370538|NCT01089543|11620870|FG002|Overall Study|Physician Decision|0
7370539|NCT01089543|11620871|FG003|Overall Study|Physician Decision|1
7370540|NCT01089543|11620868|FG000|Overall Study|Adverse Event|0
7370541|NCT01089543|11620869|FG001|Overall Study|Adverse Event|1
7370542|NCT01089543|11620870|FG002|Overall Study|Adverse Event|0
7370543|NCT01089543|11620871|FG003|Overall Study|Adverse Event|0
7370544|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
7370545|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
7370546|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
7370547|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
7370548|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
7370549|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
7370550|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
7370551|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
7370552|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7370553|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7370554|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7370555|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
7370556|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
7370557|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
7370558|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7370559|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7370560|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7370561|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
7370562|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7370563|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
7370564|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7461210|NCT01834729|11757135|FG000|Overall Study|Withdrawal by Subject|1
7461211|NCT01834729|11757136|FG001|Overall Study|Withdrawal by Subject|1
7461212|NCT01834729|11757137|FG002|Overall Study|Withdrawal by Subject|0
7461213|NCT01834729|11757138|FG003|Overall Study|Withdrawal by Subject|0
7461214|NCT01834729|11757135|FG000|Overall Study|Adverse Event|0
7461215|NCT01834729|11757136|FG001|Overall Study|Adverse Event|0
7461216|NCT01834729|11757137|FG002|Overall Study|Adverse Event|0
7461217|NCT01834729|11757138|FG003|Overall Study|Adverse Event|2
7461218|NCT01835015|11757154|FG000|Overall Study|Adverse Event|0
7370565|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7370566|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7370567|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
7370568|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
7370569|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
7370570|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
7370571|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
7370572|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
7370573|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
7370574|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
7370575|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
7370576|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
7370577|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
7370578|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
7370579|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
7370580|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
7370581|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
7370582|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7370583|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7370584|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7370585|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
7370586|NCT01089556|11620883|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
7370587|NCT01089556|11620884|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
7370588|NCT01089556|11620885|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
7370589|NCT01089556|11620886|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
7370590|NCT01089556|11620887|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
7370591|NCT01089556|11620888|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
7370592|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
7370593|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
7370594|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
7370595|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
7370596|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
7370597|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
7370598|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7370599|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
7370600|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7370601|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7370602|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7370603|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
7370604|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7370605|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7370606|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7370607|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
7370608|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
7370609|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
7370610|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7370611|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7370612|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
7370613|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7370614|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7370615|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
7370616|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
7370617|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
7370618|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
7370619|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
7370620|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
7370621|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
7370622|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
7370623|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
7370624|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
7370625|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
7370626|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
7370627|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
7370628|NCT01089556|11620883|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7370629|NCT01089556|11620884|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7370630|NCT01089556|11620885|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
7370631|NCT01089556|11620886|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
7370632|NCT01089556|11620887|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
7370633|NCT01089556|11620888|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
7370634|NCT01089582|11620913|FG000|Overall Study|Death|2
7370635|NCT01089582|11620913|FG000|Overall Study|Adverse Event|15
7370636|NCT01089582|11620913|FG000|Overall Study|Lost to Follow-up|8
7370637|NCT01089582|11620913|FG000|Overall Study|Other|4
7370638|NCT01089582|11620913|FG000|Overall Study|Withdrawal by Subject|1
7370639|NCT01089608|11620930|FG000|Overall Study|Adverse Event|0
7370640|NCT01089608|11620931|FG001|Overall Study|Adverse Event|4
7370641|NCT01089608|11620930|FG000|Overall Study|Lost to Follow-up|0
7370642|NCT01089608|11620931|FG001|Overall Study|Lost to Follow-up|2
7370643|NCT01089647|11620939|FG000|Overall Study|Lost to Follow-up|2
7370644|NCT01089647|11620940|FG001|Overall Study|Lost to Follow-up|2
7370645|NCT01089647|11620939|FG000|Overall Study|Withdrawal by Subject|2
7370646|NCT01089647|11620940|FG001|Overall Study|Withdrawal by Subject|1
7370647|NCT01089647|11620939|FG000|Overall Study|Adverse Event|0
7370648|NCT01089647|11620940|FG001|Overall Study|Adverse Event|1
7370649|NCT01089725|11620951|FG000|Overall Study|Adverse Event|1
7370650|NCT01089725|11620952|FG001|Overall Study|Adverse Event|1
7370651|NCT01089725|11620953|FG002|Overall Study|Adverse Event|0
7370652|NCT01089725|11620954|FG003|Overall Study|Adverse Event|0
7370653|NCT01089725|11620955|FG004|Overall Study|Adverse Event|2
7370654|NCT01089725|11620951|FG000|Overall Study|Lack of Efficacy|4
7370655|NCT01089725|11620952|FG001|Overall Study|Lack of Efficacy|3
7370656|NCT01089725|11620953|FG002|Overall Study|Lack of Efficacy|1
7370657|NCT01089725|11620954|FG003|Overall Study|Lack of Efficacy|0
7370658|NCT01089725|11620955|FG004|Overall Study|Lack of Efficacy|4
7370659|NCT01089725|11620951|FG000|Overall Study|Lost to Follow-up|2
7370660|NCT01089725|11620952|FG001|Overall Study|Lost to Follow-up|2
7370661|NCT01089725|11620953|FG002|Overall Study|Lost to Follow-up|0
7370662|NCT01089725|11620954|FG003|Overall Study|Lost to Follow-up|3
7370663|NCT01089725|11620955|FG004|Overall Study|Lost to Follow-up|0
7370664|NCT01089725|11620951|FG000|Overall Study|Protocol Violation|0
7370665|NCT01089725|11620952|FG001|Overall Study|Protocol Violation|0
7370666|NCT01089725|11620953|FG002|Overall Study|Protocol Violation|1
7370667|NCT01089725|11620954|FG003|Overall Study|Protocol Violation|1
7370668|NCT01089725|11620955|FG004|Overall Study|Protocol Violation|0
7533311|NCT02684357|11879615|FG003|Part A|Lost to Follow-up|0
7533312|NCT02684357|11879616|FG004|Part A|Lost to Follow-up|0
7533313|NCT02684357|11879617|FG005|Part A|Lost to Follow-up|0
7533314|NCT02684357|11879612|FG000|Part A|Withdrawal by Subject|3
7533315|NCT02684357|11879613|FG001|Part A|Withdrawal by Subject|0
7533316|NCT02684357|11879614|FG002|Part A|Withdrawal by Subject|0
7533317|NCT02684357|11879615|FG003|Part A|Withdrawal by Subject|0
7533318|NCT02684357|11879616|FG004|Part A|Withdrawal by Subject|0
7533319|NCT02684357|11879617|FG005|Part A|Withdrawal by Subject|0
7533320|NCT02684357|11879612|FG000|Part A|Other|0
7533321|NCT02684357|11879613|FG001|Part A|Other|1
7533322|NCT02684357|11879614|FG002|Part A|Other|0
7533323|NCT02684357|11879615|FG003|Part A|Other|0
7533324|NCT02684357|11879616|FG004|Part A|Other|0
7533325|NCT02684357|11879617|FG005|Part A|Other|0
7533326|NCT02684357|11879612|FG000|Part B|Adverse Event (Other)|0
7533327|NCT02684357|11879613|FG001|Part B|Adverse Event (Other)|0
7533328|NCT02684357|11879614|FG002|Part B|Adverse Event (Other)|0
7533329|NCT02684357|11879615|FG003|Part B|Adverse Event (Other)|1
7533330|NCT02684357|11879616|FG004|Part B|Adverse Event (Other)|1
7533331|NCT02684357|11879617|FG005|Part B|Adverse Event (Other)|1
7533332|NCT02684357|11879612|FG000|Part B|Lost to Follow-up|0
7533333|NCT02684357|11879613|FG001|Part B|Lost to Follow-up|0
7533334|NCT02684357|11879614|FG002|Part B|Lost to Follow-up|0
7533335|NCT02684357|11879615|FG003|Part B|Lost to Follow-up|1
7533336|NCT02684357|11879616|FG004|Part B|Lost to Follow-up|1
7533337|NCT02684357|11879617|FG005|Part B|Lost to Follow-up|7
7533338|NCT02684357|11879612|FG000|Part B|Withdrawal by Subject|0
7533339|NCT02684357|11879613|FG001|Part B|Withdrawal by Subject|0
7533340|NCT02684357|11879614|FG002|Part B|Withdrawal by Subject|0
7533341|NCT02684357|11879615|FG003|Part B|Withdrawal by Subject|0
7533342|NCT02684357|11879616|FG004|Part B|Withdrawal by Subject|2
7533343|NCT02684357|11879617|FG005|Part B|Withdrawal by Subject|4
7533344|NCT02684357|11879612|FG000|Part B|Other|0
7370669|NCT01089725|11620951|FG000|Overall Study|Withdrawal by Subject|5
7370670|NCT01089725|11620952|FG001|Overall Study|Withdrawal by Subject|5
7533345|NCT02684357|11879613|FG001|Part B|Other|0
7533346|NCT02684357|11879614|FG002|Part B|Other|0
7533347|NCT02684357|11879615|FG003|Part B|Other|1
7533348|NCT02684357|11879616|FG004|Part B|Other|0
7533349|NCT02684357|11879617|FG005|Part B|Other|1
7533350|NCT02684370|11879633|FG000|Part A|Adverse Event|2
7533351|NCT02684370|11879634|FG001|Part A|Adverse Event|0
7370671|NCT01089725|11620953|FG002|Overall Study|Withdrawal by Subject|4
7370672|NCT01089725|11620954|FG003|Overall Study|Withdrawal by Subject|5
7370673|NCT01089725|11620955|FG004|Overall Study|Withdrawal by Subject|4
7370674|NCT01089725|11620951|FG000|Overall Study|Study Terminated by Sponsor|51
7370675|NCT01089725|11620952|FG001|Overall Study|Study Terminated by Sponsor|56
7370676|NCT01089725|11620953|FG002|Overall Study|Study Terminated by Sponsor|53
7370677|NCT01089725|11620954|FG003|Overall Study|Study Terminated by Sponsor|68
7370678|NCT01089725|11620955|FG004|Overall Study|Study Terminated by Sponsor|68
7370679|NCT01089725|11620951|FG000|Overall Study|Randomized, but not treated|0
7370680|NCT01089725|11620952|FG001|Overall Study|Randomized, but not treated|1
7370681|NCT01089725|11620953|FG002|Overall Study|Randomized, but not treated|2
7370682|NCT01089725|11620954|FG003|Overall Study|Randomized, but not treated|1
7370683|NCT01089725|11620955|FG004|Overall Study|Randomized, but not treated|2
7370684|NCT01089725|11620951|FG000|Overall Study|Other|3
7370685|NCT01089725|11620952|FG001|Overall Study|Other|0
7370686|NCT01089725|11620953|FG002|Overall Study|Other|0
7370687|NCT01089725|11620954|FG003|Overall Study|Other|1
7370688|NCT01089725|11620955|FG004|Overall Study|Other|0
7370689|NCT01090011|11620980|FG000|Overall Study|Progressive disease|128
7370690|NCT01090011|11620980|FG000|Overall Study|Adverse Event|32
7370691|NCT01090011|11620980|FG000|Overall Study|Protocol Violation|1
7370692|NCT01090011|11620980|FG000|Overall Study|Refusal to start/continue medication|5
7370693|NCT01090011|11620980|FG000|Overall Study|Other reason not defined above|5
7370694|NCT01090050|11620994|FG000|Overall Study|Lost to Follow-up|0
7370695|NCT01090050|11620995|FG001|Overall Study|Lost to Follow-up|1
7370696|NCT01090050|11620994|FG000|Overall Study|Lack of Efficacy|1
7370697|NCT01090050|11620995|FG001|Overall Study|Lack of Efficacy|5
7370698|NCT01090050|11620994|FG000|Overall Study|Physician Decision|0
7370699|NCT01090050|11620995|FG001|Overall Study|Physician Decision|1
7370700|NCT01090063|11621005|FG000|Screen|Screen Failed|4
7370701|NCT01090063|11621005|FG000|Treatment|Withdrawal by Subject|4
7370702|NCT01090076|11621021|FG000|Overall Study|Death|1
7370703|NCT01090076|11621022|FG001|Overall Study|Death|1
7370704|NCT01090076|11621021|FG000|Overall Study|Withdrawal by Subject|0
7370705|NCT01090076|11621022|FG001|Overall Study|Withdrawal by Subject|1
7370706|NCT01090102|11621032|FG000|First 12 Weeks|Withdrawal by Subject|1
7370707|NCT01090102|11621033|FG001|First 12 Weeks|Withdrawal by Subject|1
7370708|NCT01090102|11621032|FG000|First 12 Weeks|Adverse Event|2
7370709|NCT01090102|11621033|FG001|First 12 Weeks|Adverse Event|0
7370710|NCT01090102|11621032|FG000|First 12 Weeks|Death|1
7370711|NCT01090102|11621033|FG001|First 12 Weeks|Death|1
7370712|NCT01090102|11621032|FG000|Second 12 Weeks|Withdrawal by Subject|0
7370713|NCT01090102|11621033|FG001|Second 12 Weeks|Withdrawal by Subject|1
7370714|NCT01090310|11621052|FG000|Core Study|Adverse Event|2
7370715|NCT01090310|11621053|FG001|Core Study|Adverse Event|2
7370716|NCT01090310|11621054|FG002|Core Study|Adverse Event|1
7370717|NCT01090310|11621055|FG003|Core Study|Adverse Event|1
7370718|NCT01090310|11621052|FG000|Core Study|Subject withdrew consent|0
7370719|NCT01090310|11621053|FG001|Core Study|Subject withdrew consent|3
7370720|NCT01090310|11621054|FG002|Core Study|Subject withdrew consent|1
7370721|NCT01090310|11621055|FG003|Core Study|Subject withdrew consent|1
7370722|NCT01090310|11621052|FG000|Core Study|Abnormal test procedure result|0
7370723|NCT01090310|11621053|FG001|Core Study|Abnormal test procedure result|0
7370724|NCT01090310|11621054|FG002|Core Study|Abnormal test procedure result|1
7370725|NCT01090310|11621055|FG003|Core Study|Abnormal test procedure result|0
7370726|NCT01090310|11621052|FG000|Core Study|Administrative reasons|5
7370727|NCT01090310|11621053|FG001|Core Study|Administrative reasons|6
7370728|NCT01090310|11621054|FG002|Core Study|Administrative reasons|4
7370729|NCT01090310|11621055|FG003|Core Study|Administrative reasons|4
7370730|NCT01090310|11621052|FG000|Core Study|Protocol deviation|1
7370731|NCT01090310|11621053|FG001|Core Study|Protocol deviation|0
7370732|NCT01090310|11621054|FG002|Core Study|Protocol deviation|0
7370733|NCT01090310|11621055|FG003|Core Study|Protocol deviation|1
7370734|NCT01090310|11621052|FG000|Extension Study|Aministrative problems|13
7370735|NCT01090310|11621053|FG001|Extension Study|Aministrative problems|15
7370736|NCT01090310|11621054|FG002|Extension Study|Aministrative problems|14
7370737|NCT01090310|11621055|FG003|Extension Study|Aministrative problems|18
7370738|NCT01090310|11621052|FG000|Extension Study|Adverse Event|0
7370739|NCT01090310|11621053|FG001|Extension Study|Adverse Event|0
7370740|NCT01090310|11621054|FG002|Extension Study|Adverse Event|0
7370741|NCT01090310|11621055|FG003|Extension Study|Adverse Event|1
7370742|NCT01090310|11621052|FG000|Extension Study|Unsatisfactory therapeutic effect|1
7370743|NCT01090310|11621053|FG001|Extension Study|Unsatisfactory therapeutic effect|0
7370744|NCT01090310|11621054|FG002|Extension Study|Unsatisfactory therapeutic effect|1
7370745|NCT01090310|11621055|FG003|Extension Study|Unsatisfactory therapeutic effect|1
7370746|NCT01090310|11621052|FG000|Extension Study|Subject withdrew consent|0
7370747|NCT01090310|11621053|FG001|Extension Study|Subject withdrew consent|1
7370748|NCT01090310|11621054|FG002|Extension Study|Subject withdrew consent|0
7370749|NCT01090310|11621055|FG003|Extension Study|Subject withdrew consent|0
7370750|NCT01090323|11621067|FG000|Overall Study|Adverse Event|12
7370751|NCT01090323|11621068|FG001|Overall Study|Adverse Event|2
7370752|NCT01090323|11621067|FG000|Overall Study|Abnormal Lab Values|3
7370753|NCT01090323|11621068|FG001|Overall Study|Abnormal Lab Values|1
7370754|NCT01090323|11621067|FG000|Overall Study|Abnormal Test Procedure Results|2
7370755|NCT01090323|11621068|FG001|Overall Study|Abnormal Test Procedure Results|0
7570490|NCT03492281|11948220|FG001|Overall Study|Captured as Other in Database|6
7370756|NCT01090323|11621067|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7370757|NCT01090323|11621068|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7370758|NCT01090323|11621067|FG000|Overall Study|Condition no longer requires drug|5
7370759|NCT01090323|11621068|FG001|Overall Study|Condition no longer requires drug|4
7370760|NCT01090323|11621067|FG000|Overall Study|Protocol Violation|2
7370761|NCT01090323|11621068|FG001|Overall Study|Protocol Violation|1
7370762|NCT01090323|11621067|FG000|Overall Study|Withdrew consent|33
7370763|NCT01090323|11621068|FG001|Overall Study|Withdrew consent|11
7370764|NCT01090323|11621067|FG000|Overall Study|Lost to Follow-up|11
7370765|NCT01090323|11621068|FG001|Overall Study|Lost to Follow-up|6
7370766|NCT01090323|11621067|FG000|Overall Study|Administrative problems|6
7370767|NCT01090323|11621068|FG001|Overall Study|Administrative problems|4
7370768|NCT01090323|11621067|FG000|Overall Study|Death|1
7370769|NCT01090323|11621068|FG001|Overall Study|Death|2
7370770|NCT01090323|11621067|FG000|Overall Study|Stopped end of core|7
7370771|NCT01090323|11621068|FG001|Overall Study|Stopped end of core|0
7370772|NCT01090323|11621067|FG000|Overall Study|Stopped end of extension 1#|3
7370773|NCT01090323|11621068|FG001|Overall Study|Stopped end of extension 1#|1
7370774|NCT01090414|11621078|FG000|Study 101-99|Progressive Disease|28
7370775|NCT01090414|11621079|FG001|Study 101-99|Progressive Disease|48
7370776|NCT01090414|11621080|FG002|Study 101-99|Progressive Disease|10
7370777|NCT01090414|11621081|FG003|Study 101-99|Progressive Disease|4
7370778|NCT01090414|11621078|FG000|Study 101-99|Adverse Event|10
7370779|NCT01090414|11621079|FG001|Study 101-99|Adverse Event|28
7370780|NCT01090414|11621080|FG002|Study 101-99|Adverse Event|18
7370781|NCT01090414|11621081|FG003|Study 101-99|Adverse Event|0
7370782|NCT01090414|11621078|FG000|Study 101-99|Investigator Request|1
7370783|NCT01090414|11621079|FG001|Study 101-99|Investigator Request|11
7370784|NCT01090414|11621080|FG002|Study 101-99|Investigator Request|4
7370785|NCT01090414|11621081|FG003|Study 101-99|Investigator Request|0
7370786|NCT01090414|11621078|FG000|Study 101-99|Death|3
7370787|NCT01090414|11621079|FG001|Study 101-99|Death|8
7370788|NCT01090414|11621080|FG002|Study 101-99|Death|1
7370789|NCT01090414|11621081|FG003|Study 101-99|Death|0
7370790|NCT01090414|11621078|FG000|Study 101-99|Sponsor Discontinued Study|0
7370791|NCT01090414|11621079|FG001|Study 101-99|Sponsor Discontinued Study|7
7370792|NCT01090414|11621080|FG002|Study 101-99|Sponsor Discontinued Study|5
7370793|NCT01090414|11621081|FG003|Study 101-99|Sponsor Discontinued Study|0
7570491|NCT03492281|11948221|FG002|Overall Study|Captured as Other in Database|3
7370794|NCT01090414|11621078|FG000|Study 101-99|Other (Unknown Reasons)|3
7370795|NCT01090414|11621079|FG001|Study 101-99|Other (Unknown Reasons)|3
7370796|NCT01090414|11621080|FG002|Study 101-99|Other (Unknown Reasons)|0
7370797|NCT01090414|11621081|FG003|Study 101-99|Other (Unknown Reasons)|0
7370798|NCT01090414|11621078|FG000|Study 101-99|Withdrew Consent|0
7370799|NCT01090414|11621079|FG001|Study 101-99|Withdrew Consent|2
7370800|NCT01090414|11621080|FG002|Study 101-99|Withdrew Consent|3
7370801|NCT01090414|11621081|FG003|Study 101-99|Withdrew Consent|1
7370802|NCT01090414|11621078|FG000|Study 101-99|Participant Request|3
7370803|NCT01090414|11621079|FG001|Study 101-99|Participant Request|1
7370804|NCT01090414|11621080|FG002|Study 101-99|Participant Request|0
7370805|NCT01090414|11621081|FG003|Study 101-99|Participant Request|0
7370806|NCT01090427|11621106|FG000|After Controlled Period|Death|0
7370807|NCT01090427|11621107|FG001|After Controlled Period|Death|0
7370808|NCT01090427|11621108|FG002|After Controlled Period|Death|0
7370809|NCT01090427|11621109|FG003|After Controlled Period|Death|0
7370810|NCT01090427|11621110|FG004|After Controlled Period|Death|0
7370811|NCT01090427|11621111|FG005|After Controlled Period|Death|1
7370812|NCT01090427|11621112|FG006|After Controlled Period|Death|0
7370813|NCT01090427|11621106|FG000|After Controlled Period|Lack of Efficacy|0
7370814|NCT01090427|11621107|FG001|After Controlled Period|Lack of Efficacy|0
7370815|NCT01090427|11621108|FG002|After Controlled Period|Lack of Efficacy|0
7370816|NCT01090427|11621109|FG003|After Controlled Period|Lack of Efficacy|0
7370817|NCT01090427|11621110|FG004|After Controlled Period|Lack of Efficacy|0
7370818|NCT01090427|11621111|FG005|After Controlled Period|Lack of Efficacy|3
7370819|NCT01090427|11621112|FG006|After Controlled Period|Lack of Efficacy|2
7370820|NCT01090427|11621106|FG000|After Controlled Period|Adverse Event|0
7370821|NCT01090427|11621107|FG001|After Controlled Period|Adverse Event|0
7570492|NCT03492554|11948271|FG000|Overall Study|Protocol Violation|0
7570493|NCT03492554|11948272|FG001|Overall Study|Protocol Violation|14
7570494|NCT03493386|11948281|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7370822|NCT01090427|11621108|FG002|After Controlled Period|Adverse Event|0
7370823|NCT01090427|11621109|FG003|After Controlled Period|Adverse Event|2
7370824|NCT01090427|11621110|FG004|After Controlled Period|Adverse Event|0
7370825|NCT01090427|11621111|FG005|After Controlled Period|Adverse Event|1
7370826|NCT01090427|11621112|FG006|After Controlled Period|Adverse Event|0
7370827|NCT01090453|11621126|FG000|Overall Study|Withdrawal by Subject|1
7370828|NCT01090453|11621127|FG001|Overall Study|Withdrawal by Subject|2
7370829|NCT01090453|11621126|FG000|Overall Study|Lost to Follow-up|7
7370830|NCT01090453|11621127|FG001|Overall Study|Lost to Follow-up|7
7370831|NCT01090453|11621126|FG000|Overall Study|Non serious AEs|1
7370832|NCT01090453|11621127|FG001|Overall Study|Non serious AEs|0
7370833|NCT01090453|11621126|FG000|Overall Study|Protocol Violation|2
7370834|NCT01090453|11621127|FG001|Overall Study|Protocol Violation|0
7370835|NCT01090453|11621126|FG000|Overall Study|Other|2
7370836|NCT01090453|11621127|FG001|Overall Study|Other|4
7370837|NCT01090453|11621126|FG000|Overall Study|Eligibility Criteria|0
7370838|NCT01090453|11621127|FG001|Overall Study|Eligibility Criteria|1
7370839|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
7370840|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
7370841|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
7370842|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
7370843|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
7370844|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
7370845|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
7370846|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
7370847|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370848|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
7370849|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370850|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370851|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370852|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370853|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
7370854|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
7370855|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370856|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370857|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
7370858|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370859|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370860|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370861|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370862|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
7370863|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Other|0
7370864|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Other|0
7370865|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Other|1
7370866|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Other|1
7370867|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Other|2
7370868|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Other|0
7370869|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Other|0
7370870|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Other|0
7370871|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
7370872|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
7370873|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
7370874|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
7370875|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
7370876|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
7370877|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
7370878|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
7370879|NCT01090492|11621150|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
7370880|NCT01090492|11621151|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
7370881|NCT01090492|11621152|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
7370882|NCT01090492|11621153|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
7370883|NCT01090492|11621154|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
7370884|NCT01090492|11621155|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
7370885|NCT01090492|11621156|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
7370886|NCT01090492|11621157|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
7370887|NCT01090492|11621150|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
7370888|NCT01090492|11621151|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
7370889|NCT01090492|11621152|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
7370890|NCT01090492|11621153|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
7370891|NCT01090492|11621154|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
7370892|NCT01090492|11621155|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
7370893|NCT01090492|11621156|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
7370894|NCT01090492|11621157|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
7370895|NCT01090492|11621150|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
7370896|NCT01090492|11621151|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
7370897|NCT01090492|11621152|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
7370898|NCT01090492|11621153|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
7370899|NCT01090492|11621154|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
7370900|NCT01090492|11621155|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
7370901|NCT01090492|11621156|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
7370902|NCT01090492|11621157|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
7370903|NCT01090492|11621150|FG000|Second Intervention Period (4 Weeks)|Other|0
7370904|NCT01090492|11621151|FG001|Second Intervention Period (4 Weeks)|Other|1
7370905|NCT01090492|11621152|FG002|Second Intervention Period (4 Weeks)|Other|1
7370906|NCT01090492|11621153|FG003|Second Intervention Period (4 Weeks)|Other|0
7387704|NCT01215916|11646442|FG004|Overall Study|Progressive Disease|5
7370907|NCT01090492|11621154|FG004|Second Intervention Period (4 Weeks)|Other|0
7370908|NCT01090492|11621155|FG005|Second Intervention Period (4 Weeks)|Other|0
7370909|NCT01090492|11621156|FG006|Second Intervention Period (4 Weeks)|Other|0
7370910|NCT01090492|11621157|FG007|Second Intervention Period (4 Weeks)|Other|0
7370911|NCT01090492|11621150|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
7370912|NCT01090492|11621151|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
7370913|NCT01090492|11621152|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
7370914|NCT01090492|11621153|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
7370915|NCT01090492|11621154|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
7370916|NCT01090492|11621155|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
7370917|NCT01090492|11621156|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
7370918|NCT01090492|11621157|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
7370919|NCT01090492|11621150|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370920|NCT01090492|11621151|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370921|NCT01090492|11621152|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370922|NCT01090492|11621153|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370923|NCT01090492|11621154|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370924|NCT01090492|11621155|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370925|NCT01090492|11621156|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
7370926|NCT01090492|11621157|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
7370927|NCT01090739|11621176|FG000|Enrollment|Withdrawal by Subject|24
7370928|NCT01090739|11621176|FG000|Enrollment|Protocol Violation|14
7370929|NCT01090739|11621176|FG000|Enrollment|Lost to Follow-up|5
7370930|NCT01090739|11621176|FG000|Enrollment|Physician Decision|5
7370931|NCT01090739|11621176|FG000|Enrollment|Sponsor termination of site|4
7370932|NCT01090739|11621176|FG000|Enrollment|Study implant limit reached|2
7370933|NCT01090739|11621176|FG000|Enrollment|Adverse Event|1
7370934|NCT01090739|11621176|FG000|12 Month Follow-up|Withdrawal by Subject|2
7370935|NCT01090739|11621176|FG000|12 Month Follow-up|Lost to Follow-up|1
7370936|NCT01090739|11621176|FG000|12 Month Follow-up|Physician Decision|1
7370937|NCT01090739|11621176|FG000|12 Month Follow-up|Death|1
7370938|NCT01090739|11621176|FG000|24 Month Follow-up|Withdrawal by Subject|7
7370939|NCT01090739|11621176|FG000|24 Month Follow-up|Lost to Follow-up|1
7370940|NCT01090739|11621176|FG000|24 Month Follow-up|Death|1
7370941|NCT01090739|11621176|FG000|36 Month Follow-up|Withdrawal by Subject|6
7370942|NCT01090739|11621176|FG000|36 Month Follow-up|Visit still pending|17
7370943|NCT01090765|11621196|FG000|Overall Study|Patient withdrew consent|0
7370944|NCT01090765|11621197|FG001|Overall Study|Patient withdrew consent|0
7370945|NCT01090765|11621198|FG002|Overall Study|Patient withdrew consent|0
7370946|NCT01090765|11621199|FG003|Overall Study|Patient withdrew consent|0
7370947|NCT01090765|11621200|FG004|Overall Study|Patient withdrew consent|1
7461219|NCT01835015|11757155|FG001|Overall Study|Adverse Event|0
7461220|NCT01835015|11757156|FG002|Overall Study|Adverse Event|1
7461221|NCT01835015|11757157|FG003|Overall Study|Adverse Event|0
7461222|NCT01835015|11757158|FG004|Overall Study|Adverse Event|0
7461223|NCT01835132|11757171|FG000|Initial Phase|Insufficient Therapeutic Response|2
7461224|NCT01835158|11757177|FG000|Overall Study|Withdrawal by Subject|1
7461225|NCT01835158|11757178|FG001|Overall Study|Withdrawal by Subject|6
7461226|NCT01835223|11757186|FG000|Overall Study|Adverse Event|1
7461227|NCT01835223|11757187|FG001|Overall Study|Adverse Event|0
7461228|NCT01835223|11757186|FG000|Overall Study|Withdrawal by Subject|2
7461229|NCT01835223|11757187|FG001|Overall Study|Withdrawal by Subject|0
7461230|NCT01835223|11757186|FG000|Overall Study|Disease progression|2
7461231|NCT01835223|11757187|FG001|Overall Study|Disease progression|1
7461232|NCT01835223|11757186|FG000|Overall Study|Became Inelligible|4
7461233|NCT01835223|11757187|FG001|Overall Study|Became Inelligible|0
7461234|NCT01835431|11757215|FG000|Overall Study|Adverse Event|1
7461235|NCT01835431|11757216|FG001|Overall Study|Adverse Event|0
7461236|NCT01835431|11757215|FG000|Overall Study|other|0
7461237|NCT01835431|11757216|FG001|Overall Study|other|2
7461238|NCT01835431|11757215|FG000|Overall Study|Withdrawal by Subject|6
7461239|NCT01835431|11757216|FG001|Overall Study|Withdrawal by Subject|10
7461240|NCT01835431|11757215|FG000|Overall Study|Protocol Violation|1
7461241|NCT01835431|11757216|FG001|Overall Study|Protocol Violation|0
7461242|NCT01835470|11757222|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
7461243|NCT01835470|11757222|FG000|Long Term Treatment Period|Lack of Efficacy|3
7461244|NCT01835548|11757233|FG000|Dose Optimization Period|Adverse Event|0
7461245|NCT01835548|11757234|FG001|Dose Optimization Period|Adverse Event|0
7461246|NCT01835548|11757235|FG002|Dose Optimization Period|Adverse Event|1
7370948|NCT01090765|11621201|FG005|Overall Study|Patient withdrew consent|1
7370949|NCT01090765|11621196|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
7370950|NCT01090765|11621197|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
7370951|NCT01090765|11621198|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
7370952|NCT01090765|11621199|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
7370953|NCT01090765|11621200|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
7370954|NCT01090765|11621201|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
7461247|NCT01835548|11757233|FG000|Dose Optimization Period|Withdrawal by Subject|0
7370955|NCT01090765|11621196|FG000|Overall Study|Vasovagal reaction with first infusion|0
7370956|NCT01090765|11621197|FG001|Overall Study|Vasovagal reaction with first infusion|0
7370957|NCT01090765|11621198|FG002|Overall Study|Vasovagal reaction with first infusion|0
7370958|NCT01090765|11621199|FG003|Overall Study|Vasovagal reaction with first infusion|0
7370959|NCT01090765|11621200|FG004|Overall Study|Vasovagal reaction with first infusion|1
7370960|NCT01090765|11621201|FG005|Overall Study|Vasovagal reaction with first infusion|0
7370961|NCT01090973|11621220|FG000|Overall Study|Disease progression|1
7370962|NCT01091103|11621224|FG000|Overall Study|Adverse Event|1
7370963|NCT01091103|11621224|FG000|Overall Study|Progressive Disease|3
7370964|NCT01091168|11621257|FG000|Overall Study|Progressive disease|250
7370965|NCT01091168|11621258|FG001|Overall Study|Progressive disease|234
7370966|NCT01091168|11621257|FG000|Overall Study|Adverse Event|21
7370967|NCT01091168|11621258|FG001|Overall Study|Adverse Event|24
7370968|NCT01091168|11621257|FG000|Overall Study|Lost to Follow-up|0
7370969|NCT01091168|11621258|FG001|Overall Study|Lost to Follow-up|1
7370970|NCT01091168|11621257|FG000|Overall Study|Physician, patient's decision, other|27
7370971|NCT01091168|11621258|FG001|Overall Study|Physician, patient's decision, other|37
7370972|NCT01091246|11621267|FG000|Overall Study|Lost to Follow-up|23
7370973|NCT01091246|11621268|FG001|Overall Study|Lost to Follow-up|11
7370974|NCT01091246|11621269|FG002|Overall Study|Lost to Follow-up|7
7370975|NCT01091246|11621267|FG000|Overall Study|Adverse Event|1
7370976|NCT01091246|11621268|FG001|Overall Study|Adverse Event|0
7370977|NCT01091246|11621269|FG002|Overall Study|Adverse Event|1
7370978|NCT01091246|11621267|FG000|Overall Study|Withdrawal by Subject|9
7370979|NCT01091246|11621268|FG001|Overall Study|Withdrawal by Subject|5
7370980|NCT01091246|11621269|FG002|Overall Study|Withdrawal by Subject|4
7370981|NCT01091246|11621267|FG000|Overall Study|Subject not dosed|2
7370982|NCT01091246|11621268|FG001|Overall Study|Subject not dosed|0
7370983|NCT01091246|11621269|FG002|Overall Study|Subject not dosed|1
7370984|NCT01091259|11621279|FG000|Overall Study|Adverse Event|3
7370985|NCT01091259|11621279|FG000|Overall Study|Lack of Efficacy|2
7370986|NCT01091363|11621285|FG000|Overall Study|Withdrawal by Subject|11
7370987|NCT01091363|11621286|FG001|Overall Study|Withdrawal by Subject|15
7370988|NCT01091363|11621285|FG000|Overall Study|Lost to Follow-up|2
7370989|NCT01091363|11621286|FG001|Overall Study|Lost to Follow-up|2
7370990|NCT01091428|11621296|FG000|Phase 1|Progressive Disease|24
7370991|NCT01091428|11621297|FG001|Phase 1|Progressive Disease|8
7370992|NCT01091428|11621298|FG002|Phase 1|Progressive Disease|0
7370993|NCT01091428|11621299|FG003|Phase 1|Progressive Disease|0
7370994|NCT01091428|11621296|FG000|Phase 1|Symptomatic Deterioration|3
7370995|NCT01091428|11621297|FG001|Phase 1|Symptomatic Deterioration|2
7370996|NCT01091428|11621298|FG002|Phase 1|Symptomatic Deterioration|0
7370997|NCT01091428|11621299|FG003|Phase 1|Symptomatic Deterioration|0
7370998|NCT01091428|11621296|FG000|Phase 1|Adverse Event|2
7370999|NCT01091428|11621297|FG001|Phase 1|Adverse Event|0
7371000|NCT01091428|11621298|FG002|Phase 1|Adverse Event|0
7371001|NCT01091428|11621299|FG003|Phase 1|Adverse Event|0
7371002|NCT01091428|11621296|FG000|Phase 1|Withdrawal by Subject|7
7371003|NCT01091428|11621297|FG001|Phase 1|Withdrawal by Subject|0
7371004|NCT01091428|11621298|FG002|Phase 1|Withdrawal by Subject|0
7371005|NCT01091428|11621299|FG003|Phase 1|Withdrawal by Subject|0
7371006|NCT01091428|11621296|FG000|Phase 1|Reason not specified|0
7371007|NCT01091428|11621297|FG001|Phase 1|Reason not specified|1
7371008|NCT01091428|11621298|FG002|Phase 1|Reason not specified|0
7371009|NCT01091428|11621299|FG003|Phase 1|Reason not specified|0
7371010|NCT01091428|11621296|FG000|Phase 1|Single-Patient IND|2
7371011|NCT01091428|11621297|FG001|Phase 1|Single-Patient IND|0
7371012|NCT01091428|11621298|FG002|Phase 1|Single-Patient IND|0
7371013|NCT01091428|11621299|FG003|Phase 1|Single-Patient IND|0
7371014|NCT01091428|11621296|FG000|Phase 2|Progressive Disease|0
7371015|NCT01091428|11621297|FG001|Phase 2|Progressive Disease|0
7371016|NCT01091428|11621298|FG002|Phase 2|Progressive Disease|44
7371017|NCT01091428|11621299|FG003|Phase 2|Progressive Disease|46
7371018|NCT01091428|11621296|FG000|Phase 2|Symptomatic Deterioration|0
7371019|NCT01091428|11621297|FG001|Phase 2|Symptomatic Deterioration|0
7371020|NCT01091428|11621298|FG002|Phase 2|Symptomatic Deterioration|1
7371021|NCT01091428|11621299|FG003|Phase 2|Symptomatic Deterioration|6
7371022|NCT01091428|11621296|FG000|Phase 2|Adverse Event|0
7371023|NCT01091428|11621297|FG001|Phase 2|Adverse Event|0
7371024|NCT01091428|11621298|FG002|Phase 2|Adverse Event|12
7371025|NCT01091428|11621299|FG003|Phase 2|Adverse Event|5
7371026|NCT01091428|11621296|FG000|Phase 2|Withdrawal by Subject|0
7371027|NCT01091428|11621297|FG001|Phase 2|Withdrawal by Subject|0
7371028|NCT01091428|11621298|FG002|Phase 2|Withdrawal by Subject|9
7371029|NCT01091428|11621299|FG003|Phase 2|Withdrawal by Subject|8
7371030|NCT01091428|11621296|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
7371031|NCT01091428|11621297|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
7371032|NCT01091428|11621298|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
7371033|NCT01091428|11621299|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
7371034|NCT01091428|11621296|FG000|Phase 2|Reason not specified|0
7371035|NCT01091428|11621297|FG001|Phase 2|Reason not specified|0
7371036|NCT01091428|11621298|FG002|Phase 2|Reason not specified|4
7371037|NCT01091428|11621299|FG003|Phase 2|Reason not specified|3
7371038|NCT01091428|11621296|FG000|Phase 2|Physician Decision|0
7371039|NCT01091428|11621297|FG001|Phase 2|Physician Decision|0
7371040|NCT01091428|11621298|FG002|Phase 2|Physician Decision|2
7371041|NCT01091428|11621299|FG003|Phase 2|Physician Decision|0
7371042|NCT01091454|11621318|FG000|Overall Study|Ineligible|1
7371043|NCT01091519|11621324|FG000|Overall Study|Adverse Event|12
7371044|NCT01091519|11621325|FG001|Overall Study|Adverse Event|16
7371045|NCT01091519|11621324|FG000|Overall Study|Death|1
7371046|NCT01091519|11621325|FG001|Overall Study|Death|0
7371047|NCT01091519|11621324|FG000|Overall Study|Lack of Efficacy|16
7371048|NCT01091519|11621325|FG001|Overall Study|Lack of Efficacy|19
7371049|NCT01091519|11621324|FG000|Overall Study|Lost to Follow-up|14
7371050|NCT01091519|11621325|FG001|Overall Study|Lost to Follow-up|24
7371051|NCT01091519|11621324|FG000|Overall Study|Withdrawal by Subject|2
7371052|NCT01091519|11621325|FG001|Overall Study|Withdrawal by Subject|2
7371053|NCT01091519|11621324|FG000|Overall Study|Other|6
7371054|NCT01091519|11621325|FG001|Overall Study|Other|8
7371055|NCT01091519|11621324|FG000|Overall Study|Randomized not treated|4
7371056|NCT01091519|11621325|FG001|Overall Study|Randomized not treated|4
7371057|NCT01091662|11621333|FG000|Overall Study|Adverse Event|1
7371058|NCT01091662|11621334|FG001|Overall Study|Adverse Event|9
7371059|NCT01091662|11621333|FG000|Overall Study|Physician Decision|1
7371060|NCT01091662|11621334|FG001|Overall Study|Physician Decision|1
7371061|NCT01091662|11621333|FG000|Overall Study|Withdrawal by Subject|7
7371062|NCT01091662|11621334|FG001|Overall Study|Withdrawal by Subject|6
7371063|NCT01091662|11621333|FG000|Overall Study|met exit criteria|7
7371064|NCT01091662|11621334|FG001|Overall Study|met exit criteria|13
7371065|NCT01091662|11621333|FG000|Overall Study|met exclusion criteria|1
7371066|NCT01091662|11621334|FG001|Overall Study|met exclusion criteria|0
7371067|NCT01091662|11621333|FG000|Overall Study|Lost to Follow-up|0
7371068|NCT01091662|11621334|FG001|Overall Study|Lost to Follow-up|1
7371069|NCT01091662|11621333|FG000|Overall Study|Pregnancy|0
7371070|NCT01091662|11621334|FG001|Overall Study|Pregnancy|1
7371071|NCT01091662|11621333|FG000|Overall Study|Protocol Violation|0
7371072|NCT01091662|11621334|FG001|Overall Study|Protocol Violation|2
7371073|NCT01091662|11621333|FG000|Overall Study|unable to swallow capsule|0
7371074|NCT01091662|11621334|FG001|Overall Study|unable to swallow capsule|1
7371075|NCT01091675|11621345|FG000|Overall Study|Adverse Event|7
7371076|NCT01091675|11621345|FG000|Overall Study|Lack of Efficacy|27
7371077|NCT01091974|11621363|FG000|Overall Study|Did not start intervention|3
7371078|NCT01091974|11621364|FG001|Overall Study|Did not start intervention|1
7371079|NCT01091974|11621365|FG002|Overall Study|Did not start intervention|3
7371080|NCT01091974|11621366|FG003|Overall Study|Did not start intervention|1
7371081|NCT01091974|11621363|FG000|Overall Study|resumed sleep medication|0
7371082|NCT01091974|11621364|FG001|Overall Study|resumed sleep medication|0
7371083|NCT01091974|11621365|FG002|Overall Study|resumed sleep medication|1
7371084|NCT01091974|11621366|FG003|Overall Study|resumed sleep medication|2
7371085|NCT01091974|11621363|FG000|Overall Study|Withdrawal by Subject|1
7371086|NCT01091974|11621364|FG001|Overall Study|Withdrawal by Subject|3
7371087|NCT01091974|11621365|FG002|Overall Study|Withdrawal by Subject|2
7371088|NCT01091974|11621366|FG003|Overall Study|Withdrawal by Subject|2
7371089|NCT01091974|11621363|FG000|Overall Study|side-effects|1
7371090|NCT01091974|11621364|FG001|Overall Study|side-effects|1
7371091|NCT01091974|11621365|FG002|Overall Study|side-effects|0
7371092|NCT01091974|11621366|FG003|Overall Study|side-effects|2
7371093|NCT01092182|11621379|FG000|Overall Study|Death|0
7371094|NCT01092182|11621380|FG001|Overall Study|Death|5
7371095|NCT01092182|11621381|FG002|Overall Study|Death|3
7371096|NCT01092182|11621379|FG000|Overall Study|participant safety|1
7371097|NCT01092182|11621380|FG001|Overall Study|participant safety|2
7371098|NCT01092182|11621381|FG002|Overall Study|participant safety|0
7371099|NCT01092182|11621379|FG000|Overall Study|Physician Decision|0
7371100|NCT01092182|11621380|FG001|Overall Study|Physician Decision|6
7371101|NCT01092182|11621381|FG002|Overall Study|Physician Decision|0
7371102|NCT01092182|11621379|FG000|Overall Study|Did not meet criteria|0
7371103|NCT01092182|11621380|FG001|Overall Study|Did not meet criteria|0
7371104|NCT01092182|11621381|FG002|Overall Study|Did not meet criteria|25
7371105|NCT01092182|11621379|FG000|Overall Study|Non-compliance|0
7371106|NCT01092182|11621380|FG001|Overall Study|Non-compliance|3
7371107|NCT01092182|11621381|FG002|Overall Study|Non-compliance|0
7371108|NCT01092182|11621379|FG000|Overall Study|Participant refused follow-up|0
7371109|NCT01092182|11621380|FG001|Overall Study|Participant refused follow-up|2
7371110|NCT01092182|11621381|FG002|Overall Study|Participant refused follow-up|0
7371111|NCT01092416|11621424|FG000|Enrollment|Atherectomy device not inserted|3
7371112|NCT01092416|11621424|FG000|30-Day Follow-up|Death|2
7371113|NCT01092416|11621424|FG000|30-Day Follow-up|Missed 30-day follow-up|3
7371114|NCT01092416|11621424|FG000|30-Day Follow-up|Data collected after close of 30D window|5
7371115|NCT01092416|11621424|FG000|12-Month Follow-up|Death|16
7371116|NCT01092416|11621424|FG000|12-Month Follow-up|Lost to Follow-up|4
7371117|NCT01092416|11621424|FG000|12-Month Follow-up|Withdrawal by Subject|2
7371118|NCT01092416|11621424|FG000|12-Month Follow-up|Missed 1-year follow-up|1
7371119|NCT01092416|11621424|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
7371120|NCT01092507|11621447|FG000|Overall Study|Withdrawal by Subject|2
7371121|NCT01092507|11621448|FG001|Overall Study|Withdrawal by Subject|0
7371122|NCT01092546|11621454|FG000|Overall Study|Subjects withdrawn prior to dosing|4
7371123|NCT01092637|11621464|FG000|Overall Study|Death|47
7371124|NCT01092637|11621465|FG001|Overall Study|Death|49
7371125|NCT01092663|11621474|FG000|Overall Study|Withdrawal by Subject|3
7371126|NCT01092663|11621475|FG001|Overall Study|Withdrawal by Subject|2
7371127|NCT01092663|11621474|FG000|Overall Study|Glucose >300mg/dL|1
7371128|NCT01092663|11621475|FG001|Overall Study|Glucose >300mg/dL|0
7371129|NCT01092663|11621474|FG000|Overall Study|High fasting triglyceride|2
7371130|NCT01092663|11621475|FG001|Overall Study|High fasting triglyceride|0
7371131|NCT01092663|11621474|FG000|Overall Study|Adverse Event|1
7371132|NCT01092663|11621475|FG001|Overall Study|Adverse Event|1
7371133|NCT01092663|11621474|FG000|Overall Study|Protocol Violation|0
7371134|NCT01092663|11621475|FG001|Overall Study|Protocol Violation|1
7386903|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386904|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386905|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386906|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386907|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7386908|NCT01212770|11645401|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
7386909|NCT01212770|11645402|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
7386910|NCT01212770|11645403|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
7386911|NCT01212770|11645404|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386912|NCT01212770|11645405|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386913|NCT01212770|11645406|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386914|NCT01212770|11645407|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386915|NCT01212770|11645408|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386916|NCT01212770|11645409|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
7386917|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7386918|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
7386919|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7386920|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
7386921|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7386922|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7386923|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
7386924|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7386925|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
7386926|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7386927|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
7386928|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
7386929|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
7386930|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
7386931|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
7386932|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7386933|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7386934|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
7386935|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7386936|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
7386937|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7386938|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
7386939|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7386940|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7386941|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
7386942|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7386943|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
7386944|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386945|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386946|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
7386947|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386948|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386949|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386950|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386951|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386952|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
7386953|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386954|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386955|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386956|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
7386957|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386958|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386959|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386960|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386961|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
7386962|NCT01212770|11645401|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386963|NCT01212770|11645402|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7371135|NCT01092702|11621495|FG000|Overall Study|Withdrawal by Subject|7
7371136|NCT01092702|11621495|FG000|Overall Study|Lost to Follow-up|2
7371137|NCT01092728|11621501|FG000|Overall Study|Withdrawal by Subject|2
7371138|NCT01092728|11621502|FG001|Overall Study|Withdrawal by Subject|0
7371139|NCT01092728|11621501|FG000|Overall Study|Adverse Event|0
7371140|NCT01092728|11621502|FG001|Overall Study|Adverse Event|1
7371141|NCT01092728|11621501|FG000|Overall Study|Disease Progression|1
7371142|NCT01092728|11621502|FG001|Overall Study|Disease Progression|13
7371143|NCT01092728|11621501|FG000|Overall Study|Prohibited Concomitant Medications|1
7371144|NCT01092728|11621502|FG001|Overall Study|Prohibited Concomitant Medications|0
7371145|NCT01092780|11621512|FG000|Washout Period 1|Adverse Event|0
7371146|NCT01092780|11621513|FG001|Washout Period 1|Adverse Event|1
7371147|NCT01092780|11621514|FG002|Washout Period 1|Adverse Event|0
7371148|NCT01092780|11621515|FG003|Washout Period 1|Adverse Event|0
7371149|NCT01092780|11621512|FG000|Washout Period 1|Noncompliance with nCPAP|1
7371150|NCT01092780|11621513|FG001|Washout Period 1|Noncompliance with nCPAP|0
7371151|NCT01092780|11621514|FG002|Washout Period 1|Noncompliance with nCPAP|0
7371152|NCT01092780|11621515|FG003|Washout Period 1|Noncompliance with nCPAP|0
7371153|NCT01092780|11621512|FG000|Washout Period 2|Adverse Event|0
7371154|NCT01092780|11621513|FG001|Washout Period 2|Adverse Event|1
7371155|NCT01092780|11621514|FG002|Washout Period 2|Adverse Event|1
7371156|NCT01092780|11621515|FG003|Washout Period 2|Adverse Event|0
7371157|NCT01092832|11621527|FG000|Overall Study|Other|1
7371158|NCT01092832|11621528|FG001|Overall Study|Other|0
7371159|NCT01093222|11621579|FG000|Overall Study|Ineligible|6
7371160|NCT01093222|11621579|FG000|Overall Study|Adverse Event|7
7371161|NCT01093222|11621579|FG000|Overall Study|Progression/relapse|24
7371162|NCT01093222|11621579|FG000|Overall Study|Death|2
7371163|NCT01093222|11621579|FG000|Overall Study|Not protocol specified|1
7371164|NCT01093534|11621618|FG000|Overall Study|Adverse Event|2
7371165|NCT01093534|11621619|FG001|Overall Study|Adverse Event|5
7371166|NCT01093534|11621620|FG002|Overall Study|Adverse Event|2
7371167|NCT01093534|11621618|FG000|Overall Study|Lack of Efficacy|2
7371168|NCT01093534|11621619|FG001|Overall Study|Lack of Efficacy|1
7371169|NCT01093534|11621620|FG002|Overall Study|Lack of Efficacy|1
7371170|NCT01093534|11621618|FG000|Overall Study|Withdrawal by Subject|5
7371171|NCT01093534|11621619|FG001|Overall Study|Withdrawal by Subject|7
7371172|NCT01093534|11621620|FG002|Overall Study|Withdrawal by Subject|2
7371173|NCT01093534|11621618|FG000|Overall Study|Other|1
7371174|NCT01093534|11621619|FG001|Overall Study|Other|3
7371175|NCT01093534|11621620|FG002|Overall Study|Other|4
7371176|NCT01093586|11621629|FG000|Overall Study|Failed to engraft|3
7371177|NCT01093599|11621635|FG000|Overall Study|Lost to Follow-up|32
7371178|NCT01093599|11621636|FG001|Overall Study|Lost to Follow-up|46
7371179|NCT01093625|11621644|FG000|Baseline and Dispensed|Withdrawal by Subject|2
7371180|NCT01093625|11621645|FG001|Baseline and Dispensed|Withdrawal by Subject|0
7371181|NCT01093625|11621644|FG000|2-Week Visit|Withdrawal by Subject|1
7371182|NCT01093625|11621645|FG001|2-Week Visit|Withdrawal by Subject|0
7371183|NCT01093625|11621644|FG000|1-Month Visit|Lost to Follow-up|2
7371184|NCT01093625|11621645|FG001|1-Month Visit|Lost to Follow-up|0
7371185|NCT01093625|11621644|FG000|3-Month Visit|Lost to Follow-up|2
7371186|NCT01093625|11621645|FG001|3-Month Visit|Lost to Follow-up|0
7371187|NCT01093625|11621644|FG000|6-Month Visit|Withdrawal by Subject|6
7371188|NCT01093625|11621645|FG001|6-Month Visit|Withdrawal by Subject|7
7371189|NCT01093625|11621644|FG000|6-Month Visit|Lost to Follow-up|2
7371190|NCT01093625|11621645|FG001|6-Month Visit|Lost to Follow-up|2
7371191|NCT01093625|11621644|FG000|1-Year Visit|Lost to Follow-up|5
7371192|NCT01093625|11621645|FG001|1-Year Visit|Lost to Follow-up|3
7371193|NCT01093755|11621671|FG000|Overall Study|Withdrawal by Subject|3
7533352|NCT02684370|11879635|FG002|Part A|Adverse Event|1
7533353|NCT02684370|11879636|FG003|Part A|Adverse Event|0
7533354|NCT02684370|11879637|FG004|Part A|Adverse Event|0
7533355|NCT02684370|11879638|FG005|Part A|Adverse Event|0
7533356|NCT02684370|11879633|FG000|Part A|Lost to Follow-up|1
7533357|NCT02684370|11879634|FG001|Part A|Lost to Follow-up|1
7371194|NCT01093755|11621672|FG001|Overall Study|Withdrawal by Subject|4
7371195|NCT01093885|11621691|FG000|Overall Study|Adverse Event|4
7371196|NCT01093885|11621691|FG000|Overall Study|Lost to Follow-up|1
7371197|NCT01094119|11621711|FG000|Overall Study|Lack of Efficacy|2
7371198|NCT01094119|11621712|FG001|Overall Study|Lack of Efficacy|4
7371199|NCT01094171|11621718|FG000|Overall Study|Lost to Follow-up|2
7371200|NCT01094171|11621718|FG000|Overall Study|Informed consent withdrawal|4
7371201|NCT01094171|11621718|FG000|Overall Study|Migration from the study area|3
7371202|NCT01094171|11621718|FG000|Overall Study|Other|1
7371203|NCT01094184|11621724|FG000|Overall Study|Death|35
7371204|NCT01094184|11621725|FG001|Overall Study|Death|11
7371205|NCT01094288|11621739|FG000|Overall Study|Adverse Event|0
7371206|NCT01094288|11621740|FG001|Overall Study|Adverse Event|3
7371207|NCT01094288|11621741|FG002|Overall Study|Adverse Event|1
7371208|NCT01094288|11621742|FG003|Overall Study|Adverse Event|1
7371209|NCT01094288|11621743|FG004|Overall Study|Adverse Event|0
7371210|NCT01094288|11621744|FG005|Overall Study|Adverse Event|0
7371211|NCT01094288|11621745|FG006|Overall Study|Adverse Event|0
7371212|NCT01094288|11621746|FG007|Overall Study|Adverse Event|0
7371213|NCT01094288|11621739|FG000|Overall Study|Withdrawal by Subject|0
7533358|NCT02684370|11879635|FG002|Part A|Lost to Follow-up|0
7533359|NCT02684370|11879636|FG003|Part A|Lost to Follow-up|0
7371214|NCT01094288|11621740|FG001|Overall Study|Withdrawal by Subject|1
7371215|NCT01094288|11621741|FG002|Overall Study|Withdrawal by Subject|2
7371216|NCT01094288|11621742|FG003|Overall Study|Withdrawal by Subject|0
7371217|NCT01094288|11621743|FG004|Overall Study|Withdrawal by Subject|0
7371218|NCT01094288|11621744|FG005|Overall Study|Withdrawal by Subject|0
7371219|NCT01094288|11621745|FG006|Overall Study|Withdrawal by Subject|0
7371220|NCT01094288|11621746|FG007|Overall Study|Withdrawal by Subject|2
7371221|NCT01094288|11621739|FG000|Overall Study|Initiation of Alternative Therapy|0
7371222|NCT01094288|11621740|FG001|Overall Study|Initiation of Alternative Therapy|0
7371223|NCT01094288|11621741|FG002|Overall Study|Initiation of Alternative Therapy|1
7371224|NCT01094288|11621742|FG003|Overall Study|Initiation of Alternative Therapy|0
7371225|NCT01094288|11621743|FG004|Overall Study|Initiation of Alternative Therapy|0
7371226|NCT01094288|11621744|FG005|Overall Study|Initiation of Alternative Therapy|0
7371227|NCT01094288|11621745|FG006|Overall Study|Initiation of Alternative Therapy|0
7371228|NCT01094288|11621746|FG007|Overall Study|Initiation of Alternative Therapy|0
7371229|NCT01094288|11621739|FG000|Overall Study|Reason not Specified|2
7371230|NCT01094288|11621740|FG001|Overall Study|Reason not Specified|3
7371231|NCT01094288|11621741|FG002|Overall Study|Reason not Specified|0
7371232|NCT01094288|11621742|FG003|Overall Study|Reason not Specified|1
7371233|NCT01094288|11621743|FG004|Overall Study|Reason not Specified|0
7371234|NCT01094288|11621744|FG005|Overall Study|Reason not Specified|0
7371235|NCT01094288|11621745|FG006|Overall Study|Reason not Specified|0
7371236|NCT01094288|11621746|FG007|Overall Study|Reason not Specified|0
7371237|NCT01094288|11621739|FG000|Overall Study|Ongoing Participants|0
7371238|NCT01094288|11621740|FG001|Overall Study|Ongoing Participants|3
7371239|NCT01094288|11621741|FG002|Overall Study|Ongoing Participants|0
7371240|NCT01094288|11621742|FG003|Overall Study|Ongoing Participants|0
7371241|NCT01094288|11621743|FG004|Overall Study|Ongoing Participants|0
7371242|NCT01094288|11621744|FG005|Overall Study|Ongoing Participants|0
7371243|NCT01094288|11621745|FG006|Overall Study|Ongoing Participants|0
7371244|NCT01094288|11621746|FG007|Overall Study|Ongoing Participants|0
7371245|NCT01094301|11621768|FG000|Trial Stage|Withdrawal by Subject|1
7371246|NCT01094301|11621768|FG000|Implant Stage|Adverse Event|1
7371247|NCT01094301|11621768|FG000|Implant Stage|Protocol Violation|1
7371248|NCT01094301|11621768|FG000|Implant Stage|Withdrawal by Subject|2
7570495|NCT03493386|11948282|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7570496|NCT03493386|11948283|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7570497|NCT03493386|11948284|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7570498|NCT03493542|11948303|FG000|Overall Study|Ongoing|2
7570499|NCT03493542|11948304|FG001|Overall Study|Ongoing|3
7570500|NCT03493542|11948303|FG000|Overall Study|Withdrawal by parent or guardian|3
7570501|NCT03493542|11948304|FG001|Overall Study|Withdrawal by parent or guardian|0
7570502|NCT03493542|11948303|FG000|Overall Study|Withdrawal by Subject|2
7570503|NCT03493542|11948304|FG001|Overall Study|Withdrawal by Subject|6
7570504|NCT03493698|11948314|FG000|Treatment Period C|Adverse Event|1
7570505|NCT03493698|11948314|FG000|Treatment Period C|Withdrawal by Subject|1
7570506|NCT03494725|11948352|FG000|Overall Study|Withdrawal by Subject|0
7570507|NCT03494725|11948353|FG001|Overall Study|Withdrawal by Subject|2
7570508|NCT03494725|11948352|FG000|Overall Study|Antibiotic use|1
7570509|NCT03494725|11948353|FG001|Overall Study|Antibiotic use|0
7570510|NCT03494816|11948365|FG000|Overall Study|Protocol Violation|2
7570511|NCT03494816|11948365|FG000|Overall Study|Physician Decision|2
7570512|NCT03494816|11948365|FG000|Overall Study|Did not start trial treatment|1
7570513|NCT03494816|11948365|FG000|Overall Study|Adverse Event|1
7570514|NCT03494985|11948377|FG000|Overall Study|Adverse Event|3
7570515|NCT03494985|11948378|FG001|Overall Study|Adverse Event|2
7371249|NCT01094301|11621768|FG000|Implant Stage|No return of pain|4
7371250|NCT01094730|11621845|FG000|Period 1 (14 Days)|Lost to Follow-up|0
7371251|NCT01094730|11621846|FG001|Period 1 (14 Days)|Lost to Follow-up|1
7371252|NCT01094730|11621845|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
7371253|NCT01094730|11621846|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
7371254|NCT01094730|11621845|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
7371255|NCT01094730|11621846|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
7371256|NCT01094730|11621845|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
7371257|NCT01094730|11621846|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
7371258|NCT01094730|11621845|FG000|Period 2 (14 Days)|Protocol Violation|2
7371259|NCT01094730|11621846|FG001|Period 2 (14 Days)|Protocol Violation|0
7570516|NCT03494985|11948379|FG002|Overall Study|Adverse Event|3
7371260|NCT01094730|11621845|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
7371261|NCT01094730|11621846|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
7371262|NCT01094730|11621845|FG000|Period 2 (14 Days)|Adverse Event|0
7371263|NCT01094730|11621846|FG001|Period 2 (14 Days)|Adverse Event|1
7371264|NCT01094730|11621845|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
7371265|NCT01094730|11621846|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
7371266|NCT01094743|11621853|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
7371267|NCT01094808|11621861|FG000|Overall Study|Withdrawal by Subject|1
7371268|NCT01094808|11621862|FG001|Overall Study|Withdrawal by Subject|1
7371269|NCT01094808|11621863|FG002|Overall Study|Withdrawal by Subject|0
7371270|NCT01094886|11621871|FG000|Overall Study|Adverse Event|2
7371271|NCT01094886|11621871|FG000|Overall Study|Withdrawal by Subject|5
7371272|NCT01095094|11621875|FG000|Overall Study|Withdrawal by Subject|1
7371273|NCT01095094|11621875|FG000|Overall Study|Death|1
7371274|NCT01095094|11621875|FG000|Overall Study|Physician Decision|1
7371275|NCT01095653|11621910|FG000|Overall Study|Lack of Efficacy|3
7371276|NCT01095653|11621911|FG001|Overall Study|Lack of Efficacy|0
7371277|NCT01095653|11621912|FG002|Overall Study|Lack of Efficacy|0
7371278|NCT01095653|11621910|FG000|Overall Study|Adverse Event|1
7371279|NCT01095653|11621911|FG001|Overall Study|Adverse Event|4
7371280|NCT01095653|11621912|FG002|Overall Study|Adverse Event|4
7371281|NCT01095653|11621910|FG000|Overall Study|Lost to Follow-up|1
7371282|NCT01095653|11621911|FG001|Overall Study|Lost to Follow-up|0
7371283|NCT01095653|11621912|FG002|Overall Study|Lost to Follow-up|4
7371284|NCT01095653|11621910|FG000|Overall Study|Withdrawal by Subject|4
7371285|NCT01095653|11621911|FG001|Overall Study|Withdrawal by Subject|5
7371286|NCT01095653|11621912|FG002|Overall Study|Withdrawal by Subject|3
7371287|NCT01095653|11621910|FG000|Overall Study|non-compliance, not met criteria, etc.|10
7371288|NCT01095653|11621911|FG001|Overall Study|non-compliance, not met criteria, etc.|6
7371289|NCT01095653|11621912|FG002|Overall Study|non-compliance, not met criteria, etc.|5
7371290|NCT01095666|11621923|FG000|Overall Study|Lack of Efficacy|0
7371291|NCT01095666|11621924|FG001|Overall Study|Lack of Efficacy|0
7371292|NCT01095666|11621925|FG002|Overall Study|Lack of Efficacy|1
7371293|NCT01095666|11621923|FG000|Overall Study|Adverse Event|2
7371294|NCT01095666|11621924|FG001|Overall Study|Adverse Event|1
7371295|NCT01095666|11621925|FG002|Overall Study|Adverse Event|3
7371296|NCT01095666|11621923|FG000|Overall Study|Lost to Follow-up|2
7371297|NCT01095666|11621924|FG001|Overall Study|Lost to Follow-up|2
7371298|NCT01095666|11621925|FG002|Overall Study|Lost to Follow-up|0
7371299|NCT01095666|11621923|FG000|Overall Study|Withdrawal by Subject|6
7371300|NCT01095666|11621924|FG001|Overall Study|Withdrawal by Subject|6
7371301|NCT01095666|11621925|FG002|Overall Study|Withdrawal by Subject|1
7371302|NCT01095666|11621923|FG000|Overall Study|Non-compliance, not met criteria etc.|7
7371303|NCT01095666|11621924|FG001|Overall Study|Non-compliance, not met criteria etc.|2
7371304|NCT01095666|11621925|FG002|Overall Study|Non-compliance, not met criteria etc.|2
7371305|NCT01095796|11621940|FG000|Overall Study|Randomized but Not Treated|5
7371306|NCT01095796|11621941|FG001|Overall Study|Randomized but Not Treated|2
7371307|NCT01095796|11621940|FG000|Overall Study|Adverse Event|9
7371308|NCT01095796|11621941|FG001|Overall Study|Adverse Event|19
7371309|NCT01095796|11621940|FG000|Overall Study|Death|3
7371310|NCT01095796|11621941|FG001|Overall Study|Death|2
7371311|NCT01095796|11621940|FG000|Overall Study|Pregnancy|2
7371312|NCT01095796|11621941|FG001|Overall Study|Pregnancy|0
7371313|NCT01095796|11621940|FG000|Overall Study|Lack of Efficacy|5
7371314|NCT01095796|11621941|FG001|Overall Study|Lack of Efficacy|3
7371315|NCT01095796|11621940|FG000|Overall Study|Investigator's Discretion|7
7371316|NCT01095796|11621941|FG001|Overall Study|Investigator's Discretion|2
7371317|NCT01095796|11621940|FG000|Overall Study|Withdrew Consent|16
7371318|NCT01095796|11621941|FG001|Overall Study|Withdrew Consent|22
7371319|NCT01095796|11621940|FG000|Overall Study|Lost to Follow-up|27
7371320|NCT01095796|11621941|FG001|Overall Study|Lost to Follow-up|29
7371321|NCT01095796|11621940|FG000|Overall Study|Participant Noncompliance|5
7371322|NCT01095796|11621941|FG001|Overall Study|Participant Noncompliance|10
7371323|NCT01095796|11621940|FG000|Overall Study|Protocol Violation|1
7371324|NCT01095796|11621941|FG001|Overall Study|Protocol Violation|0
7371325|NCT01095796|11621940|FG000|Overall Study|Participant Transferred to Another Study|215
7371326|NCT01095796|11621941|FG001|Overall Study|Participant Transferred to Another Study|200
7371327|NCT01095835|11621950|FG000|Overall Study|Adverse Event|8
7371328|NCT01095835|11621951|FG001|Overall Study|Adverse Event|6
7371329|NCT01095835|11621952|FG002|Overall Study|Adverse Event|6
7371330|NCT01095835|11621950|FG000|Overall Study|Lack of Efficacy|0
7371331|NCT01095835|11621951|FG001|Overall Study|Lack of Efficacy|1
7371332|NCT01095835|11621952|FG002|Overall Study|Lack of Efficacy|0
7371333|NCT01095835|11621950|FG000|Overall Study|Physician Decision|0
7371334|NCT01095835|11621951|FG001|Overall Study|Physician Decision|0
7371335|NCT01095835|11621952|FG002|Overall Study|Physician Decision|1
7371336|NCT01095835|11621950|FG000|Overall Study|Withdrawal by Subject|1
7371337|NCT01095835|11621951|FG001|Overall Study|Withdrawal by Subject|3
7371338|NCT01095835|11621952|FG002|Overall Study|Withdrawal by Subject|0
7371339|NCT01095835|11621950|FG000|Overall Study|Non study compliance|0
7371340|NCT01095835|11621951|FG001|Overall Study|Non study compliance|0
7371341|NCT01095835|11621952|FG002|Overall Study|Non study compliance|1
7371342|NCT01095835|11621950|FG000|Overall Study|Protocol Violation|1
7371343|NCT01095835|11621951|FG001|Overall Study|Protocol Violation|2
7371344|NCT01095835|11621952|FG002|Overall Study|Protocol Violation|0
7371345|NCT01095978|11621965|FG000|Overall Study|Did not take Klacid SR|2
7371346|NCT01095978|11621965|FG000|Overall Study|Adverse Event|1
7371347|NCT01096017|11621971|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
7371348|NCT01096017|11621972|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
7371349|NCT01096056|11621980|FG000|Overall Study|Lost to Follow-up|0
7371350|NCT01096056|11621981|FG001|Overall Study|Lost to Follow-up|1
7371351|NCT01096160|11621997|FG000|Overall Study|Adverse Event|0
7371352|NCT01096160|11621998|FG001|Overall Study|Adverse Event|0
7371353|NCT01096160|11621999|FG002|Overall Study|Adverse Event|1
7371354|NCT01096160|11622000|FG003|Overall Study|Adverse Event|0
7371355|NCT01096160|11622001|FG004|Overall Study|Adverse Event|0
7570517|NCT03494985|11948380|FG003|Overall Study|Adverse Event|0
7570518|NCT03494985|11948377|FG000|Overall Study|Other (Withdrawal of consent)|2
7570519|NCT03494985|11948378|FG001|Overall Study|Other (Withdrawal of consent)|3
7371356|NCT01096160|11622002|FG005|Overall Study|Adverse Event|0
7371357|NCT01096160|11622003|FG006|Overall Study|Adverse Event|0
7371358|NCT01096160|11622004|FG007|Overall Study|Adverse Event|0
7371359|NCT01096160|11622005|FG008|Overall Study|Adverse Event|0
7371360|NCT01096160|11622006|FG009|Overall Study|Adverse Event|1
7371361|NCT01096160|11621997|FG000|Overall Study|Met stopping criteria per protocol|0
7371362|NCT01096160|11621998|FG001|Overall Study|Met stopping criteria per protocol|0
7371363|NCT01096160|11621999|FG002|Overall Study|Met stopping criteria per protocol|0
7371364|NCT01096160|11622000|FG003|Overall Study|Met stopping criteria per protocol|0
7371365|NCT01096160|11622001|FG004|Overall Study|Met stopping criteria per protocol|1
7371366|NCT01096160|11622002|FG005|Overall Study|Met stopping criteria per protocol|0
7371367|NCT01096160|11622003|FG006|Overall Study|Met stopping criteria per protocol|2
7371368|NCT01096160|11622004|FG007|Overall Study|Met stopping criteria per protocol|0
7371369|NCT01096160|11622005|FG008|Overall Study|Met stopping criteria per protocol|2
7371370|NCT01096160|11622006|FG009|Overall Study|Met stopping criteria per protocol|0
7371371|NCT01096186|11622041|FG000|Overall Study|Adverse Event|16
7371372|NCT01096186|11622041|FG000|Overall Study|Death|4
7371373|NCT01096186|11622041|FG000|Overall Study|Lack of Efficacy|4
7371374|NCT01096186|11622041|FG000|Overall Study|Lost to Follow-up|2
7371375|NCT01096186|11622041|FG000|Overall Study|Withdrawal by Subject|22
7371376|NCT01096186|11622041|FG000|Overall Study|Physician Decision|1
7371377|NCT01096186|11622041|FG000|Overall Study|Noncompliance with study drug|1
7371378|NCT01096316|11622056|FG000|Overall Study|Lost to Follow-up|15
7371379|NCT01096316|11622057|FG001|Overall Study|Lost to Follow-up|9
7371380|NCT01096342|11622063|FG000|Overall Study|Protocol Violation|1
7371381|NCT01096446|11622069|FG000|Overall Study|Death|1
7371382|NCT01096446|11622070|FG001|Overall Study|Death|0
7371383|NCT01096446|11622069|FG000|Overall Study|Protocol Violation|2
7371384|NCT01096446|11622070|FG001|Overall Study|Protocol Violation|0
7371385|NCT01096550|11622077|FG000|Overall Study|discontinued site|10
7371386|NCT01096550|11622078|FG001|Overall Study|discontinued site|11
7371387|NCT01096550|11622077|FG000|Overall Study|non-regular treatment track at clinic|1
7371388|NCT01096550|11622078|FG001|Overall Study|non-regular treatment track at clinic|1
7371389|NCT01096550|11622077|FG000|Overall Study|clinic readmission|1
7371390|NCT01096550|11622078|FG001|Overall Study|clinic readmission|1
7371391|NCT01096550|11622077|FG000|Overall Study|Withdrawal by Subject|0
7371392|NCT01096550|11622078|FG001|Overall Study|Withdrawal by Subject|1
7371393|NCT01096550|11622077|FG000|Overall Study|non-African American participant|13
7371394|NCT01096550|11622078|FG001|Overall Study|non-African American participant|6
7371395|NCT01096550|11622077|FG000|Overall Study|Lost to Follow-up|12
7371396|NCT01096550|11622078|FG001|Overall Study|Lost to Follow-up|9
7371397|NCT01096589|11622088|FG000|Overall Study|Adverse Event|2
7371398|NCT01096589|11622089|FG001|Overall Study|Adverse Event|1
7371399|NCT01096589|11622090|FG002|Overall Study|Adverse Event|2
7371400|NCT01096589|11622091|FG003|Overall Study|Adverse Event|1
7371401|NCT01096589|11622088|FG000|Overall Study|Withdrawal by Subject|2
7371402|NCT01096589|11622089|FG001|Overall Study|Withdrawal by Subject|1
7371403|NCT01096589|11622090|FG002|Overall Study|Withdrawal by Subject|1
7371404|NCT01096589|11622091|FG003|Overall Study|Withdrawal by Subject|1
7371405|NCT01096589|11622088|FG000|Overall Study|Compliance with protocol|0
7371406|NCT01096589|11622089|FG001|Overall Study|Compliance with protocol|0
7371407|NCT01096589|11622090|FG002|Overall Study|Compliance with protocol|1
7371408|NCT01096589|11622091|FG003|Overall Study|Compliance with protocol|0
7371409|NCT01096589|11622088|FG000|Overall Study|found treatment exhausting|0
7371410|NCT01096589|11622089|FG001|Overall Study|found treatment exhausting|0
7371411|NCT01096589|11622090|FG002|Overall Study|found treatment exhausting|0
7371412|NCT01096589|11622091|FG003|Overall Study|found treatment exhausting|1
7371413|NCT01096667|11622110|FG000|Overall Study|Lost to Follow-up|1
7371414|NCT01096667|11622111|FG001|Overall Study|Lost to Follow-up|1
7371415|NCT01096667|11622112|FG002|Overall Study|Lost to Follow-up|1
7371416|NCT01096667|11622113|FG003|Overall Study|Lost to Follow-up|0
7371417|NCT01096667|11622114|FG004|Overall Study|Lost to Follow-up|0
7371418|NCT01096667|11622110|FG000|Overall Study|Withdrawal by Subject|1
7371419|NCT01096667|11622111|FG001|Overall Study|Withdrawal by Subject|0
7371420|NCT01096667|11622112|FG002|Overall Study|Withdrawal by Subject|0
7371421|NCT01096667|11622113|FG003|Overall Study|Withdrawal by Subject|1
7371422|NCT01096667|11622114|FG004|Overall Study|Withdrawal by Subject|0
7371423|NCT01096667|11622110|FG000|Overall Study|Reason not available|0
7371424|NCT01096667|11622111|FG001|Overall Study|Reason not available|1
7371425|NCT01096667|11622112|FG002|Overall Study|Reason not available|1
7371426|NCT01096667|11622113|FG003|Overall Study|Reason not available|1
7371427|NCT01096667|11622114|FG004|Overall Study|Reason not available|0
7371428|NCT01096667|11622110|FG000|Overall Study|Protocol Violation|0
7570520|NCT03494985|11948379|FG002|Overall Study|Other (Withdrawal of consent)|2
7371429|NCT01096667|11622111|FG001|Overall Study|Protocol Violation|0
7371430|NCT01096667|11622112|FG002|Overall Study|Protocol Violation|0
7371431|NCT01096667|11622113|FG003|Overall Study|Protocol Violation|1
7371432|NCT01096667|11622114|FG004|Overall Study|Protocol Violation|0
7371433|NCT01096667|11622110|FG000|Overall Study|Not treated|1
7371434|NCT01096667|11622111|FG001|Overall Study|Not treated|0
7371435|NCT01096667|11622112|FG002|Overall Study|Not treated|0
7371436|NCT01096667|11622113|FG003|Overall Study|Not treated|0
7371437|NCT01096667|11622114|FG004|Overall Study|Not treated|0
7371438|NCT01096784|11622159|FG000|Overall Study|Withdrawal by Subject|2
7371439|NCT01096784|11622160|FG001|Overall Study|Withdrawal by Subject|1
7371440|NCT01096784|11622159|FG000|Overall Study|Adverse Event|11
7371441|NCT01096784|11622160|FG001|Overall Study|Adverse Event|9
7371442|NCT01096784|11622159|FG000|Overall Study|Protocol Deviation|2
7371443|NCT01096784|11622160|FG001|Overall Study|Protocol Deviation|2
7371444|NCT01096784|11622159|FG000|Overall Study|Administrative Decision|0
7371445|NCT01096784|11622160|FG001|Overall Study|Administrative Decision|1
7371446|NCT01096784|11622159|FG000|Overall Study|Other Unspecified|0
7371447|NCT01096784|11622160|FG001|Overall Study|Other Unspecified|1
7371448|NCT01096849|11622184|FG000|Overall Study|Consent Withdrawn|1
7371449|NCT01096849|11622185|FG001|Overall Study|Consent Withdrawn|4
7371450|NCT01096849|11622186|FG002|Overall Study|Consent Withdrawn|2
7371451|NCT01096849|11622184|FG000|Overall Study|Lack of Efficacy|0
7371452|NCT01096849|11622185|FG001|Overall Study|Lack of Efficacy|2
7371453|NCT01096849|11622186|FG002|Overall Study|Lack of Efficacy|0
7371454|NCT01096849|11622184|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
7371455|NCT01096849|11622185|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
7371456|NCT01096849|11622186|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
7371457|NCT01096849|11622184|FG000|Overall Study|Investigator or Medical Monitor Decision|0
7371458|NCT01096849|11622185|FG001|Overall Study|Investigator or Medical Monitor Decision|1
7371459|NCT01096849|11622186|FG002|Overall Study|Investigator or Medical Monitor Decision|0
7371460|NCT01096849|11622184|FG000|Overall Study|Administrative Reasons|0
7371461|NCT01096849|11622185|FG001|Overall Study|Administrative Reasons|1
7371462|NCT01096849|11622186|FG002|Overall Study|Administrative Reasons|2
7371463|NCT01096849|11622184|FG000|Overall Study|Lost to Follow-up|1
7371464|NCT01096849|11622185|FG001|Overall Study|Lost to Follow-up|3
7371465|NCT01096849|11622186|FG002|Overall Study|Lost to Follow-up|1
7371466|NCT01097044|11622229|FG000|Overall Study|Withdrawal by Subject|4
7371467|NCT01097044|11622230|FG001|Overall Study|Withdrawal by Subject|4
7371468|NCT01097044|11622229|FG000|Overall Study|Lost to Follow-up|1
7371469|NCT01097044|11622230|FG001|Overall Study|Lost to Follow-up|0
7371470|NCT01097044|11622229|FG000|Overall Study|Withdrawal by Sponsor|0
7371471|NCT01097044|11622230|FG001|Overall Study|Withdrawal by Sponsor|1
7371472|NCT01097057|11622238|FG000|Overall Study|Physician Decision|3
7371473|NCT01097330|11622249|FG000|Overall Study|Study terminated early|7
7371474|NCT01097330|11622250|FG001|Overall Study|Study terminated early|5
7371475|NCT01097421|11622272|FG000|Overall Study|Adverse Event|8
7371476|NCT01097421|11622272|FG000|Overall Study|Protocol Violation|2
7371477|NCT01097421|11622272|FG000|Overall Study|Lost to Follow-up|1
7371478|NCT01097421|11622272|FG000|Overall Study|Withdrawal by Subject|3
7371479|NCT01097577|11622282|FG000|Overall Study|Adverse Event|0
7371480|NCT01097577|11622283|FG001|Overall Study|Adverse Event|1
7371481|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
7371482|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
7371483|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
7371484|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371485|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371486|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371487|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371488|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371489|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
7371490|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7371491|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
7371492|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371493|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7570521|NCT03494985|11948380|FG003|Overall Study|Other (Withdrawal of consent)|5
7570522|NCT03494985|11948377|FG000|Overall Study|Other (Not specified)|0
7570523|NCT03494985|11948378|FG001|Overall Study|Other (Not specified)|1
7570524|NCT03494985|11948379|FG002|Overall Study|Other (Not specified)|1
7570525|NCT03494985|11948380|FG003|Overall Study|Other (Not specified)|0
7570526|NCT03495102|11948393|FG000|Overall Study|Adverse Event|5
7570527|NCT03495102|11948394|FG001|Overall Study|Adverse Event|7
7371494|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371495|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371496|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371497|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7371498|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
7371499|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
7371500|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371501|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371502|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7570528|NCT03495102|11948395|FG002|Overall Study|Adverse Event|10
7570529|NCT03495102|11948393|FG000|Overall Study|Death|3
7570530|NCT03495102|11948394|FG001|Overall Study|Death|4
7570531|NCT03495102|11948395|FG002|Overall Study|Death|4
7570532|NCT03495102|11948393|FG000|Overall Study|Lost to Follow-up|15
7570533|NCT03495102|11948394|FG001|Overall Study|Lost to Follow-up|16
7570534|NCT03495102|11948395|FG002|Overall Study|Lost to Follow-up|17
7570535|NCT03495102|11948393|FG000|Overall Study|Physician Decision|2
7570536|NCT03495102|11948394|FG001|Overall Study|Physician Decision|0
7570537|NCT03495102|11948395|FG002|Overall Study|Physician Decision|2
7570538|NCT03495102|11948393|FG000|Overall Study|Withdrawal by Subject|25
7570539|NCT03495102|11948394|FG001|Overall Study|Withdrawal by Subject|36
7570540|NCT03495102|11948395|FG002|Overall Study|Withdrawal by Subject|18
7371503|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371504|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371505|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7371506|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7371507|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371508|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371509|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371510|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371511|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371512|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371513|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
7371514|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7371515|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
7371516|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371517|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371518|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371519|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371520|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371521|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7371522|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
7371523|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371524|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371525|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371526|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371527|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371528|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
7371529|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
7371530|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
7371531|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371532|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371533|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371534|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371535|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371536|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371537|NCT01097616|11622292|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371538|NCT01097616|11622293|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371539|NCT01097616|11622294|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7371540|NCT01097616|11622295|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371541|NCT01097616|11622296|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371542|NCT01097616|11622297|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371543|NCT01097616|11622298|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371544|NCT01097616|11622299|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371545|NCT01097616|11622292|FG000|Optional DB EXT Phase|Adverse Event|0
7371546|NCT01097616|11622293|FG001|Optional DB EXT Phase|Adverse Event|7
7371547|NCT01097616|11622294|FG002|Optional DB EXT Phase|Adverse Event|2
7371548|NCT01097616|11622295|FG003|Optional DB EXT Phase|Adverse Event|0
7371549|NCT01097616|11622296|FG004|Optional DB EXT Phase|Adverse Event|0
7371550|NCT01097616|11622297|FG005|Optional DB EXT Phase|Adverse Event|0
7371551|NCT01097616|11622298|FG006|Optional DB EXT Phase|Adverse Event|0
7371552|NCT01097616|11622299|FG007|Optional DB EXT Phase|Adverse Event|0
7371553|NCT01097616|11622292|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
7371554|NCT01097616|11622293|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
7371555|NCT01097616|11622294|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
7371556|NCT01097616|11622295|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
7371557|NCT01097616|11622296|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
7371558|NCT01097616|11622297|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
7371559|NCT01097616|11622298|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
7371560|NCT01097616|11622299|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
7371561|NCT01097616|11622292|FG000|Optional DB EXT Phase|Protocol Violation|0
7371562|NCT01097616|11622293|FG001|Optional DB EXT Phase|Protocol Violation|2
7371563|NCT01097616|11622294|FG002|Optional DB EXT Phase|Protocol Violation|3
7371564|NCT01097616|11622295|FG003|Optional DB EXT Phase|Protocol Violation|0
7570541|NCT03495102|11948393|FG000|Overall Study|Protocol Violation|1
7371565|NCT01097616|11622296|FG004|Optional DB EXT Phase|Protocol Violation|0
7371566|NCT01097616|11622297|FG005|Optional DB EXT Phase|Protocol Violation|0
7371567|NCT01097616|11622298|FG006|Optional DB EXT Phase|Protocol Violation|0
7371568|NCT01097616|11622299|FG007|Optional DB EXT Phase|Protocol Violation|0
7371569|NCT01097616|11622292|FG000|Optional DB EXT Phase|Lost to Follow-up|1
7371570|NCT01097616|11622293|FG001|Optional DB EXT Phase|Lost to Follow-up|5
7371571|NCT01097616|11622294|FG002|Optional DB EXT Phase|Lost to Follow-up|1
7371572|NCT01097616|11622295|FG003|Optional DB EXT Phase|Lost to Follow-up|0
7371573|NCT01097616|11622296|FG004|Optional DB EXT Phase|Lost to Follow-up|0
7371574|NCT01097616|11622297|FG005|Optional DB EXT Phase|Lost to Follow-up|0
7371575|NCT01097616|11622298|FG006|Optional DB EXT Phase|Lost to Follow-up|0
7371576|NCT01097616|11622299|FG007|Optional DB EXT Phase|Lost to Follow-up|0
7371577|NCT01097616|11622292|FG000|Optional DB EXT Phase|Lack of Efficacy|1
7371578|NCT01097616|11622293|FG001|Optional DB EXT Phase|Lack of Efficacy|1
7371579|NCT01097616|11622294|FG002|Optional DB EXT Phase|Lack of Efficacy|1
7371580|NCT01097616|11622295|FG003|Optional DB EXT Phase|Lack of Efficacy|0
7371581|NCT01097616|11622296|FG004|Optional DB EXT Phase|Lack of Efficacy|0
7371582|NCT01097616|11622297|FG005|Optional DB EXT Phase|Lack of Efficacy|0
7371583|NCT01097616|11622298|FG006|Optional DB EXT Phase|Lack of Efficacy|0
7461248|NCT01835548|11757234|FG001|Dose Optimization Period|Withdrawal by Subject|0
7461249|NCT01835548|11757235|FG002|Dose Optimization Period|Withdrawal by Subject|1
7461250|NCT01835548|11757233|FG000|Double-Blind Treatment Period|Adverse Event|0
7461251|NCT01835548|11757234|FG001|Double-Blind Treatment Period|Adverse Event|1
7461252|NCT01835548|11757235|FG002|Double-Blind Treatment Period|Adverse Event|0
7461253|NCT01835548|11757233|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7461254|NCT01835548|11757234|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7461255|NCT01835548|11757235|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
7461256|NCT01835587|11757251|FG000|Overall Study|Disease Recurrence or Relapse|0
7461257|NCT01835587|11757252|FG001|Overall Study|Disease Recurrence or Relapse|3
7461258|NCT01835587|11757253|FG002|Overall Study|Disease Recurrence or Relapse|0
7461259|NCT01835587|11757254|FG003|Overall Study|Disease Recurrence or Relapse|3
7461260|NCT01835587|11757251|FG000|Overall Study|Withdrawal by Subject|2
7461261|NCT01835587|11757252|FG001|Overall Study|Withdrawal by Subject|0
7461262|NCT01835587|11757253|FG002|Overall Study|Withdrawal by Subject|0
7461263|NCT01835587|11757254|FG003|Overall Study|Withdrawal by Subject|3
7461264|NCT01835587|11757251|FG000|Overall Study|Adverse Event|0
7461265|NCT01835587|11757252|FG001|Overall Study|Adverse Event|0
7461266|NCT01835587|11757253|FG002|Overall Study|Adverse Event|2
7461267|NCT01835587|11757254|FG003|Overall Study|Adverse Event|2
7461268|NCT01835587|11757251|FG000|Overall Study|Death|0
7461269|NCT01835587|11757252|FG001|Overall Study|Death|0
7461270|NCT01835587|11757253|FG002|Overall Study|Death|0
7461271|NCT01835587|11757254|FG003|Overall Study|Death|1
7461272|NCT01835587|11757251|FG000|Overall Study|Miscellaneous|0
7461273|NCT01835587|11757252|FG001|Overall Study|Miscellaneous|1
7461274|NCT01835587|11757253|FG002|Overall Study|Miscellaneous|0
7461275|NCT01835587|11757254|FG003|Overall Study|Miscellaneous|0
7461276|NCT01835899|11757298|FG000|Overall Study|Adverse Event|0
7461277|NCT01835899|11757299|FG001|Overall Study|Adverse Event|0
7461278|NCT01835899|11757300|FG002|Overall Study|Adverse Event|1
7461279|NCT01835899|11757298|FG000|Overall Study|Other than stated above|0
7461280|NCT01835899|11757299|FG001|Overall Study|Other than stated above|1
7461281|NCT01835899|11757300|FG002|Overall Study|Other than stated above|0
7461282|NCT01836198|11757365|FG000|Part A, Period 2|Protocol Violation|0
7461283|NCT01836198|11757366|FG001|Part A, Period 2|Protocol Violation|1
7461284|NCT01836198|11757367|FG002|Part A, Period 2|Protocol Violation|0
7461285|NCT01836276|11757385|FG000|Overall Study|Lost to Follow-up|28
7461286|NCT01836276|11757386|FG001|Overall Study|Lost to Follow-up|51
7461287|NCT01836458|11757405|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7461288|NCT01836458|11757406|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7461289|NCT01836458|11757407|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7461290|NCT01836458|11757408|FG003|Overall Study|Unsatisfactory therapeutic effect|6
7461291|NCT01836471|11757423|FG000|Overall Study|Pregnancy|1
7461292|NCT01836471|11757424|FG001|Overall Study|Pregnancy|0
7461293|NCT01836471|11757425|FG002|Overall Study|Pregnancy|0
7461294|NCT01836471|11757426|FG003|Overall Study|Pregnancy|0
7461295|NCT01836471|11757427|FG004|Overall Study|Pregnancy|0
7461296|NCT01836471|11757423|FG000|Overall Study|Withdrawal by Subject|3
7461297|NCT01836471|11757424|FG001|Overall Study|Withdrawal by Subject|4
7461298|NCT01836471|11757425|FG002|Overall Study|Withdrawal by Subject|1
7461299|NCT01836471|11757426|FG003|Overall Study|Withdrawal by Subject|0
7461300|NCT01836471|11757427|FG004|Overall Study|Withdrawal by Subject|2
7461301|NCT01836471|11757423|FG000|Overall Study|Physician Decision|0
7461302|NCT01836471|11757424|FG001|Overall Study|Physician Decision|1
7461303|NCT01836471|11757425|FG002|Overall Study|Physician Decision|0
7461304|NCT01836471|11757426|FG003|Overall Study|Physician Decision|0
7461305|NCT01836471|11757427|FG004|Overall Study|Physician Decision|0
7461306|NCT01836471|11757423|FG000|Overall Study|Lost to Follow-up|0
7461307|NCT01836471|11757424|FG001|Overall Study|Lost to Follow-up|0
7461308|NCT01836471|11757425|FG002|Overall Study|Lost to Follow-up|0
7461309|NCT01836471|11757426|FG003|Overall Study|Lost to Follow-up|1
7461310|NCT01836471|11757427|FG004|Overall Study|Lost to Follow-up|1
7461311|NCT01836471|11757423|FG000|Overall Study|Adverse Event|6
7371584|NCT01097616|11622299|FG007|Optional DB EXT Phase|Lack of Efficacy|0
7371585|NCT01097616|11622292|FG000|Optional DB EXT Phase|Physician Decision|1
7371586|NCT01097616|11622293|FG001|Optional DB EXT Phase|Physician Decision|0
7371587|NCT01097616|11622294|FG002|Optional DB EXT Phase|Physician Decision|0
7371588|NCT01097616|11622295|FG003|Optional DB EXT Phase|Physician Decision|0
7371589|NCT01097616|11622296|FG004|Optional DB EXT Phase|Physician Decision|0
7371590|NCT01097616|11622297|FG005|Optional DB EXT Phase|Physician Decision|0
7371591|NCT01097616|11622298|FG006|Optional DB EXT Phase|Physician Decision|0
7371592|NCT01097616|11622299|FG007|Optional DB EXT Phase|Physician Decision|0
7371593|NCT01097616|11622292|FG000|DB RO Phase|Adverse Event|0
7371594|NCT01097616|11622293|FG001|DB RO Phase|Adverse Event|0
7371595|NCT01097616|11622294|FG002|DB RO Phase|Adverse Event|0
7371596|NCT01097616|11622295|FG003|DB RO Phase|Adverse Event|0
7371597|NCT01097616|11622296|FG004|DB RO Phase|Adverse Event|0
7371598|NCT01097616|11622297|FG005|DB RO Phase|Adverse Event|0
7371599|NCT01097616|11622298|FG006|DB RO Phase|Adverse Event|1
7371600|NCT01097616|11622299|FG007|DB RO Phase|Adverse Event|0
7371601|NCT01097616|11622292|FG000|DB RO Phase|Withdrawal by Subject|0
7371602|NCT01097616|11622293|FG001|DB RO Phase|Withdrawal by Subject|0
7371603|NCT01097616|11622294|FG002|DB RO Phase|Withdrawal by Subject|0
7371604|NCT01097616|11622295|FG003|DB RO Phase|Withdrawal by Subject|0
7371605|NCT01097616|11622296|FG004|DB RO Phase|Withdrawal by Subject|0
7371606|NCT01097616|11622297|FG005|DB RO Phase|Withdrawal by Subject|1
7371607|NCT01097616|11622298|FG006|DB RO Phase|Withdrawal by Subject|0
7371608|NCT01097616|11622299|FG007|DB RO Phase|Withdrawal by Subject|0
7371609|NCT01097616|11622292|FG000|DB RO Phase|Lost to Follow-up|0
7371610|NCT01097616|11622293|FG001|DB RO Phase|Lost to Follow-up|0
7371611|NCT01097616|11622294|FG002|DB RO Phase|Lost to Follow-up|0
7371612|NCT01097616|11622295|FG003|DB RO Phase|Lost to Follow-up|1
7371613|NCT01097616|11622296|FG004|DB RO Phase|Lost to Follow-up|1
7371614|NCT01097616|11622297|FG005|DB RO Phase|Lost to Follow-up|0
7371615|NCT01097616|11622298|FG006|DB RO Phase|Lost to Follow-up|0
7371616|NCT01097616|11622299|FG007|DB RO Phase|Lost to Follow-up|1
7371617|NCT01097616|11622292|FG000|DB RO Phase|Not Treated in RO|0
7371618|NCT01097616|11622293|FG001|DB RO Phase|Not Treated in RO|0
7371619|NCT01097616|11622294|FG002|DB RO Phase|Not Treated in RO|0
7371620|NCT01097616|11622295|FG003|DB RO Phase|Not Treated in RO|0
7371621|NCT01097616|11622296|FG004|DB RO Phase|Not Treated in RO|0
7371622|NCT01097616|11622297|FG005|DB RO Phase|Not Treated in RO|1
7371623|NCT01097616|11622298|FG006|DB RO Phase|Not Treated in RO|0
7371624|NCT01097616|11622299|FG007|DB RO Phase|Not Treated in RO|0
7371625|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
7371626|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
7371627|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
7371628|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371629|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371630|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371631|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371632|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
7371633|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
7371634|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
7371635|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
7371636|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371637|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371638|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371639|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371640|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
7371641|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
7371642|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
7371643|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
7371644|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371645|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371646|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371647|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371648|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
7371649|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
7371650|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
7371651|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
7371652|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371653|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371654|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371655|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371656|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
7371657|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
7371658|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
7371659|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
7371660|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371661|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371662|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371663|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371664|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
7371665|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
7371666|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
7371667|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371668|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371669|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371670|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371671|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371672|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
7371673|NCT01097629|11622328|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
7371674|NCT01097629|11622329|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
7371675|NCT01097629|11622330|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
7371676|NCT01097629|11622331|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371677|NCT01097629|11622332|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371678|NCT01097629|11622333|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371679|NCT01097629|11622334|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371680|NCT01097629|11622335|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
7371681|NCT01097629|11622328|FG000|DB RO Phase|Withdrawal by Subject|0
7371682|NCT01097629|11622329|FG001|DB RO Phase|Withdrawal by Subject|0
7371683|NCT01097629|11622330|FG002|DB RO Phase|Withdrawal by Subject|0
7371684|NCT01097629|11622331|FG003|DB RO Phase|Withdrawal by Subject|0
7371685|NCT01097629|11622332|FG004|DB RO Phase|Withdrawal by Subject|0
7371686|NCT01097629|11622333|FG005|DB RO Phase|Withdrawal by Subject|0
7371687|NCT01097629|11622334|FG006|DB RO Phase|Withdrawal by Subject|0
7371688|NCT01097629|11622335|FG007|DB RO Phase|Withdrawal by Subject|1
7371689|NCT01097629|11622328|FG000|DB RO Phase|Protocol Violation|0
7371690|NCT01097629|11622329|FG001|DB RO Phase|Protocol Violation|0
7371691|NCT01097629|11622330|FG002|DB RO Phase|Protocol Violation|0
7371692|NCT01097629|11622331|FG003|DB RO Phase|Protocol Violation|1
7371693|NCT01097629|11622332|FG004|DB RO Phase|Protocol Violation|0
7371694|NCT01097629|11622333|FG005|DB RO Phase|Protocol Violation|1
7371695|NCT01097629|11622334|FG006|DB RO Phase|Protocol Violation|1
7371696|NCT01097629|11622335|FG007|DB RO Phase|Protocol Violation|0
7371697|NCT01097629|11622328|FG000|DB RO Phase|Lost to Follow-up|0
7371698|NCT01097629|11622329|FG001|DB RO Phase|Lost to Follow-up|0
7371699|NCT01097629|11622330|FG002|DB RO Phase|Lost to Follow-up|0
7371700|NCT01097629|11622331|FG003|DB RO Phase|Lost to Follow-up|0
7371701|NCT01097629|11622332|FG004|DB RO Phase|Lost to Follow-up|0
7371702|NCT01097629|11622333|FG005|DB RO Phase|Lost to Follow-up|0
7371703|NCT01097629|11622334|FG006|DB RO Phase|Lost to Follow-up|2
7371704|NCT01097629|11622335|FG007|DB RO Phase|Lost to Follow-up|0
7371705|NCT01097655|11622367|FG000|Overall Study|Withdrawal by Subject|1
7371706|NCT01097655|11622367|FG000|Overall Study|Subject Documented Twice|1
7371707|NCT01097655|11622367|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
7371708|NCT01097668|11622373|FG000|Overall Study|Withdrawal by Subject|1
7371709|NCT01097668|11622374|FG001|Overall Study|Withdrawal by Subject|2
7371710|NCT01097668|11622373|FG000|Overall Study|Lost to Follow-up|1
7371711|NCT01097668|11622374|FG001|Overall Study|Lost to Follow-up|0
7371712|NCT01097694|11622386|FG000|Overall Study|Adverse Event|5
7371713|NCT01097694|11622387|FG001|Overall Study|Adverse Event|0
7371714|NCT01097694|11622386|FG000|Overall Study|Lost to Follow-up|0
7371715|NCT01097694|11622387|FG001|Overall Study|Lost to Follow-up|3
7371716|NCT01097694|11622386|FG000|Overall Study|Withdrawal by Subject|3
7371717|NCT01097694|11622387|FG001|Overall Study|Withdrawal by Subject|1
7371718|NCT01097707|11622398|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7371719|NCT01097707|11622399|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7371720|NCT01097707|11622400|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7371721|NCT01097707|11622401|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7371722|NCT01097707|11622402|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7371723|NCT01097707|11622398|FG000|Overall Study|Adverse Event|4
7371724|NCT01097707|11622399|FG001|Overall Study|Adverse Event|2
7371725|NCT01097707|11622400|FG002|Overall Study|Adverse Event|3
7371726|NCT01097707|11622401|FG003|Overall Study|Adverse Event|1
7371727|NCT01097707|11622402|FG004|Overall Study|Adverse Event|3
7371728|NCT01097707|11622398|FG000|Overall Study|Entry Criteria Not Met|2
7371729|NCT01097707|11622399|FG001|Overall Study|Entry Criteria Not Met|1
7371730|NCT01097707|11622400|FG002|Overall Study|Entry Criteria Not Met|1
7371731|NCT01097707|11622401|FG003|Overall Study|Entry Criteria Not Met|0
7371732|NCT01097707|11622402|FG004|Overall Study|Entry Criteria Not Met|1
7371733|NCT01097707|11622398|FG000|Overall Study|Lack of Efficacy|1
7371734|NCT01097707|11622399|FG001|Overall Study|Lack of Efficacy|0
7371735|NCT01097707|11622400|FG002|Overall Study|Lack of Efficacy|0
7371736|NCT01097707|11622401|FG003|Overall Study|Lack of Efficacy|1
7371737|NCT01097707|11622402|FG004|Overall Study|Lack of Efficacy|0
7371738|NCT01097707|11622398|FG000|Overall Study|Lost to Follow-up|1
7371739|NCT01097707|11622399|FG001|Overall Study|Lost to Follow-up|1
7371740|NCT01097707|11622400|FG002|Overall Study|Lost to Follow-up|2
7371741|NCT01097707|11622401|FG003|Overall Study|Lost to Follow-up|0
7371742|NCT01097707|11622402|FG004|Overall Study|Lost to Follow-up|3
7371743|NCT01097707|11622398|FG000|Overall Study|Protocol Violation|2
7371744|NCT01097707|11622399|FG001|Overall Study|Protocol Violation|2
7371745|NCT01097707|11622400|FG002|Overall Study|Protocol Violation|3
7371746|NCT01097707|11622401|FG003|Overall Study|Protocol Violation|2
7371747|NCT01097707|11622402|FG004|Overall Study|Protocol Violation|2
7371748|NCT01097707|11622398|FG000|Overall Study|Sponsor Decision|31
7371749|NCT01097707|11622399|FG001|Overall Study|Sponsor Decision|31
7371750|NCT01097707|11622400|FG002|Overall Study|Sponsor Decision|34
7371751|NCT01097707|11622401|FG003|Overall Study|Sponsor Decision|35
7371752|NCT01097707|11622402|FG004|Overall Study|Sponsor Decision|36
7371753|NCT01097707|11622398|FG000|Overall Study|Withdrawal by Subject|3
7371754|NCT01097707|11622399|FG001|Overall Study|Withdrawal by Subject|6
7371755|NCT01097707|11622400|FG002|Overall Study|Withdrawal by Subject|1
7371756|NCT01097707|11622401|FG003|Overall Study|Withdrawal by Subject|4
7371757|NCT01097707|11622402|FG004|Overall Study|Withdrawal by Subject|3
7371758|NCT01097707|11622398|FG000|Overall Study|Reason unknown|0
7371759|NCT01097707|11622399|FG001|Overall Study|Reason unknown|0
7371760|NCT01097707|11622400|FG002|Overall Study|Reason unknown|0
7371761|NCT01097707|11622401|FG003|Overall Study|Reason unknown|0
7371762|NCT01097707|11622402|FG004|Overall Study|Reason unknown|1
7371763|NCT01097863|11622427|FG000|Overall Study|Discomfort|1
7371764|NCT01097863|11622428|FG001|Overall Study|Discomfort|0
7371765|NCT01097863|11622429|FG002|Overall Study|Discomfort|1
7371766|NCT01097863|11622427|FG000|Overall Study|Did not return for final visit|0
7371767|NCT01097863|11622428|FG001|Overall Study|Did not return for final visit|0
7371768|NCT01097863|11622429|FG002|Overall Study|Did not return for final visit|1
7371769|NCT01098097|11622474|FG000|Overall Study|Adverse Event|17
7371770|NCT01098097|11622474|FG000|Overall Study|Lost to Follow-up|18
7371771|NCT01098097|11622474|FG000|Overall Study|Status unknown|16
7371772|NCT01098097|11622474|FG000|Overall Study|No reason reported|31
7371773|NCT01098162|11622478|FG000|Overall Study|Adverse Event|37
7371774|NCT01098162|11622478|FG000|Overall Study|Lack of Efficacy|4
7371775|NCT01098162|11622478|FG000|Overall Study|Wish of Patient|7
7371776|NCT01098162|11622478|FG000|Overall Study|Lost to Follow-up|9
7371777|NCT01098162|11622478|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
7371778|NCT01098162|11622478|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
7371779|NCT01098162|11622478|FG000|Overall Study|Adverse Event & Wish of Patient|13
7371780|NCT01098162|11622478|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
7371781|NCT01098162|11622478|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
7371782|NCT01098162|11622478|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
7371783|NCT01098162|11622478|FG000|Overall Study|Other Reason|1
7371784|NCT01098162|11622478|FG000|Overall Study|Reason Unknown|26
7371785|NCT01098240|11622482|FG000|Open-Label Phase|Study Terminated by Sponsor|27
7371786|NCT01098240|11622483|FG001|Open-Label Phase|Study Terminated by Sponsor|0
7371787|NCT01098240|11622484|FG002|Open-Label Phase|Study Terminated by Sponsor|0
7371788|NCT01098240|11622482|FG000|Open-Label Phase|Protocol Violation|4
7371789|NCT01098240|11622483|FG001|Open-Label Phase|Protocol Violation|0
7371790|NCT01098240|11622484|FG002|Open-Label Phase|Protocol Violation|0
7371791|NCT01098240|11622482|FG000|Open-Label Phase|Lost to Follow-up|13
7371792|NCT01098240|11622483|FG001|Open-Label Phase|Lost to Follow-up|0
7371793|NCT01098240|11622484|FG002|Open-Label Phase|Lost to Follow-up|0
7371794|NCT01098240|11622482|FG000|Open-Label Phase|Other|19
7371795|NCT01098240|11622483|FG001|Open-Label Phase|Other|0
7371796|NCT01098240|11622484|FG002|Open-Label Phase|Other|0
7371797|NCT01098240|11622482|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
7371798|NCT01098240|11622483|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
7371799|NCT01098240|11622484|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
7371800|NCT01098240|11622482|FG000|Open-Label Phase|Pregnancy|1
7371801|NCT01098240|11622483|FG001|Open-Label Phase|Pregnancy|0
7371802|NCT01098240|11622484|FG002|Open-Label Phase|Pregnancy|0
7371803|NCT01098240|11622482|FG000|Open-Label Phase|Withdrawal by Subject|9
7371804|NCT01098240|11622483|FG001|Open-Label Phase|Withdrawal by Subject|0
7371805|NCT01098240|11622484|FG002|Open-Label Phase|Withdrawal by Subject|0
7371806|NCT01098240|11622482|FG000|Open-Label Phase|Adverse Event|12
7371807|NCT01098240|11622483|FG001|Open-Label Phase|Adverse Event|0
7371808|NCT01098240|11622484|FG002|Open-Label Phase|Adverse Event|0
7461312|NCT01836471|11757424|FG001|Overall Study|Adverse Event|3
7461313|NCT01836471|11757425|FG002|Overall Study|Adverse Event|1
7461314|NCT01836471|11757426|FG003|Overall Study|Adverse Event|1
7461315|NCT01836471|11757427|FG004|Overall Study|Adverse Event|2
7461316|NCT01836471|11757423|FG000|Overall Study|Non compliance with tx|1
7461317|NCT01836471|11757424|FG001|Overall Study|Non compliance with tx|1
7461318|NCT01836471|11757425|FG002|Overall Study|Non compliance with tx|0
7461319|NCT01836471|11757426|FG003|Overall Study|Non compliance with tx|0
7461320|NCT01836471|11757427|FG004|Overall Study|Non compliance with tx|0
7461321|NCT01836523|11757444|FG000|Overall Study|Adverse Event|15
7461322|NCT01836523|11757445|FG001|Overall Study|Adverse Event|41
7371809|NCT01098240|11622482|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
7371810|NCT01098240|11622483|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
7371811|NCT01098240|11622484|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
7461323|NCT01836523|11757446|FG002|Overall Study|Adverse Event|49
7461324|NCT01836523|11757447|FG003|Overall Study|Adverse Event|14
7371812|NCT01098240|11622482|FG000|Double-Blind Phase|Protocol Violation|0
7371813|NCT01098240|11622483|FG001|Double-Blind Phase|Protocol Violation|2
7371814|NCT01098240|11622484|FG002|Double-Blind Phase|Protocol Violation|4
7371815|NCT01098240|11622482|FG000|Double-Blind Phase|Lost to Follow-up|0
7371816|NCT01098240|11622483|FG001|Double-Blind Phase|Lost to Follow-up|2
7371817|NCT01098240|11622484|FG002|Double-Blind Phase|Lost to Follow-up|0
7371818|NCT01098240|11622482|FG000|Double-Blind Phase|Other|0
7371819|NCT01098240|11622483|FG001|Double-Blind Phase|Other|2
7371820|NCT01098240|11622484|FG002|Double-Blind Phase|Other|2
7371821|NCT01098240|11622482|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7371822|NCT01098240|11622483|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
7371823|NCT01098240|11622484|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
7371824|NCT01098240|11622482|FG000|Double-Blind Phase|Insufficient Clinical Response|0
7371825|NCT01098240|11622483|FG001|Double-Blind Phase|Insufficient Clinical Response|1
7371826|NCT01098240|11622484|FG002|Double-Blind Phase|Insufficient Clinical Response|2
7371827|NCT01098240|11622482|FG000|Double-Blind Phase|Withdrawal by Subject|0
7371828|NCT01098240|11622483|FG001|Double-Blind Phase|Withdrawal by Subject|1
7371829|NCT01098240|11622484|FG002|Double-Blind Phase|Withdrawal by Subject|3
7371830|NCT01098240|11622482|FG000|Double-Blind Phase|Adverse Event|0
7371831|NCT01098240|11622483|FG001|Double-Blind Phase|Adverse Event|3
7371832|NCT01098240|11622484|FG002|Double-Blind Phase|Adverse Event|3
7371833|NCT01098266|11622502|FG000|Overall Study|Physician Decision|1
7371834|NCT01098266|11622503|FG001|Overall Study|Physician Decision|0
7371835|NCT01098266|11622502|FG000|Overall Study|Death|3
7371836|NCT01098266|11622503|FG001|Overall Study|Death|2
7371837|NCT01098266|11622502|FG000|Overall Study|Withdrawal by Subject|3
7371838|NCT01098266|11622503|FG001|Overall Study|Withdrawal by Subject|5
7371839|NCT01098305|11622511|FG000|Overall Study|Lost to Follow-up|31
7371840|NCT01098305|11622512|FG001|Overall Study|Lost to Follow-up|33
7371841|NCT01098461|11622539|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
7371842|NCT01098461|11622540|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
7371843|NCT01098461|11622541|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7371844|NCT01098461|11622542|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
7371845|NCT01098461|11622539|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7371846|NCT01098461|11622540|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
7371847|NCT01098461|11622541|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
7371848|NCT01098461|11622542|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
7371849|NCT01098461|11622539|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
7371850|NCT01098461|11622540|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
7371851|NCT01098461|11622541|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7371852|NCT01098461|11622542|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
7371853|NCT01098461|11622539|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7371854|NCT01098461|11622540|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
7371855|NCT01098461|11622541|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7371856|NCT01098461|11622542|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
7371857|NCT01098461|11622539|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7371858|NCT01098461|11622540|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
7371859|NCT01098461|11622541|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7371860|NCT01098461|11622542|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
7371861|NCT01098461|11622539|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7371862|NCT01098461|11622540|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
7371863|NCT01098461|11622541|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7371864|NCT01098461|11622542|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
7371865|NCT01098461|11622539|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7371866|NCT01098461|11622540|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7371867|NCT01098461|11622541|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
7371868|NCT01098461|11622542|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
7371869|NCT01098474|11622559|FG000|Active Phase|Other|0
7371870|NCT01098474|11622560|FG001|Active Phase|Other|0
7371871|NCT01098474|11622561|FG002|Active Phase|Other|3
7371872|NCT01098474|11622562|FG003|Active Phase|Other|0
7371873|NCT01098474|11622563|FG004|Active Phase|Other|0
7371874|NCT01098474|11622564|FG005|Active Phase|Other|0
7371875|NCT01098474|11622559|FG000|Active Phase|Withdrawal by Subject|1
7371876|NCT01098474|11622560|FG001|Active Phase|Withdrawal by Subject|1
7371877|NCT01098474|11622561|FG002|Active Phase|Withdrawal by Subject|2
7371878|NCT01098474|11622562|FG003|Active Phase|Withdrawal by Subject|0
7371879|NCT01098474|11622563|FG004|Active Phase|Withdrawal by Subject|0
7371880|NCT01098474|11622564|FG005|Active Phase|Withdrawal by Subject|0
7371881|NCT01098474|11622559|FG000|Active Phase|Lost to Follow-up|1
7371882|NCT01098474|11622560|FG001|Active Phase|Lost to Follow-up|0
7371883|NCT01098474|11622561|FG002|Active Phase|Lost to Follow-up|0
7371884|NCT01098474|11622562|FG003|Active Phase|Lost to Follow-up|0
7371885|NCT01098474|11622563|FG004|Active Phase|Lost to Follow-up|0
7371886|NCT01098474|11622564|FG005|Active Phase|Lost to Follow-up|0
7371887|NCT01098474|11622559|FG000|Follow Up Phase|Travelled out of study area|0
7371888|NCT01098474|11622560|FG001|Follow Up Phase|Travelled out of study area|0
7387705|NCT01215916|11646443|FG005|Overall Study|Progressive Disease|4
7371889|NCT01098474|11622561|FG002|Follow Up Phase|Travelled out of study area|0
7371890|NCT01098474|11622562|FG003|Follow Up Phase|Travelled out of study area|0
7371891|NCT01098474|11622563|FG004|Follow Up Phase|Travelled out of study area|1
7371892|NCT01098474|11622564|FG005|Follow Up Phase|Travelled out of study area|0
7371893|NCT01098474|11622559|FG000|Follow Up Phase|Other|0
7371894|NCT01098474|11622560|FG001|Follow Up Phase|Other|0
7371895|NCT01098474|11622561|FG002|Follow Up Phase|Other|0
7371896|NCT01098474|11622562|FG003|Follow Up Phase|Other|0
7371897|NCT01098474|11622563|FG004|Follow Up Phase|Other|0
7371898|NCT01098474|11622564|FG005|Follow Up Phase|Other|4
7371899|NCT01098474|11622559|FG000|Follow Up Phase|Withdrawal by Subject|0
7371900|NCT01098474|11622560|FG001|Follow Up Phase|Withdrawal by Subject|0
7371901|NCT01098474|11622561|FG002|Follow Up Phase|Withdrawal by Subject|0
7371902|NCT01098474|11622562|FG003|Follow Up Phase|Withdrawal by Subject|2
7371903|NCT01098474|11622563|FG004|Follow Up Phase|Withdrawal by Subject|0
7371904|NCT01098474|11622564|FG005|Follow Up Phase|Withdrawal by Subject|1
7371905|NCT01098474|11622559|FG000|Follow Up Phase|Lost to Follow-up|0
7371906|NCT01098474|11622560|FG001|Follow Up Phase|Lost to Follow-up|0
7371907|NCT01098474|11622561|FG002|Follow Up Phase|Lost to Follow-up|0
7371908|NCT01098474|11622562|FG003|Follow Up Phase|Lost to Follow-up|0
7371909|NCT01098474|11622563|FG004|Follow Up Phase|Lost to Follow-up|1
7371910|NCT01098474|11622564|FG005|Follow Up Phase|Lost to Follow-up|0
7386964|NCT01212770|11645403|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7386965|NCT01212770|11645404|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
7386966|NCT01212770|11645405|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386967|NCT01212770|11645406|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386968|NCT01212770|11645407|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386969|NCT01212770|11645408|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386970|NCT01212770|11645409|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
7386971|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
7386972|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
7386973|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
7386974|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
7386975|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
7386976|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
7386977|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
7386978|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
7386979|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
7386980|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7386981|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7386982|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7386983|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7386984|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7386985|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7386986|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7386987|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7386988|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
7372042|NCT01100437|11622914|FG001|Maintenance|Sponsor termination of study|0
7386989|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386990|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
7386991|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386992|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386993|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386994|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386995|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386996|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386997|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
7386998|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7386999|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
7387000|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7387001|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7387002|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7387003|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7387004|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7387005|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7387006|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
7387007|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7387008|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
7387009|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7387010|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7387011|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7387012|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7387013|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
7387014|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7387015|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
7387016|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
7371911|NCT01098487|11622588|FG000|Overall Study|Adverse Event|22
7371912|NCT01098487|11622588|FG000|Overall Study|Lack of Efficacy|11
7371913|NCT01098487|11622588|FG000|Overall Study|Withdrawal by Subject|7
7371914|NCT01098487|11622588|FG000|Overall Study|Lost to Follow-up|3
7371915|NCT01098487|11622588|FG000|Overall Study|Physician Decision|1
7371916|NCT01098539|11622598|FG000|Overall Study|Adverse Event|26
7371917|NCT01098539|11622599|FG001|Overall Study|Adverse Event|26
7371918|NCT01098539|11622598|FG000|Overall Study|Protocol Violation|1
7371919|NCT01098539|11622599|FG001|Overall Study|Protocol Violation|4
7371920|NCT01098539|11622598|FG000|Overall Study|Noncompliance|3
7371921|NCT01098539|11622599|FG001|Overall Study|Noncompliance|5
7371922|NCT01098539|11622598|FG000|Overall Study|Lost to Follow-up|4
7371923|NCT01098539|11622599|FG001|Overall Study|Lost to Follow-up|4
7371924|NCT01098539|11622598|FG000|Overall Study|Withdrawal by Subject|12
7371925|NCT01098539|11622599|FG001|Overall Study|Withdrawal by Subject|26
7371926|NCT01098539|11622598|FG000|Overall Study|Physician Decision|5
7371927|NCT01098539|11622599|FG001|Overall Study|Physician Decision|3
7371928|NCT01098812|11622630|FG000|Overall Study|Death|2
7371929|NCT01098812|11622631|FG001|Overall Study|Death|0
7371930|NCT01098812|11622632|FG002|Overall Study|Death|1
7371931|NCT01098812|11622630|FG000|Overall Study|Lost to Follow-up|0
7371932|NCT01098812|11622631|FG001|Overall Study|Lost to Follow-up|1
7371933|NCT01098812|11622632|FG002|Overall Study|Lost to Follow-up|0
7371934|NCT01098851|11622641|FG000|Overall Study|Equipment failure|1
7371935|NCT01098851|11622642|FG001|Overall Study|Equipment failure|0
7371936|NCT01099215|11622681|FG000|Overall Study|Withdrawal by Subject|1
7371937|NCT01099215|11622682|FG001|Overall Study|Withdrawal by Subject|0
7371938|NCT01099215|11622681|FG000|Overall Study|Adverse Event|0
7371939|NCT01099215|11622682|FG001|Overall Study|Adverse Event|1
7371940|NCT01099267|11622688|FG000|MDS-003 Study|Adverse Event|37
7371941|NCT01099267|11622688|FG000|MDS-003 Study|Lack of Efficacy|52
7371942|NCT01099267|11622688|FG000|MDS-003 Study|Withdrawal by Subject|8
7371943|NCT01099267|11622688|FG000|MDS-003 Study|Lost to Follow-up|1
7371944|NCT01099267|11622688|FG000|MDS-003 Study|Death|11
7371945|NCT01099267|11622688|FG000|MDS-003 Study|Study Closed by Sponsor|2
7371946|NCT01099267|11622688|FG000|MDS-003 Study|Disease Progression|7
7371947|NCT01099267|11622688|FG000|MDS-003 Study|Investigator Decision|2
7371948|NCT01099267|11622688|FG000|MDS-003 Study|Non-Compliance|2
7371949|NCT01099267|11622688|FG000|MDS-003 Study|Loss of Response|1
7371950|NCT01099267|11622688|FG000|MDS-003 Study|Secondary Malign Disease|1
7371951|NCT01099397|11622706|FG000|Overall Study|Lost to Follow-up|4
7371952|NCT01099397|11622706|FG000|Overall Study|Protocol Violation|4
7371953|NCT01099397|11622706|FG000|Overall Study|Withdrawal by Subject|5
7371954|NCT01099579|11622749|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
7371955|NCT01099579|11622750|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
7371956|NCT01099579|11622751|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
7371957|NCT01099579|11622749|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7371958|NCT01099579|11622750|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
7371959|NCT01099579|11622751|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
7371960|NCT01099579|11622749|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7371961|NCT01099579|11622750|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
7371962|NCT01099579|11622751|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
7371963|NCT01099579|11622749|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7371964|NCT01099579|11622750|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
7371965|NCT01099579|11622751|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
7371966|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
7371967|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
7371968|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
7371969|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7371970|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7371971|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
7371972|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7371973|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
7371974|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
7371975|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7371976|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7371977|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
7371978|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
7371979|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
7371980|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
7371981|NCT01099579|11622749|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
7371982|NCT01099579|11622750|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
7371983|NCT01099579|11622751|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
7371984|NCT01099709|11622805|FG000|Period 1|Withdrawal by Subject|0
7371985|NCT01099709|11622806|FG001|Period 1|Withdrawal by Subject|1
7371986|NCT01099709|11622805|FG000|Period 1|Positive cotinine test|0
7371987|NCT01099709|11622806|FG001|Period 1|Positive cotinine test|1
7371988|NCT01099709|11622805|FG000|Period 1|Adverse Event|1
7371989|NCT01099709|11622806|FG001|Period 1|Adverse Event|0
7371990|NCT01099917|11622838|FG000|Overall Study|Adverse Event|3
7371991|NCT01099917|11622838|FG000|Overall Study|Not Treated|24
7371992|NCT01100034|11622859|FG000|Overall Study|Lost to Follow-up|11
7371993|NCT01100034|11622859|FG000|Overall Study|Withdrawal of parent/guardian consent|1
7371994|NCT01100034|11622859|FG000|Overall Study|Withdrawal by Subject|4
7371995|NCT01100034|11622859|FG000|Overall Study|Sponsor decision|21
7371996|NCT01100034|11622859|FG000|Overall Study|Participated in another clinical trial|1
7371997|NCT01100034|11622859|FG000|Overall Study|Participants moved to another hospital|4
7371998|NCT01100034|11622859|FG000|Overall Study|Site closed due to non-responsiveness|1
7371999|NCT01100073|11622863|FG000|Overall Study|Lack of Efficacy|4
7372000|NCT01100073|11622863|FG000|Overall Study|Insufficient Tolerability|21
7372001|NCT01100073|11622863|FG000|Overall Study|Withdrawal by Subject|13
7372002|NCT01100073|11622863|FG000|Overall Study|Lost to Follow-up|39
7372003|NCT01100073|11622863|FG000|Overall Study|Lack of effect + patient's wish|2
7372004|NCT01100073|11622863|FG000|Overall Study|Insufficient tolerability +patients wish|8
7372005|NCT01100073|11622863|FG000|Overall Study|Other|8
7372006|NCT01100073|11622863|FG000|Overall Study|Missing|5
7372007|NCT01100086|11622867|FG000|Period 1|Withdrawal by Subject|1
7372008|NCT01100086|11622868|FG001|Period 1|Withdrawal by Subject|0
7372009|NCT01100307|11622897|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7372010|NCT01100307|11622898|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
7372011|NCT01100307|11622897|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
7372012|NCT01100307|11622898|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
7372013|NCT01100307|11622897|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
7372014|NCT01100307|11622898|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
7372015|NCT01100307|11622897|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
7372016|NCT01100307|11622898|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
7372017|NCT01100307|11622897|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
7372018|NCT01100307|11622898|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
7372019|NCT01100307|11622897|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
7372020|NCT01100307|11622898|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
7372021|NCT01100320|11622906|FG000|Period 1|Withdrawal by Subject|2
7372022|NCT01100320|11622907|FG001|Period 1|Withdrawal by Subject|4
7372023|NCT01100320|11622906|FG000|Period 1|Positive Drug Screen|1
7372024|NCT01100320|11622907|FG001|Period 1|Positive Drug Screen|1
7372025|NCT01100320|11622906|FG000|Period 1|Adverse Event|2
7372026|NCT01100320|11622907|FG001|Period 1|Adverse Event|2
7372027|NCT01100320|11622906|FG000|Period 2|Withdrawal by Subject|1
7372028|NCT01100320|11622907|FG001|Period 2|Withdrawal by Subject|1
7372029|NCT01100437|11622913|FG000|Titration/Stabilization|Adverse Event|0
7372030|NCT01100437|11622914|FG001|Titration/Stabilization|Adverse Event|0
7372031|NCT01100437|11622915|FG002|Titration/Stabilization|Adverse Event|4
7372032|NCT01100437|11622913|FG000|Titration/Stabilization|Non-compliance|0
7372033|NCT01100437|11622914|FG001|Titration/Stabilization|Non-compliance|0
7372034|NCT01100437|11622915|FG002|Titration/Stabilization|Non-compliance|1
7372035|NCT01100437|11622913|FG000|Titration/Stabilization|Sponsor canceled study|0
7372036|NCT01100437|11622914|FG001|Titration/Stabilization|Sponsor canceled study|0
7372037|NCT01100437|11622915|FG002|Titration/Stabilization|Sponsor canceled study|1
7372038|NCT01100437|11622913|FG000|Maintenance|Withdrawal by Subject|0
7372039|NCT01100437|11622914|FG001|Maintenance|Withdrawal by Subject|0
7372040|NCT01100437|11622915|FG002|Maintenance|Withdrawal by Subject|1
7372041|NCT01100437|11622913|FG000|Maintenance|Sponsor termination of study|0
7372043|NCT01100437|11622915|FG002|Maintenance|Sponsor termination of study|1
7372044|NCT01100502|11622926|FG000|Overall Study|Withdrawal by Subject|18
7372045|NCT01100502|11622927|FG001|Overall Study|Withdrawal by Subject|25
7372046|NCT01100502|11622926|FG000|Overall Study|Lost to Follow-up|13
7372047|NCT01100502|11622927|FG001|Overall Study|Lost to Follow-up|28
7372048|NCT01100502|11622926|FG000|Overall Study|Site request to end participation in study|0
7372049|NCT01100502|11622927|FG001|Overall Study|Site request to end participation in study|1
7372050|NCT01100502|11622926|FG000|Overall Study|Death|45
7372051|NCT01100502|11622927|FG001|Overall Study|Death|40
7372052|NCT01100528|11622933|FG000|Overall Study|Death|1
7372053|NCT01100528|11622933|FG000|Overall Study|Withdrawal by Subject|2
7372054|NCT01100567|11622939|FG000|Overall Study|Withdrawal by Subject|5
7372055|NCT01100567|11622940|FG001|Overall Study|Withdrawal by Subject|8
7372056|NCT01100567|11622939|FG000|Overall Study|Early Hospital Discharge|6
7372057|NCT01100567|11622940|FG001|Overall Study|Early Hospital Discharge|4
7372058|NCT01100567|11622939|FG000|Overall Study|Lost to Follow-up|1
7372059|NCT01100567|11622940|FG001|Overall Study|Lost to Follow-up|2
7372060|NCT01100567|11622939|FG000|Overall Study|Physician Decision|0
7372061|NCT01100567|11622940|FG001|Overall Study|Physician Decision|1
7372062|NCT01100567|11622939|FG000|Overall Study|Deemed ineligible after consent|0
7372063|NCT01100567|11622940|FG001|Overall Study|Deemed ineligible after consent|1
7372064|NCT01100853|11622970|FG000|Overall Study|Lost to Follow-up|11
7372065|NCT01100853|11622971|FG001|Overall Study|Lost to Follow-up|6
7372066|NCT01100853|11622970|FG000|Overall Study|Received <4 study injections|10
7372067|NCT01100853|11622971|FG001|Overall Study|Received <4 study injections|13
7372068|NCT01100853|11622970|FG000|Overall Study|Withdrawal by Subject|6
7372069|NCT01100853|11622971|FG001|Overall Study|Withdrawal by Subject|4
7372070|NCT01100944|11622987|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
7372071|NCT01100944|11622988|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7372072|NCT01100944|11622989|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
7372073|NCT01100944|11622987|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
7372074|NCT01100944|11622988|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7372075|NCT01100944|11622989|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
7372076|NCT01100944|11622987|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
7372077|NCT01100944|11622988|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7372078|NCT01100944|11622989|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
7372079|NCT01100944|11622987|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7372080|NCT01100944|11622988|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
7372081|NCT01100944|11622989|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
7372082|NCT01101022|11623012|FG000|Overall Study|Adverse Event|6
7372083|NCT01101022|11623013|FG001|Overall Study|Adverse Event|2
7372084|NCT01101022|11623012|FG000|Overall Study|Protocol Violation|4
7372085|NCT01101022|11623013|FG001|Overall Study|Protocol Violation|3
7372086|NCT01101022|11623012|FG000|Overall Study|Withdrawal by Subject|3
7372087|NCT01101022|11623013|FG001|Overall Study|Withdrawal by Subject|8
7372088|NCT01101022|11623012|FG000|Overall Study|Lost to Follow-up|1
7372089|NCT01101022|11623013|FG001|Overall Study|Lost to Follow-up|4
7372090|NCT01101022|11623012|FG000|Overall Study|Lack of Efficacy|0
7372091|NCT01101022|11623013|FG001|Overall Study|Lack of Efficacy|7
7372092|NCT01101022|11623012|FG000|Overall Study|Sponsor decision|1
7372093|NCT01101022|11623013|FG001|Overall Study|Sponsor decision|1
7372094|NCT01101022|11623012|FG000|Overall Study|Non-compliance|1
7372095|NCT01101022|11623013|FG001|Overall Study|Non-compliance|0
7372096|NCT01101022|11623012|FG000|Overall Study|Work schedule|1
7372097|NCT01101022|11623013|FG001|Overall Study|Work schedule|1
7372098|NCT01101022|11623012|FG000|Overall Study|Vacation|0
7372099|NCT01101022|11623013|FG001|Overall Study|Vacation|1
7372100|NCT01101035|11623021|FG000|Overall Study|Adverse Event|191
7372101|NCT01101035|11623022|FG001|Overall Study|Adverse Event|172
7372102|NCT01101035|11623021|FG000|Overall Study|Major Protocol Deviation|52
7372103|NCT01101035|11623022|FG001|Overall Study|Major Protocol Deviation|46
7372104|NCT01101035|11623021|FG000|Overall Study|Lost to Follow-up|226
7372105|NCT01101035|11623022|FG001|Overall Study|Lost to Follow-up|223
7372106|NCT01101035|11623021|FG000|Overall Study|Voluntary Withdrawal|595
7372107|NCT01101035|11623022|FG001|Overall Study|Voluntary Withdrawal|587
7372108|NCT01101035|11623021|FG000|Overall Study|Reason not Specified|333
7372109|NCT01101035|11623022|FG001|Overall Study|Reason not Specified|363
7372110|NCT01101061|11623034|FG000|Overall Study|Adverse Event|0
7372111|NCT01101061|11623035|FG001|Overall Study|Adverse Event|0
7372112|NCT01101061|11623036|FG002|Overall Study|Adverse Event|1
7372113|NCT01101061|11623037|FG003|Overall Study|Adverse Event|0
7372114|NCT01101061|11623038|FG004|Overall Study|Adverse Event|0
7372115|NCT01101061|11623039|FG005|Overall Study|Adverse Event|0
7372116|NCT01101165|11623062|FG000|Period 1|Adverse Event|1
7372117|NCT01101165|11623063|FG001|Period 1|Adverse Event|2
7372118|NCT01101165|11623062|FG000|Period 1|Withdrawal by Subject|0
7372119|NCT01101165|11623063|FG001|Period 1|Withdrawal by Subject|2
7372120|NCT01101165|11623062|FG000|Period 1|Positive Drug Screen|0
7372121|NCT01101165|11623063|FG001|Period 1|Positive Drug Screen|1
7372122|NCT01101165|11623062|FG000|Period 1|Lost to Follow-up|1
7372123|NCT01101165|11623063|FG001|Period 1|Lost to Follow-up|0
7372124|NCT01101165|11623062|FG000|Period 2|Withdrawal by Subject|3
7372125|NCT01101165|11623063|FG001|Period 2|Withdrawal by Subject|1
7372126|NCT01101165|11623062|FG000|Period 2|Adverse Event|1
7372127|NCT01101165|11623063|FG001|Period 2|Adverse Event|0
7372128|NCT01101178|11623069|FG000|Period 1|Withdrawal by Subject|1
7372129|NCT01101178|11623070|FG001|Period 1|Withdrawal by Subject|2
7372130|NCT01101178|11623069|FG000|Period 1|Positive drug screen|1
7372131|NCT01101178|11623070|FG001|Period 1|Positive drug screen|1
7372132|NCT01101178|11623069|FG000|Period 1|Adverse Event|2
7372133|NCT01101178|11623070|FG001|Period 1|Adverse Event|1
7372134|NCT01101178|11623069|FG000|Period 2|Withdrawal by Subject|0
7372135|NCT01101178|11623070|FG001|Period 2|Withdrawal by Subject|1
7372136|NCT01101191|11623077|FG000|Period 1|Withdrawal by Subject|1
7372137|NCT01101191|11623078|FG001|Period 1|Withdrawal by Subject|0
7372138|NCT01101191|11623077|FG000|Period 1|Adverse Event|1
7372139|NCT01101191|11623078|FG001|Period 1|Adverse Event|2
7372140|NCT01101308|11623085|FG000|Period 1|Adverse Event|2
7372141|NCT01101308|11623086|FG001|Period 1|Adverse Event|1
7372142|NCT01101308|11623085|FG000|Period 1|Positive for cotinine|1
7372143|NCT01101308|11623086|FG001|Period 1|Positive for cotinine|0
7372144|NCT01101321|11623093|FG000|Period 1|Withdrawal by Subject|1
7372145|NCT01101321|11623094|FG001|Period 1|Withdrawal by Subject|1
7372146|NCT01101321|11623093|FG000|Period 1|Adverse Event|3
7372147|NCT01101321|11623094|FG001|Period 1|Adverse Event|3
7372148|NCT01101334|11623102|FG000|Overall Study|Adverse Event|9
7372149|NCT01101334|11623103|FG001|Overall Study|Adverse Event|4
7372150|NCT01101334|11623102|FG000|Overall Study|Death|7
7372151|NCT01101334|11623103|FG001|Overall Study|Death|1
7372152|NCT01101334|11623102|FG000|Overall Study|Withdrawal by Subject|4
7372153|NCT01101334|11623103|FG001|Overall Study|Withdrawal by Subject|3
7372154|NCT01101334|11623102|FG000|Overall Study|Withdrawal by Sponsor|1
7372155|NCT01101334|11623103|FG001|Overall Study|Withdrawal by Sponsor|1
7372156|NCT01101334|11623102|FG000|Overall Study|Progressive Disease|22
7372157|NCT01101334|11623103|FG001|Overall Study|Progressive Disease|35
7372158|NCT01101334|11623102|FG000|Overall Study|Other|2
7372159|NCT01101334|11623103|FG001|Overall Study|Other|1
7372160|NCT01101477|11623112|FG000|Overall Study|Protocol Violation|5
7372161|NCT01101477|11623113|FG001|Overall Study|Protocol Violation|3
7372162|NCT01101477|11623114|FG002|Overall Study|Protocol Violation|1
7372163|NCT01101542|11623122|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
7372164|NCT01101542|11623122|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
7372165|NCT01101542|11623122|FG000|Year 4 Surveillance Period|Other|287
7372166|NCT01101542|11623122|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
7372167|NCT01101542|11623122|FG000|Year 5 Surveillance Period|Pregnancy|1
7372168|NCT01101542|11623122|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
7372169|NCT01101542|11623122|FG000|Year 6 Surveillance Period|Pregnancy|1
7372170|NCT01101542|11623122|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
7372171|NCT01101841|11623132|FG000|Overall Study|Adverse Event|15
7372172|NCT01101841|11623133|FG001|Overall Study|Adverse Event|15
7372173|NCT01101841|11623132|FG000|Overall Study|Lost to Follow-up|9
7372174|NCT01101841|11623133|FG001|Overall Study|Lost to Follow-up|3
7372175|NCT01101841|11623132|FG000|Overall Study|Withdrawal by Subject|21
7372176|NCT01101841|11623133|FG001|Overall Study|Withdrawal by Subject|40
7372177|NCT01101841|11623132|FG000|Overall Study|Protocol Violation|1
7372178|NCT01101841|11623133|FG001|Overall Study|Protocol Violation|1
7372179|NCT01101841|11623132|FG000|Overall Study|Physician Decision|0
7372180|NCT01101841|11623133|FG001|Overall Study|Physician Decision|2
7372181|NCT01101841|11623132|FG000|Overall Study|Lack of Efficacy|0
7372182|NCT01101841|11623133|FG001|Overall Study|Lack of Efficacy|2
7372183|NCT01101841|11623132|FG000|Overall Study|Other|0
7372184|NCT01101841|11623133|FG001|Overall Study|Other|1
7372185|NCT01101841|11623132|FG000|Overall Study|Suicidality Tracking Scale|3
7372186|NCT01101841|11623133|FG001|Overall Study|Suicidality Tracking Scale|1
7372187|NCT01101841|11623132|FG000|Overall Study|Eligibility Criteria|1
7372188|NCT01101841|11623133|FG001|Overall Study|Eligibility Criteria|2
7372189|NCT01101997|11623170|FG000|Overall Study|Withdrawal by Subject|2
7372190|NCT01102231|11623185|FG000|Overall Study|Protocol Violation|3
7372191|NCT01102231|11623185|FG000|Overall Study|Lack of Efficacy|2
7372192|NCT01102231|11623185|FG000|Overall Study|Death|2
7372193|NCT01102231|11623185|FG000|Overall Study|Adverse Event|3
7372194|NCT01102231|11623185|FG000|Overall Study|Withdrawal by Subject|1
7372195|NCT01102231|11623185|FG000|Overall Study|Did not received the treatment|4
7372196|NCT01102257|11623192|FG000|Overall Study|Adverse Event|1
7372197|NCT01102257|11623193|FG001|Overall Study|Adverse Event|0
7372198|NCT01102257|11623192|FG000|Overall Study|Adverse Event|1
7372199|NCT01102257|11623193|FG001|Overall Study|Adverse Event|0
7372200|NCT01102374|11623208|FG000|Overall Study|Death|9
7372201|NCT01102374|11623209|FG001|Overall Study|Death|13
7372202|NCT01102374|11623208|FG000|Overall Study|Lost to Follow-up|7
7372203|NCT01102374|11623209|FG001|Overall Study|Lost to Follow-up|6
7372204|NCT01102426|11623226|FG000|Overall Study|Randomized but not treated|4
7372205|NCT01102426|11623227|FG001|Overall Study|Randomized but not treated|1
7372206|NCT01102426|11623226|FG000|Overall Study|Adverse Events (treatment-related)|15
7372207|NCT01102426|11623227|FG001|Overall Study|Adverse Events (treatment-related)|8
7372208|NCT01102426|11623226|FG000|Overall Study|Physician Decision|9
7372209|NCT01102426|11623227|FG001|Overall Study|Physician Decision|6
7372210|NCT01102426|11623226|FG000|Overall Study|Progressive Disease|85
7372211|NCT01102426|11623227|FG001|Overall Study|Progressive Disease|44
7372212|NCT01102426|11623226|FG000|Overall Study|Adverse Events (unrelated to|9
7372213|NCT01102426|11623227|FG001|Overall Study|Adverse Events (unrelated to|1
7372214|NCT01102426|11623226|FG000|Overall Study|Patient Refusal|24
7372215|NCT01102426|11623227|FG001|Overall Study|Patient Refusal|12
7372216|NCT01102426|11623226|FG000|Overall Study|Death (due to adverse events|0
7372217|NCT01102426|11623227|FG001|Overall Study|Death (due to adverse events|1
7372218|NCT01102426|11623226|FG000|Overall Study|Death (non-related to the study|19
7372219|NCT01102426|11623227|FG001|Overall Study|Death (non-related to the study|8
7372220|NCT01102491|11623235|FG000|Overall Study|Protocol Violation|11
7372221|NCT01102491|11623236|FG001|Overall Study|Protocol Violation|12
7372222|NCT01102777|11623257|FG000|Overall Study|Death|2
7372223|NCT01102777|11623258|FG001|Overall Study|Death|6
7372224|NCT01102777|11623257|FG000|Overall Study|Lost to Follow-up|7
7372225|NCT01102777|11623258|FG001|Overall Study|Lost to Follow-up|10
7372226|NCT01102803|11623267|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
7372227|NCT01102803|11623268|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
7372228|NCT01102803|11623267|FG000|Post to Follow-Up|Lost to Follow-up|1
7372229|NCT01102803|11623268|FG001|Post to Follow-Up|Lost to Follow-up|3
7372230|NCT01102972|11623284|FG000|Overall Study|Adverse Event|8
7372231|NCT01102972|11623285|FG001|Overall Study|Adverse Event|2
7372232|NCT01102972|11623284|FG000|Overall Study|Lack of Efficacy|2
7372233|NCT01102972|11623285|FG001|Overall Study|Lack of Efficacy|1
7461325|NCT01836523|11757444|FG000|Overall Study|Protocol Violation|6
7372234|NCT01102972|11623284|FG000|Overall Study|Protocol Violation|1
7372235|NCT01102972|11623285|FG001|Overall Study|Protocol Violation|0
7372236|NCT01102972|11623284|FG000|Overall Study|Lost to Follow-up|10
7372237|NCT01102972|11623285|FG001|Overall Study|Lost to Follow-up|5
7372238|NCT01102972|11623284|FG000|Overall Study|Investigator Discretion|2
7372239|NCT01102972|11623285|FG001|Overall Study|Investigator Discretion|0
7372240|NCT01102972|11623284|FG000|Overall Study|Withdrawal by Subject|6
7372241|NCT01102972|11623285|FG001|Overall Study|Withdrawal by Subject|6
7461326|NCT01836523|11757445|FG001|Overall Study|Protocol Violation|3
7372242|NCT01103063|11623293|FG000|Overall Study|Adverse Event|3
7372243|NCT01103063|11623294|FG001|Overall Study|Adverse Event|1
7372244|NCT01103063|11623293|FG000|Overall Study|Lost to Follow-up|68
7372245|NCT01103063|11623294|FG001|Overall Study|Lost to Follow-up|51
7372246|NCT01103063|11623293|FG000|Overall Study|Withdrawal by Subject|60
7372247|NCT01103063|11623294|FG001|Overall Study|Withdrawal by Subject|15
7372248|NCT01103063|11623293|FG000|Overall Study|Other|16
7372249|NCT01103063|11623294|FG001|Overall Study|Other|11
7372250|NCT01103063|11623293|FG000|Overall Study|Protocol Violation|1
7372251|NCT01103063|11623294|FG001|Overall Study|Protocol Violation|0
7372252|NCT01103063|11623293|FG000|Overall Study|Study terminated by Sponsor|326
7372253|NCT01103063|11623294|FG001|Overall Study|Study terminated by Sponsor|342
7372254|NCT01103063|11623293|FG000|Overall Study|Death|3
7372255|NCT01103063|11623294|FG001|Overall Study|Death|1
7372256|NCT01103141|11623304|FG000|Overall Study|Death|0
7372257|NCT01103141|11623305|FG001|Overall Study|Death|1
7372258|NCT01103141|11623304|FG000|Overall Study|Lost to Follow-up|2
7372259|NCT01103141|11623305|FG001|Overall Study|Lost to Follow-up|1
7372260|NCT01103232|11623313|FG000|Overall Study|Withdrawal by Subject|1
7372261|NCT01103232|11623314|FG001|Overall Study|Withdrawal by Subject|1
7372262|NCT01103232|11623313|FG000|Overall Study|Protocol Violation|0
7372263|NCT01103232|11623314|FG001|Overall Study|Protocol Violation|1
7372264|NCT01103245|11623324|FG000|Overall Study|Withdrawal by Subject|1
7372265|NCT01103245|11623325|FG001|Overall Study|Withdrawal by Subject|0
7372266|NCT01103245|11623326|FG002|Overall Study|Withdrawal by Subject|3
7372267|NCT01103245|11623327|FG003|Overall Study|Withdrawal by Subject|0
7372268|NCT01103245|11623324|FG000|Overall Study|Inadequate IV access|1
7372269|NCT01103245|11623325|FG001|Overall Study|Inadequate IV access|0
7372270|NCT01103245|11623326|FG002|Overall Study|Inadequate IV access|0
7372271|NCT01103245|11623327|FG003|Overall Study|Inadequate IV access|0
7372272|NCT01103245|11623324|FG000|Overall Study|Adverse Event|0
7372273|NCT01103245|11623325|FG001|Overall Study|Adverse Event|2
7372274|NCT01103245|11623326|FG002|Overall Study|Adverse Event|1
7372275|NCT01103245|11623327|FG003|Overall Study|Adverse Event|0
7372276|NCT01103245|11623324|FG000|Overall Study|Physician Decision|1
7372277|NCT01103245|11623325|FG001|Overall Study|Physician Decision|0
7372278|NCT01103245|11623326|FG002|Overall Study|Physician Decision|0
7372279|NCT01103245|11623327|FG003|Overall Study|Physician Decision|0
7372280|NCT01103284|11623349|FG000|Overall Study|Death|2
7372281|NCT01103284|11623350|FG001|Overall Study|Death|0
7372282|NCT01103284|11623349|FG000|Overall Study|Lost to Follow-up|9
7372283|NCT01103284|11623350|FG001|Overall Study|Lost to Follow-up|10
7372284|NCT01103284|11623349|FG000|Overall Study|Pregnancy|3
7372285|NCT01103284|11623350|FG001|Overall Study|Pregnancy|1
7372286|NCT01103284|11623349|FG000|Overall Study|Protocol Violation|12
7372287|NCT01103284|11623350|FG001|Overall Study|Protocol Violation|5
7372288|NCT01103284|11623349|FG000|Overall Study|Adverse Event|0
7372289|NCT01103284|11623350|FG001|Overall Study|Adverse Event|5
7372290|NCT01103284|11623349|FG000|Overall Study|Withdrawal by Subject|14
7372291|NCT01103284|11623350|FG001|Overall Study|Withdrawal by Subject|18
7372292|NCT01103284|11623349|FG000|Overall Study|Dermal Hypersensitivity|0
7372293|NCT01103284|11623350|FG001|Overall Study|Dermal Hypersensitivity|1
7372294|NCT01103284|11623349|FG000|Overall Study|Termination by the Sponsor|0
7372295|NCT01103284|11623350|FG001|Overall Study|Termination by the Sponsor|1
7372296|NCT01103284|11623349|FG000|Overall Study|Not described|2
7372297|NCT01103284|11623350|FG001|Overall Study|Not described|1
7372298|NCT01103284|11623349|FG000|Overall Study|Missing CRF entries for study completion|0
7372299|NCT01103284|11623350|FG001|Overall Study|Missing CRF entries for study completion|2
7372300|NCT01103323|11623358|FG000|Without/Before Drug Switch|Adverse Event|50
7372301|NCT01103323|11623359|FG001|Without/Before Drug Switch|Adverse Event|7
7372302|NCT01103323|11623358|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
7372303|NCT01103323|11623359|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
7372304|NCT01103323|11623358|FG000|Without/Before Drug Switch|Protocol Violation|2
7372305|NCT01103323|11623359|FG001|Without/Before Drug Switch|Protocol Violation|0
7372306|NCT01103323|11623358|FG000|Without/Before Drug Switch|Physician Decision|2
7372307|NCT01103323|11623359|FG001|Without/Before Drug Switch|Physician Decision|0
7372308|NCT01103323|11623358|FG000|Without/Before Drug Switch|did not receive study treatment|5
7372309|NCT01103323|11623359|FG001|Without/Before Drug Switch|did not receive study treatment|2
7372310|NCT01103323|11623358|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
7372311|NCT01103323|11623359|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
7372312|NCT01103323|11623358|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
7372313|NCT01103323|11623359|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
7372314|NCT01103362|11623366|FG000|Overall Study|study terminated|596
7372315|NCT01103466|11623400|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
7372316|NCT01103466|11623401|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
7372317|NCT01103466|11623402|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
7372318|NCT01103466|11623400|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
7372319|NCT01103466|11623401|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
7372320|NCT01103466|11623402|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
7372321|NCT01103466|11623400|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
7372322|NCT01103466|11623401|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7372323|NCT01103466|11623402|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
7372324|NCT01103466|11623400|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
7372325|NCT01103466|11623401|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
7372326|NCT01103466|11623402|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
7372327|NCT01103466|11623400|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
7372328|NCT01103466|11623401|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7372329|NCT01103466|11623402|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
7372330|NCT01103466|11623400|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
7372331|NCT01103466|11623401|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
7372332|NCT01103466|11623402|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
7372333|NCT01103479|11623413|FG000|Overall Study|Up to date with CRC screening|1
7372334|NCT01103479|11623414|FG001|Overall Study|Up to date with CRC screening|9
7372335|NCT01103479|11623415|FG002|Overall Study|Up to date with CRC screening|12
7372336|NCT01103479|11623413|FG000|Overall Study|Family history of CRC|1
7372337|NCT01103479|11623414|FG001|Overall Study|Family history of CRC|0
7372338|NCT01103479|11623415|FG002|Overall Study|Family history of CRC|2
7372339|NCT01103479|11623413|FG000|Overall Study|Active cancer|1
7372340|NCT01103479|11623414|FG001|Overall Study|Active cancer|0
7372341|NCT01103479|11623415|FG002|Overall Study|Active cancer|0
7372342|NCT01103479|11623413|FG000|Overall Study|Saw non-study physician|2
7372343|NCT01103479|11623414|FG001|Overall Study|Saw non-study physician|0
7372344|NCT01103479|11623415|FG002|Overall Study|Saw non-study physician|0
7372345|NCT01103713|11623445|FG000|Overall Study|Lost to Follow-up|2
7372346|NCT01103713|11623445|FG000|Overall Study|Withdrawal by Subject|8
7372347|NCT01103713|11623445|FG000|Overall Study|Study terminated by sponsor|2
7372348|NCT01103713|11623445|FG000|Overall Study|Other|1
7372349|NCT01103778|11623452|FG000|Overall Study|Lost to Follow-up|1
7372350|NCT01103778|11623452|FG000|Overall Study|Proteinuria improved prior to enrollment|1
7372351|NCT01103778|11623452|FG000|Overall Study|Screen failure|1
7372352|NCT01103960|11623469|FG000|Overall Study|Adverse Event|2
7372353|NCT01103960|11623470|FG001|Overall Study|Adverse Event|1
7372354|NCT01103960|11623469|FG000|Overall Study|Withdrawal by Subject|2
7372355|NCT01103960|11623470|FG001|Overall Study|Withdrawal by Subject|1
7372356|NCT01103960|11623469|FG000|Overall Study|Other|1
7372357|NCT01103960|11623470|FG001|Overall Study|Other|0
7372358|NCT01104155|11623511|FG000|Overall Study|Adverse Event|15
7372359|NCT01104155|11623512|FG001|Overall Study|Adverse Event|8
7372360|NCT01104155|11623511|FG000|Overall Study|Participant choice|6
7372361|NCT01104155|11623512|FG001|Overall Study|Participant choice|5
7372362|NCT01104155|11623511|FG000|Overall Study|Withdrawal of consent|1
7372363|NCT01104155|11623512|FG001|Overall Study|Withdrawal of consent|1
7372364|NCT01104155|11623511|FG000|Overall Study|Other|3
7372365|NCT01104155|11623512|FG001|Overall Study|Other|4
7372366|NCT01104246|11623527|FG000|Overall Study|Withdrawal by Subject|1
7372367|NCT01104246|11623527|FG000|Overall Study|did not meet inclusion criteria|4
7387017|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
7387018|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
7387019|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
7387020|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
7387021|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
7387022|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
7387023|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
7387024|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
7387025|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
7387026|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
7570542|NCT03495102|11948394|FG001|Overall Study|Protocol Violation|1
7570543|NCT03495102|11948395|FG002|Overall Study|Protocol Violation|0
7570544|NCT03495102|11948393|FG000|Overall Study|Site Closure|3
7570545|NCT03495102|11948394|FG001|Overall Study|Site Closure|1
7570546|NCT03495102|11948395|FG002|Overall Study|Site Closure|2
7570547|NCT03495102|11948393|FG000|Overall Study|Non-compliance|1
7570548|NCT03495102|11948394|FG001|Overall Study|Non-compliance|0
7387027|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
7387028|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
7387029|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
7387030|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
7387031|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
7387032|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
7387033|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
7387034|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7387035|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
7387036|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7387037|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7387038|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7387039|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7387040|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7387041|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7570549|NCT03495102|11948395|FG002|Overall Study|Non-compliance|0
7570550|NCT03495102|11948393|FG000|Overall Study|Participant Duplicated at Another Site|0
7570551|NCT03495102|11948394|FG001|Overall Study|Participant Duplicated at Another Site|0
7372368|NCT01104311|11623542|FG000|Overall Study|Withdrawal by Subject|6
7372369|NCT01104311|11623543|FG001|Overall Study|Withdrawal by Subject|6
7372370|NCT01104311|11623542|FG000|Overall Study|Protocol Violation|0
7372371|NCT01104311|11623543|FG001|Overall Study|Protocol Violation|1
7372372|NCT01104311|11623542|FG000|Overall Study|Physician Decision|2
7372373|NCT01104311|11623543|FG001|Overall Study|Physician Decision|2
7372374|NCT01104311|11623542|FG000|Overall Study|low compliance|1
7372375|NCT01104311|11623543|FG001|Overall Study|low compliance|1
7372376|NCT01104311|11623542|FG000|Overall Study|Adverse Event|1
7372377|NCT01104311|11623543|FG001|Overall Study|Adverse Event|2
7372378|NCT01104376|11623553|FG000|Overall Study|Withdrawal by Subject|15
7372379|NCT01104376|11623553|FG000|Overall Study|Consented but excluded after labs|13
7372380|NCT01104415|11623566|FG000|Core Phase|Consent withdrawn by subjects|1
7372381|NCT01104415|11623567|FG001|Core Phase|Consent withdrawn by subjects|0
7372382|NCT01104415|11623566|FG000|Extension Period|Progressive disease|0
7372383|NCT01104415|11623567|FG001|Extension Period|Progressive disease|4
7372384|NCT01104415|11623566|FG000|Extension Period|Death|0
7372385|NCT01104415|11623567|FG001|Extension Period|Death|1
7372386|NCT01104415|11623566|FG000|Extension Period|Physician Decision|0
7372387|NCT01104415|11623567|FG001|Extension Period|Physician Decision|1
7372388|NCT01104415|11623566|FG000|Extension Period|Transition to Study LX1606.302|0
7372389|NCT01104415|11623567|FG001|Extension Period|Transition to Study LX1606.302|4
7372390|NCT01104415|11623566|FG000|Extension Period|Heart surgery/feeling miserable|0
7372391|NCT01104415|11623567|FG001|Extension Period|Heart surgery/feeling miserable|1
7372392|NCT01104493|11623576|FG000|Overall Study|Lost to Follow-up|0
7372393|NCT01104493|11623577|FG001|Overall Study|Lost to Follow-up|2
7372394|NCT01104545|11623586|FG000|Overall Study|Adverse Event|0
7372395|NCT01104545|11623587|FG001|Overall Study|Adverse Event|1
7372396|NCT01104545|11623588|FG002|Overall Study|Adverse Event|2
7372397|NCT01104558|11623633|FG000|Overall Study|Protocol Violation|6
7372398|NCT01104558|11623633|FG000|Overall Study|Missing of primary efficacy assessment|10
7372399|NCT01104558|11623633|FG000|Overall Study|Missing of genetic analysis results|1
7372400|NCT01104584|11623637|FG000|Overall Study|Study drug never administered|21
7372401|NCT01104584|11623637|FG000|Overall Study|Study prematurely discontinued|2
7372402|NCT01104636|11623659|FG000|Overall Study|Lack of Efficacy|43
7372403|NCT01104636|11623659|FG000|Overall Study|Lost to Follow-up|24
7372404|NCT01104636|11623659|FG000|Overall Study|Withdrawal by Subject|4
7372405|NCT01104636|11623659|FG000|Overall Study|Other|43
7372406|NCT01104636|11623659|FG000|Overall Study|Study terminated by sponsor|1
7372407|NCT01104636|11623659|FG000|Overall Study|Pregnancy|2
7372408|NCT01104636|11623659|FG000|Overall Study|Adverse Event|40
7372409|NCT01104636|11623659|FG000|Overall Study|Ongoing|21
7372410|NCT01104662|11623671|FG000|Overall Study|Adverse Event|2
7372411|NCT01104662|11623672|FG001|Overall Study|Adverse Event|2
7372412|NCT01104662|11623673|FG002|Overall Study|Adverse Event|0
7372413|NCT01104662|11623674|FG003|Overall Study|Adverse Event|1
7372414|NCT01104662|11623675|FG004|Overall Study|Adverse Event|1
7372415|NCT01104662|11623676|FG005|Overall Study|Adverse Event|1
7372416|NCT01104662|11623677|FG006|Overall Study|Adverse Event|0
7372417|NCT01104662|11623678|FG007|Overall Study|Adverse Event|0
7372418|NCT01104662|11623671|FG000|Overall Study|Clinical Failure|1
7372419|NCT01104662|11623672|FG001|Overall Study|Clinical Failure|0
7372420|NCT01104662|11623673|FG002|Overall Study|Clinical Failure|0
7372421|NCT01104662|11623674|FG003|Overall Study|Clinical Failure|0
7372422|NCT01104662|11623675|FG004|Overall Study|Clinical Failure|0
7372423|NCT01104662|11623676|FG005|Overall Study|Clinical Failure|1
7372424|NCT01104662|11623677|FG006|Overall Study|Clinical Failure|0
7372425|NCT01104662|11623678|FG007|Overall Study|Clinical Failure|0
7372426|NCT01104662|11623671|FG000|Overall Study|Participant left investigator's care|1
7372427|NCT01104662|11623672|FG001|Overall Study|Participant left investigator's care|1
7372428|NCT01104662|11623673|FG002|Overall Study|Participant left investigator's care|0
7372429|NCT01104662|11623674|FG003|Overall Study|Participant left investigator's care|0
7372430|NCT01104662|11623675|FG004|Overall Study|Participant left investigator's care|0
7372431|NCT01104662|11623676|FG005|Overall Study|Participant left investigator's care|0
7372432|NCT01104662|11623677|FG006|Overall Study|Participant left investigator's care|0
7372433|NCT01104662|11623678|FG007|Overall Study|Participant left investigator's care|0
7372434|NCT01104662|11623671|FG000|Overall Study|Reason not specified|3
7372435|NCT01104662|11623672|FG001|Overall Study|Reason not specified|3
7372436|NCT01104662|11623673|FG002|Overall Study|Reason not specified|0
7372437|NCT01104662|11623674|FG003|Overall Study|Reason not specified|0
7372438|NCT01104662|11623675|FG004|Overall Study|Reason not specified|0
7372439|NCT01104662|11623676|FG005|Overall Study|Reason not specified|1
7372440|NCT01104662|11623677|FG006|Overall Study|Reason not specified|0
7372441|NCT01104662|11623678|FG007|Overall Study|Reason not specified|0
7372442|NCT01104662|11623671|FG000|Overall Study|Randomized but not treated|3
7372443|NCT01104662|11623672|FG001|Overall Study|Randomized but not treated|4
7372444|NCT01104662|11623673|FG002|Overall Study|Randomized but not treated|1
7372445|NCT01104662|11623674|FG003|Overall Study|Randomized but not treated|0
7372446|NCT01104662|11623675|FG004|Overall Study|Randomized but not treated|0
7372447|NCT01104662|11623676|FG005|Overall Study|Randomized but not treated|1
7372448|NCT01104662|11623677|FG006|Overall Study|Randomized but not treated|0
7372449|NCT01104662|11623678|FG007|Overall Study|Randomized but not treated|0
7372450|NCT01104701|11623701|FG000|Overall Study|Withdrawal by Subject|0
7372451|NCT01104701|11623702|FG001|Overall Study|Withdrawal by Subject|1
7372452|NCT01104701|11623703|FG002|Overall Study|Withdrawal by Subject|2
7372453|NCT01104701|11623704|FG003|Overall Study|Withdrawal by Subject|1
7372454|NCT01104701|11623701|FG000|Overall Study|Adverse Event|0
7372455|NCT01104701|11623702|FG001|Overall Study|Adverse Event|0
7372456|NCT01104701|11623703|FG002|Overall Study|Adverse Event|0
7372457|NCT01104701|11623704|FG003|Overall Study|Adverse Event|1
7372458|NCT01104701|11623701|FG000|Overall Study|Physician Decision|0
7372459|NCT01104701|11623702|FG001|Overall Study|Physician Decision|2
7461327|NCT01836523|11757446|FG002|Overall Study|Protocol Violation|2
7461328|NCT01836523|11757447|FG003|Overall Study|Protocol Violation|4
7461329|NCT01836523|11757444|FG000|Overall Study|Met Withdrawal Criteria|13
7461330|NCT01836523|11757445|FG001|Overall Study|Met Withdrawal Criteria|13
7461331|NCT01836523|11757446|FG002|Overall Study|Met Withdrawal Criteria|21
7461332|NCT01836523|11757447|FG003|Overall Study|Met Withdrawal Criteria|27
7461333|NCT01836523|11757444|FG000|Overall Study|Unclassified|17
7461334|NCT01836523|11757445|FG001|Overall Study|Unclassified|28
7461335|NCT01836523|11757446|FG002|Overall Study|Unclassified|19
7461336|NCT01836523|11757447|FG003|Overall Study|Unclassified|29
7461337|NCT01836549|11757463|FG000|Overall Study|Did not receive study drug|0
7461338|NCT01836549|11757464|FG001|Overall Study|Did not receive study drug|0
7461339|NCT01836549|11757465|FG002|Overall Study|Did not receive study drug|1
7461340|NCT01836549|11757466|FG003|Overall Study|Did not receive study drug|0
7461341|NCT01836549|11757467|FG004|Overall Study|Did not receive study drug|0
7461342|NCT01836549|11757468|FG005|Overall Study|Did not receive study drug|0
7461343|NCT01836549|11757469|FG006|Overall Study|Did not receive study drug|0
7461344|NCT01836549|11757463|FG000|Overall Study|Patient declared ineligible|0
7461345|NCT01836549|11757464|FG001|Overall Study|Patient declared ineligible|0
7461346|NCT01836549|11757465|FG002|Overall Study|Patient declared ineligible|0
7461347|NCT01836549|11757466|FG003|Overall Study|Patient declared ineligible|1
7461348|NCT01836549|11757467|FG004|Overall Study|Patient declared ineligible|0
7461349|NCT01836549|11757468|FG005|Overall Study|Patient declared ineligible|0
7461350|NCT01836549|11757469|FG006|Overall Study|Patient declared ineligible|0
7461351|NCT01836549|11757463|FG000|Overall Study|Patient inevaluable to start therapy|0
7461352|NCT01836549|11757464|FG001|Overall Study|Patient inevaluable to start therapy|0
7461353|NCT01836549|11757465|FG002|Overall Study|Patient inevaluable to start therapy|0
7461354|NCT01836549|11757466|FG003|Overall Study|Patient inevaluable to start therapy|0
7461355|NCT01836549|11757467|FG004|Overall Study|Patient inevaluable to start therapy|0
7461356|NCT01836549|11757468|FG005|Overall Study|Patient inevaluable to start therapy|0
7461357|NCT01836549|11757469|FG006|Overall Study|Patient inevaluable to start therapy|1
7461358|NCT01837680|11757527|FG000|Overall Study|Lost to Follow-up|2
7461359|NCT01837680|11757528|FG001|Overall Study|Lost to Follow-up|2
7461360|NCT01837680|11757527|FG000|Overall Study|lack of insurance|0
7461361|NCT01837680|11757528|FG001|Overall Study|lack of insurance|2
7372460|NCT01104701|11623703|FG002|Overall Study|Physician Decision|0
7372461|NCT01104701|11623704|FG003|Overall Study|Physician Decision|0
7372462|NCT01104766|11623718|FG000|Overall Study|Did not meet inc/exc criteria|1
7372463|NCT01104766|11623719|FG001|Overall Study|Did not meet inc/exc criteria|0
7372464|NCT01104766|11623720|FG002|Overall Study|Did not meet inc/exc criteria|0
7387706|NCT01215916|11646444|FG006|Overall Study|Progressive Disease|5
7387707|NCT01215916|11646445|FG007|Overall Study|Progressive Disease|3
7387708|NCT01215916|11646446|FG008|Overall Study|Progressive Disease|1
7387709|NCT01215916|11646438|FG000|Overall Study|Adverse Event|1
7387710|NCT01215916|11646439|FG001|Overall Study|Adverse Event|1
7387711|NCT01215916|11646440|FG002|Overall Study|Adverse Event|0
7387712|NCT01215916|11646441|FG003|Overall Study|Adverse Event|1
7387713|NCT01215916|11646442|FG004|Overall Study|Adverse Event|0
7387714|NCT01215916|11646443|FG005|Overall Study|Adverse Event|0
7387715|NCT01215916|11646444|FG006|Overall Study|Adverse Event|3
7387716|NCT01215916|11646445|FG007|Overall Study|Adverse Event|0
7387717|NCT01215916|11646446|FG008|Overall Study|Adverse Event|0
7387718|NCT01215916|11646438|FG000|Overall Study|Withdrawal by Subject|0
7387719|NCT01215916|11646439|FG001|Overall Study|Withdrawal by Subject|1
7387720|NCT01215916|11646440|FG002|Overall Study|Withdrawal by Subject|1
7387721|NCT01215916|11646441|FG003|Overall Study|Withdrawal by Subject|2
7387722|NCT01215916|11646442|FG004|Overall Study|Withdrawal by Subject|0
7387723|NCT01215916|11646443|FG005|Overall Study|Withdrawal by Subject|0
7387724|NCT01215916|11646444|FG006|Overall Study|Withdrawal by Subject|1
7387725|NCT01215916|11646445|FG007|Overall Study|Withdrawal by Subject|0
7387726|NCT01215916|11646446|FG008|Overall Study|Withdrawal by Subject|0
7461362|NCT01837680|11757527|FG000|Overall Study|allergic reaction|6
7461363|NCT01837680|11757528|FG001|Overall Study|allergic reaction|0
7461364|NCT01837680|11757527|FG000|Overall Study|switched to oral hypoglycemic or diet|2
7461365|NCT01837680|11757528|FG001|Overall Study|switched to oral hypoglycemic or diet|4
7461366|NCT01837719|11757534|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
7461367|NCT01837719|11757534|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
7461368|NCT01837797|11757552|FG000|Period 1|Adverse Event|9
7461369|NCT01837797|11757553|FG001|Period 1|Adverse Event|0
7461370|NCT01837797|11757554|FG002|Period 1|Adverse Event|0
7461371|NCT01837797|11757555|FG003|Period 1|Adverse Event|0
7461372|NCT01837797|11757556|FG004|Period 1|Adverse Event|0
7461373|NCT01837797|11757552|FG000|Period 1|Withdrawal by Subject|6
7570552|NCT03495102|11948395|FG002|Overall Study|Participant Duplicated at Another Site|1
7570553|NCT03495102|11948393|FG000|Overall Study|Primary Care Physician Recommendation|0
7372465|NCT01104766|11623721|FG003|Overall Study|Did not meet inc/exc criteria|0
7372466|NCT01104766|11623718|FG000|Overall Study|Adverse Event|17
7372467|NCT01104766|11623719|FG001|Overall Study|Adverse Event|15
7372468|NCT01104766|11623720|FG002|Overall Study|Adverse Event|20
7372469|NCT01104766|11623721|FG003|Overall Study|Adverse Event|14
7372470|NCT01104766|11623718|FG000|Overall Study|Lack of Efficacy|20
7372471|NCT01104766|11623719|FG001|Overall Study|Lack of Efficacy|15
7372472|NCT01104766|11623720|FG002|Overall Study|Lack of Efficacy|14
7372473|NCT01104766|11623721|FG003|Overall Study|Lack of Efficacy|8
7372474|NCT01104766|11623718|FG000|Overall Study|Protocol Violation|2
7372475|NCT01104766|11623719|FG001|Overall Study|Protocol Violation|0
7372476|NCT01104766|11623720|FG002|Overall Study|Protocol Violation|0
7372477|NCT01104766|11623721|FG003|Overall Study|Protocol Violation|0
7372478|NCT01104766|11623718|FG000|Overall Study|Withdrawal by Subject|17
7372479|NCT01104766|11623719|FG001|Overall Study|Withdrawal by Subject|19
7372480|NCT01104766|11623720|FG002|Overall Study|Withdrawal by Subject|25
7372481|NCT01104766|11623721|FG003|Overall Study|Withdrawal by Subject|15
7372482|NCT01104766|11623718|FG000|Overall Study|Lost to Follow-up|1
7372483|NCT01104766|11623719|FG001|Overall Study|Lost to Follow-up|2
7372484|NCT01104766|11623720|FG002|Overall Study|Lost to Follow-up|1
7372485|NCT01104766|11623721|FG003|Overall Study|Lost to Follow-up|1
7372486|NCT01104779|11623734|FG000|Overall Study|Protocol Violation|1
7372487|NCT01104779|11623735|FG001|Overall Study|Protocol Violation|2
7372488|NCT01104779|11623736|FG002|Overall Study|Protocol Violation|2
7372489|NCT01104779|11623734|FG000|Overall Study|Lack of Efficacy|26
7372490|NCT01104779|11623735|FG001|Overall Study|Lack of Efficacy|12
7372491|NCT01104779|11623736|FG002|Overall Study|Lack of Efficacy|13
7372492|NCT01104779|11623734|FG000|Overall Study|Adverse Event|13
7372493|NCT01104779|11623735|FG001|Overall Study|Adverse Event|14
7372494|NCT01104779|11623736|FG002|Overall Study|Adverse Event|13
7372495|NCT01104779|11623734|FG000|Overall Study|Did not meet inc/exc criteria|1
7372496|NCT01104779|11623735|FG001|Overall Study|Did not meet inc/exc criteria|1
7372497|NCT01104779|11623736|FG002|Overall Study|Did not meet inc/exc criteria|1
7372498|NCT01104779|11623734|FG000|Overall Study|Other reasons|0
7372499|NCT01104779|11623735|FG001|Overall Study|Other reasons|1
7372500|NCT01104779|11623736|FG002|Overall Study|Other reasons|0
7372501|NCT01104779|11623734|FG000|Overall Study|Lost to Follow-up|2
7372502|NCT01104779|11623735|FG001|Overall Study|Lost to Follow-up|0
7372503|NCT01104779|11623736|FG002|Overall Study|Lost to Follow-up|1
7372504|NCT01104779|11623734|FG000|Overall Study|Withdrawal by Subject|16
7372505|NCT01104779|11623735|FG001|Overall Study|Withdrawal by Subject|25
7372506|NCT01104779|11623736|FG002|Overall Study|Withdrawal by Subject|32
7372507|NCT01104792|11623744|FG000|Overall Study|Adverse Event|77
7372508|NCT01104792|11623744|FG000|Overall Study|Insufficient Therapeutic Response|22
7372509|NCT01104792|11623744|FG000|Overall Study|Protocol Violation|45
7372510|NCT01104792|11623744|FG000|Overall Study|Withdrawal of Consent|179
7372511|NCT01104792|11623744|FG000|Overall Study|Lost to Follow-up|43
7372512|NCT01104792|11623744|FG000|Overall Study|Reasons Not Specified|27
7372513|NCT01104792|11623744|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
7372514|NCT01104870|11623751|FG000|Overall Study|Adverse Event|1
7372515|NCT01104870|11623752|FG001|Overall Study|Adverse Event|1
7570554|NCT03495102|11948394|FG001|Overall Study|Primary Care Physician Recommendation|1
7372516|NCT01104870|11623753|FG002|Overall Study|Adverse Event|0
7372517|NCT01104870|11623751|FG000|Overall Study|Death|0
7372518|NCT01104870|11623752|FG001|Overall Study|Death|0
7372519|NCT01104870|11623753|FG002|Overall Study|Death|1
7372520|NCT01104870|11623751|FG000|Overall Study|Withdrawal by Subject|0
7372521|NCT01104870|11623752|FG001|Overall Study|Withdrawal by Subject|0
7372522|NCT01104870|11623753|FG002|Overall Study|Withdrawal by Subject|1
7372523|NCT01105065|11623761|FG000|Overall Study|Adverse Event|5
7372524|NCT01105065|11623761|FG000|Overall Study|Technical Problems|1
7372525|NCT01105091|11623769|FG000|Overall Study|Death|2
7372526|NCT01105091|11623770|FG001|Overall Study|Death|0
7372527|NCT01105130|11623790|FG000|Overall Study|Withdrawal by Subject|4
7372528|NCT01105130|11623791|FG001|Overall Study|Withdrawal by Subject|6
7372529|NCT01105130|11623792|FG002|Overall Study|Withdrawal by Subject|2
7372530|NCT01105130|11623790|FG000|Overall Study|Never Started|2
7372531|NCT01105130|11623791|FG001|Overall Study|Never Started|2
7461374|NCT01837797|11757553|FG001|Period 1|Withdrawal by Subject|0
7461375|NCT01837797|11757554|FG002|Period 1|Withdrawal by Subject|0
7372532|NCT01105130|11623792|FG002|Overall Study|Never Started|4
7372533|NCT01105130|11623790|FG000|Overall Study|Toxicity|1
7372534|NCT01105130|11623791|FG001|Overall Study|Toxicity|3
7372535|NCT01105130|11623792|FG002|Overall Study|Toxicity|2
7372536|NCT01105130|11623790|FG000|Overall Study|Multiple Reasons|3
7372537|NCT01105130|11623791|FG001|Overall Study|Multiple Reasons|0
7372538|NCT01105130|11623792|FG002|Overall Study|Multiple Reasons|2
7372539|NCT01105377|11623829|FG000|Overall Study|Withdrawal by Subject|0
7372540|NCT01105377|11623830|FG001|Overall Study|Withdrawal by Subject|1
7372541|NCT01105533|11623836|FG000|Overall Study|Death|0
7372542|NCT01105533|11623837|FG001|Overall Study|Death|0
7372543|NCT01105533|11623838|FG002|Overall Study|Death|0
7372544|NCT01105533|11623839|FG003|Overall Study|Death|0
7372545|NCT01105533|11623840|FG004|Overall Study|Death|1
7372546|NCT01105533|11623841|FG005|Overall Study|Death|0
7372547|NCT01105533|11623842|FG006|Overall Study|Death|0
7372548|NCT01105533|11623843|FG007|Overall Study|Death|0
7372549|NCT01105533|11623844|FG008|Overall Study|Death|0
7372550|NCT01105533|11623836|FG000|Overall Study|Lack of Efficacy|1
7372551|NCT01105533|11623837|FG001|Overall Study|Lack of Efficacy|1
7372552|NCT01105533|11623838|FG002|Overall Study|Lack of Efficacy|3
7372553|NCT01105533|11623839|FG003|Overall Study|Lack of Efficacy|3
7372554|NCT01105533|11623840|FG004|Overall Study|Lack of Efficacy|4
7372555|NCT01105533|11623841|FG005|Overall Study|Lack of Efficacy|5
7372556|NCT01105533|11623842|FG006|Overall Study|Lack of Efficacy|3
7372557|NCT01105533|11623843|FG007|Overall Study|Lack of Efficacy|2
7372558|NCT01105533|11623844|FG008|Overall Study|Lack of Efficacy|9
7372559|NCT01105533|11623836|FG000|Overall Study|Adverse Event|0
7372560|NCT01105533|11623837|FG001|Overall Study|Adverse Event|0
7372561|NCT01105533|11623838|FG002|Overall Study|Adverse Event|0
7372562|NCT01105533|11623839|FG003|Overall Study|Adverse Event|0
7372563|NCT01105533|11623840|FG004|Overall Study|Adverse Event|1
7372564|NCT01105533|11623841|FG005|Overall Study|Adverse Event|2
7372565|NCT01105533|11623842|FG006|Overall Study|Adverse Event|2
7372566|NCT01105533|11623843|FG007|Overall Study|Adverse Event|0
7372567|NCT01105533|11623844|FG008|Overall Study|Adverse Event|1
7372568|NCT01105533|11623836|FG000|Overall Study|Other|0
7372569|NCT01105533|11623837|FG001|Overall Study|Other|0
7372570|NCT01105533|11623838|FG002|Overall Study|Other|0
7372571|NCT01105533|11623839|FG003|Overall Study|Other|0
7372572|NCT01105533|11623840|FG004|Overall Study|Other|1
7372573|NCT01105533|11623841|FG005|Overall Study|Other|0
7372574|NCT01105533|11623842|FG006|Overall Study|Other|3
7372575|NCT01105533|11623843|FG007|Overall Study|Other|1
7372576|NCT01105533|11623844|FG008|Overall Study|Other|2
7372577|NCT01105533|11623836|FG000|Overall Study|Physician Decision|0
7372578|NCT01105533|11623837|FG001|Overall Study|Physician Decision|0
7372579|NCT01105533|11623838|FG002|Overall Study|Physician Decision|0
7372580|NCT01105533|11623839|FG003|Overall Study|Physician Decision|0
7372581|NCT01105533|11623840|FG004|Overall Study|Physician Decision|0
7372582|NCT01105533|11623841|FG005|Overall Study|Physician Decision|0
7372583|NCT01105533|11623842|FG006|Overall Study|Physician Decision|0
7372584|NCT01105533|11623843|FG007|Overall Study|Physician Decision|1
7372585|NCT01105533|11623844|FG008|Overall Study|Physician Decision|0
7372586|NCT01105767|11623889|FG000|Overall Study|Lost to Follow-up|1160
7372587|NCT01105767|11623890|FG001|Overall Study|Lost to Follow-up|1614
7372588|NCT01105767|11623891|FG002|Overall Study|Lost to Follow-up|1184
7372589|NCT01105936|11623899|FG000|Period 1|Adverse Event|0
7372590|NCT01105936|11623900|FG001|Period 1|Adverse Event|0
7372591|NCT01105936|11623901|FG002|Period 1|Adverse Event|0
7372592|NCT01105936|11623902|FG003|Period 1|Adverse Event|1
7372593|NCT01105936|11623899|FG000|Period 2|Adverse Event|1
7372594|NCT01105936|11623900|FG001|Period 2|Adverse Event|0
7372595|NCT01105936|11623901|FG002|Period 2|Adverse Event|0
7372596|NCT01105936|11623902|FG003|Period 2|Adverse Event|0
7372597|NCT01105936|11623899|FG000|Period 3|Protocol Violation|0
7372598|NCT01105936|11623900|FG001|Period 3|Protocol Violation|2
7372599|NCT01105936|11623901|FG002|Period 3|Protocol Violation|0
7372600|NCT01105936|11623902|FG003|Period 3|Protocol Violation|0
7372601|NCT01105975|11623921|FG000|Overall Study|Adverse Event|2
7372602|NCT01105975|11623922|FG001|Overall Study|Adverse Event|1
7372603|NCT01105975|11623923|FG002|Overall Study|Adverse Event|5
7372604|NCT01105975|11623924|FG003|Overall Study|Adverse Event|1
7372605|NCT01105975|11623925|FG004|Overall Study|Adverse Event|0
7372606|NCT01105975|11623926|FG005|Overall Study|Adverse Event|1
7372607|NCT01105975|11623927|FG006|Overall Study|Adverse Event|2
7372608|NCT01105975|11623928|FG007|Overall Study|Adverse Event|4
7372609|NCT01105975|11623929|FG008|Overall Study|Adverse Event|1
7372610|NCT01105975|11623930|FG009|Overall Study|Adverse Event|4
7372611|NCT01105975|11623921|FG000|Overall Study|Withdrawal by Subject|2
7372612|NCT01105975|11623922|FG001|Overall Study|Withdrawal by Subject|2
7372613|NCT01105975|11623923|FG002|Overall Study|Withdrawal by Subject|2
7372614|NCT01105975|11623924|FG003|Overall Study|Withdrawal by Subject|0
7372615|NCT01105975|11623925|FG004|Overall Study|Withdrawal by Subject|4
7372616|NCT01105975|11623926|FG005|Overall Study|Withdrawal by Subject|1
7372617|NCT01105975|11623927|FG006|Overall Study|Withdrawal by Subject|2
7372618|NCT01105975|11623928|FG007|Overall Study|Withdrawal by Subject|1
7372619|NCT01105975|11623929|FG008|Overall Study|Withdrawal by Subject|0
7372620|NCT01105975|11623930|FG009|Overall Study|Withdrawal by Subject|3
7372621|NCT01105975|11623921|FG000|Overall Study|Lost to Follow-up|1
7372622|NCT01105975|11623922|FG001|Overall Study|Lost to Follow-up|0
7372623|NCT01105975|11623923|FG002|Overall Study|Lost to Follow-up|0
7372624|NCT01105975|11623924|FG003|Overall Study|Lost to Follow-up|1
7372625|NCT01105975|11623925|FG004|Overall Study|Lost to Follow-up|1
7372626|NCT01105975|11623926|FG005|Overall Study|Lost to Follow-up|0
7372627|NCT01105975|11623927|FG006|Overall Study|Lost to Follow-up|0
7372628|NCT01105975|11623928|FG007|Overall Study|Lost to Follow-up|0
7372629|NCT01105975|11623929|FG008|Overall Study|Lost to Follow-up|1
7372630|NCT01105975|11623930|FG009|Overall Study|Lost to Follow-up|0
7372631|NCT01105975|11623921|FG000|Overall Study|Physician Decision|0
7372632|NCT01105975|11623922|FG001|Overall Study|Physician Decision|0
7372633|NCT01105975|11623923|FG002|Overall Study|Physician Decision|0
7372634|NCT01105975|11623924|FG003|Overall Study|Physician Decision|0
7372635|NCT01105975|11623925|FG004|Overall Study|Physician Decision|0
7372636|NCT01105975|11623926|FG005|Overall Study|Physician Decision|0
7372637|NCT01105975|11623927|FG006|Overall Study|Physician Decision|2
7372638|NCT01105975|11623928|FG007|Overall Study|Physician Decision|0
7372639|NCT01105975|11623929|FG008|Overall Study|Physician Decision|0
7372640|NCT01105975|11623930|FG009|Overall Study|Physician Decision|0
7372641|NCT01105975|11623921|FG000|Overall Study|Protocol Violation|0
7372642|NCT01105975|11623922|FG001|Overall Study|Protocol Violation|2
7372643|NCT01105975|11623923|FG002|Overall Study|Protocol Violation|2
7372644|NCT01105975|11623924|FG003|Overall Study|Protocol Violation|0
7372645|NCT01105975|11623925|FG004|Overall Study|Protocol Violation|1
7372646|NCT01105975|11623926|FG005|Overall Study|Protocol Violation|1
7372647|NCT01105975|11623927|FG006|Overall Study|Protocol Violation|1
7372648|NCT01105975|11623928|FG007|Overall Study|Protocol Violation|1
7372649|NCT01105975|11623929|FG008|Overall Study|Protocol Violation|2
7372650|NCT01105975|11623930|FG009|Overall Study|Protocol Violation|2
7372651|NCT01105975|11623921|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7372652|NCT01105975|11623922|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7372653|NCT01105975|11623923|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7372654|NCT01105975|11623924|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7372655|NCT01105975|11623925|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7372656|NCT01105975|11623926|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7372657|NCT01105975|11623927|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7372658|NCT01105975|11623928|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
7372659|NCT01105975|11623929|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
7372660|NCT01105975|11623930|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
7570555|NCT03495102|11948395|FG002|Overall Study|Primary Care Physician Recommendation|0
7372661|NCT01106014|11623973|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
7372662|NCT01106014|11623974|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
7372663|NCT01106014|11623973|FG000|Overall Study|Adverse Event|78
7372664|NCT01106014|11623974|FG001|Overall Study|Adverse Event|42
7372665|NCT01106014|11623973|FG000|Overall Study|Withdrawal by Subject|43
7372666|NCT01106014|11623974|FG001|Overall Study|Withdrawal by Subject|37
7372667|NCT01106014|11623973|FG000|Overall Study|Administrative reason|7
7372668|NCT01106014|11623974|FG001|Overall Study|Administrative reason|6
7372669|NCT01106014|11623973|FG000|Overall Study|Lost to Follow-up|2
7372670|NCT01106014|11623974|FG001|Overall Study|Lost to Follow-up|3
7372671|NCT01106027|11623980|FG000|Overall Study|Lost graft early, discontinued|1
7372672|NCT01106092|11623993|FG000|Overall Study|Withdrawal by Subject|0
7372673|NCT01106092|11623994|FG001|Overall Study|Withdrawal by Subject|0
7372674|NCT01106092|11623995|FG002|Overall Study|Withdrawal by Subject|0
7372675|NCT01106092|11623996|FG003|Overall Study|Withdrawal by Subject|1
7372676|NCT01106157|11624008|FG000|Overall Study|Withdrawal by Subject|1
7372677|NCT01106157|11624009|FG001|Overall Study|Withdrawal by Subject|0
7372678|NCT01106248|11624015|FG000|Overall Study|Adverse Event|1
7372679|NCT01106248|11624015|FG000|Overall Study|Administrative|2
7372680|NCT01106287|11624023|FG000|Overall Study|Adverse Event|1
7372681|NCT01106287|11624024|FG001|Overall Study|Adverse Event|0
7372682|NCT01106287|11624025|FG002|Overall Study|Adverse Event|0
7372683|NCT01106287|11624026|FG003|Overall Study|Adverse Event|0
7372684|NCT01106352|11624051|FG000|Overall Study|Subjects untreated|0
7372685|NCT01106352|11624052|FG001|Overall Study|Subjects untreated|0
7372686|NCT01106352|11624053|FG002|Overall Study|Subjects untreated|0
7372687|NCT01106352|11624054|FG003|Overall Study|Subjects untreated|3
7372688|NCT01106352|11624055|FG004|Overall Study|Subjects untreated|4
7372689|NCT01106352|11624051|FG000|Overall Study|Sponsor Decision|1
7372690|NCT01106352|11624052|FG001|Overall Study|Sponsor Decision|0
7372691|NCT01106352|11624053|FG002|Overall Study|Sponsor Decision|0
7372692|NCT01106352|11624054|FG003|Overall Study|Sponsor Decision|0
7372693|NCT01106352|11624055|FG004|Overall Study|Sponsor Decision|0
7372694|NCT01106352|11624051|FG000|Overall Study|Too ill to come in for the visit|0
7372695|NCT01106352|11624052|FG001|Overall Study|Too ill to come in for the visit|0
7372696|NCT01106352|11624053|FG002|Overall Study|Too ill to come in for the visit|1
7372697|NCT01106352|11624054|FG003|Overall Study|Too ill to come in for the visit|0
7372698|NCT01106352|11624055|FG004|Overall Study|Too ill to come in for the visit|0
7372699|NCT01106352|11624051|FG000|Overall Study|Lost to Follow-up|0
7372700|NCT01106352|11624052|FG001|Overall Study|Lost to Follow-up|0
7372701|NCT01106352|11624053|FG002|Overall Study|Lost to Follow-up|0
7372702|NCT01106352|11624054|FG003|Overall Study|Lost to Follow-up|0
7570556|NCT03495102|11948393|FG000|Overall Study|Relocated to Another Country|0
7372703|NCT01106352|11624055|FG004|Overall Study|Lost to Follow-up|1
7372704|NCT01106352|11624051|FG000|Overall Study|Death|0
7372705|NCT01106352|11624052|FG001|Overall Study|Death|0
7372706|NCT01106352|11624053|FG002|Overall Study|Death|1
7372707|NCT01106352|11624054|FG003|Overall Study|Death|3
7372708|NCT01106352|11624055|FG004|Overall Study|Death|1
7372709|NCT01106352|11624051|FG000|Overall Study|Disease progression|0
7372710|NCT01106352|11624052|FG001|Overall Study|Disease progression|0
7372711|NCT01106352|11624053|FG002|Overall Study|Disease progression|0
7372712|NCT01106352|11624054|FG003|Overall Study|Disease progression|1
7372713|NCT01106352|11624055|FG004|Overall Study|Disease progression|0
7372714|NCT01106352|11624051|FG000|Overall Study|Withdrawal by Subject|0
7372715|NCT01106352|11624052|FG001|Overall Study|Withdrawal by Subject|0
7372716|NCT01106352|11624053|FG002|Overall Study|Withdrawal by Subject|0
7372717|NCT01106352|11624054|FG003|Overall Study|Withdrawal by Subject|3
7372718|NCT01106352|11624055|FG004|Overall Study|Withdrawal by Subject|2
7372719|NCT01106352|11624051|FG000|Overall Study|Went on hospice|0
7372720|NCT01106352|11624052|FG001|Overall Study|Went on hospice|0
7372721|NCT01106352|11624053|FG002|Overall Study|Went on hospice|0
7372722|NCT01106352|11624054|FG003|Overall Study|Went on hospice|1
7372723|NCT01106352|11624055|FG004|Overall Study|Went on hospice|0
7372724|NCT01106352|11624051|FG000|Overall Study|Subject entered hospice|0
7372725|NCT01106352|11624052|FG001|Overall Study|Subject entered hospice|0
7372726|NCT01106352|11624053|FG002|Overall Study|Subject entered hospice|0
7372727|NCT01106352|11624054|FG003|Overall Study|Subject entered hospice|1
7372728|NCT01106352|11624055|FG004|Overall Study|Subject entered hospice|0
7372729|NCT01106352|11624051|FG000|Overall Study|Home hospice since July 2013|0
7372730|NCT01106352|11624052|FG001|Overall Study|Home hospice since July 2013|0
7372731|NCT01106352|11624053|FG002|Overall Study|Home hospice since July 2013|0
7372732|NCT01106352|11624054|FG003|Overall Study|Home hospice since July 2013|1
7372733|NCT01106352|11624055|FG004|Overall Study|Home hospice since July 2013|0
7372734|NCT01106404|11624077|FG000|Period I (First 6 Weeks)|Adverse Event|2
7372735|NCT01106404|11624078|FG001|Period I (First 6 Weeks)|Adverse Event|0
7372736|NCT01106404|11624077|FG000|Period I (First 6 Weeks)|Physician Decision|1
7372737|NCT01106404|11624078|FG001|Period I (First 6 Weeks)|Physician Decision|0
7372738|NCT01106404|11624077|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
7372739|NCT01106404|11624078|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
7372740|NCT01106404|11624077|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
7372741|NCT01106404|11624078|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
7372742|NCT01106430|11624092|FG000|Overall Study|Adverse Event|8
7372743|NCT01106430|11624093|FG001|Overall Study|Adverse Event|10
7372744|NCT01106430|11624092|FG000|Overall Study|Lack of Efficacy|2
7372745|NCT01106430|11624093|FG001|Overall Study|Lack of Efficacy|13
7372746|NCT01106430|11624092|FG000|Overall Study|Lost to Follow-up|5
7372747|NCT01106430|11624093|FG001|Overall Study|Lost to Follow-up|1
7372748|NCT01106430|11624092|FG000|Overall Study|Early Termination Requested By Sponsor|1
7372749|NCT01106430|11624093|FG001|Overall Study|Early Termination Requested By Sponsor|0
7372750|NCT01106430|11624092|FG000|Overall Study|Moved Out Of State|0
7372751|NCT01106430|11624093|FG001|Overall Study|Moved Out Of State|1
7372752|NCT01106430|11624092|FG000|Overall Study|Refused To Take Medication|0
7372753|NCT01106430|11624093|FG001|Overall Study|Refused To Take Medication|1
7372754|NCT01106430|11624092|FG000|Overall Study|Noncompliance|0
7372755|NCT01106430|11624093|FG001|Overall Study|Noncompliance|1
7372756|NCT01106430|11624092|FG000|Overall Study|Hard Time Swallowing The Pills|1
7372757|NCT01106430|11624093|FG001|Overall Study|Hard Time Swallowing The Pills|0
7372758|NCT01106430|11624092|FG000|Overall Study|Previous Use Of Marijuana|1
7372759|NCT01106430|11624093|FG001|Overall Study|Previous Use Of Marijuana|0
7372760|NCT01106430|11624092|FG000|Overall Study|Protocol Violation|7
7372761|NCT01106430|11624093|FG001|Overall Study|Protocol Violation|2
7372762|NCT01106430|11624092|FG000|Overall Study|Withdrawal by Subject|8
7372763|NCT01106430|11624093|FG001|Overall Study|Withdrawal by Subject|4
7372764|NCT01106586|11624110|FG000|Overall Study|Adverse Event|9
7372765|NCT01106586|11624111|FG001|Overall Study|Adverse Event|15
7372766|NCT01106586|11624110|FG000|Overall Study|Death|1
7372767|NCT01106586|11624111|FG001|Overall Study|Death|3
7372768|NCT01106586|11624110|FG000|Overall Study|Pregnancy|2
7372769|NCT01106586|11624111|FG001|Overall Study|Pregnancy|2
7372770|NCT01106586|11624110|FG000|Overall Study|Lack of Efficacy|1
7372771|NCT01106586|11624111|FG001|Overall Study|Lack of Efficacy|0
7372772|NCT01106586|11624110|FG000|Overall Study|Investigator's Discretion|5
7372773|NCT01106586|11624111|FG001|Overall Study|Investigator's Discretion|8
7372774|NCT01106586|11624110|FG000|Overall Study|Withdrew Consent|18
7372775|NCT01106586|11624111|FG001|Overall Study|Withdrew Consent|30
7372776|NCT01106586|11624110|FG000|Overall Study|Lost to Follow-up|24
7372777|NCT01106586|11624111|FG001|Overall Study|Lost to Follow-up|20
7372778|NCT01106586|11624110|FG000|Overall Study|Participant Noncompliance|12
7372779|NCT01106586|11624111|FG001|Overall Study|Participant Noncompliance|10
7372780|NCT01106586|11624110|FG000|Overall Study|Protocol Violation|1
7372781|NCT01106586|11624111|FG001|Overall Study|Protocol Violation|0
7372782|NCT01106586|11624110|FG000|Overall Study|Participant Transferred to Another Study|212
7372783|NCT01106586|11624111|FG001|Overall Study|Participant Transferred to Another Study|197
7372784|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Adverse Event|6
7372785|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Adverse Event|8
7372786|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Adverse Event|8
7372787|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
7372788|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
7372789|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
7372790|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Physician Decision|1
7372791|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Physician Decision|0
7372792|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Physician Decision|0
7372793|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
7372794|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
7372795|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
7372796|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7372797|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
7372798|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
7372799|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
7372800|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7372801|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7372802|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
7372803|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7372804|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
7372805|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7372806|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7372807|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7372808|NCT01106625|11624120|FG000|Core Period: Baseline to Week 26|Other|8
7372809|NCT01106625|11624121|FG001|Core Period: Baseline to Week 26|Other|7
7372810|NCT01106625|11624122|FG002|Core Period: Baseline to Week 26|Other|4
7372811|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
7372812|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
7372813|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
7372814|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7372815|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
7372816|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7372817|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
7372818|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
7372819|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
7372820|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
7372821|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
7372822|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7372823|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
7372824|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7372825|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7372826|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
7372827|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
7372828|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
7372829|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7372830|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
7372831|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7372832|NCT01106625|11624120|FG000|Extension Period: Week 26 to Week 52|Other|5
7372833|NCT01106625|11624121|FG001|Extension Period: Week 26 to Week 52|Other|5
7372834|NCT01106625|11624122|FG002|Extension Period: Week 26 to Week 52|Other|4
7372835|NCT01106651|11624136|FG000|Overall Study|Adverse Event|17
7372836|NCT01106651|11624137|FG001|Overall Study|Adverse Event|9
7372837|NCT01106651|11624138|FG002|Overall Study|Adverse Event|23
7372838|NCT01106651|11624136|FG000|Overall Study|Lost to Follow-up|8
7372839|NCT01106651|11624137|FG001|Overall Study|Lost to Follow-up|2
7570557|NCT03495102|11948394|FG001|Overall Study|Relocated to Another Country|1
7570558|NCT03495102|11948395|FG002|Overall Study|Relocated to Another Country|0
7570559|NCT03495102|11948393|FG000|Overall Study|Participant was in Rehabilitation|1
7570560|NCT03495102|11948394|FG001|Overall Study|Participant was in Rehabilitation|0
7570561|NCT03495102|11948395|FG002|Overall Study|Participant was in Rehabilitation|0
7570562|NCT03495817|11948412|FG000|26 Week Open Label|Adverse Event|3
7570563|NCT03495817|11948412|FG000|26 Week Open Label|Withdrawal by Subject|4
7570564|NCT03495817|11948412|FG000|26 Week Open Label|Lost to Follow-up|1
7570565|NCT03495817|11948412|FG000|26 Week Extension|Lost to Follow-up|2
7570566|NCT03495869|11948424|FG000|Overall Study|Lost to Follow-up|4
7570567|NCT03495869|11948425|FG001|Overall Study|Lost to Follow-up|17
7570568|NCT03495869|11948426|FG002|Overall Study|Lost to Follow-up|8
7372840|NCT01106651|11624138|FG002|Overall Study|Lost to Follow-up|6
7372841|NCT01106651|11624136|FG000|Overall Study|Physician Decision|4
7570569|NCT03495869|11948427|FG003|Overall Study|Lost to Follow-up|14
7570570|NCT03495869|11948424|FG000|Overall Study|Withdrawal by Subject|0
7570571|NCT03495869|11948425|FG001|Overall Study|Withdrawal by Subject|3
7372842|NCT01106651|11624137|FG001|Overall Study|Physician Decision|3
7372843|NCT01106651|11624138|FG002|Overall Study|Physician Decision|1
7372844|NCT01106651|11624136|FG000|Overall Study|Protocol Violation|1
7372845|NCT01106651|11624137|FG001|Overall Study|Protocol Violation|2
7372846|NCT01106651|11624138|FG002|Overall Study|Protocol Violation|1
7372847|NCT01106651|11624136|FG000|Overall Study|Withdrawal by Subject|14
7372848|NCT01106651|11624137|FG001|Overall Study|Withdrawal by Subject|7
7372849|NCT01106651|11624138|FG002|Overall Study|Withdrawal by Subject|4
7372850|NCT01106651|11624136|FG000|Overall Study|Noncompliance with study drug|1
7372851|NCT01106651|11624137|FG001|Overall Study|Noncompliance with study drug|0
7372852|NCT01106651|11624138|FG002|Overall Study|Noncompliance with study drug|2
7372853|NCT01106651|11624136|FG000|Overall Study|Other|34
7372854|NCT01106651|11624137|FG001|Overall Study|Other|31
7372855|NCT01106651|11624138|FG002|Overall Study|Other|21
7372856|NCT01106651|11624136|FG000|Overall Study|Death|0
7372857|NCT01106651|11624137|FG001|Overall Study|Death|3
7372858|NCT01106651|11624138|FG002|Overall Study|Death|0
7372859|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Adverse Event|7
7372860|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Adverse Event|18
7372861|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Adverse Event|6
7372862|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Adverse Event|8
7372863|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Death|0
7372864|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Death|0
7372865|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Death|1
7372866|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Death|0
7372867|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
7372868|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
7372869|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
7372870|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
7372871|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
7372872|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
7372873|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
7372874|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
7372875|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Physician Decision|2
7372876|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Physician Decision|1
7372877|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Physician Decision|3
7372878|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Physician Decision|1
7372879|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
7372880|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
7372881|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7372882|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
7372883|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
7372884|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
7372885|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
7372886|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
7372887|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7372888|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7372889|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
7372890|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7372891|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7372892|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
7372893|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7372894|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7372895|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7372896|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
7372897|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
7372898|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
7372899|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
7372900|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
7372901|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
7570575|NCT03495869|11948425|FG001|Overall Study|Dropped from study|7
7372902|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
7372903|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Other|8
7372904|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Other|14
7372905|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Other|8
7372906|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Other|23
7372907|NCT01106677|11624153|FG000|Core Period: Baseline to Week 26|Pregnancy|0
7372908|NCT01106677|11624154|FG001|Core Period: Baseline to Week 26|Pregnancy|1
7372909|NCT01106677|11624155|FG002|Core Period: Baseline to Week 26|Pregnancy|0
7372910|NCT01106677|11624156|FG003|Core Period: Baseline to Week 26|Pregnancy|0
7372911|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7372912|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7372913|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
7372914|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
7372915|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Death|0
7372916|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Death|0
7372917|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Death|0
7372918|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Death|1
7372919|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
7372920|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7372921|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
7372922|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
7372923|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7372924|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7372925|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7372926|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
7372927|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
7372928|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
7372929|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
7372930|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
7372931|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
7372932|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
7372933|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
7372934|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
7372935|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7372936|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
7372937|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
7372938|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7372939|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7372940|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
7372941|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
7372942|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
7372943|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7372944|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7372945|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7372946|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7372947|NCT01106677|11624153|FG000|Extension Period: Week 26 to Week 52|Other|6
7372948|NCT01106677|11624154|FG001|Extension Period: Week 26 to Week 52|Other|5
7372949|NCT01106677|11624155|FG002|Extension Period: Week 26 to Week 52|Other|8
7372950|NCT01106677|11624156|FG003|Extension Period: Week 26 to Week 52|Other|5
7372951|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Adverse Event|6
7372952|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Adverse Event|1
7372953|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Adverse Event|4
7372954|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
7372955|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
7372956|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
7372957|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
7372958|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
7372959|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
7372960|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
7372961|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
7372962|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
7372963|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
7372964|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
7372965|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
7372966|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7372967|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
7372968|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
7570572|NCT03495869|11948426|FG002|Overall Study|Withdrawal by Subject|0
7570573|NCT03495869|11948427|FG003|Overall Study|Withdrawal by Subject|3
7570574|NCT03495869|11948424|FG000|Overall Study|Dropped from study|0
7372969|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
7372970|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7372971|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
7372972|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
7372973|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7372974|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
7372975|NCT01106690|11624176|FG000|Core Period: Baseline to Week 26|Other|10
7372976|NCT01106690|11624177|FG001|Core Period: Baseline to Week 26|Other|2
7372977|NCT01106690|11624178|FG002|Core Period: Baseline to Week 26|Other|6
7372978|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
7372979|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
7372980|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
7372981|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
7372982|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7372983|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
7372984|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
7372985|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
7372986|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
7372987|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7570576|NCT03495869|11948426|FG002|Overall Study|Dropped from study|2
7570577|NCT03495869|11948427|FG003|Overall Study|Dropped from study|4
7570578|NCT03495908|11948439|FG000|Overall Study|Withdrawal by Subject|3
7372988|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
7372989|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
7372990|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7372991|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
7372992|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
7372993|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Other|8
7372994|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Other|3
7372995|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Other|4
7372996|NCT01106690|11624176|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
7372997|NCT01106690|11624177|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7372998|NCT01106690|11624178|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
7372999|NCT01106846|11624200|FG000|Overall Study|Change in surgical procedure|0
7373000|NCT01106846|11624201|FG001|Overall Study|Change in surgical procedure|1
7373001|NCT01106898|11624218|FG000|Overall Study|Adverse Event|6
7373002|NCT01106911|11624222|FG000|Overall Study|Physician Decision|2
7373003|NCT01106911|11624222|FG000|Overall Study|deemed ineligible after screening|3
7373004|NCT01106976|11624232|FG000|Overall Study|Lost to Follow-up|8
7373005|NCT01107197|11624255|FG000|Overall Study|Death|12
7373006|NCT01107197|11624256|FG001|Overall Study|Death|10
7373007|NCT01107197|11624255|FG000|Overall Study|Lost to Follow-up|5
7373008|NCT01107197|11624256|FG001|Overall Study|Lost to Follow-up|8
7373009|NCT01107197|11624255|FG000|Overall Study|Withdrawal by Subject|3
7373010|NCT01107197|11624256|FG001|Overall Study|Withdrawal by Subject|5
7373011|NCT01107353|11624264|FG000|Overall Study|Positive Drug Screen|1
7373012|NCT01107353|11624265|FG001|Overall Study|Positive Drug Screen|0
7373013|NCT01107379|11624271|FG000|Overall Study|Withdrawal by Subject|18
7373014|NCT01107379|11624271|FG000|Overall Study|Lost to Follow-up|3
7373015|NCT01107392|11624277|FG000|Overall Study|Adverse Event|2
7373016|NCT01107392|11624278|FG001|Overall Study|Adverse Event|0
7373017|NCT01107392|11624277|FG000|Overall Study|Personal Reasons|2
7373018|NCT01107392|11624278|FG001|Overall Study|Personal Reasons|3
7373019|NCT01107392|11624277|FG000|Overall Study|Administrative decision|1
7373020|NCT01107392|11624278|FG001|Overall Study|Administrative decision|0
7373021|NCT01107405|11624289|FG000|Overall Study|Adverse Event|1
7373022|NCT01107405|11624290|FG001|Overall Study|Adverse Event|1
7373023|NCT01107405|11624291|FG002|Overall Study|Adverse Event|0
7373024|NCT01107405|11624292|FG003|Overall Study|Adverse Event|0
7373025|NCT01107405|11624293|FG004|Overall Study|Adverse Event|2
7373026|NCT01107405|11624289|FG000|Overall Study|Withdrawal by Subject|1
7373027|NCT01107405|11624290|FG001|Overall Study|Withdrawal by Subject|0
7373028|NCT01107405|11624291|FG002|Overall Study|Withdrawal by Subject|1
7373029|NCT01107405|11624292|FG003|Overall Study|Withdrawal by Subject|2
7373030|NCT01107405|11624293|FG004|Overall Study|Withdrawal by Subject|1
7373031|NCT01107405|11624289|FG000|Overall Study|Protocol Violation|0
7373032|NCT01107405|11624290|FG001|Overall Study|Protocol Violation|0
7373033|NCT01107405|11624291|FG002|Overall Study|Protocol Violation|1
7373034|NCT01107405|11624292|FG003|Overall Study|Protocol Violation|1
7373035|NCT01107405|11624293|FG004|Overall Study|Protocol Violation|0
7373036|NCT01107418|11624309|FG000|Overall Study|Disease Progression|45
7373037|NCT01107418|11624309|FG000|Overall Study|Adverse Event|3
7373038|NCT01107418|11624309|FG000|Overall Study|Withdrawal by Subject|1
7373039|NCT01107418|11624309|FG000|Overall Study|Study Closing|1
7373040|NCT01107418|11624309|FG000|Overall Study|Started Other Therapy|1
7373041|NCT01107418|11624309|FG000|Overall Study|Entered Extension Study|1
7373042|NCT01107444|11624326|FG000|Overall Study|Withdrawal by Subject|8
7373043|NCT01107444|11624327|FG001|Overall Study|Withdrawal by Subject|12
7373044|NCT01107444|11624326|FG000|Overall Study|Protocol Entry Criteria Not Met|0
7373045|NCT01107444|11624327|FG001|Overall Study|Protocol Entry Criteria Not Met|1
7373046|NCT01107457|11624341|FG000|Part A|Adverse Event|1
7570579|NCT03495908|11948440|FG001|Overall Study|Withdrawal by Subject|1
7373047|NCT01107457|11624342|FG001|Part A|Adverse Event|2
7373048|NCT01107457|11624343|FG002|Part A|Adverse Event|1
7373049|NCT01107457|11624344|FG003|Part A|Adverse Event|0
7373050|NCT01107457|11624345|FG004|Part A|Adverse Event|0
7373051|NCT01107457|11624346|FG005|Part A|Adverse Event|0
7373052|NCT01107457|11624341|FG000|Part A|Withdrawal by Subject|3
7373053|NCT01107457|11624342|FG001|Part A|Withdrawal by Subject|3
7570580|NCT03495908|11948439|FG000|Overall Study|Lost to Follow-up|1
7373054|NCT01107457|11624343|FG002|Part A|Withdrawal by Subject|0
7373055|NCT01107457|11624344|FG003|Part A|Withdrawal by Subject|3
7373056|NCT01107457|11624345|FG004|Part A|Withdrawal by Subject|1
7373057|NCT01107457|11624346|FG005|Part A|Withdrawal by Subject|0
7373058|NCT01107457|11624341|FG000|Part A|Lost to Follow-up|0
7373059|NCT01107457|11624342|FG001|Part A|Lost to Follow-up|1
7373060|NCT01107457|11624343|FG002|Part A|Lost to Follow-up|0
7373061|NCT01107457|11624344|FG003|Part A|Lost to Follow-up|0
7373062|NCT01107457|11624345|FG004|Part A|Lost to Follow-up|0
7373063|NCT01107457|11624346|FG005|Part A|Lost to Follow-up|0
7373064|NCT01107457|11624341|FG000|Part A|Lack of Efficacy|1
7373065|NCT01107457|11624342|FG001|Part A|Lack of Efficacy|0
7373066|NCT01107457|11624343|FG002|Part A|Lack of Efficacy|0
7373067|NCT01107457|11624344|FG003|Part A|Lack of Efficacy|0
7373068|NCT01107457|11624345|FG004|Part A|Lack of Efficacy|0
7373069|NCT01107457|11624346|FG005|Part A|Lack of Efficacy|0
7373070|NCT01107457|11624341|FG000|Part A|Protocol Violation|0
7373071|NCT01107457|11624342|FG001|Part A|Protocol Violation|1
7373072|NCT01107457|11624343|FG002|Part A|Protocol Violation|0
7373073|NCT01107457|11624344|FG003|Part A|Protocol Violation|0
7373074|NCT01107457|11624345|FG004|Part A|Protocol Violation|0
7373075|NCT01107457|11624346|FG005|Part A|Protocol Violation|0
7373076|NCT01107457|11624341|FG000|Part B and C|Adverse Event|0
7373077|NCT01107457|11624342|FG001|Part B and C|Adverse Event|0
7373078|NCT01107457|11624343|FG002|Part B and C|Adverse Event|0
7373079|NCT01107457|11624344|FG003|Part B and C|Adverse Event|0
7373080|NCT01107457|11624345|FG004|Part B and C|Adverse Event|0
7373081|NCT01107457|11624346|FG005|Part B and C|Adverse Event|12
7373082|NCT01107457|11624341|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7373083|NCT01107457|11624342|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7373084|NCT01107457|11624343|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7373085|NCT01107457|11624344|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7373086|NCT01107457|11624345|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
7373087|NCT01107457|11624346|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
7373088|NCT01107457|11624341|FG000|Part B and C|Physician Decision|0
7373089|NCT01107457|11624342|FG001|Part B and C|Physician Decision|0
7373090|NCT01107457|11624343|FG002|Part B and C|Physician Decision|0
7373091|NCT01107457|11624344|FG003|Part B and C|Physician Decision|0
7373092|NCT01107457|11624345|FG004|Part B and C|Physician Decision|0
7373093|NCT01107457|11624346|FG005|Part B and C|Physician Decision|3
7373094|NCT01107457|11624341|FG000|Part B and C|Lack of Efficacy|0
7373095|NCT01107457|11624342|FG001|Part B and C|Lack of Efficacy|0
7373096|NCT01107457|11624343|FG002|Part B and C|Lack of Efficacy|0
7373097|NCT01107457|11624344|FG003|Part B and C|Lack of Efficacy|0
7373098|NCT01107457|11624345|FG004|Part B and C|Lack of Efficacy|0
7373099|NCT01107457|11624346|FG005|Part B and C|Lack of Efficacy|7
7373100|NCT01107457|11624341|FG000|Part B and C|Lost to Follow-up|0
7373101|NCT01107457|11624342|FG001|Part B and C|Lost to Follow-up|0
7373102|NCT01107457|11624343|FG002|Part B and C|Lost to Follow-up|0
7373103|NCT01107457|11624344|FG003|Part B and C|Lost to Follow-up|0
7373104|NCT01107457|11624345|FG004|Part B and C|Lost to Follow-up|0
7373105|NCT01107457|11624346|FG005|Part B and C|Lost to Follow-up|10
7373106|NCT01107457|11624341|FG000|Part B and C|Protocol Violation|0
7373107|NCT01107457|11624342|FG001|Part B and C|Protocol Violation|0
7373108|NCT01107457|11624343|FG002|Part B and C|Protocol Violation|0
7373109|NCT01107457|11624344|FG003|Part B and C|Protocol Violation|0
7373110|NCT01107457|11624345|FG004|Part B and C|Protocol Violation|0
7373111|NCT01107457|11624346|FG005|Part B and C|Protocol Violation|1
7373112|NCT01107457|11624341|FG000|Part B and C|Sponsor Decision|0
7373113|NCT01107457|11624342|FG001|Part B and C|Sponsor Decision|0
7373114|NCT01107457|11624343|FG002|Part B and C|Sponsor Decision|0
7373115|NCT01107457|11624344|FG003|Part B and C|Sponsor Decision|0
7373116|NCT01107457|11624345|FG004|Part B and C|Sponsor Decision|0
7373117|NCT01107457|11624346|FG005|Part B and C|Sponsor Decision|66
7373118|NCT01107457|11624341|FG000|Part B and C|Withdrawal by Subject|0
7373119|NCT01107457|11624342|FG001|Part B and C|Withdrawal by Subject|0
7373120|NCT01107457|11624343|FG002|Part B and C|Withdrawal by Subject|0
7373121|NCT01107457|11624344|FG003|Part B and C|Withdrawal by Subject|0
7373122|NCT01107457|11624345|FG004|Part B and C|Withdrawal by Subject|0
7373123|NCT01107457|11624346|FG005|Part B and C|Withdrawal by Subject|16
7373124|NCT01107457|11624341|FG000|Part B and C|Clinical Relapse|0
7373125|NCT01107457|11624342|FG001|Part B and C|Clinical Relapse|0
7373126|NCT01107457|11624343|FG002|Part B and C|Clinical Relapse|0
7373127|NCT01107457|11624344|FG003|Part B and C|Clinical Relapse|0
7373128|NCT01107457|11624345|FG004|Part B and C|Clinical Relapse|0
7373129|NCT01107457|11624346|FG005|Part B and C|Clinical Relapse|4
7373130|NCT01107535|11624364|FG000|Overall Study|Death|5
7373131|NCT01107743|11624387|FG000|Overall Study|Protocol Violation|46
7373132|NCT01107886|11624447|FG000|Overall Study|Lost to Follow-up|15
7373133|NCT01107886|11624448|FG001|Overall Study|Lost to Follow-up|13
7373134|NCT01107886|11624447|FG000|Overall Study|Withdrawal by Subject|180
7373135|NCT01107886|11624448|FG001|Overall Study|Withdrawal by Subject|196
7373136|NCT01107886|11624447|FG000|Overall Study|Administrative withdrawal of consent|7
7373137|NCT01107886|11624448|FG001|Overall Study|Administrative withdrawal of consent|5
7373138|NCT01107899|11624457|FG000|Overall Study|Physician Decision|5
7373139|NCT01107899|11624458|FG001|Overall Study|Physician Decision|0
7373140|NCT01107899|11624459|FG002|Overall Study|Physician Decision|3
7373141|NCT01107899|11624457|FG000|Overall Study|Withdrawal by Subject|0
7373142|NCT01107899|11624458|FG001|Overall Study|Withdrawal by Subject|0
7373143|NCT01107899|11624459|FG002|Overall Study|Withdrawal by Subject|1
7373144|NCT01107912|11624474|FG000|Period 1|Adverse Event|0
7373145|NCT01107912|11624475|FG001|Period 1|Adverse Event|0
7373146|NCT01107912|11624476|FG002|Period 1|Adverse Event|0
7373147|NCT01107912|11624477|FG003|Period 1|Adverse Event|0
7373148|NCT01107912|11624478|FG004|Period 1|Adverse Event|2
7373149|NCT01107912|11624479|FG005|Period 1|Adverse Event|0
7373150|NCT01107912|11624474|FG000|Period 1|Physician Decision|0
7373151|NCT01107912|11624475|FG001|Period 1|Physician Decision|0
7373152|NCT01107912|11624476|FG002|Period 1|Physician Decision|0
7373153|NCT01107912|11624477|FG003|Period 1|Physician Decision|0
7373154|NCT01107912|11624478|FG004|Period 1|Physician Decision|1
7373155|NCT01107912|11624479|FG005|Period 1|Physician Decision|0
7373156|NCT01107912|11624474|FG000|Period 1|Withdrawal by Subject|1
7373157|NCT01107912|11624475|FG001|Period 1|Withdrawal by Subject|0
7373158|NCT01107912|11624476|FG002|Period 1|Withdrawal by Subject|0
7373159|NCT01107912|11624477|FG003|Period 1|Withdrawal by Subject|0
7373160|NCT01107912|11624478|FG004|Period 1|Withdrawal by Subject|0
7373161|NCT01107912|11624479|FG005|Period 1|Withdrawal by Subject|0
7373162|NCT01107912|11624474|FG000|Period 2|Physician Decision|0
7373163|NCT01107912|11624475|FG001|Period 2|Physician Decision|0
7373164|NCT01107912|11624476|FG002|Period 2|Physician Decision|1
7373165|NCT01107912|11624477|FG003|Period 2|Physician Decision|0
7373166|NCT01107912|11624478|FG004|Period 2|Physician Decision|0
7373167|NCT01107912|11624479|FG005|Period 2|Physician Decision|0
7373168|NCT01107912|11624474|FG000|Period 3|Adverse Event|0
7373169|NCT01107912|11624475|FG001|Period 3|Adverse Event|1
7373170|NCT01107912|11624476|FG002|Period 3|Adverse Event|1
7373171|NCT01107912|11624477|FG003|Period 3|Adverse Event|0
7373172|NCT01107912|11624478|FG004|Period 3|Adverse Event|0
7373173|NCT01107912|11624479|FG005|Period 3|Adverse Event|0
7373174|NCT01107912|11624474|FG000|Period 3|Withdrawal by Subject|0
7373175|NCT01107912|11624475|FG001|Period 3|Withdrawal by Subject|0
7373176|NCT01107912|11624476|FG002|Period 3|Withdrawal by Subject|0
7373177|NCT01107912|11624477|FG003|Period 3|Withdrawal by Subject|1
7373178|NCT01107912|11624478|FG004|Period 3|Withdrawal by Subject|0
7373179|NCT01107912|11624479|FG005|Period 3|Withdrawal by Subject|0
7373180|NCT01107925|11624498|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7373181|NCT01107925|11624499|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7373182|NCT01107925|11624500|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7373183|NCT01107925|11624501|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7373184|NCT01107925|11624502|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
7373185|NCT01107925|11624503|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
7373186|NCT01107925|11624498|FG000|Period 2|Withdrawal by Subject|0
7373187|NCT01107925|11624499|FG001|Period 2|Withdrawal by Subject|1
7373188|NCT01107925|11624500|FG002|Period 2|Withdrawal by Subject|0
7373189|NCT01107925|11624501|FG003|Period 2|Withdrawal by Subject|0
7373190|NCT01107925|11624502|FG004|Period 2|Withdrawal by Subject|0
7373191|NCT01107925|11624503|FG005|Period 2|Withdrawal by Subject|1
7373192|NCT01108068|11624551|FG000|Overall Study|5 not started, 1 stop due to side effect|6
7373193|NCT01108068|11624552|FG001|Overall Study|5 not started, 1 stop due to side effect|0
7373194|NCT01108094|11624580|FG000|Overall Study|Adverse Event|2
7373195|NCT01108094|11624581|FG001|Overall Study|Adverse Event|0
7373196|NCT01108094|11624582|FG002|Overall Study|Adverse Event|0
7373197|NCT01108094|11624583|FG003|Overall Study|Adverse Event|0
7373198|NCT01108094|11624580|FG000|Overall Study|Withdrawal by Subject|1
7373199|NCT01108094|11624581|FG001|Overall Study|Withdrawal by Subject|0
7373200|NCT01108094|11624582|FG002|Overall Study|Withdrawal by Subject|0
7373201|NCT01108094|11624583|FG003|Overall Study|Withdrawal by Subject|0
7373202|NCT01108185|11624596|FG000|Overall Study|Non-compliance|15
7373203|NCT01108185|11624596|FG000|Overall Study|Lost to Follow-up|12
7373204|NCT01108237|11624602|FG000|Overall Study|No alignment data|2
7373205|NCT01108237|11624603|FG001|Overall Study|No alignment data|17
7373206|NCT01108237|11624602|FG000|Overall Study|Did not meet criteria for analysis|7
7373207|NCT01108237|11624603|FG001|Overall Study|Did not meet criteria for analysis|0
7373208|NCT01108263|11624611|FG000|Overall Study|Adverse Event|0
7373209|NCT01108263|11624612|FG001|Overall Study|Adverse Event|1
7373210|NCT01108341|11624618|FG000|Overall Study|Death|2
7373211|NCT01108341|11624618|FG000|Overall Study|Withdrawal by Subject|1
7373212|NCT01108341|11624618|FG000|Overall Study|Lost to Follow-up|1
7373213|NCT01108341|11624618|FG000|Overall Study|Other|1
7373214|NCT01108458|11624637|FG000|Overall Study|Withdrawal by Subject|1
7373215|NCT01108510|11624643|FG000|Overall Study|Randomized but Not Treated|5
7373216|NCT01108510|11624644|FG001|Overall Study|Randomized but Not Treated|1
7373217|NCT01108510|11624643|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
7373218|NCT01108510|11624644|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
7373219|NCT01108510|11624643|FG000|Overall Study|Adverse Event|26
7373220|NCT01108510|11624644|FG001|Overall Study|Adverse Event|19
7373221|NCT01108510|11624643|FG000|Overall Study|Lost to Follow-up|20
7373222|NCT01108510|11624644|FG001|Overall Study|Lost to Follow-up|17
7373223|NCT01108510|11624643|FG000|Overall Study|Withdrew Consent|21
7373224|NCT01108510|11624644|FG001|Overall Study|Withdrew Consent|15
7373225|NCT01108510|11624643|FG000|Overall Study|Investigator's Discretion|12
7373226|NCT01108510|11624644|FG001|Overall Study|Investigator's Discretion|10
7373227|NCT01108510|11624643|FG000|Overall Study|Participant Noncompliance|5
7373228|NCT01108510|11624644|FG001|Overall Study|Participant Noncompliance|7
7373229|NCT01108510|11624643|FG000|Overall Study|Lack of Efficacy|3
7373230|NCT01108510|11624644|FG001|Overall Study|Lack of Efficacy|0
7373231|NCT01108510|11624643|FG000|Overall Study|Pregnancy|0
7373232|NCT01108510|11624644|FG001|Overall Study|Pregnancy|3
7373233|NCT01108510|11624643|FG000|Overall Study|Death|1
7373234|NCT01108510|11624644|FG001|Overall Study|Death|1
7373235|NCT01108718|11624652|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
7373236|NCT01108718|11624653|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
7373237|NCT01108731|11624660|FG000|Overall Study|Withdrawal by Subject|1
7373238|NCT01108731|11624661|FG001|Overall Study|Withdrawal by Subject|1
7373239|NCT01108731|11624660|FG000|Overall Study|Adverse Event|3
7373240|NCT01108731|11624661|FG001|Overall Study|Adverse Event|3
7373241|NCT01108796|11624680|FG000|Overall Study|Adverse Event|0
7373242|NCT01108796|11624681|FG001|Overall Study|Adverse Event|1
7373243|NCT01108796|11624680|FG000|Overall Study|Lost to Follow-up|7
7373244|NCT01108796|11624681|FG001|Overall Study|Lost to Follow-up|6
7373245|NCT01108809|11624689|FG000|Overall Study|Adverse Event|3
7373246|NCT01108809|11624689|FG000|Overall Study|Lost to Follow-up|1
7373247|NCT01109173|11624744|FG000|Overall Study|Adverse Event|15
7373248|NCT01109173|11624745|FG001|Overall Study|Adverse Event|17
7373249|NCT01109173|11624746|FG002|Overall Study|Adverse Event|9
7373250|NCT01109173|11624747|FG003|Overall Study|Adverse Event|6
7373251|NCT01109173|11624744|FG000|Overall Study|Lost to Follow-up|0
7373252|NCT01109173|11624745|FG001|Overall Study|Lost to Follow-up|1
7373253|NCT01109173|11624746|FG002|Overall Study|Lost to Follow-up|0
7373254|NCT01109173|11624747|FG003|Overall Study|Lost to Follow-up|0
7373255|NCT01109173|11624744|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
7373256|NCT01109173|11624745|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7373257|NCT01109173|11624746|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
7373258|NCT01109173|11624747|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
7373259|NCT01109173|11624744|FG000|Overall Study|Noncompliance|0
7373260|NCT01109173|11624745|FG001|Overall Study|Noncompliance|1
7373261|NCT01109173|11624746|FG002|Overall Study|Noncompliance|0
7373262|NCT01109173|11624747|FG003|Overall Study|Noncompliance|0
7373263|NCT01109173|11624744|FG000|Overall Study|Treatment Failure|25
7373264|NCT01109173|11624745|FG001|Overall Study|Treatment Failure|32
7373265|NCT01109173|11624746|FG002|Overall Study|Treatment Failure|69
7373266|NCT01109173|11624747|FG003|Overall Study|Treatment Failure|64
7373267|NCT01109173|11624744|FG000|Overall Study|Protocol Violation|4
7461376|NCT01837797|11757555|FG003|Period 1|Withdrawal by Subject|0
7461377|NCT01837797|11757556|FG004|Period 1|Withdrawal by Subject|0
7461378|NCT01837797|11757552|FG000|Period 1|Administrative reasons|76
7461379|NCT01837797|11757553|FG001|Period 1|Administrative reasons|0
7461380|NCT01837797|11757554|FG002|Period 1|Administrative reasons|0
7461381|NCT01837797|11757555|FG003|Period 1|Administrative reasons|0
7461382|NCT01837797|11757556|FG004|Period 1|Administrative reasons|0
7461383|NCT01837797|11757552|FG000|Period 1|Withdrawal of consent before treatment|1
7461384|NCT01837797|11757553|FG001|Period 1|Withdrawal of consent before treatment|0
7461385|NCT01837797|11757554|FG002|Period 1|Withdrawal of consent before treatment|0
7461386|NCT01837797|11757555|FG003|Period 1|Withdrawal of consent before treatment|0
7461387|NCT01837797|11757556|FG004|Period 1|Withdrawal of consent before treatment|0
7461388|NCT01837797|11757552|FG000|Period 1|Other|10
7461389|NCT01837797|11757553|FG001|Period 1|Other|0
7461390|NCT01837797|11757554|FG002|Period 1|Other|0
7461391|NCT01837797|11757555|FG003|Period 1|Other|0
7461392|NCT01837797|11757556|FG004|Period 1|Other|0
7461393|NCT01837797|11757552|FG000|Period 2|Administrative or other reasons|0
7461394|NCT01837797|11757553|FG001|Period 2|Administrative or other reasons|5
7461395|NCT01837797|11757554|FG002|Period 2|Administrative or other reasons|2
7461396|NCT01837797|11757555|FG003|Period 2|Administrative or other reasons|4
7461397|NCT01837797|11757556|FG004|Period 2|Administrative or other reasons|0
7461398|NCT01837797|11757552|FG000|Period 2|Adverse Event|0
7461399|NCT01837797|11757553|FG001|Period 2|Adverse Event|0
7461400|NCT01837797|11757554|FG002|Period 2|Adverse Event|0
7461401|NCT01837797|11757555|FG003|Period 2|Adverse Event|1
7461402|NCT01837797|11757556|FG004|Period 2|Adverse Event|0
7461403|NCT01837797|11757552|FG000|Period 3|Adverse Event|0
7461404|NCT01837797|11757553|FG001|Period 3|Adverse Event|0
7461405|NCT01837797|11757554|FG002|Period 3|Adverse Event|0
7461406|NCT01837797|11757555|FG003|Period 3|Adverse Event|0
7461407|NCT01837797|11757556|FG004|Period 3|Adverse Event|1
7461408|NCT01837797|11757552|FG000|Period 3|Administrative reasons|0
7461409|NCT01837797|11757553|FG001|Period 3|Administrative reasons|0
7461410|NCT01837797|11757554|FG002|Period 3|Administrative reasons|0
7461411|NCT01837797|11757555|FG003|Period 3|Administrative reasons|0
7461412|NCT01837797|11757556|FG004|Period 3|Administrative reasons|20
7461413|NCT01837797|11757552|FG000|Period 3|Other|0
7461414|NCT01837797|11757553|FG001|Period 3|Other|0
7373268|NCT01109173|11624745|FG001|Overall Study|Protocol Violation|5
7373269|NCT01109173|11624746|FG002|Overall Study|Protocol Violation|1
7373270|NCT01109173|11624747|FG003|Overall Study|Protocol Violation|2
7461415|NCT01837797|11757554|FG002|Period 3|Other|0
7461416|NCT01837797|11757555|FG003|Period 3|Other|0
7461417|NCT01837797|11757556|FG004|Period 3|Other|2
7461418|NCT01837823|11757564|FG000|Overall Study|Lost to Follow-up|6
7461419|NCT01837966|11757587|FG000|Overall Study|Withdrawal by Subject|2
7373271|NCT01109173|11624744|FG000|Overall Study|Patient Did Not Use Study Medication|34
7373272|NCT01109173|11624745|FG001|Overall Study|Patient Did Not Use Study Medication|26
7373273|NCT01109173|11624746|FG002|Overall Study|Patient Did Not Use Study Medication|11
7373274|NCT01109173|11624747|FG003|Overall Study|Patient Did Not Use Study Medication|7
7373275|NCT01109173|11624744|FG000|Overall Study|Not Specifiied|5
7373276|NCT01109173|11624745|FG001|Overall Study|Not Specifiied|4
7373277|NCT01109173|11624746|FG002|Overall Study|Not Specifiied|9
7373278|NCT01109173|11624747|FG003|Overall Study|Not Specifiied|14
7373279|NCT01109316|11624763|FG000|Study Period 1|Adverse Event|0
7373280|NCT01109316|11624764|FG001|Study Period 1|Adverse Event|0
7373281|NCT01109316|11624765|FG002|Study Period 1|Adverse Event|1
7373282|NCT01109316|11624766|FG003|Study Period 1|Adverse Event|0
7373283|NCT01109316|11624767|FG004|Study Period 1|Adverse Event|0
7373284|NCT01109316|11624768|FG005|Study Period 1|Adverse Event|0
7373285|NCT01109316|11624763|FG000|Study Period 1|Lost to Follow-up|0
7373286|NCT01109316|11624764|FG001|Study Period 1|Lost to Follow-up|0
7373287|NCT01109316|11624765|FG002|Study Period 1|Lost to Follow-up|1
7373288|NCT01109316|11624766|FG003|Study Period 1|Lost to Follow-up|1
7373289|NCT01109316|11624767|FG004|Study Period 1|Lost to Follow-up|0
7373290|NCT01109316|11624768|FG005|Study Period 1|Lost to Follow-up|0
7373291|NCT01109316|11624763|FG000|Study Period 1|Withdrawal by Subject|0
7373292|NCT01109316|11624764|FG001|Study Period 1|Withdrawal by Subject|0
7373293|NCT01109316|11624765|FG002|Study Period 1|Withdrawal by Subject|1
7373294|NCT01109316|11624766|FG003|Study Period 1|Withdrawal by Subject|0
7373295|NCT01109316|11624767|FG004|Study Period 1|Withdrawal by Subject|2
7373296|NCT01109316|11624768|FG005|Study Period 1|Withdrawal by Subject|0
7373297|NCT01109316|11624763|FG000|Study Period 1|Sponsor Decision|0
7373298|NCT01109316|11624764|FG001|Study Period 1|Sponsor Decision|0
7373299|NCT01109316|11624765|FG002|Study Period 1|Sponsor Decision|0
7373300|NCT01109316|11624766|FG003|Study Period 1|Sponsor Decision|0
7373301|NCT01109316|11624767|FG004|Study Period 1|Sponsor Decision|0
7373302|NCT01109316|11624768|FG005|Study Period 1|Sponsor Decision|2
7373303|NCT01109316|11624763|FG000|Study Period 2|Entry Criteria Not Met|0
7373304|NCT01109316|11624764|FG001|Study Period 2|Entry Criteria Not Met|1
7373305|NCT01109316|11624765|FG002|Study Period 2|Entry Criteria Not Met|0
7373306|NCT01109316|11624766|FG003|Study Period 2|Entry Criteria Not Met|0
7373307|NCT01109316|11624767|FG004|Study Period 2|Entry Criteria Not Met|0
7373308|NCT01109316|11624768|FG005|Study Period 2|Entry Criteria Not Met|0
7373309|NCT01109316|11624763|FG000|Study Period 2|Physician Decision|0
7373310|NCT01109316|11624764|FG001|Study Period 2|Physician Decision|0
7373311|NCT01109316|11624765|FG002|Study Period 2|Physician Decision|0
7373312|NCT01109316|11624766|FG003|Study Period 2|Physician Decision|1
7373313|NCT01109316|11624767|FG004|Study Period 2|Physician Decision|0
7373314|NCT01109316|11624768|FG005|Study Period 2|Physician Decision|0
7373315|NCT01109316|11624763|FG000|Study Period 2|Protocol Violation|1
7373316|NCT01109316|11624764|FG001|Study Period 2|Protocol Violation|0
7373317|NCT01109316|11624765|FG002|Study Period 2|Protocol Violation|0
7373318|NCT01109316|11624766|FG003|Study Period 2|Protocol Violation|0
7373319|NCT01109316|11624767|FG004|Study Period 2|Protocol Violation|0
7373320|NCT01109316|11624768|FG005|Study Period 2|Protocol Violation|0
7373321|NCT01109316|11624763|FG000|Study Period 2|Withdrawal by Subject|0
7373322|NCT01109316|11624764|FG001|Study Period 2|Withdrawal by Subject|0
7373323|NCT01109316|11624765|FG002|Study Period 2|Withdrawal by Subject|1
7373324|NCT01109316|11624766|FG003|Study Period 2|Withdrawal by Subject|0
7373325|NCT01109316|11624767|FG004|Study Period 2|Withdrawal by Subject|0
7373326|NCT01109316|11624768|FG005|Study Period 2|Withdrawal by Subject|1
7373327|NCT01109316|11624763|FG000|Study Period 3|Lost to Follow-up|0
7373328|NCT01109316|11624764|FG001|Study Period 3|Lost to Follow-up|0
7373329|NCT01109316|11624765|FG002|Study Period 3|Lost to Follow-up|0
7373330|NCT01109316|11624766|FG003|Study Period 3|Lost to Follow-up|0
7373331|NCT01109316|11624767|FG004|Study Period 3|Lost to Follow-up|1
7373332|NCT01109316|11624768|FG005|Study Period 3|Lost to Follow-up|0
7373333|NCT01109316|11624763|FG000|Study Period 3|Withdrawal by Subject|1
7373334|NCT01109316|11624764|FG001|Study Period 3|Withdrawal by Subject|0
7373335|NCT01109316|11624765|FG002|Study Period 3|Withdrawal by Subject|0
7373336|NCT01109316|11624766|FG003|Study Period 3|Withdrawal by Subject|0
7373337|NCT01109316|11624767|FG004|Study Period 3|Withdrawal by Subject|1
7373338|NCT01109316|11624768|FG005|Study Period 3|Withdrawal by Subject|0
7373339|NCT01109524|11624782|FG000|Overall Study|Disease Progression|29
7373340|NCT01109524|11624782|FG000|Overall Study|Study Drug toxicity|6
7373341|NCT01109524|11624782|FG000|Overall Study|Adverse Event|4
7373342|NCT01109524|11624782|FG000|Overall Study|Withdrawal by Subject|2
7373343|NCT01109524|11624782|FG000|Overall Study|Maximum clinical benefit|3
7373344|NCT01109524|11624782|FG000|Overall Study|Death|2
7373345|NCT01109524|11624782|FG000|Overall Study|No longer meets criteria|2
7373346|NCT01109524|11624782|FG000|Overall Study|Participant requested to end treatment|4
7373347|NCT01109524|11624782|FG000|Overall Study|Other|5
7387042|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7387043|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7387044|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
7387045|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7387046|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7387047|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7373348|NCT01109849|11624804|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
7373349|NCT01109849|11624805|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
7373350|NCT01109849|11624806|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7373351|NCT01109849|11624807|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7373352|NCT01109849|11624808|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
7373353|NCT01109849|11624804|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
7373354|NCT01109849|11624805|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
7373355|NCT01109849|11624806|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
7373356|NCT01109849|11624807|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
7373357|NCT01109849|11624808|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
7373358|NCT01109849|11624804|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
7373359|NCT01109849|11624805|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
7373360|NCT01109849|11624806|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7373361|NCT01109849|11624807|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7373362|NCT01109849|11624808|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
7373363|NCT01109849|11624804|FG000|Initial Randomization: ADHD Treatment|move away|2
7373364|NCT01109849|11624805|FG001|Initial Randomization: ADHD Treatment|move away|7
7373365|NCT01109849|11624806|FG002|Initial Randomization: ADHD Treatment|move away|0
7373366|NCT01109849|11624807|FG003|Initial Randomization: ADHD Treatment|move away|0
7373367|NCT01109849|11624808|FG004|Initial Randomization: ADHD Treatment|move away|0
7373368|NCT01109849|11624804|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7373369|NCT01109849|11624805|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
7373370|NCT01109849|11624806|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7373371|NCT01109849|11624807|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7373372|NCT01109849|11624808|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
7373373|NCT01109849|11624804|FG000|Adaptive Randomization: Weight Recovery|moved away|0
7373374|NCT01109849|11624805|FG001|Adaptive Randomization: Weight Recovery|moved away|0
7373375|NCT01109849|11624806|FG002|Adaptive Randomization: Weight Recovery|moved away|0
7373376|NCT01109849|11624807|FG003|Adaptive Randomization: Weight Recovery|moved away|2
7373377|NCT01109849|11624808|FG004|Adaptive Randomization: Weight Recovery|moved away|0
7373378|NCT01109940|11624832|FG000|Overall Study|Administrative problems|2
7373379|NCT01109940|11624833|FG001|Overall Study|Administrative problems|0
7373380|NCT01109940|11624834|FG002|Overall Study|Administrative problems|0
7373381|NCT01109940|11624835|FG003|Overall Study|Administrative problems|0
7373382|NCT01109940|11624832|FG000|Overall Study|Serious Adverse Event|2
7373383|NCT01109940|11624833|FG001|Overall Study|Serious Adverse Event|1
7373384|NCT01109940|11624834|FG002|Overall Study|Serious Adverse Event|0
7373385|NCT01109940|11624835|FG003|Overall Study|Serious Adverse Event|0
7373386|NCT01109940|11624832|FG000|Overall Study|Lost to Follow-up|1
7373387|NCT01109940|11624833|FG001|Overall Study|Lost to Follow-up|0
7373388|NCT01109940|11624834|FG002|Overall Study|Lost to Follow-up|0
7373389|NCT01109940|11624835|FG003|Overall Study|Lost to Follow-up|0
7373390|NCT01109940|11624832|FG000|Overall Study|Patient withdrew consent|1
7373391|NCT01109940|11624833|FG001|Overall Study|Patient withdrew consent|1
7373392|NCT01109940|11624834|FG002|Overall Study|Patient withdrew consent|0
7373393|NCT01109940|11624835|FG003|Overall Study|Patient withdrew consent|0
7373394|NCT01109940|11624832|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7373395|NCT01109940|11624833|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7373396|NCT01109940|11624834|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7373397|NCT01109940|11624835|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7373398|NCT01109979|11624847|FG000|Overall Study|Physician Decision|2
7373399|NCT01109979|11624848|FG001|Overall Study|Physician Decision|0
7373400|NCT01109979|11624847|FG000|Overall Study|Withdrawal by Subject|0
7373401|NCT01109979|11624848|FG001|Overall Study|Withdrawal by Subject|1
7373402|NCT01109992|11624856|FG000|Overall Study|Withdrawal by Subject|0
7373403|NCT01109992|11624857|FG001|Overall Study|Withdrawal by Subject|1
7373404|NCT01109992|11624856|FG000|Overall Study|Movement during rest scan.|0
7373405|NCT01109992|11624857|FG001|Overall Study|Movement during rest scan.|1
7373406|NCT01110005|11624868|FG000|Overall Study|ineligible|1
7373407|NCT01110005|11624869|FG001|Overall Study|ineligible|2
7373408|NCT01110005|11624868|FG000|Overall Study|missing consent|3
7373409|NCT01110005|11624869|FG001|Overall Study|missing consent|2
7373410|NCT01110005|11624868|FG000|Overall Study|Withdrawal by Subject|0
7373411|NCT01110005|11624869|FG001|Overall Study|Withdrawal by Subject|1
7373412|NCT01110200|11624892|FG000|Overall Study|Adverse Event|28
7373413|NCT01110200|11624893|FG001|Overall Study|Adverse Event|28
7373414|NCT01110200|11624892|FG000|Overall Study|Withdrawal by Subject|25
7373415|NCT01110200|11624893|FG001|Overall Study|Withdrawal by Subject|32
7373416|NCT01110200|11624892|FG000|Overall Study|Lack of Efficacy|16
7373417|NCT01110200|11624893|FG001|Overall Study|Lack of Efficacy|25
7373418|NCT01110200|11624892|FG000|Overall Study|Protocol Violation|14
7373419|NCT01110200|11624893|FG001|Overall Study|Protocol Violation|12
7373420|NCT01110200|11624892|FG000|Overall Study|Physician Decision|13
7373421|NCT01110200|11624893|FG001|Overall Study|Physician Decision|17
7373422|NCT01110200|11624892|FG000|Overall Study|Lost to Follow-up|10
7373423|NCT01110200|11624893|FG001|Overall Study|Lost to Follow-up|7
7373424|NCT01110239|11624903|FG000|Sham Preconditioning|Withdrawal by Subject|0
7373425|NCT01110239|11624904|FG001|Sham Preconditioning|Withdrawal by Subject|0
7373426|NCT01110239|11624905|FG002|Sham Preconditioning|Withdrawal by Subject|1
7373427|NCT01110239|11624906|FG003|Sham Preconditioning|Withdrawal by Subject|0
7373428|NCT01110239|11624903|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
7373429|NCT01110239|11624904|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
7373430|NCT01110239|11624905|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
7373431|NCT01110239|11624906|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
7373432|NCT01110330|11624925|FG000|Overall Study|Adverse Event|0
7373433|NCT01110330|11624926|FG001|Overall Study|Adverse Event|4
7373434|NCT01110330|11624927|FG002|Overall Study|Adverse Event|3
7373435|NCT01110330|11624925|FG000|Overall Study|Lack of Efficacy|3
7373436|NCT01110330|11624926|FG001|Overall Study|Lack of Efficacy|1
7373437|NCT01110330|11624927|FG002|Overall Study|Lack of Efficacy|1
7373438|NCT01110330|11624925|FG000|Overall Study|Lost to Follow-up|9
7373439|NCT01110330|11624926|FG001|Overall Study|Lost to Follow-up|10
7373440|NCT01110330|11624927|FG002|Overall Study|Lost to Follow-up|15
7373441|NCT01110330|11624925|FG000|Overall Study|Physician Decision|0
7373442|NCT01110330|11624926|FG001|Overall Study|Physician Decision|1
7373443|NCT01110330|11624927|FG002|Overall Study|Physician Decision|0
7373444|NCT01110330|11624925|FG000|Overall Study|Protocol Violation|2
7373445|NCT01110330|11624926|FG001|Overall Study|Protocol Violation|0
7373446|NCT01110330|11624927|FG002|Overall Study|Protocol Violation|4
7373447|NCT01110330|11624925|FG000|Overall Study|Withdrawal by Subject|0
7373448|NCT01110330|11624926|FG001|Overall Study|Withdrawal by Subject|6
7373449|NCT01110330|11624927|FG002|Overall Study|Withdrawal by Subject|2
7373450|NCT01110330|11624925|FG000|Overall Study|Other|1
7373451|NCT01110330|11624926|FG001|Overall Study|Other|1
7373452|NCT01110330|11624927|FG002|Overall Study|Other|1
7373453|NCT01110382|11624937|FG000|Overall Study|Withdrawal by Subject|0
7373454|NCT01110382|11624938|FG001|Overall Study|Withdrawal by Subject|1
7373455|NCT01110382|11624937|FG000|Overall Study|Protocol Violation|0
7373456|NCT01110382|11624938|FG001|Overall Study|Protocol Violation|1
7373457|NCT01110408|11624950|FG000|Overall Study|Protocol Violation|1
7373458|NCT01110408|11624951|FG001|Overall Study|Protocol Violation|0
7373459|NCT01110707|11625016|FG000|Overall Study|Protocol Violation|0
7373460|NCT01110707|11625017|FG001|Overall Study|Protocol Violation|3
7373461|NCT01110915|11625036|FG000|Overall Study|Death|2
7373462|NCT01110915|11625037|FG001|Overall Study|Death|1
7373463|NCT01110915|11625036|FG000|Overall Study|Lost to Follow-up|1
7373464|NCT01110915|11625037|FG001|Overall Study|Lost to Follow-up|0
7373465|NCT01110915|11625036|FG000|Overall Study|Withdrawal by Subject|7
7373466|NCT01110915|11625037|FG001|Overall Study|Withdrawal by Subject|1
7373467|NCT01111123|11625059|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
7373468|NCT01111123|11625060|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
7373469|NCT01111123|11625059|FG000|Maintenance Phase|Lost to Follow-up|0
7373470|NCT01111123|11625060|FG001|Maintenance Phase|Lost to Follow-up|2
7373471|NCT01111149|11625071|FG000|Overall Study|Protocol Violation|1
7373472|NCT01111149|11625072|FG001|Overall Study|Protocol Violation|1
7373473|NCT01111149|11625073|FG002|Overall Study|Protocol Violation|2
7373474|NCT01111149|11625071|FG000|Overall Study|Withdrawal by Subject|1
7373475|NCT01111149|11625072|FG001|Overall Study|Withdrawal by Subject|0
7373476|NCT01111149|11625073|FG002|Overall Study|Withdrawal by Subject|2
7373477|NCT01111240|11625086|FG000|Overall Study|Adverse Event|190
7461420|NCT01837966|11757588|FG001|Overall Study|Withdrawal by Subject|1
7570581|NCT03495908|11948440|FG001|Overall Study|Lost to Follow-up|4
7570582|NCT03495908|11948439|FG000|Overall Study|Adverse Event|0
7570583|NCT03495908|11948440|FG001|Overall Study|Adverse Event|2
7570584|NCT03495908|11948439|FG000|Overall Study|Death|1
7570585|NCT03495908|11948440|FG001|Overall Study|Death|0
7570586|NCT03495908|11948439|FG000|Overall Study|Physician Decision|5
7570587|NCT03495908|11948440|FG001|Overall Study|Physician Decision|4
7570588|NCT03495908|11948439|FG000|Overall Study|No documented reason|0
7570589|NCT03495908|11948440|FG001|Overall Study|No documented reason|2
7570590|NCT03496298|11948459|FG000|Overall Study|Adverse Event|49
7570591|NCT03496298|11948460|FG001|Overall Study|Adverse Event|68
7373478|NCT01111240|11625086|FG000|Overall Study|Lack of Efficacy|545
7373479|NCT01111240|11625086|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
7373480|NCT01111240|11625086|FG000|Overall Study|Other|312
7373481|NCT01111292|11625092|FG000|Treatment|Physician Decision|1
7373482|NCT01111292|11625093|FG001|Treatment|Physician Decision|1
7373483|NCT01111461|11625131|FG000|Overall Study|Adverse Event|32
7373484|NCT01111461|11625131|FG000|Overall Study|Participant choice|11
7373485|NCT01111461|11625131|FG000|Overall Study|Lost to Follow-up|1
7373486|NCT01111461|11625131|FG000|Overall Study|Withdrawal by Subject|1
7373487|NCT01111461|11625131|FG000|Overall Study|Other|6
7373488|NCT01111474|11625135|FG000|Overall Study|Lost to Follow-up|12
7373489|NCT01111526|11625141|FG000|Overall Study|GVHD Disease Progression|0
7373490|NCT01111526|11625142|FG001|Overall Study|GVHD Disease Progression|1
7373491|NCT01111526|11625143|FG002|Overall Study|GVHD Disease Progression|2
7373492|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
7373493|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373494|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373495|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373496|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373497|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
7373498|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
7373499|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
7373500|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
7373501|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
7373502|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
7373503|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373504|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373505|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373506|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373507|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
7373508|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7373509|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7373510|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7373511|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
7373512|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
7373513|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7373514|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7373515|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7373516|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
7373517|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
7373518|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373519|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373520|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373521|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373522|NCT01111539|11625147|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
7373523|NCT01111539|11625148|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7373524|NCT01111539|11625149|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7373525|NCT01111539|11625150|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7373526|NCT01111539|11625151|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
7373527|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7373528|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7373529|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7373530|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7373531|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7373532|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373533|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373534|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7373535|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373536|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
7373537|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7373538|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
7373539|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7373540|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7373541|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7373542|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7373543|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7373544|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7373545|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
7373546|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
7373547|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7373548|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7373549|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7373550|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
7373551|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
7373552|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7373553|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7373554|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7373753|NCT01113801|11625441|FG001|Overall Study|Protocol Violation|1
7373555|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
7373556|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
7373557|NCT01111539|11625147|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373558|NCT01111539|11625148|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373559|NCT01111539|11625149|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373560|NCT01111539|11625150|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373561|NCT01111539|11625151|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7373562|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
7373563|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373564|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373565|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373566|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
7373567|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
7373568|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
7373569|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
7373570|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
7373571|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
7373572|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
7373573|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373574|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7570592|NCT03496298|11948461|FG002|Overall Study|Adverse Event|79
7570593|NCT03496298|11948459|FG000|Overall Study|Study terminated by Sponsor|1050
7570594|NCT03496298|11948460|FG001|Overall Study|Study terminated by Sponsor|1063
7570595|NCT03496298|11948461|FG002|Overall Study|Study terminated by Sponsor|1071
7373575|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373576|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
7373577|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
7373578|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7373579|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7373580|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7373581|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
7373582|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
7387727|NCT01215916|11646438|FG000|Overall Study|Death|0
7533360|NCT02684370|11879637|FG004|Part A|Lost to Follow-up|0
7533361|NCT02684370|11879638|FG005|Part A|Lost to Follow-up|0
7533362|NCT02684370|11879633|FG000|Part A|Subject Withdrawal|1
7533363|NCT02684370|11879634|FG001|Part A|Subject Withdrawal|0
7533364|NCT02684370|11879635|FG002|Part A|Subject Withdrawal|3
7533365|NCT02684370|11879636|FG003|Part A|Subject Withdrawal|0
7533366|NCT02684370|11879637|FG004|Part A|Subject Withdrawal|0
7533367|NCT02684370|11879638|FG005|Part A|Subject Withdrawal|0
7533368|NCT02684370|11879633|FG000|Part A|Other|0
7533369|NCT02684370|11879634|FG001|Part A|Other|0
7533370|NCT02684370|11879635|FG002|Part A|Other|1
7533371|NCT02684370|11879636|FG003|Part A|Other|0
7533372|NCT02684370|11879637|FG004|Part A|Other|0
7533373|NCT02684370|11879638|FG005|Part A|Other|0
7533374|NCT02684370|11879633|FG000|Part B|Adverse Event|0
7570596|NCT03496298|11948459|FG000|Overall Study|Physician decision (other than Adverse event)|12
7570597|NCT03496298|11948460|FG001|Overall Study|Physician decision (other than Adverse event)|17
7570598|NCT03496298|11948461|FG002|Overall Study|Physician decision (other than Adverse event)|10
7570599|NCT03496298|11948459|FG000|Overall Study|Withdrawal by Subject|176
7570600|NCT03496298|11948460|FG001|Overall Study|Withdrawal by Subject|154
7570601|NCT03496298|11948461|FG002|Overall Study|Withdrawal by Subject|151
7570602|NCT03496298|11948459|FG000|Overall Study|Other|29
7570603|NCT03496298|11948460|FG001|Overall Study|Other|20
7570604|NCT03496298|11948461|FG002|Overall Study|Other|23
7570605|NCT03496298|11948459|FG000|Overall Study|Randomized and not treated|1
7373583|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7373584|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7373585|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7373586|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
7373587|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
7373588|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7373589|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7373590|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7373591|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
7373592|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
7373593|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373594|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373595|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373596|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
7373597|NCT01111552|11625161|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
7373598|NCT01111552|11625162|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7373599|NCT01111552|11625163|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7373600|NCT01111552|11625164|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7373754|NCT01113801|11625442|FG002|Overall Study|Protocol Violation|0
7373601|NCT01111552|11625165|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
7373602|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7570606|NCT03496298|11948460|FG001|Overall Study|Randomized and not treated|1
7570607|NCT03496298|11948461|FG002|Overall Study|Randomized and not treated|1
7373603|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373604|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373605|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
7373606|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
7373607|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7373608|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7373609|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
7373610|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7373611|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
7373612|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7373613|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
7373614|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7373615|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7373616|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
7373617|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7373618|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
7373619|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7373620|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7373621|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
7373622|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7373623|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
7373624|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7373625|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7373626|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
7373627|NCT01111552|11625161|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373628|NCT01111552|11625162|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373629|NCT01111552|11625163|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
7373630|NCT01111552|11625164|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373631|NCT01111552|11625165|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
7373632|NCT01111604|11625178|FG000|Overall Study|Lost to Follow-up|0
7373633|NCT01111604|11625179|FG001|Overall Study|Lost to Follow-up|0
7373634|NCT01111604|11625180|FG002|Overall Study|Lost to Follow-up|1
7373635|NCT01111604|11625178|FG000|Overall Study|Withdrew Consent|3
7373636|NCT01111604|11625179|FG001|Overall Study|Withdrew Consent|0
7373637|NCT01111604|11625180|FG002|Overall Study|Withdrew Consent|2
7373638|NCT01111604|11625178|FG000|Overall Study|Withdrawal by Subject|2
7373639|NCT01111604|11625179|FG001|Overall Study|Withdrawal by Subject|0
7373640|NCT01111604|11625180|FG002|Overall Study|Withdrawal by Subject|0
7373641|NCT01111604|11625178|FG000|Overall Study|Death|1
7373642|NCT01111604|11625179|FG001|Overall Study|Death|0
7373643|NCT01111604|11625180|FG002|Overall Study|Death|0
7373644|NCT01111604|11625178|FG000|Overall Study|Met Exclusion Criteria|2
7373645|NCT01111604|11625179|FG001|Overall Study|Met Exclusion Criteria|0
7373646|NCT01111604|11625180|FG002|Overall Study|Met Exclusion Criteria|0
7373647|NCT01111825|11625210|FG000|Overall Study|Withdrawal by Subject|0
7570608|NCT03497039|11948533|FG000|Overall Study|Withdrawal by Subject|1
7570609|NCT03497039|11948534|FG001|Overall Study|Withdrawal by Subject|0
7570610|NCT03497039|11948533|FG000|Overall Study|Protocol Violation|0
7570611|NCT03497039|11948534|FG001|Overall Study|Protocol Violation|1
7373648|NCT01111825|11625211|FG001|Overall Study|Withdrawal by Subject|0
7373649|NCT01111825|11625212|FG002|Overall Study|Withdrawal by Subject|1
7373650|NCT01111825|11625213|FG003|Overall Study|Withdrawal by Subject|0
7373651|NCT01111825|11625210|FG000|Overall Study|Lost to Follow-up|0
7373652|NCT01111825|11625211|FG001|Overall Study|Lost to Follow-up|0
7373653|NCT01111825|11625212|FG002|Overall Study|Lost to Follow-up|3
7373654|NCT01111825|11625213|FG003|Overall Study|Lost to Follow-up|1
7373655|NCT01111825|11625210|FG000|Overall Study|Adverse Event|2
7373656|NCT01111825|11625211|FG001|Overall Study|Adverse Event|1
7373657|NCT01111825|11625212|FG002|Overall Study|Adverse Event|4
7373658|NCT01111825|11625213|FG003|Overall Study|Adverse Event|0
7373659|NCT01111825|11625210|FG000|Overall Study|Disease Progression|1
7373660|NCT01111825|11625211|FG001|Overall Study|Disease Progression|0
7373661|NCT01111825|11625212|FG002|Overall Study|Disease Progression|0
7373662|NCT01111825|11625213|FG003|Overall Study|Disease Progression|0
7373663|NCT01111825|11625210|FG000|Overall Study|Discontinuation by Sponsor|0
7373664|NCT01111825|11625211|FG001|Overall Study|Discontinuation by Sponsor|0
7373665|NCT01111825|11625212|FG002|Overall Study|Discontinuation by Sponsor|0
7373666|NCT01111825|11625213|FG003|Overall Study|Discontinuation by Sponsor|20
7373667|NCT01111838|11625223|FG000|Overall Study|Patient Ineligible|2
7373668|NCT01111838|11625223|FG000|Overall Study|Not Treated|3
7373669|NCT01111838|11625223|FG000|Overall Study|Clinical deterioration|1
7373670|NCT01111838|11625223|FG000|Overall Study|Other Complicating Disease|1
7373671|NCT01111851|11625229|FG000|Overall Study|All planned PET scans were not obtained.|2
7373672|NCT01111851|11625230|FG001|Overall Study|All planned PET scans were not obtained.|0
7373673|NCT01112059|11625238|FG000|Overall Study|Withdrawal by Subject|1
7373674|NCT01112059|11625239|FG001|Overall Study|Withdrawal by Subject|0
7373675|NCT01112267|11625260|FG000|Overall Study|Adverse Event|24
7373676|NCT01112267|11625261|FG001|Overall Study|Adverse Event|6
7373677|NCT01112267|11625260|FG000|Overall Study|Withdrawal by Subject|3
7373678|NCT01112267|11625261|FG001|Overall Study|Withdrawal by Subject|5
7373679|NCT01112267|11625260|FG000|Overall Study|Protocol Violation|5
7373680|NCT01112267|11625261|FG001|Overall Study|Protocol Violation|3
7373681|NCT01112267|11625260|FG000|Overall Study|Participants not compliant|1
7373682|NCT01112267|11625261|FG001|Overall Study|Participants not compliant|2
7373683|NCT01112267|11625260|FG000|Overall Study|Participants not receive any study drug|1
7373684|NCT01112267|11625261|FG001|Overall Study|Participants not receive any study drug|2
7373685|NCT01112514|11625280|FG000|Overall Study|Lost to Follow-up|1
7373686|NCT01112579|11625286|FG000|Overall Study|Missed Visit|1
7373687|NCT01112579|11625287|FG001|Overall Study|Missed Visit|1
7373688|NCT01112579|11625286|FG000|Overall Study|Death|0
7373689|NCT01112579|11625287|FG001|Overall Study|Death|2
7373690|NCT01112917|11625335|FG000|Overall Study|Death|2
7373691|NCT01112917|11625336|FG001|Overall Study|Death|11
7373692|NCT01112917|11625335|FG000|Overall Study|Lost to Follow-up|1
7373693|NCT01112917|11625336|FG001|Overall Study|Lost to Follow-up|1
7373694|NCT01112917|11625335|FG000|Overall Study|Withdrawal by Subject|1
7373695|NCT01112917|11625336|FG001|Overall Study|Withdrawal by Subject|3
7373696|NCT01112917|11625335|FG000|Overall Study|Unable to Convert Filter|3
7373697|NCT01112917|11625336|FG001|Overall Study|Unable to Convert Filter|0
7373698|NCT01112982|11625340|FG000|Overall Study|Withdrawal by Subject|1
7373699|NCT01112982|11625340|FG000|Overall Study|exceeded weight limit to complete MRI|1
7373700|NCT01113463|11625364|FG000|Overall Study|Physician Decision|5
7373701|NCT01113502|11625373|FG000|Overall Study|Withdrawal by Subject|1
7373702|NCT01113502|11625374|FG001|Overall Study|Withdrawal by Subject|0
7373703|NCT01113502|11625375|FG002|Overall Study|Withdrawal by Subject|1
7373704|NCT01113502|11625376|FG003|Overall Study|Withdrawal by Subject|1
7373705|NCT01113502|11625377|FG004|Overall Study|Withdrawal by Subject|0
7373706|NCT01113502|11625373|FG000|Overall Study|Adverse Event|0
7373707|NCT01113502|11625374|FG001|Overall Study|Adverse Event|0
7373708|NCT01113502|11625375|FG002|Overall Study|Adverse Event|3
7373709|NCT01113502|11625376|FG003|Overall Study|Adverse Event|2
7373710|NCT01113502|11625377|FG004|Overall Study|Adverse Event|0
7373711|NCT01113541|11625390|FG000|Overall Study|Withdrawal by Subject|1
7373712|NCT01113541|11625390|FG000|Overall Study|Protocol Violation|1
7373713|NCT01113541|11625390|FG000|Overall Study|Study Terminated by Sponsor|7
7373714|NCT01113541|11625390|FG000|Overall Study|Adverse Event|4
7373715|NCT01113580|11625396|FG000|Overall Study|Protocol Violation|1
7373716|NCT01113580|11625397|FG001|Overall Study|Protocol Violation|0
7373717|NCT01113710|11625412|FG000|Overall Study|Adverse Event|64
7373718|NCT01113710|11625412|FG000|Overall Study|Lack of Efficacy|41
7373719|NCT01113710|11625412|FG000|Overall Study|No Information Available|40
7373720|NCT01113710|11625412|FG000|Overall Study|Withdrawal by Subject|28
7373721|NCT01113710|11625412|FG000|Overall Study|Lost to Follow-up|20
7373722|NCT01113710|11625412|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
7373723|NCT01113710|11625412|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
7373724|NCT01113710|11625412|FG000|Overall Study|Lack of Patient's Compliance|8
7373725|NCT01113710|11625412|FG000|Overall Study|Other|7
7373726|NCT01113710|11625412|FG000|Overall Study|Adverse Event/Other|5
7373727|NCT01113710|11625412|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
7373728|NCT01113710|11625412|FG000|Overall Study|Lack of Efficacy/Other|4
7373729|NCT01113710|11625412|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
7373730|NCT01113710|11625412|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
7373731|NCT01113710|11625412|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
7373732|NCT01113710|11625412|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
7373733|NCT01113710|11625412|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
7373734|NCT01113710|11625412|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
7373735|NCT01113710|11625412|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
7373736|NCT01113710|11625412|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
7373737|NCT01113710|11625412|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
7373738|NCT01113710|11625412|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
7373739|NCT01113710|11625412|FG000|Overall Study|Lack of Patient's Compliance/Other|1
7373740|NCT01113710|11625412|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
7373741|NCT01113710|11625412|FG000|Overall Study|Subject Did Not Receive Neupro|3
7373742|NCT01113749|11625429|FG000|Overall Study|Lost to Follow-up|1
7373743|NCT01113749|11625430|FG001|Overall Study|Lost to Follow-up|2
7373744|NCT01113801|11625440|FG000|Overall Study|Adverse Event|4
7373745|NCT01113801|11625441|FG001|Overall Study|Adverse Event|0
7373746|NCT01113801|11625442|FG002|Overall Study|Adverse Event|2
7373747|NCT01113801|11625443|FG003|Overall Study|Adverse Event|6
7373748|NCT01113801|11625440|FG000|Overall Study|Death|4
7373749|NCT01113801|11625441|FG001|Overall Study|Death|5
7373750|NCT01113801|11625442|FG002|Overall Study|Death|3
7373751|NCT01113801|11625443|FG003|Overall Study|Death|4
7373752|NCT01113801|11625440|FG000|Overall Study|Protocol Violation|0
7373755|NCT01113801|11625443|FG003|Overall Study|Protocol Violation|0
7373756|NCT01113801|11625440|FG000|Overall Study|Withdrawal by Subject|9
7373757|NCT01113801|11625441|FG001|Overall Study|Withdrawal by Subject|7
7373758|NCT01113801|11625442|FG002|Overall Study|Withdrawal by Subject|7
7373759|NCT01113801|11625443|FG003|Overall Study|Withdrawal by Subject|8
7373760|NCT01113801|11625440|FG000|Overall Study|Physician Decision|2
7461421|NCT01838044|11757596|FG000|Overall Study|Adverse Event|4
7461422|NCT01838044|11757597|FG001|Overall Study|Adverse Event|6
7461423|NCT01838044|11757596|FG000|Overall Study|Protocol Violation|3
7461424|NCT01838044|11757597|FG001|Overall Study|Protocol Violation|3
7461425|NCT01838044|11757596|FG000|Overall Study|Withdrawal by Subject|0
7461426|NCT01838044|11757597|FG001|Overall Study|Withdrawal by Subject|2
7461427|NCT01838044|11757596|FG000|Overall Study|Insufficient clinical response|1
7461428|NCT01838044|11757597|FG001|Overall Study|Insufficient clinical response|2
7461429|NCT01838044|11757596|FG000|Overall Study|Medication error without associated AE|0
7461430|NCT01838044|11757597|FG001|Overall Study|Medication error without associated AE|1
7461431|NCT01838044|11757596|FG000|Overall Study|Lost to Follow-up|0
7461432|NCT01838044|11757597|FG001|Overall Study|Lost to Follow-up|2
7468412|NCT01910129|11769168|FG001|Randomized Phase 2|Withdrawal by Subject|1
7468413|NCT01910129|11769169|FG002|Randomized Phase 2|Withdrawal by Subject|0
7468414|NCT01910129|11769167|FG000|Randomized Phase 3|Withdrawal by Subject|0
7468415|NCT01910129|11769168|FG001|Randomized Phase 3|Withdrawal by Subject|1
7468416|NCT01910129|11769169|FG002|Randomized Phase 3|Withdrawal by Subject|0
7468417|NCT01910181|11769187|FG000|Overall Study|Death|37
7468418|NCT01910181|11769187|FG000|Overall Study|Lost to Follow-up|3
7468419|NCT01910181|11769187|FG000|Overall Study|Study Terminated by Sponsor|6
7468420|NCT01910298|11769194|FG000|Overall Study|Adverse Event|1
7468421|NCT01910298|11769195|FG001|Overall Study|Adverse Event|0
7468422|NCT01910298|11769194|FG000|Overall Study|Withdrawal by Subject|2
7468423|NCT01910298|11769195|FG001|Overall Study|Withdrawal by Subject|7
7468424|NCT01910298|11769194|FG000|Overall Study|Protocol Deviation|0
7468425|NCT01910298|11769195|FG001|Overall Study|Protocol Deviation|5
7468426|NCT01910298|11769194|FG000|Overall Study|Lost to Follow-up|1
7468427|NCT01910298|11769195|FG001|Overall Study|Lost to Follow-up|1
7468428|NCT01910298|11769194|FG000|Overall Study|Study Terminated by Sponsor|1
7468429|NCT01910298|11769195|FG001|Overall Study|Study Terminated by Sponsor|17
7468430|NCT01910298|11769194|FG000|Overall Study|Other Miscellaneous Reasons|0
7468431|NCT01910298|11769195|FG001|Overall Study|Other Miscellaneous Reasons|2
7468432|NCT01910519|11769211|FG000|Overall Study|Withdrawal by Subject|2
7468433|NCT01910519|11769212|FG001|Overall Study|Withdrawal by Subject|0
7468434|NCT01910519|11769211|FG000|Overall Study|Adverse Event|2
7468435|NCT01910519|11769212|FG001|Overall Study|Adverse Event|0
7468436|NCT01911260|11769271|FG000|Supplementation Period|transference or evasion of school|7
7468437|NCT01911260|11769272|FG001|Supplementation Period|transference or evasion of school|9
7468438|NCT01911260|11769273|FG002|Supplementation Period|transference or evasion of school|7
7468439|NCT01911260|11769274|FG003|Supplementation Period|transference or evasion of school|6
7468440|NCT01911260|11769271|FG000|Supplementation Period|Adverse Event|2
7468441|NCT01911260|11769272|FG001|Supplementation Period|Adverse Event|0
7468442|NCT01911260|11769273|FG002|Supplementation Period|Adverse Event|1
7533375|NCT02684370|11879634|FG001|Part B|Adverse Event|0
7373761|NCT01113801|11625441|FG001|Overall Study|Physician Decision|2
7373762|NCT01113801|11625442|FG002|Overall Study|Physician Decision|3
7373763|NCT01113801|11625443|FG003|Overall Study|Physician Decision|3
7373764|NCT01113801|11625440|FG000|Overall Study|Sponsor Decision|15
7373765|NCT01113801|11625441|FG001|Overall Study|Sponsor Decision|21
7373766|NCT01113801|11625442|FG002|Overall Study|Sponsor Decision|20
7373767|NCT01113801|11625443|FG003|Overall Study|Sponsor Decision|15
7373768|NCT01113801|11625440|FG000|Overall Study|Clinical Endpoint (ESRD)|7
7373769|NCT01113801|11625441|FG001|Overall Study|Clinical Endpoint (ESRD)|4
7373770|NCT01113801|11625442|FG002|Overall Study|Clinical Endpoint (ESRD)|2
7373771|NCT01113801|11625443|FG003|Overall Study|Clinical Endpoint (ESRD)|5
7373772|NCT01113879|11625455|FG000|Period 1: Block 1|Withdrawal by Subject|2
7373773|NCT01113879|11625456|FG001|Period 1: Block 1|Withdrawal by Subject|0
7373774|NCT01113892|11625466|FG000|Overall Study|Lost to Follow-up|2
7373775|NCT01113892|11625467|FG001|Overall Study|Lost to Follow-up|2
7373776|NCT01113892|11625466|FG000|Overall Study|Withdrawal by Subject|1
7373777|NCT01113892|11625467|FG001|Overall Study|Withdrawal by Subject|1
7373778|NCT01113892|11625466|FG000|Overall Study|Death|2
7373779|NCT01113892|11625467|FG001|Overall Study|Death|4
7373780|NCT01113892|11625466|FG000|Overall Study|Graft no longer evaluable|9
7373781|NCT01113892|11625467|FG001|Overall Study|Graft no longer evaluable|9
7373782|NCT01113931|11625475|FG000|Overall Study|Adverse Event|2
7373783|NCT01113931|11625476|FG001|Overall Study|Adverse Event|2
7373784|NCT01113931|11625475|FG000|Overall Study|Physician Decision|0
7373785|NCT01113931|11625476|FG001|Overall Study|Physician Decision|2
7373786|NCT01113931|11625475|FG000|Overall Study|Lost to Follow-up|12
7373787|NCT01113931|11625476|FG001|Overall Study|Lost to Follow-up|9
7373788|NCT01113931|11625475|FG000|Overall Study|Various|2
7373789|NCT01113931|11625476|FG001|Overall Study|Various|4
7373790|NCT01113931|11625475|FG000|Overall Study|Withdrawal by Subject|3
7373791|NCT01113931|11625476|FG001|Overall Study|Withdrawal by Subject|0
7373792|NCT01114360|11625501|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
7373793|NCT01114360|11625502|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
7373794|NCT01114373|11625522|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
7373795|NCT01114373|11625523|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
7373796|NCT01114373|11625522|FG000|Intervention 1 (4 Weeks)|Incarceration|1
7373797|NCT01114373|11625523|FG001|Intervention 1 (4 Weeks)|Incarceration|0
7373798|NCT01114373|11625522|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
7373799|NCT01114373|11625523|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
7373800|NCT01114373|11625522|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
7373801|NCT01114373|11625523|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
7373802|NCT01114438|11625533|FG000|Overall Study|Adverse Event|10
7373803|NCT01114438|11625533|FG000|Overall Study|concomitant medication|1
7373804|NCT01114438|11625533|FG000|Overall Study|Physician Decision|1
7373805|NCT01114438|11625533|FG000|Overall Study|Withdrawal by Subject|2
7373806|NCT01114516|11625548|FG000|Overall Study|Lost to Follow-up|2
7373807|NCT01114516|11625549|FG001|Overall Study|Lost to Follow-up|1
7373808|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Adverse Event|87
7373809|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Adverse Event|18
7373810|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Adverse Event|17
7373811|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
7373812|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
7373813|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
7373814|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
7373815|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
7373816|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
7373817|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
7373818|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
7373819|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
7373820|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
7373821|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
7373822|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
7373823|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
7373824|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
7373825|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
7373826|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
7373827|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
7373828|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
7373829|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Administrative problems|2
7373830|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Administrative problems|1
7373831|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Administrative problems|2
7373832|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Death|2
7373833|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Death|1
7373834|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Death|2
7373835|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Graft loss|0
7373836|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Graft loss|2
7373837|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Graft loss|0
7373838|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Protocol Violation|0
7373839|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Protocol Violation|5
7373840|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Protocol Violation|2
7373841|NCT01114529|11625558|FG000|Completed Study Medication at Month 24|Missing|2
7373842|NCT01114529|11625559|FG001|Completed Study Medication at Month 24|Missing|0
7373843|NCT01114529|11625560|FG002|Completed Study Medication at Month 24|Missing|0
7373844|NCT01114529|11625558|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
7373845|NCT01114529|11625559|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
7373846|NCT01114529|11625560|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
7373847|NCT01114529|11625558|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
7373848|NCT01114529|11625559|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
7373849|NCT01114529|11625560|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
7373850|NCT01114529|11625558|FG000|Completed Study Phase at Month 24|Death|8
7373851|NCT01114529|11625559|FG001|Completed Study Phase at Month 24|Death|5
7373852|NCT01114529|11625560|FG002|Completed Study Phase at Month 24|Death|4
7373853|NCT01114529|11625558|FG000|Completed Study Phase at Month 24|Other|2
7373854|NCT01114529|11625559|FG001|Completed Study Phase at Month 24|Other|0
7373855|NCT01114529|11625560|FG002|Completed Study Phase at Month 24|Other|0
7373856|NCT01114529|11625558|FG000|Completed Study Phase at Month 24|Missing|2
7373857|NCT01114529|11625559|FG001|Completed Study Phase at Month 24|Missing|0
7373858|NCT01114529|11625560|FG002|Completed Study Phase at Month 24|Missing|0
7373859|NCT01114646|11625589|FG000|Overall Study|Withdrawal by Subject|3
7373860|NCT01114646|11625590|FG001|Overall Study|Withdrawal by Subject|2
7373861|NCT01114672|11625598|FG000|Overall Study|Death|0
7373862|NCT01114672|11625599|FG001|Overall Study|Death|1
7373863|NCT01114672|11625598|FG000|Overall Study|Withdrawal by Subject|2
7373864|NCT01114672|11625599|FG001|Overall Study|Withdrawal by Subject|1
7373865|NCT01114672|11625598|FG000|Overall Study|Lost to Follow-up|1
7373866|NCT01114672|11625599|FG001|Overall Study|Lost to Follow-up|0
7373867|NCT01114672|11625598|FG000|Overall Study|transplanted|1
7373868|NCT01114672|11625599|FG001|Overall Study|transplanted|0
7373869|NCT01114724|11625605|FG000|Overall Study|Death|8
7373870|NCT01114724|11625605|FG000|Overall Study|Lost to Follow-up|1
7373871|NCT01114724|11625605|FG000|Overall Study|Withdrawal by Subject|1
7373872|NCT01114737|11625612|FG000|Randomized Treatment Period|Withdrawal by Subject|1
7373873|NCT01114737|11625613|FG001|Randomized Treatment Period|Withdrawal by Subject|0
7373874|NCT01114737|11625612|FG000|Randomized Treatment Period|Lost to Follow-up|1
7373875|NCT01114737|11625613|FG001|Randomized Treatment Period|Lost to Follow-up|1
7373876|NCT01114737|11625612|FG000|Randomized Treatment Period|Pregnancy|1
7373877|NCT01114737|11625613|FG001|Randomized Treatment Period|Pregnancy|0
7373878|NCT01114737|11625612|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
7373879|NCT01114737|11625613|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
7373880|NCT01114737|11625612|FG000|Open-Label Treatment Period|Lost to Follow-up|3
7373881|NCT01114737|11625613|FG001|Open-Label Treatment Period|Lost to Follow-up|1
7373882|NCT01114737|11625612|FG000|Open-Label Treatment Period|Difficult Personal Events|1
7373883|NCT01114737|11625613|FG001|Open-Label Treatment Period|Difficult Personal Events|0
7373884|NCT01114828|11625632|FG000|Overall Study|Adverse Event|1
7373885|NCT01114828|11625633|FG001|Overall Study|Adverse Event|1
7373886|NCT01114828|11625632|FG000|Overall Study|Lack of Efficacy|0
7373887|NCT01114828|11625633|FG001|Overall Study|Lack of Efficacy|2
7373888|NCT01114828|11625632|FG000|Overall Study|Protocol Violation|2
7373889|NCT01114828|11625633|FG001|Overall Study|Protocol Violation|0
7373890|NCT01114828|11625632|FG000|Overall Study|Withdrawal by Subject|0
7373891|NCT01114828|11625633|FG001|Overall Study|Withdrawal by Subject|1
7373892|NCT01114880|11625641|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
7373893|NCT01114880|11625642|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
7373894|NCT01114880|11625641|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
7373895|NCT01114880|11625642|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
7373896|NCT01114880|11625641|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
7373897|NCT01114880|11625642|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
7373898|NCT01114880|11625641|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
7373899|NCT01114880|11625642|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
7373900|NCT01114880|11625641|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
7373901|NCT01114880|11625642|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
7373902|NCT01114880|11625641|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
7373903|NCT01114880|11625642|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
7373904|NCT01115309|11625739|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
7373905|NCT01115309|11625739|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
7373906|NCT01115309|11625739|FG000|Long-term Follow-up|Lost to Follow-up|6
7373907|NCT01115491|11625752|FG000|Overall Study|Death|22
7373908|NCT01115491|11625752|FG000|Overall Study|Adverse Event|3
7373909|NCT01115491|11625752|FG000|Overall Study|Lost to Follow-up|3
7373910|NCT01115491|11625752|FG000|Overall Study|Withdrawal by Subject|1
7373911|NCT01115491|11625752|FG000|Overall Study|Physician Decision|1
7387048|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7387049|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7387050|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7387051|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
7387052|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387053|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7387054|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387055|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387056|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7373912|NCT01115569|11625776|FG000|Conversion/Titration Phase|Adverse Event|59
7373913|NCT01115569|11625777|FG001|Conversion/Titration Phase|Adverse Event|0
7373914|NCT01115569|11625776|FG000|Conversion/Titration Phase|Lost to Follow-up|3
7373915|NCT01115569|11625777|FG001|Conversion/Titration Phase|Lost to Follow-up|0
7373916|NCT01115569|11625776|FG000|Conversion/Titration Phase|Physician Decision|5
7373917|NCT01115569|11625777|FG001|Conversion/Titration Phase|Physician Decision|0
7373918|NCT01115569|11625776|FG000|Conversion/Titration Phase|Protocol Violation|68
7373919|NCT01115569|11625777|FG001|Conversion/Titration Phase|Protocol Violation|0
7373920|NCT01115569|11625776|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
7373921|NCT01115569|11625777|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
7373922|NCT01115569|11625776|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
7373923|NCT01115569|11625777|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
7373924|NCT01115569|11625776|FG000|Maintenance Phase|Adverse Event|0
7373925|NCT01115569|11625777|FG001|Maintenance Phase|Adverse Event|43
7373926|NCT01115569|11625776|FG000|Maintenance Phase|Lost to Follow-up|0
7373927|NCT01115569|11625777|FG001|Maintenance Phase|Lost to Follow-up|8
7373928|NCT01115569|11625776|FG000|Maintenance Phase|Physician Decision|0
7373929|NCT01115569|11625777|FG001|Maintenance Phase|Physician Decision|3
7373930|NCT01115569|11625776|FG000|Maintenance Phase|Protocol Violation|0
7373931|NCT01115569|11625777|FG001|Maintenance Phase|Protocol Violation|9
7373932|NCT01115569|11625776|FG000|Maintenance Phase|Withdrawal by Subject|0
7373933|NCT01115569|11625777|FG001|Maintenance Phase|Withdrawal by Subject|27
7373934|NCT01115569|11625776|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
7373935|NCT01115569|11625777|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
7373936|NCT01115569|11625776|FG000|Maintenance Phase|Administrative|0
7373937|NCT01115569|11625777|FG001|Maintenance Phase|Administrative|1
7373938|NCT01115738|11625811|FG000|Overall Study|Death|1
7373939|NCT01115738|11625812|FG001|Overall Study|Death|0
7373940|NCT01115738|11625813|FG002|Overall Study|Death|0
7373941|NCT01115738|11625811|FG000|Overall Study|Lost to Follow-up|0
7373942|NCT01115738|11625812|FG001|Overall Study|Lost to Follow-up|0
7373943|NCT01115738|11625813|FG002|Overall Study|Lost to Follow-up|1
7373944|NCT01115738|11625811|FG000|Overall Study|Physician Decision|18
7373945|NCT01115738|11625812|FG001|Overall Study|Physician Decision|15
7373946|NCT01115738|11625813|FG002|Overall Study|Physician Decision|17
7373947|NCT01115738|11625811|FG000|Overall Study|Withdrawal by Subject|6
7373948|NCT01115738|11625812|FG001|Overall Study|Withdrawal by Subject|6
7373949|NCT01115738|11625813|FG002|Overall Study|Withdrawal by Subject|9
7373950|NCT01115803|11625836|FG000|Overall Study|Withdrawal by Subject|0
7373951|NCT01115803|11625837|FG001|Overall Study|Withdrawal by Subject|0
7373952|NCT01115803|11625838|FG002|Overall Study|Withdrawal by Subject|0
7373953|NCT01115803|11625839|FG003|Overall Study|Withdrawal by Subject|0
7373954|NCT01115803|11625840|FG004|Overall Study|Withdrawal by Subject|0
7373955|NCT01115803|11625841|FG005|Overall Study|Withdrawal by Subject|0
7373956|NCT01115803|11625842|FG006|Overall Study|Withdrawal by Subject|1
7373957|NCT01115803|11625836|FG000|Overall Study|Lost to Follow-up|0
7373958|NCT01115803|11625837|FG001|Overall Study|Lost to Follow-up|0
7373959|NCT01115803|11625838|FG002|Overall Study|Lost to Follow-up|1
7373960|NCT01115803|11625839|FG003|Overall Study|Lost to Follow-up|0
7373961|NCT01115803|11625840|FG004|Overall Study|Lost to Follow-up|0
7373962|NCT01115803|11625841|FG005|Overall Study|Lost to Follow-up|0
7373963|NCT01115803|11625842|FG006|Overall Study|Lost to Follow-up|0
7373964|NCT01115803|11625836|FG000|Overall Study|Progressive Disease during Cycle1|0
7373965|NCT01115803|11625837|FG001|Overall Study|Progressive Disease during Cycle1|0
7373966|NCT01115803|11625838|FG002|Overall Study|Progressive Disease during Cycle1|0
7373967|NCT01115803|11625839|FG003|Overall Study|Progressive Disease during Cycle1|0
7373968|NCT01115803|11625840|FG004|Overall Study|Progressive Disease during Cycle1|0
7373969|NCT01115803|11625841|FG005|Overall Study|Progressive Disease during Cycle1|0
7373970|NCT01115803|11625842|FG006|Overall Study|Progressive Disease during Cycle1|1
7373971|NCT01115855|11625865|FG000|Overall Study|Adverse Event|16
7373972|NCT01115855|11625866|FG001|Overall Study|Adverse Event|18
7373973|NCT01115855|11625865|FG000|Overall Study|Death|6
7373974|NCT01115855|11625866|FG001|Overall Study|Death|5
7373975|NCT01115855|11625865|FG000|Overall Study|Lab Abnormality|1
7373976|NCT01115855|11625866|FG001|Overall Study|Lab Abnormality|1
7373977|NCT01115855|11625865|FG000|Overall Study|Protocol Violation|0
7373978|NCT01115855|11625866|FG001|Overall Study|Protocol Violation|1
7373979|NCT01115855|11625865|FG000|Overall Study|Withdrawal by Subject|5
7373980|NCT01115855|11625866|FG001|Overall Study|Withdrawal by Subject|5
7373981|NCT01115855|11625865|FG000|Overall Study|Other|8
7373982|NCT01115855|11625866|FG001|Overall Study|Other|6
7373983|NCT01115933|11625872|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
7533376|NCT02684370|11879635|FG002|Part B|Adverse Event|0
7373984|NCT01115998|11625931|FG000|Overall Study|Lost to Follow-up|6
7373985|NCT01115998|11625932|FG001|Overall Study|Lost to Follow-up|6
7373986|NCT01116427|11626007|FG000|Core Phase|Adverse Event|0
7373987|NCT01116427|11626008|FG001|Core Phase|Adverse Event|1
7373988|NCT01116427|11626007|FG000|Core Phase|Lost to Follow-up|1
7373989|NCT01116427|11626008|FG001|Core Phase|Lost to Follow-up|0
7373990|NCT01116427|11626007|FG000|Core Phase|Withdrawal by Subject|3
7373991|NCT01116427|11626008|FG001|Core Phase|Withdrawal by Subject|0
7373992|NCT01116427|11626007|FG000|Core Phase|Worsening Multiple Sclerosis|1
7373993|NCT01116427|11626008|FG001|Core Phase|Worsening Multiple Sclerosis|0
7373994|NCT01116427|11626007|FG000|Extension Phase|Adverse Event|1
7373995|NCT01116427|11626008|FG001|Extension Phase|Adverse Event|1
7373996|NCT01116427|11626007|FG000|Extension Phase|Lost to Follow-up|2
7373997|NCT01116427|11626008|FG001|Extension Phase|Lost to Follow-up|0
7373998|NCT01116427|11626007|FG000|Extension Phase|Withdrawal by Subject|5
7373999|NCT01116427|11626008|FG001|Extension Phase|Withdrawal by Subject|1
7374000|NCT01116427|11626007|FG000|Extension Phase|Not using appropriate birth control|1
7374001|NCT01116427|11626008|FG001|Extension Phase|Not using appropriate birth control|0
7374002|NCT01116440|11626020|FG000|Treatment|Withdrawal by Subject|2
7374003|NCT01116440|11626021|FG001|Treatment|Withdrawal by Subject|2
7374004|NCT01116440|11626020|FG000|Treatment|Lost to Follow-up|1
7374005|NCT01116440|11626021|FG001|Treatment|Lost to Follow-up|1
7374006|NCT01116440|11626020|FG000|Treatment|Protocol Violation|0
7374007|NCT01116440|11626021|FG001|Treatment|Protocol Violation|2
7374008|NCT01116440|11626020|FG000|Treatment|Lack of Efficacy|0
7374009|NCT01116440|11626021|FG001|Treatment|Lack of Efficacy|1
7374010|NCT01116440|11626020|FG000|Treatment|Adverse Event|0
7374011|NCT01116440|11626021|FG001|Treatment|Adverse Event|1
7374012|NCT01116440|11626020|FG000|Withdrawal|Withdrawal by Subject|0
7570612|NCT03497130|11948542|FG000|Overall Study|Lost to Follow-up|1
7570613|NCT03497130|11948543|FG001|Overall Study|Lost to Follow-up|1
7570614|NCT03497429|11948551|FG000|Overall Study|Progressive disease|3
7570615|NCT03497429|11948552|FG001|Overall Study|Progressive disease|4
7374013|NCT01116440|11626021|FG001|Withdrawal|Withdrawal by Subject|1
7374014|NCT01116440|11626020|FG000|Withdrawal|Lost to Follow-up|0
7374015|NCT01116440|11626021|FG001|Withdrawal|Lost to Follow-up|1
7374016|NCT01116440|11626020|FG000|Follow-up|Lost to Follow-up|0
7374017|NCT01116440|11626021|FG001|Follow-up|Lost to Follow-up|1
7374018|NCT01116440|11626020|FG000|Follow-up|Withdrawal by Subject|0
7374019|NCT01116440|11626021|FG001|Follow-up|Withdrawal by Subject|1
7374020|NCT01116544|11626036|FG000|Overall Study|Protocol Violation|1
7374021|NCT01116544|11626037|FG001|Overall Study|Protocol Violation|0
7570616|NCT03497429|11948551|FG000|Overall Study|Adverse Event|0
7570617|NCT03497429|11948552|FG001|Overall Study|Adverse Event|2
7570618|NCT03498287|11948623|FG000|Overall Study|Withdrawal by Subject|3
7570619|NCT03498287|11948624|FG001|Overall Study|Withdrawal by Subject|0
7570620|NCT03498287|11948623|FG000|Overall Study|Protocol Violation|0
7570621|NCT03498287|11948624|FG001|Overall Study|Protocol Violation|4
7570622|NCT03498287|11948623|FG000|Overall Study|Adverse Event|0
7570623|NCT03498287|11948624|FG001|Overall Study|Adverse Event|1
7570624|NCT03499028|11948642|FG000|Overall Study|Lost to Follow-up|12
7570625|NCT03499028|11948643|FG001|Overall Study|Lost to Follow-up|9
7374022|NCT01116544|11626036|FG000|Overall Study|Withdrawal by Subject|1
7374023|NCT01116544|11626037|FG001|Overall Study|Withdrawal by Subject|1
7374024|NCT01116687|11626047|FG000|Overall Study|Withdrawal by Subject|4
7374025|NCT01116739|11626053|FG000|Overall Study|Child had 2 years of HS|110
7374026|NCT01116739|11626054|FG001|Overall Study|Child had 2 years of HS|128
7374027|NCT01116739|11626053|FG000|Overall Study|Withdrawal by Subject|6
7374028|NCT01116739|11626054|FG001|Overall Study|Withdrawal by Subject|0
7374029|NCT01116739|11626053|FG000|Overall Study|child too young|2
7374030|NCT01116739|11626054|FG001|Overall Study|child too young|6
7374031|NCT01116739|11626053|FG000|Overall Study|child not enrolled in head start|10
7374032|NCT01116739|11626054|FG001|Overall Study|child not enrolled in head start|2
7374033|NCT01116739|11626053|FG000|Overall Study|enrolled caregiver not legal guardian|2
7374034|NCT01116739|11626054|FG001|Overall Study|enrolled caregiver not legal guardian|0
7374035|NCT01116882|11626062|FG000|30-day|Lost to Follow-up|50
7374036|NCT01116882|11626063|FG001|30-day|Lost to Follow-up|21
7374037|NCT01116882|11626062|FG000|30-day|Withdrawal by Subject|2
7374038|NCT01116882|11626063|FG001|30-day|Withdrawal by Subject|4
7374039|NCT01116882|11626062|FG000|30-day|Other Reasons|16
7374040|NCT01116882|11626063|FG001|30-day|Other Reasons|6
7374041|NCT01116882|11626062|FG000|12-month|Lost to Follow-up|111
7374042|NCT01116882|11626063|FG001|12-month|Lost to Follow-up|42
7374043|NCT01116882|11626062|FG000|12-month|Other Reasons|151
7374044|NCT01116882|11626063|FG001|12-month|Other Reasons|49
7374045|NCT01116882|11626062|FG000|12-month|Withdrawal by Subject|5
7374046|NCT01116882|11626063|FG001|12-month|Withdrawal by Subject|8
7374047|NCT01117012|11626192|FG000|Overall Study|Adverse Event|0
7374048|NCT01117012|11626193|FG001|Overall Study|Adverse Event|1
7374049|NCT01117012|11626192|FG000|Overall Study|Death|1
7374050|NCT01117012|11626193|FG001|Overall Study|Death|1
7374051|NCT01117012|11626192|FG000|Overall Study|Withdrawal by Subject|3
7374052|NCT01117012|11626193|FG001|Overall Study|Withdrawal by Subject|0
7374053|NCT01117012|11626192|FG000|Overall Study|Undefined|4
7374054|NCT01117012|11626193|FG001|Overall Study|Undefined|3
7374055|NCT01117051|11626201|FG000|Overall Study|Withdrawal by Subject|5
7374056|NCT01117051|11626202|FG001|Overall Study|Withdrawal by Subject|3
7374057|NCT01117051|11626201|FG000|Overall Study|Adverse Event|4
7374058|NCT01117051|11626202|FG001|Overall Study|Adverse Event|3
7374059|NCT01117051|11626201|FG000|Overall Study|Lost to Follow-up|0
7374060|NCT01117051|11626202|FG001|Overall Study|Lost to Follow-up|1
7374061|NCT01117051|11626201|FG000|Overall Study|Did not meet in-/exclusion criteria|0
7570626|NCT03499028|11948642|FG000|Overall Study|Withdrawal by Subject|5
7570627|NCT03499028|11948643|FG001|Overall Study|Withdrawal by Subject|8
7570628|NCT03499028|11948642|FG000|Overall Study|Unplanned SNF discharge|5
7374062|NCT01117051|11626202|FG001|Overall Study|Did not meet in-/exclusion criteria|1
7374063|NCT01117051|11626201|FG000|Overall Study|Sponsor's decision|3
7374064|NCT01117051|11626202|FG001|Overall Study|Sponsor's decision|1
7374065|NCT01117051|11626201|FG000|Overall Study|Surgical procedure|0
7374066|NCT01117051|11626202|FG001|Overall Study|Surgical procedure|1
7374067|NCT01117051|11626201|FG000|Overall Study|Randomized by mistake|0
7374068|NCT01117051|11626202|FG001|Overall Study|Randomized by mistake|1
7374069|NCT01117051|11626201|FG000|Overall Study|Convenience issue|1
7374070|NCT01117051|11626202|FG001|Overall Study|Convenience issue|0
7374071|NCT01117181|11626222|FG000|Overall Study|Lost to Follow-up|1
7374072|NCT01117181|11626223|FG001|Overall Study|Lost to Follow-up|0
7374073|NCT01117181|11626222|FG000|Overall Study|Withdrawal by Subject|0
7374074|NCT01117181|11626223|FG001|Overall Study|Withdrawal by Subject|2
7374075|NCT01117337|11626240|FG000|Overall Study|Lost to Follow-up|4
7374076|NCT01117337|11626241|FG001|Overall Study|Lost to Follow-up|0
7374077|NCT01117350|11626249|FG000|Comparative Period|Not Treated|5
7374078|NCT01117350|11626250|FG001|Comparative Period|Not Treated|8
7374079|NCT01117350|11626249|FG000|Comparative Period|Adverse Event|6
7374080|NCT01117350|11626250|FG001|Comparative Period|Adverse Event|33
7374081|NCT01117350|11626249|FG000|Comparative Period|Lost to Follow-up|11
7374082|NCT01117350|11626250|FG001|Comparative Period|Lost to Follow-up|7
7374083|NCT01117350|11626249|FG000|Comparative Period|Withdrawal by Subject|9
7374084|NCT01117350|11626250|FG001|Comparative Period|Withdrawal by Subject|13
7374085|NCT01117350|11626249|FG000|Comparative Period|Protocol Violation|8
7374086|NCT01117350|11626250|FG001|Comparative Period|Protocol Violation|12
7374087|NCT01117350|11626249|FG000|Comparative Period|Lack of Efficacy|1
7374088|NCT01117350|11626250|FG001|Comparative Period|Lack of Efficacy|0
7374089|NCT01117350|11626249|FG000|Comparative Period|Physician Decision|0
7374090|NCT01117350|11626250|FG001|Comparative Period|Physician Decision|1
7374091|NCT01117350|11626249|FG000|Comparative Period|Move to another city/country|2
7374092|NCT01117350|11626250|FG001|Comparative Period|Move to another city/country|1
7374093|NCT01117350|11626249|FG000|Extension Period|Not included in extension, not treated|0
7374094|NCT01117350|11626250|FG001|Extension Period|Not included in extension, not treated|50
7374095|NCT01117350|11626249|FG000|Extension Period|Adverse Event|0
7374096|NCT01117350|11626250|FG001|Extension Period|Adverse Event|2
7374097|NCT01117350|11626249|FG000|Extension Period|Protocol Violation|0
7374098|NCT01117350|11626250|FG001|Extension Period|Protocol Violation|2
7374099|NCT01117350|11626249|FG000|Extension Period|Lost to Follow-up|0
7374100|NCT01117350|11626250|FG001|Extension Period|Lost to Follow-up|2
7374101|NCT01117350|11626249|FG000|Extension Period|Withdrawal by Subject|0
7374102|NCT01117350|11626250|FG001|Extension Period|Withdrawal by Subject|3
7374103|NCT01117350|11626249|FG000|Extension Period|Lack of Efficacy|0
7374104|NCT01117350|11626250|FG001|Extension Period|Lack of Efficacy|2
7374105|NCT01117350|11626249|FG000|Extension Period|Inclusion criteria not respected|0
7374106|NCT01117350|11626250|FG001|Extension Period|Inclusion criteria not respected|1
7374107|NCT01117350|11626249|FG000|Extension Period|Prohibited medication|0
7374108|NCT01117350|11626250|FG001|Extension Period|Prohibited medication|1
7374109|NCT01117428|11626265|FG000|Overall Study|Lack of Efficacy|1
7374110|NCT01117428|11626266|FG001|Overall Study|Lack of Efficacy|0
7374111|NCT01117428|11626267|FG002|Overall Study|Lack of Efficacy|0
7374112|NCT01117428|11626268|FG003|Overall Study|Lack of Efficacy|0
7374113|NCT01117428|11626269|FG004|Overall Study|Lack of Efficacy|0
7374114|NCT01117428|11626270|FG005|Overall Study|Lack of Efficacy|0
7374115|NCT01117428|11626265|FG000|Overall Study|Adverse Event|4
7374116|NCT01117428|11626266|FG001|Overall Study|Adverse Event|0
7374117|NCT01117428|11626267|FG002|Overall Study|Adverse Event|0
7374118|NCT01117428|11626268|FG003|Overall Study|Adverse Event|0
7374119|NCT01117428|11626269|FG004|Overall Study|Adverse Event|1
7374120|NCT01117428|11626270|FG005|Overall Study|Adverse Event|2
7374121|NCT01117428|11626265|FG000|Overall Study|Death|0
7374122|NCT01117428|11626266|FG001|Overall Study|Death|1
7374123|NCT01117428|11626267|FG002|Overall Study|Death|2
7374124|NCT01117428|11626268|FG003|Overall Study|Death|0
7374125|NCT01117428|11626269|FG004|Overall Study|Death|0
7374126|NCT01117428|11626270|FG005|Overall Study|Death|1
7374127|NCT01117428|11626265|FG000|Overall Study|Physician Decision|0
7374128|NCT01117428|11626266|FG001|Overall Study|Physician Decision|1
7374129|NCT01117428|11626267|FG002|Overall Study|Physician Decision|0
7374130|NCT01117428|11626268|FG003|Overall Study|Physician Decision|0
7374131|NCT01117428|11626269|FG004|Overall Study|Physician Decision|0
7374132|NCT01117428|11626270|FG005|Overall Study|Physician Decision|0
7374133|NCT01117428|11626265|FG000|Overall Study|Withdrawal by Subject|0
7461433|NCT01838200|11757606|FG000|Overall Study|Adverse Event|0
7461434|NCT01838200|11757607|FG001|Overall Study|Adverse Event|2
7461435|NCT01838200|11757606|FG000|Overall Study|Progressive disease|3
7461436|NCT01838200|11757607|FG001|Overall Study|Progressive disease|0
7461437|NCT01838213|11757615|FG000|Overall Study|Ineligible|166
7461438|NCT01838213|11757616|FG001|Overall Study|Ineligible|191
7461439|NCT01838447|11757651|FG000|Overall Study|Change in surgical plan|1
7461440|NCT01838447|11757652|FG001|Overall Study|Change in surgical plan|2
7461441|NCT01838447|11757651|FG000|Overall Study|Withdrawal by Subject|1
7374134|NCT01117428|11626266|FG001|Overall Study|Withdrawal by Subject|0
7374135|NCT01117428|11626267|FG002|Overall Study|Withdrawal by Subject|1
7374136|NCT01117428|11626268|FG003|Overall Study|Withdrawal by Subject|0
7374137|NCT01117428|11626269|FG004|Overall Study|Withdrawal by Subject|0
7374138|NCT01117428|11626270|FG005|Overall Study|Withdrawal by Subject|0
7461442|NCT01838447|11757652|FG001|Overall Study|Withdrawal by Subject|1
7461443|NCT01838499|11757660|FG000|Overall Study|Protocol Violation|0
7374139|NCT01117428|11626265|FG000|Overall Study|Progressive disease|15
7374140|NCT01117428|11626266|FG001|Overall Study|Progressive disease|27
7374141|NCT01117428|11626267|FG002|Overall Study|Progressive disease|10
7374142|NCT01117428|11626268|FG003|Overall Study|Progressive disease|12
7374143|NCT01117428|11626269|FG004|Overall Study|Progressive disease|16
7374144|NCT01117428|11626270|FG005|Overall Study|Progressive disease|17
7374145|NCT01117454|11626288|FG000|Overall Study|Pregnancy|0
7374146|NCT01117454|11626289|FG001|Overall Study|Pregnancy|1
7374147|NCT01117480|11626295|FG000|Overall Study|Protocol Violation|8
7374148|NCT01117480|11626295|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
7374149|NCT01117623|11626307|FG000|Overall Study|Adverse Event|0
7374150|NCT01117623|11626308|FG001|Overall Study|Adverse Event|2
7374151|NCT01117623|11626309|FG002|Overall Study|Adverse Event|4
7374152|NCT01117623|11626310|FG003|Overall Study|Adverse Event|0
7374153|NCT01117623|11626311|FG004|Overall Study|Adverse Event|2
7374154|NCT01117623|11626312|FG005|Overall Study|Adverse Event|0
7374155|NCT01117623|11626313|FG006|Overall Study|Adverse Event|0
7374156|NCT01117623|11626314|FG007|Overall Study|Adverse Event|2
7374157|NCT01117623|11626307|FG000|Overall Study|Disease progression, recurrence, relapse|3
7374158|NCT01117623|11626308|FG001|Overall Study|Disease progression, recurrence, relapse|6
7374159|NCT01117623|11626309|FG002|Overall Study|Disease progression, recurrence, relapse|5
7374160|NCT01117623|11626310|FG003|Overall Study|Disease progression, recurrence, relapse|6
7374161|NCT01117623|11626311|FG004|Overall Study|Disease progression, recurrence, relapse|8
7374242|NCT01118299|11626465|FG001|Overall Study|Lost to Follow-up|1
7374162|NCT01117623|11626312|FG005|Overall Study|Disease progression, recurrence, relapse|14
7374163|NCT01117623|11626313|FG006|Overall Study|Disease progression, recurrence, relapse|5
7374164|NCT01117623|11626314|FG007|Overall Study|Disease progression, recurrence, relapse|22
7374165|NCT01117623|11626307|FG000|Overall Study|Withdrawal by Subject|0
7374166|NCT01117623|11626308|FG001|Overall Study|Withdrawal by Subject|0
7374167|NCT01117623|11626309|FG002|Overall Study|Withdrawal by Subject|2
7374168|NCT01117623|11626310|FG003|Overall Study|Withdrawal by Subject|0
7374169|NCT01117623|11626311|FG004|Overall Study|Withdrawal by Subject|0
7374170|NCT01117623|11626312|FG005|Overall Study|Withdrawal by Subject|1
7374171|NCT01117623|11626313|FG006|Overall Study|Withdrawal by Subject|1
7374172|NCT01117623|11626314|FG007|Overall Study|Withdrawal by Subject|1
7374173|NCT01117623|11626307|FG000|Overall Study|Non-compliance with study medication|0
7374174|NCT01117623|11626308|FG001|Overall Study|Non-compliance with study medication|0
7374175|NCT01117623|11626309|FG002|Overall Study|Non-compliance with study medication|0
7374176|NCT01117623|11626310|FG003|Overall Study|Non-compliance with study medication|0
7374177|NCT01117623|11626311|FG004|Overall Study|Non-compliance with study medication|0
7374178|NCT01117623|11626312|FG005|Overall Study|Non-compliance with study medication|0
7374179|NCT01117623|11626313|FG006|Overall Study|Non-compliance with study medication|0
7374180|NCT01117623|11626314|FG007|Overall Study|Non-compliance with study medication|1
7374181|NCT01117623|11626307|FG000|Overall Study|Invest. text: completed all planned txs|0
7374182|NCT01117623|11626308|FG001|Overall Study|Invest. text: completed all planned txs|0
7374183|NCT01117623|11626309|FG002|Overall Study|Invest. text: completed all planned txs|0
7374184|NCT01117623|11626310|FG003|Overall Study|Invest. text: completed all planned txs|0
7374185|NCT01117623|11626311|FG004|Overall Study|Invest. text: completed all planned txs|0
7374186|NCT01117623|11626312|FG005|Overall Study|Invest. text: completed all planned txs|1
7374187|NCT01117623|11626313|FG006|Overall Study|Invest. text: completed all planned txs|0
7374188|NCT01117623|11626314|FG007|Overall Study|Invest. text: completed all planned txs|0
7374189|NCT01117766|11626339|FG000|First Intervention|Adverse Event|0
7374190|NCT01117766|11626340|FG001|First Intervention|Adverse Event|1
7374191|NCT01117766|11626339|FG000|First Intervention|Protocol Violation|1
7374192|NCT01117766|11626340|FG001|First Intervention|Protocol Violation|0
7374193|NCT01117766|11626339|FG000|Washout Period|Protocol Violation|0
7374194|NCT01117766|11626340|FG001|Washout Period|Protocol Violation|2
7374195|NCT01117766|11626339|FG000|Second Intervention|Lost to Follow-up|1
7374196|NCT01117766|11626340|FG001|Second Intervention|Lost to Follow-up|0
7374197|NCT01117766|11626339|FG000|Second Intervention|Other|1
7374198|NCT01117766|11626340|FG001|Second Intervention|Other|2
7374199|NCT01117766|11626339|FG000|Second Intervention|Adverse Event|0
7374200|NCT01117766|11626340|FG001|Second Intervention|Adverse Event|2
7374201|NCT01117766|11626339|FG000|Second Intervention|Withdrawal by Subject|0
7374202|NCT01117766|11626340|FG001|Second Intervention|Withdrawal by Subject|1
7374203|NCT01117792|11626346|FG000|Overall Study|Death|1
7374204|NCT01117792|11626346|FG000|Overall Study|Adverse Event|3
7374205|NCT01117857|11626350|FG000|Overall Study|Lost to Follow-up|4
7374206|NCT01117857|11626350|FG000|Overall Study|Withdrawal by Subject|4
7374207|NCT01117857|11626350|FG000|Overall Study|Physician Decision|1
7374208|NCT01117870|11626356|FG000|Overall Study|Inability to place needle|1
7374209|NCT01117870|11626357|FG001|Overall Study|Inability to place needle|0
7374210|NCT01117987|11626378|FG000|Overall Study|Protocol deviation|0
7374211|NCT01117987|11626379|FG001|Overall Study|Protocol deviation|1
7374212|NCT01117987|11626378|FG000|Overall Study|Subject no longer requires study drug|1
7374213|NCT01117987|11626379|FG001|Overall Study|Subject no longer requires study drug|0
7374214|NCT01117987|11626378|FG000|Overall Study|Lost to Follow-up|1
7374215|NCT01117987|11626379|FG001|Overall Study|Lost to Follow-up|1
7461444|NCT01838499|11757661|FG001|Overall Study|Protocol Violation|1
7374216|NCT01117987|11626378|FG000|Overall Study|Abnormal test procedure result|2
7374217|NCT01117987|11626379|FG001|Overall Study|Abnormal test procedure result|0
7374218|NCT01117987|11626378|FG000|Overall Study|Lack of Efficacy|3
7374219|NCT01117987|11626379|FG001|Overall Study|Lack of Efficacy|4
7374220|NCT01117987|11626378|FG000|Overall Study|Death|5
7374221|NCT01117987|11626379|FG001|Overall Study|Death|10
7374222|NCT01117987|11626378|FG000|Overall Study|Withdrawal by Subject|5
7374223|NCT01117987|11626379|FG001|Overall Study|Withdrawal by Subject|10
7374224|NCT01117987|11626378|FG000|Overall Study|Adverse Event|19
7374225|NCT01117987|11626379|FG001|Overall Study|Adverse Event|26
7374226|NCT01117987|11626378|FG000|Overall Study|Administrative problems|25
7374227|NCT01117987|11626379|FG001|Overall Study|Administrative problems|22
7374228|NCT01118052|11626385|FG000|Overall Study|Never treated|2
7374229|NCT01118117|11626406|FG000|Overall Study|Death|8
7374230|NCT01118117|11626407|FG001|Overall Study|Death|0
7374231|NCT01118117|11626406|FG000|Overall Study|Lost to Follow-up|6
7374232|NCT01118117|11626407|FG001|Overall Study|Lost to Follow-up|0
7374233|NCT01118117|11626406|FG000|Overall Study|Missed 12 Month Visit|7
7374234|NCT01118117|11626407|FG001|Overall Study|Missed 12 Month Visit|0
7374235|NCT01118143|11626415|FG000|Overall Study|Withdrawal by Subject|2
7374236|NCT01118143|11626416|FG001|Overall Study|Withdrawal by Subject|5
7374237|NCT01118299|11626464|FG000|Overall Study|Death|7
7374238|NCT01118299|11626465|FG001|Overall Study|Death|5
7374239|NCT01118299|11626464|FG000|Overall Study|Withdrawal by Subject|8
7374240|NCT01118299|11626465|FG001|Overall Study|Withdrawal by Subject|8
7374241|NCT01118299|11626464|FG000|Overall Study|Lost to Follow-up|2
7374243|NCT01118299|11626464|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
7374244|NCT01118299|11626465|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
7374245|NCT01118312|11626472|FG000|Overall Study|Lost to Follow-up|33
7374246|NCT01118312|11626473|FG001|Overall Study|Lost to Follow-up|32
7374247|NCT01118312|11626472|FG000|Overall Study|Withdrawal by Subject|1
7374248|NCT01118312|11626473|FG001|Overall Study|Withdrawal by Subject|3
7374249|NCT01118325|11626482|FG000|Overall Study|Adverse Event|1
7374250|NCT01118325|11626483|FG001|Overall Study|Adverse Event|0
7374251|NCT01118325|11626484|FG002|Overall Study|Adverse Event|1
7374252|NCT01118351|11626514|FG000|Overall Study|Adverse Event|3
7374253|NCT01118351|11626514|FG000|Overall Study|Withdrawal by Subject|1
7374254|NCT01118377|11626518|FG000|Overall Study|Did Not Receive Study Medication|1
7374255|NCT01118377|11626518|FG000|Overall Study|Death|38
7374256|NCT01118377|11626518|FG000|Overall Study|Failure to Return|3
7374257|NCT01118455|11626524|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
7374258|NCT01118455|11626525|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
7374259|NCT01118520|11626542|FG000|Overall Study|AAA repair|9
7374260|NCT01118520|11626543|FG001|Overall Study|AAA repair|7
7374261|NCT01118520|11626544|FG002|Overall Study|AAA repair|9
7374262|NCT01118520|11626542|FG000|Overall Study|Adverse Event|3
7374263|NCT01118520|11626543|FG001|Overall Study|Adverse Event|3
7374264|NCT01118520|11626544|FG002|Overall Study|Adverse Event|3
7374265|NCT01118520|11626542|FG000|Overall Study|Withdrawal by Subject|8
7374266|NCT01118520|11626543|FG001|Overall Study|Withdrawal by Subject|13
7374267|NCT01118520|11626544|FG002|Overall Study|Withdrawal by Subject|8
7374268|NCT01118663|11626558|FG000|Overall Study|Adverse Event|2
7374269|NCT01118663|11626559|FG001|Overall Study|Adverse Event|1
7374270|NCT01118663|11626558|FG000|Overall Study|Withdrawal by Subject|0
7374271|NCT01118663|11626559|FG001|Overall Study|Withdrawal by Subject|1
7374272|NCT01118728|11626595|FG000|Overall Study|Adverse Event|17
7374273|NCT01118728|11626595|FG000|Overall Study|Lack of Efficacy|27
7374274|NCT01118728|11626595|FG000|Overall Study|Sponsor's decision to discontinue study|172
7374275|NCT01118728|11626595|FG000|Overall Study|Withdrawal by Subject|3
7374276|NCT01118728|11626595|FG000|Overall Study|Lost to Follow-up|4
7374277|NCT01118780|11626612|FG000|Overall Study|Adverse Event|15
7374278|NCT01118780|11626613|FG001|Overall Study|Adverse Event|15
7374279|NCT01118780|11626612|FG000|Overall Study|Death|1
7374280|NCT01118780|11626613|FG001|Overall Study|Death|0
7374281|NCT01118780|11626612|FG000|Overall Study|Lack of Efficacy|2
7374282|NCT01118780|11626613|FG001|Overall Study|Lack of Efficacy|6
7374283|NCT01118780|11626612|FG000|Overall Study|Physician Decision|2
7374284|NCT01118780|11626613|FG001|Overall Study|Physician Decision|0
7374285|NCT01118780|11626612|FG000|Overall Study|Protocol Violation|3
7374286|NCT01118780|11626613|FG001|Overall Study|Protocol Violation|6
7374287|NCT01118780|11626612|FG000|Overall Study|Withdrawal by Subject|13
7374288|NCT01118780|11626613|FG001|Overall Study|Withdrawal by Subject|8
7374289|NCT01118949|11626626|FG000|Overall Study|Adverse Event|5
7374290|NCT01118949|11626626|FG000|Overall Study|Withdrawal by Subject|4
7374291|NCT01118962|11626630|FG000|Overall Study|Adverse Event|2
7374292|NCT01118962|11626630|FG000|Overall Study|Lack of Efficacy|1
7374293|NCT01118962|11626630|FG000|Overall Study|Protocol Violation|1
7374294|NCT01118962|11626630|FG000|Overall Study|Withdrawal by Subject|4
7374295|NCT01118962|11626630|FG000|Overall Study|Pregnancy|1
7374296|NCT01118962|11626630|FG000|Overall Study|Non-compliance with Medicinal Product|1
7374297|NCT01118975|11626636|FG000|Overall Study|Adverse Event|0
7374298|NCT01118975|11626637|FG001|Overall Study|Adverse Event|1
7374299|NCT01119001|11626655|FG000|Overall Study|Withdrawal by Subject|2
7374300|NCT01119105|11626668|FG000|Overall Study|Withdrawal by Subject|1
7374301|NCT01119105|11626669|FG001|Overall Study|Withdrawal by Subject|1
7374302|NCT01119105|11626670|FG002|Overall Study|Withdrawal by Subject|1
7374303|NCT01119105|11626668|FG000|Overall Study|Lost to Follow-up|0
7374304|NCT01119105|11626669|FG001|Overall Study|Lost to Follow-up|2
7374305|NCT01119105|11626670|FG002|Overall Study|Lost to Follow-up|5
7374306|NCT01119105|11626668|FG000|Overall Study|Adverse Event|1
7374307|NCT01119105|11626669|FG001|Overall Study|Adverse Event|0
7374308|NCT01119105|11626670|FG002|Overall Study|Adverse Event|1
7374309|NCT01119105|11626668|FG000|Overall Study|study drug missed on 2 consecutive days|1
7374310|NCT01119105|11626669|FG001|Overall Study|study drug missed on 2 consecutive days|2
7374311|NCT01119105|11626670|FG002|Overall Study|study drug missed on 2 consecutive days|1
7374312|NCT01119105|11626668|FG000|Overall Study|Other|1
7374313|NCT01119105|11626669|FG001|Overall Study|Other|1
7374314|NCT01119105|11626670|FG002|Overall Study|Other|0
7374315|NCT01119118|11626678|FG000|Overall Study|Adverse Event|1
7374316|NCT01119131|11626685|FG000|Overall Study|Adverse Event|1
7374317|NCT01119131|11626686|FG001|Overall Study|Adverse Event|1
7374318|NCT01119131|11626687|FG002|Overall Study|Adverse Event|1
7374319|NCT01119131|11626685|FG000|Overall Study|Non-Compliance|1
7374320|NCT01119131|11626686|FG001|Overall Study|Non-Compliance|0
7374321|NCT01119131|11626687|FG002|Overall Study|Non-Compliance|4
7374322|NCT01119131|11626685|FG000|Overall Study|Physician Decision|0
7374323|NCT01119131|11626686|FG001|Overall Study|Physician Decision|0
7374324|NCT01119131|11626687|FG002|Overall Study|Physician Decision|1
7374325|NCT01119248|11626711|FG000|Overall Study|Physician Decision|5
7374326|NCT01119287|11626722|FG000|Overall Study|Patient Decision, not related to AE|0
7374327|NCT01119287|11626723|FG001|Overall Study|Patient Decision, not related to AE|0
7374328|NCT01119287|11626724|FG002|Overall Study|Patient Decision, not related to AE|2
7374329|NCT01119287|11626725|FG003|Overall Study|Patient Decision, not related to AE|2
7374330|NCT01119287|11626726|FG004|Overall Study|Patient Decision, not related to AE|1
7374331|NCT01119287|11626727|FG005|Overall Study|Patient Decision, not related to AE|0
7374332|NCT01119443|11626741|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
7374333|NCT01119443|11626742|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
7374334|NCT01119508|11626791|FG000|Overall Study|Adverse Event|56
7374335|NCT01119508|11626791|FG000|Overall Study|Withdrawal by Subject|2
7374336|NCT01119508|11626791|FG000|Overall Study|Died before tumor response evaluation|1
7374337|NCT01119625|11626797|FG000|Overall Study|Lost to Follow-up|1
7374338|NCT01119625|11626798|FG001|Overall Study|Lost to Follow-up|2
7374339|NCT01119625|11626797|FG000|Overall Study|Withdrawal by Subject|2
7374340|NCT01119625|11626798|FG001|Overall Study|Withdrawal by Subject|1
7374341|NCT01119625|11626797|FG000|Overall Study|Other|0
7374342|NCT01119625|11626798|FG001|Overall Study|Other|1
7374343|NCT01119703|11626806|FG000|Overall Study|Adverse Event|0
7374344|NCT01119703|11626807|FG001|Overall Study|Adverse Event|1
7374345|NCT01119768|11626826|FG000|Treatment Period|Lack of Efficacy|18
7374346|NCT01119768|11626827|FG001|Treatment Period|Lack of Efficacy|25
7374347|NCT01119846|11626840|FG000|Overall Study|Adverse Event|1
7374348|NCT01119846|11626841|FG001|Overall Study|Adverse Event|0
7374349|NCT01119846|11626842|FG002|Overall Study|Adverse Event|6
7374350|NCT01119846|11626840|FG000|Overall Study|Physician Decision|1
7374351|NCT01119846|11626841|FG001|Overall Study|Physician Decision|0
7374352|NCT01119846|11626842|FG002|Overall Study|Physician Decision|0
7374353|NCT01119846|11626840|FG000|Overall Study|Protocol Violation|0
7374354|NCT01119846|11626841|FG001|Overall Study|Protocol Violation|0
7374355|NCT01119846|11626842|FG002|Overall Study|Protocol Violation|1
7374356|NCT01119846|11626840|FG000|Overall Study|Withdrawal by Subject|0
7374357|NCT01119846|11626841|FG001|Overall Study|Withdrawal by Subject|0
7374358|NCT01119846|11626842|FG002|Overall Study|Withdrawal by Subject|4
7374359|NCT01119859|11626879|FG000|Overall Study|Adverse Event|9
7374360|NCT01119859|11626880|FG001|Overall Study|Adverse Event|10
7374361|NCT01119859|11626879|FG000|Overall Study|Death|2
7374362|NCT01119859|11626880|FG001|Overall Study|Death|0
7374363|NCT01119859|11626879|FG000|Overall Study|Insufficient therapeutic response|7
7374364|NCT01119859|11626880|FG001|Overall Study|Insufficient therapeutic response|14
7374365|NCT01119859|11626879|FG000|Overall Study|Refused treatment|3
7374366|NCT01119859|11626880|FG001|Overall Study|Refused treatment|6
7374367|NCT01119859|11626879|FG000|Overall Study|Failure to return|3
7374368|NCT01119859|11626880|FG001|Overall Study|Failure to return|0
7374369|NCT01119898|11626888|FG000|Overall Study|Adverse Event|4
7374370|NCT01119898|11626889|FG001|Overall Study|Adverse Event|5
7374371|NCT01119898|11626888|FG000|Overall Study|Withdrawal by Subject|1
7374372|NCT01119898|11626889|FG001|Overall Study|Withdrawal by Subject|4
7374373|NCT01119898|11626888|FG000|Overall Study|Lack of Efficacy|0
7374374|NCT01119898|11626889|FG001|Overall Study|Lack of Efficacy|2
7374375|NCT01119898|11626888|FG000|Overall Study|Protocol Violation|1
7374376|NCT01119898|11626889|FG001|Overall Study|Protocol Violation|1
7374377|NCT01119898|11626888|FG000|Overall Study|Medical procedure|1
7374378|NCT01119898|11626889|FG001|Overall Study|Medical procedure|0
7374379|NCT01119898|11626888|FG000|Overall Study|Randomized in error did not participate|1
7374380|NCT01119898|11626889|FG001|Overall Study|Randomized in error did not participate|0
7374381|NCT01119937|11626897|FG000|Overall Study|Adverse Event|11
7374382|NCT01119937|11626898|FG001|Overall Study|Adverse Event|5
7374383|NCT01119937|11626897|FG000|Overall Study|Protocol deviation|3
7374384|NCT01119937|11626898|FG001|Overall Study|Protocol deviation|1
7374385|NCT01119937|11626897|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7374386|NCT01119937|11626898|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7374387|NCT01119937|11626897|FG000|Overall Study|Withdrawal by Subject|2
7374388|NCT01119937|11626898|FG001|Overall Study|Withdrawal by Subject|1
7374389|NCT01119950|11626904|FG000|Overall Study|Adverse Event|25
7374390|NCT01119950|11626904|FG000|Overall Study|Withdrawal by Subject|9
7374391|NCT01119950|11626904|FG000|Overall Study|Protocol Violation|5
7374392|NCT01119950|11626904|FG000|Overall Study|Lost to Follow-up|4
7374393|NCT01119950|11626904|FG000|Overall Study|Administrative|2
7374394|NCT01119950|11626904|FG000|Overall Study|Abnormal lab value|1
7374395|NCT01119950|11626904|FG000|Overall Study|Death|1
7374396|NCT01119963|11626932|FG000|Overall Study|Lost to Follow-up|1
7374397|NCT01119963|11626933|FG001|Overall Study|Lost to Follow-up|1
7374398|NCT01120028|11626945|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7374399|NCT01120028|11626946|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
7374400|NCT01120028|11626947|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7374401|NCT01120028|11626948|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
7374402|NCT01120028|11626945|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
7374403|NCT01120028|11626946|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
7374404|NCT01120028|11626947|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7374405|NCT01120028|11626948|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
7374406|NCT01120067|11626961|FG000|Overall Study|Lost to Follow-up|3
7374407|NCT01120067|11626962|FG001|Overall Study|Lost to Follow-up|1
7374408|NCT01120067|11626961|FG000|Overall Study|fail to engage >3 sessions|2
7374409|NCT01120067|11626962|FG001|Overall Study|fail to engage >3 sessions|0
7374410|NCT01120093|11626968|FG000|Treatment Period 1|Adverse Event|0
7374411|NCT01120093|11626969|FG001|Treatment Period 1|Adverse Event|0
7461445|NCT01838499|11757660|FG000|Overall Study|Lost to Follow-up|2
7461446|NCT01838499|11757661|FG001|Overall Study|Lost to Follow-up|4
7461447|NCT01838499|11757660|FG000|Overall Study|Lack of Efficacy|1
7461448|NCT01838499|11757661|FG001|Overall Study|Lack of Efficacy|2
7461449|NCT01838499|11757660|FG000|Overall Study|Adverse Event|2
7461450|NCT01838499|11757661|FG001|Overall Study|Adverse Event|1
7461451|NCT01838499|11757660|FG000|Overall Study|Withdrawal by Subject|19
7461452|NCT01838499|11757661|FG001|Overall Study|Withdrawal by Subject|9
7461453|NCT01838551|11757667|FG000|Overall Study|Adverse Event|16
7461454|NCT01838551|11757667|FG000|Overall Study|Death|1
7461455|NCT01838551|11757667|FG000|Overall Study|Lack of Efficacy|10
7533377|NCT02684370|11879636|FG003|Part B|Adverse Event|0
7533378|NCT02684370|11879637|FG004|Part B|Adverse Event|2
7533379|NCT02684370|11879638|FG005|Part B|Adverse Event|1
7533380|NCT02684370|11879633|FG000|Part B|Lost to Follow-up|0
7533381|NCT02684370|11879634|FG001|Part B|Lost to Follow-up|0
7533382|NCT02684370|11879635|FG002|Part B|Lost to Follow-up|0
7533383|NCT02684370|11879636|FG003|Part B|Lost to Follow-up|1
7533384|NCT02684370|11879637|FG004|Part B|Lost to Follow-up|2
7533385|NCT02684370|11879638|FG005|Part B|Lost to Follow-up|5
7533386|NCT02684370|11879633|FG000|Part B|Subject Withdrawal|0
7533387|NCT02684370|11879634|FG001|Part B|Subject Withdrawal|0
7533388|NCT02684370|11879635|FG002|Part B|Subject Withdrawal|0
7533389|NCT02684370|11879636|FG003|Part B|Subject Withdrawal|1
7533390|NCT02684370|11879637|FG004|Part B|Subject Withdrawal|1
7533391|NCT02684370|11879638|FG005|Part B|Subject Withdrawal|2
7533392|NCT02684617|11879702|FG000|Overall Study|Adverse Event|1
7533393|NCT02684617|11879703|FG001|Overall Study|Adverse Event|0
7533394|NCT02684617|11879704|FG002|Overall Study|Adverse Event|1
7533395|NCT02684617|11879702|FG000|Overall Study|Death|8
7533396|NCT02684617|11879703|FG001|Overall Study|Death|16
7533397|NCT02684617|11879704|FG002|Overall Study|Death|28
7533398|NCT02684617|11879702|FG000|Overall Study|Withdrawal by Subject|2
7533399|NCT02684617|11879703|FG001|Overall Study|Withdrawal by Subject|0
7533400|NCT02684617|11879704|FG002|Overall Study|Withdrawal by Subject|4
7533401|NCT02684617|11879702|FG000|Overall Study|Screen Failure|1
7533402|NCT02684617|11879703|FG001|Overall Study|Screen Failure|0
7533403|NCT02684617|11879704|FG002|Overall Study|Screen Failure|2
7533404|NCT02684617|11879702|FG000|Overall Study|Study Terminated by Sponsor|6
7533405|NCT02684617|11879703|FG001|Overall Study|Study Terminated by Sponsor|1
7533406|NCT02684617|11879704|FG002|Overall Study|Study Terminated by Sponsor|5
7533407|NCT02684981|11879742|FG000|Overall Study|Permanently discontinued the treatment|157
7533408|NCT02684981|11879743|FG001|Overall Study|Permanently discontinued the treatment|161
7533409|NCT02684981|11879744|FG002|Overall Study|Permanently discontinued the treatment|110
7533410|NCT02684981|11879742|FG000|Overall Study|Other|83
7461456|NCT01838551|11757667|FG000|Overall Study|Physician Decision|4
7461457|NCT01838551|11757667|FG000|Overall Study|Withdrawal by Subject|10
7461458|NCT01838551|11757667|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
7461459|NCT01838590|11757675|FG000|Overall Study|Lack of Efficacy|12
7461460|NCT01838590|11757676|FG001|Overall Study|Lack of Efficacy|4
7533411|NCT02684981|11879743|FG001|Overall Study|Other|49
7533412|NCT02684981|11879744|FG002|Overall Study|Other|17
7461461|NCT01838590|11757675|FG000|Overall Study|Lost to Follow-up|0
7461462|NCT01838590|11757676|FG001|Overall Study|Lost to Follow-up|1
7461463|NCT01838616|11757688|FG000|Titration Period|Adverse Event|18
7461464|NCT01838616|11757689|FG001|Titration Period|Adverse Event|48
7533413|NCT02685033|11879764|FG000|Overall Study|Withdrawal of Consent|0
7374412|NCT01120093|11626970|FG002|Treatment Period 1|Adverse Event|1
7374413|NCT01120093|11626971|FG003|Treatment Period 1|Adverse Event|0
7374414|NCT01120093|11626972|FG004|Treatment Period 1|Adverse Event|1
7374415|NCT01120093|11626968|FG000|Treatment Period 1|Withdrawal by Subject|0
7374416|NCT01120093|11626969|FG001|Treatment Period 1|Withdrawal by Subject|1
7374417|NCT01120093|11626970|FG002|Treatment Period 1|Withdrawal by Subject|0
7374418|NCT01120093|11626971|FG003|Treatment Period 1|Withdrawal by Subject|0
7374419|NCT01120093|11626972|FG004|Treatment Period 1|Withdrawal by Subject|0
7374420|NCT01120093|11626968|FG000|Treatment Period 2|Adverse Event|0
7374421|NCT01120093|11626969|FG001|Treatment Period 2|Adverse Event|0
7374422|NCT01120093|11626970|FG002|Treatment Period 2|Adverse Event|0
7374423|NCT01120093|11626971|FG003|Treatment Period 2|Adverse Event|1
7374424|NCT01120093|11626972|FG004|Treatment Period 2|Adverse Event|0
7374425|NCT01120093|11626968|FG000|Treatment Period 2|Withdrawal by Subject|0
7374426|NCT01120093|11626969|FG001|Treatment Period 2|Withdrawal by Subject|0
7374427|NCT01120093|11626970|FG002|Treatment Period 2|Withdrawal by Subject|0
7374428|NCT01120093|11626971|FG003|Treatment Period 2|Withdrawal by Subject|0
7374429|NCT01120093|11626972|FG004|Treatment Period 2|Withdrawal by Subject|1
7374430|NCT01120093|11626968|FG000|Treatment Period 3|Lack of Efficacy|0
7374431|NCT01120093|11626969|FG001|Treatment Period 3|Lack of Efficacy|0
7374432|NCT01120093|11626970|FG002|Treatment Period 3|Lack of Efficacy|0
7374433|NCT01120093|11626971|FG003|Treatment Period 3|Lack of Efficacy|1
7374434|NCT01120093|11626972|FG004|Treatment Period 3|Lack of Efficacy|0
7374435|NCT01120093|11626968|FG000|Treatment Period 3|Adverse Event|0
7374436|NCT01120093|11626969|FG001|Treatment Period 3|Adverse Event|0
7374437|NCT01120093|11626970|FG002|Treatment Period 3|Adverse Event|0
7374438|NCT01120093|11626971|FG003|Treatment Period 3|Adverse Event|0
7374439|NCT01120093|11626972|FG004|Treatment Period 3|Adverse Event|1
7374440|NCT01120093|11626968|FG000|Treatment Period 3|Withdrawal by Subject|0
7374441|NCT01120093|11626969|FG001|Treatment Period 3|Withdrawal by Subject|0
7374442|NCT01120093|11626970|FG002|Treatment Period 3|Withdrawal by Subject|1
7374443|NCT01120093|11626971|FG003|Treatment Period 3|Withdrawal by Subject|0
7374444|NCT01120093|11626972|FG004|Treatment Period 3|Withdrawal by Subject|0
7374445|NCT01120093|11626968|FG000|Treatment Period 4|Adverse Event|1
7374446|NCT01120093|11626969|FG001|Treatment Period 4|Adverse Event|0
7374447|NCT01120093|11626970|FG002|Treatment Period 4|Adverse Event|0
7374448|NCT01120093|11626971|FG003|Treatment Period 4|Adverse Event|0
7374449|NCT01120093|11626972|FG004|Treatment Period 4|Adverse Event|0
7374450|NCT01120093|11626968|FG000|Treatment Period 5|Adverse Event|0
7374451|NCT01120093|11626969|FG001|Treatment Period 5|Adverse Event|1
7374452|NCT01120093|11626970|FG002|Treatment Period 5|Adverse Event|0
7374453|NCT01120093|11626971|FG003|Treatment Period 5|Adverse Event|1
7374454|NCT01120093|11626972|FG004|Treatment Period 5|Adverse Event|0
7374455|NCT01120184|11626987|FG000|Overall Study|Adverse Event|0
7374456|NCT01120184|11626988|FG001|Overall Study|Adverse Event|1
7374457|NCT01120184|11626989|FG002|Overall Study|Adverse Event|0
7374458|NCT01120184|11626987|FG000|Overall Study|Lost to Follow-up|13
7374459|NCT01120184|11626988|FG001|Overall Study|Lost to Follow-up|13
7374460|NCT01120184|11626989|FG002|Overall Study|Lost to Follow-up|11
7374461|NCT01120184|11626987|FG000|Overall Study|Physician Decision|9
7374462|NCT01120184|11626988|FG001|Overall Study|Physician Decision|1
7374463|NCT01120184|11626989|FG002|Overall Study|Physician Decision|3
7374464|NCT01120184|11626987|FG000|Overall Study|Reason not Specified|8
7374465|NCT01120184|11626988|FG001|Overall Study|Reason not Specified|3
7374466|NCT01120184|11626989|FG002|Overall Study|Reason not Specified|12
7374467|NCT01120184|11626987|FG000|Overall Study|Sponsor Decision to Terminate Study|133
7374468|NCT01120184|11626988|FG001|Overall Study|Sponsor Decision to Terminate Study|144
7374469|NCT01120184|11626989|FG002|Overall Study|Sponsor Decision to Terminate Study|143
7374470|NCT01120184|11626987|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
7374471|NCT01120184|11626988|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
7374472|NCT01120184|11626989|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
7374473|NCT01120184|11626987|FG000|Overall Study|Death|170
7374474|NCT01120184|11626988|FG001|Overall Study|Death|176
7374475|NCT01120184|11626989|FG002|Overall Study|Death|169
7374476|NCT01120210|11627009|FG000|MAIN INFUSION|Adverse Event|1
7374477|NCT01120210|11627010|FG001|MAIN INFUSION|Adverse Event|0
7374478|NCT01120210|11627009|FG000|MAIN INFUSION|Withdrawal by Subject|0
7374479|NCT01120210|11627010|FG001|MAIN INFUSION|Withdrawal by Subject|1
7387057|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387058|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387059|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387060|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7387061|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387062|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387063|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387064|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387065|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387066|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387067|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387068|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
7387069|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
7387728|NCT01215916|11646439|FG001|Overall Study|Death|1
7374480|NCT01120275|11627037|FG000|Overall Study|Adverse Event|3
7374481|NCT01120275|11627037|FG000|Overall Study|Progression|27
7374482|NCT01120275|11627037|FG000|Overall Study|Ineligible|3
7374483|NCT01120275|11627037|FG000|Overall Study|Withdrawal by Subject|1
7374484|NCT01120275|11627037|FG000|Overall Study|Refusal|1
7374485|NCT01120275|11627037|FG000|Overall Study|Not specific|1
7374486|NCT01120379|11627042|FG000|One Year Timepoint|Withdrawal by Subject|41
7374487|NCT01120379|11627042|FG000|One Year Timepoint|Lost to Follow-up|115
7374488|NCT01120379|11627042|FG000|One Year Timepoint|Death|108
7374489|NCT01120379|11627042|FG000|One Year Timepoint|Physician Decision|9
7374490|NCT01120379|11627042|FG000|One Year Timepoint|Any other reason for early termination|5
7374491|NCT01120379|11627042|FG000|Two Year Timepoint|Withdrawal by Subject|11
7374492|NCT01120379|11627042|FG000|Two Year Timepoint|Lost to Follow-up|87
7374493|NCT01120379|11627042|FG000|Two Year Timepoint|Death|123
7374494|NCT01120379|11627042|FG000|Two Year Timepoint|Physician Decision|12
7374495|NCT01120379|11627042|FG000|Two Year Timepoint|Any other reason for early termination|4
7374496|NCT01120379|11627042|FG000|Three Year Timepoint|Withdrawal by Subject|25
7374497|NCT01120379|11627042|FG000|Three Year Timepoint|Lost to Follow-up|43
7374498|NCT01120379|11627042|FG000|Three Year Timepoint|Death|120
7374499|NCT01120379|11627042|FG000|Three Year Timepoint|Physician Decision|9
7374500|NCT01120379|11627042|FG000|Three Year Timepoint|Any other reason for early termination|17
7374501|NCT01120379|11627042|FG000|Four Year Timepoint|Withdrawal by Subject|5
7374502|NCT01120379|11627042|FG000|Four Year Timepoint|Lost to Follow-up|10
7374503|NCT01120379|11627042|FG000|Four Year Timepoint|Death|131
7374504|NCT01120379|11627042|FG000|Four Year Timepoint|Physician Decision|5
7374505|NCT01120379|11627042|FG000|Four Year Timepoint|Any other reason for early termination|217
7374506|NCT01120600|11627059|FG000|Overall Study|Adverse Event|7
7374507|NCT01120600|11627060|FG001|Overall Study|Adverse Event|7
7374508|NCT01120600|11627059|FG000|Overall Study|Excessive Bone Loss|0
7374509|NCT01120600|11627060|FG001|Overall Study|Excessive Bone Loss|4
7374510|NCT01120600|11627059|FG000|Overall Study|Lost to Follow-up|1
7374511|NCT01120600|11627060|FG001|Overall Study|Lost to Follow-up|3
7374512|NCT01120600|11627059|FG000|Overall Study|Physician Decision|1
7374513|NCT01120600|11627060|FG001|Overall Study|Physician Decision|3
7374514|NCT01120600|11627059|FG000|Overall Study|Protocol Violation|0
7374515|NCT01120600|11627060|FG001|Overall Study|Protocol Violation|4
7374516|NCT01120600|11627059|FG000|Overall Study|Withdrawal by Subject|10
7374517|NCT01120600|11627060|FG001|Overall Study|Withdrawal by Subject|11
7374518|NCT01120626|11627068|FG000|Overall Study|Withdrawal by Subject|1
7374519|NCT01120626|11627069|FG001|Overall Study|Withdrawal by Subject|0
7374520|NCT01120691|11627095|FG000|Overall Study|Adverse Event|59
7374521|NCT01120691|11627096|FG001|Overall Study|Adverse Event|67
7374522|NCT01120691|11627097|FG002|Overall Study|Adverse Event|47
7374523|NCT01120691|11627095|FG000|Overall Study|Subject withdrew consent|33
7374524|NCT01120691|11627096|FG001|Overall Study|Subject withdrew consent|50
7374525|NCT01120691|11627097|FG002|Overall Study|Subject withdrew consent|44
7374526|NCT01120691|11627095|FG000|Overall Study|Death|21
7374527|NCT01120691|11627096|FG001|Overall Study|Death|22
7374528|NCT01120691|11627097|FG002|Overall Study|Death|24
7374529|NCT01120691|11627095|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7374530|NCT01120691|11627096|FG001|Overall Study|Unsatisfactory therapeutic effect|32
7374531|NCT01120691|11627097|FG002|Overall Study|Unsatisfactory therapeutic effect|38
7374532|NCT01120691|11627095|FG000|Overall Study|Administrative problems|15
7374533|NCT01120691|11627096|FG001|Overall Study|Administrative problems|8
7374534|NCT01120691|11627097|FG002|Overall Study|Administrative problems|9
7374535|NCT01120691|11627095|FG000|Overall Study|Protocol deviation|13
7374536|NCT01120691|11627096|FG001|Overall Study|Protocol deviation|12
7374537|NCT01120691|11627097|FG002|Overall Study|Protocol deviation|12
7374538|NCT01120691|11627095|FG000|Overall Study|Lost to Follow-up|5
7374539|NCT01120691|11627096|FG001|Overall Study|Lost to Follow-up|6
7374540|NCT01120691|11627097|FG002|Overall Study|Lost to Follow-up|4
7374541|NCT01120691|11627095|FG000|Overall Study|Abnormal test procedure result(s)|3
7374542|NCT01120691|11627096|FG001|Overall Study|Abnormal test procedure result(s)|2
7374543|NCT01120691|11627097|FG002|Overall Study|Abnormal test procedure result(s)|1
7374544|NCT01120691|11627095|FG000|Overall Study|Patient's inability to use the device|3
7374545|NCT01120691|11627096|FG001|Overall Study|Patient's inability to use the device|1
7374546|NCT01120691|11627097|FG002|Overall Study|Patient's inability to use the device|0
7374547|NCT01120691|11627095|FG000|Overall Study|Abnormal laboratory value(s)|1
7374548|NCT01120691|11627096|FG001|Overall Study|Abnormal laboratory value(s)|3
7374549|NCT01120691|11627097|FG002|Overall Study|Abnormal laboratory value(s)|4
7374550|NCT01120717|11627188|FG000|Overall Study|Withdrawal by Subject|11
7374551|NCT01120717|11627189|FG001|Overall Study|Withdrawal by Subject|6
7374552|NCT01120717|11627188|FG000|Overall Study|Adverse Event|10
7374553|NCT01120717|11627189|FG001|Overall Study|Adverse Event|6
7374554|NCT01120717|11627188|FG000|Overall Study|Protocol Deviation|2
7374555|NCT01120717|11627189|FG001|Overall Study|Protocol Deviation|5
7374556|NCT01120717|11627188|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7374557|NCT01120717|11627189|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
7374558|NCT01120717|11627188|FG000|Overall Study|Lost to Follow-up|2
7374559|NCT01120717|11627189|FG001|Overall Study|Lost to Follow-up|3
7374560|NCT01120717|11627188|FG000|Overall Study|Death|3
7374561|NCT01120717|11627189|FG001|Overall Study|Death|1
7374562|NCT01120717|11627188|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7374563|NCT01120717|11627189|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7374564|NCT01120756|11627197|FG000|Overall Study|Withdrawal by Subject|1
7374565|NCT01120756|11627198|FG001|Overall Study|Withdrawal by Subject|1
7374566|NCT01120782|11627204|FG000|Overall Study|Test article shipping error|11
7374567|NCT01120899|11627216|FG000|Overall Study|Withdrawal by Subject|3
7374568|NCT01121146|11627226|FG000|Overall Study|Death|17
7374569|NCT01121146|11627227|FG001|Overall Study|Death|15
7374570|NCT01121146|11627226|FG000|Overall Study|Adverse Event|2
7374571|NCT01121146|11627227|FG001|Overall Study|Adverse Event|11
7374572|NCT01121146|11627226|FG000|Overall Study|Lost to Follow-up|7
7374573|NCT01121146|11627227|FG001|Overall Study|Lost to Follow-up|16
7374574|NCT01121185|11627246|FG000|Overall Study|Not infused|0
7374575|NCT01121185|11627247|FG001|Overall Study|Not infused|1
7374576|NCT01121185|11627246|FG000|Overall Study|Not transplanted|1
7374577|NCT01121185|11627247|FG001|Overall Study|Not transplanted|0
7374578|NCT01121263|11627288|FG000|Overall Study|Death|3
7374579|NCT01121263|11627289|FG001|Overall Study|Death|2
7374580|NCT01121263|11627288|FG000|Overall Study|Lost to Follow-up|22
7374581|NCT01121263|11627289|FG001|Overall Study|Lost to Follow-up|12
7374582|NCT01121263|11627288|FG000|Overall Study|Withdrawal by Subject|0
7374583|NCT01121263|11627289|FG001|Overall Study|Withdrawal by Subject|1
7374584|NCT01121393|11627299|FG000|Overall Study|Progressive disease|201
7374585|NCT01121393|11627300|FG001|Overall Study|Progressive disease|20
7374586|NCT01121393|11627299|FG000|Overall Study|Other Adverse events|24
7374587|NCT01121393|11627300|FG001|Overall Study|Other Adverse events|45
7374588|NCT01121393|11627299|FG000|Overall Study|Non-compliant with protocol|0
7374589|NCT01121393|11627300|FG001|Overall Study|Non-compliant with protocol|3
7374590|NCT01121393|11627299|FG000|Overall Study|Lost to Follow-up|1
7374591|NCT01121393|11627300|FG001|Overall Study|Lost to Follow-up|0
7374592|NCT01121393|11627299|FG000|Overall Study|Refused cont. medication|7
7374593|NCT01121393|11627300|FG001|Overall Study|Refused cont. medication|7
7374594|NCT01121393|11627299|FG000|Overall Study|Not treated|3
7374595|NCT01121393|11627300|FG001|Overall Study|Not treated|9
7374596|NCT01121393|11627299|FG000|Overall Study|Other than listed|6
7374597|NCT01121393|11627300|FG001|Overall Study|Other than listed|0
7374598|NCT01121406|11627314|FG000|Overall Study|Progressive disease RECIST|44
7374599|NCT01121406|11627315|FG001|Overall Study|Progressive disease RECIST|28
7374600|NCT01121406|11627314|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
7374601|NCT01121406|11627315|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
7374602|NCT01121406|11627314|FG000|Overall Study|Other AE|3
7374603|NCT01121406|11627315|FG001|Overall Study|Other AE|10
7374604|NCT01121406|11627314|FG000|Overall Study|Non-compliant with protocol|0
7374605|NCT01121406|11627315|FG001|Overall Study|Non-compliant with protocol|2
7374606|NCT01121406|11627314|FG000|Overall Study|Lost to Follow-up|0
7374607|NCT01121406|11627315|FG001|Overall Study|Lost to Follow-up|1
7374608|NCT01121406|11627314|FG000|Overall Study|Refused continuation of study med.|1
7374609|NCT01121406|11627315|FG001|Overall Study|Refused continuation of study med.|2
7374610|NCT01121406|11627314|FG000|Overall Study|Reason other than specified above|2
7374611|NCT01121406|11627315|FG001|Overall Study|Reason other than specified above|6
7374612|NCT01121406|11627314|FG000|Overall Study|Not treated|1
7374613|NCT01121406|11627315|FG001|Overall Study|Not treated|0
7374614|NCT01121484|11627326|FG000|Overall Study|Adverse Event|12
7374615|NCT01121484|11627327|FG001|Overall Study|Adverse Event|5
7374616|NCT01121484|11627326|FG000|Overall Study|Lack of Efficacy|3
7374617|NCT01121484|11627327|FG001|Overall Study|Lack of Efficacy|11
7374618|NCT01121484|11627326|FG000|Overall Study|Lost to Follow-up|5
7374619|NCT01121484|11627327|FG001|Overall Study|Lost to Follow-up|9
7374620|NCT01121484|11627326|FG000|Overall Study|Physician Decision|0
7374621|NCT01121484|11627327|FG001|Overall Study|Physician Decision|3
7374622|NCT01121484|11627326|FG000|Overall Study|Protocol Violation|1
7374623|NCT01121484|11627327|FG001|Overall Study|Protocol Violation|0
7374624|NCT01121484|11627326|FG000|Overall Study|Withdrawal by Subject|8
7374625|NCT01121484|11627327|FG001|Overall Study|Withdrawal by Subject|7
7374626|NCT01121484|11627326|FG000|Overall Study|Discontinuation of study by sponsor|0
7374627|NCT01121484|11627327|FG001|Overall Study|Discontinuation of study by sponsor|1
7374628|NCT01121484|11627326|FG000|Overall Study|Other|3
7374629|NCT01121484|11627327|FG001|Overall Study|Other|3
7374630|NCT01121484|11627326|FG000|Overall Study|Randomized, not treated|1
7374631|NCT01121484|11627327|FG001|Overall Study|Randomized, not treated|4
7374632|NCT01121536|11627333|FG000|Overall Study|Adverse Event|63
7374633|NCT01121536|11627333|FG000|Overall Study|Lack of Efficacy|35
7374634|NCT01121536|11627333|FG000|Overall Study|Withdrawal by Subject|65
7374635|NCT01121536|11627333|FG000|Overall Study|Protocol Violation|20
7374636|NCT01121536|11627333|FG000|Overall Study|Noncompliance with study medication|12
7374637|NCT01121536|11627333|FG000|Overall Study|Noncompliance with study procedures|9
7374638|NCT01121536|11627333|FG000|Overall Study|Lost to Follow-up|39
7374639|NCT01121536|11627333|FG000|Overall Study|Other|118
7374640|NCT01121549|11627337|FG000|Overall Study|Adverse Event|10
7374641|NCT01121549|11627337|FG000|Overall Study|Lack of Efficacy|11
7374642|NCT01121549|11627337|FG000|Overall Study|Lost to Follow-up|12
7374643|NCT01121549|11627337|FG000|Overall Study|Did not meet entrance criteria|9
7374644|NCT01121549|11627337|FG000|Overall Study|Study terminated by sponsor|197
7374645|NCT01121549|11627337|FG000|Overall Study|Pregnancy|1
7374646|NCT01121549|11627337|FG000|Overall Study|Protocol Violation|33
7374647|NCT01121549|11627337|FG000|Overall Study|Withdrawal by Subject|16
7374648|NCT01121549|11627337|FG000|Overall Study|Other|58
7374649|NCT01121562|11627341|FG000|Overall Study|Objective progression or relapse|8
7374650|NCT01121562|11627341|FG000|Overall Study|Withdrawal by Subject|1
7374651|NCT01121562|11627341|FG000|Overall Study|Adverse Event|1
7374652|NCT01121562|11627341|FG000|Overall Study|Sponsor Decision|1
7374653|NCT01121562|11627341|FG000|Overall Study|Met study discontinuation criteria|1
7374654|NCT01121575|11627351|FG000|Overall Study|Participant Refused Further Follow-Up|0
7374655|NCT01121575|11627352|FG001|Overall Study|Participant Refused Further Follow-Up|0
7374656|NCT01121575|11627353|FG002|Overall Study|Participant Refused Further Follow-Up|0
7374657|NCT01121575|11627354|FG003|Overall Study|Participant Refused Further Follow-Up|0
7374658|NCT01121575|11627355|FG004|Overall Study|Participant Refused Further Follow-Up|5
7374659|NCT01121575|11627356|FG005|Overall Study|Participant Refused Further Follow-Up|1
7374660|NCT01121575|11627351|FG000|Overall Study|Unspecified Reasons|8
7374661|NCT01121575|11627352|FG001|Overall Study|Unspecified Reasons|6
7374662|NCT01121575|11627353|FG002|Overall Study|Unspecified Reasons|7
7374663|NCT01121575|11627354|FG003|Overall Study|Unspecified Reasons|5
7374664|NCT01121575|11627355|FG004|Overall Study|Unspecified Reasons|13
7374665|NCT01121575|11627356|FG005|Overall Study|Unspecified Reasons|10
7374666|NCT01121575|11627351|FG000|Overall Study|Death|6
7374667|NCT01121575|11627352|FG001|Overall Study|Death|0
7374668|NCT01121575|11627353|FG002|Overall Study|Death|0
7374669|NCT01121575|11627354|FG003|Overall Study|Death|1
7374670|NCT01121575|11627355|FG004|Overall Study|Death|7
7374671|NCT01121575|11627356|FG005|Overall Study|Death|1
7374672|NCT01121666|11627377|FG000|Overall Study|Protocol Violation|29
7374673|NCT01121666|11627378|FG001|Overall Study|Protocol Violation|10
7374674|NCT01121757|11627386|FG000|First Drug|Death|1
7374675|NCT01121757|11627387|FG001|First Drug|Death|0
7374676|NCT01121757|11627386|FG000|First Drug|Disease Progression|0
7374677|NCT01121757|11627387|FG001|First Drug|Disease Progression|2
7461465|NCT01838616|11757688|FG000|Titration Period|Lack of Efficacy|5
7461466|NCT01838616|11757689|FG001|Titration Period|Lack of Efficacy|12
7461467|NCT01838616|11757688|FG000|Titration Period|Withdrawal by Subject|5
7461468|NCT01838616|11757689|FG001|Titration Period|Withdrawal by Subject|5
7461469|NCT01838616|11757688|FG000|Titration Period|Technical problems|1
7461470|NCT01838616|11757689|FG001|Titration Period|Technical problems|0
7374678|NCT01121757|11627386|FG000|Combination|Physician Decision|0
7374679|NCT01121757|11627387|FG001|Combination|Physician Decision|1
7374680|NCT01121757|11627386|FG000|Combination|Disease Progression|2
7374681|NCT01121757|11627387|FG001|Combination|Disease Progression|0
7374682|NCT01121900|11627395|FG000|First Intervention Period|Adverse Event|1
7374683|NCT01121900|11627396|FG001|First Intervention Period|Adverse Event|1
7374684|NCT01121900|11627395|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
7374685|NCT01121900|11627396|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
7374686|NCT01121913|11627402|FG000|First Intervention Period|Adverse Event|0
7374687|NCT01121913|11627403|FG001|First Intervention Period|Adverse Event|0
7374688|NCT01121913|11627404|FG002|First Intervention Period|Adverse Event|1
7374689|NCT01121913|11627405|FG003|First Intervention Period|Adverse Event|0
7374690|NCT01121913|11627402|FG000|First Washout Period|Withdrawal by Subject|1
7374691|NCT01121913|11627403|FG001|First Washout Period|Withdrawal by Subject|0
7374692|NCT01121913|11627404|FG002|First Washout Period|Withdrawal by Subject|0
7374693|NCT01121913|11627405|FG003|First Washout Period|Withdrawal by Subject|0
7374694|NCT01121913|11627402|FG000|Second Intervention Period|Adverse Event|0
7374695|NCT01121913|11627403|FG001|Second Intervention Period|Adverse Event|0
7374696|NCT01121913|11627404|FG002|Second Intervention Period|Adverse Event|1
7374697|NCT01121913|11627405|FG003|Second Intervention Period|Adverse Event|0
7374698|NCT01121913|11627402|FG000|Second Washout Period|Withdrawal by Subject|0
7374699|NCT01121913|11627403|FG001|Second Washout Period|Withdrawal by Subject|0
7374700|NCT01121913|11627404|FG002|Second Washout Period|Withdrawal by Subject|1
7374701|NCT01121913|11627405|FG003|Second Washout Period|Withdrawal by Subject|0
7374702|NCT01121913|11627402|FG000|Third Washout Period|Adverse Event|1
7374703|NCT01121913|11627403|FG001|Third Washout Period|Adverse Event|0
7374704|NCT01121913|11627404|FG002|Third Washout Period|Adverse Event|0
7374705|NCT01121913|11627405|FG003|Third Washout Period|Adverse Event|0
7374706|NCT01121926|11627415|FG000|First Intervention Period|Adverse Event|1
7374707|NCT01121926|11627416|FG001|First Intervention Period|Adverse Event|0
7374708|NCT01121926|11627415|FG000|Washout Period|Adverse Event|0
7374709|NCT01121926|11627416|FG001|Washout Period|Adverse Event|1
7374710|NCT01121926|11627415|FG000|Washout Period|Positive pregnancy test|0
7374711|NCT01121926|11627416|FG001|Washout Period|Positive pregnancy test|1
7374712|NCT01121991|11627429|FG000|Overall Study|Lack of Ovarian Response|2
7374713|NCT01121991|11627429|FG000|Overall Study|No Oocytes Retrieved|3
7374714|NCT01121991|11627429|FG000|Overall Study|No Fertilization|1
7374715|NCT01122173|11627484|FG000|Overall Study|Lost to Follow-up|3
7461471|NCT01838616|11757688|FG000|Titration Period|Other|1
7461472|NCT01838616|11757689|FG001|Titration Period|Other|0
7461473|NCT01838616|11757688|FG000|Titration Period|Protocol Violation|0
7374716|NCT01122173|11627484|FG000|Overall Study|Withdrawal by Subject|3
7374717|NCT01122173|11627484|FG000|Overall Study|Left study for other reasons|3
7374718|NCT01122264|11627537|FG000|Overall Study|Adverse Event|6
7374719|NCT01122264|11627538|FG001|Overall Study|Adverse Event|5
7374720|NCT01122264|11627539|FG002|Overall Study|Adverse Event|7
7374721|NCT01122264|11627537|FG000|Overall Study|Death|1
7374722|NCT01122264|11627538|FG001|Overall Study|Death|0
7374723|NCT01122264|11627539|FG002|Overall Study|Death|0
7374724|NCT01122264|11627537|FG000|Overall Study|Lost to Follow-up|5
7374725|NCT01122264|11627538|FG001|Overall Study|Lost to Follow-up|9
7374726|NCT01122264|11627539|FG002|Overall Study|Lost to Follow-up|13
7374727|NCT01122264|11627537|FG000|Overall Study|Entry Criteria Not Met|1
7374728|NCT01122264|11627538|FG001|Overall Study|Entry Criteria Not Met|0
7374729|NCT01122264|11627539|FG002|Overall Study|Entry Criteria Not Met|0
7374730|NCT01122264|11627537|FG000|Overall Study|Protocol Violation|7
7374731|NCT01122264|11627538|FG001|Overall Study|Protocol Violation|7
7374732|NCT01122264|11627539|FG002|Overall Study|Protocol Violation|9
7374733|NCT01122264|11627537|FG000|Overall Study|Withdrawal by Subject|6
7374734|NCT01122264|11627538|FG001|Overall Study|Withdrawal by Subject|6
7374735|NCT01122264|11627539|FG002|Overall Study|Withdrawal by Subject|16
7374736|NCT01122264|11627537|FG000|Overall Study|Physician Decision|3
7374737|NCT01122264|11627538|FG001|Overall Study|Physician Decision|1
7374738|NCT01122264|11627539|FG002|Overall Study|Physician Decision|1
7374739|NCT01122264|11627537|FG000|Overall Study|Lack of Efficacy|3
7374740|NCT01122264|11627538|FG001|Overall Study|Lack of Efficacy|1
7374741|NCT01122264|11627539|FG002|Overall Study|Lack of Efficacy|1
7374742|NCT01122394|11627557|FG000|Overall Study|Withdrawal by Subject|1
7374743|NCT01122394|11627558|FG001|Overall Study|Withdrawal by Subject|1
7374744|NCT01122394|11627557|FG000|Overall Study|Lost to Follow-up|2
7374745|NCT01122394|11627558|FG001|Overall Study|Lost to Follow-up|2
7374746|NCT01122394|11627557|FG000|Overall Study|Adverse Event|0
7374747|NCT01122394|11627558|FG001|Overall Study|Adverse Event|1
7374748|NCT01122576|11627578|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
7374749|NCT01122576|11627579|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
7374750|NCT01122576|11627580|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
7374751|NCT01122576|11627578|FG000|Post-Cataract Surgery|Central Macular Edema|0
7374752|NCT01122576|11627579|FG001|Post-Cataract Surgery|Central Macular Edema|0
7374753|NCT01122576|11627580|FG002|Post-Cataract Surgery|Central Macular Edema|1
7374754|NCT01122576|11627578|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
7374755|NCT01122576|11627579|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
7374756|NCT01122576|11627580|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
7374757|NCT01122680|11627591|FG000|Period 1 (4 Weeks)|Adverse Event|1
7374758|NCT01122680|11627592|FG001|Period 1 (4 Weeks)|Adverse Event|0
7374759|NCT01122680|11627593|FG002|Period 1 (4 Weeks)|Adverse Event|0
7374760|NCT01122680|11627594|FG003|Period 1 (4 Weeks)|Adverse Event|0
7374761|NCT01122680|11627591|FG000|Period 1 (4 Weeks)|Protocol Violation|1
7374762|NCT01122680|11627592|FG001|Period 1 (4 Weeks)|Protocol Violation|0
7374763|NCT01122680|11627593|FG002|Period 1 (4 Weeks)|Protocol Violation|0
7374764|NCT01122680|11627594|FG003|Period 1 (4 Weeks)|Protocol Violation|0
7374765|NCT01122680|11627591|FG000|Period 1 (4 Weeks)|Other|1
7374766|NCT01122680|11627592|FG001|Period 1 (4 Weeks)|Other|1
7374767|NCT01122680|11627593|FG002|Period 1 (4 Weeks)|Other|0
7374768|NCT01122680|11627594|FG003|Period 1 (4 Weeks)|Other|0
7374769|NCT01122680|11627591|FG000|Period 2 (4 Weeks)|Protocol Violation|0
7374770|NCT01122680|11627592|FG001|Period 2 (4 Weeks)|Protocol Violation|0
7374771|NCT01122680|11627593|FG002|Period 2 (4 Weeks)|Protocol Violation|0
7374772|NCT01122680|11627594|FG003|Period 2 (4 Weeks)|Protocol Violation|1
7374773|NCT01122680|11627591|FG000|Period 2 (4 Weeks)|Other|1
7374774|NCT01122680|11627592|FG001|Period 2 (4 Weeks)|Other|0
7374775|NCT01122680|11627593|FG002|Period 2 (4 Weeks)|Other|0
7374776|NCT01122680|11627594|FG003|Period 2 (4 Weeks)|Other|0
7461474|NCT01838616|11757689|FG001|Titration Period|Protocol Violation|1
7461475|NCT01838616|11757688|FG000|Continuation Period|Lack of Efficacy|3
7461476|NCT01838616|11757689|FG001|Continuation Period|Lack of Efficacy|5
7461477|NCT01838616|11757688|FG000|Continuation Period|Adverse Event|8
7461478|NCT01838616|11757689|FG001|Continuation Period|Adverse Event|4
7461479|NCT01838616|11757688|FG000|Continuation Period|Protocol Violation|2
7461480|NCT01838616|11757689|FG001|Continuation Period|Protocol Violation|0
7461481|NCT01838616|11757688|FG000|Continuation Period|Lost to Follow-up|1
7461482|NCT01838616|11757689|FG001|Continuation Period|Lost to Follow-up|0
7461483|NCT01838616|11757688|FG000|Continuation Period|Withdrawal by Subject|0
7461484|NCT01838616|11757689|FG001|Continuation Period|Withdrawal by Subject|4
7461485|NCT01838616|11757688|FG000|Continuation Period|Technical problems|0
7461486|NCT01838616|11757689|FG001|Continuation Period|Technical problems|1
7461487|NCT01838616|11757688|FG000|Pick-up Arm|Lack of Efficacy|4
7461488|NCT01838616|11757689|FG001|Pick-up Arm|Lack of Efficacy|0
7461489|NCT01838616|11757688|FG000|Pick-up Arm|Adverse Event|9
7461490|NCT01838616|11757689|FG001|Pick-up Arm|Adverse Event|0
7461491|NCT01838616|11757688|FG000|Pick-up Arm|Withdrawal by Subject|1
7461492|NCT01838616|11757689|FG001|Pick-up Arm|Withdrawal by Subject|0
7461493|NCT01838616|11757688|FG000|Pick-up Arm|Technical problems|1
7374777|NCT01122680|11627591|FG000|Period 3 (4 Weeks)|Adverse Event|1
7374778|NCT01122680|11627592|FG001|Period 3 (4 Weeks)|Adverse Event|0
7374779|NCT01122680|11627593|FG002|Period 3 (4 Weeks)|Adverse Event|0
7374780|NCT01122680|11627594|FG003|Period 3 (4 Weeks)|Adverse Event|0
7374781|NCT01122680|11627591|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
7374782|NCT01122680|11627592|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
7374783|NCT01122680|11627593|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
7374784|NCT01122680|11627594|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
7374785|NCT01122862|11627627|FG000|Period 1|Protocol Violation|0
7374786|NCT01122862|11627628|FG001|Period 1|Protocol Violation|1
7374787|NCT01122862|11627629|FG002|Period 1|Protocol Violation|0
7374788|NCT01122862|11627627|FG000|Period 2|Adverse Event|0
7374789|NCT01122862|11627628|FG001|Period 2|Adverse Event|0
7374790|NCT01122862|11627629|FG002|Period 2|Adverse Event|1
7374791|NCT01122927|11627652|FG000|Period 1 - Conversion Phase|Adverse Event|3
7374792|NCT01122927|11627653|FG001|Period 1 - Conversion Phase|Adverse Event|0
7374793|NCT01122927|11627652|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7374794|NCT01122927|11627653|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7374795|NCT01122927|11627652|FG000|Period 1 - Conversion Phase|Physician Decision|2
7374796|NCT01122927|11627653|FG001|Period 1 - Conversion Phase|Physician Decision|0
7374797|NCT01122927|11627652|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
7374798|NCT01122927|11627653|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
7374799|NCT01122927|11627652|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
7374800|NCT01122927|11627653|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
7374801|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
7374802|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
7374803|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
7374804|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
7374805|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
7374806|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
7374807|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
7374808|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
7374809|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
7374810|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
7374811|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
7374812|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
7374813|NCT01122927|11627652|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
7374814|NCT01122927|11627653|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
7374815|NCT01123070|11627667|FG000|Part B Double Blind Period|Protocol Violation|0
7374816|NCT01123070|11627668|FG001|Part B Double Blind Period|Protocol Violation|0
7374817|NCT01123070|11627669|FG002|Part B Double Blind Period|Protocol Violation|0
7374818|NCT01123070|11627670|FG003|Part B Double Blind Period|Protocol Violation|1
7374819|NCT01123070|11627667|FG000|Part B Double Blind Period|Adverse Event|0
7374820|NCT01123070|11627668|FG001|Part B Double Blind Period|Adverse Event|0
7374821|NCT01123070|11627669|FG002|Part B Double Blind Period|Adverse Event|2
7374822|NCT01123070|11627670|FG003|Part B Double Blind Period|Adverse Event|0
7374823|NCT01123070|11627667|FG000|Part B Double Blind Period|Sponsor's Decision|0
7374824|NCT01123070|11627668|FG001|Part B Double Blind Period|Sponsor's Decision|0
7374825|NCT01123070|11627669|FG002|Part B Double Blind Period|Sponsor's Decision|2
7374826|NCT01123070|11627670|FG003|Part B Double Blind Period|Sponsor's Decision|2
7374827|NCT01123083|11627683|FG000|Overall Study|Investigator recommendation|1
7374828|NCT01123083|11627684|FG001|Overall Study|Investigator recommendation|1
7374829|NCT01123083|11627683|FG000|Overall Study|Administrative reasons|0
7374830|NCT01123083|11627684|FG001|Overall Study|Administrative reasons|4
7374831|NCT01123083|11627683|FG000|Overall Study|Lost to Follow-up|2
7374832|NCT01123083|11627684|FG001|Overall Study|Lost to Follow-up|6
7374833|NCT01123083|11627683|FG000|Overall Study|Adverse Event|1
7374834|NCT01123083|11627684|FG001|Overall Study|Adverse Event|0
7374835|NCT01123083|11627683|FG000|Overall Study|Withdrew for another reason not covered|0
7374836|NCT01123083|11627684|FG001|Overall Study|Withdrew for another reason not covered|1
7374837|NCT01123083|11627683|FG000|Overall Study|Participant/legal representative request|7
7374838|NCT01123083|11627684|FG001|Overall Study|Participant/legal representative request|3
7374839|NCT01123148|11627690|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
7374840|NCT01123148|11627690|FG000|Overall Study|Didn't meet milestone criteria|1
7374841|NCT01123161|11627696|FG000|Overall Study|Lost to Follow-up|1
7374842|NCT01123161|11627697|FG001|Overall Study|Lost to Follow-up|0
7374843|NCT01123161|11627696|FG000|Overall Study|Withdrawal by Subject|1
7374844|NCT01123161|11627697|FG001|Overall Study|Withdrawal by Subject|0
7374845|NCT01123200|11627706|FG000|Overall Study|Withdrawal by Subject|1
7374846|NCT01123356|11627710|FG000|Overall Study|Adverse Event|2
7374847|NCT01123356|11627710|FG000|Overall Study|Lack of Efficacy|4
7374848|NCT01123356|11627710|FG000|Overall Study|Withdrawal by Subject|1
7374849|NCT01123382|11627717|FG000|Overall Study|Withdrawal by Subject|1
7374850|NCT01123382|11627718|FG001|Overall Study|Withdrawal by Subject|4
7374851|NCT01123382|11627717|FG000|Overall Study|Lost to Follow-up|1
7374852|NCT01123382|11627718|FG001|Overall Study|Lost to Follow-up|2
7374853|NCT01123395|11627724|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
7374854|NCT01123395|11627725|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
7374855|NCT01123642|11627740|FG000|Overall Study|Lost to Follow-up|23
7374856|NCT01123642|11627740|FG000|Overall Study|Withdrawal by Subject|9
7374857|NCT01123642|11627740|FG000|Overall Study|ineligible at baseline assessment|36
7374858|NCT01123655|11627747|FG000|Overall Study|Medication for RA had to be changed|1
7374859|NCT01123655|11627748|FG001|Overall Study|Medication for RA had to be changed|0
7374860|NCT01123655|11627749|FG002|Overall Study|Medication for RA had to be changed|0
7374861|NCT01123655|11627747|FG000|Overall Study|new illness|0
7374862|NCT01123655|11627748|FG001|Overall Study|new illness|1
7374863|NCT01123655|11627749|FG002|Overall Study|new illness|0
7374864|NCT01123655|11627747|FG000|Overall Study|began prohibitive drug|0
7374865|NCT01123655|11627748|FG001|Overall Study|began prohibitive drug|0
7374866|NCT01123655|11627749|FG002|Overall Study|began prohibitive drug|1
7374867|NCT01123889|11627757|FG000|Overall Study|Lost to Follow-up|3
7374868|NCT01123889|11627758|FG001|Overall Study|Lost to Follow-up|1
7374869|NCT01123941|11627775|FG000|Overall Study|Lost to Follow-up|2
7374870|NCT01123941|11627776|FG001|Overall Study|Lost to Follow-up|1
7374871|NCT01123980|11627784|FG000|Overall Study|Adverse Event|1
7374872|NCT01123980|11627785|FG001|Overall Study|Adverse Event|1
7374873|NCT01123980|11627784|FG000|Overall Study|Lack of Efficacy|1
7374874|NCT01123980|11627785|FG001|Overall Study|Lack of Efficacy|0
7374875|NCT01123980|11627784|FG000|Overall Study|Physician Decision|0
7374876|NCT01123980|11627785|FG001|Overall Study|Physician Decision|1
7374877|NCT01123980|11627784|FG000|Overall Study|Lost to Follow-up|0
7374878|NCT01123980|11627785|FG001|Overall Study|Lost to Follow-up|6
7374879|NCT01123980|11627784|FG000|Overall Study|Protocol Violation|6
7374880|NCT01123980|11627785|FG001|Overall Study|Protocol Violation|6
7374881|NCT01123980|11627784|FG000|Overall Study|Withdrawal by Subject|5
7374882|NCT01123980|11627785|FG001|Overall Study|Withdrawal by Subject|3
7374883|NCT01123980|11627784|FG000|Overall Study|Unclassified|6
7374884|NCT01123980|11627785|FG001|Overall Study|Unclassified|7
7374885|NCT01124006|11627794|FG000|Overall Study|Withdrawal by Subject|2
7374886|NCT01124006|11627795|FG001|Overall Study|Withdrawal by Subject|2
7374887|NCT01124006|11627796|FG002|Overall Study|Withdrawal by Subject|0
7374888|NCT01124006|11627794|FG000|Overall Study|Lost to Follow-up|1
7374889|NCT01124006|11627795|FG001|Overall Study|Lost to Follow-up|0
7374890|NCT01124006|11627796|FG002|Overall Study|Lost to Follow-up|1
7374891|NCT01124006|11627794|FG000|Overall Study|Other|0
7374892|NCT01124006|11627795|FG001|Overall Study|Other|0
7374893|NCT01124006|11627796|FG002|Overall Study|Other|1
7374894|NCT01124045|11627806|FG000|Overall Study|Lost to Follow-up|0
7374895|NCT01124045|11627807|FG001|Overall Study|Lost to Follow-up|1
7374896|NCT01124045|11627806|FG000|Overall Study|Physician Decision|0
7374897|NCT01124045|11627807|FG001|Overall Study|Physician Decision|2
7374898|NCT01124097|11627817|FG000|Overall Study|Withdrawal by Subject|4
7374899|NCT01124097|11627818|FG001|Overall Study|Withdrawal by Subject|3
7374900|NCT01124097|11627819|FG002|Overall Study|Withdrawal by Subject|2
7374901|NCT01124097|11627820|FG003|Overall Study|Withdrawal by Subject|3
7374902|NCT01124097|11627817|FG000|Overall Study|Lack of Efficacy|2
7374903|NCT01124097|11627818|FG001|Overall Study|Lack of Efficacy|3
7374904|NCT01124097|11627819|FG002|Overall Study|Lack of Efficacy|1
7374905|NCT01124097|11627820|FG003|Overall Study|Lack of Efficacy|3
7374906|NCT01124097|11627817|FG000|Overall Study|Adverse Event|24
7374907|NCT01124097|11627818|FG001|Overall Study|Adverse Event|15
7374908|NCT01124097|11627819|FG002|Overall Study|Adverse Event|15
7374909|NCT01124097|11627820|FG003|Overall Study|Adverse Event|7
7374910|NCT01124097|11627817|FG000|Overall Study|Protocol Violation|2
7374911|NCT01124097|11627818|FG001|Overall Study|Protocol Violation|0
7374912|NCT01124097|11627819|FG002|Overall Study|Protocol Violation|2
7374913|NCT01124097|11627820|FG003|Overall Study|Protocol Violation|1
7374914|NCT01124097|11627817|FG000|Overall Study|Physician Decision|2
7374915|NCT01124097|11627818|FG001|Overall Study|Physician Decision|1
7374916|NCT01124097|11627819|FG002|Overall Study|Physician Decision|0
7374917|NCT01124097|11627820|FG003|Overall Study|Physician Decision|0
7374918|NCT01124149|11627830|FG000|Acute Phase|Withdrawal by Subject|22
7374919|NCT01124149|11627830|FG000|Acute Phase|Adverse Event|21
7374920|NCT01124149|11627830|FG000|Acute Phase|Lack of Efficacy|17
7374921|NCT01124149|11627830|FG000|Acute Phase|Protocol Violation|14
7374922|NCT01124149|11627830|FG000|Acute Phase|Lost to Follow-up|2
7374923|NCT01124149|11627830|FG000|Acute Phase|Prolonged antibiotic therapy|1
7374924|NCT01124149|11627830|FG000|Acute Phase|Sponsor request|1
7374925|NCT01124149|11627830|FG000|Acute Phase|UC symptoms not ameliorated|1
7374926|NCT01124149|11627830|FG000|Acute Phase|Non-compliance|1
7374927|NCT01124149|11627830|FG000|Acute Phase|Low hemoglobin|1
7374928|NCT01124149|11627830|FG000|Acute Phase|Travelling to another country|1
7374929|NCT01124149|11627830|FG000|Acute Phase|Sponsor decision|1
7374930|NCT01124149|11627830|FG000|Maintenance Phase|Lack of Efficacy|40
7374931|NCT01124149|11627830|FG000|Maintenance Phase|Adverse Event|24
7374932|NCT01124149|11627830|FG000|Maintenance Phase|Lost to Follow-up|15
7374933|NCT01124149|11627830|FG000|Maintenance Phase|Withdrawal by Subject|10
7374934|NCT01124149|11627830|FG000|Maintenance Phase|Protocol Violation|5
7374935|NCT01124149|11627830|FG000|Maintenance Phase|Coordinator error|1
7374936|NCT01124149|11627830|FG000|Maintenance Phase|Non-compliance|1
7374937|NCT01124162|11627839|FG000|First Intervention|Adverse Event|2
7374938|NCT01124162|11627840|FG001|First Intervention|Adverse Event|0
7374939|NCT01124162|11627839|FG000|Washout of 7 Days|Withdrawal by Subject|1
7374940|NCT01124162|11627840|FG001|Washout of 7 Days|Withdrawal by Subject|0
7374941|NCT01124175|11627848|FG000|Washout of 7 Days|Withdrawal by Subject|0
7374942|NCT01124175|11627849|FG001|Washout of 7 Days|Withdrawal by Subject|2
7374943|NCT01124292|11627867|FG000|Overall Study|Lost to Follow-up|2
7374944|NCT01124292|11627868|FG001|Overall Study|Lost to Follow-up|4
7374945|NCT01124292|11627869|FG002|Overall Study|Lost to Follow-up|3
7374946|NCT01124292|11627867|FG000|Overall Study|Physician Decision|0
7374947|NCT01124292|11627868|FG001|Overall Study|Physician Decision|3
7374948|NCT01124292|11627869|FG002|Overall Study|Physician Decision|2
7374949|NCT01124292|11627867|FG000|Overall Study|Withdrawal by Subject|0
7374950|NCT01124292|11627868|FG001|Overall Study|Withdrawal by Subject|6
7374951|NCT01124292|11627869|FG002|Overall Study|Withdrawal by Subject|2
7374952|NCT01124292|11627867|FG000|Overall Study|medical issue unrelated to the study|0
7374953|NCT01124292|11627868|FG001|Overall Study|medical issue unrelated to the study|0
7374954|NCT01124292|11627869|FG002|Overall Study|medical issue unrelated to the study|2
7374955|NCT01124292|11627867|FG000|Overall Study|piercing track closed|0
7374956|NCT01124292|11627868|FG001|Overall Study|piercing track closed|2
7374957|NCT01124292|11627869|FG002|Overall Study|piercing track closed|1
7374958|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
7374959|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7374960|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
7374961|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
7374962|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
7374963|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
7374964|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
7374965|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
7374966|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
7374967|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
7374968|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7374969|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
7374970|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
7374971|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7374972|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
7374973|NCT01124422|11627895|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
7374974|NCT01124422|11627896|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
7374975|NCT01124422|11627897|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
7374976|NCT01124422|11627895|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7374977|NCT01124422|11627896|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
7374978|NCT01124422|11627897|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
7374979|NCT01124422|11627895|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
7374980|NCT01124422|11627896|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
7374981|NCT01124422|11627897|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
7374982|NCT01124422|11627895|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
7374983|NCT01124422|11627896|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
7374984|NCT01124422|11627897|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
7374985|NCT01124422|11627895|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7374986|NCT01124422|11627896|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
7374987|NCT01124422|11627897|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
7374988|NCT01124448|11627906|FG000|Overall Study|Lost to Follow-up|0
7374989|NCT01124448|11627907|FG001|Overall Study|Lost to Follow-up|3
7374990|NCT01124448|11627906|FG000|Overall Study|Protocol Violation|2
7374991|NCT01124448|11627907|FG001|Overall Study|Protocol Violation|0
7374992|NCT01124604|11627915|FG000|Overall Study|Adverse Event|10
7374993|NCT01124604|11627916|FG001|Overall Study|Adverse Event|1
7374994|NCT01124604|11627915|FG000|Overall Study|Lack of Efficacy|1
7374995|NCT01124604|11627916|FG001|Overall Study|Lack of Efficacy|0
7374996|NCT01124604|11627915|FG000|Overall Study|Withdrawal by Subject|4
7374997|NCT01124604|11627916|FG001|Overall Study|Withdrawal by Subject|0
7374998|NCT01124604|11627915|FG000|Overall Study|Disease Progression|0
7374999|NCT01124604|11627916|FG001|Overall Study|Disease Progression|1
7375000|NCT01124617|11627924|FG000|Overall Study|Adverse Event|5
7375001|NCT01124617|11627925|FG001|Overall Study|Adverse Event|2
7375002|NCT01124617|11627924|FG000|Overall Study|Lack of Efficacy|2
7375003|NCT01124617|11627925|FG001|Overall Study|Lack of Efficacy|1
7375004|NCT01124617|11627924|FG000|Overall Study|Protocol Violation|1
7375005|NCT01124617|11627925|FG001|Overall Study|Protocol Violation|1
7375006|NCT01124617|11627924|FG000|Overall Study|Withdrawal by Subject|9
7375007|NCT01124617|11627925|FG001|Overall Study|Withdrawal by Subject|1
7375008|NCT01124617|11627924|FG000|Overall Study|Other|2
7375009|NCT01124617|11627925|FG001|Overall Study|Other|1
7375010|NCT01124643|11627931|FG000|Overall Study|Death|1
7375011|NCT01124734|11627935|FG000|Overall Study|Disease progression|13
7375012|NCT01124734|11627935|FG000|Overall Study|Adverse Event|1
7375013|NCT01124734|11627935|FG000|Overall Study|Withdrawal by Subject|1
7375014|NCT01124734|11627935|FG000|Overall Study|Elected for alternative treatment|2
7375015|NCT01124838|11627955|FG000|Overall Study|Miscellaneous|4
7375016|NCT01124838|11627956|FG001|Overall Study|Miscellaneous|2
7375017|NCT01124838|11627955|FG000|Overall Study|Adverse Event|7
7375018|NCT01124838|11627956|FG001|Overall Study|Adverse Event|11
7375019|NCT01124838|11627955|FG000|Overall Study|Lack of Efficacy|2
7375020|NCT01124838|11627956|FG001|Overall Study|Lack of Efficacy|0
7375021|NCT01124838|11627955|FG000|Overall Study|Withdrawal by Subject|3
7375022|NCT01124838|11627956|FG001|Overall Study|Withdrawal by Subject|2
7375023|NCT01124838|11627955|FG000|Overall Study|Lost to Follow-up|2
7375024|NCT01124838|11627956|FG001|Overall Study|Lost to Follow-up|0
7375025|NCT01124864|11627970|FG000|Overall Study|Follow up phase competed as per protocol|18
7375026|NCT01124864|11627971|FG001|Overall Study|Follow up phase competed as per protocol|22
7375027|NCT01124864|11627972|FG002|Overall Study|Follow up phase competed as per protocol|24
7375028|NCT01124864|11627973|FG003|Overall Study|Follow up phase competed as per protocol|18
7375029|NCT01124864|11627974|FG004|Overall Study|Follow up phase competed as per protocol|26
7375030|NCT01124864|11627975|FG005|Overall Study|Follow up phase competed as per protocol|2
7375031|NCT01124864|11627970|FG000|Overall Study|Death|6
7375032|NCT01124864|11627971|FG001|Overall Study|Death|9
7375033|NCT01124864|11627972|FG002|Overall Study|Death|6
7375034|NCT01124864|11627973|FG003|Overall Study|Death|2
7375035|NCT01124864|11627974|FG004|Overall Study|Death|1
7375036|NCT01124864|11627975|FG005|Overall Study|Death|0
7375037|NCT01124864|11627970|FG000|Overall Study|Withdrawal by Subject|2
7375038|NCT01124864|11627971|FG001|Overall Study|Withdrawal by Subject|3
7375039|NCT01124864|11627972|FG002|Overall Study|Withdrawal by Subject|4
7375040|NCT01124864|11627973|FG003|Overall Study|Withdrawal by Subject|0
7375041|NCT01124864|11627974|FG004|Overall Study|Withdrawal by Subject|2
7375042|NCT01124864|11627975|FG005|Overall Study|Withdrawal by Subject|1
7375043|NCT01124864|11627970|FG000|Overall Study|Lost to Follow-up|1
7375044|NCT01124864|11627971|FG001|Overall Study|Lost to Follow-up|1
7375045|NCT01124864|11627972|FG002|Overall Study|Lost to Follow-up|0
7375046|NCT01124864|11627973|FG003|Overall Study|Lost to Follow-up|1
7375047|NCT01124864|11627974|FG004|Overall Study|Lost to Follow-up|0
7375048|NCT01124864|11627975|FG005|Overall Study|Lost to Follow-up|0
7375049|NCT01124864|11627970|FG000|Overall Study|Protocol Violation|1
7375050|NCT01124864|11627971|FG001|Overall Study|Protocol Violation|0
7375051|NCT01124864|11627972|FG002|Overall Study|Protocol Violation|0
7375052|NCT01124864|11627973|FG003|Overall Study|Protocol Violation|0
7375053|NCT01124864|11627974|FG004|Overall Study|Protocol Violation|1
7375054|NCT01124864|11627975|FG005|Overall Study|Protocol Violation|0
7375055|NCT01124916|11627993|FG000|Overall Study|Lost to Follow-up|3
7375056|NCT01124916|11627994|FG001|Overall Study|Lost to Follow-up|2
7375057|NCT01125046|11628009|FG000|First 6 Months of Treatment|Death|1
7375058|NCT01125046|11628009|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
7375059|NCT01125046|11628009|FG000|First 6 Months of Treatment|Non-compliance|1
7375060|NCT01125046|11628009|FG000|First 6 Months of Treatment|Surgery|1
7375061|NCT01125046|11628009|FG000|First 6 Months of Treatment|Progressive Disease|7
7375062|NCT01125046|11628009|FG000|First 6 Months of Treatment|Adverse Event|2
7375063|NCT01125046|11628009|FG000|Continued Treatment After 6 Months|Progressive Disease|2
7375064|NCT01125046|11628009|FG000|Continued Treatment After 6 Months|Adverse Event|1
7375065|NCT01125046|11628009|FG000|Follow-up/Data Cut Off Point|Death|29
7375066|NCT01125046|11628009|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
7375067|NCT01125189|11628035|FG000|Treatment Period|Lack of Efficacy|15
7375068|NCT01125189|11628036|FG001|Treatment Period|Lack of Efficacy|18
7375069|NCT01125189|11628037|FG002|Treatment Period|Lack of Efficacy|25
7375070|NCT01125189|11628035|FG000|Treatment Period|Adverse Event|7
7375071|NCT01125189|11628036|FG001|Treatment Period|Adverse Event|8
7375072|NCT01125189|11628037|FG002|Treatment Period|Adverse Event|8
7375073|NCT01125189|11628035|FG000|Treatment Period|Withdrawal by Subject|3
7375074|NCT01125189|11628036|FG001|Treatment Period|Withdrawal by Subject|1
7375075|NCT01125189|11628037|FG002|Treatment Period|Withdrawal by Subject|1
7375076|NCT01125189|11628035|FG000|Treatment Period|Death|1
7375077|NCT01125189|11628036|FG001|Treatment Period|Death|0
7375078|NCT01125189|11628037|FG002|Treatment Period|Death|0
7375079|NCT01125189|11628035|FG000|Treatment Period|Lost to Follow-up|1
7375080|NCT01125189|11628036|FG001|Treatment Period|Lost to Follow-up|2
7375081|NCT01125189|11628037|FG002|Treatment Period|Lost to Follow-up|1
7375082|NCT01125189|11628035|FG000|Treatment Period|Poor compliance/noncompliance|0
7375083|NCT01125189|11628036|FG001|Treatment Period|Poor compliance/noncompliance|1
7375084|NCT01125189|11628037|FG002|Treatment Period|Poor compliance/noncompliance|0
7375085|NCT01125189|11628035|FG000|Treatment Period|Participants requested to discontinue|1
7375086|NCT01125189|11628036|FG001|Treatment Period|Participants requested to discontinue|3
7375087|NCT01125189|11628037|FG002|Treatment Period|Participants requested to discontinue|4
7375088|NCT01125189|11628035|FG000|Treatment Period|Other reasons|1
7375089|NCT01125189|11628036|FG001|Treatment Period|Other reasons|1
7375090|NCT01125189|11628037|FG002|Treatment Period|Other reasons|0
7375091|NCT01125189|11628035|FG000|Treatment Period|Completed 24 week treatment period only|2
7375092|NCT01125189|11628036|FG001|Treatment Period|Completed 24 week treatment period only|1
7375093|NCT01125189|11628037|FG002|Treatment Period|Completed 24 week treatment period only|2
7375094|NCT01125189|11628035|FG000|Follow up Period|Withdrawal by Subject|3
7375095|NCT01125189|11628036|FG001|Follow up Period|Withdrawal by Subject|2
7375096|NCT01125189|11628037|FG002|Follow up Period|Withdrawal by Subject|5
7375097|NCT01125189|11628035|FG000|Follow up Period|Death|1
7375098|NCT01125189|11628036|FG001|Follow up Period|Death|0
7375099|NCT01125189|11628037|FG002|Follow up Period|Death|0
7375100|NCT01125189|11628035|FG000|Follow up Period|Lost to Follow-up|12
7375101|NCT01125189|11628036|FG001|Follow up Period|Lost to Follow-up|9
7375102|NCT01125189|11628037|FG002|Follow up Period|Lost to Follow-up|6
7375103|NCT01125189|11628035|FG000|Follow up Period|Other reasons|4
7375104|NCT01125189|11628036|FG001|Follow up Period|Other reasons|4
7375105|NCT01125189|11628037|FG002|Follow up Period|Other reasons|5
7375106|NCT01125293|11628063|FG000|Overall Study|Disease Progression|1
7375107|NCT01125293|11628064|FG001|Overall Study|Disease Progression|3
7375108|NCT01125293|11628065|FG002|Overall Study|Disease Progression|4
7375109|NCT01125293|11628066|FG003|Overall Study|Disease Progression|3
7375110|NCT01125293|11628067|FG004|Overall Study|Disease Progression|5
7375111|NCT01125293|11628068|FG005|Overall Study|Disease Progression|12
7375112|NCT01125293|11628063|FG000|Overall Study|Adverse Event|1
7375113|NCT01125293|11628064|FG001|Overall Study|Adverse Event|0
7375114|NCT01125293|11628065|FG002|Overall Study|Adverse Event|0
7375115|NCT01125293|11628066|FG003|Overall Study|Adverse Event|0
7375116|NCT01125293|11628067|FG004|Overall Study|Adverse Event|2
7375117|NCT01125293|11628068|FG005|Overall Study|Adverse Event|8
7375118|NCT01125293|11628063|FG000|Overall Study|Symptomatic Deterioration|1
7375119|NCT01125293|11628064|FG001|Overall Study|Symptomatic Deterioration|0
7375120|NCT01125293|11628065|FG002|Overall Study|Symptomatic Deterioration|0
7375121|NCT01125293|11628066|FG003|Overall Study|Symptomatic Deterioration|0
7375122|NCT01125293|11628067|FG004|Overall Study|Symptomatic Deterioration|0
7461494|NCT01838616|11757689|FG001|Pick-up Arm|Technical problems|0
7461495|NCT01838642|11757700|FG000|Overall Study|Died on study|1
7461496|NCT01838681|11757709|FG000|Period A|Adverse Event|39
7461497|NCT01838681|11757710|FG001|Period A|Adverse Event|0
7461498|NCT01838681|11757711|FG002|Period A|Adverse Event|0
7461499|NCT01838681|11757712|FG003|Period A|Adverse Event|0
7461500|NCT01838681|11757709|FG000|Period A|Lack of Efficacy|21
7461501|NCT01838681|11757710|FG001|Period A|Lack of Efficacy|0
7461502|NCT01838681|11757711|FG002|Period A|Lack of Efficacy|0
7461503|NCT01838681|11757712|FG003|Period A|Lack of Efficacy|0
7461504|NCT01838681|11757709|FG000|Period A|Early response|148
7461505|NCT01838681|11757710|FG001|Period A|Early response|0
7461506|NCT01838681|11757711|FG002|Period A|Early response|0
7461507|NCT01838681|11757712|FG003|Period A|Early response|0
7461508|NCT01838681|11757709|FG000|Period A|Withdrawal by Subject|70
7461509|NCT01838681|11757710|FG001|Period A|Withdrawal by Subject|0
7461510|NCT01838681|11757711|FG002|Period A|Withdrawal by Subject|0
7461511|NCT01838681|11757712|FG003|Period A|Withdrawal by Subject|0
7461512|NCT01838681|11757709|FG000|Period A|Protocol Violation|16
7461513|NCT01838681|11757710|FG001|Period A|Protocol Violation|0
7461514|NCT01838681|11757711|FG002|Period A|Protocol Violation|0
7461515|NCT01838681|11757712|FG003|Period A|Protocol Violation|0
7461516|NCT01838681|11757709|FG000|Period A|Non-compliance with IMP|6
7461517|NCT01838681|11757710|FG001|Period A|Non-compliance with IMP|0
7461518|NCT01838681|11757711|FG002|Period A|Non-compliance with IMP|0
7461519|NCT01838681|11757712|FG003|Period A|Non-compliance with IMP|0
7461520|NCT01838681|11757709|FG000|Period A|Lost to Follow-up|4
7461521|NCT01838681|11757710|FG001|Period A|Lost to Follow-up|0
7461522|NCT01838681|11757711|FG002|Period A|Lost to Follow-up|0
7461523|NCT01838681|11757712|FG003|Period A|Lost to Follow-up|0
7461524|NCT01838681|11757709|FG000|Period A|Withdrawal before treatment|4
7461525|NCT01838681|11757710|FG001|Period A|Withdrawal before treatment|0
7461526|NCT01838681|11757711|FG002|Period A|Withdrawal before treatment|0
7461527|NCT01838681|11757712|FG003|Period A|Withdrawal before treatment|0
7461528|NCT01838681|11757709|FG000|Period A|Administrative or other reasons|17
7461529|NCT01838681|11757710|FG001|Period A|Administrative or other reasons|0
7461530|NCT01838681|11757711|FG002|Period A|Administrative or other reasons|0
7461531|NCT01838681|11757712|FG003|Period A|Administrative or other reasons|0
7461532|NCT01838681|11757709|FG000|Period B/A+|Adverse Event|0
7461533|NCT01838681|11757710|FG001|Period B/A+|Adverse Event|13
7461534|NCT01838681|11757711|FG002|Period B/A+|Adverse Event|27
7461535|NCT01838681|11757712|FG003|Period B/A+|Adverse Event|16
7461536|NCT01838681|11757709|FG000|Period B/A+|Lack of Efficacy|0
7461537|NCT01838681|11757710|FG001|Period B/A+|Lack of Efficacy|9
7461538|NCT01838681|11757711|FG002|Period B/A+|Lack of Efficacy|11
7461539|NCT01838681|11757712|FG003|Period B/A+|Lack of Efficacy|6
7461540|NCT01838681|11757709|FG000|Period B/A+|Withdrawal by Subject|0
7461541|NCT01838681|11757710|FG001|Period B/A+|Withdrawal by Subject|28
7461542|NCT01838681|11757711|FG002|Period B/A+|Withdrawal by Subject|35
7461543|NCT01838681|11757712|FG003|Period B/A+|Withdrawal by Subject|47
7461544|NCT01838681|11757709|FG000|Period B/A+|Protocol Violation|0
7461545|NCT01838681|11757710|FG001|Period B/A+|Protocol Violation|1
7461546|NCT01838681|11757711|FG002|Period B/A+|Protocol Violation|4
7461547|NCT01838681|11757712|FG003|Period B/A+|Protocol Violation|6
7461548|NCT01838681|11757709|FG000|Period B/A+|Non-compliance with IMP|0
7461549|NCT01838681|11757710|FG001|Period B/A+|Non-compliance with IMP|2
7461550|NCT01838681|11757711|FG002|Period B/A+|Non-compliance with IMP|3
7461551|NCT01838681|11757712|FG003|Period B/A+|Non-compliance with IMP|3
7461552|NCT01838681|11757709|FG000|Period B/A+|Lost to Follow-up|0
7461553|NCT01838681|11757710|FG001|Period B/A+|Lost to Follow-up|2
7461554|NCT01838681|11757711|FG002|Period B/A+|Lost to Follow-up|5
7461555|NCT01838681|11757712|FG003|Period B/A+|Lost to Follow-up|11
7461556|NCT01838681|11757709|FG000|Period B/A+|Withdrawal before treatment|0
7461557|NCT01838681|11757710|FG001|Period B/A+|Withdrawal before treatment|1
7461558|NCT01838681|11757711|FG002|Period B/A+|Withdrawal before treatment|0
7461559|NCT01838681|11757712|FG003|Period B/A+|Withdrawal before treatment|0
7461560|NCT01838681|11757709|FG000|Period B/A+|Administrative or other reasons|0
7461561|NCT01838681|11757710|FG001|Period B/A+|Administrative or other reasons|6
7461562|NCT01838681|11757711|FG002|Period B/A+|Administrative or other reasons|10
7461563|NCT01838681|11757712|FG003|Period B/A+|Administrative or other reasons|28
7461564|NCT01838694|11757720|FG000|Overall Study|Adverse Event|0
7461565|NCT01838694|11757721|FG001|Overall Study|Adverse Event|1
7461566|NCT01838876|11757743|FG000|Overall Study|Adverse Event|49
7461567|NCT01838876|11757743|FG000|Overall Study|Insufficient Therapeutic Response|10
7461568|NCT01838876|11757743|FG000|Overall Study|Protocol Violation|34
7375123|NCT01125293|11628068|FG005|Overall Study|Symptomatic Deterioration|0
7375124|NCT01125293|11628063|FG000|Overall Study|Death|0
7375125|NCT01125293|11628064|FG001|Overall Study|Death|0
7375126|NCT01125293|11628065|FG002|Overall Study|Death|0
7375127|NCT01125293|11628066|FG003|Overall Study|Death|0
7375128|NCT01125293|11628067|FG004|Overall Study|Death|1
7375129|NCT01125293|11628068|FG005|Overall Study|Death|0
7375130|NCT01125293|11628063|FG000|Overall Study|Withdrawal by Subject|0
7375131|NCT01125293|11628064|FG001|Overall Study|Withdrawal by Subject|0
7375132|NCT01125293|11628065|FG002|Overall Study|Withdrawal by Subject|0
7375133|NCT01125293|11628066|FG003|Overall Study|Withdrawal by Subject|0
7375134|NCT01125293|11628067|FG004|Overall Study|Withdrawal by Subject|2
7375135|NCT01125293|11628068|FG005|Overall Study|Withdrawal by Subject|1
7375136|NCT01125293|11628063|FG000|Overall Study|Physician Decision|0
7375137|NCT01125293|11628064|FG001|Overall Study|Physician Decision|0
7375138|NCT01125293|11628065|FG002|Overall Study|Physician Decision|0
7375139|NCT01125293|11628066|FG003|Overall Study|Physician Decision|0
7375140|NCT01125293|11628067|FG004|Overall Study|Physician Decision|0
7375141|NCT01125293|11628068|FG005|Overall Study|Physician Decision|2
7375142|NCT01125358|11628089|FG000|Overall Study|Adverse Event|3
7375143|NCT01125358|11628090|FG001|Overall Study|Adverse Event|0
7375144|NCT01125358|11628091|FG002|Overall Study|Adverse Event|0
7375145|NCT01125358|11628092|FG003|Overall Study|Adverse Event|2
7375146|NCT01125358|11628089|FG000|Overall Study|Perceived Lack of Efficacy|6
7375147|NCT01125358|11628090|FG001|Overall Study|Perceived Lack of Efficacy|3
7375148|NCT01125358|11628091|FG002|Overall Study|Perceived Lack of Efficacy|7
7375149|NCT01125358|11628092|FG003|Overall Study|Perceived Lack of Efficacy|4
7375150|NCT01125358|11628089|FG000|Overall Study|Protocol Violation|1
7375151|NCT01125358|11628090|FG001|Overall Study|Protocol Violation|0
7375152|NCT01125358|11628091|FG002|Overall Study|Protocol Violation|0
7375153|NCT01125358|11628092|FG003|Overall Study|Protocol Violation|0
7375154|NCT01125358|11628089|FG000|Overall Study|Sponsor Decision|0
7375155|NCT01125358|11628090|FG001|Overall Study|Sponsor Decision|0
7375156|NCT01125358|11628091|FG002|Overall Study|Sponsor Decision|1
7375157|NCT01125358|11628092|FG003|Overall Study|Sponsor Decision|1
7375158|NCT01125358|11628089|FG000|Overall Study|Withdrawal by Subject|2
7375159|NCT01125358|11628090|FG001|Overall Study|Withdrawal by Subject|1
7375160|NCT01125358|11628091|FG002|Overall Study|Withdrawal by Subject|1
7375161|NCT01125358|11628092|FG003|Overall Study|Withdrawal by Subject|1
7387070|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
7387071|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
7387072|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
7387073|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
7387074|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
7387075|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
7387076|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
7387077|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
7387078|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
7387079|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
7387080|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
7387081|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
7387082|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
7387083|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
7387084|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
7387085|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
7461569|NCT01838876|11757743|FG000|Overall Study|Withdrawal of Consent|33
7461570|NCT01838876|11757743|FG000|Overall Study|Lost to Follow-up|21
7461571|NCT01838876|11757743|FG000|Overall Study|Study or Site Terminated by Sponsor|1
7461572|NCT01838876|11757743|FG000|Overall Study|Reason not Specified|7
7461573|NCT01838876|11757743|FG000|Overall Study|Did not meet eligibility criteria|78
7461574|NCT01838941|11757749|FG000|Overall Study|Adverse Event|1
7461575|NCT01838941|11757749|FG000|Overall Study|Withdrawal by Subject|1
7461576|NCT01839188|11757780|FG000|Overall Study|Withdrawal by Subject|1
7461577|NCT01839279|11757792|FG000|Overall Study|Adverse Event|4
7461578|NCT01839279|11757793|FG001|Overall Study|Adverse Event|1
7461579|NCT01839279|11757794|FG002|Overall Study|Adverse Event|1
7461580|NCT01839279|11757792|FG000|Overall Study|Withdrawal by Subject|4
7461581|NCT01839279|11757793|FG001|Overall Study|Withdrawal by Subject|1
7461582|NCT01839279|11757794|FG002|Overall Study|Withdrawal by Subject|1
7461583|NCT01839279|11757792|FG000|Overall Study|Classified as 'Other'|5
7461584|NCT01839279|11757793|FG001|Overall Study|Classified as 'Other'|0
7461585|NCT01839279|11757794|FG002|Overall Study|Classified as 'Other'|0
7461586|NCT01839487|11757824|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
7461587|NCT01839487|11757825|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7461588|NCT01839487|11757826|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7461589|NCT01839487|11757827|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7461590|NCT01839487|11757828|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7461591|NCT01839487|11757829|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
7461592|NCT01839487|11757824|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
7461593|NCT01839487|11757825|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
7461594|NCT01839487|11757826|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7375176|NCT04364737|11628138|FG000|Overall Study|Withdrawal by Subject|4
7375177|NCT04364737|11628139|FG001|Overall Study|Withdrawal by Subject|9
7375178|NCT04364737|11628138|FG000|Overall Study|Lost to Follow-up|1
7375179|NCT04364737|11628139|FG001|Overall Study|Lost to Follow-up|1
7375180|NCT04354155|11628145|FG000|Overall Study|Withdrawal by Subject|1
7375181|NCT04354155|11628145|FG000|Overall Study|Did not meet criteria for study intervention|1
7375182|NCT04085367|11628151|FG000|Overall Study|Adverse Event|1
7375183|NCT04085367|11628152|FG001|Overall Study|Adverse Event|1
7375184|NCT04085367|11628151|FG000|Overall Study|Withdrawal by Subject|13
7375185|NCT04085367|11628152|FG001|Overall Study|Withdrawal by Subject|4
7375186|NCT04085367|11628151|FG000|Overall Study|Lost to Follow-up|3
7375187|NCT04085367|11628152|FG001|Overall Study|Lost to Follow-up|1
7375188|NCT04085367|11628151|FG000|Overall Study|Other unspecified|2
7375189|NCT04085367|11628152|FG001|Overall Study|Other unspecified|1
7375190|NCT04085367|11628151|FG000|Overall Study|Status Unknown|1
7375191|NCT04085367|11628152|FG001|Overall Study|Status Unknown|1
7375192|NCT03621696|11628166|FG000|Overall Study|Not eligible|0
7375193|NCT03621696|11628167|FG001|Overall Study|Not eligible|0
7375194|NCT03621696|11628168|FG002|Overall Study|Not eligible|0
7375195|NCT03621696|11628169|FG003|Overall Study|Not eligible|5
7375196|NCT03621696|11628166|FG000|Overall Study|Withdrawal by Subject|1
7375197|NCT03621696|11628167|FG001|Overall Study|Withdrawal by Subject|1
7375198|NCT03621696|11628168|FG002|Overall Study|Withdrawal by Subject|1
7375199|NCT03621696|11628169|FG003|Overall Study|Withdrawal by Subject|0
7375200|NCT03621696|11628166|FG000|Overall Study|Physician Decision|0
7375201|NCT03621696|11628167|FG001|Overall Study|Physician Decision|0
7375202|NCT03621696|11628168|FG002|Overall Study|Physician Decision|1
7375203|NCT03621696|11628169|FG003|Overall Study|Physician Decision|0
7375204|NCT03544268|11628179|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2
7375205|NCT03544268|11628180|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0
7375206|NCT03038438|11628232|FG000|Overall Study|Death|2
7375207|NCT03038438|11628232|FG000|Overall Study|Lost to Follow-up|4
7375208|NCT03038438|11628232|FG000|Overall Study|Subject Incarceration|1
7375209|NCT03038438|11628232|FG000|Overall Study|Withdrawal by Subject|2
7375210|NCT03038438|11628232|FG000|Overall Study|No 24-Month Follow-Up|43
7375211|NCT02451943|11628247|FG000|Overall Study|On Treatment|4
7375212|NCT02451943|11628248|FG001|Overall Study|On Treatment|4
7375213|NCT02451943|11628247|FG000|Overall Study|Withdrawal by Subject|13
7375214|NCT02451943|11628248|FG001|Overall Study|Withdrawal by Subject|16
7375215|NCT02451943|11628247|FG000|Overall Study|Lost to Follow-up|3
7375216|NCT02451943|11628248|FG001|Overall Study|Lost to Follow-up|4
7375217|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
7375218|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7375219|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7375220|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
7375221|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
7375222|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
7375223|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
7375224|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
7375225|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
7375226|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7375227|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7375228|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
7375229|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
7375230|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7375231|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7375232|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
7375233|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Death|8
7375234|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Death|0
7375235|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Death|0
7375236|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Death|0
7375237|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
7375238|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7375239|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7375240|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
7375241|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
7375242|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
7375243|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
7375244|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
7375245|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
7375246|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
7375247|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
7375248|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
7375249|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
7375250|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7375251|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7375252|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
7375253|NCT02198794|11628254|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
7375254|NCT02198794|11628255|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7375255|NCT02198794|11628256|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7375256|NCT02198794|11628257|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
7375257|NCT02198794|11628254|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
7375258|NCT02198794|11628255|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
7375259|NCT02198794|11628256|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
7375260|NCT02198794|11628257|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
7375261|NCT02198794|11628254|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
7375262|NCT02198794|11628255|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7375263|NCT02198794|11628256|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
7375264|NCT02198794|11628257|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
7375265|NCT02198794|11628254|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7375266|NCT02198794|11628255|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7375267|NCT02198794|11628256|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
7375268|NCT02198794|11628257|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
7375269|NCT02198794|11628254|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7375270|NCT02198794|11628255|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7375271|NCT02198794|11628256|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
7375272|NCT02198794|11628257|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
7375273|NCT02198794|11628254|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
7375274|NCT02198794|11628255|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
7461595|NCT01839487|11757827|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7461596|NCT01839487|11757828|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7461597|NCT01839487|11757829|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
7461598|NCT01839487|11757824|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7375411|NCT01126424|11628454|FG003|Overall Study|Adverse Event|0
7461599|NCT01839487|11757825|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
7461600|NCT01839487|11757826|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7461601|NCT01839487|11757827|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7461602|NCT01839487|11757828|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7461603|NCT01839487|11757829|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
7461604|NCT01839487|11757824|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
7461605|NCT01839487|11757825|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7461606|NCT01839487|11757826|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7461607|NCT01839487|11757827|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7461608|NCT01839487|11757828|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7461609|NCT01839487|11757829|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
7461610|NCT01839487|11757824|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7461611|NCT01839487|11757825|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
7461612|NCT01839487|11757826|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
7461613|NCT01839487|11757827|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
7461614|NCT01839487|11757828|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
7461615|NCT01839487|11757829|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
7375275|NCT02198794|11628256|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
7375276|NCT02198794|11628257|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
7375277|NCT01877655|11628268|FG000|Overall Study|Death|57
7375278|NCT01877655|11628269|FG001|Overall Study|Death|52
7375279|NCT01877655|11628268|FG000|Overall Study|Withdrawal by Subject|18
7375280|NCT01877655|11628269|FG001|Overall Study|Withdrawal by Subject|26
7375281|NCT01877655|11628268|FG000|Overall Study|Physician Decision|11
7375282|NCT01877655|11628269|FG001|Overall Study|Physician Decision|10
7375283|NCT01877655|11628268|FG000|Overall Study|Miscellaneous|4
7375284|NCT01877655|11628269|FG001|Overall Study|Miscellaneous|4
7375285|NCT01877655|11628268|FG000|Overall Study|Randomized but Never Received Drug|8
7375286|NCT01877655|11628269|FG001|Overall Study|Randomized but Never Received Drug|5
7375287|NCT00308685|11628277|FG000|Overall Study|Lost to Follow-up|1
7375288|NCT00308685|11628278|FG001|Overall Study|Lost to Follow-up|0
7375289|NCT00308685|11628277|FG000|Overall Study|Need to administer prohibited medication|1
7375290|NCT00308685|11628278|FG001|Overall Study|Need to administer prohibited medication|2
7375291|NCT00308685|11628277|FG000|Overall Study|Other than specified|1
7375292|NCT00308685|11628278|FG001|Overall Study|Other than specified|3
7375293|NCT01125514|11628284|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
7375294|NCT01125514|11628284|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
7375295|NCT01125514|11628284|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
7375296|NCT01125514|11628284|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
7375297|NCT01125514|11628284|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
7375298|NCT01125514|11628284|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
7375299|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
7375300|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
7375301|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
7375302|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7375303|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
7375304|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
7375305|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
7375306|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
7375307|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
7375308|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7375309|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
7375310|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
7375311|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
7375312|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
7375313|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
7375314|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
7375315|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
7375316|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
7375317|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
7375318|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
7375319|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
7375320|NCT01125566|11628300|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7375321|NCT01125566|11628301|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
7375322|NCT01125566|11628302|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
7375323|NCT01125566|11628300|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7375324|NCT01125566|11628301|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
7375325|NCT01125566|11628302|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
7375326|NCT01125566|11628300|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7375327|NCT01125566|11628301|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
7375328|NCT01125566|11628302|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
7375329|NCT01125566|11628300|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7375330|NCT01125566|11628301|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
7375331|NCT01125566|11628302|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
7375332|NCT01125566|11628300|FG000|Patients Who Switched From AV to TV|Other than listed above|0
7375333|NCT01125566|11628301|FG001|Patients Who Switched From AV to TV|Other than listed above|0
7375334|NCT01125566|11628302|FG002|Patients Who Switched From AV to TV|Other than listed above|4
7375335|NCT01125722|11628328|FG000|Overall Study|Withdrawal by Subject|2
7375336|NCT01125722|11628329|FG001|Overall Study|Withdrawal by Subject|1
7375337|NCT01125722|11628328|FG000|Overall Study|Lost to Follow-up|1
7375338|NCT01125722|11628329|FG001|Overall Study|Lost to Follow-up|0
7375339|NCT01125748|11628337|FG000|Overall Study|Adverse Event|0
7375340|NCT01125748|11628338|FG001|Overall Study|Adverse Event|2
7375341|NCT01125748|11628337|FG000|Overall Study|Lost to Follow-up|0
7375342|NCT01125748|11628338|FG001|Overall Study|Lost to Follow-up|1
7375343|NCT01125748|11628337|FG000|Overall Study|Physician Decision|8
7375344|NCT01125748|11628338|FG001|Overall Study|Physician Decision|7
7375345|NCT01125748|11628337|FG000|Overall Study|Patient Decision to Withdraw|2
7375346|NCT01125748|11628338|FG001|Overall Study|Patient Decision to Withdraw|4
7375347|NCT01125800|11628360|FG000|Phase I|Protocol Violation|0
7375348|NCT01125800|11628361|FG001|Phase I|Protocol Violation|3
7375349|NCT01125800|11628362|FG002|Phase I|Protocol Violation|1
7375350|NCT01125800|11628363|FG003|Phase I|Protocol Violation|1
7375351|NCT01125800|11628364|FG004|Phase I|Protocol Violation|0
7375352|NCT01125800|11628360|FG000|Phase I|Adverse Event|2
7375353|NCT01125800|11628361|FG001|Phase I|Adverse Event|2
7375354|NCT01125800|11628362|FG002|Phase I|Adverse Event|1
7375355|NCT01125800|11628363|FG003|Phase I|Adverse Event|7
7375356|NCT01125800|11628364|FG004|Phase I|Adverse Event|0
7375357|NCT01125800|11628360|FG000|Phase I|Administrative problems|1
7375358|NCT01125800|11628361|FG001|Phase I|Administrative problems|0
7375359|NCT01125800|11628362|FG002|Phase I|Administrative problems|0
7375360|NCT01125800|11628363|FG003|Phase I|Administrative problems|0
7375361|NCT01125800|11628364|FG004|Phase I|Administrative problems|0
7375362|NCT01125800|11628360|FG000|Phase I|Withdrawal by Subject|0
7375363|NCT01125800|11628361|FG001|Phase I|Withdrawal by Subject|0
7375364|NCT01125800|11628362|FG002|Phase I|Withdrawal by Subject|1
7375365|NCT01125800|11628363|FG003|Phase I|Withdrawal by Subject|0
7375366|NCT01125800|11628364|FG004|Phase I|Withdrawal by Subject|0
7375367|NCT01125800|11628360|FG000|Phase I|Disease progression|5
7375368|NCT01125800|11628361|FG001|Phase I|Disease progression|4
7375369|NCT01125800|11628362|FG002|Phase I|Disease progression|1
7375370|NCT01125800|11628363|FG003|Phase I|Disease progression|3
7375371|NCT01125800|11628364|FG004|Phase I|Disease progression|0
7375372|NCT01125800|11628360|FG000|Phase II|Protocol Violation|0
7375373|NCT01125800|11628361|FG001|Phase II|Protocol Violation|0
7375374|NCT01125800|11628362|FG002|Phase II|Protocol Violation|0
7375375|NCT01125800|11628363|FG003|Phase II|Protocol Violation|0
7375376|NCT01125800|11628364|FG004|Phase II|Protocol Violation|1
7375377|NCT01125800|11628360|FG000|Phase II|Adverse Event|0
7375378|NCT01125800|11628361|FG001|Phase II|Adverse Event|0
7375379|NCT01125800|11628362|FG002|Phase II|Adverse Event|0
7375380|NCT01125800|11628363|FG003|Phase II|Adverse Event|0
7375381|NCT01125800|11628364|FG004|Phase II|Adverse Event|2
7375382|NCT01125800|11628360|FG000|Phase II|Disease progression|0
7375383|NCT01125800|11628361|FG001|Phase II|Disease progression|0
7375384|NCT01125800|11628362|FG002|Phase II|Disease progression|0
7375385|NCT01125800|11628363|FG003|Phase II|Disease progression|1
7375386|NCT01125800|11628364|FG004|Phase II|Disease progression|8
7375387|NCT01125813|11628379|FG000|Overall Study|Death|1
7375388|NCT01125813|11628379|FG000|Overall Study|Withdrawal by Subject|1
7375389|NCT01125813|11628379|FG000|Overall Study|Screen Failures|4
7375390|NCT01125917|11628383|FG000|Overall Study|Adverse Event|43
7375391|NCT01125917|11628383|FG000|Overall Study|Lost to Follow-up|23
7375392|NCT01125917|11628383|FG000|Overall Study|Withdrawal by Subject|31
7375393|NCT01125917|11628383|FG000|Overall Study|Administrative|223
7375394|NCT01125917|11628383|FG000|Overall Study|Lack of Efficacy|19
7375395|NCT01125930|11628389|FG000|Overall Study|Adverse Event|0
7375396|NCT01125930|11628390|FG001|Overall Study|Adverse Event|1
7375397|NCT01125930|11628389|FG000|Overall Study|Withdrawal by Subject|1
7375398|NCT01125930|11628390|FG001|Overall Study|Withdrawal by Subject|6
7375399|NCT01125930|11628389|FG000|Overall Study|Protocol Violation|0
7375400|NCT01125930|11628390|FG001|Overall Study|Protocol Violation|1
7375401|NCT01125930|11628389|FG000|Overall Study|Lost to Follow-up|0
7375402|NCT01125930|11628390|FG001|Overall Study|Lost to Follow-up|2
7375403|NCT01126060|11628414|FG000|Overall Study|Protocol Violation|0
7375404|NCT01126060|11628415|FG001|Overall Study|Protocol Violation|2
7375405|NCT01126268|11628430|FG000|Overall Study|Adverse Event|1
7375406|NCT01126359|11628434|FG000|First Intervention (20-minutes)|Physician Decision|0
7375407|NCT01126359|11628435|FG001|First Intervention (20-minutes)|Physician Decision|1
7375408|NCT01126424|11628451|FG000|Overall Study|Adverse Event|0
7375409|NCT01126424|11628452|FG001|Overall Study|Adverse Event|0
7375410|NCT01126424|11628453|FG002|Overall Study|Adverse Event|0
7375412|NCT01126424|11628455|FG004|Overall Study|Adverse Event|1
7375413|NCT01126424|11628456|FG005|Overall Study|Adverse Event|0
7375414|NCT01126424|11628451|FG000|Overall Study|Withdrawal by Subject|0
7375415|NCT01126424|11628452|FG001|Overall Study|Withdrawal by Subject|0
7375416|NCT01126424|11628453|FG002|Overall Study|Withdrawal by Subject|1
7375417|NCT01126424|11628454|FG003|Overall Study|Withdrawal by Subject|3
7375418|NCT01126424|11628455|FG004|Overall Study|Withdrawal by Subject|1
7375419|NCT01126424|11628456|FG005|Overall Study|Withdrawal by Subject|0
7375420|NCT01126437|11628467|FG000|Overall Study|Not treated|11
7375421|NCT01126437|11628468|FG001|Overall Study|Not treated|18
7375422|NCT01126437|11628469|FG002|Overall Study|Not treated|19
7375423|NCT01126437|11628467|FG000|Overall Study|Sites with data irregularities/fraud|6
7375424|NCT01126437|11628468|FG001|Overall Study|Sites with data irregularities/fraud|6
7461616|NCT01839487|11757824|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
7375425|NCT01126437|11628469|FG002|Overall Study|Sites with data irregularities/fraud|7
7375426|NCT01126437|11628467|FG000|Overall Study|Adverse Event|602
7375427|NCT01126437|11628468|FG001|Overall Study|Adverse Event|606
7375428|NCT01126437|11628469|FG002|Overall Study|Adverse Event|635
7375429|NCT01126437|11628467|FG000|Overall Study|Lack of Efficacy|65
7375430|NCT01126437|11628468|FG001|Overall Study|Lack of Efficacy|60
7375431|NCT01126437|11628469|FG002|Overall Study|Lack of Efficacy|59
7375432|NCT01126437|11628467|FG000|Overall Study|Protocol Violation|64
7375433|NCT01126437|11628468|FG001|Overall Study|Protocol Violation|66
7375434|NCT01126437|11628469|FG002|Overall Study|Protocol Violation|41
7375435|NCT01126437|11628467|FG000|Overall Study|Lost to Follow-up|52
7375436|NCT01126437|11628468|FG001|Overall Study|Lost to Follow-up|63
7375437|NCT01126437|11628469|FG002|Overall Study|Lost to Follow-up|55
7375438|NCT01126437|11628467|FG000|Overall Study|Withdrawal by Subject|331
7375439|NCT01126437|11628468|FG001|Overall Study|Withdrawal by Subject|335
7375440|NCT01126437|11628469|FG002|Overall Study|Withdrawal by Subject|319
7375441|NCT01126437|11628467|FG000|Overall Study|Other reason not specified|210
7375442|NCT01126437|11628468|FG001|Overall Study|Other reason not specified|176
7375443|NCT01126437|11628469|FG002|Overall Study|Other reason not specified|178
7375444|NCT01126541|11628480|FG000|Overall Study|Adverse Event|0
7375445|NCT01126541|11628481|FG001|Overall Study|Adverse Event|2
7375446|NCT01126541|11628482|FG002|Overall Study|Adverse Event|4
7375447|NCT01126541|11628480|FG000|Overall Study|Death|0
7375448|NCT01126541|11628481|FG001|Overall Study|Death|1
7375449|NCT01126541|11628482|FG002|Overall Study|Death|0
7375450|NCT01126541|11628480|FG000|Overall Study|Lack of Efficacy|6
7375451|NCT01126541|11628481|FG001|Overall Study|Lack of Efficacy|1
7375452|NCT01126541|11628482|FG002|Overall Study|Lack of Efficacy|11
7375453|NCT01126541|11628480|FG000|Overall Study|Lost to Follow-up|1
7375454|NCT01126541|11628481|FG001|Overall Study|Lost to Follow-up|2
7375455|NCT01126541|11628482|FG002|Overall Study|Lost to Follow-up|2
7375456|NCT01126541|11628480|FG000|Overall Study|Withdrawal by Subject|2
7375457|NCT01126541|11628481|FG001|Overall Study|Withdrawal by Subject|5
7375458|NCT01126541|11628482|FG002|Overall Study|Withdrawal by Subject|6
7375459|NCT01126541|11628480|FG000|Overall Study|Protocol Violation|0
7375460|NCT01126541|11628481|FG001|Overall Study|Protocol Violation|0
7375461|NCT01126541|11628482|FG002|Overall Study|Protocol Violation|1
7375462|NCT01126541|11628480|FG000|Overall Study|Administrative reason or other|1
7375463|NCT01126541|11628481|FG001|Overall Study|Administrative reason or other|1
7375464|NCT01126541|11628482|FG002|Overall Study|Administrative reason or other|2
7375465|NCT01126580|11628495|FG000|Overall Study|Adverse Event|14
7375466|NCT01126580|11628496|FG001|Overall Study|Adverse Event|8
7375467|NCT01126580|11628497|FG002|Overall Study|Adverse Event|12
7375468|NCT01126580|11628495|FG000|Overall Study|Withdrawal by Subject|11
7375469|NCT01126580|11628496|FG001|Overall Study|Withdrawal by Subject|19
7375470|NCT01126580|11628497|FG002|Overall Study|Withdrawal by Subject|14
7375471|NCT01126580|11628495|FG000|Overall Study|Sponsor Decision|5
7375472|NCT01126580|11628496|FG001|Overall Study|Sponsor Decision|4
7375473|NCT01126580|11628497|FG002|Overall Study|Sponsor Decision|7
7375474|NCT01126580|11628495|FG000|Overall Study|Physician Decision|1
7375475|NCT01126580|11628496|FG001|Overall Study|Physician Decision|1
7375476|NCT01126580|11628497|FG002|Overall Study|Physician Decision|2
7375477|NCT01126580|11628495|FG000|Overall Study|Entry Criteria Not Met|1
7461617|NCT01839487|11757825|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
7461618|NCT01839487|11757826|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
7461619|NCT01839487|11757827|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
7461620|NCT01839487|11757828|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
7461621|NCT01839487|11757829|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
7461622|NCT01839487|11757824|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7461623|NCT01839487|11757825|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7461624|NCT01839487|11757826|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
7461625|NCT01839487|11757827|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7461626|NCT01839487|11757828|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
7461627|NCT01839487|11757829|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
7461628|NCT01839487|11757824|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7461629|NCT01839487|11757825|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7461630|NCT01839487|11757826|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
7461631|NCT01839487|11757827|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
7461632|NCT01839487|11757828|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
7461633|NCT01839487|11757829|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
7461634|NCT01839487|11757824|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7461635|NCT01839487|11757825|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
7461636|NCT01839487|11757826|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7461637|NCT01839487|11757827|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
7461638|NCT01839487|11757828|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
7461639|NCT01839487|11757829|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
7461640|NCT01839656|11757860|FG000|Overall Study|Withdrawal by Subject|1
7461641|NCT01839656|11757861|FG001|Overall Study|Withdrawal by Subject|1
7461642|NCT01839656|11757860|FG000|Overall Study|Adverse event, serious fatal|1
7461643|NCT01839656|11757861|FG001|Overall Study|Adverse event, serious fatal|4
7461644|NCT01839656|11757860|FG000|Overall Study|Early study closure|0
7461645|NCT01839656|11757861|FG001|Overall Study|Early study closure|11
7461646|NCT01839656|11757860|FG000|Overall Study|Adverse Event|1
7461647|NCT01839656|11757861|FG001|Overall Study|Adverse Event|0
7461648|NCT01839916|11757889|FG000|Overall Study|Death|9
7461649|NCT01839916|11757889|FG000|Overall Study|Physician Decision|17
7461650|NCT01839916|11757889|FG000|Overall Study|Relapse|12
7461651|NCT01839916|11757889|FG000|Overall Study|GVHD|2
7461652|NCT01839916|11757889|FG000|Overall Study|Graft Failure|1
7461653|NCT01840163|11757906|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
7461654|NCT01840163|11757907|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
7375478|NCT01126580|11628496|FG001|Overall Study|Entry Criteria Not Met|1
7375479|NCT01126580|11628497|FG002|Overall Study|Entry Criteria Not Met|2
7375480|NCT01126580|11628495|FG000|Overall Study|Lack of Efficacy|2
7375481|NCT01126580|11628496|FG001|Overall Study|Lack of Efficacy|3
7375482|NCT01126580|11628497|FG002|Overall Study|Lack of Efficacy|4
7375483|NCT01126580|11628495|FG000|Overall Study|Protocol Violation|0
7375484|NCT01126580|11628496|FG001|Overall Study|Protocol Violation|1
7375485|NCT01126580|11628497|FG002|Overall Study|Protocol Violation|2
7375486|NCT01126580|11628495|FG000|Overall Study|Lost to Follow-up|15
7375487|NCT01126580|11628496|FG001|Overall Study|Lost to Follow-up|13
7375488|NCT01126580|11628497|FG002|Overall Study|Lost to Follow-up|9
7375489|NCT01126580|11628495|FG000|Overall Study|Treatment Non-compliance|0
7375490|NCT01126580|11628496|FG001|Overall Study|Treatment Non-compliance|2
7375491|NCT01126580|11628497|FG002|Overall Study|Treatment Non-compliance|3
7375492|NCT01126619|11628519|FG000|Overall Study|Not eligible for the study|2
7375493|NCT01126619|11628519|FG000|Overall Study|Investigator decision|4
7375494|NCT01126619|11628519|FG000|Overall Study|Serious adverse event|1
7375495|NCT01126619|11628519|FG000|Overall Study|Withdrawal by Subject|9
7375496|NCT01126619|11628519|FG000|Overall Study|Non-compliance|1
7375497|NCT01127061|11628547|FG000|Overall Study|Lost to Follow-up|7
7375498|NCT01127061|11628548|FG001|Overall Study|Lost to Follow-up|10
7375499|NCT01127061|11628547|FG000|Overall Study|Physician Decision|3
7375500|NCT01127061|11628548|FG001|Overall Study|Physician Decision|3
7375501|NCT01127139|11628565|FG000|Overall Study|Adverse Event|40
7375502|NCT01127139|11628565|FG000|Overall Study|Incompliance|12
7375503|NCT01127139|11628565|FG000|Overall Study|Lack of Efficacy|4
7375504|NCT01127139|11628565|FG000|Overall Study|Reason not specified|1
7375505|NCT01127165|11628574|FG000|Overall Study|Adverse Event|2
7375506|NCT01127165|11628575|FG001|Overall Study|Adverse Event|2
7375507|NCT01127165|11628574|FG000|Overall Study|Lack of Efficacy|10
7375508|NCT01127165|11628575|FG001|Overall Study|Lack of Efficacy|8
7375509|NCT01127165|11628574|FG000|Overall Study|Lost to Follow-up|3
7375510|NCT01127165|11628575|FG001|Overall Study|Lost to Follow-up|5
7375511|NCT01127165|11628574|FG000|Overall Study|Withdrawal by Subject|1
7375512|NCT01127165|11628575|FG001|Overall Study|Withdrawal by Subject|3
7375513|NCT01127165|11628574|FG000|Overall Study|Protocol Violation|0
7375514|NCT01127165|11628575|FG001|Overall Study|Protocol Violation|1
7461655|NCT01840163|11757906|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
7461656|NCT01840163|11757907|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
7461657|NCT01840163|11757906|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
7461658|NCT01840163|11757907|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
7461659|NCT01840228|11757915|FG000|Overall Study|Lost to Follow-up|1
7461660|NCT01840228|11757916|FG001|Overall Study|Lost to Follow-up|1
7461661|NCT01840410|11757936|FG000|Overall Study|Physician Decision|1
7461662|NCT01840410|11757937|FG001|Overall Study|Physician Decision|2
7461663|NCT01840410|11757936|FG000|Overall Study|Pregnancy|1
7461664|NCT01840410|11757937|FG001|Overall Study|Pregnancy|0
7461665|NCT01840410|11757936|FG000|Overall Study|Protocol deviation|1
7461666|NCT01840410|11757937|FG001|Overall Study|Protocol deviation|0
7461667|NCT01840410|11757936|FG000|Overall Study|Lost to Follow-up|1
7461668|NCT01840410|11757937|FG001|Overall Study|Lost to Follow-up|0
7461669|NCT01840410|11757936|FG000|Overall Study|Withdrawal by Subject|2
7461670|NCT01840410|11757937|FG001|Overall Study|Withdrawal by Subject|1
7461671|NCT01840410|11757936|FG000|Overall Study|Adverse Event|1
7461672|NCT01840410|11757937|FG001|Overall Study|Adverse Event|1
7461673|NCT01840579|11757955|FG000|Overall Study|Status not recorded|0
7461674|NCT01840579|11757956|FG001|Overall Study|Status not recorded|0
7461675|NCT01840579|11757957|FG002|Overall Study|Status not recorded|2
7461676|NCT01840579|11757958|FG003|Overall Study|Status not recorded|3
7461677|NCT01840579|11757959|FG004|Overall Study|Status not recorded|4
7461678|NCT01840579|11757960|FG005|Overall Study|Status not recorded|3
7461679|NCT01840579|11757961|FG006|Overall Study|Status not recorded|0
7461680|NCT01840579|11757962|FG007|Overall Study|Status not recorded|3
7461681|NCT01840579|11757963|FG008|Overall Study|Status not recorded|3
7461682|NCT01840579|11757964|FG009|Overall Study|Status not recorded|3
7461683|NCT01840579|11757955|FG000|Overall Study|Progressive disease|3
7461684|NCT01840579|11757956|FG001|Overall Study|Progressive disease|5
7461685|NCT01840579|11757957|FG002|Overall Study|Progressive disease|0
7461686|NCT01840579|11757958|FG003|Overall Study|Progressive disease|0
7461687|NCT01840579|11757959|FG004|Overall Study|Progressive disease|0
7461688|NCT01840579|11757960|FG005|Overall Study|Progressive disease|0
7461689|NCT01840579|11757961|FG006|Overall Study|Progressive disease|0
7461690|NCT01840579|11757962|FG007|Overall Study|Progressive disease|0
7461691|NCT01840579|11757963|FG008|Overall Study|Progressive disease|0
7461692|NCT01840579|11757964|FG009|Overall Study|Progressive disease|0
7461693|NCT01840579|11757955|FG000|Overall Study|Ongoing in study|0
7461694|NCT01840579|11757956|FG001|Overall Study|Ongoing in study|1
7461695|NCT01840579|11757957|FG002|Overall Study|Ongoing in study|0
7461696|NCT01840579|11757958|FG003|Overall Study|Ongoing in study|0
7461697|NCT01840579|11757959|FG004|Overall Study|Ongoing in study|0
7461698|NCT01840579|11757960|FG005|Overall Study|Ongoing in study|0
7461699|NCT01840579|11757961|FG006|Overall Study|Ongoing in study|0
7461700|NCT01840579|11757962|FG007|Overall Study|Ongoing in study|0
7375515|NCT01127373|11628602|FG000|Overall Study|Not Treated|3
7461701|NCT01840579|11757963|FG008|Overall Study|Ongoing in study|0
7461702|NCT01840579|11757964|FG009|Overall Study|Ongoing in study|0
7375516|NCT01127373|11628602|FG000|Overall Study|Lost to Follow-up|7
7375517|NCT01127373|11628602|FG000|Overall Study|Withdrawal by Subject|1
7375518|NCT01127373|11628602|FG000|Overall Study|Disease progression|1
7375519|NCT01127607|11628638|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
7375520|NCT01127607|11628639|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
7375521|NCT01127607|11628638|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
7375522|NCT01127607|11628639|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
7375523|NCT01127633|11628664|FG000|Overall Study|Adverse Event|74
7375524|NCT01127633|11628665|FG001|Overall Study|Adverse Event|73
7375525|NCT01127633|11628664|FG000|Overall Study|Death|40
7375526|NCT01127633|11628665|FG001|Overall Study|Death|43
7375527|NCT01127633|11628664|FG000|Overall Study|Lost to Follow-up|4
7375528|NCT01127633|11628665|FG001|Overall Study|Lost to Follow-up|0
7375529|NCT01127633|11628664|FG000|Overall Study|Parent/Caregiver Decision|246
7375530|NCT01127633|11628665|FG001|Overall Study|Parent/Caregiver Decision|228
7375531|NCT01127633|11628664|FG000|Overall Study|Physician Decision|60
7375532|NCT01127633|11628665|FG001|Overall Study|Physician Decision|45
7375533|NCT01127633|11628664|FG000|Overall Study|Withdrawal by Subject|57
7375534|NCT01127633|11628665|FG001|Overall Study|Withdrawal by Subject|72
7375535|NCT01127633|11628664|FG000|Overall Study|Sponsor Decision|163
7375536|NCT01127633|11628665|FG001|Overall Study|Sponsor Decision|195
7375537|NCT01127633|11628664|FG000|Overall Study|Protocol Violation|8
7375538|NCT01127633|11628665|FG001|Overall Study|Protocol Violation|16
7375539|NCT01127633|11628664|FG000|Overall Study|Abnormal Lab/ECG Result|0
7375540|NCT01127633|11628665|FG001|Overall Study|Abnormal Lab/ECG Result|1
7375541|NCT01127633|11628664|FG000|Overall Study|Not treated|1
7375542|NCT01127633|11628665|FG001|Overall Study|Not treated|0
7387086|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
7387087|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
7387088|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387089|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7387090|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
7387091|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387092|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387093|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387094|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387095|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
7387096|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7387097|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387098|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7387099|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7387100|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387101|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387102|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387103|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387104|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
7387105|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
7387106|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387107|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
7387108|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
7387109|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387110|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387111|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387112|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387113|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387114|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7387115|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387116|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387117|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7387118|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387119|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387120|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387121|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387122|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387123|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7387124|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387125|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
7387126|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387127|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387128|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387129|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387130|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387131|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
7387132|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
7387133|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Missing|0
7387134|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Missing|0
7375543|NCT01127646|11628673|FG000|Overall Study|Entry Criteria Not Met|1
7375544|NCT01127646|11628674|FG001|Overall Study|Entry Criteria Not Met|0
7375545|NCT01127646|11628673|FG000|Overall Study|Protocol Violation|0
7375546|NCT01127646|11628674|FG001|Overall Study|Protocol Violation|1
7375547|NCT01127763|11628716|FG000|Overall Study|Adverse Event|2
7375548|NCT01127763|11628716|FG000|Overall Study|Withdrawal by Subject|1
7375549|NCT01127763|11628716|FG000|Overall Study|Physician Decision|2
7375550|NCT01127893|11628724|FG000|Overall Study|Study Termination by the Sponsor|1
7375551|NCT01128153|11628743|FG000|Overall Study|Adverse Event|1
7375552|NCT01128153|11628744|FG001|Overall Study|Adverse Event|3
7375553|NCT01128153|11628743|FG000|Overall Study|Condition under investigation worsened|8
7375554|NCT01128153|11628744|FG001|Overall Study|Condition under investigation worsened|7
7375555|NCT01128153|11628743|FG000|Overall Study|Withdrawal by Subject|2
7375556|NCT01128153|11628744|FG001|Overall Study|Withdrawal by Subject|3
7375557|NCT01128153|11628743|FG000|Overall Study|Incorrect enrolment to study|2
7375558|NCT01128153|11628744|FG001|Overall Study|Incorrect enrolment to study|1
7375559|NCT01128153|11628743|FG000|Overall Study|Protocol Violation|2
7375560|NCT01128153|11628744|FG001|Overall Study|Protocol Violation|0
7375561|NCT01128153|11628743|FG000|Overall Study|Developed discontinuation criteria|1
7375562|NCT01128153|11628744|FG001|Overall Study|Developed discontinuation criteria|1
7375563|NCT01128179|11628752|FG000|Overall Study|Death|1
7375564|NCT01128179|11628753|FG001|Overall Study|Death|0
7375565|NCT01128179|11628752|FG000|Overall Study|Protocol Violation|1
7375566|NCT01128179|11628753|FG001|Overall Study|Protocol Violation|0
7375567|NCT01128244|11628774|FG000|Overall Study|Adverse Event|1
7375568|NCT01128244|11628774|FG000|Overall Study|Scheduling conflict|2
7375569|NCT01128296|11628794|FG000|Overall Study|Physician Decision|0
7375570|NCT01128296|11628795|FG001|Overall Study|Physician Decision|0
7375571|NCT01128296|11628796|FG002|Overall Study|Physician Decision|0
7375572|NCT01128296|11628797|FG003|Overall Study|Physician Decision|0
7375573|NCT01128296|11628798|FG004|Overall Study|Physician Decision|0
7375574|NCT01128296|11628799|FG005|Overall Study|Physician Decision|3
7375575|NCT01128296|11628794|FG000|Overall Study|Withdrawal by Subject|0
7375576|NCT01128296|11628795|FG001|Overall Study|Withdrawal by Subject|0
7375577|NCT01128296|11628796|FG002|Overall Study|Withdrawal by Subject|0
7375578|NCT01128296|11628797|FG003|Overall Study|Withdrawal by Subject|0
7375579|NCT01128296|11628798|FG004|Overall Study|Withdrawal by Subject|0
7375580|NCT01128296|11628799|FG005|Overall Study|Withdrawal by Subject|2
7375581|NCT01128361|11628812|FG000|Overall Study|Lost to Follow-up|0
7375582|NCT01128361|11628813|FG001|Overall Study|Lost to Follow-up|1
7375583|NCT01128361|11628812|FG000|Overall Study|Withdrawal by Subject|5
7375584|NCT01128361|11628813|FG001|Overall Study|Withdrawal by Subject|2
7375585|NCT01128387|11628821|FG000|Overall Study|Physician Decision|0
7375586|NCT01128387|11628822|FG001|Overall Study|Physician Decision|1
7375587|NCT01128400|11628831|FG000|Overall Study|Lost to Follow-up|1
7375588|NCT01128400|11628832|FG001|Overall Study|Lost to Follow-up|0
7375589|NCT01128400|11628833|FG002|Overall Study|Lost to Follow-up|1
7375590|NCT01128400|11628831|FG000|Overall Study|Screening failure|1
7375591|NCT01128400|11628832|FG001|Overall Study|Screening failure|0
7375592|NCT01128400|11628833|FG002|Overall Study|Screening failure|0
7375593|NCT01128400|11628831|FG000|Overall Study|were not invited to participate on taste|0
7375594|NCT01128400|11628832|FG001|Overall Study|were not invited to participate on taste|0
7375595|NCT01128400|11628833|FG002|Overall Study|were not invited to participate on taste|15
7375596|NCT01128400|11628831|FG000|Overall Study|Excluded due to sinus problems|0
7375597|NCT01128400|11628832|FG001|Overall Study|Excluded due to sinus problems|1
7375598|NCT01128400|11628833|FG002|Overall Study|Excluded due to sinus problems|0
7375599|NCT01128413|11628843|FG000|Overall Study|Withdrawal by Subject|1
7375600|NCT01128413|11628844|FG001|Overall Study|Withdrawal by Subject|0
7375601|NCT01128413|11628843|FG000|Overall Study|NICOM Monitor Problems|2
7375602|NCT01128413|11628844|FG001|Overall Study|NICOM Monitor Problems|1
7375603|NCT01128413|11628843|FG000|Overall Study|Pt made DNR|1
7375604|NCT01128413|11628844|FG001|Overall Study|Pt made DNR|0
7375605|NCT01128543|11628856|FG000|Overall Study|Withdrawal by Subject|3
7375606|NCT01128543|11628856|FG000|Overall Study|Protocol Violation|1
7375607|NCT01128569|11628860|FG000|Washout Period 1|Adverse Event|0
7375608|NCT01128569|11628861|FG001|Washout Period 1|Adverse Event|0
7570629|NCT03499028|11948643|FG001|Overall Study|Unplanned SNF discharge|8
7375609|NCT01128569|11628862|FG002|Washout Period 1|Adverse Event|1
7375610|NCT01128569|11628863|FG003|Washout Period 1|Adverse Event|0
7375611|NCT01128569|11628864|FG004|Washout Period 1|Adverse Event|0
7375612|NCT01128569|11628865|FG005|Washout Period 1|Adverse Event|0
7375613|NCT01128569|11628860|FG000|Treatment Period 2|Withdrawal by Subject|0
7375614|NCT01128569|11628861|FG001|Treatment Period 2|Withdrawal by Subject|1
7375615|NCT01128569|11628862|FG002|Treatment Period 2|Withdrawal by Subject|0
7375616|NCT01128569|11628863|FG003|Treatment Period 2|Withdrawal by Subject|0
7375617|NCT01128569|11628864|FG004|Treatment Period 2|Withdrawal by Subject|0
7375618|NCT01128569|11628865|FG005|Treatment Period 2|Withdrawal by Subject|0
7375619|NCT01128595|11628873|FG000|Treatment Period 3|Withdrawal by Subject|0
7375620|NCT01128595|11628874|FG001|Treatment Period 3|Withdrawal by Subject|1
7375621|NCT01128595|11628875|FG002|Treatment Period 3|Withdrawal by Subject|0
7375622|NCT01128595|11628876|FG003|Treatment Period 3|Withdrawal by Subject|0
7375623|NCT01128621|11628889|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
7387135|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Missing|1
7375624|NCT01128621|11628890|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
7375625|NCT01128738|11628914|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
7375626|NCT01128738|11628915|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
7375627|NCT01128738|11628914|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
7375628|NCT01128738|11628915|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
7375629|NCT01128738|11628914|FG000|Second TP|Lost to Follow-up|0
7375630|NCT01128738|11628915|FG001|Second TP|Lost to Follow-up|1
7375631|NCT01128738|11628914|FG000|Second TP|Withdrawal by Subject|0
7375632|NCT01128738|11628915|FG001|Second TP|Withdrawal by Subject|2
7375633|NCT01128842|11628927|FG000|Overall Study|Adverse Event|1
7375634|NCT01128842|11628927|FG000|Overall Study|Disease Progression|6
7375635|NCT01128894|11628934|FG000|Overall Study|Adverse Event|31
7375636|NCT01128894|11628935|FG001|Overall Study|Adverse Event|41
7375637|NCT01128894|11628934|FG000|Overall Study|Protocol Violation|2
7375638|NCT01128894|11628935|FG001|Overall Study|Protocol Violation|1
7375639|NCT01128894|11628934|FG000|Overall Study|Noncompliance|4
7375640|NCT01128894|11628935|FG001|Overall Study|Noncompliance|5
7375641|NCT01128894|11628934|FG000|Overall Study|Lost to Follow-up|8
7375642|NCT01128894|11628935|FG001|Overall Study|Lost to Follow-up|8
7375643|NCT01128894|11628934|FG000|Overall Study|Withdrawal by Subject|10
7375644|NCT01128894|11628935|FG001|Overall Study|Withdrawal by Subject|12
7375645|NCT01128894|11628934|FG000|Overall Study|Physician Decision|2
7375646|NCT01128894|11628935|FG001|Overall Study|Physician Decision|1
7375647|NCT01128894|11628934|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
7375648|NCT01128894|11628935|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
7375649|NCT01128946|11628941|FG000|Period I|Protocol Violation|0
7375650|NCT01128946|11628942|FG001|Period I|Protocol Violation|1
7375651|NCT01128946|11628943|FG002|Period I|Protocol Violation|0
7375652|NCT01128946|11628944|FG003|Period I|Protocol Violation|0
7375653|NCT01128946|11628941|FG000|Period I|Withdrawal by Subject|0
7375654|NCT01128946|11628942|FG001|Period I|Withdrawal by Subject|0
7375655|NCT01128946|11628943|FG002|Period I|Withdrawal by Subject|1
7375656|NCT01128946|11628944|FG003|Period I|Withdrawal by Subject|1
7375657|NCT01128946|11628941|FG000|Period II|Protocol Violation|0
7375658|NCT01128946|11628942|FG001|Period II|Protocol Violation|1
7375659|NCT01128946|11628943|FG002|Period II|Protocol Violation|0
7375660|NCT01128946|11628944|FG003|Period II|Protocol Violation|0
7375661|NCT01128946|11628941|FG000|Period II|Withdrawal by Subject|0
7375662|NCT01128946|11628942|FG001|Period II|Withdrawal by Subject|0
7375663|NCT01128946|11628943|FG002|Period II|Withdrawal by Subject|0
7375664|NCT01128946|11628944|FG003|Period II|Withdrawal by Subject|1
7375665|NCT01128946|11628941|FG000|Period III|Protocol Violation|1
7375666|NCT01128946|11628942|FG001|Period III|Protocol Violation|0
7375667|NCT01128946|11628943|FG002|Period III|Protocol Violation|0
7375668|NCT01128946|11628944|FG003|Period III|Protocol Violation|0
7375669|NCT01128959|11628955|FG000|Lead in Period|Adverse Event|3
7375670|NCT01128959|11628955|FG000|Treatment Period|Adverse Event|3
7375671|NCT01128959|11628955|FG000|Treatment Period|Withdrawal by Subject|1
7375672|NCT01129024|11628983|FG000|Overall Study|Physician Decision|5
7375673|NCT01129024|11628983|FG000|Overall Study|Study Terminated by Sponsor|8
7375674|NCT01129024|11628983|FG000|Overall Study|Withdrawal by Subject|2
7375675|NCT01129024|11628983|FG000|Overall Study|Lack of Efficacy|3
7375676|NCT01129024|11628983|FG000|Overall Study|Needed a Platelet Transfusion|1
7375677|NCT01129102|11628990|FG000|Overall Study|No study drug treatment|2
7375678|NCT01129102|11628991|FG001|Overall Study|No study drug treatment|3
7375679|NCT01129102|11628992|FG002|Overall Study|No study drug treatment|1
7375680|NCT01129102|11628990|FG000|Overall Study|Withdrawal by Subject|2
7375681|NCT01129102|11628991|FG001|Overall Study|Withdrawal by Subject|0
7375682|NCT01129102|11628992|FG002|Overall Study|Withdrawal by Subject|3
7375683|NCT01129102|11628990|FG000|Overall Study|Protocol Violation|0
7375684|NCT01129102|11628991|FG001|Overall Study|Protocol Violation|1
7375685|NCT01129102|11628992|FG002|Overall Study|Protocol Violation|1
7375686|NCT01129102|11628990|FG000|Overall Study|Pregnancy|0
7375687|NCT01129102|11628991|FG001|Overall Study|Pregnancy|0
7375688|NCT01129102|11628992|FG002|Overall Study|Pregnancy|1
7375689|NCT01129102|11628990|FG000|Overall Study|Adverse Event|2
7375690|NCT01129102|11628991|FG001|Overall Study|Adverse Event|2
7375691|NCT01129102|11628992|FG002|Overall Study|Adverse Event|1
7375692|NCT01129102|11628990|FG000|Overall Study|Lost to Follow-up|2
7375693|NCT01129102|11628991|FG001|Overall Study|Lost to Follow-up|0
7375694|NCT01129102|11628992|FG002|Overall Study|Lost to Follow-up|0
7375695|NCT01129115|11629003|FG000|Overall Study|Adverse Event|1
7375696|NCT01129115|11629004|FG001|Overall Study|Adverse Event|2
7375697|NCT01129115|11629005|FG002|Overall Study|Adverse Event|3
7375698|NCT01129115|11629006|FG003|Overall Study|Adverse Event|3
7375699|NCT01129115|11629003|FG000|Overall Study|Withdrawal by Subject|1
7375700|NCT01129115|11629004|FG001|Overall Study|Withdrawal by Subject|3
7375701|NCT01129115|11629005|FG002|Overall Study|Withdrawal by Subject|1
7375702|NCT01129115|11629006|FG003|Overall Study|Withdrawal by Subject|4
7375703|NCT01129115|11629003|FG000|Overall Study|Protocol Violation|0
7375704|NCT01129115|11629004|FG001|Overall Study|Protocol Violation|2
7375705|NCT01129115|11629005|FG002|Overall Study|Protocol Violation|2
7375706|NCT01129115|11629006|FG003|Overall Study|Protocol Violation|2
7375707|NCT01129128|11629019|FG000|Overall Study|Lost to Follow-up|2
7375708|NCT01129128|11629020|FG001|Overall Study|Lost to Follow-up|2
7375709|NCT01129128|11629021|FG002|Overall Study|Lost to Follow-up|1
7375710|NCT01129128|11629019|FG000|Overall Study|Protocol Violation|0
7375711|NCT01129128|11629020|FG001|Overall Study|Protocol Violation|1
7375712|NCT01129128|11629021|FG002|Overall Study|Protocol Violation|0
7375713|NCT01129128|11629019|FG000|Overall Study|Withdrawal by Subject|0
7375714|NCT01129128|11629020|FG001|Overall Study|Withdrawal by Subject|1
7375715|NCT01129128|11629021|FG002|Overall Study|Withdrawal by Subject|3
7375716|NCT01129128|11629019|FG000|Overall Study|Physician Decision|1
7375717|NCT01129128|11629020|FG001|Overall Study|Physician Decision|0
7375718|NCT01129128|11629021|FG002|Overall Study|Physician Decision|0
7375719|NCT01129284|11629060|FG000|Overall Study|Adverse Event|2
7375720|NCT01129284|11629061|FG001|Overall Study|Adverse Event|0
7375721|NCT01129284|11629062|FG002|Overall Study|Adverse Event|1
7375722|NCT01129336|11629072|FG000|Overall Study|Protocol Violation|1
7375723|NCT01129336|11629073|FG001|Overall Study|Protocol Violation|0
7375724|NCT01129336|11629072|FG000|Overall Study|Disease Progression|1
7375725|NCT01129336|11629073|FG001|Overall Study|Disease Progression|4
7375726|NCT01129336|11629072|FG000|Overall Study|Lost to Follow-up|1
7375727|NCT01129336|11629073|FG001|Overall Study|Lost to Follow-up|0
7375728|NCT01129336|11629072|FG000|Overall Study|Withdrawal by Subject|7
7375729|NCT01129336|11629073|FG001|Overall Study|Withdrawal by Subject|4
7375730|NCT01129336|11629072|FG000|Overall Study|Adverse Event|0
7375731|NCT01129336|11629073|FG001|Overall Study|Adverse Event|1
7375732|NCT01129336|11629072|FG000|Overall Study|Missing Study Completion Status|2
7375733|NCT01129336|11629073|FG001|Overall Study|Missing Study Completion Status|3
7375734|NCT01129336|11629072|FG000|Overall Study|Death|0
7375735|NCT01129336|11629073|FG001|Overall Study|Death|4
7375736|NCT01129557|11629109|FG000|Overall Study|Adverse Event|1
7375737|NCT01129557|11629110|FG001|Overall Study|Adverse Event|2
7375738|NCT01129557|11629111|FG002|Overall Study|Adverse Event|2
7375739|NCT01129557|11629109|FG000|Overall Study|Novartis terminated study early|3
7375740|NCT01129557|11629110|FG001|Overall Study|Novartis terminated study early|3
7375741|NCT01129557|11629111|FG002|Overall Study|Novartis terminated study early|2
7375742|NCT01129583|11629132|FG000|Overall Study|Death|1
7375743|NCT01129583|11629133|FG001|Overall Study|Death|0
7375744|NCT01129583|11629132|FG000|Overall Study|Lost to Follow-up|1
7375745|NCT01129583|11629133|FG001|Overall Study|Lost to Follow-up|1
7375746|NCT01129583|11629132|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
7375747|NCT01129583|11629133|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
7375748|NCT01129622|11629143|FG000|Overall Study|Withdrawal by Subject|2
7375749|NCT01129882|11629165|FG000|Overall Study|Adverse Event|39
7375750|NCT01129882|11629165|FG000|Overall Study|Death|6
7375751|NCT01129882|11629165|FG000|Overall Study|Lack of Efficacy|5
7375752|NCT01129882|11629165|FG000|Overall Study|Lost to Follow-up|13
7375753|NCT01129882|11629165|FG000|Overall Study|Physician Decision|27
7375754|NCT01129882|11629165|FG000|Overall Study|Protocol Deviation|3
7375755|NCT01129882|11629165|FG000|Overall Study|Withdrawal Criteria Met|19
7375756|NCT01129882|11629165|FG000|Overall Study|Trial Termination by Sponsor|6
7375757|NCT01129882|11629165|FG000|Overall Study|Withdrawal by Subject|160
7375758|NCT01129921|11629171|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
7375759|NCT01129921|11629172|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
7375760|NCT01129921|11629171|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
7375761|NCT01129921|11629172|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
7375762|NCT01129921|11629171|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
7375763|NCT01129921|11629172|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
7375764|NCT01129921|11629171|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
7375765|NCT01129921|11629172|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
7375766|NCT01129960|11629186|FG000|Overall Study|Withdrawal by Subject|3
7375767|NCT01129960|11629187|FG001|Overall Study|Withdrawal by Subject|0
7375768|NCT01129960|11629188|FG002|Overall Study|Withdrawal by Subject|3
7375769|NCT01129960|11629189|FG003|Overall Study|Withdrawal by Subject|2
7375770|NCT01129960|11629186|FG000|Overall Study|Lack of Efficacy|1
7375771|NCT01129960|11629187|FG001|Overall Study|Lack of Efficacy|1
7375772|NCT01129960|11629188|FG002|Overall Study|Lack of Efficacy|1
7375773|NCT01129960|11629189|FG003|Overall Study|Lack of Efficacy|1
7375774|NCT01129960|11629186|FG000|Overall Study|Adverse Event|23
7375775|NCT01129960|11629187|FG001|Overall Study|Adverse Event|16
7375776|NCT01129960|11629188|FG002|Overall Study|Adverse Event|16
7375777|NCT01129960|11629189|FG003|Overall Study|Adverse Event|7
7375778|NCT01129960|11629186|FG000|Overall Study|Protocol Violation|1
7375779|NCT01129960|11629187|FG001|Overall Study|Protocol Violation|2
7375780|NCT01129960|11629188|FG002|Overall Study|Protocol Violation|3
7375781|NCT01129960|11629189|FG003|Overall Study|Protocol Violation|0
7375782|NCT01129960|11629186|FG000|Overall Study|Lost to Follow-up|0
7375783|NCT01129960|11629187|FG001|Overall Study|Lost to Follow-up|2
7375784|NCT01129960|11629188|FG002|Overall Study|Lost to Follow-up|3
7375785|NCT01129960|11629189|FG003|Overall Study|Lost to Follow-up|3
7375786|NCT01129960|11629186|FG000|Overall Study|Discontinuation of the study by Sponsor|0
7375787|NCT01129960|11629187|FG001|Overall Study|Discontinuation of the study by Sponsor|1
7375788|NCT01129960|11629188|FG002|Overall Study|Discontinuation of the study by Sponsor|0
7375789|NCT01129960|11629189|FG003|Overall Study|Discontinuation of the study by Sponsor|0
7375790|NCT01129960|11629186|FG000|Overall Study|Physician Decision|1
7375791|NCT01129960|11629187|FG001|Overall Study|Physician Decision|0
7375792|NCT01129960|11629188|FG002|Overall Study|Physician Decision|0
7375793|NCT01129960|11629189|FG003|Overall Study|Physician Decision|0
7375794|NCT01129960|11629186|FG000|Overall Study|Pregnancy|1
7375795|NCT01129960|11629187|FG001|Overall Study|Pregnancy|0
7375796|NCT01129960|11629188|FG002|Overall Study|Pregnancy|0
7375797|NCT01129960|11629189|FG003|Overall Study|Pregnancy|0
7375798|NCT01130051|11629199|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
7375799|NCT01130051|11629200|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
7375800|NCT01130051|11629199|FG000|Washout Period of 14 Days|Protocol Violation|1
7375801|NCT01130051|11629200|FG001|Washout Period of 14 Days|Protocol Violation|1
7375802|NCT01130103|11629208|FG000|Randomized Treatment|Adverse Event|1
7375803|NCT01130103|11629209|FG001|Randomized Treatment|Adverse Event|1
7375804|NCT01130103|11629208|FG000|Randomized Treatment|Lost to Follow-up|1
7375805|NCT01130103|11629209|FG001|Randomized Treatment|Lost to Follow-up|0
7375806|NCT01130103|11629208|FG000|Randomized Treatment|Protocol Violation|3
7375807|NCT01130103|11629209|FG001|Randomized Treatment|Protocol Violation|2
7375808|NCT01130103|11629208|FG000|Randomized Treatment|Withdrawal by Subject|1
7375809|NCT01130103|11629209|FG001|Randomized Treatment|Withdrawal by Subject|2
7375810|NCT01130103|11629208|FG000|Maintenance Treatment|Lack of Efficacy|0
7375811|NCT01130103|11629209|FG001|Maintenance Treatment|Lack of Efficacy|1
7375812|NCT01130103|11629208|FG000|Maintenance Treatment|Lost to Follow-up|1
7375813|NCT01130103|11629209|FG001|Maintenance Treatment|Lost to Follow-up|1
7375814|NCT01130103|11629208|FG000|Maintenance Treatment|Withdrawal by Subject|1
7375815|NCT01130103|11629209|FG001|Maintenance Treatment|Withdrawal by Subject|0
7375816|NCT01130168|11629215|FG000|Period 1|Withdrawal by Subject|0
7375817|NCT01130168|11629216|FG001|Period 1|Withdrawal by Subject|1
7375818|NCT01130168|11629217|FG002|Period 1|Withdrawal by Subject|0
7375819|NCT01130168|11629218|FG003|Period 1|Withdrawal by Subject|1
7375820|NCT01130168|11629219|FG004|Period 1|Withdrawal by Subject|0
7375821|NCT01130168|11629220|FG005|Period 1|Withdrawal by Subject|0
7375822|NCT01130168|11629215|FG000|Period 1|Discontinued For Other Reason|0
7375823|NCT01130168|11629216|FG001|Period 1|Discontinued For Other Reason|0
7375824|NCT01130168|11629217|FG002|Period 1|Discontinued For Other Reason|1
7375825|NCT01130168|11629218|FG003|Period 1|Discontinued For Other Reason|1
7375826|NCT01130168|11629219|FG004|Period 1|Discontinued For Other Reason|0
7375827|NCT01130168|11629220|FG005|Period 1|Discontinued For Other Reason|0
7375828|NCT01130168|11629215|FG000|Period 1|Adverse Event|0
7375829|NCT01130168|11629216|FG001|Period 1|Adverse Event|0
7375830|NCT01130168|11629217|FG002|Period 1|Adverse Event|0
7375831|NCT01130168|11629218|FG003|Period 1|Adverse Event|1
7375832|NCT01130168|11629219|FG004|Period 1|Adverse Event|0
7375833|NCT01130168|11629220|FG005|Period 1|Adverse Event|0
7375834|NCT01130272|11629234|FG000|Overall Study|Adverse Event|2
7375835|NCT01130272|11629235|FG001|Overall Study|Adverse Event|5
7375836|NCT01130272|11629236|FG002|Overall Study|Adverse Event|6
7375837|NCT01130272|11629237|FG003|Overall Study|Adverse Event|22
7375838|NCT01130272|11629238|FG004|Overall Study|Adverse Event|7
7375839|NCT01130272|11629234|FG000|Overall Study|IVRS-confirmed constipation|0
7375840|NCT01130272|11629235|FG001|Overall Study|IVRS-confirmed constipation|1
7375841|NCT01130272|11629236|FG002|Overall Study|IVRS-confirmed constipation|1
7375842|NCT01130272|11629237|FG003|Overall Study|IVRS-confirmed constipation|2
7375843|NCT01130272|11629238|FG004|Overall Study|IVRS-confirmed constipation|0
7375844|NCT01130272|11629234|FG000|Overall Study|Rescue medications due to diarrhea|3
7375845|NCT01130272|11629235|FG001|Overall Study|Rescue medications due to diarrhea|5
7375846|NCT01130272|11629236|FG002|Overall Study|Rescue medications due to diarrhea|8
7375847|NCT01130272|11629237|FG003|Overall Study|Rescue medications due to diarrhea|8
7375848|NCT01130272|11629238|FG004|Overall Study|Rescue medications due to diarrhea|6
7375849|NCT01130272|11629234|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7375850|NCT01130272|11629235|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
7375851|NCT01130272|11629236|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7375852|NCT01130272|11629237|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
7375853|NCT01130272|11629238|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
7375854|NCT01130272|11629234|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7375855|NCT01130272|11629235|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7375856|NCT01130272|11629236|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7375857|NCT01130272|11629237|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
7375858|NCT01130272|11629238|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
7375859|NCT01130272|11629234|FG000|Overall Study|Protocol Violation|0
7375860|NCT01130272|11629235|FG001|Overall Study|Protocol Violation|0
7375861|NCT01130272|11629236|FG002|Overall Study|Protocol Violation|3
7375862|NCT01130272|11629237|FG003|Overall Study|Protocol Violation|5
7375863|NCT01130272|11629238|FG004|Overall Study|Protocol Violation|5
7375864|NCT01130272|11629234|FG000|Overall Study|Lost to Follow-up|4
7375865|NCT01130272|11629235|FG001|Overall Study|Lost to Follow-up|3
7375866|NCT01130272|11629236|FG002|Overall Study|Lost to Follow-up|4
7375867|NCT01130272|11629237|FG003|Overall Study|Lost to Follow-up|7
7375868|NCT01130272|11629238|FG004|Overall Study|Lost to Follow-up|6
7375869|NCT01130272|11629234|FG000|Overall Study|Withdrawal by Subject|4
7375870|NCT01130272|11629235|FG001|Overall Study|Withdrawal by Subject|11
7375871|NCT01130272|11629236|FG002|Overall Study|Withdrawal by Subject|10
7375872|NCT01130272|11629237|FG003|Overall Study|Withdrawal by Subject|9
7375873|NCT01130272|11629238|FG004|Overall Study|Withdrawal by Subject|8
7375874|NCT01130272|11629234|FG000|Overall Study|Physician Decision|1
7375875|NCT01130272|11629235|FG001|Overall Study|Physician Decision|1
7375876|NCT01130272|11629236|FG002|Overall Study|Physician Decision|0
7375877|NCT01130272|11629237|FG003|Overall Study|Physician Decision|1
7375878|NCT01130272|11629238|FG004|Overall Study|Physician Decision|2
7375879|NCT01130272|11629234|FG000|Overall Study|Sponsor decision|6
7375880|NCT01130272|11629235|FG001|Overall Study|Sponsor decision|15
7375881|NCT01130272|11629236|FG002|Overall Study|Sponsor decision|16
7375882|NCT01130272|11629237|FG003|Overall Study|Sponsor decision|13
7375883|NCT01130272|11629238|FG004|Overall Study|Sponsor decision|16
7375884|NCT01130272|11629234|FG000|Overall Study|Study arm discontinued|38
7375885|NCT01130272|11629235|FG001|Overall Study|Study arm discontinued|0
7375886|NCT01130272|11629236|FG002|Overall Study|Study arm discontinued|0
7375887|NCT01130272|11629237|FG003|Overall Study|Study arm discontinued|0
7375888|NCT01130272|11629238|FG004|Overall Study|Study arm discontinued|0
7375889|NCT01130337|11629250|FG000|Overall Study|Withdrawal by Subject|3
7375890|NCT01130337|11629250|FG000|Overall Study|Principal investigator decision|1
7375891|NCT01130337|11629250|FG000|Overall Study|Death|1
7375892|NCT01130337|11629250|FG000|Overall Study|Disease progression|1
7375893|NCT01130337|11629250|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
7375894|NCT01130337|11629250|FG000|Overall Study|Surgical resection (R2)|1
7375895|NCT01130493|11629254|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
7375896|NCT01130493|11629255|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
7375897|NCT01130493|11629256|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
7375898|NCT01130493|11629254|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
7375899|NCT01130493|11629255|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
7375900|NCT01130493|11629256|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
7375901|NCT01130493|11629254|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
7375902|NCT01130493|11629255|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7375903|NCT01130493|11629256|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
7375904|NCT01130493|11629254|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
7375905|NCT01130493|11629255|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7375906|NCT01130493|11629256|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
7375907|NCT01130493|11629254|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
7375908|NCT01130493|11629255|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7375909|NCT01130493|11629256|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
7375910|NCT01130493|11629254|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7375911|NCT01130493|11629255|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
7375912|NCT01130493|11629256|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
7375913|NCT01130493|11629254|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7375914|NCT01130493|11629255|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
7375915|NCT01130493|11629256|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
7375916|NCT01130493|11629254|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7375917|NCT01130493|11629255|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
7375918|NCT01130493|11629256|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
7375919|NCT01130493|11629254|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7375920|NCT01130493|11629255|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
7375921|NCT01130493|11629256|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
7375922|NCT01130493|11629254|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7375923|NCT01130493|11629255|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
7375924|NCT01130493|11629256|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
7375925|NCT01130493|11629254|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7375926|NCT01130493|11629255|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
7375927|NCT01130493|11629256|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
7375928|NCT01130493|11629254|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7375929|NCT01130493|11629255|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
7375930|NCT01130493|11629256|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
7375931|NCT01130493|11629254|FG000|Part 2: OLE|Adverse Event|0
7375932|NCT01130493|11629255|FG001|Part 2: OLE|Adverse Event|2
7375933|NCT01130493|11629256|FG002|Part 2: OLE|Adverse Event|1
7375934|NCT01130493|11629254|FG000|Part 2: OLE|Withdrawal by Subject|0
7375935|NCT01130493|11629255|FG001|Part 2: OLE|Withdrawal by Subject|1
7375936|NCT01130493|11629256|FG002|Part 2: OLE|Withdrawal by Subject|4
7375937|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Adverse Event|3
7375938|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Adverse Event|3
7375939|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Adverse Event|2
7375940|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Adverse Event|0
7375941|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7375942|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
7375943|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
7375944|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
7375945|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
7375946|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
7375947|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
7375948|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
7375949|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
7375950|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
7375951|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
7375952|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
7375953|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Protocol Violation|0
7375954|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Protocol Violation|0
7375955|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Protocol Violation|1
7375956|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Protocol Violation|0
7375957|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
7375958|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
7375959|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
7375960|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
7375961|NCT01130532|11629270|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
7375962|NCT01130532|11629271|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
7375963|NCT01130532|11629272|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
7375964|NCT01130532|11629273|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
7375965|NCT01130532|11629270|FG000|Period IV (Weeks 13-16)|Adverse Event|0
7375966|NCT01130532|11629271|FG001|Period IV (Weeks 13-16)|Adverse Event|0
7375967|NCT01130532|11629272|FG002|Period IV (Weeks 13-16)|Adverse Event|0
7375968|NCT01130532|11629273|FG003|Period IV (Weeks 13-16)|Adverse Event|1
7375969|NCT01130532|11629270|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7375970|NCT01130532|11629271|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7375971|NCT01130532|11629272|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
7375972|NCT01130532|11629273|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
7375973|NCT01130532|11629270|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
7375974|NCT01130532|11629271|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
7375975|NCT01130532|11629272|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
7375976|NCT01130532|11629273|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
7375977|NCT01130532|11629270|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7375978|NCT01130532|11629271|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7375979|NCT01130532|11629272|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
7375980|NCT01130532|11629273|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
7375981|NCT01130597|11629285|FG000|Overall Study|Protocol-specified (High K+)|1
7375982|NCT01130597|11629285|FG000|Overall Study|Adverse Event|4
7375983|NCT01130597|11629285|FG000|Overall Study|Death|1
7375984|NCT01130597|11629285|FG000|Overall Study|Protocol Violation|1
7375985|NCT01130831|11629298|FG000|Overall Study|Withdrawal by Subject|7
7375986|NCT01130831|11629298|FG000|Overall Study|Death|4
7375987|NCT01130831|11629298|FG000|Overall Study|Information was missing|3
7375988|NCT01130883|11629330|FG000|Overall Study|Patient Noncompliance|6
7375989|NCT01130883|11629330|FG000|Overall Study|Reason Unknown|1
7375990|NCT01130883|11629330|FG000|Overall Study|Adverse Event|3
7375991|NCT01130974|11629340|FG000|Overall Study|Protocol Violation|10
7375992|NCT01130974|11629341|FG001|Overall Study|Protocol Violation|10
7375993|NCT01130974|11629340|FG000|Overall Study|Withdrawal by Subject|0
7375994|NCT01130974|11629341|FG001|Overall Study|Withdrawal by Subject|1
7375995|NCT01130974|11629340|FG000|Overall Study|Ineligibility criteria|5
7375996|NCT01130974|11629341|FG001|Overall Study|Ineligibility criteria|2
7375997|NCT01131078|11629364|FG000|Overall Study|Adverse Event|22
7375998|NCT01131078|11629365|FG001|Overall Study|Adverse Event|12
7375999|NCT01131078|11629366|FG002|Overall Study|Adverse Event|17
7376000|NCT01131078|11629364|FG000|Overall Study|Progressive Disease|58
7376001|NCT01131078|11629365|FG001|Overall Study|Progressive Disease|77
7376002|NCT01131078|11629366|FG002|Overall Study|Progressive Disease|71
7376003|NCT01131078|11629364|FG000|Overall Study|Protocol Violation|1
7376004|NCT01131078|11629365|FG001|Overall Study|Protocol Violation|0
7376005|NCT01131078|11629366|FG002|Overall Study|Protocol Violation|0
7376006|NCT01131078|11629364|FG000|Overall Study|Lost to Follow-up|1
7376007|NCT01131078|11629365|FG001|Overall Study|Lost to Follow-up|1
7376008|NCT01131078|11629366|FG002|Overall Study|Lost to Follow-up|1
7376009|NCT01131078|11629364|FG000|Overall Study|Withdrawal by Subject|2
7376010|NCT01131078|11629365|FG001|Overall Study|Withdrawal by Subject|4
7376011|NCT01131078|11629366|FG002|Overall Study|Withdrawal by Subject|3
7376012|NCT01131078|11629364|FG000|Overall Study|Non-compliance|3
7376013|NCT01131078|11629365|FG001|Overall Study|Non-compliance|0
7376014|NCT01131078|11629366|FG002|Overall Study|Non-compliance|0
7376015|NCT01131078|11629364|FG000|Overall Study|Physician Decision|10
7376016|NCT01131078|11629365|FG001|Overall Study|Physician Decision|6
7376017|NCT01131078|11629366|FG002|Overall Study|Physician Decision|8
7376018|NCT01131078|11629364|FG000|Overall Study|Death|4
7376019|NCT01131078|11629365|FG001|Overall Study|Death|0
7376020|NCT01131078|11629366|FG002|Overall Study|Death|2
7376021|NCT01131078|11629364|FG000|Overall Study|Other|0
7376022|NCT01131078|11629365|FG001|Overall Study|Other|1
7376023|NCT01131078|11629366|FG002|Overall Study|Other|0
7376024|NCT01131104|11629376|FG000|Overall Study|Withdrawal by Subject|3
7376025|NCT01131104|11629376|FG000|Overall Study|Physician Decision|4
7376026|NCT01131104|11629376|FG000|Overall Study|Information Not Available|5
7376027|NCT01131104|11629376|FG000|Overall Study|No Information on Index Date of Onset|1
7376028|NCT01131130|11629380|FG000|Period 1 - Baseline|Pregnancy|1
7376029|NCT01131130|11629380|FG000|Period 3- Crossover|+ Slit lamp finding|1
7376036|NCT01131260|11629399|FG000|Overall Study|Randomization error|5
7376037|NCT01131260|11629400|FG001|Overall Study|Randomization error|1
7376038|NCT01131260|11629399|FG000|Overall Study|Declined to continue participation|8
7376039|NCT01131260|11629400|FG001|Overall Study|Declined to continue participation|13
7376040|NCT01131260|11629399|FG000|Overall Study|Physician Decision|22
7376041|NCT01131260|11629400|FG001|Overall Study|Physician Decision|24
7376042|NCT01131260|11629399|FG000|Overall Study|Technical problems|7
7376043|NCT01131260|11629400|FG001|Overall Study|Technical problems|6
7376044|NCT01131260|11629399|FG000|Overall Study|Staff error|2
7376045|NCT01131260|11629400|FG001|Overall Study|Staff error|1
7376046|NCT01131260|11629399|FG000|Overall Study|Ineligible|0
7376047|NCT01131260|11629400|FG001|Overall Study|Ineligible|2
7376048|NCT01131299|11629408|FG000|Overall Study|Withdrawal by Subject|4
7376049|NCT01131299|11629409|FG001|Overall Study|Withdrawal by Subject|7
7376050|NCT01131312|11629417|FG000|Overall Study|Lost to Follow-up|425
7376051|NCT01131312|11629418|FG001|Overall Study|Lost to Follow-up|229
7376052|NCT01131312|11629419|FG002|Overall Study|Lost to Follow-up|351
7376053|NCT01131325|11629427|FG000|Overall Study|Adverse Event|1
7376054|NCT01131325|11629427|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
7376055|NCT01131351|11629433|FG000|Overall Study|Adverse Event|0
7376056|NCT01131351|11629434|FG001|Overall Study|Adverse Event|2
7376057|NCT01131351|11629433|FG000|Overall Study|Protocol Deviation|0
7376058|NCT01131351|11629434|FG001|Overall Study|Protocol Deviation|1
7376059|NCT01131494|11629440|FG000|Overall Study|Withdrawal by Subject|2
7376060|NCT01131507|11629445|FG000|Overall Study|Adverse Event|1
7376061|NCT01131507|11629445|FG000|Overall Study|Lost to Follow-up|1
7376062|NCT01131507|11629445|FG000|Overall Study|Withdrawal by Subject|1
7376063|NCT01131520|11629451|FG000|Overall Study|Computer problem|1
7376064|NCT01131520|11629452|FG001|Overall Study|Computer problem|0
7376065|NCT01131520|11629451|FG000|Overall Study|Counselor not available|0
7376066|NCT01131520|11629452|FG001|Overall Study|Counselor not available|3
7376067|NCT01131520|11629451|FG000|Overall Study|Subject changed history after enrollment|0
7376068|NCT01131520|11629452|FG001|Overall Study|Subject changed history after enrollment|1
7376069|NCT01131585|11629460|FG000|Overall Study|Adverse Event|0
7376070|NCT01131585|11629461|FG001|Overall Study|Adverse Event|2
7376071|NCT01131585|11629460|FG000|Overall Study|Abnormal laboratory value|1
7376072|NCT01131585|11629461|FG001|Overall Study|Abnormal laboratory value|0
7376073|NCT01131585|11629460|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7376074|NCT01131585|11629461|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7376075|NCT01131585|11629460|FG000|Overall Study|Protocol Violation|2
7376076|NCT01131585|11629461|FG001|Overall Study|Protocol Violation|1
7376077|NCT01131585|11629460|FG000|Overall Study|Withdrawal by Subject|3
7376078|NCT01131585|11629461|FG001|Overall Study|Withdrawal by Subject|3
7376079|NCT01131585|11629460|FG000|Overall Study|Lost to Follow-up|0
7376080|NCT01131585|11629461|FG001|Overall Study|Lost to Follow-up|1
7376081|NCT01131585|11629460|FG000|Overall Study|Administrative problems|1
7376082|NCT01131585|11629461|FG001|Overall Study|Administrative problems|1
7376083|NCT01131585|11629460|FG000|Overall Study|Study termination|78
7376084|NCT01131585|11629461|FG001|Overall Study|Study termination|32
7376085|NCT01131676|11629470|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
7376086|NCT01131676|11629471|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
7376087|NCT01131676|11629472|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
7376088|NCT01131676|11629470|FG000|Discontinuation From Treatment|Not treated|4
7376089|NCT01131676|11629471|FG001|Discontinuation From Treatment|Not treated|2
7376090|NCT01131676|11629472|FG002|Discontinuation From Treatment|Not treated|2
7376091|NCT01131676|11629470|FG000|Discontinuation From Treatment|Lack of Efficacy|11
7376092|NCT01131676|11629471|FG001|Discontinuation From Treatment|Lack of Efficacy|1
7376093|NCT01131676|11629472|FG002|Discontinuation From Treatment|Lack of Efficacy|0
7376094|NCT01131676|11629470|FG000|Discontinuation From Treatment|Non compliant with protocol|15
7376095|NCT01131676|11629471|FG001|Discontinuation From Treatment|Non compliant with protocol|15
7376096|NCT01131676|11629472|FG002|Discontinuation From Treatment|Non compliant with protocol|12
7376097|NCT01131676|11629470|FG000|Discontinuation From Treatment|Lost to Follow-up|15
7376098|NCT01131676|11629471|FG001|Discontinuation From Treatment|Lost to Follow-up|9
7376099|NCT01131676|11629472|FG002|Discontinuation From Treatment|Lost to Follow-up|6
7376100|NCT01131676|11629470|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
7376101|NCT01131676|11629471|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
7376102|NCT01131676|11629472|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
7376103|NCT01131676|11629470|FG000|Discontinuation From Treatment|Other than those specified|162
7376104|NCT01131676|11629471|FG001|Discontinuation From Treatment|Other than those specified|142
7376105|NCT01131676|11629472|FG002|Discontinuation From Treatment|Other than those specified|125
7376106|NCT01131676|11629470|FG000|Discontinuation From Treatment|Adverse Event|303
7376107|NCT01131676|11629471|FG001|Discontinuation From Treatment|Adverse Event|267
7376108|NCT01131676|11629472|FG002|Discontinuation From Treatment|Adverse Event|273
7376109|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
7376110|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
7376111|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
7376112|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
7376113|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
7376114|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
7376115|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
7376116|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
7376117|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
7376118|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
7376119|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
7376120|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
7376121|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
7376122|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
7376123|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
7376124|NCT01131676|11629470|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7376125|NCT01131676|11629471|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
7376126|NCT01131676|11629472|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
7376127|NCT01132118|11629483|FG000|First Intervention (8 Weeks)|Adverse Event|1
7376128|NCT01132118|11629484|FG001|First Intervention (8 Weeks)|Adverse Event|0
7376129|NCT01132118|11629483|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7376130|NCT01132118|11629484|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
7376131|NCT01132118|11629483|FG000|Second Intervention (8 Weeks)|Adverse Event|0
7376132|NCT01132118|11629484|FG001|Second Intervention (8 Weeks)|Adverse Event|1
7376133|NCT01132313|11629513|FG000|Overall Study|Lack of Efficacy|1
7376134|NCT01132313|11629514|FG001|Overall Study|Lack of Efficacy|0
7376135|NCT01132313|11629515|FG002|Overall Study|Lack of Efficacy|0
7376136|NCT01132313|11629516|FG003|Overall Study|Lack of Efficacy|0
7376137|NCT01132313|11629517|FG004|Overall Study|Lack of Efficacy|0
7376138|NCT01132313|11629518|FG005|Overall Study|Lack of Efficacy|0
7376139|NCT01132313|11629519|FG006|Overall Study|Lack of Efficacy|0
7376140|NCT01132313|11629520|FG007|Overall Study|Lack of Efficacy|3
7376141|NCT01132313|11629521|FG008|Overall Study|Lack of Efficacy|14
7376142|NCT01132313|11629522|FG009|Overall Study|Lack of Efficacy|16
7376143|NCT01132313|11629523|FG010|Overall Study|Lack of Efficacy|0
7376144|NCT01132313|11629524|FG011|Overall Study|Lack of Efficacy|0
7376145|NCT01132313|11629513|FG000|Overall Study|Not treated|2
7376146|NCT01132313|11629514|FG001|Overall Study|Not treated|0
7376147|NCT01132313|11629515|FG002|Overall Study|Not treated|0
7376148|NCT01132313|11629516|FG003|Overall Study|Not treated|0
7376149|NCT01132313|11629517|FG004|Overall Study|Not treated|2
7376150|NCT01132313|11629518|FG005|Overall Study|Not treated|1
7376151|NCT01132313|11629519|FG006|Overall Study|Not treated|3
7376152|NCT01132313|11629520|FG007|Overall Study|Not treated|0
7376153|NCT01132313|11629521|FG008|Overall Study|Not treated|0
7376154|NCT01132313|11629522|FG009|Overall Study|Not treated|0
7376155|NCT01132313|11629523|FG010|Overall Study|Not treated|0
7376156|NCT01132313|11629524|FG011|Overall Study|Not treated|0
7376157|NCT01132313|11629513|FG000|Overall Study|Adverse Event|0
7376158|NCT01132313|11629514|FG001|Overall Study|Adverse Event|0
7376159|NCT01132313|11629515|FG002|Overall Study|Adverse Event|4
7376160|NCT01132313|11629516|FG003|Overall Study|Adverse Event|10
7376161|NCT01132313|11629517|FG004|Overall Study|Adverse Event|19
7376162|NCT01132313|11629518|FG005|Overall Study|Adverse Event|6
7376163|NCT01132313|11629519|FG006|Overall Study|Adverse Event|5
7376164|NCT01132313|11629520|FG007|Overall Study|Adverse Event|3
7376165|NCT01132313|11629521|FG008|Overall Study|Adverse Event|7
7376166|NCT01132313|11629522|FG009|Overall Study|Adverse Event|2
7376167|NCT01132313|11629523|FG010|Overall Study|Adverse Event|0
7376168|NCT01132313|11629524|FG011|Overall Study|Adverse Event|0
7376169|NCT01132313|11629513|FG000|Overall Study|Protocol Violation|0
7376170|NCT01132313|11629514|FG001|Overall Study|Protocol Violation|0
7376171|NCT01132313|11629515|FG002|Overall Study|Protocol Violation|0
7376172|NCT01132313|11629516|FG003|Overall Study|Protocol Violation|1
7376173|NCT01132313|11629517|FG004|Overall Study|Protocol Violation|0
7376174|NCT01132313|11629518|FG005|Overall Study|Protocol Violation|0
7376175|NCT01132313|11629519|FG006|Overall Study|Protocol Violation|0
7376176|NCT01132313|11629520|FG007|Overall Study|Protocol Violation|0
7376177|NCT01132313|11629521|FG008|Overall Study|Protocol Violation|0
7376178|NCT01132313|11629522|FG009|Overall Study|Protocol Violation|0
7376179|NCT01132313|11629523|FG010|Overall Study|Protocol Violation|0
7376180|NCT01132313|11629524|FG011|Overall Study|Protocol Violation|0
7376181|NCT01132313|11629513|FG000|Overall Study|Lost to Follow-up|0
7376182|NCT01132313|11629514|FG001|Overall Study|Lost to Follow-up|0
7376183|NCT01132313|11629515|FG002|Overall Study|Lost to Follow-up|1
7376184|NCT01132313|11629516|FG003|Overall Study|Lost to Follow-up|0
7376185|NCT01132313|11629517|FG004|Overall Study|Lost to Follow-up|0
7376186|NCT01132313|11629518|FG005|Overall Study|Lost to Follow-up|0
7376187|NCT01132313|11629519|FG006|Overall Study|Lost to Follow-up|0
7376188|NCT01132313|11629520|FG007|Overall Study|Lost to Follow-up|1
7376189|NCT01132313|11629521|FG008|Overall Study|Lost to Follow-up|0
7376190|NCT01132313|11629522|FG009|Overall Study|Lost to Follow-up|0
7376191|NCT01132313|11629523|FG010|Overall Study|Lost to Follow-up|0
7376192|NCT01132313|11629524|FG011|Overall Study|Lost to Follow-up|0
7376193|NCT01132313|11629513|FG000|Overall Study|Withdrawal by Subject|0
7376194|NCT01132313|11629514|FG001|Overall Study|Withdrawal by Subject|0
7376195|NCT01132313|11629515|FG002|Overall Study|Withdrawal by Subject|3
7376196|NCT01132313|11629516|FG003|Overall Study|Withdrawal by Subject|3
7376197|NCT01132313|11629517|FG004|Overall Study|Withdrawal by Subject|6
7376198|NCT01132313|11629518|FG005|Overall Study|Withdrawal by Subject|0
7376199|NCT01132313|11629519|FG006|Overall Study|Withdrawal by Subject|1
7376200|NCT01132313|11629520|FG007|Overall Study|Withdrawal by Subject|0
7376201|NCT01132313|11629521|FG008|Overall Study|Withdrawal by Subject|0
7376202|NCT01132313|11629522|FG009|Overall Study|Withdrawal by Subject|2
7376203|NCT01132313|11629523|FG010|Overall Study|Withdrawal by Subject|0
7376204|NCT01132313|11629524|FG011|Overall Study|Withdrawal by Subject|0
7376205|NCT01132313|11629513|FG000|Overall Study|Lack of antiviral response|0
7376206|NCT01132313|11629514|FG001|Overall Study|Lack of antiviral response|0
7376207|NCT01132313|11629515|FG002|Overall Study|Lack of antiviral response|12
7376208|NCT01132313|11629516|FG003|Overall Study|Lack of antiviral response|18
7376209|NCT01132313|11629517|FG004|Overall Study|Lack of antiviral response|18
7461703|NCT01840579|11757955|FG000|Overall Study|Death|0
7461704|NCT01840579|11757956|FG001|Overall Study|Death|0
7461705|NCT01840579|11757957|FG002|Overall Study|Death|0
7461706|NCT01840579|11757958|FG003|Overall Study|Death|0
7461707|NCT01840579|11757959|FG004|Overall Study|Death|0
7461708|NCT01840579|11757960|FG005|Overall Study|Death|1
7461709|NCT01840579|11757961|FG006|Overall Study|Death|0
7461710|NCT01840579|11757962|FG007|Overall Study|Death|0
7461711|NCT01840579|11757963|FG008|Overall Study|Death|0
7461712|NCT01840579|11757964|FG009|Overall Study|Death|0
7461713|NCT01840579|11757955|FG000|Overall Study|Adverse Event|0
7461714|NCT01840579|11757956|FG001|Overall Study|Adverse Event|1
7461715|NCT01840579|11757957|FG002|Overall Study|Adverse Event|0
7461716|NCT01840579|11757958|FG003|Overall Study|Adverse Event|0
7461717|NCT01840579|11757959|FG004|Overall Study|Adverse Event|0
7461718|NCT01840579|11757960|FG005|Overall Study|Adverse Event|0
7461719|NCT01840579|11757961|FG006|Overall Study|Adverse Event|0
7461720|NCT01840579|11757962|FG007|Overall Study|Adverse Event|0
7461721|NCT01840579|11757963|FG008|Overall Study|Adverse Event|0
7461722|NCT01840579|11757964|FG009|Overall Study|Adverse Event|0
7461723|NCT01840579|11757955|FG000|Overall Study|Follow-up ended by Sponsor|0
7461724|NCT01840579|11757956|FG001|Overall Study|Follow-up ended by Sponsor|0
7461725|NCT01840579|11757957|FG002|Overall Study|Follow-up ended by Sponsor|0
7461726|NCT01840579|11757958|FG003|Overall Study|Follow-up ended by Sponsor|0
7461727|NCT01840579|11757959|FG004|Overall Study|Follow-up ended by Sponsor|0
7461728|NCT01840579|11757960|FG005|Overall Study|Follow-up ended by Sponsor|0
7461729|NCT01840579|11757961|FG006|Overall Study|Follow-up ended by Sponsor|2
7461730|NCT01840579|11757962|FG007|Overall Study|Follow-up ended by Sponsor|0
7461731|NCT01840579|11757963|FG008|Overall Study|Follow-up ended by Sponsor|0
7461732|NCT01840579|11757964|FG009|Overall Study|Follow-up ended by Sponsor|0
7461733|NCT01840605|11758000|FG000|Overall Study|Adverse Event|0
7461734|NCT01840605|11758001|FG001|Overall Study|Adverse Event|1
7461735|NCT01840605|11758000|FG000|Overall Study|Physician Decision|2
7461736|NCT01840605|11758001|FG001|Overall Study|Physician Decision|1
7461737|NCT01840943|11758018|FG000|Overall Study|Withdrawal by Subject|5
7461738|NCT01840943|11758019|FG001|Overall Study|Withdrawal by Subject|6
7461739|NCT01840943|11758018|FG000|Overall Study|Physician Decision|4
7461740|NCT01840943|11758019|FG001|Overall Study|Physician Decision|2
7461741|NCT01840943|11758018|FG000|Overall Study|Lost to Follow-up|4
7461742|NCT01840943|11758019|FG001|Overall Study|Lost to Follow-up|4
7461743|NCT01841060|11758033|FG000|Overall Study|Protocol Violation|10
7461744|NCT01841073|11758039|FG000|Overall Study|Adverse Event|1
7461745|NCT01841073|11758040|FG001|Overall Study|Adverse Event|1
7461746|NCT01841073|11758039|FG000|Overall Study|Physician Decision|1
7461747|NCT01841073|11758040|FG001|Overall Study|Physician Decision|0
7461748|NCT01841073|11758039|FG000|Overall Study|Lost to Follow-up|0
7461749|NCT01841073|11758040|FG001|Overall Study|Lost to Follow-up|2
7461750|NCT01841554|11758078|FG000|Overall Study|Death|7
7461751|NCT01841554|11758078|FG000|Overall Study|No Implantation|1
7461752|NCT01841554|11758078|FG000|Overall Study|Discontinued Follow Up|5
7461753|NCT01841554|11758078|FG000|Overall Study|Study exit due to secondary intervention|6
7461754|NCT01841567|11758082|FG000|Overall Study|Adverse Event|3
7461755|NCT01841593|11758088|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
7461756|NCT01841593|11758089|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
7461757|NCT01841593|11758088|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
7461758|NCT01841593|11758089|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
7461759|NCT01841697|11758118|FG000|Overall Study|Death|0
7461760|NCT01841697|11758119|FG001|Overall Study|Death|1
7461761|NCT01841697|11758118|FG000|Overall Study|Lost to Follow-up|4
7461762|NCT01841697|11758119|FG001|Overall Study|Lost to Follow-up|1
7376210|NCT01132313|11629518|FG005|Overall Study|Lack of antiviral response|18
7376211|NCT01132313|11629519|FG006|Overall Study|Lack of antiviral response|21
7376212|NCT01132313|11629520|FG007|Overall Study|Lack of antiviral response|0
7376213|NCT01132313|11629521|FG008|Overall Study|Lack of antiviral response|0
7376214|NCT01132313|11629522|FG009|Overall Study|Lack of antiviral response|0
7376215|NCT01132313|11629523|FG010|Overall Study|Lack of antiviral response|1
7376216|NCT01132313|11629524|FG011|Overall Study|Lack of antiviral response|0
7376217|NCT01132313|11629513|FG000|Overall Study|Other reason not defined above|0
7376218|NCT01132313|11629514|FG001|Overall Study|Other reason not defined above|0
7376219|NCT01132313|11629515|FG002|Overall Study|Other reason not defined above|0
7376220|NCT01132313|11629516|FG003|Overall Study|Other reason not defined above|0
7376221|NCT01132313|11629517|FG004|Overall Study|Other reason not defined above|0
7376222|NCT01132313|11629518|FG005|Overall Study|Other reason not defined above|0
7376223|NCT01132313|11629519|FG006|Overall Study|Other reason not defined above|0
7376224|NCT01132313|11629520|FG007|Overall Study|Other reason not defined above|1
7376225|NCT01132313|11629521|FG008|Overall Study|Other reason not defined above|0
7376226|NCT01132313|11629522|FG009|Overall Study|Other reason not defined above|0
7376227|NCT01132313|11629523|FG010|Overall Study|Other reason not defined above|0
7376228|NCT01132313|11629524|FG011|Overall Study|Other reason not defined above|0
7376229|NCT01132326|11629555|FG000|Overall Study|Lack of Efficacy|25
7376230|NCT01132326|11629555|FG000|Overall Study|Adverse Event|37
7376231|NCT01132326|11629555|FG000|Overall Study|Protocol Violation|1
7376232|NCT01132326|11629555|FG000|Overall Study|Lost to Follow-up|16
7376233|NCT01132326|11629555|FG000|Overall Study|Withdrawal by Subject|40
7376234|NCT01132326|11629555|FG000|Overall Study|Physician Decision|10
7376235|NCT01132326|11629555|FG000|Overall Study|Study Termination|80
7376236|NCT01132326|11629555|FG000|Overall Study|Declining Health|1
7376237|NCT01132326|11629555|FG000|Overall Study|Pregnancy|1
7376238|NCT01132326|11629555|FG000|Overall Study|Caregiver Withdrew Consent|1
7376239|NCT01132326|11629555|FG000|Overall Study|Death|5
7376240|NCT01132326|11629555|FG000|Overall Study|Subject Unable to Come To Visits|1
7376241|NCT01132482|11629566|FG000|Overall Study|Adverse Event|1
7376242|NCT01132482|11629567|FG001|Overall Study|Adverse Event|0
7376243|NCT01132495|11629577|FG000|Overall Study|Various reasons|40
7376244|NCT01132495|11629578|FG001|Overall Study|Various reasons|38
7376245|NCT01132495|11629579|FG002|Overall Study|Various reasons|20
7376246|NCT01132495|11629580|FG003|Overall Study|Various reasons|12
7376247|NCT01132547|11629597|FG000|Overall Study|Withdrawal by Subject|3
7376248|NCT01132547|11629598|FG001|Overall Study|Withdrawal by Subject|1
7376249|NCT01132547|11629597|FG000|Overall Study|Death|1
7376250|NCT01132547|11629598|FG001|Overall Study|Death|0
7376251|NCT01132612|11629607|FG000|Overall Study|Death|0
7376252|NCT01132612|11629608|FG001|Overall Study|Death|0
7376253|NCT01132612|11629609|FG002|Overall Study|Death|1
7376254|NCT01132612|11629607|FG000|Overall Study|Protocol deviation|0
7376255|NCT01132612|11629608|FG001|Overall Study|Protocol deviation|0
7376256|NCT01132612|11629609|FG002|Overall Study|Protocol deviation|3
7376257|NCT01132612|11629607|FG000|Overall Study|Lost to Follow-up|2
7376258|NCT01132612|11629608|FG001|Overall Study|Lost to Follow-up|2
7376259|NCT01132612|11629609|FG002|Overall Study|Lost to Follow-up|7
7376260|NCT01132612|11629607|FG000|Overall Study|Adverse Event|5
7376261|NCT01132612|11629608|FG001|Overall Study|Adverse Event|2
7376262|NCT01132612|11629609|FG002|Overall Study|Adverse Event|15
7376263|NCT01132612|11629607|FG000|Overall Study|Withdrawal by Subject|5
7376264|NCT01132612|11629608|FG001|Overall Study|Withdrawal by Subject|8
7376265|NCT01132612|11629609|FG002|Overall Study|Withdrawal by Subject|19
7376266|NCT01132612|11629607|FG000|Overall Study|Administrative problems|5
7376267|NCT01132612|11629608|FG001|Overall Study|Administrative problems|1
7376268|NCT01132612|11629609|FG002|Overall Study|Administrative problems|52
7376269|NCT01132612|11629607|FG000|Overall Study|Lack of Efficacy|23
7376270|NCT01132612|11629608|FG001|Overall Study|Lack of Efficacy|22
7376271|NCT01132612|11629609|FG002|Overall Study|Lack of Efficacy|73
7376272|NCT01132651|11629619|FG000|Overall Study|Lost to Follow-up|1
7376273|NCT01132651|11629620|FG001|Overall Study|Lost to Follow-up|1
7376274|NCT01132664|11629631|FG000|Phase lb|Adverse Event|0
7376275|NCT01132664|11629632|FG001|Phase lb|Adverse Event|1
7376276|NCT01132664|11629633|FG002|Phase lb|Adverse Event|0
7376277|NCT01132664|11629634|FG003|Phase lb|Adverse Event|0
7376278|NCT01132664|11629635|FG004|Phase lb|Adverse Event|0
7376279|NCT01132664|11629631|FG000|Phase lb|Withdrawal by Subject|1
7376280|NCT01132664|11629632|FG001|Phase lb|Withdrawal by Subject|2
7376281|NCT01132664|11629633|FG002|Phase lb|Withdrawal by Subject|0
7376282|NCT01132664|11629634|FG003|Phase lb|Withdrawal by Subject|0
7376283|NCT01132664|11629635|FG004|Phase lb|Withdrawal by Subject|0
7376284|NCT01132664|11629631|FG000|Phase lb|Disease Progression|4
7376285|NCT01132664|11629632|FG001|Phase lb|Disease Progression|9
7376286|NCT01132664|11629633|FG002|Phase lb|Disease Progression|0
7376287|NCT01132664|11629634|FG003|Phase lb|Disease Progression|0
7376288|NCT01132664|11629635|FG004|Phase lb|Disease Progression|0
7376289|NCT01132664|11629631|FG000|Phase ll|Death|0
7376290|NCT01132664|11629632|FG001|Phase ll|Death|0
7376291|NCT01132664|11629633|FG002|Phase ll|Death|2
7376292|NCT01132664|11629634|FG003|Phase ll|Death|0
7376293|NCT01132664|11629635|FG004|Phase ll|Death|0
7376294|NCT01132664|11629631|FG000|Phase ll|Adverse Event|0
7376295|NCT01132664|11629632|FG001|Phase ll|Adverse Event|0
7376296|NCT01132664|11629633|FG002|Phase ll|Adverse Event|10
7376297|NCT01132664|11629634|FG003|Phase ll|Adverse Event|0
7376298|NCT01132664|11629635|FG004|Phase ll|Adverse Event|0
7376299|NCT01132664|11629631|FG000|Phase ll|Withdrawal by Subject|0
7376300|NCT01132664|11629632|FG001|Phase ll|Withdrawal by Subject|0
7376301|NCT01132664|11629633|FG002|Phase ll|Withdrawal by Subject|3
7376302|NCT01132664|11629634|FG003|Phase ll|Withdrawal by Subject|0
7376303|NCT01132664|11629635|FG004|Phase ll|Withdrawal by Subject|0
7376304|NCT01132664|11629631|FG000|Phase ll|Disease progression|0
7376305|NCT01132664|11629632|FG001|Phase ll|Disease progression|0
7376306|NCT01132664|11629633|FG002|Phase ll|Disease progression|35
7376307|NCT01132664|11629634|FG003|Phase ll|Disease progression|0
7376308|NCT01132664|11629635|FG004|Phase ll|Disease progression|0
7376309|NCT01132664|11629631|FG000|BM Cohort|Disease progression|0
7376310|NCT01132664|11629632|FG001|BM Cohort|Disease progression|0
7376311|NCT01132664|11629633|FG002|BM Cohort|Disease progression|0
7376312|NCT01132664|11629634|FG003|BM Cohort|Disease progression|3
7376313|NCT01132664|11629635|FG004|BM Cohort|Disease progression|4
7376314|NCT01132664|11629631|FG000|BM Cohort|Adverse Event|0
7376315|NCT01132664|11629632|FG001|BM Cohort|Adverse Event|0
7376316|NCT01132664|11629633|FG002|BM Cohort|Adverse Event|0
7376317|NCT01132664|11629634|FG003|BM Cohort|Adverse Event|0
7376318|NCT01132664|11629635|FG004|BM Cohort|Adverse Event|1
7376319|NCT01132664|11629631|FG000|BM Cohort|Withdrawal by Subject|0
7376320|NCT01132664|11629632|FG001|BM Cohort|Withdrawal by Subject|0
7376321|NCT01132664|11629633|FG002|BM Cohort|Withdrawal by Subject|0
7376322|NCT01132664|11629634|FG003|BM Cohort|Withdrawal by Subject|0
7376323|NCT01132664|11629635|FG004|BM Cohort|Withdrawal by Subject|1
7376324|NCT01132755|11629656|FG000|Overall Study|Procedure not done due to medical reason|23
7376325|NCT01132755|11629656|FG000|Overall Study|Protocol Violation|15
7376326|NCT01132755|11629656|FG000|Overall Study|Withdrawal by Subject|4
7376327|NCT01132807|11629660|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
7376328|NCT01132807|11629661|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7376329|NCT01132807|11629662|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
7376330|NCT01132807|11629660|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
7376331|NCT01132807|11629661|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7376332|NCT01132807|11629662|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
7376333|NCT01132820|11629670|FG000|Overall Study|Ineligible: wrong cell type|1
7376334|NCT01132820|11629670|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
7376335|NCT01132820|11629670|FG000|Overall Study|Ineligible:Inadequate pathology|1
7376336|NCT01132820|11629670|FG000|Overall Study|Never treated|1
7376337|NCT01132820|11629670|FG000|Overall Study|Inadequate data|1
7376338|NCT01133067|11629689|FG000|Overall Study|Death|136
7376339|NCT01133067|11629689|FG000|Overall Study|Lost to Follow-up|3
7376340|NCT01133171|11629702|FG000|Overall Study|Withdrawal by Subject|1
7376341|NCT01133171|11629703|FG001|Overall Study|Withdrawal by Subject|2
7376342|NCT01133171|11629704|FG002|Overall Study|Withdrawal by Subject|0
7376343|NCT01133275|11629712|FG000|Overall Study|Withdrawal by Subject|1
7376344|NCT01133275|11629712|FG000|Overall Study|Cerebrovascular accident (CVA)|1
7387136|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Missing|0
7387137|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Missing|0
7387138|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Missing|0
7387139|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Missing|0
7387140|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Missing|0
7387141|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Missing|0
7387142|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387143|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387144|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
7387145|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387146|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387147|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387148|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387149|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387150|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
7387151|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
7387152|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
7387153|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
7387154|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
7387155|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
7387156|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
7387157|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
7387158|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
7387159|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
7387160|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387161|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7376345|NCT01133379|11629719|FG000|Overall Study|Withdrawal by Subject|0
7376346|NCT01133379|11629720|FG001|Overall Study|Withdrawal by Subject|1
7376347|NCT01133379|11629721|FG002|Overall Study|Withdrawal by Subject|1
7376348|NCT01133379|11629719|FG000|Overall Study|Lost to Follow-up|1
7376349|NCT01133379|11629720|FG001|Overall Study|Lost to Follow-up|1
7376350|NCT01133379|11629721|FG002|Overall Study|Lost to Follow-up|1
7376351|NCT01133392|11629731|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
7376352|NCT01133392|11629732|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
7376353|NCT01133392|11629731|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
7376354|NCT01133392|11629732|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
7376355|NCT01133405|11629748|FG000|Period 1|Withdrawal by Subject|0
7376356|NCT01133405|11629749|FG001|Period 1|Withdrawal by Subject|1
7376357|NCT01133405|11629750|FG002|Period 1|Withdrawal by Subject|0
7376358|NCT01133405|11629751|FG003|Period 1|Withdrawal by Subject|1
7376359|NCT01133405|11629752|FG004|Period 1|Withdrawal by Subject|0
7376360|NCT01133405|11629753|FG005|Period 1|Withdrawal by Subject|1
7376361|NCT01133405|11629754|FG006|Period 1|Withdrawal by Subject|0
7376362|NCT01133405|11629755|FG007|Period 1|Withdrawal by Subject|0
7376363|NCT01133405|11629756|FG008|Period 1|Withdrawal by Subject|0
7376364|NCT01133405|11629757|FG009|Period 1|Withdrawal by Subject|0
7570630|NCT03499067|11948651|FG000|First Intervention|Physician Decision|2
7570631|NCT03499067|11948652|FG001|First Intervention|Physician Decision|1
7570632|NCT03499067|11948651|FG000|First Intervention|Withdrawal by Subject|3
7570633|NCT03499067|11948652|FG001|First Intervention|Withdrawal by Subject|6
7570634|NCT03499353|11948658|FG000|Treatment|Adverse Event|3
7570635|NCT03499353|11948658|FG000|Treatment|Progressive Disease|10
7570636|NCT03499353|11948658|FG000|Treatment|Other|1
7376365|NCT01133405|11629748|FG000|Period 1|Physician Decision|0
7376366|NCT01133405|11629749|FG001|Period 1|Physician Decision|0
7376367|NCT01133405|11629750|FG002|Period 1|Physician Decision|0
7376368|NCT01133405|11629751|FG003|Period 1|Physician Decision|1
7376369|NCT01133405|11629752|FG004|Period 1|Physician Decision|0
7376370|NCT01133405|11629753|FG005|Period 1|Physician Decision|0
7376371|NCT01133405|11629754|FG006|Period 1|Physician Decision|0
7376372|NCT01133405|11629755|FG007|Period 1|Physician Decision|0
7376373|NCT01133405|11629756|FG008|Period 1|Physician Decision|0
7376374|NCT01133405|11629757|FG009|Period 1|Physician Decision|0
7376375|NCT01133405|11629748|FG000|Period 1|Discontinued after randomization|1
7376376|NCT01133405|11629749|FG001|Period 1|Discontinued after randomization|0
7376377|NCT01133405|11629750|FG002|Period 1|Discontinued after randomization|0
7376378|NCT01133405|11629751|FG003|Period 1|Discontinued after randomization|0
7376379|NCT01133405|11629752|FG004|Period 1|Discontinued after randomization|0
7376380|NCT01133405|11629753|FG005|Period 1|Discontinued after randomization|0
7376381|NCT01133405|11629754|FG006|Period 1|Discontinued after randomization|1
7376382|NCT01133405|11629755|FG007|Period 1|Discontinued after randomization|0
7376383|NCT01133405|11629756|FG008|Period 1|Discontinued after randomization|0
7376384|NCT01133405|11629757|FG009|Period 1|Discontinued after randomization|0
7376385|NCT01133405|11629748|FG000|Period 1|Received drug only in period 2|0
7376386|NCT01133405|11629749|FG001|Period 1|Received drug only in period 2|1
7376387|NCT01133405|11629750|FG002|Period 1|Received drug only in period 2|0
7376388|NCT01133405|11629751|FG003|Period 1|Received drug only in period 2|2
7376389|NCT01133405|11629752|FG004|Period 1|Received drug only in period 2|0
7376390|NCT01133405|11629753|FG005|Period 1|Received drug only in period 2|1
7376391|NCT01133405|11629754|FG006|Period 1|Received drug only in period 2|0
7376392|NCT01133405|11629755|FG007|Period 1|Received drug only in period 2|0
7376393|NCT01133405|11629756|FG008|Period 1|Received drug only in period 2|0
7376394|NCT01133405|11629757|FG009|Period 1|Received drug only in period 2|0
7376395|NCT01133405|11629748|FG000|Period 1|Received drug only in period 3|0
7376396|NCT01133405|11629749|FG001|Period 1|Received drug only in period 3|1
7376397|NCT01133405|11629750|FG002|Period 1|Received drug only in period 3|1
7461763|NCT01841697|11758118|FG000|Overall Study|Withdrawal by Subject|16
7461764|NCT01841697|11758119|FG001|Overall Study|Withdrawal by Subject|16
7461765|NCT01841762|11758125|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
7461766|NCT01841762|11758125|FG000|Treatment Period|Adverse Event|16
7461767|NCT01841762|11758125|FG000|Treatment Period|Death|1
7461768|NCT01841762|11758125|FG000|Treatment Period|Withdrawal by Subject|7
7461769|NCT01841762|11758125|FG000|Treatment Period|Lost to Follow-up|1
7461770|NCT01841762|11758125|FG000|Treatment Period|Physician Decision|2
7461771|NCT01841762|11758125|FG000|Treatment Period|Other, including non-compliance|5
7461772|NCT01841762|11758125|FG000|Post-Treatment Safety Follow-Up Period|Death|1
7461773|NCT01841762|11758125|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
7461774|NCT01841762|11758125|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
7461775|NCT01841762|11758125|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
7461776|NCT01841970|11758129|FG000|Overall Study|Withdrawal by Subject|1
7570637|NCT03499353|11948658|FG000|Treatment|Withdrawal by Subject|2
7570638|NCT03499353|11948658|FG000|Long-Term Follow-up|Death|2
7376398|NCT01133405|11629751|FG003|Period 1|Received drug only in period 3|0
7376399|NCT01133405|11629752|FG004|Period 1|Received drug only in period 3|0
7376400|NCT01133405|11629753|FG005|Period 1|Received drug only in period 3|0
7376401|NCT01133405|11629754|FG006|Period 1|Received drug only in period 3|0
7376402|NCT01133405|11629755|FG007|Period 1|Received drug only in period 3|0
7376403|NCT01133405|11629756|FG008|Period 1|Received drug only in period 3|0
7376404|NCT01133405|11629757|FG009|Period 1|Received drug only in period 3|0
7376405|NCT01133405|11629748|FG000|Period 2|Adverse Event|0
7376406|NCT01133405|11629749|FG001|Period 2|Adverse Event|0
7376407|NCT01133405|11629750|FG002|Period 2|Adverse Event|1
7376408|NCT01133405|11629751|FG003|Period 2|Adverse Event|0
7376409|NCT01133405|11629752|FG004|Period 2|Adverse Event|0
7376410|NCT01133405|11629753|FG005|Period 2|Adverse Event|0
7376411|NCT01133405|11629754|FG006|Period 2|Adverse Event|0
7376412|NCT01133405|11629755|FG007|Period 2|Adverse Event|0
7376413|NCT01133405|11629756|FG008|Period 2|Adverse Event|0
7376414|NCT01133405|11629757|FG009|Period 2|Adverse Event|0
7376415|NCT01133405|11629748|FG000|Period 2|Withdrawal by Subject|0
7376416|NCT01133405|11629749|FG001|Period 2|Withdrawal by Subject|0
7376417|NCT01133405|11629750|FG002|Period 2|Withdrawal by Subject|0
7376418|NCT01133405|11629751|FG003|Period 2|Withdrawal by Subject|1
7376419|NCT01133405|11629752|FG004|Period 2|Withdrawal by Subject|0
7376420|NCT01133405|11629753|FG005|Period 2|Withdrawal by Subject|1
7376421|NCT01133405|11629754|FG006|Period 2|Withdrawal by Subject|0
7376422|NCT01133405|11629755|FG007|Period 2|Withdrawal by Subject|0
7376423|NCT01133405|11629756|FG008|Period 2|Withdrawal by Subject|0
7376424|NCT01133405|11629757|FG009|Period 2|Withdrawal by Subject|0
7376425|NCT01133405|11629748|FG000|Period 2|Entry Criteria Not Met|0
7376426|NCT01133405|11629749|FG001|Period 2|Entry Criteria Not Met|1
7376427|NCT01133405|11629750|FG002|Period 2|Entry Criteria Not Met|0
7376428|NCT01133405|11629751|FG003|Period 2|Entry Criteria Not Met|0
7376429|NCT01133405|11629752|FG004|Period 2|Entry Criteria Not Met|0
7376430|NCT01133405|11629753|FG005|Period 2|Entry Criteria Not Met|0
7376431|NCT01133405|11629754|FG006|Period 2|Entry Criteria Not Met|0
7376432|NCT01133405|11629755|FG007|Period 2|Entry Criteria Not Met|0
7376433|NCT01133405|11629756|FG008|Period 2|Entry Criteria Not Met|0
7376434|NCT01133405|11629757|FG009|Period 2|Entry Criteria Not Met|0
7376435|NCT01133405|11629748|FG000|Period 2|Physician Decision|0
7376436|NCT01133405|11629749|FG001|Period 2|Physician Decision|0
7376437|NCT01133405|11629750|FG002|Period 2|Physician Decision|0
7376438|NCT01133405|11629751|FG003|Period 2|Physician Decision|0
7376439|NCT01133405|11629752|FG004|Period 2|Physician Decision|0
7376440|NCT01133405|11629753|FG005|Period 2|Physician Decision|1
7376441|NCT01133405|11629754|FG006|Period 2|Physician Decision|0
7376442|NCT01133405|11629755|FG007|Period 2|Physician Decision|0
7376443|NCT01133405|11629756|FG008|Period 2|Physician Decision|0
7376444|NCT01133405|11629757|FG009|Period 2|Physician Decision|0
7376445|NCT01133418|11629789|FG000|Overall Study|Lost to Follow-up|5
7376446|NCT01133418|11629790|FG001|Overall Study|Lost to Follow-up|6
7376447|NCT01133522|11629806|FG000|Overall Study|Withdrawal by Subject|0
7376448|NCT01133522|11629807|FG001|Overall Study|Withdrawal by Subject|1
7376449|NCT01133522|11629808|FG002|Overall Study|Withdrawal by Subject|0
7376450|NCT01133522|11629809|FG003|Overall Study|Withdrawal by Subject|1
7376451|NCT01133522|11629810|FG004|Overall Study|Withdrawal by Subject|0
7376452|NCT01133522|11629811|FG005|Overall Study|Withdrawal by Subject|0
7376453|NCT01133522|11629812|FG006|Overall Study|Withdrawal by Subject|0
7376454|NCT01133522|11629813|FG007|Overall Study|Withdrawal by Subject|0
7376455|NCT01133522|11629814|FG008|Overall Study|Withdrawal by Subject|0
7376456|NCT01133522|11629815|FG009|Overall Study|Withdrawal by Subject|0
7376457|NCT01133522|11629806|FG000|Overall Study|Physician Decision|0
7376458|NCT01133522|11629807|FG001|Overall Study|Physician Decision|0
7376459|NCT01133522|11629808|FG002|Overall Study|Physician Decision|0
7376460|NCT01133522|11629809|FG003|Overall Study|Physician Decision|0
7376461|NCT01133522|11629810|FG004|Overall Study|Physician Decision|1
7376462|NCT01133522|11629811|FG005|Overall Study|Physician Decision|0
7376463|NCT01133522|11629812|FG006|Overall Study|Physician Decision|0
7376464|NCT01133522|11629813|FG007|Overall Study|Physician Decision|0
7461777|NCT01841970|11758129|FG000|Overall Study|Physician Decision|2
7461778|NCT01841970|11758129|FG000|Overall Study|Lost to Follow-up|8
7461779|NCT01842308|11758150|FG000|Overall Study|Withdrawal by Subject|0
7461780|NCT01842308|11758151|FG001|Overall Study|Withdrawal by Subject|0
7461781|NCT01842308|11758152|FG002|Overall Study|Withdrawal by Subject|0
7461782|NCT01842308|11758153|FG003|Overall Study|Withdrawal by Subject|0
7461783|NCT01842308|11758154|FG004|Overall Study|Withdrawal by Subject|1
7461784|NCT01842334|11758169|FG000|Overall Study|Withdrawal by Subject|3
7376465|NCT01133522|11629814|FG008|Overall Study|Physician Decision|0
7376466|NCT01133522|11629815|FG009|Overall Study|Physician Decision|0
7376467|NCT01133626|11629847|FG000|Overall Study|Adverse Event|0
7376468|NCT01133626|11629848|FG001|Overall Study|Adverse Event|1
7376469|NCT01133626|11629849|FG002|Overall Study|Adverse Event|0
7376470|NCT01133626|11629847|FG000|Overall Study|Withdrawal by Subject|1
7376471|NCT01133626|11629848|FG001|Overall Study|Withdrawal by Subject|2
7376472|NCT01133626|11629849|FG002|Overall Study|Withdrawal by Subject|2
7376473|NCT01133626|11629847|FG000|Overall Study|Other|0
7461785|NCT01842334|11758170|FG001|Overall Study|Withdrawal by Subject|3
7376474|NCT01133626|11629848|FG001|Overall Study|Other|2
7376475|NCT01133626|11629849|FG002|Overall Study|Other|0
7376476|NCT01133665|11629857|FG000|Overall Study|Physician Decision|2
7376477|NCT01133678|11629863|FG000|Overall Study|Death|1
7376478|NCT01133678|11629864|FG001|Overall Study|Death|1
7376479|NCT01133704|11629872|FG000|Overall Study|Death|44
7376480|NCT01133704|11629873|FG001|Overall Study|Death|26
7376481|NCT01133704|11629872|FG000|Overall Study|Patient refused to continue|4
7376482|NCT01133704|11629873|FG001|Overall Study|Patient refused to continue|0
7376483|NCT01133704|11629872|FG000|Overall Study|Study Closure|1
7376484|NCT01133704|11629873|FG001|Overall Study|Study Closure|0
7376485|NCT01133756|11629882|FG000|Overall Study|Adverse Event|1
7376486|NCT01133756|11629883|FG001|Overall Study|Adverse Event|2
7376487|NCT01133756|11629884|FG002|Overall Study|Adverse Event|1
7376488|NCT01133756|11629882|FG000|Overall Study|Investigator Decision|1
7376489|NCT01133756|11629883|FG001|Overall Study|Investigator Decision|0
7376490|NCT01133756|11629884|FG002|Overall Study|Investigator Decision|0
7376491|NCT01133756|11629882|FG000|Overall Study|Withdrawal by Subject|0
7376492|NCT01133756|11629883|FG001|Overall Study|Withdrawal by Subject|1
7376493|NCT01133756|11629884|FG002|Overall Study|Withdrawal by Subject|0
7376494|NCT01133756|11629882|FG000|Overall Study|Progression of Disease|0
7376495|NCT01133756|11629883|FG001|Overall Study|Progression of Disease|0
7376496|NCT01133756|11629884|FG002|Overall Study|Progression of Disease|1
7376497|NCT01133821|11629894|FG000|Overall Study|Lost to Follow-up|8
7376498|NCT01133821|11629895|FG001|Overall Study|Lost to Follow-up|11
7376499|NCT01133821|11629894|FG000|Overall Study|Withdrawal by Subject|8
7376500|NCT01133821|11629895|FG001|Overall Study|Withdrawal by Subject|3
7376501|NCT01133821|11629894|FG000|Overall Study|preferred other treatment|1
7376502|NCT01133821|11629895|FG001|Overall Study|preferred other treatment|1
7376503|NCT01133821|11629894|FG000|Overall Study|Protocol Violation|0
7376504|NCT01133821|11629895|FG001|Overall Study|Protocol Violation|1
7376505|NCT01133821|11629894|FG000|Overall Study|Refused participation|1
7376506|NCT01133821|11629895|FG001|Overall Study|Refused participation|3
7376507|NCT01133847|11629904|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
7376508|NCT01133847|11629905|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
7376509|NCT01133847|11629906|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
7376510|NCT01133847|11629904|FG000|Follow-Up Phase|Lost to Follow-up|1
7376511|NCT01133847|11629905|FG001|Follow-Up Phase|Lost to Follow-up|3
7376512|NCT01133847|11629906|FG002|Follow-Up Phase|Lost to Follow-up|7
7376513|NCT01133977|11629925|FG000|Overall Study|Adverse Event|0
7376514|NCT01133977|11629926|FG001|Overall Study|Adverse Event|0
7376515|NCT01133977|11629927|FG002|Overall Study|Adverse Event|1
7376516|NCT01133977|11629928|FG003|Overall Study|Adverse Event|0
7376517|NCT01133977|11629929|FG004|Overall Study|Adverse Event|0
7376518|NCT01133977|11629925|FG000|Overall Study|Death|1
7376519|NCT01133977|11629926|FG001|Overall Study|Death|1
7376520|NCT01133977|11629927|FG002|Overall Study|Death|1
7376521|NCT01133977|11629928|FG003|Overall Study|Death|7
7376522|NCT01133977|11629929|FG004|Overall Study|Death|3
7376523|NCT01133977|11629925|FG000|Overall Study|Started a New Line of Therapy|2
7376524|NCT01133977|11629926|FG001|Overall Study|Started a New Line of Therapy|6
7376525|NCT01133977|11629927|FG002|Overall Study|Started a New Line of Therapy|4
7376526|NCT01133977|11629928|FG003|Overall Study|Started a New Line of Therapy|25
7376527|NCT01133977|11629929|FG004|Overall Study|Started a New Line of Therapy|33
7376528|NCT01133977|11629925|FG000|Overall Study|Lost to Follow-up|0
7376529|NCT01133977|11629926|FG001|Overall Study|Lost to Follow-up|0
7376530|NCT01133977|11629927|FG002|Overall Study|Lost to Follow-up|0
7376531|NCT01133977|11629928|FG003|Overall Study|Lost to Follow-up|2
7376532|NCT01133977|11629929|FG004|Overall Study|Lost to Follow-up|1
7376533|NCT01133977|11629925|FG000|Overall Study|Withdrawal by Subject|0
7376534|NCT01133977|11629926|FG001|Overall Study|Withdrawal by Subject|0
7376535|NCT01133977|11629927|FG002|Overall Study|Withdrawal by Subject|0
7376536|NCT01133977|11629928|FG003|Overall Study|Withdrawal by Subject|5
7376537|NCT01133977|11629929|FG004|Overall Study|Withdrawal by Subject|1
7376538|NCT01134042|11629980|FG000|Overall Study|Adverse Event|3
7376539|NCT01134042|11629981|FG001|Overall Study|Adverse Event|7
7376540|NCT01134042|11629982|FG002|Overall Study|Adverse Event|2
7376541|NCT01134042|11629980|FG000|Overall Study|Lack of Efficacy|21
7376542|NCT01134042|11629981|FG001|Overall Study|Lack of Efficacy|6
7376543|NCT01134042|11629982|FG002|Overall Study|Lack of Efficacy|18
7376544|NCT01134042|11629980|FG000|Overall Study|Protocol Violation|5
7376545|NCT01134042|11629981|FG001|Overall Study|Protocol Violation|3
7376546|NCT01134042|11629982|FG002|Overall Study|Protocol Violation|5
7376547|NCT01134042|11629980|FG000|Overall Study|Lost to Follow-up|2
7376548|NCT01134042|11629981|FG001|Overall Study|Lost to Follow-up|0
7376549|NCT01134042|11629982|FG002|Overall Study|Lost to Follow-up|1
7376550|NCT01134042|11629980|FG000|Overall Study|Physician Decision|4
7376551|NCT01134042|11629981|FG001|Overall Study|Physician Decision|8
7376552|NCT01134042|11629982|FG002|Overall Study|Physician Decision|1
7376553|NCT01134042|11629980|FG000|Overall Study|Withdrawal by Subject|13
7376554|NCT01134042|11629981|FG001|Overall Study|Withdrawal by Subject|4
7376555|NCT01134042|11629982|FG002|Overall Study|Withdrawal by Subject|7
7376556|NCT01134055|11629998|FG000|Overall Study|Adverse Event|5
7376557|NCT01134055|11629999|FG001|Overall Study|Adverse Event|2
7376558|NCT01134055|11630000|FG002|Overall Study|Adverse Event|2
7376559|NCT01134055|11630001|FG003|Overall Study|Adverse Event|2
7376560|NCT01134055|11630002|FG004|Overall Study|Adverse Event|5
7376561|NCT01134055|11630003|FG005|Overall Study|Adverse Event|7
7376562|NCT01134055|11630004|FG006|Overall Study|Adverse Event|2
7376563|NCT01134055|11629998|FG000|Overall Study|Lost to Follow-up|0
7376564|NCT01134055|11629999|FG001|Overall Study|Lost to Follow-up|1
7376565|NCT01134055|11630000|FG002|Overall Study|Lost to Follow-up|0
7376566|NCT01134055|11630001|FG003|Overall Study|Lost to Follow-up|1
7376567|NCT01134055|11630002|FG004|Overall Study|Lost to Follow-up|0
7376568|NCT01134055|11630003|FG005|Overall Study|Lost to Follow-up|0
7376569|NCT01134055|11630004|FG006|Overall Study|Lost to Follow-up|0
7376570|NCT01134055|11629998|FG000|Overall Study|Withdrawal by Subject|3
7376571|NCT01134055|11629999|FG001|Overall Study|Withdrawal by Subject|3
7376572|NCT01134055|11630000|FG002|Overall Study|Withdrawal by Subject|1
7376573|NCT01134055|11630001|FG003|Overall Study|Withdrawal by Subject|2
7376574|NCT01134055|11630002|FG004|Overall Study|Withdrawal by Subject|0
7376575|NCT01134055|11630003|FG005|Overall Study|Withdrawal by Subject|0
7376576|NCT01134055|11630004|FG006|Overall Study|Withdrawal by Subject|8
7376577|NCT01134055|11629998|FG000|Overall Study|Protocol Violation|0
7376578|NCT01134055|11629999|FG001|Overall Study|Protocol Violation|0
7376579|NCT01134055|11630000|FG002|Overall Study|Protocol Violation|0
7376580|NCT01134055|11630001|FG003|Overall Study|Protocol Violation|1
7376581|NCT01134055|11630002|FG004|Overall Study|Protocol Violation|1
7376582|NCT01134055|11630003|FG005|Overall Study|Protocol Violation|0
7376583|NCT01134055|11630004|FG006|Overall Study|Protocol Violation|0
7376584|NCT01134055|11629998|FG000|Overall Study|Physician Decision|0
7376585|NCT01134055|11629999|FG001|Overall Study|Physician Decision|0
7376586|NCT01134055|11630000|FG002|Overall Study|Physician Decision|0
7376587|NCT01134055|11630001|FG003|Overall Study|Physician Decision|0
7376588|NCT01134055|11630002|FG004|Overall Study|Physician Decision|0
7376589|NCT01134055|11630003|FG005|Overall Study|Physician Decision|0
7376590|NCT01134055|11630004|FG006|Overall Study|Physician Decision|1
7376591|NCT01134107|11630036|FG000|Period 1-First Treatment Intervention|Adverse Event|1
7376592|NCT01134107|11630037|FG001|Period 1-First Treatment Intervention|Adverse Event|0
7376593|NCT01134107|11630036|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7376594|NCT01134107|11630037|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
7376595|NCT01134107|11630036|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
7376596|NCT01134107|11630037|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
7376597|NCT01134107|11630036|FG000|Period 1-First Treatment Intervention|Physician Decision|1
7376598|NCT01134107|11630037|FG001|Period 1-First Treatment Intervention|Physician Decision|0
7376599|NCT01134107|11630036|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
7376600|NCT01134107|11630037|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
7376601|NCT01134107|11630036|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
7376602|NCT01134107|11630037|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
7376603|NCT01134107|11630036|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
7376604|NCT01134107|11630037|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
7376605|NCT01134263|11630057|FG000|Overall Study|Serious adverse event|2
7376606|NCT01134263|11630058|FG001|Overall Study|Serious adverse event|1
7376607|NCT01134263|11630059|FG002|Overall Study|Serious adverse event|1
7376608|NCT01134263|11630060|FG003|Overall Study|Serious adverse event|1
7376609|NCT01134263|11630061|FG004|Overall Study|Serious adverse event|1
7376610|NCT01134263|11630057|FG000|Overall Study|Other adverse event|1
7376611|NCT01134263|11630058|FG001|Overall Study|Other adverse event|2
7376612|NCT01134263|11630059|FG002|Overall Study|Other adverse event|5
7376613|NCT01134263|11630060|FG003|Overall Study|Other adverse event|3
7376614|NCT01134263|11630061|FG004|Overall Study|Other adverse event|0
7376615|NCT01134263|11630057|FG000|Overall Study|Protocol Violation|8
7376616|NCT01134263|11630058|FG001|Overall Study|Protocol Violation|7
7376617|NCT01134263|11630059|FG002|Overall Study|Protocol Violation|2
7376618|NCT01134263|11630060|FG003|Overall Study|Protocol Violation|4
7376619|NCT01134263|11630061|FG004|Overall Study|Protocol Violation|2
7376620|NCT01134263|11630057|FG000|Overall Study|Lost to Follow-up|4
7376621|NCT01134263|11630058|FG001|Overall Study|Lost to Follow-up|3
7376622|NCT01134263|11630059|FG002|Overall Study|Lost to Follow-up|5
7376623|NCT01134263|11630060|FG003|Overall Study|Lost to Follow-up|3
7376624|NCT01134263|11630061|FG004|Overall Study|Lost to Follow-up|1
7376625|NCT01134263|11630057|FG000|Overall Study|Withdrawal by Subject|8
7376626|NCT01134263|11630058|FG001|Overall Study|Withdrawal by Subject|6
7376627|NCT01134263|11630059|FG002|Overall Study|Withdrawal by Subject|16
7376628|NCT01134263|11630060|FG003|Overall Study|Withdrawal by Subject|7
7376629|NCT01134263|11630061|FG004|Overall Study|Withdrawal by Subject|5
7376630|NCT01134263|11630057|FG000|Overall Study|Enrolled, but not treated|1
7376631|NCT01134263|11630058|FG001|Overall Study|Enrolled, but not treated|1
7376632|NCT01134263|11630059|FG002|Overall Study|Enrolled, but not treated|0
7376633|NCT01134263|11630060|FG003|Overall Study|Enrolled, but not treated|1
7376634|NCT01134263|11630061|FG004|Overall Study|Enrolled, but not treated|0
7376635|NCT01134315|11630093|FG000|Overall Study|Adverse Event|1
7376636|NCT01134315|11630094|FG001|Overall Study|Adverse Event|2
7376637|NCT01134315|11630093|FG000|Overall Study|Other Reason|8
7376638|NCT01134315|11630094|FG001|Overall Study|Other Reason|17
7376639|NCT01134393|11630117|FG000|Overall Study|Adverse Event|18
7376640|NCT01134393|11630117|FG000|Overall Study|Lack of Efficacy|2
7376641|NCT01134393|11630117|FG000|Overall Study|Protocol Violation|12
7376642|NCT01134393|11630117|FG000|Overall Study|Lost to Follow-up|3
7376643|NCT01134393|11630117|FG000|Overall Study|Withdrawal by Subject|11
7376644|NCT01134393|11630117|FG000|Overall Study|Other|6
7376645|NCT01129011|11630136|FG000|Overall Study|Adverse Event|20
7376646|NCT01129011|11630137|FG001|Overall Study|Adverse Event|30
7376647|NCT01129011|11630136|FG000|Overall Study|Withdrawal by Subject|24
7376648|NCT01129011|11630137|FG001|Overall Study|Withdrawal by Subject|8
7376649|NCT01129011|11630136|FG000|Overall Study|Lost to Follow-up|6
7376650|NCT01129011|11630137|FG001|Overall Study|Lost to Follow-up|7
7376651|NCT01129011|11630136|FG000|Overall Study|Duodenal Ulcer|2
7376652|NCT01129011|11630137|FG001|Overall Study|Duodenal Ulcer|8
7376653|NCT01129011|11630136|FG000|Overall Study|misc|7
7376654|NCT01129011|11630137|FG001|Overall Study|misc|4
7376655|NCT01134562|11630174|FG000|Overall Study|Adverse Event|0
7376656|NCT01134562|11630175|FG001|Overall Study|Adverse Event|1
7376657|NCT01134562|11630176|FG002|Overall Study|Adverse Event|0
7376658|NCT01134562|11630177|FG003|Overall Study|Adverse Event|0
7376659|NCT01134562|11630178|FG004|Overall Study|Adverse Event|0
7376660|NCT01134627|11630213|FG000|Overall Study|Adverse Event|47
7376661|NCT01134627|11630214|FG001|Overall Study|Adverse Event|31
7376662|NCT01134627|11630213|FG000|Overall Study|Lost to Follow-up|1
7376663|NCT01134627|11630214|FG001|Overall Study|Lost to Follow-up|2
7376664|NCT01134627|11630213|FG000|Overall Study|Protocol Violation|3
7376665|NCT01134627|11630214|FG001|Overall Study|Protocol Violation|5
7376666|NCT01134627|11630213|FG000|Overall Study|Lack of Efficacy|2
7376667|NCT01134627|11630214|FG001|Overall Study|Lack of Efficacy|12
7376668|NCT01134627|11630213|FG000|Overall Study|Withdrawal by Subject|4
7376669|NCT01134627|11630214|FG001|Overall Study|Withdrawal by Subject|3
7376670|NCT01134627|11630213|FG000|Overall Study|Planning to become pregnant/pregnancy|1
7376671|NCT01134627|11630214|FG001|Overall Study|Planning to become pregnant/pregnancy|0
7376672|NCT01134627|11630213|FG000|Overall Study|Other|11
7376673|NCT01134627|11630214|FG001|Overall Study|Other|14
7376674|NCT01134705|11630222|FG000|Overall Study|Adverse Event|1
7376675|NCT01134705|11630223|FG001|Overall Study|Adverse Event|7
7376676|NCT01134705|11630222|FG000|Overall Study|Withdrawal by Subject|6
7376677|NCT01134705|11630223|FG001|Overall Study|Withdrawal by Subject|6
7376678|NCT01134705|11630222|FG000|Overall Study|Pregnancy|1
7376679|NCT01134705|11630223|FG001|Overall Study|Pregnancy|0
7376680|NCT01134705|11630222|FG000|Overall Study|Lost to Follow-up|5
7376681|NCT01134705|11630223|FG001|Overall Study|Lost to Follow-up|2
7376682|NCT01134705|11630222|FG000|Overall Study|Protocol Violation|1
7376683|NCT01134705|11630223|FG001|Overall Study|Protocol Violation|1
7376684|NCT01134705|11630222|FG000|Overall Study|Other|1
7376685|NCT01134705|11630223|FG001|Overall Study|Other|6
7376686|NCT01134731|11630232|FG000|Overall Study|Adverse Event|3
7376687|NCT01134731|11630233|FG001|Overall Study|Adverse Event|2
7376688|NCT01134731|11630234|FG002|Overall Study|Adverse Event|1
7376689|NCT01134731|11630232|FG000|Overall Study|Physician Decision|2
7376690|NCT01134731|11630233|FG001|Overall Study|Physician Decision|2
7376691|NCT01134731|11630234|FG002|Overall Study|Physician Decision|2
7376692|NCT01134731|11630232|FG000|Overall Study|Lack of Efficacy|0
7376693|NCT01134731|11630233|FG001|Overall Study|Lack of Efficacy|0
7376694|NCT01134731|11630234|FG002|Overall Study|Lack of Efficacy|1
7376695|NCT01134731|11630232|FG000|Overall Study|Withdrawal by Subject|3
7376696|NCT01134731|11630233|FG001|Overall Study|Withdrawal by Subject|3
7376697|NCT01134731|11630234|FG002|Overall Study|Withdrawal by Subject|1
7376698|NCT01134731|11630232|FG000|Overall Study|Lost to Follow-up|5
7376699|NCT01134731|11630233|FG001|Overall Study|Lost to Follow-up|4
7376700|NCT01134731|11630234|FG002|Overall Study|Lost to Follow-up|3
7376701|NCT01134783|11630245|FG000|Overall Study|Pregnancy|16
7376702|NCT01134783|11630246|FG001|Overall Study|Pregnancy|8
7376703|NCT01134783|11630245|FG000|Overall Study|Withdrawal by Subject|15
7376704|NCT01134783|11630246|FG001|Overall Study|Withdrawal by Subject|9
7376705|NCT01134783|11630245|FG000|Overall Study|Lost to Follow-up|5
7376706|NCT01134783|11630246|FG001|Overall Study|Lost to Follow-up|20
7376707|NCT01134939|11630288|FG000|Overall Study|Adverse Event|9
7376708|NCT01134939|11630289|FG001|Overall Study|Adverse Event|3
7376709|NCT01134939|11630290|FG002|Overall Study|Adverse Event|4
7376710|NCT01134939|11630291|FG003|Overall Study|Adverse Event|5
7376711|NCT01134939|11630292|FG004|Overall Study|Adverse Event|5
7376712|NCT01134939|11630293|FG005|Overall Study|Adverse Event|5
7376713|NCT01134939|11630294|FG006|Overall Study|Adverse Event|1
7376714|NCT01134939|11630295|FG007|Overall Study|Adverse Event|0
7376715|NCT01134939|11630288|FG000|Overall Study|Lack of Efficacy|2
7376716|NCT01134939|11630289|FG001|Overall Study|Lack of Efficacy|5
7376717|NCT01134939|11630290|FG002|Overall Study|Lack of Efficacy|1
7376718|NCT01134939|11630291|FG003|Overall Study|Lack of Efficacy|0
7376719|NCT01134939|11630292|FG004|Overall Study|Lack of Efficacy|3
7376720|NCT01134939|11630293|FG005|Overall Study|Lack of Efficacy|0
7376721|NCT01134939|11630294|FG006|Overall Study|Lack of Efficacy|1
7376722|NCT01134939|11630295|FG007|Overall Study|Lack of Efficacy|0
7376723|NCT01134939|11630288|FG000|Overall Study|Lost to Follow-up|2
7376724|NCT01134939|11630289|FG001|Overall Study|Lost to Follow-up|3
7376725|NCT01134939|11630290|FG002|Overall Study|Lost to Follow-up|0
7376726|NCT01134939|11630291|FG003|Overall Study|Lost to Follow-up|1
7376727|NCT01134939|11630292|FG004|Overall Study|Lost to Follow-up|2
7376728|NCT01134939|11630293|FG005|Overall Study|Lost to Follow-up|1
7376729|NCT01134939|11630294|FG006|Overall Study|Lost to Follow-up|0
7376730|NCT01134939|11630295|FG007|Overall Study|Lost to Follow-up|0
7376731|NCT01134939|11630288|FG000|Overall Study|Death|0
7376732|NCT01134939|11630289|FG001|Overall Study|Death|1
7376733|NCT01134939|11630290|FG002|Overall Study|Death|0
7376734|NCT01134939|11630291|FG003|Overall Study|Death|0
7376735|NCT01134939|11630292|FG004|Overall Study|Death|0
7376736|NCT01134939|11630293|FG005|Overall Study|Death|0
7376737|NCT01134939|11630294|FG006|Overall Study|Death|0
7376738|NCT01134939|11630295|FG007|Overall Study|Death|0
7376739|NCT01134939|11630288|FG000|Overall Study|Termination page not available|4
7376740|NCT01134939|11630289|FG001|Overall Study|Termination page not available|6
7376741|NCT01134939|11630290|FG002|Overall Study|Termination page not available|5
7376742|NCT01134939|11630291|FG003|Overall Study|Termination page not available|8
7376743|NCT01134939|11630292|FG004|Overall Study|Termination page not available|0
7376744|NCT01134939|11630293|FG005|Overall Study|Termination page not available|3
7376745|NCT01134939|11630294|FG006|Overall Study|Termination page not available|7
7376746|NCT01134939|11630295|FG007|Overall Study|Termination page not available|0
7376747|NCT01135017|11630319|FG000|Overall Study|Adverse Event|3
7376748|NCT01135017|11630320|FG001|Overall Study|Adverse Event|8
7376749|NCT01135017|11630319|FG000|Overall Study|Other than above|3
7533414|NCT02685033|11879765|FG001|Overall Study|Withdrawal of Consent|1
7533415|NCT02685033|11879764|FG000|Overall Study|Lost to Follow-up|2
7533416|NCT02685033|11879765|FG001|Overall Study|Lost to Follow-up|1
7533417|NCT02685033|11879764|FG000|Overall Study|Adverse Event|1
7533418|NCT02685033|11879765|FG001|Overall Study|Adverse Event|0
7533419|NCT02685072|11879773|FG000|Treatment Period|Lost to Follow-up|12
7533420|NCT02685072|11879774|FG001|Treatment Period|Lost to Follow-up|6
7533421|NCT02685072|11879773|FG000|Treatment Period|Withdrawal by Subject|1
7533422|NCT02685072|11879774|FG001|Treatment Period|Withdrawal by Subject|3
7533423|NCT02685072|11879773|FG000|1-Month Follow-Up|Withdrawal by Subject|1
7533424|NCT02685072|11879774|FG001|1-Month Follow-Up|Withdrawal by Subject|0
7533425|NCT02685488|11879803|FG000|Overall Study|Withdrawal by Subject|0
7533426|NCT02685488|11879804|FG001|Overall Study|Withdrawal by Subject|1
7533427|NCT02685995|11879832|FG000|Overall Study|Insertion of immediately puncturable graft.|1
7533428|NCT02685995|11879833|FG001|Overall Study|Insertion of immediately puncturable graft.|1
7533429|NCT02686034|11879841|FG000|Run-In Period 1|Eligibility|12
7533430|NCT02686034|11879842|FG001|Run-In Period 1|Eligibility|10
7533431|NCT02686034|11879841|FG000|Run-In Period 1|Withdrawal by Subject|4
7376750|NCT01135017|11630320|FG001|Overall Study|Other than above|4
7376751|NCT01135394|11630409|FG000|Screening|Lost to Follow-up|2
7376752|NCT01135394|11630409|FG000|Screening|Withdrawal by Subject|10
7376753|NCT01135394|11630409|FG000|Screening|Screening failure|16
7376754|NCT01135394|11630409|FG000|Screening|Physician Decision|5
7461786|NCT01842334|11758169|FG000|Overall Study|Moved away mid-study|0
7461787|NCT01842334|11758170|FG001|Overall Study|Moved away mid-study|1
7461788|NCT01842438|11758178|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
7461789|NCT01842438|11758179|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
7461790|NCT01842438|11758178|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
7461791|NCT01842438|11758179|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
7461792|NCT01842438|11758178|FG000|T2: 6month Follow-up|Death|0
7461793|NCT01842438|11758179|FG001|T2: 6month Follow-up|Death|1
7461794|NCT01842581|11758196|FG000|Overall Study|Adverse Event|6
7461795|NCT01842581|11758197|FG001|Overall Study|Adverse Event|4
7461796|NCT01842581|11758196|FG000|Overall Study|HE breakthrough|26
7461797|NCT01842581|11758197|FG001|Overall Study|HE breakthrough|13
7461798|NCT01842581|11758196|FG000|Overall Study|Liver transplant|2
7461799|NCT01842581|11758197|FG001|Overall Study|Liver transplant|0
7461800|NCT01842581|11758196|FG000|Overall Study|Lost to Follow-up|2
7461801|NCT01842581|11758197|FG001|Overall Study|Lost to Follow-up|5
7461802|NCT01842581|11758196|FG000|Overall Study|Withdrawal by Subject|5
7461803|NCT01842581|11758197|FG001|Overall Study|Withdrawal by Subject|7
7461804|NCT01842581|11758196|FG000|Overall Study|Other than specified|3
7533432|NCT02686034|11879842|FG001|Run-In Period 1|Withdrawal by Subject|3
7376755|NCT01135394|11630409|FG000|Baseline Assessment|Withdrawal by Subject|9
7461805|NCT01842581|11758197|FG001|Overall Study|Other than specified|1
7461806|NCT01842607|11758207|FG000|Overall Study|Adverse Event|11
7461807|NCT01842607|11758207|FG000|Overall Study|Lack of Efficacy|19
7461808|NCT01842607|11758207|FG000|Overall Study|Protocol Violation|8
7376756|NCT01135394|11630409|FG000|Baseline Assessment|Physician Decision|3
7376757|NCT01135394|11630409|FG000|Baseline Assessment|Lost to Follow-up|2
7376758|NCT01135394|11630409|FG000|Baseline Assessment|Adverse Event|1
7376759|NCT01135394|11630409|FG000|Study Treatment|Withdrawal by Subject|1
7376760|NCT01135394|11630409|FG000|Study Treatment|Physician Decision|1
7376761|NCT01135394|11630409|FG000|Study Treatment|Adverse Event|2
7376762|NCT01135498|11630422|FG000|Overall Study|Adverse Event|20
7376763|NCT01135498|11630422|FG000|Overall Study|Progressive disease|38
7376764|NCT01135498|11630422|FG000|Overall Study|Investigator judgement|25
7376765|NCT01135498|11630422|FG000|Overall Study|Withdrawal by Subject|4
7376766|NCT01135498|11630422|FG000|Overall Study|Death|1
7376767|NCT01135498|11630422|FG000|Overall Study|Ongoing at time of analysis|2
7376768|NCT01135511|11630436|FG000|Overall Study|Adverse Event|0
7376769|NCT01135511|11630437|FG001|Overall Study|Adverse Event|1
7376770|NCT01135511|11630438|FG002|Overall Study|Adverse Event|2
7376771|NCT01135511|11630439|FG003|Overall Study|Adverse Event|0
7376772|NCT01135511|11630440|FG004|Overall Study|Adverse Event|0
7376773|NCT01135511|11630441|FG005|Overall Study|Adverse Event|1
7376774|NCT01135511|11630442|FG006|Overall Study|Adverse Event|0
7376775|NCT01135511|11630443|FG007|Overall Study|Adverse Event|1
7376776|NCT01135511|11630444|FG008|Overall Study|Adverse Event|0
7376777|NCT01135511|11630436|FG000|Overall Study|Lack of Efficacy|0
7376778|NCT01135511|11630437|FG001|Overall Study|Lack of Efficacy|1
7376779|NCT01135511|11630438|FG002|Overall Study|Lack of Efficacy|1
7376780|NCT01135511|11630439|FG003|Overall Study|Lack of Efficacy|2
7376781|NCT01135511|11630440|FG004|Overall Study|Lack of Efficacy|0
7376782|NCT01135511|11630441|FG005|Overall Study|Lack of Efficacy|0
7376783|NCT01135511|11630442|FG006|Overall Study|Lack of Efficacy|0
7376784|NCT01135511|11630443|FG007|Overall Study|Lack of Efficacy|0
7376785|NCT01135511|11630444|FG008|Overall Study|Lack of Efficacy|0
7376786|NCT01135511|11630436|FG000|Overall Study|Protocol Violation|0
7376787|NCT01135511|11630437|FG001|Overall Study|Protocol Violation|0
7376788|NCT01135511|11630438|FG002|Overall Study|Protocol Violation|3
7376789|NCT01135511|11630439|FG003|Overall Study|Protocol Violation|0
7376790|NCT01135511|11630440|FG004|Overall Study|Protocol Violation|0
7376791|NCT01135511|11630441|FG005|Overall Study|Protocol Violation|0
7376792|NCT01135511|11630442|FG006|Overall Study|Protocol Violation|0
7376793|NCT01135511|11630443|FG007|Overall Study|Protocol Violation|0
7376794|NCT01135511|11630444|FG008|Overall Study|Protocol Violation|0
7376795|NCT01135511|11630436|FG000|Overall Study|Pregnancy|0
7376796|NCT01135511|11630437|FG001|Overall Study|Pregnancy|0
7376797|NCT01135511|11630438|FG002|Overall Study|Pregnancy|0
7376798|NCT01135511|11630439|FG003|Overall Study|Pregnancy|1
7376799|NCT01135511|11630440|FG004|Overall Study|Pregnancy|0
7376800|NCT01135511|11630441|FG005|Overall Study|Pregnancy|0
7376801|NCT01135511|11630442|FG006|Overall Study|Pregnancy|0
7376802|NCT01135511|11630443|FG007|Overall Study|Pregnancy|0
7376803|NCT01135511|11630444|FG008|Overall Study|Pregnancy|0
7376804|NCT01135511|11630436|FG000|Overall Study|could not visit the clinic|0
7376805|NCT01135511|11630437|FG001|Overall Study|could not visit the clinic|1
7376806|NCT01135511|11630438|FG002|Overall Study|could not visit the clinic|2
7376807|NCT01135511|11630439|FG003|Overall Study|could not visit the clinic|0
7376808|NCT01135511|11630440|FG004|Overall Study|could not visit the clinic|0
7376809|NCT01135511|11630441|FG005|Overall Study|could not visit the clinic|0
7376810|NCT01135511|11630442|FG006|Overall Study|could not visit the clinic|0
7376811|NCT01135511|11630443|FG007|Overall Study|could not visit the clinic|0
7376812|NCT01135511|11630444|FG008|Overall Study|could not visit the clinic|0
7376813|NCT01135511|11630436|FG000|Overall Study|noncompliance with study drug taken|0
7376814|NCT01135511|11630437|FG001|Overall Study|noncompliance with study drug taken|0
7376815|NCT01135511|11630438|FG002|Overall Study|noncompliance with study drug taken|0
7376816|NCT01135511|11630439|FG003|Overall Study|noncompliance with study drug taken|0
7376817|NCT01135511|11630440|FG004|Overall Study|noncompliance with study drug taken|1
7376818|NCT01135511|11630441|FG005|Overall Study|noncompliance with study drug taken|0
7376819|NCT01135511|11630442|FG006|Overall Study|noncompliance with study drug taken|0
7376820|NCT01135511|11630443|FG007|Overall Study|noncompliance with study drug taken|0
7376821|NCT01135511|11630444|FG008|Overall Study|noncompliance with study drug taken|0
7376822|NCT01135511|11630436|FG000|Overall Study|Withdrawal by Subject|0
7376823|NCT01135511|11630437|FG001|Overall Study|Withdrawal by Subject|0
7376824|NCT01135511|11630438|FG002|Overall Study|Withdrawal by Subject|0
7376825|NCT01135511|11630439|FG003|Overall Study|Withdrawal by Subject|0
7376826|NCT01135511|11630440|FG004|Overall Study|Withdrawal by Subject|0
7376827|NCT01135511|11630441|FG005|Overall Study|Withdrawal by Subject|0
7376828|NCT01135511|11630442|FG006|Overall Study|Withdrawal by Subject|1
7376829|NCT01135511|11630443|FG007|Overall Study|Withdrawal by Subject|0
7376830|NCT01135511|11630444|FG008|Overall Study|Withdrawal by Subject|1
7376831|NCT01135524|11630464|FG000|Overall Study|Withdrawal by Subject|14
7376832|NCT01135524|11630464|FG000|Overall Study|Adverse Event|20
7376833|NCT01135524|11630464|FG000|Overall Study|Lost to Follow-up|3
7376834|NCT01135524|11630464|FG000|Overall Study|Administrative|151
7376835|NCT01135524|11630464|FG000|Overall Study|Lack of Efficacy|8
7376836|NCT01135914|11630475|FG000|Overall Study|Withdrawal by Subject|1
7376837|NCT01135914|11630476|FG001|Overall Study|Withdrawal by Subject|3
7376838|NCT01135914|11630477|FG002|Overall Study|Withdrawal by Subject|6
7376839|NCT01135914|11630475|FG000|Overall Study|Lost to Follow-up|1
7376840|NCT01135914|11630476|FG001|Overall Study|Lost to Follow-up|0
7376841|NCT01135914|11630477|FG002|Overall Study|Lost to Follow-up|1
7376842|NCT01135914|11630475|FG000|Overall Study|Protocol Violation|0
7376843|NCT01135914|11630476|FG001|Overall Study|Protocol Violation|0
7376844|NCT01135914|11630477|FG002|Overall Study|Protocol Violation|3
7376845|NCT01135914|11630475|FG000|Overall Study|Lack of Efficacy|2
7376846|NCT01135914|11630476|FG001|Overall Study|Lack of Efficacy|1
7376847|NCT01135914|11630477|FG002|Overall Study|Lack of Efficacy|10
7376848|NCT01135914|11630475|FG000|Overall Study|Adverse Event|0
7376849|NCT01135914|11630476|FG001|Overall Study|Adverse Event|1
7376850|NCT01135914|11630477|FG002|Overall Study|Adverse Event|2
7376851|NCT01135992|11630485|FG000|Overall Study|Adverse Event|1
7376852|NCT01135992|11630485|FG000|Overall Study|Lack of Efficacy|1
7376853|NCT01135992|11630485|FG000|Overall Study|Protocol Violation|2
7376854|NCT01135992|11630485|FG000|Overall Study|Withdrawal criteria|10
7376855|NCT01135992|11630485|FG000|Overall Study|Unclassified|7
7376856|NCT01136174|11630493|FG000|Overall Study|Adverse Event|0
7376857|NCT01136174|11630494|FG001|Overall Study|Adverse Event|0
7376858|NCT01136174|11630495|FG002|Overall Study|Adverse Event|0
7376859|NCT01136174|11630496|FG003|Overall Study|Adverse Event|4
7376860|NCT01136291|11630522|FG000|Overall Study|Lost to Follow-up|1
7376861|NCT01136291|11630523|FG001|Overall Study|Lost to Follow-up|1
7376862|NCT01136356|11630529|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
7376863|NCT01136356|11630530|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
7376864|NCT01136356|11630529|FG000|First 18-day Withdrawal|Physician Decision|1
7376865|NCT01136356|11630530|FG001|First 18-day Withdrawal|Physician Decision|0
7376866|NCT01136356|11630529|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
7376867|NCT01136356|11630530|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
7376868|NCT01136382|11630537|FG000|Overall Study|Other|8
7376869|NCT01136382|11630538|FG001|Overall Study|Other|3
7376870|NCT01136382|11630537|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
7376871|NCT01136382|11630538|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
7376872|NCT01136382|11630537|FG000|Overall Study|Severe Non-Compliance to Protocol|0
7376873|NCT01136382|11630538|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7376874|NCT01136382|11630537|FG000|Overall Study|Withdrawal by Subject|4
7376875|NCT01136382|11630538|FG001|Overall Study|Withdrawal by Subject|1
7376876|NCT01136408|11630547|FG000|Overall Study|Adverse Event|4
7376877|NCT01136408|11630548|FG001|Overall Study|Adverse Event|8
7376878|NCT01136408|11630549|FG002|Overall Study|Adverse Event|4
7376879|NCT01136408|11630547|FG000|Overall Study|Protocol Violation|1
7376880|NCT01136408|11630548|FG001|Overall Study|Protocol Violation|1
7376881|NCT01136408|11630549|FG002|Overall Study|Protocol Violation|1
7376882|NCT01136655|11630565|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
7376883|NCT01136655|11630565|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
7376884|NCT01136655|11630565|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
7376885|NCT01136655|11630565|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
7376886|NCT01136733|11630585|FG000|Phase 1b|Adverse Event|0
7376887|NCT01136733|11630586|FG001|Phase 1b|Adverse Event|3
7376888|NCT01136733|11630587|FG002|Phase 1b|Adverse Event|1
7376889|NCT01136733|11630588|FG003|Phase 1b|Adverse Event|0
7376890|NCT01136733|11630589|FG004|Phase 1b|Adverse Event|0
7376891|NCT01136733|11630590|FG005|Phase 1b|Adverse Event|0
7376892|NCT01136733|11630591|FG006|Phase 1b|Adverse Event|0
7376893|NCT01136733|11630585|FG000|Phase 1b|Participant Choice|0
7376894|NCT01136733|11630586|FG001|Phase 1b|Participant Choice|0
7376895|NCT01136733|11630587|FG002|Phase 1b|Participant Choice|1
7376896|NCT01136733|11630588|FG003|Phase 1b|Participant Choice|0
7376897|NCT01136733|11630589|FG004|Phase 1b|Participant Choice|0
7376898|NCT01136733|11630590|FG005|Phase 1b|Participant Choice|0
7376899|NCT01136733|11630591|FG006|Phase 1b|Participant Choice|0
7376900|NCT01136733|11630585|FG000|Phase 1b|Administrative-Withdrew Consent|0
7376901|NCT01136733|11630586|FG001|Phase 1b|Administrative-Withdrew Consent|1
7376902|NCT01136733|11630587|FG002|Phase 1b|Administrative-Withdrew Consent|0
7376903|NCT01136733|11630588|FG003|Phase 1b|Administrative-Withdrew Consent|0
7376904|NCT01136733|11630589|FG004|Phase 1b|Administrative-Withdrew Consent|0
7376905|NCT01136733|11630590|FG005|Phase 1b|Administrative-Withdrew Consent|0
7376906|NCT01136733|11630591|FG006|Phase 1b|Administrative-Withdrew Consent|0
7376907|NCT01136733|11630585|FG000|Phase 1b|Clinical Progression|1
7376908|NCT01136733|11630586|FG001|Phase 1b|Clinical Progression|1
7376909|NCT01136733|11630587|FG002|Phase 1b|Clinical Progression|0
7376910|NCT01136733|11630588|FG003|Phase 1b|Clinical Progression|0
7376911|NCT01136733|11630589|FG004|Phase 1b|Clinical Progression|0
7376912|NCT01136733|11630590|FG005|Phase 1b|Clinical Progression|0
7376913|NCT01136733|11630591|FG006|Phase 1b|Clinical Progression|0
7376914|NCT01136733|11630585|FG000|Phase 2|Disease Progression|0
7376915|NCT01136733|11630586|FG001|Phase 2|Disease Progression|0
7376916|NCT01136733|11630587|FG002|Phase 2|Disease Progression|0
7376917|NCT01136733|11630588|FG003|Phase 2|Disease Progression|0
7376918|NCT01136733|11630589|FG004|Phase 2|Disease Progression|30
7376919|NCT01136733|11630590|FG005|Phase 2|Disease Progression|32
7376920|NCT01136733|11630591|FG006|Phase 2|Disease Progression|38
7376921|NCT01136733|11630585|FG000|Phase 2|Adverse Event|0
7376922|NCT01136733|11630586|FG001|Phase 2|Adverse Event|0
7376923|NCT01136733|11630587|FG002|Phase 2|Adverse Event|0
7376924|NCT01136733|11630588|FG003|Phase 2|Adverse Event|0
7376925|NCT01136733|11630589|FG004|Phase 2|Adverse Event|11
7376926|NCT01136733|11630590|FG005|Phase 2|Adverse Event|13
7376927|NCT01136733|11630591|FG006|Phase 2|Adverse Event|5
7376928|NCT01136733|11630585|FG000|Phase 2|Participant Choice|0
7376929|NCT01136733|11630586|FG001|Phase 2|Participant Choice|0
7376930|NCT01136733|11630587|FG002|Phase 2|Participant Choice|0
7376931|NCT01136733|11630588|FG003|Phase 2|Participant Choice|0
7376932|NCT01136733|11630589|FG004|Phase 2|Participant Choice|3
7376933|NCT01136733|11630590|FG005|Phase 2|Participant Choice|0
7376934|NCT01136733|11630591|FG006|Phase 2|Participant Choice|1
7376935|NCT01136733|11630585|FG000|Phase 2|Administrative-Withdrew Consent|0
7376936|NCT01136733|11630586|FG001|Phase 2|Administrative-Withdrew Consent|0
7376937|NCT01136733|11630587|FG002|Phase 2|Administrative-Withdrew Consent|0
7376938|NCT01136733|11630588|FG003|Phase 2|Administrative-Withdrew Consent|0
7376939|NCT01136733|11630589|FG004|Phase 2|Administrative-Withdrew Consent|1
7376940|NCT01136733|11630590|FG005|Phase 2|Administrative-Withdrew Consent|0
7376941|NCT01136733|11630591|FG006|Phase 2|Administrative-Withdrew Consent|0
7376942|NCT01136733|11630585|FG000|Phase 2|Other|0
7376943|NCT01136733|11630586|FG001|Phase 2|Other|0
7376944|NCT01136733|11630587|FG002|Phase 2|Other|0
7376945|NCT01136733|11630588|FG003|Phase 2|Other|0
7376946|NCT01136733|11630589|FG004|Phase 2|Other|6
7376947|NCT01136733|11630590|FG005|Phase 2|Other|7
7376948|NCT01136733|11630591|FG006|Phase 2|Other|6
7376949|NCT01136746|11630623|FG000|Overall Study|Lost to Follow-up|0
7376950|NCT01136746|11630624|FG001|Overall Study|Lost to Follow-up|2
7376951|NCT01136746|11630623|FG000|Overall Study|Protocol Violation|2
7376952|NCT01136746|11630624|FG001|Overall Study|Protocol Violation|1
7376953|NCT01136746|11630623|FG000|Overall Study|Death|1
7376954|NCT01136746|11630624|FG001|Overall Study|Death|0
7376955|NCT01136772|11630632|FG000|Overall Study|Adverse Event|15
7376956|NCT01136772|11630633|FG001|Overall Study|Adverse Event|14
7376957|NCT01136772|11630632|FG000|Overall Study|Lack of Efficacy|42
7376958|NCT01136772|11630633|FG001|Overall Study|Lack of Efficacy|39
7376959|NCT01136772|11630632|FG000|Overall Study|Administrative|14
7376960|NCT01136772|11630633|FG001|Overall Study|Administrative|12
7376961|NCT01136772|11630632|FG000|Overall Study|Withdrawal by Subject|33
7376962|NCT01136772|11630633|FG001|Overall Study|Withdrawal by Subject|36
7376963|NCT01136772|11630632|FG000|Overall Study|Did not receive injection|10
7376964|NCT01136772|11630633|FG001|Overall Study|Did not receive injection|7
7376965|NCT01136772|11630632|FG000|Overall Study|Did not follow up after first injection|2
7376966|NCT01136772|11630633|FG001|Overall Study|Did not follow up after first injection|2
7376967|NCT01136785|11630641|FG000|Overall Study|Protocol Violation|2
7376968|NCT01136785|11630642|FG001|Overall Study|Protocol Violation|1
7376969|NCT01136876|11630663|FG000|Overall Study|Lost to Follow-up|0
7376970|NCT01136876|11630664|FG001|Overall Study|Lost to Follow-up|1
7376971|NCT01136876|11630663|FG000|Overall Study|Physician Decision|3
7376972|NCT01136876|11630664|FG001|Overall Study|Physician Decision|5
7376973|NCT01136876|11630663|FG000|Overall Study|Missing NGAL measurement|2
7376974|NCT01136876|11630664|FG001|Overall Study|Missing NGAL measurement|5
7376975|NCT01136915|11630674|FG000|Overall Study|Lost to Follow-up|2
7376976|NCT01136915|11630675|FG001|Overall Study|Lost to Follow-up|0
7376977|NCT01136915|11630674|FG000|Overall Study|Exclusion criterion met|0
7376978|NCT01136915|11630675|FG001|Overall Study|Exclusion criterion met|1
7376979|NCT01136954|11630685|FG000|Overall Study|Adverse Event|3
7376980|NCT01136954|11630686|FG001|Overall Study|Adverse Event|2
7376981|NCT01136954|11630685|FG000|Overall Study|Withdrawal by Subject|6
7376982|NCT01136954|11630686|FG001|Overall Study|Withdrawal by Subject|2
7376983|NCT01136954|11630685|FG000|Overall Study|Lack of Efficacy|14
7376984|NCT01136954|11630686|FG001|Overall Study|Lack of Efficacy|13
7376985|NCT01136954|11630685|FG000|Overall Study|Physician Decision|0
7376986|NCT01136954|11630686|FG001|Overall Study|Physician Decision|1
7376987|NCT01136954|11630685|FG000|Overall Study|Other|1
7376988|NCT01136954|11630686|FG001|Overall Study|Other|3
7376989|NCT01137071|11630727|FG000|Overall Study|Disease Progression|11
7376990|NCT01137071|11630727|FG000|Overall Study|Withdrawal by Subject|2
7376991|NCT01137071|11630727|FG000|Overall Study|Wrongly Included|1
7376992|NCT01137110|11630738|FG000|Overall Study|Protocol Violation|1
7376993|NCT01137110|11630739|FG001|Overall Study|Protocol Violation|0
7376994|NCT01137292|11630745|FG000|Overall Study|Death|30
7376995|NCT01137292|11630745|FG000|Overall Study|Adverse Event|3
7376996|NCT01137292|11630745|FG000|Overall Study|Lack of Efficacy|13
7376997|NCT01137292|11630745|FG000|Overall Study|Lost to Follow-up|1
7376998|NCT01137292|11630745|FG000|Overall Study|Other|7
7376999|NCT01137474|11630771|FG000|Overall Study|Adverse Event|3
7377000|NCT01137474|11630772|FG001|Overall Study|Adverse Event|5
7377001|NCT01137474|11630773|FG002|Overall Study|Adverse Event|1
7377002|NCT01137474|11630774|FG003|Overall Study|Adverse Event|3
7377003|NCT01137474|11630771|FG000|Overall Study|Withdrawal by Subject|7
7377004|NCT01137474|11630772|FG001|Overall Study|Withdrawal by Subject|2
7377005|NCT01137474|11630773|FG002|Overall Study|Withdrawal by Subject|6
7377006|NCT01137474|11630774|FG003|Overall Study|Withdrawal by Subject|9
7377007|NCT01137474|11630771|FG000|Overall Study|No longer met study criteria|6
7377008|NCT01137474|11630772|FG001|Overall Study|No longer met study criteria|1
7377009|NCT01137474|11630773|FG002|Overall Study|No longer met study criteria|0
7377010|NCT01137474|11630774|FG003|Overall Study|No longer met study criteria|5
7377011|NCT01137474|11630771|FG000|Overall Study|Lost to Follow-up|5
7377012|NCT01137474|11630772|FG001|Overall Study|Lost to Follow-up|1
7377013|NCT01137474|11630773|FG002|Overall Study|Lost to Follow-up|0
7377014|NCT01137474|11630774|FG003|Overall Study|Lost to Follow-up|2
7377015|NCT01137474|11630771|FG000|Overall Study|Lack of Efficacy|0
7377016|NCT01137474|11630772|FG001|Overall Study|Lack of Efficacy|0
7377017|NCT01137474|11630773|FG002|Overall Study|Lack of Efficacy|0
7377018|NCT01137474|11630774|FG003|Overall Study|Lack of Efficacy|2
7377019|NCT01137474|11630771|FG000|Overall Study|Other|3
7377020|NCT01137474|11630772|FG001|Overall Study|Other|1
7377021|NCT01137474|11630773|FG002|Overall Study|Other|0
7377022|NCT01137474|11630774|FG003|Overall Study|Other|0
7377023|NCT01137474|11630771|FG000|Overall Study|Pregnancy|0
7377024|NCT01137474|11630772|FG001|Overall Study|Pregnancy|1
7377025|NCT01137474|11630773|FG002|Overall Study|Pregnancy|0
7377026|NCT01137474|11630774|FG003|Overall Study|Pregnancy|0
7377027|NCT01137474|11630771|FG000|Overall Study|Administrative reason by sponsor|0
7377028|NCT01137474|11630772|FG001|Overall Study|Administrative reason by sponsor|1
7377029|NCT01137474|11630773|FG002|Overall Study|Administrative reason by sponsor|0
7377030|NCT01137474|11630774|FG003|Overall Study|Administrative reason by sponsor|0
7377031|NCT01137578|11630788|FG000|Overall Study|Participant requested to Discontinue|3
7377032|NCT01137578|11630789|FG001|Overall Study|Participant requested to Discontinue|0
7377033|NCT01137578|11630790|FG002|Overall Study|Participant requested to Discontinue|0
7377034|NCT01137578|11630788|FG000|Overall Study|Withdrawal by Subject|1
7377035|NCT01137578|11630789|FG001|Overall Study|Withdrawal by Subject|0
7377036|NCT01137578|11630790|FG002|Overall Study|Withdrawal by Subject|0
7377037|NCT01137578|11630788|FG000|Overall Study|Other|12
7377038|NCT01137578|11630789|FG001|Overall Study|Other|2
7377039|NCT01137578|11630790|FG002|Overall Study|Other|6
7461809|NCT01842607|11758207|FG000|Overall Study|Protocol defined stopping criteria|2
7461810|NCT01842607|11758207|FG000|Overall Study|Lost to Follow-up|3
7461811|NCT01842607|11758207|FG000|Overall Study|Physician Decision|9
7461812|NCT01842607|11758207|FG000|Overall Study|Withdrawal by Subject|14
7461813|NCT01842620|11758211|FG000|Period 1|Withdrawal by Subject|1
7461814|NCT01842620|11758212|FG001|Period 1|Withdrawal by Subject|0
7461815|NCT01842633|11758221|FG000|Overall Study|Screen Failure|1
7461816|NCT01842633|11758222|FG001|Overall Study|Screen Failure|0
7461817|NCT01842633|11758223|FG002|Overall Study|Screen Failure|0
7461818|NCT01842633|11758221|FG000|Overall Study|Adverse Event|1
7461819|NCT01842633|11758222|FG001|Overall Study|Adverse Event|1
7461820|NCT01842633|11758223|FG002|Overall Study|Adverse Event|0
7461821|NCT01842633|11758221|FG000|Overall Study|Withdrawal by Subject|0
7461822|NCT01842633|11758222|FG001|Overall Study|Withdrawal by Subject|1
7461823|NCT01842633|11758223|FG002|Overall Study|Withdrawal by Subject|0
7461824|NCT01842633|11758221|FG000|Overall Study|Technical issues|1
7461825|NCT01842633|11758222|FG001|Overall Study|Technical issues|0
7461826|NCT01842633|11758223|FG002|Overall Study|Technical issues|0
7461827|NCT01842958|11758267|FG000|Overall Study|Lost to Follow-up|1
7461828|NCT01842958|11758268|FG001|Overall Study|Lost to Follow-up|1
7461829|NCT01843023|11758276|FG000|Overall Study|Death|1
7461830|NCT01843023|11758277|FG001|Overall Study|Death|0
7461831|NCT01843023|11758276|FG000|Overall Study|Lost to Follow-up|24
7461832|NCT01843023|11758277|FG001|Overall Study|Lost to Follow-up|29
7461833|NCT01843023|11758276|FG000|Overall Study|Withdrawal by Subject|8
7461834|NCT01843023|11758277|FG001|Overall Study|Withdrawal by Subject|6
7461835|NCT01843062|11758285|FG000|Overall Study|Protocol Violation|1
7461836|NCT01843062|11758286|FG001|Overall Study|Protocol Violation|0
7461837|NCT01843062|11758285|FG000|Overall Study|New treatment following progression|2
7461838|NCT01843062|11758286|FG001|Overall Study|New treatment following progression|0
7461839|NCT01843062|11758285|FG000|Overall Study|Pregnancy|1
7461840|NCT01843062|11758286|FG001|Overall Study|Pregnancy|0
7461841|NCT01843062|11758285|FG000|Overall Study|Adverse Event|2
7461842|NCT01843062|11758286|FG001|Overall Study|Adverse Event|0
7461843|NCT01843062|11758285|FG000|Overall Study|Incorrect randomisation|1
7461844|NCT01843062|11758286|FG001|Overall Study|Incorrect randomisation|0
7461845|NCT01843062|11758285|FG000|Overall Study|Withdrawal by Subject|12
7461846|NCT01843062|11758286|FG001|Overall Study|Withdrawal by Subject|3
7461847|NCT01843062|11758285|FG000|Overall Study|Death|1
7461848|NCT01843062|11758286|FG001|Overall Study|Death|2
7461849|NCT01843062|11758285|FG000|Overall Study|Lost to Follow-up|2
7461850|NCT01843062|11758286|FG001|Overall Study|Lost to Follow-up|4
7461851|NCT01843192|11758295|FG000|Overall Study|Intra-operative exclusions per protocol|2
7377040|NCT01137604|11630822|FG000|Overall Study|Adverse Event|1
7377041|NCT01137604|11630823|FG001|Overall Study|Adverse Event|6
7377042|NCT01137604|11630824|FG002|Overall Study|Adverse Event|9
7377043|NCT01137604|11630825|FG003|Overall Study|Adverse Event|9
7377044|NCT01137604|11630822|FG000|Overall Study|Withdrawal by Subject|0
7377045|NCT01137604|11630823|FG001|Overall Study|Withdrawal by Subject|2
7377046|NCT01137604|11630824|FG002|Overall Study|Withdrawal by Subject|2
7377047|NCT01137604|11630825|FG003|Overall Study|Withdrawal by Subject|1
7377048|NCT01137604|11630822|FG000|Overall Study|Clinical Progression|0
7377049|NCT01137604|11630823|FG001|Overall Study|Clinical Progression|2
7377050|NCT01137604|11630824|FG002|Overall Study|Clinical Progression|1
7377051|NCT01137604|11630825|FG003|Overall Study|Clinical Progression|0
7377052|NCT01137604|11630822|FG000|Overall Study|Participant's Decision|1
7377053|NCT01137604|11630823|FG001|Overall Study|Participant's Decision|0
7377054|NCT01137604|11630824|FG002|Overall Study|Participant's Decision|0
7377055|NCT01137604|11630825|FG003|Overall Study|Participant's Decision|0
7377056|NCT01137604|11630822|FG000|Overall Study|Clinical Decline|0
7377057|NCT01137604|11630823|FG001|Overall Study|Clinical Decline|0
7377058|NCT01137604|11630824|FG002|Overall Study|Clinical Decline|1
7377059|NCT01137604|11630825|FG003|Overall Study|Clinical Decline|1
7377060|NCT01137682|11630838|FG000|Overall Study|Adverse Event-CORE|2
7377061|NCT01137682|11630839|FG001|Overall Study|Adverse Event-CORE|4
7377062|NCT01137682|11630840|FG002|Overall Study|Adverse Event-CORE|0
7377063|NCT01137682|11630838|FG000|Overall Study|Withdrawal by Subject-CORE|2
7377064|NCT01137682|11630839|FG001|Overall Study|Withdrawal by Subject-CORE|2
7377065|NCT01137682|11630840|FG002|Overall Study|Withdrawal by Subject-CORE|2
7377066|NCT01137682|11630838|FG000|Overall Study|Administrative problems-CORE|2
7377067|NCT01137682|11630839|FG001|Overall Study|Administrative problems-CORE|1
7377068|NCT01137682|11630840|FG002|Overall Study|Administrative problems-CORE|0
7377069|NCT01137682|11630838|FG000|Overall Study|Protocol Violation-CORE|0
7377070|NCT01137682|11630839|FG001|Overall Study|Protocol Violation-CORE|1
7377071|NCT01137682|11630840|FG002|Overall Study|Protocol Violation-CORE|1
7377072|NCT01137682|11630838|FG000|Overall Study|Adverse Event-Extension|4
7377073|NCT01137682|11630839|FG001|Overall Study|Adverse Event-Extension|8
7377074|NCT01137682|11630840|FG002|Overall Study|Adverse Event-Extension|7
7377075|NCT01137682|11630838|FG000|Overall Study|Lack of Efficacy-Extension|15
7377076|NCT01137682|11630839|FG001|Overall Study|Lack of Efficacy-Extension|9
7377077|NCT01137682|11630840|FG002|Overall Study|Lack of Efficacy-Extension|13
7377078|NCT01137682|11630838|FG000|Overall Study|Withdrawal by Subject-Extension|6
7377079|NCT01137682|11630839|FG001|Overall Study|Withdrawal by Subject-Extension|8
7570639|NCT03499353|11948658|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55
7570640|NCT03499353|11948658|FG000|Long-Term Follow-up|Withdrawal by Subject|1
7570641|NCT03499873|11948665|FG000|Overall Study|Withdrawal by Subject|4
7570642|NCT03499873|11948666|FG001|Overall Study|Withdrawal by Subject|6
7570643|NCT03499873|11948667|FG002|Overall Study|Withdrawal by Subject|1
7570644|NCT03499873|11948665|FG000|Overall Study|Subjects condition worsened|0
7377080|NCT01137682|11630840|FG002|Overall Study|Withdrawal by Subject-Extension|8
7377081|NCT01137682|11630838|FG000|Overall Study|Lost to Follow Up-Extension|0
7377082|NCT01137682|11630839|FG001|Overall Study|Lost to Follow Up-Extension|1
7377083|NCT01137682|11630840|FG002|Overall Study|Lost to Follow Up-Extension|0
7377084|NCT01137682|11630838|FG000|Overall Study|Administrative problems-Extension|0
7377085|NCT01137682|11630839|FG001|Overall Study|Administrative problems-Extension|2
7377086|NCT01137682|11630840|FG002|Overall Study|Administrative problems-Extension|0
7377087|NCT01137682|11630838|FG000|Overall Study|Death-Extension|2
7377088|NCT01137682|11630839|FG001|Overall Study|Death-Extension|0
7377089|NCT01137682|11630840|FG002|Overall Study|Death-Extension|0
7377090|NCT01137682|11630838|FG000|Overall Study|Protocol Violation-Extension|2
7377091|NCT01137682|11630839|FG001|Overall Study|Protocol Violation-Extension|1
7377092|NCT01137682|11630840|FG002|Overall Study|Protocol Violation-Extension|0
7377093|NCT01137682|11630838|FG000|Overall Study|Did not enter extension|2
7377094|NCT01137682|11630839|FG001|Overall Study|Did not enter extension|3
7377095|NCT01137682|11630840|FG002|Overall Study|Did not enter extension|2
7377096|NCT01137682|11630838|FG000|Overall Study|Did not receive treatment in extension|0
7377097|NCT01137682|11630839|FG001|Overall Study|Did not receive treatment in extension|0
7377098|NCT01137682|11630840|FG002|Overall Study|Did not receive treatment in extension|1
7377099|NCT01137786|11630854|FG000|Overall Study|Lost to Follow-up|0
7377100|NCT01137786|11630855|FG001|Overall Study|Lost to Follow-up|2
7377101|NCT01137786|11630854|FG000|Overall Study|Withdrawal by Subject|1
7570645|NCT03499873|11948666|FG001|Overall Study|Subjects condition worsened|3
7570646|NCT03499873|11948667|FG002|Overall Study|Subjects condition worsened|11
7570647|NCT03499873|11948665|FG000|Overall Study|Adverse Event|8
7570648|NCT03499873|11948666|FG001|Overall Study|Adverse Event|3
7570649|NCT03499873|11948667|FG002|Overall Study|Adverse Event|6
7377102|NCT01137786|11630855|FG001|Overall Study|Withdrawal by Subject|1
7570650|NCT03499873|11948665|FG000|Overall Study|Physician Decision|1
7377103|NCT01137812|11630865|FG000|Overall Study|Adverse Event|21
7377104|NCT01137812|11630866|FG001|Overall Study|Adverse Event|14
7377105|NCT01137812|11630865|FG000|Overall Study|Lost to Follow-up|6
7570651|NCT03499873|11948666|FG001|Overall Study|Physician Decision|0
7377106|NCT01137812|11630866|FG001|Overall Study|Lost to Follow-up|8
7570652|NCT03499873|11948667|FG002|Overall Study|Physician Decision|0
7377107|NCT01137812|11630865|FG000|Overall Study|Physician Decision|25
7377108|NCT01137812|11630866|FG001|Overall Study|Physician Decision|17
7377109|NCT01137812|11630865|FG000|Overall Study|Protocol Violation|5
7377110|NCT01137812|11630866|FG001|Overall Study|Protocol Violation|4
7377111|NCT01137812|11630865|FG000|Overall Study|Withdrawal by Subject|5
7377112|NCT01137812|11630866|FG001|Overall Study|Withdrawal by Subject|13
7377113|NCT01137812|11630865|FG000|Overall Study|Death|2
7377114|NCT01137812|11630866|FG001|Overall Study|Death|0
7377115|NCT01137812|11630865|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
7377116|NCT01137812|11630866|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
7377117|NCT01137812|11630865|FG000|Overall Study|Other|19
7377118|NCT01137812|11630866|FG001|Overall Study|Other|27
7377119|NCT01138007|11630930|FG000|Overall Study|Adverse Event|4
7377120|NCT01138007|11630931|FG001|Overall Study|Adverse Event|12
7377121|NCT01138007|11630932|FG002|Overall Study|Adverse Event|9
7377122|NCT01138007|11630930|FG000|Overall Study|Lack of Efficacy|2
7377123|NCT01138007|11630931|FG001|Overall Study|Lack of Efficacy|0
7377124|NCT01138007|11630932|FG002|Overall Study|Lack of Efficacy|6
7377125|NCT01138007|11630930|FG000|Overall Study|Protocol Violation|2
7377126|NCT01138007|11630931|FG001|Overall Study|Protocol Violation|3
7377127|NCT01138007|11630932|FG002|Overall Study|Protocol Violation|2
7377128|NCT01138007|11630930|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
7377129|NCT01138007|11630931|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
7377130|NCT01138007|11630932|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
7377131|NCT01138007|11630930|FG000|Overall Study|Lost to Follow-up|3
7377132|NCT01138007|11630931|FG001|Overall Study|Lost to Follow-up|3
7377133|NCT01138007|11630932|FG002|Overall Study|Lost to Follow-up|5
7377134|NCT01138007|11630930|FG000|Overall Study|Physician Decision|0
7377135|NCT01138007|11630931|FG001|Overall Study|Physician Decision|5
7377136|NCT01138007|11630932|FG002|Overall Study|Physician Decision|3
7377137|NCT01138007|11630930|FG000|Overall Study|Withdrawal by Subject|5
7377138|NCT01138007|11630931|FG001|Overall Study|Withdrawal by Subject|6
7377139|NCT01138007|11630932|FG002|Overall Study|Withdrawal by Subject|15
7377140|NCT01138046|11630942|FG000|Overall Study|Withdrawal due to death|6
7377141|NCT01138111|11630955|FG000|Overall Study|Withdrawal by Subject|5
7377142|NCT01138111|11630955|FG000|Overall Study|Adverse Event|1
7377143|NCT01138111|11630955|FG000|Overall Study|Death|1
7377144|NCT01138111|11630955|FG000|Overall Study|Lost to Follow-up|2
7377145|NCT01138150|11631001|FG000|Overall Study|blood unable to be processed|0
7377146|NCT01138150|11631002|FG001|Overall Study|blood unable to be processed|1
7377147|NCT01138150|11631001|FG000|Overall Study|Physician Decision|1
7377148|NCT01138150|11631002|FG001|Overall Study|Physician Decision|0
7377149|NCT01138501|11631037|FG000|Overall Study|Protocol Violation|2
7377150|NCT01138501|11631037|FG000|Overall Study|Withdrawal by Subject|3
7377151|NCT01138657|11631057|FG000|Overall Study|Adverse Event|3
7377152|NCT01138657|11631058|FG001|Overall Study|Adverse Event|10
7377153|NCT01138657|11631057|FG000|Overall Study|Lack of Efficacy|2
7377154|NCT01138657|11631058|FG001|Overall Study|Lack of Efficacy|1
7377155|NCT01138657|11631057|FG000|Overall Study|Lost to Follow-up|0
7377156|NCT01138657|11631058|FG001|Overall Study|Lost to Follow-up|3
7377157|NCT01138657|11631057|FG000|Overall Study|Miscellaneous Reasons|3
7377158|NCT01138657|11631058|FG001|Overall Study|Miscellaneous Reasons|4
7377159|NCT01138826|11631075|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
7377160|NCT01138826|11631076|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
7377161|NCT01138826|11631077|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
7377162|NCT01138826|11631078|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
7377163|NCT01138826|11631079|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
7377164|NCT01138826|11631080|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
7387162|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
7387163|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387164|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387165|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387166|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387167|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387168|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7387169|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387170|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7387171|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7387172|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387173|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387174|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387175|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387176|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7387177|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7387178|NCT01212770|11645401|FG000|Long-term Safety Phase (Year 5)|Death|0
7387179|NCT01212770|11645402|FG001|Long-term Safety Phase (Year 5)|Death|0
7387180|NCT01212770|11645403|FG002|Long-term Safety Phase (Year 5)|Death|0
7387181|NCT01212770|11645404|FG003|Long-term Safety Phase (Year 5)|Death|0
7387182|NCT01212770|11645405|FG004|Long-term Safety Phase (Year 5)|Death|0
7377167|NCT01139021|11631128|FG000|Overall Study|Adverse Event|0
7377168|NCT01139021|11631129|FG001|Overall Study|Adverse Event|0
7377169|NCT01139021|11631130|FG002|Overall Study|Adverse Event|0
7377170|NCT01139021|11631131|FG003|Overall Study|Adverse Event|0
7377171|NCT01139021|11631132|FG004|Overall Study|Adverse Event|1
7377172|NCT01139021|11631133|FG005|Overall Study|Adverse Event|0
7377173|NCT01139021|11631128|FG000|Overall Study|Lost to Follow-up|0
7377174|NCT01139021|11631129|FG001|Overall Study|Lost to Follow-up|0
7377175|NCT01139021|11631130|FG002|Overall Study|Lost to Follow-up|0
7377176|NCT01139021|11631131|FG003|Overall Study|Lost to Follow-up|0
7377177|NCT01139021|11631132|FG004|Overall Study|Lost to Follow-up|2
7377178|NCT01139021|11631133|FG005|Overall Study|Lost to Follow-up|0
7377179|NCT01139021|11631128|FG000|Overall Study|Protocol Violation|1
7377180|NCT01139021|11631129|FG001|Overall Study|Protocol Violation|0
7377181|NCT01139021|11631130|FG002|Overall Study|Protocol Violation|0
7377182|NCT01139021|11631131|FG003|Overall Study|Protocol Violation|0
7377183|NCT01139021|11631132|FG004|Overall Study|Protocol Violation|2
7377184|NCT01139021|11631133|FG005|Overall Study|Protocol Violation|0
7377185|NCT01139021|11631128|FG000|Overall Study|Withdrawal by Subject|0
7377186|NCT01139021|11631129|FG001|Overall Study|Withdrawal by Subject|0
7377187|NCT01139021|11631130|FG002|Overall Study|Withdrawal by Subject|0
7377188|NCT01139021|11631131|FG003|Overall Study|Withdrawal by Subject|1
7377189|NCT01139021|11631132|FG004|Overall Study|Withdrawal by Subject|4
7377190|NCT01139021|11631133|FG005|Overall Study|Withdrawal by Subject|0
7377192|NCT01139164|11631158|FG000|Overall Study|Withdrawn prior to study start|0
7377193|NCT01139164|11631159|FG001|Overall Study|Withdrawn prior to study start|2
7377194|NCT01139164|11631160|FG002|Overall Study|Withdrawn prior to study start|0
7377195|NCT01139450|11631191|FG000|Overall Study|Withdrawal by Subject|7
7377196|NCT01139450|11631192|FG001|Overall Study|Withdrawal by Subject|10
7377197|NCT01139450|11631193|FG002|Overall Study|Withdrawal by Subject|13
7377198|NCT01139450|11631191|FG000|Overall Study|Lack of Efficacy|3
7377199|NCT01139450|11631192|FG001|Overall Study|Lack of Efficacy|1
7377200|NCT01139450|11631193|FG002|Overall Study|Lack of Efficacy|8
7377201|NCT01139450|11631191|FG000|Overall Study|Protocol Violation|6
7377202|NCT01139450|11631192|FG001|Overall Study|Protocol Violation|5
7377203|NCT01139450|11631193|FG002|Overall Study|Protocol Violation|2
7377204|NCT01139450|11631191|FG000|Overall Study|Lost to Follow-up|9
7377205|NCT01139450|11631192|FG001|Overall Study|Lost to Follow-up|7
7377206|NCT01139450|11631193|FG002|Overall Study|Lost to Follow-up|11
7377207|NCT01139450|11631191|FG000|Overall Study|Administrative|0
7377208|NCT01139450|11631192|FG001|Overall Study|Administrative|0
7377209|NCT01139450|11631193|FG002|Overall Study|Administrative|1
7377210|NCT01139450|11631191|FG000|Overall Study|Adverse Event|2
7377211|NCT01139450|11631192|FG001|Overall Study|Adverse Event|2
7377212|NCT01139450|11631193|FG002|Overall Study|Adverse Event|3
7377213|NCT01139580|11631216|FG000|Overall Study|Adverse Event|5
7377214|NCT01139580|11631217|FG001|Overall Study|Adverse Event|4
7377215|NCT01139580|11631216|FG000|Overall Study|Lost to Follow-up|9
7377216|NCT01139580|11631217|FG001|Overall Study|Lost to Follow-up|1
7377217|NCT01139580|11631216|FG000|Overall Study|Lack of Efficacy|0
7377218|NCT01139580|11631217|FG001|Overall Study|Lack of Efficacy|2
7377219|NCT01139580|11631216|FG000|Overall Study|Withdrawal by Subject|6
7377220|NCT01139580|11631217|FG001|Overall Study|Withdrawal by Subject|9
7377221|NCT01139580|11631216|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
7377222|NCT01139580|11631217|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
7377223|NCT01139580|11631216|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
7377224|NCT01139580|11631217|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
7377225|NCT01139580|11631216|FG000|Overall Study|Misrandomized|1
7377226|NCT01139580|11631217|FG001|Overall Study|Misrandomized|0
7377227|NCT01139580|11631216|FG000|Overall Study|Beginning Study Exclusion Treatment|0
7377228|NCT01139580|11631217|FG001|Overall Study|Beginning Study Exclusion Treatment|1
7377229|NCT01139580|11631216|FG000|Overall Study|Participant Randomization in Error|0
7377230|NCT01139580|11631217|FG001|Overall Study|Participant Randomization in Error|1
7377231|NCT01139658|11631225|FG000|Overall Study|Adverse Event|10
7377232|NCT01139658|11631226|FG001|Overall Study|Adverse Event|27
7377233|NCT01139658|11631225|FG000|Overall Study|Lack of Efficacy|15
7377234|NCT01139658|11631226|FG001|Overall Study|Lack of Efficacy|7
7377235|NCT01139658|11631225|FG000|Overall Study|Withdrawal by Subject|2
7377236|NCT01139658|11631226|FG001|Overall Study|Withdrawal by Subject|4
7377237|NCT01139658|11631225|FG000|Overall Study|No documentation of treatment|1
7377238|NCT01139658|11631226|FG001|Overall Study|No documentation of treatment|0
7377239|NCT01139658|11631225|FG000|Overall Study|Other|28
7377240|NCT01139658|11631226|FG001|Overall Study|Other|75
7377241|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
7377242|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7377243|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
7377244|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
7377245|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
7377246|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
7377247|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
7377248|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7377249|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
7377250|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
7377251|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
7377252|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
7377253|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
7377254|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
7377255|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
7377256|NCT01139762|11631234|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
7377257|NCT01139762|11631235|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7377258|NCT01139762|11631236|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
7377259|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
7377260|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
7377261|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
7377262|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Death|0
7377263|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Death|1
7377264|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Death|1
7570653|NCT03499873|11948665|FG000|Overall Study|Administrative reasons|0
7570654|NCT03499873|11948666|FG001|Overall Study|Administrative reasons|1
7570655|NCT03499873|11948667|FG002|Overall Study|Administrative reasons|0
7570656|NCT03499873|11948665|FG000|Overall Study|Concomitant therapy|5
7570657|NCT03499873|11948666|FG001|Overall Study|Concomitant therapy|4
7570658|NCT03499873|11948667|FG002|Overall Study|Concomitant therapy|7
7570659|NCT03499873|11948665|FG000|Overall Study|Miscellaneous|1
7570660|NCT03499873|11948666|FG001|Overall Study|Miscellaneous|2
7570661|NCT03499873|11948667|FG002|Overall Study|Miscellaneous|2
7570662|NCT03499873|11948665|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
7570663|NCT03499873|11948666|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
7570664|NCT03499873|11948667|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
7570665|NCT03500094|11948675|FG000|Overall Study|Withdrawal by Subject|1
7570666|NCT03500094|11948675|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
7570667|NCT03500094|11948675|FG000|Overall Study|Lost to Follow-up|1
7570668|NCT03500198|11948683|FG000|Overall Study|Lost to Follow-up|0
7570669|NCT03500198|11948684|FG001|Overall Study|Lost to Follow-up|1
7570670|NCT03500211|11948694|FG000|Overall Study|Withdrawal by Subject|1
7570671|NCT03500211|11948695|FG001|Overall Study|Withdrawal by Subject|1
7570672|NCT03500224|11948701|FG000|Overall Study|Withdrawal by Subject|2
7377265|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
7377266|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
7377267|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
7377268|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
7377269|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
7377270|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
7377271|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
7377272|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
7377273|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
7377274|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
7377275|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
7377276|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
7377277|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
7377278|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
7377279|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
7377280|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
7377281|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
7377282|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
7377283|NCT01139762|11631234|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
7377284|NCT01139762|11631235|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
7377285|NCT01139762|11631236|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
7377286|NCT01139775|11631246|FG000|Overall Study|Adverse Event|0
7377287|NCT01139775|11631247|FG001|Overall Study|Adverse Event|6
7377288|NCT01139775|11631248|FG002|Overall Study|Adverse Event|2
7377289|NCT01139775|11631246|FG000|Overall Study|Protocol Violation|0
7377290|NCT01139775|11631247|FG001|Overall Study|Protocol Violation|5
7377291|NCT01139775|11631248|FG002|Overall Study|Protocol Violation|0
7377292|NCT01139775|11631246|FG000|Overall Study|Withdrawal by Subject|1
7377293|NCT01139775|11631247|FG001|Overall Study|Withdrawal by Subject|0
7377294|NCT01139775|11631248|FG002|Overall Study|Withdrawal by Subject|2
7377295|NCT01139775|11631246|FG000|Overall Study|Physician Decision|0
7377296|NCT01139775|11631247|FG001|Overall Study|Physician Decision|2
7377297|NCT01139775|11631248|FG002|Overall Study|Physician Decision|2
7377298|NCT01140061|11631288|FG000|Part I|Adverse Event|1
7377299|NCT01140061|11631289|FG001|Part I|Adverse Event|0
7377300|NCT01140061|11631290|FG002|Part I|Adverse Event|0
7377301|NCT01140061|11631291|FG003|Part I|Adverse Event|0
7377302|NCT01140061|11631292|FG004|Part I|Adverse Event|0
7377303|NCT01140061|11631293|FG005|Part I|Adverse Event|0
7377304|NCT01140061|11631294|FG006|Part I|Adverse Event|0
7377305|NCT01140061|11631295|FG007|Part I|Adverse Event|0
7377306|NCT01140061|11631296|FG008|Part I|Adverse Event|0
7377307|NCT01140061|11631297|FG009|Part I|Adverse Event|0
7377308|NCT01140061|11631288|FG000|Extension|Laboratory Adverse Event|0
7377309|NCT01140061|11631289|FG001|Extension|Laboratory Adverse Event|0
7377310|NCT01140061|11631290|FG002|Extension|Laboratory Adverse Event|0
7377311|NCT01140061|11631291|FG003|Extension|Laboratory Adverse Event|0
7377312|NCT01140061|11631292|FG004|Extension|Laboratory Adverse Event|0
7377313|NCT01140061|11631293|FG005|Extension|Laboratory Adverse Event|0
7377314|NCT01140061|11631294|FG006|Extension|Laboratory Adverse Event|0
7377315|NCT01140061|11631295|FG007|Extension|Laboratory Adverse Event|0
7377316|NCT01140061|11631296|FG008|Extension|Laboratory Adverse Event|0
7377317|NCT01140061|11631297|FG009|Extension|Laboratory Adverse Event|1
7377318|NCT01140347|11631329|FG000|Overall Study|Lost to Follow-up|5
7377319|NCT01140347|11631330|FG001|Overall Study|Lost to Follow-up|6
7377320|NCT01140347|11631329|FG000|Overall Study|Withdrawal by Subject|13
7377321|NCT01140347|11631330|FG001|Overall Study|Withdrawal by Subject|8
7377322|NCT01140477|11631342|FG000|Overall Study|Lost to Follow-up|4
7377323|NCT01140477|11631343|FG001|Overall Study|Lost to Follow-up|0
7377324|NCT01140477|11631342|FG000|Overall Study|Withdrawal by Subject|1
7377325|NCT01140477|11631343|FG001|Overall Study|Withdrawal by Subject|4
7377326|NCT01140477|11631342|FG000|Overall Study|Surgical complication preventing implant|2
7377327|NCT01140477|11631343|FG001|Overall Study|Surgical complication preventing implant|0
7377328|NCT01140477|11631342|FG000|Overall Study|Death|1
7377329|NCT01140477|11631343|FG001|Overall Study|Death|1
7461852|NCT01843192|11758296|FG001|Overall Study|Intra-operative exclusions per protocol|6
7461853|NCT01843192|11758297|FG002|Overall Study|Intra-operative exclusions per protocol|2
7461854|NCT01843205|11758305|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
7461855|NCT01843205|11758306|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
7461856|NCT01843348|11758315|FG000|Overall Study|Withdrawal by Subject|4
7461857|NCT01843348|11758316|FG001|Overall Study|Withdrawal by Subject|16
7461858|NCT01843348|11758317|FG002|Overall Study|Withdrawal by Subject|18
7461859|NCT01843348|11758315|FG000|Overall Study|Lost to Follow-up|5
7461860|NCT01843348|11758316|FG001|Overall Study|Lost to Follow-up|4
7461861|NCT01843348|11758317|FG002|Overall Study|Lost to Follow-up|2
7461862|NCT01843348|11758315|FG000|Overall Study|Death|5
7461863|NCT01843348|11758316|FG001|Overall Study|Death|3
7461864|NCT01843348|11758317|FG002|Overall Study|Death|4
7461865|NCT01843348|11758315|FG000|Overall Study|Graft loss/retransplantation|5
7461866|NCT01843348|11758316|FG001|Overall Study|Graft loss/retransplantation|8
7461867|NCT01843348|11758317|FG002|Overall Study|Graft loss/retransplantation|11
7461868|NCT01843348|11758315|FG000|Overall Study|Various reasons|4
7461869|NCT01843348|11758316|FG001|Overall Study|Various reasons|9
7461870|NCT01843348|11758317|FG002|Overall Study|Various reasons|6
7461871|NCT01843660|11758343|FG000|Overall Study|Other|30
7461872|NCT01843673|11758347|FG000|Overall Study|Lack of Efficacy|2
7461873|NCT01843673|11758347|FG000|Overall Study|Withdrawal by Subject|4
7461874|NCT01843777|11758364|FG000|Overall Study|Withdrawal by Subject|1
7461875|NCT01843777|11758365|FG001|Overall Study|Withdrawal by Subject|0
7461876|NCT01843803|11758373|FG000|Overall Study|not a Veteran, did not see provider|1
7461877|NCT01843803|11758374|FG001|Overall Study|not a Veteran, did not see provider|3
7461878|NCT01843842|11758382|FG000|Overall Study|Do not meet inclusion criteria|1
7461879|NCT01843842|11758383|FG001|Overall Study|Do not meet inclusion criteria|1
7461880|NCT01843933|11758400|FG000|Overall Study|Data lost|6
7461881|NCT01843933|11758401|FG001|Overall Study|Data lost|4
7461882|NCT01843972|11758417|FG000|Overall Study|Withdrawal by Subject|0
7461883|NCT01843972|11758418|FG001|Overall Study|Withdrawal by Subject|0
7461884|NCT01843972|11758419|FG002|Overall Study|Withdrawal by Subject|0
7461885|NCT01843972|11758420|FG003|Overall Study|Withdrawal by Subject|0
7461886|NCT01843972|11758421|FG004|Overall Study|Withdrawal by Subject|1
7461887|NCT01843972|11758422|FG005|Overall Study|Withdrawal by Subject|0
7461888|NCT01843972|11758423|FG006|Overall Study|Withdrawal by Subject|0
7461889|NCT01843972|11758424|FG007|Overall Study|Withdrawal by Subject|0
7461890|NCT01843972|11758425|FG008|Overall Study|Withdrawal by Subject|0
7461891|NCT01843972|11758426|FG009|Overall Study|Withdrawal by Subject|0
7461892|NCT01844076|11758466|FG000|Overall Study|Adverse Event|1
7461893|NCT01844076|11758467|FG001|Overall Study|Adverse Event|0
7461894|NCT01844076|11758468|FG002|Overall Study|Adverse Event|0
7377330|NCT01140477|11631342|FG000|Overall Study|Subject explanted|0
7377331|NCT01140477|11631343|FG001|Overall Study|Subject explanted|1
7377332|NCT01140503|11631349|FG000|Overall Study|Withdrawal by Subject|1
7377333|NCT01140568|11631353|FG000|Overall Study|disease progression|31
7377334|NCT01140568|11631353|FG000|Overall Study|Withdrawal by Subject|1
7377335|NCT01140568|11631353|FG000|Overall Study|Screen Fail|4
7461895|NCT01844076|11758469|FG003|Overall Study|Adverse Event|0
7377336|NCT01140646|11631357|FG000|Overall Study|Adverse Event|4
7377337|NCT01140646|11631357|FG000|Overall Study|Refused Further Treatment|5
7377338|NCT01140880|11631374|FG000|Overall Study|Death|0
7377339|NCT01140880|11631375|FG001|Overall Study|Death|1
7377340|NCT01140880|11631374|FG000|Overall Study|Withdrawal by Subject|6
7377341|NCT01140880|11631375|FG001|Overall Study|Withdrawal by Subject|3
7377342|NCT01140880|11631374|FG000|Overall Study|Lost to Follow-up|8
7377343|NCT01140880|11631375|FG001|Overall Study|Lost to Follow-up|10
7377344|NCT01140880|11631374|FG000|Overall Study|Protocol Violation|0
7377345|NCT01140880|11631375|FG001|Overall Study|Protocol Violation|30
7377346|NCT01140906|11631385|FG000|Overall Study|Adverse Event|7
7377347|NCT01140906|11631386|FG001|Overall Study|Adverse Event|10
7377348|NCT01140906|11631387|FG002|Overall Study|Adverse Event|17
7377349|NCT01140906|11631388|FG003|Overall Study|Adverse Event|7
7377350|NCT01140906|11631385|FG000|Overall Study|Lack of Efficacy|6
7377351|NCT01140906|11631386|FG001|Overall Study|Lack of Efficacy|8
7377352|NCT01140906|11631387|FG002|Overall Study|Lack of Efficacy|2
7377353|NCT01140906|11631388|FG003|Overall Study|Lack of Efficacy|1
7377354|NCT01140906|11631385|FG000|Overall Study|Non-compliance|0
7377355|NCT01140906|11631386|FG001|Overall Study|Non-compliance|1
7377356|NCT01140906|11631387|FG002|Overall Study|Non-compliance|0
7377357|NCT01140906|11631388|FG003|Overall Study|Non-compliance|1
7377358|NCT01140906|11631385|FG000|Overall Study|Protocol Violation|5
7377359|NCT01140906|11631386|FG001|Overall Study|Protocol Violation|3
7377360|NCT01140906|11631387|FG002|Overall Study|Protocol Violation|2
7377361|NCT01140906|11631388|FG003|Overall Study|Protocol Violation|1
7377362|NCT01140906|11631385|FG000|Overall Study|Withdrawal of consent|6
7377363|NCT01140906|11631386|FG001|Overall Study|Withdrawal of consent|6
7377364|NCT01140906|11631387|FG002|Overall Study|Withdrawal of consent|2
7377365|NCT01140906|11631388|FG003|Overall Study|Withdrawal of consent|2
7377366|NCT01140906|11631385|FG000|Overall Study|Lost to Follow-up|1
7377367|NCT01140906|11631386|FG001|Overall Study|Lost to Follow-up|1
7377368|NCT01140906|11631387|FG002|Overall Study|Lost to Follow-up|0
7377369|NCT01140906|11631388|FG003|Overall Study|Lost to Follow-up|2
7377370|NCT01140906|11631385|FG000|Overall Study|Administrative or other reason|0
7377371|NCT01140906|11631386|FG001|Overall Study|Administrative or other reason|5
7377372|NCT01140906|11631387|FG002|Overall Study|Administrative or other reason|3
7377373|NCT01140906|11631388|FG003|Overall Study|Administrative or other reason|2
7377374|NCT01141205|11631413|FG000|Overall Study|Physician Decision|1
7377375|NCT01141205|11631414|FG001|Overall Study|Physician Decision|1
7377376|NCT01141205|11631413|FG000|Overall Study|Lost to Follow-up|1
7377377|NCT01141205|11631414|FG001|Overall Study|Lost to Follow-up|0
7377378|NCT01141205|11631413|FG000|Overall Study|Withdrawal by Subject|1
7377379|NCT01141205|11631414|FG001|Overall Study|Withdrawal by Subject|1
7377380|NCT01141283|11631424|FG000|Overall Study|Adverse Event|56
7377381|NCT01141283|11631424|FG000|Overall Study|Lost to Follow-up|4
7377382|NCT01141283|11631424|FG000|Overall Study|Withdrawal by Subject|14
7377383|NCT01141283|11631424|FG000|Overall Study|Administrative|4
7377384|NCT01141283|11631424|FG000|Overall Study|Lack of Efficacy|10
7377385|NCT01141478|11631445|FG000|Overall Study|Withdrawal by Subject|1
7377386|NCT01141478|11631446|FG001|Overall Study|Withdrawal by Subject|1
7377387|NCT01141660|11631489|FG000|Overall Study|Physician Decision|0
7377388|NCT01141660|11631490|FG001|Overall Study|Physician Decision|12
7377389|NCT01142089|11631516|FG000|Overall Study|Physician Decision|1
7377390|NCT01142089|11631517|FG001|Overall Study|Physician Decision|0
7377391|NCT01142089|11631516|FG000|Overall Study|Withdrawal by Subject|1
7377392|NCT01142089|11631517|FG001|Overall Study|Withdrawal by Subject|2
7377393|NCT01142089|11631516|FG000|Overall Study|Use of prohibited medications|0
7377394|NCT01142089|11631517|FG001|Overall Study|Use of prohibited medications|1
7377395|NCT01142089|11631516|FG000|Overall Study|Noncompliance with study procedures|2
7377396|NCT01142089|11631517|FG001|Overall Study|Noncompliance with study procedures|1
7377397|NCT01142089|11631516|FG000|Overall Study|Patient required rescue medication|8
7377398|NCT01142089|11631517|FG001|Overall Study|Patient required rescue medication|17
7377399|NCT01142115|11631523|FG000|First Intervention|Lack of Efficacy|1
7377400|NCT01142115|11631524|FG001|First Intervention|Lack of Efficacy|1
7377401|NCT01142115|11631523|FG000|First Intervention|Adverse Event|1
7377402|NCT01142115|11631524|FG001|First Intervention|Adverse Event|0
7377403|NCT01142193|11631531|FG000|Overall Study|Adverse Event|12
7377404|NCT01142193|11631532|FG001|Overall Study|Adverse Event|4
7377405|NCT01142193|11631531|FG000|Overall Study|Lack of Efficacy|2
7377406|NCT01142193|11631532|FG001|Overall Study|Lack of Efficacy|1
7570673|NCT03500419|11948720|FG000|Overall Study|Withdrawal by Subject|2
7570674|NCT03500419|11948721|FG001|Overall Study|Withdrawal by Subject|25
7570675|NCT03500679|11948729|FG000|Overall Study|Lost to Follow-up|6
7570676|NCT03500679|11948730|FG001|Overall Study|Lost to Follow-up|3
7570677|NCT03500679|11948729|FG000|Overall Study|Withdrawal by Subject|3
7570678|NCT03500679|11948730|FG001|Overall Study|Withdrawal by Subject|0
7570679|NCT03501277|11948809|FG000|Intervention Period 1 (4 Days)|Other|0
7377407|NCT01142193|11631531|FG000|Overall Study|Physician Decision|1
7377408|NCT01142193|11631532|FG001|Overall Study|Physician Decision|1
7377409|NCT01142193|11631531|FG000|Overall Study|Withdrawal by Subject|4
7377410|NCT01142193|11631532|FG001|Overall Study|Withdrawal by Subject|3
7377411|NCT01142193|11631531|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
7377412|NCT01142193|11631532|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
7570680|NCT03501277|11948810|FG001|Intervention Period 1 (4 Days)|Other|0
7570681|NCT03501277|11948811|FG002|Intervention Period 1 (4 Days)|Other|1
7570682|NCT03501277|11948812|FG003|Intervention Period 1 (4 Days)|Other|0
7377413|NCT01142193|11631531|FG000|Overall Study|Other|1
7377414|NCT01142193|11631532|FG001|Overall Study|Other|2
7377415|NCT01142232|11631543|FG000|Overall Study|Adverse Event|1
7377416|NCT01142232|11631544|FG001|Overall Study|Adverse Event|2
7377417|NCT01142232|11631545|FG002|Overall Study|Adverse Event|1
7377418|NCT01142232|11631546|FG003|Overall Study|Adverse Event|0
7377419|NCT01142232|11631547|FG004|Overall Study|Adverse Event|4
7377420|NCT01142232|11631543|FG000|Overall Study|Death|0
7377421|NCT01142232|11631544|FG001|Overall Study|Death|0
7377422|NCT01142232|11631545|FG002|Overall Study|Death|0
7377423|NCT01142232|11631546|FG003|Overall Study|Death|0
7377424|NCT01142232|11631547|FG004|Overall Study|Death|1
7377425|NCT01142232|11631543|FG000|Overall Study|Disease Progression|2
7377426|NCT01142232|11631544|FG001|Overall Study|Disease Progression|0
7377427|NCT01142232|11631545|FG002|Overall Study|Disease Progression|1
7377428|NCT01142232|11631546|FG003|Overall Study|Disease Progression|2
7377429|NCT01142232|11631547|FG004|Overall Study|Disease Progression|12
7377430|NCT01142232|11631543|FG000|Overall Study|Withdrawal by Subject|0
7377431|NCT01142232|11631544|FG001|Overall Study|Withdrawal by Subject|0
7377432|NCT01142232|11631545|FG002|Overall Study|Withdrawal by Subject|0
7377433|NCT01142232|11631546|FG003|Overall Study|Withdrawal by Subject|1
7377434|NCT01142232|11631547|FG004|Overall Study|Withdrawal by Subject|3
7377435|NCT01142232|11631543|FG000|Overall Study|Physician Decision|0
7377436|NCT01142232|11631544|FG001|Overall Study|Physician Decision|1
7377437|NCT01142232|11631545|FG002|Overall Study|Physician Decision|0
7377438|NCT01142232|11631546|FG003|Overall Study|Physician Decision|2
7377439|NCT01142232|11631547|FG004|Overall Study|Physician Decision|10
7377440|NCT01142232|11631543|FG000|Overall Study|Alternative Therapy|0
7377441|NCT01142232|11631544|FG001|Overall Study|Alternative Therapy|1
7377442|NCT01142232|11631545|FG002|Overall Study|Alternative Therapy|1
7377443|NCT01142232|11631546|FG003|Overall Study|Alternative Therapy|0
7377444|NCT01142232|11631547|FG004|Overall Study|Alternative Therapy|1
7377445|NCT01142232|11631543|FG000|Overall Study|Off Trt for other complicating disease|0
7377446|NCT01142232|11631544|FG001|Overall Study|Off Trt for other complicating disease|0
7377447|NCT01142232|11631545|FG002|Overall Study|Off Trt for other complicating disease|0
7377448|NCT01142232|11631546|FG003|Overall Study|Off Trt for other complicating disease|0
7377449|NCT01142232|11631547|FG004|Overall Study|Off Trt for other complicating disease|1
7377450|NCT01142232|11631543|FG000|Overall Study|Noncompliance|0
7377451|NCT01142232|11631544|FG001|Overall Study|Noncompliance|0
7377452|NCT01142232|11631545|FG002|Overall Study|Noncompliance|0
7377453|NCT01142232|11631546|FG003|Overall Study|Noncompliance|0
7377454|NCT01142232|11631547|FG004|Overall Study|Noncompliance|2
7377455|NCT01142336|11631583|FG000|Overall Study|Adverse Event|1
7377456|NCT01142336|11631584|FG001|Overall Study|Adverse Event|1
7377457|NCT01142336|11631583|FG000|Overall Study|Lost to Follow-up|0
7377458|NCT01142336|11631584|FG001|Overall Study|Lost to Follow-up|1
7377459|NCT01142466|11631595|FG000|Overall Study|Adverse Event|2
7377460|NCT01142466|11631596|FG001|Overall Study|Adverse Event|1
7377461|NCT01142466|11631595|FG000|Overall Study|Withdrawal by Subject|1
7377462|NCT01142466|11631596|FG001|Overall Study|Withdrawal by Subject|1
7377463|NCT01142661|11631602|FG000|Overall Study|Adverse Event|2
7377464|NCT01142661|11631602|FG000|Overall Study|Withdrawal by Subject|1
7377465|NCT01142661|11631602|FG000|Overall Study|Physician Decision|1
7377466|NCT01142726|11631609|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7377467|NCT01142726|11631610|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
7377468|NCT01142726|11631611|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
7377469|NCT01142726|11631609|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
7377470|NCT01142726|11631610|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
7377471|NCT01142726|11631611|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
7377472|NCT01142726|11631609|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7377473|NCT01142726|11631610|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
7377474|NCT01142726|11631611|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
7377475|NCT01142726|11631609|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
7377476|NCT01142726|11631610|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7377477|NCT01142726|11631611|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
7377478|NCT01142726|11631609|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
7377479|NCT01142726|11631610|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
7377480|NCT01142726|11631611|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
7377481|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7377482|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
7377483|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
7377484|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7377485|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
7377486|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
7377487|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7377488|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
7377489|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
7377490|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
7377491|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7377492|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
7377493|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
7377494|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7377495|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
7377496|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
7377497|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
7377498|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
7377499|NCT01142726|11631609|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
7377500|NCT01142726|11631610|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
7461896|NCT01844076|11758466|FG000|Overall Study|Withdrawal by Subject|1
7461897|NCT01844076|11758467|FG001|Overall Study|Withdrawal by Subject|0
7461898|NCT01844076|11758468|FG002|Overall Study|Withdrawal by Subject|0
7461899|NCT01844076|11758469|FG003|Overall Study|Withdrawal by Subject|0
7461900|NCT01844115|11758481|FG000|Overall Study|Adverse Event|4
7461901|NCT01844115|11758482|FG001|Overall Study|Adverse Event|22
7461902|NCT01844115|11758481|FG000|Overall Study|Lack of Efficacy|1
7461903|NCT01844115|11758482|FG001|Overall Study|Lack of Efficacy|4
7461904|NCT01844115|11758481|FG000|Overall Study|Protocol Violation|12
7461905|NCT01844115|11758482|FG001|Overall Study|Protocol Violation|10
7461906|NCT01844115|11758481|FG000|Overall Study|Withdrawal by Subject|11
7461907|NCT01844115|11758482|FG001|Overall Study|Withdrawal by Subject|11
7461908|NCT01844115|11758481|FG000|Overall Study|Lost to Follow-up|11
7461909|NCT01844115|11758482|FG001|Overall Study|Lost to Follow-up|10
7461910|NCT01844115|11758481|FG000|Overall Study|Pregnancy|0
7461911|NCT01844115|11758482|FG001|Overall Study|Pregnancy|1
7461912|NCT01844284|11758499|FG000|Overall Study|Lost to Follow-up|12
7461913|NCT01844284|11758500|FG001|Overall Study|Lost to Follow-up|7
7461914|NCT01844375|11758508|FG000|Overall Study|Protocol Violation|1
7461915|NCT01844375|11758509|FG001|Overall Study|Protocol Violation|1
7461916|NCT01844531|11758536|FG000|Overall Study|Withdrawal by Subject|0
7461917|NCT01844531|11758537|FG001|Overall Study|Withdrawal by Subject|1
7461918|NCT01844531|11758538|FG002|Overall Study|Withdrawal by Subject|0
7461919|NCT01844531|11758539|FG003|Overall Study|Withdrawal by Subject|0
7461920|NCT01844583|11758551|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
7461921|NCT01844583|11758552|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
7461922|NCT01844687|11758563|FG000|Visit 1|Protocol Violation|3
7461923|NCT01844687|11758563|FG000|Visit 1|Lost to Follow-up|5
7461924|NCT01844687|11758563|FG000|Visit 2|Withdrawal by Subject|1
7461925|NCT01844687|11758563|FG000|Visit 2|Protocol Violation|1
7461926|NCT01844687|11758563|FG000|Visit 3|Lost to Follow-up|1
7461927|NCT01844687|11758563|FG000|Visit 3|Withdrawal by Subject|3
7461928|NCT01844687|11758563|FG000|Visit 3|child care problems|1
7461929|NCT01844687|11758563|FG000|Visit 4|Pregnancy|1
7461930|NCT01844687|11758563|FG000|Visit 4|Lost to Follow-up|1
7461931|NCT01844687|11758563|FG000|Visit 4|Withdrawal by Subject|2
7461932|NCT01844700|11758587|FG000|Overall Study|Lack of Efficacy|1
7461933|NCT01844700|11758588|FG001|Overall Study|Lack of Efficacy|0
7461934|NCT01844700|11758587|FG000|Overall Study|refused medication switch|1
7461935|NCT01844700|11758588|FG001|Overall Study|refused medication switch|0
7461936|NCT01844700|11758587|FG000|Overall Study|Withdrawal by Subject|1
7461937|NCT01844700|11758588|FG001|Overall Study|Withdrawal by Subject|0
7461938|NCT01844700|11758587|FG000|Overall Study|stopped taking meds|0
7461939|NCT01844700|11758588|FG001|Overall Study|stopped taking meds|1
7461940|NCT01844765|11758596|FG000|Overall Study|Adverse Event|6
7461941|NCT01844765|11758597|FG001|Overall Study|Adverse Event|8
7461942|NCT01844765|11758596|FG000|Overall Study|Withdrawal by Subject|2
7461943|NCT01844765|11758597|FG001|Overall Study|Withdrawal by Subject|3
7461944|NCT01844765|11758596|FG000|Overall Study|Disease progression|1
7461945|NCT01844765|11758597|FG001|Overall Study|Disease progression|0
7461946|NCT01844765|11758596|FG000|Overall Study|Administrative problems|3
7461947|NCT01844765|11758597|FG001|Overall Study|Administrative problems|4
7461948|NCT01844765|11758596|FG000|Overall Study|Protocol deviation|2
7461949|NCT01844765|11758597|FG001|Overall Study|Protocol deviation|0
7461950|NCT01844765|11758596|FG000|Overall Study|Untreated|1
7461951|NCT01844765|11758597|FG001|Overall Study|Untreated|0
7468443|NCT01911260|11769274|FG003|Supplementation Period|Adverse Event|0
7468444|NCT01911260|11769271|FG000|Supplementation Period|refused to receive supplement|1
7468445|NCT01911260|11769272|FG001|Supplementation Period|refused to receive supplement|0
7468446|NCT01911260|11769273|FG002|Supplementation Period|refused to receive supplement|1
7468447|NCT01911260|11769274|FG003|Supplementation Period|refused to receive supplement|0
7468448|NCT01911260|11769271|FG000|Supplementation Period|less than 12 weeks supplementation|0
7468449|NCT01911260|11769272|FG001|Supplementation Period|less than 12 weeks supplementation|3
7468450|NCT01911260|11769273|FG002|Supplementation Period|less than 12 weeks supplementation|1
7468451|NCT01911260|11769274|FG003|Supplementation Period|less than 12 weeks supplementation|2
7468452|NCT01911260|11769271|FG000|Follow-up Period|transference or evasion of school|13
7468453|NCT01911260|11769272|FG001|Follow-up Period|transference or evasion of school|20
7468454|NCT01911260|11769273|FG002|Follow-up Period|transference or evasion of school|15
7377501|NCT01142726|11631611|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
7377502|NCT01142726|11631609|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7377503|NCT01142726|11631610|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
7377504|NCT01142726|11631611|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
7377505|NCT01142726|11631609|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7377506|NCT01142726|11631610|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7377507|NCT01142726|11631611|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
7377508|NCT01142726|11631609|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7377509|NCT01142726|11631610|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
7377510|NCT01142726|11631611|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
7377511|NCT01142726|11631609|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7377512|NCT01142726|11631610|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
7377513|NCT01142726|11631611|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
7377514|NCT01142791|11631627|FG000|Overall Study|Alternative Treatment|1
7377515|NCT01142791|11631628|FG001|Overall Study|Alternative Treatment|0
7377516|NCT01142791|11631627|FG000|Overall Study|Lost to Follow-up|1
7377517|NCT01142791|11631628|FG001|Overall Study|Lost to Follow-up|0
7377518|NCT01142791|11631627|FG000|Overall Study|Withdrawal by Subject|5
7377519|NCT01142791|11631628|FG001|Overall Study|Withdrawal by Subject|0
7377520|NCT01142791|11631627|FG000|Overall Study|Received only 1 sonication|0
7377521|NCT01142791|11631628|FG001|Overall Study|Received only 1 sonication|6
7377522|NCT01142908|11631634|FG000|Overall Study|Lost to Follow-up|19
7377523|NCT01142908|11631635|FG001|Overall Study|Lost to Follow-up|13
7377524|NCT01142908|11631634|FG000|Overall Study|Death|1
7377525|NCT01142908|11631635|FG001|Overall Study|Death|4
7377526|NCT01142908|11631634|FG000|Overall Study|Excluded - did not meet criteria|9
7377527|NCT01142908|11631635|FG001|Overall Study|Excluded - did not meet criteria|5
7377528|NCT01142908|11631634|FG000|Overall Study|Withdrawal by Subject|3
7377529|NCT01142908|11631635|FG001|Overall Study|Withdrawal by Subject|0
7377536|NCT01143051|11631655|FG000|3-14 Day Washout|Withdrawal by Subject|0
7377537|NCT01143051|11631656|FG001|3-14 Day Washout|Withdrawal by Subject|0
7377538|NCT01143051|11631657|FG002|3-14 Day Washout|Withdrawal by Subject|1
7377539|NCT01143051|11631658|FG003|3-14 Day Washout|Withdrawal by Subject|0
7377540|NCT01143051|11631659|FG004|3-14 Day Washout|Withdrawal by Subject|0
7377541|NCT01143051|11631660|FG005|3-14 Day Washout|Withdrawal by Subject|0
7377542|NCT01143051|11631655|FG000|3-14 Day Washout|Withdrawal by Subject|0
7377543|NCT01143051|11631656|FG001|3-14 Day Washout|Withdrawal by Subject|0
7377544|NCT01143051|11631657|FG002|3-14 Day Washout|Withdrawal by Subject|0
7377545|NCT01143051|11631658|FG003|3-14 Day Washout|Withdrawal by Subject|0
7377546|NCT01143051|11631659|FG004|3-14 Day Washout|Withdrawal by Subject|0
7377547|NCT01143051|11631660|FG005|3-14 Day Washout|Withdrawal by Subject|1
7377548|NCT01143077|11631673|FG000|Overall Study|Lack of Efficacy|0
7377549|NCT01143077|11631674|FG001|Overall Study|Lack of Efficacy|2
7377550|NCT01143077|11631675|FG002|Overall Study|Lack of Efficacy|1
7377551|NCT01143077|11631673|FG000|Overall Study|Adverse Event|5
7377552|NCT01143077|11631674|FG001|Overall Study|Adverse Event|6
7377553|NCT01143077|11631675|FG002|Overall Study|Adverse Event|5
7377554|NCT01143077|11631673|FG000|Overall Study|Lost to Follow-up|2
7377555|NCT01143077|11631674|FG001|Overall Study|Lost to Follow-up|3
7377556|NCT01143077|11631675|FG002|Overall Study|Lost to Follow-up|4
7377557|NCT01143077|11631673|FG000|Overall Study|Protocol Violation|2
7377558|NCT01143077|11631674|FG001|Overall Study|Protocol Violation|0
7377559|NCT01143077|11631675|FG002|Overall Study|Protocol Violation|0
7377560|NCT01143077|11631673|FG000|Overall Study|Withdrawal by Subject|4
7377561|NCT01143077|11631674|FG001|Overall Study|Withdrawal by Subject|3
7377562|NCT01143077|11631675|FG002|Overall Study|Withdrawal by Subject|3
7377563|NCT01143077|11631673|FG000|Overall Study|Non-compliance with study drug|0
7377564|NCT01143077|11631674|FG001|Overall Study|Non-compliance with study drug|1
7377565|NCT01143077|11631675|FG002|Overall Study|Non-compliance with study drug|1
7377566|NCT01143077|11631673|FG000|Overall Study|Administrative|1
7377567|NCT01143077|11631674|FG001|Overall Study|Administrative|0
7377568|NCT01143077|11631675|FG002|Overall Study|Administrative|0
7377569|NCT01143077|11631673|FG000|Overall Study|Principal Investigator Decision|2
7377570|NCT01143077|11631674|FG001|Overall Study|Principal Investigator Decision|0
7377571|NCT01143077|11631675|FG002|Overall Study|Principal Investigator Decision|1
7377572|NCT01143090|11631683|FG000|Overall Study|Lack of Efficacy|2
7377573|NCT01143090|11631683|FG000|Overall Study|Adverse Event|17
7377574|NCT01143090|11631683|FG000|Overall Study|Lost to Follow-up|9
7377575|NCT01143090|11631683|FG000|Overall Study|Protocol Violation|2
7377576|NCT01143090|11631683|FG000|Overall Study|Withdrawal by Subject|18
7377577|NCT01143090|11631683|FG000|Overall Study|Non-compliance with study drug|1
7377578|NCT01143090|11631683|FG000|Overall Study|Failure to meet eligibility criteria|1
7377579|NCT01143090|11631683|FG000|Overall Study|Administrative|1
7377580|NCT01143207|11631713|FG000|Overall Study|Lost to Follow-up|2
7377581|NCT01143259|11631719|FG000|Overall Study|Withdrawal by Subject|3
7377582|NCT01143259|11631720|FG001|Overall Study|Withdrawal by Subject|2
7377583|NCT01143259|11631719|FG000|Overall Study|Protocol Violation|13
7377584|NCT01143259|11631720|FG001|Overall Study|Protocol Violation|9
7377585|NCT01143259|11631719|FG000|Overall Study|Screen Failure|7
7377586|NCT01143259|11631720|FG001|Overall Study|Screen Failure|9
7377587|NCT01143324|11631735|FG000|Overall Study|Lost to Follow-up|11
7377588|NCT01143324|11631735|FG000|Overall Study|Withdrawal by Subject|4
7377589|NCT01143324|11631735|FG000|Overall Study|Explant of the device|4
7377590|NCT01143337|11631741|FG000|Overall Study|Adverse Event|3
7377591|NCT01143337|11631742|FG001|Overall Study|Adverse Event|9
7377592|NCT01143337|11631743|FG002|Overall Study|Adverse Event|5
7377593|NCT01143337|11631741|FG000|Overall Study|Lack of Efficacy|6
7377594|NCT01143337|11631742|FG001|Overall Study|Lack of Efficacy|2
7377595|NCT01143337|11631743|FG002|Overall Study|Lack of Efficacy|1
7377596|NCT01143337|11631741|FG000|Overall Study|Protocol Violation|1
7377597|NCT01143337|11631742|FG001|Overall Study|Protocol Violation|0
7377598|NCT01143337|11631743|FG002|Overall Study|Protocol Violation|0
7377599|NCT01143337|11631741|FG000|Overall Study|Withdrawal by Subject|0
7377600|NCT01143337|11631742|FG001|Overall Study|Withdrawal by Subject|0
7377601|NCT01143337|11631743|FG002|Overall Study|Withdrawal by Subject|1
7377602|NCT01143337|11631741|FG000|Overall Study|Other reason|0
7377603|NCT01143337|11631742|FG001|Overall Study|Other reason|0
7377604|NCT01143337|11631743|FG002|Overall Study|Other reason|5
7377605|NCT01143389|11631751|FG000|Overall Study|Lost to Follow-up|26
7377606|NCT01143389|11631752|FG001|Overall Study|Lost to Follow-up|25
7377607|NCT01143402|11631761|FG000|Overall Study|Rapid clinical decline|1
7377608|NCT01143402|11631762|FG001|Overall Study|Rapid clinical decline|1
7377609|NCT01143402|11631763|FG002|Overall Study|Rapid clinical decline|0
7377610|NCT01143402|11631761|FG000|Overall Study|Not Treated|0
7377611|NCT01143402|11631762|FG001|Overall Study|Not Treated|0
7377612|NCT01143402|11631763|FG002|Overall Study|Not Treated|1
7377613|NCT01143714|11631840|FG000|Overall Study|Adverse Event|4
7377614|NCT01143714|11631841|FG001|Overall Study|Adverse Event|2
7377615|NCT01143714|11631840|FG000|Overall Study|Withdrawal by Subject|1
7377616|NCT01143714|11631841|FG001|Overall Study|Withdrawal by Subject|0
7377617|NCT01143714|11631840|FG000|Overall Study|Subject non-compliance|0
7377618|NCT01143714|11631841|FG001|Overall Study|Subject non-compliance|1
7377619|NCT01143714|11631840|FG000|Overall Study|wound closed = deemed healed|1
7377620|NCT01143714|11631841|FG001|Overall Study|wound closed = deemed healed|0
7377621|NCT01143714|11631840|FG000|Overall Study|wound size increased|1
7377622|NCT01143714|11631841|FG001|Overall Study|wound size increased|0
7377623|NCT01143896|11631919|FG000|Overall Study|Did not complete Baseline Interview|5
7377624|NCT01143896|11631920|FG001|Overall Study|Did not complete Baseline Interview|4
7377625|NCT01143896|11631919|FG000|Overall Study|Lost to Follow-up|18
7377626|NCT01143896|11631920|FG001|Overall Study|Lost to Follow-up|13
7377627|NCT01143896|11631919|FG000|Overall Study|Withdrawal by Subject|13
7377628|NCT01143896|11631920|FG001|Overall Study|Withdrawal by Subject|5
7377629|NCT01143896|11631919|FG000|Overall Study|Death|6
7377630|NCT01143896|11631920|FG001|Overall Study|Death|3
7377631|NCT01144052|11631938|FG000|Overall Study|Withdrawal by Subject|1
7377632|NCT01144052|11631939|FG001|Overall Study|Withdrawal by Subject|1
7377633|NCT01144182|11631966|FG000|Overall Study|Death|5
7377634|NCT01144182|11631967|FG001|Overall Study|Death|6
7377635|NCT01144182|11631966|FG000|Overall Study|Withdrawal by Subject|3
7377636|NCT01144182|11631967|FG001|Overall Study|Withdrawal by Subject|6
7377637|NCT01144182|11631966|FG000|Overall Study|Lost to Follow-up|9
7377638|NCT01144182|11631967|FG001|Overall Study|Lost to Follow-up|9
7377639|NCT01144299|11631993|FG000|Overall Study|Lost to Follow-up|1
7377640|NCT01144299|11631994|FG001|Overall Study|Lost to Follow-up|0
7377641|NCT01144299|11631993|FG000|Overall Study|Withdrawal by Subject|1
7377642|NCT01144299|11631994|FG001|Overall Study|Withdrawal by Subject|0
7377643|NCT01144364|11632011|FG000|Induction Phase|Disease progression|14
7377644|NCT01144364|11632012|FG001|Induction Phase|Disease progression|0
7377645|NCT01144364|11632013|FG002|Induction Phase|Disease progression|0
7377646|NCT01144364|11632011|FG000|Induction Phase|Adverse Event|9
7377647|NCT01144364|11632012|FG001|Induction Phase|Adverse Event|0
7377648|NCT01144364|11632013|FG002|Induction Phase|Adverse Event|0
7377649|NCT01144364|11632011|FG000|Induction Phase|Death|1
7377650|NCT01144364|11632012|FG001|Induction Phase|Death|0
7377651|NCT01144364|11632013|FG002|Induction Phase|Death|0
7377652|NCT01144364|11632011|FG000|Induction Phase|Withdrawal by Subject|1
7377653|NCT01144364|11632012|FG001|Induction Phase|Withdrawal by Subject|0
7377654|NCT01144364|11632013|FG002|Induction Phase|Withdrawal by Subject|0
7461952|NCT01844778|11758611|FG000|Overall Study|Protocol deviation|0
7461953|NCT01844778|11758612|FG001|Overall Study|Protocol deviation|1
7461954|NCT01844778|11758613|FG002|Overall Study|Protocol deviation|2
7461955|NCT01844778|11758611|FG000|Overall Study|Withdrawal by Subject|2
7461956|NCT01844778|11758612|FG001|Overall Study|Withdrawal by Subject|0
7461957|NCT01844778|11758613|FG002|Overall Study|Withdrawal by Subject|0
7461958|NCT01844778|11758611|FG000|Overall Study|Adverse Event|0
7461959|NCT01844778|11758612|FG001|Overall Study|Adverse Event|2
7461960|NCT01844778|11758613|FG002|Overall Study|Adverse Event|2
7461961|NCT01844817|11758627|FG000|Enrolled and Randomized|Withdrawal by Subject|2
7377655|NCT01144364|11632011|FG000|Induction Phase|Lost to Follow-up|2
7377656|NCT01144364|11632012|FG001|Induction Phase|Lost to Follow-up|0
7377657|NCT01144364|11632013|FG002|Induction Phase|Lost to Follow-up|0
7377658|NCT01144364|11632011|FG000|Induction Phase|Physician Decision|1
7377659|NCT01144364|11632012|FG001|Induction Phase|Physician Decision|0
7377660|NCT01144364|11632013|FG002|Induction Phase|Physician Decision|0
7377661|NCT01144364|11632011|FG000|Induction Phase|Stable disease|2
7377662|NCT01144364|11632012|FG001|Induction Phase|Stable disease|0
7377663|NCT01144364|11632013|FG002|Induction Phase|Stable disease|0
7377664|NCT01144364|11632011|FG000|Induction Phase|Secondary neoplasia|1
7377665|NCT01144364|11632012|FG001|Induction Phase|Secondary neoplasia|0
7377666|NCT01144364|11632013|FG002|Induction Phase|Secondary neoplasia|0
7377667|NCT01144364|11632011|FG000|Induction Phase|Protocol Violation|1
7377668|NCT01144364|11632012|FG001|Induction Phase|Protocol Violation|0
7377669|NCT01144364|11632013|FG002|Induction Phase|Protocol Violation|0
7377670|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Disease progression|0
7377671|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Disease progression|23
7377672|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Disease progression|29
7377673|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
7377674|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
7377675|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
7377676|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Death|0
7377677|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Death|2
7377678|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Death|0
7377679|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
7377680|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7377681|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
7377682|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
7377683|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
7377684|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
7377685|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Relapse|0
7377686|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Relapse|5
7377687|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Relapse|5
7377688|NCT01144364|11632011|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
7377689|NCT01144364|11632012|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
7377690|NCT01144364|11632013|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
7377691|NCT01144377|11632028|FG000|52 Week Treatment Period|Adverse Event|0
7377692|NCT01144377|11632029|FG001|52 Week Treatment Period|Adverse Event|0
7377693|NCT01144377|11632030|FG002|52 Week Treatment Period|Adverse Event|3
7377694|NCT01144377|11632031|FG003|52 Week Treatment Period|Adverse Event|2
7377695|NCT01144377|11632032|FG004|52 Week Treatment Period|Adverse Event|1
7377696|NCT01144377|11632028|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
7377697|NCT01144377|11632029|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
7377698|NCT01144377|11632030|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
7377699|NCT01144377|11632031|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
7377700|NCT01144377|11632032|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
7377701|NCT01144377|11632028|FG000|52 Week Treatment Period|Protocol Violation|0
7377702|NCT01144377|11632029|FG001|52 Week Treatment Period|Protocol Violation|0
7377703|NCT01144377|11632030|FG002|52 Week Treatment Period|Protocol Violation|0
7377704|NCT01144377|11632031|FG003|52 Week Treatment Period|Protocol Violation|0
7377705|NCT01144377|11632032|FG004|52 Week Treatment Period|Protocol Violation|1
7377706|NCT01144377|11632028|FG000|52 Week Treatment Period|Lost to Follow-up|1
7377707|NCT01144377|11632029|FG001|52 Week Treatment Period|Lost to Follow-up|0
7377708|NCT01144377|11632030|FG002|52 Week Treatment Period|Lost to Follow-up|0
7377709|NCT01144377|11632031|FG003|52 Week Treatment Period|Lost to Follow-up|0
7377710|NCT01144377|11632032|FG004|52 Week Treatment Period|Lost to Follow-up|0
7377711|NCT01144377|11632028|FG000|52 Week Treatment Period|Withdrawal by Subject|4
7377712|NCT01144377|11632029|FG001|52 Week Treatment Period|Withdrawal by Subject|1
7377713|NCT01144377|11632030|FG002|52 Week Treatment Period|Withdrawal by Subject|1
7377714|NCT01144377|11632031|FG003|52 Week Treatment Period|Withdrawal by Subject|1
7377715|NCT01144377|11632032|FG004|52 Week Treatment Period|Withdrawal by Subject|0
7377716|NCT01144377|11632028|FG000|52 Week Treatment Period|Sponsor Decision|0
7377717|NCT01144377|11632029|FG001|52 Week Treatment Period|Sponsor Decision|0
7377718|NCT01144377|11632030|FG002|52 Week Treatment Period|Sponsor Decision|0
7377719|NCT01144377|11632031|FG003|52 Week Treatment Period|Sponsor Decision|0
7377720|NCT01144377|11632032|FG004|52 Week Treatment Period|Sponsor Decision|1
7377721|NCT01144377|11632028|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7377722|NCT01144377|11632029|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7377723|NCT01144377|11632030|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7377724|NCT01144377|11632031|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
7377725|NCT01144377|11632032|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
7377726|NCT01144377|11632028|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7377727|NCT01144377|11632029|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7377728|NCT01144377|11632030|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7377729|NCT01144377|11632031|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
7377730|NCT01144377|11632032|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
7377731|NCT01144377|11632028|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
7377732|NCT01144377|11632029|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7377733|NCT01144377|11632030|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7377734|NCT01144377|11632031|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7377735|NCT01144377|11632032|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
7377736|NCT01144403|11632046|FG000|Overall Study|Lost to Follow-up|3
7377737|NCT01144403|11632046|FG000|Overall Study|Death|1
7377738|NCT01144403|11632046|FG000|Overall Study|Adverse Event|1
7377739|NCT01144663|11632118|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
7377740|NCT01144663|11632119|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
7377741|NCT01144663|11632120|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
7377742|NCT01144663|11632121|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
7377743|NCT01144663|11632118|FG000|Primary Vaccination Phase|Adverse Event|1
7377744|NCT01144663|11632119|FG001|Primary Vaccination Phase|Adverse Event|0
7377745|NCT01144663|11632120|FG002|Primary Vaccination Phase|Adverse Event|0
7377746|NCT01144663|11632121|FG003|Primary Vaccination Phase|Adverse Event|1
7377747|NCT01144663|11632118|FG000|Primary Vaccination Phase|Protocol Violation|2
7377748|NCT01144663|11632119|FG001|Primary Vaccination Phase|Protocol Violation|0
7377749|NCT01144663|11632120|FG002|Primary Vaccination Phase|Protocol Violation|1
7377750|NCT01144663|11632121|FG003|Primary Vaccination Phase|Protocol Violation|0
7377751|NCT01144663|11632118|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
7377752|NCT01144663|11632119|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
7377753|NCT01144663|11632120|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
7377754|NCT01144663|11632121|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
7377755|NCT01144663|11632118|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
7377756|NCT01144663|11632119|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
7377757|NCT01144663|11632120|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
7377758|NCT01144663|11632121|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
7377759|NCT01144663|11632118|FG000|Primary Vaccination Phase|Lost to Follow-up|2
7377760|NCT01144663|11632119|FG001|Primary Vaccination Phase|Lost to Follow-up|0
7377761|NCT01144663|11632120|FG002|Primary Vaccination Phase|Lost to Follow-up|1
7377762|NCT01144663|11632121|FG003|Primary Vaccination Phase|Lost to Follow-up|2
7377763|NCT01144663|11632118|FG000|Primary Vaccination Phase|Other|0
7377764|NCT01144663|11632119|FG001|Primary Vaccination Phase|Other|1
7377765|NCT01144663|11632120|FG002|Primary Vaccination Phase|Other|0
7377766|NCT01144663|11632121|FG003|Primary Vaccination Phase|Other|2
7377767|NCT01144663|11632118|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
7377768|NCT01144663|11632119|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7377769|NCT01144663|11632120|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
7377770|NCT01144663|11632121|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
7377771|NCT01144663|11632118|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
7377772|NCT01144663|11632119|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
7377773|NCT01144663|11632120|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
7377774|NCT01144663|11632121|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
7377775|NCT01144663|11632118|FG000|Booster Vaccination Phase|Lost to Follow-up|2
7377776|NCT01144663|11632119|FG001|Booster Vaccination Phase|Lost to Follow-up|1
7377777|NCT01144663|11632120|FG002|Booster Vaccination Phase|Lost to Follow-up|3
7377778|NCT01144663|11632121|FG003|Booster Vaccination Phase|Lost to Follow-up|0
7377779|NCT01144663|11632118|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7377780|NCT01144663|11632119|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
7377781|NCT01144663|11632120|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7377782|NCT01144663|11632121|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
7377783|NCT01144663|11632118|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7377784|NCT01144663|11632119|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
7377785|NCT01144663|11632120|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
7377786|NCT01144663|11632121|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
7377787|NCT01144663|11632118|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
7377788|NCT01144663|11632119|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
7377789|NCT01144663|11632120|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
7377790|NCT01144663|11632121|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
7377791|NCT01144715|11632133|FG000|Overall Study|Lost to Follow-up|2
7377792|NCT01144715|11632134|FG001|Overall Study|Lost to Follow-up|1
7377793|NCT01144715|11632133|FG000|Overall Study|Withdrawal by Subject|2
7377794|NCT01144715|11632134|FG001|Overall Study|Withdrawal by Subject|1
7377795|NCT01144715|11632133|FG000|Overall Study|Adverse Event|0
7377796|NCT01144715|11632134|FG001|Overall Study|Adverse Event|1
7387183|NCT01212770|11645406|FG005|Long-term Safety Phase (Year 5)|Death|0
7387184|NCT01212770|11645407|FG006|Long-term Safety Phase (Year 5)|Death|0
7387185|NCT01212770|11645408|FG007|Long-term Safety Phase (Year 5)|Death|1
7387186|NCT01212770|11645409|FG008|Long-term Safety Phase (Year 5)|Death|0
7387187|NCT01212991|11645466|FG000|Double-blind|Lost to Follow-up|8
7387188|NCT01212991|11645467|FG001|Double-blind|Lost to Follow-up|4
7387189|NCT01212991|11645468|FG002|Double-blind|Lost to Follow-up|0
7387190|NCT01212991|11645466|FG000|Double-blind|Death|699
7387191|NCT01212991|11645467|FG001|Double-blind|Death|550
7387192|NCT01212991|11645468|FG002|Double-blind|Death|0
7387193|NCT01212991|11645466|FG000|Double-blind|Withdrawal by Subject|16
7387194|NCT01212991|11645467|FG001|Double-blind|Withdrawal by Subject|19
7387195|NCT01212991|11645468|FG002|Double-blind|Withdrawal by Subject|0
7387196|NCT01212991|11645466|FG000|Double-blind|Other|7
7387197|NCT01212991|11645467|FG001|Double-blind|Other|0
7387198|NCT01212991|11645468|FG002|Double-blind|Other|0
7387199|NCT01212991|11645466|FG000|Double-blind|Sponsor decision|142
7387200|NCT01212991|11645467|FG001|Double-blind|Sponsor decision|38
7387201|NCT01212991|11645468|FG002|Double-blind|Sponsor decision|0
7387202|NCT01212991|11645466|FG000|Open-label|Death|0
7387203|NCT01212991|11645467|FG001|Open-label|Death|0
7387204|NCT01212991|11645468|FG002|Open-label|Death|166
7387205|NCT01212991|11645466|FG000|Open-label|Lost to Follow-up|0
7387206|NCT01212991|11645467|FG001|Open-label|Lost to Follow-up|0
7387207|NCT01212991|11645468|FG002|Open-label|Lost to Follow-up|5
7387208|NCT01212991|11645466|FG000|Open-label|Withdrawal by Subject|0
7387209|NCT01212991|11645467|FG001|Open-label|Withdrawal by Subject|0
7387210|NCT01212991|11645468|FG002|Open-label|Withdrawal by Subject|7
7387211|NCT01212991|11645466|FG000|Open-label|Sponsor decision|0
7387212|NCT01212991|11645467|FG001|Open-label|Sponsor decision|0
7387213|NCT01212991|11645468|FG002|Open-label|Sponsor decision|53
7387214|NCT01212991|11645466|FG000|Open-label|Other|0
7387215|NCT01212991|11645467|FG001|Open-label|Other|0
7387216|NCT01212991|11645468|FG002|Open-label|Other|3
7387217|NCT01213082|11645488|FG000|Overall Study|Lost to Follow-up|6
7387218|NCT01213082|11645489|FG001|Overall Study|Lost to Follow-up|7
7387219|NCT01213082|11645490|FG002|Overall Study|Lost to Follow-up|4
7387220|NCT01213082|11645488|FG000|Overall Study|Physician Decision|0
7387221|NCT01213082|11645489|FG001|Overall Study|Physician Decision|0
7387222|NCT01213082|11645490|FG002|Overall Study|Physician Decision|1
7387223|NCT01213173|11645500|FG000|Overall Study|Protocol Violation|2
7387224|NCT01213173|11645501|FG001|Overall Study|Protocol Violation|0
7387225|NCT01213173|11645500|FG000|Overall Study|Adverse Event|4
7387226|NCT01213173|11645501|FG001|Overall Study|Adverse Event|8
7387227|NCT01213173|11645500|FG000|Overall Study|Withdrawal by Subject|5
7387228|NCT01213173|11645501|FG001|Overall Study|Withdrawal by Subject|5
7387229|NCT01213173|11645500|FG000|Overall Study|Incorrect Enrollment|1
7387230|NCT01213173|11645501|FG001|Overall Study|Incorrect Enrollment|3
7387729|NCT01215916|11646440|FG002|Overall Study|Death|0
7387730|NCT01215916|11646441|FG003|Overall Study|Death|0
7387731|NCT01215916|11646442|FG004|Overall Study|Death|1
7387732|NCT01215916|11646443|FG005|Overall Study|Death|0
7387733|NCT01215916|11646444|FG006|Overall Study|Death|0
7387734|NCT01215916|11646445|FG007|Overall Study|Death|0
7387735|NCT01215916|11646446|FG008|Overall Study|Death|1
7387736|NCT01215916|11646438|FG000|Overall Study|Physician Decision|0
7387737|NCT01215916|11646439|FG001|Overall Study|Physician Decision|0
7387738|NCT01215916|11646440|FG002|Overall Study|Physician Decision|1
7387739|NCT01215916|11646441|FG003|Overall Study|Physician Decision|1
7387740|NCT01215916|11646442|FG004|Overall Study|Physician Decision|0
7387741|NCT01215916|11646443|FG005|Overall Study|Physician Decision|0
7387742|NCT01215916|11646444|FG006|Overall Study|Physician Decision|0
7387743|NCT01215916|11646445|FG007|Overall Study|Physician Decision|0
7387744|NCT01215916|11646446|FG008|Overall Study|Physician Decision|0
7387745|NCT01215942|11646481|FG000|Treatment Period|Adverse Event|15
7387746|NCT01215942|11646482|FG001|Treatment Period|Adverse Event|26
7387747|NCT01215942|11646481|FG000|Treatment Period|Death|2
7387748|NCT01215942|11646482|FG001|Treatment Period|Death|4
7387749|NCT01215942|11646481|FG000|Treatment Period|Lack of Efficacy|23
7387750|NCT01215942|11646482|FG001|Treatment Period|Lack of Efficacy|62
7387751|NCT01215942|11646481|FG000|Treatment Period|Lost to Follow-up|3
7387752|NCT01215942|11646482|FG001|Treatment Period|Lost to Follow-up|4
7387753|NCT01215942|11646481|FG000|Treatment Period|Withdrawal by Subject|17
7387754|NCT01215942|11646482|FG001|Treatment Period|Withdrawal by Subject|40
7387755|NCT01215942|11646481|FG000|Treatment Period|Physician Decision|5
7387756|NCT01215942|11646482|FG001|Treatment Period|Physician Decision|5
7387757|NCT01215942|11646481|FG000|Treatment Period|Protocol Violation|0
7387758|NCT01215942|11646482|FG001|Treatment Period|Protocol Violation|1
7387759|NCT01215942|11646481|FG000|Treatment Period|Sponsor Decision|349
7387760|NCT01215942|11646482|FG001|Treatment Period|Sponsor Decision|530
7377797|NCT01145053|11632166|FG000|Overall Study|Adverse Event|22
7377798|NCT01145053|11632166|FG000|Overall Study|Lost to Follow-up|28
7377799|NCT01145053|11632166|FG000|Overall Study|Withdrawal by Subject|25
7377800|NCT01145053|11632166|FG000|Overall Study|Other|18
7377801|NCT01145066|11632173|FG000|Overall Study|To resume NSAIDs|2
7377802|NCT01145066|11632174|FG001|Overall Study|To resume NSAIDs|2
7377803|NCT01145066|11632175|FG002|Overall Study|To resume NSAIDs|1
7377804|NCT01145066|11632173|FG000|Overall Study|Non-related surgery|0
7377805|NCT01145066|11632174|FG001|Overall Study|Non-related surgery|0
7377806|NCT01145066|11632175|FG002|Overall Study|Non-related surgery|1
7377807|NCT01145066|11632173|FG000|Overall Study|Withdrawal by Subject|0
7377808|NCT01145066|11632174|FG001|Overall Study|Withdrawal by Subject|0
7377809|NCT01145066|11632175|FG002|Overall Study|Withdrawal by Subject|2
7377810|NCT01145066|11632173|FG000|Overall Study|To start new med|1
7377811|NCT01145066|11632174|FG001|Overall Study|To start new med|0
7377812|NCT01145066|11632175|FG002|Overall Study|To start new med|0
7377813|NCT01145066|11632173|FG000|Overall Study|problems swallowing capsule|1
7377814|NCT01145066|11632174|FG001|Overall Study|problems swallowing capsule|0
7377815|NCT01145066|11632175|FG002|Overall Study|problems swallowing capsule|0
7377816|NCT01145066|11632173|FG000|Overall Study|Abdominal discomfort|0
7377817|NCT01145066|11632174|FG001|Overall Study|Abdominal discomfort|1
7377818|NCT01145066|11632175|FG002|Overall Study|Abdominal discomfort|0
7377819|NCT01145066|11632173|FG000|Overall Study|Low platelet count|0
7377820|NCT01145066|11632174|FG001|Overall Study|Low platelet count|1
7377821|NCT01145066|11632175|FG002|Overall Study|Low platelet count|0
7377822|NCT01145222|11632204|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
7377823|NCT01145222|11632205|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
7377824|NCT01145222|11632206|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
7377825|NCT01145222|11632207|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
7377826|NCT01145222|11632204|FG000|Overall Study|Poor bowel preparation|0
7377827|NCT01145222|11632205|FG001|Overall Study|Poor bowel preparation|0
7377828|NCT01145222|11632206|FG002|Overall Study|Poor bowel preparation|0
7377829|NCT01145222|11632207|FG003|Overall Study|Poor bowel preparation|1
7377830|NCT01145352|11632217|FG000|Overall Study|Found to have been registered twice|6
7377831|NCT01145352|11632217|FG000|Overall Study|Treated before marketing approval|4
7377832|NCT01145352|11632217|FG000|Overall Study|Syringe formulation was used|1
7377833|NCT01145417|11632234|FG000|Overall Study|Death|1
7377834|NCT01145417|11632235|FG001|Overall Study|Death|0
7377835|NCT01145417|11632234|FG000|Overall Study|Lost to Follow-up|2
7377836|NCT01145417|11632235|FG001|Overall Study|Lost to Follow-up|1
7377837|NCT01145417|11632234|FG000|Overall Study|Withdrawal by Subject|1
7377838|NCT01145417|11632235|FG001|Overall Study|Withdrawal by Subject|2
7377839|NCT01145417|11632234|FG000|Overall Study|Pregnancy|1
7377840|NCT01145417|11632235|FG001|Overall Study|Pregnancy|0
7377841|NCT01145417|11632234|FG000|Overall Study|Adverse Event|0
7377842|NCT01145417|11632235|FG001|Overall Study|Adverse Event|1
7377843|NCT01145417|11632234|FG000|Overall Study|Study terminated by sponsor|35
7377844|NCT01145417|11632235|FG001|Overall Study|Study terminated by sponsor|43
7377845|NCT01145417|11632234|FG000|Overall Study|Other|1
7377846|NCT01145417|11632235|FG001|Overall Study|Other|0
7377847|NCT01145482|11632243|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7377848|NCT01145482|11632244|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7377849|NCT01145508|11632252|FG000|Overall Study|Adverse Event|1
7377850|NCT01145508|11632253|FG001|Overall Study|Adverse Event|0
7377851|NCT01145508|11632252|FG000|Overall Study|Death|1
7377852|NCT01145508|11632253|FG001|Overall Study|Death|0
7377853|NCT01145508|11632252|FG000|Overall Study|Physician Decision|2
7377854|NCT01145508|11632253|FG001|Overall Study|Physician Decision|1
7377855|NCT01145508|11632252|FG000|Overall Study|Never started treatment|1
7377856|NCT01145508|11632253|FG001|Overall Study|Never started treatment|1
7570683|NCT03501277|11948809|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
7570684|NCT03501277|11948810|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
7570685|NCT03501277|11948811|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
7570686|NCT03501277|11948812|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
7570687|NCT03501277|11948809|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
7570688|NCT03501277|11948810|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
7570689|NCT03501277|11948811|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
7377857|NCT01145560|11632269|FG000|Overall Study|Withdrawal by Subject|2
7377858|NCT01145560|11632270|FG001|Overall Study|Withdrawal by Subject|1
7377859|NCT01145560|11632271|FG002|Overall Study|Withdrawal by Subject|0
7377860|NCT01145560|11632269|FG000|Overall Study|Lost to Follow-up|1
7377861|NCT01145560|11632270|FG001|Overall Study|Lost to Follow-up|1
7377862|NCT01145560|11632271|FG002|Overall Study|Lost to Follow-up|1
7377863|NCT01145560|11632269|FG000|Overall Study|No study drug by 24h after organ failure|1
7377864|NCT01145560|11632270|FG001|Overall Study|No study drug by 24h after organ failure|0
7377865|NCT01145560|11632271|FG002|Overall Study|No study drug by 24h after organ failure|0
7377866|NCT01145560|11632269|FG000|Overall Study|Accidental unblinding of study treatment|0
7377867|NCT01145560|11632270|FG001|Overall Study|Accidental unblinding of study treatment|1
7377868|NCT01145560|11632271|FG002|Overall Study|Accidental unblinding of study treatment|0
7377869|NCT01145560|11632269|FG000|Overall Study|False insurance information|0
7377870|NCT01145560|11632270|FG001|Overall Study|False insurance information|1
7377871|NCT01145560|11632271|FG002|Overall Study|False insurance information|0
7377872|NCT01145560|11632269|FG000|Overall Study|Withdrawal of therapy|0
7377873|NCT01145560|11632270|FG001|Overall Study|Withdrawal of therapy|0
7377874|NCT01145560|11632271|FG002|Overall Study|Withdrawal of therapy|1
7377875|NCT01145625|11632281|FG000|Overall Study|Lost to Follow-up|8
7377876|NCT01145625|11632282|FG001|Overall Study|Lost to Follow-up|9
7377877|NCT01145625|11632281|FG000|Overall Study|Adverse Event|6
7377878|NCT01145625|11632282|FG001|Overall Study|Adverse Event|4
7377879|NCT01145625|11632281|FG000|Overall Study|Protocol Violation|3
7377880|NCT01145625|11632282|FG001|Overall Study|Protocol Violation|1
7377881|NCT01145625|11632281|FG000|Overall Study|Withdrawal by Subject|7
7377882|NCT01145625|11632282|FG001|Overall Study|Withdrawal by Subject|16
7377883|NCT01145625|11632281|FG000|Overall Study|Pregnancy|0
7377884|NCT01145625|11632282|FG001|Overall Study|Pregnancy|1
7377885|NCT01145755|11632300|FG000|Overall Study|Adverse Event|2
7377886|NCT01145755|11632301|FG001|Overall Study|Adverse Event|4
7377887|NCT01145755|11632302|FG002|Overall Study|Adverse Event|2
7377888|NCT01145755|11632300|FG000|Overall Study|Withdrawal by Subject|2
7377889|NCT01145755|11632301|FG001|Overall Study|Withdrawal by Subject|2
7377890|NCT01145755|11632302|FG002|Overall Study|Withdrawal by Subject|2
7377891|NCT01145755|11632300|FG000|Overall Study|Lost to Follow-up|2
7377892|NCT01145755|11632301|FG001|Overall Study|Lost to Follow-up|3
7377893|NCT01145755|11632302|FG002|Overall Study|Lost to Follow-up|1
7377894|NCT01145755|11632300|FG000|Overall Study|Protocol Violation|0
7377895|NCT01145755|11632301|FG001|Overall Study|Protocol Violation|3
7377896|NCT01145755|11632302|FG002|Overall Study|Protocol Violation|1
7377897|NCT01145755|11632300|FG000|Overall Study|Study Closure|14
7377898|NCT01145755|11632301|FG001|Overall Study|Study Closure|14
7377899|NCT01145755|11632302|FG002|Overall Study|Study Closure|17
7377900|NCT01145755|11632300|FG000|Overall Study|Lack of Efficacy|0
7377901|NCT01145755|11632301|FG001|Overall Study|Lack of Efficacy|1
7377902|NCT01145755|11632302|FG002|Overall Study|Lack of Efficacy|0
7377903|NCT01145755|11632300|FG000|Overall Study|Patient could not swollow medication|0
7377904|NCT01145755|11632301|FG001|Overall Study|Patient could not swollow medication|0
7377905|NCT01145755|11632302|FG002|Overall Study|Patient could not swollow medication|1
7377906|NCT01145755|11632300|FG000|Overall Study|Withdrawal by Subject|0
7377907|NCT01145755|11632301|FG001|Overall Study|Withdrawal by Subject|0
7377908|NCT01145755|11632302|FG002|Overall Study|Withdrawal by Subject|1
7377909|NCT01145755|11632300|FG000|Overall Study|Positive urine ethanol|0
7377910|NCT01145755|11632301|FG001|Overall Study|Positive urine ethanol|1
7377911|NCT01145755|11632302|FG002|Overall Study|Positive urine ethanol|0
7377912|NCT01145885|11632319|FG000|Overall Study|Progressive Disease|7
7377913|NCT01145898|11632331|FG000|3-year Treatment|medication change by treating physician|3
7377914|NCT01145898|11632332|FG001|3-year Treatment|medication change by treating physician|16
7377915|NCT01146054|11632337|FG000|Overall Study|Did not meet dose constraints for SBRT|5
7377916|NCT01146054|11632337|FG000|Overall Study|Rapid tumor progression|2
7377917|NCT01146054|11632337|FG000|Overall Study|Other illness precluded treatment|2
7377918|NCT01146054|11632337|FG000|Overall Study|Lost to Follow-up|1
7377919|NCT01146288|11632348|FG000|First Intervention(1 Day)|Adverse Event|0
7377920|NCT01146288|11632349|FG001|First Intervention(1 Day)|Adverse Event|1
7377921|NCT01146561|11632404|FG000|Overall Study|Withdrawal by Subject|1
7377922|NCT01146561|11632404|FG000|Overall Study|Lost to Follow-up|1
7377923|NCT01146613|11632420|FG000|Overall Study|Lost to Follow-up|3
7377924|NCT01146613|11632421|FG001|Overall Study|Lost to Follow-up|8
7377925|NCT01146613|11632420|FG000|Overall Study|Lack of Efficacy|0
7377926|NCT01146613|11632421|FG001|Overall Study|Lack of Efficacy|1
7377927|NCT01146613|11632420|FG000|Overall Study|Death|1
7377928|NCT01146613|11632421|FG001|Overall Study|Death|0
7377929|NCT01146613|11632420|FG000|Overall Study|Physician Decision|1
7377930|NCT01146613|11632421|FG001|Overall Study|Physician Decision|0
7377931|NCT01146613|11632420|FG000|Overall Study|Withdrawal by Subject|0
7377932|NCT01146613|11632421|FG001|Overall Study|Withdrawal by Subject|3
7377933|NCT01146613|11632420|FG000|Overall Study|schedule conflict|1
7377934|NCT01146613|11632421|FG001|Overall Study|schedule conflict|0
7377935|NCT01146613|11632420|FG000|Overall Study|Outpatient detox|1
7377936|NCT01146613|11632421|FG001|Overall Study|Outpatient detox|0
7377937|NCT01146665|11632429|FG000|Overall Study|Withdrawal by Subject|10
7377938|NCT01146665|11632430|FG001|Overall Study|Withdrawal by Subject|16
7377939|NCT01146782|11632454|FG000|Screening Cohort|Screen Failure|187
7377940|NCT01146782|11632454|FG000|Screening Cohort|Lost to Follow-up|4
7377941|NCT01146782|11632454|FG000|Screening Cohort|Physician Decision|1
7377942|NCT01146782|11632454|FG000|Screening Cohort|Withdrawal by Subject|29
7377943|NCT01146782|11632454|FG000|Safety Cohort|Screen Failure|61
7377944|NCT01146782|11632454|FG000|Safety Cohort|Withdrawal by Subject|4
7377945|NCT01146782|11632454|FG000|Safety Cohort|Control AHI <5|4
7377946|NCT01146782|11632454|FG000|Safety Cohort|TST <4 hrs|14
7377947|NCT01146782|11632454|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
7377948|NCT01146782|11632454|FG000|Primary Endpoint Cohort|Physician Decision|1
7377949|NCT01146795|11632459|FG000|Overall Study|Withdrawal by Subject|4
7377950|NCT01146795|11632459|FG000|Overall Study|Adverse Event|6
7377951|NCT01146795|11632459|FG000|Overall Study|Still in treatment at study closure|10
7377952|NCT01146860|11632490|FG000|Overall Study|Withdrawal by Subject|0
7377953|NCT01146860|11632491|FG001|Overall Study|Withdrawal by Subject|1
7377954|NCT01146873|11632499|FG000|Overall Study|Transfer out|0
7377955|NCT01146873|11632500|FG001|Overall Study|Transfer out|6
7377956|NCT01146912|11632513|FG000|Overall Study|Already received influenza vaccination|817
7377957|NCT01146912|11632514|FG001|Overall Study|Already received influenza vaccination|822
7377958|NCT01146912|11632515|FG002|Overall Study|Already received influenza vaccination|13
7377959|NCT01146912|11632516|FG003|Overall Study|Already received influenza vaccination|15
7377960|NCT01146912|11632517|FG004|Overall Study|Already received influenza vaccination|41
7377961|NCT01146912|11632518|FG005|Overall Study|Already received influenza vaccination|61
7377962|NCT01146912|11632519|FG006|Overall Study|Already received influenza vaccination|56
7377963|NCT01146912|11632520|FG007|Overall Study|Already received influenza vaccination|0
7377964|NCT01146912|11632513|FG000|Overall Study|< 14 weeks gestational age|0
7377965|NCT01146912|11632514|FG001|Overall Study|< 14 weeks gestational age|0
7377966|NCT01146912|11632515|FG002|Overall Study|< 14 weeks gestational age|3
7377967|NCT01146912|11632516|FG003|Overall Study|< 14 weeks gestational age|2
7377968|NCT01146912|11632517|FG004|Overall Study|< 14 weeks gestational age|0
7377969|NCT01146912|11632518|FG005|Overall Study|< 14 weeks gestational age|0
7377970|NCT01146912|11632519|FG006|Overall Study|< 14 weeks gestational age|0
7377971|NCT01146912|11632520|FG007|Overall Study|< 14 weeks gestational age|0
7377972|NCT01146912|11632513|FG000|Overall Study|Duplicate patient|0
7377973|NCT01146912|11632514|FG001|Overall Study|Duplicate patient|0
7377974|NCT01146912|11632515|FG002|Overall Study|Duplicate patient|1
7377975|NCT01146912|11632516|FG003|Overall Study|Duplicate patient|0
7377976|NCT01146912|11632517|FG004|Overall Study|Duplicate patient|0
7377977|NCT01146912|11632518|FG005|Overall Study|Duplicate patient|0
7377978|NCT01146912|11632519|FG006|Overall Study|Duplicate patient|0
7377979|NCT01146912|11632520|FG007|Overall Study|Duplicate patient|0
7377980|NCT01146951|11632541|FG000|Overall Study|Adverse Event|4
7377981|NCT01146951|11632542|FG001|Overall Study|Adverse Event|1
7377982|NCT01147055|11632548|FG000|First Intervention Period|Lost to Follow-up|1
7377983|NCT01147055|11632549|FG001|First Intervention Period|Lost to Follow-up|0
7377984|NCT01147068|11632562|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
7570690|NCT03501277|11948812|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
7570691|NCT03501277|11948809|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
7570692|NCT03501277|11948810|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
7570693|NCT03501277|11948811|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
7377985|NCT01147068|11632563|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
7377986|NCT01147068|11632564|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
7377987|NCT01147068|11632565|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
7377988|NCT01147068|11632566|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
7377989|NCT01147068|11632567|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
7377990|NCT01147068|11632568|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
7377991|NCT01147068|11632562|FG000|Subjects That Received 2nd Dose|Ineligible|0
7377992|NCT01147068|11632563|FG001|Subjects That Received 2nd Dose|Ineligible|1
7377993|NCT01147068|11632564|FG002|Subjects That Received 2nd Dose|Ineligible|0
7377994|NCT01147068|11632565|FG003|Subjects That Received 2nd Dose|Ineligible|0
7468708|NCT01913353|11769604|FG000|Overall Study|multiple reasons|10
7377995|NCT01147068|11632566|FG004|Subjects That Received 2nd Dose|Ineligible|0
7377996|NCT01147068|11632567|FG005|Subjects That Received 2nd Dose|Ineligible|0
7377997|NCT01147068|11632568|FG006|Subjects That Received 2nd Dose|Ineligible|0
7377998|NCT01147068|11632562|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
7377999|NCT01147068|11632563|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
7378000|NCT01147068|11632564|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
7378001|NCT01147068|11632565|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
7378002|NCT01147068|11632566|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
7378003|NCT01147068|11632567|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
7378004|NCT01147068|11632568|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
7461962|NCT01844817|11758628|FG001|Enrolled and Randomized|Withdrawal by Subject|3
7461963|NCT01844817|11758627|FG000|Treatment|Progressive Disease|27
7461964|NCT01844817|11758628|FG001|Treatment|Progressive Disease|36
7461965|NCT01844817|11758627|FG000|Treatment|Adverse Event|17
7461966|NCT01844817|11758628|FG001|Treatment|Adverse Event|9
7461967|NCT01844817|11758627|FG000|Treatment|Withdrawal by Subject|10
7461968|NCT01844817|11758628|FG001|Treatment|Withdrawal by Subject|6
7461969|NCT01844817|11758627|FG000|Treatment|Death|10
7461970|NCT01844817|11758628|FG001|Treatment|Death|8
7461971|NCT01844817|11758627|FG000|Treatment|Lost to Follow-up|0
7461972|NCT01844817|11758628|FG001|Treatment|Lost to Follow-up|1
7461973|NCT01844817|11758627|FG000|Treatment|Other|0
7461974|NCT01844817|11758628|FG001|Treatment|Other|3
7461975|NCT01844830|11758637|FG000|Overall Study|Withdrawal by Subject|1
7461976|NCT01844830|11758638|FG001|Overall Study|Withdrawal by Subject|0
7570694|NCT03501277|11948812|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
7570695|NCT03502616|11948839|FG000|Up to Week 16|Withdrawal by Subject|1
7570696|NCT03502616|11948840|FG001|Up to Week 16|Withdrawal by Subject|2
7570697|NCT03502616|11948839|FG000|Up to Week 16|Lost to Follow-up|0
7461977|NCT01844895|11758644|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
7461978|NCT01844895|11758644|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
7461979|NCT01844895|11758644|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
7461980|NCT01844895|11758644|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
7461981|NCT01844895|11758644|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
7461982|NCT01844895|11758644|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
7461983|NCT01844895|11758644|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
7461984|NCT01845025|11758659|FG000|Overall Study|Adverse Event|6
7461985|NCT01845025|11758660|FG001|Overall Study|Adverse Event|3
7461986|NCT01845025|11758659|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7461987|NCT01845025|11758660|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7461988|NCT01845025|11758659|FG000|Overall Study|Withdrawal by Subject|48
7461989|NCT01845025|11758660|FG001|Overall Study|Withdrawal by Subject|44
7461990|NCT01845025|11758659|FG000|Overall Study|Lost to Follow-up|13
7461991|NCT01845025|11758660|FG001|Overall Study|Lost to Follow-up|13
7461992|NCT01845025|11758659|FG000|Overall Study|Administrative problems|8
7461993|NCT01845025|11758660|FG001|Overall Study|Administrative problems|8
7461994|NCT01845025|11758659|FG000|Overall Study|Death|2
7461995|NCT01845025|11758660|FG001|Overall Study|Death|0
7461996|NCT01845025|11758659|FG000|Overall Study|Protocol deviation|3
7461997|NCT01845025|11758660|FG001|Overall Study|Protocol deviation|6
7461998|NCT01845025|11758659|FG000|Overall Study|Missing|1
7461999|NCT01845025|11758660|FG001|Overall Study|Missing|1
7462000|NCT01845077|11758669|FG000|Washout Period|Lost to Follow-up|0
7462001|NCT01845077|11758670|FG001|Washout Period|Lost to Follow-up|1
7462002|NCT01845077|11758671|FG002|Washout Period|Lost to Follow-up|0
7462003|NCT01845077|11758672|FG003|Washout Period|Lost to Follow-up|1
7462004|NCT01845077|11758673|FG004|Washout Period|Lost to Follow-up|0
7462005|NCT01845077|11758674|FG005|Washout Period|Lost to Follow-up|1
7462006|NCT01845077|11758669|FG000|Washout Period|Adverse Event|1
7462007|NCT01845077|11758670|FG001|Washout Period|Adverse Event|0
7462008|NCT01845077|11758671|FG002|Washout Period|Adverse Event|0
7462009|NCT01845077|11758672|FG003|Washout Period|Adverse Event|0
7462010|NCT01845077|11758673|FG004|Washout Period|Adverse Event|0
7462011|NCT01845077|11758674|FG005|Washout Period|Adverse Event|0
7462012|NCT01845077|11758669|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
7462013|NCT01845077|11758670|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
7462014|NCT01845077|11758671|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
7462015|NCT01845077|11758672|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
7462016|NCT01845077|11758673|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
7462017|NCT01845077|11758674|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
7462018|NCT01845077|11758669|FG000|Washout Period|Protocol Violation|0
7462019|NCT01845077|11758670|FG001|Washout Period|Protocol Violation|0
7462020|NCT01845077|11758671|FG002|Washout Period|Protocol Violation|0
7462021|NCT01845077|11758672|FG003|Washout Period|Protocol Violation|1
7462022|NCT01845077|11758673|FG004|Washout Period|Protocol Violation|1
7462023|NCT01845077|11758674|FG005|Washout Period|Protocol Violation|0
7462024|NCT01845818|11758724|FG000|Overall Study|Withdrawal by Subject|0
7462025|NCT01845818|11758725|FG001|Overall Study|Withdrawal by Subject|1
7462026|NCT01845818|11758724|FG000|Overall Study|Lost to Follow-up|7
7378005|NCT01147068|11632562|FG000|Subjects That Received 2nd Dose|Other|0
7378006|NCT01147068|11632563|FG001|Subjects That Received 2nd Dose|Other|3
7378007|NCT01147068|11632564|FG002|Subjects That Received 2nd Dose|Other|3
7378008|NCT01147068|11632565|FG003|Subjects That Received 2nd Dose|Other|0
7378009|NCT01147068|11632566|FG004|Subjects That Received 2nd Dose|Other|1
7378010|NCT01147068|11632567|FG005|Subjects That Received 2nd Dose|Other|0
7378011|NCT01147068|11632568|FG006|Subjects That Received 2nd Dose|Other|0
7378012|NCT01147068|11632562|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7378013|NCT01147068|11632563|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7378014|NCT01147068|11632564|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7378015|NCT01147068|11632565|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7378016|NCT01147068|11632566|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
7378017|NCT01147068|11632567|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7378018|NCT01147068|11632568|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
7225265|NCT00065156|11434699|FG000|Overall Study|Investigator Decision|2
7378019|NCT01147068|11632562|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378020|NCT01147068|11632563|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378021|NCT01147068|11632564|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378022|NCT01147068|11632565|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
7378023|NCT01147068|11632566|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378024|NCT01147068|11632567|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378025|NCT01147068|11632568|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
7378026|NCT01147068|11632562|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
7378027|NCT01147068|11632563|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
7378028|NCT01147068|11632564|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
7378029|NCT01147068|11632565|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
7378030|NCT01147068|11632566|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
7378031|NCT01147068|11632567|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
7378032|NCT01147068|11632568|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
7378033|NCT01147107|11632586|FG000|Overall Study|Lack of Efficacy|5
7378034|NCT01147107|11632587|FG001|Overall Study|Lack of Efficacy|0
7378035|NCT01147107|11632586|FG000|Overall Study|Withdrawal by Subject|1
7378036|NCT01147107|11632587|FG001|Overall Study|Withdrawal by Subject|1
7378037|NCT01147172|11632593|FG000|Overall Study|Withdrawal by Subject|2
7378038|NCT01147172|11632593|FG000|Overall Study|Lost to Follow-up|2
7378039|NCT01147250|11632601|FG000|Overall Study|Lost to Follow-up|14
7378040|NCT01147250|11632602|FG001|Overall Study|Lost to Follow-up|11
7378041|NCT01147250|11632601|FG000|Overall Study|Withdrawal by Subject|83
7378042|NCT01147250|11632602|FG001|Overall Study|Withdrawal by Subject|88
7378043|NCT01147250|11632601|FG000|Overall Study|Site termination by sponsor|13
7378044|NCT01147250|11632602|FG001|Overall Study|Site termination by sponsor|5
7378045|NCT01147250|11632601|FG000|Overall Study|Other than specified|0
7378046|NCT01147250|11632602|FG001|Overall Study|Other than specified|1
7378047|NCT01147341|11632619|FG000|Double Blind Period|Lack of Efficacy|1
7378048|NCT01147341|11632620|FG001|Double Blind Period|Lack of Efficacy|1
7378049|NCT01147341|11632619|FG000|Double Blind Period|Withdrawal by Subject|0
7378050|NCT01147341|11632620|FG001|Double Blind Period|Withdrawal by Subject|1
7378051|NCT01147341|11632619|FG000|Open Label Period|Lack of Efficacy|3
7378052|NCT01147341|11632620|FG001|Open Label Period|Lack of Efficacy|0
7378053|NCT01147341|11632619|FG000|Open Label Period|Subject moved|1
7378054|NCT01147341|11632620|FG001|Open Label Period|Subject moved|0
7378055|NCT01147458|11632663|FG000|First Intervention|Study terminated by sponsor|8
7378056|NCT01147458|11632664|FG001|First Intervention|Study terminated by sponsor|8
7378057|NCT01147458|11632665|FG002|First Intervention|Study terminated by sponsor|7
7378058|NCT01147458|11632666|FG003|First Intervention|Study terminated by sponsor|8
7378059|NCT01147458|11632663|FG000|First Intervention|Protocol Violation|2
7378060|NCT01147458|11632664|FG001|First Intervention|Protocol Violation|3
7378061|NCT01147458|11632665|FG002|First Intervention|Protocol Violation|2
7378062|NCT01147458|11632666|FG003|First Intervention|Protocol Violation|3
7378063|NCT01147458|11632663|FG000|First Intervention|Withdrawal by Subject|3
7378064|NCT01147458|11632664|FG001|First Intervention|Withdrawal by Subject|0
7378065|NCT01147458|11632665|FG002|First Intervention|Withdrawal by Subject|1
7378066|NCT01147458|11632666|FG003|First Intervention|Withdrawal by Subject|0
7378067|NCT01147458|11632663|FG000|First Intervention|Adverse Event|0
7378068|NCT01147458|11632664|FG001|First Intervention|Adverse Event|3
7378069|NCT01147458|11632665|FG002|First Intervention|Adverse Event|2
7378070|NCT01147458|11632666|FG003|First Intervention|Adverse Event|3
7378071|NCT01147458|11632663|FG000|First Intervention|Other|1
7378072|NCT01147458|11632664|FG001|First Intervention|Other|2
7378073|NCT01147458|11632665|FG002|First Intervention|Other|0
7378074|NCT01147458|11632666|FG003|First Intervention|Other|0
7378075|NCT01147458|11632663|FG000|Second Intervention|Study terminated by sponsor|7
7378076|NCT01147458|11632664|FG001|Second Intervention|Study terminated by sponsor|5
7378077|NCT01147458|11632665|FG002|Second Intervention|Study terminated by sponsor|5
7378078|NCT01147458|11632666|FG003|Second Intervention|Study terminated by sponsor|3
7378079|NCT01147458|11632663|FG000|Second Intervention|Protocol Violation|0
7378080|NCT01147458|11632664|FG001|Second Intervention|Protocol Violation|1
7378081|NCT01147458|11632665|FG002|Second Intervention|Protocol Violation|1
7378082|NCT01147458|11632666|FG003|Second Intervention|Protocol Violation|0
7378083|NCT01147458|11632663|FG000|Second Intervention|Withdrawal by Subject|0
7378084|NCT01147458|11632664|FG001|Second Intervention|Withdrawal by Subject|1
7378085|NCT01147458|11632665|FG002|Second Intervention|Withdrawal by Subject|0
7378086|NCT01147458|11632666|FG003|Second Intervention|Withdrawal by Subject|0
7378087|NCT01147458|11632663|FG000|Second Intervention|Adverse Event|2
7378088|NCT01147458|11632664|FG001|Second Intervention|Adverse Event|0
7378089|NCT01147458|11632665|FG002|Second Intervention|Adverse Event|1
7378090|NCT01147458|11632666|FG003|Second Intervention|Adverse Event|1
7378091|NCT01147458|11632663|FG000|Second Intervention|Other|0
7378092|NCT01147458|11632664|FG001|Second Intervention|Other|0
7378093|NCT01147458|11632665|FG002|Second Intervention|Other|1
7378094|NCT01147458|11632666|FG003|Second Intervention|Other|0
7378095|NCT01147471|11632680|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
7378096|NCT01147471|11632681|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
7378097|NCT01147471|11632680|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
7378181|NCT01147809|11632768|FG000|Phase I (168 Days)|Lost to Follow-up|1
7378098|NCT01147471|11632681|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
7378099|NCT01147471|11632680|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
7378100|NCT01147471|11632681|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
7378101|NCT01147471|11632680|FG000|3 Month Follow Up|Lost to Follow-up|1
7378102|NCT01147471|11632681|FG001|3 Month Follow Up|Lost to Follow-up|1
7378103|NCT01147471|11632680|FG000|3 Month Follow Up|Physician Decision|0
7378104|NCT01147471|11632681|FG001|3 Month Follow Up|Physician Decision|1
7378105|NCT01147471|11632680|FG000|6 Month Follow Up|Lost to Follow-up|4
7378106|NCT01147471|11632681|FG001|6 Month Follow Up|Lost to Follow-up|2
7378107|NCT01147497|11632689|FG000|Overall Study|failed insertion|2
7378108|NCT01147497|11632690|FG001|Overall Study|failed insertion|0
7378109|NCT01147640|11632720|FG000|Overall Study|Adverse Event|2
7378110|NCT01147640|11632721|FG001|Overall Study|Adverse Event|0
7378111|NCT01147640|11632720|FG000|Overall Study|Physician Decision|1
7378112|NCT01147640|11632721|FG001|Overall Study|Physician Decision|0
7378113|NCT01147640|11632720|FG000|Overall Study|Withdrawal by Subject|1
7378114|NCT01147640|11632721|FG001|Overall Study|Withdrawal by Subject|0
7378115|NCT01147640|11632720|FG000|Overall Study|Lost to Follow-up|0
7378116|NCT01147640|11632721|FG001|Overall Study|Lost to Follow-up|1
7378117|NCT01147640|11632720|FG000|Overall Study|Didn't meet eligibility criteria|1
7378118|NCT01147640|11632721|FG001|Overall Study|Didn't meet eligibility criteria|0
7378119|NCT01147744|11632734|FG000|Overall Study|Protocol Violation|1
7378120|NCT01147744|11632735|FG001|Overall Study|Protocol Violation|0
7378121|NCT01147744|11632736|FG002|Overall Study|Protocol Violation|1
7378122|NCT01147744|11632737|FG003|Overall Study|Protocol Violation|0
7378123|NCT01147744|11632738|FG004|Overall Study|Protocol Violation|1
7378124|NCT01147744|11632739|FG005|Overall Study|Protocol Violation|3
7378125|NCT01147744|11632740|FG006|Overall Study|Protocol Violation|1
7378126|NCT01147744|11632734|FG000|Overall Study|Physician Decision|0
7378127|NCT01147744|11632735|FG001|Overall Study|Physician Decision|1
7378128|NCT01147744|11632736|FG002|Overall Study|Physician Decision|1
7378129|NCT01147744|11632737|FG003|Overall Study|Physician Decision|0
7378130|NCT01147744|11632738|FG004|Overall Study|Physician Decision|0
7378131|NCT01147744|11632739|FG005|Overall Study|Physician Decision|0
7378132|NCT01147744|11632740|FG006|Overall Study|Physician Decision|1
7378133|NCT01147744|11632734|FG000|Overall Study|Lack of Efficacy|11
7378134|NCT01147744|11632735|FG001|Overall Study|Lack of Efficacy|11
7378135|NCT01147744|11632736|FG002|Overall Study|Lack of Efficacy|9
7378136|NCT01147744|11632737|FG003|Overall Study|Lack of Efficacy|11
7378137|NCT01147744|11632738|FG004|Overall Study|Lack of Efficacy|13
7378138|NCT01147744|11632739|FG005|Overall Study|Lack of Efficacy|8
7378139|NCT01147744|11632740|FG006|Overall Study|Lack of Efficacy|7
7378140|NCT01147744|11632734|FG000|Overall Study|Adverse Event|1
7378141|NCT01147744|11632735|FG001|Overall Study|Adverse Event|2
7378142|NCT01147744|11632736|FG002|Overall Study|Adverse Event|3
7378143|NCT01147744|11632737|FG003|Overall Study|Adverse Event|0
7378144|NCT01147744|11632738|FG004|Overall Study|Adverse Event|2
7378145|NCT01147744|11632739|FG005|Overall Study|Adverse Event|1
7378146|NCT01147744|11632740|FG006|Overall Study|Adverse Event|2
7378147|NCT01147744|11632734|FG000|Overall Study|Withdrawal by Subject|8
7378148|NCT01147744|11632735|FG001|Overall Study|Withdrawal by Subject|4
7378149|NCT01147744|11632736|FG002|Overall Study|Withdrawal by Subject|2
7378150|NCT01147744|11632737|FG003|Overall Study|Withdrawal by Subject|2
7378151|NCT01147744|11632738|FG004|Overall Study|Withdrawal by Subject|2
7378152|NCT01147744|11632739|FG005|Overall Study|Withdrawal by Subject|5
7378153|NCT01147744|11632740|FG006|Overall Study|Withdrawal by Subject|2
7378154|NCT01147744|11632734|FG000|Overall Study|Lost to Follow-up|0
7378155|NCT01147744|11632735|FG001|Overall Study|Lost to Follow-up|1
7378156|NCT01147744|11632736|FG002|Overall Study|Lost to Follow-up|0
7378157|NCT01147744|11632737|FG003|Overall Study|Lost to Follow-up|0
7378158|NCT01147744|11632738|FG004|Overall Study|Lost to Follow-up|0
7378159|NCT01147744|11632739|FG005|Overall Study|Lost to Follow-up|0
7378160|NCT01147744|11632740|FG006|Overall Study|Lost to Follow-up|0
7378161|NCT01147744|11632734|FG000|Overall Study|Sponsor decision to amend protocol|7
7378162|NCT01147744|11632735|FG001|Overall Study|Sponsor decision to amend protocol|4
7378163|NCT01147744|11632736|FG002|Overall Study|Sponsor decision to amend protocol|2
7378164|NCT01147744|11632737|FG003|Overall Study|Sponsor decision to amend protocol|5
7378165|NCT01147744|11632738|FG004|Overall Study|Sponsor decision to amend protocol|7
7378166|NCT01147744|11632739|FG005|Overall Study|Sponsor decision to amend protocol|2
7378167|NCT01147744|11632740|FG006|Overall Study|Sponsor decision to amend protocol|6
7378168|NCT01147744|11632734|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
7378169|NCT01147744|11632735|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
7378170|NCT01147744|11632736|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
7378171|NCT01147744|11632737|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
7378172|NCT01147744|11632738|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
7378173|NCT01147744|11632739|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
7378174|NCT01147744|11632740|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
7378175|NCT01147809|11632768|FG000|Phase I (168 Days)|Adverse Event|0
7378176|NCT01147809|11632769|FG001|Phase I (168 Days)|Adverse Event|0
7378177|NCT01147809|11632770|FG002|Phase I (168 Days)|Adverse Event|0
7378178|NCT01147809|11632771|FG003|Phase I (168 Days)|Adverse Event|1
7378179|NCT01147809|11632772|FG004|Phase I (168 Days)|Adverse Event|0
7378180|NCT01147809|11632773|FG005|Phase I (168 Days)|Adverse Event|0
7378182|NCT01147809|11632769|FG001|Phase I (168 Days)|Lost to Follow-up|0
7378183|NCT01147809|11632770|FG002|Phase I (168 Days)|Lost to Follow-up|0
7378184|NCT01147809|11632771|FG003|Phase I (168 Days)|Lost to Follow-up|1
7378185|NCT01147809|11632772|FG004|Phase I (168 Days)|Lost to Follow-up|0
7378186|NCT01147809|11632773|FG005|Phase I (168 Days)|Lost to Follow-up|0
7378187|NCT01147809|11632768|FG000|Phase I (168 Days)|Physician Decision|0
7378188|NCT01147809|11632769|FG001|Phase I (168 Days)|Physician Decision|1
7378189|NCT01147809|11632770|FG002|Phase I (168 Days)|Physician Decision|2
7378190|NCT01147809|11632771|FG003|Phase I (168 Days)|Physician Decision|0
7378191|NCT01147809|11632772|FG004|Phase I (168 Days)|Physician Decision|0
7378192|NCT01147809|11632773|FG005|Phase I (168 Days)|Physician Decision|0
7378193|NCT01147809|11632768|FG000|Phase I (168 Days)|Withdrawal by Subject|0
7378194|NCT01147809|11632769|FG001|Phase I (168 Days)|Withdrawal by Subject|0
7378195|NCT01147809|11632770|FG002|Phase I (168 Days)|Withdrawal by Subject|0
7378196|NCT01147809|11632771|FG003|Phase I (168 Days)|Withdrawal by Subject|3
7378197|NCT01147809|11632772|FG004|Phase I (168 Days)|Withdrawal by Subject|0
7378198|NCT01147809|11632773|FG005|Phase I (168 Days)|Withdrawal by Subject|0
7570698|NCT03502616|11948840|FG001|Up to Week 16|Lost to Follow-up|1
7378199|NCT01147809|11632768|FG000|Phase II (168 Days)|Adverse Event|0
7378200|NCT01147809|11632769|FG001|Phase II (168 Days)|Adverse Event|0
7378201|NCT01147809|11632770|FG002|Phase II (168 Days)|Adverse Event|0
7378202|NCT01147809|11632771|FG003|Phase II (168 Days)|Adverse Event|0
7378203|NCT01147809|11632772|FG004|Phase II (168 Days)|Adverse Event|3
7378204|NCT01147809|11632773|FG005|Phase II (168 Days)|Adverse Event|6
7378205|NCT01147809|11632768|FG000|Phase II (168 Days)|Protocol Violation|0
7378206|NCT01147809|11632769|FG001|Phase II (168 Days)|Protocol Violation|0
7378207|NCT01147809|11632770|FG002|Phase II (168 Days)|Protocol Violation|0
7378208|NCT01147809|11632771|FG003|Phase II (168 Days)|Protocol Violation|0
7378209|NCT01147809|11632772|FG004|Phase II (168 Days)|Protocol Violation|0
7378210|NCT01147809|11632773|FG005|Phase II (168 Days)|Protocol Violation|1
7378211|NCT01147809|11632768|FG000|Phase II (168 Days)|Physician Decision|0
7378212|NCT01147809|11632769|FG001|Phase II (168 Days)|Physician Decision|0
7378213|NCT01147809|11632770|FG002|Phase II (168 Days)|Physician Decision|0
7378214|NCT01147809|11632771|FG003|Phase II (168 Days)|Physician Decision|0
7378215|NCT01147809|11632772|FG004|Phase II (168 Days)|Physician Decision|5
7378216|NCT01147809|11632773|FG005|Phase II (168 Days)|Physician Decision|11
7378217|NCT01147809|11632768|FG000|Phase II (168 Days)|Withdrawal by Subject|0
7378218|NCT01147809|11632769|FG001|Phase II (168 Days)|Withdrawal by Subject|0
7378219|NCT01147809|11632770|FG002|Phase II (168 Days)|Withdrawal by Subject|0
7570699|NCT03502616|11948839|FG000|Up to Week 16|Randomized, but not treated|1
7570700|NCT03502616|11948840|FG001|Up to Week 16|Randomized, but not treated|0
7570701|NCT03502616|11948839|FG000|Week 16 to Week 48|Withdrawal by Subject|6
7570702|NCT03502616|11948840|FG001|Week 16 to Week 48|Withdrawal by Subject|6
7570703|NCT03502616|11948839|FG000|Week 16 to Week 48|Lost to Follow-up|1
7570704|NCT03502616|11948840|FG001|Week 16 to Week 48|Lost to Follow-up|0
7570705|NCT03502798|11948850|FG000|Overall Study|equipment failure|0
7570706|NCT03502798|11948851|FG001|Overall Study|equipment failure|7
7570707|NCT03503162|11948879|FG000|Overall Study|did not meet eligibility|1
7570708|NCT03503188|11948885|FG000|Overall Study|Non eligible in the sub study|0
7570709|NCT03503188|11948886|FG001|Overall Study|Non eligible in the sub study|1
7570710|NCT03504189|11948914|FG000|Overall Study|Withdrawal by Subject|1
7570711|NCT03504189|11948914|FG000|Overall Study|Screening Failure|1
7570712|NCT03504189|11948914|FG000|Overall Study|Device Failure|2
7570713|NCT03504852|11948930|FG000|Overall Study|Withdrawal of informed consent|2
7378220|NCT01147809|11632771|FG003|Phase II (168 Days)|Withdrawal by Subject|0
7378221|NCT01147809|11632772|FG004|Phase II (168 Days)|Withdrawal by Subject|7
7378222|NCT01147809|11632773|FG005|Phase II (168 Days)|Withdrawal by Subject|15
7378223|NCT01147809|11632768|FG000|Phase II (168 Days)|Ongoing|0
7378224|NCT01147809|11632769|FG001|Phase II (168 Days)|Ongoing|0
7378225|NCT01147809|11632770|FG002|Phase II (168 Days)|Ongoing|0
7378226|NCT01147809|11632771|FG003|Phase II (168 Days)|Ongoing|0
7378227|NCT01147809|11632772|FG004|Phase II (168 Days)|Ongoing|1
7378228|NCT01147809|11632773|FG005|Phase II (168 Days)|Ongoing|0
7378229|NCT01147848|11632790|FG000|Run-in Period|Screen Failure|623
7378230|NCT01147848|11632791|FG001|Run-in Period|Screen Failure|0
7378231|NCT01147848|11632792|FG002|Run-in Period|Screen Failure|0
7378232|NCT01147848|11632790|FG000|Run-in Period|Run-in Failure|135
7378233|NCT01147848|11632791|FG001|Run-in Period|Run-in Failure|0
7378234|NCT01147848|11632792|FG002|Run-in Period|Run-in Failure|0
7378235|NCT01147848|11632790|FG000|Randomized Phase|Adverse Event|0
7378236|NCT01147848|11632791|FG001|Randomized Phase|Adverse Event|6
7378237|NCT01147848|11632792|FG002|Randomized Phase|Adverse Event|8
7378238|NCT01147848|11632790|FG000|Randomized Phase|Lack of Efficacy|0
7378239|NCT01147848|11632791|FG001|Randomized Phase|Lack of Efficacy|20
7378240|NCT01147848|11632792|FG002|Randomized Phase|Lack of Efficacy|11
7378241|NCT01147848|11632790|FG000|Randomized Phase|Protocol Violation|0
7378242|NCT01147848|11632791|FG001|Randomized Phase|Protocol Violation|7
7378243|NCT01147848|11632792|FG002|Randomized Phase|Protocol Violation|10
7378244|NCT01147848|11632790|FG000|Randomized Phase|Lost to Follow-up|0
7378245|NCT01147848|11632791|FG001|Randomized Phase|Lost to Follow-up|5
7378246|NCT01147848|11632792|FG002|Randomized Phase|Lost to Follow-up|7
7378247|NCT01147848|11632790|FG000|Randomized Phase|Physician Decision|0
7378248|NCT01147848|11632791|FG001|Randomized Phase|Physician Decision|0
7378249|NCT01147848|11632792|FG002|Randomized Phase|Physician Decision|1
7378250|NCT01147848|11632790|FG000|Randomized Phase|Withdrawal by Subject|0
7378251|NCT01147848|11632791|FG001|Randomized Phase|Withdrawal by Subject|7
7378252|NCT01147848|11632792|FG002|Randomized Phase|Withdrawal by Subject|9
7378253|NCT01147874|11632799|FG000|Overall Study|Adverse Event|5
7378254|NCT01147874|11632799|FG000|Overall Study|Investigator's Request|1
7378255|NCT01147874|11632799|FG000|Overall Study|Lost to Follow-up|25
7378256|NCT01147874|11632799|FG000|Overall Study|Other|5
7378257|NCT01147874|11632799|FG000|Overall Study|Protocol Violation|5
7378258|NCT01147874|11632799|FG000|Overall Study|Sponsor's Decision|2
7378259|NCT01147874|11632799|FG000|Overall Study|Withdrawal by Subject|24
7378260|NCT01147900|11632806|FG000|At Year 10|Lost to Follow-up|0
7378261|NCT01147900|11632807|FG001|At Year 10|Lost to Follow-up|1
7378262|NCT01147900|11632808|FG002|At Year 10|Lost to Follow-up|0
7378263|NCT01147926|11632818|FG000|Overall Study|Subject Withdrew Consent|9
7378264|NCT01147926|11632819|FG001|Overall Study|Subject Withdrew Consent|10
7378265|NCT01147926|11632818|FG000|Overall Study|Adverse Event|7
7378266|NCT01147926|11632819|FG001|Overall Study|Adverse Event|6
7378267|NCT01147926|11632818|FG000|Overall Study|Subject Non-Compliant|5
7378268|NCT01147926|11632819|FG001|Overall Study|Subject Non-Compliant|4
7378269|NCT01147926|11632818|FG000|Overall Study|Principal investigator left hospital|1
7378270|NCT01147926|11632819|FG001|Overall Study|Principal investigator left hospital|3
7378271|NCT01147926|11632818|FG000|Overall Study|Selection criteria not met|3
7378272|NCT01147926|11632819|FG001|Overall Study|Selection criteria not met|1
7378273|NCT01147926|11632818|FG000|Overall Study|Lost to Follow-up|0
7378274|NCT01147926|11632819|FG001|Overall Study|Lost to Follow-up|2
7378275|NCT01147926|11632818|FG000|Overall Study|Sponsor's Decision|0
7378276|NCT01147926|11632819|FG001|Overall Study|Sponsor's Decision|1
7378277|NCT01147926|11632818|FG000|Overall Study|Lack of Efficacy|1
7378278|NCT01147926|11632819|FG001|Overall Study|Lack of Efficacy|0
7378279|NCT01147926|11632818|FG000|Overall Study|Too busy, no time for study|1
7378280|NCT01147926|11632819|FG001|Overall Study|Too busy, no time for study|0
7378281|NCT01147926|11632818|FG000|Overall Study|Went on holiday|0
7378282|NCT01147926|11632819|FG001|Overall Study|Went on holiday|1
7378283|NCT01147926|11632818|FG000|Overall Study|Colonoscopy result|0
7378284|NCT01147926|11632819|FG001|Overall Study|Colonoscopy result|1
7378285|NCT01148017|11632829|FG000|Overall Study|Withdrawal by Subject|31
7378286|NCT01148017|11632830|FG001|Overall Study|Withdrawal by Subject|14
7378287|NCT01148017|11632831|FG002|Overall Study|Withdrawal by Subject|0
7378288|NCT01148017|11632832|FG003|Overall Study|Withdrawal by Subject|0
7378289|NCT01148017|11632829|FG000|Overall Study|Lost to Follow-up|23
7378290|NCT01148017|11632830|FG001|Overall Study|Lost to Follow-up|10
7378291|NCT01148017|11632831|FG002|Overall Study|Lost to Follow-up|0
7378292|NCT01148017|11632832|FG003|Overall Study|Lost to Follow-up|0
7378293|NCT01148017|11632829|FG000|Overall Study|Inappropriate enrollment|1
7378294|NCT01148017|11632830|FG001|Overall Study|Inappropriate enrollment|0
7378295|NCT01148017|11632831|FG002|Overall Study|Inappropriate enrollment|0
7378296|NCT01148017|11632832|FG003|Overall Study|Inappropriate enrollment|0
7378297|NCT01148017|11632829|FG000|Overall Study|Administrative reason|22
7378298|NCT01148017|11632830|FG001|Overall Study|Administrative reason|9
7378299|NCT01148017|11632831|FG002|Overall Study|Administrative reason|0
7378300|NCT01148017|11632832|FG003|Overall Study|Administrative reason|0
7378301|NCT01148017|11632829|FG000|Overall Study|Unable to classify|3
7378302|NCT01148017|11632830|FG001|Overall Study|Unable to classify|1
7378303|NCT01148017|11632831|FG002|Overall Study|Unable to classify|0
7378304|NCT01148017|11632832|FG003|Overall Study|Unable to classify|0
7378305|NCT01148225|11632843|FG000|Overall Study|Other|185
7378306|NCT01148459|11632857|FG000|Overall Study|Serious Adverse Event|5
7378307|NCT01148459|11632858|FG001|Overall Study|Serious Adverse Event|4
7378308|NCT01148459|11632857|FG000|Overall Study|Withdrawal by Subject|1
7378309|NCT01148459|11632858|FG001|Overall Study|Withdrawal by Subject|0
7378310|NCT01148459|11632857|FG000|Overall Study|Migrated/moved from study area|3
7378311|NCT01148459|11632858|FG001|Overall Study|Migrated/moved from study area|6
7378312|NCT01148459|11632857|FG000|Overall Study|Lost to Follow-up|2
7378313|NCT01148459|11632858|FG001|Overall Study|Lost to Follow-up|0
7378314|NCT01148459|11632857|FG000|Overall Study|Refusal|1
7378315|NCT01148459|11632858|FG001|Overall Study|Refusal|0
7378316|NCT01148459|11632857|FG000|Overall Study|Failure to comply with study procedures|0
7378317|NCT01148459|11632858|FG001|Overall Study|Failure to comply with study procedures|1
7378318|NCT01148511|11632866|FG000|Exposed to Study Drug|Protocol Violation|2
7378319|NCT01148511|11632867|FG001|Exposed to Study Drug|Protocol Violation|0
7378320|NCT01148511|11632868|FG002|Exposed to Study Drug|Protocol Violation|0
7378321|NCT01148511|11632866|FG000|Exposed to Study Drug|Lost to Follow-up|4
7378322|NCT01148511|11632867|FG001|Exposed to Study Drug|Lost to Follow-up|0
7378323|NCT01148511|11632868|FG002|Exposed to Study Drug|Lost to Follow-up|0
7378324|NCT01148511|11632866|FG000|Randomized|Adverse Event|0
7378325|NCT01148511|11632867|FG001|Randomized|Adverse Event|1
7378326|NCT01148511|11632868|FG002|Randomized|Adverse Event|0
7378327|NCT01148511|11632866|FG000|Randomized|Protocol Violation|0
7378328|NCT01148511|11632867|FG001|Randomized|Protocol Violation|2
7378329|NCT01148511|11632868|FG002|Randomized|Protocol Violation|1
7378330|NCT01148511|11632866|FG000|Randomized|Lost to Follow-up|0
7378331|NCT01148511|11632867|FG001|Randomized|Lost to Follow-up|1
7378332|NCT01148511|11632868|FG002|Randomized|Lost to Follow-up|1
7378333|NCT01148511|11632866|FG000|Randomized|Consent withdrawal|0
7378334|NCT01148511|11632867|FG001|Randomized|Consent withdrawal|5
7378335|NCT01148511|11632868|FG002|Randomized|Consent withdrawal|3
7378336|NCT01148511|11632866|FG000|Randomized|Other|0
7378337|NCT01148511|11632867|FG001|Randomized|Other|1
7378338|NCT01148511|11632868|FG002|Randomized|Other|1
7378339|NCT01148537|11632915|FG000|Overall Study|Withdrawal by Subject|1
7378340|NCT01148537|11632916|FG001|Overall Study|Withdrawal by Subject|0
7378341|NCT01148537|11632917|FG002|Overall Study|Withdrawal by Subject|2
7378342|NCT01148537|11632915|FG000|Overall Study|Adverse Event|2
7378343|NCT01148537|11632916|FG001|Overall Study|Adverse Event|0
7378344|NCT01148537|11632917|FG002|Overall Study|Adverse Event|1
7378345|NCT01148693|11632938|FG000|Overall Study|Attempts for cannulation were failed|13
7378346|NCT01148693|11632939|FG001|Overall Study|Attempts for cannulation were failed|10
7378347|NCT01148771|11632953|FG000|Washout Period|Withdrawal by Subject|0
7378348|NCT01148771|11632954|FG001|Washout Period|Withdrawal by Subject|1
7378349|NCT01148810|11632966|FG000|Overall Study|Adverse Event|0
7378350|NCT01148810|11632967|FG001|Overall Study|Adverse Event|2
7378351|NCT01148810|11632966|FG000|Overall Study|Lack of Efficacy|0
7378352|NCT01148810|11632967|FG001|Overall Study|Lack of Efficacy|1
7378353|NCT01148810|11632966|FG000|Overall Study|Withdrawal by Subject|0
7378354|NCT01148810|11632967|FG001|Overall Study|Withdrawal by Subject|2
7378355|NCT01148810|11632966|FG000|Overall Study|Protocol Violation|1
7378356|NCT01148810|11632967|FG001|Overall Study|Protocol Violation|0
7378357|NCT01148862|11632983|FG000|Second Intervention|Withdrawal by Subject|0
7378358|NCT01148862|11632984|FG001|Second Intervention|Withdrawal by Subject|2
7378359|NCT01148979|11633004|FG000|Overall Study|Lost to Follow-up|0
7378360|NCT01148979|11633005|FG001|Overall Study|Lost to Follow-up|1
7378361|NCT01149057|11633011|FG000|Overall Study|Lack of Efficacy|16
7378362|NCT01149057|11633011|FG000|Overall Study|Adverse Event|13
7378363|NCT01149057|11633011|FG000|Overall Study|Withdrawal by Subject|9
7378364|NCT01149057|11633011|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
7378365|NCT01149057|11633011|FG000|Overall Study|B Cell Depletion|4
7378366|NCT01149057|11633011|FG000|Overall Study|Participant Non-Compliance|2
7378367|NCT01149057|11633011|FG000|Overall Study|Lost to Follow-up|1
7378368|NCT01149057|11633011|FG000|Overall Study|High Parathyroid Hormone Value|1
7378369|NCT01149057|11633011|FG000|Overall Study|Other|6
7378370|NCT01149096|11633017|FG000|Overall Study|Lost to Follow-up|0
7378371|NCT01149096|11633018|FG001|Overall Study|Lost to Follow-up|1
7378372|NCT01149148|11633027|FG000|Overall Study|Lost to Follow-up|1
7378373|NCT01149148|11633028|FG001|Overall Study|Lost to Follow-up|2
7378374|NCT01149148|11633027|FG000|Overall Study|Death|1
7378375|NCT01149148|11633028|FG001|Overall Study|Death|0
7378376|NCT01149343|11633039|FG000|Overall Study|Withdrawal by Subject|1
7378377|NCT01149343|11633040|FG001|Overall Study|Withdrawal by Subject|1
7378378|NCT01149343|11633041|FG002|Overall Study|Withdrawal by Subject|1
7378379|NCT01149343|11633042|FG003|Overall Study|Withdrawal by Subject|5
7378380|NCT01149343|11633039|FG000|Overall Study|Death|10
7378381|NCT01149343|11633040|FG001|Overall Study|Death|13
7378382|NCT01149343|11633041|FG002|Overall Study|Death|18
7378383|NCT01149343|11633042|FG003|Overall Study|Death|18
7378384|NCT01149343|11633039|FG000|Overall Study|Lost to Follow-up|1
7378385|NCT01149343|11633040|FG001|Overall Study|Lost to Follow-up|0
7378386|NCT01149343|11633041|FG002|Overall Study|Lost to Follow-up|0
7378387|NCT01149343|11633042|FG003|Overall Study|Lost to Follow-up|1
7378388|NCT01149343|11633039|FG000|Overall Study|Other|8
7378389|NCT01149343|11633040|FG001|Overall Study|Other|10
7378390|NCT01149343|11633041|FG002|Overall Study|Other|2
7378391|NCT01149343|11633042|FG003|Overall Study|Other|14
7378392|NCT01149343|11633039|FG000|Overall Study|Sponsor study termination|0
7378393|NCT01149343|11633040|FG001|Overall Study|Sponsor study termination|0
7378394|NCT01149343|11633041|FG002|Overall Study|Sponsor study termination|0
7378395|NCT01149343|11633042|FG003|Overall Study|Sponsor study termination|2
7378396|NCT01149343|11633039|FG000|Overall Study|Recurrence / Progressive disease|0
7378397|NCT01149343|11633040|FG001|Overall Study|Recurrence / Progressive disease|0
7378398|NCT01149343|11633041|FG002|Overall Study|Recurrence / Progressive disease|1
7378399|NCT01149343|11633042|FG003|Overall Study|Recurrence / Progressive disease|0
7378400|NCT01149369|11633058|FG000|Overall Study|Adverse Event|6
7378401|NCT01149369|11633059|FG001|Overall Study|Adverse Event|3
7378402|NCT01149421|11633068|FG000|Overall Study|Adverse Event|22
7378403|NCT01149421|11633069|FG001|Overall Study|Adverse Event|6
7378404|NCT01149421|11633070|FG002|Overall Study|Adverse Event|11
7378405|NCT01149421|11633068|FG000|Overall Study|Withdrawal by Subject|20
7378406|NCT01149421|11633069|FG001|Overall Study|Withdrawal by Subject|12
7378407|NCT01149421|11633070|FG002|Overall Study|Withdrawal by Subject|13
7378408|NCT01149421|11633068|FG000|Overall Study|Sponsor Decision|0
7378409|NCT01149421|11633069|FG001|Overall Study|Sponsor Decision|1
7378410|NCT01149421|11633070|FG002|Overall Study|Sponsor Decision|1
7378411|NCT01149421|11633068|FG000|Overall Study|Lost to Follow-up|2
7378412|NCT01149421|11633069|FG001|Overall Study|Lost to Follow-up|4
7378413|NCT01149421|11633070|FG002|Overall Study|Lost to Follow-up|5
7378414|NCT01149421|11633068|FG000|Overall Study|Physician Decision|5
7378415|NCT01149421|11633069|FG001|Overall Study|Physician Decision|3
7378416|NCT01149421|11633070|FG002|Overall Study|Physician Decision|6
7378417|NCT01149421|11633068|FG000|Overall Study|Entry Criteria Not Met|1
7378418|NCT01149421|11633069|FG001|Overall Study|Entry Criteria Not Met|1
7378419|NCT01149421|11633070|FG002|Overall Study|Entry Criteria Not Met|2
7378420|NCT01149421|11633068|FG000|Overall Study|Protocol Violation|2
7378421|NCT01149421|11633069|FG001|Overall Study|Protocol Violation|2
7378422|NCT01149421|11633070|FG002|Overall Study|Protocol Violation|6
7378423|NCT01149460|11633090|FG000|Overall Study|Withdrawal by Subject|0
7378424|NCT01149460|11633091|FG001|Overall Study|Withdrawal by Subject|2
7378425|NCT01149473|11633099|FG000|First Intervention|Adverse Event|1
7378426|NCT01149473|11633100|FG001|First Intervention|Adverse Event|1
7378427|NCT01149473|11633099|FG000|Washout of 7 Days|Withdrawal by Subject|1
7378428|NCT01149473|11633100|FG001|Washout of 7 Days|Withdrawal by Subject|1
7378429|NCT01149486|11633108|FG000|First Intervention|Adverse Event|0
7378430|NCT01149486|11633109|FG001|First Intervention|Adverse Event|1
7378431|NCT01149538|11633121|FG000|Overall Study|Lost to Follow-up|0
7378432|NCT01149538|11633122|FG001|Overall Study|Lost to Follow-up|1
7378433|NCT01149538|11633121|FG000|Overall Study|Withdrawal by Subject|5
7378434|NCT01149538|11633122|FG001|Overall Study|Withdrawal by Subject|3
7378435|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
7378436|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
7378437|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
7378438|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
7378439|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
7378440|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7378441|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7378442|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
7378443|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
7378444|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7378445|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7378446|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
7378447|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Physician Decision|2
7378448|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Physician Decision|0
7378449|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Physician Decision|0
7378450|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Physician Decision|0
7378451|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
7378452|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
7378453|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
7378454|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
7378455|NCT01149655|11633141|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
7378456|NCT01149655|11633142|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7378457|NCT01149655|11633143|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7378458|NCT01149655|11633144|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
7378459|NCT01149655|11633141|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7378460|NCT01149655|11633142|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
7378461|NCT01149655|11633143|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7378462|NCT01149655|11633144|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
7378463|NCT01149655|11633141|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7378464|NCT01149655|11633142|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
7378465|NCT01149655|11633143|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7378466|NCT01149655|11633144|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
7378467|NCT01149655|11633141|FG000|Period 2-Stabilization Phase|Physician Decision|0
7378468|NCT01149655|11633142|FG001|Period 2-Stabilization Phase|Physician Decision|3
7378469|NCT01149655|11633143|FG002|Period 2-Stabilization Phase|Physician Decision|0
7378470|NCT01149655|11633144|FG003|Period 2-Stabilization Phase|Physician Decision|0
7378471|NCT01149655|11633141|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
7378472|NCT01149655|11633142|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
7378473|NCT01149655|11633143|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
7378474|NCT01149655|11633144|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
7378475|NCT01149655|11633141|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7378476|NCT01149655|11633142|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
7378477|NCT01149655|11633143|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7378478|NCT01149655|11633144|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
7378479|NCT01149655|11633141|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7378480|NCT01149655|11633142|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
7378481|NCT01149655|11633143|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
7378482|NCT01149655|11633144|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
7378483|NCT01149655|11633141|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
7378484|NCT01149655|11633142|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
7378485|NCT01149655|11633143|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
7378486|NCT01149655|11633144|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
7378487|NCT01149655|11633141|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7378488|NCT01149655|11633142|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
7378489|NCT01149655|11633143|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7378490|NCT01149655|11633144|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
7378491|NCT01149655|11633141|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7378492|NCT01149655|11633142|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
7378493|NCT01149655|11633143|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7378494|NCT01149655|11633144|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
7378495|NCT01149655|11633141|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
7378496|NCT01149655|11633142|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
7378497|NCT01149655|11633143|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
7378498|NCT01149655|11633144|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
7378499|NCT01149681|11633152|FG000|Overall Study|Withdrawal by Subject|7
7378500|NCT01149681|11633152|FG000|Overall Study|Progressive disease|1
7378501|NCT01149681|11633152|FG000|Overall Study|Physician Decision|2
7387231|NCT01213251|11645514|FG000|Overall Study|Death|2
7462027|NCT01845818|11758725|FG001|Overall Study|Lost to Follow-up|5
7462028|NCT01845818|11758724|FG000|Overall Study|Administrative Reasons|3
7378502|NCT01149681|11633152|FG000|Overall Study|adverse events nonrelated study drug|2
7378503|NCT01149863|11633188|FG000|Overall Study|Missing data or Not receiveing studydrug|3
7378504|NCT01150097|11633213|FG000|Months 24 to 36 Post-transplantation|Death|2
7378505|NCT01150097|11633214|FG001|Months 24 to 36 Post-transplantation|Death|0
7378506|NCT01150097|11633215|FG002|Months 24 to 36 Post-transplantation|Death|0
7378507|NCT01150097|11633213|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
7378508|NCT01150097|11633214|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
7378509|NCT01150097|11633215|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
7378510|NCT01150097|11633213|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7378511|NCT01150097|11633214|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
7378512|NCT01150097|11633215|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
7378513|NCT01150097|11633213|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7378514|NCT01150097|11633214|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
7378515|NCT01150097|11633215|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
7378516|NCT01150097|11633213|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
7378517|NCT01150097|11633214|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
7378518|NCT01150097|11633215|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
7378519|NCT01150097|11633213|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
7378520|NCT01150097|11633214|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7462029|NCT01845818|11758725|FG001|Overall Study|Administrative Reasons|1
7462030|NCT01845818|11758724|FG000|Overall Study|Serious Adverse Event|1
7462031|NCT01845818|11758725|FG001|Overall Study|Serious Adverse Event|1
7462032|NCT01845818|11758724|FG000|Overall Study|Other|25
7462033|NCT01845818|11758725|FG001|Overall Study|Other|8
7462034|NCT01845818|11758724|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
7462035|NCT01845818|11758725|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
7462036|NCT01845818|11758724|FG000|Overall Study|No Follow-Up Data Available|4
7462037|NCT01845818|11758725|FG001|Overall Study|No Follow-Up Data Available|1
7462038|NCT01845831|11758735|FG000|Inpatient Phase|Withdrawal by Subject|1
7462039|NCT01845831|11758736|FG001|Inpatient Phase|Withdrawal by Subject|1
7462040|NCT01845831|11758737|FG002|Inpatient Phase|Withdrawal by Subject|0
7462041|NCT01845831|11758738|FG003|Inpatient Phase|Withdrawal by Subject|0
7462042|NCT01845831|11758739|FG004|Inpatient Phase|Withdrawal by Subject|0
7462043|NCT01845974|11758752|FG000|Overall Study|screen failure|1
7462044|NCT01845974|11758753|FG001|Overall Study|screen failure|0
7462045|NCT01846039|11758759|FG000|Overall Study|Protocol Violation|1
7462046|NCT01846039|11758759|FG000|Overall Study|Subject Withdrew Consent|1
7462047|NCT01846104|11758763|FG000|Overall Study|Withdrawal by Subject|1
7462048|NCT01846208|11758770|FG000|Overall Study|Withdrew prior to treatment|1
7462049|NCT01846208|11758771|FG001|Overall Study|Withdrew prior to treatment|1
7462050|NCT01846208|11758772|FG002|Overall Study|Withdrew prior to treatment|1
7462051|NCT01846208|11758770|FG000|Overall Study|Dosing Symptoms|1
7462052|NCT01846208|11758771|FG001|Overall Study|Dosing Symptoms|2
7462053|NCT01846208|11758772|FG002|Overall Study|Dosing Symptoms|6
7462054|NCT01846208|11758770|FG000|Overall Study|Withdrawal by Subject|5
7462055|NCT01846208|11758771|FG001|Overall Study|Withdrawal by Subject|0
7462056|NCT01846208|11758772|FG002|Overall Study|Withdrawal by Subject|0
7462057|NCT01846208|11758770|FG000|Overall Study|Non-compliance|1
7462058|NCT01846208|11758771|FG001|Overall Study|Non-compliance|1
7462059|NCT01846208|11758772|FG002|Overall Study|Non-compliance|0
7462060|NCT01846208|11758770|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
7462061|NCT01846208|11758771|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7462062|NCT01846208|11758772|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
7462063|NCT01846208|11758770|FG000|Overall Study|Refused SU OFC|0
7462064|NCT01846208|11758771|FG001|Overall Study|Refused SU OFC|0
7462065|NCT01846208|11758772|FG002|Overall Study|Refused SU OFC|1
7462066|NCT01846221|11758782|FG000|Overall Study|Catheter Failure|2
7462067|NCT01846221|11758783|FG001|Overall Study|Catheter Failure|0
7462068|NCT01846221|11758782|FG000|Overall Study|Age Exclusion|1
7462069|NCT01846221|11758783|FG001|Overall Study|Age Exclusion|0
7462070|NCT01846299|11758791|FG000|Overall Study|Physician Decision|4
7462071|NCT01846299|11758792|FG001|Overall Study|Physician Decision|2
7462072|NCT01846299|11758791|FG000|Overall Study|Protocol deviation|1
7462073|NCT01846299|11758792|FG001|Overall Study|Protocol deviation|0
7462074|NCT01846299|11758791|FG000|Overall Study|Death|1
7462075|NCT01846299|11758792|FG001|Overall Study|Death|2
7462076|NCT01846299|11758791|FG000|Overall Study|Lost to Follow-up|3
7462077|NCT01846299|11758792|FG001|Overall Study|Lost to Follow-up|0
7462078|NCT01846299|11758791|FG000|Overall Study|Withdrawal by Subject|1
7462079|NCT01846299|11758792|FG001|Overall Study|Withdrawal by Subject|6
7462080|NCT01846299|11758791|FG000|Overall Study|Adverse Event|2
7462081|NCT01846299|11758792|FG001|Overall Study|Adverse Event|0
7462082|NCT01846416|11758803|FG000|Treatment Phase|Death|2
7462083|NCT01846416|11758804|FG001|Treatment Phase|Death|9
7462084|NCT01846416|11758805|FG002|Treatment Phase|Death|1
7462085|NCT01846416|11758803|FG000|Treatment Phase|Withdrawal by Subject|2
7462086|NCT01846416|11758804|FG001|Treatment Phase|Withdrawal by Subject|4
7462087|NCT01846416|11758805|FG002|Treatment Phase|Withdrawal by Subject|2
7462088|NCT01846416|11758803|FG000|Treatment Phase|Other|1
7462089|NCT01846416|11758804|FG001|Treatment Phase|Other|5
7378521|NCT01150097|11633215|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
7378522|NCT01150097|11633213|FG000|Months 24 to 48 Post-transplantation|Death|2
7378523|NCT01150097|11633214|FG001|Months 24 to 48 Post-transplantation|Death|0
7378524|NCT01150097|11633215|FG002|Months 24 to 48 Post-transplantation|Death|0
7378525|NCT01150123|11633243|FG000|Overall Study|Withdrawal by Subject|1
7378526|NCT01150123|11633244|FG001|Overall Study|Withdrawal by Subject|1
7378527|NCT01150123|11633245|FG002|Overall Study|Withdrawal by Subject|2
7378528|NCT01150123|11633246|FG003|Overall Study|Withdrawal by Subject|1
7378529|NCT01150123|11633247|FG004|Overall Study|Withdrawal by Subject|1
7378530|NCT01150123|11633248|FG005|Overall Study|Withdrawal by Subject|1
7378531|NCT01150123|11633249|FG006|Overall Study|Withdrawal by Subject|0
7378532|NCT01150123|11633250|FG007|Overall Study|Withdrawal by Subject|3
7378533|NCT01150123|11633251|FG008|Overall Study|Withdrawal by Subject|2
7378534|NCT01150123|11633252|FG009|Overall Study|Withdrawal by Subject|0
7378535|NCT01150123|11633253|FG010|Overall Study|Withdrawal by Subject|1
7378536|NCT01150123|11633254|FG011|Overall Study|Withdrawal by Subject|0
7378537|NCT01150123|11633255|FG012|Overall Study|Withdrawal by Subject|1
7378538|NCT01150123|11633256|FG013|Overall Study|Withdrawal by Subject|0
7378539|NCT01150123|11633257|FG014|Overall Study|Withdrawal by Subject|0
7378540|NCT01150123|11633258|FG015|Overall Study|Withdrawal by Subject|1
7378541|NCT01150123|11633259|FG016|Overall Study|Withdrawal by Subject|0
7378542|NCT01150123|11633260|FG017|Overall Study|Withdrawal by Subject|1
7378543|NCT01150123|11633243|FG000|Overall Study|Lost to Follow-up|2
7378544|NCT01150123|11633244|FG001|Overall Study|Lost to Follow-up|1
7378545|NCT01150123|11633245|FG002|Overall Study|Lost to Follow-up|2
7378546|NCT01150123|11633246|FG003|Overall Study|Lost to Follow-up|2
7378547|NCT01150123|11633247|FG004|Overall Study|Lost to Follow-up|2
7378548|NCT01150123|11633248|FG005|Overall Study|Lost to Follow-up|5
7378549|NCT01150123|11633249|FG006|Overall Study|Lost to Follow-up|0
7378550|NCT01150123|11633250|FG007|Overall Study|Lost to Follow-up|0
7378551|NCT01150123|11633251|FG008|Overall Study|Lost to Follow-up|3
7378552|NCT01150123|11633252|FG009|Overall Study|Lost to Follow-up|1
7378553|NCT01150123|11633253|FG010|Overall Study|Lost to Follow-up|1
7378554|NCT01150123|11633254|FG011|Overall Study|Lost to Follow-up|1
7378555|NCT01150123|11633255|FG012|Overall Study|Lost to Follow-up|2
7378556|NCT01150123|11633256|FG013|Overall Study|Lost to Follow-up|0
7378557|NCT01150123|11633257|FG014|Overall Study|Lost to Follow-up|0
7378558|NCT01150123|11633258|FG015|Overall Study|Lost to Follow-up|0
7378559|NCT01150123|11633259|FG016|Overall Study|Lost to Follow-up|0
7378560|NCT01150123|11633260|FG017|Overall Study|Lost to Follow-up|0
7378561|NCT01150357|11633320|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
7378562|NCT01150357|11633321|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
7378563|NCT01150357|11633322|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
7378564|NCT01150357|11633320|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
7378565|NCT01150357|11633321|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7378566|NCT01150357|11633322|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
7378567|NCT01150357|11633320|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
7378568|NCT01150357|11633321|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
7378569|NCT01150357|11633322|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
7378570|NCT01150357|11633320|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
7378571|NCT01150357|11633321|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
7378572|NCT01150357|11633322|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
7378573|NCT01150357|11633320|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7378574|NCT01150357|11633321|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
7378575|NCT01150357|11633322|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
7378576|NCT01150357|11633320|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
7378577|NCT01150357|11633321|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7378578|NCT01150357|11633322|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
7378579|NCT01150357|11633320|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
7378580|NCT01150357|11633321|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7378581|NCT01150357|11633322|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
7378582|NCT01150474|11633353|FG000|Overall Study|Withdrawal by Subject|5
7378583|NCT01150474|11633354|FG001|Overall Study|Withdrawal by Subject|2
7378584|NCT01150474|11633353|FG000|Overall Study|Cancer found|1
7378585|NCT01150474|11633354|FG001|Overall Study|Cancer found|0
7378586|NCT01150474|11633353|FG000|Overall Study|Multiple Studies|0
7378587|NCT01150474|11633354|FG001|Overall Study|Multiple Studies|1
7378588|NCT01150474|11633353|FG000|Overall Study|Rectotomy|1
7378589|NCT01150474|11633354|FG001|Overall Study|Rectotomy|0
7378590|NCT01150474|11633353|FG000|Overall Study|Drug did not arrive in time|1
7378591|NCT01150474|11633354|FG001|Overall Study|Drug did not arrive in time|0
7378592|NCT01150474|11633353|FG000|Overall Study|Drug not administered|1
7378593|NCT01150474|11633354|FG001|Overall Study|Drug not administered|0
7378594|NCT01150474|11633353|FG000|Overall Study|Surgery Changed|1
7378595|NCT01150474|11633354|FG001|Overall Study|Surgery Changed|0
7387232|NCT01213251|11645515|FG001|Overall Study|Death|1
7387233|NCT01213251|11645516|FG002|Overall Study|Death|2
7387234|NCT01213251|11645514|FG000|Overall Study|Exit|3
7387235|NCT01213251|11645515|FG001|Overall Study|Exit|2
7387236|NCT01213251|11645516|FG002|Overall Study|Exit|8
7378596|NCT01151020|11633409|FG000|Overall Study|Death|25
7378597|NCT01151020|11633409|FG000|Overall Study|Conversion to open repair|1
7378598|NCT01151020|11633409|FG000|Overall Study|Lost to Follow-up|4
7378599|NCT01151020|11633409|FG000|Overall Study|Withdrawal by Subject|22
7378600|NCT01151020|11633409|FG000|Overall Study|Patients did not receive the device|2
7378601|NCT01151085|11633426|FG000|Overall Study|Lost to Follow-up|31
7378602|NCT01151085|11633426|FG000|Overall Study|Protocol Violation|25
7378603|NCT01151098|11633437|FG000|Overall Study|Adverse Event|82
7378604|NCT01151098|11633437|FG000|Overall Study|Lost to Follow-up|6
7378605|NCT01151098|11633437|FG000|Overall Study|Lack of Efficacy|15
7378606|NCT01151098|11633437|FG000|Overall Study|Protocol Violation|1
7378607|NCT01151098|11633437|FG000|Overall Study|Miscellaneous|13
7378608|NCT01151137|11633443|FG000|Overall Study|Death|15
7378609|NCT01151137|11633444|FG001|Overall Study|Death|27
7378610|NCT01151137|11633443|FG000|Overall Study|Lost to Follow-up|1
7378611|NCT01151137|11633444|FG001|Overall Study|Lost to Follow-up|1
7378612|NCT01151215|11633462|FG000|Overall Study|Worsening of condition under study|1
7378613|NCT01151215|11633463|FG001|Overall Study|Worsening of condition under study|1
7378614|NCT01151215|11633464|FG002|Overall Study|Worsening of condition under study|1
7378615|NCT01151215|11633462|FG000|Overall Study|Death|16
7378616|NCT01151215|11633463|FG001|Overall Study|Death|20
7378617|NCT01151215|11633464|FG002|Overall Study|Death|11
7378618|NCT01151215|11633462|FG000|Overall Study|Lost to Follow-up|0
7378619|NCT01151215|11633463|FG001|Overall Study|Lost to Follow-up|0
7378620|NCT01151215|11633464|FG002|Overall Study|Lost to Follow-up|3
7378621|NCT01151215|11633462|FG000|Overall Study|Withdrawal by Subject|3
7378622|NCT01151215|11633463|FG001|Overall Study|Withdrawal by Subject|1
7378623|NCT01151215|11633464|FG002|Overall Study|Withdrawal by Subject|2
7378624|NCT01151215|11633462|FG000|Overall Study|Disease progression|0
7378625|NCT01151215|11633463|FG001|Overall Study|Disease progression|1
7378626|NCT01151215|11633464|FG002|Overall Study|Disease progression|1
7378627|NCT01151215|11633462|FG000|Overall Study|Safety as judged by the investigator|0
7378628|NCT01151215|11633463|FG001|Overall Study|Safety as judged by the investigator|0
7378629|NCT01151215|11633464|FG002|Overall Study|Safety as judged by the investigator|1
7378630|NCT01151280|11633472|FG000|Overall Study|Adverse Event|1
7378631|NCT01151280|11633472|FG000|Overall Study|Lack of Efficacy|3
7378632|NCT01151345|11633476|FG000|First Intervention Period|Protocol Violation|0
7378633|NCT01151345|11633477|FG001|First Intervention Period|Protocol Violation|1
7378634|NCT01151410|11633498|FG000|Overall Study|Withdrawal by Subject|3
7378635|NCT01151410|11633499|FG001|Overall Study|Withdrawal by Subject|5
7378636|NCT01151410|11633498|FG000|Overall Study|Lost to Follow-up|3
7378637|NCT01151410|11633499|FG001|Overall Study|Lost to Follow-up|4
7378638|NCT01151410|11633498|FG000|Overall Study|Adverse Event|1
7378639|NCT01151410|11633499|FG001|Overall Study|Adverse Event|2
7378640|NCT01151410|11633498|FG000|Overall Study|Protocol deviation|2
7378641|NCT01151410|11633499|FG001|Overall Study|Protocol deviation|1
7378642|NCT01151410|11633498|FG000|Overall Study|Administrative problems|1
7378643|NCT01151410|11633499|FG001|Overall Study|Administrative problems|1
7378644|NCT01151410|11633498|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7378645|NCT01151410|11633499|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7378646|NCT01151410|11633498|FG000|Overall Study|Abnormal laboratory value(s)|0
7378647|NCT01151410|11633499|FG001|Overall Study|Abnormal laboratory value(s)|1
7378648|NCT01151423|11633507|FG000|Overall Study|Study terminated by Sponsor|9
7378649|NCT01151423|11633508|FG001|Overall Study|Study terminated by Sponsor|10
7570714|NCT03504852|11948931|FG001|Overall Study|Withdrawal of informed consent|1
7378650|NCT01151423|11633507|FG000|Overall Study|Protocol Violation|0
7378651|NCT01151423|11633508|FG001|Overall Study|Protocol Violation|1
7378652|NCT01151423|11633507|FG000|Overall Study|Physician Decision|1
7378653|NCT01151423|11633508|FG001|Overall Study|Physician Decision|1
7378654|NCT01151423|11633507|FG000|Overall Study|Pregnancy|0
7378655|NCT01151423|11633508|FG001|Overall Study|Pregnancy|1
7378656|NCT01151423|11633507|FG000|Overall Study|Death|0
7378657|NCT01151423|11633508|FG001|Overall Study|Death|1
7378658|NCT01151423|11633507|FG000|Overall Study|Adverse Event|3
7378659|NCT01151423|11633508|FG001|Overall Study|Adverse Event|0
7378660|NCT01151423|11633507|FG000|Overall Study|Withdrawal by Subject|1
7378661|NCT01151423|11633508|FG001|Overall Study|Withdrawal by Subject|3
7378662|NCT01151423|11633507|FG000|Overall Study|Lost to Follow-up|1
7378663|NCT01151423|11633508|FG001|Overall Study|Lost to Follow-up|0
7378664|NCT01151423|11633507|FG000|Overall Study|Diagnosed as non-TTP patient|0
7378665|NCT01151423|11633508|FG001|Overall Study|Diagnosed as non-TTP patient|1
7378666|NCT01151423|11633507|FG000|Overall Study|Participated in other clinical trial|1
7378667|NCT01151423|11633508|FG001|Overall Study|Participated in other clinical trial|0
7570715|NCT03504852|11948932|FG002|Overall Study|Withdrawal of informed consent|0
7570716|NCT03504852|11948930|FG000|Overall Study|Withdrawal by Subject|5
7378668|NCT01151540|11633522|FG000|Overall Study|Other|2
7378669|NCT01151540|11633522|FG000|Overall Study|Adverse event, non-fatal|4
7378670|NCT01151540|11633522|FG000|Overall Study|Withdrawal by Subject|7
7378671|NCT01151579|11633528|FG000|Overall Study|Physician Decision|3
7378672|NCT01151579|11633529|FG001|Overall Study|Physician Decision|1
7378673|NCT01151579|11633528|FG000|Overall Study|Withdrawal by Subject|3
7378674|NCT01151579|11633529|FG001|Overall Study|Withdrawal by Subject|2
7378675|NCT01151579|11633528|FG000|Overall Study|Not meet inclusion criteria|6
7378676|NCT01151579|11633529|FG001|Overall Study|Not meet inclusion criteria|4
7378677|NCT01151618|11633535|FG000|Overall Study|Adverse Event|2
7378678|NCT01151618|11633535|FG000|Overall Study|Withdrawal by Subject|7
7378679|NCT01152021|11633562|FG000|Overall Study|Adverse Event|4
7378680|NCT01152021|11633563|FG001|Overall Study|Adverse Event|4
7378681|NCT01152021|11633562|FG000|Overall Study|Study drug had expired|1
7378682|NCT01152021|11633563|FG001|Overall Study|Study drug had expired|0
7378683|NCT01152021|11633562|FG000|Overall Study|Physician Decision|1
7378684|NCT01152021|11633563|FG001|Overall Study|Physician Decision|1
7378685|NCT01152021|11633562|FG000|Overall Study|No access to study drug in Pharmacy|0
7378686|NCT01152021|11633563|FG001|Overall Study|No access to study drug in Pharmacy|1
7378687|NCT01152190|11633582|FG000|Overall Study|Adverse Event|2
7378688|NCT01152190|11633583|FG001|Overall Study|Adverse Event|4
7378689|NCT01152190|11633582|FG000|Overall Study|Death|1
7378690|NCT01152190|11633583|FG001|Overall Study|Death|0
7378691|NCT01152190|11633582|FG000|Overall Study|Protocol Violation|1
7378692|NCT01152190|11633583|FG001|Overall Study|Protocol Violation|1
7378693|NCT01152190|11633582|FG000|Overall Study|Withdrawal by Subject|1
7378694|NCT01152190|11633583|FG001|Overall Study|Withdrawal by Subject|3
7378695|NCT01152385|11633620|FG000|Overall Study|Withdrawal by Subject|3
7378696|NCT01152385|11633621|FG001|Overall Study|Withdrawal by Subject|1
7378697|NCT01152385|11633622|FG002|Overall Study|Withdrawal by Subject|1
7378698|NCT01152385|11633623|FG003|Overall Study|Withdrawal by Subject|1
7378699|NCT01152385|11633620|FG000|Overall Study|Protocol Violation|0
7378700|NCT01152385|11633621|FG001|Overall Study|Protocol Violation|0
7378701|NCT01152385|11633622|FG002|Overall Study|Protocol Violation|0
7378702|NCT01152385|11633623|FG003|Overall Study|Protocol Violation|1
7378703|NCT01152385|11633620|FG000|Overall Study|Adverse Event|1
7378704|NCT01152385|11633621|FG001|Overall Study|Adverse Event|1
7378705|NCT01152385|11633622|FG002|Overall Study|Adverse Event|0
7378706|NCT01152385|11633623|FG003|Overall Study|Adverse Event|0
7378707|NCT01152385|11633620|FG000|Overall Study|Study-specific withdrawal criteria|1
7378708|NCT01152385|11633621|FG001|Overall Study|Study-specific withdrawal criteria|1
7378709|NCT01152385|11633622|FG002|Overall Study|Study-specific withdrawal criteria|2
7378710|NCT01152385|11633623|FG003|Overall Study|Study-specific withdrawal criteria|0
7378711|NCT01152385|11633620|FG000|Overall Study|Other|4
7378712|NCT01152385|11633621|FG001|Overall Study|Other|3
7378713|NCT01152385|11633622|FG002|Overall Study|Other|2
7378714|NCT01152385|11633623|FG003|Overall Study|Other|3
7378715|NCT01152437|11633640|FG000|Overall Study|Other Adverse Event|8
7378716|NCT01152437|11633641|FG001|Overall Study|Other Adverse Event|1
7378717|NCT01152437|11633642|FG002|Overall Study|Other Adverse Event|7
7378718|NCT01152437|11633640|FG000|Overall Study|Not treated|0
7378719|NCT01152437|11633641|FG001|Overall Study|Not treated|1
7378720|NCT01152437|11633642|FG002|Overall Study|Not treated|2
7378721|NCT01152437|11633640|FG000|Overall Study|Progressive disease|27
7378722|NCT01152437|11633641|FG001|Overall Study|Progressive disease|13
7378723|NCT01152437|11633642|FG002|Overall Study|Progressive disease|32
7378724|NCT01152437|11633640|FG000|Overall Study|Refusal to continue taking trial medicat|1
7378725|NCT01152437|11633641|FG001|Overall Study|Refusal to continue taking trial medicat|0
7378726|NCT01152437|11633642|FG002|Overall Study|Refusal to continue taking trial medicat|2
7378727|NCT01152450|11633652|FG000|Period 1 (4 Weeks)|Adverse Event|0
7378728|NCT01152450|11633653|FG001|Period 1 (4 Weeks)|Adverse Event|0
7378729|NCT01152450|11633654|FG002|Period 1 (4 Weeks)|Adverse Event|0
7378730|NCT01152450|11633655|FG003|Period 1 (4 Weeks)|Adverse Event|0
7378731|NCT01152450|11633656|FG004|Period 1 (4 Weeks)|Adverse Event|1
7378732|NCT01152450|11633657|FG005|Period 1 (4 Weeks)|Adverse Event|1
7378733|NCT01152450|11633652|FG000|Period 1 (4 Weeks)|Protocol Violation|0
7378734|NCT01152450|11633653|FG001|Period 1 (4 Weeks)|Protocol Violation|0
7378735|NCT01152450|11633654|FG002|Period 1 (4 Weeks)|Protocol Violation|0
7378736|NCT01152450|11633655|FG003|Period 1 (4 Weeks)|Protocol Violation|0
7378737|NCT01152450|11633656|FG004|Period 1 (4 Weeks)|Protocol Violation|1
7378738|NCT01152450|11633657|FG005|Period 1 (4 Weeks)|Protocol Violation|0
7378739|NCT01152450|11633652|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
7378740|NCT01152450|11633653|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
7378741|NCT01152450|11633654|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
7378742|NCT01152450|11633655|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
7378743|NCT01152450|11633656|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
7378744|NCT01152450|11633657|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
7378745|NCT01152554|11633676|FG000|Overall Study|Withdrawal by Subject|73
7378746|NCT01152554|11633677|FG001|Overall Study|Withdrawal by Subject|28
7378747|NCT01152554|11633676|FG000|Overall Study|Eligiblity criteria not fulfilled|0
7378748|NCT01152554|11633677|FG001|Overall Study|Eligiblity criteria not fulfilled|1
7378749|NCT01152554|11633676|FG000|Overall Study|Adverse Event|67
7378750|NCT01152554|11633677|FG001|Overall Study|Adverse Event|14
7378751|NCT01152554|11633676|FG000|Overall Study|Severe non-compliance to protocol|36
7378752|NCT01152554|11633677|FG001|Overall Study|Severe non-compliance to protocol|14
7378753|NCT01152554|11633676|FG000|Overall Study|Condition under investigation worsened|5
7378754|NCT01152554|11633677|FG001|Overall Study|Condition under investigation worsened|2
7378755|NCT01152554|11633676|FG000|Overall Study|Lack of Efficacy|20
7378756|NCT01152554|11633677|FG001|Overall Study|Lack of Efficacy|3
7378757|NCT01152554|11633676|FG000|Overall Study|Study-specific withdrawal criteria|17
7378758|NCT01152554|11633677|FG001|Overall Study|Study-specific withdrawal criteria|8
7378759|NCT01152554|11633676|FG000|Overall Study|Lost to Follow-up|87
7378760|NCT01152554|11633677|FG001|Overall Study|Lost to Follow-up|32
7378761|NCT01152554|11633676|FG000|Overall Study|Other|28
7378762|NCT01152554|11633677|FG001|Overall Study|Other|8
7378763|NCT01152554|11633676|FG000|Overall Study|Death|1
7378764|NCT01152554|11633677|FG001|Overall Study|Death|1
7378765|NCT01152580|11633685|FG000|Overall Study|Withdrawal by Subject|0
7378766|NCT01152580|11633686|FG001|Overall Study|Withdrawal by Subject|1
7378767|NCT01152788|11633698|FG000|Overall Study|Withdrawal by Subject|0
7378768|NCT01152788|11633699|FG001|Overall Study|Withdrawal by Subject|3
7378769|NCT01152788|11633698|FG000|Overall Study|No treatment|0
7378770|NCT01152788|11633699|FG001|Overall Study|No treatment|1
7378771|NCT01152814|11633705|FG000|Overall Study|Lost to Follow-up|2
7378772|NCT01152996|11633709|FG000|Overall Study|Withdrawal by Subject|142
7378773|NCT01152996|11633709|FG000|Overall Study|Adverse Event|115
7378774|NCT01152996|11633709|FG000|Overall Study|Lost to Follow-up|112
7462090|NCT01846416|11758805|FG002|Treatment Phase|Other|1
7462091|NCT01846416|11758803|FG000|Treatment Phase|Physician Decision|1
7462092|NCT01846416|11758804|FG001|Treatment Phase|Physician Decision|2
7462093|NCT01846416|11758805|FG002|Treatment Phase|Physician Decision|0
7462094|NCT01846416|11758803|FG000|Treatment Phase|Adverse Event|3
7462095|NCT01846416|11758804|FG001|Treatment Phase|Adverse Event|4
7462096|NCT01846416|11758805|FG002|Treatment Phase|Adverse Event|0
7462097|NCT01846416|11758803|FG000|Treatment Phase|Non-compliance|0
7462098|NCT01846416|11758804|FG001|Treatment Phase|Non-compliance|2
7462099|NCT01846416|11758805|FG002|Treatment Phase|Non-compliance|0
7462100|NCT01846416|11758803|FG000|Treatment Phase|Study Terminated by Sponsor|1
7462101|NCT01846416|11758804|FG001|Treatment Phase|Study Terminated by Sponsor|4
7462102|NCT01846416|11758805|FG002|Treatment Phase|Study Terminated by Sponsor|0
7462103|NCT01846416|11758803|FG000|Treatment Phase|Progressive Disease|21
7462104|NCT01846416|11758804|FG001|Treatment Phase|Progressive Disease|63
7462105|NCT01846416|11758805|FG002|Treatment Phase|Progressive Disease|9
7462106|NCT01846416|11758803|FG000|Survival Follow-up|Death|21
7462107|NCT01846416|11758804|FG001|Survival Follow-up|Death|62
7462108|NCT01846416|11758805|FG002|Survival Follow-up|Death|9
7462109|NCT01846416|11758803|FG000|Survival Follow-up|Lost to Follow-up|0
7462110|NCT01846416|11758804|FG001|Survival Follow-up|Lost to Follow-up|2
7462111|NCT01846416|11758805|FG002|Survival Follow-up|Lost to Follow-up|2
7462112|NCT01846416|11758803|FG000|Survival Follow-up|Withdrawal by Subject|2
7462113|NCT01846416|11758804|FG001|Survival Follow-up|Withdrawal by Subject|7
7462114|NCT01846416|11758805|FG002|Survival Follow-up|Withdrawal by Subject|0
7462115|NCT01846416|11758803|FG000|Survival Follow-up|Study Terminated by Sponsor|2
7462116|NCT01846416|11758804|FG001|Survival Follow-up|Study Terminated by Sponsor|8
7462117|NCT01846416|11758805|FG002|Survival Follow-up|Study Terminated by Sponsor|0
7462118|NCT01846416|11758803|FG000|Survival Follow-up|Other|3
7462119|NCT01846416|11758804|FG001|Survival Follow-up|Other|1
7462120|NCT01846416|11758805|FG002|Survival Follow-up|Other|1
7462121|NCT01846442|11758818|FG000|Overall Study|Adverse Event|2
7462122|NCT01846442|11758819|FG001|Overall Study|Adverse Event|4
7462123|NCT01846442|11758820|FG002|Overall Study|Adverse Event|2
7462124|NCT01846442|11758821|FG003|Overall Study|Adverse Event|1
7462125|NCT01846442|11758818|FG000|Overall Study|Lost to Follow-up|0
7462126|NCT01846442|11758819|FG001|Overall Study|Lost to Follow-up|0
7462127|NCT01846442|11758820|FG002|Overall Study|Lost to Follow-up|1
7462128|NCT01846442|11758821|FG003|Overall Study|Lost to Follow-up|0
7462129|NCT01846442|11758818|FG000|Overall Study|Withdrawal by Subject|3
7462130|NCT01846442|11758819|FG001|Overall Study|Withdrawal by Subject|2
7462131|NCT01846442|11758820|FG002|Overall Study|Withdrawal by Subject|0
7462132|NCT01846442|11758821|FG003|Overall Study|Withdrawal by Subject|1
7462133|NCT01846442|11758818|FG000|Overall Study|Left the city/Lost medication|1
7462134|NCT01846442|11758819|FG001|Overall Study|Left the city/Lost medication|0
7462135|NCT01846442|11758820|FG002|Overall Study|Left the city/Lost medication|1
7462136|NCT01846442|11758821|FG003|Overall Study|Left the city/Lost medication|1
7462137|NCT01846507|11758861|FG000|Overall Study|Lost to Follow-up|4
7462138|NCT01846507|11758861|FG000|Overall Study|Protocol Violation|1
7462139|NCT01846507|11758861|FG000|Overall Study|Missing data|2
7462140|NCT01846611|11758869|FG000|Overall Study|Lost to Follow-up|4
7462141|NCT01846611|11758870|FG001|Overall Study|Lost to Follow-up|6
7462142|NCT01846611|11758869|FG000|Overall Study|Withdrawal by Subject|15
7462143|NCT01846611|11758870|FG001|Overall Study|Withdrawal by Subject|19
7462144|NCT01846611|11758869|FG000|Overall Study|Other|19
7462145|NCT01846611|11758870|FG001|Overall Study|Other|18
7462146|NCT01846624|11758876|FG000|Overall Study|Died during induction, no midostaurin|1
7462147|NCT01846741|11758921|FG000|Baseline Visit|Subject did not meet entry criteria|2
7462148|NCT01847092|11759010|FG000|Overall Study|Adverse Event|12
7462149|NCT01847092|11759011|FG001|Overall Study|Adverse Event|3
7462150|NCT01847092|11759010|FG000|Overall Study|Withdrawal by Subject|5
7462151|NCT01847092|11759011|FG001|Overall Study|Withdrawal by Subject|5
7462152|NCT01847092|11759010|FG000|Overall Study|Protocol Specified|8
7462153|NCT01847092|11759011|FG001|Overall Study|Protocol Specified|0
7462154|NCT01847092|11759010|FG000|Overall Study|Physician Decision|1
7462155|NCT01847092|11759011|FG001|Overall Study|Physician Decision|1
7462156|NCT01847092|11759010|FG000|Overall Study|Protocol Violation|0
7462157|NCT01847092|11759011|FG001|Overall Study|Protocol Violation|2
7378775|NCT01152996|11633709|FG000|Overall Study|Lack of Efficacy|68
7378776|NCT01152996|11633709|FG000|Overall Study|Noncompliance|41
7462158|NCT01847209|11759030|FG000|Overall Study|Withdrawal by Subject|1
7378777|NCT01152996|11633709|FG000|Overall Study|Other|36
7378778|NCT01152996|11633709|FG000|Overall Study|Protocol Violation|22
7378779|NCT01152996|11633709|FG000|Overall Study|Elevated liver enzymes|1
7378780|NCT01153009|11633717|FG000|Overall Study|Adverse Event|4
7378781|NCT01153009|11633718|FG001|Overall Study|Adverse Event|14
7378782|NCT01153009|11633719|FG002|Overall Study|Adverse Event|14
7378783|NCT01153009|11633720|FG003|Overall Study|Adverse Event|10
7378784|NCT01153009|11633717|FG000|Overall Study|Lack of Efficacy|9
7378785|NCT01153009|11633718|FG001|Overall Study|Lack of Efficacy|0
7378786|NCT01153009|11633719|FG002|Overall Study|Lack of Efficacy|2
7378787|NCT01153009|11633720|FG003|Overall Study|Lack of Efficacy|1
7378788|NCT01153009|11633717|FG000|Overall Study|Noncompliance with Study Medication|1
7378789|NCT01153009|11633718|FG001|Overall Study|Noncompliance with Study Medication|3
7378790|NCT01153009|11633719|FG002|Overall Study|Noncompliance with Study Medication|4
7378791|NCT01153009|11633720|FG003|Overall Study|Noncompliance with Study Medication|1
7378792|NCT01153009|11633717|FG000|Overall Study|Protocol Deviations|4
7378793|NCT01153009|11633718|FG001|Overall Study|Protocol Deviations|3
7378794|NCT01153009|11633719|FG002|Overall Study|Protocol Deviations|3
7378795|NCT01153009|11633720|FG003|Overall Study|Protocol Deviations|2
7378796|NCT01153009|11633717|FG000|Overall Study|Withdrawal of Consent|5
7378797|NCT01153009|11633718|FG001|Overall Study|Withdrawal of Consent|5
7378798|NCT01153009|11633719|FG002|Overall Study|Withdrawal of Consent|4
7378799|NCT01153009|11633720|FG003|Overall Study|Withdrawal of Consent|6
7378800|NCT01153009|11633717|FG000|Overall Study|Lost to Follow-up|8
7378801|NCT01153009|11633718|FG001|Overall Study|Lost to Follow-up|8
7378802|NCT01153009|11633719|FG002|Overall Study|Lost to Follow-up|11
7378803|NCT01153009|11633720|FG003|Overall Study|Lost to Follow-up|15
7378804|NCT01153009|11633717|FG000|Overall Study|Other|1
7378805|NCT01153009|11633718|FG001|Overall Study|Other|1
7378806|NCT01153009|11633719|FG002|Overall Study|Other|3
7378807|NCT01153009|11633720|FG003|Overall Study|Other|2
7378808|NCT01153269|11633730|FG000|Overall Study|Withdrawal by Subject|1
7378809|NCT01153269|11633730|FG000|Overall Study|Antiretroviral therapy break|1
7378810|NCT01153321|11633739|FG000|Overall Study|Development of study withdrawal criteria|0
7378811|NCT01153321|11633740|FG001|Overall Study|Development of study withdrawal criteria|1
7378812|NCT01153321|11633739|FG000|Overall Study|Withdrawal by Subject|0
7378813|NCT01153321|11633740|FG001|Overall Study|Withdrawal by Subject|1
7378814|NCT01153321|11633739|FG000|Overall Study|Adverse Event|1
7378815|NCT01153321|11633740|FG001|Overall Study|Adverse Event|1
7378816|NCT01153347|11633750|FG000|Overall Study|Withdrawal by Subject|7
7378817|NCT01153347|11633751|FG001|Overall Study|Withdrawal by Subject|7
7378818|NCT01153347|11633752|FG002|Overall Study|Withdrawal by Subject|7
7378819|NCT01153347|11633753|FG003|Overall Study|Withdrawal by Subject|7
7378820|NCT01153347|11633750|FG000|Overall Study|Eligibility criteria not fulfilled|0
7378821|NCT01153347|11633751|FG001|Overall Study|Eligibility criteria not fulfilled|1
7378822|NCT01153347|11633752|FG002|Overall Study|Eligibility criteria not fulfilled|2
7378823|NCT01153347|11633753|FG003|Overall Study|Eligibility criteria not fulfilled|1
7378824|NCT01153347|11633750|FG000|Overall Study|Adverse Event|3
7378825|NCT01153347|11633751|FG001|Overall Study|Adverse Event|9
7378826|NCT01153347|11633752|FG002|Overall Study|Adverse Event|21
7378827|NCT01153347|11633753|FG003|Overall Study|Adverse Event|7
7378828|NCT01153347|11633750|FG000|Overall Study|Severe non-compliance to protocol|6
7378829|NCT01153347|11633751|FG001|Overall Study|Severe non-compliance to protocol|7
7378830|NCT01153347|11633752|FG002|Overall Study|Severe non-compliance to protocol|4
7378831|NCT01153347|11633753|FG003|Overall Study|Severe non-compliance to protocol|3
7378832|NCT01153347|11633750|FG000|Overall Study|Condition under investigation worsened|1
7378833|NCT01153347|11633751|FG001|Overall Study|Condition under investigation worsened|1
7378834|NCT01153347|11633752|FG002|Overall Study|Condition under investigation worsened|0
7378835|NCT01153347|11633753|FG003|Overall Study|Condition under investigation worsened|0
7378836|NCT01153347|11633750|FG000|Overall Study|Lack of Efficacy|2
7378837|NCT01153347|11633751|FG001|Overall Study|Lack of Efficacy|2
7378838|NCT01153347|11633752|FG002|Overall Study|Lack of Efficacy|0
7378839|NCT01153347|11633753|FG003|Overall Study|Lack of Efficacy|4
7378840|NCT01153347|11633750|FG000|Overall Study|Study-specific withdrawal criteria|4
7378841|NCT01153347|11633751|FG001|Overall Study|Study-specific withdrawal criteria|3
7378842|NCT01153347|11633752|FG002|Overall Study|Study-specific withdrawal criteria|1
7378843|NCT01153347|11633753|FG003|Overall Study|Study-specific withdrawal criteria|2
7378844|NCT01153347|11633750|FG000|Overall Study|Lost to Follow-up|4
7378845|NCT01153347|11633751|FG001|Overall Study|Lost to Follow-up|9
7378846|NCT01153347|11633752|FG002|Overall Study|Lost to Follow-up|11
7378847|NCT01153347|11633753|FG003|Overall Study|Lost to Follow-up|8
7378848|NCT01153347|11633750|FG000|Overall Study|Other|5
7378849|NCT01153347|11633751|FG001|Overall Study|Other|5
7378850|NCT01153347|11633752|FG002|Overall Study|Other|4
7378851|NCT01153347|11633753|FG003|Overall Study|Other|0
7378852|NCT01153347|11633750|FG000|Overall Study|Death|1
7378853|NCT01153347|11633751|FG001|Overall Study|Death|0
7378854|NCT01153347|11633752|FG002|Overall Study|Death|0
7378855|NCT01153347|11633753|FG003|Overall Study|Death|0
7378856|NCT01153425|11633765|FG000|Overall Study|Withdrawal by Subject|3
7378857|NCT01153425|11633766|FG001|Overall Study|Withdrawal by Subject|3
7378858|NCT01153516|11633788|FG000|Overall Study|Both subjects refused surgery|2
7378859|NCT01153516|11633789|FG001|Overall Study|Both subjects refused surgery|0
7378860|NCT01153633|11633816|FG000|Overall Study|Protocol Violation|1
7378861|NCT01153633|11633817|FG001|Overall Study|Protocol Violation|1
7378862|NCT01153633|11633816|FG000|Overall Study|Therapeutic failure|3
7378863|NCT01153633|11633817|FG001|Overall Study|Therapeutic failure|3
7378864|NCT01153698|11633838|FG000|Overall Study|Adverse Event|12
7378865|NCT01153698|11633838|FG000|Overall Study|Lost to Follow-up|4
7378866|NCT01153698|11633838|FG000|Overall Study|Withdrawal by Subject|2
7378867|NCT01153698|11633838|FG000|Overall Study|Switch to other anticoagulants|4
7378868|NCT01153698|11633838|FG000|Overall Study|Other|2
7378869|NCT01153698|11633838|FG000|Overall Study|Not treated with Pradaxa|5
7378870|NCT01153724|11633849|FG000|Treatment Period 1|Withdrawal by Subject|1
7378871|NCT01153724|11633849|FG000|Treatment Period 2|Adverse Event|1
7378872|NCT01153724|11633849|FG000|Treatment Period 2|Other reason not defined above|1
7378873|NCT01153763|11633855|FG000|Overall Study|Study Closed|16
7378874|NCT01153763|11633855|FG000|Overall Study|Lost to Follow-up|1
7378875|NCT01153763|11633855|FG000|Overall Study|Physician Decision|2
7378876|NCT01153763|11633855|FG000|Overall Study|Withdrawal by Subject|2
7378877|NCT01153815|11633861|FG000|Overall Study|Adverse Event|3
7378878|NCT01153815|11633862|FG001|Overall Study|Adverse Event|1
7378879|NCT01153815|11633861|FG000|Overall Study|Withdrawal by Subject|6
7378880|NCT01153815|11633862|FG001|Overall Study|Withdrawal by Subject|4
7378881|NCT01153841|11633870|FG000|Overall Study|Adverse Event|1
7378882|NCT01153841|11633871|FG001|Overall Study|Adverse Event|0
7378883|NCT01153841|11633870|FG000|Overall Study|Withdrawal by Subject|1
7378884|NCT01153841|11633871|FG001|Overall Study|Withdrawal by Subject|0
7378885|NCT01153841|11633870|FG000|Overall Study|Protocol Violation|2
7378886|NCT01153841|11633871|FG001|Overall Study|Protocol Violation|0
7378887|NCT01153841|11633870|FG000|Overall Study|Lost to Follow-up|2
7378888|NCT01153841|11633871|FG001|Overall Study|Lost to Follow-up|0
7378889|NCT01153893|11633879|FG000|Overall Study|Adverse Event|1
7378890|NCT01153893|11633880|FG001|Overall Study|Adverse Event|0
7378891|NCT01153958|11633888|FG000|Overall Study|Study Terminated|36
7378892|NCT01153958|11633889|FG001|Overall Study|Study Terminated|32
7378893|NCT01153971|11633895|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
7378894|NCT01153971|11633895|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
7378895|NCT01153971|11633895|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
7378896|NCT01153971|11633895|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
7378897|NCT01153971|11633895|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
7378898|NCT01153971|11633895|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
7378899|NCT01153971|11633895|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
7378900|NCT01153984|11633899|FG000|Overall Study|Withdrawal by Subject|1
7378901|NCT01153984|11633899|FG000|Overall Study|Adverse Event|1
7378902|NCT01154010|11633905|FG000|Overall Study|Lost to Follow-up|0
7378903|NCT01154010|11633906|FG001|Overall Study|Lost to Follow-up|1
7378904|NCT01154088|11633915|FG000|Overall Study|Lost to Follow-up|4
7378905|NCT01154088|11633916|FG001|Overall Study|Lost to Follow-up|6
7378906|NCT01154088|11633917|FG002|Overall Study|Lost to Follow-up|7
7378907|NCT01154101|11633931|FG000|Overall Study|Adverse Event|0
7378908|NCT01154101|11633932|FG001|Overall Study|Adverse Event|2
7378909|NCT01154101|11633933|FG002|Overall Study|Adverse Event|1
7378910|NCT01154101|11633934|FG003|Overall Study|Adverse Event|1
7378911|NCT01154101|11633935|FG004|Overall Study|Adverse Event|0
7378912|NCT01154101|11633931|FG000|Overall Study|Lost to Follow-up|0
7378913|NCT01154101|11633932|FG001|Overall Study|Lost to Follow-up|1
7378914|NCT01154101|11633933|FG002|Overall Study|Lost to Follow-up|0
7378915|NCT01154101|11633934|FG003|Overall Study|Lost to Follow-up|1
7378916|NCT01154101|11633935|FG004|Overall Study|Lost to Follow-up|0
7378917|NCT01154101|11633931|FG000|Overall Study|Withdrawal by Subject|0
7378918|NCT01154101|11633932|FG001|Overall Study|Withdrawal by Subject|1
7378919|NCT01154101|11633933|FG002|Overall Study|Withdrawal by Subject|2
7378920|NCT01154101|11633934|FG003|Overall Study|Withdrawal by Subject|0
7378921|NCT01154101|11633935|FG004|Overall Study|Withdrawal by Subject|1
7378922|NCT01154127|11633954|FG000|Period 1 (21 Days)|Adverse Event|3
7378923|NCT01154127|11633955|FG001|Period 1 (21 Days)|Adverse Event|4
7378924|NCT01154127|11633954|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
7378925|NCT01154127|11633955|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
7378926|NCT01154127|11633954|FG000|Washout (14 - 28 Days)|Adverse Event|2
7378927|NCT01154127|11633955|FG001|Washout (14 - 28 Days)|Adverse Event|0
7378928|NCT01154127|11633954|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
7378929|NCT01154127|11633955|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
7378930|NCT01154127|11633954|FG000|Period 2 (21 Days)|Protocol Deviation|0
7378931|NCT01154127|11633955|FG001|Period 2 (21 Days)|Protocol Deviation|1
7378932|NCT01154140|11633963|FG000|Overall Study|Death|71
7378933|NCT01154140|11633964|FG001|Overall Study|Death|81
7378934|NCT01154140|11633963|FG000|Overall Study|Lost to Follow-up|4
7378935|NCT01154140|11633964|FG001|Overall Study|Lost to Follow-up|5
7378936|NCT01154140|11633963|FG000|Overall Study|Withdrawal by Subject|12
7378937|NCT01154140|11633964|FG001|Overall Study|Withdrawal by Subject|13
7378938|NCT01154140|11633963|FG000|Overall Study|Other|3
7378939|NCT01154140|11633964|FG001|Overall Study|Other|1
7378940|NCT01154140|11633963|FG000|Overall Study|Randomized but not treated|1
7378941|NCT01154140|11633964|FG001|Overall Study|Randomized but not treated|2
7378942|NCT01154153|11633972|FG000|Overall Study|Poor compliance to protocol|2
7378943|NCT01154153|11633973|FG001|Overall Study|Poor compliance to protocol|0
7378944|NCT01154153|11633972|FG000|Overall Study|Unable to use labs|2
7378945|NCT01154153|11633973|FG001|Overall Study|Unable to use labs|3
7378946|NCT01154153|11633972|FG000|Overall Study|Withdrew consent|1
7378947|NCT01154153|11633973|FG001|Overall Study|Withdrew consent|0
7378948|NCT01154166|11633981|FG000|Overall Study|Adverse Event|14
7378949|NCT01154166|11633982|FG001|Overall Study|Adverse Event|9
7378950|NCT01154166|11633981|FG000|Overall Study|Lost to Follow-up|1
7378951|NCT01154166|11633982|FG001|Overall Study|Lost to Follow-up|1
7378952|NCT01154166|11633981|FG000|Overall Study|Protocol Violation|4
7378953|NCT01154166|11633982|FG001|Overall Study|Protocol Violation|1
7378954|NCT01154166|11633981|FG000|Overall Study|Withdrawal by Subject|10
7378955|NCT01154166|11633982|FG001|Overall Study|Withdrawal by Subject|1
7378956|NCT01154166|11633981|FG000|Overall Study|Lack of Efficacy|3
7378957|NCT01154166|11633982|FG001|Overall Study|Lack of Efficacy|0
7378958|NCT01154166|11633981|FG000|Overall Study|Disease Progression|1
7378959|NCT01154166|11633982|FG001|Overall Study|Disease Progression|0
7378960|NCT01154166|11633981|FG000|Overall Study|Poor Compliance|1
7378961|NCT01154166|11633982|FG001|Overall Study|Poor Compliance|0
7378962|NCT01154218|11634002|FG000|Third Intervention Period|Adverse Event|0
7378963|NCT01154218|11634003|FG001|Third Intervention Period|Adverse Event|1
7378964|NCT01154218|11634004|FG002|Third Intervention Period|Adverse Event|0
7378965|NCT01154218|11634005|FG003|Third Intervention Period|Adverse Event|0
7378966|NCT01154218|11634002|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7378967|NCT01154218|11634003|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7378968|NCT01154218|11634004|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
7378969|NCT01154218|11634005|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
7378970|NCT01154218|11634002|FG000|Fourth Intervention Period|Withdrawal by Subject|1
7378971|NCT01154218|11634003|FG001|Fourth Intervention Period|Withdrawal by Subject|0
7378972|NCT01154218|11634004|FG002|Fourth Intervention Period|Withdrawal by Subject|0
7378973|NCT01154218|11634005|FG003|Fourth Intervention Period|Withdrawal by Subject|0
7378974|NCT01154231|11634015|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
7378975|NCT01154231|11634015|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
7378976|NCT01154283|11634021|FG000|0-6 Weeks|Withdrawal by Subject|7
7378977|NCT01154283|11634022|FG001|0-6 Weeks|Withdrawal by Subject|2
7378978|NCT01154283|11634021|FG000|0-6 Weeks|Death|0
7378979|NCT01154283|11634022|FG001|0-6 Weeks|Death|1
7378980|NCT01154283|11634021|FG000|7-12 Weeks|Death|1
7378981|NCT01154283|11634022|FG001|7-12 Weeks|Death|0
7378982|NCT01154283|11634021|FG000|7-12 Weeks|Withdrawal by Subject|0
7378983|NCT01154283|11634022|FG001|7-12 Weeks|Withdrawal by Subject|1
7378984|NCT01154296|11634030|FG000|Randomization and Intervention|Decided to decline|1
7378985|NCT01154296|11634031|FG001|Randomization and Intervention|Decided to decline|1
7378986|NCT01154296|11634030|FG000|Randomization and Intervention|Declined by staff|1
7378987|NCT01154296|11634031|FG001|Randomization and Intervention|Declined by staff|0
7378988|NCT01154296|11634030|FG000|Randomization and Intervention|Did not return|1
7378989|NCT01154296|11634031|FG001|Randomization and Intervention|Did not return|0
7378990|NCT01154296|11634030|FG000|Randomization and Intervention|Left before test|0
7378991|NCT01154296|11634031|FG001|Randomization and Intervention|Left before test|1
7378992|NCT01154296|11634030|FG000|Randomization and Intervention|Left clinic early|2
7378993|NCT01154296|11634031|FG001|Randomization and Intervention|Left clinic early|0
7378994|NCT01154296|11634030|FG000|6-month Follow-up|Lost contact|269
7378995|NCT01154296|11634031|FG001|6-month Follow-up|Lost contact|275
7378996|NCT01154296|11634030|FG000|6-month Follow-up|Incarcerated|37
7378997|NCT01154296|11634031|FG001|6-month Follow-up|Incarcerated|32
7378998|NCT01154296|11634030|FG000|6-month Follow-up|Withdrew consent|14
7378999|NCT01154296|11634031|FG001|6-month Follow-up|Withdrew consent|15
7379000|NCT01154296|11634030|FG000|6-month Follow-up|Death|3
7379001|NCT01154296|11634031|FG001|6-month Follow-up|Death|2
7379002|NCT01154296|11634030|FG000|6-month Follow-up|Declined by Study Coordinator|5
7379003|NCT01154296|11634031|FG001|6-month Follow-up|Declined by Study Coordinator|4
7379004|NCT01154452|11634046|FG000|Phase Ib|Not Treated|1
7379005|NCT01154452|11634047|FG001|Phase Ib|Not Treated|0
7379006|NCT01154452|11634048|FG002|Phase Ib|Not Treated|0
7379007|NCT01154452|11634049|FG003|Phase Ib|Not Treated|0
7379008|NCT01154452|11634046|FG000|Phase Ib|Adverse Event|2
7379009|NCT01154452|11634047|FG001|Phase Ib|Adverse Event|1
7379010|NCT01154452|11634048|FG002|Phase Ib|Adverse Event|0
7379011|NCT01154452|11634049|FG003|Phase Ib|Adverse Event|0
7379012|NCT01154452|11634046|FG000|Phase II|Withdrawal by Subject|0
7379013|NCT01154452|11634047|FG001|Phase II|Withdrawal by Subject|0
7379014|NCT01154452|11634048|FG002|Phase II|Withdrawal by Subject|1
7379015|NCT01154452|11634049|FG003|Phase II|Withdrawal by Subject|2
7379016|NCT01154452|11634046|FG000|Phase II|Adverse Event|0
7379017|NCT01154452|11634047|FG001|Phase II|Adverse Event|0
7379018|NCT01154452|11634048|FG002|Phase II|Adverse Event|4
7379019|NCT01154452|11634049|FG003|Phase II|Adverse Event|4
7379020|NCT01154673|11634081|FG000|Overall Study|Lost to Follow-up|1
7379021|NCT01154673|11634082|FG001|Overall Study|Lost to Follow-up|0
7379022|NCT01154673|11634081|FG000|Overall Study|moved out of province|1
7379023|NCT01154673|11634082|FG001|Overall Study|moved out of province|0
7379024|NCT01154816|11634115|FG000|Overall Study|Withdrawal by Subject|1
7379025|NCT01154816|11634116|FG001|Overall Study|Withdrawal by Subject|0
7379026|NCT01154816|11634117|FG002|Overall Study|Withdrawal by Subject|0
7379027|NCT01154816|11634118|FG003|Overall Study|Withdrawal by Subject|1
7379028|NCT01154816|11634119|FG004|Overall Study|Withdrawal by Subject|0
7379029|NCT01154816|11634120|FG005|Overall Study|Withdrawal by Subject|0
7379030|NCT01154816|11634121|FG006|Overall Study|Withdrawal by Subject|0
7379031|NCT01154816|11634122|FG007|Overall Study|Withdrawal by Subject|0
7379032|NCT01154816|11634123|FG008|Overall Study|Withdrawal by Subject|1
7379033|NCT01154816|11634124|FG009|Overall Study|Withdrawal by Subject|3
7379034|NCT01154816|11634125|FG010|Overall Study|Withdrawal by Subject|0
7379035|NCT01154816|11634126|FG011|Overall Study|Withdrawal by Subject|0
7379036|NCT01154816|11634115|FG000|Overall Study|Progressive Disease|13
7379037|NCT01154816|11634116|FG001|Overall Study|Progressive Disease|8
7379038|NCT01154816|11634117|FG002|Overall Study|Progressive Disease|9
7379039|NCT01154816|11634118|FG003|Overall Study|Progressive Disease|9
7379040|NCT01154816|11634119|FG004|Overall Study|Progressive Disease|8
7379041|NCT01154816|11634120|FG005|Overall Study|Progressive Disease|8
7379042|NCT01154816|11634121|FG006|Overall Study|Progressive Disease|5
7379043|NCT01154816|11634122|FG007|Overall Study|Progressive Disease|6
7379044|NCT01154816|11634123|FG008|Overall Study|Progressive Disease|8
7379045|NCT01154816|11634124|FG009|Overall Study|Progressive Disease|6
7379046|NCT01154816|11634125|FG010|Overall Study|Progressive Disease|10
7379047|NCT01154816|11634126|FG011|Overall Study|Progressive Disease|3
7379048|NCT01154816|11634115|FG000|Overall Study|Physician Decision|1
7379049|NCT01154816|11634116|FG001|Overall Study|Physician Decision|0
7379050|NCT01154816|11634117|FG002|Overall Study|Physician Decision|1
7379051|NCT01154816|11634118|FG003|Overall Study|Physician Decision|0
7379052|NCT01154816|11634119|FG004|Overall Study|Physician Decision|2
7379053|NCT01154816|11634120|FG005|Overall Study|Physician Decision|0
7379054|NCT01154816|11634121|FG006|Overall Study|Physician Decision|0
7379055|NCT01154816|11634122|FG007|Overall Study|Physician Decision|0
7379056|NCT01154816|11634123|FG008|Overall Study|Physician Decision|0
7379057|NCT01154816|11634124|FG009|Overall Study|Physician Decision|1
7379058|NCT01154816|11634125|FG010|Overall Study|Physician Decision|1
7379059|NCT01154816|11634126|FG011|Overall Study|Physician Decision|1
7379060|NCT01154816|11634115|FG000|Overall Study|Adverse Event|5
7379061|NCT01154816|11634116|FG001|Overall Study|Adverse Event|2
7379062|NCT01154816|11634117|FG002|Overall Study|Adverse Event|0
7379063|NCT01154816|11634118|FG003|Overall Study|Adverse Event|0
7379064|NCT01154816|11634119|FG004|Overall Study|Adverse Event|0
7379065|NCT01154816|11634120|FG005|Overall Study|Adverse Event|0
7379066|NCT01154816|11634121|FG006|Overall Study|Adverse Event|1
7379067|NCT01154816|11634122|FG007|Overall Study|Adverse Event|1
7379068|NCT01154816|11634123|FG008|Overall Study|Adverse Event|0
7379069|NCT01154816|11634124|FG009|Overall Study|Adverse Event|0
7379070|NCT01154816|11634125|FG010|Overall Study|Adverse Event|0
7379071|NCT01154816|11634126|FG011|Overall Study|Adverse Event|0
7379072|NCT01155011|11634169|FG000|Baseline to 6 Months|Withdrawal by Subject|18
7379073|NCT01155011|11634170|FG001|Baseline to 6 Months|Withdrawal by Subject|19
7379074|NCT01155011|11634169|FG000|Baseline to 6 Months|investigator decision, moved|4
7379075|NCT01155011|11634170|FG001|Baseline to 6 Months|investigator decision, moved|5
7379076|NCT01155011|11634169|FG000|Baseline to 6 Months|Death|0
7379077|NCT01155011|11634170|FG001|Baseline to 6 Months|Death|1
7379078|NCT01155011|11634169|FG000|6 to 12 Months|Withdrawal by Subject|8
7379079|NCT01155011|11634170|FG001|6 to 12 Months|Withdrawal by Subject|5
7379080|NCT01155011|11634169|FG000|6 to 12 Months|Death|1
7379081|NCT01155011|11634170|FG001|6 to 12 Months|Death|5
7379082|NCT01155024|11634180|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
7379083|NCT01155024|11634181|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
7379084|NCT01155024|11634180|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
7379085|NCT01155024|11634181|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
7379086|NCT01155024|11634180|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
7379087|NCT01155024|11634181|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
7379088|NCT01155050|11634192|FG000|Overall Study|Lost to Follow-up|15
7379089|NCT01155050|11634193|FG001|Overall Study|Lost to Follow-up|20
7379090|NCT01155050|11634194|FG002|Overall Study|Lost to Follow-up|19
7379091|NCT01155050|11634195|FG003|Overall Study|Lost to Follow-up|22
7379092|NCT01155063|11634205|FG000|Overall Study|Adverse Event|1
7379093|NCT01155063|11634205|FG000|Overall Study|Withdrawal by Subject|1
7379094|NCT01155063|11634205|FG000|Overall Study|Study terminated by sponsor|87
7379095|NCT01155141|11634209|FG000|Overall Study|Withdrawal by Subject|1
7379096|NCT01155141|11634209|FG000|Overall Study|Screen Failure|1
7379097|NCT01155167|11634228|FG000|Overall Study|Insufficient ultrasound data|2
7379098|NCT01155167|11634229|FG001|Overall Study|Insufficient ultrasound data|0
7462162|NCT01847313|11759036|FG000|Overall Study|Withdrawal by Subject|0
7379099|NCT01155167|11634228|FG000|Overall Study|Access site changed to femoral artery|1
7379100|NCT01155167|11634229|FG001|Overall Study|Access site changed to femoral artery|0
7379101|NCT01155219|11634268|FG000|Overall Study|Adverse Event|3
7379102|NCT01155219|11634269|FG001|Overall Study|Adverse Event|1
7379103|NCT01155219|11634268|FG000|Overall Study|non-medical reason|1
7379104|NCT01155219|11634269|FG001|Overall Study|non-medical reason|2
7379105|NCT01155284|11634277|FG000|Overall Study|Withdrawal by Subject|4
7379106|NCT01155284|11634278|FG001|Overall Study|Withdrawal by Subject|3
7379107|NCT01155284|11634277|FG000|Overall Study|Lost to Follow-up|1
7379108|NCT01155284|11634278|FG001|Overall Study|Lost to Follow-up|2
7379109|NCT01155284|11634277|FG000|Overall Study|Physician Decision|1
7379110|NCT01155284|11634278|FG001|Overall Study|Physician Decision|0
7379111|NCT01155284|11634277|FG000|Overall Study|Adverse Event|1
7379112|NCT01155284|11634278|FG001|Overall Study|Adverse Event|0
7379113|NCT01155323|11634286|FG000|First Intervention|exclusion criteria|1
7379114|NCT01155323|11634287|FG001|First Intervention|exclusion criteria|1
7379115|NCT01155323|11634286|FG000|Second Intervention|Lost to Follow-up|1
7379116|NCT01155323|11634287|FG001|Second Intervention|Lost to Follow-up|1
7379117|NCT01155466|11634307|FG000|Overall Study|Adverse Event|13
7379118|NCT01155466|11634308|FG001|Overall Study|Adverse Event|15
7379119|NCT01155466|11634309|FG002|Overall Study|Adverse Event|6
7379120|NCT01155466|11634310|FG003|Overall Study|Adverse Event|17
7379121|NCT01155466|11634311|FG004|Overall Study|Adverse Event|18
7379122|NCT01155466|11634307|FG000|Overall Study|Lost to Follow-up|0
7379123|NCT01155466|11634308|FG001|Overall Study|Lost to Follow-up|0
7379124|NCT01155466|11634309|FG002|Overall Study|Lost to Follow-up|0
7379125|NCT01155466|11634310|FG003|Overall Study|Lost to Follow-up|0
7379126|NCT01155466|11634311|FG004|Overall Study|Lost to Follow-up|2
7379127|NCT01155466|11634307|FG000|Overall Study|Withdrawal by Subject|7
7379128|NCT01155466|11634308|FG001|Overall Study|Withdrawal by Subject|5
7379129|NCT01155466|11634309|FG002|Overall Study|Withdrawal by Subject|9
7379130|NCT01155466|11634310|FG003|Overall Study|Withdrawal by Subject|4
7379131|NCT01155466|11634311|FG004|Overall Study|Withdrawal by Subject|4
7379132|NCT01155466|11634307|FG000|Overall Study|Protocol Violation|0
7379133|NCT01155466|11634308|FG001|Overall Study|Protocol Violation|0
7379134|NCT01155466|11634309|FG002|Overall Study|Protocol Violation|2
7379135|NCT01155466|11634310|FG003|Overall Study|Protocol Violation|0
7379136|NCT01155466|11634311|FG004|Overall Study|Protocol Violation|1
7379137|NCT01155466|11634307|FG000|Overall Study|Administrative|0
7379138|NCT01155466|11634308|FG001|Overall Study|Administrative|3
7379139|NCT01155466|11634309|FG002|Overall Study|Administrative|0
7379140|NCT01155466|11634310|FG003|Overall Study|Administrative|0
7379141|NCT01155466|11634311|FG004|Overall Study|Administrative|0
7379142|NCT01155466|11634307|FG000|Overall Study|Randomized not treated|2
7379143|NCT01155466|11634308|FG001|Overall Study|Randomized not treated|2
7379144|NCT01155466|11634309|FG002|Overall Study|Randomized not treated|3
7379145|NCT01155466|11634310|FG003|Overall Study|Randomized not treated|0
7379146|NCT01155466|11634311|FG004|Overall Study|Randomized not treated|2
7379147|NCT01155479|11634328|FG000|Part I|Adverse Event|13
7379148|NCT01155479|11634329|FG001|Part I|Adverse Event|8
7379149|NCT01155479|11634330|FG002|Part I|Adverse Event|18
7379150|NCT01155479|11634331|FG003|Part I|Adverse Event|7
7379151|NCT01155479|11634332|FG004|Part I|Adverse Event|6
7379152|NCT01155479|11634328|FG000|Part I|Administrative|2
7379153|NCT01155479|11634329|FG001|Part I|Administrative|2
7379154|NCT01155479|11634330|FG002|Part I|Administrative|2
7379155|NCT01155479|11634331|FG003|Part I|Administrative|0
7379156|NCT01155479|11634332|FG004|Part I|Administrative|0
7379157|NCT01155479|11634328|FG000|Part I|Did Not Meet Protocol Eligibility|3
7379158|NCT01155479|11634329|FG001|Part I|Did Not Meet Protocol Eligibility|1
7379159|NCT01155479|11634330|FG002|Part I|Did Not Meet Protocol Eligibility|2
7379160|NCT01155479|11634331|FG003|Part I|Did Not Meet Protocol Eligibility|1
7379161|NCT01155479|11634332|FG004|Part I|Did Not Meet Protocol Eligibility|3
7379162|NCT01155479|11634328|FG000|Part I|Withdrawal by Subject|11
7379163|NCT01155479|11634329|FG001|Part I|Withdrawal by Subject|13
7379164|NCT01155479|11634330|FG002|Part I|Withdrawal by Subject|8
7379165|NCT01155479|11634331|FG003|Part I|Withdrawal by Subject|8
7379166|NCT01155479|11634332|FG004|Part I|Withdrawal by Subject|9
7379167|NCT01155479|11634328|FG000|Part I|Lost to Follow-up|0
7379168|NCT01155479|11634329|FG001|Part I|Lost to Follow-up|0
7379169|NCT01155479|11634330|FG002|Part I|Lost to Follow-up|1
7379170|NCT01155479|11634331|FG003|Part I|Lost to Follow-up|1
7379171|NCT01155479|11634332|FG004|Part I|Lost to Follow-up|0
7379172|NCT01155479|11634328|FG000|Part I|Treatment Failure|3
7379173|NCT01155479|11634329|FG001|Part I|Treatment Failure|0
7379174|NCT01155479|11634330|FG002|Part I|Treatment Failure|3
7379175|NCT01155479|11634331|FG003|Part I|Treatment Failure|1
7379176|NCT01155479|11634332|FG004|Part I|Treatment Failure|2
7379177|NCT01155479|11634328|FG000|Part I|Did Not Receive Treatment|4
7379178|NCT01155479|11634329|FG001|Part I|Did Not Receive Treatment|2
7379179|NCT01155479|11634330|FG002|Part I|Did Not Receive Treatment|2
7379180|NCT01155479|11634331|FG003|Part I|Did Not Receive Treatment|6
7379181|NCT01155479|11634332|FG004|Part I|Did Not Receive Treatment|1
7379182|NCT01155479|11634328|FG000|Part I|Non-Compliance with Protocol|2
7462159|NCT01847209|11759030|FG000|Overall Study|No lung nodule found on intraop CT scan|1
7462160|NCT01847313|11759036|FG000|Overall Study|Death|0
7462161|NCT01847313|11759037|FG001|Overall Study|Death|1
7379183|NCT01155479|11634329|FG001|Part I|Non-Compliance with Protocol|1
7379184|NCT01155479|11634330|FG002|Part I|Non-Compliance with Protocol|3
7379185|NCT01155479|11634331|FG003|Part I|Non-Compliance with Protocol|3
7379186|NCT01155479|11634332|FG004|Part I|Non-Compliance with Protocol|2
7379187|NCT01155479|11634328|FG000|Part II|Adverse Event|7
7379188|NCT01155479|11634329|FG001|Part II|Adverse Event|6
7379189|NCT01155479|11634330|FG002|Part II|Adverse Event|8
7379190|NCT01155479|11634331|FG003|Part II|Adverse Event|3
7379191|NCT01155479|11634332|FG004|Part II|Adverse Event|4
7379192|NCT01155479|11634328|FG000|Part II|Administrative|43
7379193|NCT01155479|11634329|FG001|Part II|Administrative|49
7379194|NCT01155479|11634330|FG002|Part II|Administrative|36
7462163|NCT01847313|11759037|FG001|Overall Study|Withdrawal by Subject|1
7462164|NCT01847443|11759047|FG000|Study Period 1|Withdrawal by Subject|0
7462165|NCT01847443|11759048|FG001|Study Period 1|Withdrawal by Subject|1
7462166|NCT01847443|11759049|FG002|Study Period 1|Withdrawal by Subject|0
7462167|NCT01847443|11759050|FG003|Study Period 1|Withdrawal by Subject|0
7462168|NCT01847443|11759047|FG000|Washout Period Before Study Period 2|Adverse Event|1
7462169|NCT01847443|11759048|FG001|Washout Period Before Study Period 2|Adverse Event|1
7379195|NCT01155479|11634331|FG003|Part II|Administrative|38
7379196|NCT01155479|11634332|FG004|Part II|Administrative|46
7379197|NCT01155479|11634328|FG000|Part II|Withdrawal by Subject|8
7379198|NCT01155479|11634329|FG001|Part II|Withdrawal by Subject|4
7379199|NCT01155479|11634330|FG002|Part II|Withdrawal by Subject|12
7379200|NCT01155479|11634331|FG003|Part II|Withdrawal by Subject|7
7379201|NCT01155479|11634332|FG004|Part II|Withdrawal by Subject|3
7379202|NCT01155479|11634328|FG000|Part II|Lost to Follow-up|1
7379203|NCT01155479|11634329|FG001|Part II|Lost to Follow-up|0
7379204|NCT01155479|11634330|FG002|Part II|Lost to Follow-up|0
7379205|NCT01155479|11634331|FG003|Part II|Lost to Follow-up|0
7379206|NCT01155479|11634332|FG004|Part II|Lost to Follow-up|1
7379207|NCT01155479|11634328|FG000|Part II|Treatment Failure|0
7379208|NCT01155479|11634329|FG001|Part II|Treatment Failure|1
7379209|NCT01155479|11634330|FG002|Part II|Treatment Failure|2
7379210|NCT01155479|11634331|FG003|Part II|Treatment Failure|0
7379211|NCT01155479|11634332|FG004|Part II|Treatment Failure|1
7379212|NCT01155479|11634328|FG000|Part II|Non-Compliance with Protocol|0
7379213|NCT01155479|11634329|FG001|Part II|Non-Compliance with Protocol|1
7379214|NCT01155479|11634330|FG002|Part II|Non-Compliance with Protocol|0
7379215|NCT01155479|11634331|FG003|Part II|Non-Compliance with Protocol|2
7379216|NCT01155479|11634332|FG004|Part II|Non-Compliance with Protocol|0
7379217|NCT01155531|11634364|FG000|Overall Study|Adverse Event|0
7379218|NCT01155531|11634365|FG001|Overall Study|Adverse Event|0
7379219|NCT01155531|11634366|FG002|Overall Study|Adverse Event|1
7379220|NCT01155531|11634367|FG003|Overall Study|Adverse Event|0
7379221|NCT01155531|11634364|FG000|Overall Study|Lost to Follow-up|0
7379222|NCT01155531|11634365|FG001|Overall Study|Lost to Follow-up|0
7379223|NCT01155531|11634366|FG002|Overall Study|Lost to Follow-up|0
7379224|NCT01155531|11634367|FG003|Overall Study|Lost to Follow-up|1
7379225|NCT01155531|11634364|FG000|Overall Study|Withdrawal by Subject|1
7379226|NCT01155531|11634365|FG001|Overall Study|Withdrawal by Subject|0
7379227|NCT01155531|11634366|FG002|Overall Study|Withdrawal by Subject|1
7379228|NCT01155531|11634367|FG003|Overall Study|Withdrawal by Subject|0
7379229|NCT01155570|11634377|FG000|Overall Study|Adverse Event|39
7379230|NCT01155570|11634377|FG000|Overall Study|Lack of Efficacy|46
7379231|NCT01155570|11634377|FG000|Overall Study|Participant's Economic Reasons|17
7379232|NCT01155570|11634377|FG000|Overall Study|No Hospital Visits|7
7379233|NCT01155570|11634377|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
7379234|NCT01155570|11634377|FG000|Overall Study|Adverse Event + Other Reasons|7
7379235|NCT01155570|11634377|FG000|Overall Study|Participant's Economic Reasons + Other|1
7379236|NCT01155570|11634377|FG000|Overall Study|Other Reasons|23
7379237|NCT01155583|11634392|FG000|Phase I|Screen failure - did not start treatment|0
7379238|NCT01155583|11634393|FG001|Phase I|Screen failure - did not start treatment|0
7379239|NCT01155583|11634394|FG002|Phase I|Screen failure - did not start treatment|0
7379240|NCT01155583|11634395|FG003|Phase I|Screen failure - did not start treatment|0
7379241|NCT01155583|11634396|FG004|Phase I|Screen failure - did not start treatment|1
7379242|NCT01155583|11634397|FG005|Phase I|Screen failure - did not start treatment|0
7379243|NCT01155583|11634398|FG006|Phase I|Screen failure - did not start treatment|0
7379244|NCT01155583|11634399|FG007|Phase I|Screen failure - did not start treatment|2
7379245|NCT01155583|11634400|FG008|Phase I|Screen failure - did not start treatment|0
7379246|NCT01155583|11634392|FG000|Phase I|Withdrawal by Subject|0
7379247|NCT01155583|11634393|FG001|Phase I|Withdrawal by Subject|0
7379248|NCT01155583|11634394|FG002|Phase I|Withdrawal by Subject|0
7379249|NCT01155583|11634395|FG003|Phase I|Withdrawal by Subject|0
7379250|NCT01155583|11634396|FG004|Phase I|Withdrawal by Subject|0
7379251|NCT01155583|11634397|FG005|Phase I|Withdrawal by Subject|0
7379252|NCT01155583|11634398|FG006|Phase I|Withdrawal by Subject|0
7379253|NCT01155583|11634399|FG007|Phase I|Withdrawal by Subject|1
7379254|NCT01155583|11634400|FG008|Phase I|Withdrawal by Subject|0
7387237|NCT01213251|11645514|FG000|Overall Study|Protocol Violation|1
7387238|NCT01213251|11645515|FG001|Overall Study|Protocol Violation|1
7387239|NCT01213251|11645516|FG002|Overall Study|Protocol Violation|0
7387240|NCT01213251|11645514|FG000|Overall Study|Missed 18-Month Follow-up|0
7387241|NCT01213251|11645515|FG001|Overall Study|Missed 18-Month Follow-up|0
7387242|NCT01213251|11645516|FG002|Overall Study|Missed 18-Month Follow-up|1
7387243|NCT01213264|11645532|FG000|Overall Study|Adverse Event|1
7387244|NCT01213264|11645533|FG001|Overall Study|Adverse Event|0
7387245|NCT01213264|11645534|FG002|Overall Study|Adverse Event|0
7387246|NCT01213264|11645532|FG000|Overall Study|Lost to Follow-up|1
7387247|NCT01213264|11645533|FG001|Overall Study|Lost to Follow-up|2
7387248|NCT01213264|11645534|FG002|Overall Study|Lost to Follow-up|6
7387249|NCT01213472|11645553|FG000|Overall Study|Recurrence/Progressive disease|25
7387250|NCT01213472|11645553|FG000|Overall Study|Withdrawal by Subject|1
7387251|NCT01213472|11645553|FG000|Overall Study|Physician Decision|1
7387252|NCT01213524|11645559|FG000|Baseline|Withdrawal by Subject|5
7387253|NCT01213524|11645559|FG000|Baseline|high breath alcohol levels|1
7379255|NCT01155661|11634416|FG000|Overall Study|Adverse Event|101
7379256|NCT01155661|11634416|FG000|Overall Study|Death|1
7379257|NCT01155661|11634416|FG000|Overall Study|Lack of Efficacy|32
7379258|NCT01155661|11634416|FG000|Overall Study|Lost to Follow-up|22
7379259|NCT01155661|11634416|FG000|Overall Study|Physician Decision|3
7379260|NCT01155661|11634416|FG000|Overall Study|Protocol Violation|35
7379261|NCT01155661|11634416|FG000|Overall Study|Withdrawal by Subject|73
7379262|NCT01155661|11634416|FG000|Overall Study|Sponsor Decision|13
7379263|NCT01155726|11634422|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
7379264|NCT01155726|11634423|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
7379265|NCT01155726|11634424|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
7379266|NCT01155726|11634425|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
7379267|NCT01155869|11634475|FG000|Overall Study|Lost to Follow-up|3
7379268|NCT01155869|11634476|FG001|Overall Study|Lost to Follow-up|1
7379269|NCT01156012|11634493|FG000|Overall Study|Adverse Event|3
7379270|NCT01156012|11634494|FG001|Overall Study|Adverse Event|1
7379271|NCT01156012|11634493|FG000|Overall Study|Lost to Follow-up|1
7379272|NCT01156012|11634494|FG001|Overall Study|Lost to Follow-up|0
7379273|NCT01156012|11634493|FG000|Overall Study|Withdrawal by Subject|1
7379274|NCT01156012|11634494|FG001|Overall Study|Withdrawal by Subject|0
7379275|NCT01156012|11634493|FG000|Overall Study|use of commercial drug instead of study|0
7379276|NCT01156012|11634494|FG001|Overall Study|use of commercial drug instead of study|1
7379277|NCT01156012|11634493|FG000|Overall Study|Non respect of one of inclusion criteria|2
7379278|NCT01156012|11634494|FG001|Overall Study|Non respect of one of inclusion criteria|1
7379279|NCT01156051|11634502|FG000|Overall Study|Lost to Follow-up|1
7379280|NCT01156051|11634503|FG001|Overall Study|Lost to Follow-up|0
7379281|NCT01156051|11634502|FG000|Overall Study|patient not compliant with protocol|0
7379282|NCT01156051|11634503|FG001|Overall Study|patient not compliant with protocol|1
7379283|NCT01156116|11634511|FG000|Overall Study|Withdrawal by Subject|3
7379284|NCT01156116|11634512|FG001|Overall Study|Withdrawal by Subject|1
7379285|NCT01156116|11634511|FG000|Overall Study|CPAP intolerance|2
7379286|NCT01156116|11634512|FG001|Overall Study|CPAP intolerance|0
7379287|NCT01156142|11634520|FG000|Overall Study|Withdrawal by Subject|8
7379288|NCT01156142|11634521|FG001|Overall Study|Withdrawal by Subject|6
7379289|NCT01156142|11634520|FG000|Overall Study|Ineligible|0
7379290|NCT01156142|11634521|FG001|Overall Study|Ineligible|1
7379291|NCT01156311|11634529|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
7379292|NCT01156311|11634530|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
7379293|NCT01156311|11634531|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
7379294|NCT01156311|11634532|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
7379295|NCT01156311|11634529|FG000|2-Month Monotherapy Period|Physician Decision|0
7379296|NCT01156311|11634530|FG001|2-Month Monotherapy Period|Physician Decision|1
7379297|NCT01156311|11634531|FG002|2-Month Monotherapy Period|Physician Decision|0
7379298|NCT01156311|11634532|FG003|2-Month Monotherapy Period|Physician Decision|0
7379299|NCT01156311|11634529|FG000|2-Month Monotherapy Period|Other|1
7379300|NCT01156311|11634530|FG001|2-Month Monotherapy Period|Other|0
7379301|NCT01156311|11634531|FG002|2-Month Monotherapy Period|Other|0
7379302|NCT01156311|11634532|FG003|2-Month Monotherapy Period|Other|0
7379303|NCT01156311|11634529|FG000|6-month Add-on Therapy Period|Adverse Event|0
7379304|NCT01156311|11634530|FG001|6-month Add-on Therapy Period|Adverse Event|0
7379305|NCT01156311|11634531|FG002|6-month Add-on Therapy Period|Adverse Event|7
7379306|NCT01156311|11634532|FG003|6-month Add-on Therapy Period|Adverse Event|6
7379307|NCT01156311|11634529|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
7379308|NCT01156311|11634530|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
7379309|NCT01156311|11634531|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
7379310|NCT01156311|11634532|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
7379311|NCT01156311|11634529|FG000|6-month Add-on Therapy Period|Disease Activity|0
7379312|NCT01156311|11634530|FG001|6-month Add-on Therapy Period|Disease Activity|0
7379313|NCT01156311|11634531|FG002|6-month Add-on Therapy Period|Disease Activity|1
7379314|NCT01156311|11634532|FG003|6-month Add-on Therapy Period|Disease Activity|2
7379315|NCT01156311|11634529|FG000|6-month Add-on Therapy Period|Physician Decision|0
7379316|NCT01156311|11634530|FG001|6-month Add-on Therapy Period|Physician Decision|0
7379317|NCT01156311|11634531|FG002|6-month Add-on Therapy Period|Physician Decision|1
7379318|NCT01156311|11634532|FG003|6-month Add-on Therapy Period|Physician Decision|0
7379319|NCT01156311|11634529|FG000|6-month Add-on Therapy Period|Other|0
7379320|NCT01156311|11634530|FG001|6-month Add-on Therapy Period|Other|0
7379321|NCT01156311|11634531|FG002|6-month Add-on Therapy Period|Other|1
7379322|NCT01156311|11634532|FG003|6-month Add-on Therapy Period|Other|2
7379323|NCT01156363|11634543|FG000|Overall Study|Adverse Event|6
7379324|NCT01156363|11634543|FG000|Overall Study|Insufficient Therapeutic Response|5
7379325|NCT01156363|11634543|FG000|Overall Study|Failure to Return|1
7379326|NCT01156363|11634543|FG000|Overall Study|Refused Treatment|4
7379327|NCT01156363|11634543|FG000|Overall Study|Other|6
7379328|NCT01156376|11634557|FG000|Overall Study|Adverse Event|1
7379329|NCT01156376|11634558|FG001|Overall Study|Adverse Event|0
7462170|NCT01847443|11759049|FG002|Washout Period Before Study Period 2|Adverse Event|0
7379330|NCT01156376|11634559|FG002|Overall Study|Adverse Event|1
7379331|NCT01156376|11634557|FG000|Overall Study|Withdrawal by Subject|0
7379332|NCT01156376|11634558|FG001|Overall Study|Withdrawal by Subject|0
7379333|NCT01156376|11634559|FG002|Overall Study|Withdrawal by Subject|3
7379334|NCT01156480|11634569|FG000|Overall Study|change in diagnosis|0
7379335|NCT01156480|11634570|FG001|Overall Study|change in diagnosis|1
7379336|NCT01156532|11634578|FG000|Overall Study|Family Reasons|1
7379337|NCT01156532|11634578|FG000|Overall Study|Lost to Follow-up|1
7379338|NCT01156675|11634604|FG000|Overall Study|Death|5
7379339|NCT01156675|11634605|FG001|Overall Study|Death|3
7379340|NCT01156675|11634606|FG002|Overall Study|Death|0
7379341|NCT01156675|11634604|FG000|Overall Study|No data|29
7379342|NCT01156675|11634605|FG001|Overall Study|No data|22
7379343|NCT01156675|11634606|FG002|Overall Study|No data|2
7379344|NCT01156714|11634631|FG000|Overall Study|Withdrawal by Subject|9
7379345|NCT01156714|11634632|FG001|Overall Study|Withdrawal by Subject|4
7379346|NCT01156714|11634633|FG002|Overall Study|Withdrawal by Subject|3
7379347|NCT01156792|11634644|FG000|Overall Study|Adverse Event|1
7379348|NCT01156792|11634644|FG000|Overall Study|Lack of Efficacy|36
7379349|NCT01156792|11634644|FG000|Overall Study|Protocol Violation|6
7379350|NCT01156792|11634644|FG000|Overall Study|Lost to Follow-up|3
7379351|NCT01156792|11634644|FG000|Overall Study|Physician Decision|3
7379352|NCT01156792|11634644|FG000|Overall Study|Withdrawal by Subject|9
7379353|NCT01156792|11634644|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
7379354|NCT01156844|11634672|FG000|Overall Study|Adverse Event|0
7379355|NCT01156844|11634673|FG001|Overall Study|Adverse Event|0
7379356|NCT01156844|11634674|FG002|Overall Study|Adverse Event|1
7379357|NCT01156844|11634675|FG003|Overall Study|Adverse Event|1
7379358|NCT01156844|11634672|FG000|Overall Study|Abnormal test procedure result(s)|0
7379359|NCT01156844|11634673|FG001|Overall Study|Abnormal test procedure result(s)|1
7379360|NCT01156844|11634674|FG002|Overall Study|Abnormal test procedure result(s)|2
7379361|NCT01156844|11634675|FG003|Overall Study|Abnormal test procedure result(s)|2
7379362|NCT01156844|11634672|FG000|Overall Study|Withdrawal by Subject|0
7379363|NCT01156844|11634673|FG001|Overall Study|Withdrawal by Subject|0
7379364|NCT01156844|11634674|FG002|Overall Study|Withdrawal by Subject|2
7379365|NCT01156844|11634675|FG003|Overall Study|Withdrawal by Subject|2
7379366|NCT01156844|11634672|FG000|Overall Study|Lost to Follow-up|0
7379367|NCT01156844|11634673|FG001|Overall Study|Lost to Follow-up|0
7379368|NCT01156844|11634674|FG002|Overall Study|Lost to Follow-up|1
7379369|NCT01156844|11634675|FG003|Overall Study|Lost to Follow-up|0
7379370|NCT01156844|11634672|FG000|Overall Study|Administrative problems|0
7379371|NCT01156844|11634673|FG001|Overall Study|Administrative problems|1
7379372|NCT01156844|11634674|FG002|Overall Study|Administrative problems|0
7379373|NCT01156844|11634675|FG003|Overall Study|Administrative problems|1
7379374|NCT01156844|11634672|FG000|Overall Study|Protocol deviation|2
7379375|NCT01156844|11634673|FG001|Overall Study|Protocol deviation|0
7379376|NCT01156844|11634674|FG002|Overall Study|Protocol deviation|0
7379377|NCT01156844|11634675|FG003|Overall Study|Protocol deviation|0
7379378|NCT01157065|11634699|FG000|Overall Study|Death|0
7379379|NCT01157065|11634700|FG001|Overall Study|Death|1
7379380|NCT01157078|11634708|FG000|Overall Study|Withdrawal by Subject|12
7379381|NCT01157078|11634709|FG001|Overall Study|Withdrawal by Subject|14
7379382|NCT01157078|11634708|FG000|Overall Study|Eligibility criteria not fulfilled|2
7379383|NCT01157078|11634709|FG001|Overall Study|Eligibility criteria not fulfilled|0
7379384|NCT01157078|11634708|FG000|Overall Study|Adverse Event|6
7379385|NCT01157078|11634709|FG001|Overall Study|Adverse Event|6
7379386|NCT01157078|11634708|FG000|Overall Study|Severe non-compliance to protocol|2
7379387|NCT01157078|11634709|FG001|Overall Study|Severe non-compliance to protocol|4
7379388|NCT01157078|11634708|FG000|Overall Study|Condition under investigation worsened|0
7533433|NCT02686034|11879841|FG000|Run-In Period 1|Lost to Follow-up|4
7379389|NCT01157078|11634709|FG001|Overall Study|Condition under investigation worsened|1
7379390|NCT01157078|11634708|FG000|Overall Study|Lack of Efficacy|2
7379391|NCT01157078|11634709|FG001|Overall Study|Lack of Efficacy|0
7379392|NCT01157078|11634708|FG000|Overall Study|Study-specific withdrawal criteria|2
7379393|NCT01157078|11634709|FG001|Overall Study|Study-specific withdrawal criteria|2
7379394|NCT01157078|11634708|FG000|Overall Study|Lost to Follow-up|7
7379395|NCT01157078|11634709|FG001|Overall Study|Lost to Follow-up|5
7379396|NCT01157078|11634708|FG000|Overall Study|Other|2
7379397|NCT01157078|11634709|FG001|Overall Study|Other|4
7379398|NCT01157117|11634718|FG000|Overall Study|Dosing Symptoms|0
7379399|NCT01157117|11634719|FG001|Overall Study|Dosing Symptoms|4
7379400|NCT01157117|11634720|FG002|Overall Study|Dosing Symptoms|0
7379401|NCT01157117|11634718|FG000|Overall Study|Withdrawal by Subject|4
7379402|NCT01157117|11634719|FG001|Overall Study|Withdrawal by Subject|1
7379403|NCT01157117|11634720|FG002|Overall Study|Withdrawal by Subject|1
7379404|NCT01157117|11634718|FG000|Overall Study|Lack of Efficacy|1
7379405|NCT01157117|11634719|FG001|Overall Study|Lack of Efficacy|1
7379406|NCT01157117|11634720|FG002|Overall Study|Lack of Efficacy|0
7379407|NCT01157117|11634718|FG000|Overall Study|Lost to Follow-up|0
7462171|NCT01847443|11759050|FG003|Washout Period Before Study Period 2|Adverse Event|0
7462172|NCT01847443|11759047|FG000|Washout Period Before Study Period 2|Other reason|1
7462173|NCT01847443|11759048|FG001|Washout Period Before Study Period 2|Other reason|0
7462174|NCT01847443|11759049|FG002|Washout Period Before Study Period 2|Other reason|0
7462175|NCT01847443|11759050|FG003|Washout Period Before Study Period 2|Other reason|0
7462176|NCT01847443|11759047|FG000|Washout Period Before Study Period 3|Other reason|1
7462177|NCT01847443|11759048|FG001|Washout Period Before Study Period 3|Other reason|0
7462178|NCT01847443|11759049|FG002|Washout Period Before Study Period 3|Other reason|0
7468709|NCT01913353|11769605|FG001|Overall Study|multiple reasons|7
7379408|NCT01157117|11634719|FG001|Overall Study|Lost to Follow-up|0
7379409|NCT01157117|11634720|FG002|Overall Study|Lost to Follow-up|1
7379410|NCT01157117|11634718|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
7379411|NCT01157117|11634719|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
7379412|NCT01157117|11634720|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
7379413|NCT01157169|11634730|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
7379414|NCT01157169|11634731|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
7379415|NCT01157169|11634730|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
7379416|NCT01157169|11634731|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
7379417|NCT01157182|11634739|FG000|Washout of 28 Days|Adverse Event|2
7379418|NCT01157182|11634740|FG001|Washout of 28 Days|Adverse Event|0
7379419|NCT01157234|11634748|FG000|Overall Study|Withdrawal by Subject|1
7379420|NCT01157234|11634749|FG001|Overall Study|Withdrawal by Subject|0
7379421|NCT01157351|11634764|FG000|Overall Study|Adverse Event|5
7379422|NCT01157351|11634765|FG001|Overall Study|Adverse Event|4
7379423|NCT01157351|11634764|FG000|Overall Study|Death|1
7379424|NCT01157351|11634765|FG001|Overall Study|Death|0
7379425|NCT01157351|11634764|FG000|Overall Study|Lost to Follow-up|53
7379426|NCT01157351|11634765|FG001|Overall Study|Lost to Follow-up|55
7379427|NCT01157351|11634764|FG000|Overall Study|Withdrawal by Subject|37
7379428|NCT01157351|11634765|FG001|Overall Study|Withdrawal by Subject|27
7379429|NCT01157351|11634764|FG000|Overall Study|Physician Decision|5
7379430|NCT01157351|11634765|FG001|Overall Study|Physician Decision|4
7379431|NCT01157351|11634764|FG000|Overall Study|Protocol Violation|0
7379432|NCT01157351|11634765|FG001|Overall Study|Protocol Violation|1
7379433|NCT01157351|11634764|FG000|Overall Study|Other|32
7379434|NCT01157351|11634765|FG001|Overall Study|Other|36
7379435|NCT01157351|11634764|FG000|Overall Study|Noncompliance with Study Drug|0
7379436|NCT01157351|11634765|FG001|Overall Study|Noncompliance with Study Drug|3
7379437|NCT01157351|11634764|FG000|Overall Study|Randomized but not Treated|4
7379438|NCT01157351|11634765|FG001|Overall Study|Randomized but not Treated|2
7379439|NCT01157364|11634777|FG000|Overall Study|Other Reasons|1
7379440|NCT01157364|11634778|FG001|Overall Study|Other Reasons|1
7379441|NCT01157364|11634779|FG002|Overall Study|Other Reasons|2
7379442|NCT01157364|11634780|FG003|Overall Study|Other Reasons|1
7379443|NCT01157364|11634781|FG004|Overall Study|Other Reasons|0
7379444|NCT01157364|11634782|FG005|Overall Study|Other Reasons|0
7379445|NCT01157364|11634777|FG000|Overall Study|Personal Reasons|0
7379446|NCT01157364|11634778|FG001|Overall Study|Personal Reasons|2
7379447|NCT01157364|11634779|FG002|Overall Study|Personal Reasons|0
7379448|NCT01157364|11634780|FG003|Overall Study|Personal Reasons|0
7379449|NCT01157364|11634781|FG004|Overall Study|Personal Reasons|1
7379450|NCT01157364|11634782|FG005|Overall Study|Personal Reasons|1
7379451|NCT01157364|11634777|FG000|Overall Study|Lost to Follow-up|1
7379452|NCT01157364|11634778|FG001|Overall Study|Lost to Follow-up|0
7379453|NCT01157364|11634779|FG002|Overall Study|Lost to Follow-up|1
7379454|NCT01157364|11634780|FG003|Overall Study|Lost to Follow-up|0
7379455|NCT01157364|11634781|FG004|Overall Study|Lost to Follow-up|0
7379456|NCT01157364|11634782|FG005|Overall Study|Lost to Follow-up|0
7379457|NCT01157364|11634777|FG000|Overall Study|Lack of Efficacy|0
7379458|NCT01157364|11634778|FG001|Overall Study|Lack of Efficacy|0
7379459|NCT01157364|11634779|FG002|Overall Study|Lack of Efficacy|0
7379460|NCT01157364|11634780|FG003|Overall Study|Lack of Efficacy|1
7379461|NCT01157364|11634781|FG004|Overall Study|Lack of Efficacy|0
7379462|NCT01157364|11634782|FG005|Overall Study|Lack of Efficacy|0
7379463|NCT01157364|11634777|FG000|Overall Study|Adverse Event|0
7379464|NCT01157364|11634778|FG001|Overall Study|Adverse Event|1
7379465|NCT01157364|11634779|FG002|Overall Study|Adverse Event|1
7379466|NCT01157364|11634780|FG003|Overall Study|Adverse Event|0
7379467|NCT01157364|11634781|FG004|Overall Study|Adverse Event|1
7379468|NCT01157364|11634782|FG005|Overall Study|Adverse Event|0
7379469|NCT01157377|11634803|FG000|Overall Study|Lost to Follow-up|0
7379470|NCT01157377|11634804|FG001|Overall Study|Lost to Follow-up|0
7379471|NCT01157377|11634805|FG002|Overall Study|Lost to Follow-up|1
7379472|NCT01157377|11634806|FG003|Overall Study|Lost to Follow-up|0
7379473|NCT01157377|11634807|FG004|Overall Study|Lost to Follow-up|1
7379474|NCT01157377|11634808|FG005|Overall Study|Lost to Follow-up|1
7379475|NCT01157377|11634809|FG006|Overall Study|Lost to Follow-up|0
7379476|NCT01157377|11634803|FG000|Overall Study|Personal Reasons|2
7379477|NCT01157377|11634804|FG001|Overall Study|Personal Reasons|1
7379478|NCT01157377|11634805|FG002|Overall Study|Personal Reasons|0
7379479|NCT01157377|11634806|FG003|Overall Study|Personal Reasons|1
7379480|NCT01157377|11634807|FG004|Overall Study|Personal Reasons|0
7379481|NCT01157377|11634808|FG005|Overall Study|Personal Reasons|0
7379482|NCT01157377|11634809|FG006|Overall Study|Personal Reasons|0
7379483|NCT01157377|11634803|FG000|Overall Study|Protocol Violation|0
7379484|NCT01157377|11634804|FG001|Overall Study|Protocol Violation|0
7379485|NCT01157377|11634805|FG002|Overall Study|Protocol Violation|0
7379486|NCT01157377|11634806|FG003|Overall Study|Protocol Violation|0
7379487|NCT01157377|11634807|FG004|Overall Study|Protocol Violation|0
7379488|NCT01157377|11634808|FG005|Overall Study|Protocol Violation|1
7379489|NCT01157377|11634809|FG006|Overall Study|Protocol Violation|0
7379490|NCT01157377|11634803|FG000|Overall Study|Lack of Efficacy|0
7379491|NCT01157377|11634804|FG001|Overall Study|Lack of Efficacy|0
7379492|NCT01157377|11634805|FG002|Overall Study|Lack of Efficacy|0
7379493|NCT01157377|11634806|FG003|Overall Study|Lack of Efficacy|0
7379494|NCT01157377|11634807|FG004|Overall Study|Lack of Efficacy|0
7379495|NCT01157377|11634808|FG005|Overall Study|Lack of Efficacy|0
7379496|NCT01157377|11634809|FG006|Overall Study|Lack of Efficacy|1
7379497|NCT01157377|11634803|FG000|Overall Study|Other Miscellaneous Reasons|0
7379498|NCT01157377|11634804|FG001|Overall Study|Other Miscellaneous Reasons|2
7379499|NCT01157377|11634805|FG002|Overall Study|Other Miscellaneous Reasons|0
7379500|NCT01157377|11634806|FG003|Overall Study|Other Miscellaneous Reasons|0
7379501|NCT01157377|11634807|FG004|Overall Study|Other Miscellaneous Reasons|1
7379502|NCT01157377|11634808|FG005|Overall Study|Other Miscellaneous Reasons|1
7379503|NCT01157377|11634809|FG006|Overall Study|Other Miscellaneous Reasons|1
7379504|NCT01157676|11634845|FG000|Randomization|Death|1
7379505|NCT01157676|11634846|FG001|Randomization|Death|1
7379506|NCT01157676|11634845|FG000|Randomization|unresectable|2
7379507|NCT01157676|11634846|FG001|Randomization|unresectable|3
7379508|NCT01157676|11634845|FG000|Randomization|Withdrawal by Subject|17
7379509|NCT01157676|11634846|FG001|Randomization|Withdrawal by Subject|13
7379510|NCT01157676|11634845|FG000|Randomization|Physician Decision|1
7379511|NCT01157676|11634846|FG001|Randomization|Physician Decision|0
7379512|NCT01157676|11634845|FG000|Surgery|underwent open cystectomy|0
7379513|NCT01157676|11634846|FG001|Surgery|underwent open cystectomy|4
7379514|NCT01157676|11634845|FG000|Surgery|converted to open procedure|0
7379515|NCT01157676|11634846|FG001|Surgery|converted to open procedure|5
7379516|NCT01157676|11634845|FG000|Surgery|underwent robotic cystectomy|1
7379517|NCT01157676|11634846|FG001|Surgery|underwent robotic cystectomy|0
7379518|NCT01157845|11634858|FG000|Overall Study|Lost to Follow-up|5
7379519|NCT01157845|11634858|FG000|Overall Study|Withdrawal by Subject|12
7379520|NCT01157845|11634858|FG000|Overall Study|Physician Decision|3
7379521|NCT01157845|11634858|FG000|Overall Study|Protocol Violation|13
7379522|NCT01157845|11634858|FG000|Overall Study|Study was ended|1
7379523|NCT01157845|11634858|FG000|Overall Study|Device malfunction|1
7379524|NCT01157897|11634866|FG000|Overall Study|Lost to Follow-up|2
7379525|NCT01157897|11634867|FG001|Overall Study|Lost to Follow-up|0
7379526|NCT01157897|11634868|FG002|Overall Study|Lost to Follow-up|0
7379527|NCT01157897|11634869|FG003|Overall Study|Lost to Follow-up|1
7379528|NCT01157897|11634866|FG000|Overall Study|Relocated|0
7379529|NCT01157897|11634867|FG001|Overall Study|Relocated|2
7379530|NCT01157897|11634868|FG002|Overall Study|Relocated|0
7379531|NCT01157897|11634869|FG003|Overall Study|Relocated|0
7379532|NCT01158118|11634881|FG000|Overall Study|Screen failure|1
7379533|NCT01158118|11634882|FG001|Overall Study|Screen failure|0
7379534|NCT01158118|11634881|FG000|Overall Study|Donor match was a screen failure|0
7379535|NCT01158118|11634882|FG001|Overall Study|Donor match was a screen failure|1
7379536|NCT01158118|11634881|FG000|Overall Study|Suffered stroke prior to transplant|0
7379537|NCT01158118|11634882|FG001|Overall Study|Suffered stroke prior to transplant|1
7379538|NCT01158118|11634881|FG000|Overall Study|Death|0
7379539|NCT01158118|11634882|FG001|Overall Study|Death|1
7379540|NCT01158222|11634892|FG000|Overall Study|Not eligible for intermediate phase|17
7379541|NCT01158261|11634896|FG000|Overall Study|Lost to Follow-up|9
7379542|NCT01158261|11634896|FG000|Overall Study|Death|7
7379543|NCT01158261|11634896|FG000|Overall Study|Withdrawal by Subject|1
7379544|NCT01158378|11634902|FG000|Overall Study|Death|4
7379545|NCT01158378|11634903|FG001|Overall Study|Death|5
7379546|NCT01158378|11634902|FG000|Overall Study|Lost to Follow-up|2
7379547|NCT01158378|11634903|FG001|Overall Study|Lost to Follow-up|4
7379548|NCT01158378|11634902|FG000|Overall Study|Withdrawal by Subject|4
7379549|NCT01158378|11634903|FG001|Overall Study|Withdrawal by Subject|0
7379550|NCT01158404|11634918|FG000|Overall Study|Withdrawal by Subject|0
7379551|NCT01158404|11634919|FG001|Overall Study|Withdrawal by Subject|1
7379552|NCT01158404|11634920|FG002|Overall Study|Withdrawal by Subject|0
7379553|NCT01158404|11634921|FG003|Overall Study|Withdrawal by Subject|0
7379554|NCT01158404|11634922|FG004|Overall Study|Withdrawal by Subject|3
7379555|NCT01158404|11634923|FG005|Overall Study|Withdrawal by Subject|1
7379556|NCT01158404|11634924|FG006|Overall Study|Withdrawal by Subject|0
7379557|NCT01158404|11634925|FG007|Overall Study|Withdrawal by Subject|1
7379558|NCT01158404|11634918|FG000|Overall Study|Physician Decision|0
7379559|NCT01158404|11634919|FG001|Overall Study|Physician Decision|0
7379560|NCT01158404|11634920|FG002|Overall Study|Physician Decision|0
7379561|NCT01158404|11634921|FG003|Overall Study|Physician Decision|0
7379562|NCT01158404|11634922|FG004|Overall Study|Physician Decision|0
7379563|NCT01158404|11634923|FG005|Overall Study|Physician Decision|0
7379564|NCT01158404|11634924|FG006|Overall Study|Physician Decision|0
7379565|NCT01158404|11634925|FG007|Overall Study|Physician Decision|1
7379566|NCT01158404|11634918|FG000|Overall Study|Progressive Disease|0
7379567|NCT01158404|11634919|FG001|Overall Study|Progressive Disease|0
7379568|NCT01158404|11634920|FG002|Overall Study|Progressive Disease|0
7379569|NCT01158404|11634921|FG003|Overall Study|Progressive Disease|0
7379570|NCT01158404|11634922|FG004|Overall Study|Progressive Disease|0
7379571|NCT01158404|11634923|FG005|Overall Study|Progressive Disease|0
7379572|NCT01158404|11634924|FG006|Overall Study|Progressive Disease|1
7379573|NCT01158404|11634925|FG007|Overall Study|Progressive Disease|0
7379574|NCT01158534|11634951|FG000|Overall Study|Withdrawal by Subject|1
7379575|NCT01158534|11634951|FG000|Overall Study|Death|1
7379576|NCT01158534|11634951|FG000|Overall Study|Other|1
7379577|NCT01158924|11635010|FG000|Overall Study|Withdrawal by Subject|1
7379578|NCT01158924|11635011|FG001|Overall Study|Withdrawal by Subject|2
7379579|NCT01158924|11635010|FG000|Overall Study|Lost to Follow-up|0
7379580|NCT01158924|11635011|FG001|Overall Study|Lost to Follow-up|1
7379581|NCT01158950|11635017|FG000|1st Intervention (1 Day)|Physician Decision|1
7379582|NCT01158950|11635018|FG001|1st Intervention (1 Day)|Physician Decision|2
7570717|NCT03504852|11948931|FG001|Overall Study|Withdrawal by Subject|5
7570718|NCT03504852|11948932|FG002|Overall Study|Withdrawal by Subject|1
7570719|NCT03504852|11948930|FG000|Overall Study|Lost to Follow-up|4
7570720|NCT03504852|11948931|FG001|Overall Study|Lost to Follow-up|1
7379583|NCT01159171|11635049|FG000|Overall Study|Adverse Event|11
7379584|NCT01159171|11635049|FG000|Overall Study|Progression of Disease|28
7379585|NCT01159171|11635049|FG000|Overall Study|Protocol Violation|1
7379586|NCT01159171|11635049|FG000|Overall Study|Need for Surgery|5
7379587|NCT01159171|11635049|FG000|Overall Study|Medical Decision|4
7379588|NCT01159171|11635049|FG000|Overall Study|Death|1
7379589|NCT01159431|11635069|FG000|Overall Study|Adverse Event|1
7379590|NCT01159431|11635070|FG001|Overall Study|Adverse Event|2
7379591|NCT01159431|11635069|FG000|Overall Study|non-compliance|1
7379592|NCT01159431|11635070|FG001|Overall Study|non-compliance|1
7379593|NCT01159431|11635069|FG000|Overall Study|Lack of Efficacy|0
7379594|NCT01159431|11635070|FG001|Overall Study|Lack of Efficacy|3
7379595|NCT01159574|11635096|FG000|Treatment Phase|non-evaluable/not included in analysis|1
7379596|NCT01159574|11635096|FG000|Treatment Phase|Adverse Event|3
7379597|NCT01159574|11635096|FG000|Treatment Phase|Death|6
7379598|NCT01159574|11635096|FG000|Treatment Phase|Physician Decision|2
7379599|NCT01159574|11635096|FG000|Treatment Phase|Withdrawal by Subject|7
7379600|NCT01159574|11635096|FG000|Treatment Phase|still on treatment|2
7379601|NCT01159574|11635096|FG000|Follow Up Phase|Lost to Follow-up|2
7379602|NCT01159574|11635096|FG000|Follow Up Phase|still being followed for overall surviva|18
7379603|NCT01159600|11635108|FG000|Overall Study|Not treated|0
7379604|NCT01159600|11635109|FG001|Overall Study|Not treated|0
7379605|NCT01159600|11635110|FG002|Overall Study|Not treated|1
7379606|NCT01159600|11635111|FG003|Overall Study|Not treated|0
7379607|NCT01159600|11635112|FG004|Overall Study|Not treated|0
7379608|NCT01159600|11635113|FG005|Overall Study|Not treated|1
7379609|NCT01159600|11635114|FG006|Overall Study|Not treated|2
7379610|NCT01159600|11635115|FG007|Overall Study|Not treated|2
7379611|NCT01159600|11635108|FG000|Overall Study|Adverse Event|7
7379612|NCT01159600|11635109|FG001|Overall Study|Adverse Event|2
7379613|NCT01159600|11635110|FG002|Overall Study|Adverse Event|5
7379614|NCT01159600|11635111|FG003|Overall Study|Adverse Event|1
7379615|NCT01159600|11635112|FG004|Overall Study|Adverse Event|8
7379616|NCT01159600|11635113|FG005|Overall Study|Adverse Event|6
7379617|NCT01159600|11635114|FG006|Overall Study|Adverse Event|7
7379618|NCT01159600|11635115|FG007|Overall Study|Adverse Event|5
7379619|NCT01159600|11635108|FG000|Overall Study|Lack of Efficacy|0
7379620|NCT01159600|11635109|FG001|Overall Study|Lack of Efficacy|0
7379621|NCT01159600|11635110|FG002|Overall Study|Lack of Efficacy|0
7379622|NCT01159600|11635111|FG003|Overall Study|Lack of Efficacy|0
7379623|NCT01159600|11635112|FG004|Overall Study|Lack of Efficacy|2
7379624|NCT01159600|11635113|FG005|Overall Study|Lack of Efficacy|0
7379625|NCT01159600|11635114|FG006|Overall Study|Lack of Efficacy|0
7379626|NCT01159600|11635115|FG007|Overall Study|Lack of Efficacy|1
7379627|NCT01159600|11635108|FG000|Overall Study|Non compliant with protocol|2
7379628|NCT01159600|11635109|FG001|Overall Study|Non compliant with protocol|1
7379629|NCT01159600|11635110|FG002|Overall Study|Non compliant with protocol|0
7379630|NCT01159600|11635111|FG003|Overall Study|Non compliant with protocol|0
7379631|NCT01159600|11635112|FG004|Overall Study|Non compliant with protocol|2
7379632|NCT01159600|11635113|FG005|Overall Study|Non compliant with protocol|0
7379633|NCT01159600|11635114|FG006|Overall Study|Non compliant with protocol|2
7379634|NCT01159600|11635115|FG007|Overall Study|Non compliant with protocol|0
7379635|NCT01159600|11635108|FG000|Overall Study|Lost to Follow-up|2
7379636|NCT01159600|11635109|FG001|Overall Study|Lost to Follow-up|3
7379637|NCT01159600|11635110|FG002|Overall Study|Lost to Follow-up|4
7379638|NCT01159600|11635111|FG003|Overall Study|Lost to Follow-up|3
7379639|NCT01159600|11635112|FG004|Overall Study|Lost to Follow-up|3
7462179|NCT01847443|11759050|FG003|Washout Period Before Study Period 3|Other reason|0
7462180|NCT01847443|11759047|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
7462181|NCT01847443|11759048|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
7462182|NCT01847443|11759049|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
7462183|NCT01847443|11759050|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
7462184|NCT01847443|11759047|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
7379640|NCT01159600|11635113|FG005|Overall Study|Lost to Follow-up|0
7379641|NCT01159600|11635114|FG006|Overall Study|Lost to Follow-up|3
7379642|NCT01159600|11635115|FG007|Overall Study|Lost to Follow-up|2
7379643|NCT01159600|11635108|FG000|Overall Study|Patient refusal to continue,not due toAE|7
7379644|NCT01159600|11635109|FG001|Overall Study|Patient refusal to continue,not due toAE|2
7379645|NCT01159600|11635110|FG002|Overall Study|Patient refusal to continue,not due toAE|4
7379646|NCT01159600|11635111|FG003|Overall Study|Patient refusal to continue,not due toAE|5
7379647|NCT01159600|11635112|FG004|Overall Study|Patient refusal to continue,not due toAE|4
7379648|NCT01159600|11635113|FG005|Overall Study|Patient refusal to continue,not due toAE|4
7379649|NCT01159600|11635114|FG006|Overall Study|Patient refusal to continue,not due toAE|2
7379650|NCT01159600|11635115|FG007|Overall Study|Patient refusal to continue,not due toAE|5
7379651|NCT01159600|11635108|FG000|Overall Study|Other reason not defined above|3
7379652|NCT01159600|11635109|FG001|Overall Study|Other reason not defined above|0
7379653|NCT01159600|11635110|FG002|Overall Study|Other reason not defined above|4
7379654|NCT01159600|11635111|FG003|Overall Study|Other reason not defined above|2
7379655|NCT01159600|11635112|FG004|Overall Study|Other reason not defined above|5
7379656|NCT01159600|11635113|FG005|Overall Study|Other reason not defined above|7
7379657|NCT01159600|11635114|FG006|Overall Study|Other reason not defined above|3
7379658|NCT01159600|11635115|FG007|Overall Study|Other reason not defined above|3
7379659|NCT01159665|11635140|FG000|Overall Study|Withdrawal by Subject|0
7379660|NCT01159665|11635141|FG001|Overall Study|Withdrawal by Subject|1
7379661|NCT01159665|11635142|FG002|Overall Study|Withdrawal by Subject|0
7379662|NCT01159665|11635143|FG003|Overall Study|Withdrawal by Subject|0
7379663|NCT01159665|11635144|FG004|Overall Study|Withdrawal by Subject|0
7379664|NCT01159665|11635145|FG005|Overall Study|Withdrawal by Subject|0
7379665|NCT01159691|11635159|FG000|Overall Study|Lost to Follow-up|2
7379666|NCT01159691|11635159|FG000|Overall Study|Unknown reasons|1
7379667|NCT01159691|11635159|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
7379668|NCT01159691|11635159|FG000|Overall Study|Discontinued Neupro due to other reasons|1
7379669|NCT01159691|11635159|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
7379670|NCT01159691|11635159|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
7379671|NCT01159691|11635159|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
7379672|NCT01159691|11635159|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
7379673|NCT01159769|11635172|FG000|Overall Study|Adverse Event|1
7379674|NCT01159912|11635179|FG000|Overall Study|Adverse Event|2
7379675|NCT01159912|11635180|FG001|Overall Study|Adverse Event|2
7379676|NCT01159912|11635181|FG002|Overall Study|Adverse Event|3
7379677|NCT01159912|11635179|FG000|Overall Study|Lack of Efficacy|23
7379678|NCT01159912|11635180|FG001|Overall Study|Lack of Efficacy|15
7379679|NCT01159912|11635181|FG002|Overall Study|Lack of Efficacy|14
7379680|NCT01159912|11635179|FG000|Overall Study|Protocol Violation|1
7379681|NCT01159912|11635180|FG001|Overall Study|Protocol Violation|2
7379682|NCT01159912|11635181|FG002|Overall Study|Protocol Violation|3
7379683|NCT01159912|11635179|FG000|Overall Study|Lost to Follow-up|4
7379684|NCT01159912|11635180|FG001|Overall Study|Lost to Follow-up|0
7379685|NCT01159912|11635181|FG002|Overall Study|Lost to Follow-up|0
7379686|NCT01159912|11635179|FG000|Overall Study|Physician Decision|0
7379687|NCT01159912|11635180|FG001|Overall Study|Physician Decision|0
7379688|NCT01159912|11635181|FG002|Overall Study|Physician Decision|3
7379689|NCT01159912|11635179|FG000|Overall Study|Withdrawal by Subject|10
7379690|NCT01159912|11635180|FG001|Overall Study|Withdrawal by Subject|3
7379691|NCT01159912|11635181|FG002|Overall Study|Withdrawal by Subject|3
7379692|NCT01159938|11635192|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
7379693|NCT01159938|11635193|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
7379694|NCT01159938|11635194|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
7379695|NCT01159938|11635195|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
7379696|NCT01159938|11635196|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
7379697|NCT01160198|11635220|FG000|Overall Study|Withdrawal by Subject|2
7379698|NCT01160198|11635221|FG001|Overall Study|Withdrawal by Subject|1
7379699|NCT01160198|11635222|FG002|Overall Study|Withdrawal by Subject|0
7379700|NCT01160198|11635220|FG000|Overall Study|Adverse Event|0
7379701|NCT01160198|11635221|FG001|Overall Study|Adverse Event|1
7379702|NCT01160198|11635222|FG002|Overall Study|Adverse Event|0
7379703|NCT01160198|11635220|FG000|Overall Study|Lost to Follow-up|0
7379704|NCT01160198|11635221|FG001|Overall Study|Lost to Follow-up|1
7379705|NCT01160198|11635222|FG002|Overall Study|Lost to Follow-up|0
7379706|NCT01160198|11635220|FG000|Overall Study|Participant lost drug; withdrew consent|0
7379707|NCT01160198|11635221|FG001|Overall Study|Participant lost drug; withdrew consent|0
7379708|NCT01160198|11635222|FG002|Overall Study|Participant lost drug; withdrew consent|1
7379709|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
7379710|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
7379711|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
7379712|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
7379713|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
7379714|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
7379715|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
7379716|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7379717|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7379718|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7379719|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7379720|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
7379721|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
7379722|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7379723|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7379724|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7379725|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7379726|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
7379727|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
7379728|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7379729|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7379730|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7379731|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7379732|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
7379733|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
7379734|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
7379735|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
7570721|NCT03504852|11948932|FG002|Overall Study|Lost to Follow-up|0
7570722|NCT03504852|11948930|FG000|Overall Study|New therapy for study indication|1
7570723|NCT03504852|11948931|FG001|Overall Study|New therapy for study indication|0
7570724|NCT03504852|11948932|FG002|Overall Study|New therapy for study indication|0
7570725|NCT03504852|11948930|FG000|Overall Study|Lack of Efficacy|1
7379736|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
7379737|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
7379738|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
7379739|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
7379740|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
7379741|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
7379742|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
7379743|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
7379744|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
7379745|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
7379746|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7379747|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7379748|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7379749|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7379750|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
7379751|NCT01160289|11635248|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
7379752|NCT01160289|11635249|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7379753|NCT01160289|11635250|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7379754|NCT01160289|11635251|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7379755|NCT01160289|11635252|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7379756|NCT01160289|11635253|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
7379757|NCT01160289|11635248|FG000|Post-Randomization Period|Adverse Event|0
7379758|NCT01160289|11635249|FG001|Post-Randomization Period|Adverse Event|4
7379759|NCT01160289|11635250|FG002|Post-Randomization Period|Adverse Event|4
7379760|NCT01160289|11635251|FG003|Post-Randomization Period|Adverse Event|2
7379761|NCT01160289|11635252|FG004|Post-Randomization Period|Adverse Event|0
7379762|NCT01160289|11635253|FG005|Post-Randomization Period|Adverse Event|0
7379763|NCT01160289|11635248|FG000|Post-Randomization Period|Death|0
7379764|NCT01160289|11635249|FG001|Post-Randomization Period|Death|0
7379765|NCT01160289|11635250|FG002|Post-Randomization Period|Death|0
7379766|NCT01160289|11635251|FG003|Post-Randomization Period|Death|1
7379767|NCT01160289|11635252|FG004|Post-Randomization Period|Death|0
7379768|NCT01160289|11635253|FG005|Post-Randomization Period|Death|0
7379769|NCT01160289|11635248|FG000|Post-Randomization Period|Lack of Efficacy|0
7379770|NCT01160289|11635249|FG001|Post-Randomization Period|Lack of Efficacy|1
7379771|NCT01160289|11635250|FG002|Post-Randomization Period|Lack of Efficacy|0
7379772|NCT01160289|11635251|FG003|Post-Randomization Period|Lack of Efficacy|3
7379773|NCT01160289|11635252|FG004|Post-Randomization Period|Lack of Efficacy|0
7379774|NCT01160289|11635253|FG005|Post-Randomization Period|Lack of Efficacy|0
7379775|NCT01160289|11635248|FG000|Post-Randomization Period|Lost to Follow-up|0
7379776|NCT01160289|11635249|FG001|Post-Randomization Period|Lost to Follow-up|3
7379777|NCT01160289|11635250|FG002|Post-Randomization Period|Lost to Follow-up|2
7379778|NCT01160289|11635251|FG003|Post-Randomization Period|Lost to Follow-up|5
7379779|NCT01160289|11635252|FG004|Post-Randomization Period|Lost to Follow-up|3
7379780|NCT01160289|11635253|FG005|Post-Randomization Period|Lost to Follow-up|4
7379781|NCT01160289|11635248|FG000|Post-Randomization Period|Physician Decision|0
7379782|NCT01160289|11635249|FG001|Post-Randomization Period|Physician Decision|0
7379783|NCT01160289|11635250|FG002|Post-Randomization Period|Physician Decision|1
7379784|NCT01160289|11635251|FG003|Post-Randomization Period|Physician Decision|0
7379785|NCT01160289|11635252|FG004|Post-Randomization Period|Physician Decision|0
7379786|NCT01160289|11635253|FG005|Post-Randomization Period|Physician Decision|0
7379787|NCT01160289|11635248|FG000|Post-Randomization Period|Protocol Violation|0
7379788|NCT01160289|11635249|FG001|Post-Randomization Period|Protocol Violation|4
7379789|NCT01160289|11635250|FG002|Post-Randomization Period|Protocol Violation|2
7379790|NCT01160289|11635251|FG003|Post-Randomization Period|Protocol Violation|0
7379791|NCT01160289|11635252|FG004|Post-Randomization Period|Protocol Violation|1
7379792|NCT01160289|11635253|FG005|Post-Randomization Period|Protocol Violation|3
7379793|NCT01160289|11635248|FG000|Post-Randomization Period|Withdrawal by Subject|0
7387254|NCT01213524|11645559|FG000|Baseline|Physician Decision|1
7570726|NCT03504852|11948931|FG001|Overall Study|Lack of Efficacy|2
7570727|NCT03504852|11948932|FG002|Overall Study|Lack of Efficacy|0
7379794|NCT01160289|11635249|FG001|Post-Randomization Period|Withdrawal by Subject|5
7379795|NCT01160289|11635250|FG002|Post-Randomization Period|Withdrawal by Subject|13
7379796|NCT01160289|11635251|FG003|Post-Randomization Period|Withdrawal by Subject|8
7379797|NCT01160289|11635252|FG004|Post-Randomization Period|Withdrawal by Subject|5
7379798|NCT01160289|11635253|FG005|Post-Randomization Period|Withdrawal by Subject|7
7379799|NCT01160289|11635248|FG000|Post-Randomization Period|Entry Criteria Not Met|0
7379800|NCT01160289|11635249|FG001|Post-Randomization Period|Entry Criteria Not Met|2
7379801|NCT01160289|11635250|FG002|Post-Randomization Period|Entry Criteria Not Met|2
7379802|NCT01160289|11635251|FG003|Post-Randomization Period|Entry Criteria Not Met|2
7379803|NCT01160289|11635252|FG004|Post-Randomization Period|Entry Criteria Not Met|0
7379804|NCT01160289|11635253|FG005|Post-Randomization Period|Entry Criteria Not Met|0
7379805|NCT01160289|11635248|FG000|Post-Randomization Period|Sponsor Decision|0
7379806|NCT01160289|11635249|FG001|Post-Randomization Period|Sponsor Decision|1
7379807|NCT01160289|11635250|FG002|Post-Randomization Period|Sponsor Decision|0
7379808|NCT01160289|11635251|FG003|Post-Randomization Period|Sponsor Decision|0
7379809|NCT01160289|11635252|FG004|Post-Randomization Period|Sponsor Decision|0
7379810|NCT01160289|11635253|FG005|Post-Randomization Period|Sponsor Decision|0
7379811|NCT01160354|11635269|FG000|Overall Study|Death|0
7379812|NCT01160354|11635270|FG001|Overall Study|Death|1
7379813|NCT01160354|11635271|FG002|Overall Study|Death|1
7379814|NCT01160484|11635301|FG000|Overall Study|Lack of Efficacy|9
7379815|NCT01160484|11635301|FG000|Overall Study|Adverse Event|6
7379816|NCT01160484|11635301|FG000|Overall Study|Withdrawal by Subject|2
7379817|NCT01160484|11635301|FG000|Overall Study|inclusion/exclusion criteria failure|1
7379818|NCT01160614|11635307|FG000|Overall Study|Withdrawal by Subject|0
7379819|NCT01160614|11635308|FG001|Overall Study|Withdrawal by Subject|2
7379820|NCT01160640|11635334|FG000|Overall Study|Physician Decision|3
7379821|NCT01160640|11635335|FG001|Overall Study|Physician Decision|3
7379822|NCT01160640|11635334|FG000|Overall Study|Incarceration|1
7379823|NCT01160640|11635335|FG001|Overall Study|Incarceration|0
7379824|NCT01160640|11635334|FG000|Overall Study|Withdrawal by Subject|0
7379825|NCT01160640|11635335|FG001|Overall Study|Withdrawal by Subject|3
7379826|NCT01160744|11635347|FG000|Overall Study|Withdrawal by Subject|11
7379827|NCT01160744|11635348|FG001|Overall Study|Withdrawal by Subject|5
7379828|NCT01160744|11635349|FG002|Overall Study|Withdrawal by Subject|6
7379829|NCT01160744|11635350|FG003|Overall Study|Withdrawal by Subject|4
7379830|NCT01160744|11635347|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
7379831|NCT01160744|11635348|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
7379832|NCT01160744|11635349|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
7379833|NCT01160744|11635350|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
7379834|NCT01160770|11635362|FG000|Overall Study|Adverse Event|10
7379835|NCT01160770|11635362|FG000|Overall Study|Protocol Violation|2
7379836|NCT01160770|11635362|FG000|Overall Study|Subject/parent/caregiver request|33
7379837|NCT01160770|11635362|FG000|Overall Study|Physician Decision|1
7379838|NCT01160770|11635362|FG000|Overall Study|Lost to Follow-up|7
7379839|NCT01160770|11635362|FG000|Overall Study|Study termination or sponsor request|1
7379840|NCT01160770|11635362|FG000|Overall Study|Death|9
7379841|NCT01160770|11635362|FG000|Overall Study|Lack of Efficacy|15
7379842|NCT01160770|11635362|FG000|Overall Study|Other Reasons|1
7379843|NCT01160822|11635373|FG000|Overall Study|Adverse Event|0
7379844|NCT01160822|11635374|FG001|Overall Study|Adverse Event|0
7379845|NCT01160822|11635375|FG002|Overall Study|Adverse Event|0
7379846|NCT01160822|11635376|FG003|Overall Study|Adverse Event|0
7379847|NCT01160822|11635377|FG004|Overall Study|Adverse Event|1
7379848|NCT01160822|11635378|FG005|Overall Study|Adverse Event|2
7379849|NCT01160822|11635379|FG006|Overall Study|Adverse Event|5
7379850|NCT01160822|11635373|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7379851|NCT01160822|11635374|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7379852|NCT01160822|11635375|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7379853|NCT01160822|11635376|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7379854|NCT01160822|11635377|FG004|Overall Study|Unsatisfactory therapeutic effect|4
7379855|NCT01160822|11635378|FG005|Overall Study|Unsatisfactory therapeutic effect|5
7379856|NCT01160822|11635379|FG006|Overall Study|Unsatisfactory therapeutic effect|3
7379857|NCT01160822|11635373|FG000|Overall Study|Withdrawal by Subject|0
7379858|NCT01160822|11635374|FG001|Overall Study|Withdrawal by Subject|0
7379859|NCT01160822|11635375|FG002|Overall Study|Withdrawal by Subject|0
7379860|NCT01160822|11635376|FG003|Overall Study|Withdrawal by Subject|0
7379861|NCT01160822|11635377|FG004|Overall Study|Withdrawal by Subject|0
7379862|NCT01160822|11635378|FG005|Overall Study|Withdrawal by Subject|0
7379863|NCT01160822|11635379|FG006|Overall Study|Withdrawal by Subject|1
7379864|NCT01160822|11635373|FG000|Overall Study|Lost to Follow-up|0
7379865|NCT01160822|11635374|FG001|Overall Study|Lost to Follow-up|0
7379866|NCT01160822|11635375|FG002|Overall Study|Lost to Follow-up|0
7379867|NCT01160822|11635376|FG003|Overall Study|Lost to Follow-up|0
7379868|NCT01160822|11635377|FG004|Overall Study|Lost to Follow-up|1
7379869|NCT01160822|11635378|FG005|Overall Study|Lost to Follow-up|0
7379870|NCT01160822|11635379|FG006|Overall Study|Lost to Follow-up|0
7379871|NCT01160822|11635373|FG000|Overall Study|Administrative problems|0
7379872|NCT01160822|11635374|FG001|Overall Study|Administrative problems|0
7379873|NCT01160822|11635375|FG002|Overall Study|Administrative problems|0
7379874|NCT01160822|11635376|FG003|Overall Study|Administrative problems|0
7379875|NCT01160822|11635377|FG004|Overall Study|Administrative problems|1
7379876|NCT01160822|11635378|FG005|Overall Study|Administrative problems|0
7379877|NCT01160822|11635379|FG006|Overall Study|Administrative problems|0
7379878|NCT01160822|11635373|FG000|Overall Study|Protocol deviation|0
7379879|NCT01160822|11635374|FG001|Overall Study|Protocol deviation|0
7379880|NCT01160822|11635375|FG002|Overall Study|Protocol deviation|0
7379881|NCT01160822|11635376|FG003|Overall Study|Protocol deviation|0
7379882|NCT01160822|11635377|FG004|Overall Study|Protocol deviation|2
7379883|NCT01160822|11635378|FG005|Overall Study|Protocol deviation|0
7379884|NCT01160822|11635379|FG006|Overall Study|Protocol deviation|0
7379885|NCT01161043|11635409|FG000|Overall Study|Withdrawal by Subject|3
7379886|NCT01161173|11635434|FG000|Overall Study|Protocol Violation|13
7379887|NCT01161173|11635434|FG000|Overall Study|Lost to Follow-up|7
7379888|NCT01161173|11635434|FG000|Overall Study|Progressive Disease|82
7379889|NCT01161173|11635434|FG000|Overall Study|Withdrawal of Consent|5
7379890|NCT01161173|11635434|FG000|Overall Study|Unacceptable Toxicity|21
7379891|NCT01161173|11635434|FG000|Overall Study|Death|194
7379892|NCT01161173|11635434|FG000|Overall Study|End of Study|2
7379893|NCT01161173|11635434|FG000|Overall Study|Reasons Not Specified|23
7379894|NCT01161407|11635467|FG000|Overall Study|Protocol Violation|3
7379895|NCT01161407|11635468|FG001|Overall Study|Protocol Violation|1
7379896|NCT01161446|11635486|FG000|Overall Study|Lost to Follow-up|18
7379897|NCT01161446|11635487|FG001|Overall Study|Lost to Follow-up|14
7379898|NCT01161446|11635486|FG000|Overall Study|Withdrawal by Subject|0
7379899|NCT01161446|11635487|FG001|Overall Study|Withdrawal by Subject|1
7379900|NCT01161472|11635493|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
7379901|NCT01161472|11635494|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7379902|NCT01161472|11635495|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7379903|NCT01161472|11635496|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
7379904|NCT01161498|11635508|FG000|Overall Study|Disease Progression|0
7379905|NCT01161498|11635509|FG001|Overall Study|Disease Progression|1
7379906|NCT01161524|11635517|FG000|Core Study (23 Weeks)|Adverse Event|3
7379907|NCT01161524|11635518|FG001|Core Study (23 Weeks)|Adverse Event|0
7379908|NCT01161524|11635519|FG002|Core Study (23 Weeks)|Adverse Event|0
7379909|NCT01161524|11635517|FG000|Core Study (23 Weeks)|Other|1
7379910|NCT01161524|11635518|FG001|Core Study (23 Weeks)|Other|0
7379911|NCT01161524|11635519|FG002|Core Study (23 Weeks)|Other|0
7379912|NCT01161524|11635517|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
7379913|NCT01161524|11635518|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
7379914|NCT01161524|11635519|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
7379915|NCT01161524|11635517|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
7379916|NCT01161524|11635518|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
7379917|NCT01161524|11635519|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
7379918|NCT01161524|11635517|FG000|Core Study (23 Weeks)|Subject Choice|3
7379919|NCT01161524|11635518|FG001|Core Study (23 Weeks)|Subject Choice|2
7379920|NCT01161524|11635519|FG002|Core Study (23 Weeks)|Subject Choice|0
7379921|NCT01161524|11635517|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7379922|NCT01161524|11635518|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
7379923|NCT01161524|11635519|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
7379924|NCT01161524|11635517|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
7379925|NCT01161524|11635518|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
7379926|NCT01161524|11635519|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
7379927|NCT01161524|11635517|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7379928|NCT01161524|11635518|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
7379929|NCT01161524|11635519|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
7379930|NCT01161524|11635517|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7379931|NCT01161524|11635518|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
7379932|NCT01161524|11635519|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
7379933|NCT01161524|11635517|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7379934|NCT01161524|11635518|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
7379935|NCT01161524|11635519|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
7379936|NCT01161537|11635528|FG000|Part B|Withdrawal by Subject|2
7379937|NCT01161628|11635546|FG000|Overall Study|Death|6
7379938|NCT01161628|11635546|FG000|Overall Study|Lack of Efficacy|2
7387255|NCT01213524|11645559|FG000|Session 2|Withdrawal by Subject|5
7387256|NCT01213524|11645559|FG000|Session 3|Withdrawal by Subject|4
7387257|NCT01213524|11645559|FG000|Session 4|Physician Decision|1
7387258|NCT01213524|11645559|FG000|Session 4|Withdrawal by Subject|2
7387259|NCT01213836|11645617|FG000|Period 1, First Intervention|Adverse Event|2
7570728|NCT03504852|11948930|FG000|Overall Study|Death|0
7387260|NCT01213836|11645618|FG001|Period 1, First Intervention|Adverse Event|1
7387261|NCT01213836|11645617|FG000|Period 1, First Intervention|Protocol Violation|0
7387262|NCT01213836|11645618|FG001|Period 1, First Intervention|Protocol Violation|1
7387263|NCT01213836|11645617|FG000|Period 1, First Intervention|Withdrawal by Subject|1
7387264|NCT01213836|11645618|FG001|Period 1, First Intervention|Withdrawal by Subject|1
7387265|NCT01213966|11645640|FG000|Overall Study|Protocol Violation|1
7387266|NCT01213966|11645641|FG001|Overall Study|Protocol Violation|0
7387267|NCT01213966|11645642|FG002|Overall Study|Protocol Violation|3
7387268|NCT01213966|11645643|FG003|Overall Study|Protocol Violation|1
7379939|NCT01162122|11635584|FG000|Overall Study|Withdrawal by Subject|52
7379940|NCT01162122|11635585|FG001|Overall Study|Withdrawal by Subject|43
7379941|NCT01162122|11635584|FG000|Overall Study|Lost to Follow-up|73
7379942|NCT01162122|11635585|FG001|Overall Study|Lost to Follow-up|91
7379943|NCT01162122|11635584|FG000|Overall Study|Adverse Event|3
7379944|NCT01162122|11635585|FG001|Overall Study|Adverse Event|2
7379945|NCT01162122|11635584|FG000|Overall Study|Death|51
7379946|NCT01162122|11635585|FG001|Overall Study|Death|46
7379947|NCT01162122|11635584|FG000|Overall Study|Protocol Violation|2
7379948|NCT01162122|11635585|FG001|Overall Study|Protocol Violation|2
7379949|NCT01162122|11635584|FG000|Overall Study|Inappropriate enrollment|5
7379950|NCT01162122|11635585|FG001|Overall Study|Inappropriate enrollment|4
7379951|NCT01162122|11635584|FG000|Overall Study|Administrative reason|1
7379952|NCT01162122|11635585|FG001|Overall Study|Administrative reason|1
7379953|NCT01162122|11635584|FG000|Overall Study|Unable to classify|3
7379954|NCT01162122|11635585|FG001|Overall Study|Unable to classify|7
7379955|NCT01162122|11635584|FG000|Overall Study|Missing primary reason|1
7379956|NCT01162122|11635585|FG001|Overall Study|Missing primary reason|0
7379957|NCT01162135|11635594|FG000|Overall Study|Withdrawal by Subject|1
7379958|NCT01162135|11635594|FG000|Overall Study|Severe back pain|1
7379959|NCT01162135|11635594|FG000|Overall Study|Ineligible|1
7379960|NCT01162239|11635602|FG000|Treatment Phase|Withdrawal by Subject|1
7379961|NCT01162239|11635603|FG001|Treatment Phase|Withdrawal by Subject|3
7379962|NCT01162239|11635604|FG002|Treatment Phase|Withdrawal by Subject|2
7379963|NCT01162239|11635605|FG003|Treatment Phase|Withdrawal by Subject|3
7379964|NCT01162239|11635602|FG000|Treatment Phase|Death|0
7379965|NCT01162239|11635603|FG001|Treatment Phase|Death|0
7379966|NCT01162239|11635604|FG002|Treatment Phase|Death|0
7379967|NCT01162239|11635605|FG003|Treatment Phase|Death|1
7379968|NCT01162239|11635602|FG000|Treatment Phase|Lost to Follow-up|5
7379969|NCT01162239|11635603|FG001|Treatment Phase|Lost to Follow-up|4
7379970|NCT01162239|11635604|FG002|Treatment Phase|Lost to Follow-up|2
7379971|NCT01162239|11635605|FG003|Treatment Phase|Lost to Follow-up|1
7379972|NCT01162239|11635602|FG000|Extended Follow-up|Lost to Follow-up|8
7379973|NCT01162239|11635603|FG001|Extended Follow-up|Lost to Follow-up|13
7379974|NCT01162239|11635604|FG002|Extended Follow-up|Lost to Follow-up|8
7379975|NCT01162239|11635605|FG003|Extended Follow-up|Lost to Follow-up|6
7379976|NCT01162343|11635625|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
7379977|NCT01162343|11635625|FG000|Overall Study|Refused psychiatrist assessment|12
7379978|NCT01162421|11635631|FG000|Overall Study|Did not receive study drug|2
7379979|NCT01162421|11635632|FG001|Overall Study|Did not receive study drug|1
7379980|NCT01162421|11635631|FG000|Overall Study|Adverse Event|2
7379981|NCT01162421|11635632|FG001|Overall Study|Adverse Event|5
7379982|NCT01162421|11635631|FG000|Overall Study|Lost to Follow-up|0
7379983|NCT01162421|11635632|FG001|Overall Study|Lost to Follow-up|2
7379984|NCT01162421|11635631|FG000|Overall Study|Lack of Efficacy|2
7379985|NCT01162421|11635632|FG001|Overall Study|Lack of Efficacy|2
7379986|NCT01162421|11635631|FG000|Overall Study|Other|2
7379987|NCT01162421|11635632|FG001|Overall Study|Other|3
7379988|NCT01162473|11635640|FG000|Overall Study|Adverse Event|2
7379989|NCT01162473|11635641|FG001|Overall Study|Adverse Event|1
7379990|NCT01162473|11635640|FG000|Overall Study|Withdrawal by Subject|0
7379991|NCT01162473|11635641|FG001|Overall Study|Withdrawal by Subject|4
7379992|NCT01162486|11635652|FG000|Overall Study|low ANC|1
7379993|NCT01162486|11635653|FG001|Overall Study|low ANC|0
7379994|NCT01162486|11635654|FG002|Overall Study|low ANC|0
7379995|NCT01162486|11635655|FG003|Overall Study|low ANC|0
7379996|NCT01162486|11635656|FG004|Overall Study|low ANC|0
7379997|NCT01162486|11635652|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
7379998|NCT01162486|11635653|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
7379999|NCT01162486|11635654|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
7380000|NCT01162486|11635655|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
7380001|NCT01162486|11635656|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
7380002|NCT01162486|11635652|FG000|Overall Study|elevated LFTs|0
7380003|NCT01162486|11635653|FG001|Overall Study|elevated LFTs|0
7380004|NCT01162486|11635654|FG002|Overall Study|elevated LFTs|1
7380005|NCT01162486|11635655|FG003|Overall Study|elevated LFTs|0
7380006|NCT01162486|11635656|FG004|Overall Study|elevated LFTs|0
7380007|NCT01162486|11635652|FG000|Overall Study|Pregnancy|0
7380008|NCT01162486|11635653|FG001|Overall Study|Pregnancy|0
7380009|NCT01162486|11635654|FG002|Overall Study|Pregnancy|0
7380010|NCT01162486|11635655|FG003|Overall Study|Pregnancy|1
7380011|NCT01162486|11635656|FG004|Overall Study|Pregnancy|0
7380012|NCT01162499|11635672|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
7380013|NCT01162499|11635673|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
7380014|NCT01162863|11635697|FG000|Overall Study|Lack of Efficacy|1
7380015|NCT01162863|11635698|FG001|Overall Study|Lack of Efficacy|0
7380016|NCT01162863|11635699|FG002|Overall Study|Lack of Efficacy|0
7380017|NCT01162863|11635697|FG000|Overall Study|Adverse Event|0
7380018|NCT01162863|11635698|FG001|Overall Study|Adverse Event|1
7380019|NCT01162863|11635699|FG002|Overall Study|Adverse Event|0
7380020|NCT01163032|11635710|FG000|Randomization Phase|Withdrawal by Subject|2
7380021|NCT01163032|11635711|FG001|Randomization Phase|Withdrawal by Subject|3
7380022|NCT01163032|11635712|FG002|Randomization Phase|Withdrawal by Subject|0
7380023|NCT01163032|11635710|FG000|Randomization Phase|Adverse Event|3
7380024|NCT01163032|11635711|FG001|Randomization Phase|Adverse Event|3
7380025|NCT01163032|11635712|FG002|Randomization Phase|Adverse Event|0
7380026|NCT01163032|11635710|FG000|Randomization Phase|Protocol Violation|0
7380027|NCT01163032|11635711|FG001|Randomization Phase|Protocol Violation|1
7380028|NCT01163032|11635712|FG002|Randomization Phase|Protocol Violation|0
7380029|NCT01163032|11635710|FG000|Randomization Phase|Various*|5
7380030|NCT01163032|11635711|FG001|Randomization Phase|Various*|4
7380031|NCT01163032|11635712|FG002|Randomization Phase|Various*|0
7380032|NCT01163032|11635710|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7380033|NCT01163032|11635711|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
7380034|NCT01163032|11635712|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
7380035|NCT01163032|11635710|FG000|Open Label Extension Phase|Adverse Event|0
7380036|NCT01163032|11635711|FG001|Open Label Extension Phase|Adverse Event|0
7380037|NCT01163032|11635712|FG002|Open Label Extension Phase|Adverse Event|3
7380038|NCT01163032|11635710|FG000|Open Label Extension Phase|Withdrawal by Subject|0
7380039|NCT01163032|11635711|FG001|Open Label Extension Phase|Withdrawal by Subject|0
7380040|NCT01163032|11635712|FG002|Open Label Extension Phase|Withdrawal by Subject|3
7380041|NCT01163032|11635710|FG000|Open Label Extension Phase|Protocol Violation|0
7380042|NCT01163032|11635711|FG001|Open Label Extension Phase|Protocol Violation|0
7380043|NCT01163032|11635712|FG002|Open Label Extension Phase|Protocol Violation|1
7380044|NCT01163032|11635710|FG000|Open Label Extension Phase|Study Termination|0
7380045|NCT01163032|11635711|FG001|Open Label Extension Phase|Study Termination|0
7380046|NCT01163032|11635712|FG002|Open Label Extension Phase|Study Termination|7
7380047|NCT01163032|11635710|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7380048|NCT01163032|11635711|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
7380049|NCT01163032|11635712|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
7380050|NCT01163149|11635738|FG000|Extension Treatment Period|Withdrawal by Subject|2
7380051|NCT01163149|11635739|FG001|Extension Treatment Period|Withdrawal by Subject|0
7380052|NCT01163149|11635740|FG002|Extension Treatment Period|Withdrawal by Subject|1
7380053|NCT01163149|11635738|FG000|Extension Treatment Period|Adverse Event|0
7380054|NCT01163149|11635739|FG001|Extension Treatment Period|Adverse Event|1
7380055|NCT01163149|11635740|FG002|Extension Treatment Period|Adverse Event|0
7380056|NCT01163149|11635738|FG000|Extension Treatment Period|Noncompliance|0
7380057|NCT01163149|11635739|FG001|Extension Treatment Period|Noncompliance|0
7380058|NCT01163149|11635740|FG002|Extension Treatment Period|Noncompliance|1
7380059|NCT01163253|11635777|FG000|Overall Study|Withdrawn Due to Pregnancy|12
7380060|NCT01163253|11635778|FG001|Overall Study|Withdrawn Due to Pregnancy|2
7380061|NCT01163253|11635777|FG000|Overall Study|Study Terminated by Sponsor|978
7380062|NCT01163253|11635778|FG001|Overall Study|Study Terminated by Sponsor|349
7380063|NCT01163253|11635777|FG000|Overall Study|Protocol Violation|43
7380064|NCT01163253|11635778|FG001|Overall Study|Protocol Violation|12
7380065|NCT01163253|11635777|FG000|Overall Study|Withdrawal by Subject|199
7380066|NCT01163253|11635778|FG001|Overall Study|Withdrawal by Subject|50
7380067|NCT01163253|11635777|FG000|Overall Study|Medication Error|1
7380068|NCT01163253|11635778|FG001|Overall Study|Medication Error|0
7380069|NCT01163253|11635777|FG000|Overall Study|Lost to Follow-up|125
7380070|NCT01163253|11635778|FG001|Overall Study|Lost to Follow-up|23
7380071|NCT01163253|11635777|FG000|Overall Study|Insufficient Clinical Response|423
7380072|NCT01163253|11635778|FG001|Overall Study|Insufficient Clinical Response|29
7380073|NCT01163253|11635777|FG000|Overall Study|Adverse Event|300
7380074|NCT01163253|11635778|FG001|Overall Study|Adverse Event|78
7380075|NCT01163253|11635777|FG000|Overall Study|Death|17
7380076|NCT01163253|11635778|FG001|Overall Study|Death|5
7380077|NCT01163253|11635777|FG000|Overall Study|Ongoing|13
7380078|NCT01163253|11635778|FG001|Overall Study|Ongoing|4
7380079|NCT01163253|11635777|FG000|Overall Study|Other Unspecified|170
7380080|NCT01163253|11635778|FG001|Overall Study|Other Unspecified|34
7380081|NCT01163266|11635787|FG000|Overall Study|Pretreatment Event or Adverse Event|2
7380082|NCT01163266|11635788|FG001|Overall Study|Pretreatment Event or Adverse Event|9
7380083|NCT01163266|11635789|FG002|Overall Study|Pretreatment Event or Adverse Event|7
7380084|NCT01163266|11635787|FG000|Overall Study|Lack of Efficacy|1
7380085|NCT01163266|11635788|FG001|Overall Study|Lack of Efficacy|3
7380086|NCT01163266|11635789|FG002|Overall Study|Lack of Efficacy|1
7380087|NCT01163266|11635787|FG000|Overall Study|Noncompliance with Study Drug|0
7380088|NCT01163266|11635788|FG001|Overall Study|Noncompliance with Study Drug|2
7380089|NCT01163266|11635789|FG002|Overall Study|Noncompliance with Study Drug|0
7380090|NCT01163266|11635787|FG000|Overall Study|Protocol Deviations|2
7380091|NCT01163266|11635788|FG001|Overall Study|Protocol Deviations|2
7380092|NCT01163266|11635789|FG002|Overall Study|Protocol Deviations|5
7380093|NCT01163266|11635787|FG000|Overall Study|Withdrawal of Consent|5
7380094|NCT01163266|11635788|FG001|Overall Study|Withdrawal of Consent|7
7380095|NCT01163266|11635789|FG002|Overall Study|Withdrawal of Consent|3
7380096|NCT01163266|11635787|FG000|Overall Study|Lost to Follow-up|7
7380097|NCT01163266|11635788|FG001|Overall Study|Lost to Follow-up|7
7380098|NCT01163266|11635789|FG002|Overall Study|Lost to Follow-up|10
7380099|NCT01163266|11635787|FG000|Overall Study|Other|1
7380100|NCT01163266|11635788|FG001|Overall Study|Other|1
7380101|NCT01163266|11635789|FG002|Overall Study|Other|2
7380102|NCT01163279|11635799|FG000|Overall Study|Withdrawal by Subject|2
7380103|NCT01163279|11635800|FG001|Overall Study|Withdrawal by Subject|0
7380104|NCT01163292|11635809|FG000|Overall Study|Lack of Efficacy|9
7380105|NCT01163292|11635810|FG001|Overall Study|Lack of Efficacy|0
7380106|NCT01163292|11635809|FG000|Overall Study|Adverse Event|6
7380107|NCT01163292|11635810|FG001|Overall Study|Adverse Event|0
7380108|NCT01163292|11635809|FG000|Overall Study|Initiation of biological therapy|0
7380109|NCT01163292|11635810|FG001|Overall Study|Initiation of biological therapy|15
7380110|NCT01163292|11635809|FG000|Overall Study|Sufficient response to adalimumab|8
7380111|NCT01163292|11635810|FG001|Overall Study|Sufficient response to adalimumab|0
7380112|NCT01163292|11635809|FG000|Overall Study|Refusal to receive adalimumab|7
7380113|NCT01163292|11635810|FG001|Overall Study|Refusal to receive adalimumab|0
7380114|NCT01163292|11635809|FG000|Overall Study|Economic reasons|6
7380115|NCT01163292|11635810|FG001|Overall Study|Economic reasons|0
7380116|NCT01163292|11635809|FG000|Overall Study|No further visits|5
7380117|NCT01163292|11635810|FG001|Overall Study|No further visits|7
7380118|NCT01163318|11635816|FG000|Overall Study|Off-Label Use of Adalimumab|8
7380119|NCT01163318|11635816|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
7380120|NCT01163318|11635816|FG000|Overall Study|History/comorbidity of malignant tumor|3
7380121|NCT01163318|11635816|FG000|Overall Study|Participants Without Case Report Form|7
7380122|NCT01163318|11635816|FG000|Overall Study|Multiple Reasons Per Participant|224
7380123|NCT01163474|11635825|FG000|Overall Study|Withdrawal by Subject|1
7570729|NCT03504852|11948931|FG001|Overall Study|Death|1
7570730|NCT03504852|11948932|FG002|Overall Study|Death|0
7570731|NCT03504852|11948930|FG000|Overall Study|Adverse Event|4
7570732|NCT03504852|11948931|FG001|Overall Study|Adverse Event|8
7570733|NCT03504852|11948932|FG002|Overall Study|Adverse Event|2
7570734|NCT03504917|11948944|FG000|Blinded Treatment Period|Protocol Violation|1
7570735|NCT03504917|11948945|FG001|Blinded Treatment Period|Protocol Violation|0
7570736|NCT03504917|11948944|FG000|Blinded Treatment Period|Withdrawal by Subject|12
7570737|NCT03504917|11948945|FG001|Blinded Treatment Period|Withdrawal by Subject|9
7570738|NCT03504917|11948944|FG000|Blinded Treatment Period|Lack of Efficacy|1
7570739|NCT03504917|11948945|FG001|Blinded Treatment Period|Lack of Efficacy|1
7570740|NCT03504917|11948944|FG000|Blinded Treatment Period|Lost to Follow-up|1
7570741|NCT03504917|11948945|FG001|Blinded Treatment Period|Lost to Follow-up|4
7570742|NCT03504917|11948944|FG000|Blinded Treatment Period|Adverse Event|4
7570743|NCT03504917|11948945|FG001|Blinded Treatment Period|Adverse Event|4
7570744|NCT03504917|11948944|FG000|Blinded Treatment Period|Physician Decision|1
7570745|NCT03504917|11948945|FG001|Blinded Treatment Period|Physician Decision|0
7570746|NCT03504917|11948944|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
7570747|NCT03504917|11948945|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
7570748|NCT03504917|11948944|FG000|Blinded Treatment Period|Study terminated by sponsor|39
7570749|NCT03504917|11948945|FG001|Blinded Treatment Period|Study terminated by sponsor|34
7570750|NCT03504917|11948944|FG000|Blinded Treatment Period|Non-compliance with study drug|0
7570751|NCT03504917|11948945|FG001|Blinded Treatment Period|Non-compliance with study drug|1
7570752|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|The participant left the study site|0
7570753|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|The participant left the study site|1
7570754|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
7570755|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
7380124|NCT01163474|11635825|FG000|Overall Study|Tech barriers to videoteleconference vis|12
7380125|NCT01163474|11635825|FG000|Overall Study|Lost to Follow-up|3
7380126|NCT01163617|11635841|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380127|NCT01163617|11635842|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
7380128|NCT01163617|11635843|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380129|NCT01163617|11635844|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380130|NCT01163617|11635845|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380131|NCT01163617|11635846|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380132|NCT01163617|11635847|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380133|NCT01163617|11635848|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
7380134|NCT01163617|11635841|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380135|NCT01163617|11635842|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
7380136|NCT01163617|11635843|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380137|NCT01163617|11635844|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380138|NCT01163617|11635845|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380139|NCT01163617|11635846|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380140|NCT01163617|11635847|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380141|NCT01163617|11635848|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
7380142|NCT01163617|11635841|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380143|NCT01163617|11635842|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380144|NCT01163617|11635843|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
7380145|NCT01163617|11635844|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380146|NCT01163617|11635845|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380147|NCT01163617|11635846|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380148|NCT01163617|11635847|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380149|NCT01163617|11635848|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
7380150|NCT01163721|11635904|FG000|Overall Study|Adverse Event|5
7380151|NCT01163721|11635905|FG001|Overall Study|Adverse Event|6
7380152|NCT01163721|11635904|FG000|Overall Study|Withdrawal by Subject|3
7380153|NCT01163721|11635905|FG001|Overall Study|Withdrawal by Subject|4
7380154|NCT01163721|11635904|FG000|Overall Study|Lost to Follow-up|0
7380155|NCT01163721|11635905|FG001|Overall Study|Lost to Follow-up|1
7380156|NCT01163721|11635904|FG000|Overall Study|Physician Decision|0
7380157|NCT01163721|11635905|FG001|Overall Study|Physician Decision|1
7380158|NCT01163747|11635913|FG000|Overall Study|Adverse Event|0
7380159|NCT01163747|11635914|FG001|Overall Study|Adverse Event|5
7380160|NCT01163747|11635913|FG000|Overall Study|Insufficient Therapeutic Response|0
7380161|NCT01163747|11635914|FG001|Overall Study|Insufficient Therapeutic Response|1
7380162|NCT01163747|11635913|FG000|Overall Study|Protocol Violation|0
7380163|NCT01163747|11635914|FG001|Overall Study|Protocol Violation|1
7380164|NCT01163747|11635913|FG000|Overall Study|Refused Treatment|6
7380165|NCT01163747|11635914|FG001|Overall Study|Refused Treatment|4
7380166|NCT01163786|11635931|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
7380167|NCT01163786|11635931|FG000|Treatment With Bortezomib|Adverse Event|2
7380168|NCT01163786|11635931|FG000|Completed Follow up (Visit 9 and 10)|Other|1
7380169|NCT01163851|11635937|FG000|Overall Study|Site Closure|0
7380170|NCT01163851|11635938|FG001|Overall Study|Site Closure|1
7380171|NCT01163851|11635937|FG000|Overall Study|Enrolled but not treated|1
7380172|NCT01163851|11635938|FG001|Overall Study|Enrolled but not treated|0
7380173|NCT01163916|11635947|FG000|Overall Study|Withdrawal by Subject|2
7380174|NCT01163916|11635948|FG001|Overall Study|Withdrawal by Subject|0
7380175|NCT01163916|11635949|FG002|Overall Study|Withdrawal by Subject|2
7380176|NCT01163916|11635947|FG000|Overall Study|Adverse Event|2
7380177|NCT01163916|11635948|FG001|Overall Study|Adverse Event|0
7380178|NCT01163916|11635949|FG002|Overall Study|Adverse Event|1
7380179|NCT01163916|11635947|FG000|Overall Study|Lack of Efficacy|2
7380180|NCT01163916|11635948|FG001|Overall Study|Lack of Efficacy|0
7380181|NCT01163916|11635949|FG002|Overall Study|Lack of Efficacy|1
7380182|NCT01163916|11635947|FG000|Overall Study|Other|24
7380183|NCT01163916|11635948|FG001|Overall Study|Other|4
7380184|NCT01163916|11635949|FG002|Overall Study|Other|16
7380185|NCT01164007|11635971|FG000|Overall Study|Adverse Event|5
7380186|NCT01164007|11635971|FG000|Overall Study|Progression of Disease|30
7380187|NCT01164007|11635971|FG000|Overall Study|Protocol Violation|1
7380188|NCT01164007|11635971|FG000|Overall Study|Withdrawal by Subject|1
7380189|NCT01164007|11635971|FG000|Overall Study|Medical Decision|3
7380190|NCT01164475|11635995|FG000|Overall Study|Lack of Efficacy|1
7380191|NCT01164475|11635996|FG001|Overall Study|Lack of Efficacy|0
7380192|NCT01164475|11635995|FG000|Overall Study|Other|0
7380193|NCT01164475|11635996|FG001|Overall Study|Other|1
7380194|NCT01164475|11635995|FG000|Overall Study|Progressive disease|0
7380195|NCT01164475|11635996|FG001|Overall Study|Progressive disease|1
7380196|NCT01164475|11635995|FG000|Overall Study|Protocol Violation|1
7380197|NCT01164475|11635996|FG001|Overall Study|Protocol Violation|0
7380198|NCT01164501|11636005|FG000|Overall Study|Not treated|2
7380199|NCT01164501|11636006|FG001|Overall Study|Not treated|0
7380200|NCT01164501|11636007|FG002|Overall Study|Not treated|1
7380201|NCT01164501|11636005|FG000|Overall Study|Adverse Event|18
7380202|NCT01164501|11636006|FG001|Overall Study|Adverse Event|4
7380203|NCT01164501|11636007|FG002|Overall Study|Adverse Event|21
7380204|NCT01164501|11636005|FG000|Overall Study|Lack of Efficacy|0
7380205|NCT01164501|11636006|FG001|Overall Study|Lack of Efficacy|0
7380206|NCT01164501|11636007|FG002|Overall Study|Lack of Efficacy|1
7380207|NCT01164501|11636005|FG000|Overall Study|Non compliant with protocol|1
7380208|NCT01164501|11636006|FG001|Overall Study|Non compliant with protocol|1
7380209|NCT01164501|11636007|FG002|Overall Study|Non compliant with protocol|4
7380210|NCT01164501|11636005|FG000|Overall Study|Lost to Follow-up|3
7380211|NCT01164501|11636006|FG001|Overall Study|Lost to Follow-up|0
7380212|NCT01164501|11636007|FG002|Overall Study|Lost to Follow-up|3
7380213|NCT01164501|11636005|FG000|Overall Study|Patient refusal to continue,not due toAE|10
7380214|NCT01164501|11636006|FG001|Overall Study|Patient refusal to continue,not due toAE|4
7380215|NCT01164501|11636007|FG002|Overall Study|Patient refusal to continue,not due toAE|8
7380216|NCT01164501|11636005|FG000|Overall Study|Other reason not defined above|9
7380217|NCT01164501|11636006|FG001|Overall Study|Other reason not defined above|1
7380218|NCT01164501|11636007|FG002|Overall Study|Other reason not defined above|4
7380219|NCT01164579|11636020|FG000|Overall Study|Lack of Efficacy|0
7462185|NCT01847443|11759048|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
7462186|NCT01847443|11759049|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
7462187|NCT01847443|11759050|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
7462188|NCT01847755|11759151|FG000|Overall Study|Adverse Event|2
7462189|NCT01847755|11759151|FG000|Overall Study|Withdrawal by Subject|2
7462190|NCT01847755|11759151|FG000|Overall Study|Physician Decision|1
7462191|NCT01847885|11759157|FG000|Initial Enrollment (Consented)|Protocol Violation|1
7462192|NCT01847885|11759158|FG001|Initial Enrollment (Consented)|Protocol Violation|0
7462193|NCT01847885|11759159|FG002|Initial Enrollment (Consented)|Protocol Violation|0
7462194|NCT01847885|11759157|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
7462195|NCT01847885|11759158|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
7462196|NCT01847885|11759159|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
7462197|NCT01847885|11759157|FG000|Initial Enrollment (Consented)|Screen failure|39
7462198|NCT01847885|11759158|FG001|Initial Enrollment (Consented)|Screen failure|0
7462199|NCT01847885|11759159|FG002|Initial Enrollment (Consented)|Screen failure|0
7462200|NCT01847885|11759157|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
7462201|NCT01847885|11759158|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7462202|NCT01847885|11759159|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
7462203|NCT01847885|11759157|FG000|Randomization|Protocol Violation|0
7462204|NCT01847885|11759158|FG001|Randomization|Protocol Violation|1
7462205|NCT01847885|11759159|FG002|Randomization|Protocol Violation|0
7462206|NCT01847885|11759157|FG000|Randomization|Withdrawal by Subject|0
7462207|NCT01847885|11759158|FG001|Randomization|Withdrawal by Subject|0
7462208|NCT01847885|11759159|FG002|Randomization|Withdrawal by Subject|2
7462209|NCT01847885|11759157|FG000|Randomization|Screen Failure|0
7462210|NCT01847885|11759158|FG001|Randomization|Screen Failure|3
7462211|NCT01847885|11759159|FG002|Randomization|Screen Failure|0
7462212|NCT01848145|11759204|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
7462213|NCT01848145|11759204|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
7462214|NCT01848145|11759204|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
7462215|NCT01848145|11759204|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
7462216|NCT01848145|11759204|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
7462217|NCT01848145|11759204|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
7462218|NCT01848145|11759204|FG000|Subsequent Infusions: Weeks 3-8|Death|1
7462219|NCT01848210|11759229|FG000|Overall Study|Informed Consent Form Withdrawal|28
7462220|NCT01848210|11759230|FG001|Overall Study|Informed Consent Form Withdrawal|24
7462221|NCT01848210|11759229|FG000|Overall Study|Lost to Follow-up|24
7462222|NCT01848210|11759230|FG001|Overall Study|Lost to Follow-up|12
7462223|NCT01848210|11759229|FG000|Overall Study|Protocol Violation|3
7462224|NCT01848210|11759230|FG001|Overall Study|Protocol Violation|5
7462225|NCT01848210|11759229|FG000|Overall Study|Use of Forbidden Drugs|9
7462226|NCT01848210|11759230|FG001|Overall Study|Use of Forbidden Drugs|10
7462227|NCT01848210|11759229|FG000|Overall Study|Impedition Condition|5
7462228|NCT01848210|11759230|FG001|Overall Study|Impedition Condition|9
7462229|NCT01848210|11759229|FG000|Overall Study|Adverse Event|7
7462230|NCT01848210|11759230|FG001|Overall Study|Adverse Event|9
7462231|NCT01848210|11759229|FG000|Overall Study|Discontinuation Criterion|5
7462232|NCT01848210|11759230|FG001|Overall Study|Discontinuation Criterion|7
7462233|NCT01848210|11759229|FG000|Overall Study|Hypesensitivity|1
7462234|NCT01848210|11759230|FG001|Overall Study|Hypesensitivity|0
7462235|NCT01848210|11759229|FG000|Overall Study|Hepatic Function Alteration|4
7462236|NCT01848210|11759230|FG001|Overall Study|Hepatic Function Alteration|0
7462237|NCT01848210|11759229|FG000|Overall Study|Chronic Venous Insufficiency Course|1
7462238|NCT01848210|11759230|FG001|Overall Study|Chronic Venous Insufficiency Course|2
7462239|NCT01848210|11759229|FG000|Overall Study|Administrative|1
7462240|NCT01848210|11759230|FG001|Overall Study|Administrative|0
7462241|NCT01848288|11759236|FG000|Overall Study|Death|1
7462242|NCT01848288|11759236|FG000|Overall Study|Protocol Violation|1
7462243|NCT01848288|11759236|FG000|Overall Study|Withdrawal by Subject|1
7462244|NCT01848353|11759245|FG000|Phase 1|Withdrawal by Subject|3
7462245|NCT01848353|11759246|FG001|Phase 1|Withdrawal by Subject|1
7462246|NCT01848353|11759247|FG002|Phase 1|Withdrawal by Subject|0
7462247|NCT01848353|11759248|FG003|Phase 1|Withdrawal by Subject|0
7462248|NCT01848353|11759245|FG000|Phase 2|Withdrawal by Subject|3
7462249|NCT01848353|11759246|FG001|Phase 2|Withdrawal by Subject|2
7380220|NCT01164579|11636021|FG001|Overall Study|Lack of Efficacy|0
7380221|NCT01164579|11636022|FG002|Overall Study|Lack of Efficacy|6
7380222|NCT01164579|11636020|FG000|Overall Study|Lost to Follow-up|1
7380223|NCT01164579|11636021|FG001|Overall Study|Lost to Follow-up|1
7380224|NCT01164579|11636022|FG002|Overall Study|Lost to Follow-up|0
7380225|NCT01164579|11636020|FG000|Overall Study|Withdrawal by Subject|2
7380226|NCT01164579|11636021|FG001|Overall Study|Withdrawal by Subject|5
7380227|NCT01164579|11636022|FG002|Overall Study|Withdrawal by Subject|3
7380228|NCT01164579|11636020|FG000|Overall Study|Protocol Violation|0
7380229|NCT01164579|11636021|FG001|Overall Study|Protocol Violation|1
7380230|NCT01164579|11636022|FG002|Overall Study|Protocol Violation|2
7380231|NCT01164579|11636020|FG000|Overall Study|Adverse Event|4
7380232|NCT01164579|11636021|FG001|Overall Study|Adverse Event|2
7380233|NCT01164579|11636022|FG002|Overall Study|Adverse Event|5
7380234|NCT01164579|11636020|FG000|Overall Study|Reason not specified|1
7380235|NCT01164579|11636021|FG001|Overall Study|Reason not specified|0
7380236|NCT01164579|11636022|FG002|Overall Study|Reason not specified|0
7380237|NCT01164722|11636042|FG000|Overall Study|Adverse Event|0
7380238|NCT01164722|11636043|FG001|Overall Study|Adverse Event|1
7380239|NCT01164722|11636042|FG000|Overall Study|Withdrawal by Subject|3
7380240|NCT01164722|11636043|FG001|Overall Study|Withdrawal by Subject|4
7380241|NCT01164722|11636042|FG000|Overall Study|Lost to Follow-up|3
7380242|NCT01164722|11636043|FG001|Overall Study|Lost to Follow-up|6
7380243|NCT01164722|11636042|FG000|Overall Study|met protocol criteria for non-treatment|11
7380244|NCT01164722|11636043|FG001|Overall Study|met protocol criteria for non-treatment|1
7380245|NCT01164722|11636042|FG000|Overall Study|enrolled on other study, concomitant med|1
7380246|NCT01164722|11636043|FG001|Overall Study|enrolled on other study, concomitant med|3
7380247|NCT01164865|11636051|FG000|Overall Study|Lost to Follow-up|2
7380248|NCT01164865|11636052|FG001|Overall Study|Lost to Follow-up|1
7570756|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
7380249|NCT01164891|11636058|FG000|Overall Study|Disease Progression|5
7380250|NCT01164891|11636058|FG000|Overall Study|Adverse Event|1
7380251|NCT01164956|11636063|FG000|Overall Study|Side Effects|1
7380252|NCT01164956|11636064|FG001|Overall Study|Side Effects|0
7380253|NCT01164956|11636065|FG002|Overall Study|Side Effects|1
7380254|NCT01165021|11636073|FG000|Overall Study|Death|1
7380255|NCT01165138|11636088|FG000|Overall Study|Adverse Event|0
7380256|NCT01165138|11636089|FG001|Overall Study|Adverse Event|1
7380257|NCT01165138|11636090|FG002|Overall Study|Adverse Event|0
7380258|NCT01165138|11636091|FG003|Overall Study|Adverse Event|2
7380259|NCT01165138|11636088|FG000|Overall Study|Lack of Efficacy|0
7380260|NCT01165138|11636089|FG001|Overall Study|Lack of Efficacy|32
7380261|NCT01165138|11636090|FG002|Overall Study|Lack of Efficacy|6
7380262|NCT01165138|11636091|FG003|Overall Study|Lack of Efficacy|7
7380263|NCT01165138|11636088|FG000|Overall Study|Protocol Violation|0
7380264|NCT01165138|11636089|FG001|Overall Study|Protocol Violation|7
7380265|NCT01165138|11636090|FG002|Overall Study|Protocol Violation|0
7380266|NCT01165138|11636091|FG003|Overall Study|Protocol Violation|2
7380267|NCT01165138|11636088|FG000|Overall Study|Lost to Follow-up|0
7380268|NCT01165138|11636089|FG001|Overall Study|Lost to Follow-up|0
7380269|NCT01165138|11636090|FG002|Overall Study|Lost to Follow-up|1
7380270|NCT01165138|11636091|FG003|Overall Study|Lost to Follow-up|2
7380271|NCT01165138|11636088|FG000|Overall Study|Physician Decision|0
7380272|NCT01165138|11636089|FG001|Overall Study|Physician Decision|6
7380273|NCT01165138|11636090|FG002|Overall Study|Physician Decision|7
7380274|NCT01165138|11636091|FG003|Overall Study|Physician Decision|6
7380275|NCT01165138|11636088|FG000|Overall Study|Withdrawal by Subject|0
7380276|NCT01165138|11636089|FG001|Overall Study|Withdrawal by Subject|6
7380277|NCT01165138|11636090|FG002|Overall Study|Withdrawal by Subject|6
7380278|NCT01165138|11636091|FG003|Overall Study|Withdrawal by Subject|3
7380279|NCT01165177|11636101|FG000|Overall Study|Serious Adverse Event|227
7380280|NCT01165177|11636102|FG001|Overall Study|Serious Adverse Event|235
7380281|NCT01165177|11636101|FG000|Overall Study|Withdrawal by Subject|368
7380282|NCT01165177|11636102|FG001|Overall Study|Withdrawal by Subject|354
7380283|NCT01165177|11636101|FG000|Overall Study|Protocol Violation|19
7380284|NCT01165177|11636102|FG001|Overall Study|Protocol Violation|21
7380285|NCT01165177|11636101|FG000|Overall Study|Non-serious adverse event|30
7380286|NCT01165177|11636102|FG001|Overall Study|Non-serious adverse event|18
7380287|NCT01165177|11636101|FG000|Overall Study|Other unspecified reasons|47
7380288|NCT01165177|11636102|FG001|Overall Study|Other unspecified reasons|35
7380289|NCT01165177|11636101|FG000|Overall Study|Suspected HZ episode|0
7380290|NCT01165177|11636102|FG001|Overall Study|Suspected HZ episode|2
7380291|NCT01165177|11636101|FG000|Overall Study|Lost to Follow-up|183
7380292|NCT01165177|11636102|FG001|Overall Study|Lost to Follow-up|194
7380293|NCT01165177|11636101|FG000|Overall Study|Migrated/ moved from study area|48
7380294|NCT01165177|11636102|FG001|Overall Study|Migrated/ moved from study area|43
7380295|NCT01165203|11636118|FG000|Active Phase|Serious Adverse Event|1
7380296|NCT01165203|11636119|FG001|Active Phase|Serious Adverse Event|0
7380297|NCT01165203|11636118|FG000|Active Phase|Withdrawal by Subject|2
7380298|NCT01165203|11636119|FG001|Active Phase|Withdrawal by Subject|1
7380299|NCT01165203|11636118|FG000|Active Phase|Migrated/moved from study area|0
7380300|NCT01165203|11636119|FG001|Active Phase|Migrated/moved from study area|1
7380301|NCT01165203|11636118|FG000|Active Phase|Lost to Follow-up|2
7380302|NCT01165203|11636119|FG001|Active Phase|Lost to Follow-up|0
7380303|NCT01165203|11636118|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
7380304|NCT01165203|11636119|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
7380305|NCT01165203|11636118|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7380306|NCT01165203|11636119|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
7380307|NCT01165203|11636118|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
7380308|NCT01165203|11636119|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
7380309|NCT01165203|11636118|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
7380310|NCT01165203|11636119|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
7380311|NCT01165203|11636118|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
7380312|NCT01165203|11636119|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
7380313|NCT01165216|11636134|FG000|Overall Study|Adverse Event|6
7380314|NCT01165216|11636135|FG001|Overall Study|Adverse Event|3
7380315|NCT01165216|11636134|FG000|Overall Study|Withdrawal by Subject|1
7380316|NCT01165216|11636135|FG001|Overall Study|Withdrawal by Subject|1
7380317|NCT01165216|11636134|FG000|Overall Study|Disease progression|1
7380318|NCT01165216|11636135|FG001|Overall Study|Disease progression|3
7380319|NCT01165229|11636145|FG000|Overall Study|Serious Adverse Event|456
7380320|NCT01165229|11636146|FG001|Overall Study|Serious Adverse Event|487
7380321|NCT01165229|11636145|FG000|Overall Study|Non-Serious Adverse Event|47
7380322|NCT01165229|11636146|FG001|Overall Study|Non-Serious Adverse Event|15
7380323|NCT01165229|11636145|FG000|Overall Study|Protocol Violation|6
7380324|NCT01165229|11636146|FG001|Overall Study|Protocol Violation|8
7380325|NCT01165229|11636145|FG000|Overall Study|Withdrawal by Subject|387
7380326|NCT01165229|11636146|FG001|Overall Study|Withdrawal by Subject|396
7380327|NCT01165229|11636145|FG000|Overall Study|Migrated/moved from study area|51
7380328|NCT01165229|11636146|FG001|Overall Study|Migrated/moved from study area|46
7380329|NCT01165229|11636145|FG000|Overall Study|Lost to Follow-up|123
7380330|NCT01165229|11636146|FG001|Overall Study|Lost to Follow-up|133
7380331|NCT01165229|11636145|FG000|Overall Study|Suspected HZ Episode|2
7380332|NCT01165229|11636146|FG001|Overall Study|Suspected HZ Episode|2
7380333|NCT01165229|11636145|FG000|Overall Study|No reason from the subject|108
7380334|NCT01165229|11636146|FG001|Overall Study|No reason from the subject|102
7380335|NCT01165229|11636145|FG000|Overall Study|Unknown completion status|0
7380336|NCT01165229|11636146|FG001|Overall Study|Unknown completion status|1
7380337|NCT01165242|11636185|FG000|Overall Study|Unreachable Subjects|1
7380338|NCT01165242|11636186|FG001|Overall Study|Unreachable Subjects|0
7380339|NCT01165242|11636187|FG002|Overall Study|Unreachable Subjects|0
7380340|NCT01165242|11636185|FG000|Overall Study|Incarcerated Subjects|0
7380341|NCT01165242|11636186|FG001|Overall Study|Incarcerated Subjects|1
7380342|NCT01165242|11636187|FG002|Overall Study|Incarcerated Subjects|0
7380343|NCT01165242|11636185|FG000|Overall Study|Visit 2 Declined by Subject|0
7380344|NCT01165242|11636186|FG001|Overall Study|Visit 2 Declined by Subject|0
7380345|NCT01165242|11636187|FG002|Overall Study|Visit 2 Declined by Subject|1
7380346|NCT01165242|11636185|FG000|Overall Study|Withdrawal by Subject|0
7380347|NCT01165242|11636186|FG001|Overall Study|Withdrawal by Subject|2
7380348|NCT01165242|11636187|FG002|Overall Study|Withdrawal by Subject|2
7380349|NCT01165242|11636185|FG000|Overall Study|Extended Holiday|0
7380350|NCT01165242|11636186|FG001|Overall Study|Extended Holiday|0
7570757|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
7570758|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
7570759|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
7380351|NCT01165242|11636187|FG002|Overall Study|Extended Holiday|1
7380352|NCT01165242|11636185|FG000|Overall Study|Lost to Follow-up|9
7380353|NCT01165242|11636186|FG001|Overall Study|Lost to Follow-up|7
7380354|NCT01165242|11636187|FG002|Overall Study|Lost to Follow-up|10
7380355|NCT01165281|11636199|FG000|Overall Study|Adverse Event|12
7380356|NCT01165281|11636200|FG001|Overall Study|Adverse Event|14
7380357|NCT01165281|11636199|FG000|Overall Study|Death|3
7380358|NCT01165281|11636200|FG001|Overall Study|Death|4
7380359|NCT01165281|11636199|FG000|Overall Study|Lack of Efficacy|4
7380360|NCT01165281|11636200|FG001|Overall Study|Lack of Efficacy|1
7462250|NCT01848353|11759247|FG002|Phase 2|Withdrawal by Subject|0
7570760|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Adverse Event|7
7570761|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Adverse Event|0
7570762|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
7380361|NCT01165281|11636199|FG000|Overall Study|Lost to Follow-up|0
7380362|NCT01165281|11636200|FG001|Overall Study|Lost to Follow-up|1
7380363|NCT01165281|11636199|FG000|Overall Study|Physician Decision|8
7380364|NCT01165281|11636200|FG001|Overall Study|Physician Decision|1
7380365|NCT01165281|11636199|FG000|Overall Study|Protocol Violation|6
7380366|NCT01165281|11636200|FG001|Overall Study|Protocol Violation|5
7380367|NCT01165281|11636199|FG000|Overall Study|Withdrawal by Subject|8
7380368|NCT01165281|11636200|FG001|Overall Study|Withdrawal by Subject|7
7380369|NCT01165281|11636199|FG000|Overall Study|Noncompliance with Study Drug|1
7380370|NCT01165281|11636200|FG001|Overall Study|Noncompliance with Study Drug|4
7380371|NCT01165281|11636199|FG000|Overall Study|Progressive Disease|10
7380372|NCT01165281|11636200|FG001|Overall Study|Progressive Disease|14
7380373|NCT01165281|11636199|FG000|Overall Study|Other|6
7380374|NCT01165281|11636200|FG001|Overall Study|Other|0
7380375|NCT01165307|11636208|FG000|Overall Study|Lost to Follow-up|11
7380376|NCT01165307|11636209|FG001|Overall Study|Lost to Follow-up|3
7380377|NCT01165307|11636208|FG000|Overall Study|Withdrawal by Subject|2
7380378|NCT01165307|11636209|FG001|Overall Study|Withdrawal by Subject|0
7380379|NCT01165307|11636208|FG000|Overall Study|Subject not available for contact|1
7380380|NCT01165307|11636209|FG001|Overall Study|Subject not available for contact|0
7380381|NCT01165320|11636217|FG000|Overall Study|Clinical adverse experience|2
7380382|NCT01165320|11636218|FG001|Overall Study|Clinical adverse experience|1
7380383|NCT01165320|11636219|FG002|Overall Study|Clinical adverse experience|0
7380384|NCT01165320|11636217|FG000|Overall Study|Laboratory adverse experience|1
7380385|NCT01165320|11636218|FG001|Overall Study|Laboratory adverse experience|0
7380386|NCT01165320|11636219|FG002|Overall Study|Laboratory adverse experience|0
7380387|NCT01165320|11636217|FG000|Overall Study|Lack of Efficacy|0
7380388|NCT01165320|11636218|FG001|Overall Study|Lack of Efficacy|2
7380389|NCT01165320|11636219|FG002|Overall Study|Lack of Efficacy|0
7380390|NCT01165320|11636217|FG000|Overall Study|Reason unknown|0
7380391|NCT01165320|11636218|FG001|Overall Study|Reason unknown|1
7380392|NCT01165320|11636219|FG002|Overall Study|Reason unknown|0
7380393|NCT01165554|11636231|FG000|Overall Study|Withdrawal by Subject|23
7380394|NCT01165684|11636240|FG000|Overall Study|Adverse Event|1
7380395|NCT01165684|11636241|FG001|Overall Study|Adverse Event|1
7380396|NCT01165684|11636240|FG000|Overall Study|Lack of Efficacy|2
7380397|NCT01165684|11636241|FG001|Overall Study|Lack of Efficacy|1
7380398|NCT01165684|11636240|FG000|Overall Study|Protocol Violation|7
7380399|NCT01165684|11636241|FG001|Overall Study|Protocol Violation|15
7380400|NCT01165684|11636240|FG000|Overall Study|Withdrawal Criteria|2
7380401|NCT01165684|11636241|FG001|Overall Study|Withdrawal Criteria|13
7380402|NCT01165684|11636240|FG000|Overall Study|Unclassified|16
7380403|NCT01165684|11636241|FG001|Overall Study|Unclassified|22
7380404|NCT01165996|11636270|FG000|Overall Study|Death|1
7380405|NCT01165996|11636270|FG000|Overall Study|Physician Decision|1
7380406|NCT01166282|11636294|FG000|Open-label Period|Adverse Event|0
7380407|NCT01166282|11636295|FG001|Open-label Period|Adverse Event|0
7380408|NCT01166282|11636296|FG002|Open-label Period|Adverse Event|6
7380409|NCT01166282|11636294|FG000|Open-label Period|Withdrawal by Subject|0
7380410|NCT01166282|11636295|FG001|Open-label Period|Withdrawal by Subject|0
7380411|NCT01166282|11636296|FG002|Open-label Period|Withdrawal by Subject|4
7380412|NCT01166282|11636294|FG000|Open-label Period|Lack of Efficacy|0
7380413|NCT01166282|11636295|FG001|Open-label Period|Lack of Efficacy|0
7380414|NCT01166282|11636296|FG002|Open-label Period|Lack of Efficacy|2
7380415|NCT01166282|11636294|FG000|Open-label Period|Remission|0
7380416|NCT01166282|11636295|FG001|Open-label Period|Remission|0
7380417|NCT01166282|11636296|FG002|Open-label Period|Remission|4
7380418|NCT01166282|11636294|FG000|Open-label Period|Irregular Compliance|0
7380419|NCT01166282|11636295|FG001|Open-label Period|Irregular Compliance|0
7380420|NCT01166282|11636296|FG002|Open-label Period|Irregular Compliance|1
7380421|NCT01166373|11636317|FG000|Overall Study|Lost to Follow-up|3
7380422|NCT01166373|11636318|FG001|Overall Study|Lost to Follow-up|2
7380423|NCT01166373|11636319|FG002|Overall Study|Lost to Follow-up|2
7380424|NCT01166373|11636320|FG003|Overall Study|Lost to Follow-up|2
7380425|NCT01166373|11636317|FG000|Overall Study|Withdrawal by Subject|1
7380426|NCT01166373|11636318|FG001|Overall Study|Withdrawal by Subject|2
7380427|NCT01166373|11636319|FG002|Overall Study|Withdrawal by Subject|2
7380428|NCT01166373|11636320|FG003|Overall Study|Withdrawal by Subject|3
7380429|NCT01166373|11636317|FG000|Overall Study|Physician Decision|1
7380430|NCT01166373|11636318|FG001|Overall Study|Physician Decision|0
7380431|NCT01166373|11636319|FG002|Overall Study|Physician Decision|0
7380432|NCT01166373|11636320|FG003|Overall Study|Physician Decision|0
7380433|NCT01166438|11636334|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
7380434|NCT01166438|11636335|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
7380435|NCT01166438|11636334|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
7380436|NCT01166438|11636335|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
7380437|NCT01166438|11636334|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
7380438|NCT01166438|11636335|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
7380439|NCT01166438|11636334|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
7380440|NCT01166438|11636335|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
7380441|NCT01166438|11636334|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
7380442|NCT01166438|11636335|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
7380443|NCT01166438|11636334|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
7380444|NCT01166438|11636335|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
7380445|NCT01166568|11636345|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
7380446|NCT01166568|11636346|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
7380447|NCT01166568|11636347|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
7380448|NCT01166568|11636345|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
7380449|NCT01166568|11636346|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
7380450|NCT01166568|11636347|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
7380451|NCT01166568|11636345|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
7380452|NCT01166568|11636346|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
7380453|NCT01166568|11636347|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
7380454|NCT01166646|11636355|FG000|Overall Study|Protocol Violation|0
7380455|NCT01166646|11636356|FG001|Overall Study|Protocol Violation|1
7380456|NCT01166646|11636355|FG000|Overall Study|Adverse Event|1
7380457|NCT01166646|11636356|FG001|Overall Study|Adverse Event|0
7380458|NCT01166659|11636362|FG000|Overall Study|Subject Decision|8
7380459|NCT01166659|11636362|FG000|Overall Study|Investigator Decision|2
7380460|NCT01166659|11636362|FG000|Overall Study|Death|1
7380461|NCT01166659|11636362|FG000|Overall Study|Lost to Follow-up|1
7380462|NCT01166659|11636362|FG000|Overall Study|Study Closed at Site|1
7380463|NCT01166750|11636369|FG000|Overall Study|Lost to Follow-up|1
7380464|NCT01166750|11636370|FG001|Overall Study|Lost to Follow-up|0
7380465|NCT01166763|11636376|FG000|Overall Study|Withdrawal by Subject|3
7380466|NCT01166945|11636382|FG000|Randomized|diagnosed with Group A strep|4
7380467|NCT01166945|11636383|FG001|Randomized|diagnosed with Group A strep|4
7380468|NCT01166945|11636382|FG000|Day 10|NonCompliance/Lost to Follow Up|3
7380469|NCT01166945|11636383|FG001|Day 10|NonCompliance/Lost to Follow Up|2
7380470|NCT01166945|11636382|FG000|Day 15|NonCompliance/Lost to Follow Up|2
7380471|NCT01166945|11636383|FG001|Day 15|NonCompliance/Lost to Follow Up|1
7380472|NCT01166945|11636382|FG000|Day 30|Lost to Follow-up|4
7380473|NCT01166945|11636383|FG001|Day 30|Lost to Follow-up|3
7380474|NCT01166958|11636393|FG000|Overall Study|Withdrawal by Subject|1
7380475|NCT01166958|11636394|FG001|Overall Study|Withdrawal by Subject|0
7380476|NCT01167023|11636453|FG000|Overall Study|Lost to Follow-up|0
7380477|NCT01167023|11636454|FG001|Overall Study|Lost to Follow-up|1
7380478|NCT01167023|11636455|FG002|Overall Study|Lost to Follow-up|1
7380479|NCT01167023|11636453|FG000|Overall Study|Screen Failure|0
7380480|NCT01167023|11636454|FG001|Overall Study|Screen Failure|1
7380481|NCT01167023|11636455|FG002|Overall Study|Screen Failure|0
7380482|NCT01167023|11636453|FG000|Overall Study|Sponsor Decision|0
7380483|NCT01167023|11636454|FG001|Overall Study|Sponsor Decision|1
7380484|NCT01167023|11636455|FG002|Overall Study|Sponsor Decision|0
7380485|NCT01167023|11636453|FG000|Overall Study|Withdrawal by Subject|0
7380486|NCT01167023|11636454|FG001|Overall Study|Withdrawal by Subject|0
7380487|NCT01167023|11636455|FG002|Overall Study|Withdrawal by Subject|1
7380488|NCT01167140|11636461|FG000|Overall Study|Withdrawal by Subject|1
7380489|NCT01167153|11636467|FG000|Overall Study|Non-effective therapy|1
7380490|NCT01167153|11636468|FG001|Overall Study|Non-effective therapy|4
7380491|NCT01167153|11636467|FG000|Overall Study|AE including clinical laboratory AE|2
7380492|NCT01167153|11636468|FG001|Overall Study|AE including clinical laboratory AE|8
7380493|NCT01167153|11636467|FG000|Overall Study|Hypotension|1
7380494|NCT01167153|11636468|FG001|Overall Study|Hypotension|0
7380495|NCT01167153|11636467|FG000|Overall Study|Lost to Follow-up|7
7380496|NCT01167153|11636468|FG001|Overall Study|Lost to Follow-up|9
7380497|NCT01167153|11636467|FG000|Overall Study|Non-compliance to concomitant medication|0
7380498|NCT01167153|11636468|FG001|Overall Study|Non-compliance to concomitant medication|2
7380499|NCT01167153|11636467|FG000|Overall Study|Investigator initiation withdrawal,Other|1
7380500|NCT01167153|11636468|FG001|Overall Study|Investigator initiation withdrawal,Other|1
7380501|NCT01167153|11636467|FG000|Overall Study|Withdrawal consent|1
7380502|NCT01167153|11636468|FG001|Overall Study|Withdrawal consent|1
7380503|NCT01167153|11636467|FG000|Overall Study|Subject initiation withdrawal, Other|5
7380504|NCT01167153|11636468|FG001|Overall Study|Subject initiation withdrawal, Other|8
7380505|NCT01167179|11636476|FG000|Overall Study|disease recurrence|4
7380506|NCT01167179|11636477|FG001|Overall Study|disease recurrence|4
7380507|NCT01167179|11636476|FG000|Overall Study|Death|4
7380508|NCT01167179|11636477|FG001|Overall Study|Death|10
7380509|NCT01167179|11636476|FG000|Overall Study|Withdrawal by Subject|1
7380510|NCT01167179|11636477|FG001|Overall Study|Withdrawal by Subject|2
7380511|NCT01167179|11636476|FG000|Overall Study|diverse|6
7380512|NCT01167179|11636477|FG001|Overall Study|diverse|5
7380513|NCT01167192|11636483|FG000|Overall Study|Adverse Event|1
7380514|NCT01167192|11636483|FG000|Overall Study|Death|1
7380515|NCT01167192|11636483|FG000|Overall Study|Withdrawal by Subject|1
7380516|NCT01167192|11636483|FG000|Overall Study|Insurance denial|1
7462251|NCT01848353|11759248|FG003|Phase 2|Withdrawal by Subject|0
7462252|NCT01848353|11759245|FG000|Phase 3|Withdrawal by Subject|1
7462253|NCT01848353|11759246|FG001|Phase 3|Withdrawal by Subject|1
7462254|NCT01848353|11759247|FG002|Phase 3|Withdrawal by Subject|0
7462255|NCT01848353|11759248|FG003|Phase 3|Withdrawal by Subject|0
7462256|NCT01848457|11759274|FG000|Overall Study|Death|1
7462257|NCT01848457|11759275|FG001|Overall Study|Death|0
7462258|NCT01848457|11759276|FG002|Overall Study|Death|0
7380517|NCT01167257|11636489|FG000|Overall Study|Lost to Follow-up|2
7380518|NCT01167257|11636490|FG001|Overall Study|Lost to Follow-up|2
7380519|NCT01167257|11636489|FG000|Overall Study|Withdrew consent|1
7380520|NCT01167257|11636490|FG001|Overall Study|Withdrew consent|1
7380521|NCT01167426|11636500|FG000|Overall Study|Lost to Follow-up|6
7380522|NCT01167426|11636500|FG000|Overall Study|Protocol Violation|1
7380523|NCT01167426|11636500|FG000|Overall Study|Withdrawal by Subject|2
7380524|NCT01167426|11636500|FG000|Overall Study|Sponsor Decision|1
7380525|NCT01167582|11636527|FG000|Overall Study|Lost to Follow-up|0
7380526|NCT01167582|11636528|FG001|Overall Study|Lost to Follow-up|1
7380527|NCT01167634|11636552|FG000|Overall Study|Lost to Follow-up|1
7380528|NCT01167634|11636553|FG001|Overall Study|Lost to Follow-up|3
7380529|NCT01167634|11636554|FG002|Overall Study|Lost to Follow-up|3
7380530|NCT01167634|11636555|FG003|Overall Study|Lost to Follow-up|4
7380531|NCT01167634|11636552|FG000|Overall Study|Withdrawal by Subject|1
7380532|NCT01167634|11636553|FG001|Overall Study|Withdrawal by Subject|1
7380533|NCT01167634|11636554|FG002|Overall Study|Withdrawal by Subject|0
7380534|NCT01167634|11636555|FG003|Overall Study|Withdrawal by Subject|0
7387269|NCT01214044|11645653|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
7387270|NCT01214044|11645653|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
7387271|NCT01214044|11645653|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
7387272|NCT01214044|11645653|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
7387273|NCT01214044|11645653|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
7387274|NCT01214044|11645653|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
7387275|NCT01214174|11645713|FG000|Overall Study|Withdrawal by Subject|0
7387276|NCT01214174|11645714|FG001|Overall Study|Withdrawal by Subject|0
7387277|NCT01214174|11645715|FG002|Overall Study|Withdrawal by Subject|1
7387278|NCT01214187|11645725|FG000|Overall Study|Adverse Event|6
7387279|NCT01214187|11645726|FG001|Overall Study|Adverse Event|2
7387280|NCT01214187|11645725|FG000|Overall Study|Death|1
7387281|NCT01214187|11645726|FG001|Overall Study|Death|1
7387282|NCT01214187|11645725|FG000|Overall Study|Withdrawal by Subject|0
7387283|NCT01214187|11645726|FG001|Overall Study|Withdrawal by Subject|3
7387284|NCT01214200|11645732|FG000|Overall Study|Did not meet inclusion/exclusion|9
7387285|NCT01214200|11645732|FG000|Overall Study|Withdrawal by Subject|2
7387286|NCT01214239|11645740|FG000|Overall Study|Adverse Event|3
7387287|NCT01214239|11645741|FG001|Overall Study|Adverse Event|4
7387288|NCT01214239|11645740|FG000|Overall Study|Protocol Violation|2
7387289|NCT01214239|11645741|FG001|Overall Study|Protocol Violation|1
7570763|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
7570764|NCT03504917|11948944|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
7387290|NCT01214239|11645740|FG000|Overall Study|Lost to Follow-up|1
7387291|NCT01214239|11645741|FG001|Overall Study|Lost to Follow-up|1
7387292|NCT01214239|11645740|FG000|Overall Study|Withdrawal by Subject|4
7387293|NCT01214239|11645741|FG001|Overall Study|Withdrawal by Subject|9
7387294|NCT01214239|11645740|FG000|Overall Study|Lack of Efficacy|1
7387295|NCT01214239|11645741|FG001|Overall Study|Lack of Efficacy|2
7387296|NCT01214239|11645740|FG000|Overall Study|patient's private reason|1
7387297|NCT01214239|11645741|FG001|Overall Study|patient's private reason|1
7387298|NCT01214252|11645747|FG000|Overall Study|Not eligible per protocol|82
7387299|NCT01214395|11645776|FG000|Overall Study|All patients had infection|5
7387300|NCT01214421|11645785|FG000|Overall Study|Lost to Follow-up|7
7387301|NCT01214421|11645786|FG001|Overall Study|Lost to Follow-up|3
7387302|NCT01214421|11645787|FG002|Overall Study|Lost to Follow-up|7
7387303|NCT01214421|11645788|FG003|Overall Study|Lost to Follow-up|3
7387304|NCT01214421|11645785|FG000|Overall Study|Adverse Event|16
7387305|NCT01214421|11645786|FG001|Overall Study|Adverse Event|35
7387306|NCT01214421|11645787|FG002|Overall Study|Adverse Event|14
7387307|NCT01214421|11645788|FG003|Overall Study|Adverse Event|3
7387308|NCT01214421|11645785|FG000|Overall Study|Sponsor Discontinued Site|1
7387309|NCT01214421|11645786|FG001|Overall Study|Sponsor Discontinued Site|2
7387310|NCT01214421|11645787|FG002|Overall Study|Sponsor Discontinued Site|0
7387311|NCT01214421|11645788|FG003|Overall Study|Sponsor Discontinued Site|0
7387312|NCT01214421|11645785|FG000|Overall Study|Withdrawal Criteria Met|3
7387313|NCT01214421|11645786|FG001|Overall Study|Withdrawal Criteria Met|0
7387314|NCT01214421|11645787|FG002|Overall Study|Withdrawal Criteria Met|2
7387315|NCT01214421|11645788|FG003|Overall Study|Withdrawal Criteria Met|1
7387316|NCT01214421|11645785|FG000|Overall Study|Physician Decision|2
7387317|NCT01214421|11645786|FG001|Overall Study|Physician Decision|0
7387318|NCT01214421|11645787|FG002|Overall Study|Physician Decision|4
7387319|NCT01214421|11645788|FG003|Overall Study|Physician Decision|0
7387320|NCT01214421|11645785|FG000|Overall Study|Withdrawal by Subject|21
7387321|NCT01214421|11645786|FG001|Overall Study|Withdrawal by Subject|18
7387322|NCT01214421|11645787|FG002|Overall Study|Withdrawal by Subject|11
7387323|NCT01214421|11645788|FG003|Overall Study|Withdrawal by Subject|2
7387324|NCT01214434|11645800|FG000|Overall Study|Withdrawal by Subject|1
7387325|NCT01214434|11645801|FG001|Overall Study|Withdrawal by Subject|0
7387326|NCT01214434|11645800|FG000|Overall Study|Lost to Follow-up|2
7387327|NCT01214434|11645801|FG001|Overall Study|Lost to Follow-up|2
7387328|NCT01214434|11645800|FG000|Overall Study|Site error|1
7387329|NCT01214434|11645801|FG001|Overall Study|Site error|0
7387330|NCT01214603|11645810|FG000|Overall Study|Adverse Event|0
7387331|NCT01214603|11645811|FG001|Overall Study|Adverse Event|0
7387332|NCT01214603|11645812|FG002|Overall Study|Adverse Event|1
7387333|NCT01214603|11645810|FG000|Overall Study|Death|1
7387334|NCT01214603|11645811|FG001|Overall Study|Death|0
7387335|NCT01214603|11645812|FG002|Overall Study|Death|0
7387336|NCT01214603|11645810|FG000|Overall Study|Progressive Disease|4
7387337|NCT01214603|11645811|FG001|Overall Study|Progressive Disease|1
7387338|NCT01214603|11645812|FG002|Overall Study|Progressive Disease|3
7387339|NCT01214616|11645825|FG000|Overall Study|Progressive disease|2
7387340|NCT01214616|11645826|FG001|Overall Study|Progressive disease|2
7387341|NCT01214616|11645827|FG002|Overall Study|Progressive disease|2
7387342|NCT01214616|11645828|FG003|Overall Study|Progressive disease|4
7387343|NCT01214616|11645825|FG000|Overall Study|Dose limiting toxicity|0
7387344|NCT01214616|11645826|FG001|Overall Study|Dose limiting toxicity|2
7380535|NCT01167881|11636582|FG000|Overall Study|Adverse Event|47
7380536|NCT01167881|11636583|FG001|Overall Study|Adverse Event|51
7380537|NCT01167881|11636582|FG000|Overall Study|Lack of Efficacy|4
7380538|NCT01167881|11636583|FG001|Overall Study|Lack of Efficacy|7
7380539|NCT01167881|11636582|FG000|Overall Study|Non compliant with protocol|9
7380540|NCT01167881|11636583|FG001|Overall Study|Non compliant with protocol|18
7380541|NCT01167881|11636582|FG000|Overall Study|Lost to Follow-up|19
7380542|NCT01167881|11636583|FG001|Overall Study|Lost to Follow-up|20
7570765|NCT03504917|11948945|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
7570766|NCT03505593|11948978|FG000|Overall Study|Withdrawal by Subject|1
7570767|NCT03505593|11948978|FG000|Overall Study|Died before procedure|1
7570768|NCT03505593|11948978|FG000|Overall Study|Anatomical abnormality|1
7570769|NCT03505593|11948978|FG000|Overall Study|Unable to pass through esophagus|1
7570770|NCT03505593|11948978|FG000|Overall Study|Obstruction by Endotracheal tube|1
7570771|NCT03506425|11949004|FG000|Overall Study|Adverse Event|1
7570772|NCT03506425|11949005|FG001|Overall Study|Adverse Event|3
7570773|NCT03506425|11949006|FG002|Overall Study|Adverse Event|0
7570774|NCT03506425|11949004|FG000|Overall Study|Death|1
7570775|NCT03506425|11949005|FG001|Overall Study|Death|0
7570776|NCT03506425|11949006|FG002|Overall Study|Death|0
7380543|NCT01167881|11636582|FG000|Overall Study|Patient refusal to cont., not due to AE|45
7380544|NCT01167881|11636583|FG001|Overall Study|Patient refusal to cont., not due to AE|40
7380545|NCT01167881|11636582|FG000|Overall Study|Not treated|4
7380546|NCT01167881|11636583|FG001|Overall Study|Not treated|0
7380547|NCT01167881|11636582|FG000|Overall Study|Other not defined above|31
7380548|NCT01167881|11636583|FG001|Overall Study|Other not defined above|55
7380549|NCT01167907|11636591|FG000|Overall Study|Protocol Violation|1
7380550|NCT01167907|11636592|FG001|Overall Study|Protocol Violation|0
7380551|NCT01167907|11636591|FG000|Overall Study|saphenous catheter dislodged before comp|1
7380552|NCT01167907|11636592|FG001|Overall Study|saphenous catheter dislodged before comp|1
7380553|NCT01168232|11636607|FG000|Overall Study|Ineligible-Second primary cancer site|1
7380554|NCT01168232|11636607|FG000|Overall Study|Ineligible- Wrong cell type|6
7380555|NCT01168232|11636607|FG000|Overall Study|Ineligible-Inadequate pathology|1
7380556|NCT01168349|11636611|FG000|Overall Study|Death|157
7380557|NCT01168349|11636611|FG000|Overall Study|Lost to Follow-up|34
7380558|NCT01168349|11636611|FG000|Overall Study|Withdrawal by Subject|9
7380559|NCT01168349|11636611|FG000|Overall Study|Kidney transplantation|3
7380560|NCT01168349|11636611|FG000|Overall Study|Other|22
7380561|NCT01168349|11636611|FG000|Overall Study|Protocol Violation|76
7380562|NCT01168401|11636642|FG000|Overall Study|Lost to Follow-up|1
7380563|NCT01168401|11636643|FG001|Overall Study|Lost to Follow-up|1
7380564|NCT01168401|11636644|FG002|Overall Study|Lost to Follow-up|2
7380565|NCT01168401|11636645|FG003|Overall Study|Lost to Follow-up|1
7380566|NCT01168401|11636646|FG004|Overall Study|Lost to Follow-up|0
7380567|NCT01168401|11636647|FG005|Overall Study|Lost to Follow-up|0
7380568|NCT01168401|11636648|FG006|Overall Study|Lost to Follow-up|0
7380569|NCT01168401|11636649|FG007|Overall Study|Lost to Follow-up|0
7380570|NCT01168401|11636650|FG008|Overall Study|Lost to Follow-up|0
7380571|NCT01168401|11636651|FG009|Overall Study|Lost to Follow-up|0
7380572|NCT01168401|11636652|FG010|Overall Study|Lost to Follow-up|0
7380573|NCT01168401|11636642|FG000|Overall Study|Withdrawal by Subject|0
7380574|NCT01168401|11636643|FG001|Overall Study|Withdrawal by Subject|0
7380575|NCT01168401|11636644|FG002|Overall Study|Withdrawal by Subject|0
7380576|NCT01168401|11636645|FG003|Overall Study|Withdrawal by Subject|1
7380577|NCT01168401|11636646|FG004|Overall Study|Withdrawal by Subject|0
7380578|NCT01168401|11636647|FG005|Overall Study|Withdrawal by Subject|0
7380579|NCT01168401|11636648|FG006|Overall Study|Withdrawal by Subject|0
7380580|NCT01168401|11636649|FG007|Overall Study|Withdrawal by Subject|0
7380581|NCT01168401|11636650|FG008|Overall Study|Withdrawal by Subject|0
7380582|NCT01168401|11636651|FG009|Overall Study|Withdrawal by Subject|0
7380583|NCT01168401|11636652|FG010|Overall Study|Withdrawal by Subject|0
7380584|NCT01168427|11636676|FG000|Overall Study|Patient exited prior to implant|1
7380585|NCT01168596|11636682|FG000|Overall Study|Withdrawal by Subject|3
7380586|NCT01168596|11636683|FG001|Overall Study|Withdrawal by Subject|1
7380587|NCT01168856|11636721|FG000|Overall Study|Lost to Follow-up|4
7380588|NCT01168856|11636722|FG001|Overall Study|Lost to Follow-up|34
7380589|NCT01168856|11636721|FG000|Overall Study|Withdrawal by Subject|6
7380590|NCT01168856|11636722|FG001|Overall Study|Withdrawal by Subject|8
7380591|NCT01168856|11636721|FG000|Overall Study|Physician Decision|2
7380592|NCT01168856|11636722|FG001|Overall Study|Physician Decision|1
7380593|NCT01168856|11636721|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
7380594|NCT01168856|11636722|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
7380595|NCT01168856|11636721|FG000|Overall Study|Participant received anti-HCV treatment|1
7380596|NCT01168856|11636722|FG001|Overall Study|Participant received anti-HCV treatment|0
7570777|NCT03506425|11949004|FG000|Overall Study|Withdrawal by Subject|0
7380597|NCT01168856|11636721|FG000|Overall Study|Death|0
7380598|NCT01168856|11636722|FG001|Overall Study|Death|2
7380599|NCT01168856|11636721|FG000|Overall Study|Other|1
7380600|NCT01168856|11636722|FG001|Overall Study|Other|291
7380601|NCT01168856|11636721|FG000|Overall Study|Protocol Violation|4
7380602|NCT01168856|11636722|FG001|Overall Study|Protocol Violation|6
7380603|NCT01168973|11636752|FG000|Overall Study|Progressive Disease|341
7570778|NCT03506425|11949005|FG001|Overall Study|Withdrawal by Subject|0
7380604|NCT01168973|11636753|FG001|Overall Study|Progressive Disease|429
7380605|NCT01168973|11636752|FG000|Overall Study|Adverse Event|94
7380606|NCT01168973|11636753|FG001|Overall Study|Adverse Event|55
7380607|NCT01168973|11636752|FG000|Overall Study|Withdrawal by Subject|90
7380608|NCT01168973|11636753|FG001|Overall Study|Withdrawal by Subject|53
7380609|NCT01168973|11636752|FG000|Overall Study|Death|42
7380610|NCT01168973|11636753|FG001|Overall Study|Death|45
7380611|NCT01168973|11636752|FG000|Overall Study|Physician Decision|37
7380612|NCT01168973|11636753|FG001|Overall Study|Physician Decision|19
7380613|NCT01168973|11636752|FG000|Overall Study|Sponsor Decision|2
7380614|NCT01168973|11636753|FG001|Overall Study|Sponsor Decision|1
7380615|NCT01168973|11636752|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
7380616|NCT01168973|11636753|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
7380617|NCT01168999|11636776|FG000|Overall Study|Lost to Follow-up|2
7380618|NCT01168999|11636777|FG001|Overall Study|Lost to Follow-up|1
7380619|NCT01168999|11636778|FG002|Overall Study|Lost to Follow-up|0
7380620|NCT01168999|11636779|FG003|Overall Study|Lost to Follow-up|0
7380621|NCT01169038|11636789|FG000|Overall Study|Death|1
7380622|NCT01169038|11636789|FG000|Overall Study|Adverse Event|5
7380623|NCT01169038|11636789|FG000|Overall Study|Required antibiotic administration|1
7380624|NCT01169103|11636806|FG000|Overall Study|Lost to Follow-up|3
7380625|NCT01169103|11636807|FG001|Overall Study|Lost to Follow-up|3
7380626|NCT01169103|11636806|FG000|Overall Study|Withdrawal by Subject|3
7380627|NCT01169103|11636807|FG001|Overall Study|Withdrawal by Subject|1
7380628|NCT01169337|11636821|FG000|Overall Study|Lack of Efficacy|5
7380629|NCT01169337|11636822|FG001|Overall Study|Lack of Efficacy|7
7380630|NCT01169337|11636823|FG002|Overall Study|Lack of Efficacy|0
7380631|NCT01169337|11636821|FG000|Overall Study|Adverse Event|12
7380632|NCT01169337|11636822|FG001|Overall Study|Adverse Event|18
7380633|NCT01169337|11636823|FG002|Overall Study|Adverse Event|0
7380634|NCT01169337|11636821|FG000|Overall Study|Death|2
7380635|NCT01169337|11636822|FG001|Overall Study|Death|0
7380636|NCT01169337|11636823|FG002|Overall Study|Death|0
7380637|NCT01169337|11636821|FG000|Overall Study|Withdrawal by Subject|11
7380638|NCT01169337|11636822|FG001|Overall Study|Withdrawal by Subject|11
7380639|NCT01169337|11636823|FG002|Overall Study|Withdrawal by Subject|6
7380640|NCT01169337|11636821|FG000|Overall Study|Noncompliance|2
7380641|NCT01169337|11636822|FG001|Overall Study|Noncompliance|0
7380642|NCT01169337|11636823|FG002|Overall Study|Noncompliance|0
7380643|NCT01169337|11636821|FG000|Overall Study|Other complicating disease|1
7380644|NCT01169337|11636822|FG001|Overall Study|Other complicating disease|1
7380645|NCT01169337|11636823|FG002|Overall Study|Other complicating disease|0
7380646|NCT01169337|11636821|FG000|Overall Study|Physician Decision|1
7380647|NCT01169337|11636822|FG001|Overall Study|Physician Decision|5
7380648|NCT01169337|11636823|FG002|Overall Study|Physician Decision|0
7380649|NCT01169337|11636821|FG000|Overall Study|Alternative therapy|0
7380650|NCT01169337|11636822|FG001|Overall Study|Alternative therapy|2
7380651|NCT01169337|11636823|FG002|Overall Study|Alternative therapy|0
7380652|NCT01169337|11636821|FG000|Overall Study|Changed hospital|0
7380653|NCT01169337|11636822|FG001|Overall Study|Changed hospital|1
7380654|NCT01169337|11636823|FG002|Overall Study|Changed hospital|0
7380655|NCT01169337|11636821|FG000|Overall Study|Never started treatment|0
7380656|NCT01169337|11636822|FG001|Overall Study|Never started treatment|2
7380657|NCT01169337|11636823|FG002|Overall Study|Never started treatment|0
7380658|NCT01169337|11636821|FG000|Overall Study|Reason not reported|1
7380659|NCT01169337|11636822|FG001|Overall Study|Reason not reported|0
7380660|NCT01169337|11636823|FG002|Overall Study|Reason not reported|0
7380661|NCT01169337|11636821|FG000|Overall Study|Continuing lenalidomide|9
7380662|NCT01169337|11636822|FG001|Overall Study|Continuing lenalidomide|43
7380663|NCT01169337|11636823|FG002|Overall Study|Continuing lenalidomide|0
7380664|NCT01169350|11636831|FG000|Overall Study|Physician Decision|3
7380665|NCT01169350|11636831|FG000|Overall Study|Lost to Follow-up|2
7380666|NCT01169493|11636850|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
7380667|NCT01169493|11636851|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
7380668|NCT01169493|11636852|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
7380669|NCT01169493|11636853|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
7380670|NCT01169493|11636854|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
7380671|NCT01169493|11636855|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
7380672|NCT01169493|11636850|FG000|Period 3 (6 Months)|Adverse Event|0
7380673|NCT01169493|11636851|FG001|Period 3 (6 Months)|Adverse Event|1
7380674|NCT01169493|11636852|FG002|Period 3 (6 Months)|Adverse Event|0
7380675|NCT01169493|11636853|FG003|Period 3 (6 Months)|Adverse Event|0
7380676|NCT01169493|11636854|FG004|Period 3 (6 Months)|Adverse Event|0
7380677|NCT01169493|11636855|FG005|Period 3 (6 Months)|Adverse Event|0
7380678|NCT01169493|11636850|FG000|Period 3 (6 Months)|Physician Decision|0
7380679|NCT01169493|11636851|FG001|Period 3 (6 Months)|Physician Decision|1
7380680|NCT01169493|11636852|FG002|Period 3 (6 Months)|Physician Decision|1
7380681|NCT01169493|11636853|FG003|Period 3 (6 Months)|Physician Decision|0
7380682|NCT01169493|11636854|FG004|Period 3 (6 Months)|Physician Decision|0
7380683|NCT01169493|11636855|FG005|Period 3 (6 Months)|Physician Decision|0
7380684|NCT01169532|11636875|FG000|Overall Study|Withdrawal by Subject|1
7380685|NCT01169558|11636879|FG000|Overall Study|Disease progression|98
7380686|NCT01169558|11636879|FG000|Overall Study|Adverse Event|25
7380687|NCT01169558|11636879|FG000|Overall Study|Withdrawal of Consent|8
7380688|NCT01169558|11636879|FG000|Overall Study|Medical Decision|7
7380689|NCT01169558|11636879|FG000|Overall Study|Stable Disease|4
7380690|NCT01169558|11636879|FG000|Overall Study|Lost to Follow-up|4
7380691|NCT01169558|11636879|FG000|Overall Study|Need for Surgery|4
7380692|NCT01169558|11636879|FG000|Overall Study|Non-compliance|2
7380693|NCT01169558|11636879|FG000|Overall Study|Protocol Violation|2
7380694|NCT01169558|11636879|FG000|Overall Study|Partial response|2
7380695|NCT01169636|11636888|FG000|Overall Study|Adverse Event|0
7380696|NCT01169636|11636889|FG001|Overall Study|Adverse Event|0
7380697|NCT01169636|11636890|FG002|Overall Study|Adverse Event|1
7380698|NCT01169636|11636891|FG003|Overall Study|Adverse Event|1
7380699|NCT01169636|11636892|FG004|Overall Study|Adverse Event|0
7380700|NCT01169636|11636888|FG000|Overall Study|Screen failure|0
7380701|NCT01169636|11636889|FG001|Overall Study|Screen failure|0
7380702|NCT01169636|11636890|FG002|Overall Study|Screen failure|2
7380703|NCT01169636|11636891|FG003|Overall Study|Screen failure|0
7380704|NCT01169636|11636892|FG004|Overall Study|Screen failure|0
7380705|NCT01169636|11636888|FG000|Overall Study|Withdrawal by Subject|0
7380706|NCT01169636|11636889|FG001|Overall Study|Withdrawal by Subject|0
7380707|NCT01169636|11636890|FG002|Overall Study|Withdrawal by Subject|0
7380708|NCT01169636|11636891|FG003|Overall Study|Withdrawal by Subject|0
7380709|NCT01169636|11636892|FG004|Overall Study|Withdrawal by Subject|3
7380710|NCT01169649|11636902|FG000|Overall Study|Patient Not Treated|3
7380711|NCT01169675|11636911|FG000|Overall Study|Progressive disease|13
7380712|NCT01169675|11636912|FG001|Overall Study|Progressive disease|2
7380713|NCT01169675|11636913|FG002|Overall Study|Progressive disease|5
7380714|NCT01169675|11636914|FG003|Overall Study|Progressive disease|15
7380715|NCT01169675|11636915|FG004|Overall Study|Progressive disease|1
7380716|NCT01169675|11636911|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
7380717|NCT01169675|11636912|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
7380718|NCT01169675|11636913|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
7380719|NCT01169675|11636914|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
7380720|NCT01169675|11636915|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
7380721|NCT01169675|11636911|FG000|Overall Study|Adverse Event|5
7380722|NCT01169675|11636912|FG001|Overall Study|Adverse Event|1
7380723|NCT01169675|11636913|FG002|Overall Study|Adverse Event|2
7380724|NCT01169675|11636914|FG003|Overall Study|Adverse Event|0
7380725|NCT01169675|11636915|FG004|Overall Study|Adverse Event|0
7380726|NCT01169675|11636911|FG000|Overall Study|Withdrawal by Subject|1
7380727|NCT01169675|11636912|FG001|Overall Study|Withdrawal by Subject|0
7380728|NCT01169675|11636913|FG002|Overall Study|Withdrawal by Subject|0
7380729|NCT01169675|11636914|FG003|Overall Study|Withdrawal by Subject|1
7380730|NCT01169675|11636915|FG004|Overall Study|Withdrawal by Subject|2
7380731|NCT01169675|11636911|FG000|Overall Study|Other Reason Not Defined Above|0
7380732|NCT01169675|11636912|FG001|Overall Study|Other Reason Not Defined Above|0
7380733|NCT01169675|11636913|FG002|Overall Study|Other Reason Not Defined Above|0
7380734|NCT01169675|11636914|FG003|Overall Study|Other Reason Not Defined Above|1
7380735|NCT01169675|11636915|FG004|Overall Study|Other Reason Not Defined Above|1
7380736|NCT01169701|11636929|FG000|Overall Study|Lost to Follow-up|1
7380737|NCT01169701|11636930|FG001|Overall Study|Lost to Follow-up|1
7380738|NCT01169701|11636929|FG000|Overall Study|Withdrawal by Subject|1
7380739|NCT01169701|11636930|FG001|Overall Study|Withdrawal by Subject|3
7380740|NCT01169701|11636929|FG000|Overall Study|Adverse Event|1
7380741|NCT01169701|11636930|FG001|Overall Study|Adverse Event|2
7380742|NCT01169701|11636929|FG000|Overall Study|Exclusion criteria|2
7380743|NCT01169701|11636930|FG001|Overall Study|Exclusion criteria|0
7380744|NCT01169701|11636929|FG000|Overall Study|Death|0
7380745|NCT01169701|11636930|FG001|Overall Study|Death|1
7380746|NCT01169701|11636929|FG000|Overall Study|Administrative problems|0
7380747|NCT01169701|11636930|FG001|Overall Study|Administrative problems|1
7380748|NCT01169701|11636929|FG000|Overall Study|Serious adverse event|0
7380749|NCT01169701|11636930|FG001|Overall Study|Serious adverse event|1
7380750|NCT01169701|11636929|FG000|Overall Study|Sponsor decision|0
7380751|NCT01169701|11636930|FG001|Overall Study|Sponsor decision|1
7380752|NCT01169779|11636938|FG000|Overall Study|Adverse Event|3
7380753|NCT01169779|11636939|FG001|Overall Study|Adverse Event|11
7380754|NCT01169779|11636938|FG000|Overall Study|Lack of Efficacy|1
7380755|NCT01169779|11636939|FG001|Overall Study|Lack of Efficacy|0
7380756|NCT01169779|11636938|FG000|Overall Study|Protocol Violation|1
7380757|NCT01169779|11636939|FG001|Overall Study|Protocol Violation|1
7380758|NCT01169779|11636938|FG000|Overall Study|Withdrawal by Subject|3
7380759|NCT01169779|11636939|FG001|Overall Study|Withdrawal by Subject|2
7380760|NCT01169779|11636938|FG000|Overall Study|Familial and personal reasons|3
7380761|NCT01169779|11636939|FG001|Overall Study|Familial and personal reasons|3
7380762|NCT01169844|11636947|FG000|Overall Study|Adverse Event|0
7533434|NCT02686034|11879842|FG001|Run-In Period 1|Lost to Follow-up|4
7380763|NCT01169844|11636948|FG001|Overall Study|Adverse Event|1
7533435|NCT02686034|11879841|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
7380764|NCT01169844|11636947|FG000|Overall Study|Patient withdrew consent|4
7380765|NCT01169844|11636948|FG001|Overall Study|Patient withdrew consent|0
7380766|NCT01169844|11636947|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7533436|NCT02686034|11879842|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
7380767|NCT01169844|11636948|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7380768|NCT01169987|11636954|FG000|Overall Study|Withdrawal by Subject|3
7380769|NCT01169987|11636954|FG000|Overall Study|Lost to Follow-up|24
7380770|NCT01169987|11636954|FG000|Overall Study|Other|4
7380771|NCT01170039|11636966|FG000|Overall Study|Withdrawal by Subject|5
7380772|NCT01170039|11636967|FG001|Overall Study|Withdrawal by Subject|3
7380773|NCT01170039|11636966|FG000|Overall Study|Lack of funding, drug not available|3
7380774|NCT01170039|11636967|FG001|Overall Study|Lack of funding, drug not available|3
7380775|NCT01170065|11636976|FG000|Overall Study|Adverse Event|17
7380776|NCT01170065|11636977|FG001|Overall Study|Adverse Event|50
7380777|NCT01170065|11636978|FG002|Overall Study|Adverse Event|10
7380778|NCT01170065|11636976|FG000|Overall Study|Lost to Follow-up|1
7380779|NCT01170065|11636977|FG001|Overall Study|Lost to Follow-up|4
7380780|NCT01170065|11636978|FG002|Overall Study|Lost to Follow-up|1
7380781|NCT01170065|11636976|FG000|Overall Study|Consent withdrawn, not due to AE|2
7380782|NCT01170065|11636977|FG001|Overall Study|Consent withdrawn, not due to AE|4
7380783|NCT01170065|11636978|FG002|Overall Study|Consent withdrawn, not due to AE|2
7380784|NCT01170065|11636976|FG000|Overall Study|Reason other than specified|3
7380785|NCT01170065|11636977|FG001|Overall Study|Reason other than specified|8
7380786|NCT01170065|11636978|FG002|Overall Study|Reason other than specified|3
7380787|NCT01170065|11636976|FG000|Overall Study|Ongoing after planned observation time|5
7380788|NCT01170065|11636977|FG001|Overall Study|Ongoing after planned observation time|26
7380789|NCT01170065|11636978|FG002|Overall Study|Ongoing after planned observation time|10
7380790|NCT01170091|11636986|FG000|Overall Study|Missing efficacy evaluation|3
7380791|NCT01170091|11636986|FG000|Overall Study|Treatment duration is less than 4 weeks|21
7380792|NCT01170208|11637002|FG000|Overall Study|Withdrawal by Subject|5
7380793|NCT01170208|11637003|FG001|Overall Study|Withdrawal by Subject|0
7380794|NCT01170208|11637004|FG002|Overall Study|Withdrawal by Subject|1
7380795|NCT01170208|11637002|FG000|Overall Study|Protocol Violation|1
7380796|NCT01170208|11637003|FG001|Overall Study|Protocol Violation|0
7380797|NCT01170208|11637004|FG002|Overall Study|Protocol Violation|1
7380798|NCT01170221|11637017|FG000|Overall Study|Lost to Follow-up|22
7380799|NCT01170221|11637018|FG001|Overall Study|Lost to Follow-up|21
7380800|NCT01170221|11637017|FG000|Overall Study|Withdrawal by Subject|9
7380801|NCT01170221|11637018|FG001|Overall Study|Withdrawal by Subject|7
7380802|NCT01170221|11637017|FG000|Overall Study|Subject completed only screening and LFU|1
7380803|NCT01170221|11637018|FG001|Overall Study|Subject completed only screening and LFU|0
7380804|NCT01170221|11637017|FG000|Overall Study|Randomized but not treated|1
7380805|NCT01170221|11637018|FG001|Overall Study|Randomized but not treated|0
7380806|NCT01170273|11637035|FG000|Overall Study|Lost to Follow-up|6
7380807|NCT01170273|11637036|FG001|Overall Study|Lost to Follow-up|8
7380808|NCT01170273|11637035|FG000|Overall Study|Protocol Violation|1
7380809|NCT01170273|11637036|FG001|Overall Study|Protocol Violation|0
7380810|NCT01170273|11637035|FG000|Overall Study|Death|1
7380811|NCT01170273|11637036|FG001|Overall Study|Death|0
7380812|NCT01170273|11637035|FG000|Overall Study|Adverse Event|0
7380813|NCT01170273|11637036|FG001|Overall Study|Adverse Event|1
7380814|NCT01170364|11637044|FG000|Overall Study|Protocol Violation|4
7380815|NCT01170364|11637045|FG001|Overall Study|Protocol Violation|1
7380816|NCT01170598|11637091|FG000|Overall Study|Withdrawal by Subject|1
7380817|NCT01170598|11637091|FG000|Overall Study|Death|3
7380818|NCT01170598|11637091|FG000|Overall Study|Lost to Follow-up|1
7380819|NCT01170598|11637091|FG000|Overall Study|Refused|1
7380820|NCT01170663|11637097|FG000|Overall Study|Lost to Follow-up|3
7380821|NCT01170663|11637098|FG001|Overall Study|Lost to Follow-up|9
7380822|NCT01170663|11637097|FG000|Overall Study|Withdrawal of consent without follow-up|11
7380823|NCT01170663|11637098|FG001|Overall Study|Withdrawal of consent without follow-up|11
7380824|NCT01170962|11637140|FG000|Treatment Period|Lack of Efficacy|96
7380825|NCT01170962|11637141|FG001|Treatment Period|Lack of Efficacy|91
7380826|NCT01170962|11637142|FG002|Treatment Period|Lack of Efficacy|7
7380827|NCT01170962|11637140|FG000|Treatment Period|Adverse Event|11
7380828|NCT01170962|11637141|FG001|Treatment Period|Adverse Event|12
7570779|NCT03506425|11949006|FG002|Overall Study|Withdrawal by Subject|1
7570780|NCT03506477|11949017|FG000|Overall Study|Withdrawal by Subject|1
7570781|NCT03506477|11949018|FG001|Overall Study|Withdrawal by Subject|0
7570782|NCT03508050|11949059|FG000|Overall Study|Pleural adhesions|1
7570783|NCT03508050|11949060|FG001|Overall Study|Pleural adhesions|0
7570784|NCT03508050|11949059|FG000|Overall Study|Mucus plug|1
7570785|NCT03508050|11949060|FG001|Overall Study|Mucus plug|0
7570786|NCT03508050|11949059|FG000|Overall Study|Negative biopsy, surgery cancelled|3
7570787|NCT03508050|11949060|FG001|Overall Study|Negative biopsy, surgery cancelled|1
7570788|NCT03508050|11949059|FG000|Overall Study|Sustained desaturation|0
7570789|NCT03508050|11949060|FG001|Overall Study|Sustained desaturation|1
7570790|NCT03508609|11949067|FG000|Overall Study|Withdrawal by Subject|1
7570791|NCT03508830|11949088|FG000|Overall Study|Withdrawal by Subject|3
7570792|NCT03508830|11949089|FG001|Overall Study|Withdrawal by Subject|4
7570793|NCT03508830|11949088|FG000|Overall Study|Physician Decision|2
7570794|NCT03508830|11949089|FG001|Overall Study|Physician Decision|2
7570795|NCT03508843|11949095|FG000|Overall Study|Withdrawal by Subject|1
7380829|NCT01170962|11637142|FG002|Treatment Period|Adverse Event|3
7380830|NCT01170962|11637140|FG000|Treatment Period|Withdrawal by Subject|2
7570796|NCT03508843|11949095|FG000|Overall Study|technical difficulties|2
7570797|NCT03509350|11949101|FG000|Overall Study|Withdrawal by Subject|0
7570798|NCT03509350|11949102|FG001|Overall Study|Withdrawal by Subject|2
7380831|NCT01170962|11637141|FG001|Treatment Period|Withdrawal by Subject|1
7570799|NCT03509675|11949110|FG000|First Intervention (7 Days)|Lost to Follow-up|3
7570800|NCT03509675|11949111|FG001|First Intervention (7 Days)|Lost to Follow-up|3
7570801|NCT03509675|11949110|FG000|First Intervention (7 Days)|Lack of Efficacy|2
7570802|NCT03509675|11949111|FG001|First Intervention (7 Days)|Lack of Efficacy|1
7570803|NCT03509675|11949110|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
7570804|NCT03509675|11949111|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
7570805|NCT03509675|11949110|FG000|Second Intervention )7 Days)|Lost Rinse B|1
7570806|NCT03509675|11949111|FG001|Second Intervention )7 Days)|Lost Rinse B|0
7570807|NCT03509948|11949132|FG000|Overall Study|Protocol Violation|0
7570808|NCT03509948|11949133|FG001|Overall Study|Protocol Violation|1
7570809|NCT03510182|11949143|FG000|Overall Study|Withdrawal by Subject|2
7570810|NCT03510273|11949161|FG000|Overall Study|Withdrawal by Subject|2
7570811|NCT03510273|11949161|FG000|Overall Study|Care outside study, ineligible to cont.|3
7570812|NCT03510273|11949161|FG000|Overall Study|Moved away from study area|4
7570813|NCT03510455|11949169|FG000|Overall Study|Physician Decision|1
7570814|NCT03510663|11949202|FG000|Overall Study|Withdrawal by Subject|0
7570815|NCT03510663|11949203|FG001|Overall Study|Withdrawal by Subject|1
7570816|NCT03510663|11949204|FG002|Overall Study|Withdrawal by Subject|0
7570817|NCT03510663|11949205|FG003|Overall Study|Withdrawal by Subject|0
7380832|NCT01170962|11637142|FG002|Treatment Period|Withdrawal by Subject|0
7380833|NCT01170962|11637140|FG000|Treatment Period|Lost to Follow-up|1
7380834|NCT01170962|11637141|FG001|Treatment Period|Lost to Follow-up|1
7380835|NCT01170962|11637142|FG002|Treatment Period|Lost to Follow-up|1
7380836|NCT01170962|11637140|FG000|Treatment Period|Participant no longer meets criteria|0
7380837|NCT01170962|11637141|FG001|Treatment Period|Participant no longer meets criteria|1
7380838|NCT01170962|11637142|FG002|Treatment Period|Participant no longer meets criteria|0
7380839|NCT01170962|11637140|FG000|Treatment Period|Request to discontinue treatment|7
7380840|NCT01170962|11637141|FG001|Treatment Period|Request to discontinue treatment|3
7380841|NCT01170962|11637142|FG002|Treatment Period|Request to discontinue treatment|1
7380842|NCT01170962|11637140|FG000|Treatment Period|Completed 24 Week treatment period only|10
7380843|NCT01170962|11637141|FG001|Treatment Period|Completed 24 Week treatment period only|2
7380844|NCT01170962|11637142|FG002|Treatment Period|Completed 24 Week treatment period only|0
7380845|NCT01170962|11637140|FG000|Follow up Period|Withdrawal by Subject|14
7380846|NCT01170962|11637141|FG001|Follow up Period|Withdrawal by Subject|10
7380847|NCT01170962|11637142|FG002|Follow up Period|Withdrawal by Subject|2
7380848|NCT01170962|11637140|FG000|Follow up Period|Lost to Follow-up|13
7380849|NCT01170962|11637141|FG001|Follow up Period|Lost to Follow-up|8
7380850|NCT01170962|11637142|FG002|Follow up Period|Lost to Follow-up|1
7380851|NCT01170962|11637140|FG000|Follow up Period|Death|2
7380852|NCT01170962|11637141|FG001|Follow up Period|Death|2
7380853|NCT01170962|11637142|FG002|Follow up Period|Death|0
7380854|NCT01170962|11637140|FG000|Follow up Period|Others|10
7380855|NCT01170962|11637141|FG001|Follow up Period|Others|7
7380856|NCT01170962|11637142|FG002|Follow up Period|Others|3
7380857|NCT01171183|11637171|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7380858|NCT01171183|11637172|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
7380859|NCT01171183|11637171|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
7380860|NCT01171183|11637172|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
7380861|NCT01171183|11637171|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
7380862|NCT01171183|11637172|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
7380863|NCT01171183|11637171|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7380864|NCT01171183|11637172|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
7380865|NCT01171183|11637171|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
7380866|NCT01171183|11637172|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
7380867|NCT01171183|11637171|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
7380868|NCT01171183|11637172|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
7380869|NCT01171521|11637178|FG000|Overall Study|Lost to Follow-up|5
7380870|NCT01171521|11637178|FG000|Overall Study|screen failure|1
7380871|NCT01171612|11637182|FG000|Overall Study|Lost to Follow-up|51
7380872|NCT01171625|11637189|FG000|Overall Study|On-Protocol|67
7380873|NCT01171625|11637189|FG000|Overall Study|Death|38
7380874|NCT01171625|11637189|FG000|Overall Study|Withdrawal by Subject|31
7380875|NCT01171625|11637189|FG000|Overall Study|Explanted|10
7380876|NCT01171625|11637189|FG000|Overall Study|Lost to Follow-up|5
7380877|NCT01171625|11637189|FG000|Overall Study|Patient received valve-in-valve|3
7380878|NCT01171625|11637189|FG000|Overall Study|Other|1
7380879|NCT01171625|11637189|FG000|Overall Study|Consented but did not receive device|25
7380880|NCT01171677|11637203|FG000|Overall Study|Withdrawal by Subject|0
7380881|NCT01171677|11637204|FG001|Overall Study|Withdrawal by Subject|3
7380882|NCT01171677|11637203|FG000|Overall Study|Adverse Event|1
7380883|NCT01171677|11637204|FG001|Overall Study|Adverse Event|0
7380884|NCT01171677|11637203|FG000|Overall Study|completed <70% IntenSati classes|5
7380885|NCT01171677|11637204|FG001|Overall Study|completed <70% IntenSati classes|0
7380886|NCT01171820|11637230|FG000|Overall Study|Death|3
7570818|NCT03510663|11949206|FG004|Overall Study|Withdrawal by Subject|0
7570819|NCT03510663|11949207|FG005|Overall Study|Withdrawal by Subject|0
7570820|NCT03510663|11949208|FG006|Overall Study|Withdrawal by Subject|0
7570821|NCT03510663|11949209|FG007|Overall Study|Withdrawal by Subject|0
7380887|NCT01171820|11637231|FG001|Overall Study|Death|3
7380888|NCT01171820|11637230|FG000|Overall Study|Lost to Follow-up|0
7380889|NCT01171820|11637231|FG001|Overall Study|Lost to Follow-up|1
7380890|NCT01171820|11637230|FG000|Overall Study|Withdrawal by Subject|2
7380891|NCT01171820|11637231|FG001|Overall Study|Withdrawal by Subject|0
7380892|NCT01171820|11637230|FG000|Overall Study|Physician Decision|0
7380893|NCT01171820|11637231|FG001|Overall Study|Physician Decision|1
7380894|NCT01171820|11637230|FG000|Overall Study|1-Year Missed Visit|1
7380895|NCT01171820|11637231|FG001|Overall Study|1-Year Missed Visit|1
7380896|NCT01171963|11637248|FG000|Overall Study|Adverse Event|10
7380897|NCT01171963|11637249|FG001|Overall Study|Adverse Event|15
7380898|NCT01171963|11637248|FG000|Overall Study|Lost to Follow-up|23
7380899|NCT01171963|11637249|FG001|Overall Study|Lost to Follow-up|24
7380900|NCT01171963|11637248|FG000|Overall Study|Other - diarrhoea|1
7380901|NCT01171963|11637249|FG001|Overall Study|Other - diarrhoea|0
7380902|NCT01171963|11637248|FG000|Overall Study|Withdrawal by Subject|114
7380903|NCT01171963|11637249|FG001|Overall Study|Withdrawal by Subject|129
7380904|NCT01171976|11637261|FG000|Overall Study|Protocol Violation|0
7380905|NCT01171976|11637262|FG001|Overall Study|Protocol Violation|0
7380906|NCT01171976|11637263|FG002|Overall Study|Protocol Violation|1
7380907|NCT01171976|11637261|FG000|Overall Study|Death|2
7380908|NCT01171976|11637262|FG001|Overall Study|Death|4
7570822|NCT03510715|11949221|FG000|Overall Study|Adverse Event|1
7570823|NCT03510715|11949222|FG001|Overall Study|Adverse Event|0
7570824|NCT03510910|11949231|FG000|Overall Study|Incomplete Survey|2
7570825|NCT03510910|11949232|FG001|Overall Study|Incomplete Survey|3
7570826|NCT03511053|11949247|FG000|Overall Study|Withdrawal by Subject|1
7570827|NCT03511105|11949253|FG000|Overall Study|Adverse Event|1
7570828|NCT03511105|11949254|FG001|Overall Study|Adverse Event|0
7570829|NCT03511105|11949253|FG000|Overall Study|Withdrew consent|1
7570830|NCT03511105|11949254|FG001|Overall Study|Withdrew consent|0
7380909|NCT01171976|11637263|FG002|Overall Study|Death|1
7380910|NCT01171976|11637261|FG000|Overall Study|Lost to Follow-up|4
7380911|NCT01171976|11637262|FG001|Overall Study|Lost to Follow-up|0
7380912|NCT01171976|11637263|FG002|Overall Study|Lost to Follow-up|2
7380913|NCT01171976|11637261|FG000|Overall Study|Withdrawal by Subject|1
7380914|NCT01171976|11637262|FG001|Overall Study|Withdrawal by Subject|5
7380915|NCT01171976|11637263|FG002|Overall Study|Withdrawal by Subject|6
7380916|NCT01171976|11637261|FG000|Overall Study|Abnormal test result|1
7380917|NCT01171976|11637262|FG001|Overall Study|Abnormal test result|0
7380918|NCT01171976|11637263|FG002|Overall Study|Abnormal test result|0
7380919|NCT01171976|11637261|FG000|Overall Study|Adverse Event|6
7380920|NCT01171976|11637262|FG001|Overall Study|Adverse Event|2
7380921|NCT01171976|11637263|FG002|Overall Study|Adverse Event|5
7380922|NCT01171989|11637274|FG000|Overall Study|Lost to Follow-up|0
7380923|NCT01171989|11637275|FG001|Overall Study|Lost to Follow-up|0
7462259|NCT01848457|11759277|FG003|Overall Study|Death|0
7462260|NCT01848483|11759297|FG000|Overall Study|Death|2
7462261|NCT01848483|11759298|FG001|Overall Study|Death|1
7462262|NCT01848483|11759297|FG000|Overall Study|Lost to Follow-up|6
7462263|NCT01848483|11759298|FG001|Overall Study|Lost to Follow-up|8
7462264|NCT01848483|11759297|FG000|Overall Study|Withdrawal by Subject|1
7462265|NCT01848483|11759298|FG001|Overall Study|Withdrawal by Subject|0
7462266|NCT01848483|11759297|FG000|Overall Study|Incarceration|2
7462267|NCT01848483|11759298|FG001|Overall Study|Incarceration|2
7462268|NCT01848756|11759305|FG000|Overall Study|Adverse Event|1
7462269|NCT01848756|11759305|FG000|Overall Study|Withdrawal by Subject|1
7462270|NCT01848756|11759305|FG000|Overall Study|Enrolled in Error|1
7462271|NCT01848834|11759324|FG000|Overall Study|Adverse Event|3
7462272|NCT01848834|11759325|FG001|Overall Study|Adverse Event|11
7462273|NCT01848834|11759326|FG002|Overall Study|Adverse Event|3
7462274|NCT01848834|11759327|FG003|Overall Study|Adverse Event|5
7462275|NCT01848834|11759328|FG004|Overall Study|Adverse Event|9
7462276|NCT01848834|11759324|FG000|Overall Study|Death|2
7462277|NCT01848834|11759325|FG001|Overall Study|Death|11
7462278|NCT01848834|11759326|FG002|Overall Study|Death|1
7462279|NCT01848834|11759327|FG003|Overall Study|Death|8
7462280|NCT01848834|11759328|FG004|Overall Study|Death|27
7462281|NCT01848834|11759324|FG000|Overall Study|Excluded Medication|5
7462282|NCT01848834|11759325|FG001|Overall Study|Excluded Medication|4
7462283|NCT01848834|11759326|FG002|Overall Study|Excluded Medication|3
7462284|NCT01848834|11759327|FG003|Overall Study|Excluded Medication|6
7462285|NCT01848834|11759328|FG004|Overall Study|Excluded Medication|6
7462286|NCT01848834|11759324|FG000|Overall Study|Lost to Follow-up|5
7462287|NCT01848834|11759325|FG001|Overall Study|Lost to Follow-up|5
7462288|NCT01848834|11759326|FG002|Overall Study|Lost to Follow-up|3
7462289|NCT01848834|11759327|FG003|Overall Study|Lost to Follow-up|0
7462290|NCT01848834|11759328|FG004|Overall Study|Lost to Follow-up|3
7380924|NCT01171989|11637276|FG002|Overall Study|Lost to Follow-up|1
7380925|NCT01172275|11637317|FG000|Overall Study|Lost to Follow-up|1
7380926|NCT01172275|11637318|FG001|Overall Study|Lost to Follow-up|0
7380927|NCT01172275|11637317|FG000|Overall Study|Protocol Violation|1
7380928|NCT01172275|11637318|FG001|Overall Study|Protocol Violation|0
7380929|NCT01172288|11637326|FG000|Overall Study|Adverse Event|1
7380930|NCT01172288|11637327|FG001|Overall Study|Adverse Event|0
7380931|NCT01172288|11637326|FG000|Overall Study|Protocol Violation|0
7380932|NCT01172288|11637327|FG001|Overall Study|Protocol Violation|1
7462291|NCT01848834|11759324|FG000|Overall Study|Physician Decision|1
7570831|NCT03511326|11949261|FG000|Overall Study|Withdrawal by Subject|1
7570832|NCT03511378|11949267|FG000|Overall Study|Withdrawal by Subject|2
7380933|NCT01172535|11637361|FG000|Overall Study|Death|3
7380934|NCT01172535|11637361|FG000|Overall Study|Withdrawal by Subject|2
7380935|NCT01172535|11637361|FG000|Overall Study|Lost to Follow-up|1
7380936|NCT01172535|11637361|FG000|Overall Study|Ineligible at study entry|1
7380937|NCT01172535|11637361|FG000|Overall Study|Unwilling to adhere to study requirement|1
7380938|NCT01172639|11637382|FG000|Overall Study|Death|1
7380939|NCT01172639|11637383|FG001|Overall Study|Death|1
7380940|NCT01172639|11637384|FG002|Overall Study|Death|0
7380941|NCT01172639|11637385|FG003|Overall Study|Death|0
7380942|NCT01172639|11637386|FG004|Overall Study|Death|0
7380943|NCT01172639|11637382|FG000|Overall Study|Lost to Follow-up|9
7380944|NCT01172639|11637383|FG001|Overall Study|Lost to Follow-up|7
7380945|NCT01172639|11637384|FG002|Overall Study|Lost to Follow-up|11
7380946|NCT01172639|11637385|FG003|Overall Study|Lost to Follow-up|6
7380947|NCT01172639|11637386|FG004|Overall Study|Lost to Follow-up|6
7380948|NCT01172639|11637382|FG000|Overall Study|Withdrawal by Subject|3
7380949|NCT01172639|11637383|FG001|Overall Study|Withdrawal by Subject|3
7380950|NCT01172639|11637384|FG002|Overall Study|Withdrawal by Subject|5
7380951|NCT01172639|11637385|FG003|Overall Study|Withdrawal by Subject|5
7380952|NCT01172639|11637386|FG004|Overall Study|Withdrawal by Subject|0
7380953|NCT01172808|11637402|FG000|Overall Study|Adverse Event|8
7380954|NCT01172808|11637403|FG001|Overall Study|Adverse Event|4
7380955|NCT01172808|11637404|FG002|Overall Study|Adverse Event|8
7380956|NCT01172808|11637405|FG003|Overall Study|Adverse Event|3
7380957|NCT01172808|11637402|FG000|Overall Study|Lack of Efficacy|1
7380958|NCT01172808|11637403|FG001|Overall Study|Lack of Efficacy|0
7380959|NCT01172808|11637404|FG002|Overall Study|Lack of Efficacy|0
7380960|NCT01172808|11637405|FG003|Overall Study|Lack of Efficacy|0
7380961|NCT01172808|11637402|FG000|Overall Study|Protocol Violation|2
7380962|NCT01172808|11637403|FG001|Overall Study|Protocol Violation|2
7380963|NCT01172808|11637404|FG002|Overall Study|Protocol Violation|2
7380964|NCT01172808|11637405|FG003|Overall Study|Protocol Violation|0
7380965|NCT01172808|11637402|FG000|Overall Study|Lost to Follow-up|0
7380966|NCT01172808|11637403|FG001|Overall Study|Lost to Follow-up|1
7380967|NCT01172808|11637404|FG002|Overall Study|Lost to Follow-up|1
7380968|NCT01172808|11637405|FG003|Overall Study|Lost to Follow-up|3
7380969|NCT01172808|11637402|FG000|Overall Study|Withdrawal by Subject|4
7380970|NCT01172808|11637403|FG001|Overall Study|Withdrawal by Subject|1
7380971|NCT01172808|11637404|FG002|Overall Study|Withdrawal by Subject|3
7380972|NCT01172808|11637405|FG003|Overall Study|Withdrawal by Subject|2
7380973|NCT01172808|11637402|FG000|Overall Study|Other|6
7380974|NCT01172808|11637403|FG001|Overall Study|Other|5
7380975|NCT01172808|11637404|FG002|Overall Study|Other|9
7380976|NCT01172808|11637405|FG003|Overall Study|Other|7
7380977|NCT01172821|11637419|FG000|Overall Study|Adverse Event|5
7380978|NCT01172821|11637420|FG001|Overall Study|Adverse Event|2
7380979|NCT01172821|11637421|FG002|Overall Study|Adverse Event|2
7380980|NCT01172821|11637422|FG003|Overall Study|Adverse Event|7
7380981|NCT01172821|11637419|FG000|Overall Study|Protocol Violation|0
7380982|NCT01172821|11637420|FG001|Overall Study|Protocol Violation|2
7380983|NCT01172821|11637421|FG002|Overall Study|Protocol Violation|1
7380984|NCT01172821|11637422|FG003|Overall Study|Protocol Violation|2
7380985|NCT01172821|11637419|FG000|Overall Study|Lost to Follow-up|4
7380986|NCT01172821|11637420|FG001|Overall Study|Lost to Follow-up|1
7380987|NCT01172821|11637421|FG002|Overall Study|Lost to Follow-up|2
7380988|NCT01172821|11637422|FG003|Overall Study|Lost to Follow-up|2
7380989|NCT01172821|11637419|FG000|Overall Study|Withdrawal by Subject|2
7380990|NCT01172821|11637420|FG001|Overall Study|Withdrawal by Subject|3
7380991|NCT01172821|11637421|FG002|Overall Study|Withdrawal by Subject|3
7380992|NCT01172821|11637422|FG003|Overall Study|Withdrawal by Subject|3
7380993|NCT01172821|11637419|FG000|Overall Study|Other|3
7380994|NCT01172821|11637420|FG001|Overall Study|Other|4
7380995|NCT01172821|11637421|FG002|Overall Study|Other|5
7380996|NCT01172821|11637422|FG003|Overall Study|Other|3
7380997|NCT01172847|11637432|FG000|Overall Study|Withdrawal by Subject|3
7380998|NCT01172873|11637444|FG000|Overall Study|Withdrawal by Subject|3
7380999|NCT01172873|11637445|FG001|Overall Study|Withdrawal by Subject|2
7381000|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
7381001|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
7381002|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
7381003|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381004|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381005|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381006|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381007|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381008|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
7381009|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7381010|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
7381011|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
7381012|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7462292|NCT01848834|11759325|FG001|Overall Study|Physician Decision|3
7381013|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7381014|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7381015|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7381016|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7381017|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
7381018|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381019|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
7381020|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
7381021|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381022|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381023|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381024|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381025|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381026|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
7381027|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
7381028|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
7570833|NCT03511378|11949268|FG001|Overall Study|Withdrawal by Subject|2
7570834|NCT03511378|11949267|FG000|Overall Study|Patient not coming or schedule visit|1
7570835|NCT03511378|11949268|FG001|Overall Study|Patient not coming or schedule visit|0
7570836|NCT03512028|11949305|FG000|Overall Study|Withdrawal by Subject|2
7570837|NCT03512028|11949306|FG001|Overall Study|Withdrawal by Subject|0
7570838|NCT03512028|11949305|FG000|Overall Study|Protocol Violation|2
7570839|NCT03512028|11949306|FG001|Overall Study|Protocol Violation|0
7570840|NCT03512288|11949335|FG000|Overall Study|Adverse Event|1
7570841|NCT03512288|11949336|FG001|Overall Study|Adverse Event|0
7570842|NCT03512288|11949335|FG000|Overall Study|Lost to Follow-up|12
7570843|NCT03512288|11949336|FG001|Overall Study|Lost to Follow-up|15
7570844|NCT03512288|11949335|FG000|Overall Study|Physician Decision|0
7570845|NCT03512288|11949336|FG001|Overall Study|Physician Decision|2
7570846|NCT03512288|11949335|FG000|Overall Study|Protocol Violation|6
7570847|NCT03512288|11949336|FG001|Overall Study|Protocol Violation|4
7570848|NCT03512288|11949335|FG000|Overall Study|Medication error without associated adverse event|1
7570849|NCT03512288|11949336|FG001|Overall Study|Medication error without associated adverse event|0
7570850|NCT03512288|11949335|FG000|Overall Study|No longer met eligibility criteria|5
7570851|NCT03512288|11949336|FG001|Overall Study|No longer met eligibility criteria|2
7570852|NCT03512288|11949335|FG000|Overall Study|Withdrawal by parent/guardian|14
7570853|NCT03512288|11949336|FG001|Overall Study|Withdrawal by parent/guardian|18
7381029|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
7381030|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381031|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381032|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381033|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381034|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381035|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
7381036|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
7381037|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
7381038|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
7381039|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
7381040|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
7381041|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
7381042|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
7381043|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
7381044|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
7381045|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
7381046|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381047|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381048|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381049|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381050|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381051|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381052|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381053|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
7381054|NCT01172938|11637454|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
7381055|NCT01172938|11637455|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
7381056|NCT01172938|11637456|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
7381057|NCT01172938|11637457|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
7381058|NCT01172938|11637458|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
7381059|NCT01172938|11637459|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
7381060|NCT01172938|11637460|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
7381061|NCT01172938|11637461|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
7381062|NCT01172938|11637462|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
7387345|NCT01214616|11645827|FG002|Overall Study|Dose limiting toxicity|0
7570854|NCT03512288|11949335|FG000|Overall Study|Other|1
7381063|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7381064|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7381065|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
7381066|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7381067|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
7381068|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
7381069|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7381070|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7381071|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
7381072|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7381073|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
7381074|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
7381075|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7381076|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
7381077|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
7381078|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7381079|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7381080|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
7381081|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381082|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381083|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
7381084|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381085|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381086|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381087|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381088|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381089|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
7381090|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7381091|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
7381092|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7381093|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7381094|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
7381095|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
7381096|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
7381097|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7381098|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
7381099|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381100|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7381101|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7381102|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
7381103|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381104|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381105|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381106|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381107|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
7381108|NCT01172938|11637454|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
7381109|NCT01172938|11637455|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
7381110|NCT01172938|11637456|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
7381111|NCT01172938|11637457|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
7381112|NCT01172938|11637458|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
7381113|NCT01172938|11637459|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
7381114|NCT01172938|11637460|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
7381115|NCT01172938|11637461|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
7381116|NCT01172938|11637462|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
7381117|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7381118|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
7381119|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7381120|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7381121|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7381122|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7381123|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
7381124|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
7381125|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
7381126|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381127|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
7381128|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
7381129|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381130|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381131|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381132|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381133|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
7381134|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
7381135|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381136|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381137|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
7381138|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381139|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381140|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381141|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381142|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381143|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
7381144|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7381145|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
7381146|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
7381147|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7381148|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7381149|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7381150|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
7381151|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
7381152|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
7381153|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
7381154|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
7381155|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
7381156|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
7381157|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
7381158|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
7381159|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
7381160|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
7381161|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
7381162|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381163|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7381164|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
7381165|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381166|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381167|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381168|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381169|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
7381170|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
7381171|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381172|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
7381173|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381174|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381175|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381176|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381177|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381178|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
7381179|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
7381180|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381181|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
7381182|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381183|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381184|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381185|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381186|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381187|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381188|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
7381189|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381190|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381191|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381192|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381193|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381194|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381195|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381196|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
7381197|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
7381198|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7381199|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
7381200|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7381201|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7381202|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7381203|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7381204|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
7381205|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7381206|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
7381207|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7381208|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
7381209|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
7381210|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7381211|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7381212|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7381213|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
7381214|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
7381215|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
7381216|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
7381217|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
7381218|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
7381219|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
7381220|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
7381221|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
7381222|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
7381223|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
7381224|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
7381225|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381226|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
7381227|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381228|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381229|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381230|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381231|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381232|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381233|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
7381234|NCT01172938|11637454|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381235|NCT01172938|11637455|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381236|NCT01172938|11637456|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
7381237|NCT01172938|11637457|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381238|NCT01172938|11637458|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381239|NCT01172938|11637459|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381240|NCT01172938|11637460|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381241|NCT01172938|11637461|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381242|NCT01172938|11637462|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
7381243|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381244|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
7381245|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
7381246|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381247|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381248|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381249|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381250|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
7381251|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
7381252|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7381253|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7381254|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
7381255|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7381256|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7381257|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7381258|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
7381259|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
7381260|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
7381261|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7381262|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7381263|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7381264|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7381265|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7381266|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7570855|NCT03512288|11949336|FG001|Overall Study|Other|1
7570856|NCT03512288|11949335|FG000|Overall Study|Randomized but not treated|1
7381267|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
7381268|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
7381269|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
7381270|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381271|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381272|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7381273|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381274|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381275|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381276|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381277|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
7381278|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
7381279|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381280|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381281|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381282|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381283|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381284|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381285|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381286|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
7381287|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
7381288|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381289|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381290|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7381291|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381292|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381293|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381294|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
7381295|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7381296|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
7381297|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381298|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381299|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
7381300|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381301|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381302|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381303|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381304|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381305|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
7381306|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381307|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7381308|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381309|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381310|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381311|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381312|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381313|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
7381314|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
7381315|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381316|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
7381317|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
7381318|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381319|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381320|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381321|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381322|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
7381323|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
7381324|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
7381325|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
7381326|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
7381327|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
7381328|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
7381329|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
7381330|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
7381331|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
7381332|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
7381333|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381334|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381335|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
7381336|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381337|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381338|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381339|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381340|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381341|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
7381342|NCT01172938|11637454|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381343|NCT01172938|11637455|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381344|NCT01172938|11637456|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381345|NCT01172938|11637457|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381346|NCT01172938|11637458|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381347|NCT01172938|11637459|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381348|NCT01172938|11637460|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381349|NCT01172938|11637461|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
7381350|NCT01172938|11637462|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
7381351|NCT01173055|11637504|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7381352|NCT01173055|11637505|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
7381353|NCT01173055|11637504|FG000|Period 2 - Day 64 to 112|Adverse Event|0
7381354|NCT01173055|11637505|FG001|Period 2 - Day 64 to 112|Adverse Event|1
7381355|NCT01173120|11637511|FG000|Overall Study|Lack of Efficacy|2
7381356|NCT01173120|11637511|FG000|Overall Study|Lost to Follow-up|1
7381357|NCT01173120|11637511|FG000|Overall Study|Participant Decision|2
7381358|NCT01173120|11637511|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
7381359|NCT01173120|11637511|FG000|Overall Study|Switch-Participant Decision|12
7381360|NCT01173120|11637511|FG000|Overall Study|Switch-Difficulty With Device|12
7381361|NCT01173471|11637550|FG000|Overall Study|Eligibility criteria not fulfilled|0
7381362|NCT01173471|11637551|FG001|Overall Study|Eligibility criteria not fulfilled|0
7381363|NCT01173471|11637552|FG002|Overall Study|Eligibility criteria not fulfilled|1
7381364|NCT01173471|11637553|FG003|Overall Study|Eligibility criteria not fulfilled|1
7381365|NCT01173471|11637550|FG000|Overall Study|Condition under investigation worsened|2
7381366|NCT01173471|11637551|FG001|Overall Study|Condition under investigation worsened|0
7381367|NCT01173471|11637552|FG002|Overall Study|Condition under investigation worsened|0
7381368|NCT01173471|11637553|FG003|Overall Study|Condition under investigation worsened|0
7381369|NCT01173471|11637550|FG000|Overall Study|Lost to Follow-up|0
7381370|NCT01173471|11637551|FG001|Overall Study|Lost to Follow-up|0
7381371|NCT01173471|11637552|FG002|Overall Study|Lost to Follow-up|1
7381372|NCT01173471|11637553|FG003|Overall Study|Lost to Follow-up|0
7381373|NCT01173471|11637550|FG000|Overall Study|Reason given as Other|0
7381374|NCT01173471|11637551|FG001|Overall Study|Reason given as Other|0
7381375|NCT01173471|11637552|FG002|Overall Study|Reason given as Other|1
7381376|NCT01173471|11637553|FG003|Overall Study|Reason given as Other|0
7381377|NCT01173523|11637565|FG000|Overall Study|Clinical Progression|1
7381378|NCT01173523|11637566|FG001|Overall Study|Clinical Progression|1
7381379|NCT01173523|11637565|FG000|Overall Study|Progressive Disease|10
7381380|NCT01173523|11637566|FG001|Overall Study|Progressive Disease|8
7381381|NCT01173523|11637565|FG000|Overall Study|Other|2
7381382|NCT01173523|11637566|FG001|Overall Study|Other|3
7381383|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
7381384|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7381385|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7381386|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7381387|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7381388|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
7381389|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7381390|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7381391|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7381392|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7381393|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
7381394|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7381395|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7381396|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7381397|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7381398|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
7381399|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7381400|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7381401|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7381402|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7381403|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
7381404|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7381405|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7381406|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7381407|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7462293|NCT01848834|11759326|FG002|Overall Study|Physician Decision|4
7462294|NCT01848834|11759327|FG003|Overall Study|Physician Decision|0
7381408|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
7381409|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7381410|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7381411|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7381412|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7381413|NCT01173601|11637576|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
7381414|NCT01173601|11637577|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7381415|NCT01173601|11637578|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7381416|NCT01173601|11637579|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7381417|NCT01173601|11637580|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7381418|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7381419|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
7381420|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
7381421|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
7381422|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
7381423|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7381424|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
7381425|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
7381426|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7381427|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
7381428|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7381429|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7381430|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7381431|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7381432|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7381433|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7381434|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7381435|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7381436|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7381437|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7381438|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7381439|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
7381440|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7381441|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
7381442|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7381443|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7381444|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7381445|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
7381446|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
7381447|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7381448|NCT01173601|11637576|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7381449|NCT01173601|11637577|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7381450|NCT01173601|11637578|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7381451|NCT01173601|11637579|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7381452|NCT01173601|11637580|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
7381453|NCT01173653|11637600|FG000|Overall Study|Pts unwilling to provide follow-up|53
7381454|NCT01173653|11637601|FG001|Overall Study|Pts unwilling to provide follow-up|41
7381455|NCT01173679|11637607|FG000|Overall Study|Death|1
7381456|NCT01173692|11637614|FG000|Overall Study|Adverse Event|1
7381457|NCT01173692|11637615|FG001|Overall Study|Adverse Event|2
7381458|NCT01173692|11637614|FG000|Overall Study|Withdrawal by Subject|1
7381459|NCT01173692|11637615|FG001|Overall Study|Withdrawal by Subject|3
7381460|NCT01173718|11637621|FG000|Overall Study|Death|17
7381461|NCT01173718|11637621|FG000|Overall Study|Abandonment of study graft|27
7387346|NCT01214616|11645828|FG003|Overall Study|Dose limiting toxicity|0
7387347|NCT01214616|11645825|FG000|Overall Study|Other adverse events|0
7387348|NCT01214616|11645826|FG001|Overall Study|Other adverse events|1
7387349|NCT01214616|11645827|FG002|Overall Study|Other adverse events|1
7387350|NCT01214616|11645828|FG003|Overall Study|Other adverse events|1
7387351|NCT01214616|11645825|FG000|Overall Study|Withdrawal by Subject|1
7387352|NCT01214616|11645826|FG001|Overall Study|Withdrawal by Subject|0
7387353|NCT01214616|11645827|FG002|Overall Study|Withdrawal by Subject|0
7387354|NCT01214616|11645828|FG003|Overall Study|Withdrawal by Subject|1
7387355|NCT01214629|11645857|FG000|Overall Study|Progressive Disease|1
7387356|NCT01214629|11645858|FG001|Overall Study|Progressive Disease|1
7387357|NCT01214629|11645859|FG002|Overall Study|Progressive Disease|0
7387358|NCT01214629|11645860|FG003|Overall Study|Progressive Disease|1
7387359|NCT01214629|11645861|FG004|Overall Study|Progressive Disease|2
7387360|NCT01214629|11645862|FG005|Overall Study|Progressive Disease|3
7387361|NCT01214629|11645863|FG006|Overall Study|Progressive Disease|1
7387362|NCT01214629|11645864|FG007|Overall Study|Progressive Disease|1
7387363|NCT01214629|11645865|FG008|Overall Study|Progressive Disease|1
7462295|NCT01848834|11759328|FG004|Overall Study|Physician Decision|11
7381462|NCT01174004|11637644|FG000|Overall Study|Adverse Event|2
7381463|NCT01174004|11637645|FG001|Overall Study|Adverse Event|10
7381464|NCT01174004|11637644|FG000|Overall Study|Withdrawal by Subject|2
7381465|NCT01174004|11637645|FG001|Overall Study|Withdrawal by Subject|3
7381466|NCT01174004|11637644|FG000|Overall Study|At Discretion of Sponsor|2
7381467|NCT01174004|11637645|FG001|Overall Study|At Discretion of Sponsor|2
7381468|NCT01174004|11637644|FG000|Overall Study|Protocol Violation|0
7381469|NCT01174004|11637645|FG001|Overall Study|Protocol Violation|1
7381470|NCT01174004|11637644|FG000|Overall Study|Physician Decision|1
7381471|NCT01174004|11637645|FG001|Overall Study|Physician Decision|0
7381472|NCT01174043|11637672|FG000|Overall Study|Disease progression|5
7381473|NCT01174043|11637672|FG000|Overall Study|Adverse Event|3
7381474|NCT01174043|11637672|FG000|Overall Study|Death|1
7381475|NCT01174043|11637672|FG000|Overall Study|Withdrawal by Subject|2
7381476|NCT01174160|11637687|FG000|Overall Study|Adverse Event|1
7381477|NCT01174160|11637688|FG001|Overall Study|Adverse Event|0
7381478|NCT01174160|11637687|FG000|Overall Study|Lost to Follow-up|1
7381479|NCT01174160|11637688|FG001|Overall Study|Lost to Follow-up|0
7381480|NCT01174160|11637687|FG000|Overall Study|Physician Decision|1
7381481|NCT01174160|11637688|FG001|Overall Study|Physician Decision|0
7381482|NCT01174160|11637687|FG000|Overall Study|Protocol Violation|4
7462296|NCT01848834|11759324|FG000|Overall Study|Protocol Violation|0
7462297|NCT01848834|11759325|FG001|Overall Study|Protocol Violation|0
7462298|NCT01848834|11759326|FG002|Overall Study|Protocol Violation|0
7462299|NCT01848834|11759327|FG003|Overall Study|Protocol Violation|0
7462300|NCT01848834|11759328|FG004|Overall Study|Protocol Violation|1
7462301|NCT01848834|11759324|FG000|Overall Study|Sponsor Decision|1
7462302|NCT01848834|11759325|FG001|Overall Study|Sponsor Decision|1
7462303|NCT01848834|11759326|FG002|Overall Study|Sponsor Decision|0
7462304|NCT01848834|11759327|FG003|Overall Study|Sponsor Decision|1
7462305|NCT01848834|11759328|FG004|Overall Study|Sponsor Decision|1
7462306|NCT01848834|11759324|FG000|Overall Study|Withdrawal by Subject|2
7462307|NCT01848834|11759325|FG001|Overall Study|Withdrawal by Subject|13
7462308|NCT01848834|11759326|FG002|Overall Study|Withdrawal by Subject|10
7462309|NCT01848834|11759327|FG003|Overall Study|Withdrawal by Subject|6
7462310|NCT01848834|11759328|FG004|Overall Study|Withdrawal by Subject|36
7462311|NCT01848938|11759364|FG000|Overall Study|Lost to Follow-up|1
7462312|NCT01848938|11759365|FG001|Overall Study|Lost to Follow-up|1
7462313|NCT01848990|11759383|FG000|Overall Study|Adverse Event|6
7462314|NCT01848990|11759384|FG001|Overall Study|Adverse Event|2
7462315|NCT01848990|11759385|FG002|Overall Study|Adverse Event|0
7462316|NCT01848990|11759383|FG000|Overall Study|Lost to Follow-up|6
7462317|NCT01848990|11759384|FG001|Overall Study|Lost to Follow-up|2
7462318|NCT01848990|11759385|FG002|Overall Study|Lost to Follow-up|2
7462319|NCT01848990|11759383|FG000|Overall Study|Protocol Violation|1
7462320|NCT01848990|11759384|FG001|Overall Study|Protocol Violation|1
7462321|NCT01848990|11759385|FG002|Overall Study|Protocol Violation|0
7462322|NCT01848990|11759383|FG000|Overall Study|Withdrawal by Subject|29
7462323|NCT01848990|11759384|FG001|Overall Study|Withdrawal by Subject|10
7462324|NCT01848990|11759385|FG002|Overall Study|Withdrawal by Subject|11
7462325|NCT01848990|11759383|FG000|Overall Study|Physician Decision|1
7462326|NCT01848990|11759384|FG001|Overall Study|Physician Decision|1
7462327|NCT01848990|11759385|FG002|Overall Study|Physician Decision|0
7462328|NCT01848990|11759383|FG000|Overall Study|Non Compliance|1
7462329|NCT01848990|11759384|FG001|Overall Study|Non Compliance|0
7462330|NCT01848990|11759385|FG002|Overall Study|Non Compliance|0
7462331|NCT01848990|11759383|FG000|Overall Study|Death|1
7462332|NCT01848990|11759384|FG001|Overall Study|Death|0
7462333|NCT01848990|11759385|FG002|Overall Study|Death|1
7462334|NCT01848990|11759383|FG000|Overall Study|Other|1
7462335|NCT01848990|11759384|FG001|Overall Study|Other|4
7462336|NCT01848990|11759385|FG002|Overall Study|Other|2
7381483|NCT01174160|11637688|FG001|Overall Study|Protocol Violation|6
7381484|NCT01174160|11637687|FG000|Overall Study|Withdrawal by Subject|1
7462337|NCT01849055|11759403|FG000|Overall Study|Withdrawal by Subject|0
7462338|NCT01849055|11759404|FG001|Overall Study|Withdrawal by Subject|0
7462339|NCT01849055|11759405|FG002|Overall Study|Withdrawal by Subject|1
7462340|NCT01849055|11759406|FG003|Overall Study|Withdrawal by Subject|0
7381485|NCT01174160|11637688|FG001|Overall Study|Withdrawal by Subject|0
7381486|NCT01174173|11637694|FG000|Overall Study|drug-drug interaction|1
7462341|NCT01849055|11759407|FG004|Overall Study|Withdrawal by Subject|0
7381487|NCT01174186|11637701|FG000|Overall Study|Lost to Follow-up|0
7381488|NCT01174186|11637702|FG001|Overall Study|Lost to Follow-up|1
7381489|NCT01174186|11637701|FG000|Overall Study|Withdrawal by Subject|0
7381490|NCT01174186|11637702|FG001|Overall Study|Withdrawal by Subject|2
7381491|NCT01174238|11637708|FG000|Overall Study|Lost to Follow-up|2
7381492|NCT01174264|11637718|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
7381493|NCT01174264|11637719|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
7381494|NCT01174264|11637720|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
7381495|NCT01174264|11637718|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
7381496|NCT01174264|11637719|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
7381497|NCT01174264|11637720|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
7381498|NCT01174264|11637718|FG000|Steady-state Pharmacokinetics|Not evaluable|6
7381499|NCT01174264|11637719|FG001|Steady-state Pharmacokinetics|Not evaluable|0
7381500|NCT01174264|11637720|FG002|Steady-state Pharmacokinetics|Not evaluable|2
7381501|NCT01174342|11637728|FG000|Overall Study|Conversion to cesarean section|4
7381502|NCT01174446|11637732|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7381503|NCT01174446|11637733|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7381504|NCT01174446|11637734|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
7381505|NCT01174446|11637735|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
7381506|NCT01174446|11637732|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7381507|NCT01174446|11637733|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7381508|NCT01174446|11637734|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
7381509|NCT01174446|11637735|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
7381510|NCT01174446|11637732|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
7381511|NCT01174446|11637733|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7381512|NCT01174446|11637734|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7381513|NCT01174446|11637735|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
7381514|NCT01174446|11637732|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7381515|NCT01174446|11637733|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
7381516|NCT01174446|11637734|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7381517|NCT01174446|11637735|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
7381518|NCT01174459|11637782|FG000|Overall Study|case report form (CRF) not collected|5
7381519|NCT01174550|11637788|FG000|Overall Study|Death|75
7381520|NCT01174550|11637789|FG001|Overall Study|Death|74
7381521|NCT01174550|11637788|FG000|Overall Study|Lost to Follow-up|652
7381522|NCT01174550|11637789|FG001|Overall Study|Lost to Follow-up|510
7381523|NCT01174550|11637788|FG000|Overall Study|Withdrawal by Subject|543
7381524|NCT01174550|11637789|FG001|Overall Study|Withdrawal by Subject|289
7381525|NCT01174784|11637808|FG000|Overall Study|Screen fails|4
7381526|NCT01175018|11637829|FG000|Overall Study|Adverse Event|3
7381527|NCT01175018|11637830|FG001|Overall Study|Adverse Event|1
7381528|NCT01175083|11637852|FG000|Primary Epoch|Withdrawal by Subject|0
7381529|NCT01175083|11637853|FG001|Primary Epoch|Withdrawal by Subject|0
7381530|NCT01175083|11637854|FG002|Primary Epoch|Withdrawal by Subject|0
7381531|NCT01175083|11637855|FG003|Primary Epoch|Withdrawal by Subject|0
7381532|NCT01175083|11637856|FG004|Primary Epoch|Withdrawal by Subject|0
7381533|NCT01175083|11637857|FG005|Primary Epoch|Withdrawal by Subject|2
7381534|NCT01175083|11637852|FG000|Primary Epoch|Lost to Follow-up|0
7381535|NCT01175083|11637853|FG001|Primary Epoch|Lost to Follow-up|0
7381536|NCT01175083|11637854|FG002|Primary Epoch|Lost to Follow-up|0
7381537|NCT01175083|11637855|FG003|Primary Epoch|Lost to Follow-up|0
7381538|NCT01175083|11637856|FG004|Primary Epoch|Lost to Follow-up|0
7381539|NCT01175083|11637857|FG005|Primary Epoch|Lost to Follow-up|1
7381540|NCT01175083|11637852|FG000|Booster Epoch|Death|0
7381541|NCT01175083|11637853|FG001|Booster Epoch|Death|0
7381542|NCT01175083|11637854|FG002|Booster Epoch|Death|1
7381543|NCT01175083|11637855|FG003|Booster Epoch|Death|0
7381544|NCT01175083|11637856|FG004|Booster Epoch|Death|0
7381545|NCT01175083|11637857|FG005|Booster Epoch|Death|0
7381546|NCT01175083|11637852|FG000|Booster Epoch|Withdrawal by Subject|0
7381547|NCT01175083|11637853|FG001|Booster Epoch|Withdrawal by Subject|0
7381548|NCT01175083|11637854|FG002|Booster Epoch|Withdrawal by Subject|0
7381549|NCT01175083|11637855|FG003|Booster Epoch|Withdrawal by Subject|1
7381550|NCT01175083|11637856|FG004|Booster Epoch|Withdrawal by Subject|0
7381551|NCT01175083|11637857|FG005|Booster Epoch|Withdrawal by Subject|0
7381552|NCT01175135|11637879|FG000|Overall Study|Adverse Event|2
7381553|NCT01175135|11637880|FG001|Overall Study|Adverse Event|5
7381554|NCT01175135|11637881|FG002|Overall Study|Adverse Event|3
7381555|NCT01175135|11637882|FG003|Overall Study|Adverse Event|4
7381556|NCT01175135|11637879|FG000|Overall Study|Death|1
7381557|NCT01175135|11637880|FG001|Overall Study|Death|0
7381558|NCT01175135|11637881|FG002|Overall Study|Death|0
7462342|NCT01849055|11759408|FG005|Overall Study|Withdrawal by Subject|0
7381559|NCT01175135|11637882|FG003|Overall Study|Death|0
7381560|NCT01175135|11637879|FG000|Overall Study|Lack of Efficacy|4
7381561|NCT01175135|11637880|FG001|Overall Study|Lack of Efficacy|5
7381562|NCT01175135|11637881|FG002|Overall Study|Lack of Efficacy|0
7381563|NCT01175135|11637882|FG003|Overall Study|Lack of Efficacy|5
7381564|NCT01175135|11637879|FG000|Overall Study|Lost to Follow-up|1
7381565|NCT01175135|11637880|FG001|Overall Study|Lost to Follow-up|2
7381566|NCT01175135|11637881|FG002|Overall Study|Lost to Follow-up|0
7381567|NCT01175135|11637882|FG003|Overall Study|Lost to Follow-up|0
7381568|NCT01175135|11637879|FG000|Overall Study|Protocol Violation|1
7381569|NCT01175135|11637880|FG001|Overall Study|Protocol Violation|1
7381570|NCT01175135|11637881|FG002|Overall Study|Protocol Violation|0
7381571|NCT01175135|11637882|FG003|Overall Study|Protocol Violation|0
7381572|NCT01175135|11637879|FG000|Overall Study|Withdrawal by Subject|4
7381573|NCT01175135|11637880|FG001|Overall Study|Withdrawal by Subject|8
7381574|NCT01175135|11637881|FG002|Overall Study|Withdrawal by Subject|5
7381575|NCT01175135|11637882|FG003|Overall Study|Withdrawal by Subject|5
7381576|NCT01175135|11637879|FG000|Overall Study|Other|3
7381577|NCT01175135|11637880|FG001|Overall Study|Other|1
7381578|NCT01175135|11637881|FG002|Overall Study|Other|3
7381579|NCT01175135|11637882|FG003|Overall Study|Other|0
7381580|NCT01175135|11637879|FG000|Overall Study|Randomized But Not Treated|0
7381581|NCT01175135|11637880|FG001|Overall Study|Randomized But Not Treated|0
7381582|NCT01175135|11637881|FG002|Overall Study|Randomized But Not Treated|1
7381583|NCT01175135|11637882|FG003|Overall Study|Randomized But Not Treated|0
7381584|NCT01175213|11637904|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
7381585|NCT01175213|11637905|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
7381586|NCT01175213|11637904|FG000|IGSC, 10%/rHuPH20|Death|1
7381587|NCT01175213|11637905|FG001|IGSC, 10%/rHuPH20|Death|0
7381588|NCT01175213|11637904|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
7381589|NCT01175213|11637905|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
7381590|NCT01175213|11637904|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
7381591|NCT01175213|11637905|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
7381592|NCT01175213|11637904|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
7381593|NCT01175213|11637905|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
7381594|NCT01175213|11637904|FG000|Safety Follow-up|Adverse Event|1
7381595|NCT01175213|11637905|FG001|Safety Follow-up|Adverse Event|0
7381596|NCT01175382|11637948|FG000|Overall Study|Lost to Follow-up|4
7381597|NCT01175382|11637949|FG001|Overall Study|Lost to Follow-up|3
7381598|NCT01175382|11637950|FG002|Overall Study|Lost to Follow-up|1
7381599|NCT01175382|11637948|FG000|Overall Study|Physician Decision|0
7381600|NCT01175382|11637949|FG001|Overall Study|Physician Decision|1
7381601|NCT01175382|11637950|FG002|Overall Study|Physician Decision|0
7381602|NCT01175382|11637948|FG000|Overall Study|Withdrawal by Subject|0
7381603|NCT01175382|11637949|FG001|Overall Study|Withdrawal by Subject|0
7381604|NCT01175382|11637950|FG002|Overall Study|Withdrawal by Subject|1
7381605|NCT01175382|11637948|FG000|Overall Study|No longer having problem|1
7381606|NCT01175382|11637949|FG001|Overall Study|No longer having problem|0
7381607|NCT01175382|11637950|FG002|Overall Study|No longer having problem|1
7381608|NCT01175382|11637948|FG000|Overall Study|Unable/unwilling to attend visits|3
7381609|NCT01175382|11637949|FG001|Overall Study|Unable/unwilling to attend visits|1
7381610|NCT01175382|11637950|FG002|Overall Study|Unable/unwilling to attend visits|2
7381611|NCT01175382|11637948|FG000|Overall Study|Unwilling to follow protocol|0
7381612|NCT01175382|11637949|FG001|Overall Study|Unwilling to follow protocol|1
7381613|NCT01175382|11637950|FG002|Overall Study|Unwilling to follow protocol|0
7381614|NCT01175382|11637948|FG000|Overall Study|Unable to tolerate study meds|0
7381615|NCT01175382|11637949|FG001|Overall Study|Unable to tolerate study meds|1
7381616|NCT01175382|11637950|FG002|Overall Study|Unable to tolerate study meds|1
7381617|NCT01175473|11637973|FG000|Overall Study|Adverse Event|2
7462343|NCT01849276|11759444|FG000|Followed for Survival for 5 Years|Death|1
7462344|NCT01849276|11759444|FG000|Followed for Survival for 5 Years|Early termination of the study|1
7462345|NCT01849289|11759450|FG000|Overall Study|Adverse Event|3
7462346|NCT01849289|11759451|FG001|Overall Study|Adverse Event|3
7462347|NCT01849289|11759450|FG000|Overall Study|Protocol Violation|3
7462348|NCT01849289|11759451|FG001|Overall Study|Protocol Violation|3
7462349|NCT01849289|11759450|FG000|Overall Study|Withdrawal criteria|1
7462350|NCT01849289|11759451|FG001|Overall Study|Withdrawal criteria|0
7462351|NCT01849289|11759450|FG000|Overall Study|Unclassified|25
7462352|NCT01849289|11759451|FG001|Overall Study|Unclassified|18
7462353|NCT01849458|11759462|FG000|Overall Study|Lost to Follow-up|4
7462354|NCT01849497|11759468|FG000|Overall Study|Withdrawal by Subject|1
7462355|NCT01849497|11759469|FG001|Overall Study|Withdrawal by Subject|2
7462356|NCT01849497|11759468|FG000|Overall Study|Sponsor Decision|0
7462357|NCT01849497|11759469|FG001|Overall Study|Sponsor Decision|1
7462358|NCT01849497|11759468|FG000|Overall Study|Lost to Follow-up|0
7462359|NCT01849497|11759469|FG001|Overall Study|Lost to Follow-up|1
7462360|NCT01849562|11759478|FG000|Overall Study|Lost to Follow-up|1
7462361|NCT01849562|11759479|FG001|Overall Study|Lost to Follow-up|0
7462362|NCT01849562|11759480|FG002|Overall Study|Lost to Follow-up|0
7462363|NCT01849562|11759478|FG000|Overall Study|Non-compliance with Study Drug|1
7462364|NCT01849562|11759479|FG001|Overall Study|Non-compliance with Study Drug|0
7462365|NCT01849562|11759480|FG002|Overall Study|Non-compliance with Study Drug|0
7462366|NCT01849588|11759500|FG000|Overall Study|Lack of Efficacy|3
7462367|NCT01849848|11759553|FG000|Overall Study|Physician Decision|1
7462368|NCT01849848|11759553|FG000|Overall Study|Progression of the primary disease|3
7462369|NCT01850030|11759559|FG000|Overall Study|Adverse Event|64
7462370|NCT01850030|11759560|FG001|Overall Study|Adverse Event|82
7462371|NCT01850030|11759559|FG000|Overall Study|Lack of Efficacy|3
7462372|NCT01850030|11759560|FG001|Overall Study|Lack of Efficacy|1
7462373|NCT01850030|11759559|FG000|Overall Study|Lost to Follow-up|5
7381618|NCT01175473|11637974|FG001|Overall Study|Adverse Event|2
7381619|NCT01175590|11637982|FG000|Overall Study|Lost to Follow-up|1
7381620|NCT01175590|11637983|FG001|Overall Study|Lost to Follow-up|0
7381621|NCT01175590|11637982|FG000|Overall Study|Withdrawal by Subject|0
7381622|NCT01175590|11637983|FG001|Overall Study|Withdrawal by Subject|2
7381623|NCT01175590|11637982|FG000|Overall Study|Adverse Event|4
7381624|NCT01175590|11637983|FG001|Overall Study|Adverse Event|0
7381625|NCT01175590|11637982|FG000|Overall Study|Physician Decision|1
7381626|NCT01175590|11637983|FG001|Overall Study|Physician Decision|4
7381627|NCT01175590|11637982|FG000|Overall Study|Lack of Efficacy|1
7381628|NCT01175590|11637983|FG001|Overall Study|Lack of Efficacy|1
7381629|NCT01175590|11637982|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
7381630|NCT01175590|11637983|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
7381631|NCT01175590|11637982|FG000|Overall Study|Treated not as randomized|3
7381632|NCT01175590|11637983|FG001|Overall Study|Treated not as randomized|2
7381633|NCT01175590|11637982|FG000|Overall Study|Herpes Simplex Dermatitis|1
7381634|NCT01175590|11637983|FG001|Overall Study|Herpes Simplex Dermatitis|0
7381635|NCT01175590|11637982|FG000|Overall Study|Protocol Violation|0
7381636|NCT01175590|11637983|FG001|Overall Study|Protocol Violation|1
7381637|NCT01175668|11637992|FG000|Overall Study|Withdrawal by Subject|2
7381638|NCT01175668|11637993|FG001|Overall Study|Withdrawal by Subject|0
7381639|NCT01175707|11638001|FG000|Overall Study|Adverse Event|4
7381640|NCT01175707|11638002|FG001|Overall Study|Adverse Event|6
7381641|NCT01175811|11638020|FG000|Overall Study|Adverse Event|1
7381642|NCT01175811|11638021|FG001|Overall Study|Adverse Event|1
7381643|NCT01175811|11638020|FG000|Overall Study|Entry criteria not met|3
7381644|NCT01175811|11638021|FG001|Overall Study|Entry criteria not met|1
7381645|NCT01175811|11638020|FG000|Overall Study|Lack of Efficacy|1
7381646|NCT01175811|11638021|FG001|Overall Study|Lack of Efficacy|0
7381647|NCT01175811|11638020|FG000|Overall Study|Lost to Follow-up|3
7381648|NCT01175811|11638021|FG001|Overall Study|Lost to Follow-up|2
7381649|NCT01175811|11638020|FG000|Overall Study|Physician Decision|1
7381650|NCT01175811|11638021|FG001|Overall Study|Physician Decision|1
7381651|NCT01175811|11638020|FG000|Overall Study|Protocol Violation|1
7381652|NCT01175811|11638021|FG001|Overall Study|Protocol Violation|2
7381653|NCT01175811|11638020|FG000|Overall Study|Withdrawal by Subject|6
7381654|NCT01175811|11638021|FG001|Overall Study|Withdrawal by Subject|7
7381655|NCT01175824|11638029|FG000|Overall Study|Adverse Event|2
7381656|NCT01175824|11638030|FG001|Overall Study|Adverse Event|1
7381657|NCT01175824|11638029|FG000|Overall Study|Lack of Efficacy|2
7381658|NCT01175824|11638030|FG001|Overall Study|Lack of Efficacy|0
7381659|NCT01175824|11638029|FG000|Overall Study|Lost to Follow-up|0
7381660|NCT01175824|11638030|FG001|Overall Study|Lost to Follow-up|1
7381661|NCT01175824|11638029|FG000|Overall Study|Physician Decision|0
7381662|NCT01175824|11638030|FG001|Overall Study|Physician Decision|4
7381663|NCT01175824|11638029|FG000|Overall Study|Protocol Violation|2
7381664|NCT01175824|11638030|FG001|Overall Study|Protocol Violation|5
7381665|NCT01175824|11638029|FG000|Overall Study|Withdrawal by Subject|3
7381666|NCT01175824|11638030|FG001|Overall Study|Withdrawal by Subject|7
7381667|NCT01175824|11638029|FG000|Overall Study|Sponsor Decision|1
7381668|NCT01175824|11638030|FG001|Overall Study|Sponsor Decision|0
7381669|NCT01175824|11638029|FG000|Overall Study|Entry Criteria Not Met|6
7381670|NCT01175824|11638030|FG001|Overall Study|Entry Criteria Not Met|4
7381671|NCT01176032|11638063|FG000|Overall Study|Adverse Event|1
7381672|NCT01176032|11638064|FG001|Overall Study|Adverse Event|0
7381673|NCT01176032|11638063|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7381674|NCT01176032|11638064|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7381675|NCT01176032|11638063|FG000|Overall Study|Protocol Violation|1
7381676|NCT01176032|11638064|FG001|Overall Study|Protocol Violation|0
7381677|NCT01176032|11638063|FG000|Overall Study|Informed consent withdrawn|3
7381678|NCT01176032|11638064|FG001|Overall Study|Informed consent withdrawn|0
7381679|NCT01176032|11638063|FG000|Overall Study|Other|1
7381680|NCT01176032|11638064|FG001|Overall Study|Other|0
7381681|NCT01176058|11638077|FG000|Overall Study|Adverse Event|1
7381682|NCT01176058|11638078|FG001|Overall Study|Adverse Event|0
7381683|NCT01176058|11638077|FG000|Overall Study|Insufficient clinical response|2
7381684|NCT01176058|11638078|FG001|Overall Study|Insufficient clinical response|2
7381685|NCT01176058|11638077|FG000|Overall Study|Insufficient mycological response|0
7381686|NCT01176058|11638078|FG001|Overall Study|Insufficient mycological response|1
7381687|NCT01176058|11638077|FG000|Overall Study|Withdrawal by Subject|1
7381688|NCT01176058|11638078|FG001|Overall Study|Withdrawal by Subject|0
7381689|NCT01176240|11638088|FG000|Study 306A|Lack of Efficacy|2
7381690|NCT01176240|11638089|FG001|Study 306A|Lack of Efficacy|1
7381691|NCT01176240|11638088|FG000|Study 306A|Protocol Violation|0
7381692|NCT01176240|11638089|FG001|Study 306A|Protocol Violation|1
7381693|NCT01176240|11638088|FG000|Study 306A|Withdrawal by Subject|0
7381694|NCT01176240|11638089|FG001|Study 306A|Withdrawal by Subject|1
7381695|NCT01176240|11638088|FG000|Study 306A|Stop due to diverse problems|1
7381696|NCT01176240|11638089|FG001|Study 306A|Stop due to diverse problems|0
7381697|NCT01176240|11638088|FG000|Study 306B|Lack of Efficacy|5
7381698|NCT01176240|11638089|FG001|Study 306B|Lack of Efficacy|3
7381699|NCT01176240|11638088|FG000|Study 306B|Adverse Event|10
7381700|NCT01176240|11638089|FG001|Study 306B|Adverse Event|5
7381701|NCT01176240|11638088|FG000|Study 306B|Protocol Violation|2
7381702|NCT01176240|11638089|FG001|Study 306B|Protocol Violation|3
7381703|NCT01176240|11638088|FG000|Study 306B|Withdrawal by Subject|4
7381704|NCT01176240|11638089|FG001|Study 306B|Withdrawal by Subject|1
7381705|NCT01176240|11638088|FG000|Study 306B|Physician Decision|2
7381706|NCT01176240|11638089|FG001|Study 306B|Physician Decision|1
7381707|NCT01176240|11638088|FG000|Study 306B|Supine Hypertension|1
7381708|NCT01176240|11638089|FG001|Study 306B|Supine Hypertension|2
7381709|NCT01176240|11638088|FG000|Study 306B|Lost to Follow-up|0
7381710|NCT01176240|11638089|FG001|Study 306B|Lost to Follow-up|1
7381711|NCT01176240|11638088|FG000|Study 306B|withdrew prior to dosing|2
7381712|NCT01176240|11638089|FG001|Study 306B|withdrew prior to dosing|1
7381713|NCT01176266|11638095|FG000|Overall Study|Death|6
7381714|NCT01176266|11638095|FG000|Overall Study|Withdrawal by Subject|3
7381715|NCT01176292|11638105|FG000|Overall Study|Lost to Follow-up|2
7381716|NCT01176292|11638106|FG001|Overall Study|Lost to Follow-up|4
7381717|NCT01176292|11638105|FG000|Overall Study|Adverse Event|1
7381718|NCT01176292|11638106|FG001|Overall Study|Adverse Event|1
7381719|NCT01176292|11638105|FG000|Overall Study|Physician Decision|0
7381720|NCT01176292|11638106|FG001|Overall Study|Physician Decision|2
7381721|NCT01176292|11638105|FG000|Overall Study|Has not scheduled one-year visit yet|2
7381722|NCT01176292|11638106|FG001|Overall Study|Has not scheduled one-year visit yet|2
7381723|NCT01176565|11638135|FG000|Overall Study|Lost to Follow-up|12
7381724|NCT01176565|11638136|FG001|Overall Study|Lost to Follow-up|16
7533437|NCT02686034|11879841|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
7570857|NCT03512288|11949336|FG001|Overall Study|Randomized but not treated|1
7570858|NCT03512353|11949342|FG000|Overall Study|Sponsor Decision|3
7570859|NCT03512353|11949342|FG000|Overall Study|Death|1
7570860|NCT03513588|11949362|FG000|Overall Study|Lost to Follow-up|0
7570861|NCT03513588|11949363|FG001|Overall Study|Lost to Follow-up|1
7570862|NCT03513588|11949364|FG002|Overall Study|Lost to Follow-up|1
7570863|NCT03513588|11949362|FG000|Overall Study|Study dosing paused by sponsor|1
7570864|NCT03513588|11949363|FG001|Overall Study|Study dosing paused by sponsor|1
7381725|NCT01176565|11638135|FG000|Overall Study|Withdrawal by Subject|7
7381726|NCT01176565|11638136|FG001|Overall Study|Withdrawal by Subject|1
7381727|NCT01176565|11638135|FG000|Overall Study|Not Analyzed (any other reason)|1
7381728|NCT01176565|11638136|FG001|Overall Study|Not Analyzed (any other reason)|2
7381729|NCT01176773|11638165|FG000|Overall Study|Screen Failure|2
7381730|NCT01176773|11638165|FG000|Overall Study|Withdrew consent|1
7381731|NCT01176916|11638175|FG000|Overall Study|Adverse Event|61
7533438|NCT02686034|11879842|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
7533439|NCT02686034|11879841|FG000|Randomized Controlled Period 2|Adverse Event|0
7533440|NCT02686034|11879842|FG001|Randomized Controlled Period 2|Adverse Event|2
7533441|NCT02686034|11879841|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
7533442|NCT02686034|11879842|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
7533443|NCT02686034|11879841|FG000|Open Label Period 3|Lost to Follow-up|0
7533444|NCT02686034|11879842|FG001|Open Label Period 3|Lost to Follow-up|1
7533445|NCT02686164|11879857|FG000|Overall Study|Adverse Event|1
7381732|NCT01176916|11638175|FG000|Overall Study|Death|1
7381733|NCT01176916|11638175|FG000|Overall Study|Lost to Follow-up|15
7381734|NCT01176916|11638175|FG000|Overall Study|Objective progression or relapse|17
7381735|NCT01176916|11638175|FG000|Overall Study|Protocol Violation|24
7381736|NCT01176916|11638175|FG000|Overall Study|Withdrawal by Subject|37
7570865|NCT03513588|11949364|FG002|Overall Study|Study dosing paused by sponsor|0
7570866|NCT03513588|11949362|FG000|Overall Study|Death|0
7570867|NCT03513588|11949363|FG001|Overall Study|Death|0
7381737|NCT01176916|11638175|FG000|Overall Study|Other|6
7381738|NCT01176916|11638175|FG000|Overall Study|Withdrawal prior to Treatment|6
7381739|NCT01176968|11638193|FG000|Overall Study|Adverse Event|10
7381740|NCT01176968|11638194|FG001|Overall Study|Adverse Event|11
7381741|NCT01176968|11638193|FG000|Overall Study|Death|2
7381742|NCT01176968|11638194|FG001|Overall Study|Death|3
7381743|NCT01176968|11638193|FG000|Overall Study|Lack of Efficacy|0
7381744|NCT01176968|11638194|FG001|Overall Study|Lack of Efficacy|1
7381745|NCT01176968|11638193|FG000|Overall Study|Lost to Follow-up|16
7381746|NCT01176968|11638194|FG001|Overall Study|Lost to Follow-up|14
7381747|NCT01176968|11638193|FG000|Overall Study|Withdrawal by Subject|48
7381748|NCT01176968|11638194|FG001|Overall Study|Withdrawal by Subject|48
7381749|NCT01176968|11638193|FG000|Overall Study|Protocol Violation|2
7381750|NCT01176968|11638194|FG001|Overall Study|Protocol Violation|1
7381751|NCT01176968|11638193|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7381752|NCT01176968|11638194|FG001|Overall Study|Did Not Meet Entrance Criteria|0
7381753|NCT01176968|11638193|FG000|Overall Study|Study terminated by sponsor|0
7381754|NCT01176968|11638194|FG001|Overall Study|Study terminated by sponsor|1
7381755|NCT01176968|11638193|FG000|Overall Study|Reason not defined|5
7381756|NCT01176968|11638194|FG001|Overall Study|Reason not defined|3
7381757|NCT01177007|11638204|FG000|Overall Study|Lost to Follow-up|2
7381758|NCT01177007|11638204|FG000|Overall Study|Death|4
7381759|NCT01177007|11638204|FG000|Overall Study|Entered hospice care|5
7381760|NCT01177007|11638204|FG000|Overall Study|Required additional Y90 treatment|6
7381761|NCT01177007|11638204|FG000|Overall Study|Change in treatment modality|21
7381762|NCT01177059|11638210|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
7381763|NCT01177059|11638210|FG000|Overall Study|Withdrew consent|2
7381764|NCT01177059|11638210|FG000|Overall Study|Lost to Follow-up|18
7381765|NCT01177137|11638226|FG000|Overall Study|Withdrawal by Subject|10
7381766|NCT01177137|11638227|FG001|Overall Study|Withdrawal by Subject|10
7381767|NCT01177137|11638228|FG002|Overall Study|Withdrawal by Subject|2
7381768|NCT01177228|11638252|FG000|Overall Study|Positive tuberculosis test|0
7381769|NCT01177228|11638253|FG001|Overall Study|Positive tuberculosis test|1
7381770|NCT01177228|11638254|FG002|Overall Study|Positive tuberculosis test|0
7381771|NCT01177228|11638255|FG003|Overall Study|Positive tuberculosis test|0
7381772|NCT01177228|11638252|FG000|Overall Study|Worsening disease activity|1
7381773|NCT01177228|11638253|FG001|Overall Study|Worsening disease activity|0
7381774|NCT01177228|11638254|FG002|Overall Study|Worsening disease activity|0
7381775|NCT01177228|11638255|FG003|Overall Study|Worsening disease activity|0
7381776|NCT01177228|11638252|FG000|Overall Study|Withdrawal by Subject|0
7381777|NCT01177228|11638253|FG001|Overall Study|Withdrawal by Subject|1
7381778|NCT01177228|11638254|FG002|Overall Study|Withdrawal by Subject|0
7381779|NCT01177228|11638255|FG003|Overall Study|Withdrawal by Subject|0
7381780|NCT01177293|11638270|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
7381781|NCT01177293|11638271|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
7381782|NCT01177384|11638279|FG000|Overall Study|Adverse Event|6
7381783|NCT01177384|11638280|FG001|Overall Study|Adverse Event|4
7381784|NCT01177384|11638279|FG000|Overall Study|Lack of Efficacy|0
7381785|NCT01177384|11638280|FG001|Overall Study|Lack of Efficacy|1
7381786|NCT01177384|11638279|FG000|Overall Study|Lost to Follow-up|3
7381787|NCT01177384|11638280|FG001|Overall Study|Lost to Follow-up|4
7381788|NCT01177384|11638279|FG000|Overall Study|Physician Decision|0
7381789|NCT01177384|11638280|FG001|Overall Study|Physician Decision|3
7381790|NCT01177384|11638279|FG000|Overall Study|Protocol Violation|0
7381791|NCT01177384|11638280|FG001|Overall Study|Protocol Violation|2
7381792|NCT01177384|11638279|FG000|Overall Study|Withdrawal by Subject|5
7381793|NCT01177384|11638280|FG001|Overall Study|Withdrawal by Subject|12
7381794|NCT01177410|11638289|FG000|Overall Study|Adverse Event|0
7381795|NCT01177410|11638290|FG001|Overall Study|Adverse Event|2
7381796|NCT01177410|11638291|FG002|Overall Study|Adverse Event|2
7381797|NCT01177410|11638289|FG000|Overall Study|Withdrawal by Subject|1
7381798|NCT01177410|11638290|FG001|Overall Study|Withdrawal by Subject|4
7381799|NCT01177410|11638291|FG002|Overall Study|Withdrawal by Subject|3
7381800|NCT01177410|11638289|FG000|Overall Study|Lost to Follow-up|0
7381801|NCT01177410|11638290|FG001|Overall Study|Lost to Follow-up|1
7381802|NCT01177410|11638291|FG002|Overall Study|Lost to Follow-up|0
7381803|NCT01177553|11638301|FG000|Overall Study|babies not yet 6 months of age|1
7381804|NCT01177553|11638302|FG001|Overall Study|babies not yet 6 months of age|0
7381805|NCT01177670|11638308|FG000|Overall Study|Study Terminated|115
7381806|NCT01177670|11638308|FG000|Overall Study|Physician Decision|50
7381807|NCT01177670|11638308|FG000|Overall Study|Withdrawal by Subject|4
7381808|NCT01177722|11638320|FG000|Overall Study|Serious Adverse Event|0
7381809|NCT01177722|11638321|FG001|Overall Study|Serious Adverse Event|0
7381810|NCT01177722|11638322|FG002|Overall Study|Serious Adverse Event|1
7381811|NCT01177722|11638323|FG003|Overall Study|Serious Adverse Event|0
7381812|NCT01177722|11638320|FG000|Overall Study|Protocol Violation|0
7381813|NCT01177722|11638321|FG001|Overall Study|Protocol Violation|0
7381814|NCT01177722|11638322|FG002|Overall Study|Protocol Violation|1
7381815|NCT01177722|11638323|FG003|Overall Study|Protocol Violation|0
7381816|NCT01177722|11638320|FG000|Overall Study|Lost to Follow-up|3
7381817|NCT01177722|11638321|FG001|Overall Study|Lost to Follow-up|4
7381818|NCT01177722|11638322|FG002|Overall Study|Lost to Follow-up|3
7381819|NCT01177722|11638323|FG003|Overall Study|Lost to Follow-up|1
7381820|NCT01177722|11638320|FG000|Overall Study|Withdrawal by Subject|10
7381821|NCT01177722|11638321|FG001|Overall Study|Withdrawal by Subject|6
7381822|NCT01177722|11638322|FG002|Overall Study|Withdrawal by Subject|4
7381823|NCT01177722|11638323|FG003|Overall Study|Withdrawal by Subject|6
7381824|NCT01177787|11638338|FG000|Cryolipolysis on Thigh|Protocol Violation|4
7381825|NCT01177787|11638338|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
7381826|NCT01177787|11638338|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
7381827|NCT01177800|11638352|FG000|Overall Study|Adverse Event|9
7381828|NCT01177800|11638353|FG001|Overall Study|Adverse Event|3
7381829|NCT01177800|11638352|FG000|Overall Study|Protocol Violation|0
7381830|NCT01177800|11638353|FG001|Overall Study|Protocol Violation|1
7381831|NCT01177800|11638352|FG000|Overall Study|Physician Decision|1
7381832|NCT01177800|11638353|FG001|Overall Study|Physician Decision|0
7381833|NCT01177800|11638352|FG000|Overall Study|Withdrawal of informed consent|0
7381834|NCT01177800|11638353|FG001|Overall Study|Withdrawal of informed consent|1
7381835|NCT01177813|11638364|FG000|Overall Study|Adverse Event|8
7381836|NCT01177813|11638365|FG001|Overall Study|Adverse Event|2
7381837|NCT01177813|11638366|FG002|Overall Study|Adverse Event|4
7381838|NCT01177813|11638367|FG003|Overall Study|Adverse Event|6
7381839|NCT01177813|11638368|FG004|Overall Study|Adverse Event|3
7381840|NCT01177813|11638364|FG000|Overall Study|Lack of Efficacy|1
7381841|NCT01177813|11638365|FG001|Overall Study|Lack of Efficacy|0
7381842|NCT01177813|11638366|FG002|Overall Study|Lack of Efficacy|0
7381843|NCT01177813|11638367|FG003|Overall Study|Lack of Efficacy|0
7381844|NCT01177813|11638368|FG004|Overall Study|Lack of Efficacy|0
7381845|NCT01177813|11638364|FG000|Overall Study|Protocol Violation|3
7381846|NCT01177813|11638365|FG001|Overall Study|Protocol Violation|2
7381847|NCT01177813|11638366|FG002|Overall Study|Protocol Violation|2
7381848|NCT01177813|11638367|FG003|Overall Study|Protocol Violation|0
7381849|NCT01177813|11638368|FG004|Overall Study|Protocol Violation|1
7381850|NCT01177813|11638364|FG000|Overall Study|Lost to Follow-up|12
7381851|NCT01177813|11638365|FG001|Overall Study|Lost to Follow-up|5
7381852|NCT01177813|11638366|FG002|Overall Study|Lost to Follow-up|6
7381853|NCT01177813|11638367|FG003|Overall Study|Lost to Follow-up|3
7381854|NCT01177813|11638368|FG004|Overall Study|Lost to Follow-up|0
7381855|NCT01177813|11638364|FG000|Overall Study|Withdrawal by Subject|12
7381856|NCT01177813|11638365|FG001|Overall Study|Withdrawal by Subject|7
7381857|NCT01177813|11638366|FG002|Overall Study|Withdrawal by Subject|6
7381858|NCT01177813|11638367|FG003|Overall Study|Withdrawal by Subject|5
7381859|NCT01177813|11638368|FG004|Overall Study|Withdrawal by Subject|3
7381860|NCT01177813|11638364|FG000|Overall Study|Other reason not defined above|5
7381861|NCT01177813|11638365|FG001|Overall Study|Other reason not defined above|2
7381862|NCT01177813|11638366|FG002|Overall Study|Other reason not defined above|2
7381863|NCT01177813|11638367|FG003|Overall Study|Other reason not defined above|3
7381864|NCT01177813|11638368|FG004|Overall Study|Other reason not defined above|2
7381865|NCT01177943|11638382|FG000|First Intervention|Withdrawal by Subject|2
7381866|NCT01177943|11638383|FG001|First Intervention|Withdrawal by Subject|0
7381867|NCT01177969|11638396|FG000|Overall Study|Protocol Violation|2
7381868|NCT01177969|11638397|FG001|Overall Study|Protocol Violation|1
7381869|NCT01177969|11638396|FG000|Overall Study|Withdrawal by Subject|1
7381870|NCT01177969|11638397|FG001|Overall Study|Withdrawal by Subject|2
7381871|NCT01178073|11638406|FG000|Overall Study|Adverse Event|34
7381872|NCT01178073|11638407|FG001|Overall Study|Adverse Event|27
7381873|NCT01178073|11638408|FG002|Overall Study|Adverse Event|24
7381874|NCT01178073|11638406|FG000|Overall Study|Protocol Violation|1
7381875|NCT01178073|11638407|FG001|Overall Study|Protocol Violation|1
7381876|NCT01178073|11638408|FG002|Overall Study|Protocol Violation|1
7381877|NCT01178073|11638406|FG000|Overall Study|Lost to Follow-up|2
7381878|NCT01178073|11638407|FG001|Overall Study|Lost to Follow-up|0
7381879|NCT01178073|11638408|FG002|Overall Study|Lost to Follow-up|3
7381880|NCT01178073|11638406|FG000|Overall Study|Physician Decision|14
7381881|NCT01178073|11638407|FG001|Overall Study|Physician Decision|10
7381882|NCT01178073|11638408|FG002|Overall Study|Physician Decision|10
7381883|NCT01178073|11638406|FG000|Overall Study|Withdrawal by Subject|10
7381884|NCT01178073|11638407|FG001|Overall Study|Withdrawal by Subject|6
7381885|NCT01178073|11638408|FG002|Overall Study|Withdrawal by Subject|8
7381886|NCT01178073|11638406|FG000|Overall Study|Missing Completion Status|1
7381887|NCT01178073|11638407|FG001|Overall Study|Missing Completion Status|0
7381888|NCT01178073|11638408|FG002|Overall Study|Missing Completion Status|0
7381889|NCT01178086|11638419|FG000|Overall Study|Participant refusal|7
7381890|NCT01178086|11638419|FG000|Overall Study|Physician Decision|44
7381891|NCT01178086|11638419|FG000|Overall Study|Switch to other CLL therapy|113
7381892|NCT01178086|11638419|FG000|Overall Study|Death|59
7381893|NCT01178086|11638419|FG000|Overall Study|Other unspecified|89
7381894|NCT01178086|11638419|FG000|Overall Study|Excluded from EAS|20
7381895|NCT01178099|11638429|FG000|Overall Study|Physician Decision|0
7381896|NCT01178099|11638430|FG001|Overall Study|Physician Decision|1
7381897|NCT01178125|11638440|FG000|Overall Study|Lost to Follow-up|397
7381898|NCT01178125|11638440|FG000|Overall Study|Adverse Event|244
7381899|NCT01178125|11638440|FG000|Overall Study|Withdrawal by Subject|209
7381900|NCT01178125|11638440|FG000|Overall Study|Noncompliance|184
7381901|NCT01178125|11638440|FG000|Overall Study|Pregnancy|55
7381902|NCT01178125|11638440|FG000|Overall Study|Other Reason|39
7381903|NCT01178125|11638440|FG000|Overall Study|Sponsor Decision|28
7381904|NCT01178125|11638440|FG000|Overall Study|Protocol Violation|17
7381905|NCT01178125|11638440|FG000|Overall Study|Investigator Decision|5
7381906|NCT01178138|11638449|FG000|Overall Study|Lost to Follow-up|8
7381907|NCT01178138|11638449|FG000|Overall Study|Withdrawal by Subject|7
7381908|NCT01178138|11638449|FG000|Overall Study|Physician Decision|8
7381909|NCT01178294|11638486|FG000|Overall Study|Adverse Event|4
7381910|NCT01178294|11638486|FG000|Overall Study|Lost to Follow-up|2
7381911|NCT01178294|11638486|FG000|Overall Study|Lack of Efficacy|1
7381912|NCT01178294|11638486|FG000|Overall Study|Death|1
7381913|NCT01178294|11638486|FG000|Overall Study|Development of inhibitors to OBI-1|1
7381914|NCT01178294|11638486|FG000|Overall Study|Subject status is terminal|1
7381915|NCT01178294|11638486|FG000|Overall Study|Completion status could not be verified|1
7381916|NCT01178385|11638507|FG000|Overall Study|Withdrawal by Subject|2
7381917|NCT01178385|11638508|FG001|Overall Study|Withdrawal by Subject|0
7381918|NCT01178411|11638514|FG000|Overall Study|Adverse Event|5
7381919|NCT01178411|11638514|FG000|Overall Study|Withdrawal by Subject|4
7381920|NCT01178411|11638514|FG000|Overall Study|Protocol Violation|1
7381921|NCT01178411|11638514|FG000|Overall Study|Progressive disease per RECIST|32
7381922|NCT01178411|11638514|FG000|Overall Study|Progressive disease per clinician|9
7381923|NCT01178411|11638514|FG000|Overall Study|Physician Decision|6
7381924|NCT01178411|11638514|FG000|Overall Study|Death|1
7381925|NCT01178411|11638514|FG000|Overall Study|No reason provided|1
7381926|NCT01178411|11638514|FG000|Overall Study|Drug manufacturing ended|1
7381927|NCT01178671|11638534|FG000|Overall Study|Adverse Event|4
7381928|NCT01178671|11638535|FG001|Overall Study|Adverse Event|6
7381929|NCT01178671|11638534|FG000|Overall Study|Protocol Violation|1
7381930|NCT01178671|11638535|FG001|Overall Study|Protocol Violation|1
7381931|NCT01178671|11638534|FG000|Overall Study|Lack of Efficacy|0
7381932|NCT01178671|11638535|FG001|Overall Study|Lack of Efficacy|1
7381933|NCT01178671|11638534|FG000|Overall Study|Lost to Follow-up|3
7381934|NCT01178671|11638535|FG001|Overall Study|Lost to Follow-up|1
7381935|NCT01178671|11638534|FG000|Overall Study|Physician Decision|4
7381936|NCT01178671|11638535|FG001|Overall Study|Physician Decision|6
7381937|NCT01178762|11638541|FG000|Overall Study|Lost to Follow-up|15
7381938|NCT01178853|11638560|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
7381939|NCT01178853|11638561|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
7381940|NCT01178853|11638560|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
7381941|NCT01178853|11638561|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
7381942|NCT01178853|11638560|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
7381943|NCT01178853|11638561|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
7381944|NCT01178853|11638560|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
7381945|NCT01178853|11638561|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
7381946|NCT01178853|11638560|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
7381947|NCT01178853|11638561|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
7381948|NCT01179048|11638573|FG000|Overall Study|Withdrawn - does not allow contact|4
7381949|NCT01179048|11638574|FG001|Overall Study|Withdrawn - does not allow contact|8
7381950|NCT01179048|11638573|FG000|Overall Study|Lost to Follow-up|8
7381951|NCT01179048|11638574|FG001|Overall Study|Lost to Follow-up|9
7381952|NCT01179048|11638573|FG000|Overall Study|Alive|127
7381953|NCT01179048|11638574|FG001|Overall Study|Alive|142
7381954|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
7381955|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
7381956|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
7381957|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
7381958|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
7381959|NCT01179191|11638589|FG000|Titration Phase (up to 6 Weeks)|Other|62
7381960|NCT01179191|11638589|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
7381961|NCT01179191|11638589|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
7381962|NCT01179191|11638589|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
7381963|NCT01179191|11638589|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
7381964|NCT01179191|11638589|FG000|Maintenance Phase (8 Weeks)|Other|66
7381965|NCT01179334|11638606|FG000|Treatment Period|Adverse Event|1
7381966|NCT01179334|11638607|FG001|Treatment Period|Adverse Event|0
7381967|NCT01179334|11638606|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
7381968|NCT01179334|11638607|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
7381969|NCT01179334|11638606|FG000|Long-term Extension (LTE) Period|Death|3
7381970|NCT01179334|11638607|FG001|Long-term Extension (LTE) Period|Death|0
7381971|NCT01179334|11638606|FG000|Long-term Extension (LTE) Period|Adverse Event|2
7381972|NCT01179334|11638607|FG001|Long-term Extension (LTE) Period|Adverse Event|4
7381973|NCT01179347|11638615|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
7381974|NCT01179347|11638616|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
7381975|NCT01179347|11638615|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
7381976|NCT01179347|11638616|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
7381977|NCT01179347|11638615|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
7381978|NCT01179347|11638616|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7381979|NCT01179347|11638615|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
7381980|NCT01179347|11638616|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
7381981|NCT01179347|11638615|FG000|Double-blind Period (12 Weeks)|Other|2
7381982|NCT01179347|11638616|FG001|Double-blind Period (12 Weeks)|Other|4
7381983|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Adverse Event|5
7381984|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Adverse Event|9
7381985|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
7381986|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
7381987|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
7381988|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
7381989|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7381990|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
7381991|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
7381992|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
7381993|NCT01179347|11638615|FG000|Open-label Period (12 Weeks)|Other|7
7381994|NCT01179347|11638616|FG001|Open-label Period (12 Weeks)|Other|4
7387364|NCT01214629|11645866|FG009|Overall Study|Progressive Disease|5
7387365|NCT01214629|11645867|FG010|Overall Study|Progressive Disease|1
7387366|NCT01214629|11645857|FG000|Overall Study|Adverse Event|0
7387367|NCT01214629|11645858|FG001|Overall Study|Adverse Event|0
7387368|NCT01214629|11645859|FG002|Overall Study|Adverse Event|0
7387369|NCT01214629|11645860|FG003|Overall Study|Adverse Event|1
7387370|NCT01214629|11645861|FG004|Overall Study|Adverse Event|0
7387371|NCT01214629|11645862|FG005|Overall Study|Adverse Event|1
7387372|NCT01214629|11645863|FG006|Overall Study|Adverse Event|0
7387373|NCT01214629|11645864|FG007|Overall Study|Adverse Event|0
7387374|NCT01214629|11645865|FG008|Overall Study|Adverse Event|0
7387375|NCT01214629|11645866|FG009|Overall Study|Adverse Event|1
7387376|NCT01214629|11645867|FG010|Overall Study|Adverse Event|0
7387377|NCT01214629|11645857|FG000|Overall Study|Physician Decision|0
7387378|NCT01214629|11645858|FG001|Overall Study|Physician Decision|0
7387379|NCT01214629|11645859|FG002|Overall Study|Physician Decision|0
7387380|NCT01214629|11645860|FG003|Overall Study|Physician Decision|0
7387381|NCT01214629|11645861|FG004|Overall Study|Physician Decision|0
7387382|NCT01214629|11645862|FG005|Overall Study|Physician Decision|0
7387383|NCT01214629|11645863|FG006|Overall Study|Physician Decision|0
7387384|NCT01214629|11645864|FG007|Overall Study|Physician Decision|0
7387385|NCT01214629|11645865|FG008|Overall Study|Physician Decision|0
7387386|NCT01214629|11645866|FG009|Overall Study|Physician Decision|0
7387387|NCT01214629|11645867|FG010|Overall Study|Physician Decision|1
7387388|NCT01214629|11645857|FG000|Overall Study|Withdrawal by Subject|0
7387389|NCT01214629|11645858|FG001|Overall Study|Withdrawal by Subject|0
7387390|NCT01214629|11645859|FG002|Overall Study|Withdrawal by Subject|0
7387391|NCT01214629|11645860|FG003|Overall Study|Withdrawal by Subject|0
7387392|NCT01214629|11645861|FG004|Overall Study|Withdrawal by Subject|0
7387393|NCT01214629|11645862|FG005|Overall Study|Withdrawal by Subject|0
7387394|NCT01214629|11645863|FG006|Overall Study|Withdrawal by Subject|0
7387395|NCT01214629|11645864|FG007|Overall Study|Withdrawal by Subject|0
7387396|NCT01214629|11645865|FG008|Overall Study|Withdrawal by Subject|0
7387397|NCT01214629|11645866|FG009|Overall Study|Withdrawal by Subject|1
7387398|NCT01214629|11645867|FG010|Overall Study|Withdrawal by Subject|0
7387399|NCT01214642|11645917|FG000|Overall Study|Progressive Disease|3
7387400|NCT01214642|11645918|FG001|Overall Study|Progressive Disease|2
7387401|NCT01214642|11645919|FG002|Overall Study|Progressive Disease|3
7387402|NCT01214642|11645920|FG003|Overall Study|Progressive Disease|5
7387403|NCT01214642|11645921|FG004|Overall Study|Progressive Disease|5
7387404|NCT01214642|11645922|FG005|Overall Study|Progressive Disease|3
7387405|NCT01214642|11645923|FG006|Overall Study|Progressive Disease|5
7387406|NCT01214642|11645924|FG007|Overall Study|Progressive Disease|3
7387407|NCT01214642|11645925|FG008|Overall Study|Progressive Disease|10
7387408|NCT01214642|11645926|FG009|Overall Study|Progressive Disease|2
7387409|NCT01214642|11645927|FG010|Overall Study|Progressive Disease|1
7387410|NCT01214642|11645928|FG011|Overall Study|Progressive Disease|4
7387411|NCT01214642|11645917|FG000|Overall Study|Adverse Event|0
7387412|NCT01214642|11645918|FG001|Overall Study|Adverse Event|1
7387413|NCT01214642|11645919|FG002|Overall Study|Adverse Event|0
7387414|NCT01214642|11645920|FG003|Overall Study|Adverse Event|0
7387415|NCT01214642|11645921|FG004|Overall Study|Adverse Event|0
7387416|NCT01214642|11645922|FG005|Overall Study|Adverse Event|0
7387417|NCT01214642|11645923|FG006|Overall Study|Adverse Event|1
7387418|NCT01214642|11645924|FG007|Overall Study|Adverse Event|0
7387419|NCT01214642|11645925|FG008|Overall Study|Adverse Event|0
7387420|NCT01214642|11645926|FG009|Overall Study|Adverse Event|1
7387421|NCT01214642|11645927|FG010|Overall Study|Adverse Event|1
7387422|NCT01214642|11645928|FG011|Overall Study|Adverse Event|0
7387423|NCT01214642|11645917|FG000|Overall Study|Death|0
7387424|NCT01214642|11645918|FG001|Overall Study|Death|0
7387425|NCT01214642|11645919|FG002|Overall Study|Death|1
7387426|NCT01214642|11645920|FG003|Overall Study|Death|0
7387427|NCT01214642|11645921|FG004|Overall Study|Death|0
7387428|NCT01214642|11645922|FG005|Overall Study|Death|0
7387429|NCT01214642|11645923|FG006|Overall Study|Death|0
7387430|NCT01214642|11645924|FG007|Overall Study|Death|0
7387431|NCT01214642|11645925|FG008|Overall Study|Death|0
7387432|NCT01214642|11645926|FG009|Overall Study|Death|0
7387433|NCT01214642|11645927|FG010|Overall Study|Death|1
7387434|NCT01214642|11645928|FG011|Overall Study|Death|0
7387435|NCT01214642|11645917|FG000|Overall Study|Withdrawal by Subject|0
7387436|NCT01214642|11645918|FG001|Overall Study|Withdrawal by Subject|0
7387437|NCT01214642|11645919|FG002|Overall Study|Withdrawal by Subject|1
7387438|NCT01214642|11645920|FG003|Overall Study|Withdrawal by Subject|0
7387439|NCT01214642|11645921|FG004|Overall Study|Withdrawal by Subject|0
7381995|NCT01179477|11638624|FG000|Overall Study|Death|542
7381996|NCT01179477|11638624|FG000|Overall Study|Unsuccessful implant|80
7381997|NCT01179477|11638624|FG000|Overall Study|Non-death withdrawal|438
7381998|NCT01179477|11638624|FG000|Overall Study|Did not complete final visit|27
7381999|NCT01179516|11638635|FG000|Overall Study|Pretreatment Event or Adverse Event|6
7382000|NCT01179516|11638636|FG001|Overall Study|Pretreatment Event or Adverse Event|8
7382001|NCT01179516|11638637|FG002|Overall Study|Pretreatment Event or Adverse Event|12
7382002|NCT01179516|11638635|FG000|Overall Study|Lack of Efficacy|4
7382003|NCT01179516|11638636|FG001|Overall Study|Lack of Efficacy|2
7382004|NCT01179516|11638637|FG002|Overall Study|Lack of Efficacy|0
7382005|NCT01179516|11638635|FG000|Overall Study|Noncompliance with Study Drug|2
7382006|NCT01179516|11638636|FG001|Overall Study|Noncompliance with Study Drug|0
7382007|NCT01179516|11638637|FG002|Overall Study|Noncompliance with Study Drug|1
7382008|NCT01179516|11638635|FG000|Overall Study|Protocol Deviations|4
7382009|NCT01179516|11638636|FG001|Overall Study|Protocol Deviations|3
7382010|NCT01179516|11638637|FG002|Overall Study|Protocol Deviations|3
7382011|NCT01179516|11638635|FG000|Overall Study|Withdrawal of Consent|2
7382012|NCT01179516|11638636|FG001|Overall Study|Withdrawal of Consent|6
7382013|NCT01179516|11638637|FG002|Overall Study|Withdrawal of Consent|10
7462374|NCT01850030|11759560|FG001|Overall Study|Lost to Follow-up|5
7462375|NCT01850030|11759559|FG000|Overall Study|Withdrawal by Subject|3
7462376|NCT01850030|11759560|FG001|Overall Study|Withdrawal by Subject|4
7462377|NCT01850030|11759559|FG000|Overall Study|Protocol Violation|24
7462378|NCT01850030|11759560|FG001|Overall Study|Protocol Violation|28
7462379|NCT01850030|11759559|FG000|Overall Study|pregnancy not confirmed at visit 4|248
7462380|NCT01850030|11759560|FG001|Overall Study|pregnancy not confirmed at visit 4|249
7462381|NCT01850446|11759581|FG000|Overall Study|Lack of Efficacy|1
7382014|NCT01179516|11638635|FG000|Overall Study|Lost to Follow-up|7
7382015|NCT01179516|11638636|FG001|Overall Study|Lost to Follow-up|7
7382016|NCT01179516|11638637|FG002|Overall Study|Lost to Follow-up|3
7382017|NCT01179516|11638635|FG000|Overall Study|Other|2
7382018|NCT01179516|11638636|FG001|Overall Study|Other|0
7382019|NCT01179516|11638637|FG002|Overall Study|Other|2
7382020|NCT01179672|11638667|FG000|Overall Study|Adverse Event|17
7382021|NCT01179672|11638668|FG001|Overall Study|Adverse Event|8
7382022|NCT01179672|11638667|FG000|Overall Study|Withdrawal by Subject|10
7382023|NCT01179672|11638668|FG001|Overall Study|Withdrawal by Subject|12
7382024|NCT01179672|11638667|FG000|Overall Study|Entry Criteria Not Met|0
7382025|NCT01179672|11638668|FG001|Overall Study|Entry Criteria Not Met|2
7382026|NCT01179672|11638667|FG000|Overall Study|Lost to Follow-up|0
7382027|NCT01179672|11638668|FG001|Overall Study|Lost to Follow-up|1
7382028|NCT01179672|11638667|FG000|Overall Study|Protocol Violation|2
7382029|NCT01179672|11638668|FG001|Overall Study|Protocol Violation|2
7382030|NCT01179672|11638667|FG000|Overall Study|Physician Decision|1
7382031|NCT01179672|11638668|FG001|Overall Study|Physician Decision|1
7382032|NCT01179919|11638678|FG000|Overall Study|Protocol Violation|1
7382033|NCT01179919|11638678|FG000|Overall Study|Adverse Event|1
7382034|NCT01180049|11638700|FG000|Overall Study|Other|9
7382035|NCT01180049|11638701|FG001|Overall Study|Other|7
7382036|NCT01180049|11638700|FG000|Overall Study|Lost to Follow-up|8
7382037|NCT01180049|11638701|FG001|Overall Study|Lost to Follow-up|6
7382038|NCT01180049|11638700|FG000|Overall Study|Death|36
7382039|NCT01180049|11638701|FG001|Overall Study|Death|35
7382040|NCT01180244|11638730|FG000|Overall Study|Lack of Efficacy|0
7382041|NCT01180244|11638731|FG001|Overall Study|Lack of Efficacy|7
7382042|NCT01180244|11638730|FG000|Overall Study|Physician Decision|3
7382043|NCT01180244|11638731|FG001|Overall Study|Physician Decision|0
7382044|NCT01180244|11638730|FG000|Overall Study|Adverse Event|1
7382045|NCT01180244|11638731|FG001|Overall Study|Adverse Event|0
7382046|NCT01180244|11638730|FG000|Overall Study|Withdrawal by Subject|0
7382047|NCT01180244|11638731|FG001|Overall Study|Withdrawal by Subject|1
7382048|NCT01180244|11638730|FG000|Overall Study|Protocol Violation|1
7382049|NCT01180244|11638731|FG001|Overall Study|Protocol Violation|0
7382050|NCT01180244|11638730|FG000|Overall Study|Lost to Follow-up|1
7382051|NCT01180244|11638731|FG001|Overall Study|Lost to Follow-up|0
7382052|NCT01180296|11638739|FG000|Overall Study|Protocol Violation|1
7382053|NCT01180296|11638740|FG001|Overall Study|Protocol Violation|2
7382054|NCT01180400|11638750|FG000|Overall Study|Withdrawal by Subject|5
7382055|NCT01180400|11638751|FG001|Overall Study|Withdrawal by Subject|6
7382056|NCT01180400|11638750|FG000|Overall Study|Eligibility criteria not fulfilled|0
7382057|NCT01180400|11638751|FG001|Overall Study|Eligibility criteria not fulfilled|2
7382058|NCT01180400|11638750|FG000|Overall Study|Adverse Event|12
7382059|NCT01180400|11638751|FG001|Overall Study|Adverse Event|10
7382060|NCT01180400|11638750|FG000|Overall Study|Severe non-compliance to protocol|1
7382061|NCT01180400|11638751|FG001|Overall Study|Severe non-compliance to protocol|2
7382062|NCT01180400|11638750|FG000|Overall Study|Condition under investigation worsened|2
7382063|NCT01180400|11638751|FG001|Overall Study|Condition under investigation worsened|1
7382064|NCT01180400|11638750|FG000|Overall Study|Lack of Efficacy|2
7382065|NCT01180400|11638751|FG001|Overall Study|Lack of Efficacy|0
7382066|NCT01180400|11638750|FG000|Overall Study|Study-specific withdrawal criteria|1
7382067|NCT01180400|11638751|FG001|Overall Study|Study-specific withdrawal criteria|2
7382068|NCT01180400|11638750|FG000|Overall Study|Lost to Follow-up|2
7382069|NCT01180400|11638751|FG001|Overall Study|Lost to Follow-up|3
7382070|NCT01180400|11638750|FG000|Overall Study|Other|0
7382071|NCT01180400|11638751|FG001|Overall Study|Other|1
7382072|NCT01180647|11638770|FG000|Overall Study|Lost to Follow-up|5
7382073|NCT01180647|11638771|FG001|Overall Study|Lost to Follow-up|6
7382074|NCT01180660|11638779|FG000|Overall Study|Changed to open surgery|1
7382075|NCT01180660|11638780|FG001|Overall Study|Changed to open surgery|0
7382076|NCT01180777|11638786|FG000|Overall Study|Protocol Violation|6
7382077|NCT01180777|11638786|FG000|Overall Study|Poor lens fit|4
7382078|NCT01180777|11638786|FG000|Overall Study|Lost to Follow-up|1
7382079|NCT01180777|11638786|FG000|Overall Study|Adverse Event|1
7382080|NCT01180790|11638799|FG000|Overall Study|Adverse Event|1
7382081|NCT01180790|11638800|FG001|Overall Study|Adverse Event|1
7382082|NCT01180790|11638801|FG002|Overall Study|Adverse Event|2
7382083|NCT01180790|11638802|FG003|Overall Study|Adverse Event|0
7382084|NCT01180790|11638803|FG004|Overall Study|Adverse Event|1
7382085|NCT01180790|11638804|FG005|Overall Study|Adverse Event|3
7382086|NCT01180790|11638805|FG006|Overall Study|Adverse Event|0
7382087|NCT01180790|11638799|FG000|Overall Study|Withdrawal by Subject|3
7382088|NCT01180790|11638800|FG001|Overall Study|Withdrawal by Subject|0
7382089|NCT01180790|11638801|FG002|Overall Study|Withdrawal by Subject|5
7382090|NCT01180790|11638802|FG003|Overall Study|Withdrawal by Subject|0
7382091|NCT01180790|11638803|FG004|Overall Study|Withdrawal by Subject|2
7382092|NCT01180790|11638804|FG005|Overall Study|Withdrawal by Subject|1
7382093|NCT01180790|11638805|FG006|Overall Study|Withdrawal by Subject|0
7382094|NCT01180790|11638799|FG000|Overall Study|Lost to Follow-up|3
7382095|NCT01180790|11638800|FG001|Overall Study|Lost to Follow-up|1
7382096|NCT01180790|11638801|FG002|Overall Study|Lost to Follow-up|0
7382097|NCT01180790|11638802|FG003|Overall Study|Lost to Follow-up|2
7382098|NCT01180790|11638803|FG004|Overall Study|Lost to Follow-up|1
7382099|NCT01180790|11638804|FG005|Overall Study|Lost to Follow-up|0
7382100|NCT01180790|11638805|FG006|Overall Study|Lost to Follow-up|1
7382101|NCT01180790|11638799|FG000|Overall Study|Physician Decision|1
7382102|NCT01180790|11638800|FG001|Overall Study|Physician Decision|0
7382103|NCT01180790|11638801|FG002|Overall Study|Physician Decision|0
7382104|NCT01180790|11638802|FG003|Overall Study|Physician Decision|1
7382105|NCT01180790|11638803|FG004|Overall Study|Physician Decision|0
7382106|NCT01180790|11638804|FG005|Overall Study|Physician Decision|0
7382107|NCT01180790|11638805|FG006|Overall Study|Physician Decision|0
7382108|NCT01180790|11638799|FG000|Overall Study|Lack of Efficacy|1
7382109|NCT01180790|11638800|FG001|Overall Study|Lack of Efficacy|2
7382110|NCT01180790|11638801|FG002|Overall Study|Lack of Efficacy|5
7382111|NCT01180790|11638802|FG003|Overall Study|Lack of Efficacy|6
7382112|NCT01180790|11638803|FG004|Overall Study|Lack of Efficacy|1
7382113|NCT01180790|11638804|FG005|Overall Study|Lack of Efficacy|3
7382114|NCT01180790|11638805|FG006|Overall Study|Lack of Efficacy|0
7382115|NCT01180790|11638799|FG000|Overall Study|compliance|0
7382116|NCT01180790|11638800|FG001|Overall Study|compliance|1
7382117|NCT01180790|11638801|FG002|Overall Study|compliance|0
7382118|NCT01180790|11638802|FG003|Overall Study|compliance|0
7382119|NCT01180790|11638803|FG004|Overall Study|compliance|0
7382120|NCT01180790|11638804|FG005|Overall Study|compliance|0
7382121|NCT01180790|11638805|FG006|Overall Study|compliance|0
7382122|NCT01180790|11638799|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
7382123|NCT01180790|11638800|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
7382124|NCT01180790|11638801|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
7382125|NCT01180790|11638802|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
7382126|NCT01180790|11638803|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
7382127|NCT01180790|11638804|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
7382128|NCT01180790|11638805|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
7382129|NCT01180985|11638860|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
7382130|NCT01180985|11638861|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
7382131|NCT01180998|11638871|FG000|Overall Study|Poor Vision|0
7382132|NCT01180998|11638872|FG001|Overall Study|Poor Vision|2
7382133|NCT01180998|11638873|FG002|Overall Study|Poor Vision|2
7382134|NCT01180998|11638871|FG000|Overall Study|Lost to Follow-up|0
7382135|NCT01180998|11638872|FG001|Overall Study|Lost to Follow-up|0
7382136|NCT01180998|11638873|FG002|Overall Study|Lost to Follow-up|1
7382137|NCT01180998|11638871|FG000|Overall Study|Protocol Violation|1
7382138|NCT01180998|11638872|FG001|Overall Study|Protocol Violation|2
7382139|NCT01180998|11638873|FG002|Overall Study|Protocol Violation|0
7382140|NCT01180998|11638871|FG000|Overall Study|Withdrawal by Subject|0
7382141|NCT01180998|11638872|FG001|Overall Study|Withdrawal by Subject|0
7382142|NCT01180998|11638873|FG002|Overall Study|Withdrawal by Subject|1
7382143|NCT01180998|11638871|FG000|Overall Study|Poor comfort|3
7382144|NCT01180998|11638872|FG001|Overall Study|Poor comfort|0
7382145|NCT01180998|11638873|FG002|Overall Study|Poor comfort|4
7382146|NCT01180998|11638871|FG000|Overall Study|Poor lens handling|0
7382147|NCT01180998|11638872|FG001|Overall Study|Poor lens handling|0
7382148|NCT01180998|11638873|FG002|Overall Study|Poor lens handling|2
7382149|NCT01181011|11638882|FG000|Overall Study|Adverse Event|2
7382150|NCT01181011|11638882|FG000|Overall Study|Lost to Follow-up|1
7382151|NCT01181102|11638911|FG000|Overall Study|Adverse Event|28
7382152|NCT01181102|11638912|FG001|Overall Study|Adverse Event|26
7382153|NCT01181102|11638911|FG000|Overall Study|Lack of Efficacy|3
7462382|NCT01850446|11759582|FG001|Overall Study|Lack of Efficacy|0
7382154|NCT01181102|11638912|FG001|Overall Study|Lack of Efficacy|1
7382155|NCT01181102|11638911|FG000|Overall Study|Lost to Follow-up|2
7382156|NCT01181102|11638912|FG001|Overall Study|Lost to Follow-up|0
7382157|NCT01181102|11638911|FG000|Overall Study|Physician Decision|3
7382158|NCT01181102|11638912|FG001|Overall Study|Physician Decision|1
7382159|NCT01181102|11638911|FG000|Overall Study|Protocol Violation|5
7382160|NCT01181102|11638912|FG001|Overall Study|Protocol Violation|6
7382161|NCT01181102|11638911|FG000|Overall Study|Withdrawal by Subject|10
7382162|NCT01181102|11638912|FG001|Overall Study|Withdrawal by Subject|12
7382163|NCT01181128|11638921|FG000|Overall Study|Withdrawal by Subject|2
7382164|NCT01181128|11638922|FG001|Overall Study|Withdrawal by Subject|2
7382165|NCT01181128|11638923|FG002|Overall Study|Withdrawal by Subject|0
7382166|NCT01181128|11638921|FG000|Overall Study|Death|1
7382167|NCT01181128|11638922|FG001|Overall Study|Death|0
7382168|NCT01181128|11638923|FG002|Overall Study|Death|0
7382169|NCT01181128|11638921|FG000|Overall Study|Physician Decision|2
7382170|NCT01181128|11638922|FG001|Overall Study|Physician Decision|0
7382171|NCT01181128|11638923|FG002|Overall Study|Physician Decision|0
7382172|NCT01181128|11638921|FG000|Overall Study|Adverse Event|0
7382173|NCT01181128|11638922|FG001|Overall Study|Adverse Event|2
7382174|NCT01181128|11638923|FG002|Overall Study|Adverse Event|0
7382175|NCT01181128|11638921|FG000|Overall Study|Other|1
7382176|NCT01181128|11638922|FG001|Overall Study|Other|1
7382177|NCT01181128|11638923|FG002|Overall Study|Other|1
7382178|NCT01181141|11638945|FG000|Overall Study|Adverse Event|2
7382179|NCT01181141|11638946|FG001|Overall Study|Adverse Event|1
7382180|NCT01181141|11638945|FG000|Overall Study|Lack of Efficacy|1
7382181|NCT01181141|11638946|FG001|Overall Study|Lack of Efficacy|0
7382182|NCT01181141|11638945|FG000|Overall Study|Lost to Follow-up|1
7382183|NCT01181141|11638946|FG001|Overall Study|Lost to Follow-up|1
7382184|NCT01181141|11638945|FG000|Overall Study|Physician Decision|2
7382185|NCT01181141|11638946|FG001|Overall Study|Physician Decision|0
7382186|NCT01181141|11638945|FG000|Overall Study|Protocol Violation|3
7382187|NCT01181141|11638946|FG001|Overall Study|Protocol Violation|1
7382188|NCT01181141|11638945|FG000|Overall Study|Withdrawal by Subject|3
7382189|NCT01181141|11638946|FG001|Overall Study|Withdrawal by Subject|1
7382190|NCT01181167|11638954|FG000|Overall Study|Adverse Event|11
7382191|NCT01181167|11638955|FG001|Overall Study|Adverse Event|21
7382192|NCT01181167|11638954|FG000|Overall Study|Lost to Follow-up|1
7382193|NCT01181167|11638955|FG001|Overall Study|Lost to Follow-up|0
7382194|NCT01181167|11638954|FG000|Overall Study|Physician Decision|2
7382195|NCT01181167|11638955|FG001|Overall Study|Physician Decision|3
7570868|NCT03513588|11949364|FG002|Overall Study|Death|1
7570869|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
7570870|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
7570871|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
7570872|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
7570873|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Adverse Event|5
7570874|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Adverse Event|2
7382196|NCT01181167|11638954|FG000|Overall Study|Protocol Violation|3
7382197|NCT01181167|11638955|FG001|Overall Study|Protocol Violation|0
7382198|NCT01181167|11638954|FG000|Overall Study|Withdrawal by Subject|6
7382199|NCT01181167|11638955|FG001|Overall Study|Withdrawal by Subject|8
7382200|NCT01181271|11638965|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
7382201|NCT01181271|11638965|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
7382202|NCT01181271|11638965|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
7382203|NCT01181271|11638965|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
7382204|NCT01181531|11639035|FG000|Overall Study|Other|17
7382205|NCT01181531|11639036|FG001|Overall Study|Other|12
7382206|NCT01181531|11639035|FG000|Overall Study|Partial consent by subject withdrawn|0
7382207|NCT01181531|11639036|FG001|Overall Study|Partial consent by subject withdrawn|1
7382208|NCT01181531|11639035|FG000|Overall Study|Physician Decision|3
7382209|NCT01181531|11639036|FG001|Overall Study|Physician Decision|1
7382210|NCT01181531|11639035|FG000|Overall Study|Noncompliance|2
7382211|NCT01181531|11639036|FG001|Overall Study|Noncompliance|2
7382212|NCT01181531|11639035|FG000|Overall Study|Ineligibility determined|1
7382213|NCT01181531|11639036|FG001|Overall Study|Ineligibility determined|2
7382214|NCT01181531|11639035|FG000|Overall Study|Protocol Specified Criteria|15
7382215|NCT01181531|11639036|FG001|Overall Study|Protocol Specified Criteria|8
7382216|NCT01181531|11639035|FG000|Overall Study|Pregnancy|0
7382217|NCT01181531|11639036|FG001|Overall Study|Pregnancy|1
7462383|NCT01850446|11759581|FG000|Overall Study|Withdrawal by Subject|4
7570875|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Adverse Event|0
7382218|NCT01181531|11639035|FG000|Overall Study|Withdrawal by Subject|8
7570876|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Adverse Event|0
7382219|NCT01181531|11639036|FG001|Overall Study|Withdrawal by Subject|7
7382220|NCT01181531|11639035|FG000|Overall Study|Protocol Violation|6
7382221|NCT01181531|11639036|FG001|Overall Study|Protocol Violation|6
7382222|NCT01181531|11639035|FG000|Overall Study|Death|9
7382223|NCT01181531|11639036|FG001|Overall Study|Death|12
7382224|NCT01181531|11639035|FG000|Overall Study|Adverse Event|0
7382225|NCT01181531|11639036|FG001|Overall Study|Adverse Event|1
7382226|NCT01181609|11639047|FG000|Overall Study|Adverse Event|1
7382227|NCT01181609|11639047|FG000|Overall Study|Withdrawal by Subject|1
7382228|NCT01181609|11639047|FG000|Overall Study|Lost to Follow-up|1
7382229|NCT01181609|11639047|FG000|Overall Study|Death|50
7382230|NCT01181726|11639066|FG000|First Intervention|Adverse Event|1
7382231|NCT01181726|11639067|FG001|First Intervention|Adverse Event|0
7382232|NCT01181895|11639093|FG000|Overall Study|Adverse Event|3
7382233|NCT01181895|11639094|FG001|Overall Study|Adverse Event|1
7382234|NCT01181895|11639095|FG002|Overall Study|Adverse Event|1
7382235|NCT01181895|11639093|FG000|Overall Study|Lack of Efficacy|8
7382236|NCT01181895|11639094|FG001|Overall Study|Lack of Efficacy|9
7382237|NCT01181895|11639095|FG002|Overall Study|Lack of Efficacy|9
7382238|NCT01181895|11639093|FG000|Overall Study|Protocol Violation|2
7382239|NCT01181895|11639094|FG001|Overall Study|Protocol Violation|1
7382240|NCT01181895|11639095|FG002|Overall Study|Protocol Violation|0
7382241|NCT01181895|11639093|FG000|Overall Study|Lost to Follow-up|0
7382242|NCT01181895|11639094|FG001|Overall Study|Lost to Follow-up|1
7382243|NCT01181895|11639095|FG002|Overall Study|Lost to Follow-up|2
7382244|NCT01181895|11639093|FG000|Overall Study|Investigator Discretion|1
7382245|NCT01181895|11639094|FG001|Overall Study|Investigator Discretion|2
7382246|NCT01181895|11639095|FG002|Overall Study|Investigator Discretion|1
7382247|NCT01181895|11639093|FG000|Overall Study|Withdrawal by Subject|3
7382248|NCT01181895|11639094|FG001|Overall Study|Withdrawal by Subject|0
7382249|NCT01181895|11639095|FG002|Overall Study|Withdrawal by Subject|5
7382250|NCT01181986|11639110|FG000|Phase 1|Lost to Follow-up|0
7382251|NCT01181986|11639111|FG001|Phase 1|Lost to Follow-up|1
7382252|NCT01181986|11639112|FG002|Phase 1|Lost to Follow-up|1
7382253|NCT01181986|11639110|FG000|Phase 1|Adverse Event|0
7382254|NCT01181986|11639111|FG001|Phase 1|Adverse Event|0
7382255|NCT01181986|11639112|FG002|Phase 1|Adverse Event|1
7382256|NCT01181986|11639110|FG000|Phase 1|Protocol Violation|1
7382257|NCT01181986|11639111|FG001|Phase 1|Protocol Violation|0
7382258|NCT01181986|11639112|FG002|Phase 1|Protocol Violation|0
7382259|NCT01181986|11639110|FG000|Phase 2|Adverse Event|0
7382260|NCT01181986|11639111|FG001|Phase 2|Adverse Event|3
7382261|NCT01181986|11639112|FG002|Phase 2|Adverse Event|0
7382262|NCT01181986|11639110|FG000|Phase 2|Medical condition|0
7382263|NCT01181986|11639111|FG001|Phase 2|Medical condition|1
7382264|NCT01181986|11639112|FG002|Phase 2|Medical condition|0
7382265|NCT01182181|11639140|FG000|First Intervention|Adverse Event|1
7382266|NCT01182181|11639141|FG001|First Intervention|Adverse Event|0
7382267|NCT01182181|11639140|FG000|Washout of 21 Days|Withdrawal by Subject|0
7382268|NCT01182181|11639141|FG001|Washout of 21 Days|Withdrawal by Subject|1
7382269|NCT01182194|11639149|FG000|Washout of 28 Days|Withdrawal by Subject|1
7382270|NCT01182194|11639150|FG001|Washout of 28 Days|Withdrawal by Subject|0
7382271|NCT01182207|11639158|FG000|First Intervention|Positive Hepatitis Results|0
7382272|NCT01182207|11639159|FG001|First Intervention|Positive Hepatitis Results|1
7382273|NCT01182207|11639158|FG000|Second Intervention|Emeses within 1 hour of dosing|1
7382274|NCT01182207|11639159|FG001|Second Intervention|Emeses within 1 hour of dosing|0
7382275|NCT01182285|11639165|FG000|First Intervention Week 1-10|Disease progression|1
7382276|NCT01182285|11639166|FG001|First Intervention Week 1-10|Disease progression|0
7382277|NCT01182285|11639167|FG002|First Intervention Week 1-10|Disease progression|0
7382278|NCT01182285|11639165|FG000|First Intervention Week 1-10|Adverse Event|1
7382279|NCT01182285|11639166|FG001|First Intervention Week 1-10|Adverse Event|0
7382280|NCT01182285|11639167|FG002|First Intervention Week 1-10|Adverse Event|0
7382281|NCT01182285|11639165|FG000|First Intervention Week 1-10|Non-compliance|1
7382282|NCT01182285|11639166|FG001|First Intervention Week 1-10|Non-compliance|0
7382283|NCT01182285|11639167|FG002|First Intervention Week 1-10|Non-compliance|0
7382284|NCT01182285|11639165|FG000|Third Intervention Week 11-52|Disease Progression|0
7382285|NCT01182285|11639166|FG001|Third Intervention Week 11-52|Disease Progression|0
7382286|NCT01182285|11639167|FG002|Third Intervention Week 11-52|Disease Progression|6
7382287|NCT01182285|11639165|FG000|Third Intervention Week 11-52|Other|0
7382288|NCT01182285|11639166|FG001|Third Intervention Week 11-52|Other|0
7382289|NCT01182285|11639167|FG002|Third Intervention Week 11-52|Other|2
7382290|NCT01182298|11639174|FG000|Overall Study|Lack of Efficacy|4
7382291|NCT01182298|11639174|FG000|Overall Study|Withdrawal by Subject|2
7382292|NCT01182337|11639180|FG000|Overall Study|Withdrawal by Subject|3
7382293|NCT01182337|11639181|FG001|Overall Study|Withdrawal by Subject|1
7382294|NCT01182337|11639180|FG000|Overall Study|Lost to Follow-up|0
7382295|NCT01182337|11639181|FG001|Overall Study|Lost to Follow-up|1
7382296|NCT01182350|11639188|FG000|Overall Study|Adverse Event|5
7382297|NCT01182350|11639189|FG001|Overall Study|Adverse Event|0
7382298|NCT01182350|11639190|FG002|Overall Study|Adverse Event|0
7382299|NCT01182350|11639191|FG003|Overall Study|Adverse Event|0
7382300|NCT01182350|11639192|FG004|Overall Study|Adverse Event|0
7382301|NCT01182350|11639188|FG000|Overall Study|Disease Progression|15
7382302|NCT01182350|11639189|FG001|Overall Study|Disease Progression|12
7382303|NCT01182350|11639190|FG002|Overall Study|Disease Progression|0
7382304|NCT01182350|11639191|FG003|Overall Study|Disease Progression|1
7382305|NCT01182350|11639192|FG004|Overall Study|Disease Progression|0
7382306|NCT01182350|11639188|FG000|Overall Study|Death|0
7382307|NCT01182350|11639189|FG001|Overall Study|Death|1
7382308|NCT01182350|11639190|FG002|Overall Study|Death|1
7382309|NCT01182350|11639191|FG003|Overall Study|Death|0
7382310|NCT01182350|11639192|FG004|Overall Study|Death|0
7382311|NCT01182350|11639188|FG000|Overall Study|Withdrawal by Subject|3
7382312|NCT01182350|11639189|FG001|Overall Study|Withdrawal by Subject|1
7382313|NCT01182350|11639190|FG002|Overall Study|Withdrawal by Subject|0
7382314|NCT01182350|11639191|FG003|Overall Study|Withdrawal by Subject|1
7382315|NCT01182350|11639192|FG004|Overall Study|Withdrawal by Subject|0
7382316|NCT01182350|11639188|FG000|Overall Study|Alternative Therapy|2
7382317|NCT01182350|11639189|FG001|Overall Study|Alternative Therapy|0
7382318|NCT01182350|11639190|FG002|Overall Study|Alternative Therapy|1
7382319|NCT01182350|11639191|FG003|Overall Study|Alternative Therapy|0
7382320|NCT01182350|11639192|FG004|Overall Study|Alternative Therapy|0
7382321|NCT01182350|11639188|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
7382322|NCT01182350|11639189|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
7462384|NCT01850446|11759582|FG001|Overall Study|Withdrawal by Subject|0
7462385|NCT01850446|11759581|FG000|Overall Study|Protocol Violation|0
7462386|NCT01850446|11759582|FG001|Overall Study|Protocol Violation|2
7462387|NCT01850589|11759608|FG000|Overall Study|Withdrawal by Subject|8
7462388|NCT01850589|11759609|FG001|Overall Study|Withdrawal by Subject|0
7462389|NCT01850602|11759617|FG000|Overall Study|Adverse Event|7
7462390|NCT01850602|11759618|FG001|Overall Study|Adverse Event|10
7462391|NCT01850602|11759617|FG000|Overall Study|Physician Decision|2
7462392|NCT01850602|11759618|FG001|Overall Study|Physician Decision|1
7462393|NCT01850602|11759617|FG000|Overall Study|Withdrawal by Subject|2
7462394|NCT01850602|11759618|FG001|Overall Study|Withdrawal by Subject|4
7462395|NCT01850602|11759617|FG000|Overall Study|Decrease in serum calcium|2
7462396|NCT01850602|11759618|FG001|Overall Study|Decrease in serum calcium|3
7462397|NCT01850602|11759617|FG000|Overall Study|Increase in serum ferritin|1
7462398|NCT01850602|11759618|FG001|Overall Study|Increase in serum ferritin|0
7462399|NCT01850615|11759626|FG000|Overall Study|Protocol Violation|4
7462400|NCT01850615|11759627|FG001|Overall Study|Protocol Violation|1
7462401|NCT01850615|11759626|FG000|Overall Study|Adverse Event|2
7462402|NCT01850615|11759627|FG001|Overall Study|Adverse Event|1
7462403|NCT01850615|11759626|FG000|Overall Study|Withdrawal by Subject|3
7462404|NCT01850615|11759627|FG001|Overall Study|Withdrawal by Subject|1
7462405|NCT01850615|11759626|FG000|Overall Study|Lost to Follow-up|0
7462406|NCT01850615|11759627|FG001|Overall Study|Lost to Follow-up|1
7462407|NCT01850615|11759626|FG000|Overall Study|Unclassified|0
7462408|NCT01850615|11759627|FG001|Overall Study|Unclassified|1
7462409|NCT01850641|11759633|FG000|Overall Study|Physician Decision|1
7462410|NCT01850641|11759633|FG000|Overall Study|Decrease in serum phosphorus|1
7462411|NCT01850641|11759633|FG000|Overall Study|Decrease in serum calcium|2
7462412|NCT01850641|11759633|FG000|Overall Study|Increase in serum ferritin|1
7462413|NCT01850823|11759653|FG000|Overall Study|Early Visit Window|0
7462414|NCT01850823|11759654|FG001|Overall Study|Early Visit Window|1
7462415|NCT01850823|11759655|FG002|Overall Study|Early Visit Window|4
7462416|NCT01850823|11759653|FG000|Overall Study|Enrolled in Error|0
7462417|NCT01850823|11759654|FG001|Overall Study|Enrolled in Error|1
7462418|NCT01850823|11759655|FG002|Overall Study|Enrolled in Error|2
7462419|NCT01850823|11759653|FG000|Overall Study|Lack of Efficacy|1
7462420|NCT01850823|11759654|FG001|Overall Study|Lack of Efficacy|0
7462421|NCT01850823|11759655|FG002|Overall Study|Lack of Efficacy|0
7462422|NCT01850823|11759653|FG000|Overall Study|Lost to Follow-up|0
7462423|NCT01850823|11759654|FG001|Overall Study|Lost to Follow-up|0
7462424|NCT01850823|11759655|FG002|Overall Study|Lost to Follow-up|1
7462425|NCT01850823|11759653|FG000|Overall Study|Restricted Medication|0
7462426|NCT01850823|11759654|FG001|Overall Study|Restricted Medication|0
7462427|NCT01850823|11759655|FG002|Overall Study|Restricted Medication|2
7462428|NCT01850823|11759653|FG000|Overall Study|Significant worstening of SAR|0
7462429|NCT01850823|11759654|FG001|Overall Study|Significant worstening of SAR|1
7462430|NCT01850823|11759655|FG002|Overall Study|Significant worstening of SAR|0
7462431|NCT01850823|11759653|FG000|Overall Study|Withdrawal by Subject|2
7462432|NCT01850823|11759654|FG001|Overall Study|Withdrawal by Subject|0
7462433|NCT01850823|11759655|FG002|Overall Study|Withdrawal by Subject|1
7462434|NCT01851330|11759668|FG000|Overall Study|Lack of Efficacy|10
7462435|NCT01851330|11759669|FG001|Overall Study|Lack of Efficacy|9
7462436|NCT01851330|11759670|FG002|Overall Study|Lack of Efficacy|2
7462437|NCT01851330|11759668|FG000|Overall Study|Lost to Follow-up|1
7462438|NCT01851330|11759669|FG001|Overall Study|Lost to Follow-up|6
7462439|NCT01851330|11759670|FG002|Overall Study|Lost to Follow-up|9
7462440|NCT01851330|11759668|FG000|Overall Study|Withdrew Consent|2
7462441|NCT01851330|11759669|FG001|Overall Study|Withdrew Consent|1
7462442|NCT01851330|11759670|FG002|Overall Study|Withdrew Consent|0
7462443|NCT01851330|11759668|FG000|Overall Study|Investigator's Discretion|0
7462444|NCT01851330|11759669|FG001|Overall Study|Investigator's Discretion|0
7462445|NCT01851330|11759670|FG002|Overall Study|Investigator's Discretion|1
7462446|NCT01851590|11759681|FG000|Overall Study|Withdrawal by Subject|0
7462447|NCT01851590|11759682|FG001|Overall Study|Withdrawal by Subject|0
7462448|NCT01851590|11759683|FG002|Overall Study|Withdrawal by Subject|1
7462449|NCT01851590|11759681|FG000|Overall Study|Adverse Event|0
7462450|NCT01851590|11759682|FG001|Overall Study|Adverse Event|0
7462451|NCT01851590|11759683|FG002|Overall Study|Adverse Event|2
7462452|NCT01851590|11759681|FG000|Overall Study|Lack of Efficacy|0
7462453|NCT01851590|11759682|FG001|Overall Study|Lack of Efficacy|1
7462454|NCT01851590|11759683|FG002|Overall Study|Lack of Efficacy|0
7462455|NCT01851720|11759706|FG000|Overall Study|Lost to Follow-up|0
7462456|NCT01851720|11759707|FG001|Overall Study|Lost to Follow-up|1
7462457|NCT01851863|11759721|FG000|Overall Study|Did not receive study medication|2
7462458|NCT01851863|11759722|FG001|Overall Study|Did not receive study medication|5
7462459|NCT01851863|11759723|FG002|Overall Study|Did not receive study medication|3
7462460|NCT01851863|11759724|FG003|Overall Study|Did not receive study medication|0
7462461|NCT01851863|11759721|FG000|Overall Study|Lost to Follow-up|3
7462462|NCT01851863|11759722|FG001|Overall Study|Lost to Follow-up|4
7462463|NCT01851863|11759723|FG002|Overall Study|Lost to Follow-up|2
7462464|NCT01851863|11759724|FG003|Overall Study|Lost to Follow-up|3
7468455|NCT01911260|11769274|FG003|Follow-up Period|transference or evasion of school|12
7468456|NCT01911273|11769286|FG000|Overall Study|Progression of Disease|1
7468457|NCT01911273|11769287|FG001|Overall Study|Progression of Disease|0
7468458|NCT01911273|11769286|FG000|Overall Study|Withdrawal by Subject|0
7468459|NCT01911273|11769287|FG001|Overall Study|Withdrawal by Subject|2
7468460|NCT01911429|11769331|FG000|Overall Study|Adverse Event|5
7468461|NCT01911429|11769332|FG001|Overall Study|Adverse Event|3
7468462|NCT01911429|11769333|FG002|Overall Study|Adverse Event|9
7468463|NCT01911429|11769331|FG000|Overall Study|Lack of Efficacy|1
7468464|NCT01911429|11769332|FG001|Overall Study|Lack of Efficacy|2
7468465|NCT01911429|11769333|FG002|Overall Study|Lack of Efficacy|4
7468466|NCT01911429|11769331|FG000|Overall Study|Lost to Follow-up|0
7468467|NCT01911429|11769332|FG001|Overall Study|Lost to Follow-up|0
7468468|NCT01911429|11769333|FG002|Overall Study|Lost to Follow-up|1
7468469|NCT01911429|11769331|FG000|Overall Study|Protocol Violation|0
7468470|NCT01911429|11769332|FG001|Overall Study|Protocol Violation|0
7468471|NCT01911429|11769333|FG002|Overall Study|Protocol Violation|1
7468472|NCT01911429|11769331|FG000|Overall Study|Withdrawal by Subject|5
7468473|NCT01911429|11769332|FG001|Overall Study|Withdrawal by Subject|5
7468474|NCT01911429|11769333|FG002|Overall Study|Withdrawal by Subject|4
7468475|NCT01911429|11769331|FG000|Overall Study|Accidental randomization|0
7468476|NCT01911429|11769332|FG001|Overall Study|Accidental randomization|0
7468477|NCT01911429|11769333|FG002|Overall Study|Accidental randomization|1
7468478|NCT01911429|11769331|FG000|Overall Study|subject left study|1
7468479|NCT01911429|11769332|FG001|Overall Study|subject left study|0
7468480|NCT01911429|11769333|FG002|Overall Study|subject left study|0
7468481|NCT01911442|11769344|FG000|Overall Study|Adverse Event|2
7468482|NCT01911442|11769345|FG001|Overall Study|Adverse Event|2
7468483|NCT01911442|11769346|FG002|Overall Study|Adverse Event|4
7468484|NCT01911442|11769344|FG000|Overall Study|Lack of Efficacy|1
7468485|NCT01911442|11769345|FG001|Overall Study|Lack of Efficacy|1
7468486|NCT01911442|11769346|FG002|Overall Study|Lack of Efficacy|1
7468487|NCT01911442|11769344|FG000|Overall Study|Lost to Follow-up|2
7468488|NCT01911442|11769345|FG001|Overall Study|Lost to Follow-up|0
7468489|NCT01911442|11769346|FG002|Overall Study|Lost to Follow-up|1
7468490|NCT01911442|11769344|FG000|Overall Study|Withdrawal by Subject|1
7468491|NCT01911442|11769345|FG001|Overall Study|Withdrawal by Subject|0
7225266|NCT00065156|11434699|FG000|Overall Study|Non-Compliance|2
7225267|NCT00065156|11434699|FG000|Overall Study|Loss of Response|1
7225268|NCT00065156|11434699|FG000|Overall Study|Secondary Malign Disease|1
7225269|NCT00065182|11434705|FG000|Overall Study|Adverse Event|24
7225270|NCT00065182|11434706|FG001|Overall Study|Adverse Event|17
7225271|NCT00065182|11434705|FG000|Overall Study|Lost to Follow-up|0
7225272|NCT00065182|11434706|FG001|Overall Study|Lost to Follow-up|4
7225273|NCT00065182|11434705|FG000|Overall Study|Protocol Violation|3
7225274|NCT00065182|11434706|FG001|Overall Study|Protocol Violation|4
7225275|NCT00065182|11434705|FG000|Overall Study|Serious adverse events (SAE)|1
7570877|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
7225276|NCT00065182|11434706|FG001|Overall Study|Serious adverse events (SAE)|0
7225277|NCT00065182|11434705|FG000|Overall Study|Sponsor Decision|11
7468492|NCT01911442|11769346|FG002|Overall Study|Withdrawal by Subject|6
7468493|NCT01911442|11769344|FG000|Overall Study|Mother's Work Schedule|0
7468494|NCT01911442|11769345|FG001|Overall Study|Mother's Work Schedule|1
7570878|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
7570879|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7570880|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
7570881|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
7570882|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
7570883|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
7570884|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
7570885|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Physician Decision|1
7570886|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Physician Decision|0
7570887|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Physician Decision|0
7570888|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Physician Decision|0
7570889|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
7468495|NCT01911442|11769346|FG002|Overall Study|Mother's Work Schedule|0
7468496|NCT01911546|11769358|FG000|Overall Study|Lost to Follow-up|1
7570890|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
7570891|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
7570892|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
7570893|NCT03514641|11949416|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7468497|NCT01911546|11769358|FG000|Overall Study|Everolimus was discontinued|5
7468498|NCT01911780|11769380|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
7468499|NCT01911780|11769381|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
7468500|NCT01911780|11769380|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7462647|NCT01852292|11759923|FG001|Overall Study|Adverse Event|11
7468501|NCT01911780|11769381|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
7468502|NCT01911780|11769380|FG000|Double-blind Period (8 Weeks)|Personal reason|1
7468503|NCT01911780|11769381|FG001|Double-blind Period (8 Weeks)|Personal reason|0
7462465|NCT01852045|11759772|FG000|Overall Study|Adverse Event|1
7462466|NCT01852045|11759773|FG001|Overall Study|Adverse Event|0
7462467|NCT01852045|11759774|FG002|Overall Study|Adverse Event|0
7462468|NCT01852045|11759772|FG000|Overall Study|Lack of Efficacy|3
7462469|NCT01852045|11759773|FG001|Overall Study|Lack of Efficacy|0
7462470|NCT01852045|11759774|FG002|Overall Study|Lack of Efficacy|0
7462471|NCT01852045|11759772|FG000|Overall Study|Lost to Follow-up|0
7462472|NCT01852045|11759773|FG001|Overall Study|Lost to Follow-up|1
7462473|NCT01852045|11759774|FG002|Overall Study|Lost to Follow-up|1
7462474|NCT01852045|11759772|FG000|Overall Study|Withdrawal by Subject|1
7462475|NCT01852045|11759773|FG001|Overall Study|Withdrawal by Subject|0
7462476|NCT01852045|11759774|FG002|Overall Study|Withdrawal by Subject|1
7462477|NCT01852045|11759772|FG000|Overall Study|Other Miscellaneous Reasons|1
7462478|NCT01852045|11759773|FG001|Overall Study|Other Miscellaneous Reasons|3
7462479|NCT01852045|11759774|FG002|Overall Study|Other Miscellaneous Reasons|2
7462480|NCT01852058|11759785|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
7462481|NCT01852058|11759786|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462482|NCT01852058|11759787|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462483|NCT01852058|11759788|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462484|NCT01852058|11759789|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462485|NCT01852058|11759790|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462486|NCT01852058|11759791|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462487|NCT01852058|11759792|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462488|NCT01852058|11759793|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462489|NCT01852058|11759794|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462490|NCT01852058|11759795|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462491|NCT01852058|11759796|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
7462492|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462493|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462494|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462495|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462496|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
7462497|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462498|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462499|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462500|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462501|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462502|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462503|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
7462504|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462505|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462506|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462507|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462508|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7462509|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
7462510|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462511|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462512|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462513|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462514|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462515|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
7462516|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462517|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462518|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462519|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462520|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
7462521|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462522|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462523|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462524|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462525|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462526|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462527|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
7462528|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462529|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462530|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462531|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462532|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
7462533|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
7462534|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462535|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462536|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462537|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462538|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462539|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
7462540|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462541|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462542|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462543|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
7462544|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462545|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462546|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462547|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462548|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462549|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462550|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462551|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
7462552|NCT01852058|11759785|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462553|NCT01852058|11759786|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462554|NCT01852058|11759787|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462555|NCT01852058|11759788|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462556|NCT01852058|11759789|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
7462557|NCT01852058|11759790|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
7462558|NCT01852058|11759791|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462559|NCT01852058|11759792|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462560|NCT01852058|11759793|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462561|NCT01852058|11759794|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462562|NCT01852058|11759795|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462563|NCT01852058|11759796|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
7462564|NCT01852058|11759785|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462565|NCT01852058|11759786|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462566|NCT01852058|11759787|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462567|NCT01852058|11759788|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462568|NCT01852058|11759789|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462569|NCT01852058|11759790|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462570|NCT01852058|11759791|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462571|NCT01852058|11759792|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
7462572|NCT01852058|11759793|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462573|NCT01852058|11759794|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462574|NCT01852058|11759795|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7462575|NCT01852058|11759796|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
7533446|NCT02686164|11879857|FG000|Overall Study|Withdrawal of consent|1
7533447|NCT02686164|11879857|FG000|Overall Study|Clinical progression|1
7533448|NCT02687035|11879873|FG000|Overall Study|Withdrawal by Subject|1
7533449|NCT02687035|11879873|FG000|Overall Study|Death|87
7533450|NCT02687035|11879873|FG000|Overall Study|Lost to Follow-up|1
7533451|NCT02687035|11879873|FG000|Overall Study|Missed Visit|87
7533452|NCT02687035|11879873|FG000|Overall Study|Did not receive Study Device|8
7533453|NCT02687191|11879894|FG000|Overall Study|Death|0
7533454|NCT02687191|11879895|FG001|Overall Study|Death|1
7533455|NCT02687191|11879896|FG002|Overall Study|Death|1
7533456|NCT02687191|11879897|FG003|Overall Study|Death|0
7533457|NCT02687191|11879898|FG004|Overall Study|Death|1
7533458|NCT02687191|11879899|FG005|Overall Study|Death|1
7533459|NCT02687191|11879894|FG000|Overall Study|Withdrawal by Subject|0
7533460|NCT02687191|11879895|FG001|Overall Study|Withdrawal by Subject|0
7533461|NCT02687191|11879896|FG002|Overall Study|Withdrawal by Subject|0
7533462|NCT02687191|11879897|FG003|Overall Study|Withdrawal by Subject|1
7533463|NCT02687191|11879898|FG004|Overall Study|Withdrawal by Subject|0
7533464|NCT02687191|11879899|FG005|Overall Study|Withdrawal by Subject|0
7533465|NCT02687451|11879937|FG000|Overall Study|Withdrawal by Subject|1
7533466|NCT02687451|11879938|FG001|Overall Study|Withdrawal by Subject|0
7533467|NCT02687451|11879939|FG002|Overall Study|Withdrawal by Subject|0
7533468|NCT02687451|11879940|FG003|Overall Study|Withdrawal by Subject|0
7533469|NCT02687451|11879941|FG004|Overall Study|Withdrawal by Subject|0
7533470|NCT02687451|11879942|FG005|Overall Study|Withdrawal by Subject|1
7533471|NCT02687542|11879972|FG000|Overall Study|Medication error without associated AEs|0
7533472|NCT02687542|11879973|FG001|Overall Study|Medication error without associated AEs|0
7533473|NCT02687542|11879974|FG002|Overall Study|Medication error without associated AEs|0
7462648|NCT01852292|11759922|FG000|Overall Study|Physician Decision|6
7533474|NCT02687542|11879975|FG003|Overall Study|Medication error without associated AEs|0
7462576|NCT01852058|11759785|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462577|NCT01852058|11759786|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462578|NCT01852058|11759787|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462579|NCT01852058|11759788|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462580|NCT01852058|11759789|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462581|NCT01852058|11759790|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462582|NCT01852058|11759791|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462583|NCT01852058|11759792|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462584|NCT01852058|11759793|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
7462585|NCT01852058|11759794|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462586|NCT01852058|11759795|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462587|NCT01852058|11759796|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
7462588|NCT01852110|11759865|FG000|Overall Study|Adverse Event|12
7462589|NCT01852110|11759866|FG001|Overall Study|Adverse Event|5
7462590|NCT01852110|11759867|FG002|Overall Study|Adverse Event|0
7462591|NCT01852110|11759868|FG003|Overall Study|Adverse Event|0
7462592|NCT01852110|11759869|FG004|Overall Study|Adverse Event|0
7462593|NCT01852110|11759870|FG005|Overall Study|Adverse Event|0
7462594|NCT01852110|11759865|FG000|Overall Study|Lost to Follow-up|1
7462595|NCT01852110|11759866|FG001|Overall Study|Lost to Follow-up|3
7462596|NCT01852110|11759867|FG002|Overall Study|Lost to Follow-up|0
7462597|NCT01852110|11759868|FG003|Overall Study|Lost to Follow-up|0
7462598|NCT01852110|11759869|FG004|Overall Study|Lost to Follow-up|0
7462599|NCT01852110|11759870|FG005|Overall Study|Lost to Follow-up|0
7462600|NCT01852110|11759865|FG000|Overall Study|Non-compliance with Study Drug|2
7462601|NCT01852110|11759866|FG001|Overall Study|Non-compliance with Study Drug|1
7462602|NCT01852110|11759867|FG002|Overall Study|Non-compliance with Study Drug|0
7462603|NCT01852110|11759868|FG003|Overall Study|Non-compliance with Study Drug|0
7462604|NCT01852110|11759869|FG004|Overall Study|Non-compliance with Study Drug|0
7462605|NCT01852110|11759870|FG005|Overall Study|Non-compliance with Study Drug|0
7462606|NCT01852110|11759865|FG000|Overall Study|Physician Decision|1
7462607|NCT01852110|11759866|FG001|Overall Study|Physician Decision|0
7462608|NCT01852110|11759867|FG002|Overall Study|Physician Decision|0
7462609|NCT01852110|11759868|FG003|Overall Study|Physician Decision|0
7462610|NCT01852110|11759869|FG004|Overall Study|Physician Decision|0
7462611|NCT01852110|11759870|FG005|Overall Study|Physician Decision|0
7462612|NCT01852110|11759865|FG000|Overall Study|Protocol Violation|0
7462613|NCT01852110|11759866|FG001|Overall Study|Protocol Violation|1
7462614|NCT01852110|11759867|FG002|Overall Study|Protocol Violation|0
7462615|NCT01852110|11759868|FG003|Overall Study|Protocol Violation|0
7462616|NCT01852110|11759869|FG004|Overall Study|Protocol Violation|0
7462617|NCT01852110|11759870|FG005|Overall Study|Protocol Violation|0
7462618|NCT01852110|11759865|FG000|Overall Study|Study Terminated by Sponsor|30
7462619|NCT01852110|11759866|FG001|Overall Study|Study Terminated by Sponsor|32
7462620|NCT01852110|11759867|FG002|Overall Study|Study Terminated by Sponsor|0
7462621|NCT01852110|11759868|FG003|Overall Study|Study Terminated by Sponsor|0
7462622|NCT01852110|11759869|FG004|Overall Study|Study Terminated by Sponsor|0
7462623|NCT01852110|11759870|FG005|Overall Study|Study Terminated by Sponsor|0
7462624|NCT01852110|11759865|FG000|Overall Study|Withdrawal by Subject|4
7462625|NCT01852110|11759866|FG001|Overall Study|Withdrawal by Subject|4
7462626|NCT01852110|11759867|FG002|Overall Study|Withdrawal by Subject|0
7570894|NCT03514641|11949417|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
7570895|NCT03514641|11949418|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7570896|NCT03514641|11949419|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
7570897|NCT03514641|11949416|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
7570898|NCT03514641|11949417|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
7570899|NCT03514641|11949418|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
7570900|NCT03514641|11949419|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
7462627|NCT01852110|11759868|FG003|Overall Study|Withdrawal by Subject|0
7462628|NCT01852110|11759869|FG004|Overall Study|Withdrawal by Subject|0
7462629|NCT01852110|11759870|FG005|Overall Study|Withdrawal by Subject|0
7462630|NCT01852162|11759886|FG000|Overall Study|Adverse Event|1
7462631|NCT01852162|11759887|FG001|Overall Study|Adverse Event|0
7462632|NCT01852162|11759886|FG000|Overall Study|Withdrawal by Subject|3
7462633|NCT01852162|11759887|FG001|Overall Study|Withdrawal by Subject|1
7462634|NCT01852214|11759912|FG000|Period 1|Adverse Event|1
7462635|NCT01852214|11759913|FG001|Period 1|Adverse Event|2
7462636|NCT01852214|11759912|FG000|Period 1|Withdrawal by Subject|0
7462637|NCT01852214|11759913|FG001|Period 1|Withdrawal by Subject|1
7462638|NCT01852214|11759912|FG000|Washout Period|Withdrawal by Subject|0
7462639|NCT01852214|11759913|FG001|Washout Period|Withdrawal by Subject|1
7462640|NCT01852292|11759922|FG000|Overall Study|Untreated - did not receive study drug|3
7462641|NCT01852292|11759923|FG001|Overall Study|Untreated - did not receive study drug|1
7462642|NCT01852292|11759922|FG000|Overall Study|Death|9
7462643|NCT01852292|11759923|FG001|Overall Study|Death|8
7462644|NCT01852292|11759922|FG000|Overall Study|Patient/guardian decision|8
7462645|NCT01852292|11759923|FG001|Overall Study|Patient/guardian decision|4
7462646|NCT01852292|11759922|FG000|Overall Study|Adverse Event|8
7462649|NCT01852292|11759923|FG001|Overall Study|Physician Decision|2
7462650|NCT01852292|11759922|FG000|Overall Study|Protocol Violation|2
7462651|NCT01852292|11759923|FG001|Overall Study|Protocol Violation|0
7462652|NCT01852292|11759922|FG000|Overall Study|Non-compliance with study treatment|1
7462653|NCT01852292|11759923|FG001|Overall Study|Non-compliance with study treatment|0
7462654|NCT01852292|11759922|FG000|Overall Study|Study terminated by Sponsor|0
7462655|NCT01852292|11759923|FG001|Overall Study|Study terminated by Sponsor|1
7462656|NCT01852292|11759922|FG000|Overall Study|Progressive disease|42
7462657|NCT01852292|11759923|FG001|Overall Study|Progressive disease|52
7462658|NCT01852591|11759961|FG000|Overall Study|Withdrawal by Subject|2
7462659|NCT01852591|11759961|FG000|Overall Study|Not Evaluable at Time of Analysis|1
7462660|NCT01852825|11759981|FG000|Overall Study|Withdrawal by Subject|2
7462661|NCT01852825|11759982|FG001|Overall Study|Withdrawal by Subject|0
7462662|NCT01852825|11759983|FG002|Overall Study|Withdrawal by Subject|0
7462663|NCT01852942|11759993|FG000|Overall Study|Physician Decision|1
7462664|NCT01852942|11759994|FG001|Overall Study|Physician Decision|0
7462665|NCT01852942|11759993|FG000|Overall Study|Death|1
7462666|NCT01852942|11759994|FG001|Overall Study|Death|1
7462667|NCT01852942|11759993|FG000|Overall Study|Withdrawal by Subject|2
7462668|NCT01852942|11759994|FG001|Overall Study|Withdrawal by Subject|3
7462669|NCT01852942|11759993|FG000|Overall Study|Lost to Follow-up|1
7462670|NCT01852942|11759994|FG001|Overall Study|Lost to Follow-up|2
7462671|NCT01853046|11760012|FG000|Overall Study|Withdrawal by Subject|1
7462672|NCT01853046|11760013|FG001|Overall Study|Withdrawal by Subject|1
7462673|NCT01853046|11760012|FG000|Overall Study|Adverse Event|4
7462674|NCT01853046|11760013|FG001|Overall Study|Adverse Event|2
7462675|NCT01853046|11760012|FG000|Overall Study|Disease progression|13
7462676|NCT01853046|11760013|FG001|Overall Study|Disease progression|3
7462677|NCT01853072|11760022|FG000|Overall Study|Adverse event prior to treatment|0
7462678|NCT01853072|11760023|FG001|Overall Study|Adverse event prior to treatment|1
7462679|NCT01853072|11760022|FG000|Overall Study|Adverse Event|0
7462680|NCT01853072|11760023|FG001|Overall Study|Adverse Event|3
7462681|NCT01853072|11760022|FG000|Overall Study|Death|1
7462682|NCT01853072|11760023|FG001|Overall Study|Death|4
7462683|NCT01853072|11760022|FG000|Overall Study|Lost to Follow-up|0
7462684|NCT01853072|11760023|FG001|Overall Study|Lost to Follow-up|3
7462685|NCT01853072|11760022|FG000|Overall Study|Non-compliance with study drug|0
7462686|NCT01853072|11760023|FG001|Overall Study|Non-compliance with study drug|1
7462687|NCT01853072|11760022|FG000|Overall Study|Physician Decision|1
7462688|NCT01853072|11760023|FG001|Overall Study|Physician Decision|1
7462689|NCT01853072|11760022|FG000|Overall Study|Withdrawal by Subject|1
7462690|NCT01853072|11760023|FG001|Overall Study|Withdrawal by Subject|2
7462691|NCT01853072|11760022|FG000|Overall Study|Reason not specified|9
7462692|NCT01853072|11760023|FG001|Overall Study|Reason not specified|6
7462693|NCT01853137|11760037|FG000|Overall Study|Lost to Follow-up|4
7462694|NCT01853137|11760038|FG001|Overall Study|Lost to Follow-up|1
7462695|NCT01853228|11760050|FG000|Phase 1|Lack of Efficacy|8
7462696|NCT01853228|11760051|FG001|Phase 1|Lack of Efficacy|0
7462697|NCT01853228|11760050|FG000|Phase 1|Other|1
7462698|NCT01853228|11760051|FG001|Phase 1|Other|0
7462699|NCT01853228|11760050|FG000|Phase 2|Physician Decision|0
7462700|NCT01853228|11760051|FG001|Phase 2|Physician Decision|1
7462701|NCT01853228|11760050|FG000|Phase 2|Proceed To Transplant|0
7462702|NCT01853228|11760051|FG001|Phase 2|Proceed To Transplant|3
7462703|NCT01853228|11760050|FG000|Phase 2|Lack of Efficacy|0
7462704|NCT01853228|11760051|FG001|Phase 2|Lack of Efficacy|4
7462705|NCT01853254|11760056|FG000|Overall Study|Abnormal Laboratory Test|1
7462706|NCT01853254|11760056|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
7462707|NCT01853254|11760056|FG000|Overall Study|Death|1
7462708|NCT01853254|11760056|FG000|Overall Study|Failure to Return|43
7462709|NCT01853254|11760056|FG000|Overall Study|Insufficient Therapeutic Response|22
7462710|NCT01853254|11760056|FG000|Overall Study|Refusal of Treatment|1
7462711|NCT01853254|11760056|FG000|Overall Study|Other Protocol Violation|1
7462712|NCT01853254|11760056|FG000|Overall Study|Withdrawal of Consent|16
7462713|NCT01853254|11760056|FG000|Overall Study|Administrative/Other|16
7462714|NCT01853280|11760062|FG000|Overall Study|Lack of Efficacy|2
7462715|NCT01853280|11760063|FG001|Overall Study|Lack of Efficacy|2
7462716|NCT01853280|11760062|FG000|Overall Study|Lost to Follow-up|0
7462717|NCT01853280|11760063|FG001|Overall Study|Lost to Follow-up|1
7462718|NCT01853280|11760062|FG000|Overall Study|Physician Decision|0
7462719|NCT01853280|11760063|FG001|Overall Study|Physician Decision|1
7462720|NCT01853280|11760062|FG000|Overall Study|Withdrawal by Subject|0
7462721|NCT01853280|11760063|FG001|Overall Study|Withdrawal by Subject|1
7462722|NCT01853280|11760062|FG000|Overall Study|Ineligible|0
7462723|NCT01853280|11760063|FG001|Overall Study|Ineligible|1
7462724|NCT01853384|11760085|FG000|Randomized|Adverse Event|5
7462725|NCT01853384|11760086|FG001|Randomized|Adverse Event|3
7462726|NCT01853384|11760085|FG000|Randomized|Death|1
7462727|NCT01853384|11760086|FG001|Randomized|Death|2
7462728|NCT01853384|11760085|FG000|Randomized|Lost to Follow-up|1
7462729|NCT01853384|11760086|FG001|Randomized|Lost to Follow-up|1
7462730|NCT01853384|11760085|FG000|Randomized|Withdrawal by Subject|5
7462731|NCT01853384|11760086|FG001|Randomized|Withdrawal by Subject|3
7462732|NCT01853384|11760085|FG000|Randomized|Sponsor Decision|47
7462733|NCT01853384|11760086|FG001|Randomized|Sponsor Decision|34
7462734|NCT01853384|11760085|FG000|Randomized|Other|3
7462735|NCT01853384|11760086|FG001|Randomized|Other|3
7462736|NCT01853384|11760085|FG000|Completed Follow up Visit 1|Early Termination|13
7462737|NCT01853384|11760086|FG001|Completed Follow up Visit 1|Early Termination|9
7462738|NCT01853384|11760085|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
7462739|NCT01853384|11760086|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
7462740|NCT01853384|11760085|FG000|Completed Follow up Visit 2|Adverse Event|1
7462741|NCT01853384|11760086|FG001|Completed Follow up Visit 2|Adverse Event|0
7462742|NCT01853384|11760085|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
7462743|NCT01853384|11760086|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
7462744|NCT01853384|11760085|FG000|Completed Follow up Visit 2|Death|1
7462745|NCT01853384|11760086|FG001|Completed Follow up Visit 2|Death|0
7462746|NCT01853384|11760085|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
7462747|NCT01853384|11760086|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
7462748|NCT01853397|11760096|FG000|Overall Study|Withdrawal by Subject|0
7462749|NCT01853397|11760097|FG001|Overall Study|Withdrawal by Subject|0
7462750|NCT01853397|11760098|FG002|Overall Study|Withdrawal by Subject|0
7462751|NCT01853397|11760099|FG003|Overall Study|Withdrawal by Subject|1
7462752|NCT01853397|11760096|FG000|Overall Study|Subject Noncompliance|0
7462753|NCT01853397|11760097|FG001|Overall Study|Subject Noncompliance|0
7462754|NCT01853397|11760098|FG002|Overall Study|Subject Noncompliance|0
7462755|NCT01853397|11760099|FG003|Overall Study|Subject Noncompliance|1
7462756|NCT01853462|11760111|FG000|Overall Study|Withdrawal by Subject|1
7462757|NCT01853462|11760112|FG001|Overall Study|Withdrawal by Subject|1
7462758|NCT01853475|11760123|FG000|Overall Study|Withdrawal by Subject|0
7462759|NCT01853475|11760124|FG001|Overall Study|Withdrawal by Subject|1
7462760|NCT01853475|11760125|FG002|Overall Study|Withdrawal by Subject|0
7462761|NCT01853618|11760164|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
7462762|NCT01853618|11760165|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
7462763|NCT01853618|11760166|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
7462764|NCT01853618|11760167|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
7462765|NCT01853618|11760168|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
7462766|NCT01853618|11760164|FG000|Overall Study|Progressive disease|1
7462767|NCT01853618|11760165|FG001|Overall Study|Progressive disease|1
7462768|NCT01853618|11760166|FG002|Overall Study|Progressive disease|1
7462769|NCT01853618|11760167|FG003|Overall Study|Progressive disease|1
7462770|NCT01853618|11760168|FG004|Overall Study|Progressive disease|2
7462771|NCT01853618|11760164|FG000|Overall Study|Physician Decision|0
7462772|NCT01853618|11760165|FG001|Overall Study|Physician Decision|1
7462773|NCT01853618|11760166|FG002|Overall Study|Physician Decision|1
7462774|NCT01853618|11760167|FG003|Overall Study|Physician Decision|0
7462775|NCT01853618|11760168|FG004|Overall Study|Physician Decision|0
7462776|NCT01853618|11760164|FG000|Overall Study|Refused further treatment|0
7462777|NCT01853618|11760165|FG001|Overall Study|Refused further treatment|0
7462778|NCT01853618|11760166|FG002|Overall Study|Refused further treatment|0
7462779|NCT01853618|11760167|FG003|Overall Study|Refused further treatment|0
7462780|NCT01853618|11760168|FG004|Overall Study|Refused further treatment|1
7462781|NCT01853644|11760181|FG000|Registration and Treatment Start|Did not start treatment|1
7462782|NCT01853644|11760181|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
7462783|NCT01853644|11760181|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
7462784|NCT01853644|11760181|FG000|Reached First Response/Complete 2 Cycles|Other|1
7462785|NCT01853644|11760181|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
7462786|NCT01853644|11760181|FG000|Continued Treatment After First Response|Adverse Event|2
7462787|NCT01853644|11760181|FG000|Continued Treatment After First Response|Progressive Diseaes|10
7462788|NCT01853696|11760187|FG000|Overall Study|Withdrawal by Subject|1
7462789|NCT01853696|11760188|FG001|Overall Study|Withdrawal by Subject|1
7462790|NCT01853696|11760187|FG000|Overall Study|Lost to Follow-up|5
7462791|NCT01853696|11760188|FG001|Overall Study|Lost to Follow-up|4
7462792|NCT01853839|11760205|FG000|Overall Study|Violated inclusion criteria|2
7462793|NCT01853839|11760205|FG000|Overall Study|Not meet ITT population definition|58
7462794|NCT01853839|11760205|FG000|Overall Study|End of treatment visit too early|33
7462795|NCT01853839|11760205|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
7462796|NCT01853878|11760215|FG000|Overall Study|Recurrence|2
7462797|NCT01853878|11760216|FG001|Overall Study|Recurrence|0
7462798|NCT01853878|11760215|FG000|Overall Study|Adverse Event|2
7462799|NCT01853878|11760216|FG001|Overall Study|Adverse Event|0
7462800|NCT01853878|11760215|FG000|Overall Study|Withdrawal by Subject|3
7462801|NCT01853878|11760216|FG001|Overall Study|Withdrawal by Subject|1
7462802|NCT01853878|11760215|FG000|Overall Study|Migrated/moved from the study area|1
7462803|NCT01853878|11760216|FG001|Overall Study|Migrated/moved from the study area|0
7462804|NCT01853878|11760215|FG000|Overall Study|Other|55
7462805|NCT01853878|11760216|FG001|Overall Study|Other|43
7462806|NCT01854047|11760240|FG000|Overall Study|Lack of Efficacy|1
7462807|NCT01854047|11760241|FG001|Overall Study|Lack of Efficacy|0
7462808|NCT01854047|11760242|FG002|Overall Study|Lack of Efficacy|0
7462809|NCT01854047|11760243|FG003|Overall Study|Lack of Efficacy|0
7462810|NCT01854047|11760244|FG004|Overall Study|Lack of Efficacy|0
7462811|NCT01854047|11760240|FG000|Overall Study|Poor compliance to protocol|3
7462812|NCT01854047|11760241|FG001|Overall Study|Poor compliance to protocol|0
7462813|NCT01854047|11760242|FG002|Overall Study|Poor compliance to protocol|2
7462814|NCT01854047|11760243|FG003|Overall Study|Poor compliance to protocol|0
7462815|NCT01854047|11760244|FG004|Overall Study|Poor compliance to protocol|0
7462816|NCT01854047|11760240|FG000|Overall Study|Adverse Event|5
7462817|NCT01854047|11760241|FG001|Overall Study|Adverse Event|4
7462818|NCT01854047|11760242|FG002|Overall Study|Adverse Event|6
7462819|NCT01854047|11760243|FG003|Overall Study|Adverse Event|10
7462820|NCT01854047|11760244|FG004|Overall Study|Adverse Event|7
7462821|NCT01854047|11760240|FG000|Overall Study|Randomized but not treated|0
7462822|NCT01854047|11760241|FG001|Overall Study|Randomized but not treated|1
7462823|NCT01854047|11760242|FG002|Overall Study|Randomized but not treated|2
7462824|NCT01854047|11760243|FG003|Overall Study|Randomized but not treated|0
7462825|NCT01854047|11760244|FG004|Overall Study|Randomized but not treated|4
7462826|NCT01854047|11760240|FG000|Overall Study|Other than specified above|3
7462827|NCT01854047|11760241|FG001|Overall Study|Other than specified above|3
7462828|NCT01854047|11760242|FG002|Overall Study|Other than specified above|3
7462829|NCT01854047|11760243|FG003|Overall Study|Other than specified above|5
7462830|NCT01854047|11760244|FG004|Overall Study|Other than specified above|8
7462831|NCT01854528|11760312|FG000|Overall Study|Adverse Event|0
7462832|NCT01854528|11760313|FG001|Overall Study|Adverse Event|4
7462833|NCT01854528|11760312|FG000|Overall Study|Withdrawal by Subject|0
7462834|NCT01854528|11760313|FG001|Overall Study|Withdrawal by Subject|2
7462835|NCT01854528|11760312|FG000|Overall Study|Virologic Failure|0
7462836|NCT01854528|11760313|FG001|Overall Study|Virologic Failure|9
7462837|NCT01854645|11760343|FG000|Overall Study|Protocol-Specified Criteria|13
7462838|NCT01854645|11760344|FG001|Overall Study|Protocol-Specified Criteria|10
7462839|NCT01854645|11760345|FG002|Overall Study|Protocol-Specified Criteria|8
7462840|NCT01854645|11760346|FG003|Overall Study|Protocol-Specified Criteria|5
7462841|NCT01854645|11760347|FG004|Overall Study|Protocol-Specified Criteria|7
7462842|NCT01854645|11760343|FG000|Overall Study|Administrative Reasons / Missing|0
7462843|NCT01854645|11760344|FG001|Overall Study|Administrative Reasons / Missing|0
7462844|NCT01854645|11760345|FG002|Overall Study|Administrative Reasons / Missing|0
7462845|NCT01854645|11760346|FG003|Overall Study|Administrative Reasons / Missing|1
7462846|NCT01854645|11760347|FG004|Overall Study|Administrative Reasons / Missing|1
7462847|NCT01854645|11760343|FG000|Overall Study|Protocol Violation|3
7462848|NCT01854645|11760344|FG001|Overall Study|Protocol Violation|0
7462849|NCT01854645|11760345|FG002|Overall Study|Protocol Violation|5
7462850|NCT01854645|11760346|FG003|Overall Study|Protocol Violation|4
7462851|NCT01854645|11760347|FG004|Overall Study|Protocol Violation|1
7462852|NCT01854645|11760343|FG000|Overall Study|Lost to Follow-up|10
7462853|NCT01854645|11760344|FG001|Overall Study|Lost to Follow-up|7
7462854|NCT01854645|11760345|FG002|Overall Study|Lost to Follow-up|8
7462855|NCT01854645|11760346|FG003|Overall Study|Lost to Follow-up|5
7462856|NCT01854645|11760347|FG004|Overall Study|Lost to Follow-up|0
7462857|NCT01854645|11760343|FG000|Overall Study|Physician Decision|1
7462858|NCT01854645|11760344|FG001|Overall Study|Physician Decision|5
7462859|NCT01854645|11760345|FG002|Overall Study|Physician Decision|3
7462860|NCT01854645|11760346|FG003|Overall Study|Physician Decision|3
7462861|NCT01854645|11760347|FG004|Overall Study|Physician Decision|7
7462862|NCT01854645|11760343|FG000|Overall Study|Withdrawal by Subject|31
7462863|NCT01854645|11760344|FG001|Overall Study|Withdrawal by Subject|41
7533475|NCT02687542|11879976|FG004|Overall Study|Medication error without associated AEs|1
7533476|NCT02687542|11879972|FG000|Overall Study|Lost to Follow-up|0
7533477|NCT02687542|11879973|FG001|Overall Study|Lost to Follow-up|0
7533478|NCT02687542|11879974|FG002|Overall Study|Lost to Follow-up|0
7570901|NCT03514641|11949416|FG000|603B: 24-36 Week Study Period|Adverse Event|0
7570902|NCT03514641|11949417|FG001|603B: 24-36 Week Study Period|Adverse Event|0
7570903|NCT03514641|11949418|FG002|603B: 24-36 Week Study Period|Adverse Event|3
7570904|NCT03514641|11949419|FG003|603B: 24-36 Week Study Period|Adverse Event|1
7570905|NCT03514641|11949416|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7570906|NCT03514641|11949417|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
7570907|NCT03514641|11949418|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
7570908|NCT03514641|11949419|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
7570909|NCT03514641|11949416|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
7570910|NCT03514641|11949417|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
7533479|NCT02687542|11879975|FG003|Overall Study|Lost to Follow-up|0
7533480|NCT02687542|11879976|FG004|Overall Study|Lost to Follow-up|1
7462864|NCT01854645|11760345|FG002|Overall Study|Withdrawal by Subject|30
7533481|NCT02687542|11879972|FG000|Overall Study|Protocol Violation|0
7570911|NCT03514641|11949418|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
7570912|NCT03514641|11949419|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
7570913|NCT03514641|11949416|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7462865|NCT01854645|11760346|FG003|Overall Study|Withdrawal by Subject|21
7533482|NCT02687542|11879973|FG001|Overall Study|Protocol Violation|1
7533483|NCT02687542|11879974|FG002|Overall Study|Protocol Violation|0
7533484|NCT02687542|11879975|FG003|Overall Study|Protocol Violation|0
7533485|NCT02687542|11879976|FG004|Overall Study|Protocol Violation|0
7462866|NCT01854645|11760347|FG004|Overall Study|Withdrawal by Subject|24
7462867|NCT01854645|11760343|FG000|Overall Study|Lack of Efficacy|7
7462868|NCT01854645|11760344|FG001|Overall Study|Lack of Efficacy|12
7462869|NCT01854645|11760345|FG002|Overall Study|Lack of Efficacy|9
7462870|NCT01854645|11760346|FG003|Overall Study|Lack of Efficacy|3
7462871|NCT01854645|11760347|FG004|Overall Study|Lack of Efficacy|9
7462872|NCT01854645|11760343|FG000|Overall Study|Adverse Event|33
7462873|NCT01854645|11760344|FG001|Overall Study|Adverse Event|31
7462874|NCT01854645|11760345|FG002|Overall Study|Adverse Event|19
7462875|NCT01854645|11760346|FG003|Overall Study|Adverse Event|20
7462876|NCT01854645|11760347|FG004|Overall Study|Adverse Event|11
7462877|NCT01854658|11760363|FG000|Overall Study|Protocol Violation|6
7462878|NCT01854658|11760364|FG001|Overall Study|Protocol Violation|2
7462879|NCT01854658|11760365|FG002|Overall Study|Protocol Violation|2
7462880|NCT01854658|11760366|FG003|Overall Study|Protocol Violation|1
7462881|NCT01854658|11760363|FG000|Overall Study|Physician Decision|7
7462882|NCT01854658|11760364|FG001|Overall Study|Physician Decision|5
7462883|NCT01854658|11760365|FG002|Overall Study|Physician Decision|2
7462884|NCT01854658|11760366|FG003|Overall Study|Physician Decision|4
7462885|NCT01854658|11760363|FG000|Overall Study|Lost to Follow-up|8
7462886|NCT01854658|11760364|FG001|Overall Study|Lost to Follow-up|9
7462887|NCT01854658|11760365|FG002|Overall Study|Lost to Follow-up|8
7462888|NCT01854658|11760366|FG003|Overall Study|Lost to Follow-up|4
7462889|NCT01854658|11760363|FG000|Overall Study|Withdrawal by Subject|28
7462890|NCT01854658|11760364|FG001|Overall Study|Withdrawal by Subject|21
7462891|NCT01854658|11760365|FG002|Overall Study|Withdrawal by Subject|29
7462892|NCT01854658|11760366|FG003|Overall Study|Withdrawal by Subject|15
7462893|NCT01854658|11760363|FG000|Overall Study|Protocol-specified criteria|15
7462894|NCT01854658|11760364|FG001|Overall Study|Protocol-specified criteria|15
7462895|NCT01854658|11760365|FG002|Overall Study|Protocol-specified criteria|10
7462896|NCT01854658|11760366|FG003|Overall Study|Protocol-specified criteria|7
7462897|NCT01854658|11760363|FG000|Overall Study|Lack of Efficacy|3
7462898|NCT01854658|11760364|FG001|Overall Study|Lack of Efficacy|8
7462899|NCT01854658|11760365|FG002|Overall Study|Lack of Efficacy|4
7462900|NCT01854658|11760366|FG003|Overall Study|Lack of Efficacy|7
7462901|NCT01854658|11760363|FG000|Overall Study|Adverse Event|21
7462902|NCT01854658|11760364|FG001|Overall Study|Adverse Event|14
7462903|NCT01854658|11760365|FG002|Overall Study|Adverse Event|23
7462904|NCT01854658|11760366|FG003|Overall Study|Adverse Event|19
7462905|NCT01854658|11760363|FG000|Overall Study|Administrative reasons|5
7462906|NCT01854658|11760364|FG001|Overall Study|Administrative reasons|1
7462907|NCT01854658|11760365|FG002|Overall Study|Administrative reasons|2
7462908|NCT01854658|11760366|FG003|Overall Study|Administrative reasons|2
7462909|NCT01854697|11760381|FG000|Overall Study|Adverse Event|1
7462910|NCT01854697|11760382|FG001|Overall Study|Adverse Event|0
7462911|NCT01854697|11760383|FG002|Overall Study|Adverse Event|0
7462912|NCT01854697|11760384|FG003|Overall Study|Adverse Event|0
7462913|NCT01854697|11760385|FG004|Overall Study|Adverse Event|1
7462914|NCT01854697|11760381|FG000|Overall Study|Lost to Follow-up|4
7462915|NCT01854697|11760382|FG001|Overall Study|Lost to Follow-up|1
7462916|NCT01854697|11760383|FG002|Overall Study|Lost to Follow-up|1
7462917|NCT01854697|11760384|FG003|Overall Study|Lost to Follow-up|2
7462918|NCT01854697|11760385|FG004|Overall Study|Lost to Follow-up|0
7462919|NCT01854697|11760381|FG000|Overall Study|To enter another AbbVie study|1
7462920|NCT01854697|11760382|FG001|Overall Study|To enter another AbbVie study|0
7462921|NCT01854697|11760383|FG002|Overall Study|To enter another AbbVie study|0
7462922|NCT01854697|11760384|FG003|Overall Study|To enter another AbbVie study|0
7462923|NCT01854697|11760385|FG004|Overall Study|To enter another AbbVie study|1
7462924|NCT01854697|11760381|FG000|Overall Study|Withdrew Consent|0
7462925|NCT01854697|11760382|FG001|Overall Study|Withdrew Consent|1
7462926|NCT01854697|11760383|FG002|Overall Study|Withdrew Consent|0
7462927|NCT01854697|11760384|FG003|Overall Study|Withdrew Consent|1
7462928|NCT01854697|11760385|FG004|Overall Study|Withdrew Consent|0
7462929|NCT01854697|11760381|FG000|Overall Study|Other|0
7462930|NCT01854697|11760382|FG001|Overall Study|Other|1
7462931|NCT01854697|11760383|FG002|Overall Study|Other|1
7462932|NCT01854697|11760384|FG003|Overall Study|Other|0
7462933|NCT01854697|11760385|FG004|Overall Study|Other|0
7462934|NCT01854710|11760395|FG000|Overall Study|Withdrawal by Subject|2
7462935|NCT01854710|11760396|FG001|Overall Study|Withdrawal by Subject|1
7462936|NCT01854710|11760397|FG002|Overall Study|Withdrawal by Subject|0
7462937|NCT01854710|11760398|FG003|Overall Study|Withdrawal by Subject|0
7462938|NCT01854710|11760399|FG004|Overall Study|Withdrawal by Subject|0
7462939|NCT01854710|11760400|FG005|Overall Study|Withdrawal by Subject|0
7462940|NCT01854710|11760395|FG000|Overall Study|CRI procedural error|2
7462941|NCT01854710|11760396|FG001|Overall Study|CRI procedural error|2
7462942|NCT01854710|11760397|FG002|Overall Study|CRI procedural error|2
7462943|NCT01854710|11760398|FG003|Overall Study|CRI procedural error|2
7462944|NCT01854710|11760399|FG004|Overall Study|CRI procedural error|2
7462945|NCT01854710|11760400|FG005|Overall Study|CRI procedural error|2
7462946|NCT01854827|11760410|FG000|Overall Study|Death|1
7462947|NCT01854879|11760414|FG000|Overall Study|Could not complete testing within the scheduled time.|1
7462948|NCT01854879|11760414|FG000|Overall Study|screen fail|3
7462949|NCT01854879|11760414|FG000|Overall Study|incomplete data set|1
7462950|NCT01854918|11760424|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
7462951|NCT01854918|11760425|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
7462952|NCT01854918|11760424|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
7462953|NCT01854918|11760425|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
7462954|NCT01854918|11760424|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
7462955|NCT01854918|11760425|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
7462956|NCT01854918|11760424|FG000|SOC-controlled Period (Year 1)|Death|5
7462957|NCT01854918|11760425|FG001|SOC-controlled Period (Year 1)|Death|5
7462958|NCT01854918|11760424|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
7462959|NCT01854918|11760425|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
7462960|NCT01854918|11760424|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
7462961|NCT01854918|11760425|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
7462962|NCT01854918|11760424|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
7462963|NCT01854918|11760425|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
7462964|NCT01854918|11760424|FG000|All-IP Period (Years 2 and 3)|Death|5
7462965|NCT01854918|11760425|FG001|All-IP Period (Years 2 and 3)|Death|16
7462966|NCT01854944|11760441|FG000|Overall Study|Withdrawal by Subject|0
7462967|NCT01854944|11760442|FG001|Overall Study|Withdrawal by Subject|0
7462968|NCT01854944|11760443|FG002|Overall Study|Withdrawal by Subject|1
7462969|NCT01855048|11760471|FG000|Overall Study|Withdrawal by Subject|0
7462970|NCT01855048|11760472|FG001|Overall Study|Withdrawal by Subject|1
7462971|NCT01855048|11760473|FG002|Overall Study|Withdrawal by Subject|0
7462972|NCT01855048|11760474|FG003|Overall Study|Withdrawal by Subject|0
7462973|NCT01855048|11760475|FG004|Overall Study|Withdrawal by Subject|1
7462974|NCT01855048|11760476|FG005|Overall Study|Withdrawal by Subject|0
7462975|NCT01855074|11760500|FG000|Overall Study|Adverse Event|1
7462976|NCT01855074|11760500|FG000|Overall Study|Lost to Follow-up|4
7462977|NCT01855074|11760500|FG000|Overall Study|Withdrawal by Subject|8
7462978|NCT01855074|11760500|FG000|Overall Study|Started but not treated|1
7462979|NCT01855126|11760506|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
7462980|NCT01855126|11760507|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
7462981|NCT01855126|11760506|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7462982|NCT01855126|11760507|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7462983|NCT01855243|11760520|FG000|Overall Study|develpoed diabetic ketoacidosis|1
7462984|NCT01855243|11760521|FG001|Overall Study|develpoed diabetic ketoacidosis|0
7462985|NCT01855243|11760522|FG002|Overall Study|develpoed diabetic ketoacidosis|0
7462986|NCT01855399|11760536|FG000|6 Month|Lost to Follow-up|12
7462987|NCT01855399|11760537|FG001|6 Month|Lost to Follow-up|9
7462988|NCT01855399|11760536|FG000|6 Month|Withdrawal by Subject|8
7462989|NCT01855399|11760537|FG001|6 Month|Withdrawal by Subject|6
7570914|NCT03514641|11949417|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
7570915|NCT03514641|11949418|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7570916|NCT03514641|11949419|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
7570917|NCT03515824|11949452|FG000|Overall Study|Death|3
7570918|NCT03515824|11949453|FG001|Overall Study|Death|2
7570919|NCT03515824|11949454|FG002|Overall Study|Death|6
7570920|NCT03515824|11949455|FG003|Overall Study|Death|0
7570921|NCT03515824|11949452|FG000|Overall Study|Lost to Follow-up|0
7570922|NCT03515824|11949453|FG001|Overall Study|Lost to Follow-up|1
7570923|NCT03515824|11949454|FG002|Overall Study|Lost to Follow-up|1
7570924|NCT03515824|11949455|FG003|Overall Study|Lost to Follow-up|0
7570925|NCT03515824|11949452|FG000|Overall Study|Study terminated by sponsor|0
7570926|NCT03515824|11949453|FG001|Overall Study|Study terminated by sponsor|1
7570927|NCT03515824|11949454|FG002|Overall Study|Study terminated by sponsor|6
7570928|NCT03515824|11949455|FG003|Overall Study|Study terminated by sponsor|0
7570929|NCT03515824|11949452|FG000|Overall Study|Status not recorded|0
7570930|NCT03515824|11949453|FG001|Overall Study|Status not recorded|0
7570931|NCT03515824|11949454|FG002|Overall Study|Status not recorded|2
7570932|NCT03515824|11949455|FG003|Overall Study|Status not recorded|0
7570933|NCT03515941|11949465|FG000|Overall Study|Adverse Event|1
7570934|NCT03515941|11949466|FG001|Overall Study|Adverse Event|0
7462990|NCT01855399|11760536|FG000|12 Month|Lost to Follow-up|7
7570935|NCT03517436|11949482|FG000|Overall Study|Death|3
7570936|NCT03517436|11949482|FG000|Overall Study|Withdrawal by Subject|4
7570937|NCT03517436|11949482|FG000|Overall Study|Did not receive study valve.|1
7570938|NCT03517566|11949491|FG000|Overall Study|Adverse Event|5
7570939|NCT03517566|11949492|FG001|Overall Study|Adverse Event|2
7462991|NCT01855399|11760537|FG001|12 Month|Lost to Follow-up|11
7462992|NCT01855425|11760543|FG000|Overall Study|Physician Decision|20
7462993|NCT01855750|11760549|FG000|Overall Study|Death|78
7462994|NCT01855750|11760550|FG001|Overall Study|Death|78
7462995|NCT01855750|11760549|FG000|Overall Study|Lost to Follow-up|9
7462996|NCT01855750|11760550|FG001|Overall Study|Lost to Follow-up|23
7462997|NCT01855750|11760549|FG000|Overall Study|Withdrawal by Subject|35
7462998|NCT01855750|11760550|FG001|Overall Study|Withdrawal by Subject|28
7462999|NCT01855750|11760549|FG000|Overall Study|Sponsor ends the study|297
7463000|NCT01855750|11760550|FG001|Overall Study|Sponsor ends the study|290
7463001|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Adverse Event|37
7463002|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Adverse Event|0
7463003|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Adverse Event|0
7463004|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Adverse Event|0
7463005|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Death|2
7463006|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Death|0
7463007|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Death|0
7463008|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Death|0
7463009|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
7463010|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
7463011|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
7463012|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
7463013|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
7463014|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
7463015|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
7463016|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
7463017|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Protocol Violation|4
7463018|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Protocol Violation|0
7463019|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Protocol Violation|0
7463020|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Protocol Violation|0
7463021|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
7463022|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
7463023|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
7463024|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
7463025|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Physician Decision|4
7463026|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Physician Decision|0
7463027|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Physician Decision|0
7463028|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Physician Decision|0
7463029|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Pregnancy|1
7463030|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Pregnancy|0
7463031|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Pregnancy|0
7463032|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Pregnancy|0
7463033|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
7463034|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
7463035|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
7463036|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
7463037|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Sponsor Decision|3
7463038|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Sponsor Decision|0
7463039|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Sponsor Decision|0
7463040|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Sponsor Decision|0
7463041|NCT01855789|11760556|FG000|1) Baseline up to Week 24|Other|4
7570940|NCT03517566|11949493|FG002|Overall Study|Adverse Event|2
7570941|NCT03517566|11949494|FG003|Overall Study|Adverse Event|8
7463042|NCT01855789|11760557|FG001|1) Baseline up to Week 24|Other|0
7463043|NCT01855789|11760558|FG002|1) Baseline up to Week 24|Other|0
7463044|NCT01855789|11760559|FG003|1) Baseline up to Week 24|Other|0
7570942|NCT03517566|11949495|FG004|Overall Study|Adverse Event|7
7570943|NCT03517566|11949491|FG000|Overall Study|Lack of Efficacy|3
7570944|NCT03517566|11949492|FG001|Overall Study|Lack of Efficacy|2
7570945|NCT03517566|11949493|FG002|Overall Study|Lack of Efficacy|1
7570946|NCT03517566|11949494|FG003|Overall Study|Lack of Efficacy|1
7570947|NCT03517566|11949495|FG004|Overall Study|Lack of Efficacy|4
7570948|NCT03517566|11949491|FG000|Overall Study|Lost to Follow-up|3
7570949|NCT03517566|11949492|FG001|Overall Study|Lost to Follow-up|1
7570950|NCT03517566|11949493|FG002|Overall Study|Lost to Follow-up|1
7570951|NCT03517566|11949494|FG003|Overall Study|Lost to Follow-up|1
7570952|NCT03517566|11949495|FG004|Overall Study|Lost to Follow-up|0
7570953|NCT03517566|11949491|FG000|Overall Study|Physician Decision|1
7570954|NCT03517566|11949492|FG001|Overall Study|Physician Decision|1
7570955|NCT03517566|11949493|FG002|Overall Study|Physician Decision|0
7570956|NCT03517566|11949494|FG003|Overall Study|Physician Decision|1
7570957|NCT03517566|11949495|FG004|Overall Study|Physician Decision|0
7570958|NCT03517566|11949491|FG000|Overall Study|Pregnancy|0
7570959|NCT03517566|11949492|FG001|Overall Study|Pregnancy|1
7463045|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Adverse Event|0
7463046|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Adverse Event|4
7463047|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Adverse Event|5
7463048|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Adverse Event|21
7463049|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7463050|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7463051|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
7463052|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
7463053|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
7463054|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
7463055|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
7463056|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
7463057|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
7463058|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
7463059|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
7463060|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
7463061|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Protocol Violation|0
7463062|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Protocol Violation|0
7463063|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Protocol Violation|0
7463064|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Protocol Violation|1
7570960|NCT03517566|11949493|FG002|Overall Study|Pregnancy|0
7570961|NCT03517566|11949494|FG003|Overall Study|Pregnancy|0
7570962|NCT03517566|11949495|FG004|Overall Study|Pregnancy|0
7570963|NCT03517566|11949491|FG000|Overall Study|Protocol Deviation|0
7570964|NCT03517566|11949492|FG001|Overall Study|Protocol Deviation|1
7570965|NCT03517566|11949493|FG002|Overall Study|Protocol Deviation|0
7463065|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
7463066|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
7463067|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
7463068|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
7463069|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Physician Decision|0
7463070|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Physician Decision|0
7463071|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Physician Decision|2
7463072|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Physician Decision|4
7463073|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
7463074|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
7463075|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
7463076|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
7463077|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
7463078|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
7463079|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
7463080|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
7463081|NCT01855789|11760556|FG000|2) Week 24 up to End of Study|Other|0
7463082|NCT01855789|11760557|FG001|2) Week 24 up to End of Study|Other|0
7463083|NCT01855789|11760558|FG002|2) Week 24 up to End of Study|Other|0
7463084|NCT01855789|11760559|FG003|2) Week 24 up to End of Study|Other|1
7463085|NCT01855828|11760565|FG000|Overall Study|Adverse Event|1
7463086|NCT01855828|11760565|FG000|Overall Study|Withdrawal by Subject|1
7463087|NCT01855919|11760576|FG000|Overall Study|Adverse Event|16
7463088|NCT01855919|11760577|FG001|Overall Study|Adverse Event|8
7463089|NCT01855919|11760576|FG000|Overall Study|Lack of Efficacy|1
7463090|NCT01855919|11760577|FG001|Overall Study|Lack of Efficacy|3
7570966|NCT03517566|11949494|FG003|Overall Study|Protocol Deviation|1
7570967|NCT03517566|11949495|FG004|Overall Study|Protocol Deviation|1
7570968|NCT03517566|11949491|FG000|Overall Study|Study terminated by Sponsor|11
7570969|NCT03517566|11949492|FG001|Overall Study|Study terminated by Sponsor|5
7570970|NCT03517566|11949493|FG002|Overall Study|Study terminated by Sponsor|6
7570971|NCT03517566|11949494|FG003|Overall Study|Study terminated by Sponsor|14
7570972|NCT03517566|11949495|FG004|Overall Study|Study terminated by Sponsor|12
7570973|NCT03517566|11949491|FG000|Overall Study|Subject Decision /Guardian Decision|9
7570974|NCT03517566|11949492|FG001|Overall Study|Subject Decision /Guardian Decision|8
7570975|NCT03517566|11949493|FG002|Overall Study|Subject Decision /Guardian Decision|5
7570976|NCT03517566|11949494|FG003|Overall Study|Subject Decision /Guardian Decision|8
7463091|NCT01855919|11760576|FG000|Overall Study|Withdrawal by Subject|4
7463092|NCT01855919|11760577|FG001|Overall Study|Withdrawal by Subject|10
7463093|NCT01855919|11760576|FG000|Overall Study|Entry Criteria Not Met|1
7463094|NCT01855919|11760577|FG001|Overall Study|Entry Criteria Not Met|1
7463095|NCT01855919|11760576|FG000|Overall Study|Protocol Violation|1
7463096|NCT01855919|11760577|FG001|Overall Study|Protocol Violation|4
7463097|NCT01855945|11760596|FG000|Overall Study|Adverse Event|0
7463098|NCT01855945|11760597|FG001|Overall Study|Adverse Event|0
7463099|NCT01855945|11760598|FG002|Overall Study|Adverse Event|0
7463100|NCT01855945|11760599|FG003|Overall Study|Adverse Event|0
7463101|NCT01855945|11760600|FG004|Overall Study|Adverse Event|0
7463102|NCT01855945|11760601|FG005|Overall Study|Adverse Event|0
7463103|NCT01855945|11760602|FG006|Overall Study|Adverse Event|1
7463104|NCT01855945|11760603|FG007|Overall Study|Adverse Event|0
7463105|NCT01855945|11760604|FG008|Overall Study|Adverse Event|0
7463106|NCT01855945|11760605|FG009|Overall Study|Adverse Event|0
7382323|NCT01182350|11639190|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
7382324|NCT01182350|11639191|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
7382325|NCT01182350|11639192|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
7382326|NCT01182350|11639188|FG000|Overall Study|Unevaluable for Biopsy|0
7382327|NCT01182350|11639189|FG001|Overall Study|Unevaluable for Biopsy|0
7382328|NCT01182350|11639190|FG002|Overall Study|Unevaluable for Biopsy|0
7382329|NCT01182350|11639191|FG003|Overall Study|Unevaluable for Biopsy|0
7382330|NCT01182350|11639192|FG004|Overall Study|Unevaluable for Biopsy|3
7382331|NCT01182415|11639217|FG000|Overall Study|Lost to Follow-up|1
7382332|NCT01182428|11639223|FG000|Overall Study|Physician Decision|1
7382333|NCT01182428|11639224|FG001|Overall Study|Physician Decision|0
7382334|NCT01182428|11639223|FG000|Overall Study|Lost to Follow-up|9
7382335|NCT01182428|11639224|FG001|Overall Study|Lost to Follow-up|1
7382336|NCT01182428|11639223|FG000|Overall Study|Withdrawal by Subject|1
7382337|NCT01182428|11639224|FG001|Overall Study|Withdrawal by Subject|0
7382338|NCT01182441|11639232|FG000|Overall Study|Patient Still in Follow-up|152
7382339|NCT01182441|11639233|FG001|Overall Study|Patient Still in Follow-up|72
7382340|NCT01182441|11639232|FG000|Overall Study|Death|37
7382341|NCT01182441|11639233|FG001|Overall Study|Death|25
7382342|NCT01182441|11639232|FG000|Overall Study|Implant Attempt Unsuccessful|13
7382343|NCT01182441|11639233|FG001|Overall Study|Implant Attempt Unsuccessful|0
7382344|NCT01182441|11639232|FG000|Overall Study|Lost to Follow-up|5
7382345|NCT01182441|11639233|FG001|Overall Study|Lost to Follow-up|8
7382346|NCT01182441|11639232|FG000|Overall Study|Withdrawal by Subject|6
7382347|NCT01182441|11639233|FG001|Overall Study|Withdrawal by Subject|13
7382348|NCT01182441|11639232|FG000|Overall Study|Implant Not Attempted|4
7382349|NCT01182441|11639233|FG001|Overall Study|Implant Not Attempted|0
7382350|NCT01182441|11639232|FG000|Overall Study|Adverse Event|2
7382351|NCT01182441|11639233|FG001|Overall Study|Adverse Event|0
7382352|NCT01182441|11639232|FG000|Overall Study|Physician Decision|1
7382353|NCT01182441|11639233|FG001|Overall Study|Physician Decision|1
7382354|NCT01182844|11639271|FG000|Overall Study|Withdrawal by Subject|0
7382355|NCT01182844|11639272|FG001|Overall Study|Withdrawal by Subject|2
7382356|NCT01183013|11639285|FG000|Overall Study|Adverse Event|6
7382357|NCT01183013|11639286|FG001|Overall Study|Adverse Event|8
7382358|NCT01183013|11639287|FG002|Overall Study|Adverse Event|5
7382359|NCT01183013|11639288|FG003|Overall Study|Adverse Event|5
7382360|NCT01183013|11639289|FG004|Overall Study|Adverse Event|10
7382361|NCT01183013|11639290|FG005|Overall Study|Adverse Event|10
7463107|NCT01855945|11760606|FG010|Overall Study|Adverse Event|0
7463108|NCT01855945|11760607|FG011|Overall Study|Adverse Event|0
7463109|NCT01855945|11760596|FG000|Overall Study|Death|0
7463110|NCT01855945|11760597|FG001|Overall Study|Death|0
7382362|NCT01183013|11639291|FG006|Overall Study|Adverse Event|6
7382363|NCT01183013|11639285|FG000|Overall Study|Lack of Efficacy|3
7382364|NCT01183013|11639286|FG001|Overall Study|Lack of Efficacy|2
7382365|NCT01183013|11639287|FG002|Overall Study|Lack of Efficacy|1
7382366|NCT01183013|11639288|FG003|Overall Study|Lack of Efficacy|2
7382367|NCT01183013|11639289|FG004|Overall Study|Lack of Efficacy|1
7382368|NCT01183013|11639290|FG005|Overall Study|Lack of Efficacy|2
7382369|NCT01183013|11639291|FG006|Overall Study|Lack of Efficacy|0
7382370|NCT01183013|11639285|FG000|Overall Study|Protocol Violation|5
7382371|NCT01183013|11639286|FG001|Overall Study|Protocol Violation|2
7382372|NCT01183013|11639287|FG002|Overall Study|Protocol Violation|4
7463111|NCT01855945|11760598|FG002|Overall Study|Death|0
7463112|NCT01855945|11760599|FG003|Overall Study|Death|0
7463113|NCT01855945|11760600|FG004|Overall Study|Death|0
7463114|NCT01855945|11760601|FG005|Overall Study|Death|0
7463115|NCT01855945|11760602|FG006|Overall Study|Death|2
7463116|NCT01855945|11760603|FG007|Overall Study|Death|0
7463117|NCT01855945|11760604|FG008|Overall Study|Death|0
7463118|NCT01855945|11760605|FG009|Overall Study|Death|0
7463119|NCT01855945|11760606|FG010|Overall Study|Death|0
7463120|NCT01855945|11760607|FG011|Overall Study|Death|0
7463121|NCT01855945|11760596|FG000|Overall Study|Lost to Follow-up|11
7463122|NCT01855945|11760597|FG001|Overall Study|Lost to Follow-up|10
7463123|NCT01855945|11760598|FG002|Overall Study|Lost to Follow-up|7
7463124|NCT01855945|11760599|FG003|Overall Study|Lost to Follow-up|3
7463125|NCT01855945|11760600|FG004|Overall Study|Lost to Follow-up|0
7463126|NCT01855945|11760601|FG005|Overall Study|Lost to Follow-up|3
7463127|NCT01855945|11760602|FG006|Overall Study|Lost to Follow-up|4
7463128|NCT01855945|11760603|FG007|Overall Study|Lost to Follow-up|7
7463129|NCT01855945|11760604|FG008|Overall Study|Lost to Follow-up|2
7463130|NCT01855945|11760605|FG009|Overall Study|Lost to Follow-up|0
7463131|NCT01855945|11760606|FG010|Overall Study|Lost to Follow-up|0
7463132|NCT01855945|11760607|FG011|Overall Study|Lost to Follow-up|2
7463133|NCT01855945|11760596|FG000|Overall Study|Other - Unclassified|1
7463134|NCT01855945|11760597|FG001|Overall Study|Other - Unclassified|1
7463135|NCT01855945|11760598|FG002|Overall Study|Other - Unclassified|1
7463136|NCT01855945|11760599|FG003|Overall Study|Other - Unclassified|0
7463137|NCT01855945|11760600|FG004|Overall Study|Other - Unclassified|0
7463138|NCT01855945|11760601|FG005|Overall Study|Other - Unclassified|0
7463139|NCT01855945|11760602|FG006|Overall Study|Other - Unclassified|2
7463140|NCT01855945|11760603|FG007|Overall Study|Other - Unclassified|1
7463141|NCT01855945|11760604|FG008|Overall Study|Other - Unclassified|0
7463142|NCT01855945|11760605|FG009|Overall Study|Other - Unclassified|0
7463143|NCT01855945|11760606|FG010|Overall Study|Other - Unclassified|1
7463144|NCT01855945|11760607|FG011|Overall Study|Other - Unclassified|0
7463145|NCT01855945|11760596|FG000|Overall Study|Withdrawal by Subject|4
7463146|NCT01855945|11760597|FG001|Overall Study|Withdrawal by Subject|0
7463147|NCT01855945|11760598|FG002|Overall Study|Withdrawal by Subject|4
7463148|NCT01855945|11760599|FG003|Overall Study|Withdrawal by Subject|1
7463149|NCT01855945|11760600|FG004|Overall Study|Withdrawal by Subject|1
7463150|NCT01855945|11760601|FG005|Overall Study|Withdrawal by Subject|0
7463151|NCT01855945|11760602|FG006|Overall Study|Withdrawal by Subject|1
7463152|NCT01855945|11760603|FG007|Overall Study|Withdrawal by Subject|0
7463153|NCT01855945|11760604|FG008|Overall Study|Withdrawal by Subject|0
7463154|NCT01855945|11760605|FG009|Overall Study|Withdrawal by Subject|2
7463155|NCT01855945|11760606|FG010|Overall Study|Withdrawal by Subject|4
7463156|NCT01855945|11760607|FG011|Overall Study|Withdrawal by Subject|1
7463157|NCT01855958|11760672|FG000|Overall Study|Withdrawal by Subject|1
7463158|NCT01855958|11760673|FG001|Overall Study|Withdrawal by Subject|0
7463159|NCT01856114|11760695|FG000|Overall Study|Withdrawal by Subject|1
7463160|NCT01856114|11760696|FG001|Overall Study|Withdrawal by Subject|0
7463161|NCT01856114|11760695|FG000|Overall Study|Adverse Event|1
7463162|NCT01856114|11760696|FG001|Overall Study|Adverse Event|0
7463163|NCT01856257|11760709|FG000|Overall Study|Death|2
7463164|NCT01856257|11760710|FG001|Overall Study|Death|0
7463165|NCT01856257|11760711|FG002|Overall Study|Death|0
7463166|NCT01856257|11760712|FG003|Overall Study|Death|0
7463167|NCT01856257|11760709|FG000|Overall Study|Physician Decision|0
7463168|NCT01856257|11760710|FG001|Overall Study|Physician Decision|0
7463169|NCT01856257|11760711|FG002|Overall Study|Physician Decision|0
7463170|NCT01856257|11760712|FG003|Overall Study|Physician Decision|1
7463171|NCT01856257|11760709|FG000|Overall Study|Withdrawal by Subject|1
7463172|NCT01856257|11760710|FG001|Overall Study|Withdrawal by Subject|1
7463173|NCT01856257|11760711|FG002|Overall Study|Withdrawal by Subject|0
7463174|NCT01856257|11760712|FG003|Overall Study|Withdrawal by Subject|0
7463175|NCT01856257|11760709|FG000|Overall Study|Donor complication|0
7463176|NCT01856257|11760710|FG001|Overall Study|Donor complication|0
7463177|NCT01856257|11760711|FG002|Overall Study|Donor complication|0
7463178|NCT01856257|11760712|FG003|Overall Study|Donor complication|1
7463179|NCT01856309|11760725|FG000|Overall Study|Death|4
7463180|NCT01856309|11760726|FG001|Overall Study|Death|6
7463181|NCT01856309|11760727|FG002|Overall Study|Death|11
7463182|NCT01856309|11760728|FG003|Overall Study|Death|6
7463183|NCT01856309|11760725|FG000|Overall Study|Lost to Follow-up|6
7463184|NCT01856309|11760726|FG001|Overall Study|Lost to Follow-up|2
7463185|NCT01856309|11760727|FG002|Overall Study|Lost to Follow-up|4
7463186|NCT01856309|11760728|FG003|Overall Study|Lost to Follow-up|8
7463187|NCT01856309|11760725|FG000|Overall Study|Withdrawal by Subject|11
7463188|NCT01856309|11760726|FG001|Overall Study|Withdrawal by Subject|13
7463189|NCT01856309|11760727|FG002|Overall Study|Withdrawal by Subject|28
7463190|NCT01856309|11760728|FG003|Overall Study|Withdrawal by Subject|26
7463191|NCT01856309|11760725|FG000|Overall Study|Other|227
7463192|NCT01856309|11760726|FG001|Overall Study|Other|225
7463193|NCT01856309|11760727|FG002|Overall Study|Other|447
7463194|NCT01856309|11760728|FG003|Overall Study|Other|469
7463195|NCT01856309|11760725|FG000|Overall Study|Lack of Efficacy|14
7463196|NCT01856309|11760726|FG001|Overall Study|Lack of Efficacy|9
7463197|NCT01856309|11760727|FG002|Overall Study|Lack of Efficacy|40
7463198|NCT01856309|11760728|FG003|Overall Study|Lack of Efficacy|25
7463199|NCT01856309|11760725|FG000|Overall Study|Adverse Event|31
7463200|NCT01856309|11760726|FG001|Overall Study|Adverse Event|31
7463201|NCT01856309|11760727|FG002|Overall Study|Adverse Event|55
7463202|NCT01856309|11760728|FG003|Overall Study|Adverse Event|65
7463203|NCT01856309|11760725|FG000|Overall Study|Pregnancy|0
7463204|NCT01856309|11760726|FG001|Overall Study|Pregnancy|0
7463205|NCT01856309|11760727|FG002|Overall Study|Pregnancy|0
7463206|NCT01856309|11760728|FG003|Overall Study|Pregnancy|1
7463207|NCT01856309|11760725|FG000|Overall Study|Physician Decision|6
7463208|NCT01856309|11760726|FG001|Overall Study|Physician Decision|1
7463209|NCT01856309|11760727|FG002|Overall Study|Physician Decision|6
7463210|NCT01856309|11760728|FG003|Overall Study|Physician Decision|8
7463211|NCT01856309|11760725|FG000|Overall Study|Noncompliance With Study Drug|0
7463212|NCT01856309|11760726|FG001|Overall Study|Noncompliance With Study Drug|1
7463213|NCT01856309|11760727|FG002|Overall Study|Noncompliance With Study Drug|4
7463214|NCT01856309|11760728|FG003|Overall Study|Noncompliance With Study Drug|1
7463215|NCT01856543|11760753|FG000|Overall Study|Treatment discontinued|6
7463216|NCT01856543|11760754|FG001|Overall Study|Treatment discontinued|3
7463217|NCT01856543|11760753|FG000|Overall Study|Withdrawn before start|7
7463218|NCT01856543|11760754|FG001|Overall Study|Withdrawn before start|3
7463219|NCT01856569|11760761|FG000|Overall Study|Other|1
7463220|NCT01856569|11760761|FG000|Overall Study|Changed Site/Structure|1
7463221|NCT01856569|11760761|FG000|Overall Study|Lost to Follow-up|3
7463222|NCT01856569|11760761|FG000|Overall Study|Did not met inclusion criteria|8
7463223|NCT01856582|11760765|FG000|Overall Study|Died prior to Boost infusion|1
7463224|NCT01856595|11760778|FG000|Overall Study|Withdrawal by Subject|0
7463225|NCT01856595|11760779|FG001|Overall Study|Withdrawal by Subject|1
7463226|NCT01856595|11760780|FG002|Overall Study|Withdrawal by Subject|0
7463227|NCT01856595|11760781|FG003|Overall Study|Withdrawal by Subject|0
7463228|NCT01856595|11760782|FG004|Overall Study|Withdrawal by Subject|0
7463229|NCT01856595|11760783|FG005|Overall Study|Withdrawal by Subject|0
7463230|NCT01856595|11760784|FG006|Overall Study|Withdrawal by Subject|1
7463231|NCT01856595|11760785|FG007|Overall Study|Withdrawal by Subject|0
7463232|NCT01856595|11760786|FG008|Overall Study|Withdrawal by Subject|0
7463233|NCT01856673|11760824|FG000|Overall Study|Withdrawal by Subject|44
7463234|NCT01856673|11760825|FG001|Overall Study|Withdrawal by Subject|50
7463235|NCT01856673|11760826|FG002|Overall Study|Withdrawal by Subject|33
7463236|NCT01856673|11760824|FG000|Overall Study|Lost to Follow-up|31
7463237|NCT01856673|11760825|FG001|Overall Study|Lost to Follow-up|34
7463238|NCT01856673|11760826|FG002|Overall Study|Lost to Follow-up|0
7463239|NCT01856673|11760824|FG000|Overall Study|Unknown reasons|9
7463240|NCT01856673|11760825|FG001|Overall Study|Unknown reasons|0
7463241|NCT01856673|11760826|FG002|Overall Study|Unknown reasons|0
7463242|NCT01856673|11760824|FG000|Overall Study|Psychologist decision|1
7463243|NCT01856673|11760825|FG001|Overall Study|Psychologist decision|0
7463244|NCT01856673|11760826|FG002|Overall Study|Psychologist decision|0
7463245|NCT01856673|11760824|FG000|Overall Study|Paperwork errors|8
7463246|NCT01856673|11760825|FG001|Overall Study|Paperwork errors|0
7463247|NCT01856673|11760826|FG002|Overall Study|Paperwork errors|0
7463248|NCT01856673|11760824|FG000|Overall Study|Death|1
7463249|NCT01856673|11760825|FG001|Overall Study|Death|1
7463250|NCT01856673|11760826|FG002|Overall Study|Death|0
7463251|NCT01856673|11760824|FG000|Overall Study|Protocol Violation|1
7463252|NCT01856673|11760825|FG001|Overall Study|Protocol Violation|0
7463253|NCT01856673|11760826|FG002|Overall Study|Protocol Violation|1
7463254|NCT01856686|11760836|FG000|Overall Study|Lost to Follow-up|5
7463255|NCT01856686|11760837|FG001|Overall Study|Lost to Follow-up|11
7463256|NCT01856790|11760865|FG000|Closed Loop Control|Withdrawal by Subject|2
7463257|NCT01856790|11760865|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
7463258|NCT01856907|11760879|FG000|Overall Study|Pregnancy|0
7463259|NCT01856907|11760880|FG001|Overall Study|Pregnancy|1
7463260|NCT01856907|11760881|FG002|Overall Study|Pregnancy|0
7463261|NCT01856907|11760879|FG000|Overall Study|Pregnancy|0
7463262|NCT01856907|11760880|FG001|Overall Study|Pregnancy|1
7463263|NCT01856907|11760881|FG002|Overall Study|Pregnancy|0
7463264|NCT01856907|11760879|FG000|Overall Study|Withdrawal by Subject|0
7463265|NCT01856907|11760880|FG001|Overall Study|Withdrawal by Subject|1
7463266|NCT01856907|11760881|FG002|Overall Study|Withdrawal by Subject|0
7463267|NCT01857102|11760896|FG000|Period 1|No longer meets Eligibility Criteria|0
7463268|NCT01857102|11760897|FG001|Period 1|No longer meets Eligibility Criteria|2
7463269|NCT01857102|11760896|FG000|Period 1|Lost to Follow-up|0
7463270|NCT01857102|11760897|FG001|Period 1|Lost to Follow-up|3
7463271|NCT01857102|11760896|FG000|Period 1|Unsatisfactory Lens Fit|1
7463272|NCT01857102|11760897|FG001|Period 1|Unsatisfactory Lens Fit|0
7463273|NCT01857102|11760896|FG000|Period 1|Unsatisfactory Visual Response|1
7463274|NCT01857102|11760897|FG001|Period 1|Unsatisfactory Visual Response|0
7463275|NCT01857102|11760896|FG000|Period 1|Physician Decision|1
7463276|NCT01857102|11760897|FG001|Period 1|Physician Decision|0
7463277|NCT01857102|11760896|FG000|Period 2|Lens Discomfort|1
7463278|NCT01857102|11760897|FG001|Period 2|Lens Discomfort|0
7463279|NCT01857102|11760896|FG000|Period 2|Unsatisfactory Lens Fit|1
7463280|NCT01857102|11760897|FG001|Period 2|Unsatisfactory Lens Fit|0
7463281|NCT01857206|11760907|FG000|Overall Study|ADMINISTRATIVE REASON|0
7463282|NCT01857206|11760908|FG001|Overall Study|ADMINISTRATIVE REASON|1
7463283|NCT01857206|11760907|FG000|Overall Study|Lost to Follow-up|9
7570977|NCT03517566|11949495|FG004|Overall Study|Subject Decision /Guardian Decision|8
7570978|NCT03518008|11949508|FG000|Period 2, Second Week of Wear|Family emergency|0
7463284|NCT01857206|11760908|FG001|Overall Study|Lost to Follow-up|6
7463285|NCT01857206|11760907|FG000|Overall Study|Unclassified|3
7463286|NCT01857206|11760908|FG001|Overall Study|Unclassified|3
7463287|NCT01857206|11760907|FG000|Overall Study|Withdrawal by Subject|1
7463288|NCT01857206|11760908|FG001|Overall Study|Withdrawal by Subject|0
7463289|NCT01857310|11760962|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
7463290|NCT01857310|11760963|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
7468504|NCT01911780|11769380|FG000|Extension Period (52 Weeks)|Adverse Event|3
7463291|NCT01857323|11760969|FG000|Overall Study|Adverse Event|1
7463292|NCT01857323|11760969|FG000|Overall Study|Withdrawal by Subject|3
7463293|NCT01857323|11760969|FG000|Overall Study|Non-compliance|1
7463294|NCT01857323|11760969|FG000|Overall Study|Protocol Violation|6
7463295|NCT01857323|11760969|FG000|Overall Study|Lost to Follow-up|1
7463296|NCT01857323|11760969|FG000|Overall Study|Other|4
7463297|NCT01857323|11760969|FG000|Overall Study|Did not complete 180 doses|48
7463298|NCT01857531|11760980|FG000|Overall Study|Withdrawal by Subject|4
7463299|NCT01857583|11760988|FG000|Overall Study|Adverse Event|0
7463300|NCT01857583|11760989|FG001|Overall Study|Adverse Event|0
7463301|NCT01857583|11760990|FG002|Overall Study|Adverse Event|1
7463302|NCT01857583|11760991|FG003|Overall Study|Adverse Event|1
7463303|NCT01857583|11760988|FG000|Overall Study|Death|0
7463304|NCT01857583|11760989|FG001|Overall Study|Death|1
7382373|NCT01183013|11639288|FG003|Overall Study|Protocol Violation|0
7382374|NCT01183013|11639289|FG004|Overall Study|Protocol Violation|4
7382375|NCT01183013|11639290|FG005|Overall Study|Protocol Violation|3
7382376|NCT01183013|11639291|FG006|Overall Study|Protocol Violation|3
7382377|NCT01183013|11639285|FG000|Overall Study|Lost to Follow-up|7
7382378|NCT01183013|11639286|FG001|Overall Study|Lost to Follow-up|3
7382379|NCT01183013|11639287|FG002|Overall Study|Lost to Follow-up|4
7382380|NCT01183013|11639288|FG003|Overall Study|Lost to Follow-up|3
7382381|NCT01183013|11639289|FG004|Overall Study|Lost to Follow-up|2
7382382|NCT01183013|11639290|FG005|Overall Study|Lost to Follow-up|6
7463305|NCT01857583|11760990|FG002|Overall Study|Death|1
7463306|NCT01857583|11760991|FG003|Overall Study|Death|0
7463307|NCT01857583|11760988|FG000|Overall Study|Physician Decision|0
7463308|NCT01857583|11760989|FG001|Overall Study|Physician Decision|0
7463309|NCT01857583|11760990|FG002|Overall Study|Physician Decision|0
7463310|NCT01857583|11760991|FG003|Overall Study|Physician Decision|1
7463311|NCT01857583|11760988|FG000|Overall Study|Withdrawal by Subject|1
7463312|NCT01857583|11760989|FG001|Overall Study|Withdrawal by Subject|0
7463313|NCT01857583|11760990|FG002|Overall Study|Withdrawal by Subject|1
7463314|NCT01857583|11760991|FG003|Overall Study|Withdrawal by Subject|2
7463315|NCT01857622|11761004|FG000|Overall Study|Adverse Event|5
7463316|NCT01857622|11761005|FG001|Overall Study|Adverse Event|0
7463317|NCT01857622|11761006|FG002|Overall Study|Adverse Event|2
7463318|NCT01857622|11761004|FG000|Overall Study|Physician Decision|1
7463319|NCT01857622|11761005|FG001|Overall Study|Physician Decision|0
7463320|NCT01857622|11761006|FG002|Overall Study|Physician Decision|0
7463321|NCT01857622|11761004|FG000|Overall Study|Protocol Violation|4
7463322|NCT01857622|11761005|FG001|Overall Study|Protocol Violation|1
7463323|NCT01857622|11761006|FG002|Overall Study|Protocol Violation|0
7463324|NCT01857622|11761004|FG000|Overall Study|Withdrawal by Subject|1
7463325|NCT01857622|11761005|FG001|Overall Study|Withdrawal by Subject|0
7463326|NCT01857622|11761006|FG002|Overall Study|Withdrawal by Subject|0
7463327|NCT01857869|11761030|FG000|Primary/Challenge Phase|Lost to Follow-up|2
7463328|NCT01857869|11761031|FG001|Primary/Challenge Phase|Lost to Follow-up|0
7463329|NCT01857869|11761032|FG002|Primary/Challenge Phase|Lost to Follow-up|0
7463330|NCT01857869|11761033|FG003|Primary/Challenge Phase|Lost to Follow-up|0
7463331|NCT01857869|11761034|FG004|Primary/Challenge Phase|Lost to Follow-up|0
7463332|NCT01857869|11761035|FG005|Primary/Challenge Phase|Lost to Follow-up|0
7463333|NCT01857869|11761036|FG006|Primary/Challenge Phase|Lost to Follow-up|0
7463334|NCT01857869|11761037|FG007|Primary/Challenge Phase|Lost to Follow-up|0
7463335|NCT01857869|11761038|FG008|Primary/Challenge Phase|Lost to Follow-up|0
7463336|NCT01857869|11761039|FG009|Primary/Challenge Phase|Lost to Follow-up|0
7463337|NCT01857869|11761030|FG000|Primary/Challenge Phase|Pregnancy|1
7463338|NCT01857869|11761031|FG001|Primary/Challenge Phase|Pregnancy|0
7463339|NCT01857869|11761032|FG002|Primary/Challenge Phase|Pregnancy|0
7463340|NCT01857869|11761033|FG003|Primary/Challenge Phase|Pregnancy|0
7463341|NCT01857869|11761034|FG004|Primary/Challenge Phase|Pregnancy|0
7463342|NCT01857869|11761035|FG005|Primary/Challenge Phase|Pregnancy|0
7463343|NCT01857869|11761036|FG006|Primary/Challenge Phase|Pregnancy|0
7463344|NCT01857869|11761037|FG007|Primary/Challenge Phase|Pregnancy|0
7463345|NCT01857869|11761038|FG008|Primary/Challenge Phase|Pregnancy|0
7463346|NCT01857869|11761039|FG009|Primary/Challenge Phase|Pregnancy|0
7463347|NCT01857869|11761030|FG000|Primary/Challenge Phase|Protocol Violation|1
7463348|NCT01857869|11761031|FG001|Primary/Challenge Phase|Protocol Violation|0
7463349|NCT01857869|11761032|FG002|Primary/Challenge Phase|Protocol Violation|0
7463350|NCT01857869|11761033|FG003|Primary/Challenge Phase|Protocol Violation|0
7463351|NCT01857869|11761034|FG004|Primary/Challenge Phase|Protocol Violation|0
7463352|NCT01857869|11761035|FG005|Primary/Challenge Phase|Protocol Violation|0
7463353|NCT01857869|11761036|FG006|Primary/Challenge Phase|Protocol Violation|0
7463354|NCT01857869|11761037|FG007|Primary/Challenge Phase|Protocol Violation|0
7463355|NCT01857869|11761038|FG008|Primary/Challenge Phase|Protocol Violation|0
7463356|NCT01857869|11761039|FG009|Primary/Challenge Phase|Protocol Violation|0
7463357|NCT01857869|11761030|FG000|Primary/Challenge Phase|Other|1
7463358|NCT01857869|11761031|FG001|Primary/Challenge Phase|Other|1
7463359|NCT01857869|11761032|FG002|Primary/Challenge Phase|Other|0
7463360|NCT01857869|11761033|FG003|Primary/Challenge Phase|Other|0
7463361|NCT01857869|11761034|FG004|Primary/Challenge Phase|Other|0
7463362|NCT01857869|11761035|FG005|Primary/Challenge Phase|Other|0
7463363|NCT01857869|11761036|FG006|Primary/Challenge Phase|Other|0
7463364|NCT01857869|11761037|FG007|Primary/Challenge Phase|Other|0
7463365|NCT01857869|11761038|FG008|Primary/Challenge Phase|Other|0
7463366|NCT01857869|11761039|FG009|Primary/Challenge Phase|Other|0
7463367|NCT01857869|11761030|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463368|NCT01857869|11761031|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463369|NCT01857869|11761032|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463370|NCT01857869|11761033|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
7463371|NCT01857869|11761034|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463372|NCT01857869|11761035|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463373|NCT01857869|11761036|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463374|NCT01857869|11761037|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463375|NCT01857869|11761038|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463376|NCT01857869|11761039|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
7463377|NCT01857869|11761030|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463378|NCT01857869|11761031|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463379|NCT01857869|11761032|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463380|NCT01857869|11761033|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
7463381|NCT01857869|11761034|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7468505|NCT01911780|11769381|FG001|Extension Period (52 Weeks)|Adverse Event|0
7463382|NCT01857869|11761035|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463383|NCT01857869|11761036|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463384|NCT01857869|11761037|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463385|NCT01857869|11761038|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463386|NCT01857869|11761039|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
7463387|NCT01857973|11761071|FG000|Overall Study|Subject did not meet required BG range|3
7463388|NCT01857973|11761071|FG000|Overall Study|drop out after 3 failed attempts|1
7463389|NCT01857973|11761071|FG000|Overall Study|Physician Decision|1
7463390|NCT01858194|11761086|FG000|Overall Study|Total Artificial Heart Implant|0
7463391|NCT01858194|11761087|FG001|Overall Study|Total Artificial Heart Implant|1
7463392|NCT01858194|11761086|FG000|Overall Study|Lost to Follow-up|0
7463393|NCT01858194|11761087|FG001|Overall Study|Lost to Follow-up|1
7463394|NCT01858363|11761097|FG000|Overall Study|Death|35
7463395|NCT01858363|11761098|FG001|Overall Study|Death|9
7463396|NCT01858363|11761097|FG000|Overall Study|Withdrawal by Subject|28
7463397|NCT01858363|11761098|FG001|Overall Study|Withdrawal by Subject|14
7463398|NCT01858363|11761097|FG000|Overall Study|Lost to Follow-up|13
7463399|NCT01858363|11761098|FG001|Overall Study|Lost to Follow-up|3
7463400|NCT01858376|11761104|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
7463401|NCT01858389|11761110|FG000|Overall Study|Death|1
7463402|NCT01858389|11761111|FG001|Overall Study|Death|3
7463403|NCT01858389|11761110|FG000|Overall Study|Study terminated by sponsor|0
7463404|NCT01858389|11761111|FG001|Overall Study|Study terminated by sponsor|2
7463405|NCT01858389|11761110|FG000|Overall Study|Withdrawal by Subject|0
7463406|NCT01858389|11761111|FG001|Overall Study|Withdrawal by Subject|1
7463407|NCT01858389|11761110|FG000|Overall Study|Progressive disease|10
7463408|NCT01858389|11761111|FG001|Overall Study|Progressive disease|11
7463409|NCT01858389|11761110|FG000|Overall Study|Other|2
7463410|NCT01858389|11761111|FG001|Overall Study|Other|4
7463411|NCT01858389|11761110|FG000|Overall Study|Adverse Event|3
7463412|NCT01858389|11761111|FG001|Overall Study|Adverse Event|1
7463413|NCT01858389|11761110|FG000|Overall Study|Did not receive treatment|0
7463414|NCT01858389|11761111|FG001|Overall Study|Did not receive treatment|3
7463415|NCT01858532|11761132|FG000|Overall Study|Adverse Event|58
7463416|NCT01858532|11761133|FG001|Overall Study|Adverse Event|50
7463417|NCT01858532|11761134|FG002|Overall Study|Adverse Event|23
7463418|NCT01858532|11761135|FG003|Overall Study|Adverse Event|28
7463419|NCT01858532|11761132|FG000|Overall Study|Withdrew consent|71
7463420|NCT01858532|11761133|FG001|Overall Study|Withdrew consent|93
7463421|NCT01858532|11761134|FG002|Overall Study|Withdrew consent|46
7463422|NCT01858532|11761135|FG003|Overall Study|Withdrew consent|27
7463423|NCT01858532|11761132|FG000|Overall Study|Lost to Follow-up|17
7463424|NCT01858532|11761133|FG001|Overall Study|Lost to Follow-up|26
7463425|NCT01858532|11761134|FG002|Overall Study|Lost to Follow-up|11
7463426|NCT01858532|11761135|FG003|Overall Study|Lost to Follow-up|14
7463427|NCT01858532|11761132|FG000|Overall Study|Deterioration of medical status|3
7463428|NCT01858532|11761133|FG001|Overall Study|Deterioration of medical status|4
7463429|NCT01858532|11761134|FG002|Overall Study|Deterioration of medical status|3
7463430|NCT01858532|11761135|FG003|Overall Study|Deterioration of medical status|7
7463431|NCT01858532|11761132|FG000|Overall Study|Investigator request|3
7463432|NCT01858532|11761133|FG001|Overall Study|Investigator request|4
7463433|NCT01858532|11761134|FG002|Overall Study|Investigator request|2
7463434|NCT01858532|11761135|FG003|Overall Study|Investigator request|6
7463435|NCT01858532|11761132|FG000|Overall Study|Other, not specified|29
7463436|NCT01858532|11761133|FG001|Overall Study|Other, not specified|15
7463437|NCT01858532|11761134|FG002|Overall Study|Other, not specified|13
7463438|NCT01858532|11761135|FG003|Overall Study|Other, not specified|11
7463439|NCT01858558|11761156|FG000|Overall Study|Death|1
7463440|NCT01858558|11761157|FG001|Overall Study|Death|1
7463441|NCT01858558|11761156|FG000|Overall Study|Lost to Follow-up|1
7463442|NCT01858558|11761157|FG001|Overall Study|Lost to Follow-up|0
7463443|NCT01858558|11761156|FG000|Overall Study|Disease progression|3
7463444|NCT01858558|11761157|FG001|Overall Study|Disease progression|1
7463445|NCT01858558|11761156|FG000|Overall Study|Product contamination|2
7463446|NCT01858558|11761157|FG001|Overall Study|Product contamination|0
7463447|NCT01858558|11761156|FG000|Overall Study|Failed expansion of cell product|2
7463448|NCT01858558|11761157|FG001|Overall Study|Failed expansion of cell product|0
7463449|NCT01858636|11761163|FG000|Overall Study|No Device Deployment Attempted|24
7463450|NCT01858636|11761163|FG000|Overall Study|Physician Decision|1
7463451|NCT01858636|11761163|FG000|Overall Study|Death|1
7463452|NCT01858636|11761163|FG000|Overall Study|Lost to Follow-up|1
7463453|NCT01858636|11761163|FG000|Overall Study|Withdrawal by Subject|1
7463454|NCT01858701|11761168|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7463455|NCT01858701|11761169|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7463456|NCT01858701|11761168|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
7463457|NCT01858701|11761169|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
7463458|NCT01858701|11761168|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
7463459|NCT01858701|11761169|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
7463460|NCT01858701|11761168|FG000|Period 2, Second 30 Days of Wear|Comfort|0
7463461|NCT01858701|11761169|FG001|Period 2, Second 30 Days of Wear|Comfort|1
7463462|NCT01858766|11761203|FG000|Overall Study|Randomized but Never Treated|0
7463463|NCT01858766|11761204|FG001|Overall Study|Randomized but Never Treated|0
7463464|NCT01858766|11761205|FG002|Overall Study|Randomized but Never Treated|0
7463465|NCT01858766|11761206|FG003|Overall Study|Randomized but Never Treated|0
7463466|NCT01858766|11761207|FG004|Overall Study|Randomized but Never Treated|0
7463467|NCT01858766|11761208|FG005|Overall Study|Randomized but Never Treated|1
7463468|NCT01858766|11761209|FG006|Overall Study|Randomized but Never Treated|0
7463469|NCT01858766|11761210|FG007|Overall Study|Randomized but Never Treated|0
7463470|NCT01858766|11761211|FG008|Overall Study|Randomized but Never Treated|0
7463471|NCT01858766|11761212|FG009|Overall Study|Randomized but Never Treated|0
7463472|NCT01858766|11761213|FG010|Overall Study|Randomized but Never Treated|0
7463473|NCT01858766|11761214|FG011|Overall Study|Randomized but Never Treated|0
7463474|NCT01858766|11761215|FG012|Overall Study|Randomized but Never Treated|0
7463475|NCT01858766|11761216|FG013|Overall Study|Randomized but Never Treated|0
7463476|NCT01858766|11761217|FG014|Overall Study|Randomized but Never Treated|0
7463477|NCT01858766|11761218|FG015|Overall Study|Randomized but Never Treated|0
7463478|NCT01858766|11761219|FG016|Overall Study|Randomized but Never Treated|0
7463479|NCT01858766|11761220|FG017|Overall Study|Randomized but Never Treated|1
7463480|NCT01858766|11761221|FG018|Overall Study|Randomized but Never Treated|0
7463481|NCT01858766|11761203|FG000|Overall Study|Death|0
7463482|NCT01858766|11761204|FG001|Overall Study|Death|0
7463483|NCT01858766|11761205|FG002|Overall Study|Death|1
7463484|NCT01858766|11761206|FG003|Overall Study|Death|0
7463485|NCT01858766|11761207|FG004|Overall Study|Death|0
7463486|NCT01858766|11761208|FG005|Overall Study|Death|0
7463487|NCT01858766|11761209|FG006|Overall Study|Death|0
7463488|NCT01858766|11761210|FG007|Overall Study|Death|0
7463489|NCT01858766|11761211|FG008|Overall Study|Death|0
7463490|NCT01858766|11761212|FG009|Overall Study|Death|0
7463491|NCT01858766|11761213|FG010|Overall Study|Death|0
7463492|NCT01858766|11761214|FG011|Overall Study|Death|0
7463493|NCT01858766|11761215|FG012|Overall Study|Death|0
7463494|NCT01858766|11761216|FG013|Overall Study|Death|0
7463495|NCT01858766|11761217|FG014|Overall Study|Death|0
7463496|NCT01858766|11761218|FG015|Overall Study|Death|0
7463497|NCT01858766|11761219|FG016|Overall Study|Death|0
7463498|NCT01858766|11761220|FG017|Overall Study|Death|0
7463499|NCT01858766|11761221|FG018|Overall Study|Death|0
7463500|NCT01858766|11761203|FG000|Overall Study|Lack of Efficacy|1
7463501|NCT01858766|11761204|FG001|Overall Study|Lack of Efficacy|0
7463502|NCT01858766|11761205|FG002|Overall Study|Lack of Efficacy|0
7463503|NCT01858766|11761206|FG003|Overall Study|Lack of Efficacy|0
7463504|NCT01858766|11761207|FG004|Overall Study|Lack of Efficacy|1
7463505|NCT01858766|11761208|FG005|Overall Study|Lack of Efficacy|2
7463506|NCT01858766|11761209|FG006|Overall Study|Lack of Efficacy|0
7463507|NCT01858766|11761210|FG007|Overall Study|Lack of Efficacy|0
7463508|NCT01858766|11761211|FG008|Overall Study|Lack of Efficacy|0
7463509|NCT01858766|11761212|FG009|Overall Study|Lack of Efficacy|0
7463510|NCT01858766|11761213|FG010|Overall Study|Lack of Efficacy|0
7463511|NCT01858766|11761214|FG011|Overall Study|Lack of Efficacy|3
7463512|NCT01858766|11761215|FG012|Overall Study|Lack of Efficacy|5
7463513|NCT01858766|11761216|FG013|Overall Study|Lack of Efficacy|3
7463514|NCT01858766|11761217|FG014|Overall Study|Lack of Efficacy|5
7463515|NCT01858766|11761218|FG015|Overall Study|Lack of Efficacy|5
7463516|NCT01858766|11761219|FG016|Overall Study|Lack of Efficacy|2
7463517|NCT01858766|11761220|FG017|Overall Study|Lack of Efficacy|3
7463518|NCT01858766|11761221|FG018|Overall Study|Lack of Efficacy|3
7463519|NCT01858766|11761203|FG000|Overall Study|Lost to Follow-up|0
7463520|NCT01858766|11761204|FG001|Overall Study|Lost to Follow-up|0
7463521|NCT01858766|11761205|FG002|Overall Study|Lost to Follow-up|0
7463522|NCT01858766|11761206|FG003|Overall Study|Lost to Follow-up|0
7463523|NCT01858766|11761207|FG004|Overall Study|Lost to Follow-up|0
7463524|NCT01858766|11761208|FG005|Overall Study|Lost to Follow-up|1
7463525|NCT01858766|11761209|FG006|Overall Study|Lost to Follow-up|0
7463526|NCT01858766|11761210|FG007|Overall Study|Lost to Follow-up|2
7463527|NCT01858766|11761211|FG008|Overall Study|Lost to Follow-up|0
7463528|NCT01858766|11761212|FG009|Overall Study|Lost to Follow-up|0
7463529|NCT01858766|11761213|FG010|Overall Study|Lost to Follow-up|0
7463530|NCT01858766|11761214|FG011|Overall Study|Lost to Follow-up|1
7463531|NCT01858766|11761215|FG012|Overall Study|Lost to Follow-up|0
7463532|NCT01858766|11761216|FG013|Overall Study|Lost to Follow-up|0
7463533|NCT01858766|11761217|FG014|Overall Study|Lost to Follow-up|3
7463534|NCT01858766|11761218|FG015|Overall Study|Lost to Follow-up|1
7463535|NCT01858766|11761219|FG016|Overall Study|Lost to Follow-up|1
7463536|NCT01858766|11761220|FG017|Overall Study|Lost to Follow-up|0
7463537|NCT01858766|11761221|FG018|Overall Study|Lost to Follow-up|1
7463538|NCT01858766|11761203|FG000|Overall Study|Withdrew Consent|0
7463539|NCT01858766|11761204|FG001|Overall Study|Withdrew Consent|0
7463540|NCT01858766|11761205|FG002|Overall Study|Withdrew Consent|0
7463541|NCT01858766|11761206|FG003|Overall Study|Withdrew Consent|0
7463542|NCT01858766|11761207|FG004|Overall Study|Withdrew Consent|0
7463543|NCT01858766|11761208|FG005|Overall Study|Withdrew Consent|0
7463544|NCT01858766|11761209|FG006|Overall Study|Withdrew Consent|0
7463545|NCT01858766|11761210|FG007|Overall Study|Withdrew Consent|0
7463546|NCT01858766|11761211|FG008|Overall Study|Withdrew Consent|0
7463547|NCT01858766|11761212|FG009|Overall Study|Withdrew Consent|0
7463548|NCT01858766|11761213|FG010|Overall Study|Withdrew Consent|0
7463549|NCT01858766|11761214|FG011|Overall Study|Withdrew Consent|1
7463550|NCT01858766|11761215|FG012|Overall Study|Withdrew Consent|0
7463551|NCT01858766|11761216|FG013|Overall Study|Withdrew Consent|0
7463552|NCT01858766|11761217|FG014|Overall Study|Withdrew Consent|0
7463553|NCT01858766|11761218|FG015|Overall Study|Withdrew Consent|0
7463554|NCT01858766|11761219|FG016|Overall Study|Withdrew Consent|0
7463555|NCT01858766|11761220|FG017|Overall Study|Withdrew Consent|0
7463556|NCT01858766|11761221|FG018|Overall Study|Withdrew Consent|0
7463557|NCT01859143|11761271|FG000|Overall Study|Lost to Follow-up|2
7463558|NCT01859143|11761272|FG001|Overall Study|Lost to Follow-up|0
7463559|NCT01859390|11761341|FG000|Overall Study|Insufficient Sputum Collected|1
7463560|NCT01859390|11761342|FG001|Overall Study|Insufficient Sputum Collected|3
7463561|NCT01859390|11761341|FG000|Overall Study|Sample Missing Collection Date|0
7463562|NCT01859390|11761342|FG001|Overall Study|Sample Missing Collection Date|1
7463563|NCT01859390|11761341|FG000|Overall Study|Tube Cracked|0
7463564|NCT01859390|11761342|FG001|Overall Study|Tube Cracked|2
7463565|NCT01859390|11761341|FG000|Overall Study|Shipment Error|0
7463566|NCT01859390|11761342|FG001|Overall Study|Shipment Error|1
7463567|NCT01859403|11761350|FG000|Primary Endpoint Measure|Lost to Follow-up|0
7463568|NCT01859403|11761351|FG001|Primary Endpoint Measure|Lost to Follow-up|2
7463569|NCT01859403|11761350|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
7463570|NCT01859403|11761351|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
7463571|NCT01859403|11761350|FG000|Primary Endpoint Measure|Physician Decision|0
7463572|NCT01859403|11761351|FG001|Primary Endpoint Measure|Physician Decision|1
7463573|NCT01859403|11761350|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
7463574|NCT01859403|11761351|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
7463575|NCT01859494|11761357|FG000|Overall Study|Adverse Event|1
7463576|NCT01859507|11761361|FG000|Overall Study|left the country|4
7463577|NCT01859598|11761366|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
7463578|NCT01859702|11761380|FG000|Overall Study|Protocol deviation|3
7463579|NCT01859702|11761380|FG000|Overall Study|Adverse Event|2
7463580|NCT01859715|11761387|FG000|Overall Study|No 2nd VAS|16
7463581|NCT01859715|11761388|FG001|Overall Study|No 2nd VAS|8
7463582|NCT01859715|11761389|FG002|Overall Study|No 2nd VAS|23
7463583|NCT01859741|11761407|FG000|Overall Study|Death|3
7463584|NCT01859741|11761408|FG001|Overall Study|Death|2
7463585|NCT01859741|11761409|FG002|Overall Study|Death|4
7463586|NCT01859741|11761410|FG003|Overall Study|Death|3
7463587|NCT01859741|11761411|FG004|Overall Study|Death|5
7463588|NCT01859741|11761412|FG005|Overall Study|Death|4
7463589|NCT01859741|11761413|FG006|Overall Study|Death|51
7463590|NCT01859741|11761414|FG007|Overall Study|Death|51
7463591|NCT01859741|11761407|FG000|Overall Study|Lost to Follow-up|0
7463592|NCT01859741|11761408|FG001|Overall Study|Lost to Follow-up|0
7463593|NCT01859741|11761409|FG002|Overall Study|Lost to Follow-up|0
7463594|NCT01859741|11761410|FG003|Overall Study|Lost to Follow-up|0
7463595|NCT01859741|11761411|FG004|Overall Study|Lost to Follow-up|0
7463596|NCT01859741|11761412|FG005|Overall Study|Lost to Follow-up|1
7463597|NCT01859741|11761413|FG006|Overall Study|Lost to Follow-up|0
7463598|NCT01859741|11761414|FG007|Overall Study|Lost to Follow-up|4
7463599|NCT01859741|11761407|FG000|Overall Study|Withdrawal by Subject|0
7570979|NCT03518008|11949509|FG001|Period 2, Second Week of Wear|Family emergency|1
7570980|NCT03518125|11949521|FG000|Overall Study|Lost to Follow-up|0
7570981|NCT03518125|11949522|FG001|Overall Study|Lost to Follow-up|2
7463600|NCT01859741|11761408|FG001|Overall Study|Withdrawal by Subject|1
7570982|NCT03518125|11949523|FG002|Overall Study|Lost to Follow-up|0
7570983|NCT03518125|11949524|FG003|Overall Study|Lost to Follow-up|0
7570984|NCT03518125|11949525|FG004|Overall Study|Lost to Follow-up|3
7570985|NCT03518125|11949526|FG005|Overall Study|Lost to Follow-up|5
7570986|NCT03518125|11949521|FG000|Overall Study|Physician Decision|0
7570987|NCT03518125|11949522|FG001|Overall Study|Physician Decision|1
7570988|NCT03518125|11949523|FG002|Overall Study|Physician Decision|0
7570989|NCT03518125|11949524|FG003|Overall Study|Physician Decision|0
7570990|NCT03518125|11949525|FG004|Overall Study|Physician Decision|0
7570991|NCT03518125|11949526|FG005|Overall Study|Physician Decision|0
7570992|NCT03518125|11949521|FG000|Overall Study|Withdrawal by Subject|1
7570993|NCT03518125|11949522|FG001|Overall Study|Withdrawal by Subject|1
7570994|NCT03518125|11949523|FG002|Overall Study|Withdrawal by Subject|0
7570995|NCT03518125|11949524|FG003|Overall Study|Withdrawal by Subject|1
7570996|NCT03518125|11949525|FG004|Overall Study|Withdrawal by Subject|1
7570997|NCT03518125|11949526|FG005|Overall Study|Withdrawal by Subject|3
7570998|NCT03518125|11949521|FG000|Overall Study|Missed Day 394 Visit|1
7570999|NCT03518125|11949522|FG001|Overall Study|Missed Day 394 Visit|0
7571000|NCT03518125|11949523|FG002|Overall Study|Missed Day 394 Visit|0
7571001|NCT03518125|11949524|FG003|Overall Study|Missed Day 394 Visit|0
7571002|NCT03518125|11949525|FG004|Overall Study|Missed Day 394 Visit|0
7571003|NCT03518125|11949526|FG005|Overall Study|Missed Day 394 Visit|0
7571004|NCT03518658|11949543|FG000|Overall Study|Other|51
7571005|NCT03518658|11949544|FG001|Overall Study|Other|0
7571006|NCT03518840|11949552|FG000|Overall Study|Lost to Follow-up|6
7571007|NCT03519087|11949561|FG000|Clinic Evaluation|Physician Decision|15
7571008|NCT03519087|11949562|FG001|Clinic Evaluation|Physician Decision|18
7571009|NCT03519087|11949563|FG002|Clinic Evaluation|Physician Decision|0
7571010|NCT03519087|11949564|FG003|Clinic Evaluation|Physician Decision|0
7571011|NCT03519087|11949565|FG004|Clinic Evaluation|Physician Decision|0
7571012|NCT03519087|11949561|FG000|Clinic Evaluation|Protocol Violation|1
7571013|NCT03519087|11949562|FG001|Clinic Evaluation|Protocol Violation|0
7571014|NCT03519087|11949563|FG002|Clinic Evaluation|Protocol Violation|0
7571015|NCT03519087|11949564|FG003|Clinic Evaluation|Protocol Violation|0
7571016|NCT03519087|11949565|FG004|Clinic Evaluation|Protocol Violation|0
7571017|NCT03519087|11949561|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
7571018|NCT03519087|11949562|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
7571019|NCT03519087|11949563|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
7571020|NCT03519087|11949564|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
7571021|NCT03519087|11949565|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
7571022|NCT03519087|11949561|FG000|Re-randomization for Treatment|Not appropriate|2
7571023|NCT03519087|11949562|FG001|Re-randomization for Treatment|Not appropriate|3
7571024|NCT03519087|11949563|FG002|Re-randomization for Treatment|Not appropriate|0
7571025|NCT03519087|11949564|FG003|Re-randomization for Treatment|Not appropriate|0
7571026|NCT03519087|11949565|FG004|Re-randomization for Treatment|Not appropriate|0
7571027|NCT03519087|11949561|FG000|Laboratory Testing|Lost to Follow-up|0
7571028|NCT03519087|11949562|FG001|Laboratory Testing|Lost to Follow-up|0
7571029|NCT03519087|11949563|FG002|Laboratory Testing|Lost to Follow-up|2
7571030|NCT03519087|11949564|FG003|Laboratory Testing|Lost to Follow-up|3
7571031|NCT03519087|11949565|FG004|Laboratory Testing|Lost to Follow-up|6
7571032|NCT03519087|11949561|FG000|Laboratory Testing|Protocol Violation|0
7571033|NCT03519087|11949562|FG001|Laboratory Testing|Protocol Violation|0
7571034|NCT03519087|11949563|FG002|Laboratory Testing|Protocol Violation|0
7571035|NCT03519087|11949564|FG003|Laboratory Testing|Protocol Violation|1
7571036|NCT03519087|11949565|FG004|Laboratory Testing|Protocol Violation|0
7571037|NCT03519204|11949583|FG000|Overall Study|Lost to Follow-up|3
7571038|NCT03519204|11949584|FG001|Overall Study|Lost to Follow-up|8
7571039|NCT03519204|11949583|FG000|Overall Study|Withdrawal by Subject|9
7571040|NCT03519204|11949584|FG001|Overall Study|Withdrawal by Subject|7
7571041|NCT03519204|11949583|FG000|Overall Study|Other Miscellaneous Reasons|1
7571042|NCT03519204|11949584|FG001|Overall Study|Other Miscellaneous Reasons|0
7571043|NCT03519516|11949617|FG000|Overall Study|Adverse Event|0
7571044|NCT03519516|11949618|FG001|Overall Study|Adverse Event|1
7571045|NCT03519854|11949642|FG000|Overall Study|Technical Error|0
7571046|NCT03519854|11949643|FG001|Overall Study|Technical Error|0
7571047|NCT03519854|11949644|FG002|Overall Study|Technical Error|1
7571048|NCT03519854|11949645|FG003|Overall Study|Technical Error|0
7463601|NCT01859741|11761409|FG002|Overall Study|Withdrawal by Subject|2
7463602|NCT01859741|11761410|FG003|Overall Study|Withdrawal by Subject|0
7463603|NCT01859741|11761411|FG004|Overall Study|Withdrawal by Subject|0
7463604|NCT01859741|11761412|FG005|Overall Study|Withdrawal by Subject|1
7463605|NCT01859741|11761413|FG006|Overall Study|Withdrawal by Subject|1
7463606|NCT01859741|11761414|FG007|Overall Study|Withdrawal by Subject|1
7463607|NCT01859741|11761407|FG000|Overall Study|Study Terminated by Sponsor|0
7463608|NCT01859741|11761408|FG001|Overall Study|Study Terminated by Sponsor|0
7463609|NCT01859741|11761409|FG002|Overall Study|Study Terminated by Sponsor|0
7463610|NCT01859741|11761410|FG003|Overall Study|Study Terminated by Sponsor|0
7463611|NCT01859741|11761411|FG004|Overall Study|Study Terminated by Sponsor|1
7463612|NCT01859741|11761412|FG005|Overall Study|Study Terminated by Sponsor|0
7463613|NCT01859741|11761413|FG006|Overall Study|Study Terminated by Sponsor|16
7463614|NCT01859741|11761414|FG007|Overall Study|Study Terminated by Sponsor|14
7463615|NCT01859741|11761407|FG000|Overall Study|Other|0
7463616|NCT01859741|11761408|FG001|Overall Study|Other|0
7463617|NCT01859741|11761409|FG002|Overall Study|Other|0
7463618|NCT01859741|11761410|FG003|Overall Study|Other|0
7463619|NCT01859741|11761411|FG004|Overall Study|Other|0
7463620|NCT01859741|11761412|FG005|Overall Study|Other|0
7463621|NCT01859741|11761413|FG006|Overall Study|Other|2
7463622|NCT01859741|11761414|FG007|Overall Study|Other|0
7463623|NCT01859793|11761434|FG000|First Intervention (8 Weeks)|Protocol Violation|2
7463624|NCT01859793|11761435|FG001|First Intervention (8 Weeks)|Protocol Violation|0
7463625|NCT01859793|11761434|FG000|First Intervention (8 Weeks)|Adverse Event|1
7463626|NCT01859793|11761435|FG001|First Intervention (8 Weeks)|Adverse Event|0
7463627|NCT01859793|11761434|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7463628|NCT01859793|11761435|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7463629|NCT01859793|11761434|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
7463630|NCT01859793|11761435|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
7463631|NCT01859923|11761445|FG000|Overall Study|Adverse Event|0
7463632|NCT01859923|11761446|FG001|Overall Study|Adverse Event|0
7463633|NCT01859923|11761447|FG002|Overall Study|Adverse Event|1
7463634|NCT01859923|11761448|FG003|Overall Study|Adverse Event|1
7463635|NCT01859949|11761463|FG000|Overall Study|Family Matters|0
7463636|NCT01859949|11761464|FG001|Overall Study|Family Matters|1
7463637|NCT01859949|11761463|FG000|Overall Study|Physician Decision|2
7463638|NCT01859949|11761464|FG001|Overall Study|Physician Decision|4
7463639|NCT01859949|11761463|FG000|Overall Study|Withdrawal by Subject|11
7463640|NCT01859949|11761464|FG001|Overall Study|Withdrawal by Subject|10
7463641|NCT01859949|11761463|FG000|Overall Study|Protocol Violation|1
7463642|NCT01859949|11761464|FG001|Overall Study|Protocol Violation|1
7463643|NCT01859949|11761463|FG000|Overall Study|Adverse Event|0
7463644|NCT01859949|11761464|FG001|Overall Study|Adverse Event|1
7463645|NCT01859988|11761476|FG000|Overall Study|Withdrawal by Subject|6
7463646|NCT01859988|11761477|FG001|Overall Study|Withdrawal by Subject|3
7463647|NCT01859988|11761478|FG002|Overall Study|Withdrawal by Subject|4
7463648|NCT01859988|11761479|FG003|Overall Study|Withdrawal by Subject|3
7463649|NCT01859988|11761480|FG004|Overall Study|Withdrawal by Subject|2
7463650|NCT01859988|11761481|FG005|Overall Study|Withdrawal by Subject|2
7463651|NCT01859988|11761476|FG000|Overall Study|Lack of Efficacy|1
7463652|NCT01859988|11761477|FG001|Overall Study|Lack of Efficacy|1
7463653|NCT01859988|11761478|FG002|Overall Study|Lack of Efficacy|5
7463654|NCT01859988|11761479|FG003|Overall Study|Lack of Efficacy|0
7463655|NCT01859988|11761480|FG004|Overall Study|Lack of Efficacy|7
7463656|NCT01859988|11761481|FG005|Overall Study|Lack of Efficacy|9
7463657|NCT01859988|11761476|FG000|Overall Study|Physician Decision|1
7463658|NCT01859988|11761477|FG001|Overall Study|Physician Decision|3
7463659|NCT01859988|11761478|FG002|Overall Study|Physician Decision|1
7463660|NCT01859988|11761479|FG003|Overall Study|Physician Decision|3
7463661|NCT01859988|11761480|FG004|Overall Study|Physician Decision|4
7463662|NCT01859988|11761481|FG005|Overall Study|Physician Decision|1
7463663|NCT01859988|11761476|FG000|Overall Study|Adverse Event|2
7463664|NCT01859988|11761477|FG001|Overall Study|Adverse Event|1
7463665|NCT01859988|11761478|FG002|Overall Study|Adverse Event|3
7463666|NCT01859988|11761479|FG003|Overall Study|Adverse Event|1
7463667|NCT01859988|11761480|FG004|Overall Study|Adverse Event|2
7463668|NCT01859988|11761481|FG005|Overall Study|Adverse Event|2
7463669|NCT01859988|11761476|FG000|Overall Study|Lost to Follow-up|1
7463670|NCT01859988|11761477|FG001|Overall Study|Lost to Follow-up|2
7463671|NCT01859988|11761478|FG002|Overall Study|Lost to Follow-up|3
7463672|NCT01859988|11761479|FG003|Overall Study|Lost to Follow-up|0
7463673|NCT01859988|11761480|FG004|Overall Study|Lost to Follow-up|3
7463674|NCT01859988|11761481|FG005|Overall Study|Lost to Follow-up|2
7463675|NCT01859988|11761476|FG000|Overall Study|Protocol Violation|0
7463676|NCT01859988|11761477|FG001|Overall Study|Protocol Violation|0
7463677|NCT01859988|11761478|FG002|Overall Study|Protocol Violation|1
7463678|NCT01859988|11761479|FG003|Overall Study|Protocol Violation|0
7463679|NCT01859988|11761480|FG004|Overall Study|Protocol Violation|0
7463680|NCT01859988|11761481|FG005|Overall Study|Protocol Violation|0
7463681|NCT01859988|11761476|FG000|Overall Study|Other than specified above|0
7463682|NCT01859988|11761477|FG001|Overall Study|Other than specified above|2
7463683|NCT01859988|11761478|FG002|Overall Study|Other than specified above|11
7463684|NCT01859988|11761479|FG003|Overall Study|Other than specified above|3
7463685|NCT01859988|11761480|FG004|Overall Study|Other than specified above|5
7463686|NCT01859988|11761481|FG005|Overall Study|Other than specified above|3
7463687|NCT01860079|11761497|FG000|Overall Study|Physician Decision|14
7463688|NCT01860079|11761498|FG001|Overall Study|Physician Decision|22
7463689|NCT01860534|11761541|FG000|ROP #1|Needed treatment for ROP|0
7463690|NCT01860534|11761542|FG001|ROP #1|Needed treatment for ROP|1
7463691|NCT01860534|11761541|FG000|ROP #2|discharged prior to ROP #2|1
7463692|NCT01860534|11761542|FG001|ROP #2|discharged prior to ROP #2|0
7463693|NCT01860677|11761579|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
7463694|NCT01860677|11761580|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
7463695|NCT01860703|11761587|FG000|Overall Study|Adverse Event|1
7463696|NCT01860703|11761588|FG001|Overall Study|Adverse Event|4
7463697|NCT01860703|11761589|FG002|Overall Study|Adverse Event|0
7571049|NCT03519854|11949646|FG004|Overall Study|Technical Error|0
7463698|NCT01860703|11761590|FG003|Overall Study|Adverse Event|2
7463699|NCT01860703|11761587|FG000|Overall Study|Withdrawal by Subject|0
7463700|NCT01860703|11761588|FG001|Overall Study|Withdrawal by Subject|1
7463701|NCT01860703|11761589|FG002|Overall Study|Withdrawal by Subject|0
7571050|NCT03519854|11949647|FG005|Overall Study|Technical Error|0
7571051|NCT03519854|11949648|FG006|Overall Study|Technical Error|0
7571052|NCT03519854|11949649|FG007|Overall Study|Technical Error|0
7571053|NCT03519854|11949650|FG008|Overall Study|Technical Error|0
7571054|NCT03519854|11949651|FG009|Overall Study|Technical Error|0
7571055|NCT03519854|11949652|FG010|Overall Study|Technical Error|0
7571056|NCT03519854|11949653|FG011|Overall Study|Technical Error|0
7571057|NCT03519854|11949654|FG012|Overall Study|Technical Error|0
7571058|NCT03519854|11949655|FG013|Overall Study|Technical Error|0
7571059|NCT03519854|11949656|FG014|Overall Study|Technical Error|0
7571060|NCT03519854|11949657|FG015|Overall Study|Technical Error|0
7571061|NCT03519854|11949658|FG016|Overall Study|Technical Error|0
7571062|NCT03519854|11949659|FG017|Overall Study|Technical Error|0
7571063|NCT03519867|11949707|FG000|Overall Study|Adverse Event|1
7571064|NCT03519867|11949708|FG001|Overall Study|Adverse Event|1
7571065|NCT03519867|11949709|FG002|Overall Study|Adverse Event|0
7571066|NCT03519867|11949710|FG003|Overall Study|Adverse Event|0
7571067|NCT03519867|11949711|FG004|Overall Study|Adverse Event|0
7571068|NCT03519867|11949712|FG005|Overall Study|Adverse Event|0
7571069|NCT03519867|11949713|FG006|Overall Study|Adverse Event|0
7571070|NCT03519867|11949714|FG007|Overall Study|Adverse Event|0
7463702|NCT01860703|11761590|FG003|Overall Study|Withdrawal by Subject|0
7463703|NCT01860703|11761587|FG000|Overall Study|Personal reason|1
7463704|NCT01860703|11761588|FG001|Overall Study|Personal reason|0
7463705|NCT01860703|11761589|FG002|Overall Study|Personal reason|1
7463706|NCT01860703|11761590|FG003|Overall Study|Personal reason|0
7463707|NCT01860846|11761615|FG000|Overall Study|Lost to Follow-up|33
7463708|NCT01860989|11761645|FG000|Overall Study|Unsatisfactory therapeutic|5
7463709|NCT01861522|11761690|FG000|Overall Study|Adverse Event|1
7463710|NCT01861522|11761691|FG001|Overall Study|Adverse Event|0
7463711|NCT01861522|11761690|FG000|Overall Study|Withdrawal by Subject|2
7463712|NCT01861522|11761691|FG001|Overall Study|Withdrawal by Subject|0
7463713|NCT01862029|11761771|FG000|Overall Study|Physician Decision|1
7463714|NCT01862250|11761787|FG000|Overall Study|Adverse Event|4
7463715|NCT01862328|11761798|FG000|Overall Study|Progressive Disease|3
7463716|NCT01862328|11761799|FG001|Overall Study|Progressive Disease|11
7463717|NCT01862328|11761800|FG002|Overall Study|Progressive Disease|5
7463718|NCT01862328|11761801|FG003|Overall Study|Progressive Disease|6
7463719|NCT01862328|11761802|FG004|Overall Study|Progressive Disease|7
7463720|NCT01862328|11761803|FG005|Overall Study|Progressive Disease|4
7463721|NCT01862328|11761804|FG006|Overall Study|Progressive Disease|3
7463722|NCT01862328|11761798|FG000|Overall Study|Adverse Event|0
7463723|NCT01862328|11761799|FG001|Overall Study|Adverse Event|4
7463724|NCT01862328|11761800|FG002|Overall Study|Adverse Event|0
7463725|NCT01862328|11761801|FG003|Overall Study|Adverse Event|1
7463726|NCT01862328|11761802|FG004|Overall Study|Adverse Event|0
7463727|NCT01862328|11761803|FG005|Overall Study|Adverse Event|2
7463728|NCT01862328|11761804|FG006|Overall Study|Adverse Event|4
7463729|NCT01862328|11761798|FG000|Overall Study|Other|0
7463730|NCT01862328|11761799|FG001|Overall Study|Other|2
7463731|NCT01862328|11761800|FG002|Overall Study|Other|1
7463732|NCT01862328|11761801|FG003|Overall Study|Other|0
7463733|NCT01862328|11761802|FG004|Overall Study|Other|4
7463734|NCT01862328|11761803|FG005|Overall Study|Other|0
7463735|NCT01862328|11761804|FG006|Overall Study|Other|1
7463736|NCT01862328|11761798|FG000|Overall Study|Withdrawal by Subject|1
7463737|NCT01862328|11761799|FG001|Overall Study|Withdrawal by Subject|1
7463738|NCT01862328|11761800|FG002|Overall Study|Withdrawal by Subject|0
7463739|NCT01862328|11761801|FG003|Overall Study|Withdrawal by Subject|0
7463740|NCT01862328|11761802|FG004|Overall Study|Withdrawal by Subject|1
7463741|NCT01862328|11761803|FG005|Overall Study|Withdrawal by Subject|1
7463742|NCT01862328|11761804|FG006|Overall Study|Withdrawal by Subject|1
7463743|NCT01862328|11761798|FG000|Overall Study|Symptomatic Deterioration|0
7463744|NCT01862328|11761799|FG001|Overall Study|Symptomatic Deterioration|0
7463745|NCT01862328|11761800|FG002|Overall Study|Symptomatic Deterioration|0
7463746|NCT01862328|11761801|FG003|Overall Study|Symptomatic Deterioration|0
7463747|NCT01862328|11761802|FG004|Overall Study|Symptomatic Deterioration|0
7463748|NCT01862328|11761803|FG005|Overall Study|Symptomatic Deterioration|0
7463749|NCT01862328|11761804|FG006|Overall Study|Symptomatic Deterioration|1
7463750|NCT01862484|11761837|FG000|Overall Study|Lack of Efficacy|1
7463751|NCT01862484|11761838|FG001|Overall Study|Lack of Efficacy|1
7463752|NCT01862484|11761837|FG000|Overall Study|Lost to Follow-up|1
7463753|NCT01862484|11761838|FG001|Overall Study|Lost to Follow-up|2
7463754|NCT01862484|11761837|FG000|Overall Study|Protocol Violation|0
7463755|NCT01862484|11761838|FG001|Overall Study|Protocol Violation|2
7463756|NCT01862484|11761837|FG000|Overall Study|Withdrawal by Subject|0
7463757|NCT01862484|11761838|FG001|Overall Study|Withdrawal by Subject|3
7463758|NCT01862640|11761866|FG000|Overall Study|Adverse Event|4
7463759|NCT01862640|11761867|FG001|Overall Study|Adverse Event|10
7463760|NCT01862640|11761868|FG002|Overall Study|Adverse Event|6
7463761|NCT01862640|11761869|FG003|Overall Study|Adverse Event|8
7463762|NCT01862640|11761866|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7463763|NCT01862640|11761867|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7463764|NCT01862640|11761868|FG002|Overall Study|Participant Met Withdrawal Criteria|2
7463765|NCT01862640|11761869|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7463766|NCT01862640|11761866|FG000|Overall Study|Participant Withdrawn by Investigator|0
7463767|NCT01862640|11761867|FG001|Overall Study|Participant Withdrawn by Investigator|1
7463768|NCT01862640|11761868|FG002|Overall Study|Participant Withdrawn by Investigator|1
7463769|NCT01862640|11761869|FG003|Overall Study|Participant Withdrawn by Investigator|1
7533486|NCT02687542|11879972|FG000|Overall Study|Other|5
7463770|NCT01862640|11761866|FG000|Overall Study|Withdrawal by Subject|2
7463771|NCT01862640|11761867|FG001|Overall Study|Withdrawal by Subject|4
7463772|NCT01862640|11761868|FG002|Overall Study|Withdrawal by Subject|8
7463773|NCT01862640|11761869|FG003|Overall Study|Withdrawal by Subject|5
7463774|NCT01862640|11761866|FG000|Overall Study|Protocol Deviation|0
7463775|NCT01862640|11761867|FG001|Overall Study|Protocol Deviation|0
7463776|NCT01862640|11761868|FG002|Overall Study|Protocol Deviation|1
7463777|NCT01862640|11761869|FG003|Overall Study|Protocol Deviation|0
7463778|NCT01862796|11761881|FG000|Overall Study|Prohibited medications|0
7463779|NCT01862796|11761882|FG001|Overall Study|Prohibited medications|0
7463780|NCT01862796|11761883|FG002|Overall Study|Prohibited medications|1
7463781|NCT01862874|11761893|FG000|Overall Study|Randomized not treated|1
7463782|NCT01862874|11761894|FG001|Overall Study|Randomized not treated|0
7463783|NCT01862874|11761893|FG000|Overall Study|Adverse Event|0
7463784|NCT01862874|11761894|FG001|Overall Study|Adverse Event|3
7463785|NCT01862874|11761893|FG000|Overall Study|Lost to Follow-up|26
7463786|NCT01862874|11761894|FG001|Overall Study|Lost to Follow-up|29
7463787|NCT01862874|11761893|FG000|Overall Study|Physician Decision|5
7463788|NCT01862874|11761894|FG001|Overall Study|Physician Decision|3
7463789|NCT01862874|11761893|FG000|Overall Study|Withdrawn by parent/guardian|1
7463790|NCT01862874|11761894|FG001|Overall Study|Withdrawn by parent/guardian|1
7463791|NCT01862874|11761893|FG000|Overall Study|Withdrawal by Subject|46
7463792|NCT01862874|11761894|FG001|Overall Study|Withdrawal by Subject|40
7463793|NCT01862874|11761893|FG000|Overall Study|Death|0
7463794|NCT01862874|11761894|FG001|Overall Study|Death|1
7463795|NCT01862991|11761903|FG000|Overall Study|Lost to Follow-up|2
7463796|NCT01862991|11761904|FG001|Overall Study|Lost to Follow-up|1
7463797|NCT01862991|11761905|FG002|Overall Study|Lost to Follow-up|1
7463798|NCT01862991|11761903|FG000|Overall Study|Protocol Violation|1
7463799|NCT01862991|11761904|FG001|Overall Study|Protocol Violation|0
7463800|NCT01862991|11761905|FG002|Overall Study|Protocol Violation|0
7463801|NCT01863368|11761938|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
7463802|NCT01863368|11761939|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
7463803|NCT01863368|11761938|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
7463804|NCT01863368|11761939|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
7463805|NCT01863368|11761938|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
7463806|NCT01863368|11761939|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
7463807|NCT01863368|11761938|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
7463808|NCT01863368|11761939|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
7463809|NCT01863368|11761938|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
7463810|NCT01863368|11761939|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
7463811|NCT01863368|11761938|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
7463812|NCT01863368|11761939|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
7463813|NCT01863433|11761946|FG000|Overall Study|Protocol Violation|1
7463814|NCT01863667|11761965|FG000|Overall Study|Adverse Event|1
7463815|NCT01863667|11761966|FG001|Overall Study|Adverse Event|0
7463816|NCT01863667|11761965|FG000|Overall Study|Study terminated by Sponsor|30
7463817|NCT01863667|11761966|FG001|Overall Study|Study terminated by Sponsor|30
7463818|NCT01863667|11761965|FG000|Overall Study|Withdrawal by Subject|2
7463819|NCT01863667|11761966|FG001|Overall Study|Withdrawal by Subject|2
7463820|NCT01863680|11761972|FG000|Overall Study|Adverse Event|17
7463821|NCT01863680|11761972|FG000|Overall Study|Risk of OHSS|17
7463822|NCT01863680|11761972|FG000|Overall Study|Spontaneous pregnancy|2
7463823|NCT01863680|11761972|FG000|Overall Study|Withdrawal by Subject|1
7463824|NCT01863680|11761972|FG000|Overall Study|Did not undergo IVF/ET|14
7463825|NCT01863680|11761972|FG000|Overall Study|Other|6
7463826|NCT01863732|11761980|FG000|Overall Study|Adverse Event|2
7463827|NCT01863732|11761981|FG001|Overall Study|Adverse Event|0
7463828|NCT01863732|11761982|FG002|Overall Study|Adverse Event|3
7463829|NCT01863732|11761983|FG003|Overall Study|Adverse Event|3
7463830|NCT01863732|11761980|FG000|Overall Study|Lack of Efficacy|1
7463831|NCT01863732|11761981|FG001|Overall Study|Lack of Efficacy|0
7463832|NCT01863732|11761982|FG002|Overall Study|Lack of Efficacy|2
7463833|NCT01863732|11761983|FG003|Overall Study|Lack of Efficacy|1
7463834|NCT01863732|11761980|FG000|Overall Study|Lost to Follow-up|2
7463835|NCT01863732|11761981|FG001|Overall Study|Lost to Follow-up|2
7463836|NCT01863732|11761982|FG002|Overall Study|Lost to Follow-up|1
7463837|NCT01863732|11761983|FG003|Overall Study|Lost to Follow-up|1
7463838|NCT01863732|11761980|FG000|Overall Study|Physician Decision|1
7463839|NCT01863732|11761981|FG001|Overall Study|Physician Decision|0
7463840|NCT01863732|11761982|FG002|Overall Study|Physician Decision|1
7463841|NCT01863732|11761983|FG003|Overall Study|Physician Decision|0
7463842|NCT01863732|11761980|FG000|Overall Study|Pregnancy|0
7463843|NCT01863732|11761981|FG001|Overall Study|Pregnancy|0
7463844|NCT01863732|11761982|FG002|Overall Study|Pregnancy|0
7463845|NCT01863732|11761983|FG003|Overall Study|Pregnancy|1
7463846|NCT01863732|11761980|FG000|Overall Study|Technical problems|0
7463847|NCT01863732|11761981|FG001|Overall Study|Technical problems|1
7463848|NCT01863732|11761982|FG002|Overall Study|Technical problems|1
7463849|NCT01863732|11761983|FG003|Overall Study|Technical problems|0
7463850|NCT01863732|11761980|FG000|Overall Study|Subject/guardian decision|6
7463851|NCT01863732|11761981|FG001|Overall Study|Subject/guardian decision|9
7463852|NCT01863732|11761982|FG002|Overall Study|Subject/guardian decision|3
7463853|NCT01863732|11761983|FG003|Overall Study|Subject/guardian decision|1
7463854|NCT01863732|11761980|FG000|Overall Study|Death|1
7463855|NCT01863732|11761981|FG001|Overall Study|Death|0
7463856|NCT01863732|11761982|FG002|Overall Study|Death|0
7463857|NCT01863732|11761983|FG003|Overall Study|Death|1
7463858|NCT01863758|11761992|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
7463859|NCT01863758|11761992|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
7463860|NCT01863771|11761996|FG000|Induction Phase|Adverse Event|9
7463861|NCT01863771|11761997|FG001|Induction Phase|Adverse Event|0
7463862|NCT01863771|11761998|FG002|Induction Phase|Adverse Event|0
7463863|NCT01863771|11761999|FG003|Induction Phase|Adverse Event|0
7463864|NCT01863771|11761996|FG000|Induction Phase|Lack of Efficacy|10
7463865|NCT01863771|11761997|FG001|Induction Phase|Lack of Efficacy|0
7463866|NCT01863771|11761998|FG002|Induction Phase|Lack of Efficacy|0
7463867|NCT01863771|11761999|FG003|Induction Phase|Lack of Efficacy|0
7463868|NCT01863771|11761996|FG000|Induction Phase|Withdrawal by Subject|2
7463869|NCT01863771|11761997|FG001|Induction Phase|Withdrawal by Subject|0
7463870|NCT01863771|11761998|FG002|Induction Phase|Withdrawal by Subject|0
7463871|NCT01863771|11761999|FG003|Induction Phase|Withdrawal by Subject|0
7463872|NCT01863771|11761996|FG000|Maintenance Phase|Adverse Event|0
7463873|NCT01863771|11761997|FG001|Maintenance Phase|Adverse Event|0
7463874|NCT01863771|11761998|FG002|Maintenance Phase|Adverse Event|1
7463875|NCT01863771|11761999|FG003|Maintenance Phase|Adverse Event|1
7463876|NCT01863771|11761996|FG000|Maintenance Phase|Lack of Efficacy|0
7463877|NCT01863771|11761997|FG001|Maintenance Phase|Lack of Efficacy|3
7533487|NCT02687542|11879973|FG001|Overall Study|Other|9
7533488|NCT02687542|11879974|FG002|Overall Study|Other|10
7463878|NCT01863771|11761998|FG002|Maintenance Phase|Lack of Efficacy|7
7463879|NCT01863771|11761999|FG003|Maintenance Phase|Lack of Efficacy|38
7463880|NCT01863771|11761996|FG000|Maintenance Phase|Physician Decision|0
7463881|NCT01863771|11761997|FG001|Maintenance Phase|Physician Decision|0
7463882|NCT01863771|11761998|FG002|Maintenance Phase|Physician Decision|2
7463883|NCT01863771|11761999|FG003|Maintenance Phase|Physician Decision|1
7463884|NCT01863771|11761996|FG000|Maintenance Phase|Pregnancy|0
7463885|NCT01863771|11761997|FG001|Maintenance Phase|Pregnancy|1
7463886|NCT01863771|11761998|FG002|Maintenance Phase|Pregnancy|0
7463887|NCT01863771|11761999|FG003|Maintenance Phase|Pregnancy|0
7463888|NCT01863771|11761996|FG000|Maintenance Phase|Withdrawal by Subject|0
7463889|NCT01863771|11761997|FG001|Maintenance Phase|Withdrawal by Subject|1
7463890|NCT01863771|11761998|FG002|Maintenance Phase|Withdrawal by Subject|2
7463891|NCT01863771|11761999|FG003|Maintenance Phase|Withdrawal by Subject|3
7463892|NCT01863849|11762009|FG000|Overall Study|Lost to Follow-up|1
7463893|NCT01863849|11762010|FG001|Overall Study|Lost to Follow-up|0
7463894|NCT01863953|11762020|FG000|Overall Study|Adverse Event|0
7463895|NCT01863953|11762021|FG001|Overall Study|Adverse Event|0
7463896|NCT01863953|11762022|FG002|Overall Study|Adverse Event|1
7463897|NCT01864005|11762032|FG000|Overall Study|Protocol Violation|0
7463898|NCT01864005|11762033|FG001|Overall Study|Protocol Violation|1
7463899|NCT01864005|11762032|FG000|Overall Study|Withdrawal by Subject|0
7463900|NCT01864005|11762033|FG001|Overall Study|Withdrawal by Subject|1
7463901|NCT01864005|11762032|FG000|Overall Study|Incorrect enrolment|1
7463902|NCT01864005|11762033|FG001|Overall Study|Incorrect enrolment|0
7463903|NCT01864005|11762032|FG000|Overall Study|Disease need|1
7463904|NCT01864005|11762033|FG001|Overall Study|Disease need|1
7463905|NCT01864005|11762032|FG000|Overall Study|Need GP IIb/IIIa|1
7463906|NCT01864005|11762033|FG001|Overall Study|Need GP IIb/IIIa|3
7463907|NCT01864148|11762044|FG000|Overall Study|Other|2
7463908|NCT01864148|11762045|FG001|Overall Study|Other|1
7463909|NCT01864148|11762046|FG002|Overall Study|Other|1
7463910|NCT01864148|11762047|FG003|Overall Study|Other|3
7463911|NCT01864148|11762048|FG004|Overall Study|Other|1
7463912|NCT01864148|11762044|FG000|Overall Study|Death|0
7463913|NCT01864148|11762045|FG001|Overall Study|Death|0
7463914|NCT01864148|11762046|FG002|Overall Study|Death|0
7463915|NCT01864148|11762047|FG003|Overall Study|Death|1
7463916|NCT01864148|11762048|FG004|Overall Study|Death|0
7463917|NCT01864148|11762044|FG000|Overall Study|Investigator Decision|5
7463918|NCT01864148|11762045|FG001|Overall Study|Investigator Decision|0
7463919|NCT01864148|11762046|FG002|Overall Study|Investigator Decision|0
7463920|NCT01864148|11762047|FG003|Overall Study|Investigator Decision|4
7463921|NCT01864148|11762048|FG004|Overall Study|Investigator Decision|6
7463922|NCT01864148|11762044|FG000|Overall Study|Withdrawal by Subject|9
7463923|NCT01864148|11762045|FG001|Overall Study|Withdrawal by Subject|2
7463924|NCT01864148|11762046|FG002|Overall Study|Withdrawal by Subject|6
7463925|NCT01864148|11762047|FG003|Overall Study|Withdrawal by Subject|8
7463926|NCT01864148|11762048|FG004|Overall Study|Withdrawal by Subject|8
7463927|NCT01864148|11762044|FG000|Overall Study|Lost to Follow-up|0
7463928|NCT01864148|11762045|FG001|Overall Study|Lost to Follow-up|0
7463929|NCT01864148|11762046|FG002|Overall Study|Lost to Follow-up|0
7463930|NCT01864148|11762047|FG003|Overall Study|Lost to Follow-up|2
7463931|NCT01864148|11762048|FG004|Overall Study|Lost to Follow-up|1
7463932|NCT01864148|11762044|FG000|Overall Study|Adverse Event|4
7463933|NCT01864148|11762045|FG001|Overall Study|Adverse Event|2
7463934|NCT01864148|11762046|FG002|Overall Study|Adverse Event|4
7463935|NCT01864148|11762047|FG003|Overall Study|Adverse Event|7
7463936|NCT01864148|11762048|FG004|Overall Study|Adverse Event|7
7463937|NCT01864148|11762044|FG000|Overall Study|Not Dosed|0
7463938|NCT01864148|11762045|FG001|Overall Study|Not Dosed|0
7463939|NCT01864148|11762046|FG002|Overall Study|Not Dosed|0
7463940|NCT01864148|11762047|FG003|Overall Study|Not Dosed|1
7463941|NCT01864148|11762048|FG004|Overall Study|Not Dosed|0
7463942|NCT01864174|11762067|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
7463943|NCT01864174|11762068|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
7533489|NCT02687542|11879975|FG003|Overall Study|Other|6
7533490|NCT02687542|11879976|FG004|Overall Study|Other|5
7463944|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Adverse Event|6
7463945|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Adverse Event|1
7463946|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
7463947|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
7463948|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
7463949|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
7463950|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Death|1
7463951|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Death|0
7463952|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
7463953|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
7463954|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
7463955|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
7533491|NCT02687542|11879972|FG000|Overall Study|Adverse Event|3
7463956|NCT01864174|11762067|FG000|Double Blind - Compliant Randomized|Other|6
7463957|NCT01864174|11762068|FG001|Double Blind - Compliant Randomized|Other|10
7463958|NCT01864174|11762067|FG000|Off Treatment Follow-Up|Other|2
7463959|NCT01864174|11762068|FG001|Off Treatment Follow-Up|Other|0
7463960|NCT01864174|11762067|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
7463961|NCT01864174|11762068|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
7463962|NCT01864200|11762076|FG000|Overall Study|Lost to Follow-up|1
7463963|NCT01864200|11762077|FG001|Overall Study|Lost to Follow-up|3
7463964|NCT01864200|11762076|FG000|Overall Study|Protocol Violation|1
7463965|NCT01864200|11762077|FG001|Overall Study|Protocol Violation|0
7468506|NCT01911780|11769380|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
7468507|NCT01911780|11769381|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
7468508|NCT01911780|11769380|FG000|Extension Period (52 Weeks)|Personal reason|1
7468509|NCT01911780|11769381|FG001|Extension Period (52 Weeks)|Personal reason|1
7468510|NCT01911819|11769394|FG000|Overall Study|Adverse Event|0
7463966|NCT01864291|11762083|FG000|Overall Study|need for revision surgery|2
7463967|NCT01864525|11762098|FG000|Overall Study|Adverse Event|1
7463968|NCT01864525|11762099|FG001|Overall Study|Adverse Event|0
7463969|NCT01864564|11762111|FG000|Overall Study|Lost to Follow-up|17
7463970|NCT01864564|11762112|FG001|Overall Study|Lost to Follow-up|23
7463971|NCT01864564|11762111|FG000|Overall Study|Withdrawal by Subject|20
7463972|NCT01864564|11762112|FG001|Overall Study|Withdrawal by Subject|11
7463973|NCT01864564|11762111|FG000|Overall Study|Protocol Violation|0
7463974|NCT01864564|11762112|FG001|Overall Study|Protocol Violation|27
7463975|NCT01864564|11762111|FG000|Overall Study|not reported|0
7463976|NCT01864564|11762112|FG001|Overall Study|not reported|34
7463977|NCT01865084|11762121|FG000|Double Blind Period (DB)|Adverse Event|2
7463978|NCT01865084|11762122|FG001|Double Blind Period (DB)|Adverse Event|2
7463979|NCT01865084|11762123|FG002|Double Blind Period (DB)|Adverse Event|1
7463980|NCT01865084|11762121|FG000|Double Blind Period (DB)|Protocol Violation|0
7463981|NCT01865084|11762122|FG001|Double Blind Period (DB)|Protocol Violation|0
7463982|NCT01865084|11762123|FG002|Double Blind Period (DB)|Protocol Violation|1
7463983|NCT01865084|11762121|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7463984|NCT01865084|11762122|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
7463985|NCT01865084|11762123|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
7463986|NCT01865084|11762121|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
7463987|NCT01865084|11762122|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
7463988|NCT01865084|11762123|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
7463989|NCT01865084|11762121|FG000|Open Label Extension (OLE) Period|Adverse Event|0
7463990|NCT01865084|11762122|FG001|Open Label Extension (OLE) Period|Adverse Event|0
7463991|NCT01865084|11762123|FG002|Open Label Extension (OLE) Period|Adverse Event|1
7463992|NCT01865084|11762121|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
7463993|NCT01865084|11762122|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
7463994|NCT01865084|11762123|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
7463995|NCT01865084|11762121|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
7463996|NCT01865084|11762122|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
7463997|NCT01865084|11762123|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
7463998|NCT01865084|11762121|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
7463999|NCT01865084|11762122|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
7464000|NCT01865084|11762123|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
7464001|NCT01865084|11762121|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
7464002|NCT01865084|11762122|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7464003|NCT01865084|11762123|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
7464004|NCT01865448|11762137|FG000|Overall Study|Adverse Event|1
7464005|NCT01865448|11762138|FG001|Overall Study|Adverse Event|1
7464006|NCT01865448|11762137|FG000|Overall Study|Pregnancy|0
7464007|NCT01865448|11762138|FG001|Overall Study|Pregnancy|1
7464008|NCT01865448|11762137|FG000|Overall Study|dropout unrelated to study|1
7464009|NCT01865448|11762138|FG001|Overall Study|dropout unrelated to study|1
7464010|NCT01865487|11762151|FG000|Overall Study|Lost to Follow-up|0
7464011|NCT01865487|11762152|FG001|Overall Study|Lost to Follow-up|0
7464012|NCT01865487|11762153|FG002|Overall Study|Lost to Follow-up|0
7464013|NCT01865487|11762154|FG003|Overall Study|Lost to Follow-up|1
7464014|NCT01865487|11762155|FG004|Overall Study|Lost to Follow-up|0
7464015|NCT01865487|11762156|FG005|Overall Study|Lost to Follow-up|0
7464016|NCT01865487|11762157|FG006|Overall Study|Lost to Follow-up|1
7464017|NCT01865487|11762158|FG007|Overall Study|Lost to Follow-up|0
7464018|NCT01865487|11762159|FG008|Overall Study|Lost to Follow-up|0
7464019|NCT01865487|11762160|FG009|Overall Study|Lost to Follow-up|0
7464020|NCT01865487|11762151|FG000|Overall Study|Withdrawal by Subject|0
7464021|NCT01865487|11762152|FG001|Overall Study|Withdrawal by Subject|0
7464022|NCT01865487|11762153|FG002|Overall Study|Withdrawal by Subject|0
7464023|NCT01865487|11762154|FG003|Overall Study|Withdrawal by Subject|0
7464024|NCT01865487|11762155|FG004|Overall Study|Withdrawal by Subject|1
7464025|NCT01865487|11762156|FG005|Overall Study|Withdrawal by Subject|0
7464026|NCT01865487|11762157|FG006|Overall Study|Withdrawal by Subject|0
7464027|NCT01865487|11762158|FG007|Overall Study|Withdrawal by Subject|0
7464028|NCT01865487|11762159|FG008|Overall Study|Withdrawal by Subject|0
7464029|NCT01865487|11762160|FG009|Overall Study|Withdrawal by Subject|0
7464030|NCT01865552|11762194|FG000|Period 1|Adverse Event|1
7464031|NCT01865552|11762195|FG001|Period 1|Adverse Event|0
7464032|NCT01865552|11762196|FG002|Period 1|Adverse Event|0
7464033|NCT01865552|11762197|FG003|Period 1|Adverse Event|1
7464034|NCT01865552|11762198|FG004|Period 1|Adverse Event|1
7533492|NCT02687542|11879973|FG001|Overall Study|Adverse Event|1
7464035|NCT01865552|11762199|FG005|Period 1|Adverse Event|1
7464036|NCT01865552|11762194|FG000|Period 1|Pathological lab|0
7464037|NCT01865552|11762195|FG001|Period 1|Pathological lab|0
7464038|NCT01865552|11762196|FG002|Period 1|Pathological lab|0
7464039|NCT01865552|11762197|FG003|Period 1|Pathological lab|0
7464040|NCT01865552|11762198|FG004|Period 1|Pathological lab|1
7464041|NCT01865552|11762199|FG005|Period 1|Pathological lab|0
7464042|NCT01865552|11762194|FG000|Period 1|Other|0
7464043|NCT01865552|11762195|FG001|Period 1|Other|0
7464044|NCT01865552|11762196|FG002|Period 1|Other|0
7464045|NCT01865552|11762197|FG003|Period 1|Other|0
7464046|NCT01865552|11762198|FG004|Period 1|Other|1
7464047|NCT01865552|11762199|FG005|Period 1|Other|0
7464048|NCT01865747|11762219|FG000|Overall Study (ITT)|Adverse Event|32
7464049|NCT01865747|11762220|FG001|Overall Study (ITT)|Adverse Event|31
7464050|NCT01865747|11762219|FG000|Overall Study (ITT)|Clinical Deterioration|29
7464051|NCT01865747|11762220|FG001|Overall Study (ITT)|Clinical Deterioration|50
7464052|NCT01865747|11762219|FG000|Overall Study (ITT)|Lack of Efficacy|3
7464053|NCT01865747|11762220|FG001|Overall Study (ITT)|Lack of Efficacy|0
7464054|NCT01865747|11762219|FG000|Overall Study (ITT)|Protocol Violation|1
7464055|NCT01865747|11762220|FG001|Overall Study (ITT)|Protocol Violation|1
7464056|NCT01865747|11762219|FG000|Overall Study (ITT)|Physician Decision|5
7464057|NCT01865747|11762220|FG001|Overall Study (ITT)|Physician Decision|2
7464058|NCT01865747|11762219|FG000|Overall Study (ITT)|Withdrawal by Subject|6
7464059|NCT01865747|11762220|FG001|Overall Study (ITT)|Withdrawal by Subject|11
7464060|NCT01865747|11762219|FG000|Overall Study (ITT)|Sponsor Decision|0
7464061|NCT01865747|11762220|FG001|Overall Study (ITT)|Sponsor Decision|1
7464062|NCT01865747|11762219|FG000|Overall Study (ITT)|Progressive Disease|122
7464063|NCT01865747|11762220|FG001|Overall Study (ITT)|Progressive Disease|158
7464064|NCT01865747|11762219|FG000|Overall Study (ITT)|Reason Not Provided|0
7464065|NCT01865747|11762220|FG001|Overall Study (ITT)|Reason Not Provided|1
7464066|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
7464067|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
7464068|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
7464069|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
7464070|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
7464071|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
7464072|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
7464073|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
7464074|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
7464075|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
7464076|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
7464077|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
7464078|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
7464079|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
7464080|NCT01865747|11762219|FG000|Primary Intent to Treat (PITT)|Other|0
7464081|NCT01865747|11762220|FG001|Primary Intent to Treat (PITT)|Other|1
7464083|NCT01866098|11762233|FG000|Overall Study|Lost to Follow-up|11
7464084|NCT01866098|11762234|FG001|Overall Study|Lost to Follow-up|18
7464085|NCT01866098|11762235|FG002|Overall Study|Lost to Follow-up|13
7464086|NCT01866098|11762233|FG000|Overall Study|Physician Decision|0
7464087|NCT01866098|11762234|FG001|Overall Study|Physician Decision|1
7464088|NCT01866098|11762235|FG002|Overall Study|Physician Decision|2
7464089|NCT01866098|11762233|FG000|Overall Study|Adverse Event|1
7464090|NCT01866098|11762234|FG001|Overall Study|Adverse Event|5
7464091|NCT01866098|11762235|FG002|Overall Study|Adverse Event|4
7464092|NCT01866098|11762233|FG000|Overall Study|Protocol Violation|1
7464093|NCT01866098|11762234|FG001|Overall Study|Protocol Violation|0
7464094|NCT01866098|11762235|FG002|Overall Study|Protocol Violation|0
7464095|NCT01866098|11762233|FG000|Overall Study|Withdrawal by Subject|1
7464096|NCT01866098|11762234|FG001|Overall Study|Withdrawal by Subject|2
7464097|NCT01866098|11762235|FG002|Overall Study|Withdrawal by Subject|0
7464098|NCT01866098|11762233|FG000|Overall Study|Unrelated Hospitalization|2
7464099|NCT01866098|11762234|FG001|Overall Study|Unrelated Hospitalization|0
7533493|NCT02687542|11879974|FG002|Overall Study|Adverse Event|3
7464100|NCT01866098|11762235|FG002|Overall Study|Unrelated Hospitalization|1
7464101|NCT01866098|11762233|FG000|Overall Study|Non-compliance|1
7464102|NCT01866098|11762234|FG001|Overall Study|Non-compliance|0
7464103|NCT01866098|11762235|FG002|Overall Study|Non-compliance|1
7464104|NCT01866098|11762233|FG000|Overall Study|Pregnancy|2
7464105|NCT01866098|11762234|FG001|Overall Study|Pregnancy|0
7464106|NCT01866098|11762235|FG002|Overall Study|Pregnancy|0
7464107|NCT01866098|11762233|FG000|Overall Study|Death|0
7464108|NCT01866098|11762234|FG001|Overall Study|Death|1
7464109|NCT01866098|11762235|FG002|Overall Study|Death|0
7464110|NCT01866293|11762259|FG000|Overall Study|Adverse Event|2
7464111|NCT01866319|11762295|FG000|Overall Study|Adverse Event|12
7464112|NCT01866319|11762296|FG001|Overall Study|Adverse Event|5
7464113|NCT01866319|11762297|FG002|Overall Study|Adverse Event|9
7464114|NCT01866319|11762295|FG000|Overall Study|Clinical progression|3
7464115|NCT01866319|11762296|FG001|Overall Study|Clinical progression|2
7464116|NCT01866319|11762297|FG002|Overall Study|Clinical progression|2
7464117|NCT01866319|11762295|FG000|Overall Study|Death|153
7464118|NCT01866319|11762296|FG001|Overall Study|Death|154
7464119|NCT01866319|11762297|FG002|Overall Study|Death|147
7464120|NCT01866319|11762295|FG000|Overall Study|Lost to Follow-up|6
7464121|NCT01866319|11762296|FG001|Overall Study|Lost to Follow-up|3
7464122|NCT01866319|11762297|FG002|Overall Study|Lost to Follow-up|8
7464123|NCT01866319|11762295|FG000|Overall Study|Physician Decision|1
7464124|NCT01866319|11762296|FG001|Overall Study|Physician Decision|0
7464125|NCT01866319|11762297|FG002|Overall Study|Physician Decision|1
7464126|NCT01866319|11762295|FG000|Overall Study|Protocol Violation|0
7464127|NCT01866319|11762296|FG001|Overall Study|Protocol Violation|0
7464128|NCT01866319|11762297|FG002|Overall Study|Protocol Violation|1
7464129|NCT01866319|11762295|FG000|Overall Study|Withdrawal by Subject|32
7464130|NCT01866319|11762296|FG001|Overall Study|Withdrawal by Subject|14
7464131|NCT01866319|11762297|FG002|Overall Study|Withdrawal by Subject|12
7464132|NCT01866423|11762312|FG000|Overall Study|Lack of Efficacy|3
7464133|NCT01866423|11762312|FG000|Overall Study|Sponsor Decision|1
7571071|NCT03519867|11949715|FG008|Overall Study|Adverse Event|0
7571072|NCT03519867|11949716|FG009|Overall Study|Adverse Event|0
7571073|NCT03519867|11949707|FG000|Overall Study|Protocol Violation|0
7571074|NCT03519867|11949708|FG001|Overall Study|Protocol Violation|0
7571075|NCT03519867|11949709|FG002|Overall Study|Protocol Violation|0
7571076|NCT03519867|11949710|FG003|Overall Study|Protocol Violation|0
7464134|NCT01866826|11762320|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
7464135|NCT01866826|11762321|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
7464136|NCT01866826|11762320|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
7464137|NCT01866826|11762321|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
7464138|NCT01866826|11762320|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
7571077|NCT03519867|11949711|FG004|Overall Study|Protocol Violation|0
7571078|NCT03519867|11949712|FG005|Overall Study|Protocol Violation|1
7571079|NCT03519867|11949713|FG006|Overall Study|Protocol Violation|0
7571080|NCT03519867|11949714|FG007|Overall Study|Protocol Violation|0
7571081|NCT03519867|11949715|FG008|Overall Study|Protocol Violation|0
7571082|NCT03519867|11949716|FG009|Overall Study|Protocol Violation|0
7571083|NCT03519867|11949707|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
7571084|NCT03519867|11949708|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
7571085|NCT03519867|11949709|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
7571086|NCT03519867|11949710|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
7571087|NCT03519867|11949711|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
7571088|NCT03519867|11949712|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
7571089|NCT03519867|11949713|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
7571090|NCT03519867|11949714|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
7571091|NCT03519867|11949715|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
7571092|NCT03519867|11949716|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
7571093|NCT03519867|11949707|FG000|Overall Study|Admin. of other reversal agent|1
7571094|NCT03519867|11949708|FG001|Overall Study|Admin. of other reversal agent|1
7571095|NCT03519867|11949709|FG002|Overall Study|Admin. of other reversal agent|0
7571096|NCT03519867|11949710|FG003|Overall Study|Admin. of other reversal agent|0
7571097|NCT03519867|11949711|FG004|Overall Study|Admin. of other reversal agent|0
7571098|NCT03519867|11949712|FG005|Overall Study|Admin. of other reversal agent|1
7571099|NCT03519867|11949713|FG006|Overall Study|Admin. of other reversal agent|0
7571100|NCT03519867|11949714|FG007|Overall Study|Admin. of other reversal agent|0
7571101|NCT03519867|11949715|FG008|Overall Study|Admin. of other reversal agent|0
7571102|NCT03519867|11949716|FG009|Overall Study|Admin. of other reversal agent|0
7571103|NCT03519867|11949707|FG000|Overall Study|Reason not provided|1
7464139|NCT01866826|11762321|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
7464140|NCT01866917|11762333|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
7464141|NCT01866917|11762334|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
7464142|NCT01867008|11762352|FG000|Overall Study|Withdrawal by Subject|1
7464143|NCT01867021|11762358|FG000|Overall Study|Adverse Event|0
7464144|NCT01867021|11762359|FG001|Overall Study|Adverse Event|1
7464145|NCT01867021|11762358|FG000|Overall Study|Not Eligible|0
7464146|NCT01867021|11762359|FG001|Overall Study|Not Eligible|1
7464147|NCT01867021|11762358|FG000|Overall Study|Death|1
7464148|NCT01867021|11762359|FG001|Overall Study|Death|0
7464149|NCT01867021|11762358|FG000|Overall Study|Lost to Follow-up|0
7464150|NCT01867021|11762359|FG001|Overall Study|Lost to Follow-up|2
7464151|NCT01867021|11762358|FG000|Overall Study|Withdrawal by Subject|1
7464152|NCT01867021|11762359|FG001|Overall Study|Withdrawal by Subject|6
7464153|NCT01867047|11762372|FG000|Overall Study|Lost to Follow-up|3
7464154|NCT01867047|11762373|FG001|Overall Study|Lost to Follow-up|3
7464155|NCT01867047|11762372|FG000|Overall Study|Withdrawal by Subject|2
7464156|NCT01867047|11762373|FG001|Overall Study|Withdrawal by Subject|0
7464157|NCT01867047|11762372|FG000|Overall Study|Physician Decision|2
7464158|NCT01867047|11762373|FG001|Overall Study|Physician Decision|0
7464159|NCT01867047|11762372|FG000|Overall Study|surgery not indicated in protocol|1
7464160|NCT01867047|11762373|FG001|Overall Study|surgery not indicated in protocol|2
7464161|NCT01867086|11762383|FG000|Overall Study|Disease Progression|1
7464162|NCT01867216|11762403|FG000|Overall Study|Withdrawal by Subject|2
7464163|NCT01867216|11762404|FG001|Overall Study|Withdrawal by Subject|0
7464164|NCT01867216|11762405|FG002|Overall Study|Withdrawal by Subject|0
7464165|NCT01867216|11762406|FG003|Overall Study|Withdrawal by Subject|0
7464166|NCT01867216|11762407|FG004|Overall Study|Withdrawal by Subject|1
7464167|NCT01867216|11762408|FG005|Overall Study|Withdrawal by Subject|0
7464168|NCT01867216|11762409|FG006|Overall Study|Withdrawal by Subject|1
7464169|NCT01867216|11762403|FG000|Overall Study|Physician Decision|1
7464170|NCT01867216|11762404|FG001|Overall Study|Physician Decision|0
7464171|NCT01867216|11762405|FG002|Overall Study|Physician Decision|0
7464172|NCT01867216|11762406|FG003|Overall Study|Physician Decision|0
7464173|NCT01867216|11762407|FG004|Overall Study|Physician Decision|0
7464174|NCT01867216|11762408|FG005|Overall Study|Physician Decision|0
7464175|NCT01867216|11762409|FG006|Overall Study|Physician Decision|0
7464176|NCT01867216|11762403|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
7464177|NCT01867216|11762404|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
7464178|NCT01867216|11762405|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
7464179|NCT01867216|11762406|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
7464180|NCT01867216|11762407|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
7464181|NCT01867216|11762408|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
7464182|NCT01867216|11762409|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
7464183|NCT01867294|11762435|FG000|Overall Study|Withdrawal by Subject|1
7464184|NCT01867294|11762436|FG001|Overall Study|Withdrawal by Subject|1
7464185|NCT01867294|11762437|FG002|Overall Study|Withdrawal by Subject|0
7464186|NCT01867294|11762438|FG003|Overall Study|Withdrawal by Subject|0
7464187|NCT01867307|11762448|FG000|Overall Study|Protocol Violation|2
7464188|NCT01867307|11762449|FG001|Overall Study|Protocol Violation|0
7464189|NCT01867307|11762448|FG000|Overall Study|Other Adverse Event|1
7464190|NCT01867307|11762449|FG001|Overall Study|Other Adverse Event|3
7464191|NCT01867424|11762457|FG000|Overall Study|Patient noncompliance|2
7464192|NCT01867424|11762458|FG001|Overall Study|Patient noncompliance|1
7464211|NCT01867658|11762495|FG000|Overall Study|Withdrawal by Subject|6
7464212|NCT01867658|11762495|FG000|Overall Study|Death|2
7464213|NCT01867658|11762495|FG000|Overall Study|Subject could not be contacted|1
7464214|NCT01867671|11762501|FG000|Overall Study|Adverse Event|5
7464215|NCT01867671|11762502|FG001|Overall Study|Adverse Event|3
7464216|NCT01867671|11762501|FG000|Overall Study|Anaphylaxis|0
7464217|NCT01867671|11762502|FG001|Overall Study|Anaphylaxis|1
7464218|NCT01867671|11762501|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
7464219|NCT01867671|11762502|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
7464220|NCT01867671|11762501|FG000|Overall Study|Lost to Follow-up|0
7464221|NCT01867671|11762502|FG001|Overall Study|Lost to Follow-up|1
7464222|NCT01867671|11762501|FG000|Overall Study|Non-compliance with Study Drug|1
7464223|NCT01867671|11762502|FG001|Overall Study|Non-compliance with Study Drug|2
7464224|NCT01867671|11762501|FG000|Overall Study|Withdrawal by Subject|21
7464225|NCT01867671|11762502|FG001|Overall Study|Withdrawal by Subject|21
7464226|NCT01867710|11762512|FG000|Overall Study|Death|25
7464227|NCT01867710|11762513|FG001|Overall Study|Death|15
7464228|NCT01867710|11762514|FG002|Overall Study|Death|27
7464229|NCT01867710|11762515|FG003|Overall Study|Death|20
7464230|NCT01867710|11762512|FG000|Overall Study|Lost to Follow-up|3
7464231|NCT01867710|11762513|FG001|Overall Study|Lost to Follow-up|4
7464232|NCT01867710|11762514|FG002|Overall Study|Lost to Follow-up|3
7464233|NCT01867710|11762515|FG003|Overall Study|Lost to Follow-up|2
7464234|NCT01867710|11762512|FG000|Overall Study|Withdrawal of consent|2
7464235|NCT01867710|11762513|FG001|Overall Study|Withdrawal of consent|5
7464236|NCT01867710|11762514|FG002|Overall Study|Withdrawal of consent|1
7464237|NCT01867710|11762515|FG003|Overall Study|Withdrawal of consent|2
7464238|NCT01867710|11762512|FG000|Overall Study|Study Terminated by Sponsor|9
7464239|NCT01867710|11762513|FG001|Overall Study|Study Terminated by Sponsor|13
7464240|NCT01867710|11762514|FG002|Overall Study|Study Terminated by Sponsor|8
7464241|NCT01867710|11762515|FG003|Overall Study|Study Terminated by Sponsor|16
7464242|NCT01867710|11762512|FG000|Overall Study|Biochemical progression|0
7464243|NCT01867710|11762513|FG001|Overall Study|Biochemical progression|1
7464244|NCT01867710|11762514|FG002|Overall Study|Biochemical progression|0
7464245|NCT01867710|11762515|FG003|Overall Study|Biochemical progression|0
7464246|NCT01867710|11762512|FG000|Overall Study|Clinical progression|0
7464247|NCT01867710|11762513|FG001|Overall Study|Clinical progression|0
7464248|NCT01867710|11762514|FG002|Overall Study|Clinical progression|1
7464249|NCT01867710|11762515|FG003|Overall Study|Clinical progression|0
7464250|NCT01867710|11762512|FG000|Overall Study|Disease progression|1
7464251|NCT01867710|11762513|FG001|Overall Study|Disease progression|0
7464252|NCT01867710|11762514|FG002|Overall Study|Disease progression|0
7464253|NCT01867710|11762515|FG003|Overall Study|Disease progression|0
7464254|NCT01867710|11762512|FG000|Overall Study|Patient decision|0
7464255|NCT01867710|11762513|FG001|Overall Study|Patient decision|0
7464256|NCT01867710|11762514|FG002|Overall Study|Patient decision|0
7464257|NCT01867710|11762515|FG003|Overall Study|Patient decision|1
7464258|NCT01867710|11762512|FG000|Overall Study|Patient to follow subsequent treatment|0
7464259|NCT01867710|11762513|FG001|Overall Study|Patient to follow subsequent treatment|1
7464260|NCT01867710|11762514|FG002|Overall Study|Patient to follow subsequent treatment|0
7464261|NCT01867710|11762515|FG003|Overall Study|Patient to follow subsequent treatment|0
7464262|NCT01867710|11762512|FG000|Overall Study|Progressive disease|1
7464263|NCT01867710|11762513|FG001|Overall Study|Progressive disease|0
7464264|NCT01867710|11762514|FG002|Overall Study|Progressive disease|0
7464265|NCT01867710|11762515|FG003|Overall Study|Progressive disease|0
7464266|NCT01867710|11762512|FG000|Overall Study|Protocol Violation|0
7464267|NCT01867710|11762513|FG001|Overall Study|Protocol Violation|0
7464268|NCT01867710|11762514|FG002|Overall Study|Protocol Violation|0
7464269|NCT01867710|11762515|FG003|Overall Study|Protocol Violation|1
7464270|NCT01867710|11762512|FG000|Overall Study|PSA-progression|0
7464271|NCT01867710|11762513|FG001|Overall Study|PSA-progression|1
7464272|NCT01867710|11762514|FG002|Overall Study|PSA-progression|0
7464273|NCT01867710|11762515|FG003|Overall Study|PSA-progression|0
7464274|NCT01867710|11762512|FG000|Overall Study|Study medication no longer effective|0
7464275|NCT01867710|11762513|FG001|Overall Study|Study medication no longer effective|1
7464276|NCT01867710|11762514|FG002|Overall Study|Study medication no longer effective|0
7464277|NCT01867710|11762515|FG003|Overall Study|Study medication no longer effective|0
7464278|NCT01868009|11762525|FG000|Period 1 (5-9 Days)|Adverse Event|0
7464279|NCT01868009|11762526|FG001|Period 1 (5-9 Days)|Adverse Event|2
7464280|NCT01868009|11762525|FG000|Period 2 (5-9 Days)|Adverse Event|1
7464281|NCT01868009|11762526|FG001|Period 2 (5-9 Days)|Adverse Event|0
7464282|NCT01868009|11762525|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
7464283|NCT01868009|11762526|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
7464284|NCT01868022|11762541|FG000|Overall Study|Withdrawal by Subject|0
7464285|NCT01868022|11762542|FG001|Overall Study|Withdrawal by Subject|0
7464286|NCT01868022|11762543|FG002|Overall Study|Withdrawal by Subject|1
7464287|NCT01868022|11762544|FG003|Overall Study|Withdrawal by Subject|1
7464288|NCT01868022|11762545|FG004|Overall Study|Withdrawal by Subject|0
7464289|NCT01868022|11762546|FG005|Overall Study|Withdrawal by Subject|0
7533494|NCT02687542|11879975|FG003|Overall Study|Adverse Event|2
7533495|NCT02687542|11879976|FG004|Overall Study|Adverse Event|9
7533496|NCT02687542|11879972|FG000|Overall Study|Withdrawal by Subject|0
7533497|NCT02687542|11879973|FG001|Overall Study|Withdrawal by Subject|1
7533498|NCT02687542|11879974|FG002|Overall Study|Withdrawal by Subject|1
7533499|NCT02687542|11879975|FG003|Overall Study|Withdrawal by Subject|2
7533500|NCT02687542|11879976|FG004|Overall Study|Withdrawal by Subject|4
7533501|NCT02687711|11879988|FG000|Overall Study|Adverse Event|89
7533502|NCT02687711|11879988|FG000|Overall Study|Lack of Efficacy|70
7533503|NCT02687711|11879988|FG000|Overall Study|Lost to Follow-up|20
7533504|NCT02687711|11879988|FG000|Overall Study|Consent withdrawn|15
7533505|NCT02687711|11879988|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
7533506|NCT02687711|11879988|FG000|Overall Study|Too expensive|4
7533507|NCT02687711|11879988|FG000|Overall Study|Participant moved abroad|1
7533508|NCT02687711|11879988|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
7533509|NCT02687711|11879988|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
7533510|NCT02687711|11879988|FG000|Overall Study|Disliked taste|1
7533511|NCT02687711|11879988|FG000|Overall Study|Low mood|1
7533512|NCT02687711|11879988|FG000|Overall Study|Side effects|1
7533513|NCT02687711|11879988|FG000|Overall Study|Change of Hospital|1
7533514|NCT02687711|11879988|FG000|Overall Study|Liver Encephalopathy|1
7533515|NCT02687711|11879988|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
7533516|NCT02687711|11879988|FG000|Overall Study|Withdrawn due to intake interruption|1
7533517|NCT02687711|11879988|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
7533518|NCT02687711|11879988|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
7533519|NCT02687711|11879988|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
7533520|NCT02687815|11879994|FG000|Overall Study|Lost to Follow-up|2
7464290|NCT01868022|11762547|FG006|Overall Study|Withdrawal by Subject|0
7464291|NCT01868022|11762548|FG007|Overall Study|Withdrawal by Subject|1
7464292|NCT01868022|11762549|FG008|Overall Study|Withdrawal by Subject|0
7464293|NCT01868022|11762541|FG000|Overall Study|Adverse Event|0
7464294|NCT01868022|11762542|FG001|Overall Study|Adverse Event|0
7464295|NCT01868022|11762543|FG002|Overall Study|Adverse Event|0
7464296|NCT01868022|11762544|FG003|Overall Study|Adverse Event|0
7464297|NCT01868022|11762545|FG004|Overall Study|Adverse Event|2
7464298|NCT01868022|11762546|FG005|Overall Study|Adverse Event|0
7464299|NCT01868022|11762547|FG006|Overall Study|Adverse Event|0
7464300|NCT01868022|11762548|FG007|Overall Study|Adverse Event|2
7464301|NCT01868022|11762549|FG008|Overall Study|Adverse Event|2
7464302|NCT01868022|11762541|FG000|Overall Study|Physician Decision|0
7464303|NCT01868022|11762542|FG001|Overall Study|Physician Decision|0
7464304|NCT01868022|11762543|FG002|Overall Study|Physician Decision|0
7464305|NCT01868022|11762544|FG003|Overall Study|Physician Decision|0
7464306|NCT01868022|11762545|FG004|Overall Study|Physician Decision|0
7464307|NCT01868022|11762546|FG005|Overall Study|Physician Decision|1
7533521|NCT02687815|11879995|FG001|Overall Study|Lost to Follow-up|4
7533522|NCT02687815|11879994|FG000|Overall Study|Withdrawal by Subject|2
7533523|NCT02687815|11879995|FG001|Overall Study|Withdrawal by Subject|4
7533524|NCT02687919|11880003|FG000|Overall Study|Withdrawal by Subject|6
7533525|NCT02687919|11880004|FG001|Overall Study|Withdrawal by Subject|6
7533526|NCT02687919|11880003|FG000|Overall Study|Protocol Violation|2
7533527|NCT02687919|11880004|FG001|Overall Study|Protocol Violation|0
7533528|NCT02688153|11880012|FG000|Overall Study|Death|7
7533529|NCT02688153|11880013|FG001|Overall Study|Death|5
7533530|NCT02688153|11880012|FG000|Overall Study|Withdrawal by Subject|4
7533531|NCT02688153|11880013|FG001|Overall Study|Withdrawal by Subject|2
7533532|NCT02688153|11880012|FG000|Overall Study|Valve Explant|1
7533533|NCT02688153|11880013|FG001|Overall Study|Valve Explant|0
7533534|NCT02688153|11880012|FG000|Overall Study|Conversion to Commercial Valve|3
7533535|NCT02688153|11880013|FG001|Overall Study|Conversion to Commercial Valve|0
7533536|NCT02688192|11880022|FG000|Overall Study|Lost to Follow-up|11
7533537|NCT02688192|11880023|FG001|Overall Study|Lost to Follow-up|5
7533538|NCT02688192|11880022|FG000|Overall Study|Physician Decision|1
7533539|NCT02688192|11880023|FG001|Overall Study|Physician Decision|0
7533540|NCT02688387|11880043|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533541|NCT02688387|11880044|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533542|NCT02688387|11880045|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
7533543|NCT02688387|11880046|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533544|NCT02688387|11880047|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533545|NCT02688387|11880048|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533546|NCT02688387|11880049|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533547|NCT02688387|11880050|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533548|NCT02688387|11880051|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533549|NCT02688387|11880052|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533550|NCT02688387|11880053|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533551|NCT02688387|11880054|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533552|NCT02688387|11880055|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533553|NCT02688387|11880056|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533554|NCT02688387|11880057|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533555|NCT02688387|11880058|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533556|NCT02688387|11880059|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533557|NCT02688387|11880060|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533558|NCT02688387|11880061|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533559|NCT02688387|11880062|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533560|NCT02688387|11880063|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533561|NCT02688387|11880064|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
7533562|NCT02688387|11880043|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533563|NCT02688387|11880044|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533564|NCT02688387|11880045|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533565|NCT02688387|11880046|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7533566|NCT02688387|11880047|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533567|NCT02688387|11880048|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533568|NCT02688387|11880049|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533569|NCT02688387|11880050|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533570|NCT02688387|11880051|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533571|NCT02688387|11880052|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533572|NCT02688387|11880053|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533573|NCT02688387|11880054|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533574|NCT02688387|11880055|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533575|NCT02688387|11880056|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533576|NCT02688387|11880057|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7464308|NCT01868022|11762547|FG006|Overall Study|Physician Decision|0
7464309|NCT01868022|11762548|FG007|Overall Study|Physician Decision|2
7464310|NCT01868022|11762549|FG008|Overall Study|Physician Decision|0
7464311|NCT01868022|11762541|FG000|Overall Study|Study closed/terminated|0
7464312|NCT01868022|11762542|FG001|Overall Study|Study closed/terminated|0
7464313|NCT01868022|11762543|FG002|Overall Study|Study closed/terminated|0
7464314|NCT01868022|11762544|FG003|Overall Study|Study closed/terminated|0
7533577|NCT02688387|11880058|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533578|NCT02688387|11880059|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7571104|NCT03519867|11949708|FG001|Overall Study|Reason not provided|1
7571105|NCT03519867|11949709|FG002|Overall Study|Reason not provided|1
7571106|NCT03519867|11949710|FG003|Overall Study|Reason not provided|1
7571107|NCT03519867|11949711|FG004|Overall Study|Reason not provided|0
7571108|NCT03519867|11949712|FG005|Overall Study|Reason not provided|1
7571109|NCT03519867|11949713|FG006|Overall Study|Reason not provided|0
7571110|NCT03519867|11949714|FG007|Overall Study|Reason not provided|1
7571111|NCT03519867|11949715|FG008|Overall Study|Reason not provided|1
7571112|NCT03519867|11949716|FG009|Overall Study|Reason not provided|0
7571113|NCT03519919|11949738|FG000|Overall Study|Withdrawal by Subject|1
7571114|NCT03519919|11949738|FG000|Overall Study|Lack of Efficacy|1
7571115|NCT03519919|11949738|FG000|Overall Study|Screen Failure|1
7571116|NCT03519932|11949768|FG000|First Intervention|Adverse Event|1
7571117|NCT03519932|11949769|FG001|First Intervention|Adverse Event|3
7571118|NCT03520387|11949812|FG000|Pre-Randomization|Withdrawal by Subject|1
7571119|NCT03520387|11949813|FG001|Pre-Randomization|Withdrawal by Subject|0
7571120|NCT03520387|11949814|FG002|Pre-Randomization|Withdrawal by Subject|0
7571121|NCT03520387|11949815|FG003|Pre-Randomization|Withdrawal by Subject|0
7571122|NCT03520387|11949816|FG004|Pre-Randomization|Withdrawal by Subject|0
7571123|NCT03520387|11949812|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
7571124|NCT03520387|11949813|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7571125|NCT03520387|11949814|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7571126|NCT03520387|11949815|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7571127|NCT03520387|11949816|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
7571128|NCT03520400|11949829|FG000|Overall Study|Physician Decision|15
7571129|NCT03520400|11949830|FG001|Overall Study|Physician Decision|7
7571130|NCT03520920|11949839|FG000|Overall Study|Death|13
7571131|NCT03520920|11949840|FG001|Overall Study|Death|1
7571132|NCT03520920|11949841|FG002|Overall Study|Death|0
7571133|NCT03520920|11949839|FG000|Overall Study|Withdrawal by Subject|2
7571134|NCT03520920|11949840|FG001|Overall Study|Withdrawal by Subject|1
7571135|NCT03520920|11949841|FG002|Overall Study|Withdrawal by Subject|0
7571136|NCT03520920|11949839|FG000|Overall Study|Study Terminated by the Sponsor|5
7571137|NCT03520920|11949840|FG001|Overall Study|Study Terminated by the Sponsor|14
7571138|NCT03520920|11949841|FG002|Overall Study|Study Terminated by the Sponsor|5
7571139|NCT03520959|11949857|FG000|Overall Study|Study terminated by Sponsor|0
7571140|NCT03520959|11949858|FG001|Overall Study|Study terminated by Sponsor|1
7575325|NCT03722030|11958994|FG000|Overall Study|Withdrawal by Subject|1
7575326|NCT03722030|11958995|FG001|Overall Study|Withdrawal by Subject|0
7575327|NCT03722238|11959004|FG000|Overall Study|Protocol Violation|1
7575328|NCT03722238|11959005|FG001|Overall Study|Protocol Violation|0
7575329|NCT03722238|11959004|FG000|Overall Study|Physician Decision|1
7575330|NCT03722238|11959005|FG001|Overall Study|Physician Decision|0
7575331|NCT03722238|11959004|FG000|Overall Study|Death|1
7575332|NCT03722238|11959005|FG001|Overall Study|Death|0
7575333|NCT03722238|11959004|FG000|Overall Study|Lost to Follow-up|6
7575334|NCT03722238|11959005|FG001|Overall Study|Lost to Follow-up|0
7575335|NCT03722238|11959004|FG000|Overall Study|Partial missing data|44
7575336|NCT03722238|11959005|FG001|Overall Study|Partial missing data|1
7464315|NCT01868022|11762545|FG004|Overall Study|Study closed/terminated|0
7533579|NCT02688387|11880060|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533580|NCT02688387|11880061|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533581|NCT02688387|11880062|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533582|NCT02688387|11880063|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533583|NCT02688387|11880064|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533584|NCT02688387|11880043|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7537685|NCT02759185|11886788|FG000|Stage 2|Withdrawal by Subject|0
7533585|NCT02688387|11880044|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
7533586|NCT02688387|11880045|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533587|NCT02688387|11880046|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533588|NCT02688387|11880047|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533589|NCT02688387|11880048|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533590|NCT02688387|11880049|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533591|NCT02688387|11880050|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533592|NCT02688387|11880051|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533593|NCT02688387|11880052|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533594|NCT02688387|11880053|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533595|NCT02688387|11880054|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533596|NCT02688387|11880055|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533597|NCT02688387|11880056|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533598|NCT02688387|11880057|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533599|NCT02688387|11880058|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533600|NCT02688387|11880059|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533601|NCT02688387|11880060|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533602|NCT02688387|11880061|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533603|NCT02688387|11880062|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533604|NCT02688387|11880063|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533605|NCT02688387|11880064|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
7533606|NCT02688387|11880043|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533607|NCT02688387|11880044|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533608|NCT02688387|11880045|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7533609|NCT02688387|11880046|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533610|NCT02688387|11880047|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
7533611|NCT02688387|11880048|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533612|NCT02688387|11880049|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533613|NCT02688387|11880050|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533614|NCT02688387|11880051|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533615|NCT02688387|11880052|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533616|NCT02688387|11880053|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533617|NCT02688387|11880054|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533618|NCT02688387|11880055|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533619|NCT02688387|11880056|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533620|NCT02688387|11880057|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533621|NCT02688387|11880058|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533622|NCT02688387|11880059|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533623|NCT02688387|11880060|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533624|NCT02688387|11880061|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533625|NCT02688387|11880062|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533626|NCT02688387|11880063|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533627|NCT02688387|11880064|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
7533628|NCT02688387|11880043|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
7533629|NCT02688387|11880044|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533630|NCT02688387|11880045|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533631|NCT02688387|11880046|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533632|NCT02688387|11880047|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533633|NCT02688387|11880048|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533634|NCT02688387|11880049|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533635|NCT02688387|11880050|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533636|NCT02688387|11880051|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533637|NCT02688387|11880052|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533638|NCT02688387|11880053|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533639|NCT02688387|11880054|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533640|NCT02688387|11880055|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533641|NCT02688387|11880056|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533642|NCT02688387|11880057|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533643|NCT02688387|11880058|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533644|NCT02688387|11880059|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533645|NCT02688387|11880060|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7571141|NCT03521115|11949884|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
7571142|NCT03521115|11949885|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
7571143|NCT03521115|11949884|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
7571144|NCT03521115|11949885|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
7571145|NCT03521141|11949900|FG000|Overall Study|Death|1
7382383|NCT01183013|11639291|FG006|Overall Study|Lost to Follow-up|5
7382384|NCT01183013|11639285|FG000|Overall Study|Withdrawal by Subject|9
7382385|NCT01183013|11639286|FG001|Overall Study|Withdrawal by Subject|13
7382386|NCT01183013|11639287|FG002|Overall Study|Withdrawal by Subject|10
7382387|NCT01183013|11639288|FG003|Overall Study|Withdrawal by Subject|8
7382388|NCT01183013|11639289|FG004|Overall Study|Withdrawal by Subject|7
7571146|NCT03521141|11949901|FG001|Overall Study|Death|0
7382389|NCT01183013|11639290|FG005|Overall Study|Withdrawal by Subject|9
7571147|NCT03521141|11949902|FG002|Overall Study|Death|1
7571152|NCT03521635|11949948|FG000|Overall Study|Adverse Event|1
7571153|NCT03521635|11949949|FG001|Overall Study|Adverse Event|1
7571154|NCT03521635|11949948|FG000|Overall Study|Refused to complete study visit|1
7571155|NCT03521635|11949949|FG001|Overall Study|Refused to complete study visit|0
7571156|NCT03521635|11949948|FG000|Overall Study|Refused to continue trial medication|2
7571157|NCT03521635|11949949|FG001|Overall Study|Refused to continue trial medication|2
7571158|NCT03521635|11949948|FG000|Overall Study|Lost to Follow-up|0
7382390|NCT01183013|11639291|FG006|Overall Study|Withdrawal by Subject|10
7382391|NCT01183013|11639285|FG000|Overall Study|Reasons other than stated above|15
7382392|NCT01183013|11639286|FG001|Overall Study|Reasons other than stated above|11
7382393|NCT01183013|11639287|FG002|Overall Study|Reasons other than stated above|17
7382394|NCT01183013|11639288|FG003|Overall Study|Reasons other than stated above|12
7382395|NCT01183013|11639289|FG004|Overall Study|Reasons other than stated above|12
7382396|NCT01183013|11639290|FG005|Overall Study|Reasons other than stated above|15
7382397|NCT01183013|11639291|FG006|Overall Study|Reasons other than stated above|13
7382398|NCT01183065|11639308|FG000|Overall Study|Patient no longer fits eligibility crite|1
7382399|NCT01183104|11639314|FG000|Overall Study|Adverse Event|8
7382400|NCT01183104|11639315|FG001|Overall Study|Adverse Event|6
7382401|NCT01183104|11639314|FG000|Overall Study|Death|0
7382402|NCT01183104|11639315|FG001|Overall Study|Death|1
7382403|NCT01183104|11639314|FG000|Overall Study|Lost to Follow-up|14
7382404|NCT01183104|11639315|FG001|Overall Study|Lost to Follow-up|7
7382405|NCT01183104|11639314|FG000|Overall Study|Physician Decision|5
7382406|NCT01183104|11639315|FG001|Overall Study|Physician Decision|8
7571159|NCT03521635|11949949|FG001|Overall Study|Lost to Follow-up|1
7571160|NCT03521635|11949948|FG000|Overall Study|Meet exclusion criteria|0
7571161|NCT03521635|11949949|FG001|Overall Study|Meet exclusion criteria|1
7571162|NCT03521635|11949948|FG000|Overall Study|Patient not taken study medicine|0
7571163|NCT03521635|11949949|FG001|Overall Study|Patient not taken study medicine|1
7571164|NCT03521791|11949957|FG000|Overall Study|Protocol Violation|7
7571165|NCT03521791|11949958|FG001|Overall Study|Protocol Violation|17
7382407|NCT01183104|11639314|FG000|Overall Study|Withdrawal by Subject|6
7382408|NCT01183104|11639315|FG001|Overall Study|Withdrawal by Subject|11
7382409|NCT01183104|11639314|FG000|Overall Study|Nonparticipation in Extension Study|39
7571166|NCT03521817|11949966|FG000|Overall Study|Protocol Violation|0
7571167|NCT03521817|11949967|FG001|Overall Study|Protocol Violation|1
7533646|NCT02688387|11880061|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7225278|NCT00065182|11434706|FG001|Overall Study|Sponsor Decision|7
7225279|NCT00065182|11434705|FG000|Overall Study|Withdrawal by Subject|8
7225280|NCT00065182|11434706|FG001|Overall Study|Withdrawal by Subject|3
7225281|NCT00065182|11434705|FG000|Overall Study|No clinical benefit|1
7225282|NCT00065182|11434706|FG001|Overall Study|No clinical benefit|0
7225283|NCT00065182|11434705|FG000|Overall Study|Death|0
7225284|NCT00065182|11434706|FG001|Overall Study|Death|1
7225285|NCT00065182|11434705|FG000|Overall Study|Decline in Status|0
7225286|NCT00065182|11434706|FG001|Overall Study|Decline in Status|1
7225287|NCT00065260|11434714|FG000|Overall Study|Death|0
7225288|NCT00065260|11434715|FG001|Overall Study|Death|1
7225289|NCT00065429|11434728|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225290|NCT00065429|11434729|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225291|NCT00065429|11434730|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225292|NCT00065429|11434731|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225293|NCT00065429|11434732|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225294|NCT00065429|11434733|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
7225295|NCT00065429|11434734|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
7225296|NCT00065429|11434728|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225297|NCT00065429|11434729|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225298|NCT00065429|11434730|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
7225299|NCT00065429|11434731|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225300|NCT00065429|11434732|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225301|NCT00065429|11434733|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225302|NCT00065429|11434734|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
7225303|NCT00065429|11434728|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
7225304|NCT00065429|11434729|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225305|NCT00065429|11434730|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225306|NCT00065429|11434731|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225307|NCT00065429|11434732|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225308|NCT00065429|11434733|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225309|NCT00065429|11434734|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
7225310|NCT00065429|11434728|FG000|Phase I - May 2001 - Oct 2002|Death|0
7225311|NCT00065429|11434729|FG001|Phase I - May 2001 - Oct 2002|Death|0
7225312|NCT00065429|11434730|FG002|Phase I - May 2001 - Oct 2002|Death|0
7225313|NCT00065429|11434731|FG003|Phase I - May 2001 - Oct 2002|Death|0
7225314|NCT00065429|11434732|FG004|Phase I - May 2001 - Oct 2002|Death|1
7225315|NCT00065429|11434733|FG005|Phase I - May 2001 - Oct 2002|Death|0
7225316|NCT00065429|11434734|FG006|Phase I - May 2001 - Oct 2002|Death|0
7225317|NCT00065429|11434728|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
7225318|NCT00065429|11434729|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
7225319|NCT00065429|11434730|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
7225320|NCT00065429|11434731|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
7225321|NCT00065429|11434732|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
7225322|NCT00065429|11434733|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
7225323|NCT00065429|11434734|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
7225324|NCT00065429|11434728|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7571168|NCT03522506|11949996|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7571169|NCT03522506|11949997|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7571170|NCT03522506|11949998|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
7571171|NCT03522506|11949999|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
7571172|NCT03522506|11949996|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7571173|NCT03522506|11949997|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7571174|NCT03522506|11949998|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
7571175|NCT03522506|11949999|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
7571176|NCT03522675|11950013|FG000|Overall Study|Screen fail|1
7571177|NCT03522675|11950013|FG000|Overall Study|Non-reactive to histamine|1
7571178|NCT03522948|11950021|FG000|Overall Study|Lost to Follow-up|1
7571179|NCT03523715|11950027|FG000|Overall Study|Lost to Follow-up|11
7571180|NCT03523715|11950028|FG001|Overall Study|Lost to Follow-up|14
7571181|NCT03523715|11950027|FG000|Overall Study|Did not meet inclusion criteria|1
7571182|NCT03523715|11950028|FG001|Overall Study|Did not meet inclusion criteria|0
7571183|NCT03523715|11950027|FG000|Overall Study|Internally inconsistent reporting|0
7571184|NCT03523715|11950028|FG001|Overall Study|Internally inconsistent reporting|2
7571185|NCT03523871|11950034|FG000|Overall Study|Death|1
7571186|NCT03524157|11950054|FG000|Overall Study|cytology not readable|0
7571187|NCT03524157|11950055|FG001|Overall Study|cytology not readable|0
7571188|NCT03524157|11950056|FG002|Overall Study|cytology not readable|1
7382410|NCT01183104|11639315|FG001|Overall Study|Nonparticipation in Extension Study|50
7382411|NCT01183104|11639314|FG000|Overall Study|Did not receive study drug|5
7382412|NCT01183104|11639315|FG001|Overall Study|Did not receive study drug|9
7382413|NCT01183143|11639321|FG000|Overall Study|Protocol Violation|115
7382414|NCT01183143|11639321|FG000|Overall Study|Withdrawal by Subject|19
7533647|NCT02688387|11880062|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533648|NCT02688387|11880063|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533649|NCT02688387|11880064|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
7533650|NCT02688387|11880043|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533651|NCT02688387|11880044|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533652|NCT02688387|11880045|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7571204|NCT03525444|11950099|FG000|Overall Study|Adverse Event|0
7571205|NCT03525444|11950100|FG001|Overall Study|Adverse Event|1
7571206|NCT03525444|11950099|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7571207|NCT03525444|11950100|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
7571208|NCT03525444|11950099|FG000|Overall Study|Other|0
7571209|NCT03525444|11950100|FG001|Overall Study|Other|1
7571210|NCT03525834|11950116|FG000|Overall Study|Progressive disease|1
7571211|NCT03526458|11950130|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7571212|NCT03526458|11950131|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
7571213|NCT03526458|11950130|FG000|Overall Study|Stone passed, surgery cancelled|2
7571214|NCT03526458|11950131|FG001|Overall Study|Stone passed, surgery cancelled|1
7571215|NCT03526458|11950130|FG000|Overall Study|Withdrawal by Subject|1
7571216|NCT03526458|11950131|FG001|Overall Study|Withdrawal by Subject|0
7571217|NCT03526458|11950130|FG000|Overall Study|Physician Decision|2
7571218|NCT03526458|11950131|FG001|Overall Study|Physician Decision|1
7571219|NCT03526458|11950130|FG000|Overall Study|Lack of equipment|1
7571220|NCT03526458|11950131|FG001|Overall Study|Lack of equipment|1
7575337|NCT03722238|11959004|FG000|Overall Study|Withdrawal by Subject|2
7225325|NCT00065429|11434729|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7225326|NCT00065429|11434730|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7225327|NCT00065429|11434731|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7255469|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Move|1
7575338|NCT03722238|11959005|FG001|Overall Study|Withdrawal by Subject|0
7575339|NCT03722238|11959004|FG000|Overall Study|Other|4
7575340|NCT03722238|11959005|FG001|Overall Study|Other|0
7382415|NCT01183143|11639321|FG000|Overall Study|Subject Questionnaires not returned|5
7382416|NCT01183143|11639321|FG000|Overall Study|Subjects enrolled, but not treated|11
7382417|NCT01183234|11639355|FG000|First Intervention|Adverse Event|1
7382418|NCT01183234|11639356|FG001|First Intervention|Adverse Event|0
7382419|NCT01183260|11639364|FG000|Overall Study|Intraop screen failure|2
7382420|NCT01183260|11639365|FG001|Overall Study|Intraop screen failure|0
7571302|NCT03527160|11950170|FG000|Overall Study|No urine collected|13
7571303|NCT03527160|11950170|FG000|Overall Study|No clinical serum creatinine collected|6
7571304|NCT03527160|11950170|FG000|Overall Study|Did not meet inclusion|2
7571305|NCT03527173|11950179|FG000|Overall Study|Lost to Follow-up|4
7571306|NCT03527173|11950180|FG001|Overall Study|Lost to Follow-up|2
7571307|NCT03527173|11950179|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
7571308|NCT03527173|11950180|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
7571309|NCT03527173|11950179|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7571310|NCT03527173|11950180|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
7571311|NCT03527173|11950179|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7571312|NCT03527173|11950180|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7571313|NCT03527550|11950188|FG000|Overall Study|Lost to Follow-up|4
7571314|NCT03527550|11950189|FG001|Overall Study|Lost to Follow-up|2
7571315|NCT03527550|11950188|FG000|Overall Study|Withdrawal by Subject|4
7571316|NCT03527550|11950189|FG001|Overall Study|Withdrawal by Subject|1
7571317|NCT03527550|11950188|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
7571318|NCT03527550|11950189|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
7571319|NCT03527745|11950223|FG000|Overall Study|Lost to Follow-up|3
7571320|NCT03527745|11950224|FG001|Overall Study|Lost to Follow-up|6
7571321|NCT03527745|11950225|FG002|Overall Study|Lost to Follow-up|7
7571322|NCT03527745|11950226|FG003|Overall Study|Lost to Follow-up|9
7571323|NCT03527745|11950227|FG004|Overall Study|Lost to Follow-up|0
7571324|NCT03527745|11950228|FG005|Overall Study|Lost to Follow-up|2
7571325|NCT03527745|11950229|FG006|Overall Study|Lost to Follow-up|3
7571326|NCT03527745|11950230|FG007|Overall Study|Lost to Follow-up|2
7571327|NCT03527745|11950231|FG008|Overall Study|Lost to Follow-up|3
7571328|NCT03527745|11950232|FG009|Overall Study|Lost to Follow-up|2
7571329|NCT03527745|11950233|FG010|Overall Study|Lost to Follow-up|1
7571330|NCT03527745|11950234|FG011|Overall Study|Lost to Follow-up|1
7571331|NCT03527745|11950235|FG012|Overall Study|Lost to Follow-up|0
7571332|NCT03527745|11950236|FG013|Overall Study|Lost to Follow-up|0
7571333|NCT03527745|11950237|FG014|Overall Study|Lost to Follow-up|0
7571334|NCT03527745|11950238|FG015|Overall Study|Lost to Follow-up|0
7571335|NCT03527745|11950239|FG016|Overall Study|Lost to Follow-up|1
7571336|NCT03527745|11950240|FG017|Overall Study|Lost to Follow-up|0
7571337|NCT03527745|11950241|FG018|Overall Study|Lost to Follow-up|0
7571338|NCT03527745|11950242|FG019|Overall Study|Lost to Follow-up|1
7571339|NCT03527745|11950243|FG020|Overall Study|Lost to Follow-up|1
7571340|NCT03527745|11950244|FG021|Overall Study|Lost to Follow-up|5
7571341|NCT03527745|11950245|FG022|Overall Study|Lost to Follow-up|6
7571342|NCT03527745|11950246|FG023|Overall Study|Lost to Follow-up|8
7571343|NCT03527745|11950247|FG024|Overall Study|Lost to Follow-up|1
7571344|NCT03527745|11950248|FG025|Overall Study|Lost to Follow-up|3
7571345|NCT03527966|11950306|FG000|Overall Study|Lost to Follow-up|3
7571346|NCT03527966|11950307|FG001|Overall Study|Lost to Follow-up|0
7571347|NCT03528174|11950313|FG000|Overall Study|Adverse Event|1
7571348|NCT03528174|11950313|FG000|Overall Study|sensors dislodged|1
7571349|NCT03528369|11950320|FG000|Overall Study|Withdrawal by Subject|2
7571350|NCT03528369|11950321|FG001|Overall Study|Withdrawal by Subject|0
7571351|NCT03528369|11950322|FG002|Overall Study|Withdrawal by Subject|0
7571352|NCT03528369|11950320|FG000|Overall Study|Lost to Follow-up|1
7571353|NCT03528369|11950321|FG001|Overall Study|Lost to Follow-up|0
7571354|NCT03528369|11950322|FG002|Overall Study|Lost to Follow-up|0
7571355|NCT03528369|11950320|FG000|Overall Study|Adverse Event|0
7571356|NCT03528369|11950321|FG001|Overall Study|Adverse Event|1
7571357|NCT03528369|11950322|FG002|Overall Study|Adverse Event|0
7571358|NCT03528551|11950342|FG000|Overall Study|Lost to Follow-up|0
7571359|NCT03528551|11950343|FG001|Overall Study|Lost to Follow-up|1
7571360|NCT03528551|11950344|FG002|Overall Study|Lost to Follow-up|0
7571361|NCT03528551|11950342|FG000|Overall Study|Transferred to other arm/group|2
7571362|NCT03528551|11950343|FG001|Overall Study|Transferred to other arm/group|3
7571363|NCT03528551|11950344|FG002|Overall Study|Transferred to other arm/group|0
7571364|NCT03528551|11950342|FG000|Overall Study|Withdrawal by parent/guardian|0
7571365|NCT03528551|11950343|FG001|Overall Study|Withdrawal by parent/guardian|5
7571366|NCT03528551|11950344|FG002|Overall Study|Withdrawal by parent/guardian|0
7571367|NCT03528551|11950342|FG000|Overall Study|Protocol Violation|0
7571368|NCT03528551|11950343|FG001|Overall Study|Protocol Violation|3
7571369|NCT03528551|11950344|FG002|Overall Study|Protocol Violation|0
7571370|NCT03528551|11950342|FG000|Overall Study|Withdrawal by Subject|0
7571371|NCT03528551|11950343|FG001|Overall Study|Withdrawal by Subject|7
7571372|NCT03528551|11950344|FG002|Overall Study|Withdrawal by Subject|0
7571373|NCT03528577|11950353|FG000|Sequence 1|Failed Spirometry|1
7571374|NCT03528577|11950353|FG000|Sequence 1|Restricted medication|1
7571375|NCT03528577|11950353|FG000|Sequence 2|Adverse Event|1
7571376|NCT03528577|11950353|FG000|Sequence 2|Withdrawal by Subject|1
7571377|NCT03528577|11950353|FG000|Sequence 2|Failed Spirometry|1
7571378|NCT03528577|11950353|FG000|Sequence 3|Failed Spirometry|1
7571379|NCT03528577|11950353|FG000|Sequence 4|Failed Spirometry|2
7571380|NCT03528577|11950353|FG000|Sequence 4|Adverse Event|1
7571381|NCT03529162|11950362|FG000|Overall Study|Lost to Follow-up|2
7571382|NCT03529162|11950363|FG001|Overall Study|Lost to Follow-up|2
7571383|NCT03530345|11950393|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7571384|NCT03530345|11950394|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
7382421|NCT01183260|11639364|FG000|Overall Study|Withdrawal by Subject|1
7382422|NCT01183260|11639365|FG001|Overall Study|Withdrawal by Subject|1
7382423|NCT01183260|11639364|FG000|Overall Study|Revised within 30 days|0
7382424|NCT01183260|11639365|FG001|Overall Study|Revised within 30 days|1
7382425|NCT01183260|11639364|FG000|Overall Study|Death|1
7382426|NCT01183260|11639365|FG001|Overall Study|Death|0
7382427|NCT01183390|11639382|FG000|First Intervention|Adverse Event|0
7382428|NCT01183390|11639383|FG001|First Intervention|Adverse Event|1
7382429|NCT01183780|11639438|FG000|Overall Study|Withdrawal by Subject|25
7382430|NCT01183780|11639439|FG001|Overall Study|Withdrawal by Subject|14
7382431|NCT01183780|11639438|FG000|Overall Study|Lost to Follow-up|6
7382432|NCT01183780|11639439|FG001|Overall Study|Lost to Follow-up|11
7382433|NCT01183858|11639447|FG000|Overall Study|Death not related to Progressive Disease|5
7382434|NCT01183858|11639448|FG001|Overall Study|Death not related to Progressive Disease|6
7382435|NCT01183858|11639447|FG000|Overall Study|Adverse Event|14
7382436|NCT01183858|11639448|FG001|Overall Study|Adverse Event|11
7382437|NCT01183858|11639447|FG000|Overall Study|Investigator's Decision|0
7382438|NCT01183858|11639448|FG001|Overall Study|Investigator's Decision|3
7382439|NCT01183858|11639447|FG000|Overall Study|Insufficient Therapeutic Response|2
7382440|NCT01183858|11639448|FG001|Overall Study|Insufficient Therapeutic Response|0
7382441|NCT01183858|11639447|FG000|Overall Study|Refused Treatment|1
7382442|NCT01183858|11639448|FG001|Overall Study|Refused Treatment|4
7382443|NCT01183858|11639447|FG000|Overall Study|Withdrew Consent|4
7382444|NCT01183858|11639448|FG001|Overall Study|Withdrew Consent|4
7382445|NCT01183858|11639447|FG000|Overall Study|Discontinued Smoking|3
7382446|NCT01183858|11639448|FG001|Overall Study|Discontinued Smoking|1
7382447|NCT01183858|11639447|FG000|Overall Study|Protocol Violation|1
7382448|NCT01183858|11639448|FG001|Overall Study|Protocol Violation|0
7382449|NCT01183858|11639447|FG000|Overall Study|Administrative/Other|6
7382450|NCT01183858|11639448|FG001|Overall Study|Administrative/Other|6
7382451|NCT01183858|11639447|FG000|Overall Study|Progressive Disease|112
7382452|NCT01183858|11639448|FG001|Overall Study|Progressive Disease|115
7382453|NCT01183858|11639447|FG000|Overall Study|Death related to Progressive Disease|4
7382454|NCT01183858|11639448|FG001|Overall Study|Death related to Progressive Disease|5
7382455|NCT01183858|11639447|FG000|Overall Study|Lost to Follow-up|1
7382456|NCT01183858|11639448|FG001|Overall Study|Lost to Follow-up|1
7382457|NCT01183975|11639460|FG000|Overall Study|Lost to Follow-up|73
7382458|NCT01184053|11639473|FG000|Overall Study|progression while on treatment|3
7382459|NCT01184079|11639480|FG000|Overall Study|Lost to Follow-up|14
7382460|NCT01184079|11639481|FG001|Overall Study|Lost to Follow-up|2
7382461|NCT01184118|11639489|FG000|Overall Study|Only asthma step 1 - screen fail|1
7382462|NCT01184118|11639489|FG000|Overall Study|No physiologic confirmation of asthma|8
7382463|NCT01184118|11639489|FG000|Overall Study|FEV1 <60% predicted|2
7382464|NCT01184118|11639489|FG000|Overall Study|Exclusionary medical condition|2
7382465|NCT01184118|11639489|FG000|Overall Study|Withdrawal by Subject|5
7382466|NCT01184326|11639496|FG000|Overall Study|Adverse Event|1
7382467|NCT01184326|11639497|FG001|Overall Study|Adverse Event|2
7382468|NCT01184326|11639498|FG002|Overall Study|Adverse Event|0
7382469|NCT01184326|11639496|FG000|Overall Study|Death|0
7382470|NCT01184326|11639497|FG001|Overall Study|Death|0
7382471|NCT01184326|11639498|FG002|Overall Study|Death|1
7382472|NCT01184326|11639496|FG000|Overall Study|Withdrawal by Subject|0
7382473|NCT01184326|11639497|FG001|Overall Study|Withdrawal by Subject|0
7382474|NCT01184326|11639498|FG002|Overall Study|Withdrawal by Subject|1
7382475|NCT01184326|11639496|FG000|Overall Study|Physician Decision|1
7382476|NCT01184326|11639497|FG001|Overall Study|Physician Decision|1
7382477|NCT01184326|11639498|FG002|Overall Study|Physician Decision|0
7382478|NCT01184326|11639496|FG000|Overall Study|Disease Progression|1
7382479|NCT01184326|11639497|FG001|Overall Study|Disease Progression|3
7382480|NCT01184326|11639498|FG002|Overall Study|Disease Progression|12
7382481|NCT01184508|11639520|FG000|Overall Study|Adverse Event|4
7382482|NCT01184508|11639521|FG001|Overall Study|Adverse Event|6
7382483|NCT01184508|11639520|FG000|Overall Study|Lack of Efficacy|1
7382484|NCT01184508|11639521|FG001|Overall Study|Lack of Efficacy|1
7382485|NCT01184508|11639520|FG000|Overall Study|Lost to Follow-up|1
7382486|NCT01184508|11639521|FG001|Overall Study|Lost to Follow-up|1
7382487|NCT01184508|11639520|FG000|Overall Study|Physician Decision|1
7382488|NCT01184508|11639521|FG001|Overall Study|Physician Decision|0
7382489|NCT01184508|11639520|FG000|Overall Study|Protocol Violation|3
7382490|NCT01184508|11639521|FG001|Overall Study|Protocol Violation|1
7382491|NCT01184508|11639520|FG000|Overall Study|Sponsor Decision|5
7382492|NCT01184508|11639521|FG001|Overall Study|Sponsor Decision|2
7382493|NCT01184508|11639520|FG000|Overall Study|Withdrawal by Subject|1
7382494|NCT01184508|11639521|FG001|Overall Study|Withdrawal by Subject|3
7382495|NCT01184508|11639520|FG000|Overall Study|Randomized, Not Treated|0
7382496|NCT01184508|11639521|FG001|Overall Study|Randomized, Not Treated|1
7382497|NCT01184846|11639541|FG000|Overall Study|Adverse Event|2
7382498|NCT01184846|11639541|FG000|Overall Study|Insufficient response|1
7382499|NCT01184859|11639552|FG000|Period 1: Single Dose|Insufficient urine production|0
7382500|NCT01184859|11639553|FG001|Period 1: Single Dose|Insufficient urine production|1
7382501|NCT01184859|11639554|FG002|Period 1: Single Dose|Insufficient urine production|0
7382502|NCT01184859|11639555|FG003|Period 1: Single Dose|Insufficient urine production|0
7382503|NCT01184859|11639556|FG004|Period 1: Single Dose|Insufficient urine production|0
7382504|NCT01184859|11639552|FG000|Period 1: Single Dose|Protocol Violation|0
7382505|NCT01184859|11639553|FG001|Period 1: Single Dose|Protocol Violation|1
7382506|NCT01184859|11639554|FG002|Period 1: Single Dose|Protocol Violation|0
7382507|NCT01184859|11639555|FG003|Period 1: Single Dose|Protocol Violation|0
7382508|NCT01184859|11639556|FG004|Period 1: Single Dose|Protocol Violation|0
7382509|NCT01184859|11639552|FG000|Period 1: Single Dose|Adverse Event|0
7382510|NCT01184859|11639553|FG001|Period 1: Single Dose|Adverse Event|0
7382511|NCT01184859|11639554|FG002|Period 1: Single Dose|Adverse Event|0
7382512|NCT01184859|11639555|FG003|Period 1: Single Dose|Adverse Event|0
7382513|NCT01184859|11639556|FG004|Period 1: Single Dose|Adverse Event|1
7382514|NCT01184859|11639552|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7382515|NCT01184859|11639553|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7382516|NCT01184859|11639554|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7382517|NCT01184859|11639555|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
7382518|NCT01184859|11639556|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
7382519|NCT01184859|11639552|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
7382520|NCT01184859|11639553|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
7382521|NCT01184859|11639554|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
7382522|NCT01184859|11639555|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
7382523|NCT01184859|11639556|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
7382524|NCT01184872|11639575|FG000|Overall Study|Adverse Event|3
7382525|NCT01184872|11639576|FG001|Overall Study|Adverse Event|4
7382526|NCT01184872|11639575|FG000|Overall Study|Unsatisfactory therapeutic effect|3
7382527|NCT01184872|11639576|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7382528|NCT01184872|11639575|FG000|Overall Study|Withdrawal by Subject|2
7382529|NCT01184872|11639576|FG001|Overall Study|Withdrawal by Subject|0
7571385|NCT03530345|11950393|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7571386|NCT03530345|11950394|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7571387|NCT03530345|11950393|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
7571388|NCT03530345|11950394|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
7571389|NCT03530345|11950393|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
7382530|NCT01184872|11639575|FG000|Overall Study|Lost to Follow-up|0
7382531|NCT01184872|11639576|FG001|Overall Study|Lost to Follow-up|1
7382532|NCT01184872|11639575|FG000|Overall Study|Administrative problems|1
7382533|NCT01184872|11639576|FG001|Overall Study|Administrative problems|1
7382534|NCT01184872|11639575|FG000|Overall Study|Protocol deviation|1
7382535|NCT01184872|11639576|FG001|Overall Study|Protocol deviation|0
7382536|NCT01184989|11639591|FG000|Overall Study|Adverse Event|11
7382537|NCT01184989|11639591|FG000|Overall Study|Withdrawal by Subject|1
7382538|NCT01185080|11639602|FG000|Overall Study|Adverse Event|1
7382539|NCT01185080|11639603|FG001|Overall Study|Adverse Event|1
7382540|NCT01185080|11639604|FG002|Overall Study|Adverse Event|0
7382541|NCT01185080|11639602|FG000|Overall Study|Personal reasons|0
7382542|NCT01185080|11639603|FG001|Overall Study|Personal reasons|0
7382543|NCT01185080|11639604|FG002|Overall Study|Personal reasons|1
7382544|NCT01185171|11639612|FG000|Induction Chemotherapy|Withdrawal by Subject|1
7382545|NCT01185171|11639612|FG000|Induction Chemotherapy|Duodenal Ulcer|1
7382546|NCT01185171|11639612|FG000|Concurrent Chemo and Radiation Treatment|Death|3
7382547|NCT01185171|11639612|FG000|Maintenance|Elevated liver transaminases|3
7382548|NCT01185171|11639612|FG000|Maintenance|Rush|2
7382549|NCT01185171|11639612|FG000|Maintenance|Diarrhea|1
7382550|NCT01185171|11639612|FG000|Maintenance|Xerostomia|1
7382551|NCT01185171|11639612|FG000|Maintenance|Nausea|1
7382552|NCT01185171|11639612|FG000|Maintenance|Comorbid Illness|2
7382553|NCT01185171|11639612|FG000|Maintenance|Withdrawal by Subject|1
7382554|NCT01185171|11639612|FG000|Maintenance|Disease Recurrence|1
7382555|NCT01185249|11639616|FG000|Overall Study|Patients discharged or change in status|42
7382556|NCT01185288|11639623|FG000|Overall Study|Adverse Event|7
7382557|NCT01185288|11639624|FG001|Overall Study|Adverse Event|6
7382558|NCT01185288|11639623|FG000|Overall Study|Withdrawal by Subject|6
7382559|NCT01185288|11639624|FG001|Overall Study|Withdrawal by Subject|4
7382560|NCT01185288|11639623|FG000|Overall Study|Lost to Follow-up|2
7382561|NCT01185288|11639624|FG001|Overall Study|Lost to Follow-up|5
7382562|NCT01185288|11639623|FG000|Overall Study|Lack of Efficacy|2
7382563|NCT01185288|11639624|FG001|Overall Study|Lack of Efficacy|0
7382564|NCT01185288|11639623|FG000|Overall Study|Investigator discretion|1
7382565|NCT01185288|11639624|FG001|Overall Study|Investigator discretion|0
7382566|NCT01185288|11639623|FG000|Overall Study|Did not meet inclusion criteria|1
7382567|NCT01185288|11639624|FG001|Overall Study|Did not meet inclusion criteria|0
7382568|NCT01185288|11639623|FG000|Overall Study|Noncompliance|0
7382569|NCT01185288|11639624|FG001|Overall Study|Noncompliance|1
7382570|NCT01185301|11639634|FG000|Overall Study|Adverse Event|3
7382571|NCT01185301|11639635|FG001|Overall Study|Adverse Event|0
7382572|NCT01185301|11639636|FG002|Overall Study|Adverse Event|2
7382573|NCT01185301|11639637|FG003|Overall Study|Adverse Event|3
7382574|NCT01185301|11639634|FG000|Overall Study|Withdrawal by Subject|7
7382575|NCT01185301|11639635|FG001|Overall Study|Withdrawal by Subject|5
7382576|NCT01185301|11639636|FG002|Overall Study|Withdrawal by Subject|2
7382577|NCT01185301|11639637|FG003|Overall Study|Withdrawal by Subject|3
7382578|NCT01185301|11639634|FG000|Overall Study|Lost to Follow-up|2
7382579|NCT01185301|11639635|FG001|Overall Study|Lost to Follow-up|0
7382580|NCT01185301|11639636|FG002|Overall Study|Lost to Follow-up|0
7382581|NCT01185301|11639637|FG003|Overall Study|Lost to Follow-up|1
7382582|NCT01185301|11639634|FG000|Overall Study|Other Reason|3
7382583|NCT01185301|11639635|FG001|Overall Study|Other Reason|2
7382584|NCT01185301|11639636|FG002|Overall Study|Other Reason|2
7382585|NCT01185301|11639637|FG003|Overall Study|Other Reason|2
7387440|NCT01214642|11645922|FG005|Overall Study|Withdrawal by Subject|0
7387441|NCT01214642|11645923|FG006|Overall Study|Withdrawal by Subject|0
7387442|NCT01214642|11645924|FG007|Overall Study|Withdrawal by Subject|0
7387443|NCT01214642|11645925|FG008|Overall Study|Withdrawal by Subject|3
7387444|NCT01214642|11645926|FG009|Overall Study|Withdrawal by Subject|1
7387445|NCT01214642|11645927|FG010|Overall Study|Withdrawal by Subject|1
7387446|NCT01214642|11645928|FG011|Overall Study|Withdrawal by Subject|0
7387447|NCT01214642|11645917|FG000|Overall Study|Physician Decision|0
7387448|NCT01214642|11645918|FG001|Overall Study|Physician Decision|0
7387449|NCT01214642|11645919|FG002|Overall Study|Physician Decision|1
7387450|NCT01214642|11645920|FG003|Overall Study|Physician Decision|1
7387451|NCT01214642|11645921|FG004|Overall Study|Physician Decision|1
7387452|NCT01214642|11645922|FG005|Overall Study|Physician Decision|0
7387453|NCT01214642|11645923|FG006|Overall Study|Physician Decision|0
7387454|NCT01214642|11645924|FG007|Overall Study|Physician Decision|0
7387455|NCT01214642|11645925|FG008|Overall Study|Physician Decision|0
7387456|NCT01214642|11645926|FG009|Overall Study|Physician Decision|0
7387457|NCT01214642|11645927|FG010|Overall Study|Physician Decision|0
7387458|NCT01214642|11645928|FG011|Overall Study|Physician Decision|2
7387459|NCT01214655|11645974|FG000|Part A|Progressive Disease|7
7387460|NCT01214655|11645975|FG001|Part A|Progressive Disease|0
7387461|NCT01214655|11645976|FG002|Part A|Progressive Disease|0
7387462|NCT01214655|11645974|FG000|Part A|Physician Decision|1
7387463|NCT01214655|11645975|FG001|Part A|Physician Decision|0
7387464|NCT01214655|11645976|FG002|Part A|Physician Decision|0
7387465|NCT01214655|11645974|FG000|Part B|Progressive disease|0
7387466|NCT01214655|11645975|FG001|Part B|Progressive disease|10
7387467|NCT01214655|11645976|FG002|Part B|Progressive disease|0
7387468|NCT01214655|11645974|FG000|Part B|Death|0
7387469|NCT01214655|11645975|FG001|Part B|Death|1
7387470|NCT01214655|11645976|FG002|Part B|Death|0
7387471|NCT01214655|11645974|FG000|Part B|Withdrawal by Subject|0
7387472|NCT01214655|11645975|FG001|Part B|Withdrawal by Subject|2
7387473|NCT01214655|11645976|FG002|Part B|Withdrawal by Subject|0
7387474|NCT01214655|11645974|FG000|Part C|Progressive Disease|0
7387475|NCT01214655|11645975|FG001|Part C|Progressive Disease|0
7387476|NCT01214655|11645976|FG002|Part C|Progressive Disease|5
7387477|NCT01214655|11645974|FG000|Part C|Death|0
7387478|NCT01214655|11645975|FG001|Part C|Death|0
7387479|NCT01214655|11645976|FG002|Part C|Death|1
7387480|NCT01214655|11645974|FG000|Part C|Physician Decision|0
7387481|NCT01214655|11645975|FG001|Part C|Physician Decision|0
7533653|NCT02688387|11880046|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7387482|NCT01214655|11645976|FG002|Part C|Physician Decision|1
7387483|NCT01214668|11646028|FG000|Overall Study|Adverse Event|0
7387484|NCT01214668|11646029|FG001|Overall Study|Adverse Event|1
7387485|NCT01214668|11646030|FG002|Overall Study|Adverse Event|0
7387486|NCT01214668|11646031|FG003|Overall Study|Adverse Event|2
7387487|NCT01214668|11646032|FG004|Overall Study|Adverse Event|1
7387488|NCT01214668|11646033|FG005|Overall Study|Adverse Event|1
7387489|NCT01214668|11646028|FG000|Overall Study|Death|0
7382586|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
7382587|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7382588|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7382589|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7382590|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
7571390|NCT03530345|11950394|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
7571391|NCT03531840|11950484|FG000|Overall Study|Death on study|3
7382591|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7464316|NCT01868022|11762546|FG005|Overall Study|Study closed/terminated|0
7382592|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7571392|NCT03531840|11950485|FG001|Overall Study|Death on study|2
7571393|NCT03531840|11950486|FG002|Overall Study|Death on study|1
7571394|NCT03531840|11950487|FG003|Overall Study|Death on study|2
7571395|NCT03531840|11950484|FG000|Overall Study|Death during follow up|2
7571396|NCT03531840|11950485|FG001|Overall Study|Death during follow up|3
7571397|NCT03531840|11950486|FG002|Overall Study|Death during follow up|4
7571398|NCT03531840|11950487|FG003|Overall Study|Death during follow up|1
7571399|NCT03531905|11950505|FG000|Overall Study|Withdrawal by Subject|3
7571400|NCT03531905|11950506|FG001|Overall Study|Withdrawal by Subject|3
7571401|NCT03531905|11950507|FG002|Overall Study|Withdrawal by Subject|2
7571402|NCT03531905|11950505|FG000|Overall Study|Lost to Follow-up|2
7571403|NCT03531905|11950506|FG001|Overall Study|Lost to Follow-up|2
7571404|NCT03531905|11950507|FG002|Overall Study|Lost to Follow-up|1
7571405|NCT03531905|11950505|FG000|Overall Study|Participant was out of town|1
7571406|NCT03531905|11950506|FG001|Overall Study|Participant was out of town|0
7571407|NCT03531905|11950507|FG002|Overall Study|Participant was out of town|0
7571408|NCT03531905|11950505|FG000|Overall Study|Could not speak with the participant|1
7571409|NCT03531905|11950506|FG001|Overall Study|Could not speak with the participant|0
7571410|NCT03531905|11950507|FG002|Overall Study|Could not speak with the participant|0
7571411|NCT03532009|11950519|FG000|Overall Study|Other|1
7571412|NCT03532009|11950520|FG001|Overall Study|Other|1
7571413|NCT03532009|11950519|FG000|Overall Study|Death|1
7571414|NCT03532009|11950520|FG001|Overall Study|Death|1
7571415|NCT03532009|11950519|FG000|Overall Study|Withdrawal by Patient|0
7571416|NCT03532009|11950520|FG001|Overall Study|Withdrawal by Patient|2
7382593|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7382594|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
7382595|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7382596|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7382597|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7382598|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7382599|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7382600|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7382601|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7382602|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
7382603|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7382604|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7382605|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7382606|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
7382607|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7382608|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7382609|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7382610|NCT01185340|11639650|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
7382611|NCT01185340|11639651|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7382612|NCT01185340|11639652|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7382613|NCT01185340|11639653|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7382614|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7382615|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7382616|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
7382617|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7382618|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7382619|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7382620|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
7382621|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
7382622|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7382623|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
7382624|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7382625|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
7382626|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7382627|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7382628|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7382629|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7382630|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7382631|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7382632|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
7382633|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7382634|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7382635|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7382636|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
7382637|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
7382638|NCT01185340|11639650|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7382639|NCT01185340|11639651|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7382640|NCT01185340|11639652|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
7382641|NCT01185340|11639653|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7382642|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
7382643|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
7382644|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
7382645|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
7382646|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
7382647|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
7382648|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
7382649|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
7382650|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
7382651|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
7382652|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382653|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382654|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382655|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382656|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
7571417|NCT03532048|11950528|FG000|Overall Study|Lost to Follow-up|12
7571418|NCT03532048|11950529|FG001|Overall Study|Lost to Follow-up|17
7464317|NCT01868022|11762547|FG006|Overall Study|Study closed/terminated|0
7464318|NCT01868022|11762548|FG007|Overall Study|Study closed/terminated|1
7571419|NCT03532048|11950528|FG000|Overall Study|Withdrawal by Subject|7
7571420|NCT03532048|11950529|FG001|Overall Study|Withdrawal by Subject|0
7571421|NCT03533114|11950569|FG000|Overall|Adverse Event|16
7571422|NCT03533114|11950570|FG001|Overall|Adverse Event|11
7571423|NCT03533114|11950569|FG000|Overall|Consent Withdrawal by Participant|7
7571424|NCT03533114|11950570|FG001|Overall|Consent Withdrawal by Participant|6
7571425|NCT03533114|11950569|FG000|Overall|Lack of Efficacy|5
7571426|NCT03533114|11950570|FG001|Overall|Lack of Efficacy|3
7571427|NCT03533114|11950569|FG000|Overall|Lost to Follow-up|1
7571428|NCT03533114|11950570|FG001|Overall|Lost to Follow-up|1
7571429|NCT03533114|11950569|FG000|Overall|Physician Decision|0
7571430|NCT03533114|11950570|FG001|Overall|Physician Decision|2
7571431|NCT03533114|11950569|FG000|Overall|Protocol deviation|1
7571432|NCT03533114|11950570|FG001|Overall|Protocol deviation|1
7571433|NCT03533114|11950569|FG000|Overall|Failure to meet randomization criteria|1
7571434|NCT03533114|11950570|FG001|Overall|Failure to meet randomization criteria|2
7571435|NCT03533114|11950569|FG000|Overall|Non-Compliance with study drug|0
7571436|NCT03533114|11950570|FG001|Overall|Non-Compliance with study drug|1
7571437|NCT03533114|11950569|FG000|Overall|Other|0
7571438|NCT03533114|11950570|FG001|Overall|Other|1
7571439|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Adverse Event|11
7571440|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Adverse Event|8
7571441|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
7571442|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
7571443|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
7571444|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
7571445|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
7571446|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
7571447|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Protocol Deviation|0
7571448|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Protocol Deviation|1
7571449|NCT03533114|11950569|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
7571450|NCT03533114|11950570|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
7571451|NCT03533114|11950569|FG000|Stable Dose|Adverse Event|0
7571452|NCT03533114|11950570|FG001|Stable Dose|Adverse Event|2
7571453|NCT03533114|11950569|FG000|Stable Dose|Consent Withdrawal by Participant|1
7571454|NCT03533114|11950570|FG001|Stable Dose|Consent Withdrawal by Participant|0
7571455|NCT03533114|11950569|FG000|Stable Dose|Lack of Efficacy|1
7571456|NCT03533114|11950570|FG001|Stable Dose|Lack of Efficacy|0
7571457|NCT03533114|11950569|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
7571458|NCT03533114|11950570|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
7571459|NCT03533114|11950569|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
7571460|NCT03533114|11950570|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
7571461|NCT03533114|11950569|FG000|Open-Label Safety Extension|Adverse Event|3
7571462|NCT03533114|11950570|FG001|Open-Label Safety Extension|Adverse Event|0
7571463|NCT03533114|11950569|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
7571464|NCT03533114|11950570|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
7571465|NCT03533114|11950569|FG000|Open-Label Safety Extension|Lack of Efficacy|1
7571466|NCT03533114|11950570|FG001|Open-Label Safety Extension|Lack of Efficacy|0
7571467|NCT03533114|11950569|FG000|Open-Label Safety Extension|Lost to Follow-up|1
7571468|NCT03533114|11950570|FG001|Open-Label Safety Extension|Lost to Follow-up|0
7571469|NCT03533114|11950569|FG000|Open-Label Safety Extension|Protocol Deviation|1
7571470|NCT03533114|11950570|FG001|Open-Label Safety Extension|Protocol Deviation|0
7571471|NCT03533608|11950600|FG000|Overall Study|Withdrawal by Subject|3
7571472|NCT03533608|11950600|FG000|Overall Study|Physician Decision|2
7571473|NCT03535194|11950645|FG000|Induction Period|Adverse Event|2
7571474|NCT03535194|11950646|FG001|Induction Period|Adverse Event|2
7571475|NCT03535194|11950647|FG002|Induction Period|Adverse Event|1
7571476|NCT03535194|11950648|FG003|Induction Period|Adverse Event|3
7571477|NCT03535194|11950649|FG004|Induction Period|Adverse Event|0
7571478|NCT03535194|11950645|FG000|Induction Period|Death|0
7571479|NCT03535194|11950646|FG001|Induction Period|Death|1
7571480|NCT03535194|11950647|FG002|Induction Period|Death|0
7571481|NCT03535194|11950648|FG003|Induction Period|Death|0
7571482|NCT03535194|11950649|FG004|Induction Period|Death|0
7571483|NCT03535194|11950645|FG000|Induction Period|Lack of Efficacy|1
7571484|NCT03535194|11950646|FG001|Induction Period|Lack of Efficacy|3
7571485|NCT03535194|11950647|FG002|Induction Period|Lack of Efficacy|2
7571486|NCT03535194|11950648|FG003|Induction Period|Lack of Efficacy|2
7571487|NCT03535194|11950649|FG004|Induction Period|Lack of Efficacy|0
7571488|NCT03535194|11950645|FG000|Induction Period|Lost to Follow-up|3
7571489|NCT03535194|11950646|FG001|Induction Period|Lost to Follow-up|5
7571490|NCT03535194|11950647|FG002|Induction Period|Lost to Follow-up|2
7571491|NCT03535194|11950648|FG003|Induction Period|Lost to Follow-up|3
7571492|NCT03535194|11950649|FG004|Induction Period|Lost to Follow-up|0
7571493|NCT03535194|11950645|FG000|Induction Period|Physician Decision|1
7571494|NCT03535194|11950646|FG001|Induction Period|Physician Decision|1
7571495|NCT03535194|11950647|FG002|Induction Period|Physician Decision|0
7571496|NCT03535194|11950648|FG003|Induction Period|Physician Decision|0
7571497|NCT03535194|11950649|FG004|Induction Period|Physician Decision|0
7571498|NCT03535194|11950645|FG000|Induction Period|Protocol Violation|1
7571499|NCT03535194|11950646|FG001|Induction Period|Protocol Violation|0
7571500|NCT03535194|11950647|FG002|Induction Period|Protocol Violation|0
7571501|NCT03535194|11950648|FG003|Induction Period|Protocol Violation|1
7571502|NCT03535194|11950649|FG004|Induction Period|Protocol Violation|0
7571503|NCT03535194|11950645|FG000|Induction Period|Screen Failure|0
7571504|NCT03535194|11950646|FG001|Induction Period|Screen Failure|1
7571505|NCT03535194|11950647|FG002|Induction Period|Screen Failure|0
7571506|NCT03535194|11950648|FG003|Induction Period|Screen Failure|0
7571507|NCT03535194|11950649|FG004|Induction Period|Screen Failure|0
7571508|NCT03535194|11950645|FG000|Induction Period|Withdrawal by Subject|3
7571509|NCT03535194|11950646|FG001|Induction Period|Withdrawal by Subject|4
7571510|NCT03535194|11950647|FG002|Induction Period|Withdrawal by Subject|3
7571511|NCT03535194|11950648|FG003|Induction Period|Withdrawal by Subject|2
7571512|NCT03535194|11950649|FG004|Induction Period|Withdrawal by Subject|0
7571513|NCT03535194|11950645|FG000|Maintenance Period|Adverse Event|6
7571514|NCT03535194|11950646|FG001|Maintenance Period|Adverse Event|5
7571515|NCT03535194|11950647|FG002|Maintenance Period|Adverse Event|1
7571516|NCT03535194|11950648|FG003|Maintenance Period|Adverse Event|11
7571517|NCT03535194|11950649|FG004|Maintenance Period|Adverse Event|4
7571518|NCT03535194|11950645|FG000|Maintenance Period|Lack of Efficacy|3
7571519|NCT03535194|11950646|FG001|Maintenance Period|Lack of Efficacy|2
7571520|NCT03535194|11950647|FG002|Maintenance Period|Lack of Efficacy|5
7571521|NCT03535194|11950648|FG003|Maintenance Period|Lack of Efficacy|9
7571522|NCT03535194|11950649|FG004|Maintenance Period|Lack of Efficacy|0
7571523|NCT03535194|11950645|FG000|Maintenance Period|Lost to Follow-up|4
7382657|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7571524|NCT03535194|11950646|FG001|Maintenance Period|Lost to Follow-up|2
7571525|NCT03535194|11950647|FG002|Maintenance Period|Lost to Follow-up|1
7382658|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382659|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382660|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382661|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
7382662|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
7382663|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382664|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382665|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382666|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
7571526|NCT03535194|11950648|FG003|Maintenance Period|Lost to Follow-up|5
7571527|NCT03535194|11950649|FG004|Maintenance Period|Lost to Follow-up|2
7571528|NCT03535194|11950645|FG000|Maintenance Period|Other|1
7571529|NCT03535194|11950646|FG001|Maintenance Period|Other|2
7571530|NCT03535194|11950647|FG002|Maintenance Period|Other|0
7571531|NCT03535194|11950648|FG003|Maintenance Period|Other|0
7571532|NCT03535194|11950649|FG004|Maintenance Period|Other|0
7571533|NCT03535194|11950645|FG000|Maintenance Period|Physician Decision|1
7571534|NCT03535194|11950646|FG001|Maintenance Period|Physician Decision|2
7533654|NCT02688387|11880047|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7382667|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382668|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382669|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382670|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382671|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
7382672|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
7382673|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
7382674|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
7382675|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
7382676|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
7382677|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
7382678|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
7382679|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
7382680|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
7382681|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
7382682|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382683|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382684|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
7571535|NCT03535194|11950647|FG002|Maintenance Period|Physician Decision|0
7571536|NCT03535194|11950648|FG003|Maintenance Period|Physician Decision|2
7571537|NCT03535194|11950649|FG004|Maintenance Period|Physician Decision|0
7571538|NCT03535194|11950645|FG000|Maintenance Period|Pregnancy|0
7571539|NCT03535194|11950646|FG001|Maintenance Period|Pregnancy|0
7571540|NCT03535194|11950647|FG002|Maintenance Period|Pregnancy|0
7571541|NCT03535194|11950648|FG003|Maintenance Period|Pregnancy|2
7571542|NCT03535194|11950649|FG004|Maintenance Period|Pregnancy|0
7382685|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382686|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
7382687|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382688|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382689|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382690|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382691|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
7382692|NCT01185353|11639670|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
7382693|NCT01185353|11639671|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382694|NCT01185353|11639672|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382695|NCT01185353|11639673|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382696|NCT01185353|11639674|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
7382697|NCT01185353|11639675|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382698|NCT01185353|11639676|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7571543|NCT03535194|11950645|FG000|Maintenance Period|Protocol Violation|0
7571544|NCT03535194|11950646|FG001|Maintenance Period|Protocol Violation|1
7571545|NCT03535194|11950647|FG002|Maintenance Period|Protocol Violation|0
7533655|NCT02688387|11880048|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533656|NCT02688387|11880049|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7225328|NCT00065429|11434732|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
7225329|NCT00065429|11434733|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7225330|NCT00065429|11434734|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
7225331|NCT00065429|11434728|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7571546|NCT03535194|11950648|FG003|Maintenance Period|Protocol Violation|0
7571547|NCT03535194|11950649|FG004|Maintenance Period|Protocol Violation|0
7571548|NCT03535194|11950645|FG000|Maintenance Period|Withdrawal by Subject|7
7571549|NCT03535194|11950646|FG001|Maintenance Period|Withdrawal by Subject|2
7571550|NCT03535194|11950647|FG002|Maintenance Period|Withdrawal by Subject|1
7571551|NCT03535194|11950648|FG003|Maintenance Period|Withdrawal by Subject|8
7571552|NCT03535194|11950649|FG004|Maintenance Period|Withdrawal by Subject|0
7571553|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Adverse Event|4
7382699|NCT01185353|11639677|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382700|NCT01185353|11639678|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382701|NCT01185353|11639679|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
7382702|NCT01185353|11639670|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
7382703|NCT01185353|11639671|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
7382704|NCT01185353|11639672|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
7382705|NCT01185353|11639673|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
7382706|NCT01185353|11639674|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
7382707|NCT01185353|11639675|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
7382708|NCT01185353|11639676|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
7255470|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Move|0
7382709|NCT01185353|11639677|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
7382710|NCT01185353|11639678|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
7382711|NCT01185353|11639679|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
7382712|NCT01185353|11639670|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382713|NCT01185353|11639671|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7382714|NCT01185353|11639672|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7571554|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Adverse Event|5
7571555|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Adverse Event|1
7571556|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Adverse Event|8
7571557|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Adverse Event|0
7571558|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
7571559|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
7571560|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
7571561|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
7571562|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
7571563|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
7571564|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
7571565|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
7382715|NCT01185353|11639673|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
7382716|NCT01185353|11639674|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382717|NCT01185353|11639675|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382718|NCT01185353|11639676|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382719|NCT01185353|11639677|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382720|NCT01185353|11639678|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382721|NCT01185353|11639679|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
7382722|NCT01185353|11639670|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382723|NCT01185353|11639671|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382724|NCT01185353|11639672|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382725|NCT01185353|11639673|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7382726|NCT01185353|11639674|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382727|NCT01185353|11639675|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382728|NCT01185353|11639676|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
7533657|NCT02688387|11880050|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7571566|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
7571567|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
7571568|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Other|1
7571569|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Other|0
7571570|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Other|0
7571571|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Other|5
7571572|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Other|0
7571573|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Physician Decision|0
7382729|NCT01185353|11639677|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382730|NCT01185353|11639678|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382731|NCT01185353|11639679|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
7382732|NCT01185353|11639670|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382733|NCT01185353|11639671|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382734|NCT01185353|11639672|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
7382735|NCT01185353|11639673|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
7387490|NCT01214668|11646029|FG001|Overall Study|Death|0
7571574|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Physician Decision|2
7571575|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Physician Decision|1
7571576|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Physician Decision|1
7571577|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Physician Decision|0
7571578|NCT03535194|11950645|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
7571579|NCT03535194|11950646|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
7571580|NCT03535194|11950647|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
7571581|NCT03535194|11950648|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
7571582|NCT03535194|11950649|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
7571583|NCT03535844|11950685|FG000|Overall Study|Withdrawal by Subject|0
7571584|NCT03535844|11950686|FG001|Overall Study|Withdrawal by Subject|1
7571585|NCT03535974|11950695|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7571586|NCT03535974|11950696|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
7571587|NCT03535974|11950697|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
7571588|NCT03535974|11950695|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
7571589|NCT03535974|11950696|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
7571590|NCT03535974|11950697|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
7571591|NCT03536663|11950705|FG000|Endexo|Protocol Violation|1
7571592|NCT03536949|11950733|FG000|Overall Study|Adverse Event|4
7571593|NCT03536949|11950734|FG001|Overall Study|Adverse Event|0
7571594|NCT03536949|11950733|FG000|Overall Study|Lost to Follow-up|2
7571595|NCT03536949|11950734|FG001|Overall Study|Lost to Follow-up|1
7571596|NCT03536949|11950733|FG000|Overall Study|Withdrawal by Subject|6
7571597|NCT03536949|11950734|FG001|Overall Study|Withdrawal by Subject|0
7571598|NCT03536949|11950733|FG000|Overall Study|Non-compliance|2
7571599|NCT03536949|11950734|FG001|Overall Study|Non-compliance|1
7571600|NCT03537261|11950746|FG000|Overall Study|Lost to Follow-up|4
7571601|NCT03537261|11950747|FG001|Overall Study|Lost to Follow-up|5
7571602|NCT03537261|11950746|FG000|Overall Study|Withdrawal by Subject|4
7571603|NCT03537261|11950747|FG001|Overall Study|Withdrawal by Subject|6
7571604|NCT03537261|11950746|FG000|Overall Study|Did not return study questionnaires|0
7571605|NCT03537261|11950747|FG001|Overall Study|Did not return study questionnaires|1
7571606|NCT03537651|11950798|FG000|Overall Study|Adverse Event|2
7571607|NCT03537651|11950798|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
7571608|NCT03537651|11950798|FG000|Overall Study|Commercial Drug is Available for Participant|56
7571609|NCT03537651|11950798|FG000|Overall Study|Other|1
7571610|NCT03538431|11950817|FG000|Overall Study|Physician Decision|0
7571611|NCT03538431|11950818|FG001|Overall Study|Physician Decision|1
7571612|NCT03538431|11950817|FG000|Overall Study|Withdrawal by Subject|1
7571613|NCT03538431|11950818|FG001|Overall Study|Withdrawal by Subject|0
7571614|NCT03538743|11950844|FG000|Overall Study|Adverse Event|0
7571615|NCT03538743|11950845|FG001|Overall Study|Adverse Event|0
7571616|NCT03538743|11950846|FG002|Overall Study|Adverse Event|1
7571617|NCT03538743|11950847|FG003|Overall Study|Adverse Event|1
7571618|NCT03538743|11950848|FG004|Overall Study|Adverse Event|0
7571619|NCT03538743|11950849|FG005|Overall Study|Adverse Event|0
7571620|NCT03538743|11950850|FG006|Overall Study|Adverse Event|0
7571621|NCT03538743|11950851|FG007|Overall Study|Adverse Event|0
7571622|NCT03538743|11950852|FG008|Overall Study|Adverse Event|0
7382736|NCT01185353|11639674|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382737|NCT01185353|11639675|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
7382738|NCT01185353|11639676|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
7382739|NCT01185353|11639677|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382740|NCT01185353|11639678|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382741|NCT01185353|11639679|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
7382742|NCT01185353|11639670|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382743|NCT01185353|11639671|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382744|NCT01185353|11639672|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382745|NCT01185353|11639673|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382746|NCT01185353|11639674|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382747|NCT01185353|11639675|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382748|NCT01185353|11639676|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
7382749|NCT01185353|11639677|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382750|NCT01185353|11639678|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382751|NCT01185353|11639679|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
7382752|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
7382753|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
7382754|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
7382755|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
7382756|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
7382757|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
7382758|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
7382759|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
7382760|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
7382761|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
7382762|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7382763|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7382764|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7382765|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7387491|NCT01214668|11646030|FG002|Overall Study|Death|1
7571623|NCT03538743|11950844|FG000|Overall Study|Non-Treatment-Related Reasons|0
7571624|NCT03538743|11950845|FG001|Overall Study|Non-Treatment-Related Reasons|0
7571625|NCT03538743|11950846|FG002|Overall Study|Non-Treatment-Related Reasons|0
7571626|NCT03538743|11950847|FG003|Overall Study|Non-Treatment-Related Reasons|0
7571627|NCT03538743|11950848|FG004|Overall Study|Non-Treatment-Related Reasons|0
7571628|NCT03538743|11950849|FG005|Overall Study|Non-Treatment-Related Reasons|0
7571629|NCT03538743|11950850|FG006|Overall Study|Non-Treatment-Related Reasons|0
7571630|NCT03538743|11950851|FG007|Overall Study|Non-Treatment-Related Reasons|0
7571631|NCT03538743|11950852|FG008|Overall Study|Non-Treatment-Related Reasons|3
7571632|NCT03538743|11950844|FG000|Overall Study|Withdrawal by Subject|0
7571633|NCT03538743|11950845|FG001|Overall Study|Withdrawal by Subject|0
7571634|NCT03538743|11950846|FG002|Overall Study|Withdrawal by Subject|0
7571635|NCT03538743|11950847|FG003|Overall Study|Withdrawal by Subject|1
7571636|NCT03538743|11950848|FG004|Overall Study|Withdrawal by Subject|0
7571637|NCT03538743|11950849|FG005|Overall Study|Withdrawal by Subject|0
7571638|NCT03538743|11950850|FG006|Overall Study|Withdrawal by Subject|0
7571639|NCT03538743|11950851|FG007|Overall Study|Withdrawal by Subject|0
7464319|NCT01868022|11762549|FG008|Overall Study|Study closed/terminated|0
7571640|NCT03538743|11950852|FG008|Overall Study|Withdrawal by Subject|0
7571641|NCT03539432|11950912|FG000|Overall Study|Lost to Follow-up|0
7464320|NCT01868022|11762541|FG000|Overall Study|Ongoing|0
7464321|NCT01868022|11762542|FG001|Overall Study|Ongoing|0
7464322|NCT01868022|11762543|FG002|Overall Study|Ongoing|0
7464323|NCT01868022|11762544|FG003|Overall Study|Ongoing|0
7571642|NCT03539432|11950913|FG001|Overall Study|Lost to Follow-up|1
7464324|NCT01868022|11762545|FG004|Overall Study|Ongoing|0
7571643|NCT03539484|11950926|FG000|Overall Study|Death|1
7571644|NCT03539484|11950927|FG001|Overall Study|Death|0
7571645|NCT03539484|11950928|FG002|Overall Study|Death|0
7571646|NCT03539484|11950929|FG003|Overall Study|Death|2
7571647|NCT03539484|11950930|FG004|Overall Study|Death|8
7571648|NCT03539484|11950931|FG005|Overall Study|Death|3
7571649|NCT03539484|11950932|FG006|Overall Study|Death|0
7571650|NCT03539484|11950926|FG000|Overall Study|Lost to Follow-up|0
7571651|NCT03539484|11950927|FG001|Overall Study|Lost to Follow-up|1
7571652|NCT03539484|11950928|FG002|Overall Study|Lost to Follow-up|0
7571653|NCT03539484|11950929|FG003|Overall Study|Lost to Follow-up|0
7571654|NCT03539484|11950930|FG004|Overall Study|Lost to Follow-up|1
7571655|NCT03539484|11950931|FG005|Overall Study|Lost to Follow-up|0
7571656|NCT03539484|11950932|FG006|Overall Study|Lost to Follow-up|0
7571657|NCT03539484|11950926|FG000|Overall Study|Withdrawal by Subject|0
7571658|NCT03539484|11950927|FG001|Overall Study|Withdrawal by Subject|0
7571659|NCT03539484|11950928|FG002|Overall Study|Withdrawal by Subject|0
7571660|NCT03539484|11950929|FG003|Overall Study|Withdrawal by Subject|0
7571661|NCT03539484|11950930|FG004|Overall Study|Withdrawal by Subject|2
7571662|NCT03539484|11950931|FG005|Overall Study|Withdrawal by Subject|0
7571663|NCT03539484|11950932|FG006|Overall Study|Withdrawal by Subject|1
7571664|NCT03539484|11950926|FG000|Overall Study|Study Terminated by Sponsor|0
7571665|NCT03539484|11950927|FG001|Overall Study|Study Terminated by Sponsor|0
7571666|NCT03539484|11950928|FG002|Overall Study|Study Terminated by Sponsor|1
7571667|NCT03539484|11950929|FG003|Overall Study|Study Terminated by Sponsor|1
7571668|NCT03539484|11950930|FG004|Overall Study|Study Terminated by Sponsor|2
7571669|NCT03539484|11950931|FG005|Overall Study|Study Terminated by Sponsor|2
7571670|NCT03539484|11950932|FG006|Overall Study|Study Terminated by Sponsor|1
7571671|NCT03539549|11950953|FG000|Overall Study|Adverse Event|12
7571672|NCT03539549|11950953|FG000|Overall Study|Lost to Follow-up|1
7571673|NCT03539549|11950953|FG000|Overall Study|Death|2
7571674|NCT03539549|11950953|FG000|Overall Study|Progressive Disease|1
7571675|NCT03539549|11950953|FG000|Overall Study|Reason not Specified|1
7571676|NCT03540030|11950959|FG000|Overall Study|Withdrawal by Subject|2
7571677|NCT03540030|11950960|FG001|Overall Study|Withdrawal by Subject|1
7571678|NCT03540030|11950959|FG000|Overall Study|screen fail|7
7571679|NCT03540030|11950960|FG001|Overall Study|screen fail|1
7571680|NCT03540030|11950959|FG000|Overall Study|never had surgery after signing consent|9
7571681|NCT03540030|11950960|FG001|Overall Study|never had surgery after signing consent|1
7571682|NCT03540160|11950982|FG000|Overall Study|Protocol Violation|1
7571683|NCT03540160|11950982|FG000|Overall Study|Physician Decision|8
7571684|NCT03540160|11950982|FG000|Overall Study|Lack of Efficacy|60
7571685|NCT03540160|11950982|FG000|Overall Study|Pregnancy|1
7571686|NCT03540160|11950982|FG000|Overall Study|Adverse Event|20
7571687|NCT03540160|11950982|FG000|Overall Study|Withdrawal by Subject|68
7571688|NCT03540160|11950982|FG000|Overall Study|COVID-19|2
7571689|NCT03540160|11950982|FG000|Overall Study|Study Closure|10
7571690|NCT03540160|11950982|FG000|Overall Study|Lost to Follow-up|18
7571691|NCT03540160|11950982|FG000|Overall Study|Sponsor decision|191
7571692|NCT03541044|11950986|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7571693|NCT03541044|11950987|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7571694|NCT03541044|11950986|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7571695|NCT03541044|11950987|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7571696|NCT03543137|11951087|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
7571697|NCT03543137|11951088|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
7571698|NCT03543137|11951087|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
7571699|NCT03543137|11951088|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
7571700|NCT03543137|11951087|FG000|Study Period 2: Up to Day 8|Adverse Event|0
7571701|NCT03543137|11951088|FG001|Study Period 2: Up to Day 8|Adverse Event|1
7575341|NCT03722238|11959004|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
7575342|NCT03722238|11959005|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
7575343|NCT03722238|11959004|FG000|Overall Study|Did not meet risk classification group criteria|90
7575344|NCT03722238|11959005|FG001|Overall Study|Did not meet risk classification group criteria|0
7575345|NCT03722238|11959004|FG000|Overall Study|Did not sign consent|17
7575346|NCT03722238|11959005|FG001|Overall Study|Did not sign consent|0
7575347|NCT03722238|11959004|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
7575348|NCT03722238|11959005|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
7575349|NCT03722238|11959004|FG000|Overall Study|Not willing to purchase study medication|142
7575350|NCT03722238|11959005|FG001|Overall Study|Not willing to purchase study medication|0
7575351|NCT03722238|11959004|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
7575352|NCT03722238|11959005|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
7575353|NCT03722264|11959011|FG000|Overall Study|Physician Decision|3
7575354|NCT03722446|11959019|FG000|Overall Study|Protocol Violation|15
7575355|NCT03722446|11959020|FG001|Overall Study|Protocol Violation|2
7575356|NCT03722524|11959026|FG000|Overall Study|Protocol Violation|86
7575357|NCT03722524|11959026|FG000|Overall Study|Adverse Event|7
7575358|NCT03722524|11959026|FG000|Overall Study|Lost to Follow-up|1
7575359|NCT03722524|11959026|FG000|Overall Study|Reason is not stated|1
7575360|NCT03722524|11959026|FG000|Overall Study|Physician Decision|1
7575361|NCT03722524|11959026|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
7575362|NCT03722576|11959030|FG000|Overall Study|Withdrawal by Subject|3
7575363|NCT03722576|11959030|FG000|Overall Study|Adverse Event|2
7571702|NCT03544333|11951136|FG000|Overall Study|Withdrawal by Subject|1
7571703|NCT03544333|11951137|FG001|Overall Study|Withdrawal by Subject|0
7571704|NCT03545503|11951164|FG000|Overall Study|Protocol Violation|14
7571705|NCT03545503|11951165|FG001|Overall Study|Protocol Violation|16
7571706|NCT03545984|11951182|FG000|Overall Study|CSF cases not present during rotation|11
7571707|NCT03545984|11951183|FG001|Overall Study|CSF cases not present during rotation|9
7571708|NCT03546621|11951212|FG000|Overall Study|Withdrawal by Subject|0
7571709|NCT03546621|11951213|FG001|Overall Study|Withdrawal by Subject|1
7571710|NCT03546621|11951214|FG002|Overall Study|Withdrawal by Subject|2
7571711|NCT03546621|11951215|FG003|Overall Study|Withdrawal by Subject|1
7571712|NCT03546621|11951212|FG000|Overall Study|Lost to Follow-up|0
7571713|NCT03546621|11951213|FG001|Overall Study|Lost to Follow-up|1
7571714|NCT03546621|11951214|FG002|Overall Study|Lost to Follow-up|0
7571715|NCT03546621|11951215|FG003|Overall Study|Lost to Follow-up|0
7571716|NCT03546621|11951212|FG000|Overall Study|Adverse Event|0
7571717|NCT03546621|11951213|FG001|Overall Study|Adverse Event|1
7571718|NCT03546621|11951214|FG002|Overall Study|Adverse Event|0
7571719|NCT03546621|11951215|FG003|Overall Study|Adverse Event|1
7571720|NCT03546621|11951212|FG000|Overall Study|Progressive disease|0
7571721|NCT03546621|11951213|FG001|Overall Study|Progressive disease|0
7571722|NCT03546621|11951214|FG002|Overall Study|Progressive disease|0
7571723|NCT03546621|11951215|FG003|Overall Study|Progressive disease|1
7571724|NCT03546647|11951225|FG000|Overall Study|Adverse Event|1
7571725|NCT03546647|11951226|FG001|Overall Study|Adverse Event|0
7571726|NCT03546816|11951234|FG000|Overall Study|Adverse Event|5
7571727|NCT03546816|11951235|FG001|Overall Study|Adverse Event|3
7571728|NCT03546816|11951234|FG000|Overall Study|Lack of Efficacy|2
7571729|NCT03546816|11951235|FG001|Overall Study|Lack of Efficacy|4
7571730|NCT03546816|11951234|FG000|Overall Study|Pregnancy|1
7571731|NCT03546816|11951235|FG001|Overall Study|Pregnancy|0
7571732|NCT03546816|11951234|FG000|Overall Study|Physician Decision|2
7571733|NCT03546816|11951235|FG001|Overall Study|Physician Decision|0
7571734|NCT03546816|11951234|FG000|Overall Study|Withdrawal by Subject|8
7571735|NCT03546816|11951235|FG001|Overall Study|Withdrawal by Subject|10
7571736|NCT03546816|11951234|FG000|Overall Study|Lost to Follow-up|3
7571737|NCT03546816|11951235|FG001|Overall Study|Lost to Follow-up|2
7571738|NCT03546842|11951243|FG000|Overall Study|Protocol Violation|1
7571739|NCT03546842|11951243|FG000|Overall Study|Withdrawal by Subject|2
7571740|NCT03547154|11951249|FG000|Overall Study|Disease Progression/Recurrence|6
7571741|NCT03547154|11951250|FG001|Overall Study|Disease Progression/Recurrence|14
7571742|NCT03547154|11951249|FG000|Overall Study|Adverse Event|26
7571743|NCT03547154|11951250|FG001|Overall Study|Adverse Event|31
7571744|NCT03547154|11951249|FG000|Overall Study|Protocol Violation|6
7571745|NCT03547154|11951250|FG001|Overall Study|Protocol Violation|1
7571746|NCT03547154|11951249|FG000|Overall Study|Physician Decision|4
7571747|NCT03547154|11951250|FG001|Overall Study|Physician Decision|3
7571748|NCT03547154|11951249|FG000|Overall Study|Insufficient Therapeutic Response|13
7571749|NCT03547154|11951250|FG001|Overall Study|Insufficient Therapeutic Response|10
7571750|NCT03547154|11951249|FG000|Overall Study|Withdrawal by Subject|10
7571751|NCT03547154|11951250|FG001|Overall Study|Withdrawal by Subject|6
7571752|NCT03547154|11951249|FG000|Overall Study|Not Selected|0
7571753|NCT03547154|11951250|FG001|Overall Study|Not Selected|1
7571754|NCT03547154|11951249|FG000|Overall Study|Continued treatment beyond 12 mo.|58
7571755|NCT03547154|11951250|FG001|Overall Study|Continued treatment beyond 12 mo.|50
7571756|NCT03547167|11951258|FG000|Overall Study|Withdrawal by Subject|34
7571757|NCT03547167|11951259|FG001|Overall Study|Withdrawal by Subject|12
7571758|NCT03547167|11951258|FG000|Overall Study|Screen Failure|0
7571759|NCT03547167|11951259|FG001|Overall Study|Screen Failure|1
7571760|NCT03547167|11951258|FG000|Overall Study|Lost to Follow-up|59
7571761|NCT03547167|11951259|FG001|Overall Study|Lost to Follow-up|15
7571762|NCT03547167|11951258|FG000|Overall Study|Death|4
7571763|NCT03547167|11951259|FG001|Overall Study|Death|2
7571764|NCT03547531|11951271|FG000|Overall Study|not coming in data collection : sick|2
7571765|NCT03547531|11951272|FG001|Overall Study|not coming in data collection : sick|2
7571766|NCT03547531|11951271|FG000|Overall Study|having family occasion|0
7571767|NCT03547531|11951272|FG001|Overall Study|having family occasion|2
7571768|NCT03547583|11951281|FG000|Overall Study|Adverse Event|16
7571769|NCT03547583|11951282|FG001|Overall Study|Adverse Event|11
7571770|NCT03547583|11951283|FG002|Overall Study|Adverse Event|10
7571771|NCT03547583|11951281|FG000|Overall Study|Death|11
7571772|NCT03547583|11951282|FG001|Overall Study|Death|7
7571773|NCT03547583|11951283|FG002|Overall Study|Death|4
7571774|NCT03547583|11951281|FG000|Overall Study|Lost to Follow-up|1
7571775|NCT03547583|11951282|FG001|Overall Study|Lost to Follow-up|0
7571776|NCT03547583|11951283|FG002|Overall Study|Lost to Follow-up|0
7571777|NCT03547583|11951281|FG000|Overall Study|Non-compliance with study drug|0
7571778|NCT03547583|11951282|FG001|Overall Study|Non-compliance with study drug|0
7571779|NCT03547583|11951283|FG002|Overall Study|Non-compliance with study drug|1
7571780|NCT03547583|11951281|FG000|Overall Study|Physician Decision|1
7571781|NCT03547583|11951282|FG001|Overall Study|Physician Decision|0
7571782|NCT03547583|11951283|FG002|Overall Study|Physician Decision|3
7571783|NCT03547583|11951281|FG000|Overall Study|Protocol Violation|2
7571784|NCT03547583|11951282|FG001|Overall Study|Protocol Violation|1
7571785|NCT03547583|11951283|FG002|Overall Study|Protocol Violation|1
7571786|NCT03547583|11951281|FG000|Overall Study|Withdrawal by Subject|12
7571787|NCT03547583|11951282|FG001|Overall Study|Withdrawal by Subject|19
7571788|NCT03547583|11951283|FG002|Overall Study|Withdrawal by Subject|10
7571789|NCT03547583|11951281|FG000|Overall Study|Other|2
7571790|NCT03547583|11951282|FG001|Overall Study|Other|2
7571791|NCT03547583|11951283|FG002|Overall Study|Other|3
7571792|NCT03547635|11951297|FG000|Overall Study|Adverse Event|5
7571793|NCT03547635|11951298|FG001|Overall Study|Adverse Event|2
7571794|NCT03547635|11951299|FG002|Overall Study|Adverse Event|3
7571795|NCT03547635|11951297|FG000|Overall Study|Lost to Follow-up|1
7571796|NCT03547635|11951298|FG001|Overall Study|Lost to Follow-up|3
7571797|NCT03547635|11951299|FG002|Overall Study|Lost to Follow-up|4
7571798|NCT03547635|11951297|FG000|Overall Study|Withdrawal by Subject|1
7571799|NCT03547635|11951298|FG001|Overall Study|Withdrawal by Subject|0
7571800|NCT03547635|11951299|FG002|Overall Study|Withdrawal by Subject|0
7571801|NCT03547635|11951297|FG000|Overall Study|Withdrawal By PI|0
7571802|NCT03547635|11951298|FG001|Overall Study|Withdrawal By PI|1
7571803|NCT03547635|11951299|FG002|Overall Study|Withdrawal By PI|0
7571804|NCT03547635|11951297|FG000|Overall Study|Withdrawal by Sponsor|0
7571805|NCT03547635|11951298|FG001|Overall Study|Withdrawal by Sponsor|0
7382766|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7382767|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7571806|NCT03547635|11951299|FG002|Overall Study|Withdrawal by Sponsor|1
7571807|NCT03547635|11951297|FG000|Overall Study|Errant Randomization before Treatment|0
7572000|NCT03556891|11951773|FG000|Overall Study|Adverse Event|4
7571808|NCT03547635|11951298|FG001|Overall Study|Errant Randomization before Treatment|1
7571809|NCT03547635|11951299|FG002|Overall Study|Errant Randomization before Treatment|0
7571810|NCT03547635|11951297|FG000|Overall Study|Withdrawal by Subject|1
7571811|NCT03547635|11951298|FG001|Overall Study|Withdrawal by Subject|0
7571812|NCT03547635|11951299|FG002|Overall Study|Withdrawal by Subject|0
7571813|NCT03547687|11951307|FG000|Overall Study|Withdrawal by Subject|1
7571814|NCT03547687|11951307|FG000|Overall Study|Death|1
7533658|NCT02688387|11880051|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533659|NCT02688387|11880052|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533660|NCT02688387|11880053|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
7533661|NCT02688387|11880054|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533662|NCT02688387|11880055|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533663|NCT02688387|11880056|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533664|NCT02688387|11880057|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533665|NCT02688387|11880058|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533666|NCT02688387|11880059|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533667|NCT02688387|11880060|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533668|NCT02688387|11880061|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533669|NCT02688387|11880062|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533670|NCT02688387|11880063|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533671|NCT02688387|11880064|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
7533672|NCT02688387|11880043|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7571815|NCT03548337|11951313|FG000|Infant Series|Withdrawal by Parent/Guardian|8
7571816|NCT03548337|11951314|FG001|Infant Series|Withdrawal by Parent/Guardian|8
7571817|NCT03548337|11951313|FG000|Infant Series|No Longer Met Eligibility Criteria|1
7571818|NCT03548337|11951314|FG001|Infant Series|No Longer Met Eligibility Criteria|0
7571819|NCT03548337|11951313|FG000|Infant Series|Lost to Follow-up|2
7571820|NCT03548337|11951314|FG001|Infant Series|Lost to Follow-up|1
7571821|NCT03548337|11951313|FG000|Infant Series|Adverse Event|0
7571822|NCT03548337|11951314|FG001|Infant Series|Adverse Event|2
7571823|NCT03548337|11951313|FG000|Infant Series|Randomized but Not Vaccinated|1
7571824|NCT03548337|11951314|FG001|Infant Series|Randomized but Not Vaccinated|0
7571825|NCT03548337|11951313|FG000|Toddler Dose|Withdrawal by parent/guardian|1
7571826|NCT03548337|11951314|FG001|Toddler Dose|Withdrawal by parent/guardian|1
7571827|NCT03548935|11951328|FG000|Overall Study|Withdrawal by Subject|26
7571828|NCT03548935|11951329|FG001|Overall Study|Withdrawal by Subject|17
7571829|NCT03548935|11951328|FG000|Overall Study|Lost to Follow-up|39
7571830|NCT03548935|11951329|FG001|Overall Study|Lost to Follow-up|28
7571831|NCT03548935|11951328|FG000|Overall Study|Death|1
7571832|NCT03548935|11951329|FG001|Overall Study|Death|1
7571833|NCT03549117|11951337|FG000|Overall Study|Withdrawal by Subject|1
7571834|NCT03549117|11951338|FG001|Overall Study|Withdrawal by Subject|0
7571835|NCT03549130|11951346|FG000|Overall Study|Adverse Event|0
7571836|NCT03549130|11951347|FG001|Overall Study|Adverse Event|1
7571837|NCT03549130|11951346|FG000|Overall Study|Lost to Follow-up|0
7571838|NCT03549130|11951347|FG001|Overall Study|Lost to Follow-up|1
7571839|NCT03549338|11951367|FG000|Overall Study|Progressive Disease|1
7571840|NCT03549338|11951368|FG001|Overall Study|Progressive Disease|0
7571841|NCT03549338|11951369|FG002|Overall Study|Progressive Disease|0
7571842|NCT03549338|11951367|FG000|Overall Study|Clinical Progression|0
7571843|NCT03549338|11951368|FG001|Overall Study|Clinical Progression|1
7571844|NCT03549338|11951369|FG002|Overall Study|Clinical Progression|0
7571845|NCT03549429|11951377|FG000|Overall Study|Protocol Violation|5
7571846|NCT03549429|11951378|FG001|Overall Study|Protocol Violation|3
7571847|NCT03550209|11951405|FG000|Overall Study|Lost to Follow-up|1
7571848|NCT03550209|11951406|FG001|Overall Study|Lost to Follow-up|0
7571849|NCT03550209|11951407|FG002|Overall Study|Lost to Follow-up|1
7571850|NCT03550209|11951408|FG003|Overall Study|Lost to Follow-up|0
7571851|NCT03550209|11951405|FG000|Overall Study|Withdrawal by Subject|0
7571852|NCT03550209|11951406|FG001|Overall Study|Withdrawal by Subject|3
7571853|NCT03550209|11951407|FG002|Overall Study|Withdrawal by Subject|1
7571854|NCT03550209|11951408|FG003|Overall Study|Withdrawal by Subject|2
7571855|NCT03550209|11951405|FG000|Overall Study|Excluded due to ineligibility after randomization|0
7571856|NCT03550209|11951406|FG001|Overall Study|Excluded due to ineligibility after randomization|0
7571857|NCT03550209|11951407|FG002|Overall Study|Excluded due to ineligibility after randomization|0
7571858|NCT03550209|11951408|FG003|Overall Study|Excluded due to ineligibility after randomization|2
7571859|NCT03550313|11951421|FG000|Overall Study|Adverse Event|0
7571860|NCT03550313|11951422|FG001|Overall Study|Adverse Event|1
7571861|NCT03550313|11951423|FG002|Overall Study|Adverse Event|0
7571862|NCT03550313|11951421|FG000|Overall Study|Lost to Follow-up|5
7571863|NCT03550313|11951422|FG001|Overall Study|Lost to Follow-up|7
7571864|NCT03550313|11951423|FG002|Overall Study|Lost to Follow-up|12
7382768|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
7382769|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
7571865|NCT03550313|11951421|FG000|Overall Study|Study terminated by sponsor|44
7571866|NCT03550313|11951422|FG001|Overall Study|Study terminated by sponsor|37
7571867|NCT03550313|11951423|FG002|Overall Study|Study terminated by sponsor|48
7571868|NCT03550313|11951421|FG000|Overall Study|No longer met eligibility criteria|3
7571869|NCT03550313|11951422|FG001|Overall Study|No longer met eligibility criteria|5
7571870|NCT03550313|11951423|FG002|Overall Study|No longer met eligibility criteria|6
7571871|NCT03550313|11951421|FG000|Overall Study|Withdrawal by parent/guardian|20
7571872|NCT03550313|11951422|FG001|Overall Study|Withdrawal by parent/guardian|18
7571873|NCT03550313|11951423|FG002|Overall Study|Withdrawal by parent/guardian|26
7571874|NCT03550313|11951421|FG000|Overall Study|Other|4
7571875|NCT03550313|11951422|FG001|Overall Study|Other|2
7571876|NCT03550313|11951423|FG002|Overall Study|Other|2
7571877|NCT03550313|11951421|FG000|Overall Study|Randomized but not vaccinated|3
7571878|NCT03550313|11951422|FG001|Overall Study|Randomized but not vaccinated|23
7571879|NCT03550313|11951423|FG002|Overall Study|Randomized but not vaccinated|2
7571880|NCT03550313|11951421|FG000|Overall Study|Sites terminated due to quality issues|18
7571881|NCT03550313|11951422|FG001|Overall Study|Sites terminated due to quality issues|17
7571882|NCT03550313|11951423|FG002|Overall Study|Sites terminated due to quality issues|18
7571883|NCT03550378|11951434|FG000|Overall Study|Death|0
7571884|NCT03550378|11951435|FG001|Overall Study|Death|1
7571885|NCT03551730|11951467|FG000|Overall Study|Adverse Event|1
7571886|NCT03551730|11951468|FG001|Overall Study|Adverse Event|0
7571887|NCT03551730|11951469|FG002|Overall Study|Adverse Event|0
7571888|NCT03551730|11951470|FG003|Overall Study|Adverse Event|0
7571889|NCT03551743|11951484|FG000|Overall Study|Adverse Event|1
7571890|NCT03551743|11951485|FG001|Overall Study|Adverse Event|0
7571891|NCT03551743|11951486|FG002|Overall Study|Adverse Event|0
7571892|NCT03551743|11951487|FG003|Overall Study|Adverse Event|0
7571893|NCT03551743|11951484|FG000|Overall Study|Withdrawal by Subject|1
7571894|NCT03551743|11951485|FG001|Overall Study|Withdrawal by Subject|0
7571895|NCT03551743|11951486|FG002|Overall Study|Withdrawal by Subject|0
7571896|NCT03551743|11951487|FG003|Overall Study|Withdrawal by Subject|0
7571897|NCT03552198|11951505|FG000|Overall Study|Lost to Follow-up|42
7571898|NCT03552198|11951506|FG001|Overall Study|Lost to Follow-up|48
7571899|NCT03552198|11951507|FG002|Overall Study|Lost to Follow-up|15
7571900|NCT03552198|11951508|FG003|Overall Study|Lost to Follow-up|19
7571901|NCT03552198|11951505|FG000|Overall Study|Incomplete/unmatched questionnaire|6
7571902|NCT03552198|11951506|FG001|Overall Study|Incomplete/unmatched questionnaire|7
7571903|NCT03552198|11951507|FG002|Overall Study|Incomplete/unmatched questionnaire|2
7571904|NCT03552198|11951508|FG003|Overall Study|Incomplete/unmatched questionnaire|2
7571905|NCT03552198|11951505|FG000|Overall Study|Did not receive air alerts|1
7571906|NCT03552198|11951506|FG001|Overall Study|Did not receive air alerts|0
7571907|NCT03552198|11951507|FG002|Overall Study|Did not receive air alerts|0
7571908|NCT03552198|11951508|FG003|Overall Study|Did not receive air alerts|1
7571909|NCT03552523|11951527|FG000|Overall Study|Withdrawal by Subject|1
7571910|NCT03552523|11951528|FG001|Overall Study|Withdrawal by Subject|1
7571911|NCT03552549|11951547|FG000|Overall Study|Disease progression|25
7571912|NCT03552549|11951548|FG001|Overall Study|Disease progression|17
7571913|NCT03552549|11951547|FG000|Overall Study|Adverse event in first 12 months|12
7571914|NCT03552549|11951548|FG001|Overall Study|Adverse event in first 12 months|8
7571915|NCT03552549|11951547|FG000|Overall Study|Withdrawal by Subject|7
7571916|NCT03552549|11951548|FG001|Overall Study|Withdrawal by Subject|7
7571917|NCT03552549|11951547|FG000|Overall Study|Unknown (no reason provided)|4
7571918|NCT03552549|11951548|FG001|Overall Study|Unknown (no reason provided)|2
7571919|NCT03552549|11951547|FG000|Overall Study|Not in participant's best interest|2
7571920|NCT03552549|11951548|FG001|Overall Study|Not in participant's best interest|1
7225332|NCT00065429|11434729|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7382770|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7382771|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
7382772|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7571921|NCT03552549|11951547|FG000|Overall Study|Did not complete study treatment|2
7571922|NCT03552549|11951548|FG001|Overall Study|Did not complete study treatment|3
7571923|NCT03552549|11951547|FG000|Overall Study|Did not meet eligibility criteria|1
7571924|NCT03552549|11951548|FG001|Overall Study|Did not meet eligibility criteria|0
7571925|NCT03552549|11951547|FG000|Overall Study|Administrative|0
7571926|NCT03552549|11951548|FG001|Overall Study|Administrative|14
7571927|NCT03552757|11951557|FG000|Overall Study|Withdrawal by Subject|10
7571928|NCT03552757|11951558|FG001|Overall Study|Withdrawal by Subject|5
7571929|NCT03552757|11951559|FG002|Overall Study|Withdrawal by Subject|12
7571930|NCT03552757|11951557|FG000|Overall Study|Lost to Follow-up|2
7571931|NCT03552757|11951558|FG001|Overall Study|Lost to Follow-up|7
7571932|NCT03552757|11951559|FG002|Overall Study|Lost to Follow-up|7
7571933|NCT03552757|11951557|FG000|Overall Study|Death|1
7571934|NCT03552757|11951558|FG001|Overall Study|Death|1
7571935|NCT03552757|11951559|FG002|Overall Study|Death|1
7571936|NCT03553758|11951570|FG000|Overall Study|Lost to Follow-up|1
7571937|NCT03553823|11951578|FG000|Overall Study|Physician Decision|0
7533673|NCT02688387|11880044|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533674|NCT02688387|11880045|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533675|NCT02688387|11880046|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533676|NCT02688387|11880047|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533677|NCT02688387|11880048|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7537686|NCT02759185|11886789|FG001|Stage 2|Withdrawal by Subject|0
7571938|NCT03553823|11951579|FG001|Overall Study|Physician Decision|1
7571939|NCT03554005|11951600|FG000|Overall Study|Not in participant's best interest|0
7464325|NCT01868022|11762546|FG005|Overall Study|Ongoing|0
7464326|NCT01868022|11762547|FG006|Overall Study|Ongoing|0
7571940|NCT03554005|11951601|FG001|Overall Study|Not in participant's best interest|0
7571941|NCT03554005|11951602|FG002|Overall Study|Not in participant's best interest|0
7571942|NCT03554005|11951603|FG003|Overall Study|Not in participant's best interest|0
7464327|NCT01868022|11762548|FG007|Overall Study|Ongoing|3
7571943|NCT03554005|11951604|FG004|Overall Study|Not in participant's best interest|0
7571944|NCT03554005|11951605|FG005|Overall Study|Not in participant's best interest|1
7571945|NCT03554005|11951600|FG000|Overall Study|Disease Progression|1
7571946|NCT03554005|11951601|FG001|Overall Study|Disease Progression|1
7571947|NCT03554005|11951602|FG002|Overall Study|Disease Progression|1
7571948|NCT03554005|11951603|FG003|Overall Study|Disease Progression|1
7571949|NCT03554005|11951604|FG004|Overall Study|Disease Progression|5
7571950|NCT03554005|11951605|FG005|Overall Study|Disease Progression|6
7571951|NCT03554005|11951600|FG000|Overall Study|Adverse Event|0
7571952|NCT03554005|11951601|FG001|Overall Study|Adverse Event|0
7571953|NCT03554005|11951602|FG002|Overall Study|Adverse Event|0
7571954|NCT03554005|11951603|FG003|Overall Study|Adverse Event|0
7571955|NCT03554005|11951604|FG004|Overall Study|Adverse Event|0
7571956|NCT03554005|11951605|FG005|Overall Study|Adverse Event|3
7571957|NCT03554005|11951600|FG000|Overall Study|Physician Decision|0
7571958|NCT03554005|11951601|FG001|Overall Study|Physician Decision|0
7571959|NCT03554005|11951602|FG002|Overall Study|Physician Decision|0
7571960|NCT03554005|11951603|FG003|Overall Study|Physician Decision|0
7571961|NCT03554005|11951604|FG004|Overall Study|Physician Decision|1
7571962|NCT03554005|11951605|FG005|Overall Study|Physician Decision|0
7571963|NCT03554005|11951600|FG000|Overall Study|Other|0
7571964|NCT03554005|11951601|FG001|Overall Study|Other|0
7571965|NCT03554005|11951602|FG002|Overall Study|Other|0
7571966|NCT03554005|11951603|FG003|Overall Study|Other|0
7571967|NCT03554005|11951604|FG004|Overall Study|Other|0
7571968|NCT03554005|11951605|FG005|Overall Study|Other|1
7571969|NCT03554018|11951621|FG000|Overall Study|Lost to Follow-up|3
7571970|NCT03554018|11951622|FG001|Overall Study|Lost to Follow-up|7
7571971|NCT03554486|11951630|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
7571972|NCT03554486|11951631|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
7571973|NCT03554486|11951632|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
7571974|NCT03554486|11951630|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
7571975|NCT03554486|11951631|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
7571976|NCT03554486|11951632|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
7571977|NCT03554486|11951630|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
7571978|NCT03554486|11951631|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7382773|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7382774|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7382775|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7571979|NCT03554486|11951632|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
7571980|NCT03554629|11951639|FG000|Overall Study|Inadequate data|6
7571981|NCT03554772|11951680|FG000|Overall Study|Lost to Follow-up|0
7571982|NCT03554772|11951681|FG001|Overall Study|Lost to Follow-up|0
7382776|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7382777|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7382778|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
7382779|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
7382780|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7382781|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
7382782|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382783|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382784|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382785|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382786|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382787|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382788|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382789|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382790|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
7382791|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
7382792|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Death|0
7571983|NCT03554772|11951682|FG002|Overall Study|Lost to Follow-up|0
7571984|NCT03554772|11951683|FG003|Overall Study|Lost to Follow-up|2
7571985|NCT03555266|11951703|FG000|Overall Study|Protocol Violation|6
7571986|NCT03555266|11951704|FG001|Overall Study|Protocol Violation|4
7571987|NCT03555305|11951710|FG000|Period 1|Physician Decision|0
7571988|NCT03555305|11951711|FG001|Period 1|Physician Decision|1
7571989|NCT03555305|11951710|FG000|Period 1|Adverse Event|0
7571990|NCT03555305|11951711|FG001|Period 1|Adverse Event|1
7571991|NCT03555435|11951720|FG000|Overall Study|Lost to Follow-up|17
7571992|NCT03555435|11951721|FG001|Overall Study|Lost to Follow-up|19
7571993|NCT03555435|11951722|FG002|Overall Study|Lost to Follow-up|8
7571994|NCT03555565|11951730|FG000|Overall Study|Case Report Forms Uncollected|2
7571995|NCT03555565|11951730|FG000|Overall Study|Protocol Deviation|13
7571996|NCT03555890|11951738|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7571997|NCT03555890|11951739|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7571998|NCT03555890|11951740|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7571999|NCT03555890|11951741|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7572001|NCT03556891|11951773|FG000|Overall Study|MRI Need|3
7572002|NCT03556891|11951773|FG000|Overall Study|Device Failure|1
7382793|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Death|0
7382794|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Death|0
7382795|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Death|0
7382796|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Death|0
7382797|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Death|0
7382798|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Death|0
7382799|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Death|0
7572003|NCT03556891|11951773|FG000|Overall Study|Death|1
7572004|NCT03556891|11951773|FG000|Overall Study|Lost to Follow-up|1
7572005|NCT03556891|11951773|FG000|Overall Study|Missing at random|1
7572006|NCT03556891|11951773|FG000|Overall Study|Missing due to COVID|1
7464328|NCT01868022|11762549|FG008|Overall Study|Ongoing|0
7572007|NCT03556891|11951773|FG000|Overall Study|Protocol Violation|1
7572008|NCT03557034|11951779|FG000|Overall Study|Withdrawal by Subject|1
7572009|NCT03557034|11951780|FG001|Overall Study|Withdrawal by Subject|0
7572010|NCT03557775|11951837|FG000|Overall Study|Withdrawal by Subject|1
7572011|NCT03557775|11951838|FG001|Overall Study|Withdrawal by Subject|2
7572012|NCT03557775|11951839|FG002|Overall Study|Withdrawal by Subject|4
7572013|NCT03557775|11951837|FG000|Overall Study|Physician Decision|0
7572014|NCT03557775|11951838|FG001|Overall Study|Physician Decision|1
7572015|NCT03557775|11951839|FG002|Overall Study|Physician Decision|0
7572016|NCT03557801|11951850|FG000|Overall Study|Protocol Violation|1
7572017|NCT03557801|11951851|FG001|Overall Study|Protocol Violation|0
7572018|NCT03557801|11951852|FG002|Overall Study|Protocol Violation|0
7572019|NCT03557801|11951850|FG000|Overall Study|Withdrawal by Subject|1
7572020|NCT03557801|11951851|FG001|Overall Study|Withdrawal by Subject|0
7572021|NCT03557801|11951852|FG002|Overall Study|Withdrawal by Subject|3
7572022|NCT03557801|11951850|FG000|Overall Study|Lost to Follow-up|0
7572023|NCT03557801|11951851|FG001|Overall Study|Lost to Follow-up|1
7572024|NCT03557801|11951852|FG002|Overall Study|Lost to Follow-up|0
7572025|NCT03558516|11951880|FG000|Overall Study|Protocol Violation|2
7572026|NCT03558516|11951881|FG001|Overall Study|Protocol Violation|2
7572027|NCT03558555|11951889|FG000|Overall Study|Lost to Follow-up|2
7572028|NCT03558555|11951890|FG001|Overall Study|Lost to Follow-up|1
7572029|NCT03558672|11951896|FG000|Overall Study|Study Early Termination|10
7572030|NCT03558997|11951904|FG000|Overall Study|Adverse Event|0
7572031|NCT03558997|11951905|FG001|Overall Study|Adverse Event|2
7572032|NCT03558997|11951906|FG002|Overall Study|Adverse Event|5
7572033|NCT03558997|11951907|FG003|Overall Study|Adverse Event|1
7572034|NCT03558997|11951904|FG000|Overall Study|Physician Decision|0
7572035|NCT03558997|11951905|FG001|Overall Study|Physician Decision|0
7572036|NCT03558997|11951906|FG002|Overall Study|Physician Decision|1
7572037|NCT03558997|11951907|FG003|Overall Study|Physician Decision|0
7572038|NCT03558997|11951904|FG000|Overall Study|Withdrawal by Subject|1
7572039|NCT03558997|11951905|FG001|Overall Study|Withdrawal by Subject|0
7572040|NCT03558997|11951906|FG002|Overall Study|Withdrawal by Subject|1
7572041|NCT03558997|11951907|FG003|Overall Study|Withdrawal by Subject|1
7464329|NCT01868035|11762575|FG000|Overall Study|Lost to Follow-up|3
7464330|NCT01868035|11762575|FG000|Overall Study|Withdrawal by Subject|1
7464331|NCT01868035|11762575|FG000|Overall Study|Progressive Disease|2
7464332|NCT01868035|11762575|FG000|Overall Study|Non-compliance|1
7464333|NCT01868074|11762581|FG000|Overall Study|Lost to Follow-up|3
7464334|NCT01868074|11762582|FG001|Overall Study|Lost to Follow-up|2
7464335|NCT01868074|11762581|FG000|Overall Study|Withdrawal by Subject|4
7464336|NCT01868074|11762582|FG001|Overall Study|Withdrawal by Subject|2
7572042|NCT03558997|11951904|FG000|Overall Study|Lost to Follow-up|0
7572043|NCT03558997|11951905|FG001|Overall Study|Lost to Follow-up|0
7572044|NCT03558997|11951906|FG002|Overall Study|Lost to Follow-up|1
7572045|NCT03558997|11951907|FG003|Overall Study|Lost to Follow-up|0
7572046|NCT03559062|11951923|FG000|Overall Study|Other|0
7464337|NCT01868165|11762588|FG000|Overall Study|Withdrawal by Subject|36
7464338|NCT01868165|11762588|FG000|Overall Study|Physician Decision|2
7572047|NCT03559062|11951924|FG001|Overall Study|Other|1
7572048|NCT03559062|11951925|FG002|Overall Study|Other|0
7464339|NCT01868165|11762588|FG000|Overall Study|Lost to Follow-up|3
7533678|NCT02688387|11880049|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533679|NCT02688387|11880050|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533680|NCT02688387|11880051|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7537687|NCT02759185|11886790|FG002|Stage 2|Withdrawal by Subject|0
7382800|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Death|0
7382801|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Death|1
7382802|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382803|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382804|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382805|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382806|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382807|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382808|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382809|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7572049|NCT03559218|11951967|FG000|Overall Study|Withdrawal by Subject|1
7572050|NCT03559218|11951968|FG001|Overall Study|Withdrawal by Subject|0
7572051|NCT03559257|11951976|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
7572052|NCT03559257|11951977|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
7382810|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
7382811|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
7382812|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
7382813|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
7382814|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
7382815|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
7382816|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
7382817|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
7382818|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
7382819|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
7572053|NCT03559257|11951976|FG000|Double Blind Treatment Period|Protocol Violation|1
7572054|NCT03559257|11951977|FG001|Double Blind Treatment Period|Protocol Violation|4
7572055|NCT03559257|11951976|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7572056|NCT03559257|11951977|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7572057|NCT03559257|11951976|FG000|Double Blind Treatment Period|Adverse Event|0
7572058|NCT03559257|11951977|FG001|Double Blind Treatment Period|Adverse Event|1
7572059|NCT03559257|11951976|FG000|Double Blind Treatment Period|Screen Failure|0
7572060|NCT03559257|11951977|FG001|Double Blind Treatment Period|Screen Failure|1
7572061|NCT03559257|11951976|FG000|Open-label Treatment Period|Adverse Event|1
7572062|NCT03559257|11951977|FG001|Open-label Treatment Period|Adverse Event|4
7572063|NCT03559257|11951976|FG000|Open-label Treatment Period|Lack of Efficacy|3
7572064|NCT03559257|11951977|FG001|Open-label Treatment Period|Lack of Efficacy|2
7572065|NCT03559257|11951976|FG000|Open-label Treatment Period|Withdrawal by Subject|3
7572066|NCT03559257|11951977|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7382820|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
7382821|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
7382822|NCT01185353|11639670|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
7382823|NCT01185353|11639671|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
7382824|NCT01185353|11639672|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
7382825|NCT01185353|11639673|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
7382826|NCT01185353|11639674|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
7382827|NCT01185353|11639675|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
7382828|NCT01185353|11639676|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
7382829|NCT01185353|11639677|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
7382830|NCT01185353|11639678|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
7382831|NCT01185353|11639679|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
7382832|NCT01185353|11639670|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382833|NCT01185353|11639671|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382834|NCT01185353|11639672|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382835|NCT01185353|11639673|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382836|NCT01185353|11639674|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382837|NCT01185353|11639675|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382838|NCT01185353|11639676|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382839|NCT01185353|11639677|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
7382840|NCT01185353|11639678|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
7382841|NCT01185353|11639679|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
7382842|NCT01185353|11639670|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382843|NCT01185353|11639671|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382844|NCT01185353|11639672|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382845|NCT01185353|11639673|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382846|NCT01185353|11639674|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382847|NCT01185353|11639675|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382848|NCT01185353|11639676|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
7382849|NCT01185353|11639677|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7382850|NCT01185353|11639678|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
7382851|NCT01185353|11639679|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
7382852|NCT01185353|11639670|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
7382853|NCT01185353|11639671|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
7382854|NCT01185353|11639672|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
7382855|NCT01185353|11639673|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
7382856|NCT01185353|11639674|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
7382857|NCT01185353|11639675|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
7382858|NCT01185353|11639676|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
7382859|NCT01185353|11639677|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
7382860|NCT01185353|11639678|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
7382861|NCT01185353|11639679|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
7464340|NCT01868165|11762588|FG000|Overall Study|Death|4
7464341|NCT01868243|11762594|FG000|Overall Study|Death|0
7464342|NCT01868243|11762595|FG001|Overall Study|Death|1
7464343|NCT01868477|11762657|FG000|Overall Study|Adverse Event|2
7464344|NCT01868477|11762658|FG001|Overall Study|Adverse Event|4
7464345|NCT01868477|11762657|FG000|Overall Study|Disease progression|1
7464346|NCT01868477|11762658|FG001|Overall Study|Disease progression|1
7464347|NCT01868477|11762657|FG000|Overall Study|Withdrawal by Subject|1
7464348|NCT01868477|11762658|FG001|Overall Study|Withdrawal by Subject|0
7464349|NCT01868503|11762671|FG000|Overall Study|Withdrawal by Subject|1
7464350|NCT01868503|11762671|FG000|Overall Study|Protocol Violation|1
7464351|NCT01868542|11762679|FG000|Overall Study|Protocol Violation|0
7464352|NCT01868542|11762680|FG001|Overall Study|Protocol Violation|1
7464353|NCT01868542|11762679|FG000|Overall Study|Unclassified|0
7464354|NCT01868542|11762680|FG001|Overall Study|Unclassified|1
7464355|NCT01868594|11762688|FG000|Overall Study|Do not meet inclusion criteria|4
7464356|NCT01868594|11762689|FG001|Overall Study|Do not meet inclusion criteria|3
7464357|NCT01868646|11762708|FG000|Overall Study|Do not meet inclusion criteria|3
7464358|NCT01868646|11762709|FG001|Overall Study|Do not meet inclusion criteria|5
7464359|NCT01868893|11762733|FG000|Overall Study|Adverse Event|2
7464360|NCT01868893|11762733|FG000|Overall Study|Commercial availability of study drug|17
7464361|NCT01868893|11762733|FG000|Overall Study|Neutropenia|1
7464362|NCT01868997|11762741|FG000|Overall Study|Adverse Event|2
7464363|NCT01868997|11762742|FG001|Overall Study|Adverse Event|5
7464364|NCT01868997|11762741|FG000|Overall Study|Lack of Efficacy|2
7464365|NCT01868997|11762742|FG001|Overall Study|Lack of Efficacy|0
7464366|NCT01868997|11762741|FG000|Overall Study|Other|3
7464367|NCT01868997|11762742|FG001|Overall Study|Other|1
7464368|NCT01869192|11762775|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
7464369|NCT01869192|11762776|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
7464370|NCT01869192|11762775|FG000|Postoperative Chemotherapy|Physician Decision|0
7464371|NCT01869192|11762776|FG001|Postoperative Chemotherapy|Physician Decision|2
7464372|NCT01869348|11762784|FG000|Overall Study|Withdrawal by Subject|1
7464373|NCT01869348|11762785|FG001|Overall Study|Withdrawal by Subject|1
7468511|NCT01911819|11769395|FG001|Overall Study|Adverse Event|1
7468512|NCT01911819|11769396|FG002|Overall Study|Adverse Event|0
7468513|NCT01911819|11769394|FG000|Overall Study|Withdrawal by Subject|1
7468514|NCT01911819|11769395|FG001|Overall Study|Withdrawal by Subject|1
7468515|NCT01911819|11769396|FG002|Overall Study|Withdrawal by Subject|0
7468516|NCT01911845|11769404|FG000|Overall Study|Adverse Event|2
7468517|NCT01911845|11769404|FG000|Overall Study|Lost to Follow-up|1
7468518|NCT01911845|11769404|FG000|Overall Study|Other (not specified)|3
7468519|NCT01912222|11769422|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
7468520|NCT01912222|11769423|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7468521|NCT01912222|11769424|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
7468522|NCT01912222|11769422|FG000|Part B: Treatment Period|Progressive disease|10
7468523|NCT01912222|11769423|FG001|Part B: Treatment Period|Progressive disease|12
7468524|NCT01912222|11769424|FG002|Part B: Treatment Period|Progressive disease|15
7468525|NCT01912222|11769422|FG000|Part B: Treatment Period|Adverse Event|1
7533681|NCT02688387|11880052|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7572067|NCT03559257|11951976|FG000|Open-label Treatment Period|Protocol Violation|2
7572068|NCT03559257|11951977|FG001|Open-label Treatment Period|Protocol Violation|0
7572069|NCT03559257|11951976|FG000|Open-label Treatment Period|Lost to Follow-up|1
7572070|NCT03559257|11951977|FG001|Open-label Treatment Period|Lost to Follow-up|0
7572071|NCT03559257|11951976|FG000|Open-label Treatment Period|Physician Decision|0
7572072|NCT03559257|11951977|FG001|Open-label Treatment Period|Physician Decision|1
7572073|NCT03559517|11951989|FG000|Overall Study|Withdrawal by Subject|1
7572074|NCT03559517|11951990|FG001|Overall Study|Withdrawal by Subject|0
7572075|NCT03559517|11951991|FG002|Overall Study|Withdrawal by Subject|0
7572076|NCT03559530|11951999|FG000|Overall Study|non-location of medical records|44
7572077|NCT03559530|11952000|FG001|Overall Study|non-location of medical records|0
7255471|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Move|0
7464374|NCT01869699|11762832|FG000|Overall Study|Withdrawal by Subject|1
7464375|NCT01869699|11762833|FG001|Overall Study|Withdrawal by Subject|0
7464376|NCT01869725|11762839|FG000|Overall Study|ineligible after registration|1
7382862|NCT01185366|11639720|FG000|First Line Therapy|Insurance Coverage Denied|1
7382863|NCT01185366|11639721|FG001|First Line Therapy|Insurance Coverage Denied|1
7382864|NCT01185366|11639720|FG000|First Line Therapy|Withdrawal by Subject|1
7572078|NCT03559530|11951999|FG000|Overall Study|culture results not considered for treat|29
7572079|NCT03559530|11952000|FG001|Overall Study|culture results not considered for treat|0
7572080|NCT03559530|11951999|FG000|Overall Study|duplicate cases|8
7572081|NCT03559530|11952000|FG001|Overall Study|duplicate cases|0
7572082|NCT03559530|11951999|FG000|Overall Study|other species of Acinetobacte|7
7572083|NCT03559530|11952000|FG001|Overall Study|other species of Acinetobacte|0
7572084|NCT03559530|11951999|FG000|Overall Study|contamination / colonization|3
7572085|NCT03559530|11952000|FG001|Overall Study|contamination / colonization|0
7572086|NCT03560245|11952040|FG000|Overall Study|Withdrawal by Subject|3
7572087|NCT03560245|11952041|FG001|Overall Study|Withdrawal by Subject|2
7572088|NCT03560245|11952040|FG000|Overall Study|Adverse Event|1
7572089|NCT03560245|11952041|FG001|Overall Study|Adverse Event|1
7572090|NCT03560245|11952040|FG000|Overall Study|Protocol Violation|1
7572091|NCT03560245|11952041|FG001|Overall Study|Protocol Violation|0
7572092|NCT03560245|11952040|FG000|Overall Study|Death|0
7572093|NCT03560245|11952041|FG001|Overall Study|Death|1
7572094|NCT03560245|11952040|FG000|Overall Study|Lost to Follow-up|0
7572095|NCT03560245|11952041|FG001|Overall Study|Lost to Follow-up|1
7572096|NCT03560245|11952040|FG000|Overall Study|Physician Decision|0
7464377|NCT01869725|11762839|FG000|Overall Study|Death|1
7464378|NCT01869725|11762839|FG000|Overall Study|Lost to Follow-up|2
7464379|NCT01869764|11762845|FG000|Overall Study|Withdrawal by Subject|0
7464380|NCT01869764|11762846|FG001|Overall Study|Withdrawal by Subject|2
7464381|NCT01869777|11762852|FG000|Overall Study|Excluded from the analysis, ineligible|1
7464382|NCT01869959|11762860|FG000|Randomization Period|Physician Decision|0
7464383|NCT01869959|11762861|FG001|Randomization Period|Physician Decision|0
7464384|NCT01869959|11762862|FG002|Randomization Period|Physician Decision|0
7464385|NCT01869959|11762863|FG003|Randomization Period|Physician Decision|0
7464386|NCT01869959|11762864|FG004|Randomization Period|Physician Decision|1
7464387|NCT01869959|11762860|FG000|Treatment Period|Adverse Event|1
7464388|NCT01869959|11762861|FG001|Treatment Period|Adverse Event|0
7464389|NCT01869959|11762862|FG002|Treatment Period|Adverse Event|3
7464390|NCT01869959|11762863|FG003|Treatment Period|Adverse Event|1
7464391|NCT01869959|11762864|FG004|Treatment Period|Adverse Event|0
7464392|NCT01869959|11762860|FG000|Treatment Period|Sponsor decision|0
7464393|NCT01869959|11762861|FG001|Treatment Period|Sponsor decision|1
7464394|NCT01869959|11762862|FG002|Treatment Period|Sponsor decision|0
7464395|NCT01869959|11762863|FG003|Treatment Period|Sponsor decision|1
7464396|NCT01869959|11762864|FG004|Treatment Period|Sponsor decision|0
7464397|NCT01869959|11762860|FG000|Treatment Period|Withdrawal by Subject|0
7464398|NCT01869959|11762861|FG001|Treatment Period|Withdrawal by Subject|1
7464399|NCT01869959|11762862|FG002|Treatment Period|Withdrawal by Subject|0
7464400|NCT01869959|11762863|FG003|Treatment Period|Withdrawal by Subject|0
7464401|NCT01869959|11762864|FG004|Treatment Period|Withdrawal by Subject|0
7464402|NCT01870076|11762878|FG000|Overall Study|Withdrawal by Subject|1
7464403|NCT01870076|11762879|FG001|Overall Study|Withdrawal by Subject|0
7464404|NCT01870076|11762880|FG002|Overall Study|Withdrawal by Subject|1
7464405|NCT01870076|11762881|FG003|Overall Study|Withdrawal by Subject|0
7464406|NCT01870297|11762898|FG000|Overall Study|Adverse Event|0
7464407|NCT01870297|11762899|FG001|Overall Study|Adverse Event|0
7464408|NCT01870297|11762900|FG002|Overall Study|Adverse Event|0
7464409|NCT01870297|11762901|FG003|Overall Study|Adverse Event|0
7464410|NCT01870297|11762902|FG004|Overall Study|Adverse Event|2
7572097|NCT03560245|11952041|FG001|Overall Study|Physician Decision|1
7572098|NCT03560245|11952040|FG000|Overall Study|Other|0
7572099|NCT03560245|11952041|FG001|Overall Study|Other|1
7572100|NCT03560518|11952052|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
7464411|NCT01870297|11762903|FG005|Overall Study|Adverse Event|0
7464412|NCT01870297|11762904|FG006|Overall Study|Adverse Event|0
7464413|NCT01870297|11762898|FG000|Overall Study|Lost to Follow-up|0
7464414|NCT01870297|11762899|FG001|Overall Study|Lost to Follow-up|1
7464415|NCT01870297|11762900|FG002|Overall Study|Lost to Follow-up|1
7464416|NCT01870297|11762901|FG003|Overall Study|Lost to Follow-up|0
7464417|NCT01870297|11762902|FG004|Overall Study|Lost to Follow-up|0
7464418|NCT01870297|11762903|FG005|Overall Study|Lost to Follow-up|0
7464419|NCT01870297|11762904|FG006|Overall Study|Lost to Follow-up|0
7464420|NCT01870297|11762898|FG000|Overall Study|Withdrawal by Subject|0
7464421|NCT01870297|11762899|FG001|Overall Study|Withdrawal by Subject|0
7464422|NCT01870297|11762900|FG002|Overall Study|Withdrawal by Subject|0
7464423|NCT01870297|11762901|FG003|Overall Study|Withdrawal by Subject|0
7464424|NCT01870297|11762902|FG004|Overall Study|Withdrawal by Subject|1
7464425|NCT01870297|11762903|FG005|Overall Study|Withdrawal by Subject|1
7464426|NCT01870297|11762904|FG006|Overall Study|Withdrawal by Subject|1
7464427|NCT01870297|11762898|FG000|Overall Study|Sponsor Decision|0
7464428|NCT01870297|11762899|FG001|Overall Study|Sponsor Decision|6
7255472|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Move|0
7382865|NCT01185366|11639721|FG001|First Line Therapy|Withdrawal by Subject|0
7464429|NCT01870297|11762900|FG002|Overall Study|Sponsor Decision|0
7464430|NCT01870297|11762901|FG003|Overall Study|Sponsor Decision|0
7464431|NCT01870297|11762902|FG004|Overall Study|Sponsor Decision|0
7464432|NCT01870297|11762903|FG005|Overall Study|Sponsor Decision|0
7464433|NCT01870297|11762904|FG006|Overall Study|Sponsor Decision|1
7464434|NCT01870583|11762943|FG000|Overall Study|Protocol Violation|0
7464435|NCT01870583|11762944|FG001|Overall Study|Protocol Violation|5
7464436|NCT01870583|11762945|FG002|Overall Study|Protocol Violation|3
7464437|NCT01870583|11762943|FG000|Overall Study|Lost to Follow-up|11
7464438|NCT01870583|11762944|FG001|Overall Study|Lost to Follow-up|13
7464439|NCT01870583|11762945|FG002|Overall Study|Lost to Follow-up|5
7464440|NCT01870726|11762969|FG000|Overall Study|Withdrawal of informed consent|0
7464441|NCT01870726|11762970|FG001|Overall Study|Withdrawal of informed consent|0
7464442|NCT01870726|11762971|FG002|Overall Study|Withdrawal of informed consent|0
7464443|NCT01870726|11762972|FG003|Overall Study|Withdrawal of informed consent|1
7464444|NCT01870726|11762973|FG004|Overall Study|Withdrawal of informed consent|0
7464445|NCT01870726|11762974|FG005|Overall Study|Withdrawal of informed consent|0
7464446|NCT01870726|11762975|FG006|Overall Study|Withdrawal of informed consent|0
7464447|NCT01870726|11762969|FG000|Overall Study|Withdrawal by Subject|0
7464448|NCT01870726|11762970|FG001|Overall Study|Withdrawal by Subject|1
7464449|NCT01870726|11762971|FG002|Overall Study|Withdrawal by Subject|0
7464450|NCT01870726|11762972|FG003|Overall Study|Withdrawal by Subject|0
7464451|NCT01870726|11762973|FG004|Overall Study|Withdrawal by Subject|0
7572101|NCT03560518|11952053|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
7572102|NCT03560518|11952054|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
7572103|NCT03560518|11952052|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
7572104|NCT03560518|11952053|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
7572105|NCT03560518|11952054|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
7572106|NCT03560518|11952052|FG000|Double Blind Treatment Period|Protocol Violation|1
7572107|NCT03560518|11952053|FG001|Double Blind Treatment Period|Protocol Violation|2
7572108|NCT03560518|11952054|FG002|Double Blind Treatment Period|Protocol Violation|0
7572109|NCT03560518|11952052|FG000|Double Blind Treatment Period|Pregnancy|0
7572110|NCT03560518|11952053|FG001|Double Blind Treatment Period|Pregnancy|2
7572111|NCT03560518|11952054|FG002|Double Blind Treatment Period|Pregnancy|0
7572112|NCT03560518|11952052|FG000|Double Blind Treatment Period|Lost to Follow-up|5
7572113|NCT03560518|11952053|FG001|Double Blind Treatment Period|Lost to Follow-up|6
7572114|NCT03560518|11952054|FG002|Double Blind Treatment Period|Lost to Follow-up|6
7572115|NCT03560518|11952052|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
7572116|NCT03560518|11952053|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
7572117|NCT03560518|11952054|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
7572118|NCT03560518|11952052|FG000|Double Blind Treatment Period|Lack of Efficacy|2
7572119|NCT03560518|11952053|FG001|Double Blind Treatment Period|Lack of Efficacy|1
7572120|NCT03560518|11952054|FG002|Double Blind Treatment Period|Lack of Efficacy|1
7572121|NCT03560518|11952052|FG000|Double Blind Treatment Period|Adverse Event|0
7572122|NCT03560518|11952053|FG001|Double Blind Treatment Period|Adverse Event|3
7572123|NCT03560518|11952054|FG002|Double Blind Treatment Period|Adverse Event|1
7572124|NCT03560739|11952066|FG000|Overall Study|Adverse Event|0
7572125|NCT03560739|11952067|FG001|Overall Study|Adverse Event|1
7572126|NCT03560739|11952068|FG002|Overall Study|Adverse Event|0
7572127|NCT03560739|11952069|FG003|Overall Study|Adverse Event|0
7572128|NCT03560869|11952079|FG000|Overall Study|Withdrawal by Subject|3
7572129|NCT03560869|11952080|FG001|Overall Study|Withdrawal by Subject|4
7572130|NCT03560869|11952079|FG000|Overall Study|Screening failure|4
7572131|NCT03560869|11952080|FG001|Overall Study|Screening failure|4
7572132|NCT03560869|11952079|FG000|Overall Study|Withdrawal by PI|0
7572133|NCT03560869|11952080|FG001|Overall Study|Withdrawal by PI|1
7572134|NCT03560986|11952088|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
7572135|NCT03560986|11952089|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
7572136|NCT03560986|11952088|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7572137|NCT03560986|11952089|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
7572138|NCT03560986|11952088|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
7572139|NCT03560986|11952089|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
7572140|NCT03560986|11952088|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
7572141|NCT03560986|11952089|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
7572142|NCT03560986|11952088|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
7572143|NCT03560986|11952089|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
7572144|NCT03560986|11952088|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
7572145|NCT03560986|11952089|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
7572146|NCT03560986|11952088|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7572147|NCT03560986|11952089|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
7572148|NCT03561090|11952103|FG000|Overall Study|Adverse Event|11
7572149|NCT03561090|11952104|FG001|Overall Study|Adverse Event|7
7572150|NCT03561090|11952103|FG000|Overall Study|Non-Compliance With Study Drug|2
7572151|NCT03561090|11952104|FG001|Overall Study|Non-Compliance With Study Drug|0
7572152|NCT03561090|11952103|FG000|Overall Study|Protocol Violation|2
7572153|NCT03561090|11952104|FG001|Overall Study|Protocol Violation|2
7572154|NCT03561090|11952103|FG000|Overall Study|Withdrawal by Subject|7
7572155|NCT03561090|11952104|FG001|Overall Study|Withdrawal by Subject|7
7572156|NCT03561090|11952103|FG000|Overall Study|Lost to Follow-up|7
7572157|NCT03561090|11952104|FG001|Overall Study|Lost to Follow-up|2
7572158|NCT03561090|11952103|FG000|Overall Study|Study Terminated by Sponsor|10
7572159|NCT03561090|11952104|FG001|Overall Study|Study Terminated by Sponsor|15
7572160|NCT03561090|11952103|FG000|Overall Study|Randomized by Mistake|1
7572161|NCT03561090|11952104|FG001|Overall Study|Randomized by Mistake|1
7572162|NCT03561090|11952103|FG000|Overall Study|Other Not Specified|0
7572163|NCT03561090|11952104|FG001|Overall Study|Other Not Specified|2
7572164|NCT03561883|11952114|FG000|Overall Study|Adverse Event|10
7572165|NCT03561883|11952115|FG001|Overall Study|Adverse Event|13
7572166|NCT03561883|11952114|FG000|Overall Study|Non-Compliance With Study Drug|1
7572167|NCT03561883|11952115|FG001|Overall Study|Non-Compliance With Study Drug|2
7572168|NCT03561883|11952114|FG000|Overall Study|Protocol Violation|2
7572169|NCT03561883|11952115|FG001|Overall Study|Protocol Violation|3
7572170|NCT03561883|11952114|FG000|Overall Study|Withdrawal by Subject|14
7572171|NCT03561883|11952115|FG001|Overall Study|Withdrawal by Subject|6
7572172|NCT03561883|11952114|FG000|Overall Study|Lost to Follow-up|2
7572173|NCT03561883|11952115|FG001|Overall Study|Lost to Follow-up|6
7572174|NCT03561883|11952114|FG000|Overall Study|Study Terminated by Sponsor|12
7572175|NCT03561883|11952115|FG001|Overall Study|Study Terminated by Sponsor|11
7572176|NCT03561883|11952114|FG000|Overall Study|Physician Decision|1
7572177|NCT03561883|11952115|FG001|Overall Study|Physician Decision|0
7572178|NCT03561883|11952114|FG000|Overall Study|Randomized by Mistake|1
7572179|NCT03561883|11952115|FG001|Overall Study|Randomized by Mistake|0
7572180|NCT03561883|11952114|FG000|Overall Study|Other, Not Specified|3
7572181|NCT03561883|11952115|FG001|Overall Study|Other, Not Specified|2
7572182|NCT03562117|11952124|FG000|Part 1, Up to 3 Days|Adverse Event|1
7572183|NCT03562117|11952125|FG001|Part 1, Up to 3 Days|Adverse Event|0
7572184|NCT03562117|11952126|FG002|Part 1, Up to 3 Days|Adverse Event|0
7572185|NCT03562481|11952145|FG000|First Intervention|Lost to Follow-up|1
7572186|NCT03562481|11952146|FG001|First Intervention|Lost to Follow-up|0
7575364|NCT03722576|11959030|FG000|Overall Study|Physician Decision|1
7572187|NCT03565068|11952260|FG000|Overall Study|Protocol Violation|0
7572188|NCT03565068|11952261|FG001|Overall Study|Protocol Violation|0
7572189|NCT03565068|11952262|FG002|Overall Study|Protocol Violation|0
7572190|NCT03565068|11952263|FG003|Overall Study|Protocol Violation|0
7572191|NCT03565068|11952264|FG004|Overall Study|Protocol Violation|1
7572192|NCT03565068|11952265|FG005|Overall Study|Protocol Violation|0
7572193|NCT03565068|11952266|FG006|Overall Study|Protocol Violation|0
7572194|NCT03565068|11952267|FG007|Overall Study|Protocol Violation|1
7572195|NCT03565068|11952268|FG008|Overall Study|Protocol Violation|0
7572196|NCT03565068|11952260|FG000|Overall Study|Sponsor decision|0
7572197|NCT03565068|11952261|FG001|Overall Study|Sponsor decision|0
7572198|NCT03565068|11952262|FG002|Overall Study|Sponsor decision|0
7572199|NCT03565068|11952263|FG003|Overall Study|Sponsor decision|0
7572200|NCT03565068|11952264|FG004|Overall Study|Sponsor decision|1
7572201|NCT03565068|11952265|FG005|Overall Study|Sponsor decision|1
7572202|NCT03565068|11952266|FG006|Overall Study|Sponsor decision|0
7572203|NCT03565068|11952267|FG007|Overall Study|Sponsor decision|0
7572204|NCT03565068|11952268|FG008|Overall Study|Sponsor decision|0
7572205|NCT03565068|11952260|FG000|Overall Study|Withdrawal by Subject|0
7572206|NCT03565068|11952261|FG001|Overall Study|Withdrawal by Subject|0
7572207|NCT03565068|11952262|FG002|Overall Study|Withdrawal by Subject|1
7572208|NCT03565068|11952263|FG003|Overall Study|Withdrawal by Subject|0
7572209|NCT03565068|11952264|FG004|Overall Study|Withdrawal by Subject|2
7572210|NCT03565068|11952265|FG005|Overall Study|Withdrawal by Subject|0
7572211|NCT03565068|11952266|FG006|Overall Study|Withdrawal by Subject|1
7572212|NCT03565068|11952267|FG007|Overall Study|Withdrawal by Subject|5
7572213|NCT03565068|11952268|FG008|Overall Study|Withdrawal by Subject|1
7572214|NCT03565068|11952260|FG000|Overall Study|Physician Decision|0
7572215|NCT03565068|11952261|FG001|Overall Study|Physician Decision|0
7572216|NCT03565068|11952262|FG002|Overall Study|Physician Decision|0
7572217|NCT03565068|11952263|FG003|Overall Study|Physician Decision|0
7572218|NCT03565068|11952264|FG004|Overall Study|Physician Decision|0
7572219|NCT03565068|11952265|FG005|Overall Study|Physician Decision|0
7572220|NCT03565068|11952266|FG006|Overall Study|Physician Decision|0
7572221|NCT03565068|11952267|FG007|Overall Study|Physician Decision|1
7572222|NCT03565068|11952268|FG008|Overall Study|Physician Decision|0
7572223|NCT03565068|11952260|FG000|Overall Study|Lost to Follow-up|0
7572224|NCT03565068|11952261|FG001|Overall Study|Lost to Follow-up|0
7572225|NCT03565068|11952262|FG002|Overall Study|Lost to Follow-up|0
7572226|NCT03565068|11952263|FG003|Overall Study|Lost to Follow-up|0
7572227|NCT03565068|11952264|FG004|Overall Study|Lost to Follow-up|0
7572228|NCT03565068|11952265|FG005|Overall Study|Lost to Follow-up|0
7572229|NCT03565068|11952266|FG006|Overall Study|Lost to Follow-up|0
7572230|NCT03565068|11952267|FG007|Overall Study|Lost to Follow-up|1
7572231|NCT03565068|11952268|FG008|Overall Study|Lost to Follow-up|0
7572232|NCT03565211|11952325|FG000|Overall Study|Withdrawal by Subject|2
7572233|NCT03565211|11952325|FG000|Overall Study|Lost to Follow-up|1
7572234|NCT03565211|11952325|FG000|Overall Study|Adverse Event|44
7572235|NCT03565211|11952325|FG000|Overall Study|Personal issues|1
7572236|NCT03565315|11952333|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7572237|NCT03565315|11952334|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7572238|NCT03565315|11952335|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
7572239|NCT03565315|11952336|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
7572240|NCT03565887|11952385|FG000|Overall Study|Adverse Event|1
7572241|NCT03565887|11952386|FG001|Overall Study|Adverse Event|0
7572242|NCT03565887|11952385|FG000|Overall Study|Withdrawal by Subject|0
7572243|NCT03565887|11952386|FG001|Overall Study|Withdrawal by Subject|2
7572244|NCT03566238|11952395|FG000|Overall Study|Adverse Event|0
7572245|NCT03566238|11952396|FG001|Overall Study|Adverse Event|1
7572246|NCT03566238|11952397|FG002|Overall Study|Adverse Event|0
7572247|NCT03566238|11952395|FG000|Overall Study|Lack of Efficacy|4
7572248|NCT03566238|11952396|FG001|Overall Study|Lack of Efficacy|2
7572249|NCT03566238|11952397|FG002|Overall Study|Lack of Efficacy|5
7572250|NCT03566238|11952395|FG000|Overall Study|Other|1
7572251|NCT03566238|11952396|FG001|Overall Study|Other|0
7572252|NCT03566238|11952397|FG002|Overall Study|Other|0
7572253|NCT03566485|11952407|FG000|Overall Study|Disease progression|5
7572254|NCT03566485|11952408|FG001|Overall Study|Disease progression|4
7572255|NCT03566485|11952407|FG000|Overall Study|Clinical progression|0
7572256|NCT03566485|11952408|FG001|Overall Study|Clinical progression|1
7572257|NCT03566485|11952407|FG000|Overall Study|Toxicity|0
7572258|NCT03566485|11952408|FG001|Overall Study|Toxicity|2
7572259|NCT03566550|11952416|FG000|Overall Study|Withdrawal by Subject|0
7572260|NCT03566550|11952417|FG001|Overall Study|Withdrawal by Subject|1
7572261|NCT03566680|11952423|FG000|Overall Study|Pregnancy|1
7572262|NCT03566680|11952423|FG000|Overall Study|Lost to Follow-up|13
7572263|NCT03566680|11952423|FG000|Overall Study|Withdrawal by Subject|3
7572264|NCT03566810|11952431|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7572265|NCT03566810|11952432|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
7572266|NCT03566810|11952433|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7572267|NCT03566810|11952434|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
7572268|NCT03566823|11952447|FG000|Overall Study|Lack of Efficacy|0
7572269|NCT03566823|11952448|FG001|Overall Study|Lack of Efficacy|1
7572270|NCT03566823|11952449|FG002|Overall Study|Lack of Efficacy|0
7572271|NCT03566823|11952447|FG000|Overall Study|Withdrawal by Subject|1
7572272|NCT03566823|11952448|FG001|Overall Study|Withdrawal by Subject|2
7572273|NCT03566823|11952449|FG002|Overall Study|Withdrawal by Subject|0
7572274|NCT03566823|11952447|FG000|Overall Study|Adverse Event|1
7572275|NCT03566823|11952448|FG001|Overall Study|Adverse Event|0
7572276|NCT03566823|11952449|FG002|Overall Study|Adverse Event|2
7572277|NCT03566979|11952461|FG000|Overall Study|Withdrawal by Subject|2
7572278|NCT03566979|11952462|FG001|Overall Study|Withdrawal by Subject|0
7572279|NCT03566979|11952463|FG002|Overall Study|Withdrawal by Subject|1
7572280|NCT03566979|11952464|FG003|Overall Study|Withdrawal by Subject|1
7572281|NCT03566979|11952461|FG000|Overall Study|Lost to Follow-up|2
7572282|NCT03566979|11952462|FG001|Overall Study|Lost to Follow-up|7
7572283|NCT03566979|11952463|FG002|Overall Study|Lost to Follow-up|9
7572284|NCT03566979|11952464|FG003|Overall Study|Lost to Follow-up|5
7572285|NCT03566979|11952461|FG000|Overall Study|Adverse Event|1
7572286|NCT03566979|11952462|FG001|Overall Study|Adverse Event|0
7572287|NCT03566979|11952463|FG002|Overall Study|Adverse Event|0
7572288|NCT03566979|11952464|FG003|Overall Study|Adverse Event|0
7572289|NCT03567291|11952490|FG000|Period I|Adverse Event|14
7572290|NCT03567291|11952491|FG001|Period I|Adverse Event|0
7572291|NCT03567291|11952492|FG002|Period I|Adverse Event|0
7572292|NCT03567291|11952493|FG003|Period I|Adverse Event|0
7572293|NCT03567291|11952490|FG000|Period I|Protocol Violation|1
7572294|NCT03567291|11952491|FG001|Period I|Protocol Violation|0
7572295|NCT03567291|11952492|FG002|Period I|Protocol Violation|0
7572296|NCT03567291|11952493|FG003|Period I|Protocol Violation|0
7572297|NCT03567291|11952490|FG000|Period I|Withdrawal by Subject|23
7572298|NCT03567291|11952491|FG001|Period I|Withdrawal by Subject|0
7572299|NCT03567291|11952492|FG002|Period I|Withdrawal by Subject|0
7572300|NCT03567291|11952493|FG003|Period I|Withdrawal by Subject|0
7572301|NCT03567291|11952490|FG000|Period I|Lost to Follow-up|2
7572302|NCT03567291|11952491|FG001|Period I|Lost to Follow-up|0
7572303|NCT03567291|11952492|FG002|Period I|Lost to Follow-up|0
7572304|NCT03567291|11952493|FG003|Period I|Lost to Follow-up|0
7572305|NCT03567291|11952490|FG000|Period I|Terminated by sponsor|44
7572306|NCT03567291|11952491|FG001|Period I|Terminated by sponsor|0
7572307|NCT03567291|11952492|FG002|Period I|Terminated by sponsor|0
7572308|NCT03567291|11952493|FG003|Period I|Terminated by sponsor|0
7572309|NCT03567291|11952490|FG000|Period I|Missing or unknown|7
7572310|NCT03567291|11952491|FG001|Period I|Missing or unknown|0
7572311|NCT03567291|11952492|FG002|Period I|Missing or unknown|0
7572312|NCT03567291|11952493|FG003|Period I|Missing or unknown|0
7572313|NCT03567291|11952490|FG000|Period II|Adverse Event|0
7572314|NCT03567291|11952491|FG001|Period II|Adverse Event|1
7572315|NCT03567291|11952492|FG002|Period II|Adverse Event|0
7572316|NCT03567291|11952493|FG003|Period II|Adverse Event|0
7572317|NCT03567291|11952490|FG000|Period II|Missing or unknown|0
7572318|NCT03567291|11952491|FG001|Period II|Missing or unknown|2
7572319|NCT03567291|11952492|FG002|Period II|Missing or unknown|1
7572320|NCT03567291|11952493|FG003|Period II|Missing or unknown|0
7572321|NCT03567291|11952490|FG000|Period III|Adverse Event|0
7572322|NCT03567291|11952491|FG001|Period III|Adverse Event|0
7572323|NCT03567291|11952492|FG002|Period III|Adverse Event|0
7572324|NCT03567291|11952493|FG003|Period III|Adverse Event|4
7572325|NCT03567291|11952490|FG000|Period III|Withdrawal by Subject|0
7572326|NCT03567291|11952491|FG001|Period III|Withdrawal by Subject|0
7572327|NCT03567291|11952492|FG002|Period III|Withdrawal by Subject|0
7572328|NCT03567291|11952493|FG003|Period III|Withdrawal by Subject|4
7572329|NCT03567291|11952490|FG000|Period III|Lost to Follow-up|0
7572330|NCT03567291|11952491|FG001|Period III|Lost to Follow-up|0
7572331|NCT03567291|11952492|FG002|Period III|Lost to Follow-up|0
7572332|NCT03567291|11952493|FG003|Period III|Lost to Follow-up|1
7572333|NCT03567291|11952490|FG000|Period III|Terminated by sponsor|0
7572334|NCT03567291|11952491|FG001|Period III|Terminated by sponsor|0
7572335|NCT03567291|11952492|FG002|Period III|Terminated by sponsor|0
7572336|NCT03567291|11952493|FG003|Period III|Terminated by sponsor|68
7572337|NCT03567291|11952490|FG000|Period III|Missing or unknown|0
7572338|NCT03567291|11952491|FG001|Period III|Missing or unknown|0
7572339|NCT03567291|11952492|FG002|Period III|Missing or unknown|0
7572340|NCT03567291|11952493|FG003|Period III|Missing or unknown|8
7572341|NCT03567382|11952501|FG000|Overall Study|Lost to Follow-up|1
7572342|NCT03567382|11952502|FG001|Overall Study|Lost to Follow-up|21
7572343|NCT03567382|11952503|FG002|Overall Study|Lost to Follow-up|1
7572344|NCT03567382|11952504|FG003|Overall Study|Lost to Follow-up|21
7572345|NCT03567382|11952501|FG000|Overall Study|Withdrawal by Subject|2
7572346|NCT03567382|11952502|FG001|Overall Study|Withdrawal by Subject|14
7572347|NCT03567382|11952503|FG002|Overall Study|Withdrawal by Subject|1
7572348|NCT03567382|11952504|FG003|Overall Study|Withdrawal by Subject|12
7572349|NCT03567616|11952517|FG000|Overall Study|Disease progression|4
7572350|NCT03567616|11952517|FG000|Overall Study|Withdrawal by Subject|1
7572351|NCT03567616|11952517|FG000|Overall Study|Physician Decision|1
7572352|NCT03567616|11952517|FG000|Overall Study|Death|1
7572353|NCT03567616|11952517|FG000|Overall Study|Adverse Event|1
7572354|NCT03567980|11952524|FG000|Overall Study|Adverse Event|1
7572355|NCT03568500|11952531|FG000|Overall Study|Lost to Follow-up|1
7572356|NCT03568500|11952532|FG001|Overall Study|Lost to Follow-up|1
7572357|NCT03568500|11952533|FG002|Overall Study|Lost to Follow-up|2
7572358|NCT03568500|11952531|FG000|Overall Study|Adverse Event|1
7572359|NCT03568500|11952532|FG001|Overall Study|Adverse Event|1
7572360|NCT03568500|11952533|FG002|Overall Study|Adverse Event|2
7572361|NCT03568500|11952531|FG000|Overall Study|Physician Decision|1
7572362|NCT03568500|11952532|FG001|Overall Study|Physician Decision|0
7572363|NCT03568500|11952533|FG002|Overall Study|Physician Decision|0
7572364|NCT03568500|11952531|FG000|Overall Study|Withdrawal by Subject|4
7572365|NCT03568500|11952532|FG001|Overall Study|Withdrawal by Subject|2
7572366|NCT03568500|11952533|FG002|Overall Study|Withdrawal by Subject|0
7572367|NCT03568500|11952531|FG000|Overall Study|Technical Problems|2
7572368|NCT03568500|11952532|FG001|Overall Study|Technical Problems|1
7572369|NCT03568500|11952533|FG002|Overall Study|Technical Problems|0
7572370|NCT03568500|11952531|FG000|Overall Study|Participant Noncompliance|1
7572371|NCT03568500|11952532|FG001|Overall Study|Participant Noncompliance|1
7572372|NCT03568500|11952533|FG002|Overall Study|Participant Noncompliance|0
7572373|NCT03568942|11952556|FG000|Overall Study|Family emergency|1
7572374|NCT03568942|11952556|FG000|Overall Study|Lost to Follow-up|1
7572375|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7572376|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
7572377|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
7572378|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
7572379|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
7572380|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
7572381|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7572382|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
7572383|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
7572384|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
7572385|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
7572386|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
7572387|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
7572388|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
7572389|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
7572390|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
7572391|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
7572392|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
7572393|NCT03569098|11952585|FG000|Double-Blind Treatment Cycle 1|Other|1
7572394|NCT03569098|11952586|FG001|Double-Blind Treatment Cycle 1|Other|0
7572395|NCT03569098|11952587|FG002|Double-Blind Treatment Cycle 1|Other|1
7572396|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7572397|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
7572398|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
7572399|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7572400|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
7572401|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
7572402|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7533682|NCT02688387|11880053|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533683|NCT02688387|11880054|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533684|NCT02688387|11880055|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533685|NCT02688387|11880056|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533686|NCT02688387|11880057|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
7533687|NCT02688387|11880058|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533688|NCT02688387|11880059|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533689|NCT02688387|11880060|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533690|NCT02688387|11880061|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533691|NCT02688387|11880062|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533692|NCT02688387|11880063|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533693|NCT02688387|11880064|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
7533694|NCT02688387|11880043|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533695|NCT02688387|11880044|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533696|NCT02688387|11880045|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533697|NCT02688387|11880046|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533698|NCT02688387|11880047|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533699|NCT02688387|11880048|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533700|NCT02688387|11880049|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533701|NCT02688387|11880050|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533702|NCT02688387|11880051|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533703|NCT02688387|11880052|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7572403|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
7572404|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
7572405|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7572406|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
7572407|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
7572408|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
7572409|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7533704|NCT02688387|11880053|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533705|NCT02688387|11880054|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533706|NCT02688387|11880055|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533707|NCT02688387|11880056|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533708|NCT02688387|11880057|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533709|NCT02688387|11880058|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533710|NCT02688387|11880059|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533711|NCT02688387|11880060|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7572410|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
7572411|NCT03569098|11952585|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7572412|NCT03569098|11952586|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
7572413|NCT03569098|11952587|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
7572414|NCT03569202|11952600|FG000|Part 3|Physician Decision|1
7572415|NCT03569202|11952601|FG001|Part 3|Physician Decision|0
7572416|NCT03569202|11952600|FG000|Part 3|Other|1
7572417|NCT03569202|11952601|FG001|Part 3|Other|1
7572421|NCT03570554|11952678|FG000|Overall Study|Non-compliance with study drug|0
7572422|NCT03570554|11952679|FG001|Overall Study|Non-compliance with study drug|0
7572423|NCT03570554|11952680|FG002|Overall Study|Non-compliance with study drug|1
7572424|NCT03570554|11952681|FG003|Overall Study|Non-compliance with study drug|0
7572425|NCT03570554|11952678|FG000|Overall Study|Adverse Event|0
7572426|NCT03570554|11952679|FG001|Overall Study|Adverse Event|0
7572427|NCT03570554|11952680|FG002|Overall Study|Adverse Event|0
7572428|NCT03570554|11952681|FG003|Overall Study|Adverse Event|1
7572429|NCT03571256|11952725|FG000|Overall Study|Adverse Event|3
7572430|NCT03571256|11952726|FG001|Overall Study|Adverse Event|0
7572431|NCT03571256|11952727|FG002|Overall Study|Adverse Event|1
7572432|NCT03571256|11952725|FG000|Overall Study|Withdrawal by Subject|3
7572433|NCT03571256|11952726|FG001|Overall Study|Withdrawal by Subject|1
7572434|NCT03571256|11952727|FG002|Overall Study|Withdrawal by Subject|1
7572435|NCT03571256|11952725|FG000|Overall Study|Other than specified|0
7572436|NCT03571256|11952726|FG001|Overall Study|Other than specified|1
7572437|NCT03571256|11952727|FG002|Overall Study|Other than specified|1
7572438|NCT03571256|11952725|FG000|Overall Study|Protocol Violation|0
7572439|NCT03571256|11952726|FG001|Overall Study|Protocol Violation|1
7572440|NCT03571256|11952727|FG002|Overall Study|Protocol Violation|1
7572441|NCT03571516|11952739|FG000|Overall Study|Severe diarrhea|1
7572442|NCT03571516|11952740|FG001|Overall Study|Severe diarrhea|0
7572443|NCT03571516|11952739|FG000|Overall Study|Withdrawal by Subject|0
7572444|NCT03571516|11952740|FG001|Overall Study|Withdrawal by Subject|1
7572445|NCT03572062|11952810|FG000|Overall Study|Adverse Event|0
7572446|NCT03572062|11952811|FG001|Overall Study|Adverse Event|0
7572447|NCT03572062|11952812|FG002|Overall Study|Adverse Event|0
7572448|NCT03572062|11952813|FG003|Overall Study|Adverse Event|0
7572449|NCT03572062|11952814|FG004|Overall Study|Adverse Event|0
7572450|NCT03572062|11952815|FG005|Overall Study|Adverse Event|0
7572451|NCT03572062|11952816|FG006|Overall Study|Adverse Event|0
7572452|NCT03572062|11952817|FG007|Overall Study|Adverse Event|0
7572453|NCT03572062|11952818|FG008|Overall Study|Adverse Event|1
7572454|NCT03572062|11952819|FG009|Overall Study|Adverse Event|3
7572455|NCT03572062|11952810|FG000|Overall Study|Death|0
7572456|NCT03572062|11952811|FG001|Overall Study|Death|0
7572457|NCT03572062|11952812|FG002|Overall Study|Death|0
7572458|NCT03572062|11952813|FG003|Overall Study|Death|0
7572459|NCT03572062|11952814|FG004|Overall Study|Death|0
7572460|NCT03572062|11952815|FG005|Overall Study|Death|1
7572461|NCT03572062|11952816|FG006|Overall Study|Death|0
7572462|NCT03572062|11952817|FG007|Overall Study|Death|0
7572463|NCT03572062|11952818|FG008|Overall Study|Death|0
7572464|NCT03572062|11952819|FG009|Overall Study|Death|0
7464452|NCT01870726|11762974|FG005|Overall Study|Withdrawal by Subject|0
7464453|NCT01870726|11762975|FG006|Overall Study|Withdrawal by Subject|0
7464454|NCT01870726|11762969|FG000|Overall Study|Adverse Event|0
7464455|NCT01870726|11762970|FG001|Overall Study|Adverse Event|0
7464456|NCT01870726|11762971|FG002|Overall Study|Adverse Event|0
7464457|NCT01870726|11762972|FG003|Overall Study|Adverse Event|0
7464458|NCT01870726|11762973|FG004|Overall Study|Adverse Event|1
7464459|NCT01870726|11762974|FG005|Overall Study|Adverse Event|1
7464460|NCT01870726|11762975|FG006|Overall Study|Adverse Event|0
7464461|NCT01870726|11762969|FG000|Overall Study|Progressive disease|5
7572465|NCT03572062|11952810|FG000|Overall Study|Lost to Follow-up|0
7572466|NCT03572062|11952811|FG001|Overall Study|Lost to Follow-up|0
7572467|NCT03572062|11952812|FG002|Overall Study|Lost to Follow-up|0
7464462|NCT01870726|11762970|FG001|Overall Study|Progressive disease|5
7464463|NCT01870726|11762971|FG002|Overall Study|Progressive disease|4
7464464|NCT01870726|11762972|FG003|Overall Study|Progressive disease|5
7464465|NCT01870726|11762973|FG004|Overall Study|Progressive disease|6
7572468|NCT03572062|11952813|FG003|Overall Study|Lost to Follow-up|0
7464466|NCT01870726|11762974|FG005|Overall Study|Progressive disease|4
7572469|NCT03572062|11952814|FG004|Overall Study|Lost to Follow-up|0
7572470|NCT03572062|11952815|FG005|Overall Study|Lost to Follow-up|1
7572471|NCT03572062|11952816|FG006|Overall Study|Lost to Follow-up|1
7572472|NCT03572062|11952817|FG007|Overall Study|Lost to Follow-up|0
7572473|NCT03572062|11952818|FG008|Overall Study|Lost to Follow-up|0
7572474|NCT03572062|11952819|FG009|Overall Study|Lost to Follow-up|0
7572475|NCT03572062|11952810|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7572476|NCT03572062|11952811|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7572477|NCT03572062|11952812|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7572478|NCT03572062|11952813|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7572479|NCT03572062|11952814|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7464467|NCT01870726|11762975|FG006|Overall Study|Progressive disease|10
7464468|NCT01870739|11763002|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
7464469|NCT01870739|11763003|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
7464470|NCT01870739|11763002|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
7464471|NCT01870739|11763003|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
7464472|NCT01870739|11763002|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
7464473|NCT01870739|11763003|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
7464474|NCT01870739|11763002|FG000|Add-on Period (40 Weeks)|Adverse Event|0
7464475|NCT01870739|11763003|FG001|Add-on Period (40 Weeks)|Adverse Event|1
7464476|NCT01870739|11763002|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
7464477|NCT01870739|11763003|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
7464478|NCT01870739|11763002|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
7464479|NCT01870739|11763003|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
7464480|NCT01870739|11763002|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
7572480|NCT03572062|11952815|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7572481|NCT03572062|11952816|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
7572482|NCT03572062|11952817|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7572483|NCT03572062|11952818|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
7572484|NCT03572062|11952819|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
7572485|NCT03572062|11952810|FG000|Overall Study|Study Terminated By Sponsor|0
7572486|NCT03572062|11952811|FG001|Overall Study|Study Terminated By Sponsor|0
7572487|NCT03572062|11952812|FG002|Overall Study|Study Terminated By Sponsor|0
7572488|NCT03572062|11952813|FG003|Overall Study|Study Terminated By Sponsor|0
7572489|NCT03572062|11952814|FG004|Overall Study|Study Terminated By Sponsor|0
7572490|NCT03572062|11952815|FG005|Overall Study|Study Terminated By Sponsor|0
7572491|NCT03572062|11952816|FG006|Overall Study|Study Terminated By Sponsor|0
7572492|NCT03572062|11952817|FG007|Overall Study|Study Terminated By Sponsor|0
7572493|NCT03572062|11952818|FG008|Overall Study|Study Terminated By Sponsor|29
7572494|NCT03572062|11952819|FG009|Overall Study|Study Terminated By Sponsor|27
7572495|NCT03572062|11952810|FG000|Overall Study|Physician Decision|0
7572496|NCT03572062|11952811|FG001|Overall Study|Physician Decision|0
7572497|NCT03572062|11952812|FG002|Overall Study|Physician Decision|0
7572498|NCT03572062|11952813|FG003|Overall Study|Physician Decision|0
7572499|NCT03572062|11952814|FG004|Overall Study|Physician Decision|0
7572500|NCT03572062|11952815|FG005|Overall Study|Physician Decision|0
7572501|NCT03572062|11952816|FG006|Overall Study|Physician Decision|0
7572502|NCT03572062|11952817|FG007|Overall Study|Physician Decision|0
7572503|NCT03572062|11952818|FG008|Overall Study|Physician Decision|1
7572504|NCT03572062|11952819|FG009|Overall Study|Physician Decision|0
7572505|NCT03572062|11952810|FG000|Overall Study|Withdrawal by Subject|0
7572506|NCT03572062|11952811|FG001|Overall Study|Withdrawal by Subject|0
7572507|NCT03572062|11952812|FG002|Overall Study|Withdrawal by Subject|0
7572508|NCT03572062|11952813|FG003|Overall Study|Withdrawal by Subject|0
7572509|NCT03572062|11952814|FG004|Overall Study|Withdrawal by Subject|0
7572510|NCT03572062|11952815|FG005|Overall Study|Withdrawal by Subject|0
7572511|NCT03572062|11952816|FG006|Overall Study|Withdrawal by Subject|0
7572512|NCT03572062|11952817|FG007|Overall Study|Withdrawal by Subject|0
7572513|NCT03572062|11952818|FG008|Overall Study|Withdrawal by Subject|0
7572514|NCT03572062|11952819|FG009|Overall Study|Withdrawal by Subject|1
7572515|NCT03572062|11952810|FG000|Overall Study|Randomized But Not Treated|0
7572516|NCT03572062|11952811|FG001|Overall Study|Randomized But Not Treated|0
7572517|NCT03572062|11952812|FG002|Overall Study|Randomized But Not Treated|0
7572518|NCT03572062|11952813|FG003|Overall Study|Randomized But Not Treated|0
7572519|NCT03572062|11952814|FG004|Overall Study|Randomized But Not Treated|1
7572520|NCT03572062|11952815|FG005|Overall Study|Randomized But Not Treated|2
7572521|NCT03572062|11952816|FG006|Overall Study|Randomized But Not Treated|0
7572522|NCT03572062|11952817|FG007|Overall Study|Randomized But Not Treated|1
7572523|NCT03572062|11952818|FG008|Overall Study|Randomized But Not Treated|0
7572524|NCT03572062|11952819|FG009|Overall Study|Randomized But Not Treated|0
7225333|NCT00065429|11434730|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7225334|NCT00065429|11434731|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7225335|NCT00065429|11434732|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
7225336|NCT00065429|11434733|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7225337|NCT00065429|11434734|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
7255473|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7255474|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7255475|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7572525|NCT03572218|11952841|FG000|Overall Study|Lost to Follow-up|3
7572526|NCT03572218|11952842|FG001|Overall Study|Lost to Follow-up|2
7572527|NCT03572218|11952841|FG000|Overall Study|No longer available for study visits|2
7572528|NCT03572218|11952842|FG001|Overall Study|No longer available for study visits|1
7572529|NCT03572218|11952841|FG000|Overall Study|No longer interested|1
7572530|NCT03572218|11952842|FG001|Overall Study|No longer interested|2
7572531|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7572532|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
7572533|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
7572534|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
7572535|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
7572536|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
7572537|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
7572538|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
7572539|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
7572540|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
7572541|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
7572542|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
7572543|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
7572544|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
7572545|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
7572546|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
7572547|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
7572548|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
7572549|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
7572550|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
7572551|NCT03573323|11952887|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
7572552|NCT03573323|11952888|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
7572553|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
7572554|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
7572555|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
7572556|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
7572557|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
7572558|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
7572559|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
7572560|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
7572561|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
7572562|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
7572563|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
7572564|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
7572565|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
7572566|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
7572567|NCT03573323|11952887|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
7572568|NCT03573323|11952888|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
7572569|NCT03573505|11952900|FG000|Overall Study|Adverse Event|1
7572570|NCT03573505|11952901|FG001|Overall Study|Adverse Event|1
7572571|NCT03573505|11952900|FG000|Overall Study|Consent withdrawn|0
7572572|NCT03573505|11952901|FG001|Overall Study|Consent withdrawn|1
7572573|NCT03573505|11952900|FG000|Overall Study|Disease progression|0
7572574|NCT03573505|11952901|FG001|Overall Study|Disease progression|1
7572575|NCT03573505|11952900|FG000|Overall Study|Site Terminated by Sponsor|1
7572576|NCT03573505|11952901|FG001|Overall Study|Site Terminated by Sponsor|1
7572577|NCT03573505|11952900|FG000|Overall Study|Study terminated by sponsor|50
7572578|NCT03573505|11952901|FG001|Overall Study|Study terminated by sponsor|45
7572579|NCT03573505|11952900|FG000|Overall Study|Reason not specified|0
7572580|NCT03573505|11952901|FG001|Overall Study|Reason not specified|1
7572581|NCT03573505|11952900|FG000|Overall Study|Death|0
7572582|NCT03573505|11952901|FG001|Overall Study|Death|4
7572583|NCT03573804|11952908|FG000|Overall Study|claustrophobia or MRI table problems|10
7572584|NCT03573830|11952920|FG000|Overall Study|Dropped without completing treatment|0
7572585|NCT03573830|11952921|FG001|Overall Study|Dropped without completing treatment|7
7572586|NCT03573830|11952920|FG000|Overall Study|Lost to Follow-up|4
7572587|NCT03573830|11952921|FG001|Overall Study|Lost to Follow-up|0
7572588|NCT03573908|11952928|FG000|Treatment Period|Adverse Event|4
7464481|NCT01870739|11763003|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
7464482|NCT01870778|11763021|FG000|Overall Study|Withdrawal by Subject|8
7464483|NCT01870778|11763022|FG001|Overall Study|Withdrawal by Subject|7
7464484|NCT01870778|11763021|FG000|Overall Study|Lost to Follow-up|0
7464485|NCT01870778|11763022|FG001|Overall Study|Lost to Follow-up|2
7464486|NCT01870843|11763028|FG000|Overall Study|Adverse Event|10
7464487|NCT01870843|11763028|FG000|Overall Study|Lost to Follow-up|24
7464488|NCT01870843|11763028|FG000|Overall Study|Death|1
7464489|NCT01870843|11763028|FG000|Overall Study|Withdrawal by Subject|18
7464490|NCT01870869|11763047|FG000|Overall Study|Implanted with nonstudy device|1
7572646|NCT03575702|11952970|FG001|Overall Study|Protocol Violation|1
7464491|NCT01870869|11763048|FG001|Overall Study|Implanted with nonstudy device|3
7464492|NCT01870869|11763049|FG002|Overall Study|Implanted with nonstudy device|14
7464493|NCT01870869|11763050|FG003|Overall Study|Implanted with nonstudy device|4
7464494|NCT01870869|11763047|FG000|Overall Study|Death|0
7464495|NCT01870869|11763048|FG001|Overall Study|Death|0
7464496|NCT01870869|11763049|FG002|Overall Study|Death|7
7464497|NCT01870869|11763050|FG003|Overall Study|Death|1
7464498|NCT01870869|11763047|FG000|Overall Study|Subject choice|6
7464499|NCT01870869|11763048|FG001|Overall Study|Subject choice|2
7464500|NCT01870869|11763049|FG002|Overall Study|Subject choice|22
7464501|NCT01870869|11763050|FG003|Overall Study|Subject choice|8
7464502|NCT01870869|11763047|FG000|Overall Study|Lost to Follow-up|10
7464503|NCT01870869|11763048|FG001|Overall Study|Lost to Follow-up|2
7464504|NCT01870869|11763049|FG002|Overall Study|Lost to Follow-up|25
7572589|NCT03573908|11952929|FG001|Treatment Period|Adverse Event|9
7572590|NCT03573908|11952930|FG002|Treatment Period|Adverse Event|0
7572591|NCT03573908|11952931|FG003|Treatment Period|Adverse Event|0
7572592|NCT03573908|11952932|FG004|Treatment Period|Adverse Event|0
7572593|NCT03573908|11952928|FG000|Treatment Period|Protocol Violation|1
7572594|NCT03573908|11952929|FG001|Treatment Period|Protocol Violation|0
7572595|NCT03573908|11952930|FG002|Treatment Period|Protocol Violation|0
7572596|NCT03573908|11952931|FG003|Treatment Period|Protocol Violation|0
7572597|NCT03573908|11952932|FG004|Treatment Period|Protocol Violation|0
7572598|NCT03573908|11952928|FG000|Treatment Period|Withdrawal by Subject|7
7572599|NCT03573908|11952929|FG001|Treatment Period|Withdrawal by Subject|5
7572600|NCT03573908|11952930|FG002|Treatment Period|Withdrawal by Subject|0
7572601|NCT03573908|11952931|FG003|Treatment Period|Withdrawal by Subject|0
7572602|NCT03573908|11952932|FG004|Treatment Period|Withdrawal by Subject|0
7572603|NCT03573908|11952928|FG000|Treatment Period|Lost to Follow-up|7
7572604|NCT03573908|11952929|FG001|Treatment Period|Lost to Follow-up|6
7572605|NCT03573908|11952930|FG002|Treatment Period|Lost to Follow-up|0
7572606|NCT03573908|11952931|FG003|Treatment Period|Lost to Follow-up|0
7572607|NCT03573908|11952932|FG004|Treatment Period|Lost to Follow-up|0
7572608|NCT03573908|11952928|FG000|Treatment Period|Pregnancy|1
7572609|NCT03573908|11952929|FG001|Treatment Period|Pregnancy|0
7382866|NCT01185366|11639720|FG000|First Line Therapy|Lack of Metastatic Site|1
7382867|NCT01185366|11639721|FG001|First Line Therapy|Lack of Metastatic Site|0
7382868|NCT01185366|11639720|FG000|Crossover to Second Line Therapy|Adverse Event|3
7382869|NCT01185366|11639721|FG001|Crossover to Second Line Therapy|Adverse Event|6
7382870|NCT01185366|11639720|FG000|Crossover to Second Line Therapy|Physician Decision|5
7382871|NCT01185366|11639721|FG001|Crossover to Second Line Therapy|Physician Decision|1
7382872|NCT01185366|11639720|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
7382873|NCT01185366|11639721|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
7382874|NCT01185366|11639720|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
7572610|NCT03573908|11952930|FG002|Treatment Period|Pregnancy|0
7572611|NCT03573908|11952931|FG003|Treatment Period|Pregnancy|0
7572612|NCT03573908|11952932|FG004|Treatment Period|Pregnancy|0
7572613|NCT03573908|11952928|FG000|Treatment Period|Other, Not Specified|4
7572614|NCT03573908|11952929|FG001|Treatment Period|Other, Not Specified|6
7572615|NCT03573908|11952930|FG002|Treatment Period|Other, Not Specified|0
7572616|NCT03573908|11952931|FG003|Treatment Period|Other, Not Specified|0
7572617|NCT03573908|11952932|FG004|Treatment Period|Other, Not Specified|0
7572618|NCT03573908|11952928|FG000|Randomized Withdrawal Period|Adverse Event|0
7572619|NCT03573908|11952929|FG001|Randomized Withdrawal Period|Adverse Event|0
7572620|NCT03573908|11952930|FG002|Randomized Withdrawal Period|Adverse Event|3
7572621|NCT03573908|11952931|FG003|Randomized Withdrawal Period|Adverse Event|0
7572622|NCT03573908|11952932|FG004|Randomized Withdrawal Period|Adverse Event|0
7572623|NCT03573908|11952928|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
7572624|NCT03573908|11952929|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
7572625|NCT03573908|11952930|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
7572626|NCT03573908|11952931|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
7572627|NCT03573908|11952932|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
7572628|NCT03573908|11952928|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
7572629|NCT03573908|11952929|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
7572630|NCT03573908|11952930|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
7572631|NCT03573908|11952931|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
7572632|NCT03573908|11952932|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
7572633|NCT03573908|11952928|FG000|Randomized Withdrawal Period|Other, Not Specified|0
7572634|NCT03573908|11952929|FG001|Randomized Withdrawal Period|Other, Not Specified|0
7572635|NCT03573908|11952930|FG002|Randomized Withdrawal Period|Other, Not Specified|4
7572636|NCT03573908|11952931|FG003|Randomized Withdrawal Period|Other, Not Specified|2
7572637|NCT03573908|11952932|FG004|Randomized Withdrawal Period|Other, Not Specified|0
7572638|NCT03574753|11952958|FG000|Overall Study|Adverse Event|3
7572639|NCT03574753|11952958|FG000|Overall Study|Progression/relapse|19
7572640|NCT03574753|11952958|FG000|Overall Study|Death|1
7572641|NCT03575702|11952969|FG000|Overall Study|Withdrawal by Subject|1
7572642|NCT03575702|11952970|FG001|Overall Study|Withdrawal by Subject|1
7572643|NCT03575702|11952969|FG000|Overall Study|Lost to Follow-up|1
7572644|NCT03575702|11952970|FG001|Overall Study|Lost to Follow-up|2
7572645|NCT03575702|11952969|FG000|Overall Study|Protocol Violation|0
7572647|NCT03575702|11952969|FG000|Overall Study|Patient non compliance|4
7572648|NCT03575702|11952970|FG001|Overall Study|Patient non compliance|0
7572649|NCT03575806|11952987|FG000|Overall Study|Withdrawal by Subject|0
7572650|NCT03575806|11952988|FG001|Overall Study|Withdrawal by Subject|2
7572651|NCT03575806|11952987|FG000|Overall Study|Protocol Violation|0
7572652|NCT03575806|11952988|FG001|Overall Study|Protocol Violation|2
7572653|NCT03575871|11952997|FG000|Overall Study|Adverse Event|5
7572654|NCT03575871|11952998|FG001|Overall Study|Adverse Event|5
7572655|NCT03575871|11952999|FG002|Overall Study|Adverse Event|8
7572656|NCT03575871|11952997|FG000|Overall Study|Death|1
7572657|NCT03575871|11952998|FG001|Overall Study|Death|0
7572658|NCT03575871|11952999|FG002|Overall Study|Death|0
7572659|NCT03575871|11952997|FG000|Overall Study|Lack of Efficacy|5
7572660|NCT03575871|11952998|FG001|Overall Study|Lack of Efficacy|4
7572661|NCT03575871|11952999|FG002|Overall Study|Lack of Efficacy|7
7572662|NCT03575871|11952997|FG000|Overall Study|Lost to Follow-up|1
7572663|NCT03575871|11952998|FG001|Overall Study|Lost to Follow-up|1
7572664|NCT03575871|11952999|FG002|Overall Study|Lost to Follow-up|1
7572665|NCT03575871|11952997|FG000|Overall Study|Protocol Deviation|1
7572666|NCT03575871|11952998|FG001|Overall Study|Protocol Deviation|1
7572667|NCT03575871|11952999|FG002|Overall Study|Protocol Deviation|1
7572668|NCT03575871|11952997|FG000|Overall Study|Withdrawal by Subject|6
7572669|NCT03575871|11952998|FG001|Overall Study|Withdrawal by Subject|1
7572670|NCT03575871|11952999|FG002|Overall Study|Withdrawal by Subject|9
7572671|NCT03575871|11952997|FG000|Overall Study|Other than specified|2
7572672|NCT03575871|11952998|FG001|Overall Study|Other than specified|2
7572673|NCT03575871|11952999|FG002|Overall Study|Other than specified|0
7572674|NCT03575975|11953017|FG000|Overall Study|Lost to Follow-up|1
7572675|NCT03575975|11953018|FG001|Overall Study|Lost to Follow-up|0
7572676|NCT03575975|11953019|FG002|Overall Study|Lost to Follow-up|0
7572677|NCT03576066|11953027|FG000|Overall Study|Noncompliance with study drug|0
7572678|NCT03576066|11953028|FG001|Overall Study|Noncompliance with study drug|1
7572679|NCT03576768|11953060|FG000|Overall Study|Lost to Follow-up|3
7572680|NCT03576768|11953061|FG001|Overall Study|Lost to Follow-up|3
7572681|NCT03576768|11953062|FG002|Overall Study|Lost to Follow-up|0
7572682|NCT03576768|11953063|FG003|Overall Study|Lost to Follow-up|0
7572683|NCT03577730|11953098|FG000|Overall Study|Physician Decision|3
7572684|NCT03577730|11953099|FG001|Overall Study|Physician Decision|1
7572685|NCT03577730|11953098|FG000|Overall Study|Did not receive allocated intervention|1
7572686|NCT03577730|11953099|FG001|Overall Study|Did not receive allocated intervention|0
7572687|NCT03578146|11953111|FG000|Overall Study|Did Not Receive Treatment|1
7572688|NCT03578146|11953112|FG001|Overall Study|Did Not Receive Treatment|0
7572689|NCT03578146|11953113|FG002|Overall Study|Did Not Receive Treatment|0
7572690|NCT03578146|11953114|FG003|Overall Study|Did Not Receive Treatment|0
7572691|NCT03578146|11953115|FG004|Overall Study|Did Not Receive Treatment|0
7572692|NCT03578146|11953116|FG005|Overall Study|Did Not Receive Treatment|2
7572693|NCT03578146|11953111|FG000|Overall Study|Lost to Follow-up|0
7572694|NCT03578146|11953112|FG001|Overall Study|Lost to Follow-up|1
7572695|NCT03578146|11953113|FG002|Overall Study|Lost to Follow-up|1
7572696|NCT03578146|11953114|FG003|Overall Study|Lost to Follow-up|0
7572697|NCT03578146|11953115|FG004|Overall Study|Lost to Follow-up|0
7572698|NCT03578146|11953116|FG005|Overall Study|Lost to Follow-up|1
7572699|NCT03579290|11953143|FG000|Overall Study|Lost to Follow-up|9
7572700|NCT03579719|11953155|FG000|Overall Study|Protocol deviation, pre-existent disease|1
7572701|NCT03579940|11953170|FG000|Period 2|Withdrawal by Subject|0
7572702|NCT03579940|11953171|FG001|Period 2|Withdrawal by Subject|0
7572703|NCT03579940|11953172|FG002|Period 2|Withdrawal by Subject|1
7572704|NCT03579940|11953173|FG003|Period 2|Withdrawal by Subject|0
7572705|NCT03579940|11953174|FG004|Period 2|Withdrawal by Subject|0
7572706|NCT03579940|11953175|FG005|Period 2|Withdrawal by Subject|0
7572707|NCT03579940|11953176|FG006|Period 2|Withdrawal by Subject|0
7572708|NCT03579940|11953177|FG007|Period 2|Withdrawal by Subject|0
7572709|NCT03579940|11953178|FG008|Period 2|Withdrawal by Subject|0
7572710|NCT03579940|11953179|FG009|Period 2|Withdrawal by Subject|0
7572711|NCT03579940|11953180|FG010|Period 2|Withdrawal by Subject|0
7572712|NCT03581825|11953235|FG000|Period 1|Lens Discomfort|1
7572713|NCT03581825|11953236|FG001|Period 1|Lens Discomfort|0
7572714|NCT03581825|11953235|FG000|Period 2|Unsatisfactory Vision to Test|0
7572715|NCT03581825|11953236|FG001|Period 2|Unsatisfactory Vision to Test|1
7572716|NCT03582215|11953250|FG000|Overall Study|Adverse Event|1
7572717|NCT03582215|11953251|FG001|Overall Study|Adverse Event|0
7572718|NCT03582215|11953252|FG002|Overall Study|Adverse Event|0
7572719|NCT03582215|11953253|FG003|Overall Study|Adverse Event|0
7572720|NCT03582215|11953254|FG004|Overall Study|Adverse Event|0
7572721|NCT03582215|11953255|FG005|Overall Study|Adverse Event|0
7572722|NCT03582215|11953256|FG006|Overall Study|Adverse Event|2
7572723|NCT03582215|11953257|FG007|Overall Study|Adverse Event|2
7572724|NCT03582813|11953317|FG000|Overall Study|Lost to Follow-up|18
7572725|NCT03582813|11953318|FG001|Overall Study|Lost to Follow-up|21
7572726|NCT03582813|11953317|FG000|Overall Study|Withdrawal by Subject|1
7572727|NCT03582813|11953318|FG001|Overall Study|Withdrawal by Subject|0
7572728|NCT03582826|11953326|FG000|Overall Study|Lost to Follow-up|39
7572729|NCT03582826|11953327|FG001|Overall Study|Lost to Follow-up|0
7572730|NCT03582826|11953326|FG000|Overall Study|Withdrawal by Subject|2
7572731|NCT03582826|11953327|FG001|Overall Study|Withdrawal by Subject|0
7572732|NCT03582943|11953344|FG000|Allocated to Groups|Withdrawal by Subject|1
7572733|NCT03582943|11953345|FG001|Allocated to Groups|Withdrawal by Subject|1
7572734|NCT03582943|11953344|FG000|Intervention and Follow up|Withdrawal by Subject|4
7572735|NCT03582943|11953345|FG001|Intervention and Follow up|Withdrawal by Subject|2
7572736|NCT03582943|11953344|FG000|Analyzed|Protocol Violation|4
7572737|NCT03582943|11953345|FG001|Analyzed|Protocol Violation|1
7572738|NCT03583372|11953355|FG000|Overall Study|Withdrawal by Subject|6
7572739|NCT03583372|11953356|FG001|Overall Study|Withdrawal by Subject|11
7572740|NCT03583372|11953357|FG002|Overall Study|Withdrawal by Subject|7
7572741|NCT03583372|11953358|FG003|Overall Study|Withdrawal by Subject|8
7572742|NCT03583372|11953355|FG000|Overall Study|Lost to Follow-up|4
7572743|NCT03583372|11953356|FG001|Overall Study|Lost to Follow-up|6
7572744|NCT03583372|11953357|FG002|Overall Study|Lost to Follow-up|3
7572745|NCT03583372|11953358|FG003|Overall Study|Lost to Follow-up|2
7572746|NCT03583372|11953355|FG000|Overall Study|Adverse Event|1
7572747|NCT03583372|11953356|FG001|Overall Study|Adverse Event|3
7572748|NCT03583372|11953357|FG002|Overall Study|Adverse Event|4
7572749|NCT03583372|11953358|FG003|Overall Study|Adverse Event|4
7572750|NCT03583372|11953355|FG000|Overall Study|Physician Decision|0
7572751|NCT03583372|11953356|FG001|Overall Study|Physician Decision|1
7572752|NCT03583372|11953357|FG002|Overall Study|Physician Decision|1
7572753|NCT03583372|11953358|FG003|Overall Study|Physician Decision|1
7572754|NCT03583372|11953355|FG000|Overall Study|Lack of Efficacy|0
7572755|NCT03583372|11953356|FG001|Overall Study|Lack of Efficacy|1
7572756|NCT03583372|11953357|FG002|Overall Study|Lack of Efficacy|0
7572757|NCT03583372|11953358|FG003|Overall Study|Lack of Efficacy|1
7572758|NCT03583372|11953355|FG000|Overall Study|Death|1
7572759|NCT03583372|11953356|FG001|Overall Study|Death|0
7572760|NCT03583372|11953357|FG002|Overall Study|Death|0
7572761|NCT03583372|11953358|FG003|Overall Study|Death|0
7572762|NCT03583372|11953355|FG000|Overall Study|Protocol Violation|0
7572763|NCT03583372|11953356|FG001|Overall Study|Protocol Violation|1
7572764|NCT03583372|11953357|FG002|Overall Study|Protocol Violation|0
7572765|NCT03583372|11953358|FG003|Overall Study|Protocol Violation|0
7572766|NCT03583372|11953355|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
7572767|NCT03583372|11953356|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
7572768|NCT03583372|11953357|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
7572769|NCT03583372|11953358|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
7572770|NCT03583372|11953355|FG000|Overall Study|Did Not Receive Study Drug|0
7572771|NCT03583372|11953356|FG001|Overall Study|Did Not Receive Study Drug|1
7572772|NCT03583372|11953357|FG002|Overall Study|Did Not Receive Study Drug|0
7572773|NCT03583372|11953358|FG003|Overall Study|Did Not Receive Study Drug|0
7572774|NCT03583372|11953355|FG000|Overall Study|Captured as Other in the Database|1
7572775|NCT03583372|11953356|FG001|Overall Study|Captured as Other in the Database|2
7572776|NCT03583372|11953357|FG002|Overall Study|Captured as Other in the Database|4
7572777|NCT03583372|11953358|FG003|Overall Study|Captured as Other in the Database|1
7572778|NCT03583385|11953368|FG000|Treatment Period 1|Withdrawal by Subject|1
7572779|NCT03583385|11953369|FG001|Treatment Period 1|Withdrawal by Subject|1
7572780|NCT03583385|11953368|FG000|Treatment Period 2|Adverse Event|1
7572781|NCT03583385|11953369|FG001|Treatment Period 2|Adverse Event|0
7572782|NCT03583450|11953377|FG000|Overall Study|hardware malfunction (battery depletion)|1
7572783|NCT03583450|11953378|FG001|Overall Study|hardware malfunction (battery depletion)|0
7572784|NCT03583606|11953389|FG000|Overall Study|Lost to Follow-up|0
7572785|NCT03583606|11953390|FG001|Overall Study|Lost to Follow-up|1
7572786|NCT03583606|11953391|FG002|Overall Study|Lost to Follow-up|0
7572787|NCT03583606|11953389|FG000|Overall Study|Ineligible at baseline|1
7572788|NCT03583606|11953390|FG001|Overall Study|Ineligible at baseline|0
7572789|NCT03583606|11953391|FG002|Overall Study|Ineligible at baseline|0
7572790|NCT03585244|11953407|FG000|Overall Study|Withdrawal by Subject|15
7572791|NCT03585296|11953411|FG000|Overall Study|Adverse Event|1
7572792|NCT03585296|11953411|FG000|Overall Study|Lost to Follow-up|2
7572793|NCT03585296|11953411|FG000|Overall Study|Withdrawal by Subject|2
7575365|NCT03722576|11959030|FG000|Overall Study|Lost to Follow-up|1
7575366|NCT03722784|11959036|FG000|Overall Study|Withdrawal by Subject|1
7575367|NCT03722784|11959037|FG001|Overall Study|Withdrawal by Subject|0
7575368|NCT03722784|11959036|FG000|Overall Study|Physician Decision|1
7575369|NCT03722784|11959037|FG001|Overall Study|Physician Decision|1
7575370|NCT03722784|11959036|FG000|Overall Study|Protocol Violation|0
7464505|NCT01870869|11763050|FG003|Overall Study|Lost to Follow-up|3
7464506|NCT01870869|11763047|FG000|Overall Study|Reason not Specified|1
7464507|NCT01870869|11763048|FG001|Overall Study|Reason not Specified|2
7464508|NCT01870869|11763049|FG002|Overall Study|Reason not Specified|20
7464509|NCT01870869|11763050|FG003|Overall Study|Reason not Specified|4
7464510|NCT01870869|11763047|FG000|Overall Study|Not evaluable|10
7464511|NCT01870869|11763048|FG001|Overall Study|Not evaluable|5
7464512|NCT01870869|11763049|FG002|Overall Study|Not evaluable|42
7464513|NCT01870869|11763050|FG003|Overall Study|Not evaluable|10
7464514|NCT01870921|11763060|FG000|Overall Study|Subject decision|80
7464515|NCT01870921|11763060|FG000|Overall Study|Severe non-compliance to protocol|7
7464516|NCT01870921|11763060|FG000|Overall Study|Subject Lost to Follow up|2
7464517|NCT01870921|11763060|FG000|Overall Study|Other|1
7464518|NCT01870973|11763066|FG000|Overall Study|Lost to Follow-up|10
7464519|NCT01870973|11763067|FG001|Overall Study|Lost to Follow-up|3
7464520|NCT01870999|11763076|FG000|Overall Study|Adverse Event|0
7464521|NCT01870999|11763077|FG001|Overall Study|Adverse Event|4
7464522|NCT01870999|11763078|FG002|Overall Study|Adverse Event|1
7464523|NCT01870999|11763076|FG000|Overall Study|Subject met withdrawal criteria|3
7464524|NCT01870999|11763077|FG001|Overall Study|Subject met withdrawal criteria|2
7464525|NCT01870999|11763078|FG002|Overall Study|Subject met withdrawal criteria|0
7464526|NCT01870999|11763076|FG000|Overall Study|Subject withdrawn by Investigator|1
7464527|NCT01870999|11763077|FG001|Overall Study|Subject withdrawn by Investigator|0
7464528|NCT01870999|11763078|FG002|Overall Study|Subject withdrawn by Investigator|0
7464529|NCT01870999|11763076|FG000|Overall Study|Withdrawal by Subject|0
7464530|NCT01870999|11763077|FG001|Overall Study|Withdrawal by Subject|2
7464531|NCT01870999|11763078|FG002|Overall Study|Withdrawal by Subject|5
7464532|NCT01870999|11763076|FG000|Overall Study|Protocol Violation|0
7464533|NCT01870999|11763077|FG001|Overall Study|Protocol Violation|0
7464534|NCT01870999|11763078|FG002|Overall Study|Protocol Violation|1
7464535|NCT01871090|11763092|FG000|Overall Study|Interrogation not done in Emergency Room|1
7464536|NCT01871090|11763093|FG001|Overall Study|Interrogation not done in Emergency Room|22
7464537|NCT01871090|11763092|FG000|Overall Study|Interrogation not completed correctly|1
7464538|NCT01871090|11763093|FG001|Overall Study|Interrogation not completed correctly|0
7464539|NCT01871090|11763092|FG000|Overall Study|Subject Non-Compliance|0
7464540|NCT01871090|11763093|FG001|Overall Study|Subject Non-Compliance|1
7464541|NCT01871142|11763099|FG000|Overall Study|Adverse Event|1
7464542|NCT01871285|11763115|FG000|First Intervention (1 Day)|Adverse Event|1
7464543|NCT01871285|11763116|FG001|First Intervention (1 Day)|Adverse Event|0
7464544|NCT01871285|11763117|FG002|First Intervention (1 Day)|Adverse Event|0
7464545|NCT01871285|11763118|FG003|First Intervention (1 Day)|Adverse Event|0
7464546|NCT01871285|11763115|FG000|First Intervention (1 Day)|Lost to Follow-up|0
7464547|NCT01871285|11763116|FG001|First Intervention (1 Day)|Lost to Follow-up|1
7464548|NCT01871285|11763117|FG002|First Intervention (1 Day)|Lost to Follow-up|1
7572794|NCT03585504|11953417|FG000|Overall Study|Lost to Follow-up|26
7572795|NCT03585504|11953418|FG001|Overall Study|Lost to Follow-up|29
7572796|NCT03585712|11953429|FG000|Treatment Period 1|Protocol Violation|1
7572797|NCT03585712|11953430|FG001|Treatment Period 1|Protocol Violation|0
7572798|NCT03585712|11953431|FG002|Treatment Period 1|Protocol Violation|0
7572799|NCT03585712|11953429|FG000|Treatment Periods 2 and 3|Protocol Violation|0
7572800|NCT03585712|11953430|FG001|Treatment Periods 2 and 3|Protocol Violation|1
7572801|NCT03585712|11953431|FG002|Treatment Periods 2 and 3|Protocol Violation|1
7464549|NCT01871285|11763118|FG003|First Intervention (1 Day)|Lost to Follow-up|0
7464550|NCT01871402|11763130|FG000|Overall Study|Lost to Follow-up|1
7464551|NCT01871402|11763131|FG001|Overall Study|Lost to Follow-up|0
7464552|NCT01871402|11763130|FG000|Overall Study|Withdrawal by Subject|0
7464553|NCT01871402|11763131|FG001|Overall Study|Withdrawal by Subject|2
7464554|NCT01871402|11763130|FG000|Overall Study|Non-compliance|0
7464555|NCT01871402|11763131|FG001|Overall Study|Non-compliance|1
7464556|NCT01871519|11763164|FG000|Overall Study|Death|26
7464557|NCT01871519|11763164|FG000|Overall Study|Lost to Follow-up|15
7464558|NCT01871519|11763164|FG000|Overall Study|Withdrawal by Subject|49
7464559|NCT01871532|11763171|FG000|Overall Study|Withdrawal by Subject|1
7464560|NCT01871532|11763172|FG001|Overall Study|Withdrawal by Subject|2
7464561|NCT01871545|11763180|FG000|Overall Study|Death|2
7464562|NCT01871545|11763181|FG001|Overall Study|Death|0
7464563|NCT01871545|11763180|FG000|Overall Study|Lack of Efficacy|11
7464564|NCT01871545|11763181|FG001|Overall Study|Lack of Efficacy|2
7464565|NCT01871545|11763180|FG000|Overall Study|Physician Decision|4
7464566|NCT01871545|11763181|FG001|Overall Study|Physician Decision|0
7464567|NCT01871545|11763180|FG000|Overall Study|Withdrawal by Subject|0
7464568|NCT01871545|11763181|FG001|Overall Study|Withdrawal by Subject|1
7464569|NCT01871558|11763192|FG000|Overall Study|Other reason|0
7464570|NCT01871558|11763193|FG001|Overall Study|Other reason|1
7464571|NCT01871558|11763192|FG000|Overall Study|antidiabetic drug prematurely stopped|1
7464572|NCT01871558|11763193|FG001|Overall Study|antidiabetic drug prematurely stopped|1
7464573|NCT01871558|11763192|FG000|Overall Study|Withdrawal by Subject|2
7464574|NCT01871558|11763193|FG001|Overall Study|Withdrawal by Subject|0
7464575|NCT01871805|11763205|FG000|Phase I|Death|7
7464576|NCT01871805|11763206|FG001|Phase I|Death|4
7464577|NCT01871805|11763207|FG002|Phase I|Death|6
7464578|NCT01871805|11763208|FG003|Phase I|Death|2
7464579|NCT01871805|11763209|FG004|Phase I|Death|9
7464580|NCT01871805|11763210|FG005|Phase I|Death|0
7464581|NCT01871805|11763205|FG000|Phase I|Alive in Survival Follow-up|0
7464582|NCT01871805|11763206|FG001|Phase I|Alive in Survival Follow-up|2
7464583|NCT01871805|11763207|FG002|Phase I|Alive in Survival Follow-up|4
7464584|NCT01871805|11763208|FG003|Phase I|Alive in Survival Follow-up|5
7464585|NCT01871805|11763209|FG004|Phase I|Alive in Survival Follow-up|4
7464586|NCT01871805|11763210|FG005|Phase I|Alive in Survival Follow-up|0
7464587|NCT01871805|11763205|FG000|Phase I|Lost to Follow-up|0
7464588|NCT01871805|11763206|FG001|Phase I|Lost to Follow-up|1
7464589|NCT01871805|11763207|FG002|Phase I|Lost to Follow-up|3
7464590|NCT01871805|11763208|FG003|Phase I|Lost to Follow-up|0
7464591|NCT01871805|11763209|FG004|Phase I|Lost to Follow-up|0
7464592|NCT01871805|11763210|FG005|Phase I|Lost to Follow-up|0
7464593|NCT01871805|11763205|FG000|Phase II|Death|0
7464594|NCT01871805|11763206|FG001|Phase II|Death|0
7464595|NCT01871805|11763207|FG002|Phase II|Death|0
7464596|NCT01871805|11763208|FG003|Phase II|Death|0
7464597|NCT01871805|11763209|FG004|Phase II|Death|0
7464598|NCT01871805|11763210|FG005|Phase II|Death|45
7464599|NCT01871805|11763205|FG000|Phase II|Alive in Survival Follow-up|0
7464600|NCT01871805|11763206|FG001|Phase II|Alive in Survival Follow-up|0
7464601|NCT01871805|11763207|FG002|Phase II|Alive in Survival Follow-up|0
7464602|NCT01871805|11763208|FG003|Phase II|Alive in Survival Follow-up|0
7464603|NCT01871805|11763209|FG004|Phase II|Alive in Survival Follow-up|0
7464604|NCT01871805|11763210|FG005|Phase II|Alive in Survival Follow-up|29
7464605|NCT01871805|11763205|FG000|Phase II|Lost to Follow-up|0
7464606|NCT01871805|11763206|FG001|Phase II|Lost to Follow-up|0
7464607|NCT01871805|11763207|FG002|Phase II|Lost to Follow-up|0
7464608|NCT01871805|11763208|FG003|Phase II|Lost to Follow-up|0
7464609|NCT01871805|11763209|FG004|Phase II|Lost to Follow-up|0
7464610|NCT01871805|11763210|FG005|Phase II|Lost to Follow-up|13
7464611|NCT01871870|11763241|FG000|Overall Study|Hardware issues|7
7464612|NCT01871870|11763241|FG000|Overall Study|hyperglycemia|2
7464613|NCT01872078|11763249|FG000|Overall Study|Adverse Event|0
7464614|NCT01872078|11763250|FG001|Overall Study|Adverse Event|0
7464615|NCT01872078|11763251|FG002|Overall Study|Adverse Event|1
7464616|NCT01872078|11763252|FG003|Overall Study|Adverse Event|0
7464617|NCT01872078|11763249|FG000|Overall Study|Dose administration non-compliance|0
7464618|NCT01872078|11763250|FG001|Overall Study|Dose administration non-compliance|0
7464619|NCT01872078|11763251|FG002|Overall Study|Dose administration non-compliance|0
7464620|NCT01872078|11763252|FG003|Overall Study|Dose administration non-compliance|1
7464621|NCT01872078|11763249|FG000|Overall Study|Protocol Violation|0
7464622|NCT01872078|11763250|FG001|Overall Study|Protocol Violation|0
7464623|NCT01872078|11763251|FG002|Overall Study|Protocol Violation|1
7464624|NCT01872078|11763252|FG003|Overall Study|Protocol Violation|0
7464625|NCT01872078|11763249|FG000|Overall Study|Withdrawal by Subject|0
7464626|NCT01872078|11763250|FG001|Overall Study|Withdrawal by Subject|0
7464627|NCT01872078|11763251|FG002|Overall Study|Withdrawal by Subject|1
7464628|NCT01872078|11763252|FG003|Overall Study|Withdrawal by Subject|0
7464629|NCT01872078|11763249|FG000|Overall Study|Patient met exclusion criterion 16.|0
7464630|NCT01872078|11763250|FG001|Overall Study|Patient met exclusion criterion 16.|0
7464631|NCT01872078|11763251|FG002|Overall Study|Patient met exclusion criterion 16.|0
7464632|NCT01872078|11763252|FG003|Overall Study|Patient met exclusion criterion 16.|1
7468526|NCT01912222|11769423|FG001|Part B: Treatment Period|Adverse Event|2
7468527|NCT01912222|11769424|FG002|Part B: Treatment Period|Adverse Event|3
7468528|NCT01912222|11769422|FG000|Part B: Treatment Period|Withdrawal by Subject|2
7468529|NCT01912222|11769423|FG001|Part B: Treatment Period|Withdrawal by Subject|1
7468530|NCT01912222|11769424|FG002|Part B: Treatment Period|Withdrawal by Subject|2
7468531|NCT01912287|11769440|FG000|Overall Study|Ineligible|1
7468532|NCT01912287|11769441|FG001|Overall Study|Ineligible|0
7468533|NCT01912287|11769442|FG002|Overall Study|Ineligible|1
7468534|NCT01912287|11769440|FG000|Overall Study|No-show|0
7468535|NCT01912287|11769441|FG001|Overall Study|No-show|0
7468536|NCT01912287|11769442|FG002|Overall Study|No-show|1
7468537|NCT01912287|11769440|FG000|Overall Study|Dissatisfaction with assigned treatment|4
7468538|NCT01912287|11769441|FG001|Overall Study|Dissatisfaction with assigned treatment|2
7468539|NCT01912287|11769442|FG002|Overall Study|Dissatisfaction with assigned treatment|1
7468540|NCT01912287|11769440|FG000|Overall Study|Felt treatment no longer needed|0
7468541|NCT01912287|11769441|FG001|Overall Study|Felt treatment no longer needed|1
7468542|NCT01912287|11769442|FG002|Overall Study|Felt treatment no longer needed|0
7468543|NCT01912287|11769440|FG000|Overall Study|Life circumstances|4
7468544|NCT01912287|11769441|FG001|Overall Study|Life circumstances|2
7468545|NCT01912287|11769442|FG002|Overall Study|Life circumstances|0
7468546|NCT01912287|11769440|FG000|Overall Study|Lost Interest|1
7468547|NCT01912287|11769441|FG001|Overall Study|Lost Interest|0
7572802|NCT03585712|11953429|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
7572803|NCT03585712|11953430|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
7572804|NCT03585712|11953431|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
7572805|NCT03585712|11953429|FG000|Treatment Periods 2 and 3|Physician Decision|0
7572806|NCT03585712|11953430|FG001|Treatment Periods 2 and 3|Physician Decision|0
7572807|NCT03585712|11953431|FG002|Treatment Periods 2 and 3|Physician Decision|2
7572808|NCT03585959|11953458|FG000|Overall Study|Physician Decision|1
7572809|NCT03585959|11953458|FG000|Overall Study|Unsuccessful Procedure|2
7572810|NCT03586167|11953466|FG000|Overall Study|Other|1
7572811|NCT03586167|11953467|FG001|Overall Study|Other|0
7572812|NCT03586544|11953475|FG000|First Intervention|Adverse Event|0
7572813|NCT03586544|11953476|FG001|First Intervention|Adverse Event|1
7572814|NCT03586544|11953475|FG000|Second Intervention|Withdrawal by Subject|0
7468548|NCT01912287|11769442|FG002|Overall Study|Lost Interest|0
7468549|NCT01912287|11769440|FG000|Overall Study|Uknown reason - subject drop out|5
7468550|NCT01912287|11769441|FG001|Overall Study|Uknown reason - subject drop out|7
7468551|NCT01912287|11769442|FG002|Overall Study|Uknown reason - subject drop out|3
7468552|NCT01912287|11769440|FG000|Overall Study|Missed Assesment|1
7572815|NCT03586544|11953476|FG001|Second Intervention|Withdrawal by Subject|1
7572816|NCT03586648|11953487|FG000|Period 1|Withdrawal by Subject|0
7572817|NCT03586648|11953488|FG001|Period 1|Withdrawal by Subject|1
7572818|NCT03586648|11953487|FG000|Period 1|Lost to Follow-up|1
7572819|NCT03586648|11953488|FG001|Period 1|Lost to Follow-up|1
7464633|NCT01872611|11763282|FG000|Overall Study|Adverse Event|3
7464634|NCT01872611|11763283|FG001|Overall Study|Adverse Event|1
7464635|NCT01872611|11763282|FG000|Overall Study|Adverse Event, prior to treatment|0
7464636|NCT01872611|11763283|FG001|Overall Study|Adverse Event, prior to treatment|1
7464637|NCT01872611|11763282|FG000|Overall Study|Death|0
7464638|NCT01872611|11763283|FG001|Overall Study|Death|1
7464639|NCT01872611|11763282|FG000|Overall Study|Death, prior to treatment|0
7464640|NCT01872611|11763283|FG001|Overall Study|Death, prior to treatment|1
7464641|NCT01872611|11763282|FG000|Overall Study|Lost to Follow-up|8
7464642|NCT01872611|11763283|FG001|Overall Study|Lost to Follow-up|1
7464643|NCT01872611|11763282|FG000|Overall Study|Physician Decision|1
7464644|NCT01872611|11763283|FG001|Overall Study|Physician Decision|0
7464645|NCT01872611|11763282|FG000|Overall Study|Withdrawal by Subject|6
7464646|NCT01872611|11763283|FG001|Overall Study|Withdrawal by Subject|1
7464647|NCT01872611|11763282|FG000|Overall Study|Reason not provided|6
7464648|NCT01872611|11763283|FG001|Overall Study|Reason not provided|6
7464649|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7464650|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
7464651|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7464652|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
7464653|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Other|1
7464654|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Other|1
7464655|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Other|6
7464656|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Other|3
7464657|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
7464658|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
7464659|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
7464660|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
7464661|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7464662|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
7464663|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7464664|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
7464665|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
7464666|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7464667|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
7464668|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
7464669|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7464670|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7464671|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
7572820|NCT03586648|11953487|FG000|Period 1|Adverse Event|1
7572821|NCT03586648|11953488|FG001|Period 1|Adverse Event|0
7572822|NCT03586648|11953487|FG000|Period 1|Study related symptoms or complaints|2
7572823|NCT03586648|11953488|FG001|Period 1|Study related symptoms or complaints|1
7572824|NCT03586648|11953487|FG000|Period 1|Physician Decision|0
7572825|NCT03586648|11953488|FG001|Period 1|Physician Decision|1
7572826|NCT03586648|11953487|FG000|Period 2|Adverse Event|1
7572827|NCT03586648|11953488|FG001|Period 2|Adverse Event|0
7572828|NCT03586726|11953494|FG000|Overall Study|Withdrawal by Subject|1
7572829|NCT03586830|11953502|FG000|Overall Study|Site terminated by Sponsor|1
7572830|NCT03586830|11953503|FG001|Overall Study|Site terminated by Sponsor|4
7572831|NCT03586830|11953504|FG002|Overall Study|Site terminated by Sponsor|3
7572832|NCT03586830|11953505|FG003|Overall Study|Site terminated by Sponsor|3
7572833|NCT03586830|11953502|FG000|Overall Study|Lost to Follow-up|0
7572834|NCT03586830|11953503|FG001|Overall Study|Lost to Follow-up|2
7572835|NCT03586830|11953504|FG002|Overall Study|Lost to Follow-up|2
7464672|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
7464673|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Death|3
7464674|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Death|4
7464675|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Death|14
7464676|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Death|9
7464677|NCT01872689|11763295|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
7464678|NCT01872689|11763296|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
7464679|NCT01872689|11763297|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
7464680|NCT01872689|11763298|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
7464681|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Other|2
7464682|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Other|3
7464683|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Other|0
7464684|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Other|0
7225338|NCT00065442|11434747|FG000|Overall Study|Lost to Follow-up|1
7225339|NCT00065442|11434748|FG001|Overall Study|Lost to Follow-up|1
7225340|NCT00065442|11434747|FG000|Overall Study|Death|121
7225341|NCT00065442|11434748|FG001|Overall Study|Death|210
7225342|NCT00065442|11434747|FG000|Overall Study|Withdrawal by Subject|3
7225343|NCT00065442|11434748|FG001|Overall Study|Withdrawal by Subject|9
7225344|NCT00065468|11434757|FG000|Overall Study|Death|172
7225345|NCT00065468|11434758|FG001|Overall Study|Death|169
7225346|NCT00065468|11434759|FG002|Overall Study|Death|171
7225347|NCT00065468|11434757|FG000|Overall Study|Withdrawal by Subject|3
7225348|NCT00065468|11434758|FG001|Overall Study|Withdrawal by Subject|4
7225349|NCT00065468|11434759|FG002|Overall Study|Withdrawal by Subject|5
7225350|NCT00065468|11434757|FG000|Overall Study|Lost to Follow-up|5
7225351|NCT00065468|11434758|FG001|Overall Study|Lost to Follow-up|3
7225352|NCT00065468|11434759|FG002|Overall Study|Lost to Follow-up|2
7225353|NCT00065468|11434757|FG000|Overall Study|Discontinuation of study by Sponsor|13
7464685|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
7464686|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
7464687|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7464688|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
7464689|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7464690|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
7572836|NCT03586830|11953505|FG003|Overall Study|Lost to Follow-up|1
7464691|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7464692|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
7464693|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
7464694|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
7464695|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7464696|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
7464697|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Death|5
7464698|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Death|3
7464699|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Death|0
7464700|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Death|0
7464701|NCT01872689|11763295|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
7464702|NCT01872689|11763296|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
7464703|NCT01872689|11763297|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7464704|NCT01872689|11763298|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
7464708|NCT01872910|11763336|FG000|Overall Study|Lost to Follow-up|2
7464709|NCT01872910|11763337|FG001|Overall Study|Lost to Follow-up|0
7464710|NCT01872910|11763338|FG002|Overall Study|Lost to Follow-up|2
7464711|NCT01872910|11763339|FG003|Overall Study|Lost to Follow-up|0
7464712|NCT01872910|11763340|FG004|Overall Study|Lost to Follow-up|0
7464713|NCT01872910|11763341|FG005|Overall Study|Lost to Follow-up|0
7464714|NCT01873417|11763365|FG000|Overall Study|Did Not Receive Any Study Drug|4
7464715|NCT01873417|11763365|FG000|Overall Study|Adverse Event|24
7464716|NCT01873417|11763365|FG000|Overall Study|Lost to Follow-up|2
7464717|NCT01873417|11763365|FG000|Overall Study|Withdrawal by Subject|2
7464718|NCT01873417|11763365|FG000|Overall Study|Physician Decision|3
7464719|NCT01873495|11763369|FG000|Overall Study|Withdrawal by Subject|1
7464720|NCT01873495|11763369|FG000|Overall Study|Physician Decision|3
7464721|NCT01873495|11763369|FG000|Overall Study|Adverse Event|1
7464722|NCT01873495|11763369|FG000|Overall Study|Removed for Transplantation|1
7464723|NCT01873495|11763369|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
7464724|NCT01873586|11763373|FG000|Overall Study|Lost to Follow-up|3
7464725|NCT01873729|11763380|FG000|Overall Study|Withdrawal by Subject|1
7464726|NCT01873742|11763386|FG000|Overall Study|Lost to Follow-up|68
7464727|NCT01873742|11763387|FG001|Overall Study|Lost to Follow-up|76
7464728|NCT01873859|11763399|FG000|Overall Study|Withdrawal by Subject|0
7464729|NCT01873859|11763400|FG001|Overall Study|Withdrawal by Subject|4
7464730|NCT01873950|11763407|FG000|Period 5|Withdrawal by Subject|0
7464731|NCT01873950|11763408|FG001|Period 5|Withdrawal by Subject|0
7464732|NCT01873950|11763409|FG002|Period 5|Withdrawal by Subject|0
7464733|NCT01873950|11763410|FG003|Period 5|Withdrawal by Subject|1
7464734|NCT01873950|11763411|FG004|Period 5|Withdrawal by Subject|0
7464735|NCT01874054|11763434|FG000|Overall Study|Withdrawal by Subject|3
7464736|NCT01874054|11763434|FG000|Overall Study|Study Termination by Sponsor|42
7464737|NCT01874054|11763434|FG000|Overall Study|Lost to Follow-up|5
7464738|NCT01874054|11763434|FG000|Overall Study|Death|5
7464739|NCT01874145|11763460|FG000|Core Period|Non-compliance|1
7464740|NCT01874145|11763461|FG001|Core Period|Non-compliance|0
7464741|NCT01874145|11763460|FG000|Core Period|Protocol Violation|1
7464742|NCT01874145|11763461|FG001|Core Period|Protocol Violation|1
7464743|NCT01874145|11763460|FG000|Core Period|Physician Decision|1
7464744|NCT01874145|11763461|FG001|Core Period|Physician Decision|1
7464745|NCT01874145|11763460|FG000|Core Period|Adverse Event|0
7464746|NCT01874145|11763461|FG001|Core Period|Adverse Event|1
7464747|NCT01874145|11763460|FG000|Core Period|Withdrawal by Subject|0
7464748|NCT01874145|11763461|FG001|Core Period|Withdrawal by Subject|4
7572837|NCT03586830|11953502|FG000|Overall Study|Withdrawal by Subject|1
7572838|NCT03586830|11953503|FG001|Overall Study|Withdrawal by Subject|0
7572839|NCT03586830|11953504|FG002|Overall Study|Withdrawal by Subject|3
7464749|NCT01874145|11763460|FG000|Extension Period|Adverse Event|3
7464750|NCT01874145|11763461|FG001|Extension Period|Adverse Event|2
7572840|NCT03586830|11953505|FG003|Overall Study|Withdrawal by Subject|1
7572841|NCT03587974|11953551|FG000|Overall Study|caregiver demented, care recipient died|3
7572842|NCT03587974|11953552|FG001|Overall Study|caregiver demented, care recipient died|3
7572843|NCT03587974|11953551|FG000|Overall Study|Withdrawal by Subject|2
7572844|NCT03587974|11953552|FG001|Overall Study|Withdrawal by Subject|1
7572845|NCT03588572|11953560|FG000|Visitation 1|Lack of Efficacy|1
7572846|NCT03588572|11953561|FG001|Visitation 1|Lack of Efficacy|1
7572847|NCT03588572|11953560|FG000|Visitation 2|Lost to Follow-up|1
7572848|NCT03588572|11953561|FG001|Visitation 2|Lost to Follow-up|1
7572849|NCT03588572|11953560|FG000|Visitation 2|Lack of Efficacy|0
7572850|NCT03588572|11953561|FG001|Visitation 2|Lack of Efficacy|1
7572851|NCT03588572|11953560|FG000|Visitation 2|Withdrawal by Subject|1
7572852|NCT03588572|11953561|FG001|Visitation 2|Withdrawal by Subject|0
7572853|NCT03588572|11953560|FG000|Visitation 3|Lost to Follow-up|1
7464751|NCT01874145|11763460|FG000|Extension Period|Withdrawal by Subject|2
7464752|NCT01874145|11763461|FG001|Extension Period|Withdrawal by Subject|1
7464753|NCT01874145|11763460|FG000|Extension Period|Lost to Follow-up|1
7464754|NCT01874145|11763461|FG001|Extension Period|Lost to Follow-up|1
7464755|NCT01874275|11763482|FG000|Overall Study|Lost to Follow-up|1
7464756|NCT01874275|11763483|FG001|Overall Study|Lost to Follow-up|0
7464757|NCT01874288|11763500|FG000|Overall Study|Withdrawal by Subject|1
7464758|NCT01874288|11763501|FG001|Overall Study|Withdrawal by Subject|0
7464759|NCT01874288|11763502|FG002|Overall Study|Withdrawal by Subject|2
7464760|NCT01874288|11763503|FG003|Overall Study|Withdrawal by Subject|1
7464761|NCT01874288|11763504|FG004|Overall Study|Withdrawal by Subject|1
7464762|NCT01874288|11763500|FG000|Overall Study|Physician Decision|0
7464763|NCT01874288|11763501|FG001|Overall Study|Physician Decision|0
7464764|NCT01874288|11763502|FG002|Overall Study|Physician Decision|0
7464765|NCT01874288|11763503|FG003|Overall Study|Physician Decision|1
7464766|NCT01874288|11763504|FG004|Overall Study|Physician Decision|0
7464767|NCT01874288|11763500|FG000|Overall Study|Progressive disease|2
7464768|NCT01874288|11763501|FG001|Overall Study|Progressive disease|0
7464769|NCT01874288|11763502|FG002|Overall Study|Progressive disease|3
7572854|NCT03588572|11953561|FG001|Visitation 3|Lost to Follow-up|1
7464770|NCT01874288|11763503|FG003|Overall Study|Progressive disease|5
7572855|NCT03588572|11953560|FG000|Visitation 3|Physician Decision|1
7572856|NCT03588572|11953561|FG001|Visitation 3|Physician Decision|1
7572857|NCT03588572|11953560|FG000|Visitation 3|Withdrawal by Subject|1
7572858|NCT03588572|11953561|FG001|Visitation 3|Withdrawal by Subject|0
7572859|NCT03588741|11953567|FG000|Overall Study|Withdrawal by Subject|1
7572860|NCT03588910|11953577|FG000|Overall Study|Withdrawal by Subject|1
7464771|NCT01874288|11763504|FG004|Overall Study|Progressive disease|1
7464772|NCT01874340|11763521|FG000|Overall Study|Study terminated by Sponsor|6
7464773|NCT01874340|11763522|FG001|Overall Study|Study terminated by Sponsor|8
7464774|NCT01874340|11763523|FG002|Overall Study|Study terminated by Sponsor|8
7464775|NCT01874340|11763524|FG003|Overall Study|Study terminated by Sponsor|4
7464776|NCT01874340|11763521|FG000|Overall Study|Withdrawal by Subject|0
7464777|NCT01874340|11763522|FG001|Overall Study|Withdrawal by Subject|0
7464778|NCT01874340|11763523|FG002|Overall Study|Withdrawal by Subject|0
7464779|NCT01874340|11763524|FG003|Overall Study|Withdrawal by Subject|1
7464780|NCT01874431|11763546|FG000|Overall Study|Physician Decision|0
7464781|NCT01874431|11763547|FG001|Overall Study|Physician Decision|0
7464782|NCT01874431|11763548|FG002|Overall Study|Physician Decision|1
7464783|NCT01874431|11763549|FG003|Overall Study|Physician Decision|0
7464784|NCT01874431|11763550|FG004|Overall Study|Physician Decision|0
7464785|NCT01874431|11763551|FG005|Overall Study|Physician Decision|0
7572861|NCT03588910|11953578|FG001|Overall Study|Withdrawal by Subject|0
7572862|NCT03588910|11953577|FG000|Overall Study|Allergy|2
7572863|NCT03588910|11953578|FG001|Overall Study|Allergy|0
7572864|NCT03588910|11953577|FG000|Overall Study|Protocol Violation|0
7572865|NCT03588910|11953578|FG001|Overall Study|Protocol Violation|3
7572866|NCT03588910|11953577|FG000|Overall Study|Did not complete Day 1 Survey|5
7572867|NCT03588910|11953578|FG001|Overall Study|Did not complete Day 1 Survey|10
7572868|NCT03588910|11953577|FG000|Overall Study|Did not complete Day 7 Survey|5
7572869|NCT03588910|11953578|FG001|Overall Study|Did not complete Day 7 Survey|2
7572870|NCT03589807|11953590|FG000|Overall Study|Lost to Follow-up|0
7572871|NCT03589807|11953591|FG001|Overall Study|Lost to Follow-up|2
7572872|NCT03589807|11953592|FG002|Overall Study|Lost to Follow-up|2
7572873|NCT03589807|11953593|FG003|Overall Study|Lost to Follow-up|3
7572874|NCT03589807|11953594|FG004|Overall Study|Lost to Follow-up|1
7572875|NCT03589807|11953595|FG005|Overall Study|Lost to Follow-up|1
7572876|NCT03589807|11953590|FG000|Overall Study|Withdrawal by Subject|0
7572877|NCT03589807|11953591|FG001|Overall Study|Withdrawal by Subject|5
7572878|NCT03589807|11953592|FG002|Overall Study|Withdrawal by Subject|0
7572879|NCT03589807|11953593|FG003|Overall Study|Withdrawal by Subject|0
7572880|NCT03589807|11953594|FG004|Overall Study|Withdrawal by Subject|0
7572881|NCT03589807|11953595|FG005|Overall Study|Withdrawal by Subject|0
7572882|NCT03589807|11953590|FG000|Overall Study|Protocol Violation|0
7572883|NCT03589807|11953591|FG001|Overall Study|Protocol Violation|0
7572884|NCT03589807|11953592|FG002|Overall Study|Protocol Violation|0
7572885|NCT03589807|11953593|FG003|Overall Study|Protocol Violation|1
7572886|NCT03589807|11953594|FG004|Overall Study|Protocol Violation|0
7225354|NCT00065468|11434758|FG001|Overall Study|Discontinuation of study by Sponsor|9
7382875|NCT01185366|11639721|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
7382876|NCT01185509|11639731|FG000|Overall Study|Progression/Relapse|9
7382877|NCT01185509|11639732|FG001|Overall Study|Progression/Relapse|15
7382878|NCT01185509|11639731|FG000|Overall Study|Physician Decision|2
7382879|NCT01185509|11639732|FG001|Overall Study|Physician Decision|2
7382880|NCT01185509|11639731|FG000|Overall Study|Withdrawal by Subject|0
7382881|NCT01185509|11639732|FG001|Overall Study|Withdrawal by Subject|1
7382882|NCT01185509|11639731|FG000|Overall Study|Death|0
7382883|NCT01185509|11639732|FG001|Overall Study|Death|1
7382884|NCT01185509|11639731|FG000|Overall Study|Intercurrent Illness|0
7382885|NCT01185509|11639732|FG001|Overall Study|Intercurrent Illness|1
7382886|NCT01185522|11639739|FG000|Overall Study|Lack of Efficacy|28
7533712|NCT02688387|11880061|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533713|NCT02688387|11880062|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533714|NCT02688387|11880063|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
7533715|NCT02688387|11880064|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
7533716|NCT02688387|11880043|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533717|NCT02688387|11880044|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533718|NCT02688387|11880045|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533719|NCT02688387|11880046|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533720|NCT02688387|11880047|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533721|NCT02688387|11880048|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533722|NCT02688387|11880049|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533723|NCT02688387|11880050|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533724|NCT02688387|11880051|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533725|NCT02688387|11880052|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533726|NCT02688387|11880053|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533727|NCT02688387|11880054|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533728|NCT02688387|11880055|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533729|NCT02688387|11880056|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533730|NCT02688387|11880057|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533731|NCT02688387|11880058|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7225355|NCT00065468|11434759|FG002|Overall Study|Discontinuation of study by Sponsor|13
7225356|NCT00065468|11434757|FG000|Overall Study|Disease progression|0
7225357|NCT00065468|11434758|FG001|Overall Study|Disease progression|0
7225358|NCT00065468|11434759|FG002|Overall Study|Disease progression|1
7225359|NCT00065468|11434757|FG000|Overall Study|Other|14
7225360|NCT00065468|11434758|FG001|Overall Study|Other|24
7225361|NCT00065468|11434759|FG002|Overall Study|Other|18
7225362|NCT00065507|11434769|FG000|Overall Study|Death|16
7225363|NCT00065507|11434770|FG001|Overall Study|Death|17
7225364|NCT00065507|11434769|FG000|Overall Study|Adverse Event|4
7225365|NCT00065507|11434770|FG001|Overall Study|Adverse Event|3
7225366|NCT00065507|11434769|FG000|Overall Study|Lack of Efficacy|0
7225367|NCT00065507|11434770|FG001|Overall Study|Lack of Efficacy|6
7225368|NCT00065507|11434769|FG000|Overall Study|Poor/Non-compliance|3
7225369|NCT00065507|11434770|FG001|Overall Study|Poor/Non-compliance|2
7225370|NCT00065507|11434769|FG000|Overall Study|Lost to Follow-up|3
7225371|NCT00065507|11434770|FG001|Overall Study|Lost to Follow-up|0
7225372|NCT00065507|11434769|FG000|Overall Study|Subject Withdrew Consent|2
7225373|NCT00065507|11434770|FG001|Overall Study|Subject Withdrew Consent|1
7225374|NCT00065507|11434769|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
7225375|NCT00065507|11434770|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
7225376|NCT00066066|11434801|FG000|Overall Study|Lost to Follow-up|6
7225377|NCT00066066|11434802|FG001|Overall Study|Lost to Follow-up|4
7225378|NCT00066066|11434803|FG002|Overall Study|Lost to Follow-up|7
7225379|NCT00066066|11434804|FG003|Overall Study|Lost to Follow-up|4
7225380|NCT00066066|11434805|FG004|Overall Study|Lost to Follow-up|3
7225381|NCT00066066|11434806|FG005|Overall Study|Lost to Follow-up|5
7225382|NCT00066170|11434824|FG000|Overall Study|Adverse Event|2
7225383|NCT00066170|11434825|FG001|Overall Study|Adverse Event|4
7225384|NCT00066170|11434826|FG002|Overall Study|Adverse Event|1
7225385|NCT00066170|11434827|FG003|Overall Study|Adverse Event|7
7225386|NCT00066170|11434824|FG000|Overall Study|Serious Adverse Event|0
7225387|NCT00066170|11434825|FG001|Overall Study|Serious Adverse Event|0
7225388|NCT00066170|11434826|FG002|Overall Study|Serious Adverse Event|1
7225389|NCT00066170|11434827|FG003|Overall Study|Serious Adverse Event|1
7225390|NCT00066170|11434824|FG000|Overall Study|Lost to Follow-up|0
7225391|NCT00066170|11434825|FG001|Overall Study|Lost to Follow-up|1
7225392|NCT00066170|11434826|FG002|Overall Study|Lost to Follow-up|0
7225393|NCT00066170|11434827|FG003|Overall Study|Lost to Follow-up|0
7225394|NCT00066170|11434824|FG000|Overall Study|Non-Compliance with Trial Medicine|1
7225395|NCT00066170|11434825|FG001|Overall Study|Non-Compliance with Trial Medicine|0
7572887|NCT03589807|11953595|FG005|Overall Study|Protocol Violation|0
7572888|NCT03589807|11953590|FG000|Overall Study|Enrolled but treatment not administered|0
7572889|NCT03589807|11953591|FG001|Overall Study|Enrolled but treatment not administered|0
7572890|NCT03589807|11953592|FG002|Overall Study|Enrolled but treatment not administered|0
7572891|NCT03589807|11953593|FG003|Overall Study|Enrolled but treatment not administered|0
7572892|NCT03589807|11953594|FG004|Overall Study|Enrolled but treatment not administered|1
7572893|NCT03589807|11953595|FG005|Overall Study|Enrolled but treatment not administered|0
7572894|NCT03589885|11953615|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
7225396|NCT00066170|11434826|FG002|Overall Study|Non-Compliance with Trial Medicine|0
7225397|NCT00066170|11434827|FG003|Overall Study|Non-Compliance with Trial Medicine|1
7225398|NCT00066170|11434824|FG000|Overall Study|Protocol Violation|3
7225399|NCT00066170|11434825|FG001|Overall Study|Protocol Violation|0
7225400|NCT00066170|11434826|FG002|Overall Study|Protocol Violation|0
7225401|NCT00066170|11434827|FG003|Overall Study|Protocol Violation|0
7225402|NCT00066170|11434824|FG000|Overall Study|Other|1
7533732|NCT02688387|11880059|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533733|NCT02688387|11880060|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533734|NCT02688387|11880061|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7533735|NCT02688387|11880062|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533736|NCT02688387|11880063|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
7533737|NCT02688387|11880064|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
7533738|NCT02688387|11880043|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7572895|NCT03589885|11953616|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
7572896|NCT03589885|11953617|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
7572897|NCT03589885|11953618|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
7572898|NCT03589885|11953619|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
7572899|NCT03589885|11953615|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7572900|NCT03589885|11953616|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7572901|NCT03589885|11953617|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
7572902|NCT03589885|11953618|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7572903|NCT03589885|11953619|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
7572904|NCT03589885|11953615|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7572905|NCT03589885|11953616|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
7572906|NCT03589885|11953617|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7572907|NCT03589885|11953618|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7572908|NCT03589885|11953619|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
7572909|NCT03589885|11953615|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7572910|NCT03589885|11953616|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7572911|NCT03589885|11953617|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
7572912|NCT03589885|11953618|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7572913|NCT03589885|11953619|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
7572914|NCT03589885|11953615|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
7572915|NCT03589885|11953616|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
7572916|NCT03589885|11953617|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
7572917|NCT03589885|11953618|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
7572918|NCT03589885|11953619|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
7572919|NCT03589885|11953615|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
7572920|NCT03589885|11953616|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
7572921|NCT03589885|11953617|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
7572922|NCT03589885|11953618|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
7572923|NCT03589885|11953619|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
7572924|NCT03589885|11953615|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7572925|NCT03589885|11953616|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
7572926|NCT03589885|11953617|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7572927|NCT03589885|11953618|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
7572928|NCT03589885|11953619|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
7572929|NCT03589885|11953615|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7572930|NCT03589885|11953616|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
7572931|NCT03589885|11953617|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7572932|NCT03589885|11953618|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7572933|NCT03589885|11953619|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
7572934|NCT03590613|11953637|FG000|Period 2, 4 Days|Physician Decision|0
7572935|NCT03590613|11953638|FG001|Period 2, 4 Days|Physician Decision|0
7572936|NCT03590613|11953639|FG002|Period 2, 4 Days|Physician Decision|0
7572937|NCT03590613|11953640|FG003|Period 2, 4 Days|Physician Decision|1
7575371|NCT03722784|11959037|FG001|Overall Study|Protocol Violation|1
7464786|NCT01874431|11763552|FG006|Overall Study|Physician Decision|0
7464787|NCT01874431|11763553|FG007|Overall Study|Physician Decision|0
7464788|NCT01874431|11763546|FG000|Overall Study|Adverse Event|5
7382887|NCT01185522|11639739|FG000|Overall Study|Lost to Follow-up|19
7382888|NCT01185522|11639739|FG000|Overall Study|Withdrawal by Subject|10
7382889|NCT01185522|11639739|FG000|Overall Study|Poor tolerance|39
7382890|NCT01185522|11639739|FG000|Overall Study|Other reasons|12
7382891|NCT01185548|11639744|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
7382892|NCT01185561|11639759|FG000|Overall Study|Lost to Follow-up|0
7382893|NCT01185561|11639760|FG001|Overall Study|Lost to Follow-up|4
7382894|NCT01185561|11639759|FG000|Overall Study|Withdrawal by Subject|2
7382895|NCT01185561|11639760|FG001|Overall Study|Withdrawal by Subject|8
7382896|NCT01185600|11639768|FG000|Overall Study|Adverse Event|1
7382897|NCT01185600|11639769|FG001|Overall Study|Adverse Event|1
7464789|NCT01874431|11763547|FG001|Overall Study|Adverse Event|4
7572938|NCT03591146|11953664|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7572939|NCT03591146|11953665|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7572940|NCT03591146|11953666|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7572941|NCT03591146|11953667|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
7572942|NCT03591146|11953668|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
7572943|NCT03591146|11953664|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7572944|NCT03591146|11953665|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
7572945|NCT03591146|11953666|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7572946|NCT03591146|11953667|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7572947|NCT03591146|11953668|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
7225403|NCT00066170|11434825|FG001|Overall Study|Other|5
7225404|NCT00066170|11434826|FG002|Overall Study|Other|2
7225405|NCT00066170|11434827|FG003|Overall Study|Other|0
7225406|NCT00066222|11434837|FG000|Overall Study|No protocol treatment received|1
7225407|NCT00066365|11434843|FG000|Overall Study|Adverse Event|1
7572948|NCT03591146|11953664|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7572949|NCT03591146|11953665|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7572950|NCT03591146|11953666|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7572951|NCT03591146|11953667|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
7572952|NCT03591146|11953668|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
7572953|NCT03591146|11953664|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7572954|NCT03591146|11953665|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7572955|NCT03591146|11953666|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7572956|NCT03591146|11953667|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
7572957|NCT03591146|11953668|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
7572958|NCT03591406|11953682|FG000|Overall Study|Adverse Event|5
7572959|NCT03591406|11953683|FG001|Overall Study|Adverse Event|3
7572960|NCT03591406|11953682|FG000|Overall Study|Protocol Violation|2
7464790|NCT01874431|11763548|FG002|Overall Study|Adverse Event|6
7225408|NCT00066365|11434844|FG001|Overall Study|Adverse Event|0
7225409|NCT00066365|11434843|FG000|Overall Study|Lack of Efficacy|15
7225410|NCT00066365|11434844|FG001|Overall Study|Lack of Efficacy|12
7225411|NCT00066365|11434843|FG000|Overall Study|Physician Decision|1
7225412|NCT00066365|11434844|FG001|Overall Study|Physician Decision|0
7225413|NCT00066365|11434843|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
7225414|NCT00066365|11434844|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
7225415|NCT00066365|11434843|FG000|Overall Study|Ineligible|4
7225416|NCT00066365|11434844|FG001|Overall Study|Ineligible|2
7225417|NCT00066469|11434852|FG000|Overall Study|Death|3
7225418|NCT00066469|11434852|FG000|Overall Study|Lack of Efficacy|9
7225419|NCT00066469|11434852|FG000|Overall Study|Lost to Follow-up|1
7225420|NCT00066469|11434852|FG000|Overall Study|Physician Decision|1
7225421|NCT00066469|11434852|FG000|Overall Study|Withdrawal by Subject|1
7225422|NCT00066469|11434852|FG000|Overall Study|ineligible|1
7225423|NCT00066573|11434858|FG000|Overall Study|Did not received protocol treatment|28
7225424|NCT00066573|11434859|FG001|Overall Study|Did not received protocol treatment|28
7225425|NCT00066690|11434877|FG000|Overall Study|Adverse Event|145
7225426|NCT00066690|11434878|FG001|Overall Study|Adverse Event|58
7225427|NCT00066690|11434879|FG002|Overall Study|Adverse Event|126
7225428|NCT00066690|11434877|FG000|Overall Study|Death|3
7225429|NCT00066690|11434878|FG001|Overall Study|Death|0
7225430|NCT00066690|11434879|FG002|Overall Study|Death|2
7225431|NCT00066690|11434877|FG000|Overall Study|Lack of Efficacy|114
7225432|NCT00066690|11434878|FG001|Overall Study|Lack of Efficacy|110
7225433|NCT00066690|11434879|FG002|Overall Study|Lack of Efficacy|76
7225434|NCT00066690|11434877|FG000|Overall Study|Lost to Follow-up|40
7225435|NCT00066690|11434878|FG001|Overall Study|Lost to Follow-up|21
7225436|NCT00066690|11434879|FG002|Overall Study|Lost to Follow-up|29
7225437|NCT00066690|11434877|FG000|Overall Study|Withdrawal by Subject|50
7225438|NCT00066690|11434878|FG001|Overall Study|Withdrawal by Subject|55
7225439|NCT00066690|11434879|FG002|Overall Study|Withdrawal by Subject|49
7225440|NCT00066690|11434877|FG000|Overall Study|Treatment Ongoing|246
7225441|NCT00066690|11434878|FG001|Overall Study|Treatment Ongoing|278
7225442|NCT00066690|11434879|FG002|Overall Study|Treatment Ongoing|282
7225443|NCT00066703|11434892|FG000|Overall Study|Adverse Event|80
7225444|NCT00066703|11434893|FG001|Overall Study|Adverse Event|111
7225445|NCT00066703|11434892|FG000|Overall Study|Death|3
7225446|NCT00066703|11434893|FG001|Overall Study|Death|0
7225447|NCT00066703|11434892|FG000|Overall Study|Lack of Efficacy|114
7225448|NCT00066703|11434893|FG001|Overall Study|Lack of Efficacy|69
7225449|NCT00066703|11434892|FG000|Overall Study|Lost to Follow-up|31
7225450|NCT00066703|11434893|FG001|Overall Study|Lost to Follow-up|28
7225451|NCT00066703|11434892|FG000|Overall Study|Withdrawal by Subject|38
7225452|NCT00066703|11434893|FG001|Overall Study|Withdrawal by Subject|63
7225453|NCT00066703|11434892|FG000|Overall Study|Treatment ongoing|346
7225454|NCT00066703|11434893|FG001|Overall Study|Treatment ongoing|311
7225455|NCT00066729|11434899|FG000|Overall Study|Lost to Follow-up|1
7225456|NCT00066729|11434899|FG000|Overall Study|Disease progression|1
7225457|NCT00066742|11434903|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
7225458|NCT00066742|11434903|FG000|Induction Chemoradiotherapy|Adverse Event|21
7225459|NCT00066742|11434903|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
7225460|NCT00066742|11434903|FG000|Induction Chemoradiotherapy|not protocol specified|2
7225461|NCT00066742|11434903|FG000|Induction Chemoradiotherapy|Ineligible|3
7225462|NCT00066742|11434903|FG000|Consolidation Chemotherapy|not protocol specified|1
7225463|NCT00066742|11434903|FG000|Consolidation Chemotherapy|Ineligible|2
7225464|NCT00067002|11434937|FG000|Overall Study|Early Death|1
7225465|NCT00067002|11434938|FG001|Overall Study|Early Death|2
7225466|NCT00067002|11434937|FG000|Overall Study|Delayed|1
7225467|NCT00067002|11434938|FG001|Overall Study|Delayed|1
7225468|NCT00067002|11434937|FG000|Overall Study|Graft Failure|5
7225469|NCT00067002|11434938|FG001|Overall Study|Graft Failure|6
7225470|NCT00067470|11434970|FG000|Overall Study|Withdrawal by Subject|0
7382898|NCT01185600|11639768|FG000|Overall Study|Death|0
7382899|NCT01185600|11639769|FG001|Overall Study|Death|1
7382900|NCT01185600|11639768|FG000|Overall Study|Lost to Follow-up|0
7382901|NCT01185600|11639769|FG001|Overall Study|Lost to Follow-up|5
7382902|NCT01185600|11639768|FG000|Overall Study|Physician Decision|29
7382903|NCT01185600|11639769|FG001|Overall Study|Physician Decision|35
7382904|NCT01185600|11639768|FG000|Overall Study|Withdrawal by Subject|1
7382905|NCT01185600|11639769|FG001|Overall Study|Withdrawal by Subject|1
7382906|NCT01185600|11639768|FG000|Overall Study|Hold by DSMB|1
7382907|NCT01185600|11639769|FG001|Overall Study|Hold by DSMB|2
7382908|NCT01185639|11639778|FG000|Overall Study|Progressed and didn't receive therapy|2
7382909|NCT01185704|11639784|FG000|Overall Study|Randomized but not treated|3
7382910|NCT01185704|11639785|FG001|Overall Study|Randomized but not treated|3
7382911|NCT01185704|11639784|FG000|Overall Study|Lack of ovarian response|5
7382912|NCT01185704|11639785|FG001|Overall Study|Lack of ovarian response|1
7382913|NCT01185704|11639784|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
7382914|NCT01185704|11639785|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
7382915|NCT01185704|11639784|FG000|Overall Study|Ectopic pregnancy|0
7382916|NCT01185704|11639785|FG001|Overall Study|Ectopic pregnancy|1
7382917|NCT01185782|11639793|FG000|Overall Study|Adverse Event|0
7382918|NCT01185782|11639794|FG001|Overall Study|Adverse Event|1
7382919|NCT01185782|11639793|FG000|Overall Study|Protocol Violation|1
7382920|NCT01185782|11639794|FG001|Overall Study|Protocol Violation|0
7382921|NCT01185782|11639793|FG000|Overall Study|Poor Response to Treatment|3
7382922|NCT01185782|11639794|FG001|Overall Study|Poor Response to Treatment|1
7572961|NCT03591406|11953683|FG001|Overall Study|Protocol Violation|1
7572962|NCT03591406|11953682|FG000|Overall Study|Withdrawal by Subject|0
7572963|NCT03591406|11953683|FG001|Overall Study|Withdrawal by Subject|5
7572964|NCT03592745|11953700|FG000|Overall Study|Adverse Event|0
7572965|NCT03592745|11953701|FG001|Overall Study|Adverse Event|2
7572966|NCT03592745|11953700|FG000|Overall Study|Lost to Follow-up|2
7572967|NCT03592745|11953701|FG001|Overall Study|Lost to Follow-up|0
7572968|NCT03592745|11953700|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
7572969|NCT03592745|11953701|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
7572970|NCT03593681|11953724|FG000|Overall Study|Inadequate sample collected|12
7572971|NCT03593681|11953724|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
7572972|NCT03593681|11953724|FG000|Overall Study|Protocol Violation|3
7572973|NCT03593681|11953724|FG000|Overall Study|Withdrawal by Subject|3
7572974|NCT03593681|11953724|FG000|Overall Study|Procedure not attempted|3
7572975|NCT03593681|11953724|FG000|Overall Study|Adverse Event|2
7572976|NCT03593681|11953724|FG000|Overall Study|Physician Decision|1
7572977|NCT03593876|11953745|FG000|Overall Study|Withdrawal by Subject|1
7382923|NCT01185782|11639793|FG000|Overall Study|Other|2
7382924|NCT01185782|11639794|FG001|Overall Study|Other|5
7382925|NCT01185782|11639793|FG000|Overall Study|Randomized but not treated|0
7382926|NCT01185782|11639794|FG001|Overall Study|Randomized but not treated|4
7382927|NCT01185821|11639805|FG000|Overall Study|Abnormal laboratory value(s)|1
7382928|NCT01185821|11639806|FG001|Overall Study|Abnormal laboratory value(s)|2
7382929|NCT01185821|11639807|FG002|Overall Study|Abnormal laboratory value(s)|1
7382930|NCT01185821|11639808|FG003|Overall Study|Abnormal laboratory value(s)|0
7382931|NCT01185821|11639809|FG004|Overall Study|Abnormal laboratory value(s)|0
7382932|NCT01185821|11639805|FG000|Overall Study|Protocol Violation|0
7382933|NCT01185821|11639806|FG001|Overall Study|Protocol Violation|0
7382934|NCT01185821|11639807|FG002|Overall Study|Protocol Violation|0
7382935|NCT01185821|11639808|FG003|Overall Study|Protocol Violation|1
7382936|NCT01185821|11639809|FG004|Overall Study|Protocol Violation|1
7382937|NCT01185821|11639805|FG000|Overall Study|Abnormal test procedure result|0
7382938|NCT01185821|11639806|FG001|Overall Study|Abnormal test procedure result|0
7387492|NCT01214668|11646031|FG003|Overall Study|Death|0
7225471|NCT00067470|11434971|FG001|Overall Study|Withdrawal by Subject|1
7225472|NCT00067990|11434992|FG000|Overall Study|Death|5
7225473|NCT00067990|11434993|FG001|Overall Study|Death|7
7225474|NCT00067990|11434992|FG000|Overall Study|ESRD, Non IF/TA|1
7225475|NCT00067990|11434993|FG001|Overall Study|ESRD, Non IF/TA|3
7225476|NCT00067990|11434992|FG000|Overall Study|Withdrawal by Subject|4
7225477|NCT00067990|11434993|FG001|Overall Study|Withdrawal by Subject|12
7225478|NCT00068107|11434999|FG000|Overall Study|end-stage renal disease|6
7225479|NCT00068107|11434999|FG000|Overall Study|Death|2
7225480|NCT00068107|11434999|FG000|Overall Study|Withdrawal by Subject|1
7225481|NCT00068237|11435006|FG000|Overall Study|Ineligible|3
7225482|NCT00068237|11435006|FG000|Overall Study|No protocol treatment received|2
7225483|NCT00068250|11435013|FG000|Phase I: Dose Level 2|Protocol Violation|0
7225484|NCT00068250|11435014|FG001|Phase I: Dose Level 2|Protocol Violation|1
7225485|NCT00068250|11435015|FG002|Phase I: Dose Level 2|Protocol Violation|0
7225486|NCT00068250|11435016|FG003|Phase I: Dose Level 2|Protocol Violation|0
7225487|NCT00068380|11435054|FG000|Overall Study|Withdrawal by Subject|3
7225488|NCT00068380|11435054|FG000|Overall Study|Adverse Event|2
7225489|NCT00068393|11435058|FG000|Overall Study|Adverse Event|2
7225490|NCT00068393|11435058|FG000|Overall Study|Death|3
7225491|NCT00068393|11435058|FG000|Overall Study|Withdrawal by Subject|3
7225492|NCT00068393|11435058|FG000|Overall Study|Alternative treatment|1
7225493|NCT00068393|11435058|FG000|Overall Study|Quality of life worsening|1
7225494|NCT00068406|11435062|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
7225495|NCT00068406|11435062|FG000|Overall Study|Ineligible-Inadequate Pathology|2
7225496|NCT00068419|11435066|FG000|Overall Study|Adverse Event|3
7225497|NCT00068419|11435066|FG000|Overall Study|Lack of Efficacy|24
7225498|NCT00068419|11435066|FG000|Overall Study|Lost to Follow-up|1
7225499|NCT00068419|11435066|FG000|Overall Study|Physician Decision|7
7225500|NCT00068419|11435066|FG000|Overall Study|Withdrawal by Subject|14
7225501|NCT00068419|11435066|FG000|Overall Study|Ineligible|11
7225502|NCT00068445|11435072|FG000|Randomization|Cancel|1
7225503|NCT00068445|11435073|FG001|Randomization|Cancel|3
7225504|NCT00068445|11435072|FG000|Randomization|Ineligible|1
7225505|NCT00068445|11435073|FG001|Randomization|Ineligible|1
7225506|NCT00068445|11435072|FG000|Treatment|Refused Further Treatment|13
7225507|NCT00068445|11435073|FG001|Treatment|Refused Further Treatment|10
7225508|NCT00068445|11435072|FG000|Treatment|Adverse Event|7
7225509|NCT00068445|11435073|FG001|Treatment|Adverse Event|1
7225510|NCT00068445|11435072|FG000|Treatment|Other (Specifics not available)|9
7225511|NCT00068445|11435073|FG001|Treatment|Other (Specifics not available)|5
7225512|NCT00068588|11435086|FG000|Overall Study|Adverse Event|0
7225513|NCT00068588|11435087|FG001|Overall Study|Adverse Event|0
7225514|NCT00068588|11435088|FG002|Overall Study|Adverse Event|2
7225515|NCT00068588|11435086|FG000|Overall Study|Withdrawal by Subject|0
7225516|NCT00068588|11435087|FG001|Overall Study|Withdrawal by Subject|0
7225517|NCT00068588|11435088|FG002|Overall Study|Withdrawal by Subject|1
7225518|NCT00068588|11435086|FG000|Overall Study|Poor KPS|0
7225519|NCT00068588|11435087|FG001|Overall Study|Poor KPS|0
7225520|NCT00068588|11435088|FG002|Overall Study|Poor KPS|1
7225521|NCT00068601|11435097|FG000|Overall Study|Ineligible|11
7225522|NCT00068601|11435098|FG001|Overall Study|Ineligible|13
7225523|NCT00068601|11435097|FG000|Overall Study|Not evaluable: withdrew consent|5
7225524|NCT00068601|11435098|FG001|Overall Study|Not evaluable: withdrew consent|4
7225525|NCT00068601|11435097|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
7382939|NCT01185821|11639807|FG002|Overall Study|Abnormal test procedure result|0
7382940|NCT01185821|11639808|FG003|Overall Study|Abnormal test procedure result|0
7382941|NCT01185821|11639809|FG004|Overall Study|Abnormal test procedure result|1
7382942|NCT01185821|11639805|FG000|Overall Study|Death|0
7382943|NCT01185821|11639806|FG001|Overall Study|Death|1
7382944|NCT01185821|11639807|FG002|Overall Study|Death|0
7382945|NCT01185821|11639808|FG003|Overall Study|Death|0
7382946|NCT01185821|11639809|FG004|Overall Study|Death|0
7382947|NCT01185821|11639805|FG000|Overall Study|Condition no longer required study drug|0
7382948|NCT01185821|11639806|FG001|Overall Study|Condition no longer required study drug|0
7382949|NCT01185821|11639807|FG002|Overall Study|Condition no longer required study drug|0
7382950|NCT01185821|11639808|FG003|Overall Study|Condition no longer required study drug|0
7382951|NCT01185821|11639809|FG004|Overall Study|Condition no longer required study drug|1
7382952|NCT01185821|11639805|FG000|Overall Study|Adverse Event|2
7382953|NCT01185821|11639806|FG001|Overall Study|Adverse Event|3
7382954|NCT01185821|11639807|FG002|Overall Study|Adverse Event|1
7382955|NCT01185821|11639808|FG003|Overall Study|Adverse Event|2
7382956|NCT01185821|11639809|FG004|Overall Study|Adverse Event|5
7382957|NCT01185821|11639805|FG000|Overall Study|Lack of Efficacy|0
7382958|NCT01185821|11639806|FG001|Overall Study|Lack of Efficacy|0
7382959|NCT01185821|11639807|FG002|Overall Study|Lack of Efficacy|3
7382960|NCT01185821|11639808|FG003|Overall Study|Lack of Efficacy|0
7382961|NCT01185821|11639809|FG004|Overall Study|Lack of Efficacy|9
7464791|NCT01874431|11763549|FG003|Overall Study|Adverse Event|5
7382962|NCT01185821|11639805|FG000|Overall Study|Withdrawal by Subject|3
7382963|NCT01185821|11639806|FG001|Overall Study|Withdrawal by Subject|2
7464792|NCT01874431|11763550|FG004|Overall Study|Adverse Event|2
7382964|NCT01185821|11639807|FG002|Overall Study|Withdrawal by Subject|2
7382965|NCT01185821|11639808|FG003|Overall Study|Withdrawal by Subject|1
7382966|NCT01185821|11639809|FG004|Overall Study|Withdrawal by Subject|3
7382967|NCT01185821|11639805|FG000|Overall Study|Lost to Follow-up|1
7382968|NCT01185821|11639806|FG001|Overall Study|Lost to Follow-up|1
7382969|NCT01185821|11639807|FG002|Overall Study|Lost to Follow-up|2
7225526|NCT00068601|11435098|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
7225527|NCT00068601|11435097|FG000|Overall Study|Death|11
7225528|NCT00068601|11435098|FG001|Overall Study|Death|3
7225529|NCT00068601|11435097|FG000|Overall Study|Lost to Follow-up|3
7225530|NCT00068601|11435098|FG001|Overall Study|Lost to Follow-up|2
7225531|NCT00068601|11435097|FG000|Overall Study|Missing primary outcome data|30
7225532|NCT00068601|11435098|FG001|Overall Study|Missing primary outcome data|34
7225533|NCT00068692|11435107|FG000|Step 1: Registration|Disese progression/relapse|5
7225534|NCT00068692|11435108|FG001|Step 1: Registration|Disese progression/relapse|0
7225535|NCT00068692|11435109|FG002|Step 1: Registration|Disese progression/relapse|0
7225536|NCT00068692|11435110|FG003|Step 1: Registration|Disese progression/relapse|0
7225537|NCT00068692|11435111|FG004|Step 1: Registration|Disese progression/relapse|0
7225538|NCT00068692|11435112|FG005|Step 1: Registration|Disese progression/relapse|0
7225539|NCT00068692|11435113|FG006|Step 1: Registration|Disese progression/relapse|0
7225540|NCT00068692|11435114|FG007|Step 1: Registration|Disese progression/relapse|0
7225541|NCT00068692|11435107|FG000|Step 1: Registration|Adverse Event|7
7225542|NCT00068692|11435108|FG001|Step 1: Registration|Adverse Event|0
7225543|NCT00068692|11435109|FG002|Step 1: Registration|Adverse Event|0
7225544|NCT00068692|11435110|FG003|Step 1: Registration|Adverse Event|0
7225545|NCT00068692|11435111|FG004|Step 1: Registration|Adverse Event|0
7225546|NCT00068692|11435112|FG005|Step 1: Registration|Adverse Event|0
7225547|NCT00068692|11435113|FG006|Step 1: Registration|Adverse Event|0
7225548|NCT00068692|11435114|FG007|Step 1: Registration|Adverse Event|0
7225549|NCT00068692|11435107|FG000|Step 1: Registration|Death|1
7225550|NCT00068692|11435108|FG001|Step 1: Registration|Death|0
7225551|NCT00068692|11435109|FG002|Step 1: Registration|Death|0
7225552|NCT00068692|11435110|FG003|Step 1: Registration|Death|0
7225553|NCT00068692|11435111|FG004|Step 1: Registration|Death|0
7225554|NCT00068692|11435112|FG005|Step 1: Registration|Death|0
7225555|NCT00068692|11435113|FG006|Step 1: Registration|Death|0
7225556|NCT00068692|11435114|FG007|Step 1: Registration|Death|0
7225557|NCT00068692|11435107|FG000|Step 1: Registration|Withdrawal by Subject|11
7225558|NCT00068692|11435108|FG001|Step 1: Registration|Withdrawal by Subject|0
7225559|NCT00068692|11435109|FG002|Step 1: Registration|Withdrawal by Subject|0
7225560|NCT00068692|11435110|FG003|Step 1: Registration|Withdrawal by Subject|0
7225561|NCT00068692|11435111|FG004|Step 1: Registration|Withdrawal by Subject|0
7225562|NCT00068692|11435112|FG005|Step 1: Registration|Withdrawal by Subject|0
7225563|NCT00068692|11435113|FG006|Step 1: Registration|Withdrawal by Subject|0
7225564|NCT00068692|11435114|FG007|Step 1: Registration|Withdrawal by Subject|0
7225565|NCT00068692|11435107|FG000|Step 1: Registration|Alternative therapy|2
7225566|NCT00068692|11435108|FG001|Step 1: Registration|Alternative therapy|0
7382970|NCT01185821|11639808|FG003|Overall Study|Lost to Follow-up|1
7382971|NCT01185821|11639809|FG004|Overall Study|Lost to Follow-up|2
7382972|NCT01185821|11639805|FG000|Overall Study|Administrative problems|0
7382973|NCT01185821|11639806|FG001|Overall Study|Administrative problems|0
7382974|NCT01185821|11639807|FG002|Overall Study|Administrative problems|1
7382975|NCT01185821|11639808|FG003|Overall Study|Administrative problems|1
7382976|NCT01185821|11639809|FG004|Overall Study|Administrative problems|2
7382977|NCT01185834|11639823|FG000|Overall Study|Lost to Follow-up|2
7382978|NCT01185834|11639823|FG000|Overall Study|Discomfort|4
7382979|NCT01185834|11639823|FG000|Overall Study|Biomicroscopy|4
7382980|NCT01185834|11639823|FG000|Overall Study|Time/Job Conflict|2
7382981|NCT01185834|11639823|FG000|Overall Study|Early exit - Site error|2
7382982|NCT01185964|11639830|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
7382983|NCT01185964|11639831|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
7382984|NCT01185964|11639832|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
7382985|NCT01185964|11639833|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
7382986|NCT01185964|11639830|FG000|Phase 1b and Phase 2|Other Therapy Started|0
7382987|NCT01185964|11639831|FG001|Phase 1b and Phase 2|Other Therapy Started|3
7382988|NCT01185964|11639832|FG002|Phase 1b and Phase 2|Other Therapy Started|3
7382989|NCT01185964|11639833|FG003|Phase 1b and Phase 2|Other Therapy Started|0
7382990|NCT01185964|11639830|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7382991|NCT01185964|11639831|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7382992|NCT01185964|11639832|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
7382993|NCT01185964|11639833|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
7382994|NCT01185964|11639830|FG000|Phase 1b and Phase 2|Adverse Event|1
7382995|NCT01185964|11639831|FG001|Phase 1b and Phase 2|Adverse Event|0
7382996|NCT01185964|11639832|FG002|Phase 1b and Phase 2|Adverse Event|2
7382997|NCT01185964|11639833|FG003|Phase 1b and Phase 2|Adverse Event|0
7382998|NCT01185964|11639830|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7382999|NCT01185964|11639831|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7383000|NCT01185964|11639832|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
7383001|NCT01185964|11639833|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
7383002|NCT01185964|11639830|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7383003|NCT01185964|11639831|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7383004|NCT01185964|11639832|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
7383005|NCT01185964|11639833|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
7383006|NCT01185964|11639830|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7383007|NCT01185964|11639831|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7383008|NCT01185964|11639832|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
7383009|NCT01185964|11639833|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
7383010|NCT01185964|11639830|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7383011|NCT01185964|11639831|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7383012|NCT01185964|11639832|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
7383013|NCT01185964|11639833|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
7383014|NCT01186328|11639858|FG000|Overall Study|Death|1
7383015|NCT01186328|11639859|FG001|Overall Study|Death|0
7383016|NCT01186328|11639860|FG002|Overall Study|Death|0
7383017|NCT01186419|11639871|FG000|Overall Study|Withdrawal by Subject|5
7383018|NCT01186419|11639872|FG001|Overall Study|Withdrawal by Subject|3
7383019|NCT01186419|11639871|FG000|Overall Study|Adverse Event|1
7383020|NCT01186419|11639872|FG001|Overall Study|Adverse Event|2
7383021|NCT01186419|11639871|FG000|Overall Study|Physician Decision|0
7383022|NCT01186419|11639872|FG001|Overall Study|Physician Decision|3
7383023|NCT01186419|11639871|FG000|Overall Study|Other|1
7383024|NCT01186419|11639872|FG001|Overall Study|Other|1
7383025|NCT01186458|11639877|FG000|Overall Study|Adverse Event|1
7383026|NCT01186692|11639890|FG000|Overall Study|Not Catheterized|11
7383027|NCT01186692|11639890|FG000|Overall Study|Futher testing contraindicated implant|19
7383028|NCT01186692|11639890|FG000|Overall Study|Adverse Event|2
7383029|NCT01186744|11639908|FG000|Overall Study|Lack of Efficacy|156
7383030|NCT01186744|11639909|FG001|Overall Study|Lack of Efficacy|99
7383031|NCT01186744|11639910|FG002|Overall Study|Lack of Efficacy|0
7383032|NCT01186744|11639911|FG003|Overall Study|Lack of Efficacy|2
7383033|NCT01186744|11639912|FG004|Overall Study|Lack of Efficacy|2
7383034|NCT01186744|11639913|FG005|Overall Study|Lack of Efficacy|5
7383035|NCT01186744|11639908|FG000|Overall Study|Protocol Violation|1
7383036|NCT01186744|11639909|FG001|Overall Study|Protocol Violation|2
7383037|NCT01186744|11639910|FG002|Overall Study|Protocol Violation|0
7383038|NCT01186744|11639911|FG003|Overall Study|Protocol Violation|1
7383039|NCT01186744|11639912|FG004|Overall Study|Protocol Violation|1
7383040|NCT01186744|11639913|FG005|Overall Study|Protocol Violation|2
7383041|NCT01186744|11639908|FG000|Overall Study|Lost to Follow-up|15
7383042|NCT01186744|11639909|FG001|Overall Study|Lost to Follow-up|16
7383043|NCT01186744|11639910|FG002|Overall Study|Lost to Follow-up|2
7383044|NCT01186744|11639911|FG003|Overall Study|Lost to Follow-up|1
7383045|NCT01186744|11639912|FG004|Overall Study|Lost to Follow-up|1
7383046|NCT01186744|11639913|FG005|Overall Study|Lost to Follow-up|4
7383047|NCT01186744|11639908|FG000|Overall Study|Screen failure|1
7383048|NCT01186744|11639909|FG001|Overall Study|Screen failure|1
7383049|NCT01186744|11639910|FG002|Overall Study|Screen failure|0
7383050|NCT01186744|11639911|FG003|Overall Study|Screen failure|1
7383051|NCT01186744|11639912|FG004|Overall Study|Screen failure|0
7383052|NCT01186744|11639913|FG005|Overall Study|Screen failure|0
7383053|NCT01186744|11639908|FG000|Overall Study|Withdrawal by Subject|14
7383054|NCT01186744|11639909|FG001|Overall Study|Withdrawal by Subject|10
7383055|NCT01186744|11639910|FG002|Overall Study|Withdrawal by Subject|2
7383056|NCT01186744|11639911|FG003|Overall Study|Withdrawal by Subject|5
7383057|NCT01186744|11639912|FG004|Overall Study|Withdrawal by Subject|0
7383058|NCT01186744|11639913|FG005|Overall Study|Withdrawal by Subject|6
7383059|NCT01186744|11639908|FG000|Overall Study|Study terminated by Sponsor|1
7383060|NCT01186744|11639909|FG001|Overall Study|Study terminated by Sponsor|0
7383061|NCT01186744|11639910|FG002|Overall Study|Study terminated by Sponsor|0
7383062|NCT01186744|11639911|FG003|Overall Study|Study terminated by Sponsor|0
7383063|NCT01186744|11639912|FG004|Overall Study|Study terminated by Sponsor|0
7383064|NCT01186744|11639913|FG005|Overall Study|Study terminated by Sponsor|0
7383065|NCT01186744|11639908|FG000|Overall Study|Other|9
7383066|NCT01186744|11639909|FG001|Overall Study|Other|10
7383067|NCT01186744|11639910|FG002|Overall Study|Other|1
7383068|NCT01186744|11639911|FG003|Overall Study|Other|2
7383069|NCT01186744|11639912|FG004|Overall Study|Other|1
7383070|NCT01186744|11639913|FG005|Overall Study|Other|5
7383071|NCT01186744|11639908|FG000|Overall Study|Adverse Event|10
7383072|NCT01186744|11639909|FG001|Overall Study|Adverse Event|14
7383073|NCT01186744|11639910|FG002|Overall Study|Adverse Event|1
7383074|NCT01186744|11639911|FG003|Overall Study|Adverse Event|0
7383075|NCT01186744|11639912|FG004|Overall Study|Adverse Event|1
7383076|NCT01186744|11639913|FG005|Overall Study|Adverse Event|4
7383077|NCT01186744|11639908|FG000|Overall Study|Death|1
7383078|NCT01186744|11639909|FG001|Overall Study|Death|0
7383079|NCT01186744|11639910|FG002|Overall Study|Death|0
7383080|NCT01186744|11639911|FG003|Overall Study|Death|0
7383081|NCT01186744|11639912|FG004|Overall Study|Death|0
7383082|NCT01186744|11639913|FG005|Overall Study|Death|0
7383083|NCT01186770|11639952|FG000|Overall Study|Ineligibility|0
7383084|NCT01186770|11639953|FG001|Overall Study|Ineligibility|0
7383085|NCT01186770|11639954|FG002|Overall Study|Ineligibility|2
7383086|NCT01186770|11639955|FG003|Overall Study|Ineligibility|0
7383087|NCT01186770|11639952|FG000|Overall Study|Protocol Violation|7
7383088|NCT01186770|11639953|FG001|Overall Study|Protocol Violation|9
7383089|NCT01186770|11639954|FG002|Overall Study|Protocol Violation|12
7383090|NCT01186770|11639955|FG003|Overall Study|Protocol Violation|14
7383091|NCT01186770|11639952|FG000|Overall Study|Adverse Event|2
7383092|NCT01186770|11639953|FG001|Overall Study|Adverse Event|9
7383093|NCT01186770|11639954|FG002|Overall Study|Adverse Event|7
7383094|NCT01186770|11639955|FG003|Overall Study|Adverse Event|9
7383095|NCT01186770|11639952|FG000|Overall Study|Withdrawal by Subject|15
7383096|NCT01186770|11639953|FG001|Overall Study|Withdrawal by Subject|13
7383097|NCT01186770|11639954|FG002|Overall Study|Withdrawal by Subject|11
7383098|NCT01186770|11639955|FG003|Overall Study|Withdrawal by Subject|17
7383099|NCT01186770|11639952|FG000|Overall Study|Lost to Follow-up|10
7383100|NCT01186770|11639953|FG001|Overall Study|Lost to Follow-up|6
7383101|NCT01186770|11639954|FG002|Overall Study|Lost to Follow-up|14
7383102|NCT01186770|11639955|FG003|Overall Study|Lost to Follow-up|9
7383103|NCT01186770|11639952|FG000|Overall Study|Insufficient response to treatment|7
7383104|NCT01186770|11639953|FG001|Overall Study|Insufficient response to treatment|8
7383105|NCT01186770|11639954|FG002|Overall Study|Insufficient response to treatment|5
7383106|NCT01186770|11639955|FG003|Overall Study|Insufficient response to treatment|7
7383107|NCT01186770|11639952|FG000|Overall Study|Other than specified|0
7383108|NCT01186770|11639953|FG001|Overall Study|Other than specified|1
7383109|NCT01186770|11639954|FG002|Overall Study|Other than specified|1
7383110|NCT01186770|11639955|FG003|Overall Study|Other than specified|2
7383111|NCT01186796|11639967|FG000|Overall Study|Adverse Event|3
7383112|NCT01186796|11639968|FG001|Overall Study|Adverse Event|0
7383113|NCT01186796|11639967|FG000|Overall Study|Withdrawal by Subject|1
7383114|NCT01186796|11639968|FG001|Overall Study|Withdrawal by Subject|1
7383115|NCT01186796|11639967|FG000|Overall Study|Protocol Violation|0
7383116|NCT01186796|11639968|FG001|Overall Study|Protocol Violation|1
7383117|NCT01186809|11639974|FG000|Overall Study|Death|30
7383118|NCT01186939|11639978|FG000|Overall Study|Death|7
7383119|NCT01186939|11639978|FG000|Overall Study|Withdrawal by Subject|2
7383120|NCT01186939|11639978|FG000|Overall Study|No longer receiving clinical benefit|17
7383121|NCT01186939|11639978|FG000|Overall Study|Program closed|5
7383122|NCT01186939|11639978|FG000|Overall Study|Sponsor decision|4
7383123|NCT01186939|11639978|FG000|Overall Study|Started additional treatment|1
7383124|NCT01186939|11639978|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
7383125|NCT01186939|11639978|FG000|Overall Study|Myocardial infarction|1
7383126|NCT01186939|11639978|FG000|Overall Study|Bone marrow transplant|1
7464793|NCT01874431|11763551|FG005|Overall Study|Adverse Event|8
7464794|NCT01874431|11763552|FG006|Overall Study|Adverse Event|2
7464795|NCT01874431|11763553|FG007|Overall Study|Adverse Event|3
7383127|NCT01186939|11639978|FG000|Overall Study|Transformation to AML|1
7383128|NCT01186978|11639982|FG000|Overall Study|Withdrawal by Subject|1
7383129|NCT01187043|11640007|FG000|Overall Study|Adverse Event|0
7383130|NCT01187043|11640008|FG001|Overall Study|Adverse Event|0
7383131|NCT01187043|11640009|FG002|Overall Study|Adverse Event|0
7383132|NCT01187043|11640010|FG003|Overall Study|Adverse Event|0
7383133|NCT01187043|11640011|FG004|Overall Study|Adverse Event|1
7383134|NCT01187043|11640007|FG000|Overall Study|Unable to make scheduled visits|1
7383135|NCT01187043|11640008|FG001|Overall Study|Unable to make scheduled visits|0
7383136|NCT01187043|11640009|FG002|Overall Study|Unable to make scheduled visits|4
7383137|NCT01187043|11640010|FG003|Overall Study|Unable to make scheduled visits|0
7464796|NCT01874431|11763546|FG000|Overall Study|Protocol Violation|1
7464797|NCT01874431|11763547|FG001|Overall Study|Protocol Violation|1
7464798|NCT01874431|11763548|FG002|Overall Study|Protocol Violation|1
7464799|NCT01874431|11763549|FG003|Overall Study|Protocol Violation|0
7464800|NCT01874431|11763550|FG004|Overall Study|Protocol Violation|3
7464801|NCT01874431|11763551|FG005|Overall Study|Protocol Violation|2
7464802|NCT01874431|11763552|FG006|Overall Study|Protocol Violation|1
7464803|NCT01874431|11763553|FG007|Overall Study|Protocol Violation|1
7464804|NCT01874431|11763546|FG000|Overall Study|Non-compliance|0
7464805|NCT01874431|11763547|FG001|Overall Study|Non-compliance|0
7464806|NCT01874431|11763548|FG002|Overall Study|Non-compliance|0
7464807|NCT01874431|11763549|FG003|Overall Study|Non-compliance|0
7464808|NCT01874431|11763550|FG004|Overall Study|Non-compliance|1
7464809|NCT01874431|11763551|FG005|Overall Study|Non-compliance|0
7464810|NCT01874431|11763552|FG006|Overall Study|Non-compliance|1
7464811|NCT01874431|11763553|FG007|Overall Study|Non-compliance|0
7464812|NCT01874431|11763546|FG000|Overall Study|Logistical difficulties|0
7464813|NCT01874431|11763547|FG001|Overall Study|Logistical difficulties|0
7464814|NCT01874431|11763548|FG002|Overall Study|Logistical difficulties|0
7464815|NCT01874431|11763549|FG003|Overall Study|Logistical difficulties|0
7464816|NCT01874431|11763550|FG004|Overall Study|Logistical difficulties|0
7464817|NCT01874431|11763551|FG005|Overall Study|Logistical difficulties|0
7464818|NCT01874431|11763552|FG006|Overall Study|Logistical difficulties|1
7464819|NCT01874431|11763553|FG007|Overall Study|Logistical difficulties|0
7464820|NCT01874431|11763546|FG000|Overall Study|Withdrawal by Subject|0
7464821|NCT01874431|11763547|FG001|Overall Study|Withdrawal by Subject|0
7464822|NCT01874431|11763548|FG002|Overall Study|Withdrawal by Subject|1
7464823|NCT01874431|11763549|FG003|Overall Study|Withdrawal by Subject|2
7464824|NCT01874431|11763550|FG004|Overall Study|Withdrawal by Subject|1
7464825|NCT01874431|11763551|FG005|Overall Study|Withdrawal by Subject|1
7464826|NCT01874431|11763552|FG006|Overall Study|Withdrawal by Subject|3
7464827|NCT01874431|11763553|FG007|Overall Study|Withdrawal by Subject|0
7464828|NCT01874431|11763546|FG000|Overall Study|Sponsor decision|0
7464829|NCT01874431|11763547|FG001|Overall Study|Sponsor decision|0
7464830|NCT01874431|11763548|FG002|Overall Study|Sponsor decision|0
7464831|NCT01874431|11763549|FG003|Overall Study|Sponsor decision|0
7464832|NCT01874431|11763550|FG004|Overall Study|Sponsor decision|1
7464833|NCT01874431|11763551|FG005|Overall Study|Sponsor decision|0
7464834|NCT01874431|11763552|FG006|Overall Study|Sponsor decision|0
7464835|NCT01874431|11763553|FG007|Overall Study|Sponsor decision|0
7464836|NCT01874431|11763546|FG000|Overall Study|Lost to Follow-up|0
7464837|NCT01874431|11763547|FG001|Overall Study|Lost to Follow-up|0
7464838|NCT01874431|11763548|FG002|Overall Study|Lost to Follow-up|1
7464839|NCT01874431|11763549|FG003|Overall Study|Lost to Follow-up|0
7464840|NCT01874431|11763550|FG004|Overall Study|Lost to Follow-up|0
7383138|NCT01187043|11640011|FG004|Overall Study|Unable to make scheduled visits|1
7383139|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
7383140|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7383141|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7383142|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7383143|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
7383144|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
7383145|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7464841|NCT01874431|11763551|FG005|Overall Study|Lost to Follow-up|0
7464842|NCT01874431|11763552|FG006|Overall Study|Lost to Follow-up|0
7464843|NCT01874431|11763553|FG007|Overall Study|Lost to Follow-up|0
7464844|NCT01874535|11763573|FG000|Overall Study|Lost to Follow-up|10
7464845|NCT01874535|11763574|FG001|Overall Study|Lost to Follow-up|9
7464846|NCT01874535|11763573|FG000|Overall Study|incomplete symptom resolution|45
7383146|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7383147|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7383148|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
7383149|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
7383150|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7383151|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7383152|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7383153|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
7383154|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
7383155|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7383156|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7383157|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7383158|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
7383159|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
7383160|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7383161|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7383162|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7383163|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
7383164|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
7383165|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7383166|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7383167|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7383168|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
7383169|NCT01187407|11640058|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
7383170|NCT01187407|11640059|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7383171|NCT01187407|11640060|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7383172|NCT01187407|11640061|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7383173|NCT01187407|11640062|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
7383174|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
7383175|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
7383176|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
7383177|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
7383178|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
7383179|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
7383180|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
7383181|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
7383182|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
7383183|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
7383184|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
7383185|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
7387493|NCT01214668|11646032|FG004|Overall Study|Death|0
7383186|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
7383187|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
7383188|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
7383189|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7383190|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7383191|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
7383192|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
7383193|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
7383194|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
7383195|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
7383196|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
7383197|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
7383198|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
7383199|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
7383200|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7383201|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
7383202|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
7383203|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
7383204|NCT01187407|11640058|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
7383205|NCT01187407|11640059|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7383206|NCT01187407|11640060|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7383207|NCT01187407|11640061|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
7383208|NCT01187407|11640062|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
7383209|NCT01187446|11640081|FG000|Overall Study|Patient started non-protocol therapy|0
7383210|NCT01187446|11640082|FG001|Overall Study|Patient started non-protocol therapy|1
7383211|NCT01187550|11640108|FG000|Overall Study|Protocol Violation|3
7383212|NCT01187550|11640109|FG001|Overall Study|Protocol Violation|1
7383213|NCT01187550|11640108|FG000|Overall Study|Other|3
7383214|NCT01187550|11640109|FG001|Overall Study|Other|0
7383215|NCT01187550|11640108|FG000|Overall Study|Randomized but not treated|8
7383216|NCT01187550|11640109|FG001|Overall Study|Randomized but not treated|0
7383217|NCT01187901|11640128|FG000|Overall Study|Protocol Violation|1
7383218|NCT01187901|11640129|FG001|Overall Study|Protocol Violation|0
7383219|NCT01187901|11640128|FG000|Overall Study|Lost to Follow-up|1
7383220|NCT01187901|11640129|FG001|Overall Study|Lost to Follow-up|2
7383221|NCT01187901|11640128|FG000|Overall Study|Unrelated Health Reasons|1
7383222|NCT01187901|11640129|FG001|Overall Study|Unrelated Health Reasons|2
7383223|NCT01187901|11640128|FG000|Overall Study|Suspected Allergic Reaction|1
7383224|NCT01187901|11640129|FG001|Overall Study|Suspected Allergic Reaction|1
7383225|NCT01187901|11640128|FG000|Overall Study|Adverse Event|3
7383226|NCT01187901|11640129|FG001|Overall Study|Adverse Event|0
7383227|NCT01187901|11640128|FG000|Overall Study|No Endpoint due to Early Study Halt|2
7383228|NCT01187901|11640129|FG001|Overall Study|No Endpoint due to Early Study Halt|3
7383229|NCT01187901|11640128|FG000|Overall Study|Pregnancy|0
7383230|NCT01187901|11640129|FG001|Overall Study|Pregnancy|2
7383231|NCT01187953|11640141|FG000|Overall Study|Death|11
7383232|NCT01187953|11640142|FG001|Overall Study|Death|13
7383233|NCT01187953|11640141|FG000|Overall Study|Adverse Event|1
7383234|NCT01187953|11640142|FG001|Overall Study|Adverse Event|2
7383235|NCT01187953|11640141|FG000|Overall Study|Lost to Follow-up|0
7383236|NCT01187953|11640142|FG001|Overall Study|Lost to Follow-up|3
7383237|NCT01187953|11640141|FG000|Overall Study|Withdrawal by Subject|3
7383238|NCT01187953|11640142|FG001|Overall Study|Withdrawal by Subject|3
7383239|NCT01188226|11640152|FG000|Overall Study|Withdrawal by Subject|4
7383240|NCT01188343|11640169|FG000|Overall Study|Not vaccinated|0
7383241|NCT01188343|11640170|FG001|Overall Study|Not vaccinated|2
7383242|NCT01188343|11640171|FG002|Overall Study|Not vaccinated|1
7383243|NCT01188343|11640169|FG000|Overall Study|Withdrawal by Subject|1
7383244|NCT01188343|11640170|FG001|Overall Study|Withdrawal by Subject|24
7383245|NCT01188343|11640171|FG002|Overall Study|Withdrawal by Subject|0
7383246|NCT01188538|11640241|FG000|Overall Study|Lost to Follow-up|0
7383247|NCT01188538|11640242|FG001|Overall Study|Lost to Follow-up|1
7383248|NCT01188551|11640254|FG000|Overall Study|Pharmacy issues|1
7383249|NCT01188551|11640255|FG001|Overall Study|Pharmacy issues|0
7383250|NCT01188551|11640256|FG002|Overall Study|Pharmacy issues|0
7383251|NCT01188551|11640257|FG003|Overall Study|Pharmacy issues|0
7383252|NCT01188564|11640269|FG000|Double-blind Phase|randomized not treated|1
7383253|NCT01188564|11640270|FG001|Double-blind Phase|randomized not treated|0
7383254|NCT01188655|11640289|FG000|Overall Study|Lack of Efficacy|1
7383255|NCT01188655|11640289|FG000|Overall Study|Lost to Follow-up|1
7383256|NCT01188655|11640289|FG000|Overall Study|Other|11
7383257|NCT01188668|11640293|FG000|Period 1: ARIP Alone|Protocol Violation|2
7383258|NCT01188668|11640293|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
7383259|NCT01188668|11640293|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
7383260|NCT01188681|11640304|FG000|Overall Study|bladder cancer|0
7383261|NCT01188681|11640305|FG001|Overall Study|bladder cancer|0
7383262|NCT01188681|11640306|FG002|Overall Study|bladder cancer|1
7383263|NCT01188681|11640307|FG003|Overall Study|bladder cancer|0
7383264|NCT01188681|11640304|FG000|Overall Study|Withdrawal by Subject|0
7383265|NCT01188681|11640305|FG001|Overall Study|Withdrawal by Subject|0
7383266|NCT01188681|11640306|FG002|Overall Study|Withdrawal by Subject|0
7383267|NCT01188681|11640307|FG003|Overall Study|Withdrawal by Subject|1
7383268|NCT01188772|11640338|FG000|Overall Study|Randomized but Not Treated|0
7383269|NCT01188772|11640339|FG001|Overall Study|Randomized but Not Treated|1
7383270|NCT01188772|11640340|FG002|Overall Study|Randomized but Not Treated|0
7383271|NCT01188772|11640341|FG003|Overall Study|Randomized but Not Treated|0
7383272|NCT01188772|11640338|FG000|Overall Study|Adverse Event|0
7383273|NCT01188772|11640339|FG001|Overall Study|Adverse Event|1
7383274|NCT01188772|11640340|FG002|Overall Study|Adverse Event|2
7383275|NCT01188772|11640341|FG003|Overall Study|Adverse Event|0
7383276|NCT01188772|11640338|FG000|Overall Study|Lost to Follow-up|4
7383277|NCT01188772|11640339|FG001|Overall Study|Lost to Follow-up|1
7383278|NCT01188772|11640340|FG002|Overall Study|Lost to Follow-up|1
7383279|NCT01188772|11640341|FG003|Overall Study|Lost to Follow-up|1
7383280|NCT01188772|11640338|FG000|Overall Study|Non-responder|0
7383281|NCT01188772|11640339|FG001|Overall Study|Non-responder|0
7383282|NCT01188772|11640340|FG002|Overall Study|Non-responder|3
7383283|NCT01188772|11640341|FG003|Overall Study|Non-responder|0
7383284|NCT01188772|11640338|FG000|Overall Study|Physician Decision|0
7383285|NCT01188772|11640339|FG001|Overall Study|Physician Decision|0
7383286|NCT01188772|11640340|FG002|Overall Study|Physician Decision|1
7383287|NCT01188772|11640341|FG003|Overall Study|Physician Decision|0
7383288|NCT01188772|11640338|FG000|Overall Study|Terminated by Sponsor|0
7383289|NCT01188772|11640339|FG001|Overall Study|Terminated by Sponsor|0
7383290|NCT01188772|11640340|FG002|Overall Study|Terminated by Sponsor|1
7383291|NCT01188772|11640341|FG003|Overall Study|Terminated by Sponsor|0
7383292|NCT01188772|11640338|FG000|Overall Study|Treatment Failure|0
7383293|NCT01188772|11640339|FG001|Overall Study|Treatment Failure|0
7383294|NCT01188772|11640340|FG002|Overall Study|Treatment Failure|1
7383295|NCT01188772|11640341|FG003|Overall Study|Treatment Failure|0
7383296|NCT01188772|11640338|FG000|Overall Study|Virologic Failure|1
7383297|NCT01188772|11640339|FG001|Overall Study|Virologic Failure|0
7383298|NCT01188772|11640340|FG002|Overall Study|Virologic Failure|0
7383299|NCT01188772|11640341|FG003|Overall Study|Virologic Failure|0
7383300|NCT01188772|11640338|FG000|Overall Study|Withdrawal by Subject|0
7383301|NCT01188772|11640339|FG001|Overall Study|Withdrawal by Subject|0
7383302|NCT01188772|11640340|FG002|Overall Study|Withdrawal by Subject|2
7383303|NCT01188772|11640341|FG003|Overall Study|Withdrawal by Subject|0
7383304|NCT01188811|11640356|FG000|Overall Study|Withdrawal by Subject|0
7383305|NCT01188811|11640357|FG001|Overall Study|Withdrawal by Subject|2
7383306|NCT01188811|11640356|FG000|Overall Study|Adverse Event|6
7383307|NCT01188811|11640357|FG001|Overall Study|Adverse Event|0
7383308|NCT01188967|11640386|FG000|Overall Study|Withdrawal by Subject|1
7383309|NCT01188967|11640387|FG001|Overall Study|Withdrawal by Subject|1
7383310|NCT01188967|11640386|FG000|Overall Study|Physician Decision|1
7383311|NCT01188967|11640387|FG001|Overall Study|Physician Decision|1
7383312|NCT01188967|11640386|FG000|Overall Study|Lost to Follow-up|3
7383313|NCT01188967|11640387|FG001|Overall Study|Lost to Follow-up|2
7383314|NCT01189032|11640398|FG000|Overall Study|Adverse Event|1
7383315|NCT01189032|11640399|FG001|Overall Study|Adverse Event|3
7383316|NCT01189032|11640400|FG002|Overall Study|Adverse Event|4
7383317|NCT01189032|11640398|FG000|Overall Study|Lack of Efficacy|2
7383318|NCT01189032|11640399|FG001|Overall Study|Lack of Efficacy|3
7383319|NCT01189032|11640400|FG002|Overall Study|Lack of Efficacy|0
7383320|NCT01189032|11640398|FG000|Overall Study|Withdrawal by Subject|1
7383321|NCT01189032|11640399|FG001|Overall Study|Withdrawal by Subject|0
7383322|NCT01189032|11640400|FG002|Overall Study|Withdrawal by Subject|1
7383323|NCT01189032|11640398|FG000|Overall Study|Protocol Violation|1
7383324|NCT01189032|11640399|FG001|Overall Study|Protocol Violation|1
7383325|NCT01189032|11640400|FG002|Overall Study|Protocol Violation|1
7383326|NCT01189201|11640435|FG000|Overall Study|Adverse Event|1
7383327|NCT01189266|11640465|FG000|Overall Study|Adverse Event|1
7383328|NCT01189266|11640466|FG001|Overall Study|Adverse Event|0
7383329|NCT01189266|11640467|FG002|Overall Study|Adverse Event|5
7383330|NCT01189266|11640465|FG000|Overall Study|Death|0
7383331|NCT01189266|11640466|FG001|Overall Study|Death|0
7383332|NCT01189266|11640467|FG002|Overall Study|Death|5
7383333|NCT01189266|11640465|FG000|Overall Study|Lack of Efficacy|4
7383334|NCT01189266|11640466|FG001|Overall Study|Lack of Efficacy|5
7383335|NCT01189266|11640467|FG002|Overall Study|Lack of Efficacy|44
7383336|NCT01189266|11640465|FG000|Overall Study|Physician Decision|0
7383337|NCT01189266|11640466|FG001|Overall Study|Physician Decision|0
7383338|NCT01189266|11640467|FG002|Overall Study|Physician Decision|1
7383339|NCT01189266|11640465|FG000|Overall Study|Protocol Violation|0
7383340|NCT01189266|11640466|FG001|Overall Study|Protocol Violation|1
7383341|NCT01189266|11640467|FG002|Overall Study|Protocol Violation|1
7383342|NCT01189266|11640465|FG000|Overall Study|Withdrawal by Subject|0
7383343|NCT01189266|11640466|FG001|Overall Study|Withdrawal by Subject|0
7383344|NCT01189266|11640467|FG002|Overall Study|Withdrawal by Subject|1
7383345|NCT01189266|11640465|FG000|Overall Study|Patient refuses further therapy|1
7383346|NCT01189266|11640466|FG001|Overall Study|Patient refuses further therapy|0
7383347|NCT01189266|11640467|FG002|Overall Study|Patient refuses further therapy|7
7383348|NCT01189266|11640465|FG000|Overall Study|No treatment|0
7383349|NCT01189266|11640466|FG001|Overall Study|No treatment|0
7383350|NCT01189266|11640467|FG002|Overall Study|No treatment|1
7383351|NCT01189461|11640523|FG000|Overall Study|Lack of Efficacy|13
7383352|NCT01189461|11640523|FG000|Overall Study|Lost to Follow-up|1
7383353|NCT01189461|11640523|FG000|Overall Study|Withdrawal by Subject|6
7383354|NCT01189461|11640523|FG000|Overall Study|Protocol Violation|1
7383355|NCT01189461|11640523|FG000|Overall Study|Adverse Event|2
7383356|NCT01189461|11640523|FG000|Overall Study|Did not meet entrance criteria|3
7383357|NCT01189461|11640523|FG000|Overall Study|Other|8
7383358|NCT01189487|11640527|FG000|Overall Study|Lack of Efficacy|2
7383359|NCT01189487|11640527|FG000|Overall Study|Adverse Event|1
7383360|NCT01189500|11640531|FG000|Period 1: TAMOX Alone|Adverse Event|1
7383361|NCT01189500|11640531|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
7383362|NCT01189604|11640545|FG000|Overall Study|Impossible to visit|0
7383363|NCT01189604|11640546|FG001|Overall Study|Impossible to visit|0
7383364|NCT01189604|11640547|FG002|Overall Study|Impossible to visit|0
7383365|NCT01189604|11640548|FG003|Overall Study|Impossible to visit|0
7383366|NCT01189604|11640549|FG004|Overall Study|Impossible to visit|0
7383367|NCT01189604|11640550|FG005|Overall Study|Impossible to visit|1
7383368|NCT01189604|11640551|FG006|Overall Study|Impossible to visit|0
7383369|NCT01189604|11640545|FG000|Overall Study|Adverse Event|0
7383370|NCT01189604|11640546|FG001|Overall Study|Adverse Event|1
7383371|NCT01189604|11640547|FG002|Overall Study|Adverse Event|0
7383372|NCT01189604|11640548|FG003|Overall Study|Adverse Event|0
7383373|NCT01189604|11640549|FG004|Overall Study|Adverse Event|2
7383374|NCT01189604|11640550|FG005|Overall Study|Adverse Event|0
7383375|NCT01189604|11640551|FG006|Overall Study|Adverse Event|1
7383376|NCT01189604|11640545|FG000|Overall Study|Withdrawal by Subject|1
7383377|NCT01189604|11640546|FG001|Overall Study|Withdrawal by Subject|0
7383378|NCT01189604|11640547|FG002|Overall Study|Withdrawal by Subject|0
7383379|NCT01189604|11640548|FG003|Overall Study|Withdrawal by Subject|0
7383380|NCT01189604|11640549|FG004|Overall Study|Withdrawal by Subject|0
7383381|NCT01189604|11640550|FG005|Overall Study|Withdrawal by Subject|0
7383382|NCT01189604|11640551|FG006|Overall Study|Withdrawal by Subject|0
7383383|NCT01189812|11640600|FG000|Overall Study|Withdrawal by Subject|2
7383384|NCT01189812|11640601|FG001|Overall Study|Withdrawal by Subject|3
7383385|NCT01189812|11640600|FG000|Overall Study|Adverse Event|1
7383386|NCT01189812|11640601|FG001|Overall Study|Adverse Event|0
7383387|NCT01189812|11640600|FG000|Overall Study|Out of Window|4
7383388|NCT01189812|11640601|FG001|Overall Study|Out of Window|3
7383389|NCT01189812|11640600|FG000|Overall Study|Moved out of State|1
7383390|NCT01189812|11640601|FG001|Overall Study|Moved out of State|2
7383391|NCT01189890|11640609|FG000|Overall Study|Adverse Event|3
7383392|NCT01189890|11640610|FG001|Overall Study|Adverse Event|4
7383393|NCT01189890|11640609|FG000|Overall Study|Lack of Efficacy|7
7383394|NCT01189890|11640610|FG001|Overall Study|Lack of Efficacy|2
7383395|NCT01189890|11640609|FG000|Overall Study|Lost to Follow-up|1
7383396|NCT01189890|11640610|FG001|Overall Study|Lost to Follow-up|7
7383397|NCT01189890|11640609|FG000|Overall Study|Protocol Violation|1
7383398|NCT01189890|11640610|FG001|Overall Study|Protocol Violation|5
7383399|NCT01189890|11640609|FG000|Overall Study|Withdrawal by Subject|15
7383400|NCT01189890|11640610|FG001|Overall Study|Withdrawal by Subject|11
7383401|NCT01189890|11640609|FG000|Overall Study|Non Compliance|0
7383402|NCT01189890|11640610|FG001|Overall Study|Non Compliance|1
7383403|NCT01189890|11640609|FG000|Overall Study|Physician Decision|5
7383404|NCT01189890|11640610|FG001|Overall Study|Physician Decision|4
7383405|NCT01189890|11640609|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
7383406|NCT01189890|11640610|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
7383407|NCT01190007|11640616|FG000|Overall Study|Withdrawal by Subject|4
7383408|NCT01190007|11640616|FG000|Overall Study|Adverse Event|8
7383409|NCT01190007|11640616|FG000|Overall Study|Difficulty of visit for complications|1
7383410|NCT01190007|11640616|FG000|Overall Study|Participant was arrested|1
7383411|NCT01190020|11640622|FG000|Overall Study|Adverse Event|2
7383412|NCT01190020|11640623|FG001|Overall Study|Adverse Event|0
7383413|NCT01190020|11640622|FG000|Overall Study|Lost to Follow-up|2
7383414|NCT01190020|11640623|FG001|Overall Study|Lost to Follow-up|0
7383415|NCT01190020|11640622|FG000|Overall Study|Withdrawal by Subject|3
7464847|NCT01874535|11763574|FG001|Overall Study|incomplete symptom resolution|35
7383416|NCT01190020|11640623|FG001|Overall Study|Withdrawal by Subject|0
7383417|NCT01190098|11640644|FG000|Overall Study|Adverse Event|2
7383418|NCT01190098|11640645|FG001|Overall Study|Adverse Event|0
7383419|NCT01190098|11640644|FG000|Overall Study|Patient coomorbidity|0
7383420|NCT01190098|11640645|FG001|Overall Study|Patient coomorbidity|1
7383421|NCT01190098|11640644|FG000|Overall Study|Lack of transportation|1
7572978|NCT03593876|11953745|FG000|Overall Study|Discharged home before intervention completion|2
7572979|NCT03594071|11953762|FG000|Overall Study|Re-operation|3
7572980|NCT03594071|11953762|FG000|Overall Study|Missed visit|2
7572981|NCT03594227|11953770|FG000|Overall Study|Adverse Event|2
7572982|NCT03594227|11953771|FG001|Overall Study|Adverse Event|1
7572983|NCT03594227|11953772|FG002|Overall Study|Adverse Event|0
7225567|NCT00068692|11435109|FG002|Step 1: Registration|Alternative therapy|0
7225568|NCT00068692|11435110|FG003|Step 1: Registration|Alternative therapy|0
7225569|NCT00068692|11435111|FG004|Step 1: Registration|Alternative therapy|0
7225570|NCT00068692|11435112|FG005|Step 1: Registration|Alternative therapy|0
7225571|NCT00068692|11435113|FG006|Step 1: Registration|Alternative therapy|0
7225572|NCT00068692|11435114|FG007|Step 1: Registration|Alternative therapy|0
7225573|NCT00068692|11435107|FG000|Step 1: Registration|Complicating disease|2
7225574|NCT00068692|11435108|FG001|Step 1: Registration|Complicating disease|0
7225575|NCT00068692|11435109|FG002|Step 1: Registration|Complicating disease|0
7225576|NCT00068692|11435110|FG003|Step 1: Registration|Complicating disease|0
7225577|NCT00068692|11435111|FG004|Step 1: Registration|Complicating disease|0
7225578|NCT00068692|11435112|FG005|Step 1: Registration|Complicating disease|0
7225579|NCT00068692|11435113|FG006|Step 1: Registration|Complicating disease|0
7225580|NCT00068692|11435114|FG007|Step 1: Registration|Complicating disease|0
7225581|NCT00068692|11435107|FG000|Step 1: Registration|Protocol Violation|1
7383422|NCT01190098|11640645|FG001|Overall Study|Lack of transportation|0
7383423|NCT01190098|11640644|FG000|Overall Study|Other|0
7383424|NCT01190098|11640645|FG001|Overall Study|Other|1
7383425|NCT01190124|11640654|FG000|Overall Study|Death|3
7383426|NCT01190124|11640655|FG001|Overall Study|Death|0
7383427|NCT01190124|11640656|FG002|Overall Study|Death|0
7383428|NCT01190124|11640654|FG000|Overall Study|Therapeutic Failure|12
7383429|NCT01190124|11640655|FG001|Overall Study|Therapeutic Failure|0
7383430|NCT01190124|11640656|FG002|Overall Study|Therapeutic Failure|1
7383431|NCT01190124|11640654|FG000|Overall Study|Lost to Follow-up|2
7383432|NCT01190124|11640655|FG001|Overall Study|Lost to Follow-up|0
7383433|NCT01190124|11640656|FG002|Overall Study|Lost to Follow-up|0
7383434|NCT01190150|11640669|FG000|First Treatment|Withdrawal by Subject|1
7383435|NCT01190150|11640670|FG001|First Treatment|Withdrawal by Subject|0
7383436|NCT01190150|11640669|FG000|Washout|Withdrawal by Subject|0
7383437|NCT01190150|11640670|FG001|Washout|Withdrawal by Subject|1
7383438|NCT01190150|11640669|FG000|Washout|Difficulty in adherence|0
7383439|NCT01190150|11640670|FG001|Washout|Difficulty in adherence|1
7383440|NCT01190176|11640676|FG000|Overall Study|Withdrawal by Subject|1
7383441|NCT01190176|11640676|FG000|Overall Study|Lost to Follow-up|1
7383442|NCT01190189|11640680|FG000|Overall Study|Lost to Follow-up|4
7383443|NCT01190189|11640680|FG000|Overall Study|Withdrawal by Subject|1
7383444|NCT01190189|11640680|FG000|Overall Study|Migrated/moved from study area|1
7383445|NCT01190215|11640686|FG000|Up to Month 6|Lost to Follow-up|2
7383446|NCT01190215|11640687|FG001|Up to Month 6|Lost to Follow-up|0
7383447|NCT01190410|11640695|FG000|Overall Study|Adverse Event|0
7383448|NCT01190410|11640696|FG001|Overall Study|Adverse Event|3
7383449|NCT01190410|11640695|FG000|Overall Study|Lack of Efficacy|0
7383450|NCT01190410|11640696|FG001|Overall Study|Lack of Efficacy|2
7572984|NCT03594227|11953773|FG003|Overall Study|Adverse Event|2
7572985|NCT03594227|11953770|FG000|Overall Study|Lost to Follow-up|1
7572986|NCT03594227|11953771|FG001|Overall Study|Lost to Follow-up|1
7572987|NCT03594227|11953772|FG002|Overall Study|Lost to Follow-up|1
7572988|NCT03594227|11953773|FG003|Overall Study|Lost to Follow-up|0
7572989|NCT03594227|11953770|FG000|Overall Study|Withdrawal by Subject|1
7572990|NCT03594227|11953771|FG001|Overall Study|Withdrawal by Subject|1
7572991|NCT03594227|11953772|FG002|Overall Study|Withdrawal by Subject|1
7572992|NCT03594227|11953773|FG003|Overall Study|Withdrawal by Subject|1
7572993|NCT03594227|11953770|FG000|Overall Study|Pregnancy|0
7383451|NCT01190410|11640695|FG000|Overall Study|Withdrawal by Subject|0
7383452|NCT01190410|11640696|FG001|Overall Study|Withdrawal by Subject|2
7383453|NCT01190410|11640695|FG000|Overall Study|Administrative decision|1
7383454|NCT01190410|11640696|FG001|Overall Study|Administrative decision|0
7383455|NCT01190410|11640695|FG000|Overall Study|PI discretion|0
7572994|NCT03594227|11953771|FG001|Overall Study|Pregnancy|1
7464848|NCT01874665|11763582|FG000|Overall Study|Adverse Event|6
7383456|NCT01190410|11640696|FG001|Overall Study|PI discretion|2
7383457|NCT01190436|11640708|FG000|Overall Study|Lost to Follow-up|35
7383458|NCT01190436|11640708|FG000|Overall Study|Other|4
7225582|NCT00068692|11435108|FG001|Step 1: Registration|Protocol Violation|0
7225583|NCT00068692|11435109|FG002|Step 1: Registration|Protocol Violation|0
7225584|NCT00068692|11435110|FG003|Step 1: Registration|Protocol Violation|0
7225585|NCT00068692|11435111|FG004|Step 1: Registration|Protocol Violation|0
7225586|NCT00068692|11435112|FG005|Step 1: Registration|Protocol Violation|0
7225587|NCT00068692|11435113|FG006|Step 1: Registration|Protocol Violation|0
7225588|NCT00068692|11435114|FG007|Step 1: Registration|Protocol Violation|0
7225589|NCT00068692|11435107|FG000|Step 1: Registration|Not eligible|6
7225590|NCT00068692|11435108|FG001|Step 1: Registration|Not eligible|0
7225591|NCT00068692|11435109|FG002|Step 1: Registration|Not eligible|0
7225592|NCT00068692|11435110|FG003|Step 1: Registration|Not eligible|0
7383459|NCT01190449|11640715|FG000|Overall Study|Ineligible|0
7225593|NCT00068692|11435111|FG004|Step 1: Registration|Not eligible|0
7383460|NCT01190449|11640716|FG001|Overall Study|Ineligible|4
7225594|NCT00068692|11435112|FG005|Step 1: Registration|Not eligible|0
7225595|NCT00068692|11435113|FG006|Step 1: Registration|Not eligible|0
7225596|NCT00068692|11435114|FG007|Step 1: Registration|Not eligible|0
7225597|NCT00068692|11435107|FG000|Step 1: Registration|Other|2
7225598|NCT00068692|11435108|FG001|Step 1: Registration|Other|0
7225599|NCT00068692|11435109|FG002|Step 1: Registration|Other|0
7225600|NCT00068692|11435110|FG003|Step 1: Registration|Other|0
7225601|NCT00068692|11435111|FG004|Step 1: Registration|Other|0
7225602|NCT00068692|11435112|FG005|Step 1: Registration|Other|0
7225603|NCT00068692|11435113|FG006|Step 1: Registration|Other|0
7225604|NCT00068692|11435114|FG007|Step 1: Registration|Other|0
7225605|NCT00068692|11435107|FG000|Step 1: Registration|Not start protocol therapy|3
7225606|NCT00068692|11435108|FG001|Step 1: Registration|Not start protocol therapy|0
7225607|NCT00068692|11435109|FG002|Step 1: Registration|Not start protocol therapy|0
7383461|NCT01190475|11640725|FG000|Overall Study|Withdrawal by Subject|0
7383462|NCT01190475|11640726|FG001|Overall Study|Withdrawal by Subject|0
7383463|NCT01190475|11640727|FG002|Overall Study|Withdrawal by Subject|1
7383464|NCT01190514|11640737|FG000|First Intervention (Period 1)|Adverse Event|1
7383465|NCT01190514|11640738|FG001|First Intervention (Period 1)|Adverse Event|0
7383466|NCT01190514|11640739|FG002|First Intervention (Period 1)|Adverse Event|0
7383467|NCT01190514|11640740|FG003|First Intervention (Period 1)|Adverse Event|0
7383468|NCT01190514|11640737|FG000|Third Intervention (Period 3)|Adverse Event|1
7383469|NCT01190514|11640738|FG001|Third Intervention (Period 3)|Adverse Event|0
7383470|NCT01190514|11640739|FG002|Third Intervention (Period 3)|Adverse Event|0
7383471|NCT01190514|11640740|FG003|Third Intervention (Period 3)|Adverse Event|0
7387494|NCT01214668|11646033|FG005|Overall Study|Death|0
7387495|NCT01214668|11646028|FG000|Overall Study|Progressive Disease|4
7387496|NCT01214668|11646029|FG001|Overall Study|Progressive Disease|2
7387497|NCT01214668|11646030|FG002|Overall Study|Progressive Disease|5
7387498|NCT01214668|11646031|FG003|Overall Study|Progressive Disease|4
7387499|NCT01214668|11646032|FG004|Overall Study|Progressive Disease|4
7387500|NCT01214668|11646033|FG005|Overall Study|Progressive Disease|5
7387501|NCT01214668|11646028|FG000|Overall Study|Withdrawal by Subject|0
7387502|NCT01214668|11646029|FG001|Overall Study|Withdrawal by Subject|0
7387503|NCT01214668|11646030|FG002|Overall Study|Withdrawal by Subject|0
7387504|NCT01214668|11646031|FG003|Overall Study|Withdrawal by Subject|0
7387505|NCT01214668|11646032|FG004|Overall Study|Withdrawal by Subject|1
7387506|NCT01214668|11646033|FG005|Overall Study|Withdrawal by Subject|0
7387507|NCT01214720|11646050|FG000|Overall Study|Alive and still on treatment|34
7387508|NCT01214720|11646051|FG001|Overall Study|Alive and still on treatment|18
7387509|NCT01214720|11646050|FG000|Overall Study|Alive and in follow-up|45
7383472|NCT01190813|11640766|FG000|Overall Study|Lost to Follow-up|1
7383473|NCT01190813|11640767|FG001|Overall Study|Lost to Follow-up|2
7383474|NCT01190813|11640766|FG000|Overall Study|Withdrawal by Subject|2
7383475|NCT01190813|11640767|FG001|Overall Study|Withdrawal by Subject|1
7383476|NCT01190813|11640766|FG000|Overall Study|Refused study treatment after randomized|1
7383477|NCT01190813|11640767|FG001|Overall Study|Refused study treatment after randomized|0
7383478|NCT01190813|11640766|FG000|Overall Study|Adverse Event|0
7383479|NCT01190813|11640767|FG001|Overall Study|Adverse Event|1
7383480|NCT01190839|11640775|FG000|Overall Study|Adverse Event|32
7383481|NCT01190839|11640776|FG001|Overall Study|Adverse Event|41
7383482|NCT01190839|11640775|FG000|Overall Study|Protocol Violation|2
7383483|NCT01190839|11640776|FG001|Overall Study|Protocol Violation|2
7383484|NCT01190839|11640775|FG000|Overall Study|Lost to Follow-up|7
7383485|NCT01190839|11640776|FG001|Overall Study|Lost to Follow-up|1
7383486|NCT01190839|11640775|FG000|Overall Study|Death|1
7383487|NCT01190839|11640776|FG001|Overall Study|Death|0
7383488|NCT01190839|11640775|FG000|Overall Study|Trial stopped by Sponsor|71
7383489|NCT01190839|11640776|FG001|Overall Study|Trial stopped by Sponsor|68
7383490|NCT01190839|11640775|FG000|Overall Study|Undefined|35
7383491|NCT01190839|11640776|FG001|Overall Study|Undefined|31
7383492|NCT01190839|11640775|FG000|Overall Study|Randomized but not treated|2
7383493|NCT01190839|11640776|FG001|Overall Study|Randomized but not treated|4
7383494|NCT01190865|11640784|FG000|Overall Study|Withdrawal by Subject|1
7383495|NCT01190865|11640784|FG000|Overall Study|Non-compliance|2
7383496|NCT01190891|11640807|FG000|Overall Study|Protocol Violation|1
7383497|NCT01190891|11640808|FG001|Overall Study|Protocol Violation|0
7383498|NCT01190891|11640807|FG000|Overall Study|Withdrawal by Subject|5
7383499|NCT01190891|11640808|FG001|Overall Study|Withdrawal by Subject|0
7572995|NCT03594227|11953772|FG002|Overall Study|Pregnancy|0
7572996|NCT03594227|11953773|FG003|Overall Study|Pregnancy|0
7572997|NCT03594227|11953770|FG000|Overall Study|Sponsor Decision|0
7572998|NCT03594227|11953771|FG001|Overall Study|Sponsor Decision|0
7572999|NCT03594227|11953772|FG002|Overall Study|Sponsor Decision|0
7573000|NCT03594227|11953773|FG003|Overall Study|Sponsor Decision|1
7225608|NCT00068692|11435110|FG003|Step 1: Registration|Not start protocol therapy|0
7225609|NCT00068692|11435111|FG004|Step 1: Registration|Not start protocol therapy|0
7225610|NCT00068692|11435112|FG005|Step 1: Registration|Not start protocol therapy|0
7225611|NCT00068692|11435113|FG006|Step 1: Registration|Not start protocol therapy|0
7225612|NCT00068692|11435114|FG007|Step 1: Registration|Not start protocol therapy|0
7225613|NCT00068692|11435107|FG000|Step 1: Registration|Registered but not randomized|0
7225614|NCT00068692|11435108|FG001|Step 1: Registration|Registered but not randomized|1
7225615|NCT00068692|11435109|FG002|Step 1: Registration|Registered but not randomized|0
7225616|NCT00068692|11435110|FG003|Step 1: Registration|Registered but not randomized|0
7225617|NCT00068692|11435111|FG004|Step 1: Registration|Registered but not randomized|0
7225618|NCT00068692|11435112|FG005|Step 1: Registration|Registered but not randomized|0
7225619|NCT00068692|11435113|FG006|Step 1: Registration|Registered but not randomized|0
7225620|NCT00068692|11435114|FG007|Step 1: Registration|Registered but not randomized|0
7225621|NCT00068692|11435107|FG000|Step 2: Randomization|Disesae progression/replase|0
7225622|NCT00068692|11435108|FG001|Step 2: Randomization|Disesae progression/replase|0
7225623|NCT00068692|11435109|FG002|Step 2: Randomization|Disesae progression/replase|1
7573001|NCT03594227|11953770|FG000|Overall Study|Programmatic Analysis Non-completer|1
7573002|NCT03594227|11953771|FG001|Overall Study|Programmatic Analysis Non-completer|0
7573003|NCT03594227|11953772|FG002|Overall Study|Programmatic Analysis Non-completer|1
7573004|NCT03594227|11953773|FG003|Overall Study|Programmatic Analysis Non-completer|1
7573005|NCT03595280|11953813|FG000|Overall Study|Lost to Follow-up|6
7573006|NCT03595280|11953814|FG001|Overall Study|Lost to Follow-up|9
7573007|NCT03595280|11953815|FG002|Overall Study|Lost to Follow-up|15
7573008|NCT03595618|11953845|FG000|Overall Study|Adverse Event|16
7573009|NCT03595618|11953846|FG001|Overall Study|Adverse Event|17
7573010|NCT03595618|11953847|FG002|Overall Study|Adverse Event|20
7573011|NCT03595618|11953848|FG003|Overall Study|Adverse Event|8
7573012|NCT03595618|11953845|FG000|Overall Study|Withdrawal by Subject|12
7573013|NCT03595618|11953846|FG001|Overall Study|Withdrawal by Subject|14
7573014|NCT03595618|11953847|FG002|Overall Study|Withdrawal by Subject|14
7573015|NCT03595618|11953848|FG003|Overall Study|Withdrawal by Subject|10
7573016|NCT03595618|11953845|FG000|Overall Study|Lost to Follow-up|6
7573017|NCT03595618|11953846|FG001|Overall Study|Lost to Follow-up|4
7573018|NCT03595618|11953847|FG002|Overall Study|Lost to Follow-up|5
7573019|NCT03595618|11953848|FG003|Overall Study|Lost to Follow-up|6
7256769|NCT00325468|11468504|FG004|Overall Study|Physician Decision|0
7573020|NCT03595618|11953845|FG000|Overall Study|Protocol Violation|2
7464849|NCT01874665|11763583|FG001|Overall Study|Adverse Event|2
7573021|NCT03595618|11953846|FG001|Overall Study|Protocol Violation|0
7573022|NCT03595618|11953847|FG002|Overall Study|Protocol Violation|6
7573023|NCT03595618|11953848|FG003|Overall Study|Protocol Violation|2
7573024|NCT03595618|11953845|FG000|Overall Study|Physician Decision|0
7573025|NCT03595618|11953846|FG001|Overall Study|Physician Decision|0
7573026|NCT03595618|11953847|FG002|Overall Study|Physician Decision|1
7573027|NCT03595618|11953848|FG003|Overall Study|Physician Decision|2
7573028|NCT03595618|11953845|FG000|Overall Study|Miscellaneous|7
7573029|NCT03595618|11953846|FG001|Overall Study|Miscellaneous|5
7573030|NCT03595618|11953847|FG002|Overall Study|Miscellaneous|10
7573031|NCT03595618|11953848|FG003|Overall Study|Miscellaneous|6
7573032|NCT03595904|11953860|FG000|Overall Study|Protocol Violation|3
7573033|NCT03595904|11953861|FG001|Overall Study|Protocol Violation|1
7573034|NCT03595904|11953860|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
7573035|NCT03595904|11953861|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
7573036|NCT03595904|11953860|FG000|Overall Study|Insurance complications|1
7573037|NCT03595904|11953861|FG001|Overall Study|Insurance complications|0
7573038|NCT03595904|11953860|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
7573039|NCT03595904|11953861|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
7573040|NCT03596151|11953867|FG000|Overall Study|Withdrawal by Subject|1
7573041|NCT03596177|11953873|FG000|Single Blind Period|Withdrawal by Subject|1
7573042|NCT03596177|11953874|FG001|Single Blind Period|Withdrawal by Subject|1
7573043|NCT03596177|11953873|FG000|Single Blind Period|Other|1
7573044|NCT03596177|11953874|FG001|Single Blind Period|Other|0
7573045|NCT03596177|11953873|FG000|Double Blind Period|Withdrawal by Subject|0
7573046|NCT03596177|11953874|FG001|Double Blind Period|Withdrawal by Subject|1
7573047|NCT03596177|11953873|FG000|Double Blind Period|Other|0
7573048|NCT03596177|11953874|FG001|Double Blind Period|Other|4
7573049|NCT03596177|11953873|FG000|Double Blind Period|Death during safety follow-up|0
7573050|NCT03596177|11953874|FG001|Double Blind Period|Death during safety follow-up|1
7573051|NCT03597022|11953896|FG000|Overall Study|Premature termination of the study|7
7573052|NCT03597022|11953897|FG001|Overall Study|Premature termination of the study|7
7573053|NCT03597022|11953898|FG002|Overall Study|Premature termination of the study|8
7573054|NCT03597022|11953896|FG000|Overall Study|Serious adverse event|1
7573055|NCT03597022|11953897|FG001|Overall Study|Serious adverse event|1
7573056|NCT03597022|11953898|FG002|Overall Study|Serious adverse event|0
7573057|NCT03597061|11953908|FG000|Overall Study|Lost to Follow-up|1
7573058|NCT03597061|11953909|FG001|Overall Study|Lost to Follow-up|0
7573059|NCT03597061|11953908|FG000|Overall Study|Protocol Violation|0
7573060|NCT03597061|11953909|FG001|Overall Study|Protocol Violation|1
7573061|NCT03597139|11953917|FG000|Overall Study|Adverse Event|3
7573062|NCT03597139|11953918|FG001|Overall Study|Adverse Event|0
7573063|NCT03597139|11953917|FG000|Overall Study|Protocol Non-compliance|1
7573064|NCT03597139|11953918|FG001|Overall Study|Protocol Non-compliance|0
7573065|NCT03597347|11953931|FG000|Overall Study|Withdrawal by Subject|1
7573066|NCT03597347|11953932|FG001|Overall Study|Withdrawal by Subject|1
7573067|NCT03597347|11953933|FG002|Overall Study|Withdrawal by Subject|0
7573068|NCT03597347|11953931|FG000|Overall Study|Withdrawal due to Covid-19|3
7573069|NCT03597347|11953932|FG001|Overall Study|Withdrawal due to Covid-19|0
7573070|NCT03597347|11953933|FG002|Overall Study|Withdrawal due to Covid-19|0
7573071|NCT03597347|11953931|FG000|Overall Study|Sponsor decision to terminate study|3
7573072|NCT03597347|11953932|FG001|Overall Study|Sponsor decision to terminate study|2
7573073|NCT03597347|11953933|FG002|Overall Study|Sponsor decision to terminate study|4
7573074|NCT03597529|11953943|FG000|Overall Study|Lost to Follow-up|10
7573075|NCT03597529|11953944|FG001|Overall Study|Lost to Follow-up|12
7573076|NCT03597529|11953943|FG000|Overall Study|Physician Decision|3
7573077|NCT03597529|11953944|FG001|Overall Study|Physician Decision|1
7573078|NCT03597529|11953943|FG000|Overall Study|Withdrawal by Subject|6
7573079|NCT03597529|11953944|FG001|Overall Study|Withdrawal by Subject|3
7573080|NCT03597529|11953943|FG000|Overall Study|Non-compliant with study activities|1
7573081|NCT03597529|11953944|FG001|Overall Study|Non-compliant with study activities|2
7573082|NCT03599089|11953973|FG000|Overall Study|Lost to Follow-up|1
7573083|NCT03599089|11953974|FG001|Overall Study|Lost to Follow-up|0
7573084|NCT03599089|11953975|FG002|Overall Study|Lost to Follow-up|0
7573085|NCT03599089|11953976|FG003|Overall Study|Lost to Follow-up|0
7573086|NCT03599089|11953973|FG000|Overall Study|Withdrawal by Subject|2
7573087|NCT03599089|11953974|FG001|Overall Study|Withdrawal by Subject|1
7573088|NCT03599089|11953975|FG002|Overall Study|Withdrawal by Subject|0
7573089|NCT03599089|11953976|FG003|Overall Study|Withdrawal by Subject|0
7573090|NCT03599089|11953973|FG000|Overall Study|Lack of Efficacy|0
7573091|NCT03599089|11953974|FG001|Overall Study|Lack of Efficacy|0
7573092|NCT03599089|11953975|FG002|Overall Study|Lack of Efficacy|1
7573093|NCT03599089|11953976|FG003|Overall Study|Lack of Efficacy|2
7573094|NCT03599193|11953988|FG000|Overall Study|Adverse Event|0
7573095|NCT03599193|11953989|FG001|Overall Study|Adverse Event|2
7573096|NCT03599193|11953988|FG000|Overall Study|Withdrawal by Subject|1
7573097|NCT03599193|11953989|FG001|Overall Study|Withdrawal by Subject|0
7573098|NCT03599193|11953988|FG000|Overall Study|Protocol Violation|1
7573099|NCT03599193|11953989|FG001|Overall Study|Protocol Violation|0
7573100|NCT03599193|11953988|FG000|Overall Study|Lost to Follow-up|0
7573101|NCT03599193|11953989|FG001|Overall Study|Lost to Follow-up|1
7573102|NCT03599349|11954007|FG000|Overall Study|Lost to Follow-up|1
7573103|NCT03599362|11954011|FG000|Overall Study|Screen Failure|3
7573104|NCT03600376|11954044|FG000|Overall Study|Adverse Event|1
7573105|NCT03600376|11954045|FG001|Overall Study|Adverse Event|1
7573106|NCT03600376|11954044|FG000|Overall Study|Transferred to other facility|1
7573107|NCT03600376|11954045|FG001|Overall Study|Transferred to other facility|0
7573108|NCT03600376|11954044|FG000|Overall Study|Investigator Decision|0
7573109|NCT03600376|11954045|FG001|Overall Study|Investigator Decision|4
7573110|NCT03600376|11954044|FG000|Overall Study|Determined to be ineligible for study|0
7573111|NCT03600376|11954045|FG001|Overall Study|Determined to be ineligible for study|1
7573112|NCT03600428|11954053|FG000|Overall Study|Not eligible|0
7573113|NCT03600428|11954054|FG001|Overall Study|Not eligible|1
7573114|NCT03600428|11954053|FG000|Overall Study|Lost to Follow-up|5
7573115|NCT03600428|11954054|FG001|Overall Study|Lost to Follow-up|4
7573116|NCT03601052|11954060|FG000|Overall Study|Lost to Follow-up|2
7573117|NCT03601715|11954072|FG000|Second Intervention|Lost to Follow-up|1
7573118|NCT03601715|11954073|FG001|Second Intervention|Lost to Follow-up|1
7573119|NCT03601715|11954074|FG002|Second Intervention|Lost to Follow-up|0
7573120|NCT03602053|11954085|FG000|Overall Study|Withdrawal by Subject|7
7573121|NCT03602053|11954086|FG001|Overall Study|Withdrawal by Subject|9
7573122|NCT03602053|11954087|FG002|Overall Study|Withdrawal by Subject|7
7573123|NCT03602053|11954085|FG000|Overall Study|Lost to Follow-up|5
7573124|NCT03602053|11954086|FG001|Overall Study|Lost to Follow-up|6
7573125|NCT03602053|11954087|FG002|Overall Study|Lost to Follow-up|0
7573126|NCT03602053|11954085|FG000|Overall Study|Protocol Violation|3
7573127|NCT03602053|11954086|FG001|Overall Study|Protocol Violation|0
7573128|NCT03602053|11954087|FG002|Overall Study|Protocol Violation|4
7573129|NCT03602053|11954085|FG000|Overall Study|Physician Decision|1
7573130|NCT03602053|11954086|FG001|Overall Study|Physician Decision|0
7573131|NCT03602053|11954087|FG002|Overall Study|Physician Decision|0
7573132|NCT03602053|11954085|FG000|Overall Study|migration|2
7573133|NCT03602053|11954086|FG001|Overall Study|migration|3
7573134|NCT03602053|11954087|FG002|Overall Study|migration|0
7573135|NCT03602053|11954085|FG000|Overall Study|Other|1
7573136|NCT03602053|11954086|FG001|Overall Study|Other|0
7573137|NCT03602053|11954087|FG002|Overall Study|Other|0
7573138|NCT03602339|11954099|FG000|Overall Study|Withdrawal by Subject|9
7573139|NCT03602339|11954099|FG000|Overall Study|Physician Decision|2
7573140|NCT03602339|11954099|FG000|Overall Study|Other reason|4
7573141|NCT03602482|11954108|FG000|Overall Study|Withdrawal by Subject|6
7573142|NCT03602482|11954109|FG001|Overall Study|Withdrawal by Subject|7
7573143|NCT03602482|11954110|FG002|Overall Study|Withdrawal by Subject|0
7573144|NCT03602482|11954111|FG003|Overall Study|Withdrawal by Subject|0
7573145|NCT03603028|11954124|FG000|Overall Study|Withdrawal by Subject|1
7573146|NCT03603652|11954182|FG000|Overall Study|Death|2
7573147|NCT03604341|11954192|FG000|Overall Study|Withdrawal by Subject|1
7573148|NCT03604341|11954193|FG001|Overall Study|Withdrawal by Subject|1
7573149|NCT03604341|11954192|FG000|Overall Study|Adverse Event|1
7573150|NCT03604341|11954193|FG001|Overall Study|Adverse Event|0
7573151|NCT03604341|11954192|FG000|Overall Study|Protocol Violation|0
7573152|NCT03604341|11954193|FG001|Overall Study|Protocol Violation|1
7573153|NCT03604497|11954199|FG000|Overall Study|Protocol Violation|52
7573154|NCT03604523|11954209|FG000|Overall Study|Physician Decision|1
7573155|NCT03604523|11954210|FG001|Overall Study|Physician Decision|0
7573156|NCT03605212|11954233|FG000|Treatment Period|Adverse Event|1
7573157|NCT03605212|11954234|FG001|Treatment Period|Adverse Event|0
7573158|NCT03605212|11954235|FG002|Treatment Period|Adverse Event|0
7573159|NCT03605212|11954236|FG003|Treatment Period|Adverse Event|0
7573160|NCT03605212|11954237|FG004|Treatment Period|Adverse Event|0
7573161|NCT03605212|11954233|FG000|Treatment Period|Physician Decision|0
7573162|NCT03605212|11954234|FG001|Treatment Period|Physician Decision|0
7573163|NCT03605212|11954235|FG002|Treatment Period|Physician Decision|0
7573164|NCT03605212|11954236|FG003|Treatment Period|Physician Decision|0
7573165|NCT03605212|11954237|FG004|Treatment Period|Physician Decision|1
7573166|NCT03605693|11954252|FG000|Overall Study|Lost to Follow-up|4
7573167|NCT03605693|11954253|FG001|Overall Study|Lost to Follow-up|0
7573168|NCT03605693|11954252|FG000|Overall Study|Physician Decision|1
7573169|NCT03605693|11954253|FG001|Overall Study|Physician Decision|0
7573170|NCT03605745|11954259|FG000|Overall Study|Study was terminated for business reasons|47
7573171|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
7573172|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7573173|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7573174|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
7573175|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
7573176|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7573177|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7573178|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
7573179|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
7573180|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7573181|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7573182|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
7573183|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
7573184|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7573185|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7573186|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
7573187|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
7464850|NCT01874665|11763582|FG000|Overall Study|Withdrawal by Subject|4
7573188|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7573189|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7573190|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
7573191|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
7573192|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7573193|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7573194|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
7464851|NCT01874665|11763583|FG001|Overall Study|Withdrawal by Subject|1
7464852|NCT01874665|11763582|FG000|Overall Study|Physician Decision|3
7464853|NCT01874665|11763583|FG001|Overall Study|Physician Decision|0
7225624|NCT00068692|11435110|FG003|Step 2: Randomization|Disesae progression/replase|1
7225625|NCT00068692|11435111|FG004|Step 2: Randomization|Disesae progression/replase|0
7225626|NCT00068692|11435112|FG005|Step 2: Randomization|Disesae progression/replase|0
7225627|NCT00068692|11435113|FG006|Step 2: Randomization|Disesae progression/replase|0
7225628|NCT00068692|11435114|FG007|Step 2: Randomization|Disesae progression/replase|0
7225629|NCT00068692|11435107|FG000|Step 2: Randomization|Adverse Event|0
7225630|NCT00068692|11435108|FG001|Step 2: Randomization|Adverse Event|0
7225631|NCT00068692|11435109|FG002|Step 2: Randomization|Adverse Event|4
7225632|NCT00068692|11435110|FG003|Step 2: Randomization|Adverse Event|2
7225633|NCT00068692|11435111|FG004|Step 2: Randomization|Adverse Event|2
7225634|NCT00068692|11435112|FG005|Step 2: Randomization|Adverse Event|3
7225635|NCT00068692|11435113|FG006|Step 2: Randomization|Adverse Event|4
7225636|NCT00068692|11435114|FG007|Step 2: Randomization|Adverse Event|4
7225637|NCT00068692|11435107|FG000|Step 2: Randomization|Death|0
7225638|NCT00068692|11435108|FG001|Step 2: Randomization|Death|0
7225639|NCT00068692|11435109|FG002|Step 2: Randomization|Death|0
7225640|NCT00068692|11435110|FG003|Step 2: Randomization|Death|0
7225641|NCT00068692|11435111|FG004|Step 2: Randomization|Death|1
7225642|NCT00068692|11435112|FG005|Step 2: Randomization|Death|0
7225643|NCT00068692|11435113|FG006|Step 2: Randomization|Death|0
7225644|NCT00068692|11435114|FG007|Step 2: Randomization|Death|1
7225645|NCT00068692|11435107|FG000|Step 2: Randomization|Withdrawal by Subject|0
7225646|NCT00068692|11435108|FG001|Step 2: Randomization|Withdrawal by Subject|0
7225647|NCT00068692|11435109|FG002|Step 2: Randomization|Withdrawal by Subject|4
7225648|NCT00068692|11435110|FG003|Step 2: Randomization|Withdrawal by Subject|6
7225649|NCT00068692|11435111|FG004|Step 2: Randomization|Withdrawal by Subject|3
7225650|NCT00068692|11435112|FG005|Step 2: Randomization|Withdrawal by Subject|2
7225651|NCT00068692|11435113|FG006|Step 2: Randomization|Withdrawal by Subject|0
7225652|NCT00068692|11435114|FG007|Step 2: Randomization|Withdrawal by Subject|3
7225653|NCT00068692|11435107|FG000|Step 2: Randomization|alternative therapy|0
7225654|NCT00068692|11435108|FG001|Step 2: Randomization|alternative therapy|0
7225655|NCT00068692|11435109|FG002|Step 2: Randomization|alternative therapy|0
7225656|NCT00068692|11435110|FG003|Step 2: Randomization|alternative therapy|1
7225657|NCT00068692|11435111|FG004|Step 2: Randomization|alternative therapy|1
7225658|NCT00068692|11435112|FG005|Step 2: Randomization|alternative therapy|0
7225659|NCT00068692|11435113|FG006|Step 2: Randomization|alternative therapy|0
7225660|NCT00068692|11435114|FG007|Step 2: Randomization|alternative therapy|0
7225661|NCT00068692|11435107|FG000|Step 2: Randomization|Physician Decision|0
7225662|NCT00068692|11435108|FG001|Step 2: Randomization|Physician Decision|0
7225663|NCT00068692|11435109|FG002|Step 2: Randomization|Physician Decision|0
7225664|NCT00068692|11435110|FG003|Step 2: Randomization|Physician Decision|1
7225665|NCT00068692|11435111|FG004|Step 2: Randomization|Physician Decision|1
7225666|NCT00068692|11435112|FG005|Step 2: Randomization|Physician Decision|0
7225667|NCT00068692|11435113|FG006|Step 2: Randomization|Physician Decision|0
7225668|NCT00068692|11435114|FG007|Step 2: Randomization|Physician Decision|0
7225669|NCT00068692|11435107|FG000|Step 2: Randomization|Other|0
7225670|NCT00068692|11435108|FG001|Step 2: Randomization|Other|0
7225671|NCT00068692|11435109|FG002|Step 2: Randomization|Other|0
7225672|NCT00068692|11435110|FG003|Step 2: Randomization|Other|1
7225673|NCT00068692|11435111|FG004|Step 2: Randomization|Other|0
7225674|NCT00068692|11435112|FG005|Step 2: Randomization|Other|1
7225675|NCT00068692|11435113|FG006|Step 2: Randomization|Other|0
7225676|NCT00068692|11435114|FG007|Step 2: Randomization|Other|0
7225677|NCT00068692|11435107|FG000|Step 2: Randomization|never start protocol therapy|0
7225678|NCT00068692|11435108|FG001|Step 2: Randomization|never start protocol therapy|0
7225679|NCT00068692|11435109|FG002|Step 2: Randomization|never start protocol therapy|1
7225680|NCT00068692|11435110|FG003|Step 2: Randomization|never start protocol therapy|0
7225681|NCT00068692|11435111|FG004|Step 2: Randomization|never start protocol therapy|1
7225682|NCT00068692|11435112|FG005|Step 2: Randomization|never start protocol therapy|0
7225683|NCT00068692|11435113|FG006|Step 2: Randomization|never start protocol therapy|0
7573195|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
7573196|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7573197|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7573198|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
7573199|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
7225684|NCT00068692|11435114|FG007|Step 2: Randomization|never start protocol therapy|0
7573200|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7573201|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7573202|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
7256770|NCT00325468|11468500|FG000|Overall Study|Withdrawal by Subject|3
7573203|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
7573204|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7573205|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7225685|NCT00068822|11435144|FG000|First Randomized Intervention|Lost to Follow-up|1
7225686|NCT00068822|11435145|FG001|First Randomized Intervention|Lost to Follow-up|2
7225687|NCT00069095|11435157|FG000|Primary Treatment Phase|Ongoing|0
7225688|NCT00069095|11435158|FG001|Primary Treatment Phase|Ongoing|0
7225689|NCT00069095|11435159|FG002|Primary Treatment Phase|Ongoing|5
7225690|NCT00069095|11435160|FG003|Primary Treatment Phase|Ongoing|7
7225691|NCT00069095|11435161|FG004|Primary Treatment Phase|Ongoing|7
7225692|NCT00069095|11435162|FG005|Primary Treatment Phase|Ongoing|4
7225693|NCT00069095|11435157|FG000|Primary Treatment Phase|Admin/Other|29
7225694|NCT00069095|11435158|FG001|Primary Treatment Phase|Admin/Other|38
7225695|NCT00069095|11435159|FG002|Primary Treatment Phase|Admin/Other|31
7225696|NCT00069095|11435160|FG003|Primary Treatment Phase|Admin/Other|45
7225697|NCT00069095|11435161|FG004|Primary Treatment Phase|Admin/Other|48
7225698|NCT00069095|11435162|FG005|Primary Treatment Phase|Admin/Other|42
7225699|NCT00069095|11435157|FG000|Primary Treatment Phase|Adverse Event|99
7225700|NCT00069095|11435158|FG001|Primary Treatment Phase|Adverse Event|92
7225701|NCT00069095|11435159|FG002|Primary Treatment Phase|Adverse Event|71
7225702|NCT00069095|11435160|FG003|Primary Treatment Phase|Adverse Event|72
7225703|NCT00069095|11435161|FG004|Primary Treatment Phase|Adverse Event|109
7225704|NCT00069095|11435162|FG005|Primary Treatment Phase|Adverse Event|101
7225705|NCT00069095|11435157|FG000|Primary Treatment Phase|Death|14
7225706|NCT00069095|11435158|FG001|Primary Treatment Phase|Death|8
7225707|NCT00069095|11435159|FG002|Primary Treatment Phase|Death|2
7225708|NCT00069095|11435160|FG003|Primary Treatment Phase|Death|5
7225709|NCT00069095|11435161|FG004|Primary Treatment Phase|Death|8
7225710|NCT00069095|11435162|FG005|Primary Treatment Phase|Death|8
7225711|NCT00069095|11435157|FG000|Primary Treatment Phase|Failure to return|5
7225712|NCT00069095|11435158|FG001|Primary Treatment Phase|Failure to return|5
7225713|NCT00069095|11435159|FG002|Primary Treatment Phase|Failure to return|0
7225714|NCT00069095|11435160|FG003|Primary Treatment Phase|Failure to return|0
7225715|NCT00069095|11435161|FG004|Primary Treatment Phase|Failure to return|0
7225716|NCT00069095|11435162|FG005|Primary Treatment Phase|Failure to return|2
7225717|NCT00069095|11435157|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
7225718|NCT00069095|11435158|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
7225719|NCT00069095|11435159|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
7225720|NCT00069095|11435160|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
7225721|NCT00069095|11435161|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
7225722|NCT00069095|11435162|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
7225723|NCT00069095|11435157|FG000|Primary Treatment Phase|Refused treatment|15
7225724|NCT00069095|11435158|FG001|Primary Treatment Phase|Refused treatment|26
7225725|NCT00069095|11435159|FG002|Primary Treatment Phase|Refused treatment|17
7225726|NCT00069095|11435160|FG003|Primary Treatment Phase|Refused treatment|31
7225727|NCT00069095|11435161|FG004|Primary Treatment Phase|Refused treatment|24
7225728|NCT00069095|11435162|FG005|Primary Treatment Phase|Refused treatment|27
7225729|NCT00069095|11435157|FG000|Primary Treatment Phase|Withdrew|2
7225730|NCT00069095|11435158|FG001|Primary Treatment Phase|Withdrew|3
7225731|NCT00069095|11435159|FG002|Primary Treatment Phase|Withdrew|8
7225732|NCT00069095|11435160|FG003|Primary Treatment Phase|Withdrew|2
7225733|NCT00069095|11435161|FG004|Primary Treatment Phase|Withdrew|4
7225734|NCT00069095|11435162|FG005|Primary Treatment Phase|Withdrew|9
7225735|NCT00069095|11435157|FG000|Primary Treatment Phase|Other Violation|0
7225736|NCT00069095|11435158|FG001|Primary Treatment Phase|Other Violation|1
7225737|NCT00069095|11435159|FG002|Primary Treatment Phase|Other Violation|1
7225738|NCT00069095|11435160|FG003|Primary Treatment Phase|Other Violation|1
7225739|NCT00069095|11435161|FG004|Primary Treatment Phase|Other Violation|0
7573206|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
7573207|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
7573208|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7225740|NCT00069095|11435162|FG005|Primary Treatment Phase|Other Violation|1
7225741|NCT00069095|11435157|FG000|Primary Treatment Phase|Violation criteria|0
7225742|NCT00069095|11435158|FG001|Primary Treatment Phase|Violation criteria|2
7225743|NCT00069095|11435159|FG002|Primary Treatment Phase|Violation criteria|4
7225744|NCT00069095|11435160|FG003|Primary Treatment Phase|Violation criteria|3
7225745|NCT00069095|11435161|FG004|Primary Treatment Phase|Violation criteria|1
7225746|NCT00069095|11435162|FG005|Primary Treatment Phase|Violation criteria|5
7225747|NCT00069095|11435157|FG000|Post-study Treatment Phase|Missing reason|1
7225748|NCT00069095|11435158|FG001|Post-study Treatment Phase|Missing reason|3
7225749|NCT00069095|11435159|FG002|Post-study Treatment Phase|Missing reason|12
7225750|NCT00069095|11435160|FG003|Post-study Treatment Phase|Missing reason|8
7225751|NCT00069095|11435161|FG004|Post-study Treatment Phase|Missing reason|18
7225752|NCT00069095|11435162|FG005|Post-study Treatment Phase|Missing reason|17
7225753|NCT00069095|11435157|FG000|Post-study Treatment Phase|Adverse Event|2
7225754|NCT00069095|11435158|FG001|Post-study Treatment Phase|Adverse Event|3
7225755|NCT00069095|11435159|FG002|Post-study Treatment Phase|Adverse Event|1
7225756|NCT00069095|11435160|FG003|Post-study Treatment Phase|Adverse Event|0
7225757|NCT00069095|11435161|FG004|Post-study Treatment Phase|Adverse Event|5
7225758|NCT00069095|11435162|FG005|Post-study Treatment Phase|Adverse Event|1
7225759|NCT00069095|11435157|FG000|Post-study Treatment Phase|Eligible for surgery|2
7225760|NCT00069095|11435158|FG001|Post-study Treatment Phase|Eligible for surgery|0
7225761|NCT00069095|11435159|FG002|Post-study Treatment Phase|Eligible for surgery|0
7225762|NCT00069095|11435160|FG003|Post-study Treatment Phase|Eligible for surgery|0
7225763|NCT00069095|11435161|FG004|Post-study Treatment Phase|Eligible for surgery|0
7225764|NCT00069095|11435162|FG005|Post-study Treatment Phase|Eligible for surgery|0
7225765|NCT00069095|11435157|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
7225766|NCT00069095|11435158|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
7225767|NCT00069095|11435159|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
7225768|NCT00069095|11435160|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
7225769|NCT00069095|11435161|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
7225770|NCT00069095|11435162|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
7225771|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7225772|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7225773|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7225774|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7225775|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
7225776|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
7225777|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant had complete response|1
7225778|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant had complete response|1
7225779|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant had complete response|0
7225780|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant had complete response|0
7225781|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant had complete response|0
7225782|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant had complete response|0
7225783|NCT00069095|11435157|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
7225784|NCT00069095|11435158|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
7225785|NCT00069095|11435159|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
7225786|NCT00069095|11435160|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
7225787|NCT00069095|11435161|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
7225788|NCT00069095|11435162|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
7225789|NCT00069095|11435157|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7225790|NCT00069095|11435158|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7225791|NCT00069095|11435159|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7225792|NCT00069095|11435160|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7225793|NCT00069095|11435161|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
7225794|NCT00069095|11435162|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
7225795|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant withdrew consent|0
7225796|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant withdrew consent|0
7225797|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant withdrew consent|1
7225798|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant withdrew consent|0
7225799|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant withdrew consent|0
7225800|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant withdrew consent|0
7225801|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant will start new treatment|0
7225802|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant will start new treatment|0
7225803|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant will start new treatment|1
7225804|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant will start new treatment|0
7225805|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant will start new treatment|0
7225806|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant will start new treatment|0
7225807|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
7225808|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
7256771|NCT00325468|11468501|FG001|Overall Study|Withdrawal by Subject|1
7225809|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
7225810|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
7225811|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
7225812|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
7225813|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant completed treatment|0
7225814|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant completed treatment|0
7225815|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant completed treatment|0
7225816|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant completed treatment|1
7225817|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant completed treatment|0
7225818|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant completed treatment|0
7225819|NCT00069095|11435157|FG000|Post-study Treatment Phase|Surgery|0
7225820|NCT00069095|11435158|FG001|Post-study Treatment Phase|Surgery|0
7225821|NCT00069095|11435159|FG002|Post-study Treatment Phase|Surgery|0
7225822|NCT00069095|11435160|FG003|Post-study Treatment Phase|Surgery|1
7225823|NCT00069095|11435161|FG004|Post-study Treatment Phase|Surgery|1
7225824|NCT00069095|11435162|FG005|Post-study Treatment Phase|Surgery|0
7225825|NCT00069095|11435157|FG000|Post-study Treatment Phase|Death|0
7225826|NCT00069095|11435158|FG001|Post-study Treatment Phase|Death|0
7225827|NCT00069095|11435159|FG002|Post-study Treatment Phase|Death|0
7225828|NCT00069095|11435160|FG003|Post-study Treatment Phase|Death|0
7225829|NCT00069095|11435161|FG004|Post-study Treatment Phase|Death|1
7225830|NCT00069095|11435162|FG005|Post-study Treatment Phase|Death|0
7225831|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant had progressive disease|0
7225832|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant had progressive disease|0
7225833|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant had progressive disease|0
7225834|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant had progressive disease|0
7225835|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant had progressive disease|1
7225836|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant had progressive disease|0
7225837|NCT00069095|11435157|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
7225838|NCT00069095|11435158|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
7225839|NCT00069095|11435159|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
7225840|NCT00069095|11435160|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
7225841|NCT00069095|11435161|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
7225842|NCT00069095|11435162|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
7225843|NCT00069095|11435157|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7225844|NCT00069095|11435158|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7225845|NCT00069095|11435159|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7225846|NCT00069095|11435160|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7225847|NCT00069095|11435161|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
7225848|NCT00069095|11435162|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
7225849|NCT00069095|11435157|FG000|Post-study Treatment Phase|Investigator decision|0
7225850|NCT00069095|11435158|FG001|Post-study Treatment Phase|Investigator decision|0
7225851|NCT00069095|11435159|FG002|Post-study Treatment Phase|Investigator decision|0
7225852|NCT00069095|11435160|FG003|Post-study Treatment Phase|Investigator decision|0
7225853|NCT00069095|11435161|FG004|Post-study Treatment Phase|Investigator decision|0
7225854|NCT00069095|11435162|FG005|Post-study Treatment Phase|Investigator decision|1
7225855|NCT00069095|11435157|FG000|Follow-up Phase|Death|174
7225856|NCT00069095|11435158|FG001|Follow-up Phase|Death|206
7225857|NCT00069095|11435159|FG002|Follow-up Phase|Death|120
7225858|NCT00069095|11435160|FG003|Follow-up Phase|Death|112
7225859|NCT00069095|11435161|FG004|Follow-up Phase|Death|92
7225860|NCT00069095|11435162|FG005|Follow-up Phase|Death|101
7225861|NCT00069108|11435176|FG000|Overall Study|Withdrawal by Subject|5
7225862|NCT00069108|11435177|FG001|Overall Study|Withdrawal by Subject|9
7225863|NCT00069108|11435176|FG000|Overall Study|Adverse Event|64
7225864|NCT00069108|11435177|FG001|Overall Study|Adverse Event|42
7225865|NCT00069108|11435176|FG000|Overall Study|Death|6
7225866|NCT00069108|11435177|FG001|Overall Study|Death|6
7225867|NCT00069108|11435176|FG000|Overall Study|Administration|15
7225868|NCT00069108|11435177|FG001|Overall Study|Administration|4
7225869|NCT00069108|11435176|FG000|Overall Study|Insufficient therapy|117
7225870|NCT00069108|11435177|FG001|Overall Study|Insufficient therapy|144
7225871|NCT00069108|11435176|FG000|Overall Study|Violation criteria|1
7225872|NCT00069108|11435177|FG001|Overall Study|Violation criteria|4
7225873|NCT00069108|11435176|FG000|Overall Study|Refused treatment|5
7225874|NCT00069108|11435177|FG001|Overall Study|Refused treatment|10
7225875|NCT00069121|11435186|FG000|Overall Study|Death|286
7225876|NCT00069121|11435187|FG001|Overall Study|Death|242
7225877|NCT00069121|11435186|FG000|Overall Study|Withdrawal by Subject|18
7225878|NCT00069121|11435187|FG001|Overall Study|Withdrawal by Subject|20
7225879|NCT00069121|11435186|FG000|Overall Study|Lost to Follow-up|63
7225880|NCT00069121|11435187|FG001|Overall Study|Lost to Follow-up|63
7225881|NCT00069264|11435209|FG000|Overall Study|Adverse Event|3
7225882|NCT00069264|11435209|FG000|Overall Study|Progressive Disease|23
7225883|NCT00069264|11435209|FG000|Overall Study|Withdrawal by Subject|3
7225884|NCT00069264|11435209|FG000|Overall Study|Discon Therapy|3
7225885|NCT00069277|11435213|FG000|Overall Study|Adverse Event|3
7225886|NCT00069277|11435213|FG000|Overall Study|Withdrawal by Subject|1
7225887|NCT00069277|11435213|FG000|Overall Study|Progressive Disease|15
7225888|NCT00069277|11435213|FG000|Overall Study|Physician Decision|2
7225889|NCT00069576|11435223|FG000|Original Trial|Lost to Follow-up|25
7225890|NCT00069576|11435224|FG001|Original Trial|Lost to Follow-up|33
7225891|NCT00069576|11435223|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
7225892|NCT00069576|11435224|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
7225893|NCT00069641|11435233|FG000|Overall Study|Death|1
7225894|NCT00069641|11435234|FG001|Overall Study|Death|0
7225895|NCT00069641|11435235|FG002|Overall Study|Death|1
7225896|NCT00069784|11435246|FG000|Overall Study|Adverse Event|105
7225897|NCT00069784|11435247|FG001|Overall Study|Adverse Event|0
7225898|NCT00069784|11435246|FG000|Overall Study|Withdrawal by Subject|1090
7225899|NCT00069784|11435247|FG001|Overall Study|Withdrawal by Subject|0
7225900|NCT00069784|11435246|FG000|Overall Study|Other|17
7225901|NCT00069784|11435247|FG001|Overall Study|Other|0
7225902|NCT00069823|11435255|FG000|Overall Study|Did not have follow-up diary cards|6
7225903|NCT00069823|11435256|FG001|Overall Study|Did not have follow-up diary cards|3
7225904|NCT00069953|11435262|FG000|Overall Study|Protocol Violation|2
7225905|NCT00070109|11435288|FG000|Overall Study|Death|1
7225906|NCT00070109|11435289|FG001|Overall Study|Death|1
7225907|NCT00070109|11435290|FG002|Overall Study|Death|0
7225908|NCT00070109|11435291|FG003|Overall Study|Death|0
7225909|NCT00070109|11435292|FG004|Overall Study|Death|1
7225910|NCT00070109|11435288|FG000|Overall Study|Lack of Efficacy|6
7225911|NCT00070109|11435289|FG001|Overall Study|Lack of Efficacy|4
7225912|NCT00070109|11435290|FG002|Overall Study|Lack of Efficacy|5
7225913|NCT00070109|11435291|FG003|Overall Study|Lack of Efficacy|15
7225914|NCT00070109|11435292|FG004|Overall Study|Lack of Efficacy|5
7225915|NCT00070109|11435288|FG000|Overall Study|Physician Decision|1
7225916|NCT00070109|11435289|FG001|Overall Study|Physician Decision|0
7573209|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7225917|NCT00070109|11435290|FG002|Overall Study|Physician Decision|0
7225918|NCT00070109|11435291|FG003|Overall Study|Physician Decision|0
7225919|NCT00070109|11435292|FG004|Overall Study|Physician Decision|0
7225920|NCT00070109|11435288|FG000|Overall Study|Withdrawal by Subject|0
7225921|NCT00070109|11435289|FG001|Overall Study|Withdrawal by Subject|1
7225922|NCT00070109|11435290|FG002|Overall Study|Withdrawal by Subject|1
7225923|NCT00070109|11435291|FG003|Overall Study|Withdrawal by Subject|0
7225924|NCT00070109|11435292|FG004|Overall Study|Withdrawal by Subject|0
7225925|NCT00070109|11435288|FG000|Overall Study|Adverse Event|0
7225926|NCT00070109|11435289|FG001|Overall Study|Adverse Event|0
7225927|NCT00070109|11435290|FG002|Overall Study|Adverse Event|2
7225928|NCT00070109|11435291|FG003|Overall Study|Adverse Event|4
7225929|NCT00070109|11435292|FG004|Overall Study|Adverse Event|2
7225930|NCT00070109|11435288|FG000|Overall Study|removed from prot thpy prior to chemo|0
7225931|NCT00070109|11435289|FG001|Overall Study|removed from prot thpy prior to chemo|0
7225932|NCT00070109|11435290|FG002|Overall Study|removed from prot thpy prior to chemo|0
7225933|NCT00070109|11435291|FG003|Overall Study|removed from prot thpy prior to chemo|1
7225934|NCT00070109|11435292|FG004|Overall Study|removed from prot thpy prior to chemo|0
7225935|NCT00070291|11435315|FG000|Step 1|Withdrawal by Subject|1
7225936|NCT00070291|11435315|FG000|Step 1|Adverse Event|1
7225937|NCT00070291|11435315|FG000|Step 2|Adverse Event|1
7225938|NCT00070317|11435319|FG000|Overall Study|Inevaluable (Never Treated)|1
7225939|NCT00070317|11435319|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
7225940|NCT00070317|11435319|FG000|Overall Study|Ineligible required test not done|1
7225941|NCT00070317|11435319|FG000|Overall Study|Ineligible-Improper prior treatment|2
7225942|NCT00070317|11435319|FG000|Overall Study|Ineligible-Inadequate pathology|6
7225943|NCT00070941|11435326|FG000|Overall Study|Adverse Event|10
7225944|NCT00070941|11435327|FG001|Overall Study|Adverse Event|8
7225945|NCT00070941|11435328|FG002|Overall Study|Adverse Event|4
7225946|NCT00071006|11435336|FG000|Overall Study|Lack of Efficacy|7
7225947|NCT00071006|11435336|FG000|Overall Study|Adverse Event|1
7225948|NCT00071006|11435336|FG000|Overall Study|Withdrawal by Subject|1
7225949|NCT00071006|11435336|FG000|Overall Study|Other|3
7225950|NCT00071032|11435342|FG000|Overall Study|Lost to Follow-up|1
7225951|NCT00071032|11435343|FG001|Overall Study|Lost to Follow-up|1
7225952|NCT00071032|11435342|FG000|Overall Study|Withdrawal by Subject|8
7225953|NCT00071032|11435343|FG001|Overall Study|Withdrawal by Subject|6
7225954|NCT00071032|11435342|FG000|Overall Study|Missing Primary Outcome|0
7225955|NCT00071032|11435343|FG001|Overall Study|Missing Primary Outcome|1
7225956|NCT00071058|11435350|FG000|Overall Study|brain tumor-removed from study|1
7225957|NCT00071110|11435357|FG000|Overall Study|Protocol Violation|0
7225958|NCT00071110|11435358|FG001|Overall Study|Protocol Violation|4
7225959|NCT00071396|11435364|FG000|Overall Study|Withdrawal by Subject|1
7225960|NCT00071396|11435364|FG000|Overall Study|Physician Decision|2
7225961|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Adverse Event|5
7225962|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Adverse Event|8
7225963|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Adverse Event|4
7225964|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Adverse Event|8
7225965|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
7225966|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
7225967|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
7225968|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
7225969|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
7225970|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
7225971|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
7225972|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
7225973|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Physician Decision|1
7225974|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Physician Decision|0
7225975|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Physician Decision|0
7225976|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Physician Decision|0
7225977|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
7225978|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
7225979|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
7225980|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
7225981|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Pregnancy|0
7225982|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Pregnancy|1
7225983|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Pregnancy|0
7225984|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Pregnancy|0
7225985|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Protocol Violation|0
7225986|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Protocol Violation|1
7225987|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Protocol Violation|1
7225988|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Protocol Violation|0
7225989|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Death|0
7225990|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Death|1
7225991|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Death|0
7225992|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Death|0
7225993|NCT00071487|11435372|FG000|52-Week Double-Blind Period|Lack of Compliance|6
7225994|NCT00071487|11435373|FG001|52-Week Double-Blind Period|Lack of Compliance|3
7225995|NCT00071487|11435374|FG002|52-Week Double-Blind Period|Lack of Compliance|3
7225996|NCT00071487|11435375|FG003|52-Week Double-Blind Period|Lack of Compliance|3
7225997|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Adverse Event|0
7225998|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Adverse Event|0
7225999|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Adverse Event|1
7226000|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Adverse Event|6
7226001|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226002|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226003|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226004|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
7226005|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226006|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226007|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226008|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
7226009|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Pregnancy|0
7226010|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Pregnancy|0
7226011|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Pregnancy|0
7226012|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Pregnancy|1
7226013|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226014|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226015|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226016|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
7226017|NCT00071487|11435372|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
7226018|NCT00071487|11435373|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
7226019|NCT00071487|11435374|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
7226020|NCT00071487|11435375|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
7226021|NCT00071513|11435389|FG000|Intervention Component|Withdrawal by Subject|2
7226022|NCT00071513|11435390|FG001|Intervention Component|Withdrawal by Subject|3
7226023|NCT00071513|11435389|FG000|Follow-up Assessment|Withdrawal by Subject|6
7226024|NCT00071513|11435390|FG001|Follow-up Assessment|Withdrawal by Subject|6
7226025|NCT00071760|11435407|FG000|Overall Study|Adverse Event|3
7226026|NCT00071760|11435407|FG000|Overall Study|Lost to Follow-up|4
7226027|NCT00071760|11435407|FG000|Overall Study|Protocol Violation|1
7226028|NCT00071760|11435407|FG000|Overall Study|Withdrawal by Subject|3
7226029|NCT00071760|11435407|FG000|Overall Study|Insufficient Viral Load Response|3
7226030|NCT00071760|11435407|FG000|Overall Study|Pulmonary Tuberculosis|1
7226031|NCT00071760|11435407|FG000|Overall Study|Unavailability of RTV|8
7226032|NCT00071760|11435407|FG000|Overall Study|Relocation|1
7226033|NCT00071760|11435407|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
7226034|NCT00071760|11435407|FG000|Overall Study|Study Team Rec./Resistance|1
7226035|NCT00071760|11435407|FG000|Overall Study|Ongoing|25
7226036|NCT00071799|11435419|FG000|Overall Study|Adverse Event|19
7226037|NCT00071799|11435420|FG001|Overall Study|Adverse Event|10
7226038|NCT00071799|11435419|FG000|Overall Study|Protocol Violation|1
7226039|NCT00071799|11435420|FG001|Overall Study|Protocol Violation|7
7226040|NCT00071799|11435419|FG000|Overall Study|Lost to Follow-up|1
7226041|NCT00071799|11435420|FG001|Overall Study|Lost to Follow-up|1
7226042|NCT00071799|11435419|FG000|Overall Study|Withdrawal by Subject|15
7226043|NCT00071799|11435420|FG001|Overall Study|Withdrawal by Subject|37
7226044|NCT00071799|11435419|FG000|Overall Study|Physician Decision|0
7226045|NCT00071799|11435420|FG001|Overall Study|Physician Decision|2
7226046|NCT00071799|11435419|FG000|Overall Study|Lack of Efficacy|11
7226047|NCT00071799|11435420|FG001|Overall Study|Lack of Efficacy|18
7226048|NCT00071799|11435419|FG000|Overall Study|Disease Progression|23
7226049|NCT00071799|11435420|FG001|Overall Study|Disease Progression|20
7226050|NCT00071799|11435419|FG000|Overall Study|Different Central+Local Pathology Review|0
7226051|NCT00071799|11435420|FG001|Overall Study|Different Central+Local Pathology Review|1
7226052|NCT00071799|11435419|FG000|Overall Study|Not Documented|0
7226053|NCT00071799|11435420|FG001|Overall Study|Not Documented|2
7226054|NCT00071812|11435436|FG000|24-Week Double-Blind Period|Adverse Event|2
7226055|NCT00071812|11435437|FG001|24-Week Double-Blind Period|Adverse Event|3
7226056|NCT00071812|11435438|FG002|24-Week Double-Blind Period|Adverse Event|4
7226057|NCT00071812|11435439|FG003|24-Week Double-Blind Period|Adverse Event|4
7226058|NCT00071812|11435436|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
7226059|NCT00071812|11435437|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
7226060|NCT00071812|11435438|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
7226061|NCT00071812|11435439|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
7226062|NCT00071812|11435436|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
7573210|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
7573211|NCT03605836|11954267|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
7226063|NCT00071812|11435437|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
7226064|NCT00071812|11435438|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
7226065|NCT00071812|11435439|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
7226066|NCT00071812|11435436|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
7226067|NCT00071812|11435437|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
7226068|NCT00071812|11435438|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
7226069|NCT00071812|11435439|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
7226070|NCT00071812|11435436|FG000|24-Week Double-Blind Period|Protocol Violation|0
7226071|NCT00071812|11435437|FG001|24-Week Double-Blind Period|Protocol Violation|0
7226072|NCT00071812|11435438|FG002|24-Week Double-Blind Period|Protocol Violation|0
7226073|NCT00071812|11435439|FG003|24-Week Double-Blind Period|Protocol Violation|1
7226074|NCT00071812|11435436|FG000|24-Week Open-Label Extension Period|Adverse Event|0
7226075|NCT00071812|11435437|FG001|24-Week Open-Label Extension Period|Adverse Event|0
7226076|NCT00071812|11435438|FG002|24-Week Open-Label Extension Period|Adverse Event|0
7226077|NCT00071812|11435439|FG003|24-Week Open-Label Extension Period|Adverse Event|7
7226078|NCT00071812|11435436|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226079|NCT00071812|11435437|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226080|NCT00071812|11435438|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
7226081|NCT00071812|11435439|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
7226082|NCT00071812|11435436|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226083|NCT00071812|11435437|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226084|NCT00071812|11435438|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
7226085|NCT00071812|11435439|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
7226086|NCT00071812|11435436|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226087|NCT00071812|11435437|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226088|NCT00071812|11435438|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
7226089|NCT00071812|11435439|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
7226090|NCT00071812|11435436|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
7226091|NCT00071812|11435437|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
7226092|NCT00071812|11435438|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
7226093|NCT00071812|11435439|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
7226094|NCT00071981|11435464|FG000|Overall Study|Lack of Efficacy|37
7226095|NCT00071981|11435465|FG001|Overall Study|Lack of Efficacy|29
7226096|NCT00071981|11435466|FG002|Overall Study|Lack of Efficacy|30
7226097|NCT00071981|11435467|FG003|Overall Study|Lack of Efficacy|43
7226098|NCT00071981|11435464|FG000|Overall Study|Adverse Event|4
7226099|NCT00071981|11435465|FG001|Overall Study|Adverse Event|4
7226100|NCT00071981|11435466|FG002|Overall Study|Adverse Event|3
7226101|NCT00071981|11435467|FG003|Overall Study|Adverse Event|1
7226102|NCT00071981|11435464|FG000|Overall Study|Death|0
7226103|NCT00071981|11435465|FG001|Overall Study|Death|0
7226104|NCT00071981|11435466|FG002|Overall Study|Death|1
7226105|NCT00071981|11435467|FG003|Overall Study|Death|1
7226106|NCT00071981|11435464|FG000|Overall Study|Withdrawal by Subject|3
7226107|NCT00071981|11435465|FG001|Overall Study|Withdrawal by Subject|1
7226108|NCT00071981|11435466|FG002|Overall Study|Withdrawal by Subject|0
7226109|NCT00071981|11435467|FG003|Overall Study|Withdrawal by Subject|0
7226110|NCT00071981|11435464|FG000|Overall Study|No protocol therapy|2
7226111|NCT00071981|11435465|FG001|Overall Study|No protocol therapy|5
7226112|NCT00071981|11435466|FG002|Overall Study|No protocol therapy|1
7226113|NCT00071981|11435467|FG003|Overall Study|No protocol therapy|0
7226114|NCT00071981|11435464|FG000|Overall Study|others (not specified in the study)|0
7226115|NCT00071981|11435465|FG001|Overall Study|others (not specified in the study)|2
7226116|NCT00071981|11435466|FG002|Overall Study|others (not specified in the study)|2
7226117|NCT00071981|11435467|FG003|Overall Study|others (not specified in the study)|0
7226118|NCT00072176|11435479|FG000|Overall Study|Withdrawal by Subject|1
7226119|NCT00072176|11435480|FG001|Overall Study|Withdrawal by Subject|0
7226120|NCT00072176|11435479|FG000|Overall Study|Protocol Violation|0
7226121|NCT00072176|11435480|FG001|Overall Study|Protocol Violation|1
7226122|NCT00072189|11435486|FG000|Overall Study|Withdrawal by Subject|1
7226123|NCT00072280|11435492|FG000|Treatment|Found ineligible|1
7226124|NCT00072280|11435493|FG001|Treatment|Found ineligible|2
7226125|NCT00072280|11435492|FG000|Follow-up|Early termination of study|2
7226126|NCT00072280|11435493|FG001|Follow-up|Early termination of study|2
7226127|NCT00072293|11435500|FG000|Overall Study|Lost to Follow-up|1
7226128|NCT00072293|11435501|FG001|Overall Study|Lost to Follow-up|1
7226129|NCT00072293|11435500|FG000|Overall Study|Withdrawal by Subject|0
7226130|NCT00072293|11435501|FG001|Overall Study|Withdrawal by Subject|1
7226131|NCT00072384|11435507|FG000|Overall Study|Physician Decision|1
7226132|NCT00072384|11435507|FG000|Overall Study|Ineligible|8
7226133|NCT00072475|11435517|FG000|Overall Study|Adverse Event|44
7226134|NCT00072475|11435517|FG000|Overall Study|Death|3
7226135|NCT00072475|11435517|FG000|Overall Study|Withdrawal by Subject|46
7226136|NCT00072475|11435517|FG000|Overall Study|Patient/Investigator Decision|4
7226137|NCT00073008|11435540|FG000|Overall Study|Missing|6
7226138|NCT00073008|11435541|FG001|Overall Study|Missing|6
7226139|NCT00073008|11435540|FG000|Overall Study|Withdrawal by Subject|2
7226140|NCT00073008|11435541|FG001|Overall Study|Withdrawal by Subject|2
7226141|NCT00073008|11435540|FG000|Overall Study|Lost to Follow-up|1
7226142|NCT00073008|11435541|FG001|Overall Study|Lost to Follow-up|3
7226143|NCT00073008|11435540|FG000|Overall Study|Death|46
7226144|NCT00073008|11435541|FG001|Overall Study|Death|47
7226145|NCT00073008|11435540|FG000|Overall Study|"Other selected on Case Report Form"|7
7226146|NCT00073008|11435541|FG001|Overall Study|"Other selected on Case Report Form"|5
7226147|NCT00073021|11435549|FG000|Overall Study|Protocol Violation|2
7226148|NCT00073021|11435550|FG001|Overall Study|Protocol Violation|1
7226149|NCT00073021|11435549|FG000|Overall Study|Adverse Event|4
7226150|NCT00073021|11435550|FG001|Overall Study|Adverse Event|4
7226151|NCT00073021|11435549|FG000|Overall Study|Withdrawal by Subject|6
7226152|NCT00073021|11435550|FG001|Overall Study|Withdrawal by Subject|5
7226153|NCT00073021|11435549|FG000|Overall Study|Physician Decision|3
7226154|NCT00073021|11435550|FG001|Overall Study|Physician Decision|1
7226155|NCT00073021|11435549|FG000|Overall Study|Lack of Efficacy|11
7226156|NCT00073021|11435550|FG001|Overall Study|Lack of Efficacy|5
7226157|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
7226158|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
7226159|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
7226160|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
7226161|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
7226162|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
7226163|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
7226164|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
7226165|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
7226166|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7226167|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
7226168|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
7226169|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
7226170|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
7226171|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
7226172|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
7226173|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7226174|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
7226175|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7226176|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
7226177|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
7226178|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
7226179|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
7226180|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
7226181|NCT00073307|11435562|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7226182|NCT00073307|11435563|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
7226183|NCT00073307|11435564|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
7226184|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
7226185|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
7226186|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
7226187|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7226188|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
7226189|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
7226190|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
7226191|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
7226192|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
7226193|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
7226194|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
7226195|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
7226196|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7226197|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
7226198|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
7226199|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7226200|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
7226201|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
7226202|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7226203|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
7226204|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
7226205|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
7226206|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
7226207|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
7226208|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
7226209|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
7226210|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
7226211|NCT00073307|11435562|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
7226212|NCT00073307|11435563|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
7226213|NCT00073307|11435564|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
7226214|NCT00073528|11435588|FG000|Overall Study|Death|488
7226215|NCT00073528|11435589|FG001|Overall Study|Death|473
7226216|NCT00073528|11435588|FG000|Overall Study|Lost to Follow-up|52
7226217|NCT00073528|11435589|FG001|Overall Study|Lost to Follow-up|45
7226218|NCT00073528|11435588|FG000|Overall Study|Withdrawal by Subject|50
7226219|NCT00073528|11435589|FG001|Overall Study|Withdrawal by Subject|45
7226220|NCT00073528|11435588|FG000|Overall Study|Study terminated by Sponsor|10
7226221|NCT00073528|11435589|FG001|Overall Study|Study terminated by Sponsor|29
7226222|NCT00073528|11435588|FG000|Overall Study|Other|18
7573212|NCT03605836|11954268|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7573213|NCT03605836|11954269|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7573214|NCT03605836|11954270|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
7226302|NCT00074282|11435670|FG001|Step 1|Disease progression|0
7573215|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
7573216|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
7573217|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7226223|NCT00073528|11435589|FG001|Overall Study|Other|19
7226224|NCT00073528|11435588|FG000|Overall Study|Other|9
7226225|NCT00073528|11435589|FG001|Overall Study|Other|12
7226226|NCT00073528|11435588|FG000|Overall Study|Protocol Violation|3
7226227|NCT00073528|11435589|FG001|Overall Study|Protocol Violation|5
7226228|NCT00073749|11435602|FG000|Overall Study|Disease Progression|2
7226229|NCT00073749|11435603|FG001|Overall Study|Disease Progression|0
7226230|NCT00073749|11435604|FG002|Overall Study|Disease Progression|3
7226231|NCT00073749|11435605|FG003|Overall Study|Disease Progression|2
7226232|NCT00073749|11435606|FG004|Overall Study|Disease Progression|3
7226233|NCT00073749|11435607|FG005|Overall Study|Disease Progression|1
7226234|NCT00073749|11435608|FG006|Overall Study|Disease Progression|3
7226235|NCT00073749|11435602|FG000|Overall Study|Death|0
7226236|NCT00073749|11435603|FG001|Overall Study|Death|1
7226237|NCT00073749|11435604|FG002|Overall Study|Death|1
7226238|NCT00073749|11435605|FG003|Overall Study|Death|0
7226239|NCT00073749|11435606|FG004|Overall Study|Death|0
7226240|NCT00073749|11435607|FG005|Overall Study|Death|0
7226241|NCT00073749|11435608|FG006|Overall Study|Death|29
7226242|NCT00073749|11435602|FG000|Overall Study|Adverse Event|0
7226243|NCT00073749|11435603|FG001|Overall Study|Adverse Event|3
7226244|NCT00073749|11435604|FG002|Overall Study|Adverse Event|6
7226245|NCT00073749|11435605|FG003|Overall Study|Adverse Event|4
7226246|NCT00073749|11435606|FG004|Overall Study|Adverse Event|2
7226247|NCT00073749|11435607|FG005|Overall Study|Adverse Event|1
7226248|NCT00073749|11435608|FG006|Overall Study|Adverse Event|0
7226249|NCT00073749|11435602|FG000|Overall Study|Physician Decision|0
7226250|NCT00073749|11435603|FG001|Overall Study|Physician Decision|0
7226251|NCT00073749|11435604|FG002|Overall Study|Physician Decision|1
7226252|NCT00073749|11435605|FG003|Overall Study|Physician Decision|0
7226253|NCT00073749|11435606|FG004|Overall Study|Physician Decision|0
7226254|NCT00073749|11435607|FG005|Overall Study|Physician Decision|2
7226255|NCT00073749|11435608|FG006|Overall Study|Physician Decision|0
7226256|NCT00073749|11435602|FG000|Overall Study|Withdrawal by Subject|0
7226257|NCT00073749|11435603|FG001|Overall Study|Withdrawal by Subject|1
7226258|NCT00073749|11435604|FG002|Overall Study|Withdrawal by Subject|0
7226259|NCT00073749|11435605|FG003|Overall Study|Withdrawal by Subject|0
7226260|NCT00073749|11435606|FG004|Overall Study|Withdrawal by Subject|1
7226261|NCT00073749|11435607|FG005|Overall Study|Withdrawal by Subject|0
7226262|NCT00073749|11435608|FG006|Overall Study|Withdrawal by Subject|2
7226263|NCT00073749|11435602|FG000|Overall Study|Discontinuation of Study by Sponsor|0
7226264|NCT00073749|11435603|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7226265|NCT00073749|11435604|FG002|Overall Study|Discontinuation of Study by Sponsor|0
7226266|NCT00073749|11435605|FG003|Overall Study|Discontinuation of Study by Sponsor|0
7226267|NCT00073749|11435606|FG004|Overall Study|Discontinuation of Study by Sponsor|0
7226268|NCT00073749|11435607|FG005|Overall Study|Discontinuation of Study by Sponsor|0
7226269|NCT00073749|11435608|FG006|Overall Study|Discontinuation of Study by Sponsor|4
7226270|NCT00073749|11435602|FG000|Overall Study|Lost to Follow-up|0
7226271|NCT00073749|11435603|FG001|Overall Study|Lost to Follow-up|0
7226272|NCT00073749|11435604|FG002|Overall Study|Lost to Follow-up|0
7226273|NCT00073749|11435605|FG003|Overall Study|Lost to Follow-up|0
7226274|NCT00073749|11435606|FG004|Overall Study|Lost to Follow-up|0
7226275|NCT00073749|11435607|FG005|Overall Study|Lost to Follow-up|0
7226276|NCT00073749|11435608|FG006|Overall Study|Lost to Follow-up|2
7226277|NCT00073749|11435602|FG000|Overall Study|Other|0
7226278|NCT00073749|11435603|FG001|Overall Study|Other|0
7573218|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
7573219|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7573220|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
7226279|NCT00073749|11435604|FG002|Overall Study|Other|0
7226280|NCT00073749|11435605|FG003|Overall Study|Other|0
7226281|NCT00073749|11435606|FG004|Overall Study|Other|0
7226282|NCT00073749|11435607|FG005|Overall Study|Other|2
7226283|NCT00073749|11435608|FG006|Overall Study|Other|0
7226284|NCT00073918|11435627|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
7226285|NCT00073918|11435627|FG000|Overall Study|Rapid disease progression|2
7226286|NCT00073918|11435627|FG000|Overall Study|Eligibility requirement not met-low CD20|1
7226287|NCT00073983|11435637|FG000|Overall Study|not evaluable|1
7226288|NCT00074152|11435649|FG000|Overall Study|Death|21
7226289|NCT00074152|11435650|FG001|Overall Study|Death|9
7226290|NCT00074152|11435649|FG000|Overall Study|Lack of Efficacy|34
7226291|NCT00074152|11435650|FG001|Overall Study|Lack of Efficacy|24
7226292|NCT00074282|11435669|FG000|Step 1|Adverse Event|32
7226293|NCT00074282|11435670|FG001|Step 1|Adverse Event|0
7226294|NCT00074282|11435671|FG002|Step 1|Adverse Event|0
7226295|NCT00074282|11435669|FG000|Step 1|Death|6
7226296|NCT00074282|11435670|FG001|Step 1|Death|0
7226297|NCT00074282|11435671|FG002|Step 1|Death|0
7226298|NCT00074282|11435669|FG000|Step 1|Withdrawal by Subject|7
7226299|NCT00074282|11435670|FG001|Step 1|Withdrawal by Subject|0
7226300|NCT00074282|11435671|FG002|Step 1|Withdrawal by Subject|0
7226301|NCT00074282|11435669|FG000|Step 1|Disease progression|2
7226303|NCT00074282|11435671|FG002|Step 1|Disease progression|0
7226304|NCT00074282|11435669|FG000|Step 1|Alternative therapy|2
7226305|NCT00074282|11435670|FG001|Step 1|Alternative therapy|0
7226306|NCT00074282|11435671|FG002|Step 1|Alternative therapy|0
7226307|NCT00074282|11435669|FG000|Step 1|Other complicating disease|2
7226308|NCT00074282|11435670|FG001|Step 1|Other complicating disease|0
7226309|NCT00074282|11435671|FG002|Step 1|Other complicating disease|0
7226310|NCT00074282|11435669|FG000|Step 1|Physician Decision|1
7226311|NCT00074282|11435670|FG001|Step 1|Physician Decision|0
7226312|NCT00074282|11435671|FG002|Step 1|Physician Decision|0
7226313|NCT00074282|11435669|FG000|Step 1|Ineligible|4
7226314|NCT00074282|11435670|FG001|Step 1|Ineligible|0
7226315|NCT00074282|11435671|FG002|Step 1|Ineligible|0
7226316|NCT00074282|11435669|FG000|Step 1|Never started treatment|2
7226317|NCT00074282|11435670|FG001|Step 1|Never started treatment|0
7226318|NCT00074282|11435671|FG002|Step 1|Never started treatment|0
7226319|NCT00074282|11435669|FG000|Step 2|Adverse Event|0
7226320|NCT00074282|11435670|FG001|Step 2|Adverse Event|2
7226321|NCT00074282|11435671|FG002|Step 2|Adverse Event|12
7226322|NCT00074282|11435669|FG000|Step 2|Disease progression|0
7226323|NCT00074282|11435670|FG001|Step 2|Disease progression|0
7226324|NCT00074282|11435671|FG002|Step 2|Disease progression|5
7226325|NCT00074282|11435669|FG000|Step 2|Death|0
7226326|NCT00074282|11435670|FG001|Step 2|Death|0
7226327|NCT00074282|11435671|FG002|Step 2|Death|3
7226328|NCT00074282|11435669|FG000|Step 2|Withdrawal by Subject|0
7226329|NCT00074282|11435670|FG001|Step 2|Withdrawal by Subject|0
7226330|NCT00074282|11435671|FG002|Step 2|Withdrawal by Subject|2
7226331|NCT00074282|11435669|FG000|Step 2|Physician Decision|0
7226332|NCT00074282|11435670|FG001|Step 2|Physician Decision|0
7226333|NCT00074282|11435671|FG002|Step 2|Physician Decision|1
7226334|NCT00074282|11435669|FG000|Step 2|Ineligible|0
7226335|NCT00074282|11435670|FG001|Step 2|Ineligible|0
7226336|NCT00074282|11435671|FG002|Step 2|Ineligible|1
7226341|NCT00074490|11435710|FG000|Overall Study|Progressive malignancy|0
7226342|NCT00074490|11435711|FG001|Overall Study|Progressive malignancy|7
7226343|NCT00074490|11435712|FG002|Overall Study|Progressive malignancy|0
7226344|NCT00074490|11435713|FG003|Overall Study|Progressive malignancy|0
7226345|NCT00074490|11435714|FG004|Overall Study|Progressive malignancy|3
7226346|NCT00074490|11435715|FG005|Overall Study|Progressive malignancy|0
7226347|NCT00074581|11435730|FG000|Overall Study|Death|15
7226348|NCT00074581|11435731|FG001|Overall Study|Death|16
7226349|NCT00074581|11435730|FG000|Overall Study|Withdrawal by Subject|50
7226350|NCT00074581|11435731|FG001|Overall Study|Withdrawal by Subject|49
7226351|NCT00074581|11435730|FG000|Overall Study|Unable to adhere to visit schedule|13
7226352|NCT00074581|11435731|FG001|Overall Study|Unable to adhere to visit schedule|14
7226353|NCT00074581|11435730|FG000|Overall Study|Relocated|14
7226354|NCT00074581|11435731|FG001|Overall Study|Relocated|9
7226355|NCT00074581|11435730|FG000|Overall Study|Were withdrawn by investigator|5
7226356|NCT00074581|11435731|FG001|Overall Study|Were withdrawn by investigator|2
7226357|NCT00074581|11435730|FG000|Overall Study|Lost to Follow-up|16
7226358|NCT00074581|11435731|FG001|Overall Study|Lost to Follow-up|11
7226359|NCT00074581|11435730|FG000|Overall Study|Ended relationship w. index participant|117
7226360|NCT00074581|11435731|FG001|Overall Study|Ended relationship w. index participant|106
7226361|NCT00074581|11435730|FG000|Overall Study|Other|14
7226362|NCT00074581|11435731|FG001|Overall Study|Other|19
7226363|NCT00074711|11435739|FG000|Overall Study|Withdrawal by Subject|1
7226364|NCT00074711|11435740|FG001|Overall Study|Withdrawal by Subject|1
7226365|NCT00074711|11435739|FG000|Overall Study|Lost to Follow-up|10
7226366|NCT00074711|11435740|FG001|Overall Study|Lost to Follow-up|8
7226367|NCT00074711|11435739|FG000|Overall Study|Participant stopped study drug|4
7226368|NCT00074711|11435740|FG001|Overall Study|Participant stopped study drug|6
7226369|NCT00074958|11435768|FG000|Overall Study|Adverse Event|1
7226370|NCT00074984|11435774|FG000|Overall Study|Death|1
7226371|NCT00074984|11435775|FG001|Overall Study|Death|2
7226372|NCT00074984|11435774|FG000|Overall Study|Withdrawal by Subject|2
7226373|NCT00074984|11435775|FG001|Overall Study|Withdrawal by Subject|3
7226374|NCT00074984|11435774|FG000|Overall Study|Patient Withdrawn Per Protocol|0
7226375|NCT00074984|11435775|FG001|Overall Study|Patient Withdrawn Per Protocol|3
7226376|NCT00075023|11435784|FG000|Pilot Study|Physician Decision|1
7226377|NCT00075023|11435785|FG001|Pilot Study|Physician Decision|2
7226378|NCT00075023|11435784|FG000|Pilot Study|Withdrawal by Subject|1
7226379|NCT00075023|11435785|FG001|Pilot Study|Withdrawal by Subject|0
7226380|NCT00075218|11435804|FG000|Double-Blind Treatment|Adverse Event|23
7226381|NCT00075218|11435805|FG001|Double-Blind Treatment|Adverse Event|4
7226382|NCT00075218|11435806|FG002|Double-Blind Treatment|Adverse Event|0
7226383|NCT00075218|11435804|FG000|Double-Blind Treatment|Withdrawal by Subject|7
7226384|NCT00075218|11435805|FG001|Double-Blind Treatment|Withdrawal by Subject|4
7226385|NCT00075218|11435806|FG002|Double-Blind Treatment|Withdrawal by Subject|0
7226386|NCT00075218|11435804|FG000|Double-Blind Treatment|Lost to Follow-up|1
7226387|NCT00075218|11435805|FG001|Double-Blind Treatment|Lost to Follow-up|0
7226388|NCT00075218|11435806|FG002|Double-Blind Treatment|Lost to Follow-up|0
7226389|NCT00075218|11435804|FG000|Double-Blind Treatment|Lack of Efficacy|58
7226390|NCT00075218|11435805|FG001|Double-Blind Treatment|Lack of Efficacy|6
7226391|NCT00075218|11435806|FG002|Double-Blind Treatment|Lack of Efficacy|0
7226392|NCT00075218|11435804|FG000|Double-Blind Treatment|Decision of Sponsor|0
7226393|NCT00075218|11435805|FG001|Double-Blind Treatment|Decision of Sponsor|1
7226394|NCT00075218|11435806|FG002|Double-Blind Treatment|Decision of Sponsor|0
7226395|NCT00075218|11435804|FG000|Double-Blind Treatment|No study medication taken|2
7226396|NCT00075218|11435805|FG001|Double-Blind Treatment|No study medication taken|0
7226397|NCT00075218|11435806|FG002|Double-Blind Treatment|No study medication taken|0
7226398|NCT00075218|11435804|FG000|Open-Label Treatment|Lack of Efficacy|0
7226399|NCT00075218|11435805|FG001|Open-Label Treatment|Lack of Efficacy|0
7226400|NCT00075218|11435806|FG002|Open-Label Treatment|Lack of Efficacy|174
7226401|NCT00075218|11435804|FG000|Open-Label Treatment|Adverse Event|0
7226402|NCT00075218|11435805|FG001|Open-Label Treatment|Adverse Event|0
7226403|NCT00075218|11435806|FG002|Open-Label Treatment|Adverse Event|51
7226404|NCT00075218|11435804|FG000|Open-Label Treatment|Withdrawal by Subject|0
7226405|NCT00075218|11435805|FG001|Open-Label Treatment|Withdrawal by Subject|0
7226406|NCT00075218|11435806|FG002|Open-Label Treatment|Withdrawal by Subject|12
7226407|NCT00075218|11435804|FG000|Open-Label Treatment|Decision of Sponsor|0
7226408|NCT00075218|11435805|FG001|Open-Label Treatment|Decision of Sponsor|0
7226409|NCT00075218|11435806|FG002|Open-Label Treatment|Decision of Sponsor|8
7226410|NCT00075218|11435804|FG000|Open-Label Treatment|Protocol Violation|0
7226411|NCT00075218|11435805|FG001|Open-Label Treatment|Protocol Violation|0
7226412|NCT00075218|11435806|FG002|Open-Label Treatment|Protocol Violation|1
7226413|NCT00075218|11435804|FG000|Open-Label Treatment|enrolled in a separate continuation|0
7226414|NCT00075218|11435805|FG001|Open-Label Treatment|enrolled in a separate continuation|0
7226415|NCT00075218|11435806|FG002|Open-Label Treatment|enrolled in a separate continuation|9
7226416|NCT00075270|11435815|FG000|Overall Study|Withdrawal by Subject|28
7226417|NCT00075270|11435816|FG001|Overall Study|Withdrawal by Subject|21
7226418|NCT00075270|11435815|FG000|Overall Study|Lost to Follow-up|25
7226419|NCT00075270|11435816|FG001|Overall Study|Lost to Follow-up|28
7226420|NCT00075270|11435815|FG000|Overall Study|Protocol Violation|0
7226421|NCT00075270|11435816|FG001|Overall Study|Protocol Violation|2
7226422|NCT00075270|11435815|FG000|Overall Study|Death|198
7226423|NCT00075270|11435816|FG001|Overall Study|Death|215
7226424|NCT00075270|11435815|FG000|Overall Study|Other/Unknown|9
7226425|NCT00075270|11435816|FG001|Overall Study|Other/Unknown|5
7226426|NCT00075270|11435815|FG000|Overall Study|Missing|26
7226427|NCT00075270|11435816|FG001|Overall Study|Missing|13
7226428|NCT00075400|11435827|FG000|Overall Study|Ineligible: wrong primary|1
7226429|NCT00075400|11435827|FG000|Overall Study|Never treated|2
7226430|NCT00075478|11435838|FG000|Overall Study|not eligible|1
7226431|NCT00075478|11435839|FG001|Overall Study|not eligible|0
7226432|NCT00075478|11435838|FG000|Overall Study|Physician Decision|0
7226433|NCT00075478|11435839|FG001|Overall Study|Physician Decision|1
7226434|NCT00075504|11435847|FG000|Overall Study|Withdrawal by Subject|9
7226435|NCT00075504|11435848|FG001|Overall Study|Withdrawal by Subject|7
7226436|NCT00075582|11435856|FG000|Overall Study|Adverse Event|3
7226437|NCT00075582|11435857|FG001|Overall Study|Adverse Event|1
7226438|NCT00075582|11435856|FG000|Overall Study|Lack of Efficacy|4
7226439|NCT00075582|11435857|FG001|Overall Study|Lack of Efficacy|8
7226440|NCT00075582|11435856|FG000|Overall Study|Physician Decision|5
7226441|NCT00075582|11435857|FG001|Overall Study|Physician Decision|8
7226442|NCT00075582|11435856|FG000|Overall Study|Withdrawal by Subject|2
7226443|NCT00075582|11435857|FG001|Overall Study|Withdrawal by Subject|2
7226444|NCT00075582|11435856|FG000|Overall Study|Ineligible for study|36
7226445|NCT00075582|11435857|FG001|Overall Study|Ineligible for study|16
7226446|NCT00075725|11435879|FG000|Overall Study|Adverse Event|6
7226447|NCT00075725|11435880|FG001|Overall Study|Adverse Event|6
7226448|NCT00075725|11435881|FG002|Overall Study|Adverse Event|20
7226449|NCT00075725|11435882|FG003|Overall Study|Adverse Event|8
7226450|NCT00075725|11435883|FG004|Overall Study|Adverse Event|4
7226451|NCT00075725|11435884|FG005|Overall Study|Adverse Event|38
7226452|NCT00075725|11435885|FG006|Overall Study|Adverse Event|3
7226453|NCT00075725|11435886|FG007|Overall Study|Adverse Event|51
7226454|NCT00075725|11435887|FG008|Overall Study|Adverse Event|15
7226455|NCT00075725|11435888|FG009|Overall Study|Adverse Event|4
7226456|NCT00075725|11435889|FG010|Overall Study|Adverse Event|2
7226457|NCT00075725|11435890|FG011|Overall Study|Adverse Event|2
7226458|NCT00075725|11435879|FG000|Overall Study|Death|3
7226459|NCT00075725|11435880|FG001|Overall Study|Death|5
7226460|NCT00075725|11435881|FG002|Overall Study|Death|10
7226461|NCT00075725|11435882|FG003|Overall Study|Death|2
7226462|NCT00075725|11435883|FG004|Overall Study|Death|3
7226463|NCT00075725|11435884|FG005|Overall Study|Death|25
7226464|NCT00075725|11435885|FG006|Overall Study|Death|4
7226465|NCT00075725|11435886|FG007|Overall Study|Death|22
7226466|NCT00075725|11435887|FG008|Overall Study|Death|14
7226467|NCT00075725|11435888|FG009|Overall Study|Death|4
7226468|NCT00075725|11435889|FG010|Overall Study|Death|3
7226469|NCT00075725|11435890|FG011|Overall Study|Death|0
7226470|NCT00075725|11435879|FG000|Overall Study|Lost to Follow-up|1
7226471|NCT00075725|11435880|FG001|Overall Study|Lost to Follow-up|1
7226472|NCT00075725|11435881|FG002|Overall Study|Lost to Follow-up|4
7226473|NCT00075725|11435882|FG003|Overall Study|Lost to Follow-up|1
7226474|NCT00075725|11435883|FG004|Overall Study|Lost to Follow-up|0
7226475|NCT00075725|11435884|FG005|Overall Study|Lost to Follow-up|13
7226476|NCT00075725|11435885|FG006|Overall Study|Lost to Follow-up|2
7226477|NCT00075725|11435886|FG007|Overall Study|Lost to Follow-up|4
7226478|NCT00075725|11435887|FG008|Overall Study|Lost to Follow-up|1
7226479|NCT00075725|11435888|FG009|Overall Study|Lost to Follow-up|0
7226480|NCT00075725|11435889|FG010|Overall Study|Lost to Follow-up|0
7226481|NCT00075725|11435890|FG011|Overall Study|Lost to Follow-up|0
7226482|NCT00075725|11435879|FG000|Overall Study|Physician Decision|2
7226483|NCT00075725|11435880|FG001|Overall Study|Physician Decision|6
7226484|NCT00075725|11435881|FG002|Overall Study|Physician Decision|5
7226485|NCT00075725|11435882|FG003|Overall Study|Physician Decision|8
7226486|NCT00075725|11435883|FG004|Overall Study|Physician Decision|4
7226487|NCT00075725|11435884|FG005|Overall Study|Physician Decision|19
7226488|NCT00075725|11435885|FG006|Overall Study|Physician Decision|3
7226489|NCT00075725|11435886|FG007|Overall Study|Physician Decision|17
7226490|NCT00075725|11435887|FG008|Overall Study|Physician Decision|5
7226491|NCT00075725|11435888|FG009|Overall Study|Physician Decision|0
7226492|NCT00075725|11435889|FG010|Overall Study|Physician Decision|1
7226493|NCT00075725|11435890|FG011|Overall Study|Physician Decision|0
7226494|NCT00075725|11435879|FG000|Overall Study|Pregnancy|0
7226495|NCT00075725|11435880|FG001|Overall Study|Pregnancy|0
7226496|NCT00075725|11435881|FG002|Overall Study|Pregnancy|0
7226497|NCT00075725|11435882|FG003|Overall Study|Pregnancy|0
7226498|NCT00075725|11435883|FG004|Overall Study|Pregnancy|0
7226499|NCT00075725|11435884|FG005|Overall Study|Pregnancy|1
7226500|NCT00075725|11435885|FG006|Overall Study|Pregnancy|0
7226501|NCT00075725|11435886|FG007|Overall Study|Pregnancy|1
7226502|NCT00075725|11435887|FG008|Overall Study|Pregnancy|0
7226503|NCT00075725|11435888|FG009|Overall Study|Pregnancy|0
7226504|NCT00075725|11435889|FG010|Overall Study|Pregnancy|0
7226505|NCT00075725|11435890|FG011|Overall Study|Pregnancy|0
7226506|NCT00075725|11435879|FG000|Overall Study|Protocol Violation|1
7226507|NCT00075725|11435880|FG001|Overall Study|Protocol Violation|1
7226508|NCT00075725|11435881|FG002|Overall Study|Protocol Violation|0
7226509|NCT00075725|11435882|FG003|Overall Study|Protocol Violation|3
7226510|NCT00075725|11435883|FG004|Overall Study|Protocol Violation|3
7226511|NCT00075725|11435884|FG005|Overall Study|Protocol Violation|2
7226512|NCT00075725|11435885|FG006|Overall Study|Protocol Violation|1
7226513|NCT00075725|11435886|FG007|Overall Study|Protocol Violation|2
7226514|NCT00075725|11435887|FG008|Overall Study|Protocol Violation|3
7226515|NCT00075725|11435888|FG009|Overall Study|Protocol Violation|0
7226516|NCT00075725|11435889|FG010|Overall Study|Protocol Violation|0
7226517|NCT00075725|11435890|FG011|Overall Study|Protocol Violation|1
7226518|NCT00075725|11435879|FG000|Overall Study|Withdrawal by Subject|12
7226519|NCT00075725|11435880|FG001|Overall Study|Withdrawal by Subject|3
7226520|NCT00075725|11435881|FG002|Overall Study|Withdrawal by Subject|6
7226521|NCT00075725|11435882|FG003|Overall Study|Withdrawal by Subject|10
7226522|NCT00075725|11435883|FG004|Overall Study|Withdrawal by Subject|6
7226523|NCT00075725|11435884|FG005|Overall Study|Withdrawal by Subject|27
7226524|NCT00075725|11435885|FG006|Overall Study|Withdrawal by Subject|7
7226525|NCT00075725|11435886|FG007|Overall Study|Withdrawal by Subject|31
7226526|NCT00075725|11435887|FG008|Overall Study|Withdrawal by Subject|10
7226527|NCT00075725|11435888|FG009|Overall Study|Withdrawal by Subject|2
7226528|NCT00075725|11435889|FG010|Overall Study|Withdrawal by Subject|0
7226529|NCT00075725|11435890|FG011|Overall Study|Withdrawal by Subject|0
7226530|NCT00075725|11435879|FG000|Overall Study|Disease Progression, all other reasons|17
7226531|NCT00075725|11435880|FG001|Overall Study|Disease Progression, all other reasons|5
7226532|NCT00075725|11435881|FG002|Overall Study|Disease Progression, all other reasons|33
7226533|NCT00075725|11435882|FG003|Overall Study|Disease Progression, all other reasons|6
7226534|NCT00075725|11435883|FG004|Overall Study|Disease Progression, all other reasons|21
7226535|NCT00075725|11435884|FG005|Overall Study|Disease Progression, all other reasons|59
7226536|NCT00075725|11435885|FG006|Overall Study|Disease Progression, all other reasons|20
7226537|NCT00075725|11435886|FG007|Overall Study|Disease Progression, all other reasons|46
7226538|NCT00075725|11435887|FG008|Overall Study|Disease Progression, all other reasons|21
7226539|NCT00075725|11435888|FG009|Overall Study|Disease Progression, all other reasons|4
7226540|NCT00075725|11435889|FG010|Overall Study|Disease Progression, all other reasons|0
7226541|NCT00075725|11435890|FG011|Overall Study|Disease Progression, all other reasons|5
7226542|NCT00075725|11435879|FG000|Overall Study|Patient off treatment|0
7226543|NCT00075725|11435880|FG001|Overall Study|Patient off treatment|0
7226544|NCT00075725|11435881|FG002|Overall Study|Patient off treatment|1
7226545|NCT00075725|11435882|FG003|Overall Study|Patient off treatment|2
7226546|NCT00075725|11435883|FG004|Overall Study|Patient off treatment|1
7226547|NCT00075725|11435884|FG005|Overall Study|Patient off treatment|0
7226548|NCT00075725|11435885|FG006|Overall Study|Patient off treatment|0
7226549|NCT00075725|11435886|FG007|Overall Study|Patient off treatment|2
7226550|NCT00075725|11435887|FG008|Overall Study|Patient off treatment|1
7226551|NCT00075725|11435888|FG009|Overall Study|Patient off treatment|0
7226552|NCT00075725|11435889|FG010|Overall Study|Patient off treatment|0
7226553|NCT00075725|11435890|FG011|Overall Study|Patient off treatment|0
7226554|NCT00075725|11435879|FG000|Overall Study|Ineligible or wrong diagnosis|8
7226555|NCT00075725|11435880|FG001|Overall Study|Ineligible or wrong diagnosis|3
7226556|NCT00075725|11435881|FG002|Overall Study|Ineligible or wrong diagnosis|3
7226557|NCT00075725|11435882|FG003|Overall Study|Ineligible or wrong diagnosis|10
7226558|NCT00075725|11435883|FG004|Overall Study|Ineligible or wrong diagnosis|3
7226559|NCT00075725|11435884|FG005|Overall Study|Ineligible or wrong diagnosis|17
7226560|NCT00075725|11435885|FG006|Overall Study|Ineligible or wrong diagnosis|6
7226561|NCT00075725|11435886|FG007|Overall Study|Ineligible or wrong diagnosis|9
7226562|NCT00075725|11435887|FG008|Overall Study|Ineligible or wrong diagnosis|10
7226563|NCT00075725|11435888|FG009|Overall Study|Ineligible or wrong diagnosis|1
7226564|NCT00075725|11435889|FG010|Overall Study|Ineligible or wrong diagnosis|2
7226565|NCT00075725|11435890|FG011|Overall Study|Ineligible or wrong diagnosis|4
7226566|NCT00075725|11435879|FG000|Overall Study|Pt/Guardian refused RT therapy|1
7226567|NCT00075725|11435880|FG001|Overall Study|Pt/Guardian refused RT therapy|0
7226568|NCT00075725|11435881|FG002|Overall Study|Pt/Guardian refused RT therapy|1
7226569|NCT00075725|11435882|FG003|Overall Study|Pt/Guardian refused RT therapy|2
7226570|NCT00075725|11435883|FG004|Overall Study|Pt/Guardian refused RT therapy|1
7226571|NCT00075725|11435884|FG005|Overall Study|Pt/Guardian refused RT therapy|0
7226572|NCT00075725|11435885|FG006|Overall Study|Pt/Guardian refused RT therapy|0
7226573|NCT00075725|11435886|FG007|Overall Study|Pt/Guardian refused RT therapy|0
7226574|NCT00075725|11435887|FG008|Overall Study|Pt/Guardian refused RT therapy|0
7226575|NCT00075725|11435888|FG009|Overall Study|Pt/Guardian refused RT therapy|0
7226576|NCT00075725|11435889|FG010|Overall Study|Pt/Guardian refused RT therapy|0
7226577|NCT00075725|11435890|FG011|Overall Study|Pt/Guardian refused RT therapy|0
7226578|NCT00075725|11435879|FG000|Overall Study|Pt non compliant with therapy|2
7226579|NCT00075725|11435880|FG001|Overall Study|Pt non compliant with therapy|1
7226580|NCT00075725|11435881|FG002|Overall Study|Pt non compliant with therapy|1
7226581|NCT00075725|11435882|FG003|Overall Study|Pt non compliant with therapy|0
7226582|NCT00075725|11435883|FG004|Overall Study|Pt non compliant with therapy|2
7226583|NCT00075725|11435884|FG005|Overall Study|Pt non compliant with therapy|14
7226584|NCT00075725|11435885|FG006|Overall Study|Pt non compliant with therapy|2
7226585|NCT00075725|11435886|FG007|Overall Study|Pt non compliant with therapy|5
7226586|NCT00075725|11435887|FG008|Overall Study|Pt non compliant with therapy|3
7226587|NCT00075725|11435888|FG009|Overall Study|Pt non compliant with therapy|0
7226588|NCT00075725|11435889|FG010|Overall Study|Pt non compliant with therapy|0
7226589|NCT00075725|11435890|FG011|Overall Study|Pt non compliant with therapy|0
7226590|NCT00075725|11435879|FG000|Overall Study|Pt age out of range for treatment|0
7226591|NCT00075725|11435880|FG001|Overall Study|Pt age out of range for treatment|1
7226592|NCT00075725|11435881|FG002|Overall Study|Pt age out of range for treatment|0
7226593|NCT00075725|11435882|FG003|Overall Study|Pt age out of range for treatment|0
7226594|NCT00075725|11435883|FG004|Overall Study|Pt age out of range for treatment|0
7226595|NCT00075725|11435884|FG005|Overall Study|Pt age out of range for treatment|1
7226596|NCT00075725|11435885|FG006|Overall Study|Pt age out of range for treatment|0
7226597|NCT00075725|11435886|FG007|Overall Study|Pt age out of range for treatment|1
7226598|NCT00075725|11435887|FG008|Overall Study|Pt age out of range for treatment|0
7226599|NCT00075725|11435888|FG009|Overall Study|Pt age out of range for treatment|0
7226600|NCT00075725|11435889|FG010|Overall Study|Pt age out of range for treatment|0
7226601|NCT00075725|11435890|FG011|Overall Study|Pt age out of range for treatment|0
7226602|NCT00075725|11435879|FG000|Overall Study|Insurance issues|0
7226603|NCT00075725|11435880|FG001|Overall Study|Insurance issues|1
7226604|NCT00075725|11435881|FG002|Overall Study|Insurance issues|0
7226605|NCT00075725|11435882|FG003|Overall Study|Insurance issues|1
7226606|NCT00075725|11435883|FG004|Overall Study|Insurance issues|1
7226607|NCT00075725|11435884|FG005|Overall Study|Insurance issues|1
7226608|NCT00075725|11435885|FG006|Overall Study|Insurance issues|0
7226609|NCT00075725|11435886|FG007|Overall Study|Insurance issues|1
7226610|NCT00075725|11435887|FG008|Overall Study|Insurance issues|0
7226611|NCT00075725|11435888|FG009|Overall Study|Insurance issues|0
7226612|NCT00075725|11435889|FG010|Overall Study|Insurance issues|0
7226613|NCT00075725|11435890|FG011|Overall Study|Insurance issues|0
7226614|NCT00075725|11435879|FG000|Overall Study|MRD positive after extended ind|0
7226615|NCT00075725|11435880|FG001|Overall Study|MRD positive after extended ind|1
7226616|NCT00075725|11435881|FG002|Overall Study|MRD positive after extended ind|1
7226617|NCT00075725|11435882|FG003|Overall Study|MRD positive after extended ind|0
7226618|NCT00075725|11435883|FG004|Overall Study|MRD positive after extended ind|1
7226619|NCT00075725|11435884|FG005|Overall Study|MRD positive after extended ind|2
7226620|NCT00075725|11435885|FG006|Overall Study|MRD positive after extended ind|0
7226621|NCT00075725|11435886|FG007|Overall Study|MRD positive after extended ind|1
7226622|NCT00075725|11435887|FG008|Overall Study|MRD positive after extended ind|0
7226623|NCT00075725|11435888|FG009|Overall Study|MRD positive after extended ind|0
7226624|NCT00075725|11435889|FG010|Overall Study|MRD positive after extended ind|0
7226625|NCT00075725|11435890|FG011|Overall Study|MRD positive after extended ind|0
7226626|NCT00075725|11435879|FG000|Overall Study|Pt has very high risk ALL characteristic|15
7226627|NCT00075725|11435880|FG001|Overall Study|Pt has very high risk ALL characteristic|11
7226628|NCT00075725|11435881|FG002|Overall Study|Pt has very high risk ALL characteristic|26
7226629|NCT00075725|11435882|FG003|Overall Study|Pt has very high risk ALL characteristic|18
7226630|NCT00075725|11435883|FG004|Overall Study|Pt has very high risk ALL characteristic|11
7226631|NCT00075725|11435884|FG005|Overall Study|Pt has very high risk ALL characteristic|75
7226632|NCT00075725|11435885|FG006|Overall Study|Pt has very high risk ALL characteristic|23
7226633|NCT00075725|11435886|FG007|Overall Study|Pt has very high risk ALL characteristic|74
7226634|NCT00075725|11435887|FG008|Overall Study|Pt has very high risk ALL characteristic|29
7226635|NCT00075725|11435888|FG009|Overall Study|Pt has very high risk ALL characteristic|1
7226636|NCT00075725|11435889|FG010|Overall Study|Pt has very high risk ALL characteristic|0
7226637|NCT00075725|11435890|FG011|Overall Study|Pt has very high risk ALL characteristic|3
7226638|NCT00075725|11435879|FG000|Overall Study|Inevaluable|1
7226639|NCT00075725|11435880|FG001|Overall Study|Inevaluable|1
7226640|NCT00075725|11435881|FG002|Overall Study|Inevaluable|4
7226641|NCT00075725|11435882|FG003|Overall Study|Inevaluable|2
7226642|NCT00075725|11435883|FG004|Overall Study|Inevaluable|2
7226643|NCT00075725|11435884|FG005|Overall Study|Inevaluable|9
7226644|NCT00075725|11435885|FG006|Overall Study|Inevaluable|1
7226645|NCT00075725|11435886|FG007|Overall Study|Inevaluable|11
7226646|NCT00075725|11435887|FG008|Overall Study|Inevaluable|2
7226647|NCT00075725|11435888|FG009|Overall Study|Inevaluable|0
7226648|NCT00075725|11435889|FG010|Overall Study|Inevaluable|1
7226649|NCT00075725|11435890|FG011|Overall Study|Inevaluable|0
7226650|NCT00075725|11435879|FG000|Overall Study|Other|4
7226651|NCT00075725|11435880|FG001|Overall Study|Other|2
7226652|NCT00075725|11435881|FG002|Overall Study|Other|1
7226653|NCT00075725|11435882|FG003|Overall Study|Other|1
7226654|NCT00075725|11435883|FG004|Overall Study|Other|1
7226655|NCT00075725|11435884|FG005|Overall Study|Other|4
7226656|NCT00075725|11435885|FG006|Overall Study|Other|2
7226657|NCT00075725|11435886|FG007|Overall Study|Other|9
7226658|NCT00075725|11435887|FG008|Overall Study|Other|2
7226659|NCT00075725|11435888|FG009|Overall Study|Other|1
7226660|NCT00075725|11435889|FG010|Overall Study|Other|0
7226661|NCT00075725|11435890|FG011|Overall Study|Other|3
7226662|NCT00075725|11435879|FG000|Overall Study|Pt trying to find a BM donor|0
7226663|NCT00075725|11435880|FG001|Overall Study|Pt trying to find a BM donor|1
7226664|NCT00075725|11435881|FG002|Overall Study|Pt trying to find a BM donor|0
7226665|NCT00075725|11435882|FG003|Overall Study|Pt trying to find a BM donor|0
7226666|NCT00075725|11435883|FG004|Overall Study|Pt trying to find a BM donor|0
7226667|NCT00075725|11435884|FG005|Overall Study|Pt trying to find a BM donor|0
7226668|NCT00075725|11435885|FG006|Overall Study|Pt trying to find a BM donor|0
7226669|NCT00075725|11435886|FG007|Overall Study|Pt trying to find a BM donor|0
7226670|NCT00075725|11435887|FG008|Overall Study|Pt trying to find a BM donor|0
7226671|NCT00075725|11435888|FG009|Overall Study|Pt trying to find a BM donor|0
7226672|NCT00075725|11435889|FG010|Overall Study|Pt trying to find a BM donor|0
7226673|NCT00075725|11435890|FG011|Overall Study|Pt trying to find a BM donor|0
7226674|NCT00075725|11435879|FG000|Overall Study|Clinic chart lost unable to recreate|0
7226675|NCT00075725|11435880|FG001|Overall Study|Clinic chart lost unable to recreate|0
7226676|NCT00075725|11435881|FG002|Overall Study|Clinic chart lost unable to recreate|1
7226677|NCT00075725|11435882|FG003|Overall Study|Clinic chart lost unable to recreate|0
7226678|NCT00075725|11435883|FG004|Overall Study|Clinic chart lost unable to recreate|0
7226679|NCT00075725|11435884|FG005|Overall Study|Clinic chart lost unable to recreate|0
7226680|NCT00075725|11435885|FG006|Overall Study|Clinic chart lost unable to recreate|0
7226681|NCT00075725|11435886|FG007|Overall Study|Clinic chart lost unable to recreate|0
7226682|NCT00075725|11435887|FG008|Overall Study|Clinic chart lost unable to recreate|0
7226683|NCT00075725|11435888|FG009|Overall Study|Clinic chart lost unable to recreate|0
7226684|NCT00075725|11435889|FG010|Overall Study|Clinic chart lost unable to recreate|0
7226685|NCT00075725|11435890|FG011|Overall Study|Clinic chart lost unable to recreate|0
7226686|NCT00075725|11435879|FG000|Overall Study|Unsuccessful institutional transfer|0
7226687|NCT00075725|11435880|FG001|Overall Study|Unsuccessful institutional transfer|0
7226688|NCT00075725|11435881|FG002|Overall Study|Unsuccessful institutional transfer|2
7226689|NCT00075725|11435882|FG003|Overall Study|Unsuccessful institutional transfer|0
7226690|NCT00075725|11435883|FG004|Overall Study|Unsuccessful institutional transfer|0
7226691|NCT00075725|11435884|FG005|Overall Study|Unsuccessful institutional transfer|0
7226692|NCT00075725|11435885|FG006|Overall Study|Unsuccessful institutional transfer|0
7226693|NCT00075725|11435886|FG007|Overall Study|Unsuccessful institutional transfer|0
7226694|NCT00075725|11435887|FG008|Overall Study|Unsuccessful institutional transfer|0
7226695|NCT00075725|11435888|FG009|Overall Study|Unsuccessful institutional transfer|1
7226696|NCT00075725|11435889|FG010|Overall Study|Unsuccessful institutional transfer|0
7226697|NCT00075725|11435890|FG011|Overall Study|Unsuccessful institutional transfer|0
7226698|NCT00075725|11435879|FG000|Overall Study|specimen(s) not submitted|0
7226699|NCT00075725|11435880|FG001|Overall Study|specimen(s) not submitted|0
7226700|NCT00075725|11435881|FG002|Overall Study|specimen(s) not submitted|2
7226701|NCT00075725|11435882|FG003|Overall Study|specimen(s) not submitted|0
7226702|NCT00075725|11435883|FG004|Overall Study|specimen(s) not submitted|0
7226703|NCT00075725|11435884|FG005|Overall Study|specimen(s) not submitted|0
7226704|NCT00075725|11435885|FG006|Overall Study|specimen(s) not submitted|0
7226705|NCT00075725|11435886|FG007|Overall Study|specimen(s) not submitted|0
7226706|NCT00075725|11435887|FG008|Overall Study|specimen(s) not submitted|0
7226707|NCT00075725|11435888|FG009|Overall Study|specimen(s) not submitted|0
7226708|NCT00075725|11435889|FG010|Overall Study|specimen(s) not submitted|0
7226709|NCT00075725|11435890|FG011|Overall Study|specimen(s) not submitted|0
7226710|NCT00075725|11435879|FG000|Overall Study|Pt went to transplant|0
7226711|NCT00075725|11435880|FG001|Overall Study|Pt went to transplant|0
7226712|NCT00075725|11435881|FG002|Overall Study|Pt went to transplant|0
7226713|NCT00075725|11435882|FG003|Overall Study|Pt went to transplant|1
7226714|NCT00075725|11435883|FG004|Overall Study|Pt went to transplant|0
7226715|NCT00075725|11435884|FG005|Overall Study|Pt went to transplant|1
7226716|NCT00075725|11435885|FG006|Overall Study|Pt went to transplant|0
7226717|NCT00075725|11435886|FG007|Overall Study|Pt went to transplant|0
7226718|NCT00075725|11435887|FG008|Overall Study|Pt went to transplant|0
7226719|NCT00075725|11435888|FG009|Overall Study|Pt went to transplant|0
7226720|NCT00075725|11435889|FG010|Overall Study|Pt went to transplant|0
7226721|NCT00075725|11435890|FG011|Overall Study|Pt went to transplant|0
7226722|NCT00075725|11435879|FG000|Overall Study|Pt received additional steroids|0
7226723|NCT00075725|11435880|FG001|Overall Study|Pt received additional steroids|0
7226724|NCT00075725|11435881|FG002|Overall Study|Pt received additional steroids|0
7226725|NCT00075725|11435882|FG003|Overall Study|Pt received additional steroids|1
7226726|NCT00075725|11435883|FG004|Overall Study|Pt received additional steroids|0
7226727|NCT00075725|11435884|FG005|Overall Study|Pt received additional steroids|0
7226728|NCT00075725|11435885|FG006|Overall Study|Pt received additional steroids|0
7226729|NCT00075725|11435886|FG007|Overall Study|Pt received additional steroids|0
7226730|NCT00075725|11435887|FG008|Overall Study|Pt received additional steroids|0
7226731|NCT00075725|11435888|FG009|Overall Study|Pt received additional steroids|0
7226732|NCT00075725|11435889|FG010|Overall Study|Pt received additional steroids|0
7226733|NCT00075725|11435890|FG011|Overall Study|Pt received additional steroids|0
7226734|NCT00075725|11435879|FG000|Overall Study|Pt relocated|0
7226735|NCT00075725|11435880|FG001|Overall Study|Pt relocated|0
7226736|NCT00075725|11435881|FG002|Overall Study|Pt relocated|0
7226737|NCT00075725|11435882|FG003|Overall Study|Pt relocated|2
7226738|NCT00075725|11435883|FG004|Overall Study|Pt relocated|0
7226739|NCT00075725|11435884|FG005|Overall Study|Pt relocated|1
7226740|NCT00075725|11435885|FG006|Overall Study|Pt relocated|1
7226741|NCT00075725|11435886|FG007|Overall Study|Pt relocated|2
7226742|NCT00075725|11435887|FG008|Overall Study|Pt relocated|1
7226743|NCT00075725|11435888|FG009|Overall Study|Pt relocated|0
7226744|NCT00075725|11435889|FG010|Overall Study|Pt relocated|0
7226745|NCT00075725|11435890|FG011|Overall Study|Pt relocated|0
7226746|NCT00075725|11435879|FG000|Overall Study|Institution Terminated|0
7226747|NCT00075725|11435880|FG001|Overall Study|Institution Terminated|0
7226748|NCT00075725|11435881|FG002|Overall Study|Institution Terminated|0
7226749|NCT00075725|11435882|FG003|Overall Study|Institution Terminated|0
7226750|NCT00075725|11435883|FG004|Overall Study|Institution Terminated|1
7226751|NCT00075725|11435884|FG005|Overall Study|Institution Terminated|0
7226752|NCT00075725|11435885|FG006|Overall Study|Institution Terminated|0
7226753|NCT00075725|11435886|FG007|Overall Study|Institution Terminated|3
7226754|NCT00075725|11435887|FG008|Overall Study|Institution Terminated|0
7226755|NCT00075725|11435888|FG009|Overall Study|Institution Terminated|0
7226756|NCT00075725|11435889|FG010|Overall Study|Institution Terminated|0
7226757|NCT00075725|11435890|FG011|Overall Study|Institution Terminated|0
7226758|NCT00075725|11435879|FG000|Overall Study|Study Closure|1
7226759|NCT00075725|11435880|FG001|Overall Study|Study Closure|0
7226760|NCT00075725|11435881|FG002|Overall Study|Study Closure|0
7226761|NCT00075725|11435882|FG003|Overall Study|Study Closure|0
7226762|NCT00075725|11435883|FG004|Overall Study|Study Closure|1
7226763|NCT00075725|11435884|FG005|Overall Study|Study Closure|3
7226764|NCT00075725|11435885|FG006|Overall Study|Study Closure|0
7226765|NCT00075725|11435886|FG007|Overall Study|Study Closure|1
7226766|NCT00075725|11435887|FG008|Overall Study|Study Closure|0
7226767|NCT00075725|11435888|FG009|Overall Study|Study Closure|0
7226768|NCT00075725|11435889|FG010|Overall Study|Study Closure|0
7226769|NCT00075725|11435890|FG011|Overall Study|Study Closure|0
7226770|NCT00075725|11435879|FG000|Overall Study|Other complications|0
7226771|NCT00075725|11435880|FG001|Overall Study|Other complications|0
7226772|NCT00075725|11435881|FG002|Overall Study|Other complications|0
7226773|NCT00075725|11435882|FG003|Overall Study|Other complications|0
7226774|NCT00075725|11435883|FG004|Overall Study|Other complications|0
7226775|NCT00075725|11435884|FG005|Overall Study|Other complications|1
7226776|NCT00075725|11435885|FG006|Overall Study|Other complications|0
7226777|NCT00075725|11435886|FG007|Overall Study|Other complications|0
7226778|NCT00075725|11435887|FG008|Overall Study|Other complications|0
7226779|NCT00075725|11435888|FG009|Overall Study|Other complications|0
7226780|NCT00075725|11435889|FG010|Overall Study|Other complications|0
7226781|NCT00075725|11435890|FG011|Overall Study|Other complications|0
7226782|NCT00075725|11435879|FG000|Overall Study|Pt care terminated due to pt behavior|0
7226783|NCT00075725|11435880|FG001|Overall Study|Pt care terminated due to pt behavior|0
7226784|NCT00075725|11435881|FG002|Overall Study|Pt care terminated due to pt behavior|0
7226785|NCT00075725|11435882|FG003|Overall Study|Pt care terminated due to pt behavior|0
7226786|NCT00075725|11435883|FG004|Overall Study|Pt care terminated due to pt behavior|0
7226787|NCT00075725|11435884|FG005|Overall Study|Pt care terminated due to pt behavior|0
7226788|NCT00075725|11435885|FG006|Overall Study|Pt care terminated due to pt behavior|0
7226789|NCT00075725|11435886|FG007|Overall Study|Pt care terminated due to pt behavior|1
7226790|NCT00075725|11435887|FG008|Overall Study|Pt care terminated due to pt behavior|0
7226791|NCT00075725|11435888|FG009|Overall Study|Pt care terminated due to pt behavior|0
7226792|NCT00075725|11435889|FG010|Overall Study|Pt care terminated due to pt behavior|0
7226793|NCT00075725|11435890|FG011|Overall Study|Pt care terminated due to pt behavior|0
7226794|NCT00075725|11435879|FG000|Overall Study|Pt incarcerated|0
7226795|NCT00075725|11435880|FG001|Overall Study|Pt incarcerated|0
7226796|NCT00075725|11435881|FG002|Overall Study|Pt incarcerated|0
7226797|NCT00075725|11435882|FG003|Overall Study|Pt incarcerated|0
7226798|NCT00075725|11435883|FG004|Overall Study|Pt incarcerated|0
7226799|NCT00075725|11435884|FG005|Overall Study|Pt incarcerated|0
7226800|NCT00075725|11435885|FG006|Overall Study|Pt incarcerated|0
7226801|NCT00075725|11435886|FG007|Overall Study|Pt incarcerated|1
7226802|NCT00075725|11435887|FG008|Overall Study|Pt incarcerated|0
7226803|NCT00075725|11435888|FG009|Overall Study|Pt incarcerated|0
7226804|NCT00075725|11435889|FG010|Overall Study|Pt incarcerated|0
7226805|NCT00075725|11435890|FG011|Overall Study|Pt incarcerated|0
7226806|NCT00075764|11435923|FG000|Overall Study|Adverse Event|5
7226807|NCT00075764|11435924|FG001|Overall Study|Adverse Event|12
7226808|NCT00075764|11435923|FG000|Overall Study|Death|4
7226809|NCT00075764|11435924|FG001|Overall Study|Death|8
7226810|NCT00075764|11435923|FG000|Overall Study|Withdrawal by Subject|28
7226811|NCT00075764|11435924|FG001|Overall Study|Withdrawal by Subject|18
7226812|NCT00075764|11435923|FG000|Overall Study|Progression|269
7226813|NCT00075764|11435924|FG001|Overall Study|Progression|274
7226814|NCT00075764|11435923|FG000|Overall Study|Still on treatment|8
7226815|NCT00075764|11435924|FG001|Overall Study|Still on treatment|15
7226816|NCT00075764|11435923|FG000|Overall Study|Delinquent|4
7226817|NCT00075764|11435924|FG001|Overall Study|Delinquent|2
7226818|NCT00075764|11435923|FG000|Overall Study|Not protocol specified|27
7226819|NCT00075764|11435924|FG001|Overall Study|Not protocol specified|19
7226820|NCT00075764|11435923|FG000|Overall Study|Under review|0
7226821|NCT00075764|11435924|FG001|Overall Study|Under review|1
7226822|NCT00075816|11435943|FG000|Overall Study|Did not undergo transplantation|14
7226823|NCT00075816|11435944|FG001|Overall Study|Did not undergo transplantation|11
7226824|NCT00075881|11435972|FG000|Overall Study|Lack of Efficacy|18
7226825|NCT00075881|11435972|FG000|Overall Study|Adverse Event|7
7226826|NCT00075881|11435972|FG000|Overall Study|Death|1
7226827|NCT00075881|11435972|FG000|Overall Study|Withdrawal by Subject|2
7226828|NCT00075881|11435972|FG000|Overall Study|Protocol Violation|4
7226829|NCT00075881|11435972|FG000|Overall Study|other complicating disease|3
7226830|NCT00075881|11435972|FG000|Overall Study|other|4
7226831|NCT00075881|11435972|FG000|Overall Study|missing data|2
7226832|NCT00075881|11435972|FG000|Overall Study|Ineligible|1
7226833|NCT00075881|11435972|FG000|Overall Study|never start protocol therapy|1
7226834|NCT00076011|11435978|FG000|Overall Study|Death|1
7226835|NCT00076011|11435978|FG000|Overall Study|Adverse Event|10
7226836|NCT00076011|11435978|FG000|Overall Study|Lack of Efficacy|25
7226837|NCT00076011|11435978|FG000|Overall Study|Withdrawal by Subject|1
7226838|NCT00076011|11435978|FG000|Overall Study|Study terminated by sponsor|3
7226839|NCT00076011|11435978|FG000|Overall Study|Other|11
7226840|NCT00076011|11435978|FG000|Overall Study|Ongoing|1
7226841|NCT00076024|11435985|FG000|Phase 1, Lead-in|Lack of Efficacy|4
7226842|NCT00076024|11435986|FG001|Phase 1, Lead-in|Lack of Efficacy|0
7226843|NCT00076024|11435987|FG002|Phase 1, Lead-in|Lack of Efficacy|0
7226844|NCT00076024|11435988|FG003|Phase 1, Lead-in|Lack of Efficacy|0
7226845|NCT00076024|11435985|FG000|Phase 1, Lead-in|Adverse Event|1
7226846|NCT00076024|11435986|FG001|Phase 1, Lead-in|Adverse Event|0
7226847|NCT00076024|11435987|FG002|Phase 1, Lead-in|Adverse Event|0
7226848|NCT00076024|11435988|FG003|Phase 1, Lead-in|Adverse Event|0
7226849|NCT00076024|11435985|FG000|Phase 1, Lead-in|Clinical progression|1
7226850|NCT00076024|11435986|FG001|Phase 1, Lead-in|Clinical progression|0
7226851|NCT00076024|11435987|FG002|Phase 1, Lead-in|Clinical progression|0
7226852|NCT00076024|11435988|FG003|Phase 1, Lead-in|Clinical progression|0
7226853|NCT00076024|11435985|FG000|Phase 2, Double-blind|Lack of Efficacy|0
7226854|NCT00076024|11435986|FG001|Phase 2, Double-blind|Lack of Efficacy|59
7226855|NCT00076024|11435987|FG002|Phase 2, Double-blind|Lack of Efficacy|40
7226856|NCT00076024|11435988|FG003|Phase 2, Double-blind|Lack of Efficacy|0
7226857|NCT00076024|11435985|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
7226858|NCT00076024|11435986|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
7226859|NCT00076024|11435987|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
7226860|NCT00076024|11435988|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
7226861|NCT00076024|11435985|FG000|Phase 2, Double-blind|Adverse Event|0
7226862|NCT00076024|11435986|FG001|Phase 2, Double-blind|Adverse Event|25
7226863|NCT00076024|11435987|FG002|Phase 2, Double-blind|Adverse Event|6
7226864|NCT00076024|11435988|FG003|Phase 2, Double-blind|Adverse Event|0
7226865|NCT00076024|11435985|FG000|Phase 2, Double-blind|Un-specified|0
7226866|NCT00076024|11435986|FG001|Phase 2, Double-blind|Un-specified|14
7226867|NCT00076024|11435987|FG002|Phase 2, Double-blind|Un-specified|6
7226868|NCT00076024|11435988|FG003|Phase 2, Double-blind|Un-specified|0
7226869|NCT00076024|11435985|FG000|Phase 2, Double-blind|Randomized but not treated|0
7226870|NCT00076024|11435986|FG001|Phase 2, Double-blind|Randomized but not treated|1
7226871|NCT00076024|11435987|FG002|Phase 2, Double-blind|Randomized but not treated|0
7226872|NCT00076024|11435988|FG003|Phase 2, Double-blind|Randomized but not treated|0
7226873|NCT00076024|11435985|FG000|Phase 2, Open-label|Adverse Event|0
7226874|NCT00076024|11435986|FG001|Phase 2, Open-label|Adverse Event|0
7226875|NCT00076024|11435987|FG002|Phase 2, Open-label|Adverse Event|0
7226876|NCT00076024|11435988|FG003|Phase 2, Open-label|Adverse Event|2
7226877|NCT00076024|11435985|FG000|Phase 2, Open-label|Lack of Efficacy|0
7226878|NCT00076024|11435986|FG001|Phase 2, Open-label|Lack of Efficacy|0
7226879|NCT00076024|11435987|FG002|Phase 2, Open-label|Lack of Efficacy|0
7226880|NCT00076024|11435988|FG003|Phase 2, Open-label|Lack of Efficacy|11
7226881|NCT00076024|11435985|FG000|Phase 2, Open-label|Withdrawal by Subject|0
7226882|NCT00076024|11435986|FG001|Phase 2, Open-label|Withdrawal by Subject|0
7226883|NCT00076024|11435987|FG002|Phase 2, Open-label|Withdrawal by Subject|0
7226884|NCT00076024|11435988|FG003|Phase 2, Open-label|Withdrawal by Subject|1
7226885|NCT00076024|11435985|FG000|Phase 2, Open-label|Other|0
7226886|NCT00076024|11435986|FG001|Phase 2, Open-label|Other|0
7226887|NCT00076024|11435987|FG002|Phase 2, Open-label|Other|0
7226888|NCT00076024|11435988|FG003|Phase 2, Open-label|Other|2
7226889|NCT00076102|11436006|FG000|Overall Study|Clinical progression|1
7226890|NCT00076102|11436006|FG000|Overall Study|Progression in pre-existing brain tumor|1
7226891|NCT00076102|11436006|FG000|Overall Study|plexiform neurofibroma surgery|1
7226892|NCT00076102|11436006|FG000|Overall Study|refusal of further therapy|2
7226893|NCT00076336|11436049|FG000|Overall Study|Death|13
7226894|NCT00076336|11436050|FG001|Overall Study|Death|17
7226895|NCT00076336|11436049|FG000|Overall Study|Adverse Event|4
7226896|NCT00076336|11436050|FG001|Overall Study|Adverse Event|4
7226897|NCT00076336|11436049|FG000|Overall Study|Lost to Follow-up|4
7226898|NCT00076336|11436050|FG001|Overall Study|Lost to Follow-up|4
7226899|NCT00076336|11436049|FG000|Overall Study|Non-Compliance|2
7226900|NCT00076336|11436050|FG001|Overall Study|Non-Compliance|0
7226901|NCT00076336|11436049|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
7226902|NCT00076336|11436050|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
7226903|NCT00076336|11436049|FG000|Overall Study|Patient, Investigator, Sponsor request|8
7226904|NCT00076336|11436050|FG001|Overall Study|Patient, Investigator, Sponsor request|6
7226905|NCT00076336|11436049|FG000|Overall Study|Liver Transplantation|3
7226906|NCT00076336|11436050|FG001|Overall Study|Liver Transplantation|3
7226907|NCT00076336|11436049|FG000|Overall Study|Virologic Breakthrough|14
7226908|NCT00076336|11436050|FG001|Overall Study|Virologic Breakthrough|16
7226909|NCT00076336|11436049|FG000|Overall Study|Treatment failure|4
7226910|NCT00076336|11436050|FG001|Overall Study|Treatment failure|5
7226911|NCT00076570|11436058|FG000|Overall Study|Drug intolerance|8
7226912|NCT00076570|11436059|FG001|Overall Study|Drug intolerance|8
7226913|NCT00076752|11436099|FG000|Overall Study|Death|2
7226914|NCT00076752|11436099|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
7226915|NCT00076804|11436106|FG000|Overall Study|Death|9
7226916|NCT00076804|11436107|FG001|Overall Study|Death|20
7226917|NCT00076804|11436106|FG000|Overall Study|Lost to Follow-up|9
7226918|NCT00076804|11436107|FG001|Overall Study|Lost to Follow-up|9
7226919|NCT00076804|11436106|FG000|Overall Study|Withdrawal by Subject|10
7226920|NCT00076804|11436107|FG001|Overall Study|Withdrawal by Subject|8
7226921|NCT00076804|11436106|FG000|Overall Study|Early study Closure|32
7226922|NCT00076804|11436107|FG001|Overall Study|Early study Closure|32
7226923|NCT00076999|11436117|FG000|Overall Study|Adverse Event|2
7226924|NCT00076999|11436118|FG001|Overall Study|Adverse Event|8
7226925|NCT00076999|11436119|FG002|Overall Study|Adverse Event|6
7226926|NCT00076999|11436120|FG003|Overall Study|Adverse Event|0
7226927|NCT00076999|11436121|FG004|Overall Study|Adverse Event|2
7226928|NCT00076999|11436117|FG000|Overall Study|Protocol Violation|0
7226929|NCT00076999|11436118|FG001|Overall Study|Protocol Violation|3
7226930|NCT00076999|11436119|FG002|Overall Study|Protocol Violation|4
7226931|NCT00076999|11436120|FG003|Overall Study|Protocol Violation|0
7226932|NCT00076999|11436121|FG004|Overall Study|Protocol Violation|9
7226933|NCT00076999|11436117|FG000|Overall Study|Lost to Follow-up|2
7226934|NCT00076999|11436118|FG001|Overall Study|Lost to Follow-up|1
7226935|NCT00076999|11436119|FG002|Overall Study|Lost to Follow-up|0
7226936|NCT00076999|11436120|FG003|Overall Study|Lost to Follow-up|0
7226937|NCT00076999|11436121|FG004|Overall Study|Lost to Follow-up|0
7226938|NCT00076999|11436117|FG000|Overall Study|Withdrawal by Subject|0
7226939|NCT00076999|11436118|FG001|Overall Study|Withdrawal by Subject|4
7226940|NCT00076999|11436119|FG002|Overall Study|Withdrawal by Subject|3
7226941|NCT00076999|11436120|FG003|Overall Study|Withdrawal by Subject|0
7573221|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
7573222|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
7226942|NCT00076999|11436121|FG004|Overall Study|Withdrawal by Subject|1
7226943|NCT00076999|11436117|FG000|Overall Study|Other reason (not specified)|8
7226944|NCT00076999|11436118|FG001|Overall Study|Other reason (not specified)|8
7226945|NCT00076999|11436119|FG002|Overall Study|Other reason (not specified)|4
7226946|NCT00076999|11436120|FG003|Overall Study|Other reason (not specified)|1
7226947|NCT00076999|11436121|FG004|Overall Study|Other reason (not specified)|13
7226948|NCT00077064|11436136|FG000|Overall Study|Adverse Event|0
7226949|NCT00077064|11436137|FG001|Overall Study|Adverse Event|4
7226950|NCT00077064|11436136|FG000|Overall Study|Patient refusal|0
7226951|NCT00077064|11436137|FG001|Overall Study|Patient refusal|2
7573223|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7573224|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
7573225|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
7573226|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
7573227|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
7573228|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
7573229|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
7573230|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
7573231|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7573232|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
7573233|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
7573234|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
7573235|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7573236|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
7226952|NCT00077207|11436144|FG000|Overall Study|Adverse Event|5
7226953|NCT00077207|11436144|FG000|Overall Study|Lack of Efficacy|12
7226954|NCT00077207|11436144|FG000|Overall Study|Physician Decision|6
7226955|NCT00077207|11436144|FG000|Overall Study|Withdrawal by Subject|6
7226956|NCT00077207|11436144|FG000|Overall Study|Ineligible|1
7226957|NCT00077376|11436149|FG000|Overall Study|Adverse Event|8
7226958|NCT00077376|11436149|FG000|Overall Study|Withdrawal by Subject|2
7226959|NCT00077376|11436149|FG000|Overall Study|Death|1
7226960|NCT00077376|11436149|FG000|Overall Study|Physician Decision|1
7226961|NCT00077376|11436149|FG000|Overall Study|Alternative therapy|5
7226962|NCT00077376|11436149|FG000|Overall Study|Complicating disease|1
7226963|NCT00077376|11436149|FG000|Overall Study|Still on treatment|1
7226964|NCT00077376|11436149|FG000|Overall Study|Symptomatic deterioration|1
7226965|NCT00077376|11436149|FG000|Overall Study|Surgery|1
7226966|NCT00077376|11436149|FG000|Overall Study|Insurance ran out|1
7226967|NCT00077610|11436156|FG000|Overall Study|Adverse Event|9
7226968|NCT00077610|11436157|FG001|Overall Study|Adverse Event|7
7226969|NCT00077610|11436158|FG002|Overall Study|Adverse Event|1
7226970|NCT00077610|11436156|FG000|Overall Study|Lost to Follow-up|0
7226971|NCT00077610|11436157|FG001|Overall Study|Lost to Follow-up|1
7226972|NCT00077610|11436158|FG002|Overall Study|Lost to Follow-up|2
7226973|NCT00077610|11436156|FG000|Overall Study|Withdrawal by Subject|4
7226974|NCT00077610|11436157|FG001|Overall Study|Withdrawal by Subject|10
7226975|NCT00077610|11436158|FG002|Overall Study|Withdrawal by Subject|6
7226976|NCT00077610|11436156|FG000|Overall Study|Death|17
7226977|NCT00077610|11436157|FG001|Overall Study|Death|13
7226978|NCT00077610|11436158|FG002|Overall Study|Death|13
7226979|NCT00077610|11436156|FG000|Overall Study|Renal transplant|12
7226980|NCT00077610|11436157|FG001|Overall Study|Renal transplant|15
7226981|NCT00077610|11436158|FG002|Overall Study|Renal transplant|11
7226982|NCT00077610|11436156|FG000|Overall Study|Withdrew from dialysis care|5
7226983|NCT00077610|11436157|FG001|Overall Study|Withdrew from dialysis care|0
7226984|NCT00077610|11436158|FG002|Overall Study|Withdrew from dialysis care|3
7226985|NCT00077610|11436156|FG000|Overall Study|Insufficient Therapeutic Response|1
7226986|NCT00077610|11436157|FG001|Overall Study|Insufficient Therapeutic Response|0
7226987|NCT00077610|11436158|FG002|Overall Study|Insufficient Therapeutic Response|0
7226988|NCT00077610|11436156|FG000|Overall Study|Multiple blood transfusions|0
7226989|NCT00077610|11436157|FG001|Overall Study|Multiple blood transfusions|0
7226990|NCT00077610|11436158|FG002|Overall Study|Multiple blood transfusions|1
7226991|NCT00077610|11436156|FG000|Overall Study|Principal Investigator's decision|1
7226992|NCT00077610|11436157|FG001|Overall Study|Principal Investigator's decision|0
7226993|NCT00077610|11436158|FG002|Overall Study|Principal Investigator's decision|1
7226994|NCT00077610|11436156|FG000|Overall Study|Worsening of health condition|1
7226995|NCT00077610|11436157|FG001|Overall Study|Worsening of health condition|1
7226996|NCT00077610|11436158|FG002|Overall Study|Worsening of health condition|0
7226997|NCT00077610|11436156|FG000|Overall Study|Given Epogen in hospital|1
7226998|NCT00077610|11436157|FG001|Overall Study|Given Epogen in hospital|0
7226999|NCT00077610|11436158|FG002|Overall Study|Given Epogen in hospital|0
7227000|NCT00077610|11436156|FG000|Overall Study|Transferred to other unit|0
7227001|NCT00077610|11436157|FG001|Overall Study|Transferred to other unit|0
7227002|NCT00077610|11436158|FG002|Overall Study|Transferred to other unit|1
7227003|NCT00077610|11436156|FG000|Overall Study|Transferred to nursing home|0
7227004|NCT00077610|11436157|FG001|Overall Study|Transferred to nursing home|0
7227005|NCT00077610|11436158|FG002|Overall Study|Transferred to nursing home|1
7227006|NCT00077610|11436156|FG000|Overall Study|Transfer to satellite unit|1
7227007|NCT00077610|11436157|FG001|Overall Study|Transfer to satellite unit|0
7227008|NCT00077610|11436158|FG002|Overall Study|Transfer to satellite unit|0
7227009|NCT00077610|11436156|FG000|Overall Study|Transfer to other center for surgery|1
7227010|NCT00077610|11436157|FG001|Overall Study|Transfer to other center for surgery|0
7227011|NCT00077610|11436158|FG002|Overall Study|Transfer to other center for surgery|0
7227012|NCT00077610|11436156|FG000|Overall Study|Change in dialysis modality|1
7227013|NCT00077610|11436157|FG001|Overall Study|Change in dialysis modality|0
7227014|NCT00077610|11436158|FG002|Overall Study|Change in dialysis modality|0
7227015|NCT00077610|11436156|FG000|Overall Study|Relocation|0
7227016|NCT00077610|11436157|FG001|Overall Study|Relocation|8
7227017|NCT00077610|11436158|FG002|Overall Study|Relocation|5
7227018|NCT00077610|11436156|FG000|Overall Study|Financial issues|0
7227019|NCT00077610|11436157|FG001|Overall Study|Financial issues|1
7227020|NCT00077610|11436158|FG002|Overall Study|Financial issues|0
7227021|NCT00077610|11436156|FG000|Overall Study|Sponsors decision to withdraw|0
7227022|NCT00077610|11436157|FG001|Overall Study|Sponsors decision to withdraw|0
7227023|NCT00077610|11436158|FG002|Overall Study|Sponsors decision to withdraw|1
7227024|NCT00077623|11436174|FG000|Overall Study|Adverse Event|1
7227025|NCT00077623|11436175|FG001|Overall Study|Adverse Event|0
7227026|NCT00077623|11436176|FG002|Overall Study|Adverse Event|1
7227027|NCT00077623|11436174|FG000|Overall Study|Withdrawal by Subject|2
7227028|NCT00077623|11436175|FG001|Overall Study|Withdrawal by Subject|10
7227029|NCT00077623|11436176|FG002|Overall Study|Withdrawal by Subject|1
7227030|NCT00077623|11436174|FG000|Overall Study|Other-Non safety reason|18
7227031|NCT00077623|11436175|FG001|Overall Study|Other-Non safety reason|15
7227032|NCT00077623|11436176|FG002|Overall Study|Other-Non safety reason|19
7227033|NCT00077623|11436174|FG000|Overall Study|Insufficient therapeutic response|2
7227034|NCT00077623|11436175|FG001|Overall Study|Insufficient therapeutic response|0
7227035|NCT00077623|11436176|FG002|Overall Study|Insufficient therapeutic response|0
7227036|NCT00077623|11436174|FG000|Overall Study|Death|12
7227037|NCT00077623|11436175|FG001|Overall Study|Death|18
7227038|NCT00077623|11436176|FG002|Overall Study|Death|11
7227039|NCT00077623|11436174|FG000|Overall Study|Failure to return|1
7227040|NCT00077623|11436175|FG001|Overall Study|Failure to return|0
7227041|NCT00077623|11436176|FG002|Overall Study|Failure to return|0
7227042|NCT00077636|11436186|FG000|Overall Study|Refused Treatment|9
7227043|NCT00077636|11436187|FG001|Overall Study|Refused Treatment|31
7227044|NCT00077636|11436186|FG000|Overall Study|Admin|3
7227045|NCT00077636|11436187|FG001|Overall Study|Admin|3
7227046|NCT00077636|11436186|FG000|Overall Study|Withdrawal by Subject|2
7227047|NCT00077636|11436187|FG001|Overall Study|Withdrawal by Subject|2
7227048|NCT00077636|11436186|FG000|Overall Study|Adverse Event|17
7227049|NCT00077636|11436187|FG001|Overall Study|Adverse Event|34
7227050|NCT00077636|11436186|FG000|Overall Study|Protocol Violation|0
7227051|NCT00077636|11436187|FG001|Overall Study|Protocol Violation|2
7227052|NCT00077636|11436186|FG000|Overall Study|Lost to Follow-up|10
7227053|NCT00077636|11436187|FG001|Overall Study|Lost to Follow-up|18
7227054|NCT00077636|11436186|FG000|Overall Study|Abnormality Of Laboratory Test|3
7227055|NCT00077636|11436187|FG001|Overall Study|Abnormality Of Laboratory Test|2
7227056|NCT00077649|11436198|FG000|Overall Study|Adverse Event|5
7227057|NCT00077649|11436199|FG001|Overall Study|Adverse Event|1
7227058|NCT00077649|11436200|FG002|Overall Study|Adverse Event|7
7227059|NCT00077649|11436201|FG003|Overall Study|Adverse Event|9
7227060|NCT00077649|11436198|FG000|Overall Study|Lack of Efficacy|5
7227061|NCT00077649|11436199|FG001|Overall Study|Lack of Efficacy|3
7227062|NCT00077649|11436200|FG002|Overall Study|Lack of Efficacy|3
7227063|NCT00077649|11436201|FG003|Overall Study|Lack of Efficacy|2
7227064|NCT00077649|11436198|FG000|Overall Study|Withdrawal by Subject|0
7227065|NCT00077649|11436199|FG001|Overall Study|Withdrawal by Subject|1
7227066|NCT00077649|11436200|FG002|Overall Study|Withdrawal by Subject|1
7227067|NCT00077649|11436201|FG003|Overall Study|Withdrawal by Subject|2
7227068|NCT00077649|11436198|FG000|Overall Study|Lost to Follow-up|2
7227069|NCT00077649|11436199|FG001|Overall Study|Lost to Follow-up|2
7227070|NCT00077649|11436200|FG002|Overall Study|Lost to Follow-up|3
7227071|NCT00077649|11436201|FG003|Overall Study|Lost to Follow-up|2
7227072|NCT00077649|11436198|FG000|Overall Study|Abnormality of Laboratory Test|1
7227073|NCT00077649|11436199|FG001|Overall Study|Abnormality of Laboratory Test|2
7227074|NCT00077649|11436200|FG002|Overall Study|Abnormality of Laboratory Test|1
7227075|NCT00077649|11436201|FG003|Overall Study|Abnormality of Laboratory Test|2
7227076|NCT00077649|11436198|FG000|Overall Study|Randomized but never dosed|1
7227077|NCT00077649|11436199|FG001|Overall Study|Randomized but never dosed|0
7227078|NCT00077649|11436200|FG002|Overall Study|Randomized but never dosed|0
7227079|NCT00077649|11436201|FG003|Overall Study|Randomized but never dosed|0
7227080|NCT00077675|11436217|FG000|Overall Study|Adverse Event|1
7227081|NCT00077675|11436218|FG001|Overall Study|Adverse Event|2
7227082|NCT00077675|11436217|FG000|Overall Study|Lost to Follow-up|6
7227083|NCT00077675|11436218|FG001|Overall Study|Lost to Follow-up|3
7227084|NCT00077675|11436217|FG000|Overall Study|Withdrawal by Subject|1
7227085|NCT00077675|11436218|FG001|Overall Study|Withdrawal by Subject|0
7227086|NCT00077675|11436217|FG000|Overall Study|Other|0
7227087|NCT00077675|11436218|FG001|Overall Study|Other|1
7227088|NCT00077675|11436217|FG000|Overall Study|Never received study treatment|3
7227089|NCT00077675|11436218|FG001|Overall Study|Never received study treatment|3
7227090|NCT00077766|11436226|FG000|Overall Study|Adverse Event|1
7227091|NCT00077766|11436227|FG001|Overall Study|Adverse Event|1
7227092|NCT00077766|11436226|FG000|Overall Study|Withdrawal by Subject|4
7227093|NCT00077766|11436227|FG001|Overall Study|Withdrawal by Subject|3
7227094|NCT00077766|11436226|FG000|Overall Study|Death|12
7227095|NCT00077766|11436227|FG001|Overall Study|Death|10
7227096|NCT00077766|11436226|FG000|Overall Study|Lost to Follow-up|2
7227097|NCT00077766|11436227|FG001|Overall Study|Lost to Follow-up|0
7227098|NCT00077766|11436226|FG000|Overall Study|Protocol Violation|1
7227099|NCT00077766|11436227|FG001|Overall Study|Protocol Violation|0
7227100|NCT00077766|11436226|FG000|Overall Study|Kidney Transplantation|9
7227101|NCT00077766|11436227|FG001|Overall Study|Kidney Transplantation|5
7573237|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7227102|NCT00077766|11436226|FG000|Overall Study|Transplantation|5
7227103|NCT00077766|11436227|FG001|Overall Study|Transplantation|1
7227104|NCT00077766|11436226|FG000|Overall Study|Investigators Discretion|1
7227105|NCT00077766|11436227|FG001|Overall Study|Investigators Discretion|0
7227106|NCT00077766|11436226|FG000|Overall Study|Participant's decision|1
7227107|NCT00077766|11436227|FG001|Overall Study|Participant's decision|0
7227108|NCT00077766|11436226|FG000|Overall Study|Dialysis Discontinued|1
7227109|NCT00077766|11436227|FG001|Overall Study|Dialysis Discontinued|0
7227110|NCT00077766|11436226|FG000|Overall Study|Dialysis|0
7227111|NCT00077766|11436227|FG001|Overall Study|Dialysis|1
7227112|NCT00077766|11436226|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
7227113|NCT00077766|11436227|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
7227114|NCT00077766|11436226|FG000|Overall Study|Started Nocturnal Dialysis|0
7227115|NCT00077766|11436227|FG001|Overall Study|Started Nocturnal Dialysis|1
7573238|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
7227116|NCT00077766|11436226|FG000|Overall Study|Stop Dialysis|0
7227117|NCT00077766|11436227|FG001|Overall Study|Stop Dialysis|1
7227118|NCT00077766|11436226|FG000|Overall Study|Participants Vacation|2
7227119|NCT00077766|11436227|FG001|Overall Study|Participants Vacation|1
7227120|NCT00077857|11436236|FG000|Overall Study|Adverse Event|30
7227121|NCT00077857|11436237|FG001|Overall Study|Adverse Event|32
7227122|NCT00077857|11436236|FG000|Overall Study|Death|7
7227123|NCT00077857|11436237|FG001|Overall Study|Death|3
7227124|NCT00077857|11436236|FG000|Overall Study|Insufficient therapeutic response|112
7227125|NCT00077857|11436237|FG001|Overall Study|Insufficient therapeutic response|128
7227126|NCT00077857|11436236|FG000|Overall Study|Violation of selection criteria at entry|3
7227127|NCT00077857|11436237|FG001|Overall Study|Violation of selection criteria at entry|1
7227128|NCT00077857|11436236|FG000|Overall Study|Other protocol violation|0
7227129|NCT00077857|11436237|FG001|Overall Study|Other protocol violation|1
7227130|NCT00077857|11436236|FG000|Overall Study|Refused treatment|29
7227131|NCT00077857|11436237|FG001|Overall Study|Refused treatment|21
7227132|NCT00077857|11436236|FG000|Overall Study|Failure to return|5
7227133|NCT00077857|11436237|FG001|Overall Study|Failure to return|5
7227134|NCT00077857|11436236|FG000|Overall Study|Other|15
7227135|NCT00077857|11436237|FG001|Overall Study|Other|13
7227136|NCT00077974|11436247|FG000|Overall Study|Adverse Event|22
7227137|NCT00077974|11436247|FG000|Overall Study|Protocol Violation|1
7227138|NCT00077974|11436247|FG000|Overall Study|Withdrawal by Subject|3
7227139|NCT00077974|11436247|FG000|Overall Study|Lack of Efficacy|76
7227140|NCT00077974|11436247|FG000|Overall Study|Decision of Sponsor|2
7227141|NCT00078312|11436260|FG000|Overall Study|Adverse Event|43
7227142|NCT00078312|11436260|FG000|Overall Study|Lack of Efficacy|15
7227143|NCT00078312|11436260|FG000|Overall Study|Lost to Follow-up|41
7227144|NCT00078312|11436260|FG000|Overall Study|Physician Decision|9
7227145|NCT00078312|11436260|FG000|Overall Study|Protocol Violation|3
7227146|NCT00078312|11436260|FG000|Overall Study|Withdrawal by Subject|33
7227147|NCT00078312|11436260|FG000|Overall Study|Miscellaneous|33
7227148|NCT00078325|11436267|FG000|Overall Study|Adverse Event|15
7227149|NCT00078325|11436268|FG001|Overall Study|Adverse Event|10
7227150|NCT00078325|11436269|FG002|Overall Study|Adverse Event|5
7227151|NCT00078325|11436267|FG000|Overall Study|Protocol Violation|2
7227152|NCT00078325|11436268|FG001|Overall Study|Protocol Violation|2
7227153|NCT00078325|11436269|FG002|Overall Study|Protocol Violation|0
7227154|NCT00078325|11436267|FG000|Overall Study|Withdrawal by Subject|1
7227155|NCT00078325|11436268|FG001|Overall Study|Withdrawal by Subject|5
7227156|NCT00078325|11436269|FG002|Overall Study|Withdrawal by Subject|3
7227157|NCT00078325|11436267|FG000|Overall Study|Lost to Follow-up|0
7227158|NCT00078325|11436268|FG001|Overall Study|Lost to Follow-up|1
7227159|NCT00078325|11436269|FG002|Overall Study|Lost to Follow-up|1
7227160|NCT00078325|11436267|FG000|Overall Study|Physician Decision|2
7227161|NCT00078325|11436268|FG001|Overall Study|Physician Decision|0
7227162|NCT00078325|11436269|FG002|Overall Study|Physician Decision|1
7227163|NCT00078325|11436267|FG000|Overall Study|Miscellaneous|1
7227164|NCT00078325|11436268|FG001|Overall Study|Miscellaneous|1
7227165|NCT00078325|11436269|FG002|Overall Study|Miscellaneous|1
7227166|NCT00078338|11436279|FG000|Overall Study|Adverse Event|31
7227167|NCT00078338|11436280|FG001|Overall Study|Adverse Event|24
7227168|NCT00078338|11436279|FG000|Overall Study|Lost to Follow-up|17
7227169|NCT00078338|11436280|FG001|Overall Study|Lost to Follow-up|2
7227170|NCT00078338|11436279|FG000|Overall Study|Protocol Violation|2
7227171|NCT00078338|11436280|FG001|Overall Study|Protocol Violation|2
7227172|NCT00078338|11436279|FG000|Overall Study|Disease Progression|4
7227173|NCT00078338|11436280|FG001|Overall Study|Disease Progression|7
7227174|NCT00078338|11436279|FG000|Overall Study|Other|28
7227175|NCT00078338|11436280|FG001|Overall Study|Other|16
7227176|NCT00078338|11436279|FG000|Overall Study|Subjects randomized, but not treated|3
7227177|NCT00078338|11436280|FG001|Overall Study|Subjects randomized, but not treated|3
7227178|NCT00078377|11436289|FG000|Overall Study|Adverse Event|2
7227179|NCT00078377|11436290|FG001|Overall Study|Adverse Event|5
7227180|NCT00078377|11436291|FG002|Overall Study|Adverse Event|1
7227181|NCT00078377|11436289|FG000|Overall Study|Lack of Efficacy|2
7227182|NCT00078377|11436290|FG001|Overall Study|Lack of Efficacy|0
7227183|NCT00078377|11436291|FG002|Overall Study|Lack of Efficacy|2
7227184|NCT00078377|11436289|FG000|Overall Study|Lost to Follow-up|0
7227185|NCT00078377|11436290|FG001|Overall Study|Lost to Follow-up|1
7227186|NCT00078377|11436291|FG002|Overall Study|Lost to Follow-up|1
7227187|NCT00078377|11436289|FG000|Overall Study|Physician Decision|2
7227188|NCT00078377|11436290|FG001|Overall Study|Physician Decision|0
7227189|NCT00078377|11436291|FG002|Overall Study|Physician Decision|0
7227190|NCT00078377|11436289|FG000|Overall Study|Withdrawal by Subject|3
7227191|NCT00078377|11436290|FG001|Overall Study|Withdrawal by Subject|4
7227192|NCT00078377|11436291|FG002|Overall Study|Withdrawal by Subject|4
7227193|NCT00078377|11436289|FG000|Overall Study|Miscellaneous|2
7227194|NCT00078377|11436290|FG001|Overall Study|Miscellaneous|6
7227195|NCT00078377|11436291|FG002|Overall Study|Miscellaneous|1
7227196|NCT00078767|11436356|FG000|Overall Study|Withdrawal by Subject|1
7227197|NCT00078767|11436357|FG001|Overall Study|Withdrawal by Subject|1
7227198|NCT00078819|11436365|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7227199|NCT00078819|11436366|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
7227200|NCT00078819|11436367|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7227201|NCT00078819|11436368|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
7227202|NCT00078819|11436365|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
7227203|NCT00078819|11436366|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7227204|NCT00078819|11436367|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7227205|NCT00078819|11436368|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
7227206|NCT00078819|11436365|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7227207|NCT00078819|11436366|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
7227208|NCT00078819|11436367|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7227209|NCT00078819|11436368|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
7227210|NCT00078819|11436365|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
7227211|NCT00078819|11436366|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
7227212|NCT00078819|11436367|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7227213|NCT00078819|11436368|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
7227214|NCT00078819|11436365|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7227215|NCT00078819|11436366|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
7227216|NCT00078819|11436367|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7227217|NCT00078819|11436368|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
7227218|NCT00078819|11436365|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
7227219|NCT00078819|11436366|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
7227220|NCT00078819|11436367|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7227221|NCT00078819|11436368|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
7227222|NCT00078819|11436365|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7227223|NCT00078819|11436366|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
7227224|NCT00078819|11436367|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
7227225|NCT00078819|11436368|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
7227226|NCT00078819|11436365|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7227227|NCT00078819|11436366|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7227228|NCT00078819|11436367|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
7227229|NCT00078819|11436368|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
7227230|NCT00078949|11436398|FG000|Overall Study|No treated|4
7227231|NCT00078949|11436399|FG001|Overall Study|No treated|5
7227232|NCT00078949|11436400|FG002|Overall Study|No treated|3
7227233|NCT00078949|11436401|FG003|Overall Study|No treated|3
7227234|NCT00079040|11436422|FG000|Overall Study|Withdrew before treatment|1
7227235|NCT00079040|11436422|FG000|Overall Study|Ineligible|1
7227236|NCT00079183|11436426|FG000|Overall Study|Withdrawal by Subject|4
7227237|NCT00079183|11436426|FG000|Overall Study|Study medication non-compliance|2
7227238|NCT00079183|11436426|FG000|Overall Study|Specimen collection non-compliance|1
7227239|NCT00079274|11436438|FG000|Overall Study|Withdrawal by Subject|111
7227240|NCT00079274|11436439|FG001|Overall Study|Withdrawal by Subject|10
7227241|NCT00079274|11436440|FG002|Overall Study|Withdrawal by Subject|12
7227242|NCT00079274|11436441|FG003|Overall Study|Withdrawal by Subject|163
7227243|NCT00079274|11436442|FG004|Overall Study|Withdrawal by Subject|7
7227244|NCT00079274|11436443|FG005|Overall Study|Withdrawal by Subject|8
7227245|NCT00079274|11436444|FG006|Overall Study|Withdrawal by Subject|0
7227246|NCT00079274|11436438|FG000|Overall Study|Adverse Event|130
7227247|NCT00079274|11436439|FG001|Overall Study|Adverse Event|8
7227248|NCT00079274|11436440|FG002|Overall Study|Adverse Event|8
7227249|NCT00079274|11436441|FG003|Overall Study|Adverse Event|184
7227250|NCT00079274|11436442|FG004|Overall Study|Adverse Event|7
7227251|NCT00079274|11436443|FG005|Overall Study|Adverse Event|8
7227252|NCT00079274|11436444|FG006|Overall Study|Adverse Event|0
7227253|NCT00079274|11436438|FG000|Overall Study|Recurrence|21
7227254|NCT00079274|11436439|FG001|Overall Study|Recurrence|0
7227255|NCT00079274|11436440|FG002|Overall Study|Recurrence|1
7227256|NCT00079274|11436441|FG003|Overall Study|Recurrence|15
7227257|NCT00079274|11436442|FG004|Overall Study|Recurrence|0
7227258|NCT00079274|11436443|FG005|Overall Study|Recurrence|2
7227259|NCT00079274|11436444|FG006|Overall Study|Recurrence|0
7227260|NCT00079274|11436438|FG000|Overall Study|Alternate Treatment|6
7227261|NCT00079274|11436439|FG001|Overall Study|Alternate Treatment|1
7227262|NCT00079274|11436440|FG002|Overall Study|Alternate Treatment|0
7227263|NCT00079274|11436441|FG003|Overall Study|Alternate Treatment|3
7227264|NCT00079274|11436442|FG004|Overall Study|Alternate Treatment|0
7227265|NCT00079274|11436443|FG005|Overall Study|Alternate Treatment|0
7227266|NCT00079274|11436444|FG006|Overall Study|Alternate Treatment|0
7227267|NCT00079274|11436438|FG000|Overall Study|Other Medical Problems|6
7227268|NCT00079274|11436439|FG001|Overall Study|Other Medical Problems|1
7227269|NCT00079274|11436440|FG002|Overall Study|Other Medical Problems|0
7227270|NCT00079274|11436441|FG003|Overall Study|Other Medical Problems|7
7227271|NCT00079274|11436442|FG004|Overall Study|Other Medical Problems|0
7227272|NCT00079274|11436443|FG005|Overall Study|Other Medical Problems|0
7227273|NCT00079274|11436444|FG006|Overall Study|Other Medical Problems|0
7227274|NCT00079274|11436438|FG000|Overall Study|Death|4
7227275|NCT00079274|11436439|FG001|Overall Study|Death|0
7227276|NCT00079274|11436440|FG002|Overall Study|Death|1
7227277|NCT00079274|11436441|FG003|Overall Study|Death|15
7227278|NCT00079274|11436442|FG004|Overall Study|Death|0
7227279|NCT00079274|11436443|FG005|Overall Study|Death|0
7227280|NCT00079274|11436444|FG006|Overall Study|Death|0
7227281|NCT00079274|11436438|FG000|Overall Study|Cytogenetic resistance|0
7227282|NCT00079274|11436439|FG001|Overall Study|Cytogenetic resistance|0
7227283|NCT00079274|11436440|FG002|Overall Study|Cytogenetic resistance|0
7227284|NCT00079274|11436441|FG003|Overall Study|Cytogenetic resistance|2
7227285|NCT00079274|11436442|FG004|Overall Study|Cytogenetic resistance|0
7227286|NCT00079274|11436443|FG005|Overall Study|Cytogenetic resistance|0
7227287|NCT00079274|11436444|FG006|Overall Study|Cytogenetic resistance|0
7227288|NCT00079274|11436438|FG000|Overall Study|Other|43
7227289|NCT00079274|11436439|FG001|Overall Study|Other|7
7227290|NCT00079274|11436440|FG002|Overall Study|Other|5
7227291|NCT00079274|11436441|FG003|Overall Study|Other|55
7227292|NCT00079274|11436442|FG004|Overall Study|Other|1
7227293|NCT00079274|11436443|FG005|Overall Study|Other|2
7227294|NCT00079274|11436444|FG006|Overall Study|Other|0
7227295|NCT00079339|11436468|FG000|Overall Study|Adverse Event|1
7227296|NCT00079339|11436469|FG001|Overall Study|Adverse Event|7
7227297|NCT00079339|11436470|FG002|Overall Study|Adverse Event|2
7227298|NCT00079339|11436468|FG000|Overall Study|Death|1
7227299|NCT00079339|11436469|FG001|Overall Study|Death|0
7227300|NCT00079339|11436470|FG002|Overall Study|Death|0
7227301|NCT00079339|11436468|FG000|Overall Study|Non-compliance|0
7227302|NCT00079339|11436469|FG001|Overall Study|Non-compliance|0
7227303|NCT00079339|11436470|FG002|Overall Study|Non-compliance|1
7227304|NCT00079339|11436468|FG000|Overall Study|Withdrawal by Subject|0
7227305|NCT00079339|11436469|FG001|Overall Study|Withdrawal by Subject|4
7227306|NCT00079339|11436470|FG002|Overall Study|Withdrawal by Subject|1
7227307|NCT00079339|11436468|FG000|Overall Study|Disease progression|3
7227308|NCT00079339|11436469|FG001|Overall Study|Disease progression|28
7227309|NCT00079339|11436470|FG002|Overall Study|Disease progression|2
7227310|NCT00079391|11436483|FG000|Overall Study|Withdrawal by Subject|1
7227311|NCT00079417|11436489|FG000|Overall Study|Physician Decision|2
7227312|NCT00079417|11436489|FG000|Overall Study|Ineligible|7
7227313|NCT00079677|11436495|FG000|Overall Study|Adverse Event|5
7227314|NCT00079677|11436496|FG001|Overall Study|Adverse Event|6
7227315|NCT00079677|11436495|FG000|Overall Study|Lack of Efficacy|1
7227316|NCT00079677|11436496|FG001|Overall Study|Lack of Efficacy|0
7227317|NCT00079677|11436495|FG000|Overall Study|Lost to Follow-up|2
7227318|NCT00079677|11436496|FG001|Overall Study|Lost to Follow-up|2
7227319|NCT00079677|11436495|FG000|Overall Study|Physician Decision|3
7227320|NCT00079677|11436496|FG001|Overall Study|Physician Decision|0
7227321|NCT00079677|11436495|FG000|Overall Study|Protocol Violation|2
7227322|NCT00079677|11436496|FG001|Overall Study|Protocol Violation|3
7227323|NCT00079677|11436495|FG000|Overall Study|Withdrawal by Subject|5
7227324|NCT00079677|11436496|FG001|Overall Study|Withdrawal by Subject|3
7227325|NCT00079677|11436495|FG000|Overall Study|Miscellaneous|2
7227326|NCT00079677|11436496|FG001|Overall Study|Miscellaneous|0
7227327|NCT00079781|11436505|FG000|Pre-implant Period|Withdrawal by Subject|2
7227328|NCT00079781|11436506|FG001|Pre-implant Period|Withdrawal by Subject|0
7227329|NCT00079781|11436507|FG002|Pre-implant Period|Withdrawal by Subject|0
7227330|NCT00079781|11436505|FG000|Pre-implant Period|Did not meet I/E criteria|1
7227331|NCT00079781|11436506|FG001|Pre-implant Period|Did not meet I/E criteria|1
7227332|NCT00079781|11436507|FG002|Pre-implant Period|Did not meet I/E criteria|1
7227333|NCT00079781|11436505|FG000|Follow-up Period|Withdrawal by Subject|3
7227334|NCT00079781|11436506|FG001|Follow-up Period|Withdrawal by Subject|0
7227335|NCT00079781|11436507|FG002|Follow-up Period|Withdrawal by Subject|1
7227336|NCT00079781|11436505|FG000|Follow-up Period|Lost to Follow-up|1
7227337|NCT00079781|11436506|FG001|Follow-up Period|Lost to Follow-up|0
7227338|NCT00079781|11436507|FG002|Follow-up Period|Lost to Follow-up|0
7227339|NCT00079781|11436505|FG000|Follow-up Period|Death|0
7227340|NCT00079781|11436506|FG001|Follow-up Period|Death|0
7227341|NCT00079781|11436507|FG002|Follow-up Period|Death|1
7227342|NCT00079937|11436515|FG000|Overall Study|Adverse Event|2
7227343|NCT00079937|11436516|FG001|Overall Study|Adverse Event|1
7227344|NCT00079937|11436515|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7227345|NCT00079937|11436516|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7227346|NCT00079937|11436515|FG000|Overall Study|Subject no longer requires study drug|3
7227347|NCT00079937|11436516|FG001|Overall Study|Subject no longer requires study drug|0
7227348|NCT00079937|11436515|FG000|Overall Study|Protocol Violation|8
7227349|NCT00079937|11436516|FG001|Overall Study|Protocol Violation|6
7227350|NCT00079937|11436515|FG000|Overall Study|Withdrawal by Subject|21
7227351|NCT00079937|11436516|FG001|Overall Study|Withdrawal by Subject|7
7227352|NCT00079937|11436515|FG000|Overall Study|Lost to Follow-up|12
7227353|NCT00079937|11436516|FG001|Overall Study|Lost to Follow-up|5
7227354|NCT00079937|11436515|FG000|Overall Study|Administrative problems|22
7227355|NCT00079937|11436516|FG001|Overall Study|Administrative problems|11
7227356|NCT00080119|11436526|FG000|Overall Study|Discontinued because of study closure|0
7227357|NCT00080119|11436527|FG001|Overall Study|Discontinued because of study closure|0
7227358|NCT00080119|11436528|FG002|Overall Study|Discontinued because of study closure|130
7227359|NCT00080119|11436529|FG003|Overall Study|Discontinued because of study closure|141
7227360|NCT00080119|11436526|FG000|Overall Study|Unable to get to clinic|24
7227361|NCT00080119|11436527|FG001|Overall Study|Unable to get to clinic|24
7227362|NCT00080119|11436528|FG002|Overall Study|Unable to get to clinic|7
7227363|NCT00080119|11436529|FG003|Overall Study|Unable to get to clinic|1
7227364|NCT00080119|11436526|FG000|Overall Study|Consent withdrawn|13
7227365|NCT00080119|11436527|FG001|Overall Study|Consent withdrawn|17
7227366|NCT00080119|11436528|FG002|Overall Study|Consent withdrawn|4
7227367|NCT00080119|11436529|FG003|Overall Study|Consent withdrawn|6
7227368|NCT00080119|11436526|FG000|Overall Study|Unwilling to adhere to study requirement|3
7227369|NCT00080119|11436527|FG001|Overall Study|Unwilling to adhere to study requirement|2
7227370|NCT00080119|11436528|FG002|Overall Study|Unwilling to adhere to study requirement|5
7227371|NCT00080119|11436529|FG003|Overall Study|Unwilling to adhere to study requirement|1
7227372|NCT00080119|11436526|FG000|Overall Study|Lost to Follow-up|16
7227373|NCT00080119|11436527|FG001|Overall Study|Lost to Follow-up|19
7227374|NCT00080119|11436528|FG002|Overall Study|Lost to Follow-up|19
7227375|NCT00080119|11436529|FG003|Overall Study|Lost to Follow-up|14
7227376|NCT00080223|11436541|FG000|Overall Study|Adverse Event|23
7227377|NCT00080223|11436541|FG000|Overall Study|Death|21
7227378|NCT00080223|11436541|FG000|Overall Study|Withdrawal by Subject|13
7227379|NCT00080223|11436541|FG000|Overall Study|Lung Transplantation|9
7227380|NCT00080223|11436541|FG000|Overall Study|Non-compliance With Study Treatment|7
7227381|NCT00080223|11436541|FG000|Overall Study|Participant unwilling to continue|2
7227382|NCT00080223|11436541|FG000|Overall Study|Physician Decision|1
7227383|NCT00080288|11436547|FG000|Overall Study|Adverse Event|7
7227384|NCT00080288|11436548|FG001|Overall Study|Adverse Event|4
7227385|NCT00080288|11436547|FG000|Overall Study|Lost to Follow-up|3
7227386|NCT00080288|11436548|FG001|Overall Study|Lost to Follow-up|5
7227387|NCT00080288|11436547|FG000|Overall Study|Physician Decision|6
7227388|NCT00080288|11436548|FG001|Overall Study|Physician Decision|2
7227389|NCT00080288|11436547|FG000|Overall Study|Withdrawal by Subject|3
7227390|NCT00080288|11436548|FG001|Overall Study|Withdrawal by Subject|16
7227391|NCT00080288|11436547|FG000|Overall Study|Miscellaneous|11
7227392|NCT00080288|11436548|FG001|Overall Study|Miscellaneous|11
7227393|NCT00080301|11436556|FG000|Overall Study|Randomized but Never Treated|5
7227394|NCT00080301|11436557|FG001|Overall Study|Randomized but Never Treated|10
7227395|NCT00080301|11436556|FG000|Overall Study|Still on Treatment as of CSR date|0
7227396|NCT00080301|11436557|FG001|Overall Study|Still on Treatment as of CSR date|1
7227397|NCT00080483|11436577|FG000|Overall Study|Lost to Follow-up|1
7227398|NCT00080483|11436578|FG001|Overall Study|Lost to Follow-up|1
7227399|NCT00080483|11436577|FG000|Overall Study|Physician Decision|1
7227400|NCT00080483|11436578|FG001|Overall Study|Physician Decision|1
7227401|NCT00080899|11436588|FG000|Overall Study|Adverse Event|1
7227402|NCT00080938|11436601|FG000|Overall Study|Adverse Event|3
7227403|NCT00080938|11436601|FG000|Overall Study|Withdrawal by Subject|6
7227404|NCT00080938|11436601|FG000|Overall Study|Death|2
7227405|NCT00080938|11436601|FG000|Overall Study|Lack of Efficacy|7
7227406|NCT00080938|11436601|FG000|Overall Study|other disease|1
7227407|NCT00080938|11436601|FG000|Overall Study|Not started protocol therapy|1
7227408|NCT00080938|11436601|FG000|Overall Study|Ineligible|4
7227409|NCT00081159|11436607|FG000|Overall Study|Withdrawal by Subject|0
7227410|NCT00081159|11436608|FG001|Overall Study|Withdrawal by Subject|3
7227411|NCT00081159|11436607|FG000|Overall Study|Myelosuppression prior to treatment|0
7227412|NCT00081159|11436608|FG001|Overall Study|Myelosuppression prior to treatment|1
7227413|NCT00081159|11436607|FG000|Overall Study|Lost to Follow-up|2
7227414|NCT00081159|11436608|FG001|Overall Study|Lost to Follow-up|1
7227415|NCT00081263|11436616|FG000|Overall Study|clerical error|1
7227416|NCT00081263|11436617|FG001|Overall Study|clerical error|0
7227417|NCT00081263|11436616|FG000|Overall Study|wrong cell type|7
7227418|NCT00081263|11436617|FG001|Overall Study|wrong cell type|5
7227419|NCT00081263|11436616|FG000|Overall Study|improper pre-protocol therapy|0
7227420|NCT00081263|11436617|FG001|Overall Study|improper pre-protocol therapy|1
7227421|NCT00081263|11436616|FG000|Overall Study|Inadequate pathology|0
7227422|NCT00081263|11436617|FG001|Overall Study|Inadequate pathology|1
7227423|NCT00081263|11436616|FG000|Overall Study|Never treated|4
7227424|NCT00081263|11436617|FG001|Overall Study|Never treated|5
7227425|NCT00081263|11436616|FG000|Overall Study|Inadequate data|5
7227426|NCT00081263|11436617|FG001|Overall Study|Inadequate data|10
7227427|NCT00081289|11436625|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
7227428|NCT00081289|11436626|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
7227429|NCT00081289|11436625|FG000|Overall Study|Ineligible / no protocol treatment|3
7227430|NCT00081289|11436626|FG001|Overall Study|Ineligible / no protocol treatment|4
7227431|NCT00081458|11436650|FG000|Overall Study|Adverse Event|1
7227432|NCT00081458|11436651|FG001|Overall Study|Adverse Event|5
7227433|NCT00081458|11436652|FG002|Overall Study|Adverse Event|2
7227434|NCT00081458|11436650|FG000|Overall Study|Withdrawal by Subject|0
7227435|NCT00081458|11436651|FG001|Overall Study|Withdrawal by Subject|3
7227436|NCT00081458|11436652|FG002|Overall Study|Withdrawal by Subject|1
7227437|NCT00081458|11436650|FG000|Overall Study|Randomized but not dosed|0
7227438|NCT00081458|11436651|FG001|Overall Study|Randomized but not dosed|0
7227439|NCT00081458|11436652|FG002|Overall Study|Randomized but not dosed|1
7227440|NCT00081497|11436663|FG000|Overall Study|Adverse Event|2
7227441|NCT00081497|11436664|FG001|Overall Study|Adverse Event|0
7227442|NCT00081497|11436663|FG000|Overall Study|Death|0
7227443|NCT00081497|11436664|FG001|Overall Study|Death|1
7227444|NCT00081497|11436663|FG000|Overall Study|Withdrawal by Subject|1
7227445|NCT00081497|11436664|FG001|Overall Study|Withdrawal by Subject|0
7227446|NCT00081497|11436663|FG000|Overall Study|Non-compliance|0
7227447|NCT00081497|11436664|FG001|Overall Study|Non-compliance|1
7227448|NCT00081653|11436678|FG000|Overall Study|Adverse Event|23
7227449|NCT00081653|11436679|FG001|Overall Study|Adverse Event|17
7227450|NCT00081653|11436678|FG000|Overall Study|Lost to Follow-up|2
7227451|NCT00081653|11436679|FG001|Overall Study|Lost to Follow-up|4
7227452|NCT00081653|11436678|FG000|Overall Study|Refused Treatment|18
7227453|NCT00081653|11436679|FG001|Overall Study|Refused Treatment|14
7227454|NCT00081653|11436678|FG000|Overall Study|Low bone mineral density|1
7227455|NCT00081653|11436679|FG001|Overall Study|Low bone mineral density|0
7227456|NCT00081653|11436678|FG000|Overall Study|Bone loss|2
7227457|NCT00081653|11436679|FG001|Overall Study|Bone loss|0
7227458|NCT00081653|11436678|FG000|Overall Study|Participant leaving country|1
7227459|NCT00081653|11436679|FG001|Overall Study|Participant leaving country|0
7227460|NCT00081653|11436678|FG000|Overall Study|Loss of bone mass|0
7227461|NCT00081653|11436679|FG001|Overall Study|Loss of bone mass|2
7227462|NCT00081731|11436688|FG000|Overall Study|scientific integrity issue|8
7227463|NCT00081731|11436689|FG001|Overall Study|scientific integrity issue|8
7227464|NCT00081770|11436698|FG000|Overall Study|Adverse Event|130
7227465|NCT00081770|11436699|FG001|Overall Study|Adverse Event|98
7227466|NCT00081770|11436700|FG002|Overall Study|Adverse Event|136
7227467|NCT00081770|11436698|FG000|Overall Study|Lack of Efficacy|262
7227468|NCT00081770|11436699|FG001|Overall Study|Lack of Efficacy|357
7227469|NCT00081770|11436700|FG002|Overall Study|Lack of Efficacy|211
7227470|NCT00081770|11436698|FG000|Overall Study|Lost to Follow-up|45
7227471|NCT00081770|11436699|FG001|Overall Study|Lost to Follow-up|34
7227472|NCT00081770|11436700|FG002|Overall Study|Lost to Follow-up|45
7227473|NCT00081770|11436698|FG000|Overall Study|Protocol Violation|15
7227474|NCT00081770|11436699|FG001|Overall Study|Protocol Violation|10
7227475|NCT00081770|11436700|FG002|Overall Study|Protocol Violation|10
7227476|NCT00081770|11436698|FG000|Overall Study|Withdrawal by Subject|45
7227477|NCT00081770|11436699|FG001|Overall Study|Withdrawal by Subject|40
7227478|NCT00081770|11436700|FG002|Overall Study|Withdrawal by Subject|42
7227479|NCT00081770|11436698|FG000|Overall Study|Did not meet protocol eligibility|2
7227480|NCT00081770|11436699|FG001|Overall Study|Did not meet protocol eligibility|0
7227481|NCT00081770|11436700|FG002|Overall Study|Did not meet protocol eligibility|3
7227482|NCT00081770|11436698|FG000|Overall Study|Administrative|1
7227483|NCT00081770|11436699|FG001|Overall Study|Administrative|0
7227484|NCT00081770|11436700|FG002|Overall Study|Administrative|1
7227485|NCT00081770|11436698|FG000|Overall Study|Other|2
7227486|NCT00081770|11436699|FG001|Overall Study|Other|7
7227487|NCT00081770|11436700|FG002|Overall Study|Other|8
7227488|NCT00082173|11436725|FG000|Overall Study|Withdrawal by Subject|3
7227489|NCT00082173|11436726|FG001|Overall Study|Withdrawal by Subject|5
7227490|NCT00082173|11436725|FG000|Overall Study|Lost to Follow-up|1
7227491|NCT00082173|11436726|FG001|Overall Study|Lost to Follow-up|0
7227492|NCT00082173|11436725|FG000|Overall Study|Adverse Event|1
7227493|NCT00082173|11436726|FG001|Overall Study|Adverse Event|0
7227494|NCT00082173|11436725|FG000|Overall Study|Culture negative or resistant at baselin|5
7227495|NCT00082173|11436726|FG001|Overall Study|Culture negative or resistant at baselin|6
7227496|NCT00082355|11436759|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
7573239|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
7573240|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
7573241|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7573242|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
7573243|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
7227497|NCT00082355|11436759|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
7227498|NCT00082355|11436759|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
7227499|NCT00082368|11436763|FG000|Overall Study|Not treated-pt had poor IV access|1
7227500|NCT00082381|11436769|FG000|Overall Study|Adverse Event|27
7227501|NCT00082381|11436770|FG001|Overall Study|Adverse Event|2
7227502|NCT00082381|11436769|FG000|Overall Study|Lost to Follow-up|5
7227503|NCT00082381|11436770|FG001|Overall Study|Lost to Follow-up|7
7227504|NCT00082381|11436769|FG000|Overall Study|Patient Decision|8
7227505|NCT00082381|11436770|FG001|Overall Study|Patient Decision|4
7227506|NCT00082381|11436769|FG000|Overall Study|Physician Decision|1
7227507|NCT00082381|11436770|FG001|Overall Study|Physician Decision|2
7227508|NCT00082381|11436769|FG000|Overall Study|Protocol Violation|10
7227509|NCT00082381|11436770|FG001|Overall Study|Protocol Violation|11
7227510|NCT00082381|11436769|FG000|Overall Study|Loss of Glucose Control|4
7227511|NCT00082381|11436770|FG001|Overall Study|Loss of Glucose Control|0
7255476|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
7255477|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
7255478|NCT00318461|11467022|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
7255479|NCT00318461|11467023|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7255480|NCT00318461|11467024|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7255481|NCT00318461|11467025|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
7255482|NCT00318461|11467026|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
7255483|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Work commitment|0
7255484|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Work commitment|0
7255485|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Work commitment|0
7227512|NCT00082407|11436778|FG000|Overall Study|Adverse Event|20
7227513|NCT00082407|11436779|FG001|Overall Study|Adverse Event|0
7227514|NCT00082407|11436778|FG000|Overall Study|Protocol Violation|14
7227515|NCT00082407|11436779|FG001|Overall Study|Protocol Violation|12
7227516|NCT00082407|11436778|FG000|Overall Study|Patient Decision|13
7227517|NCT00082407|11436779|FG001|Overall Study|Patient Decision|6
7227518|NCT00082407|11436778|FG000|Overall Study|Physician Decision|5
7227519|NCT00082407|11436779|FG001|Overall Study|Physician Decision|3
7227520|NCT00082407|11436778|FG000|Overall Study|Loss of Glucose Control|2
7227521|NCT00082407|11436779|FG001|Overall Study|Loss of Glucose Control|2
7227522|NCT00082407|11436778|FG000|Overall Study|Death|2
7227523|NCT00082407|11436779|FG001|Overall Study|Death|1
7227524|NCT00082407|11436778|FG000|Overall Study|Lost to Follow-up|0
7227525|NCT00082407|11436779|FG001|Overall Study|Lost to Follow-up|3
7227526|NCT00082433|11436787|FG000|Overall Study|Adverse Event|12
7227527|NCT00082433|11436788|FG001|Overall Study|Adverse Event|17
7227528|NCT00082433|11436787|FG000|Overall Study|Death|8
7227529|NCT00082433|11436788|FG001|Overall Study|Death|18
7227530|NCT00082433|11436787|FG000|Overall Study|Disease Progression/Relapse|270
7227531|NCT00082433|11436788|FG001|Overall Study|Disease Progression/Relapse|388
7227532|NCT00082433|11436787|FG000|Overall Study|Physician Decision|50
7227533|NCT00082433|11436788|FG001|Overall Study|Physician Decision|61
7227534|NCT00082433|11436787|FG000|Overall Study|Lost to Follow-up|1
7227535|NCT00082433|11436788|FG001|Overall Study|Lost to Follow-up|2
7227536|NCT00082433|11436787|FG000|Overall Study|Study Drug Toxicity|179
7227537|NCT00082433|11436788|FG001|Overall Study|Study Drug Toxicity|66
7227538|NCT00082433|11436787|FG000|Overall Study|Withdrawal by Subject|55
7227539|NCT00082433|11436788|FG001|Overall Study|Withdrawal by Subject|30
7227540|NCT00082433|11436787|FG000|Overall Study|Still On Treatment|2
7227541|NCT00082433|11436788|FG001|Overall Study|Still On Treatment|1
7227542|NCT00082433|11436787|FG000|Overall Study|Not Treated|12
7227543|NCT00082433|11436788|FG001|Overall Study|Not Treated|11
7227544|NCT00082433|11436787|FG000|Overall Study|Ineligible|2
7227545|NCT00082433|11436788|FG001|Overall Study|Ineligible|1
7227546|NCT00082433|11436787|FG000|Overall Study|Noncompliance|2
7227547|NCT00082433|11436788|FG001|Overall Study|Noncompliance|1
7227548|NCT00082433|11436787|FG000|Overall Study|New primary cancer|1
7227549|NCT00082433|11436788|FG001|Overall Study|New primary cancer|0
7227550|NCT00082433|11436787|FG000|Overall Study|Impending surgery|0
7227551|NCT00082433|11436788|FG001|Overall Study|Impending surgery|1
7227552|NCT00082628|11436796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7227553|NCT00082628|11436797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
7227554|NCT00082628|11436798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7227555|NCT00082628|11436799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7227556|NCT00082628|11436800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
7227557|NCT00082628|11436796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
7227558|NCT00082628|11436797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
7227559|NCT00082628|11436798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7227560|NCT00082628|11436799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7227561|NCT00082628|11436800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
7227562|NCT00082628|11436796|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
7227563|NCT00082628|11436797|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
7227564|NCT00082628|11436798|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7227565|NCT00082628|11436799|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7227566|NCT00082628|11436800|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
7227567|NCT00082628|11436796|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
7227568|NCT00082628|11436797|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
7227569|NCT00082628|11436798|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7227570|NCT00082628|11436799|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7227571|NCT00082628|11436800|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
7227572|NCT00082628|11436796|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7227573|NCT00082628|11436797|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7227574|NCT00082628|11436798|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7227575|NCT00082628|11436799|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
7227576|NCT00082628|11436800|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
7227577|NCT00082628|11436796|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7227578|NCT00082628|11436797|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7227579|NCT00082628|11436798|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7227580|NCT00082628|11436799|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
7227581|NCT00082628|11436800|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
7227582|NCT00082628|11436796|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7227583|NCT00082628|11436797|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
7227669|NCT00084266|11436949|FG001|Overall Study|Adverse Event|5
7227584|NCT00082628|11436798|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7227585|NCT00082628|11436799|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
7227586|NCT00082628|11436800|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
7227587|NCT00082758|11436825|FG000|Overall Study|Adverse Event|0
7227588|NCT00082758|11436826|FG001|Overall Study|Adverse Event|2
7227589|NCT00082758|11436827|FG002|Overall Study|Adverse Event|0
7227590|NCT00082758|11436825|FG000|Overall Study|Lack of Efficacy|12
7227591|NCT00082758|11436826|FG001|Overall Study|Lack of Efficacy|13
7227592|NCT00082758|11436827|FG002|Overall Study|Lack of Efficacy|0
7227593|NCT00082758|11436825|FG000|Overall Study|Physician Decision|0
7227594|NCT00082758|11436826|FG001|Overall Study|Physician Decision|1
7227595|NCT00082758|11436827|FG002|Overall Study|Physician Decision|0
7227596|NCT00082758|11436825|FG000|Overall Study|Withdrawal by Subject|3
7227597|NCT00082758|11436826|FG001|Overall Study|Withdrawal by Subject|0
7227598|NCT00082758|11436827|FG002|Overall Study|Withdrawal by Subject|0
7227599|NCT00082758|11436825|FG000|Overall Study|Protocol Violation|0
7227600|NCT00082758|11436826|FG001|Overall Study|Protocol Violation|1
7227601|NCT00082758|11436827|FG002|Overall Study|Protocol Violation|0
7227602|NCT00082810|11436835|FG000|Overall Study|Adverse Event|3
7227603|NCT00082810|11436835|FG000|Overall Study|Progressive disease|24
7227604|NCT00082810|11436835|FG000|Overall Study|Withdrawal by Subject|4
7227605|NCT00082888|11436843|FG000|Overall Study|Ineligible|1
7227606|NCT00082888|11436844|FG001|Overall Study|Ineligible|0
7227607|NCT00082888|11436845|FG002|Overall Study|Ineligible|0
7227608|NCT00083226|11436877|FG000|Overall Study|Lack of Efficacy|19
7227609|NCT00083226|11436877|FG000|Overall Study|Adverse Event|9
7227610|NCT00083226|11436877|FG000|Overall Study|Death|4
7227611|NCT00083226|11436877|FG000|Overall Study|Withdrawal by Subject|4
7227612|NCT00083226|11436877|FG000|Overall Study|Other|2
7227613|NCT00083226|11436877|FG000|Overall Study|ineligible or not receiving treatment|4
7227614|NCT00083616|11436894|FG000|Overall Study|Disease Progression|16
7227615|NCT00083616|11436894|FG000|Overall Study|Lost to Follow-up|1
7227616|NCT00083616|11436894|FG000|Overall Study|Physician Decision|2
7227617|NCT00083616|11436894|FG000|Overall Study|Withdrawal by Subject|3
7227618|NCT00083616|11436894|FG000|Overall Study|Ineligibility determined|2
7227619|NCT00083616|11436894|FG000|Overall Study|Non-compliance|1
7227620|NCT00083616|11436894|FG000|Overall Study|Other|6
7227621|NCT00083889|11436904|FG000|Overall Study|Adverse Event|76
7227622|NCT00083889|11436905|FG001|Overall Study|Adverse Event|86
7227623|NCT00083889|11436904|FG000|Overall Study|Protocol Violation|2
7227624|NCT00083889|11436905|FG001|Overall Study|Protocol Violation|2
7227625|NCT00083889|11436904|FG000|Overall Study|Withdrawal by Subject|22
7227626|NCT00083889|11436905|FG001|Overall Study|Withdrawal by Subject|24
7227627|NCT00083889|11436904|FG000|Overall Study|Lack of Efficacy|240
7227628|NCT00083889|11436905|FG001|Overall Study|Lack of Efficacy|219
7227629|NCT00083889|11436904|FG000|Overall Study|Decision of sponsor|32
7227630|NCT00083889|11436905|FG001|Overall Study|Decision of sponsor|4
7227631|NCT00083889|11436904|FG000|Overall Study|Randomized: did not take study drug|0
7227632|NCT00083889|11436905|FG001|Overall Study|Randomized: did not take study drug|15
7227633|NCT00083889|11436904|FG000|Overall Study|Completed on marketed sunitinub|3
7227634|NCT00083889|11436905|FG001|Overall Study|Completed on marketed sunitinub|0
7227635|NCT00083889|11436904|FG000|Overall Study|Crossover to SU011248|0
7227636|NCT00083889|11436905|FG001|Overall Study|Crossover to SU011248|25
7227637|NCT00084084|11436914|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
7227638|NCT00084084|11436914|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
7227639|NCT00084136|11436922|FG000|PI Comparison|Death|10
7227640|NCT00084136|11436923|FG001|PI Comparison|Death|9
7227641|NCT00084136|11436924|FG002|PI Comparison|Death|0
7227642|NCT00084136|11436922|FG000|PI Comparison|Lost to Follow-up|11
7227643|NCT00084136|11436923|FG001|PI Comparison|Lost to Follow-up|8
7227644|NCT00084136|11436924|FG002|PI Comparison|Lost to Follow-up|0
7227645|NCT00084136|11436922|FG000|PI Comparison|Withdrawal by Subject|33
7227646|NCT00084136|11436923|FG001|PI Comparison|Withdrawal by Subject|30
7227647|NCT00084136|11436924|FG002|PI Comparison|Withdrawal by Subject|0
7227648|NCT00084136|11436922|FG000|PI Comparison|Clinic site closed|1
7227649|NCT00084136|11436923|FG001|PI Comparison|Clinic site closed|0
7227650|NCT00084136|11436924|FG002|PI Comparison|Clinic site closed|0
7227651|NCT00084136|11436922|FG000|NRTI Comparison|Death|20
7227652|NCT00084136|11436923|FG001|NRTI Comparison|Death|0
7227653|NCT00084136|11436924|FG002|NRTI Comparison|Death|18
7227654|NCT00084136|11436922|FG000|NRTI Comparison|Lost to Follow-up|14
7227655|NCT00084136|11436923|FG001|NRTI Comparison|Lost to Follow-up|0
7227656|NCT00084136|11436924|FG002|NRTI Comparison|Lost to Follow-up|12
7227657|NCT00084136|11436922|FG000|NRTI Comparison|Withdrawal by Subject|54
7227658|NCT00084136|11436923|FG001|NRTI Comparison|Withdrawal by Subject|0
7227659|NCT00084136|11436924|FG002|NRTI Comparison|Withdrawal by Subject|38
7227660|NCT00084136|11436922|FG000|NRTI Comparison|Clinic site closed|12
7227661|NCT00084136|11436923|FG001|NRTI Comparison|Clinic site closed|0
7227662|NCT00084136|11436924|FG002|NRTI Comparison|Clinic site closed|14
7227663|NCT00084136|11436922|FG000|NRTI Comparison|Not reason above|1
7227664|NCT00084136|11436923|FG001|NRTI Comparison|Not reason above|0
7227665|NCT00084136|11436924|FG002|NRTI Comparison|Not reason above|0
7227666|NCT00084266|11436948|FG000|Overall Study|Death|42
7227667|NCT00084266|11436949|FG001|Overall Study|Death|39
7227668|NCT00084266|11436948|FG000|Overall Study|Adverse Event|8
7227670|NCT00084266|11436948|FG000|Overall Study|Lack of Efficacy|2
7227671|NCT00084266|11436949|FG001|Overall Study|Lack of Efficacy|4
7227672|NCT00084266|11436948|FG000|Overall Study|Lost to Follow-up|5
7227673|NCT00084266|11436949|FG001|Overall Study|Lost to Follow-up|3
7227674|NCT00084266|11436948|FG000|Overall Study|Participant not willing to participate|3
7227675|NCT00084266|11436949|FG001|Overall Study|Participant not willing to participate|8
7227676|NCT00084266|11436948|FG000|Overall Study|Other|360
7227677|NCT00084266|11436949|FG001|Overall Study|Other|344
7227678|NCT00084266|11436948|FG000|Overall Study|Randomized not treated|21
7227679|NCT00084266|11436949|FG001|Overall Study|Randomized not treated|20
7227680|NCT00084318|11436957|FG000|Overall Study|Withdrawal by Subject|5
7227681|NCT00084318|11436958|FG001|Overall Study|Withdrawal by Subject|2
7227682|NCT00084318|11436957|FG000|Overall Study|Protocol Violation|15
7227683|NCT00084318|11436958|FG001|Overall Study|Protocol Violation|11
7227684|NCT00084318|11436957|FG000|Overall Study|No protocol treatment|2
7227685|NCT00084318|11436958|FG001|Overall Study|No protocol treatment|0
7227686|NCT00084487|11436981|FG000|Overall Study|Death|1
7227687|NCT00084617|11436994|FG000|Overall Study|Withdrawal by Subject|7
7227688|NCT00084617|11436994|FG000|Overall Study|Lack of Efficacy|1
7227689|NCT00084617|11436994|FG000|Overall Study|Protocol Violation|1
7227690|NCT00084682|11436998|FG000|Overall Study|Withdrawal by Subject|1
7227691|NCT00084747|11437003|FG000|Overall Study|Relapsed|8
7227692|NCT00084747|11437003|FG000|Overall Study|Death|3
7227693|NCT00084747|11437003|FG000|Overall Study|Withdrawal by Subject|2
7227694|NCT00084838|11437008|FG000|Overall Study|Death|1
7227695|NCT00084838|11437008|FG000|Overall Study|Adverse Event|2
7227696|NCT00084838|11437008|FG000|Overall Study|Withdrawal by Subject|1
7227697|NCT00084838|11437008|FG000|Overall Study|Progressive Disease|4
7227698|NCT00084838|11437008|FG000|Overall Study|Pt Non-Compliance|1
7227699|NCT00084838|11437008|FG000|Overall Study|Ineligible|4
7227700|NCT00084864|11437018|FG000|Overall Study|Adverse Event|1
7227701|NCT00084864|11437019|FG001|Overall Study|Adverse Event|0
7227702|NCT00084864|11437020|FG002|Overall Study|Adverse Event|0
7227703|NCT00084864|11437021|FG003|Overall Study|Adverse Event|0
7227704|NCT00084929|11437031|FG000|Overall Study|ineligible - medical contraindication|1
7227705|NCT00084929|11437031|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
7227706|NCT00084929|11437031|FG000|Overall Study|Ineligible - Medical history|6
7227707|NCT00084929|11437031|FG000|Overall Study|Withdrawal by Subject|10
7227708|NCT00084929|11437031|FG000|Overall Study|Missing/incomplete CTC exam|9
7227709|NCT00084929|11437031|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
7227710|NCT00085098|11437041|FG000|Overall Study|Withdrawal by Subject|0
7227711|NCT00085098|11437042|FG001|Overall Study|Withdrawal by Subject|1
7227712|NCT00085098|11437041|FG000|Overall Study|Ineligible|1
7227713|NCT00085098|11437042|FG001|Overall Study|Ineligible|1
7227714|NCT00085423|11437079|FG000|Overall Study|Withdrawal by Subject|1
7227715|NCT00085423|11437079|FG000|Overall Study|screen failure|1
7227716|NCT00085540|11437090|FG000|Overall Study|Withdrawal by Subject|0
7227717|NCT00085540|11437091|FG001|Overall Study|Withdrawal by Subject|1
7227718|NCT00085540|11437090|FG000|Overall Study|Protocol Violation|0
7227719|NCT00085540|11437091|FG001|Overall Study|Protocol Violation|1
7227720|NCT00085566|11437100|FG000|Overall Study|Adverse Event|0
7227721|NCT00085566|11437101|FG001|Overall Study|Adverse Event|0
7227722|NCT00085566|11437102|FG002|Overall Study|Adverse Event|10
7227723|NCT00085566|11437100|FG000|Overall Study|Patient Not treated|0
7227724|NCT00085566|11437101|FG001|Overall Study|Patient Not treated|0
7227725|NCT00085566|11437102|FG002|Overall Study|Patient Not treated|3
7227726|NCT00085566|11437100|FG000|Overall Study|Clinical progression|0
7227727|NCT00085566|11437101|FG001|Overall Study|Clinical progression|0
7227728|NCT00085566|11437102|FG002|Overall Study|Clinical progression|1
7227729|NCT00085644|11437112|FG000|Double-Blind Period|Adverse Event|5
7227730|NCT00085644|11437113|FG001|Double-Blind Period|Adverse Event|2
7227731|NCT00085644|11437114|FG002|Double-Blind Period|Adverse Event|0
7227732|NCT00085644|11437112|FG000|Double-Blind Period|Withdrawal by Subject|3
7227733|NCT00085644|11437113|FG001|Double-Blind Period|Withdrawal by Subject|0
7227734|NCT00085644|11437114|FG002|Double-Blind Period|Withdrawal by Subject|0
7227735|NCT00085644|11437112|FG000|Double-Blind Period|Lost to Follow-up|2
7227736|NCT00085644|11437113|FG001|Double-Blind Period|Lost to Follow-up|1
7227737|NCT00085644|11437114|FG002|Double-Blind Period|Lost to Follow-up|0
7227738|NCT00085644|11437112|FG000|Double-Blind Period|Lack/loss of efficacy|2
7227739|NCT00085644|11437113|FG001|Double-Blind Period|Lack/loss of efficacy|2
7227740|NCT00085644|11437114|FG002|Double-Blind Period|Lack/loss of efficacy|0
7227741|NCT00085644|11437112|FG000|Double-Blind Period|Contemplating pregnancy|1
7227742|NCT00085644|11437113|FG001|Double-Blind Period|Contemplating pregnancy|0
7227743|NCT00085644|11437114|FG002|Double-Blind Period|Contemplating pregnancy|0
7227744|NCT00085644|11437112|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
7227745|NCT00085644|11437113|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
7227746|NCT00085644|11437114|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
7227747|NCT00085644|11437112|FG000|Open-Label Period|Adverse Event|0
7227748|NCT00085644|11437113|FG001|Open-Label Period|Adverse Event|0
7227749|NCT00085644|11437114|FG002|Open-Label Period|Adverse Event|38
7227750|NCT00085644|11437112|FG000|Open-Label Period|Withdrawal by Subject|0
7227751|NCT00085644|11437113|FG001|Open-Label Period|Withdrawal by Subject|0
7227752|NCT00085644|11437114|FG002|Open-Label Period|Withdrawal by Subject|29
7227753|NCT00085644|11437112|FG000|Open-Label Period|Lost to Follow-up|0
7227754|NCT00085644|11437113|FG001|Open-Label Period|Lost to Follow-up|0
7227755|NCT00085644|11437114|FG002|Open-Label Period|Lost to Follow-up|13
7227756|NCT00085644|11437112|FG000|Open-Label Period|Lack of Efficacy|0
7227757|NCT00085644|11437113|FG001|Open-Label Period|Lack of Efficacy|0
7227758|NCT00085644|11437114|FG002|Open-Label Period|Lack of Efficacy|15
7227759|NCT00085644|11437112|FG000|Open-Label Period|Pregnancy|0
7227760|NCT00085644|11437113|FG001|Open-Label Period|Pregnancy|0
7227761|NCT00085644|11437114|FG002|Open-Label Period|Pregnancy|3
7227762|NCT00085644|11437112|FG000|Open-Label Period|Contemplating pregnancy|0
7227763|NCT00085644|11437113|FG001|Open-Label Period|Contemplating pregnancy|0
7227764|NCT00085644|11437114|FG002|Open-Label Period|Contemplating pregnancy|3
7227765|NCT00085644|11437112|FG000|Open-Label Period|Protocol Violation|0
7227766|NCT00085644|11437113|FG001|Open-Label Period|Protocol Violation|0
7227767|NCT00085644|11437114|FG002|Open-Label Period|Protocol Violation|4
7227768|NCT00085644|11437112|FG000|Open-Label Period|Personal reason|0
7227769|NCT00085644|11437113|FG001|Open-Label Period|Personal reason|0
7227770|NCT00085644|11437114|FG002|Open-Label Period|Personal reason|4
7227771|NCT00085709|11437123|FG000|Overall Study|Adverse Event|8
7227772|NCT00085709|11437124|FG001|Overall Study|Adverse Event|0
7227773|NCT00085709|11437123|FG000|Overall Study|Death|8
7227774|NCT00085709|11437124|FG001|Overall Study|Death|2
7227775|NCT00085709|11437123|FG000|Overall Study|Refusal unrelated to adverse events|1
7227776|NCT00085709|11437124|FG001|Overall Study|Refusal unrelated to adverse events|2
7227777|NCT00085709|11437123|FG000|Overall Study|Progression|3
7227778|NCT00085709|11437124|FG001|Overall Study|Progression|4
7227779|NCT00085709|11437123|FG000|Overall Study|Not protocol specified|12
7227780|NCT00085709|11437124|FG001|Overall Study|Not protocol specified|22
7227781|NCT00085709|11437123|FG000|Overall Study|Not eligible|19
7227782|NCT00085709|11437124|FG001|Overall Study|Not eligible|19
7227783|NCT00085709|11437123|FG000|Overall Study|Withdrawal by Subject|2
7227784|NCT00085709|11437124|FG001|Overall Study|Withdrawal by Subject|1
7227785|NCT00085917|11437149|FG000|Overall Study|Adverse Event|4
7227786|NCT00085917|11437150|FG001|Overall Study|Adverse Event|3
7227787|NCT00086047|11437158|FG000|Overall Study|Lost to Follow-up|7
7227788|NCT00086047|11437159|FG001|Overall Study|Lost to Follow-up|6
7227789|NCT00086047|11437158|FG000|Overall Study|Physician Decision|0
7227790|NCT00086047|11437159|FG001|Overall Study|Physician Decision|1
7227791|NCT00086190|11437177|FG000|Overall Study|Adverse Event|6
7227792|NCT00086190|11437178|FG001|Overall Study|Adverse Event|2
7227793|NCT00086190|11437179|FG002|Overall Study|Adverse Event|2
7227794|NCT00086190|11437177|FG000|Overall Study|Withdrawal by Subject|0
7227795|NCT00086190|11437178|FG001|Overall Study|Withdrawal by Subject|2
7227796|NCT00086190|11437179|FG002|Overall Study|Withdrawal by Subject|2
7227797|NCT00086190|11437177|FG000|Overall Study|Protocol Violation|1
7227798|NCT00086190|11437178|FG001|Overall Study|Protocol Violation|0
7227799|NCT00086190|11437179|FG002|Overall Study|Protocol Violation|0
7227800|NCT00086190|11437177|FG000|Overall Study|Moved|1
7227801|NCT00086190|11437178|FG001|Overall Study|Moved|0
7227802|NCT00086190|11437179|FG002|Overall Study|Moved|0
7227803|NCT00086190|11437177|FG000|Overall Study|Worsening depression|0
7227804|NCT00086190|11437178|FG001|Overall Study|Worsening depression|0
7227805|NCT00086190|11437179|FG002|Overall Study|Worsening depression|2
7227806|NCT00086281|11437202|FG000|Phase 1|Adverse Event|0
7227807|NCT00086281|11437203|FG001|Phase 1|Adverse Event|0
7227808|NCT00086281|11437204|FG002|Phase 1|Adverse Event|0
7227809|NCT00086281|11437205|FG003|Phase 1|Adverse Event|0
7227810|NCT00086281|11437206|FG004|Phase 1|Adverse Event|0
7227811|NCT00086281|11437207|FG005|Phase 1|Adverse Event|0
7227812|NCT00086281|11437208|FG006|Phase 1|Adverse Event|0
7227813|NCT00086281|11437209|FG007|Phase 1|Adverse Event|0
7227814|NCT00086281|11437210|FG008|Phase 1|Adverse Event|0
7227815|NCT00086281|11437211|FG009|Phase 1|Adverse Event|1
7227816|NCT00086281|11437212|FG010|Phase 1|Adverse Event|2
7227817|NCT00086281|11437213|FG011|Phase 1|Adverse Event|1
7227818|NCT00086281|11437214|FG012|Phase 1|Adverse Event|1
7227819|NCT00086281|11437215|FG013|Phase 1|Adverse Event|1
7227820|NCT00086281|11437216|FG014|Phase 1|Adverse Event|2
7227821|NCT00086281|11437202|FG000|Phase 1|Protocol Violation|0
7227822|NCT00086281|11437203|FG001|Phase 1|Protocol Violation|0
7227823|NCT00086281|11437204|FG002|Phase 1|Protocol Violation|0
7227824|NCT00086281|11437205|FG003|Phase 1|Protocol Violation|0
7227825|NCT00086281|11437206|FG004|Phase 1|Protocol Violation|0
7227826|NCT00086281|11437207|FG005|Phase 1|Protocol Violation|0
7227827|NCT00086281|11437208|FG006|Phase 1|Protocol Violation|0
7227828|NCT00086281|11437209|FG007|Phase 1|Protocol Violation|0
7227829|NCT00086281|11437210|FG008|Phase 1|Protocol Violation|0
7227830|NCT00086281|11437211|FG009|Phase 1|Protocol Violation|0
7227831|NCT00086281|11437212|FG010|Phase 1|Protocol Violation|1
7227832|NCT00086281|11437213|FG011|Phase 1|Protocol Violation|0
7227833|NCT00086281|11437214|FG012|Phase 1|Protocol Violation|0
7227834|NCT00086281|11437215|FG013|Phase 1|Protocol Violation|0
7227835|NCT00086281|11437216|FG014|Phase 1|Protocol Violation|0
7227836|NCT00086281|11437202|FG000|Phase 1|Serious Adverse Event|0
7227837|NCT00086281|11437203|FG001|Phase 1|Serious Adverse Event|0
7227838|NCT00086281|11437204|FG002|Phase 1|Serious Adverse Event|0
7227839|NCT00086281|11437205|FG003|Phase 1|Serious Adverse Event|0
7227840|NCT00086281|11437206|FG004|Phase 1|Serious Adverse Event|0
7227841|NCT00086281|11437207|FG005|Phase 1|Serious Adverse Event|0
7227842|NCT00086281|11437208|FG006|Phase 1|Serious Adverse Event|0
7227843|NCT00086281|11437209|FG007|Phase 1|Serious Adverse Event|0
7227844|NCT00086281|11437210|FG008|Phase 1|Serious Adverse Event|0
7227845|NCT00086281|11437211|FG009|Phase 1|Serious Adverse Event|0
7227846|NCT00086281|11437212|FG010|Phase 1|Serious Adverse Event|0
7227847|NCT00086281|11437213|FG011|Phase 1|Serious Adverse Event|0
7227848|NCT00086281|11437214|FG012|Phase 1|Serious Adverse Event|0
7227849|NCT00086281|11437215|FG013|Phase 1|Serious Adverse Event|0
7227850|NCT00086281|11437216|FG014|Phase 1|Serious Adverse Event|1
7227851|NCT00086281|11437202|FG000|Phase 2|Adverse Event|0
7227852|NCT00086281|11437203|FG001|Phase 2|Adverse Event|0
7227853|NCT00086281|11437204|FG002|Phase 2|Adverse Event|0
7227854|NCT00086281|11437205|FG003|Phase 2|Adverse Event|0
7227855|NCT00086281|11437206|FG004|Phase 2|Adverse Event|0
7227856|NCT00086281|11437207|FG005|Phase 2|Adverse Event|0
7227857|NCT00086281|11437208|FG006|Phase 2|Adverse Event|0
7227858|NCT00086281|11437209|FG007|Phase 2|Adverse Event|0
7227859|NCT00086281|11437210|FG008|Phase 2|Adverse Event|0
7227860|NCT00086281|11437211|FG009|Phase 2|Adverse Event|0
7227861|NCT00086281|11437212|FG010|Phase 2|Adverse Event|0
7227862|NCT00086281|11437213|FG011|Phase 2|Adverse Event|0
7227863|NCT00086281|11437214|FG012|Phase 2|Adverse Event|1
7227864|NCT00086281|11437215|FG013|Phase 2|Adverse Event|1
7227865|NCT00086281|11437216|FG014|Phase 2|Adverse Event|0
7227866|NCT00086307|11437229|FG000|Overall Study|Lack of Efficacy|1
7227867|NCT00086307|11437230|FG001|Overall Study|Lack of Efficacy|1
7227868|NCT00086307|11437231|FG002|Overall Study|Lack of Efficacy|2
7227869|NCT00086307|11437229|FG000|Overall Study|Shortness of breath and muscle spasms|1
7227870|NCT00086307|11437230|FG001|Overall Study|Shortness of breath and muscle spasms|0
7227871|NCT00086307|11437231|FG002|Overall Study|Shortness of breath and muscle spasms|0
7227872|NCT00086307|11437229|FG000|Overall Study|Nausea and headaches|0
7227873|NCT00086307|11437230|FG001|Overall Study|Nausea and headaches|0
7227874|NCT00086307|11437231|FG002|Overall Study|Nausea and headaches|1
7227875|NCT00086307|11437229|FG000|Overall Study|Constipation and sleepiness|0
7227876|NCT00086307|11437230|FG001|Overall Study|Constipation and sleepiness|0
7227877|NCT00086307|11437231|FG002|Overall Study|Constipation and sleepiness|1
7227878|NCT00086307|11437229|FG000|Overall Study|Suicidal ideation|0
7227879|NCT00086307|11437230|FG001|Overall Study|Suicidal ideation|0
7227880|NCT00086307|11437231|FG002|Overall Study|Suicidal ideation|1
7227881|NCT00086307|11437229|FG000|Overall Study|Fatigue and difficulty falling asleep|0
7227882|NCT00086307|11437230|FG001|Overall Study|Fatigue and difficulty falling asleep|0
7227883|NCT00086307|11437231|FG002|Overall Study|Fatigue and difficulty falling asleep|1
7227884|NCT00086307|11437229|FG000|Overall Study|Withdrawal by Subject|0
7227885|NCT00086307|11437230|FG001|Overall Study|Withdrawal by Subject|0
7227886|NCT00086307|11437231|FG002|Overall Study|Withdrawal by Subject|2
7227887|NCT00086346|11437241|FG000|Randomization|Did not receive test article|4
7227888|NCT00086346|11437242|FG001|Randomization|Did not receive test article|4
7227889|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Adverse Event|94
7227890|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Adverse Event|11
7227891|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
7227892|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
7227893|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Nonmedical event|7
7227894|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Nonmedical event|3
7227895|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
7227896|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
7227897|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Protocol Violation|11
7227898|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Protocol Violation|3
7227899|NCT00086346|11437241|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
7227900|NCT00086346|11437242|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
7227901|NCT00086385|11437252|FG000|Overall Study|Death|2
7227902|NCT00086385|11437253|FG001|Overall Study|Death|2
7227903|NCT00086385|11437254|FG002|Overall Study|Death|1
7227904|NCT00086385|11437255|FG003|Overall Study|Death|1
7227905|NCT00086411|11437269|FG000|Overall Study|Lost to Follow-up|11
7227906|NCT00086411|11437270|FG001|Overall Study|Lost to Follow-up|11
7227907|NCT00086411|11437271|FG002|Overall Study|Lost to Follow-up|13
7227908|NCT00086411|11437272|FG003|Overall Study|Lost to Follow-up|12
7227909|NCT00086502|11437294|FG000|Overall Study|Adverse Event|11
7227910|NCT00086502|11437295|FG001|Overall Study|Adverse Event|2
7227911|NCT00086502|11437294|FG000|Overall Study|Lack of Efficacy|0
7227912|NCT00086502|11437295|FG001|Overall Study|Lack of Efficacy|2
7227913|NCT00086502|11437294|FG000|Overall Study|Lost to Follow-up|3
7227914|NCT00086502|11437295|FG001|Overall Study|Lost to Follow-up|1
7227915|NCT00086502|11437294|FG000|Overall Study|Physician Decision|1
7227916|NCT00086502|11437295|FG001|Overall Study|Physician Decision|1
7227917|NCT00086502|11437294|FG000|Overall Study|Pregnancy|0
7227918|NCT00086502|11437295|FG001|Overall Study|Pregnancy|1
7227919|NCT00086502|11437294|FG000|Overall Study|Protocol Violation|3
7227920|NCT00086502|11437295|FG001|Overall Study|Protocol Violation|3
7227921|NCT00086502|11437294|FG000|Overall Study|Withdrawal by Subject|5
7227922|NCT00086502|11437295|FG001|Overall Study|Withdrawal by Subject|6
7227923|NCT00086502|11437294|FG000|Overall Study|Patient Moved|1
7227924|NCT00086502|11437295|FG001|Overall Study|Patient Moved|1
7228085|NCT00087139|11437378|FG001|Overall Study|Disease progression|19
7227925|NCT00086502|11437294|FG000|Overall Study|Protocol Discontinuation Criteria|1
7227926|NCT00086502|11437295|FG001|Overall Study|Protocol Discontinuation Criteria|3
7227927|NCT00086502|11437294|FG000|Overall Study|Patient Accidentally Unblinded|1
7227928|NCT00086502|11437295|FG001|Overall Study|Patient Accidentally Unblinded|0
7227929|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Adverse Event|17
7227930|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Adverse Event|9
7227931|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
7227932|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
7227933|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
7227934|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
7227935|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
7227936|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
7227937|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7227938|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
7227939|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Patient Moved|2
7227940|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Patient Moved|3
7227941|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
7227942|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
7227943|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Poor compliance|1
7227944|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Poor compliance|0
7227945|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
7227946|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
7227947|NCT00086515|11437303|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
7227948|NCT00086515|11437304|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
7227949|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Adverse Event|2
7227950|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Adverse Event|1
7227951|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
7227952|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
7227953|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
7227954|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
7227955|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
7227956|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
7227957|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
7227958|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
7227959|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7227960|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
7227961|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Poor compliance|1
7227962|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Poor compliance|0
7227963|NCT00086515|11437303|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
7227964|NCT00086515|11437304|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
7227965|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Adverse Event|16
7227966|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Adverse Event|10
7227967|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
7227968|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
7227969|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
7227970|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
7227971|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Physician Decision|3
7227972|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Physician Decision|0
7227973|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
7227974|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
7227975|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
7227976|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
7227977|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Patient Moved|2
7227978|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Patient Moved|2
7227979|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
7227980|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
7227981|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
7227982|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
7227983|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Patient Died|3
7227984|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Patient Died|1
7227985|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
7227986|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
7227987|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
7227988|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
7227989|NCT00086515|11437303|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
7227990|NCT00086515|11437304|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
7227991|NCT00086580|11437312|FG000|Treatment Period|Disease progression|9
7227992|NCT00086580|11437313|FG001|Treatment Period|Disease progression|8
7227993|NCT00086580|11437312|FG000|Treatment Period|Unable to comply with protocol|3
7227994|NCT00086580|11437313|FG001|Treatment Period|Unable to comply with protocol|1
7227995|NCT00086580|11437312|FG000|Treatment Period|Withdrawal by Subject|7
7227996|NCT00086580|11437313|FG001|Treatment Period|Withdrawal by Subject|8
7227997|NCT00086580|11437312|FG000|Treatment Period|Physician Decision|13
7227998|NCT00086580|11437313|FG001|Treatment Period|Physician Decision|7
7227999|NCT00086580|11437312|FG000|Treatment Period|AE - not treatment related|7
7228000|NCT00086580|11437313|FG001|Treatment Period|AE - not treatment related|7
7228001|NCT00086580|11437312|FG000|Treatment Period|Toxicity - treatment related|15
7228002|NCT00086580|11437313|FG001|Treatment Period|Toxicity - treatment related|15
7228003|NCT00086580|11437312|FG000|Treatment Period|Anemia or thrombocytopenia|1
7228004|NCT00086580|11437313|FG001|Treatment Period|Anemia or thrombocytopenia|4
7228005|NCT00086580|11437312|FG000|Treatment Period|Death|5
7228006|NCT00086580|11437313|FG001|Treatment Period|Death|7
7228007|NCT00086580|11437312|FG000|Treatment Period|Other|5
7228008|NCT00086580|11437313|FG001|Treatment Period|Other|3
7228009|NCT00086580|11437312|FG000|Follow-up Period|Disease progression|72
7228010|NCT00086580|11437313|FG001|Follow-up Period|Disease progression|99
7228011|NCT00086580|11437312|FG000|Follow-up Period|Unable to comply with protocol|5
7228012|NCT00086580|11437313|FG001|Follow-up Period|Unable to comply with protocol|0
7228013|NCT00086580|11437312|FG000|Follow-up Period|Withdrawal by Subject|6
7228014|NCT00086580|11437313|FG001|Follow-up Period|Withdrawal by Subject|6
7228015|NCT00086580|11437312|FG000|Follow-up Period|Physician Decision|0
7228016|NCT00086580|11437313|FG001|Follow-up Period|Physician Decision|1
7228017|NCT00086580|11437312|FG000|Follow-up Period|AE - not related|1
7228018|NCT00086580|11437313|FG001|Follow-up Period|AE - not related|0
7228019|NCT00086580|11437312|FG000|Follow-up Period|Death|13
7228020|NCT00086580|11437313|FG001|Follow-up Period|Death|7
7228021|NCT00086580|11437312|FG000|Follow-up Period|Other|7
7228022|NCT00086580|11437313|FG001|Follow-up Period|Other|6
7228023|NCT00086580|11437312|FG000|Observation Period|Unable to comply with protocol|1
7228024|NCT00086580|11437313|FG001|Observation Period|Unable to comply with protocol|1
7228025|NCT00086580|11437312|FG000|Observation Period|Withdrawal by Subject|4
7228026|NCT00086580|11437313|FG001|Observation Period|Withdrawal by Subject|2
7228027|NCT00086580|11437312|FG000|Observation Period|Death|33
7228028|NCT00086580|11437313|FG001|Observation Period|Death|55
7228029|NCT00086580|11437312|FG000|Observation Period|Other|8
7228030|NCT00086580|11437313|FG001|Observation Period|Other|7
7228031|NCT00086619|11437321|FG000|Overall Study|Withdrawal by Subject|6
7228032|NCT00086619|11437322|FG001|Overall Study|Withdrawal by Subject|6
7228033|NCT00086619|11437321|FG000|Overall Study|Adverse Event|8
7228034|NCT00086619|11437322|FG001|Overall Study|Adverse Event|10
7228035|NCT00086619|11437321|FG000|Overall Study|Protocol Violation|1
7228036|NCT00086619|11437322|FG001|Overall Study|Protocol Violation|1
7228037|NCT00086684|11437331|FG000|Overall Study|Adverse Event|12
7228038|NCT00086684|11437332|FG001|Overall Study|Adverse Event|17
7228039|NCT00086684|11437333|FG002|Overall Study|Adverse Event|14
7228040|NCT00086684|11437331|FG000|Overall Study|Lack of Efficacy|6
7228041|NCT00086684|11437332|FG001|Overall Study|Lack of Efficacy|6
7228042|NCT00086684|11437333|FG002|Overall Study|Lack of Efficacy|5
7228043|NCT00086684|11437331|FG000|Overall Study|Lost to Follow-up|15
7228044|NCT00086684|11437332|FG001|Overall Study|Lost to Follow-up|8
7228045|NCT00086684|11437333|FG002|Overall Study|Lost to Follow-up|10
7228046|NCT00086684|11437331|FG000|Overall Study|Protocol Violation|8
7228047|NCT00086684|11437332|FG001|Overall Study|Protocol Violation|3
7228048|NCT00086684|11437333|FG002|Overall Study|Protocol Violation|0
7228049|NCT00086684|11437331|FG000|Overall Study|Withdrawal by Subject|0
7228050|NCT00086684|11437332|FG001|Overall Study|Withdrawal by Subject|4
7228051|NCT00086684|11437333|FG002|Overall Study|Withdrawal by Subject|10
7228052|NCT00086684|11437331|FG000|Overall Study|NONCOMPLIANCE|5
7228053|NCT00086684|11437332|FG001|Overall Study|NONCOMPLIANCE|7
7228054|NCT00086684|11437333|FG002|Overall Study|NONCOMPLIANCE|6
7228055|NCT00086684|11437331|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
7228056|NCT00086684|11437332|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
7228057|NCT00086684|11437333|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
7228058|NCT00086684|11437331|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
7228059|NCT00086684|11437332|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
7228060|NCT00086684|11437333|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
7228061|NCT00086684|11437331|FG000|Overall Study|Other|4
7228062|NCT00086684|11437332|FG001|Overall Study|Other|2
7228063|NCT00086684|11437333|FG002|Overall Study|Other|3
7228064|NCT00086996|11437352|FG000|Overall Study|Adverse Event|29
7228065|NCT00086996|11437352|FG000|Overall Study|Death|4
7228066|NCT00086996|11437352|FG000|Overall Study|progression/relapse|7
7228067|NCT00086996|11437352|FG000|Overall Study|Withdrawal by Subject|13
7228068|NCT00086996|11437352|FG000|Overall Study|Other|6
7228069|NCT00086996|11437352|FG000|Overall Study|not eligible|5
7228070|NCT00087126|11437365|FG000|Overall Study|Ineligible - second primary|1
7228071|NCT00087126|11437365|FG000|Overall Study|Never treated|1
7228072|NCT00087139|11437377|FG000|Overall Study|Adverse Event|18
7228073|NCT00087139|11437378|FG001|Overall Study|Adverse Event|17
7228074|NCT00087139|11437379|FG002|Overall Study|Adverse Event|13
7228075|NCT00087139|11437377|FG000|Overall Study|Death|2
7228076|NCT00087139|11437378|FG001|Overall Study|Death|1
7228077|NCT00087139|11437379|FG002|Overall Study|Death|0
7228078|NCT00087139|11437377|FG000|Overall Study|Withdrawal by Subject|3
7228079|NCT00087139|11437378|FG001|Overall Study|Withdrawal by Subject|2
7228080|NCT00087139|11437379|FG002|Overall Study|Withdrawal by Subject|2
7228081|NCT00087139|11437377|FG000|Overall Study|Physician Decision|1
7228082|NCT00087139|11437378|FG001|Overall Study|Physician Decision|1
7228083|NCT00087139|11437379|FG002|Overall Study|Physician Decision|1
7228084|NCT00087139|11437377|FG000|Overall Study|Disease progression|9
7228086|NCT00087139|11437379|FG002|Overall Study|Disease progression|12
7228087|NCT00087139|11437377|FG000|Overall Study|Ineligible|4
7228088|NCT00087139|11437378|FG001|Overall Study|Ineligible|7
7228089|NCT00087139|11437379|FG002|Overall Study|Ineligible|4
7228090|NCT00087139|11437377|FG000|Overall Study|Symptomatic deterioration|1
7228091|NCT00087139|11437378|FG001|Overall Study|Symptomatic deterioration|1
7228092|NCT00087139|11437379|FG002|Overall Study|Symptomatic deterioration|3
7228093|NCT00087139|11437377|FG000|Overall Study|Use of coumadin|1
7228094|NCT00087139|11437378|FG001|Overall Study|Use of coumadin|0
7228095|NCT00087139|11437379|FG002|Overall Study|Use of coumadin|0
7228096|NCT00087139|11437377|FG000|Overall Study|Response achieved|0
7228097|NCT00087139|11437378|FG001|Overall Study|Response achieved|1
7228098|NCT00087139|11437379|FG002|Overall Study|Response achieved|0
7228099|NCT00087139|11437377|FG000|Overall Study|Extradural disease|0
7228100|NCT00087139|11437378|FG001|Overall Study|Extradural disease|0
7228101|NCT00087139|11437379|FG002|Overall Study|Extradural disease|1
7228102|NCT00087152|11437385|FG000|Overall Study|Ineligible|6
7228103|NCT00087438|11437390|FG000|Overall Study|Ineligible / No protocol treatment|4
7228104|NCT00087490|11437398|FG000|Overall Study|Death|6
7228105|NCT00087490|11437399|FG001|Overall Study|Death|4
7228106|NCT00087490|11437398|FG000|Overall Study|Adverse Event|3
7228107|NCT00087490|11437399|FG001|Overall Study|Adverse Event|8
7228108|NCT00087490|11437398|FG000|Overall Study|Lack of Efficacy|0
7228109|NCT00087490|11437399|FG001|Overall Study|Lack of Efficacy|2
7228110|NCT00087490|11437398|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
7228111|NCT00087490|11437399|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
7228112|NCT00087490|11437398|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
7228113|NCT00087490|11437399|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
7228114|NCT00087490|11437398|FG000|Overall Study|Randomized but not treated|7
7228115|NCT00087490|11437399|FG001|Overall Study|Randomized but not treated|18
7228116|NCT00087516|11437408|FG000|Overall Study|Adverse Event|10
7228117|NCT00087516|11437409|FG001|Overall Study|Adverse Event|10
7228118|NCT00087516|11437410|FG002|Overall Study|Adverse Event|3
7228119|NCT00087516|11437411|FG003|Overall Study|Adverse Event|6
7228120|NCT00087516|11437408|FG000|Overall Study|Lack of Efficacy|82
7228121|NCT00087516|11437409|FG001|Overall Study|Lack of Efficacy|80
7228122|NCT00087516|11437410|FG002|Overall Study|Lack of Efficacy|39
7228123|NCT00087516|11437411|FG003|Overall Study|Lack of Efficacy|29
7228124|NCT00087516|11437408|FG000|Overall Study|Lost to Follow-up|8
7228125|NCT00087516|11437409|FG001|Overall Study|Lost to Follow-up|6
7228126|NCT00087516|11437410|FG002|Overall Study|Lost to Follow-up|5
7228127|NCT00087516|11437411|FG003|Overall Study|Lost to Follow-up|5
7228128|NCT00087516|11437408|FG000|Overall Study|Protocol Violation|4
7228129|NCT00087516|11437409|FG001|Overall Study|Protocol Violation|8
7228130|NCT00087516|11437410|FG002|Overall Study|Protocol Violation|3
7228131|NCT00087516|11437411|FG003|Overall Study|Protocol Violation|6
7228132|NCT00087516|11437408|FG000|Overall Study|Withdrawal by Subject|16
7228133|NCT00087516|11437409|FG001|Overall Study|Withdrawal by Subject|27
7228134|NCT00087516|11437410|FG002|Overall Study|Withdrawal by Subject|11
7228135|NCT00087516|11437411|FG003|Overall Study|Withdrawal by Subject|12
7228136|NCT00087516|11437408|FG000|Overall Study|Site terminated|0
7228137|NCT00087516|11437409|FG001|Overall Study|Site terminated|2
7228138|NCT00087516|11437410|FG002|Overall Study|Site terminated|1
7228139|NCT00087516|11437411|FG003|Overall Study|Site terminated|0
7228140|NCT00087516|11437408|FG000|Overall Study|Protocol specified discontinuation|35
7228141|NCT00087516|11437409|FG001|Overall Study|Protocol specified discontinuation|33
7228142|NCT00087516|11437410|FG002|Overall Study|Protocol specified discontinuation|33
7228143|NCT00087516|11437411|FG003|Overall Study|Protocol specified discontinuation|26
7228144|NCT00087516|11437408|FG000|Overall Study|Patient moved|3
7228145|NCT00087516|11437409|FG001|Overall Study|Patient moved|2
7228146|NCT00087516|11437410|FG002|Overall Study|Patient moved|1
7228147|NCT00087516|11437411|FG003|Overall Study|Patient moved|0
7228148|NCT00087516|11437408|FG000|Overall Study|Patient was non-compliant|3
7228149|NCT00087516|11437409|FG001|Overall Study|Patient was non-compliant|1
7228150|NCT00087516|11437410|FG002|Overall Study|Patient was non-compliant|0
7228151|NCT00087516|11437411|FG003|Overall Study|Patient was non-compliant|0
7228152|NCT00087516|11437408|FG000|Overall Study|Recommendation of Primary Care Physician|0
7228153|NCT00087516|11437409|FG001|Overall Study|Recommendation of Primary Care Physician|0
7228154|NCT00087516|11437410|FG002|Overall Study|Recommendation of Primary Care Physician|0
7228155|NCT00087516|11437411|FG003|Overall Study|Recommendation of Primary Care Physician|1
7228156|NCT00087516|11437408|FG000|Overall Study|Other|0
7228157|NCT00087516|11437409|FG001|Overall Study|Other|0
7228158|NCT00087516|11437410|FG002|Overall Study|Other|1
7228159|NCT00087516|11437411|FG003|Overall Study|Other|0
7228160|NCT00087529|11437427|FG000|Overall Study|Death|1
7228161|NCT00087529|11437428|FG001|Overall Study|Death|0
7228162|NCT00087529|11437427|FG000|Overall Study|Adverse Event|0
7228163|NCT00087529|11437428|FG001|Overall Study|Adverse Event|8
7228164|NCT00087529|11437427|FG000|Overall Study|Pregnancy|0
7228165|NCT00087529|11437428|FG001|Overall Study|Pregnancy|1
7228166|NCT00087529|11437427|FG000|Overall Study|Lost to Follow-up|2
7228167|NCT00087529|11437428|FG001|Overall Study|Lost to Follow-up|3
7228168|NCT00087529|11437427|FG000|Overall Study|Participant Decision|14
7228169|NCT00087529|11437428|FG001|Overall Study|Participant Decision|37
7228170|NCT00087529|11437427|FG000|Overall Study|Physician Decision|4
7228171|NCT00087529|11437428|FG001|Overall Study|Physician Decision|8
7228172|NCT00087529|11437427|FG000|Overall Study|Initiation of Excluded Therapy|0
7228173|NCT00087529|11437428|FG001|Overall Study|Initiation of Excluded Therapy|1
7228174|NCT00087529|11437427|FG000|Overall Study|Participant Noncompliance|0
7228175|NCT00087529|11437428|FG001|Overall Study|Participant Noncompliance|1
7228176|NCT00087529|11437427|FG000|Overall Study|Disease Progression|5
7228177|NCT00087529|11437428|FG001|Overall Study|Disease Progression|4
7228178|NCT00087529|11437427|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
7228179|NCT00087529|11437428|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
7228180|NCT00087555|11437437|FG000|Overall Study|Adverse Event|3
7228181|NCT00087555|11437438|FG001|Overall Study|Adverse Event|6
7228182|NCT00087555|11437439|FG002|Overall Study|Adverse Event|14
7228183|NCT00087555|11437437|FG000|Overall Study|Lost to Follow-up|0
7228184|NCT00087555|11437438|FG001|Overall Study|Lost to Follow-up|1
7228185|NCT00087555|11437439|FG002|Overall Study|Lost to Follow-up|1
7228186|NCT00087555|11437437|FG000|Overall Study|Non - Compliance|1
7228187|NCT00087555|11437438|FG001|Overall Study|Non - Compliance|0
7573244|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
7228188|NCT00087555|11437439|FG002|Overall Study|Non - Compliance|0
7228189|NCT00087555|11437437|FG000|Overall Study|Protocol Violation|0
7228190|NCT00087555|11437438|FG001|Overall Study|Protocol Violation|0
7228191|NCT00087555|11437439|FG002|Overall Study|Protocol Violation|2
7228192|NCT00087555|11437437|FG000|Overall Study|Screen Failure|1
7228193|NCT00087555|11437438|FG001|Overall Study|Screen Failure|1
7228194|NCT00087555|11437439|FG002|Overall Study|Screen Failure|0
7228195|NCT00087555|11437437|FG000|Overall Study|Pregnancy|0
7228196|NCT00087555|11437438|FG001|Overall Study|Pregnancy|1
7228197|NCT00087555|11437439|FG002|Overall Study|Pregnancy|1
7228198|NCT00087555|11437437|FG000|Overall Study|Withdrawal by Subject|3
7228199|NCT00087555|11437438|FG001|Overall Study|Withdrawal by Subject|2
7228200|NCT00087555|11437439|FG002|Overall Study|Withdrawal by Subject|1
7228201|NCT00087555|11437437|FG000|Overall Study|Lack of Efficacy|2
7228202|NCT00087555|11437438|FG001|Overall Study|Lack of Efficacy|0
7228203|NCT00087555|11437439|FG002|Overall Study|Lack of Efficacy|1
7228204|NCT00087555|11437437|FG000|Overall Study|Non Compliance|0
7228205|NCT00087555|11437438|FG001|Overall Study|Non Compliance|0
7228206|NCT00087555|11437439|FG002|Overall Study|Non Compliance|1
7228207|NCT00087555|11437437|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
7228208|NCT00087555|11437438|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
7228209|NCT00087555|11437439|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
7228210|NCT00087555|11437437|FG000|Overall Study|Patient wanted to go back on Med|1
7228211|NCT00087555|11437438|FG001|Overall Study|Patient wanted to go back on Med|0
7228212|NCT00087555|11437439|FG002|Overall Study|Patient wanted to go back on Med|0
7228213|NCT00087568|11437449|FG000|Overall Study|Adverse Event|4
7228214|NCT00087568|11437450|FG001|Overall Study|Adverse Event|0
7228215|NCT00087568|11437449|FG000|Overall Study|Withdrawal by Subject|1
7228216|NCT00087568|11437450|FG001|Overall Study|Withdrawal by Subject|1
7228217|NCT00087568|11437449|FG000|Overall Study|Lost to Follow-up|1
7228218|NCT00087568|11437450|FG001|Overall Study|Lost to Follow-up|0
7228219|NCT00087568|11437449|FG000|Overall Study|Lack of Efficacy|24
7228220|NCT00087568|11437450|FG001|Overall Study|Lack of Efficacy|1
7228221|NCT00087594|11437458|FG000|Overall Study|Adverse Event|2
7228222|NCT00087594|11437459|FG001|Overall Study|Adverse Event|3
7228223|NCT00087594|11437458|FG000|Overall Study|Lost to Follow-up|0
7228224|NCT00087594|11437459|FG001|Overall Study|Lost to Follow-up|2
7228225|NCT00087594|11437458|FG000|Overall Study|Withdrawal by Subject|4
7228226|NCT00087594|11437459|FG001|Overall Study|Withdrawal by Subject|2
7228227|NCT00087594|11437458|FG000|Overall Study|Lack of Efficacy|2
7228228|NCT00087594|11437459|FG001|Overall Study|Lack of Efficacy|5
7228229|NCT00087607|11437467|FG000|Overall Study|Adverse Event|14
7228230|NCT00087607|11437468|FG001|Overall Study|Adverse Event|24
7228231|NCT00087607|11437467|FG000|Overall Study|Death|0
7228232|NCT00087607|11437468|FG001|Overall Study|Death|1
7228233|NCT00087607|11437467|FG000|Overall Study|Insufficient Therapeutic Response|53
7228234|NCT00087607|11437468|FG001|Overall Study|Insufficient Therapeutic Response|42
7228235|NCT00087607|11437467|FG000|Overall Study|Failure to return|21
7228236|NCT00087607|11437468|FG001|Overall Study|Failure to return|17
7228237|NCT00087607|11437467|FG000|Overall Study|Withdrew Consent|12
7228238|NCT00087607|11437468|FG001|Overall Study|Withdrew Consent|16
7228239|NCT00087607|11437467|FG000|Overall Study|Administrative|12
7228240|NCT00087607|11437468|FG001|Overall Study|Administrative|12
7228241|NCT00087607|11437467|FG000|Overall Study|Refused Treatment|5
7228242|NCT00087607|11437468|FG001|Overall Study|Refused Treatment|7
7228243|NCT00087607|11437467|FG000|Overall Study|Other Protocol Violation|5
7228244|NCT00087607|11437468|FG001|Overall Study|Other Protocol Violation|2
7228245|NCT00087607|11437467|FG000|Overall Study|Violation of Selection Criteria at Entry|0
7228246|NCT00087607|11437468|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7228247|NCT00087646|11437491|FG000|Overall Study|Adverse Event|37
7228248|NCT00087646|11437492|FG001|Overall Study|Adverse Event|6
7228249|NCT00087646|11437493|FG002|Overall Study|Adverse Event|18
7228250|NCT00087646|11437494|FG003|Overall Study|Adverse Event|20
7228251|NCT00087646|11437491|FG000|Overall Study|Death|0
7228252|NCT00087646|11437492|FG001|Overall Study|Death|1
7228253|NCT00087646|11437493|FG002|Overall Study|Death|0
7228254|NCT00087646|11437494|FG003|Overall Study|Death|0
7228255|NCT00087646|11437491|FG000|Overall Study|Withdrawal by Subject|6
7228256|NCT00087646|11437492|FG001|Overall Study|Withdrawal by Subject|1
7228257|NCT00087646|11437493|FG002|Overall Study|Withdrawal by Subject|2
7228258|NCT00087646|11437494|FG003|Overall Study|Withdrawal by Subject|2
7228259|NCT00087646|11437491|FG000|Overall Study|Insufficient therapeutic response|64
7228260|NCT00087646|11437492|FG001|Overall Study|Insufficient therapeutic response|24
7228261|NCT00087646|11437493|FG002|Overall Study|Insufficient therapeutic response|38
7228262|NCT00087646|11437494|FG003|Overall Study|Insufficient therapeutic response|51
7228263|NCT00087646|11437491|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
7228264|NCT00087646|11437492|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
7228265|NCT00087646|11437493|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
7228266|NCT00087646|11437494|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
7228267|NCT00087646|11437491|FG000|Overall Study|Failure to Return|5
7228268|NCT00087646|11437492|FG001|Overall Study|Failure to Return|2
7228269|NCT00087646|11437493|FG002|Overall Study|Failure to Return|2
7228270|NCT00087646|11437494|FG003|Overall Study|Failure to Return|3
7228271|NCT00087646|11437491|FG000|Overall Study|Administrative/Other|6
7228272|NCT00087646|11437492|FG001|Overall Study|Administrative/Other|1
7228273|NCT00087646|11437493|FG002|Overall Study|Administrative/Other|1
7228274|NCT00087646|11437494|FG003|Overall Study|Administrative/Other|2
7228275|NCT00087646|11437491|FG000|Overall Study|Other Protocol Violation|3
7228276|NCT00087646|11437492|FG001|Overall Study|Other Protocol Violation|1
7228277|NCT00087646|11437493|FG002|Overall Study|Other Protocol Violation|0
7228278|NCT00087646|11437494|FG003|Overall Study|Other Protocol Violation|0
7228279|NCT00087646|11437491|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7228280|NCT00087646|11437492|FG001|Overall Study|Violation of Selection Criteria at Entry|0
7228281|NCT00087646|11437493|FG002|Overall Study|Violation of Selection Criteria at Entry|0
7228282|NCT00087646|11437494|FG003|Overall Study|Violation of Selection Criteria at Entry|1
7228283|NCT00087685|11437513|FG000|Overall Study|Adverse Event|5
7228284|NCT00087685|11437513|FG000|Overall Study|Non-Compliance|1
7228285|NCT00087685|11437513|FG000|Overall Study|Progressive Disease|5
7228286|NCT00087685|11437513|FG000|Overall Study|Withdrawal by Subject|3
7228287|NCT00087698|11437517|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
7228288|NCT00087698|11437517|FG000|Overall Study|Death from Other Causes|3
7228289|NCT00087698|11437517|FG000|Overall Study|Adverse Event|4
7228290|NCT00087698|11437517|FG000|Overall Study|Withdrawal by Subject|4
7228291|NCT00087698|11437517|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
7228292|NCT00087698|11437517|FG000|Overall Study|Protocol Entry Criteria Not Met|2
7228293|NCT00087698|11437517|FG000|Overall Study|Clinical Relapse|1
7228294|NCT00087698|11437517|FG000|Overall Study|Death from Study Disease|2
7228295|NCT00087698|11437517|FG000|Overall Study|Death from Study Drug Toxicity|2
7228296|NCT00087698|11437517|FG000|Overall Study|Protocol Violation|1
7228297|NCT00088153|11437523|FG000|Overall Study|Physician Decision|3
7228298|NCT00088153|11437524|FG001|Overall Study|Physician Decision|3
7228299|NCT00088153|11437523|FG000|Overall Study|Withdrawal by Subject|10
7228300|NCT00088153|11437524|FG001|Overall Study|Withdrawal by Subject|10
7228301|NCT00088153|11437523|FG000|Overall Study|Lost to Follow-up|11
7228302|NCT00088153|11437524|FG001|Overall Study|Lost to Follow-up|12
7228303|NCT00088166|11437532|FG000|Overall Study|Adverse Event|11
7228304|NCT00088166|11437533|FG001|Overall Study|Adverse Event|9
7228305|NCT00088166|11437532|FG000|Overall Study|Death|3
7228306|NCT00088166|11437533|FG001|Overall Study|Death|1
7228307|NCT00088166|11437532|FG000|Overall Study|Lost to Follow-up|0
7228308|NCT00088166|11437533|FG001|Overall Study|Lost to Follow-up|1
7228309|NCT00088166|11437532|FG000|Overall Study|Physician Decision|4
7228310|NCT00088166|11437533|FG001|Overall Study|Physician Decision|1
7228311|NCT00088166|11437532|FG000|Overall Study|Protocol Violation|1
7228312|NCT00088166|11437533|FG001|Overall Study|Protocol Violation|5
7228313|NCT00088166|11437532|FG000|Overall Study|Patient deterioration|29
7228314|NCT00088166|11437533|FG001|Overall Study|Patient deterioration|39
7228315|NCT00088166|11437532|FG000|Overall Study|Withdrawal by Subject|5
7228316|NCT00088166|11437533|FG001|Overall Study|Withdrawal by Subject|5
7228317|NCT00088205|11437539|FG000|Overall Study|Adverse Event|4
7228318|NCT00088205|11437539|FG000|Overall Study|Progressive Disease|51
7228319|NCT00088205|11437539|FG000|Overall Study|Physician Decision|1
7228320|NCT00088205|11437539|FG000|Overall Study|Death Due to Study Disease|4
7228321|NCT00088374|11437552|FG000|Overall Study|patient did not receive any 17AAG|1
7228322|NCT00088374|11437552|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
7228323|NCT00088413|11437560|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7228324|NCT00088413|11437561|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7228325|NCT00088413|11437562|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
7228326|NCT00088413|11437563|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
7228327|NCT00088413|11437560|FG000|Overall Study|Adverse Events/Side Effects|0
7228328|NCT00088413|11437561|FG001|Overall Study|Adverse Events/Side Effects|1
7228329|NCT00088413|11437562|FG002|Overall Study|Adverse Events/Side Effects|1
7228330|NCT00088413|11437563|FG003|Overall Study|Adverse Events/Side Effects|0
7228331|NCT00088413|11437560|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
7228332|NCT00088413|11437561|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
7228333|NCT00088413|11437562|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
7228334|NCT00088413|11437563|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
7228335|NCT00088413|11437560|FG000|Overall Study|Off study due to missing a vaccine dose|1
7228336|NCT00088413|11437561|FG001|Overall Study|Off study due to missing a vaccine dose|0
7228337|NCT00088413|11437562|FG002|Overall Study|Off study due to missing a vaccine dose|0
7228338|NCT00088413|11437563|FG003|Overall Study|Off study due to missing a vaccine dose|0
7228339|NCT00088413|11437560|FG000|Overall Study|Death|0
7228340|NCT00088413|11437561|FG001|Overall Study|Death|1
7228341|NCT00088413|11437562|FG002|Overall Study|Death|0
7228342|NCT00088413|11437563|FG003|Overall Study|Death|0
7228343|NCT00088413|11437560|FG000|Overall Study|Progressive disease|9
7228344|NCT00088413|11437561|FG001|Overall Study|Progressive disease|11
7228345|NCT00088413|11437562|FG002|Overall Study|Progressive disease|8
7228346|NCT00088413|11437563|FG003|Overall Study|Progressive disease|14
7228347|NCT00088413|11437560|FG000|Overall Study|Other|0
7228348|NCT00088413|11437561|FG001|Overall Study|Other|1
7228349|NCT00088413|11437562|FG002|Overall Study|Other|0
7228350|NCT00088413|11437563|FG003|Overall Study|Other|0
7228351|NCT00088413|11437560|FG000|Overall Study|Patient unevaluable due to adverse event|0
7228352|NCT00088413|11437561|FG001|Overall Study|Patient unevaluable due to adverse event|0
7228353|NCT00088413|11437562|FG002|Overall Study|Patient unevaluable due to adverse event|1
7228354|NCT00088413|11437563|FG003|Overall Study|Patient unevaluable due to adverse event|0
7228355|NCT00088452|11437578|FG000|Overall Study|Did not receive intervention|1
7228356|NCT00088452|11437579|FG001|Overall Study|Did not receive intervention|0
7228357|NCT00088452|11437580|FG002|Overall Study|Did not receive intervention|1
7228358|NCT00088465|11437588|FG000|Overall Study|Withdrawal by Subject|290
7228359|NCT00088465|11437588|FG000|Overall Study|Adverse Event|77
7228360|NCT00088465|11437588|FG000|Overall Study|Lost to Follow-up|57
7228361|NCT00088465|11437588|FG000|Overall Study|Physician Decision|45
7228362|NCT00088465|11437588|FG000|Overall Study|Sponsor Decision|37
7228363|NCT00088465|11437588|FG000|Overall Study|Lack of Efficacy|27
7228364|NCT00088465|11437588|FG000|Overall Study|Protocol Violation|17
7228365|NCT00088465|11437588|FG000|Overall Study|Death|11
7228366|NCT00088530|11437594|FG000|Overall Study|Progressive/Relapsed Disease|28
7228367|NCT00088530|11437595|FG001|Overall Study|Progressive/Relapsed Disease|39
7228368|NCT00088530|11437594|FG000|Overall Study|Adverse Event|15
7228369|NCT00088530|11437595|FG001|Overall Study|Adverse Event|9
7228370|NCT00088530|11437594|FG000|Overall Study|Withdrawal by Subject|2
7228371|NCT00088530|11437595|FG001|Overall Study|Withdrawal by Subject|5
7228372|NCT00088530|11437594|FG000|Overall Study|Lost to Follow-up|2
7228373|NCT00088530|11437595|FG001|Overall Study|Lost to Follow-up|0
7228374|NCT00088530|11437594|FG000|Overall Study|Physician Decision|2
7228375|NCT00088530|11437595|FG001|Overall Study|Physician Decision|0
7228376|NCT00088530|11437594|FG000|Overall Study|Sponsor decision|0
7228377|NCT00088530|11437595|FG001|Overall Study|Sponsor decision|1
7228378|NCT00088530|11437594|FG000|Overall Study|Patient never treated|1
7228379|NCT00088530|11437595|FG001|Overall Study|Patient never treated|0
7228380|NCT00088595|11437601|FG000|Overall Study|Adverse Event|11
7228381|NCT00088595|11437601|FG000|Overall Study|Withdrawal by Subject|8
7228382|NCT00088595|11437601|FG000|Overall Study|Ongoing (After Core)|7
7228383|NCT00088595|11437601|FG000|Overall Study|New Cancer Therapy|2
7228384|NCT00088881|11437643|FG000|Step 1 - R-CHOP|Patient ineligible|9
7228385|NCT00088881|11437643|FG000|Step 1 - R-CHOP|Adverse Event|1
7228386|NCT00088881|11437643|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
7228387|NCT00088881|11437643|FG000|Step 1 - R-CHOP|Physician Decision|1
7228388|NCT00088881|11437643|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
7228389|NCT00088881|11437643|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
7228390|NCT00088881|11437643|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
7228391|NCT00088907|11437651|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
7228392|NCT00088907|11437652|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
7228393|NCT00088907|11437651|FG000|Randomized Study (Step 1)|Adverse Event|14
7228394|NCT00088907|11437652|FG001|Randomized Study (Step 1)|Adverse Event|19
7228395|NCT00088907|11437651|FG000|Randomized Study (Step 1)|Death|11
7228396|NCT00088907|11437652|FG001|Randomized Study (Step 1)|Death|12
7228397|NCT00088907|11437651|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
7228398|NCT00088907|11437652|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
7228399|NCT00088907|11437651|FG000|Randomized Study (Step 1)|complicating disease|3
7228400|NCT00088907|11437652|FG001|Randomized Study (Step 1)|complicating disease|1
7228401|NCT00088907|11437651|FG000|Randomized Study (Step 1)|unknown/not specify|24
7228402|NCT00088907|11437652|FG001|Randomized Study (Step 1)|unknown/not specify|13
7228403|NCT00088907|11437651|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
7573245|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
7228404|NCT00088907|11437652|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
7228405|NCT00088907|11437651|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
7228406|NCT00088907|11437652|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
7228407|NCT00088907|11437651|FG000|Single Gefitinib Treatment (Step 2)|Death|1
7228408|NCT00088907|11437652|FG001|Single Gefitinib Treatment (Step 2)|Death|0
7228409|NCT00088907|11437651|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
7228410|NCT00088907|11437652|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
7228411|NCT00088907|11437651|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
7228412|NCT00088907|11437652|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
7228413|NCT00089076|11437676|FG000|Overall Study|Alternate Therapy|1
7228414|NCT00089076|11437676|FG000|Overall Study|Withdrawal by Subject|2
7228415|NCT00089076|11437676|FG000|Overall Study|Progression|7
7228416|NCT00089284|11437689|FG000|Overall Study|Adverse event before starting treatment|0
7228417|NCT00089284|11437690|FG001|Overall Study|Adverse event before starting treatment|0
7228418|NCT00089284|11437691|FG002|Overall Study|Adverse event before starting treatment|0
7228419|NCT00089284|11437692|FG003|Overall Study|Adverse event before starting treatment|0
7228420|NCT00089284|11437693|FG004|Overall Study|Adverse event before starting treatment|0
7228421|NCT00089284|11437694|FG005|Overall Study|Adverse event before starting treatment|0
7228422|NCT00089284|11437695|FG006|Overall Study|Adverse event before starting treatment|1
7228423|NCT00089297|11437717|FG000|Overall Study|Adverse Event|9
7228424|NCT00089297|11437717|FG000|Overall Study|Death|1
7228425|NCT00089297|11437717|FG000|Overall Study|Withdrawal by Subject|12
7228426|NCT00089297|11437717|FG000|Overall Study|Disease progression|2
7228427|NCT00089297|11437717|FG000|Overall Study|Ineligible|11
7228428|NCT00089297|11437717|FG000|Overall Study|Secondary malignancy|1
7228429|NCT00089297|11437717|FG000|Overall Study|IRB approval not ready|1
7228430|NCT00089297|11437717|FG000|Overall Study|Non-compliance|1
7228431|NCT00089479|11437723|FG000|Overall Study|Death|108
7228432|NCT00089479|11437724|FG001|Overall Study|Death|75
7228433|NCT00089479|11437723|FG000|Overall Study|Withdrawal by Subject|86
7228434|NCT00089479|11437724|FG001|Overall Study|Withdrawal by Subject|107
7228435|NCT00089479|11437723|FG000|Overall Study|Lost to Follow-up|137
7228436|NCT00089479|11437724|FG001|Overall Study|Lost to Follow-up|107
7228437|NCT00089505|11437734|FG000|Overall Study|Death|4
7228438|NCT00089505|11437735|FG001|Overall Study|Death|1
7228439|NCT00089505|11437736|FG002|Overall Study|Death|5
7228440|NCT00089505|11437737|FG003|Overall Study|Death|8
7228441|NCT00089505|11437734|FG000|Overall Study|Withdrawal by Subject|3
7228442|NCT00089505|11437735|FG001|Overall Study|Withdrawal by Subject|0
7228443|NCT00089505|11437736|FG002|Overall Study|Withdrawal by Subject|6
7228444|NCT00089505|11437737|FG003|Overall Study|Withdrawal by Subject|6
7228445|NCT00089505|11437734|FG000|Overall Study|Lost to Follow-up|1
7228446|NCT00089505|11437735|FG001|Overall Study|Lost to Follow-up|1
7228447|NCT00089505|11437736|FG002|Overall Study|Lost to Follow-up|9
7228448|NCT00089505|11437737|FG003|Overall Study|Lost to Follow-up|7
7228449|NCT00089505|11437734|FG000|Overall Study|Physician Decision|1
7228450|NCT00089505|11437735|FG001|Overall Study|Physician Decision|0
7228451|NCT00089505|11437736|FG002|Overall Study|Physician Decision|0
7228452|NCT00089505|11437737|FG003|Overall Study|Physician Decision|0
7228453|NCT00089505|11437734|FG000|Overall Study|Protocol Violation|0
7228454|NCT00089505|11437735|FG001|Overall Study|Protocol Violation|0
7228455|NCT00089505|11437736|FG002|Overall Study|Protocol Violation|1
7228456|NCT00089505|11437737|FG003|Overall Study|Protocol Violation|0
7228457|NCT00089544|11437749|FG000|Overall Study|Ineligible|1
7228458|NCT00089544|11437750|FG001|Overall Study|Ineligible|0
7255486|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Work commitment|0
7255487|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Work commitment|1
7255488|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Investigator decision|0
7255489|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Investigator decision|0
7255490|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Investigator decision|0
7255491|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Investigator decision|0
7255492|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Investigator decision|1
7255493|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Lack of time|1
7255494|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Lack of time|0
7255495|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Lack of time|0
7255496|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Lack of time|0
7255497|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Lack of time|0
7255498|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7255499|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7255500|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7255501|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
7255502|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
7255503|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
7255504|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
7255505|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
7255506|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
7255507|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
7255508|NCT00318461|11467022|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7255509|NCT00318461|11467023|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7255510|NCT00318461|11467024|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7255511|NCT00318461|11467025|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
7255512|NCT00318461|11467026|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
7255513|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
7255514|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
7255515|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
7255516|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
7255517|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
7255518|NCT00318461|11467022|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
7255519|NCT00318461|11467023|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
7228459|NCT00089583|11437758|FG000|Overall Study|Adverse Event|0
7228460|NCT00089583|11437759|FG001|Overall Study|Adverse Event|3
7228461|NCT00089583|11437758|FG000|Overall Study|Insufficient Viral Load Response|5
7228462|NCT00089583|11437759|FG001|Overall Study|Insufficient Viral Load Response|5
7228463|NCT00089583|11437758|FG000|Overall Study|Withdrawal by Subject|0
7228464|NCT00089583|11437759|FG001|Overall Study|Withdrawal by Subject|4
7228465|NCT00089583|11437758|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
7228466|NCT00089583|11437759|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
7228467|NCT00089583|11437758|FG000|Overall Study|Participant Refused Study Medication|0
7228468|NCT00089583|11437759|FG001|Overall Study|Participant Refused Study Medication|2
7228469|NCT00089583|11437758|FG000|Overall Study|Non-Compliance|0
7228470|NCT00089583|11437759|FG001|Overall Study|Non-Compliance|4
7228471|NCT00089583|11437758|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
7228472|NCT00089583|11437759|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
7228473|NCT00089583|11437758|FG000|Overall Study|Participant Management Criteria Met|0
7228474|NCT00089583|11437759|FG001|Overall Study|Participant Management Criteria Met|1
7228475|NCT00089583|11437758|FG000|Overall Study|Reason Not Provided|0
7228476|NCT00089583|11437759|FG001|Overall Study|Reason Not Provided|1
7228477|NCT00089583|11437758|FG000|Overall Study|Protocol Violation|0
7228478|NCT00089583|11437759|FG001|Overall Study|Protocol Violation|3
7228479|NCT00089583|11437758|FG000|Overall Study|Principal Investigator Decision|0
7228480|NCT00089583|11437759|FG001|Overall Study|Principal Investigator Decision|10
7228481|NCT00089583|11437758|FG000|Overall Study|Start of Disallowed Medication|0
7228482|NCT00089583|11437759|FG001|Overall Study|Start of Disallowed Medication|1
7228483|NCT00089583|11437758|FG000|Overall Study|Necessity to Use Prohibited Drug|1
7228484|NCT00089583|11437759|FG001|Overall Study|Necessity to Use Prohibited Drug|0
7228485|NCT00089583|11437758|FG000|Overall Study|Participant Incarcerated|0
7228486|NCT00089583|11437759|FG001|Overall Study|Participant Incarcerated|1
7228487|NCT00089609|11437773|FG000|Overall Study|Withdrawal by Subject|3
7228488|NCT00089609|11437774|FG001|Overall Study|Withdrawal by Subject|1
7228489|NCT00089635|11437783|FG000|Overall Study|Adverse Event|2
7228490|NCT00089635|11437783|FG000|Overall Study|Death|17
7228491|NCT00089635|11437783|FG000|Overall Study|Disease Progression|12
7228492|NCT00089635|11437783|FG000|Overall Study|Lost to Follow-up|3
7228493|NCT00089635|11437783|FG000|Overall Study|Withdrawal by Subject|6
7228494|NCT00089635|11437783|FG000|Overall Study|Ineligibility determined|1
7573246|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
7573247|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7573248|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
7228495|NCT00089635|11437783|FG000|Overall Study|Other|2
7228496|NCT00089648|11437787|FG000|Overall Study|Adverse Event|7
7228497|NCT00089648|11437787|FG000|Overall Study|Withdrawal by Subject|1
7228498|NCT00089648|11437787|FG000|Overall Study|Lack of Efficacy|33
7228499|NCT00089661|11437793|FG000|Overall Study|Adverse Event|0
7228500|NCT00089661|11437794|FG001|Overall Study|Adverse Event|2
7228501|NCT00089661|11437793|FG000|Overall Study|Death|1
7228502|NCT00089661|11437794|FG001|Overall Study|Death|0
7228503|NCT00089661|11437793|FG000|Overall Study|Lost to Follow-up|0
7228504|NCT00089661|11437794|FG001|Overall Study|Lost to Follow-up|3
7228505|NCT00089661|11437793|FG000|Overall Study|Withdrawal by Subject|11
7228506|NCT00089661|11437794|FG001|Overall Study|Withdrawal by Subject|9
7228507|NCT00089661|11437793|FG000|Overall Study|Disease progression|1
7228508|NCT00089661|11437794|FG001|Overall Study|Disease progression|3
7228509|NCT00089661|11437793|FG000|Overall Study|Ineligibility determined|4
7228510|NCT00089661|11437794|FG001|Overall Study|Ineligibility determined|4
7228511|NCT00089661|11437793|FG000|Overall Study|Noncompliance|2
7228512|NCT00089661|11437794|FG001|Overall Study|Noncompliance|4
7228513|NCT00089661|11437793|FG000|Overall Study|Other|2
7228514|NCT00089661|11437794|FG001|Overall Study|Other|1
7228515|NCT00089674|11437802|FG000|Overall Study|Physician Decision|4
7228516|NCT00089674|11437803|FG001|Overall Study|Physician Decision|2
7228517|NCT00089674|11437802|FG000|Overall Study|Adverse Event|23
7228518|NCT00089674|11437803|FG001|Overall Study|Adverse Event|29
7228519|NCT00089674|11437802|FG000|Overall Study|Withdrawal by Subject|143
7228520|NCT00089674|11437803|FG001|Overall Study|Withdrawal by Subject|127
7228521|NCT00089674|11437802|FG000|Overall Study|Death|43
7228522|NCT00089674|11437803|FG001|Overall Study|Death|43
7228523|NCT00089674|11437802|FG000|Overall Study|Disease progression|21
7228524|NCT00089674|11437803|FG001|Overall Study|Disease progression|23
7228525|NCT00089674|11437802|FG000|Overall Study|Ineligibility determined|8
7228526|NCT00089674|11437803|FG001|Overall Study|Ineligibility determined|10
7228527|NCT00089674|11437802|FG000|Overall Study|Lost to Follow-up|21
7228528|NCT00089674|11437803|FG001|Overall Study|Lost to Follow-up|17
7228529|NCT00089674|11437802|FG000|Overall Study|Noncompliance|7
7228530|NCT00089674|11437803|FG001|Overall Study|Noncompliance|3
7228531|NCT00089674|11437802|FG000|Overall Study|Other|5
7228532|NCT00089674|11437803|FG001|Overall Study|Other|9
7228533|NCT00089674|11437802|FG000|Overall Study|Requirement for alternative therapy|14
7228534|NCT00089674|11437803|FG001|Overall Study|Requirement for alternative therapy|4
7228535|NCT00089778|11437823|FG000|Overall Study|Protocol Violation|0
7228536|NCT00089778|11437824|FG001|Overall Study|Protocol Violation|0
7228537|NCT00089778|11437825|FG002|Overall Study|Protocol Violation|1
7228538|NCT00089843|11437839|FG000|Overall Study|Withdrawal by Subject|1
7228539|NCT00089843|11437840|FG001|Overall Study|Withdrawal by Subject|4
7228540|NCT00089843|11437841|FG002|Overall Study|Withdrawal by Subject|5
7228541|NCT00089843|11437842|FG003|Overall Study|Withdrawal by Subject|6
7228542|NCT00089843|11437839|FG000|Overall Study|Physician Decision|1
7228543|NCT00089843|11437840|FG001|Overall Study|Physician Decision|0
7228544|NCT00089843|11437841|FG002|Overall Study|Physician Decision|0
7228545|NCT00089843|11437842|FG003|Overall Study|Physician Decision|1
7228546|NCT00089973|11437852|FG000|Overall Study|Adverse Event|3
7228547|NCT00089973|11437852|FG000|Overall Study|Withdrawal by Subject|1
7228548|NCT00089973|11437852|FG000|Overall Study|Disease progression|45
7228549|NCT00089973|11437852|FG000|Overall Study|Death|1
7228550|NCT00089986|11437859|FG000|Overall Study|Adverse Event|6
7228551|NCT00089986|11437860|FG001|Overall Study|Adverse Event|9
7228552|NCT00089986|11437861|FG002|Overall Study|Adverse Event|6
7228553|NCT00089986|11437859|FG000|Overall Study|Lost to Follow-up|3
7228554|NCT00089986|11437860|FG001|Overall Study|Lost to Follow-up|1
7228555|NCT00089986|11437861|FG002|Overall Study|Lost to Follow-up|1
7228556|NCT00089986|11437859|FG000|Overall Study|Protocol Violation|0
7228557|NCT00089986|11437860|FG001|Overall Study|Protocol Violation|1
7228558|NCT00089986|11437861|FG002|Overall Study|Protocol Violation|0
7228559|NCT00089986|11437859|FG000|Overall Study|Patient transferred to another hospital|2
7228560|NCT00089986|11437860|FG001|Overall Study|Patient transferred to another hospital|1
7228561|NCT00089986|11437861|FG002|Overall Study|Patient transferred to another hospital|0
7228562|NCT00089986|11437859|FG000|Overall Study|Subject withdrew but agreed follow up|1
7228563|NCT00089986|11437860|FG001|Overall Study|Subject withdrew but agreed follow up|2
7228564|NCT00089986|11437861|FG002|Overall Study|Subject withdrew but agreed follow up|0
7228565|NCT00089986|11437859|FG000|Overall Study|Hemohlobin stopping rule|0
7228566|NCT00089986|11437860|FG001|Overall Study|Hemohlobin stopping rule|1
7228567|NCT00089986|11437861|FG002|Overall Study|Hemohlobin stopping rule|0
7228568|NCT00089986|11437859|FG000|Overall Study|Investigator decision to withdrew|0
7228569|NCT00089986|11437860|FG001|Overall Study|Investigator decision to withdrew|1
7228570|NCT00089986|11437861|FG002|Overall Study|Investigator decision to withdrew|0
7228571|NCT00089986|11437859|FG000|Overall Study|Enrollment in another study|0
7228572|NCT00089986|11437860|FG001|Overall Study|Enrollment in another study|1
7228573|NCT00089986|11437861|FG002|Overall Study|Enrollment in another study|0
7228574|NCT00089986|11437859|FG000|Overall Study|Family decision|0
7228575|NCT00089986|11437860|FG001|Overall Study|Family decision|1
7228576|NCT00089986|11437861|FG002|Overall Study|Family decision|0
7228577|NCT00089986|11437859|FG000|Overall Study|Do not resuscitate (DNR)|0
7228578|NCT00089986|11437860|FG001|Overall Study|Do not resuscitate (DNR)|0
7228579|NCT00089986|11437861|FG002|Overall Study|Do not resuscitate (DNR)|1
7228580|NCT00089986|11437859|FG000|Overall Study|Withdrawal by Subject|3
7228581|NCT00089986|11437860|FG001|Overall Study|Withdrawal by Subject|6
7228582|NCT00089986|11437861|FG002|Overall Study|Withdrawal by Subject|2
7228583|NCT00089999|11437871|FG000|Overall Study|Adverse Event|4
7228584|NCT00089999|11437872|FG001|Overall Study|Adverse Event|7
7228585|NCT00089999|11437871|FG000|Overall Study|Withdrawal by Subject|0
7228586|NCT00089999|11437872|FG001|Overall Study|Withdrawal by Subject|4
7228587|NCT00089999|11437871|FG000|Overall Study|Lost to Follow-up|2
7228588|NCT00089999|11437872|FG001|Overall Study|Lost to Follow-up|1
7228589|NCT00089999|11437871|FG000|Overall Study|Radiological Progression of Cancer|52
7228590|NCT00089999|11437872|FG001|Overall Study|Radiological Progression of Cancer|44
7228591|NCT00089999|11437871|FG000|Overall Study|Symptomatic Progression of Cancer|2
7228592|NCT00089999|11437872|FG001|Overall Study|Symptomatic Progression of Cancer|5
7228593|NCT00089999|11437871|FG000|Overall Study|Death|3
7228594|NCT00089999|11437872|FG001|Overall Study|Death|3
7228595|NCT00089999|11437871|FG000|Overall Study|Poor General Condition|1
7228596|NCT00089999|11437872|FG001|Overall Study|Poor General Condition|0
7228597|NCT00089999|11437871|FG000|Overall Study|Clinical Progression|1
7228598|NCT00089999|11437872|FG001|Overall Study|Clinical Progression|2
7228599|NCT00089999|11437871|FG000|Overall Study|Physician Decision|2
7228600|NCT00089999|11437872|FG001|Overall Study|Physician Decision|2
7228601|NCT00089999|11437871|FG000|Overall Study|Patient Underwent Surgery|2
7228602|NCT00089999|11437872|FG001|Overall Study|Patient Underwent Surgery|0
7228603|NCT00089999|11437871|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
7228604|NCT00089999|11437872|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
7228605|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
7228606|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
7228607|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
7228608|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
7228609|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
7228610|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
7228611|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
7228612|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
7228613|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
7228614|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7228615|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
7228616|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
7228617|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
7228618|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
7228619|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
7228620|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
7228621|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
7228622|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
7228623|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7228624|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
7228625|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
7228626|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
7228627|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
7228628|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
7228629|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
7228630|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
7228631|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
7228632|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
7228633|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
7228634|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
7228635|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
7228636|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
7228637|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
7228638|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7228639|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
7228640|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
7228641|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
7228642|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7228643|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
7228644|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
7228645|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7228646|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
7228647|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
7228648|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
7228649|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
7228650|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
7228651|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
7228652|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
7228653|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
7228654|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
7228655|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
7228656|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
7228657|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
7228658|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
7228659|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
7228660|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7228661|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
7464854|NCT01874665|11763582|FG000|Overall Study|Clinical Progressive Disease|4
7464855|NCT01874665|11763583|FG001|Overall Study|Clinical Progressive Disease|3
7464856|NCT01874665|11763582|FG000|Overall Study|Study Terminated by Sponsor|0
7464857|NCT01874665|11763583|FG001|Overall Study|Study Terminated by Sponsor|2
7228662|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7228663|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
7228664|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
7228665|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7228666|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
7228667|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
7228668|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
7464858|NCT01874665|11763582|FG000|Overall Study|Documented Progressive Disease|11
7464859|NCT01874665|11763583|FG001|Overall Study|Documented Progressive Disease|7
7464860|NCT01874665|11763582|FG000|Overall Study|Other|2
7573249|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
7228669|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7228670|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
7228671|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7228672|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
7228673|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
7228674|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7228675|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
7228676|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
7228677|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
7228678|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
7228679|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
7228680|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7228681|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
7228682|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
7228683|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7228684|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
7228685|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
7228686|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
7228687|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
7228688|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
7228689|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7228690|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
7228691|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
7228692|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7228693|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
7228694|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
7228695|NCT00090103|11437903|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7228696|NCT00090103|11437904|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
7228697|NCT00090103|11437905|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
7228698|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Adverse Event|34
7228699|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Adverse Event|39
7228700|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Adverse Event|44
7228701|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
7228702|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
7228703|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
7228704|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
7228705|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
7228706|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
7228707|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
7228708|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
7228709|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
7228710|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
7228711|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
7228712|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
7228713|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
7228714|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
7228715|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
7228716|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
7228717|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
7228718|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
7228719|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
7228720|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7228721|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
7228722|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Participant relocated|2
7228723|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Participant relocated|3
7228724|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Participant relocated|1
7228725|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7228726|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
7228727|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
7228728|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
7228729|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
7228730|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
7228731|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
7228732|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
7228733|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
7228734|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
7228735|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
7228736|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
7228737|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
7228738|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
7228739|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
7228740|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
7228741|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
7228742|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
7228743|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
7228744|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
7228745|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
7228746|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Death|1
7228747|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Death|0
7228748|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Death|1
7228749|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
7228750|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
7228751|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
7228752|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
7228753|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
7228754|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
7228755|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
7228756|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
7228757|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
7228758|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
7228759|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
7228760|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
7228761|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Back Pain|0
7228762|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Back Pain|1
7228763|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Back Pain|0
7228764|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
7228765|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
7228766|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
7228767|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
7228768|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
7228769|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
7228770|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Depression|0
7228771|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Depression|1
7228772|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Depression|0
7228773|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7228774|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
7228775|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
7228776|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Jailed|0
7228777|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Jailed|1
7228778|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Jailed|0
7228779|NCT00090103|11437903|FG000|16-Week Safety Follow-up Period|Other|0
7228780|NCT00090103|11437904|FG001|16-Week Safety Follow-up Period|Other|1
7228781|NCT00090103|11437905|FG002|16-Week Safety Follow-up Period|Other|0
7228782|NCT00090220|11437915|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
7228783|NCT00090220|11437916|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
7228784|NCT00090220|11437917|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
7228785|NCT00090220|11437918|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
7228786|NCT00090220|11437919|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
7228787|NCT00090220|11437920|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
7228788|NCT00090220|11437915|FG000|Base Study Vaccination Period|Adverse Event|6
7228789|NCT00090220|11437916|FG001|Base Study Vaccination Period|Adverse Event|1
7228790|NCT00090220|11437917|FG002|Base Study Vaccination Period|Adverse Event|0
7228791|NCT00090220|11437918|FG003|Base Study Vaccination Period|Adverse Event|0
7228792|NCT00090220|11437919|FG004|Base Study Vaccination Period|Adverse Event|0
7228793|NCT00090220|11437920|FG005|Base Study Vaccination Period|Adverse Event|0
7228794|NCT00090220|11437915|FG000|Base Study Vaccination Period|Lost to Follow-up|24
7228795|NCT00090220|11437916|FG001|Base Study Vaccination Period|Lost to Follow-up|28
7228796|NCT00090220|11437917|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7228797|NCT00090220|11437918|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7228798|NCT00090220|11437919|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7228799|NCT00090220|11437920|FG005|Base Study Vaccination Period|Lost to Follow-up|0
7228800|NCT00090220|11437915|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
7228801|NCT00090220|11437916|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
7228802|NCT00090220|11437917|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7228803|NCT00090220|11437918|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7228804|NCT00090220|11437919|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7256772|NCT00325468|11468502|FG002|Overall Study|Withdrawal by Subject|0
7228805|NCT00090220|11437920|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
7228806|NCT00090220|11437915|FG000|Base Study Vaccination Period|Patient Moved|6
7228807|NCT00090220|11437916|FG001|Base Study Vaccination Period|Patient Moved|2
7228808|NCT00090220|11437917|FG002|Base Study Vaccination Period|Patient Moved|0
7228809|NCT00090220|11437918|FG003|Base Study Vaccination Period|Patient Moved|0
7228810|NCT00090220|11437919|FG004|Base Study Vaccination Period|Patient Moved|0
7228811|NCT00090220|11437920|FG005|Base Study Vaccination Period|Patient Moved|0
7228812|NCT00090220|11437915|FG000|Base Study Vaccination Period|Other|4
7228813|NCT00090220|11437916|FG001|Base Study Vaccination Period|Other|4
7228814|NCT00090220|11437917|FG002|Base Study Vaccination Period|Other|0
7228815|NCT00090220|11437918|FG003|Base Study Vaccination Period|Other|0
7228816|NCT00090220|11437919|FG004|Base Study Vaccination Period|Other|0
7228817|NCT00090220|11437920|FG005|Base Study Vaccination Period|Other|0
7228818|NCT00090220|11437915|FG000|Base Study Follow-up Period|Adverse Event|6
7228819|NCT00090220|11437916|FG001|Base Study Follow-up Period|Adverse Event|1
7228820|NCT00090220|11437917|FG002|Base Study Follow-up Period|Adverse Event|0
7228821|NCT00090220|11437918|FG003|Base Study Follow-up Period|Adverse Event|0
7228822|NCT00090220|11437919|FG004|Base Study Follow-up Period|Adverse Event|0
7228823|NCT00090220|11437920|FG005|Base Study Follow-up Period|Adverse Event|0
7228824|NCT00090220|11437915|FG000|Base Study Follow-up Period|Lost to Follow-up|88
7228825|NCT00090220|11437916|FG001|Base Study Follow-up Period|Lost to Follow-up|78
7228826|NCT00090220|11437917|FG002|Base Study Follow-up Period|Lost to Follow-up|0
7228827|NCT00090220|11437918|FG003|Base Study Follow-up Period|Lost to Follow-up|0
7228828|NCT00090220|11437919|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7228829|NCT00090220|11437920|FG005|Base Study Follow-up Period|Lost to Follow-up|0
7228830|NCT00090220|11437915|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
7228831|NCT00090220|11437916|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
7228832|NCT00090220|11437917|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7228833|NCT00090220|11437918|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7228834|NCT00090220|11437919|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7228835|NCT00090220|11437920|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
7228836|NCT00090220|11437915|FG000|Base Study Follow-up Period|Patient Moved|20
7228837|NCT00090220|11437916|FG001|Base Study Follow-up Period|Patient Moved|28
7228838|NCT00090220|11437917|FG002|Base Study Follow-up Period|Patient Moved|0
7228839|NCT00090220|11437918|FG003|Base Study Follow-up Period|Patient Moved|0
7228840|NCT00090220|11437919|FG004|Base Study Follow-up Period|Patient Moved|0
7228841|NCT00090220|11437920|FG005|Base Study Follow-up Period|Patient Moved|0
7228842|NCT00090220|11437915|FG000|Base Study Follow-up Period|Other|19
7228843|NCT00090220|11437916|FG001|Base Study Follow-up Period|Other|21
7228844|NCT00090220|11437917|FG002|Base Study Follow-up Period|Other|0
7228845|NCT00090220|11437918|FG003|Base Study Follow-up Period|Other|0
7228846|NCT00090220|11437919|FG004|Base Study Follow-up Period|Other|0
7228847|NCT00090220|11437920|FG005|Base Study Follow-up Period|Other|0
7228848|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Adverse Event|0
7228849|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Adverse Event|0
7228850|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Adverse Event|4
7228851|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Adverse Event|0
7228852|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Adverse Event|0
7228853|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Adverse Event|0
7228854|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
7228855|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
7228856|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
7228857|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
7228858|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
7228859|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
7228860|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Moved|0
7228861|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Moved|0
7228862|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Moved|2
7228863|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Moved|1
7228864|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Moved|0
7228865|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Moved|0
7228866|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
7228867|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
7228868|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
7228869|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
7228870|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
7228871|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
7228872|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Protocol Violation|0
7228873|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Protocol Violation|0
7228874|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Protocol Violation|0
7228875|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Protocol Violation|1
7228876|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Protocol Violation|0
7228877|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Protocol Violation|0
7228878|NCT00090220|11437915|FG000|Extension 1 (EXT1)|Other reason|0
7228879|NCT00090220|11437916|FG001|Extension 1 (EXT1)|Other reason|0
7228880|NCT00090220|11437917|FG002|Extension 1 (EXT1)|Other reason|2
7228881|NCT00090220|11437918|FG003|Extension 1 (EXT1)|Other reason|0
7228882|NCT00090220|11437919|FG004|Extension 1 (EXT1)|Other reason|0
7228883|NCT00090220|11437920|FG005|Extension 1 (EXT1)|Other reason|0
7228884|NCT00090220|11437915|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7228885|NCT00090220|11437916|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7256773|NCT00325468|11468503|FG003|Overall Study|Withdrawal by Subject|14
7228886|NCT00090220|11437917|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7228887|NCT00090220|11437918|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7228888|NCT00090220|11437919|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
7228889|NCT00090220|11437920|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
7228890|NCT00090220|11437915|FG000|Long-term Follow-up (EXT2)|Death|0
7228891|NCT00090220|11437916|FG001|Long-term Follow-up (EXT2)|Death|0
7228892|NCT00090220|11437917|FG002|Long-term Follow-up (EXT2)|Death|0
7228893|NCT00090220|11437918|FG003|Long-term Follow-up (EXT2)|Death|0
7228894|NCT00090220|11437919|FG004|Long-term Follow-up (EXT2)|Death|1
7228895|NCT00090220|11437920|FG005|Long-term Follow-up (EXT2)|Death|1
7228896|NCT00090220|11437915|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7228897|NCT00090220|11437916|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7228898|NCT00090220|11437917|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7228899|NCT00090220|11437918|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7228900|NCT00090220|11437919|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7228901|NCT00090220|11437920|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
7228902|NCT00090220|11437915|FG000|Long-term Follow-up (EXT2)|Other|0
7228903|NCT00090220|11437916|FG001|Long-term Follow-up (EXT2)|Other|0
7228904|NCT00090220|11437917|FG002|Long-term Follow-up (EXT2)|Other|0
7228905|NCT00090220|11437918|FG003|Long-term Follow-up (EXT2)|Other|0
7228906|NCT00090220|11437919|FG004|Long-term Follow-up (EXT2)|Other|1
7228907|NCT00090220|11437920|FG005|Long-term Follow-up (EXT2)|Other|0
7228908|NCT00090233|11437939|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
7228909|NCT00090233|11437940|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
7228910|NCT00090233|11437939|FG000|Overall Study|Adverse Event|214
7228911|NCT00090233|11437940|FG001|Overall Study|Adverse Event|198
7228912|NCT00090233|11437939|FG000|Overall Study|Lost to Follow-up|68
7228913|NCT00090233|11437940|FG001|Overall Study|Lost to Follow-up|95
7228914|NCT00090233|11437939|FG000|Overall Study|Protocol Violation|960
7228915|NCT00090233|11437940|FG001|Overall Study|Protocol Violation|1022
7228916|NCT00090233|11437939|FG000|Overall Study|Withdrawal by Subject|182
7228917|NCT00090233|11437940|FG001|Overall Study|Withdrawal by Subject|211
7228918|NCT00090233|11437939|FG000|Overall Study|Moved|203
7228919|NCT00090233|11437940|FG001|Overall Study|Moved|189
7228920|NCT00090233|11437939|FG000|Overall Study|Other|1211
7228921|NCT00090233|11437940|FG001|Overall Study|Other|1160
7573250|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
7573251|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
7228922|NCT00090233|11437939|FG000|Overall Study|Data not available at data cut-off point|1552
7228923|NCT00090233|11437940|FG001|Overall Study|Data not available at data cut-off point|1563
7228924|NCT00090285|11437952|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
7228925|NCT00090285|11437953|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
7228926|NCT00090285|11437954|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
7228927|NCT00090285|11437955|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
7228928|NCT00090285|11437956|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
7228929|NCT00090285|11437957|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
7228930|NCT00090285|11437952|FG000|Base Study Vaccination Period|Adverse Event|2
7228931|NCT00090285|11437953|FG001|Base Study Vaccination Period|Adverse Event|4
7228932|NCT00090285|11437954|FG002|Base Study Vaccination Period|Adverse Event|0
7228933|NCT00090285|11437955|FG003|Base Study Vaccination Period|Adverse Event|0
7228934|NCT00090285|11437956|FG004|Base Study Vaccination Period|Adverse Event|0
7228935|NCT00090285|11437957|FG005|Base Study Vaccination Period|Adverse Event|0
7228936|NCT00090285|11437952|FG000|Base Study Vaccination Period|Lost to Follow-up|111
7228937|NCT00090285|11437953|FG001|Base Study Vaccination Period|Lost to Follow-up|112
7228938|NCT00090285|11437954|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7228939|NCT00090285|11437955|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7228940|NCT00090285|11437956|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7228941|NCT00090285|11437957|FG005|Base Study Vaccination Period|Lost to Follow-up|0
7228942|NCT00090285|11437952|FG000|Base Study Vaccination Period|Protocol Violation|2
7228943|NCT00090285|11437953|FG001|Base Study Vaccination Period|Protocol Violation|3
7228944|NCT00090285|11437954|FG002|Base Study Vaccination Period|Protocol Violation|0
7228945|NCT00090285|11437955|FG003|Base Study Vaccination Period|Protocol Violation|0
7228946|NCT00090285|11437956|FG004|Base Study Vaccination Period|Protocol Violation|0
7228947|NCT00090285|11437957|FG005|Base Study Vaccination Period|Protocol Violation|0
7228948|NCT00090285|11437952|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
7228949|NCT00090285|11437953|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
7228950|NCT00090285|11437954|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7228951|NCT00090285|11437955|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7228952|NCT00090285|11437956|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7228953|NCT00090285|11437957|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
7228954|NCT00090285|11437952|FG000|Base Study Vaccination Period|Uncooperative|2
7228955|NCT00090285|11437953|FG001|Base Study Vaccination Period|Uncooperative|2
7228956|NCT00090285|11437954|FG002|Base Study Vaccination Period|Uncooperative|0
7228957|NCT00090285|11437955|FG003|Base Study Vaccination Period|Uncooperative|0
7228958|NCT00090285|11437956|FG004|Base Study Vaccination Period|Uncooperative|0
7228959|NCT00090285|11437957|FG005|Base Study Vaccination Period|Uncooperative|0
7228960|NCT00090285|11437952|FG000|Base Study Vaccination Period|Moved|20
7573252|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
7573253|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
7573254|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
7573255|NCT03605836|11954267|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7573256|NCT03605836|11954268|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
7573257|NCT03605836|11954269|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
7573258|NCT03605836|11954270|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
7228961|NCT00090285|11437953|FG001|Base Study Vaccination Period|Moved|21
7228962|NCT00090285|11437954|FG002|Base Study Vaccination Period|Moved|0
7228963|NCT00090285|11437955|FG003|Base Study Vaccination Period|Moved|0
7228964|NCT00090285|11437956|FG004|Base Study Vaccination Period|Moved|0
7228965|NCT00090285|11437957|FG005|Base Study Vaccination Period|Moved|0
7228966|NCT00090285|11437952|FG000|Base Study Vaccination Period|Site Terminated|1
7228967|NCT00090285|11437953|FG001|Base Study Vaccination Period|Site Terminated|0
7228968|NCT00090285|11437954|FG002|Base Study Vaccination Period|Site Terminated|0
7228969|NCT00090285|11437955|FG003|Base Study Vaccination Period|Site Terminated|0
7228970|NCT00090285|11437956|FG004|Base Study Vaccination Period|Site Terminated|0
7228971|NCT00090285|11437957|FG005|Base Study Vaccination Period|Site Terminated|0
7228972|NCT00090285|11437952|FG000|Base Study Vaccination Period|Other|2
7228973|NCT00090285|11437953|FG001|Base Study Vaccination Period|Other|2
7228974|NCT00090285|11437954|FG002|Base Study Vaccination Period|Other|0
7228975|NCT00090285|11437955|FG003|Base Study Vaccination Period|Other|0
7228976|NCT00090285|11437956|FG004|Base Study Vaccination Period|Other|0
7228977|NCT00090285|11437957|FG005|Base Study Vaccination Period|Other|0
7228978|NCT00090285|11437952|FG000|Base Study Vaccination Period|Subject Incarcerated|2
7228979|NCT00090285|11437953|FG001|Base Study Vaccination Period|Subject Incarcerated|2
7228980|NCT00090285|11437954|FG002|Base Study Vaccination Period|Subject Incarcerated|0
7228981|NCT00090285|11437955|FG003|Base Study Vaccination Period|Subject Incarcerated|0
7228982|NCT00090285|11437956|FG004|Base Study Vaccination Period|Subject Incarcerated|0
7228983|NCT00090285|11437957|FG005|Base Study Vaccination Period|Subject Incarcerated|0
7228984|NCT00090285|11437952|FG000|Base Study Vaccination Period|HIV positive|1
7228985|NCT00090285|11437953|FG001|Base Study Vaccination Period|HIV positive|1
7228986|NCT00090285|11437954|FG002|Base Study Vaccination Period|HIV positive|0
7228987|NCT00090285|11437955|FG003|Base Study Vaccination Period|HIV positive|0
7228988|NCT00090285|11437956|FG004|Base Study Vaccination Period|HIV positive|0
7228989|NCT00090285|11437957|FG005|Base Study Vaccination Period|HIV positive|0
7228990|NCT00090285|11437952|FG000|Base Study Follow-up Period|Adverse Event|3
7228991|NCT00090285|11437953|FG001|Base Study Follow-up Period|Adverse Event|10
7228992|NCT00090285|11437954|FG002|Base Study Follow-up Period|Adverse Event|0
7228993|NCT00090285|11437955|FG003|Base Study Follow-up Period|Adverse Event|0
7228994|NCT00090285|11437956|FG004|Base Study Follow-up Period|Adverse Event|0
7228995|NCT00090285|11437957|FG005|Base Study Follow-up Period|Adverse Event|0
7228996|NCT00090285|11437952|FG000|Base Study Follow-up Period|Lost to Follow-up|232
7228997|NCT00090285|11437953|FG001|Base Study Follow-up Period|Lost to Follow-up|226
7228998|NCT00090285|11437954|FG002|Base Study Follow-up Period|Lost to Follow-up|0
7228999|NCT00090285|11437955|FG003|Base Study Follow-up Period|Lost to Follow-up|0
7229000|NCT00090285|11437956|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7229001|NCT00090285|11437957|FG005|Base Study Follow-up Period|Lost to Follow-up|0
7229002|NCT00090285|11437952|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
7229003|NCT00090285|11437953|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
7229004|NCT00090285|11437954|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7229005|NCT00090285|11437955|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7229006|NCT00090285|11437956|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7229007|NCT00090285|11437957|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
7229008|NCT00090285|11437952|FG000|Base Study Follow-up Period|Moved|41
7229009|NCT00090285|11437953|FG001|Base Study Follow-up Period|Moved|36
7229010|NCT00090285|11437954|FG002|Base Study Follow-up Period|Moved|0
7229011|NCT00090285|11437955|FG003|Base Study Follow-up Period|Moved|0
7229012|NCT00090285|11437956|FG004|Base Study Follow-up Period|Moved|0
7229013|NCT00090285|11437957|FG005|Base Study Follow-up Period|Moved|0
7229014|NCT00090285|11437952|FG000|Base Study Follow-up Period|Other|2
7229015|NCT00090285|11437953|FG001|Base Study Follow-up Period|Other|0
7229016|NCT00090285|11437954|FG002|Base Study Follow-up Period|Other|0
7229017|NCT00090285|11437955|FG003|Base Study Follow-up Period|Other|0
7229018|NCT00090285|11437956|FG004|Base Study Follow-up Period|Other|0
7229019|NCT00090285|11437957|FG005|Base Study Follow-up Period|Other|0
7229020|NCT00090285|11437952|FG000|Base Study Follow-up Period|Protocol Violation|1
7229021|NCT00090285|11437953|FG001|Base Study Follow-up Period|Protocol Violation|0
7229022|NCT00090285|11437954|FG002|Base Study Follow-up Period|Protocol Violation|0
7229023|NCT00090285|11437955|FG003|Base Study Follow-up Period|Protocol Violation|0
7229024|NCT00090285|11437956|FG004|Base Study Follow-up Period|Protocol Violation|0
7229025|NCT00090285|11437957|FG005|Base Study Follow-up Period|Protocol Violation|0
7229026|NCT00090285|11437952|FG000|Base Study Follow-up Period|Uncooperative|3
7229027|NCT00090285|11437953|FG001|Base Study Follow-up Period|Uncooperative|4
7229028|NCT00090285|11437954|FG002|Base Study Follow-up Period|Uncooperative|0
7229029|NCT00090285|11437955|FG003|Base Study Follow-up Period|Uncooperative|0
7229030|NCT00090285|11437956|FG004|Base Study Follow-up Period|Uncooperative|0
7229031|NCT00090285|11437957|FG005|Base Study Follow-up Period|Uncooperative|0
7229032|NCT00090285|11437952|FG000|Base Study Follow-up Period|Subject Incarcerated|0
7229033|NCT00090285|11437953|FG001|Base Study Follow-up Period|Subject Incarcerated|2
7229034|NCT00090285|11437954|FG002|Base Study Follow-up Period|Subject Incarcerated|0
7229035|NCT00090285|11437955|FG003|Base Study Follow-up Period|Subject Incarcerated|0
7229036|NCT00090285|11437956|FG004|Base Study Follow-up Period|Subject Incarcerated|0
7229037|NCT00090285|11437957|FG005|Base Study Follow-up Period|Subject Incarcerated|0
7229038|NCT00090285|11437952|FG000|Extension 1|Adverse Event|0
7229039|NCT00090285|11437953|FG001|Extension 1|Adverse Event|0
7229040|NCT00090285|11437954|FG002|Extension 1|Adverse Event|2
7229041|NCT00090285|11437955|FG003|Extension 1|Adverse Event|0
7229042|NCT00090285|11437956|FG004|Extension 1|Adverse Event|0
7229043|NCT00090285|11437957|FG005|Extension 1|Adverse Event|0
7229044|NCT00090285|11437952|FG000|Extension 1|Lost to Follow-up|0
7229045|NCT00090285|11437953|FG001|Extension 1|Lost to Follow-up|0
7229046|NCT00090285|11437954|FG002|Extension 1|Lost to Follow-up|35
7229047|NCT00090285|11437955|FG003|Extension 1|Lost to Follow-up|0
7229048|NCT00090285|11437956|FG004|Extension 1|Lost to Follow-up|0
7229049|NCT00090285|11437957|FG005|Extension 1|Lost to Follow-up|0
7229050|NCT00090285|11437952|FG000|Extension 1|Withdrawal by Subject|0
7229051|NCT00090285|11437953|FG001|Extension 1|Withdrawal by Subject|0
7229052|NCT00090285|11437954|FG002|Extension 1|Withdrawal by Subject|13
7229053|NCT00090285|11437955|FG003|Extension 1|Withdrawal by Subject|1
7229054|NCT00090285|11437956|FG004|Extension 1|Withdrawal by Subject|0
7229055|NCT00090285|11437957|FG005|Extension 1|Withdrawal by Subject|0
7229056|NCT00090285|11437952|FG000|Extension 1|Other|0
7229057|NCT00090285|11437953|FG001|Extension 1|Other|0
7229058|NCT00090285|11437954|FG002|Extension 1|Other|4
7229059|NCT00090285|11437955|FG003|Extension 1|Other|0
7229060|NCT00090285|11437956|FG004|Extension 1|Other|0
7229061|NCT00090285|11437957|FG005|Extension 1|Other|0
7229062|NCT00090285|11437952|FG000|Extension 1|Moved|0
7229063|NCT00090285|11437953|FG001|Extension 1|Moved|0
7229064|NCT00090285|11437954|FG002|Extension 1|Moved|3
7229065|NCT00090285|11437955|FG003|Extension 1|Moved|0
7229066|NCT00090285|11437956|FG004|Extension 1|Moved|0
7229067|NCT00090285|11437957|FG005|Extension 1|Moved|0
7229068|NCT00090285|11437952|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
7229069|NCT00090285|11437953|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
7229070|NCT00090285|11437954|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
7229071|NCT00090285|11437955|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
7229072|NCT00090285|11437956|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
7229073|NCT00090285|11437957|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
7229074|NCT00090285|11437952|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7229075|NCT00090285|11437953|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7229076|NCT00090285|11437954|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7229077|NCT00090285|11437955|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
7229078|NCT00090285|11437956|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
7229079|NCT00090285|11437957|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
7229080|NCT00090285|11437952|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7229081|NCT00090285|11437953|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7229082|NCT00090285|11437954|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7229083|NCT00090285|11437955|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
7229084|NCT00090285|11437956|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
7229085|NCT00090285|11437957|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
7229086|NCT00090285|11437952|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
7229087|NCT00090285|11437953|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
7229088|NCT00090285|11437954|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
7229089|NCT00090285|11437955|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
7229090|NCT00090285|11437956|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
7229091|NCT00090285|11437957|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
7229092|NCT00090363|11437975|FG000|Overall Study|Lost to Follow-up|1
7229093|NCT00090363|11437976|FG001|Overall Study|Lost to Follow-up|2
7229094|NCT00090363|11437977|FG002|Overall Study|Lost to Follow-up|1
7229095|NCT00090363|11437975|FG000|Overall Study|Withdrawal by Subject|7
7229096|NCT00090363|11437976|FG001|Overall Study|Withdrawal by Subject|7
7229097|NCT00090363|11437977|FG002|Overall Study|Withdrawal by Subject|6
7229098|NCT00090363|11437975|FG000|Overall Study|Study-specific discontinuation criteria|75
7229099|NCT00090363|11437976|FG001|Overall Study|Study-specific discontinuation criteria|74
7229100|NCT00090363|11437977|FG002|Overall Study|Study-specific discontinuation criteria|62
7229101|NCT00090363|11437975|FG000|Overall Study|Eligibility criteria not fulfilled|0
7229102|NCT00090363|11437976|FG001|Overall Study|Eligibility criteria not fulfilled|0
7229103|NCT00090363|11437977|FG002|Overall Study|Eligibility criteria not fulfilled|1
7229104|NCT00090363|11437975|FG000|Overall Study|Consent expired|7
7229105|NCT00090363|11437976|FG001|Overall Study|Consent expired|10
7229106|NCT00090363|11437977|FG002|Overall Study|Consent expired|9
7229107|NCT00090363|11437975|FG000|Overall Study|Reasons not specified|2
7229108|NCT00090363|11437976|FG001|Overall Study|Reasons not specified|1
7229109|NCT00090363|11437977|FG002|Overall Study|Reasons not specified|1
7229110|NCT00090363|11437975|FG000|Overall Study|Continuing on study off treatment|14
7229111|NCT00090363|11437976|FG001|Overall Study|Continuing on study off treatment|13
7229112|NCT00090363|11437977|FG002|Overall Study|Continuing on study off treatment|16
7229113|NCT00090402|11437988|FG000|Overall Study|Death|1
7229114|NCT00090402|11437989|FG001|Overall Study|Death|1
7229115|NCT00090402|11437990|FG002|Overall Study|Death|0
7229116|NCT00090402|11437988|FG000|Overall Study|subject moved|0
7229117|NCT00090402|11437989|FG001|Overall Study|subject moved|1
7229118|NCT00090402|11437990|FG002|Overall Study|subject moved|0
7229119|NCT00090402|11437988|FG000|Overall Study|stopped taking study medication|1
7229120|NCT00090402|11437989|FG001|Overall Study|stopped taking study medication|0
7229121|NCT00090402|11437990|FG002|Overall Study|stopped taking study medication|1
7229122|NCT00090493|11438001|FG000|Overall Study|Physician Decision|2
7229123|NCT00090519|11438007|FG000|Overall Study|Adverse Event|5
7229124|NCT00090519|11438008|FG001|Overall Study|Adverse Event|4
7229125|NCT00090519|11438007|FG000|Overall Study|Death|9
7229126|NCT00090519|11438008|FG001|Overall Study|Death|9
7573259|NCT03606460|11954303|FG000|Overall Study|Lost to Follow-up|1
7573260|NCT03606460|11954304|FG001|Overall Study|Lost to Follow-up|8
7573261|NCT03607682|11954320|FG000|Overall Study|Withdrawal by Subject|1
7573262|NCT03607682|11954320|FG000|Overall Study|Disease progression|1
7573263|NCT03607695|11954324|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
7573264|NCT03607695|11954324|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
7573265|NCT03608774|11954347|FG000|Overall Study|Lost to Follow-up|5
7573266|NCT03608774|11954348|FG001|Overall Study|Lost to Follow-up|5
7573267|NCT03608774|11954347|FG000|Overall Study|Withdrawal by Subject|1
7573268|NCT03608774|11954348|FG001|Overall Study|Withdrawal by Subject|0
7573269|NCT03608774|11954347|FG000|Overall Study|Protocol Violation|1
7573270|NCT03608774|11954348|FG001|Overall Study|Protocol Violation|0
7573271|NCT03608774|11954347|FG000|Overall Study|Not eligible at enrollment|0
7229127|NCT00090519|11438007|FG000|Overall Study|Lost to Follow-up|26
7229128|NCT00090519|11438008|FG001|Overall Study|Lost to Follow-up|29
7229129|NCT00090519|11438007|FG000|Overall Study|Withdrawal by Subject|28
7229130|NCT00090519|11438008|FG001|Overall Study|Withdrawal by Subject|29
7573272|NCT03608774|11954348|FG001|Overall Study|Not eligible at enrollment|1
7573273|NCT03608774|11954347|FG000|Overall Study|Health related event|0
7229131|NCT00090519|11438007|FG000|Overall Study|Physician Decision|2
7229132|NCT00090519|11438008|FG001|Overall Study|Physician Decision|3
7229133|NCT00090519|11438007|FG000|Overall Study|Sponsor Decision|3
7229134|NCT00090519|11438008|FG001|Overall Study|Sponsor Decision|1
7573274|NCT03608774|11954348|FG001|Overall Study|Health related event|1
7573275|NCT03609619|11954369|FG000|Overall Study|Adverse Event|1
7573276|NCT03609619|11954370|FG001|Overall Study|Adverse Event|0
7229135|NCT00090545|11438016|FG000|Overall Study|Disease progression on study|21
7229136|NCT00090545|11438017|FG001|Overall Study|Disease progression on study|17
7229137|NCT00090545|11438016|FG000|Overall Study|Refused further treatment|1
7229138|NCT00090545|11438017|FG001|Overall Study|Refused further treatment|4
7229139|NCT00090545|11438016|FG000|Overall Study|Death|0
7229140|NCT00090545|11438017|FG001|Overall Study|Death|1
7229141|NCT00090545|11438016|FG000|Overall Study|Adverse Event|0
7229142|NCT00090545|11438017|FG001|Overall Study|Adverse Event|2
7229143|NCT00090584|11438027|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
7229144|NCT00090584|11438028|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
7229145|NCT00090584|11438027|FG000|Baseline to 8 Months|Lost to Follow-up|44
7229146|NCT00090584|11438028|FG001|Baseline to 8 Months|Lost to Follow-up|41
7229147|NCT00090610|11438044|FG000|Overall Study|Withdrawal by Subject|1
7229148|NCT00090610|11438045|FG001|Overall Study|Withdrawal by Subject|1
7229149|NCT00090753|11438053|FG000|First Treatment Period|Adverse Event|20
7229150|NCT00090753|11438054|FG001|First Treatment Period|Adverse Event|8
7229151|NCT00090753|11438053|FG000|First Treatment Period|Death|88
7229152|NCT00090753|11438054|FG001|First Treatment Period|Death|62
7229153|NCT00090753|11438053|FG000|First Treatment Period|Lack of Efficacy|2
7229154|NCT00090753|11438054|FG001|First Treatment Period|Lack of Efficacy|1
7229155|NCT00090753|11438053|FG000|First Treatment Period|Refused Treatment|32
7229156|NCT00090753|11438054|FG001|First Treatment Period|Refused Treatment|25
7229157|NCT00090753|11438053|FG000|First Treatment Period|Lost to Follow-up|4
7229158|NCT00090753|11438054|FG001|First Treatment Period|Lost to Follow-up|4
7229159|NCT00090753|11438053|FG000|First Treatment Period|Renal Transplant|70
7229160|NCT00090753|11438054|FG001|First Treatment Period|Renal Transplant|50
7229161|NCT00090753|11438053|FG000|First Treatment Period|Mircera Commercialization|1
7229162|NCT00090753|11438054|FG001|First Treatment Period|Mircera Commercialization|0
7229163|NCT00090753|11438053|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
7229164|NCT00090753|11438054|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
7229165|NCT00090753|11438053|FG000|Extended Treatment Period|Adverse Event|11
7229166|NCT00090753|11438054|FG001|Extended Treatment Period|Adverse Event|0
7229167|NCT00090753|11438053|FG000|Extended Treatment Period|Death|58
7229168|NCT00090753|11438054|FG001|Extended Treatment Period|Death|30
7229169|NCT00090753|11438053|FG000|Extended Treatment Period|Lack of Efficacy|1
7229170|NCT00090753|11438054|FG001|Extended Treatment Period|Lack of Efficacy|0
7229171|NCT00090753|11438053|FG000|Extended Treatment Period|Refused Treatment|18
7229172|NCT00090753|11438054|FG001|Extended Treatment Period|Refused Treatment|12
7229173|NCT00090753|11438053|FG000|Extended Treatment Period|Lost to Follow-up|3
7229174|NCT00090753|11438054|FG001|Extended Treatment Period|Lost to Follow-up|1
7229175|NCT00090753|11438053|FG000|Extended Treatment Period|Renal Transplant|15
7229176|NCT00090753|11438054|FG001|Extended Treatment Period|Renal Transplant|12
7573277|NCT03609619|11954369|FG000|Overall Study|Lack of Efficacy|1
7573278|NCT03609619|11954370|FG001|Overall Study|Lack of Efficacy|2
7229177|NCT00090753|11438053|FG000|Extended Treatment Period|Mircera Commercialization|188
7229178|NCT00090753|11438054|FG001|Extended Treatment Period|Mircera Commercialization|93
7229179|NCT00090753|11438053|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
7229180|NCT00090753|11438054|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
7229181|NCT00090766|11438063|FG000|Overall Study|Nephrectomy Planned|0
7229182|NCT00090766|11438064|FG001|Overall Study|Nephrectomy Planned|0
7229183|NCT00090766|11438065|FG002|Overall Study|Nephrectomy Planned|1
7229184|NCT00090766|11438063|FG000|Overall Study|Death|1
7229185|NCT00090766|11438064|FG001|Overall Study|Death|0
7573279|NCT03609619|11954369|FG000|Overall Study|Protocol Violation|5
7229186|NCT00090766|11438065|FG002|Overall Study|Death|0
7229187|NCT00090766|11438063|FG000|Overall Study|Admin|0
7229188|NCT00090766|11438064|FG001|Overall Study|Admin|2
7229189|NCT00090766|11438065|FG002|Overall Study|Admin|0
7229190|NCT00090766|11438063|FG000|Overall Study|Lost to Follow-up|2
7229191|NCT00090766|11438064|FG001|Overall Study|Lost to Follow-up|0
7229192|NCT00090766|11438065|FG002|Overall Study|Lost to Follow-up|2
7229193|NCT00090779|11438077|FG000|Step 1|Withdrawal by Subject|4
7229194|NCT00090779|11438078|FG001|Step 1|Withdrawal by Subject|2
7229195|NCT00090779|11438077|FG000|Step 1|Lost to Follow-up|3
7229196|NCT00090779|11438078|FG001|Step 1|Lost to Follow-up|2
7229197|NCT00090779|11438077|FG000|Step 1|Death|0
7229198|NCT00090779|11438078|FG001|Step 1|Death|2
7229199|NCT00090779|11438077|FG000|Step 1|Physician Decision|1
7229200|NCT00090779|11438078|FG001|Step 1|Physician Decision|0
7229201|NCT00090779|11438077|FG000|Step 1|Pregnancy|1
7229202|NCT00090779|11438078|FG001|Step 1|Pregnancy|0
7464861|NCT01874665|11763583|FG001|Overall Study|Other|0
7464862|NCT01875237|11763630|FG000|Overall Study|GVDH before DLI|1
7464863|NCT01875237|11763631|FG001|Overall Study|GVDH before DLI|0
7464864|NCT01875237|11763630|FG000|Overall Study|DLI cells could not be produced|1
7464865|NCT01875237|11763631|FG001|Overall Study|DLI cells could not be produced|0
7464866|NCT01875250|11763641|FG000|Overall Study|Adverse Event|2
7464867|NCT01875250|11763642|FG001|Overall Study|Adverse Event|0
7464868|NCT01875367|11763652|FG000|Overall Study|Not complete at least 2 questionaries|4
7464869|NCT01875367|11763653|FG001|Overall Study|Not complete at least 2 questionaries|2
7464870|NCT01875367|11763652|FG000|Overall Study|Not receive study treatment|1
7464871|NCT01875367|11763653|FG001|Overall Study|Not receive study treatment|0
7464872|NCT01875445|11763665|FG000|Overall Study|Lost to Follow-up|5
7464873|NCT01875445|11763666|FG001|Overall Study|Lost to Follow-up|0
7464874|NCT01875445|11763665|FG000|Overall Study|Withdrawal by Subject|2
7464875|NCT01875445|11763666|FG001|Overall Study|Withdrawal by Subject|0
7464876|NCT01875471|11763674|FG000|Overall Study|Adverse Event|0
7464877|NCT01875471|11763675|FG001|Overall Study|Adverse Event|1
7464878|NCT01875471|11763674|FG000|Overall Study|Unsatisfactory Lens Fitting|1
7464879|NCT01875471|11763675|FG001|Overall Study|Unsatisfactory Lens Fitting|0
7464880|NCT01875731|11763692|FG000|Overall Study|Fail to obtain lab sample|1
7464881|NCT01875731|11763693|FG001|Overall Study|Fail to obtain lab sample|0
7464882|NCT01875848|11763707|FG000|Overall Study|Withdrawal by Subject|2
7464883|NCT01875848|11763708|FG001|Overall Study|Withdrawal by Subject|0
7464884|NCT01875874|11763724|FG000|Overall Study|Death|3
7464885|NCT01875991|11763742|FG000|Overall Study|Withdrawal by Subject|6
7464886|NCT01875991|11763743|FG001|Overall Study|Withdrawal by Subject|6
7464887|NCT01875991|11763742|FG000|Overall Study|Sponsor Decision|1
7464888|NCT01875991|11763743|FG001|Overall Study|Sponsor Decision|0
7464889|NCT01876043|11763752|FG000|Overall Study|Death|1
7464890|NCT01876043|11763752|FG000|Overall Study|Withdrawal by Subject|1
7229203|NCT00090779|11438077|FG000|Step 1|Non-compliance to study requirements|0
7229204|NCT00090779|11438078|FG001|Step 1|Non-compliance to study requirements|1
7229205|NCT00090779|11438077|FG000|Step 1|Subject relocated|2
7229206|NCT00090779|11438078|FG001|Step 1|Subject relocated|8
7229207|NCT00090779|11438077|FG000|Step 2|Off study per study closure|6
7229208|NCT00090779|11438078|FG001|Step 2|Off study per study closure|16
7229209|NCT00090779|11438077|FG000|Step 2|Subject relocated|0
7229210|NCT00090779|11438078|FG001|Step 2|Subject relocated|1
7229211|NCT00090779|11438077|FG000|Step 2|Non-compliance to study requirements|0
7229212|NCT00090779|11438078|FG001|Step 2|Non-compliance to study requirements|1
7229213|NCT00090779|11438077|FG000|Step 3|Initiation of ART and off extended study|3
7229214|NCT00090779|11438078|FG001|Step 3|Initiation of ART and off extended study|2
7229215|NCT00090779|11438077|FG000|Step 3|Off extended study due to study closure|4
7229216|NCT00090779|11438078|FG001|Step 3|Off extended study due to study closure|3
7229217|NCT00090857|11438096|FG000|Overall Study|Lost to Follow-up|0
7229218|NCT00090857|11438097|FG001|Overall Study|Lost to Follow-up|1
7229219|NCT00090857|11438096|FG000|Overall Study|Withdrawal by Subject|2
7229220|NCT00090857|11438097|FG001|Overall Study|Withdrawal by Subject|0
7229221|NCT00090857|11438096|FG000|Overall Study|Adverse Event|2
7229222|NCT00090857|11438097|FG001|Overall Study|Adverse Event|2
7229223|NCT00090987|11438103|FG000|Overall Study|Adverse Event|5
7229224|NCT00090987|11438103|FG000|Overall Study|Lack of Efficacy|7
7229225|NCT00090987|11438103|FG000|Overall Study|Withdrawal by Subject|3
7229226|NCT00090987|11438103|FG000|Overall Study|alternative therapy|1
7229227|NCT00090987|11438103|FG000|Overall Study|Non-compliance|4
7229228|NCT00090987|11438103|FG000|Overall Study|Incarcerated|1
7229229|NCT00091026|11438109|FG000|Overall Study|Patient deemed non eligible-never receiv|1
7229230|NCT00091026|11438110|FG001|Overall Study|Patient deemed non eligible-never receiv|0
7229231|NCT00091026|11438109|FG000|Overall Study|Patient withdrew and never received trea|0
7464891|NCT01876082|11763758|FG000|Overall Study|Withdrawal by Subject|0
7229232|NCT00091026|11438110|FG001|Overall Study|Patient withdrew and never received trea|2
7464892|NCT01876082|11763759|FG001|Overall Study|Withdrawal by Subject|2
7229233|NCT00091026|11438109|FG000|Overall Study|Unknown-never received treatment|0
7229234|NCT00091026|11438110|FG001|Overall Study|Unknown-never received treatment|1
7229235|NCT00091169|11438118|FG000|Overall Study|Disease progression|3
7464893|NCT01876082|11763758|FG000|Overall Study|Protocol Violation|1
7464894|NCT01876082|11763759|FG001|Overall Study|Protocol Violation|0
7464895|NCT01876082|11763758|FG000|Overall Study|Adverse Event|1
7229236|NCT00091169|11438119|FG001|Overall Study|Disease progression|1
7229237|NCT00091169|11438118|FG000|Overall Study|Adverse Event|11
7229238|NCT00091169|11438119|FG001|Overall Study|Adverse Event|17
7229239|NCT00091169|11438118|FG000|Overall Study|Death|4
7229240|NCT00091169|11438119|FG001|Overall Study|Death|1
7229241|NCT00091169|11438118|FG000|Overall Study|Withdrawal by Subject|10
7229242|NCT00091169|11438119|FG001|Overall Study|Withdrawal by Subject|13
7229243|NCT00091169|11438118|FG000|Overall Study|Other|3
7229244|NCT00091169|11438119|FG001|Overall Study|Other|4
7229245|NCT00091169|11438118|FG000|Overall Study|Not start protocol therapy|26
7229246|NCT00091169|11438119|FG001|Overall Study|Not start protocol therapy|17
7229247|NCT00091390|11438136|FG000|Overall Study|Protocol Violation|1
7229248|NCT00091390|11438136|FG000|Overall Study|No protocol treatment|3
7229249|NCT00091442|11438142|FG000|Overall Study|Progressive Disease|220
7229250|NCT00091442|11438143|FG001|Overall Study|Progressive Disease|189
7229251|NCT00091442|11438142|FG000|Overall Study|Physician Decision|61
7229252|NCT00091442|11438143|FG001|Overall Study|Physician Decision|58
7229253|NCT00091442|11438142|FG000|Overall Study|Withdrawal by Subject|38
7229254|NCT00091442|11438143|FG001|Overall Study|Withdrawal by Subject|46
7229255|NCT00091442|11438142|FG000|Overall Study|Adverse Event|29
7229256|NCT00091442|11438143|FG001|Overall Study|Adverse Event|48
7229257|NCT00091442|11438142|FG000|Overall Study|2cycles therapy beyond Complete response|9
7229258|NCT00091442|11438143|FG001|Overall Study|2cycles therapy beyond Complete response|16
7229259|NCT00091442|11438142|FG000|Overall Study|Death|9
7229260|NCT00091442|11438143|FG001|Overall Study|Death|7
7229261|NCT00091442|11438142|FG000|Overall Study|Lost to Follow-up|1
7229262|NCT00091442|11438143|FG001|Overall Study|Lost to Follow-up|3
7229263|NCT00091442|11438142|FG000|Overall Study|Other|2
7229264|NCT00091442|11438143|FG001|Overall Study|Other|6
7229265|NCT00091572|11438160|FG000|Overall Study|Lost to Follow-up|1
7229266|NCT00091572|11438161|FG001|Overall Study|Lost to Follow-up|1
7229267|NCT00091572|11438160|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
7229268|NCT00091572|11438161|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
7229269|NCT00091572|11438160|FG000|Overall Study|Death not due to malignancy/toxicity|1
7229270|NCT00091572|11438161|FG001|Overall Study|Death not due to malignancy/toxicity|3
7229271|NCT00091572|11438160|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
7229272|NCT00091572|11438161|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
7229273|NCT00091572|11438160|FG000|Overall Study|Other Reason|6
7229274|NCT00091572|11438161|FG001|Overall Study|Other Reason|13
7229275|NCT00091572|11438160|FG000|Overall Study|Ongoing (still on treatment)|8
7229276|NCT00091572|11438161|FG001|Overall Study|Ongoing (still on treatment)|12
7229277|NCT00091572|11438160|FG000|Overall Study|Major Protocol Violation|2
7229278|NCT00091572|11438161|FG001|Overall Study|Major Protocol Violation|0
7229279|NCT00091572|11438160|FG000|Overall Study|Toxicity (Related AE)|53
7229280|NCT00091572|11438161|FG001|Overall Study|Toxicity (Related AE)|9
7229281|NCT00091793|11438169|FG000|Overall Study|Adverse Event|1
7229282|NCT00091793|11438170|FG001|Overall Study|Adverse Event|2
7229283|NCT00091793|11438169|FG000|Overall Study|Withdrawal by Subject|10
7229284|NCT00091793|11438170|FG001|Overall Study|Withdrawal by Subject|15
7229285|NCT00091793|11438169|FG000|Overall Study|Ineligibility determined|2
7229286|NCT00091793|11438170|FG001|Overall Study|Ineligibility determined|0
7229287|NCT00091793|11438169|FG000|Overall Study|Lost to Follow-up|7
7229288|NCT00091793|11438170|FG001|Overall Study|Lost to Follow-up|5
7229289|NCT00091793|11438169|FG000|Overall Study|Noncompliance|2
7229290|NCT00091793|11438170|FG001|Overall Study|Noncompliance|0
7229291|NCT00091793|11438169|FG000|Overall Study|Other|2
7229292|NCT00091793|11438170|FG001|Overall Study|Other|0
7229293|NCT00091819|11438178|FG000|Overall Study|Adverse Event|1
7229294|NCT00091819|11438179|FG001|Overall Study|Adverse Event|1
7229295|NCT00091819|11438178|FG000|Overall Study|Death|4
7229296|NCT00091819|11438179|FG001|Overall Study|Death|5
7229297|NCT00091819|11438178|FG000|Overall Study|Lost to Follow-up|26
7229298|NCT00091819|11438179|FG001|Overall Study|Lost to Follow-up|23
7229299|NCT00091819|11438178|FG000|Overall Study|Withdrawal by Subject|5
7229300|NCT00091819|11438179|FG001|Overall Study|Withdrawal by Subject|8
7229301|NCT00091819|11438178|FG000|Overall Study|Protocol Violation|1
7229302|NCT00091819|11438179|FG001|Overall Study|Protocol Violation|2
7229303|NCT00091819|11438178|FG000|Overall Study|Other|2
7229304|NCT00091819|11438179|FG001|Overall Study|Other|3
7229305|NCT00091819|11438178|FG000|Overall Study|Never received study treatment|3
7229306|NCT00091819|11438179|FG001|Overall Study|Never received study treatment|4
7229307|NCT00091832|11438191|FG000|Overall Study|Physician Decision|1
7229308|NCT00091832|11438192|FG001|Overall Study|Physician Decision|0
7229309|NCT00091832|11438193|FG002|Overall Study|Physician Decision|0
7229310|NCT00091832|11438194|FG003|Overall Study|Physician Decision|0
7229311|NCT00091832|11438195|FG004|Overall Study|Physician Decision|0
7229312|NCT00091832|11438196|FG005|Overall Study|Physician Decision|0
7229313|NCT00091832|11438191|FG000|Overall Study|Adverse Event|0
7229314|NCT00091832|11438192|FG001|Overall Study|Adverse Event|0
7229315|NCT00091832|11438193|FG002|Overall Study|Adverse Event|0
7229316|NCT00091832|11438194|FG003|Overall Study|Adverse Event|1
7229317|NCT00091832|11438195|FG004|Overall Study|Adverse Event|3
7229318|NCT00091832|11438196|FG005|Overall Study|Adverse Event|0
7229319|NCT00091832|11438191|FG000|Overall Study|Withdrawal by Subject|4
7229320|NCT00091832|11438192|FG001|Overall Study|Withdrawal by Subject|5
7229321|NCT00091832|11438193|FG002|Overall Study|Withdrawal by Subject|0
7229322|NCT00091832|11438194|FG003|Overall Study|Withdrawal by Subject|1
7229323|NCT00091832|11438195|FG004|Overall Study|Withdrawal by Subject|3
7229324|NCT00091832|11438196|FG005|Overall Study|Withdrawal by Subject|1
7229325|NCT00091832|11438191|FG000|Overall Study|Death|6
7229326|NCT00091832|11438192|FG001|Overall Study|Death|4
7229327|NCT00091832|11438193|FG002|Overall Study|Death|5
7229328|NCT00091832|11438194|FG003|Overall Study|Death|8
7229329|NCT00091832|11438195|FG004|Overall Study|Death|5
7229330|NCT00091832|11438196|FG005|Overall Study|Death|6
7229331|NCT00091832|11438191|FG000|Overall Study|Disease Progression|2
7229332|NCT00091832|11438192|FG001|Overall Study|Disease Progression|0
7229333|NCT00091832|11438193|FG002|Overall Study|Disease Progression|0
7229334|NCT00091832|11438194|FG003|Overall Study|Disease Progression|1
7229335|NCT00091832|11438195|FG004|Overall Study|Disease Progression|1
7229336|NCT00091832|11438196|FG005|Overall Study|Disease Progression|2
7573280|NCT03609619|11954370|FG001|Overall Study|Protocol Violation|0
7573281|NCT03609619|11954369|FG000|Overall Study|Withdrawal by Subject|2
7573282|NCT03609619|11954370|FG001|Overall Study|Withdrawal by Subject|3
7573283|NCT03609619|11954369|FG000|Overall Study|Lost to Follow-up|1
7229337|NCT00091832|11438191|FG000|Overall Study|Ineligibility Determined|0
7229338|NCT00091832|11438192|FG001|Overall Study|Ineligibility Determined|0
7229339|NCT00091832|11438193|FG002|Overall Study|Ineligibility Determined|1
7229340|NCT00091832|11438194|FG003|Overall Study|Ineligibility Determined|0
7229341|NCT00091832|11438195|FG004|Overall Study|Ineligibility Determined|1
7229342|NCT00091832|11438196|FG005|Overall Study|Ineligibility Determined|0
7229343|NCT00091832|11438191|FG000|Overall Study|Lost to Follow-up|1
7229344|NCT00091832|11438192|FG001|Overall Study|Lost to Follow-up|0
7229345|NCT00091832|11438193|FG002|Overall Study|Lost to Follow-up|3
7229346|NCT00091832|11438194|FG003|Overall Study|Lost to Follow-up|3
7229347|NCT00091832|11438195|FG004|Overall Study|Lost to Follow-up|2
7229348|NCT00091832|11438196|FG005|Overall Study|Lost to Follow-up|1
7229349|NCT00091832|11438191|FG000|Overall Study|Noncompliance|0
7229350|NCT00091832|11438192|FG001|Overall Study|Noncompliance|1
7229351|NCT00091832|11438193|FG002|Overall Study|Noncompliance|0
7229352|NCT00091832|11438194|FG003|Overall Study|Noncompliance|0
7229353|NCT00091832|11438195|FG004|Overall Study|Noncompliance|0
7229354|NCT00091832|11438196|FG005|Overall Study|Noncompliance|0
7229355|NCT00091832|11438191|FG000|Overall Study|Other|0
7229356|NCT00091832|11438192|FG001|Overall Study|Other|1
7229357|NCT00091832|11438193|FG002|Overall Study|Other|2
7229358|NCT00091832|11438194|FG003|Overall Study|Other|0
7229359|NCT00091832|11438195|FG004|Overall Study|Other|0
7229360|NCT00091832|11438196|FG005|Overall Study|Other|0
7229361|NCT00091832|11438191|FG000|Overall Study|Protocol Violation|0
7229362|NCT00091832|11438192|FG001|Overall Study|Protocol Violation|0
7229363|NCT00091832|11438193|FG002|Overall Study|Protocol Violation|1
7229364|NCT00091832|11438194|FG003|Overall Study|Protocol Violation|0
7229365|NCT00091832|11438195|FG004|Overall Study|Protocol Violation|0
7229366|NCT00091832|11438196|FG005|Overall Study|Protocol Violation|1
7229367|NCT00091949|11438212|FG000|Overall Study|Withdrawal by Subject|117
7229368|NCT00091949|11438213|FG001|Overall Study|Withdrawal by Subject|110
7229369|NCT00091949|11438212|FG000|Overall Study|Lost to Follow-up|58
7229370|NCT00091949|11438213|FG001|Overall Study|Lost to Follow-up|41
7229371|NCT00092417|11438237|FG000|Overall Study|Lost to Follow-up|2
7229372|NCT00092417|11438238|FG001|Overall Study|Lost to Follow-up|0
7229373|NCT00092417|11438237|FG000|Overall Study|Withdrawal by Subject|2
7229374|NCT00092417|11438238|FG001|Overall Study|Withdrawal by Subject|1
7229375|NCT00092417|11438237|FG000|Overall Study|Other|1
7229376|NCT00092417|11438238|FG001|Overall Study|Other|0
7229377|NCT00092443|11438246|FG000|Overall Study|Adverse Event|9
7229378|NCT00092443|11438247|FG001|Overall Study|Adverse Event|13
7229379|NCT00092443|11438246|FG000|Overall Study|Lost to Follow-up|7
7229380|NCT00092443|11438247|FG001|Overall Study|Lost to Follow-up|3
7229381|NCT00092443|11438246|FG000|Overall Study|Protocol Violation|11
7229382|NCT00092443|11438247|FG001|Overall Study|Protocol Violation|9
7229383|NCT00092443|11438246|FG000|Overall Study|Withdrawal by Subject|9
7229384|NCT00092443|11438247|FG001|Overall Study|Withdrawal by Subject|11
7229385|NCT00092443|11438246|FG000|Overall Study|Moved|5
7229386|NCT00092443|11438247|FG001|Overall Study|Moved|5
7229387|NCT00092443|11438246|FG000|Overall Study|Other|17
7229388|NCT00092443|11438247|FG001|Overall Study|Other|13
7229389|NCT00092456|11438267|FG000|Overall Study|Adverse Event|0
7229390|NCT00092456|11438268|FG001|Overall Study|Adverse Event|0
7229391|NCT00092456|11438269|FG002|Overall Study|Adverse Event|1
7573284|NCT03609619|11954370|FG001|Overall Study|Lost to Follow-up|1
7229392|NCT00092456|11438270|FG003|Overall Study|Adverse Event|1
7229393|NCT00092456|11438267|FG000|Overall Study|Lost to Follow-up|2
7229394|NCT00092456|11438268|FG001|Overall Study|Lost to Follow-up|2
7229395|NCT00092456|11438269|FG002|Overall Study|Lost to Follow-up|1
7229396|NCT00092456|11438270|FG003|Overall Study|Lost to Follow-up|2
7229397|NCT00092456|11438267|FG000|Overall Study|Protocol Violation|5
7229398|NCT00092456|11438268|FG001|Overall Study|Protocol Violation|7
7229399|NCT00092456|11438269|FG002|Overall Study|Protocol Violation|8
7229400|NCT00092456|11438270|FG003|Overall Study|Protocol Violation|6
7229401|NCT00092456|11438267|FG000|Overall Study|Withdrawal by Subject|13
7229402|NCT00092456|11438268|FG001|Overall Study|Withdrawal by Subject|5
7229403|NCT00092456|11438269|FG002|Overall Study|Withdrawal by Subject|16
7229404|NCT00092456|11438270|FG003|Overall Study|Withdrawal by Subject|6
7229405|NCT00092456|11438267|FG000|Overall Study|Moved|1
7229406|NCT00092456|11438268|FG001|Overall Study|Moved|1
7229407|NCT00092456|11438269|FG002|Overall Study|Moved|0
7229408|NCT00092456|11438270|FG003|Overall Study|Moved|1
7229409|NCT00092456|11438267|FG000|Overall Study|Other|4
7229410|NCT00092456|11438268|FG001|Overall Study|Other|2
7229411|NCT00092456|11438269|FG002|Overall Study|Other|3
7229412|NCT00092456|11438270|FG003|Overall Study|Other|0
7229413|NCT00092495|11438284|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
7229414|NCT00092495|11438285|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
7229415|NCT00092495|11438286|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
7229416|NCT00092495|11438287|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
7229417|NCT00092495|11438288|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
7229418|NCT00092495|11438284|FG000|Base Study Vaccination Period|Extended|0
7229419|NCT00092495|11438285|FG001|Base Study Vaccination Period|Extended|0
7229420|NCT00092495|11438286|FG002|Base Study Vaccination Period|Extended|0
7229421|NCT00092495|11438287|FG003|Base Study Vaccination Period|Extended|1
7229422|NCT00092495|11438288|FG004|Base Study Vaccination Period|Extended|0
7229423|NCT00092495|11438284|FG000|Base Study Vaccination Period|*Clinical AE|1
7229424|NCT00092495|11438285|FG001|Base Study Vaccination Period|*Clinical AE|0
7229425|NCT00092495|11438286|FG002|Base Study Vaccination Period|*Clinical AE|1
7229426|NCT00092495|11438287|FG003|Base Study Vaccination Period|*Clinical AE|2
7229427|NCT00092495|11438288|FG004|Base Study Vaccination Period|*Clinical AE|0
7229428|NCT00092495|11438284|FG000|Base Study Vaccination Period|*Other reasons|1
7229429|NCT00092495|11438285|FG001|Base Study Vaccination Period|*Other reasons|0
7229430|NCT00092495|11438286|FG002|Base Study Vaccination Period|*Other reasons|0
7229431|NCT00092495|11438287|FG003|Base Study Vaccination Period|*Other reasons|1
7229432|NCT00092495|11438288|FG004|Base Study Vaccination Period|*Other reasons|0
7229433|NCT00092495|11438284|FG000|Base Study Vaccination Period|*Pregnancy|0
7229434|NCT00092495|11438285|FG001|Base Study Vaccination Period|*Pregnancy|2
7229435|NCT00092495|11438286|FG002|Base Study Vaccination Period|*Pregnancy|5
7229436|NCT00092495|11438287|FG003|Base Study Vaccination Period|*Pregnancy|7
7229437|NCT00092495|11438288|FG004|Base Study Vaccination Period|*Pregnancy|0
7229438|NCT00092495|11438284|FG000|Base Study Vaccination Period|Adverse Event|1
7229439|NCT00092495|11438285|FG001|Base Study Vaccination Period|Adverse Event|0
7229440|NCT00092495|11438286|FG002|Base Study Vaccination Period|Adverse Event|0
7229441|NCT00092495|11438287|FG003|Base Study Vaccination Period|Adverse Event|3
7229442|NCT00092495|11438288|FG004|Base Study Vaccination Period|Adverse Event|0
7229443|NCT00092495|11438284|FG000|Base Study Vaccination Period|Lost to Follow-up|16
7229444|NCT00092495|11438285|FG001|Base Study Vaccination Period|Lost to Follow-up|6
7229445|NCT00092495|11438286|FG002|Base Study Vaccination Period|Lost to Follow-up|11
7229446|NCT00092495|11438287|FG003|Base Study Vaccination Period|Lost to Follow-up|36
7229447|NCT00092495|11438288|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7229448|NCT00092495|11438284|FG000|Base Study Vaccination Period|Moved|3
7229449|NCT00092495|11438285|FG001|Base Study Vaccination Period|Moved|1
7229450|NCT00092495|11438286|FG002|Base Study Vaccination Period|Moved|2
7229451|NCT00092495|11438287|FG003|Base Study Vaccination Period|Moved|2
7229452|NCT00092495|11438288|FG004|Base Study Vaccination Period|Moved|0
7229453|NCT00092495|11438284|FG000|Base Study Vaccination Period|Other|1
7229454|NCT00092495|11438285|FG001|Base Study Vaccination Period|Other|1
7229455|NCT00092495|11438286|FG002|Base Study Vaccination Period|Other|0
7229456|NCT00092495|11438287|FG003|Base Study Vaccination Period|Other|2
7229457|NCT00092495|11438288|FG004|Base Study Vaccination Period|Other|0
7229458|NCT00092495|11438284|FG000|Base Study Vaccination Period|Pregnancy|2
7229459|NCT00092495|11438285|FG001|Base Study Vaccination Period|Pregnancy|0
7229460|NCT00092495|11438286|FG002|Base Study Vaccination Period|Pregnancy|0
7229461|NCT00092495|11438287|FG003|Base Study Vaccination Period|Pregnancy|0
7229462|NCT00092495|11438288|FG004|Base Study Vaccination Period|Pregnancy|0
7229463|NCT00092495|11438284|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
7229464|NCT00092495|11438285|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
7229465|NCT00092495|11438286|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
7229466|NCT00092495|11438287|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
7229467|NCT00092495|11438288|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
7229468|NCT00092495|11438284|FG000|Base Study Vaccination Period|Protocol Violation|1
7229469|NCT00092495|11438285|FG001|Base Study Vaccination Period|Protocol Violation|0
7229470|NCT00092495|11438286|FG002|Base Study Vaccination Period|Protocol Violation|0
7229471|NCT00092495|11438287|FG003|Base Study Vaccination Period|Protocol Violation|0
7229472|NCT00092495|11438288|FG004|Base Study Vaccination Period|Protocol Violation|0
7229473|NCT00092495|11438284|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
7229474|NCT00092495|11438285|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
7229475|NCT00092495|11438286|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
7229476|NCT00092495|11438287|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
7229477|NCT00092495|11438288|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7229478|NCT00092495|11438284|FG000|Base Study Follow-up Period|Extended|0
7229479|NCT00092495|11438285|FG001|Base Study Follow-up Period|Extended|0
7229480|NCT00092495|11438286|FG002|Base Study Follow-up Period|Extended|1
7229481|NCT00092495|11438287|FG003|Base Study Follow-up Period|Extended|2
7229482|NCT00092495|11438288|FG004|Base Study Follow-up Period|Extended|0
7229483|NCT00092495|11438284|FG000|Base Study Follow-up Period|Lost to Follow-up|1
7229484|NCT00092495|11438285|FG001|Base Study Follow-up Period|Lost to Follow-up|3
7229485|NCT00092495|11438286|FG002|Base Study Follow-up Period|Lost to Follow-up|3
7229486|NCT00092495|11438287|FG003|Base Study Follow-up Period|Lost to Follow-up|12
7229487|NCT00092495|11438288|FG004|Base Study Follow-up Period|Lost to Follow-up|0
7229488|NCT00092495|11438284|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
7229489|NCT00092495|11438285|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
7229490|NCT00092495|11438286|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
7229491|NCT00092495|11438287|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
7229492|NCT00092495|11438288|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
7229493|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
7229494|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7229495|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
7229496|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
7229497|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
7229498|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7229499|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
7229500|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
7229501|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Death|0
7229502|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Death|0
7229503|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Death|1
7229504|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Death|0
7229505|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
7229506|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
7229507|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
7229508|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
7229509|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
7229510|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7229511|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
7229512|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
7229513|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
7229514|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
7229515|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
7229516|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
7229517|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
7229518|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
7229519|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
7229520|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
7229521|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
7229522|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
7229523|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
7229524|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
7229525|NCT00092521|11438304|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
7229526|NCT00092521|11438305|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7229527|NCT00092521|11438306|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7229528|NCT00092521|11438307|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
7229529|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
7229530|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
7229531|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
7229532|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
7229533|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
7229534|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
7229535|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
7229536|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
7229537|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Adverse Event|1
7229538|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Adverse Event|0
7229539|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Adverse Event|0
7229540|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Adverse Event|0
7229541|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Death|2
7229542|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Death|0
7229543|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Death|1
7229544|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Death|0
7229545|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
7229546|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
7229547|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
7229548|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
7229549|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Protocol Violation|1
7229550|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Protocol Violation|1
7229551|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Protocol Violation|5
7229552|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Protocol Violation|0
7229553|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
7229554|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
7229555|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
7229556|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
7229557|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Moved|32
7229558|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Moved|2
7229559|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Moved|28
7229560|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Moved|0
7229561|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Site Terminated|3
7229562|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Site Terminated|0
7229563|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Site Terminated|3
7229564|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Site Terminated|0
7229565|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Travel|2
7229566|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Travel|0
7229567|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Travel|0
7229568|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Travel|0
7229569|NCT00092521|11438304|FG000|Follow-Up (After Month 7)|Visits Compressed|5
7229570|NCT00092521|11438305|FG001|Follow-Up (After Month 7)|Visits Compressed|0
7229571|NCT00092521|11438306|FG002|Follow-Up (After Month 7)|Visits Compressed|5
7229572|NCT00092521|11438307|FG003|Follow-Up (After Month 7)|Visits Compressed|0
7229573|NCT00092521|11438304|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
7229574|NCT00092521|11438305|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
7229575|NCT00092521|11438306|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
7229576|NCT00092521|11438307|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
7229577|NCT00092521|11438304|FG000|Extension Study (Group 4)|Adverse Event|0
7229578|NCT00092521|11438305|FG001|Extension Study (Group 4)|Adverse Event|0
7229579|NCT00092521|11438306|FG002|Extension Study (Group 4)|Adverse Event|0
7229580|NCT00092521|11438307|FG003|Extension Study (Group 4)|Adverse Event|2
7229581|NCT00092521|11438304|FG000|Extension Study (Group 4)|Lost to Follow-up|0
7229582|NCT00092521|11438305|FG001|Extension Study (Group 4)|Lost to Follow-up|0
7229583|NCT00092521|11438306|FG002|Extension Study (Group 4)|Lost to Follow-up|0
7229584|NCT00092521|11438307|FG003|Extension Study (Group 4)|Lost to Follow-up|87
7229585|NCT00092521|11438304|FG000|Extension Study (Group 4)|Pregnancy|0
7229586|NCT00092521|11438305|FG001|Extension Study (Group 4)|Pregnancy|0
7229587|NCT00092521|11438306|FG002|Extension Study (Group 4)|Pregnancy|0
7229588|NCT00092521|11438307|FG003|Extension Study (Group 4)|Pregnancy|4
7229589|NCT00092521|11438304|FG000|Extension Study (Group 4)|Protocol Violation|0
7229590|NCT00092521|11438305|FG001|Extension Study (Group 4)|Protocol Violation|0
7229591|NCT00092521|11438306|FG002|Extension Study (Group 4)|Protocol Violation|0
7229592|NCT00092521|11438307|FG003|Extension Study (Group 4)|Protocol Violation|2
7229593|NCT00092521|11438304|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
7229594|NCT00092521|11438305|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
7229595|NCT00092521|11438306|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
7229596|NCT00092521|11438307|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
7229597|NCT00092521|11438304|FG000|Extension Study (Group 4)|Moved|0
7229598|NCT00092521|11438305|FG001|Extension Study (Group 4)|Moved|0
7229599|NCT00092521|11438306|FG002|Extension Study (Group 4)|Moved|0
7229600|NCT00092521|11438307|FG003|Extension Study (Group 4)|Moved|16
7229601|NCT00092521|11438304|FG000|Extension Study (Group 4)|Site Terminated|0
7229602|NCT00092521|11438305|FG001|Extension Study (Group 4)|Site Terminated|0
7229603|NCT00092521|11438306|FG002|Extension Study (Group 4)|Site Terminated|0
7229604|NCT00092521|11438307|FG003|Extension Study (Group 4)|Site Terminated|4
7229605|NCT00092521|11438304|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
7229606|NCT00092521|11438305|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
7229607|NCT00092521|11438306|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
7229608|NCT00092521|11438307|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
7573285|NCT03610048|11954385|FG000|Overall Study|Study terminated by sponsor|84
7573286|NCT03610048|11954385|FG000|Overall Study|Adverse Event|32
7229774|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
7229775|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
7229776|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
7229777|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
7229778|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
7229779|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
7229780|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
7229781|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
7229782|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
7229783|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
7229784|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
7229785|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
7229786|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
7229787|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
7229788|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
7229789|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7229790|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
7229791|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
7229792|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7229793|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
7229794|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
7229795|NCT00092547|11438333|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
7229796|NCT00092547|11438334|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
7229797|NCT00092547|11438335|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
7229798|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
7229799|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
7229800|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
7229801|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
7229802|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
7229803|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
7229804|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
7229805|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
7229806|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
7229807|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
7229808|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7229809|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
7229810|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
7229811|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7229812|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
7229813|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
7229814|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
7229815|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
7229816|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
7229817|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
7229818|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
7229819|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
7229820|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7229821|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
7229822|NCT00092547|11438333|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
7229823|NCT00092547|11438334|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7229824|NCT00092547|11438335|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
7229825|NCT00092547|11438333|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
7229826|NCT00092547|11438334|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7229827|NCT00092547|11438335|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
7229828|NCT00092547|11438333|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
7229829|NCT00092547|11438334|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
7229830|NCT00092547|11438335|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
7229831|NCT00092547|11438333|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
7229832|NCT00092547|11438334|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
7229833|NCT00092547|11438335|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
7229834|NCT00092547|11438333|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
7229835|NCT00092547|11438334|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7229836|NCT00092547|11438335|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
7229843|NCT00093145|11438380|FG000|Overall Study|Unacceptable Toxicity Only|2
7229844|NCT00093145|11438380|FG000|Overall Study|Physician Decision|5
7229845|NCT00093145|11438380|FG000|Overall Study|Withdrawal by Subject|9
7229846|NCT00093145|11438380|FG000|Overall Study|Other|1
7229847|NCT00093470|11438390|FG000|Overall Study|Disease progression|39
7229848|NCT00093470|11438391|FG001|Overall Study|Disease progression|0
7229849|NCT00093470|11438390|FG000|Overall Study|Adverse Event|15
7229850|NCT00093470|11438391|FG001|Overall Study|Adverse Event|0
7229851|NCT00093470|11438390|FG000|Overall Study|Death|2
7229852|NCT00093470|11438391|FG001|Overall Study|Death|0
7229853|NCT00093470|11438390|FG000|Overall Study|Withdrawal by Subject|8
7229854|NCT00093470|11438391|FG001|Overall Study|Withdrawal by Subject|0
7229855|NCT00093470|11438390|FG000|Overall Study|Alternative therapy|2
7229856|NCT00093470|11438391|FG001|Overall Study|Alternative therapy|0
7229857|NCT00093470|11438390|FG000|Overall Study|Other complicating disease|3
7229858|NCT00093470|11438391|FG001|Overall Study|Other complicating disease|0
7229859|NCT00093470|11438390|FG000|Overall Study|Physician Decision|2
7229860|NCT00093470|11438391|FG001|Overall Study|Physician Decision|0
7229861|NCT00093470|11438390|FG000|Overall Study|Never started treatment|1
7229862|NCT00093470|11438391|FG001|Overall Study|Never started treatment|0
7229863|NCT00093470|11438390|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
7229864|NCT00093470|11438391|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
7229865|NCT00093496|11438399|FG000|Overall Study|Protocol Violation|1
7229866|NCT00093496|11438400|FG001|Overall Study|Protocol Violation|3
7229867|NCT00093795|11438423|FG000|Overall Study|No follow up data|20
7229868|NCT00093795|11438424|FG001|Overall Study|No follow up data|16
7229869|NCT00093795|11438425|FG002|Overall Study|No follow up data|17
7229870|NCT00093808|11438433|FG000|Overall Study|Cancel participation before receiving tx|1
7229871|NCT00093808|11438433|FG000|Overall Study|Protocol Violation|1
7229872|NCT00094055|11438457|FG000|Overall Study|Adverse Event|11
7229873|NCT00094055|11438457|FG000|Overall Study|Death|4
7229874|NCT00094055|11438457|FG000|Overall Study|Lack of Efficacy|17
7229875|NCT00094055|11438457|FG000|Overall Study|Lost to Follow-up|2
7229876|NCT00094055|11438457|FG000|Overall Study|progressive disease|2
7229877|NCT00094055|11438457|FG000|Overall Study|clinical progression|1
7229878|NCT00094055|11438457|FG000|Overall Study|roll-over to another study|14
7229879|NCT00094055|11438457|FG000|Overall Study|Withdrawal by Subject|9
7229880|NCT00094094|11438461|FG000|Overall Study|Death|2
7229881|NCT00094094|11438461|FG000|Overall Study|Lack of Efficacy|23
7229882|NCT00094094|11438461|FG000|Overall Study|Adverse Event|7
7229883|NCT00094107|11438465|FG000|Overall Study|Lack of Efficacy|23
7229884|NCT00094107|11438465|FG000|Overall Study|Death|5
7229885|NCT00094107|11438465|FG000|Overall Study|Adverse Event|3
7229886|NCT00094107|11438465|FG000|Overall Study|Withdrawal due to Disease Progression|1
7229887|NCT00094172|11438471|FG000|Overall Study|Adverse Event|0
7229888|NCT00094172|11438472|FG001|Overall Study|Adverse Event|1
7229889|NCT00094172|11438471|FG000|Overall Study|Lost to Follow-up|2
7229890|NCT00094172|11438472|FG001|Overall Study|Lost to Follow-up|0
7229891|NCT00094172|11438471|FG000|Overall Study|Protocol Violation|0
7229892|NCT00094172|11438472|FG001|Overall Study|Protocol Violation|1
7229893|NCT00094172|11438471|FG000|Overall Study|Withdrawal by Subject|10
7229894|NCT00094172|11438472|FG001|Overall Study|Withdrawal by Subject|5
7229895|NCT00094172|11438471|FG000|Overall Study|Primary endpoint met.|1
7229896|NCT00094172|11438472|FG001|Overall Study|Primary endpoint met.|0
7573287|NCT03610048|11954385|FG000|Overall Study|Withdrawal by Subject|31
7573288|NCT03610048|11954385|FG000|Overall Study|Lost to Follow-up|8
7229897|NCT00094172|11438471|FG000|Overall Study|Started other MS therapy due to disease|1
7229898|NCT00094172|11438472|FG001|Overall Study|Started other MS therapy due to disease|0
7229899|NCT00094302|11438501|FG000|Overall Study|Lost to Follow-up|43
7229900|NCT00094302|11438502|FG001|Overall Study|Lost to Follow-up|41
7229901|NCT00094302|11438501|FG000|Overall Study|Physician Decision|5
7229902|NCT00094302|11438502|FG001|Overall Study|Physician Decision|8
7229903|NCT00094302|11438501|FG000|Overall Study|Withdrawal by Subject|103
7229904|NCT00094302|11438502|FG001|Overall Study|Withdrawal by Subject|111
7229905|NCT00094302|11438501|FG000|Overall Study|Death|266
7229906|NCT00094302|11438502|FG001|Overall Study|Death|246
7229907|NCT00094328|11438508|FG000|Overall Study|Lost to Follow-up|1
7229908|NCT00094445|11438512|FG000|Overall Study|Withdrawal by Subject|3
7229909|NCT00094445|11438512|FG000|Overall Study|Lost to Follow-up|1
7229910|NCT00094445|11438512|FG000|Overall Study|Progressive Disease|2
7229911|NCT00094458|11438519|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
7229912|NCT00094458|11438520|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
7229913|NCT00094458|11438521|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
7229914|NCT00094458|11438522|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
7229915|NCT00094458|11438523|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
7229916|NCT00094458|11438524|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
7229917|NCT00094458|11438519|FG000|Main Study: Through Week 30|Lost to Follow-up|5
7229918|NCT00094458|11438520|FG001|Main Study: Through Week 30|Lost to Follow-up|5
7573289|NCT03610048|11954385|FG000|Overall Study|Other|4
7573290|NCT03610048|11954385|FG000|Overall Study|Physician Decision|1
7229919|NCT00094458|11438521|FG002|Main Study: Through Week 30|Lost to Follow-up|2
7229920|NCT00094458|11438522|FG003|Main Study: Through Week 30|Lost to Follow-up|0
7229921|NCT00094458|11438523|FG004|Main Study: Through Week 30|Lost to Follow-up|0
7229922|NCT00094458|11438524|FG005|Main Study: Through Week 30|Lost to Follow-up|0
7573291|NCT03610048|11954385|FG000|Overall Study|Pregnancy|1
7573292|NCT03610165|11954391|FG000|Overall Study|Device didn't work|0
7229923|NCT00094458|11438519|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
7229924|NCT00094458|11438520|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
7229925|NCT00094458|11438521|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
7229926|NCT00094458|11438522|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
7229927|NCT00094458|11438523|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
7229928|NCT00094458|11438524|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
7229929|NCT00094458|11438519|FG000|Main Study: Through Week 30|Adverse Event|38
7229930|NCT00094458|11438520|FG001|Main Study: Through Week 30|Adverse Event|20
7229931|NCT00094458|11438521|FG002|Main Study: Through Week 30|Adverse Event|28
7229932|NCT00094458|11438522|FG003|Main Study: Through Week 30|Adverse Event|0
7229933|NCT00094458|11438523|FG004|Main Study: Through Week 30|Adverse Event|0
7229934|NCT00094458|11438524|FG005|Main Study: Through Week 30|Adverse Event|0
7229935|NCT00094458|11438519|FG000|Main Study: Through Week 30|Death|1
7229936|NCT00094458|11438520|FG001|Main Study: Through Week 30|Death|0
7573293|NCT03610165|11954392|FG001|Overall Study|Device didn't work|1
7229937|NCT00094458|11438521|FG002|Main Study: Through Week 30|Death|0
7229938|NCT00094458|11438522|FG003|Main Study: Through Week 30|Death|0
7229939|NCT00094458|11438523|FG004|Main Study: Through Week 30|Death|0
7229940|NCT00094458|11438524|FG005|Main Study: Through Week 30|Death|0
7229941|NCT00094458|11438519|FG000|Main Study: Through Week 30|Other|19
7229942|NCT00094458|11438520|FG001|Main Study: Through Week 30|Other|16
7229943|NCT00094458|11438521|FG002|Main Study: Through Week 30|Other|9
7229944|NCT00094458|11438522|FG003|Main Study: Through Week 30|Other|0
7229945|NCT00094458|11438523|FG004|Main Study: Through Week 30|Other|0
7229946|NCT00094458|11438524|FG005|Main Study: Through Week 30|Other|0
7229947|NCT00094458|11438519|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
7229948|NCT00094458|11438520|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
7229949|NCT00094458|11438521|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
7229950|NCT00094458|11438522|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7229951|NCT00094458|11438523|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7229952|NCT00094458|11438524|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
7229953|NCT00094458|11438519|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
7229954|NCT00094458|11438520|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7229955|NCT00094458|11438521|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
7229956|NCT00094458|11438522|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7229957|NCT00094458|11438523|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7229958|NCT00094458|11438524|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
7229959|NCT00094458|11438519|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
7229960|NCT00094458|11438520|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
7229961|NCT00094458|11438521|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
7229962|NCT00094458|11438522|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
7229963|NCT00094458|11438523|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
7229964|NCT00094458|11438524|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
7229965|NCT00094458|11438519|FG000|Study Extension: Week 30 Through Week 50|Other|1
7229966|NCT00094458|11438520|FG001|Study Extension: Week 30 Through Week 50|Other|2
7229967|NCT00094458|11438521|FG002|Study Extension: Week 30 Through Week 50|Other|3
7229968|NCT00094458|11438522|FG003|Study Extension: Week 30 Through Week 50|Other|0
7229969|NCT00094458|11438523|FG004|Study Extension: Week 30 Through Week 50|Other|0
7229970|NCT00094458|11438524|FG005|Study Extension: Week 30 Through Week 50|Other|0
7229971|NCT00094458|11438519|FG000|OLE: Open-Label Extension|Adverse Event|0
7229972|NCT00094458|11438520|FG001|OLE: Open-Label Extension|Adverse Event|0
7229973|NCT00094458|11438521|FG002|OLE: Open-Label Extension|Adverse Event|0
7229974|NCT00094458|11438522|FG003|OLE: Open-Label Extension|Adverse Event|0
7229975|NCT00094458|11438523|FG004|OLE: Open-Label Extension|Adverse Event|3
7229976|NCT00094458|11438524|FG005|OLE: Open-Label Extension|Adverse Event|4
7229977|NCT00094458|11438519|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7229978|NCT00094458|11438520|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7229979|NCT00094458|11438521|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7229980|NCT00094458|11438522|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7229981|NCT00094458|11438523|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
7229982|NCT00094458|11438524|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
7229983|NCT00094458|11438519|FG000|OLE: Open-Label Extension|Patient decision|0
7229984|NCT00094458|11438520|FG001|OLE: Open-Label Extension|Patient decision|0
7229985|NCT00094458|11438521|FG002|OLE: Open-Label Extension|Patient decision|0
7229986|NCT00094458|11438522|FG003|OLE: Open-Label Extension|Patient decision|0
7229987|NCT00094458|11438523|FG004|OLE: Open-Label Extension|Patient decision|1
7229988|NCT00094458|11438524|FG005|OLE: Open-Label Extension|Patient decision|0
7229989|NCT00094536|11438547|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
7229990|NCT00094536|11438547|FG000|Treatment and Follow-up|Adverse Event|4
7229991|NCT00094536|11438547|FG000|Treatment and Follow-up|Lack of Efficacy|9
7229992|NCT00094536|11438547|FG000|Treatment and Follow-up|Lost to Follow-up|7
7229993|NCT00094536|11438547|FG000|Treatment and Follow-up|Withdrawal by Subject|1
7229994|NCT00094536|11438547|FG000|Treatment and Follow-up|Subject non-compliance|9
7229995|NCT00094536|11438547|FG000|Treatment and Follow-up|Unable to attend visits|1
7229996|NCT00094575|11438553|FG000|Overall Study|Death|146
7229997|NCT00094575|11438554|FG001|Overall Study|Death|146
7229998|NCT00094653|11438565|FG000|Overall Study|Death|306
7229999|NCT00094653|11438566|FG001|Overall Study|Death|100
7230000|NCT00094653|11438567|FG002|Overall Study|Death|119
7230001|NCT00094653|11438565|FG000|Overall Study|Subject Withdrew Consent|10
7230002|NCT00094653|11438566|FG001|Overall Study|Subject Withdrew Consent|2
7230003|NCT00094653|11438567|FG002|Overall Study|Subject Withdrew Consent|3
7230004|NCT00094653|11438565|FG000|Overall Study|Other|2
7230005|NCT00094653|11438566|FG001|Overall Study|Other|2
7230006|NCT00094653|11438567|FG002|Overall Study|Other|2
7230007|NCT00094653|11438565|FG000|Overall Study|Lost to Follow-up|3
7230008|NCT00094653|11438566|FG001|Overall Study|Lost to Follow-up|2
7230009|NCT00094653|11438567|FG002|Overall Study|Lost to Follow-up|1
7230010|NCT00094653|11438565|FG000|Overall Study|Protocol Violation|0
7230011|NCT00094653|11438566|FG001|Overall Study|Protocol Violation|0
7230012|NCT00094653|11438567|FG002|Overall Study|Protocol Violation|1
7230013|NCT00094757|11438579|FG000|Overall Study|Adverse Event|11
7230014|NCT00094757|11438580|FG001|Overall Study|Adverse Event|9
7230015|NCT00094757|11438581|FG002|Overall Study|Adverse Event|6
7230016|NCT00094757|11438579|FG000|Overall Study|Lack of Efficacy|11
7230017|NCT00094757|11438580|FG001|Overall Study|Lack of Efficacy|15
7230018|NCT00094757|11438581|FG002|Overall Study|Lack of Efficacy|8
7230019|NCT00094757|11438579|FG000|Overall Study|Lost to Follow-up|3
7230020|NCT00094757|11438580|FG001|Overall Study|Lost to Follow-up|5
7230021|NCT00094757|11438581|FG002|Overall Study|Lost to Follow-up|6
7230022|NCT00094757|11438579|FG000|Overall Study|Patient Moved|2
7230023|NCT00094757|11438580|FG001|Overall Study|Patient Moved|1
7230024|NCT00094757|11438581|FG002|Overall Study|Patient Moved|1
7230025|NCT00094757|11438579|FG000|Overall Study|Protocol Violation|8
7230026|NCT00094757|11438580|FG001|Overall Study|Protocol Violation|5
7230027|NCT00094757|11438581|FG002|Overall Study|Protocol Violation|3
7230028|NCT00094757|11438579|FG000|Overall Study|Withdrawal by Subject|14
7230029|NCT00094757|11438580|FG001|Overall Study|Withdrawal by Subject|21
7230030|NCT00094757|11438581|FG002|Overall Study|Withdrawal by Subject|5
7230031|NCT00094757|11438579|FG000|Overall Study|Other|3
7230032|NCT00094757|11438580|FG001|Overall Study|Other|3
7230033|NCT00094757|11438581|FG002|Overall Study|Other|1
7230034|NCT00094757|11438579|FG000|Overall Study|Protocol specified discontinuation|1
7230035|NCT00094757|11438580|FG001|Overall Study|Protocol specified discontinuation|3
7230036|NCT00094757|11438581|FG002|Overall Study|Protocol specified discontinuation|0
7573294|NCT03610269|11954398|FG000|Overall Study|Physician Decision|10
7573295|NCT03610269|11954398|FG000|Overall Study|Protocol Violation|1
7573296|NCT03610269|11954398|FG000|Overall Study|Unable to draw blood|1
7230037|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
7230038|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
7230039|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
7230040|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
7230041|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
7230042|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
7230043|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7230044|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
7230045|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
7230046|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
7230047|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
7230048|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
7230049|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
7230050|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
7230051|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7230052|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
7230053|NCT00094770|11438591|FG000|Year 1 ( Week 0 to Week 52)|Other|10
7230054|NCT00094770|11438592|FG001|Year 1 ( Week 0 to Week 52)|Other|11
7230055|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
7230056|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
7230057|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
7230058|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
7230059|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
7230060|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
7230061|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
7230062|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
7230063|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
7230064|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
7230065|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
7230066|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
7230067|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
7230068|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
7230069|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
7230070|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
7230071|NCT00094770|11438591|FG000|Year 2 (Week 0 to Week 104)|Other|15
7230072|NCT00094770|11438592|FG001|Year 2 (Week 0 to Week 104)|Other|23
7230073|NCT00094809|11438600|FG000|Overall Study|Protocol deviation|2
7230074|NCT00094809|11438601|FG001|Overall Study|Protocol deviation|2
7230075|NCT00094809|11438600|FG000|Overall Study|Noncompliance|1
7230076|NCT00094809|11438601|FG001|Overall Study|Noncompliance|0
7230077|NCT00094809|11438600|FG000|Overall Study|Adverse Event|3
7230078|NCT00094809|11438601|FG001|Overall Study|Adverse Event|1
7230079|NCT00094809|11438600|FG000|Overall Study|Withdrawal by Subject|8
7230080|NCT00094809|11438601|FG001|Overall Study|Withdrawal by Subject|9
7230081|NCT00094809|11438600|FG000|Overall Study|Disease progression|3
7230082|NCT00094809|11438601|FG001|Overall Study|Disease progression|3
7230083|NCT00094809|11438600|FG000|Overall Study|Physician Decision|3
7230084|NCT00094809|11438601|FG001|Overall Study|Physician Decision|5
7230085|NCT00094809|11438600|FG000|Overall Study|Lost to Follow-up|6
7230086|NCT00094809|11438601|FG001|Overall Study|Lost to Follow-up|6
7230087|NCT00094809|11438600|FG000|Overall Study|Death|19
7230088|NCT00094809|11438601|FG001|Overall Study|Death|25
7230089|NCT00094809|11438600|FG000|Overall Study|Protocol-specified criteria|1
7230090|NCT00094809|11438601|FG001|Overall Study|Protocol-specified criteria|1
7230091|NCT00094809|11438600|FG000|Overall Study|Other|2
7573297|NCT03610269|11954398|FG000|Overall Study|Screen fail|4
7230092|NCT00094809|11438601|FG001|Overall Study|Other|4
7230093|NCT00094809|11438600|FG000|Overall Study|Informed consent signed after treatment|1
7230094|NCT00094809|11438601|FG001|Overall Study|Informed consent signed after treatment|0
7230095|NCT00094809|11438600|FG000|Overall Study|Study drug not received|2
7230096|NCT00094809|11438601|FG001|Overall Study|Study drug not received|8
7230097|NCT00094809|11438600|FG000|Overall Study|Other|1
7230098|NCT00094809|11438601|FG001|Overall Study|Other|1
7230099|NCT00094835|11438614|FG000|Overall Study|Physician Decision|1
7230100|NCT00094835|11438615|FG001|Overall Study|Physician Decision|0
7230101|NCT00094835|11438616|FG002|Overall Study|Physician Decision|0
7230102|NCT00094835|11438617|FG003|Overall Study|Physician Decision|0
7230103|NCT00094835|11438618|FG004|Overall Study|Physician Decision|0
7230104|NCT00094835|11438619|FG005|Overall Study|Physician Decision|1
7230105|NCT00094835|11438620|FG006|Overall Study|Physician Decision|0
7230106|NCT00094835|11438614|FG000|Overall Study|Withdrawal by Subject|0
7230107|NCT00094835|11438615|FG001|Overall Study|Withdrawal by Subject|0
7230108|NCT00094835|11438616|FG002|Overall Study|Withdrawal by Subject|0
7230109|NCT00094835|11438617|FG003|Overall Study|Withdrawal by Subject|0
7230110|NCT00094835|11438618|FG004|Overall Study|Withdrawal by Subject|0
7230111|NCT00094835|11438619|FG005|Overall Study|Withdrawal by Subject|0
7230112|NCT00094835|11438620|FG006|Overall Study|Withdrawal by Subject|1
7230113|NCT00094835|11438614|FG000|Overall Study|Lost to Follow-up|0
7230114|NCT00094835|11438615|FG001|Overall Study|Lost to Follow-up|0
7230115|NCT00094835|11438616|FG002|Overall Study|Lost to Follow-up|0
7230116|NCT00094835|11438617|FG003|Overall Study|Lost to Follow-up|0
7230117|NCT00094835|11438618|FG004|Overall Study|Lost to Follow-up|1
7230118|NCT00094835|11438619|FG005|Overall Study|Lost to Follow-up|0
7230119|NCT00094835|11438620|FG006|Overall Study|Lost to Follow-up|0
7230120|NCT00094835|11438614|FG000|Overall Study|Death|1
7230121|NCT00094835|11438615|FG001|Overall Study|Death|0
7230122|NCT00094835|11438616|FG002|Overall Study|Death|0
7230123|NCT00094835|11438617|FG003|Overall Study|Death|0
7230124|NCT00094835|11438618|FG004|Overall Study|Death|1
7230125|NCT00094835|11438619|FG005|Overall Study|Death|0
7230126|NCT00094835|11438620|FG006|Overall Study|Death|0
7230127|NCT00094835|11438614|FG000|Overall Study|Non-compliance|1
7230128|NCT00094835|11438615|FG001|Overall Study|Non-compliance|2
7230129|NCT00094835|11438616|FG002|Overall Study|Non-compliance|2
7230130|NCT00094835|11438617|FG003|Overall Study|Non-compliance|0
7230131|NCT00094835|11438618|FG004|Overall Study|Non-compliance|2
7230132|NCT00094835|11438619|FG005|Overall Study|Non-compliance|2
7230133|NCT00094835|11438620|FG006|Overall Study|Non-compliance|1
7230134|NCT00094835|11438614|FG000|Overall Study|Other|1
7230135|NCT00094835|11438615|FG001|Overall Study|Other|1
7230136|NCT00094835|11438616|FG002|Overall Study|Other|1
7230137|NCT00094835|11438617|FG003|Overall Study|Other|1
7230138|NCT00094835|11438618|FG004|Overall Study|Other|0
7230139|NCT00094835|11438619|FG005|Overall Study|Other|0
7230140|NCT00094835|11438620|FG006|Overall Study|Other|0
7230141|NCT00094861|11438643|FG000|Overall Study|Adverse Event|5
7230142|NCT00094861|11438644|FG001|Overall Study|Adverse Event|2
7230143|NCT00094861|11438643|FG000|Overall Study|Withdrawal by Subject|5
7230144|NCT00094861|11438644|FG001|Overall Study|Withdrawal by Subject|3
7230145|NCT00094861|11438643|FG000|Overall Study|Physician Decision|1
7230146|NCT00094861|11438644|FG001|Overall Study|Physician Decision|1
7573298|NCT03610581|11954422|FG000|Overall Study|Study terminated by sponsor|2
7573299|NCT03610581|11954423|FG001|Overall Study|Study terminated by sponsor|0
7573300|NCT03610581|11954422|FG000|Overall Study|Other|0
7573301|NCT03610581|11954423|FG001|Overall Study|Other|1
7573302|NCT03610581|11954422|FG000|Overall Study|Withdrawal by Subject|1
7573303|NCT03610581|11954423|FG001|Overall Study|Withdrawal by Subject|0
7575372|NCT03723915|11959044|FG000|Screening|Failed to meet screening requirements.|2
7575373|NCT03723915|11959044|FG000|On Treatment|Failed to meet treatment requirements|2
7575374|NCT03724812|11959048|FG000|Overall Study|Missed Visit|1
7575375|NCT03724812|11959048|FG000|Overall Study|Death|2
7575376|NCT03724812|11959048|FG000|Overall Study|Withdrawal by Subject|1
7575377|NCT03725982|11959055|FG000|First Intervention|Withdrawal by Subject|0
7575378|NCT03725982|11959056|FG001|First Intervention|Withdrawal by Subject|1
7575379|NCT03725982|11959055|FG000|First Intervention|Physician Decision|1
7575380|NCT03725982|11959056|FG001|First Intervention|Physician Decision|1
7230147|NCT00094861|11438643|FG000|Overall Study|Lost to Follow-up|0
7230148|NCT00094861|11438644|FG001|Overall Study|Lost to Follow-up|1
7230149|NCT00094861|11438643|FG000|Overall Study|Death|4
7230150|NCT00094861|11438644|FG001|Overall Study|Death|2
7230151|NCT00094861|11438643|FG000|Overall Study|Other|3
7230152|NCT00094861|11438644|FG001|Overall Study|Other|0
7230153|NCT00095056|11438665|FG000|Phase A (Weeks 0-12)|Adverse Event|1
7230154|NCT00095056|11438666|FG001|Phase A (Weeks 0-12)|Adverse Event|1
7575383|NCT03736967|11959081|FG000|Overall Study|Withdrawal by Subject|26
7575384|NCT03736967|11959082|FG001|Overall Study|Withdrawal by Subject|25
7230155|NCT00095056|11438665|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
7230156|NCT00095056|11438666|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
7575385|NCT03736967|11959083|FG002|Overall Study|Withdrawal by Subject|23
7575386|NCT03736967|11959084|FG003|Overall Study|Withdrawal by Subject|26
7575387|NCT03736967|11959081|FG000|Overall Study|Lost to Follow-up|3
7573304|NCT03611582|11954449|FG000|Overall Study|Adverse Event|26
7573305|NCT03611582|11954450|FG001|Overall Study|Adverse Event|6
7573306|NCT03611582|11954449|FG000|Overall Study|Protocol Violation|0
7573307|NCT03611582|11954450|FG001|Overall Study|Protocol Violation|1
7573308|NCT03611582|11954449|FG000|Overall Study|Pregnancy|1
7573309|NCT03611582|11954450|FG001|Overall Study|Pregnancy|2
7573310|NCT03611582|11954449|FG000|Overall Study|Lack of Efficacy|0
7573311|NCT03611582|11954450|FG001|Overall Study|Lack of Efficacy|1
7573312|NCT03611582|11954449|FG000|Overall Study|At the discretion of the investigator|1
7573313|NCT03611582|11954450|FG001|Overall Study|At the discretion of the investigator|0
7573314|NCT03611582|11954449|FG000|Overall Study|Safety concern as judged by the investigator|1
7573315|NCT03611582|11954450|FG001|Overall Study|Safety concern as judged by the investigator|2
7230157|NCT00095056|11438665|FG000|Phase A (Weeks 0-12)|Death|1
7230158|NCT00095056|11438666|FG001|Phase A (Weeks 0-12)|Death|0
7230159|NCT00095056|11438665|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
7230160|NCT00095056|11438666|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
7230161|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Adverse Event|2
7230162|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Adverse Event|2
7230163|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
7230164|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
7230165|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
7230166|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
7230167|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Patient Moved|1
7230168|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Patient Moved|0
7230169|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Death|3
7230170|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Death|1
7230171|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
7230172|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
7230173|NCT00095056|11438665|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
7230174|NCT00095056|11438666|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
7230175|NCT00095121|11438674|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
7230176|NCT00095121|11438675|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
7230177|NCT00095121|11438674|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
7230178|NCT00095121|11438675|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
7230179|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Death|1
7230180|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Death|0
7230181|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Death|0
7230182|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Death|0
7230183|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Death|0
7573316|NCT03611582|11954449|FG000|Overall Study|Withdrawal by Subject|4
7573317|NCT03611582|11954450|FG001|Overall Study|Withdrawal by Subject|3
7573318|NCT03611582|11954449|FG000|Overall Study|Lost to Follow-up|18
7573319|NCT03611582|11954450|FG001|Overall Study|Lost to Follow-up|7
7573320|NCT03611582|11954449|FG000|Overall Study|other|17
7573321|NCT03611582|11954450|FG001|Overall Study|other|16
7573322|NCT03613129|11954482|FG000|Pre-treatment Assessment|Protocol Violation|2
7573323|NCT03613129|11954483|FG001|Pre-treatment Assessment|Protocol Violation|0
7230184|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
7230185|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
7230186|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
7230187|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7230188|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
7573324|NCT03613129|11954484|FG002|Pre-treatment Assessment|Protocol Violation|0
7573325|NCT03613129|11954485|FG003|Pre-treatment Assessment|Protocol Violation|0
7230189|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7230190|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
7230191|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
7230192|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7256774|NCT00325468|11468504|FG004|Overall Study|Withdrawal by Subject|4
7230193|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
7230194|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7230195|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
7230196|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7230197|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7230198|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
7230199|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7230200|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7230201|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
7230202|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7230203|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
7230204|NCT00095147|11438694|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7230205|NCT00095147|11438695|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
7230206|NCT00095147|11438696|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7230207|NCT00095147|11438697|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7230208|NCT00095147|11438698|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
7230209|NCT00095147|11438694|FG000|Double-blind Period 2 (Days 198-365)|Death|0
7230210|NCT00095147|11438695|FG001|Double-blind Period 2 (Days 198-365)|Death|1
7230211|NCT00095147|11438696|FG002|Double-blind Period 2 (Days 198-365)|Death|0
7230212|NCT00095147|11438697|FG003|Double-blind Period 2 (Days 198-365)|Death|1
7230213|NCT00095147|11438698|FG004|Double-blind Period 2 (Days 198-365)|Death|0
7230214|NCT00095147|11438694|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
7230215|NCT00095147|11438695|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
7573326|NCT03613129|11954486|FG004|Pre-treatment Assessment|Protocol Violation|0
7573327|NCT03613129|11954482|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
7573328|NCT03613129|11954483|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
7573329|NCT03613129|11954484|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
7573330|NCT03613129|11954485|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
7573331|NCT03613129|11954486|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
7573332|NCT03613454|11954500|FG000|Overall Study|Protocol Violation|1
7573333|NCT03613454|11954501|FG001|Overall Study|Protocol Violation|0
7230216|NCT00095147|11438696|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7230217|NCT00095147|11438697|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7230218|NCT00095147|11438698|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
7230219|NCT00095147|11438694|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
7230220|NCT00095147|11438695|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
7230221|NCT00095147|11438696|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7230222|NCT00095147|11438697|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
7230223|NCT00095147|11438698|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
7230224|NCT00095147|11438694|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
7230225|NCT00095147|11438695|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
7230226|NCT00095147|11438696|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7230227|NCT00095147|11438697|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7230228|NCT00095147|11438698|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
7230229|NCT00095147|11438694|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7230230|NCT00095147|11438695|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7230231|NCT00095147|11438696|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7230232|NCT00095147|11438697|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
7230233|NCT00095147|11438698|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
7230234|NCT00095147|11438694|FG000|Long-term Extension Period|Death|0
7230235|NCT00095147|11438695|FG001|Long-term Extension Period|Death|0
7230236|NCT00095147|11438696|FG002|Long-term Extension Period|Death|0
7230237|NCT00095147|11438697|FG003|Long-term Extension Period|Death|0
7230238|NCT00095147|11438698|FG004|Long-term Extension Period|Death|3
7230239|NCT00095147|11438694|FG000|Long-term Extension Period|Adverse Event|0
7230240|NCT00095147|11438695|FG001|Long-term Extension Period|Adverse Event|0
7230241|NCT00095147|11438696|FG002|Long-term Extension Period|Adverse Event|0
7230242|NCT00095147|11438697|FG003|Long-term Extension Period|Adverse Event|0
7230243|NCT00095147|11438698|FG004|Long-term Extension Period|Adverse Event|11
7230244|NCT00095147|11438694|FG000|Long-term Extension Period|Lack of Efficacy|0
7230245|NCT00095147|11438695|FG001|Long-term Extension Period|Lack of Efficacy|0
7230246|NCT00095147|11438696|FG002|Long-term Extension Period|Lack of Efficacy|0
7230247|NCT00095147|11438697|FG003|Long-term Extension Period|Lack of Efficacy|0
7230248|NCT00095147|11438698|FG004|Long-term Extension Period|Lack of Efficacy|9
7230249|NCT00095147|11438694|FG000|Long-term Extension Period|Lost to Follow-up|0
7230250|NCT00095147|11438695|FG001|Long-term Extension Period|Lost to Follow-up|0
7230251|NCT00095147|11438696|FG002|Long-term Extension Period|Lost to Follow-up|0
7230252|NCT00095147|11438697|FG003|Long-term Extension Period|Lost to Follow-up|0
7230253|NCT00095147|11438698|FG004|Long-term Extension Period|Lost to Follow-up|6
7230254|NCT00095147|11438694|FG000|Long-term Extension Period|Withdrawal of consent|0
7230255|NCT00095147|11438695|FG001|Long-term Extension Period|Withdrawal of consent|0
7230256|NCT00095147|11438696|FG002|Long-term Extension Period|Withdrawal of consent|0
7230257|NCT00095147|11438697|FG003|Long-term Extension Period|Withdrawal of consent|0
7230258|NCT00095147|11438698|FG004|Long-term Extension Period|Withdrawal of consent|12
7230259|NCT00095147|11438694|FG000|Long-term Extension Period|Pregnancy|0
7230260|NCT00095147|11438695|FG001|Long-term Extension Period|Pregnancy|0
7230261|NCT00095147|11438696|FG002|Long-term Extension Period|Pregnancy|0
7230262|NCT00095147|11438697|FG003|Long-term Extension Period|Pregnancy|0
7230263|NCT00095147|11438698|FG004|Long-term Extension Period|Pregnancy|1
7230264|NCT00095147|11438694|FG000|Long-term Extension Period|No longer meets study criteria|0
7230265|NCT00095147|11438695|FG001|Long-term Extension Period|No longer meets study criteria|0
7230266|NCT00095147|11438696|FG002|Long-term Extension Period|No longer meets study criteria|0
7230267|NCT00095147|11438697|FG003|Long-term Extension Period|No longer meets study criteria|0
7230268|NCT00095147|11438698|FG004|Long-term Extension Period|No longer meets study criteria|1
7230269|NCT00095147|11438694|FG000|Long-term Extension Period|Participant chose to use Revellex|0
7230270|NCT00095147|11438695|FG001|Long-term Extension Period|Participant chose to use Revellex|0
7230271|NCT00095147|11438696|FG002|Long-term Extension Period|Participant chose to use Revellex|0
7230272|NCT00095147|11438697|FG003|Long-term Extension Period|Participant chose to use Revellex|0
7573334|NCT03613454|11954500|FG000|Overall Study|Protocol Violation|0
7573335|NCT03613454|11954501|FG001|Overall Study|Protocol Violation|1
7573336|NCT03613649|11954535|FG000|Second Treatment|Lost to Follow-up|0
7573337|NCT03613649|11954536|FG001|Second Treatment|Lost to Follow-up|0
7573338|NCT03613649|11954537|FG002|Second Treatment|Lost to Follow-up|1
7573339|NCT03613649|11954538|FG003|Second Treatment|Lost to Follow-up|0
7573340|NCT03613649|11954539|FG004|Second Treatment|Lost to Follow-up|0
7573341|NCT03613649|11954540|FG005|Second Treatment|Lost to Follow-up|0
7573342|NCT03613649|11954541|FG006|Second Treatment|Lost to Follow-up|0
7573343|NCT03613649|11954542|FG007|Second Treatment|Lost to Follow-up|0
7573344|NCT03613649|11954543|FG008|Second Treatment|Lost to Follow-up|0
7573345|NCT03613649|11954544|FG009|Second Treatment|Lost to Follow-up|0
7573346|NCT03613649|11954545|FG010|Second Treatment|Lost to Follow-up|0
7573347|NCT03613649|11954546|FG011|Second Treatment|Lost to Follow-up|0
7573348|NCT03613649|11954535|FG000|Second Treatment|Withdrawal by Subject|0
7573349|NCT03613649|11954536|FG001|Second Treatment|Withdrawal by Subject|0
7573350|NCT03613649|11954537|FG002|Second Treatment|Withdrawal by Subject|0
7573351|NCT03613649|11954538|FG003|Second Treatment|Withdrawal by Subject|0
7573352|NCT03613649|11954539|FG004|Second Treatment|Withdrawal by Subject|1
7230273|NCT00095147|11438698|FG004|Long-term Extension Period|Participant chose to use Revellex|1
7230274|NCT00095147|11438694|FG000|Long-term Extension Period|Leaving country|0
7230275|NCT00095147|11438695|FG001|Long-term Extension Period|Leaving country|0
7230276|NCT00095147|11438696|FG002|Long-term Extension Period|Leaving country|0
7230277|NCT00095147|11438697|FG003|Long-term Extension Period|Leaving country|0
7230278|NCT00095147|11438698|FG004|Long-term Extension Period|Leaving country|1
7230279|NCT00095173|11438716|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
7230280|NCT00095173|11438717|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7230281|NCT00095173|11438718|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7230282|NCT00095173|11438719|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7230283|NCT00095173|11438720|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7230284|NCT00095173|11438721|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
7230285|NCT00095173|11438716|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
7230286|NCT00095173|11438717|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7230287|NCT00095173|11438718|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7230288|NCT00095173|11438719|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7230289|NCT00095173|11438720|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7230290|NCT00095173|11438721|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
7230291|NCT00095173|11438716|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
7230292|NCT00095173|11438717|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7230293|NCT00095173|11438718|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7230294|NCT00095173|11438719|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7230295|NCT00095173|11438720|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7230296|NCT00095173|11438721|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
7230297|NCT00095173|11438716|FG000|Open-Label Lead-In Phase (Period A)|Other|1
7230298|NCT00095173|11438717|FG001|Open-Label Lead-In Phase (Period A)|Other|0
7230299|NCT00095173|11438718|FG002|Open-Label Lead-In Phase (Period A)|Other|0
7230300|NCT00095173|11438719|FG003|Open-Label Lead-In Phase (Period A)|Other|0
7230301|NCT00095173|11438720|FG004|Open-Label Lead-In Phase (Period A)|Other|0
7230302|NCT00095173|11438721|FG005|Open-Label Lead-In Phase (Period A)|Other|0
7230303|NCT00095173|11438716|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
7230304|NCT00095173|11438717|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
7230305|NCT00095173|11438718|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
7230306|NCT00095173|11438719|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
7573353|NCT03613649|11954540|FG005|Second Treatment|Withdrawal by Subject|0
7573354|NCT03613649|11954541|FG006|Second Treatment|Withdrawal by Subject|0
7230307|NCT00095173|11438720|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
7230308|NCT00095173|11438721|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
7230309|NCT00095173|11438716|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7573355|NCT03613649|11954542|FG007|Second Treatment|Withdrawal by Subject|0
7230310|NCT00095173|11438717|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
7230311|NCT00095173|11438718|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7230312|NCT00095173|11438719|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7230313|NCT00095173|11438720|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7230314|NCT00095173|11438721|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
7230315|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Death|0
7230316|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Death|0
7230317|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Death|0
7230318|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Death|0
7230319|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Death|0
7230320|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Death|1
7230321|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
7230322|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
7230323|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
7230324|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
7230325|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
7230326|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
7230327|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7230328|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7230329|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
7230330|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
7230331|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
7230332|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
7573356|NCT03613649|11954543|FG008|Second Treatment|Withdrawal by Subject|0
7573357|NCT03613649|11954544|FG009|Second Treatment|Withdrawal by Subject|0
7230333|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7230334|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7230335|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
7230336|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
7230337|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
7230338|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
7230339|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7230340|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7230341|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7230342|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
7230343|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
7230344|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
7230345|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7230346|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7230347|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7230348|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
7230349|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7230350|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
7230351|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7230352|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7230353|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7230354|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
7230355|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7230356|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
7230357|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
7230358|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
7230359|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
7230360|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
7230361|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
7230362|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
7230363|NCT00095173|11438716|FG000|Open-Label Extension Phase (Period C)|Other|0
7230364|NCT00095173|11438717|FG001|Open-Label Extension Phase (Period C)|Other|0
7230365|NCT00095173|11438718|FG002|Open-Label Extension Phase (Period C)|Other|0
7230366|NCT00095173|11438719|FG003|Open-Label Extension Phase (Period C)|Other|4
7230367|NCT00095173|11438720|FG004|Open-Label Extension Phase (Period C)|Other|6
7230368|NCT00095173|11438721|FG005|Open-Label Extension Phase (Period C)|Other|8
7230369|NCT00095199|11438739|FG000|Overall Study|Adverse Event|40
7230370|NCT00095199|11438740|FG001|Overall Study|Adverse Event|22
7230371|NCT00095199|11438741|FG002|Overall Study|Adverse Event|26
7230372|NCT00095199|11438742|FG003|Overall Study|Adverse Event|11
7230373|NCT00095199|11438739|FG000|Overall Study|Progressive disease|213
7230374|NCT00095199|11438740|FG001|Overall Study|Progressive disease|179
7230375|NCT00095199|11438741|FG002|Overall Study|Progressive disease|105
7230376|NCT00095199|11438742|FG003|Overall Study|Progressive disease|98
7230377|NCT00095199|11438739|FG000|Overall Study|Death|10
7230378|NCT00095199|11438740|FG001|Overall Study|Death|6
7230379|NCT00095199|11438741|FG002|Overall Study|Death|11
7573358|NCT03613649|11954545|FG010|Second Treatment|Withdrawal by Subject|0
7230380|NCT00095199|11438742|FG003|Overall Study|Death|9
7230381|NCT00095199|11438739|FG000|Overall Study|Withdrawal by Subject|21
7230382|NCT00095199|11438740|FG001|Overall Study|Withdrawal by Subject|16
7230383|NCT00095199|11438741|FG002|Overall Study|Withdrawal by Subject|13
7230384|NCT00095199|11438742|FG003|Overall Study|Withdrawal by Subject|22
7230385|NCT00095199|11438739|FG000|Overall Study|Protocol Violation|4
7230386|NCT00095199|11438740|FG001|Overall Study|Protocol Violation|4
7230387|NCT00095199|11438741|FG002|Overall Study|Protocol Violation|2
7230388|NCT00095199|11438742|FG003|Overall Study|Protocol Violation|0
7230389|NCT00095199|11438739|FG000|Overall Study|Liver function test results elevated|0
7230390|NCT00095199|11438740|FG001|Overall Study|Liver function test results elevated|0
7230391|NCT00095199|11438741|FG002|Overall Study|Liver function test results elevated|1
7230392|NCT00095199|11438742|FG003|Overall Study|Liver function test results elevated|1
7230393|NCT00095199|11438739|FG000|Overall Study|Surgery needed could not start in 7 days|0
7230394|NCT00095199|11438740|FG001|Overall Study|Surgery needed could not start in 7 days|0
7230395|NCT00095199|11438741|FG002|Overall Study|Surgery needed could not start in 7 days|1
7230396|NCT00095199|11438742|FG003|Overall Study|Surgery needed could not start in 7 days|0
7230397|NCT00095199|11438739|FG000|Overall Study|Physician Decision|5
7230398|NCT00095199|11438740|FG001|Overall Study|Physician Decision|6
7230399|NCT00095199|11438741|FG002|Overall Study|Physician Decision|1
7230400|NCT00095199|11438742|FG003|Overall Study|Physician Decision|1
7230401|NCT00095199|11438739|FG000|Overall Study|Not eligible|1
7230402|NCT00095199|11438740|FG001|Overall Study|Not eligible|7
7230403|NCT00095199|11438741|FG002|Overall Study|Not eligible|0
7230404|NCT00095199|11438742|FG003|Overall Study|Not eligible|1
7230405|NCT00095199|11438739|FG000|Overall Study|Started Palliative Radiotherapy|1
7230406|NCT00095199|11438740|FG001|Overall Study|Started Palliative Radiotherapy|0
7230407|NCT00095199|11438741|FG002|Overall Study|Started Palliative Radiotherapy|0
7230408|NCT00095199|11438742|FG003|Overall Study|Started Palliative Radiotherapy|0
7230409|NCT00095199|11438739|FG000|Overall Study|Started radiotherapy regimen|0
7230410|NCT00095199|11438740|FG001|Overall Study|Started radiotherapy regimen|1
7230411|NCT00095199|11438741|FG002|Overall Study|Started radiotherapy regimen|0
7230412|NCT00095199|11438742|FG003|Overall Study|Started radiotherapy regimen|0
7230413|NCT00095199|11438739|FG000|Overall Study|Primary tumor removed in other surgery|0
7230414|NCT00095199|11438740|FG001|Overall Study|Primary tumor removed in other surgery|1
7230415|NCT00095199|11438741|FG002|Overall Study|Primary tumor removed in other surgery|0
7230416|NCT00095199|11438742|FG003|Overall Study|Primary tumor removed in other surgery|0
7230417|NCT00095199|11438739|FG000|Overall Study|Data inadvertently lost by site|1
7230418|NCT00095199|11438740|FG001|Overall Study|Data inadvertently lost by site|0
7230419|NCT00095199|11438741|FG002|Overall Study|Data inadvertently lost by site|0
7230420|NCT00095199|11438742|FG003|Overall Study|Data inadvertently lost by site|0
7230421|NCT00095212|11438759|FG000|Overall Study|Withdrawal by Subject|1
7230422|NCT00095212|11438760|FG001|Overall Study|Withdrawal by Subject|3
7230423|NCT00095238|11438768|FG000|Overall Study|Lack of Efficacy|9
7230424|NCT00095238|11438769|FG001|Overall Study|Lack of Efficacy|9
7230425|NCT00095238|11438768|FG000|Overall Study|Adverse Event|331
7230426|NCT00095238|11438769|FG001|Overall Study|Adverse Event|287
7230427|NCT00095238|11438768|FG000|Overall Study|Subject Withdrew Consent|208
7230428|NCT00095238|11438769|FG001|Overall Study|Subject Withdrew Consent|223
7464896|NCT01876082|11763759|FG001|Overall Study|Adverse Event|1
7464897|NCT01876082|11763758|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
7230429|NCT00095238|11438768|FG000|Overall Study|Death|154
7230430|NCT00095238|11438769|FG001|Overall Study|Death|170
7230431|NCT00095238|11438768|FG000|Overall Study|Lost to Follow-up|19
7230432|NCT00095238|11438769|FG001|Overall Study|Lost to Follow-up|24
7230433|NCT00095238|11438768|FG000|Overall Study|Noncompliance|44
7230434|NCT00095238|11438769|FG001|Overall Study|Noncompliance|45
7230435|NCT00095238|11438768|FG000|Overall Study|No longer met study criteria|4
7230436|NCT00095238|11438769|FG001|Overall Study|No longer met study criteria|5
7230437|NCT00095238|11438768|FG000|Overall Study|Study terminated by sponsor|0
7230438|NCT00095238|11438769|FG001|Overall Study|Study terminated by sponsor|1
7230439|NCT00095238|11438768|FG000|Overall Study|Missing|1
7230440|NCT00095238|11438769|FG001|Overall Study|Missing|0
7230441|NCT00095238|11438768|FG000|Overall Study|Other Reasons|87
7230442|NCT00095238|11438769|FG001|Overall Study|Other Reasons|88
7230443|NCT00095303|11438809|FG000|Main Study|Lost to Follow-up|91
7230444|NCT00095303|11438810|FG001|Main Study|Lost to Follow-up|87
7230445|NCT00095303|11438809|FG000|Follow Up Study|Lost to Follow-up|59
7230446|NCT00095303|11438810|FG001|Follow Up Study|Lost to Follow-up|58
7230447|NCT00095498|11438819|FG000|Overall Study|Physician Decision|9
7230448|NCT00095498|11438820|FG001|Overall Study|Physician Decision|10
7230449|NCT00095498|11438821|FG002|Overall Study|Physician Decision|8
7230450|NCT00095498|11438819|FG000|Overall Study|Adverse Event|1
7230451|NCT00095498|11438820|FG001|Overall Study|Adverse Event|0
7230452|NCT00095498|11438821|FG002|Overall Study|Adverse Event|1
7230453|NCT00095498|11438819|FG000|Overall Study|Withdrawal by Subject|15
7230454|NCT00095498|11438820|FG001|Overall Study|Withdrawal by Subject|16
7464898|NCT01876082|11763759|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
7230455|NCT00095498|11438821|FG002|Overall Study|Withdrawal by Subject|15
7230456|NCT00095498|11438819|FG000|Overall Study|Disease progression|0
7230457|NCT00095498|11438820|FG001|Overall Study|Disease progression|1
7230458|NCT00095498|11438821|FG002|Overall Study|Disease progression|1
7230459|NCT00095498|11438819|FG000|Overall Study|Ineligibility determined|3
7230460|NCT00095498|11438820|FG001|Overall Study|Ineligibility determined|0
7230461|NCT00095498|11438821|FG002|Overall Study|Ineligibility determined|2
7230462|NCT00095498|11438819|FG000|Overall Study|Lost to Follow-up|1
7230463|NCT00095498|11438820|FG001|Overall Study|Lost to Follow-up|1
7230464|NCT00095498|11438821|FG002|Overall Study|Lost to Follow-up|2
7230465|NCT00095498|11438819|FG000|Overall Study|Noncompliance|1
7230466|NCT00095498|11438820|FG001|Overall Study|Noncompliance|0
7230467|NCT00095498|11438821|FG002|Overall Study|Noncompliance|1
7230468|NCT00095498|11438819|FG000|Overall Study|Other|6
7230469|NCT00095498|11438820|FG001|Overall Study|Other|7
7230470|NCT00095498|11438821|FG002|Overall Study|Other|6
7230471|NCT00095498|11438819|FG000|Overall Study|Protocol Violation|0
7230472|NCT00095498|11438820|FG001|Overall Study|Protocol Violation|0
7230473|NCT00095498|11438821|FG002|Overall Study|Protocol Violation|1
7230474|NCT00095498|11438819|FG000|Overall Study|Requirement for alternative therapy|1
7230475|NCT00095498|11438820|FG001|Overall Study|Requirement for alternative therapy|0
7230476|NCT00095498|11438821|FG002|Overall Study|Requirement for alternative therapy|2
7230477|NCT00095576|11438835|FG000|Overall Study|Adverse Event|5
7230478|NCT00095576|11438836|FG001|Overall Study|Adverse Event|3
7230479|NCT00095576|11438835|FG000|Overall Study|Lost to Follow-up|233
7230480|NCT00095576|11438836|FG001|Overall Study|Lost to Follow-up|229
7230481|NCT00095576|11438835|FG000|Overall Study|Protocol Violation|1
7230482|NCT00095576|11438836|FG001|Overall Study|Protocol Violation|0
7230483|NCT00095576|11438835|FG000|Overall Study|Withdrawal by Subject|34
7230484|NCT00095576|11438836|FG001|Overall Study|Withdrawal by Subject|47
7230485|NCT00095576|11438835|FG000|Overall Study|Option to switch to a rollover study|1097
7230486|NCT00095576|11438836|FG001|Overall Study|Option to switch to a rollover study|1099
7230487|NCT00095576|11438835|FG000|Overall Study|Site terminated|75
7230488|NCT00095576|11438836|FG001|Overall Study|Site terminated|67
7230489|NCT00095576|11438835|FG000|Overall Study|Subject moved|30
7230490|NCT00095576|11438836|FG001|Overall Study|Subject moved|36
7230491|NCT00095628|11438842|FG000|Overall Study|Disease progression prior to treatment|1
7230492|NCT00095836|11438846|FG000|Overall Study|Lost to Follow-up|1
7230493|NCT00095836|11438846|FG000|Overall Study|Adverse Event|1
7230494|NCT00095836|11438846|FG000|Overall Study|Death|2
7230495|NCT00095940|11438866|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
7230496|NCT00095940|11438867|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
7230497|NCT00095940|11438868|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
7230498|NCT00095940|11438869|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
7230499|NCT00095940|11438870|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
7230500|NCT00095940|11438871|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
7573359|NCT03613649|11954546|FG011|Second Treatment|Withdrawal by Subject|0
7230501|NCT00095940|11438872|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
7230502|NCT00095940|11438873|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
7230503|NCT00095940|11438874|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
7230504|NCT00095940|11438866|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7230505|NCT00095940|11438867|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7230506|NCT00095940|11438868|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7230507|NCT00095940|11438869|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7230508|NCT00095940|11438870|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7230509|NCT00095940|11438871|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7230510|NCT00095940|11438872|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7230511|NCT00095940|11438873|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
7230512|NCT00095940|11438874|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
7230513|NCT00095940|11438866|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
7230514|NCT00095940|11438867|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
7230515|NCT00095940|11438868|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
7230516|NCT00095940|11438869|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
7230517|NCT00095940|11438870|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
7230518|NCT00095940|11438871|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
7230519|NCT00095940|11438872|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
7230520|NCT00095940|11438873|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
7230521|NCT00095940|11438874|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
7230522|NCT00095979|11438892|FG000|Overall Study|Ineligible: Second primary cancer site|2
7230523|NCT00096018|11438903|FG000|Overall Study|Became Ineligible (not treated)|0
7230524|NCT00096018|11438904|FG001|Overall Study|Became Ineligible (not treated)|3
7230525|NCT00096018|11438903|FG000|Overall Study|Miscellaneous (not treated)|0
7230526|NCT00096018|11438904|FG001|Overall Study|Miscellaneous (not treated)|2
7230527|NCT00096018|11438903|FG000|Overall Study|Adverse Event|0
7230528|NCT00096018|11438904|FG001|Overall Study|Adverse Event|5
7230529|NCT00096018|11438903|FG000|Overall Study|Death|0
7230530|NCT00096018|11438904|FG001|Overall Study|Death|1
7230531|NCT00096018|11438903|FG000|Overall Study|Withdrawal by Subject|0
7230532|NCT00096018|11438904|FG001|Overall Study|Withdrawal by Subject|2
7230533|NCT00096018|11438903|FG000|Overall Study|Miscellaneous|2
7230534|NCT00096018|11438904|FG001|Overall Study|Miscellaneous|1
7230535|NCT00096031|11438910|FG000|Overall Study|Adverse Event|3
7230536|NCT00096031|11438910|FG000|Overall Study|Lack of Efficacy|42
7230537|NCT00096031|11438910|FG000|Overall Study|Death|4
7230538|NCT00096031|11438910|FG000|Overall Study|Withdrawal by Subject|1
7230539|NCT00096031|11438910|FG000|Overall Study|Ineligible|8
7230540|NCT00096031|11438910|FG000|Overall Study|Not protocol specified|5
7230541|NCT00096044|11438914|FG000|Overall Study|Withdrawal by Subject|9
7230542|NCT00096044|11438914|FG000|Overall Study|Adverse Event|21
7230543|NCT00096044|11438914|FG000|Overall Study|Disease Progression|4
7230544|NCT00096135|11438928|FG000|Overall Study|Physician Decision|20
7230545|NCT00096135|11438929|FG001|Overall Study|Physician Decision|4
7230546|NCT00096135|11438928|FG000|Overall Study|Refusal of further protocol therapy|4
7230547|NCT00096135|11438929|FG001|Overall Study|Refusal of further protocol therapy|1
7230548|NCT00096135|11438928|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
7230549|NCT00096135|11438929|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
7230550|NCT00096135|11438928|FG000|Overall Study|Other, specify|15
7230551|NCT00096135|11438929|FG001|Overall Study|Other, specify|3
7230552|NCT00096135|11438928|FG000|Overall Study|Ineligible|2
7230553|NCT00096135|11438929|FG001|Overall Study|Ineligible|0
7230554|NCT00096174|11438952|FG000|Overall Study|Lack of Efficacy|9
7230555|NCT00096174|11438952|FG000|Overall Study|Adverse Event|15
7230556|NCT00096174|11438952|FG000|Overall Study|Death|6
7230557|NCT00096174|11438952|FG000|Overall Study|Withdrawal by Subject|15
7230558|NCT00096174|11438952|FG000|Overall Study|Not started protocol therapy|3
7230559|NCT00096174|11438952|FG000|Overall Study|Ineligible|6
7230560|NCT00096174|11438952|FG000|Overall Study|other reason|8
7230561|NCT00096226|11438956|FG000|Overall Study|Ineligible|2
7230562|NCT00096226|11438956|FG000|Overall Study|Protocol treatment not started|1
7230563|NCT00096265|11438963|FG000|Overall Study|Ineligible|1
7230564|NCT00096265|11438964|FG001|Overall Study|Ineligible|0
7230565|NCT00096265|11438965|FG002|Overall Study|Ineligible|0
7230566|NCT00096278|11438976|FG000|Overall Study|No follow-up data|15
7230567|NCT00096278|11438977|FG001|Overall Study|No follow-up data|18
7230568|NCT00096278|11438976|FG000|Overall Study|Patient not at risk for primary endpoint|3
7230569|NCT00096278|11438977|FG001|Overall Study|Patient not at risk for primary endpoint|2
7230570|NCT00096356|11438987|FG000|Overall Study|Adverse Event|11
7230571|NCT00096356|11438988|FG001|Overall Study|Adverse Event|9
7230572|NCT00096356|11438987|FG000|Overall Study|Physician Decision|5
7230573|NCT00096356|11438988|FG001|Overall Study|Physician Decision|3
7230574|NCT00096356|11438987|FG000|Overall Study|Withdrawal by Subject|17
7230575|NCT00096356|11438988|FG001|Overall Study|Withdrawal by Subject|23
7230576|NCT00096356|11438987|FG000|Overall Study|Lack of Efficacy|1
7230577|NCT00096356|11438988|FG001|Overall Study|Lack of Efficacy|0
7230578|NCT00096356|11438987|FG000|Overall Study|multiple reasons|10
7230579|NCT00096356|11438988|FG001|Overall Study|multiple reasons|18
7230580|NCT00096382|11438997|FG000|Overall Study|Not treated|1
7230581|NCT00096382|11438998|FG001|Overall Study|Not treated|0
7230582|NCT00096382|11438997|FG000|Overall Study|Death during treatment|1
7230583|NCT00096382|11438998|FG001|Overall Study|Death during treatment|0
7230584|NCT00096447|11439004|FG000|Overall Study|Never treated|1
7230585|NCT00096486|11439026|FG000|Overall Study|Withdrawal by Subject|0
7230586|NCT00096486|11439027|FG001|Overall Study|Withdrawal by Subject|0
7230587|NCT00096486|11439028|FG002|Overall Study|Withdrawal by Subject|1
7230588|NCT00096486|11439029|FG003|Overall Study|Withdrawal by Subject|1
7230589|NCT00096486|11439026|FG000|Overall Study|Not Treated|0
7230590|NCT00096486|11439027|FG001|Overall Study|Not Treated|0
7230591|NCT00096486|11439028|FG002|Overall Study|Not Treated|1
7230592|NCT00096486|11439029|FG003|Overall Study|Not Treated|1
7230593|NCT00096538|11439039|FG000|Overall Study|Withdrawal by Subject|1
7230594|NCT00096785|11439049|FG000|Overall Study|Lost to Follow-up|1
7230595|NCT00096785|11439050|FG001|Overall Study|Lost to Follow-up|0
7230596|NCT00096785|11439049|FG000|Overall Study|Withdrawal by Subject|0
7230597|NCT00096785|11439050|FG001|Overall Study|Withdrawal by Subject|1
7230598|NCT00096785|11439049|FG000|Overall Study|Relocated|1
7230599|NCT00096785|11439050|FG001|Overall Study|Relocated|0
7230600|NCT00096941|11439056|FG000|Overall Study|disease progression|3
7230601|NCT00096954|11439062|FG000|Overall Study|Adverse Event|3
7230602|NCT00096954|11439063|FG001|Overall Study|Adverse Event|1
7230603|NCT00096954|11439062|FG000|Overall Study|Withdrawal by Subject|9
7230604|NCT00096954|11439063|FG001|Overall Study|Withdrawal by Subject|8
7230605|NCT00096954|11439062|FG000|Overall Study|Physician Decision|1
7230606|NCT00096954|11439063|FG001|Overall Study|Physician Decision|1
7230607|NCT00096954|11439062|FG000|Overall Study|Sponsors Decision|1
7230608|NCT00096954|11439063|FG001|Overall Study|Sponsors Decision|1
7230609|NCT00096954|11439062|FG000|Overall Study|Pregnancy|1
7230610|NCT00096954|11439063|FG001|Overall Study|Pregnancy|1
7230611|NCT00096954|11439062|FG000|Overall Study|Initiation of immunotherapy|1
7230612|NCT00096954|11439063|FG001|Overall Study|Initiation of immunotherapy|0
7230613|NCT00096954|11439062|FG000|Overall Study|Non-compliance|0
7230614|NCT00096954|11439063|FG001|Overall Study|Non-compliance|3
7230615|NCT00096954|11439062|FG000|Overall Study|Lost to Follow-up|8
7230616|NCT00096954|11439063|FG001|Overall Study|Lost to Follow-up|5
7230617|NCT00096993|11439071|FG000|Overall Study|Death|1
7230618|NCT00096993|11439072|FG001|Overall Study|Death|0
7230619|NCT00096993|11439071|FG000|Overall Study|Disease progression|56
7230620|NCT00096993|11439072|FG001|Overall Study|Disease progression|53
7230621|NCT00096993|11439071|FG000|Overall Study|Adverse Event|2
7230622|NCT00096993|11439072|FG001|Overall Study|Adverse Event|8
7230623|NCT00096993|11439071|FG000|Overall Study|Subject's decision|3
7230624|NCT00096993|11439072|FG001|Overall Study|Subject's decision|1
7230625|NCT00096993|11439071|FG000|Overall Study|Physician Decision|2
7230626|NCT00096993|11439072|FG001|Overall Study|Physician Decision|1
7230627|NCT00096993|11439071|FG000|Overall Study|Non-compliance|0
7230628|NCT00096993|11439072|FG001|Overall Study|Non-compliance|1
7230629|NCT00096993|11439071|FG000|Overall Study|Other unspecified|1
7230630|NCT00096993|11439072|FG001|Overall Study|Other unspecified|1
7230631|NCT00097370|11439086|FG000|Stage 1|Adverse Event|3
7230632|NCT00097370|11439086|FG000|Stage 1|Withdrawal by Subject|1
7230633|NCT00097370|11439086|FG000|Stage 1|Lack of Efficacy|2
7230634|NCT00097370|11439086|FG000|Stage 2|Adverse Event|5
7230635|NCT00097370|11439086|FG000|Stage 2|Withdrawal by Subject|1
7230636|NCT00097370|11439086|FG000|Stage 2|Lack of Efficacy|3
7230637|NCT00097370|11439086|FG000|Stage 2|Pregnancy|1
7230638|NCT00097370|11439086|FG000|Stage 2|Sponsor Terminated Study|2
7230639|NCT00097370|11439086|FG000|Stage 2|Lost to Follow-up|1
7230640|NCT00097370|11439086|FG000|Stage 3|Adverse Event|2
7230641|NCT00097370|11439086|FG000|Stage 3|Withdrawal by Subject|3
7230642|NCT00097370|11439086|FG000|Stage 3|Lack of Efficacy|1
7230643|NCT00097370|11439086|FG000|Stage 3|Sponsor Terminated Study|52
7230644|NCT00097370|11439086|FG000|Stage 3|Lost to Follow-up|1
7230645|NCT00097500|11439101|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7230646|NCT00097500|11439102|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
7230647|NCT00097500|11439101|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
7230648|NCT00097500|11439102|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
7230649|NCT00097500|11439101|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
7230650|NCT00097500|11439102|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
7230651|NCT00097500|11439101|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
7230652|NCT00097500|11439102|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
7230653|NCT00097500|11439101|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
7230654|NCT00097500|11439102|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
7230655|NCT00097500|11439101|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
7230656|NCT00097500|11439102|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
7230657|NCT00097500|11439101|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
7230658|NCT00097500|11439102|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
7230659|NCT00097539|11439115|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
7230660|NCT00097539|11439116|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
7230661|NCT00097539|11439117|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
7230662|NCT00097539|11439118|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
7230663|NCT00097539|11439119|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
7230664|NCT00097539|11439120|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
7230665|NCT00097539|11439121|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
7230666|NCT00097539|11439115|FG000|Overall Study|Withdrawal by Subject|925
7230667|NCT00097539|11439116|FG001|Overall Study|Withdrawal by Subject|323
7230668|NCT00097539|11439117|FG002|Overall Study|Withdrawal by Subject|346
7230669|NCT00097539|11439118|FG003|Overall Study|Withdrawal by Subject|217
7230670|NCT00097539|11439119|FG004|Overall Study|Withdrawal by Subject|68
7230671|NCT00097539|11439120|FG005|Overall Study|Withdrawal by Subject|229
7230672|NCT00097539|11439121|FG006|Overall Study|Withdrawal by Subject|3
7230673|NCT00097539|11439115|FG000|Overall Study|Participant Non-compliant|2140
7230674|NCT00097539|11439116|FG001|Overall Study|Participant Non-compliant|567
7230675|NCT00097539|11439117|FG002|Overall Study|Participant Non-compliant|1067
7230676|NCT00097539|11439118|FG003|Overall Study|Participant Non-compliant|353
7230677|NCT00097539|11439119|FG004|Overall Study|Participant Non-compliant|136
7230678|NCT00097539|11439120|FG005|Overall Study|Participant Non-compliant|543
7230679|NCT00097539|11439121|FG006|Overall Study|Participant Non-compliant|18
7230680|NCT00097539|11439115|FG000|Overall Study|Lack of Efficacy|249
7230681|NCT00097539|11439116|FG001|Overall Study|Lack of Efficacy|122
7230682|NCT00097539|11439117|FG002|Overall Study|Lack of Efficacy|202
7230683|NCT00097539|11439118|FG003|Overall Study|Lack of Efficacy|105
7230684|NCT00097539|11439119|FG004|Overall Study|Lack of Efficacy|45
7230685|NCT00097539|11439120|FG005|Overall Study|Lack of Efficacy|228
7230686|NCT00097539|11439121|FG006|Overall Study|Lack of Efficacy|5
7230687|NCT00097539|11439115|FG000|Overall Study|Adverse Event|78
7230688|NCT00097539|11439116|FG001|Overall Study|Adverse Event|133
7230689|NCT00097539|11439117|FG002|Overall Study|Adverse Event|37
7230690|NCT00097539|11439118|FG003|Overall Study|Adverse Event|27
7230691|NCT00097539|11439119|FG004|Overall Study|Adverse Event|30
7230692|NCT00097539|11439120|FG005|Overall Study|Adverse Event|59
7230693|NCT00097539|11439121|FG006|Overall Study|Adverse Event|1
7230694|NCT00097539|11439115|FG000|Overall Study|Death|2
7230695|NCT00097539|11439116|FG001|Overall Study|Death|7
7230696|NCT00097539|11439117|FG002|Overall Study|Death|0
7230697|NCT00097539|11439118|FG003|Overall Study|Death|0
7230698|NCT00097539|11439119|FG004|Overall Study|Death|1
7230699|NCT00097539|11439120|FG005|Overall Study|Death|3
7230700|NCT00097539|11439121|FG006|Overall Study|Death|0
7230701|NCT00097539|11439115|FG000|Overall Study|Reasons Other Than Above|3602
7230702|NCT00097539|11439116|FG001|Overall Study|Reasons Other Than Above|1382
7230703|NCT00097539|11439117|FG002|Overall Study|Reasons Other Than Above|1757
7230704|NCT00097539|11439118|FG003|Overall Study|Reasons Other Than Above|692
7230705|NCT00097539|11439119|FG004|Overall Study|Reasons Other Than Above|361
7230706|NCT00097539|11439120|FG005|Overall Study|Reasons Other Than Above|1244
7230707|NCT00097539|11439121|FG006|Overall Study|Reasons Other Than Above|34
7230708|NCT00097539|11439115|FG000|Overall Study|Reason not Specified|111
7230709|NCT00097539|11439116|FG001|Overall Study|Reason not Specified|49
7230710|NCT00097539|11439117|FG002|Overall Study|Reason not Specified|53
7230711|NCT00097539|11439118|FG003|Overall Study|Reason not Specified|21
7230712|NCT00097539|11439119|FG004|Overall Study|Reason not Specified|11
7230713|NCT00097539|11439120|FG005|Overall Study|Reason not Specified|40
7230714|NCT00097539|11439121|FG006|Overall Study|Reason not Specified|2
7230715|NCT00097591|11439139|FG000|Overall Study|Withdrawal of consent|342
7230716|NCT00097591|11439140|FG001|Overall Study|Withdrawal of consent|323
7230717|NCT00097591|11439139|FG000|Overall Study|Less than 6 months on study drug|9
7230718|NCT00097591|11439140|FG001|Overall Study|Less than 6 months on study drug|7
7230719|NCT00097591|11439139|FG000|Overall Study|Unable to attend termination visit|53
7230720|NCT00097591|11439140|FG001|Overall Study|Unable to attend termination visit|51
7230721|NCT00097591|11439139|FG000|Overall Study|Lost to follow up|6
7230722|NCT00097591|11439140|FG001|Overall Study|Lost to follow up|10
7230723|NCT00097591|11439139|FG000|Overall Study|Other|0
7230724|NCT00097591|11439140|FG001|Overall Study|Other|3
7230725|NCT00097721|11439189|FG000|Overall Study|Adverse Event|8
7230726|NCT00097721|11439190|FG001|Overall Study|Adverse Event|1
7230727|NCT00097721|11439189|FG000|Overall Study|Withdrawal by Subject|6
7230728|NCT00097721|11439190|FG001|Overall Study|Withdrawal by Subject|1
7230729|NCT00097721|11439189|FG000|Overall Study|Progressive Disease|55
7230730|NCT00097721|11439190|FG001|Overall Study|Progressive Disease|27
7230731|NCT00097721|11439189|FG000|Overall Study|Physician Decision|1
7230732|NCT00097721|11439190|FG001|Overall Study|Physician Decision|3
7230733|NCT00097721|11439189|FG000|Overall Study|Reason not given|1
7230734|NCT00097721|11439190|FG001|Overall Study|Reason not given|1
7230735|NCT00097773|11439200|FG000|Overall Study|Lost to Follow-up|2
7230736|NCT00097773|11439201|FG001|Overall Study|Lost to Follow-up|2
7230737|NCT00097773|11439202|FG002|Overall Study|Lost to Follow-up|0
7230738|NCT00097773|11439203|FG003|Overall Study|Lost to Follow-up|1
7230739|NCT00097773|11439200|FG000|Overall Study|Physician Decision|2
7230740|NCT00097773|11439201|FG001|Overall Study|Physician Decision|2
7230741|NCT00097773|11439202|FG002|Overall Study|Physician Decision|3
7230742|NCT00097773|11439203|FG003|Overall Study|Physician Decision|1
7230743|NCT00097773|11439200|FG000|Overall Study|Withdrawal by Subject|3
7230744|NCT00097773|11439201|FG001|Overall Study|Withdrawal by Subject|3
7230745|NCT00097773|11439202|FG002|Overall Study|Withdrawal by Subject|3
7230746|NCT00097773|11439203|FG003|Overall Study|Withdrawal by Subject|1
7230747|NCT00097773|11439200|FG000|Overall Study|Adverse Event|0
7230748|NCT00097773|11439201|FG001|Overall Study|Adverse Event|1
7230749|NCT00097773|11439202|FG002|Overall Study|Adverse Event|0
7230750|NCT00097773|11439203|FG003|Overall Study|Adverse Event|0
7230751|NCT00097773|11439200|FG000|Overall Study|Other|1
7230752|NCT00097773|11439201|FG001|Overall Study|Other|0
7230753|NCT00097773|11439202|FG002|Overall Study|Other|2
7230754|NCT00097773|11439203|FG003|Overall Study|Other|0
7230755|NCT00097786|11439222|FG000|Overall Study|lost to follow-up for all-cause death|296
7230756|NCT00097786|11439223|FG001|Overall Study|lost to follow-up for all-cause death|292
7230757|NCT00097786|11439224|FG002|Overall Study|lost to follow-up for all-cause death|313
7230758|NCT00097786|11439225|FG003|Overall Study|lost to follow-up for all-cause death|310
7230759|NCT00097981|11439237|FG000|Overall Study|Adverse Event|31
7230760|NCT00097981|11439238|FG001|Overall Study|Adverse Event|44
7230761|NCT00097981|11439237|FG000|Overall Study|Withdrawal by Subject|10
7230762|NCT00097981|11439238|FG001|Overall Study|Withdrawal by Subject|8
7230763|NCT00097981|11439237|FG000|Overall Study|Protocol Violation|1
7230764|NCT00097981|11439238|FG001|Overall Study|Protocol Violation|1
7230765|NCT00097981|11439237|FG000|Overall Study|Death|2
7230766|NCT00097981|11439238|FG001|Overall Study|Death|4
7230767|NCT00097981|11439237|FG000|Overall Study|Physician Decision|7
7230768|NCT00097981|11439238|FG001|Overall Study|Physician Decision|1
7230769|NCT00097981|11439237|FG000|Overall Study|Disease Progression|8
7230770|NCT00097981|11439238|FG001|Overall Study|Disease Progression|2
7230771|NCT00097981|11439237|FG000|Overall Study|Transplant planned|28
7230772|NCT00097981|11439238|FG001|Overall Study|Transplant planned|27
7230773|NCT00097981|11439237|FG000|Overall Study|Other|19
7230774|NCT00097981|11439238|FG001|Overall Study|Other|13
7230775|NCT00098020|11439244|FG000|Overall Study|Adverse Event|2
7230776|NCT00098020|11439244|FG000|Overall Study|Lost to Follow-up|1
7230777|NCT00098020|11439244|FG000|Overall Study|elevated liver enzymes|1
7230778|NCT00098020|11439244|FG000|Overall Study|Low urine PCR|1
7230779|NCT00098020|11439244|FG000|Overall Study|Low epidermal growth factor receptor|1
7230780|NCT00098254|11439262|FG000|Overall Study|Adverse Event|2
7230781|NCT00098254|11439262|FG000|Overall Study|Death|1
7230782|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Adverse Event|14
7230783|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Adverse Event|27
7230784|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Adverse Event|60
7230785|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Adverse Event|0
7230786|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Adverse Event|0
7230787|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Pregnancy|0
7230788|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Pregnancy|7
7230789|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Pregnancy|9
7230790|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Pregnancy|0
7230791|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Pregnancy|0
7230792|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Participant Defaulted|11
7230793|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Participant Defaulted|40
7230794|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Participant Defaulted|36
7230795|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Participant Defaulted|0
7230796|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Participant Defaulted|0
7230797|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
7230798|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
7230799|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
7230800|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
7230801|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
7230802|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Death|1
7230803|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Death|2
7230804|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Death|2
7230805|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Death|0
7230806|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Death|0
7230807|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
7230808|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
7230809|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
7230810|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
7230811|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
7230812|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Protocol Violation|2
7230813|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Protocol Violation|18
7230814|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Protocol Violation|22
7230815|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Protocol Violation|0
7230816|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Protocol Violation|0
7230817|NCT00098293|11439269|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
7230818|NCT00098293|11439270|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
7230819|NCT00098293|11439271|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
7230820|NCT00098293|11439272|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
7230821|NCT00098293|11439273|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
7230822|NCT00098293|11439269|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7230823|NCT00098293|11439270|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7230824|NCT00098293|11439271|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
7230825|NCT00098293|11439272|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7230826|NCT00098293|11439273|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
7230827|NCT00098293|11439269|FG000|Open-label (OL) Phase|Adverse Event|0
7230828|NCT00098293|11439270|FG001|Open-label (OL) Phase|Adverse Event|3
7230829|NCT00098293|11439271|FG002|Open-label (OL) Phase|Adverse Event|7
7230830|NCT00098293|11439272|FG003|Open-label (OL) Phase|Adverse Event|6
7230831|NCT00098293|11439273|FG004|Open-label (OL) Phase|Adverse Event|0
7230832|NCT00098293|11439269|FG000|Open-label (OL) Phase|Lack of Efficacy|0
7230833|NCT00098293|11439270|FG001|Open-label (OL) Phase|Lack of Efficacy|7
7230834|NCT00098293|11439271|FG002|Open-label (OL) Phase|Lack of Efficacy|2
7230835|NCT00098293|11439272|FG003|Open-label (OL) Phase|Lack of Efficacy|20
7230836|NCT00098293|11439273|FG004|Open-label (OL) Phase|Lack of Efficacy|0
7230837|NCT00098293|11439269|FG000|Open-label (OL) Phase|Pregnancy|0
7230838|NCT00098293|11439270|FG001|Open-label (OL) Phase|Pregnancy|1
7230839|NCT00098293|11439271|FG002|Open-label (OL) Phase|Pregnancy|0
7230840|NCT00098293|11439272|FG003|Open-label (OL) Phase|Pregnancy|3
7230841|NCT00098293|11439273|FG004|Open-label (OL) Phase|Pregnancy|0
7230842|NCT00098293|11439269|FG000|Open-label (OL) Phase|Protocol Violation|0
7230843|NCT00098293|11439270|FG001|Open-label (OL) Phase|Protocol Violation|6
7230844|NCT00098293|11439271|FG002|Open-label (OL) Phase|Protocol Violation|13
7230845|NCT00098293|11439272|FG003|Open-label (OL) Phase|Protocol Violation|16
7230846|NCT00098293|11439273|FG004|Open-label (OL) Phase|Protocol Violation|0
7230847|NCT00098293|11439269|FG000|Open-label (OL) Phase|Participant Defaulted|0
7230848|NCT00098293|11439270|FG001|Open-label (OL) Phase|Participant Defaulted|6
7230849|NCT00098293|11439271|FG002|Open-label (OL) Phase|Participant Defaulted|16
7230850|NCT00098293|11439272|FG003|Open-label (OL) Phase|Participant Defaulted|20
7230851|NCT00098293|11439273|FG004|Open-label (OL) Phase|Participant Defaulted|0
7230852|NCT00098293|11439269|FG000|Open-label (OL) Phase|Death|0
7230853|NCT00098293|11439270|FG001|Open-label (OL) Phase|Death|2
7230854|NCT00098293|11439271|FG002|Open-label (OL) Phase|Death|3
7230855|NCT00098293|11439272|FG003|Open-label (OL) Phase|Death|0
7230856|NCT00098293|11439273|FG004|Open-label (OL) Phase|Death|0
7230857|NCT00098293|11439269|FG000|Supplemental Phase (SP)|Death|0
7230858|NCT00098293|11439270|FG001|Supplemental Phase (SP)|Death|0
7230859|NCT00098293|11439271|FG002|Supplemental Phase (SP)|Death|0
7230860|NCT00098293|11439272|FG003|Supplemental Phase (SP)|Death|0
7230861|NCT00098293|11439273|FG004|Supplemental Phase (SP)|Death|1
7230862|NCT00098293|11439269|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
7230863|NCT00098293|11439270|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
7230864|NCT00098293|11439271|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
7230865|NCT00098293|11439272|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
7230866|NCT00098293|11439273|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
7230867|NCT00098293|11439269|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
7230868|NCT00098293|11439270|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
7230869|NCT00098293|11439271|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
7230870|NCT00098293|11439272|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
7230871|NCT00098293|11439273|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
7230872|NCT00098293|11439269|FG000|Supplemental Phase (SP)|Other|0
7230873|NCT00098293|11439270|FG001|Supplemental Phase (SP)|Other|0
7230874|NCT00098293|11439271|FG002|Supplemental Phase (SP)|Other|0
7230875|NCT00098293|11439272|FG003|Supplemental Phase (SP)|Other|0
7230876|NCT00098293|11439273|FG004|Supplemental Phase (SP)|Other|22
7230877|NCT00098306|11439287|FG000|Double Blind|Randomized, not treated|9
7230878|NCT00098306|11439288|FG001|Double Blind|Randomized, not treated|5
7230879|NCT00098306|11439289|FG002|Double Blind|Randomized, not treated|2
7230880|NCT00098306|11439290|FG003|Double Blind|Randomized, not treated|0
7230881|NCT00098306|11439291|FG004|Double Blind|Randomized, not treated|0
7230882|NCT00098306|11439292|FG005|Double Blind|Randomized, not treated|0
7230883|NCT00098306|11439293|FG006|Double Blind|Randomized, not treated|0
7230884|NCT00098306|11439287|FG000|Double Blind|Ongoing at cut-off date|151
7230885|NCT00098306|11439288|FG001|Double Blind|Ongoing at cut-off date|166
7230886|NCT00098306|11439289|FG002|Double Blind|Ongoing at cut-off date|72
7230887|NCT00098306|11439290|FG003|Double Blind|Ongoing at cut-off date|0
7230888|NCT00098306|11439291|FG004|Double Blind|Ongoing at cut-off date|0
7230889|NCT00098306|11439292|FG005|Double Blind|Ongoing at cut-off date|0
7230890|NCT00098306|11439293|FG006|Double Blind|Ongoing at cut-off date|0
7230891|NCT00098306|11439287|FG000|Double Blind|Adverse Event|11
7230892|NCT00098306|11439288|FG001|Double Blind|Adverse Event|10
7230893|NCT00098306|11439289|FG002|Double Blind|Adverse Event|6
7230894|NCT00098306|11439290|FG003|Double Blind|Adverse Event|0
7230895|NCT00098306|11439291|FG004|Double Blind|Adverse Event|0
7230896|NCT00098306|11439292|FG005|Double Blind|Adverse Event|0
7230897|NCT00098306|11439293|FG006|Double Blind|Adverse Event|0
7230898|NCT00098306|11439287|FG000|Double Blind|Lack of Efficacy|43
7230899|NCT00098306|11439288|FG001|Double Blind|Lack of Efficacy|34
7230900|NCT00098306|11439289|FG002|Double Blind|Lack of Efficacy|17
7230901|NCT00098306|11439290|FG003|Double Blind|Lack of Efficacy|0
7230902|NCT00098306|11439291|FG004|Double Blind|Lack of Efficacy|0
7230903|NCT00098306|11439292|FG005|Double Blind|Lack of Efficacy|0
7230904|NCT00098306|11439293|FG006|Double Blind|Lack of Efficacy|0
7230905|NCT00098306|11439287|FG000|Double Blind|Death|1
7230906|NCT00098306|11439288|FG001|Double Blind|Death|4
7230907|NCT00098306|11439289|FG002|Double Blind|Death|1
7230908|NCT00098306|11439290|FG003|Double Blind|Death|0
7230909|NCT00098306|11439291|FG004|Double Blind|Death|0
7230910|NCT00098306|11439292|FG005|Double Blind|Death|0
7230911|NCT00098306|11439293|FG006|Double Blind|Death|0
7230912|NCT00098306|11439287|FG000|Double Blind|Participant defaulted|19
7230913|NCT00098306|11439288|FG001|Double Blind|Participant defaulted|18
7230914|NCT00098306|11439289|FG002|Double Blind|Participant defaulted|11
7230915|NCT00098306|11439290|FG003|Double Blind|Participant defaulted|0
7230916|NCT00098306|11439291|FG004|Double Blind|Participant defaulted|0
7230917|NCT00098306|11439292|FG005|Double Blind|Participant defaulted|0
7230918|NCT00098306|11439293|FG006|Double Blind|Participant defaulted|0
7230919|NCT00098306|11439287|FG000|Double Blind|Un-specified|7
7230920|NCT00098306|11439288|FG001|Double Blind|Un-specified|3
7230921|NCT00098306|11439289|FG002|Double Blind|Un-specified|11
7230922|NCT00098306|11439290|FG003|Double Blind|Un-specified|0
7230923|NCT00098306|11439291|FG004|Double Blind|Un-specified|0
7230924|NCT00098306|11439292|FG005|Double Blind|Un-specified|0
7230925|NCT00098306|11439293|FG006|Double Blind|Un-specified|0
7230926|NCT00098306|11439287|FG000|Open Label|Lack of Efficacy|0
7230927|NCT00098306|11439288|FG001|Open Label|Lack of Efficacy|0
7230928|NCT00098306|11439289|FG002|Open Label|Lack of Efficacy|0
7230929|NCT00098306|11439290|FG003|Open Label|Lack of Efficacy|13
7230930|NCT00098306|11439291|FG004|Open Label|Lack of Efficacy|0
7230931|NCT00098306|11439292|FG005|Open Label|Lack of Efficacy|0
7230932|NCT00098306|11439293|FG006|Open Label|Lack of Efficacy|0
7230933|NCT00098306|11439287|FG000|Open Label|Adverse Event|0
7230934|NCT00098306|11439288|FG001|Open Label|Adverse Event|0
7230935|NCT00098306|11439289|FG002|Open Label|Adverse Event|0
7230936|NCT00098306|11439290|FG003|Open Label|Adverse Event|2
7230937|NCT00098306|11439291|FG004|Open Label|Adverse Event|0
7230938|NCT00098306|11439292|FG005|Open Label|Adverse Event|0
7230939|NCT00098306|11439293|FG006|Open Label|Adverse Event|0
7230940|NCT00098306|11439287|FG000|Open Label|Death|0
7230941|NCT00098306|11439288|FG001|Open Label|Death|0
7230942|NCT00098306|11439289|FG002|Open Label|Death|0
7230943|NCT00098306|11439290|FG003|Open Label|Death|4
7230944|NCT00098306|11439291|FG004|Open Label|Death|0
7230945|NCT00098306|11439292|FG005|Open Label|Death|0
7230946|NCT00098306|11439293|FG006|Open Label|Death|0
7230947|NCT00098306|11439287|FG000|Open Label|Participant defaulted|0
7230948|NCT00098306|11439288|FG001|Open Label|Participant defaulted|0
7230949|NCT00098306|11439289|FG002|Open Label|Participant defaulted|0
7230950|NCT00098306|11439290|FG003|Open Label|Participant defaulted|24
7230951|NCT00098306|11439291|FG004|Open Label|Participant defaulted|0
7230952|NCT00098306|11439292|FG005|Open Label|Participant defaulted|0
7230953|NCT00098306|11439293|FG006|Open Label|Participant defaulted|0
7230954|NCT00098306|11439287|FG000|Open Label|Un-specified|0
7230955|NCT00098306|11439288|FG001|Open Label|Un-specified|0
7230956|NCT00098306|11439289|FG002|Open Label|Un-specified|0
7230957|NCT00098306|11439290|FG003|Open Label|Un-specified|15
7230958|NCT00098306|11439291|FG004|Open Label|Un-specified|0
7230959|NCT00098306|11439292|FG005|Open Label|Un-specified|0
7230960|NCT00098306|11439293|FG006|Open Label|Un-specified|0
7230961|NCT00098306|11439287|FG000|Open Label|Ongoing at cut-off date|0
7230962|NCT00098306|11439288|FG001|Open Label|Ongoing at cut-off date|0
7230963|NCT00098306|11439289|FG002|Open Label|Ongoing at cut-off date|0
7230964|NCT00098306|11439290|FG003|Open Label|Ongoing at cut-off date|269
7230965|NCT00098306|11439291|FG004|Open Label|Ongoing at cut-off date|62
7230966|NCT00098306|11439292|FG005|Open Label|Ongoing at cut-off date|0
7230967|NCT00098306|11439293|FG006|Open Label|Ongoing at cut-off date|0
7230968|NCT00098306|11439287|FG000|Observational Phase|Death|0
7230969|NCT00098306|11439288|FG001|Observational Phase|Death|0
7230970|NCT00098306|11439289|FG002|Observational Phase|Death|0
7230971|NCT00098306|11439290|FG003|Observational Phase|Death|0
7230972|NCT00098306|11439291|FG004|Observational Phase|Death|0
7230973|NCT00098306|11439292|FG005|Observational Phase|Death|5
7230974|NCT00098306|11439293|FG006|Observational Phase|Death|4
7230975|NCT00098306|11439287|FG000|Observational Phase|Participant defaulted|0
7230976|NCT00098306|11439288|FG001|Observational Phase|Participant defaulted|0
7230977|NCT00098306|11439289|FG002|Observational Phase|Participant defaulted|0
7230978|NCT00098306|11439290|FG003|Observational Phase|Participant defaulted|0
7230979|NCT00098306|11439291|FG004|Observational Phase|Participant defaulted|0
7230980|NCT00098306|11439292|FG005|Observational Phase|Participant defaulted|34
7230981|NCT00098306|11439293|FG006|Observational Phase|Participant defaulted|18
7230982|NCT00098306|11439287|FG000|Observational Phase|Un-specified|0
7230983|NCT00098306|11439288|FG001|Observational Phase|Un-specified|0
7230984|NCT00098306|11439289|FG002|Observational Phase|Un-specified|0
7230985|NCT00098306|11439290|FG003|Observational Phase|Un-specified|0
7230986|NCT00098306|11439291|FG004|Observational Phase|Un-specified|0
7230987|NCT00098306|11439292|FG005|Observational Phase|Un-specified|7
7230988|NCT00098306|11439293|FG006|Observational Phase|Un-specified|4
7230989|NCT00098345|11439306|FG000|Overall Study|Adverse Event|7
7230990|NCT00098345|11439306|FG000|Overall Study|Withdrawal by Subject|2
7230991|NCT00098345|11439306|FG000|Overall Study|progression|4
7230992|NCT00098722|11439333|FG000|Double Blind Phase|Adverse Event|7
7230993|NCT00098722|11439334|FG001|Double Blind Phase|Adverse Event|7
7230994|NCT00098722|11439335|FG002|Double Blind Phase|Adverse Event|3
7230995|NCT00098722|11439336|FG003|Double Blind Phase|Adverse Event|0
7230996|NCT00098722|11439337|FG004|Double Blind Phase|Adverse Event|0
7230997|NCT00098722|11439338|FG005|Double Blind Phase|Adverse Event|0
7230998|NCT00098722|11439339|FG006|Double Blind Phase|Adverse Event|0
7230999|NCT00098722|11439333|FG000|Double Blind Phase|Death|2
7231000|NCT00098722|11439334|FG001|Double Blind Phase|Death|5
7231001|NCT00098722|11439335|FG002|Double Blind Phase|Death|0
7231002|NCT00098722|11439336|FG003|Double Blind Phase|Death|0
7231003|NCT00098722|11439337|FG004|Double Blind Phase|Death|0
7231004|NCT00098722|11439338|FG005|Double Blind Phase|Death|0
7231005|NCT00098722|11439339|FG006|Double Blind Phase|Death|0
7231006|NCT00098722|11439333|FG000|Double Blind Phase|Lack of Efficacy|21
7231007|NCT00098722|11439334|FG001|Double Blind Phase|Lack of Efficacy|23
7231008|NCT00098722|11439335|FG002|Double Blind Phase|Lack of Efficacy|15
7231009|NCT00098722|11439336|FG003|Double Blind Phase|Lack of Efficacy|0
7231010|NCT00098722|11439337|FG004|Double Blind Phase|Lack of Efficacy|0
7231011|NCT00098722|11439338|FG005|Double Blind Phase|Lack of Efficacy|0
7231012|NCT00098722|11439339|FG006|Double Blind Phase|Lack of Efficacy|0
7231013|NCT00098722|11439333|FG000|Double Blind Phase|Participant defaulted|16
7231014|NCT00098722|11439334|FG001|Double Blind Phase|Participant defaulted|11
7231015|NCT00098722|11439335|FG002|Double Blind Phase|Participant defaulted|9
7231016|NCT00098722|11439336|FG003|Double Blind Phase|Participant defaulted|0
7231017|NCT00098722|11439337|FG004|Double Blind Phase|Participant defaulted|0
7231018|NCT00098722|11439338|FG005|Double Blind Phase|Participant defaulted|0
7231019|NCT00098722|11439339|FG006|Double Blind Phase|Participant defaulted|0
7231020|NCT00098722|11439333|FG000|Double Blind Phase|Pregnancy|1
7231021|NCT00098722|11439334|FG001|Double Blind Phase|Pregnancy|0
7231022|NCT00098722|11439335|FG002|Double Blind Phase|Pregnancy|0
7231023|NCT00098722|11439336|FG003|Double Blind Phase|Pregnancy|0
7231024|NCT00098722|11439337|FG004|Double Blind Phase|Pregnancy|0
7231025|NCT00098722|11439338|FG005|Double Blind Phase|Pregnancy|0
7231026|NCT00098722|11439339|FG006|Double Blind Phase|Pregnancy|0
7231027|NCT00098722|11439333|FG000|Double Blind Phase|Randomized, not treated|4
7231028|NCT00098722|11439334|FG001|Double Blind Phase|Randomized, not treated|3
7231029|NCT00098722|11439335|FG002|Double Blind Phase|Randomized, not treated|3
7231030|NCT00098722|11439336|FG003|Double Blind Phase|Randomized, not treated|0
7231031|NCT00098722|11439337|FG004|Double Blind Phase|Randomized, not treated|0
7231032|NCT00098722|11439338|FG005|Double Blind Phase|Randomized, not treated|0
7231033|NCT00098722|11439339|FG006|Double Blind Phase|Randomized, not treated|0
7231034|NCT00098722|11439333|FG000|Double Blind Phase|Ongoing at cut-off date|128
7231035|NCT00098722|11439334|FG001|Double Blind Phase|Ongoing at cut-off date|137
7231036|NCT00098722|11439335|FG002|Double Blind Phase|Ongoing at cut-off date|57
7231037|NCT00098722|11439336|FG003|Double Blind Phase|Ongoing at cut-off date|0
7231038|NCT00098722|11439337|FG004|Double Blind Phase|Ongoing at cut-off date|0
7231039|NCT00098722|11439338|FG005|Double Blind Phase|Ongoing at cut-off date|0
7231040|NCT00098722|11439339|FG006|Double Blind Phase|Ongoing at cut-off date|0
7231041|NCT00098722|11439333|FG000|Double Blind Phase|Other|7
7231042|NCT00098722|11439334|FG001|Double Blind Phase|Other|8
7231043|NCT00098722|11439335|FG002|Double Blind Phase|Other|7
7231044|NCT00098722|11439336|FG003|Double Blind Phase|Other|0
7231045|NCT00098722|11439337|FG004|Double Blind Phase|Other|0
7231046|NCT00098722|11439338|FG005|Double Blind Phase|Other|0
7231047|NCT00098722|11439339|FG006|Double Blind Phase|Other|0
7231048|NCT00098722|11439333|FG000|Open Label Phase|Adverse Event|0
7231049|NCT00098722|11439334|FG001|Open Label Phase|Adverse Event|0
7231050|NCT00098722|11439335|FG002|Open Label Phase|Adverse Event|0
7231051|NCT00098722|11439336|FG003|Open Label Phase|Adverse Event|5
7231052|NCT00098722|11439337|FG004|Open Label Phase|Adverse Event|0
7231053|NCT00098722|11439338|FG005|Open Label Phase|Adverse Event|0
7231054|NCT00098722|11439339|FG006|Open Label Phase|Adverse Event|0
7231055|NCT00098722|11439333|FG000|Open Label Phase|Death|0
7231056|NCT00098722|11439334|FG001|Open Label Phase|Death|0
7231057|NCT00098722|11439335|FG002|Open Label Phase|Death|0
7231058|NCT00098722|11439336|FG003|Open Label Phase|Death|2
7231059|NCT00098722|11439337|FG004|Open Label Phase|Death|0
7231060|NCT00098722|11439338|FG005|Open Label Phase|Death|0
7231061|NCT00098722|11439339|FG006|Open Label Phase|Death|0
7231062|NCT00098722|11439333|FG000|Open Label Phase|Lack of Efficacy|0
7231063|NCT00098722|11439334|FG001|Open Label Phase|Lack of Efficacy|0
7231064|NCT00098722|11439335|FG002|Open Label Phase|Lack of Efficacy|0
7231065|NCT00098722|11439336|FG003|Open Label Phase|Lack of Efficacy|8
7231066|NCT00098722|11439337|FG004|Open Label Phase|Lack of Efficacy|0
7231067|NCT00098722|11439338|FG005|Open Label Phase|Lack of Efficacy|0
7231068|NCT00098722|11439339|FG006|Open Label Phase|Lack of Efficacy|0
7231069|NCT00098722|11439333|FG000|Open Label Phase|Pregnancy|0
7231070|NCT00098722|11439334|FG001|Open Label Phase|Pregnancy|0
7231071|NCT00098722|11439335|FG002|Open Label Phase|Pregnancy|0
7231072|NCT00098722|11439336|FG003|Open Label Phase|Pregnancy|1
7231073|NCT00098722|11439337|FG004|Open Label Phase|Pregnancy|0
7231074|NCT00098722|11439338|FG005|Open Label Phase|Pregnancy|0
7231075|NCT00098722|11439339|FG006|Open Label Phase|Pregnancy|0
7231076|NCT00098722|11439333|FG000|Open Label Phase|Participant defaulted|0
7231077|NCT00098722|11439334|FG001|Open Label Phase|Participant defaulted|0
7231078|NCT00098722|11439335|FG002|Open Label Phase|Participant defaulted|0
7231079|NCT00098722|11439336|FG003|Open Label Phase|Participant defaulted|18
7231080|NCT00098722|11439337|FG004|Open Label Phase|Participant defaulted|0
7231081|NCT00098722|11439338|FG005|Open Label Phase|Participant defaulted|0
7231082|NCT00098722|11439339|FG006|Open Label Phase|Participant defaulted|0
7231083|NCT00098722|11439333|FG000|Open Label Phase|Ongoing at cut-off date|0
7231084|NCT00098722|11439334|FG001|Open Label Phase|Ongoing at cut-off date|0
7231085|NCT00098722|11439335|FG002|Open Label Phase|Ongoing at cut-off date|0
7231086|NCT00098722|11439336|FG003|Open Label Phase|Ongoing at cut-off date|220
7231087|NCT00098722|11439337|FG004|Open Label Phase|Ongoing at cut-off date|50
7231088|NCT00098722|11439338|FG005|Open Label Phase|Ongoing at cut-off date|0
7231089|NCT00098722|11439339|FG006|Open Label Phase|Ongoing at cut-off date|0
7231090|NCT00098722|11439333|FG000|Open Label Phase|Other|0
7231091|NCT00098722|11439334|FG001|Open Label Phase|Other|0
7231092|NCT00098722|11439335|FG002|Open Label Phase|Other|0
7231093|NCT00098722|11439336|FG003|Open Label Phase|Other|18
7231094|NCT00098722|11439337|FG004|Open Label Phase|Other|0
7231095|NCT00098722|11439338|FG005|Open Label Phase|Other|0
7231096|NCT00098722|11439339|FG006|Open Label Phase|Other|0
7231097|NCT00098722|11439333|FG000|Observation Phase|Death|0
7231098|NCT00098722|11439334|FG001|Observation Phase|Death|0
7231099|NCT00098722|11439335|FG002|Observation Phase|Death|0
7231100|NCT00098722|11439336|FG003|Observation Phase|Death|0
7231101|NCT00098722|11439337|FG004|Observation Phase|Death|0
7231102|NCT00098722|11439338|FG005|Observation Phase|Death|5
7231103|NCT00098722|11439339|FG006|Observation Phase|Death|3
7231104|NCT00098722|11439333|FG000|Observation Phase|Lack of Efficacy|0
7231105|NCT00098722|11439334|FG001|Observation Phase|Lack of Efficacy|0
7231106|NCT00098722|11439335|FG002|Observation Phase|Lack of Efficacy|0
7231107|NCT00098722|11439336|FG003|Observation Phase|Lack of Efficacy|0
7231108|NCT00098722|11439337|FG004|Observation Phase|Lack of Efficacy|0
7231109|NCT00098722|11439338|FG005|Observation Phase|Lack of Efficacy|2
7231110|NCT00098722|11439339|FG006|Observation Phase|Lack of Efficacy|0
7231111|NCT00098722|11439333|FG000|Observation Phase|Participant defaulted|0
7231112|NCT00098722|11439334|FG001|Observation Phase|Participant defaulted|0
7231113|NCT00098722|11439335|FG002|Observation Phase|Participant defaulted|0
7231114|NCT00098722|11439336|FG003|Observation Phase|Participant defaulted|0
7231115|NCT00098722|11439337|FG004|Observation Phase|Participant defaulted|0
7231116|NCT00098722|11439338|FG005|Observation Phase|Participant defaulted|17
7231117|NCT00098722|11439339|FG006|Observation Phase|Participant defaulted|4
7231118|NCT00098722|11439333|FG000|Observation Phase|Other|0
7231119|NCT00098722|11439334|FG001|Observation Phase|Other|0
7231120|NCT00098722|11439335|FG002|Observation Phase|Other|0
7231121|NCT00098722|11439336|FG003|Observation Phase|Other|0
7231122|NCT00098722|11439337|FG004|Observation Phase|Other|0
7231123|NCT00098722|11439338|FG005|Observation Phase|Other|21
7231124|NCT00098722|11439339|FG006|Observation Phase|Other|10
7231125|NCT00098748|11439354|FG000|Assigned to Study Treatment|Randomized, but not treated|0
7231126|NCT00098748|11439355|FG001|Assigned to Study Treatment|Randomized, but not treated|2
7231127|NCT00098748|11439356|FG002|Assigned to Study Treatment|Randomized, but not treated|2
7573360|NCT03613649|11954535|FG000|Third Treatment|Lost to Follow-up|0
7573361|NCT03613649|11954536|FG001|Third Treatment|Lost to Follow-up|0
7573362|NCT03613649|11954537|FG002|Third Treatment|Lost to Follow-up|0
7231128|NCT00098748|11439354|FG000|Received Study Treatment|Death|2
7231129|NCT00098748|11439355|FG001|Received Study Treatment|Death|1
7231130|NCT00098748|11439356|FG002|Received Study Treatment|Death|2
7231131|NCT00098748|11439354|FG000|Received Study Treatment|Adverse Event|1
7231132|NCT00098748|11439355|FG001|Received Study Treatment|Adverse Event|2
7231133|NCT00098748|11439356|FG002|Received Study Treatment|Adverse Event|5
7231134|NCT00098748|11439354|FG000|Received Study Treatment|Lack of Efficacy|40
7231135|NCT00098748|11439355|FG001|Received Study Treatment|Lack of Efficacy|27
7231136|NCT00098748|11439356|FG002|Received Study Treatment|Lack of Efficacy|27
7231137|NCT00098748|11439354|FG000|Received Study Treatment|Other|2
7231138|NCT00098748|11439355|FG001|Received Study Treatment|Other|2
7231139|NCT00098748|11439356|FG002|Received Study Treatment|Other|6
7231140|NCT00098748|11439354|FG000|Received Study Treatment|Subject defaulted|3
7231141|NCT00098748|11439355|FG001|Received Study Treatment|Subject defaulted|4
7231142|NCT00098748|11439356|FG002|Received Study Treatment|Subject defaulted|4
7231143|NCT00098748|11439354|FG000|Continued on Open-Label Treatment|Adverse Event|0
7231144|NCT00098748|11439355|FG001|Continued on Open-Label Treatment|Adverse Event|1
7231145|NCT00098748|11439356|FG002|Continued on Open-Label Treatment|Adverse Event|0
7231146|NCT00098748|11439354|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
7231147|NCT00098748|11439355|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
7231148|NCT00098748|11439356|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
7231149|NCT00098748|11439354|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
7231150|NCT00098748|11439355|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
7231151|NCT00098748|11439356|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
7231152|NCT00098748|11439354|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
7231153|NCT00098748|11439355|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
7231154|NCT00098748|11439356|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
7231155|NCT00098748|11439354|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
7231156|NCT00098748|11439355|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
7231157|NCT00098748|11439356|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
7231158|NCT00098774|11439364|FG000|Overall Study|Adverse Event|2
7231159|NCT00098774|11439364|FG000|Overall Study|Disease Progression|9
7231160|NCT00098774|11439364|FG000|Overall Study|Withdrawal by Subject|1
7231161|NCT00098774|11439364|FG000|Overall Study|Failed (to respond) during induction|4
7231162|NCT00098774|11439364|FG000|Overall Study|Physician Decision|2
7231163|NCT00098787|11439371|FG000|Overall Study|Never started treatment|3
7231164|NCT00098787|11439372|FG001|Overall Study|Never started treatment|2
7231165|NCT00098787|11439373|FG002|Overall Study|Never started treatment|1
7231166|NCT00098787|11439371|FG000|Overall Study|Ineligible|9
7231167|NCT00098787|11439372|FG001|Overall Study|Ineligible|7
7231168|NCT00098787|11439373|FG002|Overall Study|Ineligible|3
7231169|NCT00098787|11439371|FG000|Overall Study|Disease progression|28
7231170|NCT00098787|11439372|FG001|Overall Study|Disease progression|17
7231171|NCT00098787|11439373|FG002|Overall Study|Disease progression|23
7231172|NCT00098787|11439371|FG000|Overall Study|Adverse Event|8
7231173|NCT00098787|11439372|FG001|Overall Study|Adverse Event|17
7231174|NCT00098787|11439373|FG002|Overall Study|Adverse Event|8
7231175|NCT00098787|11439371|FG000|Overall Study|Death|6
7231176|NCT00098787|11439372|FG001|Overall Study|Death|1
7231177|NCT00098787|11439373|FG002|Overall Study|Death|0
7231178|NCT00098787|11439371|FG000|Overall Study|Withdrawal by Subject|4
7231179|NCT00098787|11439372|FG001|Overall Study|Withdrawal by Subject|12
7231180|NCT00098787|11439373|FG002|Overall Study|Withdrawal by Subject|6
7231181|NCT00098787|11439371|FG000|Overall Study|Alternative therapy|8
7231182|NCT00098787|11439372|FG001|Overall Study|Alternative therapy|13
7231183|NCT00098787|11439373|FG002|Overall Study|Alternative therapy|13
7231184|NCT00098787|11439371|FG000|Overall Study|Other|7
7231185|NCT00098787|11439372|FG001|Overall Study|Other|6
7231186|NCT00098787|11439373|FG002|Overall Study|Other|9
7231187|NCT00098813|11439381|FG000|Overall Study|Death|8
7231188|NCT00098813|11439381|FG000|Overall Study|Protocol Violation|1
7231189|NCT00098813|11439381|FG000|Overall Study|Withdrawal by Subject|7
7231190|NCT00098813|11439381|FG000|Overall Study|Progression of Disease|1
7231191|NCT00098813|11439381|FG000|Overall Study|Other complicating disease|1
7231192|NCT00098813|11439381|FG000|Overall Study|Reversal of RAI resistance|1
7231193|NCT00098839|11439387|FG000|Overall Study|Adverse Event|5
7231194|NCT00098839|11439388|FG001|Overall Study|Adverse Event|2
7231195|NCT00098839|11439387|FG000|Overall Study|Death|1
7231196|NCT00098839|11439388|FG001|Overall Study|Death|2
7231197|NCT00098839|11439387|FG000|Overall Study|Physician Decision|4
7231198|NCT00098839|11439388|FG001|Overall Study|Physician Decision|14
7231199|NCT00098839|11439387|FG000|Overall Study|Withdrawal by Subject|1
7231200|NCT00098839|11439388|FG001|Overall Study|Withdrawal by Subject|0
7231201|NCT00098839|11439387|FG000|Overall Study|Refusal of further protocol therapy|3
7231202|NCT00098839|11439388|FG001|Overall Study|Refusal of further protocol therapy|1
7231203|NCT00098839|11439387|FG000|Overall Study|Relapse|6
7231204|NCT00098839|11439388|FG001|Overall Study|Relapse|3
7231205|NCT00098839|11439387|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
7231206|NCT00098839|11439388|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
7231207|NCT00098839|11439387|FG000|Overall Study|Ineligible|2
7231208|NCT00098839|11439388|FG001|Overall Study|Ineligible|0
7231209|NCT00098865|11439395|FG000|Overall Study|Progressive Disease|6
7231210|NCT00098865|11439395|FG000|Overall Study|Adverse Event|2
7231211|NCT00098865|11439395|FG000|Overall Study|Alternative Therapy|1
7231212|NCT00099268|11439418|FG000|Overall Study|Withdrawal by Subject|46
7231213|NCT00099268|11439419|FG001|Overall Study|Withdrawal by Subject|28
7231214|NCT00099268|11439418|FG000|Overall Study|Adverse Event|19
7231215|NCT00099268|11439419|FG001|Overall Study|Adverse Event|19
7231216|NCT00099268|11439418|FG000|Overall Study|Protocol Violation|9
7231217|NCT00099268|11439419|FG001|Overall Study|Protocol Violation|8
7231218|NCT00099268|11439418|FG000|Overall Study|Lost to Follow-up|6
7231219|NCT00099268|11439419|FG001|Overall Study|Lost to Follow-up|4
7231220|NCT00099268|11439418|FG000|Overall Study|Lack of Efficacy|5
7231221|NCT00099268|11439419|FG001|Overall Study|Lack of Efficacy|18
7231222|NCT00099268|11439418|FG000|Overall Study|Administrative problems|4
7231223|NCT00099268|11439419|FG001|Overall Study|Administrative problems|4
7231224|NCT00099268|11439418|FG000|Overall Study|Death|3
7231225|NCT00099268|11439419|FG001|Overall Study|Death|1
7231226|NCT00099359|11439428|FG000|Overall Study|Death|11
7231227|NCT00099359|11439429|FG001|Overall Study|Death|15
7231228|NCT00099359|11439430|FG002|Overall Study|Death|17
7231229|NCT00099359|11439428|FG000|Overall Study|Withdrawal by Subject|19
7231230|NCT00099359|11439429|FG001|Overall Study|Withdrawal by Subject|19
7231231|NCT00099359|11439430|FG002|Overall Study|Withdrawal by Subject|23
7231232|NCT00099359|11439428|FG000|Overall Study|Lost to Follow-up|15
7231233|NCT00099359|11439429|FG001|Overall Study|Lost to Follow-up|24
7231234|NCT00099359|11439430|FG002|Overall Study|Lost to Follow-up|24
7231235|NCT00099359|11439428|FG000|Overall Study|moved out of area|9
7231236|NCT00099359|11439429|FG001|Overall Study|moved out of area|7
7231237|NCT00099359|11439430|FG002|Overall Study|moved out of area|4
7231238|NCT00099632|11439465|FG000|Overall Study|Lost to Follow-up|1
7231239|NCT00099632|11439466|FG001|Overall Study|Lost to Follow-up|0
7231240|NCT00099632|11439467|FG002|Overall Study|Lost to Follow-up|3
7231241|NCT00099632|11439468|FG003|Overall Study|Lost to Follow-up|1
7231242|NCT00099632|11439469|FG004|Overall Study|Lost to Follow-up|1
7231243|NCT00099632|11439470|FG005|Overall Study|Lost to Follow-up|0
7231244|NCT00099632|11439465|FG000|Overall Study|Withdrawal by Subject|0
7231245|NCT00099632|11439466|FG001|Overall Study|Withdrawal by Subject|1
7231246|NCT00099632|11439467|FG002|Overall Study|Withdrawal by Subject|0
7573363|NCT03613649|11954538|FG003|Third Treatment|Lost to Follow-up|0
7573364|NCT03613649|11954539|FG004|Third Treatment|Lost to Follow-up|1
7573365|NCT03613649|11954540|FG005|Third Treatment|Lost to Follow-up|0
7573366|NCT03613649|11954541|FG006|Third Treatment|Lost to Follow-up|0
7231247|NCT00099632|11439468|FG003|Overall Study|Withdrawal by Subject|0
7231248|NCT00099632|11439469|FG004|Overall Study|Withdrawal by Subject|0
7231249|NCT00099632|11439470|FG005|Overall Study|Withdrawal by Subject|1
7231250|NCT00099632|11439465|FG000|Overall Study|Protocol Violation|0
7231251|NCT00099632|11439466|FG001|Overall Study|Protocol Violation|0
7231252|NCT00099632|11439467|FG002|Overall Study|Protocol Violation|0
7231253|NCT00099632|11439468|FG003|Overall Study|Protocol Violation|0
7231254|NCT00099632|11439469|FG004|Overall Study|Protocol Violation|0
7231255|NCT00099632|11439470|FG005|Overall Study|Protocol Violation|1
7231256|NCT00099983|11439486|FG000|Overall Study|Lost to Follow-up|2
7231257|NCT00099983|11439487|FG001|Overall Study|Lost to Follow-up|3
7231258|NCT00099983|11439486|FG000|Overall Study|Missing Source Documents|14
7231259|NCT00099983|11439487|FG001|Overall Study|Missing Source Documents|15
7231260|NCT00099983|11439486|FG000|Overall Study|Withdrawal by Subject|3
7231261|NCT00099983|11439487|FG001|Overall Study|Withdrawal by Subject|2
7231262|NCT00099983|11439486|FG000|Overall Study|Adverse Event|1
7231263|NCT00099983|11439487|FG001|Overall Study|Adverse Event|1
7231264|NCT00099983|11439486|FG000|Overall Study|Lack of Efficacy|0
7231265|NCT00099983|11439487|FG001|Overall Study|Lack of Efficacy|1
7231266|NCT00099983|11439486|FG000|Overall Study|Unable to return for appointments|1
7231267|NCT00099983|11439487|FG001|Overall Study|Unable to return for appointments|1
7231268|NCT00099983|11439486|FG000|Overall Study|Moved|1
7231269|NCT00099983|11439487|FG001|Overall Study|Moved|0
7231270|NCT00099983|11439486|FG000|Overall Study|Other psychiatric problem|1
7231271|NCT00099983|11439487|FG001|Overall Study|Other psychiatric problem|0
7231272|NCT00099983|11439486|FG000|Overall Study|Incarcerated|0
7231273|NCT00099983|11439487|FG001|Overall Study|Incarcerated|1
7231274|NCT00099983|11439486|FG000|Overall Study|Intolerant of burden of visits|0
7231275|NCT00099983|11439487|FG001|Overall Study|Intolerant of burden of visits|1
7231276|NCT00099983|11439486|FG000|Overall Study|Other issue|1
7231277|NCT00099983|11439487|FG001|Overall Study|Other issue|0
7231278|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
7573367|NCT03613649|11954542|FG007|Third Treatment|Lost to Follow-up|0
7573368|NCT03613649|11954543|FG008|Third Treatment|Lost to Follow-up|0
7231279|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
7231280|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
7464899|NCT01876251|11763777|FG000|Overall Study|Clinical progression|1
7464900|NCT01876251|11763778|FG001|Overall Study|Clinical progression|0
7464901|NCT01876251|11763779|FG002|Overall Study|Clinical progression|0
7464902|NCT01876251|11763777|FG000|Overall Study|Death|2
7464903|NCT01876251|11763778|FG001|Overall Study|Death|0
7464904|NCT01876251|11763779|FG002|Overall Study|Death|1
7464905|NCT01876251|11763777|FG000|Overall Study|Participant started new treatment|1
7231281|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
7231282|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
7231283|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
7231284|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7231285|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7231286|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
7231287|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7231288|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
7231289|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
7231290|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
7231291|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
7231292|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7231293|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7231294|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
7231295|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
7231296|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7231297|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
7231298|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7231299|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
7231300|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
7231301|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
7231302|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
7231303|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7231304|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
7231305|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
7231306|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
7231307|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
7231308|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
7231309|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
7231310|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
7231311|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
7231312|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
7231313|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
7231314|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7231315|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
7231316|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7231317|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7231318|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
7231319|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
7231320|NCT00100048|11439498|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7231321|NCT00100048|11439499|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7231322|NCT00100048|11439500|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7231323|NCT00100048|11439501|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
7231324|NCT00100048|11439502|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7231325|NCT00100048|11439503|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
7231326|NCT00100178|11439547|FG000|Overall Study|Lost to Follow-up|0
7231327|NCT00100178|11439548|FG001|Overall Study|Lost to Follow-up|6
7231328|NCT00100178|11439549|FG002|Overall Study|Lost to Follow-up|5
7231329|NCT00100178|11439547|FG000|Overall Study|Adverse Event|2
7231330|NCT00100178|11439548|FG001|Overall Study|Adverse Event|2
7231331|NCT00100178|11439549|FG002|Overall Study|Adverse Event|1
7231332|NCT00100178|11439547|FG000|Overall Study|Withdrawal by Subject|1
7231333|NCT00100178|11439548|FG001|Overall Study|Withdrawal by Subject|1
7231334|NCT00100178|11439549|FG002|Overall Study|Withdrawal by Subject|1
7231335|NCT00100178|11439547|FG000|Overall Study|Physician Decision|6
7231336|NCT00100178|11439548|FG001|Overall Study|Physician Decision|1
7231337|NCT00100178|11439549|FG002|Overall Study|Physician Decision|3
7231338|NCT00100789|11439588|FG000|Overall Study|Adverse Event|10
7231339|NCT00100789|11439588|FG000|Overall Study|Withdrawal by Subject|1
7231340|NCT00100789|11439588|FG000|Overall Study|Progression/relapse|42
7231341|NCT00100789|11439588|FG000|Overall Study|Death|2
7231342|NCT00100789|11439588|FG000|Overall Study|Not protocol specified|5
7464906|NCT01876251|11763778|FG001|Overall Study|Participant started new treatment|0
7231343|NCT00100789|11439588|FG000|Overall Study|Ineligible|3
7231344|NCT00100789|11439588|FG000|Overall Study|Never received treatment|1
7231345|NCT00100802|11439593|FG000|Overall Study|Adverse Event|9
7231346|NCT00100802|11439593|FG000|Overall Study|Death|1
7231347|NCT00100802|11439593|FG000|Overall Study|Lack of Efficacy|47
7231348|NCT00100802|11439593|FG000|Overall Study|Physician Decision|5
7231349|NCT00100802|11439593|FG000|Overall Study|Protocol Violation|1
7231350|NCT00100802|11439593|FG000|Overall Study|Withdrawal by Subject|5
7231351|NCT00100802|11439593|FG000|Overall Study|Ineligible|12
7231352|NCT00100815|11439597|FG000|Overall Study|Progression|24
7231353|NCT00100815|11439597|FG000|Overall Study|Adverse Event|18
7231354|NCT00100815|11439597|FG000|Overall Study|Death|4
7231355|NCT00100815|11439597|FG000|Overall Study|Other|3
7231356|NCT00100932|11439607|FG000|Overall Study|Adverse Event|11
7231357|NCT00100932|11439608|FG001|Overall Study|Adverse Event|2
7231358|NCT00100932|11439607|FG000|Overall Study|Withdrawal by Subject|6
7231359|NCT00100932|11439608|FG001|Overall Study|Withdrawal by Subject|0
7231360|NCT00100932|11439607|FG000|Overall Study|Progressive Disease|44
7231361|NCT00100932|11439608|FG001|Overall Study|Progressive Disease|18
7231362|NCT00100932|11439607|FG000|Overall Study|Physician Decision|7
7231363|NCT00100932|11439608|FG001|Overall Study|Physician Decision|5
7231364|NCT00100932|11439607|FG000|Overall Study|Other|5
7231365|NCT00100932|11439608|FG001|Overall Study|Other|2
7231366|NCT00101010|11439614|FG000|Overall Study|Physician Decision|1
7231368|NCT00101166|11439631|FG000|Overall Study|progressive disease|10
7231369|NCT00101192|11439635|FG000|Overall Study|Ineligible|6
7231370|NCT00101192|11439635|FG000|Overall Study|Inevaluable|1
7231371|NCT00101283|11439641|FG000|Overall Study|Withdrawal by Subject|0
7231372|NCT00101283|11439642|FG001|Overall Study|Withdrawal by Subject|1
7231373|NCT00101283|11439641|FG000|Overall Study|Insurance Refusal|0
7231374|NCT00101283|11439642|FG001|Overall Study|Insurance Refusal|1
7231375|NCT00101283|11439641|FG000|Overall Study|Prostate Cancer Recurrence|0
7231376|NCT00101283|11439642|FG001|Overall Study|Prostate Cancer Recurrence|1
7231377|NCT00101400|11439657|FG000|Survival Follow-Up|Alive|7
7231378|NCT00101452|11439668|FG000|Overall Study|Adverse Event|2
7231379|NCT00101452|11439669|FG001|Overall Study|Adverse Event|0
7231380|NCT00101452|11439670|FG002|Overall Study|Adverse Event|1
7231381|NCT00101452|11439668|FG000|Overall Study|Lost to Follow-up|13
7231382|NCT00101452|11439669|FG001|Overall Study|Lost to Follow-up|8
7231383|NCT00101452|11439670|FG002|Overall Study|Lost to Follow-up|14
7231384|NCT00101452|11439668|FG000|Overall Study|Withdrawal by Subject|10
7231385|NCT00101452|11439669|FG001|Overall Study|Withdrawal by Subject|14
7231386|NCT00101452|11439670|FG002|Overall Study|Withdrawal by Subject|9
7231387|NCT00101452|11439668|FG000|Overall Study|Baseline Fail|2
7231388|NCT00101452|11439669|FG001|Overall Study|Baseline Fail|1
7231389|NCT00101452|11439670|FG002|Overall Study|Baseline Fail|2
7231390|NCT00101452|11439668|FG000|Overall Study|Physician Decision|0
7231391|NCT00101452|11439669|FG001|Overall Study|Physician Decision|3
7231392|NCT00101452|11439670|FG002|Overall Study|Physician Decision|2
7231393|NCT00101452|11439668|FG000|Overall Study|Protocol Violation|2
7231394|NCT00101452|11439669|FG001|Overall Study|Protocol Violation|1
7231395|NCT00101452|11439670|FG002|Overall Study|Protocol Violation|3
7231396|NCT00101452|11439668|FG000|Overall Study|Other|15
7231397|NCT00101452|11439669|FG001|Overall Study|Other|16
7231398|NCT00101452|11439670|FG002|Overall Study|Other|12
7231399|NCT00101582|11439684|FG000|Overall Study|Ineligibility determined|0
7231400|NCT00101582|11439685|FG001|Overall Study|Ineligibility determined|1
7231401|NCT00101582|11439684|FG000|Overall Study|Adverse Event|1
7231402|NCT00101582|11439685|FG001|Overall Study|Adverse Event|4
7231403|NCT00101582|11439684|FG000|Overall Study|Withdrawal by Subject|6
7231404|NCT00101582|11439685|FG001|Overall Study|Withdrawal by Subject|4
7231405|NCT00101582|11439684|FG000|Overall Study|Physician Decision|1
7231406|NCT00101582|11439685|FG001|Overall Study|Physician Decision|0
7231407|NCT00101582|11439684|FG000|Overall Study|Death|3
7231408|NCT00101582|11439685|FG001|Overall Study|Death|5
7231409|NCT00101582|11439684|FG000|Overall Study|Other|0
7231410|NCT00101582|11439685|FG001|Overall Study|Other|1
7231411|NCT00101686|11439735|FG000|Overall Study|Progressive Disease|37
7231412|NCT00101686|11439736|FG001|Overall Study|Progressive Disease|28
7231413|NCT00101686|11439737|FG002|Overall Study|Progressive Disease|37
7231414|NCT00101686|11439738|FG003|Overall Study|Progressive Disease|38
7231415|NCT00101686|11439739|FG004|Overall Study|Progressive Disease|28
7231416|NCT00101686|11439740|FG005|Overall Study|Progressive Disease|25
7231417|NCT00101686|11439741|FG006|Overall Study|Progressive Disease|5
7231418|NCT00101686|11439742|FG007|Overall Study|Progressive Disease|7
7231419|NCT00101686|11439743|FG008|Overall Study|Progressive Disease|10
7231420|NCT00101686|11439744|FG009|Overall Study|Progressive Disease|8
7231421|NCT00101686|11439735|FG000|Overall Study|initiation other anti-cancer treatment|4
7231422|NCT00101686|11439736|FG001|Overall Study|initiation other anti-cancer treatment|3
7231423|NCT00101686|11439737|FG002|Overall Study|initiation other anti-cancer treatment|4
7231424|NCT00101686|11439738|FG003|Overall Study|initiation other anti-cancer treatment|3
7231425|NCT00101686|11439739|FG004|Overall Study|initiation other anti-cancer treatment|1
7231426|NCT00101686|11439740|FG005|Overall Study|initiation other anti-cancer treatment|1
7231427|NCT00101686|11439741|FG006|Overall Study|initiation other anti-cancer treatment|2
7231428|NCT00101686|11439742|FG007|Overall Study|initiation other anti-cancer treatment|2
7231429|NCT00101686|11439743|FG008|Overall Study|initiation other anti-cancer treatment|3
7231430|NCT00101686|11439744|FG009|Overall Study|initiation other anti-cancer treatment|3
7231431|NCT00101686|11439735|FG000|Overall Study|>3 week delay treatment due toxicity|6
7231432|NCT00101686|11439736|FG001|Overall Study|>3 week delay treatment due toxicity|2
7231433|NCT00101686|11439737|FG002|Overall Study|>3 week delay treatment due toxicity|1
7231434|NCT00101686|11439738|FG003|Overall Study|>3 week delay treatment due toxicity|2
7231435|NCT00101686|11439739|FG004|Overall Study|>3 week delay treatment due toxicity|7
7231436|NCT00101686|11439740|FG005|Overall Study|>3 week delay treatment due toxicity|3
7231437|NCT00101686|11439741|FG006|Overall Study|>3 week delay treatment due toxicity|2
7231438|NCT00101686|11439742|FG007|Overall Study|>3 week delay treatment due toxicity|1
7231439|NCT00101686|11439743|FG008|Overall Study|>3 week delay treatment due toxicity|3
7231440|NCT00101686|11439744|FG009|Overall Study|>3 week delay treatment due toxicity|0
7231441|NCT00101686|11439735|FG000|Overall Study|unacceptable toxicity|3
7231442|NCT00101686|11439736|FG001|Overall Study|unacceptable toxicity|9
7231443|NCT00101686|11439737|FG002|Overall Study|unacceptable toxicity|10
7231444|NCT00101686|11439738|FG003|Overall Study|unacceptable toxicity|6
7231445|NCT00101686|11439739|FG004|Overall Study|unacceptable toxicity|16
7231446|NCT00101686|11439740|FG005|Overall Study|unacceptable toxicity|10
7231447|NCT00101686|11439741|FG006|Overall Study|unacceptable toxicity|4
7231448|NCT00101686|11439742|FG007|Overall Study|unacceptable toxicity|2
7231449|NCT00101686|11439743|FG008|Overall Study|unacceptable toxicity|1
7231450|NCT00101686|11439744|FG009|Overall Study|unacceptable toxicity|4
7231451|NCT00101686|11439735|FG000|Overall Study|Randomized but did not receive treament|1
7231452|NCT00101686|11439736|FG001|Overall Study|Randomized but did not receive treament|6
7231453|NCT00101686|11439737|FG002|Overall Study|Randomized but did not receive treament|2
7231454|NCT00101686|11439738|FG003|Overall Study|Randomized but did not receive treament|2
7231455|NCT00101686|11439739|FG004|Overall Study|Randomized but did not receive treament|2
7231456|NCT00101686|11439740|FG005|Overall Study|Randomized but did not receive treament|2
7231457|NCT00101686|11439741|FG006|Overall Study|Randomized but did not receive treament|0
7231458|NCT00101686|11439742|FG007|Overall Study|Randomized but did not receive treament|1
7231459|NCT00101686|11439743|FG008|Overall Study|Randomized but did not receive treament|0
7231460|NCT00101686|11439744|FG009|Overall Study|Randomized but did not receive treament|1
7231461|NCT00101686|11439735|FG000|Overall Study|intercurrent non-cancer related illness|0
7231462|NCT00101686|11439736|FG001|Overall Study|intercurrent non-cancer related illness|0
7231463|NCT00101686|11439737|FG002|Overall Study|intercurrent non-cancer related illness|2
7231464|NCT00101686|11439738|FG003|Overall Study|intercurrent non-cancer related illness|0
7231465|NCT00101686|11439739|FG004|Overall Study|intercurrent non-cancer related illness|1
7231466|NCT00101686|11439740|FG005|Overall Study|intercurrent non-cancer related illness|3
7231467|NCT00101686|11439741|FG006|Overall Study|intercurrent non-cancer related illness|1
7231468|NCT00101686|11439742|FG007|Overall Study|intercurrent non-cancer related illness|0
7231469|NCT00101686|11439743|FG008|Overall Study|intercurrent non-cancer related illness|1
7231470|NCT00101686|11439744|FG009|Overall Study|intercurrent non-cancer related illness|1
7231471|NCT00101686|11439735|FG000|Overall Study|Physician Decision|10
7231472|NCT00101686|11439736|FG001|Overall Study|Physician Decision|13
7231473|NCT00101686|11439737|FG002|Overall Study|Physician Decision|6
7231474|NCT00101686|11439738|FG003|Overall Study|Physician Decision|7
7231475|NCT00101686|11439739|FG004|Overall Study|Physician Decision|8
7231476|NCT00101686|11439740|FG005|Overall Study|Physician Decision|9
7231477|NCT00101686|11439741|FG006|Overall Study|Physician Decision|5
7231478|NCT00101686|11439742|FG007|Overall Study|Physician Decision|5
7231479|NCT00101686|11439743|FG008|Overall Study|Physician Decision|1
7231480|NCT00101686|11439744|FG009|Overall Study|Physician Decision|1
7231481|NCT00101686|11439735|FG000|Overall Study|Other|1
7231482|NCT00101686|11439736|FG001|Overall Study|Other|4
7231483|NCT00101686|11439737|FG002|Overall Study|Other|1
7231484|NCT00101686|11439738|FG003|Overall Study|Other|6
7231485|NCT00101686|11439739|FG004|Overall Study|Other|2
7231486|NCT00101686|11439740|FG005|Overall Study|Other|12
7231487|NCT00101686|11439741|FG006|Overall Study|Other|1
7231488|NCT00101686|11439742|FG007|Overall Study|Other|5
7231489|NCT00101686|11439743|FG008|Overall Study|Other|3
7231490|NCT00101686|11439744|FG009|Overall Study|Other|3
7231491|NCT00101686|11439735|FG000|Overall Study|Withdrawal by Subject|9
7231492|NCT00101686|11439736|FG001|Overall Study|Withdrawal by Subject|8
7231493|NCT00101686|11439737|FG002|Overall Study|Withdrawal by Subject|6
7231494|NCT00101686|11439738|FG003|Overall Study|Withdrawal by Subject|8
7231495|NCT00101686|11439739|FG004|Overall Study|Withdrawal by Subject|8
7231496|NCT00101686|11439740|FG005|Overall Study|Withdrawal by Subject|7
7231497|NCT00101686|11439741|FG006|Overall Study|Withdrawal by Subject|7
7231498|NCT00101686|11439742|FG007|Overall Study|Withdrawal by Subject|7
7231499|NCT00101686|11439743|FG008|Overall Study|Withdrawal by Subject|8
7231500|NCT00101686|11439744|FG009|Overall Study|Withdrawal by Subject|9
7231501|NCT00101868|11439780|FG000|Overall Study|Death|10
7231502|NCT00101868|11439781|FG001|Overall Study|Death|10
7231503|NCT00101868|11439780|FG000|Overall Study|Withdrawal by Subject|8
7231504|NCT00101868|11439781|FG001|Overall Study|Withdrawal by Subject|9
7231505|NCT00101868|11439780|FG000|Overall Study|Protocol Violation|3
7231506|NCT00101868|11439781|FG001|Overall Study|Protocol Violation|0
7231507|NCT00101868|11439780|FG000|Overall Study|Lost to Follow-up|8
7231508|NCT00101868|11439781|FG001|Overall Study|Lost to Follow-up|13
7231509|NCT00101907|11439795|FG000|Overall Study|Adverse Event|1
7231510|NCT00101907|11439796|FG001|Overall Study|Adverse Event|0
7231511|NCT00101907|11439797|FG002|Overall Study|Adverse Event|0
7231512|NCT00101907|11439798|FG003|Overall Study|Adverse Event|0
7231513|NCT00101907|11439799|FG004|Overall Study|Adverse Event|0
7231514|NCT00101907|11439800|FG005|Overall Study|Adverse Event|0
7231515|NCT00101907|11439795|FG000|Overall Study|Death|0
7231516|NCT00101907|11439796|FG001|Overall Study|Death|1
7231517|NCT00101907|11439797|FG002|Overall Study|Death|0
7231518|NCT00101907|11439798|FG003|Overall Study|Death|0
7231519|NCT00101907|11439799|FG004|Overall Study|Death|3
7231520|NCT00101907|11439800|FG005|Overall Study|Death|0
7231521|NCT00101907|11439795|FG000|Overall Study|Physician Decision|0
7231522|NCT00101907|11439796|FG001|Overall Study|Physician Decision|0
7231523|NCT00101907|11439797|FG002|Overall Study|Physician Decision|0
7231524|NCT00101907|11439798|FG003|Overall Study|Physician Decision|1
7231525|NCT00101907|11439799|FG004|Overall Study|Physician Decision|1
7231526|NCT00101907|11439800|FG005|Overall Study|Physician Decision|0
7231527|NCT00101907|11439795|FG000|Overall Study|Withdrawal by Subject|1
7231528|NCT00101907|11439796|FG001|Overall Study|Withdrawal by Subject|0
7231529|NCT00101907|11439797|FG002|Overall Study|Withdrawal by Subject|1
7231530|NCT00101907|11439798|FG003|Overall Study|Withdrawal by Subject|0
7231531|NCT00101907|11439799|FG004|Overall Study|Withdrawal by Subject|1
7231532|NCT00101907|11439800|FG005|Overall Study|Withdrawal by Subject|0
7231533|NCT00102063|11439834|FG000|Overall Study|Lack of Efficacy|5
7231534|NCT00102063|11439835|FG001|Overall Study|Lack of Efficacy|1
7231535|NCT00102063|11439836|FG002|Overall Study|Lack of Efficacy|1
7231536|NCT00102063|11439834|FG000|Overall Study|Adverse Event|7
7231537|NCT00102063|11439835|FG001|Overall Study|Adverse Event|4
7231538|NCT00102063|11439836|FG002|Overall Study|Adverse Event|2
7231539|NCT00102063|11439834|FG000|Overall Study|Withdrawal by Subject|4
7231540|NCT00102063|11439835|FG001|Overall Study|Withdrawal by Subject|12
7231541|NCT00102063|11439836|FG002|Overall Study|Withdrawal by Subject|5
7231542|NCT00102063|11439834|FG000|Overall Study|Lost to Follow-up|0
7231543|NCT00102063|11439835|FG001|Overall Study|Lost to Follow-up|0
7231544|NCT00102063|11439836|FG002|Overall Study|Lost to Follow-up|1
7231545|NCT00102063|11439834|FG000|Overall Study|Protocol Violation|0
7231546|NCT00102063|11439835|FG001|Overall Study|Protocol Violation|1
7231547|NCT00102063|11439836|FG002|Overall Study|Protocol Violation|1
7231548|NCT00102440|11439847|FG000|Overall Study|Lost to Follow-up|25
7231549|NCT00102440|11439848|FG001|Overall Study|Lost to Follow-up|18
7231550|NCT00102440|11439849|FG002|Overall Study|Lost to Follow-up|21
7231551|NCT00102440|11439847|FG000|Overall Study|Adverse Event|16
7231552|NCT00102440|11439848|FG001|Overall Study|Adverse Event|23
7231553|NCT00102440|11439849|FG002|Overall Study|Adverse Event|8
7231554|NCT00102440|11439847|FG000|Overall Study|Gout Flare|10
7231555|NCT00102440|11439848|FG001|Overall Study|Gout Flare|28
7231556|NCT00102440|11439849|FG002|Overall Study|Gout Flare|9
7231557|NCT00102440|11439847|FG000|Overall Study|Personal Reason(s)|19
7231558|NCT00102440|11439848|FG001|Overall Study|Personal Reason(s)|13
7231559|NCT00102440|11439849|FG002|Overall Study|Personal Reason(s)|13
7231560|NCT00102440|11439847|FG000|Overall Study|Other|11
7231561|NCT00102440|11439848|FG001|Overall Study|Other|14
7231562|NCT00102440|11439849|FG002|Overall Study|Other|14
7231563|NCT00102440|11439847|FG000|Overall Study|Protocol Violation|7
7231564|NCT00102440|11439848|FG001|Overall Study|Protocol Violation|2
7231565|NCT00102440|11439849|FG002|Overall Study|Protocol Violation|1
7231566|NCT00102531|11439863|FG000|Overall Study|Adverse Event|0
7231567|NCT00102531|11439864|FG001|Overall Study|Adverse Event|1
7231568|NCT00102531|11439863|FG000|Overall Study|Disease Progression|5
7231569|NCT00102531|11439864|FG001|Overall Study|Disease Progression|9
7231570|NCT00102531|11439863|FG000|Overall Study|Physician Decision|0
7231571|NCT00102531|11439864|FG001|Overall Study|Physician Decision|1
7231572|NCT00102596|11439870|FG000|Part A|Screen failures|6
7231573|NCT00102596|11439871|FG001|Part A|Screen failures|0
7231574|NCT00102596|11439870|FG000|Part A|Adverse Event|1
7231575|NCT00102596|11439871|FG001|Part A|Adverse Event|0
7231576|NCT00102687|11439881|FG000|Initial Period|Withdrawal by Subject|6
7231577|NCT00102687|11439882|FG001|Initial Period|Withdrawal by Subject|3
7231578|NCT00102687|11439883|FG002|Initial Period|Withdrawal by Subject|5
7231579|NCT00102687|11439884|FG003|Initial Period|Withdrawal by Subject|0
7231580|NCT00102687|11439885|FG004|Initial Period|Withdrawal by Subject|0
7231581|NCT00102687|11439881|FG000|Initial Period|Adverse Event|4
7231582|NCT00102687|11439882|FG001|Initial Period|Adverse Event|7
7231583|NCT00102687|11439883|FG002|Initial Period|Adverse Event|9
7231584|NCT00102687|11439884|FG003|Initial Period|Adverse Event|0
7231585|NCT00102687|11439885|FG004|Initial Period|Adverse Event|0
7231586|NCT00102687|11439881|FG000|Initial Period|Transformation to AML (blast > 30%)|1
7231587|NCT00102687|11439882|FG001|Initial Period|Transformation to AML (blast > 30%)|3
7231588|NCT00102687|11439883|FG002|Initial Period|Transformation to AML (blast > 30%)|0
7231589|NCT00102687|11439884|FG003|Initial Period|Transformation to AML (blast > 30%)|0
7231590|NCT00102687|11439885|FG004|Initial Period|Transformation to AML (blast > 30%)|0
7231591|NCT00102687|11439881|FG000|Initial Period|Protocol Violation|0
7231592|NCT00102687|11439882|FG001|Initial Period|Protocol Violation|0
7231593|NCT00102687|11439883|FG002|Initial Period|Protocol Violation|2
7231594|NCT00102687|11439884|FG003|Initial Period|Protocol Violation|0
7231595|NCT00102687|11439885|FG004|Initial Period|Protocol Violation|0
7231596|NCT00102687|11439881|FG000|Initial Period|Physician Decision|2
7231597|NCT00102687|11439882|FG001|Initial Period|Physician Decision|9
7231598|NCT00102687|11439883|FG002|Initial Period|Physician Decision|6
7231599|NCT00102687|11439884|FG003|Initial Period|Physician Decision|0
7231600|NCT00102687|11439885|FG004|Initial Period|Physician Decision|0
7231601|NCT00102687|11439881|FG000|Initial Period|Sponsor's decision|0
7231602|NCT00102687|11439882|FG001|Initial Period|Sponsor's decision|1
7231603|NCT00102687|11439883|FG002|Initial Period|Sponsor's decision|1
7231604|NCT00102687|11439884|FG003|Initial Period|Sponsor's decision|0
7231605|NCT00102687|11439885|FG004|Initial Period|Sponsor's decision|0
7231606|NCT00102687|11439881|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
7231607|NCT00102687|11439882|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
7231608|NCT00102687|11439883|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
7231609|NCT00102687|11439884|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
7231610|NCT00102687|11439885|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
7231611|NCT00102687|11439881|FG000|Initial Period|Death|1
7231612|NCT00102687|11439882|FG001|Initial Period|Death|1
7231613|NCT00102687|11439883|FG002|Initial Period|Death|1
7231614|NCT00102687|11439884|FG003|Initial Period|Death|0
7231615|NCT00102687|11439885|FG004|Initial Period|Death|0
7231616|NCT00102687|11439881|FG000|Maintenance Period|Withdrawal by Subject|4
7231617|NCT00102687|11439882|FG001|Maintenance Period|Withdrawal by Subject|0
7231618|NCT00102687|11439883|FG002|Maintenance Period|Withdrawal by Subject|2
7231619|NCT00102687|11439884|FG003|Maintenance Period|Withdrawal by Subject|3
7231620|NCT00102687|11439885|FG004|Maintenance Period|Withdrawal by Subject|1
7231621|NCT00102687|11439881|FG000|Maintenance Period|Adverse Event|1
7231622|NCT00102687|11439882|FG001|Maintenance Period|Adverse Event|0
7231623|NCT00102687|11439883|FG002|Maintenance Period|Adverse Event|0
7231624|NCT00102687|11439884|FG003|Maintenance Period|Adverse Event|1
7231625|NCT00102687|11439885|FG004|Maintenance Period|Adverse Event|3
7231626|NCT00102687|11439881|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
7231627|NCT00102687|11439882|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
7231628|NCT00102687|11439883|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
7231629|NCT00102687|11439884|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
7231630|NCT00102687|11439885|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
7231631|NCT00102687|11439881|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7231632|NCT00102687|11439882|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7231633|NCT00102687|11439883|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
7231634|NCT00102687|11439884|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
7231635|NCT00102687|11439885|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
7231636|NCT00102687|11439881|FG000|Maintenance Period|Death|0
7231637|NCT00102687|11439882|FG001|Maintenance Period|Death|0
7231638|NCT00102687|11439883|FG002|Maintenance Period|Death|0
7231639|NCT00102687|11439884|FG003|Maintenance Period|Death|1
7231640|NCT00102687|11439885|FG004|Maintenance Period|Death|1
7231641|NCT00102687|11439881|FG000|Maintenance Period|Physician Decision|1
7231642|NCT00102687|11439882|FG001|Maintenance Period|Physician Decision|2
7231643|NCT00102687|11439883|FG002|Maintenance Period|Physician Decision|3
7231644|NCT00102687|11439884|FG003|Maintenance Period|Physician Decision|0
7231645|NCT00102687|11439885|FG004|Maintenance Period|Physician Decision|4
7231646|NCT00102804|11439903|FG000|Overall Study|Progressive Disease (PD)|307
7231647|NCT00102804|11439904|FG001|Overall Study|Progressive Disease (PD)|196
7231648|NCT00102804|11439903|FG000|Overall Study|Withdrawal by Subject|46
7231649|NCT00102804|11439904|FG001|Overall Study|Withdrawal by Subject|7
7231650|NCT00102804|11439903|FG000|Overall Study|Adverse Event|37
7231651|NCT00102804|11439904|FG001|Overall Study|Adverse Event|3
7231652|NCT00102804|11439903|FG000|Overall Study|Physician Decision|24
7231653|NCT00102804|11439904|FG001|Overall Study|Physician Decision|6
7231654|NCT00102804|11439903|FG000|Overall Study|Death|5
7231655|NCT00102804|11439904|FG001|Overall Study|Death|6
7231656|NCT00102804|11439903|FG000|Overall Study|Enrollment Criteria Not Met|6
7231657|NCT00102804|11439904|FG001|Overall Study|Enrollment Criteria Not Met|0
7231658|NCT00102804|11439903|FG000|Overall Study|Lost to Follow-up|4
7231659|NCT00102804|11439904|FG001|Overall Study|Lost to Follow-up|1
7231660|NCT00102804|11439903|FG000|Overall Study|Protocol Violation|2
7231661|NCT00102804|11439904|FG001|Overall Study|Protocol Violation|1
7231662|NCT00102804|11439903|FG000|Overall Study|Satisfactory Response|2
7231663|NCT00102804|11439904|FG001|Overall Study|Satisfactory Response|0
7231664|NCT00102804|11439903|FG000|Overall Study|Sponsor Decision|1
7231665|NCT00102804|11439904|FG001|Overall Study|Sponsor Decision|0
7231666|NCT00102804|11439903|FG000|Overall Study|Alive, Receiving Treatment|7
7231667|NCT00102804|11439904|FG001|Overall Study|Alive, Receiving Treatment|2
7231668|NCT00102960|11439913|FG000|Overall Study|Death|23
7231669|NCT00102960|11439914|FG001|Overall Study|Death|11
7231670|NCT00102960|11439915|FG002|Overall Study|Death|11
7231671|NCT00102960|11439913|FG000|Overall Study|Lost to Follow-up|6
7231672|NCT00102960|11439914|FG001|Overall Study|Lost to Follow-up|12
7231673|NCT00102960|11439915|FG002|Overall Study|Lost to Follow-up|16
7231674|NCT00102960|11439913|FG000|Overall Study|Withdrawal by Subject|1
7231675|NCT00102960|11439914|FG001|Overall Study|Withdrawal by Subject|0
7231676|NCT00102960|11439915|FG002|Overall Study|Withdrawal by Subject|1
7231677|NCT00103012|11439930|FG000|Overall Study|Withdrawal by Subject|2
7231678|NCT00103012|11439931|FG001|Overall Study|Withdrawal by Subject|1
7231679|NCT00103012|11439932|FG002|Overall Study|Withdrawal by Subject|2
7231680|NCT00103012|11439930|FG000|Overall Study|Pregnancy|1
7231681|NCT00103012|11439931|FG001|Overall Study|Pregnancy|0
7231682|NCT00103012|11439932|FG002|Overall Study|Pregnancy|0
7231683|NCT00103012|11439930|FG000|Overall Study|Adverse Event|0
7231684|NCT00103012|11439931|FG001|Overall Study|Adverse Event|0
7231685|NCT00103012|11439932|FG002|Overall Study|Adverse Event|1
7231686|NCT00103012|11439930|FG000|Overall Study|Subject non-compliant with medications|0
7231687|NCT00103012|11439931|FG001|Overall Study|Subject non-compliant with medications|0
7231688|NCT00103012|11439932|FG002|Overall Study|Subject non-compliant with medications|1
7231689|NCT00103142|11439946|FG000|Overall Study|Adverse Event|1
7231690|NCT00103142|11439947|FG001|Overall Study|Adverse Event|0
7231691|NCT00103142|11439946|FG000|Overall Study|Progression of disease|2
7231692|NCT00103142|11439947|FG001|Overall Study|Progression of disease|1
7231693|NCT00103207|11439959|FG000|Overall Study|Adverse Event|3
7231694|NCT00103207|11439959|FG000|Overall Study|Death|1
7231695|NCT00103207|11439959|FG000|Overall Study|Withdrawal by Subject|2
7231696|NCT00103207|11439959|FG000|Overall Study|Other complicating disease|1
7231697|NCT00103207|11439959|FG000|Overall Study|Ineligible|4
7231698|NCT00103207|11439959|FG000|Overall Study|Diagnosis of BAC not confirmed|27
7231699|NCT00103259|11439967|FG000|Overall Study|Death|3
7231700|NCT00103259|11439968|FG001|Overall Study|Death|2
7231701|NCT00103259|11439967|FG000|Overall Study|Withdrawal by Subject|2
7231702|NCT00103259|11439968|FG001|Overall Study|Withdrawal by Subject|3
7231703|NCT00103259|11439967|FG000|Overall Study|alternative therapy|1
7231704|NCT00103259|11439968|FG001|Overall Study|alternative therapy|0
7231705|NCT00103259|11439967|FG000|Overall Study|other (reasons were not specified)|2
7231706|NCT00103259|11439968|FG001|Overall Study|other (reasons were not specified)|1
7231707|NCT00103259|11439967|FG000|Overall Study|ineligible/no protocol therapy|4
7231708|NCT00103259|11439968|FG001|Overall Study|ineligible/no protocol therapy|6
7255520|NCT00318461|11467024|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
7255521|NCT00318461|11467025|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
7255522|NCT00318461|11467026|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
7255523|NCT00318461|11467022|FG000|Open-Label Extension, 18 Months|Adverse Event|11
7255524|NCT00318461|11467023|FG001|Open-Label Extension, 18 Months|Adverse Event|8
7255525|NCT00318461|11467024|FG002|Open-Label Extension, 18 Months|Adverse Event|6
7255526|NCT00318461|11467025|FG003|Open-Label Extension, 18 Months|Adverse Event|1
7255527|NCT00318461|11467026|FG004|Open-Label Extension, 18 Months|Adverse Event|6
7255528|NCT00318461|11467022|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
7255529|NCT00318461|11467023|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
7255530|NCT00318461|11467024|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
7255531|NCT00318461|11467025|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
7255532|NCT00318461|11467026|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
7255533|NCT00318461|11467022|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
7255534|NCT00318461|11467023|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
7255535|NCT00318461|11467024|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
7255536|NCT00318461|11467025|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
7255537|NCT00318461|11467026|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
7255538|NCT00318474|11467040|FG000|Overall Study|Adverse Event|1
7255539|NCT00318474|11467041|FG001|Overall Study|Adverse Event|1
7255540|NCT00318474|11467040|FG000|Overall Study|Lost to Follow-up|0
7255541|NCT00318474|11467041|FG001|Overall Study|Lost to Follow-up|1
7255542|NCT00318474|11467040|FG000|Overall Study|Pregnancy|0
7255543|NCT00318474|11467041|FG001|Overall Study|Pregnancy|2
7255544|NCT00318474|11467040|FG000|Overall Study|Protocol Violation|1
7255545|NCT00318474|11467041|FG001|Overall Study|Protocol Violation|0
7255546|NCT00318474|11467040|FG000|Overall Study|Withdrawal by Subject|3
7255547|NCT00318474|11467041|FG001|Overall Study|Withdrawal by Subject|2
7255548|NCT00318474|11467040|FG000|Overall Study|Fall in GFR|3
7255549|NCT00318474|11467041|FG001|Overall Study|Fall in GFR|3
7255550|NCT00318474|11467040|FG000|Overall Study|Post-therapy hyperflycemia|0
7255551|NCT00318474|11467041|FG001|Overall Study|Post-therapy hyperflycemia|1
7255552|NCT00318474|11467040|FG000|Overall Study|Trial terminated|10
7573369|NCT03613649|11954544|FG009|Third Treatment|Lost to Follow-up|0
7573370|NCT03613649|11954545|FG010|Third Treatment|Lost to Follow-up|0
7573371|NCT03613649|11954546|FG011|Third Treatment|Lost to Follow-up|1
7255553|NCT00318474|11467041|FG001|Overall Study|Trial terminated|7
7255554|NCT00318565|11467047|FG000|Overall Study|Excluded per protocol|24
7255555|NCT00318643|11467067|FG000|Overall Study|Adverse Event|0
7255556|NCT00318643|11467068|FG001|Overall Study|Adverse Event|0
7255557|NCT00318643|11467069|FG002|Overall Study|Adverse Event|0
7255558|NCT00318643|11467070|FG003|Overall Study|Adverse Event|0
7255559|NCT00318643|11467071|FG004|Overall Study|Adverse Event|1
7255560|NCT00318643|11467067|FG000|Overall Study|Participant's Decision|0
7255561|NCT00318643|11467068|FG001|Overall Study|Participant's Decision|0
7573372|NCT03613649|11954535|FG000|Third Treatment|Protocol Violation|0
7573373|NCT03613649|11954536|FG001|Third Treatment|Protocol Violation|0
7255562|NCT00318643|11467069|FG002|Overall Study|Participant's Decision|0
7255563|NCT00318643|11467070|FG003|Overall Study|Participant's Decision|0
7231709|NCT00103285|11439976|FG000|Induction|Adverse Event|14
7231710|NCT00103285|11439977|FG001|Induction|Adverse Event|0
7231711|NCT00103285|11439978|FG002|Induction|Adverse Event|0
7231712|NCT00103285|11439979|FG003|Induction|Adverse Event|0
7231713|NCT00103285|11439980|FG004|Induction|Adverse Event|0
7231714|NCT00103285|11439981|FG005|Induction|Adverse Event|0
7231715|NCT00103285|11439982|FG006|Induction|Adverse Event|0
7231716|NCT00103285|11439983|FG007|Induction|Adverse Event|0
7231717|NCT00103285|11439976|FG000|Induction|Death|24
7231718|NCT00103285|11439977|FG001|Induction|Death|0
7231719|NCT00103285|11439978|FG002|Induction|Death|0
7231720|NCT00103285|11439979|FG003|Induction|Death|0
7231721|NCT00103285|11439980|FG004|Induction|Death|0
7231722|NCT00103285|11439981|FG005|Induction|Death|0
7231723|NCT00103285|11439982|FG006|Induction|Death|0
7231724|NCT00103285|11439983|FG007|Induction|Death|0
7231725|NCT00103285|11439976|FG000|Induction|Physician Decision|103
7231726|NCT00103285|11439977|FG001|Induction|Physician Decision|0
7231727|NCT00103285|11439978|FG002|Induction|Physician Decision|0
7231728|NCT00103285|11439979|FG003|Induction|Physician Decision|0
7231729|NCT00103285|11439980|FG004|Induction|Physician Decision|0
7231730|NCT00103285|11439981|FG005|Induction|Physician Decision|0
7231731|NCT00103285|11439982|FG006|Induction|Physician Decision|0
7231732|NCT00103285|11439983|FG007|Induction|Physician Decision|0
7231733|NCT00103285|11439976|FG000|Induction|Withdrawal by Subject|1
7231734|NCT00103285|11439977|FG001|Induction|Withdrawal by Subject|0
7231735|NCT00103285|11439978|FG002|Induction|Withdrawal by Subject|0
7231736|NCT00103285|11439979|FG003|Induction|Withdrawal by Subject|0
7231737|NCT00103285|11439980|FG004|Induction|Withdrawal by Subject|0
7231738|NCT00103285|11439981|FG005|Induction|Withdrawal by Subject|0
7231739|NCT00103285|11439982|FG006|Induction|Withdrawal by Subject|0
7231740|NCT00103285|11439983|FG007|Induction|Withdrawal by Subject|0
7231741|NCT00103285|11439976|FG000|Induction|Ineligible|43
7231742|NCT00103285|11439977|FG001|Induction|Ineligible|0
7231743|NCT00103285|11439978|FG002|Induction|Ineligible|0
7231744|NCT00103285|11439979|FG003|Induction|Ineligible|0
7231745|NCT00103285|11439980|FG004|Induction|Ineligible|0
7231746|NCT00103285|11439981|FG005|Induction|Ineligible|0
7231747|NCT00103285|11439982|FG006|Induction|Ineligible|0
7231748|NCT00103285|11439983|FG007|Induction|Ineligible|0
7231749|NCT00103285|11439976|FG000|Induction|Refusal|906
7231750|NCT00103285|11439977|FG001|Induction|Refusal|0
7231751|NCT00103285|11439978|FG002|Induction|Refusal|0
7231752|NCT00103285|11439979|FG003|Induction|Refusal|0
7231753|NCT00103285|11439980|FG004|Induction|Refusal|0
7231754|NCT00103285|11439981|FG005|Induction|Refusal|0
7231755|NCT00103285|11439982|FG006|Induction|Refusal|0
7231756|NCT00103285|11439983|FG007|Induction|Refusal|0
7231757|NCT00103285|11439976|FG000|Induction|Other|258
7231758|NCT00103285|11439977|FG001|Induction|Other|0
7231759|NCT00103285|11439978|FG002|Induction|Other|0
7231760|NCT00103285|11439979|FG003|Induction|Other|0
7231761|NCT00103285|11439980|FG004|Induction|Other|0
7231762|NCT00103285|11439981|FG005|Induction|Other|0
7231763|NCT00103285|11439982|FG006|Induction|Other|0
7231764|NCT00103285|11439983|FG007|Induction|Other|0
7231765|NCT00103285|11439976|FG000|Response Assignment|Adverse Event|0
7231766|NCT00103285|11439977|FG001|Response Assignment|Adverse Event|8
7231767|NCT00103285|11439978|FG002|Response Assignment|Adverse Event|3
7231768|NCT00103285|11439979|FG003|Response Assignment|Adverse Event|2
7231769|NCT00103285|11439980|FG004|Response Assignment|Adverse Event|3
7231770|NCT00103285|11439981|FG005|Response Assignment|Adverse Event|1
7231771|NCT00103285|11439982|FG006|Response Assignment|Adverse Event|1
7231772|NCT00103285|11439983|FG007|Response Assignment|Adverse Event|2
7231773|NCT00103285|11439976|FG000|Response Assignment|Death|0
7231774|NCT00103285|11439977|FG001|Response Assignment|Death|5
7231775|NCT00103285|11439978|FG002|Response Assignment|Death|2
7231776|NCT00103285|11439979|FG003|Response Assignment|Death|2
7231777|NCT00103285|11439980|FG004|Response Assignment|Death|3
7231778|NCT00103285|11439981|FG005|Response Assignment|Death|1
7231779|NCT00103285|11439982|FG006|Response Assignment|Death|0
7231780|NCT00103285|11439983|FG007|Response Assignment|Death|8
7231781|NCT00103285|11439976|FG000|Response Assignment|Lost to Follow-up|0
7231782|NCT00103285|11439977|FG001|Response Assignment|Lost to Follow-up|9
7231783|NCT00103285|11439978|FG002|Response Assignment|Lost to Follow-up|5
7231784|NCT00103285|11439979|FG003|Response Assignment|Lost to Follow-up|5
7231785|NCT00103285|11439980|FG004|Response Assignment|Lost to Follow-up|1
7231786|NCT00103285|11439981|FG005|Response Assignment|Lost to Follow-up|2
7231787|NCT00103285|11439982|FG006|Response Assignment|Lost to Follow-up|2
7231788|NCT00103285|11439983|FG007|Response Assignment|Lost to Follow-up|5
7231789|NCT00103285|11439976|FG000|Response Assignment|Physician Decision|0
7231790|NCT00103285|11439977|FG001|Response Assignment|Physician Decision|13
7231791|NCT00103285|11439978|FG002|Response Assignment|Physician Decision|14
7231792|NCT00103285|11439979|FG003|Response Assignment|Physician Decision|9
7231793|NCT00103285|11439980|FG004|Response Assignment|Physician Decision|13
7231794|NCT00103285|11439981|FG005|Response Assignment|Physician Decision|7
7231795|NCT00103285|11439982|FG006|Response Assignment|Physician Decision|4
7231796|NCT00103285|11439983|FG007|Response Assignment|Physician Decision|35
7231797|NCT00103285|11439976|FG000|Response Assignment|Protocol Violation|0
7231798|NCT00103285|11439977|FG001|Response Assignment|Protocol Violation|2
7231799|NCT00103285|11439978|FG002|Response Assignment|Protocol Violation|0
7231800|NCT00103285|11439979|FG003|Response Assignment|Protocol Violation|0
7231801|NCT00103285|11439980|FG004|Response Assignment|Protocol Violation|0
7231802|NCT00103285|11439981|FG005|Response Assignment|Protocol Violation|0
7231803|NCT00103285|11439982|FG006|Response Assignment|Protocol Violation|0
7231804|NCT00103285|11439983|FG007|Response Assignment|Protocol Violation|0
7231805|NCT00103285|11439976|FG000|Response Assignment|Withdrawal by Subject|0
7231806|NCT00103285|11439977|FG001|Response Assignment|Withdrawal by Subject|4
7231807|NCT00103285|11439978|FG002|Response Assignment|Withdrawal by Subject|1
7231808|NCT00103285|11439979|FG003|Response Assignment|Withdrawal by Subject|1
7231809|NCT00103285|11439980|FG004|Response Assignment|Withdrawal by Subject|2
7231810|NCT00103285|11439981|FG005|Response Assignment|Withdrawal by Subject|2
7231811|NCT00103285|11439982|FG006|Response Assignment|Withdrawal by Subject|0
7231812|NCT00103285|11439983|FG007|Response Assignment|Withdrawal by Subject|2
7231813|NCT00103285|11439976|FG000|Response Assignment|Ineligible|0
7231814|NCT00103285|11439977|FG001|Response Assignment|Ineligible|8
7231815|NCT00103285|11439978|FG002|Response Assignment|Ineligible|6
7231816|NCT00103285|11439979|FG003|Response Assignment|Ineligible|2
7231817|NCT00103285|11439980|FG004|Response Assignment|Ineligible|0
7231818|NCT00103285|11439981|FG005|Response Assignment|Ineligible|3
7231819|NCT00103285|11439982|FG006|Response Assignment|Ineligible|1
7231820|NCT00103285|11439983|FG007|Response Assignment|Ineligible|5
7231821|NCT00103285|11439976|FG000|Response Assignment|Refusal|0
7231822|NCT00103285|11439977|FG001|Response Assignment|Refusal|53
7231823|NCT00103285|11439978|FG002|Response Assignment|Refusal|5
7231824|NCT00103285|11439979|FG003|Response Assignment|Refusal|3
7231825|NCT00103285|11439980|FG004|Response Assignment|Refusal|25
7231826|NCT00103285|11439981|FG005|Response Assignment|Refusal|15
7231827|NCT00103285|11439982|FG006|Response Assignment|Refusal|30
7231828|NCT00103285|11439983|FG007|Response Assignment|Refusal|10
7231829|NCT00103285|11439976|FG000|Response Assignment|Other|0
7231830|NCT00103285|11439977|FG001|Response Assignment|Other|30
7231831|NCT00103285|11439978|FG002|Response Assignment|Other|48
7231832|NCT00103285|11439979|FG003|Response Assignment|Other|38
7231833|NCT00103285|11439980|FG004|Response Assignment|Other|37
7231834|NCT00103285|11439981|FG005|Response Assignment|Other|17
7231835|NCT00103285|11439982|FG006|Response Assignment|Other|11
7231836|NCT00103285|11439983|FG007|Response Assignment|Other|53
7231837|NCT00103311|11440010|FG000|Overall Study|Lost to Follow-up|1
7231838|NCT00103311|11440011|FG001|Overall Study|Lost to Follow-up|0
7231839|NCT00103311|11440010|FG000|Overall Study|Withdrawal by Subject|2
7231840|NCT00103311|11440011|FG001|Overall Study|Withdrawal by Subject|1
7231841|NCT00103311|11440010|FG000|Overall Study|Adverse Event|1
7231842|NCT00103311|11440011|FG001|Overall Study|Adverse Event|0
7231843|NCT00103402|11440038|FG000|Overall Study|Adverse Event|3
7231844|NCT00103402|11440039|FG001|Overall Study|Adverse Event|4
7231845|NCT00103402|11440038|FG000|Overall Study|Lost to Follow-up|8
7231846|NCT00103402|11440039|FG001|Overall Study|Lost to Follow-up|7
7231847|NCT00103402|11440038|FG000|Overall Study|Dissatisfied/No longer interested|6
7231848|NCT00103402|11440039|FG001|Overall Study|Dissatisfied/No longer interested|6
7231849|NCT00103402|11440038|FG000|Overall Study|Personal constraints/Other|5
7231850|NCT00103402|11440039|FG001|Overall Study|Personal constraints/Other|0
7231851|NCT00103506|11440047|FG000|Overall Study|Study closed by sponsor|34
7231852|NCT00103506|11440048|FG001|Overall Study|Study closed by sponsor|37
7231853|NCT00103506|11440047|FG000|Overall Study|Death|257
7231854|NCT00103506|11440048|FG001|Overall Study|Death|253
7231855|NCT00103506|11440047|FG000|Overall Study|Lost to Follow-up|13
7231856|NCT00103506|11440048|FG001|Overall Study|Lost to Follow-up|13
7231857|NCT00103506|11440047|FG000|Overall Study|Withdrawal by Subject|18
7231858|NCT00103506|11440048|FG001|Overall Study|Withdrawal by Subject|21
7231859|NCT00103610|11440056|FG000|Overall Study|Entered Rescue Procedure|10
7231860|NCT00103610|11440057|FG001|Overall Study|Entered Rescue Procedure|52
7231861|NCT00103610|11440056|FG000|Overall Study|Death|16
7231862|NCT00103610|11440057|FG001|Overall Study|Death|12
7231863|NCT00103610|11440056|FG000|Overall Study|Elective Withdrawal|4
7231864|NCT00103610|11440057|FG001|Overall Study|Elective Withdrawal|0
7231865|NCT00103610|11440056|FG000|Overall Study|Lost to Follow-up|3
7231866|NCT00103610|11440057|FG001|Overall Study|Lost to Follow-up|1
7231867|NCT00103610|11440056|FG000|Overall Study|Adverse Event|2
7231868|NCT00103610|11440057|FG001|Overall Study|Adverse Event|2
7231869|NCT00103610|11440056|FG000|Overall Study|Other|2
7231870|NCT00103610|11440057|FG001|Overall Study|Other|7
7231871|NCT00103610|11440056|FG000|Overall Study|Failed mobilization|1
7231872|NCT00103610|11440057|FG001|Overall Study|Failed mobilization|5
7231873|NCT00103610|11440056|FG000|Overall Study|Noncompliance|0
7231874|NCT00103610|11440057|FG001|Overall Study|Noncompliance|1
7231875|NCT00103662|11440066|FG000|Overall Study|Entered Rescue Procedure|0
7231876|NCT00103662|11440067|FG001|Overall Study|Entered Rescue Procedure|7
7231877|NCT00103662|11440066|FG000|Overall Study|Death|7
7231878|NCT00103662|11440067|FG001|Overall Study|Death|7
7231879|NCT00103662|11440066|FG000|Overall Study|Elective Withdrawal|5
7231880|NCT00103662|11440067|FG001|Overall Study|Elective Withdrawal|5
7231881|NCT00103662|11440066|FG000|Overall Study|Lost to Follow-up|0
7231882|NCT00103662|11440067|FG001|Overall Study|Lost to Follow-up|1
7231883|NCT00103662|11440066|FG000|Overall Study|Other|6
7231884|NCT00103662|11440067|FG001|Overall Study|Other|9
7231885|NCT00103662|11440066|FG000|Overall Study|Failed mobilization|0
7231886|NCT00103662|11440067|FG001|Overall Study|Failed mobilization|4
7231887|NCT00103662|11440066|FG000|Overall Study|Intercurrent illness|1
7231888|NCT00103662|11440067|FG001|Overall Study|Intercurrent illness|0
7231889|NCT00103740|11440075|FG000|Period 1 - Core|Adverse Event|1
7231890|NCT00103740|11440076|FG001|Period 1 - Core|Adverse Event|0
7231891|NCT00103740|11440075|FG000|Period 1 - Core|Protocol Violation|3
7231892|NCT00103740|11440076|FG001|Period 1 - Core|Protocol Violation|2
7231893|NCT00103740|11440075|FG000|Period 1 - Core|Patient withdrew consent|3
7231894|NCT00103740|11440076|FG001|Period 1 - Core|Patient withdrew consent|2
7231895|NCT00103740|11440075|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
7231896|NCT00103740|11440076|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
7231897|NCT00103740|11440075|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
7231898|NCT00103740|11440076|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
7231899|NCT00103740|11440075|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
7231900|NCT00103740|11440076|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
7231901|NCT00103740|11440075|FG000|Period 2 - Extended Observation Period|Death|6
7231902|NCT00103740|11440076|FG001|Period 2 - Extended Observation Period|Death|2
7231903|NCT00103740|11440075|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
7231904|NCT00103740|11440076|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
7231905|NCT00103857|11440098|FG000|54-Week Base Study|Adverse Event|12
7231906|NCT00103857|11440099|FG001|54-Week Base Study|Adverse Event|9
7231907|NCT00103857|11440100|FG002|54-Week Base Study|Adverse Event|11
7231908|NCT00103857|11440101|FG003|54-Week Base Study|Adverse Event|6
7231909|NCT00103857|11440102|FG004|54-Week Base Study|Adverse Event|5
7231910|NCT00103857|11440103|FG005|54-Week Base Study|Adverse Event|11
7231911|NCT00103857|11440104|FG006|54-Week Base Study|Adverse Event|3
7231912|NCT00103857|11440098|FG000|54-Week Base Study|Death|0
7231913|NCT00103857|11440099|FG001|54-Week Base Study|Death|0
7231914|NCT00103857|11440100|FG002|54-Week Base Study|Death|0
7231915|NCT00103857|11440101|FG003|54-Week Base Study|Death|0
7231916|NCT00103857|11440102|FG004|54-Week Base Study|Death|1
7231917|NCT00103857|11440103|FG005|54-Week Base Study|Death|1
7231918|NCT00103857|11440104|FG006|54-Week Base Study|Death|0
7231919|NCT00103857|11440098|FG000|54-Week Base Study|Lack of Efficacy|11
7231920|NCT00103857|11440099|FG001|54-Week Base Study|Lack of Efficacy|14
7231921|NCT00103857|11440100|FG002|54-Week Base Study|Lack of Efficacy|8
7231922|NCT00103857|11440101|FG003|54-Week Base Study|Lack of Efficacy|4
7231923|NCT00103857|11440102|FG004|54-Week Base Study|Lack of Efficacy|3
7231924|NCT00103857|11440103|FG005|54-Week Base Study|Lack of Efficacy|14
7231925|NCT00103857|11440104|FG006|54-Week Base Study|Lack of Efficacy|19
7231926|NCT00103857|11440098|FG000|54-Week Base Study|Lost to Follow-up|5
7231927|NCT00103857|11440099|FG001|54-Week Base Study|Lost to Follow-up|4
7231928|NCT00103857|11440100|FG002|54-Week Base Study|Lost to Follow-up|7
7231929|NCT00103857|11440101|FG003|54-Week Base Study|Lost to Follow-up|5
7231930|NCT00103857|11440102|FG004|54-Week Base Study|Lost to Follow-up|10
7231931|NCT00103857|11440103|FG005|54-Week Base Study|Lost to Follow-up|9
7231932|NCT00103857|11440104|FG006|54-Week Base Study|Lost to Follow-up|3
7231933|NCT00103857|11440098|FG000|54-Week Base Study|Physician Decision|1
7231934|NCT00103857|11440099|FG001|54-Week Base Study|Physician Decision|1
7231935|NCT00103857|11440100|FG002|54-Week Base Study|Physician Decision|0
7231936|NCT00103857|11440101|FG003|54-Week Base Study|Physician Decision|0
7231937|NCT00103857|11440102|FG004|54-Week Base Study|Physician Decision|1
7231938|NCT00103857|11440103|FG005|54-Week Base Study|Physician Decision|0
7231939|NCT00103857|11440104|FG006|54-Week Base Study|Physician Decision|0
7231940|NCT00103857|11440098|FG000|54-Week Base Study|Pregnancy|1
7231941|NCT00103857|11440099|FG001|54-Week Base Study|Pregnancy|0
7231942|NCT00103857|11440100|FG002|54-Week Base Study|Pregnancy|0
7231943|NCT00103857|11440101|FG003|54-Week Base Study|Pregnancy|0
7231944|NCT00103857|11440102|FG004|54-Week Base Study|Pregnancy|1
7231945|NCT00103857|11440103|FG005|54-Week Base Study|Pregnancy|0
7231946|NCT00103857|11440104|FG006|54-Week Base Study|Pregnancy|1
7231947|NCT00103857|11440098|FG000|54-Week Base Study|Protocol Violation|6
7231948|NCT00103857|11440099|FG001|54-Week Base Study|Protocol Violation|4
7231949|NCT00103857|11440100|FG002|54-Week Base Study|Protocol Violation|2
7231950|NCT00103857|11440101|FG003|54-Week Base Study|Protocol Violation|4
7231951|NCT00103857|11440102|FG004|54-Week Base Study|Protocol Violation|0
7231952|NCT00103857|11440103|FG005|54-Week Base Study|Protocol Violation|3
7231953|NCT00103857|11440104|FG006|54-Week Base Study|Protocol Violation|3
7231954|NCT00103857|11440098|FG000|54-Week Base Study|Withdrawal by Subject|17
7231955|NCT00103857|11440099|FG001|54-Week Base Study|Withdrawal by Subject|16
7231956|NCT00103857|11440100|FG002|54-Week Base Study|Withdrawal by Subject|16
7231957|NCT00103857|11440101|FG003|54-Week Base Study|Withdrawal by Subject|15
7231958|NCT00103857|11440102|FG004|54-Week Base Study|Withdrawal by Subject|10
7231959|NCT00103857|11440103|FG005|54-Week Base Study|Withdrawal by Subject|15
7231960|NCT00103857|11440104|FG006|54-Week Base Study|Withdrawal by Subject|4
7231961|NCT00103857|11440098|FG000|54-Week Base Study|protocol discontinuation criteria|2
7231962|NCT00103857|11440099|FG001|54-Week Base Study|protocol discontinuation criteria|5
7231963|NCT00103857|11440100|FG002|54-Week Base Study|protocol discontinuation criteria|2
7231964|NCT00103857|11440101|FG003|54-Week Base Study|protocol discontinuation criteria|6
7231965|NCT00103857|11440102|FG004|54-Week Base Study|protocol discontinuation criteria|5
7231966|NCT00103857|11440103|FG005|54-Week Base Study|protocol discontinuation criteria|3
7231967|NCT00103857|11440104|FG006|54-Week Base Study|protocol discontinuation criteria|5
7231968|NCT00103857|11440098|FG000|54-Week Base Study|patient moved|0
7231969|NCT00103857|11440099|FG001|54-Week Base Study|patient moved|1
7231970|NCT00103857|11440100|FG002|54-Week Base Study|patient moved|1
7231971|NCT00103857|11440101|FG003|54-Week Base Study|patient moved|2
7231972|NCT00103857|11440102|FG004|54-Week Base Study|patient moved|3
7231973|NCT00103857|11440103|FG005|54-Week Base Study|patient moved|1
7231974|NCT00103857|11440104|FG006|54-Week Base Study|patient moved|0
7231975|NCT00103857|11440098|FG000|54-Week Base Study|non-compliance with study procedures|1
7231976|NCT00103857|11440099|FG001|54-Week Base Study|non-compliance with study procedures|2
7231977|NCT00103857|11440100|FG002|54-Week Base Study|non-compliance with study procedures|0
7231978|NCT00103857|11440101|FG003|54-Week Base Study|non-compliance with study procedures|0
7231979|NCT00103857|11440102|FG004|54-Week Base Study|non-compliance with study procedures|0
7231980|NCT00103857|11440103|FG005|54-Week Base Study|non-compliance with study procedures|2
7231981|NCT00103857|11440104|FG006|54-Week Base Study|non-compliance with study procedures|0
7231982|NCT00103857|11440098|FG000|54-Week Base Study|patient incarcerated|0
7231983|NCT00103857|11440099|FG001|54-Week Base Study|patient incarcerated|0
7231984|NCT00103857|11440100|FG002|54-Week Base Study|patient incarcerated|0
7231985|NCT00103857|11440101|FG003|54-Week Base Study|patient incarcerated|0
7231986|NCT00103857|11440102|FG004|54-Week Base Study|patient incarcerated|1
7231987|NCT00103857|11440103|FG005|54-Week Base Study|patient incarcerated|1
7231988|NCT00103857|11440104|FG006|54-Week Base Study|patient incarcerated|0
7231989|NCT00103857|11440098|FG000|54-Week Base Study|laboratory reporting error|0
7231990|NCT00103857|11440099|FG001|54-Week Base Study|laboratory reporting error|0
7231991|NCT00103857|11440100|FG002|54-Week Base Study|laboratory reporting error|0
7231992|NCT00103857|11440101|FG003|54-Week Base Study|laboratory reporting error|0
7231993|NCT00103857|11440102|FG004|54-Week Base Study|laboratory reporting error|1
7231994|NCT00103857|11440103|FG005|54-Week Base Study|laboratory reporting error|0
7231995|NCT00103857|11440104|FG006|54-Week Base Study|laboratory reporting error|0
7231996|NCT00103857|11440098|FG000|54-Week Base Study|site error|0
7231997|NCT00103857|11440099|FG001|54-Week Base Study|site error|0
7231998|NCT00103857|11440100|FG002|54-Week Base Study|site error|0
7231999|NCT00103857|11440101|FG003|54-Week Base Study|site error|0
7232000|NCT00103857|11440102|FG004|54-Week Base Study|site error|0
7232001|NCT00103857|11440103|FG005|54-Week Base Study|site error|1
7232002|NCT00103857|11440104|FG006|54-Week Base Study|site error|0
7232003|NCT00103857|11440098|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
7232004|NCT00103857|11440099|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
7232005|NCT00103857|11440100|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
7232006|NCT00103857|11440101|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
7232007|NCT00103857|11440102|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
7232008|NCT00103857|11440103|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
7232009|NCT00103857|11440104|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
7232010|NCT00103857|11440098|FG000|50-Week Extension Study|Adverse Event|2
7232011|NCT00103857|11440099|FG001|50-Week Extension Study|Adverse Event|3
7232012|NCT00103857|11440100|FG002|50-Week Extension Study|Adverse Event|2
7232013|NCT00103857|11440101|FG003|50-Week Extension Study|Adverse Event|0
7232014|NCT00103857|11440102|FG004|50-Week Extension Study|Adverse Event|1
7232015|NCT00103857|11440103|FG005|50-Week Extension Study|Adverse Event|1
7232016|NCT00103857|11440104|FG006|50-Week Extension Study|Adverse Event|0
7232017|NCT00103857|11440098|FG000|50-Week Extension Study|Death|0
7232018|NCT00103857|11440099|FG001|50-Week Extension Study|Death|0
7232019|NCT00103857|11440100|FG002|50-Week Extension Study|Death|0
7232020|NCT00103857|11440101|FG003|50-Week Extension Study|Death|1
7232021|NCT00103857|11440102|FG004|50-Week Extension Study|Death|0
7232022|NCT00103857|11440103|FG005|50-Week Extension Study|Death|1
7232023|NCT00103857|11440104|FG006|50-Week Extension Study|Death|0
7232024|NCT00103857|11440098|FG000|50-Week Extension Study|Lack of Efficacy|26
7232025|NCT00103857|11440099|FG001|50-Week Extension Study|Lack of Efficacy|15
7232026|NCT00103857|11440100|FG002|50-Week Extension Study|Lack of Efficacy|13
7232027|NCT00103857|11440101|FG003|50-Week Extension Study|Lack of Efficacy|16
7232028|NCT00103857|11440102|FG004|50-Week Extension Study|Lack of Efficacy|8
7232029|NCT00103857|11440103|FG005|50-Week Extension Study|Lack of Efficacy|8
7232030|NCT00103857|11440104|FG006|50-Week Extension Study|Lack of Efficacy|0
7232031|NCT00103857|11440098|FG000|50-Week Extension Study|Lost to Follow-up|4
7232032|NCT00103857|11440099|FG001|50-Week Extension Study|Lost to Follow-up|0
7232033|NCT00103857|11440100|FG002|50-Week Extension Study|Lost to Follow-up|1
7232034|NCT00103857|11440101|FG003|50-Week Extension Study|Lost to Follow-up|4
7232035|NCT00103857|11440102|FG004|50-Week Extension Study|Lost to Follow-up|3
7232036|NCT00103857|11440103|FG005|50-Week Extension Study|Lost to Follow-up|3
7232037|NCT00103857|11440104|FG006|50-Week Extension Study|Lost to Follow-up|0
7232038|NCT00103857|11440098|FG000|50-Week Extension Study|Physician Decision|0
7232039|NCT00103857|11440099|FG001|50-Week Extension Study|Physician Decision|1
7232040|NCT00103857|11440100|FG002|50-Week Extension Study|Physician Decision|1
7232041|NCT00103857|11440101|FG003|50-Week Extension Study|Physician Decision|0
7232042|NCT00103857|11440102|FG004|50-Week Extension Study|Physician Decision|0
7232043|NCT00103857|11440103|FG005|50-Week Extension Study|Physician Decision|0
7232044|NCT00103857|11440104|FG006|50-Week Extension Study|Physician Decision|0
7232045|NCT00103857|11440098|FG000|50-Week Extension Study|Pregnancy|0
7232046|NCT00103857|11440099|FG001|50-Week Extension Study|Pregnancy|0
7232047|NCT00103857|11440100|FG002|50-Week Extension Study|Pregnancy|1
7232048|NCT00103857|11440101|FG003|50-Week Extension Study|Pregnancy|0
7232049|NCT00103857|11440102|FG004|50-Week Extension Study|Pregnancy|1
7232050|NCT00103857|11440103|FG005|50-Week Extension Study|Pregnancy|0
7232051|NCT00103857|11440104|FG006|50-Week Extension Study|Pregnancy|0
7232052|NCT00103857|11440098|FG000|50-Week Extension Study|Protocol Violation|1
7232053|NCT00103857|11440099|FG001|50-Week Extension Study|Protocol Violation|1
7232054|NCT00103857|11440100|FG002|50-Week Extension Study|Protocol Violation|1
7232055|NCT00103857|11440101|FG003|50-Week Extension Study|Protocol Violation|2
7232056|NCT00103857|11440102|FG004|50-Week Extension Study|Protocol Violation|0
7232057|NCT00103857|11440103|FG005|50-Week Extension Study|Protocol Violation|1
7232058|NCT00103857|11440104|FG006|50-Week Extension Study|Protocol Violation|0
7232059|NCT00103857|11440098|FG000|50-Week Extension Study|Withdrawal by Subject|2
7232060|NCT00103857|11440099|FG001|50-Week Extension Study|Withdrawal by Subject|5
7232061|NCT00103857|11440100|FG002|50-Week Extension Study|Withdrawal by Subject|2
7232062|NCT00103857|11440101|FG003|50-Week Extension Study|Withdrawal by Subject|8
7232063|NCT00103857|11440102|FG004|50-Week Extension Study|Withdrawal by Subject|3
7232064|NCT00103857|11440103|FG005|50-Week Extension Study|Withdrawal by Subject|3
7232065|NCT00103857|11440104|FG006|50-Week Extension Study|Withdrawal by Subject|0
7232066|NCT00103857|11440098|FG000|50-Week Extension Study|protocol discontinuation criteria|2
7232067|NCT00103857|11440099|FG001|50-Week Extension Study|protocol discontinuation criteria|2
7232068|NCT00103857|11440100|FG002|50-Week Extension Study|protocol discontinuation criteria|3
7232069|NCT00103857|11440101|FG003|50-Week Extension Study|protocol discontinuation criteria|2
7232070|NCT00103857|11440102|FG004|50-Week Extension Study|protocol discontinuation criteria|3
7232071|NCT00103857|11440103|FG005|50-Week Extension Study|protocol discontinuation criteria|3
7232072|NCT00103857|11440104|FG006|50-Week Extension Study|protocol discontinuation criteria|0
7232073|NCT00103857|11440098|FG000|50-Week Extension Study|non-compliance with study procedures|1
7232074|NCT00103857|11440099|FG001|50-Week Extension Study|non-compliance with study procedures|0
7232075|NCT00103857|11440100|FG002|50-Week Extension Study|non-compliance with study procedures|0
7232076|NCT00103857|11440101|FG003|50-Week Extension Study|non-compliance with study procedures|1
7232077|NCT00103857|11440102|FG004|50-Week Extension Study|non-compliance with study procedures|1
7232078|NCT00103857|11440103|FG005|50-Week Extension Study|non-compliance with study procedures|0
7232079|NCT00103857|11440104|FG006|50-Week Extension Study|non-compliance with study procedures|0
7232080|NCT00103857|11440098|FG000|50-Week Extension Study|patient moved|0
7232081|NCT00103857|11440099|FG001|50-Week Extension Study|patient moved|0
7232082|NCT00103857|11440100|FG002|50-Week Extension Study|patient moved|1
7232083|NCT00103857|11440101|FG003|50-Week Extension Study|patient moved|2
7232084|NCT00103857|11440102|FG004|50-Week Extension Study|patient moved|0
7232085|NCT00103857|11440103|FG005|50-Week Extension Study|patient moved|0
7232086|NCT00103857|11440104|FG006|50-Week Extension Study|patient moved|0
7232087|NCT00103857|11440098|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
7232088|NCT00103857|11440099|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
7232089|NCT00103857|11440100|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
7232090|NCT00103857|11440101|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
7232091|NCT00103857|11440102|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
7232092|NCT00103857|11440103|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
7232093|NCT00103857|11440104|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
7232094|NCT00103857|11440098|FG000|50-Week Extension Study|reason unspecified|0
7232095|NCT00103857|11440099|FG001|50-Week Extension Study|reason unspecified|0
7232096|NCT00103857|11440100|FG002|50-Week Extension Study|reason unspecified|0
7232097|NCT00103857|11440101|FG003|50-Week Extension Study|reason unspecified|0
7232098|NCT00103857|11440102|FG004|50-Week Extension Study|reason unspecified|1
7232099|NCT00103857|11440103|FG005|50-Week Extension Study|reason unspecified|0
7232100|NCT00103857|11440104|FG006|50-Week Extension Study|reason unspecified|0
7232101|NCT00104052|11440119|FG000|Overall Study|Adverse Event|1
7232102|NCT00104052|11440119|FG000|Overall Study|Lack of Efficacy|26
7232103|NCT00104052|11440119|FG000|Overall Study|Discontinuation unrelated to treatment|2
7232104|NCT00104104|11440125|FG000|Overall Study|Adverse Event|8
7232105|NCT00104104|11440126|FG001|Overall Study|Adverse Event|8
7232106|NCT00104104|11440125|FG000|Overall Study|Abnormal laboratory value(s)|20
7232107|NCT00104104|11440126|FG001|Overall Study|Abnormal laboratory value(s)|14
7232108|NCT00104104|11440125|FG000|Overall Study|Lack of Efficacy|0
7232109|NCT00104104|11440126|FG001|Overall Study|Lack of Efficacy|3
7232110|NCT00104104|11440125|FG000|Overall Study|Condition no longer requires study drug|7
7232111|NCT00104104|11440126|FG001|Overall Study|Condition no longer requires study drug|4
7232112|NCT00104104|11440125|FG000|Overall Study|Protocol Violation|5
7232113|NCT00104104|11440126|FG001|Overall Study|Protocol Violation|2
7232114|NCT00104104|11440125|FG000|Overall Study|Withdrawal by Subject|11
7232115|NCT00104104|11440126|FG001|Overall Study|Withdrawal by Subject|15
7232116|NCT00104104|11440125|FG000|Overall Study|Lost to Follow-up|3
7232117|NCT00104104|11440126|FG001|Overall Study|Lost to Follow-up|7
7232118|NCT00104104|11440125|FG000|Overall Study|Administrative problems|12
7232119|NCT00104104|11440126|FG001|Overall Study|Administrative problems|13
7232120|NCT00104104|11440125|FG000|Overall Study|Death|9
7232121|NCT00104104|11440126|FG001|Overall Study|Death|6
7232122|NCT00104247|11440143|FG000|Overall Study|Withdrawal by Subject|1
7232123|NCT00104247|11440144|FG001|Overall Study|Withdrawal by Subject|0
7232124|NCT00104247|11440143|FG000|Overall Study|Noncompliant with dosing|0
7232125|NCT00104247|11440144|FG001|Overall Study|Noncompliant with dosing|1
7232126|NCT00104299|11440152|FG000|Overall Study|Adverse Event|3
7232127|NCT00104299|11440153|FG001|Overall Study|Adverse Event|1
7232128|NCT00104299|11440152|FG000|Overall Study|Death|2
7232129|NCT00104299|11440153|FG001|Overall Study|Death|2
7232130|NCT00104299|11440152|FG000|Overall Study|Withdrawal by Subject|2
7232131|NCT00104299|11440153|FG001|Overall Study|Withdrawal by Subject|6
7232132|NCT00104299|11440152|FG000|Overall Study|Physician Decision|1
7232133|NCT00104299|11440153|FG001|Overall Study|Physician Decision|1
7232134|NCT00104299|11440152|FG000|Overall Study|To have renal transplant|1
7232135|NCT00104299|11440153|FG001|Overall Study|To have renal transplant|0
7232136|NCT00104416|11440161|FG000|Double-Blind Phase|Adverse Event|2
7232137|NCT00104416|11440162|FG001|Double-Blind Phase|Adverse Event|1
7232138|NCT00104416|11440163|FG002|Double-Blind Phase|Adverse Event|0
7232139|NCT00104416|11440164|FG003|Double-Blind Phase|Adverse Event|0
7232140|NCT00104416|11440165|FG004|Double-Blind Phase|Adverse Event|0
7232141|NCT00104416|11440161|FG000|Double-Blind Phase|Lost to Follow-up|0
7232142|NCT00104416|11440162|FG001|Double-Blind Phase|Lost to Follow-up|1
7232143|NCT00104416|11440163|FG002|Double-Blind Phase|Lost to Follow-up|0
7232144|NCT00104416|11440164|FG003|Double-Blind Phase|Lost to Follow-up|0
7232145|NCT00104416|11440165|FG004|Double-Blind Phase|Lost to Follow-up|0
7232146|NCT00104416|11440161|FG000|Double-Blind Phase|Protocol Violation|0
7232147|NCT00104416|11440162|FG001|Double-Blind Phase|Protocol Violation|1
7232148|NCT00104416|11440163|FG002|Double-Blind Phase|Protocol Violation|0
7232149|NCT00104416|11440164|FG003|Double-Blind Phase|Protocol Violation|0
7232150|NCT00104416|11440165|FG004|Double-Blind Phase|Protocol Violation|0
7232151|NCT00104416|11440161|FG000|Double-Blind Phase|Withdrawal by Subject|2
7232152|NCT00104416|11440162|FG001|Double-Blind Phase|Withdrawal by Subject|3
7232153|NCT00104416|11440163|FG002|Double-Blind Phase|Withdrawal by Subject|0
7232154|NCT00104416|11440164|FG003|Double-Blind Phase|Withdrawal by Subject|0
7232155|NCT00104416|11440165|FG004|Double-Blind Phase|Withdrawal by Subject|0
7232156|NCT00104416|11440161|FG000|Double-Blind Phase|Pregnancy|1
7232157|NCT00104416|11440162|FG001|Double-Blind Phase|Pregnancy|0
7232158|NCT00104416|11440163|FG002|Double-Blind Phase|Pregnancy|0
7232159|NCT00104416|11440164|FG003|Double-Blind Phase|Pregnancy|0
7232160|NCT00104416|11440165|FG004|Double-Blind Phase|Pregnancy|0
7232161|NCT00104416|11440161|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
7232162|NCT00104416|11440162|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
7232163|NCT00104416|11440163|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
7232164|NCT00104416|11440164|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
7232165|NCT00104416|11440165|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
7232166|NCT00104416|11440161|FG000|Continuation Phase|Adverse Event|0
7232167|NCT00104416|11440162|FG001|Continuation Phase|Adverse Event|0
7232168|NCT00104416|11440163|FG002|Continuation Phase|Adverse Event|2
7232169|NCT00104416|11440164|FG003|Continuation Phase|Adverse Event|0
7232170|NCT00104416|11440165|FG004|Continuation Phase|Adverse Event|2
7232171|NCT00104416|11440161|FG000|Continuation Phase|Lost to Follow-up|0
7232172|NCT00104416|11440162|FG001|Continuation Phase|Lost to Follow-up|0
7232173|NCT00104416|11440163|FG002|Continuation Phase|Lost to Follow-up|1
7232174|NCT00104416|11440164|FG003|Continuation Phase|Lost to Follow-up|0
7232175|NCT00104416|11440165|FG004|Continuation Phase|Lost to Follow-up|1
7232176|NCT00104416|11440161|FG000|Continuation Phase|Withdrawal by Subject|0
7232177|NCT00104416|11440162|FG001|Continuation Phase|Withdrawal by Subject|0
7232178|NCT00104416|11440163|FG002|Continuation Phase|Withdrawal by Subject|2
7232179|NCT00104416|11440164|FG003|Continuation Phase|Withdrawal by Subject|1
7232180|NCT00104416|11440165|FG004|Continuation Phase|Withdrawal by Subject|1
7232181|NCT00104416|11440161|FG000|Continuation Phase|Pregnancy|0
7232182|NCT00104416|11440162|FG001|Continuation Phase|Pregnancy|0
7232183|NCT00104416|11440163|FG002|Continuation Phase|Pregnancy|1
7232184|NCT00104416|11440164|FG003|Continuation Phase|Pregnancy|1
7232185|NCT00104416|11440165|FG004|Continuation Phase|Pregnancy|0
7232186|NCT00104416|11440161|FG000|Continuation Phase|Non-compliance|0
7232187|NCT00104416|11440162|FG001|Continuation Phase|Non-compliance|0
7232188|NCT00104416|11440163|FG002|Continuation Phase|Non-compliance|0
7232189|NCT00104416|11440164|FG003|Continuation Phase|Non-compliance|0
7232190|NCT00104416|11440165|FG004|Continuation Phase|Non-compliance|1
7232191|NCT00104520|11440179|FG000|Overall Study|Unrelated adverse event|34
7232192|NCT00104520|11440180|FG001|Overall Study|Unrelated adverse event|47
7232193|NCT00104520|11440179|FG000|Overall Study|Study drug intolerance|0
7232194|NCT00104520|11440180|FG001|Overall Study|Study drug intolerance|1
7232195|NCT00104520|11440179|FG000|Overall Study|Related adverse event|13
7232196|NCT00104520|11440180|FG001|Overall Study|Related adverse event|15
7232197|NCT00104520|11440179|FG000|Overall Study|Lost to Follow-up|1
7232198|NCT00104520|11440180|FG001|Overall Study|Lost to Follow-up|0
7232199|NCT00104520|11440179|FG000|Overall Study|Noncompliance|0
7232200|NCT00104520|11440180|FG001|Overall Study|Noncompliance|2
7232201|NCT00104520|11440179|FG000|Overall Study|Personal/administrative|1
7232202|NCT00104520|11440180|FG001|Overall Study|Personal/administrative|1
7232203|NCT00104520|11440179|FG000|Overall Study|Other|1
7232204|NCT00104520|11440180|FG001|Overall Study|Other|5
7232205|NCT00104572|11440189|FG000|Overall Study|Withdrawal by Subject|3
7232206|NCT00104572|11440190|FG001|Overall Study|Withdrawal by Subject|3
7232207|NCT00104572|11440191|FG002|Overall Study|Withdrawal by Subject|0
7232208|NCT00104637|11440199|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
7232209|NCT00104637|11440200|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
7232210|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Physician Decision|0
7232211|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Physician Decision|0
7232212|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Physician Decision|1
7232213|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
7232214|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7232215|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
7232216|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Death|7
7232217|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Death|5
7232218|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Death|6
7232219|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Disease progression|2
7232220|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Disease progression|3
7232221|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Disease progression|2
7232222|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
7232223|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
7232224|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
7232225|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Other|1
7232226|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Other|0
7232227|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Other|0
7232228|NCT00104650|11440212|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
7232229|NCT00104650|11440213|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
7232230|NCT00104650|11440214|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
7232231|NCT00104650|11440212|FG000|Follow-up Period|Physician Decision|1
7232232|NCT00104650|11440213|FG001|Follow-up Period|Physician Decision|1
7232233|NCT00104650|11440214|FG002|Follow-up Period|Physician Decision|0
7232234|NCT00104650|11440212|FG000|Follow-up Period|Adverse Event|1
7232235|NCT00104650|11440213|FG001|Follow-up Period|Adverse Event|0
7232236|NCT00104650|11440214|FG002|Follow-up Period|Adverse Event|1
7232237|NCT00104650|11440212|FG000|Follow-up Period|Withdrawal by Subject|0
7232238|NCT00104650|11440213|FG001|Follow-up Period|Withdrawal by Subject|3
7232239|NCT00104650|11440214|FG002|Follow-up Period|Withdrawal by Subject|3
7232240|NCT00104650|11440212|FG000|Follow-up Period|Death|6
7232241|NCT00104650|11440213|FG001|Follow-up Period|Death|6
7232242|NCT00104650|11440214|FG002|Follow-up Period|Death|4
7232243|NCT00104650|11440212|FG000|Follow-up Period|Disease progression|3
7232244|NCT00104650|11440213|FG001|Follow-up Period|Disease progression|1
7232245|NCT00104650|11440214|FG002|Follow-up Period|Disease progression|0
7232246|NCT00104650|11440212|FG000|Follow-up Period|Lost to Follow-up|0
7232247|NCT00104650|11440213|FG001|Follow-up Period|Lost to Follow-up|1
7232248|NCT00104650|11440214|FG002|Follow-up Period|Lost to Follow-up|2
7232249|NCT00104650|11440212|FG000|Follow-up Period|Other|0
7232250|NCT00104650|11440213|FG001|Follow-up Period|Other|1
7232251|NCT00104650|11440214|FG002|Follow-up Period|Other|0
7232252|NCT00104871|11440228|FG000|Overall Study|Not evaluable|1
7232253|NCT00104884|11440232|FG000|Overall Study|Disease progression|4
7232254|NCT00105066|11440276|FG000|Overall Study|Adverse Event|2
7232255|NCT00105066|11440277|FG001|Overall Study|Adverse Event|5
7232256|NCT00105079|11440285|FG000|Overall Study|Adverse Event|5
7232257|NCT00105079|11440286|FG001|Overall Study|Adverse Event|12
7232258|NCT00105079|11440285|FG000|Overall Study|Death|3
7232259|NCT00105079|11440286|FG001|Overall Study|Death|1
7232260|NCT00105079|11440285|FG000|Overall Study|Lost to Follow-up|12
7232261|NCT00105079|11440286|FG001|Overall Study|Lost to Follow-up|12
7232262|NCT00105079|11440285|FG000|Overall Study|Lack of Efficacy|9
7232263|NCT00105079|11440286|FG001|Overall Study|Lack of Efficacy|3
7232264|NCT00105079|11440285|FG000|Overall Study|Refused treatment|6
7232265|NCT00105079|11440286|FG001|Overall Study|Refused treatment|4
7232266|NCT00105079|11440285|FG000|Overall Study|Violation of selection criteria at entry|0
7232267|NCT00105079|11440286|FG001|Overall Study|Violation of selection criteria at entry|2
7232268|NCT00105079|11440285|FG000|Overall Study|Protocol Violation|1
7232269|NCT00105079|11440286|FG001|Overall Study|Protocol Violation|0
7232270|NCT00105079|11440285|FG000|Overall Study|Other|3
7232271|NCT00105079|11440286|FG001|Overall Study|Other|1
7232272|NCT00105157|11440296|FG000|Double-Blind (DB)|Never Treated|1
7232273|NCT00105157|11440297|FG001|Double-Blind (DB)|Never Treated|0
7232274|NCT00105157|11440298|FG002|Double-Blind (DB)|Never Treated|0
7232275|NCT00105157|11440299|FG003|Double-Blind (DB)|Never Treated|0
7232276|NCT00105157|11440296|FG000|Double-Blind (DB)|Adverse Event|2
7232277|NCT00105157|11440297|FG001|Double-Blind (DB)|Adverse Event|0
7232278|NCT00105157|11440298|FG002|Double-Blind (DB)|Adverse Event|1
7232279|NCT00105157|11440299|FG003|Double-Blind (DB)|Adverse Event|1
7232280|NCT00105157|11440296|FG000|Double-Blind (DB)|Lack of Efficacy|11
7232281|NCT00105157|11440297|FG001|Double-Blind (DB)|Lack of Efficacy|14
7232282|NCT00105157|11440298|FG002|Double-Blind (DB)|Lack of Efficacy|11
7232283|NCT00105157|11440299|FG003|Double-Blind (DB)|Lack of Efficacy|38
7232284|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Adverse Event|3
7232285|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Adverse Event|1
7232286|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Adverse Event|0
7232287|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Adverse Event|0
7232288|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
7232289|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
7232290|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
7232291|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
7232292|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
7232293|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
7232294|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
7232295|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
7232296|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
7232297|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
7232298|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
7232299|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
7232300|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
7232301|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
7232302|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
7232303|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
7232304|NCT00105157|11440296|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
7232305|NCT00105157|11440297|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
7232306|NCT00105157|11440298|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
7232307|NCT00105157|11440299|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
7232308|NCT00105157|11440296|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7232309|NCT00105157|11440297|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7232310|NCT00105157|11440298|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
7232311|NCT00105157|11440299|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
7232312|NCT00105157|11440296|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
7232313|NCT00105157|11440297|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
7232314|NCT00105157|11440298|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
7232315|NCT00105157|11440299|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
7232316|NCT00105157|11440296|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7232317|NCT00105157|11440297|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7232318|NCT00105157|11440298|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
7232319|NCT00105157|11440299|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
7232320|NCT00105157|11440296|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7232321|NCT00105157|11440297|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7232322|NCT00105157|11440298|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
7232323|NCT00105157|11440299|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
7232324|NCT00105157|11440296|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7232325|NCT00105157|11440297|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
7232326|NCT00105157|11440298|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7232327|NCT00105157|11440299|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
7232328|NCT00105183|11440310|FG000|Overall Study|Death|19
7232329|NCT00105183|11440311|FG001|Overall Study|Death|13
7232330|NCT00105183|11440312|FG002|Overall Study|Death|15
7232331|NCT00105183|11440310|FG000|Overall Study|Withdrawal by Subject|1
7232332|NCT00105183|11440311|FG001|Overall Study|Withdrawal by Subject|1
7232333|NCT00105183|11440312|FG002|Overall Study|Withdrawal by Subject|4
7232334|NCT00105183|11440310|FG000|Overall Study|Physician Decision|1
7232335|NCT00105183|11440311|FG001|Overall Study|Physician Decision|2
7232336|NCT00105183|11440312|FG002|Overall Study|Physician Decision|3
7232337|NCT00105183|11440310|FG000|Overall Study|Lost to Follow-up|0
7232338|NCT00105183|11440311|FG001|Overall Study|Lost to Follow-up|1
7232339|NCT00105183|11440312|FG002|Overall Study|Lost to Follow-up|1
7232340|NCT00105183|11440310|FG000|Overall Study|Other reason|1
7232341|NCT00105183|11440311|FG001|Overall Study|Other reason|2
7232342|NCT00105183|11440312|FG002|Overall Study|Other reason|0
7232343|NCT00105196|11440322|FG000|Overall Study|Lack of Efficacy|2
7232344|NCT00105196|11440323|FG001|Overall Study|Lack of Efficacy|3
7232345|NCT00105196|11440322|FG000|Overall Study|Adverse Event|11
7232346|NCT00105196|11440323|FG001|Overall Study|Adverse Event|3
7232347|NCT00105196|11440322|FG000|Overall Study|Withdrawal by Subject|6
7232348|NCT00105196|11440323|FG001|Overall Study|Withdrawal by Subject|6
7232349|NCT00105196|11440322|FG000|Overall Study|Lost to Follow-up|3
7232350|NCT00105196|11440323|FG001|Overall Study|Lost to Follow-up|2
7232351|NCT00105196|11440322|FG000|Overall Study|Poor/noncompliance|3
7232352|NCT00105196|11440323|FG001|Overall Study|Poor/noncompliance|4
7232353|NCT00105196|11440322|FG000|Overall Study|Protocol Violation|5
7232354|NCT00105196|11440323|FG001|Overall Study|Protocol Violation|2
7232355|NCT00105196|11440322|FG000|Overall Study|pending surgery|0
7232356|NCT00105196|11440323|FG001|Overall Study|pending surgery|1
7232357|NCT00105196|11440322|FG000|Overall Study|marijuana use|0
7232358|NCT00105196|11440323|FG001|Overall Study|marijuana use|1
7232359|NCT00105196|11440322|FG000|Overall Study|Subject became unblinded|0
7232360|NCT00105196|11440323|FG001|Overall Study|Subject became unblinded|1
7232361|NCT00105235|11440329|FG000|Overall Study|Death|4
7232362|NCT00105235|11440329|FG000|Overall Study|Physician Decision|1
7232363|NCT00105235|11440329|FG000|Overall Study|Withdrawal by Subject|2
7232364|NCT00105443|11440339|FG000|Double-Blind Treatment|Adverse Event|1
7232365|NCT00105443|11440340|FG001|Double-Blind Treatment|Adverse Event|0
7232366|NCT00105443|11440341|FG002|Double-Blind Treatment|Adverse Event|0
7573374|NCT03613649|11954537|FG002|Third Treatment|Protocol Violation|0
7232367|NCT00105443|11440342|FG003|Double-Blind Treatment|Adverse Event|0
7232368|NCT00105443|11440339|FG000|Double-Blind Treatment|Lost to Follow-up|0
7232369|NCT00105443|11440340|FG001|Double-Blind Treatment|Lost to Follow-up|0
7232370|NCT00105443|11440341|FG002|Double-Blind Treatment|Lost to Follow-up|1
7232371|NCT00105443|11440342|FG003|Double-Blind Treatment|Lost to Follow-up|0
7232372|NCT00105443|11440339|FG000|Double-Blind Treatment|Withdrawal by Subject|8
7232373|NCT00105443|11440340|FG001|Double-Blind Treatment|Withdrawal by Subject|0
7232374|NCT00105443|11440341|FG002|Double-Blind Treatment|Withdrawal by Subject|7
7232375|NCT00105443|11440342|FG003|Double-Blind Treatment|Withdrawal by Subject|0
7232376|NCT00105443|11440339|FG000|Double-Blind Treatment|Physician Decision|1
7232377|NCT00105443|11440340|FG001|Double-Blind Treatment|Physician Decision|0
7232378|NCT00105443|11440341|FG002|Double-Blind Treatment|Physician Decision|2
7232379|NCT00105443|11440342|FG003|Double-Blind Treatment|Physician Decision|0
7232380|NCT00105443|11440339|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
7232381|NCT00105443|11440340|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
7232382|NCT00105443|11440341|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
7232383|NCT00105443|11440342|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
7232384|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Death|180
7232385|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Death|7
7232386|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Death|219
7232387|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Death|4
7232388|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
7232389|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7232390|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
7232391|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
7232392|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
7232393|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
7232394|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
7232395|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
7232396|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
7232397|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
7232398|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
7232399|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
7232400|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
7232401|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
7232402|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
7232403|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
7232404|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7232405|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
7232406|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7232407|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
7232408|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7232409|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
7232410|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
7232411|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
7232412|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7232413|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7232414|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
7232415|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
7232416|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
7232417|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7232418|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
7232419|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
7232420|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7232421|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7232422|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
7232423|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
7232424|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
7232425|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7232426|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7232427|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
7232428|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7232429|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7232430|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
7255564|NCT00318643|11467071|FG004|Overall Study|Participant's Decision|1
7573375|NCT03613649|11954538|FG003|Third Treatment|Protocol Violation|0
7232431|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
7232432|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7232433|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7232434|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
7232435|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
7232436|NCT00105443|11440339|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7232437|NCT00105443|11440340|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
7232438|NCT00105443|11440341|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
7232439|NCT00105443|11440342|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
7232440|NCT00105469|11440353|FG000|Overall Study|Adverse Event|9
7232441|NCT00105469|11440354|FG001|Overall Study|Adverse Event|8
7232442|NCT00105469|11440353|FG000|Overall Study|Protocol Violation|4
7232443|NCT00105469|11440354|FG001|Overall Study|Protocol Violation|0
7232444|NCT00105469|11440353|FG000|Overall Study|Withdrawal by Subject|2
7232445|NCT00105469|11440354|FG001|Overall Study|Withdrawal by Subject|3
7232446|NCT00105469|11440353|FG000|Overall Study|Lost to Follow-up|1
7232447|NCT00105469|11440354|FG001|Overall Study|Lost to Follow-up|0
7232448|NCT00105469|11440353|FG000|Overall Study|Lack of Efficacy|2
7232449|NCT00105469|11440354|FG001|Overall Study|Lack of Efficacy|0
7232450|NCT00105469|11440353|FG000|Overall Study|Other Reason|4
7232451|NCT00105469|11440354|FG001|Overall Study|Other Reason|0
7232452|NCT00105482|11440362|FG000|Overall Study|Adverse Event|1
7232453|NCT00105482|11440363|FG001|Overall Study|Adverse Event|1
7232454|NCT00105482|11440362|FG000|Overall Study|Lost to Follow-up|26
7232455|NCT00105482|11440363|FG001|Overall Study|Lost to Follow-up|17
7232456|NCT00105482|11440362|FG000|Overall Study|Withdrawal by Subject|0
7232457|NCT00105482|11440363|FG001|Overall Study|Withdrawal by Subject|1
7232458|NCT00105482|11440362|FG000|Overall Study|Lost Interest|29
7232459|NCT00105482|11440363|FG001|Overall Study|Lost Interest|32
7232460|NCT00105482|11440362|FG000|Overall Study|Scheduling Conflict|2
7232461|NCT00105482|11440363|FG001|Overall Study|Scheduling Conflict|3
7232462|NCT00105482|11440362|FG000|Overall Study|Withdrawn by PI|1
7232463|NCT00105482|11440363|FG001|Overall Study|Withdrawn by PI|1
7232464|NCT00105508|11440371|FG000|Overall Study|Prephase Dropout|1
7232465|NCT00105508|11440372|FG001|Overall Study|Prephase Dropout|0
7232466|NCT00105508|11440371|FG000|Overall Study|Adverse Event|16
7232467|NCT00105508|11440372|FG001|Overall Study|Adverse Event|19
7232468|NCT00105508|11440371|FG000|Overall Study|Insufficient Efficacy|1
7232469|NCT00105508|11440372|FG001|Overall Study|Insufficient Efficacy|0
7573376|NCT03613649|11954539|FG004|Third Treatment|Protocol Violation|0
7573377|NCT03613649|11954540|FG005|Third Treatment|Protocol Violation|0
7573378|NCT03613649|11954541|FG006|Third Treatment|Protocol Violation|1
7573379|NCT03613649|11954542|FG007|Third Treatment|Protocol Violation|0
7573380|NCT03613649|11954543|FG008|Third Treatment|Protocol Violation|0
7573381|NCT03613649|11954544|FG009|Third Treatment|Protocol Violation|0
7573382|NCT03613649|11954545|FG010|Third Treatment|Protocol Violation|0
7573383|NCT03613649|11954546|FG011|Third Treatment|Protocol Violation|1
7573384|NCT03613649|11954535|FG000|Fourth Treatment|Protocol Violation|1
7573385|NCT03613649|11954536|FG001|Fourth Treatment|Protocol Violation|0
7573386|NCT03613649|11954537|FG002|Fourth Treatment|Protocol Violation|0
7232470|NCT00105508|11440371|FG000|Overall Study|Withdrawal by Subject|10
7232471|NCT00105508|11440372|FG001|Overall Study|Withdrawal by Subject|6
7232472|NCT00105508|11440371|FG000|Overall Study|Lost to Follow-up|3
7232473|NCT00105508|11440372|FG001|Overall Study|Lost to Follow-up|0
7232474|NCT00105508|11440371|FG000|Overall Study|Protocol Violation|1
7232475|NCT00105508|11440372|FG001|Overall Study|Protocol Violation|2
7232476|NCT00105508|11440371|FG000|Overall Study|Other|8
7232477|NCT00105508|11440372|FG001|Overall Study|Other|9
7232478|NCT00105521|11440382|FG000|Overall Study|Other|1
7232479|NCT00105521|11440383|FG001|Overall Study|Other|1
7232480|NCT00105521|11440384|FG002|Overall Study|Other|2
7232481|NCT00105521|11440385|FG003|Overall Study|Other|0
7232482|NCT00105521|11440382|FG000|Overall Study|Adverse Event|10
7232483|NCT00105521|11440383|FG001|Overall Study|Adverse Event|4
7232484|NCT00105521|11440384|FG002|Overall Study|Adverse Event|10
7232485|NCT00105521|11440385|FG003|Overall Study|Adverse Event|8
7232486|NCT00105521|11440382|FG000|Overall Study|Withdrawal by Subject|1
7232487|NCT00105521|11440383|FG001|Overall Study|Withdrawal by Subject|0
7573387|NCT03613649|11954538|FG003|Fourth Treatment|Protocol Violation|0
7573388|NCT03613649|11954539|FG004|Fourth Treatment|Protocol Violation|1
7232488|NCT00105521|11440384|FG002|Overall Study|Withdrawal by Subject|1
7232489|NCT00105521|11440385|FG003|Overall Study|Withdrawal by Subject|4
7232490|NCT00105521|11440382|FG000|Overall Study|Lack of Efficacy|0
7232491|NCT00105521|11440383|FG001|Overall Study|Lack of Efficacy|0
7232492|NCT00105521|11440384|FG002|Overall Study|Lack of Efficacy|0
7232493|NCT00105521|11440385|FG003|Overall Study|Lack of Efficacy|1
7232494|NCT00105521|11440382|FG000|Overall Study|Protocol Violation|3
7232495|NCT00105521|11440383|FG001|Overall Study|Protocol Violation|5
7573389|NCT03613649|11954540|FG005|Fourth Treatment|Protocol Violation|0
7232496|NCT00105521|11440384|FG002|Overall Study|Protocol Violation|4
7232497|NCT00105521|11440385|FG003|Overall Study|Protocol Violation|4
7232498|NCT00105521|11440382|FG000|Overall Study|Lost to Follow-up|0
7232499|NCT00105521|11440383|FG001|Overall Study|Lost to Follow-up|1
7232500|NCT00105521|11440384|FG002|Overall Study|Lost to Follow-up|0
7232501|NCT00105521|11440385|FG003|Overall Study|Lost to Follow-up|0
7232502|NCT00105534|11440397|FG000|Overall Study|Adverse Event|2
7232503|NCT00105534|11440398|FG001|Overall Study|Adverse Event|5
7232504|NCT00105534|11440397|FG000|Overall Study|Protocol Violation|1
7232505|NCT00105534|11440398|FG001|Overall Study|Protocol Violation|4
7232506|NCT00105534|11440397|FG000|Overall Study|Withdrawal by Subject|6
7232507|NCT00105534|11440398|FG001|Overall Study|Withdrawal by Subject|6
7232508|NCT00105534|11440397|FG000|Overall Study|Lost to Follow-up|5
7232509|NCT00105534|11440398|FG001|Overall Study|Lost to Follow-up|1
7232510|NCT00105534|11440397|FG000|Overall Study|Lack of Efficacy|7
7232511|NCT00105534|11440398|FG001|Overall Study|Lack of Efficacy|15
7232512|NCT00105534|11440397|FG000|Overall Study|Treatment unmasked|1
7232513|NCT00105534|11440398|FG001|Overall Study|Treatment unmasked|0
7232514|NCT00105534|11440397|FG000|Overall Study|Other Reason|0
7232515|NCT00105534|11440398|FG001|Overall Study|Other Reason|2
7232516|NCT00105586|11440406|FG000|Overall Study|Adverse Event|4
7232517|NCT00105586|11440407|FG001|Overall Study|Adverse Event|3
7232518|NCT00105586|11440406|FG000|Overall Study|Physician Decision|13
7232519|NCT00105586|11440407|FG001|Overall Study|Physician Decision|13
7232520|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
7232521|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
7232522|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
7232523|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
7232524|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
7232525|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
7232526|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
7232527|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
7232528|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
7232529|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
7232530|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
7232531|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
7232532|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
7232533|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
7232534|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Death|1
7232535|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Death|0
7232536|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7232537|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
7232538|NCT00105989|11440415|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7232539|NCT00105989|11440416|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
7232540|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
7232541|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
7232542|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
7232543|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
7232544|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
7232545|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
7232546|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
7232547|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
7232548|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
7232549|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
7232550|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
7232551|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
7232552|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
7232553|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
7232554|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Death|0
7232555|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Death|0
7232556|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
7232557|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
7232558|NCT00105989|11440415|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7232559|NCT00105989|11440416|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
7232560|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
7232561|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
7232562|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
7232563|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
7232564|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7232565|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
7232566|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7232567|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
7232568|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
7232569|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
7232570|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
7232571|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
7232572|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
7232573|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
7232574|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
7232575|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
7232576|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
7232577|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
7232578|NCT00105989|11440415|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7232579|NCT00105989|11440416|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
7232580|NCT00106002|11440432|FG000|Overall Study|Did not take any study drug|1
7232581|NCT00106002|11440432|FG000|Overall Study|Ineligible after Registration|1
7232582|NCT00106028|11440438|FG000|Overall Study|Adverse Event|3
7232583|NCT00106028|11440439|FG001|Overall Study|Adverse Event|2
7232584|NCT00106028|11440438|FG000|Overall Study|Protocol Violation|1
7232585|NCT00106028|11440439|FG001|Overall Study|Protocol Violation|1
7232586|NCT00106028|11440438|FG000|Overall Study|Withdrawal by Subject|2
7232587|NCT00106028|11440439|FG001|Overall Study|Withdrawal by Subject|8
7232588|NCT00106028|11440438|FG000|Overall Study|Lost to Follow-up|0
7232589|NCT00106028|11440439|FG001|Overall Study|Lost to Follow-up|1
7232590|NCT00106080|11440449|FG000|Overall Study|Withdrew/Loss to follow-up|43
7232591|NCT00106080|11440450|FG001|Overall Study|Withdrew/Loss to follow-up|27
7232592|NCT00106184|11440474|FG000|Overall Study|Withdrawal by Subject|3
7232593|NCT00106184|11440475|FG001|Overall Study|Withdrawal by Subject|2
7232594|NCT00106249|11440485|FG000|Overall Study|Lost to Follow-up|3
7232595|NCT00106249|11440486|FG001|Overall Study|Lost to Follow-up|2
7232596|NCT00106353|11440494|FG000|Part 1|Disease progression|3
7232597|NCT00106353|11440495|FG001|Part 1|Disease progression|4
7232598|NCT00106353|11440496|FG002|Part 1|Disease progression|1
7232599|NCT00106353|11440497|FG003|Part 1|Disease progression|3
7232600|NCT00106353|11440498|FG004|Part 1|Disease progression|0
7232601|NCT00106353|11440499|FG005|Part 1|Disease progression|0
7232602|NCT00106353|11440500|FG006|Part 1|Disease progression|0
7232603|NCT00106353|11440494|FG000|Part 1|Withdrawal by Subject|0
7232604|NCT00106353|11440495|FG001|Part 1|Withdrawal by Subject|0
7232605|NCT00106353|11440496|FG002|Part 1|Withdrawal by Subject|1
7232606|NCT00106353|11440497|FG003|Part 1|Withdrawal by Subject|2
7232607|NCT00106353|11440498|FG004|Part 1|Withdrawal by Subject|0
7232608|NCT00106353|11440499|FG005|Part 1|Withdrawal by Subject|0
7232609|NCT00106353|11440500|FG006|Part 1|Withdrawal by Subject|0
7232610|NCT00106353|11440494|FG000|Part 1|Symptomatic deterioration|0
7232611|NCT00106353|11440495|FG001|Part 1|Symptomatic deterioration|0
7232612|NCT00106353|11440496|FG002|Part 1|Symptomatic deterioration|1
7232613|NCT00106353|11440497|FG003|Part 1|Symptomatic deterioration|0
7232614|NCT00106353|11440498|FG004|Part 1|Symptomatic deterioration|0
7232615|NCT00106353|11440499|FG005|Part 1|Symptomatic deterioration|0
7232616|NCT00106353|11440500|FG006|Part 1|Symptomatic deterioration|0
7232617|NCT00106353|11440494|FG000|Part 1|Entered follow-up phase|1
7232618|NCT00106353|11440495|FG001|Part 1|Entered follow-up phase|1
7232619|NCT00106353|11440496|FG002|Part 1|Entered follow-up phase|0
7232620|NCT00106353|11440497|FG003|Part 1|Entered follow-up phase|1
7232621|NCT00106353|11440498|FG004|Part 1|Entered follow-up phase|0
7232622|NCT00106353|11440499|FG005|Part 1|Entered follow-up phase|0
7232623|NCT00106353|11440500|FG006|Part 1|Entered follow-up phase|0
7232624|NCT00106353|11440494|FG000|Part 1|Adverse Event|0
7232625|NCT00106353|11440495|FG001|Part 1|Adverse Event|0
7232626|NCT00106353|11440496|FG002|Part 1|Adverse Event|0
7232627|NCT00106353|11440497|FG003|Part 1|Adverse Event|1
7232628|NCT00106353|11440498|FG004|Part 1|Adverse Event|0
7232629|NCT00106353|11440499|FG005|Part 1|Adverse Event|0
7232630|NCT00106353|11440500|FG006|Part 1|Adverse Event|0
7232631|NCT00106353|11440494|FG000|Part 2|Disease progression|0
7232632|NCT00106353|11440495|FG001|Part 2|Disease progression|0
7232633|NCT00106353|11440496|FG002|Part 2|Disease progression|0
7232634|NCT00106353|11440497|FG003|Part 2|Disease progression|0
7232635|NCT00106353|11440498|FG004|Part 2|Disease progression|8
7232636|NCT00106353|11440499|FG005|Part 2|Disease progression|14
7232637|NCT00106353|11440500|FG006|Part 2|Disease progression|13
7232638|NCT00106353|11440494|FG000|Part 2|Death|0
7232639|NCT00106353|11440495|FG001|Part 2|Death|0
7232640|NCT00106353|11440496|FG002|Part 2|Death|0
7232641|NCT00106353|11440497|FG003|Part 2|Death|0
7232642|NCT00106353|11440498|FG004|Part 2|Death|3
7232643|NCT00106353|11440499|FG005|Part 2|Death|0
7573390|NCT03613649|11954541|FG006|Fourth Treatment|Protocol Violation|0
7232644|NCT00106353|11440500|FG006|Part 2|Death|1
7232645|NCT00106353|11440494|FG000|Part 2|Symptomatic deterioration|0
7232646|NCT00106353|11440495|FG001|Part 2|Symptomatic deterioration|0
7232647|NCT00106353|11440496|FG002|Part 2|Symptomatic deterioration|0
7232648|NCT00106353|11440497|FG003|Part 2|Symptomatic deterioration|0
7232649|NCT00106353|11440498|FG004|Part 2|Symptomatic deterioration|3
7232650|NCT00106353|11440499|FG005|Part 2|Symptomatic deterioration|0
7232651|NCT00106353|11440500|FG006|Part 2|Symptomatic deterioration|0
7232652|NCT00106353|11440494|FG000|Part 2|Adverse Event|0
7232653|NCT00106353|11440495|FG001|Part 2|Adverse Event|0
7232654|NCT00106353|11440496|FG002|Part 2|Adverse Event|0
7232655|NCT00106353|11440497|FG003|Part 2|Adverse Event|0
7232656|NCT00106353|11440498|FG004|Part 2|Adverse Event|0
7232657|NCT00106353|11440499|FG005|Part 2|Adverse Event|2
7232658|NCT00106353|11440500|FG006|Part 2|Adverse Event|1
7232659|NCT00106353|11440494|FG000|Part 2|Other|0
7232660|NCT00106353|11440495|FG001|Part 2|Other|0
7232661|NCT00106353|11440496|FG002|Part 2|Other|0
7232662|NCT00106353|11440497|FG003|Part 2|Other|0
7232663|NCT00106353|11440498|FG004|Part 2|Other|1
7232664|NCT00106353|11440499|FG005|Part 2|Other|1
7232665|NCT00106353|11440500|FG006|Part 2|Other|1
7232666|NCT00106353|11440494|FG000|Part 2|Withdrawal by Subject|0
7232667|NCT00106353|11440495|FG001|Part 2|Withdrawal by Subject|0
7232668|NCT00106353|11440496|FG002|Part 2|Withdrawal by Subject|0
7232669|NCT00106353|11440497|FG003|Part 2|Withdrawal by Subject|0
7232670|NCT00106353|11440498|FG004|Part 2|Withdrawal by Subject|1
7232671|NCT00106353|11440499|FG005|Part 2|Withdrawal by Subject|0
7232672|NCT00106353|11440500|FG006|Part 2|Withdrawal by Subject|0
7232673|NCT00106353|11440494|FG000|Part 2|Physician Decision|0
7232674|NCT00106353|11440495|FG001|Part 2|Physician Decision|0
7232675|NCT00106353|11440496|FG002|Part 2|Physician Decision|0
7232676|NCT00106353|11440497|FG003|Part 2|Physician Decision|0
7232677|NCT00106353|11440498|FG004|Part 2|Physician Decision|0
7232678|NCT00106353|11440499|FG005|Part 2|Physician Decision|1
7232679|NCT00106353|11440500|FG006|Part 2|Physician Decision|0
7232680|NCT00106639|11440555|FG000|Overall Study|Adverse Event|3
7232681|NCT00106639|11440556|FG001|Overall Study|Adverse Event|4
7232682|NCT00106639|11440557|FG002|Overall Study|Adverse Event|1
7232683|NCT00106639|11440555|FG000|Overall Study|Protocol Violation|0
7232684|NCT00106639|11440556|FG001|Overall Study|Protocol Violation|1
7232685|NCT00106639|11440557|FG002|Overall Study|Protocol Violation|0
7232686|NCT00106639|11440555|FG000|Overall Study|Withdrawal by Subject|0
7232687|NCT00106639|11440556|FG001|Overall Study|Withdrawal by Subject|1
7232688|NCT00106639|11440557|FG002|Overall Study|Withdrawal by Subject|0
7232689|NCT00106639|11440555|FG000|Overall Study|Participant defaulted|0
7232690|NCT00106639|11440556|FG001|Overall Study|Participant defaulted|1
7232691|NCT00106639|11440557|FG002|Overall Study|Participant defaulted|1
7232692|NCT00106704|11440568|FG000|Overall Study|Adverse Event|10
7232693|NCT00106704|11440569|FG001|Overall Study|Adverse Event|7
7232694|NCT00106704|11440568|FG000|Overall Study|Death|2
7232695|NCT00106704|11440569|FG001|Overall Study|Death|1
7232696|NCT00106704|11440568|FG000|Overall Study|Lack of Efficacy|67
7232697|NCT00106704|11440569|FG001|Overall Study|Lack of Efficacy|69
7232698|NCT00106704|11440568|FG000|Overall Study|Lost to Follow-up|7
7232699|NCT00106704|11440569|FG001|Overall Study|Lost to Follow-up|3
7232700|NCT00106704|11440568|FG000|Overall Study|Pregnancy|1
7232701|NCT00106704|11440569|FG001|Overall Study|Pregnancy|0
7232702|NCT00106704|11440568|FG000|Overall Study|Protocol Violation|4
7232703|NCT00106704|11440569|FG001|Overall Study|Protocol Violation|7
7232704|NCT00106704|11440568|FG000|Overall Study|Withdrawal by Subject|14
7232705|NCT00106704|11440569|FG001|Overall Study|Withdrawal by Subject|21
7232706|NCT00106704|11440568|FG000|Overall Study|Patient moved|1
7232707|NCT00106704|11440569|FG001|Overall Study|Patient moved|0
7232708|NCT00106704|11440568|FG000|Overall Study|Site terminated|0
7232709|NCT00106704|11440569|FG001|Overall Study|Site terminated|1
7232710|NCT00106704|11440568|FG000|Overall Study|Planned major surgery|1
7232711|NCT00106704|11440569|FG001|Overall Study|Planned major surgery|0
7232712|NCT00106704|11440568|FG000|Overall Study|Patient Received Glycemic Medication|22
7232713|NCT00106704|11440569|FG001|Overall Study|Patient Received Glycemic Medication|41
7232714|NCT00106704|11440568|FG000|Overall Study|Unable to re-enter US|1
7232715|NCT00106704|11440569|FG001|Overall Study|Unable to re-enter US|0
7232716|NCT00106704|11440568|FG000|Overall Study|Laboratory test|1
7232717|NCT00106704|11440569|FG001|Overall Study|Laboratory test|1
7232718|NCT00106964|11440587|FG000|Overall Study|Lost to Follow-up|8
7232719|NCT00106964|11440588|FG001|Overall Study|Lost to Follow-up|6
7232720|NCT00106964|11440589|FG002|Overall Study|Lost to Follow-up|2
7232721|NCT00106964|11440587|FG000|Overall Study|Pregnancy|2
7232722|NCT00106964|11440588|FG001|Overall Study|Pregnancy|3
7232723|NCT00106964|11440589|FG002|Overall Study|Pregnancy|2
7232724|NCT00106964|11440587|FG000|Overall Study|Death|1
7232725|NCT00106964|11440588|FG001|Overall Study|Death|1
7232726|NCT00106964|11440589|FG002|Overall Study|Death|0
7232727|NCT00106964|11440587|FG000|Overall Study|Incarceration|0
7232728|NCT00106964|11440588|FG001|Overall Study|Incarceration|1
7232729|NCT00106964|11440589|FG002|Overall Study|Incarceration|0
7232730|NCT00106964|11440587|FG000|Overall Study|Site Funding Terminated|0
7232731|NCT00106964|11440588|FG001|Overall Study|Site Funding Terminated|1
7232732|NCT00106964|11440589|FG002|Overall Study|Site Funding Terminated|1
7232733|NCT00106964|11440587|FG000|Overall Study|Failure to adhere|2
7232734|NCT00106964|11440588|FG001|Overall Study|Failure to adhere|0
7232735|NCT00106964|11440589|FG002|Overall Study|Failure to adhere|0
7232736|NCT00106964|11440587|FG000|Overall Study|Did not meet eligibility criteria|0
7232737|NCT00106964|11440588|FG001|Overall Study|Did not meet eligibility criteria|2
7232738|NCT00106964|11440589|FG002|Overall Study|Did not meet eligibility criteria|2
7232739|NCT00106964|11440587|FG000|Overall Study|Required disallowed medication|0
7232740|NCT00106964|11440588|FG001|Overall Study|Required disallowed medication|1
7232741|NCT00106964|11440589|FG002|Overall Study|Required disallowed medication|0
7232742|NCT00107042|11440608|FG000|Overall Study|Lost to Follow-up|9
7232743|NCT00107042|11440609|FG001|Overall Study|Lost to Follow-up|7
7232744|NCT00107042|11440608|FG000|Overall Study|Withdrawal by Subject|6
7232745|NCT00107042|11440609|FG001|Overall Study|Withdrawal by Subject|1
7232746|NCT00107042|11440608|FG000|Overall Study|Moved out of area|5
7232747|NCT00107042|11440609|FG001|Overall Study|Moved out of area|3
7232748|NCT00107042|11440608|FG000|Overall Study|Pregnancy|1
7232749|NCT00107042|11440609|FG001|Overall Study|Pregnancy|1
7232750|NCT00107042|11440608|FG000|Overall Study|Inadvertent enrollment|0
7232751|NCT00107042|11440609|FG001|Overall Study|Inadvertent enrollment|1
7232752|NCT00107042|11440608|FG000|Overall Study|vaccinated outside window|1
7232753|NCT00107042|11440609|FG001|Overall Study|vaccinated outside window|1
7232754|NCT00107042|11440608|FG000|Overall Study|Disallowed medications|0
7232755|NCT00107042|11440609|FG001|Overall Study|Disallowed medications|2
7232756|NCT00107120|11440659|FG000|Overall Study|Adverse Event|4
7232757|NCT00107120|11440660|FG001|Overall Study|Adverse Event|1
7232758|NCT00107120|11440659|FG000|Overall Study|Lack of Efficacy|5
7232759|NCT00107120|11440660|FG001|Overall Study|Lack of Efficacy|5
7232760|NCT00107120|11440659|FG000|Overall Study|Protocol Violation|3
7232761|NCT00107120|11440660|FG001|Overall Study|Protocol Violation|0
7232762|NCT00107120|11440659|FG000|Overall Study|Withdrawal by Subject|8
7232763|NCT00107120|11440660|FG001|Overall Study|Withdrawal by Subject|9
7232764|NCT00107120|11440659|FG000|Overall Study|Lost to Follow-up|8
7232765|NCT00107120|11440660|FG001|Overall Study|Lost to Follow-up|6
7232766|NCT00107120|11440659|FG000|Overall Study|Pregnancy|0
7232767|NCT00107120|11440660|FG001|Overall Study|Pregnancy|1
7232768|NCT00107120|11440659|FG000|Overall Study|moving away from site|1
7232769|NCT00107120|11440660|FG001|Overall Study|moving away from site|1
7232770|NCT00107120|11440659|FG000|Overall Study|death of parent|0
7232771|NCT00107120|11440660|FG001|Overall Study|death of parent|1
7232772|NCT00107172|11440668|FG000|Overall Study|Withdrawal by Subject|1
7232773|NCT00107172|11440669|FG001|Overall Study|Withdrawal by Subject|0
7232774|NCT00107172|11440668|FG000|Overall Study|Death|0
7232775|NCT00107172|11440669|FG001|Overall Study|Death|2
7232776|NCT00107172|11440668|FG000|Overall Study|Other Reason|4
7232777|NCT00107172|11440669|FG001|Overall Study|Other Reason|3
7232783|NCT00107276|11440679|FG000|Overall Study|Progression|46
7232784|NCT00107276|11440679|FG000|Overall Study|Adverse Event|6
7232785|NCT00107276|11440679|FG000|Overall Study|M.D. decision|2
7232786|NCT00107276|11440679|FG000|Overall Study|Patient refusal|1
7232787|NCT00107276|11440679|FG000|Overall Study|Death|1
7232788|NCT00107276|11440679|FG000|Overall Study|Ineligible|16
7232789|NCT00107380|11440684|FG000|Overall Study|Adverse Event|7
7232790|NCT00107380|11440684|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
7232791|NCT00107380|11440684|FG000|Overall Study|Progression/relapse|4
7232792|NCT00107380|11440684|FG000|Overall Study|Death|3
7232793|NCT00107380|11440684|FG000|Overall Study|Other - not protocol specified|7
7232794|NCT00107380|11440684|FG000|Overall Study|Ineligible|2
7232795|NCT00107653|11440704|FG000|Overall Study|Adverse Event|24
7232796|NCT00107653|11440705|FG001|Overall Study|Adverse Event|43
7232797|NCT00107653|11440704|FG000|Overall Study|Insufficient Therapeutic Response|25
7232798|NCT00107653|11440705|FG001|Overall Study|Insufficient Therapeutic Response|11
7232799|NCT00107653|11440704|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7232800|NCT00107653|11440705|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7232801|NCT00107653|11440704|FG000|Overall Study|Protocol Violation|1
7232802|NCT00107653|11440705|FG001|Overall Study|Protocol Violation|0
7232803|NCT00107653|11440704|FG000|Overall Study|Withdrawal by Subject|12
7232804|NCT00107653|11440705|FG001|Overall Study|Withdrawal by Subject|13
7232805|NCT00107653|11440704|FG000|Overall Study|Lost to Follow-up|13
7232806|NCT00107653|11440705|FG001|Overall Study|Lost to Follow-up|5
7232807|NCT00107653|11440704|FG000|Overall Study|Administrative Reasons|3
7232808|NCT00107653|11440705|FG001|Overall Study|Administrative Reasons|3
7232809|NCT00107783|11440726|FG000|Overall Study|Adverse Event|0
7232810|NCT00107783|11440727|FG001|Overall Study|Adverse Event|2
7232811|NCT00107783|11440726|FG000|Overall Study|Death|0
7232812|NCT00107783|11440727|FG001|Overall Study|Death|1
7232813|NCT00107783|11440726|FG000|Overall Study|Withdrawal by Subject|2
7232814|NCT00107783|11440727|FG001|Overall Study|Withdrawal by Subject|0
7232815|NCT00107783|11440726|FG000|Overall Study|Second hip replacement|1
7232816|NCT00107783|11440727|FG001|Overall Study|Second hip replacement|1
7232817|NCT00107900|11440739|FG000|Overall Study|Adverse Event|3
7232818|NCT00107900|11440740|FG001|Overall Study|Adverse Event|2
7232819|NCT00107900|11440741|FG002|Overall Study|Adverse Event|10
7232820|NCT00107900|11440742|FG003|Overall Study|Adverse Event|3
7232821|NCT00107900|11440743|FG004|Overall Study|Adverse Event|5
7232822|NCT00107900|11440744|FG005|Overall Study|Adverse Event|3
7232823|NCT00107900|11440739|FG000|Overall Study|Death|0
7232824|NCT00107900|11440740|FG001|Overall Study|Death|0
7232825|NCT00107900|11440741|FG002|Overall Study|Death|0
7232826|NCT00107900|11440742|FG003|Overall Study|Death|0
7232827|NCT00107900|11440743|FG004|Overall Study|Death|1
7232828|NCT00107900|11440744|FG005|Overall Study|Death|0
7232829|NCT00107900|11440739|FG000|Overall Study|Lost to Follow-up|4
7232830|NCT00107900|11440740|FG001|Overall Study|Lost to Follow-up|1
7232831|NCT00107900|11440741|FG002|Overall Study|Lost to Follow-up|3
7232832|NCT00107900|11440742|FG003|Overall Study|Lost to Follow-up|2
7232833|NCT00107900|11440743|FG004|Overall Study|Lost to Follow-up|5
7232834|NCT00107900|11440744|FG005|Overall Study|Lost to Follow-up|5
7232835|NCT00107900|11440739|FG000|Overall Study|Protocol Violation|1
7232836|NCT00107900|11440740|FG001|Overall Study|Protocol Violation|0
7232837|NCT00107900|11440741|FG002|Overall Study|Protocol Violation|5
7232838|NCT00107900|11440742|FG003|Overall Study|Protocol Violation|5
7232839|NCT00107900|11440743|FG004|Overall Study|Protocol Violation|7
7232840|NCT00107900|11440744|FG005|Overall Study|Protocol Violation|0
7232841|NCT00107900|11440739|FG000|Overall Study|Withdrawal by Subject|1
7232842|NCT00107900|11440740|FG001|Overall Study|Withdrawal by Subject|0
7232843|NCT00107900|11440741|FG002|Overall Study|Withdrawal by Subject|5
7232844|NCT00107900|11440742|FG003|Overall Study|Withdrawal by Subject|0
7232845|NCT00107900|11440743|FG004|Overall Study|Withdrawal by Subject|1
7232846|NCT00107900|11440744|FG005|Overall Study|Withdrawal by Subject|1
7232847|NCT00107900|11440739|FG000|Overall Study|Administrative Reasons|1
7232848|NCT00107900|11440740|FG001|Overall Study|Administrative Reasons|0
7232849|NCT00107900|11440741|FG002|Overall Study|Administrative Reasons|2
7232850|NCT00107900|11440742|FG003|Overall Study|Administrative Reasons|2
7232851|NCT00107900|11440743|FG004|Overall Study|Administrative Reasons|2
7232852|NCT00107900|11440744|FG005|Overall Study|Administrative Reasons|0
7232853|NCT00107952|11440760|FG000|Overall Study|Death|75
7232854|NCT00107952|11440761|FG001|Overall Study|Death|61
7232855|NCT00107952|11440760|FG000|Overall Study|Lost to Follow-up|0
7232856|NCT00107952|11440761|FG001|Overall Study|Lost to Follow-up|3
7232857|NCT00107952|11440760|FG000|Overall Study|Withdrawal by Subject|9
7232858|NCT00107952|11440761|FG001|Overall Study|Withdrawal by Subject|6
7232859|NCT00107952|11440760|FG000|Overall Study|Other|2
7232860|NCT00107952|11440761|FG001|Overall Study|Other|5
7232861|NCT00107952|11440760|FG000|Overall Study|Never received study treatment|9
7232862|NCT00107952|11440761|FG001|Overall Study|Never received study treatment|6
7232863|NCT00107978|11440769|FG000|Overall Study|Adverse Event|1
7232864|NCT00107978|11440770|FG001|Overall Study|Adverse Event|5
7232865|NCT00107978|11440769|FG000|Overall Study|Death|3
7232866|NCT00107978|11440770|FG001|Overall Study|Death|3
7232867|NCT00107978|11440769|FG000|Overall Study|Lost to Follow-up|20
7232868|NCT00107978|11440770|FG001|Overall Study|Lost to Follow-up|28
7232869|NCT00107978|11440769|FG000|Overall Study|Withdrawal by Subject|4
7232870|NCT00107978|11440770|FG001|Overall Study|Withdrawal by Subject|9
7232871|NCT00107978|11440769|FG000|Overall Study|Protocol Violation|0
7232872|NCT00107978|11440770|FG001|Overall Study|Protocol Violation|1
7232873|NCT00107978|11440769|FG000|Overall Study|Other|5
7232874|NCT00107978|11440770|FG001|Overall Study|Other|4
7232875|NCT00107991|11440776|FG000|Eligibility Assessment|Disease not severe enough|7
7232876|NCT00107991|11440776|FG000|Eligibility Assessment|Unwilling to participate|7
7232877|NCT00107991|11440776|FG000|Eligibility Assessment|Positive purified protein derivative|4
7232878|NCT00107991|11440776|FG000|Eligibility Assessment|Abnormal labs|2
7232879|NCT00107991|11440776|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
7232880|NCT00107991|11440776|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
7232881|NCT00107991|11440776|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
7232882|NCT00107991|11440776|FG000|12 Week Treatment Period|Lack of Efficacy|2
7232883|NCT00107991|11440776|FG000|12 Week Treatment Period|Adverse Event|1
7232884|NCT00107991|11440776|FG000|12 Week Treatment Period|Protocol Violation|1
7232885|NCT00107991|11440776|FG000|12 Week Treatment Period|Incarcerated|1
7232886|NCT00107991|11440776|FG000|18-Week Post Treatment Assessment|Adverse Event|2
7232887|NCT00108069|11440782|FG000|Overall Study|Never rec'd study drug|0
7232888|NCT00108069|11440783|FG001|Overall Study|Never rec'd study drug|1
7232889|NCT00108069|11440782|FG000|Overall Study|Adverse Event|1
7232890|NCT00108069|11440783|FG001|Overall Study|Adverse Event|1
7232891|NCT00108069|11440782|FG000|Overall Study|Withdrawal by Subject|1
7232892|NCT00108069|11440783|FG001|Overall Study|Withdrawal by Subject|0
7232893|NCT00108069|11440782|FG000|Overall Study|Death|1
7232894|NCT00108069|11440783|FG001|Overall Study|Death|0
7232895|NCT00108069|11440782|FG000|Overall Study|Progessive disease|27
7232896|NCT00108069|11440783|FG001|Overall Study|Progessive disease|11
7232897|NCT00108082|11440798|FG000|Overall Study|Adverse Event|14
7232898|NCT00108082|11440799|FG001|Overall Study|Adverse Event|12
7232899|NCT00108082|11440800|FG002|Overall Study|Adverse Event|17
7232900|NCT00108082|11440798|FG000|Overall Study|Lost to Follow-up|6
7232901|NCT00108082|11440799|FG001|Overall Study|Lost to Follow-up|3
7232902|NCT00108082|11440800|FG002|Overall Study|Lost to Follow-up|7
7232903|NCT00108082|11440798|FG000|Overall Study|Consent Withdrawn|3
7232904|NCT00108082|11440799|FG001|Overall Study|Consent Withdrawn|3
7232905|NCT00108082|11440800|FG002|Overall Study|Consent Withdrawn|5
7232906|NCT00108082|11440798|FG000|Overall Study|Protocol Violation|1
7232907|NCT00108082|11440799|FG001|Overall Study|Protocol Violation|2
7232908|NCT00108082|11440800|FG002|Overall Study|Protocol Violation|0
7232909|NCT00108082|11440798|FG000|Overall Study|Lack of Efficacy|3
7232910|NCT00108082|11440799|FG001|Overall Study|Lack of Efficacy|1
7573391|NCT03613649|11954542|FG007|Fourth Treatment|Protocol Violation|0
7573392|NCT03613649|11954543|FG008|Fourth Treatment|Protocol Violation|0
7232911|NCT00108082|11440800|FG002|Overall Study|Lack of Efficacy|2
7232912|NCT00108082|11440798|FG000|Overall Study|Amendment 4: > Month 12|5
7232913|NCT00108082|11440799|FG001|Overall Study|Amendment 4: > Month 12|7
7232914|NCT00108082|11440800|FG002|Overall Study|Amendment 4: > Month 12|5
7232915|NCT00108082|11440798|FG000|Overall Study|Woman of Child-bearing Potential|2
7232916|NCT00108082|11440799|FG001|Overall Study|Woman of Child-bearing Potential|0
7232917|NCT00108082|11440800|FG002|Overall Study|Woman of Child-bearing Potential|2
7232918|NCT00108082|11440798|FG000|Overall Study|Incorrectly Randomized|0
7232919|NCT00108082|11440799|FG001|Overall Study|Incorrectly Randomized|0
7232920|NCT00108082|11440800|FG002|Overall Study|Incorrectly Randomized|2
7232921|NCT00108082|11440798|FG000|Overall Study|Non-compliance|1
7232922|NCT00108082|11440799|FG001|Overall Study|Non-compliance|0
7232923|NCT00108082|11440800|FG002|Overall Study|Non-compliance|2
7232924|NCT00108082|11440798|FG000|Overall Study|Stopped Study Medication|0
7232925|NCT00108082|11440799|FG001|Overall Study|Stopped Study Medication|0
7232926|NCT00108082|11440800|FG002|Overall Study|Stopped Study Medication|1
7232927|NCT00108082|11440798|FG000|Overall Study|Site Closed Study|0
7232928|NCT00108082|11440799|FG001|Overall Study|Site Closed Study|2
7232929|NCT00108082|11440800|FG002|Overall Study|Site Closed Study|0
7232930|NCT00108082|11440798|FG000|Overall Study|Protocol Amendment|0
7232931|NCT00108082|11440799|FG001|Overall Study|Protocol Amendment|1
7232932|NCT00108082|11440800|FG002|Overall Study|Protocol Amendment|0
7232933|NCT00108082|11440798|FG000|Overall Study|Study Medication Not Tapered|0
7232934|NCT00108082|11440799|FG001|Overall Study|Study Medication Not Tapered|1
7232935|NCT00108082|11440800|FG002|Overall Study|Study Medication Not Tapered|0
7232936|NCT00108082|11440798|FG000|Overall Study|Subject Left Site Location|1
7232937|NCT00108082|11440799|FG001|Overall Study|Subject Left Site Location|0
7232938|NCT00108082|11440800|FG002|Overall Study|Subject Left Site Location|0
7232939|NCT00108082|11440798|FG000|Overall Study|Investigator Not at Site|1
7232940|NCT00108082|11440799|FG001|Overall Study|Investigator Not at Site|0
7232941|NCT00108082|11440800|FG002|Overall Study|Investigator Not at Site|0
7232942|NCT00108082|11440798|FG000|Overall Study|Blood Pressure Not Controlled|1
7232943|NCT00108082|11440799|FG001|Overall Study|Blood Pressure Not Controlled|0
7232944|NCT00108082|11440800|FG002|Overall Study|Blood Pressure Not Controlled|0
7232945|NCT00108160|11440810|FG000|Overall Study|Lost to Follow-up|25
7573393|NCT03613649|11954544|FG009|Fourth Treatment|Protocol Violation|0
7573394|NCT03613649|11954545|FG010|Fourth Treatment|Protocol Violation|0
7573395|NCT03613649|11954546|FG011|Fourth Treatment|Protocol Violation|0
7573396|NCT03613649|11954535|FG000|Fourth Treatment|Physician Decision|0
7573397|NCT03613649|11954536|FG001|Fourth Treatment|Physician Decision|0
7573398|NCT03613649|11954537|FG002|Fourth Treatment|Physician Decision|0
7573399|NCT03613649|11954538|FG003|Fourth Treatment|Physician Decision|0
7573400|NCT03613649|11954539|FG004|Fourth Treatment|Physician Decision|0
7573401|NCT03613649|11954540|FG005|Fourth Treatment|Physician Decision|0
7573402|NCT03613649|11954541|FG006|Fourth Treatment|Physician Decision|1
7573403|NCT03613649|11954542|FG007|Fourth Treatment|Physician Decision|0
7573404|NCT03613649|11954543|FG008|Fourth Treatment|Physician Decision|0
7573405|NCT03613649|11954544|FG009|Fourth Treatment|Physician Decision|0
7573406|NCT03613649|11954545|FG010|Fourth Treatment|Physician Decision|0
7573407|NCT03613649|11954546|FG011|Fourth Treatment|Physician Decision|0
7573408|NCT03614078|11954576|FG000|Overall Study|Withdrawal by Subject|2
7573409|NCT03614078|11954577|FG001|Overall Study|Withdrawal by Subject|2
7573410|NCT03614078|11954578|FG002|Overall Study|Withdrawal by Subject|3
7232946|NCT00108160|11440811|FG001|Overall Study|Lost to Follow-up|12
7232947|NCT00108160|11440810|FG000|Overall Study|Death|1
7232948|NCT00108160|11440811|FG001|Overall Study|Death|2
7232949|NCT00108160|11440810|FG000|Overall Study|Withdrawal by Subject|4
7232950|NCT00108160|11440811|FG001|Overall Study|Withdrawal by Subject|2
7232951|NCT00108160|11440810|FG000|Overall Study|Protocol Violation|9
7232952|NCT00108160|11440811|FG001|Overall Study|Protocol Violation|5
7232953|NCT00108355|11440851|FG000|Overall Study|Peritonitis at index paracentesis|1
7232954|NCT00108355|11440852|FG001|Overall Study|Peritonitis at index paracentesis|1
7232955|NCT00108355|11440851|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
7232956|NCT00108355|11440852|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
7232957|NCT00108485|11440860|FG000|Overall Study|Withdrawal by Subject|3
7232958|NCT00108485|11440861|FG001|Overall Study|Withdrawal by Subject|0
7232959|NCT00108485|11440860|FG000|Overall Study|Lost to Follow-up|0
7232960|NCT00108485|11440861|FG001|Overall Study|Lost to Follow-up|2
7232961|NCT00108628|11440887|FG000|Overall Study|Withdrawal by Subject|17
7232962|NCT00108628|11440888|FG001|Overall Study|Withdrawal by Subject|9
7232963|NCT00108628|11440887|FG000|Overall Study|Lack of Efficacy|2
7232964|NCT00108628|11440888|FG001|Overall Study|Lack of Efficacy|1
7232965|NCT00108628|11440887|FG000|Overall Study|Death|1
7232966|NCT00108628|11440888|FG001|Overall Study|Death|0
7232967|NCT00108732|11440894|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
7232968|NCT00108732|11440894|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
7232969|NCT00108732|11440894|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
7232970|NCT00108732|11440894|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
7573411|NCT03614078|11954576|FG000|Overall Study|Participant Did Not Return for Visit|0
7573412|NCT03614078|11954577|FG001|Overall Study|Participant Did Not Return for Visit|1
7573413|NCT03614078|11954578|FG002|Overall Study|Participant Did Not Return for Visit|0
7573414|NCT03614078|11954576|FG000|Overall Study|High Neutrophils|0
7232971|NCT00108732|11440894|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
7232972|NCT00108732|11440894|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
7232973|NCT00108732|11440894|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
7232974|NCT00108745|11440901|FG000|Overall Study|Withdrawal by Subject|19
7232975|NCT00108745|11440902|FG001|Overall Study|Withdrawal by Subject|12
7232976|NCT00108745|11440903|FG002|Overall Study|Withdrawal by Subject|12
7232977|NCT00108745|11440901|FG000|Overall Study|Never Treated|8
7232978|NCT00108745|11440902|FG001|Overall Study|Never Treated|10
7232979|NCT00108745|11440903|FG002|Overall Study|Never Treated|12
7232980|NCT00108745|11440901|FG000|Overall Study|Ineligible|7
7232981|NCT00108745|11440902|FG001|Overall Study|Ineligible|13
7232982|NCT00108745|11440903|FG002|Overall Study|Ineligible|13
7232983|NCT00108862|11440913|FG000|Overall Study|Death|31
7232984|NCT00108862|11440914|FG001|Overall Study|Death|37
7232985|NCT00108862|11440913|FG000|Overall Study|Withdrawal by Subject|10
7232986|NCT00108862|11440914|FG001|Overall Study|Withdrawal by Subject|6
7232987|NCT00108862|11440913|FG000|Overall Study|Lost to Follow-up|27
7232988|NCT00108862|11440914|FG001|Overall Study|Lost to Follow-up|19
7232989|NCT00108953|11440922|FG000|Follow-up|Death|18
7232990|NCT00108953|11440923|FG001|Follow-up|Death|26
7232991|NCT00108953|11440922|FG000|Follow-up|Lost to Follow-up|1
7232992|NCT00108953|11440923|FG001|Follow-up|Lost to Follow-up|1
7232993|NCT00108953|11440922|FG000|Follow-up|Study terminated by sponsor|10
7232994|NCT00108953|11440923|FG001|Follow-up|Study terminated by sponsor|6
7232995|NCT00109031|11440945|FG000|Overall Study|Adverse Event|0
7232996|NCT00109031|11440946|FG001|Overall Study|Adverse Event|0
7232997|NCT00109031|11440947|FG002|Overall Study|Adverse Event|1
7232998|NCT00109031|11440948|FG003|Overall Study|Adverse Event|0
7232999|NCT00109031|11440945|FG000|Overall Study|Withdrawal by Subject|0
7233000|NCT00109031|11440946|FG001|Overall Study|Withdrawal by Subject|1
7233001|NCT00109031|11440947|FG002|Overall Study|Withdrawal by Subject|0
7233002|NCT00109031|11440948|FG003|Overall Study|Withdrawal by Subject|0
7233003|NCT00109031|11440945|FG000|Overall Study|Physician Decision|0
7233004|NCT00109031|11440946|FG001|Overall Study|Physician Decision|1
7233005|NCT00109031|11440947|FG002|Overall Study|Physician Decision|0
7233006|NCT00109031|11440948|FG003|Overall Study|Physician Decision|0
7233007|NCT00109031|11440945|FG000|Overall Study|Protocol Violation|0
7233008|NCT00109031|11440946|FG001|Overall Study|Protocol Violation|0
7233009|NCT00109031|11440947|FG002|Overall Study|Protocol Violation|1
7233010|NCT00109031|11440948|FG003|Overall Study|Protocol Violation|0
7233011|NCT00109343|11440961|FG000|Overall Study|Adverse Event|1
7233012|NCT00109343|11440962|FG001|Overall Study|Adverse Event|0
7233013|NCT00109343|11440963|FG002|Overall Study|Adverse Event|2
7233014|NCT00109343|11440961|FG000|Overall Study|Lack of Efficacy|1
7233015|NCT00109343|11440962|FG001|Overall Study|Lack of Efficacy|0
7233016|NCT00109343|11440963|FG002|Overall Study|Lack of Efficacy|0
7233017|NCT00109343|11440961|FG000|Overall Study|Lost to Follow-up|35
7233018|NCT00109343|11440962|FG001|Overall Study|Lost to Follow-up|20
7233019|NCT00109343|11440963|FG002|Overall Study|Lost to Follow-up|14
7233020|NCT00109343|11440961|FG000|Overall Study|Protocol Violation|1
7233021|NCT00109343|11440962|FG001|Overall Study|Protocol Violation|2
7233022|NCT00109343|11440963|FG002|Overall Study|Protocol Violation|2
7233023|NCT00109343|11440961|FG000|Overall Study|Withdrawal by Subject|15
7233024|NCT00109343|11440962|FG001|Overall Study|Withdrawal by Subject|11
7233025|NCT00109343|11440963|FG002|Overall Study|Withdrawal by Subject|10
7233026|NCT00109343|11440961|FG000|Overall Study|Subject Moved|6
7233027|NCT00109343|11440962|FG001|Overall Study|Subject Moved|2
7233028|NCT00109343|11440963|FG002|Overall Study|Subject Moved|1
7233029|NCT00109343|11440961|FG000|Overall Study|Other|5
7233030|NCT00109343|11440962|FG001|Overall Study|Other|2
7233031|NCT00109343|11440963|FG002|Overall Study|Other|1
7233032|NCT00109577|11440985|FG000|Overall Study|Withdrawal by Subject|3
7233033|NCT00109577|11440986|FG001|Overall Study|Withdrawal by Subject|3
7233034|NCT00109590|11440995|FG000|Overall Study|Lost to Follow-up|1
7233035|NCT00109590|11440996|FG001|Overall Study|Lost to Follow-up|0
7233036|NCT00109590|11440997|FG002|Overall Study|Lost to Follow-up|1
7233037|NCT00109590|11440995|FG000|Overall Study|Never Started Treatment|1
7233038|NCT00109590|11440996|FG001|Overall Study|Never Started Treatment|2
7233039|NCT00109590|11440997|FG002|Overall Study|Never Started Treatment|3
7233040|NCT00109707|11441022|FG000|Overall Study|Discontinued in core study without entering the extension study|215
7233041|NCT00109707|11441023|FG001|Overall Study|Discontinued in core study without entering the extension study|122
7233042|NCT00109707|11441024|FG002|Overall Study|Discontinued in core study without entering the extension study|34
7233043|NCT00109707|11441022|FG000|Overall Study|Abnormal laboratory values|1
7233044|NCT00109707|11441023|FG001|Overall Study|Abnormal laboratory values|0
7233045|NCT00109707|11441024|FG002|Overall Study|Abnormal laboratory values|0
7233046|NCT00109707|11441022|FG000|Overall Study|Administrative problems|2
7233047|NCT00109707|11441023|FG001|Overall Study|Administrative problems|0
7233048|NCT00109707|11441024|FG002|Overall Study|Administrative problems|1
7233049|NCT00109707|11441022|FG000|Overall Study|Adverse Event|10
7233050|NCT00109707|11441023|FG001|Overall Study|Adverse Event|2
7233051|NCT00109707|11441024|FG002|Overall Study|Adverse Event|3
7233052|NCT00109707|11441022|FG000|Overall Study|Death|4
7233053|NCT00109707|11441023|FG001|Overall Study|Death|0
7233054|NCT00109707|11441024|FG002|Overall Study|Death|0
7233055|NCT00109707|11441022|FG000|Overall Study|Disease progression|12
7233056|NCT00109707|11441023|FG001|Overall Study|Disease progression|4
7233057|NCT00109707|11441024|FG002|Overall Study|Disease progression|3
7233058|NCT00109707|11441022|FG000|Overall Study|Lost to Follow-up|3
7233059|NCT00109707|11441023|FG001|Overall Study|Lost to Follow-up|0
7233060|NCT00109707|11441024|FG002|Overall Study|Lost to Follow-up|0
7233061|NCT00109707|11441022|FG000|Overall Study|Protocol Violation|1
7233062|NCT00109707|11441023|FG001|Overall Study|Protocol Violation|0
7233063|NCT00109707|11441024|FG002|Overall Study|Protocol Violation|0
7233064|NCT00109707|11441022|FG000|Overall Study|Patient withdrew consent|6
7233065|NCT00109707|11441023|FG001|Overall Study|Patient withdrew consent|1
7233066|NCT00109707|11441024|FG002|Overall Study|Patient withdrew consent|0
7233067|NCT00109733|11441038|FG000|Overall Study|Protocol Violation|0
7233068|NCT00109733|11441039|FG001|Overall Study|Protocol Violation|1
7233069|NCT00109733|11441038|FG000|Overall Study|Stopped taking study drug|1
7233070|NCT00109733|11441039|FG001|Overall Study|Stopped taking study drug|1
7233071|NCT00109733|11441038|FG000|Overall Study|Non-compliant|0
7233072|NCT00109733|11441039|FG001|Overall Study|Non-compliant|1
7233073|NCT00109733|11441038|FG000|Overall Study|Could not commit time for study|1
7233074|NCT00109733|11441039|FG001|Overall Study|Could not commit time for study|1
7233075|NCT00109772|11441047|FG000|Double-blind Treatment|Adverse Event|14
7233076|NCT00109772|11441048|FG001|Double-blind Treatment|Adverse Event|5
7233077|NCT00109772|11441047|FG000|Double-blind Treatment|Lack of Efficacy|1
7233078|NCT00109772|11441048|FG001|Double-blind Treatment|Lack of Efficacy|0
7233079|NCT00109772|11441047|FG000|Double-blind Treatment|Withdrawal by Subject|2
7233080|NCT00109772|11441048|FG001|Double-blind Treatment|Withdrawal by Subject|1
7233081|NCT00109772|11441047|FG000|Double-blind Treatment|Lost to Follow-up|2
7233082|NCT00109772|11441048|FG001|Double-blind Treatment|Lost to Follow-up|3
7233083|NCT00109772|11441047|FG000|Double-blind Treatment|Protocol Violation|0
7233084|NCT00109772|11441048|FG001|Double-blind Treatment|Protocol Violation|1
7233085|NCT00109772|11441047|FG000|Double-blind Treatment|Other|0
7233086|NCT00109772|11441048|FG001|Double-blind Treatment|Other|4
7233087|NCT00109772|11441047|FG000|Double-blind Treatment|Withdrew prior to treatment|3
7233088|NCT00109772|11441048|FG001|Double-blind Treatment|Withdrew prior to treatment|1
7233089|NCT00109772|11441047|FG000|Open-label Extension|Adverse Event|10
7233090|NCT00109772|11441048|FG001|Open-label Extension|Adverse Event|19
7233091|NCT00109772|11441047|FG000|Open-label Extension|Lack of Efficacy|19
7233092|NCT00109772|11441048|FG001|Open-label Extension|Lack of Efficacy|11
7233093|NCT00109772|11441047|FG000|Open-label Extension|Withdrawal by Subject|9
7233094|NCT00109772|11441048|FG001|Open-label Extension|Withdrawal by Subject|6
7233095|NCT00109772|11441047|FG000|Open-label Extension|Lost to Follow-up|1
7233096|NCT00109772|11441048|FG001|Open-label Extension|Lost to Follow-up|0
7233097|NCT00109772|11441047|FG000|Open-label Extension|Death|0
7233098|NCT00109772|11441048|FG001|Open-label Extension|Death|1
7233099|NCT00109772|11441047|FG000|Open-label Extension|Protocol Violation|2
7233100|NCT00109772|11441048|FG001|Open-label Extension|Protocol Violation|2
7233101|NCT00109772|11441047|FG000|Open-label Extension|Other|4
7233102|NCT00109772|11441048|FG001|Open-label Extension|Other|10
7233103|NCT00109837|11441054|FG000|Overall Study|Adverse Event|2
7233104|NCT00109837|11441054|FG000|Overall Study|Refusal unrelated to adverse effects|1
7233105|NCT00109837|11441054|FG000|Overall Study|Death|1
7233106|NCT00109837|11441054|FG000|Overall Study|BCR/ABL+ or Ph+|17
7233107|NCT00109837|11441054|FG000|Overall Study|Not treated|1
7233108|NCT00109837|11441054|FG000|Overall Study|Ineligible|1
7233109|NCT00109850|11441062|FG000|Overall Study|Adverse Event|1
7233110|NCT00109850|11441062|FG000|Overall Study|Death|2
7233111|NCT00109850|11441062|FG000|Overall Study|Ineligible|1
7233112|NCT00109928|11441070|FG000|Overall Study|Adverse Event|2
7233113|NCT00109928|11441070|FG000|Overall Study|Progression|6
7233114|NCT00109928|11441070|FG000|Overall Study|Death|2
7233115|NCT00109928|11441070|FG000|Overall Study|not protocol specified|2
7233116|NCT00109928|11441070|FG000|Overall Study|not eligible|1
7233117|NCT00109967|11441077|FG000|Overall Study|Cancel Prior to Treatment|2
7233118|NCT00109967|11441078|FG001|Overall Study|Cancel Prior to Treatment|0
7233119|NCT00109967|11441077|FG000|Overall Study|Adverse Event|12
7233120|NCT00109967|11441078|FG001|Overall Study|Adverse Event|1
7233121|NCT00109967|11441077|FG000|Overall Study|Withdrawal by Subject|5
7233122|NCT00109967|11441078|FG001|Overall Study|Withdrawal by Subject|0
7233123|NCT00109967|11441077|FG000|Overall Study|Physician Decision|1
7233124|NCT00109967|11441078|FG001|Overall Study|Physician Decision|3
7233125|NCT00109967|11441077|FG000|Overall Study|Death|0
7233126|NCT00109967|11441078|FG001|Overall Study|Death|2
7233127|NCT00110019|11441086|FG000|Overall Study|Lack of Efficacy|253
7233128|NCT00110019|11441087|FG001|Overall Study|Lack of Efficacy|285
7233129|NCT00110019|11441086|FG000|Overall Study|Adverse Event|61
7233130|NCT00110019|11441087|FG001|Overall Study|Adverse Event|40
7233131|NCT00110019|11441086|FG000|Overall Study|Death|13
7233132|NCT00110019|11441087|FG001|Overall Study|Death|15
7233133|NCT00110019|11441086|FG000|Overall Study|Withdrawal by Subject|21
7233134|NCT00110019|11441087|FG001|Overall Study|Withdrawal by Subject|9
7233135|NCT00110019|11441086|FG000|Overall Study|alternative therapy|5
7233136|NCT00110019|11441087|FG001|Overall Study|alternative therapy|1
7233137|NCT00110019|11441086|FG000|Overall Study|complicating disease|1
7233138|NCT00110019|11441087|FG001|Overall Study|complicating disease|1
7233139|NCT00110019|11441086|FG000|Overall Study|symptom deterioration|13
7233140|NCT00110019|11441087|FG001|Overall Study|symptom deterioration|16
7233141|NCT00110019|11441086|FG000|Overall Study|Not start protocol therapy|17
7233142|NCT00110019|11441087|FG001|Overall Study|Not start protocol therapy|16
7233143|NCT00110019|11441086|FG000|Overall Study|other reasons|22
7233144|NCT00110019|11441087|FG001|Overall Study|other reasons|30
7233145|NCT00110084|11441093|FG000|Overall Study|Adverse Event|9
7233146|NCT00110084|11441093|FG000|Overall Study|Death|1
7233147|NCT00110084|11441093|FG000|Overall Study|Patient Refusal|10
7233148|NCT00110084|11441093|FG000|Overall Study|Alternate Therapy|5
7233149|NCT00110084|11441093|FG000|Overall Study|Intercurrent Illness|1
7233150|NCT00110084|11441093|FG000|Overall Study|Other|2
7255565|NCT00318643|11467067|FG000|Overall Study|Investigator's Decision|0
7255566|NCT00318643|11467068|FG001|Overall Study|Investigator's Decision|0
7255567|NCT00318643|11467069|FG002|Overall Study|Investigator's Decision|0
7255568|NCT00318643|11467070|FG003|Overall Study|Investigator's Decision|0
7255569|NCT00318643|11467071|FG004|Overall Study|Investigator's Decision|1
7255570|NCT00319020|11467112|FG000|Overall Study|Death|2
7255571|NCT00319020|11467113|FG001|Overall Study|Death|2
7255572|NCT00319020|11467112|FG000|Overall Study|Withdrawal by Subject|4
7255573|NCT00319020|11467113|FG001|Overall Study|Withdrawal by Subject|1
7255574|NCT00319020|11467112|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
7255575|NCT00319020|11467113|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
7255576|NCT00319020|11467112|FG000|Overall Study|Administrative reason|0
7255577|NCT00319020|11467113|FG001|Overall Study|Administrative reason|5
7255578|NCT00319020|11467112|FG000|Overall Study|Disease progression|0
7255579|NCT00319020|11467113|FG001|Overall Study|Disease progression|2
7255580|NCT00319020|11467112|FG000|Overall Study|Transplant|0
7255581|NCT00319020|11467113|FG001|Overall Study|Transplant|1
7255582|NCT00319020|11467112|FG000|Overall Study|Treatment failure|0
7255583|NCT00319020|11467113|FG001|Overall Study|Treatment failure|1
7255584|NCT00319020|11467112|FG000|Overall Study|Adverse Event|0
7255585|NCT00319020|11467113|FG001|Overall Study|Adverse Event|1
7255586|NCT00319046|11467121|FG000|Overall Study|withdrawal of subject's consent|7
7255587|NCT00319046|11467121|FG000|Overall Study|administrative reason|1
7255588|NCT00319098|11467129|FG000|Overall Study|Serious adverse event|3
7255589|NCT00319098|11467130|FG001|Overall Study|Serious adverse event|0
7255590|NCT00319098|11467129|FG000|Overall Study|Adverse Event|20
7255591|NCT00319098|11467130|FG001|Overall Study|Adverse Event|1
7255592|NCT00319098|11467129|FG000|Overall Study|Withdrawal by Subject|37
7255593|NCT00319098|11467130|FG001|Overall Study|Withdrawal by Subject|8
7255594|NCT00319098|11467129|FG000|Overall Study|Migrated/moved from study area|2
7255595|NCT00319098|11467130|FG001|Overall Study|Migrated/moved from study area|1
7255596|NCT00319098|11467129|FG000|Overall Study|Lost to Follow-up|37
7255597|NCT00319098|11467130|FG001|Overall Study|Lost to Follow-up|13
7255598|NCT00319098|11467129|FG000|Overall Study|Others|33
7255599|NCT00319098|11467130|FG001|Overall Study|Others|8
7255600|NCT00319098|11467129|FG000|Overall Study|Protocol Violation|3
7255601|NCT00319098|11467130|FG001|Overall Study|Protocol Violation|1
7255602|NCT00319111|11467140|FG000|Overall Study|Adverse Event|20
7255603|NCT00319111|11467140|FG000|Overall Study|Withdrawal of consent|11
7573415|NCT03614078|11954577|FG001|Overall Study|High Neutrophils|0
7573416|NCT03614078|11954578|FG002|Overall Study|High Neutrophils|2
7573417|NCT03614078|11954576|FG000|Overall Study|Patient Did Not Meet Eligibility|1
7573418|NCT03614078|11954577|FG001|Overall Study|Patient Did Not Meet Eligibility|0
7573419|NCT03614078|11954578|FG002|Overall Study|Patient Did Not Meet Eligibility|0
7573420|NCT03614078|11954576|FG000|Overall Study|Exacerbation of Psoriasis|0
7573421|NCT03614078|11954577|FG001|Overall Study|Exacerbation of Psoriasis|1
7573422|NCT03614078|11954578|FG002|Overall Study|Exacerbation of Psoriasis|0
7573423|NCT03614078|11954576|FG000|Overall Study|Adverse Event|0
7573424|NCT03614078|11954577|FG001|Overall Study|Adverse Event|2
7573425|NCT03614078|11954578|FG002|Overall Study|Adverse Event|0
7573426|NCT03614078|11954576|FG000|Overall Study|Dizziness and Rash|0
7573427|NCT03614078|11954577|FG001|Overall Study|Dizziness and Rash|1
7573428|NCT03614078|11954578|FG002|Overall Study|Dizziness and Rash|0
7573429|NCT03614156|11954600|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
7573430|NCT03614156|11954601|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7573431|NCT03614156|11954602|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7573432|NCT03614156|11954603|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
7573433|NCT03614156|11954600|FG000|Open-Label Treatment Period|Adverse Event|7
7573434|NCT03614156|11954601|FG001|Open-Label Treatment Period|Adverse Event|0
7255604|NCT00319111|11467140|FG000|Overall Study|Death|9
7255605|NCT00319111|11467140|FG000|Overall Study|Lack of clinical improvement|4
7573435|NCT03614156|11954602|FG002|Open-Label Treatment Period|Adverse Event|0
7255606|NCT00319111|11467140|FG000|Overall Study|Administrative|2
7255607|NCT00319111|11467140|FG000|Overall Study|Treatment failure|1
7573436|NCT03614156|11954603|FG003|Open-Label Treatment Period|Adverse Event|0
7573437|NCT03614156|11954600|FG000|Open-Label Treatment Period|Lack of Efficacy|18
7573438|NCT03614156|11954601|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7573439|NCT03614156|11954602|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7573440|NCT03614156|11954603|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7573441|NCT03614156|11954600|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
7573442|NCT03614156|11954601|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7573443|NCT03614156|11954602|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7573444|NCT03614156|11954603|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7573445|NCT03614156|11954600|FG000|Open-Label Treatment Period|Lost to Follow-up|10
7573446|NCT03614156|11954601|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7573447|NCT03614156|11954602|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7573448|NCT03614156|11954603|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7573449|NCT03614156|11954600|FG000|Open-Label Treatment Period|Protocol Violation|2
7573450|NCT03614156|11954601|FG001|Open-Label Treatment Period|Protocol Violation|0
7573451|NCT03614156|11954602|FG002|Open-Label Treatment Period|Protocol Violation|0
7573452|NCT03614156|11954603|FG003|Open-Label Treatment Period|Protocol Violation|0
7573453|NCT03614156|11954600|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
7573454|NCT03614156|11954601|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
7573455|NCT03614156|11954602|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7573456|NCT03614156|11954603|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7573457|NCT03614156|11954600|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
7573458|NCT03614156|11954601|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7573459|NCT03614156|11954602|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7573460|NCT03614156|11954603|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7573461|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7573462|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
7573463|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
7573464|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
7573465|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
7573466|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
7573467|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7573468|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
7573469|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7573470|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
7573471|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
7573472|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
7573473|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
7573474|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7573475|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7573476|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
7573477|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
7573478|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
7573479|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
7573480|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
7573481|NCT03614156|11954600|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7573482|NCT03614156|11954601|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
7573483|NCT03614156|11954602|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7573484|NCT03614156|11954603|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
7573485|NCT03614156|11954600|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
7573486|NCT03614156|11954601|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
7573487|NCT03614156|11954602|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
7573488|NCT03614156|11954603|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
7573489|NCT03614156|11954600|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
7573490|NCT03614156|11954601|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
7573491|NCT03614156|11954602|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
7573492|NCT03614156|11954603|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
7573493|NCT03614156|11954600|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7573494|NCT03614156|11954601|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7573495|NCT03614156|11954602|FG002|Safety Follow-Up Period|Lost to Follow-up|0
7573496|NCT03614156|11954603|FG003|Safety Follow-Up Period|Lost to Follow-up|1
7573497|NCT03614975|11954620|FG000|Overall Study|Physician Decision|7
7573498|NCT03614975|11954621|FG001|Overall Study|Physician Decision|5
7573499|NCT03614975|11954620|FG000|Overall Study|Withdrawal by Subject|2
7573500|NCT03614975|11954621|FG001|Overall Study|Withdrawal by Subject|2
7573501|NCT03614975|11954620|FG000|Overall Study|Specimens not in lab batch shipment|1
7573502|NCT03614975|11954621|FG001|Overall Study|Specimens not in lab batch shipment|1
7573503|NCT03615404|11954652|FG000|Overall Study|Death|1
7573504|NCT03615404|11954652|FG000|Overall Study|vaccine did not pass quality assurance|1
7573513|NCT03615924|11954704|FG000|Overall Study|Withdrawal by Subject|2
7573514|NCT03615924|11954705|FG001|Overall Study|Withdrawal by Subject|5
7573515|NCT03615924|11954704|FG000|Overall Study|Death|3
7573516|NCT03615924|11954705|FG001|Overall Study|Death|1
7573517|NCT03615924|11954704|FG000|Overall Study|Lost to Follow-up|1
7573518|NCT03615924|11954705|FG001|Overall Study|Lost to Follow-up|0
7573519|NCT03615924|11954704|FG000|Overall Study|Randomized in error|1
7573520|NCT03615924|11954705|FG001|Overall Study|Randomized in error|0
7573521|NCT03615924|11954704|FG000|Overall Study|Study termination by Sponsor|94
7573522|NCT03615924|11954705|FG001|Overall Study|Study termination by Sponsor|86
7573523|NCT03616106|11954713|FG000|Overall Study|Removed by PI|6
7573524|NCT03616106|11954714|FG001|Overall Study|Removed by PI|0
7573525|NCT03616106|11954713|FG000|Overall Study|Withdrawal by Subject|1
7573526|NCT03616106|11954714|FG001|Overall Study|Withdrawal by Subject|1
7573527|NCT03616106|11954713|FG000|Overall Study|Lost to Follow-up|7
7573528|NCT03616106|11954714|FG001|Overall Study|Lost to Follow-up|0
7573529|NCT03616600|11954731|FG000|Overall Study|Withdrawal by Subject|1
7573530|NCT03616600|11954732|FG001|Overall Study|Withdrawal by Subject|0
7573531|NCT03616977|11954748|FG000|Period 1|Physician Decision|0
7573532|NCT03616977|11954749|FG001|Period 1|Physician Decision|1
7573533|NCT03616977|11954748|FG000|Period 3|Adverse Event|1
7573534|NCT03616977|11954749|FG001|Period 3|Adverse Event|1
7573535|NCT03617588|11954762|FG000|Overall Study|Withdrawal by Subject|1
7573536|NCT03617588|11954763|FG001|Overall Study|Withdrawal by Subject|0
7573537|NCT03617770|11954775|FG000|Overall Study|Lost to Follow-up|1
7573538|NCT03617770|11954776|FG001|Overall Study|Lost to Follow-up|0
7573539|NCT03617861|11954784|FG000|Second Intervention (1 Day)|Adverse Event|0
7573540|NCT03617861|11954785|FG001|Second Intervention (1 Day)|Adverse Event|0
7573541|NCT03617861|11954786|FG002|Second Intervention (1 Day)|Adverse Event|1
7573542|NCT03617861|11954787|FG003|Second Intervention (1 Day)|Adverse Event|0
7573543|NCT03618628|11954839|FG000|Overall Study|Death|1
7573544|NCT03618628|11954839|FG000|Overall Study|Lost to Follow-up|1
7573545|NCT03618823|11954845|FG000|Overall Study|Lost to Follow-up|63
7573546|NCT03618823|11954846|FG001|Overall Study|Lost to Follow-up|61
7573547|NCT03619837|11954872|FG000|Screening|received organs from HCV-negative donors|47
7573548|NCT03619837|11954872|FG000|Screening|died on the wait-list|2
7573549|NCT03619837|11954872|FG000|Screening|remained on the wait list|40
7573550|NCT03619837|11954872|FG000|Screening|didn't meet eligibility criteria|3
7573551|NCT03619837|11954872|FG000|Screening|withdrew consent|2
7573552|NCT03619837|11954872|FG000|Screening|never listed for HCV-viremic donor|1
7573553|NCT03619837|11954872|FG000|Screening|developed exclusion criteria|2
7573554|NCT03619837|11954872|FG000|Screening|excluded by the investigator due to non-compliance|1
7573555|NCT03620162|11954890|FG000|Overall Study|Physician Decision|4
7573556|NCT03620162|11954891|FG001|Overall Study|Physician Decision|0
7573557|NCT03620162|11954892|FG002|Overall Study|Physician Decision|1
7573558|NCT03620162|11954893|FG003|Overall Study|Physician Decision|0
7573559|NCT03620162|11954894|FG004|Overall Study|Physician Decision|2
7573560|NCT03620162|11954890|FG000|Overall Study|Lost to Follow-up|2
7573561|NCT03620162|11954891|FG001|Overall Study|Lost to Follow-up|6
7573562|NCT03620162|11954892|FG002|Overall Study|Lost to Follow-up|7
7233151|NCT00110149|11441102|FG000|Overall Study|Physician Decision|3
7233152|NCT00110214|11441109|FG000|Overall Study|Never started treatment|21
7233153|NCT00110214|11441110|FG001|Overall Study|Never started treatment|20
7233154|NCT00110214|11441109|FG000|Overall Study|Disease progression or death|260
7233155|NCT00110214|11441110|FG001|Overall Study|Disease progression or death|151
7233156|NCT00110214|11441109|FG000|Overall Study|Adverse Event|115
7233157|NCT00110214|11441110|FG001|Overall Study|Adverse Event|192
7233158|NCT00110214|11441109|FG000|Overall Study|Refused further treatment|52
7233159|NCT00110214|11441110|FG001|Overall Study|Refused further treatment|65
7233160|NCT00110214|11441109|FG000|Overall Study|Other (not specified)|61
7233161|NCT00110214|11441110|FG001|Overall Study|Other (not specified)|75
7233162|NCT00110266|11441116|FG000|Overall Study|Adverse Event|27
7233163|NCT00110266|11441116|FG000|Overall Study|Abnormal laboratory value|15
7233164|NCT00110266|11441116|FG000|Overall Study|Withdrawal by Subject|16
7233165|NCT00110266|11441116|FG000|Overall Study|Death|17
7233166|NCT00110266|11441116|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7233167|NCT00110266|11441116|FG000|Overall Study|Participant condition no longer requires study drug|1
7573563|NCT03620162|11954893|FG003|Overall Study|Lost to Follow-up|3
7573564|NCT03620162|11954894|FG004|Overall Study|Lost to Follow-up|2
7573565|NCT03620162|11954890|FG000|Overall Study|Consent withdrawn by parent/guardian|9
7464907|NCT01876251|11763779|FG002|Overall Study|Participant started new treatment|1
7573566|NCT03620162|11954891|FG001|Overall Study|Consent withdrawn by parent/guardian|8
7573567|NCT03620162|11954892|FG002|Overall Study|Consent withdrawn by parent/guardian|25
7573568|NCT03620162|11954893|FG003|Overall Study|Consent withdrawn by parent/guardian|17
7573569|NCT03620162|11954894|FG004|Overall Study|Consent withdrawn by parent/guardian|9
7573570|NCT03620708|11954920|FG000|Overall Study|Lost to Follow-up|1
7573571|NCT03620708|11954921|FG001|Overall Study|Lost to Follow-up|1
7573572|NCT03620708|11954922|FG002|Overall Study|Lost to Follow-up|2
7573573|NCT03620708|11954920|FG000|Overall Study|Withdrawal by Subject|0
7573574|NCT03620708|11954921|FG001|Overall Study|Withdrawal by Subject|0
7573575|NCT03620708|11954922|FG002|Overall Study|Withdrawal by Subject|1
7233168|NCT00110305|11441125|FG000|Overall Study|Adverse Event|46
7233169|NCT00110305|11441126|FG001|Overall Study|Adverse Event|13
7233170|NCT00110305|11441125|FG000|Overall Study|Sponsors Decision|1
7233171|NCT00110305|11441126|FG001|Overall Study|Sponsors Decision|0
7233172|NCT00110305|11441125|FG000|Overall Study|Subject Non-Compliant|9
7233173|NCT00110305|11441126|FG001|Overall Study|Subject Non-Compliant|2
7233174|NCT00110305|11441125|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7233175|NCT00110305|11441126|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
7233176|NCT00110305|11441125|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
7233177|NCT00110305|11441126|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
7233178|NCT00110305|11441125|FG000|Overall Study|Protocol Violation|0
7233179|NCT00110305|11441126|FG001|Overall Study|Protocol Violation|1
7233180|NCT00110305|11441125|FG000|Overall Study|Withdrawal by Subject|7
7233181|NCT00110305|11441126|FG001|Overall Study|Withdrawal by Subject|7
7233182|NCT00110305|11441125|FG000|Overall Study|Lost to Follow-up|20
7233183|NCT00110305|11441126|FG001|Overall Study|Lost to Follow-up|3
7233184|NCT00110305|11441125|FG000|Overall Study|Other|8
7233185|NCT00110305|11441126|FG001|Overall Study|Other|2
7233186|NCT00110357|11441145|FG000|Overall Study|Deterioration without progression|2
7233187|NCT00110357|11441146|FG001|Overall Study|Deterioration without progression|0
7233188|NCT00110357|11441145|FG000|Overall Study|Disease progression/relapse|20
7233189|NCT00110357|11441146|FG001|Overall Study|Disease progression/relapse|15
7233190|NCT00110357|11441145|FG000|Overall Study|Study Closure|1
7233191|NCT00110357|11441146|FG001|Overall Study|Study Closure|0
7233192|NCT00110357|11441145|FG000|Overall Study|Study Drug Toxicity|1
7233193|NCT00110357|11441146|FG001|Overall Study|Study Drug Toxicity|3
7233194|NCT00110357|11441145|FG000|Overall Study|Withdrawal by Subject|3
7233195|NCT00110357|11441146|FG001|Overall Study|Withdrawal by Subject|1
7233196|NCT00110396|11441179|FG000|Overall Study|Adverse Event|15
7233197|NCT00110396|11441179|FG000|Overall Study|Lost to Follow-up|1
7233198|NCT00110396|11441179|FG000|Overall Study|Administration of plasmapheresis|1
7233199|NCT00110396|11441179|FG000|Overall Study|Initiated mitoxantrone therapy|1
7233200|NCT00110396|11441179|FG000|Overall Study|Lack of Efficacy|1
7233201|NCT00110396|11441179|FG000|Overall Study|Decided not to continue treatment|1
7233202|NCT00110396|11441179|FG000|Overall Study|Patient non-compliance|1
7233203|NCT00110396|11441179|FG000|Overall Study|Patient refused to continue|1
7233204|NCT00110396|11441179|FG000|Overall Study|Patient refused to participate|1
7233205|NCT00110396|11441179|FG000|Overall Study|Patient will|1
7233206|NCT00110396|11441179|FG000|Overall Study|Patient's decision|1
7233207|NCT00110396|11441179|FG000|Overall Study|Participation in MS vaccine study|1
7233208|NCT00110396|11441179|FG000|Overall Study|Pregnancy|1
7233209|NCT00110396|11441179|FG000|Overall Study|Pregnancy (Protocol violation)|2
7233210|NCT00110396|11441179|FG000|Overall Study|Protocol Violation|2
7233211|NCT00110396|11441179|FG000|Overall Study|Patient refused to come back|1
7233212|NCT00110396|11441179|FG000|Overall Study|The patient has refused|2
7233213|NCT00110396|11441179|FG000|Overall Study|The patient has refused to visit site|1
7233214|NCT00110396|11441179|FG000|Overall Study|Patient is to be administered copaxone|1
7233215|NCT00110617|11441202|FG000|Overall Study|Adverse Event|2
7233216|NCT00110617|11441203|FG001|Overall Study|Adverse Event|4
7233217|NCT00110617|11441202|FG000|Overall Study|Abnormal Laboratory Value|4
7233218|NCT00110617|11441203|FG001|Overall Study|Abnormal Laboratory Value|2
7233219|NCT00110617|11441202|FG000|Overall Study|Lack of Efficacy|1
7233220|NCT00110617|11441203|FG001|Overall Study|Lack of Efficacy|0
7233221|NCT00110617|11441202|FG000|Overall Study|Patient no longer requires study drug|1
7233222|NCT00110617|11441203|FG001|Overall Study|Patient no longer requires study drug|0
7233223|NCT00110617|11441202|FG000|Overall Study|Protocol Violation|5
7233224|NCT00110617|11441203|FG001|Overall Study|Protocol Violation|0
7233225|NCT00110617|11441202|FG000|Overall Study|Withdrawal by Subject|10
7233226|NCT00110617|11441203|FG001|Overall Study|Withdrawal by Subject|4
7233227|NCT00110617|11441202|FG000|Overall Study|Lost to Follow-up|9
7233228|NCT00110617|11441203|FG001|Overall Study|Lost to Follow-up|1
7233229|NCT00110617|11441202|FG000|Overall Study|Administrative problems|6
7233230|NCT00110617|11441203|FG001|Overall Study|Administrative problems|5
7233231|NCT00110617|11441202|FG000|Overall Study|Death|1
7233232|NCT00110617|11441203|FG001|Overall Study|Death|1
7233233|NCT00110617|11441202|FG000|Overall Study|Did not receive study drug|0
7233234|NCT00110617|11441203|FG001|Overall Study|Did not receive study drug|12
7233235|NCT00110812|11441214|FG000|Main Study|Death|0
7233236|NCT00110812|11441215|FG001|Main Study|Death|0
7233237|NCT00110812|11441216|FG002|Main Study|Death|2
7233238|NCT00110812|11441214|FG000|Main Study|Withdrawal by Subject|0
7233239|NCT00110812|11441215|FG001|Main Study|Withdrawal by Subject|0
7233240|NCT00110812|11441216|FG002|Main Study|Withdrawal by Subject|1
7233241|NCT00110812|11441214|FG000|Main Study|Lost to Follow-up|8
7233242|NCT00110812|11441215|FG001|Main Study|Lost to Follow-up|11
7233243|NCT00110812|11441216|FG002|Main Study|Lost to Follow-up|10
7233244|NCT00110812|11441214|FG000|Extended Follow-up|Death|1
7233245|NCT00110812|11441215|FG001|Extended Follow-up|Death|0
7233246|NCT00110812|11441216|FG002|Extended Follow-up|Death|3
7233247|NCT00110812|11441214|FG000|Extended Follow-up|Withdrawal by Subject|0
7233248|NCT00110812|11441215|FG001|Extended Follow-up|Withdrawal by Subject|1
7233249|NCT00110812|11441216|FG002|Extended Follow-up|Withdrawal by Subject|0
7233250|NCT00110812|11441214|FG000|Extended Follow-up|Lost to Follow-up|1
7233251|NCT00110812|11441215|FG001|Extended Follow-up|Lost to Follow-up|3
7233252|NCT00110812|11441216|FG002|Extended Follow-up|Lost to Follow-up|1
7233253|NCT00110890|11441231|FG000|Overall Study|Adverse Event|30
7233254|NCT00110890|11441232|FG001|Overall Study|Adverse Event|7
7233255|NCT00110890|11441231|FG000|Overall Study|Death|16
7233256|NCT00110890|11441232|FG001|Overall Study|Death|9
7233257|NCT00110890|11441231|FG000|Overall Study|Lost to Follow-up|3
7233258|NCT00110890|11441232|FG001|Overall Study|Lost to Follow-up|1
7233259|NCT00110890|11441231|FG000|Overall Study|Physician Decision|4
7233260|NCT00110890|11441232|FG001|Overall Study|Physician Decision|5
7233261|NCT00110890|11441231|FG000|Overall Study|Withdrawal by Subject|17
7233262|NCT00110890|11441232|FG001|Overall Study|Withdrawal by Subject|5
7233263|NCT00110890|11441231|FG000|Overall Study|Protocol Deviation|1
7233264|NCT00110890|11441232|FG001|Overall Study|Protocol Deviation|0
7233265|NCT00110890|11441231|FG000|Overall Study|Noncompliance|10
7233266|NCT00110890|11441232|FG001|Overall Study|Noncompliance|0
7233267|NCT00110890|11441231|FG000|Overall Study|Kidney Transplant|16
7233268|NCT00110890|11441232|FG001|Overall Study|Kidney Transplant|12
7233269|NCT00110890|11441231|FG000|Overall Study|Invest. Product Commercially Available|217
7233270|NCT00110890|11441232|FG001|Overall Study|Invest. Product Commercially Available|110
7233271|NCT00110890|11441231|FG000|Overall Study|Other|34
7233272|NCT00110890|11441232|FG001|Overall Study|Other|23
7233273|NCT00110890|11441231|FG000|Overall Study|Ineligibility determined|3
7233274|NCT00110890|11441232|FG001|Overall Study|Ineligibility determined|0
7233275|NCT00110890|11441231|FG000|Overall Study|Requirement for alternative therapy|0
7233276|NCT00110890|11441232|FG001|Overall Study|Requirement for alternative therapy|1
7233277|NCT00110890|11441231|FG000|Overall Study|Disease progression|0
7233278|NCT00110890|11441232|FG001|Overall Study|Disease progression|1
7233279|NCT00110890|11441231|FG000|Overall Study|Parathyroidectomy|0
7233280|NCT00110890|11441232|FG001|Overall Study|Parathyroidectomy|1
7233281|NCT00110890|11441231|FG000|Overall Study|Did not enter follow-up phase|10
7233282|NCT00110890|11441232|FG001|Overall Study|Did not enter follow-up phase|4
7233283|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|Adverse Event|3
7233284|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|Adverse Event|0
7233285|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|Death|1
7233286|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|Death|0
7233287|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
7233288|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
7233289|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
7233290|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
7233291|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
7233292|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
7233293|NCT00110994|11441240|FG000|Double-blind (DB) Treatment|other reasons|2
7233294|NCT00110994|11441241|FG001|Double-blind (DB) Treatment|other reasons|3
7233295|NCT00110994|11441240|FG000|Active Follow-up|Disease progression/recurrence/replace|1
7233296|NCT00110994|11441241|FG001|Active Follow-up|Disease progression/recurrence/replace|0
7233297|NCT00110994|11441240|FG000|Active Follow-up|Other reasons|0
7233298|NCT00110994|11441241|FG001|Active Follow-up|Other reasons|2
7233299|NCT00110994|11441240|FG000|Long Term Follow-up|Death|19
7233300|NCT00110994|11441241|FG001|Long Term Follow-up|Death|17
7233301|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Adverse Event|12
7233302|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Adverse Event|4
7233303|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Death|5
7233304|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Death|2
7233305|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Protocol Violation|0
7233306|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Protocol Violation|1
7233307|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
7233308|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
7233309|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
7233310|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
7233311|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Relapse|1
7233312|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Relapse|0
7233313|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
7233314|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
7233315|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
7233316|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
7233317|NCT00111007|11441249|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
7233318|NCT00111007|11441250|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
7233319|NCT00111007|11441249|FG000|Active Follow-up|Adverse Event|1
7233320|NCT00111007|11441250|FG001|Active Follow-up|Adverse Event|0
7233321|NCT00111007|11441249|FG000|Active Follow-up|Death|2
7233322|NCT00111007|11441250|FG001|Active Follow-up|Death|0
7233323|NCT00111007|11441249|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
7233324|NCT00111007|11441250|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
7233325|NCT00111007|11441249|FG000|Long Term Follow-up|Death|34
7233326|NCT00111007|11441250|FG001|Long Term Follow-up|Death|39
7233327|NCT00111007|11441249|FG000|Long Term Follow-up|Lost to Follow-up|1
7233328|NCT00111007|11441250|FG001|Long Term Follow-up|Lost to Follow-up|1
7233329|NCT00111007|11441249|FG000|Long Term Follow-up|Withdrawal by Subject|0
7233330|NCT00111007|11441250|FG001|Long Term Follow-up|Withdrawal by Subject|1
7233331|NCT00111007|11441249|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
7233332|NCT00111007|11441250|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
7233333|NCT00111007|11441249|FG000|Long Term Follow-up|Missing|10
7233334|NCT00111007|11441250|FG001|Long Term Follow-up|Missing|3
7233335|NCT00111228|11441259|FG000|Overall Study|Withdrawal by Subject|5
7233336|NCT00111228|11441260|FG001|Overall Study|Withdrawal by Subject|1
7233337|NCT00111228|11441261|FG002|Overall Study|Withdrawal by Subject|0
7233338|NCT00111241|11441271|FG000|Overall Study|Lost to Follow-up|1
7233339|NCT00111241|11441272|FG001|Overall Study|Lost to Follow-up|0
7233340|NCT00111241|11441271|FG000|Overall Study|Withdrawal by Subject|4
7233341|NCT00111241|11441272|FG001|Overall Study|Withdrawal by Subject|0
7233342|NCT00111241|11441271|FG000|Overall Study|Protocol Violation|9
7233343|NCT00111241|11441272|FG001|Overall Study|Protocol Violation|8
7233344|NCT00111241|11441271|FG000|Overall Study|Adverse Event|1
7233345|NCT00111241|11441272|FG001|Overall Study|Adverse Event|0
7233346|NCT00111475|11441290|FG000|Overall Study|Lost to Follow-up|0
7233347|NCT00111475|11441291|FG001|Overall Study|Lost to Follow-up|0
7233348|NCT00111475|11441292|FG002|Overall Study|Lost to Follow-up|0
7233349|NCT00111475|11441293|FG003|Overall Study|Lost to Follow-up|0
7233350|NCT00111475|11441294|FG004|Overall Study|Lost to Follow-up|0
7233351|NCT00111475|11441295|FG005|Overall Study|Lost to Follow-up|1
7233352|NCT00111475|11441296|FG006|Overall Study|Lost to Follow-up|0
7233353|NCT00111475|11441297|FG007|Overall Study|Lost to Follow-up|0
7233354|NCT00111475|11441298|FG008|Overall Study|Lost to Follow-up|0
7233355|NCT00111475|11441299|FG009|Overall Study|Lost to Follow-up|0
7233356|NCT00111761|11441334|FG000|Part 1|Physician Decision|0
7233357|NCT00111761|11441335|FG001|Part 1|Physician Decision|1
7233358|NCT00111761|11441334|FG000|Part 1|Death|0
7233359|NCT00111761|11441335|FG001|Part 1|Death|2
7233360|NCT00111761|11441334|FG000|Part 1|Other|0
7233361|NCT00111761|11441335|FG001|Part 1|Other|1
7233362|NCT00111761|11441334|FG000|Part 1|Withdrawal by Subject|0
7233363|NCT00111761|11441335|FG001|Part 1|Withdrawal by Subject|1
7233364|NCT00111761|11441334|FG000|Part 2|Adverse Event|1
7233365|NCT00111761|11441335|FG001|Part 2|Adverse Event|0
7233366|NCT00111761|11441334|FG000|Part 2|Physician Decision|1
7233367|NCT00111761|11441335|FG001|Part 2|Physician Decision|0
7233368|NCT00111761|11441334|FG000|Part 2|Death|1
7233369|NCT00111761|11441335|FG001|Part 2|Death|0
7233370|NCT00111761|11441334|FG000|Part 2|Disease progression|3
7233371|NCT00111761|11441335|FG001|Part 2|Disease progression|0
7233372|NCT00111761|11441334|FG000|Part 2|Protocol-specified criteria|1
7233373|NCT00111761|11441335|FG001|Part 2|Protocol-specified criteria|0
7233374|NCT00111761|11441334|FG000|Part 2|Other|1
7233375|NCT00111761|11441335|FG001|Part 2|Other|0
7233376|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
7233377|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
7233378|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7233379|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7233380|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
7233381|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
7233382|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
7233383|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7233384|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7233385|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7233386|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
7233387|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
7233388|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
7233389|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7233390|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
7233391|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
7233392|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7233393|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
7233394|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7233395|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
7233396|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
7233397|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7233398|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
7233399|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
7233400|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
7233401|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7233402|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7233403|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
7233404|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7233405|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
7233406|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7233407|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7233408|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7233409|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7233410|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
7255608|NCT00319254|11467144|FG000|Overall Study|Withdrawal by Subject|4
7233411|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
7233412|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7233413|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7233414|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7233415|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
7233416|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7233417|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
7233418|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7233419|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
7233420|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7233421|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7233422|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7233423|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
7233424|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
7233425|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7233426|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7233427|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7233428|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7233429|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
7233430|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7233431|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
7233432|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7233433|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7233434|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7233435|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
7233436|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7233437|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
7233438|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7233439|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7233440|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7233441|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
7233442|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7233443|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
7233444|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7233445|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7233446|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7233447|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
7233448|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7233449|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
7233450|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7233451|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7233452|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7233453|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
7233454|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7233455|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7233456|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7233457|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
7233458|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7233459|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
7233460|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7233461|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7233462|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7233463|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
7233464|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7573576|NCT03621189|11954948|FG000|Overall Study|Withdrawal by Subject|0
7573577|NCT03621189|11954949|FG001|Overall Study|Withdrawal by Subject|3
7573578|NCT03621189|11954948|FG000|Overall Study|Physician Decision|0
7573579|NCT03621189|11954949|FG001|Overall Study|Physician Decision|2
7233465|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
7233466|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7233467|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7233468|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7233469|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7233470|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
7233471|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
7573580|NCT03622112|11954984|FG000|Overall Study|Withdrawal by Subject|6
7233472|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7233473|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7233474|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7233475|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7233476|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
7233477|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
7233478|NCT00111800|11441347|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7233479|NCT00111800|11441348|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7233480|NCT00111800|11441349|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7233481|NCT00111800|11441350|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7233482|NCT00111800|11441351|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
7233483|NCT00111800|11441352|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
7233484|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7233485|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
7233486|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
7233487|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
7233488|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7233489|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
7233490|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7233491|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7233492|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
7233493|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7233494|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7233495|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
7233496|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7233497|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7233498|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
7233499|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7233500|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
7233501|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
7233502|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7233503|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7233504|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7233505|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7233506|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
7233507|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
7233508|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7233509|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7233510|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
7233511|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7233512|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7233513|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
7233514|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7233515|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
7233516|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7233517|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7233518|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7233519|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
7233520|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7233521|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7233522|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
7233523|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7233524|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7233525|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
7573600|NCT03622112|11954990|FG006|Overall Study|Lost to Follow-up|0
7233526|NCT00111800|11441347|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7233527|NCT00111800|11441348|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7233528|NCT00111800|11441349|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
7233529|NCT00111800|11441350|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7233530|NCT00111800|11441351|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7233531|NCT00111800|11441352|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
7233532|NCT00111813|11441375|FG000|Overall Study|Adverse Event|1
7233533|NCT00111813|11441376|FG001|Overall Study|Adverse Event|2
7233534|NCT00111813|11441377|FG002|Overall Study|Adverse Event|4
7233535|NCT00111813|11441378|FG003|Overall Study|Adverse Event|2
7233536|NCT00111813|11441379|FG004|Overall Study|Adverse Event|2
7233537|NCT00111813|11441380|FG005|Overall Study|Adverse Event|2
7233538|NCT00111813|11441375|FG000|Overall Study|Progressive disease|2
7233539|NCT00111813|11441376|FG001|Overall Study|Progressive disease|1
7233540|NCT00111813|11441377|FG002|Overall Study|Progressive disease|5
7233541|NCT00111813|11441378|FG003|Overall Study|Progressive disease|3
7233542|NCT00111813|11441379|FG004|Overall Study|Progressive disease|4
7233543|NCT00111813|11441380|FG005|Overall Study|Progressive disease|3
7233544|NCT00111813|11441375|FG000|Overall Study|Lack of Efficacy|0
7233545|NCT00111813|11441376|FG001|Overall Study|Lack of Efficacy|0
7233546|NCT00111813|11441377|FG002|Overall Study|Lack of Efficacy|0
7233547|NCT00111813|11441378|FG003|Overall Study|Lack of Efficacy|0
7233548|NCT00111813|11441379|FG004|Overall Study|Lack of Efficacy|0
7233549|NCT00111813|11441380|FG005|Overall Study|Lack of Efficacy|1
7233550|NCT00111813|11441375|FG000|Overall Study|Other|0
7233551|NCT00111813|11441376|FG001|Overall Study|Other|0
7233552|NCT00111813|11441377|FG002|Overall Study|Other|1
7233553|NCT00111813|11441378|FG003|Overall Study|Other|0
7233554|NCT00111813|11441379|FG004|Overall Study|Other|0
7233555|NCT00111813|11441380|FG005|Overall Study|Other|0
7233556|NCT00111839|11441398|FG000|Overall Study|Disease Progression|30
7233557|NCT00111839|11441399|FG001|Overall Study|Disease Progression|33
7233558|NCT00111839|11441400|FG002|Overall Study|Disease Progression|33
7233559|NCT00111839|11441398|FG000|Overall Study|Adverse Event|5
7233560|NCT00111839|11441399|FG001|Overall Study|Adverse Event|3
7233561|NCT00111839|11441400|FG002|Overall Study|Adverse Event|1
7233562|NCT00111839|11441398|FG000|Overall Study|Protocol Violation|2
7233563|NCT00111839|11441399|FG001|Overall Study|Protocol Violation|4
7233564|NCT00111839|11441400|FG002|Overall Study|Protocol Violation|2
7233565|NCT00111839|11441398|FG000|Overall Study|Death|1
7233566|NCT00111839|11441399|FG001|Overall Study|Death|1
7233567|NCT00111839|11441400|FG002|Overall Study|Death|6
7233568|NCT00111839|11441398|FG000|Overall Study|Withdrawal by Subject|2
7233569|NCT00111839|11441399|FG001|Overall Study|Withdrawal by Subject|2
7233570|NCT00111839|11441400|FG002|Overall Study|Withdrawal by Subject|2
7233571|NCT00111839|11441398|FG000|Overall Study|Lost to Follow-up|1
7233572|NCT00111839|11441399|FG001|Overall Study|Lost to Follow-up|0
7233573|NCT00111839|11441400|FG002|Overall Study|Lost to Follow-up|0
7233574|NCT00111839|11441398|FG000|Overall Study|Logistical Constraint|1
7233575|NCT00111839|11441399|FG001|Overall Study|Logistical Constraint|0
7233576|NCT00111839|11441400|FG002|Overall Study|Logistical Constraint|0
7233577|NCT00111839|11441398|FG000|Overall Study|Other|6
7233578|NCT00111839|11441399|FG001|Overall Study|Other|3
7233579|NCT00111839|11441400|FG002|Overall Study|Other|3
7233580|NCT00111839|11441398|FG000|Overall Study|Randomized but Not Treated|0
7233581|NCT00111839|11441399|FG001|Overall Study|Randomized but Not Treated|0
7233582|NCT00111839|11441400|FG002|Overall Study|Randomized but Not Treated|2
7233583|NCT00111917|11441410|FG000|Overall Study|Withdrawal by Subject|1
7233584|NCT00111917|11441411|FG001|Overall Study|Withdrawal by Subject|1
7233585|NCT00112047|11441423|FG000|Randomized Phase|Lost to Follow-up|26
7233586|NCT00112047|11441424|FG001|Randomized Phase|Lost to Follow-up|33
7233587|NCT00112047|11441423|FG000|Randomized Phase|Adverse Event|10
7233588|NCT00112047|11441424|FG001|Randomized Phase|Adverse Event|10
7233589|NCT00112047|11441423|FG000|Randomized Phase|Withrawal of consent|10
7233590|NCT00112047|11441424|FG001|Randomized Phase|Withrawal of consent|18
7233591|NCT00112047|11441423|FG000|Randomized Phase|Sub-optimal virological response|3
7233592|NCT00112047|11441424|FG001|Randomized Phase|Sub-optimal virological response|13
7233593|NCT00112047|11441423|FG000|Randomized Phase|Noncompliance|8
7233594|NCT00112047|11441424|FG001|Randomized Phase|Noncompliance|4
7233595|NCT00112047|11441423|FG000|Randomized Phase|Protocol Violation|2
7233596|NCT00112047|11441424|FG001|Randomized Phase|Protocol Violation|0
7233597|NCT00112047|11441423|FG000|Randomized Phase|Pregnancy|3
7233598|NCT00112047|11441424|FG001|Randomized Phase|Pregnancy|1
7233599|NCT00112047|11441423|FG000|Randomized Phase|Death|1
7233600|NCT00112047|11441424|FG001|Randomized Phase|Death|3
7233601|NCT00112047|11441423|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
7233602|NCT00112047|11441424|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
7233603|NCT00112047|11441423|FG000|Randomized Phase|Inability to swallow pills|0
7233604|NCT00112047|11441424|FG001|Randomized Phase|Inability to swallow pills|1
7233605|NCT00112047|11441423|FG000|Randomized Phase|Incarceration|3
7233606|NCT00112047|11441424|FG001|Randomized Phase|Incarceration|2
7233607|NCT00112047|11441423|FG000|Randomized Phase|Moved out of State|0
7233608|NCT00112047|11441424|FG001|Randomized Phase|Moved out of State|1
7233609|NCT00112047|11441423|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
7233610|NCT00112047|11441424|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
7233611|NCT00112047|11441423|FG000|Randomized Phase|High Hepatitis B DNA|0
7233612|NCT00112047|11441424|FG001|Randomized Phase|High Hepatitis B DNA|1
7233613|NCT00112047|11441423|FG000|Atripla Phase|Adverse Event|2
7233614|NCT00112047|11441424|FG001|Atripla Phase|Adverse Event|1
7233615|NCT00112047|11441423|FG000|Atripla Phase|Lost to Follow-up|5
7233616|NCT00112047|11441424|FG001|Atripla Phase|Lost to Follow-up|7
7233617|NCT00112047|11441423|FG000|Atripla Phase|Pregnancy|0
7233618|NCT00112047|11441424|FG001|Atripla Phase|Pregnancy|1
7233619|NCT00112047|11441423|FG000|Atripla Phase|Death|0
7233620|NCT00112047|11441424|FG001|Atripla Phase|Death|2
7233621|NCT00112047|11441423|FG000|Atripla Phase|Withdrew consent|7
7233622|NCT00112047|11441424|FG001|Atripla Phase|Withdrew consent|7
7233623|NCT00112047|11441423|FG000|Atripla Phase|Sub-optimal virological response|0
7233624|NCT00112047|11441424|FG001|Atripla Phase|Sub-optimal virological response|1
7233625|NCT00112047|11441423|FG000|Atripla Phase|Non-compliance|1
7233626|NCT00112047|11441424|FG001|Atripla Phase|Non-compliance|0
7233627|NCT00112047|11441423|FG000|Atripla Phase|Other|3
7233628|NCT00112047|11441424|FG001|Atripla Phase|Other|1
7233629|NCT00112294|11441506|FG000|Overall Study|Still on study|5
7573581|NCT03622112|11954985|FG001|Overall Study|Withdrawal by Subject|2
7573582|NCT03622112|11954986|FG002|Overall Study|Withdrawal by Subject|4
7573583|NCT03622112|11954987|FG003|Overall Study|Withdrawal by Subject|2
7573584|NCT03622112|11954988|FG004|Overall Study|Withdrawal by Subject|1
7573585|NCT03622112|11954989|FG005|Overall Study|Withdrawal by Subject|2
7573586|NCT03622112|11954990|FG006|Overall Study|Withdrawal by Subject|2
7573587|NCT03622112|11954984|FG000|Overall Study|Death|0
7573588|NCT03622112|11954985|FG001|Overall Study|Death|0
7573589|NCT03622112|11954986|FG002|Overall Study|Death|0
7573590|NCT03622112|11954987|FG003|Overall Study|Death|1
7573591|NCT03622112|11954988|FG004|Overall Study|Death|0
7573592|NCT03622112|11954989|FG005|Overall Study|Death|0
7573593|NCT03622112|11954990|FG006|Overall Study|Death|0
7573594|NCT03622112|11954984|FG000|Overall Study|Lost to Follow-up|1
7573595|NCT03622112|11954985|FG001|Overall Study|Lost to Follow-up|1
7233630|NCT00112294|11441507|FG001|Overall Study|Still on study|0
7233631|NCT00112359|11441515|FG000|Overall Study|Unrelated adverse event|16
7233632|NCT00112359|11441516|FG001|Overall Study|Unrelated adverse event|8
7233633|NCT00112359|11441515|FG000|Overall Study|Trial drug intolerance (adverse event)|2
7233634|NCT00112359|11441516|FG001|Overall Study|Trial drug intolerance (adverse event)|0
7233635|NCT00112359|11441515|FG000|Overall Study|Related adverse event|5
7233636|NCT00112359|11441516|FG001|Overall Study|Related adverse event|3
7233637|NCT00112359|11441515|FG000|Overall Study|Lost to Follow-up|0
7233638|NCT00112359|11441516|FG001|Overall Study|Lost to Follow-up|1
7233639|NCT00112359|11441515|FG000|Overall Study|Personal/administrative|1
7233640|NCT00112359|11441516|FG001|Overall Study|Personal/administrative|1
7233641|NCT00112359|11441515|FG000|Overall Study|Other|3
7233642|NCT00112359|11441516|FG001|Overall Study|Other|0
7233643|NCT00112385|11441524|FG000|Overall Study|Lost to Follow-up|1
7233644|NCT00112385|11441525|FG001|Overall Study|Lost to Follow-up|0
7233645|NCT00112385|11441524|FG000|Overall Study|Withdrawal by Subject|0
7233646|NCT00112385|11441525|FG001|Overall Study|Withdrawal by Subject|1
7233647|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
7233648|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
7233649|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
7233650|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
7233651|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
7233652|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
7233653|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
7233654|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
7233655|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
7233656|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
7233657|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
7233658|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
7233659|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
7233660|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
7233661|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
7233662|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
7233663|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
7233664|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
7233665|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
7233666|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
7233667|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
7233668|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
7233669|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
7233670|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
7233671|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
7233672|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
7233673|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233674|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
7233675|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233676|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233677|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233678|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233679|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233680|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233681|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233682|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233683|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233684|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233685|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233686|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233687|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233688|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233689|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233690|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233691|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233692|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233693|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233694|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233695|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233696|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233697|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233698|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
7233699|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233700|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
7233701|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233702|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233703|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233704|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233705|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233706|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233707|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233708|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233709|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233710|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233711|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233712|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233713|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233714|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233715|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233716|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233717|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233718|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233719|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233720|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233721|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233722|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233723|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233724|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
7233725|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
7233726|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
7233727|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
7233728|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
7233729|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
7233730|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
7233731|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
7233732|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
7233733|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
7233734|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
7233735|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
7233736|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
7233737|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
7233738|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
7233739|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
7233740|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
7233741|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
7233742|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
7233743|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
7233744|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
7233745|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
7233746|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
7233747|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
7233748|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
7573596|NCT03622112|11954986|FG002|Overall Study|Lost to Follow-up|0
7573597|NCT03622112|11954987|FG003|Overall Study|Lost to Follow-up|0
7573598|NCT03622112|11954988|FG004|Overall Study|Lost to Follow-up|0
7573599|NCT03622112|11954989|FG005|Overall Study|Lost to Follow-up|0
7573601|NCT03622112|11954984|FG000|Overall Study|Study-specific withdrawal criteria|10
7233749|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
7233750|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
7233751|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7233752|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
7233753|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
7233754|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
7233755|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
7233756|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233757|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233758|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233759|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233760|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233761|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233762|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233763|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233764|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233765|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233766|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233767|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233768|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233769|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233770|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233771|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233772|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233773|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233774|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233775|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233776|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
7233777|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|moved|0
7233778|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|moved|1
7573602|NCT03622112|11954985|FG001|Overall Study|Study-specific withdrawal criteria|8
7575388|NCT03736967|11959082|FG001|Overall Study|Lost to Follow-up|2
7233779|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|moved|1
7233780|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|moved|0
7233781|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|moved|0
7233782|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|moved|0
7233783|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|moved|0
7233784|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|moved|0
7233785|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|moved|0
7233786|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|moved|0
7233787|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|moved|0
7233788|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|moved|0
7233789|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|moved|0
7233790|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|moved|0
7233791|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|moved|0
7233792|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|moved|0
7233793|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|moved|0
7233794|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|moved|0
7233795|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|moved|0
7233796|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|moved|0
7233797|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|moved|0
7233798|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|moved|0
7233799|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|moved|0
7233800|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|moved|0
7233801|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|moved|0
7233802|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|moved|0
7233803|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233804|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233805|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233806|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
7233807|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233808|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233809|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233810|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233811|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233812|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233813|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233814|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233815|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233816|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233817|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233818|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233819|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233820|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233821|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233822|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233823|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233824|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233825|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233826|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233827|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233828|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
7233829|NCT00112437|11441536|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233830|NCT00112437|11441537|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233831|NCT00112437|11441538|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233832|NCT00112437|11441539|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233833|NCT00112437|11441540|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
7233834|NCT00112437|11441541|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233835|NCT00112437|11441542|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233836|NCT00112437|11441543|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233837|NCT00112437|11441544|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233838|NCT00112437|11441545|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233839|NCT00112437|11441546|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233840|NCT00112437|11441547|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233841|NCT00112437|11441548|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233842|NCT00112437|11441549|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233843|NCT00112437|11441550|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7573603|NCT03622112|11954986|FG002|Overall Study|Study-specific withdrawal criteria|7
7573604|NCT03622112|11954987|FG003|Overall Study|Study-specific withdrawal criteria|6
7573605|NCT03622112|11954988|FG004|Overall Study|Study-specific withdrawal criteria|4
7233844|NCT00112437|11441551|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233845|NCT00112437|11441552|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233846|NCT00112437|11441553|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233847|NCT00112437|11441554|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233848|NCT00112437|11441555|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233849|NCT00112437|11441556|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233850|NCT00112437|11441557|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233851|NCT00112437|11441558|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233852|NCT00112437|11441559|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233853|NCT00112437|11441560|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233854|NCT00112437|11441561|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
7233855|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Adverse Event|0
7233856|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Adverse Event|0
7233857|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Adverse Event|0
7233858|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Adverse Event|0
7233859|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Adverse Event|0
7233860|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Adverse Event|1
7233861|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Adverse Event|2
7233862|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Adverse Event|6
7233863|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Adverse Event|1
7233864|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Adverse Event|7
7233865|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Adverse Event|0
7233866|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Adverse Event|0
7233867|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Adverse Event|0
7233868|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Adverse Event|0
7233869|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Adverse Event|0
7233870|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Adverse Event|0
7233871|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Adverse Event|0
7233872|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Adverse Event|0
7233873|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Adverse Event|0
7233874|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Adverse Event|0
7233875|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Adverse Event|0
7233876|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Adverse Event|0
7233877|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Adverse Event|0
7233878|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Adverse Event|0
7233879|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Adverse Event|0
7233880|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Adverse Event|0
7233881|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233882|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233883|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233884|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233885|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233886|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
7233887|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
7233888|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233889|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233890|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
7233891|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233892|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233893|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233894|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233895|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233896|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233897|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233898|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233899|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233900|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
7573606|NCT03622112|11954989|FG005|Overall Study|Study-specific withdrawal criteria|18
7573607|NCT03622112|11954990|FG006|Overall Study|Study-specific withdrawal criteria|4
7573608|NCT03622112|11954984|FG000|Overall Study|Protocol Violation|2
7573609|NCT03622112|11954985|FG001|Overall Study|Protocol Violation|0
7573610|NCT03622112|11954986|FG002|Overall Study|Protocol Violation|1
7573611|NCT03622112|11954987|FG003|Overall Study|Protocol Violation|1
7573612|NCT03622112|11954988|FG004|Overall Study|Protocol Violation|0
7573613|NCT03622112|11954989|FG005|Overall Study|Protocol Violation|0
7573614|NCT03622112|11954990|FG006|Overall Study|Protocol Violation|0
7573615|NCT03622112|11954984|FG000|Overall Study|Adverse Event|6
7573616|NCT03622112|11954985|FG001|Overall Study|Adverse Event|8
7573617|NCT03622112|11954986|FG002|Overall Study|Adverse Event|4
7233901|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233902|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233903|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233904|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233905|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
7573618|NCT03622112|11954987|FG003|Overall Study|Adverse Event|11
7573619|NCT03622112|11954988|FG004|Overall Study|Adverse Event|4
7573620|NCT03622112|11954989|FG005|Overall Study|Adverse Event|20
7573621|NCT03622112|11954990|FG006|Overall Study|Adverse Event|2
7573622|NCT03622112|11954984|FG000|Overall Study|Reason not specified|0
7573623|NCT03622112|11954985|FG001|Overall Study|Reason not specified|1
7573624|NCT03622112|11954986|FG002|Overall Study|Reason not specified|0
7573625|NCT03622112|11954987|FG003|Overall Study|Reason not specified|1
7573626|NCT03622112|11954988|FG004|Overall Study|Reason not specified|1
7573627|NCT03622112|11954989|FG005|Overall Study|Reason not specified|2
7233906|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
7233907|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233908|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233909|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233910|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233911|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233912|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233913|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233914|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233915|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
7233916|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233917|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233918|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233919|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233920|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233921|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233922|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233923|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233924|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233925|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233926|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233927|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233928|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233929|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233930|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233931|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233932|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
7233933|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
7233934|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
7233935|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
7233936|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
7233937|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
7233938|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
7233939|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
7233940|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
7233941|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
7233942|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
7233943|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
7233944|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
7233945|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
7233946|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
7233947|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
7233948|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
7233949|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
7233950|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
7233951|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
7233952|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
7233953|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
7233954|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
7233955|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
7233956|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
7233957|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
7233958|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
7233959|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233960|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233961|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233962|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233963|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233964|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7233965|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7233966|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
7233967|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
7233968|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
7573628|NCT03622112|11954990|FG006|Overall Study|Reason not specified|1
7573629|NCT03624192|11955043|FG000|Overall Study|Lost to Follow-up|1
7233969|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233970|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233971|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233972|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233973|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233974|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233975|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233976|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233977|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233978|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233979|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7573630|NCT03624192|11955044|FG001|Overall Study|Lost to Follow-up|1
7573631|NCT03624504|11955052|FG000|Overall Study|Unsuccessful Implant|1
7573632|NCT03624946|11955077|FG000|Overall Study|Lost to Follow-up|0
7573633|NCT03624946|11955078|FG001|Overall Study|Lost to Follow-up|1
7573634|NCT03624972|11955091|FG000|Overall Study|Lost to Follow-up|2
7573635|NCT03624972|11955092|FG001|Overall Study|Lost to Follow-up|0
7573636|NCT03624972|11955093|FG002|Overall Study|Lost to Follow-up|0
7573637|NCT03624972|11955091|FG000|Overall Study|Withdrawal by Subject|0
7573638|NCT03624972|11955092|FG001|Overall Study|Withdrawal by Subject|2
7573639|NCT03624972|11955093|FG002|Overall Study|Withdrawal by Subject|0
7573640|NCT03627065|11955128|FG000|Overall Study|Study Terminated by sponsor|1
7573641|NCT03627065|11955128|FG000|Overall Study|Withdrawal by Subject|2
7573642|NCT03627195|11955138|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
7573643|NCT03627195|11955139|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
7233980|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233981|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233982|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233983|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233984|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
7233985|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233986|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233987|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233988|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233989|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233990|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233991|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233992|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233993|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233994|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
7233995|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233996|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233997|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233998|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7233999|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234064|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|Adverse Event|0
7234000|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234001|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234002|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234003|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234004|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234005|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234006|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234007|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234008|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234009|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234010|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
7234011|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
7234012|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
7234013|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
7234014|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
7573644|NCT03627195|11955140|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
7573645|NCT03627195|11955141|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
7573646|NCT03627195|11955142|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
7573647|NCT03627195|11955143|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
7573648|NCT03627416|11955163|FG000|Overall Study|Adverse Event|0
7573649|NCT03627416|11955164|FG001|Overall Study|Adverse Event|1
7573650|NCT03627494|11955182|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
7573651|NCT03627494|11955183|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
7573652|NCT03627494|11955184|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
7573653|NCT03627494|11955185|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
7573654|NCT03627494|11955186|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
7573655|NCT03627494|11955187|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
7573656|NCT03627494|11955188|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
7234015|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
7234016|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
7234017|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
7234018|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
7234019|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
7234020|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
7234021|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
7234022|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
7234023|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
7234024|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
7234025|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
7234026|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
7234027|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
7234028|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
7234029|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
7234030|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
7234031|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
7234032|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
7234033|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
7234034|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
7234035|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
7234036|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
7234037|NCT00112437|11441536|FG000|Year 2 (12-Month Extension)|Moved|0
7234038|NCT00112437|11441537|FG001|Year 2 (12-Month Extension)|Moved|0
7234039|NCT00112437|11441538|FG002|Year 2 (12-Month Extension)|Moved|0
7234040|NCT00112437|11441539|FG003|Year 2 (12-Month Extension)|Moved|0
7234041|NCT00112437|11441540|FG004|Year 2 (12-Month Extension)|Moved|0
7234042|NCT00112437|11441541|FG005|Year 2 (12-Month Extension)|Moved|0
7234043|NCT00112437|11441542|FG006|Year 2 (12-Month Extension)|Moved|0
7234044|NCT00112437|11441543|FG007|Year 2 (12-Month Extension)|Moved|0
7234045|NCT00112437|11441544|FG008|Year 2 (12-Month Extension)|Moved|0
7234046|NCT00112437|11441545|FG009|Year 2 (12-Month Extension)|Moved|1
7234047|NCT00112437|11441546|FG010|Year 2 (12-Month Extension)|Moved|0
7234048|NCT00112437|11441547|FG011|Year 2 (12-Month Extension)|Moved|0
7234049|NCT00112437|11441548|FG012|Year 2 (12-Month Extension)|Moved|0
7234050|NCT00112437|11441549|FG013|Year 2 (12-Month Extension)|Moved|0
7234051|NCT00112437|11441550|FG014|Year 2 (12-Month Extension)|Moved|0
7234052|NCT00112437|11441551|FG015|Year 2 (12-Month Extension)|Moved|0
7234053|NCT00112437|11441552|FG016|Year 2 (12-Month Extension)|Moved|0
7234054|NCT00112437|11441553|FG017|Year 2 (12-Month Extension)|Moved|0
7234055|NCT00112437|11441554|FG018|Year 2 (12-Month Extension)|Moved|0
7234056|NCT00112437|11441555|FG019|Year 2 (12-Month Extension)|Moved|0
7234057|NCT00112437|11441556|FG020|Year 2 (12-Month Extension)|Moved|0
7234058|NCT00112437|11441557|FG021|Year 2 (12-Month Extension)|Moved|0
7234059|NCT00112437|11441558|FG022|Year 2 (12-Month Extension)|Moved|0
7234060|NCT00112437|11441559|FG023|Year 2 (12-Month Extension)|Moved|0
7234061|NCT00112437|11441560|FG024|Year 2 (12-Month Extension)|Moved|0
7234062|NCT00112437|11441561|FG025|Year 2 (12-Month Extension)|Moved|0
7234063|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|Adverse Event|0
7234065|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|Adverse Event|0
7234066|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|Adverse Event|0
7234067|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|Adverse Event|0
7234068|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|Adverse Event|0
7234069|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|Adverse Event|0
7234070|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|Adverse Event|0
7234071|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|Adverse Event|0
7234072|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|Adverse Event|0
7234073|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|Adverse Event|1
7234074|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|Adverse Event|0
7234075|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|Adverse Event|0
7234076|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|Adverse Event|0
7234077|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|Adverse Event|0
7234078|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|Adverse Event|1
7234079|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|Adverse Event|3
7234080|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|Adverse Event|1
7234081|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|Adverse Event|0
7234082|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|Adverse Event|1
7234083|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|Adverse Event|0
7234084|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|Adverse Event|0
7234085|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|Adverse Event|0
7234086|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|Adverse Event|0
7234087|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|Adverse Event|0
7234088|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|Adverse Event|0
7234089|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234090|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234091|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234092|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234093|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234094|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234095|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234096|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234097|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234098|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234099|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234100|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
7234101|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234102|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
7234103|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234104|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
7234105|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234106|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234107|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
7234108|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234109|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234110|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234111|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234112|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234113|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234114|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
7234115|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234116|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234117|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234118|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234119|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234120|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234121|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234122|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234123|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234124|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234125|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234126|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234127|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234128|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234129|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234130|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
7234131|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234132|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234133|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234134|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234135|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234136|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234137|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234138|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234139|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234140|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
7234141|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
7234142|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
7234143|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
7234144|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
7234145|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
7234146|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
7234147|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
7234148|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
7234149|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
7234150|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
7234151|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
7234152|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
7234153|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
7234154|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
7234155|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
7234156|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
7234157|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
7234158|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
7234159|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
7234160|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
7234161|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
7234162|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
7234163|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
7234164|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
7234165|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
7234166|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
7234167|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234168|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234169|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234170|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234171|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234172|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234173|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234174|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234175|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234176|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234177|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234178|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
7234179|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234180|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234181|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
7234182|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234183|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234184|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234185|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234186|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234187|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234188|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234189|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234190|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234191|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234192|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
7234193|NCT00112437|11441536|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234194|NCT00112437|11441537|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234195|NCT00112437|11441538|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234196|NCT00112437|11441539|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234197|NCT00112437|11441540|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234198|NCT00112437|11441541|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234199|NCT00112437|11441542|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234200|NCT00112437|11441543|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234201|NCT00112437|11441544|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234202|NCT00112437|11441545|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234203|NCT00112437|11441546|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7234204|NCT00112437|11441547|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
7234205|NCT00112437|11441548|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234206|NCT00112437|11441549|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234207|NCT00112437|11441550|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234208|NCT00112437|11441551|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234209|NCT00112437|11441552|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234210|NCT00112437|11441553|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234211|NCT00112437|11441554|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234212|NCT00112437|11441555|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234213|NCT00112437|11441556|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234214|NCT00112437|11441557|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234215|NCT00112437|11441558|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234216|NCT00112437|11441559|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234217|NCT00112437|11441560|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234218|NCT00112437|11441561|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
7234219|NCT00112437|11441536|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234220|NCT00112437|11441537|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234221|NCT00112437|11441538|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234222|NCT00112437|11441539|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234223|NCT00112437|11441540|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234224|NCT00112437|11441541|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234225|NCT00112437|11441542|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234226|NCT00112437|11441543|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234227|NCT00112437|11441544|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234228|NCT00112437|11441545|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234229|NCT00112437|11441546|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234230|NCT00112437|11441547|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234231|NCT00112437|11441548|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234232|NCT00112437|11441549|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234233|NCT00112437|11441550|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234234|NCT00112437|11441551|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234235|NCT00112437|11441552|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234236|NCT00112437|11441553|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234237|NCT00112437|11441554|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234238|NCT00112437|11441555|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234239|NCT00112437|11441556|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
7234240|NCT00112437|11441557|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
7234241|NCT00112437|11441558|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234242|NCT00112437|11441559|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234243|NCT00112437|11441560|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234244|NCT00112437|11441561|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
7234245|NCT00112437|11441536|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234246|NCT00112437|11441537|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234247|NCT00112437|11441538|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234248|NCT00112437|11441539|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234249|NCT00112437|11441540|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234250|NCT00112437|11441541|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234251|NCT00112437|11441542|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234252|NCT00112437|11441543|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234253|NCT00112437|11441544|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234254|NCT00112437|11441545|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234255|NCT00112437|11441546|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234256|NCT00112437|11441547|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234257|NCT00112437|11441548|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234258|NCT00112437|11441549|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234259|NCT00112437|11441550|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234260|NCT00112437|11441551|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234261|NCT00112437|11441552|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234262|NCT00112437|11441553|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234263|NCT00112437|11441554|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234264|NCT00112437|11441555|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234265|NCT00112437|11441556|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
7234266|NCT00112437|11441557|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234267|NCT00112437|11441558|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234268|NCT00112437|11441559|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234269|NCT00112437|11441560|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234270|NCT00112437|11441561|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
7234271|NCT00112437|11441536|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
7234272|NCT00112437|11441537|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
7234273|NCT00112437|11441538|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
7234274|NCT00112437|11441539|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
7234275|NCT00112437|11441540|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
7234276|NCT00112437|11441541|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
7234277|NCT00112437|11441542|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
7234278|NCT00112437|11441543|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
7234279|NCT00112437|11441544|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
7234280|NCT00112437|11441545|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
7234281|NCT00112437|11441546|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
7234282|NCT00112437|11441547|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
7234283|NCT00112437|11441548|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
7234284|NCT00112437|11441549|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
7234285|NCT00112437|11441550|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
7234286|NCT00112437|11441551|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
7234287|NCT00112437|11441552|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
7234288|NCT00112437|11441553|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
7234289|NCT00112437|11441554|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
7234290|NCT00112437|11441555|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
7234291|NCT00112437|11441556|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
7234292|NCT00112437|11441557|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
7234293|NCT00112437|11441558|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
7234294|NCT00112437|11441559|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
7234295|NCT00112437|11441560|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
7234296|NCT00112437|11441561|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
7234297|NCT00112437|11441536|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
7234298|NCT00112437|11441537|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
7234299|NCT00112437|11441538|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
7234300|NCT00112437|11441539|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
7234301|NCT00112437|11441540|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
7234302|NCT00112437|11441541|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
7234303|NCT00112437|11441542|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
7234304|NCT00112437|11441543|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
7234305|NCT00112437|11441544|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
7234306|NCT00112437|11441545|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
7234307|NCT00112437|11441546|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
7234308|NCT00112437|11441547|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
7234309|NCT00112437|11441548|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
7234310|NCT00112437|11441549|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
7234311|NCT00112437|11441550|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
7234312|NCT00112437|11441551|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
7234313|NCT00112437|11441552|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
7255609|NCT00319254|11467144|FG000|Overall Study|Death|46
7234314|NCT00112437|11441553|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
7234315|NCT00112437|11441554|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
7234316|NCT00112437|11441555|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
7234317|NCT00112437|11441556|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
7234318|NCT00112437|11441557|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
7234319|NCT00112437|11441558|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
7234320|NCT00112437|11441559|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
7234321|NCT00112437|11441560|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
7234322|NCT00112437|11441561|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
7234323|NCT00112437|11441536|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234324|NCT00112437|11441537|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234325|NCT00112437|11441538|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234326|NCT00112437|11441539|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234327|NCT00112437|11441540|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234328|NCT00112437|11441541|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234329|NCT00112437|11441542|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234330|NCT00112437|11441543|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234331|NCT00112437|11441544|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234332|NCT00112437|11441545|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234333|NCT00112437|11441546|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234334|NCT00112437|11441547|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234335|NCT00112437|11441548|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234336|NCT00112437|11441549|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234337|NCT00112437|11441550|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234338|NCT00112437|11441551|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234339|NCT00112437|11441552|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234340|NCT00112437|11441553|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234341|NCT00112437|11441554|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234342|NCT00112437|11441555|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234343|NCT00112437|11441556|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
7234344|NCT00112437|11441557|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
7234345|NCT00112437|11441558|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234346|NCT00112437|11441559|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234347|NCT00112437|11441560|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234348|NCT00112437|11441561|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
7234349|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
7234350|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
7234351|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
7234352|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
7234353|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
7234354|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
7234355|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
7234356|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
7234562|NCT00113269|11441820|FG002|Overall Study|Death in operating room|0
7234357|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
7234358|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
7234359|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
7234360|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
7234361|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
7234362|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
7234363|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
7234364|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
7234365|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
7234366|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
7234367|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
7234368|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
7234369|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
7234370|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
7234371|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
7234372|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
7234373|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
7234374|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
7234375|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Death|0
7234376|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Death|0
7234377|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Death|0
7234378|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Death|0
7234379|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Death|0
7234380|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Death|0
7234381|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Death|0
7573657|NCT03627494|11955189|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
7573658|NCT03627494|11955190|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
7573659|NCT03627494|11955191|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
7573660|NCT03627494|11955192|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
7573661|NCT03627494|11955193|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
7573662|NCT03627494|11955182|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
7573663|NCT03627494|11955183|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
7573664|NCT03627494|11955184|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
7573665|NCT03627494|11955185|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
7573666|NCT03627494|11955186|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
7234382|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Death|0
7234383|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Death|0
7234384|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Death|0
7234385|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Death|0
7234386|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Death|0
7234387|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Death|0
7234388|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Death|0
7234389|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Death|0
7234390|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Death|0
7234391|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Death|0
7234392|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Death|0
7234393|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Death|0
7234394|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Death|0
7234395|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Death|0
7234396|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Death|0
7234397|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Death|0
7234398|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Death|2
7234399|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Death|0
7234400|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Death|0
7234401|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234402|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234403|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234404|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234405|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234406|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234407|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7573667|NCT03627494|11955187|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
7573668|NCT03627494|11955188|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
7573669|NCT03627494|11955189|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
7573670|NCT03627494|11955190|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
7234408|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234409|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234410|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234411|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234412|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234413|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234414|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234415|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234416|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234417|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234418|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234419|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234420|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234421|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234422|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234423|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234424|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234425|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
7234426|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
7234427|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Other|0
7234428|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Other|0
7234429|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Other|0
7234430|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Other|0
7234431|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Other|0
7234432|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Other|0
7234433|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Other|0
7234434|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Other|0
7234435|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Other|0
7234436|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Other|0
7234437|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Other|0
7234438|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Other|0
7234439|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Other|0
7234440|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Other|0
7234441|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Other|0
7234442|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Other|0
7234443|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Other|0
7234444|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Other|0
7234445|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Other|0
7234446|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Other|0
7234447|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Other|0
7234448|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Other|0
7234449|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Other|0
7234450|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Other|0
7234451|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Other|1
7234452|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Other|0
7234453|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
7234454|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
7234455|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
7234456|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
7234457|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
7234458|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
7234459|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
7234460|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
7234461|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
7234462|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
7234463|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
7234464|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
7234465|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
7234466|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
7234467|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
7234468|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
7234469|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
7234470|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
7234471|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
7234472|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
7234473|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
7234474|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
7234475|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
7234476|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
7234477|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
7234478|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
7464908|NCT01876251|11763777|FG000|Overall Study|Participant refused further follow-up|0
7464909|NCT01876251|11763778|FG001|Overall Study|Participant refused further follow-up|0
7464910|NCT01876251|11763779|FG002|Overall Study|Participant refused further follow-up|1
7464911|NCT01876251|11763777|FG000|Overall Study|Study terminated|1
7464912|NCT01876251|11763778|FG001|Overall Study|Study terminated|0
7464913|NCT01876251|11763779|FG002|Overall Study|Study terminated|0
7464914|NCT01876251|11763777|FG000|Overall Study|Objective progression or relapse|10
7464915|NCT01876251|11763778|FG001|Overall Study|Objective progression or relapse|3
7464916|NCT01876251|11763779|FG002|Overall Study|Objective progression or relapse|8
7464917|NCT01876368|11763803|FG000|Overall Study|Adverse Event|2
7464918|NCT01876368|11763804|FG001|Overall Study|Adverse Event|5
7234479|NCT00112437|11441536|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234480|NCT00112437|11441537|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234481|NCT00112437|11441538|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234482|NCT00112437|11441539|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234483|NCT00112437|11441540|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234484|NCT00112437|11441541|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234485|NCT00112437|11441542|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234486|NCT00112437|11441543|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234487|NCT00112437|11441544|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234488|NCT00112437|11441545|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234489|NCT00112437|11441546|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234490|NCT00112437|11441547|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234491|NCT00112437|11441548|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234492|NCT00112437|11441549|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7464919|NCT01876368|11763803|FG000|Overall Study|Lack of Efficacy|1
7464920|NCT01876368|11763804|FG001|Overall Study|Lack of Efficacy|0
7234493|NCT00112437|11441550|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234494|NCT00112437|11441551|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234495|NCT00112437|11441552|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234496|NCT00112437|11441553|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234497|NCT00112437|11441554|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234498|NCT00112437|11441555|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234499|NCT00112437|11441556|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234500|NCT00112437|11441557|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234501|NCT00112437|11441558|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
7234502|NCT00112437|11441559|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
7234503|NCT00112437|11441560|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
7234504|NCT00112437|11441561|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
7234505|NCT00112463|11441615|FG000|Overall Study|Physician Decision|1
7234506|NCT00112463|11441615|FG000|Overall Study|Progression|30
7234507|NCT00112463|11441615|FG000|Overall Study|Second Primary|1
7234508|NCT00112463|11441615|FG000|Overall Study|Toxicity|3
7234509|NCT00112463|11441615|FG000|Overall Study|Withdrawal by Subject|2
7234510|NCT00112463|11441615|FG000|Overall Study|Never started treatment|2
7234511|NCT00112489|11441620|FG000|Overall Study|Refused further treatment|8
7234512|NCT00112489|11441620|FG000|Overall Study|Adverse Event|12
7234513|NCT00112489|11441620|FG000|Overall Study|Death|2
7234514|NCT00112489|11441620|FG000|Overall Study|Other, Not Specified|9
7234515|NCT00112489|11441620|FG000|Overall Study|Patient never treated|2
7234516|NCT00112489|11441620|FG000|Overall Study|Ineligible|7
7234517|NCT00112502|11441638|FG000|Overall Study|Withdrawal by Subject|0
7234518|NCT00112502|11441639|FG001|Overall Study|Withdrawal by Subject|1
7234519|NCT00112502|11441640|FG002|Overall Study|Withdrawal by Subject|1
7234520|NCT00112502|11441641|FG003|Overall Study|Withdrawal by Subject|4
7234521|NCT00112502|11441642|FG004|Overall Study|Withdrawal by Subject|2
7234522|NCT00112502|11441643|FG005|Overall Study|Withdrawal by Subject|5
7234523|NCT00112502|11441644|FG006|Overall Study|Withdrawal by Subject|3
7234524|NCT00112502|11441645|FG007|Overall Study|Withdrawal by Subject|7
7234525|NCT00112580|11441675|FG000|Overall Study|Adverse Event|1
7234526|NCT00112580|11441676|FG001|Overall Study|Adverse Event|2
7234527|NCT00112580|11441675|FG000|Overall Study|Disease progression|5
7234528|NCT00112580|11441676|FG001|Overall Study|Disease progression|16
7234529|NCT00112580|11441675|FG000|Overall Study|Participant withdrew consent|2
7234530|NCT00112580|11441676|FG001|Overall Study|Participant withdrew consent|1
7234531|NCT00112736|11441715|FG000|Overall Study|1 pt never had had RX due rapid decline|1
7234532|NCT00112736|11441716|FG001|Overall Study|1 pt never had had RX due rapid decline|0
7234533|NCT00112866|11441752|FG000|Overall Study|Protocol Violation|1
7234534|NCT00112866|11441753|FG001|Overall Study|Protocol Violation|0
7234535|NCT00112866|11441752|FG000|Overall Study|did not start treatment post-op|1
7234536|NCT00112866|11441753|FG001|Overall Study|did not start treatment post-op|2
7234537|NCT00112905|11441767|FG000|Overall Study|Adverse Event|4
7234538|NCT00112905|11441767|FG000|Overall Study|Death|1
7234539|NCT00112905|11441767|FG000|Overall Study|Ineligibility|5
7234540|NCT00112905|11441767|FG000|Overall Study|Alternative treatment|1
7234541|NCT00112905|11441767|FG000|Overall Study|performance status was deteiorating|1
7234542|NCT00112957|11441784|FG000|Overall Study|Progressive disease|18
7234543|NCT00112957|11441784|FG000|Overall Study|Physician Decision|1
7234544|NCT00113087|11441799|FG000|Overall Study|Death or Transplant|14
7234545|NCT00113087|11441800|FG001|Overall Study|Death or Transplant|16
7234546|NCT00113087|11441799|FG000|Overall Study|Family or MD withdrew subject|10
7234547|NCT00113087|11441800|FG001|Overall Study|Family or MD withdrew subject|5
7234548|NCT00113269|11441818|FG000|Overall Study|Not transplanted, donor issues|4
7234549|NCT00113269|11441819|FG001|Overall Study|Not transplanted, donor issues|0
7234550|NCT00113269|11441820|FG002|Overall Study|Not transplanted, donor issues|2
7234551|NCT00113269|11441821|FG003|Overall Study|Not transplanted, donor issues|2
7234552|NCT00113269|11441818|FG000|Overall Study|Not transplanted, recipient issues|2
7234553|NCT00113269|11441819|FG001|Overall Study|Not transplanted, recipient issues|1
7234554|NCT00113269|11441820|FG002|Overall Study|Not transplanted, recipient issues|7
7234555|NCT00113269|11441821|FG003|Overall Study|Not transplanted, recipient issues|4
7234556|NCT00113269|11441818|FG000|Overall Study|Early graft loss, technical|0
7234557|NCT00113269|11441819|FG001|Overall Study|Early graft loss, technical|0
7234558|NCT00113269|11441820|FG002|Overall Study|Early graft loss, technical|2
7234559|NCT00113269|11441821|FG003|Overall Study|Early graft loss, technical|0
7234560|NCT00113269|11441818|FG000|Overall Study|Death in operating room|0
7234561|NCT00113269|11441819|FG001|Overall Study|Death in operating room|0
7234563|NCT00113269|11441821|FG003|Overall Study|Death in operating room|1
7234564|NCT00113269|11441818|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
7234565|NCT00113269|11441819|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
7234566|NCT00113269|11441820|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
7234567|NCT00113269|11441821|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
7234568|NCT00113269|11441818|FG000|Overall Study|Adverse Event|2
7234569|NCT00113269|11441819|FG001|Overall Study|Adverse Event|7
7573671|NCT03627494|11955191|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
7573672|NCT03627494|11955192|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
7234570|NCT00113269|11441820|FG002|Overall Study|Adverse Event|11
7234571|NCT00113269|11441821|FG003|Overall Study|Adverse Event|7
7234572|NCT00113269|11441818|FG000|Overall Study|Withdrawal by Subject|4
7234573|NCT00113269|11441819|FG001|Overall Study|Withdrawal by Subject|3
7234574|NCT00113269|11441820|FG002|Overall Study|Withdrawal by Subject|4
7234575|NCT00113269|11441821|FG003|Overall Study|Withdrawal by Subject|2
7234576|NCT00113269|11441818|FG000|Overall Study|Graft loss|6
7234577|NCT00113269|11441819|FG001|Overall Study|Graft loss|6
7234578|NCT00113269|11441820|FG002|Overall Study|Graft loss|4
7234579|NCT00113269|11441821|FG003|Overall Study|Graft loss|9
7234580|NCT00113269|11441818|FG000|Overall Study|Protocol Violation|1
7234581|NCT00113269|11441819|FG001|Overall Study|Protocol Violation|0
7234582|NCT00113269|11441820|FG002|Overall Study|Protocol Violation|4
7234583|NCT00113269|11441821|FG003|Overall Study|Protocol Violation|2
7234584|NCT00113269|11441818|FG000|Overall Study|Lost to Follow-up|2
7234585|NCT00113269|11441819|FG001|Overall Study|Lost to Follow-up|3
7234586|NCT00113269|11441820|FG002|Overall Study|Lost to Follow-up|6
7234587|NCT00113269|11441821|FG003|Overall Study|Lost to Follow-up|3
7234588|NCT00113269|11441818|FG000|Overall Study|Sponsor elected to discontinue patient|1
7234589|NCT00113269|11441819|FG001|Overall Study|Sponsor elected to discontinue patient|0
7234590|NCT00113269|11441820|FG002|Overall Study|Sponsor elected to discontinue patient|0
7234591|NCT00113269|11441821|FG003|Overall Study|Sponsor elected to discontinue patient|1
7234592|NCT00113269|11441818|FG000|Overall Study|Discontinued due to rejection|0
7234593|NCT00113269|11441819|FG001|Overall Study|Discontinued due to rejection|0
7234594|NCT00113269|11441820|FG002|Overall Study|Discontinued due to rejection|1
7234595|NCT00113269|11441821|FG003|Overall Study|Discontinued due to rejection|0
7234596|NCT00113269|11441818|FG000|Overall Study|Moved|0
7234597|NCT00113269|11441819|FG001|Overall Study|Moved|1
7234598|NCT00113269|11441820|FG002|Overall Study|Moved|0
7234599|NCT00113269|11441821|FG003|Overall Study|Moved|3
7234600|NCT00113269|11441818|FG000|Overall Study|Received pancreas transplant|0
7234601|NCT00113269|11441819|FG001|Overall Study|Received pancreas transplant|0
7234602|NCT00113269|11441820|FG002|Overall Study|Received pancreas transplant|0
7234603|NCT00113269|11441821|FG003|Overall Study|Received pancreas transplant|2
7234604|NCT00113269|11441818|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
7234605|NCT00113269|11441819|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
7234606|NCT00113269|11441820|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
7234607|NCT00113269|11441821|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
7234608|NCT00113269|11441818|FG000|Overall Study|Did not meet eligibility criteria|1
7234609|NCT00113269|11441819|FG001|Overall Study|Did not meet eligibility criteria|0
7234610|NCT00113269|11441820|FG002|Overall Study|Did not meet eligibility criteria|0
7234611|NCT00113269|11441821|FG003|Overall Study|Did not meet eligibility criteria|1
7234612|NCT00113269|11441818|FG000|Overall Study|Unable to return for follow up|2
7234613|NCT00113269|11441819|FG001|Overall Study|Unable to return for follow up|1
7234614|NCT00113269|11441820|FG002|Overall Study|Unable to return for follow up|0
7234615|NCT00113269|11441821|FG003|Overall Study|Unable to return for follow up|0
7234616|NCT00113295|11441833|FG000|Overall Study|Adverse Event|4
7234617|NCT00113295|11441834|FG001|Overall Study|Adverse Event|1
7234618|NCT00113295|11441833|FG000|Overall Study|Unrelated Medical Illness|1
7234619|NCT00113295|11441834|FG001|Overall Study|Unrelated Medical Illness|0
7234620|NCT00113360|11441850|FG000|Overall Study|Adverse Event|3
7234621|NCT00113360|11441850|FG000|Overall Study|Subject required surgery|1
7234622|NCT00113360|11441850|FG000|Overall Study|Did not meet eligibility criteria|3
7234623|NCT00113373|11441854|FG000|Overall Study|Ineligible: wrong primary|1
7234624|NCT00113373|11441854|FG000|Overall Study|Ineligible: second primary|1
7234625|NCT00113373|11441854|FG000|Overall Study|Never Treated|1
7234626|NCT00113490|11441870|FG000|Overall Study|Withdrawal by Subject|1
7234627|NCT00113490|11441871|FG001|Overall Study|Withdrawal by Subject|3
7234628|NCT00113490|11441870|FG000|Overall Study|Lost to Follow-up|1
7234629|NCT00113490|11441871|FG001|Overall Study|Lost to Follow-up|0
7234630|NCT00113516|11441877|FG000|Part 1|Adverse Event|6
7234631|NCT00113516|11441878|FG001|Part 1|Adverse Event|0
7234632|NCT00113516|11441877|FG000|Part 1|Death|3
7234633|NCT00113516|11441878|FG001|Part 1|Death|0
7234634|NCT00113516|11441877|FG000|Part 1|Other|3
7234635|NCT00113516|11441878|FG001|Part 1|Other|0
7234636|NCT00113516|11441877|FG000|Part 1|Withdrawal by Subject|2
7234637|NCT00113516|11441878|FG001|Part 1|Withdrawal by Subject|0
7234638|NCT00113516|11441877|FG000|Part 1|Lack of Efficacy|2
7234639|NCT00113516|11441878|FG001|Part 1|Lack of Efficacy|0
7234640|NCT00113516|11441877|FG000|Part 1|Did Not Meet Entrance Criteria|1
7234641|NCT00113516|11441878|FG001|Part 1|Did Not Meet Entrance Criteria|0
7234642|NCT00113516|11441877|FG000|Part 1|Laboratory Abnormality|1
7234643|NCT00113516|11441878|FG001|Part 1|Laboratory Abnormality|0
7234644|NCT00113516|11441877|FG000|Part 1|Ongoing|1
7234645|NCT00113516|11441878|FG001|Part 1|Ongoing|0
7234646|NCT00113516|11441877|FG000|Part 1|Missing|65
7234647|NCT00113516|11441878|FG001|Part 1|Missing|0
7234648|NCT00113516|11441877|FG000|Part 2|Adverse Event|0
7234649|NCT00113516|11441878|FG001|Part 2|Adverse Event|16
7234650|NCT00113516|11441877|FG000|Part 2|Death|0
7234651|NCT00113516|11441878|FG001|Part 2|Death|5
7234652|NCT00113516|11441877|FG000|Part 2|Lack of Efficacy|0
7234653|NCT00113516|11441878|FG001|Part 2|Lack of Efficacy|37
7234654|NCT00113516|11441877|FG000|Part 2|Withdrawal by Subject|0
7234655|NCT00113516|11441878|FG001|Part 2|Withdrawal by Subject|3
7234656|NCT00113516|11441877|FG000|Part 2|Other|0
7234657|NCT00113516|11441878|FG001|Part 2|Other|3
7234658|NCT00113516|11441877|FG000|Part 2|Laboratory Abnormality|0
7234659|NCT00113516|11441878|FG001|Part 2|Laboratory Abnormality|1
7234660|NCT00113516|11441877|FG000|Part 2|Ongoing|0
7234661|NCT00113516|11441878|FG001|Part 2|Ongoing|1
7234662|NCT00113529|11441884|FG000|Overall Study|Adverse Event|4
7234663|NCT00113529|11441884|FG000|Overall Study|Lack of Efficacy|20
7234664|NCT00113529|11441884|FG000|Overall Study|Decision of sponsor|6
7234665|NCT00113529|11441884|FG000|Overall Study|Withdrawal by Subject|4
7234666|NCT00113555|11441888|FG000|Overall Study|Baseline Failure|59
7234667|NCT00113555|11441888|FG000|Overall Study|Permanently Explanted|7
7234668|NCT00113555|11441888|FG000|Overall Study|Death|1
7573673|NCT03627494|11955193|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
7573674|NCT03627494|11955182|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
7234669|NCT00113555|11441888|FG000|Overall Study|Missed Followup|4
7234670|NCT00113555|11441888|FG000|Overall Study|Lost to Follow-up|8
7234671|NCT00113568|11441893|FG000|Overall Study|Adverse Event|97
7234672|NCT00113568|11441893|FG000|Overall Study|Death|1
7234673|NCT00113568|11441893|FG000|Overall Study|Lack of Efficacy|30
7234674|NCT00113568|11441893|FG000|Overall Study|Lost to Follow-up|156
7234675|NCT00113568|11441893|FG000|Overall Study|Protocol Violation|32
7234676|NCT00113568|11441893|FG000|Overall Study|Withdrawal by Subject|117
7234677|NCT00113568|11441893|FG000|Overall Study|Other|112
7234678|NCT00113607|11441899|FG000|Overall Study|Adverse Event|40
7234679|NCT00113607|11441900|FG001|Overall Study|Adverse Event|71
7234680|NCT00113607|11441899|FG000|Overall Study|Death|8
7234681|NCT00113607|11441900|FG001|Overall Study|Death|8
7234682|NCT00113607|11441899|FG000|Overall Study|Withdrawal by Subject|50
7234683|NCT00113607|11441900|FG001|Overall Study|Withdrawal by Subject|58
7234684|NCT00113607|11441899|FG000|Overall Study|Lost to Follow-up|0
7234685|NCT00113607|11441900|FG001|Overall Study|Lost to Follow-up|2
7234686|NCT00113607|11441899|FG000|Overall Study|Disease Progression|180
7234687|NCT00113607|11441900|FG001|Overall Study|Disease Progression|142
7234688|NCT00113607|11441899|FG000|Overall Study|Complete Response (Confirmed)|14
7234689|NCT00113607|11441900|FG001|Overall Study|Complete Response (Confirmed)|24
7234690|NCT00113607|11441899|FG000|Overall Study|Other|43
7234691|NCT00113607|11441900|FG001|Overall Study|Other|32
7234706|NCT00113841|11441919|FG000|Overall Study|Disease progression|0
7234707|NCT00113841|11441920|FG001|Overall Study|Disease progression|2
7234708|NCT00113841|11441919|FG000|Overall Study|Non-compliant|1
7234709|NCT00113841|11441920|FG001|Overall Study|Non-compliant|0
7234710|NCT00114127|11441975|FG000|Overall Study|Adverse Event|2
7234711|NCT00114127|11441976|FG001|Overall Study|Adverse Event|1
7234712|NCT00114127|11441975|FG000|Overall Study|Lost to Follow-up|1
7234713|NCT00114127|11441976|FG001|Overall Study|Lost to Follow-up|0
7234714|NCT00114127|11441975|FG000|Overall Study|Withdrawal by Subject|1
7234715|NCT00114127|11441976|FG001|Overall Study|Withdrawal by Subject|3
7234716|NCT00114166|11441984|FG000|Overall Study|Wrong primary|0
7234717|NCT00114166|11441985|FG001|Overall Study|Wrong primary|1
7234718|NCT00114218|11441993|FG000|Overall Study|Wrong Cell Type|2
7234719|NCT00114218|11441993|FG000|Overall Study|Wrong Primary|1
7234720|NCT00114218|11441993|FG000|Overall Study|Never Treated|1
7234721|NCT00114231|11441999|FG000|Overall Study|No consent|2
7234722|NCT00114231|11442000|FG001|Overall Study|No consent|0
7234723|NCT00114231|11441999|FG000|Overall Study|QARC requirement not met|1
7234724|NCT00114231|11442000|FG001|Overall Study|QARC requirement not met|0
7234725|NCT00114231|11441999|FG000|Overall Study|Suspected metastatic disease|1
7573675|NCT03627494|11955183|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
7234726|NCT00114231|11442000|FG001|Overall Study|Suspected metastatic disease|0
7234727|NCT00114231|11441999|FG000|Overall Study|No adenocarcinoma|1
7234728|NCT00114231|11442000|FG001|Overall Study|No adenocarcinoma|0
7234729|NCT00114231|11441999|FG000|Overall Study|Low creatinine clearance|0
7234730|NCT00114231|11442000|FG001|Overall Study|Low creatinine clearance|1
7234731|NCT00114231|11441999|FG000|Overall Study|Tumor size > 4cm|1
7234732|NCT00114231|11442000|FG001|Overall Study|Tumor size > 4cm|0
7234733|NCT00114231|11441999|FG000|Overall Study|Tumor fixed on digital exam|0
7234734|NCT00114231|11442000|FG001|Overall Study|Tumor fixed on digital exam|1
7234735|NCT00114231|11441999|FG000|Overall Study|No Absolute Neutrophil Count|2
7234736|NCT00114231|11442000|FG001|Overall Study|No Absolute Neutrophil Count|0
7234737|NCT00114231|11441999|FG000|Overall Study|Biopsy done after registration|1
7234738|NCT00114231|11442000|FG001|Overall Study|Biopsy done after registration|0
7234739|NCT00114244|11442007|FG000|Overall Study|Adverse Event|2
7234740|NCT00114244|11442008|FG001|Overall Study|Adverse Event|5
7234741|NCT00114244|11442007|FG000|Overall Study|Withdrawal by Subject|0
7234742|NCT00114244|11442008|FG001|Overall Study|Withdrawal by Subject|2
7234743|NCT00114530|11442042|FG000|Overall Study|Death|3
7234744|NCT00114530|11442043|FG001|Overall Study|Death|11
7234745|NCT00114530|11442042|FG000|Overall Study|Lost to Follow-up|1
7234746|NCT00114530|11442043|FG001|Overall Study|Lost to Follow-up|1
7234747|NCT00114530|11442042|FG000|Overall Study|Physician Decision|1
7234748|NCT00114530|11442043|FG001|Overall Study|Physician Decision|1
7234749|NCT00114530|11442042|FG000|Overall Study|Withdrawal by Subject|2
7234750|NCT00114530|11442043|FG001|Overall Study|Withdrawal by Subject|6
7234751|NCT00114530|11442042|FG000|Overall Study|Breast Cancer|1
7234752|NCT00114530|11442043|FG001|Overall Study|Breast Cancer|0
7234753|NCT00114530|11442042|FG000|Overall Study|Subject decision after endpoint failure|0
7234754|NCT00114530|11442043|FG001|Overall Study|Subject decision after endpoint failure|1
7234755|NCT00114530|11442042|FG000|Overall Study|Ineligible|1
7234756|NCT00114530|11442043|FG001|Overall Study|Ineligible|0
7234757|NCT00114634|11442053|FG000|Overall Study|failure to return forms|3
7234758|NCT00114738|11442059|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
7234759|NCT00114738|11442060|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7234760|NCT00114738|11442061|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
7234761|NCT00114738|11442059|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
7234762|NCT00114738|11442060|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7234763|NCT00114738|11442061|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
7234764|NCT00114738|11442059|FG000|Screening for Randomization|Neuropathy|17
7573676|NCT03627494|11955184|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
7234765|NCT00114738|11442060|FG001|Screening for Randomization|Neuropathy|0
7234766|NCT00114738|11442061|FG002|Screening for Randomization|Neuropathy|0
7234767|NCT00114738|11442059|FG000|Screening for Randomization|Progressive disease|2
7234768|NCT00114738|11442060|FG001|Screening for Randomization|Progressive disease|0
7234769|NCT00114738|11442061|FG002|Screening for Randomization|Progressive disease|0
7234770|NCT00114738|11442059|FG000|Screening for Randomization|CNS Hemorrhage|1
7234771|NCT00114738|11442060|FG001|Screening for Randomization|CNS Hemorrhage|0
7234772|NCT00114738|11442061|FG002|Screening for Randomization|CNS Hemorrhage|0
7234773|NCT00114738|11442059|FG000|Screening for Randomization|Other|1
7234774|NCT00114738|11442060|FG001|Screening for Randomization|Other|0
7234775|NCT00114738|11442061|FG002|Screening for Randomization|Other|0
7234776|NCT00114777|11442071|FG000|Randomization to Month 36|Death|10
7234777|NCT00114777|11442072|FG001|Randomization to Month 36|Death|4
7234778|NCT00114777|11442073|FG002|Randomization to Month 36|Death|3
7234779|NCT00114777|11442071|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
7234780|NCT00114777|11442072|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
7573677|NCT03627494|11955185|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
7573678|NCT03627494|11955186|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
7573679|NCT03627494|11955187|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
7573680|NCT03627494|11955188|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
7573681|NCT03627494|11955189|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
7573682|NCT03627494|11955190|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
7573683|NCT03627494|11955191|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
7234781|NCT00114777|11442073|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
7234782|NCT00114777|11442071|FG000|Randomization to Month 36|Lack of Efficacy|19
7573684|NCT03627494|11955192|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
7234783|NCT00114777|11442072|FG001|Randomization to Month 36|Lack of Efficacy|15
7234784|NCT00114777|11442073|FG002|Randomization to Month 36|Lack of Efficacy|17
7573685|NCT03627494|11955193|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
7573686|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
7573687|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7573688|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7573689|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7573690|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
7234785|NCT00114777|11442071|FG000|Randomization to Month 36|Poor or Non-Compliance|0
7234786|NCT00114777|11442072|FG001|Randomization to Month 36|Poor or Non-Compliance|0
7234787|NCT00114777|11442073|FG002|Randomization to Month 36|Poor or Non-Compliance|1
7234788|NCT00114777|11442071|FG000|Randomization to Month 36|Adverse Event|34
7234789|NCT00114777|11442072|FG001|Randomization to Month 36|Adverse Event|35
7234790|NCT00114777|11442073|FG002|Randomization to Month 36|Adverse Event|44
7234791|NCT00114777|11442071|FG000|Randomization to Month 36|Withdrawal by Subject|3
7234792|NCT00114777|11442072|FG001|Randomization to Month 36|Withdrawal by Subject|4
7234793|NCT00114777|11442073|FG002|Randomization to Month 36|Withdrawal by Subject|5
7234794|NCT00114777|11442071|FG000|Randomization to Month 36|Other|9
7234795|NCT00114777|11442072|FG001|Randomization to Month 36|Other|3
7234796|NCT00114777|11442073|FG002|Randomization to Month 36|Other|12
7234797|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Death|8
7234798|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Death|13
7234799|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Death|7
7234800|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7234801|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
7234802|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
7234803|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
7234804|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
7234805|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
7234806|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7234807|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
7234808|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
7234809|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Adverse Event|15
7234810|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Adverse Event|14
7234811|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Adverse Event|7
7234812|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
7234813|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
7234814|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
7234815|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
7234816|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
7234817|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
7234818|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7234819|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
7234820|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
7234821|NCT00114777|11442071|FG000|Long-Term Extension to Month 84|Other|2
7234822|NCT00114777|11442072|FG001|Long-Term Extension to Month 84|Other|0
7234823|NCT00114777|11442073|FG002|Long-Term Extension to Month 84|Other|2
7234824|NCT00114959|11442082|FG000|Overall Study|Lack of Efficacy|6
7234825|NCT00114959|11442082|FG000|Overall Study|Physician Decision|1
7234826|NCT00114959|11442082|FG000|Overall Study|Death|1
7234827|NCT00114972|11442088|FG000|Overall Study|Withdrawal by Subject|40
7234828|NCT00114972|11442089|FG001|Overall Study|Withdrawal by Subject|7
7234829|NCT00114972|11442088|FG000|Overall Study|Lost to Follow-up|8
7234830|NCT00114972|11442089|FG001|Overall Study|Lost to Follow-up|5
7234831|NCT00115037|11442097|FG000|Phase1|Lost to Follow-up|16
7234832|NCT00115037|11442098|FG001|Phase1|Lost to Follow-up|23
7234833|NCT00115037|11442099|FG002|Phase1|Lost to Follow-up|0
7234834|NCT00115037|11442100|FG003|Phase1|Lost to Follow-up|0
7234835|NCT00115037|11442101|FG004|Phase1|Lost to Follow-up|0
7234836|NCT00115037|11442102|FG005|Phase1|Lost to Follow-up|0
7234837|NCT00115037|11442097|FG000|Phase1|Withdrawal by Subject|9
7234838|NCT00115037|11442098|FG001|Phase1|Withdrawal by Subject|4
7234839|NCT00115037|11442099|FG002|Phase1|Withdrawal by Subject|0
7234840|NCT00115037|11442100|FG003|Phase1|Withdrawal by Subject|0
7234841|NCT00115037|11442101|FG004|Phase1|Withdrawal by Subject|0
7234842|NCT00115037|11442102|FG005|Phase1|Withdrawal by Subject|0
7234843|NCT00115037|11442097|FG000|Phase2|Death|0
7234844|NCT00115037|11442098|FG001|Phase2|Death|0
7234845|NCT00115037|11442099|FG002|Phase2|Death|1
7234846|NCT00115037|11442100|FG003|Phase2|Death|0
7234847|NCT00115037|11442101|FG004|Phase2|Death|0
7234848|NCT00115037|11442102|FG005|Phase2|Death|1
7234849|NCT00115037|11442097|FG000|Phase2|Withdrawal by Subject|0
7234850|NCT00115037|11442098|FG001|Phase2|Withdrawal by Subject|0
7234851|NCT00115037|11442099|FG002|Phase2|Withdrawal by Subject|2
7234852|NCT00115037|11442100|FG003|Phase2|Withdrawal by Subject|1
7234853|NCT00115037|11442101|FG004|Phase2|Withdrawal by Subject|2
7234854|NCT00115037|11442102|FG005|Phase2|Withdrawal by Subject|1
7234855|NCT00115037|11442097|FG000|Phase2|Lost to Follow-up|0
7234856|NCT00115037|11442098|FG001|Phase2|Lost to Follow-up|0
7234857|NCT00115037|11442099|FG002|Phase2|Lost to Follow-up|12
7234858|NCT00115037|11442100|FG003|Phase2|Lost to Follow-up|14
7234859|NCT00115037|11442101|FG004|Phase2|Lost to Follow-up|4
7234860|NCT00115037|11442102|FG005|Phase2|Lost to Follow-up|10
7234861|NCT00115063|11442118|FG000|Overall Study|Lost to Follow-up|98
7234862|NCT00115063|11442119|FG001|Overall Study|Lost to Follow-up|104
7234863|NCT00115063|11442118|FG000|Overall Study|Death|1
7234864|NCT00115063|11442119|FG001|Overall Study|Death|0
7234865|NCT00115336|11442143|FG000|Overall Study|Hospital discharge before study drug|0
7234866|NCT00115336|11442144|FG001|Overall Study|Hospital discharge before study drug|1
7234867|NCT00115349|11442154|FG000|Overall Study|Study closed due to low enrollment.|11
7234868|NCT00115349|11442155|FG001|Overall Study|Study closed due to low enrollment.|9
7234869|NCT00115739|11442161|FG000|Overall Study|Lost to Follow-up|3
7234870|NCT00115765|11442171|FG000|Overall Study|Withdrawal by Subject|22
7234871|NCT00115765|11442172|FG001|Overall Study|Withdrawal by Subject|53
7234872|NCT00115765|11442173|FG002|Overall Study|Withdrawal by Subject|76
7234873|NCT00115765|11442174|FG003|Overall Study|Withdrawal by Subject|15
7234874|NCT00115765|11442171|FG000|Overall Study|Physician Decision|4
7234875|NCT00115765|11442172|FG001|Overall Study|Physician Decision|15
7234876|NCT00115765|11442173|FG002|Overall Study|Physician Decision|18
7234877|NCT00115765|11442174|FG003|Overall Study|Physician Decision|13
7234878|NCT00115765|11442171|FG000|Overall Study|Lost to Follow-up|3
7234879|NCT00115765|11442172|FG001|Overall Study|Lost to Follow-up|20
7234880|NCT00115765|11442173|FG002|Overall Study|Lost to Follow-up|18
7234881|NCT00115765|11442174|FG003|Overall Study|Lost to Follow-up|1
7234882|NCT00115765|11442171|FG000|Overall Study|Other|6
7234883|NCT00115765|11442172|FG001|Overall Study|Other|12
7234884|NCT00115765|11442173|FG002|Overall Study|Other|9
7234885|NCT00115765|11442174|FG003|Overall Study|Other|2
7234886|NCT00115778|11442182|FG000|Overall Study|Withdrawal by Subject|0
7234887|NCT00115778|11442183|FG001|Overall Study|Withdrawal by Subject|1
7234888|NCT00115804|11442189|FG000|Overall Study|Adverse Event|2
7234889|NCT00115934|11442208|FG000|Overall Study|Lost to Follow-up|1
7234890|NCT00115934|11442209|FG001|Overall Study|Lost to Follow-up|0
7234891|NCT00115934|11442208|FG000|Overall Study|Did not receive intervention|3
7234892|NCT00115934|11442209|FG001|Overall Study|Did not receive intervention|2
7234893|NCT00116168|11442219|FG000|Overall Study|Lost to Follow-up|6
7234894|NCT00116168|11442220|FG001|Overall Study|Lost to Follow-up|5
7234895|NCT00116168|11442221|FG002|Overall Study|Lost to Follow-up|0
7234896|NCT00116168|11442222|FG003|Overall Study|Lost to Follow-up|0
7234897|NCT00116272|11442243|FG000|Overall Study|Lost to Follow-up|11
7234898|NCT00116272|11442244|FG001|Overall Study|Lost to Follow-up|6
7234899|NCT00116428|11442265|FG000|Overall Study|Withdrawal by Subject|2
7234900|NCT00116428|11442266|FG001|Overall Study|Withdrawal by Subject|5
7234901|NCT00116428|11442265|FG000|Overall Study|Did not meet inclusion criteria|1
7234902|NCT00116428|11442266|FG001|Overall Study|Did not meet inclusion criteria|0
7234903|NCT00116558|11442278|FG000|Overall Study|Death|11
7234904|NCT00116558|11442279|FG001|Overall Study|Death|5
7234905|NCT00116558|11442280|FG002|Overall Study|Death|3
7234906|NCT00116558|11442278|FG000|Overall Study|Withdrawal by Subject|17
7234907|NCT00116558|11442279|FG001|Overall Study|Withdrawal by Subject|3
7234908|NCT00116558|11442280|FG002|Overall Study|Withdrawal by Subject|12
7234909|NCT00116558|11442278|FG000|Overall Study|disease progression|3
7234910|NCT00116558|11442279|FG001|Overall Study|disease progression|7
7234911|NCT00116558|11442280|FG002|Overall Study|disease progression|18
7234912|NCT00116584|11442289|FG000|Overall Study|Withdrawal by Subject|1
7234913|NCT00116584|11442290|FG001|Overall Study|Withdrawal by Subject|0
7234914|NCT00116584|11442289|FG000|Overall Study|Protocol Violation|1
7234915|NCT00116584|11442290|FG001|Overall Study|Protocol Violation|1
7234916|NCT00116649|11442296|FG000|Overall Study|Adverse Event|20
7234917|NCT00116649|11442296|FG000|Overall Study|Lack of Efficacy|1
7234918|NCT00116649|11442296|FG000|Overall Study|Lost to Follow-up|32
7234919|NCT00116649|11442296|FG000|Overall Study|Withdrawal by Subject|68
7234920|NCT00116649|11442296|FG000|Overall Study|Local Skin Reaction|9
7234921|NCT00116649|11442296|FG000|Overall Study|Various Reasons|18
7234922|NCT00116649|11442296|FG000|Overall Study|Protocol Specified|7
7234923|NCT00116688|11442302|FG000|Overall Study|Protocol deviation|1
7234924|NCT00116688|11442303|FG001|Overall Study|Protocol deviation|0
7234925|NCT00116688|11442302|FG000|Overall Study|Noncompliance|3
7234926|NCT00116688|11442303|FG001|Overall Study|Noncompliance|1
7234927|NCT00116688|11442302|FG000|Overall Study|Adverse Event|11
7234928|NCT00116688|11442303|FG001|Overall Study|Adverse Event|0
7234929|NCT00116688|11442302|FG000|Overall Study|Withdrawal by Subject|26
7234930|NCT00116688|11442303|FG001|Overall Study|Withdrawal by Subject|2
7234931|NCT00116688|11442302|FG000|Overall Study|Requirement for alternative therapy|11
7234932|NCT00116688|11442303|FG001|Overall Study|Requirement for alternative therapy|1
7234933|NCT00116688|11442302|FG000|Overall Study|Physician Decision|7
7234934|NCT00116688|11442303|FG001|Overall Study|Physician Decision|0
7234935|NCT00116688|11442302|FG000|Overall Study|Lost to Follow-up|3
7234936|NCT00116688|11442303|FG001|Overall Study|Lost to Follow-up|0
7234937|NCT00116688|11442302|FG000|Overall Study|Death|15
7234938|NCT00116688|11442303|FG001|Overall Study|Death|0
7234939|NCT00116688|11442302|FG000|Overall Study|Protocol-specified criteria|3
7234940|NCT00116688|11442303|FG001|Overall Study|Protocol-specified criteria|0
7234941|NCT00116688|11442302|FG000|Overall Study|Pregnancy|1
7234942|NCT00116688|11442303|FG001|Overall Study|Pregnancy|0
7234943|NCT00116688|11442302|FG000|Overall Study|Other|11
7234944|NCT00116688|11442303|FG001|Overall Study|Other|0
7234945|NCT00116753|11442312|FG000|Overall Study|Adverse Event|16
7234946|NCT00116753|11442313|FG001|Overall Study|Adverse Event|10
7234947|NCT00116753|11442314|FG002|Overall Study|Adverse Event|7
7234948|NCT00116753|11442312|FG000|Overall Study|Withdrawal by Subject|11
7234949|NCT00116753|11442313|FG001|Overall Study|Withdrawal by Subject|12
7234950|NCT00116753|11442314|FG002|Overall Study|Withdrawal by Subject|8
7234951|NCT00116753|11442312|FG000|Overall Study|Lost to Follow-up|0
7234952|NCT00116753|11442313|FG001|Overall Study|Lost to Follow-up|2
7234953|NCT00116753|11442314|FG002|Overall Study|Lost to Follow-up|1
7234954|NCT00116753|11442312|FG000|Overall Study|Protocol Violation|0
7234955|NCT00116753|11442313|FG001|Overall Study|Protocol Violation|0
7234956|NCT00116753|11442314|FG002|Overall Study|Protocol Violation|1
7234957|NCT00116753|11442312|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
7234958|NCT00116753|11442313|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
7234959|NCT00116753|11442314|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
7234960|NCT00116753|11442312|FG000|Overall Study|Disease Progression|3
7234961|NCT00116753|11442313|FG001|Overall Study|Disease Progression|4
7234962|NCT00116753|11442314|FG002|Overall Study|Disease Progression|3
7234963|NCT00116753|11442312|FG000|Overall Study|Abnormal Echocardiogram|0
7234964|NCT00116753|11442313|FG001|Overall Study|Abnormal Echocardiogram|0
7234965|NCT00116753|11442314|FG002|Overall Study|Abnormal Echocardiogram|1
7234966|NCT00116753|11442312|FG000|Overall Study|Progressive Parkinson's Disease|1
7234967|NCT00116753|11442313|FG001|Overall Study|Progressive Parkinson's Disease|0
7234968|NCT00116753|11442314|FG002|Overall Study|Progressive Parkinson's Disease|0
7234969|NCT00116753|11442312|FG000|Overall Study|Dosing Error|0
7234970|NCT00116753|11442313|FG001|Overall Study|Dosing Error|1
7234971|NCT00116753|11442314|FG002|Overall Study|Dosing Error|0
7255610|NCT00319254|11467144|FG000|Overall Study|Lost to Follow-up|2
7255611|NCT00319254|11467144|FG000|Overall Study|Enrolled, Not Treated|2
7255612|NCT00319436|11467150|FG000|Overall Study|Withdrawal by Subject|6
7255613|NCT00319436|11467151|FG001|Overall Study|Withdrawal by Subject|7
7255614|NCT00319501|11467159|FG000|Double-blind Period|Withdrawal by Subject|0
7255615|NCT00319501|11467160|FG001|Double-blind Period|Withdrawal by Subject|3
7255616|NCT00319501|11467159|FG000|Double-blind Period|Sponsor Request|1
7255617|NCT00319501|11467160|FG001|Double-blind Period|Sponsor Request|0
7255618|NCT00319501|11467159|FG000|Double-blind Period|Did not receive treatment|42
7255619|NCT00319501|11467160|FG001|Double-blind Period|Did not receive treatment|29
7255620|NCT00319501|11467159|FG000|Open-label Period|Adverse Event|5
7255621|NCT00319501|11467160|FG001|Open-label Period|Adverse Event|0
7255622|NCT00319501|11467159|FG000|Open-label Period|Protocol Violation|6
7255623|NCT00319501|11467160|FG001|Open-label Period|Protocol Violation|0
7255624|NCT00319501|11467159|FG000|Open-label Period|Withdrawal by Subject|38
7255625|NCT00319501|11467160|FG001|Open-label Period|Withdrawal by Subject|0
7255626|NCT00319501|11467159|FG000|Open-label Period|Principal Investigator decision|6
7255627|NCT00319501|11467160|FG001|Open-label Period|Principal Investigator decision|0
7255628|NCT00319501|11467159|FG000|Open-label Period|Sponsor request|12
7255629|NCT00319501|11467160|FG001|Open-label Period|Sponsor request|0
7255630|NCT00319501|11467159|FG000|Open-label Period|Lost to Follow-up|5
7255631|NCT00319501|11467160|FG001|Open-label Period|Lost to Follow-up|0
7255632|NCT00319501|11467159|FG000|Open-label Period|Did not receive treatment|33
7255633|NCT00319501|11467160|FG001|Open-label Period|Did not receive treatment|0
7255634|NCT00319501|11467159|FG000|Open-label Period|Other|11
7255635|NCT00319501|11467160|FG001|Open-label Period|Other|0
7255636|NCT00319501|11467159|FG000|Open-label Extension Period|Adverse Event|2
7255637|NCT00319501|11467160|FG001|Open-label Extension Period|Adverse Event|0
7255638|NCT00319501|11467159|FG000|Open-label Extension Period|Did not receive treatment|18
7255639|NCT00319501|11467160|FG001|Open-label Extension Period|Did not receive treatment|0
7255640|NCT00319501|11467159|FG000|Open-label Extension Period|Other|1
7255641|NCT00319501|11467160|FG001|Open-label Extension Period|Other|0
7573691|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
7255642|NCT00319501|11467159|FG000|Open-label Extension Period|Principal investigator decision|2
7255643|NCT00319501|11467160|FG001|Open-label Extension Period|Principal investigator decision|0
7255644|NCT00319501|11467159|FG000|Open-label Extension Period|Sponsor request|26
7255645|NCT00319501|11467160|FG001|Open-label Extension Period|Sponsor request|0
7255646|NCT00319501|11467159|FG000|Open-label Extension Period|Withdrawal by Subject|2
7255647|NCT00319501|11467160|FG001|Open-label Extension Period|Withdrawal by Subject|0
7255648|NCT00319553|11467173|FG000|Overall Study|Protocol Violation|1
7255649|NCT00319553|11467174|FG001|Overall Study|Protocol Violation|2
7255650|NCT00319553|11467173|FG000|Overall Study|Lost to Follow-up|2
7255651|NCT00319553|11467174|FG001|Overall Study|Lost to Follow-up|1
7255652|NCT00319553|11467173|FG000|Overall Study|Withdrawal by Subject|1
7255653|NCT00319553|11467174|FG001|Overall Study|Withdrawal by Subject|1
7255654|NCT00319592|11467182|FG000|Overall Study|Protocol Violation|1
7255655|NCT00319592|11467183|FG001|Overall Study|Protocol Violation|0
7255656|NCT00319592|11467182|FG000|Overall Study|Physician Decision|0
7255657|NCT00319592|11467183|FG001|Overall Study|Physician Decision|1
7255658|NCT00319696|11467198|FG000|Overall Study|Adverse Event|36
7255659|NCT00319696|11467198|FG000|Overall Study|withdrawal of consent|14
7255660|NCT00319696|11467198|FG000|Overall Study|administrative|7
7255661|NCT00319696|11467198|FG000|Overall Study|Lost to Follow-up|3
7255662|NCT00319735|11467208|FG000|Overall Study|Death|2
7255663|NCT00319956|11467225|FG000|Overall Study|Death|20
7255664|NCT00319956|11467226|FG001|Overall Study|Death|24
7234972|NCT00116779|11442324|FG000|Overall Study|Adverse Event|4
7234973|NCT00116779|11442325|FG001|Overall Study|Adverse Event|2
7234974|NCT00116779|11442324|FG000|Overall Study|Protocol Violation|1
7234975|NCT00116779|11442325|FG001|Overall Study|Protocol Violation|4
7234976|NCT00116779|11442324|FG000|Overall Study|Withdrawal by Subject|4
7234977|NCT00116779|11442325|FG001|Overall Study|Withdrawal by Subject|1
7234978|NCT00116779|11442324|FG000|Overall Study|Inadequate testosterone suppression|7
7234979|NCT00116779|11442325|FG001|Overall Study|Inadequate testosterone suppression|9
7234980|NCT00116779|11442324|FG000|Overall Study|Physician Decision|3
7234981|NCT00116779|11442325|FG001|Overall Study|Physician Decision|1
7234982|NCT00116779|11442324|FG000|Overall Study|Elevated PSA levels|2
7234983|NCT00116779|11442325|FG001|Overall Study|Elevated PSA levels|2
7234984|NCT00116805|11442333|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
7234985|NCT00116805|11442334|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
7234986|NCT00116805|11442333|FG000|Double-blind Period Through Week 48|Protocol Violation|1
7234987|NCT00116805|11442334|FG001|Double-blind Period Through Week 48|Protocol Violation|1
7234988|NCT00116805|11442333|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
7234989|NCT00116805|11442334|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
7234990|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
7234991|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
7234992|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
7234993|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
7234994|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
7234995|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
7234996|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7234997|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
7234998|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
7234999|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
7235000|NCT00116805|11442333|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
7235001|NCT00116805|11442334|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
7235002|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
7235003|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
7235004|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
7235005|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
7235006|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
7235007|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
7235008|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
7235009|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
7235010|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
7235011|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
7235012|NCT00116805|11442333|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
7235013|NCT00116805|11442334|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
7235014|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
7235015|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
7235016|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
7235017|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
7235018|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
7235019|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
7235020|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
7235021|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
7235022|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
7235023|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
7235024|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
7235025|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
7235026|NCT00116805|11442333|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
7235027|NCT00116805|11442334|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
7235028|NCT00116805|11442333|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
7235029|NCT00116805|11442334|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
7235030|NCT00116805|11442333|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
7235031|NCT00116805|11442334|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
7235032|NCT00116805|11442333|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
7235033|NCT00116805|11442334|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
7235034|NCT00116805|11442333|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7235035|NCT00116805|11442334|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7235036|NCT00116805|11442333|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
7235037|NCT00116805|11442334|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
7235038|NCT00116805|11442333|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
7235039|NCT00116805|11442334|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7235040|NCT00116805|11442333|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
7235041|NCT00116805|11442334|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
7235042|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
7235043|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
7235044|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
7235045|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
7235046|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7235047|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
7235048|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
7235049|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
7235050|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
7235051|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
7235052|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
7235053|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
7235054|NCT00116805|11442333|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
7235055|NCT00116805|11442334|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
7235056|NCT00116805|11442333|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
7235057|NCT00116805|11442334|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
7235058|NCT00116805|11442333|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
7235059|NCT00116805|11442334|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
7235060|NCT00116805|11442333|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
7235061|NCT00116805|11442334|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
7235062|NCT00116805|11442333|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
7235063|NCT00116805|11442334|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
7235064|NCT00116805|11442333|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
7235065|NCT00116805|11442334|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
7235066|NCT00116805|11442333|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
7235067|NCT00116805|11442334|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
7235068|NCT00116805|11442333|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
7235069|NCT00116805|11442334|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
7235070|NCT00116805|11442333|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
7235071|NCT00116805|11442334|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
7235072|NCT00116805|11442333|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
7235073|NCT00116805|11442334|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
7235074|NCT00116831|11442351|FG000|Overall Study|Adverse Event|14
7235075|NCT00116831|11442352|FG001|Overall Study|Adverse Event|16
7235076|NCT00116831|11442351|FG000|Overall Study|Baseline IVUS determined unevaluable|12
7235077|NCT00116831|11442352|FG001|Overall Study|Baseline IVUS determined unevaluable|11
7235078|NCT00116831|11442351|FG000|Overall Study|Lost to Follow-up|8
7235079|NCT00116831|11442352|FG001|Overall Study|Lost to Follow-up|6
7235080|NCT00116831|11442351|FG000|Overall Study|Protocol Violation|3
7235081|NCT00116831|11442352|FG001|Overall Study|Protocol Violation|6
7235082|NCT00116831|11442351|FG000|Overall Study|Hypoglycaemic events|1
7235083|NCT00116831|11442352|FG001|Overall Study|Hypoglycaemic events|0
7235084|NCT00116831|11442351|FG000|Overall Study|Low haemoglobin on screening|1
7235085|NCT00116831|11442352|FG001|Overall Study|Low haemoglobin on screening|0
7235086|NCT00116831|11442351|FG000|Overall Study|Withdrawn investigational product|1
7235087|NCT00116831|11442352|FG001|Overall Study|Withdrawn investigational product|0
7235088|NCT00116831|11442351|FG000|Overall Study|Withdrawal by Subject|32
7235089|NCT00116831|11442352|FG001|Overall Study|Withdrawal by Subject|32
7235090|NCT00116831|11442351|FG000|Overall Study|Insufficient therapeutic effect|0
7235091|NCT00116831|11442352|FG001|Overall Study|Insufficient therapeutic effect|1
7235092|NCT00116831|11442351|FG000|Overall Study|Missing data for participant|1
7235093|NCT00116831|11442352|FG001|Overall Study|Missing data for participant|0
7235094|NCT00116844|11442360|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7235095|NCT00116844|11442361|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
7235096|NCT00116844|11442360|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
7235097|NCT00116844|11442361|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
7235098|NCT00116844|11442360|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
7235099|NCT00116844|11442361|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
7235100|NCT00116844|11442360|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
7235101|NCT00116844|11442361|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
7235102|NCT00116844|11442360|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
7235103|NCT00116844|11442361|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
7235104|NCT00116844|11442360|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
7235105|NCT00116844|11442361|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
7235106|NCT00116844|11442360|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
7235107|NCT00116844|11442361|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
7235108|NCT00116844|11442360|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
7235109|NCT00116844|11442361|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
7235110|NCT00116844|11442360|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7235111|NCT00116844|11442361|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
7235112|NCT00117156|11442393|FG000|Overall Study|Adverse Event|9
7235113|NCT00117156|11442393|FG000|Overall Study|Physician Decision|1
7255665|NCT00319982|11467234|FG000|Overall Study|Withdrawal by Subject|1
7235114|NCT00117156|11442393|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
7235115|NCT00117286|11442399|FG000|Overall Study|Adverse Event|12
7235116|NCT00117286|11442400|FG001|Overall Study|Adverse Event|6
7235117|NCT00117286|11442399|FG000|Overall Study|Lost to Follow-up|2
7235118|NCT00117286|11442400|FG001|Overall Study|Lost to Follow-up|0
7235119|NCT00117286|11442399|FG000|Overall Study|Protocol Violation|3
7235120|NCT00117286|11442400|FG001|Overall Study|Protocol Violation|3
7235121|NCT00117286|11442399|FG000|Overall Study|Withdrawal by Subject|6
7235122|NCT00117286|11442400|FG001|Overall Study|Withdrawal by Subject|2
7235123|NCT00117286|11442399|FG000|Overall Study|Physician Decision|3
7235124|NCT00117286|11442400|FG001|Overall Study|Physician Decision|7
7235125|NCT00117286|11442399|FG000|Overall Study|Lack of Efficacy|2
7235126|NCT00117286|11442400|FG001|Overall Study|Lack of Efficacy|1
7235127|NCT00117286|11442399|FG000|Overall Study|Research site closing|0
7235128|NCT00117286|11442400|FG001|Overall Study|Research site closing|2
7235129|NCT00117312|11442410|FG000|Overall Study|Testosterone >1.0 ng/mL|9
7235130|NCT00117312|11442411|FG001|Overall Study|Testosterone >1.0 ng/mL|9
7235131|NCT00117312|11442412|FG002|Overall Study|Testosterone >1.0 ng/mL|5
7235132|NCT00117312|11442413|FG003|Overall Study|Testosterone >1.0 ng/mL|9
7235133|NCT00117312|11442410|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7235134|NCT00117312|11442411|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7235135|NCT00117312|11442412|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7235136|NCT00117312|11442413|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7235137|NCT00117312|11442410|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
7235138|NCT00117312|11442411|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
7235139|NCT00117312|11442412|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
7235140|NCT00117312|11442413|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
7235141|NCT00117312|11442410|FG000|Overall Study|Other|0
7235142|NCT00117312|11442411|FG001|Overall Study|Other|1
7235143|NCT00117312|11442412|FG002|Overall Study|Other|3
7235144|NCT00117312|11442413|FG003|Overall Study|Other|1
7235145|NCT00117312|11442410|FG000|Overall Study|Patient choice|0
7235146|NCT00117312|11442411|FG001|Overall Study|Patient choice|0
7235147|NCT00117312|11442412|FG002|Overall Study|Patient choice|2
7235148|NCT00117312|11442413|FG003|Overall Study|Patient choice|1
7235149|NCT00117312|11442410|FG000|Overall Study|Adverse Event|0
7235150|NCT00117312|11442411|FG001|Overall Study|Adverse Event|2
7235151|NCT00117312|11442412|FG002|Overall Study|Adverse Event|0
7235152|NCT00117312|11442413|FG003|Overall Study|Adverse Event|0
7235153|NCT00117312|11442410|FG000|Overall Study|Protocol Violation|0
7235154|NCT00117312|11442411|FG001|Overall Study|Protocol Violation|1
7235155|NCT00117312|11442412|FG002|Overall Study|Protocol Violation|3
7235156|NCT00117312|11442413|FG003|Overall Study|Protocol Violation|0
7235157|NCT00117312|11442410|FG000|Overall Study|PSA decrease <=50%|0
7235158|NCT00117312|11442411|FG001|Overall Study|PSA decrease <=50%|2
7235159|NCT00117312|11442412|FG002|Overall Study|PSA decrease <=50%|2
7235160|NCT00117312|11442413|FG003|Overall Study|PSA decrease <=50%|4
7235161|NCT00117312|11442410|FG000|Overall Study|PSA increase >= 10ng/mL|0
7235162|NCT00117312|11442411|FG001|Overall Study|PSA increase >= 10ng/mL|1
7235163|NCT00117312|11442412|FG002|Overall Study|PSA increase >= 10ng/mL|1
7235164|NCT00117312|11442413|FG003|Overall Study|PSA increase >= 10ng/mL|0
7235165|NCT00117312|11442410|FG000|Overall Study|Hepatic abnormality|0
7235166|NCT00117312|11442411|FG001|Overall Study|Hepatic abnormality|1
7235167|NCT00117312|11442412|FG002|Overall Study|Hepatic abnormality|0
7235168|NCT00117312|11442413|FG003|Overall Study|Hepatic abnormality|1
7235169|NCT00117312|11442410|FG000|Overall Study|Withdrawal by Subject|0
7235170|NCT00117312|11442411|FG001|Overall Study|Withdrawal by Subject|2
7235171|NCT00117312|11442412|FG002|Overall Study|Withdrawal by Subject|0
7235172|NCT00117312|11442413|FG003|Overall Study|Withdrawal by Subject|0
7235173|NCT00117325|11442425|FG000|Overall Study|Adverse Event|3
7235174|NCT00117325|11442426|FG001|Overall Study|Adverse Event|3
7235175|NCT00117325|11442425|FG000|Overall Study|Lost to Follow-up|1
7235176|NCT00117325|11442426|FG001|Overall Study|Lost to Follow-up|1
7235177|NCT00117325|11442425|FG000|Overall Study|Protocol Violation|2
7235178|NCT00117325|11442426|FG001|Overall Study|Protocol Violation|3
7235179|NCT00117325|11442425|FG000|Overall Study|Withdrawal by Subject|3
7235180|NCT00117325|11442426|FG001|Overall Study|Withdrawal by Subject|2
7235181|NCT00117325|11442425|FG000|Overall Study|Lack of Efficacy|1
7235182|NCT00117325|11442426|FG001|Overall Study|Lack of Efficacy|0
7235183|NCT00117325|11442425|FG000|Overall Study|Use of prohibited medicine|1
7235184|NCT00117325|11442426|FG001|Overall Study|Use of prohibited medicine|2
7235185|NCT00117325|11442425|FG000|Overall Study|Early termination|1
7235186|NCT00117325|11442426|FG001|Overall Study|Early termination|1
7235187|NCT00117325|11442425|FG000|Overall Study|Admisnitrative|1
7235188|NCT00117325|11442426|FG001|Overall Study|Admisnitrative|0
7235189|NCT00117507|11442433|FG000|Overall Study|Adverse Event|4
7235190|NCT00117507|11442433|FG000|Overall Study|Abnormal laboratory values|3
7235191|NCT00117507|11442433|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7235192|NCT00117507|11442433|FG000|Overall Study|Patient withdrew consent|4
7235193|NCT00117507|11442433|FG000|Overall Study|Death|3
7235194|NCT00117572|11442449|FG000|Overall Study|Site withdrew before starting treatment|2
7235195|NCT00117572|11442450|FG001|Overall Study|Site withdrew before starting treatment|3
7235196|NCT00117572|11442449|FG000|Overall Study|Withdrawal by Subject|3
7235197|NCT00117572|11442450|FG001|Overall Study|Withdrawal by Subject|3
7235198|NCT00117572|11442449|FG000|Overall Study|Protocol Violation|1
7235199|NCT00117572|11442450|FG001|Overall Study|Protocol Violation|0
7235200|NCT00117598|11442463|FG000|Prior to Treatment Cross Over|Death|40
7235201|NCT00117598|11442464|FG001|Prior to Treatment Cross Over|Death|41
7235202|NCT00117598|11442465|FG002|Prior to Treatment Cross Over|Death|37
7235203|NCT00117598|11442466|FG003|Prior to Treatment Cross Over|Death|0
7235204|NCT00117598|11442467|FG004|Prior to Treatment Cross Over|Death|0
7235205|NCT00117598|11442463|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
7235206|NCT00117598|11442464|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
7235207|NCT00117598|11442465|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
7235208|NCT00117598|11442466|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
7235209|NCT00117598|11442467|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
7235210|NCT00117598|11442463|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
7235211|NCT00117598|11442464|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
7235212|NCT00117598|11442465|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
7235213|NCT00117598|11442466|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
7235214|NCT00117598|11442467|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
7235215|NCT00117598|11442463|FG000|Prior to Treatment Cross Over|Other|15
7235216|NCT00117598|11442464|FG001|Prior to Treatment Cross Over|Other|9
7235217|NCT00117598|11442465|FG002|Prior to Treatment Cross Over|Other|9
7235218|NCT00117598|11442466|FG003|Prior to Treatment Cross Over|Other|0
7235219|NCT00117598|11442467|FG004|Prior to Treatment Cross Over|Other|0
7235220|NCT00117598|11442463|FG000|After Treament Cross Over|Death|0
7235221|NCT00117598|11442464|FG001|After Treament Cross Over|Death|0
7235222|NCT00117598|11442465|FG002|After Treament Cross Over|Death|0
7235223|NCT00117598|11442466|FG003|After Treament Cross Over|Death|1
7235224|NCT00117598|11442467|FG004|After Treament Cross Over|Death|2
7235225|NCT00117598|11442463|FG000|After Treament Cross Over|Withdrawal by Subject|0
7235226|NCT00117598|11442464|FG001|After Treament Cross Over|Withdrawal by Subject|0
7235227|NCT00117598|11442465|FG002|After Treament Cross Over|Withdrawal by Subject|0
7235228|NCT00117598|11442466|FG003|After Treament Cross Over|Withdrawal by Subject|1
7235229|NCT00117598|11442467|FG004|After Treament Cross Over|Withdrawal by Subject|0
7235230|NCT00117598|11442463|FG000|After Treament Cross Over|Other|0
7235231|NCT00117598|11442464|FG001|After Treament Cross Over|Other|0
7235232|NCT00117598|11442465|FG002|After Treament Cross Over|Other|0
7235233|NCT00117598|11442466|FG003|After Treament Cross Over|Other|1
7235234|NCT00117598|11442467|FG004|After Treament Cross Over|Other|2
7235235|NCT00117637|11442479|FG000|First Intervention (Period 1)|Adverse Event|11
7235236|NCT00117637|11442480|FG001|First Intervention (Period 1)|Adverse Event|16
7235237|NCT00117637|11442479|FG000|First Intervention (Period 1)|Lost to Follow-up|0
7235238|NCT00117637|11442480|FG001|First Intervention (Period 1)|Lost to Follow-up|2
7235239|NCT00117637|11442479|FG000|First Intervention (Period 1)|Protocol Violation|1
7235240|NCT00117637|11442480|FG001|First Intervention (Period 1)|Protocol Violation|0
7235241|NCT00117637|11442479|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
7235242|NCT00117637|11442480|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
7235243|NCT00117637|11442479|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
7235244|NCT00117637|11442480|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
7235245|NCT00117637|11442479|FG000|First Intervention (Period 1)|protocol driven decision point|1
7235246|NCT00117637|11442480|FG001|First Intervention (Period 1)|protocol driven decision point|0
7235247|NCT00117637|11442479|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
7235248|NCT00117637|11442480|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
7235249|NCT00117637|11442479|FG000|First Intervention (Period 1)|reason not reported|0
7235250|NCT00117637|11442480|FG001|First Intervention (Period 1)|reason not reported|1
7235251|NCT00117637|11442479|FG000|Second Intervention (Period 2)|Adverse Event|0
7235252|NCT00117637|11442480|FG001|Second Intervention (Period 2)|Adverse Event|9
7235253|NCT00117637|11442479|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
7235254|NCT00117637|11442480|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
7235255|NCT00117637|11442479|FG000|Second Intervention (Period 2)|Protocol Violation|1
7235256|NCT00117637|11442480|FG001|Second Intervention (Period 2)|Protocol Violation|0
7235257|NCT00117637|11442479|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
7235258|NCT00117637|11442480|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
7235259|NCT00117637|11442479|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
7235260|NCT00117637|11442480|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
7235261|NCT00117637|11442479|FG000|Second Intervention (Period 2)|non compliant with study medication|1
7235262|NCT00117637|11442480|FG001|Second Intervention (Period 2)|non compliant with study medication|1
7235263|NCT00117637|11442479|FG000|Second Intervention (Period 2)|reason not reported|1
7235264|NCT00117637|11442480|FG001|Second Intervention (Period 2)|reason not reported|0
7235265|NCT00117676|11442495|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
7235266|NCT00117676|11442496|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
7235267|NCT00117676|11442495|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
7235268|NCT00117676|11442496|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
7235269|NCT00117676|11442495|FG000|Double-blind Period Through Week 48|Protocol Violation|0
7235270|NCT00117676|11442496|FG001|Double-blind Period Through Week 48|Protocol Violation|1
7235271|NCT00117676|11442495|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
7235272|NCT00117676|11442496|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
7235273|NCT00117676|11442495|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
7235274|NCT00117676|11442496|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
7235275|NCT00117676|11442495|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
7235276|NCT00117676|11442496|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
7235277|NCT00117676|11442495|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
7235278|NCT00117676|11442496|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
7235279|NCT00117676|11442495|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
7235280|NCT00117676|11442496|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
7235281|NCT00117676|11442495|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
7235282|NCT00117676|11442496|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
7235283|NCT00117676|11442495|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
7235284|NCT00117676|11442496|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
7235285|NCT00117676|11442495|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
7235286|NCT00117676|11442496|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
7235287|NCT00117676|11442495|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
7235288|NCT00117676|11442496|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
7235289|NCT00117676|11442495|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
7235290|NCT00117676|11442496|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
7235291|NCT00117676|11442495|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
7235292|NCT00117676|11442496|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
7235293|NCT00117676|11442495|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7235294|NCT00117676|11442496|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
7235295|NCT00117676|11442495|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
7235296|NCT00117676|11442496|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
7235297|NCT00117676|11442495|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
7235298|NCT00117676|11442496|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
7235299|NCT00117676|11442495|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
7235300|NCT00117676|11442496|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
7235301|NCT00117676|11442495|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
7235302|NCT00117676|11442496|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
7235303|NCT00117676|11442495|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
7235304|NCT00117676|11442496|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
7235305|NCT00117676|11442495|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
7235306|NCT00117676|11442496|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
7235307|NCT00117676|11442495|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
7235308|NCT00117676|11442496|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
7235309|NCT00117676|11442495|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
7235310|NCT00117676|11442496|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
7235311|NCT00117676|11442495|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
7235312|NCT00117676|11442496|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
7235313|NCT00117676|11442495|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7235314|NCT00117676|11442496|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
7235315|NCT00117676|11442495|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
7235316|NCT00117676|11442496|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
7235317|NCT00117676|11442495|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7235318|NCT00117676|11442496|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
7235319|NCT00117676|11442495|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
7235320|NCT00117676|11442496|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
7235321|NCT00117676|11442495|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
7235322|NCT00117676|11442496|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
7235323|NCT00117676|11442495|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
7235324|NCT00117676|11442496|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
7235325|NCT00117676|11442495|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
7235326|NCT00117676|11442496|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
7235327|NCT00117676|11442495|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
7235328|NCT00117676|11442496|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
7235329|NCT00117676|11442495|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
7235330|NCT00117676|11442496|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
7235331|NCT00117676|11442495|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7235332|NCT00117676|11442496|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
7235333|NCT00117676|11442495|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
7235334|NCT00117676|11442496|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
7235335|NCT00117793|11442511|FG000|Overall Study|Withdrawal by Subject|12
7235336|NCT00117845|11442528|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
7235337|NCT00117949|11442536|FG000|Overall Study|Testosterone >1.0 ng/mL|10
7235338|NCT00117949|11442537|FG001|Overall Study|Testosterone >1.0 ng/mL|18
7235339|NCT00117949|11442538|FG002|Overall Study|Testosterone >1.0 ng/mL|17
7235340|NCT00117949|11442539|FG003|Overall Study|Testosterone >1.0 ng/mL|15
7235341|NCT00117949|11442536|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
7235342|NCT00117949|11442537|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
7235343|NCT00117949|11442538|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
7235344|NCT00117949|11442539|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
7235345|NCT00117949|11442536|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
7235346|NCT00117949|11442537|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
7235347|NCT00117949|11442538|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
7235348|NCT00117949|11442539|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
7235349|NCT00117949|11442536|FG000|Overall Study|PSA increase >=10ng/mL|0
7235350|NCT00117949|11442537|FG001|Overall Study|PSA increase >=10ng/mL|1
7235351|NCT00117949|11442538|FG002|Overall Study|PSA increase >=10ng/mL|1
7235352|NCT00117949|11442539|FG003|Overall Study|PSA increase >=10ng/mL|0
7235353|NCT00117949|11442536|FG000|Overall Study|PSA reduction <=50%|0
7235354|NCT00117949|11442537|FG001|Overall Study|PSA reduction <=50%|2
7235355|NCT00117949|11442538|FG002|Overall Study|PSA reduction <=50%|2
7235356|NCT00117949|11442539|FG003|Overall Study|PSA reduction <=50%|4
7235357|NCT00117949|11442536|FG000|Overall Study|Hepatic abnormalities|0
7235358|NCT00117949|11442537|FG001|Overall Study|Hepatic abnormalities|1
7235359|NCT00117949|11442538|FG002|Overall Study|Hepatic abnormalities|0
7235360|NCT00117949|11442539|FG003|Overall Study|Hepatic abnormalities|1
7235361|NCT00117988|11442558|FG000|Overall Study|Death|3
7235362|NCT00117988|11442558|FG000|Overall Study|Adverse Event|1
7235363|NCT00118040|11442565|FG000|Overall Study|Adverse Event|0
7235364|NCT00118040|11442566|FG001|Overall Study|Adverse Event|1
7235365|NCT00118040|11442567|FG002|Overall Study|Adverse Event|0
7235366|NCT00118040|11442565|FG000|Overall Study|Withdrawal by Subject|0
7235367|NCT00118040|11442566|FG001|Overall Study|Withdrawal by Subject|0
7235368|NCT00118040|11442567|FG002|Overall Study|Withdrawal by Subject|2
7235369|NCT00118040|11442565|FG000|Overall Study|Medical Contraindication|0
7235370|NCT00118040|11442566|FG001|Overall Study|Medical Contraindication|0
7235371|NCT00118040|11442567|FG002|Overall Study|Medical Contraindication|1
7235372|NCT00118040|11442565|FG000|Overall Study|Non-Compliant Participant|1
7235373|NCT00118040|11442566|FG001|Overall Study|Non-Compliant Participant|1
7235374|NCT00118040|11442567|FG002|Overall Study|Non-Compliant Participant|2
7235375|NCT00118040|11442565|FG000|Overall Study|Other|0
7235376|NCT00118040|11442566|FG001|Overall Study|Other|0
7235377|NCT00118040|11442567|FG002|Overall Study|Other|1
7235378|NCT00118092|11442580|FG000|Overall Study|Withdrawal by Subject|1
7235379|NCT00118092|11442580|FG000|Overall Study|Protocol Violation|1
7235380|NCT00118157|11442594|FG000|Overall Study|Adverse Event|2
7235381|NCT00118157|11442594|FG000|Overall Study|Death|8
7235382|NCT00118157|11442594|FG000|Overall Study|Withdrawal by Subject|2
7235383|NCT00118287|11442633|FG000|Overall Study|Intracranial haemorrhage|1
7235384|NCT00118287|11442633|FG000|Overall Study|Muscle pain|1
7235385|NCT00118417|11442713|FG000|Phase I (Weeks 0 to 6)|Remission|8
7235386|NCT00118417|11442714|FG001|Phase I (Weeks 0 to 6)|Remission|0
7235387|NCT00118417|11442713|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
7235388|NCT00118417|11442714|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
7235389|NCT00118417|11442713|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
7235390|NCT00118417|11442714|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
7235391|NCT00118417|11442713|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7235392|NCT00118417|11442714|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
7235393|NCT00118417|11442713|FG000|Phase II (Weeks 6 to 12)|Remission|1
7235394|NCT00118417|11442714|FG001|Phase II (Weeks 6 to 12)|Remission|2
7235395|NCT00118430|11442727|FG000|Overall Study|Withdrawal by Subject|6
7533739|NCT02688387|11880044|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533740|NCT02688387|11880045|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533741|NCT02688387|11880046|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533742|NCT02688387|11880047|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533743|NCT02688387|11880048|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533744|NCT02688387|11880049|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533745|NCT02688387|11880050|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533746|NCT02688387|11880051|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533747|NCT02688387|11880052|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7235396|NCT00118430|11442728|FG001|Overall Study|Withdrawal by Subject|2
7235397|NCT00118430|11442729|FG002|Overall Study|Withdrawal by Subject|0
7235398|NCT00118430|11442727|FG000|Overall Study|Lost to Follow-up|15
7235399|NCT00118430|11442728|FG001|Overall Study|Lost to Follow-up|22
7235400|NCT00118430|11442729|FG002|Overall Study|Lost to Follow-up|28
7235401|NCT00118482|11442738|FG000|Overall Study|Lost to Follow-up|7
7235402|NCT00118482|11442739|FG001|Overall Study|Lost to Follow-up|7
7235403|NCT00118482|11442738|FG000|Overall Study|Withdrawal by Subject|23
7235404|NCT00118482|11442739|FG001|Overall Study|Withdrawal by Subject|22
7235405|NCT00118703|11442757|FG000|Overall Study|Protocol Violation|1
7235406|NCT00118703|11442758|FG001|Overall Study|Protocol Violation|0
7235407|NCT00118703|11442757|FG000|Overall Study|Adverse Event|1
7235408|NCT00118703|11442758|FG001|Overall Study|Adverse Event|1
7255666|NCT00319982|11467235|FG001|Overall Study|Withdrawal by Subject|0
7235409|NCT00118703|11442757|FG000|Overall Study|Participant took two different treatment|0
7235410|NCT00118703|11442758|FG001|Overall Study|Participant took two different treatment|1
7235411|NCT00118703|11442757|FG000|Overall Study|Withdrawal by Subject|2
7235412|NCT00118703|11442758|FG001|Overall Study|Withdrawal by Subject|5
7235413|NCT00118703|11442757|FG000|Overall Study|Lost to Follow-up|1
7235414|NCT00118703|11442758|FG001|Overall Study|Lost to Follow-up|2
7235415|NCT00118716|11442766|FG000|Overall Study|Adverse Event|2
7235416|NCT00118716|11442767|FG001|Overall Study|Adverse Event|7
7235417|NCT00118716|11442766|FG000|Overall Study|Protocol Violation|5
7235418|NCT00118716|11442767|FG001|Overall Study|Protocol Violation|4
7235419|NCT00118716|11442766|FG000|Overall Study|Withdrawal by Subject|0
7235420|NCT00118716|11442767|FG001|Overall Study|Withdrawal by Subject|1
7235421|NCT00118716|11442766|FG000|Overall Study|Exacerbation|2
7235422|NCT00118716|11442767|FG001|Overall Study|Exacerbation|2
7235423|NCT00118716|11442766|FG000|Overall Study|Discontinued by sponsor|1
7235424|NCT00118716|11442767|FG001|Overall Study|Discontinued by sponsor|1
7235425|NCT00118716|11442766|FG000|Overall Study|Non-compliance|1
7235426|NCT00118716|11442767|FG001|Overall Study|Non-compliance|3
7235427|NCT00118716|11442766|FG000|Overall Study|misrandomized|1
7235428|NCT00118716|11442767|FG001|Overall Study|misrandomized|1
7235429|NCT00118716|11442766|FG000|Overall Study|Expired drug use|1
7235430|NCT00118716|11442767|FG001|Overall Study|Expired drug use|2
7235431|NCT00118716|11442766|FG000|Overall Study|Investigator discretion|0
7235432|NCT00118716|11442767|FG001|Overall Study|Investigator discretion|1
7235433|NCT00118898|11442795|FG000|Overall Study|Death|6
7235434|NCT00118898|11442796|FG001|Overall Study|Death|11
7235435|NCT00118898|11442797|FG002|Overall Study|Death|6
7235436|NCT00118898|11442798|FG003|Overall Study|Death|8
7235437|NCT00118898|11442795|FG000|Overall Study|Lost to Follow-up|26
7235438|NCT00118898|11442796|FG001|Overall Study|Lost to Follow-up|34
7235439|NCT00118898|11442797|FG002|Overall Study|Lost to Follow-up|33
7235440|NCT00118898|11442798|FG003|Overall Study|Lost to Follow-up|33
7235441|NCT00118898|11442795|FG000|Overall Study|Withdrawal by Subject|10
7235442|NCT00118898|11442796|FG001|Overall Study|Withdrawal by Subject|5
7235443|NCT00118898|11442797|FG002|Overall Study|Withdrawal by Subject|8
7235444|NCT00118898|11442798|FG003|Overall Study|Withdrawal by Subject|8
7235445|NCT00118898|11442795|FG000|Overall Study|Site Closure|33
7235446|NCT00118898|11442796|FG001|Overall Study|Site Closure|31
7235447|NCT00118898|11442797|FG002|Overall Study|Site Closure|28
7235448|NCT00118898|11442798|FG003|Overall Study|Site Closure|37
7235449|NCT00118898|11442795|FG000|Overall Study|Severe debilitation|1
7235450|NCT00118898|11442796|FG001|Overall Study|Severe debilitation|4
7235451|NCT00118898|11442797|FG002|Overall Study|Severe debilitation|6
7235452|NCT00118898|11442798|FG003|Overall Study|Severe debilitation|4
7235453|NCT00118898|11442795|FG000|Overall Study|Not compliant with requirements|11
7235454|NCT00118898|11442796|FG001|Overall Study|Not compliant with requirements|13
7235455|NCT00118898|11442797|FG002|Overall Study|Not compliant with requirements|11
7235456|NCT00118898|11442798|FG003|Overall Study|Not compliant with requirements|11
7235457|NCT00118898|11442795|FG000|Overall Study|Not able to get to clinic|34
7235458|NCT00118898|11442796|FG001|Overall Study|Not able to get to clinic|43
7235459|NCT00118898|11442797|FG002|Overall Study|Not able to get to clinic|31
7235460|NCT00118898|11442798|FG003|Overall Study|Not able to get to clinic|40
7235461|NCT00118911|11442810|FG000|Overall Study|Withdrawal by Subject|2
7235462|NCT00118911|11442811|FG001|Overall Study|Withdrawal by Subject|5
7235463|NCT00119015|11442819|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
7235464|NCT00119015|11442820|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7235465|NCT00119015|11442821|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
7235466|NCT00119106|11442843|FG000|Overall Study|HIV infected at baseline|179
7235467|NCT00119106|11442844|FG001|Overall Study|HIV infected at baseline|178
7235468|NCT00119262|11442869|FG000|Overall Study|Lack of Efficacy|0
7235469|NCT00119262|11442870|FG001|Overall Study|Lack of Efficacy|3
7235470|NCT00119262|11442869|FG000|Overall Study|Withdrawal by Subject|12
7235471|NCT00119262|11442870|FG001|Overall Study|Withdrawal by Subject|11
7235472|NCT00119262|11442869|FG000|Overall Study|Adverse Event|33
7573692|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7573693|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7573694|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7573695|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
7573696|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
7573697|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7573698|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7573699|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7573700|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
7573701|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
7573702|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7573703|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7573704|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7573705|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
7235473|NCT00119262|11442870|FG001|Overall Study|Adverse Event|35
7235474|NCT00119262|11442869|FG000|Overall Study|other disease|0
7235475|NCT00119262|11442870|FG001|Overall Study|other disease|2
7573706|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
7573707|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7573708|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7573709|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7573710|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
7573711|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
7235476|NCT00119262|11442869|FG000|Overall Study|ineligble|1
7235477|NCT00119262|11442870|FG001|Overall Study|ineligble|2
7235478|NCT00119262|11442869|FG000|Overall Study|others|0
7235479|NCT00119262|11442870|FG001|Overall Study|others|5
7235480|NCT00119379|11442878|FG000|Overall Study|Adverse Event|4
7235481|NCT00119379|11442879|FG001|Overall Study|Adverse Event|1
7235482|NCT00119405|11442889|FG000|Overall Study|Withdrawal by Subject|1
7235483|NCT00119678|11442895|FG000|Double-blind Treatment Period|Death|1
7235484|NCT00119678|11442896|FG001|Double-blind Treatment Period|Death|0
7235485|NCT00119678|11442895|FG000|Double-blind Treatment Period|Adverse Event|7
7235486|NCT00119678|11442896|FG001|Double-blind Treatment Period|Adverse Event|1
7235487|NCT00119678|11442895|FG000|Double-blind Treatment Period|Lack of Efficacy|21
7235488|NCT00119678|11442896|FG001|Double-blind Treatment Period|Lack of Efficacy|12
7235489|NCT00119678|11442895|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7235490|NCT00119678|11442896|FG001|Double-blind Treatment Period|Lost to Follow-up|2
7235491|NCT00119678|11442895|FG000|Double-blind Treatment Period|Participant withdrew consent|4
7235492|NCT00119678|11442896|FG001|Double-blind Treatment Period|Participant withdrew consent|4
7235493|NCT00119678|11442895|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
7235494|NCT00119678|11442896|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
7235495|NCT00119678|11442895|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
7235496|NCT00119678|11442896|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
7235497|NCT00119678|11442895|FG000|Double-blind Treatment Period|Pregnancy|0
7235498|NCT00119678|11442896|FG001|Double-blind Treatment Period|Pregnancy|2
7235499|NCT00119678|11442895|FG000|Double-blind Treatment Period|Not treated|1
7235500|NCT00119678|11442896|FG001|Double-blind Treatment Period|Not treated|2
7235501|NCT00119678|11442895|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
7235502|NCT00119678|11442896|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
7235503|NCT00119678|11442895|FG000|Open-label Treatment Period|Death|1
7235504|NCT00119678|11442896|FG001|Open-label Treatment Period|Death|0
7235505|NCT00119678|11442895|FG000|Open-label Treatment Period|Adverse Event|3
7235506|NCT00119678|11442896|FG001|Open-label Treatment Period|Adverse Event|0
7235507|NCT00119678|11442895|FG000|Open-label Treatment Period|Lack of Efficacy|9
7235508|NCT00119678|11442896|FG001|Open-label Treatment Period|Lack of Efficacy|0
7235509|NCT00119678|11442895|FG000|Open-label Treatment Period|Lost to Follow-up|3
7235510|NCT00119678|11442896|FG001|Open-label Treatment Period|Lost to Follow-up|0
7235511|NCT00119678|11442895|FG000|Open-label Treatment Period|Participant withdrew consent|4
7235512|NCT00119678|11442896|FG001|Open-label Treatment Period|Participant withdrew consent|0
7235513|NCT00119678|11442895|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
7235514|NCT00119678|11442896|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
7235515|NCT00119678|11442895|FG000|Open-label Treatment Period|Pregnancy|1
7235516|NCT00119678|11442896|FG001|Open-label Treatment Period|Pregnancy|0
7235517|NCT00119678|11442895|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
7235518|NCT00119678|11442896|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
7235519|NCT00120250|11442904|FG000|Overall Study|Lost to Follow-up|1
7235520|NCT00120250|11442905|FG001|Overall Study|Lost to Follow-up|1
7235521|NCT00120250|11442904|FG000|Overall Study|Protocol Violation|0
7235522|NCT00120250|11442905|FG001|Overall Study|Protocol Violation|1
7235523|NCT00120289|11442914|FG000|Overall Study|Death|96
7235524|NCT00120289|11442915|FG001|Overall Study|Death|82
7235525|NCT00120289|11442914|FG000|Overall Study|Lost to Follow-up|11
7235526|NCT00120289|11442915|FG001|Overall Study|Lost to Follow-up|14
7235527|NCT00120289|11442914|FG000|Overall Study|Withdrawal by Subject|14
7235528|NCT00120289|11442915|FG001|Overall Study|Withdrawal by Subject|13
7235529|NCT00120406|11442923|FG000|Overall Study|Death|9
7235530|NCT00120406|11442924|FG001|Overall Study|Death|4
7235531|NCT00120406|11442923|FG000|Overall Study|Withdrawal by Subject|5
7235532|NCT00120406|11442924|FG001|Overall Study|Withdrawal by Subject|7
7235533|NCT00120406|11442923|FG000|Overall Study|Lost to Follow-up|5
7235534|NCT00120406|11442924|FG001|Overall Study|Lost to Follow-up|2
7235535|NCT00120406|11442923|FG000|Overall Study|received non-study stent|0
7235536|NCT00120406|11442924|FG001|Overall Study|received non-study stent|2
7235537|NCT00120406|11442923|FG000|Overall Study|patient moved but has not withdrawn|0
7573712|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7573713|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7573714|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7573715|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
7573716|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
7575389|NCT03736967|11959083|FG002|Overall Study|Lost to Follow-up|1
7235538|NCT00120406|11442924|FG001|Overall Study|patient moved but has not withdrawn|1
7235539|NCT00120627|11442942|FG000|Overall Study|Withdrawal by Subject|5
7573717|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7573718|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7573719|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7573720|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
7573721|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
7573722|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7573723|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7573724|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7573725|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
7573726|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
7573727|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7573728|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7573729|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7573730|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
7573731|NCT03627767|11955235|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
7573732|NCT03627767|11955236|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7573733|NCT03627767|11955237|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7464921|NCT01876368|11763803|FG000|Overall Study|Lost to Follow-up|0
7464922|NCT01876368|11763804|FG001|Overall Study|Lost to Follow-up|1
7464923|NCT01876368|11763803|FG000|Overall Study|Non-compliance with study treatment|0
7464924|NCT01876368|11763804|FG001|Overall Study|Non-compliance with study treatment|1
7464925|NCT01876368|11763803|FG000|Overall Study|Physician Decision|0
7235540|NCT00120627|11442943|FG001|Overall Study|Withdrawal by Subject|5
7235541|NCT00120874|11442960|FG000|Overall Study|Death|0
7235542|NCT00120874|11442961|FG001|Overall Study|Death|1
7235543|NCT00121134|11442971|FG000|Overall Study|Progression of Disease|5
7235544|NCT00121134|11442972|FG001|Overall Study|Progression of Disease|3
7235545|NCT00121134|11442973|FG002|Overall Study|Progression of Disease|4
7235546|NCT00121134|11442974|FG003|Overall Study|Progression of Disease|2
7235547|NCT00121134|11442971|FG000|Overall Study|Toxicity|4
7235548|NCT00121134|11442972|FG001|Overall Study|Toxicity|7
7235549|NCT00121134|11442973|FG002|Overall Study|Toxicity|13
7235550|NCT00121134|11442974|FG003|Overall Study|Toxicity|5
7235551|NCT00121134|11442971|FG000|Overall Study|Physician Decision|6
7235552|NCT00121134|11442972|FG001|Overall Study|Physician Decision|4
7235553|NCT00121134|11442973|FG002|Overall Study|Physician Decision|4
7235554|NCT00121134|11442974|FG003|Overall Study|Physician Decision|1
7235555|NCT00121134|11442971|FG000|Overall Study|Treatment Delay|1
7235556|NCT00121134|11442972|FG001|Overall Study|Treatment Delay|0
7235557|NCT00121134|11442973|FG002|Overall Study|Treatment Delay|0
7235558|NCT00121134|11442974|FG003|Overall Study|Treatment Delay|0
7235559|NCT00121134|11442971|FG000|Overall Study|Intercurrent Illness|0
7235560|NCT00121134|11442972|FG001|Overall Study|Intercurrent Illness|0
7235561|NCT00121134|11442973|FG002|Overall Study|Intercurrent Illness|0
7235562|NCT00121134|11442974|FG003|Overall Study|Intercurrent Illness|1
7235563|NCT00121134|11442971|FG000|Overall Study|Patient Personal Reasons|0
7235564|NCT00121134|11442972|FG001|Overall Study|Patient Personal Reasons|1
7235565|NCT00121134|11442973|FG002|Overall Study|Patient Personal Reasons|0
7235566|NCT00121134|11442974|FG003|Overall Study|Patient Personal Reasons|0
7235567|NCT00121199|11443004|FG000|Overall Study|Adverse Event|11
7235568|NCT00121199|11443004|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7235569|NCT00121199|11443004|FG000|Overall Study|Progression/Relapse|1
7235570|NCT00121199|11443004|FG000|Overall Study|Death|3
7235571|NCT00121199|11443004|FG000|Overall Study|Other - Not Protocol Specified|3
7235572|NCT00121199|11443004|FG000|Overall Study|Ineligible|9
7235573|NCT00121238|11443013|FG000|Overall Study|disease progression before intervention|1
7235574|NCT00121238|11443013|FG000|Overall Study|Protocol Violation|2
7235575|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
7235576|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
7235577|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
7235578|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
7235579|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
7235580|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
7235581|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
7235582|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
7235583|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
7235584|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
7464926|NCT01876368|11763804|FG001|Overall Study|Physician Decision|2
7464927|NCT01876368|11763803|FG000|Overall Study|Protocol deviation|3
7464928|NCT01876368|11763804|FG001|Overall Study|Protocol deviation|3
7464929|NCT01876368|11763803|FG000|Overall Study|Subject/guardian decision|3
7464930|NCT01876368|11763804|FG001|Overall Study|Subject/guardian decision|1
7464931|NCT01876381|11763810|FG000|Overall Study|Lack of Efficacy|5
7464932|NCT01876381|11763810|FG000|Overall Study|Physician Decision|1
7464933|NCT01876381|11763810|FG000|Overall Study|Withdrawal by Subject|1
7464934|NCT01876420|11763814|FG000|Overall Study|Missed 30 day visit|1
7235585|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Adverse Event|3
7235586|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Adverse Event|3
7235587|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Adverse Event|4
7235588|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Adverse Event|0
7235589|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Adverse Event|2
7235590|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
7235591|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
7235592|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
7235593|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
7235594|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
7235595|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
7235596|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
7235597|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
7235598|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
7235599|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
7235600|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7235601|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7235602|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7235603|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
7235604|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
7235605|NCT00121641|11443025|FG000|24-week Short-term Treatment Period|Other Reason|1
7235606|NCT00121641|11443026|FG001|24-week Short-term Treatment Period|Other Reason|0
7235607|NCT00121641|11443027|FG002|24-week Short-term Treatment Period|Other Reason|0
7235608|NCT00121641|11443028|FG003|24-week Short-term Treatment Period|Other Reason|0
7235609|NCT00121641|11443029|FG004|24-week Short-term Treatment Period|Other Reason|0
7235610|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
7235611|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
7235612|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
7235613|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
7235614|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
7235615|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
7235616|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
7235617|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
7235618|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
7235619|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
7235620|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Adverse Event|9
7235621|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Adverse Event|10
7235622|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Adverse Event|10
7235623|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Adverse Event|5
7235624|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Adverse Event|5
7235625|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
7235626|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
7235627|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
7235628|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
7235629|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
7235630|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7235631|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
7235632|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
7235633|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7235634|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
7235635|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7235636|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
7235637|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7235638|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
7235639|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
7235640|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Pregnancy|0
7235641|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Pregnancy|1
7235642|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Pregnancy|0
7235643|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Pregnancy|1
7235644|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Pregnancy|0
7235645|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7235646|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
7235647|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7235648|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
7235649|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
7235650|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Death|0
7235651|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Death|0
7235652|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Death|0
7235653|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Death|1
7235654|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Death|0
7235655|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Missing|0
7235656|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Missing|0
7235657|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Missing|1
7235658|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Missing|0
7235659|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Missing|0
7235660|NCT00121641|11443025|FG000|48-month Short Term + Long Term Period|Other Reason|5
7235661|NCT00121641|11443026|FG001|48-month Short Term + Long Term Period|Other Reason|3
7235662|NCT00121641|11443027|FG002|48-month Short Term + Long Term Period|Other Reason|2
7235663|NCT00121641|11443028|FG003|48-month Short Term + Long Term Period|Other Reason|0
7235664|NCT00121641|11443029|FG004|48-month Short Term + Long Term Period|Other Reason|1
7235665|NCT00121667|11443047|FG000|Short Term (ST) Period|Lack of Efficacy|25
7235666|NCT00121667|11443048|FG001|Short Term (ST) Period|Lack of Efficacy|22
7235667|NCT00121667|11443049|FG002|Short Term (ST) Period|Lack of Efficacy|27
7235668|NCT00121667|11443050|FG003|Short Term (ST) Period|Lack of Efficacy|44
7235669|NCT00121667|11443047|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
7235670|NCT00121667|11443048|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
7573734|NCT03627767|11955238|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7573735|NCT03627767|11955239|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
7573736|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7573737|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
7235671|NCT00121667|11443049|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
7235672|NCT00121667|11443050|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
7235673|NCT00121667|11443047|FG000|Short Term (ST) Period|Adverse Event|5
7235674|NCT00121667|11443048|FG001|Short Term (ST) Period|Adverse Event|6
7235675|NCT00121667|11443049|FG002|Short Term (ST) Period|Adverse Event|5
7235676|NCT00121667|11443050|FG003|Short Term (ST) Period|Adverse Event|3
7235677|NCT00121667|11443047|FG000|Short Term (ST) Period|Lost to Follow-up|3
7235678|NCT00121667|11443048|FG001|Short Term (ST) Period|Lost to Follow-up|4
7235679|NCT00121667|11443049|FG002|Short Term (ST) Period|Lost to Follow-up|4
7235680|NCT00121667|11443050|FG003|Short Term (ST) Period|Lost to Follow-up|3
7235681|NCT00121667|11443047|FG000|Short Term (ST) Period|Poor / Non-compliance|0
7235682|NCT00121667|11443048|FG001|Short Term (ST) Period|Poor / Non-compliance|1
7235683|NCT00121667|11443049|FG002|Short Term (ST) Period|Poor / Non-compliance|1
7235684|NCT00121667|11443050|FG003|Short Term (ST) Period|Poor / Non-compliance|2
7235685|NCT00121667|11443047|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7235686|NCT00121667|11443048|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7235687|NCT00121667|11443049|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
7235688|NCT00121667|11443050|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
7235689|NCT00121667|11443047|FG000|Short Term (ST) Period|Other Reason|3
7235690|NCT00121667|11443048|FG001|Short Term (ST) Period|Other Reason|0
7235691|NCT00121667|11443049|FG002|Short Term (ST) Period|Other Reason|0
7235692|NCT00121667|11443050|FG003|Short Term (ST) Period|Other Reason|0
7235693|NCT00121667|11443047|FG000|Short Term (ST) Period|Death|0
7235694|NCT00121667|11443048|FG001|Short Term (ST) Period|Death|0
7235695|NCT00121667|11443049|FG002|Short Term (ST) Period|Death|0
7235696|NCT00121667|11443050|FG003|Short Term (ST) Period|Death|1
7235697|NCT00121667|11443047|FG000|Short Term (ST) Period|Pregnancy|0
7235698|NCT00121667|11443048|FG001|Short Term (ST) Period|Pregnancy|0
7235699|NCT00121667|11443049|FG002|Short Term (ST) Period|Pregnancy|0
7235700|NCT00121667|11443050|FG003|Short Term (ST) Period|Pregnancy|1
7235701|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
7235702|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
7235703|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
7235704|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
7235705|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
7235706|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
7235707|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
7235708|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
7235709|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
7235710|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
7235711|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
7235712|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
7235713|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7235714|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
7235715|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
7235716|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
7235717|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
7235718|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
7235719|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
7235720|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
7255667|NCT00320112|11467243|FG000|Overall Study|Lost to Follow-up|3
7235721|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
7235722|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
7235723|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
7235724|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
7235725|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
7235726|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
7235727|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
7235728|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
7235729|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7235730|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7235731|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
7235732|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
7235733|NCT00121667|11443047|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
7235734|NCT00121667|11443048|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
7235735|NCT00121667|11443049|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
7235736|NCT00121667|11443050|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
7235737|NCT00121992|11443143|FG000|Overall Study|Treatment not received|2
7235738|NCT00121992|11443144|FG001|Overall Study|Treatment not received|11
7235739|NCT00122109|11443152|FG000|Overall Study|Did not meet criteria|6
7235740|NCT00122109|11443153|FG001|Overall Study|Did not meet criteria|7
7235741|NCT00122135|11443164|FG000|Overall Study|Withdrawal by Subject|3
7235742|NCT00122135|11443165|FG001|Overall Study|Withdrawal by Subject|0
7235743|NCT00122187|11443173|FG000|Overall Study|Withdrew because of resource limitations|2
7235744|NCT00122187|11443174|FG001|Overall Study|Withdrew because of resource limitations|2
7235745|NCT00122278|11443184|FG000|Overall Study|Lost to Follow-up|2
7235746|NCT00122278|11443185|FG001|Overall Study|Lost to Follow-up|0
7235747|NCT00122317|11443191|FG000|Overall Study|Death|3
7235748|NCT00122317|11443191|FG000|Overall Study|Adverse Event|4
7235749|NCT00122317|11443191|FG000|Overall Study|Physician Decision|2
7235750|NCT00122317|11443191|FG000|Overall Study|patient non-compliance|1
7235751|NCT00122317|11443191|FG000|Overall Study|Withdrawal by Subject|1
7235752|NCT00122382|11443213|FG000|Double-Blind Study|Adverse Event|9
7235753|NCT00122382|11443214|FG001|Double-Blind Study|Adverse Event|11
7235754|NCT00122382|11443215|FG002|Double-Blind Study|Adverse Event|0
7235755|NCT00122382|11443213|FG000|Double-Blind Study|Death|2
7235756|NCT00122382|11443214|FG001|Double-Blind Study|Death|2
7235757|NCT00122382|11443215|FG002|Double-Blind Study|Death|0
7235758|NCT00122382|11443213|FG000|Double-Blind Study|Lack of Efficacy|0
7235759|NCT00122382|11443214|FG001|Double-Blind Study|Lack of Efficacy|8
7235760|NCT00122382|11443215|FG002|Double-Blind Study|Lack of Efficacy|0
7235761|NCT00122382|11443213|FG000|Double-Blind Study|Lost to Follow-up|2
7235762|NCT00122382|11443214|FG001|Double-Blind Study|Lost to Follow-up|1
7235763|NCT00122382|11443215|FG002|Double-Blind Study|Lost to Follow-up|0
7235764|NCT00122382|11443213|FG000|Double-Blind Study|Pregnancy|2
7235765|NCT00122382|11443214|FG001|Double-Blind Study|Pregnancy|0
7235766|NCT00122382|11443215|FG002|Double-Blind Study|Pregnancy|0
7235767|NCT00122382|11443213|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
7235768|NCT00122382|11443214|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7235769|NCT00122382|11443215|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
7235770|NCT00122382|11443213|FG000|Double-Blind Study|Withdrawal of Consent|7
7235771|NCT00122382|11443214|FG001|Double-Blind Study|Withdrawal of Consent|3
7235772|NCT00122382|11443215|FG002|Double-Blind Study|Withdrawal of Consent|0
7235773|NCT00122382|11443213|FG000|Double-Blind Study|Protocol Violation|1
7235774|NCT00122382|11443214|FG001|Double-Blind Study|Protocol Violation|0
7235775|NCT00122382|11443215|FG002|Double-Blind Study|Protocol Violation|0
7235776|NCT00122382|11443213|FG000|Double-Blind Study|Methotrexate Discontinued|0
7235777|NCT00122382|11443214|FG001|Double-Blind Study|Methotrexate Discontinued|1
7235778|NCT00122382|11443215|FG002|Double-Blind Study|Methotrexate Discontinued|0
7235779|NCT00122382|11443213|FG000|Double-Blind Study|Randomized but not treated|0
7235780|NCT00122382|11443214|FG001|Double-Blind Study|Randomized but not treated|2
7235781|NCT00122382|11443215|FG002|Double-Blind Study|Randomized but not treated|0
7235782|NCT00122382|11443213|FG000|Open-Label Study|Adverse Event|0
7235783|NCT00122382|11443214|FG001|Open-Label Study|Adverse Event|0
7235784|NCT00122382|11443215|FG002|Open-Label Study|Adverse Event|11
7235785|NCT00122382|11443213|FG000|Open-Label Study|Death|0
7235786|NCT00122382|11443214|FG001|Open-Label Study|Death|0
7235787|NCT00122382|11443215|FG002|Open-Label Study|Death|2
7235788|NCT00122382|11443213|FG000|Open-Label Study|Lack of Efficacy|0
7235789|NCT00122382|11443214|FG001|Open-Label Study|Lack of Efficacy|0
7235790|NCT00122382|11443215|FG002|Open-Label Study|Lack of Efficacy|3
7235791|NCT00122382|11443213|FG000|Open-Label Study|Lost to Follow-up|0
7235792|NCT00122382|11443214|FG001|Open-Label Study|Lost to Follow-up|0
7235793|NCT00122382|11443215|FG002|Open-Label Study|Lost to Follow-up|3
7235794|NCT00122382|11443213|FG000|Open-Label Study|Pregnancy|0
7235795|NCT00122382|11443214|FG001|Open-Label Study|Pregnancy|0
7235796|NCT00122382|11443215|FG002|Open-Label Study|Pregnancy|2
7235797|NCT00122382|11443213|FG000|Open-Label Study|Poor/Non-Compliance|0
7235798|NCT00122382|11443214|FG001|Open-Label Study|Poor/Non-Compliance|0
7235799|NCT00122382|11443215|FG002|Open-Label Study|Poor/Non-Compliance|1
7235800|NCT00122382|11443213|FG000|Open-Label Study|Withdrawal of Consent|0
7235801|NCT00122382|11443214|FG001|Open-Label Study|Withdrawal of Consent|0
7235802|NCT00122382|11443215|FG002|Open-Label Study|Withdrawal of Consent|4
7235803|NCT00122460|11443256|FG000|Overall Study|investigational study phase ongoing|7
7235804|NCT00122460|11443257|FG001|Overall Study|investigational study phase ongoing|1
7235805|NCT00122681|11443265|FG000|Overall Study|Adverse Event|20
7235806|NCT00122681|11443266|FG001|Overall Study|Adverse Event|16
7235807|NCT00122681|11443265|FG000|Overall Study|Lost to Follow-up|1080
7235808|NCT00122681|11443266|FG001|Overall Study|Lost to Follow-up|1097
7235809|NCT00122681|11443265|FG000|Overall Study|Protocol Violation|7
7235810|NCT00122681|11443266|FG001|Overall Study|Protocol Violation|10
7235811|NCT00122681|11443265|FG000|Overall Study|Withdrawal by Subject|257
7235812|NCT00122681|11443266|FG001|Overall Study|Withdrawal by Subject|251
7235813|NCT00122681|11443265|FG000|Overall Study|Personal reasons|150
7235814|NCT00122681|11443266|FG001|Overall Study|Personal reasons|147
7235815|NCT00122954|11443282|FG000|Overall Study|Withdrawal by Subject|2
7235816|NCT00122954|11443283|FG001|Overall Study|Withdrawal by Subject|2
7573738|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
7235817|NCT00122954|11443282|FG000|Overall Study|Protocol Violation|0
7235818|NCT00122954|11443283|FG001|Overall Study|Protocol Violation|1
7235819|NCT00122980|11443291|FG000|Overall Study|Death|0
7235820|NCT00122980|11443292|FG001|Overall Study|Death|1
7235821|NCT00122980|11443291|FG000|Overall Study|Physician Decision|2
7235822|NCT00122980|11443292|FG001|Overall Study|Physician Decision|0
7235823|NCT00122980|11443291|FG000|Overall Study|Protocol Violation|5
7235824|NCT00122980|11443292|FG001|Overall Study|Protocol Violation|1
7235825|NCT00122980|11443291|FG000|Overall Study|Withdrawal by Subject|2
7235826|NCT00122980|11443292|FG001|Overall Study|Withdrawal by Subject|3
7235827|NCT00122980|11443291|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
7235828|NCT00122980|11443292|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
7235829|NCT00122980|11443291|FG000|Overall Study|Study termination|27
7235830|NCT00122980|11443292|FG001|Overall Study|Study termination|35
7235831|NCT00123422|11443347|FG000|Overall Study|Physician Decision|2
7235832|NCT00123422|11443348|FG001|Overall Study|Physician Decision|2
7235833|NCT00123422|11443349|FG002|Overall Study|Physician Decision|6
7235834|NCT00123422|11443347|FG000|Overall Study|Withdrawal by Subject|1
7235835|NCT00123422|11443348|FG001|Overall Study|Withdrawal by Subject|2
7235836|NCT00123422|11443349|FG002|Overall Study|Withdrawal by Subject|2
7235837|NCT00123422|11443347|FG000|Overall Study|Lost to Follow-up|1
7235838|NCT00123422|11443348|FG001|Overall Study|Lost to Follow-up|2
7235839|NCT00123422|11443349|FG002|Overall Study|Lost to Follow-up|2
7235840|NCT00123474|11443361|FG000|Randomized to Treatment|Randomized, never treated|1
7235841|NCT00123474|11443362|FG001|Randomized to Treatment|Randomized, never treated|4
7235842|NCT00123474|11443363|FG002|Randomized to Treatment|Randomized, never treated|2
7235843|NCT00123474|11443364|FG003|Randomized to Treatment|Randomized, never treated|1
7235844|NCT00123474|11443361|FG000|As Treated at Study Closure|not reported when site closed|1
7235845|NCT00123474|11443362|FG001|As Treated at Study Closure|not reported when site closed|0
7235846|NCT00123474|11443363|FG002|As Treated at Study Closure|not reported when site closed|1
7235847|NCT00123474|11443364|FG003|As Treated at Study Closure|not reported when site closed|0
7235848|NCT00123474|11443361|FG000|As Treated at Study Closure|Adverse Event|10
7235849|NCT00123474|11443362|FG001|As Treated at Study Closure|Adverse Event|4
7235850|NCT00123474|11443363|FG002|As Treated at Study Closure|Adverse Event|10
7235851|NCT00123474|11443364|FG003|As Treated at Study Closure|Adverse Event|8
7235852|NCT00123474|11443361|FG000|As Treated at Study Closure|Disease Progression|35
7235853|NCT00123474|11443362|FG001|As Treated at Study Closure|Disease Progression|42
7235854|NCT00123474|11443363|FG002|As Treated at Study Closure|Disease Progression|29
7235855|NCT00123474|11443364|FG003|As Treated at Study Closure|Disease Progression|27
7235856|NCT00123474|11443361|FG000|As Treated at Study Closure|Investigator Request|12
7235857|NCT00123474|11443362|FG001|As Treated at Study Closure|Investigator Request|6
7235858|NCT00123474|11443363|FG002|As Treated at Study Closure|Investigator Request|7
7235859|NCT00123474|11443364|FG003|As Treated at Study Closure|Investigator Request|5
7235860|NCT00123474|11443361|FG000|As Treated at Study Closure|non-specified|54
7235861|NCT00123474|11443362|FG001|As Treated at Study Closure|non-specified|47
7235862|NCT00123474|11443363|FG002|As Treated at Study Closure|non-specified|57
7235863|NCT00123474|11443364|FG003|As Treated at Study Closure|non-specified|60
7235864|NCT00123474|11443361|FG000|As Treated at Study Closure|Study Drug Toxicity|39
7235865|NCT00123474|11443362|FG001|As Treated at Study Closure|Study Drug Toxicity|45
7235866|NCT00123474|11443363|FG002|As Treated at Study Closure|Study Drug Toxicity|45
7235867|NCT00123474|11443364|FG003|As Treated at Study Closure|Study Drug Toxicity|51
7235868|NCT00123474|11443361|FG000|As Treated at Study Closure|Withdrawal by Subject|14
7235869|NCT00123474|11443362|FG001|As Treated at Study Closure|Withdrawal by Subject|19
7235870|NCT00123474|11443363|FG002|As Treated at Study Closure|Withdrawal by Subject|18
7235871|NCT00123474|11443364|FG003|As Treated at Study Closure|Withdrawal by Subject|16
7573739|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
7573740|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
7235872|NCT00123487|11443397|FG000|Randomized|Death prior to starting treatment|0
7235873|NCT00123487|11443398|FG001|Randomized|Death prior to starting treatment|1
7235874|NCT00123487|11443397|FG000|Randomized|SAE prior to starting treatment|1
7235875|NCT00123487|11443398|FG001|Randomized|SAE prior to starting treatment|0
7235876|NCT00123487|11443397|FG000|Treated With Study Drug|Adverse Event|23
7235877|NCT00123487|11443398|FG001|Treated With Study Drug|Adverse Event|22
7235878|NCT00123487|11443397|FG000|Treated With Study Drug|Disease Progression|141
7235879|NCT00123487|11443398|FG001|Treated With Study Drug|Disease Progression|122
7235880|NCT00123487|11443397|FG000|Treated With Study Drug|Physician Decision|8
7235881|NCT00123487|11443398|FG001|Treated With Study Drug|Physician Decision|9
7235882|NCT00123487|11443397|FG000|Treated With Study Drug|Other|59
7235883|NCT00123487|11443398|FG001|Treated With Study Drug|Other|58
7235884|NCT00123487|11443397|FG000|Treated With Study Drug|Study Drug Toxicity|62
7235885|NCT00123487|11443398|FG001|Treated With Study Drug|Study Drug Toxicity|80
7235886|NCT00123487|11443397|FG000|Treated With Study Drug|Withdrawal by Subject|11
7235887|NCT00123487|11443398|FG001|Treated With Study Drug|Withdrawal by Subject|13
7235888|NCT00123487|11443397|FG000|Treated With Study Drug|Unknown (case report form lost)|0
7235889|NCT00123487|11443398|FG001|Treated With Study Drug|Unknown (case report form lost)|1
7235890|NCT00123734|11443453|FG000|Overall Study|Death|3
7235891|NCT00123734|11443453|FG000|Overall Study|Lost to Follow-up|3
7235892|NCT00123734|11443453|FG000|Overall Study|Dropout|1
7235893|NCT00123734|11443453|FG000|Overall Study|Withdrawal by Subject|1
7235894|NCT00123955|11443462|FG000|Overall Study|Adverse Event|1
7235895|NCT00123955|11443463|FG001|Overall Study|Adverse Event|0
7235896|NCT00123955|11443462|FG000|Overall Study|Withdrawal by Subject|4
7235897|NCT00123955|11443463|FG001|Overall Study|Withdrawal by Subject|3
7235898|NCT00123955|11443462|FG000|Overall Study|Death|0
7235899|NCT00123955|11443463|FG001|Overall Study|Death|1
7255668|NCT00320112|11467244|FG001|Overall Study|Lost to Follow-up|4
7255669|NCT00320112|11467243|FG000|Overall Study|Withdrawal by Subject|3
7255670|NCT00320112|11467244|FG001|Overall Study|Withdrawal by Subject|0
7255671|NCT00320112|11467243|FG000|Overall Study|Death|2
7255672|NCT00320112|11467244|FG001|Overall Study|Death|1
7255673|NCT00320190|11467258|FG000|First 12 Months|Completed but did not enter extension|5
7255674|NCT00320190|11467259|FG001|First 12 Months|Completed but did not enter extension|3
7255675|NCT00320190|11467258|FG000|First 12 Months|Sponsor terminated study|2
7255676|NCT00320190|11467259|FG001|First 12 Months|Sponsor terminated study|2
7255677|NCT00320190|11467258|FG000|First 12 Months|Lost to Follow-up|0
7255678|NCT00320190|11467259|FG001|First 12 Months|Lost to Follow-up|1
7255679|NCT00320190|11467258|FG000|First 12 Months|Enrollment failure|0
7255680|NCT00320190|11467259|FG001|First 12 Months|Enrollment failure|1
7255681|NCT00320190|11467258|FG000|First 12 Months|Adverse event unrelated to study drug|1
7255682|NCT00320190|11467259|FG001|First 12 Months|Adverse event unrelated to study drug|0
7255683|NCT00320190|11467258|FG000|First 12 Months|Investigator request|0
7255684|NCT00320190|11467259|FG001|First 12 Months|Investigator request|1
7255685|NCT00320190|11467258|FG000|First 12 Months|Study drug toxicity|0
7255686|NCT00320190|11467259|FG001|First 12 Months|Study drug toxicity|1
7255687|NCT00320190|11467258|FG000|First 12 Months|Withdrawal by Subject|0
7255688|NCT00320190|11467259|FG001|First 12 Months|Withdrawal by Subject|1
7255689|NCT00320190|11467258|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
7255690|NCT00320190|11467259|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
7255691|NCT00320190|11467258|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
7255692|NCT00320190|11467259|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
7255693|NCT00320190|11467258|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
7255694|NCT00320190|11467259|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
7255695|NCT00320216|11467270|FG000|Overall Study|Adverse Event|0
7255696|NCT00320216|11467271|FG001|Overall Study|Adverse Event|6
7255697|NCT00320216|11467272|FG002|Overall Study|Adverse Event|0
7255698|NCT00320216|11467273|FG003|Overall Study|Adverse Event|2
7255699|NCT00320216|11467274|FG004|Overall Study|Adverse Event|2
7255700|NCT00320216|11467270|FG000|Overall Study|Lack of Efficacy|6
7255701|NCT00320216|11467271|FG001|Overall Study|Lack of Efficacy|2
7255702|NCT00320216|11467272|FG002|Overall Study|Lack of Efficacy|1
7255703|NCT00320216|11467273|FG003|Overall Study|Lack of Efficacy|0
7255704|NCT00320216|11467274|FG004|Overall Study|Lack of Efficacy|1
7255705|NCT00320216|11467270|FG000|Overall Study|Lost to Follow-up|3
7255706|NCT00320216|11467271|FG001|Overall Study|Lost to Follow-up|0
7255707|NCT00320216|11467272|FG002|Overall Study|Lost to Follow-up|0
7255708|NCT00320216|11467273|FG003|Overall Study|Lost to Follow-up|0
7255709|NCT00320216|11467274|FG004|Overall Study|Lost to Follow-up|0
7255710|NCT00320216|11467270|FG000|Overall Study|Other|7
7255711|NCT00320216|11467271|FG001|Overall Study|Other|2
7255712|NCT00320216|11467272|FG002|Overall Study|Other|5
7255713|NCT00320216|11467273|FG003|Overall Study|Other|1
7255714|NCT00320216|11467274|FG004|Overall Study|Other|3
7255715|NCT00320255|11467305|FG000|Overall Study|Lack of Efficacy|1
7255716|NCT00320255|11467306|FG001|Overall Study|Lack of Efficacy|0
7255717|NCT00320255|11467307|FG002|Overall Study|Lack of Efficacy|0
7255718|NCT00320255|11467308|FG003|Overall Study|Lack of Efficacy|0
7255719|NCT00320255|11467309|FG004|Overall Study|Lack of Efficacy|0
7255720|NCT00320255|11467310|FG005|Overall Study|Lack of Efficacy|0
7255721|NCT00320255|11467305|FG000|Overall Study|Adverse Event|5
7255722|NCT00320255|11467306|FG001|Overall Study|Adverse Event|2
7255723|NCT00320255|11467307|FG002|Overall Study|Adverse Event|3
7255724|NCT00320255|11467308|FG003|Overall Study|Adverse Event|2
7255725|NCT00320255|11467309|FG004|Overall Study|Adverse Event|0
7255726|NCT00320255|11467310|FG005|Overall Study|Adverse Event|0
7255727|NCT00320255|11467305|FG000|Overall Study|Withdrawal by Subject|1
7235900|NCT00124020|11443471|FG000|Overall Study|Death|67
7235901|NCT00124020|11443472|FG001|Overall Study|Death|71
7235902|NCT00124020|11443471|FG000|Overall Study|Withdrawal by Subject|13
7235903|NCT00124020|11443472|FG001|Overall Study|Withdrawal by Subject|11
7235904|NCT00124020|11443471|FG000|Overall Study|Lost to Follow-up|5
7235905|NCT00124020|11443472|FG001|Overall Study|Lost to Follow-up|8
7235906|NCT00124020|11443471|FG000|Overall Study|Other|1
7235907|NCT00124020|11443472|FG001|Overall Study|Other|1
7235908|NCT00124020|11443471|FG000|Overall Study|Transfer to another hospital|2
7235909|NCT00124020|11443472|FG001|Overall Study|Transfer to another hospital|0
7235910|NCT00124072|11443482|FG000|Overall Study|Lost to Follow-up for Mortality|0
7235911|NCT00124072|11443483|FG001|Overall Study|Lost to Follow-up for Mortality|3
7235912|NCT00124072|11443484|FG002|Overall Study|Lost to Follow-up for Mortality|2
7235913|NCT00124072|11443485|FG003|Overall Study|Lost to Follow-up for Mortality|2
7235914|NCT00124072|11443482|FG000|Overall Study|Lost to Follow-up for Morbidity|15
7235915|NCT00124072|11443483|FG001|Overall Study|Lost to Follow-up for Morbidity|25
7235916|NCT00124072|11443484|FG002|Overall Study|Lost to Follow-up for Morbidity|19
7235917|NCT00124072|11443485|FG003|Overall Study|Lost to Follow-up for Morbidity|18
7235918|NCT00124072|11443482|FG000|Overall Study|Death|499
7235919|NCT00124072|11443483|FG001|Overall Study|Death|484
7235920|NCT00124072|11443484|FG002|Overall Study|Death|471
7235921|NCT00124072|11443485|FG003|Overall Study|Death|480
7235922|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
7235923|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
7235924|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
7235925|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
7235926|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7235927|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
7235928|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
7235929|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
7235930|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
7235931|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
7235932|NCT00124449|11443506|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
7235933|NCT00124449|11443507|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
7235934|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Adverse Event|0
7235935|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Adverse Event|1
7235936|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
7235937|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
7235938|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
7235939|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
7235940|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Pregnancy|1
7235941|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Pregnancy|0
7235942|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
7235943|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
7235944|NCT00124449|11443506|FG000|18-Month Untreated Observation Period|Relocated|1
7235945|NCT00124449|11443507|FG001|18-Month Untreated Observation Period|Relocated|0
7235946|NCT00124462|11443516|FG000|Overall Study|Lost to Follow-up|3
7235947|NCT00124462|11443517|FG001|Overall Study|Lost to Follow-up|3
7235948|NCT00124462|11443516|FG000|Overall Study|Physician Decision|3
7235949|NCT00124462|11443517|FG001|Overall Study|Physician Decision|4
7235950|NCT00124462|11443516|FG000|Overall Study|Withdrawal by Subject|4
7235951|NCT00124462|11443517|FG001|Overall Study|Withdrawal by Subject|5
7235952|NCT00124462|11443516|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
7235953|NCT00124462|11443517|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
7235954|NCT00124618|11443544|FG000|Overall Study|Ineligible|1
7235955|NCT00124657|11443551|FG000|Overall Study|Toxicity|0
7235956|NCT00124657|11443552|FG001|Overall Study|Toxicity|0
7235957|NCT00124657|11443553|FG002|Overall Study|Toxicity|1
7235958|NCT00124657|11443551|FG000|Overall Study|Non-compliance|1
7235959|NCT00124657|11443552|FG001|Overall Study|Non-compliance|0
7235960|NCT00124657|11443553|FG002|Overall Study|Non-compliance|4
7235961|NCT00124657|11443551|FG000|Overall Study|Progressive disease|14
7235962|NCT00124657|11443552|FG001|Overall Study|Progressive disease|5
7235963|NCT00124657|11443553|FG002|Overall Study|Progressive disease|27
7573741|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7573742|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7573743|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
7573744|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
7573745|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
7573746|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7573747|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
7573748|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
7573749|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
7573750|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
7573751|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7575390|NCT03736967|11959084|FG003|Overall Study|Lost to Follow-up|1
7573752|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
7573753|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
7573754|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
7235964|NCT00124657|11443551|FG000|Overall Study|Intercurrent illness|1
7235965|NCT00124657|11443552|FG001|Overall Study|Intercurrent illness|0
7235966|NCT00124657|11443553|FG002|Overall Study|Intercurrent illness|0
7235967|NCT00124709|11443576|FG000|Overall Study|Randomized but did not take medication|3
7235968|NCT00124709|11443577|FG001|Overall Study|Randomized but did not take medication|1
7235969|NCT00124709|11443576|FG000|Overall Study|Adverse Event|3
7235970|NCT00124709|11443577|FG001|Overall Study|Adverse Event|0
7235971|NCT00124709|11443576|FG000|Overall Study|Lack of Efficacy|5
7235972|NCT00124709|11443577|FG001|Overall Study|Lack of Efficacy|10
7235973|NCT00124709|11443576|FG000|Overall Study|Protocol Violation|3
7235974|NCT00124709|11443577|FG001|Overall Study|Protocol Violation|5
7235975|NCT00124709|11443576|FG000|Overall Study|Withdrawal by Subject|127
7235976|NCT00124709|11443577|FG001|Overall Study|Withdrawal by Subject|136
7235977|NCT00124709|11443576|FG000|Overall Study|Lost to Follow-up|114
7235978|NCT00124709|11443577|FG001|Overall Study|Lost to Follow-up|120
7235979|NCT00124748|11443618|FG000|Overall Study|Adverse Event|8
7235980|NCT00124748|11443619|FG001|Overall Study|Adverse Event|39
7235981|NCT00124748|11443618|FG000|Overall Study|Abnormal laboratory Value|2
7235982|NCT00124748|11443619|FG001|Overall Study|Abnormal laboratory Value|2
7235983|NCT00124748|11443618|FG000|Overall Study|Abnormal Procedure|0
7235984|NCT00124748|11443619|FG001|Overall Study|Abnormal Procedure|1
7235985|NCT00124748|11443618|FG000|Overall Study|Lack of Efficacy|20
7235986|NCT00124748|11443619|FG001|Overall Study|Lack of Efficacy|41
7235987|NCT00124748|11443618|FG000|Overall Study|No longer requires study drug|1
7235988|NCT00124748|11443619|FG001|Overall Study|No longer requires study drug|1
7235989|NCT00124748|11443618|FG000|Overall Study|Protocol Violation|3
7235990|NCT00124748|11443619|FG001|Overall Study|Protocol Violation|1
7235991|NCT00124748|11443618|FG000|Overall Study|Withdrawal by Subject|5
7235992|NCT00124748|11443619|FG001|Overall Study|Withdrawal by Subject|15
7235993|NCT00124748|11443618|FG000|Overall Study|Lost to Follow-up|2
7235994|NCT00124748|11443619|FG001|Overall Study|Lost to Follow-up|7
7235995|NCT00124748|11443618|FG000|Overall Study|Administrative Problem(Study Terminated)|101
7235996|NCT00124748|11443619|FG001|Overall Study|Administrative Problem(Study Terminated)|174
7235997|NCT00124748|11443618|FG000|Overall Study|Death|1
7235998|NCT00124748|11443619|FG001|Overall Study|Death|3
7235999|NCT00124917|11443625|FG000|Overall Study|Physician Decision|3
7236000|NCT00124943|11443634|FG000|Phase II|Adverse Event|0
7236001|NCT00124943|11443635|FG001|Phase II|Adverse Event|2
7236002|NCT00124943|11443636|FG002|Phase II|Adverse Event|0
7236003|NCT00124943|11443637|FG003|Phase II|Adverse Event|1
7236004|NCT00124943|11443634|FG000|Phase II|Protocol Violation|0
7236005|NCT00124943|11443635|FG001|Phase II|Protocol Violation|0
7236006|NCT00124943|11443636|FG002|Phase II|Protocol Violation|0
7236007|NCT00124943|11443637|FG003|Phase II|Protocol Violation|1
7236008|NCT00124943|11443634|FG000|Phase II|Lost to Follow-up|0
7236009|NCT00124943|11443635|FG001|Phase II|Lost to Follow-up|0
7236010|NCT00124943|11443636|FG002|Phase II|Lost to Follow-up|0
7236011|NCT00124943|11443637|FG003|Phase II|Lost to Follow-up|1
7236012|NCT00124943|11443634|FG000|Phase II|Withdrawal by Subject|0
7236013|NCT00124943|11443635|FG001|Phase II|Withdrawal by Subject|0
7236014|NCT00124943|11443636|FG002|Phase II|Withdrawal by Subject|0
7236015|NCT00124943|11443637|FG003|Phase II|Withdrawal by Subject|2
7236016|NCT00124982|11443649|FG000|Short-term Period|Death|1
7236017|NCT00124982|11443650|FG001|Short-term Period|Death|1
7236018|NCT00124982|11443651|FG002|Short-term Period|Death|0
7236019|NCT00124982|11443649|FG000|Short-term Period|Adverse Event|17
7236020|NCT00124982|11443650|FG001|Short-term Period|Adverse Event|22
7236021|NCT00124982|11443651|FG002|Short-term Period|Adverse Event|0
7236022|NCT00124982|11443649|FG000|Short-term Period|Lack of Efficacy|32
7236023|NCT00124982|11443650|FG001|Short-term Period|Lack of Efficacy|73
7236024|NCT00124982|11443651|FG002|Short-term Period|Lack of Efficacy|0
7236025|NCT00124982|11443649|FG000|Short-term Period|Lost to Follow-up|8
7236026|NCT00124982|11443650|FG001|Short-term Period|Lost to Follow-up|5
7236027|NCT00124982|11443651|FG002|Short-term Period|Lost to Follow-up|0
7236028|NCT00124982|11443649|FG000|Short-term Period|Withdrawal of Consent|7
7236029|NCT00124982|11443650|FG001|Short-term Period|Withdrawal of Consent|9
7236030|NCT00124982|11443651|FG002|Short-term Period|Withdrawal of Consent|0
7236031|NCT00124982|11443649|FG000|Short-term Period|Poor/Non-compliance|3
7236032|NCT00124982|11443650|FG001|Short-term Period|Poor/Non-compliance|1
7236033|NCT00124982|11443651|FG002|Short-term Period|Poor/Non-compliance|0
7236034|NCT00124982|11443649|FG000|Short-term Period|No Longer Meets Study Criteria|1
7236035|NCT00124982|11443650|FG001|Short-term Period|No Longer Meets Study Criteria|2
7236036|NCT00124982|11443651|FG002|Short-term Period|No Longer Meets Study Criteria|0
7236037|NCT00124982|11443649|FG000|Short-term Period|Participant Decision|1
7236038|NCT00124982|11443650|FG001|Short-term Period|Participant Decision|0
7236039|NCT00124982|11443651|FG002|Short-term Period|Participant Decision|0
7236040|NCT00124982|11443649|FG000|Short-term Period|Participant Chose Own Doctor|0
7236041|NCT00124982|11443650|FG001|Short-term Period|Participant Chose Own Doctor|1
7236042|NCT00124982|11443651|FG002|Short-term Period|Participant Chose Own Doctor|0
7236043|NCT00124982|11443649|FG000|Short-term Period|Investigator Decision-No Specific AE|1
7236044|NCT00124982|11443650|FG001|Short-term Period|Investigator Decision-No Specific AE|0
7236045|NCT00124982|11443651|FG002|Short-term Period|Investigator Decision-No Specific AE|0
7236046|NCT00124982|11443649|FG000|Short-term Period|Participant Had Lymphopenia|1
7236047|NCT00124982|11443650|FG001|Short-term Period|Participant Had Lymphopenia|0
7236048|NCT00124982|11443651|FG002|Short-term Period|Participant Had Lymphopenia|0
7236049|NCT00124982|11443649|FG000|Long-term Period|Death|0
7236050|NCT00124982|11443650|FG001|Long-term Period|Death|0
7236051|NCT00124982|11443651|FG002|Long-term Period|Death|1
7236052|NCT00124982|11443649|FG000|Long-term Period|Adverse Event|0
7236053|NCT00124982|11443650|FG001|Long-term Period|Adverse Event|0
7236054|NCT00124982|11443651|FG002|Long-term Period|Adverse Event|17
7236055|NCT00124982|11443649|FG000|Long-term Period|Lack of Efficacy|0
7236056|NCT00124982|11443650|FG001|Long-term Period|Lack of Efficacy|0
7236057|NCT00124982|11443651|FG002|Long-term Period|Lack of Efficacy|46
7236058|NCT00124982|11443649|FG000|Long-term Period|Lost to Follow-up|0
7236059|NCT00124982|11443650|FG001|Long-term Period|Lost to Follow-up|0
7236060|NCT00124982|11443651|FG002|Long-term Period|Lost to Follow-up|4
7236061|NCT00124982|11443649|FG000|Long-term Period|Withdrawal by Subject|0
7236062|NCT00124982|11443650|FG001|Long-term Period|Withdrawal by Subject|0
7236063|NCT00124982|11443651|FG002|Long-term Period|Withdrawal by Subject|16
7236064|NCT00124982|11443649|FG000|Long-term Period|Pregnancy|0
7236065|NCT00124982|11443650|FG001|Long-term Period|Pregnancy|0
7236066|NCT00124982|11443651|FG002|Long-term Period|Pregnancy|1
7236067|NCT00124982|11443649|FG000|Long-term Period|Poor/Non-compliance|0
7236068|NCT00124982|11443650|FG001|Long-term Period|Poor/Non-compliance|0
7236069|NCT00124982|11443651|FG002|Long-term Period|Poor/Non-compliance|2
7236070|NCT00124982|11443649|FG000|Long-term Period|Administrative Reason by Sponsor|0
7236071|NCT00124982|11443650|FG001|Long-term Period|Administrative Reason by Sponsor|0
7236072|NCT00124982|11443651|FG002|Long-term Period|Administrative Reason by Sponsor|1
7236073|NCT00124982|11443649|FG000|Long-term Period|Neurologist Recommendation|0
7236074|NCT00124982|11443650|FG001|Long-term Period|Neurologist Recommendation|0
7236075|NCT00124982|11443651|FG002|Long-term Period|Neurologist Recommendation|1
7236076|NCT00125138|11443673|FG000|Overall Study|Adverse Event|1
7236077|NCT00125138|11443674|FG001|Overall Study|Adverse Event|0
7236078|NCT00125138|11443675|FG002|Overall Study|Adverse Event|3
7236079|NCT00125138|11443676|FG003|Overall Study|Adverse Event|2
7236080|NCT00125138|11443673|FG000|Overall Study|Withdrawal by Subject|2
7236081|NCT00125138|11443674|FG001|Overall Study|Withdrawal by Subject|3
7236082|NCT00125138|11443675|FG002|Overall Study|Withdrawal by Subject|1
7236083|NCT00125138|11443676|FG003|Overall Study|Withdrawal by Subject|1
7236084|NCT00125138|11443673|FG000|Overall Study|Lack of Efficacy|0
7236085|NCT00125138|11443674|FG001|Overall Study|Lack of Efficacy|0
7236086|NCT00125138|11443675|FG002|Overall Study|Lack of Efficacy|0
7236087|NCT00125138|11443676|FG003|Overall Study|Lack of Efficacy|1
7236088|NCT00125138|11443673|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
7236089|NCT00125138|11443674|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
7236090|NCT00125138|11443675|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
7236091|NCT00125138|11443676|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
7236092|NCT00125164|11443690|FG000|Overall Study|Adverse Event|0
7236093|NCT00125164|11443691|FG001|Overall Study|Adverse Event|0
7236094|NCT00125164|11443692|FG002|Overall Study|Adverse Event|2
7236095|NCT00125164|11443693|FG003|Overall Study|Adverse Event|4
7236096|NCT00125164|11443690|FG000|Overall Study|Lost to Follow-up|0
7236097|NCT00125164|11443691|FG001|Overall Study|Lost to Follow-up|0
7236098|NCT00125164|11443692|FG002|Overall Study|Lost to Follow-up|1
7236099|NCT00125164|11443693|FG003|Overall Study|Lost to Follow-up|1
7236100|NCT00125164|11443690|FG000|Overall Study|Withdrawal by Subject|2
7236101|NCT00125164|11443691|FG001|Overall Study|Withdrawal by Subject|0
7236102|NCT00125164|11443692|FG002|Overall Study|Withdrawal by Subject|1
7236103|NCT00125164|11443693|FG003|Overall Study|Withdrawal by Subject|1
7236104|NCT00125190|11443703|FG000|Overall Study|Subject/Parent Decision|7
7236105|NCT00125190|11443703|FG000|Overall Study|Non-compliance|2
7236106|NCT00125190|11443703|FG000|Overall Study|Adverse Event|1
7236107|NCT00125190|11443703|FG000|Overall Study|Other|1
7236108|NCT00125190|11443703|FG000|Overall Study|Lost to Follow-up|4
7236109|NCT00125242|11443710|FG000|Overall Study|did not qualify|7
7236110|NCT00125242|11443711|FG001|Overall Study|did not qualify|2
7236111|NCT00125359|11443716|FG000|Overall Study|Death|4
7236112|NCT00125359|11443716|FG000|Overall Study|Adverse Event|5
7236113|NCT00125359|11443716|FG000|Overall Study|Physician Decision|14
7236114|NCT00125853|11443789|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
7236115|NCT00125853|11443790|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
7236116|NCT00126126|11443820|FG000|Overall Study|Lost to Follow-up|0
7236117|NCT00126126|11443821|FG001|Overall Study|Lost to Follow-up|2
7236118|NCT00126191|11443829|FG000|Overall Study|Physician Decision|0
7236119|NCT00126191|11443830|FG001|Overall Study|Physician Decision|1
7236120|NCT00126191|11443829|FG000|Overall Study|Death|0
7236121|NCT00126191|11443830|FG001|Overall Study|Death|1
7236122|NCT00126425|11443838|FG000|Overall Study|Withdrawal by Subject|17
7236123|NCT00126425|11443839|FG001|Overall Study|Withdrawal by Subject|1
7236124|NCT00126425|11443838|FG000|Overall Study|Lost to Follow-up|8
7236125|NCT00126425|11443839|FG001|Overall Study|Lost to Follow-up|4
7236126|NCT00126425|11443838|FG000|Overall Study|Protocol Violation|9
7236127|NCT00126425|11443839|FG001|Overall Study|Protocol Violation|6
7236128|NCT00126425|11443838|FG000|Overall Study|Adverse Event|1
7236129|NCT00126425|11443839|FG001|Overall Study|Adverse Event|0
7236130|NCT00126425|11443838|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
7236131|NCT00126425|11443839|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
7236132|NCT00126425|11443838|FG000|Overall Study|Other|5
7236133|NCT00126425|11443839|FG001|Overall Study|Other|0
7236134|NCT00126438|11443847|FG000|Overall Study|Withdrawal due to adverse event|1
7236135|NCT00126438|11443848|FG001|Overall Study|Withdrawal due to adverse event|0
7236136|NCT00126438|11443847|FG000|Overall Study|Lost to Follow-up|22
7236137|NCT00126438|11443848|FG001|Overall Study|Lost to Follow-up|0
7236138|NCT00126438|11443847|FG000|Overall Study|Protocol Violation|8
7236139|NCT00126438|11443848|FG001|Overall Study|Protocol Violation|8
7236140|NCT00126438|11443847|FG000|Overall Study|Withdrawal by Subject|3
7236141|NCT00126438|11443848|FG001|Overall Study|Withdrawal by Subject|2
7236142|NCT00126490|11443854|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
7236143|NCT00126503|11443860|FG000|Overall Study|disease progression|23
7236144|NCT00126503|11443861|FG001|Overall Study|disease progression|14
7236145|NCT00126503|11443860|FG000|Overall Study|Withdrawal by Subject|0
7236146|NCT00126503|11443861|FG001|Overall Study|Withdrawal by Subject|1
7236147|NCT00126503|11443860|FG000|Overall Study|alternative therapy|1
7236148|NCT00126503|11443861|FG001|Overall Study|alternative therapy|1
7236149|NCT00126503|11443860|FG000|Overall Study|other complicating disease|4
7236150|NCT00126503|11443861|FG001|Overall Study|other complicating disease|1
7236151|NCT00126503|11443860|FG000|Overall Study|Death|3
7236152|NCT00126503|11443861|FG001|Overall Study|Death|0
7236153|NCT00126503|11443860|FG000|Overall Study|Adverse Event|13
7236154|NCT00126503|11443861|FG001|Overall Study|Adverse Event|3
7236155|NCT00126503|11443860|FG000|Overall Study|non-compliant|1
7236156|NCT00126503|11443861|FG001|Overall Study|non-compliant|0
7236157|NCT00126503|11443860|FG000|Overall Study|Physician Decision|2
7236158|NCT00126503|11443861|FG001|Overall Study|Physician Decision|1
7236159|NCT00126555|11443871|FG000|Overall Study|Withdrawal by Subject|1
7236160|NCT00126555|11443871|FG000|Overall Study|Adverse Event|2
7236161|NCT00126555|11443871|FG000|Overall Study|Progressive Disease|3
7236162|NCT00126568|11443887|FG000|Overall Study|Death|2
7236163|NCT00126581|11443894|FG000|Overall Study|Adverse Event|3
7236164|NCT00126581|11443895|FG001|Overall Study|Adverse Event|7
7236165|NCT00126581|11443894|FG000|Overall Study|Death|3
7236166|NCT00126581|11443895|FG001|Overall Study|Death|2
7236167|NCT00126581|11443894|FG000|Overall Study|Withdrawal by Subject|1
7236168|NCT00126581|11443895|FG001|Overall Study|Withdrawal by Subject|4
7236169|NCT00126581|11443894|FG000|Overall Study|Alternative therapy|3
7236170|NCT00126581|11443895|FG001|Overall Study|Alternative therapy|3
7236171|NCT00126581|11443894|FG000|Overall Study|Other illness/MD discretion|3
7236172|NCT00126581|11443895|FG001|Overall Study|Other illness/MD discretion|4
7236173|NCT00126594|11443905|FG000|Overall Study|Ineligible|2
7236174|NCT00126594|11443906|FG001|Overall Study|Ineligible|0
7236175|NCT00126594|11443905|FG000|Overall Study|Withdrawal by Subject|0
7236176|NCT00126594|11443906|FG001|Overall Study|Withdrawal by Subject|4
7236177|NCT00126594|11443905|FG000|Overall Study|Physician Decision|1
7236178|NCT00126594|11443906|FG001|Overall Study|Physician Decision|3
7236179|NCT00126594|11443905|FG000|Overall Study|Adverse Event|7
7236180|NCT00126594|11443906|FG001|Overall Study|Adverse Event|5
7236181|NCT00126594|11443905|FG000|Overall Study|Non-compliance|0
7236182|NCT00126594|11443906|FG001|Overall Study|Non-compliance|1
7236183|NCT00126594|11443905|FG000|Overall Study|Disease Progression|29
7236184|NCT00126594|11443906|FG001|Overall Study|Disease Progression|24
7236185|NCT00127036|11443944|FG000|Overall Study|Insufficient Data for Analysis|6
7236186|NCT00127036|11443945|FG001|Overall Study|Insufficient Data for Analysis|11
7236187|NCT00127036|11443944|FG000|Overall Study|Screen Failure|2
7236188|NCT00127036|11443945|FG001|Overall Study|Screen Failure|0
7236189|NCT00127101|11443970|FG000|Base Protocol|Adverse Event|0
7236190|NCT00127101|11443971|FG001|Base Protocol|Adverse Event|2
7236191|NCT00127101|11443972|FG002|Base Protocol|Adverse Event|1
7236192|NCT00127101|11443973|FG003|Base Protocol|Adverse Event|0
7236193|NCT00127101|11443974|FG004|Base Protocol|Adverse Event|0
7236194|NCT00127101|11443975|FG005|Base Protocol|Adverse Event|0
7236195|NCT00127101|11443970|FG000|Base Protocol|Lack of Efficacy|1
7236196|NCT00127101|11443971|FG001|Base Protocol|Lack of Efficacy|0
7575391|NCT03736967|11959081|FG000|Overall Study|Physician Decision|1
7236197|NCT00127101|11443972|FG002|Base Protocol|Lack of Efficacy|0
7236198|NCT00127101|11443973|FG003|Base Protocol|Lack of Efficacy|0
7236199|NCT00127101|11443974|FG004|Base Protocol|Lack of Efficacy|2
7236200|NCT00127101|11443975|FG005|Base Protocol|Lack of Efficacy|0
7236201|NCT00127101|11443970|FG000|Base Protocol|Withdrawal by Subject|1
7236202|NCT00127101|11443971|FG001|Base Protocol|Withdrawal by Subject|2
7236203|NCT00127101|11443972|FG002|Base Protocol|Withdrawal by Subject|1
7236204|NCT00127101|11443973|FG003|Base Protocol|Withdrawal by Subject|0
7236205|NCT00127101|11443974|FG004|Base Protocol|Withdrawal by Subject|0
7236206|NCT00127101|11443975|FG005|Base Protocol|Withdrawal by Subject|1
7236207|NCT00127101|11443970|FG000|Continuation Phase|Adverse Event|0
7236208|NCT00127101|11443971|FG001|Continuation Phase|Adverse Event|0
7236209|NCT00127101|11443972|FG002|Continuation Phase|Adverse Event|0
7236210|NCT00127101|11443973|FG003|Continuation Phase|Adverse Event|0
7236211|NCT00127101|11443974|FG004|Continuation Phase|Adverse Event|1
7236212|NCT00127101|11443975|FG005|Continuation Phase|Adverse Event|1
7236213|NCT00127101|11443970|FG000|Continuation Phase|Lack of Efficacy|0
7236214|NCT00127101|11443971|FG001|Continuation Phase|Lack of Efficacy|0
7236215|NCT00127101|11443972|FG002|Continuation Phase|Lack of Efficacy|0
7236216|NCT00127101|11443973|FG003|Continuation Phase|Lack of Efficacy|0
7236217|NCT00127101|11443974|FG004|Continuation Phase|Lack of Efficacy|0
7236218|NCT00127101|11443975|FG005|Continuation Phase|Lack of Efficacy|1
7236219|NCT00127101|11443970|FG000|Continuation Phase|Withdrawal by Subject|0
7236220|NCT00127101|11443971|FG001|Continuation Phase|Withdrawal by Subject|0
7236221|NCT00127101|11443972|FG002|Continuation Phase|Withdrawal by Subject|1
7236222|NCT00127101|11443973|FG003|Continuation Phase|Withdrawal by Subject|0
7236223|NCT00127101|11443974|FG004|Continuation Phase|Withdrawal by Subject|2
7236224|NCT00127101|11443975|FG005|Continuation Phase|Withdrawal by Subject|1
7236225|NCT00127166|11443991|FG000|Period I|Protocol Violation|0
7236226|NCT00127166|11443992|FG001|Period I|Protocol Violation|2
7236227|NCT00127166|11443991|FG000|Period I|Withdrawal by Subject|2
7236228|NCT00127166|11443992|FG001|Period I|Withdrawal by Subject|0
7236229|NCT00127166|11443991|FG000|Period I|Patient did not meet inclusion criteria|1
7236230|NCT00127166|11443992|FG001|Period I|Patient did not meet inclusion criteria|0
7236231|NCT00127166|11443991|FG000|Washout Period|Patient did not meet inclusion criteria|0
7236232|NCT00127166|11443992|FG001|Washout Period|Patient did not meet inclusion criteria|1
7236233|NCT00127166|11443991|FG000|Period II|Withdrawal by Subject|2
7236234|NCT00127166|11443992|FG001|Period II|Withdrawal by Subject|0
7236235|NCT00127166|11443991|FG000|Period II|Patient did not perform Visit 6 exercise|1
7236236|NCT00127166|11443992|FG001|Period II|Patient did not perform Visit 6 exercise|0
7236237|NCT00127192|11444003|FG000|Overall Study|Adverse Event|0
7236238|NCT00127192|11444004|FG001|Overall Study|Adverse Event|1
7236239|NCT00127192|11444005|FG002|Overall Study|Adverse Event|1
7236240|NCT00127192|11444006|FG003|Overall Study|Adverse Event|1
7236241|NCT00127192|11444007|FG004|Overall Study|Adverse Event|0
7236242|NCT00127192|11444003|FG000|Overall Study|Lack of Efficacy|2
7236243|NCT00127192|11444004|FG001|Overall Study|Lack of Efficacy|0
7236244|NCT00127192|11444005|FG002|Overall Study|Lack of Efficacy|0
7236245|NCT00127192|11444006|FG003|Overall Study|Lack of Efficacy|0
7236246|NCT00127192|11444007|FG004|Overall Study|Lack of Efficacy|2
7236247|NCT00127192|11444003|FG000|Overall Study|Withdrawal by Subject|0
7236248|NCT00127192|11444004|FG001|Overall Study|Withdrawal by Subject|0
7236249|NCT00127192|11444005|FG002|Overall Study|Withdrawal by Subject|1
7236250|NCT00127192|11444006|FG003|Overall Study|Withdrawal by Subject|0
7236251|NCT00127192|11444007|FG004|Overall Study|Withdrawal by Subject|3
7236252|NCT00127192|11444003|FG000|Overall Study|Adverse event in pre-treatment period|1
7236253|NCT00127192|11444004|FG001|Overall Study|Adverse event in pre-treatment period|0
7236254|NCT00127192|11444005|FG002|Overall Study|Adverse event in pre-treatment period|0
7236255|NCT00127192|11444006|FG003|Overall Study|Adverse event in pre-treatment period|0
7236256|NCT00127192|11444007|FG004|Overall Study|Adverse event in pre-treatment period|0
7236257|NCT00127205|11444022|FG000|Overall Study|Adverse Event|228
7236258|NCT00127205|11444023|FG001|Overall Study|Adverse Event|387
7236259|NCT00127205|11444024|FG002|Overall Study|Adverse Event|273
7236260|NCT00127205|11444022|FG000|Overall Study|Death|8
7236261|NCT00127205|11444023|FG001|Overall Study|Death|6
7236262|NCT00127205|11444024|FG002|Overall Study|Death|5
7236263|NCT00127205|11444022|FG000|Overall Study|Withdrawal by Subject|318
7236264|NCT00127205|11444023|FG001|Overall Study|Withdrawal by Subject|310
7236265|NCT00127205|11444024|FG002|Overall Study|Withdrawal by Subject|172
7236266|NCT00127205|11444022|FG000|Overall Study|Other-non protocol specified|142
7236267|NCT00127205|11444023|FG001|Overall Study|Other-non protocol specified|129
7236268|NCT00127205|11444024|FG002|Overall Study|Other-non protocol specified|77
7236269|NCT00127205|11444022|FG000|Overall Study|Data not reported|6
7236270|NCT00127205|11444023|FG001|Overall Study|Data not reported|10
7236271|NCT00127205|11444024|FG002|Overall Study|Data not reported|1
7236272|NCT00127205|11444022|FG000|Overall Study|Progression|127
7236273|NCT00127205|11444023|FG001|Overall Study|Progression|131
7236274|NCT00127205|11444024|FG002|Overall Study|Progression|84
7236275|NCT00127413|11444058|FG000|Overall Study|Lost to Follow-up|6
7236276|NCT00127413|11444059|FG001|Overall Study|Lost to Follow-up|4
7236277|NCT00127413|11444060|FG002|Overall Study|Lost to Follow-up|8
7236278|NCT00127413|11444061|FG003|Overall Study|Lost to Follow-up|2
7236279|NCT00127608|11444092|FG000|Overall Study|VZV DNA negative|1
7236280|NCT00127660|11444100|FG000|Overall Study|Protocol Violation|3
7236281|NCT00127660|11444101|FG001|Overall Study|Protocol Violation|3
7236282|NCT00127660|11444102|FG002|Overall Study|Protocol Violation|5
7236283|NCT00127660|11444103|FG003|Overall Study|Protocol Violation|0
7236284|NCT00127712|11444115|FG000|Overall Study|Adverse Event|3
7236285|NCT00127712|11444116|FG001|Overall Study|Adverse Event|0
7236286|NCT00127712|11444115|FG000|Overall Study|Lack of GI access to continue|2
7236287|NCT00127712|11444116|FG001|Overall Study|Lack of GI access to continue|0
7236288|NCT00127803|11444143|FG000|Overall Study|Adverse Event|2
7236289|NCT00127803|11444144|FG001|Overall Study|Adverse Event|0
7236290|NCT00127803|11444145|FG002|Overall Study|Adverse Event|0
7236291|NCT00127803|11444146|FG003|Overall Study|Adverse Event|0
7236292|NCT00127803|11444143|FG000|Overall Study|Withdrawal by Subject|1
7236293|NCT00127803|11444144|FG001|Overall Study|Withdrawal by Subject|0
7236294|NCT00127803|11444145|FG002|Overall Study|Withdrawal by Subject|0
7236295|NCT00127803|11444146|FG003|Overall Study|Withdrawal by Subject|0
7236296|NCT00127803|11444143|FG000|Overall Study|Lost to Follow-up|0
7236297|NCT00127803|11444144|FG001|Overall Study|Lost to Follow-up|0
7236298|NCT00127803|11444145|FG002|Overall Study|Lost to Follow-up|0
7236299|NCT00127803|11444146|FG003|Overall Study|Lost to Follow-up|1
7236300|NCT00127842|11444156|FG000|Overall Study|Adverse Event|15
7236301|NCT00127842|11444156|FG000|Overall Study|Withdrawal by Subject|3
7236302|NCT00127842|11444156|FG000|Overall Study|Lost to Follow-up|1
7236303|NCT00127842|11444156|FG000|Overall Study|Lack of Efficacy|12
7236304|NCT00127842|11444156|FG000|Overall Study|Noncompliance|2
7236305|NCT00127842|11444156|FG000|Overall Study|Protocol Violation|1
7236306|NCT00127842|11444156|FG000|Overall Study|Other|5
7236307|NCT00127855|11444165|FG000|Primary Vaccination Course|Adverse Event|0
7236308|NCT00127855|11444166|FG001|Primary Vaccination Course|Adverse Event|0
7236309|NCT00127855|11444167|FG002|Primary Vaccination Course|Adverse Event|1
7236310|NCT00127855|11444168|FG003|Primary Vaccination Course|Adverse Event|0
7236311|NCT00127855|11444169|FG004|Primary Vaccination Course|Adverse Event|0
7236312|NCT00127855|11444165|FG000|Primary Vaccination Course|Withdrawal by Subject|1
7236313|NCT00127855|11444166|FG001|Primary Vaccination Course|Withdrawal by Subject|0
7236314|NCT00127855|11444167|FG002|Primary Vaccination Course|Withdrawal by Subject|0
7236315|NCT00127855|11444168|FG003|Primary Vaccination Course|Withdrawal by Subject|0
7236316|NCT00127855|11444169|FG004|Primary Vaccination Course|Withdrawal by Subject|1
7236317|NCT00127855|11444165|FG000|Primary Vaccination Course|Lost to Follow-up|1
7236318|NCT00127855|11444166|FG001|Primary Vaccination Course|Lost to Follow-up|1
7236319|NCT00127855|11444167|FG002|Primary Vaccination Course|Lost to Follow-up|1
7236320|NCT00127855|11444168|FG003|Primary Vaccination Course|Lost to Follow-up|0
7236321|NCT00127855|11444169|FG004|Primary Vaccination Course|Lost to Follow-up|2
7236322|NCT00127855|11444165|FG000|Primary Vaccination Course|Other|0
7236323|NCT00127855|11444166|FG001|Primary Vaccination Course|Other|0
7236324|NCT00127855|11444167|FG002|Primary Vaccination Course|Other|0
7236325|NCT00127855|11444168|FG003|Primary Vaccination Course|Other|0
7236326|NCT00127855|11444169|FG004|Primary Vaccination Course|Other|1
7236327|NCT00127933|11444183|FG000|Overall Study|Randomized but not dosed|1
7236328|NCT00127933|11444184|FG001|Overall Study|Randomized but not dosed|0
7236329|NCT00128102|11444192|FG000|Overall Study|Site Discontinued|3
7236330|NCT00128102|11444193|FG001|Overall Study|Site Discontinued|6
7236331|NCT00128102|11444192|FG000|Overall Study|Other|0
7236332|NCT00128102|11444193|FG001|Overall Study|Other|1
7236333|NCT00128102|11444192|FG000|Overall Study|Progressive Disease|255
7236334|NCT00128102|11444193|FG001|Overall Study|Progressive Disease|285
7236335|NCT00128102|11444192|FG000|Overall Study|Adverse Event|34
7236336|NCT00128102|11444193|FG001|Overall Study|Adverse Event|11
7236337|NCT00128102|11444192|FG000|Overall Study|Death|12
7236338|NCT00128102|11444193|FG001|Overall Study|Death|13
7236339|NCT00128102|11444192|FG000|Overall Study|Physician Decision|3
7236340|NCT00128102|11444193|FG001|Overall Study|Physician Decision|3
7236341|NCT00128102|11444192|FG000|Overall Study|Withdrawal by Subject|19
7236342|NCT00128102|11444193|FG001|Overall Study|Withdrawal by Subject|11
7236343|NCT00128102|11444192|FG000|Overall Study|Protocol Violation|2
7236344|NCT00128102|11444193|FG001|Overall Study|Protocol Violation|2
7236345|NCT00128206|11444313|FG000|Overall Study|Lost to Follow-up|137
7236346|NCT00128206|11444314|FG001|Overall Study|Lost to Follow-up|118
7236347|NCT00128206|11444313|FG000|Overall Study|Adverse Event|0
7236348|NCT00128206|11444314|FG001|Overall Study|Adverse Event|2
7236349|NCT00128492|11444341|FG000|Overall Study|AE unrelated to study|2
7236350|NCT00128492|11444342|FG001|Overall Study|AE unrelated to study|9
7236351|NCT00128492|11444341|FG000|Overall Study|Study drug intolerance (AE)|2
7236352|NCT00128492|11444342|FG001|Overall Study|Study drug intolerance (AE)|8
7236353|NCT00128492|11444341|FG000|Overall Study|AE related to study|1
7236354|NCT00128492|11444342|FG001|Overall Study|AE related to study|4
7236355|NCT00128492|11444341|FG000|Overall Study|Death|1
7236356|NCT00128492|11444342|FG001|Overall Study|Death|0
7236357|NCT00128492|11444341|FG000|Overall Study|Lost to Follow-up|1
7236358|NCT00128492|11444342|FG001|Overall Study|Lost to Follow-up|5
7236359|NCT00128492|11444341|FG000|Overall Study|Noncompliance|0
7236360|NCT00128492|11444342|FG001|Overall Study|Noncompliance|5
7236361|NCT00128492|11444341|FG000|Overall Study|Personal or administrative|10
7236362|NCT00128492|11444342|FG001|Overall Study|Personal or administrative|22
7236363|NCT00128492|11444341|FG000|Overall Study|Withdrawal by Subject|3
7236364|NCT00128492|11444342|FG001|Overall Study|Withdrawal by Subject|5
7236365|NCT00128492|11444341|FG000|Overall Study|Pregnancy|0
7236366|NCT00128492|11444342|FG001|Overall Study|Pregnancy|1
7236367|NCT00128661|11444350|FG000|Overall Study|Adverse Event|14
7236368|NCT00128661|11444351|FG001|Overall Study|Adverse Event|11
7236369|NCT00128661|11444350|FG000|Overall Study|Lost to Follow-up|10
7236370|NCT00128661|11444351|FG001|Overall Study|Lost to Follow-up|7
7236371|NCT00128661|11444350|FG000|Overall Study|Withdrawal by Subject|243
7236372|NCT00128661|11444351|FG001|Overall Study|Withdrawal by Subject|232
7236373|NCT00128661|11444350|FG000|Overall Study|Other|7
7236374|NCT00128661|11444351|FG001|Overall Study|Other|8
7236375|NCT00128830|11444370|FG000|Overall Study|Adverse Event|10
7236376|NCT00128830|11444370|FG000|Overall Study|Withdrawal by Subject|14
7236377|NCT00128830|11444370|FG000|Overall Study|Lost to Follow-up|4
7236378|NCT00128830|11444370|FG000|Overall Study|Reached a virologic endpoint|29
7236379|NCT00128830|11444370|FG000|Overall Study|Non-compliant|4
7236380|NCT00128830|11444370|FG000|Overall Study|Discontinued or ineligible for study|2
7236381|NCT00128830|11444370|FG000|Overall Study|Other|9
7236382|NCT00129116|11444396|FG000|Primary Phase|Lost to Follow-up|1
7236383|NCT00129116|11444397|FG001|Primary Phase|Lost to Follow-up|1
7236384|NCT00129116|11444398|FG002|Primary Phase|Lost to Follow-up|0
7236385|NCT00129116|11444399|FG003|Primary Phase|Lost to Follow-up|1
7236386|NCT00129116|11444400|FG004|Primary Phase|Lost to Follow-up|1
7236387|NCT00129116|11444396|FG000|Primary Phase|Protocol Violation|0
7236388|NCT00129116|11444397|FG001|Primary Phase|Protocol Violation|1
7236389|NCT00129116|11444398|FG002|Primary Phase|Protocol Violation|0
7236390|NCT00129116|11444399|FG003|Primary Phase|Protocol Violation|0
7236391|NCT00129116|11444400|FG004|Primary Phase|Protocol Violation|0
7236392|NCT00129116|11444396|FG000|Primary Phase|Adverse Event|1
7236393|NCT00129116|11444397|FG001|Primary Phase|Adverse Event|1
7236394|NCT00129116|11444398|FG002|Primary Phase|Adverse Event|0
7236395|NCT00129116|11444399|FG003|Primary Phase|Adverse Event|0
7236396|NCT00129116|11444400|FG004|Primary Phase|Adverse Event|0
7236397|NCT00129116|11444396|FG000|Primary Phase|Withdrawal by Subject|0
7236398|NCT00129116|11444397|FG001|Primary Phase|Withdrawal by Subject|1
7236399|NCT00129116|11444398|FG002|Primary Phase|Withdrawal by Subject|0
7236400|NCT00129116|11444399|FG003|Primary Phase|Withdrawal by Subject|0
7236401|NCT00129116|11444400|FG004|Primary Phase|Withdrawal by Subject|0
7236402|NCT00129116|11444396|FG000|Primary Phase|Other|0
7236403|NCT00129116|11444397|FG001|Primary Phase|Other|0
7236404|NCT00129116|11444398|FG002|Primary Phase|Other|1
7236405|NCT00129116|11444399|FG003|Primary Phase|Other|0
7236406|NCT00129116|11444400|FG004|Primary Phase|Other|0
7236407|NCT00129116|11444396|FG000|Booster Phase|Lost to Follow-up|2
7236408|NCT00129116|11444397|FG001|Booster Phase|Lost to Follow-up|0
7236409|NCT00129116|11444398|FG002|Booster Phase|Lost to Follow-up|0
7236410|NCT00129116|11444399|FG003|Booster Phase|Lost to Follow-up|0
7236411|NCT00129116|11444400|FG004|Booster Phase|Lost to Follow-up|1
7236412|NCT00129129|11444415|FG000|Primary Phase|Adverse Event|2
7236413|NCT00129129|11444416|FG001|Primary Phase|Adverse Event|1
7236414|NCT00129129|11444417|FG002|Primary Phase|Adverse Event|0
7236415|NCT00129129|11444418|FG003|Primary Phase|Adverse Event|0
7236416|NCT00129129|11444419|FG004|Primary Phase|Adverse Event|0
7236417|NCT00129129|11444415|FG000|Primary Phase|Withdrawal by Subject|12
7236418|NCT00129129|11444416|FG001|Primary Phase|Withdrawal by Subject|10
7236419|NCT00129129|11444417|FG002|Primary Phase|Withdrawal by Subject|0
7236420|NCT00129129|11444418|FG003|Primary Phase|Withdrawal by Subject|0
7236421|NCT00129129|11444419|FG004|Primary Phase|Withdrawal by Subject|0
7236422|NCT00129129|11444415|FG000|Primary Phase|Migration from study area|1
7236423|NCT00129129|11444416|FG001|Primary Phase|Migration from study area|3
7236424|NCT00129129|11444417|FG002|Primary Phase|Migration from study area|0
7236425|NCT00129129|11444418|FG003|Primary Phase|Migration from study area|0
7236426|NCT00129129|11444419|FG004|Primary Phase|Migration from study area|0
7236427|NCT00129129|11444415|FG000|Primary Phase|Lost to Follow-up|8
7236428|NCT00129129|11444416|FG001|Primary Phase|Lost to Follow-up|6
7236429|NCT00129129|11444417|FG002|Primary Phase|Lost to Follow-up|0
7236430|NCT00129129|11444418|FG003|Primary Phase|Lost to Follow-up|0
7236431|NCT00129129|11444419|FG004|Primary Phase|Lost to Follow-up|0
7236432|NCT00129129|11444415|FG000|Primary Phase|Other|2
7236433|NCT00129129|11444416|FG001|Primary Phase|Other|5
7236434|NCT00129129|11444417|FG002|Primary Phase|Other|0
7236435|NCT00129129|11444418|FG003|Primary Phase|Other|0
7236436|NCT00129129|11444419|FG004|Primary Phase|Other|0
7236437|NCT00129129|11444415|FG000|Fourth Dose Phase|Lost to Follow-up|4
7236438|NCT00129129|11444416|FG001|Fourth Dose Phase|Lost to Follow-up|0
7236439|NCT00129129|11444417|FG002|Fourth Dose Phase|Lost to Follow-up|0
7236440|NCT00129129|11444418|FG003|Fourth Dose Phase|Lost to Follow-up|2
7236441|NCT00129129|11444419|FG004|Fourth Dose Phase|Lost to Follow-up|2
7236442|NCT00129129|11444415|FG000|Fourth Dose Phase|Withdrawal by Subject|0
7236443|NCT00129129|11444416|FG001|Fourth Dose Phase|Withdrawal by Subject|0
7236444|NCT00129129|11444417|FG002|Fourth Dose Phase|Withdrawal by Subject|0
7236445|NCT00129129|11444418|FG003|Fourth Dose Phase|Withdrawal by Subject|0
7236446|NCT00129129|11444419|FG004|Fourth Dose Phase|Withdrawal by Subject|1
7236447|NCT00129129|11444415|FG000|Fourth Dose Phase|Migration from study area|0
7236448|NCT00129129|11444416|FG001|Fourth Dose Phase|Migration from study area|0
7236449|NCT00129129|11444417|FG002|Fourth Dose Phase|Migration from study area|0
7236450|NCT00129129|11444418|FG003|Fourth Dose Phase|Migration from study area|0
7236451|NCT00129129|11444419|FG004|Fourth Dose Phase|Migration from study area|2
7236452|NCT00129129|11444415|FG000|Fourth Dose Phase|Other|0
7236453|NCT00129129|11444416|FG001|Fourth Dose Phase|Other|0
7236454|NCT00129129|11444417|FG002|Fourth Dose Phase|Other|0
7236455|NCT00129129|11444418|FG003|Fourth Dose Phase|Other|1
7236456|NCT00129129|11444419|FG004|Fourth Dose Phase|Other|1
7236457|NCT00129129|11444415|FG000|Fourth Dose Phase|Protocol Violation|0
7236458|NCT00129129|11444416|FG001|Fourth Dose Phase|Protocol Violation|0
7236459|NCT00129129|11444417|FG002|Fourth Dose Phase|Protocol Violation|0
7236460|NCT00129129|11444418|FG003|Fourth Dose Phase|Protocol Violation|1
7236461|NCT00129129|11444419|FG004|Fourth Dose Phase|Protocol Violation|0
7236462|NCT00129220|11444442|FG000|Study Period II|Adverse Event|9
7236463|NCT00129220|11444443|FG001|Study Period II|Adverse Event|5
7236464|NCT00129220|11444444|FG002|Study Period II|Adverse Event|7
7236465|NCT00129220|11444442|FG000|Study Period II|Lack of Efficacy|15
7236466|NCT00129220|11444443|FG001|Study Period II|Lack of Efficacy|1
7236467|NCT00129220|11444444|FG002|Study Period II|Lack of Efficacy|28
7236468|NCT00129220|11444442|FG000|Study Period II|Entry Criteria Not Met|2
7236469|NCT00129220|11444443|FG001|Study Period II|Entry Criteria Not Met|0
7236470|NCT00129220|11444444|FG002|Study Period II|Entry Criteria Not Met|2
7236471|NCT00129220|11444442|FG000|Study Period II|Protocol Violation|4
7236472|NCT00129220|11444443|FG001|Study Period II|Protocol Violation|2
7236473|NCT00129220|11444444|FG002|Study Period II|Protocol Violation|1
7236474|NCT00129220|11444442|FG000|Study Period II|Physician Decision|0
7236475|NCT00129220|11444443|FG001|Study Period II|Physician Decision|1
7236476|NCT00129220|11444444|FG002|Study Period II|Physician Decision|0
7236477|NCT00129220|11444442|FG000|Study Period II|Withdrawal by Subject|1
7236478|NCT00129220|11444443|FG001|Study Period II|Withdrawal by Subject|3
7236479|NCT00129220|11444444|FG002|Study Period II|Withdrawal by Subject|4
7236480|NCT00129220|11444442|FG000|Study Period II|Reason Not Specified|2
7236481|NCT00129220|11444443|FG001|Study Period II|Reason Not Specified|0
7236482|NCT00129220|11444444|FG002|Study Period II|Reason Not Specified|5
7236483|NCT00129220|11444442|FG000|Study Period III|Adverse Event|1
7236484|NCT00129220|11444443|FG001|Study Period III|Adverse Event|0
7236485|NCT00129220|11444444|FG002|Study Period III|Adverse Event|3
7236486|NCT00129220|11444442|FG000|Study Period III|Protocol Violation|1
7236487|NCT00129220|11444443|FG001|Study Period III|Protocol Violation|1
7236488|NCT00129220|11444444|FG002|Study Period III|Protocol Violation|2
7236572|NCT00129623|11444563|FG001|Overall Study|Uncertainty to return|1
7573755|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
7236489|NCT00129220|11444442|FG000|Study Period III|Withdrawal by Subject|1
7236490|NCT00129220|11444443|FG001|Study Period III|Withdrawal by Subject|0
7236491|NCT00129220|11444444|FG002|Study Period III|Withdrawal by Subject|3
7236492|NCT00129220|11444442|FG000|Study Period III|Sponsor Decision|1
7236493|NCT00129220|11444443|FG001|Study Period III|Sponsor Decision|0
7236494|NCT00129220|11444444|FG002|Study Period III|Sponsor Decision|0
7236495|NCT00129220|11444442|FG000|Study Period III|Reason Not Specified|9
7236496|NCT00129220|11444443|FG001|Study Period III|Reason Not Specified|0
7236497|NCT00129220|11444444|FG002|Study Period III|Reason Not Specified|2
7236498|NCT00129259|11444465|FG000|Overall Study|Lost to Follow-up|1
7236499|NCT00129259|11444466|FG001|Overall Study|Lost to Follow-up|1
7236500|NCT00129259|11444465|FG000|Overall Study|Withdrawal by Subject|2
7236501|NCT00129259|11444466|FG001|Overall Study|Withdrawal by Subject|1
7236502|NCT00129259|11444465|FG000|Overall Study|Only available minimal phone assessments|0
7236503|NCT00129259|11444466|FG001|Overall Study|Only available minimal phone assessments|1
7236504|NCT00129272|11444474|FG000|Overall Study|Lost to Follow-up|12
7236505|NCT00129272|11444475|FG001|Overall Study|Lost to Follow-up|11
7236506|NCT00129272|11444474|FG000|Overall Study|Withdrawal by Subject|5
7236507|NCT00129272|11444475|FG001|Overall Study|Withdrawal by Subject|11
7236508|NCT00129311|11444500|FG000|Overall Study|Withdrawal by Subject|12
7236509|NCT00129311|11444501|FG001|Overall Study|Withdrawal by Subject|19
7236510|NCT00129376|11444507|FG000|Overall Study|Adverse Event|1
7236511|NCT00129376|11444507|FG000|Overall Study|Lack of Efficacy|1
7236512|NCT00129389|11444513|FG000|Overall Study|Adverse Event|19
7236513|NCT00129389|11444514|FG001|Overall Study|Adverse Event|87
7236514|NCT00129389|11444513|FG000|Overall Study|Death|0
7236515|NCT00129389|11444514|FG001|Overall Study|Death|1
7236516|NCT00129389|11444513|FG000|Overall Study|Lost to Follow-up|2
7236517|NCT00129389|11444514|FG001|Overall Study|Lost to Follow-up|1
7236518|NCT00129389|11444513|FG000|Overall Study|Physician Decision|0
7236519|NCT00129389|11444514|FG001|Overall Study|Physician Decision|4
7236520|NCT00129389|11444513|FG000|Overall Study|Protocol Violation|0
7236521|NCT00129389|11444514|FG001|Overall Study|Protocol Violation|6
7236522|NCT00129389|11444513|FG000|Overall Study|Withdrawal by Subject|9
7236523|NCT00129389|11444514|FG001|Overall Study|Withdrawal by Subject|23
7236524|NCT00129389|11444513|FG000|Overall Study|Relapse|1
7236525|NCT00129389|11444514|FG001|Overall Study|Relapse|0
7236526|NCT00129389|11444513|FG000|Overall Study|Not eligible|1
7236527|NCT00129389|11444514|FG001|Overall Study|Not eligible|2
7236528|NCT00129389|11444513|FG000|Overall Study|Crossed to the other arm|1
7236529|NCT00129389|11444514|FG001|Overall Study|Crossed to the other arm|16
7236530|NCT00129467|11444531|FG000|Received Intervention|Death|1
7236531|NCT00129467|11444532|FG001|Received Intervention|Death|1
7236532|NCT00129467|11444531|FG000|Received Intervention|Cardiac SAE (hypertension)|1
7236533|NCT00129467|11444532|FG001|Received Intervention|Cardiac SAE (hypertension)|1
7236534|NCT00129467|11444531|FG000|Received Intervention|Delirium|2
7236535|NCT00129467|11444532|FG001|Received Intervention|Delirium|0
7236536|NCT00129467|11444531|FG000|Received Intervention|Withdrawal by Subject|1
7236537|NCT00129467|11444532|FG001|Received Intervention|Withdrawal by Subject|0
7236538|NCT00129467|11444531|FG000|Received Intervention|Nausea|1
7236539|NCT00129467|11444532|FG001|Received Intervention|Nausea|0
7236540|NCT00129467|11444531|FG000|Received Intervention|Intolerance to citalopram|0
7236541|NCT00129467|11444532|FG001|Received Intervention|Intolerance to citalopram|1
7236542|NCT00129467|11444531|FG000|Received Intervention|Dizzyness, fatigue|0
7236543|NCT00129467|11444532|FG001|Received Intervention|Dizzyness, fatigue|1
7236544|NCT00129467|11444531|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
7236545|NCT00129467|11444532|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
7236546|NCT00129467|11444531|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
7236547|NCT00129467|11444532|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
7236548|NCT00129545|11444550|FG000|Overall Study|Death|5
7236549|NCT00129545|11444551|FG001|Overall Study|Death|60
7236550|NCT00129545|11444552|FG002|Overall Study|Death|44
7236551|NCT00129545|11444550|FG000|Overall Study|Withdrawal by Subject|3
7236552|NCT00129545|11444551|FG001|Overall Study|Withdrawal by Subject|18
7236553|NCT00129545|11444552|FG002|Overall Study|Withdrawal by Subject|44
7236554|NCT00129545|11444550|FG000|Overall Study|Lost to Follow-up|2
7236555|NCT00129545|11444551|FG001|Overall Study|Lost to Follow-up|22
7236556|NCT00129545|11444552|FG002|Overall Study|Lost to Follow-up|13
7236557|NCT00129545|11444550|FG000|Overall Study|Physician Decision|0
7236558|NCT00129545|11444551|FG001|Overall Study|Physician Decision|3
7236559|NCT00129545|11444552|FG002|Overall Study|Physician Decision|10
7236560|NCT00129545|11444550|FG000|Overall Study|Device not implanted|16
7236561|NCT00129545|11444551|FG001|Overall Study|Device not implanted|61
7236562|NCT00129545|11444552|FG002|Overall Study|Device not implanted|0
7236563|NCT00129623|11444562|FG000|Overall Study|Adverse Event|3
7236564|NCT00129623|11444563|FG001|Overall Study|Adverse Event|7
7236565|NCT00129623|11444562|FG000|Overall Study|Refused Treatment|5
7236566|NCT00129623|11444563|FG001|Overall Study|Refused Treatment|3
7236567|NCT00129623|11444562|FG000|Overall Study|Failure to Return|1
7236568|NCT00129623|11444563|FG001|Overall Study|Failure to Return|1
7236569|NCT00129623|11444562|FG000|Overall Study|Relocated job out of state|1
7236570|NCT00129623|11444563|FG001|Overall Study|Relocated job out of state|0
7236571|NCT00129623|11444562|FG000|Overall Study|Uncertainty to return|0
7236573|NCT00129649|11444573|FG000|Overall Study|Withdrawal by Subject|76
7236574|NCT00129649|11444574|FG001|Overall Study|Withdrawal by Subject|65
7236575|NCT00129701|11444580|FG000|Overall Study|Withdrawal by Subject|33
7236576|NCT00129766|11444597|FG000|Overall Study|Death|3
7236577|NCT00129766|11444598|FG001|Overall Study|Death|8
7236578|NCT00129766|11444597|FG000|Overall Study|Withdrawal of consent|31
7236579|NCT00129766|11444598|FG001|Overall Study|Withdrawal of consent|30
7236580|NCT00129766|11444597|FG000|Overall Study|Lost to Follow-up|26
7236581|NCT00129766|11444598|FG001|Overall Study|Lost to Follow-up|21
7236582|NCT00129935|11444607|FG000|Overall Study|Adverse Event|18
7236583|NCT00129935|11444608|FG001|Overall Study|Adverse Event|56
7236584|NCT00129935|11444607|FG000|Overall Study|Death|1
7236585|NCT00129935|11444608|FG001|Overall Study|Death|1
7236586|NCT00129935|11444607|FG000|Overall Study|Withdrawal by Subject|7
7236587|NCT00129935|11444608|FG001|Overall Study|Withdrawal by Subject|20
7236588|NCT00129935|11444607|FG000|Overall Study|Protocol Violation|0
7236589|NCT00129935|11444608|FG001|Overall Study|Protocol Violation|4
7236590|NCT00129935|11444607|FG000|Overall Study|Physician Decision|3
7236591|NCT00129935|11444608|FG001|Overall Study|Physician Decision|4
7236592|NCT00129935|11444607|FG000|Overall Study|Recurrence|1
7236593|NCT00129935|11444608|FG001|Overall Study|Recurrence|3
7236594|NCT00129935|11444607|FG000|Overall Study|Second primary|0
7236595|NCT00129935|11444608|FG001|Overall Study|Second primary|1
7236596|NCT00129935|11444607|FG000|Overall Study|Other|3
7236597|NCT00129935|11444608|FG001|Overall Study|Other|2
7236598|NCT00129935|11444607|FG000|Overall Study|Crossed to the other arm|2
7236599|NCT00129935|11444608|FG001|Overall Study|Crossed to the other arm|1
7236600|NCT00129935|11444607|FG000|Overall Study|Incorrect study treatment|1
7236601|NCT00129935|11444608|FG001|Overall Study|Incorrect study treatment|0
7236602|NCT00129961|11444616|FG000|Overall Study|Adverse Event|1
7236603|NCT00129961|11444617|FG001|Overall Study|Adverse Event|0
7236604|NCT00129961|11444616|FG000|Overall Study|Death|1
7236605|NCT00129961|11444617|FG001|Overall Study|Death|1
7236606|NCT00129961|11444616|FG000|Overall Study|Withdrawal by Sponsor|14
7236607|NCT00129961|11444617|FG001|Overall Study|Withdrawal by Sponsor|20
7236608|NCT00129961|11444616|FG000|Overall Study|Physician Decision|1
7236609|NCT00129961|11444617|FG001|Overall Study|Physician Decision|0
7236610|NCT00129961|11444616|FG000|Overall Study|Withdrawal by Subject|2
7236611|NCT00129961|11444617|FG001|Overall Study|Withdrawal by Subject|1
7236612|NCT00129961|11444616|FG000|Overall Study|Missing Record|0
7236613|NCT00129961|11444617|FG001|Overall Study|Missing Record|1
7236614|NCT00129987|11444625|FG000|1st Educational Session|Withdrawal by Subject|141
7236615|NCT00129987|11444626|FG001|1st Educational Session|Withdrawal by Subject|109
7236616|NCT00129987|11444625|FG000|1 Year|Withdrawal by Subject|32
7236617|NCT00129987|11444626|FG001|1 Year|Withdrawal by Subject|21
7236618|NCT00130039|11444634|FG000|Overall Study|Withdrawal by Subject|15
7236619|NCT00130039|11444635|FG001|Overall Study|Withdrawal by Subject|11
7236620|NCT00130039|11444634|FG000|Overall Study|Lost to Follow-up|3
7236621|NCT00130039|11444635|FG001|Overall Study|Lost to Follow-up|1
7236622|NCT00130039|11444634|FG000|Overall Study|Adverse Event|4
7236623|NCT00130039|11444635|FG001|Overall Study|Adverse Event|2
7236624|NCT00130039|11444634|FG000|Overall Study|Physician Decision|3
7236625|NCT00130039|11444635|FG001|Overall Study|Physician Decision|0
7236626|NCT00130039|11444634|FG000|Overall Study|clinical events without follow up MRI|5
7236627|NCT00130039|11444635|FG001|Overall Study|clinical events without follow up MRI|4
7255728|NCT00320255|11467306|FG001|Overall Study|Withdrawal by Subject|2
7255729|NCT00320255|11467307|FG002|Overall Study|Withdrawal by Subject|2
7255730|NCT00320255|11467308|FG003|Overall Study|Withdrawal by Subject|4
7255731|NCT00320255|11467309|FG004|Overall Study|Withdrawal by Subject|0
7255732|NCT00320255|11467310|FG005|Overall Study|Withdrawal by Subject|0
7255733|NCT00320255|11467305|FG000|Overall Study|Poor compliance/noncompliance|1
7255734|NCT00320255|11467306|FG001|Overall Study|Poor compliance/noncompliance|1
7255735|NCT00320255|11467307|FG002|Overall Study|Poor compliance/noncompliance|0
7255736|NCT00320255|11467308|FG003|Overall Study|Poor compliance/noncompliance|1
7255737|NCT00320255|11467309|FG004|Overall Study|Poor compliance/noncompliance|0
7255738|NCT00320255|11467310|FG005|Overall Study|Poor compliance/noncompliance|0
7255739|NCT00320255|11467305|FG000|Overall Study|No longer meets study criteria|0
7255740|NCT00320255|11467306|FG001|Overall Study|No longer meets study criteria|0
7255741|NCT00320255|11467307|FG002|Overall Study|No longer meets study criteria|0
7255742|NCT00320255|11467308|FG003|Overall Study|No longer meets study criteria|1
7255743|NCT00320255|11467309|FG004|Overall Study|No longer meets study criteria|0
7255744|NCT00320255|11467310|FG005|Overall Study|No longer meets study criteria|0
7255745|NCT00320255|11467305|FG000|Overall Study|Other|3
7255746|NCT00320255|11467306|FG001|Overall Study|Other|2
7255747|NCT00320255|11467307|FG002|Overall Study|Other|1
7255748|NCT00320255|11467308|FG003|Overall Study|Other|0
7255749|NCT00320255|11467309|FG004|Overall Study|Other|0
7255750|NCT00320255|11467310|FG005|Overall Study|Other|0
7255751|NCT00320372|11467339|FG000|Overall Study|Physician Decision|4
7255752|NCT00320372|11467340|FG001|Overall Study|Physician Decision|7
7255753|NCT00320372|11467339|FG000|Overall Study|Death|7
7255754|NCT00320372|11467340|FG001|Overall Study|Death|8
7255755|NCT00320372|11467339|FG000|Overall Study|Withdrawal by Subject|55
7255756|NCT00320372|11467340|FG001|Overall Study|Withdrawal by Subject|37
7255757|NCT00320372|11467339|FG000|Overall Study|Non-Compliance|40
7255758|NCT00320372|11467340|FG001|Overall Study|Non-Compliance|39
7255759|NCT00320372|11467339|FG000|Overall Study|Did not Meet (I/E)|3
7255760|NCT00320372|11467340|FG001|Overall Study|Did not Meet (I/E)|1
7255761|NCT00320372|11467339|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
7255762|NCT00320372|11467340|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
7255763|NCT00320385|11467356|FG000|Overall Study|Lost to Follow-up|7
7255764|NCT00320385|11467357|FG001|Overall Study|Lost to Follow-up|10
7255765|NCT00320385|11467356|FG000|Overall Study|Withdrawal by Subject|6
7255766|NCT00320385|11467357|FG001|Overall Study|Withdrawal by Subject|7
7255767|NCT00320385|11467356|FG000|Overall Study|Sponsor Terminated Study|2
7255768|NCT00320385|11467357|FG001|Overall Study|Sponsor Terminated Study|1
7255769|NCT00320385|11467356|FG000|Overall Study|Investigator Decision|0
7255770|NCT00320385|11467357|FG001|Overall Study|Investigator Decision|1
7255771|NCT00320385|11467356|FG000|Overall Study|Death|1
7255772|NCT00320385|11467357|FG001|Overall Study|Death|2
7255773|NCT00320385|11467356|FG000|Overall Study|Serious Adverse Event|1
7255774|NCT00320385|11467357|FG001|Overall Study|Serious Adverse Event|0
7255775|NCT00320385|11467356|FG000|Overall Study|Withdrew Consent|1
7255776|NCT00320385|11467357|FG001|Overall Study|Withdrew Consent|0
7255777|NCT00320385|11467356|FG000|Overall Study|Adverse Event|0
7255778|NCT00320385|11467357|FG001|Overall Study|Adverse Event|1
7255779|NCT00320398|11467365|FG000|Overall Study|Adverse Event|1
7255780|NCT00320398|11467366|FG001|Overall Study|Adverse Event|4
7255781|NCT00320398|11467365|FG000|Overall Study|Other|1
7255782|NCT00320398|11467366|FG001|Overall Study|Other|0
7255783|NCT00320411|11467373|FG000|Overall Study|No investigational product admin.|4
7255784|NCT00320424|11467377|FG000|Overall Study|Adverse Event|3
7255785|NCT00320424|11467377|FG000|Overall Study|Other|3
7255786|NCT00320489|11467383|FG000|Overall Study|Adverse Event|26
7255787|NCT00320489|11467384|FG001|Overall Study|Adverse Event|25
7255788|NCT00320489|11467383|FG000|Overall Study|Clinical Relapse|26
7255789|NCT00320489|11467384|FG001|Overall Study|Clinical Relapse|20
7255790|NCT00320489|11467383|FG000|Overall Study|Death|0
7255791|NCT00320489|11467384|FG001|Overall Study|Death|2
7255792|NCT00320489|11467383|FG000|Overall Study|Entry Criteria Exclusion|2
7255793|NCT00320489|11467384|FG001|Overall Study|Entry Criteria Exclusion|4
7255794|NCT00320489|11467383|FG000|Overall Study|Lack of Efficacy|16
7255795|NCT00320489|11467384|FG001|Overall Study|Lack of Efficacy|7
7255796|NCT00320489|11467383|FG000|Overall Study|Lost to Follow-up|21
7255797|NCT00320489|11467384|FG001|Overall Study|Lost to Follow-up|22
7255798|NCT00320489|11467383|FG000|Overall Study|Physician Decision|8
7255799|NCT00320489|11467384|FG001|Overall Study|Physician Decision|8
7236628|NCT00130208|11444653|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
7236629|NCT00130208|11444654|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
7236630|NCT00130208|11444653|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
7236631|NCT00130208|11444654|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
7236632|NCT00130208|11444653|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
7236633|NCT00130208|11444654|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
7236634|NCT00130208|11444653|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
7236635|NCT00130208|11444654|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
7236636|NCT00130208|11444653|FG000|Maintenance Period (26 Weeks)|Other|1
7236637|NCT00130208|11444654|FG001|Maintenance Period (26 Weeks)|Other|1
7236638|NCT00130208|11444653|FG000|Washout Period (8 Weeks)|Adverse Event|3
7236639|NCT00130208|11444654|FG001|Washout Period (8 Weeks)|Adverse Event|6
7236640|NCT00130208|11444653|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
7236641|NCT00130208|11444654|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
7236642|NCT00130208|11444653|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
7236643|NCT00130208|11444654|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
7236644|NCT00130208|11444653|FG000|Washout Period (8 Weeks)|Other|1
7236645|NCT00130208|11444654|FG001|Washout Period (8 Weeks)|Other|1
7236646|NCT00130247|11444662|FG000|Overall Study|Pregnancy|1
7236647|NCT00130247|11444663|FG001|Overall Study|Pregnancy|0
7236648|NCT00130247|11444662|FG000|Overall Study|Post-randomization exclusion|1
7236649|NCT00130247|11444663|FG001|Overall Study|Post-randomization exclusion|2
7236650|NCT00130247|11444662|FG000|Overall Study|Not compliant with DOT|0
7236651|NCT00130247|11444663|FG001|Overall Study|Not compliant with DOT|2
7236652|NCT00130286|11444673|FG000|Overall Study|Withdrawal by Subject|0
7236653|NCT00130286|11444674|FG001|Overall Study|Withdrawal by Subject|1
7236654|NCT00130286|11444675|FG002|Overall Study|Withdrawal by Subject|2
7236655|NCT00130286|11444676|FG003|Overall Study|Withdrawal by Subject|2
7236656|NCT00130286|11444673|FG000|Overall Study|Adverse Event|0
7236657|NCT00130286|11444674|FG001|Overall Study|Adverse Event|0
7236658|NCT00130286|11444675|FG002|Overall Study|Adverse Event|2
7236659|NCT00130286|11444676|FG003|Overall Study|Adverse Event|0
7236660|NCT00130286|11444673|FG000|Overall Study|Missing lab specimens|0
7236661|NCT00130286|11444674|FG001|Overall Study|Missing lab specimens|2
7236662|NCT00130286|11444675|FG002|Overall Study|Missing lab specimens|0
7236663|NCT00130286|11444676|FG003|Overall Study|Missing lab specimens|0
7236664|NCT00130520|11444686|FG000|Overall Study|Adverse Event|11
7236665|NCT00130520|11444686|FG000|Overall Study|Death|1
7236666|NCT00130520|11444686|FG000|Overall Study|Physician Decision|1
7236667|NCT00130520|11444686|FG000|Overall Study|Withdrawal by Subject|1
7236668|NCT00130520|11444686|FG000|Overall Study|Disease Progression|23
7236669|NCT00130520|11444686|FG000|Overall Study|Protocol non-compliance|1
7236670|NCT00130520|11444686|FG000|Overall Study|Did not meet re-treatment criteria|1
7236671|NCT00130533|11444692|FG000|Overall Study|Withdrawal by Subject|33
7236672|NCT00130533|11444693|FG001|Overall Study|Withdrawal by Subject|6
7236673|NCT00130533|11444692|FG000|Overall Study|Adverse Event|34
7236674|NCT00130533|11444693|FG001|Overall Study|Adverse Event|1
7236675|NCT00130533|11444692|FG000|Overall Study|Disease relapse|9
7236676|NCT00130533|11444693|FG001|Overall Study|Disease relapse|13
7236677|NCT00130533|11444692|FG000|Overall Study|Interruption of treatment > 3 weeks|11
7236678|NCT00130533|11444693|FG001|Overall Study|Interruption of treatment > 3 weeks|0
7236679|NCT00130533|11444692|FG000|Overall Study|Death|4
7236680|NCT00130533|11444693|FG001|Overall Study|Death|2
7236681|NCT00130533|11444692|FG000|Overall Study|Protocol Violation|5
7236682|NCT00130533|11444693|FG001|Overall Study|Protocol Violation|1
7236683|NCT00130533|11444692|FG000|Overall Study|Lost to Follow-up|1
7236684|NCT00130533|11444693|FG001|Overall Study|Lost to Follow-up|1
7236685|NCT00130533|11444692|FG000|Overall Study|Sponsor´s decision|2
7236686|NCT00130533|11444693|FG001|Overall Study|Sponsor´s decision|0
7236687|NCT00130533|11444692|FG000|Overall Study|Second Primary Malignancy|0
7236688|NCT00130533|11444693|FG001|Overall Study|Second Primary Malignancy|1
7236689|NCT00130533|11444692|FG000|Overall Study|Other|12
7236690|NCT00130533|11444693|FG001|Overall Study|Other|5
7236691|NCT00130637|11444699|FG000|Overall Study|Adverse Event|2
7236692|NCT00130637|11444699|FG000|Overall Study|Withdrawal by Subject|1
7236693|NCT00130689|11444703|FG000|Overall Study|Progressive Disease|29
7236694|NCT00130689|11444703|FG000|Overall Study|Death|1
7236695|NCT00130689|11444703|FG000|Overall Study|Clinical Deterioration|4
7236696|NCT00130689|11444703|FG000|Overall Study|Withdrawal by Subject|3
7236697|NCT00130689|11444703|FG000|Overall Study|Ineligible|6
7236698|NCT00130728|11444709|FG000|Overall Study|Death|258
7236699|NCT00130728|11444710|FG001|Overall Study|Death|258
7236700|NCT00130728|11444709|FG000|Overall Study|Lost to Follow-up|4
7236701|NCT00130728|11444710|FG001|Overall Study|Lost to Follow-up|0
7236702|NCT00130728|11444709|FG000|Overall Study|Withdrawal by Subject|0
7236703|NCT00130728|11444710|FG001|Overall Study|Withdrawal by Subject|2
7236704|NCT00130793|11444727|FG000|Overall Study|Lost to Follow-up|1
7236705|NCT00130793|11444728|FG001|Overall Study|Lost to Follow-up|4
7236706|NCT00130793|11444727|FG000|Overall Study|Withdrew consent|2
7236707|NCT00130793|11444728|FG001|Overall Study|Withdrew consent|0
7236708|NCT00130832|11444737|FG000|Overall Study|Adverse Event|1
7236709|NCT00130832|11444738|FG001|Overall Study|Adverse Event|1
7236710|NCT00130832|11444737|FG000|Overall Study|Lost to Follow-up|1
7236711|NCT00130832|11444738|FG001|Overall Study|Lost to Follow-up|2
7236712|NCT00130832|11444737|FG000|Overall Study|Protocol Violation|6
7236713|NCT00130832|11444738|FG001|Overall Study|Protocol Violation|8
7236714|NCT00130832|11444737|FG000|Overall Study|Withdrawal by Subject|6
7236715|NCT00130832|11444738|FG001|Overall Study|Withdrawal by Subject|1
7236716|NCT00130832|11444737|FG000|Overall Study|Moved|2
7236717|NCT00130832|11444738|FG001|Overall Study|Moved|2
7236718|NCT00130832|11444737|FG000|Overall Study|Other|0
7236719|NCT00130832|11444738|FG001|Overall Study|Other|3
7236720|NCT00131248|11444754|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
7236721|NCT00131248|11444755|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
7236722|NCT00131352|11444763|FG000|Initial Treatment Period|Adverse Event|1
7236723|NCT00131352|11444764|FG001|Initial Treatment Period|Adverse Event|3
7236724|NCT00131352|11444763|FG000|Initial Treatment Period|Non-compliant|1
7236725|NCT00131352|11444764|FG001|Initial Treatment Period|Non-compliant|2
7236726|NCT00131352|11444763|FG000|Initial Treatment Period|Withdrawal by Subject|1
7236727|NCT00131352|11444764|FG001|Initial Treatment Period|Withdrawal by Subject|1
7236728|NCT00131352|11444763|FG000|Initial Treatment Period|Lack of Efficacy|6
7236729|NCT00131352|11444764|FG001|Initial Treatment Period|Lack of Efficacy|4
7236730|NCT00131352|11444763|FG000|Initial Treatment Period|Other|0
7236731|NCT00131352|11444764|FG001|Initial Treatment Period|Other|2
7236732|NCT00131352|11444763|FG000|Repeat Treatment Period|Adverse Event|1
7236733|NCT00131352|11444764|FG001|Repeat Treatment Period|Adverse Event|0
7236734|NCT00131352|11444763|FG000|Repeat Treatment Period|Other|1
7236735|NCT00131352|11444764|FG001|Repeat Treatment Period|Other|0
7236736|NCT00131365|11444772|FG000|Overall Study|Withdrawal by Subject|1
7236737|NCT00131365|11444772|FG000|Overall Study|Alternative treatment|3
7236738|NCT00131469|11444807|FG000|Overall Study|Withdrawal by Subject|3
7236739|NCT00131469|11444808|FG001|Overall Study|Withdrawal by Subject|4
7236740|NCT00131469|11444807|FG000|Overall Study|Protocol Violation|3
7236741|NCT00131469|11444808|FG001|Overall Study|Protocol Violation|1
7236742|NCT00131469|11444807|FG000|Overall Study|Death|0
7236743|NCT00131469|11444808|FG001|Overall Study|Death|1
7236744|NCT00131469|11444807|FG000|Overall Study|Lost to Follow-up|0
7236745|NCT00131469|11444808|FG001|Overall Study|Lost to Follow-up|1
7236746|NCT00131469|11444807|FG000|Overall Study|scan not analyzable|3
7236747|NCT00131469|11444808|FG001|Overall Study|scan not analyzable|6
7236748|NCT00131508|11444816|FG000|Overall Study|Disease progression|0
7236749|NCT00131508|11444817|FG001|Overall Study|Disease progression|2
7236750|NCT00131508|11444816|FG000|Overall Study|Non-Compliance|2
7236751|NCT00131508|11444817|FG001|Overall Study|Non-Compliance|4
7236752|NCT00131508|11444816|FG000|Overall Study|Withdrawal by Subject|1
7236753|NCT00131508|11444817|FG001|Overall Study|Withdrawal by Subject|2
7236754|NCT00131664|11444836|FG000|First Period (First 6 Months)|Lost to Follow-up|7
7236755|NCT00131664|11444837|FG001|First Period (First 6 Months)|Lost to Follow-up|3
7236756|NCT00131664|11444838|FG002|First Period (First 6 Months)|Lost to Follow-up|3
7236757|NCT00131664|11444839|FG003|First Period (First 6 Months)|Lost to Follow-up|0
7236758|NCT00131664|11444840|FG004|First Period (First 6 Months)|Lost to Follow-up|0
7236759|NCT00131664|11444841|FG005|First Period (First 6 Months)|Lost to Follow-up|0
7236760|NCT00131664|11444836|FG000|First Period (First 6 Months)|Death|0
7236761|NCT00131664|11444837|FG001|First Period (First 6 Months)|Death|1
7236762|NCT00131664|11444838|FG002|First Period (First 6 Months)|Death|0
7236763|NCT00131664|11444839|FG003|First Period (First 6 Months)|Death|0
7236764|NCT00131664|11444840|FG004|First Period (First 6 Months)|Death|0
7236765|NCT00131664|11444841|FG005|First Period (First 6 Months)|Death|0
7236766|NCT00131664|11444836|FG000|First Period (First 6 Months)|Protocol Violation|2
7236767|NCT00131664|11444837|FG001|First Period (First 6 Months)|Protocol Violation|2
7236768|NCT00131664|11444838|FG002|First Period (First 6 Months)|Protocol Violation|1
7236769|NCT00131664|11444839|FG003|First Period (First 6 Months)|Protocol Violation|0
7236770|NCT00131664|11444840|FG004|First Period (First 6 Months)|Protocol Violation|0
7236771|NCT00131664|11444841|FG005|First Period (First 6 Months)|Protocol Violation|0
7236772|NCT00131664|11444836|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
7236773|NCT00131664|11444837|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
7236774|NCT00131664|11444838|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
7236775|NCT00131664|11444839|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
7236776|NCT00131664|11444840|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
7236777|NCT00131664|11444841|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
7236778|NCT00131664|11444836|FG000|First Period (First 6 Months)|Adverse Event|9
7236779|NCT00131664|11444837|FG001|First Period (First 6 Months)|Adverse Event|4
7236780|NCT00131664|11444838|FG002|First Period (First 6 Months)|Adverse Event|5
7236781|NCT00131664|11444839|FG003|First Period (First 6 Months)|Adverse Event|0
7236782|NCT00131664|11444840|FG004|First Period (First 6 Months)|Adverse Event|0
7236783|NCT00131664|11444841|FG005|First Period (First 6 Months)|Adverse Event|0
7236784|NCT00131664|11444836|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
7236785|NCT00131664|11444837|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
7236786|NCT00131664|11444838|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7236787|NCT00131664|11444839|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7236788|NCT00131664|11444840|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7236789|NCT00131664|11444841|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
7236790|NCT00131664|11444836|FG000|First Period (First 6 Months)|Administrative reasons|2
7236791|NCT00131664|11444837|FG001|First Period (First 6 Months)|Administrative reasons|0
7236792|NCT00131664|11444838|FG002|First Period (First 6 Months)|Administrative reasons|5
7236793|NCT00131664|11444839|FG003|First Period (First 6 Months)|Administrative reasons|0
7236794|NCT00131664|11444840|FG004|First Period (First 6 Months)|Administrative reasons|0
7236795|NCT00131664|11444841|FG005|First Period (First 6 Months)|Administrative reasons|0
7236796|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
7236797|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
7236798|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
7236799|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
7236800|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
7236801|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
7236802|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
7236803|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
7236804|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
7236805|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
7236806|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
7236807|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
7236808|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
7236809|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7236810|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7236811|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7236812|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7236813|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
7236814|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Adverse Event|0
7236815|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Adverse Event|1
7236816|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Adverse Event|0
7236817|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Adverse Event|0
7236818|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Adverse Event|0
7236819|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Adverse Event|1
7236820|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7236821|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7236822|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7236823|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
7236824|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7237036|NCT00132769|11445000|FG000|Overall Study|Withdrawal by Subject|1
7236825|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
7236826|NCT00131664|11444836|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
7236827|NCT00131664|11444837|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
7236828|NCT00131664|11444838|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
7236829|NCT00131664|11444839|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
7236830|NCT00131664|11444840|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
7236831|NCT00131664|11444841|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
7236832|NCT00131911|11444885|FG000|Overall Study|Withdrawal by Subject|1
7236833|NCT00131911|11444886|FG001|Overall Study|Withdrawal by Subject|0
7236834|NCT00131937|11444891|FG000|Overall Study|Adverse Event|3
7236835|NCT00131937|11444891|FG000|Overall Study|Withdrawal by Subject|2
7236836|NCT00131937|11444891|FG000|Overall Study|Physician Decision|1
7236837|NCT00131937|11444891|FG000|Overall Study|Disease Progression|7
7236838|NCT00131937|11444891|FG000|Overall Study|Alternative therapy|1
7236839|NCT00132028|11444899|FG000|Overall Study|Adverse Event|7
7236840|NCT00132028|11444899|FG000|Overall Study|Death|2
7236841|NCT00132028|11444899|FG000|Overall Study|Lack of Efficacy|11
7236842|NCT00132028|11444899|FG000|Overall Study|Withdrawal by Subject|2
7236843|NCT00132028|11444899|FG000|Overall Study|not eligible|2
7236844|NCT00132028|11444899|FG000|Overall Study|Physician Decision|3
7236845|NCT00132041|11444903|FG000|Baseline|Ineligible|6
7236846|NCT00132041|11444903|FG000|3 Months Post Ablation|Transplant|1
7236847|NCT00132041|11444903|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
7236848|NCT00132041|11444903|FG000|6 Months Post Ablation|Withdrawal by Subject|2
7236849|NCT00132041|11444903|FG000|6 Months Post Ablation|Death|2
7236850|NCT00132041|11444903|FG000|6 Months Post Ablation|Transplant|6
7236851|NCT00132041|11444903|FG000|9 Months Post Ablation|Death|1
7236852|NCT00132041|11444903|FG000|9 Months Post Ablation|Transplant|1
7236853|NCT00132041|11444903|FG000|12 Months Post Ablation|Withdrawal by Subject|1
7236854|NCT00132041|11444903|FG000|12 Months Post Ablation|Death|1
7236855|NCT00132041|11444903|FG000|12 Months Post Ablation|Transplant|1
7236856|NCT00132041|11444903|FG000|12 Months Post Ablation|non-protocol Treatment|1
7236857|NCT00132041|11444903|FG000|15 Months Post Ablation|Withdrawal by Subject|1
7236858|NCT00132041|11444903|FG000|15 Months Post Ablation|Death|1
7236859|NCT00132041|11444903|FG000|15 Months Post Ablation|Transplant|5
7236860|NCT00132041|11444903|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
7236861|NCT00132041|11444903|FG000|18 Months Post Ablation|Withdrawal by Subject|1
7236862|NCT00132041|11444903|FG000|18 Months Post Ablation|Transplant|1
7236863|NCT00132041|11444903|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
7236864|NCT00132041|11444903|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
7236865|NCT00132132|11444915|FG000|Overall Study|Lost to Follow-up|7
7236866|NCT00132132|11444916|FG001|Overall Study|Lost to Follow-up|2
7236867|NCT00132301|11444924|FG000|Overall Study|Death|7
7236868|NCT00132301|11444925|FG001|Overall Study|Death|6
7236869|NCT00132301|11444924|FG000|Overall Study|Withdrawal by Subject|5
7236870|NCT00132301|11444925|FG001|Overall Study|Withdrawal by Subject|2
7236871|NCT00132301|11444924|FG000|Overall Study|Physician Decision|1
7236872|NCT00132301|11444925|FG001|Overall Study|Physician Decision|1
7236873|NCT00132301|11444924|FG000|Overall Study|Lost to Follow-up|5
7236874|NCT00132301|11444925|FG001|Overall Study|Lost to Follow-up|3
7236875|NCT00132301|11444924|FG000|Overall Study|Other|1
7236876|NCT00132301|11444925|FG001|Overall Study|Other|1
7236877|NCT00132301|11444924|FG000|Overall Study|Excluded by Data Monitoring Committee|1
7236878|NCT00132301|11444925|FG001|Overall Study|Excluded by Data Monitoring Committee|0
7236879|NCT00132314|11444933|FG000|Overall Study|Lost to Follow-up|70
7236880|NCT00132314|11444934|FG001|Overall Study|Lost to Follow-up|62
7236881|NCT00132314|11444933|FG000|Overall Study|Lacked SSN|1
7236882|NCT00132314|11444934|FG001|Overall Study|Lacked SSN|3
7236883|NCT00132314|11444933|FG000|Overall Study|Refused intervention at baseline|2
7236884|NCT00132314|11444934|FG001|Overall Study|Refused intervention at baseline|7
7236885|NCT00132496|11444942|FG000|Overall Study|Withdrawal by Subject|1
7236886|NCT00132496|11444943|FG001|Overall Study|Withdrawal by Subject|2
7236887|NCT00132496|11444942|FG000|Overall Study|Physician Decision|1
7236888|NCT00132496|11444943|FG001|Overall Study|Physician Decision|0
7236889|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Death|0
7236890|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Death|0
7236891|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Death|1
7236892|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7236893|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
7236894|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
7236895|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
7236896|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
7236897|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
7236898|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7236899|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
7236900|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
7236901|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7236902|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
7236903|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
7236904|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7236905|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
7236906|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
7236907|NCT00132678|11444951|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7236908|NCT00132678|11444952|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
7236909|NCT00132678|11444953|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
7236910|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Death|2
7236911|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Death|0
7236912|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Death|0
7236913|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
7236914|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
7236915|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
7236916|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Non responder|107
7236917|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Non responder|0
7236918|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Non responder|0
7236919|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
7236920|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7236921|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
7236922|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
7236923|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7236924|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
7236925|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
7236926|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7236927|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
7236928|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
7236929|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
7236930|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
7236931|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
7236932|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
7236933|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
7236934|NCT00132678|11444951|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
7236935|NCT00132678|11444952|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
7236936|NCT00132678|11444953|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
7236937|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
7236938|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
7236939|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
7236940|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7236941|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
7236942|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
7236943|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
7236944|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
7236945|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
7236946|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
7236947|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
7236948|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
7236949|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
7236950|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
7236951|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
7236952|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
7236953|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
7236954|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
7236955|NCT00132678|11444951|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
7236956|NCT00132678|11444952|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
7236957|NCT00132678|11444953|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
7236958|NCT00132691|11444963|FG000|Overall Study|Lost to Follow-up|5
7236959|NCT00132691|11444964|FG001|Overall Study|Lost to Follow-up|8
7236960|NCT00132691|11444963|FG000|Overall Study|Missed 2-year visit|4
7236961|NCT00132691|11444964|FG001|Overall Study|Missed 2-year visit|4
7236962|NCT00132691|11444963|FG000|Overall Study|Death|2
7236963|NCT00132691|11444964|FG001|Overall Study|Death|0
7236964|NCT00132730|11444979|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
7236965|NCT00132730|11444980|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
7236966|NCT00132730|11444981|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7236967|NCT00132730|11444982|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
7236968|NCT00132730|11444983|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7236969|NCT00132730|11444984|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
7236970|NCT00132730|11444979|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7236971|NCT00132730|11444980|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
7236972|NCT00132730|11444981|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7236973|NCT00132730|11444982|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7236974|NCT00132730|11444983|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7236975|NCT00132730|11444984|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
7236976|NCT00132730|11444979|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
7236977|NCT00132730|11444980|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
7236978|NCT00132730|11444981|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
7236979|NCT00132730|11444982|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
7236980|NCT00132730|11444983|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
7236981|NCT00132730|11444984|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
7236982|NCT00132730|11444979|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
7236983|NCT00132730|11444980|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
7573756|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7573757|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7573758|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
7236984|NCT00132730|11444981|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
7236985|NCT00132730|11444982|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
7236986|NCT00132730|11444983|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
7236987|NCT00132730|11444984|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
7236988|NCT00132730|11444979|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7236989|NCT00132730|11444980|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7236990|NCT00132730|11444981|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
7573759|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7236991|NCT00132730|11444982|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
7236992|NCT00132730|11444983|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7236993|NCT00132730|11444984|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
7236994|NCT00132730|11444979|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7236995|NCT00132730|11444980|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7236996|NCT00132730|11444981|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7236997|NCT00132730|11444982|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
7236998|NCT00132730|11444983|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7236999|NCT00132730|11444984|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
7237000|NCT00132730|11444979|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
7237001|NCT00132730|11444980|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
7237002|NCT00132730|11444981|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
7237003|NCT00132730|11444982|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
7237004|NCT00132730|11444983|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
7237005|NCT00132730|11444984|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
7237006|NCT00132730|11444979|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
7237007|NCT00132730|11444980|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
7237008|NCT00132730|11444981|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
7237009|NCT00132730|11444982|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
7237010|NCT00132730|11444983|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
7237011|NCT00132730|11444984|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
7237012|NCT00132730|11444979|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7237013|NCT00132730|11444980|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7237014|NCT00132730|11444981|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7237015|NCT00132730|11444982|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7237016|NCT00132730|11444983|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
7237017|NCT00132730|11444984|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
7237018|NCT00132730|11444979|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7237019|NCT00132730|11444980|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7237020|NCT00132730|11444981|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7237021|NCT00132730|11444982|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7237022|NCT00132730|11444983|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
7237023|NCT00132730|11444984|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
7237024|NCT00132730|11444979|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
7237025|NCT00132730|11444980|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
7237026|NCT00132730|11444981|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
7237027|NCT00132730|11444982|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
7237028|NCT00132730|11444983|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
7237029|NCT00132730|11444984|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
7237030|NCT00132730|11444979|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
7237031|NCT00132730|11444980|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
7237032|NCT00132730|11444981|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
7237033|NCT00132730|11444982|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
7237034|NCT00132730|11444983|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
7237035|NCT00132730|11444984|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
7237037|NCT00132769|11445001|FG001|Overall Study|Withdrawal by Subject|3
7237038|NCT00132769|11445000|FG000|Overall Study|Lack of Efficacy|7
7237039|NCT00132769|11445001|FG001|Overall Study|Lack of Efficacy|6
7237040|NCT00132769|11445000|FG000|Overall Study|Adverse Event|2
7237041|NCT00132769|11445001|FG001|Overall Study|Adverse Event|1
7237042|NCT00132769|11445000|FG000|Overall Study|Protocol Violation|1
7237043|NCT00132769|11445001|FG001|Overall Study|Protocol Violation|1
7237044|NCT00132808|11445010|FG000|Stratum I|Adverse Event|2
7237045|NCT00132808|11445011|FG001|Stratum I|Adverse Event|1
7237046|NCT00132808|11445012|FG002|Stratum I|Adverse Event|0
7237047|NCT00132808|11445010|FG000|Stratum I|Lost to Follow-up|3
7237048|NCT00132808|11445011|FG001|Stratum I|Lost to Follow-up|4
7237049|NCT00132808|11445012|FG002|Stratum I|Lost to Follow-up|1
7237050|NCT00132808|11445010|FG000|Stratum I|Withdrawal by Subject|4
7573760|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
7573761|NCT03627767|11955235|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
7573762|NCT03627767|11955236|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
7573763|NCT03627767|11955237|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
7237051|NCT00132808|11445011|FG001|Stratum I|Withdrawal by Subject|7
7237052|NCT00132808|11445012|FG002|Stratum I|Withdrawal by Subject|3
7237053|NCT00132808|11445010|FG000|Stratum I|Abnormal test procedure result (s)|0
7237054|NCT00132808|11445011|FG001|Stratum I|Abnormal test procedure result (s)|0
7237055|NCT00132808|11445012|FG002|Stratum I|Abnormal test procedure result (s)|1
7237056|NCT00132808|11445010|FG000|Stratum II|Adverse Event|1
7237057|NCT00132808|11445011|FG001|Stratum II|Adverse Event|2
7237058|NCT00132808|11445012|FG002|Stratum II|Adverse Event|1
7237059|NCT00132808|11445010|FG000|Stratum II|Death|1
7237060|NCT00132808|11445011|FG001|Stratum II|Death|0
7237061|NCT00132808|11445012|FG002|Stratum II|Death|0
7237062|NCT00132808|11445010|FG000|Stratum II|Lost to Follow-up|2
7237063|NCT00132808|11445011|FG001|Stratum II|Lost to Follow-up|2
7237064|NCT00132808|11445012|FG002|Stratum II|Lost to Follow-up|1
7237065|NCT00132808|11445010|FG000|Stratum II|Protocol Violation|0
7237066|NCT00132808|11445011|FG001|Stratum II|Protocol Violation|2
7237067|NCT00132808|11445012|FG002|Stratum II|Protocol Violation|1
7237068|NCT00132808|11445010|FG000|Stratum II|Withdrawal by Subject|4
7237069|NCT00132808|11445011|FG001|Stratum II|Withdrawal by Subject|9
7237070|NCT00132808|11445012|FG002|Stratum II|Withdrawal by Subject|6
7237071|NCT00132873|11445020|FG000|Overall Study|Adverse Event|3
7237072|NCT00132873|11445020|FG000|Overall Study|Lost to Follow-up|1
7237073|NCT00132873|11445020|FG000|Overall Study|Lack of Efficacy|1
7237074|NCT00132873|11445020|FG000|Overall Study|Withdrawal by Subject|3
7237075|NCT00132873|11445020|FG000|Overall Study|Planned Pregnancy|1
7237076|NCT00133705|11445064|FG000|Overall Study|Withdrawal by Subject|2
7237077|NCT00133705|11445065|FG001|Overall Study|Withdrawal by Subject|3
7237078|NCT00133952|11445077|FG000|Overall Study|Adverse Event|1
7237079|NCT00133952|11445078|FG001|Overall Study|Adverse Event|2
7237080|NCT00133952|11445077|FG000|Overall Study|Death|3
7237081|NCT00133952|11445078|FG001|Overall Study|Death|2
7237082|NCT00133952|11445077|FG000|Overall Study|Lost to Follow-up|9
7237083|NCT00133952|11445078|FG001|Overall Study|Lost to Follow-up|14
7237084|NCT00133952|11445077|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
7237085|NCT00133952|11445078|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
7237086|NCT00133952|11445077|FG000|Overall Study|Protocol Violation|1
7237087|NCT00133952|11445078|FG001|Overall Study|Protocol Violation|1
7237088|NCT00133952|11445077|FG000|Overall Study|Withdrawal by Subject|20
7237089|NCT00133952|11445078|FG001|Overall Study|Withdrawal by Subject|4
7237090|NCT00133952|11445077|FG000|Overall Study|Physician Decision|4
7237091|NCT00133952|11445078|FG001|Overall Study|Physician Decision|3
7237092|NCT00133952|11445077|FG000|Overall Study|Sponsor Decision|0
7237093|NCT00133952|11445078|FG001|Overall Study|Sponsor Decision|1
7237094|NCT00133991|11445105|FG000|Overall Study|Death|4
7237095|NCT00134056|11445127|FG000|Randomization|Not eligible for assigned treatment|22
7237096|NCT00134056|11445128|FG001|Randomization|Not eligible for assigned treatment|20
7237097|NCT00134056|11445127|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7237098|NCT00134056|11445128|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
7237099|NCT00134056|11445127|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
7237100|NCT00134056|11445128|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
7237101|NCT00134056|11445127|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
7237102|NCT00134056|11445128|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
7237103|NCT00134056|11445127|FG000|Eligible for Protocol Assigned Treatment|Other|55
7237104|NCT00134056|11445128|FG001|Eligible for Protocol Assigned Treatment|Other|56
7237105|NCT00134082|11445137|FG000|Overall Study|Adverse Event|2
7237106|NCT00134082|11445137|FG000|Overall Study|Death|1
7237107|NCT00134563|11445166|FG000|Overall Study|Not treated due to protocol violation|0
7237108|NCT00134563|11445167|FG001|Overall Study|Not treated due to protocol violation|1
7237109|NCT00134563|11445168|FG002|Overall Study|Not treated due to protocol violation|1
7237110|NCT00134563|11445166|FG000|Overall Study|Adverse Event|29
7237111|NCT00134563|11445167|FG001|Overall Study|Adverse Event|37
7237112|NCT00134563|11445168|FG002|Overall Study|Adverse Event|38
7237113|NCT00134563|11445166|FG000|Overall Study|Lack of Efficacy|24
7237114|NCT00134563|11445167|FG001|Overall Study|Lack of Efficacy|14
7237115|NCT00134563|11445168|FG002|Overall Study|Lack of Efficacy|17
7237116|NCT00134563|11445166|FG000|Overall Study|Protocol Violation|3
7237117|NCT00134563|11445167|FG001|Overall Study|Protocol Violation|2
7237118|NCT00134563|11445168|FG002|Overall Study|Protocol Violation|5
7237119|NCT00134563|11445166|FG000|Overall Study|Lost to Follow-up|4
7237120|NCT00134563|11445167|FG001|Overall Study|Lost to Follow-up|0
7237121|NCT00134563|11445168|FG002|Overall Study|Lost to Follow-up|2
7237122|NCT00134563|11445166|FG000|Overall Study|progressive disease|11
7237123|NCT00134563|11445167|FG001|Overall Study|progressive disease|4
7237124|NCT00134563|11445168|FG002|Overall Study|progressive disease|2
7237125|NCT00134563|11445166|FG000|Overall Study|did not wish to continue|33
7237126|NCT00134563|11445167|FG001|Overall Study|did not wish to continue|32
7237127|NCT00134563|11445168|FG002|Overall Study|did not wish to continue|26
7237128|NCT00134563|11445166|FG000|Overall Study|Reason other than above|0
7237129|NCT00134563|11445167|FG001|Overall Study|Reason other than above|2
7237130|NCT00134563|11445168|FG002|Overall Study|Reason other than above|5
7237131|NCT00134719|11445179|FG000|Primary Vaccination Phase|Adverse Event|4
7237132|NCT00134719|11445180|FG001|Primary Vaccination Phase|Adverse Event|0
7237133|NCT00134719|11445181|FG002|Primary Vaccination Phase|Adverse Event|0
7237134|NCT00134719|11445179|FG000|Primary Vaccination Phase|Protocol Violation|1
7237135|NCT00134719|11445180|FG001|Primary Vaccination Phase|Protocol Violation|0
7237136|NCT00134719|11445181|FG002|Primary Vaccination Phase|Protocol Violation|0
7237137|NCT00134719|11445179|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
7237138|NCT00134719|11445180|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
7237139|NCT00134719|11445181|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
7237140|NCT00134719|11445179|FG000|Primary Vaccination Phase|Lost to Follow-up|7
7237141|NCT00134719|11445180|FG001|Primary Vaccination Phase|Lost to Follow-up|3
7237142|NCT00134719|11445181|FG002|Primary Vaccination Phase|Lost to Follow-up|3
7237143|NCT00134719|11445179|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7237144|NCT00134719|11445180|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
7237145|NCT00134719|11445181|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
7237146|NCT00134719|11445179|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
7237147|NCT00134719|11445180|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7237148|NCT00134719|11445181|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
7237149|NCT00134784|11445193|FG000|Overall Study|Withdrawal by Subject|2
7237150|NCT00134784|11445194|FG001|Overall Study|Withdrawal by Subject|2
7237151|NCT00134784|11445195|FG002|Overall Study|Withdrawal by Subject|2
7237152|NCT00134784|11445196|FG003|Overall Study|Withdrawal by Subject|1
7237153|NCT00134901|11445205|FG000|Overall Study|Lost to Follow-up|5
7237154|NCT00134901|11445206|FG001|Overall Study|Lost to Follow-up|5
7237155|NCT00134901|11445205|FG000|Overall Study|discontinued intervention|12
7237156|NCT00134901|11445206|FG001|Overall Study|discontinued intervention|10
7237157|NCT00135330|11445236|FG000|Overall Study|Adverse Event|2
7237158|NCT00135330|11445237|FG001|Overall Study|Adverse Event|5
7237159|NCT00135330|11445238|FG002|Overall Study|Adverse Event|1
7237160|NCT00135330|11445236|FG000|Overall Study|Lost to Follow-up|0
7237161|NCT00135330|11445237|FG001|Overall Study|Lost to Follow-up|2
7237162|NCT00135330|11445238|FG002|Overall Study|Lost to Follow-up|3
7237163|NCT00135330|11445236|FG000|Overall Study|Physician Decision|1
7237164|NCT00135330|11445237|FG001|Overall Study|Physician Decision|1
7237165|NCT00135330|11445238|FG002|Overall Study|Physician Decision|0
7237166|NCT00135330|11445236|FG000|Overall Study|Protocol Violation|4
7237167|NCT00135330|11445237|FG001|Overall Study|Protocol Violation|3
7237168|NCT00135330|11445238|FG002|Overall Study|Protocol Violation|3
7237169|NCT00135330|11445236|FG000|Overall Study|Patient Decision|5
7237170|NCT00135330|11445237|FG001|Overall Study|Patient Decision|1
7237171|NCT00135330|11445238|FG002|Overall Study|Patient Decision|4
7237172|NCT00135330|11445236|FG000|Overall Study|Sponsor Decision|0
7237173|NCT00135330|11445237|FG001|Overall Study|Sponsor Decision|1
7237174|NCT00135330|11445238|FG002|Overall Study|Sponsor Decision|0
7237175|NCT00135356|11445248|FG000|Overall Study|Adverse Event|6
7237176|NCT00135356|11445249|FG001|Overall Study|Adverse Event|2
7237177|NCT00135356|11445248|FG000|Overall Study|Lack of Efficacy|2
7237178|NCT00135356|11445249|FG001|Overall Study|Lack of Efficacy|0
7237179|NCT00135356|11445248|FG000|Overall Study|Lost to Follow-up|3
7237180|NCT00135356|11445249|FG001|Overall Study|Lost to Follow-up|1
7237181|NCT00135356|11445248|FG000|Overall Study|Surgery for abdominal fat|1
7237182|NCT00135356|11445249|FG001|Overall Study|Surgery for abdominal fat|0
7237183|NCT00135356|11445248|FG000|Overall Study|Change in antiviral regimen|0
7237184|NCT00135356|11445249|FG001|Overall Study|Change in antiviral regimen|1
7237185|NCT00135356|11445248|FG000|Overall Study|Poor/noncompliance|1
7237186|NCT00135356|11445249|FG001|Overall Study|Poor/noncompliance|1
7237187|NCT00135356|11445248|FG000|Overall Study|No longer meets study criteria|2
7237188|NCT00135356|11445249|FG001|Overall Study|No longer meets study criteria|0
7237189|NCT00135356|11445248|FG000|Overall Study|Withdrawal by Subject|2
7237190|NCT00135356|11445249|FG001|Overall Study|Withdrawal by Subject|4
7237191|NCT00135512|11445255|FG000|Overall Study|Adverse Event|56
7237192|NCT00135512|11445255|FG000|Overall Study|Lack of Efficacy|25
7237193|NCT00135512|11445255|FG000|Overall Study|Other|42
7237194|NCT00135694|11445262|FG000|Overall Study|Adverse Event|17
7237195|NCT00135694|11445263|FG001|Overall Study|Adverse Event|4
7237196|NCT00135694|11445264|FG002|Overall Study|Adverse Event|0
7237197|NCT00135694|11445262|FG000|Overall Study|Death|14
7237198|NCT00135694|11445263|FG001|Overall Study|Death|1
7237199|NCT00135694|11445264|FG002|Overall Study|Death|2
7237200|NCT00135694|11445262|FG000|Overall Study|Lost to Follow-up|8
7237201|NCT00135694|11445263|FG001|Overall Study|Lost to Follow-up|7
7237202|NCT00135694|11445264|FG002|Overall Study|Lost to Follow-up|1
7237203|NCT00135694|11445262|FG000|Overall Study|Withdrawal by Subject|41
7237204|NCT00135694|11445263|FG001|Overall Study|Withdrawal by Subject|7
7237205|NCT00135694|11445264|FG002|Overall Study|Withdrawal by Subject|4
7573764|NCT03627767|11955238|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
7573765|NCT03627767|11955239|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
7573766|NCT03627767|11955235|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7573767|NCT03627767|11955236|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7573768|NCT03627767|11955237|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7573769|NCT03627767|11955238|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
7573770|NCT03627767|11955239|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
7573771|NCT03627767|11955235|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7573772|NCT03627767|11955236|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7573773|NCT03627767|11955237|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7237206|NCT00135694|11445262|FG000|Overall Study|Protocol Violation|19
7237207|NCT00135694|11445263|FG001|Overall Study|Protocol Violation|1
7237208|NCT00135694|11445264|FG002|Overall Study|Protocol Violation|0
7237209|NCT00135694|11445262|FG000|Overall Study|Hepatitis C related reasons|39
7237210|NCT00135694|11445263|FG001|Overall Study|Hepatitis C related reasons|1
7237211|NCT00135694|11445264|FG002|Overall Study|Hepatitis C related reasons|0
7237212|NCT00135694|11445262|FG000|Overall Study|Ineligible for Random assignment|42
7237213|NCT00135694|11445263|FG001|Overall Study|Ineligible for Random assignment|0
7237214|NCT00135694|11445264|FG002|Overall Study|Ineligible for Random assignment|0
7237215|NCT00135707|11445274|FG000|Overall Study|Lost to Follow-up|94
7237216|NCT00135707|11445275|FG001|Overall Study|Lost to Follow-up|89
7237217|NCT00135707|11445274|FG000|Overall Study|Withdrawal by Subject|0
7237218|NCT00135707|11445275|FG001|Overall Study|Withdrawal by Subject|1
7237219|NCT00135707|11445274|FG000|Overall Study|Institutional review board request|1
7237220|NCT00135707|11445275|FG001|Overall Study|Institutional review board request|0
7237221|NCT00136084|11445299|FG000|Overall Study|Death|12
7237222|NCT00136084|11445300|FG001|Overall Study|Death|5
7237223|NCT00136084|11445299|FG000|Overall Study|Unacceptable toxicity|8
7237224|NCT00136084|11445300|FG001|Overall Study|Unacceptable toxicity|11
7237225|NCT00136084|11445299|FG000|Overall Study|Relapse|20
7237226|NCT00136084|11445300|FG001|Overall Study|Relapse|23
7237227|NCT00136084|11445299|FG000|Overall Study|Lost to Follow-up|2
7237228|NCT00136084|11445300|FG001|Overall Study|Lost to Follow-up|0
7237229|NCT00136084|11445299|FG000|Overall Study|No Response|1
7237230|NCT00136084|11445300|FG001|Overall Study|No Response|2
7237231|NCT00136084|11445299|FG000|Overall Study|Withdrawal by Subject|5
7237232|NCT00136084|11445300|FG001|Overall Study|Withdrawal by Subject|1
7237233|NCT00136318|11445325|FG000|Overall Study|Adverse Event|5
7237234|NCT00136318|11445326|FG001|Overall Study|Adverse Event|5
7237235|NCT00136318|11445325|FG000|Overall Study|Withdrawal by Subject|2
7237236|NCT00136318|11445326|FG001|Overall Study|Withdrawal by Subject|2
7237237|NCT00136357|11445335|FG000|Overall Study|Withdrawal by Subject|3
7237238|NCT00136357|11445336|FG001|Overall Study|Withdrawal by Subject|2
7237239|NCT00136604|11445347|FG000|Overall Study|Lost to Follow-up|1
7237240|NCT00136604|11445348|FG001|Overall Study|Lost to Follow-up|0
7237241|NCT00136604|11445349|FG002|Overall Study|Lost to Follow-up|0
7237242|NCT00136604|11445350|FG003|Overall Study|Lost to Follow-up|0
7237243|NCT00136604|11445351|FG004|Overall Study|Lost to Follow-up|1
7237244|NCT00136604|11445347|FG000|Overall Study|Migrated/moved from study area|0
7237245|NCT00136604|11445348|FG001|Overall Study|Migrated/moved from study area|1
7237246|NCT00136604|11445349|FG002|Overall Study|Migrated/moved from study area|0
7237247|NCT00136604|11445350|FG003|Overall Study|Migrated/moved from study area|0
7237248|NCT00136604|11445351|FG004|Overall Study|Migrated/moved from study area|0
7237249|NCT00136916|11445413|FG000|Overall Study|Never received study treatment|3
7237250|NCT00136916|11445414|FG001|Overall Study|Never received study treatment|5
7237251|NCT00136916|11445413|FG000|Overall Study|Death|1
7237252|NCT00136916|11445414|FG001|Overall Study|Death|3
7237253|NCT00136916|11445413|FG000|Overall Study|Adverse Event|27
7237254|NCT00136916|11445414|FG001|Overall Study|Adverse Event|8
7237255|NCT00136916|11445413|FG000|Overall Study|Laboratory abnormality|0
7237256|NCT00136916|11445414|FG001|Overall Study|Laboratory abnormality|1
7237257|NCT00136916|11445413|FG000|Overall Study|Lack of Efficacy|13
7237258|NCT00136916|11445414|FG001|Overall Study|Lack of Efficacy|3
7237259|NCT00136916|11445413|FG000|Overall Study|Lost to Follow-up|12
7237260|NCT00136916|11445414|FG001|Overall Study|Lost to Follow-up|14
7237261|NCT00136916|11445413|FG000|Overall Study|Withdrawal by Subject|44
7237262|NCT00136916|11445414|FG001|Overall Study|Withdrawal by Subject|46
7237263|NCT00136916|11445413|FG000|Overall Study|Other|22
7237264|NCT00136916|11445414|FG001|Overall Study|Other|24
7237265|NCT00136916|11445413|FG000|Overall Study|Discontinued in follow up period|3
7237266|NCT00136916|11445414|FG001|Overall Study|Discontinued in follow up period|0
7237267|NCT00136955|11445422|FG000|Overall Study|Adverse Event|8
7237268|NCT00136955|11445422|FG000|Overall Study|Lost to Follow-up|1
7237269|NCT00136955|11445422|FG000|Overall Study|Withdrawal by Subject|2
7237270|NCT00136955|11445422|FG000|Overall Study|Incl. prog. disease, protocol violation|12
7237271|NCT00137046|11445428|FG000|Overall Study|Death|2
7237272|NCT00137046|11445429|FG001|Overall Study|Death|1
7237273|NCT00137046|11445428|FG000|Overall Study|Adverse Event|16
7237274|NCT00137046|11445429|FG001|Overall Study|Adverse Event|5
7237275|NCT00137046|11445428|FG000|Overall Study|Laboratory Abnormality|2
7237276|NCT00137046|11445429|FG001|Overall Study|Laboratory Abnormality|0
7237277|NCT00137046|11445428|FG000|Overall Study|Lack of Efficacy|13
7237278|NCT00137046|11445429|FG001|Overall Study|Lack of Efficacy|1
7237279|NCT00137046|11445428|FG000|Overall Study|Lost to Follow-up|8
7237280|NCT00137046|11445429|FG001|Overall Study|Lost to Follow-up|24
7237281|NCT00137046|11445428|FG000|Overall Study|Other|23
7237282|NCT00137046|11445429|FG001|Overall Study|Other|19
7237283|NCT00137046|11445428|FG000|Overall Study|Withdrawal by Subject|33
7237284|NCT00137046|11445429|FG001|Overall Study|Withdrawal by Subject|42
7237285|NCT00137046|11445428|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
7237286|NCT00137046|11445429|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
7237287|NCT00137046|11445428|FG000|Overall Study|Withdrew prior to study treatment|1
7237288|NCT00137046|11445429|FG001|Overall Study|Withdrew prior to study treatment|1
7237289|NCT00137111|11445443|FG000|Total Therapy|Death|35
7237290|NCT00137111|11445444|FG001|Total Therapy|Death|0
7237291|NCT00137111|11445445|FG002|Total Therapy|Death|0
7237292|NCT00137111|11445446|FG003|Total Therapy|Death|0
7237293|NCT00137111|11445443|FG000|Total Therapy|Non Compliance|5
7237294|NCT00137111|11445444|FG001|Total Therapy|Non Compliance|0
7237295|NCT00137111|11445445|FG002|Total Therapy|Non Compliance|0
7237296|NCT00137111|11445446|FG003|Total Therapy|Non Compliance|0
7237297|NCT00137267|11445455|FG000|Overall Study|Lost to Follow-up|15
7237298|NCT00137267|11445456|FG001|Overall Study|Lost to Follow-up|21
7237299|NCT00137423|11445473|FG000|Overall Study|Adverse Event|7
7237300|NCT00137423|11445474|FG001|Overall Study|Adverse Event|9
7237301|NCT00137423|11445473|FG000|Overall Study|consent withdrawn|1
7237302|NCT00137423|11445474|FG001|Overall Study|consent withdrawn|1
7237303|NCT00137423|11445473|FG000|Overall Study|Lack of Efficacy|31
7237304|NCT00137423|11445474|FG001|Overall Study|Lack of Efficacy|33
7237305|NCT00137423|11445473|FG000|Overall Study|Death|0
7237306|NCT00137423|11445474|FG001|Overall Study|Death|1
7237307|NCT00137436|11445484|FG000|Overall Study|Adverse Event|13
7237308|NCT00137436|11445484|FG000|Overall Study|Death|2
7237309|NCT00137436|11445484|FG000|Overall Study|Lack of Efficacy|17
7237310|NCT00137436|11445484|FG000|Overall Study|Withdrawal by Subject|6
7237311|NCT00137436|11445484|FG000|Overall Study|Other|5
7237312|NCT00137449|11445490|FG000|Overall Study|Disease Progression|8
7237313|NCT00137449|11445491|FG001|Overall Study|Disease Progression|13
7237314|NCT00137449|11445490|FG000|Overall Study|Death|4
7237315|NCT00137449|11445491|FG001|Overall Study|Death|3
7237316|NCT00137449|11445490|FG000|Overall Study|Adverse Event|3
7237317|NCT00137449|11445491|FG001|Overall Study|Adverse Event|1
7237318|NCT00137449|11445490|FG000|Overall Study|Withdrawal by Subject|1
7237319|NCT00137449|11445491|FG001|Overall Study|Withdrawal by Subject|1
7237320|NCT00137631|11445500|FG000|Overall Study|Lost to Follow-up|37
7237321|NCT00137631|11445501|FG001|Overall Study|Lost to Follow-up|41
7237322|NCT00137839|11445507|FG000|Overall Study|Adverse Event|7
7237323|NCT00137839|11445507|FG000|Overall Study|Physician Decision|7
7237324|NCT00137839|11445507|FG000|Overall Study|Death|8
7237325|NCT00137839|11445507|FG000|Overall Study|Disease Progression|60
7237326|NCT00137839|11445507|FG000|Overall Study|Not Start Treatment|1
7237327|NCT00137839|11445507|FG000|Overall Study|Prolonged Treatment Delay|1
7237328|NCT00138424|11445552|FG000|Overall Study|Physician Decision|0
7237329|NCT00138424|11445553|FG001|Overall Study|Physician Decision|1
7237330|NCT00138424|11445554|FG002|Overall Study|Physician Decision|0
7237331|NCT00138424|11445555|FG003|Overall Study|Physician Decision|0
7237332|NCT00138658|11445576|FG000|Overall Study|Adverse Event|23
7237333|NCT00138658|11445576|FG000|Overall Study|Death|1
7237334|NCT00138658|11445576|FG000|Overall Study|Disease Progression|21
7237335|NCT00138658|11445576|FG000|Overall Study|Physician Decision|11
7237336|NCT00138658|11445576|FG000|Overall Study|Withdrawal by Subject|5
7237337|NCT00138671|11445584|FG000|Overall Study|Death|0
7237338|NCT00138671|11445585|FG001|Overall Study|Death|3
7237339|NCT00138671|11445584|FG000|Overall Study|Adverse Event|6
7237340|NCT00138671|11445585|FG001|Overall Study|Adverse Event|3
7237341|NCT00138671|11445584|FG000|Overall Study|Lost to Follow-up|1
7237342|NCT00138671|11445585|FG001|Overall Study|Lost to Follow-up|2
7237343|NCT00138671|11445584|FG000|Overall Study|Withdrawal by Subject|3
7237344|NCT00138671|11445585|FG001|Overall Study|Withdrawal by Subject|5
7237345|NCT00138671|11445584|FG000|Overall Study|Other|3
7237346|NCT00138671|11445585|FG001|Overall Study|Other|3
7237347|NCT00139477|11445604|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
7237348|NCT00139477|11445605|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
7237349|NCT00139477|11445604|FG000|First Intervention -Baseline to 6Months|Relocation|1
7237350|NCT00139477|11445605|FG001|First Intervention -Baseline to 6Months|Relocation|2
7573774|NCT03627767|11955238|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
7237351|NCT00139477|11445604|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7237352|NCT00139477|11445605|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
7237353|NCT00139477|11445604|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
7237354|NCT00139477|11445605|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
7237355|NCT00139477|11445604|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
7255821|NCT00320528|11467399|FG002|Study Period II|Entry Criteria Exclusion|2
7237356|NCT00139477|11445605|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
7237357|NCT00139477|11445604|FG000|Second Intervention -6Months to 12Months|Relocation|1
7237358|NCT00139477|11445605|FG001|Second Intervention -6Months to 12Months|Relocation|0
7237359|NCT00139477|11445604|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
7237360|NCT00139477|11445605|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
7237361|NCT00139659|11445615|FG000|Overall Study|Adverse Event|12
7237362|NCT00139659|11445616|FG001|Overall Study|Adverse Event|1
7237363|NCT00139659|11445615|FG000|Overall Study|Lack of Efficacy|1
7237364|NCT00139659|11445616|FG001|Overall Study|Lack of Efficacy|1
7237365|NCT00139659|11445615|FG000|Overall Study|Lost to Follow-up|7
7237366|NCT00139659|11445616|FG001|Overall Study|Lost to Follow-up|3
7237367|NCT00139659|11445615|FG000|Overall Study|Reason not Specified|6
7237368|NCT00139659|11445616|FG001|Overall Study|Reason not Specified|3
7237369|NCT00139659|11445615|FG000|Overall Study|Withdrawal by Subject|14
7237370|NCT00139659|11445616|FG001|Overall Study|Withdrawal by Subject|10
7237371|NCT00139737|11445626|FG000|Overall Study|Withdrawal by Subject|190
7237372|NCT00139737|11445626|FG000|Overall Study|Adverse Event|58
7573775|NCT03627767|11955239|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
7237373|NCT00139737|11445626|FG000|Overall Study|Lack of Efficacy|40
7237374|NCT00139737|11445626|FG000|Overall Study|Lost to Follow-up|8
7237375|NCT00139737|11445626|FG000|Overall Study|Death|3
7237376|NCT00139737|11445626|FG000|Overall Study|Laboratory Abnormality|2
7237377|NCT00139737|11445626|FG000|Overall Study|Protocol Violation|18
7237378|NCT00139737|11445626|FG000|Overall Study|Withdrew During Screening Phase|8
7237379|NCT00139737|11445626|FG000|Overall Study|Did Not Meet Entrance Criteria|1
7237380|NCT00139737|11445626|FG000|Overall Study|Screened, Not Treated|13
7237381|NCT00139776|11445632|FG000|Period I|Did not enter Period II|575
7237382|NCT00139776|11445633|FG001|Period I|Did not enter Period II|0
7237383|NCT00139776|11445634|FG002|Period I|Did not enter Period II|0
7237384|NCT00139776|11445635|FG003|Period I|Did not enter Period II|0
7573776|NCT03627767|11955235|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7573777|NCT03627767|11955236|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7237385|NCT00139776|11445632|FG000|Period II|Not Randomized into Period III|0
7237386|NCT00139776|11445633|FG001|Period II|Not Randomized into Period III|322
7237387|NCT00139776|11445634|FG002|Period II|Not Randomized into Period III|0
7237388|NCT00139776|11445635|FG003|Period II|Not Randomized into Period III|0
7237389|NCT00139776|11445632|FG000|Period III|Adverse Event|0
7237390|NCT00139776|11445633|FG001|Period III|Adverse Event|0
7237391|NCT00139776|11445634|FG002|Period III|Adverse Event|22
7237392|NCT00139776|11445635|FG003|Period III|Adverse Event|23
7237393|NCT00139776|11445632|FG000|Period III|Other|0
7237394|NCT00139776|11445633|FG001|Period III|Other|0
7237395|NCT00139776|11445634|FG002|Period III|Other|23
7237396|NCT00139776|11445635|FG003|Period III|Other|34
7237397|NCT00139776|11445632|FG000|Period III|Lack of Efficacy|0
7237398|NCT00139776|11445633|FG001|Period III|Lack of Efficacy|0
7237399|NCT00139776|11445634|FG002|Period III|Lack of Efficacy|10
7237400|NCT00139776|11445635|FG003|Period III|Lack of Efficacy|24
7237401|NCT00139776|11445632|FG000|Period III|Lost to Follow-up|0
7237402|NCT00139776|11445633|FG001|Period III|Lost to Follow-up|0
7573778|NCT03627767|11955237|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7237403|NCT00139776|11445634|FG002|Period III|Lost to Follow-up|5
7237404|NCT00139776|11445635|FG003|Period III|Lost to Follow-up|4
7237405|NCT00139776|11445632|FG000|Period III|Withdrawal by Subject|0
7237406|NCT00139776|11445633|FG001|Period III|Withdrawal by Subject|0
7237407|NCT00139776|11445634|FG002|Period III|Withdrawal by Subject|16
7237408|NCT00139776|11445635|FG003|Period III|Withdrawal by Subject|21
7237409|NCT00140140|11445654|FG000|Overall Study|Unacceptable toxicity|1
7237410|NCT00140140|11445655|FG001|Overall Study|Unacceptable toxicity|1
7237411|NCT00140140|11445656|FG002|Overall Study|Unacceptable toxicity|2
7237412|NCT00140140|11445654|FG000|Overall Study|Physician Decision|1
7237413|NCT00140140|11445655|FG001|Overall Study|Physician Decision|1
7237414|NCT00140140|11445656|FG002|Overall Study|Physician Decision|0
7255800|NCT00320489|11467383|FG000|Overall Study|Protocol Violation|4
7255801|NCT00320489|11467384|FG001|Overall Study|Protocol Violation|4
7255802|NCT00320489|11467383|FG000|Overall Study|Sponsor Decision|3
7255803|NCT00320489|11467384|FG001|Overall Study|Sponsor Decision|3
7255804|NCT00320489|11467383|FG000|Overall Study|Withdrawal by Subject|39
7255805|NCT00320489|11467384|FG001|Overall Study|Withdrawal by Subject|41
7255806|NCT00320515|11467390|FG000|Overall Study|Death|33
7255807|NCT00320515|11467390|FG000|Overall Study|Lost to Follow-up|6
7255808|NCT00320515|11467390|FG000|Overall Study|Physician Decision|2
7255809|NCT00320515|11467390|FG000|Overall Study|Withdrawal by Subject|8
7255810|NCT00320528|11467397|FG000|Study Period II|Adverse Event|3
7255811|NCT00320528|11467398|FG001|Study Period II|Adverse Event|4
7255812|NCT00320528|11467399|FG002|Study Period II|Adverse Event|8
7255813|NCT00320528|11467397|FG000|Study Period II|Parent/Caregiver Decision|8
7255814|NCT00320528|11467398|FG001|Study Period II|Parent/Caregiver Decision|3
7255815|NCT00320528|11467399|FG002|Study Period II|Parent/Caregiver Decision|11
7255816|NCT00320528|11467397|FG000|Study Period II|Withdrawal by Subject|0
7255817|NCT00320528|11467398|FG001|Study Period II|Withdrawal by Subject|1
7255818|NCT00320528|11467399|FG002|Study Period II|Withdrawal by Subject|1
7255819|NCT00320528|11467397|FG000|Study Period II|Entry Criteria Exclusion|0
7255820|NCT00320528|11467398|FG001|Study Period II|Entry Criteria Exclusion|2
7255822|NCT00320528|11467397|FG000|Study Period III|Adverse Event|1
7255823|NCT00320528|11467398|FG001|Study Period III|Adverse Event|0
7255824|NCT00320528|11467399|FG002|Study Period III|Adverse Event|0
7255825|NCT00320528|11467397|FG000|Study Period III|Lost to Follow-up|1
7255826|NCT00320528|11467398|FG001|Study Period III|Lost to Follow-up|0
7255827|NCT00320528|11467399|FG002|Study Period III|Lost to Follow-up|0
7255828|NCT00320528|11467397|FG000|Study Period III|Withdrawal by Subject|1
7255829|NCT00320528|11467398|FG001|Study Period III|Withdrawal by Subject|1
7255830|NCT00320528|11467399|FG002|Study Period III|Withdrawal by Subject|2
7255831|NCT00320528|11467397|FG000|Study Period III|Lack of Efficacy|2
7255832|NCT00320528|11467398|FG001|Study Period III|Lack of Efficacy|0
7255833|NCT00320528|11467399|FG002|Study Period III|Lack of Efficacy|0
7255834|NCT00320528|11467397|FG000|Study Period III|Parent/Caregiver Decision|14
7255835|NCT00320528|11467398|FG001|Study Period III|Parent/Caregiver Decision|3
7255836|NCT00320528|11467399|FG002|Study Period III|Parent/Caregiver Decision|11
7255837|NCT00320528|11467397|FG000|Study Period III|Protocol Violation|0
7255838|NCT00320528|11467398|FG001|Study Period III|Protocol Violation|1
7255839|NCT00320528|11467399|FG002|Study Period III|Protocol Violation|0
7255840|NCT00320528|11467397|FG000|Study Period III|Physician Decision|0
7255841|NCT00320528|11467398|FG001|Study Period III|Physician Decision|1
7255842|NCT00320528|11467399|FG002|Study Period III|Physician Decision|2
7255843|NCT00320528|11467397|FG000|Study Period III|Sponsor Decision|0
7255844|NCT00320528|11467398|FG001|Study Period III|Sponsor Decision|0
7255845|NCT00320528|11467399|FG002|Study Period III|Sponsor Decision|1
7255846|NCT00320528|11467397|FG000|Study Period III|Atomoxetine Commercially Available|68
7573779|NCT03627767|11955238|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
7255847|NCT00320528|11467398|FG001|Study Period III|Atomoxetine Commercially Available|25
7255848|NCT00320528|11467399|FG002|Study Period III|Atomoxetine Commercially Available|90
7255849|NCT00320541|11467409|FG000|Overall Study|Adverse Event|21
7255850|NCT00320541|11467410|FG001|Overall Study|Adverse Event|19
7255851|NCT00320541|11467409|FG000|Overall Study|Protocol Violation|0
7255852|NCT00320541|11467410|FG001|Overall Study|Protocol Violation|1
7255853|NCT00320541|11467409|FG000|Overall Study|Withdrawal by Subject|12
7237415|NCT00140413|11445717|FG000|Overall Study|Lost to Follow-up|1
7237416|NCT00140413|11445718|FG001|Overall Study|Lost to Follow-up|0
7237417|NCT00140413|11445717|FG000|Overall Study|Withdrawal by Subject|2
7237418|NCT00140413|11445718|FG001|Overall Study|Withdrawal by Subject|0
7237419|NCT00140426|11445727|FG000|Overall Study|Withdrawal by Subject|0
7237420|NCT00140426|11445728|FG001|Overall Study|Withdrawal by Subject|3
7237421|NCT00140855|11445756|FG000|Overall Study|Progressive disease|2
7237422|NCT00141037|11445762|FG000|Overall Study|Physician Decision|1
7237423|NCT00141037|11445763|FG001|Overall Study|Physician Decision|2
7237424|NCT00141037|11445762|FG000|Overall Study|Lost to Follow-up|3
7237425|NCT00141037|11445763|FG001|Overall Study|Lost to Follow-up|1
7237426|NCT00141037|11445762|FG000|Overall Study|Protocol Violation|0
7237427|NCT00141037|11445763|FG001|Overall Study|Protocol Violation|2
7237428|NCT00141037|11445762|FG000|Overall Study|Withdrawal by Subject|2
7237429|NCT00141037|11445763|FG001|Overall Study|Withdrawal by Subject|1
7237430|NCT00141037|11445762|FG000|Overall Study|Other|0
7237431|NCT00141037|11445763|FG001|Overall Study|Other|1
7237432|NCT00141037|11445762|FG000|Overall Study|Moved from area|1
7237433|NCT00141037|11445763|FG001|Overall Study|Moved from area|7
7237434|NCT00141037|11445762|FG000|Overall Study|Graft Failure|3
7237435|NCT00141037|11445763|FG001|Overall Study|Graft Failure|4
7237436|NCT00141102|11445771|FG000|Overall Study|Adverse Event|233
7237437|NCT00141102|11445772|FG001|Overall Study|Adverse Event|305
7237438|NCT00141102|11445771|FG000|Overall Study|Laboratory Abnormality|9
7237439|NCT00141102|11445772|FG001|Overall Study|Laboratory Abnormality|33
7237440|NCT00141102|11445771|FG000|Overall Study|Lack of Efficacy|21
7237441|NCT00141102|11445772|FG001|Overall Study|Lack of Efficacy|26
7237442|NCT00141102|11445771|FG000|Overall Study|Lost to Follow-up|29
7237443|NCT00141102|11445772|FG001|Overall Study|Lost to Follow-up|32
7237444|NCT00141102|11445771|FG000|Overall Study|Other|87
7237445|NCT00141102|11445772|FG001|Overall Study|Other|76
7237446|NCT00141102|11445771|FG000|Overall Study|Withdrawal by Subject|112
7237447|NCT00141102|11445772|FG001|Overall Study|Withdrawal by Subject|142
7237448|NCT00141102|11445771|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
7237449|NCT00141102|11445772|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
7237450|NCT00141102|11445771|FG000|Overall Study|Death|2
7237451|NCT00141102|11445772|FG001|Overall Study|Death|2
7237452|NCT00141219|11445786|FG000|Overall Study|Protocol violations|5
7237453|NCT00141219|11445787|FG001|Overall Study|Protocol violations|4
7237454|NCT00141219|11445786|FG000|Overall Study|Adverse Event|8
7237455|NCT00141219|11445787|FG001|Overall Study|Adverse Event|6
7237456|NCT00141219|11445786|FG000|Overall Study|Lack of Efficacy|5
7237457|NCT00141219|11445787|FG001|Overall Study|Lack of Efficacy|4
7237458|NCT00141219|11445786|FG000|Overall Study|Withdrawal by Subject|6
7237459|NCT00141219|11445787|FG001|Overall Study|Withdrawal by Subject|2
7237460|NCT00141271|11445796|FG000|Overall Study|Adverse Event|31
7237461|NCT00141271|11445797|FG001|Overall Study|Adverse Event|19
7237462|NCT00141271|11445798|FG002|Overall Study|Adverse Event|17
7237463|NCT00141271|11445796|FG000|Overall Study|Laboratory Abnormality|2
7237464|NCT00141271|11445797|FG001|Overall Study|Laboratory Abnormality|1
7237465|NCT00141271|11445798|FG002|Overall Study|Laboratory Abnormality|1
7237466|NCT00141271|11445796|FG000|Overall Study|Lack of Efficacy|7
7237467|NCT00141271|11445797|FG001|Overall Study|Lack of Efficacy|7
7237468|NCT00141271|11445798|FG002|Overall Study|Lack of Efficacy|3
7237469|NCT00141271|11445796|FG000|Overall Study|Lost to Follow-up|15
7237470|NCT00141271|11445797|FG001|Overall Study|Lost to Follow-up|15
7237471|NCT00141271|11445798|FG002|Overall Study|Lost to Follow-up|21
7237472|NCT00141271|11445796|FG000|Overall Study|Withdrawal by Subject|14
7237473|NCT00141271|11445797|FG001|Overall Study|Withdrawal by Subject|9
7237474|NCT00141271|11445798|FG002|Overall Study|Withdrawal by Subject|10
7237475|NCT00141271|11445796|FG000|Overall Study|Other|11
7237476|NCT00141271|11445797|FG001|Overall Study|Other|12
7237477|NCT00141271|11445798|FG002|Overall Study|Other|5
7237478|NCT00141297|11445808|FG000|Overall Study|Adverse Event|0
7237479|NCT00141297|11445809|FG001|Overall Study|Adverse Event|0
7237480|NCT00141297|11445810|FG002|Overall Study|Adverse Event|1
7237481|NCT00141297|11445811|FG003|Overall Study|Adverse Event|0
7237482|NCT00141297|11445812|FG004|Overall Study|Adverse Event|1
7237483|NCT00141297|11445813|FG005|Overall Study|Adverse Event|1
7237484|NCT00141297|11445814|FG006|Overall Study|Adverse Event|0
7237485|NCT00141297|11445815|FG007|Overall Study|Adverse Event|1
7237486|NCT00141297|11445816|FG008|Overall Study|Adverse Event|1
7237487|NCT00141297|11445817|FG009|Overall Study|Adverse Event|0
7237488|NCT00141297|11445808|FG000|Overall Study|Death|1
7237489|NCT00141297|11445809|FG001|Overall Study|Death|0
7237490|NCT00141297|11445810|FG002|Overall Study|Death|0
7237491|NCT00141297|11445811|FG003|Overall Study|Death|0
7237492|NCT00141297|11445812|FG004|Overall Study|Death|0
7237493|NCT00141297|11445813|FG005|Overall Study|Death|0
7237494|NCT00141297|11445814|FG006|Overall Study|Death|0
7237495|NCT00141297|11445815|FG007|Overall Study|Death|0
7237496|NCT00141297|11445816|FG008|Overall Study|Death|1
7237497|NCT00141297|11445817|FG009|Overall Study|Death|0
7237498|NCT00141297|11445808|FG000|Overall Study|Withdrawal by Subject|0
7237499|NCT00141297|11445809|FG001|Overall Study|Withdrawal by Subject|0
7237500|NCT00141297|11445810|FG002|Overall Study|Withdrawal by Subject|0
7237501|NCT00141297|11445811|FG003|Overall Study|Withdrawal by Subject|0
7237502|NCT00141297|11445812|FG004|Overall Study|Withdrawal by Subject|0
7237503|NCT00141297|11445813|FG005|Overall Study|Withdrawal by Subject|0
7237504|NCT00141297|11445814|FG006|Overall Study|Withdrawal by Subject|0
7237505|NCT00141297|11445815|FG007|Overall Study|Withdrawal by Subject|0
7237506|NCT00141297|11445816|FG008|Overall Study|Withdrawal by Subject|1
7237507|NCT00141297|11445817|FG009|Overall Study|Withdrawal by Subject|0
7237508|NCT00141297|11445808|FG000|Overall Study|Other|0
7237509|NCT00141297|11445809|FG001|Overall Study|Other|0
7237510|NCT00141297|11445810|FG002|Overall Study|Other|0
7237511|NCT00141297|11445811|FG003|Overall Study|Other|1
7237512|NCT00141297|11445812|FG004|Overall Study|Other|5
7237513|NCT00141297|11445813|FG005|Overall Study|Other|0
7237514|NCT00141297|11445814|FG006|Overall Study|Other|0
7237515|NCT00141297|11445815|FG007|Overall Study|Other|0
7237516|NCT00141297|11445816|FG008|Overall Study|Other|2
7237517|NCT00141297|11445817|FG009|Overall Study|Other|0
7237518|NCT00141297|11445808|FG000|Overall Study|Progressive Disease|2
7237519|NCT00141297|11445809|FG001|Overall Study|Progressive Disease|3
7237520|NCT00141297|11445810|FG002|Overall Study|Progressive Disease|6
7237521|NCT00141297|11445811|FG003|Overall Study|Progressive Disease|2
7237522|NCT00141297|11445812|FG004|Overall Study|Progressive Disease|15
7237523|NCT00141297|11445813|FG005|Overall Study|Progressive Disease|2
7237524|NCT00141297|11445814|FG006|Overall Study|Progressive Disease|3
7237525|NCT00141297|11445815|FG007|Overall Study|Progressive Disease|3
7237526|NCT00141297|11445816|FG008|Overall Study|Progressive Disease|15
7237527|NCT00141297|11445817|FG009|Overall Study|Progressive Disease|6
7237528|NCT00141297|11445808|FG000|Overall Study|Transitioned|0
7237529|NCT00141297|11445809|FG001|Overall Study|Transitioned|0
7237530|NCT00141297|11445810|FG002|Overall Study|Transitioned|0
7237531|NCT00141297|11445811|FG003|Overall Study|Transitioned|0
7237532|NCT00141297|11445812|FG004|Overall Study|Transitioned|1
7237533|NCT00141297|11445813|FG005|Overall Study|Transitioned|0
7237534|NCT00141297|11445814|FG006|Overall Study|Transitioned|0
7237535|NCT00141297|11445815|FG007|Overall Study|Transitioned|0
7237536|NCT00141297|11445816|FG008|Overall Study|Transitioned|0
7237537|NCT00141297|11445817|FG009|Overall Study|Transitioned|0
7237538|NCT00141453|11445852|FG000|Overall Study|Protocol Violation|6
7237539|NCT00141453|11445853|FG001|Overall Study|Protocol Violation|5
7237540|NCT00141518|11445862|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
7237541|NCT00141518|11445863|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
7237542|NCT00141518|11445864|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
7237543|NCT00141518|11445862|FG000|Overall Study|Adverse Event|7
7237544|NCT00141518|11445863|FG001|Overall Study|Adverse Event|5
7237545|NCT00141518|11445864|FG002|Overall Study|Adverse Event|2
7237546|NCT00141518|11445862|FG000|Overall Study|Withdrawal by Subject|2
7237547|NCT00141518|11445863|FG001|Overall Study|Withdrawal by Subject|0
7237548|NCT00141518|11445864|FG002|Overall Study|Withdrawal by Subject|2
7237549|NCT00141518|11445862|FG000|Overall Study|Protocol Violation|1
7237550|NCT00141518|11445863|FG001|Overall Study|Protocol Violation|1
7237551|NCT00141518|11445864|FG002|Overall Study|Protocol Violation|2
7237552|NCT00141518|11445862|FG000|Overall Study|Lack of Efficacy|5
7237553|NCT00141518|11445863|FG001|Overall Study|Lack of Efficacy|0
7237554|NCT00141518|11445864|FG002|Overall Study|Lack of Efficacy|0
7237555|NCT00141726|11445874|FG000|Overall Study|Completed <50% Scheduled Dosing|3
7237556|NCT00141778|11445891|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
7237557|NCT00141778|11445892|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
7237558|NCT00141778|11445893|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
7237559|NCT00141778|11445891|FG000|Started Study Medication|Met safety criteria for discontinuation|2
7237560|NCT00141778|11445892|FG001|Started Study Medication|Met safety criteria for discontinuation|4
7237561|NCT00141778|11445893|FG002|Started Study Medication|Met safety criteria for discontinuation|3
7237562|NCT00141778|11445891|FG000|Started Study Medication|Withdrawal by Subject|0
7237563|NCT00141778|11445892|FG001|Started Study Medication|Withdrawal by Subject|2
7237564|NCT00141778|11445893|FG002|Started Study Medication|Withdrawal by Subject|0
7237565|NCT00141778|11445891|FG000|Started Study Medication|Difficulty Swallowing|0
7237566|NCT00141778|11445892|FG001|Started Study Medication|Difficulty Swallowing|1
7237567|NCT00141778|11445893|FG002|Started Study Medication|Difficulty Swallowing|0
7237568|NCT00141778|11445891|FG000|Started Study Medication|Chest Discomfort|0
7237569|NCT00141778|11445892|FG001|Started Study Medication|Chest Discomfort|0
7237570|NCT00141778|11445893|FG002|Started Study Medication|Chest Discomfort|1
7237571|NCT00141817|11445905|FG000|Overall Study|Protocol Violation|0
7237572|NCT00141817|11445906|FG001|Overall Study|Protocol Violation|0
7237573|NCT00141817|11445907|FG002|Overall Study|Protocol Violation|1
7237574|NCT00141817|11445908|FG003|Overall Study|Protocol Violation|0
7237575|NCT00141817|11445905|FG000|Overall Study|Parent request|1
7237576|NCT00141817|11445906|FG001|Overall Study|Parent request|0
7237577|NCT00141817|11445907|FG002|Overall Study|Parent request|0
7237578|NCT00141817|11445908|FG003|Overall Study|Parent request|0
7237579|NCT00141921|11445918|FG000|Overall Study|Remain on Study|28
7237580|NCT00141921|11445918|FG000|Overall Study|Withdrawal by Subject|42
7237581|NCT00141921|11445918|FG000|Overall Study|Lost to Follow-up|19
7237582|NCT00141921|11445918|FG000|Overall Study|Noncompliance|17
7237583|NCT00141921|11445918|FG000|Overall Study|Disease Progression|7
7237584|NCT00141921|11445918|FG000|Overall Study|Protocol Deviation|7
7237585|NCT00141921|11445918|FG000|Overall Study|Adverse Event|5
7237586|NCT00141921|11445918|FG000|Overall Study|Administrative Decision|2
7237587|NCT00141921|11445918|FG000|Overall Study|Pregnancy|4
7237588|NCT00141921|11445918|FG000|Overall Study|Ineligibility Determined|2
7237589|NCT00141921|11445918|FG000|Overall Study|Other|8
7237590|NCT00142298|11445941|FG000|Overall Study|Adverse Event|10
7237591|NCT00142298|11445942|FG001|Overall Study|Adverse Event|10
7237592|NCT00142298|11445943|FG002|Overall Study|Adverse Event|1
7237593|NCT00142298|11445944|FG003|Overall Study|Adverse Event|5
7237594|NCT00142298|11445945|FG004|Overall Study|Adverse Event|2
7237595|NCT00142298|11445946|FG005|Overall Study|Adverse Event|2
7237596|NCT00142298|11445947|FG006|Overall Study|Adverse Event|0
7237597|NCT00142298|11445948|FG007|Overall Study|Adverse Event|0
7237598|NCT00142298|11445949|FG008|Overall Study|Adverse Event|0
7237599|NCT00142298|11445950|FG009|Overall Study|Adverse Event|0
7237600|NCT00142298|11445941|FG000|Overall Study|Clinical disease progression|1
7237601|NCT00142298|11445942|FG001|Overall Study|Clinical disease progression|0
7237602|NCT00142298|11445943|FG002|Overall Study|Clinical disease progression|0
7237603|NCT00142298|11445944|FG003|Overall Study|Clinical disease progression|0
7237604|NCT00142298|11445945|FG004|Overall Study|Clinical disease progression|0
7237605|NCT00142298|11445946|FG005|Overall Study|Clinical disease progression|0
7237606|NCT00142298|11445947|FG006|Overall Study|Clinical disease progression|0
7237607|NCT00142298|11445948|FG007|Overall Study|Clinical disease progression|0
7237608|NCT00142298|11445949|FG008|Overall Study|Clinical disease progression|0
7237609|NCT00142298|11445950|FG009|Overall Study|Clinical disease progression|0
7237610|NCT00142298|11445941|FG000|Overall Study|Death|1
7237611|NCT00142298|11445942|FG001|Overall Study|Death|1
7237612|NCT00142298|11445943|FG002|Overall Study|Death|1
7237613|NCT00142298|11445944|FG003|Overall Study|Death|0
7237614|NCT00142298|11445945|FG004|Overall Study|Death|0
7237615|NCT00142298|11445946|FG005|Overall Study|Death|6
7237616|NCT00142298|11445947|FG006|Overall Study|Death|0
7237617|NCT00142298|11445948|FG007|Overall Study|Death|0
7237618|NCT00142298|11445949|FG008|Overall Study|Death|0
7237619|NCT00142298|11445950|FG009|Overall Study|Death|0
7237620|NCT00142298|11445941|FG000|Overall Study|Lack of Efficacy|44
7237621|NCT00142298|11445942|FG001|Overall Study|Lack of Efficacy|62
7237622|NCT00142298|11445943|FG002|Overall Study|Lack of Efficacy|9
7237623|NCT00142298|11445944|FG003|Overall Study|Lack of Efficacy|12
7237624|NCT00142298|11445945|FG004|Overall Study|Lack of Efficacy|1
7237625|NCT00142298|11445946|FG005|Overall Study|Lack of Efficacy|0
7237626|NCT00142298|11445947|FG006|Overall Study|Lack of Efficacy|0
7237627|NCT00142298|11445948|FG007|Overall Study|Lack of Efficacy|1
7237628|NCT00142298|11445949|FG008|Overall Study|Lack of Efficacy|0
7237629|NCT00142298|11445950|FG009|Overall Study|Lack of Efficacy|0
7237630|NCT00142298|11445941|FG000|Overall Study|Non-compliance|15
7237631|NCT00142298|11445942|FG001|Overall Study|Non-compliance|13
7237632|NCT00142298|11445943|FG002|Overall Study|Non-compliance|0
7237633|NCT00142298|11445944|FG003|Overall Study|Non-compliance|6
7237634|NCT00142298|11445945|FG004|Overall Study|Non-compliance|1
7237635|NCT00142298|11445946|FG005|Overall Study|Non-compliance|0
7237636|NCT00142298|11445947|FG006|Overall Study|Non-compliance|0
7237637|NCT00142298|11445948|FG007|Overall Study|Non-compliance|3
7237638|NCT00142298|11445949|FG008|Overall Study|Non-compliance|3
7237639|NCT00142298|11445950|FG009|Overall Study|Non-compliance|0
7237640|NCT00142298|11445941|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
7237641|NCT00142298|11445942|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
7237642|NCT00142298|11445943|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
7237643|NCT00142298|11445944|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
7237644|NCT00142298|11445945|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
7237645|NCT00142298|11445946|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
7237646|NCT00142298|11445947|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
7237647|NCT00142298|11445948|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
7237648|NCT00142298|11445949|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
7237649|NCT00142298|11445950|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
7237650|NCT00142298|11445941|FG000|Overall Study|Pregnancy|4
7237651|NCT00142298|11445942|FG001|Overall Study|Pregnancy|4
7237652|NCT00142298|11445943|FG002|Overall Study|Pregnancy|2
7237653|NCT00142298|11445944|FG003|Overall Study|Pregnancy|3
7237654|NCT00142298|11445945|FG004|Overall Study|Pregnancy|0
7237655|NCT00142298|11445946|FG005|Overall Study|Pregnancy|0
7237656|NCT00142298|11445947|FG006|Overall Study|Pregnancy|0
7237657|NCT00142298|11445948|FG007|Overall Study|Pregnancy|0
7237658|NCT00142298|11445949|FG008|Overall Study|Pregnancy|1
7237659|NCT00142298|11445950|FG009|Overall Study|Pregnancy|0
7237660|NCT00142298|11445941|FG000|Overall Study|Virologic breakthrough|19
7237661|NCT00142298|11445942|FG001|Overall Study|Virologic breakthrough|23
7237662|NCT00142298|11445943|FG002|Overall Study|Virologic breakthrough|9
7237663|NCT00142298|11445944|FG003|Overall Study|Virologic breakthrough|7
7237664|NCT00142298|11445945|FG004|Overall Study|Virologic breakthrough|2
7237665|NCT00142298|11445946|FG005|Overall Study|Virologic breakthrough|3
7237666|NCT00142298|11445947|FG006|Overall Study|Virologic breakthrough|3
7237667|NCT00142298|11445948|FG007|Overall Study|Virologic breakthrough|0
7237668|NCT00142298|11445949|FG008|Overall Study|Virologic breakthrough|0
7237669|NCT00142298|11445950|FG009|Overall Study|Virologic breakthrough|0
7237670|NCT00142298|11445941|FG000|Overall Study|Other- not specified|0
7237671|NCT00142298|11445942|FG001|Overall Study|Other- not specified|3
7237672|NCT00142298|11445943|FG002|Overall Study|Other- not specified|0
7237673|NCT00142298|11445944|FG003|Overall Study|Other- not specified|1
7237674|NCT00142298|11445945|FG004|Overall Study|Other- not specified|0
7237675|NCT00142298|11445946|FG005|Overall Study|Other- not specified|0
7237676|NCT00142298|11445947|FG006|Overall Study|Other- not specified|0
7237677|NCT00142298|11445948|FG007|Overall Study|Other- not specified|0
7237678|NCT00142298|11445949|FG008|Overall Study|Other- not specified|0
7237679|NCT00142298|11445950|FG009|Overall Study|Other- not specified|0
7237680|NCT00142298|11445941|FG000|Overall Study|Lost to Follow-up|0
7237681|NCT00142298|11445942|FG001|Overall Study|Lost to Follow-up|0
7237682|NCT00142298|11445943|FG002|Overall Study|Lost to Follow-up|0
7237683|NCT00142298|11445944|FG003|Overall Study|Lost to Follow-up|0
7237684|NCT00142298|11445945|FG004|Overall Study|Lost to Follow-up|0
7237685|NCT00142298|11445946|FG005|Overall Study|Lost to Follow-up|0
7237686|NCT00142298|11445947|FG006|Overall Study|Lost to Follow-up|2
7237687|NCT00142298|11445948|FG007|Overall Study|Lost to Follow-up|0
7237688|NCT00142298|11445949|FG008|Overall Study|Lost to Follow-up|0
7237689|NCT00142298|11445950|FG009|Overall Study|Lost to Follow-up|0
7237690|NCT00142298|11445941|FG000|Overall Study|Treatment Failure|0
7237691|NCT00142298|11445942|FG001|Overall Study|Treatment Failure|0
7237692|NCT00142298|11445943|FG002|Overall Study|Treatment Failure|0
7237693|NCT00142298|11445944|FG003|Overall Study|Treatment Failure|0
7237694|NCT00142298|11445945|FG004|Overall Study|Treatment Failure|0
7237695|NCT00142298|11445946|FG005|Overall Study|Treatment Failure|2
7237696|NCT00142298|11445947|FG006|Overall Study|Treatment Failure|2
7237697|NCT00142298|11445948|FG007|Overall Study|Treatment Failure|0
7237698|NCT00142298|11445949|FG008|Overall Study|Treatment Failure|0
7237699|NCT00142298|11445950|FG009|Overall Study|Treatment Failure|0
7237700|NCT00142415|11445978|FG000|Overall Study|Physician Decision|0
7237701|NCT00142415|11445979|FG001|Overall Study|Physician Decision|0
7237702|NCT00142415|11445980|FG002|Overall Study|Physician Decision|0
7237703|NCT00142415|11445981|FG003|Overall Study|Physician Decision|0
7237704|NCT00142415|11445982|FG004|Overall Study|Physician Decision|1
7237705|NCT00142415|11445983|FG005|Overall Study|Physician Decision|2
7237706|NCT00142792|11446024|FG000|Overall Study|Death|0
7237707|NCT00142792|11446025|FG001|Overall Study|Death|0
7237708|NCT00142792|11446026|FG002|Overall Study|Death|1
7237709|NCT00142792|11446024|FG000|Overall Study|Withdrawal by Subject|3
7237710|NCT00142792|11446025|FG001|Overall Study|Withdrawal by Subject|2
7237711|NCT00142792|11446026|FG002|Overall Study|Withdrawal by Subject|3
7237712|NCT00142792|11446024|FG000|Overall Study|Lost to Follow-up|8
7237713|NCT00142792|11446025|FG001|Overall Study|Lost to Follow-up|11
7237714|NCT00142792|11446026|FG002|Overall Study|Lost to Follow-up|7
7237715|NCT00142792|11446024|FG000|Overall Study|No category|1
7237716|NCT00142792|11446025|FG001|Overall Study|No category|2
7464935|NCT01876446|11763820|FG000|Overall Study|Death|0
7237717|NCT00142792|11446026|FG002|Overall Study|No category|1
7237718|NCT00142909|11446057|FG000|Randomization|Various Reasons|7
7237719|NCT00142909|11446058|FG001|Randomization|Various Reasons|10
7237720|NCT00142909|11446057|FG000|Medications Begin|Protocol Violation|2
7237721|NCT00142909|11446058|FG001|Medications Begin|Protocol Violation|0
7237722|NCT00142909|11446057|FG000|Medications Begin|Withdrawal by Subject|5
7237723|NCT00142909|11446058|FG001|Medications Begin|Withdrawal by Subject|3
7237724|NCT00142909|11446057|FG000|Medications Begin|Withdrawal by Subject|2
7237725|NCT00142909|11446058|FG001|Medications Begin|Withdrawal by Subject|0
7237726|NCT00142935|11446067|FG000|Overall Study|Other reason|1
7237727|NCT00142935|11446068|FG001|Overall Study|Other reason|1
7237728|NCT00142935|11446069|FG002|Overall Study|Other reason|1
7237729|NCT00142935|11446067|FG000|Overall Study|Lost to Follow-up|2
7237730|NCT00142935|11446068|FG001|Overall Study|Lost to Follow-up|5
7237731|NCT00142935|11446069|FG002|Overall Study|Lost to Follow-up|5
7237732|NCT00142935|11446067|FG000|Overall Study|Death|0
7237733|NCT00142935|11446068|FG001|Overall Study|Death|2
7237734|NCT00142935|11446069|FG002|Overall Study|Death|1
7237735|NCT00143247|11446081|FG000|Overall Study|Death|8
7237736|NCT00143247|11446081|FG000|Overall Study|Adverse Event|19
7237737|NCT00143247|11446081|FG000|Overall Study|Lack of Efficacy|3
7237738|NCT00143247|11446081|FG000|Overall Study|Withdrawal by Subject|55
7237739|NCT00143247|11446081|FG000|Overall Study|Study terminated by sponsor|31
7237740|NCT00143247|11446081|FG000|Overall Study|Protocol Violation|15
7237741|NCT00143247|11446081|FG000|Overall Study|Lost to Follow-up|12
7237742|NCT00143247|11446081|FG000|Overall Study|following inaccurate lab adverse event|1
7237743|NCT00143247|11446081|FG000|Overall Study|Other|12
7237744|NCT00143312|11446085|FG000|Overall Study|Death|11
7237745|NCT00143312|11446085|FG000|Overall Study|Adverse Event|2
7237746|NCT00143312|11446085|FG000|Overall Study|Lost to Follow-up|1
7237747|NCT00143312|11446085|FG000|Overall Study|Other|1
7237748|NCT00143312|11446085|FG000|Overall Study|Withdrawal by Subject|1
7237749|NCT00143390|11446091|FG000|Overall Study|Death|2
7237750|NCT00143390|11446092|FG001|Overall Study|Death|0
7237751|NCT00143390|11446091|FG000|Overall Study|Not meeting entry criteria|2
7237752|NCT00143390|11446092|FG001|Overall Study|Not meeting entry criteria|5
7237753|NCT00143390|11446091|FG000|Overall Study|Withdrawal by Subject|4
7237754|NCT00143390|11446092|FG001|Overall Study|Withdrawal by Subject|4
7237755|NCT00143390|11446091|FG000|Overall Study|Progressive disease|119
7237756|NCT00143390|11446092|FG001|Overall Study|Progressive disease|115
7237757|NCT00143390|11446091|FG000|Overall Study|Protocol Violation|2
7237758|NCT00143390|11446092|FG001|Overall Study|Protocol Violation|0
7237759|NCT00143390|11446091|FG000|Overall Study|Study termination|10
7237760|NCT00143390|11446092|FG001|Overall Study|Study termination|15
7237761|NCT00143390|11446091|FG000|Overall Study|Adverse Event|9
7237762|NCT00143390|11446092|FG001|Overall Study|Adverse Event|8
7237763|NCT00143390|11446091|FG000|Overall Study|Other|1
7237764|NCT00143390|11446092|FG001|Overall Study|Other|2
7237765|NCT00143403|11446100|FG000|Overall Study|Adverse Event|3
7237766|NCT00143403|11446101|FG001|Overall Study|Adverse Event|8
7237767|NCT00143403|11446100|FG000|Overall Study|Death|1
7237768|NCT00143403|11446101|FG001|Overall Study|Death|0
7237769|NCT00143403|11446100|FG000|Overall Study|Withdrawal by Subject|3
7237770|NCT00143403|11446101|FG001|Overall Study|Withdrawal by Subject|12
7237771|NCT00143403|11446100|FG000|Overall Study|Relapse|15
7237772|NCT00143403|11446101|FG001|Overall Study|Relapse|7
7237773|NCT00143403|11446100|FG000|Overall Study|Protocol Violation|2
7237774|NCT00143403|11446101|FG001|Overall Study|Protocol Violation|2
7237775|NCT00143403|11446100|FG000|Overall Study|specified by site|4
7237776|NCT00143403|11446101|FG001|Overall Study|specified by site|9
7237777|NCT00143403|11446100|FG000|Overall Study|Randomized Not Treated|7
7237778|NCT00143403|11446101|FG001|Overall Study|Randomized Not Treated|8
7237779|NCT00143455|11446111|FG000|Cohort 1|Adverse Event|8
7237780|NCT00143455|11446112|FG001|Cohort 1|Adverse Event|4
7237781|NCT00143455|11446113|FG002|Cohort 1|Adverse Event|0
7237782|NCT00143455|11446114|FG003|Cohort 1|Adverse Event|0
7237783|NCT00143455|11446111|FG000|Cohort 1|Death|5
7237784|NCT00143455|11446112|FG001|Cohort 1|Death|2
7237785|NCT00143455|11446113|FG002|Cohort 1|Death|0
7237786|NCT00143455|11446114|FG003|Cohort 1|Death|0
7237787|NCT00143455|11446111|FG000|Cohort 1|Progressive Disease|0
7237788|NCT00143455|11446112|FG001|Cohort 1|Progressive Disease|6
7237789|NCT00143455|11446113|FG002|Cohort 1|Progressive Disease|0
7237790|NCT00143455|11446114|FG003|Cohort 1|Progressive Disease|0
7237791|NCT00143455|11446111|FG000|Cohort 1|Withdrawal by Subject|1
7237792|NCT00143455|11446112|FG001|Cohort 1|Withdrawal by Subject|4
7237793|NCT00143455|11446113|FG002|Cohort 1|Withdrawal by Subject|0
7237794|NCT00143455|11446114|FG003|Cohort 1|Withdrawal by Subject|0
7237795|NCT00143455|11446111|FG000|Cohort 1|Randomized But Not Treated|0
7237796|NCT00143455|11446112|FG001|Cohort 1|Randomized But Not Treated|1
7237797|NCT00143455|11446113|FG002|Cohort 1|Randomized But Not Treated|0
7237798|NCT00143455|11446114|FG003|Cohort 1|Randomized But Not Treated|0
7237799|NCT00143455|11446111|FG000|Cohort 2|Adverse Event|0
7237800|NCT00143455|11446112|FG001|Cohort 2|Adverse Event|0
7237801|NCT00143455|11446113|FG002|Cohort 2|Adverse Event|42
7237802|NCT00143455|11446114|FG003|Cohort 2|Adverse Event|30
7237803|NCT00143455|11446111|FG000|Cohort 2|No Longer Required Study Treatment|0
7237804|NCT00143455|11446112|FG001|Cohort 2|No Longer Required Study Treatment|0
7237805|NCT00143455|11446113|FG002|Cohort 2|No Longer Required Study Treatment|1
7237806|NCT00143455|11446114|FG003|Cohort 2|No Longer Required Study Treatment|0
7237807|NCT00143455|11446111|FG000|Cohort 2|Protocol Violation|0
7237808|NCT00143455|11446112|FG001|Cohort 2|Protocol Violation|0
7237809|NCT00143455|11446113|FG002|Cohort 2|Protocol Violation|1
7237810|NCT00143455|11446114|FG003|Cohort 2|Protocol Violation|1
7237811|NCT00143455|11446111|FG000|Cohort 2|Lost to Follow-up|0
7237812|NCT00143455|11446112|FG001|Cohort 2|Lost to Follow-up|0
7237813|NCT00143455|11446113|FG002|Cohort 2|Lost to Follow-up|1
7237814|NCT00143455|11446114|FG003|Cohort 2|Lost to Follow-up|4
7237815|NCT00143455|11446111|FG000|Cohort 2|Death|0
7237816|NCT00143455|11446112|FG001|Cohort 2|Death|0
7237817|NCT00143455|11446113|FG002|Cohort 2|Death|20
7237818|NCT00143455|11446114|FG003|Cohort 2|Death|12
7237819|NCT00143455|11446111|FG000|Cohort 2|Progressive Disease|0
7237820|NCT00143455|11446112|FG001|Cohort 2|Progressive Disease|0
7237821|NCT00143455|11446113|FG002|Cohort 2|Progressive Disease|20
7237822|NCT00143455|11446114|FG003|Cohort 2|Progressive Disease|27
7237823|NCT00143455|11446111|FG000|Cohort 2|Withdrawal by Subject|0
7237824|NCT00143455|11446112|FG001|Cohort 2|Withdrawal by Subject|0
7237825|NCT00143455|11446113|FG002|Cohort 2|Withdrawal by Subject|13
7237826|NCT00143455|11446114|FG003|Cohort 2|Withdrawal by Subject|12
7237827|NCT00143455|11446111|FG000|Cohort 2|Other|0
7237828|NCT00143455|11446112|FG001|Cohort 2|Other|0
7237829|NCT00143455|11446113|FG002|Cohort 2|Other|7
7237830|NCT00143455|11446114|FG003|Cohort 2|Other|6
7237831|NCT00143455|11446111|FG000|Cohort 2|Randomized But Not Treated|0
7237832|NCT00143455|11446112|FG001|Cohort 2|Randomized But Not Treated|0
7237833|NCT00143455|11446113|FG002|Cohort 2|Randomized But Not Treated|1
7237834|NCT00143455|11446114|FG003|Cohort 2|Randomized But Not Treated|1
7237835|NCT00143507|11446128|FG000|Overall Study|Death|572
7237836|NCT00143507|11446129|FG001|Overall Study|Death|547
7237837|NCT00143507|11446128|FG000|Overall Study|Withdrawal by Subject|114
7237838|NCT00143507|11446129|FG001|Overall Study|Withdrawal by Subject|102
7237839|NCT00143507|11446128|FG000|Overall Study|Lost to Follow-up|1
7237840|NCT00143507|11446129|FG001|Overall Study|Lost to Follow-up|0
7237841|NCT00143507|11446128|FG000|Overall Study|Withdrawn by sponsor's decision|0
7237842|NCT00143507|11446129|FG001|Overall Study|Withdrawn by sponsor's decision|3
7237843|NCT00143598|11446137|FG000|Overall Study|Lost to Follow-up|23
7237844|NCT00143598|11446138|FG001|Overall Study|Lost to Follow-up|21
7237845|NCT00143598|11446137|FG000|Overall Study|Withdrawal by Subject|33
7237846|NCT00143598|11446138|FG001|Overall Study|Withdrawal by Subject|37
7237847|NCT00143598|11446137|FG000|Overall Study|Death|36
7237848|NCT00143598|11446138|FG001|Overall Study|Death|36
7237849|NCT00144027|11446163|FG000|Overall Study|Lost to Follow-up|1
7237850|NCT00144027|11446164|FG001|Overall Study|Lost to Follow-up|3
7237851|NCT00144027|11446163|FG000|Overall Study|Withdrawal by Subject|2
7237852|NCT00144027|11446164|FG001|Overall Study|Withdrawal by Subject|2
7237853|NCT00144027|11446163|FG000|Overall Study|did not complete baseline assessment|0
7237854|NCT00144027|11446164|FG001|Overall Study|did not complete baseline assessment|6
7237855|NCT00144170|11446172|FG000|Overall Study|Adverse Event|84
7237856|NCT00144170|11446173|FG001|Overall Study|Adverse Event|41
7237857|NCT00144170|11446172|FG000|Overall Study|Protocol Violation|23
7237858|NCT00144170|11446173|FG001|Overall Study|Protocol Violation|16
7237859|NCT00144170|11446172|FG000|Overall Study|Lost to Follow-up|5
7237860|NCT00144170|11446173|FG001|Overall Study|Lost to Follow-up|10
7237861|NCT00144170|11446172|FG000|Overall Study|Withdrawal by Subject|29
7237862|NCT00144170|11446173|FG001|Overall Study|Withdrawal by Subject|13
7237863|NCT00144170|11446172|FG000|Overall Study|Other reason not defined above|211
7237864|NCT00144170|11446173|FG001|Overall Study|Other reason not defined above|316
7237865|NCT00144300|11446181|FG000|Overall Study|Adverse Event|18
7237866|NCT00144300|11446182|FG001|Overall Study|Adverse Event|16
7237867|NCT00144300|11446181|FG000|Overall Study|Protocol Violation|1
7237868|NCT00144300|11446182|FG001|Overall Study|Protocol Violation|3
7237869|NCT00144300|11446181|FG000|Overall Study|Lost to Follow-up|3
7237870|NCT00144300|11446182|FG001|Overall Study|Lost to Follow-up|0
7237871|NCT00144300|11446181|FG000|Overall Study|Withdrawal by Subject|6
7237872|NCT00144300|11446182|FG001|Overall Study|Withdrawal by Subject|6
7237873|NCT00144300|11446181|FG000|Overall Study|Other reason (not specified)|1
7237874|NCT00144300|11446182|FG001|Overall Study|Other reason (not specified)|3
7237875|NCT00144339|11446190|FG000|Overall Study|Adverse Event|746
7237876|NCT00144339|11446191|FG001|Overall Study|Adverse Event|627
7237877|NCT00144339|11446190|FG000|Overall Study|Protocol Violation|75
7237878|NCT00144339|11446191|FG001|Overall Study|Protocol Violation|48
7237879|NCT00144339|11446190|FG000|Overall Study|Withdrawal by Subject|403
7237880|NCT00144339|11446191|FG001|Overall Study|Withdrawal by Subject|300
7237881|NCT00144339|11446190|FG000|Overall Study|Lost to Follow-up|76
7237882|NCT00144339|11446191|FG001|Overall Study|Lost to Follow-up|64
7237883|NCT00144339|11446190|FG000|Overall Study|Other|58
7237884|NCT00144339|11446191|FG001|Overall Study|Other|60
7237885|NCT00144781|11446210|FG000|Overall Study|Adverse Event|0
7237886|NCT00144781|11446211|FG001|Overall Study|Adverse Event|1
7237887|NCT00144781|11446212|FG002|Overall Study|Adverse Event|0
7237888|NCT00144781|11446213|FG003|Overall Study|Adverse Event|0
7237889|NCT00144781|11446210|FG000|Overall Study|Non-compliant|0
7237890|NCT00144781|11446211|FG001|Overall Study|Non-compliant|1
7237891|NCT00144781|11446212|FG002|Overall Study|Non-compliant|0
7237892|NCT00144781|11446213|FG003|Overall Study|Non-compliant|0
7237893|NCT00145119|11446231|FG000|Overall Study|Death|45
7237894|NCT00145327|11446255|FG000|Overall Study|Withdrawal by Subject|77
7237895|NCT00145327|11446256|FG001|Overall Study|Withdrawal by Subject|72
7237896|NCT00145327|11446257|FG002|Overall Study|Withdrawal by Subject|164
7237897|NCT00145327|11446255|FG000|Overall Study|Death|26
7237898|NCT00145327|11446256|FG001|Overall Study|Death|18
7237899|NCT00145327|11446257|FG002|Overall Study|Death|30
7237900|NCT00145327|11446255|FG000|Overall Study|Adverse Event|14
7237901|NCT00145327|11446256|FG001|Overall Study|Adverse Event|11
7237902|NCT00145327|11446257|FG002|Overall Study|Adverse Event|22
7237903|NCT00145327|11446255|FG000|Overall Study|Lost to Follow-up|9
7237904|NCT00145327|11446256|FG001|Overall Study|Lost to Follow-up|14
7237905|NCT00145327|11446257|FG002|Overall Study|Lost to Follow-up|14
7237906|NCT00145327|11446255|FG000|Overall Study|Administrative problems|12
7237907|NCT00145327|11446256|FG001|Overall Study|Administrative problems|9
7237908|NCT00145327|11446257|FG002|Overall Study|Administrative problems|13
7237909|NCT00145327|11446255|FG000|Overall Study|Protocol Violation|2
7237910|NCT00145327|11446256|FG001|Overall Study|Protocol Violation|0
7237911|NCT00145327|11446257|FG002|Overall Study|Protocol Violation|2
7237912|NCT00145327|11446255|FG000|Overall Study|Abnormal laboratory value(s)|1
7237913|NCT00145327|11446256|FG001|Overall Study|Abnormal laboratory value(s)|0
7237914|NCT00145327|11446257|FG002|Overall Study|Abnormal laboratory value(s)|2
7237915|NCT00145327|11446255|FG000|Overall Study|Missing - not stated|1
7237916|NCT00145327|11446256|FG001|Overall Study|Missing - not stated|0
7237917|NCT00145327|11446257|FG002|Overall Study|Missing - not stated|1
7237918|NCT00145574|11446272|FG000|Double Blind|Adverse Event|0
7237919|NCT00145574|11446273|FG001|Double Blind|Adverse Event|3
7237920|NCT00145574|11446274|FG002|Double Blind|Adverse Event|1
7237921|NCT00145574|11446272|FG000|Double Blind|Withdrawal by Subject|1
7237922|NCT00145574|11446273|FG001|Double Blind|Withdrawal by Subject|1
7237923|NCT00145574|11446274|FG002|Double Blind|Withdrawal by Subject|1
7237924|NCT00145574|11446272|FG000|Double Blind|required restricted medicine|0
7237925|NCT00145574|11446273|FG001|Double Blind|required restricted medicine|1
7237926|NCT00145574|11446274|FG002|Double Blind|required restricted medicine|0
7237927|NCT00145574|11446272|FG000|Open Label Long-term Extension|Adverse Event|0
7237928|NCT00145574|11446273|FG001|Open Label Long-term Extension|Adverse Event|0
7237929|NCT00145574|11446274|FG002|Open Label Long-term Extension|Adverse Event|5
7237930|NCT00145574|11446272|FG000|Open Label Long-term Extension|Lost to Follow-up|0
7237931|NCT00145574|11446273|FG001|Open Label Long-term Extension|Lost to Follow-up|0
7237932|NCT00145574|11446274|FG002|Open Label Long-term Extension|Lost to Follow-up|1
7237933|NCT00145574|11446272|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
7237934|NCT00145574|11446273|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
7237935|NCT00145574|11446274|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
7237936|NCT00145574|11446272|FG000|Open Label Long-term Extension|required restricted medicine|0
7237937|NCT00145574|11446273|FG001|Open Label Long-term Extension|required restricted medicine|0
7237938|NCT00145574|11446274|FG002|Open Label Long-term Extension|required restricted medicine|1
7237939|NCT00145626|11446298|FG000|Overall Study|Did not have NK infusions|2
7237940|NCT00145626|11446298|FG000|Overall Study|Turned 2 years old before treatment|1
7237941|NCT00145626|11446298|FG000|Overall Study|Death|1
7237942|NCT00145626|11446298|FG000|Overall Study|Withdrawal by Subject|1
7573780|NCT03627767|11955239|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
7573781|NCT03627767|11955235|FG000|Open-label Rescue Period (12 Weeks)|Other|0
7573782|NCT03627767|11955236|FG001|Open-label Rescue Period (12 Weeks)|Other|0
7573783|NCT03627767|11955237|FG002|Open-label Rescue Period (12 Weeks)|Other|0
7237943|NCT00145977|11446320|FG000|Overall Study|Lack of Efficacy|0
7237944|NCT00145977|11446321|FG001|Overall Study|Lack of Efficacy|4
7237945|NCT00145977|11446320|FG000|Overall Study|Lost to Follow-up|1
7237946|NCT00145977|11446321|FG001|Overall Study|Lost to Follow-up|0
7237947|NCT00145977|11446320|FG000|Overall Study|Withdrawal by Subject|1
7237948|NCT00145977|11446321|FG001|Overall Study|Withdrawal by Subject|0
7237949|NCT00146172|11446335|FG000|Overall Study|Adverse Event|0
7237950|NCT00146172|11446336|FG001|Overall Study|Adverse Event|0
7237951|NCT00146172|11446337|FG002|Overall Study|Adverse Event|1
7237952|NCT00146172|11446338|FG003|Overall Study|Adverse Event|1
7237953|NCT00146172|11446339|FG004|Overall Study|Adverse Event|0
7237954|NCT00146172|11446340|FG005|Overall Study|Adverse Event|2
7237955|NCT00146172|11446341|FG006|Overall Study|Adverse Event|3
7237956|NCT00146172|11446342|FG007|Overall Study|Adverse Event|10
7237957|NCT00146172|11446335|FG000|Overall Study|Lost to Follow-up|0
7237958|NCT00146172|11446336|FG001|Overall Study|Lost to Follow-up|0
7237959|NCT00146172|11446337|FG002|Overall Study|Lost to Follow-up|0
7237960|NCT00146172|11446338|FG003|Overall Study|Lost to Follow-up|0
7237961|NCT00146172|11446339|FG004|Overall Study|Lost to Follow-up|0
7237962|NCT00146172|11446340|FG005|Overall Study|Lost to Follow-up|0
7237963|NCT00146172|11446341|FG006|Overall Study|Lost to Follow-up|0
7237964|NCT00146172|11446342|FG007|Overall Study|Lost to Follow-up|1
7237965|NCT00146172|11446335|FG000|Overall Study|Disease Progression|2
7237966|NCT00146172|11446336|FG001|Overall Study|Disease Progression|4
7237967|NCT00146172|11446337|FG002|Overall Study|Disease Progression|2
7237968|NCT00146172|11446338|FG003|Overall Study|Disease Progression|5
7237969|NCT00146172|11446339|FG004|Overall Study|Disease Progression|2
7237970|NCT00146172|11446340|FG005|Overall Study|Disease Progression|2
7237971|NCT00146172|11446341|FG006|Overall Study|Disease Progression|1
7237972|NCT00146172|11446342|FG007|Overall Study|Disease Progression|22
7237973|NCT00146172|11446335|FG000|Overall Study|Death|0
7237974|NCT00146172|11446336|FG001|Overall Study|Death|0
7237975|NCT00146172|11446337|FG002|Overall Study|Death|0
7237976|NCT00146172|11446338|FG003|Overall Study|Death|0
7237977|NCT00146172|11446339|FG004|Overall Study|Death|0
7237978|NCT00146172|11446340|FG005|Overall Study|Death|0
7237979|NCT00146172|11446341|FG006|Overall Study|Death|1
7237980|NCT00146172|11446342|FG007|Overall Study|Death|0
7237981|NCT00146172|11446335|FG000|Overall Study|Physician Decision|0
7237982|NCT00146172|11446336|FG001|Overall Study|Physician Decision|0
7237983|NCT00146172|11446337|FG002|Overall Study|Physician Decision|0
7237984|NCT00146172|11446338|FG003|Overall Study|Physician Decision|0
7237985|NCT00146172|11446339|FG004|Overall Study|Physician Decision|0
7237986|NCT00146172|11446340|FG005|Overall Study|Physician Decision|0
7237987|NCT00146172|11446341|FG006|Overall Study|Physician Decision|0
7237988|NCT00146172|11446342|FG007|Overall Study|Physician Decision|1
7237989|NCT00146172|11446335|FG000|Overall Study|Withdrawal by Subject|0
7237990|NCT00146172|11446336|FG001|Overall Study|Withdrawal by Subject|0
7237991|NCT00146172|11446337|FG002|Overall Study|Withdrawal by Subject|0
7237992|NCT00146172|11446338|FG003|Overall Study|Withdrawal by Subject|0
7237993|NCT00146172|11446339|FG004|Overall Study|Withdrawal by Subject|0
7237994|NCT00146172|11446340|FG005|Overall Study|Withdrawal by Subject|1
7237995|NCT00146172|11446341|FG006|Overall Study|Withdrawal by Subject|1
7237996|NCT00146172|11446342|FG007|Overall Study|Withdrawal by Subject|4
7237997|NCT00146172|11446335|FG000|Overall Study|Symptomatic Deterioration|1
7237998|NCT00146172|11446336|FG001|Overall Study|Symptomatic Deterioration|0
7237999|NCT00146172|11446337|FG002|Overall Study|Symptomatic Deterioration|1
7238000|NCT00146172|11446338|FG003|Overall Study|Symptomatic Deterioration|0
7238001|NCT00146172|11446339|FG004|Overall Study|Symptomatic Deterioration|1
7238002|NCT00146172|11446340|FG005|Overall Study|Symptomatic Deterioration|2
7238003|NCT00146172|11446341|FG006|Overall Study|Symptomatic Deterioration|0
7238004|NCT00146172|11446342|FG007|Overall Study|Symptomatic Deterioration|2
7238005|NCT00146328|11446371|FG000|Overall Study|Adverse Event|39
7573784|NCT03627767|11955238|FG003|Open-label Rescue Period (12 Weeks)|Other|0
7573785|NCT03627767|11955239|FG004|Open-label Rescue Period (12 Weeks)|Other|1
7238006|NCT00146328|11446372|FG001|Overall Study|Adverse Event|48
7238007|NCT00146328|11446373|FG002|Overall Study|Adverse Event|79
7238008|NCT00146328|11446371|FG000|Overall Study|Protocol Violation|11
7238009|NCT00146328|11446372|FG001|Overall Study|Protocol Violation|6
7238010|NCT00146328|11446373|FG002|Overall Study|Protocol Violation|12
7238011|NCT00146328|11446371|FG000|Overall Study|Lost to Follow-up|7
7238012|NCT00146328|11446372|FG001|Overall Study|Lost to Follow-up|4
7238013|NCT00146328|11446373|FG002|Overall Study|Lost to Follow-up|7
7238014|NCT00146328|11446371|FG000|Overall Study|Withdrawal by Subject|16
7238015|NCT00146328|11446372|FG001|Overall Study|Withdrawal by Subject|16
7238016|NCT00146328|11446373|FG002|Overall Study|Withdrawal by Subject|22
7238017|NCT00146328|11446371|FG000|Overall Study|Virologic Failure/lack of efficacy|54
7238018|NCT00146328|11446372|FG001|Overall Study|Virologic Failure/lack of efficacy|72
7238019|NCT00146328|11446373|FG002|Overall Study|Virologic Failure/lack of efficacy|142
7238020|NCT00146328|11446371|FG000|Overall Study|Trial ended/site closed|8
7238021|NCT00146328|11446372|FG001|Overall Study|Trial ended/site closed|2
7238022|NCT00146328|11446373|FG002|Overall Study|Trial ended/site closed|19
7238023|NCT00146328|11446371|FG000|Overall Study|Patient decision to end|0
7238024|NCT00146328|11446372|FG001|Overall Study|Patient decision to end|1
7238025|NCT00146328|11446373|FG002|Overall Study|Patient decision to end|6
7238026|NCT00146328|11446371|FG000|Overall Study|Enroll into other trial|2
7238027|NCT00146328|11446372|FG001|Overall Study|Enroll into other trial|4
7238028|NCT00146328|11446373|FG002|Overall Study|Enroll into other trial|2
7238029|NCT00146328|11446371|FG000|Overall Study|Death|0
7238030|NCT00146328|11446372|FG001|Overall Study|Death|1
7238031|NCT00146328|11446373|FG002|Overall Study|Death|1
7238032|NCT00146328|11446371|FG000|Overall Study|Moved|2
7238033|NCT00146328|11446372|FG001|Overall Study|Moved|0
7238034|NCT00146328|11446373|FG002|Overall Study|Moved|0
7238035|NCT00146328|11446371|FG000|Overall Study|Interaction with other medication|2
7238036|NCT00146328|11446372|FG001|Overall Study|Interaction with other medication|0
7238037|NCT00146328|11446373|FG002|Overall Study|Interaction with other medication|1
7238038|NCT00146640|11446383|FG000|Overall Study|Adverse Event|12
7238039|NCT00146640|11446384|FG001|Overall Study|Adverse Event|10
7238040|NCT00146640|11446383|FG000|Overall Study|Medical Reasons|3
7238041|NCT00146640|11446384|FG001|Overall Study|Medical Reasons|0
7238042|NCT00146640|11446383|FG000|Overall Study|Non-Medical Reasons|8
7238043|NCT00146640|11446384|FG001|Overall Study|Non-Medical Reasons|4
7238044|NCT00146757|11446390|FG000|Overall Study|Death|1
7238045|NCT00146757|11446391|FG001|Overall Study|Death|0
7238046|NCT00146757|11446390|FG000|Overall Study|Adverse Event|1
7238047|NCT00146757|11446391|FG001|Overall Study|Adverse Event|0
7238048|NCT00146770|11446399|FG000|Overall Study|Adverse Event|2
7238049|NCT00146770|11446400|FG001|Overall Study|Adverse Event|0
7238050|NCT00146770|11446399|FG000|Overall Study|Pregnancy|1
7238051|NCT00146770|11446400|FG001|Overall Study|Pregnancy|0
7238052|NCT00146770|11446399|FG000|Overall Study|Withdrawal by Subject|2
7238053|NCT00146770|11446400|FG001|Overall Study|Withdrawal by Subject|0
7238054|NCT00146848|11446409|FG000|Pre-randomization|Death|19
7238055|NCT00146848|11446410|FG001|Pre-randomization|Death|0
7238056|NCT00146848|11446411|FG002|Pre-randomization|Death|0
7238057|NCT00146848|11446409|FG000|Pre-randomization|Lost to Follow-up|70
7238058|NCT00146848|11446410|FG001|Pre-randomization|Lost to Follow-up|0
7238059|NCT00146848|11446411|FG002|Pre-randomization|Lost to Follow-up|0
7238060|NCT00146848|11446409|FG000|Pre-randomization|Physician Decision|8
7238061|NCT00146848|11446410|FG001|Pre-randomization|Physician Decision|0
7238062|NCT00146848|11446411|FG002|Pre-randomization|Physician Decision|0
7238063|NCT00146848|11446409|FG000|Pre-randomization|Protocol Violation|172
7238064|NCT00146848|11446410|FG001|Pre-randomization|Protocol Violation|0
7238065|NCT00146848|11446411|FG002|Pre-randomization|Protocol Violation|0
7238066|NCT00146848|11446409|FG000|Pre-randomization|Withdrawal by Subject|40
7238067|NCT00146848|11446410|FG001|Pre-randomization|Withdrawal by Subject|0
7238068|NCT00146848|11446411|FG002|Pre-randomization|Withdrawal by Subject|0
7238069|NCT00146848|11446409|FG000|Post-randomization|Lost to Follow-up|12
7238070|NCT00146848|11446410|FG001|Post-randomization|Lost to Follow-up|15
7238071|NCT00146848|11446411|FG002|Post-randomization|Lost to Follow-up|12
7238072|NCT00146848|11446409|FG000|Post-randomization|Withdrawn|26
7238073|NCT00146848|11446410|FG001|Post-randomization|Withdrawn|32
7238074|NCT00146848|11446411|FG002|Post-randomization|Withdrawn|27
7238075|NCT00147225|11446497|FG000|Overall Study|Withdrawal by Subject|1
7238076|NCT00147225|11446498|FG001|Overall Study|Withdrawal by Subject|0
7238077|NCT00147225|11446499|FG002|Overall Study|Withdrawal by Subject|1
7238078|NCT00147225|11446500|FG003|Overall Study|Withdrawal by Subject|0
7238079|NCT00147225|11446501|FG004|Overall Study|Withdrawal by Subject|0
7238080|NCT00147225|11446502|FG005|Overall Study|Withdrawal by Subject|1
7238081|NCT00147225|11446497|FG000|Overall Study|Adverse Event|0
7238082|NCT00147225|11446498|FG001|Overall Study|Adverse Event|0
7238083|NCT00147225|11446499|FG002|Overall Study|Adverse Event|1
7238084|NCT00147225|11446500|FG003|Overall Study|Adverse Event|1
7238085|NCT00147225|11446501|FG004|Overall Study|Adverse Event|0
7238086|NCT00147225|11446502|FG005|Overall Study|Adverse Event|0
7238087|NCT00147225|11446497|FG000|Overall Study|Screen Failure|0
7238088|NCT00147225|11446498|FG001|Overall Study|Screen Failure|0
7238089|NCT00147225|11446499|FG002|Overall Study|Screen Failure|0
7238090|NCT00147225|11446500|FG003|Overall Study|Screen Failure|0
7238091|NCT00147225|11446501|FG004|Overall Study|Screen Failure|1
7238092|NCT00147225|11446502|FG005|Overall Study|Screen Failure|0
7238093|NCT00147225|11446497|FG000|Overall Study|Chemotherapy Changed|0
7238094|NCT00147225|11446498|FG001|Overall Study|Chemotherapy Changed|0
7238095|NCT00147225|11446499|FG002|Overall Study|Chemotherapy Changed|0
7238096|NCT00147225|11446500|FG003|Overall Study|Chemotherapy Changed|0
7238097|NCT00147225|11446501|FG004|Overall Study|Chemotherapy Changed|0
7238098|NCT00147225|11446502|FG005|Overall Study|Chemotherapy Changed|1
7238099|NCT00147251|11446518|FG000|Recruitment and Enrollment|change in treatment guidelines|24
7238100|NCT00147251|11446519|FG001|Recruitment and Enrollment|change in treatment guidelines|25
7238101|NCT00147498|11446546|FG000|Overall Study|Adverse Event|1
7238102|NCT00147498|11446547|FG001|Overall Study|Adverse Event|6
7238103|NCT00147498|11446548|FG002|Overall Study|Adverse Event|7
7238104|NCT00147498|11446549|FG003|Overall Study|Adverse Event|3
7238105|NCT00147498|11446546|FG000|Overall Study|Lack of Efficacy|1
7238106|NCT00147498|11446547|FG001|Overall Study|Lack of Efficacy|1
7238107|NCT00147498|11446548|FG002|Overall Study|Lack of Efficacy|1
7238108|NCT00147498|11446549|FG003|Overall Study|Lack of Efficacy|8
7238109|NCT00147498|11446546|FG000|Overall Study|Laboratory abnormality|0
7238110|NCT00147498|11446547|FG001|Overall Study|Laboratory abnormality|0
7238111|NCT00147498|11446548|FG002|Overall Study|Laboratory abnormality|2
7238112|NCT00147498|11446549|FG003|Overall Study|Laboratory abnormality|0
7238113|NCT00147498|11446546|FG000|Overall Study|Participant defaulted|0
7238114|NCT00147498|11446547|FG001|Overall Study|Participant defaulted|1
7238115|NCT00147498|11446548|FG002|Overall Study|Participant defaulted|4
7238116|NCT00147498|11446549|FG003|Overall Study|Participant defaulted|3
7238117|NCT00147498|11446546|FG000|Overall Study|Other|1
7238118|NCT00147498|11446547|FG001|Overall Study|Other|1
7238119|NCT00147498|11446548|FG002|Overall Study|Other|3
7238120|NCT00147498|11446549|FG003|Overall Study|Other|3
7238121|NCT00147537|11446563|FG000|Phase 1b|Death|0
7238122|NCT00147537|11446564|FG001|Phase 1b|Death|1
7238123|NCT00147537|11446565|FG002|Phase 1b|Death|2
7238124|NCT00147537|11446566|FG003|Phase 1b|Death|1
7238125|NCT00147537|11446567|FG004|Phase 1b|Death|2
7238126|NCT00147537|11446568|FG005|Phase 1b|Death|2
7238127|NCT00147537|11446569|FG006|Phase 1b|Death|1
7238128|NCT00147537|11446570|FG007|Phase 1b|Death|3
7238129|NCT00147537|11446571|FG008|Phase 1b|Death|9
7238130|NCT00147537|11446572|FG009|Phase 1b|Death|0
7238131|NCT00147537|11446573|FG010|Phase 1b|Death|0
7238132|NCT00147537|11446563|FG000|Phase 1b|Lost to Follow-up|2
7238133|NCT00147537|11446564|FG001|Phase 1b|Lost to Follow-up|1
7238134|NCT00147537|11446565|FG002|Phase 1b|Lost to Follow-up|0
7238135|NCT00147537|11446566|FG003|Phase 1b|Lost to Follow-up|0
7238136|NCT00147537|11446567|FG004|Phase 1b|Lost to Follow-up|0
7238137|NCT00147537|11446568|FG005|Phase 1b|Lost to Follow-up|0
7238138|NCT00147537|11446569|FG006|Phase 1b|Lost to Follow-up|2
7238139|NCT00147537|11446570|FG007|Phase 1b|Lost to Follow-up|0
7238140|NCT00147537|11446571|FG008|Phase 1b|Lost to Follow-up|1
7238141|NCT00147537|11446572|FG009|Phase 1b|Lost to Follow-up|0
7238142|NCT00147537|11446573|FG010|Phase 1b|Lost to Follow-up|0
7238143|NCT00147537|11446563|FG000|Phase 1b|Other|0
7238144|NCT00147537|11446564|FG001|Phase 1b|Other|0
7238145|NCT00147537|11446565|FG002|Phase 1b|Other|2
7238146|NCT00147537|11446566|FG003|Phase 1b|Other|1
7238147|NCT00147537|11446567|FG004|Phase 1b|Other|1
7238148|NCT00147537|11446568|FG005|Phase 1b|Other|1
7238149|NCT00147537|11446569|FG006|Phase 1b|Other|14
7238150|NCT00147537|11446570|FG007|Phase 1b|Other|4
7238151|NCT00147537|11446571|FG008|Phase 1b|Other|4
7238152|NCT00147537|11446572|FG009|Phase 1b|Other|0
7238153|NCT00147537|11446573|FG010|Phase 1b|Other|0
7238154|NCT00147537|11446563|FG000|Phase 1b|Withdrawal by Subject|0
7238155|NCT00147537|11446564|FG001|Phase 1b|Withdrawal by Subject|0
7238156|NCT00147537|11446565|FG002|Phase 1b|Withdrawal by Subject|0
7238157|NCT00147537|11446566|FG003|Phase 1b|Withdrawal by Subject|0
7238158|NCT00147537|11446567|FG004|Phase 1b|Withdrawal by Subject|0
7238159|NCT00147537|11446568|FG005|Phase 1b|Withdrawal by Subject|0
7238160|NCT00147537|11446569|FG006|Phase 1b|Withdrawal by Subject|0
7238161|NCT00147537|11446570|FG007|Phase 1b|Withdrawal by Subject|0
7238162|NCT00147537|11446571|FG008|Phase 1b|Withdrawal by Subject|2
7238163|NCT00147537|11446572|FG009|Phase 1b|Withdrawal by Subject|0
7238164|NCT00147537|11446573|FG010|Phase 1b|Withdrawal by Subject|0
7238165|NCT00147537|11446563|FG000|Phase 1b|Randomized but not treated|0
7238166|NCT00147537|11446564|FG001|Phase 1b|Randomized but not treated|0
7238167|NCT00147537|11446565|FG002|Phase 1b|Randomized but not treated|0
7238168|NCT00147537|11446566|FG003|Phase 1b|Randomized but not treated|0
7238169|NCT00147537|11446567|FG004|Phase 1b|Randomized but not treated|0
7238170|NCT00147537|11446568|FG005|Phase 1b|Randomized but not treated|0
7238171|NCT00147537|11446569|FG006|Phase 1b|Randomized but not treated|1
7238172|NCT00147537|11446570|FG007|Phase 1b|Randomized but not treated|0
7238173|NCT00147537|11446571|FG008|Phase 1b|Randomized but not treated|1
7238174|NCT00147537|11446572|FG009|Phase 1b|Randomized but not treated|0
7238175|NCT00147537|11446573|FG010|Phase 1b|Randomized but not treated|0
7238176|NCT00147537|11446563|FG000|Phase 2|Death|0
7238177|NCT00147537|11446564|FG001|Phase 2|Death|0
7238178|NCT00147537|11446565|FG002|Phase 2|Death|0
7238179|NCT00147537|11446566|FG003|Phase 2|Death|0
7238180|NCT00147537|11446567|FG004|Phase 2|Death|0
7238181|NCT00147537|11446568|FG005|Phase 2|Death|0
7238182|NCT00147537|11446569|FG006|Phase 2|Death|0
7238183|NCT00147537|11446570|FG007|Phase 2|Death|0
7238184|NCT00147537|11446571|FG008|Phase 2|Death|0
7238185|NCT00147537|11446572|FG009|Phase 2|Death|85
7238186|NCT00147537|11446573|FG010|Phase 2|Death|31
7238187|NCT00147537|11446563|FG000|Phase 2|Lost to Follow-up|0
7238188|NCT00147537|11446564|FG001|Phase 2|Lost to Follow-up|0
7238189|NCT00147537|11446565|FG002|Phase 2|Lost to Follow-up|0
7238190|NCT00147537|11446566|FG003|Phase 2|Lost to Follow-up|0
7238191|NCT00147537|11446567|FG004|Phase 2|Lost to Follow-up|0
7238192|NCT00147537|11446568|FG005|Phase 2|Lost to Follow-up|0
7238193|NCT00147537|11446569|FG006|Phase 2|Lost to Follow-up|0
7238194|NCT00147537|11446570|FG007|Phase 2|Lost to Follow-up|0
7238195|NCT00147537|11446571|FG008|Phase 2|Lost to Follow-up|0
7238196|NCT00147537|11446572|FG009|Phase 2|Lost to Follow-up|12
7238197|NCT00147537|11446573|FG010|Phase 2|Lost to Follow-up|4
7238198|NCT00147537|11446563|FG000|Phase 2|Other|0
7238199|NCT00147537|11446564|FG001|Phase 2|Other|0
7238200|NCT00147537|11446565|FG002|Phase 2|Other|0
7238201|NCT00147537|11446566|FG003|Phase 2|Other|0
7238202|NCT00147537|11446567|FG004|Phase 2|Other|0
7238203|NCT00147537|11446568|FG005|Phase 2|Other|0
7238204|NCT00147537|11446569|FG006|Phase 2|Other|0
7238205|NCT00147537|11446570|FG007|Phase 2|Other|0
7238206|NCT00147537|11446571|FG008|Phase 2|Other|0
7238207|NCT00147537|11446572|FG009|Phase 2|Other|47
7238208|NCT00147537|11446573|FG010|Phase 2|Other|12
7238209|NCT00147537|11446563|FG000|Phase 2|Withdrawal by Subject|0
7238210|NCT00147537|11446564|FG001|Phase 2|Withdrawal by Subject|0
7238211|NCT00147537|11446565|FG002|Phase 2|Withdrawal by Subject|0
7238212|NCT00147537|11446566|FG003|Phase 2|Withdrawal by Subject|0
7238213|NCT00147537|11446567|FG004|Phase 2|Withdrawal by Subject|0
7238214|NCT00147537|11446568|FG005|Phase 2|Withdrawal by Subject|0
7238215|NCT00147537|11446569|FG006|Phase 2|Withdrawal by Subject|0
7238216|NCT00147537|11446570|FG007|Phase 2|Withdrawal by Subject|0
7238217|NCT00147537|11446571|FG008|Phase 2|Withdrawal by Subject|0
7238218|NCT00147537|11446572|FG009|Phase 2|Withdrawal by Subject|16
7238219|NCT00147537|11446573|FG010|Phase 2|Withdrawal by Subject|4
7238220|NCT00147537|11446563|FG000|Phase 2|Randomized but not treated|0
7238221|NCT00147537|11446564|FG001|Phase 2|Randomized but not treated|0
7238222|NCT00147537|11446565|FG002|Phase 2|Randomized but not treated|0
7238223|NCT00147537|11446566|FG003|Phase 2|Randomized but not treated|0
7238224|NCT00147537|11446567|FG004|Phase 2|Randomized but not treated|0
7238225|NCT00147537|11446568|FG005|Phase 2|Randomized but not treated|0
7238226|NCT00147537|11446569|FG006|Phase 2|Randomized but not treated|0
7238227|NCT00147537|11446570|FG007|Phase 2|Randomized but not treated|0
7238228|NCT00147537|11446571|FG008|Phase 2|Randomized but not treated|0
7573786|NCT03627832|11955252|FG000|Overall Study|Withdrawal by Subject|10
7238229|NCT00147537|11446572|FG009|Phase 2|Randomized but not treated|1
7238230|NCT00147537|11446573|FG010|Phase 2|Randomized but not treated|1
7238231|NCT00147745|11446621|FG000|Overall Study|Withdrawal by Subject|1
7238232|NCT00147745|11446622|FG001|Overall Study|Withdrawal by Subject|0
7238233|NCT00147745|11446623|FG002|Overall Study|Withdrawal by Subject|0
7238234|NCT00147823|11446633|FG000|Overall Study|Lost to Follow-up|6
7238235|NCT00147823|11446634|FG001|Overall Study|Lost to Follow-up|12
7238236|NCT00147823|11446633|FG000|Overall Study|Physician Decision|1
7238237|NCT00147823|11446634|FG001|Overall Study|Physician Decision|0
7238238|NCT00147823|11446633|FG000|Overall Study|Withdrawal by Subject|0
7238239|NCT00147823|11446634|FG001|Overall Study|Withdrawal by Subject|1
7238240|NCT00147823|11446633|FG000|Overall Study|Did not receive vitoss due to infection|6
7238241|NCT00147823|11446634|FG001|Overall Study|Did not receive vitoss due to infection|2
7238242|NCT00148109|11446646|FG000|Overall Study|Lack of Efficacy|10
7238243|NCT00148109|11446647|FG001|Overall Study|Lack of Efficacy|18
7238244|NCT00148109|11446646|FG000|Overall Study|Adverse Event|0
7238245|NCT00148109|11446647|FG001|Overall Study|Adverse Event|2
7238246|NCT00148109|11446646|FG000|Overall Study|Withdrawal by Subject|2
7238247|NCT00148109|11446647|FG001|Overall Study|Withdrawal by Subject|0
7238248|NCT00148122|11446653|FG000|Overall Study|Withdrawal by Subject|2
7238249|NCT00148317|11446657|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
7238250|NCT00148317|11446657|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
7238251|NCT00148317|11446657|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
7238252|NCT00148343|11446666|FG000|Overall Study|Withdrawal by Subject|12
7238253|NCT00148343|11446667|FG001|Overall Study|Withdrawal by Subject|7
7238254|NCT00148343|11446666|FG000|Overall Study|Physician Decision|3
7238255|NCT00148343|11446667|FG001|Overall Study|Physician Decision|4
7238256|NCT00148759|11446684|FG000|Overall Study|Withdrawal by Subject|1
7238257|NCT00148759|11446685|FG001|Overall Study|Withdrawal by Subject|1
7238258|NCT00148759|11446684|FG000|Overall Study|Lost to Follow-up|1
7238259|NCT00148759|11446685|FG001|Overall Study|Lost to Follow-up|0
7238260|NCT00148941|11446706|FG000|Overall Study|Lost to Follow-up|17
7238261|NCT00148941|11446707|FG001|Overall Study|Lost to Follow-up|24
7238262|NCT00148941|11446708|FG002|Overall Study|Lost to Follow-up|18
7238263|NCT00148941|11446709|FG003|Overall Study|Lost to Follow-up|22
7238264|NCT00148941|11446706|FG000|Overall Study|Withdrawal by Subject|1
7238265|NCT00148941|11446707|FG001|Overall Study|Withdrawal by Subject|0
7238266|NCT00148941|11446708|FG002|Overall Study|Withdrawal by Subject|1
7238267|NCT00148941|11446709|FG003|Overall Study|Withdrawal by Subject|0
7238268|NCT00148941|11446706|FG000|Overall Study|Other|0
7573787|NCT03627832|11955253|FG001|Overall Study|Withdrawal by Subject|1
7238269|NCT00148941|11446707|FG001|Overall Study|Other|0
7238270|NCT00148941|11446708|FG002|Overall Study|Other|1
7238271|NCT00148941|11446709|FG003|Overall Study|Other|2
7238272|NCT00149214|11446730|FG000|Overall Study|Adverse Event|12
7238273|NCT00149214|11446731|FG001|Overall Study|Adverse Event|9
7238274|NCT00149214|11446730|FG000|Overall Study|Withdrawal by Subject|4
7573788|NCT03628417|11955259|FG000|Overall Study|Death|1
7573789|NCT03628417|11955260|FG001|Overall Study|Death|1
7573790|NCT03628508|11955278|FG000|Overall Study|Lost to Follow-up|1
7573791|NCT03628599|11955284|FG000|Overall Study|Adverse Event|0
7573792|NCT03628599|11955285|FG001|Overall Study|Adverse Event|1
7573793|NCT03628898|11955308|FG000|Overall Study|Device deficiency|1
7238275|NCT00149214|11446731|FG001|Overall Study|Withdrawal by Subject|1
7238276|NCT00149214|11446730|FG000|Overall Study|Physician Decision|3
7238277|NCT00149214|11446731|FG001|Overall Study|Physician Decision|3
7238278|NCT00149214|11446730|FG000|Overall Study|Sponsor Decision|0
7238279|NCT00149214|11446731|FG001|Overall Study|Sponsor Decision|1
7238280|NCT00149214|11446730|FG000|Overall Study|Progressive Disease|7
7238281|NCT00149214|11446731|FG001|Overall Study|Progressive Disease|3
7238282|NCT00149396|11446746|FG000|Overall Study|Death|15
7238283|NCT00149396|11446746|FG000|Overall Study|Withdrawal by Subject|1
7238284|NCT00149396|11446746|FG000|Overall Study|Subject noncompliance|2
7238285|NCT00149396|11446746|FG000|Overall Study|other treatment|5
7238286|NCT00149630|11446759|FG000|Overall Study|Incarceration|2
7238287|NCT00149630|11446760|FG001|Overall Study|Incarceration|0
7238288|NCT00149630|11446759|FG000|Overall Study|Treatment Programs|4
7238289|NCT00149630|11446760|FG001|Overall Study|Treatment Programs|5
7238290|NCT00149630|11446759|FG000|Overall Study|Adverse Event|2
7238291|NCT00149630|11446760|FG001|Overall Study|Adverse Event|0
7238292|NCT00149747|11446799|FG000|Overall Study|Death|1
7238293|NCT00149747|11446800|FG001|Overall Study|Death|0
7238294|NCT00149747|11446799|FG000|Overall Study|Withdrawal by Subject|3
7238295|NCT00149747|11446800|FG001|Overall Study|Withdrawal by Subject|3
7238296|NCT00149825|11446820|FG000|Overall Study|Intolerance to medication side effects|1
7238297|NCT00149825|11446821|FG001|Overall Study|Intolerance to medication side effects|2
7238298|NCT00149825|11446820|FG000|Overall Study|Time commitments|2
7238299|NCT00149825|11446821|FG001|Overall Study|Time commitments|1
7238300|NCT00149825|11446820|FG000|Overall Study|Not liking insomnia therapy|1
7238301|NCT00149825|11446821|FG001|Overall Study|Not liking insomnia therapy|0
7238302|NCT00149825|11446820|FG000|Overall Study|Other|1
7238303|NCT00149825|11446821|FG001|Overall Study|Other|0
7255854|NCT00320541|11467410|FG001|Overall Study|Withdrawal by Subject|16
7255855|NCT00320541|11467409|FG000|Overall Study|Physician Decision|9
7255856|NCT00320541|11467410|FG001|Overall Study|Physician Decision|13
7255857|NCT00320541|11467409|FG000|Overall Study|Other|3
7255858|NCT00320541|11467410|FG001|Overall Study|Other|4
7255859|NCT00320541|11467409|FG000|Overall Study|Sponsor Decision|2
7255860|NCT00320541|11467410|FG001|Overall Study|Sponsor Decision|1
7255861|NCT00320541|11467409|FG000|Overall Study|Death due to Study Disease|1
7255862|NCT00320541|11467410|FG001|Overall Study|Death due to Study Disease|3
7255863|NCT00320541|11467409|FG000|Overall Study|Death due to Adverse Event(s)|1
7255864|NCT00320541|11467410|FG001|Overall Study|Death due to Adverse Event(s)|0
7255865|NCT00320541|11467409|FG000|Overall Study|Protocol Entry Criterion Not Met|1
7255866|NCT00320541|11467410|FG001|Overall Study|Protocol Entry Criterion Not Met|0
7255867|NCT00320593|11467418|FG000|Overall Study|Lost to Follow-up|3
7255868|NCT00320593|11467419|FG001|Overall Study|Lost to Follow-up|0
7255869|NCT00320593|11467418|FG000|Overall Study|Moved to another state|1
7255870|NCT00320593|11467419|FG001|Overall Study|Moved to another state|0
7255871|NCT00320593|11467418|FG000|Overall Study|Withdrawal by Subject|2
7255872|NCT00320593|11467419|FG001|Overall Study|Withdrawal by Subject|1
7255873|NCT00320593|11467418|FG000|Overall Study|Withdrawal by clinical center|1
7255874|NCT00320593|11467419|FG001|Overall Study|Withdrawal by clinical center|0
7255875|NCT00320606|11467425|FG000|Overall Study|Adverse Event|1
7255876|NCT00320606|11467425|FG000|Overall Study|Protocol Violation|1
7255877|NCT00320606|11467425|FG000|Overall Study|Withdrawal by Subject|1
7573794|NCT03628924|11955315|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
7255878|NCT00320710|11467442|FG000|Overall Study|Disease progression|24
7255879|NCT00320710|11467443|FG001|Overall Study|Disease progression|19
7255880|NCT00320710|11467444|FG002|Overall Study|Disease progression|2
7255881|NCT00320710|11467442|FG000|Overall Study|Death|10
7255882|NCT00320710|11467443|FG001|Overall Study|Death|7
7255883|NCT00320710|11467444|FG002|Overall Study|Death|1
7573795|NCT03628924|11955316|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7573796|NCT03628924|11955317|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7255884|NCT00320710|11467442|FG000|Overall Study|Administrative problems|1
7255885|NCT00320710|11467443|FG001|Overall Study|Administrative problems|2
7255886|NCT00320710|11467444|FG002|Overall Study|Administrative problems|0
7255887|NCT00320710|11467442|FG000|Overall Study|Withdrawal by Subject|20
7255888|NCT00320710|11467443|FG001|Overall Study|Withdrawal by Subject|26
7255889|NCT00320710|11467444|FG002|Overall Study|Withdrawal by Subject|1
7255890|NCT00320710|11467442|FG000|Overall Study|Protocol Violation|6
7255891|NCT00320710|11467443|FG001|Overall Study|Protocol Violation|5
7255892|NCT00320710|11467444|FG002|Overall Study|Protocol Violation|0
7255893|NCT00320710|11467442|FG000|Overall Study|Abnormal test procedure result(s)|2
7255894|NCT00320710|11467443|FG001|Overall Study|Abnormal test procedure result(s)|0
7255895|NCT00320710|11467444|FG002|Overall Study|Abnormal test procedure result(s)|0
7238304|NCT00149890|11446844|FG000|Overall Study|Adverse Event|1
7238305|NCT00149890|11446845|FG001|Overall Study|Adverse Event|8
7238306|NCT00149890|11446844|FG000|Overall Study|Lack of Efficacy|8
7238307|NCT00149890|11446845|FG001|Overall Study|Lack of Efficacy|9
7238308|NCT00149890|11446844|FG000|Overall Study|Protocol Violation|1
7238309|NCT00149890|11446845|FG001|Overall Study|Protocol Violation|0
7238310|NCT00149890|11446844|FG000|Overall Study|Lost to Follow-up|1
7238311|NCT00149890|11446845|FG001|Overall Study|Lost to Follow-up|0
7238312|NCT00149890|11446844|FG000|Overall Study|Graft Loss|2
7238313|NCT00149890|11446845|FG001|Overall Study|Graft Loss|1
7238314|NCT00149994|11446853|FG000|Overall Study|Administrative problems:|1
7238315|NCT00149994|11446854|FG001|Overall Study|Administrative problems:|0
7238316|NCT00149994|11446853|FG000|Overall Study|Protocol Violation|0
7238317|NCT00149994|11446854|FG001|Overall Study|Protocol Violation|1
7238318|NCT00150345|11446862|FG000|Overall Study|Death|5
7238319|NCT00150345|11446863|FG001|Overall Study|Death|2
7238320|NCT00150345|11446862|FG000|Overall Study|Adverse Event|8
7238321|NCT00150345|11446863|FG001|Overall Study|Adverse Event|6
7238322|NCT00150345|11446862|FG000|Overall Study|Lack of Efficacy|5
7238323|NCT00150345|11446863|FG001|Overall Study|Lack of Efficacy|4
7238324|NCT00150345|11446862|FG000|Overall Study|Withdrawal by Subject|3
7238325|NCT00150345|11446863|FG001|Overall Study|Withdrawal by Subject|4
7238326|NCT00150345|11446862|FG000|Overall Study|Laboratory abnormality|1
7238327|NCT00150345|11446863|FG001|Overall Study|Laboratory abnormality|2
7238328|NCT00150345|11446862|FG000|Overall Study|Other|12
7238329|NCT00150345|11446863|FG001|Overall Study|Other|14
7238330|NCT00150462|11446881|FG000|Overall Study|Disease Progression or Relapse|3
7238331|NCT00150462|11446882|FG001|Overall Study|Disease Progression or Relapse|1
7238332|NCT00150462|11446883|FG002|Overall Study|Disease Progression or Relapse|2
7238333|NCT00150462|11446884|FG003|Overall Study|Disease Progression or Relapse|1
7238334|NCT00150462|11446885|FG004|Overall Study|Disease Progression or Relapse|2
7238335|NCT00150462|11446886|FG005|Overall Study|Disease Progression or Relapse|2
7238336|NCT00150462|11446887|FG006|Overall Study|Disease Progression or Relapse|3
7238337|NCT00150462|11446888|FG007|Overall Study|Disease Progression or Relapse|5
7238338|NCT00150462|11446889|FG008|Overall Study|Disease Progression or Relapse|5
7238339|NCT00150462|11446890|FG009|Overall Study|Disease Progression or Relapse|3
7238340|NCT00150462|11446891|FG010|Overall Study|Disease Progression or Relapse|2
7238341|NCT00150462|11446881|FG000|Overall Study|Withdrawal by Subject|0
7238342|NCT00150462|11446882|FG001|Overall Study|Withdrawal by Subject|1
7238343|NCT00150462|11446883|FG002|Overall Study|Withdrawal by Subject|1
7238344|NCT00150462|11446884|FG003|Overall Study|Withdrawal by Subject|0
7238345|NCT00150462|11446885|FG004|Overall Study|Withdrawal by Subject|1
7238346|NCT00150462|11446886|FG005|Overall Study|Withdrawal by Subject|2
7238347|NCT00150462|11446887|FG006|Overall Study|Withdrawal by Subject|0
7238348|NCT00150462|11446888|FG007|Overall Study|Withdrawal by Subject|1
7238349|NCT00150462|11446889|FG008|Overall Study|Withdrawal by Subject|0
7238350|NCT00150462|11446890|FG009|Overall Study|Withdrawal by Subject|1
7238351|NCT00150462|11446891|FG010|Overall Study|Withdrawal by Subject|0
7238352|NCT00150462|11446881|FG000|Overall Study|Death|0
7238353|NCT00150462|11446882|FG001|Overall Study|Death|1
7238354|NCT00150462|11446883|FG002|Overall Study|Death|0
7238355|NCT00150462|11446884|FG003|Overall Study|Death|0
7238356|NCT00150462|11446885|FG004|Overall Study|Death|0
7238357|NCT00150462|11446886|FG005|Overall Study|Death|0
7238358|NCT00150462|11446887|FG006|Overall Study|Death|0
7238359|NCT00150462|11446888|FG007|Overall Study|Death|0
7573797|NCT03628924|11955318|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7573798|NCT03628924|11955319|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7573799|NCT03628924|11955320|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7573800|NCT03628924|11955321|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
7573801|NCT03628924|11955315|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7573802|NCT03628924|11955316|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7573803|NCT03628924|11955317|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
7573804|NCT03628924|11955318|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7573805|NCT03628924|11955319|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7573806|NCT03628924|11955320|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7573807|NCT03628924|11955321|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
7238360|NCT00150462|11446889|FG008|Overall Study|Death|1
7238361|NCT00150462|11446890|FG009|Overall Study|Death|0
7238362|NCT00150462|11446891|FG010|Overall Study|Death|0
7238363|NCT00150462|11446881|FG000|Overall Study|Adverse Event|0
7238364|NCT00150462|11446882|FG001|Overall Study|Adverse Event|0
7238365|NCT00150462|11446883|FG002|Overall Study|Adverse Event|0
7238366|NCT00150462|11446884|FG003|Overall Study|Adverse Event|1
7238367|NCT00150462|11446885|FG004|Overall Study|Adverse Event|0
7238368|NCT00150462|11446886|FG005|Overall Study|Adverse Event|0
7238369|NCT00150462|11446887|FG006|Overall Study|Adverse Event|0
7238370|NCT00150462|11446888|FG007|Overall Study|Adverse Event|2
7238371|NCT00150462|11446889|FG008|Overall Study|Adverse Event|0
7238372|NCT00150462|11446890|FG009|Overall Study|Adverse Event|1
7238373|NCT00150462|11446891|FG010|Overall Study|Adverse Event|0
7238374|NCT00150462|11446881|FG000|Overall Study|Physician Decision|0
7238375|NCT00150462|11446882|FG001|Overall Study|Physician Decision|0
7238376|NCT00150462|11446883|FG002|Overall Study|Physician Decision|1
7238377|NCT00150462|11446884|FG003|Overall Study|Physician Decision|1
7238378|NCT00150462|11446885|FG004|Overall Study|Physician Decision|0
7238379|NCT00150462|11446886|FG005|Overall Study|Physician Decision|0
7238380|NCT00150462|11446887|FG006|Overall Study|Physician Decision|0
7238381|NCT00150462|11446888|FG007|Overall Study|Physician Decision|0
7238382|NCT00150462|11446889|FG008|Overall Study|Physician Decision|0
7238383|NCT00150462|11446890|FG009|Overall Study|Physician Decision|0
7238384|NCT00150462|11446891|FG010|Overall Study|Physician Decision|0
7238385|NCT00150462|11446881|FG000|Overall Study|Other|0
7238386|NCT00150462|11446882|FG001|Overall Study|Other|0
7238387|NCT00150462|11446883|FG002|Overall Study|Other|0
7238388|NCT00150462|11446884|FG003|Overall Study|Other|0
7238389|NCT00150462|11446885|FG004|Overall Study|Other|0
7238390|NCT00150462|11446886|FG005|Overall Study|Other|0
7238391|NCT00150462|11446887|FG006|Overall Study|Other|0
7238392|NCT00150462|11446888|FG007|Overall Study|Other|0
7238393|NCT00150462|11446889|FG008|Overall Study|Other|0
7238394|NCT00150462|11446890|FG009|Overall Study|Other|1
7238395|NCT00150462|11446891|FG010|Overall Study|Other|1
7238396|NCT00150592|11446920|FG000|Overall Study|Adverse Event|4
7238397|NCT00150592|11446921|FG001|Overall Study|Adverse Event|1
7238398|NCT00150592|11446920|FG000|Overall Study|Protocol Violation|1
7238399|NCT00150592|11446921|FG001|Overall Study|Protocol Violation|0
7238400|NCT00150592|11446920|FG000|Overall Study|Withdrawal by Subject|1
7238401|NCT00150592|11446921|FG001|Overall Study|Withdrawal by Subject|2
7238402|NCT00150592|11446920|FG000|Overall Study|Non-compliance|1
7238403|NCT00150592|11446921|FG001|Overall Study|Non-compliance|0
7575392|NCT03736967|11959082|FG001|Overall Study|Physician Decision|0
7238404|NCT00150618|11446932|FG000|Overall Study|Adverse Event|2
7238405|NCT00150618|11446933|FG001|Overall Study|Adverse Event|2
7238406|NCT00150618|11446934|FG002|Overall Study|Adverse Event|6
7238407|NCT00150618|11446935|FG003|Overall Study|Adverse Event|9
7238408|NCT00150618|11446936|FG004|Overall Study|Adverse Event|5
7238409|NCT00150618|11446932|FG000|Overall Study|Withdrawal by Subject|6
7238410|NCT00150618|11446933|FG001|Overall Study|Withdrawal by Subject|8
7238411|NCT00150618|11446934|FG002|Overall Study|Withdrawal by Subject|8
7238412|NCT00150618|11446935|FG003|Overall Study|Withdrawal by Subject|4
7238413|NCT00150618|11446936|FG004|Overall Study|Withdrawal by Subject|5
7238414|NCT00150618|11446932|FG000|Overall Study|Lost to Follow-up|4
7238415|NCT00150618|11446933|FG001|Overall Study|Lost to Follow-up|1
7238416|NCT00150618|11446934|FG002|Overall Study|Lost to Follow-up|5
7238417|NCT00150618|11446935|FG003|Overall Study|Lost to Follow-up|8
7238418|NCT00150618|11446936|FG004|Overall Study|Lost to Follow-up|4
7238419|NCT00150618|11446932|FG000|Overall Study|Protocol Violation|1
7238420|NCT00150618|11446933|FG001|Overall Study|Protocol Violation|0
7238421|NCT00150618|11446934|FG002|Overall Study|Protocol Violation|0
7238422|NCT00150618|11446935|FG003|Overall Study|Protocol Violation|0
7238423|NCT00150618|11446936|FG004|Overall Study|Protocol Violation|1
7238424|NCT00150618|11446932|FG000|Overall Study|Lack of Efficacy|1
7238425|NCT00150618|11446933|FG001|Overall Study|Lack of Efficacy|4
7238426|NCT00150618|11446934|FG002|Overall Study|Lack of Efficacy|7
7238427|NCT00150618|11446935|FG003|Overall Study|Lack of Efficacy|4
7238428|NCT00150618|11446936|FG004|Overall Study|Lack of Efficacy|6
7238429|NCT00150618|11446932|FG000|Overall Study|No study meds|0
7238430|NCT00150618|11446933|FG001|Overall Study|No study meds|0
7238431|NCT00150618|11446934|FG002|Overall Study|No study meds|0
7238432|NCT00150618|11446935|FG003|Overall Study|No study meds|0
7238433|NCT00150618|11446936|FG004|Overall Study|No study meds|2
7238434|NCT00150618|11446932|FG000|Overall Study|Physician Decision|0
7238435|NCT00150618|11446933|FG001|Overall Study|Physician Decision|2
7238436|NCT00150618|11446934|FG002|Overall Study|Physician Decision|0
7238437|NCT00150618|11446935|FG003|Overall Study|Physician Decision|0
7238438|NCT00150618|11446936|FG004|Overall Study|Physician Decision|1
7238439|NCT00150618|11446932|FG000|Overall Study|Lack of compliance|2
7238440|NCT00150618|11446933|FG001|Overall Study|Lack of compliance|1
7238441|NCT00150618|11446934|FG002|Overall Study|Lack of compliance|1
7238442|NCT00150618|11446935|FG003|Overall Study|Lack of compliance|0
7238443|NCT00150618|11446936|FG004|Overall Study|Lack of compliance|1
7238444|NCT00150618|11446932|FG000|Overall Study|Abnormal ECG|1
7238445|NCT00150618|11446933|FG001|Overall Study|Abnormal ECG|0
7238446|NCT00150618|11446934|FG002|Overall Study|Abnormal ECG|0
7238447|NCT00150618|11446935|FG003|Overall Study|Abnormal ECG|0
7238448|NCT00150618|11446936|FG004|Overall Study|Abnormal ECG|0
7238449|NCT00150618|11446932|FG000|Overall Study|Sponsor's decision|0
7238450|NCT00150618|11446933|FG001|Overall Study|Sponsor's decision|0
7238451|NCT00150618|11446934|FG002|Overall Study|Sponsor's decision|0
7238452|NCT00150618|11446935|FG003|Overall Study|Sponsor's decision|1
7238453|NCT00150618|11446936|FG004|Overall Study|Sponsor's decision|0
7238454|NCT00150800|11446948|FG000|Overall Study|Adverse Event|89
7238455|NCT00150800|11446948|FG000|Overall Study|Death|18
7238456|NCT00150800|11446948|FG000|Overall Study|Lack of Efficacy|166
7238457|NCT00150800|11446948|FG000|Overall Study|Lost to Follow-up|58
7238458|NCT00150800|11446948|FG000|Overall Study|Subject's choice|90
7238459|NCT00150800|11446948|FG000|Overall Study|No compliance|18
7238460|NCT00150800|11446948|FG000|Overall Study|IP misshandling|1
7238461|NCT00150800|11446948|FG000|Overall Study|Site closure|24
7238462|NCT00150800|11446948|FG000|Overall Study|Protocol non-adherence|2
7238463|NCT00150800|11446948|FG000|Overall Study|Nobody to accompany patient|1
7238464|NCT00150800|11446948|FG000|Overall Study|Distance too long for patient|1
7238465|NCT00150800|11446948|FG000|Overall Study|Neurosurgery|2
7238466|NCT00150800|11446948|FG000|Overall Study|BRV monotherapy|1
7238467|NCT00150800|11446948|FG000|Overall Study|Visit refusal|3
7238468|NCT00150800|11446948|FG000|Overall Study|Sponsor's request|2
7238469|NCT00150800|11446948|FG000|Overall Study|Generalized Epilepsy|1
7238470|NCT00150800|11446948|FG000|Overall Study|Moved from area/country|8
7238471|NCT00150800|11446948|FG000|Overall Study|PI retiring|2
7238472|NCT00150800|11446948|FG000|Overall Study|PI leaving site|2
7238473|NCT00150800|11446948|FG000|Overall Study|Patient insurance|1
7238474|NCT00150800|11446948|FG000|Overall Study|Surgical intervention|4
7238475|NCT00150800|11446948|FG000|Overall Study|Pregnancy planned|1
7238476|NCT00150800|11446948|FG000|Overall Study|PI discontinuation request|1
7238477|NCT00150813|11446953|FG000|Overall Study|Adverse Event|1
7238478|NCT00150813|11446953|FG000|Overall Study|Lack of Efficacy|1
7238479|NCT00150813|11446953|FG000|Overall Study|Lost to Follow-up|5
7238480|NCT00150813|11446953|FG000|Overall Study|Withdrawal by Subject|5
7238481|NCT00150813|11446953|FG000|Overall Study|Remission|3
7238482|NCT00150813|11446953|FG000|Overall Study|Planned pregancy|1
7238483|NCT00150813|11446953|FG000|Overall Study|Switch to commercially available LEV|2
7238484|NCT00150969|11446959|FG000|24 Month Main Study|Adverse Event|3
7238485|NCT00150969|11446960|FG001|24 Month Main Study|Adverse Event|4
7238486|NCT00150969|11446959|FG000|24 Month Main Study|Death|1
7238487|NCT00150969|11446960|FG001|24 Month Main Study|Death|1
7238488|NCT00150969|11446959|FG000|24 Month Main Study|Lack of Efficacy|1
7238489|NCT00150969|11446960|FG001|24 Month Main Study|Lack of Efficacy|8
7238490|NCT00150969|11446959|FG000|24 Month Main Study|Lost to Follow-up|3
7238491|NCT00150969|11446960|FG001|24 Month Main Study|Lost to Follow-up|2
7238492|NCT00150969|11446959|FG000|24 Month Main Study|Protocol Violation|4
7238493|NCT00150969|11446960|FG001|24 Month Main Study|Protocol Violation|2
7238494|NCT00150969|11446959|FG000|24 Month Main Study|Withdrawal by Subject|7
7238495|NCT00150969|11446960|FG001|24 Month Main Study|Withdrawal by Subject|4
7238496|NCT00150969|11446959|FG000|24-48 Month Extension|Withdrawal by Subject|6
7238497|NCT00150969|11446960|FG001|24-48 Month Extension|Withdrawal by Subject|5
7238498|NCT00150969|11446959|FG000|24-48 Month Extension|Lack of Efficacy|0
7238499|NCT00150969|11446960|FG001|24-48 Month Extension|Lack of Efficacy|1
7238500|NCT00150969|11446959|FG000|24-48 Month Extension|Adverse Event|1
7238501|NCT00150969|11446960|FG001|24-48 Month Extension|Adverse Event|3
7238502|NCT00150969|11446959|FG000|24-48 Month Extension|Other Reason|81
7238503|NCT00150969|11446960|FG001|24-48 Month Extension|Other Reason|91
7238504|NCT00151281|11446967|FG000|Overall Study|Not evaluable|3
7238505|NCT00151372|11446981|FG000|Overall Study|Death|12
7238506|NCT00151372|11446982|FG001|Overall Study|Death|11
7238507|NCT00151372|11446981|FG000|Overall Study|Lost to Follow-up|5
7238508|NCT00151372|11446982|FG001|Overall Study|Lost to Follow-up|5
7238509|NCT00151372|11446981|FG000|Overall Study|Too sick medically to continue|5
7238510|NCT00151372|11446982|FG001|Overall Study|Too sick medically to continue|6
7238511|NCT00151372|11446981|FG000|Overall Study|Withdrawal by Subject|7
7238512|NCT00151372|11446982|FG001|Overall Study|Withdrawal by Subject|7
7238513|NCT00151411|11446990|FG000|Overall Study|Lost to Follow-up|15
7238514|NCT00151411|11446991|FG001|Overall Study|Lost to Follow-up|19
7238515|NCT00151411|11446990|FG000|Overall Study|Withdrawal by Subject|12
7238516|NCT00151411|11446991|FG001|Overall Study|Withdrawal by Subject|20
7238517|NCT00151411|11446990|FG000|Overall Study|Adverse Event|6
7238518|NCT00151411|11446991|FG001|Overall Study|Adverse Event|0
7238519|NCT00151411|11446990|FG000|Overall Study|Pregnancy|0
7238520|NCT00151411|11446991|FG001|Overall Study|Pregnancy|4
7238521|NCT00151476|11447000|FG000|FAP Identified Subjects|Protocol Violation|0
7238522|NCT00151476|11447001|FG001|FAP Identified Subjects|Protocol Violation|1
7238523|NCT00151476|11447000|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
7238524|NCT00151476|11447001|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
7238525|NCT00151476|11447000|FG000|FAP Analyzed Subjects|Other study participation|0
7238526|NCT00151476|11447001|FG001|FAP Analyzed Subjects|Other study participation|1
7238527|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
7238528|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
7238529|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238530|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238531|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238532|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238533|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238534|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238535|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238536|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238537|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238538|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
7238539|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7238540|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238541|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238542|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238543|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238544|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238545|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7238546|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238547|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238548|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238549|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
7238550|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
7238551|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238552|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
7238553|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238554|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238555|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238556|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238557|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238558|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238559|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238560|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238561|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238562|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
7238563|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|Other|0
7238564|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|Other|0
7238565|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|Other|0
7238566|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|Other|0
7238567|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|Other|0
7238568|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|Other|0
7238569|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|Other|1
7238570|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|Other|0
7238571|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|Other|0
7238572|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|Other|0
7238573|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|Other|0
7238574|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|Other|0
7238575|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
7238576|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
7238577|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
7238578|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
7238579|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
7238580|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
7238581|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
7238582|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
7238583|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
7238584|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
7238585|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
7238586|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
7238587|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238588|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238589|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238590|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238591|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238592|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
7238593|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238594|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238595|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238596|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238597|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238598|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
7238599|NCT00151775|11447013|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238600|NCT00151775|11447014|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238601|NCT00151775|11447015|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238602|NCT00151775|11447016|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238603|NCT00151775|11447017|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238604|NCT00151775|11447018|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238605|NCT00151775|11447019|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
7238606|NCT00151775|11447020|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238607|NCT00151775|11447021|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238608|NCT00151775|11447022|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238609|NCT00151775|11447023|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7238610|NCT00151775|11447024|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
7464936|NCT01876446|11763821|FG001|Overall Study|Death|1
7238611|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238612|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238613|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238614|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238615|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238616|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
7238617|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238618|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238619|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238620|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238621|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7238622|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
7464937|NCT01876446|11763820|FG000|Overall Study|Withdrawal by Subject|1
7464938|NCT01876446|11763821|FG001|Overall Study|Withdrawal by Subject|2
7464939|NCT01876446|11763820|FG000|Overall Study|Physician Decision|1
7238623|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Other|0
7238624|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Other|0
7238625|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Other|1
7238626|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Other|0
7238627|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Other|0
7238628|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Other|0
7238629|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Other|0
7238630|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Other|1
7238631|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Other|0
7238632|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Other|0
7238633|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Other|0
7238634|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Other|0
7238635|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238636|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238637|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238638|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238639|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238640|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238641|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
7238642|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238643|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238644|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238645|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238646|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
7238647|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238648|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238649|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
7238650|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238651|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238652|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238653|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238654|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238730|NCT00151775|11447024|FG011|Period 4: Open Label|Lost to Follow-up|0
7238655|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238656|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238657|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238658|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
7238659|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238660|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238661|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
7238662|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238663|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238664|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238665|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238666|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238667|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238668|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238669|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238670|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
7238671|NCT00151775|11447013|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238672|NCT00151775|11447014|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238673|NCT00151775|11447015|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238674|NCT00151775|11447016|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238675|NCT00151775|11447017|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238676|NCT00151775|11447018|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238677|NCT00151775|11447019|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238678|NCT00151775|11447020|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238679|NCT00151775|11447021|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238680|NCT00151775|11447022|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238681|NCT00151775|11447023|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
7238682|NCT00151775|11447024|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
7238683|NCT00151775|11447013|FG000|Period 4: Open Label|Increased blood pressure|0
7238684|NCT00151775|11447014|FG001|Period 4: Open Label|Increased blood pressure|0
7238685|NCT00151775|11447015|FG002|Period 4: Open Label|Increased blood pressure|0
7238686|NCT00151775|11447016|FG003|Period 4: Open Label|Increased blood pressure|0
7238687|NCT00151775|11447017|FG004|Period 4: Open Label|Increased blood pressure|1
7238688|NCT00151775|11447018|FG005|Period 4: Open Label|Increased blood pressure|0
7238689|NCT00151775|11447019|FG006|Period 4: Open Label|Increased blood pressure|0
7238690|NCT00151775|11447020|FG007|Period 4: Open Label|Increased blood pressure|0
7238691|NCT00151775|11447021|FG008|Period 4: Open Label|Increased blood pressure|0
7238692|NCT00151775|11447022|FG009|Period 4: Open Label|Increased blood pressure|1
7238693|NCT00151775|11447023|FG010|Period 4: Open Label|Increased blood pressure|0
7238694|NCT00151775|11447024|FG011|Period 4: Open Label|Increased blood pressure|0
7238695|NCT00151775|11447013|FG000|Period 4: Open Label|Withdrawal by Subject|0
7238696|NCT00151775|11447014|FG001|Period 4: Open Label|Withdrawal by Subject|0
7238697|NCT00151775|11447015|FG002|Period 4: Open Label|Withdrawal by Subject|0
7238698|NCT00151775|11447016|FG003|Period 4: Open Label|Withdrawal by Subject|0
7238699|NCT00151775|11447017|FG004|Period 4: Open Label|Withdrawal by Subject|5
7238700|NCT00151775|11447018|FG005|Period 4: Open Label|Withdrawal by Subject|0
7238701|NCT00151775|11447019|FG006|Period 4: Open Label|Withdrawal by Subject|0
7238702|NCT00151775|11447020|FG007|Period 4: Open Label|Withdrawal by Subject|0
7238703|NCT00151775|11447021|FG008|Period 4: Open Label|Withdrawal by Subject|0
7238704|NCT00151775|11447022|FG009|Period 4: Open Label|Withdrawal by Subject|2
7238705|NCT00151775|11447023|FG010|Period 4: Open Label|Withdrawal by Subject|0
7238706|NCT00151775|11447024|FG011|Period 4: Open Label|Withdrawal by Subject|0
7238707|NCT00151775|11447013|FG000|Period 4: Open Label|Adverse Event|0
7238708|NCT00151775|11447014|FG001|Period 4: Open Label|Adverse Event|0
7238709|NCT00151775|11447015|FG002|Period 4: Open Label|Adverse Event|0
7238710|NCT00151775|11447016|FG003|Period 4: Open Label|Adverse Event|0
7238711|NCT00151775|11447017|FG004|Period 4: Open Label|Adverse Event|1
7238712|NCT00151775|11447018|FG005|Period 4: Open Label|Adverse Event|0
7238713|NCT00151775|11447019|FG006|Period 4: Open Label|Adverse Event|0
7238714|NCT00151775|11447020|FG007|Period 4: Open Label|Adverse Event|0
7238715|NCT00151775|11447021|FG008|Period 4: Open Label|Adverse Event|0
7238716|NCT00151775|11447022|FG009|Period 4: Open Label|Adverse Event|2
7238717|NCT00151775|11447023|FG010|Period 4: Open Label|Adverse Event|0
7238718|NCT00151775|11447024|FG011|Period 4: Open Label|Adverse Event|0
7238719|NCT00151775|11447013|FG000|Period 4: Open Label|Lost to Follow-up|0
7238720|NCT00151775|11447014|FG001|Period 4: Open Label|Lost to Follow-up|0
7238721|NCT00151775|11447015|FG002|Period 4: Open Label|Lost to Follow-up|0
7238722|NCT00151775|11447016|FG003|Period 4: Open Label|Lost to Follow-up|0
7238723|NCT00151775|11447017|FG004|Period 4: Open Label|Lost to Follow-up|17
7238724|NCT00151775|11447018|FG005|Period 4: Open Label|Lost to Follow-up|0
7238725|NCT00151775|11447019|FG006|Period 4: Open Label|Lost to Follow-up|0
7238726|NCT00151775|11447020|FG007|Period 4: Open Label|Lost to Follow-up|0
7238727|NCT00151775|11447021|FG008|Period 4: Open Label|Lost to Follow-up|0
7238728|NCT00151775|11447022|FG009|Period 4: Open Label|Lost to Follow-up|7
7238729|NCT00151775|11447023|FG010|Period 4: Open Label|Lost to Follow-up|0
7238731|NCT00151775|11447013|FG000|Period 4: Open Label|Non-compliance with protocol|0
7238732|NCT00151775|11447014|FG001|Period 4: Open Label|Non-compliance with protocol|0
7238733|NCT00151775|11447015|FG002|Period 4: Open Label|Non-compliance with protocol|0
7238734|NCT00151775|11447016|FG003|Period 4: Open Label|Non-compliance with protocol|0
7238735|NCT00151775|11447017|FG004|Period 4: Open Label|Non-compliance with protocol|4
7238736|NCT00151775|11447018|FG005|Period 4: Open Label|Non-compliance with protocol|0
7238737|NCT00151775|11447019|FG006|Period 4: Open Label|Non-compliance with protocol|0
7238738|NCT00151775|11447020|FG007|Period 4: Open Label|Non-compliance with protocol|0
7238739|NCT00151775|11447021|FG008|Period 4: Open Label|Non-compliance with protocol|0
7238740|NCT00151775|11447022|FG009|Period 4: Open Label|Non-compliance with protocol|4
7238741|NCT00151775|11447023|FG010|Period 4: Open Label|Non-compliance with protocol|0
7238742|NCT00151775|11447024|FG011|Period 4: Open Label|Non-compliance with protocol|0
7238743|NCT00151775|11447013|FG000|Period 4: Open Label|Other|0
7238744|NCT00151775|11447014|FG001|Period 4: Open Label|Other|0
7238745|NCT00151775|11447015|FG002|Period 4: Open Label|Other|0
7238746|NCT00151775|11447016|FG003|Period 4: Open Label|Other|0
7238747|NCT00151775|11447017|FG004|Period 4: Open Label|Other|1
7238748|NCT00151775|11447018|FG005|Period 4: Open Label|Other|0
7238749|NCT00151775|11447019|FG006|Period 4: Open Label|Other|0
7238750|NCT00151775|11447020|FG007|Period 4: Open Label|Other|0
7238751|NCT00151775|11447021|FG008|Period 4: Open Label|Other|0
7238752|NCT00151775|11447022|FG009|Period 4: Open Label|Other|3
7238753|NCT00151775|11447023|FG010|Period 4: Open Label|Other|0
7238754|NCT00151775|11447024|FG011|Period 4: Open Label|Other|0
7238755|NCT00151775|11447013|FG000|Period 4: Open Label|Physician Decision|0
7238756|NCT00151775|11447014|FG001|Period 4: Open Label|Physician Decision|0
7238757|NCT00151775|11447015|FG002|Period 4: Open Label|Physician Decision|0
7238758|NCT00151775|11447016|FG003|Period 4: Open Label|Physician Decision|0
7238759|NCT00151775|11447017|FG004|Period 4: Open Label|Physician Decision|0
7238760|NCT00151775|11447018|FG005|Period 4: Open Label|Physician Decision|0
7238761|NCT00151775|11447019|FG006|Period 4: Open Label|Physician Decision|0
7238762|NCT00151775|11447020|FG007|Period 4: Open Label|Physician Decision|0
7238763|NCT00151775|11447021|FG008|Period 4: Open Label|Physician Decision|0
7238764|NCT00151775|11447022|FG009|Period 4: Open Label|Physician Decision|2
7238765|NCT00151775|11447023|FG010|Period 4: Open Label|Physician Decision|0
7238766|NCT00151775|11447024|FG011|Period 4: Open Label|Physician Decision|0
7238767|NCT00151775|11447013|FG000|Period 4: Open Label|Protocol Violation|0
7238768|NCT00151775|11447014|FG001|Period 4: Open Label|Protocol Violation|0
7238769|NCT00151775|11447015|FG002|Period 4: Open Label|Protocol Violation|0
7238770|NCT00151775|11447016|FG003|Period 4: Open Label|Protocol Violation|0
7238771|NCT00151775|11447017|FG004|Period 4: Open Label|Protocol Violation|1
7238772|NCT00151775|11447018|FG005|Period 4: Open Label|Protocol Violation|0
7238773|NCT00151775|11447019|FG006|Period 4: Open Label|Protocol Violation|0
7238774|NCT00151775|11447020|FG007|Period 4: Open Label|Protocol Violation|0
7238775|NCT00151775|11447021|FG008|Period 4: Open Label|Protocol Violation|0
7238776|NCT00151775|11447022|FG009|Period 4: Open Label|Protocol Violation|0
7238777|NCT00151775|11447023|FG010|Period 4: Open Label|Protocol Violation|0
7238778|NCT00151775|11447024|FG011|Period 4: Open Label|Protocol Violation|0
7238779|NCT00151892|11447079|FG000|Overall Study|Lack of Efficacy|50
7238780|NCT00151892|11447080|FG001|Overall Study|Lack of Efficacy|57
7238781|NCT00151892|11447079|FG000|Overall Study|Patient request|10
7238782|NCT00151892|11447080|FG001|Overall Study|Patient request|7
7238783|NCT00151892|11447079|FG000|Overall Study|Lost to Follow-up|5
7238784|NCT00151892|11447080|FG001|Overall Study|Lost to Follow-up|10
7238785|NCT00151892|11447079|FG000|Overall Study|Adverse Event|6
7238786|NCT00151892|11447080|FG001|Overall Study|Adverse Event|3
7238787|NCT00151892|11447079|FG000|Overall Study|Protocol Violation|3
7238788|NCT00151892|11447080|FG001|Overall Study|Protocol Violation|3
7238789|NCT00151892|11447079|FG000|Overall Study|Non-compliance|0
7238790|NCT00151892|11447080|FG001|Overall Study|Non-compliance|1
7238791|NCT00151892|11447079|FG000|Overall Study|Pregnancy|0
7238792|NCT00151892|11447080|FG001|Overall Study|Pregnancy|1
7238793|NCT00151892|11447079|FG000|Overall Study|Did not return for a visit|1
7238794|NCT00151892|11447080|FG001|Overall Study|Did not return for a visit|0
7238795|NCT00151892|11447079|FG000|Overall Study|Used prohibited corticosteroids|1
7238796|NCT00151892|11447080|FG001|Overall Study|Used prohibited corticosteroids|0
7238797|NCT00151892|11447079|FG000|Overall Study|Lack of study medication at center|0
7238798|NCT00151892|11447080|FG001|Overall Study|Lack of study medication at center|1
7238799|NCT00151996|11447088|FG000|Overall Study|Adverse Event|3
7238800|NCT00151996|11447089|FG001|Overall Study|Adverse Event|2
7238801|NCT00151996|11447088|FG000|Overall Study|Withdrawal by Subject|1
7238802|NCT00151996|11447089|FG001|Overall Study|Withdrawal by Subject|1
7238803|NCT00151996|11447088|FG000|Overall Study|Protocol Violation|1
7238804|NCT00151996|11447089|FG001|Overall Study|Protocol Violation|2
7238805|NCT00151996|11447088|FG000|Overall Study|Sponsor's decision|0
7238806|NCT00151996|11447089|FG001|Overall Study|Sponsor's decision|2
7238807|NCT00152009|11447099|FG000|Overall Study|Adverse Event|9
7238808|NCT00152009|11447100|FG001|Overall Study|Adverse Event|13
7238809|NCT00152009|11447101|FG002|Overall Study|Adverse Event|20
7238810|NCT00152009|11447102|FG003|Overall Study|Adverse Event|1
7238811|NCT00152009|11447099|FG000|Overall Study|Protocol Violation|3
7238812|NCT00152009|11447100|FG001|Overall Study|Protocol Violation|0
7238813|NCT00152009|11447101|FG002|Overall Study|Protocol Violation|0
7238814|NCT00152009|11447102|FG003|Overall Study|Protocol Violation|1
7238815|NCT00152009|11447099|FG000|Overall Study|Withdrawal by Subject|2
7238816|NCT00152009|11447100|FG001|Overall Study|Withdrawal by Subject|3
7238817|NCT00152009|11447101|FG002|Overall Study|Withdrawal by Subject|4
7238818|NCT00152009|11447102|FG003|Overall Study|Withdrawal by Subject|9
7238819|NCT00152009|11447099|FG000|Overall Study|Lost to Follow-up|2
7238820|NCT00152009|11447100|FG001|Overall Study|Lost to Follow-up|4
7238821|NCT00152009|11447101|FG002|Overall Study|Lost to Follow-up|3
7238822|NCT00152009|11447102|FG003|Overall Study|Lost to Follow-up|3
7238823|NCT00152009|11447099|FG000|Overall Study|Lack of Efficacy|8
7238824|NCT00152009|11447100|FG001|Overall Study|Lack of Efficacy|6
7238825|NCT00152009|11447101|FG002|Overall Study|Lack of Efficacy|7
7238826|NCT00152009|11447102|FG003|Overall Study|Lack of Efficacy|15
7238827|NCT00152009|11447099|FG000|Overall Study|ECG abnormalities|2
7238828|NCT00152009|11447100|FG001|Overall Study|ECG abnormalities|2
7238829|NCT00152009|11447101|FG002|Overall Study|ECG abnormalities|2
7238830|NCT00152009|11447102|FG003|Overall Study|ECG abnormalities|1
7238831|NCT00152009|11447099|FG000|Overall Study|Sponsor's decision|3
7238832|NCT00152009|11447100|FG001|Overall Study|Sponsor's decision|3
7238833|NCT00152009|11447101|FG002|Overall Study|Sponsor's decision|1
7238834|NCT00152009|11447102|FG003|Overall Study|Sponsor's decision|3
7238835|NCT00152464|11447114|FG000|Overall Study|Adverse Event|3
7238836|NCT00152464|11447115|FG001|Overall Study|Adverse Event|6
7238837|NCT00152464|11447114|FG000|Overall Study|Lost to Follow-up|8
7238838|NCT00152464|11447115|FG001|Overall Study|Lost to Follow-up|4
7238839|NCT00152464|11447114|FG000|Overall Study|Protocol Violation|3
7238840|NCT00152464|11447115|FG001|Overall Study|Protocol Violation|1
7238841|NCT00152464|11447114|FG000|Overall Study|Withdrawal by Subject|21
7238842|NCT00152464|11447115|FG001|Overall Study|Withdrawal by Subject|22
7238843|NCT00152464|11447114|FG000|Overall Study|Atopic dermatitis poorly controlled|0
7238844|NCT00152464|11447115|FG001|Overall Study|Atopic dermatitis poorly controlled|1
7238845|NCT00152464|11447114|FG000|Overall Study|Eczema deterioration|0
7238846|NCT00152464|11447115|FG001|Overall Study|Eczema deterioration|1
7238847|NCT00152464|11447114|FG000|Overall Study|Parent decision|1
7238848|NCT00152464|11447115|FG001|Overall Study|Parent decision|1
7238849|NCT00152464|11447114|FG000|Overall Study|Investigator decision|1
7238850|NCT00152464|11447115|FG001|Overall Study|Investigator decision|0
7238851|NCT00152464|11447114|FG000|Overall Study|Lack of Efficacy|1
7238852|NCT00152464|11447115|FG001|Overall Study|Lack of Efficacy|0
7238853|NCT00152464|11447114|FG000|Overall Study|Eczema poorly controlled|1
7238854|NCT00152464|11447115|FG001|Overall Study|Eczema poorly controlled|0
7238855|NCT00152464|11447114|FG000|Overall Study|Patient relocated|1
7238856|NCT00152464|11447115|FG001|Overall Study|Patient relocated|0
7238857|NCT00152516|11447121|FG000|Overall Study|Adverse Event|18
7238858|NCT00152516|11447121|FG000|Overall Study|Lack and Loss of Efficacy|30
7238859|NCT00152516|11447121|FG000|Overall Study|Lost to Follow-up|5
7238860|NCT00152516|11447121|FG000|Overall Study|Withdrawal by Subject|8
7238861|NCT00152516|11447121|FG000|Overall Study|Protocol Violation|3
7238862|NCT00152516|11447121|FG000|Overall Study|Other: Mother Refused To Cooperate|1
7238863|NCT00152516|11447121|FG000|Overall Study|Other: Given Commercial Drug in Error|2
7238864|NCT00152516|11447121|FG000|Overall Study|Other: Parents Withdrew Consent|2
7238865|NCT00152516|11447121|FG000|Overall Study|Other: Non-Compliance|2
7238866|NCT00152516|11447121|FG000|Overall Study|Other: Primary Care Physician's Decision|1
7238867|NCT00152516|11447121|FG000|Overall Study|Other: Moved Out Of State|1
7238868|NCT00152516|11447121|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
7238869|NCT00152516|11447121|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
7238870|NCT00152763|11447129|FG000|Overall Study|Death|4
7238871|NCT00152763|11447130|FG001|Overall Study|Death|1
7238872|NCT00152763|11447131|FG002|Overall Study|Death|2
7238873|NCT00152763|11447132|FG003|Overall Study|Death|1
7238874|NCT00152763|11447129|FG000|Overall Study|Lost to Follow-up|6
7238875|NCT00152763|11447130|FG001|Overall Study|Lost to Follow-up|4
7238876|NCT00152763|11447131|FG002|Overall Study|Lost to Follow-up|2
7238877|NCT00152763|11447132|FG003|Overall Study|Lost to Follow-up|13
7238878|NCT00152971|11447147|FG000|Overall Study|Adverse Event|12
7238879|NCT00152971|11447148|FG001|Overall Study|Adverse Event|10
7238880|NCT00152971|11447149|FG002|Overall Study|Adverse Event|9
7238881|NCT00152971|11447147|FG000|Overall Study|Protocol Violation|10
7238882|NCT00152971|11447148|FG001|Overall Study|Protocol Violation|11
7238883|NCT00152971|11447149|FG002|Overall Study|Protocol Violation|8
7238884|NCT00152971|11447147|FG000|Overall Study|Lost to Follow-up|17
7238885|NCT00152971|11447148|FG001|Overall Study|Lost to Follow-up|14
7238886|NCT00152971|11447149|FG002|Overall Study|Lost to Follow-up|13
7238887|NCT00152971|11447147|FG000|Overall Study|Withdrawal by Subject|9
7238888|NCT00152971|11447148|FG001|Overall Study|Withdrawal by Subject|8
7238889|NCT00152971|11447149|FG002|Overall Study|Withdrawal by Subject|14
7238890|NCT00152971|11447147|FG000|Overall Study|Other|3
7238891|NCT00152971|11447148|FG001|Overall Study|Other|5
7238892|NCT00152971|11447149|FG002|Overall Study|Other|5
7238893|NCT00152971|11447147|FG000|Treatment|Adverse Event|49
7238894|NCT00152971|11447148|FG001|Treatment|Adverse Event|40
7238895|NCT00152971|11447149|FG002|Treatment|Adverse Event|54
7238896|NCT00152971|11447147|FG000|Treatment|Protocol Violation|8
7238897|NCT00152971|11447148|FG001|Treatment|Protocol Violation|6
7238898|NCT00152971|11447149|FG002|Treatment|Protocol Violation|10
7238899|NCT00152971|11447147|FG000|Treatment|Lost to Follow-up|1
7238900|NCT00152971|11447148|FG001|Treatment|Lost to Follow-up|2
7238901|NCT00152971|11447149|FG002|Treatment|Lost to Follow-up|1
7238902|NCT00152971|11447147|FG000|Treatment|Withdrawal by Subject|4
7238903|NCT00152971|11447148|FG001|Treatment|Withdrawal by Subject|4
7238904|NCT00152971|11447149|FG002|Treatment|Withdrawal by Subject|5
7238905|NCT00152971|11447147|FG000|Treatment|Other|9
7238906|NCT00152971|11447148|FG001|Treatment|Other|11
7238907|NCT00152971|11447149|FG002|Treatment|Other|10
7238908|NCT00153062|11447161|FG000|Overall Study|Death|360
7238909|NCT00153062|11447162|FG001|Overall Study|Death|352
7238910|NCT00153062|11447163|FG002|Overall Study|Death|369
7573808|NCT03628924|11955315|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7573809|NCT03628924|11955316|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
7573810|NCT03628924|11955317|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
7573811|NCT03628924|11955318|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7573812|NCT03628924|11955319|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7575393|NCT03736967|11959083|FG002|Overall Study|Physician Decision|0
7238911|NCT00153062|11447164|FG003|Overall Study|Death|365
7238912|NCT00153062|11447161|FG000|Overall Study|Withdrawal by Subject|14
7238913|NCT00153062|11447162|FG001|Overall Study|Withdrawal by Subject|30
7238914|NCT00153062|11447163|FG002|Overall Study|Withdrawal by Subject|27
7238915|NCT00153062|11447164|FG003|Overall Study|Withdrawal by Subject|28
7238916|NCT00153062|11447161|FG000|Overall Study|Lost to Follow-up|12
7238917|NCT00153062|11447162|FG001|Overall Study|Lost to Follow-up|20
7238918|NCT00153062|11447163|FG002|Overall Study|Lost to Follow-up|15
7238919|NCT00153062|11447164|FG003|Overall Study|Lost to Follow-up|16
7238920|NCT00153062|11447161|FG000|Overall Study|Adverse Event|0
7238921|NCT00153062|11447162|FG001|Overall Study|Adverse Event|1
7238922|NCT00153062|11447163|FG002|Overall Study|Adverse Event|1
7238923|NCT00153062|11447164|FG003|Overall Study|Adverse Event|0
7238924|NCT00153062|11447161|FG000|Overall Study|Protocol Violation|0
7238925|NCT00153062|11447162|FG001|Overall Study|Protocol Violation|2
7238926|NCT00153062|11447163|FG002|Overall Study|Protocol Violation|1
7238927|NCT00153062|11447164|FG003|Overall Study|Protocol Violation|1
7238928|NCT00153062|11447161|FG000|Overall Study|No disposition data available|1
7238929|NCT00153062|11447162|FG001|Overall Study|No disposition data available|1
7238930|NCT00153062|11447163|FG002|Overall Study|No disposition data available|1
7238931|NCT00153062|11447164|FG003|Overall Study|No disposition data available|1
7238932|NCT00153062|11447161|FG000|Overall Study|Other|0
7238933|NCT00153062|11447162|FG001|Overall Study|Other|0
7238934|NCT00153062|11447163|FG002|Overall Study|Other|1
7238935|NCT00153062|11447164|FG003|Overall Study|Other|0
7238936|NCT00153101|11447179|FG000|Overall Study|Lost to Follow-up|14
7238937|NCT00153101|11447180|FG001|Overall Study|Lost to Follow-up|14
7238938|NCT00153101|11447181|FG002|Overall Study|Lost to Follow-up|12
7238939|NCT00153101|11447182|FG003|Overall Study|Lost to Follow-up|5
7238940|NCT00153101|11447183|FG004|Overall Study|Lost to Follow-up|5
7238941|NCT00153101|11447179|FG000|Overall Study|Withdrawal by Subject|3
7238942|NCT00153101|11447180|FG001|Overall Study|Withdrawal by Subject|4
7238943|NCT00153101|11447181|FG002|Overall Study|Withdrawal by Subject|3
7238944|NCT00153101|11447182|FG003|Overall Study|Withdrawal by Subject|3
7238945|NCT00153101|11447183|FG004|Overall Study|Withdrawal by Subject|5
7238946|NCT00153179|11447213|FG000|Study Visit Day 2|Withdrawal by Subject|1
7238947|NCT00153179|11447214|FG001|Study Visit Day 2|Withdrawal by Subject|0
7238948|NCT00153179|11447215|FG002|Study Visit Day 2|Withdrawal by Subject|2
7238949|NCT00153179|11447216|FG003|Study Visit Day 2|Withdrawal by Subject|2
7238950|NCT00153816|11447242|FG000|Overall Study|Death|6
7238951|NCT00153816|11447243|FG001|Overall Study|Death|5
7238952|NCT00153816|11447244|FG002|Overall Study|Death|4
7238953|NCT00153816|11447245|FG003|Overall Study|Death|6
7238954|NCT00153816|11447246|FG004|Overall Study|Death|0
7238955|NCT00153816|11447247|FG005|Overall Study|Death|2
7238956|NCT00153816|11447242|FG000|Overall Study|Lost to Follow-up|7
7238957|NCT00153816|11447243|FG001|Overall Study|Lost to Follow-up|8
7238958|NCT00153816|11447244|FG002|Overall Study|Lost to Follow-up|5
7238959|NCT00153816|11447245|FG003|Overall Study|Lost to Follow-up|8
7238960|NCT00153816|11447246|FG004|Overall Study|Lost to Follow-up|7
7238961|NCT00153816|11447247|FG005|Overall Study|Lost to Follow-up|9
7238962|NCT00153816|11447242|FG000|Overall Study|Withdrawal by Subject|9
7238963|NCT00153816|11447243|FG001|Overall Study|Withdrawal by Subject|9
7238964|NCT00153816|11447244|FG002|Overall Study|Withdrawal by Subject|9
7238965|NCT00153816|11447245|FG003|Overall Study|Withdrawal by Subject|4
7238966|NCT00153816|11447246|FG004|Overall Study|Withdrawal by Subject|1
7238967|NCT00153816|11447247|FG005|Overall Study|Withdrawal by Subject|5
7238968|NCT00153816|11447242|FG000|Overall Study|Follow-up exam not done|8
7238969|NCT00153816|11447243|FG001|Overall Study|Follow-up exam not done|7
7238970|NCT00153816|11447244|FG002|Overall Study|Follow-up exam not done|11
7238971|NCT00153816|11447245|FG003|Overall Study|Follow-up exam not done|10
7238972|NCT00153816|11447246|FG004|Overall Study|Follow-up exam not done|8
7238973|NCT00153816|11447247|FG005|Overall Study|Follow-up exam not done|9
7238974|NCT00153816|11447242|FG000|Overall Study|Follow-up exam done, histology missing|2
7238975|NCT00153816|11447243|FG001|Overall Study|Follow-up exam done, histology missing|3
7238976|NCT00153816|11447244|FG002|Overall Study|Follow-up exam done, histology missing|3
7238977|NCT00153816|11447245|FG003|Overall Study|Follow-up exam done, histology missing|3
7238978|NCT00153816|11447246|FG004|Overall Study|Follow-up exam done, histology missing|1
7238979|NCT00153816|11447247|FG005|Overall Study|Follow-up exam done, histology missing|2
7238980|NCT00153920|11447272|FG000|Overall Study|Adverse Event|9
7238981|NCT00153920|11447272|FG000|Overall Study|Progressive Disease|9
7238982|NCT00153920|11447272|FG000|Overall Study|Physician Decision|3
7238983|NCT00153920|11447272|FG000|Overall Study|Lack of Response|3
7238984|NCT00153920|11447272|FG000|Overall Study|Death|2
7238985|NCT00153920|11447272|FG000|Overall Study|Withdrawal by Subject|1
7238986|NCT00153920|11447272|FG000|Overall Study|Non-Protocol Therapy|1
7238987|NCT00153920|11447272|FG000|Overall Study|Withdrawal of Consent before Trt|1
7238988|NCT00153920|11447272|FG000|Overall Study|Progressive Disease before Trt|1
7238989|NCT00154063|11447282|FG000|Overall Study|Adverse Event|4
7238990|NCT00154063|11447283|FG001|Overall Study|Adverse Event|8
7238991|NCT00154063|11447282|FG000|Overall Study|Protocol Violation|1
7238992|NCT00154063|11447283|FG001|Overall Study|Protocol Violation|1
7238993|NCT00154063|11447282|FG000|Overall Study|Investigator or Sponsor Request|0
7238994|NCT00154063|11447283|FG001|Overall Study|Investigator or Sponsor Request|1
7238995|NCT00154063|11447282|FG000|Overall Study|Withdrawal by Subject|4
7238996|NCT00154063|11447283|FG001|Overall Study|Withdrawal by Subject|9
7238997|NCT00154063|11447282|FG000|Overall Study|Other|3
7238998|NCT00154063|11447283|FG001|Overall Study|Other|3
7238999|NCT00154102|11447295|FG000|Overall Study|investigational study phase ongoing|7
7239000|NCT00154102|11447296|FG001|Overall Study|investigational study phase ongoing|2
7239001|NCT00154284|11447304|FG000|Overall Study|Adverse Event|6
7239002|NCT00154284|11447305|FG001|Overall Study|Adverse Event|9
7239003|NCT00154284|11447304|FG000|Overall Study|Abnormal laboratory value(s)|0
7239004|NCT00154284|11447305|FG001|Overall Study|Abnormal laboratory value(s)|1
7239005|NCT00154284|11447304|FG000|Overall Study|Lack of Efficacy|1
7239006|NCT00154284|11447305|FG001|Overall Study|Lack of Efficacy|2
7239007|NCT00154284|11447304|FG000|Overall Study|Protocol Violation|0
7239008|NCT00154284|11447305|FG001|Overall Study|Protocol Violation|1
7239009|NCT00154297|11447315|FG000|Overall Study|Death|5
7239010|NCT00154297|11447316|FG001|Overall Study|Death|2
7239011|NCT00154297|11447315|FG000|Overall Study|Withdrawal by Subject|0
7239012|NCT00154297|11447316|FG001|Overall Study|Withdrawal by Subject|5
7239013|NCT00154297|11447315|FG000|Overall Study|Lost to Follow-up|3
7239014|NCT00154297|11447316|FG001|Overall Study|Lost to Follow-up|0
7239015|NCT00154310|11447324|FG000|Overall Study|Adverse Event|19
7239016|NCT00154310|11447325|FG001|Overall Study|Adverse Event|9
7239017|NCT00154310|11447324|FG000|Overall Study|Lack of Efficacy|5
7239018|NCT00154310|11447325|FG001|Overall Study|Lack of Efficacy|4
7239019|NCT00154310|11447324|FG000|Overall Study|Protocol Violation|4
7239020|NCT00154310|11447325|FG001|Overall Study|Protocol Violation|2
7239021|NCT00154310|11447324|FG000|Overall Study|Withdrawal by Subject|9
7239022|NCT00154310|11447325|FG001|Overall Study|Withdrawal by Subject|3
7239023|NCT00154310|11447324|FG000|Overall Study|Lost to Follow-up|0
7239024|NCT00154310|11447325|FG001|Overall Study|Lost to Follow-up|8
7239025|NCT00154310|11447324|FG000|Overall Study|Administrative problems|0
7239026|NCT00154310|11447325|FG001|Overall Study|Administrative problems|1
7239027|NCT00154310|11447324|FG000|Overall Study|Death|0
7239028|NCT00154310|11447325|FG001|Overall Study|Death|1
7239029|NCT00154375|11447333|FG000|Overall Study|Unsatisfactory therapeutic effect|25
7239030|NCT00154375|11447334|FG001|Overall Study|Unsatisfactory therapeutic effect|26
7239031|NCT00154375|11447333|FG000|Overall Study|Adverse Event|18
7239032|NCT00154375|11447334|FG001|Overall Study|Adverse Event|20
7239033|NCT00154375|11447333|FG000|Overall Study|Withdrawal by Subject|14
7239034|NCT00154375|11447334|FG001|Overall Study|Withdrawal by Subject|10
7239035|NCT00154375|11447333|FG000|Overall Study|Death|5
7239036|NCT00154375|11447334|FG001|Overall Study|Death|13
7239037|NCT00154375|11447333|FG000|Overall Study|Study drug no longer required|5
7239038|NCT00154375|11447334|FG001|Overall Study|Study drug no longer required|3
7239039|NCT00154375|11447333|FG000|Overall Study|Lost to Follow-up|2
7239040|NCT00154375|11447334|FG001|Overall Study|Lost to Follow-up|1
7239041|NCT00154375|11447333|FG000|Overall Study|Abnormal laboratory value(s)|0
7239042|NCT00154375|11447334|FG001|Overall Study|Abnormal laboratory value(s)|2
7239043|NCT00154375|11447333|FG000|Overall Study|Protocol Violation|0
7239044|NCT00154375|11447334|FG001|Overall Study|Protocol Violation|1
7239045|NCT00154375|11447333|FG000|Overall Study|Suspected progression of disease|44
7239046|NCT00154375|11447334|FG001|Overall Study|Suspected progression of disease|30
7239047|NCT00156533|11447380|FG000|Overall Study|Withdrawn - Medication Expiration|0
7239048|NCT00156533|11447381|FG001|Overall Study|Withdrawn - Medication Expiration|2
7239049|NCT00156533|11447382|FG002|Overall Study|Withdrawn - Medication Expiration|1
7239050|NCT00156533|11447383|FG003|Overall Study|Withdrawn - Medication Expiration|0
7239051|NCT00156533|11447380|FG000|Overall Study|Withdrawal by Subject|1
7239052|NCT00156533|11447381|FG001|Overall Study|Withdrawal by Subject|0
7239053|NCT00156533|11447382|FG002|Overall Study|Withdrawal by Subject|0
7239054|NCT00156533|11447383|FG003|Overall Study|Withdrawal by Subject|1
7239055|NCT00156533|11447380|FG000|Overall Study|Failed Screening|1
7239056|NCT00156533|11447381|FG001|Overall Study|Failed Screening|0
7239057|NCT00156533|11447382|FG002|Overall Study|Failed Screening|1
7239058|NCT00156533|11447383|FG003|Overall Study|Failed Screening|1
7239059|NCT00156819|11447402|FG000|Overall Study|Lost to Follow-up|1
7239060|NCT00156819|11447403|FG001|Overall Study|Lost to Follow-up|1
7239061|NCT00156819|11447404|FG002|Overall Study|Lost to Follow-up|3
7239062|NCT00157014|11447443|FG000|Overall Study|Death|4
7239063|NCT00157014|11447444|FG001|Overall Study|Death|2
7239064|NCT00157014|11447445|FG002|Overall Study|Death|1
7239065|NCT00157014|11447446|FG003|Overall Study|Death|1
7239066|NCT00157014|11447443|FG000|Overall Study|Physician Decision|0
7239067|NCT00157014|11447444|FG001|Overall Study|Physician Decision|1
7239068|NCT00157014|11447445|FG002|Overall Study|Physician Decision|0
7239069|NCT00157014|11447446|FG003|Overall Study|Physician Decision|0
7239070|NCT00157014|11447443|FG000|Overall Study|Medications withdrawn on family request|0
7239071|NCT00157014|11447444|FG001|Overall Study|Medications withdrawn on family request|1
7239072|NCT00157014|11447445|FG002|Overall Study|Medications withdrawn on family request|0
7239073|NCT00157014|11447446|FG003|Overall Study|Medications withdrawn on family request|0
7239074|NCT00157014|11447443|FG000|Overall Study|Patient withdrawn by investigator|1
7239075|NCT00157014|11447444|FG001|Overall Study|Patient withdrawn by investigator|0
7239076|NCT00157014|11447445|FG002|Overall Study|Patient withdrawn by investigator|0
7239077|NCT00157014|11447446|FG003|Overall Study|Patient withdrawn by investigator|0
7239078|NCT00157014|11447443|FG000|Overall Study|Patient unable to return in nursing home|1
7239079|NCT00157014|11447444|FG001|Overall Study|Patient unable to return in nursing home|0
7239080|NCT00157014|11447445|FG002|Overall Study|Patient unable to return in nursing home|0
7239081|NCT00157014|11447446|FG003|Overall Study|Patient unable to return in nursing home|0
7239082|NCT00157014|11447443|FG000|Overall Study|Patient would not receive transplant|0
7239083|NCT00157014|11447444|FG001|Overall Study|Patient would not receive transplant|1
7239084|NCT00157014|11447445|FG002|Overall Study|Patient would not receive transplant|0
7239085|NCT00157014|11447446|FG003|Overall Study|Patient would not receive transplant|0
7239086|NCT00157014|11447443|FG000|Overall Study|Withdrawal by Subject|1
7239087|NCT00157014|11447444|FG001|Overall Study|Withdrawal by Subject|0
7239088|NCT00157014|11447445|FG002|Overall Study|Withdrawal by Subject|0
7239089|NCT00157014|11447446|FG003|Overall Study|Withdrawal by Subject|0
7239090|NCT00157157|11447456|FG000|Overall Study|Withdrawal by Subject|6
7239091|NCT00157157|11447456|FG000|Overall Study|Physician Decision|1
7239092|NCT00157157|11447456|FG000|Overall Study|Lost to Follow-up|1
7239093|NCT00157157|11447456|FG000|Overall Study|Enrolled in another study|1
7239094|NCT00157157|11447456|FG000|Overall Study|Met exclusion criteria|1
7239095|NCT00157157|11447456|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
7239096|NCT00157196|11447467|FG000|Overall Study|Ongoing at data cut-off|9
7239097|NCT00157209|11447473|FG000|Overall Study|Ongoing at data cut-off|10
7239098|NCT00157209|11447474|FG001|Overall Study|Ongoing at data cut-off|0
7239099|NCT00157248|11447484|FG000|Overall Study|Adverse Event|36
7239100|NCT00157248|11447485|FG001|Overall Study|Adverse Event|25
7239101|NCT00157248|11447486|FG002|Overall Study|Adverse Event|13
7239102|NCT00157248|11447487|FG003|Overall Study|Adverse Event|33
7239103|NCT00157248|11447484|FG000|Overall Study|Protocol Violation|4
7239104|NCT00157248|11447485|FG001|Overall Study|Protocol Violation|0
7239105|NCT00157248|11447486|FG002|Overall Study|Protocol Violation|2
7239106|NCT00157248|11447487|FG003|Overall Study|Protocol Violation|2
7239107|NCT00157248|11447484|FG000|Overall Study|Lost to Follow-up|0
7239108|NCT00157248|11447485|FG001|Overall Study|Lost to Follow-up|1
7239109|NCT00157248|11447486|FG002|Overall Study|Lost to Follow-up|0
7464940|NCT01876446|11763821|FG001|Overall Study|Physician Decision|3
7464941|NCT01876511|11763839|FG000|Overall Study|Disease Progression-clinical/radiologic|11
7464942|NCT01876511|11763840|FG001|Overall Study|Disease Progression-clinical/radiologic|24
7464943|NCT01876511|11763841|FG002|Overall Study|Disease Progression-clinical/radiologic|16
7239110|NCT00157248|11447487|FG003|Overall Study|Lost to Follow-up|0
7239111|NCT00157248|11447484|FG000|Overall Study|Withdrawal by Subject|1
7239112|NCT00157248|11447485|FG001|Overall Study|Withdrawal by Subject|4
7239113|NCT00157248|11447486|FG002|Overall Study|Withdrawal by Subject|3
7239114|NCT00157248|11447487|FG003|Overall Study|Withdrawal by Subject|3
7239115|NCT00157248|11447484|FG000|Overall Study|site closures, subject moving|7
7239116|NCT00157248|11447485|FG001|Overall Study|site closures, subject moving|7
7239117|NCT00157248|11447486|FG002|Overall Study|site closures, subject moving|3
7239118|NCT00157248|11447487|FG003|Overall Study|site closures, subject moving|9
7239119|NCT00157755|11447509|FG000|Overall Study|Death|2
7239120|NCT00157755|11447510|FG001|Overall Study|Death|3
7239121|NCT00157755|11447511|FG002|Overall Study|Death|3
7239122|NCT00157755|11447512|FG003|Overall Study|Death|2
7239123|NCT00157755|11447513|FG004|Overall Study|Death|0
7239124|NCT00157755|11447514|FG005|Overall Study|Death|0
7239125|NCT00157755|11447509|FG000|Overall Study|Lost to Follow-up|0
7239126|NCT00157755|11447510|FG001|Overall Study|Lost to Follow-up|0
7239127|NCT00157755|11447511|FG002|Overall Study|Lost to Follow-up|1
7239128|NCT00157755|11447512|FG003|Overall Study|Lost to Follow-up|0
7239129|NCT00157755|11447513|FG004|Overall Study|Lost to Follow-up|0
7239130|NCT00157755|11447514|FG005|Overall Study|Lost to Follow-up|0
7239131|NCT00157755|11447509|FG000|Overall Study|Withdrawal by Subject|0
7239132|NCT00157755|11447510|FG001|Overall Study|Withdrawal by Subject|0
7239133|NCT00157755|11447511|FG002|Overall Study|Withdrawal by Subject|1
7239134|NCT00157755|11447512|FG003|Overall Study|Withdrawal by Subject|1
7239135|NCT00157755|11447513|FG004|Overall Study|Withdrawal by Subject|1
7239136|NCT00157755|11447514|FG005|Overall Study|Withdrawal by Subject|2
7239137|NCT00157755|11447509|FG000|Overall Study|Explant due to infection|0
7239138|NCT00157755|11447510|FG001|Overall Study|Explant due to infection|0
7239139|NCT00157755|11447511|FG002|Overall Study|Explant due to infection|1
7239140|NCT00157755|11447512|FG003|Overall Study|Explant due to infection|0
7239141|NCT00157755|11447513|FG004|Overall Study|Explant due to infection|0
7239142|NCT00157755|11447514|FG005|Overall Study|Explant due to infection|0
7239143|NCT00157755|11447509|FG000|Overall Study|Medical reason|0
7239144|NCT00157755|11447510|FG001|Overall Study|Medical reason|0
7239145|NCT00157755|11447511|FG002|Overall Study|Medical reason|1
7239146|NCT00157755|11447512|FG003|Overall Study|Medical reason|1
7239147|NCT00157755|11447513|FG004|Overall Study|Medical reason|0
7239148|NCT00157755|11447514|FG005|Overall Study|Medical reason|0
7239149|NCT00157755|11447509|FG000|Overall Study|Study site closure|0
7239150|NCT00157755|11447510|FG001|Overall Study|Study site closure|1
7239151|NCT00157755|11447511|FG002|Overall Study|Study site closure|0
7239152|NCT00157755|11447512|FG003|Overall Study|Study site closure|0
7239153|NCT00157755|11447513|FG004|Overall Study|Study site closure|0
7239154|NCT00157755|11447514|FG005|Overall Study|Study site closure|0
7239155|NCT00157755|11447509|FG000|Overall Study|Subject non-compliance|0
7239156|NCT00157755|11447510|FG001|Overall Study|Subject non-compliance|0
7239157|NCT00157755|11447511|FG002|Overall Study|Subject non-compliance|0
7239158|NCT00157755|11447512|FG003|Overall Study|Subject non-compliance|0
7239159|NCT00157755|11447513|FG004|Overall Study|Subject non-compliance|0
7239160|NCT00157755|11447514|FG005|Overall Study|Subject non-compliance|1
7239161|NCT00157755|11447509|FG000|Overall Study|Study completion|0
7239162|NCT00157755|11447510|FG001|Overall Study|Study completion|0
7239163|NCT00157755|11447511|FG002|Overall Study|Study completion|0
7239164|NCT00157755|11447512|FG003|Overall Study|Study completion|0
7239165|NCT00157755|11447513|FG004|Overall Study|Study completion|1
7239166|NCT00157755|11447514|FG005|Overall Study|Study completion|2
7239167|NCT00157820|11447523|FG000|Randomized|Physician Decision|4
7239168|NCT00157820|11447524|FG001|Randomized|Physician Decision|2
7239169|NCT00157820|11447525|FG002|Randomized|Physician Decision|3
7239170|NCT00157820|11447523|FG000|Randomized|Withdrawal by Subject|1
7239171|NCT00157820|11447524|FG001|Randomized|Withdrawal by Subject|2
7239172|NCT00157820|11447525|FG002|Randomized|Withdrawal by Subject|3
7239173|NCT00157820|11447523|FG000|Randomized|Protocol Violation|2
7239174|NCT00157820|11447524|FG001|Randomized|Protocol Violation|1
7239175|NCT00157820|11447525|FG002|Randomized|Protocol Violation|2
7239176|NCT00157820|11447523|FG000|1st 8 Month|Death|7
7239177|NCT00157820|11447524|FG001|1st 8 Month|Death|8
7239178|NCT00157820|11447525|FG002|1st 8 Month|Death|3
7239179|NCT00157820|11447523|FG000|1st 8 Month|Lost to Follow-up|1
7239180|NCT00157820|11447524|FG001|1st 8 Month|Lost to Follow-up|2
7239181|NCT00157820|11447525|FG002|1st 8 Month|Lost to Follow-up|1
7239182|NCT00157820|11447523|FG000|1st 8 Month|Premature cross-over|0
7239183|NCT00157820|11447524|FG001|1st 8 Month|Premature cross-over|2
7239184|NCT00157820|11447525|FG002|1st 8 Month|Premature cross-over|2
7239185|NCT00157820|11447523|FG000|2nd 8 Months|Death|3
7239186|NCT00157820|11447524|FG001|2nd 8 Months|Death|1
7239187|NCT00157820|11447525|FG002|2nd 8 Months|Death|3
7239188|NCT00157820|11447523|FG000|2nd 8 Months|Lost to Follow-up|1
7239189|NCT00157820|11447524|FG001|2nd 8 Months|Lost to Follow-up|5
7239190|NCT00157820|11447525|FG002|2nd 8 Months|Lost to Follow-up|2
7239191|NCT00157820|11447523|FG000|2nd 8 Months|Premature cross-over|1
7239192|NCT00157820|11447524|FG001|2nd 8 Months|Premature cross-over|7
7239193|NCT00157820|11447525|FG002|2nd 8 Months|Premature cross-over|9
7239194|NCT00157950|11447536|FG000|Overall Study|Death|1
7239195|NCT00157950|11447537|FG001|Overall Study|Death|0
7239196|NCT00158054|11447545|FG000|Overall Study|Refused to continue|3
7239197|NCT00158054|11447546|FG001|Overall Study|Refused to continue|0
7239198|NCT00158054|11447545|FG000|Overall Study|Unavailable for follow up|7
7239199|NCT00158054|11447546|FG001|Overall Study|Unavailable for follow up|3
7239200|NCT00158184|11447554|FG000|Overall Study|personal issues|3
7239201|NCT00158184|11447555|FG001|Overall Study|personal issues|1
7239202|NCT00158184|11447554|FG000|Overall Study|failed for follow unit/study rules|2
7239203|NCT00158184|11447555|FG001|Overall Study|failed for follow unit/study rules|0
7239204|NCT00158184|11447554|FG000|Overall Study|Adverse Event|1
7239205|NCT00158184|11447555|FG001|Overall Study|Adverse Event|1
7239206|NCT00158262|11447600|FG000|Overall Study|Lost to Follow-up|1
7239207|NCT00158262|11447601|FG001|Overall Study|Lost to Follow-up|1
7239208|NCT00158600|11447613|FG000|Overall Study|unable to commit time to study|0
7239209|NCT00158600|11447614|FG001|Overall Study|unable to commit time to study|1
7239210|NCT00158600|11447613|FG000|Overall Study|Adverse Event|2
7239211|NCT00158600|11447614|FG001|Overall Study|Adverse Event|1
7239212|NCT00158600|11447613|FG000|Overall Study|Death|1
7239213|NCT00158600|11447614|FG001|Overall Study|Death|0
7239214|NCT00158600|11447613|FG000|Overall Study|Withdrawal by Subject|2
7239215|NCT00158600|11447614|FG001|Overall Study|Withdrawal by Subject|2
7239216|NCT00158756|11447635|FG000|Overall Study|Withdrawal by Subject|5
7239217|NCT00158756|11447636|FG001|Overall Study|Withdrawal by Subject|0
7239218|NCT00158756|11447637|FG002|Overall Study|Withdrawal by Subject|6
7239219|NCT00158756|11447638|FG003|Overall Study|Withdrawal by Subject|1
7573813|NCT03628924|11955320|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7573814|NCT03628924|11955321|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
7573815|NCT03628924|11955315|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7573816|NCT03628924|11955316|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
7573817|NCT03628924|11955317|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7239220|NCT00158756|11447639|FG004|Overall Study|Withdrawal by Subject|3
7239221|NCT00158756|11447635|FG000|Overall Study|Adverse Event|0
7239222|NCT00158756|11447636|FG001|Overall Study|Adverse Event|0
7239223|NCT00158756|11447637|FG002|Overall Study|Adverse Event|1
7239224|NCT00158756|11447638|FG003|Overall Study|Adverse Event|0
7239225|NCT00158756|11447639|FG004|Overall Study|Adverse Event|0
7239226|NCT00158756|11447635|FG000|Overall Study|Serious adverse event|0
7239227|NCT00158756|11447636|FG001|Overall Study|Serious adverse event|0
7239228|NCT00158756|11447637|FG002|Overall Study|Serious adverse event|1
7239229|NCT00158756|11447638|FG003|Overall Study|Serious adverse event|0
7239230|NCT00158756|11447639|FG004|Overall Study|Serious adverse event|0
7239231|NCT00158860|11447653|FG000|Overall Study|Adverse Event|3
7239232|NCT00158860|11447654|FG001|Overall Study|Adverse Event|6
7239233|NCT00158860|11447653|FG000|Overall Study|Lost to Follow-up|11
7239234|NCT00158860|11447654|FG001|Overall Study|Lost to Follow-up|17
7239235|NCT00158860|11447653|FG000|Overall Study|Protocol Violation|8
7239236|NCT00158860|11447654|FG001|Overall Study|Protocol Violation|23
7239237|NCT00158860|11447653|FG000|Overall Study|Withdrawal by Subject|7
7239238|NCT00158860|11447654|FG001|Overall Study|Withdrawal by Subject|17
7239239|NCT00158860|11447653|FG000|Overall Study|MOVING OUT OF STATE|1
7239240|NCT00158860|11447654|FG001|Overall Study|MOVING OUT OF STATE|0
7239241|NCT00158860|11447653|FG000|Overall Study|Pregnancy|3
7239242|NCT00158860|11447654|FG001|Overall Study|Pregnancy|3
7239243|NCT00158860|11447653|FG000|Overall Study|SPONSOR STOPPED STUDY|2
7239244|NCT00158860|11447654|FG001|Overall Study|SPONSOR STOPPED STUDY|2
7239245|NCT00158860|11447653|FG000|Overall Study|SPONSOR REQUEST|0
7239246|NCT00158860|11447654|FG001|Overall Study|SPONSOR REQUEST|1
7239247|NCT00158860|11447653|FG000|Overall Study|Lost to Follow up but returned per GSK|0
7239248|NCT00158860|11447654|FG001|Overall Study|Lost to Follow up but returned per GSK|1
7239249|NCT00158860|11447653|FG000|Overall Study|Closed per sponsor|0
7239250|NCT00158860|11447654|FG001|Overall Study|Closed per sponsor|1
7239251|NCT00159432|11447702|FG000|Overall Study|Adverse Event|1
7239252|NCT00159432|11447702|FG000|Overall Study|Death|1
7239253|NCT00159432|11447702|FG000|Overall Study|Lack of Efficacy|8
7239254|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
7239255|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Adverse Event|9
7239256|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Death|4
7239257|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Protocol Violation|2
7239258|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
7239259|NCT00159822|11447706|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
7239260|NCT00159822|11447706|FG000|Post-treatment Follow-up Period|Death|1
7239261|NCT00159822|11447706|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
7239262|NCT00159822|11447706|FG000|Post-treatment Follow-up Period|Reason unspecified|1
7239263|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Death|3
7239264|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Death|0
7239265|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Adverse Event|12
7239266|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Adverse Event|6
7464944|NCT01876511|11763839|FG000|Overall Study|Death (unrelated)|3
7464945|NCT01876511|11763840|FG001|Overall Study|Death (unrelated)|0
7464946|NCT01876511|11763841|FG002|Overall Study|Death (unrelated)|2
7464947|NCT01876511|11763839|FG000|Overall Study|Drug-related Toxicity|5
7464948|NCT01876511|11763840|FG001|Overall Study|Drug-related Toxicity|1
7464949|NCT01876511|11763841|FG002|Overall Study|Drug-related Toxicity|6
7464950|NCT01876511|11763839|FG000|Overall Study|Patient Decision|3
7464951|NCT01876511|11763840|FG001|Overall Study|Patient Decision|0
7464952|NCT01876511|11763841|FG002|Overall Study|Patient Decision|6
7573818|NCT03628924|11955318|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7573819|NCT03628924|11955319|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7573820|NCT03628924|11955320|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7464953|NCT01876511|11763839|FG000|Overall Study|Physician Decision|1
7464954|NCT01876511|11763840|FG001|Overall Study|Physician Decision|0
7464955|NCT01876511|11763841|FG002|Overall Study|Physician Decision|1
7464956|NCT01876706|11763851|FG000|Overall Study|BPH Intervention|9
7464957|NCT01876706|11763851|FG000|Overall Study|Lost to Follow-up|7
7464958|NCT01876706|11763851|FG000|Overall Study|Withdrawals|6
7464959|NCT01876706|11763851|FG000|Overall Study|Death|3
7464960|NCT01876732|11763855|FG000|Overall Study|MMA was not over 800mg/dL|75
7464961|NCT01876784|11763862|FG000|Overall Study|Withdrawal by Subject|17
7464962|NCT01876784|11763863|FG001|Overall Study|Withdrawal by Subject|2
7464963|NCT01876784|11763862|FG000|Overall Study|Adverse Event|15
7464964|NCT01876784|11763863|FG001|Overall Study|Adverse Event|2
7573821|NCT03628924|11955321|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
7573822|NCT03628924|11955315|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
7239267|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
7464965|NCT01876784|11763862|FG000|Overall Study|Protocol Violation|1
7464966|NCT01876784|11763863|FG001|Overall Study|Protocol Violation|0
7464967|NCT01876784|11763862|FG000|Overall Study|Disease progression|37
7464968|NCT01876784|11763863|FG001|Overall Study|Disease progression|67
7464969|NCT01876784|11763862|FG000|Overall Study|Lost to Follow-up|0
7575394|NCT03736967|11959084|FG003|Overall Study|Physician Decision|1
7239268|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
7239269|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Reason Unspecified|5
7239270|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Reason Unspecified|3
7239271|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Subject Defaulted|1
7239272|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Subject Defaulted|0
7239273|NCT00159861|11447712|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
7239274|NCT00159861|11447713|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
7239275|NCT00159861|11447712|FG000|Extension Study - up to 3 Years|Death|24
7464970|NCT01876784|11763863|FG001|Overall Study|Lost to Follow-up|1
7573823|NCT03628924|11955316|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7573824|NCT03628924|11955317|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
7573825|NCT03628924|11955318|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7573826|NCT03628924|11955319|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7239276|NCT00159861|11447713|FG001|Extension Study - up to 3 Years|Death|28
7239277|NCT00159861|11447712|FG000|Extension Study - up to 3 Years|Adverse Event|14
7239278|NCT00159861|11447713|FG001|Extension Study - up to 3 Years|Adverse Event|14
7239279|NCT00159861|11447712|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
7239280|NCT00159861|11447713|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
7239281|NCT00159861|11447712|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
7239282|NCT00159861|11447713|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
7239283|NCT00159861|11447712|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
7239284|NCT00159861|11447713|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
7239285|NCT00159874|11447731|FG000|Overall Study|Adverse Event|2
7239286|NCT00159874|11447732|FG001|Overall Study|Adverse Event|2
7239287|NCT00159874|11447733|FG002|Overall Study|Adverse Event|5
7239288|NCT00159874|11447734|FG003|Overall Study|Adverse Event|1
7239289|NCT00159874|11447735|FG004|Overall Study|Adverse Event|1
7239290|NCT00159874|11447736|FG005|Overall Study|Adverse Event|2
7239291|NCT00159874|11447737|FG006|Overall Study|Adverse Event|0
7239292|NCT00159874|11447731|FG000|Overall Study|Does Not Meet Entrance Criteria|1
7239293|NCT00159874|11447732|FG001|Overall Study|Does Not Meet Entrance Criteria|0
7239294|NCT00159874|11447733|FG002|Overall Study|Does Not Meet Entrance Criteria|1
7239295|NCT00159874|11447734|FG003|Overall Study|Does Not Meet Entrance Criteria|0
7239296|NCT00159874|11447735|FG004|Overall Study|Does Not Meet Entrance Criteria|0
7239297|NCT00159874|11447736|FG005|Overall Study|Does Not Meet Entrance Criteria|0
7239298|NCT00159874|11447737|FG006|Overall Study|Does Not Meet Entrance Criteria|0
7239299|NCT00159874|11447731|FG000|Overall Study|Lack of Efficacy|2
7239300|NCT00159874|11447732|FG001|Overall Study|Lack of Efficacy|0
7239301|NCT00159874|11447733|FG002|Overall Study|Lack of Efficacy|1
7239302|NCT00159874|11447734|FG003|Overall Study|Lack of Efficacy|1
7239303|NCT00159874|11447735|FG004|Overall Study|Lack of Efficacy|0
7239304|NCT00159874|11447736|FG005|Overall Study|Lack of Efficacy|3
7239305|NCT00159874|11447737|FG006|Overall Study|Lack of Efficacy|0
7239306|NCT00159874|11447731|FG000|Overall Study|Lost to Follow-up|1
7239307|NCT00159874|11447732|FG001|Overall Study|Lost to Follow-up|0
7239308|NCT00159874|11447733|FG002|Overall Study|Lost to Follow-up|3
7239309|NCT00159874|11447734|FG003|Overall Study|Lost to Follow-up|0
7239310|NCT00159874|11447735|FG004|Overall Study|Lost to Follow-up|1
7239311|NCT00159874|11447736|FG005|Overall Study|Lost to Follow-up|2
7239312|NCT00159874|11447737|FG006|Overall Study|Lost to Follow-up|1
7239313|NCT00159874|11447731|FG000|Overall Study|Other|8
7239314|NCT00159874|11447732|FG001|Overall Study|Other|8
7239315|NCT00159874|11447733|FG002|Overall Study|Other|8
7239316|NCT00159874|11447734|FG003|Overall Study|Other|0
7239317|NCT00159874|11447735|FG004|Overall Study|Other|2
7239318|NCT00159874|11447736|FG005|Overall Study|Other|1
7239319|NCT00159874|11447737|FG006|Overall Study|Other|3
7239320|NCT00159874|11447731|FG000|Overall Study|Protocol Violation|0
7239321|NCT00159874|11447732|FG001|Overall Study|Protocol Violation|5
7239322|NCT00159874|11447733|FG002|Overall Study|Protocol Violation|2
7239323|NCT00159874|11447734|FG003|Overall Study|Protocol Violation|0
7239324|NCT00159874|11447735|FG004|Overall Study|Protocol Violation|0
7239325|NCT00159874|11447736|FG005|Overall Study|Protocol Violation|0
7239326|NCT00159874|11447737|FG006|Overall Study|Protocol Violation|0
7239327|NCT00159874|11447731|FG000|Overall Study|Death|3
7239328|NCT00159874|11447732|FG001|Overall Study|Death|8
7239329|NCT00159874|11447733|FG002|Overall Study|Death|15
7239330|NCT00159874|11447734|FG003|Overall Study|Death|0
7239331|NCT00159874|11447735|FG004|Overall Study|Death|1
7239332|NCT00159874|11447736|FG005|Overall Study|Death|2
7239333|NCT00159874|11447737|FG006|Overall Study|Death|0
7239334|NCT00159874|11447731|FG000|Overall Study|Withdrawal by Subject|2
7239335|NCT00159874|11447732|FG001|Overall Study|Withdrawal by Subject|6
7239336|NCT00159874|11447733|FG002|Overall Study|Withdrawal by Subject|8
7239337|NCT00159874|11447734|FG003|Overall Study|Withdrawal by Subject|4
7239338|NCT00159874|11447735|FG004|Overall Study|Withdrawal by Subject|3
7239339|NCT00159874|11447736|FG005|Overall Study|Withdrawal by Subject|2
7239340|NCT00159874|11447737|FG006|Overall Study|Withdrawal by Subject|1
7239341|NCT00159874|11447731|FG000|Overall Study|Pregnancy|1
7239342|NCT00159874|11447732|FG001|Overall Study|Pregnancy|1
7239343|NCT00159874|11447733|FG002|Overall Study|Pregnancy|0
7239344|NCT00159874|11447734|FG003|Overall Study|Pregnancy|0
7239345|NCT00159874|11447735|FG004|Overall Study|Pregnancy|0
7239346|NCT00159874|11447736|FG005|Overall Study|Pregnancy|0
7239347|NCT00159874|11447737|FG006|Overall Study|Pregnancy|0
7239348|NCT00159913|11447757|FG000|Overall Study|Adverse Event|1
7239349|NCT00159913|11447758|FG001|Overall Study|Adverse Event|0
7239350|NCT00159913|11447759|FG002|Overall Study|Adverse Event|1
7239351|NCT00159913|11447760|FG003|Overall Study|Adverse Event|0
7239352|NCT00159913|11447757|FG000|Overall Study|Withdrawal by Subject|0
7239353|NCT00159913|11447758|FG001|Overall Study|Withdrawal by Subject|0
7573827|NCT03628924|11955320|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7239354|NCT00159913|11447759|FG002|Overall Study|Withdrawal by Subject|0
7239355|NCT00159913|11447760|FG003|Overall Study|Withdrawal by Subject|1
7239356|NCT00159913|11447757|FG000|Overall Study|Lost to Follow-up|0
7239357|NCT00159913|11447758|FG001|Overall Study|Lost to Follow-up|0
7239358|NCT00159913|11447759|FG002|Overall Study|Lost to Follow-up|0
7239359|NCT00159913|11447760|FG003|Overall Study|Lost to Follow-up|1
7239360|NCT00159913|11447757|FG000|Overall Study|Protocol Violation|1
7239361|NCT00159913|11447758|FG001|Overall Study|Protocol Violation|0
7239362|NCT00159913|11447759|FG002|Overall Study|Protocol Violation|1
7239363|NCT00159913|11447760|FG003|Overall Study|Protocol Violation|0
7239364|NCT00160199|11447783|FG000|Overall Study|Adverse Event|5
7239365|NCT00160199|11447784|FG001|Overall Study|Adverse Event|14
7239366|NCT00160199|11447783|FG000|Overall Study|Lack of Efficacy|0
7239367|NCT00160199|11447784|FG001|Overall Study|Lack of Efficacy|1
7239368|NCT00160199|11447783|FG000|Overall Study|Lost to Follow-up|7
7239369|NCT00160199|11447784|FG001|Overall Study|Lost to Follow-up|7
7239370|NCT00160199|11447783|FG000|Overall Study|Withdrawal by Subject|4
7239371|NCT00160199|11447784|FG001|Overall Study|Withdrawal by Subject|6
7239372|NCT00160199|11447783|FG000|Overall Study|Administrative|0
7239373|NCT00160199|11447784|FG001|Overall Study|Administrative|1
7239374|NCT00160199|11447783|FG000|Overall Study|Protocol Violation|8
7239375|NCT00160199|11447784|FG001|Overall Study|Protocol Violation|8
7239376|NCT00160251|11447796|FG000|Prior to Amendment 2|Adverse Event|2
7239377|NCT00160251|11447797|FG001|Prior to Amendment 2|Adverse Event|1
7239378|NCT00160251|11447798|FG002|Prior to Amendment 2|Adverse Event|3
7239379|NCT00160251|11447799|FG003|Prior to Amendment 2|Adverse Event|1
7239380|NCT00160251|11447800|FG004|Prior to Amendment 2|Adverse Event|1
7239381|NCT00160251|11447801|FG005|Prior to Amendment 2|Adverse Event|1
7239382|NCT00160251|11447802|FG006|Prior to Amendment 2|Adverse Event|1
7239383|NCT00160251|11447803|FG007|Prior to Amendment 2|Adverse Event|0
7239384|NCT00160251|11447796|FG000|Prior to Amendment 2|Lack of Efficacy|0
7239385|NCT00160251|11447797|FG001|Prior to Amendment 2|Lack of Efficacy|4
7239386|NCT00160251|11447798|FG002|Prior to Amendment 2|Lack of Efficacy|37
7239387|NCT00160251|11447799|FG003|Prior to Amendment 2|Lack of Efficacy|35
7239388|NCT00160251|11447800|FG004|Prior to Amendment 2|Lack of Efficacy|24
7239389|NCT00160251|11447801|FG005|Prior to Amendment 2|Lack of Efficacy|55
7239390|NCT00160251|11447802|FG006|Prior to Amendment 2|Lack of Efficacy|0
7239391|NCT00160251|11447803|FG007|Prior to Amendment 2|Lack of Efficacy|0
7239392|NCT00160251|11447796|FG000|Prior to Amendment 2|Lost to Follow-up|0
7239393|NCT00160251|11447797|FG001|Prior to Amendment 2|Lost to Follow-up|0
7239394|NCT00160251|11447798|FG002|Prior to Amendment 2|Lost to Follow-up|1
7239395|NCT00160251|11447799|FG003|Prior to Amendment 2|Lost to Follow-up|0
7239396|NCT00160251|11447800|FG004|Prior to Amendment 2|Lost to Follow-up|1
7239397|NCT00160251|11447801|FG005|Prior to Amendment 2|Lost to Follow-up|1
7239398|NCT00160251|11447802|FG006|Prior to Amendment 2|Lost to Follow-up|0
7239399|NCT00160251|11447803|FG007|Prior to Amendment 2|Lost to Follow-up|0
7239400|NCT00160251|11447796|FG000|Prior to Amendment 2|Withdrawal by Subject|3
7239401|NCT00160251|11447797|FG001|Prior to Amendment 2|Withdrawal by Subject|1
7239402|NCT00160251|11447798|FG002|Prior to Amendment 2|Withdrawal by Subject|3
7239403|NCT00160251|11447799|FG003|Prior to Amendment 2|Withdrawal by Subject|4
7239404|NCT00160251|11447800|FG004|Prior to Amendment 2|Withdrawal by Subject|2
7239405|NCT00160251|11447801|FG005|Prior to Amendment 2|Withdrawal by Subject|3
7239406|NCT00160251|11447802|FG006|Prior to Amendment 2|Withdrawal by Subject|3
7239407|NCT00160251|11447803|FG007|Prior to Amendment 2|Withdrawal by Subject|0
7239408|NCT00160251|11447796|FG000|Prior to Amendment 2|Noncompliance with protocol|1
7239409|NCT00160251|11447797|FG001|Prior to Amendment 2|Noncompliance with protocol|0
7239410|NCT00160251|11447798|FG002|Prior to Amendment 2|Noncompliance with protocol|0
7239411|NCT00160251|11447799|FG003|Prior to Amendment 2|Noncompliance with protocol|0
7239412|NCT00160251|11447800|FG004|Prior to Amendment 2|Noncompliance with protocol|0
7239413|NCT00160251|11447801|FG005|Prior to Amendment 2|Noncompliance with protocol|0
7239414|NCT00160251|11447802|FG006|Prior to Amendment 2|Noncompliance with protocol|0
7239415|NCT00160251|11447803|FG007|Prior to Amendment 2|Noncompliance with protocol|0
7239416|NCT00160251|11447796|FG000|Prior to Amendment 2|Completed Treatment Phase|3
7239417|NCT00160251|11447797|FG001|Prior to Amendment 2|Completed Treatment Phase|0
7239418|NCT00160251|11447798|FG002|Prior to Amendment 2|Completed Treatment Phase|0
7239419|NCT00160251|11447799|FG003|Prior to Amendment 2|Completed Treatment Phase|0
7239420|NCT00160251|11447800|FG004|Prior to Amendment 2|Completed Treatment Phase|0
7239421|NCT00160251|11447801|FG005|Prior to Amendment 2|Completed Treatment Phase|23
7239422|NCT00160251|11447802|FG006|Prior to Amendment 2|Completed Treatment Phase|0
7239423|NCT00160251|11447803|FG007|Prior to Amendment 2|Completed Treatment Phase|0
7239424|NCT00160251|11447796|FG000|Post-amendment 2|Adverse Event|0
7239425|NCT00160251|11447797|FG001|Post-amendment 2|Adverse Event|0
7239426|NCT00160251|11447798|FG002|Post-amendment 2|Adverse Event|0
7239427|NCT00160251|11447799|FG003|Post-amendment 2|Adverse Event|0
7239428|NCT00160251|11447800|FG004|Post-amendment 2|Adverse Event|0
7239429|NCT00160251|11447801|FG005|Post-amendment 2|Adverse Event|0
7239430|NCT00160251|11447802|FG006|Post-amendment 2|Adverse Event|0
7239431|NCT00160251|11447803|FG007|Post-amendment 2|Adverse Event|20
7239432|NCT00160251|11447796|FG000|Post-amendment 2|Lack of Efficacy|0
7239433|NCT00160251|11447797|FG001|Post-amendment 2|Lack of Efficacy|0
7239434|NCT00160251|11447798|FG002|Post-amendment 2|Lack of Efficacy|0
7239435|NCT00160251|11447799|FG003|Post-amendment 2|Lack of Efficacy|0
7239436|NCT00160251|11447800|FG004|Post-amendment 2|Lack of Efficacy|0
7239437|NCT00160251|11447801|FG005|Post-amendment 2|Lack of Efficacy|0
7239438|NCT00160251|11447802|FG006|Post-amendment 2|Lack of Efficacy|0
7239439|NCT00160251|11447803|FG007|Post-amendment 2|Lack of Efficacy|24
7239440|NCT00160251|11447796|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239441|NCT00160251|11447797|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239442|NCT00160251|11447798|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239443|NCT00160251|11447799|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239444|NCT00160251|11447800|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239445|NCT00160251|11447801|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239446|NCT00160251|11447802|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
7239447|NCT00160251|11447803|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
7239448|NCT00160524|11447860|FG000|Overall Study|Adverse Event|119
7239449|NCT00160524|11447860|FG000|Overall Study|Adverse Event and Other|94
7239450|NCT00160524|11447860|FG000|Overall Study|Protocol Violation|16
7239451|NCT00160524|11447860|FG000|Overall Study|Protocol Violation and Other|2
7239452|NCT00160524|11447860|FG000|Overall Study|Withdrawal by Subject|141
7239453|NCT00160524|11447860|FG000|Overall Study|Withdrawal by Subject and Other|17
7239454|NCT00160524|11447860|FG000|Overall Study|Physician Decision|27
7239455|NCT00160524|11447860|FG000|Overall Study|Physician Decision and Other|6
7239456|NCT00160524|11447860|FG000|Overall Study|Lost to Follow-up|13
7239457|NCT00160524|11447860|FG000|Overall Study|Lost to Follow-up and Other|1
7239458|NCT00160524|11447860|FG000|Overall Study|Lack of Efficacy|21
7239459|NCT00160524|11447860|FG000|Overall Study|Lack of Efficacy and Other|1
7239460|NCT00160524|11447860|FG000|Overall Study|Other|20
7239461|NCT00160615|11447866|FG000|Overall Study|Adverse Event|5
7239462|NCT00160615|11447867|FG001|Overall Study|Adverse Event|12
7239463|NCT00160615|11447866|FG000|Overall Study|Withdrawal by Subject|0
7239464|NCT00160615|11447867|FG001|Overall Study|Withdrawal by Subject|2
7239465|NCT00160615|11447866|FG000|Overall Study|Lack of Efficacy|11
7239466|NCT00160615|11447867|FG001|Overall Study|Lack of Efficacy|23
7239467|NCT00160615|11447866|FG000|Overall Study|Patient decision|1
7239468|NCT00160615|11447867|FG001|Overall Study|Patient decision|2
7239469|NCT00160615|11447866|FG000|Overall Study|Investigator decision|1
7239470|NCT00160615|11447867|FG001|Overall Study|Investigator decision|1
7239471|NCT00160615|11447866|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
7239472|NCT00160615|11447867|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
7239473|NCT00160615|11447866|FG000|Overall Study|Switch to surgical treatment|0
7239474|NCT00160615|11447867|FG001|Overall Study|Switch to surgical treatment|2
7239475|NCT00160615|11447866|FG000|Overall Study|Non-compliance was suspected|0
7239476|NCT00160615|11447867|FG001|Overall Study|Non-compliance was suspected|1
7239477|NCT00160615|11447866|FG000|Overall Study|Poor compliance|0
7239478|NCT00160615|11447867|FG001|Overall Study|Poor compliance|1
7239479|NCT00160641|11447875|FG000|Overall Study|Adverse Event|102
7239480|NCT00160641|11447875|FG000|Overall Study|Withdrawal by Subject|87
7239481|NCT00160641|11447875|FG000|Overall Study|Lost to Follow-up|8
7239482|NCT00160641|11447875|FG000|Overall Study|Lack of Efficacy|12
7239483|NCT00160641|11447875|FG000|Overall Study|Protocol Violation|3
7239484|NCT00160641|11447875|FG000|Overall Study|Other|9
7239485|NCT00160654|11447879|FG000|Overall Study|Adverse Event|14
7239486|NCT00160654|11447879|FG000|Overall Study|Lack of Efficacy|4
7239487|NCT00160654|11447879|FG000|Overall Study|Lost to Follow-up|2
7239488|NCT00160654|11447879|FG000|Overall Study|Intake of expired drug|7
7239489|NCT00160654|11447879|FG000|Overall Study|Psychological trauma|1
7239490|NCT00160654|11447879|FG000|Overall Study|Sponsor decision|1
7239491|NCT00160654|11447879|FG000|Overall Study|Patient met exclusion criteria|1
7239492|NCT00160654|11447879|FG000|Overall Study|Patient decision|1
7239493|NCT00160654|11447879|FG000|Overall Study|Poor compliance, dilantin toxicity|1
7239494|NCT00160654|11447879|FG000|Overall Study|Met exclusion criteria|1
7239495|NCT00160667|11447886|FG000|Overall Study|Adverse Event|3
7239496|NCT00160667|11447887|FG001|Overall Study|Adverse Event|1
7239497|NCT00160667|11447888|FG002|Overall Study|Adverse Event|4
7239498|NCT00160667|11447886|FG000|Overall Study|Withdrawal by Subject|2
7239499|NCT00160667|11447887|FG001|Overall Study|Withdrawal by Subject|0
7239500|NCT00160667|11447888|FG002|Overall Study|Withdrawal by Subject|1
7239501|NCT00160667|11447886|FG000|Overall Study|Lack of Efficacy|0
7239502|NCT00160667|11447887|FG001|Overall Study|Lack of Efficacy|1
7239503|NCT00160667|11447888|FG002|Overall Study|Lack of Efficacy|0
7239504|NCT00160667|11447886|FG000|Overall Study|Protocol Violation|0
7239505|NCT00160667|11447887|FG001|Overall Study|Protocol Violation|1
7239506|NCT00160667|11447888|FG002|Overall Study|Protocol Violation|0
7239507|NCT00160667|11447886|FG000|Overall Study|Patient decision|0
7239508|NCT00160667|11447887|FG001|Overall Study|Patient decision|0
7239509|NCT00160667|11447888|FG002|Overall Study|Patient decision|1
7239510|NCT00160680|11447899|FG000|Overall Study|Adverse Event|0
7239511|NCT00160680|11447900|FG001|Overall Study|Adverse Event|1
7239512|NCT00160680|11447899|FG000|Overall Study|Lack of Efficacy|2
7239513|NCT00160680|11447900|FG001|Overall Study|Lack of Efficacy|1
7239514|NCT00160680|11447899|FG000|Overall Study|Lost to Follow-up|3
7239515|NCT00160680|11447900|FG001|Overall Study|Lost to Follow-up|2
7239516|NCT00160680|11447899|FG000|Overall Study|Withdrawal by Subject|4
7239517|NCT00160680|11447900|FG001|Overall Study|Withdrawal by Subject|9
7239518|NCT00160693|11447906|FG000|Overall Study|Adverse Event|97
7239519|NCT00160693|11447906|FG000|Overall Study|Lack of Efficacy|30
7239520|NCT00160693|11447906|FG000|Overall Study|Protocol Violation|24
7239521|NCT00160693|11447906|FG000|Overall Study|Lost to Follow-up|15
7239522|NCT00160693|11447906|FG000|Overall Study|Withdrawal by Subject|54
7239523|NCT00160693|11447906|FG000|Overall Study|Study terminated by sponsor|15
7239524|NCT00160706|11447910|FG000|Overall Study|Adverse Event|53
7239525|NCT00160706|11447910|FG000|Overall Study|Adverse Event and Other Reason|105
7239526|NCT00160706|11447910|FG000|Overall Study|Protocol Violation|3
7239527|NCT00160706|11447910|FG000|Overall Study|Withdrawal by Subject|41
7239528|NCT00160706|11447910|FG000|Overall Study|Withdrawal by Subject and Other|12
7239529|NCT00160706|11447910|FG000|Overall Study|Physician Decision|10
7239530|NCT00160706|11447910|FG000|Overall Study|Physician Decision and Other|3
7239531|NCT00160706|11447910|FG000|Overall Study|Lost to Follow-up|4
7239532|NCT00160706|11447910|FG000|Overall Study|Lost to Follow-up and Other|1
7239533|NCT00160706|11447910|FG000|Overall Study|Lack of Efficacy|42
7239534|NCT00160706|11447910|FG000|Overall Study|Lack of Efficacy and Other|1
7239535|NCT00160706|11447910|FG000|Overall Study|Other Reason|11
7239536|NCT00161213|11447914|FG000|Overall Study|Withdrawal by Subject|1
7239537|NCT00161213|11447914|FG000|Overall Study|Evaluable for toxicity but not response|1
7239538|NCT00161616|11447938|FG000|Overall Study|Withdrawal by Subject|6
7239539|NCT00161616|11447939|FG001|Overall Study|Withdrawal by Subject|5
7239540|NCT00161616|11447938|FG000|Overall Study|Physician Decision|1
7239541|NCT00161616|11447939|FG001|Overall Study|Physician Decision|0
7239542|NCT00161616|11447938|FG000|Overall Study|Death|1
7239543|NCT00161616|11447939|FG001|Overall Study|Death|1
7239544|NCT00161616|11447938|FG000|Overall Study|Lost to Follow-up|17
7239545|NCT00161616|11447939|FG001|Overall Study|Lost to Follow-up|13
7239546|NCT00161616|11447938|FG000|Overall Study|Protocol deviation|1
7239547|NCT00161616|11447939|FG001|Overall Study|Protocol deviation|0
7239548|NCT00162032|11447947|FG000|Overall Study|Lost to Follow-up|4
7239549|NCT00162032|11447948|FG001|Overall Study|Lost to Follow-up|2
7239550|NCT00162032|11447947|FG000|Overall Study|Reason not specified|1
7239551|NCT00162032|11447948|FG001|Overall Study|Reason not specified|0
7239552|NCT00162097|11447963|FG000|Overall Study|Participant no longer met study criteria|0
7239553|NCT00162097|11447964|FG001|Overall Study|Participant no longer met study criteria|0
7239554|NCT00162097|11447965|FG002|Overall Study|Participant no longer met study criteria|0
7239555|NCT00162097|11447966|FG003|Overall Study|Participant no longer met study criteria|1
7239556|NCT00162123|11447990|FG000|Overall Study|Disease progression|27
7239557|NCT00162123|11447991|FG001|Overall Study|Disease progression|19
7239558|NCT00162123|11447992|FG002|Overall Study|Disease progression|10
7239559|NCT00162123|11447993|FG003|Overall Study|Disease progression|4
7239560|NCT00162123|11447994|FG004|Overall Study|Disease progression|8
7239561|NCT00162123|11447995|FG005|Overall Study|Disease progression|3
7239562|NCT00162123|11447996|FG006|Overall Study|Disease progression|1
7239563|NCT00162123|11447997|FG007|Overall Study|Disease progression|0
7239564|NCT00162123|11447990|FG000|Overall Study|Study drug toxicity|6
7239565|NCT00162123|11447991|FG001|Overall Study|Study drug toxicity|1
7239566|NCT00162123|11447992|FG002|Overall Study|Study drug toxicity|5
7239567|NCT00162123|11447993|FG003|Overall Study|Study drug toxicity|0
7239568|NCT00162123|11447994|FG004|Overall Study|Study drug toxicity|4
7239569|NCT00162123|11447995|FG005|Overall Study|Study drug toxicity|1
7239570|NCT00162123|11447996|FG006|Overall Study|Study drug toxicity|1
7239571|NCT00162123|11447997|FG007|Overall Study|Study drug toxicity|0
7239572|NCT00162123|11447990|FG000|Overall Study|Death|3
7239573|NCT00162123|11447991|FG001|Overall Study|Death|3
7239574|NCT00162123|11447992|FG002|Overall Study|Death|1
7239575|NCT00162123|11447993|FG003|Overall Study|Death|1
7239576|NCT00162123|11447994|FG004|Overall Study|Death|1
7239577|NCT00162123|11447995|FG005|Overall Study|Death|1
7239578|NCT00162123|11447996|FG006|Overall Study|Death|0
7239579|NCT00162123|11447997|FG007|Overall Study|Death|0
7239580|NCT00162123|11447990|FG000|Overall Study|Withdrawal by Subject|2
7239581|NCT00162123|11447991|FG001|Overall Study|Withdrawal by Subject|0
7239582|NCT00162123|11447992|FG002|Overall Study|Withdrawal by Subject|2
7239583|NCT00162123|11447993|FG003|Overall Study|Withdrawal by Subject|1
7239584|NCT00162123|11447994|FG004|Overall Study|Withdrawal by Subject|1
7239585|NCT00162123|11447995|FG005|Overall Study|Withdrawal by Subject|2
7239586|NCT00162123|11447996|FG006|Overall Study|Withdrawal by Subject|1
7239587|NCT00162123|11447997|FG007|Overall Study|Withdrawal by Subject|0
7239588|NCT00162123|11447990|FG000|Overall Study|Deterioration without progression|2
7239589|NCT00162123|11447991|FG001|Overall Study|Deterioration without progression|2
7239590|NCT00162123|11447992|FG002|Overall Study|Deterioration without progression|3
7239591|NCT00162123|11447993|FG003|Overall Study|Deterioration without progression|0
7239592|NCT00162123|11447994|FG004|Overall Study|Deterioration without progression|1
7239593|NCT00162123|11447995|FG005|Overall Study|Deterioration without progression|0
7239594|NCT00162123|11447996|FG006|Overall Study|Deterioration without progression|0
7239595|NCT00162123|11447997|FG007|Overall Study|Deterioration without progression|0
7239596|NCT00162123|11447990|FG000|Overall Study|Adverse Event|1
7239597|NCT00162123|11447991|FG001|Overall Study|Adverse Event|2
7239598|NCT00162123|11447992|FG002|Overall Study|Adverse Event|0
7239599|NCT00162123|11447993|FG003|Overall Study|Adverse Event|2
7239600|NCT00162123|11447994|FG004|Overall Study|Adverse Event|1
7239601|NCT00162123|11447995|FG005|Overall Study|Adverse Event|0
7239602|NCT00162123|11447996|FG006|Overall Study|Adverse Event|0
7239603|NCT00162123|11447997|FG007|Overall Study|Adverse Event|0
7239604|NCT00162123|11447990|FG000|Overall Study|Not specified (before treatment)|2
7239605|NCT00162123|11447991|FG001|Overall Study|Not specified (before treatment)|0
7239606|NCT00162123|11447992|FG002|Overall Study|Not specified (before treatment)|0
7239607|NCT00162123|11447993|FG003|Overall Study|Not specified (before treatment)|0
7239608|NCT00162123|11447994|FG004|Overall Study|Not specified (before treatment)|12
7239609|NCT00162123|11447995|FG005|Overall Study|Not specified (before treatment)|1
7239610|NCT00162123|11447996|FG006|Overall Study|Not specified (before treatment)|0
7239611|NCT00162123|11447997|FG007|Overall Study|Not specified (before treatment)|0
7239612|NCT00162123|11447990|FG000|Overall Study|Not specified (after start of treatment)|0
7239613|NCT00162123|11447991|FG001|Overall Study|Not specified (after start of treatment)|0
7239614|NCT00162123|11447992|FG002|Overall Study|Not specified (after start of treatment)|0
7239615|NCT00162123|11447993|FG003|Overall Study|Not specified (after start of treatment)|0
7239616|NCT00162123|11447994|FG004|Overall Study|Not specified (after start of treatment)|3
7239617|NCT00162123|11447995|FG005|Overall Study|Not specified (after start of treatment)|0
7239618|NCT00162123|11447996|FG006|Overall Study|Not specified (after start of treatment)|0
7239619|NCT00162123|11447997|FG007|Overall Study|Not specified (after start of treatment)|0
7239620|NCT00162123|11447990|FG000|Overall Study|Physician Decision|1
7239621|NCT00162123|11447991|FG001|Overall Study|Physician Decision|2
7239622|NCT00162123|11447992|FG002|Overall Study|Physician Decision|0
7239623|NCT00162123|11447993|FG003|Overall Study|Physician Decision|0
7239624|NCT00162123|11447994|FG004|Overall Study|Physician Decision|0
7239625|NCT00162123|11447995|FG005|Overall Study|Physician Decision|1
7464971|NCT01876784|11763862|FG000|Overall Study|Death|1
7464972|NCT01876784|11763863|FG001|Overall Study|Death|0
7239626|NCT00162123|11447996|FG006|Overall Study|Physician Decision|1
7239627|NCT00162123|11447997|FG007|Overall Study|Physician Decision|0
7239628|NCT00162123|11447990|FG000|Overall Study|Tumor assessment only (not treated)|0
7239629|NCT00162123|11447991|FG001|Overall Study|Tumor assessment only (not treated)|0
7239630|NCT00162123|11447992|FG002|Overall Study|Tumor assessment only (not treated)|0
7239631|NCT00162123|11447993|FG003|Overall Study|Tumor assessment only (not treated)|0
7239632|NCT00162123|11447994|FG004|Overall Study|Tumor assessment only (not treated)|0
7239633|NCT00162123|11447995|FG005|Overall Study|Tumor assessment only (not treated)|0
7239634|NCT00162123|11447996|FG006|Overall Study|Tumor assessment only (not treated)|0
7239635|NCT00162123|11447997|FG007|Overall Study|Tumor assessment only (not treated)|1
7239636|NCT00162123|11447990|FG000|Overall Study|Follow-up only (not treated or assessed)|0
7239637|NCT00162123|11447991|FG001|Overall Study|Follow-up only (not treated or assessed)|0
7239638|NCT00162123|11447992|FG002|Overall Study|Follow-up only (not treated or assessed)|0
7239639|NCT00162123|11447993|FG003|Overall Study|Follow-up only (not treated or assessed)|0
7239640|NCT00162123|11447994|FG004|Overall Study|Follow-up only (not treated or assessed)|0
7239641|NCT00162123|11447995|FG005|Overall Study|Follow-up only (not treated or assessed)|0
7239642|NCT00162123|11447996|FG006|Overall Study|Follow-up only (not treated or assessed)|0
7239643|NCT00162123|11447997|FG007|Overall Study|Follow-up only (not treated or assessed)|57
7239644|NCT00162136|11448022|FG000|Overall Study|Adverse Event|1
7239645|NCT00162136|11448022|FG000|Overall Study|Death|1
7239646|NCT00162136|11448022|FG000|Overall Study|Disease Progression/Relapse|23
7239647|NCT00162136|11448022|FG000|Overall Study|Investigator Request|5
7239648|NCT00162136|11448022|FG000|Overall Study|Study Drug Toxicity|4
7239649|NCT00162136|11448022|FG000|Overall Study|Withdrawal by Subject|1
7239650|NCT00162266|11448049|FG000|Double-Blind Period|Adverse Event|5
7239651|NCT00162266|11448050|FG001|Double-Blind Period|Adverse Event|9
7239652|NCT00162266|11448051|FG002|Double-Blind Period|Adverse Event|11
7239653|NCT00162266|11448052|FG003|Double-Blind Period|Adverse Event|0
7239654|NCT00162266|11448049|FG000|Double-Blind Period|Death|0
7239655|NCT00162266|11448050|FG001|Double-Blind Period|Death|1
7239656|NCT00162266|11448051|FG002|Double-Blind Period|Death|0
7239657|NCT00162266|11448052|FG003|Double-Blind Period|Death|0
7239658|NCT00162266|11448049|FG000|Double-Blind Period|Lost to Follow-up|1
7239659|NCT00162266|11448050|FG001|Double-Blind Period|Lost to Follow-up|2
7239660|NCT00162266|11448051|FG002|Double-Blind Period|Lost to Follow-up|0
7239661|NCT00162266|11448052|FG003|Double-Blind Period|Lost to Follow-up|0
7239662|NCT00162266|11448049|FG000|Double-Blind Period|Other Reason|1
7239663|NCT00162266|11448050|FG001|Double-Blind Period|Other Reason|0
7239664|NCT00162266|11448051|FG002|Double-Blind Period|Other Reason|1
7239665|NCT00162266|11448052|FG003|Double-Blind Period|Other Reason|0
7239666|NCT00162266|11448049|FG000|Double-Blind Period|Lack of Efficacy|13
7239667|NCT00162266|11448050|FG001|Double-Blind Period|Lack of Efficacy|17
7239668|NCT00162266|11448051|FG002|Double-Blind Period|Lack of Efficacy|30
7239669|NCT00162266|11448052|FG003|Double-Blind Period|Lack of Efficacy|0
7239670|NCT00162266|11448049|FG000|Double-Blind Period|Withdrawal by Subject|5
7239671|NCT00162266|11448050|FG001|Double-Blind Period|Withdrawal by Subject|2
7239672|NCT00162266|11448051|FG002|Double-Blind Period|Withdrawal by Subject|6
7239673|NCT00162266|11448052|FG003|Double-Blind Period|Withdrawal by Subject|0
7239674|NCT00162266|11448049|FG000|Open-Label Period|Death|0
7239675|NCT00162266|11448050|FG001|Open-Label Period|Death|0
7239676|NCT00162266|11448051|FG002|Open-Label Period|Death|0
7239677|NCT00162266|11448052|FG003|Open-Label Period|Death|7
7239678|NCT00162266|11448049|FG000|Open-Label Period|Adverse Event|0
7239679|NCT00162266|11448050|FG001|Open-Label Period|Adverse Event|0
7239680|NCT00162266|11448051|FG002|Open-Label Period|Adverse Event|0
7239681|NCT00162266|11448052|FG003|Open-Label Period|Adverse Event|46
7239682|NCT00162266|11448049|FG000|Open-Label Period|Lack of Efficacy|0
7239683|NCT00162266|11448050|FG001|Open-Label Period|Lack of Efficacy|0
7239684|NCT00162266|11448051|FG002|Open-Label Period|Lack of Efficacy|0
7239685|NCT00162266|11448052|FG003|Open-Label Period|Lack of Efficacy|26
7239686|NCT00162266|11448049|FG000|Open-Label Period|Lost to Follow-up|0
7239687|NCT00162266|11448050|FG001|Open-Label Period|Lost to Follow-up|0
7239688|NCT00162266|11448051|FG002|Open-Label Period|Lost to Follow-up|0
7239689|NCT00162266|11448052|FG003|Open-Label Period|Lost to Follow-up|3
7239690|NCT00162266|11448049|FG000|Open-Label Period|Withdrawal by Subject|0
7239691|NCT00162266|11448050|FG001|Open-Label Period|Withdrawal by Subject|0
7239692|NCT00162266|11448051|FG002|Open-Label Period|Withdrawal by Subject|0
7239693|NCT00162266|11448052|FG003|Open-Label Period|Withdrawal by Subject|31
7239694|NCT00162266|11448049|FG000|Open-Label Period|Administrative Reason By Sponsor|0
7239695|NCT00162266|11448050|FG001|Open-Label Period|Administrative Reason By Sponsor|0
7239696|NCT00162266|11448051|FG002|Open-Label Period|Administrative Reason By Sponsor|0
7239697|NCT00162266|11448052|FG003|Open-Label Period|Administrative Reason By Sponsor|9
7239698|NCT00162266|11448049|FG000|Open-Label Period|Other Reasons|0
7239699|NCT00162266|11448050|FG001|Open-Label Period|Other Reasons|0
7239700|NCT00162266|11448051|FG002|Open-Label Period|Other Reasons|0
7239701|NCT00162266|11448052|FG003|Open-Label Period|Other Reasons|15
7239702|NCT00162981|11448106|FG000|Overall Study|Adverse Event|2
7239703|NCT00162981|11448107|FG001|Overall Study|Adverse Event|5
7239704|NCT00162981|11448106|FG000|Overall Study|Withdrawal by Subject|1
7239705|NCT00162981|11448107|FG001|Overall Study|Withdrawal by Subject|1
7239706|NCT00162981|11448106|FG000|Overall Study|Physician Decision|1
7239707|NCT00162981|11448107|FG001|Overall Study|Physician Decision|0
7239708|NCT00163020|11448115|FG000|Overall Study|Lost to Follow-up|0
7239709|NCT00163020|11448116|FG001|Overall Study|Lost to Follow-up|2
7239710|NCT00163189|11448124|FG000|Overall Study|Other|6
7239711|NCT00163189|11448124|FG000|Overall Study|Lost to Follow-up|1
7239712|NCT00163189|11448124|FG000|Overall Study|Protocol Violation|2
7239713|NCT00163189|11448124|FG000|Overall Study|Death|3
7239714|NCT00163189|11448124|FG000|Overall Study|Adverse Event|6
7239715|NCT00163189|11448124|FG000|Overall Study|Lack of Efficacy|7
7239716|NCT00163189|11448124|FG000|Overall Study|Study terminated by sponsor|11
7239717|NCT00163189|11448124|FG000|Overall Study|Withdrawal by Subject|11
7239718|NCT00163189|11448124|FG000|Overall Study|Did not meet continuation criterion|16
7255896|NCT00320710|11467442|FG000|Overall Study|Abnormal laboratory value(s)|12
7255897|NCT00320710|11467443|FG001|Overall Study|Abnormal laboratory value(s)|3
7255898|NCT00320710|11467444|FG002|Overall Study|Abnormal laboratory value(s)|0
7255899|NCT00320710|11467442|FG000|Overall Study|Adverse Event|18
7255900|NCT00320710|11467443|FG001|Overall Study|Adverse Event|14
7255901|NCT00320710|11467444|FG002|Overall Study|Adverse Event|1
7255902|NCT00320710|11467442|FG000|Overall Study|Lost to Follow-up|1
7255903|NCT00320710|11467443|FG001|Overall Study|Lost to Follow-up|0
7255904|NCT00320710|11467444|FG002|Overall Study|Lost to Follow-up|0
7255905|NCT00320788|11467463|FG000|Overall Study|Adverse Event|0
7255906|NCT00320788|11467464|FG001|Overall Study|Adverse Event|0
7255907|NCT00320788|11467465|FG002|Overall Study|Adverse Event|0
7255908|NCT00320788|11467466|FG003|Overall Study|Adverse Event|1
7255909|NCT00320788|11467467|FG004|Overall Study|Adverse Event|0
7255910|NCT00320788|11467463|FG000|Overall Study|Death|0
7255911|NCT00320788|11467464|FG001|Overall Study|Death|0
7255912|NCT00320788|11467465|FG002|Overall Study|Death|1
7255913|NCT00320788|11467466|FG003|Overall Study|Death|0
7255914|NCT00320788|11467467|FG004|Overall Study|Death|1
7255915|NCT00320788|11467463|FG000|Overall Study|Lost to Follow-up|0
7255916|NCT00320788|11467464|FG001|Overall Study|Lost to Follow-up|2
7255917|NCT00320788|11467465|FG002|Overall Study|Lost to Follow-up|1
7255918|NCT00320788|11467466|FG003|Overall Study|Lost to Follow-up|0
7255919|NCT00320788|11467467|FG004|Overall Study|Lost to Follow-up|0
7255920|NCT00320788|11467463|FG000|Overall Study|Decision by the Sponsor|1
7255921|NCT00320788|11467464|FG001|Overall Study|Decision by the Sponsor|1
7255922|NCT00320788|11467465|FG002|Overall Study|Decision by the Sponsor|0
7255923|NCT00320788|11467466|FG003|Overall Study|Decision by the Sponsor|0
7255924|NCT00320788|11467467|FG004|Overall Study|Decision by the Sponsor|1
7239719|NCT00163215|11448128|FG000|Overall Study|Lack of Efficacy|3
7239720|NCT00163215|11448128|FG000|Overall Study|Withdrawal by Subject|5
7239721|NCT00163215|11448128|FG000|Overall Study|Other|7
7239722|NCT00163657|11448148|FG000|Overall Study|Death|12
7464973|NCT01876784|11763862|FG000|Overall Study|Randomized but not treated|2
7464974|NCT01876784|11763863|FG001|Overall Study|Randomized but not treated|1
7464975|NCT01876784|11763862|FG000|Overall Study|Other than specified above|5
7464976|NCT01876784|11763863|FG001|Overall Study|Other than specified above|6
7464977|NCT01876784|11763862|FG000|Overall Study|Ongoing|41
7239723|NCT00163657|11448149|FG001|Overall Study|Death|14
7239724|NCT00163657|11448150|FG002|Overall Study|Death|19
7239725|NCT00163657|11448148|FG000|Overall Study|graft loss|4
7239726|NCT00163657|11448149|FG001|Overall Study|graft loss|1
7239727|NCT00163657|11448150|FG002|Overall Study|graft loss|2
7239728|NCT00163657|11448148|FG000|Overall Study|Withdrawal by Subject|2
7239729|NCT00163657|11448149|FG001|Overall Study|Withdrawal by Subject|3
7239730|NCT00163657|11448150|FG002|Overall Study|Withdrawal by Subject|2
7239731|NCT00163657|11448148|FG000|Overall Study|Physician Decision|0
7239732|NCT00163657|11448149|FG001|Overall Study|Physician Decision|1
7239733|NCT00163657|11448150|FG002|Overall Study|Physician Decision|1
7239734|NCT00163657|11448148|FG000|Overall Study|Non Compliance|1
7239735|NCT00163657|11448149|FG001|Overall Study|Non Compliance|0
7239736|NCT00163657|11448150|FG002|Overall Study|Non Compliance|0
7239737|NCT00163657|11448148|FG000|Overall Study|Lost to Follow-up|1
7239738|NCT00163657|11448149|FG001|Overall Study|Lost to Follow-up|3
7239739|NCT00163657|11448150|FG002|Overall Study|Lost to Follow-up|10
7239740|NCT00163657|11448148|FG000|Overall Study|Other reason|0
7239741|NCT00163657|11448149|FG001|Overall Study|Other reason|1
7239742|NCT00163657|11448150|FG002|Overall Study|Other reason|3
7239743|NCT00165646|11448161|FG000|Overall Study|Adverse Event|1
7239744|NCT00165646|11448162|FG001|Overall Study|Adverse Event|1
7239745|NCT00165646|11448163|FG002|Overall Study|Adverse Event|1
7239746|NCT00165646|11448161|FG000|Overall Study|Lack of Efficacy|1
7239747|NCT00165646|11448162|FG001|Overall Study|Lack of Efficacy|2
7239748|NCT00165646|11448163|FG002|Overall Study|Lack of Efficacy|0
7239749|NCT00165646|11448161|FG000|Overall Study|Withdrawal by Subject|0
7239750|NCT00165646|11448162|FG001|Overall Study|Withdrawal by Subject|2
7239751|NCT00165646|11448163|FG002|Overall Study|Withdrawal by Subject|1
7239752|NCT00165646|11448161|FG000|Overall Study|Physician Decision|2
7239753|NCT00165646|11448162|FG001|Overall Study|Physician Decision|0
7239754|NCT00165646|11448163|FG002|Overall Study|Physician Decision|2
7239755|NCT00165646|11448161|FG000|Overall Study|Protocol Violation|1
7239756|NCT00165646|11448162|FG001|Overall Study|Protocol Violation|0
7239757|NCT00165646|11448163|FG002|Overall Study|Protocol Violation|0
7239758|NCT00165672|11448173|FG000|Overall Study|Adverse Event|0
7239759|NCT00165672|11448174|FG001|Overall Study|Adverse Event|1
7239760|NCT00165698|11448182|FG000|Overall Study|Adverse Event|2
7239761|NCT00165698|11448183|FG001|Overall Study|Adverse Event|10
7239762|NCT00165698|11448182|FG000|Overall Study|Lost to Follow-up|2
7239763|NCT00165698|11448183|FG001|Overall Study|Lost to Follow-up|2
7239764|NCT00165698|11448182|FG000|Overall Study|Withdrawal by Subject|2
7239765|NCT00165698|11448183|FG001|Overall Study|Withdrawal by Subject|1
7239766|NCT00165698|11448182|FG000|Overall Study|Protocol Violation|1
7239767|NCT00165698|11448183|FG001|Overall Study|Protocol Violation|0
7239768|NCT00165698|11448182|FG000|Overall Study|Not Taken/Lost the medicine|1
7239769|NCT00165698|11448183|FG001|Overall Study|Not Taken/Lost the medicine|2
7239770|NCT00165776|11448193|FG000|Overall Study|Lack of Efficacy|0
7239771|NCT00165776|11448194|FG001|Overall Study|Lack of Efficacy|0
7239772|NCT00165776|11448195|FG002|Overall Study|Lack of Efficacy|0
7239773|NCT00165776|11448196|FG003|Overall Study|Lack of Efficacy|1
7239774|NCT00165776|11448193|FG000|Overall Study|Withdrawal by Subject|4
7239775|NCT00165776|11448194|FG001|Overall Study|Withdrawal by Subject|1
7239776|NCT00165776|11448195|FG002|Overall Study|Withdrawal by Subject|2
7239777|NCT00165776|11448196|FG003|Overall Study|Withdrawal by Subject|0
7239778|NCT00165776|11448193|FG000|Overall Study|Worsening of Cervical Dystonia|0
7239779|NCT00165776|11448194|FG001|Overall Study|Worsening of Cervical Dystonia|0
7239780|NCT00165776|11448195|FG002|Overall Study|Worsening of Cervical Dystonia|0
7239781|NCT00165776|11448196|FG003|Overall Study|Worsening of Cervical Dystonia|1
7239782|NCT00165789|11448210|FG000|Overall Study|Adverse Event|0
7239783|NCT00165789|11448211|FG001|Overall Study|Adverse Event|3
7239784|NCT00165789|11448212|FG002|Overall Study|Adverse Event|0
7239785|NCT00165789|11448213|FG003|Overall Study|Adverse Event|12
7239786|NCT00165789|11448210|FG000|Overall Study|Withdrawal by Subject|0
7239787|NCT00165789|11448211|FG001|Overall Study|Withdrawal by Subject|1
7239788|NCT00165789|11448212|FG002|Overall Study|Withdrawal by Subject|1
7239789|NCT00165789|11448213|FG003|Overall Study|Withdrawal by Subject|2
7239790|NCT00165841|11448225|FG000|Overall Study|Adverse Event|2
7239791|NCT00165841|11448226|FG001|Overall Study|Adverse Event|3
7239792|NCT00165841|11448225|FG000|Overall Study|Lack of Efficacy|6
7239793|NCT00165841|11448226|FG001|Overall Study|Lack of Efficacy|33
7239794|NCT00165841|11448225|FG000|Overall Study|Lost to Follow-up|4
7239795|NCT00165841|11448226|FG001|Overall Study|Lost to Follow-up|4
7464978|NCT01876784|11763863|FG001|Overall Study|Ongoing|40
7464979|NCT01876810|11763869|FG000|Overall Study|Physician Decision|0
7239796|NCT00165841|11448225|FG000|Overall Study|Withdrawal by Subject|7
7239797|NCT00165841|11448226|FG001|Overall Study|Withdrawal by Subject|8
7239798|NCT00165841|11448225|FG000|Overall Study|Physician Decision|1
7239799|NCT00165841|11448226|FG001|Overall Study|Physician Decision|0
7239800|NCT00165841|11448225|FG000|Overall Study|Protocol Violation|6
7239801|NCT00165841|11448226|FG001|Overall Study|Protocol Violation|8
7239802|NCT00165841|11448225|FG000|Overall Study|Other|3
7573828|NCT03628924|11955321|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
7573829|NCT03628924|11955315|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7573830|NCT03628924|11955316|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7573831|NCT03628924|11955317|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
7573832|NCT03628924|11955318|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7573833|NCT03628924|11955319|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7573834|NCT03628924|11955320|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
7239803|NCT00165841|11448226|FG001|Overall Study|Other|5
7239804|NCT00165841|11448225|FG000|Overall Study|Medication Noncompliance|1
7239805|NCT00165841|11448226|FG001|Overall Study|Medication Noncompliance|1
7239806|NCT00165984|11448241|FG000|Overall Study|Death|15
7239807|NCT00166114|11448260|FG000|Overall Study|Protocol Violation|2
7239808|NCT00166114|11448261|FG001|Overall Study|Protocol Violation|1
7239809|NCT00166114|11448260|FG000|Overall Study|Withdrawal by Subject|10
7239810|NCT00166114|11448261|FG001|Overall Study|Withdrawal by Subject|4
7239811|NCT00166114|11448260|FG000|Overall Study|Adverse Event|2
7239812|NCT00166114|11448261|FG001|Overall Study|Adverse Event|1
7239813|NCT00166296|11448295|FG000|Overall Study|Withdrawal by Subject|1
7239814|NCT00166296|11448296|FG001|Overall Study|Withdrawal by Subject|3
7239815|NCT00166296|11448295|FG000|Overall Study|Adverse Event|2
7239816|NCT00166296|11448296|FG001|Overall Study|Adverse Event|4
7239817|NCT00166296|11448295|FG000|Overall Study|Lost to Follow-up|4
7239818|NCT00166296|11448296|FG001|Overall Study|Lost to Follow-up|2
7239819|NCT00166439|11448311|FG000|Overall Study|Ineligible|5
7239820|NCT00166517|11448317|FG000|Overall Study|Lost to Follow-up|1
7239821|NCT00166517|11448318|FG001|Overall Study|Lost to Follow-up|0
7239822|NCT00166517|11448317|FG000|Overall Study|Protocol Violation|4
7239823|NCT00166517|11448318|FG001|Overall Study|Protocol Violation|1
7239824|NCT00166517|11448317|FG000|Overall Study|Withdrawal by Subject|0
7239825|NCT00166517|11448318|FG001|Overall Study|Withdrawal by Subject|1
7239826|NCT00166712|11448326|FG000|Overall Study|Death|0
7239827|NCT00166712|11448327|FG001|Overall Study|Death|1
7239828|NCT00166712|11448326|FG000|Overall Study|Adverse Event|1
7239829|NCT00166712|11448327|FG001|Overall Study|Adverse Event|0
7239830|NCT00166712|11448326|FG000|Overall Study|Withdrawal by Subject|1
7239831|NCT00166712|11448327|FG001|Overall Study|Withdrawal by Subject|2
7239832|NCT00166712|11448326|FG000|Overall Study|Physician Decision|0
7239833|NCT00166712|11448327|FG001|Overall Study|Physician Decision|2
7239834|NCT00167245|11448363|FG000|Overall Study|Lost to Follow-up|20
7239835|NCT00167245|11448364|FG001|Overall Study|Lost to Follow-up|31
7239836|NCT00167245|11448363|FG000|Overall Study|Withdrawal by Subject|5
7464980|NCT01876810|11763870|FG001|Overall Study|Physician Decision|1
7464981|NCT01876823|11763879|FG000|Overall Study|Withdrawal by Subject|5
7464982|NCT01876823|11763879|FG000|Overall Study|Physician Decision|2
7464983|NCT01876823|11763879|FG000|Overall Study|Patients moved|2
7464984|NCT01876901|11763885|FG000|Overall Study|Protocol Violation|10
7464985|NCT01876901|11763886|FG001|Overall Study|Protocol Violation|2
7464986|NCT01876901|11763885|FG000|Overall Study|No or other surgical intervention|7
7464987|NCT01876901|11763886|FG001|Overall Study|No or other surgical intervention|5
7464988|NCT01876979|11763895|FG000|Overall Study|Physician Decision|2
7464989|NCT01876979|11763896|FG001|Overall Study|Physician Decision|3
7464990|NCT01877083|11763912|FG000|Treatment Phase|Disease Progression|10
7464991|NCT01877083|11763912|FG000|Treatment Phase|Clinical Progression|1
7464992|NCT01877083|11763912|FG000|Treatment Phase|Adverse Event|6
7464993|NCT01877083|11763912|FG000|Treatment Phase|Withdrawal by Subject|2
7464994|NCT01877083|11763912|FG000|Treatment Phase|Lost to Follow-up|1
7464995|NCT01877083|11763912|FG000|Extension Phase|Disease Progression|3
7464996|NCT01877083|11763912|FG000|Extension Phase|Adverse Event|2
7464997|NCT01877187|11763933|FG000|Overall Study|Death|2
7464998|NCT01877187|11763933|FG000|Overall Study|Withdrawal by Subject|4
7464999|NCT01877187|11763933|FG000|Overall Study|Lost to Follow-up|3
7465000|NCT01877187|11763933|FG000|Overall Study|Declining clinical status|11
7465001|NCT01877187|11763933|FG000|Overall Study|Liver transplant|2
7465002|NCT01877239|11763940|FG000|Overall Study|Adverse Event|4
7465003|NCT01877239|11763940|FG000|Overall Study|Disease Remission|1
7465004|NCT01877239|11763940|FG000|Overall Study|Withdrawal by Subject|4
7239837|NCT00167245|11448364|FG001|Overall Study|Withdrawal by Subject|8
7239838|NCT00167245|11448363|FG000|Overall Study|Incarcerated|3
7239839|NCT00167245|11448364|FG001|Overall Study|Incarcerated|2
7239840|NCT00167245|11448363|FG000|Overall Study|Drowsy|1
7465005|NCT01877239|11763940|FG000|Overall Study|Other|2
7465006|NCT01877239|11763940|FG000|Overall Study|Lack of Efficacy|4
7465007|NCT01877239|11763940|FG000|Overall Study|Data not available|35
7465008|NCT01877265|11763944|FG000|Treatment Period 1|Sponsor Decision|0
7465009|NCT01877265|11763945|FG001|Treatment Period 1|Sponsor Decision|0
7465010|NCT01877265|11763946|FG002|Treatment Period 1|Sponsor Decision|1
7465011|NCT01877265|11763947|FG003|Treatment Period 1|Sponsor Decision|0
7239841|NCT00167245|11448364|FG001|Overall Study|Drowsy|0
7239842|NCT00167310|11448375|FG000|Overall Study|Protocol Violation|5
7239843|NCT00167310|11448376|FG001|Overall Study|Protocol Violation|3
7239844|NCT00167310|11448375|FG000|Overall Study|Withdrawal by Subject|3
7239845|NCT00167310|11448376|FG001|Overall Study|Withdrawal by Subject|7
7239846|NCT00167414|11448397|FG000|Overall Study|Death|10
7239847|NCT00167778|11448414|FG000|Overall Study|Withdrawal by Subject|1
7239848|NCT00168038|11448428|FG000|Overall Study|Adverse Event|1
7239849|NCT00168038|11448428|FG000|Overall Study|Therapy failure|1
7239850|NCT00168064|11448434|FG000|Overall Study|Adverse Event|26
7239851|NCT00168064|11448435|FG001|Overall Study|Adverse Event|22
7239852|NCT00168064|11448434|FG000|Overall Study|Withdrawal by Subject|3
7239853|NCT00168064|11448435|FG001|Overall Study|Withdrawal by Subject|4
7239854|NCT00168064|11448434|FG000|Overall Study|Lack of Efficacy|4
7239855|NCT00168064|11448435|FG001|Overall Study|Lack of Efficacy|4
7239856|NCT00168064|11448434|FG000|Overall Study|Lost to Follow-up|4
7239857|NCT00168064|11448435|FG001|Overall Study|Lost to Follow-up|3
7239858|NCT00168064|11448434|FG000|Overall Study|Non-compliance|2
7239859|NCT00168064|11448435|FG001|Overall Study|Non-compliance|3
7239860|NCT00168064|11448434|FG000|Overall Study|Concurrent Illness|4
7239861|NCT00168064|11448435|FG001|Overall Study|Concurrent Illness|3
7239862|NCT00168064|11448434|FG000|Overall Study|Subject's Best interest|2
7239863|NCT00168064|11448435|FG001|Overall Study|Subject's Best interest|2
7239864|NCT00168064|11448434|FG000|Overall Study|Various|4
7239865|NCT00168064|11448435|FG001|Overall Study|Various|3
7239866|NCT00168103|11448446|FG000|Overall Study|Withdrawal by Subject|1
7239867|NCT00168103|11448447|FG001|Overall Study|Withdrawal by Subject|2
7239868|NCT00168103|11448448|FG002|Overall Study|Withdrawal by Subject|1
7239869|NCT00168103|11448449|FG003|Overall Study|Withdrawal by Subject|0
7239870|NCT00168103|11448446|FG000|Overall Study|Lost to Follow-up|1
7239871|NCT00168103|11448447|FG001|Overall Study|Lost to Follow-up|3
7239872|NCT00168103|11448448|FG002|Overall Study|Lost to Follow-up|0
7239873|NCT00168103|11448449|FG003|Overall Study|Lost to Follow-up|0
7239874|NCT00168805|11448555|FG000|Overall Study|Adverse Event|7
7239875|NCT00168805|11448556|FG001|Overall Study|Adverse Event|11
7239876|NCT00168805|11448557|FG002|Overall Study|Adverse Event|16
7239877|NCT00168805|11448555|FG000|Overall Study|Protocol Violation|12
7239878|NCT00168805|11448556|FG001|Overall Study|Protocol Violation|11
7239879|NCT00168805|11448557|FG002|Overall Study|Protocol Violation|8
7239880|NCT00168805|11448555|FG000|Overall Study|Lost to Follow-up|12
7239881|NCT00168805|11448556|FG001|Overall Study|Lost to Follow-up|17
7239882|NCT00168805|11448557|FG002|Overall Study|Lost to Follow-up|11
7239883|NCT00168805|11448555|FG000|Overall Study|Withdrawal by Subject|16
7239884|NCT00168805|11448556|FG001|Overall Study|Withdrawal by Subject|18
7239885|NCT00168805|11448557|FG002|Overall Study|Withdrawal by Subject|21
7239886|NCT00168805|11448555|FG000|Overall Study|Other|24
7239887|NCT00168805|11448556|FG001|Overall Study|Other|21
7239888|NCT00168805|11448557|FG002|Overall Study|Other|22
7239889|NCT00168805|11448555|FG000|Treatment|Adverse Event|25
7239890|NCT00168805|11448556|FG001|Treatment|Adverse Event|26
7239891|NCT00168805|11448557|FG002|Treatment|Adverse Event|32
7239892|NCT00168805|11448555|FG000|Treatment|Protocol Violation|3
7239893|NCT00168805|11448556|FG001|Treatment|Protocol Violation|5
7239894|NCT00168805|11448557|FG002|Treatment|Protocol Violation|5
7239895|NCT00168805|11448555|FG000|Treatment|Withdrawal by Subject|3
7239896|NCT00168805|11448556|FG001|Treatment|Withdrawal by Subject|7
7239897|NCT00168805|11448557|FG002|Treatment|Withdrawal by Subject|8
7239898|NCT00168805|11448555|FG000|Treatment|Other|18
7239899|NCT00168805|11448556|FG001|Treatment|Other|18
7239900|NCT00168805|11448557|FG002|Treatment|Other|17
7239901|NCT00168818|11448568|FG000|Overall Study|Adverse Event|23
7239902|NCT00168818|11448569|FG001|Overall Study|Adverse Event|29
7239903|NCT00168818|11448570|FG002|Overall Study|Adverse Event|31
7239904|NCT00168818|11448568|FG000|Overall Study|Protocol Violation|16
7239905|NCT00168818|11448569|FG001|Overall Study|Protocol Violation|11
7239906|NCT00168818|11448570|FG002|Overall Study|Protocol Violation|11
7239907|NCT00168818|11448568|FG000|Overall Study|Lost to Follow-up|13
7239908|NCT00168818|11448569|FG001|Overall Study|Lost to Follow-up|4
7239909|NCT00168818|11448570|FG002|Overall Study|Lost to Follow-up|15
7239910|NCT00168818|11448568|FG000|Overall Study|Withdrawal by Subject|43
7239911|NCT00168818|11448569|FG001|Overall Study|Withdrawal by Subject|41
7239912|NCT00168818|11448570|FG002|Overall Study|Withdrawal by Subject|37
7239913|NCT00168818|11448568|FG000|Overall Study|Other|22
7239914|NCT00168818|11448569|FG001|Overall Study|Other|24
7239915|NCT00168818|11448570|FG002|Overall Study|Other|30
7239916|NCT00168818|11448568|FG000|Treatment|Adverse Event|77
7239917|NCT00168818|11448569|FG001|Treatment|Adverse Event|89
7239918|NCT00168818|11448570|FG002|Treatment|Adverse Event|68
7239919|NCT00168818|11448568|FG000|Treatment|Protocol Violation|8
7239920|NCT00168818|11448569|FG001|Treatment|Protocol Violation|11
7239921|NCT00168818|11448570|FG002|Treatment|Protocol Violation|11
7239922|NCT00168818|11448568|FG000|Treatment|Lost to Follow-up|0
7239923|NCT00168818|11448569|FG001|Treatment|Lost to Follow-up|2
7239924|NCT00168818|11448570|FG002|Treatment|Lost to Follow-up|1
7239925|NCT00168818|11448568|FG000|Treatment|Withdrawal by Subject|25
7239926|NCT00168818|11448569|FG001|Treatment|Withdrawal by Subject|20
7239927|NCT00168818|11448570|FG002|Treatment|Withdrawal by Subject|22
7239928|NCT00168818|11448568|FG000|Treatment|Other|23
7239929|NCT00168818|11448569|FG001|Treatment|Other|29
7239930|NCT00168818|11448570|FG002|Treatment|Other|31
7239931|NCT00168831|11448581|FG000|Overall Study|Adverse Event|36
7239932|NCT00168831|11448582|FG001|Overall Study|Adverse Event|47
7239933|NCT00168831|11448583|FG002|Overall Study|Adverse Event|74
7239934|NCT00168831|11448581|FG000|Overall Study|Lost to Follow-up|5
7239935|NCT00168831|11448582|FG001|Overall Study|Lost to Follow-up|6
7239936|NCT00168831|11448583|FG002|Overall Study|Lost to Follow-up|4
7239937|NCT00168831|11448581|FG000|Overall Study|Withdrawal by Subject|7
7239938|NCT00168831|11448582|FG001|Overall Study|Withdrawal by Subject|14
7239939|NCT00168831|11448583|FG002|Overall Study|Withdrawal by Subject|19
7239940|NCT00168831|11448581|FG000|Overall Study|Protocol Violation|6
7239941|NCT00168831|11448582|FG001|Overall Study|Protocol Violation|11
7239942|NCT00168831|11448583|FG002|Overall Study|Protocol Violation|11
7239943|NCT00168831|11448581|FG000|Overall Study|Other|6
7239944|NCT00168831|11448582|FG001|Overall Study|Other|3
7239945|NCT00168831|11448583|FG002|Overall Study|Other|6
7239946|NCT00168844|11448594|FG000|Overall Study|Adverse Event|31
7239947|NCT00168844|11448595|FG001|Overall Study|Adverse Event|32
7239948|NCT00168844|11448596|FG002|Overall Study|Adverse Event|48
7239949|NCT00168844|11448594|FG000|Overall Study|Lost to Follow-up|4
7239950|NCT00168844|11448595|FG001|Overall Study|Lost to Follow-up|5
7239951|NCT00168844|11448596|FG002|Overall Study|Lost to Follow-up|11
7239952|NCT00168844|11448594|FG000|Overall Study|Withdrawal by Subject|12
7239953|NCT00168844|11448595|FG001|Overall Study|Withdrawal by Subject|9
7239954|NCT00168844|11448596|FG002|Overall Study|Withdrawal by Subject|19
7239955|NCT00168844|11448594|FG000|Overall Study|Protocol Violation|2
7239956|NCT00168844|11448595|FG001|Overall Study|Protocol Violation|2
7239957|NCT00168844|11448596|FG002|Overall Study|Protocol Violation|4
7239958|NCT00168844|11448594|FG000|Overall Study|Other|6
7239959|NCT00168844|11448595|FG001|Overall Study|Other|7
7239960|NCT00168844|11448596|FG002|Overall Study|Other|9
7239961|NCT00169104|11448606|FG000|Overall Study|Withdrawal by Subject|2
7239962|NCT00169104|11448607|FG001|Overall Study|Withdrawal by Subject|0
7239963|NCT00169104|11448606|FG000|Overall Study|Protocol Violation|0
7239964|NCT00169104|11448607|FG001|Overall Study|Protocol Violation|1
7239965|NCT00169104|11448606|FG000|Overall Study|Physician Decision|0
7239966|NCT00169104|11448607|FG001|Overall Study|Physician Decision|1
7239967|NCT00169442|11448620|FG000|Overall Study|Withdrawal by Subject|0
7239968|NCT00169442|11448621|FG001|Overall Study|Withdrawal by Subject|0
7239969|NCT00169442|11448622|FG002|Overall Study|Withdrawal by Subject|1
7239970|NCT00169442|11448623|FG003|Overall Study|Withdrawal by Subject|0
7239971|NCT00169442|11448624|FG004|Overall Study|Withdrawal by Subject|0
7239972|NCT00169442|11448625|FG005|Overall Study|Withdrawal by Subject|0
7239973|NCT00169442|11448620|FG000|Overall Study|Migrated/moved from study area|0
7239974|NCT00169442|11448621|FG001|Overall Study|Migrated/moved from study area|0
7239975|NCT00169442|11448622|FG002|Overall Study|Migrated/moved from study area|0
7239976|NCT00169442|11448623|FG003|Overall Study|Migrated/moved from study area|0
7239977|NCT00169442|11448624|FG004|Overall Study|Migrated/moved from study area|0
7239978|NCT00169442|11448625|FG005|Overall Study|Migrated/moved from study area|2
7239979|NCT00169442|11448620|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
7239980|NCT00169442|11448621|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
7239981|NCT00169442|11448622|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
7239982|NCT00169442|11448623|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
7239983|NCT00169442|11448624|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
7239984|NCT00169442|11448625|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
7239985|NCT00169442|11448620|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
7239986|NCT00169442|11448621|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
7239987|NCT00169442|11448622|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
7239988|NCT00169442|11448623|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
7239989|NCT00169442|11448624|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
7239990|NCT00169442|11448625|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
7239991|NCT00170846|11448655|FG000|Overall Study|Subject withdrew Informed Consent|5
7239992|NCT00170846|11448656|FG001|Overall Study|Subject withdrew Informed Consent|12
7239993|NCT00170846|11448657|FG002|Overall Study|Subject withdrew Informed Consent|8
7239994|NCT00170846|11448655|FG000|Overall Study|Lost to Follow-up|6
7239995|NCT00170846|11448656|FG001|Overall Study|Lost to Follow-up|3
7239996|NCT00170846|11448657|FG002|Overall Study|Lost to Follow-up|2
7239997|NCT00170846|11448655|FG000|Overall Study|Death|0
7239998|NCT00170846|11448656|FG001|Overall Study|Death|3
7239999|NCT00170846|11448657|FG002|Overall Study|Death|3
7240000|NCT00170846|11448655|FG000|Overall Study|Reason Missing|0
7240001|NCT00170846|11448656|FG001|Overall Study|Reason Missing|1
7240002|NCT00170846|11448657|FG002|Overall Study|Reason Missing|0
7240003|NCT00170950|11448667|FG000|Overall Study|Death|236
7240004|NCT00170950|11448668|FG001|Overall Study|Death|274
7240005|NCT00170950|11448667|FG000|Overall Study|Withdrawal by Subject|496
7240006|NCT00170950|11448668|FG001|Overall Study|Withdrawal by Subject|498
7240007|NCT00170950|11448667|FG000|Overall Study|Lost to Follow-up|134
7240008|NCT00170950|11448668|FG001|Overall Study|Lost to Follow-up|115
7240009|NCT00170950|11448667|FG000|Overall Study|Missing|2
7240010|NCT00170950|11448668|FG001|Overall Study|Missing|1
7240011|NCT00170950|11448667|FG000|Overall Study|Termination Data Not Recorded|17
7240012|NCT00170950|11448668|FG001|Overall Study|Termination Data Not Recorded|22
7240013|NCT00171054|11448676|FG000|Overall Study|Protocol Violation|1
7240014|NCT00171054|11448677|FG001|Overall Study|Protocol Violation|2
7240015|NCT00171054|11448676|FG000|Overall Study|Patient withdrew consent|1
7240016|NCT00171054|11448677|FG001|Overall Study|Patient withdrew consent|0
7240017|NCT00171054|11448676|FG000|Overall Study|Lost to Follow-up|0
7240018|NCT00171054|11448677|FG001|Overall Study|Lost to Follow-up|1
7240019|NCT00171054|11448676|FG000|Overall Study|Adverse Event|8
7240020|NCT00171054|11448677|FG001|Overall Study|Adverse Event|8
7240021|NCT00171054|11448676|FG000|Overall Study|Condition no longer required study drug|0
7240022|NCT00171054|11448677|FG001|Overall Study|Condition no longer required study drug|1
7240023|NCT00171158|11448683|FG000|Core Study|Death|27
7240024|NCT00171158|11448683|FG000|Core Study|Unsatisfactory therapeutic effect|163
7240025|NCT00171158|11448683|FG000|Core Study|Protocol Violation|4
7240026|NCT00171158|11448683|FG000|Core Study|Administrative problems|1
7240027|NCT00171158|11448683|FG000|Core Study|Adverse event, non-fatal|21
7240028|NCT00171158|11448683|FG000|Core Study|Consent withdrawn by subject|6
7240029|NCT00171158|11448683|FG000|Core Study|No longer required drug (BMT)|14
7240030|NCT00171158|11448683|FG000|Core Study|Abnormal Laboratory Values|2
7240031|NCT00171158|11448683|FG000|Core Study|Lost to Follow-up|1
7240032|NCT00171158|11448683|FG000|E2 Extension|Other|7
7240033|NCT00171210|11448689|FG000|Overall Study|Adverse Event|16
7240034|NCT00171210|11448690|FG001|Overall Study|Adverse Event|27
7240035|NCT00171210|11448689|FG000|Overall Study|Abnormal laboratory value(s)|6
7240036|NCT00171210|11448690|FG001|Overall Study|Abnormal laboratory value(s)|3
7240037|NCT00171210|11448689|FG000|Overall Study|Abnormal test procedure result(s)|0
7240038|NCT00171210|11448690|FG001|Overall Study|Abnormal test procedure result(s)|1
7240039|NCT00171210|11448689|FG000|Overall Study|Unsatisfactory therapeutic effect|11
7240040|NCT00171210|11448690|FG001|Overall Study|Unsatisfactory therapeutic effect|15
7240041|NCT00171210|11448689|FG000|Overall Study|Protocol Violation|0
7240042|NCT00171210|11448690|FG001|Overall Study|Protocol Violation|2
7240043|NCT00171210|11448689|FG000|Overall Study|Withdrawal by Subject|32
7240044|NCT00171210|11448690|FG001|Overall Study|Withdrawal by Subject|30
7240045|NCT00171210|11448689|FG000|Overall Study|Lost to Follow-up|1
7240046|NCT00171210|11448690|FG001|Overall Study|Lost to Follow-up|0
7240047|NCT00171210|11448689|FG000|Overall Study|Administrative problems|1
7573835|NCT03628924|11955321|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
7387510|NCT01214720|11646051|FG001|Overall Study|Alive and in follow-up|48
7573836|NCT03628924|11955315|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
7240048|NCT00171210|11448690|FG001|Overall Study|Administrative problems|1
7240049|NCT00171210|11448689|FG000|Overall Study|Death|2
7240050|NCT00171210|11448690|FG001|Overall Study|Death|3
7240051|NCT00171210|11448689|FG000|Overall Study|Stopped at end of core|0
7240052|NCT00171210|11448690|FG001|Overall Study|Stopped at end of core|32
7240053|NCT00171210|11448689|FG000|Overall Study|Stopped at end of extension 1|0
7240054|NCT00171210|11448690|FG001|Overall Study|Stopped at end of extension 1|1
7240055|NCT00171223|11448699|FG000|Overall Study|Adverse Event (Non-fatal)|6
7240056|NCT00171223|11448700|FG001|Overall Study|Adverse Event (Non-fatal)|5
7240057|NCT00171223|11448701|FG002|Overall Study|Adverse Event (Non-fatal)|19
7240058|NCT00171223|11448699|FG000|Overall Study|Abnormal Laboratory Value (s)|4
7240059|NCT00171223|11448700|FG001|Overall Study|Abnormal Laboratory Value (s)|2
7240060|NCT00171223|11448701|FG002|Overall Study|Abnormal Laboratory Value (s)|3
7240061|NCT00171223|11448699|FG000|Overall Study|Abnormal Procedure|1
7240062|NCT00171223|11448700|FG001|Overall Study|Abnormal Procedure|0
7240063|NCT00171223|11448701|FG002|Overall Study|Abnormal Procedure|0
7240064|NCT00171223|11448699|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
7240065|NCT00171223|11448700|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
7240066|NCT00171223|11448701|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
7240067|NCT00171223|11448699|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7240068|NCT00171223|11448700|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
7240069|NCT00171223|11448701|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
7240070|NCT00171223|11448699|FG000|Overall Study|Protocol Violation|2
7240071|NCT00171223|11448700|FG001|Overall Study|Protocol Violation|2
7240072|NCT00171223|11448701|FG002|Overall Study|Protocol Violation|3
7240073|NCT00171223|11448699|FG000|Overall Study|Participant Withdrew Consent|12
7240074|NCT00171223|11448700|FG001|Overall Study|Participant Withdrew Consent|21
7240075|NCT00171223|11448701|FG002|Overall Study|Participant Withdrew Consent|15
7240076|NCT00171223|11448699|FG000|Overall Study|Lost to Follow-up|5
7240077|NCT00171223|11448700|FG001|Overall Study|Lost to Follow-up|2
7240078|NCT00171223|11448701|FG002|Overall Study|Lost to Follow-up|3
7240079|NCT00171223|11448699|FG000|Overall Study|Administrative Problems|4
7240080|NCT00171223|11448700|FG001|Overall Study|Administrative Problems|7
7240081|NCT00171223|11448701|FG002|Overall Study|Administrative Problems|6
7573837|NCT03628924|11955316|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
7240082|NCT00171223|11448699|FG000|Overall Study|Adverse Event (Serious Fatal)|6
7240083|NCT00171223|11448700|FG001|Overall Study|Adverse Event (Serious Fatal)|8
7240084|NCT00171223|11448701|FG002|Overall Study|Adverse Event (Serious Fatal)|9
7240085|NCT00171223|11448699|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
7240086|NCT00171223|11448700|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
7240087|NCT00171223|11448701|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
7240088|NCT00171249|11448707|FG000|Overall Study|Withdrawal by Subject|2
7240089|NCT00171249|11448708|FG001|Overall Study|Withdrawal by Subject|0
7240090|NCT00171249|11448709|FG002|Overall Study|Withdrawal by Subject|0
7240091|NCT00171249|11448710|FG003|Overall Study|Withdrawal by Subject|6
7240092|NCT00171249|11448711|FG004|Overall Study|Withdrawal by Subject|0
7240093|NCT00171249|11448712|FG005|Overall Study|Withdrawal by Subject|0
7240094|NCT00171249|11448713|FG006|Overall Study|Withdrawal by Subject|0
7240095|NCT00171249|11448707|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
7240096|NCT00171249|11448708|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
7240097|NCT00171249|11448709|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
7240098|NCT00171249|11448710|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
7240099|NCT00171249|11448711|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
7240100|NCT00171249|11448712|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
7240101|NCT00171249|11448713|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
7240102|NCT00171249|11448707|FG000|Overall Study|Death|7
7240103|NCT00171249|11448708|FG001|Overall Study|Death|1
7240104|NCT00171249|11448709|FG002|Overall Study|Death|0
7240105|NCT00171249|11448710|FG003|Overall Study|Death|4
7240106|NCT00171249|11448711|FG004|Overall Study|Death|0
7240107|NCT00171249|11448712|FG005|Overall Study|Death|3
7240108|NCT00171249|11448713|FG006|Overall Study|Death|1
7240109|NCT00171249|11448707|FG000|Overall Study|Other|10
7240110|NCT00171249|11448708|FG001|Overall Study|Other|0
7240111|NCT00171249|11448709|FG002|Overall Study|Other|0
7240112|NCT00171249|11448710|FG003|Overall Study|Other|43
7240113|NCT00171249|11448711|FG004|Overall Study|Other|0
7240114|NCT00171249|11448712|FG005|Overall Study|Other|2
7240115|NCT00171249|11448713|FG006|Overall Study|Other|0
7240116|NCT00171249|11448707|FG000|Overall Study|No Longer Requires Study Drug|4
7240117|NCT00171249|11448708|FG001|Overall Study|No Longer Requires Study Drug|0
7240118|NCT00171249|11448709|FG002|Overall Study|No Longer Requires Study Drug|0
7240119|NCT00171249|11448710|FG003|Overall Study|No Longer Requires Study Drug|3
7240120|NCT00171249|11448711|FG004|Overall Study|No Longer Requires Study Drug|0
7240121|NCT00171249|11448712|FG005|Overall Study|No Longer Requires Study Drug|5
7240122|NCT00171249|11448713|FG006|Overall Study|No Longer Requires Study Drug|0
7240123|NCT00171249|11448707|FG000|Overall Study|Administrative Problems|1
7240124|NCT00171249|11448708|FG001|Overall Study|Administrative Problems|0
7240125|NCT00171249|11448709|FG002|Overall Study|Administrative Problems|0
7240126|NCT00171249|11448710|FG003|Overall Study|Administrative Problems|2
7240127|NCT00171249|11448711|FG004|Overall Study|Administrative Problems|0
7240128|NCT00171249|11448712|FG005|Overall Study|Administrative Problems|0
7240129|NCT00171249|11448713|FG006|Overall Study|Administrative Problems|0
7240130|NCT00171249|11448707|FG000|Overall Study|Adverse Event|3
7240131|NCT00171249|11448708|FG001|Overall Study|Adverse Event|1
7240132|NCT00171249|11448709|FG002|Overall Study|Adverse Event|0
7240133|NCT00171249|11448710|FG003|Overall Study|Adverse Event|15
7240134|NCT00171249|11448711|FG004|Overall Study|Adverse Event|0
7240135|NCT00171249|11448712|FG005|Overall Study|Adverse Event|2
7240136|NCT00171249|11448713|FG006|Overall Study|Adverse Event|0
7240137|NCT00171249|11448707|FG000|Overall Study|Lost to Follow-up|5
7240138|NCT00171249|11448708|FG001|Overall Study|Lost to Follow-up|0
7240139|NCT00171249|11448709|FG002|Overall Study|Lost to Follow-up|0
7240140|NCT00171249|11448710|FG003|Overall Study|Lost to Follow-up|9
7240141|NCT00171249|11448711|FG004|Overall Study|Lost to Follow-up|0
7240142|NCT00171249|11448712|FG005|Overall Study|Lost to Follow-up|0
7240143|NCT00171249|11448713|FG006|Overall Study|Lost to Follow-up|0
7240144|NCT00171301|11448724|FG000|Overall Study|Death|1
7240145|NCT00171301|11448725|FG001|Overall Study|Death|2
7240146|NCT00171301|11448724|FG000|Overall Study|Adverse Event|1
7240147|NCT00171301|11448725|FG001|Overall Study|Adverse Event|2
7240148|NCT00171301|11448724|FG000|Overall Study|Lost to Follow-up|6
7240149|NCT00171301|11448725|FG001|Overall Study|Lost to Follow-up|2
7240150|NCT00171301|11448724|FG000|Overall Study|Protocol Violation|0
7240151|NCT00171301|11448725|FG001|Overall Study|Protocol Violation|2
7240152|NCT00171301|11448724|FG000|Overall Study|Withdrawal by Subject|0
7240153|NCT00171301|11448725|FG001|Overall Study|Withdrawal by Subject|1
7240154|NCT00171314|11448734|FG000|Overall Study|Adverse Event|44
7240155|NCT00171314|11448735|FG001|Overall Study|Adverse Event|41
7240156|NCT00171314|11448734|FG000|Overall Study|Lack of Efficacy|19
7240157|NCT00171314|11448735|FG001|Overall Study|Lack of Efficacy|14
7240158|NCT00171314|11448734|FG000|Overall Study|Withdrawal by Subject|9
7240159|NCT00171314|11448735|FG001|Overall Study|Withdrawal by Subject|6
7240160|NCT00171314|11448734|FG000|Overall Study|Abnormal Test Procedure Results|9
7240161|NCT00171314|11448735|FG001|Overall Study|Abnormal Test Procedure Results|3
7240162|NCT00171314|11448734|FG000|Overall Study|Protocol Violation|3
7240163|NCT00171314|11448735|FG001|Overall Study|Protocol Violation|7
7240164|NCT00171314|11448734|FG000|Overall Study|Administrative Problems|4
7240165|NCT00171314|11448735|FG001|Overall Study|Administrative Problems|3
7240166|NCT00171314|11448734|FG000|Overall Study|Lost to Follow-up|1
7240167|NCT00171314|11448735|FG001|Overall Study|Lost to Follow-up|3
7240168|NCT00171314|11448734|FG000|Overall Study|Death|2
7240169|NCT00171314|11448735|FG001|Overall Study|Death|1
7240170|NCT00171340|11448743|FG000|Overall Study|Adverse Event|46
7240171|NCT00171340|11448744|FG001|Overall Study|Adverse Event|42
7240172|NCT00171340|11448743|FG000|Overall Study|Lack of Efficacy|29
7240173|NCT00171340|11448744|FG001|Overall Study|Lack of Efficacy|41
7240174|NCT00171340|11448743|FG000|Overall Study|Protocol Violation|7
7240175|NCT00171340|11448744|FG001|Overall Study|Protocol Violation|8
7240176|NCT00171340|11448743|FG000|Overall Study|Withdrawal by Subject|22
7240177|NCT00171340|11448744|FG001|Overall Study|Withdrawal by Subject|19
7240178|NCT00171340|11448743|FG000|Overall Study|Lost to Follow-up|0
7240179|NCT00171340|11448744|FG001|Overall Study|Lost to Follow-up|5
7240180|NCT00171340|11448743|FG000|Overall Study|Abnormal Laboratory Results|2
7240181|NCT00171340|11448744|FG001|Overall Study|Abnormal Laboratory Results|0
7240182|NCT00171340|11448743|FG000|Overall Study|Abnormal Test Procedure Results|6
7240183|NCT00171340|11448744|FG001|Overall Study|Abnormal Test Procedure Results|11
7240184|NCT00171340|11448743|FG000|Overall Study|No Longer Required Study Drug|1
7240185|NCT00171340|11448744|FG001|Overall Study|No Longer Required Study Drug|1
7240186|NCT00171340|11448743|FG000|Overall Study|Administrative Problems|5
7240187|NCT00171340|11448744|FG001|Overall Study|Administrative Problems|2
7240188|NCT00171340|11448743|FG000|Overall Study|Death|6
7240189|NCT00171340|11448744|FG001|Overall Study|Death|6
7240190|NCT00171704|11448754|FG000|Overall Study|Adverse Event|24
7240191|NCT00171704|11448755|FG001|Overall Study|Adverse Event|33
7240192|NCT00171704|11448754|FG000|Overall Study|Disease Progression|14
7240193|NCT00171704|11448755|FG001|Overall Study|Disease Progression|9
7240194|NCT00171704|11448754|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
7240195|NCT00171704|11448755|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
7240196|NCT00171704|11448754|FG000|Overall Study|Administrative Problems|2
7240197|NCT00171704|11448755|FG001|Overall Study|Administrative Problems|1
7240198|NCT00171704|11448754|FG000|Overall Study|Death|2
7240199|NCT00171704|11448755|FG001|Overall Study|Death|2
7240200|NCT00171704|11448754|FG000|Overall Study|Withdrawal by Subject|1
7240201|NCT00171704|11448755|FG001|Overall Study|Withdrawal by Subject|3
7240202|NCT00171704|11448754|FG000|Overall Study|Protocol Violation|0
7240203|NCT00171704|11448755|FG001|Overall Study|Protocol Violation|1
7240204|NCT00171730|11448761|FG000|Overall Study|Adverse Event|3
7240205|NCT00171730|11448761|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7240206|NCT00171730|11448761|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
7240207|NCT00171730|11448761|FG000|Overall Study|Withdrawal by Subject|3
7240208|NCT00171834|11448778|FG000|Overall Study|Adverse Event|2
7240209|NCT00171834|11448779|FG001|Overall Study|Adverse Event|1
7240210|NCT00171834|11448780|FG002|Overall Study|Adverse Event|3
7240211|NCT00171834|11448781|FG003|Overall Study|Adverse Event|2
7240212|NCT00171834|11448782|FG004|Overall Study|Adverse Event|2
7240213|NCT00171834|11448783|FG005|Overall Study|Adverse Event|15
7240214|NCT00171834|11448784|FG006|Overall Study|Adverse Event|1
7240215|NCT00171834|11448778|FG000|Overall Study|Withdrawal by Subject|0
7240216|NCT00171834|11448779|FG001|Overall Study|Withdrawal by Subject|2
7573838|NCT03628924|11955317|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
7573839|NCT03628924|11955318|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
7573840|NCT03628924|11955319|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
7240217|NCT00171834|11448780|FG002|Overall Study|Withdrawal by Subject|0
7240218|NCT00171834|11448781|FG003|Overall Study|Withdrawal by Subject|1
7240219|NCT00171834|11448782|FG004|Overall Study|Withdrawal by Subject|1
7240220|NCT00171834|11448783|FG005|Overall Study|Withdrawal by Subject|1
7240221|NCT00171834|11448784|FG006|Overall Study|Withdrawal by Subject|0
7240222|NCT00171834|11448778|FG000|Overall Study|Death from study indication|0
7240223|NCT00171834|11448779|FG001|Overall Study|Death from study indication|1
7240224|NCT00171834|11448780|FG002|Overall Study|Death from study indication|0
7240225|NCT00171834|11448781|FG003|Overall Study|Death from study indication|0
7240226|NCT00171834|11448782|FG004|Overall Study|Death from study indication|1
7240227|NCT00171834|11448783|FG005|Overall Study|Death from study indication|0
7573841|NCT03628924|11955320|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
7240228|NCT00171834|11448784|FG006|Overall Study|Death from study indication|0
7240229|NCT00171834|11448778|FG000|Overall Study|Disease Progression|4
7240230|NCT00171834|11448779|FG001|Overall Study|Disease Progression|8
7240231|NCT00171834|11448780|FG002|Overall Study|Disease Progression|8
7240232|NCT00171834|11448781|FG003|Overall Study|Disease Progression|9
7240233|NCT00171834|11448782|FG004|Overall Study|Disease Progression|2
7240234|NCT00171834|11448783|FG005|Overall Study|Disease Progression|18
7240235|NCT00171834|11448784|FG006|Overall Study|Disease Progression|3
7240236|NCT00171834|11448778|FG000|Overall Study|Treatment Duration Completed|0
7240237|NCT00171834|11448779|FG001|Overall Study|Treatment Duration Completed|0
7240238|NCT00171834|11448780|FG002|Overall Study|Treatment Duration Completed|1
7240239|NCT00171834|11448781|FG003|Overall Study|Treatment Duration Completed|0
7240240|NCT00171834|11448782|FG004|Overall Study|Treatment Duration Completed|2
7240241|NCT00171834|11448783|FG005|Overall Study|Treatment Duration Completed|1
7255925|NCT00320788|11467463|FG000|Overall Study|Other|1
7240242|NCT00171834|11448784|FG006|Overall Study|Treatment Duration Completed|0
7240243|NCT00171873|11448816|FG000|Overall Study|Withdrawal by Subject|4
7240244|NCT00171873|11448817|FG001|Overall Study|Withdrawal by Subject|2
7240245|NCT00171873|11448816|FG000|Overall Study|Adverse Event|5
7240246|NCT00171873|11448817|FG001|Overall Study|Adverse Event|0
7240247|NCT00171873|11448816|FG000|Overall Study|Switched to Octreotide|0
7240248|NCT00171873|11448817|FG001|Overall Study|Switched to Octreotide|1
7240249|NCT00171925|11448825|FG000|Overall Study|Adverse Event|10
7240250|NCT00171925|11448826|FG001|Overall Study|Adverse Event|6
7240251|NCT00171925|11448825|FG000|Overall Study|Protocol Violation|1
7240252|NCT00171925|11448826|FG001|Overall Study|Protocol Violation|1
7240253|NCT00171925|11448825|FG000|Overall Study|Withdrawal by Subject|6
7240254|NCT00171925|11448826|FG001|Overall Study|Withdrawal by Subject|9
7240255|NCT00171925|11448825|FG000|Overall Study|Lost to Follow-up|2
7240256|NCT00171925|11448826|FG001|Overall Study|Lost to Follow-up|2
7240257|NCT00171925|11448825|FG000|Overall Study|Administrative problems|10
7240258|NCT00171925|11448826|FG001|Overall Study|Administrative problems|11
7240259|NCT00171925|11448825|FG000|Overall Study|Death|1
7240260|NCT00171925|11448826|FG001|Overall Study|Death|2
7240261|NCT00171951|11448832|FG000|Overall Study|Adverse Event|1
7240262|NCT00171951|11448832|FG000|Overall Study|Abnormal Laboratory Values|2
7240263|NCT00171951|11448832|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7240264|NCT00171951|11448832|FG000|Overall Study|Participants Withdrew Consent|3
7240265|NCT00171951|11448832|FG000|Overall Study|New Cancer Therapy|5
7240266|NCT00171951|11448832|FG000|Overall Study|Reason not Specified|2
7240267|NCT00172042|11448841|FG000|Overall Study|Adverse Event|27
7240268|NCT00172042|11448842|FG001|Overall Study|Adverse Event|13
7240269|NCT00172042|11448841|FG000|Overall Study|Abnormal laboratory value(s)|5
7240270|NCT00172042|11448842|FG001|Overall Study|Abnormal laboratory value(s)|1
7240271|NCT00172042|11448841|FG000|Overall Study|Abnormal test procedure(s)|0
7240272|NCT00172042|11448842|FG001|Overall Study|Abnormal test procedure(s)|3
7240273|NCT00172042|11448841|FG000|Overall Study|Unsatisfactory therapeutic effect|13
7240274|NCT00172042|11448842|FG001|Overall Study|Unsatisfactory therapeutic effect|11
7240275|NCT00172042|11448841|FG000|Overall Study|Patient no longer requires study drug|10
7240276|NCT00172042|11448842|FG001|Overall Study|Patient no longer requires study drug|8
7240277|NCT00172042|11448841|FG000|Overall Study|Protocol Violation|8
7240278|NCT00172042|11448842|FG001|Overall Study|Protocol Violation|7
7240279|NCT00172042|11448841|FG000|Overall Study|Withdrawal by Subject|37
7240280|NCT00172042|11448842|FG001|Overall Study|Withdrawal by Subject|25
7240281|NCT00172042|11448841|FG000|Overall Study|Lost to Follow-up|3
7240282|NCT00172042|11448842|FG001|Overall Study|Lost to Follow-up|5
7240283|NCT00172042|11448841|FG000|Overall Study|Administrative problems|13
7240284|NCT00172042|11448842|FG001|Overall Study|Administrative problems|10
7240285|NCT00172042|11448841|FG000|Overall Study|Death|42
7240286|NCT00172042|11448842|FG001|Overall Study|Death|42
7240287|NCT00172185|11448852|FG000|Overall Study|Adverse Event|0
7240288|NCT00172185|11448853|FG001|Overall Study|Adverse Event|1
7240289|NCT00172185|11448854|FG002|Overall Study|Adverse Event|3
7240290|NCT00172185|11448855|FG003|Overall Study|Adverse Event|4
7240291|NCT00172185|11448852|FG000|Overall Study|Physician Decision|0
7240292|NCT00172185|11448853|FG001|Overall Study|Physician Decision|0
7240293|NCT00172185|11448854|FG002|Overall Study|Physician Decision|1
7240294|NCT00172185|11448855|FG003|Overall Study|Physician Decision|0
7240295|NCT00172185|11448852|FG000|Overall Study|SPONSOR Decision|0
7240296|NCT00172185|11448853|FG001|Overall Study|SPONSOR Decision|1
7240297|NCT00172185|11448854|FG002|Overall Study|SPONSOR Decision|0
7240298|NCT00172185|11448855|FG003|Overall Study|SPONSOR Decision|0
7240299|NCT00172185|11448852|FG000|Overall Study|Withdrawal by Subject|0
7240300|NCT00172185|11448853|FG001|Overall Study|Withdrawal by Subject|0
7240301|NCT00172185|11448854|FG002|Overall Study|Withdrawal by Subject|1
7240302|NCT00172185|11448855|FG003|Overall Study|Withdrawal by Subject|0
7240303|NCT00174187|11448871|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
7240304|NCT00174187|11448872|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
7240305|NCT00174187|11448873|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
7240306|NCT00174187|11448871|FG000|Period 1 (up to 3 Years)|Non compliance|0
7240307|NCT00174187|11448872|FG001|Period 1 (up to 3 Years)|Non compliance|1
7240308|NCT00174187|11448873|FG002|Period 1 (up to 3 Years)|Non compliance|0
7240309|NCT00174187|11448871|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7240310|NCT00174187|11448872|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
7240311|NCT00174187|11448873|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
7240312|NCT00174187|11448871|FG000|Period 1 (up to 3 Years)|Other|0
7240313|NCT00174187|11448872|FG001|Period 1 (up to 3 Years)|Other|1
7240314|NCT00174187|11448873|FG002|Period 1 (up to 3 Years)|Other|0
7240315|NCT00174187|11448871|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
7240316|NCT00174187|11448872|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
7240317|NCT00174187|11448873|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
7240318|NCT00174187|11448871|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7240319|NCT00174187|11448872|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
7240320|NCT00174187|11448873|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
7240321|NCT00174187|11448871|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
7240322|NCT00174187|11448872|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
7240323|NCT00174187|11448873|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
7240324|NCT00174187|11448871|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
7240325|NCT00174187|11448872|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
7240326|NCT00174187|11448873|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
7240327|NCT00174187|11448871|FG000|Period 2 (After 3 Years)|Other|0
7240328|NCT00174187|11448872|FG001|Period 2 (After 3 Years)|Other|0
7240329|NCT00174187|11448873|FG002|Period 2 (After 3 Years)|Other|5
7240330|NCT00174252|11448881|FG000|Overall Study|Protocol Violation|2
7240331|NCT00174291|11448889|FG000|Overall Study|Lost to Follow-up|1
7240332|NCT00174291|11448890|FG001|Overall Study|Lost to Follow-up|1
7240333|NCT00174291|11448889|FG000|Overall Study|Protocol Violation|0
7240334|NCT00174291|11448890|FG001|Overall Study|Protocol Violation|2
7240335|NCT00174291|11448889|FG000|Overall Study|Study terminated by sponsor|1
7240336|NCT00174291|11448890|FG001|Overall Study|Study terminated by sponsor|0
7240337|NCT00174291|11448889|FG000|Overall Study|Withdrawal by Subject|3
7240338|NCT00174291|11448890|FG001|Overall Study|Withdrawal by Subject|3
7240339|NCT00174382|11448896|FG000|Overall Study|Death|2
7240340|NCT00174382|11448896|FG000|Overall Study|Adverse Event|19
7240341|NCT00174382|11448896|FG000|Overall Study|Withdrawal by Subject|6
7240342|NCT00174382|11448896|FG000|Overall Study|Protocol Violation|3
7240343|NCT00174382|11448896|FG000|Overall Study|Arrived early for last visit in error|1
7240344|NCT00174382|11448896|FG000|Overall Study|Subject felt pill not effective enough|1
7240345|NCT00174382|11448896|FG000|Overall Study|Lost to Follow-up|1
7240346|NCT00174447|11448900|FG000|Overall Study|Adverse Event|19
7240347|NCT00174447|11448900|FG000|Overall Study|Withdrawal by Subject|15
7240348|NCT00174447|11448900|FG000|Overall Study|Protocol Violation|1
7240349|NCT00174447|11448900|FG000|Overall Study|Lack of Efficacy|1
7240350|NCT00174447|11448900|FG000|Overall Study|Administrative reason/Other|2
7240351|NCT00174460|11448906|FG000|Overall Study|Withdrawal by Subject|0
7240352|NCT00174460|11448907|FG001|Overall Study|Withdrawal by Subject|1
7240353|NCT00174785|11448916|FG000|Overall Study|Adverse Event|293
7240354|NCT00174785|11448917|FG001|Overall Study|Adverse Event|191
7240355|NCT00174785|11448916|FG000|Overall Study|Protocol Violation|14
7240356|NCT00174785|11448917|FG001|Overall Study|Protocol Violation|14
7240357|NCT00174785|11448916|FG000|Overall Study|Withdrawal by Subject|173
7240358|NCT00174785|11448917|FG001|Overall Study|Withdrawal by Subject|175
7240359|NCT00174785|11448916|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
7240360|NCT00174785|11448917|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
7240361|NCT00174785|11448916|FG000|Overall Study|Prohibited antiarrhythmic medication|39
7240362|NCT00174785|11448917|FG001|Overall Study|Prohibited antiarrhythmic medication|88
7240363|NCT00174785|11448916|FG000|Overall Study|Other prohibited medication|5
7240364|NCT00174785|11448917|FG001|Overall Study|Other prohibited medication|3
7240365|NCT00174785|11448916|FG000|Overall Study|Family request|6
7240366|NCT00174785|11448917|FG001|Overall Study|Family request|8
7240367|NCT00174785|11448916|FG000|Overall Study|Not pre-specified/Not coded|56
7240368|NCT00174785|11448917|FG001|Overall Study|Not pre-specified/Not coded|70
7240369|NCT00174915|11448928|FG000|Overall Study|Lost to Follow-up|19
7240370|NCT00174915|11448929|FG001|Overall Study|Lost to Follow-up|17
7240371|NCT00174915|11448930|FG002|Overall Study|Lost to Follow-up|9
7240372|NCT00174915|11448931|FG003|Overall Study|Lost to Follow-up|17
7240373|NCT00174915|11448932|FG004|Overall Study|Lost to Follow-up|10
7240374|NCT00174915|11448928|FG000|Overall Study|Adverse Event|18
7240375|NCT00174915|11448929|FG001|Overall Study|Adverse Event|16
7240376|NCT00174915|11448930|FG002|Overall Study|Adverse Event|11
7240377|NCT00174915|11448931|FG003|Overall Study|Adverse Event|18
7240378|NCT00174915|11448932|FG004|Overall Study|Adverse Event|5
7240379|NCT00174915|11448928|FG000|Overall Study|Personal Reason(s)|16
7240380|NCT00174915|11448929|FG001|Overall Study|Personal Reason(s)|16
7240381|NCT00174915|11448930|FG002|Overall Study|Personal Reason(s)|9
7240382|NCT00174915|11448931|FG003|Overall Study|Personal Reason(s)|9
7240383|NCT00174915|11448932|FG004|Overall Study|Personal Reason(s)|9
7240384|NCT00174915|11448928|FG000|Overall Study|Other|15
7240385|NCT00174915|11448929|FG001|Overall Study|Other|8
7240386|NCT00174915|11448930|FG002|Overall Study|Other|6
7240387|NCT00174915|11448931|FG003|Overall Study|Other|5
7240388|NCT00174915|11448932|FG004|Overall Study|Other|3
7240389|NCT00174915|11448928|FG000|Overall Study|Gout Flare|13
7240390|NCT00174915|11448929|FG001|Overall Study|Gout Flare|6
7240391|NCT00174915|11448930|FG002|Overall Study|Gout Flare|8
7240392|NCT00174915|11448931|FG003|Overall Study|Gout Flare|1
7240393|NCT00174915|11448932|FG004|Overall Study|Gout Flare|0
7240394|NCT00174915|11448928|FG000|Overall Study|Protocol Violation|6
7240395|NCT00174915|11448929|FG001|Overall Study|Protocol Violation|3
7240396|NCT00174915|11448930|FG002|Overall Study|Protocol Violation|3
7240397|NCT00174915|11448931|FG003|Overall Study|Protocol Violation|6
7240398|NCT00174915|11448932|FG004|Overall Study|Protocol Violation|3
7240399|NCT00174915|11448928|FG000|Overall Study|Therapeutic Failure|6
7240400|NCT00174915|11448929|FG001|Overall Study|Therapeutic Failure|3
7240401|NCT00174915|11448930|FG002|Overall Study|Therapeutic Failure|2
7240402|NCT00174915|11448931|FG003|Overall Study|Therapeutic Failure|1
7240403|NCT00174915|11448932|FG004|Overall Study|Therapeutic Failure|3
7240404|NCT00174941|11448947|FG000|Overall Study|Adverse Event|1
7240405|NCT00174941|11448948|FG001|Overall Study|Adverse Event|10
7240406|NCT00174941|11448949|FG002|Overall Study|Adverse Event|2
7240407|NCT00174941|11448950|FG003|Overall Study|Adverse Event|13
7240408|NCT00174941|11448947|FG000|Overall Study|Protocol Violation|0
7240409|NCT00174941|11448948|FG001|Overall Study|Protocol Violation|1
7240410|NCT00174941|11448949|FG002|Overall Study|Protocol Violation|0
7240411|NCT00174941|11448950|FG003|Overall Study|Protocol Violation|1
7240412|NCT00174941|11448947|FG000|Overall Study|Lost to Follow-up|0
7240413|NCT00174941|11448948|FG001|Overall Study|Lost to Follow-up|3
7240414|NCT00174941|11448949|FG002|Overall Study|Lost to Follow-up|2
7240415|NCT00174941|11448950|FG003|Overall Study|Lost to Follow-up|5
7240416|NCT00174941|11448947|FG000|Overall Study|Personal Reason(s)|0
7240417|NCT00174941|11448948|FG001|Overall Study|Personal Reason(s)|14
7240418|NCT00174941|11448949|FG002|Overall Study|Personal Reason(s)|8
7240419|NCT00174941|11448950|FG003|Overall Study|Personal Reason(s)|22
7240420|NCT00174941|11448947|FG000|Overall Study|Gout Flare|0
7240421|NCT00174941|11448948|FG001|Overall Study|Gout Flare|4
7240422|NCT00174941|11448949|FG002|Overall Study|Gout Flare|4
7240423|NCT00174941|11448950|FG003|Overall Study|Gout Flare|8
7240424|NCT00174941|11448947|FG000|Overall Study|Reason Not Specified|1
7240425|NCT00174941|11448948|FG001|Overall Study|Reason Not Specified|6
7240426|NCT00174941|11448949|FG002|Overall Study|Reason Not Specified|2
7240427|NCT00174941|11448950|FG003|Overall Study|Reason Not Specified|9
7240428|NCT00174954|11448960|FG000|Overall Study|Adverse Event|2
7240429|NCT00174954|11448960|FG000|Overall Study|No tophi found in MRI|1
7240430|NCT00174954|11448960|FG000|Overall Study|Physician Decision|1
7240431|NCT00174967|11448968|FG000|Overall Study|Adverse Event|1
7240432|NCT00174967|11448969|FG001|Overall Study|Adverse Event|2
7240433|NCT00174967|11448970|FG002|Overall Study|Adverse Event|2
7240434|NCT00174967|11448971|FG003|Overall Study|Adverse Event|1
7240435|NCT00174967|11448968|FG000|Overall Study|Gout Flare|0
7240436|NCT00174967|11448969|FG001|Overall Study|Gout Flare|0
7240437|NCT00174967|11448970|FG002|Overall Study|Gout Flare|0
7240438|NCT00174967|11448971|FG003|Overall Study|Gout Flare|1
7240439|NCT00174967|11448968|FG000|Overall Study|Other|0
7240440|NCT00174967|11448969|FG001|Overall Study|Other|1
7240441|NCT00174967|11448970|FG002|Overall Study|Other|0
7240442|NCT00174967|11448971|FG003|Overall Study|Other|0
7240443|NCT00175019|11448988|FG000|Overall Study|Adverse Event|54
7240444|NCT00175019|11448989|FG001|Overall Study|Adverse Event|22
7240445|NCT00175019|11448990|FG002|Overall Study|Adverse Event|2
7240446|NCT00175019|11448988|FG000|Overall Study|Protocol Violation|6
7240447|NCT00175019|11448989|FG001|Overall Study|Protocol Violation|3
7240448|NCT00175019|11448990|FG002|Overall Study|Protocol Violation|3
7240449|NCT00175019|11448988|FG000|Overall Study|Lost to Follow-up|42
7240450|NCT00175019|11448989|FG001|Overall Study|Lost to Follow-up|39
7240451|NCT00175019|11448990|FG002|Overall Study|Lost to Follow-up|9
7240452|NCT00175019|11448988|FG000|Overall Study|Did not continue under Amendment 4|1
7240453|NCT00175019|11448989|FG001|Overall Study|Did not continue under Amendment 4|1
7240454|NCT00175019|11448990|FG002|Overall Study|Did not continue under Amendment 4|2
7240455|NCT00175019|11448988|FG000|Overall Study|Personal Reason(s)|39
7240456|NCT00175019|11448989|FG001|Overall Study|Personal Reason(s)|31
7240457|NCT00175019|11448990|FG002|Overall Study|Personal Reason(s)|8
7240458|NCT00175019|11448988|FG000|Overall Study|Therapeutic Failure|10
7240459|NCT00175019|11448989|FG001|Overall Study|Therapeutic Failure|38
7240460|NCT00175019|11448990|FG002|Overall Study|Therapeutic Failure|22
7240461|NCT00175019|11448988|FG000|Overall Study|Gout Flare|2
7240462|NCT00175019|11448989|FG001|Overall Study|Gout Flare|3
7240463|NCT00175019|11448990|FG002|Overall Study|Gout Flare|0
7240464|NCT00175019|11448988|FG000|Overall Study|Reason Not Specified|40
7240465|NCT00175019|11448989|FG001|Overall Study|Reason Not Specified|34
7240466|NCT00175019|11448990|FG002|Overall Study|Reason Not Specified|11
7240467|NCT00175825|11449002|FG000|Overall Study|Adverse Event|3
7240468|NCT00175825|11449003|FG001|Overall Study|Adverse Event|2
7240469|NCT00175825|11449004|FG002|Overall Study|Adverse Event|1
7240470|NCT00175825|11449005|FG003|Overall Study|Adverse Event|1
7240471|NCT00175825|11449002|FG000|Overall Study|Lost to Follow-up|1
7240472|NCT00175825|11449003|FG001|Overall Study|Lost to Follow-up|2
7240473|NCT00175825|11449004|FG002|Overall Study|Lost to Follow-up|0
7240474|NCT00175825|11449005|FG003|Overall Study|Lost to Follow-up|0
7240475|NCT00175825|11449002|FG000|Overall Study|Withdrawal by Subject|1
7240476|NCT00175825|11449003|FG001|Overall Study|Withdrawal by Subject|0
7240477|NCT00175825|11449004|FG002|Overall Study|Withdrawal by Subject|0
7240478|NCT00175825|11449005|FG003|Overall Study|Withdrawal by Subject|0
7240479|NCT00175877|11449015|FG000|Overall Study|Adverse Event|136
7240480|NCT00175877|11449015|FG000|Overall Study|Withdrawal by Subject|141
7240481|NCT00175877|11449015|FG000|Overall Study|Lost to Follow-up|9
7240482|NCT00175877|11449015|FG000|Overall Study|Lack of Efficacy|26
7240483|NCT00175877|11449015|FG000|Overall Study|Protocol Violation|15
7240484|NCT00175877|11449015|FG000|Overall Study|Other Reason|20
7240485|NCT00175877|11449015|FG000|Overall Study|AE & Other|1
7240486|NCT00175877|11449015|FG000|Overall Study|Withdrawal by subject & Other|1
7240487|NCT00175916|11449019|FG000|Overall Study|Death|19
7240488|NCT00175916|11449019|FG000|Overall Study|Adverse Event|81
7240489|NCT00175916|11449019|FG000|Overall Study|Lack of Efficacy|354
7240490|NCT00175916|11449019|FG000|Overall Study|Lost to Follow-up|17
7240491|NCT00175916|11449019|FG000|Overall Study|Subject Choice|98
7240492|NCT00175916|11449019|FG000|Overall Study|Lack of compliance|8
7240493|NCT00175916|11449019|FG000|Overall Study|Patient cannot record seizures|1
7240494|NCT00175916|11449019|FG000|Overall Study|Sponsor decision|17
7240495|NCT00175916|11449019|FG000|Overall Study|Vigabatrin intake|1
7240496|NCT00175916|11449019|FG000|Overall Study|Suicidal behaviour|1
7240497|NCT00175916|11449019|FG000|Overall Study|Withdrawal by Subject|1
7240498|NCT00175916|11449019|FG000|Overall Study|Seizure - free|4
7240499|NCT00175916|11449019|FG000|Overall Study|Administrative reason|1
7240500|NCT00175916|11449019|FG000|Overall Study|Pregnancy|1
7240501|NCT00175916|11449019|FG000|Overall Study|Patient's request|2
7240502|NCT00175916|11449019|FG000|Overall Study|Treating physiciant's choice|1
7240503|NCT00175916|11449019|FG000|Overall Study|Moved overseas|1
7240504|NCT00175916|11449019|FG000|Overall Study|Loss of job and economic burden|1
7240505|NCT00175916|11449019|FG000|Overall Study|Site was closed|9
7240506|NCT00175916|11449019|FG000|Overall Study|Patient went to prison|1
7240507|NCT00176254|11449040|FG000|Overall Study|Lost to Follow-up|1
7240508|NCT00176462|11449059|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
7240509|NCT00176462|11449060|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
7240510|NCT00176462|11449059|FG000|Induction (4 Weeks)|Death|1
7240511|NCT00176462|11449060|FG001|Induction (4 Weeks)|Death|2
7240512|NCT00176462|11449059|FG000|Induction (4 Weeks)|Lack of Efficacy|0
7240513|NCT00176462|11449060|FG001|Induction (4 Weeks)|Lack of Efficacy|1
7240514|NCT00176462|11449059|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
7240515|NCT00176462|11449060|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
7240516|NCT00176462|11449059|FG000|Consolidation (12 Weeks)|Adverse Event|0
7240517|NCT00176462|11449060|FG001|Consolidation (12 Weeks)|Adverse Event|1
7240518|NCT00176462|11449059|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
7240519|NCT00176462|11449060|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
7573842|NCT03628924|11955321|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
7573843|NCT03628924|11955315|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
7573844|NCT03628924|11955316|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
7573845|NCT03628924|11955317|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
7573846|NCT03628924|11955318|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
7573847|NCT03628924|11955319|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
7573848|NCT03628924|11955320|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
7573849|NCT03628924|11955321|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
7573850|NCT03628924|11955315|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7573851|NCT03628924|11955316|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7573852|NCT03628924|11955317|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
7573853|NCT03628924|11955318|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
7573854|NCT03628924|11955319|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
7573855|NCT03628924|11955320|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
7573856|NCT03628924|11955321|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
7573857|NCT03628924|11955315|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7573858|NCT03628924|11955316|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7573859|NCT03628924|11955317|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7573860|NCT03628924|11955318|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
7573861|NCT03628924|11955319|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
7573862|NCT03628924|11955320|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
7573863|NCT03628924|11955321|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
7573864|NCT03629028|11955335|FG000|Overall Study|Lost to Follow-up|26
7573865|NCT03629028|11955336|FG001|Overall Study|Lost to Follow-up|23
7573866|NCT03629028|11955335|FG000|Overall Study|Pregnancy|4
7573867|NCT03629028|11955336|FG001|Overall Study|Pregnancy|2
7573868|NCT03629028|11955335|FG000|Overall Study|intolerance to examination|2
7240520|NCT00176462|11449059|FG000|Consolidation (12 Weeks)|Not documented|0
7240521|NCT00176462|11449060|FG001|Consolidation (12 Weeks)|Not documented|1
7240522|NCT00176462|11449059|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
7240523|NCT00176462|11449060|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
7573869|NCT03629028|11955336|FG001|Overall Study|intolerance to examination|0
7573870|NCT03629041|11955352|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7573871|NCT03629041|11955353|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
7573872|NCT03629041|11955354|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7573873|NCT03629041|11955355|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
7573874|NCT03629054|11955375|FG000|Period 2 (4 Days)|Not treated|0
7573875|NCT03629054|11955376|FG001|Period 2 (4 Days)|Not treated|1
7573876|NCT03629184|11955384|FG000|Overall Study|Withdrawal by Subject|2
7573877|NCT03629184|11955385|FG001|Overall Study|Withdrawal by Subject|1
7573878|NCT03629184|11955384|FG000|Overall Study|Physician Decision|1
7573879|NCT03629184|11955385|FG001|Overall Study|Physician Decision|0
7573880|NCT03629249|11955394|FG000|Overall Study|Study terminated by sponsor|197
7573881|NCT03629249|11955395|FG001|Overall Study|Study terminated by sponsor|197
7573882|NCT03629249|11955396|FG002|Overall Study|Study terminated by sponsor|194
7573883|NCT03629249|11955394|FG000|Overall Study|Protocol deviation|0
7573884|NCT03629249|11955395|FG001|Overall Study|Protocol deviation|2
7573885|NCT03629249|11955396|FG002|Overall Study|Protocol deviation|5
7573886|NCT03629249|11955394|FG000|Overall Study|Subject decision|1
7573887|NCT03629249|11955395|FG001|Overall Study|Subject decision|1
7573888|NCT03629249|11955396|FG002|Overall Study|Subject decision|3
7573889|NCT03629249|11955394|FG000|Overall Study|Adverse Event|1
7573890|NCT03629249|11955395|FG001|Overall Study|Adverse Event|1
7573891|NCT03629249|11955396|FG002|Overall Study|Adverse Event|0
7573892|NCT03629249|11955394|FG000|Overall Study|Death|1
7573893|NCT03629249|11955395|FG001|Overall Study|Death|0
7573894|NCT03629249|11955396|FG002|Overall Study|Death|0
7573895|NCT03629249|11955394|FG000|Overall Study|Physician Decision|1
7573896|NCT03629249|11955395|FG001|Overall Study|Physician Decision|0
7573897|NCT03629249|11955396|FG002|Overall Study|Physician Decision|0
7573898|NCT03629886|11955410|FG000|Overall Study|Migrated / moved from the study area|0
7573899|NCT03629886|11955411|FG001|Overall Study|Migrated / moved from the study area|55
7573900|NCT03629886|11955410|FG000|Overall Study|Consent withdrawal, not due to an AE|0
7573901|NCT03629886|11955411|FG001|Overall Study|Consent withdrawal, not due to an AE|50
7573902|NCT03629886|11955410|FG000|Overall Study|Study vaccine not administrated|0
7573903|NCT03629886|11955411|FG001|Overall Study|Study vaccine not administrated|3
7573904|NCT03629886|11955410|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
7573905|NCT03629886|11955411|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
7573906|NCT03629886|11955410|FG000|Overall Study|Refused vaccination step of the study|0
7573907|NCT03629886|11955411|FG001|Overall Study|Refused vaccination step of the study|44
7573908|NCT03630016|11955427|FG000|Overall Study|Poor Sensor Placement|1
7573909|NCT03630302|11955449|FG000|Surgery|hardware issue prevented LFP recordings|1
7573910|NCT03630302|11955449|FG000|3 Month Visit|Adverse Event|2
7573911|NCT03630302|11955449|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
7573912|NCT03631355|11955464|FG000|Overall Study|Lost to Follow-up|1
7573913|NCT03631355|11955465|FG001|Overall Study|Lost to Follow-up|2
7573914|NCT03631732|11955482|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
7573915|NCT03631732|11955483|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
7573916|NCT03631732|11955482|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
7573917|NCT03631732|11955483|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
7573918|NCT03631732|11955482|FG000|Randomized Phase Up to Week 24|Adverse Event|2
7573919|NCT03631732|11955483|FG001|Randomized Phase Up to Week 24|Adverse Event|0
7573920|NCT03631732|11955482|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
7573921|NCT03631732|11955483|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
7573922|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
7573923|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
7573924|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7573925|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
7573926|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
7573927|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
7573928|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
7573929|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
7573930|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
7573931|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
7573932|NCT03631732|11955482|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
7573933|NCT03631732|11955483|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
7573934|NCT03633331|11955540|FG000|Overall Study|Withdrawal by Subject|1
7575395|NCT03736967|11959081|FG000|Overall Study|Adverse Event|0
7575396|NCT03736967|11959082|FG001|Overall Study|Adverse Event|1
7575397|NCT03736967|11959083|FG002|Overall Study|Adverse Event|0
7575398|NCT03736967|11959084|FG003|Overall Study|Adverse Event|1
7575399|NCT03736967|11959081|FG000|Overall Study|Death|0
7575400|NCT03736967|11959082|FG001|Overall Study|Death|0
7575401|NCT03736967|11959083|FG002|Overall Study|Death|0
7575402|NCT03736967|11959084|FG003|Overall Study|Death|1
7575403|NCT03736967|11959081|FG000|Overall Study|Randomized but never treated|1
7575404|NCT03736967|11959082|FG001|Overall Study|Randomized but never treated|0
7575405|NCT03736967|11959083|FG002|Overall Study|Randomized but never treated|0
7575406|NCT03736967|11959084|FG003|Overall Study|Randomized but never treated|0
7575407|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Adverse Event|2
7575408|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Adverse Event|6
7575409|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Adverse Event|6
7575410|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Adverse Event|12
7575411|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
7575412|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
7575413|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
7575414|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
7575415|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Protocol Violation|0
7575416|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Protocol Violation|0
7575417|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Protocol Violation|1
7575418|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Protocol Violation|0
7575419|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
7575420|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
7575421|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
7575422|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
7575423|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Program Termination|3
7575424|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Program Termination|0
7575425|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Program Termination|1
7575426|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Program Termination|1
7575427|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
7575428|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7575429|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7575430|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
7575431|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
7575432|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
7575433|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
7575434|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
7575435|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Promotor Decision|0
7575436|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Promotor Decision|1
7575437|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Promotor Decision|0
7575438|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Promotor Decision|0
7575439|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7575440|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
7575441|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7575442|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
7575443|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
7575444|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
7575445|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
7575446|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
7575447|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7575448|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
7575449|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7575450|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
7575451|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Study Early Closure|0
7575452|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Study Early Closure|0
7575453|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Study Early Closure|1
7575454|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Study Early Closure|0
7575455|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7575456|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7575457|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
7575458|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
7575459|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7575460|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7575461|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
7575462|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
7575463|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7575464|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7575465|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
7575466|NCT03739840|11959104|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
7573935|NCT03633825|11955578|FG000|Enrollment|Did not post on network|5066
7573936|NCT03633825|11955579|FG001|Enrollment|Did not post on network|5080
7573937|NCT03633825|11955578|FG000|Enrollment|Post not classified as crisis|13967
7573938|NCT03633825|11955579|FG001|Enrollment|Post not classified as crisis|13757
7573939|NCT03633825|11955578|FG000|Follow up|Lost to Follow-up|478
7573940|NCT03633825|11955579|FG001|Follow up|Lost to Follow-up|450
7573941|NCT03633903|11955587|FG000|Overall Study|Withdrawal by Subject|1
7573942|NCT03633903|11955588|FG001|Overall Study|Withdrawal by Subject|2
7240524|NCT00176462|11449059|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
7240525|NCT00176462|11449060|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
7240526|NCT00176605|11449076|FG000|Overall Study|Withdrawal by Subject|2
7240527|NCT00176644|11449080|FG000|Overall Study|Withdrawal by Subject|1
7255926|NCT00320788|11467464|FG001|Overall Study|Other|2
7255927|NCT00320788|11467465|FG002|Overall Study|Other|1
7255928|NCT00320788|11467466|FG003|Overall Study|Other|1
7255929|NCT00320788|11467467|FG004|Overall Study|Other|1
7255930|NCT00320788|11467463|FG000|Overall Study|Physician Decision|1
7255931|NCT00320788|11467464|FG001|Overall Study|Physician Decision|1
7255932|NCT00320788|11467465|FG002|Overall Study|Physician Decision|0
7465012|NCT01877265|11763948|FG004|Treatment Period 1|Sponsor Decision|0
7465013|NCT01877265|11763949|FG005|Treatment Period 1|Sponsor Decision|0
7465014|NCT01877265|11763944|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7465015|NCT01877265|11763945|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7465016|NCT01877265|11763946|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7465017|NCT01877265|11763947|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7465018|NCT01877265|11763948|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
7465019|NCT01877265|11763949|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
7465020|NCT01877265|11763944|FG000|Treatment Period 3|Lost to Follow-up|1
7465021|NCT01877265|11763945|FG001|Treatment Period 3|Lost to Follow-up|0
7465022|NCT01877265|11763946|FG002|Treatment Period 3|Lost to Follow-up|0
7465023|NCT01877265|11763947|FG003|Treatment Period 3|Lost to Follow-up|0
7465024|NCT01877265|11763948|FG004|Treatment Period 3|Lost to Follow-up|0
7465025|NCT01877265|11763949|FG005|Treatment Period 3|Lost to Follow-up|0
7465026|NCT01877278|11763962|FG000|Overall Study|Lost to Follow-up|3
7465027|NCT01877278|11763963|FG001|Overall Study|Lost to Follow-up|3
7465028|NCT01877408|11763971|FG000|Overall Study|Lost to Follow-up|0
7465029|NCT01877408|11763972|FG001|Overall Study|Lost to Follow-up|2
7465030|NCT01877421|11764011|FG000|Phase 2|Lost to Follow-up|0
7465031|NCT01877421|11764012|FG001|Phase 2|Lost to Follow-up|0
7465032|NCT01877421|11764013|FG002|Phase 2|Lost to Follow-up|0
7465033|NCT01877421|11764014|FG003|Phase 2|Lost to Follow-up|0
7465034|NCT01877421|11764015|FG004|Phase 2|Lost to Follow-up|0
7465035|NCT01877421|11764016|FG005|Phase 2|Lost to Follow-up|0
7465036|NCT01877421|11764017|FG006|Phase 2|Lost to Follow-up|1
7465037|NCT01877421|11764018|FG007|Phase 2|Lost to Follow-up|0
7573943|NCT03633903|11955587|FG000|Overall Study|Lost to Follow-up|5
7573944|NCT03633903|11955588|FG001|Overall Study|Lost to Follow-up|5
7255933|NCT00320788|11467466|FG003|Overall Study|Physician Decision|0
7465038|NCT01877421|11764019|FG008|Phase 2|Lost to Follow-up|0
7255934|NCT00320788|11467467|FG004|Overall Study|Physician Decision|0
7255935|NCT00320788|11467463|FG000|Overall Study|Protocol Violation|0
7465039|NCT01877421|11764020|FG009|Phase 2|Lost to Follow-up|0
7465040|NCT01877421|11764021|FG010|Phase 2|Lost to Follow-up|0
7465041|NCT01877421|11764022|FG011|Phase 2|Lost to Follow-up|0
7465042|NCT01877421|11764023|FG012|Phase 2|Lost to Follow-up|0
7573945|NCT03633929|11955594|FG000|Overall Study|Lost to Follow-up|1
7240528|NCT00177164|11449177|FG000|Overall Study|Protocol Violation|0
7240529|NCT00177164|11449178|FG001|Overall Study|Protocol Violation|7
7240530|NCT00177164|11449177|FG000|Overall Study|Lost to Follow-up|4
7240531|NCT00177164|11449178|FG001|Overall Study|Lost to Follow-up|5
7240532|NCT00177164|11449177|FG000|Overall Study|increase in alcohol and drug use|1
7240533|NCT00177164|11449178|FG001|Overall Study|increase in alcohol and drug use|2
7240534|NCT00177164|11449177|FG000|Overall Study|Adverse Event|1
7240535|NCT00177164|11449178|FG001|Overall Study|Adverse Event|0
7240536|NCT00177164|11449177|FG000|Overall Study|discharge from hospital|1
7240537|NCT00177164|11449178|FG001|Overall Study|discharge from hospital|0
7240538|NCT00177164|11449177|FG000|Overall Study|Lack of Efficacy|2
7240539|NCT00177164|11449178|FG001|Overall Study|Lack of Efficacy|1
7240540|NCT00177164|11449177|FG000|Overall Study|Pregnancy|0
7240541|NCT00177164|11449178|FG001|Overall Study|Pregnancy|1
7240542|NCT00177216|11449187|FG000|Overall Study|Withdrawal by Subject|6
7240543|NCT00177216|11449188|FG001|Overall Study|Withdrawal by Subject|3
7240544|NCT00177216|11449189|FG002|Overall Study|Withdrawal by Subject|1
7240545|NCT00177294|11449207|FG000|Overall Study|Withdrawal by Subject|7
7240546|NCT00177294|11449208|FG001|Overall Study|Withdrawal by Subject|5
7240547|NCT00177307|11449214|FG000|Overall Study|Withdrawal by Subject|1
7240548|NCT00177671|11449220|FG000|Overall Study|Withdrawal by Subject|5
7240549|NCT00177671|11449221|FG001|Overall Study|Withdrawal by Subject|6
7240550|NCT00177671|11449220|FG000|Overall Study|medical complications|2
7240551|NCT00177671|11449221|FG001|Overall Study|medical complications|0
7240552|NCT00177671|11449220|FG000|Overall Study|Adverse Event|6
7240553|NCT00177671|11449221|FG001|Overall Study|Adverse Event|0
7240554|NCT00177671|11449220|FG000|Overall Study|Physician Decision|12
7240555|NCT00177671|11449221|FG001|Overall Study|Physician Decision|8
7240556|NCT00178126|11449229|FG000|Overall Study|Lost to Follow-up|21
7240557|NCT00178126|11449230|FG001|Overall Study|Lost to Follow-up|21
7240558|NCT00178126|11449229|FG000|Overall Study|did not receive intervention|4
7240559|NCT00178126|11449230|FG001|Overall Study|did not receive intervention|6
7240560|NCT00178256|11449266|FG000|Overall Study|Adverse Event|2
7240561|NCT00178256|11449267|FG001|Overall Study|Adverse Event|0
7240562|NCT00178256|11449268|FG002|Overall Study|Adverse Event|0
7240563|NCT00178256|11449269|FG003|Overall Study|Adverse Event|0
7240564|NCT00178256|11449266|FG000|Overall Study|Death|0
7240565|NCT00178256|11449267|FG001|Overall Study|Death|1
7240566|NCT00178256|11449268|FG002|Overall Study|Death|0
7240567|NCT00178256|11449269|FG003|Overall Study|Death|1
7240568|NCT00178256|11449266|FG000|Overall Study|Cancer progression|2
7240569|NCT00178256|11449267|FG001|Overall Study|Cancer progression|0
7240570|NCT00178256|11449268|FG002|Overall Study|Cancer progression|0
7240571|NCT00178256|11449269|FG003|Overall Study|Cancer progression|1
7240572|NCT00178399|11449276|FG000|Overall Study|Physician Decision|4
7240573|NCT00178399|11449276|FG000|Overall Study|Withdrawal by Subject|8
7240574|NCT00178399|11449276|FG000|Overall Study|Lost to Follow-up|1
7240575|NCT00178464|11449281|FG000|Overall Study|Withdrawal by Subject|1
7240576|NCT00178464|11449281|FG000|Overall Study|Physician Decision|1
7240577|NCT00178633|11449300|FG000|Overall Study|Lost to Follow-up|6
7240578|NCT00178685|11449324|FG000|Overall Study|Death|3
7240579|NCT00178685|11449325|FG001|Overall Study|Death|3
7240580|NCT00178685|11449326|FG002|Overall Study|Death|6
7240581|NCT00178685|11449324|FG000|Overall Study|Lost to Follow-up|100
7240582|NCT00178685|11449325|FG001|Overall Study|Lost to Follow-up|187
7240583|NCT00178685|11449326|FG002|Overall Study|Lost to Follow-up|183
7240584|NCT00178685|11449324|FG000|Overall Study|Withdrawal by Subject|8
7240585|NCT00178685|11449325|FG001|Overall Study|Withdrawal by Subject|14
7240586|NCT00178685|11449326|FG002|Overall Study|Withdrawal by Subject|7
7240587|NCT00179010|11449361|FG000|Overall Study|Muscle probe defective|1
7240588|NCT00179010|11449362|FG001|Overall Study|Muscle probe defective|1
7240589|NCT00179010|11449361|FG000|Overall Study|Failure to place arterial line|0
7240590|NCT00179010|11449362|FG001|Overall Study|Failure to place arterial line|1
7240591|NCT00179309|11449371|FG000|Treatment|Toxicity|2
7240592|NCT00179309|11449372|FG001|Treatment|Toxicity|3
7240593|NCT00179309|11449371|FG000|Treatment|Withdrawal by Subject|1
7240594|NCT00179309|11449372|FG001|Treatment|Withdrawal by Subject|2
7240595|NCT00179309|11449371|FG000|Treatment|Allergy|1
7240596|NCT00179309|11449372|FG001|Treatment|Allergy|0
7240597|NCT00179413|11449380|FG000|Overall Study|Adverse Event|38
7240598|NCT00179413|11449381|FG001|Overall Study|Adverse Event|20
7240599|NCT00179413|11449380|FG000|Overall Study|Withdrawal by Subject|87
7240600|NCT00179413|11449381|FG001|Overall Study|Withdrawal by Subject|95
7240601|NCT00179517|11449397|FG000|Overall Study|Withdrawal by Subject|2
7240602|NCT00179517|11449398|FG001|Overall Study|Withdrawal by Subject|1
7240603|NCT00179621|11449407|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
7240604|NCT00179621|11449408|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
7240605|NCT00179621|11449409|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
7240606|NCT00179621|11449410|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
7240607|NCT00179621|11449407|FG000|Double-Blind Period|Adverse Event|2
7240608|NCT00179621|11449408|FG001|Double-Blind Period|Adverse Event|7
7240609|NCT00179621|11449409|FG002|Double-Blind Period|Adverse Event|4
7240610|NCT00179621|11449410|FG003|Double-Blind Period|Adverse Event|0
7240611|NCT00179621|11449407|FG000|Double-Blind Period|Withdrawal by Subject|2
7240612|NCT00179621|11449408|FG001|Double-Blind Period|Withdrawal by Subject|1
7240613|NCT00179621|11449409|FG002|Double-Blind Period|Withdrawal by Subject|3
7240614|NCT00179621|11449410|FG003|Double-Blind Period|Withdrawal by Subject|0
7240615|NCT00179621|11449407|FG000|Double-Blind Period|Death|0
7240616|NCT00179621|11449408|FG001|Double-Blind Period|Death|1
7240617|NCT00179621|11449409|FG002|Double-Blind Period|Death|2
7240618|NCT00179621|11449410|FG003|Double-Blind Period|Death|0
7240619|NCT00179621|11449407|FG000|Double-Blind Period|Protocol Violation|1
7573946|NCT03633929|11955594|FG000|Overall Study|Did not login to software. Did not participate|3
7573947|NCT03634085|11955600|FG000|Overall Study|Adverse Event|1
7573948|NCT03634085|11955601|FG001|Overall Study|Adverse Event|0
7573949|NCT03634085|11955600|FG000|Overall Study|Withdrawal by Subject|0
7573950|NCT03634085|11955601|FG001|Overall Study|Withdrawal by Subject|2
7573951|NCT03634579|11955627|FG000|Overall Study|study termination|9
7573952|NCT03634800|11955631|FG000|Overall Study|Adverse Event|1
7573953|NCT03634800|11955631|FG000|Overall Study|Disease Progression|4
7573954|NCT03634800|11955631|FG000|Overall Study|Withdrawal by Subject|1
7573955|NCT03635086|11955650|FG000|Overall Study|Withdrawal of consent|0
7573956|NCT03635086|11955651|FG001|Overall Study|Withdrawal of consent|0
7573957|NCT03635086|11955652|FG002|Overall Study|Withdrawal of consent|1
7573958|NCT03635086|11955653|FG003|Overall Study|Withdrawal of consent|0
7573959|NCT03635086|11955654|FG004|Overall Study|Withdrawal of consent|0
7573960|NCT03635086|11955650|FG000|Overall Study|Adverse Event|0
7573961|NCT03635086|11955651|FG001|Overall Study|Adverse Event|1
7573962|NCT03635086|11955652|FG002|Overall Study|Adverse Event|0
7573963|NCT03635086|11955653|FG003|Overall Study|Adverse Event|0
7573964|NCT03635086|11955654|FG004|Overall Study|Adverse Event|0
7573965|NCT03635086|11955650|FG000|Overall Study|Lost to Follow-up|1
7573966|NCT03635086|11955651|FG001|Overall Study|Lost to Follow-up|0
7573967|NCT03635086|11955652|FG002|Overall Study|Lost to Follow-up|0
7573968|NCT03635086|11955653|FG003|Overall Study|Lost to Follow-up|0
7573969|NCT03635086|11955654|FG004|Overall Study|Lost to Follow-up|0
7573970|NCT03635320|11955669|FG000|Overall Study|not implanted the device|1
7573971|NCT03635320|11955670|FG001|Overall Study|not implanted the device|2
7573972|NCT03635320|11955669|FG000|Overall Study|Withdrawal by Subject|11
7573973|NCT03635320|11955670|FG001|Overall Study|Withdrawal by Subject|6
7573974|NCT03635775|11955680|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7240620|NCT00179621|11449408|FG001|Double-Blind Period|Protocol Violation|0
7240621|NCT00179621|11449409|FG002|Double-Blind Period|Protocol Violation|0
7240622|NCT00179621|11449410|FG003|Double-Blind Period|Protocol Violation|0
7240623|NCT00179621|11449407|FG000|Double-Blind Period|Other|0
7240624|NCT00179621|11449408|FG001|Double-Blind Period|Other|2
7240625|NCT00179621|11449409|FG002|Double-Blind Period|Other|2
7240626|NCT00179621|11449410|FG003|Double-Blind Period|Other|0
7240627|NCT00179621|11449407|FG000|Open-Label Period|Lack of Therapeutic Effect|0
7240628|NCT00179621|11449408|FG001|Open-Label Period|Lack of Therapeutic Effect|19
7240629|NCT00179621|11449409|FG002|Open-Label Period|Lack of Therapeutic Effect|19
7240630|NCT00179621|11449410|FG003|Open-Label Period|Lack of Therapeutic Effect|31
7240631|NCT00179621|11449407|FG000|Open-Label Period|Adverse Event|0
7240632|NCT00179621|11449408|FG001|Open-Label Period|Adverse Event|6
7240633|NCT00179621|11449409|FG002|Open-Label Period|Adverse Event|5
7240634|NCT00179621|11449410|FG003|Open-Label Period|Adverse Event|6
7240635|NCT00179621|11449407|FG000|Open-Label Period|Withdrawal by Subject|0
7240636|NCT00179621|11449408|FG001|Open-Label Period|Withdrawal by Subject|2
7240637|NCT00179621|11449409|FG002|Open-Label Period|Withdrawal by Subject|2
7240638|NCT00179621|11449410|FG003|Open-Label Period|Withdrawal by Subject|2
7240639|NCT00179621|11449407|FG000|Open-Label Period|Death|0
7240640|NCT00179621|11449408|FG001|Open-Label Period|Death|0
7240641|NCT00179621|11449409|FG002|Open-Label Period|Death|1
7240642|NCT00179621|11449410|FG003|Open-Label Period|Death|2
7240643|NCT00179621|11449407|FG000|Open-Label Period|Other|0
7240644|NCT00179621|11449408|FG001|Open-Label Period|Other|1
7240645|NCT00179621|11449409|FG002|Open-Label Period|Other|1
7240646|NCT00179621|11449410|FG003|Open-Label Period|Other|2
7240647|NCT00179647|11449419|FG000|Overall Study|Adverse Event|294
7240648|NCT00179647|11449419|FG000|Overall Study|Lack of Efficacy|478
7573975|NCT03635775|11955681|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7573976|NCT03635775|11955682|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
7573977|NCT03635775|11955683|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
7573978|NCT03635957|11955693|FG000|Run-In Period|Lost to Follow-up|1
7573979|NCT03635957|11955693|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
7573980|NCT03636893|11955729|FG000|Overall Study|Death|0
7573981|NCT03636893|11955730|FG001|Overall Study|Death|1
7573982|NCT03636893|11955729|FG000|Overall Study|Protocol Violation|0
7573983|NCT03636893|11955730|FG001|Overall Study|Protocol Violation|3
7240649|NCT00179647|11449419|FG000|Overall Study|Withdrawal by Subject|83
7240650|NCT00179647|11449419|FG000|Overall Study|Lost to Follow-up|4
7240651|NCT00179647|11449419|FG000|Overall Study|Death|94
7240652|NCT00179647|11449419|FG000|Overall Study|Other|960
7240653|NCT00179660|11449423|FG000|Overall Study|Adverse Event|7
7240654|NCT00179660|11449423|FG000|Overall Study|Lack of therapeutic effect|28
7240655|NCT00179660|11449423|FG000|Overall Study|Withdrawal by Subject|2
7240656|NCT00179660|11449423|FG000|Overall Study|Lost to Follow-up|1
7240657|NCT00179660|11449423|FG000|Overall Study|Death|3
7240658|NCT00179660|11449423|FG000|Overall Study|Other - Unspecified|9
7240659|NCT00179673|11449427|FG000|Overall Study|Adverse Event|7
7240660|NCT00179673|11449427|FG000|Overall Study|Lack of Efficacy|15
7240661|NCT00179673|11449427|FG000|Overall Study|Withdrawal by Subject|3
7240662|NCT00179673|11449427|FG000|Overall Study|Death|4
7240663|NCT00179673|11449427|FG000|Overall Study|Other Observations and options|14
7240664|NCT00179959|11449444|FG000|Overall Study|Lost to Follow-up|3
7240665|NCT00179959|11449445|FG001|Overall Study|Lost to Follow-up|1
7240666|NCT00179959|11449444|FG000|Overall Study|Withdrawal by Subject|3
7240667|NCT00179959|11449445|FG001|Overall Study|Withdrawal by Subject|2
7240668|NCT00180479|11449492|FG000|Overall Study|Death|4
7240669|NCT00180479|11449493|FG001|Overall Study|Death|2
7240670|NCT00180479|11449492|FG000|Overall Study|Lost to Follow-up|9
7240671|NCT00180479|11449493|FG001|Overall Study|Lost to Follow-up|7
7240672|NCT00180479|11449492|FG000|Overall Study|Withdrawal by Subject|3
7240673|NCT00180479|11449493|FG001|Overall Study|Withdrawal by Subject|3
7240674|NCT00180479|11449492|FG000|Overall Study|Informed consent not signed|0
7240675|NCT00180479|11449493|FG001|Overall Study|Informed consent not signed|1
7240676|NCT00180674|11449508|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
7240677|NCT00180674|11449508|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
7240678|NCT00180713|11449535|FG000|Overall Study|Withdrawal by Subject|2
7240679|NCT00180713|11449536|FG001|Overall Study|Withdrawal by Subject|0
7240680|NCT00180713|11449535|FG000|Overall Study|Adverse Event|3
7240681|NCT00180713|11449536|FG001|Overall Study|Adverse Event|3
7240682|NCT00181155|11449542|FG000|Overall Study|Physician Decision|1
7240683|NCT00181155|11449543|FG001|Overall Study|Physician Decision|0
7240684|NCT00181155|11449542|FG000|Overall Study|Withdrawal by Subject|1
7240685|NCT00181155|11449543|FG001|Overall Study|Withdrawal by Subject|0
7240686|NCT00181766|11449607|FG000|Overall Study|Lost to Follow-up|6
7240687|NCT00181766|11449607|FG000|Overall Study|Adverse Event|4
7240688|NCT00181766|11449607|FG000|Overall Study|non-compliance|2
7240689|NCT00181844|11449611|FG000|Signed Consent|Withdrawal by Subject|5
7240690|NCT00181844|11449611|FG000|Signed Consent|Did not meet entrance criteria|7
7240691|NCT00181844|11449611|FG000|Exposed to Study Medication|Adverse Event|10
7240692|NCT00181844|11449611|FG000|Exposed to Study Medication|Lack of Efficacy|2
7240693|NCT00181844|11449611|FG000|Exposed to Study Medication|Non-compliance|2
7240694|NCT00181844|11449611|FG000|Exposed to Study Medication|Withdrawal by Subject|1
7240695|NCT00181844|11449611|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
7240696|NCT00181883|11449615|FG000|Overall Study|Lack of Efficacy|2
7240697|NCT00181883|11449615|FG000|Overall Study|Treatment Limiting AEs|3
7240698|NCT00181883|11449615|FG000|Overall Study|Withdrawal by Subject|4
7240699|NCT00181883|11449615|FG000|Overall Study|Lost to Follow-up|1
7240700|NCT00182078|11449639|FG000|Overall Study|Withdrawal by Subject|1
7240701|NCT00182078|11449640|FG001|Overall Study|Withdrawal by Subject|0
7240702|NCT00182091|11449650|FG000|Overall Study|Withdrawal by Subject|1
7240703|NCT00182091|11449651|FG001|Overall Study|Withdrawal by Subject|0
7240704|NCT00182091|11449652|FG002|Overall Study|Withdrawal by Subject|0
7240705|NCT00182091|11449653|FG003|Overall Study|Withdrawal by Subject|0
7240706|NCT00182325|11449663|FG000|Overall Study|Lost to Follow-up|7
7240707|NCT00182325|11449664|FG001|Overall Study|Lost to Follow-up|7
7240708|NCT00182325|11449663|FG000|Overall Study|Miscarriage|5
7240709|NCT00182325|11449664|FG001|Overall Study|Miscarriage|3
7240710|NCT00182325|11449663|FG000|Overall Study|Did not complete survey|22
7240711|NCT00182325|11449664|FG001|Overall Study|Did not complete survey|43
7240712|NCT00182689|11449672|FG000|Overall Study|Adverse Event|8
7240713|NCT00182689|11449673|FG001|Overall Study|Adverse Event|11
7240714|NCT00182689|11449672|FG000|Overall Study|Withdrawal by Subject|2
7240715|NCT00182689|11449673|FG001|Overall Study|Withdrawal by Subject|2
7240716|NCT00182689|11449672|FG000|Overall Study|Progression|27
7240717|NCT00182689|11449673|FG001|Overall Study|Progression|29
7240718|NCT00182689|11449672|FG000|Overall Study|Death|1
7240719|NCT00182689|11449673|FG001|Overall Study|Death|0
7240720|NCT00182689|11449672|FG000|Overall Study|not protocol specified|0
7240721|NCT00182689|11449673|FG001|Overall Study|not protocol specified|3
7240722|NCT00182689|11449672|FG000|Overall Study|Ineligible|1
7240723|NCT00182689|11449673|FG001|Overall Study|Ineligible|4
7240724|NCT00182689|11449672|FG000|Overall Study|Never received treatment|1
7240725|NCT00182689|11449673|FG001|Overall Study|Never received treatment|0
7240726|NCT00183170|11449728|FG000|First Intervention|Did not complete study|1
7240727|NCT00183170|11449729|FG001|First Intervention|Did not complete study|0
7240728|NCT00183170|11449728|FG000|First Intervention|Did not meet targeted BrAC|1
7240729|NCT00183170|11449729|FG001|First Intervention|Did not meet targeted BrAC|0
7240730|NCT00183170|11449728|FG000|Washout 1 Week|Did not complete study|6
7240731|NCT00183170|11449729|FG001|Washout 1 Week|Did not complete study|8
7240732|NCT00183170|11449728|FG000|Second Intervention|Did not complete study|1
7240733|NCT00183170|11449729|FG001|Second Intervention|Did not complete study|0
7240734|NCT00183170|11449728|FG000|Second Intervention|Did not meet targeted BrAC|0
7240735|NCT00183170|11449729|FG001|Second Intervention|Did not meet targeted BrAC|2
7240736|NCT00183196|11449738|FG000|Overall Study|Withdrawal by Subject|18
7240737|NCT00183196|11449739|FG001|Overall Study|Withdrawal by Subject|11
7240738|NCT00183196|11449740|FG002|Overall Study|Withdrawal by Subject|13
7240739|NCT00183196|11449738|FG000|Overall Study|Adverse Event|1
7240740|NCT00183196|11449739|FG001|Overall Study|Adverse Event|2
7240741|NCT00183196|11449740|FG002|Overall Study|Adverse Event|2
7240742|NCT00183196|11449738|FG000|Overall Study|Legal event|1
7240743|NCT00183196|11449739|FG001|Overall Study|Legal event|1
7240744|NCT00183196|11449740|FG002|Overall Study|Legal event|1
7240745|NCT00183196|11449738|FG000|Overall Study|Required more intensive care|0
7240746|NCT00183196|11449739|FG001|Overall Study|Required more intensive care|1
7240747|NCT00183196|11449740|FG002|Overall Study|Required more intensive care|2
7240748|NCT00183248|11449750|FG000|Overall Study|Lost to Follow-up|0
7240749|NCT00183248|11449751|FG001|Overall Study|Lost to Follow-up|1
7240750|NCT00183248|11449750|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
7240751|NCT00183248|11449751|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
7240752|NCT00183274|11449757|FG000|Phase 1: Open-Label|Adverse Event|31
7240753|NCT00183274|11449758|FG001|Phase 1: Open-Label|Adverse Event|0
7240754|NCT00183274|11449759|FG002|Phase 1: Open-Label|Adverse Event|0
7240755|NCT00183274|11449760|FG003|Phase 1: Open-Label|Adverse Event|0
7240756|NCT00183274|11449761|FG004|Phase 1: Open-Label|Adverse Event|0
7240757|NCT00183274|11449762|FG005|Phase 1: Open-Label|Adverse Event|0
7240758|NCT00183274|11449757|FG000|Phase 1: Open-Label|Lack of Efficacy|13
7240759|NCT00183274|11449758|FG001|Phase 1: Open-Label|Lack of Efficacy|0
7240760|NCT00183274|11449759|FG002|Phase 1: Open-Label|Lack of Efficacy|0
7240761|NCT00183274|11449760|FG003|Phase 1: Open-Label|Lack of Efficacy|0
7240762|NCT00183274|11449761|FG004|Phase 1: Open-Label|Lack of Efficacy|0
7240763|NCT00183274|11449762|FG005|Phase 1: Open-Label|Lack of Efficacy|0
7240764|NCT00183274|11449757|FG000|Phase 1: Open-Label|Protocol Violation|11
7240765|NCT00183274|11449758|FG001|Phase 1: Open-Label|Protocol Violation|0
7240766|NCT00183274|11449759|FG002|Phase 1: Open-Label|Protocol Violation|0
7240767|NCT00183274|11449760|FG003|Phase 1: Open-Label|Protocol Violation|0
7240768|NCT00183274|11449761|FG004|Phase 1: Open-Label|Protocol Violation|0
7240769|NCT00183274|11449762|FG005|Phase 1: Open-Label|Protocol Violation|0
7240770|NCT00183274|11449757|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
7240771|NCT00183274|11449758|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
7240772|NCT00183274|11449759|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
7240773|NCT00183274|11449760|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
7240774|NCT00183274|11449761|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
7240775|NCT00183274|11449762|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
7240776|NCT00183274|11449757|FG000|Phase 1: Open-Label|Lost to Follow-up|33
7240777|NCT00183274|11449758|FG001|Phase 1: Open-Label|Lost to Follow-up|0
7240778|NCT00183274|11449759|FG002|Phase 1: Open-Label|Lost to Follow-up|0
7240779|NCT00183274|11449760|FG003|Phase 1: Open-Label|Lost to Follow-up|0
7240780|NCT00183274|11449761|FG004|Phase 1: Open-Label|Lost to Follow-up|0
7240781|NCT00183274|11449762|FG005|Phase 1: Open-Label|Lost to Follow-up|0
7240782|NCT00183274|11449757|FG000|Phase 1: Open-Label|Other|9
7240783|NCT00183274|11449758|FG001|Phase 1: Open-Label|Other|0
7240784|NCT00183274|11449759|FG002|Phase 1: Open-Label|Other|0
7240785|NCT00183274|11449760|FG003|Phase 1: Open-Label|Other|0
7240786|NCT00183274|11449761|FG004|Phase 1: Open-Label|Other|0
7240787|NCT00183274|11449762|FG005|Phase 1: Open-Label|Other|0
7240788|NCT00183274|11449757|FG000|Phase 2: Double-Blind|Relapsed|0
7240789|NCT00183274|11449758|FG001|Phase 2: Double-Blind|Relapsed|8
7240790|NCT00183274|11449759|FG002|Phase 2: Double-Blind|Relapsed|29
7240791|NCT00183274|11449760|FG003|Phase 2: Double-Blind|Relapsed|0
7240792|NCT00183274|11449761|FG004|Phase 2: Double-Blind|Relapsed|0
7240793|NCT00183274|11449762|FG005|Phase 2: Double-Blind|Relapsed|0
7240794|NCT00183274|11449757|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
7240795|NCT00183274|11449758|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
7240796|NCT00183274|11449759|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
7240797|NCT00183274|11449760|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
7240798|NCT00183274|11449761|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
7240799|NCT00183274|11449762|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
7240800|NCT00183274|11449757|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
7240801|NCT00183274|11449758|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
7240802|NCT00183274|11449759|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
7240803|NCT00183274|11449760|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
7240804|NCT00183274|11449761|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
7240805|NCT00183274|11449762|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
7240806|NCT00183274|11449757|FG000|Phase 3: Double-Blind|Relapsed|0
7240807|NCT00183274|11449758|FG001|Phase 3: Double-Blind|Relapsed|0
7240808|NCT00183274|11449759|FG002|Phase 3: Double-Blind|Relapsed|0
7240809|NCT00183274|11449760|FG003|Phase 3: Double-Blind|Relapsed|1
7240810|NCT00183274|11449761|FG004|Phase 3: Double-Blind|Relapsed|11
7240811|NCT00183274|11449762|FG005|Phase 3: Double-Blind|Relapsed|2
7240812|NCT00183391|11449791|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
7240813|NCT00183391|11449792|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
7240814|NCT00183391|11449791|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
7240815|NCT00183391|11449792|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
7240816|NCT00183430|11449802|FG000|Overall Study|Adverse Event|1
7240817|NCT00183430|11449803|FG001|Overall Study|Adverse Event|0
7240818|NCT00183430|11449802|FG000|Overall Study|Lost to Follow-up|3
7240819|NCT00183430|11449803|FG001|Overall Study|Lost to Follow-up|0
7240820|NCT00183430|11449802|FG000|Overall Study|did not meet inclusion criteria|1
7240821|NCT00183430|11449803|FG001|Overall Study|did not meet inclusion criteria|0
7240822|NCT00183430|11449802|FG000|Overall Study|Withdrawal by Subject|1
7240823|NCT00183430|11449803|FG001|Overall Study|Withdrawal by Subject|0
7240824|NCT00183625|11449850|FG000|Overall Study|Withdrawal by Subject|18
7240825|NCT00183625|11449851|FG001|Overall Study|Withdrawal by Subject|18
7240826|NCT00183625|11449852|FG002|Overall Study|Withdrawal by Subject|19
7240827|NCT00183625|11449853|FG003|Overall Study|Withdrawal by Subject|14
7240828|NCT00183872|11449878|FG000|Overall Study|Death|3
7240829|NCT00183872|11449878|FG000|Overall Study|Adverse Event|9
7240830|NCT00183872|11449878|FG000|Overall Study|Withdrawal by Subject|2
7240831|NCT00183872|11449878|FG000|Overall Study|Drug delayed more than 28 days|2
7240832|NCT00184002|11449882|FG000|Overall Study|Adverse Event|9
7240833|NCT00184002|11449882|FG000|Overall Study|Death|3
7240834|NCT00184002|11449882|FG000|Overall Study|Physician Decision|1
7240835|NCT00184002|11449882|FG000|Overall Study|Withdrawal by Subject|4
7240836|NCT00184028|11449886|FG000|Overall Study|Death|1
7240837|NCT00184028|11449886|FG000|Overall Study|Lack of Efficacy|4
7240838|NCT00184028|11449886|FG000|Overall Study|Adverse Event|2
7240839|NCT00184028|11449886|FG000|Overall Study|Withdrawal by Subject|1
7240840|NCT00184028|11449886|FG000|Overall Study|Non-compliance|2
7240841|NCT00184054|11449891|FG000|Overall Study|Adverse Event|1
7240842|NCT00184093|11449895|FG000|Overall Study|Adverse Event|3
7240843|NCT00184093|11449895|FG000|Overall Study|Lost to Follow-up|3
7240844|NCT00184093|11449895|FG000|Overall Study|Physician Decision|1
7240845|NCT00184093|11449895|FG000|Overall Study|Withdrawal by Subject|2
7240846|NCT00184600|11449919|FG000|Overall Study|Adverse Event|9
7240847|NCT00184600|11449920|FG001|Overall Study|Adverse Event|0
7240848|NCT00184600|11449921|FG002|Overall Study|Adverse Event|5
7240849|NCT00184600|11449919|FG000|Overall Study|Death|3
7240850|NCT00184600|11449920|FG001|Overall Study|Death|9
7240851|NCT00184600|11449921|FG002|Overall Study|Death|7
7240852|NCT00184600|11449919|FG000|Overall Study|Lack of Efficacy|3
7240853|NCT00184600|11449920|FG001|Overall Study|Lack of Efficacy|1
7240854|NCT00184600|11449921|FG002|Overall Study|Lack of Efficacy|3
7240855|NCT00184600|11449919|FG000|Overall Study|Lost to Follow-up|4
7240856|NCT00184600|11449920|FG001|Overall Study|Lost to Follow-up|6
7240857|NCT00184600|11449921|FG002|Overall Study|Lost to Follow-up|1
7240858|NCT00184600|11449919|FG000|Overall Study|Protocol Violation|2
7240859|NCT00184600|11449920|FG001|Overall Study|Protocol Violation|2
7240860|NCT00184600|11449921|FG002|Overall Study|Protocol Violation|3
7240861|NCT00184600|11449919|FG000|Overall Study|Withdrawal by Subject|20
7240862|NCT00184600|11449920|FG001|Overall Study|Withdrawal by Subject|28
7240863|NCT00184600|11449921|FG002|Overall Study|Withdrawal by Subject|12
7240864|NCT00184600|11449919|FG000|Overall Study|Unclassified|4
7240865|NCT00184600|11449920|FG001|Overall Study|Unclassified|5
7240866|NCT00184600|11449921|FG002|Overall Study|Unclassified|3
7240867|NCT00185211|11449948|FG000|Placebo-controlled Study (92012)|Adverse Event|8
7240868|NCT00185211|11449949|FG001|Placebo-controlled Study (92012)|Adverse Event|0
7240869|NCT00185211|11449948|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
7240870|NCT00185211|11449949|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
7240871|NCT00185211|11449948|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
7240872|NCT00185211|11449949|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
7240873|NCT00185211|11449948|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
7240874|NCT00185211|11449949|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
7240875|NCT00185211|11449948|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
7240876|NCT00185211|11449949|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
7240877|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
7240878|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
7240879|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
7240880|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
7240881|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
7240882|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
7240883|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
7240884|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
7240885|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
7240886|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
7240887|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
7240888|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
7240889|NCT00185211|11449948|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
7240890|NCT00185211|11449949|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
7240891|NCT00185380|11449959|FG000|Overall Study|Adverse Event|41
7240892|NCT00185380|11449960|FG001|Overall Study|Adverse Event|43
7240893|NCT00185380|11449961|FG002|Overall Study|Adverse Event|48
7240894|NCT00185380|11449959|FG000|Overall Study|Lost to Follow-up|0
7240895|NCT00185380|11449960|FG001|Overall Study|Lost to Follow-up|4
7240896|NCT00185380|11449961|FG002|Overall Study|Lost to Follow-up|3
7240897|NCT00185380|11449959|FG000|Overall Study|Pregnancy|1
7240898|NCT00185380|11449960|FG001|Overall Study|Pregnancy|4
7240899|NCT00185380|11449961|FG002|Overall Study|Pregnancy|0
7240900|NCT00185380|11449959|FG000|Overall Study|Protocol Violation|2
7240901|NCT00185380|11449960|FG001|Overall Study|Protocol Violation|2
7240902|NCT00185380|11449961|FG002|Overall Study|Protocol Violation|1
7240903|NCT00185380|11449959|FG000|Overall Study|Withdrawal by Subject|1
7240904|NCT00185380|11449960|FG001|Overall Study|Withdrawal by Subject|2
7240905|NCT00185380|11449961|FG002|Overall Study|Withdrawal by Subject|0
7240906|NCT00185380|11449959|FG000|Overall Study|Failed insertion|1
7240907|NCT00185380|11449960|FG001|Overall Study|Failed insertion|1
7240908|NCT00185380|11449961|FG002|Overall Study|Failed insertion|2
7240909|NCT00185380|11449959|FG000|Overall Study|Planned pregnancy|9
7240910|NCT00185380|11449960|FG001|Overall Study|Planned pregnancy|12
7240911|NCT00185380|11449961|FG002|Overall Study|Planned pregnancy|12
7240912|NCT00185380|11449959|FG000|Overall Study|No need for contraception|3
7240913|NCT00185380|11449960|FG001|Overall Study|No need for contraception|3
7240914|NCT00185380|11449961|FG002|Overall Study|No need for contraception|3
7240915|NCT00185380|11449959|FG000|Overall Study|Could not attend visits|2
7240916|NCT00185380|11449960|FG001|Overall Study|Could not attend visits|0
7240917|NCT00185380|11449961|FG002|Overall Study|Could not attend visits|4
7240918|NCT00185380|11449959|FG000|Overall Study|personal reason|6
7240919|NCT00185380|11449960|FG001|Overall Study|personal reason|1
7240920|NCT00185380|11449961|FG002|Overall Study|personal reason|1
7240921|NCT00185458|11449969|FG000|Contraception Phase|Adverse Event|37
7240922|NCT00185458|11449969|FG000|Contraception Phase|Lost to Follow-up|10
7240923|NCT00185458|11449969|FG000|Contraception Phase|Protocol Violation|2
7240924|NCT00185458|11449969|FG000|Contraception Phase|Physician Decision|2
7240925|NCT00185458|11449969|FG000|Contraception Phase|Withdrawal by Subject|7
7240926|NCT00185458|11449969|FG000|HRT Phase|Adverse Event|18
7240927|NCT00185458|11449969|FG000|HRT Phase|Lost to Follow-up|4
7240928|NCT00185458|11449969|FG000|HRT Phase|Protocol Violation|2
7240929|NCT00185458|11449969|FG000|HRT Phase|Withdrawal by Subject|3
7240930|NCT00185588|11449985|FG000|Overall Study|Adverse Event|3
7240931|NCT00185588|11449986|FG001|Overall Study|Adverse Event|1
7240932|NCT00185588|11449987|FG002|Overall Study|Adverse Event|4
7240933|NCT00185588|11449988|FG003|Overall Study|Adverse Event|2
7240934|NCT00185588|11449985|FG000|Overall Study|Lost to Follow-up|0
7240935|NCT00185588|11449986|FG001|Overall Study|Lost to Follow-up|0
7240936|NCT00185588|11449987|FG002|Overall Study|Lost to Follow-up|1
7240937|NCT00185588|11449988|FG003|Overall Study|Lost to Follow-up|2
7240938|NCT00185588|11449985|FG000|Overall Study|Withdrawal by Subject|0
7240939|NCT00185588|11449986|FG001|Overall Study|Withdrawal by Subject|1
7240940|NCT00185588|11449987|FG002|Overall Study|Withdrawal by Subject|0
7240941|NCT00185588|11449988|FG003|Overall Study|Withdrawal by Subject|0
7240942|NCT00185588|11449985|FG000|Overall Study|Physician Decision|0
7240943|NCT00185588|11449986|FG001|Overall Study|Physician Decision|0
7240944|NCT00185588|11449987|FG002|Overall Study|Physician Decision|1
7240945|NCT00185588|11449988|FG003|Overall Study|Physician Decision|0
7240946|NCT00185614|11449998|FG000|Inter-treatment Period|Physician Decision|1
7240947|NCT00185614|11449998|FG000|Inter-treatment Period|Relapse|2
7240948|NCT00185614|11449998|FG000|Inter-treatment Period|Lack of allogenic donor|1
7240949|NCT00185640|11450002|FG000|Overall Study|Not Eligible|4
7240950|NCT00185640|11450002|FG000|Overall Study|Withdrawal by Subject|3
7240951|NCT00185640|11450002|FG000|Overall Study|Death|138
7240952|NCT00185731|11450014|FG000|Overall Study|Withdrawal by Subject|1
7240953|NCT00185731|11450014|FG000|Overall Study|Not Eligible|1
7240954|NCT00185965|11450031|FG000|Overall Study|Adverse Event|0
7240955|NCT00185965|11450032|FG001|Overall Study|Adverse Event|1
7240956|NCT00186043|11450050|FG000|Overall Study|Lack of Efficacy|1
7240957|NCT00186043|11450051|FG001|Overall Study|Lack of Efficacy|3
7240958|NCT00186043|11450050|FG000|Overall Study|Lost to Follow-up|4
7240959|NCT00186043|11450051|FG001|Overall Study|Lost to Follow-up|6
7240960|NCT00186043|11450050|FG000|Overall Study|Withdrawal by Subject|1
7240961|NCT00186043|11450051|FG001|Overall Study|Withdrawal by Subject|0
7240962|NCT00186043|11450050|FG000|Overall Study|Adverse Event|7
7240963|NCT00186043|11450051|FG001|Overall Study|Adverse Event|3
7240964|NCT00186043|11450050|FG000|Overall Study|Protocol Violation|2
7240965|NCT00186043|11450051|FG001|Overall Study|Protocol Violation|1
7255936|NCT00320788|11467464|FG001|Overall Study|Protocol Violation|0
7255937|NCT00320788|11467465|FG002|Overall Study|Protocol Violation|0
7255938|NCT00320788|11467466|FG003|Overall Study|Protocol Violation|0
7255939|NCT00320788|11467467|FG004|Overall Study|Protocol Violation|1
7255940|NCT00320788|11467463|FG000|Overall Study|Withdrawal by Subject|3
7255941|NCT00320788|11467464|FG001|Overall Study|Withdrawal by Subject|0
7255942|NCT00320788|11467465|FG002|Overall Study|Withdrawal by Subject|0
7255943|NCT00320788|11467466|FG003|Overall Study|Withdrawal by Subject|3
7255944|NCT00320788|11467467|FG004|Overall Study|Withdrawal by Subject|1
7255945|NCT00320801|11467487|FG000|Open-label Run-in Period|Withdrawal by Subject|2
7255946|NCT00320801|11467488|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7255947|NCT00320801|11467489|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7255948|NCT00320801|11467490|FG003|Open-label Run-in Period|Withdrawal by Subject|0
7255949|NCT00320801|11467487|FG000|Open-label Run-in Period|Adverse Event|33
7255950|NCT00320801|11467488|FG001|Open-label Run-in Period|Adverse Event|0
7255951|NCT00320801|11467489|FG002|Open-label Run-in Period|Adverse Event|0
7255952|NCT00320801|11467490|FG003|Open-label Run-in Period|Adverse Event|0
7255953|NCT00320801|11467487|FG000|Open-label Run-in Period|Administrative|10
7255954|NCT00320801|11467488|FG001|Open-label Run-in Period|Administrative|0
7255955|NCT00320801|11467489|FG002|Open-label Run-in Period|Administrative|0
7255956|NCT00320801|11467490|FG003|Open-label Run-in Period|Administrative|0
7255957|NCT00320801|11467487|FG000|Open-label Run-in Period|Lack of Efficacy|44
7255958|NCT00320801|11467488|FG001|Open-label Run-in Period|Lack of Efficacy|0
7255959|NCT00320801|11467489|FG002|Open-label Run-in Period|Lack of Efficacy|0
7255960|NCT00320801|11467490|FG003|Open-label Run-in Period|Lack of Efficacy|0
7255961|NCT00320801|11467487|FG000|Open-label Run-in Period|Lost to Follow-up|2
7255962|NCT00320801|11467488|FG001|Open-label Run-in Period|Lost to Follow-up|0
7255963|NCT00320801|11467489|FG002|Open-label Run-in Period|Lost to Follow-up|0
7255964|NCT00320801|11467490|FG003|Open-label Run-in Period|Lost to Follow-up|0
7255965|NCT00320801|11467487|FG000|Open-label Run-in Period|Did not qualify|1
7255966|NCT00320801|11467488|FG001|Open-label Run-in Period|Did not qualify|0
7255967|NCT00320801|11467489|FG002|Open-label Run-in Period|Did not qualify|0
7255968|NCT00320801|11467490|FG003|Open-label Run-in Period|Did not qualify|0
7255969|NCT00320801|11467487|FG000|Double-blind Phase|Withdrawal by Subject|0
7255970|NCT00320801|11467488|FG001|Double-blind Phase|Withdrawal by Subject|0
7255971|NCT00320801|11467489|FG002|Double-blind Phase|Withdrawal by Subject|1
7255972|NCT00320801|11467490|FG003|Double-blind Phase|Withdrawal by Subject|0
7255973|NCT00320801|11467487|FG000|Double-blind Phase|Adverse Event|0
7255974|NCT00320801|11467488|FG001|Double-blind Phase|Adverse Event|2
7255975|NCT00320801|11467489|FG002|Double-blind Phase|Adverse Event|8
7255976|NCT00320801|11467490|FG003|Double-blind Phase|Adverse Event|0
7255977|NCT00320801|11467487|FG000|Double-blind Phase|Administrative|0
7255978|NCT00320801|11467488|FG001|Double-blind Phase|Administrative|0
7255979|NCT00320801|11467489|FG002|Double-blind Phase|Administrative|4
7255980|NCT00320801|11467490|FG003|Double-blind Phase|Administrative|0
7255981|NCT00320801|11467487|FG000|Double-blind Phase|Lack of Efficacy|0
7255982|NCT00320801|11467488|FG001|Double-blind Phase|Lack of Efficacy|9
7255983|NCT00320801|11467489|FG002|Double-blind Phase|Lack of Efficacy|1
7255984|NCT00320801|11467490|FG003|Double-blind Phase|Lack of Efficacy|0
7255985|NCT00320801|11467487|FG000|Extension Phase|Withdrawal by Subject|0
7255986|NCT00320801|11467488|FG001|Extension Phase|Withdrawal by Subject|0
7255987|NCT00320801|11467489|FG002|Extension Phase|Withdrawal by Subject|0
7255988|NCT00320801|11467490|FG003|Extension Phase|Withdrawal by Subject|6
7255989|NCT00320801|11467487|FG000|Extension Phase|Adverse Event|0
7255990|NCT00320801|11467488|FG001|Extension Phase|Adverse Event|0
7255991|NCT00320801|11467489|FG002|Extension Phase|Adverse Event|0
7255992|NCT00320801|11467490|FG003|Extension Phase|Adverse Event|8
7255993|NCT00320801|11467487|FG000|Extension Phase|Administrative|0
7255994|NCT00320801|11467488|FG001|Extension Phase|Administrative|0
7255995|NCT00320801|11467489|FG002|Extension Phase|Administrative|0
7255996|NCT00320801|11467490|FG003|Extension Phase|Administrative|29
7255997|NCT00320801|11467487|FG000|Extension Phase|Lack of Efficacy|0
7255998|NCT00320801|11467488|FG001|Extension Phase|Lack of Efficacy|0
7255999|NCT00320801|11467489|FG002|Extension Phase|Lack of Efficacy|0
7256000|NCT00320801|11467490|FG003|Extension Phase|Lack of Efficacy|2
7256001|NCT00320801|11467487|FG000|Extension Phase|Lost to Follow-up|0
7256002|NCT00320801|11467488|FG001|Extension Phase|Lost to Follow-up|0
7256003|NCT00320801|11467489|FG002|Extension Phase|Lost to Follow-up|0
7256004|NCT00320801|11467490|FG003|Extension Phase|Lost to Follow-up|3
7256005|NCT00321048|11467502|FG000|Overall Study|Withdrawal by Subject|6
7256006|NCT00321048|11467503|FG001|Overall Study|Withdrawal by Subject|8
7256007|NCT00321373|11467527|FG000|Overall Study|Adverse Event|0
7240966|NCT00186121|11450075|FG000|Overall Study|Subject withdrawal (no treatment)|1
7240967|NCT00186121|11450075|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
7240968|NCT00186121|11450075|FG000|Overall Study|Not eligible (no treatment)|1
7240969|NCT00186186|11450079|FG000|Overall Study|Lack of Efficacy|3
7240970|NCT00186186|11450079|FG000|Overall Study|Withdrawal by Subject|3
7240971|NCT00186186|11450079|FG000|Overall Study|Not reported as to reason|2
7240972|NCT00186485|11450090|FG000|Overall Study|Lost to Follow-up|3
7240973|NCT00186537|11450106|FG000|Overall Study|Withdrawal by Subject|4
7240974|NCT00186537|11450107|FG001|Overall Study|Withdrawal by Subject|0
7240975|NCT00186537|11450108|FG002|Overall Study|Withdrawal by Subject|3
7240976|NCT00186537|11450106|FG000|Overall Study|ALT > 1.5 x ULN|3
7240977|NCT00186537|11450107|FG001|Overall Study|ALT > 1.5 x ULN|0
7240978|NCT00186537|11450108|FG002|Overall Study|ALT > 1.5 x ULN|0
7240979|NCT00186628|11450116|FG000|Overall Study|Death|2
7240980|NCT00186628|11450116|FG000|Overall Study|Withdrawal by subject (before treatment)|1
7240981|NCT00186901|11450135|FG000|Overall Study|Pregnancy|6
7240982|NCT00186901|11450136|FG001|Overall Study|Pregnancy|3
7240983|NCT00186901|11450137|FG002|Overall Study|Pregnancy|0
7240984|NCT00186901|11450135|FG000|Overall Study|Lost to Follow-up|6
7240985|NCT00186901|11450136|FG001|Overall Study|Lost to Follow-up|3
7240986|NCT00186901|11450137|FG002|Overall Study|Lost to Follow-up|0
7573984|NCT03636893|11955729|FG000|Overall Study|Withdrawal by Subject|1
7240987|NCT00186901|11450135|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
7240988|NCT00186901|11450136|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
7240989|NCT00186901|11450137|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
7240990|NCT00186901|11450135|FG000|Overall Study|ALL relapse or second malignancy|1
7240991|NCT00186901|11450136|FG001|Overall Study|ALL relapse or second malignancy|2
7240992|NCT00186901|11450137|FG002|Overall Study|ALL relapse or second malignancy|0
7240993|NCT00186901|11450135|FG000|Overall Study|Withdrawal by Subject|4
7240994|NCT00186901|11450136|FG001|Overall Study|Withdrawal by Subject|5
7240995|NCT00186901|11450137|FG002|Overall Study|Withdrawal by Subject|0
7240996|NCT00186901|11450135|FG000|Overall Study|Open label|3
7240997|NCT00186901|11450136|FG001|Overall Study|Open label|2
7240998|NCT00186901|11450137|FG002|Overall Study|Open label|0
7240999|NCT00186901|11450135|FG000|Overall Study|Limited adherence to study requirements|20
7241000|NCT00186901|11450136|FG001|Overall Study|Limited adherence to study requirements|23
7241001|NCT00186901|11450137|FG002|Overall Study|Limited adherence to study requirements|0
7241002|NCT00186901|11450135|FG000|Overall Study|Bone Mineral Density > 0|0
7241003|NCT00186901|11450136|FG001|Overall Study|Bone Mineral Density > 0|0
7241004|NCT00186901|11450137|FG002|Overall Study|Bone Mineral Density > 0|149
7241005|NCT00187096|11450177|FG000|Overall Study|unacceptable toxicity|0
7241006|NCT00187096|11450178|FG001|Overall Study|unacceptable toxicity|0
7241007|NCT00187096|11450179|FG002|Overall Study|unacceptable toxicity|1
7241008|NCT00187135|11450193|FG000|Visit One|Withdrawal by Subject|1
7241009|NCT00187135|11450194|FG001|Visit One|Withdrawal by Subject|0
7241010|NCT00187135|11450195|FG002|Visit One|Withdrawal by Subject|0
7241011|NCT00187135|11450196|FG003|Visit One|Withdrawal by Subject|0
7241012|NCT00187135|11450197|FG004|Visit One|Withdrawal by Subject|0
7241013|NCT00187135|11450198|FG005|Visit One|Withdrawal by Subject|1
7241014|NCT00187135|11450193|FG000|Visit One|Physician Decision|3
7241015|NCT00187135|11450194|FG001|Visit One|Physician Decision|1
7241016|NCT00187135|11450195|FG002|Visit One|Physician Decision|0
7241017|NCT00187135|11450196|FG003|Visit One|Physician Decision|0
7241018|NCT00187135|11450197|FG004|Visit One|Physician Decision|0
7241019|NCT00187135|11450198|FG005|Visit One|Physician Decision|1
7241020|NCT00187135|11450193|FG000|Visit Two|Death|0
7241021|NCT00187135|11450194|FG001|Visit Two|Death|0
7241022|NCT00187135|11450195|FG002|Visit Two|Death|0
7241023|NCT00187135|11450196|FG003|Visit Two|Death|1
7241024|NCT00187135|11450197|FG004|Visit Two|Death|0
7241025|NCT00187135|11450198|FG005|Visit Two|Death|1
7241026|NCT00187135|11450193|FG000|Visit Two|Physician Decision|1
7241027|NCT00187135|11450194|FG001|Visit Two|Physician Decision|0
7241028|NCT00187135|11450195|FG002|Visit Two|Physician Decision|0
7241029|NCT00187135|11450196|FG003|Visit Two|Physician Decision|0
7241030|NCT00187135|11450197|FG004|Visit Two|Physician Decision|0
7241031|NCT00187135|11450198|FG005|Visit Two|Physician Decision|0
7241032|NCT00187135|11450193|FG000|Visit Two|Withdrawal by Subject|1
7241033|NCT00187135|11450194|FG001|Visit Two|Withdrawal by Subject|1
7241034|NCT00187135|11450195|FG002|Visit Two|Withdrawal by Subject|1
7241035|NCT00187135|11450196|FG003|Visit Two|Withdrawal by Subject|0
7241036|NCT00187135|11450197|FG004|Visit Two|Withdrawal by Subject|1
7241037|NCT00187135|11450198|FG005|Visit Two|Withdrawal by Subject|1
7241038|NCT00187135|11450193|FG000|Visit Two|Study Discontinued|3
7241039|NCT00187135|11450194|FG001|Visit Two|Study Discontinued|2
7241040|NCT00187135|11450195|FG002|Visit Two|Study Discontinued|1
7241041|NCT00187135|11450196|FG003|Visit Two|Study Discontinued|7
7241042|NCT00187135|11450197|FG004|Visit Two|Study Discontinued|5
7573985|NCT03636893|11955730|FG001|Overall Study|Withdrawal by Subject|2
7241043|NCT00187135|11450198|FG005|Visit Two|Study Discontinued|6
7241044|NCT00187135|11450193|FG000|Visit Three|Death|0
7241045|NCT00187135|11450194|FG001|Visit Three|Death|0
7241046|NCT00187135|11450195|FG002|Visit Three|Death|1
7241047|NCT00187135|11450196|FG003|Visit Three|Death|0
7241048|NCT00187135|11450197|FG004|Visit Three|Death|1
7241049|NCT00187135|11450198|FG005|Visit Three|Death|0
7241050|NCT00187135|11450193|FG000|Visit Three|Withdrawal by Subject|0
7241051|NCT00187135|11450194|FG001|Visit Three|Withdrawal by Subject|1
7241052|NCT00187135|11450195|FG002|Visit Three|Withdrawal by Subject|1
7241053|NCT00187135|11450196|FG003|Visit Three|Withdrawal by Subject|2
7241054|NCT00187135|11450197|FG004|Visit Three|Withdrawal by Subject|0
7241055|NCT00187135|11450198|FG005|Visit Three|Withdrawal by Subject|0
7241056|NCT00187135|11450193|FG000|Visit Three|Study Discontinued|7
7241057|NCT00187135|11450194|FG001|Visit Three|Study Discontinued|6
7241058|NCT00187135|11450195|FG002|Visit Three|Study Discontinued|7
7241059|NCT00187135|11450196|FG003|Visit Three|Study Discontinued|7
7241060|NCT00187135|11450197|FG004|Visit Three|Study Discontinued|7
7241061|NCT00187135|11450198|FG005|Visit Three|Study Discontinued|6
7241062|NCT00187278|11450223|FG000|Overall Study|Protocol Violation|10
7241063|NCT00187278|11450224|FG001|Overall Study|Protocol Violation|13
7241064|NCT00187486|11450247|FG000|Overall Study|Protocol Violation|1
7241065|NCT00187889|11450287|FG000|Overall Study|Withdrawal by Subject|6
7241066|NCT00187889|11450288|FG001|Overall Study|Withdrawal by Subject|4
7241067|NCT00189202|11450315|FG000|Overall Study|Physician Decision|5
7241068|NCT00189306|11450323|FG000|Treatment Period|Withdrawal by Subject|2
7241069|NCT00189306|11450323|FG000|Treatment Period|Adverse Event|2
7241070|NCT00189306|11450323|FG000|Treatment Period|Protocol Violation|1
7241071|NCT00189306|11450323|FG000|Posttreatment Period|Death|1
7241072|NCT00189306|11450323|FG000|Posttreatment Period|Withdrawal by Subject|2
7241073|NCT00189306|11450323|FG000|Posttreatment Period|Noncompliance|1
7241074|NCT00189306|11450323|FG000|Posttreatment Period|Target lesion excised|1
7241075|NCT00189306|11450323|FG000|Posttreatment Period|Protocol Violation|1
7241076|NCT00189306|11450323|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
7241077|NCT00189306|11450323|FG000|Posttreatment Period|Local skin reaction/sign|1
7241078|NCT00189306|11450323|FG000|Long-Term Follow-up|Adverse Event|2
7241079|NCT00189306|11450323|FG000|Long-Term Follow-up|Death|4
7241080|NCT00189306|11450323|FG000|Long-Term Follow-up|Withdrawal by Subject|1
7241081|NCT00189306|11450323|FG000|Long-Term Follow-up|Intercurrent disease|2
7241082|NCT00189306|11450323|FG000|Long-Term Follow-up|Lost to Follow-up|9
7241083|NCT00189306|11450323|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
7241084|NCT00189423|11450329|FG000|Overall Study|Death|746
7241085|NCT00189423|11450330|FG001|Overall Study|Death|747
7241086|NCT00189423|11450329|FG000|Overall Study|Withdrawal by Subject|9
7241087|NCT00189423|11450330|FG001|Overall Study|Withdrawal by Subject|9
7241088|NCT00189423|11450329|FG000|Overall Study|Lost to Follow-up|10
7241089|NCT00189423|11450330|FG001|Overall Study|Lost to Follow-up|10
7241090|NCT00189462|11450347|FG000|Overall Study|Lack of Efficacy|5
7241091|NCT00189462|11450348|FG001|Overall Study|Lack of Efficacy|1
7241092|NCT00189462|11450347|FG000|Overall Study|Lost to Follow-up|18
7241093|NCT00189462|11450348|FG001|Overall Study|Lost to Follow-up|20
7241094|NCT00189488|11450365|FG000|Overall Study|Ineligibility determined|1
7241095|NCT00189488|11450366|FG001|Overall Study|Ineligibility determined|0
7241096|NCT00189488|11450365|FG000|Overall Study|Protocol deviation|2
7241097|NCT00189488|11450366|FG001|Overall Study|Protocol deviation|1
7241098|NCT00189488|11450365|FG000|Overall Study|Adverse Event|2
7241099|NCT00189488|11450366|FG001|Overall Study|Adverse Event|1
7241100|NCT00189488|11450365|FG000|Overall Study|Withdrawal by Subject|2
7241101|NCT00189488|11450366|FG001|Overall Study|Withdrawal by Subject|6
7241102|NCT00189488|11450365|FG000|Overall Study|Disease progression|2
7241103|NCT00189488|11450366|FG001|Overall Study|Disease progression|4
7241104|NCT00189488|11450365|FG000|Overall Study|Administrative Decision|0
7241105|NCT00189488|11450366|FG001|Overall Study|Administrative Decision|2
7241106|NCT00189488|11450365|FG000|Overall Study|Death|5
7241107|NCT00189488|11450366|FG001|Overall Study|Death|8
7241108|NCT00189488|11450365|FG000|Overall Study|Other|1
7241109|NCT00189488|11450366|FG001|Overall Study|Other|0
7241110|NCT00189540|11450375|FG000|Overall Study|Withdrawal by Subject|3
7241111|NCT00189540|11450376|FG001|Overall Study|Withdrawal by Subject|0
7241112|NCT00189540|11450375|FG000|Overall Study|Death|4
7241113|NCT00189540|11450376|FG001|Overall Study|Death|1
7241114|NCT00190671|11450384|FG000|Overall Study|Satisfactory Response|4
7241115|NCT00190671|11450385|FG001|Overall Study|Satisfactory Response|7
7241116|NCT00190671|11450384|FG000|Overall Study|Lack of Efficacy|19
7241117|NCT00190671|11450385|FG001|Overall Study|Lack of Efficacy|24
7241118|NCT00190671|11450384|FG000|Overall Study|Death from Study Disease|1
7241119|NCT00190671|11450385|FG001|Overall Study|Death from Study Disease|1
7241120|NCT00190671|11450384|FG000|Overall Study|Adverse Event|3
7241121|NCT00190671|11450385|FG001|Overall Study|Adverse Event|2
7241122|NCT00190671|11450384|FG000|Overall Study|Clinical Relapse|0
7241123|NCT00190671|11450385|FG001|Overall Study|Clinical Relapse|1
7241124|NCT00190671|11450384|FG000|Overall Study|Death from Study-Drug Toxicity|0
7241125|NCT00190671|11450385|FG001|Overall Study|Death from Study-Drug Toxicity|2
7241126|NCT00190671|11450384|FG000|Overall Study|Death from Other Causes|0
7241127|NCT00190671|11450385|FG001|Overall Study|Death from Other Causes|2
7241128|NCT00190671|11450384|FG000|Overall Study|Protocol Violation|0
7241129|NCT00190671|11450385|FG001|Overall Study|Protocol Violation|1
7241130|NCT00190671|11450384|FG000|Overall Study|Withdrawal by Subject|0
7241131|NCT00190671|11450385|FG001|Overall Study|Withdrawal by Subject|2
7241132|NCT00190684|11450392|FG000|Overall Study|Adverse Event|86
7241133|NCT00190684|11450392|FG000|Overall Study|Satisfactory response|80
7241134|NCT00190684|11450392|FG000|Overall Study|Lack of efficacy|204
7241135|NCT00190684|11450392|FG000|Overall Study|Lost to Follow-up|232
7241136|NCT00190684|11450392|FG000|Overall Study|Patient moved|60
7241137|NCT00190684|11450392|FG000|Overall Study|Patient Decision|432
7241138|NCT00190684|11450392|FG000|Overall Study|Clinical relapse|67
7241139|NCT00190684|11450392|FG000|Overall Study|Sponsor's decision|17
7241140|NCT00190684|11450392|FG000|Overall Study|Physician Decision|84
7241141|NCT00190684|11450392|FG000|Overall Study|Protocol Violation|123
7241142|NCT00190684|11450392|FG000|Overall Study|Study Period III Completed|103
7241143|NCT00190684|11450392|FG000|Overall Study|Study Period V Completed|1
7241144|NCT00190749|11450398|FG000|Overall Study|Lost to Follow-up|8
7241145|NCT00190749|11450399|FG001|Overall Study|Lost to Follow-up|11
7241146|NCT00190749|11450398|FG000|Overall Study|Withdrawal by Subject|10
7241147|NCT00190749|11450399|FG001|Overall Study|Withdrawal by Subject|6
7241148|NCT00190749|11450398|FG000|Overall Study|Protocol Violation|5
7241149|NCT00190749|11450399|FG001|Overall Study|Protocol Violation|4
7241150|NCT00190749|11450398|FG000|Overall Study|Adverse Event|0
7241151|NCT00190749|11450399|FG001|Overall Study|Adverse Event|5
7241152|NCT00190749|11450398|FG000|Overall Study|Lack of Efficacy|2
7241153|NCT00190749|11450399|FG001|Overall Study|Lack of Efficacy|3
7241154|NCT00190749|11450398|FG000|Overall Study|Reason Not Specified|0
7241155|NCT00190749|11450399|FG001|Overall Study|Reason Not Specified|2
7241156|NCT00190749|11450398|FG000|Overall Study|Sponsor Decision|1
7241157|NCT00190749|11450399|FG001|Overall Study|Sponsor Decision|0
7241158|NCT00190775|11450407|FG000|Overall Study|Adverse Event|57
7465043|NCT01877421|11764024|FG013|Phase 2|Lost to Follow-up|0
7465044|NCT01877421|11764025|FG014|Phase 2|Lost to Follow-up|0
7465045|NCT01877421|11764026|FG015|Phase 2|Lost to Follow-up|0
7465046|NCT01877421|11764027|FG016|Phase 2|Lost to Follow-up|0
7465047|NCT01877421|11764028|FG017|Phase 2|Lost to Follow-up|0
7465048|NCT01877421|11764011|FG000|Phase 2|Withdrawal by Subject|0
7241159|NCT00190775|11450408|FG001|Overall Study|Adverse Event|22
7241160|NCT00190775|11450407|FG000|Overall Study|Satisfactory Response|1
7241161|NCT00190775|11450408|FG001|Overall Study|Satisfactory Response|0
7241162|NCT00190775|11450407|FG000|Overall Study|Lack of Efficacy|28
7241163|NCT00190775|11450408|FG001|Overall Study|Lack of Efficacy|32
7241164|NCT00190775|11450407|FG000|Overall Study|Lost to Follow-up|31
7241165|NCT00190775|11450408|FG001|Overall Study|Lost to Follow-up|23
7241166|NCT00190775|11450407|FG000|Overall Study|Participant Moved|0
7241167|NCT00190775|11450408|FG001|Overall Study|Participant Moved|1
7241168|NCT00190775|11450407|FG000|Overall Study|Withdrawal by Subject|24
7241169|NCT00190775|11450408|FG001|Overall Study|Withdrawal by Subject|13
7241170|NCT00190775|11450407|FG000|Overall Study|Sponsor Decision|1
7241171|NCT00190775|11450408|FG001|Overall Study|Sponsor Decision|0
7241172|NCT00190775|11450407|FG000|Overall Study|Physician Decision|3
7241173|NCT00190775|11450408|FG001|Overall Study|Physician Decision|0
7241174|NCT00190775|11450407|FG000|Overall Study|Noncompliance|3
7241175|NCT00190775|11450408|FG001|Overall Study|Noncompliance|5
7241176|NCT00190775|11450407|FG000|Overall Study|Protocol Violation|0
7241177|NCT00190775|11450408|FG001|Overall Study|Protocol Violation|1
7241178|NCT00190775|11450407|FG000|Overall Study|Exclusion Criteria Met|1
7241179|NCT00190775|11450408|FG001|Overall Study|Exclusion Criteria Met|3
7241180|NCT00190983|11450421|FG000|Overall Study|Inevaluable (never treated)|2
7241181|NCT00191100|11450427|FG000|Overall Study|Adverse Event|18
7241182|NCT00191100|11450428|FG001|Overall Study|Adverse Event|1
7241183|NCT00191100|11450427|FG000|Overall Study|Lost to Follow-up|2
7241184|NCT00191100|11450428|FG001|Overall Study|Lost to Follow-up|0
7241185|NCT00191100|11450427|FG000|Overall Study|Patient Moved|0
7241186|NCT00191100|11450428|FG001|Overall Study|Patient Moved|1
7241187|NCT00191100|11450427|FG000|Overall Study|Withdrawal by Subject|9
7241188|NCT00191100|11450428|FG001|Overall Study|Withdrawal by Subject|3
7241189|NCT00191100|11450427|FG000|Overall Study|Protocol Entry Criteria Not Met|2
7241190|NCT00191100|11450428|FG001|Overall Study|Protocol Entry Criteria Not Met|1
7241191|NCT00191100|11450427|FG000|Overall Study|Clinical Relapse|2
7241192|NCT00191100|11450428|FG001|Overall Study|Clinical Relapse|1
7241193|NCT00191100|11450427|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
7241194|NCT00191100|11450428|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
7241195|NCT00191100|11450427|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
7241196|NCT00191100|11450428|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
7241197|NCT00191100|11450427|FG000|Overall Study|Physician Decision|3
7241198|NCT00191100|11450428|FG001|Overall Study|Physician Decision|1
7241199|NCT00191100|11450427|FG000|Overall Study|Death from Study Drug Toxicity|2
7241200|NCT00191100|11450428|FG001|Overall Study|Death from Study Drug Toxicity|0
7241201|NCT00191100|11450427|FG000|Overall Study|Protocol Violation|1
7241202|NCT00191100|11450428|FG001|Overall Study|Protocol Violation|1
7241203|NCT00191100|11450427|FG000|Overall Study|Death from Other Cause|1
7241204|NCT00191100|11450428|FG001|Overall Study|Death from Other Cause|0
7241205|NCT00191100|11450427|FG000|Overall Study|Reason Not Specified|0
7241206|NCT00191100|11450428|FG001|Overall Study|Reason Not Specified|1
7241207|NCT00191113|11450436|FG000|Core Study|Withdrawal by Subject|25
7241208|NCT00191113|11450437|FG001|Core Study|Withdrawal by Subject|9
7241209|NCT00191113|11450436|FG000|Core Study|Protocol Violation|6
7241210|NCT00191113|11450437|FG001|Core Study|Protocol Violation|2
7241211|NCT00191113|11450436|FG000|Core Study|Lost to Follow-up|3
7241212|NCT00191113|11450437|FG001|Core Study|Lost to Follow-up|0
7241213|NCT00191113|11450436|FG000|Core Study|Adverse Event|0
7241214|NCT00191113|11450437|FG001|Core Study|Adverse Event|2
7241215|NCT00191113|11450436|FG000|Core Study|Lack of Efficacy|0
7241216|NCT00191113|11450437|FG001|Core Study|Lack of Efficacy|2
7241217|NCT00191113|11450436|FG000|Core Study|Death|1
7241218|NCT00191113|11450437|FG001|Core Study|Death|0
7241219|NCT00191139|11450451|FG000|Overall Study|Adverse Event|2
7241220|NCT00191139|11450452|FG001|Overall Study|Adverse Event|6
7241221|NCT00191139|11450451|FG000|Overall Study|Death|2
7241222|NCT00191139|11450452|FG001|Overall Study|Death|0
7241223|NCT00191139|11450451|FG000|Overall Study|Withdrawal by Subject|0
7241224|NCT00191139|11450452|FG001|Overall Study|Withdrawal by Subject|3
7241225|NCT00191139|11450451|FG000|Overall Study|Disease Progression|0
7241226|NCT00191139|11450452|FG001|Overall Study|Disease Progression|1
7241227|NCT00191139|11450451|FG000|Overall Study|Other|1
7241228|NCT00191139|11450452|FG001|Overall Study|Other|2
7241229|NCT00191152|11450460|FG000|Initial Treatment|Adverse Event|43
7241230|NCT00191152|11450461|FG001|Initial Treatment|Adverse Event|67
7241231|NCT00191152|11450460|FG000|Initial Treatment|Physician Decision|40
7241232|NCT00191152|11450461|FG001|Initial Treatment|Physician Decision|31
7241233|NCT00191152|11450460|FG000|Initial Treatment|Withdrawal by Subject|40
7241234|NCT00191152|11450461|FG001|Initial Treatment|Withdrawal by Subject|28
7241235|NCT00191152|11450460|FG000|Initial Treatment|Lost to Follow-up|0
7241236|NCT00191152|11450461|FG001|Initial Treatment|Lost to Follow-up|6
7241237|NCT00191152|11450460|FG000|Initial Treatment|Other|18
7241238|NCT00191152|11450461|FG001|Initial Treatment|Other|21
7241239|NCT00191152|11450460|FG000|Crossover Treatment|Adverse Event|8
7241240|NCT00191152|11450461|FG001|Crossover Treatment|Adverse Event|8
7241241|NCT00191152|11450460|FG000|Crossover Treatment|Physician Decision|7
7241242|NCT00191152|11450461|FG001|Crossover Treatment|Physician Decision|7
7241243|NCT00191152|11450460|FG000|Crossover Treatment|Withdrawal by Subject|6
7241244|NCT00191152|11450461|FG001|Crossover Treatment|Withdrawal by Subject|9
7241245|NCT00191152|11450460|FG000|Crossover Treatment|Lost to Follow-up|2
7241246|NCT00191152|11450461|FG001|Crossover Treatment|Lost to Follow-up|1
7241247|NCT00191152|11450460|FG000|Crossover Treatment|Other|4
7241248|NCT00191152|11450461|FG001|Crossover Treatment|Other|3
7241249|NCT00191165|11450481|FG000|Overall Study|Adverse Event|2
7241250|NCT00191165|11450482|FG001|Overall Study|Adverse Event|0
7241251|NCT00191165|11450481|FG000|Overall Study|Protocol Violation|0
7241252|NCT00191165|11450482|FG001|Overall Study|Protocol Violation|1
7241253|NCT00191165|11450481|FG000|Overall Study|Participant Moved Away|0
7241254|NCT00191165|11450482|FG001|Overall Study|Participant Moved Away|1
7241255|NCT00191191|11450490|FG000|Overall Study|Entry Criteria Exclusion|2
7241256|NCT00191191|11450491|FG001|Overall Study|Entry Criteria Exclusion|0
7241257|NCT00191191|11450490|FG000|Overall Study|Treated with Another Systemic Agent|1
7241258|NCT00191191|11450491|FG001|Overall Study|Treated with Another Systemic Agent|1
7241259|NCT00191191|11450490|FG000|Overall Study|Adverse Event|11
7241260|NCT00191191|11450491|FG001|Overall Study|Adverse Event|21
7241261|NCT00191191|11450490|FG000|Overall Study|Progressive Disease|84
7241262|NCT00191191|11450491|FG001|Overall Study|Progressive Disease|72
7241263|NCT00191191|11450490|FG000|Overall Study|Toxicity After Dose Reduction|7
7241264|NCT00191191|11450491|FG001|Overall Study|Toxicity After Dose Reduction|8
7241265|NCT00191191|11450490|FG000|Overall Study|Family/Caregiver Decision|5
7241266|NCT00191191|11450491|FG001|Overall Study|Family/Caregiver Decision|7
7241267|NCT00191191|11450490|FG000|Overall Study|Lost to Follow-up|1
7241268|NCT00191191|11450491|FG001|Overall Study|Lost to Follow-up|0
7241269|NCT00191191|11450490|FG000|Overall Study|Physician Decision|3
7241270|NCT00191191|11450491|FG001|Overall Study|Physician Decision|2
7241271|NCT00191191|11450490|FG000|Overall Study|Good Clinical Practice Violation|0
7241272|NCT00191191|11450491|FG001|Overall Study|Good Clinical Practice Violation|1
7241273|NCT00191269|11450499|FG000|Overall Study|Protocol Violation|0
7241274|NCT00191269|11450500|FG001|Overall Study|Protocol Violation|2
7241275|NCT00191269|11450499|FG000|Overall Study|Adverse Event|1
7241276|NCT00191269|11450500|FG001|Overall Study|Adverse Event|4
7241277|NCT00191269|11450499|FG000|Overall Study|Progression of Disease|4
7241278|NCT00191269|11450500|FG001|Overall Study|Progression of Disease|42
7241279|NCT00191269|11450499|FG000|Overall Study|Lack of Efficacy|1
7241280|NCT00191269|11450500|FG001|Overall Study|Lack of Efficacy|5
7241281|NCT00191269|11450499|FG000|Overall Study|Withdrawal by Subject|0
7241282|NCT00191269|11450500|FG001|Overall Study|Withdrawal by Subject|1
7241283|NCT00191269|11450499|FG000|Overall Study|Pathologic Aggrevation|0
7241284|NCT00191269|11450500|FG001|Overall Study|Pathologic Aggrevation|1
7241285|NCT00191269|11450499|FG000|Overall Study|Physician Decision|0
7241286|NCT00191269|11450500|FG001|Overall Study|Physician Decision|3
7241287|NCT00191282|11450509|FG000|Overall Study|Adverse Event|5
7241288|NCT00191282|11450510|FG001|Overall Study|Adverse Event|6
7241289|NCT00191282|11450509|FG000|Overall Study|Death|51
7241290|NCT00191282|11450510|FG001|Overall Study|Death|51
7241291|NCT00191282|11450509|FG000|Overall Study|Lack of Efficacy|11
7241292|NCT00191282|11450510|FG001|Overall Study|Lack of Efficacy|6
7241293|NCT00191282|11450509|FG000|Overall Study|Noncompliance|14
7241294|NCT00191282|11450510|FG001|Overall Study|Noncompliance|17
7241295|NCT00191282|11450509|FG000|Overall Study|Patient moved|11
7241296|NCT00191282|11450510|FG001|Overall Study|Patient moved|14
7241297|NCT00191282|11450509|FG000|Overall Study|Withdrawal by Subject|59
7241298|NCT00191282|11450510|FG001|Overall Study|Withdrawal by Subject|44
7573986|NCT03636893|11955729|FG000|Overall Study|Refusal to surgery|4
7573987|NCT03636893|11955730|FG001|Overall Study|Refusal to surgery|3
7573988|NCT03636893|11955729|FG000|Overall Study|Early surgery (for acute bleeding)|3
7573989|NCT03636893|11955730|FG001|Overall Study|Early surgery (for acute bleeding)|0
7241299|NCT00191282|11450509|FG000|Overall Study|Physician Decision|18
7241300|NCT00191282|11450510|FG001|Overall Study|Physician Decision|15
7241301|NCT00191282|11450509|FG000|Overall Study|Protocol entry criteria not met|14
7241302|NCT00191282|11450510|FG001|Overall Study|Protocol entry criteria not met|9
7241303|NCT00191282|11450509|FG000|Overall Study|Protocol Violation|9
7241304|NCT00191282|11450510|FG001|Overall Study|Protocol Violation|12
7241305|NCT00191282|11450509|FG000|Overall Study|Severity of outcome|2
7241306|NCT00191282|11450510|FG001|Overall Study|Severity of outcome|5
7241307|NCT00191282|11450509|FG000|Overall Study|Sponsor's decision|2
7241308|NCT00191282|11450510|FG001|Overall Study|Sponsor's decision|2
7241309|NCT00191282|11450509|FG000|Overall Study|Lost to Follow-up|24
7241310|NCT00191282|11450510|FG001|Overall Study|Lost to Follow-up|31
7241311|NCT00191308|11450516|FG000|Overall Study|Adverse Event|1
7241312|NCT00191334|11450520|FG000|Overall Study|Adverse Event|4
7241313|NCT00191334|11450520|FG000|Overall Study|Disease Progression or Relapse|8
7241314|NCT00191334|11450520|FG000|Overall Study|Physician Decision|1
7241315|NCT00191334|11450520|FG000|Overall Study|Withdrawal by Subject|4
7241316|NCT00191386|11450524|FG000|Overall Study|Adverse Event|16
7241317|NCT00191386|11450524|FG000|Overall Study|Lost to Follow-up|1
7241318|NCT00191386|11450524|FG000|Overall Study|Entry Criteria Exclusion|3
7241319|NCT00191386|11450524|FG000|Overall Study|Protocol Violation|18
7241320|NCT00191386|11450524|FG000|Overall Study|Withdrawal by Subject|96
7241321|NCT00191386|11450524|FG000|Overall Study|Physician Decision|11
7241322|NCT00191386|11450524|FG000|Overall Study|Lack of Efficacy|15
7241323|NCT00191451|11450531|FG000|Overall Study|Withdrawal by Subject|2
7241324|NCT00191451|11450532|FG001|Overall Study|Withdrawal by Subject|3
7241325|NCT00191451|11450533|FG002|Overall Study|Withdrawal by Subject|5
7241326|NCT00191451|11450531|FG000|Overall Study|Physician Decision|2
7241327|NCT00191451|11450532|FG001|Overall Study|Physician Decision|9
7241328|NCT00191451|11450533|FG002|Overall Study|Physician Decision|6
7241329|NCT00191451|11450531|FG000|Overall Study|Sponsor Decision|1
7241330|NCT00191451|11450532|FG001|Overall Study|Sponsor Decision|0
7241331|NCT00191451|11450533|FG002|Overall Study|Sponsor Decision|0
7241332|NCT00191451|11450531|FG000|Overall Study|Ineligible|0
7241333|NCT00191451|11450532|FG001|Overall Study|Ineligible|1
7241334|NCT00191451|11450533|FG002|Overall Study|Ineligible|0
7241335|NCT00191451|11450531|FG000|Overall Study|Reason Not Specified|2
7241336|NCT00191451|11450532|FG001|Overall Study|Reason Not Specified|1
7241337|NCT00191451|11450533|FG002|Overall Study|Reason Not Specified|3
7241338|NCT00191477|11450543|FG000|Overall Study|Tumor Recurrence|49
7241339|NCT00191477|11450544|FG001|Overall Study|Tumor Recurrence|48
7241340|NCT00191477|11450543|FG000|Overall Study|Death, Study Disease|1
7241341|NCT00191477|11450544|FG001|Overall Study|Death, Study Disease|1
7241342|NCT00191477|11450543|FG000|Overall Study|Death, Other Cause|3
7241343|NCT00191477|11450544|FG001|Overall Study|Death, Other Cause|6
7241344|NCT00191477|11450543|FG000|Overall Study|Lost to Follow-up|23
7241345|NCT00191477|11450544|FG001|Overall Study|Lost to Follow-up|21
7241346|NCT00191477|11450543|FG000|Overall Study|Protocol Violation|1
7241347|NCT00191477|11450544|FG001|Overall Study|Protocol Violation|1
7241348|NCT00191477|11450543|FG000|Overall Study|Treatment Change|2
7241349|NCT00191477|11450544|FG001|Overall Study|Treatment Change|0
7241350|NCT00191477|11450543|FG000|Overall Study|Withdrawal by Subject|2
7241351|NCT00191477|11450544|FG001|Overall Study|Withdrawal by Subject|0
7241352|NCT00191477|11450543|FG000|Overall Study|Other|2
7241353|NCT00191477|11450544|FG001|Overall Study|Other|0
7241354|NCT00191477|11450543|FG000|Overall Study|Not Eligible|41
7241355|NCT00191477|11450544|FG001|Overall Study|Not Eligible|38
7241356|NCT00191477|11450543|FG000|Overall Study|Pathological Specimen Lost|1
7241357|NCT00191477|11450544|FG001|Overall Study|Pathological Specimen Lost|0
7241358|NCT00191477|11450543|FG000|Overall Study|Discontinued Prior to Instillation|13
7241359|NCT00191477|11450544|FG001|Overall Study|Discontinued Prior to Instillation|14
7241360|NCT00191646|11450552|FG000|Overall Study|Toxicity|26
7241361|NCT00191646|11450553|FG001|Overall Study|Toxicity|37
7241362|NCT00191646|11450552|FG000|Overall Study|Disease Progression|5
7241363|NCT00191646|11450553|FG001|Overall Study|Disease Progression|6
7241364|NCT00191646|11450552|FG000|Overall Study|Physician Decision|20
7241365|NCT00191646|11450553|FG001|Overall Study|Physician Decision|11
7241366|NCT00191646|11450552|FG000|Overall Study|Withdrawal by Subject|58
7241367|NCT00191646|11450553|FG001|Overall Study|Withdrawal by Subject|39
7241368|NCT00191646|11450552|FG000|Overall Study|Protocol Violation|5
7241369|NCT00191646|11450553|FG001|Overall Study|Protocol Violation|7
7241370|NCT00191646|11450552|FG000|Overall Study|Death|6
7241371|NCT00191646|11450553|FG001|Overall Study|Death|8
7241372|NCT00191646|11450552|FG000|Overall Study|Other|33
7241373|NCT00191646|11450553|FG001|Overall Study|Other|34
7241374|NCT00191646|11450552|FG000|Overall Study|Missing Data|18
7241375|NCT00191646|11450553|FG001|Overall Study|Missing Data|11
7241376|NCT00191724|11450572|FG000|Overall Study|Adverse Event|0
7241377|NCT00191724|11450573|FG001|Overall Study|Adverse Event|0
7241378|NCT00191724|11450574|FG002|Overall Study|Adverse Event|1
7241379|NCT00191724|11450575|FG003|Overall Study|Adverse Event|0
7533748|NCT02688387|11880053|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533749|NCT02688387|11880054|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533750|NCT02688387|11880055|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533751|NCT02688387|11880056|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533752|NCT02688387|11880057|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533753|NCT02688387|11880058|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533754|NCT02688387|11880059|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533755|NCT02688387|11880060|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533756|NCT02688387|11880061|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533757|NCT02688387|11880062|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
7533758|NCT02688387|11880063|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533759|NCT02688387|11880064|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
7533760|NCT02688621|11880121|FG000|Overall Study|Pregnancy|1
7533761|NCT02688621|11880122|FG001|Overall Study|Pregnancy|3
7533762|NCT02688621|11880121|FG000|Overall Study|Lost to Follow-up|38
7533763|NCT02688621|11880122|FG001|Overall Study|Lost to Follow-up|15
7533764|NCT02688621|11880121|FG000|Overall Study|Withdrawal by Subject|1
7533765|NCT02688621|11880122|FG001|Overall Study|Withdrawal by Subject|0
7533766|NCT02688764|11880133|FG000|Overall Study|Adverse Event|3
7533767|NCT02688764|11880134|FG001|Overall Study|Adverse Event|3
7533768|NCT02688764|11880133|FG000|Overall Study|AE/Kidney transplant|1
7533769|NCT02688764|11880134|FG001|Overall Study|AE/Kidney transplant|0
7533770|NCT02688764|11880133|FG000|Overall Study|AE/Lack of efficacy|1
7533771|NCT02688764|11880134|FG001|Overall Study|AE/Lack of efficacy|0
7533772|NCT02688764|11880133|FG000|Overall Study|AE/Non-compl.|1
7533773|NCT02688764|11880134|FG001|Overall Study|AE/Non-compl.|0
7533774|NCT02688764|11880133|FG000|Overall Study|AE/Non-compl./Withd. parent|0
7533775|NCT02688764|11880134|FG001|Overall Study|AE/Non-compl./Withd. parent|1
7533776|NCT02688764|11880133|FG000|Overall Study|AE/Other|0
7533777|NCT02688764|11880134|FG001|Overall Study|AE/Other|1
7533778|NCT02688764|11880133|FG000|Overall Study|AE/Physician decision|1
7533779|NCT02688764|11880134|FG001|Overall Study|AE/Physician decision|0
7533780|NCT02688764|11880133|FG000|Overall Study|AE/Withd. parent|3
7533781|NCT02688764|11880134|FG001|Overall Study|AE/Withd. parent|0
7533782|NCT02688764|11880133|FG000|Overall Study|AE/Withd. parent/Withd. subject|1
7533783|NCT02688764|11880134|FG001|Overall Study|AE/Withd. parent/Withd. subject|1
7533784|NCT02688764|11880133|FG000|Overall Study|AE/Withd. subject|1
7241380|NCT00191724|11450576|FG004|Overall Study|Adverse Event|0
7241381|NCT00191724|11450572|FG000|Overall Study|Lost to Follow-up|1
7241382|NCT00191724|11450573|FG001|Overall Study|Lost to Follow-up|1
7241383|NCT00191724|11450574|FG002|Overall Study|Lost to Follow-up|0
7241384|NCT00191724|11450575|FG003|Overall Study|Lost to Follow-up|2
7241385|NCT00191724|11450576|FG004|Overall Study|Lost to Follow-up|3
7241386|NCT00191724|11450572|FG000|Overall Study|Withdrawal by Subject|0
7241387|NCT00191724|11450573|FG001|Overall Study|Withdrawal by Subject|0
7241388|NCT00191724|11450574|FG002|Overall Study|Withdrawal by Subject|0
7241389|NCT00191724|11450575|FG003|Overall Study|Withdrawal by Subject|1
7241390|NCT00191724|11450576|FG004|Overall Study|Withdrawal by Subject|0
7241391|NCT00191789|11450588|FG000|Overall Study|Adverse Event|5
7533785|NCT02688764|11880134|FG001|Overall Study|AE/Withd. subject|0
7533786|NCT02688764|11880133|FG000|Overall Study|Kidney transplant|10
7533787|NCT02688764|11880134|FG001|Overall Study|Kidney transplant|4
7533788|NCT02688764|11880133|FG000|Overall Study|Lack of Efficacy|3
7533789|NCT02688764|11880134|FG001|Overall Study|Lack of Efficacy|2
7533790|NCT02688764|11880133|FG000|Overall Study|Lack of efficacy/Physician decision|0
7533791|NCT02688764|11880134|FG001|Overall Study|Lack of efficacy/Physician decision|1
7533792|NCT02688764|11880133|FG000|Overall Study|Non-compliance with study drug|4
7533793|NCT02688764|11880134|FG001|Overall Study|Non-compliance with study drug|0
7533794|NCT02688764|11880133|FG000|Overall Study|Non-compl./Physician decision|2
7533795|NCT02688764|11880134|FG001|Overall Study|Non-compl./Physician decision|0
7533796|NCT02688764|11880133|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7533797|NCT02688764|11880134|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1
7533798|NCT02688764|11880133|FG000|Overall Study|Non-compl./Withd. subject|0
7533799|NCT02688764|11880134|FG001|Overall Study|Non-compl./Withd. subject|2
7533800|NCT02688764|11880133|FG000|Overall Study|Phosphorus level outside safe range|0
7533801|NCT02688764|11880134|FG001|Overall Study|Phosphorus level outside safe range|1
7533802|NCT02688764|11880133|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
7533803|NCT02688764|11880134|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
7533804|NCT02688764|11880133|FG000|Overall Study|Study drug taste/Withd. parent|1
7533805|NCT02688764|11880134|FG001|Overall Study|Study drug taste/Withd. parent|0
7533806|NCT02688764|11880133|FG000|Overall Study|Subject moving out|2
7533807|NCT02688764|11880134|FG001|Overall Study|Subject moving out|0
7533808|NCT02688764|11880133|FG000|Overall Study|Subject taken off dialysis|1
7533809|NCT02688764|11880134|FG001|Overall Study|Subject taken off dialysis|0
7533810|NCT02688764|11880133|FG000|Overall Study|Withdrawal by parent|3
7533811|NCT02688764|11880134|FG001|Overall Study|Withdrawal by parent|0
7533812|NCT02689076|11880175|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
7533813|NCT02689076|11880176|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
7533814|NCT02689076|11880177|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
7533815|NCT02689076|11880175|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
7533816|NCT02689076|11880176|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
7533817|NCT02689076|11880177|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
7533818|NCT02689076|11880175|FG000|Overall Study|Did not have an HIE match|2
7533819|NCT02689076|11880176|FG001|Overall Study|Did not have an HIE match|0
7241392|NCT00191789|11450588|FG000|Overall Study|Patient: Satisfactory Response|5
7241393|NCT00191789|11450588|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
7241394|NCT00191789|11450588|FG000|Overall Study|Withdrawal by Subject|4
7241395|NCT00191789|11450588|FG000|Overall Study|Death - Possibly Study Drug Related|4
7241396|NCT00191789|11450588|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
7241397|NCT00191789|11450588|FG000|Overall Study|Death - Not Study-Drug Related|1
7241398|NCT00191815|11450592|FG000|Overall Study|Adverse Event|2
7241399|NCT00191815|11450592|FG000|Overall Study|Disease progression or relapse|24
7241400|NCT00191815|11450592|FG000|Overall Study|Death|2
7241401|NCT00191815|11450592|FG000|Overall Study|Protocol Violation|3
7241402|NCT00191815|11450592|FG000|Overall Study|Physician Decision|2
7241403|NCT00191815|11450592|FG000|Overall Study|Withdrawal by Subject|7
7241404|NCT00191854|11450599|FG000|Overall Study|Death|26
7241405|NCT00191854|11450600|FG001|Overall Study|Death|23
7241406|NCT00191854|11450601|FG002|Overall Study|Death|29
7241407|NCT00191854|11450599|FG000|Overall Study|Lost to Follow-up|7
7241408|NCT00191854|11450600|FG001|Overall Study|Lost to Follow-up|5
7241409|NCT00191854|11450601|FG002|Overall Study|Lost to Follow-up|5
7241410|NCT00191854|11450599|FG000|Overall Study|Withdrawal by Subject|4
7241411|NCT00191854|11450600|FG001|Overall Study|Withdrawal by Subject|2
7241412|NCT00191854|11450601|FG002|Overall Study|Withdrawal by Subject|3
7241413|NCT00191854|11450599|FG000|Overall Study|Sponsor Decision|0
7241414|NCT00191854|11450600|FG001|Overall Study|Sponsor Decision|0
7241415|NCT00191854|11450601|FG002|Overall Study|Sponsor Decision|1
7241416|NCT00191854|11450599|FG000|Overall Study|Screen Failure|0
7241417|NCT00191854|11450600|FG001|Overall Study|Screen Failure|0
7241418|NCT00191854|11450601|FG002|Overall Study|Screen Failure|1
7241419|NCT00191906|11450613|FG000|Study Period II|Adverse Event|0
7241420|NCT00191906|11450614|FG001|Study Period II|Adverse Event|1
7241421|NCT00191906|11450615|FG002|Study Period II|Adverse Event|0
7241422|NCT00191906|11450616|FG003|Study Period II|Adverse Event|0
7241423|NCT00191906|11450613|FG000|Study Period II|Withdrawal by Subject|0
7241424|NCT00191906|11450614|FG001|Study Period II|Withdrawal by Subject|3
7241425|NCT00191906|11450615|FG002|Study Period II|Withdrawal by Subject|0
7241426|NCT00191906|11450616|FG003|Study Period II|Withdrawal by Subject|0
7241427|NCT00191906|11450613|FG000|Study Period II|Parent/Caregiver Decision|0
7241428|NCT00191906|11450614|FG001|Study Period II|Parent/Caregiver Decision|1
7241429|NCT00191906|11450615|FG002|Study Period II|Parent/Caregiver Decision|0
7241430|NCT00191906|11450616|FG003|Study Period II|Parent/Caregiver Decision|0
7241431|NCT00191906|11450613|FG000|Study Period II|Entry Criteria Exclusion|0
7241432|NCT00191906|11450614|FG001|Study Period II|Entry Criteria Exclusion|0
7241433|NCT00191906|11450615|FG002|Study Period II|Entry Criteria Exclusion|1
7241434|NCT00191906|11450616|FG003|Study Period II|Entry Criteria Exclusion|0
7241435|NCT00191906|11450613|FG000|Study Period III|Adverse Event|1
7241436|NCT00191906|11450614|FG001|Study Period III|Adverse Event|0
7241437|NCT00191906|11450615|FG002|Study Period III|Adverse Event|0
7241438|NCT00191906|11450616|FG003|Study Period III|Adverse Event|0
7241439|NCT00191906|11450613|FG000|Study Period III|Lost to Follow-up|0
7241440|NCT00191906|11450614|FG001|Study Period III|Lost to Follow-up|1
7241441|NCT00191906|11450615|FG002|Study Period III|Lost to Follow-up|0
7241442|NCT00191906|11450616|FG003|Study Period III|Lost to Follow-up|0
7241443|NCT00191906|11450613|FG000|Study Period III|Parent/Caregiver Decision|1
7241444|NCT00191906|11450614|FG001|Study Period III|Parent/Caregiver Decision|0
7241445|NCT00191906|11450615|FG002|Study Period III|Parent/Caregiver Decision|0
7241446|NCT00191906|11450616|FG003|Study Period III|Parent/Caregiver Decision|0
7241447|NCT00191906|11450613|FG000|Study Period III|Lack of Efficacy|3
7241448|NCT00191906|11450614|FG001|Study Period III|Lack of Efficacy|3
7241449|NCT00191906|11450615|FG002|Study Period III|Lack of Efficacy|0
7241450|NCT00191906|11450616|FG003|Study Period III|Lack of Efficacy|0
7241451|NCT00191945|11450634|FG000|Double-Blind Acute Treatment|Parent's Decision|3
7241452|NCT00191945|11450635|FG001|Double-Blind Acute Treatment|Parent's Decision|0
7241453|NCT00191945|11450634|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
7241454|NCT00191945|11450635|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
7241455|NCT00191945|11450634|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
7241456|NCT00191945|11450635|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
7241457|NCT00191945|11450634|FG000|Double-Blind Acute Treatment|Physician Decision|0
7241458|NCT00191945|11450635|FG001|Double-Blind Acute Treatment|Physician Decision|2
7241459|NCT00191984|11450642|FG000|Overall Study|Disease Progression|21
7241460|NCT00191984|11450642|FG000|Overall Study|Adverse Event|4
7241461|NCT00191984|11450642|FG000|Overall Study|Death|2
7241462|NCT00191984|11450642|FG000|Overall Study|Entry Criteria Exclusion|1
7241463|NCT00191984|11450642|FG000|Overall Study|Withdrawal by Subject|7
7241464|NCT00191984|11450642|FG000|Overall Study|Physician Decision|4
7241465|NCT00192023|11450648|FG000|Period III - Double-Blind|Adverse Event|3
7241466|NCT00192023|11450649|FG001|Period III - Double-Blind|Adverse Event|0
7241467|NCT00192023|11450648|FG000|Period III - Double-Blind|Physician Decision|2
7241468|NCT00192023|11450649|FG001|Period III - Double-Blind|Physician Decision|0
7241469|NCT00192023|11450648|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
7241470|NCT00192023|11450649|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
7241471|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Adverse Event|6
7241472|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Adverse Event|0
7241473|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
7241474|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
7241475|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
7241476|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
7241477|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
7241478|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
7241479|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Protocol Violation|1
7241480|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Protocol Violation|0
7241481|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
7241482|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
7241483|NCT00192023|11450648|FG000|Period IV - Optional Open-Label|Physician Decision|9
7241484|NCT00192023|11450649|FG001|Period IV - Optional Open-Label|Physician Decision|0
7241485|NCT00192036|11450655|FG000|Overall Study|Protocol Violation|3
7241486|NCT00192036|11450655|FG000|Overall Study|Adverse Event|6
7241487|NCT00192036|11450655|FG000|Overall Study|Patient/Physician Perception|1
7241488|NCT00192036|11450655|FG000|Overall Study|Objective Tumor Progression|4
7241489|NCT00192036|11450655|FG000|Overall Study|Clinical Disease Progression|1
7241490|NCT00192036|11450655|FG000|Overall Study|Death|1
7241491|NCT00192036|11450655|FG000|Overall Study|Unknown or Not Specified|5
7241492|NCT00192075|11450661|FG000|Overall Study|Disease Progression|23
7241493|NCT00192075|11450662|FG001|Overall Study|Disease Progression|6
7241494|NCT00192075|11450661|FG000|Overall Study|Adverse Event|1
7241495|NCT00192075|11450662|FG001|Overall Study|Adverse Event|3
7241496|NCT00192075|11450661|FG000|Overall Study|Death|0
7241497|NCT00192075|11450662|FG001|Overall Study|Death|1
7241498|NCT00192075|11450661|FG000|Overall Study|Lack of Efficacy|0
7241499|NCT00192075|11450662|FG001|Overall Study|Lack of Efficacy|0
7241500|NCT00192075|11450661|FG000|Overall Study|Physician Decision|3
7241501|NCT00192075|11450662|FG001|Overall Study|Physician Decision|0
7241502|NCT00192075|11450661|FG000|Overall Study|Withdrawal by Subject|5
7241503|NCT00192075|11450662|FG001|Overall Study|Withdrawal by Subject|5
7241504|NCT00192075|11450661|FG000|Overall Study|Patient Non-Compliance|0
7241505|NCT00192075|11450662|FG001|Overall Study|Patient Non-Compliance|1
7241506|NCT00192075|11450661|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
7241507|NCT00192075|11450662|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
7241508|NCT00192075|11450661|FG000|Overall Study|Other|5
7241509|NCT00192075|11450662|FG001|Overall Study|Other|2
7241510|NCT00192114|11450673|FG000|Overall Study|Objective Tumor Progression|19
7241511|NCT00192114|11450673|FG000|Overall Study|Adverse Event|2
7241512|NCT00192114|11450673|FG000|Overall Study|Clinical Progression|2
7241513|NCT00192114|11450673|FG000|Overall Study|Death|1
7241514|NCT00192296|11450681|FG000|Overall Study|Withdrawal by Subject|0
7241515|NCT00192296|11450682|FG001|Overall Study|Withdrawal by Subject|1
7241516|NCT00192296|11450683|FG002|Overall Study|Withdrawal by Subject|0
7241517|NCT00192296|11450684|FG003|Overall Study|Withdrawal by Subject|0
7241518|NCT00192504|11450698|FG000|Overall Study|Lost to Follow-up|1
7241519|NCT00192504|11450699|FG001|Overall Study|Lost to Follow-up|0
7241520|NCT00192504|11450700|FG002|Overall Study|Lost to Follow-up|0
7241521|NCT00192504|11450701|FG003|Overall Study|Lost to Follow-up|0
7241522|NCT00192504|11450698|FG000|Overall Study|Dosing window missed|0
7241523|NCT00192504|11450699|FG001|Overall Study|Dosing window missed|0
7241524|NCT00192504|11450700|FG002|Overall Study|Dosing window missed|1
7241525|NCT00192504|11450701|FG003|Overall Study|Dosing window missed|0
7573990|NCT03636893|11955729|FG000|Overall Study|Adverse Event|1
7573991|NCT03636893|11955730|FG001|Overall Study|Adverse Event|1
7573992|NCT03638635|11955797|FG000|Initial Hospitalization|Study terminated prematurely|0
7573993|NCT03638635|11955798|FG001|Initial Hospitalization|Study terminated prematurely|1
7573994|NCT03638635|11955797|FG000|Initial Hospitalization|Withdrawal by study personnel|0
7573995|NCT03638635|11955798|FG001|Initial Hospitalization|Withdrawal by study personnel|1
7241526|NCT00192647|11450713|FG000|Overall Study|Death|1
7241527|NCT00192647|11450714|FG001|Overall Study|Death|1
7241528|NCT00192647|11450713|FG000|Overall Study|Adverse Event|35
7241529|NCT00192647|11450714|FG001|Overall Study|Adverse Event|29
7241530|NCT00192647|11450713|FG000|Overall Study|Laboratory Test Abnormality|4
7241531|NCT00192647|11450714|FG001|Overall Study|Laboratory Test Abnormality|2
7241532|NCT00192647|11450713|FG000|Overall Study|Insufficient Therapeutic Response|53
7241533|NCT00192647|11450714|FG001|Overall Study|Insufficient Therapeutic Response|83
7241534|NCT00192647|11450713|FG000|Overall Study|Entry Criteria Violation|6
7241535|NCT00192647|11450714|FG001|Overall Study|Entry Criteria Violation|6
7241536|NCT00192647|11450713|FG000|Overall Study|Protocol Violation|3
7241537|NCT00192647|11450714|FG001|Overall Study|Protocol Violation|1
7241538|NCT00192647|11450713|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
7241539|NCT00192647|11450714|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
7241540|NCT00192647|11450713|FG000|Overall Study|Failure to Return|11
7241541|NCT00192647|11450714|FG001|Overall Study|Failure to Return|13
7241542|NCT00192647|11450713|FG000|Overall Study|Other/Administrative|5
7241543|NCT00192647|11450714|FG001|Overall Study|Other/Administrative|3
7241544|NCT00193050|11450729|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
7241545|NCT00193050|11450729|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
7241546|NCT00193050|11450729|FG000|Neoadjuvant Treatment|Physician Decision|2
7241547|NCT00193050|11450729|FG000|Neoadjuvant Treatment|Adverse Event|2
7241548|NCT00193050|11450729|FG000|Adjuvant|Physician Decision|5
7241549|NCT00193050|11450729|FG000|Adjuvant|Intercurrent Hospitalization|3
7241550|NCT00193050|11450729|FG000|Adjuvant|Lack of Efficacy|2
7241551|NCT00193063|11450734|FG000|Overall Study|Lack of Efficacy|3
7241552|NCT00193063|11450734|FG000|Overall Study|Adverse Event|1
7241553|NCT00193180|11450749|FG000|Overall Study|Lack of Efficacy|1
7241554|NCT00193180|11450749|FG000|Overall Study|Adverse Event|8
7241555|NCT00193180|11450749|FG000|Overall Study|Protocol Violation|1
7241556|NCT00193206|11450754|FG000|Preoperative Therapy|Lack of Efficacy|2
7241557|NCT00193206|11450754|FG000|Preoperative Therapy|Adverse Event|2
7241558|NCT00193206|11450754|FG000|Preoperative Therapy|Withdrawal by Subject|2
7241559|NCT00193206|11450754|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
7241560|NCT00193206|11450754|FG000|Postoperative Therapy|Withdrawal by Subject|7
7241561|NCT00193206|11450754|FG000|Postoperative Therapy|Physician Decision|3
7241562|NCT00193206|11450754|FG000|Postoperative Therapy|Intercurrent Illness|2
7241563|NCT00193206|11450754|FG000|Postoperative Therapy|Lack of Efficacy|1
7241564|NCT00193206|11450754|FG000|Postoperative Therapy|Protocol Violation|1
7241565|NCT00193609|11450788|FG000|Overall Study|Lack of Efficacy|2
7241566|NCT00193609|11450788|FG000|Overall Study|Adverse Event|2
7241567|NCT00194012|11450794|FG000|Randomized Phase|Lack of Efficacy|8
7241568|NCT00194012|11450795|FG001|Randomized Phase|Lack of Efficacy|18
7241569|NCT00194012|11450794|FG000|Randomized Phase|Study nonadherence|2
7241570|NCT00194012|11450795|FG001|Randomized Phase|Study nonadherence|1
7241571|NCT00194012|11450794|FG000|Randomized Phase|Withdrawal by Subject|3
7241572|NCT00194012|11450795|FG001|Randomized Phase|Withdrawal by Subject|3
7241573|NCT00194012|11450794|FG000|Randomized Phase|Adverse Event|2
7241574|NCT00194012|11450795|FG001|Randomized Phase|Adverse Event|1
7241575|NCT00194012|11450794|FG000|Randomized Phase|Participant reported having a rash|1
7241576|NCT00194012|11450795|FG001|Randomized Phase|Participant reported having a rash|0
7241577|NCT00194012|11450794|FG000|Randomized Phase|Emesis and enuresis|0
7241578|NCT00194012|11450795|FG001|Randomized Phase|Emesis and enuresis|1
7241579|NCT00194012|11450794|FG000|Randomized Phase|Oral/nasal twitching|0
7241580|NCT00194012|11450795|FG001|Randomized Phase|Oral/nasal twitching|1
7241581|NCT00194012|11450794|FG000|Open Label Extension (OLE)|Weight Gain|1
7241582|NCT00194012|11450795|FG001|Open Label Extension (OLE)|Weight Gain|0
7241583|NCT00194012|11450794|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
7241584|NCT00194012|11450795|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
7241585|NCT00194012|11450794|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
7241586|NCT00194012|11450795|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
7241587|NCT00194012|11450794|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
7241588|NCT00194012|11450795|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
7241589|NCT00194025|11450807|FG000|Overall Study|Adverse Event|1
7241590|NCT00194025|11450807|FG000|Overall Study|non-adherence with study medication|4
7241591|NCT00194077|11450813|FG000|Overall Study|Lack of Efficacy|22
7241592|NCT00194077|11450814|FG001|Overall Study|Lack of Efficacy|29
7241593|NCT00194077|11450813|FG000|Overall Study|Study nonadherence|1
7241594|NCT00194077|11450814|FG001|Overall Study|Study nonadherence|0
7241595|NCT00194077|11450813|FG000|Overall Study|Withdrawal by Subject|1
7241596|NCT00194077|11450814|FG001|Overall Study|Withdrawal by Subject|1
7241597|NCT00194675|11450865|FG000|Overall Study|Lost to Follow-up|1
7241598|NCT00194675|11450866|FG001|Overall Study|Lost to Follow-up|1
7241599|NCT00194675|11450865|FG000|Overall Study|lack of interest|1
7241600|NCT00194675|11450866|FG001|Overall Study|lack of interest|1
7241601|NCT00194675|11450865|FG000|Overall Study|"withdrew due to edgy feeling"|1
7241602|NCT00194675|11450866|FG001|Overall Study|"withdrew due to edgy feeling"|0
7241603|NCT00194675|11450865|FG000|Overall Study|Protocol Violation|1
7241604|NCT00194675|11450866|FG001|Overall Study|Protocol Violation|0
7241605|NCT00194675|11450865|FG000|Overall Study|Death|1
7241606|NCT00194675|11450866|FG001|Overall Study|Death|0
7241607|NCT00194792|11450878|FG000|Overall Study|Withdrawal by Subject|1
7241608|NCT00194987|11450901|FG000|Overall Study|Withdrawal by Subject|0
7241609|NCT00194987|11450902|FG001|Overall Study|Withdrawal by Subject|3
7241610|NCT00195260|11450925|FG000|Part 1: Dose Escalation|Adverse Event|0
7241611|NCT00195260|11450926|FG001|Part 1: Dose Escalation|Adverse Event|1
7241612|NCT00195260|11450927|FG002|Part 1: Dose Escalation|Adverse Event|0
7241613|NCT00195260|11450928|FG003|Part 1: Dose Escalation|Adverse Event|1
7241614|NCT00195260|11450929|FG004|Part 1: Dose Escalation|Adverse Event|1
7241615|NCT00195260|11450930|FG005|Part 1: Dose Escalation|Adverse Event|0
7241616|NCT00195260|11450931|FG006|Part 1: Dose Escalation|Adverse Event|3
7241617|NCT00195260|11450932|FG007|Part 1: Dose Escalation|Adverse Event|0
7241618|NCT00195260|11450933|FG008|Part 1: Dose Escalation|Adverse Event|0
7241619|NCT00195260|11450934|FG009|Part 1: Dose Escalation|Adverse Event|0
7241620|NCT00195260|11450935|FG010|Part 1: Dose Escalation|Adverse Event|0
7241621|NCT00195260|11450925|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
7241622|NCT00195260|11450926|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
7241623|NCT00195260|11450927|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
7241624|NCT00195260|11450928|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
7241625|NCT00195260|11450929|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
7241626|NCT00195260|11450930|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
7241627|NCT00195260|11450931|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
7241628|NCT00195260|11450932|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
7241629|NCT00195260|11450933|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
7241630|NCT00195260|11450934|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
7241631|NCT00195260|11450935|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
7241632|NCT00195260|11450925|FG000|Part 1: Dose Escalation|Death|0
7241633|NCT00195260|11450926|FG001|Part 1: Dose Escalation|Death|0
7241634|NCT00195260|11450927|FG002|Part 1: Dose Escalation|Death|0
7241635|NCT00195260|11450928|FG003|Part 1: Dose Escalation|Death|0
7241636|NCT00195260|11450929|FG004|Part 1: Dose Escalation|Death|0
7241637|NCT00195260|11450930|FG005|Part 1: Dose Escalation|Death|0
7241638|NCT00195260|11450931|FG006|Part 1: Dose Escalation|Death|0
7241639|NCT00195260|11450932|FG007|Part 1: Dose Escalation|Death|1
7241640|NCT00195260|11450933|FG008|Part 1: Dose Escalation|Death|0
7241641|NCT00195260|11450934|FG009|Part 1: Dose Escalation|Death|0
7241642|NCT00195260|11450935|FG010|Part 1: Dose Escalation|Death|0
7241643|NCT00195260|11450925|FG000|Part 1: Dose Escalation|Disease Progression|3
7241644|NCT00195260|11450926|FG001|Part 1: Dose Escalation|Disease Progression|2
7241645|NCT00195260|11450927|FG002|Part 1: Dose Escalation|Disease Progression|5
7241646|NCT00195260|11450928|FG003|Part 1: Dose Escalation|Disease Progression|6
7241647|NCT00195260|11450929|FG004|Part 1: Dose Escalation|Disease Progression|4
7241648|NCT00195260|11450930|FG005|Part 1: Dose Escalation|Disease Progression|6
7241649|NCT00195260|11450931|FG006|Part 1: Dose Escalation|Disease Progression|7
7241650|NCT00195260|11450932|FG007|Part 1: Dose Escalation|Disease Progression|4
7241651|NCT00195260|11450933|FG008|Part 1: Dose Escalation|Disease Progression|0
7241652|NCT00195260|11450934|FG009|Part 1: Dose Escalation|Disease Progression|0
7241653|NCT00195260|11450935|FG010|Part 1: Dose Escalation|Disease Progression|0
7241654|NCT00195260|11450925|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
7241655|NCT00195260|11450926|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
7241656|NCT00195260|11450927|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
7241657|NCT00195260|11450928|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241658|NCT00195260|11450929|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241659|NCT00195260|11450930|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
7241660|NCT00195260|11450931|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241661|NCT00195260|11450932|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241662|NCT00195260|11450933|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241663|NCT00195260|11450934|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241664|NCT00195260|11450935|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
7241665|NCT00195260|11450925|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241666|NCT00195260|11450926|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241667|NCT00195260|11450927|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241668|NCT00195260|11450928|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241669|NCT00195260|11450929|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241670|NCT00195260|11450930|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241671|NCT00195260|11450931|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241672|NCT00195260|11450932|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
7241673|NCT00195260|11450933|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
7241674|NCT00195260|11450934|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
7241675|NCT00195260|11450935|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
7241676|NCT00195260|11450925|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7573996|NCT03638635|11955797|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
7241677|NCT00195260|11450926|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241678|NCT00195260|11450927|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241679|NCT00195260|11450928|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241680|NCT00195260|11450929|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241681|NCT00195260|11450930|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241682|NCT00195260|11450931|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241683|NCT00195260|11450932|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
7241684|NCT00195260|11450933|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
7241685|NCT00195260|11450934|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
7241686|NCT00195260|11450935|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
7241687|NCT00195260|11450925|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241688|NCT00195260|11450926|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241689|NCT00195260|11450927|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241690|NCT00195260|11450928|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241691|NCT00195260|11450929|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241692|NCT00195260|11450930|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241693|NCT00195260|11450931|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241694|NCT00195260|11450932|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
7241695|NCT00195260|11450933|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
7241696|NCT00195260|11450934|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
7241697|NCT00195260|11450935|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
7241698|NCT00195260|11450925|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241699|NCT00195260|11450926|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241700|NCT00195260|11450927|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7573997|NCT03638635|11955798|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
7573998|NCT03639675|11955812|FG000|Overall Study|Withdrawal by Subject|1
7241701|NCT00195260|11450928|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241702|NCT00195260|11450929|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241703|NCT00195260|11450930|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241704|NCT00195260|11450931|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241705|NCT00195260|11450932|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
7241706|NCT00195260|11450933|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
7241707|NCT00195260|11450934|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
7241708|NCT00195260|11450935|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
7241709|NCT00195273|11450965|FG000|Overall Study|Adverse Event|9
7241710|NCT00195273|11450966|FG001|Overall Study|Adverse Event|9
7241711|NCT00195273|11450965|FG000|Overall Study|Protocol deviation|0
7241712|NCT00195273|11450966|FG001|Overall Study|Protocol deviation|1
7241713|NCT00195273|11450965|FG000|Overall Study|Lack of Efficacy|3
7241714|NCT00195273|11450966|FG001|Overall Study|Lack of Efficacy|1
7241715|NCT00195273|11450965|FG000|Overall Study|Procedural complications|9
7241716|NCT00195273|11450966|FG001|Overall Study|Procedural complications|3
7241717|NCT00195338|11450972|FG000|Overall Study|Lost to Follow-up|2
7241718|NCT00195338|11450972|FG000|Overall Study|Adverse Event|5
7241719|NCT00195338|11450972|FG000|Overall Study|Lack of Efficacy|1
7241720|NCT00195338|11450972|FG000|Overall Study|Early closure of the site|4
7241721|NCT00195351|11450978|FG000|Overall Study|Lost to Follow-up|9
7573999|NCT03639779|11955822|FG000|Overall Study|Lost to Follow-up|1
7574000|NCT03639987|11955840|FG000|Overall Study|Study terminated by sponsor|26
7241722|NCT00195351|11450979|FG001|Overall Study|Lost to Follow-up|9
7241723|NCT00195351|11450978|FG000|Overall Study|Withdrawal by Subject|6
7241724|NCT00195351|11450979|FG001|Overall Study|Withdrawal by Subject|3
7241725|NCT00195351|11450978|FG000|Overall Study|Protocol Deviation|3
7241726|NCT00195351|11450979|FG001|Overall Study|Protocol Deviation|2
7241727|NCT00195351|11450978|FG000|Overall Study|Death|3
7241728|NCT00195351|11450979|FG001|Overall Study|Death|1
7241729|NCT00195351|11450978|FG000|Overall Study|Lack of Efficacy|0
7241730|NCT00195351|11450979|FG001|Overall Study|Lack of Efficacy|1
7241731|NCT00195429|11450991|FG000|Overall Study|Adverse Event|2
7241732|NCT00195429|11450992|FG001|Overall Study|Adverse Event|4
7241733|NCT00195429|11450991|FG000|Overall Study|Lack of Efficacy|2
7241734|NCT00195429|11450992|FG001|Overall Study|Lack of Efficacy|1
7241735|NCT00195429|11450991|FG000|Overall Study|Lost to Follow-up|1
7241736|NCT00195429|11450992|FG001|Overall Study|Lost to Follow-up|0
7241737|NCT00195442|11450998|FG000|Overall Study|Less than expected therapeutic effect|38
7241738|NCT00195442|11450998|FG000|Overall Study|Lost to Follow-up|27
7241739|NCT00195442|11450998|FG000|Overall Study|Switch to other Factor VIII preparation|23
7241740|NCT00195442|11450998|FG000|Overall Study|Intermittent product shortage|21
7241741|NCT00195442|11450998|FG000|Overall Study|Death|7
7241742|NCT00195442|11450998|FG000|Overall Study|No reason specified|4
7241743|NCT00195442|11450998|FG000|Overall Study|Poor cooperation|2
7241744|NCT00195442|11450998|FG000|Overall Study|Other|14
7241745|NCT00195494|11451004|FG000|Year 1|Adverse Event|0
7241746|NCT00195494|11451005|FG001|Year 1|Adverse Event|0
7241747|NCT00195494|11451006|FG002|Year 1|Adverse Event|0
7241748|NCT00195494|11451007|FG003|Year 1|Adverse Event|0
7241749|NCT00195494|11451008|FG004|Year 1|Adverse Event|34
7241750|NCT00195494|11451009|FG005|Year 1|Adverse Event|27
7241751|NCT00195494|11451004|FG000|Year 1|System Toxicity|0
7241752|NCT00195494|11451005|FG001|Year 1|System Toxicity|0
7241753|NCT00195494|11451006|FG002|Year 1|System Toxicity|0
7241754|NCT00195494|11451007|FG003|Year 1|System Toxicity|0
7241755|NCT00195494|11451008|FG004|Year 1|System Toxicity|0
7241756|NCT00195494|11451009|FG005|Year 1|System Toxicity|1
7241757|NCT00195494|11451004|FG000|Year 1|Lack of Efficacy|0
7241758|NCT00195494|11451005|FG001|Year 1|Lack of Efficacy|0
7241759|NCT00195494|11451006|FG002|Year 1|Lack of Efficacy|0
7241760|NCT00195494|11451007|FG003|Year 1|Lack of Efficacy|0
7241761|NCT00195494|11451008|FG004|Year 1|Lack of Efficacy|24
7241762|NCT00195494|11451009|FG005|Year 1|Lack of Efficacy|9
7241763|NCT00195494|11451004|FG000|Year 1|Compliance|0
7241764|NCT00195494|11451005|FG001|Year 1|Compliance|0
7241765|NCT00195494|11451006|FG002|Year 1|Compliance|0
7241766|NCT00195494|11451007|FG003|Year 1|Compliance|0
7241767|NCT00195494|11451008|FG004|Year 1|Compliance|5
7241768|NCT00195494|11451009|FG005|Year 1|Compliance|1
7241769|NCT00195494|11451004|FG000|Year 1|Lost to Follow-up|0
7241770|NCT00195494|11451005|FG001|Year 1|Lost to Follow-up|0
7241771|NCT00195494|11451006|FG002|Year 1|Lost to Follow-up|0
7241772|NCT00195494|11451007|FG003|Year 1|Lost to Follow-up|0
7574001|NCT03639987|11955841|FG001|Overall Study|Study terminated by sponsor|25
7574002|NCT03639987|11955840|FG000|Overall Study|Lost to Follow-up|0
7574003|NCT03639987|11955841|FG001|Overall Study|Lost to Follow-up|1
7574004|NCT03640052|11955847|FG000|Overall Study|Lost to Follow-up|0
7241773|NCT00195494|11451008|FG004|Year 1|Lost to Follow-up|1
7241774|NCT00195494|11451009|FG005|Year 1|Lost to Follow-up|0
7241775|NCT00195494|11451004|FG000|Year 1|Missed >4 consecutive doses|0
7241776|NCT00195494|11451005|FG001|Year 1|Missed >4 consecutive doses|0
7241777|NCT00195494|11451006|FG002|Year 1|Missed >4 consecutive doses|0
7241778|NCT00195494|11451007|FG003|Year 1|Missed >4 consecutive doses|0
7241779|NCT00195494|11451008|FG004|Year 1|Missed >4 consecutive doses|3
7241780|NCT00195494|11451009|FG005|Year 1|Missed >4 consecutive doses|2
7241781|NCT00195494|11451004|FG000|Year 1|Protocol deviation|0
7241782|NCT00195494|11451005|FG001|Year 1|Protocol deviation|0
7241783|NCT00195494|11451006|FG002|Year 1|Protocol deviation|0
7241784|NCT00195494|11451007|FG003|Year 1|Protocol deviation|0
7241785|NCT00195494|11451008|FG004|Year 1|Protocol deviation|2
7241786|NCT00195494|11451009|FG005|Year 1|Protocol deviation|3
7241787|NCT00195494|11451004|FG000|Year 1|Physician Decision|0
7241788|NCT00195494|11451005|FG001|Year 1|Physician Decision|0
7241789|NCT00195494|11451006|FG002|Year 1|Physician Decision|0
7241790|NCT00195494|11451007|FG003|Year 1|Physician Decision|0
7241791|NCT00195494|11451008|FG004|Year 1|Physician Decision|1
7574005|NCT03640052|11955848|FG001|Overall Study|Lost to Follow-up|1
7574006|NCT03640052|11955849|FG002|Overall Study|Lost to Follow-up|0
7574007|NCT03640052|11955850|FG003|Overall Study|Lost to Follow-up|0
7574008|NCT03640052|11955851|FG004|Overall Study|Lost to Follow-up|0
7574009|NCT03640507|11955866|FG000|Overall Study|Withdrawal by Subject|0
7574010|NCT03640507|11955867|FG001|Overall Study|Withdrawal by Subject|0
7574011|NCT03640507|11955868|FG002|Overall Study|Withdrawal by Subject|1
7574012|NCT03640559|11955878|FG000|Overall Study|Physician Decision|1
7574013|NCT03640559|11955879|FG001|Overall Study|Physician Decision|1
7574014|NCT03640559|11955878|FG000|Overall Study|Withdrawal by Subject|1
7574015|NCT03640559|11955879|FG001|Overall Study|Withdrawal by Subject|0
7574016|NCT03641508|11955896|FG000|First Injection|Lost to Follow-up|2
7574017|NCT03641508|11955897|FG001|First Injection|Lost to Follow-up|0
7574018|NCT03642262|11955907|FG000|Period 1|Withdrawal by Subject|1
7241792|NCT00195494|11451009|FG005|Year 1|Physician Decision|0
7241793|NCT00195494|11451004|FG000|Year 1|Withdrawal by Subject|0
7241794|NCT00195494|11451005|FG001|Year 1|Withdrawal by Subject|0
7241795|NCT00195494|11451006|FG002|Year 1|Withdrawal by Subject|0
7241796|NCT00195494|11451007|FG003|Year 1|Withdrawal by Subject|0
7241797|NCT00195494|11451008|FG004|Year 1|Withdrawal by Subject|8
7241798|NCT00195494|11451009|FG005|Year 1|Withdrawal by Subject|9
7241799|NCT00195494|11451004|FG000|Year 1|Protocol Violation|0
7241800|NCT00195494|11451005|FG001|Year 1|Protocol Violation|0
7241801|NCT00195494|11451006|FG002|Year 1|Protocol Violation|0
7241802|NCT00195494|11451007|FG003|Year 1|Protocol Violation|0
7241803|NCT00195494|11451008|FG004|Year 1|Protocol Violation|1
7241804|NCT00195494|11451009|FG005|Year 1|Protocol Violation|1
7241805|NCT00195494|11451004|FG000|Year 2|Adverse Event|3
7241806|NCT00195494|11451005|FG001|Year 2|Adverse Event|7
7241807|NCT00195494|11451006|FG002|Year 2|Adverse Event|5
7241808|NCT00195494|11451007|FG003|Year 2|Adverse Event|9
7241809|NCT00195494|11451008|FG004|Year 2|Adverse Event|0
7574019|NCT03642262|11955908|FG001|Period 1|Withdrawal by Subject|1
7574020|NCT03642262|11955907|FG000|Period 1|Adverse Event|0
7574021|NCT03642262|11955908|FG001|Period 1|Adverse Event|1
7241810|NCT00195494|11451009|FG005|Year 2|Adverse Event|0
7241811|NCT00195494|11451004|FG000|Year 2|Lack of Efficacy|0
7241812|NCT00195494|11451005|FG001|Year 2|Lack of Efficacy|1
7241813|NCT00195494|11451006|FG002|Year 2|Lack of Efficacy|7
7241814|NCT00195494|11451007|FG003|Year 2|Lack of Efficacy|7
7241815|NCT00195494|11451008|FG004|Year 2|Lack of Efficacy|0
7241816|NCT00195494|11451009|FG005|Year 2|Lack of Efficacy|0
7241817|NCT00195494|11451004|FG000|Year 2|Compliance|1
7241818|NCT00195494|11451005|FG001|Year 2|Compliance|0
7241819|NCT00195494|11451006|FG002|Year 2|Compliance|0
7241820|NCT00195494|11451007|FG003|Year 2|Compliance|2
7241821|NCT00195494|11451008|FG004|Year 2|Compliance|0
7241822|NCT00195494|11451009|FG005|Year 2|Compliance|0
7241823|NCT00195494|11451004|FG000|Year 2|Lost to Follow-up|0
7241824|NCT00195494|11451005|FG001|Year 2|Lost to Follow-up|0
7241825|NCT00195494|11451006|FG002|Year 2|Lost to Follow-up|1
7241826|NCT00195494|11451007|FG003|Year 2|Lost to Follow-up|1
7241827|NCT00195494|11451008|FG004|Year 2|Lost to Follow-up|0
7241828|NCT00195494|11451009|FG005|Year 2|Lost to Follow-up|0
7241829|NCT00195494|11451004|FG000|Year 2|Missed >4 consecutive doses|1
7241830|NCT00195494|11451005|FG001|Year 2|Missed >4 consecutive doses|1
7241831|NCT00195494|11451006|FG002|Year 2|Missed >4 consecutive doses|1
7241832|NCT00195494|11451007|FG003|Year 2|Missed >4 consecutive doses|0
7574022|NCT03642717|11955924|FG000|Overall Study|Lost to Follow-up|2
7574023|NCT03642717|11955924|FG000|Overall Study|Inclusion/exclusion criteria violation|33
7574024|NCT03642717|11955924|FG000|Overall Study|Taken study drug prior to contract date|3
7574025|NCT03642873|11955929|FG000|Third Intervention (1 Day)|Screen failure|0
7574026|NCT03642873|11955930|FG001|Third Intervention (1 Day)|Screen failure|0
7574027|NCT03642873|11955931|FG002|Third Intervention (1 Day)|Screen failure|0
7574028|NCT03642873|11955932|FG003|Third Intervention (1 Day)|Screen failure|0
7241833|NCT00195494|11451008|FG004|Year 2|Missed >4 consecutive doses|0
7241834|NCT00195494|11451009|FG005|Year 2|Missed >4 consecutive doses|0
7241835|NCT00195494|11451004|FG000|Year 2|Protocol deviation|0
7241836|NCT00195494|11451005|FG001|Year 2|Protocol deviation|1
7241837|NCT00195494|11451006|FG002|Year 2|Protocol deviation|0
7241838|NCT00195494|11451007|FG003|Year 2|Protocol deviation|0
7241839|NCT00195494|11451008|FG004|Year 2|Protocol deviation|0
7241840|NCT00195494|11451009|FG005|Year 2|Protocol deviation|0
7241841|NCT00195494|11451004|FG000|Year 2|Physician Decision|1
7241842|NCT00195494|11451005|FG001|Year 2|Physician Decision|1
7241843|NCT00195494|11451006|FG002|Year 2|Physician Decision|0
7241844|NCT00195494|11451007|FG003|Year 2|Physician Decision|0
7241845|NCT00195494|11451008|FG004|Year 2|Physician Decision|0
7241846|NCT00195494|11451009|FG005|Year 2|Physician Decision|0
7241847|NCT00195494|11451004|FG000|Year 2|Withdrawal by Subject|1
7241848|NCT00195494|11451005|FG001|Year 2|Withdrawal by Subject|5
7241849|NCT00195494|11451006|FG002|Year 2|Withdrawal by Subject|4
7241850|NCT00195494|11451007|FG003|Year 2|Withdrawal by Subject|3
7241851|NCT00195494|11451008|FG004|Year 2|Withdrawal by Subject|0
7241852|NCT00195494|11451009|FG005|Year 2|Withdrawal by Subject|0
7241853|NCT00195494|11451004|FG000|Year 2|System toxicity|0
7241854|NCT00195494|11451005|FG001|Year 2|System toxicity|0
7241855|NCT00195494|11451006|FG002|Year 2|System toxicity|0
7241856|NCT00195494|11451007|FG003|Year 2|System toxicity|1
7241857|NCT00195494|11451008|FG004|Year 2|System toxicity|0
7241858|NCT00195494|11451009|FG005|Year 2|System toxicity|0
7241859|NCT00195507|11451027|FG000|Overall Study|Adverse Event|24
7241860|NCT00195507|11451028|FG001|Overall Study|Adverse Event|13
7241861|NCT00195507|11451027|FG000|Overall Study|Death|0
7241862|NCT00195507|11451028|FG001|Overall Study|Death|1
7241863|NCT00195507|11451027|FG000|Overall Study|Failed to Return|4
7241864|NCT00195507|11451028|FG001|Overall Study|Failed to Return|3
7241865|NCT00195507|11451027|FG000|Overall Study|Physician Decision|1
7241866|NCT00195507|11451028|FG001|Overall Study|Physician Decision|2
7241867|NCT00195507|11451027|FG000|Overall Study|Lost to Follow-up|3
7241868|NCT00195507|11451028|FG001|Overall Study|Lost to Follow-up|2
7241869|NCT00195507|11451027|FG000|Overall Study|Protocol Violation|5
7241870|NCT00195507|11451028|FG001|Overall Study|Protocol Violation|4
7241871|NCT00195507|11451027|FG000|Overall Study|Lack of Efficacy|40
7241872|NCT00195507|11451028|FG001|Overall Study|Lack of Efficacy|67
7241873|NCT00195507|11451027|FG000|Overall Study|Withdrawal by Subject|16
7241874|NCT00195507|11451028|FG001|Overall Study|Withdrawal by Subject|23
7241875|NCT00195507|11451027|FG000|Overall Study|Protocol Deviation|6
7241876|NCT00195507|11451028|FG001|Overall Study|Protocol Deviation|3
7256008|NCT00321373|11467528|FG001|Overall Study|Adverse Event|0
7256009|NCT00321373|11467529|FG002|Overall Study|Adverse Event|1
7256010|NCT00321373|11467527|FG000|Overall Study|Lost to Follow-up|1
7256011|NCT00321373|11467528|FG001|Overall Study|Lost to Follow-up|0
7256012|NCT00321373|11467529|FG002|Overall Study|Lost to Follow-up|1
7256013|NCT00321373|11467527|FG000|Overall Study|Withdrawal by Subject|1
7256014|NCT00321373|11467528|FG001|Overall Study|Withdrawal by Subject|0
7256015|NCT00321373|11467529|FG002|Overall Study|Withdrawal by Subject|0
7256016|NCT00321373|11467527|FG000|Overall Study|Other|0
7256017|NCT00321373|11467528|FG001|Overall Study|Other|0
7256018|NCT00321373|11467529|FG002|Overall Study|Other|1
7256019|NCT00321464|11467539|FG000|Overall Study|Death|169
7256020|NCT00321464|11467540|FG001|Overall Study|Death|174
7256021|NCT00321464|11467539|FG000|Overall Study|Disease progression|124
7256022|NCT00321464|11467540|FG001|Overall Study|Disease progression|124
7256023|NCT00321464|11467539|FG000|Overall Study|Withdrawal by Subject|117
7256024|NCT00321464|11467540|FG001|Overall Study|Withdrawal by Subject|118
7256025|NCT00321464|11467539|FG000|Overall Study|Participant request|57
7256026|NCT00321464|11467540|FG001|Overall Study|Participant request|61
7256027|NCT00321464|11467539|FG000|Overall Study|Adverse Event|43
7256028|NCT00321464|11467540|FG001|Overall Study|Adverse Event|28
7256029|NCT00321464|11467539|FG000|Overall Study|Physician Decision|15
7256030|NCT00321464|11467540|FG001|Overall Study|Physician Decision|14
7256031|NCT00321464|11467539|FG000|Overall Study|Noncompliance|4
7256032|NCT00321464|11467540|FG001|Overall Study|Noncompliance|10
7256033|NCT00321464|11467539|FG000|Overall Study|Lost to Follow-up|7
7256034|NCT00321464|11467540|FG001|Overall Study|Lost to Follow-up|8
7256035|NCT00321464|11467539|FG000|Overall Study|Protocol deviation|0
7256036|NCT00321464|11467540|FG001|Overall Study|Protocol deviation|2
7256037|NCT00321464|11467539|FG000|Overall Study|Ineligibility determined|2
7256038|NCT00321464|11467540|FG001|Overall Study|Ineligibility determined|1
7256039|NCT00321464|11467539|FG000|Overall Study|Other|21
7256040|NCT00321464|11467540|FG001|Overall Study|Other|18
7256041|NCT00321620|11467566|FG000|Overall Study|Death|269
7256042|NCT00321620|11467567|FG001|Overall Study|Death|294
7256043|NCT00321620|11467566|FG000|Overall Study|Withdrawal by Subject|164
7256044|NCT00321620|11467567|FG001|Overall Study|Withdrawal by Subject|147
7256045|NCT00321620|11467566|FG000|Overall Study|Disease progression|113
7256046|NCT00321620|11467567|FG001|Overall Study|Disease progression|117
7256047|NCT00321620|11467566|FG000|Overall Study|Adverse Event|43
7256048|NCT00321620|11467567|FG001|Overall Study|Adverse Event|56
7256049|NCT00321620|11467566|FG000|Overall Study|Lost to Follow-up|13
7256050|NCT00321620|11467567|FG001|Overall Study|Lost to Follow-up|9
7256051|NCT00321620|11467566|FG000|Overall Study|Physician Decision|4
7256052|NCT00321620|11467567|FG001|Overall Study|Physician Decision|1
7256053|NCT00321620|11467566|FG000|Overall Study|Noncompliance|14
7256054|NCT00321620|11467567|FG001|Overall Study|Noncompliance|7
7256055|NCT00321620|11467566|FG000|Overall Study|Protocol deviation|4
7256056|NCT00321620|11467567|FG001|Overall Study|Protocol deviation|3
7465049|NCT01877421|11764012|FG001|Phase 2|Withdrawal by Subject|0
7256057|NCT00321620|11467566|FG000|Overall Study|Ineligibility determined|2
7256058|NCT00321620|11467567|FG001|Overall Study|Ineligibility determined|3
7256059|NCT00321620|11467566|FG000|Overall Study|Participant request|75
7256060|NCT00321620|11467567|FG001|Overall Study|Participant request|52
7256061|NCT00321620|11467566|FG000|Overall Study|Other|42
7256062|NCT00321620|11467567|FG001|Overall Study|Other|33
7256063|NCT00321646|11467573|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7256064|NCT00321646|11467573|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
7256065|NCT00321646|11467573|FG000|Neoadjuvant Chemotherapy|Disease progression|1
7256066|NCT00321672|11467581|FG000|Overall Study|Withdrawal by Subject|5
7256067|NCT00321672|11467582|FG001|Overall Study|Withdrawal by Subject|1
7256068|NCT00321672|11467583|FG002|Overall Study|Withdrawal by Subject|2
7256069|NCT00321672|11467584|FG003|Overall Study|Withdrawal by Subject|0
7256070|NCT00321672|11467581|FG000|Overall Study|Noncompliance|1
7256071|NCT00321672|11467582|FG001|Overall Study|Noncompliance|2
7256072|NCT00321672|11467583|FG002|Overall Study|Noncompliance|1
7256073|NCT00321672|11467584|FG003|Overall Study|Noncompliance|0
7256074|NCT00321672|11467581|FG000|Overall Study|Adverse Event|1
7256075|NCT00321672|11467582|FG001|Overall Study|Adverse Event|1
7256076|NCT00321672|11467583|FG002|Overall Study|Adverse Event|0
7256077|NCT00321672|11467584|FG003|Overall Study|Adverse Event|0
7256078|NCT00321672|11467581|FG000|Overall Study|Lack of Efficacy|1
7256079|NCT00321672|11467582|FG001|Overall Study|Lack of Efficacy|1
7256080|NCT00321672|11467583|FG002|Overall Study|Lack of Efficacy|0
7241877|NCT00195650|11451043|FG000|Overall Study|Adverse Event|194
7241878|NCT00195650|11451043|FG000|Overall Study|Lack of Efficacy|99
7241879|NCT00195650|11451043|FG000|Overall Study|Withdrawal by Subject|67
7241880|NCT00195650|11451043|FG000|Overall Study|Lost to Follow-up|44
7241881|NCT00195650|11451043|FG000|Overall Study|Death|23
7241882|NCT00195650|11451043|FG000|Overall Study|Protocol Violation|15
7241883|NCT00195650|11451043|FG000|Overall Study|Administrative reasons|83
7241884|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Adverse Event|21
7241885|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Adverse Event|27
7241886|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Adverse Event|32
7241887|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Death|0
7241888|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Death|2
7241889|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Death|0
7241890|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
7241891|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
7241892|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
7241893|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
7241894|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
7241895|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
7241896|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
7241897|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
7241898|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
7241899|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
7241900|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
7241901|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
7241902|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
7241903|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
7241904|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
7241905|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Recovery|1
7241906|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Recovery|0
7241907|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Recovery|1
7241908|NCT00195663|11451050|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
7241909|NCT00195663|11451051|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
7241910|NCT00195663|11451052|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
7241911|NCT00195663|11451050|FG000|Open-Label Extension Period|Adverse Event|21
7241912|NCT00195663|11451051|FG001|Open-Label Extension Period|Adverse Event|32
7241913|NCT00195663|11451052|FG002|Open-Label Extension Period|Adverse Event|36
7241914|NCT00195663|11451050|FG000|Open-Label Extension Period|Lost to Follow-up|9
7241915|NCT00195663|11451051|FG001|Open-Label Extension Period|Lost to Follow-up|2
7241916|NCT00195663|11451052|FG002|Open-Label Extension Period|Lost to Follow-up|6
7241917|NCT00195663|11451050|FG000|Open-Label Extension Period|Recovery|0
7241918|NCT00195663|11451051|FG001|Open-Label Extension Period|Recovery|2
7241919|NCT00195663|11451052|FG002|Open-Label Extension Period|Recovery|2
7241920|NCT00195663|11451050|FG000|Open-Label Extension Period|Protocol Violation|3
7241921|NCT00195663|11451051|FG001|Open-Label Extension Period|Protocol Violation|4
7241922|NCT00195663|11451052|FG002|Open-Label Extension Period|Protocol Violation|4
7241923|NCT00195663|11451050|FG000|Open-Label Extension Period|Death|2
7241924|NCT00195663|11451051|FG001|Open-Label Extension Period|Death|2
7241925|NCT00195663|11451052|FG002|Open-Label Extension Period|Death|2
7241926|NCT00195663|11451050|FG000|Open-Label Extension Period|Withdrawal by Subject|16
7241927|NCT00195663|11451051|FG001|Open-Label Extension Period|Withdrawal by Subject|15
7241928|NCT00195663|11451052|FG002|Open-Label Extension Period|Withdrawal by Subject|22
7241929|NCT00195663|11451050|FG000|Open-Label Extension Period|Lack of Efficacy|14
7241930|NCT00195663|11451051|FG001|Open-Label Extension Period|Lack of Efficacy|6
7241931|NCT00195663|11451052|FG002|Open-Label Extension Period|Lack of Efficacy|12
7241932|NCT00195663|11451050|FG000|Open-Label Extension Period|Administrative reasons|11
7241933|NCT00195663|11451051|FG001|Open-Label Extension Period|Administrative reasons|11
7241934|NCT00195663|11451052|FG002|Open-Label Extension Period|Administrative reasons|13
7241935|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Adverse Event|82
7241936|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Death|6
7241937|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
7241938|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
7241939|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Protocol Violation|12
7241940|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
7241941|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Administrative reasons|2
7241942|NCT00195676|11451070|FG000|Period O - Open-label Treatment|Other reasons|68
7241943|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
7241944|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Death|2
7241945|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
7241946|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
7241947|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
7241948|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
7241949|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
7241950|NCT00195676|11451070|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
7241951|NCT00195676|11451070|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
7241952|NCT00195676|11451070|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
7241953|NCT00195676|11451070|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
7241954|NCT00195676|11451070|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
7241955|NCT00195676|11451070|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
7241956|NCT00195715|11451099|FG000|Overall Study|Adverse Event|122
7241957|NCT00195715|11451099|FG000|Overall Study|Withdrawal by Subject|58
7241958|NCT00195715|11451099|FG000|Overall Study|Lost to Follow-up|27
7241959|NCT00195715|11451099|FG000|Overall Study|Protocol Violation|13
7241960|NCT00195715|11451099|FG000|Overall Study|Lack of Efficacy|93
7241961|NCT00195715|11451099|FG000|Overall Study|Pregnancy|14
7241962|NCT00195715|11451099|FG000|Overall Study|Investigative site closure|8
7241963|NCT00195715|11451099|FG000|Overall Study|Subject moved/relocated|7
7241964|NCT00195715|11451099|FG000|Overall Study|Subject non-compliance|6
7241965|NCT00195715|11451099|FG000|Overall Study|Subject started commercial Humira|5
7241966|NCT00195715|11451099|FG000|Overall Study|Subject choice|3
7241967|NCT00195715|11451099|FG000|Overall Study|Loss of response/no improvement|3
7241968|NCT00195715|11451099|FG000|Overall Study|Sponsor stopped study|1
7241969|NCT00195715|11451099|FG000|Overall Study|Administrative reasons|2
7241970|NCT00195715|11451099|FG000|Overall Study|Investigator's decision|2
7241971|NCT00195715|11451099|FG000|Overall Study|Subject wants to get pregnant|4
7241972|NCT00195715|11451099|FG000|Overall Study|Use of prohibited medication|2
7241973|NCT00195715|11451099|FG000|Overall Study|Planned surgery|2
7241974|NCT00195715|11451099|FG000|Overall Study|Increased infection rate|1
7241975|NCT00195715|11451099|FG000|Overall Study|Ineligible|1
7241976|NCT00195715|11451099|FG000|Overall Study|Colonic stricture|1
7241977|NCT00195715|11451099|FG000|Overall Study|Sponsor discontinued trial|1
7241978|NCT00195715|11451099|FG000|Overall Study|Sponsor discretion - trial ended early|1
7241979|NCT00195819|11451103|FG000|Double-Blind|Withdrawal by Subject|1
7241980|NCT00195819|11451104|FG001|Double-Blind|Withdrawal by Subject|0
7241981|NCT00195819|11451103|FG000|Double-Blind|Moved|1
7241982|NCT00195819|11451104|FG001|Double-Blind|Moved|0
7241983|NCT00195819|11451103|FG000|Open-label|Adverse Event|0
7241984|NCT00195819|11451104|FG001|Open-label|Adverse Event|9
7241985|NCT00195819|11451103|FG000|Open-label|Lack of Efficacy|0
7241986|NCT00195819|11451104|FG001|Open-label|Lack of Efficacy|2
7241987|NCT00195819|11451103|FG000|Open-label|Pregnancy|0
7241988|NCT00195819|11451104|FG001|Open-label|Pregnancy|1
7241989|NCT00195819|11451103|FG000|Open-label|Protocol Violation|0
7241990|NCT00195819|11451104|FG001|Open-label|Protocol Violation|2
7241991|NCT00195819|11451103|FG000|Open-label|Moved|0
7574029|NCT03642873|11955933|FG004|Third Intervention (1 Day)|Screen failure|1
7574030|NCT03642873|11955934|FG005|Third Intervention (1 Day)|Screen failure|0
7574031|NCT03643432|11955948|FG000|Overall Study|Lost to Follow-up|1
7574032|NCT03643432|11955949|FG001|Overall Study|Lost to Follow-up|0
7574033|NCT03643575|11955955|FG000|Washout: 7 Days|Withdrew consent due to illness|0
7574034|NCT03643575|11955956|FG001|Washout: 7 Days|Withdrew consent due to illness|0
7574035|NCT03643575|11955957|FG002|Washout: 7 Days|Withdrew consent due to illness|0
7574036|NCT03643575|11955958|FG003|Washout: 7 Days|Withdrew consent due to illness|1
7383890|NCT01191008|11640849|FG000|Overall Study|Protocol Violation|7
7383891|NCT01191008|11640849|FG000|Overall Study|Lost to Follow-up|8
7383892|NCT01191086|11640853|FG000|Overall Study|Adverse Event|20
7241992|NCT00195819|11451104|FG001|Open-label|Moved|1
7241993|NCT00195819|11451103|FG000|Open-label|Withdrawal by Subject|0
7241994|NCT00195819|11451104|FG001|Open-label|Withdrawal by Subject|5
7241995|NCT00196105|11451119|FG000|Overall Study|Lost to Follow-up|4
7241996|NCT00196105|11451120|FG001|Overall Study|Lost to Follow-up|5
7241997|NCT00196105|11451121|FG002|Overall Study|Lost to Follow-up|7
7241998|NCT00196196|11451129|FG000|Overall Study|Withdrawal by Subject|2
7241999|NCT00196196|11451129|FG000|Overall Study|Did not have required condition (hydroce|5
7242000|NCT00196313|11451135|FG000|Overall Study|Protocol Violation|2
7242001|NCT00196313|11451136|FG001|Overall Study|Protocol Violation|3
7242002|NCT00196313|11451135|FG000|Overall Study|Withdrawal by Subject|3
7242003|NCT00196313|11451136|FG001|Overall Study|Withdrawal by Subject|1
7242004|NCT00196313|11451135|FG000|Overall Study|Adverse Event|3
7242005|NCT00196313|11451136|FG001|Overall Study|Adverse Event|1
7242006|NCT00196313|11451135|FG000|Overall Study|Subject Pregnant|1
7242007|NCT00196313|11451136|FG001|Overall Study|Subject Pregnant|1
7465050|NCT01877421|11764013|FG002|Phase 2|Withdrawal by Subject|0
7465051|NCT01877421|11764014|FG003|Phase 2|Withdrawal by Subject|0
7465052|NCT01877421|11764015|FG004|Phase 2|Withdrawal by Subject|0
7465053|NCT01877421|11764016|FG005|Phase 2|Withdrawal by Subject|0
7242008|NCT00196313|11451135|FG000|Overall Study|Lost to Follow-up|2
7242009|NCT00196313|11451136|FG001|Overall Study|Lost to Follow-up|2
7465054|NCT01877421|11764017|FG006|Phase 2|Withdrawal by Subject|0
7242010|NCT00196326|11451143|FG000|Overall Study|Did not meet protocol requirements|64
7242011|NCT00196326|11451143|FG000|Overall Study|Non-compliance with the protocol|81
7242012|NCT00196326|11451143|FG000|Overall Study|Physician Decision|3
7242013|NCT00196326|11451143|FG000|Overall Study|Withdrawal by Subject|225
7242014|NCT00196326|11451143|FG000|Overall Study|Adverse Event|253
7242015|NCT00196326|11451143|FG000|Overall Study|Pregnancy|34
7242016|NCT00196326|11451143|FG000|Overall Study|Lost to Follow-up|304
7242017|NCT00196326|11451143|FG000|Overall Study|Other|22
7383893|NCT01191086|11640853|FG000|Overall Study|Lack of Efficacy|10
7242018|NCT00196937|11451156|FG000|Overall Study|Serious Adverse Event|1
7242019|NCT00196937|11451157|FG001|Overall Study|Serious Adverse Event|0
7242020|NCT00196937|11451158|FG002|Overall Study|Serious Adverse Event|0
7242021|NCT00196937|11451156|FG000|Overall Study|Non-serious adverse event|1
7242022|NCT00196937|11451157|FG001|Overall Study|Non-serious adverse event|1
7242023|NCT00196937|11451158|FG002|Overall Study|Non-serious adverse event|1
7242024|NCT00196937|11451156|FG000|Overall Study|Withdrawal by Subject|0
7242025|NCT00196937|11451157|FG001|Overall Study|Withdrawal by Subject|0
7242026|NCT00196937|11451158|FG002|Overall Study|Withdrawal by Subject|2
7242027|NCT00196937|11451156|FG000|Overall Study|Lost to Follow-up|4
7242028|NCT00196937|11451157|FG001|Overall Study|Lost to Follow-up|3
7242029|NCT00196937|11451158|FG002|Overall Study|Lost to Follow-up|3
7242030|NCT00196937|11451156|FG000|Overall Study|Other|3
7242031|NCT00196937|11451157|FG001|Overall Study|Other|1
7242032|NCT00196937|11451158|FG002|Overall Study|Other|1
7242033|NCT00196976|11451181|FG000|Primary Study|Migrated from study area|0
7242034|NCT00196976|11451182|FG001|Primary Study|Migrated from study area|0
7242035|NCT00196976|11451183|FG002|Primary Study|Migrated from study area|0
7242036|NCT00196976|11451184|FG003|Primary Study|Migrated from study area|0
7242037|NCT00196976|11451185|FG004|Primary Study|Migrated from study area|0
7242038|NCT00196976|11451186|FG005|Primary Study|Migrated from study area|0
7242039|NCT00196976|11451187|FG006|Primary Study|Migrated from study area|0
7242040|NCT00196976|11451188|FG007|Primary Study|Migrated from study area|1
7242041|NCT00196976|11451189|FG008|Primary Study|Migrated from study area|0
7242042|NCT00196976|11451190|FG009|Primary Study|Migrated from study area|0
7242043|NCT00196976|11451191|FG010|Primary Study|Migrated from study area|0
7242044|NCT00196976|11451192|FG011|Primary Study|Migrated from study area|0
7242045|NCT00196976|11451193|FG012|Primary Study|Migrated from study area|0
7242046|NCT00196976|11451194|FG013|Primary Study|Migrated from study area|0
7242047|NCT00196976|11451181|FG000|Primary Study|Protocol Violation|0
7242048|NCT00196976|11451182|FG001|Primary Study|Protocol Violation|1
7242049|NCT00196976|11451183|FG002|Primary Study|Protocol Violation|1
7242050|NCT00196976|11451184|FG003|Primary Study|Protocol Violation|0
7242051|NCT00196976|11451185|FG004|Primary Study|Protocol Violation|0
7242052|NCT00196976|11451186|FG005|Primary Study|Protocol Violation|0
7242053|NCT00196976|11451187|FG006|Primary Study|Protocol Violation|0
7242054|NCT00196976|11451188|FG007|Primary Study|Protocol Violation|0
7242055|NCT00196976|11451189|FG008|Primary Study|Protocol Violation|0
7242056|NCT00196976|11451190|FG009|Primary Study|Protocol Violation|0
7242057|NCT00196976|11451191|FG010|Primary Study|Protocol Violation|0
7242058|NCT00196976|11451192|FG011|Primary Study|Protocol Violation|0
7242059|NCT00196976|11451193|FG012|Primary Study|Protocol Violation|0
7242060|NCT00196976|11451194|FG013|Primary Study|Protocol Violation|0
7242061|NCT00196976|11451181|FG000|Primary Study|Withdrawal by Subject|1
7242062|NCT00196976|11451182|FG001|Primary Study|Withdrawal by Subject|0
7242063|NCT00196976|11451183|FG002|Primary Study|Withdrawal by Subject|1
7242064|NCT00196976|11451184|FG003|Primary Study|Withdrawal by Subject|1
7242065|NCT00196976|11451185|FG004|Primary Study|Withdrawal by Subject|2
7242066|NCT00196976|11451186|FG005|Primary Study|Withdrawal by Subject|1
7242067|NCT00196976|11451187|FG006|Primary Study|Withdrawal by Subject|0
7242068|NCT00196976|11451188|FG007|Primary Study|Withdrawal by Subject|0
7242069|NCT00196976|11451189|FG008|Primary Study|Withdrawal by Subject|0
7242070|NCT00196976|11451190|FG009|Primary Study|Withdrawal by Subject|1
7242071|NCT00196976|11451191|FG010|Primary Study|Withdrawal by Subject|0
7242072|NCT00196976|11451192|FG011|Primary Study|Withdrawal by Subject|0
7242073|NCT00196976|11451193|FG012|Primary Study|Withdrawal by Subject|0
7242074|NCT00196976|11451194|FG013|Primary Study|Withdrawal by Subject|0
7242075|NCT00196976|11451181|FG000|Primary Study|Lost to Follow-up|0
7242076|NCT00196976|11451182|FG001|Primary Study|Lost to Follow-up|0
7242077|NCT00196976|11451183|FG002|Primary Study|Lost to Follow-up|0
7242078|NCT00196976|11451184|FG003|Primary Study|Lost to Follow-up|0
7242079|NCT00196976|11451185|FG004|Primary Study|Lost to Follow-up|1
7242080|NCT00196976|11451186|FG005|Primary Study|Lost to Follow-up|1
7242081|NCT00196976|11451187|FG006|Primary Study|Lost to Follow-up|0
7242082|NCT00196976|11451188|FG007|Primary Study|Lost to Follow-up|2
7242083|NCT00196976|11451189|FG008|Primary Study|Lost to Follow-up|0
7242084|NCT00196976|11451190|FG009|Primary Study|Lost to Follow-up|0
7242085|NCT00196976|11451191|FG010|Primary Study|Lost to Follow-up|0
7242086|NCT00196976|11451192|FG011|Primary Study|Lost to Follow-up|0
7242087|NCT00196976|11451193|FG012|Primary Study|Lost to Follow-up|0
7242088|NCT00196976|11451194|FG013|Primary Study|Lost to Follow-up|0
7242089|NCT00196976|11451181|FG000|Primary Study|Other|0
7242090|NCT00196976|11451182|FG001|Primary Study|Other|0
7242091|NCT00196976|11451183|FG002|Primary Study|Other|2
7242092|NCT00196976|11451184|FG003|Primary Study|Other|0
7242093|NCT00196976|11451185|FG004|Primary Study|Other|0
7242094|NCT00196976|11451186|FG005|Primary Study|Other|0
7242095|NCT00196976|11451187|FG006|Primary Study|Other|0
7242096|NCT00196976|11451188|FG007|Primary Study|Other|0
7242097|NCT00196976|11451189|FG008|Primary Study|Other|0
7242098|NCT00196976|11451190|FG009|Primary Study|Other|0
7242099|NCT00196976|11451191|FG010|Primary Study|Other|0
7242100|NCT00196976|11451192|FG011|Primary Study|Other|0
7242101|NCT00196976|11451193|FG012|Primary Study|Other|0
7242102|NCT00196976|11451194|FG013|Primary Study|Other|0
7242103|NCT00196976|11451181|FG000|Booster Study|Withdrawal by Subject|0
7242104|NCT00196976|11451182|FG001|Booster Study|Withdrawal by Subject|0
7242105|NCT00196976|11451183|FG002|Booster Study|Withdrawal by Subject|0
7242106|NCT00196976|11451184|FG003|Booster Study|Withdrawal by Subject|0
7242107|NCT00196976|11451185|FG004|Booster Study|Withdrawal by Subject|0
7242108|NCT00196976|11451186|FG005|Booster Study|Withdrawal by Subject|0
7242109|NCT00196976|11451187|FG006|Booster Study|Withdrawal by Subject|0
7242110|NCT00196976|11451188|FG007|Booster Study|Withdrawal by Subject|0
7242111|NCT00196976|11451189|FG008|Booster Study|Withdrawal by Subject|0
7242112|NCT00196976|11451190|FG009|Booster Study|Withdrawal by Subject|0
7242113|NCT00196976|11451191|FG010|Booster Study|Withdrawal by Subject|1
7242114|NCT00196976|11451192|FG011|Booster Study|Withdrawal by Subject|0
7242115|NCT00196976|11451193|FG012|Booster Study|Withdrawal by Subject|0
7242116|NCT00196976|11451194|FG013|Booster Study|Withdrawal by Subject|0
7242117|NCT00196976|11451181|FG000|Booster Study|Lost to Follow-up|0
7242118|NCT00196976|11451182|FG001|Booster Study|Lost to Follow-up|0
7242119|NCT00196976|11451183|FG002|Booster Study|Lost to Follow-up|0
7242120|NCT00196976|11451184|FG003|Booster Study|Lost to Follow-up|0
7242121|NCT00196976|11451185|FG004|Booster Study|Lost to Follow-up|0
7242122|NCT00196976|11451186|FG005|Booster Study|Lost to Follow-up|0
7242123|NCT00196976|11451187|FG006|Booster Study|Lost to Follow-up|0
7242124|NCT00196976|11451188|FG007|Booster Study|Lost to Follow-up|0
7242125|NCT00196976|11451189|FG008|Booster Study|Lost to Follow-up|0
7242126|NCT00196976|11451190|FG009|Booster Study|Lost to Follow-up|0
7242127|NCT00196976|11451191|FG010|Booster Study|Lost to Follow-up|1
7242128|NCT00196976|11451192|FG011|Booster Study|Lost to Follow-up|2
7242129|NCT00196976|11451193|FG012|Booster Study|Lost to Follow-up|0
7242130|NCT00196976|11451194|FG013|Booster Study|Lost to Follow-up|0
7242131|NCT00197002|11451237|FG000|Overall Study|Adverse Event|0
7242132|NCT00197002|11451238|FG001|Overall Study|Adverse Event|1
7242133|NCT00197002|11451239|FG002|Overall Study|Adverse Event|0
7242134|NCT00197002|11451237|FG000|Overall Study|Protocol Violation|1
7242135|NCT00197002|11451238|FG001|Overall Study|Protocol Violation|0
7242136|NCT00197002|11451239|FG002|Overall Study|Protocol Violation|2
7242137|NCT00197002|11451237|FG000|Overall Study|Withdrawal by Subject|9
7242138|NCT00197002|11451238|FG001|Overall Study|Withdrawal by Subject|5
7242139|NCT00197002|11451239|FG002|Overall Study|Withdrawal by Subject|7
7242140|NCT00197002|11451237|FG000|Overall Study|Migrated/moved from study area|3
7242141|NCT00197002|11451238|FG001|Overall Study|Migrated/moved from study area|5
7242142|NCT00197002|11451239|FG002|Overall Study|Migrated/moved from study area|1
7242143|NCT00197002|11451237|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
7242144|NCT00197002|11451238|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
7242145|NCT00197002|11451239|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
7242146|NCT00197002|11451237|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
7242147|NCT00197002|11451238|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
7242148|NCT00197002|11451239|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
7242149|NCT00197002|11451237|FG000|Overall Study|Others|3
7242150|NCT00197002|11451238|FG001|Overall Study|Others|1
7242151|NCT00197002|11451239|FG002|Overall Study|Others|1
7242152|NCT00197015|11451253|FG000|Overall Study|Adverse Event|3
7242153|NCT00197015|11451254|FG001|Overall Study|Adverse Event|0
7242154|NCT00197015|11451255|FG002|Overall Study|Adverse Event|1
7242155|NCT00197015|11451253|FG000|Overall Study|Protocol Violation|0
7242156|NCT00197015|11451254|FG001|Overall Study|Protocol Violation|3
7242157|NCT00197015|11451255|FG002|Overall Study|Protocol Violation|3
7242158|NCT00197015|11451253|FG000|Overall Study|Withdrawal by Subject|17
7242159|NCT00197015|11451254|FG001|Overall Study|Withdrawal by Subject|37
7242160|NCT00197015|11451255|FG002|Overall Study|Withdrawal by Subject|34
7242161|NCT00197015|11451253|FG000|Overall Study|Lost to Follow-up|28
7242162|NCT00197015|11451254|FG001|Overall Study|Lost to Follow-up|46
7242163|NCT00197015|11451255|FG002|Overall Study|Lost to Follow-up|37
7465055|NCT01877421|11764018|FG007|Phase 2|Withdrawal by Subject|0
7465056|NCT01877421|11764019|FG008|Phase 2|Withdrawal by Subject|1
7242164|NCT00197015|11451253|FG000|Overall Study|Other|2
7242165|NCT00197015|11451254|FG001|Overall Study|Other|3
7242166|NCT00197015|11451255|FG002|Overall Study|Other|2
7242167|NCT00197028|11451265|FG000|Overall Study|Adverse Event|2
7242168|NCT00197028|11451266|FG001|Overall Study|Adverse Event|2
7242169|NCT00197028|11451265|FG000|Overall Study|Protocol Violation|2
7242170|NCT00197028|11451266|FG001|Overall Study|Protocol Violation|1
7242171|NCT00197028|11451265|FG000|Overall Study|Withdrawal by Subject|8
7242172|NCT00197028|11451266|FG001|Overall Study|Withdrawal by Subject|12
7242173|NCT00197028|11451265|FG000|Overall Study|Lost to Follow-up|1
7242174|NCT00197028|11451266|FG001|Overall Study|Lost to Follow-up|0
7242175|NCT00197028|11451265|FG000|Overall Study|Other|3
7242176|NCT00197028|11451266|FG001|Overall Study|Other|6
7242177|NCT00197054|11451275|FG000|Overall Study|Withdrawal by Subject|9
7242178|NCT00197054|11451276|FG001|Overall Study|Withdrawal by Subject|3
7242179|NCT00197054|11451277|FG002|Overall Study|Withdrawal by Subject|3
7242180|NCT00197054|11451275|FG000|Overall Study|Moved from area|7
7242181|NCT00197054|11451276|FG001|Overall Study|Moved from area|14
7242182|NCT00197054|11451277|FG002|Overall Study|Moved from area|9
7242183|NCT00197054|11451275|FG000|Overall Study|Lost to Follow-up|1
7242184|NCT00197054|11451276|FG001|Overall Study|Lost to Follow-up|4
7242185|NCT00197054|11451277|FG002|Overall Study|Lost to Follow-up|0
7242186|NCT00197106|11451297|FG000|4-Week Run-In Period|Did not meet entry criteria|99
7242187|NCT00197106|11451298|FG001|4-Week Run-In Period|Did not meet entry criteria|0
7242188|NCT00197106|11451299|FG002|4-Week Run-In Period|Did not meet entry criteria|0
7242189|NCT00197106|11451297|FG000|Overall Treatment Period|Lack of Efficacy|0
7242190|NCT00197106|11451298|FG001|Overall Treatment Period|Lack of Efficacy|1
7242191|NCT00197106|11451299|FG002|Overall Treatment Period|Lack of Efficacy|0
7242192|NCT00197106|11451297|FG000|Overall Treatment Period|Lost to Follow-up|0
7242193|NCT00197106|11451298|FG001|Overall Treatment Period|Lost to Follow-up|0
7242194|NCT00197106|11451299|FG002|Overall Treatment Period|Lost to Follow-up|2
7242195|NCT00197106|11451297|FG000|Overall Treatment Period|Protocol Violation|0
7242196|NCT00197106|11451298|FG001|Overall Treatment Period|Protocol Violation|0
7242197|NCT00197106|11451299|FG002|Overall Treatment Period|Protocol Violation|2
7242198|NCT00197106|11451297|FG000|Overall Treatment Period|Withdrawal by Subject|0
7242199|NCT00197106|11451298|FG001|Overall Treatment Period|Withdrawal by Subject|0
7242200|NCT00197106|11451299|FG002|Overall Treatment Period|Withdrawal by Subject|2
7242201|NCT00197145|11451316|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7242202|NCT00197145|11451317|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
7242203|NCT00197145|11451316|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
7242204|NCT00197145|11451317|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
7574037|NCT03643575|11955959|FG004|Washout: 7 Days|Withdrew consent due to illness|0
7574038|NCT03643575|11955960|FG005|Washout: 7 Days|Withdrew consent due to illness|0
7574039|NCT03643575|11955955|FG000|Washout: 7 Days|Adverse Event|1
7574040|NCT03643575|11955956|FG001|Washout: 7 Days|Adverse Event|0
7574041|NCT03643575|11955957|FG002|Washout: 7 Days|Adverse Event|0
7574042|NCT03643575|11955958|FG003|Washout: 7 Days|Adverse Event|0
7574043|NCT03643575|11955959|FG004|Washout: 7 Days|Adverse Event|0
7574044|NCT03643575|11955960|FG005|Washout: 7 Days|Adverse Event|0
7574045|NCT03643575|11955955|FG000|Washout: 7 Days|Non compliance check in|0
7242205|NCT00197145|11451316|FG000|Period 1: Randomized Treatment Phase|Other|2
7465057|NCT01877421|11764020|FG009|Phase 2|Withdrawal by Subject|0
7465058|NCT01877421|11764021|FG010|Phase 2|Withdrawal by Subject|1
7465059|NCT01877421|11764022|FG011|Phase 2|Withdrawal by Subject|0
7465060|NCT01877421|11764023|FG012|Phase 2|Withdrawal by Subject|1
7465061|NCT01877421|11764024|FG013|Phase 2|Withdrawal by Subject|0
7242206|NCT00197145|11451317|FG001|Period 1: Randomized Treatment Phase|Other|2
7256081|NCT00321672|11467584|FG003|Overall Study|Lack of Efficacy|0
7465062|NCT01877421|11764025|FG014|Phase 2|Withdrawal by Subject|0
7574046|NCT03643575|11955956|FG001|Washout: 7 Days|Non compliance check in|1
7242207|NCT00197145|11451316|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
7242208|NCT00197145|11451317|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
7242209|NCT00197145|11451316|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
7242210|NCT00197145|11451317|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
7242211|NCT00197145|11451316|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
7242212|NCT00197145|11451317|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
7242213|NCT00197145|11451316|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
7242214|NCT00197145|11451317|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
7242215|NCT00197145|11451316|FG000|Period 2 : Open Label Phase|Other|1
7242216|NCT00197145|11451317|FG001|Period 2 : Open Label Phase|Other|0
7242217|NCT00197236|11451336|FG000|Overall Study|Adverse Event|1
7242218|NCT00197236|11451337|FG001|Overall Study|Adverse Event|0
7242219|NCT00197236|11451338|FG002|Overall Study|Adverse Event|1
7242220|NCT00197236|11451336|FG000|Overall Study|Lost to Follow-up|5
7242221|NCT00197236|11451337|FG001|Overall Study|Lost to Follow-up|14
7242222|NCT00197236|11451338|FG002|Overall Study|Lost to Follow-up|6
7242223|NCT00197236|11451336|FG000|Overall Study|Protocol Violation|0
7242224|NCT00197236|11451337|FG001|Overall Study|Protocol Violation|0
7242225|NCT00197236|11451338|FG002|Overall Study|Protocol Violation|1
7242226|NCT00197236|11451336|FG000|Overall Study|Withdrawal by Subject|7
7242227|NCT00197236|11451337|FG001|Overall Study|Withdrawal by Subject|3
7242228|NCT00197236|11451338|FG002|Overall Study|Withdrawal by Subject|11
7242229|NCT00197236|11451336|FG000|Overall Study|Study drug/medication expiration|1
7242230|NCT00197236|11451337|FG001|Overall Study|Study drug/medication expiration|0
7242231|NCT00197236|11451338|FG002|Overall Study|Study drug/medication expiration|3
7242232|NCT00197236|11451336|FG000|Overall Study|Returned out of specified time window|0
7242233|NCT00197236|11451337|FG001|Overall Study|Returned out of specified time window|0
7242234|NCT00197236|11451338|FG002|Overall Study|Returned out of specified time window|1
7242235|NCT00197496|11451376|FG000|Baseline to Discharge|not interested|1
7242236|NCT00197496|11451377|FG001|Baseline to Discharge|not interested|0
7242237|NCT00197496|11451376|FG000|Baseline to Discharge|MRSA|1
7242238|NCT00197496|11451377|FG001|Baseline to Discharge|MRSA|0
7242239|NCT00197496|11451376|FG000|Baseline to Discharge|Physician Decision|0
7242240|NCT00197496|11451377|FG001|Baseline to Discharge|Physician Decision|1
7242241|NCT00197496|11451376|FG000|Baseline to Discharge|Protocol Violation|0
7242242|NCT00197496|11451377|FG001|Baseline to Discharge|Protocol Violation|1
7242243|NCT00197496|11451376|FG000|Follow-up|Lost to Follow-up|2
7242244|NCT00197496|11451377|FG001|Follow-up|Lost to Follow-up|1
7242245|NCT00198029|11451383|FG000|Overall Study|Withdrawal by Subject|4
7242246|NCT00198107|11451407|FG000|Double-Blind Period|Adverse Event|1
7242247|NCT00198107|11451408|FG001|Double-Blind Period|Adverse Event|1
7242248|NCT00198107|11451409|FG002|Double-Blind Period|Adverse Event|0
7242249|NCT00198107|11451407|FG000|Double-Blind Period|Lack of Efficacy|2
7242250|NCT00198107|11451408|FG001|Double-Blind Period|Lack of Efficacy|0
7242251|NCT00198107|11451409|FG002|Double-Blind Period|Lack of Efficacy|0
7242252|NCT00198107|11451407|FG000|Double-Blind Period|Lost to Follow-up|2
7242253|NCT00198107|11451408|FG001|Double-Blind Period|Lost to Follow-up|1
7242254|NCT00198107|11451409|FG002|Double-Blind Period|Lost to Follow-up|0
7242255|NCT00198107|11451407|FG000|Double-Blind Period|Physician Decision|1
7242256|NCT00198107|11451408|FG001|Double-Blind Period|Physician Decision|0
7242257|NCT00198107|11451409|FG002|Double-Blind Period|Physician Decision|0
7242258|NCT00198107|11451407|FG000|Double-Blind Period|Withdrawal by Subject|0
7242259|NCT00198107|11451408|FG001|Double-Blind Period|Withdrawal by Subject|1
7242260|NCT00198107|11451409|FG002|Double-Blind Period|Withdrawal by Subject|0
7242261|NCT00198107|11451407|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7242262|NCT00198107|11451408|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
7242263|NCT00198107|11451409|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
7242264|NCT00198133|11451419|FG000|Overall Study|Disease progression|2
7242265|NCT00198133|11451420|FG001|Overall Study|Disease progression|5
7242266|NCT00198133|11451419|FG000|Overall Study|Adverse Event|1
7242267|NCT00198133|11451420|FG001|Overall Study|Adverse Event|3
7242268|NCT00198133|11451419|FG000|Overall Study|Withdrawal by Subject|1
7242269|NCT00198133|11451420|FG001|Overall Study|Withdrawal by Subject|0
7242270|NCT00198133|11451419|FG000|Overall Study|Physician Decision|1
7242271|NCT00198133|11451420|FG001|Overall Study|Physician Decision|0
7242272|NCT00198822|11451429|FG000|Overall Study|Lost to Follow-up|14
7242273|NCT00198822|11451430|FG001|Overall Study|Lost to Follow-up|20
7242274|NCT00198822|11451431|FG002|Overall Study|Lost to Follow-up|21
7242275|NCT00199381|11451439|FG000|Overall Study|Withdrawal by Subject|38
7242276|NCT00199381|11451439|FG000|Overall Study|Adverse Event|73
7242277|NCT00199381|11451439|FG000|Overall Study|Protocol Violation|6
7242278|NCT00199381|11451439|FG000|Overall Study|Lack of Efficacy|27
7242279|NCT00199381|11451439|FG000|Overall Study|Not including due to early termination|37
7242280|NCT00199381|11451439|FG000|Overall Study|Study termination by Sponsor|323
7242281|NCT00199797|11451443|FG000|Overall Study|Progressive Disease|1
7242282|NCT00199797|11451443|FG000|Overall Study|Adverse Event|1
7242283|NCT00199797|11451443|FG000|Overall Study|Physician Decision|1
7242284|NCT00199836|11451448|FG000|Overall Study|Progressive Disease|5
7242285|NCT00199836|11451448|FG000|Overall Study|Death|1
7242286|NCT00199849|11451456|FG000|Overall Study|Unrelated illness or complication|0
7574047|NCT03643575|11955957|FG002|Washout: 7 Days|Non compliance check in|0
7574048|NCT03643575|11955958|FG003|Washout: 7 Days|Non compliance check in|0
7574049|NCT03643575|11955959|FG004|Washout: 7 Days|Non compliance check in|0
7574050|NCT03643575|11955960|FG005|Washout: 7 Days|Non compliance check in|0
7574051|NCT03643952|11955972|FG000|Overall Study|Lack of Efficacy|1
7574052|NCT03644173|11955995|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
7574053|NCT03644173|11955995|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
7574054|NCT03644173|11955995|FG000|Participants at the 1-month Follow up|Death|2
7574055|NCT03644173|11955995|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
7574056|NCT03645421|11956013|FG000|Overall Study|Adverse Event|0
7574057|NCT03645421|11956014|FG001|Overall Study|Adverse Event|0
7574058|NCT03645421|11956015|FG002|Overall Study|Adverse Event|4
7574059|NCT03645421|11956016|FG003|Overall Study|Adverse Event|1
7574060|NCT03645421|11956013|FG000|Overall Study|Withdrawal by patient|0
7574061|NCT03645421|11956014|FG001|Overall Study|Withdrawal by patient|0
7242287|NCT00199849|11451457|FG001|Overall Study|Unrelated illness or complication|1
7242288|NCT00199849|11451458|FG002|Overall Study|Unrelated illness or complication|0
7242289|NCT00199849|11451456|FG000|Overall Study|Progressive disease requiring intervention|0
7574062|NCT03645421|11956015|FG002|Overall Study|Withdrawal by patient|0
7574063|NCT03645421|11956016|FG003|Overall Study|Withdrawal by patient|3
7574064|NCT03645421|11956013|FG000|Overall Study|Study specific withdrawal criteria|0
7242290|NCT00199849|11451457|FG001|Overall Study|Progressive disease requiring intervention|0
7242291|NCT00199849|11451458|FG002|Overall Study|Progressive disease requiring intervention|1
7242292|NCT00199849|11451456|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
7242293|NCT00199849|11451457|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
7242294|NCT00199849|11451458|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
7242295|NCT00199875|11451471|FG000|Overall Study|Withdrawal by Subject|0
7242296|NCT00199875|11451472|FG001|Overall Study|Withdrawal by Subject|0
7242297|NCT00199875|11451473|FG002|Overall Study|Withdrawal by Subject|0
7242298|NCT00199875|11451474|FG003|Overall Study|Withdrawal by Subject|0
7242299|NCT00199875|11451475|FG004|Overall Study|Withdrawal by Subject|1
7242300|NCT00199888|11451487|FG000|Overall Study|Lost to Follow-up|1
7242301|NCT00199901|11451493|FG000|Overall Study|Protocol Violation|2
7242302|NCT00199901|11451494|FG001|Overall Study|Protocol Violation|0
7242303|NCT00199901|11451493|FG000|Overall Study|Withdrawal by Subject|1
7242304|NCT00199901|11451494|FG001|Overall Study|Withdrawal by Subject|0
7242305|NCT00199901|11451493|FG000|Overall Study|Progressive Disease|24
7242306|NCT00199901|11451494|FG001|Overall Study|Progressive Disease|24
7242307|NCT00200057|11451511|FG000|Overall Study|Lack of Efficacy|3
7242308|NCT00200057|11451511|FG000|Overall Study|Exited due to terminal illness of PI|2
7242309|NCT00200057|11451511|FG000|Overall Study|Withdrawal by Subject|1
7242310|NCT00200057|11451511|FG000|Overall Study|Change in medical condition|1
7242311|NCT00200057|11451511|FG000|Overall Study|Infection|1
7242312|NCT00200057|11451511|FG000|Overall Study|Death|1
7242313|NCT00200356|11451539|FG000|Overall Study|Lack of Efficacy|3
7242314|NCT00200356|11451540|FG001|Overall Study|Lack of Efficacy|3
7242315|NCT00200356|11451539|FG000|Overall Study|Protocol Violation|4
7242316|NCT00200356|11451540|FG001|Overall Study|Protocol Violation|4
7242317|NCT00200356|11451539|FG000|Overall Study|Nontreatment|1
7242318|NCT00200356|11451540|FG001|Overall Study|Nontreatment|0
7242319|NCT00200850|11451558|FG000|Overall Study|relocation|1
7242320|NCT00200850|11451559|FG001|Overall Study|relocation|0
7242321|NCT00200850|11451560|FG002|Overall Study|relocation|1
7242322|NCT00200850|11451558|FG000|Overall Study|too busy|1
7242323|NCT00200850|11451559|FG001|Overall Study|too busy|0
7242324|NCT00200850|11451560|FG002|Overall Study|too busy|0
7242325|NCT00200850|11451558|FG000|Overall Study|Pregnancy|0
7242326|NCT00200850|11451559|FG001|Overall Study|Pregnancy|0
7242327|NCT00200850|11451560|FG002|Overall Study|Pregnancy|1
7242328|NCT00200850|11451558|FG000|Overall Study|Poor adherence|0
7242329|NCT00200850|11451559|FG001|Overall Study|Poor adherence|0
7242330|NCT00200850|11451560|FG002|Overall Study|Poor adherence|1
7242331|NCT00200850|11451558|FG000|Overall Study|optic neuritis|0
7242332|NCT00200850|11451559|FG001|Overall Study|optic neuritis|0
7242333|NCT00200850|11451560|FG002|Overall Study|optic neuritis|1
7242334|NCT00200850|11451558|FG000|Overall Study|Adverse Event|1
7242335|NCT00200850|11451559|FG001|Overall Study|Adverse Event|1
7242336|NCT00200850|11451560|FG002|Overall Study|Adverse Event|2
7242337|NCT00200967|11451589|FG000|First Treatment Period|Withdrawal by Subject|5
7242338|NCT00200967|11451590|FG001|First Treatment Period|Withdrawal by Subject|1
7242339|NCT00200967|11451589|FG000|First Treatment Period|Pregnancy|1
7242340|NCT00200967|11451590|FG001|First Treatment Period|Pregnancy|0
7242341|NCT00200967|11451589|FG000|Wash-out Period|Lost to Follow-up|0
7242342|NCT00200967|11451590|FG001|Wash-out Period|Lost to Follow-up|1
7242343|NCT00200967|11451589|FG000|Second Treatment Period|Withdrawal by Subject|1
7242344|NCT00200967|11451590|FG001|Second Treatment Period|Withdrawal by Subject|2
7242345|NCT00200967|11451589|FG000|Run-out Period|Lost to Follow-up|1
7242346|NCT00200967|11451590|FG001|Run-out Period|Lost to Follow-up|0
7242347|NCT00201006|11451599|FG000|Overall Study|Withdrawal by Subject|7
7242348|NCT00201006|11451600|FG001|Overall Study|Withdrawal by Subject|2
7242349|NCT00201006|11451601|FG002|Overall Study|Withdrawal by Subject|3
7242350|NCT00201006|11451599|FG000|Overall Study|Adverse Event|1
7242351|NCT00201006|11451600|FG001|Overall Study|Adverse Event|0
7242352|NCT00201006|11451601|FG002|Overall Study|Adverse Event|1
7242353|NCT00201201|11451628|FG000|Overall Study|Death|0
7242354|NCT00201201|11451629|FG001|Overall Study|Death|2
7242355|NCT00201201|11451628|FG000|Overall Study|Withdrawal by Subject|5
7242356|NCT00201201|11451629|FG001|Overall Study|Withdrawal by Subject|5
7242357|NCT00201643|11451662|FG000|Overall Study|Withdrawal by Subject|5
7242358|NCT00201643|11451663|FG001|Overall Study|Withdrawal by Subject|4
7242359|NCT00201851|11451717|FG000|Overall Study|Lost to Follow-up|2
7242360|NCT00201851|11451718|FG001|Overall Study|Lost to Follow-up|1
7242361|NCT00201851|11451719|FG002|Overall Study|Lost to Follow-up|0
7242362|NCT00201851|11451717|FG000|Overall Study|Ineligible post enrollment|6
7242363|NCT00201851|11451718|FG001|Overall Study|Ineligible post enrollment|1
7242364|NCT00201851|11451719|FG002|Overall Study|Ineligible post enrollment|1
7242365|NCT00202644|11451753|FG000|Overall Study|Adverse Event|12
7242366|NCT00202644|11451754|FG001|Overall Study|Adverse Event|13
7242367|NCT00202644|11451753|FG000|Overall Study|Withdrawal by Subject|8
7242368|NCT00202644|11451754|FG001|Overall Study|Withdrawal by Subject|6
7242369|NCT00202644|11451753|FG000|Overall Study|Lack of Efficacy|6
7242370|NCT00202644|11451754|FG001|Overall Study|Lack of Efficacy|6
7242371|NCT00202644|11451753|FG000|Overall Study|Lost to Follow-up|0
7242372|NCT00202644|11451754|FG001|Overall Study|Lost to Follow-up|1
7242373|NCT00202644|11451753|FG000|Overall Study|Other|9
7242374|NCT00202644|11451754|FG001|Overall Study|Other|1
7242375|NCT00202839|11451767|FG000|Overall Study|Adverse Event|1
7242376|NCT00202839|11451768|FG001|Overall Study|Adverse Event|5
7242377|NCT00202839|11451767|FG000|Overall Study|Physician Decision|12
7242378|NCT00202839|11451768|FG001|Overall Study|Physician Decision|0
7242379|NCT00202839|11451767|FG000|Overall Study|Withdrawal by Subject|6
7242380|NCT00202839|11451768|FG001|Overall Study|Withdrawal by Subject|2
7242381|NCT00202839|11451767|FG000|Overall Study|Protocol Violation|2
7242382|NCT00202839|11451768|FG001|Overall Study|Protocol Violation|1
7242383|NCT00202839|11451767|FG000|Overall Study|Lost to Follow-up|3
7242384|NCT00202839|11451768|FG001|Overall Study|Lost to Follow-up|2
7242385|NCT00203021|11451780|FG000|Overall Study|Death|4
7242386|NCT00203021|11451781|FG001|Overall Study|Death|1
7242387|NCT00203021|11451780|FG000|Overall Study|Adverse Event|10
7242388|NCT00203021|11451781|FG001|Overall Study|Adverse Event|5
7242389|NCT00203021|11451780|FG000|Overall Study|Withdrawal by Subject|45
7242390|NCT00203021|11451781|FG001|Overall Study|Withdrawal by Subject|48
7242391|NCT00203021|11451780|FG000|Overall Study|Lost to Follow-up|9
7242392|NCT00203021|11451781|FG001|Overall Study|Lost to Follow-up|7
7242393|NCT00203021|11451780|FG000|Overall Study|Other than specified|11
7242394|NCT00203021|11451781|FG001|Overall Study|Other than specified|16
7242395|NCT00203047|11451789|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
7242396|NCT00203047|11451790|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
7242397|NCT00203047|11451789|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
7242398|NCT00203047|11451790|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
7242399|NCT00203047|11451789|FG000|Overall Study|Withdrawal by Subject|13
7242400|NCT00203047|11451790|FG001|Overall Study|Withdrawal by Subject|47
7242401|NCT00203047|11451789|FG000|Overall Study|Teva requested participant withdrawal|1
7242402|NCT00203047|11451790|FG001|Overall Study|Teva requested participant withdrawal|1
7242403|NCT00203047|11451789|FG000|Overall Study|Physician Decision|8
7242404|NCT00203047|11451790|FG001|Overall Study|Physician Decision|7
7242405|NCT00203047|11451789|FG000|Overall Study|Non-compliance|4
7242406|NCT00203047|11451790|FG001|Overall Study|Non-compliance|8
7242407|NCT00203047|11451789|FG000|Overall Study|Protocol Violation|1
7242408|NCT00203047|11451790|FG001|Overall Study|Protocol Violation|0
7242409|NCT00203047|11451789|FG000|Overall Study|Lost to Follow-up|11
7242410|NCT00203047|11451790|FG001|Overall Study|Lost to Follow-up|5
7242411|NCT00203047|11451789|FG000|Overall Study|Adverse Event|8
7242412|NCT00203047|11451790|FG001|Overall Study|Adverse Event|18
7242413|NCT00203047|11451789|FG000|Overall Study|Death|1
7242414|NCT00203047|11451790|FG001|Overall Study|Death|2
7242415|NCT00203047|11451789|FG000|Overall Study|Pregnancy|3
7242416|NCT00203047|11451790|FG001|Overall Study|Pregnancy|0
7242417|NCT00203047|11451789|FG000|Overall Study|Other|5
7242418|NCT00203047|11451790|FG001|Overall Study|Other|5
7242419|NCT00203242|11451818|FG000|Overall Study|Lost to Follow-up|1
7242420|NCT00203268|11451822|FG000|Early Treatment|only treated one headache|2
7242421|NCT00203268|11451822|FG000|Early Treatment|Lost to Follow-up|1
7242422|NCT00203268|11451822|FG000|Early Treatment|Withdrawal by Subject|1
7242423|NCT00203294|11451830|FG000|Overall Study|Withdrawal by Subject|8
7242424|NCT00203294|11451831|FG001|Overall Study|Withdrawal by Subject|13
7242425|NCT00203307|11451839|FG000|First Intervention|Adverse Event|2
7242426|NCT00203307|11451840|FG001|First Intervention|Adverse Event|0
7242427|NCT00203411|11451846|FG000|Follow-up|Progressive Disease|4
7242428|NCT00203424|11451851|FG000|Treatment Period|Withdrawal by Subject|4
7242429|NCT00203424|11451851|FG000|Treatment Period|Adverse Event|5
7242430|NCT00203424|11451851|FG000|Treatment Period|progressive disease|2
7242431|NCT00203424|11451851|FG000|Follow-up Period|Withdrawal by Subject|1
7242432|NCT00203424|11451851|FG000|Follow-up Period|progressive disease|4
7242433|NCT00203424|11451851|FG000|Follow-up Period|Lost to Follow-up|1
7242434|NCT00203476|11451858|FG000|Overall Study|Lost to Follow-up|1
7242435|NCT00203476|11451859|FG001|Overall Study|Lost to Follow-up|0
7242436|NCT00203476|11451860|FG002|Overall Study|Lost to Follow-up|0
7242437|NCT00203476|11451858|FG000|Overall Study|Withdrawal by Subject|0
7242438|NCT00203476|11451859|FG001|Overall Study|Withdrawal by Subject|1
7242439|NCT00203476|11451860|FG002|Overall Study|Withdrawal by Subject|0
7242440|NCT00203502|11451868|FG000|Overall Study|Death|1
7242441|NCT00203892|11451875|FG000|Overall Study|Physician Decision|1
7242442|NCT00203892|11451876|FG001|Overall Study|Physician Decision|2
7242443|NCT00203892|11451877|FG002|Overall Study|Physician Decision|0
7242444|NCT00203892|11451875|FG000|Overall Study|Death|1
7242445|NCT00203892|11451876|FG001|Overall Study|Death|0
7242446|NCT00203892|11451877|FG002|Overall Study|Death|0
7242447|NCT00203996|11451904|FG000|Overall Study|Lost to Follow-up|0
7242448|NCT00203996|11451905|FG001|Overall Study|Lost to Follow-up|0
7242449|NCT00203996|11451906|FG002|Overall Study|Lost to Follow-up|0
7242450|NCT00203996|11451907|FG003|Overall Study|Lost to Follow-up|1
7242451|NCT00203996|11451908|FG004|Overall Study|Lost to Follow-up|0
7242452|NCT00203996|11451909|FG005|Overall Study|Lost to Follow-up|0
7242453|NCT00203996|11451910|FG006|Overall Study|Lost to Follow-up|0
7242454|NCT00203996|11451911|FG007|Overall Study|Lost to Follow-up|0
7242455|NCT00203996|11451912|FG008|Overall Study|Lost to Follow-up|0
7242456|NCT00203996|11451913|FG009|Overall Study|Lost to Follow-up|0
7574065|NCT03645421|11956014|FG001|Overall Study|Study specific withdrawal criteria|0
7574066|NCT03645421|11956015|FG002|Overall Study|Study specific withdrawal criteria|1
7574067|NCT03645421|11956016|FG003|Overall Study|Study specific withdrawal criteria|0
7574068|NCT03645434|11956029|FG000|Period 1|Adverse Event|0
7574069|NCT03645434|11956030|FG001|Period 1|Adverse Event|0
7242457|NCT00203996|11451904|FG000|Overall Study|Protocol Violation|0
7242458|NCT00203996|11451905|FG001|Overall Study|Protocol Violation|0
7242459|NCT00203996|11451906|FG002|Overall Study|Protocol Violation|0
7242460|NCT00203996|11451907|FG003|Overall Study|Protocol Violation|6
7242461|NCT00203996|11451908|FG004|Overall Study|Protocol Violation|1
7242462|NCT00203996|11451909|FG005|Overall Study|Protocol Violation|0
7242463|NCT00203996|11451910|FG006|Overall Study|Protocol Violation|0
7242464|NCT00203996|11451911|FG007|Overall Study|Protocol Violation|0
7242465|NCT00203996|11451912|FG008|Overall Study|Protocol Violation|0
7242466|NCT00203996|11451913|FG009|Overall Study|Protocol Violation|0
7242467|NCT00203996|11451904|FG000|Overall Study|Physician Decision|0
7242468|NCT00203996|11451905|FG001|Overall Study|Physician Decision|0
7242469|NCT00203996|11451906|FG002|Overall Study|Physician Decision|0
7242470|NCT00203996|11451907|FG003|Overall Study|Physician Decision|2
7242471|NCT00203996|11451908|FG004|Overall Study|Physician Decision|0
7242472|NCT00203996|11451909|FG005|Overall Study|Physician Decision|0
7242473|NCT00203996|11451910|FG006|Overall Study|Physician Decision|0
7242474|NCT00203996|11451911|FG007|Overall Study|Physician Decision|0
7242475|NCT00203996|11451912|FG008|Overall Study|Physician Decision|0
7242476|NCT00203996|11451913|FG009|Overall Study|Physician Decision|1
7242477|NCT00203996|11451904|FG000|Overall Study|CPAP machine malfunction|0
7242478|NCT00203996|11451905|FG001|Overall Study|CPAP machine malfunction|0
7242479|NCT00203996|11451906|FG002|Overall Study|CPAP machine malfunction|0
7242480|NCT00203996|11451907|FG003|Overall Study|CPAP machine malfunction|1
7242481|NCT00203996|11451908|FG004|Overall Study|CPAP machine malfunction|0
7242482|NCT00203996|11451909|FG005|Overall Study|CPAP machine malfunction|0
7242483|NCT00203996|11451910|FG006|Overall Study|CPAP machine malfunction|0
7242484|NCT00203996|11451911|FG007|Overall Study|CPAP machine malfunction|0
7574070|NCT03645434|11956031|FG002|Period 1|Adverse Event|0
7242485|NCT00203996|11451912|FG008|Overall Study|CPAP machine malfunction|0
7242486|NCT00203996|11451913|FG009|Overall Study|CPAP machine malfunction|0
7242487|NCT00203996|11451904|FG000|Overall Study|Scheduling issue|0
7242488|NCT00203996|11451905|FG001|Overall Study|Scheduling issue|0
7242489|NCT00203996|11451906|FG002|Overall Study|Scheduling issue|0
7242490|NCT00203996|11451907|FG003|Overall Study|Scheduling issue|0
7242491|NCT00203996|11451908|FG004|Overall Study|Scheduling issue|0
7242492|NCT00203996|11451909|FG005|Overall Study|Scheduling issue|0
7242493|NCT00203996|11451910|FG006|Overall Study|Scheduling issue|0
7242494|NCT00203996|11451911|FG007|Overall Study|Scheduling issue|2
7242495|NCT00203996|11451912|FG008|Overall Study|Scheduling issue|0
7242496|NCT00203996|11451913|FG009|Overall Study|Scheduling issue|0
7242497|NCT00205179|11451944|FG000|Overall Study|Death|0
7242498|NCT00205179|11451945|FG001|Overall Study|Death|2
7242499|NCT00205179|11451944|FG000|Overall Study|Physician Decision|1
7242500|NCT00205179|11451945|FG001|Overall Study|Physician Decision|1
7383894|NCT01191086|11640853|FG000|Overall Study|Lost to Follow-up|4
7383895|NCT01191086|11640853|FG000|Overall Study|Physician Decision|2
7242501|NCT00205179|11451944|FG000|Overall Study|Adverse Event|1
7242502|NCT00205179|11451945|FG001|Overall Study|Adverse Event|1
7242503|NCT00205699|11451991|FG000|Overall Study|Lost to Follow-up|1
7242504|NCT00205699|11451992|FG001|Overall Study|Lost to Follow-up|3
7242505|NCT00205699|11451993|FG002|Overall Study|Lost to Follow-up|5
7242506|NCT00205699|11451991|FG000|Overall Study|Adverse Event|1
7242507|NCT00205699|11451992|FG001|Overall Study|Adverse Event|0
7242508|NCT00205699|11451993|FG002|Overall Study|Adverse Event|0
7242509|NCT00205699|11451991|FG000|Overall Study|Withdrawal by Subject|1
7242510|NCT00205699|11451992|FG001|Overall Study|Withdrawal by Subject|2
7242511|NCT00205699|11451993|FG002|Overall Study|Withdrawal by Subject|1
7242512|NCT00205699|11451991|FG000|Overall Study|Lack of Efficacy|0
7242513|NCT00205699|11451992|FG001|Overall Study|Lack of Efficacy|1
7242514|NCT00205699|11451993|FG002|Overall Study|Lack of Efficacy|0
7242515|NCT00205712|11452006|FG000|Overall Study|Lost to Follow-up|0
7242516|NCT00205712|11452007|FG001|Overall Study|Lost to Follow-up|1
7242517|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Adverse Event|260
7242518|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Adverse Event|267
7242519|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Adverse Event|252
7242520|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Adverse Event|232
7242521|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Adverse Event|0
7242522|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Adverse Event|0
7242523|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Death|9
7242524|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Death|7
7242525|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Death|14
7242526|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Death|7
7242527|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Death|0
7242528|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Death|0
7242529|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Failed to return|40
7242530|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Failed to return|25
7242531|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Failed to return|27
7242532|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Failed to return|27
7242533|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Failed to return|0
7242534|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Failed to return|0
7242535|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Other Event|49
7242536|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Other Event|52
7242537|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Other Event|41
7242538|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Other Event|58
7242539|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Other Event|0
7242540|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Other Event|0
7242541|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
7242542|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
7242543|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
7242544|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
7242545|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7242546|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
7242547|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
7242548|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
7242549|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
7242550|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
7242551|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
7242552|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
7242553|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
7242554|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
7242555|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
7242556|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
7242557|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
7242558|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
7242559|NCT00205777|11452019|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
7242560|NCT00205777|11452020|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
7242561|NCT00205777|11452021|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
7242562|NCT00205777|11452022|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
7242563|NCT00205777|11452023|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
7242564|NCT00205777|11452024|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
7242565|NCT00205777|11452019|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
7242566|NCT00205777|11452020|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
7242567|NCT00205777|11452021|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
7242568|NCT00205777|11452022|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
7242569|NCT00205777|11452023|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7242570|NCT00205777|11452024|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
7242571|NCT00205777|11452019|FG000|Completed Core Study, Entered SE I|Other Event|52
7242572|NCT00205777|11452020|FG001|Completed Core Study, Entered SE I|Other Event|46
7242573|NCT00205777|11452021|FG002|Completed Core Study, Entered SE I|Other Event|47
7242574|NCT00205777|11452022|FG003|Completed Core Study, Entered SE I|Other Event|50
7242575|NCT00205777|11452023|FG004|Completed Core Study, Entered SE I|Other Event|0
7242576|NCT00205777|11452024|FG005|Completed Core Study, Entered SE I|Other Event|0
7242577|NCT00205777|11452019|FG000|Study Extension I|Adverse Event|57
7242578|NCT00205777|11452020|FG001|Study Extension I|Adverse Event|0
7242579|NCT00205777|11452021|FG002|Study Extension I|Adverse Event|0
7242580|NCT00205777|11452022|FG003|Study Extension I|Adverse Event|61
7242581|NCT00205777|11452023|FG004|Study Extension I|Adverse Event|58
7242582|NCT00205777|11452024|FG005|Study Extension I|Adverse Event|0
7242583|NCT00205777|11452019|FG000|Study Extension I|Death|5
7242584|NCT00205777|11452020|FG001|Study Extension I|Death|0
7242585|NCT00205777|11452021|FG002|Study Extension I|Death|0
7242586|NCT00205777|11452022|FG003|Study Extension I|Death|1
7242587|NCT00205777|11452023|FG004|Study Extension I|Death|2
7242588|NCT00205777|11452024|FG005|Study Extension I|Death|0
7242589|NCT00205777|11452019|FG000|Study Extension I|Withdrawal by Subject|99
7242590|NCT00205777|11452020|FG001|Study Extension I|Withdrawal by Subject|0
7242591|NCT00205777|11452021|FG002|Study Extension I|Withdrawal by Subject|0
7242592|NCT00205777|11452022|FG003|Study Extension I|Withdrawal by Subject|106
7242593|NCT00205777|11452023|FG004|Study Extension I|Withdrawal by Subject|89
7242594|NCT00205777|11452024|FG005|Study Extension I|Withdrawal by Subject|0
7242595|NCT00205777|11452019|FG000|Study Extension I|Protocol Violation|4
7242596|NCT00205777|11452020|FG001|Study Extension I|Protocol Violation|0
7242597|NCT00205777|11452021|FG002|Study Extension I|Protocol Violation|0
7242598|NCT00205777|11452022|FG003|Study Extension I|Protocol Violation|8
7242599|NCT00205777|11452023|FG004|Study Extension I|Protocol Violation|8
7242600|NCT00205777|11452024|FG005|Study Extension I|Protocol Violation|0
7242601|NCT00205777|11452019|FG000|Study Extension I|Lack of Efficacy|0
7242602|NCT00205777|11452020|FG001|Study Extension I|Lack of Efficacy|0
7242603|NCT00205777|11452021|FG002|Study Extension I|Lack of Efficacy|0
7242604|NCT00205777|11452022|FG003|Study Extension I|Lack of Efficacy|1
7242605|NCT00205777|11452023|FG004|Study Extension I|Lack of Efficacy|2
7242606|NCT00205777|11452024|FG005|Study Extension I|Lack of Efficacy|0
7242607|NCT00205777|11452019|FG000|Study Extension I|Failed to return|15
7242608|NCT00205777|11452020|FG001|Study Extension I|Failed to return|0
7242609|NCT00205777|11452021|FG002|Study Extension I|Failed to return|0
7242610|NCT00205777|11452022|FG003|Study Extension I|Failed to return|17
7242611|NCT00205777|11452023|FG004|Study Extension I|Failed to return|13
7242612|NCT00205777|11452024|FG005|Study Extension I|Failed to return|0
7242613|NCT00205777|11452019|FG000|Study Extension I|Other Event|34
7242614|NCT00205777|11452020|FG001|Study Extension I|Other Event|0
7242615|NCT00205777|11452021|FG002|Study Extension I|Other Event|0
7242616|NCT00205777|11452022|FG003|Study Extension I|Other Event|34
7242617|NCT00205777|11452023|FG004|Study Extension I|Other Event|29
7242618|NCT00205777|11452024|FG005|Study Extension I|Other Event|0
7242619|NCT00205777|11452019|FG000|Study Extension I|Withdrawn as per protocol|0
7242620|NCT00205777|11452020|FG001|Study Extension I|Withdrawn as per protocol|0
7242621|NCT00205777|11452021|FG002|Study Extension I|Withdrawn as per protocol|1070
7242622|NCT00205777|11452022|FG003|Study Extension I|Withdrawn as per protocol|0
7242623|NCT00205777|11452023|FG004|Study Extension I|Withdrawn as per protocol|0
7242624|NCT00205777|11452024|FG005|Study Extension I|Withdrawn as per protocol|0
7242625|NCT00205777|11452019|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
7242626|NCT00205777|11452020|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7242627|NCT00205777|11452021|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7242628|NCT00205777|11452022|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
7242629|NCT00205777|11452023|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
7242630|NCT00205777|11452024|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
7574071|NCT03645434|11956032|FG003|Period 1|Adverse Event|1
7574072|NCT03645434|11956033|FG004|Period 1|Adverse Event|0
7242631|NCT00205777|11452019|FG000|Study Extension II|Adverse Event|0
7242632|NCT00205777|11452020|FG001|Study Extension II|Adverse Event|0
7242633|NCT00205777|11452021|FG002|Study Extension II|Adverse Event|0
7242634|NCT00205777|11452022|FG003|Study Extension II|Adverse Event|14
7242635|NCT00205777|11452023|FG004|Study Extension II|Adverse Event|0
7242636|NCT00205777|11452024|FG005|Study Extension II|Adverse Event|30
7242637|NCT00205777|11452019|FG000|Study Extension II|Death|0
7242638|NCT00205777|11452020|FG001|Study Extension II|Death|0
7242639|NCT00205777|11452021|FG002|Study Extension II|Death|0
7242640|NCT00205777|11452022|FG003|Study Extension II|Death|2
7242641|NCT00205777|11452023|FG004|Study Extension II|Death|0
7242642|NCT00205777|11452024|FG005|Study Extension II|Death|5
7242643|NCT00205777|11452019|FG000|Study Extension II|Withdrawal by Subject|0
7242644|NCT00205777|11452020|FG001|Study Extension II|Withdrawal by Subject|0
7242645|NCT00205777|11452021|FG002|Study Extension II|Withdrawal by Subject|0
7242646|NCT00205777|11452022|FG003|Study Extension II|Withdrawal by Subject|35
7242647|NCT00205777|11452023|FG004|Study Extension II|Withdrawal by Subject|0
7242648|NCT00205777|11452024|FG005|Study Extension II|Withdrawal by Subject|59
7242649|NCT00205777|11452019|FG000|Study Extension II|Protocol Violation|0
7242650|NCT00205777|11452020|FG001|Study Extension II|Protocol Violation|0
7242651|NCT00205777|11452021|FG002|Study Extension II|Protocol Violation|0
7242652|NCT00205777|11452022|FG003|Study Extension II|Protocol Violation|1
7242653|NCT00205777|11452023|FG004|Study Extension II|Protocol Violation|0
7242654|NCT00205777|11452024|FG005|Study Extension II|Protocol Violation|10
7242655|NCT00205777|11452019|FG000|Study Extension II|Lack of Efficacy|0
7242656|NCT00205777|11452020|FG001|Study Extension II|Lack of Efficacy|0
7242657|NCT00205777|11452021|FG002|Study Extension II|Lack of Efficacy|0
7242658|NCT00205777|11452022|FG003|Study Extension II|Lack of Efficacy|0
7242659|NCT00205777|11452023|FG004|Study Extension II|Lack of Efficacy|0
7242660|NCT00205777|11452024|FG005|Study Extension II|Lack of Efficacy|1
7242661|NCT00205777|11452019|FG000|Study Extension II|Failed to return|0
7242662|NCT00205777|11452020|FG001|Study Extension II|Failed to return|0
7242663|NCT00205777|11452021|FG002|Study Extension II|Failed to return|0
7242664|NCT00205777|11452022|FG003|Study Extension II|Failed to return|14
7242665|NCT00205777|11452023|FG004|Study Extension II|Failed to return|0
7242666|NCT00205777|11452024|FG005|Study Extension II|Failed to return|26
7242667|NCT00205777|11452019|FG000|Study Extension II|Other Event|0
7242668|NCT00205777|11452020|FG001|Study Extension II|Other Event|0
7242669|NCT00205777|11452021|FG002|Study Extension II|Other Event|0
7242670|NCT00205777|11452022|FG003|Study Extension II|Other Event|12
7242671|NCT00205777|11452023|FG004|Study Extension II|Other Event|0
7242672|NCT00205777|11452024|FG005|Study Extension II|Other Event|20
7242673|NCT00205777|11452019|FG000|Study Extension II|Enrolled but not treated|0
7242674|NCT00205777|11452020|FG001|Study Extension II|Enrolled but not treated|0
7242675|NCT00205777|11452021|FG002|Study Extension II|Enrolled but not treated|0
7242676|NCT00205777|11452022|FG003|Study Extension II|Enrolled but not treated|71
7242677|NCT00205777|11452023|FG004|Study Extension II|Enrolled but not treated|0
7242678|NCT00205777|11452024|FG005|Study Extension II|Enrolled but not treated|131
7242679|NCT00205803|11452041|FG000|Infant Series|Lost to Follow-up|10
7242680|NCT00205803|11452042|FG001|Infant Series|Lost to Follow-up|4
7242681|NCT00205803|11452041|FG000|Infant Series|Withdrawal by Subject|2
7242682|NCT00205803|11452042|FG001|Infant Series|Withdrawal by Subject|5
7242683|NCT00205803|11452041|FG000|Infant Series|Physician Decision|3
7242684|NCT00205803|11452042|FG001|Infant Series|Physician Decision|1
7242685|NCT00205803|11452041|FG000|Infant Series|Protocol Violation|1
7242686|NCT00205803|11452042|FG001|Infant Series|Protocol Violation|0
7242687|NCT00205803|11452041|FG000|Infant Series|Lost Kaiser coverage|0
7242688|NCT00205803|11452042|FG001|Infant Series|Lost Kaiser coverage|1
7242689|NCT00205803|11452041|FG000|Infant Series|Non-compliant|1
7242690|NCT00205803|11452042|FG001|Infant Series|Non-compliant|0
7242691|NCT00205803|11452041|FG000|Infant Series|Sponsor request|1
7242692|NCT00205803|11452042|FG001|Infant Series|Sponsor request|0
7242693|NCT00205803|11452041|FG000|After Infant Series|Adverse Event|1
7242694|NCT00205803|11452042|FG001|After Infant Series|Adverse Event|1
7242695|NCT00205803|11452041|FG000|After Infant Series|Protocol Violation|1
7242696|NCT00205803|11452042|FG001|After Infant Series|Protocol Violation|1
7242697|NCT00205803|11452041|FG000|After Infant Series|Lost to Follow-up|2
7574073|NCT03645434|11956034|FG005|Period 1|Adverse Event|0
7574074|NCT03645434|11956029|FG000|Period 1|COPD exacerbation|0
7574075|NCT03645434|11956030|FG001|Period 1|COPD exacerbation|0
7242698|NCT00205803|11452042|FG001|After Infant Series|Lost to Follow-up|1
7242699|NCT00205803|11452041|FG000|After Infant Series|Physician Decision|3
7242700|NCT00205803|11452042|FG001|After Infant Series|Physician Decision|2
7242701|NCT00205803|11452041|FG000|After Infant Series|Withdrawal by Subject|1
7242702|NCT00205803|11452042|FG001|After Infant Series|Withdrawal by Subject|4
7242703|NCT00205803|11452041|FG000|After Infant Series|Other|10
7574076|NCT03645434|11956031|FG002|Period 1|COPD exacerbation|0
7242704|NCT00205803|11452042|FG001|After Infant Series|Other|4
7242705|NCT00205803|11452041|FG000|Toddler Dose|Lost to Follow-up|2
7242706|NCT00205803|11452042|FG001|Toddler Dose|Lost to Follow-up|3
7242707|NCT00205855|11452066|FG000|Overall Study|Only received temporary implants|16
7242708|NCT00205855|11452066|FG000|Overall Study|Withdrawal by Subject|5
7242709|NCT00205881|11452070|FG000|Overall Study|Withdrawal by Subject|16
7242710|NCT00206076|11452077|FG000|Overall Study|Physician Decision|2
7242711|NCT00206076|11452078|FG001|Overall Study|Physician Decision|0
7242712|NCT00206076|11452077|FG000|Overall Study|Withdrawal by Subject|1
7242713|NCT00206076|11452078|FG001|Overall Study|Withdrawal by Subject|1
7242714|NCT00206102|11452088|FG000|Overall Study|Adverse Event|119
7242715|NCT00206102|11452089|FG001|Overall Study|Adverse Event|82
7242716|NCT00206102|11452088|FG000|Overall Study|Protocol Violation|0
7242717|NCT00206102|11452089|FG001|Overall Study|Protocol Violation|2
7242718|NCT00206102|11452088|FG000|Overall Study|Lack of therapeutic response|16
7242719|NCT00206102|11452089|FG001|Overall Study|Lack of therapeutic response|11
7242720|NCT00206102|11452088|FG000|Overall Study|Lost to Follow-up|95
7242721|NCT00206102|11452089|FG001|Overall Study|Lost to Follow-up|66
7242722|NCT00206102|11452088|FG000|Overall Study|Withdrawal by Subject|118
7242723|NCT00206102|11452089|FG001|Overall Study|Withdrawal by Subject|101
7242724|NCT00206102|11452088|FG000|Overall Study|Study-specific discontinuation criteria|18
7242725|NCT00206102|11452089|FG001|Overall Study|Study-specific discontinuation criteria|17
7242726|NCT00206102|11452088|FG000|Overall Study|None of those categories|42
7242727|NCT00206102|11452089|FG001|Overall Study|None of those categories|36
7242728|NCT00206323|11452097|FG000|Overall Study|Lack of Efficacy|4
7242729|NCT00206323|11452098|FG001|Overall Study|Lack of Efficacy|1
7242730|NCT00206323|11452097|FG000|Overall Study|Adverse Event|1
7242731|NCT00206323|11452098|FG001|Overall Study|Adverse Event|1
7242732|NCT00206323|11452097|FG000|Overall Study|Lost to Follow-up|1
7242733|NCT00206323|11452098|FG001|Overall Study|Lost to Follow-up|1
7242734|NCT00206427|11452108|FG000|Overall Study|Adverse Event|2
7256082|NCT00321672|11467581|FG000|Overall Study|Lost to Follow-up|2
7256083|NCT00321672|11467582|FG001|Overall Study|Lost to Follow-up|0
7256084|NCT00321672|11467583|FG002|Overall Study|Lost to Follow-up|4
7256085|NCT00321672|11467584|FG003|Overall Study|Lost to Follow-up|2
7256086|NCT00321672|11467581|FG000|Overall Study|Death|1
7256087|NCT00321672|11467582|FG001|Overall Study|Death|0
7256088|NCT00321672|11467583|FG002|Overall Study|Death|0
7256089|NCT00321672|11467584|FG003|Overall Study|Death|0
7256090|NCT00321672|11467581|FG000|Overall Study|Too far to travel for visits|1
7256091|NCT00321672|11467582|FG001|Overall Study|Too far to travel for visits|0
7256092|NCT00321672|11467583|FG002|Overall Study|Too far to travel for visits|0
7256093|NCT00321672|11467584|FG003|Overall Study|Too far to travel for visits|0
7256094|NCT00321672|11467581|FG000|Overall Study|Incarcerated|0
7256095|NCT00321672|11467582|FG001|Overall Study|Incarcerated|0
7256096|NCT00321672|11467583|FG002|Overall Study|Incarcerated|2
7256097|NCT00321672|11467584|FG003|Overall Study|Incarcerated|0
7256098|NCT00321672|11467581|FG000|Overall Study|Moved out of state|0
7256099|NCT00321672|11467582|FG001|Overall Study|Moved out of state|1
7256100|NCT00321672|11467583|FG002|Overall Study|Moved out of state|1
7256101|NCT00321672|11467584|FG003|Overall Study|Moved out of state|0
7256102|NCT00321672|11467581|FG000|Overall Study|Protocol Violation|0
7256103|NCT00321672|11467582|FG001|Overall Study|Protocol Violation|0
7256104|NCT00321672|11467583|FG002|Overall Study|Protocol Violation|1
7256105|NCT00321672|11467584|FG003|Overall Study|Protocol Violation|0
7256106|NCT00321672|11467581|FG000|Overall Study|Diagnosis of testicular cancer|0
7256107|NCT00321672|11467582|FG001|Overall Study|Diagnosis of testicular cancer|1
7256108|NCT00321672|11467583|FG002|Overall Study|Diagnosis of testicular cancer|0
7256109|NCT00321672|11467584|FG003|Overall Study|Diagnosis of testicular cancer|0
7256110|NCT00321672|11467581|FG000|Overall Study|Extensive travel required for new job|0
7256111|NCT00321672|11467582|FG001|Overall Study|Extensive travel required for new job|1
7256112|NCT00321672|11467583|FG002|Overall Study|Extensive travel required for new job|0
7256113|NCT00321672|11467584|FG003|Overall Study|Extensive travel required for new job|0
7256114|NCT00321685|11467598|FG000|Overall Study|Adverse Event|18
7256115|NCT00321685|11467598|FG000|Overall Study|Death|2
7256116|NCT00321685|11467598|FG000|Overall Study|Withdrawal by Subject|8
7256117|NCT00321685|11467598|FG000|Overall Study|Alternative therapy|1
7256118|NCT00321685|11467598|FG000|Overall Study|Complicating disese|1
7256119|NCT00321685|11467598|FG000|Overall Study|Other|5
7256120|NCT00321685|11467598|FG000|Overall Study|Not start protocol therapy|2
7256121|NCT00321685|11467598|FG000|Overall Study|Ineligible|2
7256122|NCT00321711|11467607|FG000|Part A|Adverse Event|3
7256123|NCT00321711|11467608|FG001|Part A|Adverse Event|3
7256124|NCT00321711|11467609|FG002|Part A|Adverse Event|2
7256125|NCT00321711|11467610|FG003|Part A|Adverse Event|0
7256126|NCT00321711|11467611|FG004|Part A|Adverse Event|0
7256127|NCT00321711|11467607|FG000|Part A|Withdrawal by Subject|1
7256128|NCT00321711|11467608|FG001|Part A|Withdrawal by Subject|1
7256129|NCT00321711|11467609|FG002|Part A|Withdrawal by Subject|1
7256130|NCT00321711|11467610|FG003|Part A|Withdrawal by Subject|0
7256131|NCT00321711|11467611|FG004|Part A|Withdrawal by Subject|0
7256132|NCT00321711|11467607|FG000|Part A|Disease progression|0
7256133|NCT00321711|11467608|FG001|Part A|Disease progression|1
7256134|NCT00321711|11467609|FG002|Part A|Disease progression|0
7256135|NCT00321711|11467610|FG003|Part A|Disease progression|0
7242735|NCT00206440|11452114|FG000|Overall Study|Protocol Violation|1
7242736|NCT00206440|11452115|FG001|Overall Study|Protocol Violation|2
7242737|NCT00206440|11452114|FG000|Overall Study|Adverse Event|4
7242738|NCT00206440|11452115|FG001|Overall Study|Adverse Event|2
7242739|NCT00206518|11452123|FG000|Overall Study|Lack of Efficacy|6
7242740|NCT00206518|11452124|FG001|Overall Study|Lack of Efficacy|4
7242741|NCT00206518|11452123|FG000|Overall Study|Adverse Event|2
7242742|NCT00206518|11452124|FG001|Overall Study|Adverse Event|1
7242743|NCT00206518|11452123|FG000|Overall Study|Physician Decision|1
7242744|NCT00206518|11452124|FG001|Overall Study|Physician Decision|0
7242745|NCT00206518|11452123|FG000|Overall Study|Protocol Violation|1
7242746|NCT00206518|11452124|FG001|Overall Study|Protocol Violation|1
7242747|NCT00206726|11452130|FG000|Overall Study|Delayed recovery of blood counts|1
7242748|NCT00206726|11452130|FG000|Overall Study|Progressive disease or relapsed disease|18
7242749|NCT00206726|11452130|FG000|Overall Study|Placed on new protocol|1
7242750|NCT00206726|11452130|FG000|Overall Study|Bone marrow transplant|1
7242751|NCT00206726|11452130|FG000|Overall Study|Adverse Event|17
7242752|NCT00206726|11452130|FG000|Overall Study|Death|4
7242753|NCT00206726|11452130|FG000|Overall Study|Protocol Violation|1
7242754|NCT00206726|11452130|FG000|Overall Study|Withdrawal by Subject|8
7242755|NCT00207090|11452134|FG000|Overall Study|Study drug toxicity|3
7242756|NCT00207090|11452134|FG000|Overall Study|Chest wall mass larger|1
7242757|NCT00207090|11452134|FG000|Overall Study|Disease progression/relapse|2
7242758|NCT00207090|11452134|FG000|Overall Study|Physician Decision|1
7242759|NCT00207142|11452146|FG000|Induction Phase|Adverse Event|9
7242760|NCT00207142|11452147|FG001|Induction Phase|Adverse Event|0
7242761|NCT00207142|11452148|FG002|Induction Phase|Adverse Event|0
7242762|NCT00207142|11452149|FG003|Induction Phase|Adverse Event|0
7242763|NCT00207142|11452146|FG000|Induction Phase|Death|1
7242764|NCT00207142|11452147|FG001|Induction Phase|Death|0
7242765|NCT00207142|11452148|FG002|Induction Phase|Death|0
7242766|NCT00207142|11452149|FG003|Induction Phase|Death|0
7242767|NCT00207142|11452146|FG000|Induction Phase|Lack of Efficacy|1
7242768|NCT00207142|11452147|FG001|Induction Phase|Lack of Efficacy|0
7242769|NCT00207142|11452148|FG002|Induction Phase|Lack of Efficacy|0
7242770|NCT00207142|11452149|FG003|Induction Phase|Lack of Efficacy|0
7242771|NCT00207142|11452146|FG000|Induction Phase|Lost to Follow-up|5
7242772|NCT00207142|11452147|FG001|Induction Phase|Lost to Follow-up|0
7242773|NCT00207142|11452148|FG002|Induction Phase|Lost to Follow-up|0
7242774|NCT00207142|11452149|FG003|Induction Phase|Lost to Follow-up|0
7242775|NCT00207142|11452146|FG000|Induction Phase|Physician Decision|2
7242776|NCT00207142|11452147|FG001|Induction Phase|Physician Decision|0
7242777|NCT00207142|11452148|FG002|Induction Phase|Physician Decision|0
7242778|NCT00207142|11452149|FG003|Induction Phase|Physician Decision|0
7242779|NCT00207142|11452146|FG000|Induction Phase|Poor/noncompliance|2
7242780|NCT00207142|11452147|FG001|Induction Phase|Poor/noncompliance|0
7242781|NCT00207142|11452148|FG002|Induction Phase|Poor/noncompliance|0
7242782|NCT00207142|11452149|FG003|Induction Phase|Poor/noncompliance|0
7242783|NCT00207142|11452146|FG000|Induction Phase|Pregnancy|1
7242784|NCT00207142|11452147|FG001|Induction Phase|Pregnancy|0
7242785|NCT00207142|11452148|FG002|Induction Phase|Pregnancy|0
7242786|NCT00207142|11452149|FG003|Induction Phase|Pregnancy|0
7242787|NCT00207142|11452146|FG000|Induction Phase|Subject no longer meets study criteria|3
7242788|NCT00207142|11452147|FG001|Induction Phase|Subject no longer meets study criteria|0
7242789|NCT00207142|11452148|FG002|Induction Phase|Subject no longer meets study criteria|0
7242790|NCT00207142|11452149|FG003|Induction Phase|Subject no longer meets study criteria|0
7242791|NCT00207142|11452146|FG000|Induction Phase|Withdrawal by Subject|4
7242792|NCT00207142|11452147|FG001|Induction Phase|Withdrawal by Subject|0
7242793|NCT00207142|11452148|FG002|Induction Phase|Withdrawal by Subject|0
7242794|NCT00207142|11452149|FG003|Induction Phase|Withdrawal by Subject|0
7242795|NCT00207142|11452146|FG000|Induction Phase|Incarceration|1
7242796|NCT00207142|11452147|FG001|Induction Phase|Incarceration|0
7242797|NCT00207142|11452148|FG002|Induction Phase|Incarceration|0
7242798|NCT00207142|11452149|FG003|Induction Phase|Incarceration|0
7242799|NCT00207142|11452146|FG000|Induction Phase|Missing lab data|1
7242800|NCT00207142|11452147|FG001|Induction Phase|Missing lab data|0
7242801|NCT00207142|11452148|FG002|Induction Phase|Missing lab data|0
7242802|NCT00207142|11452149|FG003|Induction Phase|Missing lab data|0
7242803|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
7242804|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
7242805|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
7242806|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
7242807|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
7242808|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7242809|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
7242810|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
7242811|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7242812|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7242813|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
7242814|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
7242815|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
7242816|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7242817|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
7242818|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
7242819|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
7242820|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
7242821|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
7242822|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
7242823|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7242824|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7242825|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
7242826|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
7242827|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
7242828|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7242829|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
7242830|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
7242831|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Death|0
7242832|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Death|0
7242833|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Death|0
7242834|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Death|1
7242835|NCT00207142|11452146|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7242836|NCT00207142|11452147|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7242837|NCT00207142|11452148|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
7242838|NCT00207142|11452149|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
7242839|NCT00207714|11452169|FG000|Overall Study|Adverse Event|6
7242840|NCT00207714|11452170|FG001|Overall Study|Adverse Event|2
7242841|NCT00207714|11452171|FG002|Overall Study|Adverse Event|4
7242842|NCT00207714|11452172|FG003|Overall Study|Adverse Event|3
7242843|NCT00207714|11452173|FG004|Overall Study|Adverse Event|1
7242844|NCT00207714|11452169|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7242845|NCT00207714|11452170|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7242846|NCT00207714|11452171|FG002|Overall Study|Unsatisfactory therapeutic effect|1
7242847|NCT00207714|11452172|FG003|Overall Study|Unsatisfactory therapeutic effect|4
7242848|NCT00207714|11452173|FG004|Overall Study|Unsatisfactory therapeutic effect|4
7242849|NCT00207714|11452169|FG000|Overall Study|Other|3
7242850|NCT00207714|11452170|FG001|Overall Study|Other|2
7242851|NCT00207714|11452171|FG002|Overall Study|Other|5
7242852|NCT00207714|11452172|FG003|Overall Study|Other|1
7242853|NCT00207714|11452173|FG004|Overall Study|Other|0
7242854|NCT00207727|11452197|FG000|Overall Study|Withdrawal by Subject|0
7242855|NCT00207727|11452198|FG001|Overall Study|Withdrawal by Subject|0
7242856|NCT00207727|11452199|FG002|Overall Study|Withdrawal by Subject|0
7242857|NCT00207727|11452200|FG003|Overall Study|Withdrawal by Subject|0
7242858|NCT00207727|11452201|FG004|Overall Study|Withdrawal by Subject|1
7242859|NCT00207727|11452197|FG000|Overall Study|Lost to Follow-up|0
7242860|NCT00207727|11452198|FG001|Overall Study|Lost to Follow-up|1
7242861|NCT00207727|11452199|FG002|Overall Study|Lost to Follow-up|0
7242862|NCT00207727|11452200|FG003|Overall Study|Lost to Follow-up|0
7242863|NCT00207727|11452201|FG004|Overall Study|Lost to Follow-up|0
7242864|NCT00207727|11452197|FG000|Overall Study|Other|38
7242865|NCT00207727|11452198|FG001|Overall Study|Other|41
7242866|NCT00207727|11452199|FG002|Overall Study|Other|41
7242867|NCT00207727|11452200|FG003|Overall Study|Other|37
7242868|NCT00207727|11452201|FG004|Overall Study|Other|33
7242869|NCT00207740|11452217|FG000|Overall Study|Adverse Event|4
7242870|NCT00207740|11452218|FG001|Overall Study|Adverse Event|14
7242871|NCT00207740|11452219|FG002|Overall Study|Adverse Event|14
7242872|NCT00207740|11452220|FG003|Overall Study|Adverse Event|11
7242873|NCT00207740|11452217|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7242874|NCT00207740|11452218|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7242875|NCT00207740|11452219|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7242876|NCT00207740|11452220|FG003|Overall Study|Unsatisfactory therapeutic effect|4
7242877|NCT00207740|11452217|FG000|Overall Study|Lost to Follow-up|0
7242878|NCT00207740|11452218|FG001|Overall Study|Lost to Follow-up|2
7242879|NCT00207740|11452219|FG002|Overall Study|Lost to Follow-up|1
7242880|NCT00207740|11452220|FG003|Overall Study|Lost to Follow-up|1
7242881|NCT00207740|11452217|FG000|Overall Study|Death|0
7242882|NCT00207740|11452218|FG001|Overall Study|Death|0
7242883|NCT00207740|11452219|FG002|Overall Study|Death|0
7242884|NCT00207740|11452220|FG003|Overall Study|Death|1
7242885|NCT00207740|11452217|FG000|Overall Study|Sponsor Directive|22
7242886|NCT00207740|11452218|FG001|Overall Study|Sponsor Directive|15
7242887|NCT00207740|11452219|FG002|Overall Study|Sponsor Directive|16
7242888|NCT00207740|11452220|FG003|Overall Study|Sponsor Directive|21
7242889|NCT00207740|11452217|FG000|Overall Study|Other|2
7242890|NCT00207740|11452218|FG001|Overall Study|Other|10
7242891|NCT00207740|11452219|FG002|Overall Study|Other|7
7242892|NCT00207740|11452220|FG003|Overall Study|Other|5
7242893|NCT00208325|11452261|FG000|Overall Study|Death|18
7242894|NCT00208325|11452262|FG001|Overall Study|Death|19
7242895|NCT00208325|11452263|FG002|Overall Study|Death|7
7242896|NCT00208325|11452264|FG003|Overall Study|Death|5
7242897|NCT00208325|11452261|FG000|Overall Study|Withdrawal by Subject|0
7242898|NCT00208325|11452262|FG001|Overall Study|Withdrawal by Subject|1
7242899|NCT00208325|11452263|FG002|Overall Study|Withdrawal by Subject|0
7242900|NCT00208325|11452264|FG003|Overall Study|Withdrawal by Subject|0
7242901|NCT00208325|11452261|FG000|Overall Study|Revision|4
7242902|NCT00208325|11452262|FG001|Overall Study|Revision|1
7242903|NCT00208325|11452263|FG002|Overall Study|Revision|0
7242904|NCT00208325|11452264|FG003|Overall Study|Revision|4
7242905|NCT00208325|11452261|FG000|Overall Study|Lost to Follow-up|1
7242906|NCT00208325|11452262|FG001|Overall Study|Lost to Follow-up|0
7242907|NCT00208325|11452263|FG002|Overall Study|Lost to Follow-up|2
7242908|NCT00208325|11452264|FG003|Overall Study|Lost to Follow-up|0
7242909|NCT00208325|11452261|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
7242910|NCT00208325|11452262|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
7242911|NCT00208325|11452263|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
7242912|NCT00208325|11452264|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
7242913|NCT00208325|11452261|FG000|Overall Study|Does not wish to Continue in Study|5
7242914|NCT00208325|11452262|FG001|Overall Study|Does not wish to Continue in Study|8
7242915|NCT00208325|11452263|FG002|Overall Study|Does not wish to Continue in Study|3
7242916|NCT00208325|11452264|FG003|Overall Study|Does not wish to Continue in Study|2
7242917|NCT00208325|11452261|FG000|Overall Study|Other|2
7242918|NCT00208325|11452262|FG001|Overall Study|Other|1
7242919|NCT00208325|11452263|FG002|Overall Study|Other|1
7242920|NCT00208325|11452264|FG003|Overall Study|Other|0
7242921|NCT00208325|11452261|FG000|Overall Study|Mis-Randomized|17
7242922|NCT00208325|11452262|FG001|Overall Study|Mis-Randomized|20
7242923|NCT00208325|11452263|FG002|Overall Study|Mis-Randomized|0
7242924|NCT00208325|11452264|FG003|Overall Study|Mis-Randomized|0
7242925|NCT00208767|11452294|FG000|Overall Study|Adverse Event|9
7242926|NCT00208767|11452295|FG001|Overall Study|Adverse Event|1
7242927|NCT00208767|11452294|FG000|Overall Study|Withdrawal by Subject|14
7242928|NCT00208767|11452295|FG001|Overall Study|Withdrawal by Subject|3
7242929|NCT00208767|11452294|FG000|Overall Study|Death|1
7242930|NCT00208767|11452295|FG001|Overall Study|Death|0
7242931|NCT00208767|11452294|FG000|Overall Study|Lost to Follow-up|3
7242932|NCT00208767|11452295|FG001|Overall Study|Lost to Follow-up|3
7242933|NCT00209092|11452317|FG000|Overall Study|Progression of disease|7
7242934|NCT00209092|11452318|FG001|Overall Study|Progression of disease|1
7242935|NCT00209092|11452317|FG000|Overall Study|Adverse Event|0
7242936|NCT00209092|11452318|FG001|Overall Study|Adverse Event|1
7242937|NCT00209092|11452317|FG000|Overall Study|Withdrawal by Subject|1
7242938|NCT00209092|11452318|FG001|Overall Study|Withdrawal by Subject|0
7242939|NCT00209170|11452326|FG000|Overall Study|Adverse Event|0
7242940|NCT00209170|11452327|FG001|Overall Study|Adverse Event|1
7242941|NCT00209170|11452326|FG000|Overall Study|Withdrawal by Subject|2
7242942|NCT00209170|11452327|FG001|Overall Study|Withdrawal by Subject|1
7242943|NCT00209170|11452326|FG000|Overall Study|Lack of Efficacy|0
7242944|NCT00209170|11452327|FG001|Overall Study|Lack of Efficacy|1
7242945|NCT00209274|11452335|FG000|Overall Study|Missed visit|3
7242946|NCT00209274|11452336|FG001|Overall Study|Missed visit|2
7242947|NCT00209274|11452335|FG000|Overall Study|Death|32
7242948|NCT00209274|11452336|FG001|Overall Study|Death|15
7242949|NCT00209274|11452335|FG000|Overall Study|Withdrawal by Subject|30
7242950|NCT00209274|11452336|FG001|Overall Study|Withdrawal by Subject|15
7242951|NCT00209274|11452335|FG000|Overall Study|Randomized not treated (RNT)|6
7242952|NCT00209274|11452336|FG001|Overall Study|Randomized not treated (RNT)|15
7242953|NCT00209339|11452342|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
7242954|NCT00209339|11452342|FG000|At 12 Months Follow-up|Death|1
7242955|NCT00209339|11452342|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
7242956|NCT00209339|11452342|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
7242957|NCT00209339|11452342|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
7242958|NCT00209339|11452342|FG000|At 24 Months Follow-up|Death|1
7242959|NCT00209339|11452342|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
7242960|NCT00209339|11452342|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
7242961|NCT00209339|11452342|FG000|At 4 Years Follow-up|Death|1
7242962|NCT00209339|11452342|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
7242963|NCT00209339|11452342|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
7242964|NCT00209339|11452342|FG000|At 5 Years Follow-up|Death|1
7242965|NCT00209560|11452357|FG000|Overall Study|Lack of Efficacy|1
7242966|NCT00209560|11452358|FG001|Overall Study|Lack of Efficacy|0
7242967|NCT00210106|11452364|FG000|Overall Study|Death|1
7242968|NCT00210106|11452364|FG000|Overall Study|Protocol Violation|13
7242969|NCT00210119|11452369|FG000|Overall Study|Protocol Violation|1
7242970|NCT00210119|11452369|FG000|Overall Study|Withdrawal by Subject|1
7242971|NCT00210184|11452373|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
7242972|NCT00210626|11452404|FG000|Overall Study|Adverse Event|1
7242973|NCT00210626|11452405|FG001|Overall Study|Adverse Event|2
7242974|NCT00210626|11452404|FG000|Overall Study|Protocol Violation|1
7242975|NCT00210626|11452405|FG001|Overall Study|Protocol Violation|5
7242976|NCT00210626|11452404|FG000|Overall Study|Lost to Follow-up|11
7242977|NCT00210626|11452405|FG001|Overall Study|Lost to Follow-up|11
7242978|NCT00210626|11452404|FG000|Overall Study|Death|1
7242979|NCT00210626|11452405|FG001|Overall Study|Death|0
7242980|NCT00210626|11452404|FG000|Overall Study|Withdrawal by Subject|29
7242981|NCT00210626|11452405|FG001|Overall Study|Withdrawal by Subject|20
7242982|NCT00210626|11452404|FG000|Overall Study|Physician Decision|0
7242983|NCT00210626|11452405|FG001|Overall Study|Physician Decision|2
7242984|NCT00210626|11452404|FG000|Overall Study|Sponser Request|1
7242985|NCT00210626|11452405|FG001|Overall Study|Sponser Request|0
7242986|NCT00210626|11452404|FG000|Overall Study|Other|4
7242987|NCT00210626|11452405|FG001|Overall Study|Other|5
7242988|NCT00210639|11452413|FG000|Overall Study|Lost to Follow-up|37
7242989|NCT00210639|11452414|FG001|Overall Study|Lost to Follow-up|29
7242990|NCT00210639|11452413|FG000|Overall Study|Withdrawal by Subject|8
7242991|NCT00210639|11452414|FG001|Overall Study|Withdrawal by Subject|1
7242992|NCT00210639|11452413|FG000|Overall Study|Other|18
7242993|NCT00210639|11452414|FG001|Overall Study|Other|12
7242994|NCT00211081|11452420|FG000|Overall Study|Withdrawal by Subject|2
7242995|NCT00211172|11452426|FG000|Overall Study|Died or lost health plan eligibility|39
7242996|NCT00211172|11452427|FG001|Overall Study|Died or lost health plan eligibility|32
7242997|NCT00211185|11452433|FG000|Overall Study|Death|2
7242998|NCT00211185|11452433|FG000|Overall Study|Disease progression|7
7242999|NCT00211185|11452433|FG000|Overall Study|Withdrawal by Subject|6
7243000|NCT00211185|11452433|FG000|Overall Study|Physician Decision|5
7243001|NCT00211237|11452439|FG000|Baseline|Withdrew|1
7243002|NCT00211237|11452440|FG001|Baseline|Withdrew|3
7243003|NCT00211237|11452441|FG002|Baseline|Withdrew|0
7243004|NCT00211237|11452439|FG000|Baseline|Refused random assignment|1
7243005|NCT00211237|11452440|FG001|Baseline|Refused random assignment|0
7243006|NCT00211237|11452441|FG002|Baseline|Refused random assignment|0
7243007|NCT00211237|11452439|FG000|1 Month|Death|2
7243008|NCT00211237|11452440|FG001|1 Month|Death|1
7243009|NCT00211237|11452441|FG002|1 Month|Death|0
7243010|NCT00211237|11452439|FG000|1 Month|Lost to Follow-up|0
7243011|NCT00211237|11452440|FG001|1 Month|Lost to Follow-up|2
7243012|NCT00211237|11452441|FG002|1 Month|Lost to Follow-up|0
7243013|NCT00211237|11452439|FG000|1 Month|Withdrew|0
7243014|NCT00211237|11452440|FG001|1 Month|Withdrew|4
7243015|NCT00211237|11452441|FG002|1 Month|Withdrew|0
7243016|NCT00211237|11452439|FG000|1 Month|Additional surgery needed|1
7243017|NCT00211237|11452440|FG001|1 Month|Additional surgery needed|0
7243018|NCT00211237|11452441|FG002|1 Month|Additional surgery needed|0
7243019|NCT00211237|11452439|FG000|1 Month|Non-medical problem|0
7243020|NCT00211237|11452440|FG001|1 Month|Non-medical problem|2
7243021|NCT00211237|11452441|FG002|1 Month|Non-medical problem|0
7243022|NCT00211237|11452439|FG000|3 Months|Death|7
7243023|NCT00211237|11452440|FG001|3 Months|Death|3
7243024|NCT00211237|11452441|FG002|3 Months|Death|0
7243025|NCT00211237|11452439|FG000|3 Months|Could not comply with protocol|1
7243026|NCT00211237|11452440|FG001|3 Months|Could not comply with protocol|0
7243027|NCT00211237|11452441|FG002|3 Months|Could not comply with protocol|0
7243028|NCT00211237|11452439|FG000|3 Months|Withdrew|0
7243029|NCT00211237|11452440|FG001|3 Months|Withdrew|1
7243030|NCT00211237|11452441|FG002|3 Months|Withdrew|0
7243031|NCT00211237|11452439|FG000|3 Months|Non-medical problem|0
7243032|NCT00211237|11452440|FG001|3 Months|Non-medical problem|0
7243033|NCT00211237|11452441|FG002|3 Months|Non-medical problem|1
7574077|NCT03645434|11956032|FG003|Period 1|COPD exacerbation|0
7574078|NCT03645434|11956033|FG004|Period 1|COPD exacerbation|1
7574079|NCT03645434|11956034|FG005|Period 1|COPD exacerbation|0
7574080|NCT03646305|11956084|FG000|Overall Study|Lost to Follow-up|4
7574081|NCT03646305|11956085|FG001|Overall Study|Lost to Follow-up|2
7574082|NCT03646305|11956086|FG002|Overall Study|Lost to Follow-up|2
7574083|NCT03646305|11956087|FG003|Overall Study|Lost to Follow-up|1
7574084|NCT03646305|11956084|FG000|Overall Study|Withdrawal by Subject|1
7243034|NCT00211237|11452439|FG000|6 Months|Death|6
7243035|NCT00211237|11452440|FG001|6 Months|Death|0
7243036|NCT00211237|11452441|FG002|6 Months|Death|3
7243037|NCT00211237|11452439|FG000|6 Months|Lost to Follow-up|2
7243038|NCT00211237|11452440|FG001|6 Months|Lost to Follow-up|0
7243039|NCT00211237|11452441|FG002|6 Months|Lost to Follow-up|0
7243040|NCT00211237|11452439|FG000|6 Months|Could not comply with protocol|0
7243041|NCT00211237|11452440|FG001|6 Months|Could not comply with protocol|2
7243042|NCT00211237|11452441|FG002|6 Months|Could not comply with protocol|0
7243043|NCT00211237|11452439|FG000|12 Months|Death|8
7243044|NCT00211237|11452440|FG001|12 Months|Death|2
7243045|NCT00211237|11452441|FG002|12 Months|Death|3
7243046|NCT00211237|11452439|FG000|12 Months|Lost to Follow-up|1
7243047|NCT00211237|11452440|FG001|12 Months|Lost to Follow-up|0
7243048|NCT00211237|11452441|FG002|12 Months|Lost to Follow-up|1
7243049|NCT00211237|11452439|FG000|12 Months|Withdrew|0
7243050|NCT00211237|11452440|FG001|12 Months|Withdrew|0
7243051|NCT00211237|11452441|FG002|12 Months|Withdrew|1
7243052|NCT00211237|11452439|FG000|12 Months|unrelated medical problem|0
7243053|NCT00211237|11452440|FG001|12 Months|unrelated medical problem|0
7243054|NCT00211237|11452441|FG002|12 Months|unrelated medical problem|1
7574085|NCT03646305|11956085|FG001|Overall Study|Withdrawal by Subject|0
7574086|NCT03646305|11956086|FG002|Overall Study|Withdrawal by Subject|0
7243055|NCT00211510|11452460|FG000|Overall Study|Physician Decision|3
7574087|NCT03646305|11956087|FG003|Overall Study|Withdrawal by Subject|1
7243056|NCT00211510|11452461|FG001|Overall Study|Physician Decision|1
7243057|NCT00211510|11452460|FG000|Overall Study|Withdrawal by Subject|3
7243058|NCT00211510|11452461|FG001|Overall Study|Withdrawal by Subject|1
7243059|NCT00211536|11452472|FG000|Overall Study|Withdrawal by Subject|2
7243060|NCT00211536|11452473|FG001|Overall Study|Withdrawal by Subject|2
7243061|NCT00211536|11452472|FG000|Overall Study|Physician Decision|0
7243062|NCT00211536|11452473|FG001|Overall Study|Physician Decision|5
7243063|NCT00211536|11452472|FG000|Overall Study|Adverse Event|2
7243064|NCT00211536|11452473|FG001|Overall Study|Adverse Event|0
7243065|NCT00211757|11452490|FG000|Overall Study|Withdrawal by Subject|1
7243066|NCT00211757|11452491|FG001|Overall Study|Withdrawal by Subject|1
7243067|NCT00211757|11452490|FG000|Overall Study|Lack of Efficacy|0
7243068|NCT00211757|11452491|FG001|Overall Study|Lack of Efficacy|1
7243069|NCT00211809|11452499|FG000|Overall Study|Lack of Efficacy|1
7243070|NCT00211809|11452499|FG000|Overall Study|Lost to Follow-up|2
7243071|NCT00211809|11452499|FG000|Overall Study|Pregnancy|1
7243072|NCT00211809|11452499|FG000|Overall Study|side effects|2
7243073|NCT00211887|11452508|FG000|Overall Study|Adverse Event|8
7243074|NCT00211887|11452509|FG001|Overall Study|Adverse Event|4
7243075|NCT00211887|11452510|FG002|Overall Study|Adverse Event|6
7243076|NCT00211887|11452508|FG000|Overall Study|Death|1
7243077|NCT00211887|11452509|FG001|Overall Study|Death|1
7243078|NCT00211887|11452510|FG002|Overall Study|Death|1
7243079|NCT00211887|11452508|FG000|Overall Study|Lost to Follow-up|28
7243080|NCT00211887|11452509|FG001|Overall Study|Lost to Follow-up|13
7243081|NCT00211887|11452510|FG002|Overall Study|Lost to Follow-up|9
7243082|NCT00211887|11452508|FG000|Overall Study|Non-medical reason|31
7243083|NCT00211887|11452509|FG001|Overall Study|Non-medical reason|14
7243084|NCT00211887|11452510|FG002|Overall Study|Non-medical reason|8
7243085|NCT00211887|11452508|FG000|Overall Study|Other medical reason|15
7243086|NCT00211887|11452509|FG001|Overall Study|Other medical reason|11
7243087|NCT00211887|11452510|FG002|Overall Study|Other medical reason|7
7243088|NCT00211887|11452508|FG000|Overall Study|Side effects|19
7243089|NCT00211887|11452509|FG001|Overall Study|Side effects|13
7243090|NCT00211887|11452510|FG002|Overall Study|Side effects|5
7243091|NCT00212355|11452544|FG000|Overall Study|Adverse Event|1
7243092|NCT00212355|11452544|FG000|Overall Study|Withdrawal by Subject|1
7243093|NCT00212355|11452544|FG000|Overall Study|A change of address|1
7243094|NCT00212758|11452552|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
7243095|NCT00212758|11452553|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
7243096|NCT00212758|11452552|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7243097|NCT00212758|11452553|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
7243098|NCT00213135|11452577|FG000|Overall Study|Adverse Event|9
7243099|NCT00213135|11452578|FG001|Overall Study|Adverse Event|5
7243100|NCT00213135|11452579|FG002|Overall Study|Adverse Event|5
7243101|NCT00213135|11452577|FG000|Overall Study|Lost to Follow-up|11
7243102|NCT00213135|11452578|FG001|Overall Study|Lost to Follow-up|8
7243103|NCT00213135|11452579|FG002|Overall Study|Lost to Follow-up|4
7243104|NCT00213135|11452577|FG000|Overall Study|Protocol Violation|4
7243105|NCT00213135|11452578|FG001|Overall Study|Protocol Violation|4
7243106|NCT00213135|11452579|FG002|Overall Study|Protocol Violation|10
7243107|NCT00213135|11452577|FG000|Overall Study|Death|1
7243108|NCT00213135|11452578|FG001|Overall Study|Death|1
7243109|NCT00213135|11452579|FG002|Overall Study|Death|2
7243110|NCT00213135|11452577|FG000|Overall Study|Disease progression|4
7243111|NCT00213135|11452578|FG001|Overall Study|Disease progression|5
7243112|NCT00213135|11452579|FG002|Overall Study|Disease progression|21
7243113|NCT00213135|11452577|FG000|Overall Study|Other|21
7243114|NCT00213135|11452578|FG001|Overall Study|Other|12
7243115|NCT00213135|11452579|FG002|Overall Study|Other|15
7243116|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
7243117|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
7243118|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
7243119|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
7243120|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
7243121|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Adverse Event|0
7243122|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Adverse Event|0
7243123|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Adverse Event|1
7243124|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Adverse Event|0
7243125|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Adverse Event|0
7243126|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
7243127|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
7243128|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
7243129|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
7243130|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
7243131|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Protocol Violation|1
7243132|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Protocol Violation|0
7243133|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Protocol Violation|1
7243134|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Protocol Violation|0
7243135|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Protocol Violation|0
7243136|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Other|3
7243137|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Other|0
7243138|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Other|2
7243139|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Other|2
7243140|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Other|7
7243141|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7243142|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7243143|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7243144|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
7243145|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
7243146|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7243147|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7243148|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7243149|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
7243150|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
7243151|NCT00213148|11452591|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
7243152|NCT00213148|11452592|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
7243153|NCT00213148|11452593|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7243154|NCT00213148|11452594|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
7243155|NCT00213148|11452595|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
7243156|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
7243157|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
7243158|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
7243159|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
7243160|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
7243161|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
7243162|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
7243163|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
7243164|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
7243165|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
7243166|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Other|2
7243167|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Other|1
7243168|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Other|2
7243169|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Other|8
7243170|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Other|7
7243171|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7243172|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
7243173|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7243174|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7243175|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
7243176|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
7243177|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7243178|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7243179|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7243180|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
7243181|NCT00213148|11452591|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
7243182|NCT00213148|11452592|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
7243183|NCT00213148|11452593|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7243184|NCT00213148|11452594|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
7243185|NCT00213148|11452595|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
7243186|NCT00213148|11452591|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
7243187|NCT00213148|11452592|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
7243188|NCT00213148|11452593|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
7243189|NCT00213148|11452594|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
7243190|NCT00213148|11452595|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
7243191|NCT00213148|11452591|FG000|Cycle 3 (1 Month)|Other|0
7243192|NCT00213148|11452592|FG001|Cycle 3 (1 Month)|Other|0
7243193|NCT00213148|11452593|FG002|Cycle 3 (1 Month)|Other|1
7243194|NCT00213148|11452594|FG003|Cycle 3 (1 Month)|Other|1
7243195|NCT00213148|11452595|FG004|Cycle 3 (1 Month)|Other|0
7243196|NCT00213980|11452626|FG000|Overall Study|Withdrawal by Subject|3
7243197|NCT00213980|11452627|FG001|Overall Study|Withdrawal by Subject|1
7243198|NCT00213980|11452626|FG000|Overall Study|Adverse Event|1
7243199|NCT00213980|11452627|FG001|Overall Study|Adverse Event|1
7243200|NCT00213980|11452626|FG000|Overall Study|Disease progression|0
7243201|NCT00213980|11452627|FG001|Overall Study|Disease progression|2
7243202|NCT00213980|11452626|FG000|Overall Study|Developed ovarian cancer|1
7243203|NCT00213980|11452627|FG001|Overall Study|Developed ovarian cancer|0
7243204|NCT00213980|11452626|FG000|Overall Study|Failed to obtain all 3 DXAs|1
7243205|NCT00213980|11452627|FG001|Overall Study|Failed to obtain all 3 DXAs|3
7243206|NCT00214019|11452633|FG000|Overall Study|Lost to Follow-up|11
7243207|NCT00214019|11452633|FG000|Overall Study|Withdrawal by Subject|2
7243208|NCT00214019|11452633|FG000|Overall Study|Screen Failed prior to randomization|17
7243209|NCT00214136|11452668|FG000|Overall Study|Death|5
7243210|NCT00214201|11452674|FG000|Overall Study|Withdrawal by Subject|2
7243211|NCT00214201|11452675|FG001|Overall Study|Withdrawal by Subject|0
7243212|NCT00214201|11452674|FG000|Overall Study|Death|0
7243213|NCT00214201|11452675|FG001|Overall Study|Death|2
7243214|NCT00214383|11452684|FG000|Overall Study|Lost to Follow-up|16
7243215|NCT00214383|11452685|FG001|Overall Study|Lost to Follow-up|26
7243216|NCT00214422|11452694|FG000|Overall Study|Physician Decision|2
7243217|NCT00214422|11452695|FG001|Overall Study|Physician Decision|0
7243218|NCT00214422|11452696|FG002|Overall Study|Physician Decision|0
7243219|NCT00214422|11452694|FG000|Overall Study|Developed esophageal ca|1
7243220|NCT00214422|11452695|FG001|Overall Study|Developed esophageal ca|0
7243221|NCT00214422|11452696|FG002|Overall Study|Developed esophageal ca|0
7243222|NCT00214422|11452694|FG000|Overall Study|Pt taken off study|1
7243223|NCT00214422|11452695|FG001|Overall Study|Pt taken off study|1
7243224|NCT00214422|11452696|FG002|Overall Study|Pt taken off study|0
7243225|NCT00214422|11452694|FG000|Overall Study|Disease progression on study|1
7243226|NCT00214422|11452695|FG001|Overall Study|Disease progression on study|0
7243227|NCT00214422|11452696|FG002|Overall Study|Disease progression on study|0
7243228|NCT00214422|11452694|FG000|Overall Study|Unable to make a radiation treatment|0
7243229|NCT00214422|11452695|FG001|Overall Study|Unable to make a radiation treatment|0
7243230|NCT00214422|11452696|FG002|Overall Study|Unable to make a radiation treatment|1
7243231|NCT00214461|11452712|FG000|Overall Study|Adverse Event|0
7243232|NCT00214461|11452713|FG001|Overall Study|Adverse Event|0
7243233|NCT00214461|11452714|FG002|Overall Study|Adverse Event|1
7243234|NCT00214461|11452715|FG003|Overall Study|Adverse Event|1
7243235|NCT00214461|11452712|FG000|Overall Study|Withdrawal by Subject|0
7243236|NCT00214461|11452713|FG001|Overall Study|Withdrawal by Subject|0
7243237|NCT00214461|11452714|FG002|Overall Study|Withdrawal by Subject|1
7243238|NCT00214461|11452715|FG003|Overall Study|Withdrawal by Subject|0
7243239|NCT00215137|11452788|FG000|Open Label Escitalopram|Lack of Efficacy|1
7243240|NCT00215137|11452789|FG001|Open Label Escitalopram|Lack of Efficacy|0
7243241|NCT00215137|11452790|FG002|Open Label Escitalopram|Lack of Efficacy|0
7243242|NCT00215137|11452788|FG000|Randomization Period|Lost to Follow-up|0
7243243|NCT00215137|11452789|FG001|Randomization Period|Lost to Follow-up|1
7243244|NCT00215137|11452790|FG002|Randomization Period|Lost to Follow-up|0
7243245|NCT00215137|11452788|FG000|Randomization Period|Withdrawal by Subject|0
7243246|NCT00215137|11452789|FG001|Randomization Period|Withdrawal by Subject|1
7243247|NCT00215137|11452790|FG002|Randomization Period|Withdrawal by Subject|0
7243248|NCT00215150|11452798|FG000|Open Label Phase|Lost to Follow-up|7
7243249|NCT00215150|11452798|FG000|Open Label Phase|Withdrawal by Subject|1
7243250|NCT00215150|11452798|FG000|Open Label Phase|Did not complete a post base visit|13
7243251|NCT00215150|11452798|FG000|Open Label Phase|Did not meet randomization criteria|9
7243252|NCT00215150|11452798|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
7243253|NCT00215150|11452798|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
7243254|NCT00215150|11452798|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
7574088|NCT03646656|11956103|FG000|Overall Study|Lost to Follow-up|1
7574089|NCT03646656|11956104|FG001|Overall Study|Lost to Follow-up|0
7574090|NCT03646656|11956103|FG000|Overall Study|Withdrawal by Subject|2
7574091|NCT03646656|11956104|FG001|Overall Study|Withdrawal by Subject|0
7243255|NCT00215540|11452809|FG000|Overall Study|Withdrew from study medication|1
7243256|NCT00215540|11452810|FG001|Overall Study|Withdrew from study medication|0
7243257|NCT00215540|11452811|FG002|Overall Study|Withdrew from study medication|0
7243258|NCT00215553|11452826|FG000|Overall Study|Adverse Event|0
7243259|NCT00215553|11452827|FG001|Overall Study|Adverse Event|1
7243260|NCT00215553|11452828|FG002|Overall Study|Adverse Event|2
7243261|NCT00215553|11452829|FG003|Overall Study|Adverse Event|1
7243262|NCT00215553|11452830|FG004|Overall Study|Adverse Event|2
7243263|NCT00215553|11452831|FG005|Overall Study|Adverse Event|6
7243264|NCT00215553|11452832|FG006|Overall Study|Adverse Event|0
7243265|NCT00215644|11452850|FG000|Overall Study|Disease Progression|28
7243266|NCT00215644|11452851|FG001|Overall Study|Disease Progression|10
7243267|NCT00215644|11452850|FG000|Overall Study|Adverse Event|2
7243268|NCT00215644|11452851|FG001|Overall Study|Adverse Event|9
7243269|NCT00215644|11452850|FG000|Overall Study|Death|1
7243270|NCT00215644|11452851|FG001|Overall Study|Death|2
7243271|NCT00215644|11452850|FG000|Overall Study|Withdrawal by Subject|1
7243272|NCT00215644|11452851|FG001|Overall Study|Withdrawal by Subject|0
7243273|NCT00215644|11452850|FG000|Overall Study|Other|3
7243274|NCT00215644|11452851|FG001|Overall Study|Other|15
7243275|NCT00215644|11452850|FG000|Overall Study|Randomized but Not Treated|1
7243276|NCT00215644|11452851|FG001|Overall Study|Randomized but Not Treated|0
7243277|NCT00215657|11452865|FG000|Overall Study|Adverse Event|5
7243278|NCT00215657|11452866|FG001|Overall Study|Adverse Event|1
7243279|NCT00215657|11452867|FG002|Overall Study|Adverse Event|3
7243280|NCT00215657|11452868|FG003|Overall Study|Adverse Event|0
7243281|NCT00215657|11452869|FG004|Overall Study|Adverse Event|3
7243282|NCT00215657|11452870|FG005|Overall Study|Adverse Event|1
7243283|NCT00215657|11452871|FG006|Overall Study|Adverse Event|0
7243284|NCT00215657|11452872|FG007|Overall Study|Adverse Event|3
7243285|NCT00215657|11452865|FG000|Overall Study|Withdrawal by Subject|6
7243286|NCT00215657|11452866|FG001|Overall Study|Withdrawal by Subject|3
7243287|NCT00215657|11452867|FG002|Overall Study|Withdrawal by Subject|3
7574094|NCT03647709|11956142|FG000|Overall Study|Lost to Follow-up|5
7574095|NCT03647709|11956142|FG000|Overall Study|Physician Decision|6
7574096|NCT03647709|11956142|FG000|Overall Study|Withdrawal by Subject|3
7575467|NCT03739840|11959101|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7243288|NCT00215657|11452868|FG003|Overall Study|Withdrawal by Subject|1
7243289|NCT00215657|11452869|FG004|Overall Study|Withdrawal by Subject|6
7243290|NCT00215657|11452870|FG005|Overall Study|Withdrawal by Subject|1
7243291|NCT00215657|11452871|FG006|Overall Study|Withdrawal by Subject|10
7243292|NCT00215657|11452872|FG007|Overall Study|Withdrawal by Subject|3
7243293|NCT00215657|11452865|FG000|Overall Study|Insuff prostate specific antigen resp|3
7243294|NCT00215657|11452866|FG001|Overall Study|Insuff prostate specific antigen resp|2
7243295|NCT00215657|11452867|FG002|Overall Study|Insuff prostate specific antigen resp|2
7243296|NCT00215657|11452868|FG003|Overall Study|Insuff prostate specific antigen resp|2
7243297|NCT00215657|11452869|FG004|Overall Study|Insuff prostate specific antigen resp|1
7243298|NCT00215657|11452870|FG005|Overall Study|Insuff prostate specific antigen resp|2
7243299|NCT00215657|11452871|FG006|Overall Study|Insuff prostate specific antigen resp|3
7243300|NCT00215657|11452872|FG007|Overall Study|Insuff prostate specific antigen resp|2
7243301|NCT00215657|11452865|FG000|Overall Study|Insufficient testosterone response|5
7243302|NCT00215657|11452866|FG001|Overall Study|Insufficient testosterone response|4
7243303|NCT00215657|11452867|FG002|Overall Study|Insufficient testosterone response|1
7243304|NCT00215657|11452868|FG003|Overall Study|Insufficient testosterone response|12
7243305|NCT00215657|11452869|FG004|Overall Study|Insufficient testosterone response|8
7243306|NCT00215657|11452870|FG005|Overall Study|Insufficient testosterone response|12
7243307|NCT00215657|11452871|FG006|Overall Study|Insufficient testosterone response|4
7243308|NCT00215657|11452872|FG007|Overall Study|Insufficient testosterone response|7
7243309|NCT00215657|11452865|FG000|Overall Study|Other|3
7243310|NCT00215657|11452866|FG001|Overall Study|Other|1
7243311|NCT00215657|11452867|FG002|Overall Study|Other|2
7243312|NCT00215657|11452868|FG003|Overall Study|Other|3
7243313|NCT00215657|11452869|FG004|Overall Study|Other|5
7243314|NCT00215657|11452870|FG005|Overall Study|Other|4
7243315|NCT00215657|11452871|FG006|Overall Study|Other|6
7243316|NCT00215657|11452872|FG007|Overall Study|Other|1
7243317|NCT00215683|11452893|FG000|Overall Study|Adverse Event|15
7243318|NCT00215683|11452894|FG001|Overall Study|Adverse Event|16
7243319|NCT00215683|11452895|FG002|Overall Study|Adverse Event|15
7243320|NCT00215683|11452893|FG000|Overall Study|Lack of Efficacy|5
7243321|NCT00215683|11452894|FG001|Overall Study|Lack of Efficacy|1
7243322|NCT00215683|11452895|FG002|Overall Study|Lack of Efficacy|2
7243323|NCT00215683|11452893|FG000|Overall Study|Lost to Follow-up|0
7243324|NCT00215683|11452894|FG001|Overall Study|Lost to Follow-up|2
7243325|NCT00215683|11452895|FG002|Overall Study|Lost to Follow-up|1
7243326|NCT00215683|11452893|FG000|Overall Study|Withdrawal by Subject|9
7243327|NCT00215683|11452894|FG001|Overall Study|Withdrawal by Subject|4
7243328|NCT00215683|11452895|FG002|Overall Study|Withdrawal by Subject|13
7243329|NCT00215683|11452893|FG000|Overall Study|Physician Decision|0
7243330|NCT00215683|11452894|FG001|Overall Study|Physician Decision|0
7243331|NCT00215683|11452895|FG002|Overall Study|Physician Decision|1
7243332|NCT00215683|11452893|FG000|Overall Study|Difficult to attend visits|0
7243333|NCT00215683|11452894|FG001|Overall Study|Difficult to attend visits|1
7243334|NCT00215683|11452895|FG002|Overall Study|Difficult to attend visits|0
7243335|NCT00215683|11452893|FG000|Overall Study|No study drug available|0
7243336|NCT00215683|11452894|FG001|Overall Study|No study drug available|1
7243337|NCT00215683|11452895|FG002|Overall Study|No study drug available|0
7243338|NCT00215683|11452893|FG000|Overall Study|Intermittent therapy required|0
7243339|NCT00215683|11452894|FG001|Overall Study|Intermittent therapy required|1
7243340|NCT00215683|11452895|FG002|Overall Study|Intermittent therapy required|0
7243341|NCT00215943|11452914|FG000|Overall Study|Disease Progression|3
7243342|NCT00215943|11452915|FG001|Overall Study|Disease Progression|5
7243343|NCT00215943|11452914|FG000|Overall Study|Alternate therapy|0
7243344|NCT00215943|11452915|FG001|Overall Study|Alternate therapy|1
7243345|NCT00215943|11452914|FG000|Overall Study|Adverse Event|3
7243346|NCT00215943|11452915|FG001|Overall Study|Adverse Event|6
7243347|NCT00215943|11452914|FG000|Overall Study|Other disease|0
7243348|NCT00215943|11452915|FG001|Overall Study|Other disease|1
7243349|NCT00215943|11452914|FG000|Overall Study|Other complications|3
7243350|NCT00215943|11452915|FG001|Overall Study|Other complications|1
7243351|NCT00216086|11452932|FG000|Overall Study|Protocol Violation|1
7243352|NCT00216086|11452932|FG000|Overall Study|Diagnosis of Metastatic Disease|1
7243353|NCT00216086|11452932|FG000|Overall Study|Social Reasons|2
7243354|NCT00216203|11452949|FG000|Overall Study|Withdrawal by Subject|2
7243355|NCT00216476|11452970|FG000|Overall Study|Withdrawal by Subject|59
7243356|NCT00216476|11452971|FG001|Overall Study|Withdrawal by Subject|72
7243357|NCT00216476|11452972|FG002|Overall Study|Withdrawal by Subject|9
7243358|NCT00216476|11452970|FG000|Overall Study|Lost to Follow-up|10
7243359|NCT00216476|11452971|FG001|Overall Study|Lost to Follow-up|9
7243360|NCT00216476|11452972|FG002|Overall Study|Lost to Follow-up|1
7243361|NCT00216476|11452970|FG000|Overall Study|Adverse Event|6
7243362|NCT00216476|11452971|FG001|Overall Study|Adverse Event|10
7243363|NCT00216476|11452972|FG002|Overall Study|Adverse Event|1
7243364|NCT00216476|11452970|FG000|Overall Study|Lack of Efficacy|4
7243365|NCT00216476|11452971|FG001|Overall Study|Lack of Efficacy|3
7243366|NCT00216476|11452972|FG002|Overall Study|Lack of Efficacy|0
7243367|NCT00216476|11452970|FG000|Overall Study|Death|2
7243368|NCT00216476|11452971|FG001|Overall Study|Death|0
7243369|NCT00216476|11452972|FG002|Overall Study|Death|0
7243370|NCT00216476|11452970|FG000|Overall Study|Pregnancy|0
7243371|NCT00216476|11452971|FG001|Overall Study|Pregnancy|1
7243372|NCT00216476|11452972|FG002|Overall Study|Pregnancy|1
7243373|NCT00216476|11452970|FG000|Overall Study|Other|0
7243374|NCT00216476|11452971|FG001|Overall Study|Other|0
7243375|NCT00216476|11452972|FG002|Overall Study|Other|1
7243376|NCT00216476|11452970|FG000|Overall Study|Refuses Injection|11
7243377|NCT00216476|11452971|FG001|Overall Study|Refuses Injection|0
7243378|NCT00216476|11452972|FG002|Overall Study|Refuses Injection|0
7243379|NCT00216476|11452970|FG000|Overall Study|No Further Need for Treatment|3
7243380|NCT00216476|11452971|FG001|Overall Study|No Further Need for Treatment|4
7243381|NCT00216476|11452972|FG002|Overall Study|No Further Need for Treatment|1
7243382|NCT00216476|11452970|FG000|Overall Study|Non-compliance|0
7243383|NCT00216476|11452971|FG001|Overall Study|Non-compliance|4
7243384|NCT00216476|11452972|FG002|Overall Study|Non-compliance|1
7243385|NCT00216476|11452970|FG000|Overall Study|Higher dose/Extra Medication Required|2
7243386|NCT00216476|11452971|FG001|Overall Study|Higher dose/Extra Medication Required|0
7243387|NCT00216476|11452972|FG002|Overall Study|Higher dose/Extra Medication Required|2
7243388|NCT00216476|11452970|FG000|Overall Study|Administrative Reasons|1
7243389|NCT00216476|11452971|FG001|Overall Study|Administrative Reasons|1
7243390|NCT00216476|11452972|FG002|Overall Study|Administrative Reasons|0
7243391|NCT00216476|11452970|FG000|Overall Study|Protocol Deviation|5
7243392|NCT00216476|11452971|FG001|Overall Study|Protocol Deviation|1
7243393|NCT00216476|11452972|FG002|Overall Study|Protocol Deviation|0
7243394|NCT00216476|11452970|FG000|Overall Study|Patient Moved|2
7243395|NCT00216476|11452971|FG001|Overall Study|Patient Moved|2
7243396|NCT00216476|11452972|FG002|Overall Study|Patient Moved|0
7243397|NCT00216671|11452985|FG000|Overall Study|Adverse Event|4
7243398|NCT00216671|11452986|FG001|Overall Study|Adverse Event|9
7243399|NCT00216671|11452985|FG000|Overall Study|Pregnancy|0
7243400|NCT00216671|11452986|FG001|Overall Study|Pregnancy|1
7243401|NCT00216671|11452985|FG000|Overall Study|Withdrawal by Subject|4
7243402|NCT00216671|11452986|FG001|Overall Study|Withdrawal by Subject|2
7243403|NCT00216671|11452985|FG000|Overall Study|Refused Injections|3
7243404|NCT00216671|11452986|FG001|Overall Study|Refused Injections|13
7243405|NCT00216671|11452985|FG000|Overall Study|No Need to Continue Medication|1
7243406|NCT00216671|11452986|FG001|Overall Study|No Need to Continue Medication|1
7243407|NCT00216671|11452985|FG000|Overall Study|Insufficient Response|9
7243408|NCT00216671|11452986|FG001|Overall Study|Insufficient Response|4
7243409|NCT00216671|11452985|FG000|Overall Study|Lost to Follow-up|3
7243410|NCT00216671|11452986|FG001|Overall Study|Lost to Follow-up|5
7243411|NCT00216671|11452985|FG000|Overall Study|Non compliant|2
7243412|NCT00216671|11452986|FG001|Overall Study|Non compliant|2
7243413|NCT00216671|11452985|FG000|Overall Study|Ineligible|0
7243414|NCT00216671|11452986|FG001|Overall Study|Ineligible|2
7243415|NCT00216671|11452985|FG000|Overall Study|Physician Decision|1
7243416|NCT00216671|11452986|FG001|Overall Study|Physician Decision|1
7243417|NCT00216671|11452985|FG000|Overall Study|Protocol Violation|3
7243418|NCT00216671|11452986|FG001|Overall Study|Protocol Violation|5
7243419|NCT00216671|11452985|FG000|Overall Study|Relapse|1
7243420|NCT00216671|11452986|FG001|Overall Study|Relapse|0
7243421|NCT00216671|11452985|FG000|Overall Study|Investigator Illness|0
7243422|NCT00216671|11452986|FG001|Overall Study|Investigator Illness|1
7243423|NCT00216671|11452985|FG000|Overall Study|Patient Moved|0
7243424|NCT00216671|11452986|FG001|Overall Study|Patient Moved|1
7243425|NCT00216671|11452985|FG000|Overall Study|Ineligible, no efficacy data|2
7243426|NCT00216671|11452986|FG001|Overall Study|Ineligible, no efficacy data|2
7243427|NCT00216671|11452985|FG000|Overall Study|Insufficient Response Adverse Event|2
7243428|NCT00216671|11452986|FG001|Overall Study|Insufficient Response Adverse Event|1
7243429|NCT00216736|11452994|FG000|Overall Study|Lost to Follow-up|1
7243430|NCT00216736|11452995|FG001|Overall Study|Lost to Follow-up|1
7243431|NCT00217022|11453003|FG000|Overall Study|Withdrawal by Subject|1
7243432|NCT00217022|11453004|FG001|Overall Study|Withdrawal by Subject|1
7243433|NCT00217087|11453012|FG000|Overall Study|decided to have esophagectomy|1
7243434|NCT00217087|11453013|FG001|Overall Study|decided to have esophagectomy|2
7243435|NCT00217087|11453012|FG000|Overall Study|completed less than 12 months return|10
7243436|NCT00217087|11453013|FG001|Overall Study|completed less than 12 months return|18
7243437|NCT00217425|11453031|FG000|Overall Study|Never started treatment|2
7243438|NCT00217425|11453031|FG000|Overall Study|Patient ineligible|5
7243439|NCT00217425|11453031|FG000|Overall Study|Lack of Efficacy|13
7243440|NCT00217425|11453031|FG000|Overall Study|Adverse Event|8
7243441|NCT00217425|11453031|FG000|Overall Study|Withdrawal by Subject|4
7243442|NCT00217425|11453031|FG000|Overall Study|Other complicating disease|1
7243443|NCT00217425|11453031|FG000|Overall Study|Other|4
7243444|NCT00217464|11453044|FG000|Overall Study|Progression|15
7243445|NCT00217464|11453044|FG000|Overall Study|Other|2
7243446|NCT00217581|11453069|FG000|Overall Study|Withdrawal by Subject|1
7243447|NCT00217620|11453078|FG000|Overall Study|Adverse Event|2
7243448|NCT00217620|11453078|FG000|Overall Study|Progression|31
7243449|NCT00217620|11453078|FG000|Overall Study|Not Protocol Specified|4
7243450|NCT00217620|11453078|FG000|Overall Study|Ineligible|13
7243451|NCT00217620|11453078|FG000|Overall Study|Never received treatment|1
7243452|NCT00217672|11453086|FG000|Allocation|Ineligible|2
7243453|NCT00217672|11453087|FG001|Allocation|Ineligible|0
7243454|NCT00217672|11453086|FG000|Treatment|disease progression|33
7243455|NCT00217672|11453087|FG001|Treatment|disease progression|4
7243456|NCT00217672|11453086|FG000|Treatment|Adverse Event|18
7243457|NCT00217672|11453087|FG001|Treatment|Adverse Event|2
7243458|NCT00217672|11453086|FG000|Treatment|reqd treatment not permitted by protocol|6
7243459|NCT00217672|11453087|FG001|Treatment|reqd treatment not permitted by protocol|0
7243460|NCT00217672|11453086|FG000|Treatment|Physician Decision|6
7243461|NCT00217672|11453087|FG001|Treatment|Physician Decision|0
7243462|NCT00217672|11453086|FG000|Treatment|insurance issues|1
7243463|NCT00217672|11453087|FG001|Treatment|insurance issues|1
7243464|NCT00217672|11453086|FG000|Treatment|Death|2
7243465|NCT00217672|11453087|FG001|Treatment|Death|0
7243466|NCT00217672|11453086|FG000|Treatment|secondary malignancy|1
7243467|NCT00217672|11453087|FG001|Treatment|secondary malignancy|0
7243468|NCT00217672|11453086|FG000|Follow-up|Withdrawal by Subject|4
7243469|NCT00217672|11453087|FG001|Follow-up|Withdrawal by Subject|0
7243470|NCT00217672|11453086|FG000|Follow-up|Lost to Follow-up|1
7243471|NCT00217672|11453087|FG001|Follow-up|Lost to Follow-up|0
7243472|NCT00217971|11453100|FG000|Overall Study|Adverse Event|1
7243473|NCT00217971|11453101|FG001|Overall Study|Adverse Event|1
7243474|NCT00217971|11453100|FG000|Overall Study|Lost to Follow-up|15
7243475|NCT00217971|11453101|FG001|Overall Study|Lost to Follow-up|19
7243476|NCT00217971|11453100|FG000|Overall Study|Physician Decision|0
7243477|NCT00217971|11453101|FG001|Overall Study|Physician Decision|1
7243478|NCT00217971|11453100|FG000|Overall Study|Withdrawal by Subject|7
7243479|NCT00217971|11453101|FG001|Overall Study|Withdrawal by Subject|12
7243480|NCT00217971|11453100|FG000|Overall Study|non compliant|1
7243481|NCT00217971|11453101|FG001|Overall Study|non compliant|0
7243482|NCT00218257|11453141|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
7243483|NCT00218257|11453142|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
7243484|NCT00218296|11453153|FG000|Overall Study|Lost to Follow-up|9
7243485|NCT00218296|11453154|FG001|Overall Study|Lost to Follow-up|7
7243486|NCT00218296|11453153|FG000|Overall Study|Withdrawal by Subject|36
7243487|NCT00218296|11453154|FG001|Overall Study|Withdrawal by Subject|47
7243488|NCT00218296|11453153|FG000|Overall Study|Randomized but did not enter treatment|66
7243489|NCT00218296|11453154|FG001|Overall Study|Randomized but did not enter treatment|67
7256136|NCT00321711|11467611|FG004|Part A|Disease progression|0
7256137|NCT00321711|11467607|FG000|Part A|Requirement for alternative therapy|0
7256138|NCT00321711|11467608|FG001|Part A|Requirement for alternative therapy|2
7256139|NCT00321711|11467609|FG002|Part A|Requirement for alternative therapy|1
7256140|NCT00321711|11467610|FG003|Part A|Requirement for alternative therapy|0
7256141|NCT00321711|11467611|FG004|Part A|Requirement for alternative therapy|0
7256142|NCT00321711|11467607|FG000|Part A|Physician Decision|0
7256143|NCT00321711|11467608|FG001|Part A|Physician Decision|1
7256144|NCT00321711|11467609|FG002|Part A|Physician Decision|3
7256145|NCT00321711|11467610|FG003|Part A|Physician Decision|0
7256146|NCT00321711|11467611|FG004|Part A|Physician Decision|0
7256147|NCT00321711|11467607|FG000|Part A|Other|1
7256148|NCT00321711|11467608|FG001|Part A|Other|2
7256149|NCT00321711|11467609|FG002|Part A|Other|3
7256150|NCT00321711|11467610|FG003|Part A|Other|0
7256151|NCT00321711|11467611|FG004|Part A|Other|0
7256152|NCT00321711|11467607|FG000|Part A|Protocol deviation|0
7256153|NCT00321711|11467608|FG001|Part A|Protocol deviation|0
7256154|NCT00321711|11467609|FG002|Part A|Protocol deviation|1
7256155|NCT00321711|11467610|FG003|Part A|Protocol deviation|0
7256156|NCT00321711|11467611|FG004|Part A|Protocol deviation|0
7256157|NCT00321711|11467607|FG000|Part B|Noncompliance|0
7256158|NCT00321711|11467608|FG001|Part B|Noncompliance|0
7256159|NCT00321711|11467609|FG002|Part B|Noncompliance|0
7256160|NCT00321711|11467610|FG003|Part B|Noncompliance|0
7256161|NCT00321711|11467611|FG004|Part B|Noncompliance|1
7256162|NCT00321711|11467607|FG000|Part B|Adverse Event|0
7256163|NCT00321711|11467608|FG001|Part B|Adverse Event|0
7256164|NCT00321711|11467609|FG002|Part B|Adverse Event|0
7256165|NCT00321711|11467610|FG003|Part B|Adverse Event|2
7256166|NCT00321711|11467611|FG004|Part B|Adverse Event|1
7256167|NCT00321711|11467607|FG000|Part B|Disease progression|0
7256168|NCT00321711|11467608|FG001|Part B|Disease progression|0
7256169|NCT00321711|11467609|FG002|Part B|Disease progression|0
7256170|NCT00321711|11467610|FG003|Part B|Disease progression|1
7256171|NCT00321711|11467611|FG004|Part B|Disease progression|0
7256172|NCT00321711|11467607|FG000|Part B|Physician Decision|0
7256173|NCT00321711|11467608|FG001|Part B|Physician Decision|0
7256174|NCT00321711|11467609|FG002|Part B|Physician Decision|0
7256175|NCT00321711|11467610|FG003|Part B|Physician Decision|1
7256176|NCT00321711|11467611|FG004|Part B|Physician Decision|2
7256177|NCT00321711|11467607|FG000|Part B|Death|0
7256178|NCT00321711|11467608|FG001|Part B|Death|0
7256179|NCT00321711|11467609|FG002|Part B|Death|0
7256180|NCT00321711|11467610|FG003|Part B|Death|2
7256181|NCT00321711|11467611|FG004|Part B|Death|1
7256182|NCT00321737|11467626|FG000|Overall Study|Relapse of Erosive Esophagitis|76
7256183|NCT00321737|11467627|FG001|Overall Study|Relapse of Erosive Esophagitis|25
7256184|NCT00321737|11467628|FG002|Overall Study|Relapse of Erosive Esophagitis|19
7256185|NCT00321737|11467626|FG000|Overall Study|Adverse Event|11
7256186|NCT00321737|11467627|FG001|Overall Study|Adverse Event|3
7256187|NCT00321737|11467628|FG002|Overall Study|Adverse Event|6
7256188|NCT00321737|11467626|FG000|Overall Study|Lost to Follow-up|5
7256189|NCT00321737|11467627|FG001|Overall Study|Lost to Follow-up|5
7256190|NCT00321737|11467628|FG002|Overall Study|Lost to Follow-up|6
7256191|NCT00321737|11467626|FG000|Overall Study|Withdrawal by Subject|19
7243490|NCT00218543|11453249|FG000|Overall Study|Lost to Follow-up|8
7243491|NCT00218543|11453249|FG000|Overall Study|relocated|1
7243492|NCT00218543|11453249|FG000|Overall Study|Withdrawal by Subject|1
7243493|NCT00218543|11453249|FG000|Overall Study|Physician Decision|3
7243494|NCT00218543|11453249|FG000|Overall Study|Adverse Event|2
7243495|NCT00218634|11453255|FG000|Overall Study|Lost to Follow-up|8
7243496|NCT00218634|11453256|FG001|Overall Study|Lost to Follow-up|15
7243497|NCT00219141|11453268|FG000|Overall Study|Adverse Event|4
7243498|NCT00219141|11453269|FG001|Overall Study|Adverse Event|10
7243499|NCT00219141|11453270|FG002|Overall Study|Adverse Event|5
7243500|NCT00219141|11453268|FG000|Overall Study|Lack of Efficacy|3
7243501|NCT00219141|11453269|FG001|Overall Study|Lack of Efficacy|2
7243502|NCT00219141|11453270|FG002|Overall Study|Lack of Efficacy|0
7243503|NCT00219141|11453268|FG000|Overall Study|Administrative problems|0
7243504|NCT00219141|11453269|FG001|Overall Study|Administrative problems|1
7243505|NCT00219141|11453270|FG002|Overall Study|Administrative problems|0
7243506|NCT00219141|11453268|FG000|Overall Study|Lost to Follow-up|2
7243507|NCT00219141|11453269|FG001|Overall Study|Lost to Follow-up|4
7243508|NCT00219141|11453270|FG002|Overall Study|Lost to Follow-up|1
7243509|NCT00219141|11453268|FG000|Overall Study|Protocol Violation|3
7243510|NCT00219141|11453269|FG001|Overall Study|Protocol Violation|1
7243511|NCT00219141|11453270|FG002|Overall Study|Protocol Violation|1
7243512|NCT00219141|11453268|FG000|Overall Study|Withdrawal by Subject|1
7243513|NCT00219141|11453269|FG001|Overall Study|Withdrawal by Subject|3
7243514|NCT00219141|11453270|FG002|Overall Study|Withdrawal by Subject|5
7243515|NCT00219141|11453268|FG000|Overall Study|Condition no longer requires study drug|1
7243516|NCT00219141|11453269|FG001|Overall Study|Condition no longer requires study drug|0
7243517|NCT00219141|11453270|FG002|Overall Study|Condition no longer requires study drug|0
7243518|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
7243519|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
7243520|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
7243521|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
7243522|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
7243523|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
7243524|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
7243525|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
7243526|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
7243527|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
7243528|NCT00219284|11453280|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
7243529|NCT00219284|11453281|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
7243530|NCT00219284|11453280|FG000|Extension Phase - 8 Weeks|Adverse Event|2
7243531|NCT00219284|11453281|FG001|Extension Phase - 8 Weeks|Adverse Event|3
7243532|NCT00219284|11453280|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
7243533|NCT00219284|11453281|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
7243534|NCT00219284|11453280|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
7243535|NCT00219284|11453281|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
7243536|NCT00219349|11453287|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
7243537|NCT00219349|11453287|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
7243538|NCT00219349|11453287|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
7243539|NCT00219349|11453287|FG000|Escitalopram Phase|Withdrawal by Subject|3
7243540|NCT00219544|11453291|FG000|Single Blind Treatment Period|Lack of Efficacy|5
7243541|NCT00219544|11453292|FG001|Single Blind Treatment Period|Lack of Efficacy|0
7243542|NCT00219544|11453291|FG000|Single Blind Treatment Period|Adverse Event|9
7243543|NCT00219544|11453292|FG001|Single Blind Treatment Period|Adverse Event|0
7243544|NCT00219544|11453291|FG000|Single Blind Treatment Period|Protocol Violation|4
7243545|NCT00219544|11453292|FG001|Single Blind Treatment Period|Protocol Violation|0
7243546|NCT00219544|11453291|FG000|Single Blind Treatment Period|Lost to Follow-up|2
7243547|NCT00219544|11453292|FG001|Single Blind Treatment Period|Lost to Follow-up|0
7243548|NCT00219544|11453291|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
7243549|NCT00219544|11453292|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
7243550|NCT00219544|11453291|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
7243551|NCT00219544|11453292|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
7243552|NCT00219557|11453303|FG000|Phase 1|Lack of Efficacy|3
7243553|NCT00219557|11453304|FG001|Phase 1|Lack of Efficacy|0
7243554|NCT00219557|11453305|FG002|Phase 1|Lack of Efficacy|0
7243555|NCT00219557|11453303|FG000|Phase 1|Adverse Event|2
7243556|NCT00219557|11453304|FG001|Phase 1|Adverse Event|0
7243557|NCT00219557|11453305|FG002|Phase 1|Adverse Event|0
7243558|NCT00219557|11453303|FG000|Phase 1|Withdrawal by Subject|1
7243559|NCT00219557|11453304|FG001|Phase 1|Withdrawal by Subject|0
7243560|NCT00219557|11453305|FG002|Phase 1|Withdrawal by Subject|0
7243561|NCT00219557|11453303|FG000|Phase 1|Started chemotherapy at other institute|1
7243562|NCT00219557|11453304|FG001|Phase 1|Started chemotherapy at other institute|0
7243563|NCT00219557|11453305|FG002|Phase 1|Started chemotherapy at other institute|0
7243564|NCT00219557|11453303|FG000|Phase 2|Lack of Efficacy|0
7243565|NCT00219557|11453304|FG001|Phase 2|Lack of Efficacy|21
7243566|NCT00219557|11453305|FG002|Phase 2|Lack of Efficacy|15
7243567|NCT00219557|11453303|FG000|Phase 2|Adverse Event|0
7243568|NCT00219557|11453304|FG001|Phase 2|Adverse Event|22
7243569|NCT00219557|11453305|FG002|Phase 2|Adverse Event|2
7243570|NCT00219557|11453303|FG000|Phase 2|Death|0
7243571|NCT00219557|11453304|FG001|Phase 2|Death|8
7243572|NCT00219557|11453305|FG002|Phase 2|Death|2
7243573|NCT00219557|11453303|FG000|Phase 2|Other|0
7243574|NCT00219557|11453304|FG001|Phase 2|Other|8
7243575|NCT00219557|11453305|FG002|Phase 2|Other|6
7243576|NCT00219557|11453303|FG000|Phase 2|Withdrawal by Subject|0
7243577|NCT00219557|11453304|FG001|Phase 2|Withdrawal by Subject|9
7243578|NCT00219557|11453305|FG002|Phase 2|Withdrawal by Subject|5
7243579|NCT00219557|11453303|FG000|Phase 2|Treatment not received|0
7243580|NCT00219557|11453304|FG001|Phase 2|Treatment not received|1
7243581|NCT00219557|11453305|FG002|Phase 2|Treatment not received|3
7243582|NCT00220636|11453314|FG000|Overall Study|Withdrawal by Subject|4
7243583|NCT00220701|11453321|FG000|Overall Study|Lost to Follow-up|5
7243584|NCT00220701|11453322|FG001|Overall Study|Lost to Follow-up|4
7243585|NCT00220727|11453330|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
7243586|NCT00220727|11453331|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
7243587|NCT00220740|11453341|FG000|Efficacy Period|Entered rescue treatment with placebo|23
7243588|NCT00220740|11453342|FG001|Efficacy Period|Entered rescue treatment with placebo|0
7243589|NCT00220740|11453341|FG000|Efficacy Period|Adverse Event|1
7243590|NCT00220740|11453342|FG001|Efficacy Period|Adverse Event|1
7243591|NCT00220740|11453341|FG000|Efficacy Period|Withdrawal by Subject|1
7243592|NCT00220740|11453342|FG001|Efficacy Period|Withdrawal by Subject|0
7243593|NCT00220740|11453341|FG000|Efficacy Period|Protocol Violation|1
7243594|NCT00220740|11453342|FG001|Efficacy Period|Protocol Violation|0
7243595|NCT00220740|11453341|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
7243596|NCT00220740|11453342|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
7243597|NCT00220779|11453353|FG000|Overall Study|Adverse Event|1
7243598|NCT00220779|11453354|FG001|Overall Study|Adverse Event|0
7243599|NCT00220779|11453355|FG002|Overall Study|Adverse Event|0
7243600|NCT00220779|11453353|FG000|Overall Study|Withdrawal by Subject|1
7243601|NCT00220779|11453354|FG001|Overall Study|Withdrawal by Subject|4
7243602|NCT00220779|11453355|FG002|Overall Study|Withdrawal by Subject|1
7243603|NCT00220779|11453353|FG000|Overall Study|Non-compliance|1
7243604|NCT00220779|11453354|FG001|Overall Study|Non-compliance|0
7243605|NCT00220779|11453355|FG002|Overall Study|Non-compliance|0
7243606|NCT00220779|11453353|FG000|Overall Study|Too time consuming|1
7243607|NCT00220779|11453354|FG001|Overall Study|Too time consuming|0
7243608|NCT00220779|11453355|FG002|Overall Study|Too time consuming|0
7243609|NCT00220779|11453353|FG000|Overall Study|Pregnancy|0
7243610|NCT00220779|11453354|FG001|Overall Study|Pregnancy|0
7243611|NCT00220779|11453355|FG002|Overall Study|Pregnancy|2
7243612|NCT00220779|11453353|FG000|Overall Study|Lack of Efficacy|3
7243613|NCT00220779|11453354|FG001|Overall Study|Lack of Efficacy|0
7243614|NCT00220779|11453355|FG002|Overall Study|Lack of Efficacy|1
7243615|NCT00220805|11453365|FG000|Overall Study|Adverse Event|1
7243616|NCT00220805|11453366|FG001|Overall Study|Adverse Event|3
7243617|NCT00220805|11453365|FG000|Overall Study|Withdrawal by Subject|3
7243618|NCT00220805|11453366|FG001|Overall Study|Withdrawal by Subject|0
7243619|NCT00220805|11453365|FG000|Overall Study|Lack of Efficacy|1
7243620|NCT00220805|11453366|FG001|Overall Study|Lack of Efficacy|0
7243621|NCT00220805|11453365|FG000|Overall Study|Develop. of choroidal neovascularization|3
7243622|NCT00220805|11453366|FG001|Overall Study|Develop. of choroidal neovascularization|8
7243623|NCT00221104|11453383|FG000|Overall Study|Adverse Event|1
7243624|NCT00221104|11453384|FG001|Overall Study|Adverse Event|0
7243625|NCT00221104|11453383|FG000|Overall Study|Physician Decision|1
7243626|NCT00221104|11453384|FG001|Overall Study|Physician Decision|0
7243627|NCT00221104|11453383|FG000|Overall Study|Protocol Violation|2
7243628|NCT00221104|11453384|FG001|Overall Study|Protocol Violation|0
7243629|NCT00221104|11453383|FG000|Overall Study|Withdrawal by Subject|42
7243630|NCT00221104|11453384|FG001|Overall Study|Withdrawal by Subject|29
7243631|NCT00221104|11453383|FG000|Overall Study|Others|37
7243632|NCT00221104|11453384|FG001|Overall Study|Others|47
7243633|NCT00221195|11453405|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
7243634|NCT00221195|11453406|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
7243635|NCT00221195|11453405|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
7243636|NCT00221195|11453406|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
7243637|NCT00221195|11453405|FG000|Washout Period (Months 7-9)|Death|0
7243638|NCT00221195|11453406|FG001|Washout Period (Months 7-9)|Death|1
7243639|NCT00221195|11453405|FG000|Therapy 2 (Months 10-15)|Death|1
7243640|NCT00221195|11453406|FG001|Therapy 2 (Months 10-15)|Death|0
7243641|NCT00221195|11453405|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
7243642|NCT00221195|11453406|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
7243643|NCT00221403|11453439|FG000|Overall Study|Protocol Violation|1
7243644|NCT00221403|11453440|FG001|Overall Study|Protocol Violation|0
7243645|NCT00221403|11453441|FG002|Overall Study|Protocol Violation|0
7243646|NCT00221403|11453439|FG000|Overall Study|Physician Decision|1
7243647|NCT00221403|11453440|FG001|Overall Study|Physician Decision|0
7243648|NCT00221403|11453441|FG002|Overall Study|Physician Decision|0
7243649|NCT00221403|11453439|FG000|Overall Study|Withdrawal by Subject|0
7243650|NCT00221403|11453440|FG001|Overall Study|Withdrawal by Subject|3
7243651|NCT00221403|11453441|FG002|Overall Study|Withdrawal by Subject|0
7243652|NCT00221403|11453439|FG000|Overall Study|Lack of Efficacy|0
7243653|NCT00221403|11453440|FG001|Overall Study|Lack of Efficacy|1
7243654|NCT00221403|11453441|FG002|Overall Study|Lack of Efficacy|0
7243655|NCT00221403|11453439|FG000|Overall Study|Adverse Event|0
7243656|NCT00221403|11453440|FG001|Overall Study|Adverse Event|1
7243657|NCT00221403|11453441|FG002|Overall Study|Adverse Event|0
7243658|NCT00222105|11453449|FG000|Overall Study|Removed due to wrong diagnosis|1
7243659|NCT00222105|11453449|FG000|Overall Study|Withdrawal by Subject|1
7243660|NCT00222105|11453449|FG000|Overall Study|Adverse Event|8
7243661|NCT00222105|11453449|FG000|Overall Study|Treatment delays|2
7243662|NCT00222105|11453449|FG000|Overall Study|Death|2
7243663|NCT00222729|11453462|FG000|Overall Study|Adverse Event|3
7243664|NCT00223080|11453468|FG000|Overall Study|Withdrawal by Subject|253
7243665|NCT00223080|11453469|FG001|Overall Study|Withdrawal by Subject|232
7243666|NCT00223080|11453468|FG000|Overall Study|Required contraindicated med|0
7243667|NCT00223080|11453469|FG001|Overall Study|Required contraindicated med|1
7243668|NCT00223080|11453468|FG000|Overall Study|Non-compliant|7
7243669|NCT00223080|11453469|FG001|Overall Study|Non-compliant|7
7243670|NCT00223080|11453468|FG000|Overall Study|Moved from study area|37
7243671|NCT00223080|11453469|FG001|Overall Study|Moved from study area|47
7243672|NCT00223080|11453468|FG000|Overall Study|Lost to Follow-up|259
7243673|NCT00223080|11453469|FG001|Overall Study|Lost to Follow-up|284
7243674|NCT00223080|11453468|FG000|Overall Study|Death|85
7243675|NCT00223080|11453469|FG001|Overall Study|Death|74
7243676|NCT00223080|11453468|FG000|Overall Study|Other|14
7243677|NCT00223080|11453469|FG001|Overall Study|Other|11
7243678|NCT00223080|11453468|FG000|Overall Study|Reason not provided|141
7243679|NCT00223080|11453469|FG001|Overall Study|Reason not provided|140
7243680|NCT00223080|11453468|FG000|Overall Study|Adverse Event|0
7243681|NCT00223080|11453469|FG001|Overall Study|Adverse Event|1
7243682|NCT00223496|11453493|FG000|Overall Study|screen failure|9
7243683|NCT00223496|11453493|FG000|Overall Study|Lost to Follow-up|4
7243684|NCT00223496|11453493|FG000|Overall Study|Lack of Efficacy|6
7243685|NCT00223496|11453493|FG000|Overall Study|Withdrawal by Subject|1
7243686|NCT00223496|11453493|FG000|Overall Study|Physician Decision|2
7243687|NCT00223795|11453534|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
7243688|NCT00223795|11453535|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
7243689|NCT00223795|11453534|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7243690|NCT00223795|11453535|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
7243691|NCT00223808|11453545|FG000|Overall Study|<5 hrs therapy before discharge|3
7243692|NCT00223808|11453546|FG001|Overall Study|<5 hrs therapy before discharge|5
7243693|NCT00223808|11453547|FG002|Overall Study|<5 hrs therapy before discharge|5
7243694|NCT00223977|11453567|FG000|Overall Study|Adverse Event|7
7243695|NCT00223977|11453568|FG001|Overall Study|Adverse Event|10
7243696|NCT00223977|11453569|FG002|Overall Study|Adverse Event|0
7243697|NCT00223977|11453567|FG000|Overall Study|Protocol Violation|0
7243698|NCT00223977|11453568|FG001|Overall Study|Protocol Violation|0
7243699|NCT00223977|11453569|FG002|Overall Study|Protocol Violation|1
7243700|NCT00223977|11453567|FG000|Overall Study|Withdrawal by Subject|1
7243701|NCT00223977|11453568|FG001|Overall Study|Withdrawal by Subject|1
7243702|NCT00223977|11453569|FG002|Overall Study|Withdrawal by Subject|2
7243703|NCT00223977|11453567|FG000|Overall Study|Other|1
7243704|NCT00223977|11453568|FG001|Overall Study|Other|0
7243705|NCT00223977|11453569|FG002|Overall Study|Other|0
7243706|NCT00223990|11453579|FG000|Overall Study|Moved from area|2
7243707|NCT00223990|11453580|FG001|Overall Study|Moved from area|1
7243708|NCT00223990|11453579|FG000|Overall Study|Withdrawal by Subject|4
7243709|NCT00223990|11453580|FG001|Overall Study|Withdrawal by Subject|8
7243710|NCT00223990|11453579|FG000|Overall Study|Lost to Follow-up|1
7243711|NCT00223990|11453580|FG001|Overall Study|Lost to Follow-up|0
7243712|NCT00224016|11453588|FG000|Titration Period|Withdrawal by Subject|0
7243713|NCT00224016|11453589|FG001|Titration Period|Withdrawal by Subject|1
7243714|NCT00224016|11453588|FG000|Titration Period|Lost to Follow-up|1
7243715|NCT00224016|11453589|FG001|Titration Period|Lost to Follow-up|0
7243716|NCT00224016|11453588|FG000|Maintenance Period|Withdrawal by Subject|2
7243717|NCT00224016|11453589|FG001|Maintenance Period|Withdrawal by Subject|0
7243718|NCT00224016|11453588|FG000|Maintenance Period|Lost to Follow-up|0
7243719|NCT00224016|11453589|FG001|Maintenance Period|Lost to Follow-up|1
7243720|NCT00224029|11453595|FG000|Overall Study|Lost to Follow-up|1
7243721|NCT00224029|11453595|FG000|Overall Study|Withdrawal by Subject|4
7243722|NCT00224029|11453595|FG000|Overall Study|Other|1
7243723|NCT00224042|11453601|FG000|Overall Study|Adverse Event|2
7243724|NCT00224042|11453602|FG001|Overall Study|Adverse Event|1
7243725|NCT00224042|11453601|FG000|Overall Study|Protocol Violation|0
7243726|NCT00224042|11453602|FG001|Overall Study|Protocol Violation|1
7243727|NCT00224042|11453601|FG000|Overall Study|Physician Decision|0
7243728|NCT00224042|11453602|FG001|Overall Study|Physician Decision|1
7243729|NCT00224042|11453601|FG000|Overall Study|Did not meet lab incusion criteria|2
7243730|NCT00224042|11453602|FG001|Overall Study|Did not meet lab incusion criteria|3
7243731|NCT00224042|11453601|FG000|Overall Study|Other|2
7243732|NCT00224042|11453602|FG001|Overall Study|Other|0
7243733|NCT00224055|11453610|FG000|Overall Study|Adverse Event|9
7243734|NCT00224055|11453611|FG001|Overall Study|Adverse Event|3
7243735|NCT00224055|11453610|FG000|Overall Study|Lost to Follow-up|1
7243736|NCT00224055|11453611|FG001|Overall Study|Lost to Follow-up|2
7243737|NCT00224055|11453610|FG000|Overall Study|Protocol Violation|1
7243738|NCT00224055|11453611|FG001|Overall Study|Protocol Violation|1
7243739|NCT00224055|11453610|FG000|Overall Study|Inclusion Violation|3
7243740|NCT00224055|11453611|FG001|Overall Study|Inclusion Violation|6
7243741|NCT00224055|11453610|FG000|Overall Study|Withdrawal by Subject|0
7243742|NCT00224055|11453611|FG001|Overall Study|Withdrawal by Subject|2
7243743|NCT00224055|11453610|FG000|Overall Study|Other|1
7243744|NCT00224055|11453611|FG001|Overall Study|Other|0
7243745|NCT00224107|11453619|FG000|Overall Study|Adverse Event|20
7243746|NCT00224107|11453620|FG001|Overall Study|Adverse Event|6
7243747|NCT00224107|11453619|FG000|Overall Study|Protocol Violation|2
7243748|NCT00224107|11453620|FG001|Overall Study|Protocol Violation|3
7243749|NCT00224107|11453619|FG000|Overall Study|Withdrawal by Subject|1
7243750|NCT00224107|11453620|FG001|Overall Study|Withdrawal by Subject|4
7243751|NCT00224107|11453619|FG000|Overall Study|Lack of Efficacy|2
7243752|NCT00224107|11453620|FG001|Overall Study|Lack of Efficacy|0
7243753|NCT00224107|11453619|FG000|Overall Study|Lost to Follow-up|4
7243754|NCT00224107|11453620|FG001|Overall Study|Lost to Follow-up|0
7243755|NCT00224107|11453619|FG000|Overall Study|Physician Decision|1
7243756|NCT00224107|11453620|FG001|Overall Study|Physician Decision|0
7243757|NCT00224107|11453619|FG000|Overall Study|Other|1
7243758|NCT00224107|11453620|FG001|Overall Study|Other|1
7243759|NCT00224120|11453628|FG000|Overall Study|Adverse Event|10
7243760|NCT00224120|11453629|FG001|Overall Study|Adverse Event|4
7243761|NCT00224120|11453628|FG000|Overall Study|Protocol Violation|1
7243762|NCT00224120|11453629|FG001|Overall Study|Protocol Violation|0
7243763|NCT00224120|11453628|FG000|Overall Study|Withdrawal by Subject|5
7243764|NCT00224120|11453629|FG001|Overall Study|Withdrawal by Subject|10
7243765|NCT00224120|11453628|FG000|Overall Study|Lack of Efficacy|0
7243766|NCT00224120|11453629|FG001|Overall Study|Lack of Efficacy|2
7243767|NCT00224120|11453628|FG000|Overall Study|Lost to Follow-up|2
7243768|NCT00224120|11453629|FG001|Overall Study|Lost to Follow-up|3
7243769|NCT00224120|11453628|FG000|Overall Study|Other|4
7243770|NCT00224120|11453629|FG001|Overall Study|Other|5
7243771|NCT00224133|11453635|FG000|Overall Study|Adverse Event|93
7243772|NCT00224133|11453635|FG000|Overall Study|Protocol Violation|6
7243773|NCT00224133|11453635|FG000|Overall Study|Withdrawal by Subject|33
7243774|NCT00224133|11453635|FG000|Overall Study|Lack of Efficacy|58
7243775|NCT00224133|11453635|FG000|Overall Study|Lost to Follow-up|21
7243776|NCT00224133|11453635|FG000|Overall Study|Physician Decision|1
7243777|NCT00224133|11453635|FG000|Overall Study|Other|14
7243778|NCT00224484|11453646|FG000|Overall Study|Serious Adverse Event|1
7243779|NCT00224484|11453647|FG001|Overall Study|Serious Adverse Event|1
7243780|NCT00224484|11453648|FG002|Overall Study|Serious Adverse Event|0
7243781|NCT00224484|11453646|FG000|Overall Study|Non-Serious Adverse Event|5
7243782|NCT00224484|11453647|FG001|Overall Study|Non-Serious Adverse Event|7
7243783|NCT00224484|11453648|FG002|Overall Study|Non-Serious Adverse Event|3
7243784|NCT00224484|11453646|FG000|Overall Study|Protocol Violation|2
7243785|NCT00224484|11453647|FG001|Overall Study|Protocol Violation|2
7243786|NCT00224484|11453648|FG002|Overall Study|Protocol Violation|0
7243787|NCT00224484|11453646|FG000|Overall Study|Withdrawal by Subject|49
7243788|NCT00224484|11453647|FG001|Overall Study|Withdrawal by Subject|18
7243789|NCT00224484|11453648|FG002|Overall Study|Withdrawal by Subject|16
7243790|NCT00224484|11453646|FG000|Overall Study|Migrated/moved from study area|18
7243791|NCT00224484|11453647|FG001|Overall Study|Migrated/moved from study area|5
7243792|NCT00224484|11453648|FG002|Overall Study|Migrated/moved from study area|5
7243793|NCT00224484|11453646|FG000|Overall Study|Lost to Follow-up|66
7243794|NCT00224484|11453647|FG001|Overall Study|Lost to Follow-up|28
7243795|NCT00224484|11453648|FG002|Overall Study|Lost to Follow-up|36
7243796|NCT00224484|11453646|FG000|Overall Study|Reason not specified|5
7243797|NCT00224484|11453647|FG001|Overall Study|Reason not specified|4
7243798|NCT00224484|11453648|FG002|Overall Study|Reason not specified|2
7243799|NCT00224770|11453662|FG000|Overall Study|Lost to Follow-up|4
7243800|NCT00224770|11453663|FG001|Overall Study|Lost to Follow-up|2
7243801|NCT00224770|11453664|FG002|Overall Study|Lost to Follow-up|0
7243802|NCT00224874|11453677|FG000|Overall Study|Withdrawal by Subject|0
7243803|NCT00224874|11453678|FG001|Overall Study|Withdrawal by Subject|0
7243804|NCT00224874|11453679|FG002|Overall Study|Withdrawal by Subject|1
7243805|NCT00224874|11453680|FG003|Overall Study|Withdrawal by Subject|0
7243806|NCT00224887|11453692|FG000|Overall Study|Pregnancy|6
7243807|NCT00224887|11453693|FG001|Overall Study|Pregnancy|6
7243808|NCT00225147|11453726|FG000|Open-label Phase|Lost to Follow-up|0
7243809|NCT00225147|11453727|FG001|Open-label Phase|Lost to Follow-up|0
7243810|NCT00225147|11453728|FG002|Open-label Phase|Lost to Follow-up|0
7243811|NCT00225147|11453729|FG003|Open-label Phase|Lost to Follow-up|4
7243812|NCT00225147|11453726|FG000|Open-label Phase|Withdrawal by Subject|0
7243813|NCT00225147|11453727|FG001|Open-label Phase|Withdrawal by Subject|0
7243814|NCT00225147|11453728|FG002|Open-label Phase|Withdrawal by Subject|0
7243815|NCT00225147|11453729|FG003|Open-label Phase|Withdrawal by Subject|6
7243816|NCT00225212|11453741|FG000|Overall Study|Disease progression|2
7243817|NCT00225212|11453741|FG000|Overall Study|Death|1
7243818|NCT00225212|11453741|FG000|Overall Study|Adverse Event|2
7243819|NCT00225212|11453741|FG000|Overall Study|Intercurrent illness|1
7243820|NCT00225251|11453747|FG000|Overall Study|Withdrawal by Subject|1
7243821|NCT00225251|11453748|FG001|Overall Study|Withdrawal by Subject|1
7243822|NCT00225277|11453756|FG000|Overall Study|Adverse Event|30
7243823|NCT00225277|11453757|FG001|Overall Study|Adverse Event|34
7243824|NCT00225277|11453756|FG000|Overall Study|Lack of Efficacy|4
7243825|NCT00225277|11453757|FG001|Overall Study|Lack of Efficacy|1
7243826|NCT00225277|11453756|FG000|Overall Study|Lost to Follow-up|4
7243827|NCT00225277|11453757|FG001|Overall Study|Lost to Follow-up|6
7243828|NCT00225277|11453756|FG000|Overall Study|Physician Decision|6
7243829|NCT00225277|11453757|FG001|Overall Study|Physician Decision|8
7575468|NCT03739840|11959102|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7243830|NCT00225277|11453756|FG000|Overall Study|Protocol Violation|6
7243831|NCT00225277|11453757|FG001|Overall Study|Protocol Violation|3
7243832|NCT00225277|11453756|FG000|Overall Study|Withdrawal by Subject|40
7243833|NCT00225277|11453757|FG001|Overall Study|Withdrawal by Subject|34
7243834|NCT00225277|11453756|FG000|Overall Study|Other|7
7533820|NCT02689076|11880177|FG002|Overall Study|Did not have an HIE match|0
7533821|NCT02689076|11880175|FG000|Overall Study|Death during non-VA encounter|2
7533822|NCT02689076|11880176|FG001|Overall Study|Death during non-VA encounter|5
7533823|NCT02689076|11880177|FG002|Overall Study|Death during non-VA encounter|0
7533824|NCT02689076|11880175|FG000|Overall Study|Provider declined to participate after participant assignment|1
7533825|NCT02689076|11880176|FG001|Overall Study|Provider declined to participate after participant assignment|1
7533826|NCT02689076|11880177|FG002|Overall Study|Provider declined to participate after participant assignment|0
7243835|NCT00225277|11453757|FG001|Overall Study|Other|9
7243836|NCT00225758|11453785|FG000|Overall Study|Adverse Event|4
7243837|NCT00226499|11453806|FG000|Overall Study|Adverse Event|10
7243838|NCT00226499|11453807|FG001|Overall Study|Adverse Event|6
7243839|NCT00226499|11453808|FG002|Overall Study|Adverse Event|3
7243840|NCT00226499|11453806|FG000|Overall Study|Others|1064
7243841|NCT00226499|11453807|FG001|Overall Study|Others|1066
7243842|NCT00226499|11453808|FG002|Overall Study|Others|356
7243843|NCT00226655|11453827|FG000|Overall Study|Death|13
7243844|NCT00226655|11453827|FG000|Overall Study|Withdrawal by Subject|15
7243845|NCT00226655|11453827|FG000|Overall Study|Adverse Event|35
7243846|NCT00226655|11453827|FG000|Overall Study|Physician Decision|6
7243847|NCT00226655|11453827|FG000|Overall Study|Clinical deterioration|10
7243848|NCT00226811|11453831|FG000|Overall Study|Death|8
7243849|NCT00226811|11453831|FG000|Overall Study|Adverse Event|11
7243850|NCT00226811|11453831|FG000|Overall Study|Lack of Efficacy|55
7243851|NCT00226811|11453831|FG000|Overall Study|Withdrawal by Subject|2
7243852|NCT00226941|11453839|FG000|Overall Study|Withdrawal by subject - toxicity|0
7243853|NCT00226941|11453840|FG001|Overall Study|Withdrawal by subject - toxicity|0
7243854|NCT00226941|11453841|FG002|Overall Study|Withdrawal by subject - toxicity|0
7243855|NCT00226941|11453842|FG003|Overall Study|Withdrawal by subject - toxicity|1
7243856|NCT00226941|11453839|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
7243857|NCT00226941|11453840|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
7243858|NCT00226941|11453841|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
7243859|NCT00226941|11453842|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
7243860|NCT00227266|11453866|FG000|Overall Study|Withdrawal by Subject|0
7243861|NCT00227266|11453867|FG001|Overall Study|Withdrawal by Subject|0
7243862|NCT00227266|11453868|FG002|Overall Study|Withdrawal by Subject|1
7243863|NCT00227266|11453866|FG000|Overall Study|Protocol Violation|1
7243864|NCT00227266|11453867|FG001|Overall Study|Protocol Violation|0
7243865|NCT00227266|11453868|FG002|Overall Study|Protocol Violation|1
7243866|NCT00227266|11453866|FG000|Overall Study|Excessive weight gain|0
7243867|NCT00227266|11453867|FG001|Overall Study|Excessive weight gain|0
7243868|NCT00227266|11453868|FG002|Overall Study|Excessive weight gain|2
7383896|NCT01191086|11640853|FG000|Overall Study|Withdrawal by Subject|24
7383897|NCT01191086|11640853|FG000|Overall Study|Discontinuation criterion met|1
7383898|NCT01191086|11640853|FG000|Overall Study|Other|1
7383899|NCT01191190|11640857|FG000|Overall Study|Withdrawal by Subject|1
7383900|NCT01191268|11640885|FG000|Overall Study|Withdrawal by Subject|19
7383901|NCT01191268|11640886|FG001|Overall Study|Withdrawal by Subject|25
7383902|NCT01191268|11640887|FG002|Overall Study|Withdrawal by Subject|21
7533827|NCT02689076|11880175|FG000|Overall Study|Participant no longer active in VA system|1
7383903|NCT01191268|11640885|FG000|Overall Study|Adverse Event|21
7383904|NCT01191268|11640886|FG001|Overall Study|Adverse Event|13
7383905|NCT01191268|11640887|FG002|Overall Study|Adverse Event|8
7243869|NCT00227305|11453879|FG000|Overall Study|Adverse Event|40
7243870|NCT00227305|11453879|FG000|Overall Study|Withdrawal by Subject|42
7243871|NCT00227305|11453879|FG000|Overall Study|Lost to Follow-up|33
7243872|NCT00227305|11453879|FG000|Overall Study|Study specific discontinuation|13
7243873|NCT00227305|11453879|FG000|Overall Study|MOVED OUT OF AREA|3
7243874|NCT00227305|11453879|FG000|Overall Study|Lack of Efficacy|7
7383906|NCT01191268|11640885|FG000|Overall Study|Physician Decision|6
7383907|NCT01191268|11640886|FG001|Overall Study|Physician Decision|8
7383908|NCT01191268|11640887|FG002|Overall Study|Physician Decision|9
7383909|NCT01191268|11640885|FG000|Overall Study|Lost to Follow-up|8
7383910|NCT01191268|11640886|FG001|Overall Study|Lost to Follow-up|5
7383911|NCT01191268|11640887|FG002|Overall Study|Lost to Follow-up|9
7383912|NCT01191268|11640885|FG000|Overall Study|Entry Criteria Not Met|3
7383913|NCT01191268|11640886|FG001|Overall Study|Entry Criteria Not Met|1
7383914|NCT01191268|11640887|FG002|Overall Study|Entry Criteria Not Met|1
7383915|NCT01191268|11640885|FG000|Overall Study|Death|0
7243875|NCT00227305|11453879|FG000|Overall Study|Physician Decision|3
7243876|NCT00227305|11453879|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
7243877|NCT00227305|11453879|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
7243878|NCT00227305|11453879|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
7243879|NCT00227344|11453885|FG000|Overall Study|study terminated early|12
7243880|NCT00227344|11453886|FG001|Overall Study|study terminated early|5
7243881|NCT00227370|11453894|FG000|Overall Study|Withdrawal by Subject|1
7243882|NCT00227370|11453895|FG001|Overall Study|Withdrawal by Subject|2
7243883|NCT00227370|11453894|FG000|Overall Study|Death|3
7243884|NCT00227370|11453895|FG001|Overall Study|Death|4
7243885|NCT00227370|11453894|FG000|Overall Study|Adverse Event|6
7243886|NCT00227370|11453895|FG001|Overall Study|Adverse Event|11
7243887|NCT00227370|11453894|FG000|Overall Study|Physician Decision|9
7243888|NCT00227370|11453895|FG001|Overall Study|Physician Decision|6
7243889|NCT00227370|11453894|FG000|Overall Study|Other reasons|2
7243890|NCT00227370|11453895|FG001|Overall Study|Other reasons|1
7243891|NCT00227539|11453901|FG000|Overall Study|Protocol Violation|1
7243892|NCT00227591|11453905|FG000|Overall Study|Withdrawal by Subject|1
7243893|NCT00227721|11453923|FG000|Overall Study|On study, but never treated.|1
7243894|NCT00227877|11453935|FG000|Pre-visit Assessment|Technical difficulties|7
7243895|NCT00227877|11453936|FG001|Pre-visit Assessment|Technical difficulties|3
7243896|NCT00227877|11453937|FG002|Pre-visit Assessment|Technical difficulties|0
7243897|NCT00227877|11453938|FG003|Pre-visit Assessment|Technical difficulties|0
7243898|NCT00227877|11453935|FG000|Post-visit Checklist|Lost to Follow-up|24
7243899|NCT00227877|11453936|FG001|Post-visit Checklist|Lost to Follow-up|13
7243900|NCT00227877|11453937|FG002|Post-visit Checklist|Lost to Follow-up|1
7243901|NCT00227877|11453938|FG003|Post-visit Checklist|Lost to Follow-up|0
7243902|NCT00227877|11453935|FG000|3-months Follow-up|Completed late|135
7243903|NCT00227877|11453936|FG001|3-months Follow-up|Completed late|128
7243904|NCT00227877|11453937|FG002|3-months Follow-up|Completed late|34
7243905|NCT00227877|11453938|FG003|3-months Follow-up|Completed late|8
7243906|NCT00227877|11453935|FG000|3-months Follow-up|Lost to Follow-up|178
7243907|NCT00227877|11453936|FG001|3-months Follow-up|Lost to Follow-up|139
7243908|NCT00227877|11453937|FG002|3-months Follow-up|Lost to Follow-up|18
7243909|NCT00227877|11453938|FG003|3-months Follow-up|Lost to Follow-up|13
7243910|NCT00227877|11453935|FG000|12-months Follow-up|Completed late|78
7243911|NCT00227877|11453936|FG001|12-months Follow-up|Completed late|74
7243912|NCT00227877|11453937|FG002|12-months Follow-up|Completed late|1
7243913|NCT00227877|11453938|FG003|12-months Follow-up|Completed late|0
7243914|NCT00227877|11453935|FG000|12-months Follow-up|Lost to Follow-up|232
7243915|NCT00227877|11453936|FG001|12-months Follow-up|Lost to Follow-up|189
7243916|NCT00227877|11453937|FG002|12-months Follow-up|Lost to Follow-up|30
7243917|NCT00227877|11453938|FG003|12-months Follow-up|Lost to Follow-up|26
7243918|NCT00227903|11453952|FG000|Overall Study|Withdrawal by Subject|2
7243919|NCT00227903|11453953|FG001|Overall Study|Withdrawal by Subject|5
7243920|NCT00227903|11453952|FG000|Overall Study|Subject moved out of area|1
7243921|NCT00227903|11453953|FG001|Overall Study|Subject moved out of area|2
7243922|NCT00227903|11453952|FG000|Overall Study|Lost to Follow-up|1
7243923|NCT00227903|11453953|FG001|Overall Study|Lost to Follow-up|3
7243924|NCT00227903|11453952|FG000|Overall Study|Miscarriage|1
7243925|NCT00227903|11453953|FG001|Overall Study|Miscarriage|0
7243926|NCT00228384|11453970|FG000|Overall Study|Death|9
7243927|NCT00228384|11453971|FG001|Overall Study|Death|3
7243928|NCT00228384|11453970|FG000|Overall Study|Lost to Follow-up|6
7243929|NCT00228384|11453971|FG001|Overall Study|Lost to Follow-up|10
7243930|NCT00228384|11453970|FG000|Overall Study|Surgical Intervention (bypass)|5
7243931|NCT00228384|11453971|FG001|Overall Study|Surgical Intervention (bypass)|5
7243932|NCT00228384|11453970|FG000|Overall Study|Withdrawal by Subject|9
7243933|NCT00228384|11453971|FG001|Overall Study|Withdrawal by Subject|10
7243934|NCT00228384|11453970|FG000|Overall Study|Physician Decision|0
7243935|NCT00228384|11453971|FG001|Overall Study|Physician Decision|1
7243936|NCT00228423|11453979|FG000|Overall Study|Adverse Event|2
7243937|NCT00228423|11453980|FG001|Overall Study|Adverse Event|5
7243938|NCT00228423|11453979|FG000|Overall Study|Withdrawal by Subject|7
7243939|NCT00228423|11453980|FG001|Overall Study|Withdrawal by Subject|3
7243940|NCT00228423|11453979|FG000|Overall Study|Protocol Violation|1
7243941|NCT00228423|11453980|FG001|Overall Study|Protocol Violation|3
7243942|NCT00228423|11453979|FG000|Overall Study|Physician Decision|0
7243943|NCT00228423|11453980|FG001|Overall Study|Physician Decision|1
7243944|NCT00228553|11453986|FG000|Overall Study|Adverse Event|112
7243945|NCT00228553|11453986|FG000|Overall Study|Lack of Efficacy|34
7243946|NCT00228553|11453986|FG000|Overall Study|Lost to Follow-up|67
7243947|NCT00228553|11453986|FG000|Overall Study|Physician Decision|48
7243948|NCT00228553|11453986|FG000|Overall Study|Protocol Violation|6
7243949|NCT00228553|11453986|FG000|Overall Study|Withdrawal by Subject|115
7243950|NCT00228553|11453986|FG000|Overall Study|Pregnancy|2
7243951|NCT00228553|11453986|FG000|Overall Study|Miscellaneous|46
7243952|NCT00228566|11453990|FG000|Overall Study|Adverse Event|31
7243953|NCT00228566|11453990|FG000|Overall Study|Lack of Efficacy|14
7243954|NCT00228566|11453990|FG000|Overall Study|Lost to Follow-up|16
7243955|NCT00228566|11453990|FG000|Overall Study|Physician Decision|5
7243956|NCT00228566|11453990|FG000|Overall Study|Withdrawal by Subject|4
7243957|NCT00228566|11453990|FG000|Overall Study|Miscellaneous|1
7243958|NCT00228813|11453994|FG000|Overall Study|Death|4
7243959|NCT00228917|11454006|FG000|Overall Study|Migrated/moved from study area|0
7243960|NCT00228917|11454007|FG001|Overall Study|Migrated/moved from study area|0
7243961|NCT00228917|11454008|FG002|Overall Study|Migrated/moved from study area|0
7243962|NCT00228917|11454009|FG003|Overall Study|Migrated/moved from study area|0
7243963|NCT00228917|11454010|FG004|Overall Study|Migrated/moved from study area|0
7243964|NCT00228917|11454011|FG005|Overall Study|Migrated/moved from study area|2
7243965|NCT00228917|11454012|FG006|Overall Study|Migrated/moved from study area|0
7243966|NCT00228917|11454013|FG007|Overall Study|Migrated/moved from study area|0
7243967|NCT00229203|11454035|FG000|Overall Study|Progressive disease|18
7243968|NCT00229203|11454036|FG001|Overall Study|Progressive disease|9
7243969|NCT00229203|11454035|FG000|Overall Study|Toxicity|6
7243970|NCT00229203|11454036|FG001|Overall Study|Toxicity|1
7243971|NCT00229203|11454035|FG000|Overall Study|Death|4
7243972|NCT00229203|11454036|FG001|Overall Study|Death|2
7243973|NCT00229203|11454035|FG000|Overall Study|Other|3
7243974|NCT00229203|11454036|FG001|Overall Study|Other|3
7243975|NCT00229203|11454035|FG000|Overall Study|Withdrawal by Subject|1
7243976|NCT00229203|11454036|FG001|Overall Study|Withdrawal by Subject|4
7243977|NCT00229658|11454050|FG000|Overall Study|Administrative|2
7243978|NCT00229658|11454051|FG001|Overall Study|Administrative|1
7243979|NCT00229658|11454050|FG000|Overall Study|Investigator decision|13
7243980|NCT00229658|11454051|FG001|Overall Study|Investigator decision|10
7243981|NCT00229658|11454050|FG000|Overall Study|Other|80
7243982|NCT00229658|11454051|FG001|Overall Study|Other|60
7243983|NCT00229658|11454050|FG000|Overall Study|Lost to Follow-up|82
7243984|NCT00229658|11454051|FG001|Overall Study|Lost to Follow-up|55
7243985|NCT00229658|11454050|FG000|Overall Study|Serious Adverse Event|2
7243986|NCT00229658|11454051|FG001|Overall Study|Serious Adverse Event|2
7243987|NCT00229658|11454050|FG000|Overall Study|Withdrawal of consent|46
7243988|NCT00229658|11454051|FG001|Overall Study|Withdrawal of consent|39
7243989|NCT00229723|11454064|FG000|Concomitant Phase|Adverse Event|4
7243990|NCT00229723|11454065|FG001|Concomitant Phase|Adverse Event|2
7243991|NCT00229723|11454066|FG002|Concomitant Phase|Adverse Event|5
7243992|NCT00229723|11454067|FG003|Concomitant Phase|Adverse Event|2
7243993|NCT00229723|11454068|FG004|Concomitant Phase|Adverse Event|0
7243994|NCT00229723|11454069|FG005|Concomitant Phase|Adverse Event|1
7243995|NCT00229723|11454070|FG006|Concomitant Phase|Adverse Event|2
7243996|NCT00229723|11454064|FG000|Concomitant Phase|Objective disease progression|0
7243997|NCT00229723|11454065|FG001|Concomitant Phase|Objective disease progression|0
7243998|NCT00229723|11454066|FG002|Concomitant Phase|Objective disease progression|0
7243999|NCT00229723|11454067|FG003|Concomitant Phase|Objective disease progression|0
7244000|NCT00229723|11454068|FG004|Concomitant Phase|Objective disease progression|0
7244001|NCT00229723|11454069|FG005|Concomitant Phase|Objective disease progression|0
7244002|NCT00229723|11454070|FG006|Concomitant Phase|Objective disease progression|0
7244003|NCT00229723|11454064|FG000|Concomitant Phase|Clinical progression|0
7244004|NCT00229723|11454065|FG001|Concomitant Phase|Clinical progression|0
7244005|NCT00229723|11454066|FG002|Concomitant Phase|Clinical progression|0
7244006|NCT00229723|11454067|FG003|Concomitant Phase|Clinical progression|0
7244007|NCT00229723|11454068|FG004|Concomitant Phase|Clinical progression|0
7244008|NCT00229723|11454069|FG005|Concomitant Phase|Clinical progression|0
7244009|NCT00229723|11454070|FG006|Concomitant Phase|Clinical progression|1
7244010|NCT00229723|11454064|FG000|Concomitant Phase|Lost to Follow-up|0
7244011|NCT00229723|11454065|FG001|Concomitant Phase|Lost to Follow-up|0
7244012|NCT00229723|11454066|FG002|Concomitant Phase|Lost to Follow-up|0
7244013|NCT00229723|11454067|FG003|Concomitant Phase|Lost to Follow-up|0
7244014|NCT00229723|11454068|FG004|Concomitant Phase|Lost to Follow-up|1
7244015|NCT00229723|11454069|FG005|Concomitant Phase|Lost to Follow-up|0
7244016|NCT00229723|11454070|FG006|Concomitant Phase|Lost to Follow-up|0
7244017|NCT00229723|11454064|FG000|Concomitant Phase|Informed consent withdrawn|3
7244018|NCT00229723|11454065|FG001|Concomitant Phase|Informed consent withdrawn|2
7244019|NCT00229723|11454066|FG002|Concomitant Phase|Informed consent withdrawn|0
7244020|NCT00229723|11454067|FG003|Concomitant Phase|Informed consent withdrawn|2
7244021|NCT00229723|11454068|FG004|Concomitant Phase|Informed consent withdrawn|0
7244022|NCT00229723|11454069|FG005|Concomitant Phase|Informed consent withdrawn|0
7244023|NCT00229723|11454070|FG006|Concomitant Phase|Informed consent withdrawn|0
7244024|NCT00229723|11454064|FG000|Concomitant Phase|Severe non-compliance|0
7244025|NCT00229723|11454065|FG001|Concomitant Phase|Severe non-compliance|1
7244026|NCT00229723|11454066|FG002|Concomitant Phase|Severe non-compliance|0
7244027|NCT00229723|11454067|FG003|Concomitant Phase|Severe non-compliance|0
7244028|NCT00229723|11454068|FG004|Concomitant Phase|Severe non-compliance|1
7244029|NCT00229723|11454069|FG005|Concomitant Phase|Severe non-compliance|0
7244030|NCT00229723|11454070|FG006|Concomitant Phase|Severe non-compliance|0
7244031|NCT00229723|11454064|FG000|Concomitant Phase|Other|3
7244032|NCT00229723|11454065|FG001|Concomitant Phase|Other|0
7244033|NCT00229723|11454066|FG002|Concomitant Phase|Other|1
7244034|NCT00229723|11454067|FG003|Concomitant Phase|Other|1
7244035|NCT00229723|11454068|FG004|Concomitant Phase|Other|0
7244036|NCT00229723|11454069|FG005|Concomitant Phase|Other|2
7244037|NCT00229723|11454070|FG006|Concomitant Phase|Other|0
7244038|NCT00229723|11454064|FG000|Maintenance Phase|Adverse Event|7
7244039|NCT00229723|11454065|FG001|Maintenance Phase|Adverse Event|2
7244040|NCT00229723|11454066|FG002|Maintenance Phase|Adverse Event|1
7244041|NCT00229723|11454067|FG003|Maintenance Phase|Adverse Event|4
7244042|NCT00229723|11454068|FG004|Maintenance Phase|Adverse Event|7
7244043|NCT00229723|11454069|FG005|Maintenance Phase|Adverse Event|5
7244044|NCT00229723|11454070|FG006|Maintenance Phase|Adverse Event|2
7244045|NCT00229723|11454064|FG000|Maintenance Phase|Objective disease progression|5
7244046|NCT00229723|11454065|FG001|Maintenance Phase|Objective disease progression|5
7244047|NCT00229723|11454066|FG002|Maintenance Phase|Objective disease progression|3
7244048|NCT00229723|11454067|FG003|Maintenance Phase|Objective disease progression|6
7244049|NCT00229723|11454068|FG004|Maintenance Phase|Objective disease progression|2
7244050|NCT00229723|11454069|FG005|Maintenance Phase|Objective disease progression|9
7244051|NCT00229723|11454070|FG006|Maintenance Phase|Objective disease progression|5
7244052|NCT00229723|11454064|FG000|Maintenance Phase|Clinical progression|4
7244053|NCT00229723|11454065|FG001|Maintenance Phase|Clinical progression|1
7244054|NCT00229723|11454066|FG002|Maintenance Phase|Clinical progression|2
7244055|NCT00229723|11454067|FG003|Maintenance Phase|Clinical progression|2
7244056|NCT00229723|11454068|FG004|Maintenance Phase|Clinical progression|1
7244057|NCT00229723|11454069|FG005|Maintenance Phase|Clinical progression|1
7244058|NCT00229723|11454070|FG006|Maintenance Phase|Clinical progression|1
7244059|NCT00229723|11454064|FG000|Maintenance Phase|Lost to Follow-up|0
7244060|NCT00229723|11454065|FG001|Maintenance Phase|Lost to Follow-up|1
7244061|NCT00229723|11454066|FG002|Maintenance Phase|Lost to Follow-up|2
7244062|NCT00229723|11454067|FG003|Maintenance Phase|Lost to Follow-up|2
7244063|NCT00229723|11454068|FG004|Maintenance Phase|Lost to Follow-up|0
7244064|NCT00229723|11454069|FG005|Maintenance Phase|Lost to Follow-up|0
7244065|NCT00229723|11454070|FG006|Maintenance Phase|Lost to Follow-up|1
7244066|NCT00229723|11454064|FG000|Maintenance Phase|Informed consent withdrawn|1
7244067|NCT00229723|11454065|FG001|Maintenance Phase|Informed consent withdrawn|0
7244068|NCT00229723|11454066|FG002|Maintenance Phase|Informed consent withdrawn|0
7244069|NCT00229723|11454067|FG003|Maintenance Phase|Informed consent withdrawn|1
7244070|NCT00229723|11454068|FG004|Maintenance Phase|Informed consent withdrawn|1
7244071|NCT00229723|11454069|FG005|Maintenance Phase|Informed consent withdrawn|1
7244072|NCT00229723|11454070|FG006|Maintenance Phase|Informed consent withdrawn|0
7244073|NCT00229723|11454064|FG000|Maintenance Phase|Severe non-compliance|3
7244074|NCT00229723|11454065|FG001|Maintenance Phase|Severe non-compliance|1
7244075|NCT00229723|11454066|FG002|Maintenance Phase|Severe non-compliance|0
7244076|NCT00229723|11454067|FG003|Maintenance Phase|Severe non-compliance|0
7244077|NCT00229723|11454068|FG004|Maintenance Phase|Severe non-compliance|1
7244078|NCT00229723|11454069|FG005|Maintenance Phase|Severe non-compliance|0
7244079|NCT00229723|11454070|FG006|Maintenance Phase|Severe non-compliance|0
7244080|NCT00229723|11454064|FG000|Maintenance Phase|Other|5
7244081|NCT00229723|11454065|FG001|Maintenance Phase|Other|4
7244082|NCT00229723|11454066|FG002|Maintenance Phase|Other|1
7244083|NCT00229723|11454067|FG003|Maintenance Phase|Other|2
7244084|NCT00229723|11454068|FG004|Maintenance Phase|Other|3
7244085|NCT00229723|11454069|FG005|Maintenance Phase|Other|3
7244086|NCT00229723|11454070|FG006|Maintenance Phase|Other|1
7244087|NCT00230048|11454115|FG000|Overall Study|Lost to Follow-up|13
7244088|NCT00230048|11454116|FG001|Overall Study|Lost to Follow-up|18
7256192|NCT00321737|11467627|FG001|Overall Study|Withdrawal by Subject|12
7256193|NCT00321737|11467628|FG002|Overall Study|Withdrawal by Subject|17
7256194|NCT00321737|11467626|FG000|Overall Study|Protocol Violation|0
7256195|NCT00321737|11467627|FG001|Overall Study|Protocol Violation|0
7256196|NCT00321737|11467628|FG002|Overall Study|Protocol Violation|1
7256197|NCT00321737|11467626|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7256198|NCT00321737|11467627|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7256199|NCT00321737|11467628|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7256200|NCT00321737|11467626|FG000|Overall Study|Possible Barrett's Esophagus|2
7256201|NCT00321737|11467627|FG001|Overall Study|Possible Barrett's Esophagus|1
7256202|NCT00321737|11467628|FG002|Overall Study|Possible Barrett's Esophagus|1
7256203|NCT00321737|11467626|FG000|Overall Study|Therapeutic Failure|6
7256204|NCT00321737|11467627|FG001|Overall Study|Therapeutic Failure|0
7256205|NCT00321737|11467628|FG002|Overall Study|Therapeutic Failure|2
7256206|NCT00321737|11467626|FG000|Overall Study|Pregnancy|0
7256207|NCT00321737|11467627|FG001|Overall Study|Pregnancy|2
7256208|NCT00321737|11467628|FG002|Overall Study|Pregnancy|0
7256209|NCT00321737|11467626|FG000|Overall Study|Noncompliance|2
7256210|NCT00321737|11467627|FG001|Overall Study|Noncompliance|0
7256211|NCT00321737|11467628|FG002|Overall Study|Noncompliance|0
7256212|NCT00321737|11467626|FG000|Overall Study|Subject Request/ Subject Unavailable|0
7256213|NCT00321737|11467627|FG001|Overall Study|Subject Request/ Subject Unavailable|0
7256214|NCT00321737|11467628|FG002|Overall Study|Subject Request/ Subject Unavailable|2
7256215|NCT00321763|11467640|FG000|Overall Study|Adverse Event|1
7256216|NCT00321763|11467641|FG001|Overall Study|Adverse Event|1
7256217|NCT00321763|11467642|FG002|Overall Study|Adverse Event|0
7244089|NCT00230178|11454147|FG000|Overall Study|Adverse Event|1
7244090|NCT00230178|11454148|FG001|Overall Study|Adverse Event|5
7244091|NCT00230178|11454149|FG002|Overall Study|Adverse Event|2
7244092|NCT00230178|11454147|FG000|Overall Study|Withdrawal by Subject|0
7244093|NCT00230178|11454148|FG001|Overall Study|Withdrawal by Subject|0
7244094|NCT00230178|11454149|FG002|Overall Study|Withdrawal by Subject|1
7244095|NCT00230178|11454147|FG000|Overall Study|Various other reasons|3
7244096|NCT00230178|11454148|FG001|Overall Study|Various other reasons|2
7244097|NCT00230178|11454149|FG002|Overall Study|Various other reasons|4
7244098|NCT00230282|11454157|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
7244099|NCT00230282|11454157|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
7244100|NCT00230282|11454157|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
7244101|NCT00230282|11454157|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
7244102|NCT00230971|11454187|FG000|Randomization|No study drug administered|3
7244103|NCT00230971|11454188|FG001|Randomization|No study drug administered|3
7244104|NCT00230971|11454187|FG000|Baseline Participants|Lost to Follow-up|5
7244105|NCT00230971|11454188|FG001|Baseline Participants|Lost to Follow-up|12
7244106|NCT00230971|11454187|FG000|Baseline Participants|Death|6
7244107|NCT00230971|11454188|FG001|Baseline Participants|Death|5
7244108|NCT00230971|11454187|FG000|Baseline Participants|Withdrawal by Subject|7
7244109|NCT00230971|11454188|FG001|Baseline Participants|Withdrawal by Subject|1
7244110|NCT00230971|11454187|FG000|Baseline Participants|Adverse Event|1
7244111|NCT00230971|11454188|FG001|Baseline Participants|Adverse Event|0
7244112|NCT00230971|11454187|FG000|Baseline Participants|No bacteria observed|1
7244113|NCT00230971|11454188|FG001|Baseline Participants|No bacteria observed|0
7244114|NCT00230971|11454187|FG000|Baseline Participants|Failure to return|1
7244115|NCT00230971|11454188|FG001|Baseline Participants|Failure to return|1
7244116|NCT00230971|11454187|FG000|Baseline Participants|Reintervention|1
7244117|NCT00230971|11454188|FG001|Baseline Participants|Reintervention|0
7244118|NCT00231062|11454194|FG000|Overall Study|Physician Decision|6
7244119|NCT00231114|11454200|FG000|Randomized|Withdrawal by Subject|6
7244120|NCT00231114|11454201|FG001|Randomized|Withdrawal by Subject|3
7244121|NCT00231114|11454200|FG000|Treatment Period|Death: Motor Vehicle Accident|1
7244122|NCT00231114|11454201|FG001|Treatment Period|Death: Motor Vehicle Accident|0
7244123|NCT00231114|11454200|FG000|Post-Treatment Period|Lost to Follow-up|6
7244124|NCT00231114|11454201|FG001|Post-Treatment Period|Lost to Follow-up|1
7244125|NCT00231114|11454200|FG000|Post-Treatment Period|Physician Decision|1
7244126|NCT00231114|11454201|FG001|Post-Treatment Period|Physician Decision|0
7244127|NCT00231114|11454200|FG000|Post-Treatment Period|Withdrawal by Subject|1
7244128|NCT00231114|11454201|FG001|Post-Treatment Period|Withdrawal by Subject|0
7244129|NCT00231179|11454211|FG000|Overall Study|Lost to Follow-up|21
7244130|NCT00231179|11454212|FG001|Overall Study|Lost to Follow-up|21
7244131|NCT00231179|11454211|FG000|Overall Study|Withdrawal by Subject|3
7244132|NCT00231179|11454212|FG001|Overall Study|Withdrawal by Subject|3
7244133|NCT00231413|11454234|FG000|Overall Study|Non-serious AE|0
7244134|NCT00231413|11454235|FG001|Overall Study|Non-serious AE|0
7244135|NCT00231413|11454236|FG002|Overall Study|Non-serious AE|1
7244136|NCT00231413|11454237|FG003|Overall Study|Non-serious AE|0
7244137|NCT00231413|11454238|FG004|Overall Study|Non-serious AE|0
7244138|NCT00231413|11454239|FG005|Overall Study|Non-serious AE|0
7244139|NCT00231413|11454240|FG006|Overall Study|Non-serious AE|1
7244140|NCT00231413|11454234|FG000|Overall Study|Withdrawal by Subject|3
7244141|NCT00231413|11454235|FG001|Overall Study|Withdrawal by Subject|1
7244142|NCT00231413|11454236|FG002|Overall Study|Withdrawal by Subject|4
7244143|NCT00231413|11454237|FG003|Overall Study|Withdrawal by Subject|2
7244144|NCT00231413|11454238|FG004|Overall Study|Withdrawal by Subject|2
7244145|NCT00231413|11454239|FG005|Overall Study|Withdrawal by Subject|0
7244146|NCT00231413|11454240|FG006|Overall Study|Withdrawal by Subject|3
7244147|NCT00231413|11454234|FG000|Overall Study|Migrated/moved from study area|0
7244148|NCT00231413|11454235|FG001|Overall Study|Migrated/moved from study area|0
7244149|NCT00231413|11454236|FG002|Overall Study|Migrated/moved from study area|1
7244150|NCT00231413|11454237|FG003|Overall Study|Migrated/moved from study area|0
7244151|NCT00231413|11454238|FG004|Overall Study|Migrated/moved from study area|0
7244152|NCT00231413|11454239|FG005|Overall Study|Migrated/moved from study area|1
7244153|NCT00231413|11454240|FG006|Overall Study|Migrated/moved from study area|0
7244154|NCT00231413|11454234|FG000|Overall Study|Lost to Follow-up|4
7244155|NCT00231413|11454235|FG001|Overall Study|Lost to Follow-up|4
7244156|NCT00231413|11454236|FG002|Overall Study|Lost to Follow-up|1
7244157|NCT00231413|11454237|FG003|Overall Study|Lost to Follow-up|1
7244158|NCT00231413|11454238|FG004|Overall Study|Lost to Follow-up|1
7244159|NCT00231413|11454239|FG005|Overall Study|Lost to Follow-up|4
7244160|NCT00231413|11454240|FG006|Overall Study|Lost to Follow-up|0
7244161|NCT00231413|11454234|FG000|Overall Study|Pregnancy|1
7244162|NCT00231413|11454235|FG001|Overall Study|Pregnancy|0
7244163|NCT00231413|11454236|FG002|Overall Study|Pregnancy|0
7244164|NCT00231413|11454237|FG003|Overall Study|Pregnancy|0
7244165|NCT00231413|11454238|FG004|Overall Study|Pregnancy|0
7244166|NCT00231413|11454239|FG005|Overall Study|Pregnancy|0
7244167|NCT00231413|11454240|FG006|Overall Study|Pregnancy|0
7244168|NCT00231465|11454256|FG000|Overall Study|Completed only one cycle|1
7244169|NCT00231465|11454256|FG000|Overall Study|Did not have follow up CT scans|1
7244170|NCT00231478|11454262|FG000|Overall Study|Protocol Violation|3
7244171|NCT00231478|11454263|FG001|Overall Study|Protocol Violation|2
7244172|NCT00231478|11454262|FG000|Overall Study|Refused Treatment|1
7244173|NCT00231478|11454263|FG001|Overall Study|Refused Treatment|1
7244174|NCT00231478|11454262|FG000|Overall Study|Withdrawal by Subject|1
7244175|NCT00231478|11454263|FG001|Overall Study|Withdrawal by Subject|0
7244176|NCT00231478|11454262|FG000|Overall Study|Adverse Event|0
7244177|NCT00231478|11454263|FG001|Overall Study|Adverse Event|1
7244178|NCT00231478|11454262|FG000|Overall Study|Administrative|3
7244179|NCT00231478|11454263|FG001|Overall Study|Administrative|2
7244180|NCT00231777|11454271|FG000|Overall Study|Lost to Follow-up|3
7244181|NCT00231777|11454272|FG001|Overall Study|Lost to Follow-up|0
7244182|NCT00231777|11454271|FG000|Overall Study|Other|3
7244183|NCT00231777|11454272|FG001|Overall Study|Other|2
7244184|NCT00231816|11454280|FG000|Overall Study|Adverse Event|1
7244185|NCT00231816|11454281|FG001|Overall Study|Adverse Event|0
7244186|NCT00231816|11454280|FG000|Overall Study|Lost to Follow-up|8
7244187|NCT00231816|11454281|FG001|Overall Study|Lost to Follow-up|5
7244188|NCT00231816|11454280|FG000|Overall Study|Protocol Violation|2
7244189|NCT00231816|11454281|FG001|Overall Study|Protocol Violation|3
7244190|NCT00231816|11454280|FG000|Overall Study|Withdrawal by Subject|3
7244191|NCT00231816|11454281|FG001|Overall Study|Withdrawal by Subject|3
7244192|NCT00231816|11454280|FG000|Overall Study|Other|2
7244193|NCT00231816|11454281|FG001|Overall Study|Other|1
7244194|NCT00231842|11454288|FG000|Overall Study|Withdrawal by Subject|3
7244195|NCT00231842|11454288|FG000|Overall Study|Did not complete the last 3 cycle|8
7244196|NCT00231894|11454299|FG000|Overall Study|Withdrawal by Subject|1
7244197|NCT00231894|11454300|FG001|Overall Study|Withdrawal by Subject|1
7244198|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Death|186
7244199|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Death|222
7244200|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Death|0
7244201|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
7244202|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
7244203|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
7244204|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
7244205|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
7244206|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
7244207|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Protocol Violation|28
7244208|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Protocol Violation|21
7244209|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Protocol Violation|0
7244210|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Adverse Event|83
7244211|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Adverse Event|100
7244212|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Adverse Event|0
7244213|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Other|70
7244214|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Other|75
7244215|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Other|0
7244216|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Randomized but not treated|3
7244217|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Randomized but not treated|4
7244218|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Randomized but not treated|0
7244219|NCT00232180|11454314|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
7244220|NCT00232180|11454315|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
7244221|NCT00232180|11454316|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
7244222|NCT00232180|11454314|FG000|Open Label Phase|Death|0
7244223|NCT00232180|11454315|FG001|Open Label Phase|Death|0
7244224|NCT00232180|11454316|FG002|Open Label Phase|Death|48
7244225|NCT00232180|11454314|FG000|Open Label Phase|Lost to Follow-up|0
7244226|NCT00232180|11454315|FG001|Open Label Phase|Lost to Follow-up|0
7244227|NCT00232180|11454316|FG002|Open Label Phase|Lost to Follow-up|5
7244228|NCT00232180|11454314|FG000|Open Label Phase|Protocol Violation|0
7244229|NCT00232180|11454315|FG001|Open Label Phase|Protocol Violation|0
7244230|NCT00232180|11454316|FG002|Open Label Phase|Protocol Violation|3
7244231|NCT00232180|11454314|FG000|Open Label Phase|Study terminated by sponsor|0
7244232|NCT00232180|11454315|FG001|Open Label Phase|Study terminated by sponsor|0
7244233|NCT00232180|11454316|FG002|Open Label Phase|Study terminated by sponsor|3
7244234|NCT00232180|11454314|FG000|Open Label Phase|Withdrawal by Subject|0
7244235|NCT00232180|11454315|FG001|Open Label Phase|Withdrawal by Subject|0
7244236|NCT00232180|11454316|FG002|Open Label Phase|Withdrawal by Subject|37
7244237|NCT00232180|11454314|FG000|Open Label Phase|Other|0
7244238|NCT00232180|11454315|FG001|Open Label Phase|Other|0
7244239|NCT00232180|11454316|FG002|Open Label Phase|Other|16
7244240|NCT00232180|11454314|FG000|Open Label Phase|Adverse Event|0
7244241|NCT00232180|11454315|FG001|Open Label Phase|Adverse Event|0
7244242|NCT00232180|11454316|FG002|Open Label Phase|Adverse Event|25
7244243|NCT00232180|11454314|FG000|Open Label Phase|Laboratory abnormality|0
7244244|NCT00232180|11454315|FG001|Open Label Phase|Laboratory abnormality|0
7244245|NCT00232180|11454316|FG002|Open Label Phase|Laboratory abnormality|10
7244246|NCT00232180|11454314|FG000|Open Label Phase|Randomized but not treated|0
7244247|NCT00232180|11454315|FG001|Open Label Phase|Randomized but not treated|0
7244248|NCT00232180|11454316|FG002|Open Label Phase|Randomized but not treated|1
7244249|NCT00232544|11454345|FG000|Overall Study|Lost to Follow-up|20
7244250|NCT00232544|11454346|FG001|Overall Study|Lost to Follow-up|15
7244251|NCT00232557|11454354|FG000|Overall Study|Lost to Follow-up|3
7244252|NCT00232557|11454355|FG001|Overall Study|Lost to Follow-up|5
7244253|NCT00232596|11454376|FG000|6-Week Titration Phase|Adverse Event|6
7244254|NCT00232596|11454377|FG001|6-Week Titration Phase|Adverse Event|19
7244255|NCT00232596|11454376|FG000|6-Week Titration Phase|Failed to Return|2
7244256|NCT00232596|11454377|FG001|6-Week Titration Phase|Failed to Return|1
7244257|NCT00232596|11454376|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
7244258|NCT00232596|11454377|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
7244259|NCT00232596|11454376|FG000|6-Week Titration Phase|Protocol Violation|1
7244260|NCT00232596|11454377|FG001|6-Week Titration Phase|Protocol Violation|3
7244261|NCT00232596|11454376|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
7244262|NCT00232596|11454377|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
7244263|NCT00232596|11454376|FG000|6-Week Titration Phase|Other|3
7244264|NCT00232596|11454377|FG001|6-Week Titration Phase|Other|3
7244265|NCT00232596|11454376|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
7244266|NCT00232596|11454377|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
7574097|NCT03648879|11956152|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
7574098|NCT03649412|11956158|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
7244267|NCT00232596|11454376|FG000|12-Week Maintenance Phase|Adverse Event|7
7244268|NCT00232596|11454377|FG001|12-Week Maintenance Phase|Adverse Event|22
7244269|NCT00232596|11454376|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
7244270|NCT00232596|11454377|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
7244271|NCT00232596|11454376|FG000|12-Week Maintenance Phase|Protocol Violation|3
7244272|NCT00232596|11454377|FG001|12-Week Maintenance Phase|Protocol Violation|1
7244273|NCT00232596|11454376|FG000|12-Week Maintenance Phase|Other|1
7244274|NCT00232596|11454377|FG001|12-Week Maintenance Phase|Other|3
7244275|NCT00233064|11454401|FG000|Overall Study|Lost to Follow-up|7
7244276|NCT00233064|11454402|FG001|Overall Study|Lost to Follow-up|7
7244277|NCT00233064|11454401|FG000|Overall Study|Withdrawal by Subject|5
7244278|NCT00233064|11454402|FG001|Overall Study|Withdrawal by Subject|3
7244279|NCT00233064|11454401|FG000|Overall Study|Death|0
7244280|NCT00233064|11454402|FG001|Overall Study|Death|1
7244281|NCT00233064|11454401|FG000|Overall Study|Relocation|0
7244282|NCT00233064|11454402|FG001|Overall Study|Relocation|1
7244283|NCT00233064|11454401|FG000|Overall Study|Protocol Violation|1
7244284|NCT00233064|11454402|FG001|Overall Study|Protocol Violation|0
7244285|NCT00233064|11454401|FG000|Overall Study|Moved to Dom. Republic|1
7244286|NCT00233064|11454402|FG001|Overall Study|Moved to Dom. Republic|0
7244287|NCT00233324|11454422|FG000|Main Study|Death|68
7244288|NCT00233324|11454423|FG001|Main Study|Death|60
7244289|NCT00233324|11454424|FG002|Main Study|Death|62
7244290|NCT00233324|11454425|FG003|Main Study|Death|47
7244291|NCT00233324|11454422|FG000|Follow up at 18-22 Months Corrected Age|Death|5
7244292|NCT00233324|11454423|FG001|Follow up at 18-22 Months Corrected Age|Death|7
7244293|NCT00233324|11454424|FG002|Follow up at 18-22 Months Corrected Age|Death|5
7244294|NCT00233324|11454425|FG003|Follow up at 18-22 Months Corrected Age|Death|4
7244295|NCT00233324|11454422|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
7244296|NCT00233324|11454423|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7244297|NCT00233324|11454424|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
7244298|NCT00233324|11454425|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
7244299|NCT00233363|11454444|FG000|Overall Study|Adverse Event|1
7244300|NCT00233363|11454445|FG001|Overall Study|Adverse Event|2
7244301|NCT00233363|11454444|FG000|Overall Study|Lack of Efficacy|0
7244302|NCT00233363|11454445|FG001|Overall Study|Lack of Efficacy|2
7244303|NCT00233363|11454444|FG000|Overall Study|Withdrawal by Subject|1
7244304|NCT00233363|11454445|FG001|Overall Study|Withdrawal by Subject|1
7244305|NCT00233363|11454444|FG000|Overall Study|Aggravation of complication|1
7244306|NCT00233363|11454445|FG001|Overall Study|Aggravation of complication|0
7244307|NCT00233389|11454453|FG000|Overall Study|Adverse Event|5
7244308|NCT00233389|11454454|FG001|Overall Study|Adverse Event|5
7244309|NCT00233389|11454453|FG000|Overall Study|Lack of Efficacy|11
7244310|NCT00233389|11454454|FG001|Overall Study|Lack of Efficacy|8
7244311|NCT00233389|11454453|FG000|Overall Study|Lost to Follow-up|1
7244312|NCT00233389|11454454|FG001|Overall Study|Lost to Follow-up|1
7244313|NCT00233389|11454453|FG000|Overall Study|Physician Decision|1
7244314|NCT00233389|11454454|FG001|Overall Study|Physician Decision|0
7244315|NCT00233389|11454453|FG000|Overall Study|Protocol Violation|0
7244316|NCT00233389|11454454|FG001|Overall Study|Protocol Violation|1
7244317|NCT00233389|11454453|FG000|Overall Study|Withdrawal by Subject|0
7244318|NCT00233389|11454454|FG001|Overall Study|Withdrawal by Subject|1
7244319|NCT00233402|11454462|FG000|Overall Study|No pathology data|12
7244320|NCT00233402|11454463|FG001|Overall Study|No pathology data|9
7574099|NCT03649412|11956159|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
7244321|NCT00233402|11454462|FG000|Overall Study|No Ta/T1|89
7244322|NCT00233402|11454463|FG001|Overall Study|No Ta/T1|94
7244323|NCT00233402|11454462|FG000|Overall Study|Lost to follow up etc|3
7244324|NCT00233402|11454463|FG001|Overall Study|Lost to follow up etc|21
7244325|NCT00233454|11454471|FG000|Overall Study|Death|6
7244326|NCT00233480|11454477|FG000|Overall Study|Underwent status II heart transplant|0
7244327|NCT00233480|11454478|FG001|Overall Study|Underwent status II heart transplant|1
7244328|NCT00233948|11454497|FG000|Overall Study|Adverse Event|1
7244329|NCT00233948|11454498|FG001|Overall Study|Adverse Event|0
7244330|NCT00233948|11454499|FG002|Overall Study|Adverse Event|0
7244331|NCT00233948|11454500|FG003|Overall Study|Adverse Event|0
7244332|NCT00233948|11454501|FG004|Overall Study|Adverse Event|0
7244333|NCT00233948|11454502|FG005|Overall Study|Adverse Event|0
7244334|NCT00233987|11454517|FG000|Overall Study|Withdrawal by Subject|1
7244335|NCT00233987|11454517|FG000|Overall Study|Lack of Efficacy|2
7244336|NCT00233987|11454517|FG000|Overall Study|Reason Under Review|1
7244337|NCT00233987|11454517|FG000|Overall Study|Other - Not Protocol Specified|5
7244338|NCT00233987|11454517|FG000|Overall Study|Eligible but No Treatment Received|2
7244339|NCT00233987|11454517|FG000|Overall Study|Ineligible|4
7244340|NCT00234039|11454521|FG000|Overall Study|Adverse Event|2
7244341|NCT00234039|11454521|FG000|Overall Study|Progression/relapse|34
7244342|NCT00234039|11454521|FG000|Overall Study|Other - Not Protocol Specified|3
7244343|NCT00234039|11454521|FG000|Overall Study|Ineligible|9
7244344|NCT00234039|11454521|FG000|Overall Study|No Protocol Treatment Received|2
7244345|NCT00234052|11454525|FG000|Treatment|Withdrawal by Subject|3
7244346|NCT00234052|11454525|FG000|Treatment|Adverse Event|5
7244347|NCT00234052|11454525|FG000|Treatment|Death|2
7244348|NCT00234052|11454525|FG000|Treatment|Progressive Disease|11
7244349|NCT00234052|11454525|FG000|Follow-up for 5 Years|Death|41
7244350|NCT00234052|11454525|FG000|Follow-up for 5 Years|Lost to Follow-up|1
7244351|NCT00234052|11454525|FG000|Follow-up for 5 Years|Other|7
7244352|NCT00234065|11454531|FG000|Overall Study|Adverse Event|268
7244353|NCT00234065|11454532|FG001|Overall Study|Adverse Event|166
7244354|NCT00234065|11454531|FG000|Overall Study|Withdrawal by Subject|73
7244355|NCT00234065|11454532|FG001|Overall Study|Withdrawal by Subject|56
7244356|NCT00234065|11454531|FG000|Overall Study|Physician Decision|23
7244357|NCT00234065|11454532|FG001|Overall Study|Physician Decision|22
7244358|NCT00234065|11454531|FG000|Overall Study|Not Classified|111
7244359|NCT00234065|11454532|FG001|Overall Study|Not Classified|112
7244360|NCT00234104|11454559|FG000|Overall Study|Adverse Event|4
7244361|NCT00234104|11454560|FG001|Overall Study|Adverse Event|0
7244362|NCT00234104|11454561|FG002|Overall Study|Adverse Event|3
7244363|NCT00234104|11454562|FG003|Overall Study|Adverse Event|5
7244364|NCT00234104|11454559|FG000|Overall Study|Protocol Violation|0
7244365|NCT00234104|11454560|FG001|Overall Study|Protocol Violation|0
7244366|NCT00234104|11454561|FG002|Overall Study|Protocol Violation|0
7244367|NCT00234104|11454562|FG003|Overall Study|Protocol Violation|1
7244368|NCT00234104|11454559|FG000|Overall Study|Physician Decision|0
7244369|NCT00234104|11454560|FG001|Overall Study|Physician Decision|1
7244370|NCT00234104|11454561|FG002|Overall Study|Physician Decision|2
7244371|NCT00234104|11454562|FG003|Overall Study|Physician Decision|2
7244372|NCT00234494|11454605|FG000|Overall Study|Protocol Violation|2
7244373|NCT00234533|11454609|FG000|Overall Study|Withdrawal by Subject|6
7244374|NCT00234533|11454609|FG000|Overall Study|Adverse Event|2
7244375|NCT00234533|11454609|FG000|Overall Study|Enrolled but not treated|3
7244376|NCT00235391|11454640|FG000|Overall Study|Adverse Event|4
7244377|NCT00235391|11454641|FG001|Overall Study|Adverse Event|5
7244378|NCT00235391|11454642|FG002|Overall Study|Adverse Event|10
7244379|NCT00235391|11454643|FG003|Overall Study|Adverse Event|72
7244380|NCT00235391|11454644|FG004|Overall Study|Adverse Event|5
7244381|NCT00235391|11454645|FG005|Overall Study|Adverse Event|2
7244382|NCT00235391|11454640|FG000|Overall Study|Abnormal laboratory value(s)|3
7244383|NCT00235391|11454641|FG001|Overall Study|Abnormal laboratory value(s)|5
7244384|NCT00235391|11454642|FG002|Overall Study|Abnormal laboratory value(s)|4
7244385|NCT00235391|11454643|FG003|Overall Study|Abnormal laboratory value(s)|27
7244386|NCT00235391|11454644|FG004|Overall Study|Abnormal laboratory value(s)|1
7244387|NCT00235391|11454645|FG005|Overall Study|Abnormal laboratory value(s)|2
7244388|NCT00235391|11454640|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7244389|NCT00235391|11454641|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7244390|NCT00235391|11454642|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7244391|NCT00235391|11454643|FG003|Overall Study|Unsatisfactory therapeutic effect|17
7244392|NCT00235391|11454644|FG004|Overall Study|Unsatisfactory therapeutic effect|0
7244393|NCT00235391|11454645|FG005|Overall Study|Unsatisfactory therapeutic effect|0
7244394|NCT00235391|11454640|FG000|Overall Study|Condition no longer requires treatment|3
7244395|NCT00235391|11454641|FG001|Overall Study|Condition no longer requires treatment|0
7244396|NCT00235391|11454642|FG002|Overall Study|Condition no longer requires treatment|0
7244397|NCT00235391|11454643|FG003|Overall Study|Condition no longer requires treatment|11
7244398|NCT00235391|11454644|FG004|Overall Study|Condition no longer requires treatment|1
7244399|NCT00235391|11454645|FG005|Overall Study|Condition no longer requires treatment|0
7244400|NCT00235391|11454640|FG000|Overall Study|Protocol deviation|0
7244401|NCT00235391|11454641|FG001|Overall Study|Protocol deviation|0
7244402|NCT00235391|11454642|FG002|Overall Study|Protocol deviation|1
7244403|NCT00235391|11454643|FG003|Overall Study|Protocol deviation|11
7244404|NCT00235391|11454644|FG004|Overall Study|Protocol deviation|0
7244405|NCT00235391|11454645|FG005|Overall Study|Protocol deviation|0
7244406|NCT00235391|11454640|FG000|Overall Study|Withdrawal by Subject|2
7244407|NCT00235391|11454641|FG001|Overall Study|Withdrawal by Subject|3
7244408|NCT00235391|11454642|FG002|Overall Study|Withdrawal by Subject|3
7244409|NCT00235391|11454643|FG003|Overall Study|Withdrawal by Subject|61
7244410|NCT00235391|11454644|FG004|Overall Study|Withdrawal by Subject|5
7244411|NCT00235391|11454645|FG005|Overall Study|Withdrawal by Subject|0
7244412|NCT00235391|11454640|FG000|Overall Study|Lost to Follow-up|0
7244413|NCT00235391|11454641|FG001|Overall Study|Lost to Follow-up|3
7244414|NCT00235391|11454642|FG002|Overall Study|Lost to Follow-up|3
7244415|NCT00235391|11454643|FG003|Overall Study|Lost to Follow-up|16
7244416|NCT00235391|11454644|FG004|Overall Study|Lost to Follow-up|0
7244417|NCT00235391|11454645|FG005|Overall Study|Lost to Follow-up|0
7244418|NCT00235391|11454640|FG000|Overall Study|Administrative problems|0
7244419|NCT00235391|11454641|FG001|Overall Study|Administrative problems|0
7244420|NCT00235391|11454642|FG002|Overall Study|Administrative problems|0
7244421|NCT00235391|11454643|FG003|Overall Study|Administrative problems|1
7244422|NCT00235391|11454644|FG004|Overall Study|Administrative problems|0
7244423|NCT00235391|11454645|FG005|Overall Study|Administrative problems|0
7244424|NCT00235391|11454640|FG000|Overall Study|Death|0
7244425|NCT00235391|11454641|FG001|Overall Study|Death|0
7244426|NCT00235391|11454642|FG002|Overall Study|Death|1
7244427|NCT00235391|11454643|FG003|Overall Study|Death|4
7244428|NCT00235391|11454644|FG004|Overall Study|Death|0
7244429|NCT00235391|11454645|FG005|Overall Study|Death|0
7244430|NCT00235443|11454660|FG000|Overall Study|Adverse Event|4
7244431|NCT00235443|11454661|FG001|Overall Study|Adverse Event|12
7244432|NCT00235443|11454662|FG002|Overall Study|Adverse Event|17
7244433|NCT00235443|11454663|FG003|Overall Study|Adverse Event|44
7244434|NCT00235443|11454664|FG004|Overall Study|Adverse Event|10
7244435|NCT00235443|11454665|FG005|Overall Study|Adverse Event|15
7244436|NCT00235443|11454660|FG000|Overall Study|Lack of Efficacy|0
7244437|NCT00235443|11454661|FG001|Overall Study|Lack of Efficacy|1
7244438|NCT00235443|11454662|FG002|Overall Study|Lack of Efficacy|5
7244439|NCT00235443|11454663|FG003|Overall Study|Lack of Efficacy|12
7244440|NCT00235443|11454664|FG004|Overall Study|Lack of Efficacy|2
7244441|NCT00235443|11454665|FG005|Overall Study|Lack of Efficacy|9
7244442|NCT00235443|11454660|FG000|Overall Study|Withdrawal by Subject|3
7244443|NCT00235443|11454661|FG001|Overall Study|Withdrawal by Subject|9
7244444|NCT00235443|11454662|FG002|Overall Study|Withdrawal by Subject|25
7244445|NCT00235443|11454663|FG003|Overall Study|Withdrawal by Subject|24
7244446|NCT00235443|11454664|FG004|Overall Study|Withdrawal by Subject|10
7244447|NCT00235443|11454665|FG005|Overall Study|Withdrawal by Subject|12
7244448|NCT00235443|11454660|FG000|Overall Study|Lost to Follow-up|0
7244449|NCT00235443|11454661|FG001|Overall Study|Lost to Follow-up|8
7244450|NCT00235443|11454662|FG002|Overall Study|Lost to Follow-up|6
7244451|NCT00235443|11454663|FG003|Overall Study|Lost to Follow-up|6
7244452|NCT00235443|11454664|FG004|Overall Study|Lost to Follow-up|4
7244453|NCT00235443|11454665|FG005|Overall Study|Lost to Follow-up|3
7244454|NCT00235443|11454660|FG000|Overall Study|Unsatisfactory compliance|0
7244455|NCT00235443|11454661|FG001|Overall Study|Unsatisfactory compliance|2
7244456|NCT00235443|11454662|FG002|Overall Study|Unsatisfactory compliance|3
7244457|NCT00235443|11454663|FG003|Overall Study|Unsatisfactory compliance|4
7244458|NCT00235443|11454664|FG004|Overall Study|Unsatisfactory compliance|1
7244459|NCT00235443|11454665|FG005|Overall Study|Unsatisfactory compliance|0
7244460|NCT00235443|11454660|FG000|Overall Study|Other reasons for premature termination|1
7244461|NCT00235443|11454661|FG001|Overall Study|Other reasons for premature termination|6
7244462|NCT00235443|11454662|FG002|Overall Study|Other reasons for premature termination|6
7244463|NCT00235443|11454663|FG003|Overall Study|Other reasons for premature termination|7
7244464|NCT00235443|11454664|FG004|Overall Study|Other reasons for premature termination|3
7244465|NCT00235443|11454665|FG005|Overall Study|Other reasons for premature termination|6
7244466|NCT00235495|11454692|FG000|Overall Study|Death|52
7244467|NCT00235495|11454693|FG001|Overall Study|Death|42
7244468|NCT00235495|11454692|FG000|Overall Study|Withdrawal by Subject|5
7244469|NCT00235495|11454693|FG001|Overall Study|Withdrawal by Subject|3
7244470|NCT00235495|11454692|FG000|Overall Study|Lost to Follow-up|11
7244471|NCT00235495|11454693|FG001|Overall Study|Lost to Follow-up|13
7244472|NCT00235495|11454692|FG000|Overall Study|Visit/assessmen outside window/missing|0
7244473|NCT00235495|11454693|FG001|Overall Study|Visit/assessmen outside window/missing|10
7244474|NCT00235716|11454716|FG000|Overall Study|Death|26
7244475|NCT00235716|11454717|FG001|Overall Study|Death|39
7244476|NCT00235716|11454718|FG002|Overall Study|Death|32
7244477|NCT00235716|11454719|FG003|Overall Study|Death|31
7244478|NCT00235716|11454716|FG000|Overall Study|Withdrawal by Subject|23
7244479|NCT00235716|11454717|FG001|Overall Study|Withdrawal by Subject|19
7244480|NCT00235716|11454718|FG002|Overall Study|Withdrawal by Subject|17
7244481|NCT00235716|11454719|FG003|Overall Study|Withdrawal by Subject|18
7244482|NCT00235716|11454716|FG000|Overall Study|Lost to Follow-up|12
7244483|NCT00235716|11454717|FG001|Overall Study|Lost to Follow-up|7
7244484|NCT00235716|11454718|FG002|Overall Study|Lost to Follow-up|14
7244485|NCT00235716|11454719|FG003|Overall Study|Lost to Follow-up|10
7244486|NCT00235716|11454716|FG000|Overall Study|Adverse Event|1
7244487|NCT00235716|11454717|FG001|Overall Study|Adverse Event|1
7244488|NCT00235716|11454718|FG002|Overall Study|Adverse Event|1
7244489|NCT00235716|11454719|FG003|Overall Study|Adverse Event|0
7244490|NCT00235716|11454716|FG000|Overall Study|Physician Decision|0
7244491|NCT00235716|11454717|FG001|Overall Study|Physician Decision|1
7244492|NCT00235716|11454718|FG002|Overall Study|Physician Decision|1
7244493|NCT00235716|11454719|FG003|Overall Study|Physician Decision|3
7244494|NCT00235755|11454732|FG000|4-Week Titration Phase|Adverse Event|6
7244495|NCT00235755|11454733|FG001|4-Week Titration Phase|Adverse Event|14
7244496|NCT00235755|11454734|FG002|4-Week Titration Phase|Adverse Event|20
7244497|NCT00235755|11454732|FG000|4-Week Titration Phase|Lost to Follow-up|0
7244498|NCT00235755|11454733|FG001|4-Week Titration Phase|Lost to Follow-up|1
7244499|NCT00235755|11454734|FG002|4-Week Titration Phase|Lost to Follow-up|1
7244500|NCT00235755|11454732|FG000|4-Week Titration Phase|Protocol Violation|2
7244501|NCT00235755|11454733|FG001|4-Week Titration Phase|Protocol Violation|2
7244502|NCT00235755|11454734|FG002|4-Week Titration Phase|Protocol Violation|1
7244503|NCT00235755|11454732|FG000|4-Week Titration Phase|Withdrawal by Subject|1
7244504|NCT00235755|11454733|FG001|4-Week Titration Phase|Withdrawal by Subject|2
7244505|NCT00235755|11454734|FG002|4-Week Titration Phase|Withdrawal by Subject|3
7244506|NCT00235755|11454732|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7244507|NCT00235755|11454733|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
7244508|NCT00235755|11454734|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
7244509|NCT00235755|11454732|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
7244510|NCT00235755|11454733|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
7244511|NCT00235755|11454734|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
7244512|NCT00235755|11454732|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
7244513|NCT00235755|11454733|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7244514|NCT00235755|11454734|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
7244515|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Adverse Event|8
7244516|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Adverse Event|12
7244517|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Adverse Event|26
7244518|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
7244519|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
7244520|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
7244521|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
7244522|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
7244523|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
7244524|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Protocol Violation|0
7244525|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Protocol Violation|4
7244526|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Protocol Violation|2
7244527|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
7244528|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
7244529|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
7244530|NCT00235755|11454732|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
7244531|NCT00235755|11454733|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7574100|NCT03649412|11956158|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
7574101|NCT03649412|11956159|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
7574102|NCT03649412|11956158|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
7574103|NCT03649412|11956159|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
7574104|NCT03649412|11956158|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
7574105|NCT03649412|11956159|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
7244532|NCT00235755|11454734|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
7244533|NCT00235872|11454761|FG000|Overall Study|Adverse Event|34
7244534|NCT00235872|11454761|FG000|Overall Study|Death|1
7244535|NCT00235872|11454761|FG000|Overall Study|Lost to Follow-up|1
7244536|NCT00235872|11454761|FG000|Overall Study|Withdrawal by Subject|50
7244537|NCT00235872|11454761|FG000|Overall Study|Administrative reason|61
7574106|NCT03649412|11956158|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
7244538|NCT00235989|11454769|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
7244539|NCT00235989|11454770|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
7244540|NCT00235989|11454771|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
7244541|NCT00235989|11454772|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
7244542|NCT00235989|11454773|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
7244543|NCT00235989|11454774|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
7244544|NCT00235989|11454769|FG000|Extension Treatment Period (ET)|Adverse Event|3
7244545|NCT00235989|11454770|FG001|Extension Treatment Period (ET)|Adverse Event|0
7244546|NCT00235989|11454771|FG002|Extension Treatment Period (ET)|Adverse Event|2
7574107|NCT03649412|11956159|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
7244547|NCT00235989|11454772|FG003|Extension Treatment Period (ET)|Adverse Event|0
7244548|NCT00235989|11454773|FG004|Extension Treatment Period (ET)|Adverse Event|0
7244549|NCT00235989|11454774|FG005|Extension Treatment Period (ET)|Adverse Event|0
7244550|NCT00235989|11454769|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
7244551|NCT00235989|11454770|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
7244552|NCT00235989|11454771|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
7244553|NCT00235989|11454772|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
7244554|NCT00235989|11454773|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
7244555|NCT00235989|11454774|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
7244556|NCT00235989|11454769|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
7244557|NCT00235989|11454770|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
7244558|NCT00235989|11454771|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
7244559|NCT00235989|11454772|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
7244560|NCT00235989|11454773|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
7244561|NCT00235989|11454774|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
7244645|NCT00236899|11454829|FG002|Overall Study|Entry Criteria Exclusion|1
7244562|NCT00235989|11454769|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
7244563|NCT00235989|11454770|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
7244564|NCT00235989|11454771|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
7244565|NCT00235989|11454772|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
7244566|NCT00235989|11454773|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
7244567|NCT00235989|11454774|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
7244568|NCT00236080|11454789|FG000|Overall Study|Adverse Event|0
7244569|NCT00236080|11454790|FG001|Overall Study|Adverse Event|0
7244570|NCT00236080|11454791|FG002|Overall Study|Adverse Event|3
7244571|NCT00236080|11454792|FG003|Overall Study|Adverse Event|1
7244572|NCT00236080|11454793|FG004|Overall Study|Adverse Event|0
7244573|NCT00236080|11454789|FG000|Overall Study|Lost to Follow-up|0
7244574|NCT00236080|11454790|FG001|Overall Study|Lost to Follow-up|1
7244575|NCT00236080|11454791|FG002|Overall Study|Lost to Follow-up|0
7244576|NCT00236080|11454792|FG003|Overall Study|Lost to Follow-up|0
7244577|NCT00236080|11454793|FG004|Overall Study|Lost to Follow-up|0
7244578|NCT00236080|11454789|FG000|Overall Study|Physician Decision|1
7244579|NCT00236080|11454790|FG001|Overall Study|Physician Decision|0
7244580|NCT00236080|11454791|FG002|Overall Study|Physician Decision|1
7244581|NCT00236080|11454792|FG003|Overall Study|Physician Decision|1
7244582|NCT00236080|11454793|FG004|Overall Study|Physician Decision|1
7244583|NCT00236080|11454789|FG000|Overall Study|Withdrawal by Subject|1
7244584|NCT00236080|11454790|FG001|Overall Study|Withdrawal by Subject|0
7244585|NCT00236080|11454791|FG002|Overall Study|Withdrawal by Subject|0
7244586|NCT00236080|11454792|FG003|Overall Study|Withdrawal by Subject|0
7244587|NCT00236080|11454793|FG004|Overall Study|Withdrawal by Subject|0
7244588|NCT00236080|11454789|FG000|Overall Study|Miscellaneous|0
7244589|NCT00236080|11454790|FG001|Overall Study|Miscellaneous|0
7244590|NCT00236080|11454791|FG002|Overall Study|Miscellaneous|1
7244591|NCT00236080|11454792|FG003|Overall Study|Miscellaneous|0
7244592|NCT00236080|11454793|FG004|Overall Study|Miscellaneous|0
7244593|NCT00236184|11454807|FG000|Overall Study|Adverse Event|5
7244594|NCT00236184|11454808|FG001|Overall Study|Adverse Event|2
7244595|NCT00236184|11454807|FG000|Overall Study|Lack of Efficacy|0
7244596|NCT00236184|11454808|FG001|Overall Study|Lack of Efficacy|1
7244597|NCT00236184|11454807|FG000|Overall Study|Lost to Follow-up|3
7244598|NCT00236184|11454808|FG001|Overall Study|Lost to Follow-up|4
7244599|NCT00236184|11454807|FG000|Overall Study|Physician Decision|1
7244600|NCT00236184|11454808|FG001|Overall Study|Physician Decision|1
7244601|NCT00236184|11454807|FG000|Overall Study|Withdrawal by Subject|3
7244602|NCT00236184|11454808|FG001|Overall Study|Withdrawal by Subject|0
7244603|NCT00236184|11454807|FG000|Overall Study|Protocol Violation|3
7244604|NCT00236184|11454808|FG001|Overall Study|Protocol Violation|0
7244605|NCT00236184|11454807|FG000|Overall Study|non-compliance with study drug|2
7244606|NCT00236184|11454808|FG001|Overall Study|non-compliance with study drug|1
7244607|NCT00236184|11454807|FG000|Overall Study|other|1
7244608|NCT00236184|11454808|FG001|Overall Study|other|2
7244609|NCT00236197|11454816|FG000|Overall Study|Withdrawal by Subject|3
7244610|NCT00236197|11454817|FG001|Overall Study|Withdrawal by Subject|2
7244611|NCT00236197|11454816|FG000|Overall Study|Lost to Follow-up|1
7244612|NCT00236197|11454817|FG001|Overall Study|Lost to Follow-up|5
7244613|NCT00236197|11454816|FG000|Overall Study|Protocol Violation|0
7244614|NCT00236197|11454817|FG001|Overall Study|Protocol Violation|3
7244615|NCT00236197|11454816|FG000|Overall Study|Medication non-compliance|1
7244616|NCT00236197|11454817|FG001|Overall Study|Medication non-compliance|2
7244617|NCT00236197|11454816|FG000|Overall Study|Other|0
7244618|NCT00236197|11454817|FG001|Overall Study|Other|2
7244619|NCT00236899|11454827|FG000|Overall Study|Adverse Event (Study Related)|1
7244620|NCT00236899|11454828|FG001|Overall Study|Adverse Event (Study Related)|1
7244621|NCT00236899|11454829|FG002|Overall Study|Adverse Event (Study Related)|2
7244622|NCT00236899|11454830|FG003|Overall Study|Adverse Event (Study Related)|1
7244623|NCT00236899|11454827|FG000|Overall Study|Adverse Event (Not Study Related)|3
7244624|NCT00236899|11454828|FG001|Overall Study|Adverse Event (Not Study Related)|3
7244625|NCT00236899|11454829|FG002|Overall Study|Adverse Event (Not Study Related)|4
7244626|NCT00236899|11454830|FG003|Overall Study|Adverse Event (Not Study Related)|7
7244627|NCT00236899|11454827|FG000|Overall Study|Death (Study Disease)|1
7244628|NCT00236899|11454828|FG001|Overall Study|Death (Study Disease)|4
7244629|NCT00236899|11454829|FG002|Overall Study|Death (Study Disease)|0
7244630|NCT00236899|11454830|FG003|Overall Study|Death (Study Disease)|0
7244631|NCT00236899|11454827|FG000|Overall Study|Death (Not Study Related)|2
7244632|NCT00236899|11454828|FG001|Overall Study|Death (Not Study Related)|0
7244633|NCT00236899|11454829|FG002|Overall Study|Death (Not Study Related)|0
7244634|NCT00236899|11454830|FG003|Overall Study|Death (Not Study Related)|0
7244635|NCT00236899|11454827|FG000|Overall Study|Death (Study Drug Toxicity)|1
7244636|NCT00236899|11454828|FG001|Overall Study|Death (Study Drug Toxicity)|0
7244637|NCT00236899|11454829|FG002|Overall Study|Death (Study Drug Toxicity)|0
7244638|NCT00236899|11454830|FG003|Overall Study|Death (Study Drug Toxicity)|0
7244639|NCT00236899|11454827|FG000|Overall Study|Lost to Follow-up|0
7244640|NCT00236899|11454828|FG001|Overall Study|Lost to Follow-up|1
7244641|NCT00236899|11454829|FG002|Overall Study|Lost to Follow-up|0
7244642|NCT00236899|11454830|FG003|Overall Study|Lost to Follow-up|0
7244643|NCT00236899|11454827|FG000|Overall Study|Entry Criteria Exclusion|0
7244644|NCT00236899|11454828|FG001|Overall Study|Entry Criteria Exclusion|1
7244646|NCT00236899|11454830|FG003|Overall Study|Entry Criteria Exclusion|0
7244647|NCT00236899|11454827|FG000|Overall Study|Protocol Violation|1
7244648|NCT00236899|11454828|FG001|Overall Study|Protocol Violation|0
7244649|NCT00236899|11454829|FG002|Overall Study|Protocol Violation|0
7244650|NCT00236899|11454830|FG003|Overall Study|Protocol Violation|0
7244651|NCT00236899|11454827|FG000|Overall Study|Withdrawal by Subject|6
7244652|NCT00236899|11454828|FG001|Overall Study|Withdrawal by Subject|4
7244653|NCT00236899|11454829|FG002|Overall Study|Withdrawal by Subject|5
7244654|NCT00236899|11454830|FG003|Overall Study|Withdrawal by Subject|2
7244655|NCT00236899|11454827|FG000|Overall Study|Physician Decision|7
7244656|NCT00236899|11454828|FG001|Overall Study|Physician Decision|8
7244657|NCT00236899|11454829|FG002|Overall Study|Physician Decision|7
7244658|NCT00236899|11454830|FG003|Overall Study|Physician Decision|6
7244659|NCT00236899|11454827|FG000|Overall Study|Satisfactory Response|2
7244660|NCT00236899|11454828|FG001|Overall Study|Satisfactory Response|0
7244661|NCT00236899|11454829|FG002|Overall Study|Satisfactory Response|0
7244662|NCT00236899|11454830|FG003|Overall Study|Satisfactory Response|1
7244663|NCT00236899|11454827|FG000|Overall Study|Lack of Efficacy|18
7244664|NCT00236899|11454828|FG001|Overall Study|Lack of Efficacy|18
7244665|NCT00236899|11454829|FG002|Overall Study|Lack of Efficacy|25
7244666|NCT00236899|11454830|FG003|Overall Study|Lack of Efficacy|23
7244667|NCT00237042|11454885|FG000|Treatment|Became ineligible post-randomization|0
7244668|NCT00237042|11454886|FG001|Treatment|Became ineligible post-randomization|1
7244669|NCT00237042|11454887|FG002|Treatment|Became ineligible post-randomization|16
7244670|NCT00237042|11454885|FG000|Treatment|Moved out of state|1
7244671|NCT00237042|11454886|FG001|Treatment|Moved out of state|1
7244672|NCT00237042|11454887|FG002|Treatment|Moved out of state|1
7244673|NCT00237042|11454885|FG000|Treatment|Completed no treatment|5
7244674|NCT00237042|11454886|FG001|Treatment|Completed no treatment|5
7244675|NCT00237042|11454887|FG002|Treatment|Completed no treatment|21
7244676|NCT00237042|11454885|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
7244677|NCT00237042|11454886|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
7244678|NCT00237042|11454887|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
7244679|NCT00237042|11454885|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
7244680|NCT00237042|11454886|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
7244681|NCT00237042|11454887|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
7244682|NCT00237185|11454897|FG000|Core|Adverse Event|3
7244683|NCT00237185|11454898|FG001|Core|Adverse Event|4
7244684|NCT00237185|11454897|FG000|Core|Abnormal laboratory value|0
7244685|NCT00237185|11454898|FG001|Core|Abnormal laboratory value|4
7244686|NCT00237185|11454897|FG000|Core|Abnormal test procedure results|1
7244687|NCT00237185|11454898|FG001|Core|Abnormal test procedure results|0
7244688|NCT00237185|11454897|FG000|Core|Lack of Efficacy|30
7244689|NCT00237185|11454898|FG001|Core|Lack of Efficacy|23
7244690|NCT00237185|11454897|FG000|Core|Protocol Violation|1
7244691|NCT00237185|11454898|FG001|Core|Protocol Violation|1
7244692|NCT00237185|11454897|FG000|Core|Withdrawal by Subject|4
7244693|NCT00237185|11454898|FG001|Core|Withdrawal by Subject|4
7244694|NCT00237185|11454897|FG000|Core|Administrative problems|0
7244695|NCT00237185|11454898|FG001|Core|Administrative problems|1
7244696|NCT00237185|11454897|FG000|Core|Death|4
7244697|NCT00237185|11454898|FG001|Core|Death|0
7244698|NCT00237185|11454897|FG000|Core|Determined ineligible post randomization|1
7244699|NCT00237185|11454898|FG001|Core|Determined ineligible post randomization|0
7244700|NCT00237185|11454897|FG000|Extension|Adverse Event|1
7244701|NCT00237185|11454898|FG001|Extension|Adverse Event|0
7244702|NCT00237185|11454897|FG000|Extension|Abnormal laboratory value|0
7244703|NCT00237185|11454898|FG001|Extension|Abnormal laboratory value|1
7244704|NCT00237185|11454897|FG000|Extension|Lack of Efficacy|9
7244705|NCT00237185|11454898|FG001|Extension|Lack of Efficacy|14
7244706|NCT00237185|11454897|FG000|Extension|Condition no longer required study drug|0
7244707|NCT00237185|11454898|FG001|Extension|Condition no longer required study drug|1
7244708|NCT00237185|11454897|FG000|Extension|Withdrawal by Subject|3
7244709|NCT00237185|11454898|FG001|Extension|Withdrawal by Subject|2
7244710|NCT00237185|11454897|FG000|Extension|Lost to Follow-up|1
7244711|NCT00237185|11454898|FG001|Extension|Lost to Follow-up|0
7244712|NCT00237185|11454897|FG000|Extension|Administrative problems|1
7244713|NCT00237185|11454898|FG001|Extension|Administrative problems|0
7244714|NCT00237185|11454897|FG000|Extension|Death|1
7244715|NCT00237185|11454898|FG001|Extension|Death|1
7244716|NCT00237458|11454904|FG000|Overall Study|Lack of Efficacy|1
7244717|NCT00237458|11454904|FG000|Overall Study|Adverse Event|1
7244718|NCT00237458|11454904|FG000|Overall Study|Withdrawal by Subject|1
7244719|NCT00237692|11454916|FG000|Overall Study|Lost to Follow-up|9
7244720|NCT00237692|11454917|FG001|Overall Study|Lost to Follow-up|3
7244721|NCT00237692|11454918|FG002|Overall Study|Lost to Follow-up|5
7244722|NCT00237692|11454919|FG003|Overall Study|Lost to Follow-up|3
7244723|NCT00237692|11454916|FG000|Overall Study|Death|1
7244724|NCT00237692|11454917|FG001|Overall Study|Death|2
7244725|NCT00237692|11454918|FG002|Overall Study|Death|2
7244726|NCT00237692|11454919|FG003|Overall Study|Death|3
7244727|NCT00237692|11454916|FG000|Overall Study|Excluded - did not meet criteria|4
7244728|NCT00237692|11454917|FG001|Overall Study|Excluded - did not meet criteria|3
7244729|NCT00237692|11454918|FG002|Overall Study|Excluded - did not meet criteria|5
7244730|NCT00237692|11454919|FG003|Overall Study|Excluded - did not meet criteria|9
7244731|NCT00237692|11454916|FG000|Overall Study|Withdrawal by Subject|4
7244732|NCT00237692|11454917|FG001|Overall Study|Withdrawal by Subject|6
7244733|NCT00237692|11454918|FG002|Overall Study|Withdrawal by Subject|10
7244734|NCT00237692|11454919|FG003|Overall Study|Withdrawal by Subject|4
7244735|NCT00237744|11454941|FG000|Overall Study|Withdrawal by Subject|3
7244736|NCT00237744|11454942|FG001|Overall Study|Withdrawal by Subject|1
7244737|NCT00237744|11454943|FG002|Overall Study|Withdrawal by Subject|0
7244738|NCT00237796|11454969|FG000|Overall Study|Baseline and one other ILSS required|10
7244739|NCT00237796|11454970|FG001|Overall Study|Baseline and one other ILSS required|5
7244740|NCT00237809|11454981|FG000|Overall Study|Lost to Follow-up|11
7244741|NCT00237809|11454982|FG001|Overall Study|Lost to Follow-up|10
7244742|NCT00237809|11454983|FG002|Overall Study|Lost to Follow-up|9
7244743|NCT00237809|11454984|FG003|Overall Study|Lost to Follow-up|9
7244744|NCT00238121|11455005|FG000|Overall Study|Withdrawal by Subject|1
7244745|NCT00238121|11455006|FG001|Overall Study|Withdrawal by Subject|1
7244746|NCT00238121|11455005|FG000|Overall Study|Adverse Event|2
7244747|NCT00238121|11455006|FG001|Overall Study|Adverse Event|1
7244748|NCT00238238|11455014|FG000|Overall Study|Withdrawal by Subject|0
7244749|NCT00238238|11455015|FG001|Overall Study|Withdrawal by Subject|3
7244750|NCT00238238|11455016|FG002|Overall Study|Withdrawal by Subject|0
7244751|NCT00238264|11455024|FG000|Overall Study|Death|7
7244752|NCT00238264|11455024|FG000|Overall Study|Lost to Follow-up|18
7244753|NCT00238264|11455024|FG000|Overall Study|Withdrawal by Subject|4
7244754|NCT00238264|11455024|FG000|Overall Study|Ineligible|7
7244755|NCT00238303|11455031|FG000|Overall Study|Withdrawal by Subject|11
7244756|NCT00238303|11455032|FG001|Overall Study|Withdrawal by Subject|1
7244757|NCT00238303|11455033|FG002|Overall Study|Withdrawal by Subject|2
7244758|NCT00238303|11455031|FG000|Overall Study|Death|1
7244759|NCT00238303|11455032|FG001|Overall Study|Death|0
7244760|NCT00238303|11455033|FG002|Overall Study|Death|1
7244761|NCT00238303|11455031|FG000|Overall Study|Other Medical Problems|2
7244762|NCT00238303|11455032|FG001|Overall Study|Other Medical Problems|0
7244763|NCT00238303|11455033|FG002|Overall Study|Other Medical Problems|2
7244764|NCT00238303|11455031|FG000|Overall Study|Poor tolerance of study treatment|1
7244765|NCT00238303|11455032|FG001|Overall Study|Poor tolerance of study treatment|0
7244766|NCT00238303|11455033|FG002|Overall Study|Poor tolerance of study treatment|1
7244767|NCT00238303|11455031|FG000|Overall Study|Adverse Event|0
7244768|NCT00238303|11455032|FG001|Overall Study|Adverse Event|1
7244769|NCT00238303|11455033|FG002|Overall Study|Adverse Event|3
7244770|NCT00238433|11455046|FG000|Overall Study|Screen failure|1
7244771|NCT00238433|11455046|FG000|Overall Study|Lost to Follow-up|1
7244772|NCT00238433|11455046|FG000|Overall Study|Death|1
7244773|NCT00239005|11455059|FG000|Overall Study|Adverse Event|6
7244774|NCT00239005|11455060|FG001|Overall Study|Adverse Event|6
7244775|NCT00239005|11455059|FG000|Overall Study|Withdrawal by Subject|3
7244776|NCT00239005|11455060|FG001|Overall Study|Withdrawal by Subject|4
7244777|NCT00239005|11455059|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
7244778|NCT00239005|11455060|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
7244779|NCT00239005|11455059|FG000|Overall Study|Protocol Violation|1
7244780|NCT00239005|11455060|FG001|Overall Study|Protocol Violation|0
7244781|NCT00239005|11455059|FG000|Overall Study|Subj. cond. no longer needs study drug|0
7244782|NCT00239005|11455060|FG001|Overall Study|Subj. cond. no longer needs study drug|1
7574108|NCT03649412|11956158|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
7244783|NCT00239005|11455059|FG000|Overall Study|Lost to Follow-up|0
7244784|NCT00239005|11455060|FG001|Overall Study|Lost to Follow-up|1
7244785|NCT00239226|11455070|FG000|Overall Study|permAF during stabilization period|0
7244786|NCT00239226|11455071|FG001|Overall Study|permAF during stabilization period|0
7244787|NCT00239226|11455072|FG002|Overall Study|permAF during stabilization period|0
7244788|NCT00239226|11455073|FG003|Overall Study|permAF during stabilization period|3
7244789|NCT00239226|11455070|FG000|Overall Study|Lost to Follow-up|1
7244790|NCT00239226|11455071|FG001|Overall Study|Lost to Follow-up|0
7244791|NCT00239226|11455072|FG002|Overall Study|Lost to Follow-up|1
7244792|NCT00239226|11455073|FG003|Overall Study|Lost to Follow-up|0
7244793|NCT00239356|11455085|FG000|Overall Study|Lack of Efficacy|1
7244794|NCT00239356|11455086|FG001|Overall Study|Lack of Efficacy|0
7244795|NCT00239356|11455085|FG000|Overall Study|Adverse Event|6
7244796|NCT00239356|11455086|FG001|Overall Study|Adverse Event|0
7244797|NCT00239356|11455085|FG000|Overall Study|Withdrawal by Subject|15
7244798|NCT00239356|11455086|FG001|Overall Study|Withdrawal by Subject|6
7244799|NCT00239356|11455085|FG000|Overall Study|Lost to Follow-up|3
7244800|NCT00239356|11455086|FG001|Overall Study|Lost to Follow-up|0
7244801|NCT00239356|11455085|FG000|Overall Study|poor/non-compliance|2
7244802|NCT00239356|11455086|FG001|Overall Study|poor/non-compliance|0
7244803|NCT00239356|11455085|FG000|Overall Study|Pregnancy|1
7244804|NCT00239356|11455086|FG001|Overall Study|Pregnancy|0
7244805|NCT00239356|11455085|FG000|Overall Study|Administrative reason|0
7244806|NCT00239356|11455086|FG001|Overall Study|Administrative reason|1
7244807|NCT00239356|11455085|FG000|Overall Study|Drug available on market|11
7244808|NCT00239356|11455086|FG001|Overall Study|Drug available on market|2
7244809|NCT00239577|11455096|FG000|Primary Phase|Adverse Event|0
7244810|NCT00239577|11455097|FG001|Primary Phase|Adverse Event|0
7244811|NCT00239577|11455098|FG002|Primary Phase|Adverse Event|1
7244812|NCT00239577|11455099|FG003|Primary Phase|Adverse Event|0
7244813|NCT00239577|11455096|FG000|Primary Phase|Other|5
7244814|NCT00239577|11455097|FG001|Primary Phase|Other|3
7244815|NCT00239577|11455098|FG002|Primary Phase|Other|2
7244816|NCT00239577|11455099|FG003|Primary Phase|Other|0
7244817|NCT00239590|11455111|FG000|Randomized|Lost to Follow-up|0
7244818|NCT00239590|11455112|FG001|Randomized|Lost to Follow-up|1
7244819|NCT00239590|11455111|FG000|Randomized|Withdrawal by Subject|0
7244820|NCT00239590|11455112|FG001|Randomized|Withdrawal by Subject|1
7244821|NCT00239590|11455111|FG000|Completed Study Protocol|Adverse Event|1
7244822|NCT00239590|11455112|FG001|Completed Study Protocol|Adverse Event|1
7244823|NCT00239590|11455111|FG000|Completed Study Protocol|Withdrawal by Subject|0
7244824|NCT00239590|11455112|FG001|Completed Study Protocol|Withdrawal by Subject|1
7244825|NCT00239681|11455135|FG000|Overall Study|Adverse Event|100
7244826|NCT00239681|11455136|FG001|Overall Study|Adverse Event|99
7244827|NCT00239681|11455135|FG000|Overall Study|Withdrawal by Subject|458
7244828|NCT00239681|11455136|FG001|Overall Study|Withdrawal by Subject|489
7244829|NCT00239681|11455135|FG000|Overall Study|Lost to Follow-up|28
7244830|NCT00239681|11455136|FG001|Overall Study|Lost to Follow-up|22
7244831|NCT00239681|11455135|FG000|Overall Study|Protocol Violation|4
7244832|NCT00239681|11455136|FG001|Overall Study|Protocol Violation|4
7244833|NCT00239681|11455135|FG000|Overall Study|Physician Decision|13
7244834|NCT00239681|11455136|FG001|Overall Study|Physician Decision|17
7244835|NCT00239681|11455135|FG000|Overall Study|No information chacked on CaseReportForm|90
7244836|NCT00239681|11455136|FG001|Overall Study|No information chacked on CaseReportForm|84
7244837|NCT00239837|11455148|FG000|Overall Study|Lost to Follow-up|3
7244838|NCT00239837|11455149|FG001|Overall Study|Lost to Follow-up|7
7244839|NCT00239928|11455157|FG000|Overall Study|Lack of Efficacy|1
7244840|NCT00239928|11455157|FG000|Overall Study|Adverse Event|4
7244841|NCT00239928|11455157|FG000|Overall Study|Not need to continue study|3
7244842|NCT00239928|11455157|FG000|Overall Study|Withdrawal by Subject|2
7244843|NCT00240071|11455161|FG000|Overall Study|Withdrawal by Subject|3
7244844|NCT00240097|11455166|FG000|Part I|Adverse Event|1
7244845|NCT00240097|11455166|FG000|Part I|Death|1
7244846|NCT00240097|11455166|FG000|Part I|histology|1
7244847|NCT00240097|11455166|FG000|Part I|unevaluable|1
7244848|NCT00240097|11455166|FG000|Part II|did not continue from Part I|23
7244849|NCT00240110|11455176|FG000|Overall Study|Lost to Follow-up|6
7244850|NCT00240110|11455177|FG001|Overall Study|Lost to Follow-up|7
7244851|NCT00240331|11455191|FG000|Overall Study|Withdrawal by Subject|125
7244852|NCT00240331|11455192|FG001|Overall Study|Withdrawal by Subject|132
7244853|NCT00240331|11455191|FG000|Overall Study|Option selected by investigator|1
7244854|NCT00240331|11455192|FG001|Overall Study|Option selected by investigator|2
7256218|NCT00321763|11467643|FG003|Overall Study|Adverse Event|1
7256219|NCT00321763|11467640|FG000|Overall Study|Withdrawal by Subject|2
7256220|NCT00321763|11467641|FG001|Overall Study|Withdrawal by Subject|0
7256221|NCT00321763|11467642|FG002|Overall Study|Withdrawal by Subject|1
7256222|NCT00321763|11467643|FG003|Overall Study|Withdrawal by Subject|0
7256223|NCT00321763|11467640|FG000|Overall Study|Lost to Follow-up|3
7256224|NCT00321763|11467641|FG001|Overall Study|Lost to Follow-up|1
7256225|NCT00321763|11467642|FG002|Overall Study|Lost to Follow-up|5
7256226|NCT00321763|11467643|FG003|Overall Study|Lost to Follow-up|4
7256227|NCT00321789|11467657|FG000|Overall Study|Lost to Follow-up|4
7256228|NCT00321789|11467658|FG001|Overall Study|Lost to Follow-up|7
7256229|NCT00321789|11467657|FG000|Overall Study|Withdrawal by Subject|6
7256230|NCT00321789|11467658|FG001|Overall Study|Withdrawal by Subject|6
7256231|NCT00321789|11467657|FG000|Overall Study|Protocol Violation|5
7256232|NCT00321789|11467658|FG001|Overall Study|Protocol Violation|3
7256233|NCT00321828|11467664|FG000|Overall Study|Ineligible|3
7256234|NCT00321828|11467664|FG000|Overall Study|No follow up data|1
7256235|NCT00321854|11467670|FG000|Overall Study|Adverse Event|41
7256236|NCT00321854|11467671|FG001|Overall Study|Adverse Event|43
7256237|NCT00321854|11467670|FG000|Overall Study|Lack of Efficacy|9
7256238|NCT00321854|11467671|FG001|Overall Study|Lack of Efficacy|14
7256239|NCT00321854|11467670|FG000|Overall Study|Protocol Violation|6
7256240|NCT00321854|11467671|FG001|Overall Study|Protocol Violation|5
7256241|NCT00321854|11467670|FG000|Overall Study|Lost to Follow-up|0
7256242|NCT00321854|11467671|FG001|Overall Study|Lost to Follow-up|2
7256243|NCT00321854|11467670|FG000|Overall Study|Withdrawal by Subject|6
7244855|NCT00240994|11455255|FG000|Overall Study|Lost to Follow-up|1
7244856|NCT00240994|11455255|FG000|Overall Study|Protocol Violation|1
7244857|NCT00240994|11455255|FG000|Overall Study|Graft failure|1
7244858|NCT00241280|11455266|FG000|Overall Study|Adverse Event|2
7244859|NCT00241280|11455267|FG001|Overall Study|Adverse Event|6
7244860|NCT00241280|11455266|FG000|Overall Study|Discomfort|11
7244861|NCT00241280|11455267|FG001|Overall Study|Discomfort|16
7244862|NCT00241280|11455266|FG000|Overall Study|Pregnancy|1
7244863|NCT00241280|11455267|FG001|Overall Study|Pregnancy|5
7244864|NCT00241280|11455266|FG000|Overall Study|Lost to Follow-up|5
7244865|NCT00241280|11455267|FG001|Overall Study|Lost to Follow-up|8
7244866|NCT00241280|11455266|FG000|Overall Study|Withdrawal by Subject|7
7244867|NCT00241280|11455267|FG001|Overall Study|Withdrawal by Subject|4
7244868|NCT00241280|11455266|FG000|Overall Study|Protocol Violation|4
7244869|NCT00241280|11455267|FG001|Overall Study|Protocol Violation|10
7244870|NCT00241280|11455266|FG000|Overall Study|Relocation|4
7244871|NCT00241280|11455267|FG001|Overall Study|Relocation|4
7244872|NCT00241280|11455266|FG000|Overall Study|Unsatisfactory Physiological Response|1
7244873|NCT00241280|11455267|FG001|Overall Study|Unsatisfactory Physiological Response|1
7244874|NCT00241280|11455266|FG000|Overall Study|Unsatisfactory Visual Response|1
7244875|NCT00241280|11455267|FG001|Overall Study|Unsatisfactory Visual Response|1
7244876|NCT00241280|11455266|FG000|Overall Study|Diabetic|1
7244877|NCT00241280|11455267|FG001|Overall Study|Diabetic|0
7244878|NCT00241280|11455266|FG000|Overall Study|Subject Ineligible/Dispensed|9
7244879|NCT00241280|11455267|FG001|Overall Study|Subject Ineligible/Dispensed|6
7244880|NCT00241280|11455266|FG000|Overall Study|Dispensed incorrect test article|1
7244881|NCT00241280|11455267|FG001|Overall Study|Dispensed incorrect test article|2
7244882|NCT00241280|11455266|FG000|Overall Study|Unacceptable Fit|0
7244883|NCT00241280|11455267|FG001|Overall Study|Unacceptable Fit|1
7244884|NCT00241280|11455266|FG000|Overall Study|Scheduling Conflict|0
7244885|NCT00241280|11455267|FG001|Overall Study|Scheduling Conflict|2
7244886|NCT00241280|11455266|FG000|Overall Study|History of Ocular Surgery|0
7244887|NCT00241280|11455267|FG001|Overall Study|History of Ocular Surgery|1
7244888|NCT00241280|11455266|FG000|Overall Study|Coating on Lens|1
7244889|NCT00241280|11455267|FG001|Overall Study|Coating on Lens|0
7244890|NCT00241280|11455266|FG000|Overall Study|Excessive Dryness|0
7244891|NCT00241280|11455267|FG001|Overall Study|Excessive Dryness|1
7244892|NCT00241358|11455277|FG000|Overall Study|Determined to be not ineligible|0
7244893|NCT00241358|11455278|FG001|Overall Study|Determined to be not ineligible|1
7244894|NCT00241358|11455279|FG002|Overall Study|Determined to be not ineligible|1
7244895|NCT00241631|11455288|FG000|Run in (2 Weeks)|Physician Decision|3
7244896|NCT00241631|11455289|FG001|Run in (2 Weeks)|Physician Decision|3
7244897|NCT00241631|11455288|FG000|Phase 1 (4 Weeks)|sore throat|1
7244898|NCT00241631|11455289|FG001|Phase 1 (4 Weeks)|sore throat|0
7244899|NCT00241631|11455288|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7244900|NCT00241631|11455289|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
7244901|NCT00241631|11455288|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
7244902|NCT00241631|11455289|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
7244903|NCT00241631|11455288|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
7244904|NCT00241631|11455289|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
7244905|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Adverse Event|46
7244906|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Adverse Event|45
7244907|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Adverse Event|45
7244908|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Adverse Event|91
7244909|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
7244910|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
7244911|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
7244912|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
7244913|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
7244914|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
7244915|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
7244916|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
7244917|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
7244918|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
7244919|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
7244920|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
7244921|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Non-compliance|2
7244922|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Non-compliance|1
7244923|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Non-compliance|2
7244924|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Non-compliance|3
7244925|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
7244926|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
7244927|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
7244928|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
7244929|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7244930|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7244931|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
7244932|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
7244933|NCT00241644|11455299|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
7244934|NCT00241644|11455300|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
7244935|NCT00241644|11455301|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
7244936|NCT00241644|11455302|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
7244937|NCT00241644|11455299|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
7244938|NCT00241644|11455300|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
7244939|NCT00241644|11455301|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
7244940|NCT00241644|11455302|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
7244941|NCT00241644|11455299|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
7244942|NCT00241644|11455300|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
7244943|NCT00241644|11455301|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
7244944|NCT00241644|11455302|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
7244945|NCT00241644|11455299|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
7244946|NCT00241644|11455300|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
7244947|NCT00241644|11455301|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
7244948|NCT00241644|11455302|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
7244949|NCT00241644|11455299|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7244985|NCT00242567|11455362|FG000|Overall Study|Other|14
7244950|NCT00241644|11455300|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
7244951|NCT00241644|11455301|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
7244952|NCT00241644|11455302|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
7244953|NCT00241644|11455299|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7244954|NCT00241644|11455300|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
7244955|NCT00241644|11455301|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7244956|NCT00241644|11455302|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
7244957|NCT00241839|11455314|FG000|Overall Study|Withdrawal by Subject|18
7244958|NCT00241839|11455315|FG001|Overall Study|Withdrawal by Subject|17
7244959|NCT00241839|11455314|FG000|Overall Study|Adverse Event|1
7244960|NCT00241839|11455315|FG001|Overall Study|Adverse Event|1
7244961|NCT00242216|11455342|FG000|Overall Study|Lost to Follow-up|12
7244962|NCT00242216|11455343|FG001|Overall Study|Lost to Follow-up|17
7244963|NCT00242216|11455342|FG000|Overall Study|Death|4
7244964|NCT00242216|11455343|FG001|Overall Study|Death|2
7244965|NCT00242216|11455342|FG000|Overall Study|Lack of Efficacy|1
7244966|NCT00242216|11455343|FG001|Overall Study|Lack of Efficacy|2
7244967|NCT00242216|11455342|FG000|Overall Study|no medicaiton dispensed|1
7574109|NCT03649412|11956159|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
7574113|NCT03650387|11956252|FG000|Overall Study|Withdrawal by Subject|13
7574114|NCT03650387|11956252|FG000|Overall Study|Lost to Follow-up|12
7574115|NCT03650387|11956252|FG000|Overall Study|Adverse Event (Not related)|1
7574116|NCT03650387|11956252|FG000|Overall Study|Due to COVID-19 Pandemic|8
7574117|NCT03650400|11956267|FG000|Overall Study|Study terminated by sponsor|0
7574118|NCT03650400|11956268|FG001|Overall Study|Study terminated by sponsor|5
7574119|NCT03650452|11956276|FG000|Overall Study|Physician Decision|1
7574120|NCT03650452|11956277|FG001|Overall Study|Physician Decision|0
7574121|NCT03650452|11956276|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7574122|NCT03650452|11956277|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7574123|NCT03650452|11956276|FG000|Overall Study|Adverse Event|3
7574124|NCT03650452|11956277|FG001|Overall Study|Adverse Event|4
7574125|NCT03650452|11956276|FG000|Overall Study|Early Withdrawal from Study Treatment|3
7574126|NCT03650452|11956277|FG001|Overall Study|Early Withdrawal from Study Treatment|0
7574127|NCT03652610|11956302|FG000|Overall Study|Lost to Follow-up|1
7574128|NCT03652610|11956303|FG001|Overall Study|Lost to Follow-up|0
7574129|NCT03652610|11956302|FG000|Overall Study|Withdrawal by Subject|3
7574130|NCT03652610|11956303|FG001|Overall Study|Withdrawal by Subject|5
7574131|NCT03652662|11956311|FG000|Overall Study|Withdrawal by Subject|2
7574132|NCT03652662|11956312|FG001|Overall Study|Withdrawal by Subject|1
7574133|NCT03652662|11956311|FG000|Overall Study|Lost to Follow-up|1
7574134|NCT03652662|11956312|FG001|Overall Study|Lost to Follow-up|0
7574135|NCT03652675|11956320|FG000|Overall Study|Lost to Follow-up|4
7574136|NCT03652675|11956321|FG001|Overall Study|Lost to Follow-up|4
7574137|NCT03652818|11956332|FG000|Overall Study|Adverse Event|1
7574138|NCT03652818|11956333|FG001|Overall Study|Adverse Event|0
7574139|NCT03652818|11956334|FG002|Overall Study|Adverse Event|0
7574140|NCT03652818|11956335|FG003|Overall Study|Adverse Event|0
7574141|NCT03652818|11956336|FG004|Overall Study|Adverse Event|0
7574142|NCT03652818|11956332|FG000|Overall Study|Physician Decision|1
7574143|NCT03652818|11956333|FG001|Overall Study|Physician Decision|0
7574144|NCT03652818|11956334|FG002|Overall Study|Physician Decision|0
7574145|NCT03652818|11956335|FG003|Overall Study|Physician Decision|0
7574146|NCT03652818|11956336|FG004|Overall Study|Physician Decision|0
7574147|NCT03652818|11956332|FG000|Overall Study|Lost to Follow-up|0
7574148|NCT03652818|11956333|FG001|Overall Study|Lost to Follow-up|1
7574149|NCT03652818|11956334|FG002|Overall Study|Lost to Follow-up|2
7244968|NCT00242216|11455343|FG001|Overall Study|no medicaiton dispensed|1
7574150|NCT03652818|11956335|FG003|Overall Study|Lost to Follow-up|1
7574151|NCT03652818|11956336|FG004|Overall Study|Lost to Follow-up|1
7574152|NCT03653208|11956357|FG000|Overall Study|Withdrawal by Subject|0
7574153|NCT03653208|11956358|FG001|Overall Study|Withdrawal by Subject|0
7574154|NCT03653208|11956359|FG002|Overall Study|Withdrawal by Subject|0
7574155|NCT03653208|11956360|FG003|Overall Study|Withdrawal by Subject|0
7574156|NCT03653208|11956361|FG004|Overall Study|Withdrawal by Subject|1
7244969|NCT00242567|11455362|FG000|Overall Study|Adverse Event|70
7244970|NCT00242567|11455363|FG001|Overall Study|Adverse Event|43
7244971|NCT00242567|11455362|FG000|Overall Study|Disease Progression|17
7244972|NCT00242567|11455363|FG001|Overall Study|Disease Progression|22
7244973|NCT00242567|11455362|FG000|Overall Study|Symptomatic deterioration|9
7244974|NCT00242567|11455363|FG001|Overall Study|Symptomatic deterioration|3
7244975|NCT00242567|11455362|FG000|Overall Study|Lack of Efficacy|2
7244976|NCT00242567|11455363|FG001|Overall Study|Lack of Efficacy|2
7244977|NCT00242567|11455362|FG000|Overall Study|Lost to Follow-up|9
7244978|NCT00242567|11455363|FG001|Overall Study|Lost to Follow-up|19
7244979|NCT00242567|11455362|FG000|Overall Study|Withdrawal by Subject|33
7244980|NCT00242567|11455363|FG001|Overall Study|Withdrawal by Subject|28
7244981|NCT00242567|11455362|FG000|Overall Study|Protocol Violation|12
7244982|NCT00242567|11455363|FG001|Overall Study|Protocol Violation|12
7244983|NCT00242567|11455362|FG000|Overall Study|Use of an inhibitor of bone resorption|0
7244984|NCT00242567|11455363|FG001|Overall Study|Use of an inhibitor of bone resorption|2
7244986|NCT00242567|11455363|FG001|Overall Study|Other|9
7244987|NCT00242580|11455374|FG000|Overall Study|Adverse Event|3
7244988|NCT00242580|11455375|FG001|Overall Study|Adverse Event|0
7244989|NCT00242580|11455376|FG002|Overall Study|Adverse Event|2
7244990|NCT00242580|11455374|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7244991|NCT00242580|11455375|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7244992|NCT00242580|11455376|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7244993|NCT00242580|11455374|FG000|Overall Study|Protocol Violation|0
7244994|NCT00242580|11455375|FG001|Overall Study|Protocol Violation|0
7244995|NCT00242580|11455376|FG002|Overall Study|Protocol Violation|1
7244996|NCT00242580|11455374|FG000|Overall Study|Subject withdrew consent|2
7244997|NCT00242580|11455375|FG001|Overall Study|Subject withdrew consent|2
7244998|NCT00242580|11455376|FG002|Overall Study|Subject withdrew consent|5
7244999|NCT00242580|11455374|FG000|Overall Study|Lost to Follow-up|0
7245000|NCT00242580|11455375|FG001|Overall Study|Lost to Follow-up|3
7245001|NCT00242580|11455376|FG002|Overall Study|Lost to Follow-up|0
7245002|NCT00242580|11455374|FG000|Overall Study|Death|1
7245003|NCT00242580|11455375|FG001|Overall Study|Death|2
7245004|NCT00242580|11455376|FG002|Overall Study|Death|1
7245005|NCT00242658|11455405|FG000|Overall Study|Lost to Follow-up|22
7245006|NCT00242658|11455406|FG001|Overall Study|Lost to Follow-up|19
7245007|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Adverse Event|30
7245008|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Adverse Event|25
7245009|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Adverse Event|23
7245010|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Adverse Event|14
7245011|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Death|0
7245012|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Death|0
7245013|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Death|1
7245014|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Death|0
7245015|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Physician Decision|0
7245016|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Physician Decision|1
7245017|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Physician Decision|0
7245018|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Physician Decision|1
7245019|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
7245020|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
7245021|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
7245022|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
7245023|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Other|6
7245024|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Other|1
7245025|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Other|0
7245026|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Other|2
7245027|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Protocol Violation|2
7245028|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Protocol Violation|9
7245029|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Protocol Violation|1
7245030|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Protocol Violation|3
7574157|NCT03653208|11956362|FG005|Overall Study|Withdrawal by Subject|0
7574158|NCT03653208|11956363|FG006|Overall Study|Withdrawal by Subject|0
7574159|NCT03653208|11956364|FG007|Overall Study|Withdrawal by Subject|1
7245031|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
7245032|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
7245033|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
7245034|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
7245035|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
7245036|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
7245037|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
7245038|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
7245039|NCT00242710|11455420|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
7245040|NCT00242710|11455421|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
7245041|NCT00242710|11455422|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
7245042|NCT00242710|11455423|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
7574160|NCT03653208|11956365|FG008|Overall Study|Withdrawal by Subject|1
7245043|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Adverse Event|2
7245044|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Adverse Event|3
7245045|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Adverse Event|5
7245046|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Adverse Event|2
7245047|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Physician Decision|1
7245048|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Physician Decision|1
7245049|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Physician Decision|0
7245050|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Physician Decision|0
7245051|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Other|24
7245052|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Other|24
7245053|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Other|9
7245054|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Other|11
7245055|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Extension not Available|17
7245056|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Extension not Available|21
7245057|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Extension not Available|8
7245058|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Extension not Available|7
7245059|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Protocol Violation|0
7245060|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Protocol Violation|0
7245061|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Protocol Violation|2
7245062|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Protocol Violation|1
7245063|NCT00242710|11455420|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
7245064|NCT00242710|11455421|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
7245065|NCT00242710|11455422|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
7245066|NCT00242710|11455423|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
7245067|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Adverse Event|7
7245068|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Adverse Event|9
7245069|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Adverse Event|2
7245070|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Adverse Event|4
7245071|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Death|0
7574161|NCT03653416|11956396|FG000|Overall Study|Protocol Violation|6
7574162|NCT03653416|11956397|FG001|Overall Study|Protocol Violation|1
7245072|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Death|0
7245073|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Death|0
7245074|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Death|1
7245075|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
7245076|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
7245077|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
7245078|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
7245079|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Other|3
7245080|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Other|5
7245081|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Other|4
7245082|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Other|3
7245083|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Protocol Violation|0
7245084|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Protocol Violation|2
7245085|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Protocol Violation|0
7245086|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Protocol Violation|1
7245087|NCT00242710|11455420|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
7245088|NCT00242710|11455421|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
7245089|NCT00242710|11455422|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
7245090|NCT00242710|11455423|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
7245091|NCT00243022|11455435|FG000|Overall Study|Withdrawal by Subject|1
7245092|NCT00243022|11455436|FG001|Overall Study|Withdrawal by Subject|0
7245093|NCT00243022|11455435|FG000|Overall Study|Death|1
7245094|NCT00243022|11455436|FG001|Overall Study|Death|0
7245095|NCT00243022|11455435|FG000|Overall Study|Difficult Travel Distance|0
7245096|NCT00243022|11455436|FG001|Overall Study|Difficult Travel Distance|1
7245097|NCT00243074|11455448|FG000|Overall Study|Ineligible|6
7245098|NCT00243074|11455448|FG000|Overall Study|Adverse Event|6
7245099|NCT00243074|11455448|FG000|Overall Study|Withdrawal by Subject|2
7245100|NCT00243074|11455448|FG000|Overall Study|Lack of Efficacy|36
7245101|NCT00243074|11455448|FG000|Overall Study|Death|2
7245102|NCT00243074|11455448|FG000|Overall Study|not protocol specified|1
7245103|NCT00243074|11455448|FG000|Overall Study|Did not receive any treatment|1
7245104|NCT00243230|11455468|FG000|Double-Blind Period|Adverse Event|0
7245105|NCT00243230|11455469|FG001|Double-Blind Period|Adverse Event|2
7245106|NCT00243230|11455470|FG002|Double-Blind Period|Adverse Event|2
7245107|NCT00243230|11455471|FG003|Double-Blind Period|Adverse Event|0
7245108|NCT00243230|11455468|FG000|Double-Blind Period|Withdrawal by Subject|1
7245109|NCT00243230|11455469|FG001|Double-Blind Period|Withdrawal by Subject|0
7245110|NCT00243230|11455470|FG002|Double-Blind Period|Withdrawal by Subject|0
7245111|NCT00243230|11455471|FG003|Double-Blind Period|Withdrawal by Subject|0
7245112|NCT00243230|11455468|FG000|Double-Blind Period|Protocol Violation|0
7245113|NCT00243230|11455469|FG001|Double-Blind Period|Protocol Violation|0
7245114|NCT00243230|11455470|FG002|Double-Blind Period|Protocol Violation|1
7245115|NCT00243230|11455471|FG003|Double-Blind Period|Protocol Violation|0
7245116|NCT00243230|11455468|FG000|Double-Blind Period|Randomized but Not Treated|0
7245117|NCT00243230|11455469|FG001|Double-Blind Period|Randomized but Not Treated|0
7245118|NCT00243230|11455470|FG002|Double-Blind Period|Randomized but Not Treated|2
7245119|NCT00243230|11455471|FG003|Double-Blind Period|Randomized but Not Treated|0
7245120|NCT00243230|11455468|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
7245121|NCT00243230|11455469|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
7245122|NCT00243230|11455470|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
7245123|NCT00243230|11455471|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
7245124|NCT00243230|11455468|FG000|Open Label Period|Adverse Event|0
7245125|NCT00243230|11455469|FG001|Open Label Period|Adverse Event|0
7245126|NCT00243230|11455470|FG002|Open Label Period|Adverse Event|0
7245127|NCT00243230|11455471|FG003|Open Label Period|Adverse Event|2
7245128|NCT00243230|11455468|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
7245129|NCT00243230|11455469|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
7245130|NCT00243230|11455470|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
7245131|NCT00243230|11455471|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
7245132|NCT00243230|11455468|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
7245133|NCT00243230|11455469|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
7245213|NCT00243841|11455578|FG003|Overall Study|Physician Decision|0
7245134|NCT00243230|11455470|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
7245135|NCT00243230|11455471|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
7245136|NCT00243230|11455468|FG000|Open Label Period|Lost to Follow-up|0
7245137|NCT00243230|11455469|FG001|Open Label Period|Lost to Follow-up|0
7245138|NCT00243230|11455470|FG002|Open Label Period|Lost to Follow-up|0
7245139|NCT00243230|11455471|FG003|Open Label Period|Lost to Follow-up|2
7245140|NCT00243230|11455468|FG000|Open Label Period|Withdrawal by Subject|0
7245141|NCT00243230|11455469|FG001|Open Label Period|Withdrawal by Subject|0
7245142|NCT00243230|11455470|FG002|Open Label Period|Withdrawal by Subject|0
7245143|NCT00243230|11455471|FG003|Open Label Period|Withdrawal by Subject|2
7245144|NCT00243230|11455468|FG000|Open Label Period|Protocol Violation|0
7245145|NCT00243230|11455469|FG001|Open Label Period|Protocol Violation|0
7245146|NCT00243230|11455470|FG002|Open Label Period|Protocol Violation|0
7245147|NCT00243230|11455471|FG003|Open Label Period|Protocol Violation|2
7245148|NCT00243230|11455468|FG000|Open Label Period|Administrative Reason|0
7245149|NCT00243230|11455469|FG001|Open Label Period|Administrative Reason|0
7245150|NCT00243230|11455470|FG002|Open Label Period|Administrative Reason|0
7245151|NCT00243230|11455471|FG003|Open Label Period|Administrative Reason|63
7245152|NCT00243269|11455494|FG000|Overall Study|Protocol Violation|2
7245153|NCT00243269|11455495|FG001|Overall Study|Protocol Violation|1
7245154|NCT00243269|11455496|FG002|Overall Study|Protocol Violation|0
7245155|NCT00243269|11455497|FG003|Overall Study|Protocol Violation|1
7245156|NCT00243269|11455494|FG000|Overall Study|Lost to Follow-up|1
7245157|NCT00243269|11455495|FG001|Overall Study|Lost to Follow-up|0
7245158|NCT00243269|11455496|FG002|Overall Study|Lost to Follow-up|1
7245159|NCT00243269|11455497|FG003|Overall Study|Lost to Follow-up|3
7245160|NCT00243347|11455507|FG000|Overall Study|Lack of Efficacy|4
7245161|NCT00243347|11455507|FG000|Overall Study|Adverse Event|2
7245162|NCT00243347|11455507|FG000|Overall Study|Death|1
7245163|NCT00243347|11455507|FG000|Overall Study|Withdrawal by Subject|5
7245164|NCT00243347|11455507|FG000|Overall Study|Condition worsened|7
7245165|NCT00243386|11455511|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
7245166|NCT00243386|11455512|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7245167|NCT00243386|11455513|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
7245168|NCT00243386|11455511|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
7245169|NCT00243386|11455512|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7245170|NCT00243386|11455513|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
7245171|NCT00243386|11455511|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
7245172|NCT00243386|11455512|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
7245173|NCT00243386|11455513|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
7245174|NCT00243386|11455511|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
7245175|NCT00243386|11455512|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7245176|NCT00243386|11455513|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
7245177|NCT00243386|11455511|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
7245178|NCT00243386|11455512|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7245179|NCT00243386|11455513|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
7245180|NCT00243386|11455511|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
7245181|NCT00243386|11455512|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7245182|NCT00243386|11455513|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
7245183|NCT00243386|11455511|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7245184|NCT00243386|11455512|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
7245185|NCT00243386|11455513|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
7245186|NCT00243386|11455511|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7245187|NCT00243386|11455512|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
7245188|NCT00243386|11455513|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
7245189|NCT00243412|11455551|FG000|Overall Study|Death|0
7245190|NCT00243412|11455552|FG001|Overall Study|Death|1
7245191|NCT00243412|11455551|FG000|Overall Study|Adverse Event|4
7245192|NCT00243412|11455552|FG001|Overall Study|Adverse Event|2
7245193|NCT00243412|11455551|FG000|Overall Study|Lost to Follow-up|0
7245194|NCT00243412|11455552|FG001|Overall Study|Lost to Follow-up|1
7245195|NCT00243412|11455551|FG000|Overall Study|Physician Decision|1
7245196|NCT00243412|11455552|FG001|Overall Study|Physician Decision|1
7245197|NCT00243412|11455551|FG000|Overall Study|Withdrawal by Subject|4
7245198|NCT00243412|11455552|FG001|Overall Study|Withdrawal by Subject|5
7245199|NCT00243412|11455551|FG000|Overall Study|Other|1
7245200|NCT00243412|11455552|FG001|Overall Study|Other|1
7245201|NCT00243503|11455558|FG000|Overall Study|Adverse Event|11
7245202|NCT00243503|11455558|FG000|Overall Study|Withdrawal by Subject|1
7245203|NCT00243503|11455558|FG000|Overall Study|Lack of Efficacy|44
7245204|NCT00243503|11455558|FG000|Overall Study|Death|1
7245205|NCT00243503|11455558|FG000|Overall Study|Other|1
7245206|NCT00243659|11455565|FG000|Overall Study|Withdrawal by Subject|1
7245207|NCT00243659|11455566|FG001|Overall Study|Withdrawal by Subject|1
7245208|NCT00243659|11455565|FG000|Overall Study|Protocol Violation|1
7245209|NCT00243659|11455566|FG001|Overall Study|Protocol Violation|2
7245210|NCT00243841|11455575|FG000|Overall Study|Physician Decision|0
7245211|NCT00243841|11455576|FG001|Overall Study|Physician Decision|0
7245212|NCT00243841|11455577|FG002|Overall Study|Physician Decision|1
7245214|NCT00243841|11455579|FG004|Overall Study|Physician Decision|0
7245215|NCT00243841|11455580|FG005|Overall Study|Physician Decision|2
7245216|NCT00243919|11455599|FG000|Overall Study|Death|3
7574163|NCT03653429|11956405|FG000|Overall Study|Physician Decision|4
7574164|NCT03653429|11956406|FG001|Overall Study|Physician Decision|10
7574165|NCT03654326|11956414|FG000|Overall Study|Withdrawal by Subject|5
7574166|NCT03654326|11956415|FG001|Overall Study|Withdrawal by Subject|3
7574167|NCT03654326|11956414|FG000|Overall Study|Physician Decision|0
7574168|NCT03654326|11956415|FG001|Overall Study|Physician Decision|1
7574169|NCT03654326|11956414|FG000|Overall Study|Unable to adhere to study schedule|0
7574170|NCT03654326|11956415|FG001|Overall Study|Unable to adhere to study schedule|1
7574171|NCT03654326|11956414|FG000|Overall Study|Lost to Follow-up|1
7574172|NCT03654326|11956415|FG001|Overall Study|Lost to Follow-up|1
7574173|NCT03654560|11956432|FG000|Overall Study|Death|3
7574174|NCT03654560|11956433|FG001|Overall Study|Death|1
7574175|NCT03654560|11956432|FG000|Overall Study|Lost to Follow-up|1
7574176|NCT03654560|11956433|FG001|Overall Study|Lost to Follow-up|0
7574177|NCT03655106|11956445|FG000|Overall Study|Withdrawal by Subject|3
7574178|NCT03655106|11956446|FG001|Overall Study|Withdrawal by Subject|2
7574179|NCT03655106|11956445|FG000|Overall Study|Lost to Follow-up|2
7574180|NCT03655106|11956446|FG001|Overall Study|Lost to Follow-up|1
7574181|NCT03655106|11956445|FG000|Overall Study|Duplicate Enrollment|1
7574182|NCT03655106|11956446|FG001|Overall Study|Duplicate Enrollment|1
7574183|NCT03655106|11956445|FG000|Overall Study|Protocol Violation|3
7574184|NCT03655106|11956446|FG001|Overall Study|Protocol Violation|0
7574185|NCT03655405|11956458|FG000|Overall Study|Death after initial data collection|4
7574186|NCT03655405|11956459|FG001|Overall Study|Death after initial data collection|2
7574187|NCT03655405|11956458|FG000|Overall Study|Died before initial data collection|1
7574188|NCT03655405|11956459|FG001|Overall Study|Died before initial data collection|2
7574189|NCT03655405|11956458|FG000|Overall Study|Protocol Violation|0
7574190|NCT03655405|11956459|FG001|Overall Study|Protocol Violation|1
7574191|NCT03655951|11956476|FG000|Overall Study|Lost to Follow-up|39
7574192|NCT03655951|11956477|FG001|Overall Study|Lost to Follow-up|20
7574193|NCT03655951|11956476|FG000|Overall Study|Withdrawal by Subject|0
7574194|NCT03655951|11956477|FG001|Overall Study|Withdrawal by Subject|1
7574195|NCT03657095|11956491|FG000|Overall Study|Withdrawal by Subject|1
7574196|NCT03657095|11956492|FG001|Overall Study|Withdrawal by Subject|1
7245217|NCT00243919|11455600|FG001|Overall Study|Death|4
7245218|NCT00243919|11455601|FG002|Overall Study|Death|6
7245219|NCT00243919|11455599|FG000|Overall Study|Withdrawal by Subject|6
7245220|NCT00243919|11455600|FG001|Overall Study|Withdrawal by Subject|6
7245221|NCT00243919|11455601|FG002|Overall Study|Withdrawal by Subject|2
7245222|NCT00243919|11455599|FG000|Overall Study|Lost to Follow-up|6
7245223|NCT00243919|11455600|FG001|Overall Study|Lost to Follow-up|7
7245224|NCT00243919|11455601|FG002|Overall Study|Lost to Follow-up|3
7245225|NCT00243919|11455599|FG000|Overall Study|Administrative Error|1
7245226|NCT00243919|11455600|FG001|Overall Study|Administrative Error|0
7574197|NCT03657095|11956491|FG000|Overall Study|Adverse Event|0
7574198|NCT03657095|11956492|FG001|Overall Study|Adverse Event|3
7574199|NCT03657095|11956491|FG000|Overall Study|Study Terminated by Sponsor|58
7574200|NCT03657095|11956492|FG001|Overall Study|Study Terminated by Sponsor|49
7575469|NCT03739840|11959103|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
7245227|NCT00243919|11455601|FG002|Overall Study|Administrative Error|0
7245228|NCT00243919|11455599|FG000|Overall Study|Physician Decision|1
7245229|NCT00243919|11455600|FG001|Overall Study|Physician Decision|1
7245230|NCT00243919|11455601|FG002|Overall Study|Physician Decision|0
7245231|NCT00243932|11455612|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
7245232|NCT00243932|11455613|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
7245233|NCT00243932|11455614|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
7245234|NCT00244374|11455644|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
7245235|NCT00244374|11455645|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7245236|NCT00244374|11455646|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7245237|NCT00244374|11455647|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7245238|NCT00244374|11455648|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
7245239|NCT00244374|11455644|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
7245240|NCT00244374|11455645|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7245241|NCT00244374|11455646|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7245242|NCT00244374|11455647|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7245243|NCT00244374|11455648|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
7245244|NCT00244374|11455644|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
7245245|NCT00244374|11455645|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7245246|NCT00244374|11455646|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7245247|NCT00244374|11455647|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7245248|NCT00244374|11455648|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
7245249|NCT00244374|11455644|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
7245250|NCT00244374|11455645|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7245251|NCT00244374|11455646|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7245252|NCT00244374|11455647|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7245253|NCT00244374|11455648|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
7245254|NCT00244374|11455644|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
7245255|NCT00244374|11455645|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7245256|NCT00244374|11455646|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7245257|NCT00244374|11455647|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7245258|NCT00244374|11455648|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
7245259|NCT00244374|11455644|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
7245260|NCT00244374|11455645|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7574201|NCT03657277|11956521|FG000|Overall Study|Physician Decision|2
7245261|NCT00244374|11455646|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7245262|NCT00244374|11455647|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7245263|NCT00244374|11455648|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
7245264|NCT00244374|11455644|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
7245265|NCT00244374|11455645|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7245266|NCT00244374|11455646|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7245267|NCT00244374|11455647|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7245268|NCT00244374|11455648|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
7245269|NCT00244374|11455644|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
7245270|NCT00244374|11455645|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7245271|NCT00244374|11455646|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7245272|NCT00244374|11455647|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7245273|NCT00244374|11455648|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
7245274|NCT00244374|11455644|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
7245275|NCT00244374|11455645|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7245276|NCT00244374|11455646|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7245277|NCT00244374|11455647|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7245278|NCT00244374|11455648|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
7245279|NCT00244621|11455667|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7245280|NCT00244621|11455668|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7245281|NCT00244621|11455669|FG002|Double-blind Treatment Period|Lost to Follow-up|1
7245282|NCT00244621|11455667|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
7245283|NCT00244621|11455668|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7245284|NCT00244621|11455669|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7245285|NCT00244621|11455667|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7245286|NCT00244621|11455668|FG001|Double-blind Treatment Period|Lack of Efficacy|1
7574202|NCT03657277|11956521|FG000|Overall Study|Lost to Follow-up|1
7245287|NCT00244621|11455669|FG002|Double-blind Treatment Period|Lack of Efficacy|0
7245288|NCT00244621|11455667|FG000|Double-blind Treatment Period|Multiple Reasons|2
7245289|NCT00244621|11455668|FG001|Double-blind Treatment Period|Multiple Reasons|1
7245290|NCT00244621|11455669|FG002|Double-blind Treatment Period|Multiple Reasons|1
7245291|NCT00244621|11455667|FG000|Open-label Treatment Period|Lost to Follow-up|0
7245292|NCT00244621|11455668|FG001|Open-label Treatment Period|Lost to Follow-up|1
7245293|NCT00244621|11455669|FG002|Open-label Treatment Period|Lost to Follow-up|0
7245294|NCT00244621|11455667|FG000|Open-label Treatment Period|Withdrawal by Subject|1
7245295|NCT00244621|11455668|FG001|Open-label Treatment Period|Withdrawal by Subject|0
7245296|NCT00244621|11455669|FG002|Open-label Treatment Period|Withdrawal by Subject|0
7245297|NCT00244621|11455667|FG000|Open-label Treatment Period|Adverse Event|0
7245298|NCT00244621|11455668|FG001|Open-label Treatment Period|Adverse Event|0
7245299|NCT00244621|11455669|FG002|Open-label Treatment Period|Adverse Event|1
7245300|NCT00244621|11455667|FG000|Open-label Treatment Period|Moved abroad|0
7245301|NCT00244621|11455668|FG001|Open-label Treatment Period|Moved abroad|0
7245302|NCT00244621|11455669|FG002|Open-label Treatment Period|Moved abroad|1
7245303|NCT00244712|11455679|FG000|Overall Study|Adverse Event|20
7245304|NCT00244712|11455680|FG001|Overall Study|Adverse Event|21
7245305|NCT00244712|11455679|FG000|Overall Study|Protocol-Defined Virologic Failure|8
7245306|NCT00244712|11455680|FG001|Overall Study|Protocol-Defined Virologic Failure|6
7245307|NCT00244712|11455679|FG000|Overall Study|Lack of Compliance|10
7245308|NCT00244712|11455680|FG001|Overall Study|Lack of Compliance|11
7245309|NCT00244712|11455679|FG000|Overall Study|Lost to Follow-up|45
7245310|NCT00244712|11455680|FG001|Overall Study|Lost to Follow-up|52
7245311|NCT00244712|11455679|FG000|Overall Study|Withdrawal by Subject|13
7245312|NCT00244712|11455680|FG001|Overall Study|Withdrawal by Subject|23
7245313|NCT00244712|11455679|FG000|Overall Study|Protocol Violation, disease progression|13
7245314|NCT00244712|11455680|FG001|Overall Study|Protocol Violation, disease progression|11
7245315|NCT00244725|11455690|FG000|Overall Study|Lost to Follow-up|3
7245316|NCT00244725|11455691|FG001|Overall Study|Lost to Follow-up|4
7245317|NCT00244725|11455692|FG002|Overall Study|Lost to Follow-up|9
7245318|NCT00244725|11455693|FG003|Overall Study|Lost to Follow-up|2
7245319|NCT00244725|11455690|FG000|Overall Study|Withdrawal by Subject|9
7245320|NCT00244725|11455691|FG001|Overall Study|Withdrawal by Subject|7
7245321|NCT00244725|11455692|FG002|Overall Study|Withdrawal by Subject|7
7245322|NCT00244725|11455693|FG003|Overall Study|Withdrawal by Subject|8
7245323|NCT00244725|11455690|FG000|Overall Study|Not meet treatment eligibility criteria|1
7245324|NCT00244725|11455691|FG001|Overall Study|Not meet treatment eligibility criteria|2
7245325|NCT00244725|11455692|FG002|Overall Study|Not meet treatment eligibility criteria|0
7245326|NCT00244725|11455693|FG003|Overall Study|Not meet treatment eligibility criteria|0
7245327|NCT00244725|11455690|FG000|Overall Study|Physician Decision|3
7245328|NCT00244725|11455691|FG001|Overall Study|Physician Decision|0
7245329|NCT00244725|11455692|FG002|Overall Study|Physician Decision|1
7245330|NCT00244725|11455693|FG003|Overall Study|Physician Decision|2
7245331|NCT00244725|11455690|FG000|Overall Study|Adverse Events|3
7245332|NCT00244725|11455691|FG001|Overall Study|Adverse Events|1
7245333|NCT00244725|11455692|FG002|Overall Study|Adverse Events|4
7245334|NCT00244725|11455693|FG003|Overall Study|Adverse Events|4
7245335|NCT00244725|11455690|FG000|Overall Study|Withdrwal by participant|1
7245336|NCT00244725|11455691|FG001|Overall Study|Withdrwal by participant|0
7245337|NCT00244725|11455692|FG002|Overall Study|Withdrwal by participant|0
7245338|NCT00244725|11455693|FG003|Overall Study|Withdrwal by participant|1
7245339|NCT00244725|11455690|FG000|Overall Study|Liver function test abnormality|2
7245340|NCT00244725|11455691|FG001|Overall Study|Liver function test abnormality|0
7245341|NCT00244725|11455692|FG002|Overall Study|Liver function test abnormality|0
7245342|NCT00244725|11455693|FG003|Overall Study|Liver function test abnormality|1
7245343|NCT00244725|11455690|FG000|Overall Study|Sponsor withdrew the participant|1
7245344|NCT00244725|11455691|FG001|Overall Study|Sponsor withdrew the participant|0
7245345|NCT00244725|11455692|FG002|Overall Study|Sponsor withdrew the participant|0
7245346|NCT00244725|11455693|FG003|Overall Study|Sponsor withdrew the participant|1
7245347|NCT00244725|11455690|FG000|Overall Study|Mediciation Error|0
7245348|NCT00244725|11455691|FG001|Overall Study|Mediciation Error|1
7245349|NCT00244725|11455692|FG002|Overall Study|Mediciation Error|0
7245350|NCT00244725|11455693|FG003|Overall Study|Mediciation Error|0
7245351|NCT00244725|11455690|FG000|Overall Study|Rehab Refused to allow participantion|0
7245352|NCT00244725|11455691|FG001|Overall Study|Rehab Refused to allow participantion|1
7245353|NCT00244725|11455692|FG002|Overall Study|Rehab Refused to allow participantion|0
7245354|NCT00244725|11455693|FG003|Overall Study|Rehab Refused to allow participantion|0
7245355|NCT00244725|11455690|FG000|Overall Study|Headache|0
7245356|NCT00244725|11455691|FG001|Overall Study|Headache|1
7245357|NCT00244725|11455692|FG002|Overall Study|Headache|0
7245358|NCT00244725|11455693|FG003|Overall Study|Headache|0
7245359|NCT00244725|11455690|FG000|Overall Study|Received prohibited medication|0
7245360|NCT00244725|11455691|FG001|Overall Study|Received prohibited medication|1
7245361|NCT00244725|11455692|FG002|Overall Study|Received prohibited medication|0
7245362|NCT00244725|11455693|FG003|Overall Study|Received prohibited medication|1
7245363|NCT00244725|11455690|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
7245364|NCT00244725|11455691|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
7245365|NCT00244725|11455692|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
7245366|NCT00244725|11455693|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
7245367|NCT00244725|11455690|FG000|Overall Study|Administrative reason|0
7245368|NCT00244725|11455691|FG001|Overall Study|Administrative reason|0
7245369|NCT00244725|11455692|FG002|Overall Study|Administrative reason|1
7245370|NCT00244725|11455693|FG003|Overall Study|Administrative reason|0
7245371|NCT00244725|11455690|FG000|Overall Study|Vomit|0
7245372|NCT00244725|11455691|FG001|Overall Study|Vomit|0
7245373|NCT00244725|11455692|FG002|Overall Study|Vomit|1
7245374|NCT00244725|11455693|FG003|Overall Study|Vomit|0
7245375|NCT00244725|11455690|FG000|Overall Study|Failed to follow-up|0
7245376|NCT00244725|11455691|FG001|Overall Study|Failed to follow-up|0
7245377|NCT00244725|11455692|FG002|Overall Study|Failed to follow-up|1
7245378|NCT00244725|11455693|FG003|Overall Study|Failed to follow-up|1
7245379|NCT00244751|11455706|FG000|Overall Study|Adverse Event|7
7245380|NCT00244751|11455707|FG001|Overall Study|Adverse Event|7
7245381|NCT00244751|11455708|FG002|Overall Study|Adverse Event|5
7245382|NCT00244751|11455706|FG000|Overall Study|Lost to Follow-up|0
7245383|NCT00244751|11455707|FG001|Overall Study|Lost to Follow-up|1
7245384|NCT00244751|11455708|FG002|Overall Study|Lost to Follow-up|0
7245385|NCT00244751|11455706|FG000|Overall Study|Protocol Violation|1
7245386|NCT00244751|11455707|FG001|Overall Study|Protocol Violation|0
7245387|NCT00244751|11455708|FG002|Overall Study|Protocol Violation|1
7245388|NCT00244751|11455706|FG000|Overall Study|Withdrawal by Subject|7
7245389|NCT00244751|11455707|FG001|Overall Study|Withdrawal by Subject|5
7245390|NCT00244751|11455708|FG002|Overall Study|Withdrawal by Subject|3
7245391|NCT00244751|11455706|FG000|Overall Study|Elevated liver enzymes|1
7245392|NCT00244751|11455707|FG001|Overall Study|Elevated liver enzymes|0
7245393|NCT00244751|11455708|FG002|Overall Study|Elevated liver enzymes|0
7245394|NCT00244751|11455706|FG000|Overall Study|Lack of compliance with protocol|0
7245395|NCT00244751|11455707|FG001|Overall Study|Lack of compliance with protocol|1
7245396|NCT00244751|11455708|FG002|Overall Study|Lack of compliance with protocol|0
7245397|NCT00244751|11455706|FG000|Overall Study|Safety reasons|0
7245398|NCT00244751|11455707|FG001|Overall Study|Safety reasons|1
7245399|NCT00244751|11455708|FG002|Overall Study|Safety reasons|0
7245400|NCT00244751|11455706|FG000|Overall Study|Participant randomized by mistake|0
7245485|NCT00245466|11455821|FG001|Overall Study|Lost to Follow-up|0
7245401|NCT00244751|11455707|FG001|Overall Study|Participant randomized by mistake|0
7245402|NCT00244751|11455708|FG002|Overall Study|Participant randomized by mistake|1
7245403|NCT00244764|11455725|FG000|Overall Study|Adverse Event|37
7245404|NCT00244764|11455725|FG000|Overall Study|Lost to Follow-up|23
7245405|NCT00244764|11455725|FG000|Overall Study|Withdrawal by Subject|12
7245406|NCT00244764|11455725|FG000|Overall Study|Disease Progression|13
7245407|NCT00244764|11455725|FG000|Overall Study|Protocol Violation|2
7245408|NCT00244764|11455725|FG000|Overall Study|Death|1
7245409|NCT00244764|11455725|FG000|Overall Study|Off Study Medication for >21 Days|1
7245410|NCT00244764|11455725|FG000|Overall Study|Declining Performance Status|1
7245411|NCT00244764|11455725|FG000|Overall Study|Participant was Hospitalized until Death|1
7245412|NCT00244764|11455725|FG000|Overall Study|Primary Investigator Discretion|2
7245413|NCT00244764|11455725|FG000|Overall Study|Sponsor Terminated Study|2
7245414|NCT00244764|11455725|FG000|Overall Study|Developed Secondary Malignancy|1
7245415|NCT00244855|11455732|FG000|Overall Study|Withdrawal by Subject|0
7245416|NCT00244855|11455733|FG001|Overall Study|Withdrawal by Subject|1
7245417|NCT00244881|11455741|FG000|Overall Study|Withdrawal by Subject|3
7245418|NCT00244933|11455745|FG000|Overall Study|Not response evaluable|2
7245419|NCT00245011|11455753|FG000|Overall Study|Lack of Efficacy|1
7245420|NCT00245037|11455757|FG000|Overall Study|Death|17
7245421|NCT00245050|11455763|FG000|Overall Study|Adverse Event|3
7245422|NCT00245050|11455764|FG001|Overall Study|Adverse Event|2
7245423|NCT00245063|11455772|FG000|Overall Study|Adverse Event|6
7245424|NCT00245063|11455773|FG001|Overall Study|Adverse Event|5
7245425|NCT00245063|11455772|FG000|Overall Study|Death|1
7245426|NCT00245063|11455773|FG001|Overall Study|Death|0
7245427|NCT00245102|11455785|FG000|Overall Study|Not Treated|1
7245428|NCT00245102|11455786|FG001|Overall Study|Not Treated|0
7245429|NCT00245102|11455787|FG002|Overall Study|Not Treated|1
7245430|NCT00245102|11455788|FG003|Overall Study|Not Treated|0
7245431|NCT00245102|11455789|FG004|Overall Study|Not Treated|0
7245432|NCT00245102|11455790|FG005|Overall Study|Not Treated|0
7245433|NCT00245102|11455785|FG000|Overall Study|Protocol Violation|1
7245434|NCT00245102|11455786|FG001|Overall Study|Protocol Violation|0
7245435|NCT00245102|11455787|FG002|Overall Study|Protocol Violation|0
7245436|NCT00245102|11455788|FG003|Overall Study|Protocol Violation|0
7245437|NCT00245102|11455789|FG004|Overall Study|Protocol Violation|0
7245438|NCT00245102|11455790|FG005|Overall Study|Protocol Violation|0
7245439|NCT00245102|11455785|FG000|Overall Study|Death|0
7245440|NCT00245102|11455786|FG001|Overall Study|Death|0
7245441|NCT00245102|11455787|FG002|Overall Study|Death|0
7245442|NCT00245102|11455788|FG003|Overall Study|Death|1
7245443|NCT00245102|11455789|FG004|Overall Study|Death|0
7245444|NCT00245102|11455790|FG005|Overall Study|Death|0
7245445|NCT00245102|11455785|FG000|Overall Study|Adverse Event|4
7245446|NCT00245102|11455786|FG001|Overall Study|Adverse Event|2
7245447|NCT00245102|11455787|FG002|Overall Study|Adverse Event|5
7245448|NCT00245102|11455788|FG003|Overall Study|Adverse Event|1
7245449|NCT00245102|11455789|FG004|Overall Study|Adverse Event|0
7245450|NCT00245102|11455790|FG005|Overall Study|Adverse Event|2
7245451|NCT00245102|11455785|FG000|Overall Study|Decline in performance|0
7245452|NCT00245102|11455786|FG001|Overall Study|Decline in performance|2
7245453|NCT00245102|11455787|FG002|Overall Study|Decline in performance|0
7245454|NCT00245102|11455788|FG003|Overall Study|Decline in performance|1
7245455|NCT00245102|11455789|FG004|Overall Study|Decline in performance|0
7245456|NCT00245102|11455790|FG005|Overall Study|Decline in performance|2
7245457|NCT00245102|11455785|FG000|Overall Study|Participant needed surgery|0
7245458|NCT00245102|11455786|FG001|Overall Study|Participant needed surgery|0
7245459|NCT00245102|11455787|FG002|Overall Study|Participant needed surgery|1
7245460|NCT00245102|11455788|FG003|Overall Study|Participant needed surgery|0
7245461|NCT00245102|11455789|FG004|Overall Study|Participant needed surgery|0
7245462|NCT00245102|11455790|FG005|Overall Study|Participant needed surgery|0
7245463|NCT00245102|11455785|FG000|Overall Study|Clinical progression|1
7245464|NCT00245102|11455786|FG001|Overall Study|Clinical progression|0
7245465|NCT00245102|11455787|FG002|Overall Study|Clinical progression|0
7245466|NCT00245102|11455788|FG003|Overall Study|Clinical progression|0
7245467|NCT00245102|11455789|FG004|Overall Study|Clinical progression|0
7245468|NCT00245102|11455790|FG005|Overall Study|Clinical progression|0
7245469|NCT00245466|11455820|FG000|Overall Study|Adverse Event|2
7245470|NCT00245466|11455821|FG001|Overall Study|Adverse Event|8
7245471|NCT00245466|11455822|FG002|Overall Study|Adverse Event|4
7245472|NCT00245466|11455820|FG000|Overall Study|Low prostate specific antigen suppr|16
7245473|NCT00245466|11455821|FG001|Overall Study|Low prostate specific antigen suppr|14
7245474|NCT00245466|11455822|FG002|Overall Study|Low prostate specific antigen suppr|5
7245475|NCT00245466|11455820|FG000|Overall Study|Insufficient testosterone suppr|12
7245476|NCT00245466|11455821|FG001|Overall Study|Insufficient testosterone suppr|12
7245477|NCT00245466|11455822|FG002|Overall Study|Insufficient testosterone suppr|21
7245478|NCT00245466|11455820|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
7245479|NCT00245466|11455821|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
7245480|NCT00245466|11455822|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
7245481|NCT00245466|11455820|FG000|Overall Study|Withdrawal by Subject|2
7245482|NCT00245466|11455821|FG001|Overall Study|Withdrawal by Subject|2
7245483|NCT00245466|11455822|FG002|Overall Study|Withdrawal by Subject|1
7245484|NCT00245466|11455820|FG000|Overall Study|Lost to Follow-up|3
7245486|NCT00245466|11455822|FG002|Overall Study|Lost to Follow-up|0
7245487|NCT00245466|11455820|FG000|Overall Study|Disease progression|0
7245488|NCT00245466|11455821|FG001|Overall Study|Disease progression|3
7245489|NCT00245466|11455822|FG002|Overall Study|Disease progression|1
7245490|NCT00245466|11455820|FG000|Overall Study|Protocol Violation|1
7245491|NCT00245466|11455821|FG001|Overall Study|Protocol Violation|2
7245492|NCT00245466|11455822|FG002|Overall Study|Protocol Violation|2
7245493|NCT00245466|11455820|FG000|Overall Study|Death|0
7245494|NCT00245466|11455821|FG001|Overall Study|Death|2
7245495|NCT00245466|11455822|FG002|Overall Study|Death|0
7245496|NCT00245466|11455820|FG000|Overall Study|Administrative reasons|0
7245497|NCT00245466|11455821|FG001|Overall Study|Administrative reasons|1
7245498|NCT00245466|11455822|FG002|Overall Study|Administrative reasons|0
7245499|NCT00245583|11455851|FG000|Overall Study|Lost to Follow-up|1
7245500|NCT00245583|11455852|FG001|Overall Study|Lost to Follow-up|5
7245501|NCT00245583|11455851|FG000|Overall Study|Adverse Event|2
7245502|NCT00245583|11455852|FG001|Overall Study|Adverse Event|1
7245503|NCT00245583|11455851|FG000|Overall Study|Lack of Efficacy|1
7245504|NCT00245583|11455852|FG001|Overall Study|Lack of Efficacy|0
7245505|NCT00245583|11455851|FG000|Overall Study|Withdrawal by Subject|2
7245506|NCT00245583|11455852|FG001|Overall Study|Withdrawal by Subject|3
7245507|NCT00245765|11455870|FG000|Overall Study|Adverse Event|1
7245508|NCT00245765|11455871|FG001|Overall Study|Adverse Event|1
7245509|NCT00245765|11455872|FG002|Overall Study|Adverse Event|0
7245510|NCT00245765|11455870|FG000|Overall Study|Lack of Efficacy|14
7245511|NCT00245765|11455871|FG001|Overall Study|Lack of Efficacy|7
7245512|NCT00245765|11455872|FG002|Overall Study|Lack of Efficacy|0
7245513|NCT00245765|11455870|FG000|Overall Study|Lost to Follow-up|1
7245514|NCT00245765|11455871|FG001|Overall Study|Lost to Follow-up|2
7245515|NCT00245765|11455872|FG002|Overall Study|Lost to Follow-up|0
7245516|NCT00245765|11455870|FG000|Overall Study|Withdrawal by Subject|1
7245517|NCT00245765|11455871|FG001|Overall Study|Withdrawal by Subject|0
7574203|NCT03657277|11956521|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
7574204|NCT03658811|11956534|FG000|Overall Study|Lost to Follow-up|3
7245518|NCT00245765|11455872|FG002|Overall Study|Withdrawal by Subject|3
7245519|NCT00245765|11455870|FG000|Overall Study|Other reason|2
7245520|NCT00245765|11455871|FG001|Overall Study|Other reason|0
7245521|NCT00245765|11455872|FG002|Overall Study|Other reason|1
7245522|NCT00245765|11455870|FG000|Overall Study|Other|13
7245523|NCT00245765|11455871|FG001|Overall Study|Other|4
7245524|NCT00245765|11455872|FG002|Overall Study|Other|4
7245525|NCT00245856|11455880|FG000|Period Two|Withdrawal by Subject|0
7245526|NCT00245856|11455881|FG001|Period Two|Withdrawal by Subject|1
7245527|NCT00246012|11455897|FG000|Overall Study|Adverse Event|0
7245528|NCT00246012|11455898|FG001|Overall Study|Adverse Event|0
7245529|NCT00246012|11455899|FG002|Overall Study|Adverse Event|0
7245530|NCT00246012|11455900|FG003|Overall Study|Adverse Event|0
7245531|NCT00246012|11455901|FG004|Overall Study|Adverse Event|0
7245532|NCT00246012|11455902|FG005|Overall Study|Adverse Event|1
7245533|NCT00246012|11455903|FG006|Overall Study|Adverse Event|0
7245534|NCT00246012|11455904|FG007|Overall Study|Adverse Event|0
7245535|NCT00246012|11455905|FG008|Overall Study|Adverse Event|2
7245536|NCT00246012|11455897|FG000|Overall Study|Withdrawal by Subject|0
7245537|NCT00246012|11455898|FG001|Overall Study|Withdrawal by Subject|0
7245538|NCT00246012|11455899|FG002|Overall Study|Withdrawal by Subject|0
7245539|NCT00246012|11455900|FG003|Overall Study|Withdrawal by Subject|0
7245540|NCT00246012|11455901|FG004|Overall Study|Withdrawal by Subject|0
7245541|NCT00246012|11455902|FG005|Overall Study|Withdrawal by Subject|1
7245542|NCT00246012|11455903|FG006|Overall Study|Withdrawal by Subject|0
7245543|NCT00246012|11455904|FG007|Overall Study|Withdrawal by Subject|0
7245544|NCT00246012|11455905|FG008|Overall Study|Withdrawal by Subject|0
7245545|NCT00246012|11455897|FG000|Overall Study|Disease progression|3
7245546|NCT00246012|11455898|FG001|Overall Study|Disease progression|1
7245547|NCT00246012|11455899|FG002|Overall Study|Disease progression|2
7245548|NCT00246012|11455900|FG003|Overall Study|Disease progression|3
7245549|NCT00246012|11455901|FG004|Overall Study|Disease progression|3
7245550|NCT00246012|11455902|FG005|Overall Study|Disease progression|25
7245551|NCT00246012|11455903|FG006|Overall Study|Disease progression|30
7245552|NCT00246012|11455904|FG007|Overall Study|Disease progression|27
7245553|NCT00246012|11455905|FG008|Overall Study|Disease progression|26
7245554|NCT00246012|11455897|FG000|Overall Study|Other|0
7245555|NCT00246012|11455898|FG001|Overall Study|Other|0
7245556|NCT00246012|11455899|FG002|Overall Study|Other|0
7245557|NCT00246012|11455900|FG003|Overall Study|Other|0
7245558|NCT00246012|11455901|FG004|Overall Study|Other|0
7245559|NCT00246012|11455902|FG005|Overall Study|Other|0
7245560|NCT00246012|11455903|FG006|Overall Study|Other|0
7245561|NCT00246012|11455904|FG007|Overall Study|Other|1
7245562|NCT00246012|11455905|FG008|Overall Study|Other|0
7245563|NCT00246012|11455897|FG000|Overall Study|Randomly assigned but not treated|0
7245564|NCT00246012|11455898|FG001|Overall Study|Randomly assigned but not treated|0
7245565|NCT00246012|11455899|FG002|Overall Study|Randomly assigned but not treated|0
7245566|NCT00246012|11455900|FG003|Overall Study|Randomly assigned but not treated|0
7245567|NCT00246012|11455901|FG004|Overall Study|Randomly assigned but not treated|0
7245568|NCT00246012|11455902|FG005|Overall Study|Randomly assigned but not treated|1
7245569|NCT00246012|11455903|FG006|Overall Study|Randomly assigned but not treated|1
7574205|NCT03658876|11956540|FG000|Overall Study|Protocol Violation|3
7574206|NCT03658876|11956541|FG001|Overall Study|Protocol Violation|2
7574207|NCT03658876|11956540|FG000|Overall Study|Withdrawal by Subject|2
7574208|NCT03658876|11956541|FG001|Overall Study|Withdrawal by Subject|0
7574209|NCT03658876|11956540|FG000|Overall Study|Death|0
7245570|NCT00246012|11455904|FG007|Overall Study|Randomly assigned but not treated|0
7245571|NCT00246012|11455905|FG008|Overall Study|Randomly assigned but not treated|0
7245572|NCT00246025|11455931|FG000|Overall Study|Adverse Event|7
7245573|NCT00246025|11455932|FG001|Overall Study|Adverse Event|9
7245574|NCT00246025|11455933|FG002|Overall Study|Adverse Event|9
7245575|NCT00246025|11455934|FG003|Overall Study|Adverse Event|10
7245576|NCT00246025|11455931|FG000|Overall Study|Withdrawal by Subject|3
7245577|NCT00246025|11455932|FG001|Overall Study|Withdrawal by Subject|0
7245578|NCT00246025|11455933|FG002|Overall Study|Withdrawal by Subject|1
7245579|NCT00246025|11455934|FG003|Overall Study|Withdrawal by Subject|2
7245580|NCT00246025|11455931|FG000|Overall Study|unsuitable medical history was found|0
7245581|NCT00246025|11455932|FG001|Overall Study|unsuitable medical history was found|0
7245582|NCT00246025|11455933|FG002|Overall Study|unsuitable medical history was found|0
7245583|NCT00246025|11455934|FG003|Overall Study|unsuitable medical history was found|1
7245584|NCT00246090|11455944|FG000|Overall Study|Adverse Event|25
7245585|NCT00246090|11455944|FG000|Overall Study|Withdrawal by Subject|7
7245586|NCT00246090|11455944|FG000|Overall Study|Progressive Disease|212
7245587|NCT00246090|11455944|FG000|Overall Study|Clinical Progression|30
7245588|NCT00246090|11455944|FG000|Overall Study|Physician Decision|11
7245589|NCT00246090|11455944|FG000|Overall Study|Not Otherwise Specified|10
7245590|NCT00246129|11455950|FG000|Overall Study|Lost to Follow-up|1
7245591|NCT00246129|11455951|FG001|Overall Study|Lost to Follow-up|0
7245592|NCT00246129|11455950|FG000|Overall Study|Death|2
7245593|NCT00246129|11455951|FG001|Overall Study|Death|1
7245594|NCT00246129|11455950|FG000|Overall Study|suffered primary non-function|1
7245595|NCT00246129|11455951|FG001|Overall Study|suffered primary non-function|0
7245596|NCT00246129|11455950|FG000|Overall Study|grafts failed|3
7245597|NCT00246129|11455951|FG001|Overall Study|grafts failed|1
7245598|NCT00246259|11455962|FG000|Overall Study|Other|3
7245599|NCT00246259|11455963|FG001|Overall Study|Other|3
7245600|NCT00246259|11455962|FG000|Overall Study|Not stable by Week 18|2
7245601|NCT00246259|11455963|FG001|Overall Study|Not stable by Week 18|1
7245602|NCT00246259|11455962|FG000|Overall Study|Participant non-compliant|4
7245603|NCT00246259|11455963|FG001|Overall Study|Participant non-compliant|9
7245604|NCT00246259|11455962|FG000|Overall Study|Lack of Efficacy|2
7574210|NCT03658876|11956541|FG001|Overall Study|Death|1
7245605|NCT00246259|11455963|FG001|Overall Study|Lack of Efficacy|2
7245606|NCT00246259|11455962|FG000|Overall Study|Investigator withdrew participant|2
7245607|NCT00246259|11455963|FG001|Overall Study|Investigator withdrew participant|0
7245608|NCT00246259|11455962|FG000|Overall Study|Adverse Event|5
7574211|NCT03658876|11956540|FG000|Overall Study|Intercurrent illness|6
7245609|NCT00246259|11455963|FG001|Overall Study|Adverse Event|0
7245610|NCT00246259|11455962|FG000|Overall Study|Lost to Follow-up|3
7245611|NCT00246259|11455963|FG001|Overall Study|Lost to Follow-up|4
7245612|NCT00246259|11455962|FG000|Overall Study|Withdrawal by Subject|5
7245613|NCT00246259|11455963|FG001|Overall Study|Withdrawal by Subject|1
7245614|NCT00246259|11455962|FG000|Overall Study|randomly assigned, not eligible for ITT|2
7245615|NCT00246259|11455963|FG001|Overall Study|randomly assigned, not eligible for ITT|6
7245616|NCT00246324|11455969|FG000|Overall Study|Withdrawal by Subject|1
7245617|NCT00246337|11455982|FG000|Overall Study|Lost to Follow-up|3
7245618|NCT00246337|11455983|FG001|Overall Study|Lost to Follow-up|0
7245619|NCT00246337|11455984|FG002|Overall Study|Lost to Follow-up|0
7245620|NCT00246337|11455985|FG003|Overall Study|Lost to Follow-up|0
7245621|NCT00246337|11455986|FG004|Overall Study|Lost to Follow-up|2
7245622|NCT00246337|11455987|FG005|Overall Study|Lost to Follow-up|2
7245623|NCT00246337|11455988|FG006|Overall Study|Lost to Follow-up|1
7245624|NCT00246337|11455989|FG007|Overall Study|Lost to Follow-up|2
7245625|NCT00246337|11455990|FG008|Overall Study|Lost to Follow-up|0
7245626|NCT00246337|11455982|FG000|Overall Study|Protocol Violation|1
7245627|NCT00246337|11455983|FG001|Overall Study|Protocol Violation|0
7245628|NCT00246337|11455984|FG002|Overall Study|Protocol Violation|0
7245629|NCT00246337|11455985|FG003|Overall Study|Protocol Violation|0
7245630|NCT00246337|11455986|FG004|Overall Study|Protocol Violation|1
7245631|NCT00246337|11455987|FG005|Overall Study|Protocol Violation|0
7245632|NCT00246337|11455988|FG006|Overall Study|Protocol Violation|1
7245633|NCT00246337|11455989|FG007|Overall Study|Protocol Violation|1
7245634|NCT00246337|11455990|FG008|Overall Study|Protocol Violation|0
7245635|NCT00246337|11455982|FG000|Overall Study|Withdrawal by Subject|2
7245636|NCT00246337|11455983|FG001|Overall Study|Withdrawal by Subject|0
7245637|NCT00246337|11455984|FG002|Overall Study|Withdrawal by Subject|0
7245638|NCT00246337|11455985|FG003|Overall Study|Withdrawal by Subject|0
7245639|NCT00246337|11455986|FG004|Overall Study|Withdrawal by Subject|0
7245640|NCT00246337|11455987|FG005|Overall Study|Withdrawal by Subject|0
7245641|NCT00246337|11455988|FG006|Overall Study|Withdrawal by Subject|1
7245642|NCT00246337|11455989|FG007|Overall Study|Withdrawal by Subject|1
7245643|NCT00246337|11455990|FG008|Overall Study|Withdrawal by Subject|0
7245644|NCT00246337|11455982|FG000|Overall Study|Lack of Qualifying Event|8
7245645|NCT00246337|11455983|FG001|Overall Study|Lack of Qualifying Event|2
7245646|NCT00246337|11455984|FG002|Overall Study|Lack of Qualifying Event|1
7245647|NCT00246337|11455985|FG003|Overall Study|Lack of Qualifying Event|1
7245648|NCT00246337|11455986|FG004|Overall Study|Lack of Qualifying Event|1
7245649|NCT00246337|11455987|FG005|Overall Study|Lack of Qualifying Event|3
7245650|NCT00246337|11455988|FG006|Overall Study|Lack of Qualifying Event|3
7245651|NCT00246337|11455989|FG007|Overall Study|Lack of Qualifying Event|2
7245652|NCT00246337|11455990|FG008|Overall Study|Lack of Qualifying Event|5
7245653|NCT00246337|11455982|FG000|Overall Study|Site Terminated|10
7245654|NCT00246337|11455983|FG001|Overall Study|Site Terminated|0
7245655|NCT00246337|11455984|FG002|Overall Study|Site Terminated|0
7245656|NCT00246337|11455985|FG003|Overall Study|Site Terminated|0
7245657|NCT00246337|11455986|FG004|Overall Study|Site Terminated|0
7245658|NCT00246337|11455987|FG005|Overall Study|Site Terminated|7
7245659|NCT00246337|11455988|FG006|Overall Study|Site Terminated|1
7245660|NCT00246337|11455989|FG007|Overall Study|Site Terminated|6
7245661|NCT00246337|11455990|FG008|Overall Study|Site Terminated|2
7245662|NCT00246337|11455982|FG000|Overall Study|Abnormal baseline lab values|7
7245663|NCT00246337|11455983|FG001|Overall Study|Abnormal baseline lab values|0
7245664|NCT00246337|11455984|FG002|Overall Study|Abnormal baseline lab values|2
7245665|NCT00246337|11455985|FG003|Overall Study|Abnormal baseline lab values|0
7245666|NCT00246337|11455986|FG004|Overall Study|Abnormal baseline lab values|0
7245667|NCT00246337|11455987|FG005|Overall Study|Abnormal baseline lab values|2
7245668|NCT00246337|11455988|FG006|Overall Study|Abnormal baseline lab values|2
7245669|NCT00246337|11455989|FG007|Overall Study|Abnormal baseline lab values|0
7245670|NCT00246337|11455990|FG008|Overall Study|Abnormal baseline lab values|4
7245671|NCT00246337|11455982|FG000|Overall Study|Overwhelmed|0
7245672|NCT00246337|11455983|FG001|Overall Study|Overwhelmed|0
7245673|NCT00246337|11455984|FG002|Overall Study|Overwhelmed|0
7245674|NCT00246337|11455985|FG003|Overall Study|Overwhelmed|0
7245675|NCT00246337|11455986|FG004|Overall Study|Overwhelmed|0
7245676|NCT00246337|11455987|FG005|Overall Study|Overwhelmed|1
7245677|NCT00246337|11455988|FG006|Overall Study|Overwhelmed|0
7245678|NCT00246337|11455989|FG007|Overall Study|Overwhelmed|0
7245679|NCT00246337|11455990|FG008|Overall Study|Overwhelmed|0
7245680|NCT00246337|11455982|FG000|Overall Study|Protocol Violator|1
7245681|NCT00246337|11455983|FG001|Overall Study|Protocol Violator|0
7245682|NCT00246337|11455984|FG002|Overall Study|Protocol Violator|0
7245683|NCT00246337|11455985|FG003|Overall Study|Protocol Violator|0
7245684|NCT00246337|11455986|FG004|Overall Study|Protocol Violator|0
7245685|NCT00246337|11455987|FG005|Overall Study|Protocol Violator|0
7245686|NCT00246337|11455988|FG006|Overall Study|Protocol Violator|0
7245687|NCT00246337|11455989|FG007|Overall Study|Protocol Violator|0
7245688|NCT00246337|11455990|FG008|Overall Study|Protocol Violator|0
7245689|NCT00246337|11455982|FG000|Overall Study|Reported as completing trial in error|0
7245690|NCT00246337|11455983|FG001|Overall Study|Reported as completing trial in error|0
7245691|NCT00246337|11455984|FG002|Overall Study|Reported as completing trial in error|0
7245692|NCT00246337|11455985|FG003|Overall Study|Reported as completing trial in error|0
7245693|NCT00246337|11455986|FG004|Overall Study|Reported as completing trial in error|0
7256244|NCT00321854|11467671|FG001|Overall Study|Withdrawal by Subject|17
7245694|NCT00246337|11455987|FG005|Overall Study|Reported as completing trial in error|0
7245695|NCT00246337|11455988|FG006|Overall Study|Reported as completing trial in error|0
7245696|NCT00246337|11455989|FG007|Overall Study|Reported as completing trial in error|1
7245697|NCT00246337|11455990|FG008|Overall Study|Reported as completing trial in error|0
7245698|NCT00246376|11456015|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
7245699|NCT00246376|11456016|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
7245700|NCT00246376|11456017|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
7245701|NCT00246376|11456018|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
7574212|NCT03658876|11956541|FG001|Overall Study|Intercurrent illness|4
7245702|NCT00246376|11456019|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
7245703|NCT00246376|11456015|FG000|Overall Study|Adverse Event|2
7245704|NCT00246376|11456016|FG001|Overall Study|Adverse Event|3
7245705|NCT00246376|11456017|FG002|Overall Study|Adverse Event|1
7245706|NCT00246376|11456018|FG003|Overall Study|Adverse Event|3
7245707|NCT00246376|11456019|FG004|Overall Study|Adverse Event|1
7245708|NCT00246376|11456015|FG000|Overall Study|Lost to Follow-up|2
7245709|NCT00246376|11456016|FG001|Overall Study|Lost to Follow-up|11
7245710|NCT00246376|11456017|FG002|Overall Study|Lost to Follow-up|11
7245711|NCT00246376|11456018|FG003|Overall Study|Lost to Follow-up|16
7245712|NCT00246376|11456019|FG004|Overall Study|Lost to Follow-up|13
7245713|NCT00246571|11456057|FG000|Overall Study|Adverse Event|7
7245714|NCT00246571|11456058|FG001|Overall Study|Adverse Event|0
7245715|NCT00246571|11456057|FG000|Overall Study|Protocol Violation|0
7245716|NCT00246571|11456058|FG001|Overall Study|Protocol Violation|1
7245717|NCT00246571|11456057|FG000|Overall Study|Withdrawal by Subject|2
7245718|NCT00246571|11456058|FG001|Overall Study|Withdrawal by Subject|3
7245719|NCT00246571|11456057|FG000|Overall Study|Lack of Efficacy|84
7245720|NCT00246571|11456058|FG001|Overall Study|Lack of Efficacy|21
7245721|NCT00246571|11456057|FG000|Overall Study|Death|17
7245722|NCT00246571|11456058|FG001|Overall Study|Death|3
7245723|NCT00246571|11456057|FG000|Overall Study|Sponsor|0
7245724|NCT00246571|11456058|FG001|Overall Study|Sponsor|1
7245725|NCT00246571|11456057|FG000|Overall Study|Did not meet entrance criteria|2
7245726|NCT00246571|11456058|FG001|Overall Study|Did not meet entrance criteria|1
7245727|NCT00246571|11456057|FG000|Overall Study|Laboratory abnormalities|1
7245728|NCT00246571|11456058|FG001|Overall Study|Laboratory abnormalities|0
7245729|NCT00246571|11456057|FG000|Overall Study|Crossover participants|0
7245730|NCT00246571|11456058|FG001|Overall Study|Crossover participants|74
7245731|NCT00246740|11456066|FG000|Initial Enrollment|Death|1
7245732|NCT00246740|11456067|FG001|Initial Enrollment|Death|0
7245733|NCT00246740|11456066|FG000|Initial Enrollment|Additional surgery scheduled|0
7245734|NCT00246740|11456067|FG001|Initial Enrollment|Additional surgery scheduled|2
7245735|NCT00246740|11456066|FG000|Initial Enrollment|Surgery schedule change|4
7245736|NCT00246740|11456067|FG001|Initial Enrollment|Surgery schedule change|4
7245737|NCT00246740|11456066|FG000|Initial Enrollment|Other|1
7245738|NCT00246740|11456067|FG001|Initial Enrollment|Other|2
7245739|NCT00246753|11456073|FG000|Overall Study|Withdrawal by Subject|2
7245740|NCT00246753|11456073|FG000|Overall Study|Physician Decision|2
7245741|NCT00246753|11456073|FG000|Overall Study|Adverse Event|2
7245742|NCT00246753|11456073|FG000|Overall Study|Unacceptable toxicity|2
7245743|NCT00246805|11456079|FG000|Phase 1|Lost to Follow-up|1
7245744|NCT00246805|11456080|FG001|Phase 1|Lost to Follow-up|0
7245745|NCT00247273|11456088|FG000|Overall Study|Adverse Event|85
7245746|NCT00247273|11456089|FG001|Overall Study|Adverse Event|80
7245747|NCT00247273|11456088|FG000|Overall Study|Physician Decision|6
7245748|NCT00247273|11456089|FG001|Overall Study|Physician Decision|3
7245749|NCT00247273|11456088|FG000|Overall Study|Lost to Follow-up|7
7245750|NCT00247273|11456089|FG001|Overall Study|Lost to Follow-up|7
7245751|NCT00247273|11456088|FG000|Overall Study|Withdrawal by Subject|46
7245752|NCT00247273|11456089|FG001|Overall Study|Withdrawal by Subject|47
7245753|NCT00247273|11456088|FG000|Overall Study|Did not take any study drug|2
7245754|NCT00247273|11456089|FG001|Overall Study|Did not take any study drug|0
7245755|NCT00247416|11456106|FG000|Overall Study|3 patients were found to be ineligible|1
7245756|NCT00247416|11456107|FG001|Overall Study|3 patients were found to be ineligible|2
7245757|NCT00247611|11456117|FG000|Baselined|Completed baseline, never placed on ARVs|8
7245758|NCT00247611|11456118|FG001|Baselined|Completed baseline, never placed on ARVs|5
7245759|NCT00247611|11456117|FG000|Baselined|Completed baseline only|9
7245760|NCT00247611|11456118|FG001|Baselined|Completed baseline only|8
7245761|NCT00247676|11456139|FG000|Overall Study|Death|5
7245762|NCT00247676|11456139|FG000|Overall Study|Adverse Event|11
7245763|NCT00247676|11456139|FG000|Overall Study|Lack of Efficacy|15
7245764|NCT00247676|11456139|FG000|Overall Study|Other|3
7245765|NCT00247676|11456139|FG000|Overall Study|Withdrawal by Subject|2
7245766|NCT00247962|11456145|FG000|Overall Study|Adverse Event|15
7245767|NCT00247962|11456146|FG001|Overall Study|Adverse Event|12
7245768|NCT00247962|11456145|FG000|Overall Study|Lost to Follow-up|3
7245769|NCT00247962|11456146|FG001|Overall Study|Lost to Follow-up|1
7245770|NCT00247962|11456145|FG000|Overall Study|Physician Decision|0
7245771|NCT00247962|11456146|FG001|Overall Study|Physician Decision|1
7574213|NCT03658876|11956540|FG000|Overall Study|Transplantation/other operation|1
7245772|NCT00247962|11456145|FG000|Overall Study|Protocol Violation|1
7245773|NCT00247962|11456146|FG001|Overall Study|Protocol Violation|1
7245774|NCT00247962|11456145|FG000|Overall Study|Withdrawal by Subject|3
7245775|NCT00247962|11456146|FG001|Overall Study|Withdrawal by Subject|2
7245776|NCT00247962|11456145|FG000|Overall Study|Lack of Efficacy|4
7245777|NCT00247962|11456146|FG001|Overall Study|Lack of Efficacy|2
7245778|NCT00248040|11456155|FG000|Overall Study|transplantectomy|2
7245779|NCT00248040|11456156|FG001|Overall Study|transplantectomy|1
7245780|NCT00248040|11456157|FG002|Overall Study|transplantectomy|3
7245781|NCT00248040|11456155|FG000|Overall Study|transplant cancelled post treat start|1
7245782|NCT00248040|11456156|FG001|Overall Study|transplant cancelled post treat start|0
7245783|NCT00248040|11456157|FG002|Overall Study|transplant cancelled post treat start|0
7245784|NCT00248040|11456155|FG000|Overall Study|Death|0
7245785|NCT00248040|11456156|FG001|Overall Study|Death|0
7245786|NCT00248040|11456157|FG002|Overall Study|Death|1
7574214|NCT03658876|11956541|FG001|Overall Study|Transplantation/other operation|5
7245787|NCT00248170|11456168|FG000|Overall Study|Withdrawal by Subject|71
7245788|NCT00248170|11456169|FG001|Overall Study|Withdrawal by Subject|79
7245789|NCT00248170|11456168|FG000|Overall Study|Protocol Violation|35
7245790|NCT00248170|11456169|FG001|Overall Study|Protocol Violation|30
7245791|NCT00248170|11456168|FG000|Overall Study|Lost to Follow-up|28
7245792|NCT00248170|11456169|FG001|Overall Study|Lost to Follow-up|35
7245793|NCT00248170|11456168|FG000|Overall Study|Disease progression|196
7245794|NCT00248170|11456169|FG001|Overall Study|Disease progression|216
7245795|NCT00248170|11456168|FG000|Overall Study|Death|28
7245796|NCT00248170|11456169|FG001|Overall Study|Death|47
7245797|NCT00248170|11456168|FG000|Overall Study|Adverse Event|311
7245798|NCT00248170|11456169|FG001|Overall Study|Adverse Event|296
7245799|NCT00248170|11456168|FG000|Overall Study|Administrative problems|22
7245800|NCT00248170|11456169|FG001|Overall Study|Administrative problems|25
7245801|NCT00248170|11456168|FG000|Overall Study|Abnormal test procedure(s) result|49
7245802|NCT00248170|11456169|FG001|Overall Study|Abnormal test procedure(s) result|61
7245803|NCT00248170|11456168|FG000|Overall Study|Abnormal laboratory values|4
7245804|NCT00248170|11456169|FG001|Overall Study|Abnormal laboratory values|0
7245805|NCT00248170|11456168|FG000|Overall Study|Protocol deviation|17
7245806|NCT00248170|11456169|FG001|Overall Study|Protocol deviation|19
7245807|NCT00248495|11456175|FG000|Overall Study|Withdrawal by Subject|1
7245808|NCT00248625|11456218|FG000|Overall Study|Withdrawal by Subject|0
7245809|NCT00248625|11456219|FG001|Overall Study|Withdrawal by Subject|2
7245810|NCT00248651|11456239|FG000|Overall Study|Withdrawal by Subject|28
7245811|NCT00248651|11456240|FG001|Overall Study|Withdrawal by Subject|40
7245812|NCT00248651|11456241|FG002|Overall Study|Withdrawal by Subject|32
7245813|NCT00248794|11456261|FG000|Overall Study|Lost to Follow-up|6
7245814|NCT00248794|11456262|FG001|Overall Study|Lost to Follow-up|8
7245815|NCT00248794|11456263|FG002|Overall Study|Lost to Follow-up|3
7245816|NCT00248833|11456295|FG000|Overall Study|Adverse Event|2
7245817|NCT00248833|11456296|FG001|Overall Study|Adverse Event|0
7245818|NCT00248833|11456297|FG002|Overall Study|Adverse Event|0
7245819|NCT00248833|11456295|FG000|Overall Study|Withdrawal by Subject|0
7245820|NCT00248833|11456296|FG001|Overall Study|Withdrawal by Subject|1
7245821|NCT00248833|11456297|FG002|Overall Study|Withdrawal by Subject|1
7245822|NCT00248833|11456295|FG000|Overall Study|Lost to Follow-up|1
7245823|NCT00248833|11456296|FG001|Overall Study|Lost to Follow-up|1
7245824|NCT00248833|11456297|FG002|Overall Study|Lost to Follow-up|1
7245825|NCT00248833|11456295|FG000|Overall Study|Other|0
7245826|NCT00248833|11456296|FG001|Overall Study|Other|1
7245827|NCT00248833|11456297|FG002|Overall Study|Other|0
7245828|NCT00249002|11456307|FG000|Overall Study|Adverse Event|2
7245829|NCT00249002|11456307|FG000|Overall Study|Study cancellation|3
7245830|NCT00249002|11456307|FG000|Overall Study|Other|2
7256245|NCT00321854|11467670|FG000|Overall Study|Other|1
7256246|NCT00321854|11467671|FG001|Overall Study|Other|1
7256247|NCT00321893|11467681|FG000|Overall Study|Non-Compliance/Refusal|16
7256248|NCT00321893|11467682|FG001|Overall Study|Non-Compliance/Refusal|10
7256249|NCT00321893|11467681|FG000|Overall Study|Lost to Follow-up|2
7256250|NCT00321893|11467682|FG001|Overall Study|Lost to Follow-up|1
7256251|NCT00321893|11467681|FG000|Overall Study|Adverse Event|6
7256252|NCT00321893|11467682|FG001|Overall Study|Adverse Event|3
7256253|NCT00321906|11467690|FG000|Overall Study|Adverse Event|36
7256254|NCT00321906|11467691|FG001|Overall Study|Adverse Event|44
7256255|NCT00321906|11467690|FG000|Overall Study|Death|9
7256256|NCT00321906|11467691|FG001|Overall Study|Death|6
7256257|NCT00321906|11467690|FG000|Overall Study|Lost to Follow-up|1
7256258|NCT00321906|11467691|FG001|Overall Study|Lost to Follow-up|2
7256259|NCT00321906|11467690|FG000|Overall Study|Withdrawal by Subject|0
7256260|NCT00321906|11467691|FG001|Overall Study|Withdrawal by Subject|4
7256261|NCT00321919|11467699|FG000|Overall Study|Adverse Event|17
7256262|NCT00321919|11467700|FG001|Overall Study|Adverse Event|10
7256263|NCT00321919|11467699|FG000|Overall Study|Death|21
7256264|NCT00321919|11467700|FG001|Overall Study|Death|17
7256265|NCT00321919|11467699|FG000|Overall Study|Insufficient Therapeutic Response|1
7256266|NCT00321919|11467700|FG001|Overall Study|Insufficient Therapeutic Response|0
7256267|NCT00321919|11467699|FG000|Overall Study|Violation of Selection Criteria at Entry|1
7256268|NCT00321919|11467700|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7256269|NCT00321919|11467699|FG000|Overall Study|Refused Treatment|23
7256270|NCT00321919|11467700|FG001|Overall Study|Refused Treatment|14
7256271|NCT00321919|11467699|FG000|Overall Study|Other Protocol Violation|2
7256272|NCT00321919|11467700|FG001|Overall Study|Other Protocol Violation|3
7245831|NCT00249288|11456330|FG000|Overall Study|Lost to Follow-up|3
7245832|NCT00249288|11456331|FG001|Overall Study|Lost to Follow-up|3
7245833|NCT00249288|11456330|FG000|Overall Study|Withdrawal by Subject|2
7245834|NCT00249288|11456331|FG001|Overall Study|Withdrawal by Subject|2
7245835|NCT00249444|11456356|FG000|Overall Study|Lost to Follow-up|2
7245836|NCT00249444|11456357|FG001|Overall Study|Lost to Follow-up|2
7245837|NCT00249444|11456356|FG000|Overall Study|non-compliant|9
7245838|NCT00249444|11456357|FG001|Overall Study|non-compliant|11
7245839|NCT00249444|11456356|FG000|Overall Study|Adverse Event|1
7245840|NCT00249444|11456357|FG001|Overall Study|Adverse Event|1
7245841|NCT00249444|11456356|FG000|Overall Study|life event|0
7245842|NCT00249444|11456357|FG001|Overall Study|life event|1
7245843|NCT00249613|11456385|FG000|12 Month Follow-up|Death|1
7245844|NCT00249613|11456386|FG001|12 Month Follow-up|Death|1
7245845|NCT00249613|11456385|FG000|12 Month Follow-up|Withdrawal by Subject|6
7245846|NCT00249613|11456386|FG001|12 Month Follow-up|Withdrawal by Subject|6
7245847|NCT00249613|11456385|FG000|12 Month Follow-up|Lost to Follow-up|10
7245848|NCT00249613|11456386|FG001|12 Month Follow-up|Lost to Follow-up|8
7245849|NCT00249769|11456398|FG000|Overall Study|Withdrawal by Subject|1
7245850|NCT00249769|11456399|FG001|Overall Study|Withdrawal by Subject|10
7245851|NCT00249769|11456400|FG002|Overall Study|Withdrawal by Subject|6
7245852|NCT00249769|11456398|FG000|Overall Study|Migration from Study Area|1
7245853|NCT00249769|11456399|FG001|Overall Study|Migration from Study Area|3
7245854|NCT00249769|11456400|FG002|Overall Study|Migration from Study Area|14
7245855|NCT00249769|11456398|FG000|Overall Study|Miscellaneous|0
7245856|NCT00249769|11456399|FG001|Overall Study|Miscellaneous|2
7245857|NCT00249769|11456400|FG002|Overall Study|Miscellaneous|2
7245858|NCT00249769|11456398|FG000|Overall Study|Adverse Event|0
7245859|NCT00249769|11456399|FG001|Overall Study|Adverse Event|0
7245860|NCT00249769|11456400|FG002|Overall Study|Adverse Event|1
7245861|NCT00249769|11456398|FG000|Overall Study|Physician Decision|0
7245862|NCT00249769|11456399|FG001|Overall Study|Physician Decision|0
7245863|NCT00249769|11456400|FG002|Overall Study|Physician Decision|2
7245864|NCT00249769|11456398|FG000|Overall Study|Lost to Follow-up|0
7245865|NCT00249769|11456399|FG001|Overall Study|Lost to Follow-up|0
7245866|NCT00249769|11456400|FG002|Overall Study|Lost to Follow-up|3
7256273|NCT00321919|11467699|FG000|Overall Study|Failure to Return|3
7256274|NCT00321919|11467700|FG001|Overall Study|Failure to Return|1
7256275|NCT00321919|11467699|FG000|Overall Study|Other withdrawal reason|7
7256276|NCT00321919|11467700|FG001|Overall Study|Other withdrawal reason|6
7256721|NCT00325195|11468443|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
7256722|NCT00325195|11468444|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
7256723|NCT00325195|11468442|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7256724|NCT00325195|11468443|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
7256725|NCT00325195|11468444|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
7256726|NCT00325234|11468454|FG000|Overall Study|Adverse Event|10
7256727|NCT00325234|11468455|FG001|Overall Study|Adverse Event|7
7256728|NCT00325234|11468454|FG000|Overall Study|Death due to Study Disease|1
7256729|NCT00325234|11468455|FG001|Overall Study|Death due to Study Disease|0
7256730|NCT00325234|11468454|FG000|Overall Study|Entry Criteria Not Met|1
7256731|NCT00325234|11468455|FG001|Overall Study|Entry Criteria Not Met|2
7256732|NCT00325234|11468454|FG000|Overall Study|Subject Decision|6
7256733|NCT00325234|11468455|FG001|Overall Study|Subject Decision|8
7256734|NCT00325234|11468454|FG000|Overall Study|Physician Decision|17
7256735|NCT00325234|11468455|FG001|Overall Study|Physician Decision|12
7256736|NCT00325234|11468454|FG000|Overall Study|Progressive Disease|34
7256737|NCT00325234|11468455|FG001|Overall Study|Progressive Disease|37
7256738|NCT00325416|11468476|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
7256739|NCT00325416|11468477|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
7256740|NCT00325416|11468476|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
7256741|NCT00325416|11468477|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
7256742|NCT00325416|11468476|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
7256743|NCT00325416|11468477|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
7256744|NCT00325416|11468476|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
7256745|NCT00325416|11468477|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
7256746|NCT00325416|11468476|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
7256747|NCT00325416|11468477|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
7256748|NCT00325416|11468476|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
7256749|NCT00325416|11468477|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
7256750|NCT00325468|11468500|FG000|Overall Study|Adverse Event|1
7256751|NCT00325468|11468501|FG001|Overall Study|Adverse Event|1
7256752|NCT00325468|11468502|FG002|Overall Study|Adverse Event|0
7256753|NCT00325468|11468503|FG003|Overall Study|Adverse Event|5
7256754|NCT00325468|11468504|FG004|Overall Study|Adverse Event|1
7256755|NCT00325468|11468500|FG000|Overall Study|Death|2
7256756|NCT00325468|11468501|FG001|Overall Study|Death|0
7256757|NCT00325468|11468502|FG002|Overall Study|Death|2
7256758|NCT00325468|11468503|FG003|Overall Study|Death|4
7256759|NCT00325468|11468504|FG004|Overall Study|Death|0
7256760|NCT00325468|11468500|FG000|Overall Study|Lost to Follow-up|0
7256761|NCT00325468|11468501|FG001|Overall Study|Lost to Follow-up|0
7256762|NCT00325468|11468502|FG002|Overall Study|Lost to Follow-up|1
7245867|NCT00249795|11456410|FG000|Overall Study|Not treated|16
7245868|NCT00249795|11456411|FG001|Overall Study|Not treated|14
7245869|NCT00249795|11456410|FG000|Overall Study|Symptomatic hypotension|127
7245870|NCT00249795|11456411|FG001|Overall Study|Symptomatic hypotension|64
7245871|NCT00249795|11456410|FG000|Overall Study|Other Serious Adverse Event|84
7245872|NCT00249795|11456411|FG001|Overall Study|Other Serious Adverse Event|93
7245873|NCT00249795|11456410|FG000|Overall Study|Qualifying condition not present|26
7245874|NCT00249795|11456411|FG001|Overall Study|Qualifying condition not present|29
7245875|NCT00249795|11456410|FG000|Overall Study|Withdrawal by Subject|678
7245876|NCT00249795|11456411|FG001|Overall Study|Withdrawal by Subject|742
7245877|NCT00249795|11456410|FG000|Overall Study|Thromboembolic / outcome event|39
7245878|NCT00249795|11456411|FG001|Overall Study|Thromboembolic / outcome event|45
7245879|NCT00249795|11456410|FG000|Overall Study|Oral anticoagulant required|2
7245880|NCT00249795|11456411|FG001|Overall Study|Oral anticoagulant required|0
7245881|NCT00249795|11456410|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
7245882|NCT00249795|11456411|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
7245883|NCT00249795|11456410|FG000|Overall Study|Non-compliance|71
7245884|NCT00249795|11456411|FG001|Overall Study|Non-compliance|69
7245885|NCT00249795|11456410|FG000|Overall Study|Study drug intolerance|3
7245886|NCT00249795|11456411|FG001|Overall Study|Study drug intolerance|3
7245887|NCT00249795|11456410|FG000|Overall Study|Other adverse events (non-serious)|188
7245888|NCT00249795|11456411|FG001|Overall Study|Other adverse events (non-serious)|159
7245889|NCT00249795|11456410|FG000|Overall Study|Physician withdrew consent|71
7245890|NCT00249795|11456411|FG001|Overall Study|Physician withdrew consent|63
7245891|NCT00249795|11456410|FG000|Overall Study|Surgery / procedure|4
7245892|NCT00249795|11456411|FG001|Overall Study|Surgery / procedure|5
7245893|NCT00249795|11456410|FG000|Overall Study|Angiotensin II receptor blocker required|35
7245894|NCT00249795|11456411|FG001|Overall Study|Angiotensin II receptor blocker required|58
7245895|NCT00249795|11456410|FG000|Overall Study|Lightheadedness / dizziness|15
7245896|NCT00249795|11456411|FG001|Overall Study|Lightheadedness / dizziness|11
7245897|NCT00249795|11456410|FG000|Overall Study|Hypotension (non-symptomatic)|5
7245898|NCT00249795|11456411|FG001|Overall Study|Hypotension (non-symptomatic)|5
7245899|NCT00249795|11456410|FG000|Overall Study|Other contraindicated medication|1
7245900|NCT00249795|11456411|FG001|Overall Study|Other contraindicated medication|1
7245901|NCT00249795|11456410|FG000|Overall Study|Event related to cardiac condition|17
7245902|NCT00249795|11456411|FG001|Overall Study|Event related to cardiac condition|16
7245903|NCT00249795|11456410|FG000|Overall Study|Patient not wish to continue after May08|4
7245904|NCT00249795|11456411|FG001|Overall Study|Patient not wish to continue after May08|6
7245905|NCT00249795|11456410|FG000|Overall Study|Site not agree to continue after May08|1
7245906|NCT00249795|11456411|FG001|Overall Study|Site not agree to continue after May08|1
7245907|NCT00249795|11456410|FG000|Overall Study|Lost to Follow-up|0
7245908|NCT00249795|11456411|FG001|Overall Study|Lost to Follow-up|2
7245909|NCT00249795|11456410|FG000|Overall Study|Missing|0
7245910|NCT00249795|11456411|FG001|Overall Study|Missing|1
7245911|NCT00249808|11456417|FG000|Overall Study|Other|27
7245912|NCT00249808|11456417|FG000|Overall Study|Protocol Violation|3
7245913|NCT00249808|11456417|FG000|Overall Study|Lost to Follow-up|8
7245914|NCT00249808|11456417|FG000|Overall Study|Adverse Event|81
7245915|NCT00249808|11456417|FG000|Overall Study|Lack of Efficacy|52
7245916|NCT00249808|11456417|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
7245917|NCT00249821|11456423|FG000|Overall Study|Technical problem|0
7245918|NCT00249821|11456424|FG001|Overall Study|Technical problem|1
7245919|NCT00249834|11456438|FG000|Overall Study|Ovarian stimulation failed|1
7245920|NCT00249834|11456439|FG001|Overall Study|Ovarian stimulation failed|0
7245921|NCT00249834|11456440|FG002|Overall Study|Ovarian stimulation failed|0
7245922|NCT00249834|11456441|FG003|Overall Study|Ovarian stimulation failed|0
7245923|NCT00249834|11456442|FG004|Overall Study|Ovarian stimulation failed|0
7245924|NCT00249834|11456443|FG005|Overall Study|Ovarian stimulation failed|0
7245925|NCT00249834|11456444|FG006|Overall Study|Ovarian stimulation failed|0
7245926|NCT00249834|11456445|FG007|Overall Study|Ovarian stimulation failed|0
7245927|NCT00249834|11456438|FG000|Overall Study|Failure of down-regulation|0
7245928|NCT00249834|11456439|FG001|Overall Study|Failure of down-regulation|0
7245929|NCT00249834|11456440|FG002|Overall Study|Failure of down-regulation|0
7245930|NCT00249834|11456441|FG003|Overall Study|Failure of down-regulation|0
7245931|NCT00249834|11456442|FG004|Overall Study|Failure of down-regulation|0
7245932|NCT00249834|11456443|FG005|Overall Study|Failure of down-regulation|0
7245933|NCT00249834|11456444|FG006|Overall Study|Failure of down-regulation|1
7245934|NCT00249834|11456445|FG007|Overall Study|Failure of down-regulation|0
7245935|NCT00249834|11456438|FG000|Overall Study|Protocol Violation|0
7245936|NCT00249834|11456439|FG001|Overall Study|Protocol Violation|19
7245937|NCT00249834|11456440|FG002|Overall Study|Protocol Violation|14
7245938|NCT00249834|11456441|FG003|Overall Study|Protocol Violation|8
7245939|NCT00249834|11456442|FG004|Overall Study|Protocol Violation|5
7245940|NCT00249834|11456443|FG005|Overall Study|Protocol Violation|2
7245941|NCT00249834|11456444|FG006|Overall Study|Protocol Violation|0
7245942|NCT00249834|11456445|FG007|Overall Study|Protocol Violation|0
7245943|NCT00249873|11456459|FG000|Overall Study|Not treated|7
7245944|NCT00249873|11456460|FG001|Overall Study|Not treated|8
7245945|NCT00249873|11456459|FG000|Overall Study|Significant thrombocytopenia|9
7245946|NCT00249873|11456460|FG001|Overall Study|Significant thrombocytopenia|8
7245947|NCT00249873|11456459|FG000|Overall Study|Severe allergic reaction|8
7245948|NCT00249873|11456460|FG001|Overall Study|Severe allergic reaction|1
7245949|NCT00249873|11456459|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
7245950|NCT00249873|11456460|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
7245951|NCT00249873|11456459|FG000|Overall Study|Other Serious Adverse Event|86
7245952|NCT00249873|11456460|FG001|Overall Study|Other Serious Adverse Event|97
7245953|NCT00249873|11456459|FG000|Overall Study|Qualifying condition not present|20
7245954|NCT00249873|11456460|FG001|Overall Study|Qualifying condition not present|23
7245955|NCT00249873|11456459|FG000|Overall Study|Contraindication to oral anticoagulant|4
7245956|NCT00249873|11456460|FG001|Overall Study|Contraindication to oral anticoagulant|8
7245957|NCT00249873|11456459|FG000|Overall Study|Withdrawal by Subject|504
7245958|NCT00249873|11456460|FG001|Overall Study|Withdrawal by Subject|466
7245959|NCT00249873|11456459|FG000|Overall Study|Lost to Follow-up|4
7245960|NCT00249873|11456460|FG001|Overall Study|Lost to Follow-up|7
7245961|NCT00249873|11456459|FG000|Overall Study|Minor bleeding|99
7245962|NCT00249873|11456460|FG001|Overall Study|Minor bleeding|37
7245963|NCT00249873|11456459|FG000|Overall Study|Non-compliance|41
7245964|NCT00249873|11456460|FG001|Overall Study|Non-compliance|46
7245965|NCT00249873|11456459|FG000|Overall Study|Other non serious Adverse Event|112
7245966|NCT00249873|11456460|FG001|Overall Study|Other non serious Adverse Event|108
7245967|NCT00249873|11456459|FG000|Overall Study|Other contraindicated medication|1
7245968|NCT00249873|11456460|FG001|Overall Study|Other contraindicated medication|0
7245969|NCT00249873|11456459|FG000|Overall Study|Patient not wish to continue after May08|3
7245970|NCT00249873|11456460|FG001|Overall Study|Patient not wish to continue after May08|4
7245971|NCT00249873|11456459|FG000|Overall Study|Physician withdrew consent|59
7245972|NCT00249873|11456460|FG001|Overall Study|Physician withdrew consent|60
7245973|NCT00249873|11456459|FG000|Overall Study|Open label clopidogrel required|31
7245974|NCT00249873|11456460|FG001|Overall Study|Open label clopidogrel required|42
7245975|NCT00249873|11456459|FG000|Overall Study|Angiotensin II receptor blocker required|1
7245976|NCT00249873|11456460|FG001|Overall Study|Angiotensin II receptor blocker required|0
7245977|NCT00249873|11456459|FG000|Overall Study|Oral anticoagulant required|159
7245978|NCT00249873|11456460|FG001|Overall Study|Oral anticoagulant required|157
7245979|NCT00249873|11456459|FG000|Overall Study|Study drug intolerance|5
7245980|NCT00249873|11456460|FG001|Overall Study|Study drug intolerance|0
7245981|NCT00249873|11456459|FG000|Overall Study|Surgery/ procedure|9
7245982|NCT00249873|11456460|FG001|Overall Study|Surgery/ procedure|9
7245983|NCT00249873|11456459|FG000|Overall Study|Event related to cardiac condition|12
7245984|NCT00249873|11456460|FG001|Overall Study|Event related to cardiac condition|21
7245985|NCT00249873|11456459|FG000|Overall Study|Thromboembolic/outcome event|82
7245986|NCT00249873|11456460|FG001|Overall Study|Thromboembolic/outcome event|122
7245987|NCT00250276|11456470|FG000|Overall Study|Serious Adverse Event|0
7245988|NCT00250276|11456471|FG001|Overall Study|Serious Adverse Event|0
7245989|NCT00250276|11456472|FG002|Overall Study|Serious Adverse Event|1
7245990|NCT00250276|11456473|FG003|Overall Study|Serious Adverse Event|0
7245991|NCT00250276|11456470|FG000|Overall Study|Non-serious Adverse Event|2
7245992|NCT00250276|11456471|FG001|Overall Study|Non-serious Adverse Event|0
7245993|NCT00250276|11456472|FG002|Overall Study|Non-serious Adverse Event|0
7245994|NCT00250276|11456473|FG003|Overall Study|Non-serious Adverse Event|2
7245995|NCT00250276|11456470|FG000|Overall Study|Protocol Violation|0
7245996|NCT00250276|11456471|FG001|Overall Study|Protocol Violation|1
7245997|NCT00250276|11456472|FG002|Overall Study|Protocol Violation|0
7245998|NCT00250276|11456473|FG003|Overall Study|Protocol Violation|0
7245999|NCT00250276|11456470|FG000|Overall Study|Withdrawal by Subject|1
7246000|NCT00250276|11456471|FG001|Overall Study|Withdrawal by Subject|2
7246001|NCT00250276|11456472|FG002|Overall Study|Withdrawal by Subject|3
7246002|NCT00250276|11456473|FG003|Overall Study|Withdrawal by Subject|2
7246003|NCT00250276|11456470|FG000|Overall Study|Migrated/moved from study area|3
7246004|NCT00250276|11456471|FG001|Overall Study|Migrated/moved from study area|0
7246005|NCT00250276|11456472|FG002|Overall Study|Migrated/moved from study area|2
7246006|NCT00250276|11456473|FG003|Overall Study|Migrated/moved from study area|7
7246007|NCT00250276|11456470|FG000|Overall Study|Lost to Follow-up|11
7246008|NCT00250276|11456471|FG001|Overall Study|Lost to Follow-up|18
7246009|NCT00250276|11456472|FG002|Overall Study|Lost to Follow-up|13
7246010|NCT00250276|11456473|FG003|Overall Study|Lost to Follow-up|8
7246011|NCT00250432|11456490|FG000|Overall Study|Adverse Event|25
7246012|NCT00250432|11456491|FG001|Overall Study|Adverse Event|29
7246013|NCT00250432|11456490|FG000|Overall Study|Lack of Efficacy|2
7246014|NCT00250432|11456491|FG001|Overall Study|Lack of Efficacy|1
7246015|NCT00250432|11456490|FG000|Overall Study|Lost to Follow-up|6
7246016|NCT00250432|11456491|FG001|Overall Study|Lost to Follow-up|5
7246017|NCT00250432|11456490|FG000|Overall Study|Patient Moved|0
7246018|NCT00250432|11456491|FG001|Overall Study|Patient Moved|1
7246019|NCT00250432|11456490|FG000|Overall Study|Protocol Violation|0
7246020|NCT00250432|11456491|FG001|Overall Study|Protocol Violation|3
7246021|NCT00250432|11456490|FG000|Overall Study|Withdrawal by Subject|6
7246022|NCT00250432|11456491|FG001|Overall Study|Withdrawal by Subject|2
7246023|NCT00250432|11456490|FG000|Overall Study|Pt died out of posttherapy report period|6
7246024|NCT00250432|11456491|FG001|Overall Study|Pt died out of posttherapy report period|5
7246025|NCT00250432|11456490|FG000|Overall Study|Pt was considered untreatable|0
7246026|NCT00250432|11456491|FG001|Overall Study|Pt was considered untreatable|1
7246027|NCT00250588|11456518|FG000|Overall Study|Withdrawal by Subject|3
7246028|NCT00250588|11456519|FG001|Overall Study|Withdrawal by Subject|6
7246029|NCT00250588|11456520|FG002|Overall Study|Withdrawal by Subject|0
7246030|NCT00250588|11456518|FG000|Overall Study|Lost to Follow-up|6
7246031|NCT00250588|11456519|FG001|Overall Study|Lost to Follow-up|13
7246032|NCT00250588|11456520|FG002|Overall Study|Lost to Follow-up|13
7246033|NCT00250679|11456531|FG000|Overall Study|Adverse Event|12
7246034|NCT00250679|11456532|FG001|Overall Study|Adverse Event|15
7246035|NCT00250679|11456533|FG002|Overall Study|Adverse Event|16
7246036|NCT00250679|11456531|FG000|Overall Study|Protocol Violation|2
7246037|NCT00250679|11456532|FG001|Overall Study|Protocol Violation|4
7246038|NCT00250679|11456533|FG002|Overall Study|Protocol Violation|3
7246039|NCT00250679|11456531|FG000|Overall Study|Withdrawal by Subject|15
7246040|NCT00250679|11456532|FG001|Overall Study|Withdrawal by Subject|18
7246041|NCT00250679|11456533|FG002|Overall Study|Withdrawal by Subject|15
7246042|NCT00250679|11456531|FG000|Overall Study|Lost to Follow-up|3
7246043|NCT00250679|11456532|FG001|Overall Study|Lost to Follow-up|4
7246044|NCT00250679|11456533|FG002|Overall Study|Lost to Follow-up|2
7246045|NCT00250679|11456531|FG000|Overall Study|Does Not Meet Entry Criteria|1
7246046|NCT00250679|11456532|FG001|Overall Study|Does Not Meet Entry Criteria|4
7246047|NCT00250679|11456533|FG002|Overall Study|Does Not Meet Entry Criteria|2
7246048|NCT00250679|11456531|FG000|Overall Study|Lack of Efficacy|0
7246049|NCT00250679|11456532|FG001|Overall Study|Lack of Efficacy|1
7246050|NCT00250679|11456533|FG002|Overall Study|Lack of Efficacy|3
7246051|NCT00250679|11456531|FG000|Overall Study|Technical Holter issues|1
7246052|NCT00250679|11456532|FG001|Overall Study|Technical Holter issues|0
7246053|NCT00250679|11456533|FG002|Overall Study|Technical Holter issues|2
7246054|NCT00250679|11456531|FG000|Overall Study|Moved|1
7246055|NCT00250679|11456532|FG001|Overall Study|Moved|1
7246056|NCT00250679|11456533|FG002|Overall Study|Moved|0
7246057|NCT00250679|11456531|FG000|Overall Study|Non-compliance|1
7246058|NCT00250679|11456532|FG001|Overall Study|Non-compliance|1
7246059|NCT00250679|11456533|FG002|Overall Study|Non-compliance|0
7246060|NCT00250679|11456531|FG000|Overall Study|various single events: hip surgery,diary|3
7246061|NCT00250679|11456532|FG001|Overall Study|various single events: hip surgery,diary|1
7246062|NCT00250679|11456533|FG002|Overall Study|various single events: hip surgery,diary|1
7246063|NCT00250705|11456541|FG000|Overall Study|Lack of Efficacy|2
7246064|NCT00250835|11456547|FG000|Overall Study|Withdrawal by Subject|1
7246065|NCT00251004|11456559|FG000|Overall Study|Withdrawal by Subject|23
7246066|NCT00251004|11456560|FG001|Overall Study|Withdrawal by Subject|16
7246067|NCT00251004|11456561|FG002|Overall Study|Withdrawal by Subject|14
7246068|NCT00251004|11456559|FG000|Overall Study|Death|9
7246069|NCT00251004|11456560|FG001|Overall Study|Death|10
7246070|NCT00251004|11456561|FG002|Overall Study|Death|8
7246071|NCT00251004|11456559|FG000|Overall Study|Lost to Follow-up|1
7246072|NCT00251004|11456560|FG001|Overall Study|Lost to Follow-up|2
7246073|NCT00251004|11456561|FG002|Overall Study|Lost to Follow-up|1
7246074|NCT00251004|11456559|FG000|Overall Study|Graft Loss|12
7246075|NCT00251004|11456560|FG001|Overall Study|Graft Loss|13
7246076|NCT00251004|11456561|FG002|Overall Study|Graft Loss|8
7246077|NCT00251316|11456595|FG000|Overall Study|Physician Decision|2
7246078|NCT00251316|11456596|FG001|Overall Study|Physician Decision|3
7246079|NCT00251589|11456606|FG000|Overall Study|Adverse Event|5
7246080|NCT00251589|11456607|FG001|Overall Study|Adverse Event|1
7246081|NCT00251589|11456608|FG002|Overall Study|Adverse Event|2
7246082|NCT00251589|11456609|FG003|Overall Study|Adverse Event|1
7246083|NCT00251589|11456606|FG000|Overall Study|Withdrawal by Subject|1
7246084|NCT00251589|11456607|FG001|Overall Study|Withdrawal by Subject|1
7246085|NCT00251589|11456608|FG002|Overall Study|Withdrawal by Subject|0
7246086|NCT00251589|11456609|FG003|Overall Study|Withdrawal by Subject|0
7246087|NCT00251589|11456606|FG000|Overall Study|Discontinued due to progressive disease|9
7246088|NCT00251589|11456607|FG001|Overall Study|Discontinued due to progressive disease|1
7246089|NCT00251589|11456608|FG002|Overall Study|Discontinued due to progressive disease|0
7246090|NCT00251589|11456609|FG003|Overall Study|Discontinued due to progressive disease|1
7246091|NCT00251641|11456621|FG000|Overall Study|Adverse Event|80
7246092|NCT00251641|11456622|FG001|Overall Study|Adverse Event|8
7246093|NCT00251641|11456621|FG000|Overall Study|Lack of Efficacy|2
7246094|NCT00251641|11456622|FG001|Overall Study|Lack of Efficacy|1
7246095|NCT00251641|11456621|FG000|Overall Study|Progression of Disease|0
7246096|NCT00251641|11456622|FG001|Overall Study|Progression of Disease|2
7246097|NCT00251641|11456621|FG000|Overall Study|Lost to Follow-up|3
7246098|NCT00251641|11456622|FG001|Overall Study|Lost to Follow-up|3
7246099|NCT00251641|11456621|FG000|Overall Study|Withdrawal by Subject|6
7246100|NCT00251641|11456622|FG001|Overall Study|Withdrawal by Subject|8
7246101|NCT00251641|11456621|FG000|Overall Study|Protocol Violation|10
7246102|NCT00251641|11456622|FG001|Overall Study|Protocol Violation|2
7246103|NCT00251641|11456621|FG000|Overall Study|Did not Meet protocol Eligibility|2
7246104|NCT00251641|11456622|FG001|Overall Study|Did not Meet protocol Eligibility|1
7246105|NCT00251641|11456621|FG000|Overall Study|Switched Treatment|9
7246106|NCT00251641|11456622|FG001|Overall Study|Switched Treatment|63
7246107|NCT00251693|11456633|FG000|Overall Study|Adverse Event|17
7246108|NCT00251693|11456634|FG001|Overall Study|Adverse Event|9
7246109|NCT00251693|11456635|FG002|Overall Study|Adverse Event|9
7246110|NCT00251693|11456633|FG000|Overall Study|Protocol Violation|2
7246111|NCT00251693|11456634|FG001|Overall Study|Protocol Violation|0
7246112|NCT00251693|11456635|FG002|Overall Study|Protocol Violation|2
7246113|NCT00251693|11456633|FG000|Overall Study|Lost to Follow-up|12
7246114|NCT00251693|11456634|FG001|Overall Study|Lost to Follow-up|7
7246115|NCT00251693|11456635|FG002|Overall Study|Lost to Follow-up|8
7246116|NCT00251693|11456633|FG000|Overall Study|Withdrawal by Subject|11
7246117|NCT00251693|11456634|FG001|Overall Study|Withdrawal by Subject|17
7246118|NCT00251693|11456635|FG002|Overall Study|Withdrawal by Subject|14
7246119|NCT00251693|11456633|FG000|Overall Study|Lack of Efficacy|0
7246120|NCT00251693|11456634|FG001|Overall Study|Lack of Efficacy|1
7246121|NCT00251693|11456635|FG002|Overall Study|Lack of Efficacy|0
7246122|NCT00251693|11456633|FG000|Overall Study|Inclusion/exclusion criteria not met|5
7246123|NCT00251693|11456634|FG001|Overall Study|Inclusion/exclusion criteria not met|3
7246124|NCT00251693|11456635|FG002|Overall Study|Inclusion/exclusion criteria not met|8
7246125|NCT00251693|11456633|FG000|Overall Study|Noncompliant|0
7246126|NCT00251693|11456634|FG001|Overall Study|Noncompliant|0
7246127|NCT00251693|11456635|FG002|Overall Study|Noncompliant|2
7246128|NCT00251693|11456633|FG000|Overall Study|Possible Barrett's esophagus|3
7246129|NCT00251693|11456634|FG001|Overall Study|Possible Barrett's esophagus|5
7246130|NCT00251693|11456635|FG002|Overall Study|Possible Barrett's esophagus|2
7246131|NCT00251693|11456633|FG000|Overall Study|Subject request/subject unavailable|1
7246132|NCT00251693|11456634|FG001|Overall Study|Subject request/subject unavailable|2
7246133|NCT00251693|11456635|FG002|Overall Study|Subject request/subject unavailable|0
7246134|NCT00251693|11456633|FG000|Overall Study|Abnormal laboratory findings|0
7246135|NCT00251693|11456634|FG001|Overall Study|Abnormal laboratory findings|0
7246136|NCT00251693|11456635|FG002|Overall Study|Abnormal laboratory findings|1
7246137|NCT00251719|11456646|FG000|Overall Study|Adverse Event|14
7246138|NCT00251719|11456647|FG001|Overall Study|Adverse Event|8
7246139|NCT00251719|11456648|FG002|Overall Study|Adverse Event|7
7246140|NCT00251719|11456646|FG000|Overall Study|Protocol Violation|1
7246141|NCT00251719|11456647|FG001|Overall Study|Protocol Violation|1
7246142|NCT00251719|11456648|FG002|Overall Study|Protocol Violation|1
7246143|NCT00251719|11456646|FG000|Overall Study|Lost to Follow-up|5
7246144|NCT00251719|11456647|FG001|Overall Study|Lost to Follow-up|11
7246145|NCT00251719|11456648|FG002|Overall Study|Lost to Follow-up|8
7246146|NCT00251719|11456646|FG000|Overall Study|Withdrawal by Subject|14
7246147|NCT00251719|11456647|FG001|Overall Study|Withdrawal by Subject|12
7246148|NCT00251719|11456648|FG002|Overall Study|Withdrawal by Subject|11
7246149|NCT00251719|11456646|FG000|Overall Study|Lack of Efficacy|2
7246150|NCT00251719|11456647|FG001|Overall Study|Lack of Efficacy|1
7246151|NCT00251719|11456648|FG002|Overall Study|Lack of Efficacy|0
7246152|NCT00251719|11456646|FG000|Overall Study|Inclusion/exclusion criteria not met|12
7246153|NCT00251719|11456647|FG001|Overall Study|Inclusion/exclusion criteria not met|6
7246154|NCT00251719|11456648|FG002|Overall Study|Inclusion/exclusion criteria not met|2
7246155|NCT00251719|11456646|FG000|Overall Study|Investigator decision|1
7246156|NCT00251719|11456647|FG001|Overall Study|Investigator decision|1
7246157|NCT00251719|11456648|FG002|Overall Study|Investigator decision|0
7246158|NCT00251719|11456646|FG000|Overall Study|Noncompliance|2
7246159|NCT00251719|11456647|FG001|Overall Study|Noncompliance|3
7246160|NCT00251719|11456648|FG002|Overall Study|Noncompliance|1
7246161|NCT00251719|11456646|FG000|Overall Study|Barrett's esophagus|2
7246162|NCT00251719|11456647|FG001|Overall Study|Barrett's esophagus|2
7246163|NCT00251719|11456648|FG002|Overall Study|Barrett's esophagus|0
7246164|NCT00251745|11456659|FG000|Overall Study|Adverse Event|7
7246165|NCT00251745|11456660|FG001|Overall Study|Adverse Event|9
7246166|NCT00251745|11456661|FG002|Overall Study|Adverse Event|11
7246167|NCT00251745|11456659|FG000|Overall Study|Lost to Follow-up|4
7246168|NCT00251745|11456660|FG001|Overall Study|Lost to Follow-up|2
7246169|NCT00251745|11456661|FG002|Overall Study|Lost to Follow-up|5
7246170|NCT00251745|11456659|FG000|Overall Study|Withdrawal by Subject|13
7246171|NCT00251745|11456660|FG001|Overall Study|Withdrawal by Subject|7
7246172|NCT00251745|11456661|FG002|Overall Study|Withdrawal by Subject|3
7246173|NCT00251745|11456659|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7246174|NCT00251745|11456660|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7246175|NCT00251745|11456661|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7246176|NCT00251745|11456659|FG000|Overall Study|Lack of Efficacy|3
7246177|NCT00251745|11456660|FG001|Overall Study|Lack of Efficacy|0
7246178|NCT00251745|11456661|FG002|Overall Study|Lack of Efficacy|0
7246179|NCT00251745|11456659|FG000|Overall Study|Noncompliant|0
7246180|NCT00251745|11456660|FG001|Overall Study|Noncompliant|2
7246181|NCT00251745|11456661|FG002|Overall Study|Noncompliant|2
7246182|NCT00251745|11456659|FG000|Overall Study|Pregnancy|0
7246183|NCT00251745|11456660|FG001|Overall Study|Pregnancy|1
7574217|NCT03661983|11956621|FG000|Open Label Stabilization Phase|Adverse Event|5
7246184|NCT00251745|11456661|FG002|Overall Study|Pregnancy|0
7246185|NCT00251745|11456659|FG000|Overall Study|Per Subject Request|0
7246186|NCT00251745|11456660|FG001|Overall Study|Per Subject Request|0
7246187|NCT00251745|11456661|FG002|Overall Study|Per Subject Request|1
7246188|NCT00251745|11456659|FG000|Overall Study|Per Investigator Request|1
7246189|NCT00251745|11456660|FG001|Overall Study|Per Investigator Request|0
7246190|NCT00251745|11456661|FG002|Overall Study|Per Investigator Request|0
7246191|NCT00251758|11456672|FG000|Overall Study|Adverse Event|7
7246192|NCT00251758|11456673|FG001|Overall Study|Adverse Event|9
7246193|NCT00251758|11456674|FG002|Overall Study|Adverse Event|11
7246194|NCT00251758|11456672|FG000|Overall Study|Lost to Follow-up|4
7246195|NCT00251758|11456673|FG001|Overall Study|Lost to Follow-up|2
7246196|NCT00251758|11456674|FG002|Overall Study|Lost to Follow-up|5
7246197|NCT00251758|11456672|FG000|Overall Study|Withdrawal by Subject|13
7246198|NCT00251758|11456673|FG001|Overall Study|Withdrawal by Subject|7
7246199|NCT00251758|11456674|FG002|Overall Study|Withdrawal by Subject|3
7246200|NCT00251758|11456672|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
7246201|NCT00251758|11456673|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
7246202|NCT00251758|11456674|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7246203|NCT00251758|11456672|FG000|Overall Study|Lack of Efficacy|3
7246204|NCT00251758|11456673|FG001|Overall Study|Lack of Efficacy|0
7246205|NCT00251758|11456674|FG002|Overall Study|Lack of Efficacy|0
7246206|NCT00251758|11456672|FG000|Overall Study|Noncompliant|0
7574218|NCT03661983|11956622|FG001|Open Label Stabilization Phase|Adverse Event|0
7246207|NCT00251758|11456673|FG001|Overall Study|Noncompliant|2
7246208|NCT00251758|11456674|FG002|Overall Study|Noncompliant|2
7246209|NCT00251758|11456672|FG000|Overall Study|Pregnancy|0
7246210|NCT00251758|11456673|FG001|Overall Study|Pregnancy|1
7246211|NCT00251758|11456674|FG002|Overall Study|Pregnancy|0
7246212|NCT00251758|11456672|FG000|Overall Study|Per Subject Request|0
7246213|NCT00251758|11456673|FG001|Overall Study|Per Subject Request|0
7246214|NCT00251758|11456674|FG002|Overall Study|Per Subject Request|1
7246215|NCT00251758|11456672|FG000|Overall Study|Per Investigator Request|1
7246216|NCT00251758|11456673|FG001|Overall Study|Per Investigator Request|0
7246217|NCT00251758|11456674|FG002|Overall Study|Per Investigator Request|0
7246218|NCT00251927|11456697|FG000|Overall Study|Adverse Event|3
7246219|NCT00251927|11456698|FG001|Overall Study|Adverse Event|15
7246220|NCT00251927|11456697|FG000|Overall Study|Lack of Efficacy|22
7246221|NCT00251927|11456698|FG001|Overall Study|Lack of Efficacy|16
7246222|NCT00251927|11456697|FG000|Overall Study|Lost to Follow-up|22
7246223|NCT00251927|11456698|FG001|Overall Study|Lost to Follow-up|8
7246224|NCT00251927|11456697|FG000|Overall Study|Protocol Violation|1
7246225|NCT00251927|11456698|FG001|Overall Study|Protocol Violation|2
7246226|NCT00251927|11456697|FG000|Overall Study|Pregnancy|2
7246227|NCT00251927|11456698|FG001|Overall Study|Pregnancy|0
7246228|NCT00251927|11456697|FG000|Overall Study|Withdrawal by Subject|40
7246229|NCT00251927|11456698|FG001|Overall Study|Withdrawal by Subject|25
7246230|NCT00251927|11456697|FG000|Overall Study|Study-specific discont. achieved|13
7246231|NCT00251927|11456698|FG001|Overall Study|Study-specific discont. achieved|2
7246232|NCT00251927|11456697|FG000|Overall Study|Study procedure non-compliance|5
7246233|NCT00251927|11456698|FG001|Overall Study|Study procedure non-compliance|6
7246234|NCT00251979|11456707|FG000|Overall Study|Protocol Violation|3
7246235|NCT00251979|11456708|FG001|Overall Study|Protocol Violation|5
7246236|NCT00251979|11456707|FG000|Overall Study|Adverse Event|11
7246237|NCT00251979|11456708|FG001|Overall Study|Adverse Event|17
7246238|NCT00251979|11456707|FG000|Overall Study|Withdrawal by Subject|13
7246239|NCT00251979|11456708|FG001|Overall Study|Withdrawal by Subject|7
7246240|NCT00251979|11456707|FG000|Overall Study|Lost to Follow-up|8
7246241|NCT00251979|11456708|FG001|Overall Study|Lost to Follow-up|6
7246242|NCT00251979|11456707|FG000|Overall Study|Death|3
7246243|NCT00251979|11456708|FG001|Overall Study|Death|5
7246244|NCT00252057|11456716|FG000|Overall Study|Withdrawal by Subject|2
7246245|NCT00252057|11456717|FG001|Overall Study|Withdrawal by Subject|5
7246246|NCT00252057|11456716|FG000|Overall Study|Death|1
7246247|NCT00252057|11456717|FG001|Overall Study|Death|2
7246248|NCT00252057|11456716|FG000|Overall Study|Participant previously enrolled|0
7246249|NCT00252057|11456717|FG001|Overall Study|Participant previously enrolled|1
7246250|NCT00252187|11456725|FG000|Overall Study|Adverse Event|3
7246251|NCT00252187|11456726|FG001|Overall Study|Adverse Event|1
7246252|NCT00252187|11456725|FG000|Overall Study|Withdrawal by Subject|1
7246253|NCT00252187|11456726|FG001|Overall Study|Withdrawal by Subject|0
7246254|NCT00252239|11456736|FG000|Overall Study|Withdrawal by Subject|1
7246255|NCT00252239|11456737|FG001|Overall Study|Withdrawal by Subject|0
7246256|NCT00252239|11456738|FG002|Overall Study|Withdrawal by Subject|0
7246257|NCT00252239|11456739|FG003|Overall Study|Withdrawal by Subject|1
7246258|NCT00252239|11456736|FG000|Overall Study|Lost to Follow-up|0
7246259|NCT00252239|11456737|FG001|Overall Study|Lost to Follow-up|0
7246260|NCT00252239|11456738|FG002|Overall Study|Lost to Follow-up|2
7246261|NCT00252239|11456739|FG003|Overall Study|Lost to Follow-up|0
7246262|NCT00252499|11456756|FG000|Overall Study|Lost to Follow-up|1
7246263|NCT00252499|11456757|FG001|Overall Study|Lost to Follow-up|0
7246264|NCT00252499|11456758|FG002|Overall Study|Lost to Follow-up|0
7246265|NCT00252564|11456783|FG000|Overall Study|Adverse Event|17
7246266|NCT00252564|11456784|FG001|Overall Study|Adverse Event|13
7246267|NCT00252564|11456783|FG000|Overall Study|Unrelated Complication|2
7246268|NCT00252564|11456784|FG001|Overall Study|Unrelated Complication|1
7574219|NCT03661983|11956623|FG002|Open Label Stabilization Phase|Adverse Event|0
7246269|NCT00252564|11456783|FG000|Overall Study|Disease Progression|14
7246270|NCT00252564|11456784|FG001|Overall Study|Disease Progression|20
7246271|NCT00252564|11456783|FG000|Overall Study|Death|0
7246272|NCT00252564|11456784|FG001|Overall Study|Death|3
7246273|NCT00252564|11456783|FG000|Overall Study|Physician Decision|1
7246274|NCT00252564|11456784|FG001|Overall Study|Physician Decision|0
7246275|NCT00252564|11456783|FG000|Overall Study|Lost to Follow-up|1
7246276|NCT00252564|11456784|FG001|Overall Study|Lost to Follow-up|0
7246277|NCT00252564|11456783|FG000|Overall Study|Patient Request|4
7246278|NCT00252564|11456784|FG001|Overall Study|Patient Request|5
7246279|NCT00252564|11456783|FG000|Overall Study|Withdrawal by Subject|0
7246280|NCT00252564|11456784|FG001|Overall Study|Withdrawal by Subject|2
7246281|NCT00252577|11456790|FG000|Overall Study|Lost to Follow-up|20
7246282|NCT00252694|11456827|FG000|Overall Study|Withdrawal by Subject|83
7246283|NCT00252694|11456828|FG001|Overall Study|Withdrawal by Subject|91
7246284|NCT00252694|11456827|FG000|Overall Study|Death|36
7246285|NCT00252694|11456828|FG001|Overall Study|Death|34
7246286|NCT00252694|11456827|FG000|Overall Study|Mostly Lost to Follow Up|8
7246287|NCT00252694|11456828|FG001|Overall Study|Mostly Lost to Follow Up|13
7246288|NCT00252694|11456827|FG000|Overall Study|Patient Moving|17
7246289|NCT00252694|11456828|FG001|Overall Study|Patient Moving|16
7246290|NCT00252720|11456836|FG000|Overall Study|Withdrawal by Subject|95
7246291|NCT00252720|11456837|FG001|Overall Study|Withdrawal by Subject|97
7246292|NCT00252720|11456836|FG000|Overall Study|Death|7
7246293|NCT00252720|11456837|FG001|Overall Study|Death|8
7246294|NCT00252720|11456836|FG000|Overall Study|Moving|23
7246295|NCT00252720|11456837|FG001|Overall Study|Moving|42
7246296|NCT00252720|11456836|FG000|Overall Study|Mainly patients lost to follow-up|7
7246297|NCT00252720|11456837|FG001|Overall Study|Mainly patients lost to follow-up|18
7246298|NCT00252733|11456845|FG000|Overall Study|Withdrawal by Subject|73
7246299|NCT00252733|11456846|FG001|Overall Study|Withdrawal by Subject|67
7246300|NCT00252733|11456845|FG000|Overall Study|Death|7
7246301|NCT00252733|11456846|FG001|Overall Study|Death|5
7246302|NCT00252733|11456845|FG000|Overall Study|Lost to Follow-up|12
7246303|NCT00252733|11456846|FG001|Overall Study|Lost to Follow-up|6
7246304|NCT00252733|11456845|FG000|Overall Study|Multiple Reasons|14
7246305|NCT00252733|11456846|FG001|Overall Study|Multiple Reasons|14
7246306|NCT00253370|11456874|FG000|Overall Study|Adverse Event|18
7246307|NCT00253370|11456874|FG000|Overall Study|Disease progression|13
7246308|NCT00253370|11456874|FG000|Overall Study|Death|2
7246309|NCT00253370|11456874|FG000|Overall Study|Withdrawal by Subject|6
7246310|NCT00253370|11456874|FG000|Overall Study|Non-protocol therapy|1
7246311|NCT00253370|11456874|FG000|Overall Study|Physician Decision|1
7246312|NCT00253370|11456874|FG000|Overall Study|Protocol Violation|1
7246313|NCT00253370|11456874|FG000|Overall Study|Abdominal pain due to disease|1
7246314|NCT00253448|11456888|FG000|Overall Study|Withdrawal by Subject|1
7246315|NCT00253630|11456896|FG000|Overall Study|ineligible|2
7246316|NCT00253643|11456904|FG000|Overall Study|Withdrawal by Subject|0
7246317|NCT00253643|11456905|FG001|Overall Study|Withdrawal by Subject|0
7246318|NCT00253643|11456906|FG002|Overall Study|Withdrawal by Subject|1
7246319|NCT00253643|11456907|FG003|Overall Study|Withdrawal by Subject|1
7246320|NCT00253643|11456904|FG000|Overall Study|Non-Compliance|0
7246321|NCT00253643|11456905|FG001|Overall Study|Non-Compliance|0
7246322|NCT00253643|11456906|FG002|Overall Study|Non-Compliance|0
7246323|NCT00253643|11456907|FG003|Overall Study|Non-Compliance|2
7246324|NCT00253747|11456932|FG000|Overall Study|Lost to Follow-up|13
7246325|NCT00253747|11456933|FG001|Overall Study|Lost to Follow-up|14
7246326|NCT00253747|11456932|FG000|Overall Study|Withdrawal by Subject|10
7246327|NCT00253747|11456933|FG001|Overall Study|Withdrawal by Subject|11
7246328|NCT00253747|11456932|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
7246329|NCT00253747|11456933|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
7246330|NCT00254163|11456969|FG000|Overall Study|Adverse Event|29
7246331|NCT00254163|11456970|FG001|Overall Study|Adverse Event|26
7246332|NCT00254163|11456969|FG000|Overall Study|Patient request/withdrew consent|6
7246333|NCT00254163|11456970|FG001|Overall Study|Patient request/withdrew consent|4
7246334|NCT00254163|11456969|FG000|Overall Study|Investigator request|1
7246335|NCT00254163|11456970|FG001|Overall Study|Investigator request|3
7246336|NCT00254163|11456969|FG000|Overall Study|Failed entry|1
7246337|NCT00254163|11456970|FG001|Overall Study|Failed entry|3
7246338|NCT00254163|11456969|FG000|Overall Study|Progressive disease|0
7246339|NCT00254163|11456970|FG001|Overall Study|Progressive disease|1
7246340|NCT00254163|11456969|FG000|Overall Study|Death|0
7246341|NCT00254163|11456970|FG001|Overall Study|Death|1
7246342|NCT00254163|11456969|FG000|Overall Study|Other|8
7246343|NCT00254163|11456970|FG001|Overall Study|Other|8
7246344|NCT00254293|11456982|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7246345|NCT00254293|11456983|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7246346|NCT00254293|11456984|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7246347|NCT00254293|11456985|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
7246348|NCT00254293|11456986|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7246349|NCT00254293|11456987|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7246350|NCT00254293|11456988|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
7246351|NCT00254293|11456982|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246352|NCT00254293|11456983|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246353|NCT00254293|11456984|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
7246354|NCT00254293|11456985|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246355|NCT00254293|11456986|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246356|NCT00254293|11456987|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246357|NCT00254293|11456988|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
7246358|NCT00254293|11456982|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246359|NCT00254293|11456983|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246360|NCT00254293|11456984|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
7246361|NCT00254293|11456985|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246362|NCT00254293|11456986|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246363|NCT00254293|11456987|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246364|NCT00254293|11456988|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
7246365|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Death|0
7246366|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Death|0
7246367|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Death|1
7246368|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Death|0
7246369|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Death|0
7246370|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Death|0
7246371|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Death|0
7246372|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
7246373|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
7246374|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
7246375|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
7246376|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
7246377|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
7246378|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
7246379|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7246380|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7246381|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
7246382|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7246383|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
7246384|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7246385|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
7246386|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246387|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246388|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
7246389|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246390|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246391|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246392|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
7246393|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246394|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246395|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
7246396|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246397|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246398|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246399|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
7246400|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246401|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246402|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
7246403|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246404|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246405|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246406|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
7246407|NCT00254293|11456982|FG000|LTE Open Label Variable SC Dosing|Other|0
7246408|NCT00254293|11456983|FG001|LTE Open Label Variable SC Dosing|Other|0
7246409|NCT00254293|11456984|FG002|LTE Open Label Variable SC Dosing|Other|2
7246410|NCT00254293|11456985|FG003|LTE Open Label Variable SC Dosing|Other|0
7246411|NCT00254293|11456986|FG004|LTE Open Label Variable SC Dosing|Other|0
7246412|NCT00254293|11456987|FG005|LTE Open Label Variable SC Dosing|Other|0
7246413|NCT00254293|11456988|FG006|LTE Open Label Variable SC Dosing|Other|0
7246414|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Death|0
7246415|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Death|0
7246416|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Death|0
7246417|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Death|0
7246418|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Death|0
7246419|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Death|0
7246420|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Death|3
7246421|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
7246422|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
7246423|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
7246424|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
7246425|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
7246426|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
7246427|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
7246428|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246429|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246430|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246431|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246432|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246433|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
7246434|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
7246435|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246436|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246437|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246438|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246439|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246440|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
7246441|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
7246442|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246443|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246444|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246445|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246446|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246447|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
7246448|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
7246449|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246450|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246451|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246452|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246453|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246454|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
7246455|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
7246456|NCT00254293|11456982|FG000|LTE Open Label Fixed Dosing|Other|0
7246457|NCT00254293|11456983|FG001|LTE Open Label Fixed Dosing|Other|0
7246458|NCT00254293|11456984|FG002|LTE Open Label Fixed Dosing|Other|0
7246459|NCT00254293|11456985|FG003|LTE Open Label Fixed Dosing|Other|0
7246460|NCT00254293|11456986|FG004|LTE Open Label Fixed Dosing|Other|0
7246461|NCT00254293|11456987|FG005|LTE Open Label Fixed Dosing|Other|0
7246462|NCT00254293|11456988|FG006|LTE Open Label Fixed Dosing|Other|1
7246463|NCT00254397|11457035|FG000|Overall Study|Disease Progression|4
7246464|NCT00254397|11457036|FG001|Overall Study|Disease Progression|1
7246465|NCT00254397|11457037|FG002|Overall Study|Disease Progression|16
7246466|NCT00254397|11457038|FG003|Overall Study|Disease Progression|23
7246467|NCT00254397|11457035|FG000|Overall Study|Non-Compliant|0
7246468|NCT00254397|11457036|FG001|Overall Study|Non-Compliant|0
7246469|NCT00254397|11457037|FG002|Overall Study|Non-Compliant|0
7246470|NCT00254397|11457038|FG003|Overall Study|Non-Compliant|1
7246471|NCT00254397|11457035|FG000|Overall Study|Adverse Event|2
7246472|NCT00254397|11457036|FG001|Overall Study|Adverse Event|0
7246473|NCT00254397|11457037|FG002|Overall Study|Adverse Event|3
7246474|NCT00254397|11457038|FG003|Overall Study|Adverse Event|1
7246475|NCT00254501|11457073|FG000|Overall Study|Lost to Follow-up|1
7574220|NCT03661983|11956624|FG003|Open Label Stabilization Phase|Adverse Event|0
7574221|NCT03661983|11956621|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
7574222|NCT03661983|11956622|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
7574223|NCT03661983|11956623|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
7574224|NCT03661983|11956624|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
7574225|NCT03661983|11956621|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
7574226|NCT03661983|11956622|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7246476|NCT00254501|11457074|FG001|Overall Study|Lost to Follow-up|1
7246477|NCT00254540|11457084|FG000|Overall Study|Adverse Event|6
7246478|NCT00254540|11457085|FG001|Overall Study|Adverse Event|7
7246479|NCT00254540|11457084|FG000|Overall Study|Lack of Efficacy|13
7246480|NCT00254540|11457085|FG001|Overall Study|Lack of Efficacy|13
7246481|NCT00254540|11457084|FG000|Overall Study|Death|0
7246482|NCT00254540|11457085|FG001|Overall Study|Death|1
7246483|NCT00254540|11457084|FG000|Overall Study|Laboratory Test Abnormality|0
7246484|NCT00254540|11457085|FG001|Overall Study|Laboratory Test Abnormality|1
7246485|NCT00254566|11457094|FG000|Overall Study|Death|1
7246486|NCT00254566|11457095|FG001|Overall Study|Death|0
7246487|NCT00254566|11457094|FG000|Overall Study|Adverse Event|5
7246488|NCT00254566|11457095|FG001|Overall Study|Adverse Event|4
7246489|NCT00254566|11457094|FG000|Overall Study|Lack of Efficacy|12
7246490|NCT00254566|11457095|FG001|Overall Study|Lack of Efficacy|9
7574227|NCT03661983|11956623|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7246491|NCT00254566|11457094|FG000|Overall Study|Other|1
7246492|NCT00254566|11457095|FG001|Overall Study|Other|5
7246493|NCT00254566|11457094|FG000|Overall Study|Withdrawal by Subject|5
7246494|NCT00254566|11457095|FG001|Overall Study|Withdrawal by Subject|6
7246495|NCT00254566|11457094|FG000|Overall Study|Lost to Follow-up|7
7246496|NCT00254566|11457095|FG001|Overall Study|Lost to Follow-up|2
7246497|NCT00254982|11457107|FG000|Overall Study|Other|2
7246498|NCT00254982|11457108|FG001|Overall Study|Other|1
7246499|NCT00254982|11457107|FG000|Overall Study|Lack of Efficacy|5
7246500|NCT00254982|11457108|FG001|Overall Study|Lack of Efficacy|3
7246501|NCT00254982|11457107|FG000|Overall Study|Lost to Follow-up|5
7246502|NCT00254982|11457108|FG001|Overall Study|Lost to Follow-up|3
7246503|NCT00254982|11457107|FG000|Overall Study|Adverse Event|18
7246504|NCT00254982|11457108|FG001|Overall Study|Adverse Event|16
7246505|NCT00254982|11457107|FG000|Overall Study|Withdrawal by Subject|1
7246506|NCT00254982|11457108|FG001|Overall Study|Withdrawal by Subject|1
7246507|NCT00254982|11457107|FG000|Overall Study|Inclusion/exclusion criteria violation|0
7246508|NCT00254982|11457108|FG001|Overall Study|Inclusion/exclusion criteria violation|2
7246509|NCT00254982|11457107|FG000|Overall Study|Protocol deviation|1
7246510|NCT00254982|11457108|FG001|Overall Study|Protocol deviation|1
7246511|NCT00254982|11457107|FG000|Overall Study|Diagnosis of Tuberculosis|1
7246512|NCT00254982|11457108|FG001|Overall Study|Diagnosis of Tuberculosis|1
7246513|NCT00254982|11457107|FG000|Overall Study|Malignancy|0
7246514|NCT00254982|11457108|FG001|Overall Study|Malignancy|2
7246515|NCT00254982|11457107|FG000|Overall Study|Opportunistic infection|1
7246516|NCT00254982|11457108|FG001|Overall Study|Opportunistic infection|0
7246517|NCT00254982|11457107|FG000|Overall Study|Abnormal liver function tests|2
7246518|NCT00254982|11457108|FG001|Overall Study|Abnormal liver function tests|1
7246519|NCT00255008|11457129|FG000|Overall Study|Adverse Event|1
7246520|NCT00255008|11457130|FG001|Overall Study|Adverse Event|1
7246521|NCT00255008|11457131|FG002|Overall Study|Adverse Event|2
7246522|NCT00255008|11457132|FG003|Overall Study|Adverse Event|0
7246523|NCT00255008|11457129|FG000|Overall Study|Lost to Follow-up|1
7246524|NCT00255008|11457130|FG001|Overall Study|Lost to Follow-up|0
7246525|NCT00255008|11457131|FG002|Overall Study|Lost to Follow-up|1
7574228|NCT03661983|11956624|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
7574229|NCT03661983|11956621|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
7574230|NCT03661983|11956622|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7574231|NCT03661983|11956623|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7574232|NCT03661983|11956624|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
7574233|NCT03661983|11956621|FG000|Double-blind Randomized Phase|Adverse Event|0
7574234|NCT03661983|11956622|FG001|Double-blind Randomized Phase|Adverse Event|1
7574235|NCT03661983|11956623|FG002|Double-blind Randomized Phase|Adverse Event|0
7574236|NCT03661983|11956624|FG003|Double-blind Randomized Phase|Adverse Event|0
7574237|NCT03661983|11956621|FG000|Double-blind Randomized Phase|Disease Relapse|0
7574238|NCT03661983|11956622|FG001|Double-blind Randomized Phase|Disease Relapse|0
7574239|NCT03661983|11956623|FG002|Double-blind Randomized Phase|Disease Relapse|0
7574240|NCT03661983|11956624|FG003|Double-blind Randomized Phase|Disease Relapse|6
7574241|NCT03661983|11956621|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7574242|NCT03661983|11956622|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7574243|NCT03661983|11956623|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
7574244|NCT03661983|11956624|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
7574245|NCT03661983|11956621|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
7574246|NCT03661983|11956622|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7574247|NCT03661983|11956623|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7574248|NCT03661983|11956624|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
7574249|NCT03662334|11956654|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
7574250|NCT03662334|11956655|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
7574251|NCT03662750|11956671|FG000|Overall Study|Withdrawal by Subject|1
7574252|NCT03662789|11956677|FG000|Overall Study|Lost to Follow-up|1
7574253|NCT03662789|11956678|FG001|Overall Study|Lost to Follow-up|2
7574254|NCT03662789|11956677|FG000|Overall Study|Could not perform treadmill test|4
7574255|NCT03662789|11956678|FG001|Overall Study|Could not perform treadmill test|4
7574256|NCT03662789|11956677|FG000|Overall Study|Death|0
7574257|NCT03662789|11956678|FG001|Overall Study|Death|1
7574258|NCT03662997|11956688|FG000|Overall Study|Adverse Event|0
7574259|NCT03662997|11956689|FG001|Overall Study|Adverse Event|2
7574260|NCT03662997|11956690|FG002|Overall Study|Adverse Event|0
7574261|NCT03662997|11956691|FG003|Overall Study|Adverse Event|0
7574268|NCT03663569|11956747|FG000|Overall Study|Discontinuation of study|11
7574269|NCT03663569|11956747|FG000|Overall Study|Never taken Spiolto® Respimat®|1
7574270|NCT03663569|11956747|FG000|Overall Study|Deceased patient|6
7574271|NCT03663569|11956747|FG000|Overall Study|Lost to Follow-up|18
7574272|NCT03663569|11956747|FG000|Overall Study|Withdrawal of consent|5
7574273|NCT03663569|11956747|FG000|Overall Study|Patient's request|11
7574274|NCT03663569|11956747|FG000|Overall Study|Adverse Event|4
7574275|NCT03663569|11956747|FG000|Overall Study|Not come to second visit|3
7574276|NCT03663569|11956747|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
7574277|NCT03663569|11956747|FG000|Overall Study|Serious adverse event|1
7574278|NCT03663582|11956751|FG000|Overall Study|Physician Decision|1
7574279|NCT03666858|11956817|FG000|Cohort 1|Adverse Event|1
7246526|NCT00255008|11457132|FG003|Overall Study|Lost to Follow-up|2
7246527|NCT00255008|11457129|FG000|Overall Study|Did not meet viral reduction criteria|4
7246528|NCT00255008|11457130|FG001|Overall Study|Did not meet viral reduction criteria|5
7246529|NCT00255008|11457131|FG002|Overall Study|Did not meet viral reduction criteria|0
7246530|NCT00255008|11457132|FG003|Overall Study|Did not meet viral reduction criteria|1
7246531|NCT00255008|11457129|FG000|Overall Study|Withdrew consent|0
7574280|NCT03666858|11956818|FG001|Cohort 1|Adverse Event|0
7574281|NCT03666858|11956817|FG000|Cohort 2|Adverse Event|0
7574282|NCT03666858|11956818|FG001|Cohort 2|Adverse Event|1
7574283|NCT03667053|11956827|FG000|Overall Study|Withdrawal by Subject|1
7574284|NCT03667053|11956828|FG001|Overall Study|Withdrawal by Subject|0
7574285|NCT03667053|11956829|FG002|Overall Study|Withdrawal by Subject|0
7574286|NCT03668600|11956848|FG000|Overall Study|Study Terminated by the Sponsor|157
7574287|NCT03668600|11956848|FG000|Overall Study|Protocol Violation|1
7574288|NCT03668600|11956848|FG000|Overall Study|Pregnancy|1
7574289|NCT03668600|11956848|FG000|Overall Study|Lost to Follow-up|7
7574290|NCT03668600|11956848|FG000|Overall Study|Withdrawal by Subject|56
7574291|NCT03668600|11956848|FG000|Overall Study|Lack of Efficacy|7
7574292|NCT03668600|11956848|FG000|Overall Study|Adverse Event|1
7574293|NCT03668613|11956854|FG000|Overall Study|Adverse Event|0
7574294|NCT03668613|11956855|FG001|Overall Study|Adverse Event|2
7574295|NCT03668613|11956854|FG000|Overall Study|Lack of Efficacy|0
7574296|NCT03668613|11956855|FG001|Overall Study|Lack of Efficacy|1
7574297|NCT03669081|11956864|FG000|Overall Study|Data could not be validated|1
7574298|NCT03669081|11956865|FG001|Overall Study|Data could not be validated|1
7574299|NCT03669549|11956889|FG000|Overall Study|Adverse Event|4
7246532|NCT00255008|11457130|FG001|Overall Study|Withdrew consent|0
7246533|NCT00255008|11457131|FG002|Overall Study|Withdrew consent|2
7246534|NCT00255008|11457132|FG003|Overall Study|Withdrew consent|0
7246535|NCT00255008|11457129|FG000|Overall Study|Sponsor request|18
7246536|NCT00255008|11457130|FG001|Overall Study|Sponsor request|3
7246537|NCT00255008|11457131|FG002|Overall Study|Sponsor request|8
7246538|NCT00255008|11457132|FG003|Overall Study|Sponsor request|17
7246539|NCT00255008|11457129|FG000|Overall Study|Adverse lab experience|1
7246540|NCT00255008|11457130|FG001|Overall Study|Adverse lab experience|0
7246541|NCT00255008|11457131|FG002|Overall Study|Adverse lab experience|0
7246542|NCT00255008|11457132|FG003|Overall Study|Adverse lab experience|0
7246543|NCT00255008|11457129|FG000|Overall Study|Other|7
7246544|NCT00255008|11457130|FG001|Overall Study|Other|0
7246545|NCT00255008|11457131|FG002|Overall Study|Other|3
7574300|NCT03669549|11956889|FG000|Overall Study|Withdrawal by Subject|1
7246546|NCT00255008|11457132|FG003|Overall Study|Other|2
7246547|NCT00255034|11457144|FG000|Overall Study|Withdrawal by Subject|15
7246548|NCT00255034|11457145|FG001|Overall Study|Withdrawal by Subject|38
7246549|NCT00255047|11457155|FG000|Overall Study|Serious Adverse Events|2
7246550|NCT00255047|11457156|FG001|Overall Study|Serious Adverse Events|1
7246551|NCT00255047|11457157|FG002|Overall Study|Serious Adverse Events|2
7246552|NCT00255047|11457158|FG003|Overall Study|Serious Adverse Events|1
7246553|NCT00255047|11457155|FG000|Overall Study|Adverse Event|0
7246554|NCT00255047|11457156|FG001|Overall Study|Adverse Event|3
7246555|NCT00255047|11457157|FG002|Overall Study|Adverse Event|2
7246556|NCT00255047|11457158|FG003|Overall Study|Adverse Event|1
7246557|NCT00255047|11457155|FG000|Overall Study|Protocol Violation|13
7246558|NCT00255047|11457156|FG001|Overall Study|Protocol Violation|13
7246559|NCT00255047|11457157|FG002|Overall Study|Protocol Violation|16
7246560|NCT00255047|11457158|FG003|Overall Study|Protocol Violation|20
7246561|NCT00255047|11457155|FG000|Overall Study|Lost to Follow-up|9
7246562|NCT00255047|11457156|FG001|Overall Study|Lost to Follow-up|8
7246563|NCT00255047|11457157|FG002|Overall Study|Lost to Follow-up|5
7246564|NCT00255047|11457158|FG003|Overall Study|Lost to Follow-up|6
7246565|NCT00255047|11457155|FG000|Overall Study|Withdrawal by Subject|24
7246566|NCT00255047|11457156|FG001|Overall Study|Withdrawal by Subject|23
7246567|NCT00255047|11457157|FG002|Overall Study|Withdrawal by Subject|25
7246568|NCT00255047|11457158|FG003|Overall Study|Withdrawal by Subject|18
7246569|NCT00255086|11457170|FG000|Overall Study|Adverse Event|1
7574301|NCT03669549|11956889|FG000|Overall Study|Study terminated by the Sponsor|1
7574302|NCT03669861|11956897|FG000|Overall Study|Disease Flare|5
7574303|NCT03669861|11956897|FG000|Overall Study|Lack of Efficacy|2
7574304|NCT03670537|11956931|FG000|Overall Study|Protocol Violation|1
7574305|NCT03670641|11956935|FG000|Overall Study|Lost to Follow-up|3
7246570|NCT00255086|11457171|FG001|Overall Study|Adverse Event|1
7246571|NCT00255086|11457170|FG000|Overall Study|Protocol Violation|1
7246572|NCT00255086|11457171|FG001|Overall Study|Protocol Violation|1
7246573|NCT00255151|11457192|FG000|Overall Study|Adverse Event|10
7246574|NCT00255151|11457193|FG001|Overall Study|Adverse Event|6
7246575|NCT00255151|11457194|FG002|Overall Study|Adverse Event|9
7246576|NCT00255151|11457192|FG000|Overall Study|Lost to Follow-up|4
7246577|NCT00255151|11457193|FG001|Overall Study|Lost to Follow-up|3
7246578|NCT00255151|11457194|FG002|Overall Study|Lost to Follow-up|4
7246579|NCT00255151|11457192|FG000|Overall Study|Withdrawal by Subject|18
7246580|NCT00255151|11457193|FG001|Overall Study|Withdrawal by Subject|17
7246581|NCT00255151|11457194|FG002|Overall Study|Withdrawal by Subject|8
7246582|NCT00255151|11457192|FG000|Overall Study|Noncompliance|0
7246583|NCT00255151|11457193|FG001|Overall Study|Noncompliance|1
7246584|NCT00255151|11457194|FG002|Overall Study|Noncompliance|2
7246585|NCT00255151|11457192|FG000|Overall Study|Subject Request/Subject Unavailable|1
7246586|NCT00255151|11457193|FG001|Overall Study|Subject Request/Subject Unavailable|1
7246587|NCT00255151|11457194|FG002|Overall Study|Subject Request/Subject Unavailable|2
7246588|NCT00255151|11457192|FG000|Overall Study|Relapse of Erosive Esophagitis|78
7246589|NCT00255151|11457193|FG001|Overall Study|Relapse of Erosive Esophagitis|16
7246590|NCT00255151|11457194|FG002|Overall Study|Relapse of Erosive Esophagitis|12
7246591|NCT00255151|11457192|FG000|Overall Study|Possible Barrett's Esophagus|1
7246592|NCT00255151|11457193|FG001|Overall Study|Possible Barrett's Esophagus|3
7246593|NCT00255151|11457194|FG002|Overall Study|Possible Barrett's Esophagus|8
7246594|NCT00255151|11457192|FG000|Overall Study|Esophageal Stricture|0
7246595|NCT00255151|11457193|FG001|Overall Study|Esophageal Stricture|0
7246596|NCT00255151|11457194|FG002|Overall Study|Esophageal Stricture|1
7246597|NCT00255151|11457192|FG000|Overall Study|Therapeutic Failure|11
7246598|NCT00255151|11457193|FG001|Overall Study|Therapeutic Failure|2
7246599|NCT00255151|11457194|FG002|Overall Study|Therapeutic Failure|3
7246600|NCT00255164|11457205|FG000|Overall Study|Adverse Event|10
7246601|NCT00255164|11457206|FG001|Overall Study|Adverse Event|6
7246602|NCT00255164|11457207|FG002|Overall Study|Adverse Event|9
7246603|NCT00255164|11457205|FG000|Overall Study|Lost to Follow-up|4
7246604|NCT00255164|11457206|FG001|Overall Study|Lost to Follow-up|3
7246605|NCT00255164|11457207|FG002|Overall Study|Lost to Follow-up|4
7246606|NCT00255164|11457205|FG000|Overall Study|Withdrawal by Subject|18
7246607|NCT00255164|11457206|FG001|Overall Study|Withdrawal by Subject|17
7246608|NCT00255164|11457207|FG002|Overall Study|Withdrawal by Subject|8
7246609|NCT00255164|11457205|FG000|Overall Study|Noncompliance|0
7246610|NCT00255164|11457206|FG001|Overall Study|Noncompliance|1
7246611|NCT00255164|11457207|FG002|Overall Study|Noncompliance|2
7246612|NCT00255164|11457205|FG000|Overall Study|Subject Request/Subject Unavailable|1
7246613|NCT00255164|11457206|FG001|Overall Study|Subject Request/Subject Unavailable|1
7246614|NCT00255164|11457207|FG002|Overall Study|Subject Request/Subject Unavailable|2
7246615|NCT00255164|11457205|FG000|Overall Study|Relapse of Erosive Esophagitis|78
7246616|NCT00255164|11457206|FG001|Overall Study|Relapse of Erosive Esophagitis|16
7246617|NCT00255164|11457207|FG002|Overall Study|Relapse of Erosive Esophagitis|12
7246618|NCT00255164|11457205|FG000|Overall Study|Possible Barrett's Esophagus|1
7246619|NCT00255164|11457206|FG001|Overall Study|Possible Barrett's Esophagus|3
7246620|NCT00255164|11457207|FG002|Overall Study|Possible Barrett's Esophagus|8
7246621|NCT00255164|11457205|FG000|Overall Study|Esophageal Stricture|0
7246622|NCT00255164|11457206|FG001|Overall Study|Esophageal Stricture|0
7246623|NCT00255164|11457207|FG002|Overall Study|Esophageal Stricture|1
7246624|NCT00255164|11457205|FG000|Overall Study|Therapeutic Failure|11
7246625|NCT00255164|11457206|FG001|Overall Study|Therapeutic Failure|2
7246626|NCT00255164|11457207|FG002|Overall Study|Therapeutic Failure|3
7246627|NCT00255190|11457234|FG000|Overall Study|Adverse Event|17
7246628|NCT00255190|11457235|FG001|Overall Study|Adverse Event|36
7246629|NCT00255190|11457234|FG000|Overall Study|Protocol Violation|2
7246630|NCT00255190|11457235|FG001|Overall Study|Protocol Violation|2
7246631|NCT00255190|11457234|FG000|Overall Study|Lost to Follow-up|10
7246632|NCT00255190|11457235|FG001|Overall Study|Lost to Follow-up|27
7246633|NCT00255190|11457234|FG000|Overall Study|Withdrew Consent|17
7246634|NCT00255190|11457235|FG001|Overall Study|Withdrew Consent|48
7246635|NCT00255190|11457234|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
7246636|NCT00255190|11457235|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
7246637|NCT00255190|11457234|FG000|Overall Study|Erosive esophagitis not healed|0
7246638|NCT00255190|11457235|FG001|Overall Study|Erosive esophagitis not healed|20
7246639|NCT00255190|11457234|FG000|Overall Study|Various|4
7246640|NCT00255190|11457235|FG001|Overall Study|Various|23
7246641|NCT00255346|11457246|FG000|Overall Study|Adverse Event|1
7246642|NCT00255346|11457247|FG001|Overall Study|Adverse Event|0
7246643|NCT00255346|11457248|FG002|Overall Study|Adverse Event|0
7246644|NCT00255346|11457249|FG003|Overall Study|Adverse Event|0
7246645|NCT00255346|11457250|FG004|Overall Study|Adverse Event|0
7246646|NCT00255723|11457264|FG000|Overall Study|Adverse Event|1
7246647|NCT00255723|11457265|FG001|Overall Study|Adverse Event|1
7246648|NCT00255723|11457264|FG000|Overall Study|Death|0
7246649|NCT00255723|11457265|FG001|Overall Study|Death|1
7246650|NCT00255723|11457264|FG000|Overall Study|Response Data Not Available|1
7246651|NCT00255723|11457265|FG001|Overall Study|Response Data Not Available|0
7246652|NCT00255840|11457277|FG000|Overall Study|Lost to Follow-up|10
7246653|NCT00255840|11457278|FG001|Overall Study|Lost to Follow-up|14
7246654|NCT00255840|11457277|FG000|Overall Study|Discontinued intervention|53
7246655|NCT00255840|11457278|FG001|Overall Study|Discontinued intervention|56
7246656|NCT00255944|11457286|FG000|Overall Study|Lost to Follow-up|797
7246657|NCT00255944|11457287|FG001|Overall Study|Lost to Follow-up|834
7246658|NCT00256126|11457304|FG000|Overall Study|Adverse Event|1
7246659|NCT00256126|11457305|FG001|Overall Study|Adverse Event|0
7246660|NCT00256126|11457304|FG000|Overall Study|Other|1
7246661|NCT00256126|11457305|FG001|Overall Study|Other|2
7246662|NCT00256204|11457315|FG000|Overall Study|Adverse Event|10
7246663|NCT00256204|11457316|FG001|Overall Study|Adverse Event|14
7246664|NCT00256204|11457317|FG002|Overall Study|Adverse Event|16
7246665|NCT00256204|11457318|FG003|Overall Study|Adverse Event|14
7246666|NCT00256204|11457315|FG000|Overall Study|Death|0
7246667|NCT00256204|11457316|FG001|Overall Study|Death|1
7246668|NCT00256204|11457317|FG002|Overall Study|Death|0
7246669|NCT00256204|11457318|FG003|Overall Study|Death|0
7246670|NCT00256204|11457315|FG000|Overall Study|Lost to Follow-up|1
7246671|NCT00256204|11457316|FG001|Overall Study|Lost to Follow-up|1
7246672|NCT00256204|11457317|FG002|Overall Study|Lost to Follow-up|1
7246673|NCT00256204|11457318|FG003|Overall Study|Lost to Follow-up|2
7246674|NCT00256204|11457315|FG000|Overall Study|Protocol Violation|1
7246675|NCT00256204|11457316|FG001|Overall Study|Protocol Violation|0
7246676|NCT00256204|11457317|FG002|Overall Study|Protocol Violation|2
7246677|NCT00256204|11457318|FG003|Overall Study|Protocol Violation|1
7246678|NCT00256204|11457315|FG000|Overall Study|Physician Decision|0
7246679|NCT00256204|11457316|FG001|Overall Study|Physician Decision|0
7246680|NCT00256204|11457317|FG002|Overall Study|Physician Decision|1
7246681|NCT00256204|11457318|FG003|Overall Study|Physician Decision|2
7246682|NCT00256204|11457315|FG000|Overall Study|Withdrawal by Subject|17
7246683|NCT00256204|11457316|FG001|Overall Study|Withdrawal by Subject|6
7246684|NCT00256204|11457317|FG002|Overall Study|Withdrawal by Subject|7
7246685|NCT00256204|11457318|FG003|Overall Study|Withdrawal by Subject|5
7246686|NCT00256204|11457315|FG000|Overall Study|Need for additional prohibited treatment|38
7246687|NCT00256204|11457316|FG001|Overall Study|Need for additional prohibited treatment|28
7246688|NCT00256204|11457317|FG002|Overall Study|Need for additional prohibited treatment|27
7246689|NCT00256204|11457318|FG003|Overall Study|Need for additional prohibited treatment|25
7246690|NCT00256243|11457335|FG000|Overall Study|Lost to Follow-up|2
7246691|NCT00256243|11457335|FG000|Overall Study|Death|7
7246692|NCT00256243|11457335|FG000|Overall Study|Not treated|1
7246693|NCT00256282|11457340|FG000|Overall Study|Disease progression, relapse during acti|12
7246694|NCT00256282|11457340|FG000|Overall Study|Adverse Event|3
7246695|NCT00256282|11457340|FG000|Overall Study|Physician Decision|1
7246696|NCT00256308|11457344|FG000|Overall Study|Death|2
7246697|NCT00256698|11457363|FG000|Overall Study|Withdrawal by Subject|7
7246698|NCT00256698|11457364|FG001|Overall Study|Withdrawal by Subject|7
7246699|NCT00256698|11457363|FG000|Overall Study|Adverse Event|13
7246700|NCT00256698|11457364|FG001|Overall Study|Adverse Event|6
7246701|NCT00256698|11457363|FG000|Overall Study|Protocol Violation|6
7246702|NCT00256698|11457364|FG001|Overall Study|Protocol Violation|5
7246703|NCT00256698|11457363|FG000|Overall Study|Lost to Follow-up|1
7246704|NCT00256698|11457364|FG001|Overall Study|Lost to Follow-up|3
7246705|NCT00256698|11457363|FG000|Overall Study|disease progression|97
7246706|NCT00256698|11457364|FG001|Overall Study|disease progression|105
7246707|NCT00256698|11457363|FG000|Overall Study|still ongoing at data cut-off|41
7246708|NCT00256698|11457364|FG001|Overall Study|still ongoing at data cut-off|46
7246709|NCT00256698|11457363|FG000|Overall Study|withdrawn due to osteoporosis|1
7246710|NCT00256698|11457364|FG001|Overall Study|withdrawn due to osteoporosis|0
7246711|NCT00256698|11457363|FG000|Overall Study|Prematurely Discontinued|1
7246712|NCT00256698|11457364|FG001|Overall Study|Prematurely Discontinued|0
7246713|NCT00256724|11457372|FG000|Overall Study|Physician Decision|2
7246714|NCT00256724|11457373|FG001|Overall Study|Physician Decision|5
7246715|NCT00256724|11457372|FG000|Overall Study|Protocol Violation|3
7246716|NCT00256724|11457373|FG001|Overall Study|Protocol Violation|3
7246717|NCT00256750|11457382|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
7246718|NCT00256750|11457383|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
7246719|NCT00256750|11457384|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
7246720|NCT00256750|11457382|FG000|Transplanted Pre-Treatment|Other|2
7246721|NCT00256750|11457383|FG001|Transplanted Pre-Treatment|Other|0
7246722|NCT00256750|11457384|FG002|Transplanted Pre-Treatment|Other|0
7246723|NCT00256750|11457382|FG000|Transplanted Pre-Treatment|Death|1
7246724|NCT00256750|11457383|FG001|Transplanted Pre-Treatment|Death|0
7246725|NCT00256750|11457384|FG002|Transplanted Pre-Treatment|Death|0
7246726|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
7246727|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
7246728|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
7246729|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Death|3
7246730|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Death|2
7246731|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Death|4
7246732|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
7246733|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
7246734|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
7246735|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
7246736|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7246737|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
7246738|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Other|5
7246739|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Other|4
7246740|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Other|2
7246741|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
7246742|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
7246743|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
7246744|NCT00256750|11457382|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
7246745|NCT00256750|11457383|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
7246746|NCT00256750|11457384|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
7246747|NCT00256750|11457382|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
7246748|NCT00256750|11457383|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
7246749|NCT00256750|11457384|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
7246750|NCT00256750|11457382|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
7246751|NCT00256750|11457383|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
7246752|NCT00256750|11457384|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
7246753|NCT00256750|11457382|FG000|Post-Transplant Treated (24 Months)|Death|3
7246754|NCT00256750|11457383|FG001|Post-Transplant Treated (24 Months)|Death|0
7246755|NCT00256750|11457384|FG002|Post-Transplant Treated (24 Months)|Death|0
7246756|NCT00256750|11457382|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
7246757|NCT00256750|11457383|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
7246758|NCT00256750|11457384|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
7246759|NCT00256750|11457382|FG000|Post-Transplant Treated (24 Months)|Other|2
7246760|NCT00256750|11457383|FG001|Post-Transplant Treated (24 Months)|Other|0
7246761|NCT00256750|11457384|FG002|Post-Transplant Treated (24 Months)|Other|1
7246762|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
7246763|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
7246764|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
7246765|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7246766|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
7246767|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
7246768|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Death|0
7246769|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Death|2
7246770|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Death|1
7246771|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7246772|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
7246773|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
7246774|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
7246775|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
7246776|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
7246777|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
7246778|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
7246779|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
7246780|NCT00256750|11457382|FG000|Post-Transplant Treated (36 Months)|Other|0
7246781|NCT00256750|11457383|FG001|Post-Transplant Treated (36 Months)|Other|1
7246782|NCT00256750|11457384|FG002|Post-Transplant Treated (36 Months)|Other|1
7246783|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
7246784|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
7246785|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
7246786|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
7246787|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
7246788|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
7246789|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
7246790|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7246791|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
7246792|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Death|9
7246793|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Death|4
7246794|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Death|4
7246795|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
7246796|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
7246797|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
7246798|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
7246799|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7246800|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
7246801|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
7246802|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
7246803|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
7246804|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7246805|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
7246806|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
7246807|NCT00256750|11457382|FG000|Long Term Extension (LTE; 84 Months)|Other|5
7246808|NCT00256750|11457383|FG001|Long Term Extension (LTE; 84 Months)|Other|4
7246809|NCT00256750|11457384|FG002|Long Term Extension (LTE; 84 Months)|Other|5
7256277|NCT00321932|11467709|FG000|Overall Study|Death|3
7256278|NCT00321932|11467710|FG001|Overall Study|Death|6
7256279|NCT00321932|11467709|FG000|Overall Study|Withdrawal by Subject|3
7256280|NCT00321932|11467710|FG001|Overall Study|Withdrawal by Subject|6
7256281|NCT00321932|11467709|FG000|Overall Study|Early relapse|2
7256282|NCT00321932|11467710|FG001|Overall Study|Early relapse|8
7256283|NCT00321932|11467709|FG000|Overall Study|Missing data|2
7256284|NCT00321932|11467710|FG001|Overall Study|Missing data|1
7256285|NCT00321984|11467729|FG000|Overall Study|Adverse Event|9
7256286|NCT00321984|11467730|FG001|Overall Study|Adverse Event|6
7256287|NCT00321984|11467731|FG002|Overall Study|Adverse Event|8
7256288|NCT00321984|11467729|FG000|Overall Study|Protocol Violation|0
7256289|NCT00321984|11467730|FG001|Overall Study|Protocol Violation|1
7256290|NCT00321984|11467731|FG002|Overall Study|Protocol Violation|1
7256291|NCT00321984|11467729|FG000|Overall Study|Lost to Follow-up|2
7256292|NCT00321984|11467730|FG001|Overall Study|Lost to Follow-up|4
7256293|NCT00321984|11467731|FG002|Overall Study|Lost to Follow-up|2
7256294|NCT00321984|11467729|FG000|Overall Study|Withdrawal by Subject|8
7256295|NCT00321984|11467730|FG001|Overall Study|Withdrawal by Subject|6
7256296|NCT00321984|11467731|FG002|Overall Study|Withdrawal by Subject|5
7256297|NCT00321984|11467729|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
7256298|NCT00321984|11467730|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
7256299|NCT00321984|11467731|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
7256300|NCT00321984|11467729|FG000|Overall Study|Lack of Efficacy|3
7256301|NCT00321984|11467730|FG001|Overall Study|Lack of Efficacy|1
7256302|NCT00321984|11467731|FG002|Overall Study|Lack of Efficacy|3
7256303|NCT00321984|11467729|FG000|Overall Study|Noncompliant|0
7256304|NCT00321984|11467730|FG001|Overall Study|Noncompliant|0
7256305|NCT00321984|11467731|FG002|Overall Study|Noncompliant|2
7246810|NCT00256854|11457410|FG000|Overall Study|Withdrawal by Subject|2
7246811|NCT00256854|11457411|FG001|Overall Study|Withdrawal by Subject|3
7246812|NCT00256854|11457412|FG002|Overall Study|Withdrawal by Subject|0
7246813|NCT00256854|11457413|FG003|Overall Study|Withdrawal by Subject|0
7246814|NCT00256854|11457414|FG004|Overall Study|Withdrawal by Subject|0
7246815|NCT00256854|11457415|FG005|Overall Study|Withdrawal by Subject|0
7246816|NCT00256854|11457410|FG000|Overall Study|Lack of Efficacy|1
7246817|NCT00256854|11457411|FG001|Overall Study|Lack of Efficacy|0
7246818|NCT00256854|11457412|FG002|Overall Study|Lack of Efficacy|0
7246819|NCT00256854|11457413|FG003|Overall Study|Lack of Efficacy|0
7246820|NCT00256854|11457414|FG004|Overall Study|Lack of Efficacy|0
7246821|NCT00256854|11457415|FG005|Overall Study|Lack of Efficacy|0
7246822|NCT00256854|11457410|FG000|Overall Study|Protocol Violation|0
7246823|NCT00256854|11457411|FG001|Overall Study|Protocol Violation|1
7246824|NCT00256854|11457412|FG002|Overall Study|Protocol Violation|1
7246825|NCT00256854|11457413|FG003|Overall Study|Protocol Violation|1
7246826|NCT00256854|11457414|FG004|Overall Study|Protocol Violation|0
7246827|NCT00256854|11457415|FG005|Overall Study|Protocol Violation|0
7246828|NCT00256854|11457410|FG000|Overall Study|Adverse Event|0
7246829|NCT00256854|11457411|FG001|Overall Study|Adverse Event|0
7246830|NCT00256854|11457412|FG002|Overall Study|Adverse Event|2
7246831|NCT00256854|11457413|FG003|Overall Study|Adverse Event|2
7246832|NCT00256854|11457414|FG004|Overall Study|Adverse Event|0
7246833|NCT00256854|11457415|FG005|Overall Study|Adverse Event|1
7246834|NCT00256854|11457410|FG000|Overall Study|Not compliant with the study drug|0
7246835|NCT00256854|11457411|FG001|Overall Study|Not compliant with the study drug|0
7246836|NCT00256854|11457412|FG002|Overall Study|Not compliant with the study drug|0
7246837|NCT00256854|11457413|FG003|Overall Study|Not compliant with the study drug|0
7246838|NCT00256854|11457414|FG004|Overall Study|Not compliant with the study drug|1
7246839|NCT00256854|11457415|FG005|Overall Study|Not compliant with the study drug|0
7246840|NCT00256867|11457438|FG000|Overall Study|Adverse Event|0
7246841|NCT00256867|11457439|FG001|Overall Study|Adverse Event|1
7246842|NCT00256867|11457440|FG002|Overall Study|Adverse Event|1
7246843|NCT00256867|11457441|FG003|Overall Study|Adverse Event|1
7246844|NCT00256867|11457442|FG004|Overall Study|Adverse Event|2
7246845|NCT00256867|11457443|FG005|Overall Study|Adverse Event|2
7246846|NCT00256867|11457444|FG006|Overall Study|Adverse Event|1
7246847|NCT00256867|11457445|FG007|Overall Study|Adverse Event|4
7246848|NCT00256867|11457438|FG000|Overall Study|Lost to Follow-up|2
7246849|NCT00256867|11457439|FG001|Overall Study|Lost to Follow-up|2
7246850|NCT00256867|11457440|FG002|Overall Study|Lost to Follow-up|2
7246851|NCT00256867|11457441|FG003|Overall Study|Lost to Follow-up|3
7246852|NCT00256867|11457442|FG004|Overall Study|Lost to Follow-up|2
7246853|NCT00256867|11457443|FG005|Overall Study|Lost to Follow-up|0
7246854|NCT00256867|11457444|FG006|Overall Study|Lost to Follow-up|1
7246855|NCT00256867|11457445|FG007|Overall Study|Lost to Follow-up|2
7246856|NCT00256867|11457438|FG000|Overall Study|Protocol Violation|0
7246857|NCT00256867|11457439|FG001|Overall Study|Protocol Violation|0
7246858|NCT00256867|11457440|FG002|Overall Study|Protocol Violation|0
7246859|NCT00256867|11457441|FG003|Overall Study|Protocol Violation|1
7246860|NCT00256867|11457442|FG004|Overall Study|Protocol Violation|0
7246861|NCT00256867|11457443|FG005|Overall Study|Protocol Violation|1
7246862|NCT00256867|11457444|FG006|Overall Study|Protocol Violation|0
7246863|NCT00256867|11457445|FG007|Overall Study|Protocol Violation|1
7246864|NCT00256867|11457438|FG000|Overall Study|Withdrawal by Subject|0
7246865|NCT00256867|11457439|FG001|Overall Study|Withdrawal by Subject|0
7246866|NCT00256867|11457440|FG002|Overall Study|Withdrawal by Subject|1
7246867|NCT00256867|11457441|FG003|Overall Study|Withdrawal by Subject|1
7246868|NCT00256867|11457442|FG004|Overall Study|Withdrawal by Subject|2
7246869|NCT00256867|11457443|FG005|Overall Study|Withdrawal by Subject|2
7246870|NCT00256867|11457444|FG006|Overall Study|Withdrawal by Subject|3
7246871|NCT00256867|11457445|FG007|Overall Study|Withdrawal by Subject|2
7246872|NCT00256867|11457438|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246873|NCT00256867|11457439|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
7246874|NCT00256867|11457440|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246875|NCT00256867|11457441|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246876|NCT00256867|11457442|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246877|NCT00256867|11457443|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246878|NCT00256867|11457444|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246879|NCT00256867|11457445|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
7246880|NCT00256867|11457438|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
7246881|NCT00256867|11457439|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
7246882|NCT00256867|11457440|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
7246883|NCT00256867|11457441|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
7246884|NCT00256867|11457442|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
7246885|NCT00256867|11457443|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
7246886|NCT00256867|11457444|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
7246887|NCT00256867|11457445|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
7246888|NCT00256867|11457438|FG000|Overall Study|Investigator's Decision|0
7246889|NCT00256867|11457439|FG001|Overall Study|Investigator's Decision|0
7246890|NCT00256867|11457440|FG002|Overall Study|Investigator's Decision|0
7246891|NCT00256867|11457441|FG003|Overall Study|Investigator's Decision|0
7246892|NCT00256867|11457442|FG004|Overall Study|Investigator's Decision|1
7246893|NCT00256867|11457443|FG005|Overall Study|Investigator's Decision|0
7246894|NCT00256867|11457444|FG006|Overall Study|Investigator's Decision|0
7246895|NCT00256867|11457445|FG007|Overall Study|Investigator's Decision|0
7246896|NCT00256867|11457438|FG000|Overall Study|Non-compliance with study medication|0
7246897|NCT00256867|11457439|FG001|Overall Study|Non-compliance with study medication|0
7246898|NCT00256867|11457440|FG002|Overall Study|Non-compliance with study medication|0
7246899|NCT00256867|11457441|FG003|Overall Study|Non-compliance with study medication|0
7246900|NCT00256867|11457442|FG004|Overall Study|Non-compliance with study medication|0
7246901|NCT00256867|11457443|FG005|Overall Study|Non-compliance with study medication|0
7246902|NCT00256867|11457444|FG006|Overall Study|Non-compliance with study medication|0
7246903|NCT00256867|11457445|FG007|Overall Study|Non-compliance with study medication|1
7246904|NCT00256867|11457438|FG000|Overall Study|Participant travelled Overseas|0
7246905|NCT00256867|11457439|FG001|Overall Study|Participant travelled Overseas|1
7246906|NCT00256867|11457440|FG002|Overall Study|Participant travelled Overseas|0
7246907|NCT00256867|11457441|FG003|Overall Study|Participant travelled Overseas|0
7246908|NCT00256867|11457442|FG004|Overall Study|Participant travelled Overseas|0
7246909|NCT00256867|11457443|FG005|Overall Study|Participant travelled Overseas|0
7246910|NCT00256867|11457444|FG006|Overall Study|Participant travelled Overseas|0
7246911|NCT00256867|11457445|FG007|Overall Study|Participant travelled Overseas|0
7246912|NCT00256867|11457438|FG000|Overall Study|Participant out of assessment window|0
7246913|NCT00256867|11457439|FG001|Overall Study|Participant out of assessment window|0
7246914|NCT00256867|11457440|FG002|Overall Study|Participant out of assessment window|1
7246915|NCT00256867|11457441|FG003|Overall Study|Participant out of assessment window|0
7246916|NCT00256867|11457442|FG004|Overall Study|Participant out of assessment window|0
7246917|NCT00256867|11457443|FG005|Overall Study|Participant out of assessment window|0
7246918|NCT00256867|11457444|FG006|Overall Study|Participant out of assessment window|0
7246919|NCT00256867|11457445|FG007|Overall Study|Participant out of assessment window|0
7246920|NCT00256867|11457438|FG000|Overall Study|Withdrawal by participant|0
7246921|NCT00256867|11457439|FG001|Overall Study|Withdrawal by participant|0
7246922|NCT00256867|11457440|FG002|Overall Study|Withdrawal by participant|0
7246923|NCT00256867|11457441|FG003|Overall Study|Withdrawal by participant|0
7246924|NCT00256867|11457442|FG004|Overall Study|Withdrawal by participant|0
7246925|NCT00256867|11457443|FG005|Overall Study|Withdrawal by participant|1
7246926|NCT00256867|11457444|FG006|Overall Study|Withdrawal by participant|0
7246927|NCT00256867|11457445|FG007|Overall Study|Withdrawal by participant|0
7246928|NCT00256997|11457474|FG000|Overall Study|Protocol Violation|1
7246929|NCT00256997|11457475|FG001|Overall Study|Protocol Violation|4
7246930|NCT00256997|11457474|FG000|Overall Study|Lack of Efficacy|1
7246931|NCT00256997|11457475|FG001|Overall Study|Lack of Efficacy|4
7246932|NCT00256997|11457474|FG000|Overall Study|Death|2
7246933|NCT00256997|11457475|FG001|Overall Study|Death|0
7246934|NCT00256997|11457474|FG000|Overall Study|Adverse Event|4
7246935|NCT00256997|11457475|FG001|Overall Study|Adverse Event|0
7246936|NCT00256997|11457474|FG000|Overall Study|Lost to Follow-up|3
7246937|NCT00256997|11457475|FG001|Overall Study|Lost to Follow-up|5
7246938|NCT00256997|11457474|FG000|Overall Study|Withdrawal by Subject|13
7246939|NCT00256997|11457475|FG001|Overall Study|Withdrawal by Subject|3
7246940|NCT00256997|11457474|FG000|Overall Study|Started but not treated|2
7246941|NCT00256997|11457475|FG001|Overall Study|Started but not treated|0
7246942|NCT00256997|11457474|FG000|Overall Study|Other|5
7246943|NCT00256997|11457475|FG001|Overall Study|Other|8
7246944|NCT00256997|11457474|FG000|Overall Study|End of Study (As Per Sponsor)|12
7246945|NCT00256997|11457475|FG001|Overall Study|End of Study (As Per Sponsor)|24
7246946|NCT00256997|11457474|FG000|Overall Study|Participant Non-compliant|3
7246947|NCT00256997|11457475|FG001|Overall Study|Participant Non-compliant|6
7246948|NCT00256997|11457474|FG000|Overall Study|Investigator Withdrew Participant|2
7246949|NCT00256997|11457475|FG001|Overall Study|Investigator Withdrew Participant|1
7246950|NCT00257010|11457482|FG000|Overall Study|Lack of Efficacy|11
7246951|NCT00257010|11457482|FG000|Overall Study|Lost to Follow-up|53
7246952|NCT00257010|11457482|FG000|Overall Study|Withdrawal by Subject|34
7246953|NCT00257010|11457482|FG000|Overall Study|Adverse Event|10
7246954|NCT00257010|11457482|FG000|Overall Study|various|11
7246955|NCT00257010|11457482|FG000|Overall Study|no headache reported|9
7246956|NCT00257166|11457488|FG000|Overall Study|Adverse Event|18
7246957|NCT00257166|11457489|FG001|Overall Study|Adverse Event|13
7246958|NCT00257166|11457488|FG000|Overall Study|Laboratory abnormality|1
7246959|NCT00257166|11457489|FG001|Overall Study|Laboratory abnormality|0
7246960|NCT00257166|11457488|FG000|Overall Study|Lost to Follow-up|8
7246961|NCT00257166|11457489|FG001|Overall Study|Lost to Follow-up|1
7246962|NCT00257166|11457488|FG000|Overall Study|Withdrawal by Subject|9
7246963|NCT00257166|11457489|FG001|Overall Study|Withdrawal by Subject|2
7246964|NCT00257166|11457488|FG000|Overall Study|Other|16
7246965|NCT00257166|11457489|FG001|Overall Study|Other|21
7246966|NCT00257166|11457488|FG000|Overall Study|Randomized, but not treated|1
7246967|NCT00257166|11457489|FG001|Overall Study|Randomized, but not treated|0
7246968|NCT00257192|11457497|FG000|Overall Study|Adverse Event|21
7246969|NCT00257192|11457498|FG001|Overall Study|Adverse Event|10
7246970|NCT00257192|11457497|FG000|Overall Study|Laboratory abnormality|1
7246971|NCT00257192|11457498|FG001|Overall Study|Laboratory abnormality|1
7246972|NCT00257192|11457497|FG000|Overall Study|Lost to Follow-up|3
7246973|NCT00257192|11457498|FG001|Overall Study|Lost to Follow-up|3
7246974|NCT00257192|11457497|FG000|Overall Study|Insufficient clinical response|18
7246975|NCT00257192|11457498|FG001|Overall Study|Insufficient clinical response|18
7246976|NCT00257192|11457497|FG000|Overall Study|Withdrawal by Subject|14
7246977|NCT00257192|11457498|FG001|Overall Study|Withdrawal by Subject|2
7246978|NCT00257192|11457497|FG000|Overall Study|Randomized but not treated|0
7246979|NCT00257192|11457498|FG001|Overall Study|Randomized but not treated|1
7246980|NCT00257192|11457497|FG000|Overall Study|Study terminated by sponsor|1
7246981|NCT00257192|11457498|FG001|Overall Study|Study terminated by sponsor|0
7246982|NCT00257192|11457497|FG000|Overall Study|Miscellaneous|0
7246983|NCT00257192|11457498|FG001|Overall Study|Miscellaneous|4
7246984|NCT00257556|11457519|FG000|Overall Study|Adverse Event|1
7246985|NCT00257556|11457520|FG001|Overall Study|Adverse Event|4
7246986|NCT00257556|11457519|FG000|Overall Study|Physician Decision|6
7246987|NCT00257556|11457520|FG001|Overall Study|Physician Decision|0
7246988|NCT00257556|11457519|FG000|Overall Study|Did not meet hCG criterion|3
7246989|NCT00257556|11457520|FG001|Overall Study|Did not meet hCG criterion|0
7246990|NCT00257556|11457519|FG000|Overall Study|other reason|4
7246991|NCT00257556|11457520|FG001|Overall Study|other reason|6
7246992|NCT00257608|11457528|FG000|Chemotherapy Phase|Adverse Event|138
7246993|NCT00257608|11457529|FG001|Chemotherapy Phase|Adverse Event|0
7246994|NCT00257608|11457530|FG002|Chemotherapy Phase|Adverse Event|0
7246995|NCT00257608|11457528|FG000|Chemotherapy Phase|Disease progression|139
7246996|NCT00257608|11457529|FG001|Chemotherapy Phase|Disease progression|0
7246997|NCT00257608|11457530|FG002|Chemotherapy Phase|Disease progression|0
7246998|NCT00257608|11457528|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
7246999|NCT00257608|11457529|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
7247000|NCT00257608|11457530|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
7247001|NCT00257608|11457528|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
7247002|NCT00257608|11457529|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7247003|NCT00257608|11457530|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7247004|NCT00257608|11457528|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
7247005|NCT00257608|11457529|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
7247006|NCT00257608|11457530|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
7247007|NCT00257608|11457528|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
7247008|NCT00257608|11457529|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
7247009|NCT00257608|11457530|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
7247010|NCT00257608|11457528|FG000|Chemotherapy Phase|Physician Decision|28
7247011|NCT00257608|11457529|FG001|Chemotherapy Phase|Physician Decision|0
7247012|NCT00257608|11457530|FG002|Chemotherapy Phase|Physician Decision|0
7247013|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Adverse Event|0
7247014|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Adverse Event|34
7247015|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Adverse Event|38
7247016|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Disease progression|0
7247017|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Disease progression|204
7247018|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Disease progression|168
7247019|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
7247020|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
7247021|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
7247022|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
7247023|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7247024|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
7247025|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
7247026|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
7247027|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
7247028|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7247029|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
7247030|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
7247031|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
7247032|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
7247033|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
7247034|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Physician Decision|0
7247035|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Physician Decision|8
7247036|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Physician Decision|11
7247037|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7247038|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
7247039|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
7247040|NCT00257608|11457528|FG000|Post Chemotherapy Phase|Not treated|0
7247041|NCT00257608|11457529|FG001|Post Chemotherapy Phase|Not treated|4
7247042|NCT00257608|11457530|FG002|Post Chemotherapy Phase|Not treated|7
7247053|NCT00257725|11457577|FG000|Overall Study|Adverse Event|3
7247054|NCT00257920|11457593|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
7247055|NCT00257920|11457594|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
7247056|NCT00257920|11457593|FG000|Period: Second Intervention|Other|2
7247057|NCT00257920|11457594|FG001|Period: Second Intervention|Other|1
7247058|NCT00258154|11457627|FG000|Overall Study|Adverse Event|1
7247059|NCT00258154|11457628|FG001|Overall Study|Adverse Event|0
7247060|NCT00258154|11457627|FG000|Overall Study|Lost to Follow-up|0
7247061|NCT00258154|11457628|FG001|Overall Study|Lost to Follow-up|1
7247062|NCT00258154|11457627|FG000|Overall Study|Protocol Violation|2
7247063|NCT00258154|11457628|FG001|Overall Study|Protocol Violation|1
7247064|NCT00258154|11457627|FG000|Overall Study|Withdrawal by Subject|3
7247065|NCT00258154|11457628|FG001|Overall Study|Withdrawal by Subject|4
7247066|NCT00258154|11457627|FG000|Overall Study|Patient Moved|3
7247067|NCT00258154|11457628|FG001|Overall Study|Patient Moved|1
7247068|NCT00258440|11457661|FG000|Overall Study|Withdrawal by Subject|0
7247069|NCT00258440|11457662|FG001|Overall Study|Withdrawal by Subject|0
7247070|NCT00258440|11457663|FG002|Overall Study|Withdrawal by Subject|1
7247071|NCT00258674|11457674|FG000|Overall Study|Death|32
7247072|NCT00258674|11457675|FG001|Overall Study|Death|53
7247073|NCT00258674|11457676|FG002|Overall Study|Death|34
7247074|NCT00258856|11457706|FG000|Overall Study|Lost to Follow-up|1
7247075|NCT00258856|11457707|FG001|Overall Study|Lost to Follow-up|0
7247076|NCT00258856|11457708|FG002|Overall Study|Lost to Follow-up|2
7247077|NCT00258856|11457709|FG003|Overall Study|Lost to Follow-up|0
7247078|NCT00258856|11457706|FG000|Overall Study|Non-compliance|2
7247079|NCT00258856|11457707|FG001|Overall Study|Non-compliance|0
7247080|NCT00258856|11457708|FG002|Overall Study|Non-compliance|0
7247081|NCT00258856|11457709|FG003|Overall Study|Non-compliance|1
7247082|NCT00258895|11457732|FG000|Overall Study|Lost to Follow-up|3
7247083|NCT00258895|11457733|FG001|Overall Study|Lost to Follow-up|1
7247084|NCT00258895|11457732|FG000|Overall Study|Protocol Violation|6
7247085|NCT00258895|11457733|FG001|Overall Study|Protocol Violation|2
7247086|NCT00258895|11457732|FG000|Overall Study|Withdrawal by Subject|1
7247087|NCT00258895|11457733|FG001|Overall Study|Withdrawal by Subject|0
7247088|NCT00258960|11457743|FG000|Overall Study|Death|2
7247089|NCT00258960|11457743|FG000|Overall Study|Disease Progression|7
7247090|NCT00258960|11457743|FG000|Overall Study|Adverse Event|4
7247091|NCT00258960|11457743|FG000|Overall Study|Physician Decision|1
7247092|NCT00258960|11457743|FG000|Overall Study|Withdrawal by Subject|1
7247093|NCT00258960|11457743|FG000|Overall Study|Mistake|2
7247094|NCT00259012|11457749|FG000|Overall Study|Adverse Event|0
7247095|NCT00259012|11457750|FG001|Overall Study|Adverse Event|1
7247096|NCT00259012|11457749|FG000|Overall Study|Withdrawal by Subject|1
7247097|NCT00259012|11457750|FG001|Overall Study|Withdrawal by Subject|0
7247098|NCT00259012|11457749|FG000|Overall Study|Physician Decision|0
7247099|NCT00259012|11457750|FG001|Overall Study|Physician Decision|1
7247100|NCT00259012|11457749|FG000|Overall Study|Lost to Follow-up|0
7247101|NCT00259012|11457750|FG001|Overall Study|Lost to Follow-up|1
7247102|NCT00259012|11457749|FG000|Overall Study|Protocol Violation|1
7247103|NCT00259012|11457750|FG001|Overall Study|Protocol Violation|1
7247104|NCT00259272|11457773|FG000|Overall Study|Adverse Event|2
7247105|NCT00259272|11457774|FG001|Overall Study|Adverse Event|1
7247106|NCT00259272|11457775|FG002|Overall Study|Adverse Event|0
7247107|NCT00259272|11457776|FG003|Overall Study|Adverse Event|3
7247108|NCT00259272|11457773|FG000|Overall Study|Lack of Efficacy|5
7247109|NCT00259272|11457774|FG001|Overall Study|Lack of Efficacy|1
7247110|NCT00259272|11457775|FG002|Overall Study|Lack of Efficacy|2
7247111|NCT00259272|11457776|FG003|Overall Study|Lack of Efficacy|6
7247112|NCT00259272|11457773|FG000|Overall Study|Physician Decision|1
7247113|NCT00259272|11457774|FG001|Overall Study|Physician Decision|2
7247114|NCT00259272|11457775|FG002|Overall Study|Physician Decision|1
7247115|NCT00259272|11457776|FG003|Overall Study|Physician Decision|3
7247116|NCT00259272|11457773|FG000|Overall Study|Protocol Violation|2
7247117|NCT00259272|11457774|FG001|Overall Study|Protocol Violation|0
7247118|NCT00259272|11457775|FG002|Overall Study|Protocol Violation|0
7247119|NCT00259272|11457776|FG003|Overall Study|Protocol Violation|1
7247120|NCT00259272|11457773|FG000|Overall Study|Sponsor Decision|0
7247121|NCT00259272|11457774|FG001|Overall Study|Sponsor Decision|1
7247122|NCT00259272|11457775|FG002|Overall Study|Sponsor Decision|0
7247123|NCT00259272|11457776|FG003|Overall Study|Sponsor Decision|0
7247124|NCT00259272|11457773|FG000|Overall Study|Withdrawal by Subject|4
7247125|NCT00259272|11457774|FG001|Overall Study|Withdrawal by Subject|2
7247126|NCT00259272|11457775|FG002|Overall Study|Withdrawal by Subject|2
7247127|NCT00259272|11457776|FG003|Overall Study|Withdrawal by Subject|7
7247128|NCT00259272|11457773|FG000|Overall Study|Lost to Follow-up|1
7247129|NCT00259272|11457774|FG001|Overall Study|Lost to Follow-up|0
7247130|NCT00259272|11457775|FG002|Overall Study|Lost to Follow-up|0
7247131|NCT00259272|11457776|FG003|Overall Study|Lost to Follow-up|1
7247132|NCT00259298|11457795|FG000|Overall Study|Withdrawal by Subject|1
7247133|NCT00259298|11457795|FG000|Overall Study|Physician Decision|2
7247134|NCT00259610|11457803|FG000|Overall Study|Withdrawal by Subject|33
7247135|NCT00259610|11457804|FG001|Overall Study|Withdrawal by Subject|25
7247136|NCT00259610|11457805|FG002|Overall Study|Withdrawal by Subject|29
7247137|NCT00259610|11457806|FG003|Overall Study|Withdrawal by Subject|19
7247138|NCT00259610|11457803|FG000|Overall Study|Lost to Follow-up|19
7247139|NCT00259610|11457804|FG001|Overall Study|Lost to Follow-up|8
7247140|NCT00259610|11457805|FG002|Overall Study|Lost to Follow-up|18
7247141|NCT00259610|11457806|FG003|Overall Study|Lost to Follow-up|15
7247142|NCT00259610|11457803|FG000|Overall Study|Physician Decision|6
7247143|NCT00259610|11457804|FG001|Overall Study|Physician Decision|4
7247144|NCT00259610|11457805|FG002|Overall Study|Physician Decision|7
7247145|NCT00259610|11457806|FG003|Overall Study|Physician Decision|2
7247146|NCT00259610|11457803|FG000|Overall Study|Death|1
7247147|NCT00259610|11457804|FG001|Overall Study|Death|1
7247148|NCT00259610|11457805|FG002|Overall Study|Death|2
7247149|NCT00259610|11457806|FG003|Overall Study|Death|0
7247150|NCT00259610|11457803|FG000|Overall Study|non medical reason|6
7247151|NCT00259610|11457804|FG001|Overall Study|non medical reason|2
7247152|NCT00259610|11457805|FG002|Overall Study|non medical reason|10
7247153|NCT00259610|11457806|FG003|Overall Study|non medical reason|3
7247154|NCT00259610|11457803|FG000|Overall Study|Adverse Event|3
7247155|NCT00259610|11457804|FG001|Overall Study|Adverse Event|4
7247156|NCT00259610|11457805|FG002|Overall Study|Adverse Event|5
7247157|NCT00259610|11457806|FG003|Overall Study|Adverse Event|2
7247158|NCT00259610|11457803|FG000|Overall Study|Serious Adverse Event|8
7247159|NCT00259610|11457804|FG001|Overall Study|Serious Adverse Event|2
7247160|NCT00259610|11457805|FG002|Overall Study|Serious Adverse Event|2
7247161|NCT00259610|11457806|FG003|Overall Study|Serious Adverse Event|2
7247162|NCT00259649|11457816|FG000|Overall Study|Lost to Follow-up|7
7247163|NCT00259649|11457816|FG000|Overall Study|irregular menses|3
7247164|NCT00259740|11457822|FG000|Overall Study|Physician Decision|1
7247165|NCT00259740|11457823|FG001|Overall Study|Physician Decision|1
7247166|NCT00259740|11457822|FG000|Overall Study|Adverse Event|0
7247167|NCT00259740|11457823|FG001|Overall Study|Adverse Event|2
7247168|NCT00259740|11457822|FG000|Overall Study|Withdrawal by Subject|2
7247169|NCT00259740|11457823|FG001|Overall Study|Withdrawal by Subject|6
7247170|NCT00259740|11457822|FG000|Overall Study|Death|1
7247171|NCT00259740|11457823|FG001|Overall Study|Death|1
7247172|NCT00259740|11457822|FG000|Overall Study|Disease progression|19
7247173|NCT00259740|11457823|FG001|Overall Study|Disease progression|36
7247174|NCT00259740|11457822|FG000|Overall Study|Ongoing|17
7247175|NCT00259740|11457823|FG001|Overall Study|Ongoing|3
7247176|NCT00259740|11457822|FG000|Overall Study|Other|3
7247177|NCT00259740|11457823|FG001|Overall Study|Other|0
7247178|NCT00259740|11457822|FG000|Overall Study|Requirement for alternative therapy|0
7247179|NCT00259740|11457823|FG001|Overall Study|Requirement for alternative therapy|4
7247180|NCT00259857|11457831|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
7247181|NCT00259857|11457832|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
7247182|NCT00259857|11457831|FG000|24 Months Treatment|Lost to Follow-up|0
7247183|NCT00259857|11457832|FG001|24 Months Treatment|Lost to Follow-up|3
7247184|NCT00260065|11457838|FG000|Overall Study|Progressive Disease|22
7247185|NCT00260065|11457838|FG000|Overall Study|Adverse Event|17
7247186|NCT00260065|11457838|FG000|Overall Study|Death|13
7247187|NCT00260065|11457838|FG000|Overall Study|Withdrawal by Subject|13
7247188|NCT00260065|11457838|FG000|Overall Study|Physician Decision|19
7247189|NCT00260065|11457838|FG000|Overall Study|Not otherwise specified|8
7247190|NCT00260065|11457838|FG000|Overall Study|Medication Noncompliance|1
7247191|NCT00260208|11457854|FG000|Overall Study|Subject withdrew consent|11
7247192|NCT00260208|11457855|FG001|Overall Study|Subject withdrew consent|7
7247193|NCT00260208|11457854|FG000|Overall Study|Lost to Follow-up|6
7247194|NCT00260208|11457855|FG001|Overall Study|Lost to Follow-up|1
7247195|NCT00260208|11457854|FG000|Overall Study|Death|12
7247196|NCT00260208|11457855|FG001|Overall Study|Death|10
7247197|NCT00260208|11457854|FG000|Overall Study|Missing|18
7247198|NCT00260208|11457855|FG001|Overall Study|Missing|16
7247199|NCT00260429|11457863|FG000|Overall Study|failure to follow appointments|1
7247200|NCT00260429|11457864|FG001|Overall Study|failure to follow appointments|0
7247201|NCT00260429|11457863|FG000|Overall Study|scheduled hand surgery|1
7247202|NCT00260429|11457864|FG001|Overall Study|scheduled hand surgery|0
7247203|NCT00260533|11457872|FG000|Overall Study|Other|3
7247204|NCT00260533|11457873|FG001|Overall Study|Other|3
7247205|NCT00260832|11457894|FG000|Overall Study|Adverse Event|26
7247206|NCT00260832|11457895|FG001|Overall Study|Adverse Event|19
7247207|NCT00260832|11457894|FG000|Overall Study|Progression|116
7247208|NCT00260832|11457895|FG001|Overall Study|Progression|96
7247209|NCT00260832|11457894|FG000|Overall Study|Withdrawal by Subject|15
7247210|NCT00260832|11457895|FG001|Overall Study|Withdrawal by Subject|17
7247211|NCT00260832|11457894|FG000|Overall Study|Physician Decision|15
7247212|NCT00260832|11457895|FG001|Overall Study|Physician Decision|9
7247213|NCT00260832|11457894|FG000|Overall Study|Death|43
7247214|NCT00260832|11457895|FG001|Overall Study|Death|62
7247215|NCT00260832|11457894|FG000|Overall Study|Other|10
7247216|NCT00260832|11457895|FG001|Overall Study|Other|7
7247217|NCT00260832|11457894|FG000|Overall Study|Protocol Violation|3
7247218|NCT00260832|11457895|FG001|Overall Study|Protocol Violation|1
7247219|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
7247220|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
7247221|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
7247222|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
7247223|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7247224|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
7247225|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
7247226|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7247227|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
7247228|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
7247229|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7247230|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
7247231|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
7247232|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
7247233|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
7247234|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
7247235|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7247236|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
7247237|NCT00261443|11457921|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
7247238|NCT00261443|11457922|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
7247239|NCT00261443|11457923|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
7247240|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
7247241|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7247242|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
7247243|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
7247244|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
7247245|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
7247246|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
7247247|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7247248|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
7247249|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
7247250|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7247251|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
7247252|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
7247253|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7247254|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
7247255|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
7247256|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
7247257|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
7247258|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
7247259|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7247260|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
7247261|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
7247262|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7247263|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
7247264|NCT00261443|11457921|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
7247265|NCT00261443|11457922|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
7247266|NCT00261443|11457923|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
7247267|NCT00261443|11457921|FG000|3: Assessment of Relapse|Lack of Efficacy|0
7247268|NCT00261443|11457922|FG001|3: Assessment of Relapse|Lack of Efficacy|31
7247269|NCT00261443|11457923|FG002|3: Assessment of Relapse|Lack of Efficacy|14
7247270|NCT00261443|11457921|FG000|3: Assessment of Relapse|Adverse Event|0
7247271|NCT00261443|11457922|FG001|3: Assessment of Relapse|Adverse Event|15
7247272|NCT00261443|11457923|FG002|3: Assessment of Relapse|Adverse Event|19
7247273|NCT00261443|11457921|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
7247274|NCT00261443|11457922|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
7256306|NCT00321984|11467729|FG000|Overall Study|Pregnancy|0
7247275|NCT00261443|11457923|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
7247276|NCT00261443|11457921|FG000|3: Assessment of Relapse|Death|0
7247277|NCT00261443|11457922|FG001|3: Assessment of Relapse|Death|0
7247278|NCT00261443|11457923|FG002|3: Assessment of Relapse|Death|1
7247279|NCT00261443|11457921|FG000|3: Assessment of Relapse|Lost to Follow-up|0
7247280|NCT00261443|11457922|FG001|3: Assessment of Relapse|Lost to Follow-up|7
7247281|NCT00261443|11457923|FG002|3: Assessment of Relapse|Lost to Follow-up|6
7247282|NCT00261443|11457921|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
7247283|NCT00261443|11457922|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
7247284|NCT00261443|11457923|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
7247285|NCT00261443|11457921|FG000|3: Assessment of Relapse|Pregnancy|0
7247286|NCT00261443|11457922|FG001|3: Assessment of Relapse|Pregnancy|2
7247287|NCT00261443|11457923|FG002|3: Assessment of Relapse|Pregnancy|1
7247288|NCT00261443|11457921|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
7247289|NCT00261443|11457922|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
7247290|NCT00261443|11457923|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
7247291|NCT00261443|11457921|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7247292|NCT00261443|11457922|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
7247293|NCT00261443|11457923|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
7247294|NCT00261443|11457921|FG000|3: Assessment of Relapse|Other Reasons|0
7247295|NCT00261443|11457922|FG001|3: Assessment of Relapse|Other Reasons|4
7247296|NCT00261443|11457923|FG002|3: Assessment of Relapse|Other Reasons|3
7247297|NCT00261443|11457921|FG000|4: Extension Phase|Adverse Event|0
7247298|NCT00261443|11457922|FG001|4: Extension Phase|Adverse Event|1
7247299|NCT00261443|11457923|FG002|4: Extension Phase|Adverse Event|0
7247300|NCT00261443|11457921|FG000|4: Extension Phase|Withdrawal by Subject|0
7247301|NCT00261443|11457922|FG001|4: Extension Phase|Withdrawal by Subject|1
7247302|NCT00261443|11457923|FG002|4: Extension Phase|Withdrawal by Subject|2
7247303|NCT00261443|11457921|FG000|4: Extension Phase|Lost to Follow-up|0
7247304|NCT00261443|11457922|FG001|4: Extension Phase|Lost to Follow-up|1
7247305|NCT00261443|11457923|FG002|4: Extension Phase|Lost to Follow-up|0
7247306|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
7247307|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
7247308|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
7247309|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
7247310|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7247311|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
7247312|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
7247313|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
7247314|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
7247315|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
7247316|NCT00261495|11457936|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
7247317|NCT00261495|11457937|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
7247318|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
7247319|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
7247320|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
7247321|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
7247322|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
7247323|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
7247324|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
7247325|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
7247326|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
7247327|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
7247328|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
7247329|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
7247330|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7247331|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
7247332|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
7247333|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
7247334|NCT00261495|11457936|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
7247335|NCT00261495|11457937|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
7247336|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Other|4
7247337|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Other|2
7247338|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
7247339|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
7247340|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
7247341|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
7247342|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
7247343|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
7247344|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
7247345|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
7247346|NCT00261495|11457936|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
7247347|NCT00261495|11457937|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
7247348|NCT00261716|11457945|FG000|Overall Study|Withdrawal by Subject|6
7247349|NCT00261716|11457946|FG001|Overall Study|Withdrawal by Subject|8
7247350|NCT00261716|11457945|FG000|Overall Study|Lost to Follow-up|0
7247351|NCT00261716|11457946|FG001|Overall Study|Lost to Follow-up|2
7247352|NCT00261833|11457958|FG000|Overall Study|Death|1
7247353|NCT00261833|11457959|FG001|Overall Study|Death|3
7247354|NCT00261833|11457958|FG000|Overall Study|Adverse Event|1
7247355|NCT00261833|11457959|FG001|Overall Study|Adverse Event|4
7247356|NCT00261833|11457958|FG000|Overall Study|Withdrawal by Subject|5
7247357|NCT00261833|11457959|FG001|Overall Study|Withdrawal by Subject|7
7247358|NCT00261833|11457958|FG000|Overall Study|Protocol Violation|0
7247359|NCT00261833|11457959|FG001|Overall Study|Protocol Violation|1
7247360|NCT00261833|11457958|FG000|Overall Study|Suspicion of pulmonary cancer|0
7247361|NCT00261833|11457959|FG001|Overall Study|Suspicion of pulmonary cancer|1
7247362|NCT00261833|11457958|FG000|Overall Study|Lung transplantation|1
7247363|NCT00261833|11457959|FG001|Overall Study|Lung transplantation|1
7247364|NCT00261833|11457958|FG000|Overall Study|Missing reason|1
7247365|NCT00261833|11457959|FG001|Overall Study|Missing reason|0
7247366|NCT00261833|11457958|FG000|Overall Study|Not interested in being participant|0
7247367|NCT00261833|11457959|FG001|Overall Study|Not interested in being participant|1
7247368|NCT00261846|11457975|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7247369|NCT00261846|11457976|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
7247370|NCT00261846|11457977|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
7247371|NCT00261846|11457978|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247372|NCT00261846|11457979|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247373|NCT00261846|11457980|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247374|NCT00261846|11457981|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247375|NCT00261846|11457982|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247376|NCT00261846|11457983|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247377|NCT00261846|11457984|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247378|NCT00261846|11457985|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247379|NCT00261846|11457986|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
7247380|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247381|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247382|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247383|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7247384|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247385|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247386|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247387|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247388|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
7247389|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247390|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247391|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
7247392|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247393|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247394|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247395|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
7247396|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
7247397|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
7247398|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7247399|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
7247400|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247401|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
7247402|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247403|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
7247404|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247405|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247406|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247407|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
7247408|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7247409|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247410|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7247411|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247412|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
7247413|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7247414|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
7247415|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
7247416|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Other|0
7247417|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Other|0
7247418|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Other|0
7247419|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Other|15
7247420|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Other|4
7247421|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Other|0
7247422|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Other|1
7247423|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Other|5
7247424|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Other|4
7247425|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Other|4
7247426|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Other|0
7247427|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Other|0
7247428|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Death|0
7247429|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Death|0
7247430|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Death|0
7247431|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Death|37
7247432|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Death|7
7247433|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Death|1
7247434|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Death|10
7247435|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Death|12
7247436|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Death|3
7247437|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Death|30
7247438|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Death|44
7247439|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Death|22
7247440|NCT00261846|11457975|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
7247441|NCT00261846|11457976|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
7247442|NCT00261846|11457977|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
7247443|NCT00261846|11457978|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
7247444|NCT00261846|11457979|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
7247445|NCT00261846|11457980|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
7247446|NCT00261846|11457981|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
7247447|NCT00261846|11457982|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
7247448|NCT00261846|11457983|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
7247449|NCT00261846|11457984|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
7247450|NCT00261846|11457985|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
7247451|NCT00261846|11457986|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
7247452|NCT00261950|11458025|FG000|Overall Study|Lost to Follow-up|2
7247453|NCT00261950|11458025|FG000|Overall Study|Death|6
7247454|NCT00261950|11458025|FG000|Overall Study|Withdrawal by Subject|5
7247455|NCT00261950|11458025|FG000|Overall Study|Other|1
7247456|NCT00261950|11458025|FG000|Overall Study|Physician Decision|1
7247457|NCT00261950|11458025|FG000|Overall Study|Protocol specified Criteria|11
7247458|NCT00262002|11458036|FG000|Overall Study|Adverse Event|2
7247459|NCT00262002|11458037|FG001|Overall Study|Adverse Event|1
7247460|NCT00262002|11458038|FG002|Overall Study|Adverse Event|0
7247461|NCT00262002|11458039|FG003|Overall Study|Adverse Event|0
7247462|NCT00262002|11458040|FG004|Overall Study|Adverse Event|0
7247463|NCT00262002|11458041|FG005|Overall Study|Adverse Event|1
7247464|NCT00262002|11458042|FG006|Overall Study|Adverse Event|0
7247465|NCT00262002|11458036|FG000|Overall Study|Withdrawal by Subject|4
7247466|NCT00262002|11458037|FG001|Overall Study|Withdrawal by Subject|2
7247467|NCT00262002|11458038|FG002|Overall Study|Withdrawal by Subject|0
7247468|NCT00262002|11458039|FG003|Overall Study|Withdrawal by Subject|1
7247469|NCT00262002|11458040|FG004|Overall Study|Withdrawal by Subject|2
7247470|NCT00262002|11458041|FG005|Overall Study|Withdrawal by Subject|2
7247471|NCT00262002|11458042|FG006|Overall Study|Withdrawal by Subject|2
7247472|NCT00262002|11458036|FG000|Overall Study|Lost to Follow-up|2
7247473|NCT00262002|11458037|FG001|Overall Study|Lost to Follow-up|0
7247474|NCT00262002|11458038|FG002|Overall Study|Lost to Follow-up|0
7247475|NCT00262002|11458039|FG003|Overall Study|Lost to Follow-up|2
7247476|NCT00262002|11458040|FG004|Overall Study|Lost to Follow-up|0
7247477|NCT00262002|11458041|FG005|Overall Study|Lost to Follow-up|1
7247478|NCT00262002|11458042|FG006|Overall Study|Lost to Follow-up|0
7247479|NCT00262002|11458036|FG000|Overall Study|Inapropriate enrollment|0
7247480|NCT00262002|11458037|FG001|Overall Study|Inapropriate enrollment|1
7247481|NCT00262002|11458038|FG002|Overall Study|Inapropriate enrollment|0
7247482|NCT00262002|11458039|FG003|Overall Study|Inapropriate enrollment|0
7247483|NCT00262002|11458040|FG004|Overall Study|Inapropriate enrollment|0
7247484|NCT00262002|11458041|FG005|Overall Study|Inapropriate enrollment|0
7247485|NCT00262002|11458042|FG006|Overall Study|Inapropriate enrollment|0
7247486|NCT00262002|11458036|FG000|Overall Study|Protocol Violation|3
7247487|NCT00262002|11458037|FG001|Overall Study|Protocol Violation|2
7247488|NCT00262002|11458038|FG002|Overall Study|Protocol Violation|0
7247489|NCT00262002|11458039|FG003|Overall Study|Protocol Violation|2
7247490|NCT00262002|11458040|FG004|Overall Study|Protocol Violation|5
7247491|NCT00262002|11458041|FG005|Overall Study|Protocol Violation|3
7247492|NCT00262002|11458042|FG006|Overall Study|Protocol Violation|2
7247493|NCT00262002|11458036|FG000|Overall Study|Unable to classify|0
7247494|NCT00262002|11458037|FG001|Overall Study|Unable to classify|0
7247495|NCT00262002|11458038|FG002|Overall Study|Unable to classify|0
7247496|NCT00262002|11458039|FG003|Overall Study|Unable to classify|0
7247497|NCT00262002|11458040|FG004|Overall Study|Unable to classify|0
7247498|NCT00262002|11458041|FG005|Overall Study|Unable to classify|0
7247499|NCT00262002|11458042|FG006|Overall Study|Unable to classify|2
7247500|NCT00262028|11458116|FG000|Overall Study|Withdrawal by Subject|6
7247501|NCT00262028|11458117|FG001|Overall Study|Withdrawal by Subject|3
7247502|NCT00262028|11458118|FG002|Overall Study|Withdrawal by Subject|6
7247503|NCT00262028|11458119|FG003|Overall Study|Withdrawal by Subject|5
7247504|NCT00262028|11458120|FG004|Overall Study|Withdrawal by Subject|2
7247505|NCT00262028|11458121|FG005|Overall Study|Withdrawal by Subject|3
7247506|NCT00262028|11458122|FG006|Overall Study|Withdrawal by Subject|5
7247507|NCT00262028|11458123|FG007|Overall Study|Withdrawal by Subject|7
7247508|NCT00262028|11458124|FG008|Overall Study|Withdrawal by Subject|2
7247509|NCT00262028|11458116|FG000|Overall Study|Lost to Follow-up|7
7247510|NCT00262028|11458117|FG001|Overall Study|Lost to Follow-up|7
7247511|NCT00262028|11458118|FG002|Overall Study|Lost to Follow-up|5
7247512|NCT00262028|11458119|FG003|Overall Study|Lost to Follow-up|5
7247513|NCT00262028|11458120|FG004|Overall Study|Lost to Follow-up|4
7247514|NCT00262028|11458121|FG005|Overall Study|Lost to Follow-up|3
7247515|NCT00262028|11458122|FG006|Overall Study|Lost to Follow-up|3
7247516|NCT00262028|11458123|FG007|Overall Study|Lost to Follow-up|5
7247517|NCT00262028|11458124|FG008|Overall Study|Lost to Follow-up|6
7247518|NCT00262028|11458116|FG000|Overall Study|Administrative Reason|11
7247519|NCT00262028|11458117|FG001|Overall Study|Administrative Reason|14
7247520|NCT00262028|11458118|FG002|Overall Study|Administrative Reason|9
7247521|NCT00262028|11458119|FG003|Overall Study|Administrative Reason|12
7247522|NCT00262028|11458120|FG004|Overall Study|Administrative Reason|6
7247523|NCT00262028|11458121|FG005|Overall Study|Administrative Reason|7
7247524|NCT00262028|11458122|FG006|Overall Study|Administrative Reason|4
7247525|NCT00262028|11458123|FG007|Overall Study|Administrative Reason|6
7247526|NCT00262028|11458124|FG008|Overall Study|Administrative Reason|10
7247527|NCT00262028|11458116|FG000|Overall Study|Protocol Violation|0
7247528|NCT00262028|11458117|FG001|Overall Study|Protocol Violation|0
7247529|NCT00262028|11458118|FG002|Overall Study|Protocol Violation|0
7247530|NCT00262028|11458119|FG003|Overall Study|Protocol Violation|1
7247531|NCT00262028|11458120|FG004|Overall Study|Protocol Violation|0
7247532|NCT00262028|11458121|FG005|Overall Study|Protocol Violation|0
7247533|NCT00262028|11458122|FG006|Overall Study|Protocol Violation|0
7247534|NCT00262028|11458123|FG007|Overall Study|Protocol Violation|0
7247535|NCT00262028|11458124|FG008|Overall Study|Protocol Violation|0
7247536|NCT00262028|11458116|FG000|Overall Study|Unable to classify|0
7247537|NCT00262028|11458117|FG001|Overall Study|Unable to classify|3
7247538|NCT00262028|11458118|FG002|Overall Study|Unable to classify|0
7247539|NCT00262028|11458119|FG003|Overall Study|Unable to classify|0
7247540|NCT00262028|11458120|FG004|Overall Study|Unable to classify|0
7247541|NCT00262028|11458121|FG005|Overall Study|Unable to classify|0
7247542|NCT00262028|11458122|FG006|Overall Study|Unable to classify|0
7247543|NCT00262028|11458123|FG007|Overall Study|Unable to classify|0
7247544|NCT00262028|11458124|FG008|Overall Study|Unable to classify|1
7247545|NCT00262041|11458170|FG000|Overall Study|Withdrawal by Subject|0
7247546|NCT00262041|11458171|FG001|Overall Study|Withdrawal by Subject|3
7247547|NCT00262041|11458172|FG002|Overall Study|Withdrawal by Subject|1
7247548|NCT00262041|11458170|FG000|Overall Study|Lost to Follow-up|1
7247549|NCT00262041|11458171|FG001|Overall Study|Lost to Follow-up|1
7247550|NCT00262041|11458172|FG002|Overall Study|Lost to Follow-up|5
7247551|NCT00262041|11458170|FG000|Overall Study|Unable to classify|1
7247552|NCT00262041|11458171|FG001|Overall Study|Unable to classify|0
7247553|NCT00262041|11458172|FG002|Overall Study|Unable to classify|0
7247554|NCT00262067|11458190|FG000|Overall Study|Death|190
7247555|NCT00262067|11458191|FG001|Overall Study|Death|89
7247556|NCT00262067|11458192|FG002|Overall Study|Death|186
7247557|NCT00262067|11458193|FG003|Overall Study|Death|99
7247558|NCT00262067|11458190|FG000|Overall Study|Lost to Follow-up|5
7247559|NCT00262067|11458191|FG001|Overall Study|Lost to Follow-up|4
7247560|NCT00262067|11458192|FG002|Overall Study|Lost to Follow-up|7
7247561|NCT00262067|11458193|FG003|Overall Study|Lost to Follow-up|5
7247562|NCT00262067|11458190|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
7247563|NCT00262067|11458191|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
7247564|NCT00262067|11458192|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
7247565|NCT00262067|11458193|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
7247566|NCT00262067|11458190|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
7247567|NCT00262067|11458191|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
7247568|NCT00262067|11458192|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
7247569|NCT00262067|11458193|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
7247570|NCT00262080|11458206|FG000|Double Blind Treatment Period|Lost to Follow-up|1
7247571|NCT00262080|11458207|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7247572|NCT00262080|11458208|FG002|Double Blind Treatment Period|Lost to Follow-up|0
7247573|NCT00262080|11458206|FG000|Repeat Dose Treatment Period|Adverse Event|1
7247574|NCT00262080|11458207|FG001|Repeat Dose Treatment Period|Adverse Event|0
7247575|NCT00262080|11458208|FG002|Repeat Dose Treatment Period|Adverse Event|0
7247576|NCT00262080|11458206|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
7247577|NCT00262080|11458207|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
7247578|NCT00262080|11458208|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
7247579|NCT00262080|11458206|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
7247580|NCT00262080|11458207|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
7247581|NCT00262080|11458208|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
7247582|NCT00262080|11458206|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
7247583|NCT00262080|11458207|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
7247584|NCT00262080|11458208|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
7247585|NCT00262080|11458206|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
7247586|NCT00262080|11458207|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7247587|NCT00262080|11458208|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
7247588|NCT00262119|11458219|FG000|Overall Study|Lost to Follow-up|38
7247589|NCT00262119|11458220|FG001|Overall Study|Lost to Follow-up|51
7247590|NCT00262119|11458221|FG002|Overall Study|Lost to Follow-up|42
7247591|NCT00262119|11458219|FG000|Overall Study|Death|20
7247592|NCT00262119|11458220|FG001|Overall Study|Death|19
7247593|NCT00262119|11458221|FG002|Overall Study|Death|16
7247594|NCT00262223|11458231|FG000|Treatment Phase|Withdrawal by Subject|3
7247595|NCT00262223|11458232|FG001|Treatment Phase|Withdrawal by Subject|6
7247596|NCT00262223|11458231|FG000|Treatment Phase|Adverse Event|1
7247597|NCT00262223|11458232|FG001|Treatment Phase|Adverse Event|2
7247598|NCT00262223|11458231|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
7247599|NCT00262223|11458232|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
7247600|NCT00262223|11458231|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
7247601|NCT00262223|11458232|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
7247602|NCT00262223|11458231|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
7247603|NCT00262223|11458232|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
7247604|NCT00262301|11458242|FG000|Double-blind Phase|Lost to Follow-up|1
7247605|NCT00262301|11458243|FG001|Double-blind Phase|Lost to Follow-up|0
7247606|NCT00262301|11458244|FG002|Double-blind Phase|Lost to Follow-up|0
7247607|NCT00262301|11458242|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
7247608|NCT00262301|11458243|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
7247609|NCT00262301|11458244|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
7247610|NCT00262314|11458252|FG000|Overall Study|Changing physicians|38
7247611|NCT00262314|11458252|FG000|Overall Study|Death|12
7247612|NCT00262314|11458252|FG000|Overall Study|Patient's decision|92
7247613|NCT00262314|11458252|FG000|Overall Study|Other|95
7247614|NCT00262314|11458252|FG000|Overall Study|Lost to Follow-up|70
7247615|NCT00262314|11458252|FG000|Overall Study|Administrative withdrawal|30
7247616|NCT00262522|11458269|FG000|Study Start Through 8 Weeks|Adverse Event|1
7247617|NCT00262522|11458270|FG001|Study Start Through 8 Weeks|Adverse Event|2
7247618|NCT00262522|11458271|FG002|Study Start Through 8 Weeks|Adverse Event|3
7247619|NCT00262522|11458272|FG003|Study Start Through 8 Weeks|Adverse Event|1
7247620|NCT00262522|11458269|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
7247621|NCT00262522|11458270|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
7247622|NCT00262522|11458271|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
7247623|NCT00262522|11458272|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
7247624|NCT00262522|11458269|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
7247625|NCT00262522|11458270|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
7247626|NCT00262522|11458271|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
7247627|NCT00262522|11458272|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
7247628|NCT00262522|11458269|FG000|Study Start Through 8 Weeks|Noncompliance|0
7247629|NCT00262522|11458270|FG001|Study Start Through 8 Weeks|Noncompliance|0
7247630|NCT00262522|11458271|FG002|Study Start Through 8 Weeks|Noncompliance|2
7247631|NCT00262522|11458272|FG003|Study Start Through 8 Weeks|Noncompliance|2
7247632|NCT00262522|11458269|FG000|Study Start Through 8 Weeks|Death|1
7247633|NCT00262522|11458270|FG001|Study Start Through 8 Weeks|Death|0
7247634|NCT00262522|11458271|FG002|Study Start Through 8 Weeks|Death|0
7247635|NCT00262522|11458272|FG003|Study Start Through 8 Weeks|Death|0
7247636|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Adverse Event|16
7247637|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Adverse Event|0
7247638|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Adverse Event|10
7247639|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Adverse Event|0
7247640|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
7247641|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
7247642|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
7247643|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
7247644|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
7247645|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
7247646|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
7247647|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
7247648|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Noncompliance|3
7247649|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Noncompliance|0
7247650|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Noncompliance|8
7247651|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Noncompliance|0
7247652|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Death|2
7247653|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Death|0
7247654|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Death|1
7247655|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Death|0
7247656|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Virologic failure|2
7247657|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Virologic failure|0
7247658|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Virologic failure|4
7247659|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Virologic failure|0
7247660|NCT00262522|11458269|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
7247661|NCT00262522|11458270|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7247662|NCT00262522|11458271|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
7247663|NCT00262522|11458272|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
7247664|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Adverse Event|20
7247665|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Adverse Event|0
7247666|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Adverse Event|16
7247667|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Adverse Event|0
7247668|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
7247669|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
7247670|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
7247671|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
7247672|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
7247673|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
7247674|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
7247675|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
7247676|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Noncompliance|6
7247677|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Noncompliance|0
7247678|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Noncompliance|11
7247679|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Noncompliance|0
7247680|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Death|2
7247681|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Death|0
7247682|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Death|2
7247683|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Death|0
7247684|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Virologic failure|5
7247685|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Virologic failure|0
7247686|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Virologic failure|8
7247687|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Virologic failure|0
7247688|NCT00262522|11458269|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
7256307|NCT00321984|11467730|FG001|Overall Study|Pregnancy|1
7247689|NCT00262522|11458270|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7247690|NCT00262522|11458271|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
7247691|NCT00262522|11458272|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
7247692|NCT00262600|11458283|FG000|Overall Study|Lost to Follow-up|17
7247693|NCT00262600|11458284|FG001|Overall Study|Lost to Follow-up|31
7247694|NCT00262600|11458285|FG002|Overall Study|Lost to Follow-up|41
7247695|NCT00262600|11458283|FG000|Overall Study|Withdrawal by Subject|128
7247696|NCT00262600|11458284|FG001|Overall Study|Withdrawal by Subject|145
7247697|NCT00262600|11458285|FG002|Overall Study|Withdrawal by Subject|139
7247698|NCT00262600|11458283|FG000|Overall Study|Not Treated|32
7247699|NCT00262600|11458284|FG001|Overall Study|Not Treated|17
7247700|NCT00262600|11458285|FG002|Overall Study|Not Treated|24
7247701|NCT00262600|11458283|FG000|Overall Study|Other|58
7247702|NCT00262600|11458284|FG001|Overall Study|Other|59
7247703|NCT00262600|11458285|FG002|Overall Study|Other|62
7247704|NCT00262743|11458316|FG000|Overall Study|Adverse Event|0
7247705|NCT00262743|11458317|FG001|Overall Study|Adverse Event|9
7247706|NCT00262743|11458316|FG000|Overall Study|Disease progression|0
7247707|NCT00262743|11458317|FG001|Overall Study|Disease progression|3
7247708|NCT00262821|11458323|FG000|Overall Study|Ineligible - wrong stage|0
7247709|NCT00262821|11458324|FG001|Overall Study|Ineligible - wrong stage|3
7247710|NCT00262821|11458323|FG000|Overall Study|Ineligible - wrong cell type|2
7247711|NCT00262821|11458324|FG001|Overall Study|Ineligible - wrong cell type|2
7247712|NCT00262821|11458323|FG000|Overall Study|Ineligible - wrong primary|0
7247713|NCT00262821|11458324|FG001|Overall Study|Ineligible - wrong primary|1
7247714|NCT00262821|11458323|FG000|Overall Study|Ineligible - inadequate pathology|1
7247715|NCT00262821|11458324|FG001|Overall Study|Ineligible - inadequate pathology|3
7247716|NCT00262821|11458323|FG000|Overall Study|Ineligible - elevated creatinine|0
7247717|NCT00262821|11458324|FG001|Overall Study|Ineligible - elevated creatinine|2
7247718|NCT00262821|11458323|FG000|Overall Study|Ineligible - required test not done|1
7247719|NCT00262821|11458324|FG001|Overall Study|Ineligible - required test not done|4
7247720|NCT00262821|11458323|FG000|Overall Study|Inevaluable - inadequate data|0
7247721|NCT00262821|11458324|FG001|Overall Study|Inevaluable - inadequate data|4
7247722|NCT00262834|11458332|FG000|Overall Study|Surgery delayed/tissue not collected|1
7247723|NCT00262834|11458333|FG001|Overall Study|Surgery delayed/tissue not collected|4
7247724|NCT00262847|11458342|FG000|Overall Study|Disease Progression|309
7247725|NCT00262847|11458343|FG001|Overall Study|Disease Progression|274
7247726|NCT00262847|11458344|FG002|Overall Study|Disease Progression|195
7247727|NCT00262847|11458342|FG000|Overall Study|Patient Refusal|41
7247728|NCT00262847|11458343|FG001|Overall Study|Patient Refusal|52
7247729|NCT00262847|11458344|FG002|Overall Study|Patient Refusal|47
7247730|NCT00262847|11458342|FG000|Overall Study|Adverse Event|74
7247731|NCT00262847|11458343|FG001|Overall Study|Adverse Event|88
7247732|NCT00262847|11458344|FG002|Overall Study|Adverse Event|108
7247733|NCT00262847|11458342|FG000|Overall Study|Death|8
7247734|NCT00262847|11458343|FG001|Overall Study|Death|8
7247735|NCT00262847|11458344|FG002|Overall Study|Death|11
7247736|NCT00262847|11458342|FG000|Overall Study|Concomitant disease|3
7247737|NCT00262847|11458343|FG001|Overall Study|Concomitant disease|2
7247738|NCT00262847|11458344|FG002|Overall Study|Concomitant disease|4
7247739|NCT00262847|11458342|FG000|Overall Study|Other Reasons|79
7247740|NCT00262847|11458343|FG001|Overall Study|Other Reasons|88
7247741|NCT00262847|11458344|FG002|Overall Study|Other Reasons|27
7247742|NCT00262847|11458342|FG000|Overall Study|Did not receive study treatment|4
7247743|NCT00262847|11458343|FG001|Overall Study|Did not receive study treatment|1
7247744|NCT00262847|11458344|FG002|Overall Study|Did not receive study treatment|4
7247745|NCT00262860|11458355|FG000|Overall Study|Adverse Event|2
7247746|NCT00262873|11458359|FG000|Overall Study|Adverse Event|3
7247747|NCT00262873|11458359|FG000|Overall Study|Withdrawal by Subject|5
7247748|NCT00262925|11458363|FG000|Overall Study|Lack of Efficacy|3
7247749|NCT00262925|11458363|FG000|Overall Study|Adverse Event|4
7247750|NCT00262925|11458363|FG000|Overall Study|Death|2
7247751|NCT00262925|11458363|FG000|Overall Study|alternative therapy|1
7247752|NCT00262925|11458363|FG000|Overall Study|Other|1
7247753|NCT00262951|11458369|FG000|Overall Study|Progressive disease/relapse|3
7247754|NCT00262951|11458369|FG000|Overall Study|Adverse Event|7
7247755|NCT00262951|11458369|FG000|Overall Study|Death|1
7247756|NCT00262951|11458369|FG000|Overall Study|Withdrawal by Subject|1
7247757|NCT00262951|11458369|FG000|Overall Study|Alternative treatment|3
7247758|NCT00262951|11458369|FG000|Overall Study|Off treatment for other disease|1
7247759|NCT00263211|11458402|FG000|Overall Study|Death|1
7247760|NCT00263211|11458403|FG001|Overall Study|Death|0
7247761|NCT00263211|11458402|FG000|Overall Study|Withdrawal by Subject|3
7247762|NCT00263211|11458403|FG001|Overall Study|Withdrawal by Subject|0
7247763|NCT00263211|11458402|FG000|Overall Study|Protocol Violation|1
7247764|NCT00263211|11458403|FG001|Overall Study|Protocol Violation|0
7247765|NCT00263211|11458402|FG000|Overall Study|Disease Progression|0
7247766|NCT00263211|11458403|FG001|Overall Study|Disease Progression|1
7247767|NCT00263328|11458415|FG000|Overall Study|Death|0
7247768|NCT00263328|11458416|FG001|Overall Study|Death|0
7247769|NCT00263328|11458417|FG002|Overall Study|Death|1
7247770|NCT00263328|11458415|FG000|Overall Study|Lost to Follow-up|1
7247771|NCT00263328|11458416|FG001|Overall Study|Lost to Follow-up|1
7247772|NCT00263328|11458417|FG002|Overall Study|Lost to Follow-up|0
7247773|NCT00263328|11458415|FG000|Overall Study|Withdrawal by Subject|3
7247774|NCT00263328|11458416|FG001|Overall Study|Withdrawal by Subject|0
7247775|NCT00263328|11458417|FG002|Overall Study|Withdrawal by Subject|1
7247776|NCT00263328|11458415|FG000|Overall Study|Other|3
7247777|NCT00263328|11458416|FG001|Overall Study|Other|0
7247778|NCT00263328|11458417|FG002|Overall Study|Other|1
7247779|NCT00263328|11458415|FG000|Overall Study|Adverse Event|1
7247780|NCT00263328|11458416|FG001|Overall Study|Adverse Event|1
7247781|NCT00263328|11458417|FG002|Overall Study|Adverse Event|4
7247782|NCT00263562|11458429|FG000|Overall Study|Protocol Violation|3
7247783|NCT00263562|11458430|FG001|Overall Study|Protocol Violation|0
7247784|NCT00263575|11458438|FG000|Titration Period|Adverse Event|14
7247785|NCT00263575|11458438|FG000|Titration Period|Withdrawal by Subject|10
7247786|NCT00263575|11458438|FG000|Titration Period|Protocol Violation|9
7247787|NCT00263575|11458438|FG000|Titration Period|Sponsor Decision|2
7247788|NCT00263575|11458438|FG000|Titration Period|Other|2
7383916|NCT01191268|11640886|FG001|Overall Study|Death|1
7383917|NCT01191268|11640887|FG002|Overall Study|Death|3
7383918|NCT01191268|11640885|FG000|Overall Study|Protocol Violation|1
7383919|NCT01191268|11640886|FG001|Overall Study|Protocol Violation|0
7383920|NCT01191268|11640887|FG002|Overall Study|Protocol Violation|1
7383921|NCT01191268|11640885|FG000|Overall Study|Sponsor Decision|0
7383922|NCT01191268|11640886|FG001|Overall Study|Sponsor Decision|2
7383923|NCT01191268|11640887|FG002|Overall Study|Sponsor Decision|0
7383924|NCT01191762|11641027|FG000|Overall Study|Adverse Event|1
7383925|NCT01191762|11641028|FG001|Overall Study|Adverse Event|0
7383926|NCT01191788|11641036|FG000|Overall Study|Lost to Follow-up|21
7383927|NCT01191788|11641037|FG001|Overall Study|Lost to Follow-up|22
7383928|NCT01191801|11641046|FG000|Overall Study|Death|36
7383929|NCT01191801|11641047|FG001|Overall Study|Death|12
7383930|NCT01191801|11641046|FG000|Overall Study|Lack of Efficacy|176
7383931|NCT01191801|11641047|FG001|Overall Study|Lack of Efficacy|258
7383932|NCT01191801|11641046|FG000|Overall Study|Adverse Event|9
7383933|NCT01191801|11641047|FG001|Overall Study|Adverse Event|8
7383934|NCT01191801|11641046|FG000|Overall Study|Protocol Violation|2
7383935|NCT01191801|11641047|FG001|Overall Study|Protocol Violation|4
7383936|NCT01191801|11641046|FG000|Overall Study|Physician Decision|47
7383937|NCT01191801|11641047|FG001|Overall Study|Physician Decision|24
7383938|NCT01191801|11641046|FG000|Overall Study|Withdrawal by Subject|1
7383939|NCT01191801|11641047|FG001|Overall Study|Withdrawal by Subject|4
7383940|NCT01191801|11641046|FG000|Overall Study|Not Provided|45
7383941|NCT01191801|11641047|FG001|Overall Study|Not Provided|27
7383942|NCT01191840|11641064|FG000|Overall Study|withdrew consent|2
7383943|NCT01191840|11641065|FG001|Overall Study|withdrew consent|1
7383944|NCT01191840|11641064|FG000|Overall Study|Subject discontinued treatment|1
7383945|NCT01191840|11641065|FG001|Overall Study|Subject discontinued treatment|2
7383946|NCT01191840|11641064|FG000|Overall Study|Lost to Follow-up|4
7383947|NCT01191840|11641065|FG001|Overall Study|Lost to Follow-up|6
7383948|NCT01191840|11641064|FG000|Overall Study|Non Staph Infection|4
7383949|NCT01191840|11641065|FG001|Overall Study|Non Staph Infection|3
7383950|NCT01191840|11641064|FG000|Overall Study|ineligible at enrollment|1
7247789|NCT00263575|11458438|FG000|Titration Period|Lack of Efficacy|6
7247790|NCT00263575|11458438|FG000|Maintence Period|Adverse Event|23
7247791|NCT00263575|11458438|FG000|Maintence Period|Withdrawal by Subject|8
7247792|NCT00263575|11458438|FG000|Maintence Period|Protocol Violation|4
7247793|NCT00263575|11458438|FG000|Maintence Period|Lack of Efficacy|4
7247794|NCT00263575|11458438|FG000|Maintence Period|Physician Decision|6
7247795|NCT00263575|11458438|FG000|Maintence Period|Lost to Follow-up|1
7247796|NCT00263575|11458438|FG000|Maintence Period|Sponsor Decision|24
7247797|NCT00263575|11458438|FG000|Maintence Period|Other|7
7247798|NCT00263588|11458446|FG000|Overall Study|Death|54
7247799|NCT00263588|11458447|FG001|Overall Study|Death|90
7247800|NCT00263588|11458446|FG000|Overall Study|disease progression, coma, 1 unknown|10
7247801|NCT00263588|11458447|FG001|Overall Study|disease progression, coma, 1 unknown|11
7247802|NCT00263588|11458446|FG000|Overall Study|Lost to Follow-up|7
7247803|NCT00263588|11458447|FG001|Overall Study|Lost to Follow-up|10
7247804|NCT00263588|11458446|FG000|Overall Study|Withdrawal by Subject|3
7247805|NCT00263588|11458447|FG001|Overall Study|Withdrawal by Subject|4
7247806|NCT00263588|11458446|FG000|Overall Study|Protocol Violation|0
7247807|NCT00263588|11458447|FG001|Overall Study|Protocol Violation|1
7383951|NCT01191840|11641065|FG001|Overall Study|ineligible at enrollment|0
7383952|NCT01191840|11641064|FG000|Overall Study|IRB approval lapse|0
7247808|NCT00263588|11458446|FG000|Overall Study|Investigator decision|7
7247809|NCT00263588|11458447|FG001|Overall Study|Investigator decision|15
7383953|NCT01191840|11641065|FG001|Overall Study|IRB approval lapse|2
7383954|NCT01191840|11641064|FG000|Overall Study|lab error speciation - non Staph infecti|0
7383955|NCT01191840|11641065|FG001|Overall Study|lab error speciation - non Staph infecti|1
7383956|NCT01191840|11641064|FG000|Overall Study|Withdrawal by Subject|2
7383957|NCT01191840|11641065|FG001|Overall Study|Withdrawal by Subject|0
7383958|NCT01191944|11641073|FG000|Overall Study|Adverse Event|11
7383959|NCT01191944|11641074|FG001|Overall Study|Adverse Event|12
7383960|NCT01191944|11641073|FG000|Overall Study|Protocol Violation|1
7383961|NCT01191944|11641074|FG001|Overall Study|Protocol Violation|2
7247810|NCT00263588|11458446|FG000|Overall Study|Sponsor terminated study|0
7383962|NCT01191944|11641073|FG000|Overall Study|Withdrawal by Subject|4
7383963|NCT01191944|11641074|FG001|Overall Study|Withdrawal by Subject|2
7247811|NCT00263588|11458447|FG001|Overall Study|Sponsor terminated study|1
7247812|NCT00263666|11458456|FG000|Overall Study|Adverse Event|6
7247813|NCT00263666|11458457|FG001|Overall Study|Adverse Event|8
7247814|NCT00263666|11458456|FG000|Overall Study|Lost to Follow-up|1
7247815|NCT00263666|11458457|FG001|Overall Study|Lost to Follow-up|2
7247816|NCT00263666|11458456|FG000|Overall Study|Withdrawal by Subject|0
7247817|NCT00263666|11458457|FG001|Overall Study|Withdrawal by Subject|1
7247818|NCT00263757|11458465|FG000|Overall Study|Withdrawal by Subject|5
7247819|NCT00263757|11458466|FG001|Overall Study|Withdrawal by Subject|4
7247820|NCT00263757|11458465|FG000|Overall Study|Screen failure|0
7247821|NCT00263757|11458466|FG001|Overall Study|Screen failure|1
7247822|NCT00263757|11458465|FG000|Overall Study|Adverse Event|3
7247823|NCT00263757|11458466|FG001|Overall Study|Adverse Event|3
7247824|NCT00263887|11458474|FG000|Overall Study|Withdrawal by Subject|1
7247825|NCT00263887|11458475|FG001|Overall Study|Withdrawal by Subject|1
7247826|NCT00263887|11458474|FG000|Overall Study|Lung transplantation|1
7247827|NCT00263887|11458475|FG001|Overall Study|Lung transplantation|2
7247828|NCT00263887|11458474|FG000|Overall Study|Too ill to attend visit|1
7247829|NCT00263887|11458475|FG001|Overall Study|Too ill to attend visit|0
7247830|NCT00263887|11458474|FG000|Overall Study|Adverse Event|0
7247831|NCT00263887|11458475|FG001|Overall Study|Adverse Event|2
7247832|NCT00263887|11458474|FG000|Overall Study|Disease progression|0
7247833|NCT00263887|11458475|FG001|Overall Study|Disease progression|1
7247834|NCT00263887|11458474|FG000|Overall Study|Lack of Efficacy|0
7247835|NCT00263887|11458475|FG001|Overall Study|Lack of Efficacy|1
7247836|NCT00264004|11458485|FG000|Overall Study|Adverse Event|2
7247837|NCT00264004|11458486|FG001|Overall Study|Adverse Event|3
7247838|NCT00264004|11458487|FG002|Overall Study|Adverse Event|6
7247839|NCT00264004|11458488|FG003|Overall Study|Adverse Event|4
7247840|NCT00264004|11458485|FG000|Overall Study|Withdrawal by Subject|0
7247841|NCT00264004|11458486|FG001|Overall Study|Withdrawal by Subject|1
7247842|NCT00264004|11458487|FG002|Overall Study|Withdrawal by Subject|2
7247843|NCT00264004|11458488|FG003|Overall Study|Withdrawal by Subject|2
7247844|NCT00264004|11458485|FG000|Overall Study|Other|2
7247845|NCT00264004|11458486|FG001|Overall Study|Other|2
7247846|NCT00264004|11458487|FG002|Overall Study|Other|0
7247847|NCT00264004|11458488|FG003|Overall Study|Other|3
7247848|NCT00264004|11458485|FG000|Overall Study|Development study specific disc. crit.|1
7247849|NCT00264004|11458486|FG001|Overall Study|Development study specific disc. crit.|0
7247850|NCT00264004|11458487|FG002|Overall Study|Development study specific disc. crit.|1
7247851|NCT00264004|11458488|FG003|Overall Study|Development study specific disc. crit.|0
7247852|NCT00264004|11458485|FG000|Overall Study|Cond. under inv. worsened|9
7247853|NCT00264004|11458486|FG001|Overall Study|Cond. under inv. worsened|5
7247854|NCT00264004|11458487|FG002|Overall Study|Cond. under inv. worsened|3
7247855|NCT00264004|11458488|FG003|Overall Study|Cond. under inv. worsened|4
7247856|NCT00264004|11458485|FG000|Overall Study|Not treated|3
7247857|NCT00264004|11458486|FG001|Overall Study|Not treated|0
7247858|NCT00264004|11458487|FG002|Overall Study|Not treated|2
7247859|NCT00264004|11458488|FG003|Overall Study|Not treated|2
7247860|NCT00264238|11458498|FG000|Overall Study|Protocol Violation|1
7247861|NCT00264290|11458506|FG000|Intervention (8 Weeks)|Adverse Event|1
7247862|NCT00264290|11458507|FG001|Intervention (8 Weeks)|Adverse Event|0
7247863|NCT00264303|11458519|FG000|Overall Study|Adverse Event|4
7247864|NCT00264303|11458520|FG001|Overall Study|Adverse Event|3
7247865|NCT00264303|11458519|FG000|Overall Study|Lack of Efficacy|10
7247866|NCT00264303|11458520|FG001|Overall Study|Lack of Efficacy|13
7247867|NCT00264303|11458519|FG000|Overall Study|Lost to Follow-up|3
7247868|NCT00264303|11458520|FG001|Overall Study|Lost to Follow-up|3
7247869|NCT00264303|11458519|FG000|Overall Study|Withdrawal by Subject|2
7247870|NCT00264303|11458520|FG001|Overall Study|Withdrawal by Subject|3
7247871|NCT00264303|11458519|FG000|Overall Study|Various reasons listed in study report|6
7247872|NCT00264303|11458520|FG001|Overall Study|Various reasons listed in study report|7
7247873|NCT00264498|11458537|FG000|Randomized Treatment|Death|0
7247874|NCT00264498|11458538|FG001|Randomized Treatment|Death|3
7247875|NCT00264498|11458537|FG000|Randomized Treatment|Withdrawal by Subject|0
7247876|NCT00264498|11458538|FG001|Randomized Treatment|Withdrawal by Subject|1
7247877|NCT00264498|11458537|FG000|Randomized Treatment|Objective disease Progression|13
7247878|NCT00264498|11458538|FG001|Randomized Treatment|Objective disease Progression|14
7247879|NCT00264498|11458537|FG000|Randomized Treatment|Physician Decision|1
7247880|NCT00264498|11458538|FG001|Randomized Treatment|Physician Decision|0
7247881|NCT00264498|11458537|FG000|Randomized Treatment|Incorrectly randomized|1
7247882|NCT00264498|11458538|FG001|Randomized Treatment|Incorrectly randomized|0
7247883|NCT00264498|11458537|FG000|Randomized Treatment|Study Closure|1
7247884|NCT00264498|11458538|FG001|Randomized Treatment|Study Closure|0
7247885|NCT00264498|11458537|FG000|Randomized Treatment|Protocol Violation|1
7247886|NCT00264498|11458538|FG001|Randomized Treatment|Protocol Violation|0
7247887|NCT00264498|11458537|FG000|Crossover Treatment|Death|1
7247888|NCT00264498|11458538|FG001|Crossover Treatment|Death|3
7247889|NCT00264498|11458537|FG000|Crossover Treatment|Objective disease progression|4
7247890|NCT00264498|11458538|FG001|Crossover Treatment|Objective disease progression|5
7247891|NCT00264498|11458537|FG000|Crossover Treatment|Study closure|0
7247892|NCT00264498|11458538|FG001|Crossover Treatment|Study closure|1
7247893|NCT00264498|11458537|FG000|Crossover Treatment|Withdrawal by Subject|1
7247894|NCT00264498|11458538|FG001|Crossover Treatment|Withdrawal by Subject|0
7247895|NCT00264537|11458548|FG000|Overall Study|Death|0
7247896|NCT00264537|11458549|FG001|Overall Study|Death|3
7247897|NCT00264537|11458550|FG002|Overall Study|Death|3
7247898|NCT00264537|11458551|FG003|Overall Study|Death|2
7247899|NCT00264537|11458548|FG000|Overall Study|Lost to Follow-up|3
7247900|NCT00264537|11458549|FG001|Overall Study|Lost to Follow-up|4
7247901|NCT00264537|11458550|FG002|Overall Study|Lost to Follow-up|7
7247902|NCT00264537|11458551|FG003|Overall Study|Lost to Follow-up|6
7247903|NCT00264537|11458548|FG000|Overall Study|Adverse Event|21
7247904|NCT00264537|11458549|FG001|Overall Study|Adverse Event|32
7247905|NCT00264537|11458550|FG002|Overall Study|Adverse Event|24
7247906|NCT00264537|11458551|FG003|Overall Study|Adverse Event|34
7247907|NCT00264537|11458548|FG000|Overall Study|Unsatisfactory therapeutic effect|5
7465063|NCT01877421|11764026|FG015|Phase 2|Withdrawal by Subject|1
7465064|NCT01877421|11764027|FG016|Phase 2|Withdrawal by Subject|0
7247908|NCT00264537|11458549|FG001|Overall Study|Unsatisfactory therapeutic effect|6
7247909|NCT00264537|11458550|FG002|Overall Study|Unsatisfactory therapeutic effect|5
7247910|NCT00264537|11458551|FG003|Overall Study|Unsatisfactory therapeutic effect|7
7247911|NCT00264537|11458548|FG000|Overall Study|Other|21
7247912|NCT00264537|11458549|FG001|Overall Study|Other|11
7247913|NCT00264537|11458550|FG002|Overall Study|Other|10
7247914|NCT00264537|11458551|FG003|Overall Study|Other|11
7247915|NCT00264537|11458548|FG000|Overall Study|Not treated|0
7247916|NCT00264537|11458549|FG001|Overall Study|Not treated|2
7247917|NCT00264537|11458550|FG002|Overall Study|Not treated|1
7247918|NCT00264537|11458551|FG003|Overall Study|Not treated|0
7247919|NCT00264550|11458567|FG000|Overall Study|Death|0
7247920|NCT00264550|11458568|FG001|Overall Study|Death|3
7247921|NCT00264550|11458569|FG002|Overall Study|Death|0
7247922|NCT00264550|11458570|FG003|Overall Study|Death|0
7247923|NCT00264550|11458567|FG000|Overall Study|Lost to Follow-up|3
7247924|NCT00264550|11458568|FG001|Overall Study|Lost to Follow-up|1
7247925|NCT00264550|11458569|FG002|Overall Study|Lost to Follow-up|1
7247926|NCT00264550|11458570|FG003|Overall Study|Lost to Follow-up|1
7247927|NCT00264550|11458567|FG000|Overall Study|Adverse Event|23
7247928|NCT00264550|11458568|FG001|Overall Study|Adverse Event|18
7247929|NCT00264550|11458569|FG002|Overall Study|Adverse Event|9
7247930|NCT00264550|11458570|FG003|Overall Study|Adverse Event|14
7247931|NCT00264550|11458567|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7247932|NCT00264550|11458568|FG001|Overall Study|Unsatisfactory therapeutic effect|11
7247933|NCT00264550|11458569|FG002|Overall Study|Unsatisfactory therapeutic effect|4
7247934|NCT00264550|11458570|FG003|Overall Study|Unsatisfactory therapeutic effect|6
7247935|NCT00264550|11458567|FG000|Overall Study|Discontinued oral study agent|0
7247936|NCT00264550|11458568|FG001|Overall Study|Discontinued oral study agent|1
7247937|NCT00264550|11458569|FG002|Overall Study|Discontinued oral study agent|0
7247938|NCT00264550|11458570|FG003|Overall Study|Discontinued oral study agent|0
7247939|NCT00264550|11458567|FG000|Overall Study|Other|13
7247940|NCT00264550|11458568|FG001|Overall Study|Other|7
7247941|NCT00264550|11458569|FG002|Overall Study|Other|3
7247942|NCT00264550|11458570|FG003|Overall Study|Other|9
7247943|NCT00264576|11458582|FG000|Overall Study|Lost to Follow-up|1
7247944|NCT00264576|11458583|FG001|Overall Study|Lost to Follow-up|1
7256308|NCT00321984|11467731|FG002|Overall Study|Pregnancy|0
7256309|NCT00321984|11467729|FG000|Overall Study|Per Subject Request|1
7256310|NCT00321984|11467730|FG001|Overall Study|Per Subject Request|0
7256311|NCT00321984|11467731|FG002|Overall Study|Per Subject Request|0
7256312|NCT00321984|11467729|FG000|Overall Study|Per Investigator Request|1
7256313|NCT00321984|11467730|FG001|Overall Study|Per Investigator Request|0
7256314|NCT00321984|11467731|FG002|Overall Study|Per Investigator Request|0
7256315|NCT00321984|11467729|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7256316|NCT00321984|11467730|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
7256317|NCT00321984|11467731|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
7256318|NCT00322023|11467742|FG000|Overall Study|various|0
7256319|NCT00322023|11467743|FG001|Overall Study|various|2
7256320|NCT00322023|11467744|FG002|Overall Study|various|6
7256321|NCT00322049|11467756|FG000|Overall Study|Moved out of area|0
7256322|NCT00322049|11467757|FG001|Overall Study|Moved out of area|0
7256323|NCT00322049|11467758|FG002|Overall Study|Moved out of area|0
7256324|NCT00322049|11467759|FG003|Overall Study|Moved out of area|1
7256325|NCT00322049|11467756|FG000|Overall Study|Infected with Dengue during study|0
7256326|NCT00322049|11467757|FG001|Overall Study|Infected with Dengue during study|1
7256327|NCT00322049|11467758|FG002|Overall Study|Infected with Dengue during study|0
7256328|NCT00322049|11467759|FG003|Overall Study|Infected with Dengue during study|0
7256329|NCT00322153|11467789|FG000|Overall Study|Adverse Event|21
7256330|NCT00322153|11467790|FG001|Overall Study|Adverse Event|34
7256331|NCT00322153|11467789|FG000|Overall Study|Protocol Violation|6
7256332|NCT00322153|11467790|FG001|Overall Study|Protocol Violation|14
7465065|NCT01877421|11764028|FG017|Phase 2|Withdrawal by Subject|0
7256333|NCT00322153|11467789|FG000|Overall Study|Withdrawal by Subject|18
7256334|NCT00322153|11467790|FG001|Overall Study|Withdrawal by Subject|10
7256335|NCT00322153|11467789|FG000|Overall Study|Lack of Efficacy|8
7256336|NCT00322153|11467790|FG001|Overall Study|Lack of Efficacy|3
7256337|NCT00322153|11467789|FG000|Overall Study|Lost to Follow-up|5
7256338|NCT00322153|11467790|FG001|Overall Study|Lost to Follow-up|4
7256339|NCT00322153|11467789|FG000|Overall Study|Withdrawn for other reasons|5
7247945|NCT00264797|11458600|FG000|Overall Study|Withdrawal by Subject|11
7247946|NCT00264797|11458601|FG001|Overall Study|Withdrawal by Subject|11
7247947|NCT00264797|11458600|FG000|Overall Study|Lost to Follow-up|9
7247948|NCT00264797|11458601|FG001|Overall Study|Lost to Follow-up|17
7247949|NCT00264797|11458600|FG000|Overall Study|Moved from area|3
7247950|NCT00264797|11458601|FG001|Overall Study|Moved from area|1
7247951|NCT00264797|11458600|FG000|Overall Study|Practical Problems|2
7247952|NCT00264797|11458601|FG001|Overall Study|Practical Problems|3
7247953|NCT00264797|11458600|FG000|Overall Study|Incarceration|4
7247954|NCT00264797|11458601|FG001|Overall Study|Incarceration|5
7247955|NCT00264797|11458600|FG000|Overall Study|Pressure/advice from Outsiders|1
7247956|NCT00264797|11458601|FG001|Overall Study|Pressure/advice from Outsiders|1
7247957|NCT00264797|11458600|FG000|Overall Study|Feels treatment not necessary, not worki|0
7247958|NCT00264797|11458601|FG001|Overall Study|Feels treatment not necessary, not worki|1
7247959|NCT00264797|11458600|FG000|Overall Study|Other|3
7247960|NCT00264797|11458601|FG001|Overall Study|Other|4
7247961|NCT00264810|11458609|FG000|Baseline|Withdrawal by Subject|10
7247962|NCT00264810|11458610|FG001|Baseline|Withdrawal by Subject|10
7247963|NCT00264810|11458609|FG000|Baseline|Physician Decision|7
7247964|NCT00264810|11458610|FG001|Baseline|Physician Decision|8
7247965|NCT00264810|11458609|FG000|Baseline|Subject Compliance Failure|3
7247966|NCT00264810|11458610|FG001|Baseline|Subject Compliance Failure|3
7247967|NCT00264810|11458609|FG000|Baseline|Insufficient Seizure Frequency|2
7247968|NCT00264810|11458610|FG001|Baseline|Insufficient Seizure Frequency|2
7247969|NCT00264810|11458609|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
7247970|NCT00264810|11458610|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
7247971|NCT00264810|11458609|FG000|Baseline|Other|0
7247972|NCT00264810|11458610|FG001|Baseline|Other|1
7247973|NCT00264810|11458609|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
7247974|NCT00264810|11458610|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
7247975|NCT00264810|11458609|FG000|Stimulation Optimization Period|Death|0
7247976|NCT00264810|11458610|FG001|Stimulation Optimization Period|Death|1
7247977|NCT00264810|11458609|FG000|Blinded Evaluation Period|Explant due to infection|1
7247978|NCT00264810|11458610|FG001|Blinded Evaluation Period|Explant due to infection|1
7247979|NCT00264810|11458609|FG000|Open Label Evaluation Period|Explant due to infection|1
7247980|NCT00264810|11458610|FG001|Open Label Evaluation Period|Explant due to infection|1
7247981|NCT00264810|11458609|FG000|Open Label Evaluation Period|Death|3
7247982|NCT00264810|11458610|FG001|Open Label Evaluation Period|Death|2
7247983|NCT00264810|11458609|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
7247984|NCT00264810|11458610|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
7247985|NCT00264849|11458620|FG000|Overall Study|Adverse Event|7
7247986|NCT00264849|11458621|FG001|Overall Study|Adverse Event|2
7247987|NCT00264849|11458620|FG000|Overall Study|Withdrawal by Subject|7
7247988|NCT00264849|11458621|FG001|Overall Study|Withdrawal by Subject|11
7247989|NCT00264849|11458620|FG000|Overall Study|Protocol Violation|5
7247990|NCT00264849|11458621|FG001|Overall Study|Protocol Violation|3
7247991|NCT00264849|11458620|FG000|Overall Study|Lack of Efficacy|1
7247992|NCT00264849|11458621|FG001|Overall Study|Lack of Efficacy|6
7247993|NCT00264849|11458620|FG000|Overall Study|Lost to Follow-up|0
7247994|NCT00264849|11458621|FG001|Overall Study|Lost to Follow-up|2
7247995|NCT00264849|11458620|FG000|Overall Study|Death|0
7247996|NCT00264849|11458621|FG001|Overall Study|Death|1
7247997|NCT00264849|11458620|FG000|Overall Study|Administrative Problems|2
7247998|NCT00264849|11458621|FG001|Overall Study|Administrative Problems|0
7247999|NCT00264875|11458627|FG000|Overall Study|Adverse Event|6
7248000|NCT00264875|11458627|FG000|Overall Study|Lost to Follow-up|6
7248001|NCT00264875|11458627|FG000|Overall Study|Protocol Violation|11
7248002|NCT00264875|11458627|FG000|Overall Study|Withdrawal by Subject|7
7248003|NCT00265083|11458634|FG000|Overall Study|Adverse Event|5
7248004|NCT00265083|11458635|FG001|Overall Study|Adverse Event|13
7248005|NCT00265083|11458636|FG002|Overall Study|Adverse Event|15
7248006|NCT00265083|11458634|FG000|Overall Study|Lost to Follow-up|3
7248007|NCT00265083|11458635|FG001|Overall Study|Lost to Follow-up|4
7248008|NCT00265083|11458636|FG002|Overall Study|Lost to Follow-up|4
7248009|NCT00265083|11458634|FG000|Overall Study|Unsatisfactory therapeutic effect|8
7248010|NCT00265083|11458635|FG001|Overall Study|Unsatisfactory therapeutic effect|13
7248011|NCT00265083|11458636|FG002|Overall Study|Unsatisfactory therapeutic effect|14
7248012|NCT00265083|11458634|FG000|Overall Study|Other|1
7248013|NCT00265083|11458635|FG001|Overall Study|Other|12
7248014|NCT00265083|11458636|FG002|Overall Study|Other|9
7248015|NCT00265096|11458648|FG000|Overall Study|Adverse Event|14
7248016|NCT00265096|11458649|FG001|Overall Study|Adverse Event|18
7248017|NCT00265096|11458650|FG002|Overall Study|Adverse Event|18
7248018|NCT00265096|11458648|FG000|Overall Study|Lost to Follow-up|2
7248019|NCT00265096|11458649|FG001|Overall Study|Lost to Follow-up|5
7248020|NCT00265096|11458650|FG002|Overall Study|Lost to Follow-up|3
7248021|NCT00265096|11458648|FG000|Overall Study|Death|0
7248022|NCT00265096|11458649|FG001|Overall Study|Death|1
7248023|NCT00265096|11458650|FG002|Overall Study|Death|2
7248024|NCT00265096|11458648|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7248025|NCT00265096|11458649|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7248026|NCT00265096|11458650|FG002|Overall Study|Unsatisfactory therapeutic effect|6
7248027|NCT00265096|11458648|FG000|Overall Study|Other|11
7248028|NCT00265096|11458649|FG001|Overall Study|Other|19
7248029|NCT00265096|11458650|FG002|Overall Study|Other|10
7248030|NCT00265109|11458660|FG000|Overall Study|Withdrawal by Subject|5
7248031|NCT00265109|11458660|FG000|Overall Study|Adverse Event|1
7248032|NCT00265122|11458671|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7248033|NCT00265122|11458672|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7248034|NCT00265122|11458673|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
7248035|NCT00265122|11458674|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7248036|NCT00265122|11458675|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
7248037|NCT00265122|11458676|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
7248038|NCT00265122|11458671|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7248039|NCT00265122|11458672|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7248040|NCT00265122|11458673|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7248041|NCT00265122|11458674|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
7248042|NCT00265122|11458675|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7248043|NCT00265122|11458676|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
7248044|NCT00265122|11458671|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
7248045|NCT00265122|11458672|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
7248046|NCT00265122|11458673|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
7248047|NCT00265122|11458674|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
7248048|NCT00265122|11458675|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
7248049|NCT00265122|11458676|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
7248050|NCT00265122|11458671|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
7248051|NCT00265122|11458672|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7248052|NCT00265122|11458673|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7248053|NCT00265122|11458674|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
7248054|NCT00265122|11458675|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
7248055|NCT00265122|11458676|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
7248056|NCT00265122|11458671|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7248057|NCT00265122|11458672|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7248058|NCT00265122|11458673|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
7248059|NCT00265122|11458674|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7248060|NCT00265122|11458675|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
7248061|NCT00265122|11458676|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
7248062|NCT00265122|11458671|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
7248063|NCT00265122|11458672|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
7248064|NCT00265122|11458673|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
7248065|NCT00265122|11458674|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
7248066|NCT00265122|11458675|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
7248067|NCT00265122|11458676|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
7248068|NCT00265148|11458697|FG000|Overall Study|Adverse Event|2
7248069|NCT00265148|11458698|FG001|Overall Study|Adverse Event|2
7248070|NCT00265148|11458697|FG000|Overall Study|Lack of Efficacy|0
7248071|NCT00265148|11458698|FG001|Overall Study|Lack of Efficacy|2
7248072|NCT00265148|11458697|FG000|Overall Study|Protocol Violation|3
7248073|NCT00265148|11458698|FG001|Overall Study|Protocol Violation|2
7248074|NCT00265148|11458697|FG000|Overall Study|Lost to Follow-up|0
7248075|NCT00265148|11458698|FG001|Overall Study|Lost to Follow-up|1
7248076|NCT00265148|11458697|FG000|Overall Study|Withdrawal by Subject|2
7248077|NCT00265148|11458698|FG001|Overall Study|Withdrawal by Subject|1
7248078|NCT00265148|11458697|FG000|Overall Study|Physician Decision|1
7248079|NCT00265148|11458698|FG001|Overall Study|Physician Decision|0
7248080|NCT00265148|11458697|FG000|Overall Study|Increasing frailty|0
7248081|NCT00265148|11458698|FG001|Overall Study|Increasing frailty|1
7248082|NCT00265148|11458697|FG000|Overall Study|Subject chose to change of the dose|1
7248083|NCT00265148|11458698|FG001|Overall Study|Subject chose to change of the dose|0
7248084|NCT00265239|11458711|FG000|Overall Study|Adverse Event|2
7248085|NCT00265239|11458712|FG001|Overall Study|Adverse Event|1
7248086|NCT00265317|11458722|FG000|Lead-In|Objective progression or relapse|6
7248087|NCT00265317|11458723|FG001|Lead-In|Objective progression or relapse|11
7248088|NCT00265317|11458724|FG002|Lead-In|Objective progression or relapse|0
7248089|NCT00265317|11458725|FG003|Lead-In|Objective progression or relapse|0
7248090|NCT00265317|11458722|FG000|Lead-In|Adverse Event|2
7248091|NCT00265317|11458723|FG001|Lead-In|Adverse Event|1
7248092|NCT00265317|11458724|FG002|Lead-In|Adverse Event|0
7248093|NCT00265317|11458725|FG003|Lead-In|Adverse Event|0
7248094|NCT00265317|11458722|FG000|Lead-In|Death|3
7248095|NCT00265317|11458723|FG001|Lead-In|Death|5
7248096|NCT00265317|11458724|FG002|Lead-In|Death|0
7248097|NCT00265317|11458725|FG003|Lead-In|Death|0
7248098|NCT00265317|11458722|FG000|Lead-In|Withdrawal/other than adverse event|1
7248099|NCT00265317|11458723|FG001|Lead-In|Withdrawal/other than adverse event|0
7248100|NCT00265317|11458724|FG002|Lead-In|Withdrawal/other than adverse event|0
7248101|NCT00265317|11458725|FG003|Lead-In|Withdrawal/other than adverse event|0
7248102|NCT00265317|11458722|FG000|Phase 2|Objective progression or relapse|0
7248103|NCT00265317|11458723|FG001|Phase 2|Objective progression or relapse|0
7248104|NCT00265317|11458724|FG002|Phase 2|Objective progression or relapse|37
7248105|NCT00265317|11458725|FG003|Phase 2|Objective progression or relapse|38
7248106|NCT00265317|11458722|FG000|Phase 2|Global deterioration of health status|0
7248107|NCT00265317|11458723|FG001|Phase 2|Global deterioration of health status|0
7248108|NCT00265317|11458724|FG002|Phase 2|Global deterioration of health status|3
7248109|NCT00265317|11458725|FG003|Phase 2|Global deterioration of health status|0
7248110|NCT00265317|11458722|FG000|Phase 2|Adverse Event|0
7248111|NCT00265317|11458723|FG001|Phase 2|Adverse Event|0
7248112|NCT00265317|11458724|FG002|Phase 2|Adverse Event|7
7248113|NCT00265317|11458725|FG003|Phase 2|Adverse Event|5
7248114|NCT00265317|11458722|FG000|Phase 2|Death|0
7248115|NCT00265317|11458723|FG001|Phase 2|Death|0
7248116|NCT00265317|11458724|FG002|Phase 2|Death|12
7248117|NCT00265317|11458725|FG003|Phase 2|Death|15
7248118|NCT00265317|11458722|FG000|Phase 2|Protocol Violation|0
7248119|NCT00265317|11458723|FG001|Phase 2|Protocol Violation|0
7248120|NCT00265317|11458724|FG002|Phase 2|Protocol Violation|1
7248121|NCT00265317|11458725|FG003|Phase 2|Protocol Violation|4
7248122|NCT00265317|11458722|FG000|Phase 2|Lost to Follow-up|0
7248123|NCT00265317|11458723|FG001|Phase 2|Lost to Follow-up|0
7248124|NCT00265317|11458724|FG002|Phase 2|Lost to Follow-up|0
7248125|NCT00265317|11458725|FG003|Phase 2|Lost to Follow-up|1
7248126|NCT00265317|11458722|FG000|Phase 2|Withdrawal/other than adverse event|0
7248127|NCT00265317|11458723|FG001|Phase 2|Withdrawal/other than adverse event|0
7248128|NCT00265317|11458724|FG002|Phase 2|Withdrawal/other than adverse event|2
7248129|NCT00265317|11458725|FG003|Phase 2|Withdrawal/other than adverse event|1
7248130|NCT00265317|11458722|FG000|Phase 2|Study terminated by sponsor|0
7248131|NCT00265317|11458723|FG001|Phase 2|Study terminated by sponsor|0
7248132|NCT00265317|11458724|FG002|Phase 2|Study terminated by sponsor|1
7248133|NCT00265317|11458725|FG003|Phase 2|Study terminated by sponsor|0
7248134|NCT00265317|11458722|FG000|Phase 2|Other|0
7248135|NCT00265317|11458723|FG001|Phase 2|Other|0
7248136|NCT00265317|11458724|FG002|Phase 2|Other|1
7248137|NCT00265317|11458725|FG003|Phase 2|Other|1
7248138|NCT00265330|11458744|FG000|Overall Study|Adverse Event|41
7248139|NCT00265330|11458744|FG000|Overall Study|Lost to Follow-up|8
7248140|NCT00265330|11458744|FG000|Overall Study|Withdrawal by Subject|34
7248141|NCT00265330|11458744|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
7248142|NCT00265330|11458744|FG000|Overall Study|Lack of Efficacy|4
7248143|NCT00265330|11458744|FG000|Overall Study|Family Scheduling Conflicts|1
7248144|NCT00265330|11458744|FG000|Overall Study|Began Taking Formulary Geodon|1
7248145|NCT00265330|11458744|FG000|Overall Study|Discharged from Unit for Long Term Care|1
7248146|NCT00265330|11458744|FG000|Overall Study|Site Closed by Sponsor|1
7248147|NCT00265330|11458744|FG000|Overall Study|Principal Investigators Request|1
7248148|NCT00265330|11458744|FG000|Overall Study|Withdrew Consent|1
7248149|NCT00265330|11458744|FG000|Overall Study|Protocol Violation|1
7248150|NCT00265382|11458748|FG000|Overall Study|Adverse Event|21
7248151|NCT00265382|11458748|FG000|Overall Study|Laboratory Abnormality|1
7248152|NCT00265382|11458748|FG000|Overall Study|Lost to Follow-up|3
7248153|NCT00265382|11458748|FG000|Overall Study|Lack of Efficacy|6
7248154|NCT00265382|11458748|FG000|Overall Study|Miscellaneous|6
7248155|NCT00265382|11458748|FG000|Overall Study|Withdrawal by Subject|13
7248156|NCT00265382|11458748|FG000|Overall Study|Study terminated by sponsor|94
7248157|NCT00265382|11458748|FG000|Overall Study|Death|1
7248158|NCT00265395|11458754|FG000|Overall Study|Adverse Event|3
7248159|NCT00265395|11458755|FG001|Overall Study|Adverse Event|6
7248160|NCT00265395|11458754|FG000|Overall Study|Lost to Follow-up|2
7248161|NCT00265395|11458755|FG001|Overall Study|Lost to Follow-up|1
7248162|NCT00265395|11458754|FG000|Overall Study|Withdrawal by Subject|1
7248163|NCT00265395|11458755|FG001|Overall Study|Withdrawal by Subject|6
7248164|NCT00265395|11458754|FG000|Overall Study|Protocol Violation|2
7248165|NCT00265395|11458755|FG001|Overall Study|Protocol Violation|2
7248166|NCT00265395|11458754|FG000|Overall Study|Lack of Efficacy|0
7248167|NCT00265395|11458755|FG001|Overall Study|Lack of Efficacy|1
7248168|NCT00265395|11458754|FG000|Overall Study|Administrative|0
7248169|NCT00265395|11458755|FG001|Overall Study|Administrative|1
7248170|NCT00265564|11458793|FG000|Overall Study|Lost to Follow-up|5
7248171|NCT00265564|11458794|FG001|Overall Study|Lost to Follow-up|7
7248172|NCT00265564|11458793|FG000|Overall Study|met exclusion criteria|5
7248173|NCT00265564|11458794|FG001|Overall Study|met exclusion criteria|2
7248174|NCT00265759|11458815|FG000|Overall Study|Withdrawal by Subject|0
7248175|NCT00265759|11458816|FG001|Overall Study|Withdrawal by Subject|1
7248176|NCT00265759|11458817|FG002|Overall Study|Withdrawal by Subject|2
7248177|NCT00265759|11458818|FG003|Overall Study|Withdrawal by Subject|2
7248178|NCT00265759|11458815|FG000|Overall Study|Cancel|0
7248179|NCT00265759|11458816|FG001|Overall Study|Cancel|0
7248180|NCT00265759|11458817|FG002|Overall Study|Cancel|0
7248181|NCT00265759|11458818|FG003|Overall Study|Cancel|3
7248182|NCT00265759|11458815|FG000|Overall Study|Ineligible|0
7248183|NCT00265759|11458816|FG001|Overall Study|Ineligible|0
7248184|NCT00265759|11458817|FG002|Overall Study|Ineligible|0
7248185|NCT00265759|11458818|FG003|Overall Study|Ineligible|1
7248186|NCT00265759|11458815|FG000|Overall Study|Bilateral disease|0
7248187|NCT00265759|11458816|FG001|Overall Study|Bilateral disease|0
7248188|NCT00265759|11458817|FG002|Overall Study|Bilateral disease|0
7248189|NCT00265759|11458818|FG003|Overall Study|Bilateral disease|2
7248190|NCT00265759|11458815|FG000|Overall Study|Discontinued due to intolerability|0
7248191|NCT00265759|11458816|FG001|Overall Study|Discontinued due to intolerability|0
7248192|NCT00265759|11458817|FG002|Overall Study|Discontinued due to intolerability|0
7248193|NCT00265759|11458818|FG003|Overall Study|Discontinued due to intolerability|1
7248194|NCT00265785|11458829|FG000|Overall Study|Adverse Event|4
7248195|NCT00265785|11458829|FG000|Overall Study|Withdrawal by Subject|3
7248196|NCT00265785|11458829|FG000|Overall Study|Progression/Relapse|15
7248197|NCT00265785|11458829|FG000|Overall Study|Not protocol specified|2
7248198|NCT00265785|11458829|FG000|Overall Study|Ineligible|1
7248199|NCT00265785|11458829|FG000|Overall Study|Did not receive protocol treatment|2
7248200|NCT00265889|11458845|FG000|Overall Study|Physician Decision|1
7248201|NCT00265889|11458845|FG000|Overall Study|Protocol Violation|1
7248202|NCT00265889|11458845|FG000|Overall Study|Insurance denied the request|3
7248203|NCT00266032|11458856|FG000|Treatment|Adverse Event|42
7248204|NCT00266032|11458857|FG001|Treatment|Adverse Event|26
7248205|NCT00266032|11458858|FG002|Treatment|Adverse Event|10
7248206|NCT00266032|11458856|FG000|Treatment|Lost to Follow-up|19
7248207|NCT00266032|11458857|FG001|Treatment|Lost to Follow-up|4
7248208|NCT00266032|11458858|FG002|Treatment|Lost to Follow-up|2
7248209|NCT00266032|11458856|FG000|Treatment|Pregnancy|3
7248210|NCT00266032|11458857|FG001|Treatment|Pregnancy|2
7248211|NCT00266032|11458858|FG002|Treatment|Pregnancy|2
7248212|NCT00266032|11458856|FG000|Treatment|Protocol Violation|6
7248213|NCT00266032|11458857|FG001|Treatment|Protocol Violation|14
7248214|NCT00266032|11458858|FG002|Treatment|Protocol Violation|13
7248215|NCT00266032|11458856|FG000|Treatment|Withdrawal by Subject|28
7383964|NCT01191944|11641073|FG000|Overall Study|Other|1
7383965|NCT01191944|11641074|FG001|Overall Study|Other|3
7383966|NCT01192022|11641084|FG000|Overall Study|Withdrawal of Consent|3
7248216|NCT00266032|11458857|FG001|Treatment|Withdrawal by Subject|13
7248217|NCT00266032|11458858|FG002|Treatment|Withdrawal by Subject|12
7248218|NCT00266032|11458856|FG000|Treatment|patient moved/wish for pregnancy/no need|13
7248219|NCT00266032|11458857|FG001|Treatment|patient moved/wish for pregnancy/no need|5
7248220|NCT00266032|11458858|FG002|Treatment|patient moved/wish for pregnancy/no need|8
7248221|NCT00266032|11458856|FG000|Open-label Safety Extension|Adverse Event|5
7248222|NCT00266032|11458857|FG001|Open-label Safety Extension|Adverse Event|0
7248223|NCT00266032|11458858|FG002|Open-label Safety Extension|Adverse Event|4
7248224|NCT00266032|11458856|FG000|Open-label Safety Extension|Lost to Follow-up|2
7248225|NCT00266032|11458857|FG001|Open-label Safety Extension|Lost to Follow-up|5
7248226|NCT00266032|11458858|FG002|Open-label Safety Extension|Lost to Follow-up|4
7248227|NCT00266032|11458856|FG000|Open-label Safety Extension|Pregnancy|4
7248228|NCT00266032|11458857|FG001|Open-label Safety Extension|Pregnancy|1
7248229|NCT00266032|11458858|FG002|Open-label Safety Extension|Pregnancy|2
7248230|NCT00266032|11458856|FG000|Open-label Safety Extension|Protocol Violation|1
7248231|NCT00266032|11458857|FG001|Open-label Safety Extension|Protocol Violation|3
7248232|NCT00266032|11458858|FG002|Open-label Safety Extension|Protocol Violation|2
7248233|NCT00266032|11458856|FG000|Open-label Safety Extension|Withdrawal by Subject|19
7248234|NCT00266032|11458857|FG001|Open-label Safety Extension|Withdrawal by Subject|3
7248235|NCT00266032|11458858|FG002|Open-label Safety Extension|Withdrawal by Subject|12
7248236|NCT00266032|11458856|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
7248237|NCT00266032|11458857|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
7248238|NCT00266032|11458858|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
7248239|NCT00266227|11458873|FG000|Initial Treatment|Adverse Event|0
7248240|NCT00266227|11458874|FG001|Initial Treatment|Adverse Event|0
7248241|NCT00266227|11458875|FG002|Initial Treatment|Adverse Event|13
7248242|NCT00266227|11458873|FG000|Initial Treatment|Lost to Follow-up|0
7248243|NCT00266227|11458874|FG001|Initial Treatment|Lost to Follow-up|0
7248244|NCT00266227|11458875|FG002|Initial Treatment|Lost to Follow-up|6
7248245|NCT00266227|11458873|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
7248246|NCT00266227|11458874|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
7248247|NCT00266227|11458875|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
7248248|NCT00266227|11458873|FG000|Initial Treatment|Physician decision to withdraw|0
7248249|NCT00266227|11458874|FG001|Initial Treatment|Physician decision to withdraw|0
7248250|NCT00266227|11458875|FG002|Initial Treatment|Physician decision to withdraw|12
7248251|NCT00266227|11458873|FG000|Initial Treatment|Pregnancy|0
7248252|NCT00266227|11458874|FG001|Initial Treatment|Pregnancy|0
7248253|NCT00266227|11458875|FG002|Initial Treatment|Pregnancy|1
7248254|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Death|1
7248255|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Death|0
7248256|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Death|0
7248257|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Adverse Event|7
7248258|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Adverse Event|7
7248259|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Adverse Event|0
7248260|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
7248261|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
7248262|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
7248263|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
7248264|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
7383967|NCT01192022|11641085|FG001|Overall Study|Withdrawal of Consent|1
7248265|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
7248266|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
7248267|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
7248268|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
7248269|NCT00266227|11458873|FG000|Retreatment: Up to Week 48|Pregnancy|1
7248270|NCT00266227|11458874|FG001|Retreatment: Up to Week 48|Pregnancy|0
7248271|NCT00266227|11458875|FG002|Retreatment: Up to Week 48|Pregnancy|0
7248272|NCT00266227|11458873|FG000|Retreatment: Week 48 to Week 72|Death|1
7248273|NCT00266227|11458874|FG001|Retreatment: Week 48 to Week 72|Death|1
7248274|NCT00266227|11458875|FG002|Retreatment: Week 48 to Week 72|Death|0
7248275|NCT00266227|11458873|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
7248276|NCT00266227|11458874|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
7248277|NCT00266227|11458875|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
7248278|NCT00266227|11458873|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
7248279|NCT00266227|11458874|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7248280|NCT00266227|11458875|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
7248281|NCT00266227|11458873|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
7248282|NCT00266227|11458874|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
7248283|NCT00266227|11458875|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
7248284|NCT00266227|11458873|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
7248285|NCT00266227|11458874|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
7248286|NCT00266227|11458875|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
7248287|NCT00266409|11458893|FG000|Overall Study|Lack of Efficacy|2
7248288|NCT00266409|11458894|FG001|Overall Study|Lack of Efficacy|6
7248289|NCT00266409|11458895|FG002|Overall Study|Lack of Efficacy|1
7248290|NCT00266409|11458896|FG003|Overall Study|Lack of Efficacy|2
7248291|NCT00266409|11458893|FG000|Overall Study|Adverse Event|7
7248292|NCT00266409|11458894|FG001|Overall Study|Adverse Event|2
7248293|NCT00266409|11458895|FG002|Overall Study|Adverse Event|1
7248294|NCT00266409|11458896|FG003|Overall Study|Adverse Event|1
7248295|NCT00266409|11458893|FG000|Overall Study|Lost to Follow-up|18
7248296|NCT00266409|11458894|FG001|Overall Study|Lost to Follow-up|21
7248297|NCT00266409|11458895|FG002|Overall Study|Lost to Follow-up|6
7248298|NCT00266409|11458896|FG003|Overall Study|Lost to Follow-up|8
7248299|NCT00266409|11458893|FG000|Overall Study|Withdrawal by Subject|6
7248300|NCT00266409|11458894|FG001|Overall Study|Withdrawal by Subject|10
7248301|NCT00266409|11458895|FG002|Overall Study|Withdrawal by Subject|3
7248302|NCT00266409|11458896|FG003|Overall Study|Withdrawal by Subject|9
7248303|NCT00266409|11458893|FG000|Overall Study|Protocol Violation|5
7248304|NCT00266409|11458894|FG001|Overall Study|Protocol Violation|3
7248305|NCT00266409|11458895|FG002|Overall Study|Protocol Violation|4
7248306|NCT00266409|11458896|FG003|Overall Study|Protocol Violation|2
7248307|NCT00266409|11458893|FG000|Overall Study|Other|7
7248308|NCT00266409|11458894|FG001|Overall Study|Other|4
7248309|NCT00266409|11458895|FG002|Overall Study|Other|2
7248310|NCT00266409|11458896|FG003|Overall Study|Other|0
7248311|NCT00266630|11458908|FG000|Overall Study|Adverse Event|8
7248312|NCT00266630|11458909|FG001|Overall Study|Adverse Event|6
7248313|NCT00266630|11458908|FG000|Overall Study|Lack of Efficacy|1
7248314|NCT00266630|11458909|FG001|Overall Study|Lack of Efficacy|4
7248315|NCT00266630|11458908|FG000|Overall Study|Entry Criteria not met|1
7248316|NCT00266630|11458909|FG001|Overall Study|Entry Criteria not met|0
7248317|NCT00266630|11458908|FG000|Overall Study|Protocol Violation|1
7248318|NCT00266630|11458909|FG001|Overall Study|Protocol Violation|3
7248319|NCT00266630|11458908|FG000|Overall Study|Physician Decision|1
7248320|NCT00266630|11458909|FG001|Overall Study|Physician Decision|2
7248321|NCT00266630|11458908|FG000|Overall Study|Withdrawal by Subject|10
7248322|NCT00266630|11458909|FG001|Overall Study|Withdrawal by Subject|2
7248323|NCT00266630|11458908|FG000|Overall Study|Lost to Follow-up|1
7248324|NCT00266630|11458909|FG001|Overall Study|Lost to Follow-up|0
7248325|NCT00266630|11458908|FG000|Overall Study|Other|19
7248326|NCT00266630|11458909|FG001|Overall Study|Other|11
7248327|NCT00266656|11458919|FG000|Overall Study|Death|1
7248328|NCT00266656|11458920|FG001|Overall Study|Death|0
7248329|NCT00266656|11458919|FG000|Overall Study|Lost to Follow-up|4
7248330|NCT00266656|11458920|FG001|Overall Study|Lost to Follow-up|1
7248331|NCT00266656|11458919|FG000|Overall Study|Withdrawal by Subject|4
7248332|NCT00266656|11458920|FG001|Overall Study|Withdrawal by Subject|2
7248333|NCT00266656|11458919|FG000|Overall Study|Did Not Reach Final Height|4
7248334|NCT00266656|11458920|FG001|Overall Study|Did Not Reach Final Height|8
7248335|NCT00266656|11458919|FG000|Overall Study|Parent/Caregiver Decision|1
7248336|NCT00266656|11458920|FG001|Overall Study|Parent/Caregiver Decision|2
7248337|NCT00266695|11458926|FG000|Overall Study|Adverse Event|1
7248338|NCT00266695|11458926|FG000|Overall Study|Death|9
7248339|NCT00266695|11458926|FG000|Overall Study|Physician Decision|1
7248340|NCT00266695|11458926|FG000|Overall Study|Lost to Follow-up|3
7248341|NCT00266695|11458926|FG000|Overall Study|Withdrawal by Subject|15
7248342|NCT00266708|11458932|FG000|Overall Study|No renal function|1
7248343|NCT00266708|11458933|FG001|Overall Study|No renal function|1
7248344|NCT00266708|11458932|FG000|Overall Study|Refused biopsy|3
7248345|NCT00266708|11458933|FG001|Overall Study|Refused biopsy|6
7248346|NCT00266708|11458932|FG000|Overall Study|Asthma|0
7248347|NCT00266708|11458933|FG001|Overall Study|Asthma|2
7248348|NCT00266812|11458950|FG000|Overall Study|Disease Progression|9
7248349|NCT00266812|11458951|FG001|Overall Study|Disease Progression|3
7248350|NCT00266812|11458950|FG000|Overall Study|Death|5
7248351|NCT00266812|11458951|FG001|Overall Study|Death|4
7248352|NCT00266812|11458950|FG000|Overall Study|Adverse Event|3
7248353|NCT00266812|11458951|FG001|Overall Study|Adverse Event|1
7248354|NCT00266812|11458950|FG000|Overall Study|Protocol Violation|0
7248355|NCT00266812|11458951|FG001|Overall Study|Protocol Violation|1
7248356|NCT00266812|11458950|FG000|Overall Study|Withdrawal by Subject|0
7248357|NCT00266812|11458951|FG001|Overall Study|Withdrawal by Subject|2
7248358|NCT00266812|11458950|FG000|Overall Study|Discontinued before starting study drug|4
7248359|NCT00266812|11458951|FG001|Overall Study|Discontinued before starting study drug|0
7248360|NCT00266825|11458959|FG000|Completed Follow-Up|Lost to Follow-up|14
7248361|NCT00266825|11458960|FG001|Completed Follow-Up|Lost to Follow-up|19
7248362|NCT00266825|11458959|FG000|Completed Follow-Up|Withdrawal by Subject|11
7248363|NCT00266825|11458960|FG001|Completed Follow-Up|Withdrawal by Subject|5
7248364|NCT00266864|11458987|FG000|Overall Study|Lost to Follow-up|4
7248365|NCT00266864|11458988|FG001|Overall Study|Lost to Follow-up|1
7248366|NCT00266864|11458987|FG000|Overall Study|Withdrawal by Subject|1
7248367|NCT00266864|11458988|FG001|Overall Study|Withdrawal by Subject|1
7248368|NCT00266877|11458997|FG000|Overall Study|Death|1
7248369|NCT00266877|11458998|FG001|Overall Study|Death|1
7248370|NCT00266877|11458999|FG002|Overall Study|Death|1
7248371|NCT00266877|11458997|FG000|Overall Study|Adverse Event|6
7248372|NCT00266877|11458998|FG001|Overall Study|Adverse Event|4
7248373|NCT00266877|11458999|FG002|Overall Study|Adverse Event|1
7248374|NCT00266877|11458997|FG000|Overall Study|Physician Decision|2
7248375|NCT00266877|11458998|FG001|Overall Study|Physician Decision|1
7248376|NCT00266877|11458999|FG002|Overall Study|Physician Decision|1
7248377|NCT00266877|11458997|FG000|Overall Study|Withdrawal by Subject|3
7248378|NCT00266877|11458998|FG001|Overall Study|Withdrawal by Subject|1
7248379|NCT00266877|11458999|FG002|Overall Study|Withdrawal by Subject|1
7248380|NCT00266877|11458997|FG000|Overall Study|Disease Progression|72
7248381|NCT00266877|11458998|FG001|Overall Study|Disease Progression|37
7248382|NCT00266877|11458999|FG002|Overall Study|Disease Progression|23
7248383|NCT00266877|11458997|FG000|Overall Study|Symptomatic Deterioration|6
7248384|NCT00266877|11458998|FG001|Overall Study|Symptomatic Deterioration|3
7248385|NCT00266877|11458999|FG002|Overall Study|Symptomatic Deterioration|1
7248386|NCT00266877|11458997|FG000|Overall Study|Hospitalization|1
7248387|NCT00266877|11458998|FG001|Overall Study|Hospitalization|0
7248388|NCT00266877|11458999|FG002|Overall Study|Hospitalization|0
7248389|NCT00266877|11458997|FG000|Overall Study|Concomitant Radiotherapy|0
7248390|NCT00266877|11458998|FG001|Overall Study|Concomitant Radiotherapy|1
7248391|NCT00266877|11458999|FG002|Overall Study|Concomitant Radiotherapy|0
7248392|NCT00267007|11459009|FG000|Overall Study|Withdrawal by Subject|6
7248393|NCT00267007|11459010|FG001|Overall Study|Withdrawal by Subject|0
7248394|NCT00267007|11459009|FG000|Overall Study|Lost to Follow-up|1
7248395|NCT00267007|11459010|FG001|Overall Study|Lost to Follow-up|0
7248396|NCT00267007|11459009|FG000|Overall Study|Non-compliance|0
7248397|NCT00267007|11459010|FG001|Overall Study|Non-compliance|1
7248398|NCT00267007|11459009|FG000|Overall Study|Adverse Event|1
7248399|NCT00267007|11459010|FG001|Overall Study|Adverse Event|0
7248400|NCT00267020|11459018|FG000|Overall Study|Adverse Event|22
7248401|NCT00267020|11459019|FG001|Overall Study|Adverse Event|5
7248402|NCT00267020|11459018|FG000|Overall Study|Death|2
7248403|NCT00267020|11459019|FG001|Overall Study|Death|1
7248404|NCT00267020|11459018|FG000|Overall Study|Withdrawal by Subject|17
7248405|NCT00267020|11459019|FG001|Overall Study|Withdrawal by Subject|7
7248406|NCT00267020|11459018|FG000|Overall Study|Physician Decision|3
7248407|NCT00267020|11459019|FG001|Overall Study|Physician Decision|2
7248408|NCT00267020|11459018|FG000|Overall Study|Disease Progression|39
7248409|NCT00267020|11459019|FG001|Overall Study|Disease Progression|25
7248410|NCT00267020|11459018|FG000|Overall Study|Unrelated Complication|1
7248411|NCT00267020|11459019|FG001|Overall Study|Unrelated Complication|1
7248412|NCT00267020|11459018|FG000|Overall Study|Sponsor Request|1
7248413|NCT00267020|11459019|FG001|Overall Study|Sponsor Request|0
7248414|NCT00267020|11459018|FG000|Overall Study|Other|1
7248415|NCT00267020|11459019|FG001|Overall Study|Other|2
7248416|NCT00267046|11459027|FG000|Overall Study|Disease progression|4
7248417|NCT00267046|11459028|FG001|Overall Study|Disease progression|2
7248418|NCT00267046|11459027|FG000|Overall Study|Chemotoxicity|2
7248419|NCT00267046|11459028|FG001|Overall Study|Chemotoxicity|0
7248420|NCT00267046|11459027|FG000|Overall Study|Open-label palifermin|2
7248421|NCT00267046|11459028|FG001|Overall Study|Open-label palifermin|7
7248422|NCT00267046|11459027|FG000|Overall Study|Surgery|3
7248423|NCT00267046|11459028|FG001|Overall Study|Surgery|1
7248424|NCT00267046|11459027|FG000|Overall Study|Withdrawal by Subject|1
7248425|NCT00267046|11459028|FG001|Overall Study|Withdrawal by Subject|0
7248426|NCT00267046|11459027|FG000|Overall Study|Radiation|0
7248427|NCT00267046|11459028|FG001|Overall Study|Radiation|1
7248428|NCT00267098|11459050|FG000|Overall Study|Death|0
7248429|NCT00267098|11459051|FG001|Overall Study|Death|0
7248430|NCT00267098|11459052|FG002|Overall Study|Death|57
7248431|NCT00267098|11459053|FG003|Overall Study|Death|66
7248432|NCT00267098|11459054|FG004|Overall Study|Death|14
7248433|NCT00267098|11459055|FG005|Overall Study|Death|23
7248434|NCT00267098|11459056|FG006|Overall Study|Death|28
7248435|NCT00267098|11459057|FG007|Overall Study|Death|9
7248436|NCT00267098|11459050|FG000|Overall Study|Lost to Follow-up|0
7248437|NCT00267098|11459051|FG001|Overall Study|Lost to Follow-up|0
7248438|NCT00267098|11459052|FG002|Overall Study|Lost to Follow-up|6
7248439|NCT00267098|11459053|FG003|Overall Study|Lost to Follow-up|5
7248440|NCT00267098|11459054|FG004|Overall Study|Lost to Follow-up|2
7248441|NCT00267098|11459055|FG005|Overall Study|Lost to Follow-up|3
7248442|NCT00267098|11459056|FG006|Overall Study|Lost to Follow-up|1
7248443|NCT00267098|11459057|FG007|Overall Study|Lost to Follow-up|1
7248444|NCT00267098|11459050|FG000|Overall Study|Withdrawal by Subject|8
7248445|NCT00267098|11459051|FG001|Overall Study|Withdrawal by Subject|0
7248446|NCT00267098|11459052|FG002|Overall Study|Withdrawal by Subject|24
7248447|NCT00267098|11459053|FG003|Overall Study|Withdrawal by Subject|21
7248448|NCT00267098|11459054|FG004|Overall Study|Withdrawal by Subject|12
7248449|NCT00267098|11459055|FG005|Overall Study|Withdrawal by Subject|9
7248450|NCT00267098|11459056|FG006|Overall Study|Withdrawal by Subject|12
7248451|NCT00267098|11459057|FG007|Overall Study|Withdrawal by Subject|5
7248452|NCT00267098|11459050|FG000|Overall Study|Physician Decision|5
7248453|NCT00267098|11459051|FG001|Overall Study|Physician Decision|0
7248454|NCT00267098|11459052|FG002|Overall Study|Physician Decision|7
7248455|NCT00267098|11459053|FG003|Overall Study|Physician Decision|11
7248456|NCT00267098|11459054|FG004|Overall Study|Physician Decision|5
7248457|NCT00267098|11459055|FG005|Overall Study|Physician Decision|4
7248458|NCT00267098|11459056|FG006|Overall Study|Physician Decision|3
7248459|NCT00267098|11459057|FG007|Overall Study|Physician Decision|0
7248460|NCT00267098|11459050|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
7248461|NCT00267098|11459051|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248462|NCT00267098|11459052|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248463|NCT00267098|11459053|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248464|NCT00267098|11459054|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7248465|NCT00267098|11459055|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248466|NCT00267098|11459056|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248467|NCT00267098|11459057|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7248468|NCT00267098|11459050|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248469|NCT00267098|11459051|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
7248470|NCT00267098|11459052|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248471|NCT00267098|11459053|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248472|NCT00267098|11459054|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248473|NCT00267098|11459055|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248474|NCT00267098|11459056|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248475|NCT00267098|11459057|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
7248476|NCT00267098|11459050|FG000|Overall Study|Site closure|0
7248477|NCT00267098|11459051|FG001|Overall Study|Site closure|0
7248478|NCT00267098|11459052|FG002|Overall Study|Site closure|0
7248479|NCT00267098|11459053|FG003|Overall Study|Site closure|1
7248480|NCT00267098|11459054|FG004|Overall Study|Site closure|0
7248481|NCT00267098|11459055|FG005|Overall Study|Site closure|1
7248482|NCT00267098|11459056|FG006|Overall Study|Site closure|1
7248483|NCT00267098|11459057|FG007|Overall Study|Site closure|0
7248484|NCT00267098|11459050|FG000|Overall Study|Explanted Medtronic device|0
7248485|NCT00267098|11459051|FG001|Overall Study|Explanted Medtronic device|0
7248486|NCT00267098|11459052|FG002|Overall Study|Explanted Medtronic device|0
7248487|NCT00267098|11459053|FG003|Overall Study|Explanted Medtronic device|1
7248488|NCT00267098|11459054|FG004|Overall Study|Explanted Medtronic device|0
7248489|NCT00267098|11459055|FG005|Overall Study|Explanted Medtronic device|0
7248490|NCT00267098|11459056|FG006|Overall Study|Explanted Medtronic device|0
7248491|NCT00267098|11459057|FG007|Overall Study|Explanted Medtronic device|0
7248492|NCT00267098|11459050|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
7248493|NCT00267098|11459051|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
7248494|NCT00267098|11459052|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
7248495|NCT00267098|11459053|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
7248496|NCT00267098|11459054|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
7248497|NCT00267098|11459055|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
7248498|NCT00267098|11459056|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
7248499|NCT00267098|11459057|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
7248500|NCT00267098|11459050|FG000|Overall Study|Subject listed for heart transplant|0
7248501|NCT00267098|11459051|FG001|Overall Study|Subject listed for heart transplant|0
7248502|NCT00267098|11459052|FG002|Overall Study|Subject listed for heart transplant|0
7248503|NCT00267098|11459053|FG003|Overall Study|Subject listed for heart transplant|0
7248504|NCT00267098|11459054|FG004|Overall Study|Subject listed for heart transplant|0
7248505|NCT00267098|11459055|FG005|Overall Study|Subject listed for heart transplant|0
7248506|NCT00267098|11459056|FG006|Overall Study|Subject listed for heart transplant|1
7248507|NCT00267098|11459057|FG007|Overall Study|Subject listed for heart transplant|0
7248508|NCT00267098|11459050|FG000|Overall Study|Sponsor withdrew subject|0
7248509|NCT00267098|11459051|FG001|Overall Study|Sponsor withdrew subject|0
7248510|NCT00267098|11459052|FG002|Overall Study|Sponsor withdrew subject|0
7248511|NCT00267098|11459053|FG003|Overall Study|Sponsor withdrew subject|1
7248512|NCT00267098|11459054|FG004|Overall Study|Sponsor withdrew subject|0
7248513|NCT00267098|11459055|FG005|Overall Study|Sponsor withdrew subject|0
7248514|NCT00267098|11459056|FG006|Overall Study|Sponsor withdrew subject|0
7248515|NCT00267098|11459057|FG007|Overall Study|Sponsor withdrew subject|0
7248516|NCT00267150|11459090|FG000|Overall Study|Adverse Event|1
7248517|NCT00267189|11459096|FG000|Overall Study|Patient withdrew consent|1
7248518|NCT00267189|11459097|FG001|Overall Study|Patient withdrew consent|1
7248519|NCT00267189|11459096|FG000|Overall Study|Death|1
7248520|NCT00267189|11459097|FG001|Overall Study|Death|0
7248521|NCT00267189|11459096|FG000|Overall Study|Missing|3
7248522|NCT00267189|11459097|FG001|Overall Study|Missing|0
7248523|NCT00267202|11459105|FG000|Overall Study|Unsatisfactory therapeutic effect|21
7248524|NCT00267202|11459106|FG001|Overall Study|Unsatisfactory therapeutic effect|8
7248525|NCT00267202|11459105|FG000|Overall Study|Withdrawal by Subject|12
7248526|NCT00267202|11459106|FG001|Overall Study|Withdrawal by Subject|15
7248527|NCT00267202|11459105|FG000|Overall Study|Adverse Event|13
7248528|NCT00267202|11459106|FG001|Overall Study|Adverse Event|7
7248529|NCT00267202|11459105|FG000|Overall Study|Protocol Violation|2
7248530|NCT00267202|11459106|FG001|Overall Study|Protocol Violation|3
7248531|NCT00267202|11459105|FG000|Overall Study|Administrative problems|2
7248532|NCT00267202|11459106|FG001|Overall Study|Administrative problems|1
7248533|NCT00267202|11459105|FG000|Overall Study|Lost to Follow-up|3
7248534|NCT00267202|11459106|FG001|Overall Study|Lost to Follow-up|0
7248535|NCT00267488|11459126|FG000|Overall Study|Sponsor Terminated Study|9
7248536|NCT00267488|11459126|FG000|Overall Study|Protocol Violation|1
7248537|NCT00267488|11459126|FG000|Overall Study|Other (Disease Progression)|1
7248538|NCT00267748|11459167|FG000|Non-randomized Period|Progressive disease|10
7248539|NCT00267748|11459168|FG001|Non-randomized Period|Progressive disease|0
7248540|NCT00267748|11459169|FG002|Non-randomized Period|Progressive disease|0
7248541|NCT00267748|11459167|FG000|Non-randomized Period|Adverse Event|8
7248542|NCT00267748|11459168|FG001|Non-randomized Period|Adverse Event|0
7248543|NCT00267748|11459169|FG002|Non-randomized Period|Adverse Event|0
7248544|NCT00267748|11459167|FG000|Non-randomized Period|Death|1
7248545|NCT00267748|11459168|FG001|Non-randomized Period|Death|0
7248546|NCT00267748|11459169|FG002|Non-randomized Period|Death|0
7248547|NCT00267748|11459167|FG000|Non-randomized Period|Participant not willing to participate|1
7248548|NCT00267748|11459168|FG001|Non-randomized Period|Participant not willing to participate|0
7248549|NCT00267748|11459169|FG002|Non-randomized Period|Participant not willing to participate|0
7248550|NCT00267748|11459167|FG000|Non-randomized Period|Other|3
7248551|NCT00267748|11459168|FG001|Non-randomized Period|Other|0
7248552|NCT00267748|11459169|FG002|Non-randomized Period|Other|0
7248553|NCT00267748|11459167|FG000|Randomized Period|Death|0
7248554|NCT00267748|11459168|FG001|Randomized Period|Death|2
7248555|NCT00267748|11459169|FG002|Randomized Period|Death|3
7248556|NCT00267748|11459167|FG000|Randomized Period|Adverse Event|0
7248557|NCT00267748|11459168|FG001|Randomized Period|Adverse Event|23
7248558|NCT00267748|11459169|FG002|Randomized Period|Adverse Event|25
7248559|NCT00267748|11459167|FG000|Randomized Period|Global deterioration of health status|0
7248560|NCT00267748|11459168|FG001|Randomized Period|Global deterioration of health status|6
7248561|NCT00267748|11459169|FG002|Randomized Period|Global deterioration of health status|7
7248562|NCT00267748|11459167|FG000|Randomized Period|Lost to Follow-up|0
7248563|NCT00267748|11459168|FG001|Randomized Period|Lost to Follow-up|1
7248564|NCT00267748|11459169|FG002|Randomized Period|Lost to Follow-up|0
7248565|NCT00267748|11459167|FG000|Randomized Period|Objective progression or relapse|0
7248566|NCT00267748|11459168|FG001|Randomized Period|Objective progression or relapse|77
7248567|NCT00267748|11459169|FG002|Randomized Period|Objective progression or relapse|86
7383968|NCT01192022|11641086|FG002|Overall Study|Withdrawal of Consent|0
7383969|NCT01192022|11641087|FG003|Overall Study|Withdrawal of Consent|0
7383970|NCT01192022|11641088|FG004|Overall Study|Withdrawal of Consent|0
7383971|NCT01192022|11641084|FG000|Overall Study|Lost to Follow-up|4
7383972|NCT01192022|11641085|FG001|Overall Study|Lost to Follow-up|2
7383973|NCT01192022|11641086|FG002|Overall Study|Lost to Follow-up|1
7383974|NCT01192022|11641087|FG003|Overall Study|Lost to Follow-up|1
7383975|NCT01192022|11641088|FG004|Overall Study|Lost to Follow-up|0
7383976|NCT01192022|11641084|FG000|Overall Study|Adverse Event|1
7383977|NCT01192022|11641085|FG001|Overall Study|Adverse Event|0
7383978|NCT01192022|11641086|FG002|Overall Study|Adverse Event|0
7383979|NCT01192022|11641087|FG003|Overall Study|Adverse Event|0
7383980|NCT01192022|11641088|FG004|Overall Study|Adverse Event|0
7383981|NCT01192022|11641084|FG000|Overall Study|Fatal Adverse Event|4
7383982|NCT01192022|11641085|FG001|Overall Study|Fatal Adverse Event|6
7383983|NCT01192022|11641086|FG002|Overall Study|Fatal Adverse Event|0
7383984|NCT01192022|11641087|FG003|Overall Study|Fatal Adverse Event|0
7383985|NCT01192022|11641088|FG004|Overall Study|Fatal Adverse Event|1
7383986|NCT01192022|11641084|FG000|Overall Study|Physician withdrew-patient hardship|1
7383987|NCT01192022|11641085|FG001|Overall Study|Physician withdrew-patient hardship|0
7383988|NCT01192022|11641086|FG002|Overall Study|Physician withdrew-patient hardship|0
7383989|NCT01192022|11641087|FG003|Overall Study|Physician withdrew-patient hardship|0
7383990|NCT01192022|11641088|FG004|Overall Study|Physician withdrew-patient hardship|0
7383991|NCT01192022|11641084|FG000|Overall Study|Patient too sick from chemotherapy|0
7383992|NCT01192022|11641085|FG001|Overall Study|Patient too sick from chemotherapy|1
7248568|NCT00267748|11459167|FG000|Randomized Period|Withdrawal by Subject|0
7383993|NCT01192022|11641086|FG002|Overall Study|Patient too sick from chemotherapy|0
7383994|NCT01192022|11641087|FG003|Overall Study|Patient too sick from chemotherapy|0
7383995|NCT01192022|11641088|FG004|Overall Study|Patient too sick from chemotherapy|0
7383996|NCT01192022|11641084|FG000|Overall Study|Patient needed surgery|0
7383997|NCT01192022|11641085|FG001|Overall Study|Patient needed surgery|1
7383998|NCT01192022|11641086|FG002|Overall Study|Patient needed surgery|0
7383999|NCT01192022|11641087|FG003|Overall Study|Patient needed surgery|0
7384000|NCT01192022|11641088|FG004|Overall Study|Patient needed surgery|0
7384001|NCT01192022|11641084|FG000|Overall Study|Parents did not allow all follow up|0
7248569|NCT00267748|11459168|FG001|Randomized Period|Withdrawal by Subject|9
7248570|NCT00267748|11459169|FG002|Randomized Period|Withdrawal by Subject|2
7248571|NCT00267748|11459167|FG000|Randomized Period|Other|0
7248572|NCT00267748|11459168|FG001|Randomized Period|Other|9
7248573|NCT00267748|11459169|FG002|Randomized Period|Other|6
7248574|NCT00267748|11459167|FG000|Randomized Period|randomized but not treated|0
7248575|NCT00267748|11459168|FG001|Randomized Period|randomized but not treated|0
7248576|NCT00267748|11459169|FG002|Randomized Period|randomized but not treated|3
7248577|NCT00267865|11459185|FG000|Induction Treatment|Died before completing.|2
7248578|NCT00267865|11459185|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
7248579|NCT00267956|11459191|FG000|Controlled Period|Adverse Event|4
7248580|NCT00267956|11459192|FG001|Controlled Period|Adverse Event|1
7248581|NCT00267956|11459193|FG002|Controlled Period|Adverse Event|0
7248582|NCT00267956|11459194|FG003|Controlled Period|Adverse Event|0
7248583|NCT00267956|11459191|FG000|Controlled Period|Lack of Efficacy|4
7248584|NCT00267956|11459192|FG001|Controlled Period|Lack of Efficacy|2
7248585|NCT00267956|11459193|FG002|Controlled Period|Lack of Efficacy|0
7248586|NCT00267956|11459194|FG003|Controlled Period|Lack of Efficacy|0
7248587|NCT00267956|11459191|FG000|Controlled Period|Lost to Follow-up|2
7248588|NCT00267956|11459192|FG001|Controlled Period|Lost to Follow-up|0
7248589|NCT00267956|11459193|FG002|Controlled Period|Lost to Follow-up|0
7248590|NCT00267956|11459194|FG003|Controlled Period|Lost to Follow-up|0
7248591|NCT00267956|11459191|FG000|Controlled Period|Withdrew consent|3
7248592|NCT00267956|11459192|FG001|Controlled Period|Withdrew consent|1
7248593|NCT00267956|11459193|FG002|Controlled Period|Withdrew consent|0
7248594|NCT00267956|11459194|FG003|Controlled Period|Withdrew consent|0
7248595|NCT00267956|11459191|FG000|After Controlled Period|Adverse Event|0
7248596|NCT00267956|11459192|FG001|After Controlled Period|Adverse Event|0
7248597|NCT00267956|11459193|FG002|After Controlled Period|Adverse Event|2
7248598|NCT00267956|11459194|FG003|After Controlled Period|Adverse Event|1
7248599|NCT00267956|11459191|FG000|After Controlled Period|Lack of Efficacy|0
7248600|NCT00267956|11459192|FG001|After Controlled Period|Lack of Efficacy|0
7248601|NCT00267956|11459193|FG002|After Controlled Period|Lack of Efficacy|1
7248602|NCT00267956|11459194|FG003|After Controlled Period|Lack of Efficacy|1
7248603|NCT00267956|11459191|FG000|After Controlled Period|Lost to Follow-up|0
7248604|NCT00267956|11459192|FG001|After Controlled Period|Lost to Follow-up|0
7248605|NCT00267956|11459193|FG002|After Controlled Period|Lost to Follow-up|1
7248606|NCT00267956|11459194|FG003|After Controlled Period|Lost to Follow-up|0
7248607|NCT00267956|11459191|FG000|After Controlled Period|Withdrew consent|0
7248608|NCT00267956|11459192|FG001|After Controlled Period|Withdrew consent|0
7248609|NCT00267956|11459193|FG002|After Controlled Period|Withdrew consent|1
7248610|NCT00267956|11459194|FG003|After Controlled Period|Withdrew consent|0
7248611|NCT00267969|11459205|FG000|Controlled Period|Adverse Event|6
7248612|NCT00267969|11459206|FG001|Controlled Period|Adverse Event|0
7248613|NCT00267969|11459207|FG002|Controlled Period|Adverse Event|2
7248614|NCT00267969|11459208|FG003|Controlled Period|Adverse Event|0
7248615|NCT00267969|11459209|FG004|Controlled Period|Adverse Event|0
7248616|NCT00267969|11459210|FG005|Controlled Period|Adverse Event|0
7248617|NCT00267969|11459211|FG006|Controlled Period|Adverse Event|0
7248618|NCT00267969|11459205|FG000|Controlled Period|Lack of Efficacy|3
7248619|NCT00267969|11459206|FG001|Controlled Period|Lack of Efficacy|0
7248620|NCT00267969|11459207|FG002|Controlled Period|Lack of Efficacy|1
7248621|NCT00267969|11459208|FG003|Controlled Period|Lack of Efficacy|0
7248622|NCT00267969|11459209|FG004|Controlled Period|Lack of Efficacy|0
7248623|NCT00267969|11459210|FG005|Controlled Period|Lack of Efficacy|0
7248624|NCT00267969|11459211|FG006|Controlled Period|Lack of Efficacy|0
7248625|NCT00267969|11459205|FG000|Controlled Period|Lost to Follow-up|1
7248626|NCT00267969|11459206|FG001|Controlled Period|Lost to Follow-up|0
7248627|NCT00267969|11459207|FG002|Controlled Period|Lost to Follow-up|1
7248628|NCT00267969|11459208|FG003|Controlled Period|Lost to Follow-up|0
7248629|NCT00267969|11459209|FG004|Controlled Period|Lost to Follow-up|0
7248630|NCT00267969|11459210|FG005|Controlled Period|Lost to Follow-up|0
7248631|NCT00267969|11459211|FG006|Controlled Period|Lost to Follow-up|0
7248632|NCT00267969|11459205|FG000|Controlled Period|Randomized but not treated|0
7248633|NCT00267969|11459206|FG001|Controlled Period|Randomized but not treated|0
7248634|NCT00267969|11459207|FG002|Controlled Period|Randomized but not treated|1
7248635|NCT00267969|11459208|FG003|Controlled Period|Randomized but not treated|0
7248636|NCT00267969|11459209|FG004|Controlled Period|Randomized but not treated|0
7248637|NCT00267969|11459210|FG005|Controlled Period|Randomized but not treated|0
7248638|NCT00267969|11459211|FG006|Controlled Period|Randomized but not treated|0
7248639|NCT00267969|11459205|FG000|Controlled Period|Other|2
7248640|NCT00267969|11459206|FG001|Controlled Period|Other|1
7248641|NCT00267969|11459207|FG002|Controlled Period|Other|6
7248642|NCT00267969|11459208|FG003|Controlled Period|Other|0
7248643|NCT00267969|11459209|FG004|Controlled Period|Other|0
7248644|NCT00267969|11459210|FG005|Controlled Period|Other|0
7248645|NCT00267969|11459211|FG006|Controlled Period|Other|0
7248646|NCT00267969|11459205|FG000|After Controlled Period|Adverse Event|0
7248647|NCT00267969|11459206|FG001|After Controlled Period|Adverse Event|0
7248648|NCT00267969|11459207|FG002|After Controlled Period|Adverse Event|0
7248649|NCT00267969|11459208|FG003|After Controlled Period|Adverse Event|7
7248650|NCT00267969|11459209|FG004|After Controlled Period|Adverse Event|8
7248651|NCT00267969|11459210|FG005|After Controlled Period|Adverse Event|23
7248652|NCT00267969|11459211|FG006|After Controlled Period|Adverse Event|21
7248653|NCT00267969|11459205|FG000|After Controlled Period|Death|0
7248654|NCT00267969|11459206|FG001|After Controlled Period|Death|0
7248655|NCT00267969|11459207|FG002|After Controlled Period|Death|0
7248656|NCT00267969|11459208|FG003|After Controlled Period|Death|1
7248657|NCT00267969|11459209|FG004|After Controlled Period|Death|2
7248658|NCT00267969|11459210|FG005|After Controlled Period|Death|0
7248659|NCT00267969|11459211|FG006|After Controlled Period|Death|1
7248660|NCT00267969|11459205|FG000|After Controlled Period|Lack of Efficacy|0
7248661|NCT00267969|11459206|FG001|After Controlled Period|Lack of Efficacy|0
7248662|NCT00267969|11459207|FG002|After Controlled Period|Lack of Efficacy|0
7248663|NCT00267969|11459208|FG003|After Controlled Period|Lack of Efficacy|10
7248664|NCT00267969|11459209|FG004|After Controlled Period|Lack of Efficacy|6
7248665|NCT00267969|11459210|FG005|After Controlled Period|Lack of Efficacy|28
7248666|NCT00267969|11459211|FG006|After Controlled Period|Lack of Efficacy|15
7248667|NCT00267969|11459205|FG000|After Controlled Period|Lost to Follow-up|0
7248668|NCT00267969|11459206|FG001|After Controlled Period|Lost to Follow-up|0
7248669|NCT00267969|11459207|FG002|After Controlled Period|Lost to Follow-up|0
7248670|NCT00267969|11459208|FG003|After Controlled Period|Lost to Follow-up|5
7248671|NCT00267969|11459209|FG004|After Controlled Period|Lost to Follow-up|8
7248672|NCT00267969|11459210|FG005|After Controlled Period|Lost to Follow-up|9
7248673|NCT00267969|11459211|FG006|After Controlled Period|Lost to Follow-up|10
7248674|NCT00267969|11459205|FG000|After Controlled Period|Other|0
7248675|NCT00267969|11459206|FG001|After Controlled Period|Other|0
7248676|NCT00267969|11459207|FG002|After Controlled Period|Other|0
7248677|NCT00267969|11459208|FG003|After Controlled Period|Other|13
7248678|NCT00267969|11459209|FG004|After Controlled Period|Other|11
7248679|NCT00267969|11459210|FG005|After Controlled Period|Other|22
7248680|NCT00267969|11459211|FG006|After Controlled Period|Other|25
7248681|NCT00268203|11459229|FG000|Overall Study|Lost to Follow-up|92
7248682|NCT00268203|11459229|FG000|Overall Study|Withdrawal by Subject|9
7248683|NCT00268203|11459229|FG000|Overall Study|Received Other NHL Therapy|7
7248684|NCT00268203|11459229|FG000|Overall Study|Progressive Disease|359
7248685|NCT00268203|11459229|FG000|Overall Study|Death|84
7248686|NCT00268203|11459229|FG000|Overall Study|Reason Not Specified|34
7248687|NCT00268203|11459229|FG000|Overall Study|Completed 2 Years of Follow-up|62
7248688|NCT00268242|11459233|FG000|Overall Study|Death|1
7248689|NCT00268346|11459239|FG000|Overall Study|Adverse Event|0
7248690|NCT00268346|11459240|FG001|Overall Study|Adverse Event|1
7248691|NCT00268346|11459239|FG000|Overall Study|Death|0
7248692|NCT00268346|11459240|FG001|Overall Study|Death|1
7248693|NCT00268346|11459239|FG000|Overall Study|Withdrawal by Subject|0
7248694|NCT00268346|11459240|FG001|Overall Study|Withdrawal by Subject|1
7248695|NCT00268437|11459246|FG000|Overall Study|Ineligible|1
7248696|NCT00268892|11459258|FG000|Overall Study|Adverse Event|14
7248697|NCT00268892|11459259|FG001|Overall Study|Adverse Event|17
7248698|NCT00268892|11459260|FG002|Overall Study|Adverse Event|20
7248699|NCT00268892|11459258|FG000|Overall Study|Lack of Efficacy|1
7248700|NCT00268892|11459259|FG001|Overall Study|Lack of Efficacy|3
7248701|NCT00268892|11459260|FG002|Overall Study|Lack of Efficacy|0
7248702|NCT00268892|11459258|FG000|Overall Study|Withdrawal by Subject|14
7248703|NCT00268892|11459259|FG001|Overall Study|Withdrawal by Subject|15
7248704|NCT00268892|11459260|FG002|Overall Study|Withdrawal by Subject|13
7248705|NCT00268892|11459258|FG000|Overall Study|Physician Decision|0
7248706|NCT00268892|11459259|FG001|Overall Study|Physician Decision|1
7248707|NCT00268892|11459260|FG002|Overall Study|Physician Decision|0
7248708|NCT00268892|11459258|FG000|Overall Study|Lost to Follow-up|5
7248709|NCT00268892|11459259|FG001|Overall Study|Lost to Follow-up|2
7248710|NCT00268892|11459260|FG002|Overall Study|Lost to Follow-up|4
7248711|NCT00268892|11459258|FG000|Overall Study|Protocol Violation|0
7384002|NCT01192022|11641085|FG001|Overall Study|Parents did not allow all follow up|0
7248712|NCT00268892|11459259|FG001|Overall Study|Protocol Violation|1
7248713|NCT00268892|11459260|FG002|Overall Study|Protocol Violation|0
7248714|NCT00268892|11459258|FG000|Overall Study|Disease Progression|1
7248715|NCT00268892|11459259|FG001|Overall Study|Disease Progression|1
7248716|NCT00268892|11459260|FG002|Overall Study|Disease Progression|0
7248717|NCT00268892|11459258|FG000|Overall Study|Trial Site Closed|4
7248718|NCT00268892|11459259|FG001|Overall Study|Trial Site Closed|2
7248719|NCT00268892|11459260|FG002|Overall Study|Trial Site Closed|2
7248720|NCT00268905|11459271|FG000|Overall Study|Adverse Event|3
7248721|NCT00268905|11459272|FG001|Overall Study|Adverse Event|0
7248722|NCT00268905|11459273|FG002|Overall Study|Adverse Event|4
7248723|NCT00268905|11459271|FG000|Overall Study|Lost to Follow-up|0
7248724|NCT00268905|11459272|FG001|Overall Study|Lost to Follow-up|1
7248725|NCT00268905|11459273|FG002|Overall Study|Lost to Follow-up|0
7248726|NCT00268905|11459271|FG000|Overall Study|Withdrawal by Subject|0
7248727|NCT00268905|11459272|FG001|Overall Study|Withdrawal by Subject|0
7248728|NCT00268905|11459273|FG002|Overall Study|Withdrawal by Subject|3
7248729|NCT00268905|11459271|FG000|Overall Study|Progressive Disease|28
7248730|NCT00268905|11459272|FG001|Overall Study|Progressive Disease|4
7248731|NCT00268905|11459273|FG002|Overall Study|Progressive Disease|3
7248732|NCT00268905|11459271|FG000|Overall Study|Physician Decision|3
7248733|NCT00268905|11459272|FG001|Overall Study|Physician Decision|0
7248734|NCT00268905|11459273|FG002|Overall Study|Physician Decision|1
7248735|NCT00268905|11459271|FG000|Overall Study|Clinical Progression|9
7248736|NCT00268905|11459272|FG001|Overall Study|Clinical Progression|4
7248737|NCT00268905|11459273|FG002|Overall Study|Clinical Progression|1
7248738|NCT00268983|11459283|FG000|Overall Study|Death|3
7248739|NCT00268983|11459284|FG001|Overall Study|Death|0
7248740|NCT00268996|11459292|FG000|Overall Study|Adverse Event|11
7248741|NCT00268996|11459293|FG001|Overall Study|Adverse Event|7
7248742|NCT00268996|11459292|FG000|Overall Study|Lost to Follow-up|3
7248743|NCT00268996|11459293|FG001|Overall Study|Lost to Follow-up|1
7248744|NCT00268996|11459292|FG000|Overall Study|Withdrawal by Subject|5
7248745|NCT00268996|11459293|FG001|Overall Study|Withdrawal by Subject|11
7248746|NCT00268996|11459292|FG000|Overall Study|Non-compliance|1
7248747|NCT00268996|11459293|FG001|Overall Study|Non-compliance|0
7248748|NCT00268996|11459292|FG000|Overall Study|Other|1
7248749|NCT00268996|11459293|FG001|Overall Study|Other|1
7248750|NCT00269087|11459301|FG000|Overall Study|Adverse Event|20
7248751|NCT00269087|11459301|FG000|Overall Study|Withdrawal by Subject|1
7248752|NCT00269087|11459301|FG000|Overall Study|Exacerbation of COPD|13
7248753|NCT00269113|11459307|FG000|Overall Study|Adverse Event|14
7248754|NCT00269113|11459308|FG001|Overall Study|Adverse Event|7
7248755|NCT00269113|11459307|FG000|Overall Study|Lack of Efficacy|35
7248756|NCT00269113|11459308|FG001|Overall Study|Lack of Efficacy|18
7248757|NCT00269113|11459307|FG000|Overall Study|Early Improvement|2
7248758|NCT00269113|11459308|FG001|Overall Study|Early Improvement|0
7248759|NCT00269113|11459307|FG000|Overall Study|Withdrawal by Subject|0
7248760|NCT00269113|11459308|FG001|Overall Study|Withdrawal by Subject|2
7248761|NCT00269113|11459307|FG000|Overall Study|Death|6
7248762|NCT00269113|11459308|FG001|Overall Study|Death|2
7248763|NCT00269113|11459307|FG000|Overall Study|Lost to Follow-up|2
7248764|NCT00269113|11459308|FG001|Overall Study|Lost to Follow-up|1
7248765|NCT00269113|11459307|FG000|Overall Study|Protocol Violation|15
7248766|NCT00269113|11459308|FG001|Overall Study|Protocol Violation|5
7248767|NCT00269113|11459307|FG000|Overall Study|Other|0
7248768|NCT00269113|11459308|FG001|Overall Study|Other|2
7248769|NCT00269152|11459316|FG000|Overall Study|Adverse Event|9
7248770|NCT00269152|11459317|FG001|Overall Study|Adverse Event|3
7248771|NCT00269152|11459316|FG000|Overall Study|Withdrawal by Subject|7
7248772|NCT00269152|11459317|FG001|Overall Study|Withdrawal by Subject|3
7248773|NCT00269152|11459316|FG000|Overall Study|Physician Decision|2
7248774|NCT00269152|11459317|FG001|Overall Study|Physician Decision|3
7248775|NCT00269152|11459316|FG000|Overall Study|Protocol Violation|0
7248776|NCT00269152|11459317|FG001|Overall Study|Protocol Violation|1
7248777|NCT00269399|11459325|FG000|Overall Study|Lack of Efficacy|27
7248778|NCT00269399|11459326|FG001|Overall Study|Lack of Efficacy|10
7248779|NCT00269399|11459325|FG000|Overall Study|Adverse Event|10
7248780|NCT00269399|11459326|FG001|Overall Study|Adverse Event|4
7248781|NCT00269399|11459325|FG000|Overall Study|Withdrawal by Subject|2
7248782|NCT00269399|11459326|FG001|Overall Study|Withdrawal by Subject|5
7248783|NCT00269399|11459325|FG000|Overall Study|Negative Lab Result for C. difficile|2
7248784|NCT00269399|11459326|FG001|Overall Study|Negative Lab Result for C. difficile|3
7248785|NCT00269399|11459325|FG000|Overall Study|Other|0
7248786|NCT00269399|11459326|FG001|Overall Study|Other|4
7248787|NCT00269399|11459325|FG000|Overall Study|Development of exclusion criteria|0
7248788|NCT00269399|11459326|FG001|Overall Study|Development of exclusion criteria|1
7248789|NCT00269477|11459336|FG000|Overall Study|Protocol Violation|5
7248790|NCT00269477|11459337|FG001|Overall Study|Protocol Violation|5
7248791|NCT00269477|11459338|FG002|Overall Study|Protocol Violation|1
7248792|NCT00269477|11459339|FG003|Overall Study|Protocol Violation|0
7248793|NCT00269477|11459336|FG000|Overall Study|Missed post-vaccination blood draw|0
7248794|NCT00269477|11459337|FG001|Overall Study|Missed post-vaccination blood draw|1
7248795|NCT00269477|11459338|FG002|Overall Study|Missed post-vaccination blood draw|0
7248796|NCT00269477|11459339|FG003|Overall Study|Missed post-vaccination blood draw|0
7248797|NCT00269633|11459351|FG000|Overall Study|Withdrawal by Subject|1
7248798|NCT00269633|11459352|FG001|Overall Study|Withdrawal by Subject|0
7248799|NCT00269919|11459358|FG000|Overall Study|Other|26
7248800|NCT00269919|11459358|FG000|Overall Study|Started but not treated|1
7248801|NCT00270205|11459367|FG000|Overall Study|Lost to Follow-up|1
7248802|NCT00270205|11459368|FG001|Overall Study|Lost to Follow-up|0
7248803|NCT00270205|11459369|FG002|Overall Study|Lost to Follow-up|0
7248804|NCT00270205|11459370|FG003|Overall Study|Lost to Follow-up|1
7248805|NCT00270231|11459380|FG000|First Intervention|Lost to Follow-up|1
7248806|NCT00270231|11459381|FG001|First Intervention|Lost to Follow-up|1
7248807|NCT00270231|11459380|FG000|Washout Period|Lost to Follow-up|1
7248808|NCT00270231|11459381|FG001|Washout Period|Lost to Follow-up|0
7248809|NCT00270231|11459380|FG000|Second Intervention|Lost to Follow-up|0
7248810|NCT00270231|11459381|FG001|Second Intervention|Lost to Follow-up|1
7248811|NCT00270257|11459389|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
7248812|NCT00270257|11459390|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
7248813|NCT00270855|11459451|FG000|Overall Study|Withdrawal by Subject|8
7248814|NCT00270855|11459452|FG001|Overall Study|Withdrawal by Subject|8
7248815|NCT00270894|11459460|FG000|Overall Study|Adverse Event|1
7248816|NCT00270894|11459460|FG000|Overall Study|Withdrawal by Subject|1
7248817|NCT00270998|11459467|FG000|3 Month Follow-up|Adverse Event|1
7248818|NCT00270998|11459468|FG001|3 Month Follow-up|Adverse Event|0
7248819|NCT00270998|11459469|FG002|3 Month Follow-up|Adverse Event|0
7248820|NCT00270998|11459467|FG000|3 Month Follow-up|Lack of Efficacy|1
7248821|NCT00270998|11459468|FG001|3 Month Follow-up|Lack of Efficacy|2
7248822|NCT00270998|11459469|FG002|3 Month Follow-up|Lack of Efficacy|1
7248823|NCT00270998|11459467|FG000|3 Month Follow-up|Withdrawal by Subject|11
7248824|NCT00270998|11459468|FG001|3 Month Follow-up|Withdrawal by Subject|14
7248825|NCT00270998|11459469|FG002|3 Month Follow-up|Withdrawal by Subject|15
7248826|NCT00270998|11459467|FG000|3 Month Follow-up|Pessary did not fit|12
7248827|NCT00270998|11459468|FG001|3 Month Follow-up|Pessary did not fit|0
7248828|NCT00270998|11459469|FG002|3 Month Follow-up|Pessary did not fit|0
7248829|NCT00270998|11459467|FG000|3 Month Follow-up|Personal/family health|1
7248830|NCT00270998|11459468|FG001|3 Month Follow-up|Personal/family health|1
7248831|NCT00270998|11459469|FG002|3 Month Follow-up|Personal/family health|0
7248832|NCT00270998|11459467|FG000|3 Month Follow-up|Received/desired alternate treatment|13
7248833|NCT00270998|11459468|FG001|3 Month Follow-up|Received/desired alternate treatment|5
7248834|NCT00270998|11459469|FG002|3 Month Follow-up|Received/desired alternate treatment|2
7248835|NCT00270998|11459467|FG000|12 Month Follow-up|Lack of Efficacy|5
7248836|NCT00270998|11459468|FG001|12 Month Follow-up|Lack of Efficacy|4
7248837|NCT00270998|11459469|FG002|12 Month Follow-up|Lack of Efficacy|3
7248838|NCT00270998|11459467|FG000|12 Month Follow-up|Withdrawal by Subject|7
7248839|NCT00270998|11459468|FG001|12 Month Follow-up|Withdrawal by Subject|12
7248840|NCT00270998|11459469|FG002|12 Month Follow-up|Withdrawal by Subject|16
7248841|NCT00270998|11459467|FG000|12 Month Follow-up|Pessary did not fit|1
7248842|NCT00270998|11459468|FG001|12 Month Follow-up|Pessary did not fit|0
7248843|NCT00270998|11459469|FG002|12 Month Follow-up|Pessary did not fit|0
7248844|NCT00270998|11459467|FG000|12 Month Follow-up|Personal/family health|0
7248845|NCT00270998|11459468|FG001|12 Month Follow-up|Personal/family health|5
7248846|NCT00270998|11459469|FG002|12 Month Follow-up|Personal/family health|1
7248847|NCT00270998|11459467|FG000|12 Month Follow-up|Received/desired alternate treatment|1
7248848|NCT00270998|11459468|FG001|12 Month Follow-up|Received/desired alternate treatment|4
7248849|NCT00270998|11459469|FG002|12 Month Follow-up|Received/desired alternate treatment|1
7248850|NCT00271024|11459483|FG000|Overall Study|Lost Interest|3
7248851|NCT00271024|11459484|FG001|Overall Study|Lost Interest|4
7248852|NCT00271024|11459485|FG002|Overall Study|Lost Interest|2
7248853|NCT00271024|11459486|FG003|Overall Study|Lost Interest|3
7248854|NCT00271024|11459483|FG000|Overall Study|Unknown/Unspecified|11
7248855|NCT00271024|11459484|FG001|Overall Study|Unknown/Unspecified|11
7248856|NCT00271024|11459485|FG002|Overall Study|Unknown/Unspecified|8
7248857|NCT00271024|11459486|FG003|Overall Study|Unknown/Unspecified|4
7248858|NCT00271024|11459483|FG000|Overall Study|Protocol Violation|1
7248859|NCT00271024|11459484|FG001|Overall Study|Protocol Violation|6
7248860|NCT00271024|11459485|FG002|Overall Study|Protocol Violation|5
7248861|NCT00271024|11459486|FG003|Overall Study|Protocol Violation|11
7248862|NCT00271024|11459483|FG000|Overall Study|Unpleasant Reaction To Tablet|1
7248863|NCT00271024|11459484|FG001|Overall Study|Unpleasant Reaction To Tablet|3
7248864|NCT00271024|11459485|FG002|Overall Study|Unpleasant Reaction To Tablet|4
7248865|NCT00271024|11459486|FG003|Overall Study|Unpleasant Reaction To Tablet|2
7248866|NCT00271024|11459483|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
7248867|NCT00271024|11459484|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
7248868|NCT00271024|11459485|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
7248869|NCT00271024|11459486|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
7248870|NCT00271505|11459533|FG000|Overall Study|Screen Failure|3
7248871|NCT00271505|11459533|FG000|Overall Study|Adverse Event|1
7248872|NCT00271505|11459533|FG000|Overall Study|Death|1
7248873|NCT00271596|11459549|FG000|Overall Study|Protocol Violation|1
7248874|NCT00271596|11459550|FG001|Overall Study|Protocol Violation|0
7248875|NCT00271596|11459549|FG000|Overall Study|Withdrawal by Subject|0
7248876|NCT00271596|11459550|FG001|Overall Study|Withdrawal by Subject|1
7248877|NCT00271609|11459558|FG000|Overall Study|Adverse Event|11
7248878|NCT00271609|11459559|FG001|Overall Study|Adverse Event|3
7248879|NCT00271609|11459558|FG000|Overall Study|Withdrawal by Subject|2
7248880|NCT00271609|11459559|FG001|Overall Study|Withdrawal by Subject|0
7248881|NCT00271856|11459576|FG000|Overall Study|Withdrawal by Subject|1
7248882|NCT00271856|11459577|FG001|Overall Study|Withdrawal by Subject|7
7248883|NCT00271856|11459576|FG000|Overall Study|Lost to Follow-up|10
7248884|NCT00271856|11459577|FG001|Overall Study|Lost to Follow-up|11
7248885|NCT00272038|11459583|FG000|Overall Study|withdrew before they received 2 cycles|7
7256340|NCT00322153|11467790|FG001|Overall Study|Withdrawn for other reasons|4
7256341|NCT00322348|11467836|FG000|Overall Study|Adverse Event|0
7256342|NCT00322348|11467837|FG001|Overall Study|Adverse Event|1
7256343|NCT00322348|11467836|FG000|Overall Study|Withdrawal by Subject|1
7256344|NCT00322348|11467837|FG001|Overall Study|Withdrawal by Subject|4
7256345|NCT00322348|11467836|FG000|Overall Study|Lost to Follow-up|1
7256346|NCT00322348|11467837|FG001|Overall Study|Lost to Follow-up|0
7256347|NCT00322348|11467836|FG000|Overall Study|Death|0
7248886|NCT00272779|11459641|FG000|Baseline Through Week 48|Adverse event before Week 48|10
7248887|NCT00272779|11459642|FG001|Baseline Through Week 48|Adverse event before Week 48|14
7248888|NCT00272779|11459641|FG000|Baseline Through Week 48|Death before Week 48|4
7248889|NCT00272779|11459642|FG001|Baseline Through Week 48|Death before Week 48|4
7248890|NCT00272779|11459641|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
7248891|NCT00272779|11459642|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
7249095|NCT00274625|11459826|FG000|Overall Study|Excluded from analysis|14
7248892|NCT00272779|11459641|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
7248893|NCT00272779|11459642|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
7248894|NCT00272779|11459641|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
7248895|NCT00272779|11459642|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
7248896|NCT00272779|11459641|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
7248897|NCT00272779|11459642|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
7248898|NCT00272779|11459641|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
7248899|NCT00272779|11459642|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
7248900|NCT00272779|11459641|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
7248901|NCT00272779|11459642|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
7248902|NCT00272779|11459641|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
7248903|NCT00272779|11459642|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
7248904|NCT00272779|11459641|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
7248905|NCT00272779|11459642|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
7248906|NCT00272779|11459641|FG000|Baseline Through Week 48|Chose different site before wk 48|0
7248907|NCT00272779|11459642|FG001|Baseline Through Week 48|Chose different site before wk 48|1
7248908|NCT00272779|11459641|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
7248909|NCT00272779|11459642|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
7248910|NCT00272779|11459641|FG000|Baseline Through Week 48|Death on/after Week 48|1
7248911|NCT00272779|11459642|FG001|Baseline Through Week 48|Death on/after Week 48|1
7248912|NCT00272779|11459641|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
7248913|NCT00272779|11459642|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
7248914|NCT00272779|11459641|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
7248915|NCT00272779|11459642|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
7248916|NCT00272779|11459641|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7248917|NCT00272779|11459642|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
7248918|NCT00272779|11459641|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
7248919|NCT00272779|11459642|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
7248920|NCT00272779|11459641|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
7248921|NCT00272779|11459642|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
7248922|NCT00272779|11459641|FG000|Baseline Through Week 48|Continuing treatment|385
7248923|NCT00272779|11459642|FG001|Baseline Through Week 48|Continuing treatment|368
7248924|NCT00272779|11459641|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
7248925|NCT00272779|11459642|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
7248926|NCT00272779|11459641|FG000|Baseline Through Week 48|Never treated|2
7248927|NCT00272779|11459642|FG001|Baseline Through Week 48|Never treated|3
7248928|NCT00272779|11459641|FG000|Baseline Through Week 96|Adverse event before Week 96|13
7248929|NCT00272779|11459642|FG001|Baseline Through Week 96|Adverse event before Week 96|22
7248930|NCT00272779|11459641|FG000|Baseline Through Week 96|Death before Week 96|6
7248931|NCT00272779|11459642|FG001|Baseline Through Week 96|Death before Week 96|5
7248932|NCT00272779|11459641|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
7248933|NCT00272779|11459642|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
7248934|NCT00272779|11459641|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
7248935|NCT00272779|11459642|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
7248936|NCT00272779|11459641|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
7248937|NCT00272779|11459642|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
7248938|NCT00272779|11459641|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
7248939|NCT00272779|11459642|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
7248940|NCT00272779|11459641|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
7248941|NCT00272779|11459642|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
7248942|NCT00272779|11459641|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
7248943|NCT00272779|11459642|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
7248944|NCT00272779|11459641|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
7248945|NCT00272779|11459642|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
7248946|NCT00272779|11459641|FG000|Baseline Through Week 96|Changed address before Week 96|0
7248947|NCT00272779|11459642|FG001|Baseline Through Week 96|Changed address before Week 96|1
7248948|NCT00272779|11459641|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
7574346|NCT03672006|11956960|FG000|Overall Study|exclusion criteria met|0
7248949|NCT00272779|11459642|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
7248950|NCT00272779|11459641|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
7248951|NCT00272779|11459642|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
7248952|NCT00272779|11459641|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
7248953|NCT00272779|11459642|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
7248954|NCT00272779|11459641|FG000|Baseline Through Week 96|Never treated|2
7248955|NCT00272779|11459642|FG001|Baseline Through Week 96|Never treated|3
7248956|NCT00272779|11459641|FG000|Baseline Through Week 96|Continuing on treatment|61
7248957|NCT00272779|11459642|FG001|Baseline Through Week 96|Continuing on treatment|38
7248958|NCT00272792|11459651|FG000|Part 1: Responsiveness|Lost to Follow-up|1
7248959|NCT00272792|11459652|FG001|Part 1: Responsiveness|Lost to Follow-up|0
7248960|NCT00272792|11459651|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
7248961|NCT00272792|11459652|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
7248962|NCT00272792|11459651|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
7248963|NCT00272792|11459652|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
7248964|NCT00272792|11459651|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
7248965|NCT00272792|11459652|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
7248966|NCT00272844|11459658|FG000|Overall Study|Withdrawal by Subject|5
7248967|NCT00272961|11459667|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
7248968|NCT00272961|11459668|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7248969|NCT00272961|11459669|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7248970|NCT00272961|11459670|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7248971|NCT00272961|11459671|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
7248972|NCT00272961|11459667|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
7248973|NCT00272961|11459668|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7248974|NCT00272961|11459669|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7248975|NCT00272961|11459670|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7248976|NCT00272961|11459671|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
7248977|NCT00272961|11459667|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
7248978|NCT00272961|11459668|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7248979|NCT00272961|11459669|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7248980|NCT00272961|11459670|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7248981|NCT00272961|11459671|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
7248982|NCT00272961|11459667|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
7248983|NCT00272961|11459668|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7248984|NCT00272961|11459669|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7248985|NCT00272961|11459670|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7248986|NCT00272961|11459671|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
7248987|NCT00272961|11459667|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
7248988|NCT00272961|11459668|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
7248989|NCT00272961|11459669|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
7248990|NCT00272961|11459670|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
7248991|NCT00272961|11459671|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
7248992|NCT00272961|11459667|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7248993|NCT00272961|11459668|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7384003|NCT01192022|11641086|FG002|Overall Study|Parents did not allow all follow up|0
7384004|NCT01192022|11641087|FG003|Overall Study|Parents did not allow all follow up|1
7384005|NCT01192022|11641088|FG004|Overall Study|Parents did not allow all follow up|0
7248994|NCT00272961|11459669|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
7248995|NCT00272961|11459670|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
7248996|NCT00272961|11459671|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
7248997|NCT00272961|11459667|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7248998|NCT00272961|11459668|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7248999|NCT00272961|11459669|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
7249000|NCT00272961|11459670|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7249001|NCT00272961|11459671|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
7249002|NCT00272961|11459667|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
7249003|NCT00272961|11459668|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
7249004|NCT00272961|11459669|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
7249005|NCT00272961|11459670|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
7249006|NCT00272961|11459671|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
7249007|NCT00272987|11459686|FG000|Overall Study|Adverse Event|1
7249008|NCT00272987|11459687|FG001|Overall Study|Adverse Event|0
7249009|NCT00272987|11459688|FG002|Overall Study|Adverse Event|0
7249010|NCT00272987|11459686|FG000|Overall Study|Lost to Follow-up|3
7249011|NCT00272987|11459687|FG001|Overall Study|Lost to Follow-up|1
7249012|NCT00272987|11459688|FG002|Overall Study|Lost to Follow-up|1
7249013|NCT00272987|11459686|FG000|Overall Study|Withdrawal by Subject|1
7249014|NCT00272987|11459687|FG001|Overall Study|Withdrawal by Subject|0
7249015|NCT00272987|11459688|FG002|Overall Study|Withdrawal by Subject|3
7384006|NCT01192100|11641099|FG000|Overall Study|Withdrawal by Subject|0
7384007|NCT01192100|11641100|FG001|Overall Study|Withdrawal by Subject|0
7249016|NCT00272987|11459686|FG000|Overall Study|Sponsor Terminated study|0
7249017|NCT00272987|11459687|FG001|Overall Study|Sponsor Terminated study|1
7249018|NCT00272987|11459688|FG002|Overall Study|Sponsor Terminated study|1
7249019|NCT00272987|11459686|FG000|Overall Study|Disease progression|1
7249020|NCT00272987|11459687|FG001|Overall Study|Disease progression|1
7249021|NCT00272987|11459688|FG002|Overall Study|Disease progression|2
7249022|NCT00272987|11459686|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
7249023|NCT00272987|11459687|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
7249024|NCT00272987|11459688|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
7249025|NCT00272987|11459686|FG000|Overall Study|Death|1
7249026|NCT00272987|11459687|FG001|Overall Study|Death|0
7249027|NCT00272987|11459688|FG002|Overall Study|Death|0
7249028|NCT00273052|11459698|FG000|Overall Study|Withdrawal by Subject|16
7249029|NCT00273052|11459699|FG001|Overall Study|Withdrawal by Subject|19
7249030|NCT00273052|11459698|FG000|Overall Study|Adverse Event|21
7249031|NCT00273052|11459699|FG001|Overall Study|Adverse Event|19
7249032|NCT00273052|11459698|FG000|Overall Study|Protocol Violation|14
7249033|NCT00273052|11459699|FG001|Overall Study|Protocol Violation|18
7249034|NCT00273052|11459698|FG000|Overall Study|Lost to Follow-up|7
7574347|NCT03672006|11956961|FG001|Overall Study|exclusion criteria met|1
7574348|NCT03672097|11956978|FG000|Period 1|Withdrawal by Subject|2
7574349|NCT03672097|11956978|FG000|Period 1|Adverse Event|1
7574350|NCT03672097|11956978|FG000|Period 1|Did not receive treatment|1
7249035|NCT00273052|11459699|FG001|Overall Study|Lost to Follow-up|25
7249036|NCT00273052|11459698|FG000|Overall Study|Lack of Efficacy|6
7574351|NCT03672097|11956978|FG000|Period 2|Withdrawal by Subject|3
7574352|NCT03672097|11956978|FG000|Period 2|Other|1
7574353|NCT03672396|11956986|FG000|Overall Study|Withdrawal by Subject|4
7574354|NCT03672396|11956986|FG000|Overall Study|Physician Decision|1
7574355|NCT03672396|11956986|FG000|Overall Study|Adverse Event|1
7574356|NCT03673670|11956996|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
7574357|NCT03673670|11956997|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7574358|NCT03673670|11956998|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7574359|NCT03673670|11956999|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7249037|NCT00273052|11459699|FG001|Overall Study|Lack of Efficacy|4
7249038|NCT00273052|11459698|FG000|Overall Study|Non-Compliance|3
7249039|NCT00273052|11459699|FG001|Overall Study|Non-Compliance|1
7249040|NCT00273052|11459698|FG000|Overall Study|Other|2
7249041|NCT00273052|11459699|FG001|Overall Study|Other|0
7249042|NCT00273052|11459698|FG000|Overall Study|Worsening serum lipid levels|0
7249043|NCT00273052|11459699|FG001|Overall Study|Worsening serum lipid levels|2
7249044|NCT00273182|11459705|FG000|Overall Study|Death|450
7249045|NCT00273182|11459705|FG000|Overall Study|Lost to Follow-up|88
7249046|NCT00273182|11459705|FG000|Overall Study|Withdrawal by Subject|257
7249047|NCT00273182|11459705|FG000|Overall Study|Device/System Explant|154
7249048|NCT00273182|11459705|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
7249049|NCT00273858|11459753|FG000|Overall Study|Not completed 24 month observation time|334
7249050|NCT00273858|11459753|FG000|Overall Study|Lost to Follow-up|101
7249051|NCT00273858|11459753|FG000|Overall Study|Withdrawal by Subject|21
7249052|NCT00273858|11459753|FG000|Overall Study|Adverse Event|81
7249053|NCT00274261|11459784|FG000|Overall Study|Adverse Event|19
7249054|NCT00274261|11459785|FG001|Overall Study|Adverse Event|11
7249055|NCT00274261|11459784|FG000|Overall Study|Pregnancy|114
7249056|NCT00274261|11459785|FG001|Overall Study|Pregnancy|83
7249057|NCT00274261|11459784|FG000|Overall Study|Withdrawal by Subject|179
7249058|NCT00274261|11459785|FG001|Overall Study|Withdrawal by Subject|126
7574360|NCT03673670|11957000|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7249059|NCT00274261|11459784|FG000|Overall Study|Protocol Violation|71
7249060|NCT00274261|11459785|FG001|Overall Study|Protocol Violation|42
7249061|NCT00274261|11459784|FG000|Overall Study|Lost to Follow-up|106
7249062|NCT00274261|11459785|FG001|Overall Study|Lost to Follow-up|75
7249063|NCT00274287|11459793|FG000|Overall Study|Withdrawal by Subject|1
7249064|NCT00274287|11459793|FG000|Overall Study|subject non-compliance|1
7249065|NCT00274456|11459802|FG000|Overall Study|Still on treatment|2
7249066|NCT00274456|11459803|FG001|Overall Study|Still on treatment|3
7249067|NCT00274456|11459804|FG002|Overall Study|Still on treatment|5
7249068|NCT00274456|11459805|FG003|Overall Study|Still on treatment|1
7249069|NCT00274456|11459802|FG000|Overall Study|Unacceptable toxicity|10
7249070|NCT00274456|11459803|FG001|Overall Study|Unacceptable toxicity|5
7249071|NCT00274456|11459804|FG002|Overall Study|Unacceptable toxicity|12
7249072|NCT00274456|11459805|FG003|Overall Study|Unacceptable toxicity|16
7249073|NCT00274456|11459802|FG000|Overall Study|Adverse Event|0
7249074|NCT00274456|11459803|FG001|Overall Study|Adverse Event|1
7249075|NCT00274456|11459804|FG002|Overall Study|Adverse Event|2
7249076|NCT00274456|11459805|FG003|Overall Study|Adverse Event|2
7249077|NCT00274456|11459802|FG000|Overall Study|Physician Decision|7
7249078|NCT00274456|11459803|FG001|Overall Study|Physician Decision|5
7249079|NCT00274456|11459804|FG002|Overall Study|Physician Decision|6
7249080|NCT00274456|11459805|FG003|Overall Study|Physician Decision|13
7249081|NCT00274456|11459802|FG000|Overall Study|Lost to Follow-up|0
7249082|NCT00274456|11459803|FG001|Overall Study|Lost to Follow-up|0
7249083|NCT00274456|11459804|FG002|Overall Study|Lost to Follow-up|1
7249084|NCT00274456|11459805|FG003|Overall Study|Lost to Follow-up|0
7249085|NCT00274456|11459802|FG000|Overall Study|Withdrawal by Subject|18
7249086|NCT00274456|11459803|FG001|Overall Study|Withdrawal by Subject|13
7249087|NCT00274456|11459804|FG002|Overall Study|Withdrawal by Subject|9
7249088|NCT00274456|11459805|FG003|Overall Study|Withdrawal by Subject|13
7249089|NCT00274469|11459817|FG000|Overall Study|Death|63
7249090|NCT00274469|11459818|FG001|Overall Study|Death|74
7249091|NCT00274469|11459817|FG000|Overall Study|Did not consent to OS follow-up|16
7249092|NCT00274469|11459818|FG001|Overall Study|Did not consent to OS follow-up|19
7249093|NCT00274625|11459826|FG000|Overall Study|Lost to Follow-up|46
7249094|NCT00274625|11459827|FG001|Overall Study|Lost to Follow-up|54
7249096|NCT00274625|11459827|FG001|Overall Study|Excluded from analysis|8
7249097|NCT00274651|11459835|FG000|Overall Study|Adverse Event|6
7249098|NCT00274651|11459836|FG001|Overall Study|Adverse Event|3
7249099|NCT00274651|11459835|FG000|Overall Study|Lack of Efficacy|13
7249100|NCT00274651|11459836|FG001|Overall Study|Lack of Efficacy|6
7249101|NCT00274651|11459835|FG000|Overall Study|Death|1
7249102|NCT00274651|11459836|FG001|Overall Study|Death|3
7249103|NCT00274651|11459835|FG000|Overall Study|Withdrawal by Subject|0
7249104|NCT00274651|11459836|FG001|Overall Study|Withdrawal by Subject|1
7249105|NCT00274651|11459835|FG000|Overall Study|Physician Decision|8
7249106|NCT00274651|11459836|FG001|Overall Study|Physician Decision|7
7249107|NCT00274716|11459849|FG000|Phase A|Other non-reported reason|4
7249108|NCT00274716|11459850|FG001|Phase A|Other non-reported reason|2
7249109|NCT00274716|11459851|FG002|Phase A|Other non-reported reason|1
7249110|NCT00274716|11459852|FG003|Phase A|Other non-reported reason|2
7249111|NCT00274716|11459853|FG004|Phase A|Other non-reported reason|0
7249112|NCT00274716|11459854|FG005|Phase A|Other non-reported reason|1
7249113|NCT00274716|11459849|FG000|Phase A|Participant moved|0
7249114|NCT00274716|11459850|FG001|Phase A|Participant moved|0
7249115|NCT00274716|11459851|FG002|Phase A|Participant moved|1
7249116|NCT00274716|11459852|FG003|Phase A|Participant moved|0
7249117|NCT00274716|11459853|FG004|Phase A|Participant moved|0
7249118|NCT00274716|11459854|FG005|Phase A|Participant moved|1
7249119|NCT00274716|11459849|FG000|Phase A|Site Terminated|0
7249120|NCT00274716|11459850|FG001|Phase A|Site Terminated|0
7249121|NCT00274716|11459851|FG002|Phase A|Site Terminated|0
7249122|NCT00274716|11459852|FG003|Phase A|Site Terminated|1
7249123|NCT00274716|11459853|FG004|Phase A|Site Terminated|0
7249124|NCT00274716|11459854|FG005|Phase A|Site Terminated|0
7249125|NCT00274716|11459849|FG000|Phase A|Protocol Violation|1
7249126|NCT00274716|11459850|FG001|Phase A|Protocol Violation|0
7249127|NCT00274716|11459851|FG002|Phase A|Protocol Violation|0
7249128|NCT00274716|11459852|FG003|Phase A|Protocol Violation|1
7249129|NCT00274716|11459853|FG004|Phase A|Protocol Violation|0
7249130|NCT00274716|11459854|FG005|Phase A|Protocol Violation|0
7249131|NCT00274716|11459849|FG000|Phase A|Met criteria for discontinuation|1
7249132|NCT00274716|11459850|FG001|Phase A|Met criteria for discontinuation|1
7249133|NCT00274716|11459851|FG002|Phase A|Met criteria for discontinuation|0
7249134|NCT00274716|11459852|FG003|Phase A|Met criteria for discontinuation|0
7249135|NCT00274716|11459853|FG004|Phase A|Met criteria for discontinuation|0
7249136|NCT00274716|11459854|FG005|Phase A|Met criteria for discontinuation|0
7249137|NCT00274716|11459849|FG000|Phase A|Withdrawal by Subject|2
7249138|NCT00274716|11459850|FG001|Phase A|Withdrawal by Subject|2
7249139|NCT00274716|11459851|FG002|Phase A|Withdrawal by Subject|1
7249140|NCT00274716|11459852|FG003|Phase A|Withdrawal by Subject|3
7249141|NCT00274716|11459853|FG004|Phase A|Withdrawal by Subject|0
7249142|NCT00274716|11459854|FG005|Phase A|Withdrawal by Subject|1
7249143|NCT00274716|11459849|FG000|Phase A|Adverse Event|2
7249144|NCT00274716|11459850|FG001|Phase A|Adverse Event|3
7249145|NCT00274716|11459851|FG002|Phase A|Adverse Event|3
7249146|NCT00274716|11459852|FG003|Phase A|Adverse Event|0
7249147|NCT00274716|11459853|FG004|Phase A|Adverse Event|2
7249148|NCT00274716|11459854|FG005|Phase A|Adverse Event|0
7249149|NCT00274716|11459849|FG000|Phase A|Completed but did not enter Phase B|1
7249150|NCT00274716|11459850|FG001|Phase A|Completed but did not enter Phase B|2
7249151|NCT00274716|11459851|FG002|Phase A|Completed but did not enter Phase B|2
7249152|NCT00274716|11459852|FG003|Phase A|Completed but did not enter Phase B|2
7249153|NCT00274716|11459853|FG004|Phase A|Completed but did not enter Phase B|1
7249154|NCT00274716|11459854|FG005|Phase A|Completed but did not enter Phase B|1
7249155|NCT00274716|11459849|FG000|Phase B|Adverse Event|0
7249156|NCT00274716|11459850|FG001|Phase B|Adverse Event|0
7249157|NCT00274716|11459851|FG002|Phase B|Adverse Event|2
7249158|NCT00274716|11459852|FG003|Phase B|Adverse Event|0
7249159|NCT00274716|11459853|FG004|Phase B|Adverse Event|0
7249160|NCT00274716|11459854|FG005|Phase B|Adverse Event|1
7249161|NCT00274716|11459849|FG000|Phase B|Protocol Violation|0
7249162|NCT00274716|11459850|FG001|Phase B|Protocol Violation|2
7249163|NCT00274716|11459851|FG002|Phase B|Protocol Violation|0
7249164|NCT00274716|11459852|FG003|Phase B|Protocol Violation|0
7249165|NCT00274716|11459853|FG004|Phase B|Protocol Violation|0
7249166|NCT00274716|11459854|FG005|Phase B|Protocol Violation|0
7249167|NCT00274716|11459849|FG000|Phase B|Withdrawal by Subject|0
7249168|NCT00274716|11459850|FG001|Phase B|Withdrawal by Subject|1
7249169|NCT00274716|11459851|FG002|Phase B|Withdrawal by Subject|0
7249170|NCT00274716|11459852|FG003|Phase B|Withdrawal by Subject|0
7249171|NCT00274716|11459853|FG004|Phase B|Withdrawal by Subject|0
7249172|NCT00274716|11459854|FG005|Phase B|Withdrawal by Subject|0
7249173|NCT00274716|11459849|FG000|Phase B|Participant moved|1
7249174|NCT00274716|11459850|FG001|Phase B|Participant moved|0
7249175|NCT00274716|11459851|FG002|Phase B|Participant moved|0
7249176|NCT00274716|11459852|FG003|Phase B|Participant moved|0
7249177|NCT00274716|11459853|FG004|Phase B|Participant moved|0
7249178|NCT00274716|11459854|FG005|Phase B|Participant moved|0
7249179|NCT00274716|11459849|FG000|Phase B|Other non-reported reason|0
7249180|NCT00274716|11459850|FG001|Phase B|Other non-reported reason|0
7249181|NCT00274716|11459851|FG002|Phase B|Other non-reported reason|1
7249182|NCT00274716|11459852|FG003|Phase B|Other non-reported reason|1
7249183|NCT00274716|11459853|FG004|Phase B|Other non-reported reason|0
7249184|NCT00274716|11459854|FG005|Phase B|Other non-reported reason|0
7249185|NCT00274716|11459849|FG000|Phase B|Lost to Follow-up|0
7249186|NCT00274716|11459850|FG001|Phase B|Lost to Follow-up|1
7249187|NCT00274716|11459851|FG002|Phase B|Lost to Follow-up|0
7249188|NCT00274716|11459852|FG003|Phase B|Lost to Follow-up|0
7249189|NCT00274716|11459853|FG004|Phase B|Lost to Follow-up|0
7249190|NCT00274716|11459854|FG005|Phase B|Lost to Follow-up|0
7249191|NCT00274742|11459878|FG000|Overall Study|Adverse Event|0
7249192|NCT00274742|11459879|FG001|Overall Study|Adverse Event|4
7249193|NCT00274742|11459880|FG002|Overall Study|Adverse Event|1
7249194|NCT00274742|11459881|FG003|Overall Study|Adverse Event|4
7249195|NCT00274742|11459882|FG004|Overall Study|Adverse Event|12
7249196|NCT00274742|11459883|FG005|Overall Study|Adverse Event|3
7249197|NCT00274742|11459878|FG000|Overall Study|Lost to Follow-up|0
7249198|NCT00274742|11459879|FG001|Overall Study|Lost to Follow-up|0
7249199|NCT00274742|11459880|FG002|Overall Study|Lost to Follow-up|0
7249200|NCT00274742|11459881|FG003|Overall Study|Lost to Follow-up|0
7249201|NCT00274742|11459882|FG004|Overall Study|Lost to Follow-up|1
7249202|NCT00274742|11459883|FG005|Overall Study|Lost to Follow-up|0
7249203|NCT00274742|11459878|FG000|Overall Study|End of Study|0
7249204|NCT00274742|11459879|FG001|Overall Study|End of Study|0
7249205|NCT00274742|11459880|FG002|Overall Study|End of Study|0
7249206|NCT00274742|11459881|FG003|Overall Study|End of Study|1
7249207|NCT00274742|11459882|FG004|Overall Study|End of Study|0
7249208|NCT00274742|11459883|FG005|Overall Study|End of Study|0
7249209|NCT00274742|11459878|FG000|Overall Study|Disease Progression|0
7249210|NCT00274742|11459879|FG001|Overall Study|Disease Progression|1
7249211|NCT00274742|11459880|FG002|Overall Study|Disease Progression|1
7249212|NCT00274742|11459881|FG003|Overall Study|Disease Progression|0
7249213|NCT00274742|11459882|FG004|Overall Study|Disease Progression|1
7249214|NCT00274742|11459883|FG005|Overall Study|Disease Progression|0
7249215|NCT00274742|11459878|FG000|Overall Study|Other|0
7249216|NCT00274742|11459879|FG001|Overall Study|Other|3
7249217|NCT00274742|11459880|FG002|Overall Study|Other|0
7249218|NCT00274742|11459881|FG003|Overall Study|Other|0
7249219|NCT00274742|11459882|FG004|Overall Study|Other|2
7249220|NCT00274742|11459883|FG005|Overall Study|Other|0
7249221|NCT00274846|11459912|FG000|Overall Study|Did not receive adequate NK cells|1
7249222|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
7249223|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
7249224|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
7249225|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7249226|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
7249227|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
7249228|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7249229|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
7249230|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
7249231|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7249232|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
7249233|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
7249234|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7249235|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
7249236|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
7249237|NCT00274924|11459920|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7249238|NCT00274924|11459921|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
7249239|NCT00274924|11459922|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
7249240|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
7249241|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
7249242|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
7249243|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
7249244|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7249245|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
7249246|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
7249247|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7249248|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
7249249|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
7249250|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7249251|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
7249252|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7249253|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
7249254|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
7249255|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7249256|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
7249257|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
7249258|NCT00274924|11459920|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7249259|NCT00274924|11459921|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
7249260|NCT00274924|11459922|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
7574361|NCT03673670|11957001|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
7574362|NCT03673670|11956996|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
7249264|NCT00275002|11459935|FG000|Overall Study|Death|1
7249265|NCT00275002|11459936|FG001|Overall Study|Death|0
7249266|NCT00275002|11459935|FG000|Overall Study|Disease progression|21
7249267|NCT00275002|11459936|FG001|Overall Study|Disease progression|15
7249268|NCT00275002|11459935|FG000|Overall Study|Adverse Event|0
7249269|NCT00275002|11459936|FG001|Overall Study|Adverse Event|1
7249270|NCT00275028|11459942|FG000|Overall Study|Withdrew consent before treatment began|1
7249271|NCT00275028|11459942|FG000|Overall Study|Withdrawal by Subject|5
7249272|NCT00275028|11459942|FG000|Overall Study|Adverse Event|9
7249273|NCT00275028|11459942|FG000|Overall Study|Progressive Disease|30
7249274|NCT00275028|11459942|FG000|Overall Study|Physician Decision|2
7249275|NCT00275262|11459948|FG000|Overall Study|Adverse Event|2
7249276|NCT00275262|11459949|FG001|Overall Study|Adverse Event|0
7249277|NCT00275262|11459948|FG000|Overall Study|Disease progression|2
7249278|NCT00275262|11459949|FG001|Overall Study|Disease progression|5
7249279|NCT00275262|11459948|FG000|Overall Study|Lost to Follow-up|0
7249280|NCT00275262|11459949|FG001|Overall Study|Lost to Follow-up|2
7249281|NCT00275262|11459948|FG000|Overall Study|Protocol Violation|0
7249282|NCT00275262|11459949|FG001|Overall Study|Protocol Violation|2
7249283|NCT00275262|11459948|FG000|Overall Study|Death|1
7249284|NCT00275262|11459949|FG001|Overall Study|Death|0
7249285|NCT00275262|11459948|FG000|Overall Study|Started Chemotherapy|1
7249286|NCT00275262|11459949|FG001|Overall Study|Started Chemotherapy|0
7249287|NCT00275301|11459968|FG000|Overall Study|Adverse Event|5
7249288|NCT00275509|11459983|FG000|Overall Study|graft thrombosis, post-operative day #8|0
7249289|NCT00275509|11459984|FG001|Overall Study|graft thrombosis, post-operative day #8|1
7249290|NCT00275561|11459992|FG000|Overall Study|Withdrawal by Subject|0
7249291|NCT00275561|11459993|FG001|Overall Study|Withdrawal by Subject|1
7249292|NCT00275561|11459992|FG000|Overall Study|Travel|1
7249293|NCT00275561|11459993|FG001|Overall Study|Travel|1
7249294|NCT00275561|11459992|FG000|Overall Study|Scheduling|1
7249295|NCT00275561|11459993|FG001|Overall Study|Scheduling|2
7249296|NCT00275561|11459992|FG000|Overall Study|Family Issues|0
7249297|NCT00275561|11459993|FG001|Overall Study|Family Issues|2
7249298|NCT00275821|11460002|FG000|Overall Study|Adverse Event|4
7249299|NCT00275821|11460003|FG001|Overall Study|Adverse Event|12
7249300|NCT00275821|11460004|FG002|Overall Study|Adverse Event|5
7249301|NCT00275821|11460002|FG000|Overall Study|Administrative problems|3
7249302|NCT00275821|11460003|FG001|Overall Study|Administrative problems|4
7249303|NCT00275821|11460004|FG002|Overall Study|Administrative problems|4
7249304|NCT00275821|11460002|FG000|Overall Study|Withdrawal by Subject|0
7249305|NCT00275821|11460003|FG001|Overall Study|Withdrawal by Subject|2
7249306|NCT00275821|11460004|FG002|Overall Study|Withdrawal by Subject|1
7249307|NCT00275821|11460002|FG000|Overall Study|Lost to Follow-up|0
7249308|NCT00275821|11460003|FG001|Overall Study|Lost to Follow-up|1
7249309|NCT00275821|11460004|FG002|Overall Study|Lost to Follow-up|1
7249310|NCT00275821|11460002|FG000|Overall Study|Death|0
7249311|NCT00275821|11460003|FG001|Overall Study|Death|2
7249312|NCT00275821|11460004|FG002|Overall Study|Death|1
7249313|NCT00275821|11460002|FG000|Overall Study|Lack of Efficacy|2
7249314|NCT00275821|11460003|FG001|Overall Study|Lack of Efficacy|1
7249315|NCT00275821|11460004|FG002|Overall Study|Lack of Efficacy|0
7249316|NCT00275821|11460002|FG000|Overall Study|Protocol Violation|5
7249317|NCT00275821|11460003|FG001|Overall Study|Protocol Violation|1
7249318|NCT00275821|11460004|FG002|Overall Study|Protocol Violation|0
7249319|NCT00276094|11460030|FG000|Overall Study|Adverse Event|15
7249320|NCT00276094|11460031|FG001|Overall Study|Adverse Event|13
7249321|NCT00276094|11460032|FG002|Overall Study|Adverse Event|11
7249322|NCT00276094|11460030|FG000|Overall Study|Withdrawal by Subject|14
7249323|NCT00276094|11460031|FG001|Overall Study|Withdrawal by Subject|14
7249324|NCT00276094|11460032|FG002|Overall Study|Withdrawal by Subject|12
7249325|NCT00276094|11460030|FG000|Overall Study|Protocol Violation|16
7249326|NCT00276094|11460031|FG001|Overall Study|Protocol Violation|7
7249327|NCT00276094|11460032|FG002|Overall Study|Protocol Violation|10
7249328|NCT00276094|11460030|FG000|Overall Study|Lost to Follow-up|8
7249329|NCT00276094|11460031|FG001|Overall Study|Lost to Follow-up|6
7249330|NCT00276094|11460032|FG002|Overall Study|Lost to Follow-up|4
7249331|NCT00276094|11460030|FG000|Overall Study|Other-Subject moved out of country|1
7249332|NCT00276094|11460031|FG001|Overall Study|Other-Subject moved out of country|0
7249333|NCT00276094|11460032|FG002|Overall Study|Other-Subject moved out of country|0
7249334|NCT00276094|11460030|FG000|Overall Study|Other-Scheduled gastroplasty|1
7249335|NCT00276094|11460031|FG001|Overall Study|Other-Scheduled gastroplasty|0
7249336|NCT00276094|11460032|FG002|Overall Study|Other-Scheduled gastroplasty|0
7249337|NCT00276094|11460030|FG000|Overall Study|Other-Lack of efficacy|1
7249338|NCT00276094|11460031|FG001|Overall Study|Other-Lack of efficacy|0
7249339|NCT00276094|11460032|FG002|Overall Study|Other-Lack of efficacy|0
7249340|NCT00276094|11460030|FG000|Overall Study|Other-Refused follow-up visit|1
7249341|NCT00276094|11460031|FG001|Overall Study|Other-Refused follow-up visit|0
7249342|NCT00276094|11460032|FG002|Overall Study|Other-Refused follow-up visit|0
7249343|NCT00276094|11460030|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
7249344|NCT00276094|11460031|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
7249345|NCT00276094|11460032|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
7249346|NCT00276094|11460030|FG000|Overall Study|Other-Relocation|0
7249347|NCT00276094|11460031|FG001|Overall Study|Other-Relocation|1
7249348|NCT00276094|11460032|FG002|Overall Study|Other-Relocation|0
7249349|NCT00276094|11460030|FG000|Overall Study|Other-Study medication lost|0
7249350|NCT00276094|11460031|FG001|Overall Study|Other-Study medication lost|0
7249351|NCT00276094|11460032|FG002|Overall Study|Other-Study medication lost|1
7249352|NCT00276159|11460040|FG000|Overall Study|Did not receive all 24 doses of 852A|6
7249353|NCT00276380|11460059|FG000|Overall Study|Adverse Event|5
7249354|NCT00276380|11460060|FG001|Overall Study|Adverse Event|3
7249355|NCT00276380|11460059|FG000|Overall Study|Lost to Follow-up|1
7249356|NCT00276380|11460060|FG001|Overall Study|Lost to Follow-up|1
7249357|NCT00276380|11460059|FG000|Overall Study|Withdrawal by Subject|3
7249358|NCT00276380|11460060|FG001|Overall Study|Withdrawal by Subject|6
7249359|NCT00276380|11460059|FG000|Overall Study|Death|5
7249360|NCT00276380|11460060|FG001|Overall Study|Death|3
7249361|NCT00276380|11460059|FG000|Overall Study|Abnormal aPPT Levels|0
7249362|NCT00276380|11460060|FG001|Overall Study|Abnormal aPPT Levels|1
7249363|NCT00276614|11460080|FG000|Overall Study|Progression of disease under study|3
7249364|NCT00276744|11460084|FG000|PART A|Reason unknown|98
7249365|NCT00277095|11460093|FG000|Overall Study|Death|2
7249366|NCT00277095|11460093|FG000|Overall Study|Explanted|7
7249367|NCT00277095|11460093|FG000|Overall Study|Lost to Follow-up|2
7249368|NCT00277095|11460093|FG000|Overall Study|Missed Follow-up|9
7249369|NCT00277095|11460093|FG000|Overall Study|Physician Decision|1
7249370|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
7249371|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7249372|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
7249373|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
7249374|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
7249375|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
7249376|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
7249377|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7249378|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
7249379|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
7249380|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7249381|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
7249382|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
7249383|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7249384|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
7249385|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
7249386|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
7249387|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
7249388|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
7249389|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7249390|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
7249391|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
7249392|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7249393|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
7249394|NCT00277212|11460097|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
7249395|NCT00277212|11460098|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
7249396|NCT00277212|11460099|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
7249397|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
7249398|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
7249399|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
7249400|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
7249401|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
7249402|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
7249403|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
7249404|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
7249405|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
7249406|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
7249407|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7249408|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
7249409|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
7249410|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
7249411|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
7249412|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
7249413|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
7249414|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
7249415|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
7249416|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
7249417|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
7574363|NCT03673670|11956997|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
7249418|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
7249419|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
7249420|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
7249421|NCT00277212|11460097|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
7249422|NCT00277212|11460098|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
7249423|NCT00277212|11460099|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
7249424|NCT00277355|11460109|FG000|Overall Study|Withdrawal by Subject|3
7249425|NCT00277355|11460110|FG001|Overall Study|Withdrawal by Subject|3
7249426|NCT00277355|11460109|FG000|Overall Study|Lost to Follow-up|2
7249427|NCT00277355|11460110|FG001|Overall Study|Lost to Follow-up|2
7249428|NCT00277355|11460109|FG000|Overall Study|Adverse Event|5
7249429|NCT00277355|11460110|FG001|Overall Study|Adverse Event|0
7249430|NCT00277355|11460109|FG000|Overall Study|Death|3
7249431|NCT00277355|11460110|FG001|Overall Study|Death|0
7249432|NCT00277355|11460109|FG000|Overall Study|Physician Decision|1
7249433|NCT00277355|11460110|FG001|Overall Study|Physician Decision|0
7249434|NCT00278109|11460151|FG000|Overall Study|Adverse Event|3
7249435|NCT00278109|11460151|FG000|Overall Study|social circumstances|1
7249436|NCT00278148|11460155|FG000|Phase II - Expansion Phase|Disease progression|0
7249437|NCT00278148|11460156|FG001|Phase II - Expansion Phase|Disease progression|0
7249438|NCT00278148|11460157|FG002|Phase II - Expansion Phase|Disease progression|4
7249439|NCT00278148|11460155|FG000|Phase II - Expansion Phase|Adverse Event|0
7574364|NCT03673670|11956998|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
7249440|NCT00278148|11460156|FG001|Phase II - Expansion Phase|Adverse Event|0
7249441|NCT00278148|11460157|FG002|Phase II - Expansion Phase|Adverse Event|2
7249442|NCT00278161|11460164|FG000|Overall Study|Death|11
7249443|NCT00278200|11460170|FG000|Overall Study|Death|1
7249444|NCT00278200|11460171|FG001|Overall Study|Death|3
7249445|NCT00278200|11460170|FG000|Overall Study|Physician Decision|0
7249446|NCT00278200|11460171|FG001|Overall Study|Physician Decision|1
7249447|NCT00278395|11460177|FG000|Overall Study|Adverse Event|2
7249448|NCT00278395|11460177|FG000|Overall Study|Nonevaluable|1
7249449|NCT00278473|11460186|FG000|Overall Study|drop out|4
7249450|NCT00278473|11460187|FG001|Overall Study|drop out|3
7249451|NCT00278512|11460195|FG000|Overall Study|Death|1
7249452|NCT00278512|11460196|FG001|Overall Study|Death|0
7249453|NCT00278564|11460215|FG000|Overall Study|Lack of Efficacy|4
7249454|NCT00278629|11460219|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
7249455|NCT00278889|11460245|FG000|Overall Study|Withdrawal by Subject|0
7249456|NCT00278889|11460246|FG001|Overall Study|Withdrawal by Subject|5
7249457|NCT00278889|11460247|FG002|Overall Study|Withdrawal by Subject|3
7249458|NCT00278889|11460245|FG000|Overall Study|Lost to Follow-up|1
7249459|NCT00278889|11460246|FG001|Overall Study|Lost to Follow-up|1
7249460|NCT00278889|11460247|FG002|Overall Study|Lost to Follow-up|0
7249461|NCT00278889|11460245|FG000|Overall Study|Death|24
7249462|NCT00278889|11460246|FG001|Overall Study|Death|21
7249463|NCT00278889|11460247|FG002|Overall Study|Death|17
7249464|NCT00278954|11460255|FG000|Overall Study|Adverse Event|3
7249465|NCT00278954|11460255|FG000|Overall Study|Lost to Follow-up|1
7249466|NCT00278954|11460255|FG000|Overall Study|Withdrawal by Subject|1
7249467|NCT00278993|11460259|FG000|Overall Study|Adverse Event|24
7249468|NCT00278993|11460259|FG000|Overall Study|Withdrawal by Subject|5
7249469|NCT00278993|11460259|FG000|Overall Study|Progressive Disease|65
7249470|NCT00278993|11460259|FG000|Overall Study|Physician Decision|9
7249471|NCT00278993|11460259|FG000|Overall Study|Not Otherwise Specified|4
7249472|NCT00279201|11460265|FG000|Initiation|Death|1
7249473|NCT00279201|11460266|FG001|Initiation|Death|5
7249474|NCT00279201|11460267|FG002|Initiation|Death|0
7249475|NCT00279201|11460268|FG003|Initiation|Death|0
7249476|NCT00279201|11460269|FG004|Initiation|Death|0
7249477|NCT00279201|11460270|FG005|Initiation|Death|0
7249478|NCT00279201|11460265|FG000|Initiation|Adverse Event|6
7249479|NCT00279201|11460266|FG001|Initiation|Adverse Event|15
7249480|NCT00279201|11460267|FG002|Initiation|Adverse Event|0
7249481|NCT00279201|11460268|FG003|Initiation|Adverse Event|0
7249482|NCT00279201|11460269|FG004|Initiation|Adverse Event|0
7249483|NCT00279201|11460270|FG005|Initiation|Adverse Event|0
7249484|NCT00279201|11460265|FG000|Initiation|Lost to Follow-up|42
7249485|NCT00279201|11460266|FG001|Initiation|Lost to Follow-up|41
7249486|NCT00279201|11460267|FG002|Initiation|Lost to Follow-up|0
7249487|NCT00279201|11460268|FG003|Initiation|Lost to Follow-up|0
7249488|NCT00279201|11460269|FG004|Initiation|Lost to Follow-up|0
7249489|NCT00279201|11460270|FG005|Initiation|Lost to Follow-up|0
7249490|NCT00279201|11460265|FG000|Initiation|Entry Criteria Exclusion|7
7249491|NCT00279201|11460266|FG001|Initiation|Entry Criteria Exclusion|9
7249492|NCT00279201|11460267|FG002|Initiation|Entry Criteria Exclusion|0
7249493|NCT00279201|11460268|FG003|Initiation|Entry Criteria Exclusion|0
7249494|NCT00279201|11460269|FG004|Initiation|Entry Criteria Exclusion|0
7249495|NCT00279201|11460270|FG005|Initiation|Entry Criteria Exclusion|0
7249496|NCT00279201|11460265|FG000|Initiation|Protocol Violation|9
7249497|NCT00279201|11460266|FG001|Initiation|Protocol Violation|10
7249498|NCT00279201|11460267|FG002|Initiation|Protocol Violation|0
7249499|NCT00279201|11460268|FG003|Initiation|Protocol Violation|0
7249500|NCT00279201|11460269|FG004|Initiation|Protocol Violation|0
7249501|NCT00279201|11460270|FG005|Initiation|Protocol Violation|0
7249502|NCT00279201|11460265|FG000|Initiation|Withdrawal by Subject|35
7249503|NCT00279201|11460266|FG001|Initiation|Withdrawal by Subject|41
7249504|NCT00279201|11460267|FG002|Initiation|Withdrawal by Subject|0
7249505|NCT00279201|11460268|FG003|Initiation|Withdrawal by Subject|0
7249506|NCT00279201|11460269|FG004|Initiation|Withdrawal by Subject|0
7249507|NCT00279201|11460270|FG005|Initiation|Withdrawal by Subject|0
7249508|NCT00279201|11460265|FG000|Initiation|Physician Decision|15
7249509|NCT00279201|11460266|FG001|Initiation|Physician Decision|18
7249510|NCT00279201|11460267|FG002|Initiation|Physician Decision|0
7249511|NCT00279201|11460268|FG003|Initiation|Physician Decision|0
7249512|NCT00279201|11460269|FG004|Initiation|Physician Decision|0
7249513|NCT00279201|11460270|FG005|Initiation|Physician Decision|0
7249514|NCT00279201|11460265|FG000|Initiation|Sponsor Decision|13
7249515|NCT00279201|11460266|FG001|Initiation|Sponsor Decision|5
7249516|NCT00279201|11460267|FG002|Initiation|Sponsor Decision|0
7249517|NCT00279201|11460268|FG003|Initiation|Sponsor Decision|0
7249518|NCT00279201|11460269|FG004|Initiation|Sponsor Decision|0
7249519|NCT00279201|11460270|FG005|Initiation|Sponsor Decision|0
7249520|NCT00279201|11460265|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
7249521|NCT00279201|11460266|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
7249522|NCT00279201|11460267|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
7249523|NCT00279201|11460268|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
7249524|NCT00279201|11460269|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
7249525|NCT00279201|11460270|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
7249526|NCT00279201|11460265|FG000|Maintenance|Lack of Efficacy|32
7249527|NCT00279201|11460266|FG001|Maintenance|Lack of Efficacy|30
7249528|NCT00279201|11460267|FG002|Maintenance|Lack of Efficacy|0
7249529|NCT00279201|11460268|FG003|Maintenance|Lack of Efficacy|0
7249530|NCT00279201|11460269|FG004|Maintenance|Lack of Efficacy|0
7249531|NCT00279201|11460270|FG005|Maintenance|Lack of Efficacy|0
7249532|NCT00279201|11460265|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
7249533|NCT00279201|11460266|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
7249534|NCT00279201|11460267|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7249535|NCT00279201|11460268|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7249536|NCT00279201|11460269|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7249537|NCT00279201|11460270|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
7249538|NCT00279201|11460265|FG000|Maintenance|Adverse Event|4
7249539|NCT00279201|11460266|FG001|Maintenance|Adverse Event|4
7249540|NCT00279201|11460267|FG002|Maintenance|Adverse Event|0
7249541|NCT00279201|11460268|FG003|Maintenance|Adverse Event|0
7249542|NCT00279201|11460269|FG004|Maintenance|Adverse Event|0
7249543|NCT00279201|11460270|FG005|Maintenance|Adverse Event|0
7249544|NCT00279201|11460265|FG000|Maintenance|Death|4
7249545|NCT00279201|11460266|FG001|Maintenance|Death|4
7249546|NCT00279201|11460267|FG002|Maintenance|Death|0
7249547|NCT00279201|11460268|FG003|Maintenance|Death|0
7249548|NCT00279201|11460269|FG004|Maintenance|Death|0
7249549|NCT00279201|11460270|FG005|Maintenance|Death|0
7249550|NCT00279201|11460265|FG000|Maintenance|Lost to Follow-up|17
7249551|NCT00279201|11460266|FG001|Maintenance|Lost to Follow-up|13
7249552|NCT00279201|11460267|FG002|Maintenance|Lost to Follow-up|0
7249553|NCT00279201|11460268|FG003|Maintenance|Lost to Follow-up|0
7249554|NCT00279201|11460269|FG004|Maintenance|Lost to Follow-up|0
7249555|NCT00279201|11460270|FG005|Maintenance|Lost to Follow-up|0
7249556|NCT00279201|11460265|FG000|Maintenance|Entry Criteria Exclusion|1
7249557|NCT00279201|11460266|FG001|Maintenance|Entry Criteria Exclusion|4
7249558|NCT00279201|11460267|FG002|Maintenance|Entry Criteria Exclusion|0
7249559|NCT00279201|11460268|FG003|Maintenance|Entry Criteria Exclusion|0
7249560|NCT00279201|11460269|FG004|Maintenance|Entry Criteria Exclusion|0
7249561|NCT00279201|11460270|FG005|Maintenance|Entry Criteria Exclusion|0
7249562|NCT00279201|11460265|FG000|Maintenance|Protocol Violation|16
7249563|NCT00279201|11460266|FG001|Maintenance|Protocol Violation|24
7249564|NCT00279201|11460267|FG002|Maintenance|Protocol Violation|0
7249565|NCT00279201|11460268|FG003|Maintenance|Protocol Violation|0
7249566|NCT00279201|11460269|FG004|Maintenance|Protocol Violation|0
7249567|NCT00279201|11460270|FG005|Maintenance|Protocol Violation|0
7249568|NCT00279201|11460265|FG000|Maintenance|Withdrawal by Subject|18
7249569|NCT00279201|11460266|FG001|Maintenance|Withdrawal by Subject|18
7249570|NCT00279201|11460267|FG002|Maintenance|Withdrawal by Subject|0
7249571|NCT00279201|11460268|FG003|Maintenance|Withdrawal by Subject|0
7249572|NCT00279201|11460269|FG004|Maintenance|Withdrawal by Subject|0
7249573|NCT00279201|11460270|FG005|Maintenance|Withdrawal by Subject|0
7249574|NCT00279201|11460265|FG000|Maintenance|Physician Decision|9
7249575|NCT00279201|11460266|FG001|Maintenance|Physician Decision|9
7249576|NCT00279201|11460267|FG002|Maintenance|Physician Decision|0
7249577|NCT00279201|11460268|FG003|Maintenance|Physician Decision|0
7249578|NCT00279201|11460269|FG004|Maintenance|Physician Decision|0
7249579|NCT00279201|11460270|FG005|Maintenance|Physician Decision|0
7249580|NCT00279201|11460265|FG000|Maintenance|Sponsor Decision|4
7249581|NCT00279201|11460266|FG001|Maintenance|Sponsor Decision|0
7249582|NCT00279201|11460267|FG002|Maintenance|Sponsor Decision|0
7249583|NCT00279201|11460268|FG003|Maintenance|Sponsor Decision|0
7249584|NCT00279201|11460269|FG004|Maintenance|Sponsor Decision|0
7249585|NCT00279201|11460270|FG005|Maintenance|Sponsor Decision|0
7249586|NCT00279201|11460265|FG000|Maintenance|HbA1c>7.5%|123
7249587|NCT00279201|11460266|FG001|Maintenance|HbA1c>7.5%|126
7249588|NCT00279201|11460267|FG002|Maintenance|HbA1c>7.5%|0
7249589|NCT00279201|11460268|FG003|Maintenance|HbA1c>7.5%|0
7249590|NCT00279201|11460269|FG004|Maintenance|HbA1c>7.5%|0
7249591|NCT00279201|11460270|FG005|Maintenance|HbA1c>7.5%|0
7249592|NCT00279201|11460265|FG000|Intensification Addendum|Withdrawal by Subject|0
7249593|NCT00279201|11460266|FG001|Intensification Addendum|Withdrawal by Subject|0
7249594|NCT00279201|11460267|FG002|Intensification Addendum|Withdrawal by Subject|12
7249595|NCT00279201|11460268|FG003|Intensification Addendum|Withdrawal by Subject|14
7249596|NCT00279201|11460269|FG004|Intensification Addendum|Withdrawal by Subject|9
7249597|NCT00279201|11460270|FG005|Intensification Addendum|Withdrawal by Subject|18
7249598|NCT00279201|11460265|FG000|Intensification Addendum|Lost to Follow-up|0
7249599|NCT00279201|11460266|FG001|Intensification Addendum|Lost to Follow-up|0
7249600|NCT00279201|11460267|FG002|Intensification Addendum|Lost to Follow-up|4
7249601|NCT00279201|11460268|FG003|Intensification Addendum|Lost to Follow-up|6
7249602|NCT00279201|11460269|FG004|Intensification Addendum|Lost to Follow-up|7
7249603|NCT00279201|11460270|FG005|Intensification Addendum|Lost to Follow-up|7
7249604|NCT00279201|11460265|FG000|Intensification Addendum|Protocol Violation|0
7249605|NCT00279201|11460266|FG001|Intensification Addendum|Protocol Violation|0
7249606|NCT00279201|11460267|FG002|Intensification Addendum|Protocol Violation|2
7249607|NCT00279201|11460268|FG003|Intensification Addendum|Protocol Violation|2
7249608|NCT00279201|11460269|FG004|Intensification Addendum|Protocol Violation|6
7249609|NCT00279201|11460270|FG005|Intensification Addendum|Protocol Violation|6
7249610|NCT00279201|11460265|FG000|Intensification Addendum|Adverse Event|0
7249611|NCT00279201|11460266|FG001|Intensification Addendum|Adverse Event|0
7249612|NCT00279201|11460267|FG002|Intensification Addendum|Adverse Event|0
7249613|NCT00279201|11460268|FG003|Intensification Addendum|Adverse Event|4
7249614|NCT00279201|11460269|FG004|Intensification Addendum|Adverse Event|1
7249615|NCT00279201|11460270|FG005|Intensification Addendum|Adverse Event|3
7249616|NCT00279201|11460265|FG000|Intensification Addendum|Physician Decision|0
7249617|NCT00279201|11460266|FG001|Intensification Addendum|Physician Decision|0
7249618|NCT00279201|11460267|FG002|Intensification Addendum|Physician Decision|4
7249619|NCT00279201|11460268|FG003|Intensification Addendum|Physician Decision|1
7249620|NCT00279201|11460269|FG004|Intensification Addendum|Physician Decision|3
7249621|NCT00279201|11460270|FG005|Intensification Addendum|Physician Decision|2
7249622|NCT00279201|11460265|FG000|Intensification Addendum|Sponsor Decision|0
7249623|NCT00279201|11460266|FG001|Intensification Addendum|Sponsor Decision|0
7249624|NCT00279201|11460267|FG002|Intensification Addendum|Sponsor Decision|0
7249625|NCT00279201|11460268|FG003|Intensification Addendum|Sponsor Decision|0
7249626|NCT00279201|11460269|FG004|Intensification Addendum|Sponsor Decision|1
7249627|NCT00279201|11460270|FG005|Intensification Addendum|Sponsor Decision|1
7249628|NCT00279201|11460265|FG000|Intensification Addendum|Entry Criteria Exclusion|0
7249629|NCT00279201|11460266|FG001|Intensification Addendum|Entry Criteria Exclusion|0
7249630|NCT00279201|11460267|FG002|Intensification Addendum|Entry Criteria Exclusion|1
7249631|NCT00279201|11460268|FG003|Intensification Addendum|Entry Criteria Exclusion|0
7249632|NCT00279201|11460269|FG004|Intensification Addendum|Entry Criteria Exclusion|0
7249633|NCT00279201|11460270|FG005|Intensification Addendum|Entry Criteria Exclusion|0
7249634|NCT00279201|11460265|FG000|Intensification Addendum|Lack of Efficacy|0
7249635|NCT00279201|11460266|FG001|Intensification Addendum|Lack of Efficacy|0
7249636|NCT00279201|11460267|FG002|Intensification Addendum|Lack of Efficacy|0
7249637|NCT00279201|11460268|FG003|Intensification Addendum|Lack of Efficacy|1
7249638|NCT00279201|11460269|FG004|Intensification Addendum|Lack of Efficacy|1
7249639|NCT00279201|11460270|FG005|Intensification Addendum|Lack of Efficacy|0
7249640|NCT00279201|11460265|FG000|Intensification Addendum|Death|0
7249641|NCT00279201|11460266|FG001|Intensification Addendum|Death|0
7249642|NCT00279201|11460267|FG002|Intensification Addendum|Death|0
7249643|NCT00279201|11460268|FG003|Intensification Addendum|Death|0
7249644|NCT00279201|11460269|FG004|Intensification Addendum|Death|1
7249645|NCT00279201|11460270|FG005|Intensification Addendum|Death|0
7249646|NCT00279214|11460305|FG000|Overall Study|Physician Decision|3
7249647|NCT00279214|11460306|FG001|Overall Study|Physician Decision|2
7249648|NCT00279305|11460314|FG000|Overall Study|Pregnancy|1
7249649|NCT00279305|11460315|FG001|Overall Study|Pregnancy|0
7249650|NCT00279305|11460314|FG000|Overall Study|Withdrawal by Subject|2
7249651|NCT00279305|11460315|FG001|Overall Study|Withdrawal by Subject|0
7249652|NCT00279305|11460314|FG000|Overall Study|Dificulting establishing IV|1
7249653|NCT00279305|11460315|FG001|Overall Study|Dificulting establishing IV|0
7249654|NCT00279305|11460314|FG000|Overall Study|FDA Safety Alert|4
7249655|NCT00279305|11460315|FG001|Overall Study|FDA Safety Alert|1
7249656|NCT00279708|11460338|FG000|Overall Study|Withdrawal by Subject|2
7249657|NCT00279708|11460339|FG001|Overall Study|Withdrawal by Subject|3
7249658|NCT00279708|11460338|FG000|Overall Study|Adverse Event|1
7249659|NCT00279708|11460339|FG001|Overall Study|Adverse Event|1
7249660|NCT00279812|11460351|FG000|Overall Study|Protocol Violation|1
7249661|NCT00279812|11460352|FG001|Overall Study|Protocol Violation|1
7249662|NCT00279812|11460353|FG002|Overall Study|Protocol Violation|0
7249663|NCT00279812|11460354|FG003|Overall Study|Protocol Violation|0
7249664|NCT00279812|11460355|FG004|Overall Study|Protocol Violation|1
7249665|NCT00279812|11460356|FG005|Overall Study|Protocol Violation|0
7249666|NCT00279812|11460351|FG000|Overall Study|Withdrawal by Subject|0
7249667|NCT00279812|11460352|FG001|Overall Study|Withdrawal by Subject|4
7249668|NCT00279812|11460353|FG002|Overall Study|Withdrawal by Subject|2
7249669|NCT00279812|11460354|FG003|Overall Study|Withdrawal by Subject|0
7249670|NCT00279812|11460355|FG004|Overall Study|Withdrawal by Subject|0
7249671|NCT00279812|11460356|FG005|Overall Study|Withdrawal by Subject|0
7249672|NCT00279812|11460351|FG000|Overall Study|Adverse Event|0
7249673|NCT00279812|11460352|FG001|Overall Study|Adverse Event|1
7249674|NCT00279812|11460353|FG002|Overall Study|Adverse Event|1
7249675|NCT00279812|11460354|FG003|Overall Study|Adverse Event|0
7249676|NCT00279812|11460355|FG004|Overall Study|Adverse Event|2
7249677|NCT00279812|11460356|FG005|Overall Study|Adverse Event|1
7249678|NCT00279916|11460372|FG000|Overall Study|Withdrawal by Subject|4
7249679|NCT00279916|11460373|FG001|Overall Study|Withdrawal by Subject|3
7249680|NCT00279916|11460372|FG000|Overall Study|Lost to Follow-up|3
7249681|NCT00279916|11460373|FG001|Overall Study|Lost to Follow-up|2
7249682|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Death|2
7249683|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Death|0
7249684|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Adverse Event|33
7249685|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Adverse Event|31
7249686|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
7249687|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
7249688|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
7249689|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
7249690|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
7249691|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
7384008|NCT01192100|11641101|FG002|Overall Study|Withdrawal by Subject|0
7384009|NCT01192100|11641102|FG003|Overall Study|Withdrawal by Subject|0
7249692|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Other|7
7249693|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Other|8
7249694|NCT00280059|11460393|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
7249695|NCT00280059|11460394|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
7249696|NCT00280150|11460412|FG000|Overall Study|Adverse Event|0
7249697|NCT00280150|11460413|FG001|Overall Study|Adverse Event|1
7249698|NCT00280150|11460414|FG002|Overall Study|Adverse Event|2
7249699|NCT00280150|11460415|FG003|Overall Study|Adverse Event|3
7249700|NCT00280150|11460412|FG000|Overall Study|Lack of Efficacy|0
7249701|NCT00280150|11460413|FG001|Overall Study|Lack of Efficacy|0
7249702|NCT00280150|11460414|FG002|Overall Study|Lack of Efficacy|0
7249703|NCT00280150|11460415|FG003|Overall Study|Lack of Efficacy|3
7249704|NCT00280150|11460412|FG000|Overall Study|Physician Decision|0
7249705|NCT00280150|11460413|FG001|Overall Study|Physician Decision|0
7249706|NCT00280150|11460414|FG002|Overall Study|Physician Decision|0
7249707|NCT00280150|11460415|FG003|Overall Study|Physician Decision|1
7249708|NCT00280150|11460412|FG000|Overall Study|Protocol Violation|0
7249709|NCT00280150|11460413|FG001|Overall Study|Protocol Violation|0
7249710|NCT00280150|11460414|FG002|Overall Study|Protocol Violation|0
7249711|NCT00280150|11460415|FG003|Overall Study|Protocol Violation|1
7249712|NCT00280150|11460412|FG000|Overall Study|Withdrawal by Subject|0
7249713|NCT00280150|11460413|FG001|Overall Study|Withdrawal by Subject|0
7249714|NCT00280150|11460414|FG002|Overall Study|Withdrawal by Subject|0
7249715|NCT00280150|11460415|FG003|Overall Study|Withdrawal by Subject|1
7249716|NCT00280150|11460412|FG000|Overall Study|Did not get consolidation therapy|3
7249717|NCT00280150|11460413|FG001|Overall Study|Did not get consolidation therapy|0
7249718|NCT00280150|11460414|FG002|Overall Study|Did not get consolidation therapy|3
7249719|NCT00280150|11460415|FG003|Overall Study|Did not get consolidation therapy|0
7249720|NCT00280150|11460412|FG000|Overall Study|Declining Performance Status|0
7249721|NCT00280150|11460413|FG001|Overall Study|Declining Performance Status|0
7249722|NCT00280150|11460414|FG002|Overall Study|Declining Performance Status|0
7249723|NCT00280150|11460415|FG003|Overall Study|Declining Performance Status|1
7249724|NCT00280293|11460432|FG000|Overall Study|Protocol Violation|3
7249725|NCT00280293|11460433|FG001|Overall Study|Protocol Violation|0
7249726|NCT00280293|11460432|FG000|Overall Study|Physician Decision|5
7249727|NCT00280293|11460433|FG001|Overall Study|Physician Decision|4
7249728|NCT00280293|11460432|FG000|Overall Study|Lost to Follow-up|14
7249729|NCT00280293|11460433|FG001|Overall Study|Lost to Follow-up|12
7249730|NCT00280293|11460432|FG000|Overall Study|Withdrawal by Subject|3
7249731|NCT00280293|11460433|FG001|Overall Study|Withdrawal by Subject|5
7249732|NCT00280293|11460432|FG000|Overall Study|Incarceration/Legal Reasons|1
7249733|NCT00280293|11460433|FG001|Overall Study|Incarceration/Legal Reasons|1
7249734|NCT00280293|11460432|FG000|Overall Study|Adverse Event|0
7249735|NCT00280293|11460433|FG001|Overall Study|Adverse Event|1
7249736|NCT00280397|11460472|FG000|Overall Study|Adverse Event|1
7249737|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
7249738|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7249739|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
7249740|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
7249741|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7249742|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
7249743|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
7249744|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
7249745|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
7249746|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
7249747|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7249748|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
7249749|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
7249750|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7249751|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
7249752|NCT00280566|11460480|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
7249753|NCT00280566|11460481|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
7249754|NCT00280566|11460482|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
7249755|NCT00280566|11460480|FG000|Period 2 Double Blind|Lack of Efficacy|0
7249756|NCT00280566|11460481|FG001|Period 2 Double Blind|Lack of Efficacy|9
7249757|NCT00280566|11460482|FG002|Period 2 Double Blind|Lack of Efficacy|22
7249758|NCT00280566|11460480|FG000|Period 2 Double Blind|Laboratory Abnormality|0
7249759|NCT00280566|11460481|FG001|Period 2 Double Blind|Laboratory Abnormality|1
7249760|NCT00280566|11460482|FG002|Period 2 Double Blind|Laboratory Abnormality|0
7249761|NCT00280566|11460480|FG000|Period 2 Double Blind|Adverse Event|0
7249762|NCT00280566|11460481|FG001|Period 2 Double Blind|Adverse Event|11
7249763|NCT00280566|11460482|FG002|Period 2 Double Blind|Adverse Event|15
7249764|NCT00280566|11460480|FG000|Period 2 Double Blind|Lost to Follow-up|0
7249765|NCT00280566|11460481|FG001|Period 2 Double Blind|Lost to Follow-up|3
7249766|NCT00280566|11460482|FG002|Period 2 Double Blind|Lost to Follow-up|6
7249767|NCT00280566|11460480|FG000|Period 2 Double Blind|Withdrawal by Subject|0
7249768|NCT00280566|11460481|FG001|Period 2 Double Blind|Withdrawal by Subject|9
7249769|NCT00280566|11460482|FG002|Period 2 Double Blind|Withdrawal by Subject|9
7249770|NCT00280566|11460480|FG000|Period 2 Double Blind|miscellaneous|0
7249771|NCT00280566|11460481|FG001|Period 2 Double Blind|miscellaneous|10
7249772|NCT00280566|11460482|FG002|Period 2 Double Blind|miscellaneous|5
7249773|NCT00280683|11460491|FG000|Overall Study|Withdrawal by Subject|1
7249774|NCT00280683|11460492|FG001|Overall Study|Withdrawal by Subject|2
7249775|NCT00280683|11460491|FG000|Overall Study|Adverse Event|1
7249776|NCT00280683|11460492|FG001|Overall Study|Adverse Event|1
7249777|NCT00280735|11460500|FG000|Overall Study|Adverse Event|5
7249778|NCT00280735|11460500|FG000|Overall Study|Lack of Efficacy|3
7249779|NCT00280735|11460500|FG000|Overall Study|Withdrawal by Subject|8
7249780|NCT00280735|11460500|FG000|Overall Study|Intercurrent Illness|2
7249781|NCT00280748|11460508|FG000|Overall Study|Decline in performance|3
7249782|NCT00280748|11460508|FG000|Overall Study|Extra-cranial disease progression|1
7249783|NCT00280917|11460525|FG000|Overall Study|Adverse Event|1
7249784|NCT00280917|11460526|FG001|Overall Study|Adverse Event|1
7249785|NCT00280917|11460527|FG002|Overall Study|Adverse Event|4
7249786|NCT00280917|11460528|FG003|Overall Study|Adverse Event|1
7249787|NCT00280917|11460525|FG000|Overall Study|Change Therapy|1
7249788|NCT00280917|11460526|FG001|Overall Study|Change Therapy|2
7249789|NCT00280917|11460527|FG002|Overall Study|Change Therapy|0
7249790|NCT00280917|11460528|FG003|Overall Study|Change Therapy|0
7249791|NCT00280917|11460525|FG000|Overall Study|Withdrawal by Subject|0
7249792|NCT00280917|11460526|FG001|Overall Study|Withdrawal by Subject|2
7249793|NCT00280917|11460527|FG002|Overall Study|Withdrawal by Subject|0
7249794|NCT00280917|11460528|FG003|Overall Study|Withdrawal by Subject|1
7249795|NCT00280917|11460525|FG000|Overall Study|Noncompliance|0
7249796|NCT00280917|11460526|FG001|Overall Study|Noncompliance|1
7249797|NCT00280917|11460527|FG002|Overall Study|Noncompliance|2
7249798|NCT00280917|11460528|FG003|Overall Study|Noncompliance|0
7249799|NCT00281099|11460544|FG000|Overall Study|Death|46
7249800|NCT00281099|11460545|FG001|Overall Study|Death|57
7249801|NCT00281099|11460544|FG000|Overall Study|Lost to Follow-up|10
7249802|NCT00281099|11460545|FG001|Overall Study|Lost to Follow-up|19
7249803|NCT00281099|11460544|FG000|Overall Study|Withdrawal by Subject|65
7249804|NCT00281099|11460545|FG001|Overall Study|Withdrawal by Subject|70
7249805|NCT00281099|11460544|FG000|Overall Study|Physician Decision|79
7249806|NCT00281099|11460545|FG001|Overall Study|Physician Decision|72
7249807|NCT00281099|11460544|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
7249808|NCT00281099|11460545|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
7249809|NCT00281528|11460559|FG000|Overall Study|Progressive Disease|28
7249810|NCT00281528|11460560|FG001|Overall Study|Progressive Disease|18
7249811|NCT00281528|11460561|FG002|Overall Study|Progressive Disease|27
7249812|NCT00281528|11460559|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
7249813|NCT00281528|11460560|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
7249814|NCT00281528|11460561|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
7249815|NCT00281528|11460559|FG000|Overall Study|Adverse Event-unrelated to treatment|3
7249816|NCT00281528|11460560|FG001|Overall Study|Adverse Event-unrelated to treatment|0
7249817|NCT00281528|11460561|FG002|Overall Study|Adverse Event-unrelated to treatment|2
7249818|NCT00281528|11460559|FG000|Overall Study|Physician Decision|11
7249819|NCT00281528|11460560|FG001|Overall Study|Physician Decision|4
7249820|NCT00281528|11460561|FG002|Overall Study|Physician Decision|5
7249821|NCT00281528|11460559|FG000|Overall Study|Protocol Violation|1
7249822|NCT00281528|11460560|FG001|Overall Study|Protocol Violation|0
7249823|NCT00281528|11460561|FG002|Overall Study|Protocol Violation|1
7249824|NCT00281528|11460559|FG000|Overall Study|Withdrawal by Subject|5
7249825|NCT00281528|11460560|FG001|Overall Study|Withdrawal by Subject|5
7249826|NCT00281528|11460561|FG002|Overall Study|Withdrawal by Subject|7
7249827|NCT00281528|11460559|FG000|Overall Study|Other|6
7249828|NCT00281528|11460560|FG001|Overall Study|Other|3
7249829|NCT00281528|11460561|FG002|Overall Study|Other|5
7249830|NCT00281580|11460585|FG000|Overall Study|Adverse Event|2
7249831|NCT00281580|11460586|FG001|Overall Study|Adverse Event|0
7249832|NCT00281580|11460587|FG002|Overall Study|Adverse Event|2
7249833|NCT00281580|11460588|FG003|Overall Study|Adverse Event|4
7249834|NCT00281580|11460589|FG004|Overall Study|Adverse Event|1
7249835|NCT00281580|11460590|FG005|Overall Study|Adverse Event|0
7249836|NCT00281580|11460591|FG006|Overall Study|Adverse Event|1
7249837|NCT00281580|11460592|FG007|Overall Study|Adverse Event|0
7249838|NCT00281580|11460593|FG008|Overall Study|Adverse Event|1
7249839|NCT00281580|11460594|FG009|Overall Study|Adverse Event|6
7249840|NCT00281580|11460595|FG010|Overall Study|Adverse Event|0
7249841|NCT00281580|11460596|FG011|Overall Study|Adverse Event|5
7249842|NCT00281580|11460597|FG012|Overall Study|Adverse Event|8
7249843|NCT00281580|11460598|FG013|Overall Study|Adverse Event|2
7249844|NCT00281580|11460599|FG014|Overall Study|Adverse Event|3
7249845|NCT00281580|11460600|FG015|Overall Study|Adverse Event|3
7249846|NCT00281580|11460585|FG000|Overall Study|Protocol Violation|0
7249847|NCT00281580|11460586|FG001|Overall Study|Protocol Violation|0
7249848|NCT00281580|11460587|FG002|Overall Study|Protocol Violation|1
7249849|NCT00281580|11460588|FG003|Overall Study|Protocol Violation|1
7249850|NCT00281580|11460589|FG004|Overall Study|Protocol Violation|0
7249851|NCT00281580|11460590|FG005|Overall Study|Protocol Violation|0
7249852|NCT00281580|11460591|FG006|Overall Study|Protocol Violation|1
7249853|NCT00281580|11460592|FG007|Overall Study|Protocol Violation|0
7249854|NCT00281580|11460593|FG008|Overall Study|Protocol Violation|2
7249855|NCT00281580|11460594|FG009|Overall Study|Protocol Violation|0
7249856|NCT00281580|11460595|FG010|Overall Study|Protocol Violation|1
7249857|NCT00281580|11460596|FG011|Overall Study|Protocol Violation|2
7249858|NCT00281580|11460597|FG012|Overall Study|Protocol Violation|0
7249859|NCT00281580|11460598|FG013|Overall Study|Protocol Violation|1
7249860|NCT00281580|11460599|FG014|Overall Study|Protocol Violation|1
7249861|NCT00281580|11460600|FG015|Overall Study|Protocol Violation|3
7249862|NCT00281580|11460585|FG000|Overall Study|Withdrawal by Subject|3
7249863|NCT00281580|11460586|FG001|Overall Study|Withdrawal by Subject|0
7249864|NCT00281580|11460587|FG002|Overall Study|Withdrawal by Subject|1
7249865|NCT00281580|11460588|FG003|Overall Study|Withdrawal by Subject|1
7249866|NCT00281580|11460589|FG004|Overall Study|Withdrawal by Subject|1
7249867|NCT00281580|11460590|FG005|Overall Study|Withdrawal by Subject|2
7249868|NCT00281580|11460591|FG006|Overall Study|Withdrawal by Subject|2
7249869|NCT00281580|11460592|FG007|Overall Study|Withdrawal by Subject|0
7249870|NCT00281580|11460593|FG008|Overall Study|Withdrawal by Subject|1
7249871|NCT00281580|11460594|FG009|Overall Study|Withdrawal by Subject|4
7249872|NCT00281580|11460595|FG010|Overall Study|Withdrawal by Subject|1
7249873|NCT00281580|11460596|FG011|Overall Study|Withdrawal by Subject|1
7249874|NCT00281580|11460597|FG012|Overall Study|Withdrawal by Subject|2
7249875|NCT00281580|11460598|FG013|Overall Study|Withdrawal by Subject|2
7249876|NCT00281580|11460599|FG014|Overall Study|Withdrawal by Subject|1
7249877|NCT00281580|11460600|FG015|Overall Study|Withdrawal by Subject|5
7249878|NCT00281580|11460585|FG000|Overall Study|Lack of Efficacy|2
7249879|NCT00281580|11460586|FG001|Overall Study|Lack of Efficacy|1
7249880|NCT00281580|11460587|FG002|Overall Study|Lack of Efficacy|1
7249881|NCT00281580|11460588|FG003|Overall Study|Lack of Efficacy|6
7249882|NCT00281580|11460589|FG004|Overall Study|Lack of Efficacy|2
7249883|NCT00281580|11460590|FG005|Overall Study|Lack of Efficacy|0
7249884|NCT00281580|11460591|FG006|Overall Study|Lack of Efficacy|0
7249885|NCT00281580|11460592|FG007|Overall Study|Lack of Efficacy|0
7249886|NCT00281580|11460593|FG008|Overall Study|Lack of Efficacy|0
7249887|NCT00281580|11460594|FG009|Overall Study|Lack of Efficacy|0
7249888|NCT00281580|11460595|FG010|Overall Study|Lack of Efficacy|0
7249889|NCT00281580|11460596|FG011|Overall Study|Lack of Efficacy|1
7249890|NCT00281580|11460597|FG012|Overall Study|Lack of Efficacy|0
7249891|NCT00281580|11460598|FG013|Overall Study|Lack of Efficacy|2
7249892|NCT00281580|11460599|FG014|Overall Study|Lack of Efficacy|1
7249893|NCT00281580|11460600|FG015|Overall Study|Lack of Efficacy|0
7249894|NCT00281580|11460585|FG000|Overall Study|Lost to Follow-up|0
7249895|NCT00281580|11460586|FG001|Overall Study|Lost to Follow-up|0
7249896|NCT00281580|11460587|FG002|Overall Study|Lost to Follow-up|0
7249897|NCT00281580|11460588|FG003|Overall Study|Lost to Follow-up|3
7249898|NCT00281580|11460589|FG004|Overall Study|Lost to Follow-up|0
7249899|NCT00281580|11460590|FG005|Overall Study|Lost to Follow-up|1
7249900|NCT00281580|11460591|FG006|Overall Study|Lost to Follow-up|0
7249901|NCT00281580|11460592|FG007|Overall Study|Lost to Follow-up|1
7249902|NCT00281580|11460593|FG008|Overall Study|Lost to Follow-up|2
7249903|NCT00281580|11460594|FG009|Overall Study|Lost to Follow-up|1
7249904|NCT00281580|11460595|FG010|Overall Study|Lost to Follow-up|1
7249905|NCT00281580|11460596|FG011|Overall Study|Lost to Follow-up|0
7249906|NCT00281580|11460597|FG012|Overall Study|Lost to Follow-up|1
7249907|NCT00281580|11460598|FG013|Overall Study|Lost to Follow-up|0
7249908|NCT00281580|11460599|FG014|Overall Study|Lost to Follow-up|0
7249909|NCT00281580|11460600|FG015|Overall Study|Lost to Follow-up|0
7249910|NCT00281580|11460585|FG000|Overall Study|Randomised in error; pregnancy; moving|0
7249911|NCT00281580|11460586|FG001|Overall Study|Randomised in error; pregnancy; moving|0
7249912|NCT00281580|11460587|FG002|Overall Study|Randomised in error; pregnancy; moving|0
7249913|NCT00281580|11460588|FG003|Overall Study|Randomised in error; pregnancy; moving|2
7249914|NCT00281580|11460589|FG004|Overall Study|Randomised in error; pregnancy; moving|0
7249915|NCT00281580|11460590|FG005|Overall Study|Randomised in error; pregnancy; moving|0
7249916|NCT00281580|11460591|FG006|Overall Study|Randomised in error; pregnancy; moving|1
7249917|NCT00281580|11460592|FG007|Overall Study|Randomised in error; pregnancy; moving|0
7249918|NCT00281580|11460593|FG008|Overall Study|Randomised in error; pregnancy; moving|2
7249919|NCT00281580|11460594|FG009|Overall Study|Randomised in error; pregnancy; moving|1
7249920|NCT00281580|11460595|FG010|Overall Study|Randomised in error; pregnancy; moving|1
7249921|NCT00281580|11460596|FG011|Overall Study|Randomised in error; pregnancy; moving|1
7249922|NCT00281580|11460597|FG012|Overall Study|Randomised in error; pregnancy; moving|2
7249923|NCT00281580|11460598|FG013|Overall Study|Randomised in error; pregnancy; moving|0
7249924|NCT00281580|11460599|FG014|Overall Study|Randomised in error; pregnancy; moving|1
7249925|NCT00281580|11460600|FG015|Overall Study|Randomised in error; pregnancy; moving|2
7249926|NCT00281632|11460669|FG000|Overall Study|Adverse Event|7
7249927|NCT00281632|11460669|FG000|Overall Study|Withdrawal by Subject|2
7249928|NCT00281632|11460669|FG000|Overall Study|Disease Progression|22
7249929|NCT00281632|11460669|FG000|Overall Study|Death|1
7249930|NCT00281632|11460669|FG000|Overall Study|Physician Decision|1
7249931|NCT00281632|11460669|FG000|Overall Study|Ongoing|3
7249932|NCT00281684|11460695|FG000|Overall Study|Lost to Follow-up|0
7249933|NCT00281684|11460696|FG001|Overall Study|Lost to Follow-up|0
7249934|NCT00281684|11460697|FG002|Overall Study|Lost to Follow-up|1
7249935|NCT00281684|11460698|FG003|Overall Study|Lost to Follow-up|0
7249936|NCT00281684|11460695|FG000|Overall Study|Withdrawal by Subject|1
7249937|NCT00281684|11460696|FG001|Overall Study|Withdrawal by Subject|0
7249938|NCT00281684|11460697|FG002|Overall Study|Withdrawal by Subject|0
7249939|NCT00281684|11460698|FG003|Overall Study|Withdrawal by Subject|0
7249940|NCT00281697|11460712|FG000|Overall Study|> 60 days since last dose of study drug|4
7249941|NCT00281697|11460713|FG001|Overall Study|> 60 days since last dose of study drug|4
7249942|NCT00281697|11460712|FG000|Overall Study|Adverse Event|54
7249943|NCT00281697|11460713|FG001|Overall Study|Adverse Event|15
7249944|NCT00281697|11460712|FG000|Overall Study|Death|8
7249945|NCT00281697|11460713|FG001|Overall Study|Death|3
7249946|NCT00281697|11460712|FG000|Overall Study|Disease progression|279
7249947|NCT00281697|11460713|FG001|Overall Study|Disease progression|149
7249948|NCT00281697|11460712|FG000|Overall Study|Other|5
7249949|NCT00281697|11460713|FG001|Overall Study|Other|6
7249950|NCT00281697|11460712|FG000|Overall Study|Physician's decision to withdraw|15
7249951|NCT00281697|11460713|FG001|Overall Study|Physician's decision to withdraw|12
7249952|NCT00281697|11460712|FG000|Overall Study|Subject/guardian's decision to withdraw|33
7249953|NCT00281697|11460713|FG001|Overall Study|Subject/guardian's decision to withdraw|6
7249954|NCT00281697|11460712|FG000|Overall Study|Did not receive study drug|3
7249955|NCT00281697|11460713|FG001|Overall Study|Did not receive study drug|2
7256348|NCT00322348|11467837|FG001|Overall Study|Death|2
7256349|NCT00322348|11467836|FG000|Overall Study|Disease Progression|30
7256350|NCT00322348|11467837|FG001|Overall Study|Disease Progression|25
7256351|NCT00322348|11467836|FG000|Overall Study|Reasons not specified|5
7256352|NCT00322348|11467837|FG001|Overall Study|Reasons not specified|1
7256353|NCT00322374|11467846|FG000|Starting Dose|Physician Decision|2
7256354|NCT00322374|11467847|FG001|Starting Dose|Physician Decision|0
7256355|NCT00322374|11467848|FG002|Starting Dose|Physician Decision|0
7256356|NCT00322374|11467849|FG003|Starting Dose|Physician Decision|0
7256357|NCT00322374|11467846|FG000|Starting Dose|Study Drug Toxicity|4
7256358|NCT00322374|11467847|FG001|Starting Dose|Study Drug Toxicity|0
7256359|NCT00322374|11467848|FG002|Starting Dose|Study Drug Toxicity|0
7256360|NCT00322374|11467849|FG003|Starting Dose|Study Drug Toxicity|0
7256361|NCT00322374|11467846|FG000|First Escalation|Documented Disease Progression|0
7256362|NCT00322374|11467847|FG001|First Escalation|Documented Disease Progression|6
7256363|NCT00322374|11467848|FG002|First Escalation|Documented Disease Progression|0
7256364|NCT00322374|11467849|FG003|First Escalation|Documented Disease Progression|0
7256365|NCT00322374|11467846|FG000|First Escalation|Physician Decision|0
7256366|NCT00322374|11467847|FG001|First Escalation|Physician Decision|12
7256367|NCT00322374|11467848|FG002|First Escalation|Physician Decision|0
7256368|NCT00322374|11467849|FG003|First Escalation|Physician Decision|0
7256369|NCT00322374|11467846|FG000|First Escalation|Study Drug Toxicity|0
7256370|NCT00322374|11467847|FG001|First Escalation|Study Drug Toxicity|11
7256371|NCT00322374|11467848|FG002|First Escalation|Study Drug Toxicity|0
7256372|NCT00322374|11467849|FG003|First Escalation|Study Drug Toxicity|0
7256373|NCT00322374|11467846|FG000|First Escalation|Participant Request|0
7256374|NCT00322374|11467847|FG001|First Escalation|Participant Request|1
7256375|NCT00322374|11467848|FG002|First Escalation|Participant Request|0
7256376|NCT00322374|11467849|FG003|First Escalation|Participant Request|0
7256377|NCT00322374|11467846|FG000|Second Escalation|Physician Decision|0
7256378|NCT00322374|11467847|FG001|Second Escalation|Physician Decision|0
7256379|NCT00322374|11467848|FG002|Second Escalation|Physician Decision|5
7256380|NCT00322374|11467849|FG003|Second Escalation|Physician Decision|0
7256381|NCT00322374|11467846|FG000|Second Escalation|Study Drug Toxicity|0
7256382|NCT00322374|11467847|FG001|Second Escalation|Study Drug Toxicity|0
7256383|NCT00322374|11467848|FG002|Second Escalation|Study Drug Toxicity|1
7256384|NCT00322374|11467849|FG003|Second Escalation|Study Drug Toxicity|0
7256385|NCT00322387|11467864|FG000|Treatment Period|Adverse Event|0
7256386|NCT00322387|11467865|FG001|Treatment Period|Adverse Event|1
7256387|NCT00322387|11467864|FG000|Follow-up Period|Final assessment not done|1
7256388|NCT00322387|11467865|FG001|Follow-up Period|Final assessment not done|3
7256389|NCT00322387|11467864|FG000|Follow-up Period|Death|1
7256390|NCT00322387|11467865|FG001|Follow-up Period|Death|0
7256391|NCT00322452|11467888|FG000|Overall Study|Eligibility criteria not fulfilled|0
7256392|NCT00322452|11467889|FG001|Overall Study|Eligibility criteria not fulfilled|1
7256393|NCT00322452|11467888|FG000|Overall Study|Lost to Follow-up|5
7256394|NCT00322452|11467889|FG001|Overall Study|Lost to Follow-up|2
7256395|NCT00322452|11467888|FG000|Overall Study|Withdrawal by Subject|19
7256396|NCT00322452|11467889|FG001|Overall Study|Withdrawal by Subject|46
7256397|NCT00322452|11467888|FG000|Overall Study|Death|223
7256398|NCT00322452|11467889|FG001|Overall Study|Death|227
7256399|NCT00322491|11467917|FG000|Overall Study|Adverse Event|1
7256400|NCT00322491|11467918|FG001|Overall Study|Adverse Event|0
7256401|NCT00322491|11467917|FG000|Overall Study|Death|1
7256402|NCT00322491|11467918|FG001|Overall Study|Death|2
7256403|NCT00322556|11467925|FG000|Overall Study|Adverse Event|1
7256404|NCT00322556|11467925|FG000|Overall Study|Withdrawal by Subject|1
7256405|NCT00322556|11467925|FG000|Overall Study|Lost to Follow-up|3
7256406|NCT00322556|11467925|FG000|Overall Study|Other Reason|7
7256407|NCT00322621|11467932|FG000|Period II - Acute Therapy Phase|Adverse Event|20
7256408|NCT00322621|11467933|FG001|Period II - Acute Therapy Phase|Adverse Event|0
7256409|NCT00322621|11467934|FG002|Period II - Acute Therapy Phase|Adverse Event|0
7256410|NCT00322621|11467932|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
7256411|NCT00322621|11467933|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
7256412|NCT00322621|11467934|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
7256413|NCT00322621|11467932|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
7249956|NCT00281840|11460725|FG000|Overall Study|Adverse Event|12
7249957|NCT00281840|11460725|FG000|Overall Study|Physician Decision|6
7249958|NCT00281840|11460725|FG000|Overall Study|Withdrawal by Subject|3
7249959|NCT00281840|11460725|FG000|Overall Study|Disease Progression|2
7249960|NCT00281840|11460725|FG000|Overall Study|exceed maximum delay in treatment|1
7249961|NCT00281840|11460725|FG000|Overall Study|Complicating Disease|1
7249962|NCT00281957|11460741|FG000|Overall Study|Adverse Event|7
7249963|NCT00281957|11460742|FG001|Overall Study|Adverse Event|2
7249964|NCT00281957|11460741|FG000|Overall Study|Death|1
7249965|NCT00281957|11460742|FG001|Overall Study|Death|0
7249966|NCT00281957|11460741|FG000|Overall Study|Progression/relapse|47
7249967|NCT00281957|11460742|FG001|Overall Study|Progression/relapse|35
7249968|NCT00281957|11460741|FG000|Overall Study|Not protocol specified|8
7249969|NCT00281957|11460742|FG001|Overall Study|Not protocol specified|1
7249970|NCT00281957|11460741|FG000|Overall Study|Not eligible|1
7249971|NCT00281957|11460742|FG001|Overall Study|Not eligible|2
7249972|NCT00281957|11460741|FG000|Overall Study|Did not start treatment|3
7249973|NCT00281957|11460742|FG001|Overall Study|Did not start treatment|1
7249974|NCT00281957|11460741|FG000|Overall Study|Refusal unrelated to adverse events|0
7249975|NCT00281957|11460742|FG001|Overall Study|Refusal unrelated to adverse events|1
7249976|NCT00282048|11460750|FG000|Overall Study|Lack of Efficacy|30
7249977|NCT00282048|11460750|FG000|Overall Study|Adverse Event|22
7249978|NCT00282048|11460750|FG000|Overall Study|Withdrawal by Subject|1
7249979|NCT00282048|11460750|FG000|Overall Study|Other|8
7249980|NCT00282048|11460750|FG000|Overall Study|Ongoing|1
7249981|NCT00282087|11460754|FG000|Overall Study|Death|1
7249982|NCT00282113|11460762|FG000|Overall Study|Removed at parents request|1
7249983|NCT00282113|11460763|FG001|Overall Study|Removed at parents request|0
7249984|NCT00282113|11460764|FG002|Overall Study|Removed at parents request|0
7249985|NCT00282152|11460774|FG000|Overall Study|Withdrawal by Subject|1
7249986|NCT00282152|11460775|FG001|Overall Study|Withdrawal by Subject|0
7249987|NCT00282243|11460782|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
7249988|NCT00282243|11460782|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
7249989|NCT00282243|11460782|FG000|Extension Treatment Period|Adverse Event|15
7249990|NCT00282243|11460782|FG000|Extension Treatment Period|Withdrawal by Subject|4
7249991|NCT00282243|11460782|FG000|Extension Treatment Period|Non-compliance|2
7249992|NCT00282243|11460782|FG000|Extension Treatment Period|Physician Decision|1
7249993|NCT00282256|11460786|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
7249994|NCT00282256|11460786|FG000|Extension Treatment Period|Adverse Event|2
7249995|NCT00282295|11460798|FG000|Overall Study|Adverse Event|0
7249996|NCT00282295|11460799|FG001|Overall Study|Adverse Event|1
7249997|NCT00282295|11460800|FG002|Overall Study|Adverse Event|0
7249998|NCT00282295|11460798|FG000|Overall Study|Serious Adverse Events|0
7249999|NCT00282295|11460799|FG001|Overall Study|Serious Adverse Events|0
7250000|NCT00282295|11460800|FG002|Overall Study|Serious Adverse Events|1
7250001|NCT00282295|11460798|FG000|Overall Study|Protocol Violation|0
7250002|NCT00282295|11460799|FG001|Overall Study|Protocol Violation|2
7250003|NCT00282295|11460800|FG002|Overall Study|Protocol Violation|1
7250004|NCT00282295|11460798|FG000|Overall Study|Withdrawal by Subject|2
7250005|NCT00282295|11460799|FG001|Overall Study|Withdrawal by Subject|6
7250006|NCT00282295|11460800|FG002|Overall Study|Withdrawal by Subject|4
7250007|NCT00282295|11460798|FG000|Overall Study|Lost to Follow-up|1
7250008|NCT00282295|11460799|FG001|Overall Study|Lost to Follow-up|7
7250009|NCT00282295|11460800|FG002|Overall Study|Lost to Follow-up|2
7250010|NCT00282295|11460798|FG000|Overall Study|Other|0
7250011|NCT00282295|11460799|FG001|Overall Study|Other|1
7250012|NCT00282295|11460800|FG002|Overall Study|Other|0
7250013|NCT00282308|11460815|FG000|Treatment Period|Lost to Follow-up|1
7250014|NCT00282308|11460816|FG001|Treatment Period|Lost to Follow-up|0
7250015|NCT00282308|11460817|FG002|Treatment Period|Lost to Follow-up|0
7250016|NCT00282308|11460815|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
7250017|NCT00282308|11460816|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
7250018|NCT00282308|11460817|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
7250019|NCT00282308|11460815|FG000|Treatment Period|Adverse Event|0
7250020|NCT00282308|11460816|FG001|Treatment Period|Adverse Event|2
7250021|NCT00282308|11460817|FG002|Treatment Period|Adverse Event|0
7250022|NCT00282308|11460815|FG000|Treatment Period|Not Treated with Study Drug|1
7250023|NCT00282308|11460816|FG001|Treatment Period|Not Treated with Study Drug|0
7250024|NCT00282308|11460817|FG002|Treatment Period|Not Treated with Study Drug|0
7250025|NCT00282308|11460815|FG000|Optional Extension Re-treatment Period|Adverse Event|0
7250026|NCT00282308|11460816|FG001|Optional Extension Re-treatment Period|Adverse Event|0
7250027|NCT00282308|11460817|FG002|Optional Extension Re-treatment Period|Adverse Event|4
7250028|NCT00282308|11460815|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7250029|NCT00282308|11460816|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
7250030|NCT00282308|11460817|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
7250031|NCT00282308|11460815|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7250032|NCT00282308|11460816|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
7250033|NCT00282308|11460817|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
7250034|NCT00282308|11460815|FG000|Safety Follow-up Period|Adverse Event|0
7250035|NCT00282308|11460816|FG001|Safety Follow-up Period|Adverse Event|0
7250036|NCT00282308|11460817|FG002|Safety Follow-up Period|Adverse Event|1
7250037|NCT00282308|11460815|FG000|Safety Follow-up Period|Lost to Follow-up|0
7250038|NCT00282308|11460816|FG001|Safety Follow-up Period|Lost to Follow-up|0
7250039|NCT00282308|11460817|FG002|Safety Follow-up Period|Lost to Follow-up|5
7250040|NCT00282308|11460815|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
7250041|NCT00282308|11460816|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
7250042|NCT00282308|11460817|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
7250043|NCT00282308|11460815|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7250044|NCT00282308|11460816|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
7250045|NCT00282308|11460817|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
7250046|NCT00282334|11460829|FG000|Overall Study|Withdrawal by Subject|8
7250047|NCT00282334|11460830|FG001|Overall Study|Withdrawal by Subject|5
7250048|NCT00282347|11460838|FG000|Treatment Period|Death|2
7250049|NCT00282347|11460839|FG001|Treatment Period|Death|0
7250050|NCT00282347|11460838|FG000|Treatment Period|Lost to Follow-up|2
7250051|NCT00282347|11460839|FG001|Treatment Period|Lost to Follow-up|5
7250052|NCT00282347|11460838|FG000|Treatment Period|Withdrawal by Subject|1
7250053|NCT00282347|11460839|FG001|Treatment Period|Withdrawal by Subject|3
7250054|NCT00282347|11460838|FG000|Treatment Period|Physician Decision|0
7250055|NCT00282347|11460839|FG001|Treatment Period|Physician Decision|1
7250056|NCT00282347|11460838|FG000|Safety Follow-up Period|Lost to Follow-up|0
7250057|NCT00282347|11460839|FG001|Safety Follow-up Period|Lost to Follow-up|2
7250058|NCT00282347|11460838|FG000|Safety Follow-up Period|Withdrawal by Subject|2
7250059|NCT00282347|11460839|FG001|Safety Follow-up Period|Withdrawal by Subject|1
7250060|NCT00282347|11460838|FG000|Safety Follow-up Period|Physician Decision|1
7250061|NCT00282347|11460839|FG001|Safety Follow-up Period|Physician Decision|1
7250062|NCT00282347|11460838|FG000|Safety Follow-up Period|Protocol Deviation|0
7250063|NCT00282347|11460839|FG001|Safety Follow-up Period|Protocol Deviation|2
7250064|NCT00282347|11460838|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
7250065|NCT00282347|11460839|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
7250066|NCT00282347|11460838|FG000|B Cell Follow-up Period|Physician Decision|1
7250067|NCT00282347|11460839|FG001|B Cell Follow-up Period|Physician Decision|0
7250068|NCT00282347|11460838|FG000|B Cell Follow-up Period|Reason Not Specified|2
7250069|NCT00282347|11460839|FG001|B Cell Follow-up Period|Reason Not Specified|0
7250070|NCT00282412|11460847|FG000|Overall Study|Death|2
7250071|NCT00282438|11460853|FG000|Overall Study|Lack of Efficacy|1
7250072|NCT00282438|11460854|FG001|Overall Study|Lack of Efficacy|0
7250073|NCT00282438|11460853|FG000|Overall Study|Death|0
7250074|NCT00282438|11460854|FG001|Overall Study|Death|1
7250075|NCT00282464|11460862|FG000|Overall Study|Adverse Event|26
7250076|NCT00282464|11460863|FG001|Overall Study|Adverse Event|20
7250077|NCT00282464|11460862|FG000|Overall Study|Lack of Efficacy|8
7250078|NCT00282464|11460863|FG001|Overall Study|Lack of Efficacy|8
7250079|NCT00282464|11460862|FG000|Overall Study|Lost to Follow-up|10
7250080|NCT00282464|11460863|FG001|Overall Study|Lost to Follow-up|10
7250081|NCT00282464|11460862|FG000|Overall Study|Withdrawal by Subject|24
7250082|NCT00282464|11460863|FG001|Overall Study|Withdrawal by Subject|10
7250083|NCT00282464|11460862|FG000|Overall Study|laboratory abnormality|1
7250084|NCT00282464|11460863|FG001|Overall Study|laboratory abnormality|2
7250085|NCT00282464|11460862|FG000|Overall Study|Protocol Violation|0
7250086|NCT00282464|11460863|FG001|Overall Study|Protocol Violation|7
7250087|NCT00282464|11460862|FG000|Overall Study|Patient moved|1
7250088|NCT00282464|11460863|FG001|Overall Study|Patient moved|0
7250089|NCT00282464|11460862|FG000|Overall Study|patient non-compliant|3
7250090|NCT00282464|11460863|FG001|Overall Study|patient non-compliant|0
7250091|NCT00282464|11460862|FG000|Overall Study|patient no show|0
7250092|NCT00282464|11460863|FG001|Overall Study|patient no show|1
7250093|NCT00282464|11460862|FG000|Overall Study|patient incarcerated|0
7250094|NCT00282464|11460863|FG001|Overall Study|patient incarcerated|1
7250095|NCT00282464|11460862|FG000|Overall Study|family crisis|0
7250096|NCT00282464|11460863|FG001|Overall Study|family crisis|1
7250097|NCT00282464|11460862|FG000|Overall Study|dispensed wrong kit|0
7250098|NCT00282464|11460863|FG001|Overall Study|dispensed wrong kit|1
7250099|NCT00282464|11460862|FG000|Overall Study|dropped due to missed visits|0
7250100|NCT00282464|11460863|FG001|Overall Study|dropped due to missed visits|1
7250101|NCT00282568|11460869|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
7250102|NCT00282568|11460869|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
7250103|NCT00282568|11460869|FG000|Extended Treatment Period|Adverse Event|17
7250104|NCT00282568|11460869|FG000|Extended Treatment Period|Non-compliance|4
7250105|NCT00282568|11460869|FG000|Extended Treatment Period|Physician Decision|1
7250106|NCT00282568|11460869|FG000|Extended Treatment Period|Lost to Follow-up|2
7250107|NCT00282919|11460944|FG000|Overall Study|Lack of Efficacy|4
7250108|NCT00282919|11460944|FG000|Overall Study|Withdrawal by Subject|1
7250109|NCT00282919|11460944|FG000|Overall Study|Asymptomatic Parasitemia|2
7250110|NCT00282984|11460959|FG000|Overall Study|Death|2
7250111|NCT00282984|11460960|FG001|Overall Study|Death|5
7250112|NCT00282984|11460959|FG000|Overall Study|Adverse Event|8
7250113|NCT00282984|11460960|FG001|Overall Study|Adverse Event|5
7250114|NCT00282984|11460959|FG000|Overall Study|Lack of Efficacy|0
7250115|NCT00282984|11460960|FG001|Overall Study|Lack of Efficacy|2
7250116|NCT00282984|11460959|FG000|Overall Study|Lost to Follow-up|14
7250117|NCT00282984|11460960|FG001|Overall Study|Lost to Follow-up|10
7250118|NCT00282984|11460959|FG000|Overall Study|Withdrawal by Participant|22
7250119|NCT00282984|11460960|FG001|Overall Study|Withdrawal by Participant|34
7250120|NCT00282984|11460959|FG000|Overall Study|Participant stopped study medication|2
7250121|NCT00282984|11460960|FG001|Overall Study|Participant stopped study medication|2
7250122|NCT00282984|11460959|FG000|Overall Study|Participant only allowed phone follow-up|0
7250123|NCT00282984|11460960|FG001|Overall Study|Participant only allowed phone follow-up|1
7250124|NCT00282984|11460959|FG000|Overall Study|Participant used antipsychosis meds|0
7250125|NCT00282984|11460960|FG001|Overall Study|Participant used antipsychosis meds|1
7250126|NCT00282984|11460959|FG000|Overall Study|lack of motivation|1
7250127|NCT00282984|11460960|FG001|Overall Study|lack of motivation|0
7250128|NCT00282984|11460959|FG000|Overall Study|in prison|0
7250129|NCT00282984|11460960|FG001|Overall Study|in prison|1
7250130|NCT00282984|11460959|FG000|Overall Study|Protocol Violation|2
7250131|NCT00282984|11460960|FG001|Overall Study|Protocol Violation|0
7250132|NCT00283049|11460969|FG000|Overall Study|Adverse Event|6
7250133|NCT00283049|11460970|FG001|Overall Study|Adverse Event|1
7250134|NCT00283049|11460971|FG002|Overall Study|Adverse Event|4
7250135|NCT00283049|11460969|FG000|Overall Study|Protocol Violation|3
7250136|NCT00283049|11460970|FG001|Overall Study|Protocol Violation|0
7250137|NCT00283049|11460971|FG002|Overall Study|Protocol Violation|3
7250138|NCT00283049|11460969|FG000|Overall Study|Death|1
7250139|NCT00283049|11460970|FG001|Overall Study|Death|1
7250140|NCT00283049|11460971|FG002|Overall Study|Death|1
7250141|NCT00283049|11460969|FG000|Overall Study|Lack of Efficacy|0
7250142|NCT00283049|11460970|FG001|Overall Study|Lack of Efficacy|1
7250143|NCT00283049|11460971|FG002|Overall Study|Lack of Efficacy|1
7250144|NCT00283049|11460969|FG000|Overall Study|Lost to Follow-up|4
7250145|NCT00283049|11460970|FG001|Overall Study|Lost to Follow-up|2
7250146|NCT00283049|11460971|FG002|Overall Study|Lost to Follow-up|5
7250147|NCT00283049|11460969|FG000|Overall Study|Withdrawal by Subject|26
7250148|NCT00283049|11460970|FG001|Overall Study|Withdrawal by Subject|24
7250149|NCT00283049|11460971|FG002|Overall Study|Withdrawal by Subject|19
7250150|NCT00283049|11460969|FG000|Overall Study|Discontinuation of Study|18
7250151|NCT00283049|11460970|FG001|Overall Study|Discontinuation of Study|16
7250152|NCT00283049|11460971|FG002|Overall Study|Discontinuation of Study|20
7250153|NCT00283049|11460969|FG000|Overall Study|No longer requires study treatment|0
7250154|NCT00283049|11460970|FG001|Overall Study|No longer requires study treatment|0
7250155|NCT00283049|11460971|FG002|Overall Study|No longer requires study treatment|1
7250156|NCT00283062|11460983|FG000|Overall Study|Did not receive any study medication|5
7250157|NCT00283062|11460984|FG001|Overall Study|Did not receive any study medication|4
7250158|NCT00283062|11460985|FG002|Overall Study|Did not receive any study medication|36
7250159|NCT00283062|11460986|FG003|Overall Study|Did not receive any study medication|45
7250160|NCT00283062|11460983|FG000|Overall Study|Adverse Event|2
7250161|NCT00283062|11460984|FG001|Overall Study|Adverse Event|0
7250162|NCT00283062|11460985|FG002|Overall Study|Adverse Event|1
7250163|NCT00283062|11460986|FG003|Overall Study|Adverse Event|0
7250164|NCT00283062|11460983|FG000|Overall Study|Lost to Follow-up|1
7250165|NCT00283062|11460984|FG001|Overall Study|Lost to Follow-up|0
7250166|NCT00283062|11460985|FG002|Overall Study|Lost to Follow-up|1
7250167|NCT00283062|11460986|FG003|Overall Study|Lost to Follow-up|0
7250168|NCT00283062|11460983|FG000|Overall Study|Progressive disease|0
7250169|NCT00283062|11460984|FG001|Overall Study|Progressive disease|0
7250170|NCT00283062|11460985|FG002|Overall Study|Progressive disease|1
7250171|NCT00283062|11460986|FG003|Overall Study|Progressive disease|0
7250172|NCT00283062|11460983|FG000|Overall Study|Participant did not wish to continue|3
7250173|NCT00283062|11460984|FG001|Overall Study|Participant did not wish to continue|2
7250174|NCT00283062|11460985|FG002|Overall Study|Participant did not wish to continue|1
7250175|NCT00283062|11460986|FG003|Overall Study|Participant did not wish to continue|0
7250176|NCT00283062|11460983|FG000|Overall Study|Undefined|0
7250177|NCT00283062|11460984|FG001|Overall Study|Undefined|1
7250178|NCT00283062|11460985|FG002|Overall Study|Undefined|1
7250179|NCT00283062|11460986|FG003|Overall Study|Undefined|4
7250180|NCT00283062|11460983|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
7250181|NCT00283062|11460984|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
7250182|NCT00283062|11460985|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
7250183|NCT00283062|11460986|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
7250184|NCT00283244|11461011|FG000|Overall Study|Adverse Event|0
7250185|NCT00283244|11461012|FG001|Overall Study|Adverse Event|8
7250186|NCT00283244|11461013|FG002|Overall Study|Adverse Event|11
7250187|NCT00283244|11461011|FG000|Overall Study|Death|4
7250188|NCT00283244|11461012|FG001|Overall Study|Death|3
7250189|NCT00283244|11461013|FG002|Overall Study|Death|2
7250190|NCT00283244|11461011|FG000|Overall Study|Lack of Efficacy|8
7250191|NCT00283244|11461012|FG001|Overall Study|Lack of Efficacy|32
7250192|NCT00283244|11461013|FG002|Overall Study|Lack of Efficacy|26
7250193|NCT00283244|11461011|FG000|Overall Study|Withdrawal by Subject|1
7250194|NCT00283244|11461012|FG001|Overall Study|Withdrawal by Subject|2
7250195|NCT00283244|11461013|FG002|Overall Study|Withdrawal by Subject|2
7250196|NCT00283244|11461011|FG000|Overall Study|Physician Decision|0
7250197|NCT00283244|11461012|FG001|Overall Study|Physician Decision|0
7250198|NCT00283244|11461013|FG002|Overall Study|Physician Decision|1
7250199|NCT00283244|11461011|FG000|Overall Study|Medical illness (other complicating dz)|4
7250200|NCT00283244|11461012|FG001|Overall Study|Medical illness (other complicating dz)|3
7250201|NCT00283244|11461013|FG002|Overall Study|Medical illness (other complicating dz)|6
7250202|NCT00283244|11461011|FG000|Overall Study|Clinical deterioration|1
7250203|NCT00283244|11461012|FG001|Overall Study|Clinical deterioration|3
7250204|NCT00283244|11461013|FG002|Overall Study|Clinical deterioration|3
7250205|NCT00283296|11461044|FG000|Overall Study|in-home trial not completed|5
7250206|NCT00283387|11461049|FG000|First Intervention|Subject non-compliant|1
7250207|NCT00283387|11461050|FG001|First Intervention|Subject non-compliant|1
7250208|NCT00283387|11461049|FG000|First Intervention|Withdrawal by Subject|0
7250209|NCT00283387|11461050|FG001|First Intervention|Withdrawal by Subject|1
7250210|NCT00283400|11461060|FG000|Overall Study|Withdrawal by Subject|1
7250211|NCT00283400|11461061|FG001|Overall Study|Withdrawal by Subject|1
7250212|NCT00283400|11461062|FG002|Overall Study|Withdrawal by Subject|0
7250213|NCT00283400|11461063|FG003|Overall Study|Withdrawal by Subject|0
7250214|NCT00283400|11461060|FG000|Overall Study|Death|1
7250215|NCT00283400|11461061|FG001|Overall Study|Death|0
7250216|NCT00283400|11461062|FG002|Overall Study|Death|1
7250217|NCT00283400|11461063|FG003|Overall Study|Death|0
7250218|NCT00283439|11461077|FG000|Overall Study|Adverse Event|0
7250219|NCT00283439|11461078|FG001|Overall Study|Adverse Event|0
7250220|NCT00283439|11461079|FG002|Overall Study|Adverse Event|0
7250221|NCT00283439|11461080|FG003|Overall Study|Adverse Event|1
7250222|NCT00283439|11461077|FG000|Overall Study|Death|0
7250223|NCT00283439|11461078|FG001|Overall Study|Death|0
7250224|NCT00283439|11461079|FG002|Overall Study|Death|1
7250225|NCT00283439|11461080|FG003|Overall Study|Death|0
7250226|NCT00283439|11461077|FG000|Overall Study|Disease progression|0
7250227|NCT00283439|11461078|FG001|Overall Study|Disease progression|1
7250228|NCT00283439|11461079|FG002|Overall Study|Disease progression|0
7250229|NCT00283439|11461080|FG003|Overall Study|Disease progression|0
7250230|NCT00283439|11461077|FG000|Overall Study|Requirement for alternative therapy|1
7250231|NCT00283439|11461078|FG001|Overall Study|Requirement for alternative therapy|2
7250232|NCT00283439|11461079|FG002|Overall Study|Requirement for alternative therapy|5
7250233|NCT00283439|11461080|FG003|Overall Study|Requirement for alternative therapy|2
7250234|NCT00283439|11461077|FG000|Overall Study|Stem cell transplant|6
7250235|NCT00283439|11461078|FG001|Overall Study|Stem cell transplant|6
7250236|NCT00283439|11461079|FG002|Overall Study|Stem cell transplant|4
7250237|NCT00283439|11461080|FG003|Overall Study|Stem cell transplant|3
7250238|NCT00283439|11461077|FG000|Overall Study|Treatment discontinued|0
7250239|NCT00283439|11461078|FG001|Overall Study|Treatment discontinued|2
7250240|NCT00283439|11461079|FG002|Overall Study|Treatment discontinued|1
7250241|NCT00283439|11461080|FG003|Overall Study|Treatment discontinued|3
7250242|NCT00283439|11461077|FG000|Overall Study|Other|1
7250243|NCT00283439|11461078|FG001|Overall Study|Other|0
7250244|NCT00283439|11461079|FG002|Overall Study|Other|0
7250245|NCT00283439|11461080|FG003|Overall Study|Other|0
7250246|NCT00283595|11461103|FG000|Overall Study|Withdrawal by Subject|1
7250247|NCT00283595|11461104|FG001|Overall Study|Withdrawal by Subject|2
7250248|NCT00283686|11461114|FG000|Overall Study|Death|1
7250249|NCT00283686|11461115|FG001|Overall Study|Death|1
7250250|NCT00283686|11461116|FG002|Overall Study|Death|1
7250251|NCT00283686|11461117|FG003|Overall Study|Death|0
7250252|NCT00283686|11461114|FG000|Overall Study|Lost to Follow-up|21
7250253|NCT00283686|11461115|FG001|Overall Study|Lost to Follow-up|31
7250254|NCT00283686|11461116|FG002|Overall Study|Lost to Follow-up|26
7250255|NCT00283686|11461117|FG003|Overall Study|Lost to Follow-up|20
7250256|NCT00283686|11461114|FG000|Overall Study|Less than full participation|7
7250257|NCT00283686|11461115|FG001|Overall Study|Less than full participation|9
7250258|NCT00283686|11461116|FG002|Overall Study|Less than full participation|6
7250259|NCT00283686|11461117|FG003|Overall Study|Less than full participation|12
7250260|NCT00283712|11461129|FG000|Overall Study|Death|0
7250261|NCT00283712|11461130|FG001|Overall Study|Death|1
7250262|NCT00283803|11461136|FG000|Overall Study|Physician Decision|9
7250263|NCT00283803|11461136|FG000|Overall Study|Withdrawal by Subject|4
7250264|NCT00283842|11461156|FG000|Overall Study|Adverse Event|8
7250265|NCT00283842|11461157|FG001|Overall Study|Adverse Event|7
7250266|NCT00283842|11461158|FG002|Overall Study|Adverse Event|21
7250267|NCT00283842|11461159|FG003|Overall Study|Adverse Event|21
7250268|NCT00283842|11461160|FG004|Overall Study|Adverse Event|5
7250269|NCT00283842|11461156|FG000|Overall Study|Protocol Violation|1
7250270|NCT00283842|11461157|FG001|Overall Study|Protocol Violation|5
7250271|NCT00283842|11461158|FG002|Overall Study|Protocol Violation|4
7250272|NCT00283842|11461159|FG003|Overall Study|Protocol Violation|0
7250273|NCT00283842|11461160|FG004|Overall Study|Protocol Violation|0
7250274|NCT00283842|11461156|FG000|Overall Study|Protocol deviation|0
7250275|NCT00283842|11461157|FG001|Overall Study|Protocol deviation|0
7250276|NCT00283842|11461158|FG002|Overall Study|Protocol deviation|0
7250277|NCT00283842|11461159|FG003|Overall Study|Protocol deviation|0
7250278|NCT00283842|11461160|FG004|Overall Study|Protocol deviation|2
7250279|NCT00283842|11461156|FG000|Overall Study|Withdrawal by Subject|2
7250280|NCT00283842|11461157|FG001|Overall Study|Withdrawal by Subject|1
7250281|NCT00283842|11461158|FG002|Overall Study|Withdrawal by Subject|1
7250282|NCT00283842|11461159|FG003|Overall Study|Withdrawal by Subject|5
7250283|NCT00283842|11461160|FG004|Overall Study|Withdrawal by Subject|4
7250284|NCT00283842|11461156|FG000|Overall Study|Lack of Efficacy|1
7250285|NCT00283842|11461157|FG001|Overall Study|Lack of Efficacy|3
7250286|NCT00283842|11461158|FG002|Overall Study|Lack of Efficacy|1
7250287|NCT00283842|11461159|FG003|Overall Study|Lack of Efficacy|0
7250288|NCT00283842|11461160|FG004|Overall Study|Lack of Efficacy|3
7250289|NCT00283842|11461156|FG000|Overall Study|Lost to Follow-up|0
7250290|NCT00283842|11461157|FG001|Overall Study|Lost to Follow-up|2
7250291|NCT00283842|11461158|FG002|Overall Study|Lost to Follow-up|4
7250292|NCT00283842|11461159|FG003|Overall Study|Lost to Follow-up|1
7250293|NCT00283842|11461160|FG004|Overall Study|Lost to Follow-up|1
7250294|NCT00284050|11461179|FG000|Overall Study|Adverse Event|1
7250295|NCT00284050|11461180|FG001|Overall Study|Adverse Event|1
7250296|NCT00284050|11461181|FG002|Overall Study|Adverse Event|1
7250297|NCT00284050|11461179|FG000|Overall Study|Lack of Efficacy|0
7574365|NCT03673670|11956999|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
7574366|NCT03673670|11957000|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
7574367|NCT03673670|11957001|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
7574368|NCT03673670|11956996|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
7250298|NCT00284050|11461180|FG001|Overall Study|Lack of Efficacy|1
7250299|NCT00284050|11461181|FG002|Overall Study|Lack of Efficacy|3
7250300|NCT00284050|11461179|FG000|Overall Study|Protocol Violation|0
7250301|NCT00284050|11461180|FG001|Overall Study|Protocol Violation|1
7250302|NCT00284050|11461181|FG002|Overall Study|Protocol Violation|2
7250303|NCT00284050|11461179|FG000|Overall Study|Withdrawal by Subject|2
7250304|NCT00284050|11461180|FG001|Overall Study|Withdrawal by Subject|2
7250305|NCT00284050|11461181|FG002|Overall Study|Withdrawal by Subject|2
7250306|NCT00284050|11461179|FG000|Overall Study|Lost to Follow-up|1
7250307|NCT00284050|11461180|FG001|Overall Study|Lost to Follow-up|0
7250308|NCT00284050|11461181|FG002|Overall Study|Lost to Follow-up|1
7250309|NCT00284050|11461179|FG000|Overall Study|Death|1
7250310|NCT00284050|11461180|FG001|Overall Study|Death|0
7250311|NCT00284050|11461181|FG002|Overall Study|Death|0
7250312|NCT00284089|11461193|FG000|Multiple Dose Phase|Adverse Event|1
7250313|NCT00284089|11461194|FG001|Multiple Dose Phase|Adverse Event|0
7250314|NCT00284089|11461195|FG002|Multiple Dose Phase|Adverse Event|1
7250315|NCT00284089|11461196|FG003|Multiple Dose Phase|Adverse Event|1
7250316|NCT00284089|11461193|FG000|Multiple Dose Phase|Protocol Violation|0
7250317|NCT00284089|11461194|FG001|Multiple Dose Phase|Protocol Violation|0
7250318|NCT00284089|11461195|FG002|Multiple Dose Phase|Protocol Violation|1
7250319|NCT00284089|11461196|FG003|Multiple Dose Phase|Protocol Violation|0
7250320|NCT00284089|11461193|FG000|Multiple Dose Phase|Withdrawal by Subject|0
7250321|NCT00284089|11461194|FG001|Multiple Dose Phase|Withdrawal by Subject|0
7250322|NCT00284089|11461195|FG002|Multiple Dose Phase|Withdrawal by Subject|1
7250323|NCT00284089|11461196|FG003|Multiple Dose Phase|Withdrawal by Subject|2
7250324|NCT00284089|11461193|FG000|Multiple Dose Phase|Death|0
7250325|NCT00284089|11461194|FG001|Multiple Dose Phase|Death|0
7250326|NCT00284089|11461195|FG002|Multiple Dose Phase|Death|1
7250327|NCT00284089|11461196|FG003|Multiple Dose Phase|Death|1
7250328|NCT00284089|11461193|FG000|Extension Phase|Adverse Event|0
7250329|NCT00284089|11461194|FG001|Extension Phase|Adverse Event|0
7250330|NCT00284089|11461195|FG002|Extension Phase|Adverse Event|2
7250331|NCT00284089|11461196|FG003|Extension Phase|Adverse Event|2
7250332|NCT00284089|11461193|FG000|Extension Phase|condition no longer requires study drug|2
7250333|NCT00284089|11461194|FG001|Extension Phase|condition no longer requires study drug|0
7250334|NCT00284089|11461195|FG002|Extension Phase|condition no longer requires study drug|2
7250335|NCT00284089|11461196|FG003|Extension Phase|condition no longer requires study drug|7
7250336|NCT00284089|11461193|FG000|Extension Phase|Protocol Violation|0
7250337|NCT00284089|11461194|FG001|Extension Phase|Protocol Violation|0
7574369|NCT03673670|11956997|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
7574370|NCT03673670|11956998|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
7250338|NCT00284089|11461195|FG002|Extension Phase|Protocol Violation|1
7574371|NCT03673670|11956999|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
7250339|NCT00284089|11461196|FG003|Extension Phase|Protocol Violation|0
7250340|NCT00284089|11461193|FG000|Extension Phase|Withdrawal by Subject|0
7250341|NCT00284089|11461194|FG001|Extension Phase|Withdrawal by Subject|0
7250342|NCT00284089|11461195|FG002|Extension Phase|Withdrawal by Subject|1
7250343|NCT00284089|11461196|FG003|Extension Phase|Withdrawal by Subject|3
7250344|NCT00284141|11461206|FG000|Overall Study|Disease Progression / Lack of efficacy|51
7250345|NCT00284141|11461206|FG000|Overall Study|Adverse Event|19
7250346|NCT00284141|11461206|FG000|Overall Study|Participant's request|9
7250347|NCT00284141|11461206|FG000|Overall Study|Symptomatic / Clinical Progression|11
7250348|NCT00284141|11461206|FG000|Overall Study|Clinical deterioration / death|2
7250349|NCT00284141|11461206|FG000|Overall Study|General decline|1
7250350|NCT00284141|11461206|FG000|Overall Study|Pneumonia|1
7250351|NCT00284141|11461206|FG000|Overall Study|Did not take study medication|2
7250352|NCT00284141|11461206|FG000|Overall Study|Ongoing treatment|2
7250353|NCT00284934|11461262|FG000|Overall Study|Adverse Event|1
7250354|NCT00284934|11461263|FG001|Overall Study|Adverse Event|2
7250355|NCT00284934|11461262|FG000|Overall Study|Other reasons|3
7250356|NCT00284934|11461263|FG001|Overall Study|Other reasons|1
7250357|NCT00285012|11461271|FG000|Assigned to Study Treatment (Tx)|Other|2
7250358|NCT00285012|11461272|FG001|Assigned to Study Treatment (Tx)|Other|3
7250359|NCT00285012|11461271|FG000|Received Study Tx|Death|2
7250360|NCT00285012|11461272|FG001|Received Study Tx|Death|1
7250361|NCT00285012|11461271|FG000|Received Study Tx|Adverse Event|5
7250362|NCT00285012|11461272|FG001|Received Study Tx|Adverse Event|11
7250363|NCT00285012|11461271|FG000|Received Study Tx|Lack of Efficacy|0
7250364|NCT00285012|11461272|FG001|Received Study Tx|Lack of Efficacy|3
7250365|NCT00285012|11461271|FG000|Received Study Tx|Lost to Follow-up|29
7250366|NCT00285012|11461272|FG001|Received Study Tx|Lost to Follow-up|31
7250367|NCT00285012|11461271|FG000|Received Study Tx|Withdrawal by Subject|31
7250368|NCT00285012|11461272|FG001|Received Study Tx|Withdrawal by Subject|43
7250369|NCT00285012|11461271|FG000|Received Study Tx|Other|5
7250370|NCT00285012|11461272|FG001|Received Study Tx|Other|5
7250371|NCT00285207|11461280|FG000|Overall Study|Lost to Follow-up|3
7250372|NCT00285207|11461281|FG001|Overall Study|Lost to Follow-up|2
7250373|NCT00285207|11461280|FG000|Overall Study|Withdrawal by Subject|5
7250374|NCT00285207|11461281|FG001|Overall Study|Withdrawal by Subject|2
7250375|NCT00285207|11461280|FG000|Overall Study|Pregnancy|1
7250376|NCT00285207|11461281|FG001|Overall Study|Pregnancy|1
7250377|NCT00285207|11461280|FG000|Overall Study|non-compliance|0
7250378|NCT00285207|11461281|FG001|Overall Study|non-compliance|1
7250379|NCT00285584|11461302|FG000|Month 3|Lost to Follow-up|3
7250380|NCT00285584|11461303|FG001|Month 3|Lost to Follow-up|3
7250381|NCT00285584|11461302|FG000|Month 3|Withdrawal by Subject|1
7250382|NCT00285584|11461303|FG001|Month 3|Withdrawal by Subject|0
7250383|NCT00285584|11461302|FG000|Month 6|Lost to Follow-up|0
7250384|NCT00285584|11461303|FG001|Month 6|Lost to Follow-up|1
7250385|NCT00285649|11461316|FG000|Overall Study|Lost to Follow-up|6
7250386|NCT00285649|11461317|FG001|Overall Study|Lost to Follow-up|4
7250387|NCT00285649|11461318|FG002|Overall Study|Lost to Follow-up|4
7250388|NCT00285649|11461316|FG000|Overall Study|Withdrawal by Subject|3
7250389|NCT00285649|11461317|FG001|Overall Study|Withdrawal by Subject|2
7250390|NCT00285649|11461318|FG002|Overall Study|Withdrawal by Subject|2
7250391|NCT00285818|11461337|FG000|Overall Study|Withdrawal by Subject|3
7250392|NCT00285818|11461338|FG001|Overall Study|Withdrawal by Subject|2
7250393|NCT00285818|11461337|FG000|Overall Study|Lost to Follow-up|1
7250394|NCT00285818|11461338|FG001|Overall Study|Lost to Follow-up|0
7250395|NCT00285857|11461344|FG000|Overall Study|Withdrawal by Subject|2
7250396|NCT00285857|11461344|FG000|Overall Study|Inadequate initial breast cytology|1
7250397|NCT00285857|11461344|FG000|Overall Study|Adverse Event|1
7250398|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
7250399|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
7250400|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
7250401|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
7250402|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Death|58
7250403|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Death|65
7250404|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Adverse Event|28
7250405|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Adverse Event|40
7250406|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Disease Progression|22
7250407|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Disease Progression|35
7250408|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Other|25
7250409|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Other|33
7250410|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Administrative Decision|20
7250411|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Administrative Decision|21
7250412|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Noncompliance|8
7250413|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Noncompliance|8
7250414|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
7250415|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
7250416|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Protocol Deviation|1
7250417|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Protocol Deviation|3
7250418|NCT00286091|11461364|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
7250419|NCT00286091|11461365|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
7250420|NCT00286091|11461364|FG000|Open-label Treatment Phase|Physician Decision|24
7250421|NCT00286091|11461365|FG001|Open-label Treatment Phase|Physician Decision|21
7250422|NCT00286091|11461364|FG000|Open-label Treatment Phase|Adverse Event|5
7250423|NCT00286091|11461365|FG001|Open-label Treatment Phase|Adverse Event|16
7250424|NCT00286091|11461364|FG000|Open-label Treatment Phase|Other|11
7250425|NCT00286091|11461365|FG001|Open-label Treatment Phase|Other|11
7250426|NCT00286091|11461364|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
7250427|NCT00286091|11461365|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
7250428|NCT00286091|11461364|FG000|Open-label Treatment Phase|Death|10
7250429|NCT00286091|11461365|FG001|Open-label Treatment Phase|Death|7
7250430|NCT00286091|11461364|FG000|Open-label Treatment Phase|Disease Progression|9
7250431|NCT00286091|11461365|FG001|Open-label Treatment Phase|Disease Progression|3
7250432|NCT00286091|11461364|FG000|Open-label Treatment Phase|Noncompliance|3
7250433|NCT00286091|11461365|FG001|Open-label Treatment Phase|Noncompliance|1
7250434|NCT00286091|11461364|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7250435|NCT00286091|11461365|FG001|Open-label Treatment Phase|Lost to Follow-up|1
7250436|NCT00286091|11461364|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
7250437|NCT00286091|11461365|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
7250438|NCT00286091|11461364|FG000|Open-label Treatment Phase|Missing End of Study Information|0
7250439|NCT00286091|11461365|FG001|Open-label Treatment Phase|Missing End of Study Information|1
7250440|NCT00286156|11461376|FG000|Overall Study|Missed 12 month visit|0
7250441|NCT00286156|11461377|FG001|Overall Study|Missed 12 month visit|0
7250442|NCT00286156|11461378|FG002|Overall Study|Missed 12 month visit|1
7250443|NCT00286156|11461376|FG000|Overall Study|AE: pulmonary embolus|0
7250444|NCT00286156|11461377|FG001|Overall Study|AE: pulmonary embolus|1
7250445|NCT00286156|11461378|FG002|Overall Study|AE: pulmonary embolus|0
7250446|NCT00286156|11461376|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
7250447|NCT00286156|11461377|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
7250448|NCT00286156|11461378|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
7250449|NCT00286156|11461376|FG000|Overall Study|AE: pneumonia|1
7250450|NCT00286156|11461377|FG001|Overall Study|AE: pneumonia|0
7250451|NCT00286156|11461378|FG002|Overall Study|AE: pneumonia|0
7250452|NCT00286221|11461399|FG000|Overall Study|Protocol Violation|2
7250453|NCT00286221|11461400|FG001|Overall Study|Protocol Violation|1
7250454|NCT00286221|11461401|FG002|Overall Study|Protocol Violation|6
7250455|NCT00286221|11461402|FG003|Overall Study|Protocol Violation|4
7250456|NCT00286221|11461399|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
7250457|NCT00286221|11461400|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
7250458|NCT00286221|11461401|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
7250459|NCT00286221|11461402|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
7250460|NCT00286221|11461399|FG000|Overall Study|Inability to trigger PCA|2
7250461|NCT00286221|11461400|FG001|Overall Study|Inability to trigger PCA|0
7250462|NCT00286221|11461401|FG002|Overall Study|Inability to trigger PCA|0
7250463|NCT00286221|11461402|FG003|Overall Study|Inability to trigger PCA|0
7250464|NCT00286221|11461399|FG000|Overall Study|Unrecognized exclusion criteria met|0
7250465|NCT00286221|11461400|FG001|Overall Study|Unrecognized exclusion criteria met|1
7250466|NCT00286221|11461401|FG002|Overall Study|Unrecognized exclusion criteria met|0
7250467|NCT00286221|11461402|FG003|Overall Study|Unrecognized exclusion criteria met|0
7250468|NCT00286234|11461416|FG000|Overall Study|Protocol Violation|1
7250469|NCT00286234|11461417|FG001|Overall Study|Protocol Violation|2
7250470|NCT00286234|11461418|FG002|Overall Study|Protocol Violation|0
7250471|NCT00286234|11461419|FG003|Overall Study|Protocol Violation|1
7250472|NCT00286234|11461416|FG000|Overall Study|Physician Decision|1
7250473|NCT00286234|11461417|FG001|Overall Study|Physician Decision|0
7250474|NCT00286234|11461418|FG002|Overall Study|Physician Decision|0
7250475|NCT00286234|11461419|FG003|Overall Study|Physician Decision|1
7250476|NCT00286234|11461416|FG000|Overall Study|Adverse Event|0
7250477|NCT00286234|11461417|FG001|Overall Study|Adverse Event|0
7250478|NCT00286234|11461418|FG002|Overall Study|Adverse Event|0
7250479|NCT00286234|11461419|FG003|Overall Study|Adverse Event|1
7250480|NCT00286234|11461416|FG000|Overall Study|Adverse Event|0
7250481|NCT00286234|11461417|FG001|Overall Study|Adverse Event|0
7250482|NCT00286234|11461418|FG002|Overall Study|Adverse Event|0
7250483|NCT00286234|11461419|FG003|Overall Study|Adverse Event|1
7250484|NCT00286429|11461436|FG000|Overall Study|Adverse Event|4
7250485|NCT00286429|11461437|FG001|Overall Study|Adverse Event|1
7250486|NCT00286429|11461438|FG002|Overall Study|Adverse Event|6
7250487|NCT00286429|11461436|FG000|Overall Study|Lack of Efficacy|52
7250488|NCT00286429|11461437|FG001|Overall Study|Lack of Efficacy|27
7250489|NCT00286429|11461438|FG002|Overall Study|Lack of Efficacy|25
7250490|NCT00286429|11461436|FG000|Overall Study|Lost to Follow-up|2
7250491|NCT00286429|11461437|FG001|Overall Study|Lost to Follow-up|4
7250492|NCT00286429|11461438|FG002|Overall Study|Lost to Follow-up|3
7250493|NCT00286429|11461436|FG000|Overall Study|Physician Decision|10
7250494|NCT00286429|11461437|FG001|Overall Study|Physician Decision|7
7250495|NCT00286429|11461438|FG002|Overall Study|Physician Decision|7
7250496|NCT00286429|11461436|FG000|Overall Study|Protocol Violation|3
7250497|NCT00286429|11461437|FG001|Overall Study|Protocol Violation|5
7250498|NCT00286429|11461438|FG002|Overall Study|Protocol Violation|4
7250499|NCT00286429|11461436|FG000|Overall Study|Withdrawal by Subject|3
7250500|NCT00286429|11461437|FG001|Overall Study|Withdrawal by Subject|2
7250501|NCT00286429|11461438|FG002|Overall Study|Withdrawal by Subject|6
7250502|NCT00286429|11461436|FG000|Overall Study|Administrative Error|1
7250503|NCT00286429|11461437|FG001|Overall Study|Administrative Error|1
7250504|NCT00286429|11461438|FG002|Overall Study|Administrative Error|1
7250505|NCT00286429|11461436|FG000|Overall Study|Administrative Decision|0
7250506|NCT00286429|11461437|FG001|Overall Study|Administrative Decision|1
7250507|NCT00286429|11461438|FG002|Overall Study|Administrative Decision|0
7250508|NCT00286442|11461449|FG000|Overall Study|Hyperglycemic Rescue|19
7250509|NCT00286442|11461450|FG001|Overall Study|Hyperglycemic Rescue|17
7250510|NCT00286442|11461451|FG002|Overall Study|Hyperglycemic Rescue|25
7250511|NCT00286442|11461449|FG000|Overall Study|Adverse Event|7
7250512|NCT00286442|11461450|FG001|Overall Study|Adverse Event|6
7250513|NCT00286442|11461451|FG002|Overall Study|Adverse Event|1
7250514|NCT00286442|11461449|FG000|Overall Study|Protocol Violation|2
7250515|NCT00286442|11461450|FG001|Overall Study|Protocol Violation|4
7250516|NCT00286442|11461451|FG002|Overall Study|Protocol Violation|2
7250517|NCT00286442|11461449|FG000|Overall Study|Lost to Follow-up|5
7250518|NCT00286442|11461450|FG001|Overall Study|Lost to Follow-up|2
7250519|NCT00286442|11461451|FG002|Overall Study|Lost to Follow-up|1
7250520|NCT00286442|11461449|FG000|Overall Study|Physician Decision|1
7250521|NCT00286442|11461450|FG001|Overall Study|Physician Decision|1
7250522|NCT00286442|11461451|FG002|Overall Study|Physician Decision|1
7250523|NCT00286442|11461449|FG000|Overall Study|Administrative Error|1
7250524|NCT00286442|11461450|FG001|Overall Study|Administrative Error|1
7250525|NCT00286442|11461451|FG002|Overall Study|Administrative Error|0
7250526|NCT00286442|11461449|FG000|Overall Study|Withdrawal by Subject|2
7250527|NCT00286442|11461450|FG001|Overall Study|Withdrawal by Subject|14
7250528|NCT00286442|11461451|FG002|Overall Study|Withdrawal by Subject|2
7250529|NCT00286455|11461462|FG000|Overall Study|Hyperglycemia rescue|19
7250530|NCT00286455|11461463|FG001|Overall Study|Hyperglycemia rescue|13
7250531|NCT00286455|11461464|FG002|Overall Study|Hyperglycemia rescue|10
7250532|NCT00286455|11461462|FG000|Overall Study|Adverse Event|1
7250533|NCT00286455|11461463|FG001|Overall Study|Adverse Event|3
7250534|NCT00286455|11461464|FG002|Overall Study|Adverse Event|2
7250535|NCT00286455|11461462|FG000|Overall Study|Lost to Follow-up|0
7250536|NCT00286455|11461463|FG001|Overall Study|Lost to Follow-up|3
7250537|NCT00286455|11461464|FG002|Overall Study|Lost to Follow-up|3
7250538|NCT00286455|11461462|FG000|Overall Study|Physician Decision|3
7250539|NCT00286455|11461463|FG001|Overall Study|Physician Decision|0
7250540|NCT00286455|11461464|FG002|Overall Study|Physician Decision|2
7250541|NCT00286455|11461462|FG000|Overall Study|Protocol Violation|1
7250542|NCT00286455|11461463|FG001|Overall Study|Protocol Violation|1
7250543|NCT00286455|11461464|FG002|Overall Study|Protocol Violation|0
7250544|NCT00286455|11461462|FG000|Overall Study|Participant Non-compliance|1
7250545|NCT00286455|11461463|FG001|Overall Study|Participant Non-compliance|0
7250546|NCT00286455|11461464|FG002|Overall Study|Participant Non-compliance|0
7250547|NCT00286455|11461462|FG000|Overall Study|Withdrawal by Subject|0
7250548|NCT00286455|11461463|FG001|Overall Study|Withdrawal by Subject|8
7250549|NCT00286455|11461464|FG002|Overall Study|Withdrawal by Subject|7
7250550|NCT00286468|11461475|FG000|Overall Study|Hyperglycemic Rescue|28
7250551|NCT00286468|11461476|FG001|Overall Study|Hyperglycemic Rescue|30
7250552|NCT00286468|11461477|FG002|Overall Study|Hyperglycemic Rescue|31
7250553|NCT00286468|11461475|FG000|Overall Study|Adverse Event|2
7250554|NCT00286468|11461476|FG001|Overall Study|Adverse Event|6
7250555|NCT00286468|11461477|FG002|Overall Study|Adverse Event|4
7250556|NCT00286468|11461475|FG000|Overall Study|Protocol Violation|0
7250557|NCT00286468|11461476|FG001|Overall Study|Protocol Violation|3
7250558|NCT00286468|11461477|FG002|Overall Study|Protocol Violation|1
7250559|NCT00286468|11461475|FG000|Overall Study|Lost to Follow-up|1
7250560|NCT00286468|11461476|FG001|Overall Study|Lost to Follow-up|1
7250561|NCT00286468|11461477|FG002|Overall Study|Lost to Follow-up|2
7250562|NCT00286468|11461475|FG000|Overall Study|Withdrawal by Subject|3
7250563|NCT00286468|11461476|FG001|Overall Study|Withdrawal by Subject|8
7250564|NCT00286468|11461477|FG002|Overall Study|Withdrawal by Subject|11
7250565|NCT00286468|11461475|FG000|Overall Study|Physician Decision|3
7250566|NCT00286468|11461476|FG001|Overall Study|Physician Decision|2
7250567|NCT00286468|11461477|FG002|Overall Study|Physician Decision|1
7250568|NCT00286494|11461488|FG000|Overall Study|Hyperglycemic rescue|12
7250569|NCT00286494|11461489|FG001|Overall Study|Hyperglycemic rescue|19
7250570|NCT00286494|11461490|FG002|Overall Study|Hyperglycemic rescue|18
7250571|NCT00286494|11461488|FG000|Overall Study|Withdrawal by Subject|2
7250572|NCT00286494|11461489|FG001|Overall Study|Withdrawal by Subject|10
7250573|NCT00286494|11461490|FG002|Overall Study|Withdrawal by Subject|9
7250574|NCT00286494|11461488|FG000|Overall Study|Adverse Event|3
7250575|NCT00286494|11461489|FG001|Overall Study|Adverse Event|8
7250576|NCT00286494|11461490|FG002|Overall Study|Adverse Event|6
7250577|NCT00286494|11461488|FG000|Overall Study|Physician Decision|5
7250578|NCT00286494|11461489|FG001|Overall Study|Physician Decision|5
7250579|NCT00286494|11461490|FG002|Overall Study|Physician Decision|1
7250580|NCT00286494|11461488|FG000|Overall Study|Lost to Follow-up|3
7250581|NCT00286494|11461489|FG001|Overall Study|Lost to Follow-up|1
7250582|NCT00286494|11461490|FG002|Overall Study|Lost to Follow-up|3
7250583|NCT00286494|11461488|FG000|Overall Study|Protocol Violation|1
7250584|NCT00286494|11461489|FG001|Overall Study|Protocol Violation|1
7250585|NCT00286494|11461490|FG002|Overall Study|Protocol Violation|2
7250586|NCT00286754|11461522|FG000|Overall Study|Adverse Event|2
7250587|NCT00286754|11461523|FG001|Overall Study|Adverse Event|2
7250588|NCT00286754|11461524|FG002|Overall Study|Adverse Event|3
7250589|NCT00286754|11461522|FG000|Overall Study|Withdrawal by Subject|6
7250590|NCT00286754|11461523|FG001|Overall Study|Withdrawal by Subject|2
7250591|NCT00286754|11461524|FG002|Overall Study|Withdrawal by Subject|0
7250592|NCT00286754|11461522|FG000|Overall Study|Lost to Follow-up|12
7250593|NCT00286754|11461523|FG001|Overall Study|Lost to Follow-up|14
7250594|NCT00286754|11461524|FG002|Overall Study|Lost to Follow-up|6
7250595|NCT00286754|11461522|FG000|Overall Study|Moved out of state|0
7250596|NCT00286754|11461523|FG001|Overall Study|Moved out of state|0
7250597|NCT00286754|11461524|FG002|Overall Study|Moved out of state|1
7250598|NCT00287079|11461555|FG000|Overall Study|Qualifying relapse|12
7250599|NCT00287079|11461556|FG001|Overall Study|Qualifying relapse|1
7250600|NCT00287079|11461555|FG000|Overall Study|Non-qualifying relapse|1
7250601|NCT00287079|11461556|FG001|Overall Study|Non-qualifying relapse|0
7250602|NCT00287079|11461555|FG000|Overall Study|Adverse Event|5
7250603|NCT00287079|11461556|FG001|Overall Study|Adverse Event|0
7250604|NCT00287079|11461555|FG000|Overall Study|Protocol Violation|1
7250605|NCT00287079|11461556|FG001|Overall Study|Protocol Violation|0
7250606|NCT00287079|11461555|FG000|Overall Study|Other|3
7250607|NCT00287079|11461556|FG001|Overall Study|Other|0
7250608|NCT00287118|11461562|FG000|Overall Study|Adverse Event|30
7250609|NCT00287118|11461562|FG000|Overall Study|Death|1
7250610|NCT00287118|11461562|FG000|Overall Study|Lack of Efficacy|11
7250611|NCT00287118|11461562|FG000|Overall Study|Lost to Follow-up|1
7250612|NCT00287118|11461562|FG000|Overall Study|Protocol Violation|2
7250613|NCT00287118|11461562|FG000|Overall Study|Other|7
7250614|NCT00287365|11461583|FG000|Overall Study|sample not acquired|13
7250615|NCT00287469|11461590|FG000|Overall Study|serious adverse event|1
7250616|NCT00287469|11461591|FG001|Overall Study|serious adverse event|6
7250617|NCT00287469|11461590|FG000|Overall Study|Adverse Event|1
7250618|NCT00287469|11461591|FG001|Overall Study|Adverse Event|1
7250619|NCT00287469|11461590|FG000|Overall Study|moved from area|144
7250620|NCT00287469|11461591|FG001|Overall Study|moved from area|138
7250621|NCT00287469|11461590|FG000|Overall Study|Lost to Follow-up|74
7250622|NCT00287469|11461591|FG001|Overall Study|Lost to Follow-up|69
7250623|NCT00287586|11461601|FG000|Overall Study|Withdrew Consent|19
7250624|NCT00287586|11461602|FG001|Overall Study|Withdrew Consent|30
7250625|NCT00287586|11461601|FG000|Overall Study|Lost to Follow-up|5
7250626|NCT00287586|11461602|FG001|Overall Study|Lost to Follow-up|4
7250627|NCT00287586|11461601|FG000|Overall Study|Death|2
7250628|NCT00287586|11461602|FG001|Overall Study|Death|3
7250629|NCT00287586|11461601|FG000|Overall Study|Elevated Hematocrit|3
7250630|NCT00287586|11461602|FG001|Overall Study|Elevated Hematocrit|0
7250631|NCT00287586|11461601|FG000|Overall Study|Rash|3
7250632|NCT00287586|11461602|FG001|Overall Study|Rash|0
7250633|NCT00287586|11461601|FG000|Overall Study|Elevated Prostate Specific Antigen|2
7250634|NCT00287586|11461602|FG001|Overall Study|Elevated Prostate Specific Antigen|0
7250635|NCT00287586|11461601|FG000|Overall Study|Stroke|2
7250636|NCT00287586|11461602|FG001|Overall Study|Stroke|0
7250637|NCT00287586|11461601|FG000|Overall Study|Myocardial Infarction|1
7250638|NCT00287586|11461602|FG001|Overall Study|Myocardial Infarction|0
7250639|NCT00287586|11461601|FG000|Overall Study|Lower Urinary Tract Symptoms|1
7250640|NCT00287586|11461602|FG001|Overall Study|Lower Urinary Tract Symptoms|0
7250641|NCT00287586|11461601|FG000|Overall Study|Cognitive Impairment|1
7250642|NCT00287586|11461602|FG001|Overall Study|Cognitive Impairment|0
7250643|NCT00287586|11461601|FG000|Overall Study|Pancreatic Cancer|1
7250644|NCT00287586|11461602|FG001|Overall Study|Pancreatic Cancer|3
7250645|NCT00287586|11461601|FG000|Overall Study|Sleep Apnea|1
7250646|NCT00287586|11461602|FG001|Overall Study|Sleep Apnea|0
7250647|NCT00287586|11461601|FG000|Overall Study|Shoulder Pain|1
7250648|NCT00287586|11461602|FG001|Overall Study|Shoulder Pain|0
7250649|NCT00287586|11461601|FG000|Overall Study|Inappropriate Behaviour with Staff|1
7250650|NCT00287586|11461602|FG001|Overall Study|Inappropriate Behaviour with Staff|0
7250651|NCT00287586|11461601|FG000|Overall Study|Nonadherence|1
7250652|NCT00287586|11461602|FG001|Overall Study|Nonadherence|1
7250653|NCT00287586|11461601|FG000|Overall Study|Enrolled in Another Study|1
7250654|NCT00287586|11461602|FG001|Overall Study|Enrolled in Another Study|0
7250655|NCT00287586|11461601|FG000|Overall Study|Major Depression|0
7250656|NCT00287586|11461602|FG001|Overall Study|Major Depression|2
7250657|NCT00287586|11461601|FG000|Overall Study|Lung Cancer|0
7250658|NCT00287586|11461602|FG001|Overall Study|Lung Cancer|2
7250659|NCT00287586|11461601|FG000|Overall Study|Elevated IPSS Score|0
7250660|NCT00287586|11461602|FG001|Overall Study|Elevated IPSS Score|1
7250661|NCT00287586|11461601|FG000|Overall Study|Retroperitoneal Cancer|0
7250662|NCT00287586|11461602|FG001|Overall Study|Retroperitoneal Cancer|1
7250663|NCT00287586|11461601|FG000|Overall Study|Mastodynia and Gynecomastia|0
7250664|NCT00287586|11461602|FG001|Overall Study|Mastodynia and Gynecomastia|1
7250665|NCT00287586|11461601|FG000|Overall Study|Mood Swings and Irritability|0
7574372|NCT03673670|11957000|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
7250666|NCT00287586|11461602|FG001|Overall Study|Mood Swings and Irritability|1
7250667|NCT00287586|11461601|FG000|Overall Study|Bradycardia|0
7250668|NCT00287586|11461602|FG001|Overall Study|Bradycardia|1
7250669|NCT00287586|11461601|FG000|Overall Study|Itchy Swollen Eyes|0
7250670|NCT00287586|11461602|FG001|Overall Study|Itchy Swollen Eyes|1
7250671|NCT00287586|11461601|FG000|Overall Study|Recurrent Melanoma|0
7250672|NCT00287586|11461602|FG001|Overall Study|Recurrent Melanoma|1
7250673|NCT00287690|11461610|FG000|Overall Study|Protocol Violation|20
7250674|NCT00287690|11461611|FG001|Overall Study|Protocol Violation|26
7250675|NCT00288015|11461657|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
7250676|NCT00288015|11461657|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
7250677|NCT00288015|11461657|FG000|First Response Assessment|Withdrawal by Subject|1
7250678|NCT00288015|11461657|FG000|First Response Assessment|Death|1
7250679|NCT00288015|11461657|FG000|First Response Assessment|Physician Decision|2
7250680|NCT00288015|11461657|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
7250681|NCT00288015|11461657|FG000|Follow up for Survival x 2 Years|Death|13
7250682|NCT00288015|11461657|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
7250683|NCT00288015|11461657|FG000|Follow up for Survival x 2 Years|Other|9
7250684|NCT00288054|11461661|FG000|Overall Study|Protocol Violation|2
7250685|NCT00288054|11461661|FG000|Overall Study|Lack of Efficacy|16
7250686|NCT00288054|11461661|FG000|Overall Study|Adverse Event|3
7250687|NCT00288054|11461661|FG000|Overall Study|Withdrawal by Subject|1
7250688|NCT00288054|11461661|FG000|Overall Study|Not protocol specified|2
7250703|NCT00288587|11461700|FG000|Overall Study|Death|4
7250704|NCT00288587|11461701|FG001|Overall Study|Death|4
7250705|NCT00288587|11461700|FG000|Overall Study|Transplant|0
7250706|NCT00288587|11461701|FG001|Overall Study|Transplant|3
7250707|NCT00288587|11461700|FG000|Overall Study|Adverse Event|0
7250708|NCT00288587|11461701|FG001|Overall Study|Adverse Event|1
7250709|NCT00288587|11461700|FG000|Overall Study|Physician Decision|0
7250710|NCT00288587|11461701|FG001|Overall Study|Physician Decision|2
7250711|NCT00288587|11461700|FG000|Overall Study|Severe Aortic Stenosis|1
7250712|NCT00288587|11461701|FG001|Overall Study|Severe Aortic Stenosis|0
7250713|NCT00288626|11461716|FG000|Overall Study|Death|3
7250714|NCT00288626|11461716|FG000|Overall Study|Withdrawal by Subject|4
7250715|NCT00288639|11461722|FG000|Overall Study|Adverse Event|5
7250716|NCT00288639|11461722|FG000|Overall Study|Lack of Efficacy|4
7250717|NCT00288639|11461722|FG000|Overall Study|Withdrawal by Subject|2
7250718|NCT00288639|11461722|FG000|Overall Study|Other|1
7256763|NCT00325468|11468503|FG003|Overall Study|Lost to Follow-up|2
7250719|NCT00288704|11461729|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7250720|NCT00288704|11461730|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
7250721|NCT00288704|11461731|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
7250722|NCT00288704|11461729|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7250723|NCT00288704|11461730|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
7250724|NCT00288704|11461731|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
7250725|NCT00288704|11461729|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7250726|NCT00288704|11461730|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
7250727|NCT00288704|11461731|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
7250728|NCT00288704|11461729|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7250729|NCT00288704|11461730|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
7250730|NCT00288704|11461731|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
7250731|NCT00288704|11461729|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
7574373|NCT03673670|11957001|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
7250732|NCT00288704|11461730|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
7574374|NCT03673670|11956996|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7574375|NCT03673670|11956997|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7574376|NCT03673670|11956998|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7574377|NCT03673670|11956999|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7574378|NCT03673670|11957000|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
7250733|NCT00288704|11461731|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
7250734|NCT00288704|11461729|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7250735|NCT00288704|11461730|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
7250736|NCT00288704|11461731|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
7250737|NCT00288704|11461729|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7250738|NCT00288704|11461730|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
7250739|NCT00288704|11461731|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
7250740|NCT00288860|11461740|FG000|Overall Study|Did not complete intake|4
7250741|NCT00288860|11461741|FG001|Overall Study|Did not complete intake|8
7250742|NCT00288860|11461740|FG000|Overall Study|Death|4
7250743|NCT00288860|11461741|FG001|Overall Study|Death|3
7250744|NCT00288860|11461740|FG000|Overall Study|Withdrawal by Subject|20
7250745|NCT00288860|11461741|FG001|Overall Study|Withdrawal by Subject|15
7250746|NCT00288860|11461740|FG000|Overall Study|Lost to Follow-up|74
7250747|NCT00288860|11461741|FG001|Overall Study|Lost to Follow-up|71
7250748|NCT00288912|11461762|FG000|Overall Study|Developed exclusion criterion|4
7250749|NCT00288912|11461763|FG001|Overall Study|Developed exclusion criterion|6
7250750|NCT00288912|11461764|FG002|Overall Study|Developed exclusion criterion|7
7250751|NCT00288912|11461762|FG000|Overall Study|Lost to Follow-up|9
7250752|NCT00288912|11461763|FG001|Overall Study|Lost to Follow-up|6
7250753|NCT00288912|11461764|FG002|Overall Study|Lost to Follow-up|9
7250754|NCT00288912|11461762|FG000|Overall Study|Withdrawal by Subject|4
7250755|NCT00288912|11461763|FG001|Overall Study|Withdrawal by Subject|5
7250756|NCT00288912|11461764|FG002|Overall Study|Withdrawal by Subject|12
7250757|NCT00289016|11461772|FG000|Overall Study|Disease Progression|29
7250758|NCT00289016|11461772|FG000|Overall Study|Death|2
7250759|NCT00289016|11461772|FG000|Overall Study|Unrelated Medical Condition or Accident|2
7250760|NCT00289016|11461772|FG000|Overall Study|Withdrawal by Subject|2
7250761|NCT00289016|11461772|FG000|Overall Study|Adverse Event|1
7250762|NCT00289016|11461772|FG000|Overall Study|Other|1
7250763|NCT00289133|11461804|FG000|Overall Study|Non-study device implanted|12
7250764|NCT00289133|11461805|FG001|Overall Study|Non-study device implanted|0
7250765|NCT00289133|11461804|FG000|Overall Study|Protocol Violation|32
7250766|NCT00289133|11461805|FG001|Overall Study|Protocol Violation|38
7250767|NCT00289133|11461804|FG000|Overall Study|Withdrawal by Subject|9
7250768|NCT00289133|11461805|FG001|Overall Study|Withdrawal by Subject|10
7250769|NCT00289133|11461804|FG000|Overall Study|Death|5
7250770|NCT00289133|11461805|FG001|Overall Study|Death|10
7250771|NCT00289133|11461804|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
7250772|NCT00289133|11461805|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
7250773|NCT00289133|11461804|FG000|Overall Study|Physician Decision|41
7250774|NCT00289133|11461805|FG001|Overall Study|Physician Decision|45
7250775|NCT00289133|11461804|FG000|Overall Study|Revision|8
7250776|NCT00289133|11461805|FG001|Overall Study|Revision|6
7250777|NCT00289133|11461804|FG000|Overall Study|Lost to Follow-up|92
7250778|NCT00289133|11461805|FG001|Overall Study|Lost to Follow-up|115
7250779|NCT00289185|11461817|FG000|Overall Study|Withdrawal by Subject|4
7250780|NCT00289185|11461818|FG001|Overall Study|Withdrawal by Subject|8
7250781|NCT00289185|11461817|FG000|Overall Study|Lost to Follow-up|23
7250782|NCT00289185|11461818|FG001|Overall Study|Lost to Follow-up|17
7250783|NCT00289185|11461817|FG000|Overall Study|Death|1
7250784|NCT00289185|11461818|FG001|Overall Study|Death|1
7250785|NCT00289198|11461827|FG000|Overall Study|Adverse Event|0
7250786|NCT00289198|11461828|FG001|Overall Study|Adverse Event|2
7250787|NCT00289198|11461827|FG000|Overall Study|Protocol Violation|2
7250788|NCT00289198|11461828|FG001|Overall Study|Protocol Violation|1
7250789|NCT00289198|11461827|FG000|Overall Study|Withdrawal by Subject|4
7250790|NCT00289198|11461828|FG001|Overall Study|Withdrawal by Subject|1
7250791|NCT00289198|11461827|FG000|Overall Study|Lack of Efficacy|2
7250792|NCT00289198|11461828|FG001|Overall Study|Lack of Efficacy|0
7250793|NCT00289198|11461827|FG000|Overall Study|Other: Low compliance|0
7250794|NCT00289198|11461828|FG001|Overall Study|Other: Low compliance|1
7250795|NCT00289198|11461827|FG000|Overall Study|Other: Physician's decision|0
7250796|NCT00289198|11461828|FG001|Overall Study|Other: Physician's decision|1
7250797|NCT00289198|11461827|FG000|Overall Study|Other: Unable to attend on schedule|2
7250798|NCT00289198|11461828|FG001|Overall Study|Other: Unable to attend on schedule|1
7250799|NCT00289198|11461827|FG000|Overall Study|Other: Miscalculation of the visit date|21
7250800|NCT00289198|11461828|FG001|Overall Study|Other: Miscalculation of the visit date|22
7250801|NCT00289198|11461827|FG000|Overall Study|Other: Impossible to come on visit|0
7250802|NCT00289198|11461828|FG001|Overall Study|Other: Impossible to come on visit|1
7250803|NCT00289276|11461848|FG000|Second Part of FAST Study (Expansion)|Death|0
7250804|NCT00289276|11461849|FG001|Second Part of FAST Study (Expansion)|Death|2
7250805|NCT00289276|11461848|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
7250806|NCT00289276|11461849|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
7250807|NCT00289289|11461858|FG000|Overall Study|Withdrawal by Subject|5
7250808|NCT00289289|11461859|FG001|Overall Study|Withdrawal by Subject|3
7250809|NCT00289289|11461860|FG002|Overall Study|Withdrawal by Subject|15
7250810|NCT00289289|11461858|FG000|Overall Study|Lost to Follow-up|1
7250811|NCT00289289|11461859|FG001|Overall Study|Lost to Follow-up|0
7250812|NCT00289289|11461860|FG002|Overall Study|Lost to Follow-up|1
7250813|NCT00289289|11461858|FG000|Overall Study|Death|4
7250814|NCT00289289|11461859|FG001|Overall Study|Death|2
7250815|NCT00289289|11461860|FG002|Overall Study|Death|5
7250816|NCT00289289|11461858|FG000|Overall Study|No implant attempted|0
7250817|NCT00289289|11461859|FG001|Overall Study|No implant attempted|0
7250818|NCT00289289|11461860|FG002|Overall Study|No implant attempted|1
7574379|NCT03673670|11957001|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
7574380|NCT03673670|11956996|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
7250819|NCT00289289|11461858|FG000|Overall Study|Physician Decision|1
7250820|NCT00289289|11461859|FG001|Overall Study|Physician Decision|0
7250821|NCT00289289|11461860|FG002|Overall Study|Physician Decision|6
7250822|NCT00289289|11461858|FG000|Overall Study|Non-study device implanted|2
7250823|NCT00289289|11461859|FG001|Overall Study|Non-study device implanted|1
7250824|NCT00289289|11461860|FG002|Overall Study|Non-study device implanted|3
7250825|NCT00289289|11461858|FG000|Overall Study|Did not meet inclusion/exclusion|0
7250826|NCT00289289|11461859|FG001|Overall Study|Did not meet inclusion/exclusion|0
7574381|NCT03673670|11956997|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
7574382|NCT03673670|11956998|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
7574383|NCT03673670|11956999|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
7574384|NCT03673670|11957000|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
7250827|NCT00289289|11461860|FG002|Overall Study|Did not meet inclusion/exclusion|6
7250828|NCT00289289|11461858|FG000|Overall Study|Other Exit Reason|6
7250829|NCT00289289|11461859|FG001|Overall Study|Other Exit Reason|4
7250830|NCT00289289|11461860|FG002|Overall Study|Other Exit Reason|12
7250831|NCT00289458|11461896|FG000|Overall Study|Death|1
7250832|NCT00289458|11461897|FG001|Overall Study|Death|0
7250833|NCT00289458|11461898|FG002|Overall Study|Death|0
7250834|NCT00289458|11461896|FG000|Overall Study|Physician Decision|3
7250835|NCT00289458|11461897|FG001|Overall Study|Physician Decision|4
7250836|NCT00289458|11461898|FG002|Overall Study|Physician Decision|2
7250837|NCT00289458|11461896|FG000|Overall Study|Withdrawal by Subject|2
7250838|NCT00289458|11461897|FG001|Overall Study|Withdrawal by Subject|2
7250839|NCT00289458|11461898|FG002|Overall Study|Withdrawal by Subject|4
7250840|NCT00289536|11461910|FG000|Period 3|Lost to Follow-up|0
7250841|NCT00289536|11461911|FG001|Period 3|Lost to Follow-up|0
7250842|NCT00289536|11461912|FG002|Period 3|Lost to Follow-up|1
7250843|NCT00289731|11461935|FG000|Overall Study|Adverse Event|1
7250844|NCT00289731|11461936|FG001|Overall Study|Adverse Event|2
7250845|NCT00289731|11461937|FG002|Overall Study|Adverse Event|2
7250846|NCT00289731|11461935|FG000|Overall Study|Other|1
7250847|NCT00289731|11461936|FG001|Overall Study|Other|0
7250848|NCT00289731|11461937|FG002|Overall Study|Other|0
7250849|NCT00289770|11461961|FG000|Year 15|Withdrawal by Subject|1
7250850|NCT00289783|11461967|FG000|Primary Phase|Adverse Event|10
7250851|NCT00289783|11461968|FG001|Primary Phase|Adverse Event|1
7250852|NCT00289783|11461967|FG000|Primary Phase|Protocol Violation|27
7250853|NCT00289783|11461968|FG001|Primary Phase|Protocol Violation|6
7250854|NCT00289783|11461967|FG000|Primary Phase|Withdrawal by Subject|93
7250855|NCT00289783|11461968|FG001|Primary Phase|Withdrawal by Subject|40
7250856|NCT00289783|11461967|FG000|Primary Phase|Lost to Follow-up|60
7250857|NCT00289783|11461968|FG001|Primary Phase|Lost to Follow-up|14
7250858|NCT00289783|11461967|FG000|Primary Phase|Migration from the study area|26
7574385|NCT03673670|11957001|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
7574386|NCT03673670|11956996|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7250859|NCT00289783|11461968|FG001|Primary Phase|Migration from the study area|10
7250860|NCT00289783|11461967|FG000|Primary Phase|Other|32
7250861|NCT00289783|11461968|FG001|Primary Phase|Other|12
7574387|NCT03673670|11956997|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7250862|NCT00289783|11461967|FG000|Fourth Dose Phase|Adverse Event|1
7250863|NCT00289783|11461968|FG001|Fourth Dose Phase|Adverse Event|0
7250864|NCT00289783|11461967|FG000|Fourth Dose Phase|Withdrawal by Subject|10
7250865|NCT00289783|11461968|FG001|Fourth Dose Phase|Withdrawal by Subject|1
7250866|NCT00289783|11461967|FG000|Fourth Dose Phase|Lost to Follow-up|53
7250867|NCT00289783|11461968|FG001|Fourth Dose Phase|Lost to Follow-up|12
7250868|NCT00289783|11461967|FG000|Fourth Dose Phase|Migration from the study area|1
7250869|NCT00289783|11461968|FG001|Fourth Dose Phase|Migration from the study area|1
7250870|NCT00289783|11461967|FG000|Fourth Dose Phase|Other|22
7250871|NCT00289783|11461968|FG001|Fourth Dose Phase|Other|10
7250872|NCT00289848|11461984|FG000|Overall Study|Adverse Event|6
7250873|NCT00289848|11461985|FG001|Overall Study|Adverse Event|4
7250874|NCT00289848|11461984|FG000|Overall Study|Death|1
7250875|NCT00289848|11461985|FG001|Overall Study|Death|0
7250876|NCT00289848|11461984|FG000|Overall Study|Lack of Efficacy|20
7250877|NCT00289848|11461985|FG001|Overall Study|Lack of Efficacy|24
7250878|NCT00289848|11461984|FG000|Overall Study|Lost to Follow-up|3
7250879|NCT00289848|11461985|FG001|Overall Study|Lost to Follow-up|1
7250880|NCT00289848|11461984|FG000|Overall Study|Protocol Violation|5
7250881|NCT00289848|11461985|FG001|Overall Study|Protocol Violation|2
7250882|NCT00289848|11461984|FG000|Overall Study|Withdrawal by Subject|5
7250883|NCT00289848|11461985|FG001|Overall Study|Withdrawal by Subject|11
7250884|NCT00289848|11461984|FG000|Overall Study|Patient Moved|6
7250885|NCT00289848|11461985|FG001|Overall Study|Patient Moved|2
7250886|NCT00289848|11461984|FG000|Overall Study|Open-Label AHA Treatment Requested|0
7250887|NCT00289848|11461985|FG001|Overall Study|Open-Label AHA Treatment Requested|1
7250888|NCT00289900|11461997|FG000|Overall Study|Adverse Event|28
7250889|NCT00289900|11461998|FG001|Overall Study|Adverse Event|40
7250890|NCT00289900|11461999|FG002|Overall Study|Adverse Event|13
7250891|NCT00289900|11462000|FG003|Overall Study|Adverse Event|19
7250892|NCT00289900|11462001|FG004|Overall Study|Adverse Event|20
7250893|NCT00289900|11462002|FG005|Overall Study|Adverse Event|33
7250894|NCT00289900|11461997|FG000|Overall Study|Lost to Follow-up|7
7250895|NCT00289900|11461998|FG001|Overall Study|Lost to Follow-up|7
7250896|NCT00289900|11461999|FG002|Overall Study|Lost to Follow-up|8
7250897|NCT00289900|11462000|FG003|Overall Study|Lost to Follow-up|8
7250898|NCT00289900|11462001|FG004|Overall Study|Lost to Follow-up|4
7250899|NCT00289900|11462002|FG005|Overall Study|Lost to Follow-up|8
7250900|NCT00289900|11461997|FG000|Overall Study|Participant had flushing|18
7250901|NCT00289900|11461998|FG001|Overall Study|Participant had flushing|42
7574388|NCT03673670|11956998|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7574389|NCT03673670|11956999|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7574390|NCT03673670|11957000|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
7574391|NCT03673670|11957001|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
7574392|NCT03673670|11956996|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
7574393|NCT03673670|11956997|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
7574394|NCT03673670|11956998|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
7574395|NCT03673670|11956999|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
7574396|NCT03673670|11957000|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
7574397|NCT03673670|11957001|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
7574398|NCT03674177|11957022|FG000|Overall Study|Lost to Follow-up|2
7574399|NCT03674177|11957023|FG001|Overall Study|Lost to Follow-up|1
7574400|NCT03674177|11957024|FG002|Overall Study|Lost to Follow-up|0
7250902|NCT00289900|11461999|FG002|Overall Study|Participant had flushing|1
7250903|NCT00289900|11462000|FG003|Overall Study|Participant had flushing|2
7250904|NCT00289900|11462001|FG004|Overall Study|Participant had flushing|0
7250905|NCT00289900|11462002|FG005|Overall Study|Participant had flushing|4
7250906|NCT00289900|11461997|FG000|Overall Study|Other|0
7250907|NCT00289900|11461998|FG001|Overall Study|Other|0
7250908|NCT00289900|11461999|FG002|Overall Study|Other|0
7250909|NCT00289900|11462000|FG003|Overall Study|Other|5
7250910|NCT00289900|11462001|FG004|Overall Study|Other|1
7250911|NCT00289900|11462002|FG005|Overall Study|Other|0
7250912|NCT00289900|11461997|FG000|Overall Study|Participant moved|1
7250913|NCT00289900|11461998|FG001|Overall Study|Participant moved|0
7250914|NCT00289900|11461999|FG002|Overall Study|Participant moved|0
7250915|NCT00289900|11462000|FG003|Overall Study|Participant moved|1
7250916|NCT00289900|11462001|FG004|Overall Study|Participant moved|1
7250917|NCT00289900|11462002|FG005|Overall Study|Participant moved|1
7250918|NCT00289900|11461997|FG000|Overall Study|Withdrawal by Subject|10
7250919|NCT00289900|11461998|FG001|Overall Study|Withdrawal by Subject|21
7250920|NCT00289900|11461999|FG002|Overall Study|Withdrawal by Subject|8
7250921|NCT00289900|11462000|FG003|Overall Study|Withdrawal by Subject|18
7250922|NCT00289900|11462001|FG004|Overall Study|Withdrawal by Subject|12
7574401|NCT03674177|11957025|FG003|Overall Study|Lost to Follow-up|2
7250923|NCT00289900|11462002|FG005|Overall Study|Withdrawal by Subject|11
7250924|NCT00289900|11461997|FG000|Overall Study|Protocol Violation|3
7250925|NCT00289900|11461998|FG001|Overall Study|Protocol Violation|9
7250926|NCT00289900|11461999|FG002|Overall Study|Protocol Violation|2
7250927|NCT00289900|11462000|FG003|Overall Study|Protocol Violation|6
7250928|NCT00289900|11462001|FG004|Overall Study|Protocol Violation|7
7250929|NCT00289900|11462002|FG005|Overall Study|Protocol Violation|4
7250930|NCT00289900|11461997|FG000|Overall Study|site terminated|1
7250931|NCT00289900|11461998|FG001|Overall Study|site terminated|0
7250932|NCT00289900|11461999|FG002|Overall Study|site terminated|1
7250933|NCT00289900|11462000|FG003|Overall Study|site terminated|0
7250934|NCT00289900|11462001|FG004|Overall Study|site terminated|0
7250935|NCT00289900|11462002|FG005|Overall Study|site terminated|0
7250936|NCT00289900|11461997|FG000|Overall Study|Not treated|0
7250937|NCT00289900|11461998|FG001|Overall Study|Not treated|1
7250938|NCT00289900|11461999|FG002|Overall Study|Not treated|0
7250939|NCT00289900|11462000|FG003|Overall Study|Not treated|0
7250940|NCT00289900|11462001|FG004|Overall Study|Not treated|0
7250941|NCT00289900|11462002|FG005|Overall Study|Not treated|0
7250942|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250943|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7250944|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250945|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250946|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250947|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
7250948|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7250949|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7250950|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
7250951|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
7250952|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7250953|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7250954|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7250955|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7250956|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7250957|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7250958|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7250959|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7250960|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
7250961|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
7250962|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7250963|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7250964|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7250965|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
7250966|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
7250967|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7250968|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
7250969|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7250970|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7250971|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7250972|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
7250973|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
7250974|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7250975|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
7250976|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
7250977|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7250978|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
7250979|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
7250980|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
7250981|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7250982|NCT00289913|11462024|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
7250983|NCT00289913|11462025|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7250984|NCT00289913|11462026|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
7250985|NCT00289913|11462027|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7250986|NCT00289913|11462028|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
7250987|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250988|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250989|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7250990|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250991|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7250992|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
7250993|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
7250994|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7250995|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
7250996|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
7250997|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7250998|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
7250999|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7251000|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7251001|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
7251002|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
7251003|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
7251004|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7251005|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251006|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251007|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7251008|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7251009|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
7251010|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7251011|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
7251012|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7251013|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7251014|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
7251015|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
7251016|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
7251017|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
7251018|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
7251019|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7251020|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
7251021|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
7251022|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7251023|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
7251024|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
7251025|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7251026|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
7251027|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
7251028|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7251029|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7251030|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7251031|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
7251032|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7251033|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7251034|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7251035|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
7251036|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
7251037|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7251038|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7251039|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7251040|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
7251041|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
7251042|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7251043|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7251044|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7251045|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
7251046|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
7251047|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7251048|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7251049|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7251050|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
7251051|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
7251052|NCT00289913|11462024|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7251053|NCT00289913|11462025|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7251054|NCT00289913|11462026|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7251055|NCT00289913|11462027|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
7251056|NCT00289913|11462028|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
7251057|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7251058|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
7251059|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7251060|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7251061|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
7251062|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
7251063|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
7251064|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
7251065|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7251066|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
7251067|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251068|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251069|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251070|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
7251071|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
7251072|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7251073|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7251074|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7251075|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
7251076|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
7251077|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7251078|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
7251079|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
7251080|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
7251081|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
7251082|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7251083|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7251084|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
7251085|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7251086|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
7251087|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7251088|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7251089|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7251090|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
7251091|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
7251092|NCT00289913|11462024|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7251093|NCT00289913|11462025|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
7251094|NCT00289913|11462026|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7251095|NCT00289913|11462027|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7251096|NCT00289913|11462028|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
7251097|NCT00289978|11462046|FG000|Overall Study|Withdrawal by Subject|31
7251098|NCT00289978|11462047|FG001|Overall Study|Withdrawal by Subject|17
7251099|NCT00289978|11462048|FG002|Overall Study|Withdrawal by Subject|28
7251100|NCT00289978|11462046|FG000|Overall Study|Adverse Event|22
7251101|NCT00289978|11462047|FG001|Overall Study|Adverse Event|13
7251102|NCT00289978|11462048|FG002|Overall Study|Adverse Event|18
7251103|NCT00289978|11462046|FG000|Overall Study|Lack of Efficacy|13
7251104|NCT00289978|11462047|FG001|Overall Study|Lack of Efficacy|6
7251105|NCT00289978|11462048|FG002|Overall Study|Lack of Efficacy|25
7251106|NCT00289978|11462046|FG000|Overall Study|Abnormal laboratory value(s)|20
7251107|NCT00289978|11462047|FG001|Overall Study|Abnormal laboratory value(s)|9
7251108|NCT00289978|11462048|FG002|Overall Study|Abnormal laboratory value(s)|1
7251109|NCT00289978|11462046|FG000|Overall Study|Lost to Follow-up|3
7251110|NCT00289978|11462047|FG001|Overall Study|Lost to Follow-up|5
7251111|NCT00289978|11462048|FG002|Overall Study|Lost to Follow-up|7
7251112|NCT00289978|11462046|FG000|Overall Study|Protocol Violation|5
7251113|NCT00289978|11462047|FG001|Overall Study|Protocol Violation|5
7251114|NCT00289978|11462048|FG002|Overall Study|Protocol Violation|4
7251115|NCT00289978|11462046|FG000|Overall Study|Abnormal test procedure result(s)|2
7251116|NCT00289978|11462047|FG001|Overall Study|Abnormal test procedure result(s)|1
7251117|NCT00289978|11462048|FG002|Overall Study|Abnormal test procedure result(s)|1
7251118|NCT00289978|11462046|FG000|Overall Study|Death|1
7251119|NCT00289978|11462047|FG001|Overall Study|Death|0
7251120|NCT00289978|11462048|FG002|Overall Study|Death|2
7251121|NCT00289991|11462058|FG000|Overall Study|Death|35
7251122|NCT00289991|11462059|FG001|Overall Study|Death|38
7251123|NCT00289991|11462058|FG000|Overall Study|Adverse Event|15
7251124|NCT00289991|11462059|FG001|Overall Study|Adverse Event|13
7251125|NCT00289991|11462058|FG000|Overall Study|Failure of prophylaxis|1
7251126|NCT00289991|11462059|FG001|Overall Study|Failure of prophylaxis|1
7251127|NCT00289991|11462058|FG000|Overall Study|Fungal breakthrough infection|0
7251128|NCT00289991|11462059|FG001|Overall Study|Fungal breakthrough infection|1
7251129|NCT00289991|11462058|FG000|Overall Study|Lost to Follow-up|0
7251130|NCT00289991|11462059|FG001|Overall Study|Lost to Follow-up|1
7251131|NCT00289991|11462058|FG000|Overall Study|Withdrawal by Subject|2
7251132|NCT00289991|11462059|FG001|Overall Study|Withdrawal by Subject|12
7251133|NCT00289991|11462058|FG000|Overall Study|Other|5
7251134|NCT00289991|11462059|FG001|Overall Study|Other|14
7251135|NCT00290186|11462076|FG000|Overall Study|Adverse Event|1
7251136|NCT00290186|11462077|FG001|Overall Study|Adverse Event|1
7251137|NCT00290186|11462076|FG000|Overall Study|Lost to Follow-up|3
7251138|NCT00290186|11462077|FG001|Overall Study|Lost to Follow-up|2
7251139|NCT00290186|11462076|FG000|Overall Study|Study was terminated prior to 3-month te|1
7251140|NCT00290186|11462077|FG001|Overall Study|Study was terminated prior to 3-month te|1
7251141|NCT00290186|11462076|FG000|Overall Study|Withdrawal by Subject|0
7251142|NCT00290186|11462077|FG001|Overall Study|Withdrawal by Subject|1
7251143|NCT00290238|11462098|FG000|Overall Study|Study terminated|27
7251144|NCT00290238|11462099|FG001|Overall Study|Study terminated|27
7251145|NCT00290238|11462098|FG000|Overall Study|Lost to Follow-up|0
7251146|NCT00290238|11462099|FG001|Overall Study|Lost to Follow-up|1
7251147|NCT00290238|11462098|FG000|Overall Study|Withdrawal by Subject|15
7251148|NCT00290238|11462099|FG001|Overall Study|Withdrawal by Subject|13
7251149|NCT00290290|11462107|FG000|Overall Study|Death|3
7251150|NCT00290290|11462108|FG001|Overall Study|Death|4
7251151|NCT00290290|11462107|FG000|Overall Study|Withdrawal by Subject|2
7251152|NCT00290290|11462108|FG001|Overall Study|Withdrawal by Subject|2
7251153|NCT00290290|11462107|FG000|Overall Study|Underwent clean surgical procedure|13
7251154|NCT00290290|11462108|FG001|Overall Study|Underwent clean surgical procedure|12
7251155|NCT00290342|11462131|FG000|Overall Study|Other|0
7251156|NCT00290342|11462132|FG001|Overall Study|Other|1
7251157|NCT00290342|11462131|FG000|Overall Study|Withdrawal by Subject|6
7574402|NCT03674281|11957038|FG000|Overall Study|screen failure|2
7574403|NCT03674281|11957039|FG001|Overall Study|screen failure|0
7251158|NCT00290342|11462132|FG001|Overall Study|Withdrawal by Subject|4
7251159|NCT00290342|11462131|FG000|Overall Study|Lost to Follow-up|1
7251160|NCT00290342|11462132|FG001|Overall Study|Lost to Follow-up|0
7251161|NCT00290355|11462140|FG000|Overall Study|Serious adverse event|7
7251162|NCT00290355|11462141|FG001|Overall Study|Serious adverse event|4
7251163|NCT00290355|11462140|FG000|Overall Study|Study product reactogenicity|1
7251164|NCT00290355|11462141|FG001|Overall Study|Study product reactogenicity|0
7251165|NCT00290355|11462140|FG000|Overall Study|Protocol Violation|1
7251166|NCT00290355|11462141|FG001|Overall Study|Protocol Violation|0
7251167|NCT00290355|11462140|FG000|Overall Study|Withdrawal by Subject|2
7251168|NCT00290355|11462141|FG001|Overall Study|Withdrawal by Subject|0
7251169|NCT00290355|11462140|FG000|Overall Study|Migrated / moved from the study area|1
7251170|NCT00290355|11462141|FG001|Overall Study|Migrated / moved from the study area|0
7251171|NCT00290355|11462140|FG000|Overall Study|Lost to Follow-up|3
7251172|NCT00290355|11462141|FG001|Overall Study|Lost to Follow-up|1
7251173|NCT00290355|11462140|FG000|Overall Study|Other|2
7251174|NCT00290355|11462141|FG001|Overall Study|Other|0
7251175|NCT00290433|11462147|FG000|Overall Study|Disease Progression|13
7251176|NCT00290433|11462147|FG000|Overall Study|Adverse Event|14
7251177|NCT00290433|11462147|FG000|Overall Study|Withdrawal by Subject|1
7251178|NCT00290433|11462147|FG000|Overall Study|Non-Compliance|1
7251179|NCT00290433|11462147|FG000|Overall Study|Congestive Heart Failure|1
7251180|NCT00290433|11462147|FG000|Overall Study|Transplant in CR|5
7251181|NCT00290433|11462147|FG000|Overall Study|Unrelated Infection/Death|1
7251182|NCT00290498|11462164|FG000|Overall Study|Death|2
7251183|NCT00290498|11462165|FG001|Overall Study|Death|0
7251184|NCT00290498|11462164|FG000|Overall Study|Physician Decision|1
7251185|NCT00290498|11462165|FG001|Overall Study|Physician Decision|0
7251186|NCT00290498|11462164|FG000|Overall Study|Withdrawal by Subject|1
7251187|NCT00290498|11462165|FG001|Overall Study|Withdrawal by Subject|0
7251188|NCT00290498|11462164|FG000|Overall Study|Ineligible|3
7251189|NCT00290498|11462165|FG001|Overall Study|Ineligible|0
7251190|NCT00290498|11462164|FG000|Overall Study|Non-Compliance|1
7251191|NCT00290498|11462165|FG001|Overall Study|Non-Compliance|0
7251192|NCT00290589|11462180|FG000|Overall Study|Lost to Follow-up|2
7251193|NCT00290589|11462181|FG001|Overall Study|Lost to Follow-up|2
7251194|NCT00290693|11462195|FG000|Overall Study|Withdrawal by Subject|2
7251195|NCT00290706|11462204|FG000|Overall Study|Withdrawal by Subject|2
7251196|NCT00290706|11462205|FG001|Overall Study|Withdrawal by Subject|0
7251197|NCT00290706|11462206|FG002|Overall Study|Withdrawal by Subject|0
7251198|NCT00290706|11462207|FG003|Overall Study|Withdrawal by Subject|0
7251199|NCT00290706|11462204|FG000|Overall Study|Progressive Disease|3
7251200|NCT00290706|11462205|FG001|Overall Study|Progressive Disease|5
7251201|NCT00290706|11462206|FG002|Overall Study|Progressive Disease|4
7251202|NCT00290706|11462207|FG003|Overall Study|Progressive Disease|10
7251203|NCT00290706|11462204|FG000|Overall Study|Adverse Event|0
7251204|NCT00290706|11462205|FG001|Overall Study|Adverse Event|1
7251205|NCT00290706|11462206|FG002|Overall Study|Adverse Event|2
7251206|NCT00290706|11462207|FG003|Overall Study|Adverse Event|0
7251207|NCT00290706|11462204|FG000|Overall Study|Receive auto transplant or radiation|0
7251208|NCT00290706|11462205|FG001|Overall Study|Receive auto transplant or radiation|0
7251209|NCT00290706|11462206|FG002|Overall Study|Receive auto transplant or radiation|0
7251210|NCT00290706|11462207|FG003|Overall Study|Receive auto transplant or radiation|1
7251211|NCT00290706|11462204|FG000|Overall Study|Physician Decision|0
7251212|NCT00290706|11462205|FG001|Overall Study|Physician Decision|0
7251213|NCT00290706|11462206|FG002|Overall Study|Physician Decision|0
7251214|NCT00290706|11462207|FG003|Overall Study|Physician Decision|1
7251215|NCT00290732|11462220|FG000|Overall Study|Inability to instill drug intraductally.|0
7251216|NCT00290732|11462221|FG001|Overall Study|Inability to instill drug intraductally.|1
7251217|NCT00290732|11462222|FG002|Overall Study|Inability to instill drug intraductally.|1
7251218|NCT00290732|11462223|FG003|Overall Study|Inability to instill drug intraductally.|0
7251219|NCT00290732|11462224|FG004|Overall Study|Inability to instill drug intraductally.|0
7251220|NCT00290745|11462237|FG000|Overall Study|Withdrawal by Subject|4
7251221|NCT00290745|11462237|FG000|Overall Study|Physician Decision|2
7251222|NCT00290745|11462237|FG000|Overall Study|Surgery after 3 months for progression|3
7251223|NCT00290745|11462237|FG000|Overall Study|Baseline MRI not available|3
7251224|NCT00290771|11462243|FG000|Overall Study|Disease progression|95
7251225|NCT00290771|11462244|FG001|Overall Study|Disease progression|73
7251226|NCT00290771|11462243|FG000|Overall Study|Death|11
7251227|NCT00290771|11462244|FG001|Overall Study|Death|10
7251228|NCT00290771|11462243|FG000|Overall Study|Adverse Event|12
7251229|NCT00290771|11462244|FG001|Overall Study|Adverse Event|6
7251230|NCT00290771|11462243|FG000|Overall Study|Withdrawal by Subject|5
7251231|NCT00290771|11462244|FG001|Overall Study|Withdrawal by Subject|6
7251232|NCT00290771|11462243|FG000|Overall Study|Administrative problems|2
7251233|NCT00290771|11462244|FG001|Overall Study|Administrative problems|1
7251234|NCT00290771|11462243|FG000|Overall Study|Protocol Violation|2
7251235|NCT00290771|11462244|FG001|Overall Study|Protocol Violation|0
7251236|NCT00290771|11462243|FG000|Overall Study|Lost to Follow-up|0
7251237|NCT00290771|11462244|FG001|Overall Study|Lost to Follow-up|1
7251238|NCT00290888|11462257|FG000|Overall Study|Physician Decision|3
7251239|NCT00290888|11462258|FG001|Overall Study|Physician Decision|1
7251240|NCT00291018|11462268|FG000|Overall Study|Not Consented or Declined PAS|12
7251241|NCT00291018|11462269|FG001|Overall Study|Not Consented or Declined PAS|15
7251242|NCT00291018|11462270|FG002|Overall Study|Not Consented or Declined PAS|15
7251243|NCT00291018|11462268|FG000|Overall Study|Death|3
7251244|NCT00291018|11462269|FG001|Overall Study|Death|3
7251245|NCT00291018|11462270|FG002|Overall Study|Death|4
7251246|NCT00291018|11462268|FG000|Overall Study|Withdrawal by Subject|2
7251247|NCT00291018|11462269|FG001|Overall Study|Withdrawal by Subject|8
7251248|NCT00291018|11462270|FG002|Overall Study|Withdrawal by Subject|1
7251249|NCT00291018|11462268|FG000|Overall Study|Failures|5
7251250|NCT00291018|11462269|FG001|Overall Study|Failures|12
7251251|NCT00291018|11462270|FG002|Overall Study|Failures|5
7251252|NCT00291018|11462268|FG000|Overall Study|Lost to Follow-up|3
7251253|NCT00291018|11462269|FG001|Overall Study|Lost to Follow-up|4
7251254|NCT00291018|11462270|FG002|Overall Study|Lost to Follow-up|18
7251255|NCT00291187|11462304|FG000|Overall Study|Protocol Violation- No Drug Administered|0
7251256|NCT00291187|11462305|FG001|Overall Study|Protocol Violation- No Drug Administered|0
7251257|NCT00291187|11462306|FG002|Overall Study|Protocol Violation- No Drug Administered|1
7251258|NCT00291187|11462307|FG003|Overall Study|Protocol Violation- No Drug Administered|0
7251259|NCT00291330|11462337|FG000|Overall Study|Adverse Event|47
7251260|NCT00291330|11462338|FG001|Overall Study|Adverse Event|40
7251261|NCT00291330|11462337|FG000|Overall Study|Protocol Violation|13
7251262|NCT00291330|11462338|FG001|Overall Study|Protocol Violation|20
7251263|NCT00291330|11462337|FG000|Overall Study|Lost to Follow-up|16
7251264|NCT00291330|11462338|FG001|Overall Study|Lost to Follow-up|11
7251265|NCT00291330|11462337|FG000|Overall Study|Withdrawal by Subject|22
7251266|NCT00291330|11462338|FG001|Overall Study|Withdrawal by Subject|25
7251267|NCT00291330|11462337|FG000|Overall Study|Other|3
7251268|NCT00291330|11462338|FG001|Overall Study|Other|1
7251269|NCT00291499|11462373|FG000|Overall Study|Adverse Event|3
7251270|NCT00291499|11462374|FG001|Overall Study|Adverse Event|8
7251271|NCT00291499|11462373|FG000|Overall Study|Change to other therapy|2
7251272|NCT00291499|11462374|FG001|Overall Study|Change to other therapy|1
7251273|NCT00291499|11462373|FG000|Overall Study|Intercurrent illness|1
7251274|NCT00291499|11462374|FG001|Overall Study|Intercurrent illness|0
7251275|NCT00291499|11462373|FG000|Overall Study|Protocol Violation|2
7251276|NCT00291499|11462374|FG001|Overall Study|Protocol Violation|2
7251277|NCT00291499|11462373|FG000|Overall Study|Other reasons|1
7251278|NCT00291499|11462374|FG001|Overall Study|Other reasons|4
7251279|NCT00291551|11462380|FG000|Overall Study|Death|7
7251280|NCT00291551|11462380|FG000|Overall Study|Withdrawal by Subject|6
7251281|NCT00291577|11462385|FG000|Overall Study|Adverse Event|1
7251282|NCT00291577|11462385|FG000|Overall Study|Other|4
7251283|NCT00291577|11462385|FG000|Overall Study|Withdrawal by Subject|2
7251284|NCT00291577|11462385|FG000|Overall Study|Lack of Efficacy|14
7251285|NCT00291642|11462394|FG000|Overall Study|Adverse Event|1
7251286|NCT00291642|11462395|FG001|Overall Study|Adverse Event|0
7251287|NCT00291642|11462396|FG002|Overall Study|Adverse Event|1
7251288|NCT00291642|11462397|FG003|Overall Study|Adverse Event|0
7251289|NCT00291642|11462398|FG004|Overall Study|Adverse Event|1
7251290|NCT00291642|11462394|FG000|Overall Study|Patient missed visit|0
7251291|NCT00291642|11462395|FG001|Overall Study|Patient missed visit|0
7251292|NCT00291642|11462396|FG002|Overall Study|Patient missed visit|1
7251293|NCT00291642|11462397|FG003|Overall Study|Patient missed visit|0
7251294|NCT00291642|11462398|FG004|Overall Study|Patient missed visit|0
7251295|NCT00291642|11462394|FG000|Overall Study|Intake of prohibited medication|1
7251296|NCT00291642|11462395|FG001|Overall Study|Intake of prohibited medication|0
7251297|NCT00291642|11462396|FG002|Overall Study|Intake of prohibited medication|0
7251298|NCT00291642|11462397|FG003|Overall Study|Intake of prohibited medication|0
7251299|NCT00291642|11462398|FG004|Overall Study|Intake of prohibited medication|0
7251300|NCT00291668|11462417|FG000|Overall Study|Lack of Efficacy|1
7251301|NCT00291668|11462418|FG001|Overall Study|Lack of Efficacy|0
7251302|NCT00291668|11462419|FG002|Overall Study|Lack of Efficacy|0
7574404|NCT03674281|11957040|FG002|Overall Study|screen failure|0
7251303|NCT00291668|11462417|FG000|Overall Study|SAE, non-fatal|1
7251304|NCT00291668|11462418|FG001|Overall Study|SAE, non-fatal|1
7251305|NCT00291668|11462419|FG002|Overall Study|SAE, non-fatal|1
7251306|NCT00291668|11462417|FG000|Overall Study|AE, non-serious non-fatal|1
7251307|NCT00291668|11462418|FG001|Overall Study|AE, non-serious non-fatal|0
7251308|NCT00291668|11462419|FG002|Overall Study|AE, non-serious non-fatal|0
7251309|NCT00291668|11462417|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7251310|NCT00291668|11462418|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7251311|NCT00291668|11462419|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7251312|NCT00292045|11462442|FG000|Core Study (Through Week 13)|Adverse Event|1
7251313|NCT00292045|11462442|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
7251314|NCT00292188|11462457|FG000|Single-Blind|Adverse Event|14
7251315|NCT00292188|11462458|FG001|Single-Blind|Adverse Event|0
7251316|NCT00292188|11462459|FG002|Single-Blind|Adverse Event|0
7251317|NCT00292188|11462457|FG000|Single-Blind|Lack of Efficacy|2
7251318|NCT00292188|11462458|FG001|Single-Blind|Lack of Efficacy|0
7251319|NCT00292188|11462459|FG002|Single-Blind|Lack of Efficacy|0
7251320|NCT00292188|11462457|FG000|Single-Blind|Laboratory Abnormality|5
7251321|NCT00292188|11462458|FG001|Single-Blind|Laboratory Abnormality|0
7251322|NCT00292188|11462459|FG002|Single-Blind|Laboratory Abnormality|0
7251323|NCT00292188|11462457|FG000|Single-Blind|Lost to Follow-up|3
7251324|NCT00292188|11462458|FG001|Single-Blind|Lost to Follow-up|0
7251325|NCT00292188|11462459|FG002|Single-Blind|Lost to Follow-up|0
7251326|NCT00292188|11462457|FG000|Single-Blind|Other|77
7251327|NCT00292188|11462458|FG001|Single-Blind|Other|0
7251328|NCT00292188|11462459|FG002|Single-Blind|Other|0
7251329|NCT00292188|11462457|FG000|Single-Blind|Withdrawal by Subject|12
7251330|NCT00292188|11462458|FG001|Single-Blind|Withdrawal by Subject|0
7251331|NCT00292188|11462459|FG002|Single-Blind|Withdrawal by Subject|0
7251332|NCT00292188|11462457|FG000|Single-Blind|Did not receive treatment|1
7251333|NCT00292188|11462458|FG001|Single-Blind|Did not receive treatment|0
7251334|NCT00292188|11462459|FG002|Single-Blind|Did not receive treatment|0
7251335|NCT00292188|11462457|FG000|Double-Blind|Adverse Event|0
7251336|NCT00292188|11462458|FG001|Double-Blind|Adverse Event|25
7251337|NCT00292188|11462459|FG002|Double-Blind|Adverse Event|9
7251338|NCT00292188|11462457|FG000|Double-Blind|Lack of Efficacy|0
7251339|NCT00292188|11462458|FG001|Double-Blind|Lack of Efficacy|2
7251340|NCT00292188|11462459|FG002|Double-Blind|Lack of Efficacy|12
7251341|NCT00292188|11462457|FG000|Double-Blind|Lost to Follow-up|0
7251342|NCT00292188|11462458|FG001|Double-Blind|Lost to Follow-up|1
7251343|NCT00292188|11462459|FG002|Double-Blind|Lost to Follow-up|0
7251344|NCT00292188|11462457|FG000|Double-Blind|Other|0
7251345|NCT00292188|11462458|FG001|Double-Blind|Other|3
7251346|NCT00292188|11462459|FG002|Double-Blind|Other|4
7251347|NCT00292188|11462457|FG000|Double-Blind|Withdrawal by Subject|0
7251348|NCT00292188|11462458|FG001|Double-Blind|Withdrawal by Subject|0
7251349|NCT00292188|11462459|FG002|Double-Blind|Withdrawal by Subject|3
7251350|NCT00292188|11462457|FG000|Double-Blind|Laboratory Abnormality|0
7251351|NCT00292188|11462458|FG001|Double-Blind|Laboratory Abnormality|0
7251352|NCT00292188|11462459|FG002|Double-Blind|Laboratory Abnormality|1
7251353|NCT00292227|11462468|FG000|Patch Period|Adverse Event|1
7251354|NCT00292227|11462469|FG001|Patch Period|Adverse Event|0
7251355|NCT00292227|11462470|FG002|Patch Period|Adverse Event|2
7251356|NCT00292227|11462468|FG000|Patch Period|Withdrawal by Subject|0
7251357|NCT00292227|11462469|FG001|Patch Period|Withdrawal by Subject|0
7251358|NCT00292227|11462470|FG002|Patch Period|Withdrawal by Subject|1
7251359|NCT00292318|11462480|FG000|Overall Study|Study terminated by officials|2
7251360|NCT00292318|11462481|FG001|Overall Study|Study terminated by officials|1
7251361|NCT00292370|11462490|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
7251362|NCT00292370|11462491|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7251363|NCT00292370|11462492|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
7251364|NCT00292370|11462490|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
7251365|NCT00292370|11462491|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7251366|NCT00292370|11462492|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
7251367|NCT00292370|11462490|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
7251368|NCT00292370|11462491|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7251369|NCT00292370|11462492|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
7251370|NCT00292370|11462490|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
7251371|NCT00292370|11462491|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7251372|NCT00292370|11462492|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
7251373|NCT00292370|11462490|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
7251374|NCT00292370|11462491|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
7251375|NCT00292370|11462492|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
7251376|NCT00292370|11462490|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
7251377|NCT00292370|11462491|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
7251378|NCT00292370|11462492|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
7251379|NCT00292461|11462501|FG000|Overall Study|Adverse Event|4
7251380|NCT00292461|11462502|FG001|Overall Study|Adverse Event|2
7251381|NCT00292461|11462501|FG000|Overall Study|Lack of Efficacy|1
7251382|NCT00292461|11462502|FG001|Overall Study|Lack of Efficacy|0
7251383|NCT00292461|11462501|FG000|Overall Study|Withdrawal by Subject|0
7251384|NCT00292461|11462502|FG001|Overall Study|Withdrawal by Subject|1
7251385|NCT00292461|11462501|FG000|Overall Study|Protocol Violation|4
7251386|NCT00292461|11462502|FG001|Overall Study|Protocol Violation|3
7251387|NCT00292461|11462501|FG000|Overall Study|Lost to Follow-up|1
7251388|NCT00292461|11462502|FG001|Overall Study|Lost to Follow-up|0
7251389|NCT00292942|11462525|FG000|Overall Study|Withdrawal by Subject|0
7251390|NCT00292942|11462526|FG001|Overall Study|Withdrawal by Subject|0
7251391|NCT00292942|11462527|FG002|Overall Study|Withdrawal by Subject|1
7251392|NCT00292942|11462528|FG003|Overall Study|Withdrawal by Subject|0
7251393|NCT00292942|11462525|FG000|Overall Study|Adverse Event|0
7251394|NCT00292942|11462526|FG001|Overall Study|Adverse Event|0
7251395|NCT00292942|11462527|FG002|Overall Study|Adverse Event|0
7251396|NCT00292942|11462528|FG003|Overall Study|Adverse Event|1
7251397|NCT00292981|11462541|FG000|Overall Study|Adverse Event|1
7251398|NCT00292981|11462541|FG000|Overall Study|Lost to Follow-up|13
7251399|NCT00292981|11462541|FG000|Overall Study|Withdrawal by Subject|22
7251400|NCT00292981|11462541|FG000|Overall Study|Other|3
7251401|NCT00293020|11462545|FG000|Overall Study|Withdrawal by Subject|34
7251402|NCT00293020|11462545|FG000|Overall Study|Adverse Event|30
7251403|NCT00293020|11462545|FG000|Overall Study|Death|32
7251404|NCT00293020|11462545|FG000|Overall Study|Lack of Efficacy|12
7251405|NCT00293020|11462545|FG000|Overall Study|Lost to Follow-up|4
7251406|NCT00293020|11462545|FG000|Overall Study|Protocol Violation|6
7251407|NCT00293020|11462545|FG000|Overall Study|Physician Decision|21
7251408|NCT00293020|11462545|FG000|Overall Study|Other Reason|22
7251409|NCT00293020|11462545|FG000|Overall Study|No dose taken|1
7251410|NCT00293033|11462549|FG000|Open-label Titration Period|Adverse Event|10
7251411|NCT00293033|11462549|FG000|Open-label Titration Period|Death|3
7251412|NCT00293033|11462549|FG000|Open-label Titration Period|Lack of Efficacy|5
7251413|NCT00293033|11462549|FG000|Open-label Titration Period|Protocol Violation|2
7251414|NCT00293033|11462549|FG000|Open-label Titration Period|Withdrawal by Subject|22
7251415|NCT00293033|11462549|FG000|Open-label Titration Period|Noncompliance and other|27
7251416|NCT00293033|11462549|FG000|Double-blind Treatment Period|Adverse Event|3
7251417|NCT00293033|11462549|FG000|Double-blind Treatment Period|Lack of Efficacy|1
7251418|NCT00293033|11462549|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
7251419|NCT00293033|11462549|FG000|Double-blind Treatment Period|Noncompliance|4
7251420|NCT00293059|11462559|FG000|Overall Study|Adverse Event|12
7251421|NCT00293059|11462560|FG001|Overall Study|Adverse Event|4
7251422|NCT00293059|11462559|FG000|Overall Study|Lack of Efficacy|2
7251423|NCT00293059|11462560|FG001|Overall Study|Lack of Efficacy|0
7251424|NCT00293059|11462559|FG000|Overall Study|Lost to Follow-up|2
7251425|NCT00293059|11462560|FG001|Overall Study|Lost to Follow-up|3
7251426|NCT00293059|11462559|FG000|Overall Study|Pregnancy|1
7251427|NCT00293059|11462560|FG001|Overall Study|Pregnancy|1
7251428|NCT00293059|11462559|FG000|Overall Study|Protocol Violation|2
7251429|NCT00293059|11462560|FG001|Overall Study|Protocol Violation|0
7251430|NCT00293059|11462559|FG000|Overall Study|Withdrawal by Subject|11
7251431|NCT00293059|11462560|FG001|Overall Study|Withdrawal by Subject|5
7251432|NCT00293059|11462559|FG000|Overall Study|Participant moved out of state|1
7251433|NCT00293059|11462560|FG001|Overall Study|Participant moved out of state|0
7251434|NCT00293059|11462559|FG000|Overall Study|Participant stopped study drug|1
7251435|NCT00293059|11462560|FG001|Overall Study|Participant stopped study drug|0
7251436|NCT00293059|11462559|FG000|Overall Study|Noncompliant - sanitary pads collection|0
7251437|NCT00293059|11462560|FG001|Overall Study|Noncompliant - sanitary pads collection|1
7251438|NCT00293059|11462559|FG000|Overall Study|missing|3
7251439|NCT00293059|11462560|FG001|Overall Study|missing|5
7251440|NCT00293202|11462568|FG000|Overall Study|Withdrawal by Subject|1
7251441|NCT00293202|11462569|FG001|Overall Study|Withdrawal by Subject|2
7251442|NCT00293202|11462568|FG000|Overall Study|positive ANA (antinuclear antibody)|1
7251443|NCT00293202|11462569|FG001|Overall Study|positive ANA (antinuclear antibody)|0
7251444|NCT00293202|11462568|FG000|Overall Study|on-hold due to fistula maturation time|1
7251445|NCT00293202|11462569|FG001|Overall Study|on-hold due to fistula maturation time|0
7251446|NCT00293215|11462581|FG000|Overall Study|Progressive disease|3
7251447|NCT00293215|11462582|FG001|Overall Study|Progressive disease|1
7251448|NCT00293215|11462581|FG000|Overall Study|Adverse Event|2
7251449|NCT00293215|11462582|FG001|Overall Study|Adverse Event|2
7251450|NCT00293241|11462590|FG000|Overall Study|Lost to Follow-up|9
7251451|NCT00293241|11462591|FG001|Overall Study|Lost to Follow-up|16
7251452|NCT00293241|11462590|FG000|Overall Study|Physician Decision|23
7251453|NCT00293241|11462591|FG001|Overall Study|Physician Decision|17
7251454|NCT00293241|11462590|FG000|Overall Study|Withdrawal by Subject|4
7251455|NCT00293241|11462591|FG001|Overall Study|Withdrawal by Subject|8
7251456|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
7251457|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
7251458|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
7251459|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7251460|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Death|5
7251461|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Death|2
7251462|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7251463|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7251464|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
7251465|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7251466|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
7251467|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7251468|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
7251469|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
7251470|NCT00293254|11462602|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
7251471|NCT00293254|11462603|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
7251472|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
7251473|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
7251474|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Death|4
7251475|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Death|1
7251476|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
7251477|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
7251478|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7251479|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
7251480|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
7251481|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
7251482|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
7251483|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
7251484|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
7251485|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
7251486|NCT00293254|11462602|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7251487|NCT00293254|11462603|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
7251488|NCT00293254|11462602|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
7251489|NCT00293254|11462603|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
7251490|NCT00293254|11462602|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
7251491|NCT00293254|11462603|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7251492|NCT00293254|11462602|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7251493|NCT00293254|11462603|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
7251494|NCT00293254|11462602|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
7251495|NCT00293254|11462603|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7251496|NCT00293254|11462602|FG000|Extension - Open-Label Week 157-240|Other Reason|4
7251497|NCT00293254|11462603|FG001|Extension - Open-Label Week 157-240|Other Reason|0
7251498|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
7251499|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
7251500|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
7251501|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
7251502|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
7251503|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
7251504|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
7251505|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
7251506|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7251507|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
7251508|NCT00293254|11462602|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
7251509|NCT00293254|11462603|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
7251510|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
7251511|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
7251512|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7251513|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
7251514|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Death|3
7574405|NCT03674281|11957038|FG000|Overall Study|Withdrawal by Subject|1
7574406|NCT03674281|11957039|FG001|Overall Study|Withdrawal by Subject|3
7251515|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Death|3
7574407|NCT03674281|11957040|FG002|Overall Study|Withdrawal by Subject|3
7574408|NCT03675776|11957099|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
7574409|NCT03675776|11957100|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
7251516|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
7251517|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
7251518|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7251519|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
7251520|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7251521|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
7251522|NCT00293267|11462613|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
7251523|NCT00293267|11462614|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
7251524|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
7251525|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
7251526|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
7251527|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
7251528|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
7251529|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
7251530|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
7251531|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
7251532|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Death|3
7251533|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Death|0
7251534|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
7251535|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
7251536|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
7251537|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
7251538|NCT00293267|11462613|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
7251539|NCT00293267|11462614|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
7251540|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
7251541|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
7251542|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
7251543|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
7251544|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
7251545|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
7251546|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
7251547|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
7251548|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
7251549|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
7574410|NCT03675776|11957101|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
7251550|NCT00293267|11462613|FG000|Extension - Open-Label Week 157-240|Other Reason|3
7251551|NCT00293267|11462614|FG001|Extension - Open-Label Week 157-240|Other Reason|1
7251552|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
7251553|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
7251554|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
7251555|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
7251556|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
7251557|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
7251558|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7251559|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
7251560|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
7251561|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
7251562|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
7251563|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
7251564|NCT00293267|11462613|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
7251565|NCT00293267|11462614|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
7251566|NCT00293293|11462624|FG000|Overall Study|Withdrawal by Subject|1
7251567|NCT00293293|11462625|FG001|Overall Study|Withdrawal by Subject|1
7251568|NCT00293293|11462624|FG000|Overall Study|"Patient too anxious to complete trial"|1
7251569|NCT00293293|11462625|FG001|Overall Study|"Patient too anxious to complete trial"|0
7251570|NCT00293293|11462624|FG000|Overall Study|Patient discontinued chemotherapy|0
7251571|NCT00293293|11462625|FG001|Overall Study|Patient discontinued chemotherapy|1
7251572|NCT00293384|11462632|FG000|Overall Study|Non-compliance|2
7251573|NCT00293384|11462632|FG000|Overall Study|Missed dosage/study drug|1
7251574|NCT00293384|11462632|FG000|Overall Study|Ineligible|2
7251575|NCT00293397|11462636|FG000|Overall Study|Death|2
7251576|NCT00293423|11462643|FG000|Surgical Resection|Less than a 90% extent of resection|0
7251577|NCT00293423|11462644|FG001|Surgical Resection|Less than a 90% extent of resection|1
7251578|NCT00293423|11462643|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
7251579|NCT00293423|11462644|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
7251580|NCT00293423|11462643|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
7251581|NCT00293423|11462644|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
7251582|NCT00293423|11462643|FG000|Surgical Resection|disease progression prior to initial vaccination|2
7251583|NCT00293423|11462644|FG001|Surgical Resection|disease progression prior to initial vaccination|9
7251584|NCT00293423|11462643|FG000|Surgical Resection|processing error during surgical resection|1
7251585|NCT00293423|11462644|FG001|Surgical Resection|processing error during surgical resection|0
7251586|NCT00293423|11462643|FG000|Surgical Resection|Withdrawal by Subject|4
7251587|NCT00293423|11462644|FG001|Surgical Resection|Withdrawal by Subject|0
7251588|NCT00293423|11462643|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
7251589|NCT00293423|11462644|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
7251590|NCT00293462|11462653|FG000|Overall Study|Withdrawal by Subject|4
7251591|NCT00293462|11462654|FG001|Overall Study|Withdrawal by Subject|3
7251592|NCT00293462|11462655|FG002|Overall Study|Withdrawal by Subject|8
7251593|NCT00293462|11462653|FG000|Overall Study|Death|1
7251594|NCT00293462|11462654|FG001|Overall Study|Death|0
7251595|NCT00293462|11462655|FG002|Overall Study|Death|0
7251596|NCT00293462|11462653|FG000|Overall Study|Lost to Follow-up|0
7251597|NCT00293462|11462654|FG001|Overall Study|Lost to Follow-up|1
7251598|NCT00293462|11462655|FG002|Overall Study|Lost to Follow-up|0
7251599|NCT00293462|11462653|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
7251600|NCT00293462|11462654|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
7251601|NCT00293462|11462655|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
7251602|NCT00293462|11462653|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7251603|NCT00293462|11462654|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
7251604|NCT00293462|11462655|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
7251605|NCT00293462|11462653|FG000|Overall Study|Refuse Radiation Treatment|1
7251606|NCT00293462|11462654|FG001|Overall Study|Refuse Radiation Treatment|0
7251607|NCT00293462|11462655|FG002|Overall Study|Refuse Radiation Treatment|0
7251608|NCT00293462|11462653|FG000|Overall Study|No Show|0
7251609|NCT00293462|11462654|FG001|Overall Study|No Show|0
7251610|NCT00293462|11462655|FG002|Overall Study|No Show|1
7251611|NCT00293462|11462653|FG000|Overall Study|Went back to his home country|0
7574411|NCT03675776|11957099|FG000|Double Blind Treatment Period|Lack of Efficacy|1
7574412|NCT03675776|11957100|FG001|Double Blind Treatment Period|Lack of Efficacy|0
7574413|NCT03675776|11957101|FG002|Double Blind Treatment Period|Lack of Efficacy|0
7574414|NCT03676634|11957113|FG000|Overall Study|Red blood cell loss|1
7574415|NCT03676634|11957113|FG000|Overall Study|Out-of-limit pulse|2
7251612|NCT00293462|11462654|FG001|Overall Study|Went back to his home country|0
7251613|NCT00293462|11462655|FG002|Overall Study|Went back to his home country|1
7251614|NCT00293462|11462653|FG000|Overall Study|Blood clot after chemotherapy|0
7251615|NCT00293462|11462654|FG001|Overall Study|Blood clot after chemotherapy|0
7251616|NCT00293462|11462655|FG002|Overall Study|Blood clot after chemotherapy|1
7574416|NCT03677375|11957165|FG000|Overall Study|Incomplete procedure|8
7574417|NCT03677375|11957165|FG000|Overall Study|Adverse Event|3
7251617|NCT00293462|11462653|FG000|Overall Study|Ischemic stroke after chemotherapy|0
7251618|NCT00293462|11462654|FG001|Overall Study|Ischemic stroke after chemotherapy|0
7251619|NCT00293462|11462655|FG002|Overall Study|Ischemic stroke after chemotherapy|1
7251620|NCT00293462|11462653|FG000|Overall Study|Possible Tracheostomy leakage|0
7251621|NCT00293462|11462654|FG001|Overall Study|Possible Tracheostomy leakage|1
7251622|NCT00293462|11462655|FG002|Overall Study|Possible Tracheostomy leakage|0
7251623|NCT00293462|11462653|FG000|Overall Study|Low radiation dose in oral cavity|0
7251624|NCT00293462|11462654|FG001|Overall Study|Low radiation dose in oral cavity|1
7251625|NCT00293462|11462655|FG002|Overall Study|Low radiation dose in oral cavity|0
7251626|NCT00293462|11462653|FG000|Overall Study|Physician Decision|0
7251627|NCT00293462|11462654|FG001|Overall Study|Physician Decision|1
7251628|NCT00293462|11462655|FG002|Overall Study|Physician Decision|0
7251629|NCT00293579|11462672|FG000|Overall Study|Withdrawal by Subject|1
7251630|NCT00293709|11462677|FG000|Overall Study|Other|47
7251631|NCT00293722|11462681|FG000|Overall Study|Other|427
7251632|NCT00293813|11462688|FG000|Overall Study|Physician Decision|0
7251633|NCT00293813|11462689|FG001|Overall Study|Physician Decision|1
7251634|NCT00293813|11462690|FG002|Overall Study|Physician Decision|0
7251635|NCT00293813|11462688|FG000|Overall Study|Adverse Event|3
7251636|NCT00293813|11462689|FG001|Overall Study|Adverse Event|1
7251637|NCT00293813|11462690|FG002|Overall Study|Adverse Event|1
7251638|NCT00293813|11462688|FG000|Overall Study|Withdrawal by Subject|7
7251639|NCT00293813|11462689|FG001|Overall Study|Withdrawal by Subject|4
7251640|NCT00293813|11462690|FG002|Overall Study|Withdrawal by Subject|4
7251641|NCT00293813|11462688|FG000|Overall Study|Lost to Follow-up|3
7251642|NCT00293813|11462689|FG001|Overall Study|Lost to Follow-up|2
7251643|NCT00293813|11462690|FG002|Overall Study|Lost to Follow-up|3
7251644|NCT00293813|11462688|FG000|Overall Study|Noncompliance|0
7251645|NCT00293813|11462689|FG001|Overall Study|Noncompliance|1
7251646|NCT00293813|11462690|FG002|Overall Study|Noncompliance|0
7251647|NCT00294047|11462700|FG000|Month 48|Adverse Event|28
7251648|NCT00294047|11462701|FG001|Month 48|Adverse Event|13
7251649|NCT00294047|11462700|FG000|Month 48|Protocol Violation|4
7251650|NCT00294047|11462701|FG001|Month 48|Protocol Violation|4
7251651|NCT00294047|11462700|FG000|Month 48|Withdrawal by Subject|111
7251652|NCT00294047|11462701|FG001|Month 48|Withdrawal by Subject|115
7251653|NCT00294047|11462700|FG000|Month 48|Lost to Follow-up|272
7251654|NCT00294047|11462701|FG001|Month 48|Lost to Follow-up|287
7251655|NCT00294047|11462700|FG000|Month 48|Other|10
7251656|NCT00294047|11462701|FG001|Month 48|Other|14
7251657|NCT00294047|11462700|FG000|Month 84|Adverse Event|4
7251658|NCT00294047|11462701|FG001|Month 84|Adverse Event|2
7251659|NCT00294047|11462700|FG000|Month 84|Protocol Violation|1
7251660|NCT00294047|11462701|FG001|Month 84|Protocol Violation|1
7251661|NCT00294047|11462700|FG000|Month 84|Withdrawal by Subject|33
7251662|NCT00294047|11462701|FG001|Month 84|Withdrawal by Subject|31
7251663|NCT00294047|11462700|FG000|Month 84|Lost to Follow-up|187
7251664|NCT00294047|11462701|FG001|Month 84|Lost to Follow-up|190
7251665|NCT00294047|11462700|FG000|Month 84|Absent Cervix|2
7251666|NCT00294047|11462701|FG001|Month 84|Absent Cervix|0
7251667|NCT00294047|11462700|FG000|Month 84|Work related reasons|4
7574418|NCT03677375|11957165|FG000|Overall Study|Physician Decision|1
7574419|NCT03677401|11957171|FG000|Overall Study|Adverse Event|4
7251668|NCT00294047|11462701|FG001|Month 84|Work related reasons|2
7251669|NCT00294047|11462700|FG000|Month 84|Center closed, subject did not transfer|1
7251670|NCT00294047|11462701|FG001|Month 84|Center closed, subject did not transfer|0
7251671|NCT00294047|11462700|FG000|Month 84|Family problems|2
7251672|NCT00294047|11462701|FG001|Month 84|Family problems|2
7251673|NCT00294047|11462700|FG000|Month 84|Lack of time|3
7251674|NCT00294047|11462701|FG001|Month 84|Lack of time|1
7251675|NCT00294047|11462700|FG000|Month 84|Personal reason|2
7251676|NCT00294047|11462701|FG001|Month 84|Personal reason|4
7251677|NCT00294047|11462700|FG000|Month 84|Subject does not want male physician|1
7251678|NCT00294047|11462701|FG001|Month 84|Subject does not want male physician|0
7251679|NCT00294047|11462700|FG000|Month 84|Transport reimbursement delayed|0
7251680|NCT00294047|11462701|FG001|Month 84|Transport reimbursement delayed|1
7251681|NCT00294047|11462700|FG000|Month 84|Unable to reach study site|1
7251682|NCT00294047|11462701|FG001|Month 84|Unable to reach study site|0
7251683|NCT00294047|11462700|FG000|Month 84|Under investigation locally|1
7251684|NCT00294047|11462701|FG001|Month 84|Under investigation locally|0
7251685|NCT00294047|11462700|FG000|Month 84|Visit missed|0
7251686|NCT00294047|11462701|FG001|Month 84|Visit missed|1
7251687|NCT00294047|11462700|FG000|Month 84|No consent for Month 84 Follow-up|731
7251688|NCT00294047|11462701|FG001|Month 84|No consent for Month 84 Follow-up|754
7251689|NCT00294060|11462708|FG000|Overall Study|Death|225
7251690|NCT00294060|11462708|FG000|Overall Study|Other|59
7251691|NCT00294060|11462708|FG000|Overall Study|Lost to Follow-up|55
7251692|NCT00294060|11462708|FG000|Overall Study|Withdrawal by Subject|11
7251693|NCT00294060|11462708|FG000|Overall Study|Physician Decision|797
7251694|NCT00294060|11462708|FG000|Overall Study|Medical condition|3
7251695|NCT00294060|11462708|FG000|Overall Study|Device explanted/not replaced|23
7256414|NCT00322621|11467933|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7256415|NCT00322621|11467934|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
7256416|NCT00322621|11467932|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
7256417|NCT00322621|11467933|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
7251696|NCT00294398|11462714|FG000|Overall Study|Lost to Follow-up|21
7251697|NCT00294398|11462715|FG001|Overall Study|Lost to Follow-up|26
7251698|NCT00294554|11462732|FG000|Overall Study|Lack of Efficacy|0
7251699|NCT00294554|11462733|FG001|Overall Study|Lack of Efficacy|1
7251700|NCT00294554|11462732|FG000|Overall Study|Physician Decision|0
7251701|NCT00294554|11462733|FG001|Overall Study|Physician Decision|1
7251702|NCT00294645|11462751|FG000|Overall Study|Death|10
7251703|NCT00294645|11462752|FG001|Overall Study|Death|18
7251704|NCT00294645|11462751|FG000|Overall Study|Lost to Follow-up|1
7251705|NCT00294645|11462752|FG001|Overall Study|Lost to Follow-up|10
7251706|NCT00294645|11462751|FG000|Overall Study|Withdrawal by Subject|18
7251707|NCT00294645|11462752|FG001|Overall Study|Withdrawal by Subject|34
7251708|NCT00294645|11462751|FG000|Overall Study|Physician Decision|15
7251709|NCT00294645|11462752|FG001|Overall Study|Physician Decision|20
7251710|NCT00294645|11462751|FG000|Overall Study|Other|4
7251711|NCT00294645|11462752|FG001|Overall Study|Other|10
7251712|NCT00294658|11462760|FG000|Overall Study|Death|0
7251713|NCT00294658|11462761|FG001|Overall Study|Death|1
7251714|NCT00294658|11462760|FG000|Overall Study|Lost to Follow-up|4
7251715|NCT00294658|11462761|FG001|Overall Study|Lost to Follow-up|0
7251716|NCT00294658|11462760|FG000|Overall Study|Physician Decision|1
7251717|NCT00294658|11462761|FG001|Overall Study|Physician Decision|2
7251718|NCT00294658|11462760|FG000|Overall Study|Pregnancy|0
7251719|NCT00294658|11462761|FG001|Overall Study|Pregnancy|1
7251720|NCT00294658|11462760|FG000|Overall Study|Withdrawal by Subject|0
7251721|NCT00294658|11462761|FG001|Overall Study|Withdrawal by Subject|4
7251722|NCT00294658|11462760|FG000|Overall Study|Found to have invasive thymoma|1
7251723|NCT00294658|11462761|FG001|Overall Study|Found to have invasive thymoma|0
7251724|NCT00294658|11462760|FG000|Overall Study|Patient and family were not satisfied|0
7251725|NCT00294658|11462761|FG001|Overall Study|Patient and family were not satisfied|1
7251726|NCT00294671|11462769|FG000|Overall Study|Lack of Efficacy|11
7251727|NCT00294671|11462770|FG001|Overall Study|Lack of Efficacy|23
7251728|NCT00294671|11462769|FG000|Overall Study|Liver transplant|7
7251729|NCT00294671|11462770|FG001|Overall Study|Liver transplant|9
7251730|NCT00294671|11462769|FG000|Overall Study|Drug related adverse event (AE)|4
7251731|NCT00294671|11462770|FG001|Overall Study|Drug related adverse event (AE)|2
7251732|NCT00294671|11462769|FG000|Overall Study|Non-drug related AE|3
7251733|NCT00294671|11462770|FG001|Overall Study|Non-drug related AE|2
7251734|NCT00294671|11462769|FG000|Overall Study|Lost to Follow-up|1
7251735|NCT00294671|11462770|FG001|Overall Study|Lost to Follow-up|3
7251736|NCT00294671|11462769|FG000|Overall Study|Non-compliance|1
7251737|NCT00294671|11462770|FG001|Overall Study|Non-compliance|0
7251738|NCT00294671|11462769|FG000|Overall Study|Death|0
7251739|NCT00294671|11462770|FG001|Overall Study|Death|1
7251740|NCT00294684|11462778|FG000|Overall Study|Lost to Follow-up|5
7251741|NCT00294684|11462779|FG001|Overall Study|Lost to Follow-up|8
7251742|NCT00294723|11462788|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
7251743|NCT00294723|11462789|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
7251744|NCT00294723|11462790|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
7251745|NCT00294723|11462788|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
7251746|NCT00294723|11462789|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
7251747|NCT00294723|11462790|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
7251748|NCT00294723|11462788|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
7251749|NCT00294723|11462789|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
7251750|NCT00294723|11462790|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
7251751|NCT00294723|11462788|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
7251752|NCT00294723|11462789|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
7251753|NCT00294723|11462790|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
7251754|NCT00294723|11462788|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
7251755|NCT00294723|11462789|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
7251756|NCT00294723|11462790|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
7251757|NCT00294723|11462788|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
7251758|NCT00294723|11462789|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
7251759|NCT00294723|11462790|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
7251760|NCT00294723|11462788|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
7251761|NCT00294723|11462789|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
7251762|NCT00294723|11462790|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
7251763|NCT00294723|11462788|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
7251764|NCT00294723|11462789|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
7251765|NCT00294723|11462790|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
7251766|NCT00294723|11462788|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7251767|NCT00294723|11462789|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
7251768|NCT00294723|11462790|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
7251769|NCT00294723|11462788|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
7251770|NCT00294723|11462789|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
7251771|NCT00294723|11462790|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
7251772|NCT00294723|11462788|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7251773|NCT00294723|11462789|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7251774|NCT00294723|11462790|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
7251775|NCT00294723|11462788|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
7251776|NCT00294723|11462789|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
7251777|NCT00294723|11462790|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
7251778|NCT00294762|11462803|FG000|Overall Study|Did not receive study treatment|3
7251779|NCT00294762|11462804|FG001|Overall Study|Did not receive study treatment|3
7251780|NCT00295022|11462838|FG000|Overall Study|Adverse Event|1
7251781|NCT00295022|11462839|FG001|Overall Study|Adverse Event|1
7251782|NCT00295022|11462840|FG002|Overall Study|Adverse Event|2
7251783|NCT00295022|11462838|FG000|Overall Study|Lost to Follow-up|0
7251784|NCT00295022|11462839|FG001|Overall Study|Lost to Follow-up|0
7251785|NCT00295022|11462840|FG002|Overall Study|Lost to Follow-up|1
7251786|NCT00295022|11462838|FG000|Overall Study|Withdrawal by Subject|0
7251787|NCT00295022|11462839|FG001|Overall Study|Withdrawal by Subject|0
7251788|NCT00295022|11462840|FG002|Overall Study|Withdrawal by Subject|2
7251789|NCT00295620|11462866|FG000|Overall Study|Lost to Follow-up|9
7251790|NCT00295620|11462867|FG001|Overall Study|Lost to Follow-up|5
7251791|NCT00295620|11462866|FG000|Overall Study|Withdrawal by Subject|37
7251792|NCT00295620|11462867|FG001|Overall Study|Withdrawal by Subject|50
7251793|NCT00295620|11462866|FG000|Overall Study|Death|206
7251794|NCT00295620|11462867|FG001|Overall Study|Death|207
7251795|NCT00295620|11462866|FG000|Overall Study|Other reasons|10
7251796|NCT00295620|11462867|FG001|Overall Study|Other reasons|9
7251797|NCT00295620|11462866|FG000|Overall Study|Discontinuation by sponsor|580
7251798|NCT00295620|11462867|FG001|Overall Study|Discontinuation by sponsor|593
7251799|NCT00295620|11462866|FG000|Overall Study|Protocol Violation|30
7251800|NCT00295620|11462867|FG001|Overall Study|Protocol Violation|32
7251801|NCT00295633|11462876|FG000|Overall Study|Lack of Efficacy|19
7251802|NCT00295633|11462877|FG001|Overall Study|Lack of Efficacy|7
7251803|NCT00295633|11462878|FG002|Overall Study|Lack of Efficacy|16
7251804|NCT00295633|11462876|FG000|Overall Study|Withdrawal of consent by subject|16
7251805|NCT00295633|11462877|FG001|Overall Study|Withdrawal of consent by subject|16
7251806|NCT00295633|11462878|FG002|Overall Study|Withdrawal of consent by subject|26
7251807|NCT00295633|11462876|FG000|Overall Study|Adverse Event|9
7251808|NCT00295633|11462877|FG001|Overall Study|Adverse Event|17
7251809|NCT00295633|11462878|FG002|Overall Study|Adverse Event|9
7251810|NCT00295633|11462876|FG000|Overall Study|Lost to Follow-up|6
7251811|NCT00295633|11462877|FG001|Overall Study|Lost to Follow-up|11
7251812|NCT00295633|11462878|FG002|Overall Study|Lost to Follow-up|7
7251813|NCT00295633|11462876|FG000|Overall Study|Physician Decision|9
7251814|NCT00295633|11462877|FG001|Overall Study|Physician Decision|10
7251815|NCT00295633|11462878|FG002|Overall Study|Physician Decision|8
7251816|NCT00295633|11462876|FG000|Overall Study|Poor/Noncompliance|2
7251817|NCT00295633|11462877|FG001|Overall Study|Poor/Noncompliance|2
7251818|NCT00295633|11462878|FG002|Overall Study|Poor/Noncompliance|6
7251819|NCT00295633|11462876|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7251820|NCT00295633|11462877|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
7251821|NCT00295633|11462878|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
7251822|NCT00295633|11462876|FG000|Overall Study|Death|1
7251823|NCT00295633|11462877|FG001|Overall Study|Death|1
7251824|NCT00295633|11462878|FG002|Overall Study|Death|0
7251825|NCT00295633|11462876|FG000|Overall Study|Administrative reason by sponsor|0
7251826|NCT00295633|11462877|FG001|Overall Study|Administrative reason by sponsor|0
7251827|NCT00295633|11462878|FG002|Overall Study|Administrative reason by sponsor|1
7251828|NCT00295750|11462889|FG000|Overall Study|Adverse Event|19
7251829|NCT00295750|11462890|FG001|Overall Study|Adverse Event|15
7251830|NCT00295750|11462891|FG002|Overall Study|Adverse Event|12
7251831|NCT00295750|11462889|FG000|Overall Study|Lack of Efficacy|1
7251832|NCT00295750|11462890|FG001|Overall Study|Lack of Efficacy|1
7251833|NCT00295750|11462891|FG002|Overall Study|Lack of Efficacy|0
7251834|NCT00295750|11462889|FG000|Overall Study|Lost to Follow-up|1
7251835|NCT00295750|11462890|FG001|Overall Study|Lost to Follow-up|4
7251836|NCT00295750|11462891|FG002|Overall Study|Lost to Follow-up|1
7251837|NCT00295750|11462889|FG000|Overall Study|Taking prohibited therapy|2
7251838|NCT00295750|11462890|FG001|Overall Study|Taking prohibited therapy|3
7251839|NCT00295750|11462891|FG002|Overall Study|Taking prohibited therapy|2
7251840|NCT00295750|11462889|FG000|Overall Study|Administrative errors|2
7251841|NCT00295750|11462890|FG001|Overall Study|Administrative errors|4
7251842|NCT00295750|11462891|FG002|Overall Study|Administrative errors|5
7251843|NCT00295750|11462889|FG000|Overall Study|Trial drug errors|1
7251844|NCT00295750|11462890|FG001|Overall Study|Trial drug errors|1
7251845|NCT00295750|11462891|FG002|Overall Study|Trial drug errors|0
7251846|NCT00295750|11462889|FG000|Overall Study|Disease progression|2
7251847|NCT00295750|11462890|FG001|Overall Study|Disease progression|1
7251848|NCT00295750|11462891|FG002|Overall Study|Disease progression|0
7251849|NCT00295750|11462889|FG000|Overall Study|Personal reasons|0
7251850|NCT00295750|11462890|FG001|Overall Study|Personal reasons|1
7251851|NCT00295750|11462891|FG002|Overall Study|Personal reasons|0
7251852|NCT00295750|11462889|FG000|Overall Study|Randomized but never received trial drug|4
7251853|NCT00295750|11462890|FG001|Overall Study|Randomized but never received trial drug|3
7251854|NCT00295750|11462891|FG002|Overall Study|Randomized but never received trial drug|3
7251855|NCT00295750|11462889|FG000|Overall Study|Withdrawal by Subject|9
7251856|NCT00295750|11462890|FG001|Overall Study|Withdrawal by Subject|4
7251857|NCT00295750|11462891|FG002|Overall Study|Withdrawal by Subject|7
7251858|NCT00295750|11462889|FG000|Overall Study|Protocol Violation|2
7251859|NCT00295750|11462890|FG001|Overall Study|Protocol Violation|4
7251860|NCT00295750|11462891|FG002|Overall Study|Protocol Violation|2
7251861|NCT00295854|11462902|FG000|Overall Study|Adverse Event|7
7251862|NCT00295854|11462903|FG001|Overall Study|Adverse Event|7
7251863|NCT00295854|11462904|FG002|Overall Study|Adverse Event|6
7251864|NCT00295854|11462902|FG000|Overall Study|Protocol Violation|1
7251865|NCT00295854|11462903|FG001|Overall Study|Protocol Violation|1
7251866|NCT00295854|11462904|FG002|Overall Study|Protocol Violation|1
7251867|NCT00295854|11462902|FG000|Overall Study|Lost to Follow-up|2
7251868|NCT00295854|11462903|FG001|Overall Study|Lost to Follow-up|0
7251869|NCT00295854|11462904|FG002|Overall Study|Lost to Follow-up|1
7251870|NCT00295854|11462902|FG000|Overall Study|Withdrawal by Subject|3
7251871|NCT00295854|11462903|FG001|Overall Study|Withdrawal by Subject|7
7251872|NCT00295854|11462904|FG002|Overall Study|Withdrawal by Subject|4
7251873|NCT00295854|11462902|FG000|Overall Study|did not continue to meet criteria|1
7251874|NCT00295854|11462903|FG001|Overall Study|did not continue to meet criteria|1
7251875|NCT00295854|11462904|FG002|Overall Study|did not continue to meet criteria|2
7251876|NCT00295854|11462902|FG000|Overall Study|required a prohibited medication|1
7251877|NCT00295854|11462903|FG001|Overall Study|required a prohibited medication|0
7251878|NCT00295854|11462904|FG002|Overall Study|required a prohibited medication|0
7251879|NCT00295854|11462902|FG000|Overall Study|Other|3
7251880|NCT00295854|11462903|FG001|Overall Study|Other|5
7251881|NCT00295854|11462904|FG002|Overall Study|Other|1
7251882|NCT00295880|11462916|FG000|Overall Study|IBMI unit could not be volume reduced|1
7251883|NCT00295880|11462916|FG000|Overall Study|Unit randomization did not occur|1
7251884|NCT00295932|11462931|FG000|Overall Study|Not Treated|0
7251885|NCT00295932|11462932|FG001|Overall Study|Not Treated|0
7251886|NCT00295932|11462933|FG002|Overall Study|Not Treated|0
7251887|NCT00295932|11462934|FG003|Overall Study|Not Treated|0
7251888|NCT00295932|11462935|FG004|Overall Study|Not Treated|0
7251889|NCT00295932|11462936|FG005|Overall Study|Not Treated|0
7251890|NCT00295932|11462937|FG006|Overall Study|Not Treated|0
7251891|NCT00295932|11462938|FG007|Overall Study|Not Treated|0
7251892|NCT00295932|11462939|FG008|Overall Study|Not Treated|0
7251893|NCT00295932|11462940|FG009|Overall Study|Not Treated|0
7251894|NCT00295932|11462941|FG010|Overall Study|Not Treated|1
7251895|NCT00296036|11462969|FG000|Overall Study|Withdrawal by Subject|1
7251896|NCT00296036|11462970|FG001|Overall Study|Withdrawal by Subject|0
7251897|NCT00296036|11462971|FG002|Overall Study|Withdrawal by Subject|2
7251898|NCT00296036|11462972|FG003|Overall Study|Withdrawal by Subject|1
7251899|NCT00296036|11462973|FG004|Overall Study|Withdrawal by Subject|2
7251900|NCT00296036|11462974|FG005|Overall Study|Withdrawal by Subject|1
7251901|NCT00296036|11462969|FG000|Overall Study|Protocol Violation|0
7251902|NCT00296036|11462970|FG001|Overall Study|Protocol Violation|0
7251903|NCT00296036|11462971|FG002|Overall Study|Protocol Violation|0
7251904|NCT00296036|11462972|FG003|Overall Study|Protocol Violation|0
7251905|NCT00296036|11462973|FG004|Overall Study|Protocol Violation|0
7251906|NCT00296036|11462974|FG005|Overall Study|Protocol Violation|3
7251907|NCT00296140|11462993|FG000|Overall Study|Lost to Follow-up|1
7251908|NCT00296140|11462994|FG001|Overall Study|Lost to Follow-up|0
7251909|NCT00296140|11462993|FG000|Overall Study|Withdrawal by Subject|1
7251910|NCT00296140|11462994|FG001|Overall Study|Withdrawal by Subject|0
7251911|NCT00296140|11462993|FG000|Overall Study|Discharge to Nursing Home|1
7251912|NCT00296140|11462994|FG001|Overall Study|Discharge to Nursing Home|0
7251913|NCT00296244|11463027|FG000|Overall Study|Underwent retransplant|0
7251914|NCT00296244|11463028|FG001|Overall Study|Underwent retransplant|1
7251915|NCT00296335|11463059|FG000|Overall Study|Recurrence|3
7251916|NCT00296335|11463060|FG001|Overall Study|Recurrence|51
7251917|NCT00296335|11463059|FG000|Overall Study|Adverse Event|17
7251918|NCT00296335|11463060|FG001|Overall Study|Adverse Event|27
7251919|NCT00296335|11463059|FG000|Overall Study|Lost to Follow-up|7
7251920|NCT00296335|11463060|FG001|Overall Study|Lost to Follow-up|33
7251921|NCT00296335|11463059|FG000|Overall Study|Physician Decision|3
7251922|NCT00296335|11463060|FG001|Overall Study|Physician Decision|11
7251923|NCT00296374|11463071|FG000|Overall Study|Adverse Event|14
7251924|NCT00296374|11463072|FG001|Overall Study|Adverse Event|10
7251925|NCT00296374|11463073|FG002|Overall Study|Adverse Event|7
7251926|NCT00296374|11463071|FG000|Overall Study|Withdrawal by Subject|3
7251927|NCT00296374|11463072|FG001|Overall Study|Withdrawal by Subject|5
7251928|NCT00296374|11463073|FG002|Overall Study|Withdrawal by Subject|11
7251929|NCT00296374|11463071|FG000|Overall Study|Incorrect enrollment|3
7251930|NCT00296374|11463072|FG001|Overall Study|Incorrect enrollment|3
7251931|NCT00296374|11463073|FG002|Overall Study|Incorrect enrollment|4
7251932|NCT00296374|11463071|FG000|Overall Study|Protocol Violation|1
7251933|NCT00296374|11463072|FG001|Overall Study|Protocol Violation|2
7251934|NCT00296374|11463073|FG002|Overall Study|Protocol Violation|3
7251935|NCT00296374|11463071|FG000|Overall Study|Lost to Follow-up|3
7251936|NCT00296374|11463072|FG001|Overall Study|Lost to Follow-up|1
7251937|NCT00296374|11463073|FG002|Overall Study|Lost to Follow-up|1
7251938|NCT00296374|11463071|FG000|Overall Study|Relocated to another state|1
7251939|NCT00296374|11463072|FG001|Overall Study|Relocated to another state|0
7251940|NCT00296374|11463073|FG002|Overall Study|Relocated to another state|0
7251941|NCT00296374|11463071|FG000|Overall Study|Stopped drug before end of study visit|0
7251942|NCT00296374|11463072|FG001|Overall Study|Stopped drug before end of study visit|1
7251943|NCT00296374|11463073|FG002|Overall Study|Stopped drug before end of study visit|0
7251944|NCT00296374|11463071|FG000|Overall Study|Nephrologist introduced ACE|0
7251945|NCT00296374|11463072|FG001|Overall Study|Nephrologist introduced ACE|1
7251946|NCT00296374|11463073|FG002|Overall Study|Nephrologist introduced ACE|0
7251947|NCT00296374|11463071|FG000|Overall Study|Pregnancy|0
7251948|NCT00296374|11463072|FG001|Overall Study|Pregnancy|0
7251949|NCT00296374|11463073|FG002|Overall Study|Pregnancy|2
7251950|NCT00296374|11463071|FG000|Overall Study|Other|0
7251951|NCT00296374|11463072|FG001|Overall Study|Other|0
7251952|NCT00296374|11463073|FG002|Overall Study|Other|1
7251953|NCT00296400|11463090|FG000|Overall Study|Adverse Event|7
7251954|NCT00296400|11463091|FG001|Overall Study|Adverse Event|7
7251955|NCT00296400|11463092|FG002|Overall Study|Adverse Event|7
7251956|NCT00296400|11463090|FG000|Overall Study|Withdrawal by Subject|5
7251957|NCT00296400|11463091|FG001|Overall Study|Withdrawal by Subject|6
7251958|NCT00296400|11463092|FG002|Overall Study|Withdrawal by Subject|2
7251959|NCT00296400|11463090|FG000|Overall Study|Incorrect enrollment|2
7251960|NCT00296400|11463091|FG001|Overall Study|Incorrect enrollment|0
7251961|NCT00296400|11463092|FG002|Overall Study|Incorrect enrollment|0
7251962|NCT00296400|11463090|FG000|Overall Study|Protocol Violation|1
7251963|NCT00296400|11463091|FG001|Overall Study|Protocol Violation|1
7251964|NCT00296400|11463092|FG002|Overall Study|Protocol Violation|1
7251965|NCT00296400|11463090|FG000|Overall Study|Lost to Follow-up|1
7251966|NCT00296400|11463091|FG001|Overall Study|Lost to Follow-up|1
7251967|NCT00296400|11463092|FG002|Overall Study|Lost to Follow-up|2
7251968|NCT00296400|11463090|FG000|Overall Study|Study specific discontinuation criteria|0
7251969|NCT00296400|11463091|FG001|Overall Study|Study specific discontinuation criteria|0
7251970|NCT00296400|11463092|FG002|Overall Study|Study specific discontinuation criteria|1
7251971|NCT00296400|11463090|FG000|Overall Study|Visit 10 was performed earlier|0
7251972|NCT00296400|11463091|FG001|Overall Study|Visit 10 was performed earlier|1
7251973|NCT00296400|11463092|FG002|Overall Study|Visit 10 was performed earlier|0
7251974|NCT00296400|11463090|FG000|Overall Study|Pregnancy|1
7251975|NCT00296400|11463091|FG001|Overall Study|Pregnancy|2
7251976|NCT00296400|11463092|FG002|Overall Study|Pregnancy|0
7251977|NCT00296491|11463107|FG000|Overall Study|Low Pollen Counts|18
7251978|NCT00296491|11463108|FG001|Overall Study|Low Pollen Counts|26
7251979|NCT00296491|11463109|FG002|Overall Study|Low Pollen Counts|25
7251980|NCT00296491|11463110|FG003|Overall Study|Low Pollen Counts|16
7251981|NCT00296491|11463107|FG000|Overall Study|Protocol Violation|4
7251982|NCT00296491|11463108|FG001|Overall Study|Protocol Violation|6
7251983|NCT00296491|11463109|FG002|Overall Study|Protocol Violation|2
7251984|NCT00296491|11463110|FG003|Overall Study|Protocol Violation|3
7251985|NCT00296491|11463107|FG000|Overall Study|Adverse Event|1
7251986|NCT00296491|11463108|FG001|Overall Study|Adverse Event|3
7251987|NCT00296491|11463109|FG002|Overall Study|Adverse Event|1
7251988|NCT00296491|11463110|FG003|Overall Study|Adverse Event|4
7251989|NCT00296491|11463107|FG000|Overall Study|Withdrawn due to Asthma|0
7251990|NCT00296491|11463108|FG001|Overall Study|Withdrawn due to Asthma|0
7251991|NCT00296491|11463109|FG002|Overall Study|Withdrawn due to Asthma|0
7251992|NCT00296491|11463110|FG003|Overall Study|Withdrawn due to Asthma|4
7251993|NCT00296491|11463107|FG000|Overall Study|Withdrawal by Subject|7
7251994|NCT00296491|11463108|FG001|Overall Study|Withdrawal by Subject|3
7251995|NCT00296491|11463109|FG002|Overall Study|Withdrawal by Subject|3
7251996|NCT00296491|11463110|FG003|Overall Study|Withdrawal by Subject|2
7251997|NCT00296491|11463107|FG000|Overall Study|Non-Compliance|12
7251998|NCT00296491|11463108|FG001|Overall Study|Non-Compliance|13
7251999|NCT00296491|11463109|FG002|Overall Study|Non-Compliance|10
7252000|NCT00296491|11463110|FG003|Overall Study|Non-Compliance|14
7252001|NCT00296491|11463107|FG000|Overall Study|Lost to Follow-up|0
7252002|NCT00296491|11463108|FG001|Overall Study|Lost to Follow-up|2
7252003|NCT00296491|11463109|FG002|Overall Study|Lost to Follow-up|2
7252004|NCT00296491|11463110|FG003|Overall Study|Lost to Follow-up|0
7252005|NCT00296504|11463135|FG000|Interim Analysis|Withdrawal by Subject|8
7252006|NCT00296504|11463136|FG001|Interim Analysis|Withdrawal by Subject|0
7252007|NCT00296504|11463137|FG002|Interim Analysis|Withdrawal by Subject|12
7252008|NCT00296504|11463138|FG003|Interim Analysis|Withdrawal by Subject|0
7252009|NCT00296504|11463139|FG004|Interim Analysis|Withdrawal by Subject|5
7252010|NCT00296504|11463140|FG005|Interim Analysis|Withdrawal by Subject|5
7252011|NCT00296504|11463141|FG006|Interim Analysis|Withdrawal by Subject|9
7252012|NCT00296504|11463142|FG007|Interim Analysis|Withdrawal by Subject|3
7252013|NCT00296504|11463143|FG008|Interim Analysis|Withdrawal by Subject|0
7252014|NCT00296504|11463135|FG000|Interim Analysis|Lost to Follow-up|13
7252015|NCT00296504|11463136|FG001|Interim Analysis|Lost to Follow-up|3
7252016|NCT00296504|11463137|FG002|Interim Analysis|Lost to Follow-up|26
7252017|NCT00296504|11463138|FG003|Interim Analysis|Lost to Follow-up|8
7252018|NCT00296504|11463139|FG004|Interim Analysis|Lost to Follow-up|14
7252019|NCT00296504|11463140|FG005|Interim Analysis|Lost to Follow-up|4
7252020|NCT00296504|11463141|FG006|Interim Analysis|Lost to Follow-up|11
7252021|NCT00296504|11463142|FG007|Interim Analysis|Lost to Follow-up|4
7252022|NCT00296504|11463143|FG008|Interim Analysis|Lost to Follow-up|0
7252023|NCT00296504|11463135|FG000|Interim Analysis|Clinical Progression|1
7252024|NCT00296504|11463136|FG001|Interim Analysis|Clinical Progression|0
7252025|NCT00296504|11463137|FG002|Interim Analysis|Clinical Progression|1
7252026|NCT00296504|11463138|FG003|Interim Analysis|Clinical Progression|1
7252027|NCT00296504|11463139|FG004|Interim Analysis|Clinical Progression|0
7252028|NCT00296504|11463140|FG005|Interim Analysis|Clinical Progression|2
7252029|NCT00296504|11463141|FG006|Interim Analysis|Clinical Progression|1
7252030|NCT00296504|11463142|FG007|Interim Analysis|Clinical Progression|2
7252031|NCT00296504|11463143|FG008|Interim Analysis|Clinical Progression|0
7384010|NCT01192100|11641103|FG004|Overall Study|Withdrawal by Subject|1
7252032|NCT00296504|11463135|FG000|Interim Analysis|Insufficient Viral Load Response|5
7252033|NCT00296504|11463136|FG001|Interim Analysis|Insufficient Viral Load Response|1
7252034|NCT00296504|11463137|FG002|Interim Analysis|Insufficient Viral Load Response|12
7252035|NCT00296504|11463138|FG003|Interim Analysis|Insufficient Viral Load Response|2
7252036|NCT00296504|11463139|FG004|Interim Analysis|Insufficient Viral Load Response|7
7252037|NCT00296504|11463140|FG005|Interim Analysis|Insufficient Viral Load Response|9
7252038|NCT00296504|11463141|FG006|Interim Analysis|Insufficient Viral Load Response|2
7252039|NCT00296504|11463142|FG007|Interim Analysis|Insufficient Viral Load Response|24
7252040|NCT00296504|11463143|FG008|Interim Analysis|Insufficient Viral Load Response|0
7252041|NCT00296504|11463135|FG000|Interim Analysis|Adverse Event|0
7252042|NCT00296504|11463136|FG001|Interim Analysis|Adverse Event|0
7252043|NCT00296504|11463137|FG002|Interim Analysis|Adverse Event|13
7252044|NCT00296504|11463138|FG003|Interim Analysis|Adverse Event|4
7252045|NCT00296504|11463139|FG004|Interim Analysis|Adverse Event|6
7252046|NCT00296504|11463140|FG005|Interim Analysis|Adverse Event|3
7252047|NCT00296504|11463141|FG006|Interim Analysis|Adverse Event|4
7252048|NCT00296504|11463142|FG007|Interim Analysis|Adverse Event|5
7252049|NCT00296504|11463143|FG008|Interim Analysis|Adverse Event|0
7252050|NCT00296504|11463135|FG000|Interim Analysis|Protocol Violation|0
7252051|NCT00296504|11463136|FG001|Interim Analysis|Protocol Violation|0
7252052|NCT00296504|11463137|FG002|Interim Analysis|Protocol Violation|2
7252053|NCT00296504|11463138|FG003|Interim Analysis|Protocol Violation|0
7252054|NCT00296504|11463139|FG004|Interim Analysis|Protocol Violation|1
7252055|NCT00296504|11463140|FG005|Interim Analysis|Protocol Violation|0
7252056|NCT00296504|11463141|FG006|Interim Analysis|Protocol Violation|0
7252057|NCT00296504|11463142|FG007|Interim Analysis|Protocol Violation|1
7252058|NCT00296504|11463143|FG008|Interim Analysis|Protocol Violation|0
7252059|NCT00296504|11463135|FG000|Interim Analysis|Insufficient CD4 Response|0
7252060|NCT00296504|11463136|FG001|Interim Analysis|Insufficient CD4 Response|0
7252061|NCT00296504|11463137|FG002|Interim Analysis|Insufficient CD4 Response|0
7252062|NCT00296504|11463138|FG003|Interim Analysis|Insufficient CD4 Response|0
7252063|NCT00296504|11463139|FG004|Interim Analysis|Insufficient CD4 Response|1
7252064|NCT00296504|11463140|FG005|Interim Analysis|Insufficient CD4 Response|1
7252065|NCT00296504|11463141|FG006|Interim Analysis|Insufficient CD4 Response|0
7252066|NCT00296504|11463142|FG007|Interim Analysis|Insufficient CD4 Response|0
7252067|NCT00296504|11463143|FG008|Interim Analysis|Insufficient CD4 Response|0
7252068|NCT00296504|11463135|FG000|Interim Analysis|Switched to Commercially Available Drug|2
7252069|NCT00296504|11463136|FG001|Interim Analysis|Switched to Commercially Available Drug|0
7252070|NCT00296504|11463137|FG002|Interim Analysis|Switched to Commercially Available Drug|4
7252071|NCT00296504|11463138|FG003|Interim Analysis|Switched to Commercially Available Drug|1
7252072|NCT00296504|11463139|FG004|Interim Analysis|Switched to Commercially Available Drug|0
7252073|NCT00296504|11463140|FG005|Interim Analysis|Switched to Commercially Available Drug|5
7252074|NCT00296504|11463141|FG006|Interim Analysis|Switched to Commercially Available Drug|3
7252075|NCT00296504|11463142|FG007|Interim Analysis|Switched to Commercially Available Drug|4
7252076|NCT00296504|11463143|FG008|Interim Analysis|Switched to Commercially Available Drug|0
7252077|NCT00296504|11463135|FG000|Interim Analysis|Pregnancy|4
7252078|NCT00296504|11463136|FG001|Interim Analysis|Pregnancy|1
7252079|NCT00296504|11463137|FG002|Interim Analysis|Pregnancy|4
7252080|NCT00296504|11463138|FG003|Interim Analysis|Pregnancy|2
7252081|NCT00296504|11463139|FG004|Interim Analysis|Pregnancy|0
7252082|NCT00296504|11463140|FG005|Interim Analysis|Pregnancy|1
7252083|NCT00296504|11463141|FG006|Interim Analysis|Pregnancy|1
7252084|NCT00296504|11463142|FG007|Interim Analysis|Pregnancy|1
7252085|NCT00296504|11463143|FG008|Interim Analysis|Pregnancy|0
7252086|NCT00296504|11463135|FG000|Interim Analysis|Death|1
7252087|NCT00296504|11463136|FG001|Interim Analysis|Death|0
7252088|NCT00296504|11463137|FG002|Interim Analysis|Death|3
7252089|NCT00296504|11463138|FG003|Interim Analysis|Death|0
7252090|NCT00296504|11463139|FG004|Interim Analysis|Death|0
7252091|NCT00296504|11463140|FG005|Interim Analysis|Death|0
7252092|NCT00296504|11463141|FG006|Interim Analysis|Death|0
7252093|NCT00296504|11463142|FG007|Interim Analysis|Death|0
7252094|NCT00296504|11463143|FG008|Interim Analysis|Death|0
7252095|NCT00296504|11463135|FG000|Interim Analysis|Participant Non-compliant|0
7252096|NCT00296504|11463136|FG001|Interim Analysis|Participant Non-compliant|1
7252097|NCT00296504|11463137|FG002|Interim Analysis|Participant Non-compliant|2
7252098|NCT00296504|11463138|FG003|Interim Analysis|Participant Non-compliant|1
7252099|NCT00296504|11463139|FG004|Interim Analysis|Participant Non-compliant|1
7252100|NCT00296504|11463140|FG005|Interim Analysis|Participant Non-compliant|3
7252101|NCT00296504|11463141|FG006|Interim Analysis|Participant Non-compliant|6
7252102|NCT00296504|11463142|FG007|Interim Analysis|Participant Non-compliant|2
7252103|NCT00296504|11463143|FG008|Interim Analysis|Participant Non-compliant|0
7252104|NCT00296504|11463135|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
7252105|NCT00296504|11463136|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
7252106|NCT00296504|11463137|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
7252107|NCT00296504|11463138|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
7252108|NCT00296504|11463139|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
7252109|NCT00296504|11463140|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
7252110|NCT00296504|11463141|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
7252111|NCT00296504|11463142|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
7252112|NCT00296504|11463143|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
7252113|NCT00296504|11463135|FG000|Interim Analysis|To Simplify Treatment|0
7252114|NCT00296504|11463136|FG001|Interim Analysis|To Simplify Treatment|0
7252115|NCT00296504|11463137|FG002|Interim Analysis|To Simplify Treatment|1
7252116|NCT00296504|11463138|FG003|Interim Analysis|To Simplify Treatment|0
7252117|NCT00296504|11463139|FG004|Interim Analysis|To Simplify Treatment|0
7252118|NCT00296504|11463140|FG005|Interim Analysis|To Simplify Treatment|0
7252119|NCT00296504|11463141|FG006|Interim Analysis|To Simplify Treatment|2
7252120|NCT00296504|11463142|FG007|Interim Analysis|To Simplify Treatment|0
7252121|NCT00296504|11463143|FG008|Interim Analysis|To Simplify Treatment|0
7252122|NCT00296504|11463135|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
7252123|NCT00296504|11463136|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
7252124|NCT00296504|11463137|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
7252125|NCT00296504|11463138|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
7252126|NCT00296504|11463139|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
7252127|NCT00296504|11463140|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
7252128|NCT00296504|11463141|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
7252129|NCT00296504|11463142|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
7252130|NCT00296504|11463143|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
7252131|NCT00296504|11463135|FG000|Interim Analysis|Participant Moved|1
7252132|NCT00296504|11463136|FG001|Interim Analysis|Participant Moved|0
7252133|NCT00296504|11463137|FG002|Interim Analysis|Participant Moved|1
7252134|NCT00296504|11463138|FG003|Interim Analysis|Participant Moved|0
7252135|NCT00296504|11463139|FG004|Interim Analysis|Participant Moved|0
7252136|NCT00296504|11463140|FG005|Interim Analysis|Participant Moved|1
7252137|NCT00296504|11463141|FG006|Interim Analysis|Participant Moved|1
7252138|NCT00296504|11463142|FG007|Interim Analysis|Participant Moved|0
7252139|NCT00296504|11463143|FG008|Interim Analysis|Participant Moved|0
7252140|NCT00296504|11463135|FG000|Interim Analysis|Participant Was Incarcerated|2
7252141|NCT00296504|11463136|FG001|Interim Analysis|Participant Was Incarcerated|0
7252142|NCT00296504|11463137|FG002|Interim Analysis|Participant Was Incarcerated|1
7252143|NCT00296504|11463138|FG003|Interim Analysis|Participant Was Incarcerated|0
7252144|NCT00296504|11463139|FG004|Interim Analysis|Participant Was Incarcerated|0
7252145|NCT00296504|11463140|FG005|Interim Analysis|Participant Was Incarcerated|0
7252146|NCT00296504|11463141|FG006|Interim Analysis|Participant Was Incarcerated|0
7252147|NCT00296504|11463142|FG007|Interim Analysis|Participant Was Incarcerated|0
7252148|NCT00296504|11463143|FG008|Interim Analysis|Participant Was Incarcerated|0
7252149|NCT00296504|11463135|FG000|Interim Analysis|Resistance to FPV|0
7252150|NCT00296504|11463136|FG001|Interim Analysis|Resistance to FPV|0
7252151|NCT00296504|11463137|FG002|Interim Analysis|Resistance to FPV|1
7252152|NCT00296504|11463138|FG003|Interim Analysis|Resistance to FPV|0
7252153|NCT00296504|11463139|FG004|Interim Analysis|Resistance to FPV|0
7252154|NCT00296504|11463140|FG005|Interim Analysis|Resistance to FPV|0
7252155|NCT00296504|11463141|FG006|Interim Analysis|Resistance to FPV|0
7252156|NCT00296504|11463142|FG007|Interim Analysis|Resistance to FPV|0
7252157|NCT00296504|11463143|FG008|Interim Analysis|Resistance to FPV|0
7252158|NCT00296504|11463135|FG000|Interim Analysis|Physician Decision|0
7252159|NCT00296504|11463136|FG001|Interim Analysis|Physician Decision|0
7252160|NCT00296504|11463137|FG002|Interim Analysis|Physician Decision|1
7252161|NCT00296504|11463138|FG003|Interim Analysis|Physician Decision|0
7252162|NCT00296504|11463139|FG004|Interim Analysis|Physician Decision|0
7252163|NCT00296504|11463140|FG005|Interim Analysis|Physician Decision|0
7252164|NCT00296504|11463141|FG006|Interim Analysis|Physician Decision|0
7252165|NCT00296504|11463142|FG007|Interim Analysis|Physician Decision|0
7252166|NCT00296504|11463143|FG008|Interim Analysis|Physician Decision|0
7252167|NCT00296504|11463135|FG000|Interim Analysis|Principle Investigator Discretion|2
7252168|NCT00296504|11463136|FG001|Interim Analysis|Principle Investigator Discretion|0
7252169|NCT00296504|11463137|FG002|Interim Analysis|Principle Investigator Discretion|1
7252170|NCT00296504|11463138|FG003|Interim Analysis|Principle Investigator Discretion|1
7252171|NCT00296504|11463139|FG004|Interim Analysis|Principle Investigator Discretion|0
7252172|NCT00296504|11463140|FG005|Interim Analysis|Principle Investigator Discretion|0
7252173|NCT00296504|11463141|FG006|Interim Analysis|Principle Investigator Discretion|0
7252174|NCT00296504|11463142|FG007|Interim Analysis|Principle Investigator Discretion|0
7252175|NCT00296504|11463143|FG008|Interim Analysis|Principle Investigator Discretion|0
7252176|NCT00296504|11463135|FG000|Interim Analysis|Principle Investigator Terminated Study|0
7252177|NCT00296504|11463136|FG001|Interim Analysis|Principle Investigator Terminated Study|0
7252178|NCT00296504|11463137|FG002|Interim Analysis|Principle Investigator Terminated Study|1
7252179|NCT00296504|11463138|FG003|Interim Analysis|Principle Investigator Terminated Study|0
7252180|NCT00296504|11463139|FG004|Interim Analysis|Principle Investigator Terminated Study|0
7252181|NCT00296504|11463140|FG005|Interim Analysis|Principle Investigator Terminated Study|0
7252182|NCT00296504|11463141|FG006|Interim Analysis|Principle Investigator Terminated Study|0
7252183|NCT00296504|11463142|FG007|Interim Analysis|Principle Investigator Terminated Study|0
7252184|NCT00296504|11463143|FG008|Interim Analysis|Principle Investigator Terminated Study|0
7252185|NCT00296504|11463135|FG000|Interim Analysis|Non-adherence|2
7252186|NCT00296504|11463136|FG001|Interim Analysis|Non-adherence|0
7252187|NCT00296504|11463137|FG002|Interim Analysis|Non-adherence|0
7252188|NCT00296504|11463138|FG003|Interim Analysis|Non-adherence|0
7252189|NCT00296504|11463139|FG004|Interim Analysis|Non-adherence|1
7252190|NCT00296504|11463140|FG005|Interim Analysis|Non-adherence|0
7252191|NCT00296504|11463141|FG006|Interim Analysis|Non-adherence|0
7252192|NCT00296504|11463142|FG007|Interim Analysis|Non-adherence|1
7252193|NCT00296504|11463143|FG008|Interim Analysis|Non-adherence|0
7252194|NCT00296504|11463135|FG000|Interim Analysis|Site Closing|1
7252195|NCT00296504|11463136|FG001|Interim Analysis|Site Closing|0
7252196|NCT00296504|11463137|FG002|Interim Analysis|Site Closing|0
7252197|NCT00296504|11463138|FG003|Interim Analysis|Site Closing|0
7252198|NCT00296504|11463139|FG004|Interim Analysis|Site Closing|0
7252199|NCT00296504|11463140|FG005|Interim Analysis|Site Closing|1
7252200|NCT00296504|11463141|FG006|Interim Analysis|Site Closing|2
7252201|NCT00296504|11463142|FG007|Interim Analysis|Site Closing|0
7252202|NCT00296504|11463143|FG008|Interim Analysis|Site Closing|0
7252203|NCT00296504|11463135|FG000|Interim Analysis|Lack of Personnel at Site|1
7252204|NCT00296504|11463136|FG001|Interim Analysis|Lack of Personnel at Site|0
7252205|NCT00296504|11463137|FG002|Interim Analysis|Lack of Personnel at Site|0
7252206|NCT00296504|11463138|FG003|Interim Analysis|Lack of Personnel at Site|0
7252207|NCT00296504|11463139|FG004|Interim Analysis|Lack of Personnel at Site|0
7252208|NCT00296504|11463140|FG005|Interim Analysis|Lack of Personnel at Site|0
7252209|NCT00296504|11463141|FG006|Interim Analysis|Lack of Personnel at Site|0
7252210|NCT00296504|11463142|FG007|Interim Analysis|Lack of Personnel at Site|0
7252211|NCT00296504|11463143|FG008|Interim Analysis|Lack of Personnel at Site|0
7252212|NCT00296504|11463135|FG000|Interim Analysis|Missed Schedule Date|1
7252213|NCT00296504|11463136|FG001|Interim Analysis|Missed Schedule Date|0
7252214|NCT00296504|11463137|FG002|Interim Analysis|Missed Schedule Date|0
7252215|NCT00296504|11463138|FG003|Interim Analysis|Missed Schedule Date|0
7252216|NCT00296504|11463139|FG004|Interim Analysis|Missed Schedule Date|0
7252217|NCT00296504|11463140|FG005|Interim Analysis|Missed Schedule Date|0
7252218|NCT00296504|11463141|FG006|Interim Analysis|Missed Schedule Date|0
7252219|NCT00296504|11463142|FG007|Interim Analysis|Missed Schedule Date|0
7252220|NCT00296504|11463143|FG008|Interim Analysis|Missed Schedule Date|0
7252221|NCT00296504|11463135|FG000|Interim Analysis|Inclusion in Other Protocol|0
7252222|NCT00296504|11463136|FG001|Interim Analysis|Inclusion in Other Protocol|0
7252223|NCT00296504|11463137|FG002|Interim Analysis|Inclusion in Other Protocol|0
7252224|NCT00296504|11463138|FG003|Interim Analysis|Inclusion in Other Protocol|1
7252225|NCT00296504|11463139|FG004|Interim Analysis|Inclusion in Other Protocol|0
7252226|NCT00296504|11463140|FG005|Interim Analysis|Inclusion in Other Protocol|0
7252227|NCT00296504|11463141|FG006|Interim Analysis|Inclusion in Other Protocol|0
7252228|NCT00296504|11463142|FG007|Interim Analysis|Inclusion in Other Protocol|0
7252229|NCT00296504|11463143|FG008|Interim Analysis|Inclusion in Other Protocol|0
7252230|NCT00296504|11463135|FG000|Interim Analysis|Participant Stopped|0
7252231|NCT00296504|11463136|FG001|Interim Analysis|Participant Stopped|0
7252232|NCT00296504|11463137|FG002|Interim Analysis|Participant Stopped|0
7252233|NCT00296504|11463138|FG003|Interim Analysis|Participant Stopped|0
7252234|NCT00296504|11463139|FG004|Interim Analysis|Participant Stopped|1
7252235|NCT00296504|11463140|FG005|Interim Analysis|Participant Stopped|0
7252236|NCT00296504|11463141|FG006|Interim Analysis|Participant Stopped|0
7252237|NCT00296504|11463142|FG007|Interim Analysis|Participant Stopped|0
7252238|NCT00296504|11463143|FG008|Interim Analysis|Participant Stopped|0
7252239|NCT00296504|11463135|FG000|Interim Analysis|Physician and Participant Decision|0
7252240|NCT00296504|11463136|FG001|Interim Analysis|Physician and Participant Decision|0
7252241|NCT00296504|11463137|FG002|Interim Analysis|Physician and Participant Decision|0
7252242|NCT00296504|11463138|FG003|Interim Analysis|Physician and Participant Decision|0
7252243|NCT00296504|11463139|FG004|Interim Analysis|Physician and Participant Decision|0
7252244|NCT00296504|11463140|FG005|Interim Analysis|Physician and Participant Decision|1
7252245|NCT00296504|11463141|FG006|Interim Analysis|Physician and Participant Decision|0
7252246|NCT00296504|11463142|FG007|Interim Analysis|Physician and Participant Decision|0
7252247|NCT00296504|11463143|FG008|Interim Analysis|Physician and Participant Decision|0
7252248|NCT00296504|11463135|FG000|Interim Analysis|Participant Stopped HIV Medications|0
7252249|NCT00296504|11463136|FG001|Interim Analysis|Participant Stopped HIV Medications|0
7252250|NCT00296504|11463137|FG002|Interim Analysis|Participant Stopped HIV Medications|0
7252251|NCT00296504|11463138|FG003|Interim Analysis|Participant Stopped HIV Medications|0
7252252|NCT00296504|11463139|FG004|Interim Analysis|Participant Stopped HIV Medications|0
7252253|NCT00296504|11463140|FG005|Interim Analysis|Participant Stopped HIV Medications|0
7252254|NCT00296504|11463141|FG006|Interim Analysis|Participant Stopped HIV Medications|1
7252255|NCT00296504|11463142|FG007|Interim Analysis|Participant Stopped HIV Medications|0
7252256|NCT00296504|11463143|FG008|Interim Analysis|Participant Stopped HIV Medications|0
7252257|NCT00296504|11463135|FG000|Interim Analysis|Study Ended|0
7252258|NCT00296504|11463136|FG001|Interim Analysis|Study Ended|0
7252259|NCT00296504|11463137|FG002|Interim Analysis|Study Ended|0
7252260|NCT00296504|11463138|FG003|Interim Analysis|Study Ended|0
7252261|NCT00296504|11463139|FG004|Interim Analysis|Study Ended|0
7252262|NCT00296504|11463140|FG005|Interim Analysis|Study Ended|0
7252263|NCT00296504|11463141|FG006|Interim Analysis|Study Ended|1
7252264|NCT00296504|11463142|FG007|Interim Analysis|Study Ended|0
7252265|NCT00296504|11463143|FG008|Interim Analysis|Study Ended|0
7252266|NCT00296504|11463135|FG000|Interim Analysis|Participant Needed Interferon|0
7252267|NCT00296504|11463136|FG001|Interim Analysis|Participant Needed Interferon|0
7252268|NCT00296504|11463137|FG002|Interim Analysis|Participant Needed Interferon|0
7252269|NCT00296504|11463138|FG003|Interim Analysis|Participant Needed Interferon|0
7252270|NCT00296504|11463139|FG004|Interim Analysis|Participant Needed Interferon|0
7252271|NCT00296504|11463140|FG005|Interim Analysis|Participant Needed Interferon|0
7252272|NCT00296504|11463141|FG006|Interim Analysis|Participant Needed Interferon|0
7252273|NCT00296504|11463142|FG007|Interim Analysis|Participant Needed Interferon|1
7252274|NCT00296504|11463143|FG008|Interim Analysis|Participant Needed Interferon|0
7252275|NCT00296504|11463135|FG000|Interim Analysis|Ongoing|32
7252276|NCT00296504|11463136|FG001|Interim Analysis|Ongoing|12
7252277|NCT00296504|11463137|FG002|Interim Analysis|Ongoing|16
7252278|NCT00296504|11463138|FG003|Interim Analysis|Ongoing|22
7252279|NCT00296504|11463139|FG004|Interim Analysis|Ongoing|0
7252280|NCT00296504|11463140|FG005|Interim Analysis|Ongoing|0
7252281|NCT00296504|11463141|FG006|Interim Analysis|Ongoing|30
7252282|NCT00296504|11463142|FG007|Interim Analysis|Ongoing|1
7252283|NCT00296504|11463143|FG008|Interim Analysis|Ongoing|0
7252284|NCT00296504|11463135|FG000|Final Analysis|Withdrawal by Subject|0
7252285|NCT00296504|11463136|FG001|Final Analysis|Withdrawal by Subject|0
7252286|NCT00296504|11463137|FG002|Final Analysis|Withdrawal by Subject|0
7252287|NCT00296504|11463138|FG003|Final Analysis|Withdrawal by Subject|0
7252288|NCT00296504|11463139|FG004|Final Analysis|Withdrawal by Subject|0
7252289|NCT00296504|11463140|FG005|Final Analysis|Withdrawal by Subject|0
7252290|NCT00296504|11463141|FG006|Final Analysis|Withdrawal by Subject|0
7252291|NCT00296504|11463142|FG007|Final Analysis|Withdrawal by Subject|0
7252292|NCT00296504|11463143|FG008|Final Analysis|Withdrawal by Subject|1
7252293|NCT00296504|11463135|FG000|Final Analysis|Lost to Follow-up|0
7252294|NCT00296504|11463136|FG001|Final Analysis|Lost to Follow-up|0
7252295|NCT00296504|11463137|FG002|Final Analysis|Lost to Follow-up|0
7252296|NCT00296504|11463138|FG003|Final Analysis|Lost to Follow-up|0
7252297|NCT00296504|11463139|FG004|Final Analysis|Lost to Follow-up|0
7252298|NCT00296504|11463140|FG005|Final Analysis|Lost to Follow-up|0
7252299|NCT00296504|11463141|FG006|Final Analysis|Lost to Follow-up|0
7252300|NCT00296504|11463142|FG007|Final Analysis|Lost to Follow-up|0
7252301|NCT00296504|11463143|FG008|Final Analysis|Lost to Follow-up|5
7252302|NCT00296504|11463135|FG000|Final Analysis|Insufficient Viral Load Response|0
7252303|NCT00296504|11463136|FG001|Final Analysis|Insufficient Viral Load Response|0
7252304|NCT00296504|11463137|FG002|Final Analysis|Insufficient Viral Load Response|0
7252305|NCT00296504|11463138|FG003|Final Analysis|Insufficient Viral Load Response|0
7252306|NCT00296504|11463139|FG004|Final Analysis|Insufficient Viral Load Response|0
7252307|NCT00296504|11463140|FG005|Final Analysis|Insufficient Viral Load Response|0
7252308|NCT00296504|11463141|FG006|Final Analysis|Insufficient Viral Load Response|0
7252309|NCT00296504|11463142|FG007|Final Analysis|Insufficient Viral Load Response|0
7252310|NCT00296504|11463143|FG008|Final Analysis|Insufficient Viral Load Response|6
7252311|NCT00296504|11463135|FG000|Final Analysis|Adverse Event|0
7252312|NCT00296504|11463136|FG001|Final Analysis|Adverse Event|0
7252313|NCT00296504|11463137|FG002|Final Analysis|Adverse Event|0
7252314|NCT00296504|11463138|FG003|Final Analysis|Adverse Event|0
7252315|NCT00296504|11463139|FG004|Final Analysis|Adverse Event|0
7252316|NCT00296504|11463140|FG005|Final Analysis|Adverse Event|0
7252317|NCT00296504|11463141|FG006|Final Analysis|Adverse Event|0
7252318|NCT00296504|11463142|FG007|Final Analysis|Adverse Event|0
7252319|NCT00296504|11463143|FG008|Final Analysis|Adverse Event|2
7252320|NCT00296504|11463135|FG000|Final Analysis|Pregnancy|0
7252321|NCT00296504|11463136|FG001|Final Analysis|Pregnancy|0
7252322|NCT00296504|11463137|FG002|Final Analysis|Pregnancy|0
7252323|NCT00296504|11463138|FG003|Final Analysis|Pregnancy|0
7252324|NCT00296504|11463139|FG004|Final Analysis|Pregnancy|0
7252325|NCT00296504|11463140|FG005|Final Analysis|Pregnancy|0
7252326|NCT00296504|11463141|FG006|Final Analysis|Pregnancy|0
7252327|NCT00296504|11463142|FG007|Final Analysis|Pregnancy|0
7252328|NCT00296504|11463143|FG008|Final Analysis|Pregnancy|4
7252329|NCT00296504|11463135|FG000|Final Analysis|Tuberculosis|0
7252330|NCT00296504|11463136|FG001|Final Analysis|Tuberculosis|0
7252331|NCT00296504|11463137|FG002|Final Analysis|Tuberculosis|0
7252332|NCT00296504|11463138|FG003|Final Analysis|Tuberculosis|0
7252333|NCT00296504|11463139|FG004|Final Analysis|Tuberculosis|0
7252334|NCT00296504|11463140|FG005|Final Analysis|Tuberculosis|0
7252335|NCT00296504|11463141|FG006|Final Analysis|Tuberculosis|0
7252336|NCT00296504|11463142|FG007|Final Analysis|Tuberculosis|0
7252337|NCT00296504|11463143|FG008|Final Analysis|Tuberculosis|1
7252338|NCT00296504|11463135|FG000|Final Analysis|Participant Moved to Another Country|0
7252339|NCT00296504|11463136|FG001|Final Analysis|Participant Moved to Another Country|0
7252340|NCT00296504|11463137|FG002|Final Analysis|Participant Moved to Another Country|0
7252341|NCT00296504|11463138|FG003|Final Analysis|Participant Moved to Another Country|0
7252342|NCT00296504|11463139|FG004|Final Analysis|Participant Moved to Another Country|0
7252343|NCT00296504|11463140|FG005|Final Analysis|Participant Moved to Another Country|0
7252344|NCT00296504|11463141|FG006|Final Analysis|Participant Moved to Another Country|0
7252345|NCT00296504|11463142|FG007|Final Analysis|Participant Moved to Another Country|0
7252346|NCT00296504|11463143|FG008|Final Analysis|Participant Moved to Another Country|1
7252347|NCT00296504|11463135|FG000|Final Analysis|Poor Adherence|0
7252348|NCT00296504|11463136|FG001|Final Analysis|Poor Adherence|0
7252349|NCT00296504|11463137|FG002|Final Analysis|Poor Adherence|0
7252350|NCT00296504|11463138|FG003|Final Analysis|Poor Adherence|0
7252351|NCT00296504|11463139|FG004|Final Analysis|Poor Adherence|0
7252352|NCT00296504|11463140|FG005|Final Analysis|Poor Adherence|0
7252353|NCT00296504|11463141|FG006|Final Analysis|Poor Adherence|0
7252354|NCT00296504|11463142|FG007|Final Analysis|Poor Adherence|0
7252355|NCT00296504|11463143|FG008|Final Analysis|Poor Adherence|1
7252356|NCT00296517|11463170|FG000|Dose Level 2 - Week 2|Adverse Event|1
7252357|NCT00296517|11463171|FG001|Dose Level 2 - Week 2|Adverse Event|5
7252358|NCT00296517|11463170|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
7252359|NCT00296517|11463171|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
7252360|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
7252361|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
7252362|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
7252363|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
7252364|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
7252365|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
7252366|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
7252367|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
7252368|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
7252369|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
7252370|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
7252371|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
7252372|NCT00296517|11463170|FG000|Dose Level 3 - Weeks 3-12|Other|0
7252373|NCT00296517|11463171|FG001|Dose Level 3 - Weeks 3-12|Other|2
7252374|NCT00296647|11463182|FG000|Overall Study|Death|4
7252375|NCT00296647|11463183|FG001|Overall Study|Death|1
7252376|NCT00296647|11463184|FG002|Overall Study|Death|2
7252377|NCT00296647|11463185|FG003|Overall Study|Death|1
7252378|NCT00296647|11463186|FG004|Overall Study|Death|1
7252379|NCT00296647|11463182|FG000|Overall Study|Withdrawal by Subject|28
7252380|NCT00296647|11463183|FG001|Overall Study|Withdrawal by Subject|27
7252381|NCT00296647|11463184|FG002|Overall Study|Withdrawal by Subject|32
7252382|NCT00296647|11463185|FG003|Overall Study|Withdrawal by Subject|16
7252383|NCT00296647|11463186|FG004|Overall Study|Withdrawal by Subject|19
7252384|NCT00296725|11463198|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
7252385|NCT00296725|11463198|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
7252386|NCT00296725|11463198|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
7252387|NCT00296816|11463206|FG000|Overall Study|Disease Progression|37
7252388|NCT00296816|11463206|FG000|Overall Study|Adverse Event|18
7252389|NCT00296816|11463206|FG000|Overall Study|Investigator/Participant request|5
7252390|NCT00296816|11463206|FG000|Overall Study|Non-compliance|1
7252391|NCT00296816|11463206|FG000|Overall Study|Missing for end of treatment|4
7252392|NCT00296816|11463206|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
7252393|NCT00296816|11463206|FG000|Overall Study|Poor performance status|1
7252394|NCT00296816|11463206|FG000|Overall Study|Relocation to Florida|1
7252395|NCT00296816|11463206|FG000|Overall Study|Noncompliance/decision to discontinue|1
7252396|NCT00296816|11463206|FG000|Overall Study|Urine protein/creatinine ratio delay|1
7252397|NCT00296816|11463206|FG000|Overall Study|Neuropathy/patient preference|1
7252398|NCT00296816|11463206|FG000|Overall Study|Proteinuria|1
7252399|NCT00296816|11463206|FG000|Overall Study|ineligibility due to radiation treatment|1
7252400|NCT00297037|11463212|FG000|Overall Study|Withdrawal by Subject|2
7252401|NCT00297037|11463213|FG001|Overall Study|Withdrawal by Subject|0
7252402|NCT00297167|11463239|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7252403|NCT00297167|11463240|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
7252404|NCT00297167|11463241|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
7252405|NCT00297167|11463239|FG000|Second Double-blind Intervention Period|Protocol Violation|1
7252406|NCT00297167|11463240|FG001|Second Double-blind Intervention Period|Protocol Violation|0
7252407|NCT00297167|11463241|FG002|Second Double-blind Intervention Period|Protocol Violation|0
7252408|NCT00297232|11463248|FG000|Overall Study|Lack of Efficacy|7
7252409|NCT00297232|11463248|FG000|Overall Study|Lost to Follow-up|10
7252410|NCT00297232|11463248|FG000|Overall Study|Adverse Event|63
7252411|NCT00297232|11463248|FG000|Overall Study|Voluntary Withdrawal|120
7252412|NCT00297232|11463248|FG000|Overall Study|Subject was Noncompliant|9
7252413|NCT00297232|11463248|FG000|Overall Study|Death|9
7252414|NCT00297232|11463248|FG000|Overall Study|Anti-natalizumab Positive|8
7252415|NCT00297232|11463248|FG000|Overall Study|Switched to Commercial Tysabri|22
7252416|NCT00297232|11463248|FG000|Overall Study|Disease Progression|8
7252417|NCT00297232|11463248|FG000|Overall Study|Fear of PML|10
7252418|NCT00297232|11463248|FG000|Overall Study|Anti-JCV Antibody Positive|13
7252419|NCT00297232|11463248|FG000|Overall Study|Miscellaneous|5
7252420|NCT00297232|11463248|FG000|Overall Study|Sponsor Decision|34
7252421|NCT00297232|11463248|FG000|Overall Study|Subject Relocated|7
7252422|NCT00297232|11463248|FG000|Overall Study|Subject Withdrew Consent|37
7252423|NCT00297232|11463248|FG000|Overall Study|Persistently Positive Antibodies|11
7252424|NCT00297232|11463248|FG000|Overall Study|Investigator Withdrew From Program|19
7252425|NCT00297232|11463248|FG000|Overall Study|Did Not Enroll to Week 264|34
7252426|NCT00297232|11463248|FG000|Overall Study|Did Not Enroll to Week 480|17
7252427|NCT00297232|11463248|FG000|Overall Study|No data available after Week 264|161
7252428|NCT00297232|11463248|FG000|Overall Study|Other|1
7252429|NCT00297258|11463252|FG000|Overall Study|Disease Progression, Relapse, Death|120
7252430|NCT00297258|11463252|FG000|Overall Study|Toxicity (or Toxic Death)|10
7574420|NCT03677401|11957172|FG001|Overall Study|Adverse Event|14
7574421|NCT03677401|11957171|FG000|Overall Study|Lack of Efficacy|3
7574422|NCT03677401|11957172|FG001|Overall Study|Lack of Efficacy|1
7252431|NCT00297258|11463252|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
7252432|NCT00297258|11463252|FG000|Overall Study|Intercurrent Illness|3
7252433|NCT00297258|11463252|FG000|Overall Study|Intercurrent Death|2
7252434|NCT00297258|11463252|FG000|Overall Study|Deteriorization of General Condition|1
7252435|NCT00297258|11463252|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
7252436|NCT00297258|11463252|FG000|Overall Study|Surgery Performed on Target Lesion|1
7252437|NCT00297258|11463252|FG000|Overall Study|Switch to Commercial Treatment|1
7252438|NCT00297258|11463252|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
7252439|NCT00297427|11463261|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
7252440|NCT00297427|11463262|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
7252441|NCT00297427|11463261|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
7252442|NCT00297427|11463262|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
7252443|NCT00297427|11463261|FG000|Phase 1: Initial Intervention|Death|0
7252444|NCT00297427|11463262|FG001|Phase 1: Initial Intervention|Death|1
7252445|NCT00297427|11463261|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
7252446|NCT00297427|11463262|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
7252447|NCT00297427|11463261|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
7252448|NCT00297427|11463262|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
7252613|NCT00299104|11463470|FG001|Safety Follow-Up (SFU) Period|Death|2
7252449|NCT00297427|11463261|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
7252450|NCT00297427|11463262|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
7252451|NCT00297427|11463261|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
7252452|NCT00297427|11463262|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
7252453|NCT00297427|11463261|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
7252454|NCT00297427|11463262|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
7252455|NCT00297479|11463279|FG000|Overall Study|Lost to Follow-up|37
7252456|NCT00297479|11463280|FG001|Overall Study|Lost to Follow-up|54
7574423|NCT03677401|11957171|FG000|Overall Study|Withdrawal by Subject|2
7252457|NCT00297479|11463281|FG002|Overall Study|Lost to Follow-up|51
7252458|NCT00297492|11463292|FG000|Set Quit Date|Lost to Follow-up|7
7252459|NCT00297492|11463293|FG001|Set Quit Date|Lost to Follow-up|13
7252460|NCT00297492|11463294|FG002|Set Quit Date|Lost to Follow-up|5
7252461|NCT00297492|11463292|FG000|6 Month Follow-up|Lost to Follow-up|63
7252462|NCT00297492|11463293|FG001|6 Month Follow-up|Lost to Follow-up|49
7252463|NCT00297492|11463294|FG002|6 Month Follow-up|Lost to Follow-up|27
7252464|NCT00297648|11463306|FG000|Overall Study|Adverse Event|13
7252465|NCT00297648|11463306|FG000|Overall Study|Lack of Efficacy|18
7252466|NCT00297648|11463306|FG000|Overall Study|Lost to Follow-up|1
7252467|NCT00297648|11463306|FG000|Overall Study|Withdrawal by Subject|3
7252468|NCT00297648|11463306|FG000|Overall Study|Other: Incompliance|1
7252469|NCT00297778|11463312|FG000|Overall Study|Adverse Event|16
7252470|NCT00297778|11463313|FG001|Overall Study|Adverse Event|10
7252471|NCT00297778|11463312|FG000|Overall Study|Withdrawal by Subject|1
7252472|NCT00297778|11463313|FG001|Overall Study|Withdrawal by Subject|5
7252473|NCT00297778|11463312|FG000|Overall Study|Lack of Efficacy|2
7252474|NCT00297778|11463313|FG001|Overall Study|Lack of Efficacy|1
7252475|NCT00297778|11463312|FG000|Overall Study|Non-compliant with trial protocol|0
7252476|NCT00297778|11463313|FG001|Overall Study|Non-compliant with trial protocol|3
7252477|NCT00297778|11463312|FG000|Overall Study|Other|0
7252478|NCT00297778|11463313|FG001|Overall Study|Other|1
7252479|NCT00297830|11463322|FG000|6 Month Visit|Death|1
7252480|NCT00297830|11463323|FG001|6 Month Visit|Death|0
7252481|NCT00297830|11463324|FG002|6 Month Visit|Death|2
7252482|NCT00297830|11463322|FG000|6 Month Visit|Withdrawal by Subject|2
7252483|NCT00297830|11463323|FG001|6 Month Visit|Withdrawal by Subject|1
7252484|NCT00297830|11463324|FG002|6 Month Visit|Withdrawal by Subject|1
7252485|NCT00297830|11463322|FG000|6 Month Visit|Adverse Event|0
7252486|NCT00297830|11463323|FG001|6 Month Visit|Adverse Event|1
7252487|NCT00297830|11463324|FG002|6 Month Visit|Adverse Event|0
7252488|NCT00297830|11463322|FG000|12 Month Visit|Lost to Follow-up|1
7252489|NCT00297830|11463323|FG001|12 Month Visit|Lost to Follow-up|0
7252490|NCT00297830|11463324|FG002|12 Month Visit|Lost to Follow-up|0
7252491|NCT00297830|11463322|FG000|12 Month Visit|Adverse Event|0
7252492|NCT00297830|11463323|FG001|12 Month Visit|Adverse Event|3
7252493|NCT00297830|11463324|FG002|12 Month Visit|Adverse Event|0
7252494|NCT00297830|11463322|FG000|12 Month Visit|Withdrawal by Subject|0
7252495|NCT00297830|11463323|FG001|12 Month Visit|Withdrawal by Subject|3
7252496|NCT00297830|11463324|FG002|12 Month Visit|Withdrawal by Subject|0
7252497|NCT00297882|11463334|FG000|Day 14|Lack of Efficacy|12
7252498|NCT00297882|11463335|FG001|Day 14|Lack of Efficacy|49
7252499|NCT00297882|11463334|FG000|Day 28|Lost to Follow-up|13
7252500|NCT00297882|11463335|FG001|Day 28|Lost to Follow-up|23
7252501|NCT00297882|11463334|FG000|Day 28|Lack of Efficacy|3
7252502|NCT00297882|11463335|FG001|Day 28|Lack of Efficacy|0
7252503|NCT00298038|11463345|FG000|Overall Study|Lost to Follow-up|0
7252504|NCT00298038|11463346|FG001|Overall Study|Lost to Follow-up|1
7252505|NCT00298038|11463345|FG000|Overall Study|Liver Transplant|0
7252506|NCT00298038|11463346|FG001|Overall Study|Liver Transplant|1
7252507|NCT00298038|11463345|FG000|Overall Study|Protocol Violation|1
7252508|NCT00298038|11463346|FG001|Overall Study|Protocol Violation|3
7252509|NCT00298038|11463345|FG000|Overall Study|Death|6
7252510|NCT00298038|11463346|FG001|Overall Study|Death|3
7252511|NCT00298038|11463345|FG000|Overall Study|Withdrawal by Subject|6
7252512|NCT00298038|11463346|FG001|Overall Study|Withdrawal by Subject|9
7252513|NCT00298038|11463345|FG000|Overall Study|Adverse Event|8
7252514|NCT00298038|11463346|FG001|Overall Study|Adverse Event|7
7252515|NCT00298038|11463345|FG000|Overall Study|Breakthrough overt HE episode|28
7252516|NCT00298038|11463346|FG001|Overall Study|Breakthrough overt HE episode|69
7252517|NCT00298038|11463345|FG000|Overall Study|Noncompliance|1
7252518|NCT00298038|11463346|FG001|Overall Study|Noncompliance|0
7252519|NCT00298038|11463345|FG000|Overall Study|Cocaine Abuse|1
7252520|NCT00298038|11463346|FG001|Overall Study|Cocaine Abuse|0
7252521|NCT00298038|11463345|FG000|Overall Study|Severe Gastrointestinal Bleed|1
7252522|NCT00298038|11463346|FG001|Overall Study|Severe Gastrointestinal Bleed|0
7252523|NCT00298272|11463382|FG000|Double-blind Phase|Adverse Event|2
7252524|NCT00298272|11463383|FG001|Double-blind Phase|Adverse Event|0
7252525|NCT00298272|11463382|FG000|Double-blind Phase|Failure to Return|2
7252526|NCT00298272|11463383|FG001|Double-blind Phase|Failure to Return|0
7252527|NCT00298272|11463382|FG000|Double-blind Phase|Protocol Violation|2
7252528|NCT00298272|11463383|FG001|Double-blind Phase|Protocol Violation|0
7252529|NCT00298272|11463382|FG000|Double-blind Phase|Withdrawal by Subject|2
7252530|NCT00298272|11463383|FG001|Double-blind Phase|Withdrawal by Subject|0
7252531|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Adverse Event|1
7252532|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Adverse Event|2
7252533|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
7252534|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
7252535|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Failure to Return|1
7252536|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Failure to Return|0
7252537|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Protocol Violation|2
7252538|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Protocol Violation|1
7252539|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
7252540|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
7252541|NCT00298272|11463382|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
7252542|NCT00298272|11463383|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
7252543|NCT00298272|11463382|FG000|Safety Follow-up Phase|Failure to Return|1
7252544|NCT00298272|11463383|FG001|Safety Follow-up Phase|Failure to Return|1
7252545|NCT00298272|11463382|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
7252546|NCT00298272|11463383|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
7252547|NCT00298272|11463382|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
7252548|NCT00298272|11463383|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
7252549|NCT00298363|11463395|FG000|Overall Study|Lost to Follow-up|0
7252550|NCT00298363|11463396|FG001|Overall Study|Lost to Follow-up|0
7252551|NCT00298363|11463397|FG002|Overall Study|Lost to Follow-up|1
7252552|NCT00298363|11463395|FG000|Overall Study|Physician Decision|4
7252553|NCT00298363|11463396|FG001|Overall Study|Physician Decision|1
7252554|NCT00298363|11463397|FG002|Overall Study|Physician Decision|0
7252555|NCT00298363|11463395|FG000|Overall Study|Protocol Violation|1
7252556|NCT00298363|11463396|FG001|Overall Study|Protocol Violation|1
7252557|NCT00298363|11463397|FG002|Overall Study|Protocol Violation|0
7252558|NCT00298363|11463395|FG000|Overall Study|Withdrawal by Subject|5
7252559|NCT00298363|11463396|FG001|Overall Study|Withdrawal by Subject|1
7252560|NCT00298363|11463397|FG002|Overall Study|Withdrawal by Subject|3
7252561|NCT00298363|11463395|FG000|Overall Study|Adverse Event|5
7252562|NCT00298363|11463396|FG001|Overall Study|Adverse Event|2
7252563|NCT00298363|11463397|FG002|Overall Study|Adverse Event|2
7252564|NCT00298363|11463395|FG000|Overall Study|Lack of Efficacy|2
7252565|NCT00298363|11463396|FG001|Overall Study|Lack of Efficacy|3
7252566|NCT00298363|11463397|FG002|Overall Study|Lack of Efficacy|0
7252567|NCT00298766|11463445|FG000|Overall Study|Adverse Event|18
7252568|NCT00298766|11463445|FG000|Overall Study|Death|2
7252569|NCT00298766|11463445|FG000|Overall Study|Withdrawal by Subject|9
7252570|NCT00298766|11463445|FG000|Overall Study|Treatment ongoing|4
7252571|NCT00298766|11463445|FG000|Overall Study|Progression of amyloid markers|4
7252572|NCT00298766|11463445|FG000|Overall Study|Deterioration in KPS and organ function|1
7252573|NCT00298766|11463445|FG000|Overall Study|Subjects overall condition deterioration|4
7252574|NCT00298766|11463445|FG000|Overall Study|Other|4
7252575|NCT00298831|11463449|FG000|Overall Study|Adverse Event|1
7252576|NCT00298831|11463449|FG000|Overall Study|Lost to Follow-up|3
7252577|NCT00298831|11463449|FG000|Overall Study|Withdrawal by Subject|1
7252578|NCT00298831|11463449|FG000|Overall Study|Participants did not receive treatment|27
7252579|NCT00298896|11463453|FG000|Overall Study|Death|3
7252580|NCT00298896|11463453|FG000|Overall Study|Physician Decision|2
7252581|NCT00298896|11463453|FG000|Overall Study|Intercurrent Illness|1
7252582|NCT00298896|11463453|FG000|Overall Study|Disease Progression|41
7252583|NCT00298896|11463453|FG000|Overall Study|Withdrawal by Subject|2
7252584|NCT00298896|11463453|FG000|Overall Study|Assigned to treatment in error|1
7252585|NCT00299104|11463469|FG000|Treatment Period|Adverse Event|14
7252586|NCT00299104|11463470|FG001|Treatment Period|Adverse Event|9
7252587|NCT00299104|11463471|FG002|Treatment Period|Adverse Event|7
7252588|NCT00299104|11463469|FG000|Treatment Period|Death|1
7252589|NCT00299104|11463470|FG001|Treatment Period|Death|1
7252590|NCT00299104|11463471|FG002|Treatment Period|Death|1
7252591|NCT00299104|11463469|FG000|Treatment Period|Insufficient therapeutic response|34
7252592|NCT00299104|11463470|FG001|Treatment Period|Insufficient therapeutic response|13
7252593|NCT00299104|11463471|FG002|Treatment Period|Insufficient therapeutic response|8
7252594|NCT00299104|11463469|FG000|Treatment Period|Failure to return|9
7252595|NCT00299104|11463470|FG001|Treatment Period|Failure to return|8
7252596|NCT00299104|11463471|FG002|Treatment Period|Failure to return|8
7252597|NCT00299104|11463469|FG000|Treatment Period|Violation of selection criteria|1
7252598|NCT00299104|11463470|FG001|Treatment Period|Violation of selection criteria|2
7252599|NCT00299104|11463471|FG002|Treatment Period|Violation of selection criteria|0
7252600|NCT00299104|11463469|FG000|Treatment Period|Protocol Violation|1
7252601|NCT00299104|11463470|FG001|Treatment Period|Protocol Violation|1
7252602|NCT00299104|11463471|FG002|Treatment Period|Protocol Violation|0
7252603|NCT00299104|11463469|FG000|Treatment Period|Refused treatment|9
7252604|NCT00299104|11463470|FG001|Treatment Period|Refused treatment|2
7252605|NCT00299104|11463471|FG002|Treatment Period|Refused treatment|2
7252606|NCT00299104|11463469|FG000|Treatment Period|Withdrew consent|14
7252607|NCT00299104|11463470|FG001|Treatment Period|Withdrew consent|19
7252608|NCT00299104|11463471|FG002|Treatment Period|Withdrew consent|9
7252609|NCT00299104|11463469|FG000|Treatment Period|Administrative reasons|106
7252610|NCT00299104|11463470|FG001|Treatment Period|Administrative reasons|120
7252611|NCT00299104|11463471|FG002|Treatment Period|Administrative reasons|137
7252612|NCT00299104|11463469|FG000|Safety Follow-Up (SFU) Period|Death|3
7252614|NCT00299104|11463471|FG002|Safety Follow-Up (SFU) Period|Death|1
7252615|NCT00299104|11463469|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
7252616|NCT00299104|11463470|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
7252617|NCT00299104|11463471|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
7252618|NCT00299104|11463469|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
7252619|NCT00299104|11463470|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
7252620|NCT00299104|11463471|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
7252621|NCT00299104|11463469|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
7252622|NCT00299104|11463470|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
7252623|NCT00299104|11463471|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
7252624|NCT00299104|11463469|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
7252625|NCT00299104|11463470|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
7252626|NCT00299104|11463471|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
7252627|NCT00299104|11463469|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7252628|NCT00299104|11463470|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7252629|NCT00299104|11463471|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
7252630|NCT00299104|11463469|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
7252631|NCT00299104|11463470|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
7252632|NCT00299104|11463471|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
7252633|NCT00299104|11463469|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
7252634|NCT00299104|11463470|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7252635|NCT00299104|11463471|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
7252636|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
7252637|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
7252638|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
7252639|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Death|1
7252640|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Death|3
7252641|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Death|1
7252642|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
7252643|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7252644|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
7252645|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
7252646|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
7252647|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
7252648|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
7252649|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
7252650|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
7252651|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
7252652|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
7252653|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
7252654|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
7252655|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
7252656|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
7252657|NCT00299130|11463482|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
7252658|NCT00299130|11463483|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7252659|NCT00299130|11463484|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
7252660|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7252661|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
7252662|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
7252663|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
7252664|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
7252665|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
7252666|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7252667|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
7252668|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
7252669|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
7252670|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
7252671|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
7252672|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7252673|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
7252674|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
7252675|NCT00299130|11463482|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7252676|NCT00299130|11463483|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
7252677|NCT00299130|11463484|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
7252678|NCT00299130|11463482|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7252679|NCT00299130|11463483|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
7252680|NCT00299130|11463484|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
7252681|NCT00299130|11463482|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
7252682|NCT00299130|11463483|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7252683|NCT00299130|11463484|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
7252684|NCT00299130|11463482|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
7252685|NCT00299130|11463483|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
7252686|NCT00299130|11463484|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
7252687|NCT00299156|11463502|FG000|Period 2 (Randomized)|Screen Failure|0
7252688|NCT00299156|11463503|FG001|Period 2 (Randomized)|Screen Failure|1
7252689|NCT00299156|11463504|FG002|Period 2 (Randomized)|Screen Failure|0
7252690|NCT00299182|11463519|FG000|Overall Study|Withdrawal by Subject|0
7252691|NCT00299182|11463520|FG001|Overall Study|Withdrawal by Subject|0
7252692|NCT00299182|11463521|FG002|Overall Study|Withdrawal by Subject|1
7252693|NCT00299182|11463522|FG003|Overall Study|Withdrawal by Subject|0
7252694|NCT00299182|11463523|FG004|Overall Study|Withdrawal by Subject|1
7252695|NCT00299182|11463524|FG005|Overall Study|Withdrawal by Subject|2
7252696|NCT00299182|11463525|FG006|Overall Study|Withdrawal by Subject|0
7252697|NCT00299182|11463519|FG000|Overall Study|Chemotherapy Changed|0
7252698|NCT00299182|11463520|FG001|Overall Study|Chemotherapy Changed|0
7252699|NCT00299182|11463521|FG002|Overall Study|Chemotherapy Changed|1
7252700|NCT00299182|11463522|FG003|Overall Study|Chemotherapy Changed|0
7252701|NCT00299182|11463523|FG004|Overall Study|Chemotherapy Changed|1
7252702|NCT00299182|11463524|FG005|Overall Study|Chemotherapy Changed|0
7252703|NCT00299182|11463525|FG006|Overall Study|Chemotherapy Changed|1
7252704|NCT00299182|11463519|FG000|Overall Study|Adverse Event|0
7252705|NCT00299182|11463520|FG001|Overall Study|Adverse Event|0
7252706|NCT00299182|11463521|FG002|Overall Study|Adverse Event|0
7252707|NCT00299182|11463522|FG003|Overall Study|Adverse Event|0
7252708|NCT00299182|11463523|FG004|Overall Study|Adverse Event|0
7252709|NCT00299182|11463524|FG005|Overall Study|Adverse Event|1
7252710|NCT00299182|11463525|FG006|Overall Study|Adverse Event|0
7252711|NCT00299182|11463519|FG000|Overall Study|Not Eligible|0
7252712|NCT00299182|11463520|FG001|Overall Study|Not Eligible|0
7252713|NCT00299182|11463521|FG002|Overall Study|Not Eligible|0
7252714|NCT00299182|11463522|FG003|Overall Study|Not Eligible|0
7252715|NCT00299182|11463523|FG004|Overall Study|Not Eligible|1
7252716|NCT00299182|11463524|FG005|Overall Study|Not Eligible|0
7252717|NCT00299182|11463525|FG006|Overall Study|Not Eligible|0
7252718|NCT00299494|11463562|FG000|Overall Study|Withdrawal by Subject|0
7252719|NCT00299494|11463563|FG001|Overall Study|Withdrawal by Subject|0
7252720|NCT00299494|11463564|FG002|Overall Study|Withdrawal by Subject|0
7252721|NCT00299494|11463565|FG003|Overall Study|Withdrawal by Subject|3
7252722|NCT00299494|11463566|FG004|Overall Study|Withdrawal by Subject|1
7252723|NCT00299494|11463567|FG005|Overall Study|Withdrawal by Subject|4
7252724|NCT00299494|11463562|FG000|Overall Study|Physician Decision|0
7252725|NCT00299494|11463563|FG001|Overall Study|Physician Decision|0
7252726|NCT00299494|11463564|FG002|Overall Study|Physician Decision|0
7252727|NCT00299494|11463565|FG003|Overall Study|Physician Decision|0
7252728|NCT00299494|11463566|FG004|Overall Study|Physician Decision|1
7252729|NCT00299494|11463567|FG005|Overall Study|Physician Decision|0
7252730|NCT00299494|11463562|FG000|Overall Study|Death|3
7252731|NCT00299494|11463563|FG001|Overall Study|Death|1
7252732|NCT00299494|11463564|FG002|Overall Study|Death|4
7252733|NCT00299494|11463565|FG003|Overall Study|Death|6
7252734|NCT00299494|11463566|FG004|Overall Study|Death|18
7252735|NCT00299494|11463567|FG005|Overall Study|Death|19
7252736|NCT00299494|11463562|FG000|Overall Study|Lost to Follow-up|0
7252737|NCT00299494|11463563|FG001|Overall Study|Lost to Follow-up|0
7252738|NCT00299494|11463564|FG002|Overall Study|Lost to Follow-up|0
7252739|NCT00299494|11463565|FG003|Overall Study|Lost to Follow-up|0
7252740|NCT00299494|11463566|FG004|Overall Study|Lost to Follow-up|3
7252741|NCT00299494|11463567|FG005|Overall Study|Lost to Follow-up|1
7252742|NCT00299494|11463562|FG000|Overall Study|Other - Unspecified|0
7252743|NCT00299494|11463563|FG001|Overall Study|Other - Unspecified|0
7252744|NCT00299494|11463564|FG002|Overall Study|Other - Unspecified|0
7252745|NCT00299494|11463565|FG003|Overall Study|Other - Unspecified|0
7252746|NCT00299494|11463566|FG004|Overall Study|Other - Unspecified|3
7252747|NCT00299494|11463567|FG005|Overall Study|Other - Unspecified|1
7252748|NCT00299494|11463562|FG000|Overall Study|Other - site closure|0
7252749|NCT00299494|11463563|FG001|Overall Study|Other - site closure|0
7252750|NCT00299494|11463564|FG002|Overall Study|Other - site closure|0
7252751|NCT00299494|11463565|FG003|Overall Study|Other - site closure|1
7252752|NCT00299494|11463566|FG004|Overall Study|Other - site closure|1
7252753|NCT00299494|11463567|FG005|Overall Study|Other - site closure|1
7252754|NCT00299546|11463595|FG000|Overall Study|Death|3
7252755|NCT00299546|11463596|FG001|Overall Study|Death|2
7252756|NCT00299546|11463597|FG002|Overall Study|Death|0
7252757|NCT00299546|11463595|FG000|Overall Study|Lost to Follow-up|2
7252758|NCT00299546|11463596|FG001|Overall Study|Lost to Follow-up|2
7252759|NCT00299546|11463597|FG002|Overall Study|Lost to Follow-up|5
7252760|NCT00299546|11463595|FG000|Overall Study|Adverse Event|37
7252761|NCT00299546|11463596|FG001|Overall Study|Adverse Event|22
7252762|NCT00299546|11463597|FG002|Overall Study|Adverse Event|27
7252763|NCT00299546|11463595|FG000|Overall Study|Unsatisfactory therapeutic effect|34
7252764|NCT00299546|11463596|FG001|Overall Study|Unsatisfactory therapeutic effect|39
7252765|NCT00299546|11463597|FG002|Overall Study|Unsatisfactory therapeutic effect|34
7252766|NCT00299546|11463595|FG000|Overall Study|Other|24
7252767|NCT00299546|11463596|FG001|Overall Study|Other|26
7252768|NCT00299546|11463597|FG002|Overall Study|Other|19
7252769|NCT00299546|11463595|FG000|Overall Study|Not treated|0
7252770|NCT00299546|11463596|FG001|Overall Study|Not treated|1
7252771|NCT00299546|11463597|FG002|Overall Study|Not treated|1
7252772|NCT00299702|11463612|FG000|Overall Study|Death|1
7252773|NCT00299702|11463613|FG001|Overall Study|Death|0
7252774|NCT00299702|11463612|FG000|Overall Study|Adverse Event|0
7252775|NCT00299702|11463613|FG001|Overall Study|Adverse Event|4
7252776|NCT00299702|11463612|FG000|Overall Study|Lost to Follow-up|18
7252777|NCT00299702|11463613|FG001|Overall Study|Lost to Follow-up|10
7252778|NCT00299702|11463612|FG000|Overall Study|Withdrawal by Subject|25
7252779|NCT00299702|11463613|FG001|Overall Study|Withdrawal by Subject|23
7252780|NCT00299702|11463612|FG000|Overall Study|Pregnancy|0
7252781|NCT00299702|11463613|FG001|Overall Study|Pregnancy|1
7252782|NCT00299702|11463612|FG000|Overall Study|Insufficient Response|4
7252783|NCT00299702|11463613|FG001|Overall Study|Insufficient Response|3
7252784|NCT00299702|11463612|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
7252785|NCT00299702|11463613|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
7252786|NCT00299975|11463626|FG000|Overall Study|Adverse Event|1
7252787|NCT00299975|11463627|FG001|Overall Study|Adverse Event|0
7252788|NCT00299975|11463628|FG002|Overall Study|Adverse Event|2
7252789|NCT00299975|11463626|FG000|Overall Study|Pregnancy|0
7252790|NCT00299975|11463627|FG001|Overall Study|Pregnancy|0
7252791|NCT00299975|11463628|FG002|Overall Study|Pregnancy|1
7252792|NCT00299975|11463626|FG000|Overall Study|Lack of Efficacy|1
7252793|NCT00299975|11463627|FG001|Overall Study|Lack of Efficacy|0
7252794|NCT00299975|11463628|FG002|Overall Study|Lack of Efficacy|1
7252795|NCT00299975|11463626|FG000|Overall Study|Lost to Follow-up|1
7252796|NCT00299975|11463627|FG001|Overall Study|Lost to Follow-up|0
7252797|NCT00299975|11463628|FG002|Overall Study|Lost to Follow-up|0
7252798|NCT00299975|11463626|FG000|Overall Study|Withdrawal by Subject|0
7252799|NCT00299975|11463627|FG001|Overall Study|Withdrawal by Subject|1
7252800|NCT00299975|11463628|FG002|Overall Study|Withdrawal by Subject|3
7252801|NCT00299975|11463626|FG000|Overall Study|Physician Decision|0
7252802|NCT00299975|11463627|FG001|Overall Study|Physician Decision|0
7252803|NCT00299975|11463628|FG002|Overall Study|Physician Decision|1
7252804|NCT00300053|11463649|FG000|Overall Study|Patient/Caregiver Preference|2
7252805|NCT00300053|11463650|FG001|Overall Study|Patient/Caregiver Preference|2
7252806|NCT00300053|11463651|FG002|Overall Study|Patient/Caregiver Preference|3
7252807|NCT00300053|11463649|FG000|Overall Study|Death|0
7252808|NCT00300053|11463650|FG001|Overall Study|Death|0
7252809|NCT00300053|11463651|FG002|Overall Study|Death|3
7252810|NCT00300053|11463649|FG000|Overall Study|Lost to Follow-up|0
7252811|NCT00300053|11463650|FG001|Overall Study|Lost to Follow-up|1
7252812|NCT00300053|11463651|FG002|Overall Study|Lost to Follow-up|0
7252813|NCT00300274|11463684|FG000|Overall Study|Withdrawal by Subject|12
7252814|NCT00300274|11463685|FG001|Overall Study|Withdrawal by Subject|3
7252815|NCT00300274|11463686|FG002|Overall Study|Withdrawal by Subject|14
7252816|NCT00300274|11463684|FG000|Overall Study|Lost to Follow-up|3
7252817|NCT00300274|11463685|FG001|Overall Study|Lost to Follow-up|4
7252818|NCT00300274|11463686|FG002|Overall Study|Lost to Follow-up|5
7252819|NCT00300274|11463684|FG000|Overall Study|Death|31
7252820|NCT00300274|11463685|FG001|Overall Study|Death|20
7252821|NCT00300274|11463686|FG002|Overall Study|Death|25
7252822|NCT00300274|11463684|FG000|Overall Study|Re-transplant|0
7252823|NCT00300274|11463685|FG001|Overall Study|Re-transplant|0
7252824|NCT00300274|11463686|FG002|Overall Study|Re-transplant|1
7252825|NCT00300365|11463696|FG000|Overall Study|Lost to Follow-up|1
7252826|NCT00300365|11463697|FG001|Overall Study|Lost to Follow-up|0
7252827|NCT00300365|11463696|FG000|Overall Study|Physician Decision|2
7252828|NCT00300365|11463697|FG001|Overall Study|Physician Decision|0
7252829|NCT00300365|11463696|FG000|Overall Study|Withdrawal by Subject|1
7252830|NCT00300365|11463697|FG001|Overall Study|Withdrawal by Subject|0
7252831|NCT00300365|11463696|FG000|Overall Study|Adverse Event|0
7252832|NCT00300365|11463697|FG001|Overall Study|Adverse Event|2
7252833|NCT00300495|11463803|FG000|Overall Study|Protocol Violation|4
7252834|NCT00300495|11463804|FG001|Overall Study|Protocol Violation|1
7252835|NCT00300755|11463822|FG000|Overall Study|Adverse Event|1
7252836|NCT00300755|11463823|FG001|Overall Study|Adverse Event|2
7252837|NCT00300755|11463824|FG002|Overall Study|Adverse Event|1
7252838|NCT00300755|11463822|FG000|Overall Study|Withdrawal by Subject|0
7252839|NCT00300755|11463823|FG001|Overall Study|Withdrawal by Subject|2
7252840|NCT00300755|11463824|FG002|Overall Study|Withdrawal by Subject|0
7252841|NCT00300755|11463822|FG000|Overall Study|Protocol Violation|0
7252842|NCT00300755|11463823|FG001|Overall Study|Protocol Violation|0
7252843|NCT00300755|11463824|FG002|Overall Study|Protocol Violation|1
7252844|NCT00300781|11463834|FG000|Overall Study|Disease Progression|55
7252845|NCT00300781|11463835|FG001|Overall Study|Disease Progression|52
7252846|NCT00300781|11463834|FG000|Overall Study|Adverse Event|5
7252847|NCT00300781|11463835|FG001|Overall Study|Adverse Event|6
7252848|NCT00300781|11463834|FG000|Overall Study|Withdrawal by Subject|1
7252849|NCT00300781|11463835|FG001|Overall Study|Withdrawal by Subject|2
7252850|NCT00300781|11463834|FG000|Overall Study|Physician Decision|1
7252851|NCT00300781|11463835|FG001|Overall Study|Physician Decision|0
7252852|NCT00300781|11463834|FG000|Overall Study|Not Recorded|0
7252853|NCT00300781|11463835|FG001|Overall Study|Not Recorded|1
7252854|NCT00300781|11463834|FG000|Overall Study|Symptomatic Deterioration|1
7252855|NCT00300781|11463835|FG001|Overall Study|Symptomatic Deterioration|0
7252856|NCT00300781|11463834|FG000|Overall Study|Lost to Follow-up|0
7252857|NCT00300781|11463835|FG001|Overall Study|Lost to Follow-up|1
7252858|NCT00300885|11463843|FG000|Treatment|Adverse Event|134
7252859|NCT00300885|11463844|FG001|Treatment|Adverse Event|82
7252860|NCT00300885|11463843|FG000|Treatment|Death|20
7252861|NCT00300885|11463844|FG001|Treatment|Death|7
7252862|NCT00300885|11463843|FG000|Treatment|Lack of Efficacy|1
7252863|NCT00300885|11463844|FG001|Treatment|Lack of Efficacy|1
7252864|NCT00300885|11463843|FG000|Treatment|Lost to Follow-up|3
7252865|NCT00300885|11463844|FG001|Treatment|Lost to Follow-up|2
7252866|NCT00300885|11463843|FG000|Treatment|Physician Decision|4
7252867|NCT00300885|11463844|FG001|Treatment|Physician Decision|5
7252868|NCT00300885|11463843|FG000|Treatment|Protocol Violation|11
7252869|NCT00300885|11463844|FG001|Treatment|Protocol Violation|11
7252870|NCT00300885|11463843|FG000|Treatment|Withdrawal by Subject|26
7252871|NCT00300885|11463844|FG001|Treatment|Withdrawal by Subject|23
7252872|NCT00300885|11463843|FG000|Treatment|Disease progression|171
7252873|NCT00300885|11463844|FG001|Treatment|Disease progression|238
7252874|NCT00300885|11463843|FG000|Treatment|Random code broken (subject died)|0
7252875|NCT00300885|11463844|FG001|Treatment|Random code broken (subject died)|1
7252876|NCT00300885|11463843|FG000|Treatment|Non-compliant with study medication|3
7252877|NCT00300885|11463844|FG001|Treatment|Non-compliant with study medication|4
7252878|NCT00300885|11463843|FG000|Follow-up|Death|141
7252879|NCT00300885|11463844|FG001|Follow-up|Death|163
7252880|NCT00300885|11463843|FG000|Follow-up|Lost to Follow-up|11
7252881|NCT00300885|11463844|FG001|Follow-up|Lost to Follow-up|7
7252882|NCT00300885|11463843|FG000|Follow-up|Withdrawal by Subject|26
7252883|NCT00300885|11463844|FG001|Follow-up|Withdrawal by Subject|25
7252884|NCT00301067|11463854|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
7252885|NCT00301067|11463855|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
7252886|NCT00301067|11463856|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
7252887|NCT00301067|11463857|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
7252888|NCT00301067|11463854|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
7252889|NCT00301067|11463855|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
7252890|NCT00301067|11463856|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
7252891|NCT00301067|11463857|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
7252892|NCT00301067|11463854|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
7252893|NCT00301067|11463855|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
7252894|NCT00301067|11463856|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
7252895|NCT00301067|11463857|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
7252896|NCT00301067|11463854|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
7252897|NCT00301067|11463855|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
7252898|NCT00301067|11463856|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
7252899|NCT00301067|11463857|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
7252900|NCT00301067|11463854|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
7252901|NCT00301067|11463855|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
7252902|NCT00301067|11463856|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
7252903|NCT00301067|11463857|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
7252904|NCT00301067|11463854|FG000|Follow up Until Death|Alive at last data cut point|1
7252905|NCT00301067|11463855|FG001|Follow up Until Death|Alive at last data cut point|0
7252906|NCT00301067|11463856|FG002|Follow up Until Death|Alive at last data cut point|0
7252907|NCT00301067|11463857|FG003|Follow up Until Death|Alive at last data cut point|1
7252908|NCT00301366|11463868|FG000|Overall Study|Adverse Event|1
7252909|NCT00301808|11463882|FG000|Overall Study|Adverse Event|5
7252910|NCT00301808|11463882|FG000|Overall Study|Death|3
7252911|NCT00301808|11463882|FG000|Overall Study|Lack of Efficacy|4
7252912|NCT00301821|11463886|FG000|Overall Study|Ineligible|25
7252913|NCT00301821|11463886|FG000|Overall Study|Cancel|1
7252914|NCT00301834|11463890|FG000|Overall Study|Death|1
7256418|NCT00322621|11467934|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
7256419|NCT00322621|11467932|FG000|Period II - Acute Therapy Phase|Physician Decision|1
7256420|NCT00322621|11467933|FG001|Period II - Acute Therapy Phase|Physician Decision|0
7256421|NCT00322621|11467934|FG002|Period II - Acute Therapy Phase|Physician Decision|0
7256422|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
7256423|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
7256424|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
7256425|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
7256426|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
7256427|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
7256428|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
7256429|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
7384011|NCT01192100|11641104|FG005|Overall Study|Withdrawal by Subject|0
7384012|NCT01192100|11641099|FG000|Overall Study|Protocol Violation|0
7384013|NCT01192100|11641100|FG001|Overall Study|Protocol Violation|0
7384014|NCT01192100|11641101|FG002|Overall Study|Protocol Violation|0
7256430|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
7256431|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
7256432|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
7256433|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
7256434|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Death|0
7256435|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Death|1
7256436|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Death|0
7256437|NCT00322621|11467932|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
7256438|NCT00322621|11467933|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7256439|NCT00322621|11467934|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
7256440|NCT00322712|11467947|FG000|Overall Study|treated with bevacizumab not cetuximab|1
7252915|NCT00301964|11463901|FG000|Overall Study|Second primary|2
7252916|NCT00301964|11463901|FG000|Overall Study|Wrong primary|1
7252917|NCT00301964|11463901|FG000|Overall Study|Inadequate pathology|1
7252918|NCT00302003|11463911|FG000|Overall Study|Lack of Efficacy|62
7252919|NCT00302003|11463911|FG000|Overall Study|Lost to Follow-up|1
7252920|NCT00302003|11463911|FG000|Overall Study|Physician Decision|2
7252921|NCT00302003|11463911|FG000|Overall Study|Withdrawal by Subject|5
7252922|NCT00302003|11463911|FG000|Overall Study|Ineligible|9
7252923|NCT00302003|11463911|FG000|Overall Study|Protocol Violation|1
7252924|NCT00302081|11463950|FG000|Overall Study|Adverse Event|6
7252925|NCT00302081|11463951|FG001|Overall Study|Adverse Event|5
7252926|NCT00302081|11463952|FG002|Overall Study|Adverse Event|4
7252927|NCT00302081|11463950|FG000|Overall Study|Lost to Follow-up|21
7252928|NCT00302081|11463951|FG001|Overall Study|Lost to Follow-up|18
7252929|NCT00302081|11463952|FG002|Overall Study|Lost to Follow-up|28
7252930|NCT00302081|11463950|FG000|Overall Study|Withdrawal by Subject|8
7252931|NCT00302081|11463951|FG001|Overall Study|Withdrawal by Subject|12
7252932|NCT00302081|11463952|FG002|Overall Study|Withdrawal by Subject|8
7252933|NCT00302081|11463950|FG000|Overall Study|Protocol Violation|5
7252934|NCT00302081|11463951|FG001|Overall Study|Protocol Violation|1
7252935|NCT00302081|11463952|FG002|Overall Study|Protocol Violation|2
7252936|NCT00302081|11463950|FG000|Overall Study|Lack of Efficacy|1
7252937|NCT00302081|11463951|FG001|Overall Study|Lack of Efficacy|0
7252938|NCT00302081|11463952|FG002|Overall Study|Lack of Efficacy|5
7252939|NCT00302081|11463950|FG000|Overall Study|Death|2
7252940|NCT00302081|11463951|FG001|Overall Study|Death|1
7252941|NCT00302081|11463952|FG002|Overall Study|Death|0
7252942|NCT00302081|11463950|FG000|Overall Study|Other|13
7252943|NCT00302081|11463951|FG001|Overall Study|Other|6
7252944|NCT00302081|11463952|FG002|Overall Study|Other|5
7252945|NCT00302107|11463962|FG000|Overall Study|Lost to Follow-up|6
7252946|NCT00302107|11463963|FG001|Overall Study|Lost to Follow-up|5
7252947|NCT00302107|11463962|FG000|Overall Study|Protocol Violation|1
7252948|NCT00302107|11463963|FG001|Overall Study|Protocol Violation|0
7252949|NCT00302107|11463962|FG000|Overall Study|Relocation|0
7252950|NCT00302107|11463963|FG001|Overall Study|Relocation|1
7252951|NCT00302107|11463962|FG000|Overall Study|Withdrawal by Subject|0
7252952|NCT00302107|11463963|FG001|Overall Study|Withdrawal by Subject|3
7252953|NCT00302107|11463962|FG000|Overall Study|Adverse Event|1
7252954|NCT00302107|11463963|FG001|Overall Study|Adverse Event|0
7252955|NCT00302159|11463978|FG000|Overall Study|pt declined before treatment started|1
7252956|NCT00302159|11463978|FG000|Overall Study|pt started Avastin|1
7252957|NCT00302211|11463986|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
7252958|NCT00302211|11463987|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
7252959|NCT00302211|11463988|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
7252960|NCT00302211|11463989|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
7252961|NCT00302211|11463990|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
7252962|NCT00302211|11463986|FG000|Double Blind Period (New Patients)|Adverse Event|0
7252963|NCT00302211|11463987|FG001|Double Blind Period (New Patients)|Adverse Event|0
7252964|NCT00302211|11463988|FG002|Double Blind Period (New Patients)|Adverse Event|3
7252965|NCT00302211|11463989|FG003|Double Blind Period (New Patients)|Adverse Event|0
7252966|NCT00302211|11463990|FG004|Double Blind Period (New Patients)|Adverse Event|0
7252967|NCT00302211|11463986|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
7252968|NCT00302211|11463987|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
7252969|NCT00302211|11463988|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
7252970|NCT00302211|11463989|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
7252971|NCT00302211|11463990|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
7252972|NCT00302211|11463986|FG000|Double Blind Period (New Patients)|Disease progression|0
7252973|NCT00302211|11463987|FG001|Double Blind Period (New Patients)|Disease progression|1
7252974|NCT00302211|11463988|FG002|Double Blind Period (New Patients)|Disease progression|1
7252975|NCT00302211|11463989|FG003|Double Blind Period (New Patients)|Disease progression|0
7252976|NCT00302211|11463990|FG004|Double Blind Period (New Patients)|Disease progression|0
7252977|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7252978|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7252979|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
7252980|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7252981|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
7252982|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
7252983|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
7252984|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
7252985|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
7252986|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
7252987|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
7252988|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
7252989|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
7252990|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
7252991|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
7252992|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Disease progression|0
7252993|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Disease progression|0
7252994|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Disease progression|0
7252995|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Disease progression|1
7252996|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Disease progression|2
7252997|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Death|0
7252998|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Death|0
7252999|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Death|0
7253000|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Death|1
7253001|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Death|1
7253002|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7253003|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7253004|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7253005|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
7253006|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
7253007|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7574424|NCT03677401|11957172|FG001|Overall Study|Withdrawal by Subject|2
7253008|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7253009|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7253010|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
7253011|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
7253012|NCT00302211|11463986|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7253013|NCT00302211|11463987|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7253014|NCT00302211|11463988|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7253015|NCT00302211|11463989|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
7253016|NCT00302211|11463990|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
7253017|NCT00302328|11464005|FG000|Overall Study|Physician Decision|0
7253018|NCT00302328|11464006|FG001|Overall Study|Physician Decision|1
7253019|NCT00302328|11464007|FG002|Overall Study|Physician Decision|0
7253020|NCT00302458|11464018|FG000|Overall Study|Lost to Follow-up|1
7253021|NCT00302458|11464018|FG000|Overall Study|Ineligible after screening|1
7253022|NCT00302458|11464018|FG000|Overall Study|Withdrawal by Subject|1
7253023|NCT00302718|11464030|FG000|Overall Study|Participant left the hospital|1
7253024|NCT00302718|11464031|FG001|Overall Study|Participant left the hospital|0
7253025|NCT00302718|11464032|FG002|Overall Study|Participant left the hospital|0
7253026|NCT00302718|11464033|FG003|Overall Study|Participant left the hospital|1
7253027|NCT00302718|11464030|FG000|Overall Study|Withdrawal by Subject|0
7253028|NCT00302718|11464031|FG001|Overall Study|Withdrawal by Subject|1
7253029|NCT00302718|11464032|FG002|Overall Study|Withdrawal by Subject|0
7253030|NCT00302718|11464033|FG003|Overall Study|Withdrawal by Subject|0
7253031|NCT00302718|11464030|FG000|Overall Study|Participant left primary care setting|0
7253032|NCT00302718|11464031|FG001|Overall Study|Participant left primary care setting|0
7253033|NCT00302718|11464032|FG002|Overall Study|Participant left primary care setting|2
7253034|NCT00302718|11464033|FG003|Overall Study|Participant left primary care setting|1
7253035|NCT00302731|11464052|FG000|Overall Study|Lost to Follow-up|1
7253036|NCT00302731|11464053|FG001|Overall Study|Lost to Follow-up|2
7253037|NCT00302731|11464054|FG002|Overall Study|Lost to Follow-up|0
7253038|NCT00302731|11464055|FG003|Overall Study|Lost to Follow-up|0
7253039|NCT00302731|11464052|FG000|Overall Study|Adverse Event|0
7253040|NCT00302731|11464053|FG001|Overall Study|Adverse Event|2
7253041|NCT00302731|11464054|FG002|Overall Study|Adverse Event|2
7253042|NCT00302731|11464055|FG003|Overall Study|Adverse Event|0
7253043|NCT00302731|11464052|FG000|Overall Study|Withdrawal by Subject|1
7253044|NCT00302731|11464053|FG001|Overall Study|Withdrawal by Subject|1
7253045|NCT00302731|11464054|FG002|Overall Study|Withdrawal by Subject|0
7253046|NCT00302731|11464055|FG003|Overall Study|Withdrawal by Subject|0
7253047|NCT00302731|11464052|FG000|Overall Study|Protocol Violation|1
7253048|NCT00302731|11464053|FG001|Overall Study|Protocol Violation|0
7253049|NCT00302731|11464054|FG002|Overall Study|Protocol Violation|0
7253050|NCT00302731|11464055|FG003|Overall Study|Protocol Violation|0
7253051|NCT00302731|11464052|FG000|Overall Study|cancer unrelated to study discovered|1
7253052|NCT00302731|11464053|FG001|Overall Study|cancer unrelated to study discovered|0
7253053|NCT00302731|11464054|FG002|Overall Study|cancer unrelated to study discovered|1
7253054|NCT00302731|11464055|FG003|Overall Study|cancer unrelated to study discovered|0
7253061|NCT00303069|11464090|FG000|Overall Study|Lost to Follow-up|1
7253062|NCT00303069|11464091|FG001|Overall Study|Lost to Follow-up|0
7253063|NCT00303069|11464092|FG002|Overall Study|Lost to Follow-up|0
7253064|NCT00303069|11464093|FG003|Overall Study|Lost to Follow-up|2
7253065|NCT00303069|11464090|FG000|Overall Study|subject moved|1
7574425|NCT03677401|11957171|FG000|Overall Study|Sponsor decision|0
7253066|NCT00303069|11464091|FG001|Overall Study|subject moved|0
7253067|NCT00303069|11464092|FG002|Overall Study|subject moved|0
7253068|NCT00303069|11464093|FG003|Overall Study|subject moved|0
7253069|NCT00303069|11464090|FG000|Overall Study|Recruitment into Army Reserves|0
7253070|NCT00303069|11464091|FG001|Overall Study|Recruitment into Army Reserves|0
7253071|NCT00303069|11464092|FG002|Overall Study|Recruitment into Army Reserves|1
7253072|NCT00303069|11464093|FG003|Overall Study|Recruitment into Army Reserves|0
7253073|NCT00303108|11464106|FG000|Overall Study|Adverse Event|5
7253074|NCT00303108|11464107|FG001|Overall Study|Adverse Event|6
7253075|NCT00303108|11464108|FG002|Overall Study|Adverse Event|7
7253076|NCT00303108|11464106|FG000|Overall Study|Patient Request|4
7253077|NCT00303108|11464107|FG001|Overall Study|Patient Request|2
7253078|NCT00303108|11464108|FG002|Overall Study|Patient Request|8
7253079|NCT00303108|11464106|FG000|Overall Study|Failed Entry|1
7253080|NCT00303108|11464107|FG001|Overall Study|Failed Entry|0
7253081|NCT00303108|11464108|FG002|Overall Study|Failed Entry|1
7253082|NCT00303108|11464106|FG000|Overall Study|ineligible|2
7253083|NCT00303108|11464107|FG001|Overall Study|ineligible|1
7253084|NCT00303108|11464108|FG002|Overall Study|ineligible|0
7253085|NCT00303186|11464115|FG000|Overall Study|Other|52
7253086|NCT00303316|11464121|FG000|Overall Study|Protocol Violation|1
7253087|NCT00303316|11464122|FG001|Overall Study|Protocol Violation|0
7253088|NCT00303316|11464121|FG000|Overall Study|Lost to Follow-up|0
7253089|NCT00303316|11464122|FG001|Overall Study|Lost to Follow-up|1
7253090|NCT00303316|11464121|FG000|Overall Study|Withdrawal by Subject|1
7253091|NCT00303316|11464122|FG001|Overall Study|Withdrawal by Subject|2
7253092|NCT00303329|11464130|FG000|Overall Study|Adverse Event|7
7253093|NCT00303329|11464131|FG001|Overall Study|Adverse Event|14
7253094|NCT00303329|11464130|FG000|Overall Study|Abnormal Laboratory Values|0
7253095|NCT00303329|11464131|FG001|Overall Study|Abnormal Laboratory Values|1
7253096|NCT00303329|11464130|FG000|Overall Study|Unsatisfactory therapeutic effect|9
7253097|NCT00303329|11464131|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7253098|NCT00303329|11464130|FG000|Overall Study|Condition no longer requires study drug|0
7253099|NCT00303329|11464131|FG001|Overall Study|Condition no longer requires study drug|8
7253100|NCT00303329|11464130|FG000|Overall Study|Protocol Violation|3
7253101|NCT00303329|11464131|FG001|Overall Study|Protocol Violation|0
7253102|NCT00303329|11464130|FG000|Overall Study|Withdrawal by Subject|9
7253103|NCT00303329|11464131|FG001|Overall Study|Withdrawal by Subject|15
7253104|NCT00303329|11464130|FG000|Overall Study|Lost to Follow-up|0
7253105|NCT00303329|11464131|FG001|Overall Study|Lost to Follow-up|1
7253106|NCT00303329|11464130|FG000|Overall Study|Administrative problems|1
7253107|NCT00303329|11464131|FG001|Overall Study|Administrative problems|0
7253108|NCT00303329|11464130|FG000|Overall Study|Death|2
7253109|NCT00303329|11464131|FG001|Overall Study|Death|12
7253110|NCT00303329|11464130|FG000|Overall Study|Stopped at end of core|3
7253111|NCT00303329|11464131|FG001|Overall Study|Stopped at end of core|9
7253112|NCT00303329|11464130|FG000|Overall Study|Stopped at end of extension 1|1
7253113|NCT00303329|11464131|FG001|Overall Study|Stopped at end of extension 1|0
7253114|NCT00303446|11464139|FG000|Overall Study|Withdrawal by Subject|2
7253115|NCT00303446|11464140|FG001|Overall Study|Withdrawal by Subject|2
7253116|NCT00303446|11464139|FG000|Overall Study|Death|0
7253117|NCT00303446|11464140|FG001|Overall Study|Death|1
7253118|NCT00303446|11464139|FG000|Overall Study|Physician Decision|0
7253119|NCT00303446|11464140|FG001|Overall Study|Physician Decision|1
7253120|NCT00303459|11464148|FG000|Overall Study|Death|33
7253121|NCT00303459|11464149|FG001|Overall Study|Death|44
7253122|NCT00303459|11464148|FG000|Overall Study|Withdrawal of consent|32
7253123|NCT00303459|11464149|FG001|Overall Study|Withdrawal of consent|26
7253124|NCT00303459|11464148|FG000|Overall Study|Lost to Follow-up|5
7253125|NCT00303459|11464149|FG001|Overall Study|Lost to Follow-up|4
7253126|NCT00303459|11464148|FG000|Overall Study|Administrative reason|7
7253127|NCT00303459|11464149|FG001|Overall Study|Administrative reason|7
7253128|NCT00303459|11464148|FG000|Overall Study|Decision by the investigator|5
7253129|NCT00303459|11464149|FG001|Overall Study|Decision by the investigator|7
7253130|NCT00303459|11464148|FG000|Overall Study|Lung transplantation|1
7253131|NCT00303459|11464149|FG001|Overall Study|Lung transplantation|1
7253132|NCT00303472|11464163|FG000|Treatment Period|Adverse Event|0
7253133|NCT00303472|11464164|FG001|Treatment Period|Adverse Event|0
7253134|NCT00303472|11464165|FG002|Treatment Period|Adverse Event|0
7253135|NCT00303472|11464166|FG003|Treatment Period|Adverse Event|0
7253136|NCT00303472|11464167|FG004|Treatment Period|Adverse Event|1
7253137|NCT00303472|11464168|FG005|Treatment Period|Adverse Event|0
7253138|NCT00303472|11464169|FG006|Treatment Period|Adverse Event|0
7253139|NCT00303472|11464163|FG000|Treatment Period|Death|0
7253140|NCT00303472|11464164|FG001|Treatment Period|Death|0
7253141|NCT00303472|11464165|FG002|Treatment Period|Death|0
7253142|NCT00303472|11464166|FG003|Treatment Period|Death|1
7253143|NCT00303472|11464167|FG004|Treatment Period|Death|0
7253144|NCT00303472|11464168|FG005|Treatment Period|Death|0
7253145|NCT00303472|11464169|FG006|Treatment Period|Death|1
7253146|NCT00303472|11464163|FG000|Treatment Period|Withdrawal by Subject|0
7253147|NCT00303472|11464164|FG001|Treatment Period|Withdrawal by Subject|0
7253148|NCT00303472|11464165|FG002|Treatment Period|Withdrawal by Subject|0
7253149|NCT00303472|11464166|FG003|Treatment Period|Withdrawal by Subject|1
7253150|NCT00303472|11464167|FG004|Treatment Period|Withdrawal by Subject|0
7253151|NCT00303472|11464168|FG005|Treatment Period|Withdrawal by Subject|1
7574426|NCT03677401|11957172|FG001|Overall Study|Sponsor decision|1
7253152|NCT00303472|11464169|FG006|Treatment Period|Withdrawal by Subject|0
7253153|NCT00303472|11464163|FG000|Treatment Period|Other|0
7253154|NCT00303472|11464164|FG001|Treatment Period|Other|0
7253155|NCT00303472|11464165|FG002|Treatment Period|Other|0
7253156|NCT00303472|11464166|FG003|Treatment Period|Other|0
7253157|NCT00303472|11464167|FG004|Treatment Period|Other|1
7253158|NCT00303472|11464168|FG005|Treatment Period|Other|0
7253159|NCT00303472|11464169|FG006|Treatment Period|Other|1
7253160|NCT00303472|11464163|FG000|Treatment Period|Disease Progression (to AML)|0
7253161|NCT00303472|11464164|FG001|Treatment Period|Disease Progression (to AML)|0
7253162|NCT00303472|11464165|FG002|Treatment Period|Disease Progression (to AML)|0
7253163|NCT00303472|11464166|FG003|Treatment Period|Disease Progression (to AML)|0
7253164|NCT00303472|11464167|FG004|Treatment Period|Disease Progression (to AML)|1
7253165|NCT00303472|11464168|FG005|Treatment Period|Disease Progression (to AML)|0
7253166|NCT00303472|11464169|FG006|Treatment Period|Disease Progression (to AML)|0
7253167|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Adverse Event|1
7253168|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Adverse Event|0
7253169|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Adverse Event|1
7253170|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Adverse Event|0
7253171|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Adverse Event|0
7253172|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Adverse Event|0
7253173|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Adverse Event|0
7253174|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Death|2
7253175|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Death|0
7253176|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Death|1
7253177|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Death|0
7253178|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Death|0
7253179|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Death|0
7253180|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Death|0
7253181|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
7253182|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
7253183|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
7253184|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
7253185|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
7253186|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
7253187|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
7253188|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Physician Decision|0
7253189|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Physician Decision|4
7253190|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Physician Decision|2
7253191|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Physician Decision|3
7253192|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Physician Decision|2
7253193|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Physician Decision|0
7253194|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Physician Decision|0
7253195|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
7253196|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
7253197|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
7253198|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
7253199|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
7253200|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
7253201|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
7253202|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Other|0
7253203|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Other|2
7253204|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Other|4
7253205|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Other|2
7574427|NCT03677401|11957171|FG000|Overall Study|Reason Unspecified|1
7574428|NCT03677401|11957172|FG001|Overall Study|Reason Unspecified|0
7253206|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Other|1
7253207|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Other|0
7253208|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Other|0
7253209|NCT00303472|11464163|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
7253210|NCT00303472|11464164|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
7253211|NCT00303472|11464165|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
7253212|NCT00303472|11464166|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
7253213|NCT00303472|11464167|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
7253214|NCT00303472|11464168|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
7253215|NCT00303472|11464169|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
7253216|NCT00303485|11464187|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
7253217|NCT00303485|11464188|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
7253218|NCT00303485|11464187|FG000|Overall Study|Failure to return|0
7253219|NCT00303485|11464188|FG001|Overall Study|Failure to return|1
7253220|NCT00303485|11464187|FG000|Overall Study|Withdrawal by Subject|1
7253221|NCT00303485|11464188|FG001|Overall Study|Withdrawal by Subject|0
7253222|NCT00303602|11464200|FG000|Overall Study|Adverse Event|2
7253223|NCT00303602|11464201|FG001|Overall Study|Adverse Event|2
7253224|NCT00303602|11464200|FG000|Overall Study|Withdrawal by Subject|5
7253225|NCT00303602|11464201|FG001|Overall Study|Withdrawal by Subject|6
7253226|NCT00303602|11464200|FG000|Overall Study|Lost to Follow-up|5
7253227|NCT00303602|11464201|FG001|Overall Study|Lost to Follow-up|2
7253228|NCT00303602|11464200|FG000|Overall Study|Protocol entry criteria not met|2
7253229|NCT00303602|11464201|FG001|Overall Study|Protocol entry criteria not met|2
7253230|NCT00303602|11464200|FG000|Overall Study|Physician Decision|2
7253231|NCT00303602|11464201|FG001|Overall Study|Physician Decision|1
7253232|NCT00303602|11464200|FG000|Overall Study|Noncompliance|2
7253233|NCT00303602|11464201|FG001|Overall Study|Noncompliance|2
7253234|NCT00303602|11464200|FG000|Overall Study|Protocol Violation|1
7253235|NCT00303602|11464201|FG001|Overall Study|Protocol Violation|0
7253236|NCT00303628|11464209|FG000|Overall Study|Disease progression|0
7253237|NCT00303628|11464210|FG001|Overall Study|Disease progression|1
7253238|NCT00303628|11464209|FG000|Overall Study|Adverse Event|26
7253239|NCT00303628|11464210|FG001|Overall Study|Adverse Event|36
7253240|NCT00303628|11464209|FG000|Overall Study|Death|0
7253241|NCT00303628|11464210|FG001|Overall Study|Death|1
7253242|NCT00303628|11464209|FG000|Overall Study|Withdrawal by Subject|11
7253243|NCT00303628|11464210|FG001|Overall Study|Withdrawal by Subject|20
7253244|NCT00303628|11464209|FG000|Overall Study|Alternative therapy|2
7253245|NCT00303628|11464210|FG001|Overall Study|Alternative therapy|0
7253246|NCT00303628|11464209|FG000|Overall Study|Other complicating disease|0
7253247|NCT00303628|11464210|FG001|Overall Study|Other complicating disease|1
7253248|NCT00303628|11464209|FG000|Overall Study|Not start protocol therapy|3
7253249|NCT00303628|11464210|FG001|Overall Study|Not start protocol therapy|5
7253250|NCT00303628|11464209|FG000|Overall Study|Other|8
7253251|NCT00303628|11464210|FG001|Overall Study|Other|9
7253252|NCT00303667|11464218|FG000|Overall Study|Death|0
7253253|NCT00303667|11464219|FG001|Overall Study|Death|4
7253254|NCT00303719|11464227|FG000|Overall Study|Not evaluable, prior therapies|0
7253255|NCT00303719|11464228|FG001|Overall Study|Not evaluable, prior therapies|30
7253256|NCT00303719|11464227|FG000|Overall Study|Lost to Follow-up|0
7253257|NCT00303719|11464228|FG001|Overall Study|Lost to Follow-up|7
7253258|NCT00303953|11464252|FG000|Overall Study|Ineligible|1
7253259|NCT00303953|11464252|FG000|Overall Study|Death|1
7253260|NCT00303953|11464252|FG000|Overall Study|Adverse Event|4
7253261|NCT00303953|11464252|FG000|Overall Study|Lack of Efficacy|12
7253262|NCT00303953|11464252|FG000|Overall Study|Physician Decision|1
7253263|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
7253264|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7253265|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
7253266|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
7253267|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7253268|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
7253269|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
7253270|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7253271|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
7253272|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
7253273|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
7253274|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
7253275|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
7253276|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7253277|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
7253278|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
7253279|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7253280|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
7253281|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
7253282|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7253283|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
7253284|NCT00304031|11464285|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
7253285|NCT00304031|11464286|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7253286|NCT00304031|11464287|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
7253287|NCT00304031|11464285|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7253288|NCT00304031|11464286|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
7253289|NCT00304031|11464287|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
7253290|NCT00304083|11464304|FG000|Overall Study|Withdrawal by Subject|4
7253291|NCT00304083|11464305|FG001|Overall Study|Withdrawal by Subject|2
7253292|NCT00304083|11464304|FG000|Overall Study|Physician Decision|8
7253293|NCT00304083|11464305|FG001|Overall Study|Physician Decision|3
7253294|NCT00304083|11464304|FG000|Overall Study|Disease Progression|5
7253295|NCT00304083|11464305|FG001|Overall Study|Disease Progression|1
7253296|NCT00304083|11464304|FG000|Overall Study|Other|5
7253297|NCT00304083|11464305|FG001|Overall Study|Other|2
7253298|NCT00304278|11464349|FG000|Overall Study|lack of insurance coverage for chemoRT|1
7253299|NCT00304278|11464349|FG000|Overall Study|PT had medical condition preventing TX|1
7253300|NCT00304356|11464353|FG000|Nitazoxanide|Physician Decision|5
7253301|NCT00304356|11464353|FG000|Nitazoxanide|Physician Decision|1
7253302|NCT00304356|11464353|FG000|Nitazoxanide|number is 0|1
7253303|NCT00304356|11464353|FG000|Nitazoxanide|Physician Decision|1
7253304|NCT00304356|11464353|FG000|Nitazoxanide|Physician Decision|1
7253305|NCT00304356|11464353|FG000|Nitazoxanide|Physician Decision|1
7256441|NCT00322842|11467962|FG000|Overall Study|Withdrawal by Subject|0
7256442|NCT00322842|11467963|FG001|Overall Study|Withdrawal by Subject|1
7256443|NCT00322842|11467962|FG000|Overall Study|Lost to Follow-up|0
7256444|NCT00322842|11467963|FG001|Overall Study|Lost to Follow-up|1
7256445|NCT00322842|11467962|FG000|Overall Study|Refused transplant|1
7256446|NCT00322842|11467963|FG001|Overall Study|Refused transplant|0
7256447|NCT00322842|11467962|FG000|Overall Study|Death|1
7256448|NCT00322842|11467963|FG001|Overall Study|Death|0
7256449|NCT00322868|11467970|FG000|Overall Study|disease progression|1
7256450|NCT00322881|11467975|FG000|Overall Study|Death|2
7256451|NCT00322881|11467975|FG000|Overall Study|Adverse Event|1
7256452|NCT00322881|11467975|FG000|Overall Study|Disease Progression|2
7256457|NCT00323115|11467988|FG000|Vaccine Administration|Adverse Event|1
7256458|NCT00323115|11467988|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
7256459|NCT00323258|11468008|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
7256460|NCT00323258|11468009|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
7256461|NCT00323258|11468008|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
7256462|NCT00323258|11468009|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
7256463|NCT00323258|11468008|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
7256464|NCT00323258|11468009|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
7256465|NCT00323258|11468008|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
7256466|NCT00323258|11468009|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
7256467|NCT00323258|11468008|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
7256468|NCT00323258|11468009|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
7256469|NCT00323258|11468008|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
7256470|NCT00323258|11468009|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
7256471|NCT00323258|11468008|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
7256472|NCT00323258|11468009|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
7256473|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
7256474|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
7256475|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Death|0
7256476|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Death|1
7256477|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
7256478|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
7256479|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
7256480|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
7256481|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
7256482|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
7256483|NCT00323297|11468035|FG000|Part A (Double Blind Randomized)|Related adverse event|2
7256484|NCT00323297|11468036|FG001|Part A (Double Blind Randomized)|Related adverse event|2
7256485|NCT00323297|11468035|FG000|Part B (Open-label)|Death|0
7256486|NCT00323297|11468036|FG001|Part B (Open-label)|Death|1
7256487|NCT00323297|11468035|FG000|Part B (Open-label)|Reason unspecified|0
7256488|NCT00323297|11468036|FG001|Part B (Open-label)|Reason unspecified|1
7256489|NCT00323297|11468035|FG000|Part B (Open-label)|Withdrawal by Subject|1
7256490|NCT00323297|11468036|FG001|Part B (Open-label)|Withdrawal by Subject|3
7256491|NCT00323297|11468035|FG000|Part B (Open-label)|Lack of Efficacy|3
7256492|NCT00323297|11468036|FG001|Part B (Open-label)|Lack of Efficacy|1
7256493|NCT00323297|11468035|FG000|Part B (Open-label)|Adverse Event|5
7256494|NCT00323297|11468036|FG001|Part B (Open-label)|Adverse Event|5
7256495|NCT00323297|11468035|FG000|Part B (Open-label)|Protocol Violation|0
7256496|NCT00323297|11468036|FG001|Part B (Open-label)|Protocol Violation|1
7256497|NCT00323310|11468042|FG000|Overall Study|Withdrawal by Subject|1
7256498|NCT00323310|11468042|FG000|Overall Study|a parent refused blood draw|1
7256499|NCT00323310|11468042|FG000|Overall Study|did not complete the 24-hr f-up visit|1
7256500|NCT00323414|11468052|FG000|Overall Study|Withdrawal by Subject|0
7256501|NCT00323414|11468053|FG001|Overall Study|Withdrawal by Subject|1
7256502|NCT00323479|11468077|FG000|Overall Study|Adverse Event|2
7256503|NCT00323479|11468077|FG000|Overall Study|Withdrawal by Subject|2
7256504|NCT00323479|11468077|FG000|Overall Study|Protocol Violation|3
7256505|NCT00323479|11468077|FG000|Overall Study|house moving|1
7256506|NCT00323492|11468083|FG000|Study Phase 1|Adverse Event|2
7256507|NCT00323492|11468084|FG001|Study Phase 1|Adverse Event|0
7256508|NCT00323492|11468085|FG002|Study Phase 1|Adverse Event|0
7256509|NCT00323492|11468083|FG000|Study Phase 2|Adverse Event|1
7256510|NCT00323492|11468084|FG001|Study Phase 2|Adverse Event|0
7256511|NCT00323492|11468085|FG002|Study Phase 2|Adverse Event|0
7256512|NCT00323492|11468083|FG000|Study Phase 2|Physician Decision|1
7256513|NCT00323492|11468084|FG001|Study Phase 2|Physician Decision|0
7256514|NCT00323492|11468085|FG002|Study Phase 2|Physician Decision|0
7253306|NCT04493931|11464428|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1
7253307|NCT04493931|11464429|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253308|NCT04493931|11464430|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253309|NCT04493931|11464431|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253310|NCT04493931|11464432|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253311|NCT04493931|11464433|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253312|NCT04493931|11464434|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
7253313|NCT04493931|11464428|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253314|NCT04493931|11464429|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2
7253315|NCT04493931|11464430|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253316|NCT04493931|11464431|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253317|NCT04493931|11464432|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253318|NCT04493931|11464433|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253319|NCT04493931|11464434|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
7253320|NCT04493931|11464428|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253321|NCT04493931|11464429|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1
7253322|NCT04493931|11464430|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253323|NCT04493931|11464431|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253324|NCT04493931|11464432|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253325|NCT04493931|11464433|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253326|NCT04493931|11464434|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
7253327|NCT04493931|11464428|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253328|NCT04493931|11464429|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253329|NCT04493931|11464430|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1
7253330|NCT04493931|11464431|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253331|NCT04493931|11464432|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253332|NCT04493931|11464433|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253333|NCT04493931|11464434|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
7253336|NCT03999554|11464493|FG000|Overall Study|Lost to Follow-up|4
7253337|NCT03999554|11464494|FG001|Overall Study|Lost to Follow-up|5
7574430|NCT03678103|11957182|FG000|Overall Study|Withdrawn prior to completion|4
7574431|NCT03678285|11957186|FG000|Overall Study|Adverse Event|2
7574432|NCT03678285|11957186|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
7574433|NCT03678285|11957186|FG000|Overall Study|Dehydrated prior to start of workout|1
7574434|NCT03678870|11957196|FG000|Overall Study|prescribed non- protocol medications|10
7574435|NCT03678870|11957197|FG001|Overall Study|prescribed non- protocol medications|6
7574436|NCT03678870|11957196|FG000|Overall Study|Lost to Follow-up|3
7574437|NCT03678870|11957197|FG001|Overall Study|Lost to Follow-up|2
7574438|NCT03679741|11957212|FG000|Period 1|No longer meet eligibility criteria|1
7253338|NCT03999554|11464495|FG002|Overall Study|Lost to Follow-up|4
7253339|NCT03999554|11464496|FG003|Overall Study|Lost to Follow-up|5
7253340|NCT03999554|11464497|FG004|Overall Study|Lost to Follow-up|8
7253341|NCT03999554|11464493|FG000|Overall Study|Protocol Violation|0
7253342|NCT03999554|11464494|FG001|Overall Study|Protocol Violation|0
7253343|NCT03999554|11464495|FG002|Overall Study|Protocol Violation|5
7253344|NCT03999554|11464496|FG003|Overall Study|Protocol Violation|0
7253345|NCT03999554|11464497|FG004|Overall Study|Protocol Violation|0
7253346|NCT03999554|11464493|FG000|Overall Study|Pregnancy|0
7253347|NCT03999554|11464494|FG001|Overall Study|Pregnancy|0
7253348|NCT03999554|11464495|FG002|Overall Study|Pregnancy|1
7253349|NCT03999554|11464496|FG003|Overall Study|Pregnancy|0
7253350|NCT03999554|11464497|FG004|Overall Study|Pregnancy|0
7253351|NCT03999554|11464493|FG000|Overall Study|Withdrawal by Subject|2
7253352|NCT03999554|11464494|FG001|Overall Study|Withdrawal by Subject|2
7253353|NCT03999554|11464495|FG002|Overall Study|Withdrawal by Subject|2
7253354|NCT03999554|11464496|FG003|Overall Study|Withdrawal by Subject|1
7253355|NCT03999554|11464497|FG004|Overall Study|Withdrawal by Subject|1
7253356|NCT03999554|11464493|FG000|Overall Study|failure to comply with protocol requirements|0
7253357|NCT03999554|11464494|FG001|Overall Study|failure to comply with protocol requirements|0
7253358|NCT03999554|11464495|FG002|Overall Study|failure to comply with protocol requirements|0
7253359|NCT03999554|11464496|FG003|Overall Study|failure to comply with protocol requirements|1
7253360|NCT03999554|11464497|FG004|Overall Study|failure to comply with protocol requirements|0
7256515|NCT00323492|11468083|FG000|Study Phase 2|Lost to Follow-up|1
7256516|NCT00323492|11468084|FG001|Study Phase 2|Lost to Follow-up|0
7256517|NCT00323492|11468085|FG002|Study Phase 2|Lost to Follow-up|0
7256518|NCT00323492|11468083|FG000|Study Phase 2|Withdrawal by Subject|0
7256519|NCT00323492|11468084|FG001|Study Phase 2|Withdrawal by Subject|1
7256520|NCT00323492|11468085|FG002|Study Phase 2|Withdrawal by Subject|0
7256521|NCT00323492|11468083|FG000|Study Phase 2|Noncompliance with study schedule|0
7256522|NCT00323492|11468084|FG001|Study Phase 2|Noncompliance with study schedule|0
7256523|NCT00323492|11468085|FG002|Study Phase 2|Noncompliance with study schedule|1
7256524|NCT00323492|11468083|FG000|Study Phase 2|Protocol Violation|1
7256525|NCT00323492|11468084|FG001|Study Phase 2|Protocol Violation|0
7256526|NCT00323492|11468085|FG002|Study Phase 2|Protocol Violation|0
7256527|NCT00323557|11468094|FG000|Overall Study|Physician Decision|1
7256528|NCT00323557|11468095|FG001|Overall Study|Physician Decision|0
7256529|NCT00323609|11468104|FG000|Overall Study|Death|16
7256530|NCT00323609|11468105|FG001|Overall Study|Death|21
7256531|NCT00323609|11468106|FG002|Overall Study|Death|0
7256532|NCT00323609|11468107|FG003|Overall Study|Death|0
7256533|NCT00323609|11468104|FG000|Overall Study|Lost to Follow-up|9
7256534|NCT00323609|11468105|FG001|Overall Study|Lost to Follow-up|10
7256535|NCT00323609|11468106|FG002|Overall Study|Lost to Follow-up|0
7256536|NCT00323609|11468107|FG003|Overall Study|Lost to Follow-up|0
7256537|NCT00323609|11468104|FG000|Overall Study|Physician Decision|2
7256538|NCT00323609|11468105|FG001|Overall Study|Physician Decision|0
7256539|NCT00323609|11468106|FG002|Overall Study|Physician Decision|0
7256540|NCT00323609|11468107|FG003|Overall Study|Physician Decision|1
7256541|NCT00323609|11468104|FG000|Overall Study|Withdrawal by Subject|11
7256542|NCT00323609|11468105|FG001|Overall Study|Withdrawal by Subject|23
7256543|NCT00323609|11468106|FG002|Overall Study|Withdrawal by Subject|4
7256544|NCT00323609|11468107|FG003|Overall Study|Withdrawal by Subject|4
7256545|NCT00323609|11468104|FG000|Overall Study|Other non-VCF-related medical condition|3
7256546|NCT00323609|11468105|FG001|Overall Study|Other non-VCF-related medical condition|2
7256547|NCT00323609|11468106|FG002|Overall Study|Other non-VCF-related medical condition|0
7256548|NCT00323609|11468107|FG003|Overall Study|Other non-VCF-related medical condition|0
7256549|NCT00323609|11468104|FG000|Overall Study|Sponsor discontinued trial|29
7256550|NCT00323609|11468105|FG001|Overall Study|Sponsor discontinued trial|29
7256551|NCT00323609|11468106|FG002|Overall Study|Sponsor discontinued trial|0
7256552|NCT00323609|11468107|FG003|Overall Study|Sponsor discontinued trial|0
7256553|NCT00323609|11468104|FG000|Overall Study|Unrelenting or severe back pain|1
7256554|NCT00323609|11468105|FG001|Overall Study|Unrelenting or severe back pain|1
7256555|NCT00323609|11468106|FG002|Overall Study|Unrelenting or severe back pain|0
7256556|NCT00323609|11468107|FG003|Overall Study|Unrelenting or severe back pain|0
7256557|NCT00323609|11468104|FG000|Overall Study|Logistical withdrawal|9
7256558|NCT00323609|11468105|FG001|Overall Study|Logistical withdrawal|5
7256559|NCT00323609|11468106|FG002|Overall Study|Logistical withdrawal|0
7256560|NCT00323609|11468107|FG003|Overall Study|Logistical withdrawal|1
7256561|NCT00323609|11468104|FG000|Overall Study|Other reason|11
7256562|NCT00323609|11468105|FG001|Overall Study|Other reason|8
7256563|NCT00323609|11468106|FG002|Overall Study|Other reason|4
7256564|NCT00323609|11468107|FG003|Overall Study|Other reason|9
7256565|NCT00323622|11468121|FG000|Overall Study|Other|30
7256566|NCT00323622|11468122|FG001|Overall Study|Other|91
7256567|NCT00323622|11468123|FG002|Overall Study|Other|4
7256568|NCT00323622|11468124|FG003|Overall Study|Other|12
7256569|NCT00323622|11468125|FG004|Overall Study|Other|32
7256570|NCT00323622|11468126|FG005|Overall Study|Other|74
7256571|NCT00323622|11468127|FG006|Overall Study|Other|5
7256572|NCT00323622|11468128|FG007|Overall Study|Other|13
7256573|NCT00323622|11468121|FG000|Overall Study|Death|1
7256574|NCT00323622|11468122|FG001|Overall Study|Death|1
7256575|NCT00323622|11468123|FG002|Overall Study|Death|0
7256576|NCT00323622|11468124|FG003|Overall Study|Death|0
7256577|NCT00323622|11468125|FG004|Overall Study|Death|7
7256578|NCT00323622|11468126|FG005|Overall Study|Death|0
7256579|NCT00323622|11468127|FG006|Overall Study|Death|0
7256580|NCT00323622|11468128|FG007|Overall Study|Death|2
7256581|NCT00323869|11468158|FG000|Overall Study|Death|1
7256582|NCT00323882|11468167|FG000|Overall Study|Adverse Event|2
7256583|NCT00323882|11468168|FG001|Overall Study|Adverse Event|1
7256584|NCT00323882|11468169|FG002|Overall Study|Adverse Event|1
7256585|NCT00323882|11468170|FG003|Overall Study|Adverse Event|1
7256586|NCT00323882|11468171|FG004|Overall Study|Adverse Event|3
7256587|NCT00323882|11468167|FG000|Overall Study|Disease Progression|6
7256588|NCT00323882|11468168|FG001|Overall Study|Disease Progression|4
7256589|NCT00323882|11468169|FG002|Overall Study|Disease Progression|10
7256590|NCT00323882|11468170|FG003|Overall Study|Disease Progression|5
7256591|NCT00323882|11468171|FG004|Overall Study|Disease Progression|22
7256592|NCT00323882|11468167|FG000|Overall Study|Death|0
7253361|NCT03651622|11464513|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0
7253362|NCT03651622|11464514|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6
7253363|NCT03651622|11464515|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2
7253364|NCT03651622|11464513|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4
7253365|NCT03651622|11464514|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1
7253366|NCT03651622|11464515|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7
7253367|NCT03651622|11464513|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0
7253368|NCT03651622|11464514|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2
7253369|NCT03651622|11464515|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3
7253370|NCT03651622|11464513|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2
7253371|NCT03651622|11464514|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
7253372|NCT03651622|11464515|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
7253373|NCT03651622|11464513|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
7253374|NCT03651622|11464514|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
7253375|NCT03651622|11464515|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1
7256597|NCT00323882|11468167|FG000|Overall Study|Lost to Follow-up|0
7574439|NCT03679741|11957213|FG001|Period 1|No longer meet eligibility criteria|0
7574440|NCT03679741|11957212|FG000|Period 1|Lost to Follow-up|0
7574441|NCT03679741|11957213|FG001|Period 1|Lost to Follow-up|1
7574442|NCT03679741|11957212|FG000|Period 1|Adverse Event|1
7574443|NCT03679741|11957213|FG001|Period 1|Adverse Event|1
7574444|NCT03679741|11957212|FG000|Period 1|Withdrawal by Subject|0
7253508|NCT02678351|11464597|FG000|Overall Study|Withdrawal by Subject|1
7256593|NCT00323882|11468168|FG001|Overall Study|Death|1
7256594|NCT00323882|11468169|FG002|Overall Study|Death|1
7256595|NCT00323882|11468170|FG003|Overall Study|Death|0
7256596|NCT00323882|11468171|FG004|Overall Study|Death|5
7256598|NCT00323882|11468168|FG001|Overall Study|Lost to Follow-up|0
7256599|NCT00323882|11468169|FG002|Overall Study|Lost to Follow-up|1
7256600|NCT00323882|11468170|FG003|Overall Study|Lost to Follow-up|0
7256601|NCT00323882|11468171|FG004|Overall Study|Lost to Follow-up|1
7256602|NCT00323882|11468167|FG000|Overall Study|Other|0
7256603|NCT00323882|11468168|FG001|Overall Study|Other|0
7256604|NCT00323882|11468169|FG002|Overall Study|Other|0
7256605|NCT00323882|11468170|FG003|Overall Study|Other|1
7256606|NCT00323882|11468171|FG004|Overall Study|Other|1
7256607|NCT00324038|11468210|FG000|Overall Study|Adverse Event|38
7256608|NCT00324038|11468211|FG001|Overall Study|Adverse Event|23
7256609|NCT00324038|11468210|FG000|Overall Study|Lack of Efficacy|5
7256610|NCT00324038|11468211|FG001|Overall Study|Lack of Efficacy|13
7256611|NCT00324038|11468210|FG000|Overall Study|Lost to Follow-up|0
7256612|NCT00324038|11468211|FG001|Overall Study|Lost to Follow-up|2
7256613|NCT00324038|11468210|FG000|Overall Study|Other|6
7256614|NCT00324038|11468211|FG001|Overall Study|Other|13
7256615|NCT00324116|11468217|FG000|Overall Study|Adverse Event|5
7256616|NCT00324116|11468217|FG000|Overall Study|Lack of Efficacy|17
7256617|NCT00324116|11468217|FG000|Overall Study|Withdrawal by Subject|5
7256618|NCT00324116|11468217|FG000|Overall Study|Other|5
7256619|NCT00324155|11468223|FG000|Enrolled and Randomized|No longer met study criteria|3
7256620|NCT00324155|11468224|FG001|Enrolled and Randomized|No longer met study criteria|0
7256621|NCT00324155|11468223|FG000|Enrolled and Randomized|Lost to Follow-up|0
7256622|NCT00324155|11468224|FG001|Enrolled and Randomized|Lost to Follow-up|1
7256623|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Disease Progression|88
7256624|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Disease Progression|152
7256625|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
7256626|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
7256627|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Death|8
7256628|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Death|15
7256629|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
7256630|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
7256631|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Adverse Event|6
7256632|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Adverse Event|7
7256633|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
7256634|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
7256635|NCT00324155|11468223|FG000|Received Treatment in Induction Phase|Physician Decision|2
7256636|NCT00324155|11468224|FG001|Received Treatment in Induction Phase|Physician Decision|0
7256637|NCT00324155|11468223|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
7256638|NCT00324155|11468224|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
7256639|NCT00324155|11468223|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
7256640|NCT00324155|11468224|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
7256641|NCT00324155|11468223|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
7256642|NCT00324155|11468224|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
7256643|NCT00324155|11468223|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
7256644|NCT00324155|11468224|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
7256645|NCT00324155|11468223|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
7256646|NCT00324155|11468224|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
7256647|NCT00324155|11468223|FG000|Follow-up Phase|On-going participants still on drug|11
7256648|NCT00324155|11468224|FG001|Follow-up Phase|On-going participants still on drug|6
7256649|NCT00324168|11468245|FG000|Overall Study|Lost to Follow-up|19
7256650|NCT00324168|11468246|FG001|Overall Study|Lost to Follow-up|18
7256651|NCT00324168|11468245|FG000|Overall Study|Death|3
7256652|NCT00324168|11468246|FG001|Overall Study|Death|3
7256653|NCT00324168|11468245|FG000|Overall Study|Patient did not visit in f/u window|6
7574445|NCT03679741|11957213|FG001|Period 1|Withdrawal by Subject|1
7574446|NCT03679741|11957212|FG000|Period 2|Adverse Event|2
7574447|NCT03679741|11957213|FG001|Period 2|Adverse Event|1
7253515|NCT01693692|11464652|FG000|Overall Study|Withdrawal by Subject|12
7253516|NCT01693692|11464653|FG001|Overall Study|Withdrawal by Subject|10
7253517|NCT01693692|11464654|FG002|Overall Study|Withdrawal by Subject|11
7253518|NCT01693692|11464652|FG000|Overall Study|Adverse Event|7
7253519|NCT01693692|11464653|FG001|Overall Study|Adverse Event|14
7253520|NCT01693692|11464654|FG002|Overall Study|Adverse Event|9
7253521|NCT01693692|11464652|FG000|Overall Study|Physician Decision|0
7253522|NCT01693692|11464653|FG001|Overall Study|Physician Decision|0
7253523|NCT01693692|11464654|FG002|Overall Study|Physician Decision|1
7253524|NCT01693692|11464652|FG000|Overall Study|Protocol Violation|5
7253525|NCT01693692|11464653|FG001|Overall Study|Protocol Violation|4
7253526|NCT01693692|11464654|FG002|Overall Study|Protocol Violation|6
7253527|NCT01693692|11464652|FG000|Overall Study|Lost to Follow-up|2
7253528|NCT01693692|11464653|FG001|Overall Study|Lost to Follow-up|2
7253529|NCT01693692|11464654|FG002|Overall Study|Lost to Follow-up|3
7253530|NCT01693692|11464652|FG000|Overall Study|Other|4
7253531|NCT01693692|11464653|FG001|Overall Study|Other|4
7253532|NCT01693692|11464654|FG002|Overall Study|Other|6
7253533|NCT01685606|11464662|FG000|Overall Study|Withdrawal by Subject|1
7253534|NCT01650285|11464672|FG000|Overall Study|Adverse Event|1
7253535|NCT01083771|11464676|FG000|Overall Study|non-compliant|2
7253536|NCT01083771|11464676|FG000|Overall Study|Withdrawal by Subject|3
7253537|NCT00743197|11464682|FG000|Overall Study|Study terminated due to departure of PI.|1
7253538|NCT00743197|11464683|FG001|Overall Study|Study terminated due to departure of PI.|2
7253539|NCT00304915|11464691|FG000|Overall Study|Lost to Follow-up|11
7253540|NCT00304915|11464692|FG001|Overall Study|Lost to Follow-up|11
7253541|NCT00304915|11464691|FG000|Overall Study|Death|4
7253542|NCT00304915|11464692|FG001|Overall Study|Death|5
7253543|NCT00304915|11464691|FG000|Overall Study|Withdrawal by Subject|3
7253544|NCT00304915|11464692|FG001|Overall Study|Withdrawal by Subject|0
7253545|NCT00304954|11464702|FG000|Overall Study|Withdrawal by Subject|0
7253546|NCT00304954|11464703|FG001|Overall Study|Withdrawal by Subject|0
7253547|NCT00304954|11464704|FG002|Overall Study|Withdrawal by Subject|1
7253548|NCT00304954|11464705|FG003|Overall Study|Withdrawal by Subject|0
7253549|NCT00304954|11464702|FG000|Overall Study|Adverse Event|1
7253550|NCT00304954|11464703|FG001|Overall Study|Adverse Event|0
7253551|NCT00304954|11464704|FG002|Overall Study|Adverse Event|0
7253552|NCT00304954|11464705|FG003|Overall Study|Adverse Event|0
7253553|NCT00305006|11464725|FG000|Overall Study|Withdrawal by Subject|1
7253554|NCT00305006|11464726|FG001|Overall Study|Withdrawal by Subject|0
7253555|NCT00305006|11464725|FG000|Overall Study|Failure to complete pretest|0
7253556|NCT00305006|11464726|FG001|Overall Study|Failure to complete pretest|1
7253557|NCT00305058|11464734|FG000|Overall Study|Participant too young|1
7253558|NCT00305058|11464735|FG001|Overall Study|Participant too young|0
7253559|NCT00305058|11464734|FG000|Overall Study|Missing data collection instrument|3
7253560|NCT00305058|11464735|FG001|Overall Study|Missing data collection instrument|2
7253561|NCT00305058|11464734|FG000|Overall Study|Missing outcome data|3
7253562|NCT00305058|11464735|FG001|Overall Study|Missing outcome data|2
7253563|NCT00305110|11464790|FG000|Overall Study|Missing data|29
7253564|NCT00305227|11464806|FG000|Overall Study|Lost to Follow-up|7
7253565|NCT00305227|11464807|FG001|Overall Study|Lost to Follow-up|6
7253566|NCT00305253|11464815|FG000|Overall Study|Withdrawal by Subject|0
7253567|NCT00305253|11464816|FG001|Overall Study|Withdrawal by Subject|1
7253568|NCT00305448|11464825|FG000|Overall Study|Protocol Violation|0
7253569|NCT00305448|11464826|FG001|Overall Study|Protocol Violation|1
7253570|NCT00305448|11464827|FG002|Overall Study|Protocol Violation|0
7253571|NCT00305448|11464825|FG000|Overall Study|Withdrawal by Subject|2
7253572|NCT00305448|11464826|FG001|Overall Study|Withdrawal by Subject|0
7253573|NCT00305448|11464827|FG002|Overall Study|Withdrawal by Subject|1
7253574|NCT00305448|11464825|FG000|Overall Study|Adverse Event|1
7253575|NCT00305448|11464826|FG001|Overall Study|Adverse Event|0
7253576|NCT00305448|11464827|FG002|Overall Study|Adverse Event|1
7253577|NCT00305448|11464825|FG000|Overall Study|Disease Progression|27
7253578|NCT00305448|11464826|FG001|Overall Study|Disease Progression|31
7253579|NCT00305448|11464827|FG002|Overall Study|Disease Progression|28
7253580|NCT00305448|11464825|FG000|Overall Study|Subjective Disease Progression|1
7253581|NCT00305448|11464826|FG001|Overall Study|Subjective Disease Progression|2
7253582|NCT00305448|11464827|FG002|Overall Study|Subjective Disease Progression|2
7253583|NCT00305448|11464825|FG000|Overall Study|Tumor Marker Elevation|0
7253584|NCT00305448|11464826|FG001|Overall Study|Tumor Marker Elevation|0
7253585|NCT00305448|11464827|FG002|Overall Study|Tumor Marker Elevation|1
7253586|NCT00305604|11464861|FG000|Overall Study|Adverse Event|6
7253587|NCT00305604|11464862|FG001|Overall Study|Adverse Event|3
7253588|NCT00305604|11464861|FG000|Overall Study|Lack of Efficacy|11
7253589|NCT00305604|11464862|FG001|Overall Study|Lack of Efficacy|18
7253590|NCT00305604|11464861|FG000|Overall Study|Lost to Follow-up|0
7253591|NCT00305604|11464862|FG001|Overall Study|Lost to Follow-up|4
7253592|NCT00305604|11464861|FG000|Overall Study|Protocol Violation|2
7253593|NCT00305604|11464862|FG001|Overall Study|Protocol Violation|1
7253594|NCT00305604|11464861|FG000|Overall Study|Withdrawal by Subject|12
7253595|NCT00305604|11464862|FG001|Overall Study|Withdrawal by Subject|21
7253596|NCT00305604|11464861|FG000|Overall Study|Patient moved|1
7253597|NCT00305604|11464862|FG001|Overall Study|Patient moved|0
7253598|NCT00305695|11464895|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
7253599|NCT00305695|11464896|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
7253600|NCT00305695|11464895|FG000|Overall Study|Did not have baseline scan|1
7253601|NCT00305695|11464896|FG001|Overall Study|Did not have baseline scan|1
7253602|NCT00305773|11464908|FG000|Overall Study|Death|3
7253603|NCT00305773|11464909|FG001|Overall Study|Death|2
7253604|NCT00305773|11464908|FG000|Overall Study|Adverse Event|1
7253605|NCT00305773|11464909|FG001|Overall Study|Adverse Event|2
7253606|NCT00305773|11464908|FG000|Overall Study|Alternative Treatment|4
7253607|NCT00305773|11464909|FG001|Overall Study|Alternative Treatment|4
7253608|NCT00305773|11464908|FG000|Overall Study|Physician Decision|1
7253609|NCT00305773|11464909|FG001|Overall Study|Physician Decision|1
7253610|NCT00305773|11464908|FG000|Overall Study|Withdrawal by Subject|1
7253611|NCT00305773|11464909|FG001|Overall Study|Withdrawal by Subject|4
7253612|NCT00305773|11464908|FG000|Overall Study|Disease Progression|1
7253613|NCT00305773|11464909|FG001|Overall Study|Disease Progression|3
7253614|NCT00305773|11464908|FG000|Overall Study|All other reasons|3
7253615|NCT00305773|11464909|FG001|Overall Study|All other reasons|2
7253616|NCT00305864|11464919|FG000|Overall Study|Ineligible / No protocol treatment|0
7253617|NCT00305864|11464920|FG001|Overall Study|Ineligible / No protocol treatment|1
7253618|NCT00305864|11464921|FG002|Overall Study|Ineligible / No protocol treatment|1
7253619|NCT00305864|11464922|FG003|Overall Study|Ineligible / No protocol treatment|13
7253620|NCT00305877|11464934|FG000|Overall Study|Lack of Efficacy|6
7253621|NCT00305877|11464935|FG001|Overall Study|Lack of Efficacy|9
7253622|NCT00305877|11464934|FG000|Overall Study|Adverse Event|9
7253623|NCT00305877|11464935|FG001|Overall Study|Adverse Event|14
7253624|NCT00305877|11464934|FG000|Overall Study|Death|0
7253625|NCT00305877|11464935|FG001|Overall Study|Death|1
7253626|NCT00305877|11464934|FG000|Overall Study|Withdrawal by Subject|4
7253627|NCT00305877|11464935|FG001|Overall Study|Withdrawal by Subject|2
7253628|NCT00305877|11464934|FG000|Overall Study|Physician Decision|1
7253629|NCT00305877|11464935|FG001|Overall Study|Physician Decision|1
7253630|NCT00305877|11464934|FG000|Overall Study|Never start treatment|2
7253631|NCT00305877|11464935|FG001|Overall Study|Never start treatment|5
7253632|NCT00305877|11464934|FG000|Overall Study|Ineligible|2
7253633|NCT00305877|11464935|FG001|Overall Study|Ineligible|1
7253634|NCT00305877|11464934|FG000|Overall Study|Transportation issue with daily RT|0
7253635|NCT00305877|11464935|FG001|Overall Study|Transportation issue with daily RT|1
7253636|NCT00306189|11464958|FG000|Overall Study|Physician Decision|0
7253637|NCT00306189|11464959|FG001|Overall Study|Physician Decision|0
7253638|NCT00306189|11464960|FG002|Overall Study|Physician Decision|0
7253639|NCT00306189|11464961|FG003|Overall Study|Physician Decision|1
7253640|NCT00306189|11464958|FG000|Overall Study|Adverse Event|3
7253641|NCT00306189|11464959|FG001|Overall Study|Adverse Event|3
7253642|NCT00306189|11464960|FG002|Overall Study|Adverse Event|2
7253643|NCT00306189|11464961|FG003|Overall Study|Adverse Event|2
7253644|NCT00306189|11464958|FG000|Overall Study|Withdrawal by Subject|4
7253645|NCT00306189|11464959|FG001|Overall Study|Withdrawal by Subject|2
7253646|NCT00306189|11464960|FG002|Overall Study|Withdrawal by Subject|8
7253647|NCT00306189|11464961|FG003|Overall Study|Withdrawal by Subject|1
7253648|NCT00306189|11464958|FG000|Overall Study|Ineligibility determined|1
7253649|NCT00306189|11464959|FG001|Overall Study|Ineligibility determined|1
7253650|NCT00306189|11464960|FG002|Overall Study|Ineligibility determined|1
7253651|NCT00306189|11464961|FG003|Overall Study|Ineligibility determined|1
7253652|NCT00306189|11464958|FG000|Overall Study|Other|1
7253653|NCT00306189|11464959|FG001|Overall Study|Other|0
7253654|NCT00306189|11464960|FG002|Overall Study|Other|0
7253655|NCT00306189|11464961|FG003|Overall Study|Other|0
7253656|NCT00306293|11465022|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
7253657|NCT00306293|11465023|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
7253658|NCT00306293|11465022|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
7253659|NCT00306293|11465023|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
7253660|NCT00306293|11465022|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7253661|NCT00306293|11465023|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
7253662|NCT00306293|11465022|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7253663|NCT00306293|11465023|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
7253664|NCT00306293|11465022|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
7253665|NCT00306293|11465023|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
7253666|NCT00306293|11465022|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
7253667|NCT00306293|11465023|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
7253668|NCT00306293|11465022|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
7253669|NCT00306293|11465023|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
7253670|NCT00306293|11465022|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
7253671|NCT00306293|11465023|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
7253672|NCT00306384|11465034|FG000|Overall Study|Adverse Event|103
7253673|NCT00306384|11465035|FG001|Overall Study|Adverse Event|87
7253674|NCT00306384|11465036|FG002|Overall Study|Adverse Event|40
7253675|NCT00306384|11465034|FG000|Overall Study|Major protocol deviation|43
7253676|NCT00306384|11465035|FG001|Overall Study|Major protocol deviation|51
7253677|NCT00306384|11465036|FG002|Overall Study|Major protocol deviation|18
7253678|NCT00306384|11465034|FG000|Overall Study|Lost to Follow-up|57
7253679|NCT00306384|11465035|FG001|Overall Study|Lost to Follow-up|41
7253680|NCT00306384|11465036|FG002|Overall Study|Lost to Follow-up|35
7253681|NCT00306384|11465034|FG000|Overall Study|Voluntary withdrawal|199
7253682|NCT00306384|11465035|FG001|Overall Study|Voluntary withdrawal|187
7253683|NCT00306384|11465036|FG002|Overall Study|Voluntary withdrawal|91
7253684|NCT00306384|11465034|FG000|Overall Study|Study termination|1
7253685|NCT00306384|11465035|FG001|Overall Study|Study termination|0
7253686|NCT00306384|11465036|FG002|Overall Study|Study termination|1
7253687|NCT00306384|11465034|FG000|Overall Study|Pregnancy|3
7253688|NCT00306384|11465035|FG001|Overall Study|Pregnancy|1
7253689|NCT00306384|11465036|FG002|Overall Study|Pregnancy|1
7253690|NCT00306384|11465034|FG000|Overall Study|Lack of Efficacy|26
7253691|NCT00306384|11465035|FG001|Overall Study|Lack of Efficacy|40
7253692|NCT00306384|11465036|FG002|Overall Study|Lack of Efficacy|38
7253693|NCT00306384|11465034|FG000|Overall Study|Investigator discretion|28
7253694|NCT00306384|11465035|FG001|Overall Study|Investigator discretion|31
7253695|NCT00306384|11465036|FG002|Overall Study|Investigator discretion|21
7253696|NCT00306384|11465034|FG000|Overall Study|Other|80
7253697|NCT00306384|11465035|FG001|Overall Study|Other|70
7253698|NCT00306384|11465036|FG002|Overall Study|Other|32
7253699|NCT00306384|11465034|FG000|Overall Study|Site closure|2
7253700|NCT00306384|11465035|FG001|Overall Study|Site closure|0
7253701|NCT00306384|11465036|FG002|Overall Study|Site closure|0
7253702|NCT00306527|11465053|FG000|Overall Study|Lost to Follow-up|3
7253703|NCT00306527|11465054|FG001|Overall Study|Lost to Follow-up|4
7253704|NCT00306527|11465055|FG002|Overall Study|Lost to Follow-up|3
7253705|NCT00306527|11465056|FG003|Overall Study|Lost to Follow-up|0
7253706|NCT00306527|11465053|FG000|Overall Study|Withdrawal by Subject|2
7253707|NCT00306527|11465054|FG001|Overall Study|Withdrawal by Subject|3
7253708|NCT00306527|11465055|FG002|Overall Study|Withdrawal by Subject|0
7253709|NCT00306527|11465056|FG003|Overall Study|Withdrawal by Subject|3
7253710|NCT00306527|11465053|FG000|Overall Study|Adverse Event|0
7253711|NCT00306527|11465054|FG001|Overall Study|Adverse Event|0
7253712|NCT00306527|11465055|FG002|Overall Study|Adverse Event|1
7253713|NCT00306527|11465056|FG003|Overall Study|Adverse Event|1
7253714|NCT00306527|11465053|FG000|Overall Study|Death|1
7253715|NCT00306527|11465054|FG001|Overall Study|Death|0
7253716|NCT00306527|11465055|FG002|Overall Study|Death|1
7253717|NCT00306527|11465056|FG003|Overall Study|Death|2
7253718|NCT00306592|11465070|FG000|Overall Study|Adverse Event|8
7253719|NCT00306592|11465071|FG001|Overall Study|Adverse Event|15
7253720|NCT00306592|11465070|FG000|Overall Study|Lost to Follow-up|1
7253721|NCT00306592|11465071|FG001|Overall Study|Lost to Follow-up|0
7253722|NCT00306592|11465070|FG000|Overall Study|Noncompliance|0
7253723|NCT00306592|11465071|FG001|Overall Study|Noncompliance|2
7253724|NCT00306592|11465070|FG000|Overall Study|Persistent Antibodies|6
7253725|NCT00306592|11465071|FG001|Overall Study|Persistent Antibodies|3
7253726|NCT00306592|11465070|FG000|Overall Study|Voluntary|10
7253727|NCT00306592|11465071|FG001|Overall Study|Voluntary|6
7253728|NCT00306592|11465070|FG000|Overall Study|Other|5
7253729|NCT00306592|11465071|FG001|Overall Study|Other|10
7253730|NCT00306592|11465070|FG000|Overall Study|Other|1
7253731|NCT00306592|11465071|FG001|Overall Study|Other|2
7253732|NCT00306592|11465070|FG000|Overall Study|48-week Treatment Period Ongoing|0
7253733|NCT00306592|11465071|FG001|Overall Study|48-week Treatment Period Ongoing|20
7253734|NCT00306670|11465077|FG000|Overall Study|patients recruited; Genentech, the st|0
7253735|NCT00306670|11465078|FG001|Overall Study|patients recruited; Genentech, the st|2
7253736|NCT00306787|11465086|FG000|Overall Study|Discontinued without taking study drug|208
7253737|NCT00306787|11465087|FG001|Overall Study|Discontinued without taking study drug|215
7253738|NCT00306787|11465086|FG000|Overall Study|Adverse Event|1
7253739|NCT00306787|11465087|FG001|Overall Study|Adverse Event|1
7253740|NCT00306787|11465086|FG000|Overall Study|Lack of Efficacy|1
7253741|NCT00306787|11465087|FG001|Overall Study|Lack of Efficacy|0
7253742|NCT00306787|11465086|FG000|Overall Study|Protocol Violation|8
7253743|NCT00306787|11465087|FG001|Overall Study|Protocol Violation|10
7253744|NCT00306787|11465086|FG000|Overall Study|Withdrawal by Subject|2
7253745|NCT00306787|11465087|FG001|Overall Study|Withdrawal by Subject|9
7253746|NCT00306787|11465086|FG000|Overall Study|Lost to Follow-up|9
7253747|NCT00306787|11465087|FG001|Overall Study|Lost to Follow-up|6
7253748|NCT00306787|11465086|FG000|Overall Study|Administrative problems|4
7253749|NCT00306787|11465087|FG001|Overall Study|Administrative problems|0
7253750|NCT00306787|11465086|FG000|Overall Study|Abnormal laboratory value(s)|1
7253751|NCT00306787|11465087|FG001|Overall Study|Abnormal laboratory value(s)|0
7253752|NCT00306852|11465095|FG000|Overall Study|Death|14
7253753|NCT00306852|11465096|FG001|Overall Study|Death|14
7253754|NCT00306852|11465095|FG000|Overall Study|Lost to Follow-up|15
7253755|NCT00306852|11465096|FG001|Overall Study|Lost to Follow-up|24
7253756|NCT00306891|11465106|FG000|Part A|Withdrawal by Subject|1
7253757|NCT00306891|11465107|FG001|Part A|Withdrawal by Subject|1
7253758|NCT00306891|11465108|FG002|Part A|Withdrawal by Subject|0
7253759|NCT00306891|11465109|FG003|Part A|Withdrawal by Subject|0
7253760|NCT00306891|11465106|FG000|Part A|Condition under investigation worsened|2
7253761|NCT00306891|11465107|FG001|Part A|Condition under investigation worsened|2
7253762|NCT00306891|11465108|FG002|Part A|Condition under investigation worsened|0
7253763|NCT00306891|11465109|FG003|Part A|Condition under investigation worsened|0
7253764|NCT00306891|11465106|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
7253765|NCT00306891|11465107|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
7253766|NCT00306891|11465108|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
7253767|NCT00306891|11465109|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
7253768|NCT00306891|11465106|FG000|Part A|Partial bowel obstruction|1
7253769|NCT00306891|11465107|FG001|Part A|Partial bowel obstruction|0
7253770|NCT00306891|11465108|FG002|Part A|Partial bowel obstruction|0
7253771|NCT00306891|11465109|FG003|Part A|Partial bowel obstruction|0
7253772|NCT00306891|11465106|FG000|Part A|Reaccumul. of ascites following drainage|0
7253773|NCT00306891|11465107|FG001|Part A|Reaccumul. of ascites following drainage|1
7253774|NCT00306891|11465108|FG002|Part A|Reaccumul. of ascites following drainage|0
7253775|NCT00306891|11465109|FG003|Part A|Reaccumul. of ascites following drainage|0
7253776|NCT00306891|11465106|FG000|Part A|Suspicion of second malignancy|0
7253777|NCT00306891|11465107|FG001|Part A|Suspicion of second malignancy|1
7253778|NCT00306891|11465108|FG002|Part A|Suspicion of second malignancy|0
7253779|NCT00306891|11465109|FG003|Part A|Suspicion of second malignancy|0
7253780|NCT00306891|11465106|FG000|Part A|QTC interval outwith elig. criteria|1
7253781|NCT00306891|11465107|FG001|Part A|QTC interval outwith elig. criteria|0
7253782|NCT00306891|11465108|FG002|Part A|QTC interval outwith elig. criteria|0
7253783|NCT00306891|11465109|FG003|Part A|QTC interval outwith elig. criteria|0
7253784|NCT00306891|11465106|FG000|Part B|Death|0
7253785|NCT00306891|11465107|FG001|Part B|Death|0
7253786|NCT00306891|11465108|FG002|Part B|Death|1
7253787|NCT00306891|11465109|FG003|Part B|Death|2
7253788|NCT00306891|11465106|FG000|Part B|Adverse Event|0
7253789|NCT00306891|11465107|FG001|Part B|Adverse Event|0
7253790|NCT00306891|11465108|FG002|Part B|Adverse Event|5
7253791|NCT00306891|11465109|FG003|Part B|Adverse Event|5
7253792|NCT00306891|11465106|FG000|Part B|Withdrawal by Subject|0
7253793|NCT00306891|11465107|FG001|Part B|Withdrawal by Subject|0
7253794|NCT00306891|11465108|FG002|Part B|Withdrawal by Subject|3
7253795|NCT00306891|11465109|FG003|Part B|Withdrawal by Subject|1
7253796|NCT00306891|11465106|FG000|Part B|Condition under investigation worsened|0
7253797|NCT00306891|11465107|FG001|Part B|Condition under investigation worsened|0
7253798|NCT00306891|11465108|FG002|Part B|Condition under investigation worsened|2
7253799|NCT00306891|11465109|FG003|Part B|Condition under investigation worsened|8
7253800|NCT00306891|11465106|FG000|Part B|Development of study specific disc crit.|0
7253801|NCT00306891|11465107|FG001|Part B|Development of study specific disc crit.|0
7253802|NCT00306891|11465108|FG002|Part B|Development of study specific disc crit.|0
7253803|NCT00306891|11465109|FG003|Part B|Development of study specific disc crit.|1
7253804|NCT00306995|11465136|FG000|Study Part I|Withdrawal by Subject|0
7253805|NCT00306995|11465137|FG001|Study Part I|Withdrawal by Subject|0
7253806|NCT00306995|11465138|FG002|Study Part I|Withdrawal by Subject|0
7253807|NCT00306995|11465139|FG003|Study Part I|Withdrawal by Subject|0
7253808|NCT00306995|11465140|FG004|Study Part I|Withdrawal by Subject|0
7253809|NCT00306995|11465141|FG005|Study Part I|Withdrawal by Subject|0
7253810|NCT00306995|11465142|FG006|Study Part I|Withdrawal by Subject|1
7253811|NCT00306995|11465136|FG000|Study Part II for Subset 2|Serious Adverse Event|0
7253812|NCT00306995|11465137|FG001|Study Part II for Subset 2|Serious Adverse Event|1
7253813|NCT00306995|11465138|FG002|Study Part II for Subset 2|Serious Adverse Event|0
7253814|NCT00306995|11465139|FG003|Study Part II for Subset 2|Serious Adverse Event|0
7253815|NCT00306995|11465140|FG004|Study Part II for Subset 2|Serious Adverse Event|0
7253816|NCT00306995|11465141|FG005|Study Part II for Subset 2|Serious Adverse Event|0
7253817|NCT00306995|11465142|FG006|Study Part II for Subset 2|Serious Adverse Event|0
7253818|NCT00307034|11465189|FG000|Overall Study|Adverse Event|1
7253819|NCT00307034|11465190|FG001|Overall Study|Adverse Event|2
7253820|NCT00307034|11465189|FG000|Overall Study|Withdrawal by Subject|1
7253821|NCT00307034|11465190|FG001|Overall Study|Withdrawal by Subject|2
7253822|NCT00307034|11465189|FG000|Overall Study|Lost to Follow-up|0
7253823|NCT00307034|11465190|FG001|Overall Study|Lost to Follow-up|3
7253824|NCT00307047|11465198|FG000|Overall Study|Lost to Follow-up|35
7253825|NCT00307047|11465199|FG001|Overall Study|Lost to Follow-up|24
7253826|NCT00307047|11465198|FG000|Overall Study|Withdrawal by Subject|6
7253827|NCT00307047|11465199|FG001|Overall Study|Withdrawal by Subject|6
7253828|NCT00307047|11465198|FG000|Overall Study|Physician Decision|1
7253829|NCT00307047|11465199|FG001|Overall Study|Physician Decision|2
7384015|NCT01192100|11641102|FG003|Overall Study|Protocol Violation|1
7384016|NCT01192100|11641103|FG004|Overall Study|Protocol Violation|0
7384017|NCT01192100|11641104|FG005|Overall Study|Protocol Violation|0
7384018|NCT01192126|11641114|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
7384019|NCT01192126|11641115|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
7384020|NCT01192126|11641114|FG000|First Intervention (1 Week)|Lost to Follow-up|1
7384021|NCT01192126|11641115|FG001|First Intervention (1 Week)|Lost to Follow-up|1
7384022|NCT01192152|11641134|FG000|Period 1|left prematurely (while on treatment B)|0
7384023|NCT01192152|11641135|FG001|Period 1|left prematurely (while on treatment B)|1
7384024|NCT01192152|11641134|FG000|Period 3|family emergency|1
7384025|NCT01192152|11641135|FG001|Period 3|family emergency|0
7384026|NCT01192178|11641145|FG000|Overall Study|Withdrawal by Subject|6
7384027|NCT01192178|11641146|FG001|Overall Study|Withdrawal by Subject|10
7384028|NCT01192178|11641145|FG000|Overall Study|Protocol Violation|10
7384029|NCT01192178|11641146|FG001|Overall Study|Protocol Violation|3
7384030|NCT01192178|11641145|FG000|Overall Study|Physician Decision|2
7384031|NCT01192178|11641146|FG001|Overall Study|Physician Decision|4
7384032|NCT01192178|11641145|FG000|Overall Study|Lost to Follow-up|3
7384033|NCT01192178|11641146|FG001|Overall Study|Lost to Follow-up|3
7253830|NCT00307047|11465198|FG000|Overall Study|Lost to follow-up for other reasons|0
7253831|NCT00307047|11465199|FG001|Overall Study|Lost to follow-up for other reasons|1
7253832|NCT00307047|11465198|FG000|Overall Study|All death, all MI, all Revascularization|27
7253833|NCT00307047|11465199|FG001|Overall Study|All death, all MI, all Revascularization|16
7253834|NCT00307086|11465205|FG000|Overall Study|ineligible|5
7253835|NCT00307125|11465211|FG000|Screening Phase|Adverse Event|1
7253836|NCT00307125|11465212|FG001|Screening Phase|Adverse Event|0
7253837|NCT00307125|11465213|FG002|Screening Phase|Adverse Event|0
7253838|NCT00307125|11465211|FG000|Screening Phase|Protocol Violation|27
7253839|NCT00307125|11465212|FG001|Screening Phase|Protocol Violation|0
7253840|NCT00307125|11465213|FG002|Screening Phase|Protocol Violation|0
7253841|NCT00307125|11465211|FG000|Screening Phase|Lost to Follow-up|87
7253842|NCT00307125|11465212|FG001|Screening Phase|Lost to Follow-up|0
7253843|NCT00307125|11465213|FG002|Screening Phase|Lost to Follow-up|0
7253844|NCT00307125|11465211|FG000|Screening Phase|Death|10
7253845|NCT00307125|11465212|FG001|Screening Phase|Death|0
7253846|NCT00307125|11465213|FG002|Screening Phase|Death|0
7253847|NCT00307125|11465211|FG000|Screening Phase|Withdrawal by Subject|77
7253848|NCT00307125|11465212|FG001|Screening Phase|Withdrawal by Subject|0
7253849|NCT00307125|11465213|FG002|Screening Phase|Withdrawal by Subject|0
7253850|NCT00307125|11465211|FG000|Screening Phase|Physician Decision|26
7253851|NCT00307125|11465212|FG001|Screening Phase|Physician Decision|0
7253852|NCT00307125|11465213|FG002|Screening Phase|Physician Decision|0
7253853|NCT00307125|11465211|FG000|Screening Phase|Sponsor Decision|4
7253854|NCT00307125|11465212|FG001|Screening Phase|Sponsor Decision|0
7253855|NCT00307125|11465213|FG002|Screening Phase|Sponsor Decision|0
7253856|NCT00307125|11465211|FG000|Screening Phase|Study Terminated|17
7253857|NCT00307125|11465212|FG001|Screening Phase|Study Terminated|0
7253858|NCT00307125|11465213|FG002|Screening Phase|Study Terminated|0
7253859|NCT00307125|11465211|FG000|Screening Phase|Graft Loss|3
7253860|NCT00307125|11465212|FG001|Screening Phase|Graft Loss|0
7253861|NCT00307125|11465213|FG002|Screening Phase|Graft Loss|0
7253862|NCT00307125|11465211|FG000|Screening Phase|Graft Failure|8
7253863|NCT00307125|11465212|FG001|Screening Phase|Graft Failure|0
7253864|NCT00307125|11465213|FG002|Screening Phase|Graft Failure|0
7253865|NCT00307125|11465211|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
7253866|NCT00307125|11465212|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7253867|NCT00307125|11465213|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
7253868|NCT00307125|11465211|FG000|Screening Phase|Scheduling issues/Non-compliance|55
7253869|NCT00307125|11465212|FG001|Screening Phase|Scheduling issues/Non-compliance|0
7253870|NCT00307125|11465213|FG002|Screening Phase|Scheduling issues/Non-compliance|0
7253871|NCT00307125|11465211|FG000|Screening Phase|Moved or transferred facilities|34
7253872|NCT00307125|11465212|FG001|Screening Phase|Moved or transferred facilities|0
7253873|NCT00307125|11465213|FG002|Screening Phase|Moved or transferred facilities|0
7253874|NCT00307125|11465211|FG000|Screening Phase|Received Pancreas Transplant|8
7253875|NCT00307125|11465212|FG001|Screening Phase|Received Pancreas Transplant|0
7253876|NCT00307125|11465213|FG002|Screening Phase|Received Pancreas Transplant|0
7253877|NCT00307125|11465211|FG000|Screening Phase|Ineligible for pilot|4
7253878|NCT00307125|11465212|FG001|Screening Phase|Ineligible for pilot|0
7253879|NCT00307125|11465213|FG002|Screening Phase|Ineligible for pilot|0
7253880|NCT00307125|11465211|FG000|Screening Phase|Try to get pregnant|1
7253881|NCT00307125|11465212|FG001|Screening Phase|Try to get pregnant|0
7253882|NCT00307125|11465213|FG002|Screening Phase|Try to get pregnant|0
7253883|NCT00307125|11465211|FG000|Screening Phase|Developed acute leukemia|1
7253884|NCT00307125|11465212|FG001|Screening Phase|Developed acute leukemia|0
7253885|NCT00307125|11465213|FG002|Screening Phase|Developed acute leukemia|0
7253886|NCT00307125|11465211|FG000|Screening Phase|Metastatic colon cancer|1
7253887|NCT00307125|11465212|FG001|Screening Phase|Metastatic colon cancer|0
7253888|NCT00307125|11465213|FG002|Screening Phase|Metastatic colon cancer|0
7253889|NCT00307125|11465211|FG000|Screening Phase|Malignancy|1
7253890|NCT00307125|11465212|FG001|Screening Phase|Malignancy|0
7253891|NCT00307125|11465213|FG002|Screening Phase|Malignancy|0
7253892|NCT00307125|11465211|FG000|Screening Phase|PAK|1
7253893|NCT00307125|11465212|FG001|Screening Phase|PAK|0
7253894|NCT00307125|11465213|FG002|Screening Phase|PAK|0
7253895|NCT00307125|11465211|FG000|Screening Phase|Ineligible|1
7253896|NCT00307125|11465212|FG001|Screening Phase|Ineligible|0
7253897|NCT00307125|11465213|FG002|Screening Phase|Ineligible|0
7384034|NCT01192178|11641145|FG000|Overall Study|Adverse Event|2
7384035|NCT01192178|11641146|FG001|Overall Study|Adverse Event|1
7384036|NCT01192178|11641145|FG000|Overall Study|Lack of Efficacy|1
7384037|NCT01192178|11641146|FG001|Overall Study|Lack of Efficacy|2
7574448|NCT03679741|11957212|FG000|Period 2|Withdrawal by Subject|1
7253898|NCT00307125|11465211|FG000|Screening Phase|Screen Error|1
7253899|NCT00307125|11465212|FG001|Screening Phase|Screen Error|0
7253900|NCT00307125|11465213|FG002|Screening Phase|Screen Error|0
7253901|NCT00307125|11465211|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
7253902|NCT00307125|11465212|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7253903|NCT00307125|11465213|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
7253904|NCT00307125|11465211|FG000|Screening Phase|AMR and treated with rituximab|1
7253905|NCT00307125|11465212|FG001|Screening Phase|AMR and treated with rituximab|0
7253906|NCT00307125|11465213|FG002|Screening Phase|AMR and treated with rituximab|0
7253907|NCT00307125|11465211|FG000|Screening Phase|Coronary artery bypass|1
7253908|NCT00307125|11465212|FG001|Screening Phase|Coronary artery bypass|0
7253909|NCT00307125|11465213|FG002|Screening Phase|Coronary artery bypass|0
7253910|NCT00307125|11465211|FG000|Pilot Phase|Lost to Follow-up|0
7253911|NCT00307125|11465212|FG001|Pilot Phase|Lost to Follow-up|1
7253912|NCT00307125|11465213|FG002|Pilot Phase|Lost to Follow-up|0
7253913|NCT00307125|11465211|FG000|Pilot Phase|Withdrawal by Subject|0
7253914|NCT00307125|11465212|FG001|Pilot Phase|Withdrawal by Subject|1
7253915|NCT00307125|11465213|FG002|Pilot Phase|Withdrawal by Subject|1
7253916|NCT00307151|11465227|FG000|Overall Study|Death|4
7253917|NCT00307151|11465228|FG001|Overall Study|Death|3
7253918|NCT00307151|11465229|FG002|Overall Study|Death|10
7253919|NCT00307151|11465230|FG003|Overall Study|Death|3
7253920|NCT00307151|11465227|FG000|Overall Study|Severe debilitation, unable to continue|1
7253921|NCT00307151|11465228|FG001|Overall Study|Severe debilitation, unable to continue|0
7253922|NCT00307151|11465229|FG002|Overall Study|Severe debilitation, unable to continue|0
7253923|NCT00307151|11465230|FG003|Overall Study|Severe debilitation, unable to continue|0
7253924|NCT00307151|11465227|FG000|Overall Study|Subject unable to get to clinic|1
7253925|NCT00307151|11465228|FG001|Overall Study|Subject unable to get to clinic|0
7253926|NCT00307151|11465229|FG002|Overall Study|Subject unable to get to clinic|6
7253927|NCT00307151|11465230|FG003|Overall Study|Subject unable to get to clinic|2
7253928|NCT00307151|11465227|FG000|Overall Study|Withdrew consent|0
7253929|NCT00307151|11465228|FG001|Overall Study|Withdrew consent|1
7253930|NCT00307151|11465229|FG002|Overall Study|Withdrew consent|1
7253931|NCT00307151|11465230|FG003|Overall Study|Withdrew consent|3
7253932|NCT00307151|11465227|FG000|Overall Study|Not willing to adhere to study reqs|2
7253933|NCT00307151|11465228|FG001|Overall Study|Not willing to adhere to study reqs|0
7253934|NCT00307151|11465229|FG002|Overall Study|Not willing to adhere to study reqs|2
7253935|NCT00307151|11465230|FG003|Overall Study|Not willing to adhere to study reqs|2
7253936|NCT00307151|11465227|FG000|Overall Study|Clinic unable to contact subject|3
7253937|NCT00307151|11465228|FG001|Overall Study|Clinic unable to contact subject|3
7253938|NCT00307151|11465229|FG002|Overall Study|Clinic unable to contact subject|1
7253939|NCT00307151|11465230|FG003|Overall Study|Clinic unable to contact subject|1
7574449|NCT03679741|11957213|FG001|Period 2|Withdrawal by Subject|1
7574450|NCT03680521|11957266|FG000|Overall Study|Ongoing in long-term follow up|7
7574451|NCT03680521|11957267|FG001|Overall Study|Ongoing in long-term follow up|11
7574452|NCT03680742|11957276|FG000|Overall Study|Unsuccessful Implant Attempt|2
7574453|NCT03681093|11957283|FG000|Overall Study|Subject decision|0
7574454|NCT03681093|11957284|FG001|Overall Study|Subject decision|2
7574455|NCT03681093|11957285|FG002|Overall Study|Subject decision|1
7574456|NCT03681119|11957295|FG000|Overall Study|No specific reason|4
7574457|NCT03681119|11957296|FG001|Overall Study|No specific reason|0
7574458|NCT03681119|11957295|FG000|Overall Study|Sickness|2
7574459|NCT03681119|11957296|FG001|Overall Study|Sickness|0
7574460|NCT03681353|11957300|FG000|Overall Study|Lost to Follow-up|2
7574461|NCT03681353|11957300|FG000|Overall Study|Withdrawal by Subject|3
7574462|NCT03681353|11957300|FG000|Overall Study|withdrawn by PI|2
7574463|NCT03681405|11957306|FG000|Overall Study|Found to be ineligible after randomized|1
7574464|NCT03681405|11957307|FG001|Overall Study|Found to be ineligible after randomized|0
7574465|NCT03681951|11957353|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
7574466|NCT03681951|11957354|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7253940|NCT00307164|11465242|FG000|Overall Study|Death|1
7253941|NCT00307164|11465243|FG001|Overall Study|Death|0
7253942|NCT00307164|11465242|FG000|Overall Study|Severe debilitation, unable to continue|1
7253943|NCT00307164|11465243|FG001|Overall Study|Severe debilitation, unable to continue|0
7253944|NCT00307164|11465242|FG000|Overall Study|Subject/parent not able to get to clinic|2
7253945|NCT00307164|11465243|FG001|Overall Study|Subject/parent not able to get to clinic|1
7384038|NCT01192191|11641156|FG000|Overall Study|Adverse Event|7
7253946|NCT00307164|11465242|FG000|Overall Study|Withdrawal by Subject|1
7253947|NCT00307164|11465243|FG001|Overall Study|Withdrawal by Subject|8
7253948|NCT00307164|11465242|FG000|Overall Study|Not compliant with requirements|4
7253949|NCT00307164|11465243|FG001|Overall Study|Not compliant with requirements|4
7253950|NCT00307164|11465242|FG000|Overall Study|Lost to Follow-up|6
7253951|NCT00307164|11465243|FG001|Overall Study|Lost to Follow-up|1
7253952|NCT00307294|11465249|FG000|Overall Study|Withdrawal by Subject|1
7253953|NCT00307333|11465256|FG000|Overall Study|Lost to Follow-up|11
7253954|NCT00307333|11465257|FG001|Overall Study|Lost to Follow-up|3
7253955|NCT00307437|11465266|FG000|Controlled Period|Adverse Event|7
7253956|NCT00307437|11465267|FG001|Controlled Period|Adverse Event|2
7253957|NCT00307437|11465268|FG002|Controlled Period|Adverse Event|5
7253958|NCT00307437|11465269|FG003|Controlled Period|Adverse Event|0
7253959|NCT00307437|11465270|FG004|Controlled Period|Adverse Event|0
7253960|NCT00307437|11465271|FG005|Controlled Period|Adverse Event|0
7253961|NCT00307437|11465272|FG006|Controlled Period|Adverse Event|0
7253962|NCT00307437|11465266|FG000|Controlled Period|Death|0
7253963|NCT00307437|11465267|FG001|Controlled Period|Death|0
7253964|NCT00307437|11465268|FG002|Controlled Period|Death|1
7253965|NCT00307437|11465269|FG003|Controlled Period|Death|0
7253966|NCT00307437|11465270|FG004|Controlled Period|Death|0
7253967|NCT00307437|11465271|FG005|Controlled Period|Death|0
7253968|NCT00307437|11465272|FG006|Controlled Period|Death|0
7253969|NCT00307437|11465266|FG000|Controlled Period|Lack of Efficacy|2
7253970|NCT00307437|11465267|FG001|Controlled Period|Lack of Efficacy|0
7253971|NCT00307437|11465268|FG002|Controlled Period|Lack of Efficacy|0
7253972|NCT00307437|11465269|FG003|Controlled Period|Lack of Efficacy|0
7253973|NCT00307437|11465270|FG004|Controlled Period|Lack of Efficacy|0
7253974|NCT00307437|11465271|FG005|Controlled Period|Lack of Efficacy|0
7253975|NCT00307437|11465272|FG006|Controlled Period|Lack of Efficacy|0
7253976|NCT00307437|11465266|FG000|Controlled Period|Lost to Follow-up|2
7253977|NCT00307437|11465267|FG001|Controlled Period|Lost to Follow-up|3
7253978|NCT00307437|11465268|FG002|Controlled Period|Lost to Follow-up|0
7253979|NCT00307437|11465269|FG003|Controlled Period|Lost to Follow-up|0
7253980|NCT00307437|11465270|FG004|Controlled Period|Lost to Follow-up|0
7253981|NCT00307437|11465271|FG005|Controlled Period|Lost to Follow-up|0
7253982|NCT00307437|11465272|FG006|Controlled Period|Lost to Follow-up|0
7253983|NCT00307437|11465266|FG000|Controlled Period|Other|5
7253984|NCT00307437|11465267|FG001|Controlled Period|Other|1
7253985|NCT00307437|11465268|FG002|Controlled Period|Other|3
7253986|NCT00307437|11465269|FG003|Controlled Period|Other|0
7253987|NCT00307437|11465270|FG004|Controlled Period|Other|0
7253988|NCT00307437|11465271|FG005|Controlled Period|Other|0
7253989|NCT00307437|11465272|FG006|Controlled Period|Other|0
7253990|NCT00307437|11465266|FG000|After Controlled Period|Adverse Event|0
7253991|NCT00307437|11465267|FG001|After Controlled Period|Adverse Event|0
7253992|NCT00307437|11465268|FG002|After Controlled Period|Adverse Event|0
7253993|NCT00307437|11465269|FG003|After Controlled Period|Adverse Event|18
7253994|NCT00307437|11465270|FG004|After Controlled Period|Adverse Event|16
7253995|NCT00307437|11465271|FG005|After Controlled Period|Adverse Event|31
7253996|NCT00307437|11465272|FG006|After Controlled Period|Adverse Event|40
7253997|NCT00307437|11465266|FG000|After Controlled Period|Death|0
7253998|NCT00307437|11465267|FG001|After Controlled Period|Death|0
7253999|NCT00307437|11465268|FG002|After Controlled Period|Death|0
7254000|NCT00307437|11465269|FG003|After Controlled Period|Death|3
7254001|NCT00307437|11465270|FG004|After Controlled Period|Death|1
7254002|NCT00307437|11465271|FG005|After Controlled Period|Death|1
7254003|NCT00307437|11465272|FG006|After Controlled Period|Death|3
7254004|NCT00307437|11465266|FG000|After Controlled Period|Lack of Efficacy|0
7254005|NCT00307437|11465267|FG001|After Controlled Period|Lack of Efficacy|0
7254006|NCT00307437|11465268|FG002|After Controlled Period|Lack of Efficacy|0
7254007|NCT00307437|11465269|FG003|After Controlled Period|Lack of Efficacy|15
7254008|NCT00307437|11465270|FG004|After Controlled Period|Lack of Efficacy|17
7254009|NCT00307437|11465271|FG005|After Controlled Period|Lack of Efficacy|37
7254010|NCT00307437|11465272|FG006|After Controlled Period|Lack of Efficacy|24
7254011|NCT00307437|11465266|FG000|After Controlled Period|Lost to Follow-up|0
7254012|NCT00307437|11465267|FG001|After Controlled Period|Lost to Follow-up|0
7254013|NCT00307437|11465268|FG002|After Controlled Period|Lost to Follow-up|0
7254014|NCT00307437|11465269|FG003|After Controlled Period|Lost to Follow-up|7
7254015|NCT00307437|11465270|FG004|After Controlled Period|Lost to Follow-up|12
7254016|NCT00307437|11465271|FG005|After Controlled Period|Lost to Follow-up|13
7254017|NCT00307437|11465272|FG006|After Controlled Period|Lost to Follow-up|18
7254018|NCT00307437|11465266|FG000|After Controlled Period|Other|0
7254019|NCT00307437|11465267|FG001|After Controlled Period|Other|0
7254020|NCT00307437|11465268|FG002|After Controlled Period|Other|0
7254021|NCT00307437|11465269|FG003|After Controlled Period|Other|15
7254022|NCT00307437|11465270|FG004|After Controlled Period|Other|9
7254023|NCT00307437|11465271|FG005|After Controlled Period|Other|40
7254024|NCT00307437|11465272|FG006|After Controlled Period|Other|28
7254025|NCT00307489|11465296|FG000|Baseline Through Week 48|Lost to Follow-up|0
7254026|NCT00307489|11465297|FG001|Baseline Through Week 48|Lost to Follow-up|1
7254027|NCT00307489|11465296|FG000|Baseline Through Week 48|Physician Decision|1
7254028|NCT00307489|11465297|FG001|Baseline Through Week 48|Physician Decision|0
7254029|NCT00307489|11465296|FG000|Baseline Through Week 48|Withdrawal by Subject|0
7254030|NCT00307489|11465297|FG001|Baseline Through Week 48|Withdrawal by Subject|1
7254031|NCT00307489|11465296|FG000|Week 48 Through Week 168|Adverse Event|1
7254032|NCT00307489|11465297|FG001|Week 48 Through Week 168|Adverse Event|0
7254033|NCT00307489|11465296|FG000|Week 48 Through Week 168|Physician Decision|1
7254034|NCT00307489|11465297|FG001|Week 48 Through Week 168|Physician Decision|0
7254035|NCT00307489|11465296|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
7254036|NCT00307489|11465297|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
7254037|NCT00307489|11465296|FG000|Week 48 Through Week 168|Lack of Efficacy|2
7254038|NCT00307489|11465297|FG001|Week 48 Through Week 168|Lack of Efficacy|2
7254039|NCT00307489|11465296|FG000|Week 48 Through Week 168|Death|0
7254040|NCT00307489|11465297|FG001|Week 48 Through Week 168|Death|1
7254041|NCT00307489|11465296|FG000|Week 48 Through Week 168|Lost to Follow-up|0
7254042|NCT00307489|11465297|FG001|Week 48 Through Week 168|Lost to Follow-up|1
7254043|NCT00307489|11465296|FG000|Week 48 Through Week 168|Seroconversion|1
7254044|NCT00307489|11465297|FG001|Week 48 Through Week 168|Seroconversion|0
7254045|NCT00307684|11465303|FG000|Open Label Phase|Lack of Efficacy|0
7254046|NCT00307684|11465304|FG001|Open Label Phase|Lack of Efficacy|0
7254047|NCT00307684|11465305|FG002|Open Label Phase|Lack of Efficacy|3
7254048|NCT00307684|11465303|FG000|Open Label Phase|Adverse Event|0
7254049|NCT00307684|11465304|FG001|Open Label Phase|Adverse Event|0
7254050|NCT00307684|11465305|FG002|Open Label Phase|Adverse Event|16
7254051|NCT00307684|11465303|FG000|Open Label Phase|Withdrawal by Subject|0
7254052|NCT00307684|11465304|FG001|Open Label Phase|Withdrawal by Subject|0
7254053|NCT00307684|11465305|FG002|Open Label Phase|Withdrawal by Subject|15
7254054|NCT00307684|11465303|FG000|Open Label Phase|Lost to Follow-up|0
7254055|NCT00307684|11465304|FG001|Open Label Phase|Lost to Follow-up|0
7254056|NCT00307684|11465305|FG002|Open Label Phase|Lost to Follow-up|11
7254057|NCT00307684|11465303|FG000|Open Label Phase|non compliance|0
7254058|NCT00307684|11465304|FG001|Open Label Phase|non compliance|0
7254059|NCT00307684|11465305|FG002|Open Label Phase|non compliance|5
7254060|NCT00307684|11465303|FG000|Open Label Phase|other|0
7254061|NCT00307684|11465304|FG001|Open Label Phase|other|0
7254062|NCT00307684|11465305|FG002|Open Label Phase|other|6
7254063|NCT00307684|11465303|FG000|Double Blind Phase|Lack of Efficacy|2
7254064|NCT00307684|11465304|FG001|Double Blind Phase|Lack of Efficacy|5
7254065|NCT00307684|11465305|FG002|Double Blind Phase|Lack of Efficacy|0
7254066|NCT00307736|11465313|FG000|Overall Study|Adverse Event|0
7254067|NCT00307736|11465314|FG001|Overall Study|Adverse Event|0
7254068|NCT00307736|11465315|FG002|Overall Study|Adverse Event|1
7254069|NCT00307736|11465316|FG003|Overall Study|Adverse Event|3
7254070|NCT00307736|11465313|FG000|Overall Study|Withdrawal by Subject|0
7254071|NCT00307736|11465314|FG001|Overall Study|Withdrawal by Subject|0
7254072|NCT00307736|11465315|FG002|Overall Study|Withdrawal by Subject|2
7254073|NCT00307736|11465316|FG003|Overall Study|Withdrawal by Subject|0
7254074|NCT00307801|11465329|FG000|Overall Study|Adverse Event|12
7254075|NCT00307801|11465330|FG001|Overall Study|Adverse Event|4
7254076|NCT00307801|11465329|FG000|Overall Study|Withdrawal by Subject|9
7254077|NCT00307801|11465330|FG001|Overall Study|Withdrawal by Subject|4
7254078|NCT00307801|11465329|FG000|Overall Study|Non-compliance, not taken all tablets|1
7254079|NCT00307801|11465330|FG001|Overall Study|Non-compliance, not taken all tablets|2
7254080|NCT00307801|11465329|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
7254081|NCT00307801|11465330|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
7254082|NCT00307801|11465329|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
7254083|NCT00307801|11465330|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
7254084|NCT00307801|11465329|FG000|Overall Study|Wrong Randomization|1
7254085|NCT00307801|11465330|FG001|Overall Study|Wrong Randomization|0
7254086|NCT00307801|11465329|FG000|Overall Study|Lack of Efficacy|0
7254087|NCT00307801|11465330|FG001|Overall Study|Lack of Efficacy|2
7254088|NCT00307801|11465329|FG000|Overall Study|Lost to Follow-up, moved abroad|1
7254089|NCT00307801|11465330|FG001|Overall Study|Lost to Follow-up, moved abroad|1
7254090|NCT00307801|11465329|FG000|Overall Study|Frustration with e-diary|1
7254091|NCT00307801|11465330|FG001|Overall Study|Frustration with e-diary|0
7254092|NCT00307801|11465329|FG000|Overall Study|Protocol Violation|3
7254093|NCT00307801|11465330|FG001|Overall Study|Protocol Violation|2
7254094|NCT00307801|11465329|FG000|Overall Study|No reason specified|2
7574467|NCT03681951|11957355|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7254095|NCT00307801|11465330|FG001|Overall Study|No reason specified|0
7254096|NCT00307801|11465329|FG000|Overall Study|Pregnancy|0
7254097|NCT00307801|11465330|FG001|Overall Study|Pregnancy|1
7254098|NCT00307931|11465337|FG000|Overall Study|Adverse Event|1
7254099|NCT00308074|11465351|FG000|Overall Study|Withdrawal by Subject|1
7254100|NCT00308087|11465357|FG000|Overall Study|Progressive Disease|19
7254101|NCT00308087|11465358|FG001|Overall Study|Progressive Disease|21
7574468|NCT03681951|11957356|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7254102|NCT00308087|11465357|FG000|Overall Study|Study Closure|11
7254103|NCT00308087|11465358|FG001|Overall Study|Study Closure|12
7254104|NCT00308087|11465357|FG000|Overall Study|Withdrawal by Subject|2
7254105|NCT00308087|11465358|FG001|Overall Study|Withdrawal by Subject|1
7254106|NCT00308087|11465357|FG000|Overall Study|Other|4
7254107|NCT00308087|11465358|FG001|Overall Study|Other|3
7254108|NCT00308139|11465366|FG000|Overall Study|Adverse Event|20
7254109|NCT00308139|11465367|FG001|Overall Study|Adverse Event|14
7254110|NCT00308139|11465366|FG000|Overall Study|Lost to Follow-up|13
7254111|NCT00308139|11465367|FG001|Overall Study|Lost to Follow-up|8
7254112|NCT00308139|11465366|FG000|Overall Study|Protocol Violation|3
7254113|NCT00308139|11465367|FG001|Overall Study|Protocol Violation|2
7254114|NCT00308139|11465366|FG000|Overall Study|Withdrawal of Consent|40
7254115|NCT00308139|11465367|FG001|Overall Study|Withdrawal of Consent|42
7254116|NCT00308139|11465366|FG000|Overall Study|Investigator Decision|11
7254117|NCT00308139|11465367|FG001|Overall Study|Investigator Decision|10
7254118|NCT00308139|11465366|FG000|Overall Study|Loss of Glucose Control|5
7254119|NCT00308139|11465367|FG001|Overall Study|Loss of Glucose Control|7
7254120|NCT00308139|11465366|FG000|Overall Study|Administrative|1
7254121|NCT00308139|11465367|FG001|Overall Study|Administrative|4
7254122|NCT00308139|11465366|FG000|Overall Study|Other|1
7254123|NCT00308139|11465367|FG001|Overall Study|Other|0
7254124|NCT00308308|11465428|FG000|Overall Study|Adverse Event|17
7254125|NCT00308308|11465429|FG001|Overall Study|Adverse Event|2
7254126|NCT00308308|11465428|FG000|Overall Study|Lost to Follow-up|5
7254127|NCT00308308|11465429|FG001|Overall Study|Lost to Follow-up|5
7254128|NCT00308308|11465428|FG000|Overall Study|Physician Decision|15
7254129|NCT00308308|11465429|FG001|Overall Study|Physician Decision|7
7254130|NCT00308308|11465428|FG000|Overall Study|Protocol Violation|3
7254131|NCT00308308|11465429|FG001|Overall Study|Protocol Violation|14
7254132|NCT00308308|11465428|FG000|Overall Study|Withdrawal by Subject|47
7254133|NCT00308308|11465429|FG001|Overall Study|Withdrawal by Subject|19
7254134|NCT00308308|11465428|FG000|Overall Study|Various|7
7254135|NCT00308308|11465429|FG001|Overall Study|Various|5
7254136|NCT00308308|11465428|FG000|Overall Study|Randomized but not dosed|8
7254137|NCT00308308|11465429|FG001|Overall Study|Randomized but not dosed|16
7254138|NCT00308308|11465428|FG000|Overall Study|Other|1
7254139|NCT00308308|11465429|FG001|Overall Study|Other|0
7254140|NCT00308555|11465437|FG000|Overall Study|Withdrawal by Subject|1
7254141|NCT00308555|11465438|FG001|Overall Study|Withdrawal by Subject|0
7254142|NCT00308555|11465437|FG000|Overall Study|Physician Decision|2
7254143|NCT00308555|11465438|FG001|Overall Study|Physician Decision|0
7254144|NCT00308581|11465444|FG000|Induction Phase|Adverse Event|0
7254145|NCT00308581|11465445|FG001|Induction Phase|Adverse Event|0
7254146|NCT00308581|11465446|FG002|Induction Phase|Adverse Event|37
7254147|NCT00308581|11465444|FG000|Induction Phase|Lack of Efficacy|0
7254148|NCT00308581|11465445|FG001|Induction Phase|Lack of Efficacy|0
7254149|NCT00308581|11465446|FG002|Induction Phase|Lack of Efficacy|121
7254150|NCT00308581|11465444|FG000|Induction Phase|Withdrawal by Subject|0
7254151|NCT00308581|11465445|FG001|Induction Phase|Withdrawal by Subject|0
7254152|NCT00308581|11465446|FG002|Induction Phase|Withdrawal by Subject|5
7254153|NCT00308581|11465444|FG000|Induction Phase|Unknown reason|0
7254154|NCT00308581|11465445|FG001|Induction Phase|Unknown reason|0
7254155|NCT00308581|11465446|FG002|Induction Phase|Unknown reason|3
7254156|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Adverse Event|10
7254157|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Adverse Event|17
7254158|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Adverse Event|0
7254159|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
7254160|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
7254161|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
7254162|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
7254163|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
7254164|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
7254165|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
7254166|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
7254167|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
7254168|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
7254169|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
7574469|NCT03681951|11957357|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7574470|NCT03681951|11957358|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7574471|NCT03681951|11957359|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7574472|NCT03681951|11957360|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
7574473|NCT03681951|11957353|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
7574474|NCT03681951|11957354|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574475|NCT03681951|11957355|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574476|NCT03681951|11957356|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574477|NCT03681951|11957357|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574478|NCT03681951|11957358|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574479|NCT03681951|11957359|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574480|NCT03681951|11957360|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
7574481|NCT03681951|11957353|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
7574482|NCT03681951|11957354|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7574483|NCT03681951|11957355|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7254170|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
7254171|NCT00308581|11465444|FG000|Randomized Maintenance Phase|Unknown reason|3
7254172|NCT00308581|11465445|FG001|Randomized Maintenance Phase|Unknown reason|0
7254173|NCT00308581|11465446|FG002|Randomized Maintenance Phase|Unknown reason|0
7254174|NCT00308620|11465457|FG000|Overall Study|Death|1
7254175|NCT00308620|11465458|FG001|Overall Study|Death|1
7574484|NCT03681951|11957356|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7574485|NCT03681951|11957357|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7574486|NCT03681951|11957358|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7574487|NCT03681951|11957359|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7574488|NCT03681951|11957360|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
7254176|NCT00308620|11465459|FG002|Overall Study|Death|0
7254177|NCT00308620|11465457|FG000|Overall Study|Lost to Follow-up|0
7254178|NCT00308620|11465458|FG001|Overall Study|Lost to Follow-up|0
7254179|NCT00308620|11465459|FG002|Overall Study|Lost to Follow-up|1
7254180|NCT00308711|11465470|FG000|Overall Study|Withdrawal by Subject|1
7254181|NCT00308711|11465471|FG001|Overall Study|Withdrawal by Subject|0
7254182|NCT00308711|11465472|FG002|Overall Study|Withdrawal by Subject|1
7254183|NCT00308711|11465470|FG000|Overall Study|Protocol Violation|0
7254184|NCT00308711|11465471|FG001|Overall Study|Protocol Violation|1
7254185|NCT00308711|11465472|FG002|Overall Study|Protocol Violation|1
7254186|NCT00308711|11465470|FG000|Overall Study|Lost to Follow-up|0
7254187|NCT00308711|11465471|FG001|Overall Study|Lost to Follow-up|1
7254188|NCT00308711|11465472|FG002|Overall Study|Lost to Follow-up|0
7254189|NCT00308711|11465470|FG000|Overall Study|Baby not born within 7 days of treatment|1
7254190|NCT00308711|11465471|FG001|Overall Study|Baby not born within 7 days of treatment|2
7254191|NCT00308711|11465472|FG002|Overall Study|Baby not born within 7 days of treatment|2
7254192|NCT00308711|11465470|FG000|Overall Study|Subject incarcerated, data not allowed|0
7254193|NCT00308711|11465471|FG001|Overall Study|Subject incarcerated, data not allowed|0
7254194|NCT00308711|11465472|FG002|Overall Study|Subject incarcerated, data not allowed|1
7254195|NCT00308737|11465483|FG000|Overall Study|Adverse Event|104
7254196|NCT00308737|11465484|FG001|Overall Study|Adverse Event|9
7254197|NCT00308737|11465485|FG002|Overall Study|Adverse Event|0
7254198|NCT00308737|11465483|FG000|Overall Study|Death|4
7254199|NCT00308737|11465484|FG001|Overall Study|Death|3
7254200|NCT00308737|11465485|FG002|Overall Study|Death|0
7254201|NCT00308737|11465483|FG000|Overall Study|Lost to Follow-up|56
7254202|NCT00308737|11465484|FG001|Overall Study|Lost to Follow-up|80
7254203|NCT00308737|11465485|FG002|Overall Study|Lost to Follow-up|5
7254204|NCT00308737|11465483|FG000|Overall Study|Physician Decision|15
7254205|NCT00308737|11465484|FG001|Overall Study|Physician Decision|2
7254206|NCT00308737|11465485|FG002|Overall Study|Physician Decision|1
7254207|NCT00308737|11465483|FG000|Overall Study|Protocol Violation|34
7254208|NCT00308737|11465484|FG001|Overall Study|Protocol Violation|9
7254209|NCT00308737|11465485|FG002|Overall Study|Protocol Violation|5
7254210|NCT00308737|11465483|FG000|Overall Study|Withdrawal by Subject|218
7254211|NCT00308737|11465484|FG001|Overall Study|Withdrawal by Subject|166
7254212|NCT00308737|11465485|FG002|Overall Study|Withdrawal by Subject|18
7254213|NCT00308737|11465483|FG000|Overall Study|Various|32
7254214|NCT00308737|11465484|FG001|Overall Study|Various|20
7254215|NCT00308737|11465485|FG002|Overall Study|Various|8
7256654|NCT00324168|11468246|FG001|Overall Study|Patient did not visit in f/u window|9
7256655|NCT00324233|11468254|FG000|First Period|unable to insert catheter|1
7256656|NCT00324233|11468255|FG001|First Period|unable to insert catheter|0
7256657|NCT00324233|11468254|FG000|Second Period|unable to insert catheter|1
7256658|NCT00324233|11468255|FG001|Second Period|unable to insert catheter|1
7256659|NCT00324233|11468254|FG000|Second Period|Protocol Violation|4
7256660|NCT00324233|11468255|FG001|Second Period|Protocol Violation|6
7256661|NCT00324649|11468305|FG000|Overall Study|Adverse Event|1
7256662|NCT00324649|11468306|FG001|Overall Study|Adverse Event|4
7256663|NCT00324649|11468305|FG000|Overall Study|Withdrawal by Subject|0
7256664|NCT00324649|11468306|FG001|Overall Study|Withdrawal by Subject|1
7256665|NCT00324649|11468305|FG000|Overall Study|Noncompliance|1
7256666|NCT00324649|11468306|FG001|Overall Study|Noncompliance|0
7256667|NCT00324675|11468314|FG000|Overall Study|Adverse Event|1
7256668|NCT00324675|11468315|FG001|Overall Study|Adverse Event|0
7256669|NCT00324740|11468330|FG000|Overall Study|Withdrawal by Subject|1
7256670|NCT00324740|11468331|FG001|Overall Study|Withdrawal by Subject|0
7256671|NCT00324740|11468332|FG002|Overall Study|Withdrawal by Subject|1
7256672|NCT00324961|11468384|FG000|Overall Study|Adverse Event|5
7256673|NCT00324961|11468384|FG000|Overall Study|Consent Withdrawn|11
7256674|NCT00324961|11468384|FG000|Overall Study|Lost to Follow-up|22
7256675|NCT00324961|11468384|FG000|Overall Study|Protocol Violation|3
7256676|NCT00324961|11468384|FG000|Overall Study|Other|2
7256677|NCT00324987|11468392|FG000|Overall Study|Adverse Event|2
7384039|NCT01192191|11641157|FG001|Overall Study|Adverse Event|12
7465066|NCT01877421|11764011|FG000|Phase 2|Protocol Violation|0
7254216|NCT00308750|11465496|FG000|Overall Study|Adverse Event|9
7254217|NCT00308750|11465497|FG001|Overall Study|Adverse Event|9
7254218|NCT00308750|11465498|FG002|Overall Study|Adverse Event|13
7254219|NCT00308750|11465496|FG000|Overall Study|Withdrawal by Subject|6
7254220|NCT00308750|11465497|FG001|Overall Study|Withdrawal by Subject|2
7254221|NCT00308750|11465498|FG002|Overall Study|Withdrawal by Subject|3
7254222|NCT00308750|11465496|FG000|Overall Study|Physician Decision|3
7254223|NCT00308750|11465497|FG001|Overall Study|Physician Decision|4
7254224|NCT00308750|11465498|FG002|Overall Study|Physician Decision|3
7254225|NCT00308750|11465496|FG000|Overall Study|Sponsor Decision|1
7254226|NCT00308750|11465497|FG001|Overall Study|Sponsor Decision|0
7254227|NCT00308750|11465498|FG002|Overall Study|Sponsor Decision|0
7254228|NCT00308750|11465496|FG000|Overall Study|Disease Progression|47
7254229|NCT00308750|11465497|FG001|Overall Study|Disease Progression|24
7254230|NCT00308750|11465498|FG002|Overall Study|Disease Progression|28
7254231|NCT00308750|11465496|FG000|Overall Study|Unrelated Complication|3
7254232|NCT00308750|11465497|FG001|Overall Study|Unrelated Complication|0
7254233|NCT00308750|11465498|FG002|Overall Study|Unrelated Complication|1
7254234|NCT00308750|11465496|FG000|Overall Study|Death|1
7254235|NCT00308750|11465497|FG001|Overall Study|Death|0
7254236|NCT00308750|11465498|FG002|Overall Study|Death|1
7254237|NCT00308750|11465496|FG000|Overall Study|Protocol Violation|1
7254238|NCT00308750|11465497|FG001|Overall Study|Protocol Violation|0
7254239|NCT00308750|11465498|FG002|Overall Study|Protocol Violation|0
7254240|NCT00308750|11465496|FG000|Overall Study|New Primary Disease Identified|1
7254241|NCT00308750|11465497|FG001|Overall Study|New Primary Disease Identified|1
7254242|NCT00308750|11465498|FG002|Overall Study|New Primary Disease Identified|0
7254243|NCT00308997|11465509|FG000|Overall Study|Subject feigned clinical data|0
7254244|NCT00308997|11465510|FG001|Overall Study|Subject feigned clinical data|1
7254245|NCT00308997|11465509|FG000|Overall Study|Unable to tolerate intervention|1
7254246|NCT00308997|11465510|FG001|Overall Study|Unable to tolerate intervention|0
7254247|NCT00309166|11465522|FG000|Overall Study|Adverse event, non-fatal|1
7254248|NCT00309166|11465523|FG001|Overall Study|Adverse event, non-fatal|0
7254249|NCT00309166|11465522|FG000|Overall Study|Withdrawal by Subject|4
7254250|NCT00309166|11465523|FG001|Overall Study|Withdrawal by Subject|3
7254251|NCT00309244|11465531|FG000|Overall Study|Adverse Event|29
7254252|NCT00309244|11465532|FG001|Overall Study|Adverse Event|12
7254253|NCT00309244|11465531|FG000|Overall Study|Lost to Follow-up|6
7254254|NCT00309244|11465532|FG001|Overall Study|Lost to Follow-up|22
7254255|NCT00309244|11465531|FG000|Overall Study|Physician Decision|5
7254256|NCT00309244|11465532|FG001|Overall Study|Physician Decision|8
7254257|NCT00309244|11465531|FG000|Overall Study|Protocol Violation|6
7254258|NCT00309244|11465532|FG001|Overall Study|Protocol Violation|3
7254259|NCT00309244|11465531|FG000|Overall Study|Withdrawal by Subject|50
7254260|NCT00309244|11465532|FG001|Overall Study|Withdrawal by Subject|32
7254261|NCT00309244|11465531|FG000|Overall Study|Various|7
7254262|NCT00309244|11465532|FG001|Overall Study|Various|7
7254263|NCT00309244|11465531|FG000|Overall Study|Randomized but not dosed|11
7254264|NCT00309244|11465532|FG001|Overall Study|Randomized but not dosed|12
7254265|NCT00309244|11465531|FG000|Overall Study|Death|4
7254266|NCT00309244|11465532|FG001|Overall Study|Death|1
7254267|NCT00309387|11465540|FG000|Overall Study|Death|72
7254268|NCT00309387|11465541|FG001|Overall Study|Death|73
7254269|NCT00309387|11465540|FG000|Overall Study|Lost to Follow-up|70
7254270|NCT00309387|11465541|FG001|Overall Study|Lost to Follow-up|86
7254271|NCT00309452|11465550|FG000|Overall Study|Withdrawal by Subject|3
7254272|NCT00309452|11465551|FG001|Overall Study|Withdrawal by Subject|0
7254273|NCT00309608|11465587|FG000|Overall Study|Adverse Event|1
7254274|NCT00309608|11465588|FG001|Overall Study|Adverse Event|5
7254275|NCT00309608|11465589|FG002|Overall Study|Adverse Event|3
7254276|NCT00309608|11465590|FG003|Overall Study|Adverse Event|2
7254277|NCT00309608|11465591|FG004|Overall Study|Adverse Event|3
7254278|NCT00309608|11465587|FG000|Overall Study|Protocol Violation|2
7254279|NCT00309608|11465588|FG001|Overall Study|Protocol Violation|0
7254280|NCT00309608|11465589|FG002|Overall Study|Protocol Violation|0
7254281|NCT00309608|11465590|FG003|Overall Study|Protocol Violation|0
7254282|NCT00309608|11465591|FG004|Overall Study|Protocol Violation|0
7254283|NCT00309608|11465587|FG000|Overall Study|Lost to Follow-up|0
7254284|NCT00309608|11465588|FG001|Overall Study|Lost to Follow-up|0
7254285|NCT00309608|11465589|FG002|Overall Study|Lost to Follow-up|2
7254286|NCT00309608|11465590|FG003|Overall Study|Lost to Follow-up|0
7254287|NCT00309608|11465591|FG004|Overall Study|Lost to Follow-up|1
7254288|NCT00309608|11465587|FG000|Overall Study|Withdrawal by Subject|1
7254289|NCT00309608|11465588|FG001|Overall Study|Withdrawal by Subject|4
7254290|NCT00309608|11465589|FG002|Overall Study|Withdrawal by Subject|2
7254291|NCT00309608|11465590|FG003|Overall Study|Withdrawal by Subject|0
7254292|NCT00309608|11465591|FG004|Overall Study|Withdrawal by Subject|0
7254293|NCT00309608|11465587|FG000|Overall Study|Other incl. Lack of efficacy|10
7254294|NCT00309608|11465588|FG001|Overall Study|Other incl. Lack of efficacy|4
7254295|NCT00309608|11465589|FG002|Overall Study|Other incl. Lack of efficacy|3
7254296|NCT00309608|11465590|FG003|Overall Study|Other incl. Lack of efficacy|4
7254297|NCT00309608|11465591|FG004|Overall Study|Other incl. Lack of efficacy|0
7254298|NCT00309777|11465625|FG000|Overall Study|Adverse Event|13
7254299|NCT00309777|11465626|FG001|Overall Study|Adverse Event|2
7254300|NCT00309777|11465627|FG002|Overall Study|Adverse Event|8
7254301|NCT00309777|11465628|FG003|Overall Study|Adverse Event|1
7254302|NCT00309777|11465625|FG000|Overall Study|Protocol Violation|4
7254303|NCT00309777|11465626|FG001|Overall Study|Protocol Violation|1
7254304|NCT00309777|11465627|FG002|Overall Study|Protocol Violation|3
7254305|NCT00309777|11465628|FG003|Overall Study|Protocol Violation|1
7254306|NCT00309777|11465625|FG000|Overall Study|Withdrawal by Subject|6
7254307|NCT00309777|11465626|FG001|Overall Study|Withdrawal by Subject|5
7254308|NCT00309777|11465627|FG002|Overall Study|Withdrawal by Subject|7
7254309|NCT00309777|11465628|FG003|Overall Study|Withdrawal by Subject|2
7254310|NCT00309777|11465625|FG000|Overall Study|Lost to Follow-up|0
7254311|NCT00309777|11465626|FG001|Overall Study|Lost to Follow-up|0
7254312|NCT00309777|11465627|FG002|Overall Study|Lost to Follow-up|1
7254313|NCT00309777|11465628|FG003|Overall Study|Lost to Follow-up|0
7254314|NCT00309777|11465625|FG000|Overall Study|Death|0
7254315|NCT00309777|11465626|FG001|Overall Study|Death|1
7254316|NCT00309777|11465627|FG002|Overall Study|Death|0
7254317|NCT00309777|11465628|FG003|Overall Study|Death|0
7254318|NCT00309842|11465638|FG000|Overall Study|Lost to Follow-up|1
7254319|NCT00309907|11465642|FG000|Overall Study|Death|4
7254320|NCT00309907|11465642|FG000|Overall Study|Physician Decision|1
7254321|NCT00309907|11465642|FG000|Overall Study|Ineligible|11
7254322|NCT00309907|11465642|FG000|Overall Study|Major infectious event|4
7254323|NCT00309946|11465647|FG000|Overall Study|Withdrawal by Subject|1
7254324|NCT00309959|11465651|FG000|Overall Study|Ineligible - no prior chemotherapy|2
7254325|NCT00310037|11465662|FG000|Overall Study|Adverse Event|7
7254326|NCT00310037|11465663|FG001|Overall Study|Adverse Event|14
7254327|NCT00310037|11465662|FG000|Overall Study|Withdrawal by Subject|4
7254328|NCT00310037|11465663|FG001|Overall Study|Withdrawal by Subject|3
7254329|NCT00310037|11465662|FG000|Overall Study|Progression|6
7254330|NCT00310037|11465663|FG001|Overall Study|Progression|0
7254331|NCT00310037|11465662|FG000|Overall Study|Non-protocol treatment|1
7254332|NCT00310037|11465663|FG001|Overall Study|Non-protocol treatment|0
7254333|NCT00310375|11465707|FG000|Primary Reporting Phase|Adverse Event|28
7254334|NCT00310375|11465708|FG001|Primary Reporting Phase|Adverse Event|22
7254335|NCT00310375|11465709|FG002|Primary Reporting Phase|Adverse Event|0
7254336|NCT00310375|11465707|FG000|Primary Reporting Phase|Lack of Efficacy|24
7254337|NCT00310375|11465708|FG001|Primary Reporting Phase|Lack of Efficacy|19
7254338|NCT00310375|11465709|FG002|Primary Reporting Phase|Lack of Efficacy|0
7254339|NCT00310375|11465707|FG000|Primary Reporting Phase|Pregnancy|2
7254340|NCT00310375|11465708|FG001|Primary Reporting Phase|Pregnancy|2
7254341|NCT00310375|11465709|FG002|Primary Reporting Phase|Pregnancy|0
7254342|NCT00310375|11465707|FG000|Primary Reporting Phase|Withdrawal by Subject|10
7254343|NCT00310375|11465708|FG001|Primary Reporting Phase|Withdrawal by Subject|7
7254344|NCT00310375|11465709|FG002|Primary Reporting Phase|Withdrawal by Subject|0
7254345|NCT00310375|11465707|FG000|Primary Reporting Phase|Protocol Violation|8
7254346|NCT00310375|11465708|FG001|Primary Reporting Phase|Protocol Violation|5
7254347|NCT00310375|11465709|FG002|Primary Reporting Phase|Protocol Violation|0
7254348|NCT00310375|11465707|FG000|Primary Reporting Phase|Change in Par medical condition|2
7254349|NCT00310375|11465708|FG001|Primary Reporting Phase|Change in Par medical condition|0
7254350|NCT00310375|11465709|FG002|Primary Reporting Phase|Change in Par medical condition|0
7254351|NCT00310375|11465707|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
7254352|NCT00310375|11465708|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
7254353|NCT00310375|11465709|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
7254354|NCT00310375|11465707|FG000|Primary Reporting Phase|Physician Decision|5
7254355|NCT00310375|11465708|FG001|Primary Reporting Phase|Physician Decision|3
7254356|NCT00310375|11465709|FG002|Primary Reporting Phase|Physician Decision|0
7254357|NCT00310375|11465707|FG000|Primary Reporting Phase|Request of the sponsor|2
7254358|NCT00310375|11465708|FG001|Primary Reporting Phase|Request of the sponsor|2
7254359|NCT00310375|11465709|FG002|Primary Reporting Phase|Request of the sponsor|0
7254360|NCT00310375|11465707|FG000|Primary Reporting Phase|Failed to return|1
7254361|NCT00310375|11465708|FG001|Primary Reporting Phase|Failed to return|3
7254362|NCT00310375|11465709|FG002|Primary Reporting Phase|Failed to return|0
7254363|NCT00310375|11465707|FG000|Primary Reporting Phase|Participant request unrelated to study|1
7254364|NCT00310375|11465708|FG001|Primary Reporting Phase|Participant request unrelated to study|2
7254365|NCT00310375|11465709|FG002|Primary Reporting Phase|Participant request unrelated to study|0
7254366|NCT00310375|11465707|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
7254367|NCT00310375|11465708|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
7254368|NCT00310375|11465709|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
7254369|NCT00310375|11465707|FG000|Primary Reporting Phase|Missed study drug >5 days|1
7254370|NCT00310375|11465708|FG001|Primary Reporting Phase|Missed study drug >5 days|0
7254371|NCT00310375|11465709|FG002|Primary Reporting Phase|Missed study drug >5 days|0
7254372|NCT00310375|11465707|FG000|Primary Reporting Phase|Site closure|3
7254373|NCT00310375|11465708|FG001|Primary Reporting Phase|Site closure|0
7254374|NCT00310375|11465709|FG002|Primary Reporting Phase|Site closure|0
7254375|NCT00310375|11465707|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
7254376|NCT00310375|11465708|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
7254377|NCT00310375|11465709|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
7254378|NCT00310375|11465707|FG000|Primary Reporting Phase|Par. switched to commercial product|0
7254379|NCT00310375|11465708|FG001|Primary Reporting Phase|Par. switched to commercial product|1
7254380|NCT00310375|11465709|FG002|Primary Reporting Phase|Par. switched to commercial product|0
7254381|NCT00310375|11465707|FG000|Primary Reporting Phase|Request of Ethics Committee|0
7254382|NCT00310375|11465708|FG001|Primary Reporting Phase|Request of Ethics Committee|1
7254383|NCT00310375|11465709|FG002|Primary Reporting Phase|Request of Ethics Committee|0
7254384|NCT00310375|11465707|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7254385|NCT00310375|11465708|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
7254386|NCT00310375|11465709|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
7254387|NCT00310440|11465740|FG000|Overall Study|Lost to Follow-up|17
7254388|NCT00310440|11465741|FG001|Overall Study|Lost to Follow-up|8
7254389|NCT00310440|11465740|FG000|Overall Study|Withdrawal by Subject|2
7254390|NCT00310440|11465741|FG001|Overall Study|Withdrawal by Subject|1
7254391|NCT00310440|11465740|FG000|Overall Study|Missed 12 Month Visit|7
7254392|NCT00310440|11465741|FG001|Overall Study|Missed 12 Month Visit|4
7254393|NCT00310804|11465767|FG000|Overall Study|Lost to Follow-up|2
7254394|NCT00310804|11465768|FG001|Overall Study|Lost to Follow-up|0
7254395|NCT00310804|11465767|FG000|Overall Study|Withdrawal by Subject|3
7254396|NCT00310804|11465768|FG001|Overall Study|Withdrawal by Subject|0
7254397|NCT00310817|11465792|FG000|Overall Study|AE or Death|3
7254398|NCT00310817|11465793|FG001|Overall Study|AE or Death|1
7254399|NCT00310817|11465794|FG002|Overall Study|AE or Death|0
7254400|NCT00310817|11465795|FG003|Overall Study|AE or Death|0
7254401|NCT00310817|11465792|FG000|Overall Study|Withdrawal by Subject|1
7254402|NCT00310817|11465793|FG001|Overall Study|Withdrawal by Subject|4
7254403|NCT00310817|11465794|FG002|Overall Study|Withdrawal by Subject|6
7254404|NCT00310817|11465795|FG003|Overall Study|Withdrawal by Subject|7
7254405|NCT00310817|11465792|FG000|Overall Study|Lost to Follow-up|2
7254406|NCT00310817|11465793|FG001|Overall Study|Lost to Follow-up|1
7254407|NCT00310817|11465794|FG002|Overall Study|Lost to Follow-up|0
7254408|NCT00310817|11465795|FG003|Overall Study|Lost to Follow-up|0
7254409|NCT00310817|11465792|FG000|Overall Study|Inappropriate Enrollment|1
7254410|NCT00310817|11465793|FG001|Overall Study|Inappropriate Enrollment|0
7254411|NCT00310817|11465794|FG002|Overall Study|Inappropriate Enrollment|1
7254412|NCT00310817|11465795|FG003|Overall Study|Inappropriate Enrollment|0
7254413|NCT00310817|11465792|FG000|Overall Study|Protocol Violation|1
7254414|NCT00310817|11465793|FG001|Overall Study|Protocol Violation|1
7254415|NCT00310817|11465794|FG002|Overall Study|Protocol Violation|1
7254416|NCT00310817|11465795|FG003|Overall Study|Protocol Violation|1
7254417|NCT00310817|11465792|FG000|Overall Study|Unable to classify|3
7254418|NCT00310817|11465793|FG001|Overall Study|Unable to classify|1
7254419|NCT00310817|11465794|FG002|Overall Study|Unable to classify|0
7254420|NCT00310817|11465795|FG003|Overall Study|Unable to classify|0
7254421|NCT00310856|11465841|FG000|Overall Study|Withdrawal by Subject|2
7254422|NCT00310856|11465842|FG001|Overall Study|Withdrawal by Subject|2
7254423|NCT00310856|11465843|FG002|Overall Study|Withdrawal by Subject|2
7254424|NCT00310856|11465841|FG000|Overall Study|Lost to Follow-up|1
7254425|NCT00310856|11465842|FG001|Overall Study|Lost to Follow-up|2
7254426|NCT00310856|11465843|FG002|Overall Study|Lost to Follow-up|6
7254427|NCT00310856|11465841|FG000|Overall Study|Inappropriate enrollment|1
7254428|NCT00310856|11465842|FG001|Overall Study|Inappropriate enrollment|1
7254429|NCT00310856|11465843|FG002|Overall Study|Inappropriate enrollment|0
7254430|NCT00310856|11465841|FG000|Overall Study|Unable to classify|1
7254431|NCT00310856|11465842|FG001|Overall Study|Unable to classify|0
7254432|NCT00310856|11465843|FG002|Overall Study|Unable to classify|0
7254433|NCT00311155|11465852|FG000|Overall Study|Adverse Event|21
7254434|NCT00311155|11465852|FG000|Overall Study|Withdrawal by Subject|17
7254435|NCT00311155|11465852|FG000|Overall Study|Did not meet entry criteria|55
7254436|NCT00311168|11465858|FG000|First Intervention|Withdrawal by Subject|2
7254437|NCT00311168|11465859|FG001|First Intervention|Withdrawal by Subject|2
7254438|NCT00311168|11465858|FG000|First Intervention|Lost to Follow-up|1
7254439|NCT00311168|11465859|FG001|First Intervention|Lost to Follow-up|1
7254440|NCT00311168|11465858|FG000|First Intervention|Protocol Violation|1
7254441|NCT00311168|11465859|FG001|First Intervention|Protocol Violation|1
7254442|NCT00311168|11465858|FG000|First Intervention|Adverse Event|1
7254443|NCT00311168|11465859|FG001|First Intervention|Adverse Event|0
7254444|NCT00311168|11465858|FG000|First Intervention|Other|2
7254445|NCT00311168|11465859|FG001|First Intervention|Other|2
7254446|NCT00311168|11465858|FG000|Second Intervention|Lost to Follow-up|9
7254447|NCT00311168|11465859|FG001|Second Intervention|Lost to Follow-up|2
7254448|NCT00311168|11465858|FG000|Second Intervention|Withdrawal by Subject|0
7254449|NCT00311168|11465859|FG001|Second Intervention|Withdrawal by Subject|1
7254450|NCT00311168|11465858|FG000|Second Intervention|Other|1
7254451|NCT00311168|11465859|FG001|Second Intervention|Other|1
7254452|NCT00311181|11465867|FG000|Overall Study|Final DFTs were not obtained|96
7254453|NCT00311311|11465880|FG000|Overall Study|Adverse Event|3
7254454|NCT00311311|11465881|FG001|Overall Study|Adverse Event|2
7254455|NCT00311311|11465880|FG000|Overall Study|Withdrawal by Subject|1
7254456|NCT00311311|11465881|FG001|Overall Study|Withdrawal by Subject|1
7254457|NCT00311311|11465880|FG000|Overall Study|Noncompliance|0
7254458|NCT00311311|11465881|FG001|Overall Study|Noncompliance|1
7254459|NCT00311311|11465880|FG000|Overall Study|Study Termination by Sponsor|3
7254460|NCT00311311|11465881|FG001|Overall Study|Study Termination by Sponsor|4
7254461|NCT00311311|11465880|FG000|Overall Study|Death|1
7254462|NCT00311311|11465881|FG001|Overall Study|Death|0
7254463|NCT00311311|11465880|FG000|Overall Study|Lack of ancillary assistance|0
7254464|NCT00311311|11465881|FG001|Overall Study|Lack of ancillary assistance|1
7254465|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
7254466|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
7254467|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
7254468|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
7254469|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7254470|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
7254471|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
7254472|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7254473|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
7254474|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
7254475|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7254476|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
7254477|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
7254478|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
7254479|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
7254480|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
7254481|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
7254482|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
7254483|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
7254484|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7254485|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
7254486|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
7254487|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
7254488|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
7254489|NCT00311363|11465890|FG000|24-Week Single-Blind Treatment Period|Death|1
7254490|NCT00311363|11465891|FG001|24-Week Single-Blind Treatment Period|Death|0
7254491|NCT00311363|11465892|FG002|24-Week Single-Blind Treatment Period|Death|0
7254492|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
7254493|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
7254494|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
7254495|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
7254496|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
7254497|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
7254498|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
7254499|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
7254500|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
7254501|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
7254502|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
7254503|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
7254504|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
7254505|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
7254506|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
7254507|NCT00311363|11465890|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7254508|NCT00311363|11465891|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
7254509|NCT00311363|11465892|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
7254510|NCT00311402|11465917|FG000|Overall Study|Adverse Event|118
7254511|NCT00311402|11465918|FG001|Overall Study|Adverse Event|105
7254512|NCT00311402|11465917|FG000|Overall Study|Lost to Follow-up|0
7254513|NCT00311402|11465918|FG001|Overall Study|Lost to Follow-up|3
7254514|NCT00311402|11465917|FG000|Overall Study|Withdrawal by Subject|17
7254515|NCT00311402|11465918|FG001|Overall Study|Withdrawal by Subject|18
7254516|NCT00311402|11465917|FG000|Overall Study|Lack of Efficacy|58
7254517|NCT00311402|11465918|FG001|Overall Study|Lack of Efficacy|42
7254518|NCT00311402|11465917|FG000|Overall Study|Protocol Violation|7
7254519|NCT00311402|11465918|FG001|Overall Study|Protocol Violation|6
7254520|NCT00311402|11465917|FG000|Overall Study|IRB's rejection etc.|10
7254521|NCT00311402|11465918|FG001|Overall Study|IRB's rejection etc.|3
7254522|NCT00311584|11465926|FG000|Overall Study|Death|1
7254523|NCT00311584|11465927|FG001|Overall Study|Death|0
7254524|NCT00311584|11465926|FG000|Overall Study|Lack of Efficacy|12
7254525|NCT00311584|11465927|FG001|Overall Study|Lack of Efficacy|15
7254526|NCT00311584|11465926|FG000|Overall Study|Physician Decision|4
7254527|NCT00311584|11465927|FG001|Overall Study|Physician Decision|5
7254528|NCT00311584|11465926|FG000|Overall Study|Withdrawal by Subject|1
7254529|NCT00311584|11465927|FG001|Overall Study|Withdrawal by Subject|1
7254530|NCT00311584|11465926|FG000|Overall Study|ineligible|2
7254531|NCT00311584|11465927|FG001|Overall Study|ineligible|2
7254532|NCT00311623|11465936|FG000|Overall Study|Physician Decision|0
7254533|NCT00311623|11465937|FG001|Overall Study|Physician Decision|0
7254534|NCT00311623|11465938|FG002|Overall Study|Physician Decision|2
7254535|NCT00312195|11465958|FG000|Overall Study|Adverse Event|4
7254536|NCT00312195|11465959|FG001|Overall Study|Adverse Event|6
7254537|NCT00312195|11465958|FG000|Overall Study|Lost to Follow-up|1
7254538|NCT00312195|11465959|FG001|Overall Study|Lost to Follow-up|0
7254539|NCT00312195|11465958|FG000|Overall Study|Protocol Violation|1
7254540|NCT00312195|11465959|FG001|Overall Study|Protocol Violation|0
7254541|NCT00312208|11465969|FG000|Overall Study|Adverse Event|97
7254542|NCT00312208|11465970|FG001|Overall Study|Adverse Event|61
7254543|NCT00312208|11465969|FG000|Overall Study|Protocol Violation|5
7254544|NCT00312208|11465970|FG001|Overall Study|Protocol Violation|3
7254545|NCT00312208|11465969|FG000|Overall Study|Death|2
7574489|NCT03682107|11957388|FG000|Overall Study|Withdrawal by Subject|0
7574490|NCT03682107|11957389|FG001|Overall Study|Withdrawal by Subject|1
7574491|NCT03682107|11957390|FG002|Overall Study|Withdrawal by Subject|0
7574492|NCT03682107|11957391|FG003|Overall Study|Withdrawal by Subject|0
7574493|NCT03682107|11957392|FG004|Overall Study|Withdrawal by Subject|0
7254546|NCT00312208|11465970|FG001|Overall Study|Death|1
7254547|NCT00312208|11465969|FG000|Overall Study|Lack of Efficacy|7
7254548|NCT00312208|11465970|FG001|Overall Study|Lack of Efficacy|4
7254549|NCT00312208|11465969|FG000|Overall Study|Lost to Follow-up|3
7254550|NCT00312208|11465970|FG001|Overall Study|Lost to Follow-up|5
7254551|NCT00312208|11465969|FG000|Overall Study|Withdrawal by Subject|53
7254552|NCT00312208|11465970|FG001|Overall Study|Withdrawal by Subject|42
7254553|NCT00312208|11465969|FG000|Overall Study|Other|5
7254554|NCT00312208|11465970|FG001|Overall Study|Other|7
7254555|NCT00312221|11465979|FG000|Open-label Run-in Period|Withdrawal by Subject|6
7254556|NCT00312221|11465980|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7254557|NCT00312221|11465981|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7254558|NCT00312221|11465982|FG003|Open-label Run-in Period|Withdrawal by Subject|0
7254559|NCT00312221|11465979|FG000|Open-label Run-in Period|Adverse Event|74
7254560|NCT00312221|11465980|FG001|Open-label Run-in Period|Adverse Event|0
7254561|NCT00312221|11465981|FG002|Open-label Run-in Period|Adverse Event|0
7254562|NCT00312221|11465982|FG003|Open-label Run-in Period|Adverse Event|0
7254563|NCT00312221|11465979|FG000|Open-label Run-in Period|Lost to Follow-up|5
7254564|NCT00312221|11465980|FG001|Open-label Run-in Period|Lost to Follow-up|0
7254565|NCT00312221|11465981|FG002|Open-label Run-in Period|Lost to Follow-up|0
7254566|NCT00312221|11465982|FG003|Open-label Run-in Period|Lost to Follow-up|0
7254567|NCT00312221|11465979|FG000|Open-label Run-in Period|Administrative|42
7254568|NCT00312221|11465980|FG001|Open-label Run-in Period|Administrative|0
7254569|NCT00312221|11465981|FG002|Open-label Run-in Period|Administrative|0
7254570|NCT00312221|11465982|FG003|Open-label Run-in Period|Administrative|0
7254571|NCT00312221|11465979|FG000|Open-label Run-in Period|Lack of Efficacy|102
7254572|NCT00312221|11465980|FG001|Open-label Run-in Period|Lack of Efficacy|0
7254573|NCT00312221|11465981|FG002|Open-label Run-in Period|Lack of Efficacy|0
7254574|NCT00312221|11465982|FG003|Open-label Run-in Period|Lack of Efficacy|0
7254575|NCT00312221|11465979|FG000|Open-label Run-in Period|Did not qualify|5
7254576|NCT00312221|11465980|FG001|Open-label Run-in Period|Did not qualify|0
7254577|NCT00312221|11465981|FG002|Open-label Run-in Period|Did not qualify|0
7254578|NCT00312221|11465982|FG003|Open-label Run-in Period|Did not qualify|0
7254579|NCT00312221|11465979|FG000|Double-blind Phase|Withdrawal by Subject|0
7254580|NCT00312221|11465980|FG001|Double-blind Phase|Withdrawal by Subject|6
7254581|NCT00312221|11465981|FG002|Double-blind Phase|Withdrawal by Subject|8
7254582|NCT00312221|11465982|FG003|Double-blind Phase|Withdrawal by Subject|7
7254583|NCT00312221|11465979|FG000|Double-blind Phase|Adverse Event|0
7254584|NCT00312221|11465980|FG001|Double-blind Phase|Adverse Event|10
7254585|NCT00312221|11465981|FG002|Double-blind Phase|Adverse Event|19
7254586|NCT00312221|11465982|FG003|Double-blind Phase|Adverse Event|18
7254587|NCT00312221|11465979|FG000|Double-blind Phase|Lost to Follow-up|0
7254588|NCT00312221|11465980|FG001|Double-blind Phase|Lost to Follow-up|0
7254589|NCT00312221|11465981|FG002|Double-blind Phase|Lost to Follow-up|2
7254590|NCT00312221|11465982|FG003|Double-blind Phase|Lost to Follow-up|2
7254591|NCT00312221|11465979|FG000|Double-blind Phase|Administrative|0
7254592|NCT00312221|11465980|FG001|Double-blind Phase|Administrative|26
7254593|NCT00312221|11465981|FG002|Double-blind Phase|Administrative|37
7254594|NCT00312221|11465982|FG003|Double-blind Phase|Administrative|33
7254595|NCT00312221|11465979|FG000|Double-blind Phase|Lack of Efficacy|0
7254596|NCT00312221|11465980|FG001|Double-blind Phase|Lack of Efficacy|17
7254597|NCT00312221|11465981|FG002|Double-blind Phase|Lack of Efficacy|6
7254598|NCT00312221|11465982|FG003|Double-blind Phase|Lack of Efficacy|10
7574494|NCT03682120|11957408|FG000|Overall Study|Lost to Follow-up|11
7254599|NCT00312338|11465993|FG000|Overall Study|Adverse Event|7
7254600|NCT00312338|11465994|FG001|Overall Study|Adverse Event|2
7254601|NCT00312338|11465993|FG000|Overall Study|Lost to Follow-up|9
7254602|NCT00312338|11465994|FG001|Overall Study|Lost to Follow-up|1
7254603|NCT00312338|11465993|FG000|Overall Study|Withdrawal by Subject|4
7254604|NCT00312338|11465994|FG001|Overall Study|Withdrawal by Subject|0
7574495|NCT03682120|11957409|FG001|Overall Study|Lost to Follow-up|4
7254605|NCT00312338|11465993|FG000|Overall Study|Subsequent infection|2
7254606|NCT00312338|11465994|FG001|Overall Study|Subsequent infection|0
7254607|NCT00312377|11466002|FG000|Overall Study|Death|403
7254608|NCT00312377|11466003|FG001|Overall Study|Death|418
7254609|NCT00312377|11466002|FG000|Overall Study|Withdrawal by Subject|23
7254610|NCT00312377|11466003|FG001|Overall Study|Withdrawal by Subject|30
7254611|NCT00312377|11466002|FG000|Overall Study|Lost to Follow-up|9
7254612|NCT00312377|11466003|FG001|Overall Study|Lost to Follow-up|12
7254613|NCT00312377|11466002|FG000|Overall Study|Non-compliance|0
7254614|NCT00312377|11466003|FG001|Overall Study|Non-compliance|2
7254615|NCT00312377|11466002|FG000|Overall Study|Randomised but never received treatment|6
7254616|NCT00312377|11466003|FG001|Overall Study|Randomised but never received treatment|6
7254617|NCT00312377|11466002|FG000|Overall Study|Discontinue treatment survival follow up|202
7254618|NCT00312377|11466003|FG001|Overall Study|Discontinue treatment survival follow up|200
7254619|NCT00312377|11466002|FG000|Overall Study|Site ended participation in study|1
7254620|NCT00312377|11466003|FG001|Overall Study|Site ended participation in study|0
7254621|NCT00312494|11466012|FG000|Overall Study|Randomized; not treated with study drug|9
7254622|NCT00312494|11466013|FG001|Overall Study|Randomized; not treated with study drug|10
7254623|NCT00312494|11466014|FG002|Overall Study|Randomized; not treated with study drug|5
7254624|NCT00312494|11466012|FG000|Overall Study|Adverse Event|33
7254625|NCT00312494|11466013|FG001|Overall Study|Adverse Event|15
7254626|NCT00312494|11466014|FG002|Overall Study|Adverse Event|11
7254627|NCT00312494|11466012|FG000|Overall Study|Lack of Efficacy|4
7254628|NCT00312494|11466013|FG001|Overall Study|Lack of Efficacy|6
7254629|NCT00312494|11466014|FG002|Overall Study|Lack of Efficacy|8
7254630|NCT00312494|11466012|FG000|Overall Study|Laboratory abnormality|1
7254631|NCT00312494|11466013|FG001|Overall Study|Laboratory abnormality|0
7254632|NCT00312494|11466014|FG002|Overall Study|Laboratory abnormality|0
7254633|NCT00312494|11466012|FG000|Overall Study|Lost to Follow-up|8
7254634|NCT00312494|11466013|FG001|Overall Study|Lost to Follow-up|8
7254635|NCT00312494|11466014|FG002|Overall Study|Lost to Follow-up|8
7254636|NCT00312494|11466012|FG000|Overall Study|Withdrawal by Subject|6
7254637|NCT00312494|11466013|FG001|Overall Study|Withdrawal by Subject|9
7254638|NCT00312494|11466014|FG002|Overall Study|Withdrawal by Subject|10
7254639|NCT00312494|11466012|FG000|Overall Study|Other|10
7254640|NCT00312494|11466013|FG001|Overall Study|Other|10
7254641|NCT00312494|11466014|FG002|Overall Study|Other|1
7254642|NCT00312572|11466024|FG000|Overall Study|Adverse Event|10
7254643|NCT00312572|11466025|FG001|Overall Study|Adverse Event|16
7254644|NCT00312572|11466024|FG000|Overall Study|Lost to Follow-up|1
7254645|NCT00312572|11466025|FG001|Overall Study|Lost to Follow-up|1
7254646|NCT00312572|11466024|FG000|Overall Study|Administrative|4
7254647|NCT00312572|11466025|FG001|Overall Study|Administrative|2
7254648|NCT00312572|11466024|FG000|Overall Study|Lack of Efficacy|1
7254649|NCT00312572|11466025|FG001|Overall Study|Lack of Efficacy|2
7254650|NCT00312663|11466036|FG000|Immunization Phase|Adverse Event|0
7254651|NCT00312663|11466037|FG001|Immunization Phase|Adverse Event|1
7254652|NCT00312663|11466038|FG002|Immunization Phase|Adverse Event|0
7254653|NCT00312702|11466050|FG000|Immunization Phase|Lost to Follow-up|0
7254654|NCT00312702|11466051|FG001|Immunization Phase|Lost to Follow-up|1
7254655|NCT00312702|11466052|FG002|Immunization Phase|Lost to Follow-up|0
7254656|NCT00312728|11466060|FG000|Overall Study|Progressive disease|53
7254657|NCT00312728|11466060|FG000|Overall Study|Adverse Event|32
7254658|NCT00312728|11466060|FG000|Overall Study|Withdrawal by Subject|10
7254659|NCT00312728|11466060|FG000|Overall Study|Required non-protocol cancer treatment|2
7254660|NCT00312728|11466060|FG000|Overall Study|Protocol Violation|2
7254661|NCT00312728|11466060|FG000|Overall Study|Other|10
7254662|NCT00312728|11466060|FG000|Overall Study|Other|1
7254663|NCT00312845|11466066|FG000|Overall Study|Adverse Event|19
7254664|NCT00312845|11466067|FG001|Overall Study|Adverse Event|5
7254665|NCT00312845|11466066|FG000|Overall Study|Death|2
7254666|NCT00312845|11466067|FG001|Overall Study|Death|2
7254667|NCT00312845|11466066|FG000|Overall Study|Withdrawal by Subject|14
7254668|NCT00312845|11466067|FG001|Overall Study|Withdrawal by Subject|6
7254669|NCT00312845|11466066|FG000|Overall Study|Disease Progression|56
7254670|NCT00312845|11466067|FG001|Overall Study|Disease Progression|77
7254671|NCT00312845|11466066|FG000|Overall Study|Lost to Follow-up|2
7254672|NCT00312845|11466067|FG001|Overall Study|Lost to Follow-up|0
7254673|NCT00312845|11466066|FG000|Overall Study|Other|6
7254674|NCT00312845|11466067|FG001|Overall Study|Other|5
7254675|NCT00312858|11466075|FG000|Overall Study|Adverse Event|0
7254676|NCT00312858|11466076|FG001|Overall Study|Adverse Event|1
7254677|NCT00312858|11466075|FG000|Overall Study|Lost to Follow-up|25
7254678|NCT00312858|11466076|FG001|Overall Study|Lost to Follow-up|42
7254679|NCT00312858|11466075|FG000|Overall Study|Protocol Violation|3
7254680|NCT00312858|11466076|FG001|Overall Study|Protocol Violation|8
7254681|NCT00312858|11466075|FG000|Overall Study|Withdraw by Participant|20
7254682|NCT00312858|11466076|FG001|Overall Study|Withdraw by Participant|20
7254683|NCT00312858|11466075|FG000|Overall Study|Participant Moved|11
7254684|NCT00312858|11466076|FG001|Overall Study|Participant Moved|10
7254685|NCT00312858|11466075|FG000|Overall Study|Other|9
7254686|NCT00312858|11466076|FG001|Overall Study|Other|12
7254687|NCT00312897|11466093|FG000|Overall Study|Adverse Event|1
7254688|NCT00312897|11466094|FG001|Overall Study|Adverse Event|0
7254689|NCT00312897|11466093|FG000|Overall Study|Lost to Follow-up|2
7254690|NCT00312897|11466094|FG001|Overall Study|Lost to Follow-up|0
7254691|NCT00312897|11466093|FG000|Overall Study|Physician Decision|1
7254692|NCT00312897|11466094|FG001|Overall Study|Physician Decision|0
7254693|NCT00312897|11466093|FG000|Overall Study|Withdrawal by Subject|1
7254694|NCT00312897|11466094|FG001|Overall Study|Withdrawal by Subject|3
7254695|NCT00312897|11466093|FG000|Overall Study|Pregnancy|1
7254696|NCT00312897|11466094|FG001|Overall Study|Pregnancy|0
7254697|NCT00312897|11466093|FG000|Overall Study|discontinued prior to getting treatment|0
7254698|NCT00312897|11466094|FG001|Overall Study|discontinued prior to getting treatment|3
7254699|NCT00313014|11466112|FG000|Overall Study|Withdrawal by Subject|11
7254700|NCT00313014|11466113|FG001|Overall Study|Withdrawal by Subject|7
7254701|NCT00313014|11466114|FG002|Overall Study|Withdrawal by Subject|5
7254702|NCT00313014|11466112|FG000|Overall Study|Adverse Event|14
7254703|NCT00313014|11466113|FG001|Overall Study|Adverse Event|29
7254704|NCT00313014|11466114|FG002|Overall Study|Adverse Event|16
7254705|NCT00313014|11466112|FG000|Overall Study|Lost to Follow-up|7
7254706|NCT00313014|11466113|FG001|Overall Study|Lost to Follow-up|6
7254707|NCT00313014|11466114|FG002|Overall Study|Lost to Follow-up|10
7254708|NCT00313014|11466112|FG000|Overall Study|Administrative|9
7254709|NCT00313014|11466113|FG001|Overall Study|Administrative|6
7254710|NCT00313014|11466114|FG002|Overall Study|Administrative|14
7254711|NCT00313014|11466112|FG000|Overall Study|Lack of Efficacy|52
7254712|NCT00313014|11466113|FG001|Overall Study|Lack of Efficacy|25
7254713|NCT00313014|11466114|FG002|Overall Study|Lack of Efficacy|16
7254714|NCT00313144|11466123|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
7254715|NCT00313144|11466123|FG000|Overall Study|Death|7
7254716|NCT00313144|11466123|FG000|Overall Study|Lost to Follow-up|5
7254717|NCT00313144|11466123|FG000|Overall Study|Withdrawal by Subject|4
7254718|NCT00313144|11466123|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
7254719|NCT00313144|11466123|FG000|Overall Study|Physician Decision|4
7254720|NCT00313144|11466123|FG000|Overall Study|Adverse event - transient|5
7254721|NCT00313144|11466123|FG000|Overall Study|Liver transplant|1
7254722|NCT00313144|11466123|FG000|Overall Study|Insurance (homecare provider) change|1
7254723|NCT00313144|11466123|FG000|Overall Study|Change to different product|1
7254724|NCT00313144|11466123|FG000|Overall Study|Due to termination of the study|66
7254725|NCT00313170|11466139|FG000|Overall Study|Death|2
7254726|NCT00313170|11466140|FG001|Overall Study|Death|4
7254727|NCT00313170|11466141|FG002|Overall Study|Death|2
7254728|NCT00313170|11466139|FG000|Overall Study|Adverse Event|1
7254729|NCT00313170|11466140|FG001|Overall Study|Adverse Event|2
7254730|NCT00313170|11466141|FG002|Overall Study|Adverse Event|0
7254731|NCT00313170|11466139|FG000|Overall Study|Disease progression|31
7254732|NCT00313170|11466140|FG001|Overall Study|Disease progression|26
7254733|NCT00313170|11466141|FG002|Overall Study|Disease progression|27
7254734|NCT00313170|11466139|FG000|Overall Study|Withdrawal by Subject|1
7254735|NCT00313170|11466140|FG001|Overall Study|Withdrawal by Subject|0
7254736|NCT00313170|11466141|FG002|Overall Study|Withdrawal by Subject|1
7254737|NCT00313170|11466139|FG000|Overall Study|Incorrect enrollment|0
7254738|NCT00313170|11466140|FG001|Overall Study|Incorrect enrollment|2
7254739|NCT00313170|11466141|FG002|Overall Study|Incorrect enrollment|1
7254740|NCT00313170|11466139|FG000|Overall Study|Lost to Follow-up|0
7254741|NCT00313170|11466140|FG001|Overall Study|Lost to Follow-up|0
7254742|NCT00313170|11466141|FG002|Overall Study|Lost to Follow-up|1
7254743|NCT00313170|11466139|FG000|Overall Study|Progression (investigators opinion)|1
7254744|NCT00313170|11466140|FG001|Overall Study|Progression (investigators opinion)|0
7254745|NCT00313170|11466141|FG002|Overall Study|Progression (investigators opinion)|0
7254746|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
7254747|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
7254748|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
7254749|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
7254750|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
7254751|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
7254752|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
7254753|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
7254754|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7254755|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
7254756|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Death|3
7254757|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Death|4
7254758|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Death|0
7254759|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Death|0
7254760|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Death|0
7254761|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7254762|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
7254763|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
7254764|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7254765|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
7254766|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
7254767|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
7254768|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
7254769|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7254770|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
7254771|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
7254772|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
7254773|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
7254774|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7254775|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
7254776|NCT00313300|11466164|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
7254777|NCT00313300|11466165|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7254778|NCT00313300|11466166|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7254779|NCT00313300|11466167|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7254780|NCT00313300|11466168|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
7254781|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
7254782|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
7254783|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
7254784|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
7254785|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
7254786|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
7254787|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
7254788|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7254789|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
7254790|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
7254791|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|Death|5
7254792|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|Death|3
7254793|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|Death|1
7254794|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|Death|0
7254795|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|Death|1
7254796|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
7254797|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7254798|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7254799|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
7254800|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
7254801|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7254802|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
7254803|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
7254804|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7254805|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
7254806|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
7254807|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
7254808|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7254809|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
7254810|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
7254811|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
7254812|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
7254813|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
7254814|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
7254815|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
7254816|NCT00313300|11466164|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
7254817|NCT00313300|11466165|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
7254818|NCT00313300|11466166|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
7254819|NCT00313300|11466167|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
7254820|NCT00313300|11466168|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
7254821|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7254822|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
7254823|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
7254824|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7254825|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
7254826|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
7254827|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
7254828|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
7254829|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
7254830|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
7254831|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7254832|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
7254833|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
7254834|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7254835|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
7254836|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
7254837|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
7254838|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
7254839|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
7254840|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
7254841|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7254842|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7254843|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
7254844|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
7254845|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
7254846|NCT00313300|11466164|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
7254847|NCT00313300|11466165|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7254848|NCT00313300|11466166|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7254849|NCT00313300|11466167|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
7254850|NCT00313300|11466168|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
7254851|NCT00313313|11466189|FG000|Overall Study|Lack of Efficacy|14
7254852|NCT00313313|11466190|FG001|Overall Study|Lack of Efficacy|9
7254853|NCT00313313|11466191|FG002|Overall Study|Lack of Efficacy|20
7254854|NCT00313313|11466189|FG000|Overall Study|Withdrawal of consent by subject|18
7254855|NCT00313313|11466190|FG001|Overall Study|Withdrawal of consent by subject|17
7254856|NCT00313313|11466191|FG002|Overall Study|Withdrawal of consent by subject|31
7254857|NCT00313313|11466189|FG000|Overall Study|Lost to Follow-up|10
7254858|NCT00313313|11466190|FG001|Overall Study|Lost to Follow-up|7
7254859|NCT00313313|11466191|FG002|Overall Study|Lost to Follow-up|9
7254860|NCT00313313|11466189|FG000|Overall Study|Adverse Event|15
7254861|NCT00313313|11466190|FG001|Overall Study|Adverse Event|16
7254862|NCT00313313|11466191|FG002|Overall Study|Adverse Event|12
7254863|NCT00313313|11466189|FG000|Overall Study|Physician Decision|2
7254864|NCT00313313|11466190|FG001|Overall Study|Physician Decision|6
7254865|NCT00313313|11466191|FG002|Overall Study|Physician Decision|4
7254866|NCT00313313|11466189|FG000|Overall Study|Poor/Noncompliance|3
7254867|NCT00313313|11466190|FG001|Overall Study|Poor/Noncompliance|6
7254868|NCT00313313|11466191|FG002|Overall Study|Poor/Noncompliance|2
7254869|NCT00313313|11466189|FG000|Overall Study|Pregnancy|1
7254870|NCT00313313|11466190|FG001|Overall Study|Pregnancy|2
7254871|NCT00313313|11466191|FG002|Overall Study|Pregnancy|0
7254872|NCT00313313|11466189|FG000|Overall Study|Death|0
7254873|NCT00313313|11466190|FG001|Overall Study|Death|0
7254874|NCT00313313|11466191|FG002|Overall Study|Death|2
7254875|NCT00313313|11466189|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
7254876|NCT00313313|11466190|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
7254877|NCT00313313|11466191|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
7254878|NCT00313586|11466215|FG000|Overall Study|Disease progression|14
7254879|NCT00313586|11466216|FG001|Overall Study|Disease progression|19
7254880|NCT00313586|11466217|FG002|Overall Study|Disease progression|10
7254881|NCT00313586|11466218|FG003|Overall Study|Disease progression|3
7254882|NCT00313586|11466215|FG000|Overall Study|Adverse Event|12
7254883|NCT00313586|11466216|FG001|Overall Study|Adverse Event|18
7254884|NCT00313586|11466217|FG002|Overall Study|Adverse Event|3
7254885|NCT00313586|11466218|FG003|Overall Study|Adverse Event|10
7254886|NCT00313586|11466215|FG000|Overall Study|Death|11
7254887|NCT00313586|11466216|FG001|Overall Study|Death|8
7254888|NCT00313586|11466217|FG002|Overall Study|Death|1
7254889|NCT00313586|11466218|FG003|Overall Study|Death|7
7254890|NCT00313586|11466215|FG000|Overall Study|Withdrawal by Subject|13
7254891|NCT00313586|11466216|FG001|Overall Study|Withdrawal by Subject|6
7254892|NCT00313586|11466217|FG002|Overall Study|Withdrawal by Subject|6
7254893|NCT00313586|11466218|FG003|Overall Study|Withdrawal by Subject|2
7254894|NCT00313586|11466215|FG000|Overall Study|Alternative therapy|3
7254895|NCT00313586|11466216|FG001|Overall Study|Alternative therapy|6
7254896|NCT00313586|11466217|FG002|Overall Study|Alternative therapy|2
7254897|NCT00313586|11466218|FG003|Overall Study|Alternative therapy|0
7254898|NCT00313586|11466215|FG000|Overall Study|Other complicating disease|2
7254899|NCT00313586|11466216|FG001|Overall Study|Other complicating disease|2
7254900|NCT00313586|11466217|FG002|Overall Study|Other complicating disease|0
7254901|NCT00313586|11466218|FG003|Overall Study|Other complicating disease|0
7254902|NCT00313586|11466215|FG000|Overall Study|Did not achieve HI-major/better response|10
7254903|NCT00313586|11466216|FG001|Overall Study|Did not achieve HI-major/better response|7
7254904|NCT00313586|11466217|FG002|Overall Study|Did not achieve HI-major/better response|2
7254905|NCT00313586|11466218|FG003|Overall Study|Did not achieve HI-major/better response|1
7254906|NCT00313586|11466215|FG000|Overall Study|Physician Decision|2
7254907|NCT00313586|11466216|FG001|Overall Study|Physician Decision|1
7254908|NCT00313586|11466217|FG002|Overall Study|Physician Decision|0
7254909|NCT00313586|11466218|FG003|Overall Study|Physician Decision|0
7254910|NCT00313586|11466215|FG000|Overall Study|Absolute neutrophil count not recovered|2
7254911|NCT00313586|11466216|FG001|Overall Study|Absolute neutrophil count not recovered|1
7254912|NCT00313586|11466217|FG002|Overall Study|Absolute neutrophil count not recovered|0
7254913|NCT00313586|11466218|FG003|Overall Study|Absolute neutrophil count not recovered|0
7254914|NCT00313586|11466215|FG000|Overall Study|Lost insurance|0
7254915|NCT00313586|11466216|FG001|Overall Study|Lost insurance|1
7254916|NCT00313586|11466217|FG002|Overall Study|Lost insurance|0
7254917|NCT00313586|11466218|FG003|Overall Study|Lost insurance|0
7254918|NCT00313586|11466215|FG000|Overall Study|Moved|0
7254919|NCT00313586|11466216|FG001|Overall Study|Moved|1
7254920|NCT00313586|11466217|FG002|Overall Study|Moved|0
7254921|NCT00313586|11466218|FG003|Overall Study|Moved|0
7254922|NCT00313586|11466215|FG000|Overall Study|Death before starting treatment|1
7254923|NCT00313586|11466216|FG001|Overall Study|Death before starting treatment|0
7254924|NCT00313586|11466217|FG002|Overall Study|Death before starting treatment|0
7254925|NCT00313586|11466218|FG003|Overall Study|Death before starting treatment|0
7254926|NCT00313612|11466228|FG000|Overall Study|Patient never received treatment|0
7254927|NCT00313612|11466229|FG001|Overall Study|Patient never received treatment|1
7254928|NCT00313703|11466239|FG000|Overall Study|Lost to Follow-up|11
7254929|NCT00313703|11466240|FG001|Overall Study|Lost to Follow-up|2
7254930|NCT00313703|11466241|FG002|Overall Study|Lost to Follow-up|5
7254931|NCT00313703|11466242|FG003|Overall Study|Lost to Follow-up|12
7254932|NCT00313716|11466258|FG000|Overall Study|Death|3
7254933|NCT00313716|11466259|FG001|Overall Study|Death|2
7254934|NCT00313716|11466260|FG002|Overall Study|Death|9
7254935|NCT00313716|11466261|FG003|Overall Study|Death|3
7254936|NCT00313716|11466262|FG004|Overall Study|Death|5
7254937|NCT00313716|11466263|FG005|Overall Study|Death|9
7254938|NCT00313716|11466258|FG000|Overall Study|Lost to Follow-up|2
7254939|NCT00313716|11466259|FG001|Overall Study|Lost to Follow-up|5
7254940|NCT00313716|11466260|FG002|Overall Study|Lost to Follow-up|2
7254941|NCT00313716|11466261|FG003|Overall Study|Lost to Follow-up|1
7254942|NCT00313716|11466262|FG004|Overall Study|Lost to Follow-up|0
7254943|NCT00313716|11466263|FG005|Overall Study|Lost to Follow-up|4
7254944|NCT00313716|11466258|FG000|Overall Study|Withdrawal by Subject|0
7254945|NCT00313716|11466259|FG001|Overall Study|Withdrawal by Subject|1
7254946|NCT00313716|11466260|FG002|Overall Study|Withdrawal by Subject|1
7254947|NCT00313716|11466261|FG003|Overall Study|Withdrawal by Subject|0
7254948|NCT00313716|11466262|FG004|Overall Study|Withdrawal by Subject|1
7254949|NCT00313716|11466263|FG005|Overall Study|Withdrawal by Subject|0
7254950|NCT00313781|11466287|FG000|Before Crossover|Death|22
7254951|NCT00313781|11466288|FG001|Before Crossover|Death|8
7254952|NCT00313781|11466289|FG002|Before Crossover|Death|0
7254953|NCT00313781|11466287|FG000|Before Crossover|Lost to Follow-up|0
7254954|NCT00313781|11466288|FG001|Before Crossover|Lost to Follow-up|3
7254955|NCT00313781|11466289|FG002|Before Crossover|Lost to Follow-up|0
7254956|NCT00313781|11466287|FG000|Before Crossover|Withdrawal by Subject|3
7254957|NCT00313781|11466288|FG001|Before Crossover|Withdrawal by Subject|1
7254958|NCT00313781|11466289|FG002|Before Crossover|Withdrawal by Subject|0
7254959|NCT00313781|11466287|FG000|Before Crossover|Other|45
7254960|NCT00313781|11466288|FG001|Before Crossover|Other|30
7254961|NCT00313781|11466289|FG002|Before Crossover|Other|0
7254962|NCT00313781|11466287|FG000|Before Crossover|Crossover|0
7254963|NCT00313781|11466288|FG001|Before Crossover|Crossover|37
7254964|NCT00313781|11466289|FG002|Before Crossover|Crossover|0
7254965|NCT00313781|11466287|FG000|Before Crossover|Randomized, not treated|5
7254966|NCT00313781|11466288|FG001|Before Crossover|Randomized, not treated|0
7254967|NCT00313781|11466289|FG002|Before Crossover|Randomized, not treated|0
7254968|NCT00313781|11466287|FG000|After Crossover|Death|0
7254969|NCT00313781|11466288|FG001|After Crossover|Death|0
7254970|NCT00313781|11466289|FG002|After Crossover|Death|6
7254971|NCT00313781|11466287|FG000|After Crossover|Withdrawal by Subject|0
7254972|NCT00313781|11466288|FG001|After Crossover|Withdrawal by Subject|0
7254973|NCT00313781|11466289|FG002|After Crossover|Withdrawal by Subject|3
7254974|NCT00313781|11466287|FG000|After Crossover|Other|0
7254975|NCT00313781|11466288|FG001|After Crossover|Other|0
7254976|NCT00313781|11466289|FG002|After Crossover|Other|18
7254977|NCT00313820|11466300|FG000|Assigned to Treatment|Other|1
7254978|NCT00313820|11466301|FG001|Assigned to Treatment|Other|0
7254979|NCT00313820|11466300|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
7254980|NCT00313820|11466301|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
7254981|NCT00313820|11466300|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
7254982|NCT00313820|11466301|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
7254983|NCT00313820|11466300|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
7574496|NCT03682120|11957410|FG002|Overall Study|Lost to Follow-up|5
7574497|NCT03682120|11957411|FG003|Overall Study|Lost to Follow-up|2
7254984|NCT00313820|11466301|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
7254985|NCT00313820|11466300|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
7254986|NCT00313820|11466301|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
7254987|NCT00313820|11466300|FG000|Pregabalin or Placebo Treatment Period|Other|2
7254988|NCT00313820|11466301|FG001|Pregabalin or Placebo Treatment Period|Other|3
7254989|NCT00313846|11466309|FG000|Overall Study|Withdrawal by Subject|2
7254990|NCT00313846|11466310|FG001|Overall Study|Withdrawal by Subject|0
7254991|NCT00313846|11466309|FG000|Overall Study|Adverse Event|1
7254992|NCT00313846|11466310|FG001|Overall Study|Adverse Event|8
7254993|NCT00313846|11466309|FG000|Overall Study|Administrative|2
7254994|NCT00313846|11466310|FG001|Overall Study|Administrative|3
7254995|NCT00313911|11466319|FG000|Overall Study|Serious adverse event|6
7254996|NCT00313911|11466320|FG001|Overall Study|Serious adverse event|1
7254997|NCT00313911|11466319|FG000|Overall Study|Adverse Event|2
7254998|NCT00313911|11466320|FG001|Overall Study|Adverse Event|3
7254999|NCT00313911|11466319|FG000|Overall Study|Protocol Violation|19
7255000|NCT00313911|11466320|FG001|Overall Study|Protocol Violation|10
7255001|NCT00313911|11466319|FG000|Overall Study|Lost to Follow-up|27
7255002|NCT00313911|11466320|FG001|Overall Study|Lost to Follow-up|14
7255003|NCT00313911|11466319|FG000|Overall Study|Withdrawal by Subject|39
7255004|NCT00313911|11466320|FG001|Overall Study|Withdrawal by Subject|12
7255005|NCT00313911|11466319|FG000|Overall Study|Did not meet age criteria|1
7255006|NCT00313911|11466320|FG001|Overall Study|Did not meet age criteria|1
7255007|NCT00314132|11466337|FG000|Overall Study|Lost to Follow-up|3
7255008|NCT00314132|11466338|FG001|Overall Study|Lost to Follow-up|13
7255009|NCT00314132|11466337|FG000|Overall Study|Withdrawal by Subject|3
7255010|NCT00314132|11466338|FG001|Overall Study|Withdrawal by Subject|5
7255011|NCT00314132|11466337|FG000|Overall Study|Adverse Event|1
7255012|NCT00314132|11466338|FG001|Overall Study|Adverse Event|0
7255013|NCT00314132|11466337|FG000|Overall Study|Physician Decision|1
7255014|NCT00314132|11466338|FG001|Overall Study|Physician Decision|0
7255015|NCT00314145|11466348|FG000|Overall Study|Withdrawal by Subject|8
7255016|NCT00314145|11466349|FG001|Overall Study|Withdrawal by Subject|10
7255017|NCT00314145|11466348|FG000|Overall Study|Lost to Follow-up|5
7255018|NCT00314145|11466349|FG001|Overall Study|Lost to Follow-up|12
7255019|NCT00314145|11466348|FG000|Overall Study|Physician Decision|3
7255020|NCT00314145|11466349|FG001|Overall Study|Physician Decision|4
7255021|NCT00314145|11466348|FG000|Overall Study|Adverse Event|0
7255022|NCT00314145|11466349|FG001|Overall Study|Adverse Event|3
7255023|NCT00314145|11466348|FG000|Overall Study|Protocol Violation|3
7255024|NCT00314145|11466349|FG001|Overall Study|Protocol Violation|0
7255025|NCT00314145|11466348|FG000|Overall Study|Sponsor Decision|2
7255026|NCT00314145|11466349|FG001|Overall Study|Sponsor Decision|0
7255027|NCT00314249|11466367|FG000|Overall Study|Adverse Event|73
7255028|NCT00314249|11466368|FG001|Overall Study|Adverse Event|94
7255029|NCT00314249|11466367|FG000|Overall Study|Lack of Efficacy|33
7255030|NCT00314249|11466368|FG001|Overall Study|Lack of Efficacy|24
7255031|NCT00314249|11466367|FG000|Overall Study|Withdrawal by Subject|21
7255032|NCT00314249|11466368|FG001|Overall Study|Withdrawal by Subject|28
7255033|NCT00314249|11466367|FG000|Overall Study|Lost to Follow-up|15
7255034|NCT00314249|11466368|FG001|Overall Study|Lost to Follow-up|9
7255035|NCT00314249|11466367|FG000|Overall Study|Physician Decision|1
7255036|NCT00314249|11466368|FG001|Overall Study|Physician Decision|1
7255037|NCT00314249|11466367|FG000|Overall Study|Withdrawn for other reasons|4
7255038|NCT00314249|11466368|FG001|Overall Study|Withdrawn for other reasons|1
7255039|NCT00314249|11466367|FG000|Overall Study|Non-Compliant|5
7255040|NCT00314249|11466368|FG001|Overall Study|Non-Compliant|6
7255041|NCT00314262|11466374|FG000|Overall Study|Adverse Event|2
7255042|NCT00314262|11466374|FG000|Overall Study|Withdrawal by Subject|2
7255043|NCT00314262|11466374|FG000|Overall Study|Physician Decision|1
7255044|NCT00314340|11466378|FG000|Overall Study|lost interest|1
7255045|NCT00314574|11466386|FG000|Overall Study|Death|3
7255046|NCT00314574|11466387|FG001|Overall Study|Death|0
7255047|NCT00314574|11466386|FG000|Overall Study|Adverse Event|11
7255048|NCT00314574|11466387|FG001|Overall Study|Adverse Event|16
7255049|NCT00314574|11466386|FG000|Overall Study|Lost to Follow-up|19
7255050|NCT00314574|11466387|FG001|Overall Study|Lost to Follow-up|25
7255051|NCT00314574|11466386|FG000|Overall Study|Withdrawal by Subject|33
7255052|NCT00314574|11466387|FG001|Overall Study|Withdrawal by Subject|22
7255053|NCT00314574|11466386|FG000|Overall Study|Physician Decision|22
7255054|NCT00314574|11466387|FG001|Overall Study|Physician Decision|15
7255055|NCT00314574|11466386|FG000|Overall Study|Pregnancy|6
7255056|NCT00314574|11466387|FG001|Overall Study|Pregnancy|4
7255057|NCT00314574|11466386|FG000|Overall Study|Data unknown at database lock|0
7255058|NCT00314574|11466387|FG001|Overall Study|Data unknown at database lock|1
7255059|NCT00314795|11466393|FG000|Overall Study|Adverse Event|8
7255060|NCT00314795|11466393|FG000|Overall Study|Death|4
7255061|NCT00314795|11466393|FG000|Overall Study|Reason not Specified|3
7255062|NCT00314795|11466393|FG000|Overall Study|Renal Transplant|3
7255063|NCT00314795|11466393|FG000|Overall Study|Participants Withdrew Consent|2
7255064|NCT00314808|11466397|FG000|Overall Study|Disease Progression without AE|4
7255065|NCT00314808|11466397|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
7255066|NCT00314951|11466403|FG000|Treatment|Didn't meet criteria for mITT population|16
7255067|NCT00314951|11466404|FG001|Treatment|Didn't meet criteria for mITT population|11
7255068|NCT00314951|11466403|FG000|Follow-up|mITT failure|44
7255069|NCT00314951|11466404|FG001|Follow-up|mITT failure|34
7255070|NCT00315055|11466412|FG000|Overall Study|Protocol Violation|2
7255071|NCT00315055|11466413|FG001|Overall Study|Protocol Violation|4
7255072|NCT00315055|11466412|FG000|Overall Study|Lost to Follow-up|1
7255073|NCT00315055|11466413|FG001|Overall Study|Lost to Follow-up|1
7255074|NCT00315445|11466508|FG000|Overall Study|Adverse Event|7
7255075|NCT00315445|11466509|FG001|Overall Study|Adverse Event|12
7255076|NCT00315445|11466510|FG002|Overall Study|Adverse Event|15
7255077|NCT00315445|11466508|FG000|Overall Study|Lack of Efficacy|16
7255078|NCT00315445|11466509|FG001|Overall Study|Lack of Efficacy|1
7255079|NCT00315445|11466510|FG002|Overall Study|Lack of Efficacy|7
7255080|NCT00315445|11466508|FG000|Overall Study|Lost to Follow-up|1
7255081|NCT00315445|11466509|FG001|Overall Study|Lost to Follow-up|0
7255082|NCT00315445|11466510|FG002|Overall Study|Lost to Follow-up|1
7255083|NCT00315445|11466508|FG000|Overall Study|Protocol Violation|2
7255084|NCT00315445|11466509|FG001|Overall Study|Protocol Violation|0
7255085|NCT00315445|11466510|FG002|Overall Study|Protocol Violation|1
7255086|NCT00315445|11466508|FG000|Overall Study|Other|1
7255087|NCT00315445|11466509|FG001|Overall Study|Other|3
7255088|NCT00315445|11466510|FG002|Overall Study|Other|0
7255089|NCT00315458|11466520|FG000|Overall Study|Administrative|0
7255090|NCT00315458|11466521|FG001|Overall Study|Administrative|3
7255091|NCT00315458|11466522|FG002|Overall Study|Administrative|8
7255092|NCT00315458|11466523|FG003|Overall Study|Administrative|21
7255093|NCT00315458|11466520|FG000|Overall Study|Adverse Event|2
7255094|NCT00315458|11466521|FG001|Overall Study|Adverse Event|4
7255095|NCT00315458|11466522|FG002|Overall Study|Adverse Event|23
7255096|NCT00315458|11466523|FG003|Overall Study|Adverse Event|3
7255097|NCT00315458|11466520|FG000|Overall Study|Lost to Follow-up|1
7255098|NCT00315458|11466521|FG001|Overall Study|Lost to Follow-up|2
7255099|NCT00315458|11466522|FG002|Overall Study|Lost to Follow-up|0
7255100|NCT00315458|11466523|FG003|Overall Study|Lost to Follow-up|2
7255101|NCT00315458|11466520|FG000|Overall Study|Withdrawal by Subject|0
7255102|NCT00315458|11466521|FG001|Overall Study|Withdrawal by Subject|3
7255103|NCT00315458|11466522|FG002|Overall Study|Withdrawal by Subject|0
7255104|NCT00315458|11466523|FG003|Overall Study|Withdrawal by Subject|2
7255105|NCT00315458|11466520|FG000|Overall Study|Lack of Efficacy|0
7255106|NCT00315458|11466521|FG001|Overall Study|Lack of Efficacy|0
7255107|NCT00315458|11466522|FG002|Overall Study|Lack of Efficacy|20
7255108|NCT00315458|11466523|FG003|Overall Study|Lack of Efficacy|1
7255109|NCT00315458|11466520|FG000|Overall Study|Did not qualify|0
7255110|NCT00315458|11466521|FG001|Overall Study|Did not qualify|0
7255111|NCT00315458|11466522|FG002|Overall Study|Did not qualify|1
7255112|NCT00315458|11466523|FG003|Overall Study|Did not qualify|0
7255113|NCT00315705|11466552|FG000|Phase 1|Refused further treatment|1
7255114|NCT00315705|11466552|FG000|Phase 1|Failure to achieve response|8
7255115|NCT00315705|11466552|FG000|Phase 1|Disease relapse|4
7255116|NCT00315705|11466552|FG000|Phase 1|Scheduled for transplant|9
7255117|NCT00315705|11466552|FG000|Phase 1|Death|3
7255118|NCT00315705|11466552|FG000|Phase 2|Physician Decision|4
7255119|NCT00315705|11466552|FG000|Phase 2|Adverse Event|1
7255120|NCT00315705|11466552|FG000|Phase 2|Failure to achieve response|3
7255121|NCT00315705|11466552|FG000|Phase 2|Disease relapse|1
7255122|NCT00315705|11466552|FG000|Phase 2|Scheduled for transplant|8
7255123|NCT00315705|11466552|FG000|Phase 2|Other|1
7255124|NCT00315705|11466552|FG000|Phase 2|Death|7
7255125|NCT00315731|11466569|FG000|Overall Study|Lost to Follow-up|1
7255126|NCT00315731|11466569|FG000|Overall Study|Death|5
7255127|NCT00316004|11466595|FG000|Overall Study|Subject was not given study fluid.|14
7255128|NCT00316004|11466596|FG001|Overall Study|Subject was not given study fluid.|14
7255129|NCT00316004|11466597|FG002|Overall Study|Subject was not given study fluid.|21
7256678|NCT00324987|11468393|FG001|Overall Study|Adverse Event|1
7256679|NCT00324987|11468392|FG000|Overall Study|Withdrawal by Subject|1
7256680|NCT00324987|11468393|FG001|Overall Study|Withdrawal by Subject|1
7256681|NCT00324987|11468392|FG000|Overall Study|Progression|1
7256682|NCT00324987|11468393|FG001|Overall Study|Progression|1
7256683|NCT00324987|11468392|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
7256684|NCT00324987|11468393|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
7256685|NCT00325039|11468401|FG000|Overall Study|Lost to Follow-up|18
7256686|NCT00325039|11468402|FG001|Overall Study|Lost to Follow-up|14
7256687|NCT00325130|11468424|FG000|Overall Study|Lost to Follow-up|6
7256688|NCT00325130|11468425|FG001|Overall Study|Lost to Follow-up|14
7256689|NCT00325130|11468424|FG000|Overall Study|Withdrawal by Subject|12
7256690|NCT00325130|11468425|FG001|Overall Study|Withdrawal by Subject|14
7256691|NCT00325130|11468424|FG000|Overall Study|Protocol Deviation|0
7256692|NCT00325130|11468425|FG001|Overall Study|Protocol Deviation|1
7256693|NCT00325130|11468424|FG000|Overall Study|Moved|0
7256694|NCT00325130|11468425|FG001|Overall Study|Moved|1
7256695|NCT00325130|11468424|FG000|Overall Study|Patient Discontinued for Other|1
7256696|NCT00325130|11468425|FG001|Overall Study|Patient Discontinued for Other|0
7256697|NCT00325143|11468431|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
7256698|NCT00325143|11468431|FG000|Overall Study|Migrated/moved from study area|1
7256699|NCT00325143|11468431|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
7256700|NCT00325143|11468431|FG000|Overall Study|Withdrawal by Subject|8
7256701|NCT00325156|11468435|FG000|Overall Study|Protocol Violation|8
7256702|NCT00325156|11468435|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
7256703|NCT00325156|11468435|FG000|Overall Study|Migrated/moved from study area|12
7256704|NCT00325156|11468435|FG000|Overall Study|Adverse event, non-fatal|3
7256705|NCT00325156|11468435|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
7256706|NCT00325156|11468435|FG000|Overall Study|Other|1
7256707|NCT00325156|11468435|FG000|Overall Study|Withdrawal by Subject|31
7256708|NCT00325195|11468442|FG000|Randomized|Not dosed|5
7256709|NCT00325195|11468443|FG001|Randomized|Not dosed|5
7256710|NCT00325195|11468444|FG002|Randomized|Not dosed|3
7256711|NCT00325195|11468442|FG000|Received Intervention: ITT Population|Adverse Event|15
7256712|NCT00325195|11468443|FG001|Received Intervention: ITT Population|Adverse Event|17
7256713|NCT00325195|11468444|FG002|Received Intervention: ITT Population|Adverse Event|1
7256714|NCT00325195|11468442|FG000|Received Intervention: ITT Population|Death|3
7256715|NCT00325195|11468443|FG001|Received Intervention: ITT Population|Death|1
7256716|NCT00325195|11468444|FG002|Received Intervention: ITT Population|Death|0
7256717|NCT00325195|11468442|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
7256718|NCT00325195|11468443|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
7256719|NCT00325195|11468444|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
7256720|NCT00325195|11468442|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
7255130|NCT00316017|11466608|FG000|Overall Study|Protocol Violation|11
7255131|NCT00316017|11466609|FG001|Overall Study|Protocol Violation|13
7255132|NCT00316017|11466610|FG002|Overall Study|Protocol Violation|19
7255133|NCT00316082|11466623|FG000|Overall Study|Lack of Efficacy|2
7255134|NCT00316082|11466624|FG001|Overall Study|Lack of Efficacy|3
7255135|NCT00316082|11466625|FG002|Overall Study|Lack of Efficacy|3
7255136|NCT00316082|11466626|FG003|Overall Study|Lack of Efficacy|4
7255137|NCT00316082|11466627|FG004|Overall Study|Lack of Efficacy|6
7255138|NCT00316082|11466623|FG000|Overall Study|Withdrawal of Consent by Subject|10
7255139|NCT00316082|11466624|FG001|Overall Study|Withdrawal of Consent by Subject|8
7255140|NCT00316082|11466625|FG002|Overall Study|Withdrawal of Consent by Subject|2
7255141|NCT00316082|11466626|FG003|Overall Study|Withdrawal of Consent by Subject|9
7255142|NCT00316082|11466627|FG004|Overall Study|Withdrawal of Consent by Subject|5
7255143|NCT00316082|11466623|FG000|Overall Study|Lost to Follow-up|7
7255144|NCT00316082|11466624|FG001|Overall Study|Lost to Follow-up|6
7255145|NCT00316082|11466625|FG002|Overall Study|Lost to Follow-up|7
7255146|NCT00316082|11466626|FG003|Overall Study|Lost to Follow-up|8
7255147|NCT00316082|11466627|FG004|Overall Study|Lost to Follow-up|6
7255148|NCT00316082|11466623|FG000|Overall Study|Poor/noncompliance|6
7255149|NCT00316082|11466624|FG001|Overall Study|Poor/noncompliance|1
7255150|NCT00316082|11466625|FG002|Overall Study|Poor/noncompliance|4
7255151|NCT00316082|11466626|FG003|Overall Study|Poor/noncompliance|1
7255152|NCT00316082|11466627|FG004|Overall Study|Poor/noncompliance|4
7255153|NCT00316082|11466623|FG000|Overall Study|Adverse Event|4
7255154|NCT00316082|11466624|FG001|Overall Study|Adverse Event|2
7255155|NCT00316082|11466625|FG002|Overall Study|Adverse Event|5
7255156|NCT00316082|11466626|FG003|Overall Study|Adverse Event|1
7255157|NCT00316082|11466627|FG004|Overall Study|Adverse Event|3
7255158|NCT00316082|11466623|FG000|Overall Study|Subject no longer meets study criteria|3
7255159|NCT00316082|11466624|FG001|Overall Study|Subject no longer meets study criteria|1
7255160|NCT00316082|11466625|FG002|Overall Study|Subject no longer meets study criteria|2
7255161|NCT00316082|11466626|FG003|Overall Study|Subject no longer meets study criteria|2
7255162|NCT00316082|11466627|FG004|Overall Study|Subject no longer meets study criteria|1
7255163|NCT00316082|11466623|FG000|Overall Study|Physician Decision|1
7255164|NCT00316082|11466624|FG001|Overall Study|Physician Decision|1
7255165|NCT00316082|11466625|FG002|Overall Study|Physician Decision|2
7255166|NCT00316082|11466626|FG003|Overall Study|Physician Decision|1
7255167|NCT00316082|11466627|FG004|Overall Study|Physician Decision|1
7255168|NCT00316082|11466623|FG000|Overall Study|Death|0
7255169|NCT00316082|11466624|FG001|Overall Study|Death|0
7255170|NCT00316082|11466625|FG002|Overall Study|Death|1
7255171|NCT00316082|11466626|FG003|Overall Study|Death|0
7255172|NCT00316082|11466627|FG004|Overall Study|Death|0
7255173|NCT00316082|11466623|FG000|Overall Study|Administrative reason by sponsor|0
7574498|NCT03682120|11957408|FG000|Overall Study|Physician Decision|1
7574499|NCT03682120|11957409|FG001|Overall Study|Physician Decision|0
7574500|NCT03682120|11957410|FG002|Overall Study|Physician Decision|0
7255174|NCT00316082|11466624|FG001|Overall Study|Administrative reason by sponsor|0
7255175|NCT00316082|11466625|FG002|Overall Study|Administrative reason by sponsor|1
7255176|NCT00316082|11466626|FG003|Overall Study|Administrative reason by sponsor|0
7255177|NCT00316082|11466627|FG004|Overall Study|Administrative reason by sponsor|0
7255178|NCT00316121|11466645|FG000|Overall Study|Death|1
7255179|NCT00316121|11466646|FG001|Overall Study|Death|0
7255180|NCT00316121|11466645|FG000|Overall Study|Lost to Follow-up|14
7255181|NCT00316121|11466646|FG001|Overall Study|Lost to Follow-up|8
7255182|NCT00316121|11466645|FG000|Overall Study|Withdrawal by Subject|2
7255183|NCT00316121|11466646|FG001|Overall Study|Withdrawal by Subject|0
7255184|NCT00316121|11466645|FG000|Overall Study|Reason is missing|1
7255185|NCT00316121|11466646|FG001|Overall Study|Reason is missing|0
7255186|NCT00316121|11466645|FG000|Overall Study|Subject relocated|1
7255187|NCT00316121|11466646|FG001|Overall Study|Subject relocated|1
7255188|NCT00316121|11466645|FG000|Overall Study|Subject refused to return|1
7255189|NCT00316121|11466646|FG001|Overall Study|Subject refused to return|0
7384040|NCT01192191|11641156|FG000|Overall Study|Participants Reached Stopping Criteria|3
7255190|NCT00316121|11466645|FG000|Overall Study|Subject no show for visit x 3|1
7255191|NCT00316121|11466646|FG001|Overall Study|Subject no show for visit x 3|0
7255192|NCT00316121|11466645|FG000|Overall Study|Subject did not have 24 month visit|1
7255193|NCT00316121|11466646|FG001|Overall Study|Subject did not have 24 month visit|0
7255194|NCT00316173|11466654|FG000|Run-in Phase|Adverse Event|1
7255195|NCT00316173|11466655|FG001|Run-in Phase|Adverse Event|0
7255196|NCT00316173|11466654|FG000|Run-in Phase|Protocol Violation|1
7255197|NCT00316173|11466655|FG001|Run-in Phase|Protocol Violation|0
7255198|NCT00316173|11466654|FG000|Run-in Phase|Study Follow-up Stopped|5
7255199|NCT00316173|11466655|FG001|Run-in Phase|Study Follow-up Stopped|0
7255200|NCT00316173|11466654|FG000|Treatment Phase|Adverse Event|0
7255201|NCT00316173|11466655|FG001|Treatment Phase|Adverse Event|1
7255202|NCT00316173|11466654|FG000|Treatment Phase|Lack of Efficacy|0
7255203|NCT00316173|11466655|FG001|Treatment Phase|Lack of Efficacy|3
7255204|NCT00316173|11466654|FG000|Treatment Phase|Lost to Follow-up|0
7255205|NCT00316173|11466655|FG001|Treatment Phase|Lost to Follow-up|3
7255206|NCT00316173|11466654|FG000|Treatment Phase|Withdrawal by Subject|0
7255207|NCT00316173|11466655|FG001|Treatment Phase|Withdrawal by Subject|1
7255208|NCT00316173|11466654|FG000|Treatment Phase|Study Follow-up Stopped|0
7574501|NCT03682120|11957411|FG003|Overall Study|Physician Decision|0
7255209|NCT00316173|11466655|FG001|Treatment Phase|Study Follow-up Stopped|34
7255210|NCT00316186|11466660|FG000|Overall Study|Adverse Event|6
7255211|NCT00316186|11466660|FG000|Overall Study|Disease Progression|4
7255212|NCT00316186|11466660|FG000|Overall Study|Lost to Follow-up|1
7255213|NCT00316186|11466660|FG000|Overall Study|Other|1
7255214|NCT00316199|11466664|FG000|Overall Study|Adverse Event|2
7255215|NCT00316199|11466664|FG000|Overall Study|Death|8
7255216|NCT00316199|11466664|FG000|Overall Study|Lost to Follow-up|2
7255217|NCT00316225|11466668|FG000|Overall Study|Adverse Event|2
7255218|NCT00316225|11466668|FG000|Overall Study|Physician Decision|3
7255219|NCT00316225|11466668|FG000|Overall Study|Progressive Disease|15
7255220|NCT00316225|11466668|FG000|Overall Study|Withdrawal by Subject|3
7255221|NCT00316225|11466668|FG000|Overall Study|Death|2
7255222|NCT00316264|11466675|FG000|Overall Study|Lost to Follow-up|0
7255223|NCT00316264|11466676|FG001|Overall Study|Lost to Follow-up|1
7255224|NCT00316264|11466677|FG002|Overall Study|Lost to Follow-up|0
7255225|NCT00316264|11466675|FG000|Overall Study|Withdrawal of Consent|3
7255226|NCT00316264|11466676|FG001|Overall Study|Withdrawal of Consent|5
7255227|NCT00316264|11466677|FG002|Overall Study|Withdrawal of Consent|6
7255228|NCT00316264|11466675|FG000|Overall Study|Death|2
7255229|NCT00316264|11466676|FG001|Overall Study|Death|0
7255230|NCT00316264|11466677|FG002|Overall Study|Death|0
7255231|NCT00316264|11466675|FG000|Overall Study|Other|1
7255232|NCT00316264|11466676|FG001|Overall Study|Other|1
7255233|NCT00316264|11466677|FG002|Overall Study|Other|0
7255234|NCT00316277|11466687|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
7255235|NCT00316277|11466688|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
7255236|NCT00316277|11466687|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
7255237|NCT00316277|11466688|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
7255238|NCT00316277|11466687|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
7255239|NCT00316277|11466688|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
7255240|NCT00316277|11466687|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
7255241|NCT00316277|11466688|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
7255242|NCT00316277|11466687|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
7255243|NCT00316277|11466688|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
7255244|NCT00316303|11466704|FG000|Overall Study|Lost to Follow-up|11
7255245|NCT00316303|11466705|FG001|Overall Study|Lost to Follow-up|16
7255246|NCT00316589|11466748|FG000|Overall Study|Withdrawal by Subject|0
7255247|NCT00316589|11466749|FG001|Overall Study|Withdrawal by Subject|5
7255248|NCT00316589|11466750|FG002|Overall Study|Withdrawal by Subject|0
7255249|NCT00316589|11466751|FG003|Overall Study|Withdrawal by Subject|1
7255250|NCT00316589|11466748|FG000|Overall Study|Subject unwilling/unable to comply|0
7255251|NCT00316589|11466749|FG001|Overall Study|Subject unwilling/unable to comply|6
7255252|NCT00316589|11466750|FG002|Overall Study|Subject unwilling/unable to comply|0
7255253|NCT00316589|11466751|FG003|Overall Study|Subject unwilling/unable to comply|2
7255254|NCT00316589|11466748|FG000|Overall Study|Adverse Event|1
7255255|NCT00316589|11466749|FG001|Overall Study|Adverse Event|0
7255256|NCT00316589|11466750|FG002|Overall Study|Adverse Event|0
7255257|NCT00316589|11466751|FG003|Overall Study|Adverse Event|1
7255258|NCT00316589|11466748|FG000|Overall Study|Physician Decision|0
7255259|NCT00316589|11466749|FG001|Overall Study|Physician Decision|1
7255260|NCT00316589|11466750|FG002|Overall Study|Physician Decision|0
7255261|NCT00316589|11466751|FG003|Overall Study|Physician Decision|0
7255262|NCT00316589|11466748|FG000|Overall Study|Other reason|0
7255263|NCT00316589|11466749|FG001|Overall Study|Other reason|12
7255264|NCT00316589|11466750|FG002|Overall Study|Other reason|1
7255265|NCT00316589|11466751|FG003|Overall Study|Other reason|1
7255266|NCT00316602|11466765|FG000|Overall Study|Withdrawal by Subject|3
7255267|NCT00316602|11466766|FG001|Overall Study|Withdrawal by Subject|2
7255268|NCT00316602|11466765|FG000|Overall Study|Subject unwilling/unable to comply with|3
7255269|NCT00316602|11466766|FG001|Overall Study|Subject unwilling/unable to comply with|17
7255270|NCT00316602|11466765|FG000|Overall Study|Adverse Event|1
7255271|NCT00316602|11466766|FG001|Overall Study|Adverse Event|0
7255272|NCT00316602|11466765|FG000|Overall Study|Other|3
7255273|NCT00316602|11466766|FG001|Overall Study|Other|6
7255274|NCT00316693|11466774|FG000|Overall Study|Adverse Event|6
7255275|NCT00316693|11466775|FG001|Overall Study|Adverse Event|1
7255276|NCT00316693|11466774|FG000|Overall Study|Protocol Violation|1
7255277|NCT00316693|11466775|FG001|Overall Study|Protocol Violation|0
7255278|NCT00316693|11466774|FG000|Overall Study|Withdrawal by Subject|6
7255279|NCT00316693|11466775|FG001|Overall Study|Withdrawal by Subject|6
7255280|NCT00316693|11466774|FG000|Overall Study|Lost to Follow-up|26
7255281|NCT00316693|11466775|FG001|Overall Study|Lost to Follow-up|34
7255282|NCT00316693|11466774|FG000|Overall Study|Other|38
7255283|NCT00316693|11466775|FG001|Overall Study|Other|44
7255284|NCT00316706|11466783|FG000|Overall Study|Lost to Follow-up|38
7255285|NCT00316706|11466784|FG001|Overall Study|Lost to Follow-up|48
7255286|NCT00316719|11466792|FG000|Overall Study|Adverse Event|0
7255287|NCT00316719|11466793|FG001|Overall Study|Adverse Event|6
7255288|NCT00316719|11466792|FG000|Overall Study|Consent withdrawn|2
7255289|NCT00316719|11466793|FG001|Overall Study|Consent withdrawn|0
7255290|NCT00316914|11466805|FG000|Overall Study|Withdrawal by Subject|5
7255291|NCT00316914|11466806|FG001|Overall Study|Withdrawal by Subject|3
7255292|NCT00316914|11466805|FG000|Overall Study|Adverse Event|8
7255293|NCT00316914|11466806|FG001|Overall Study|Adverse Event|7
7255294|NCT00316914|11466805|FG000|Overall Study|Other Problems|6
7255295|NCT00316914|11466806|FG001|Overall Study|Other Problems|11
7255296|NCT00316914|11466805|FG000|Overall Study|Missing end of treatment documentation|14
7255297|NCT00316914|11466806|FG001|Overall Study|Missing end of treatment documentation|15
7533828|NCT02689076|11880176|FG001|Overall Study|Participant no longer active in VA system|0
7533829|NCT02689076|11880177|FG002|Overall Study|Participant no longer active in VA system|0
7533830|NCT02689076|11880175|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7533831|NCT02689076|11880176|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
7533832|NCT02689076|11880177|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
7533833|NCT02689206|11880194|FG000|Overall Study|Adverse Event|0
7533834|NCT02689206|11880195|FG001|Overall Study|Adverse Event|0
7533835|NCT02689206|11880196|FG002|Overall Study|Adverse Event|1
7533836|NCT02689206|11880197|FG003|Overall Study|Adverse Event|0
7533837|NCT02689206|11880198|FG004|Overall Study|Adverse Event|2
7533838|NCT02689206|11880194|FG000|Overall Study|Protocol Violation|1
7533839|NCT02689206|11880195|FG001|Overall Study|Protocol Violation|0
7533840|NCT02689206|11880196|FG002|Overall Study|Protocol Violation|0
7533841|NCT02689206|11880197|FG003|Overall Study|Protocol Violation|1
7533842|NCT02689206|11880198|FG004|Overall Study|Protocol Violation|2
7533843|NCT02689206|11880194|FG000|Overall Study|Other: Reached stopping criteria|0
7533844|NCT02689206|11880195|FG001|Overall Study|Other: Reached stopping criteria|1
7533845|NCT02689206|11880196|FG002|Overall Study|Other: Reached stopping criteria|2
7533846|NCT02689206|11880197|FG003|Overall Study|Other: Reached stopping criteria|3
7255298|NCT00317044|11466815|FG000|Overall Study|Protocol Violation|28
7255299|NCT00317044|11466816|FG001|Overall Study|Protocol Violation|22
7255300|NCT00317044|11466817|FG002|Overall Study|Protocol Violation|20
7255301|NCT00317044|11466815|FG000|Overall Study|Adverse Event|4
7255302|NCT00317044|11466816|FG001|Overall Study|Adverse Event|7
7255303|NCT00317044|11466817|FG002|Overall Study|Adverse Event|4
7255304|NCT00317044|11466815|FG000|Overall Study|Withdrawal by Subject|10
7255305|NCT00317044|11466816|FG001|Overall Study|Withdrawal by Subject|7
7255306|NCT00317044|11466817|FG002|Overall Study|Withdrawal by Subject|12
7255307|NCT00317044|11466815|FG000|Overall Study|Lost to Follow-up|0
7255308|NCT00317044|11466816|FG001|Overall Study|Lost to Follow-up|2
7255309|NCT00317044|11466817|FG002|Overall Study|Lost to Follow-up|3
7255310|NCT00317044|11466815|FG000|Overall Study|Multiple Reasons|6
7255311|NCT00317044|11466816|FG001|Overall Study|Multiple Reasons|2
7255312|NCT00317044|11466817|FG002|Overall Study|Multiple Reasons|6
7255313|NCT00317109|11466827|FG000|Overall Study|Withdrawal by Subject|2
7255314|NCT00317109|11466828|FG001|Overall Study|Withdrawal by Subject|0
7255315|NCT00317109|11466827|FG000|Overall Study|Migated/moved from study area|1
7255316|NCT00317109|11466828|FG001|Overall Study|Migated/moved from study area|0
7255317|NCT00317356|11466851|FG000|Overall Study|Adverse Event|0
7255318|NCT00317356|11466852|FG001|Overall Study|Adverse Event|0
7255319|NCT00317356|11466853|FG002|Overall Study|Adverse Event|1
7255320|NCT00317356|11466854|FG003|Overall Study|Adverse Event|0
7255321|NCT00317356|11466851|FG000|Overall Study|Lack of Efficacy|1
7255322|NCT00317356|11466852|FG001|Overall Study|Lack of Efficacy|1
7255323|NCT00317356|11466853|FG002|Overall Study|Lack of Efficacy|0
7255324|NCT00317356|11466854|FG003|Overall Study|Lack of Efficacy|3
7255325|NCT00317356|11466851|FG000|Overall Study|Physician Decision|0
7255326|NCT00317356|11466852|FG001|Overall Study|Physician Decision|1
7255327|NCT00317356|11466853|FG002|Overall Study|Physician Decision|0
7255328|NCT00317356|11466854|FG003|Overall Study|Physician Decision|0
7255329|NCT00317369|11466867|FG000|Overall Study|Adverse Event|2
7255330|NCT00317369|11466868|FG001|Overall Study|Adverse Event|1
7255331|NCT00317369|11466869|FG002|Overall Study|Adverse Event|0
7255332|NCT00317369|11466867|FG000|Overall Study|Lack of Efficacy|0
7255333|NCT00317369|11466868|FG001|Overall Study|Lack of Efficacy|1
7255334|NCT00317369|11466869|FG002|Overall Study|Lack of Efficacy|1
7255335|NCT00317369|11466867|FG000|Overall Study|Withdrawal by Subject|0
7255336|NCT00317369|11466868|FG001|Overall Study|Withdrawal by Subject|0
7255337|NCT00317369|11466869|FG002|Overall Study|Withdrawal by Subject|1
7255338|NCT00317473|11466883|FG000|Overall Study|Withdrawal by Subject|2
7255339|NCT00317473|11466884|FG001|Overall Study|Withdrawal by Subject|1
7255340|NCT00317473|11466885|FG002|Overall Study|Withdrawal by Subject|2
7255341|NCT00317473|11466886|FG003|Overall Study|Withdrawal by Subject|1
7255342|NCT00317473|11466887|FG004|Overall Study|Withdrawal by Subject|3
7255343|NCT00317473|11466888|FG005|Overall Study|Withdrawal by Subject|1
7255344|NCT00317473|11466883|FG000|Overall Study|Relocation|1
7533847|NCT02689206|11880198|FG004|Overall Study|Other: Reached stopping criteria|4
7574502|NCT03682120|11957408|FG000|Overall Study|Withdrawal by Subject|1
7574503|NCT03682120|11957409|FG001|Overall Study|Withdrawal by Subject|2
7255345|NCT00317473|11466884|FG001|Overall Study|Relocation|0
7255346|NCT00317473|11466885|FG002|Overall Study|Relocation|1
7255347|NCT00317473|11466886|FG003|Overall Study|Relocation|1
7255348|NCT00317473|11466887|FG004|Overall Study|Relocation|5
7255349|NCT00317473|11466888|FG005|Overall Study|Relocation|2
7255350|NCT00317473|11466883|FG000|Overall Study|Death|1
7533848|NCT02689206|11880194|FG000|Overall Study|Physician Decision|1
7255351|NCT00317473|11466884|FG001|Overall Study|Death|0
7255352|NCT00317473|11466885|FG002|Overall Study|Death|0
7255353|NCT00317473|11466886|FG003|Overall Study|Death|0
7255354|NCT00317473|11466887|FG004|Overall Study|Death|0
7255355|NCT00317473|11466888|FG005|Overall Study|Death|0
7255356|NCT00317473|11466883|FG000|Overall Study|Other|0
7255357|NCT00317473|11466884|FG001|Overall Study|Other|2
7255358|NCT00317473|11466885|FG002|Overall Study|Other|0
7255359|NCT00317473|11466886|FG003|Overall Study|Other|0
7255360|NCT00317473|11466887|FG004|Overall Study|Other|0
7255361|NCT00317473|11466888|FG005|Overall Study|Other|0
7255362|NCT00317603|11466912|FG000|Overall Study|Progressive Disease|3
7255363|NCT00317642|11466918|FG000|Overall Study|Not Received Either Study Drug|1
7255364|NCT00317642|11466919|FG001|Overall Study|Not Received Either Study Drug|3
7255365|NCT00317642|11466918|FG000|Overall Study|Physician Decision|15
7255366|NCT00317642|11466919|FG001|Overall Study|Physician Decision|7
7255367|NCT00317642|11466918|FG000|Overall Study|Participant declined treatment|14
7255368|NCT00317642|11466919|FG001|Overall Study|Participant declined treatment|3
7255369|NCT00317642|11466918|FG000|Overall Study|Adverse Event|17
7255370|NCT00317642|11466919|FG001|Overall Study|Adverse Event|5
7255371|NCT00317642|11466918|FG000|Overall Study|Treatment Failure|56
7255372|NCT00317642|11466919|FG001|Overall Study|Treatment Failure|102
7255373|NCT00317642|11466918|FG000|Overall Study|Disease Recurrence|1
7255374|NCT00317642|11466919|FG001|Overall Study|Disease Recurrence|2
7255375|NCT00317642|11466918|FG000|Overall Study|Death|14
7255376|NCT00317642|11466919|FG001|Overall Study|Death|7
7255377|NCT00317642|11466918|FG000|Overall Study|Not Continue to Consolidation|2
7255378|NCT00317642|11466919|FG001|Overall Study|Not Continue to Consolidation|0
7255379|NCT00317642|11466918|FG000|Overall Study|Withdrawal by Subject|0
7255380|NCT00317642|11466919|FG001|Overall Study|Withdrawal by Subject|1
7255381|NCT00317642|11466918|FG000|Overall Study|Referred For Transplantation|1
7255382|NCT00317642|11466919|FG001|Overall Study|Referred For Transplantation|0
7255383|NCT00317642|11466918|FG000|Overall Study|AML Not Centrally Confirmed|1
7255384|NCT00317642|11466919|FG001|Overall Study|AML Not Centrally Confirmed|5
7255385|NCT00318149|11466960|FG000|Overall Study|Adverse Event|0
7255386|NCT00318149|11466961|FG001|Overall Study|Adverse Event|0
7255387|NCT00318149|11466962|FG002|Overall Study|Adverse Event|0
7255388|NCT00318149|11466963|FG003|Overall Study|Adverse Event|0
7255389|NCT00318149|11466964|FG004|Overall Study|Adverse Event|0
7255390|NCT00318149|11466965|FG005|Overall Study|Adverse Event|2
7255391|NCT00318370|11466999|FG000|Period 1|Lack of Efficacy|5
7255392|NCT00318370|11467000|FG001|Period 1|Lack of Efficacy|0
7255393|NCT00318370|11467001|FG002|Period 1|Lack of Efficacy|0
7255394|NCT00318370|11466999|FG000|Period 1|Physician Decision|1
7255395|NCT00318370|11467000|FG001|Period 1|Physician Decision|0
7255396|NCT00318370|11467001|FG002|Period 1|Physician Decision|0
7255397|NCT00318370|11466999|FG000|Period 1|Withdrawal by Subject|1
7255398|NCT00318370|11467000|FG001|Period 1|Withdrawal by Subject|0
7255399|NCT00318370|11467001|FG002|Period 1|Withdrawal by Subject|0
7255400|NCT00318370|11466999|FG000|Period 2|Adverse Event|0
7255401|NCT00318370|11467000|FG001|Period 2|Adverse Event|3
7255402|NCT00318370|11467001|FG002|Period 2|Adverse Event|0
7255403|NCT00318370|11466999|FG000|Period 2|Lack of Efficacy|0
7255404|NCT00318370|11467000|FG001|Period 2|Lack of Efficacy|5
7255405|NCT00318370|11467001|FG002|Period 2|Lack of Efficacy|0
7255406|NCT00318370|11466999|FG000|Period 2|Physician Decision|0
7255407|NCT00318370|11467000|FG001|Period 2|Physician Decision|1
7255408|NCT00318370|11467001|FG002|Period 2|Physician Decision|0
7255409|NCT00318370|11466999|FG000|Period 2|Withdrawal by Subject|0
7255410|NCT00318370|11467000|FG001|Period 2|Withdrawal by Subject|1
7255411|NCT00318370|11467001|FG002|Period 2|Withdrawal by Subject|0
7255412|NCT00318370|11466999|FG000|Period 2|Other|0
7255413|NCT00318370|11467000|FG001|Period 2|Other|1
7255414|NCT00318370|11467001|FG002|Period 2|Other|0
7255415|NCT00318370|11466999|FG000|Period 3|Adverse Event|0
7255416|NCT00318370|11467000|FG001|Period 3|Adverse Event|0
7255417|NCT00318370|11467001|FG002|Period 3|Adverse Event|1
7255418|NCT00318370|11466999|FG000|Period 3|Lack of Efficacy|0
7255419|NCT00318370|11467000|FG001|Period 3|Lack of Efficacy|0
7255420|NCT00318370|11467001|FG002|Period 3|Lack of Efficacy|24
7255421|NCT00318370|11466999|FG000|Period 3|Death|0
7255422|NCT00318370|11467000|FG001|Period 3|Death|0
7255423|NCT00318370|11467001|FG002|Period 3|Death|1
7255424|NCT00318370|11466999|FG000|Period 3|Physician Decision|0
7255425|NCT00318370|11467000|FG001|Period 3|Physician Decision|0
7255426|NCT00318370|11467001|FG002|Period 3|Physician Decision|1
7255427|NCT00318370|11466999|FG000|Period 3|Withdrawal by Subject|0
7255428|NCT00318370|11467000|FG001|Period 3|Withdrawal by Subject|0
7255429|NCT00318370|11467001|FG002|Period 3|Withdrawal by Subject|3
7255430|NCT00318370|11466999|FG000|Period 3|Other|0
7255431|NCT00318370|11467000|FG001|Period 3|Other|0
7255432|NCT00318370|11467001|FG002|Period 3|Other|3
7255433|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Adverse Event|11
7255434|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Adverse Event|23
7255435|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Adverse Event|29
7255436|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Adverse Event|2
7255437|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Adverse Event|8
7255438|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
7255439|NCT00318461|11467023|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
7255440|NCT00318461|11467024|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
7255441|NCT00318461|11467025|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
7255442|NCT00318461|11467026|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
7255443|NCT00318461|11467022|FG000|Double-Blind, 6 Months|Protocol Violation|2
7256775|NCT00325468|11468500|FG000|Overall Study|site closure etc|4
7256776|NCT00325468|11468501|FG001|Overall Study|site closure etc|2
7256777|NCT00325468|11468502|FG002|Overall Study|site closure etc|1
7256778|NCT00325468|11468503|FG003|Overall Study|site closure etc|8
7256779|NCT00325468|11468504|FG004|Overall Study|site closure etc|1
7256780|NCT00325754|11468530|FG000|Overall Study|Adverse Event|4
7256781|NCT00325754|11468531|FG001|Overall Study|Adverse Event|1
7256782|NCT00325819|11468543|FG000|Overall Study|Study product lost in mail|2
7256783|NCT00325819|11468544|FG001|Overall Study|Study product lost in mail|1
7256784|NCT00325819|11468543|FG000|Overall Study|Did not take a dose of study product|4
7256785|NCT00325819|11468544|FG001|Overall Study|Did not take a dose of study product|9
7256786|NCT00325819|11468543|FG000|Overall Study|Lost to Follow-up|3
7256787|NCT00325819|11468544|FG001|Overall Study|Lost to Follow-up|3
7256788|NCT00325897|11468554|FG000|Overall Study|Lost to Follow-up|12
7256789|NCT00325897|11468555|FG001|Overall Study|Lost to Follow-up|13
7256790|NCT00326001|11468566|FG000|Overall Study|Adverse Event|4
7256791|NCT00326001|11468567|FG001|Overall Study|Adverse Event|5
7256792|NCT00326001|11468566|FG000|Overall Study|Physician Decision|3
7256793|NCT00326001|11468567|FG001|Overall Study|Physician Decision|3
7256794|NCT00326118|11468575|FG000|Active Phase|Withdrawal by Subject|4
7256795|NCT00326118|11468576|FG001|Active Phase|Withdrawal by Subject|1
7256796|NCT00326209|11468596|FG000|Overall Study|Adverse Event|28
7256797|NCT00326209|11468596|FG000|Overall Study|Withdrawal by Subject|22
7256798|NCT00326209|11468596|FG000|Overall Study|Lack of Efficacy|31
7256799|NCT00326209|11468596|FG000|Overall Study|Lost to Follow-up|18
7256800|NCT00326209|11468596|FG000|Overall Study|Participant non-compliant|6
7468738|NCT01914393|11769701|FG001|Overall Study|Withdrawal by Subject|20
7468739|NCT01914393|11769702|FG002|Overall Study|Withdrawal by Subject|47
7468740|NCT01914393|11769700|FG000|Overall Study|Lost to Follow-up|12
7468741|NCT01914393|11769701|FG001|Overall Study|Lost to Follow-up|6
7468742|NCT01914393|11769702|FG002|Overall Study|Lost to Follow-up|19
7468743|NCT01914393|11769700|FG000|Overall Study|subject never dosed|0
7468744|NCT01914393|11769701|FG001|Overall Study|subject never dosed|0
7468745|NCT01914393|11769702|FG002|Overall Study|subject never dosed|1
7468746|NCT01914666|11769722|FG000|Treatment Period|Lack of Efficacy|0
7468747|NCT01914666|11769723|FG001|Treatment Period|Lack of Efficacy|0
7468748|NCT01914666|11769724|FG002|Treatment Period|Lack of Efficacy|2
7468749|NCT01914666|11769722|FG000|Treatment Period|Adverse Event|10
7468750|NCT01914666|11769723|FG001|Treatment Period|Adverse Event|4
7468751|NCT01914666|11769724|FG002|Treatment Period|Adverse Event|2
7468752|NCT01914666|11769722|FG000|Treatment Period|Withdrawal by Subject|3
7468753|NCT01914666|11769723|FG001|Treatment Period|Withdrawal by Subject|2
7468754|NCT01914666|11769724|FG002|Treatment Period|Withdrawal by Subject|2
7468755|NCT01914666|11769722|FG000|Treatment Period|Physician Decision|0
7468756|NCT01914666|11769723|FG001|Treatment Period|Physician Decision|0
7468757|NCT01914666|11769724|FG002|Treatment Period|Physician Decision|2
7468758|NCT01914679|11769730|FG000|Overall Study|Lack of Efficacy|1
7468759|NCT01914679|11769730|FG000|Overall Study|Sponsor terminated study|4
7468760|NCT01914757|11769737|FG000|Overall Study|Severe non-compliance to protocol|3
7468761|NCT01914757|11769738|FG001|Overall Study|Severe non-compliance to protocol|1
7468762|NCT01914757|11769739|FG002|Overall Study|Severe non-compliance to protocol|2
7468763|NCT01914757|11769737|FG000|Overall Study|Lost to Follow-up|5
7468764|NCT01914757|11769738|FG001|Overall Study|Lost to Follow-up|8
7468765|NCT01914757|11769739|FG002|Overall Study|Lost to Follow-up|6
7468766|NCT01914757|11769737|FG000|Overall Study|Withdrawal by Subject|15
7468767|NCT01914757|11769738|FG001|Overall Study|Withdrawal by Subject|27
7468768|NCT01914757|11769739|FG002|Overall Study|Withdrawal by Subject|19
7468769|NCT01914757|11769737|FG000|Overall Study|Death|2
7468770|NCT01914757|11769738|FG001|Overall Study|Death|2
7468771|NCT01914757|11769739|FG002|Overall Study|Death|1
7468772|NCT01914757|11769737|FG000|Overall Study|Adverse Event|4
7468773|NCT01914757|11769738|FG001|Overall Study|Adverse Event|3
7468774|NCT01914757|11769739|FG002|Overall Study|Adverse Event|4
7468775|NCT01914757|11769737|FG000|Overall Study|Study specific withdrawal criteria|0
7468776|NCT01914757|11769738|FG001|Overall Study|Study specific withdrawal criteria|1
7468777|NCT01914757|11769739|FG002|Overall Study|Study specific withdrawal criteria|0
7468778|NCT01914757|11769737|FG000|Overall Study|Eligibility criteria not fulfilled|2
7468779|NCT01914757|11769738|FG001|Overall Study|Eligibility criteria not fulfilled|0
7256865|NCT00326885|11468703|FG000|Overall Study|Hospice withdrew consent|2
7468780|NCT01914757|11769739|FG002|Overall Study|Eligibility criteria not fulfilled|2
7468781|NCT01914757|11769737|FG000|Overall Study|Other reasons|5
7468782|NCT01914757|11769738|FG001|Overall Study|Other reasons|9
7468783|NCT01914757|11769739|FG002|Overall Study|Other reasons|4
7468784|NCT01914926|11769749|FG000|Overall Study|Adverse Event|1
7468785|NCT01914926|11769750|FG001|Overall Study|Adverse Event|0
7468786|NCT01914926|11769749|FG000|Overall Study|uncooperative, agitated and removed|0
7468787|NCT01914926|11769750|FG001|Overall Study|uncooperative, agitated and removed|1
7468788|NCT01915095|11769763|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
7468789|NCT01915095|11769764|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
7468790|NCT01915095|11769765|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
7468791|NCT01915095|11769766|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
7256801|NCT00326209|11468596|FG000|Overall Study|Sponsor closed study|173
7256802|NCT00326209|11468596|FG000|Overall Study|Prohibited medication use|1
7256803|NCT00326209|11468596|FG000|Overall Study|Violation of entry criteria|1
7256804|NCT00326209|11468596|FG000|Overall Study|Withdrawn in error|1
7256805|NCT00326209|11468596|FG000|Overall Study|Pregnancy|1
7256806|NCT00326417|11468602|FG000|Overall Study|Withdrawal by Subject|0
7256807|NCT00326417|11468603|FG001|Overall Study|Withdrawal by Subject|0
7256808|NCT00326417|11468604|FG002|Overall Study|Withdrawal by Subject|1
7256809|NCT00326417|11468605|FG003|Overall Study|Withdrawal by Subject|0
7256810|NCT00326417|11468602|FG000|Overall Study|Arm Closed|7
7256811|NCT00326417|11468603|FG001|Overall Study|Arm Closed|0
7256812|NCT00326417|11468604|FG002|Overall Study|Arm Closed|0
7256813|NCT00326417|11468605|FG003|Overall Study|Arm Closed|3
7256814|NCT00326417|11468602|FG000|Overall Study|Death|7
7256815|NCT00326417|11468603|FG001|Overall Study|Death|0
7256816|NCT00326417|11468604|FG002|Overall Study|Death|0
7256817|NCT00326417|11468605|FG003|Overall Study|Death|0
7256818|NCT00326495|11468613|FG000|Overall Study|Switched to alternative treatment|1
7256819|NCT00326495|11468613|FG000|Overall Study|Disease progression before treatment|1
7256820|NCT00326495|11468613|FG000|Overall Study|Refused further treatment|2
7256821|NCT00326495|11468613|FG000|Overall Study|Subject off study before assessment|1
7256822|NCT00326599|11468621|FG000|Overall Study|Withdrawal by Subject|1
7256823|NCT00326599|11468622|FG001|Overall Study|Withdrawal by Subject|0
7256824|NCT00326599|11468623|FG002|Overall Study|Withdrawal by Subject|5
7256825|NCT00326599|11468624|FG003|Overall Study|Withdrawal by Subject|2
7256826|NCT00326599|11468621|FG000|Overall Study|Adverse Event|1
7256827|NCT00326599|11468622|FG001|Overall Study|Adverse Event|0
7256828|NCT00326599|11468623|FG002|Overall Study|Adverse Event|32
7256829|NCT00326599|11468624|FG003|Overall Study|Adverse Event|3
7256830|NCT00326599|11468621|FG000|Overall Study|Disease Progression|3
7256831|NCT00326599|11468622|FG001|Overall Study|Disease Progression|1
7256832|NCT00326599|11468623|FG002|Overall Study|Disease Progression|13
7256833|NCT00326599|11468624|FG003|Overall Study|Disease Progression|11
7256834|NCT00326599|11468621|FG000|Overall Study|Alternate Treatment|1
7256835|NCT00326599|11468622|FG001|Overall Study|Alternate Treatment|0
7256836|NCT00326599|11468623|FG002|Overall Study|Alternate Treatment|0
7256837|NCT00326599|11468624|FG003|Overall Study|Alternate Treatment|0
7256838|NCT00326599|11468621|FG000|Overall Study|Death|0
7256839|NCT00326599|11468622|FG001|Overall Study|Death|0
7256840|NCT00326599|11468623|FG002|Overall Study|Death|1
7256841|NCT00326599|11468624|FG003|Overall Study|Death|2
7256842|NCT00326599|11468621|FG000|Overall Study|Other Unspecified Reason|0
7256843|NCT00326599|11468622|FG001|Overall Study|Other Unspecified Reason|0
7256844|NCT00326599|11468623|FG002|Overall Study|Other Unspecified Reason|2
7256845|NCT00326599|11468624|FG003|Overall Study|Other Unspecified Reason|1
7256846|NCT00326612|11468635|FG000|Overall Study|They did not have a seizure requiring tx|129
7256847|NCT00326612|11468636|FG001|Overall Study|They did not have a seizure requiring tx|137
7256858|NCT00326716|11468657|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
7256859|NCT00326716|11468658|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
7256860|NCT00326716|11468659|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7256861|NCT00326716|11468660|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
7256862|NCT00326885|11468703|FG000|Overall Study|Adverse Event|1
7575491|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7575492|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
7575493|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7575494|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
7575495|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7256863|NCT00326885|11468703|FG000|Overall Study|Withdrawal by Subject|3
7256864|NCT00326885|11468703|FG000|Overall Study|Physician Decision|1
7256866|NCT00326911|11468710|FG000|Overall Study|Hospitalization prior to treatment|0
7256867|NCT00326911|11468711|FG001|Overall Study|Hospitalization prior to treatment|1
7256868|NCT00326911|11468710|FG000|Overall Study|Physician decision prior to treatment|1
7256869|NCT00326911|11468711|FG001|Overall Study|Physician decision prior to treatment|0
7256870|NCT00326911|11468710|FG000|Overall Study|Withdrawal by subject prior to treatment|0
7256871|NCT00326911|11468711|FG001|Overall Study|Withdrawal by subject prior to treatment|1
7256872|NCT00326950|11468726|FG000|Overall Study|Progressive Disease|1
7256873|NCT00326963|11468730|FG000|Overall Study|Adverse Event|2
7256874|NCT00326963|11468730|FG000|Overall Study|Injection site reaction|1
7256875|NCT00326963|11468730|FG000|Overall Study|Death|1
7256876|NCT00326963|11468730|FG000|Overall Study|Failure to return|10
7256877|NCT00326963|11468730|FG000|Overall Study|Withdrawal by Subject|10
7256878|NCT00326963|11468730|FG000|Overall Study|Refused treatment / did not cooperate|5
7256879|NCT00326963|11468730|FG000|Overall Study|Violation of selection criteria at entry|2
7256880|NCT00326963|11468730|FG000|Overall Study|Other protocol violation|1
7256881|NCT00326963|11468730|FG000|Overall Study|Administrative / other|1
7256882|NCT00327015|11468739|FG000|Overall Study|Lack of Efficacy|18
7256883|NCT00327015|11468740|FG001|Overall Study|Lack of Efficacy|18
7256884|NCT00327015|11468741|FG002|Overall Study|Lack of Efficacy|35
7256885|NCT00327015|11468742|FG003|Overall Study|Lack of Efficacy|29
7256886|NCT00327015|11468739|FG000|Overall Study|Withdrawal of Consent by Subject|20
7256887|NCT00327015|11468740|FG001|Overall Study|Withdrawal of Consent by Subject|24
7256888|NCT00327015|11468741|FG002|Overall Study|Withdrawal of Consent by Subject|28
7256889|NCT00327015|11468742|FG003|Overall Study|Withdrawal of Consent by Subject|25
7256890|NCT00327015|11468739|FG000|Overall Study|Lost to Follow-up|22
7256891|NCT00327015|11468740|FG001|Overall Study|Lost to Follow-up|23
7256892|NCT00327015|11468741|FG002|Overall Study|Lost to Follow-up|29
7256893|NCT00327015|11468742|FG003|Overall Study|Lost to Follow-up|22
7256894|NCT00327015|11468739|FG000|Overall Study|Adverse Event|14
7256895|NCT00327015|11468740|FG001|Overall Study|Adverse Event|10
7256896|NCT00327015|11468741|FG002|Overall Study|Adverse Event|14
7468792|NCT01915095|11769767|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
7468793|NCT01915303|11769822|FG000|Core Phase|Adverse Event|7
7468794|NCT01915303|11769822|FG000|Core Phase|Unsatisfactory therapeutic effect|3
7468795|NCT01915303|11769822|FG000|Core Phase|Death|2
7468796|NCT01915303|11769822|FG000|Core Phase|Protocol Violation|2
7468797|NCT01915303|11769822|FG000|Core Phase|Abnormal lab value|1
7468798|NCT01915303|11769822|FG000|Core Phase|Withdrawal by Subject|1
7468799|NCT01915303|11769822|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
7468800|NCT01915303|11769822|FG000|Extension Phase|Withdrawal by Subject|4
7468801|NCT01915303|11769822|FG000|Extension Phase|Adverse Event|3
7468802|NCT01915303|11769822|FG000|Extension Phase|Death|1
7468803|NCT01915303|11769822|FG000|Extension Phase|Protocol Violation|1
7468804|NCT01915732|11769837|FG000|Overall Study|Withdrawal by Subject|18
7468805|NCT01915732|11769838|FG001|Overall Study|Withdrawal by Subject|18
7468806|NCT01915732|11769837|FG000|Overall Study|Failure to Meet Randomization Criteria|1
7468807|NCT01915732|11769838|FG001|Overall Study|Failure to Meet Randomization Criteria|0
7468808|NCT01915732|11769837|FG000|Overall Study|Adverse Event|12
7468809|NCT01915732|11769838|FG001|Overall Study|Adverse Event|4
7468810|NCT01915732|11769837|FG000|Overall Study|Protocol Violation|5
7468811|NCT01915732|11769838|FG001|Overall Study|Protocol Violation|5
7468812|NCT01915732|11769837|FG000|Overall Study|Lack of Efficacy|6
7468813|NCT01915732|11769838|FG001|Overall Study|Lack of Efficacy|11
7468814|NCT01915732|11769837|FG000|Overall Study|Lost to Follow-up|22
7468815|NCT01915732|11769838|FG001|Overall Study|Lost to Follow-up|26
7468816|NCT01915732|11769837|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
7468817|NCT01915732|11769838|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
7468818|NCT01915732|11769837|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
7468819|NCT01915732|11769838|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
7468820|NCT01915732|11769837|FG000|Overall Study|Drug Release Error|1
7468821|NCT01915732|11769838|FG001|Overall Study|Drug Release Error|0
7468822|NCT01915732|11769837|FG000|Overall Study|Recovered|1
7468823|NCT01915732|11769838|FG001|Overall Study|Recovered|0
7468824|NCT01915732|11769837|FG000|Overall Study|Pregnancy|1
7468825|NCT01915732|11769838|FG001|Overall Study|Pregnancy|0
7468826|NCT01915732|11769837|FG000|Overall Study|Poor Perceived Efficacy|1
7468827|NCT01915732|11769838|FG001|Overall Study|Poor Perceived Efficacy|0
7468828|NCT01915732|11769837|FG000|Overall Study|Par. Unable to Come to the Hospital|0
7468829|NCT01915732|11769838|FG001|Overall Study|Par. Unable to Come to the Hospital|1
7468830|NCT01915732|11769837|FG000|Overall Study|Got Well|0
7468831|NCT01915732|11769838|FG001|Overall Study|Got Well|1
7468832|NCT01915732|11769837|FG000|Overall Study|Par. not Willing to Continue Treatment|0
7468833|NCT01915732|11769838|FG001|Overall Study|Par. not Willing to Continue Treatment|1
7468834|NCT01915732|11769837|FG000|Overall Study|Par. Refused to Hospital Visits|0
7468835|NCT01915732|11769838|FG001|Overall Study|Par. Refused to Hospital Visits|1
7468836|NCT01915732|11769837|FG000|Overall Study|Job Transfer|0
7468837|NCT01915732|11769838|FG001|Overall Study|Job Transfer|1
7468838|NCT01915732|11769837|FG000|Overall Study|Improper Facial Procedure|0
7468839|NCT01915732|11769838|FG001|Overall Study|Improper Facial Procedure|1
7468840|NCT01915732|11769837|FG000|Overall Study|Poor Conscious Effect|0
7468841|NCT01915732|11769838|FG001|Overall Study|Poor Conscious Effect|1
7468842|NCT01915771|11769844|FG000|Day 1|Withdrawal by Subject|1
7468843|NCT01915771|11769844|FG000|Day 15|Withdrawal by Subject|1
7468844|NCT01915849|11769865|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
7468845|NCT01915849|11769866|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
7468846|NCT01915849|11769867|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
7468847|NCT01915849|11769868|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
7468848|NCT01915849|11769865|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
7468849|NCT01915849|11769866|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7256897|NCT00327015|11468742|FG003|Overall Study|Adverse Event|14
7256898|NCT00327015|11468739|FG000|Overall Study|Subject no longer meets study criteria|4
7256899|NCT00327015|11468740|FG001|Overall Study|Subject no longer meets study criteria|2
7256900|NCT00327015|11468741|FG002|Overall Study|Subject no longer meets study criteria|8
7575496|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7575497|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
7256901|NCT00327015|11468742|FG003|Overall Study|Subject no longer meets study criteria|7
7256902|NCT00327015|11468739|FG000|Overall Study|Poor/Noncompliance|11
7256903|NCT00327015|11468740|FG001|Overall Study|Poor/Noncompliance|8
7256904|NCT00327015|11468741|FG002|Overall Study|Poor/Noncompliance|4
7256905|NCT00327015|11468742|FG003|Overall Study|Poor/Noncompliance|5
7256906|NCT00327015|11468739|FG000|Overall Study|Physician Decision|0
7256907|NCT00327015|11468740|FG001|Overall Study|Physician Decision|1
7256908|NCT00327015|11468741|FG002|Overall Study|Physician Decision|3
7256909|NCT00327015|11468742|FG003|Overall Study|Physician Decision|2
7256910|NCT00327015|11468739|FG000|Overall Study|Death|1
7256911|NCT00327015|11468740|FG001|Overall Study|Death|2
7256912|NCT00327015|11468741|FG002|Overall Study|Death|2
7256913|NCT00327015|11468742|FG003|Overall Study|Death|3
7256914|NCT00327015|11468739|FG000|Overall Study|Pregnancy|0
7256915|NCT00327015|11468740|FG001|Overall Study|Pregnancy|2
7256916|NCT00327015|11468741|FG002|Overall Study|Pregnancy|1
7256917|NCT00327015|11468742|FG003|Overall Study|Pregnancy|1
7256918|NCT00327015|11468739|FG000|Overall Study|Administrative Reason by Sponsor|1
7256919|NCT00327015|11468740|FG001|Overall Study|Administrative Reason by Sponsor|2
7256920|NCT00327015|11468741|FG002|Overall Study|Administrative Reason by Sponsor|2
7256921|NCT00327015|11468742|FG003|Overall Study|Administrative Reason by Sponsor|1
7256922|NCT00327171|11468754|FG000|Overall Study|Did not receive study medication|3
7256923|NCT00327171|11468755|FG001|Overall Study|Did not receive study medication|0
7256924|NCT00327171|11468754|FG000|Overall Study|Adverse Event|23
7256925|NCT00327171|11468755|FG001|Overall Study|Adverse Event|23
7256926|NCT00327171|11468754|FG000|Overall Study|Disease progression/lack of efficacy|68
7256927|NCT00327171|11468755|FG001|Overall Study|Disease progression/lack of efficacy|69
7256928|NCT00327171|11468754|FG000|Overall Study|Investigator/participant request|1
7256929|NCT00327171|11468755|FG001|Overall Study|Investigator/participant request|8
7256930|NCT00327171|11468754|FG000|Overall Study|Clinical progression|12
7256931|NCT00327171|11468755|FG001|Overall Study|Clinical progression|8
7256932|NCT00327171|11468754|FG000|Overall Study|Undisclosed history of ischemia|0
7256933|NCT00327171|11468755|FG001|Overall Study|Undisclosed history of ischemia|1
7256934|NCT00327171|11468754|FG000|Overall Study|Other|1
7256935|NCT00327171|11468755|FG001|Overall Study|Other|0
7387780|NCT01215955|11646504|FG001|Overall Study|Entry Criteria Not Met|3
7387781|NCT01215955|11646505|FG002|Overall Study|Entry Criteria Not Met|4
7387782|NCT01215955|11646506|FG003|Overall Study|Entry Criteria Not Met|7
7387783|NCT01215955|11646503|FG000|Overall Study|Lack of Efficacy|1
7387784|NCT01215955|11646504|FG001|Overall Study|Lack of Efficacy|2
7387785|NCT01215955|11646505|FG002|Overall Study|Lack of Efficacy|1
7387786|NCT01215955|11646506|FG003|Overall Study|Lack of Efficacy|0
7387787|NCT01215955|11646503|FG000|Overall Study|Lost to Follow-up|4
7387788|NCT01215955|11646504|FG001|Overall Study|Lost to Follow-up|4
7387789|NCT01215955|11646505|FG002|Overall Study|Lost to Follow-up|8
7387790|NCT01215955|11646506|FG003|Overall Study|Lost to Follow-up|9
7387791|NCT01215955|11646503|FG000|Overall Study|Physician Decision|4
7387792|NCT01215955|11646504|FG001|Overall Study|Physician Decision|10
7387793|NCT01215955|11646505|FG002|Overall Study|Physician Decision|8
7387794|NCT01215955|11646506|FG003|Overall Study|Physician Decision|11
7387795|NCT01215955|11646503|FG000|Overall Study|Protocol Violation|17
7387796|NCT01215955|11646504|FG001|Overall Study|Protocol Violation|13
7387797|NCT01215955|11646505|FG002|Overall Study|Protocol Violation|8
7387798|NCT01215955|11646506|FG003|Overall Study|Protocol Violation|8
7387799|NCT01215955|11646503|FG000|Overall Study|Sponsor Decision|1
7387800|NCT01215955|11646504|FG001|Overall Study|Sponsor Decision|2
7387801|NCT01215955|11646505|FG002|Overall Study|Sponsor Decision|0
7387802|NCT01215955|11646506|FG003|Overall Study|Sponsor Decision|1
7387803|NCT01215955|11646503|FG000|Overall Study|Withdrawal by Subject|14
7387804|NCT01215955|11646504|FG001|Overall Study|Withdrawal by Subject|15
7387805|NCT01215955|11646505|FG002|Overall Study|Withdrawal by Subject|13
7387806|NCT01215955|11646506|FG003|Overall Study|Withdrawal by Subject|9
7387807|NCT01215955|11646503|FG000|Overall Study|Quality Issues|0
7387808|NCT01215955|11646504|FG001|Overall Study|Quality Issues|0
7387809|NCT01215955|11646505|FG002|Overall Study|Quality Issues|3
7387810|NCT01215955|11646506|FG003|Overall Study|Quality Issues|2
7387811|NCT01215968|11646521|FG000|Overall Study|Adverse Event|0
7387812|NCT01215968|11646522|FG001|Overall Study|Adverse Event|2
7387813|NCT01215968|11646521|FG000|Overall Study|Protocol Violation|2
7387814|NCT01215968|11646522|FG001|Overall Study|Protocol Violation|4
7387815|NCT01215968|11646521|FG000|Overall Study|Not received study drug|0
7387816|NCT01215968|11646522|FG001|Overall Study|Not received study drug|1
7387817|NCT01215981|11646533|FG000|Overall Study|Physician Decision|0
7387818|NCT01215981|11646534|FG001|Overall Study|Physician Decision|1
7387819|NCT01215981|11646533|FG000|Overall Study|Protocol Violation|1
7387820|NCT01215981|11646534|FG001|Overall Study|Protocol Violation|0
7387821|NCT01215981|11646533|FG000|Overall Study|Withdrawal by Subject|1
7387822|NCT01215981|11646534|FG001|Overall Study|Withdrawal by Subject|0
7387823|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
7387824|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
7256936|NCT00327340|11468763|FG000|Overall Study|Withdrawal by Subject|1
7256937|NCT00327340|11468764|FG001|Overall Study|Withdrawal by Subject|5
7256938|NCT00327340|11468763|FG000|Overall Study|Physician Decision|1
7256939|NCT00327340|11468764|FG001|Overall Study|Physician Decision|1
7256940|NCT00327340|11468763|FG000|Overall Study|Disease Progression|10
7256941|NCT00327340|11468764|FG001|Overall Study|Disease Progression|19
7256942|NCT00327340|11468763|FG000|Overall Study|Symptomatic Disease|0
7256943|NCT00327340|11468764|FG001|Overall Study|Symptomatic Disease|2
7256944|NCT00327340|11468763|FG000|Overall Study|Adverse Event|3
7256945|NCT00327340|11468764|FG001|Overall Study|Adverse Event|3
7256946|NCT00327444|11468778|FG000|Double Blind Treatment (DB) Period|Disease progression|10
7256947|NCT00327444|11468779|FG001|Double Blind Treatment (DB) Period|Disease progression|13
7256948|NCT00327444|11468778|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
7256949|NCT00327444|11468779|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
7256950|NCT00327444|11468778|FG000|Double Blind Treatment (DB) Period|Subject request|0
7256951|NCT00327444|11468779|FG001|Double Blind Treatment (DB) Period|Subject request|1
7256952|NCT00327444|11468778|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
7256953|NCT00327444|11468779|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
7256954|NCT00327444|11468778|FG000|Open Label Treatment (OL) Period|Disease progression|8
7256955|NCT00327444|11468779|FG001|Open Label Treatment (OL) Period|Disease progression|7
7256956|NCT00327444|11468778|FG000|Open Label Treatment (OL) Period|Adverse Event|2
7256957|NCT00327444|11468779|FG001|Open Label Treatment (OL) Period|Adverse Event|2
7256958|NCT00327444|11468778|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
7256959|NCT00327444|11468779|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
7256960|NCT00327444|11468778|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
7256961|NCT00327444|11468779|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
7256962|NCT00327470|11468789|FG000|Overall Study|Randomized, but not treated|0
7256963|NCT00327470|11468790|FG001|Overall Study|Randomized, but not treated|2
7256964|NCT00327470|11468789|FG000|Overall Study|Adverse Event|9
7256965|NCT00327470|11468790|FG001|Overall Study|Adverse Event|14
7256966|NCT00327470|11468789|FG000|Overall Study|Lack of Efficacy|7
7256967|NCT00327470|11468790|FG001|Overall Study|Lack of Efficacy|19
7256968|NCT00327470|11468789|FG000|Overall Study|Other|5
7256969|NCT00327470|11468790|FG001|Overall Study|Other|9
7256970|NCT00327470|11468789|FG000|Overall Study|Lost to Follow-up|1
7256971|NCT00327470|11468790|FG001|Overall Study|Lost to Follow-up|3
7256972|NCT00327470|11468789|FG000|Overall Study|Withdrawal by Subject|6
7256973|NCT00327470|11468790|FG001|Overall Study|Withdrawal by Subject|12
7256974|NCT00327470|11468789|FG000|Overall Study|Death|1
7256975|NCT00327470|11468790|FG001|Overall Study|Death|4
7256976|NCT00327717|11468798|FG000|Overall Study|Adverse Event|6
7256977|NCT00327717|11468799|FG001|Overall Study|Adverse Event|6
7468850|NCT01915849|11769867|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7468851|NCT01915849|11769868|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
7468852|NCT01915914|11769878|FG000|Acute Phase|Withdrawal by Subject|4
7468853|NCT01915914|11769879|FG001|Acute Phase|Withdrawal by Subject|0
7468854|NCT01915914|11769880|FG002|Acute Phase|Withdrawal by Subject|0
7468855|NCT01915914|11769881|FG003|Acute Phase|Withdrawal by Subject|0
7468856|NCT01915914|11769878|FG000|Acute Phase|Lost to Follow-up|4
7468857|NCT01915914|11769879|FG001|Acute Phase|Lost to Follow-up|0
7468858|NCT01915914|11769880|FG002|Acute Phase|Lost to Follow-up|0
7468859|NCT01915914|11769881|FG003|Acute Phase|Lost to Follow-up|0
7468860|NCT01915914|11769878|FG000|Acute Phase|Physician Decision|1
7468861|NCT01915914|11769879|FG001|Acute Phase|Physician Decision|0
7468862|NCT01915914|11769880|FG002|Acute Phase|Physician Decision|0
7468863|NCT01915914|11769881|FG003|Acute Phase|Physician Decision|0
7468864|NCT01915914|11769878|FG000|Acute Phase|Accepted Other Topic Therapies|1
7468865|NCT01915914|11769879|FG001|Acute Phase|Accepted Other Topic Therapies|0
7468866|NCT01915914|11769880|FG002|Acute Phase|Accepted Other Topic Therapies|0
7468867|NCT01915914|11769881|FG003|Acute Phase|Accepted Other Topic Therapies|0
7468868|NCT01915914|11769878|FG000|Acute Phase|"Not Achieved treatment success"|1
7468869|NCT01915914|11769879|FG001|Acute Phase|"Not Achieved treatment success"|0
7468870|NCT01915914|11769880|FG002|Acute Phase|"Not Achieved treatment success"|0
7468871|NCT01915914|11769881|FG003|Acute Phase|"Not Achieved treatment success"|0
7468872|NCT01915914|11769878|FG000|Acute Phase|Missing|1
7468873|NCT01915914|11769879|FG001|Acute Phase|Missing|0
7468874|NCT01915914|11769880|FG002|Acute Phase|Missing|0
7468875|NCT01915914|11769881|FG003|Acute Phase|Missing|0
7468876|NCT01915914|11769878|FG000|Maintenance Phase|Withdrawal by Subject|0
7468877|NCT01915914|11769879|FG001|Maintenance Phase|Withdrawal by Subject|1
7468878|NCT01915914|11769880|FG002|Maintenance Phase|Withdrawal by Subject|1
7468879|NCT01915914|11769881|FG003|Maintenance Phase|Withdrawal by Subject|0
7468880|NCT01915914|11769878|FG000|Maintenance Phase|Lost to Follow-up|0
7468881|NCT01915914|11769879|FG001|Maintenance Phase|Lost to Follow-up|4
7468882|NCT01915914|11769880|FG002|Maintenance Phase|Lost to Follow-up|1
7256978|NCT00327717|11468798|FG000|Overall Study|Lack of Efficacy|0
7256979|NCT00327717|11468799|FG001|Overall Study|Lack of Efficacy|1
7256980|NCT00327717|11468798|FG000|Overall Study|Withdrawal by Subject|3
7256981|NCT00327717|11468799|FG001|Overall Study|Withdrawal by Subject|7
7256982|NCT00328094|11468828|FG000|Overall Study|Physician Decision|3
7468883|NCT01915914|11769881|FG003|Maintenance Phase|Lost to Follow-up|0
7256983|NCT00328094|11468829|FG001|Overall Study|Physician Decision|3
7468884|NCT01915914|11769878|FG000|Maintenance Phase|Missing|0
7468885|NCT01915914|11769879|FG001|Maintenance Phase|Missing|1
7468886|NCT01915914|11769880|FG002|Maintenance Phase|Missing|0
7468887|NCT01915914|11769881|FG003|Maintenance Phase|Missing|0
7468888|NCT01915914|11769878|FG000|Follow-up Phase|Withdrawal by Subject|0
7468889|NCT01915914|11769879|FG001|Follow-up Phase|Withdrawal by Subject|0
7468890|NCT01915914|11769880|FG002|Follow-up Phase|Withdrawal by Subject|0
7468891|NCT01915914|11769881|FG003|Follow-up Phase|Withdrawal by Subject|1
7468892|NCT01915914|11769878|FG000|Follow-up Phase|Physician Decision|0
7468893|NCT01915914|11769879|FG001|Follow-up Phase|Physician Decision|0
7468894|NCT01915914|11769880|FG002|Follow-up Phase|Physician Decision|0
7468895|NCT01915914|11769881|FG003|Follow-up Phase|Physician Decision|1
7468896|NCT01915940|11769901|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
7468897|NCT01915940|11769902|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
7468898|NCT01915940|11769903|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
7468899|NCT01915940|11769901|FG000|Treatment Period|Decision of Participant|0
7468900|NCT01915940|11769902|FG001|Treatment Period|Decision of Participant|1
7468901|NCT01915940|11769903|FG002|Treatment Period|Decision of Participant|3
7468902|NCT01915940|11769901|FG000|Treatment Period|Adverse Event|0
7468903|NCT01915940|11769902|FG001|Treatment Period|Adverse Event|9
7468904|NCT01915940|11769903|FG002|Treatment Period|Adverse Event|1
7468905|NCT01915940|11769901|FG000|Treatment Period|Other Miscellaneous Reasons|0
7468906|NCT01915940|11769902|FG001|Treatment Period|Other Miscellaneous Reasons|1
7468907|NCT01915940|11769903|FG002|Treatment Period|Other Miscellaneous Reasons|0
7468908|NCT01916109|11769909|FG000|Overall Study|Withdrawal by Subject|1
7468909|NCT01916226|11769917|FG000|Overall Study|Adverse Event|1
7468910|NCT01916226|11769918|FG001|Overall Study|Adverse Event|0
7468911|NCT01916226|11769919|FG002|Overall Study|Adverse Event|1
7468912|NCT01916226|11769920|FG003|Overall Study|Adverse Event|1
7468913|NCT01916226|11769917|FG000|Overall Study|Lack of Efficacy|0
7468914|NCT01916226|11769918|FG001|Overall Study|Lack of Efficacy|0
7468915|NCT01916226|11769919|FG002|Overall Study|Lack of Efficacy|2
7468916|NCT01916226|11769920|FG003|Overall Study|Lack of Efficacy|1
7468917|NCT01916226|11769917|FG000|Overall Study|Protocol Violation|0
7468918|NCT01916226|11769918|FG001|Overall Study|Protocol Violation|1
7468919|NCT01916226|11769919|FG002|Overall Study|Protocol Violation|0
7468920|NCT01916226|11769920|FG003|Overall Study|Protocol Violation|1
7468921|NCT01916226|11769917|FG000|Overall Study|Physician Decision|0
7468922|NCT01916226|11769918|FG001|Overall Study|Physician Decision|0
7468923|NCT01916226|11769919|FG002|Overall Study|Physician Decision|0
7468924|NCT01916226|11769920|FG003|Overall Study|Physician Decision|1
7468925|NCT01916304|11769931|FG000|Overall Study|Screening failure|17
7468926|NCT01916824|11769977|FG000|Overall Study|Lost to Follow-up|3
7468927|NCT01916824|11769978|FG001|Overall Study|Lost to Follow-up|6
7468928|NCT01916824|11769977|FG000|Overall Study|Physician Decision|2
7468929|NCT01916824|11769978|FG001|Overall Study|Physician Decision|0
7468930|NCT01916824|11769977|FG000|Overall Study|Withdrawal by Subject|2
7468931|NCT01916824|11769978|FG001|Overall Study|Withdrawal by Subject|3
7468932|NCT01917006|11770004|FG000|Randomized-treatment Period|Lost to Follow-up|1
7468933|NCT01917006|11770005|FG001|Randomized-treatment Period|Lost to Follow-up|0
7468934|NCT01917006|11770006|FG002|Randomized-treatment Period|Lost to Follow-up|0
7468935|NCT01917006|11770007|FG003|Randomized-treatment Period|Lost to Follow-up|1
7468936|NCT01917006|11770008|FG004|Randomized-treatment Period|Lost to Follow-up|0
7468937|NCT01917006|11770009|FG005|Randomized-treatment Period|Lost to Follow-up|0
7468938|NCT01917006|11770010|FG006|Randomized-treatment Period|Lost to Follow-up|0
7468939|NCT01917006|11770011|FG007|Randomized-treatment Period|Lost to Follow-up|0
7468940|NCT01917006|11770004|FG000|Randomized-treatment Period|Personal Reasons|0
7468941|NCT01917006|11770005|FG001|Randomized-treatment Period|Personal Reasons|0
7468942|NCT01917006|11770006|FG002|Randomized-treatment Period|Personal Reasons|0
7468943|NCT01917006|11770007|FG003|Randomized-treatment Period|Personal Reasons|0
7468944|NCT01917006|11770008|FG004|Randomized-treatment Period|Personal Reasons|0
7468945|NCT01917006|11770009|FG005|Randomized-treatment Period|Personal Reasons|1
7468946|NCT01917006|11770010|FG006|Randomized-treatment Period|Personal Reasons|0
7468947|NCT01917006|11770011|FG007|Randomized-treatment Period|Personal Reasons|0
7468948|NCT01917006|11770004|FG000|Randomized-treatment Period|Protocol Violation|1
7468949|NCT01917006|11770005|FG001|Randomized-treatment Period|Protocol Violation|0
7468950|NCT01917006|11770006|FG002|Randomized-treatment Period|Protocol Violation|0
7468951|NCT01917006|11770007|FG003|Randomized-treatment Period|Protocol Violation|0
7468952|NCT01917006|11770008|FG004|Randomized-treatment Period|Protocol Violation|0
7468953|NCT01917006|11770009|FG005|Randomized-treatment Period|Protocol Violation|0
7468954|NCT01917006|11770010|FG006|Randomized-treatment Period|Protocol Violation|0
7468955|NCT01917006|11770011|FG007|Randomized-treatment Period|Protocol Violation|0
7468956|NCT01917006|11770004|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468957|NCT01917006|11770005|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468958|NCT01917006|11770006|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468959|NCT01917006|11770007|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468960|NCT01917006|11770008|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468961|NCT01917006|11770009|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
7256984|NCT00328172|11468840|FG000|Overall Study|Adverse Event|3
7256985|NCT00328172|11468841|FG001|Overall Study|Adverse Event|2
7256986|NCT00328172|11468842|FG002|Overall Study|Adverse Event|1
7256987|NCT00328172|11468843|FG003|Overall Study|Adverse Event|2
7256988|NCT00328172|11468844|FG004|Overall Study|Adverse Event|1
7256989|NCT00328172|11468840|FG000|Overall Study|Protocol Violation|0
7256990|NCT00328172|11468841|FG001|Overall Study|Protocol Violation|1
7256991|NCT00328172|11468842|FG002|Overall Study|Protocol Violation|1
7256992|NCT00328172|11468843|FG003|Overall Study|Protocol Violation|0
7256993|NCT00328172|11468844|FG004|Overall Study|Protocol Violation|0
7256994|NCT00328172|11468840|FG000|Overall Study|Lost to Follow-up|1
7256995|NCT00328172|11468841|FG001|Overall Study|Lost to Follow-up|1
7256996|NCT00328172|11468842|FG002|Overall Study|Lost to Follow-up|2
7256997|NCT00328172|11468843|FG003|Overall Study|Lost to Follow-up|1
7256998|NCT00328172|11468844|FG004|Overall Study|Lost to Follow-up|1
7256999|NCT00328172|11468840|FG000|Overall Study|Withdrawal by Subject|1
7257000|NCT00328172|11468841|FG001|Overall Study|Withdrawal by Subject|1
7257001|NCT00328172|11468842|FG002|Overall Study|Withdrawal by Subject|1
7257002|NCT00328172|11468843|FG003|Overall Study|Withdrawal by Subject|6
7257003|NCT00328172|11468844|FG004|Overall Study|Withdrawal by Subject|0
7257004|NCT00328172|11468840|FG000|Overall Study|Lack of Efficacy|14
7257005|NCT00328172|11468841|FG001|Overall Study|Lack of Efficacy|9
7257006|NCT00328172|11468842|FG002|Overall Study|Lack of Efficacy|4
7257007|NCT00328172|11468843|FG003|Overall Study|Lack of Efficacy|4
7257008|NCT00328172|11468844|FG004|Overall Study|Lack of Efficacy|3
7257009|NCT00328172|11468840|FG000|Overall Study|Other reason (not specified)|3
7257010|NCT00328172|11468841|FG001|Overall Study|Other reason (not specified)|0
7257011|NCT00328172|11468842|FG002|Overall Study|Other reason (not specified)|1
7257012|NCT00328172|11468843|FG003|Overall Study|Other reason (not specified)|0
7257013|NCT00328172|11468844|FG004|Overall Study|Other reason (not specified)|0
7257014|NCT00328198|11468856|FG000|Treatment|Adverse Event|21
7257015|NCT00328198|11468856|FG000|Treatment|Death|1
7257016|NCT00328198|11468856|FG000|Treatment|Physician Decision|5
7257017|NCT00328198|11468856|FG000|Treatment|Withdrawal by Subject|5
7257018|NCT00328198|11468856|FG000|Treatment|Evidence of disease progression|2
7257019|NCT00328198|11468856|FG000|Treatment|Non-compliance|1
7257020|NCT00328198|11468856|FG000|Treatment|Confirmed complete response, MRD -|3
7257021|NCT00328198|11468856|FG000|Follow-up|Lost to Follow-up|4
7257022|NCT00328198|11468856|FG000|Follow-up|Death|31
7257023|NCT00328510|11468871|FG000|Overall Study|Gag disorder, could not use frame|4
7257024|NCT00328510|11468872|FG001|Overall Study|Gag disorder, could not use frame|0
7257025|NCT00328510|11468871|FG000|Overall Study|Dentition problems, could not use frame|1
7257026|NCT00328510|11468872|FG001|Overall Study|Dentition problems, could not use frame|0
7257027|NCT00328510|11468871|FG000|Overall Study|Withdrawal by Subject|4
7257028|NCT00328510|11468872|FG001|Overall Study|Withdrawal by Subject|2
7257029|NCT00328510|11468871|FG000|Overall Study|Severe kyphosis, could not use mask|0
7257030|NCT00328510|11468872|FG001|Overall Study|Severe kyphosis, could not use mask|1
7257031|NCT00328510|11468871|FG000|Overall Study|Treatment changed to a single fraction|1
7257032|NCT00328510|11468872|FG001|Overall Study|Treatment changed to a single fraction|1
7257033|NCT00328562|11468878|FG000|Overall Study|Disease progression|1
7257034|NCT00328627|11468914|FG000|Overall Study|Hyperglycemic Rescue|41
7257035|NCT00328627|11468915|FG001|Overall Study|Hyperglycemic Rescue|18
7257036|NCT00328627|11468916|FG002|Overall Study|Hyperglycemic Rescue|16
7257037|NCT00328627|11468917|FG003|Overall Study|Hyperglycemic Rescue|13
7257038|NCT00328627|11468918|FG004|Overall Study|Hyperglycemic Rescue|6
7468962|NCT01917006|11770010|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
7468963|NCT01917006|11770011|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
7468964|NCT01917006|11770004|FG000|Open-label Period|Adverse Event|0
7468965|NCT01917006|11770005|FG001|Open-label Period|Adverse Event|0
7468966|NCT01917006|11770006|FG002|Open-label Period|Adverse Event|0
7468967|NCT01917006|11770007|FG003|Open-label Period|Adverse Event|0
7468968|NCT01917006|11770008|FG004|Open-label Period|Adverse Event|0
7468969|NCT01917006|11770009|FG005|Open-label Period|Adverse Event|0
7468970|NCT01917006|11770010|FG006|Open-label Period|Adverse Event|0
7575498|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
7575499|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
7257039|NCT00328627|11468919|FG005|Overall Study|Hyperglycemic Rescue|5
7257040|NCT00328627|11468920|FG006|Overall Study|Hyperglycemic Rescue|19
7257041|NCT00328627|11468921|FG007|Overall Study|Hyperglycemic Rescue|6
7257042|NCT00328627|11468922|FG008|Overall Study|Hyperglycemic Rescue|6
7257043|NCT00328627|11468923|FG009|Overall Study|Hyperglycemic Rescue|11
7257044|NCT00328627|11468924|FG010|Overall Study|Hyperglycemic Rescue|3
7257045|NCT00328627|11468925|FG011|Overall Study|Hyperglycemic Rescue|2
7257046|NCT00328627|11468914|FG000|Overall Study|Adverse Event|3
7257047|NCT00328627|11468915|FG001|Overall Study|Adverse Event|1
7257048|NCT00328627|11468916|FG002|Overall Study|Adverse Event|2
7257049|NCT00328627|11468917|FG003|Overall Study|Adverse Event|3
7257050|NCT00328627|11468918|FG004|Overall Study|Adverse Event|1
7575500|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
7257051|NCT00328627|11468919|FG005|Overall Study|Adverse Event|2
7257052|NCT00328627|11468920|FG006|Overall Study|Adverse Event|1
7257053|NCT00328627|11468921|FG007|Overall Study|Adverse Event|2
7257054|NCT00328627|11468922|FG008|Overall Study|Adverse Event|0
7257055|NCT00328627|11468923|FG009|Overall Study|Adverse Event|7
7257056|NCT00328627|11468924|FG010|Overall Study|Adverse Event|5
7257057|NCT00328627|11468925|FG011|Overall Study|Adverse Event|4
7257058|NCT00328627|11468914|FG000|Overall Study|Protocol Violation|2
7257059|NCT00328627|11468915|FG001|Overall Study|Protocol Violation|2
7257060|NCT00328627|11468916|FG002|Overall Study|Protocol Violation|2
7257061|NCT00328627|11468917|FG003|Overall Study|Protocol Violation|8
7257062|NCT00328627|11468918|FG004|Overall Study|Protocol Violation|5
7257063|NCT00328627|11468919|FG005|Overall Study|Protocol Violation|5
7257064|NCT00328627|11468920|FG006|Overall Study|Protocol Violation|6
7257065|NCT00328627|11468921|FG007|Overall Study|Protocol Violation|2
7257066|NCT00328627|11468922|FG008|Overall Study|Protocol Violation|1
7257067|NCT00328627|11468923|FG009|Overall Study|Protocol Violation|4
7257068|NCT00328627|11468924|FG010|Overall Study|Protocol Violation|6
7257069|NCT00328627|11468925|FG011|Overall Study|Protocol Violation|2
7257070|NCT00328627|11468914|FG000|Overall Study|Lost to Follow-up|4
7257071|NCT00328627|11468915|FG001|Overall Study|Lost to Follow-up|2
7257072|NCT00328627|11468916|FG002|Overall Study|Lost to Follow-up|2
7257073|NCT00328627|11468917|FG003|Overall Study|Lost to Follow-up|4
7257074|NCT00328627|11468918|FG004|Overall Study|Lost to Follow-up|0
7257075|NCT00328627|11468919|FG005|Overall Study|Lost to Follow-up|2
7257076|NCT00328627|11468920|FG006|Overall Study|Lost to Follow-up|3
7257077|NCT00328627|11468921|FG007|Overall Study|Lost to Follow-up|0
7257078|NCT00328627|11468922|FG008|Overall Study|Lost to Follow-up|3
7257079|NCT00328627|11468923|FG009|Overall Study|Lost to Follow-up|2
7257080|NCT00328627|11468924|FG010|Overall Study|Lost to Follow-up|0
7257081|NCT00328627|11468925|FG011|Overall Study|Lost to Follow-up|1
7257082|NCT00328627|11468914|FG000|Overall Study|Withdrawal by Subject|5
7257083|NCT00328627|11468915|FG001|Overall Study|Withdrawal by Subject|4
7257084|NCT00328627|11468916|FG002|Overall Study|Withdrawal by Subject|5
7257085|NCT00328627|11468917|FG003|Overall Study|Withdrawal by Subject|6
7257086|NCT00328627|11468918|FG004|Overall Study|Withdrawal by Subject|2
7257087|NCT00328627|11468919|FG005|Overall Study|Withdrawal by Subject|5
7257088|NCT00328627|11468920|FG006|Overall Study|Withdrawal by Subject|4
7257089|NCT00328627|11468921|FG007|Overall Study|Withdrawal by Subject|4
7257090|NCT00328627|11468922|FG008|Overall Study|Withdrawal by Subject|4
7257091|NCT00328627|11468923|FG009|Overall Study|Withdrawal by Subject|5
7257092|NCT00328627|11468924|FG010|Overall Study|Withdrawal by Subject|2
7257093|NCT00328627|11468925|FG011|Overall Study|Withdrawal by Subject|7
7257094|NCT00328627|11468914|FG000|Overall Study|Pregnancy|0
7257095|NCT00328627|11468915|FG001|Overall Study|Pregnancy|1
7257096|NCT00328627|11468916|FG002|Overall Study|Pregnancy|0
7257097|NCT00328627|11468917|FG003|Overall Study|Pregnancy|0
7257098|NCT00328627|11468918|FG004|Overall Study|Pregnancy|0
7257099|NCT00328627|11468919|FG005|Overall Study|Pregnancy|0
7257100|NCT00328627|11468920|FG006|Overall Study|Pregnancy|0
7257101|NCT00328627|11468921|FG007|Overall Study|Pregnancy|0
7257102|NCT00328627|11468922|FG008|Overall Study|Pregnancy|0
7257103|NCT00328627|11468923|FG009|Overall Study|Pregnancy|0
7257104|NCT00328627|11468924|FG010|Overall Study|Pregnancy|0
7257105|NCT00328627|11468925|FG011|Overall Study|Pregnancy|0
7257106|NCT00328627|11468914|FG000|Overall Study|Physician Decision|4
7257107|NCT00328627|11468915|FG001|Overall Study|Physician Decision|3
7257108|NCT00328627|11468916|FG002|Overall Study|Physician Decision|1
7257109|NCT00328627|11468917|FG003|Overall Study|Physician Decision|2
7257110|NCT00328627|11468918|FG004|Overall Study|Physician Decision|1
7257111|NCT00328627|11468919|FG005|Overall Study|Physician Decision|1
7257112|NCT00328627|11468920|FG006|Overall Study|Physician Decision|1
7257113|NCT00328627|11468921|FG007|Overall Study|Physician Decision|0
7257114|NCT00328627|11468922|FG008|Overall Study|Physician Decision|3
7257115|NCT00328627|11468923|FG009|Overall Study|Physician Decision|2
7257116|NCT00328627|11468924|FG010|Overall Study|Physician Decision|1
7257117|NCT00328627|11468925|FG011|Overall Study|Physician Decision|0
7257118|NCT00328627|11468914|FG000|Overall Study|Other|0
7257119|NCT00328627|11468915|FG001|Overall Study|Other|0
7257120|NCT00328627|11468916|FG002|Overall Study|Other|0
7257121|NCT00328627|11468917|FG003|Overall Study|Other|1
7257122|NCT00328627|11468918|FG004|Overall Study|Other|0
7257123|NCT00328627|11468919|FG005|Overall Study|Other|0
7257124|NCT00328627|11468920|FG006|Overall Study|Other|1
7257125|NCT00328627|11468921|FG007|Overall Study|Other|0
7257126|NCT00328627|11468922|FG008|Overall Study|Other|0
7257127|NCT00328627|11468923|FG009|Overall Study|Other|1
7257128|NCT00328627|11468924|FG010|Overall Study|Other|1
7257129|NCT00328627|11468925|FG011|Overall Study|Other|0
7257130|NCT00328783|11468964|FG000|Overall Study|Could not tolerate ABC|21
7257131|NCT00328783|11468964|FG000|Overall Study|No heart in RT field|4
7257132|NCT00328783|11468964|FG000|Overall Study|Withdrawal by Subject|1
7257133|NCT00328926|11468982|FG000|Overall Study|Pregnancy|2
7257134|NCT00328926|11468983|FG001|Overall Study|Pregnancy|1
7257135|NCT00328926|11468984|FG002|Overall Study|Pregnancy|0
7257136|NCT00328926|11468982|FG000|Overall Study|Lost to Follow-up|0
7257137|NCT00328926|11468983|FG001|Overall Study|Lost to Follow-up|1
7257138|NCT00328926|11468984|FG002|Overall Study|Lost to Follow-up|0
7257139|NCT00328926|11468982|FG000|Overall Study|Death|0
7257140|NCT00328926|11468983|FG001|Overall Study|Death|0
7257141|NCT00328926|11468984|FG002|Overall Study|Death|1
7257142|NCT00328926|11468982|FG000|Overall Study|In vitro fertilization treatment|0
7257143|NCT00328926|11468983|FG001|Overall Study|In vitro fertilization treatment|0
7257144|NCT00328926|11468984|FG002|Overall Study|In vitro fertilization treatment|1
7257145|NCT00328926|11468982|FG000|Overall Study|Lack of ovarian response|0
7257146|NCT00328926|11468983|FG001|Overall Study|Lack of ovarian response|1
7257147|NCT00328926|11468984|FG002|Overall Study|Lack of ovarian response|0
7257148|NCT00329030|11468994|FG000|Overall Study|Withdrawal by Subject|1
7257149|NCT00329030|11468995|FG001|Overall Study|Withdrawal by Subject|3
7257150|NCT00329030|11468994|FG000|Overall Study|Progressive Disease|6
7257151|NCT00329030|11468995|FG001|Overall Study|Progressive Disease|2
7257152|NCT00329030|11468994|FG000|Overall Study|Ineligible Pathology|1
7257153|NCT00329030|11468995|FG001|Overall Study|Ineligible Pathology|1
7257154|NCT00329160|11469001|FG000|Overall Study|Adverse Event|27
7257155|NCT00329160|11469001|FG000|Overall Study|Withdrawal by Subject|13
7257156|NCT00329160|11469001|FG000|Overall Study|Protocol Violation|2
7257157|NCT00329160|11469001|FG000|Overall Study|Did not Receive Study Drug|1
7257158|NCT00329160|11469001|FG000|Overall Study|Incomplete IVUS|45
7257159|NCT00329238|11469007|FG000|Overall Study|Adverse Event|147
7257160|NCT00329238|11469008|FG001|Overall Study|Adverse Event|129
7257161|NCT00329238|11469007|FG000|Overall Study|Protocol Violation|23
7257162|NCT00329238|11469008|FG001|Overall Study|Protocol Violation|34
7257163|NCT00329238|11469007|FG000|Overall Study|Lost to Follow-up|2
7257164|NCT00329238|11469008|FG001|Overall Study|Lost to Follow-up|6
7257165|NCT00329238|11469007|FG000|Overall Study|Withdrawal by Subject|64
7257166|NCT00329238|11469008|FG001|Overall Study|Withdrawal by Subject|58
7257167|NCT00329238|11469007|FG000|Overall Study|Other reason (not specified)|40
7257168|NCT00329238|11469008|FG001|Overall Study|Other reason (not specified)|54
7257169|NCT00329303|11469018|FG000|Overall Study|Lack of Efficacy|1
7257170|NCT00329303|11469019|FG001|Overall Study|Lack of Efficacy|0
7257171|NCT00329303|11469018|FG000|Overall Study|Decision of the sponsor|0
7257172|NCT00329303|11469019|FG001|Overall Study|Decision of the sponsor|1
7257173|NCT00329303|11469018|FG000|Overall Study|Patient no longer available|1
7257174|NCT00329303|11469019|FG001|Overall Study|Patient no longer available|0
7257175|NCT00329303|11469018|FG000|Overall Study|Patient relocated|0
7257176|NCT00329303|11469019|FG001|Overall Study|Patient relocated|1
7468971|NCT01917006|11770011|FG007|Open-label Period|Adverse Event|1
7468972|NCT01917006|11770004|FG000|Open-label Period|Lost to Follow-up|0
7468973|NCT01917006|11770005|FG001|Open-label Period|Lost to Follow-up|0
7468974|NCT01917006|11770006|FG002|Open-label Period|Lost to Follow-up|0
7468975|NCT01917006|11770007|FG003|Open-label Period|Lost to Follow-up|0
7468976|NCT01917006|11770008|FG004|Open-label Period|Lost to Follow-up|0
7468977|NCT01917006|11770009|FG005|Open-label Period|Lost to Follow-up|0
7468978|NCT01917006|11770010|FG006|Open-label Period|Lost to Follow-up|0
7257177|NCT00329407|11469026|FG000|Overall Study|Withdrawal by Subject|1
7257178|NCT00329420|11469033|FG000|Re-induction Phase|Lack of Efficacy|0
7257179|NCT00329420|11469034|FG001|Re-induction Phase|Lack of Efficacy|1
7468979|NCT01917006|11770011|FG007|Open-label Period|Lost to Follow-up|1
7468980|NCT01917084|11770028|FG000|Overall Study|Withdrawal by Subject|1
7468981|NCT01917344|11770054|FG000|Overall Study|Withdrawal by Subject|1
7468982|NCT01917526|11770069|FG000|Overall Study|Protocol Violation|1
7468983|NCT01917526|11770070|FG001|Overall Study|Protocol Violation|1
7468984|NCT01917656|11770078|FG000|Overall Study|Adverse Event|11
7468985|NCT01917656|11770079|FG001|Overall Study|Adverse Event|0
7468986|NCT01917656|11770078|FG000|Overall Study|Withdrawal criteria|8
7468987|NCT01917656|11770079|FG001|Overall Study|Withdrawal criteria|14
7468988|NCT01917656|11770078|FG000|Overall Study|Unclassified|0
7468989|NCT01917656|11770079|FG001|Overall Study|Unclassified|3
7468990|NCT01917656|11770078|FG000|Overall Study|Withdrawal by Subject|4
7468991|NCT01917656|11770079|FG001|Overall Study|Withdrawal by Subject|3
7468992|NCT01917656|11770078|FG000|Overall Study|Lost to Follow-up|3
7468993|NCT01917656|11770079|FG001|Overall Study|Lost to Follow-up|4
7468994|NCT01917747|11770092|FG000|Overall Study|Withdrawal by Subject|1
7468995|NCT01917747|11770093|FG001|Overall Study|Withdrawal by Subject|2
7468996|NCT01917747|11770092|FG000|Overall Study|Lost to Follow-up|18
7468997|NCT01917747|11770093|FG001|Overall Study|Lost to Follow-up|9
7468998|NCT01917968|11770124|FG000|Overall Study|Death|3
7468999|NCT01917968|11770125|FG001|Overall Study|Death|2
7469000|NCT01917968|11770124|FG000|Overall Study|Lost to Follow-up|21
7469001|NCT01917968|11770125|FG001|Overall Study|Lost to Follow-up|39
7469002|NCT01917968|11770124|FG000|Overall Study|Physician Decision|1
7469003|NCT01917968|11770125|FG001|Overall Study|Physician Decision|2
7469004|NCT01917968|11770124|FG000|Overall Study|Withdrawal by Subject|20
7469005|NCT01917968|11770125|FG001|Overall Study|Withdrawal by Subject|35
7469006|NCT01917968|11770124|FG000|Overall Study|Subject Relocation|5
7469007|NCT01917968|11770125|FG001|Overall Study|Subject Relocation|1
7469008|NCT01917968|11770124|FG000|Overall Study|36M Missed Visit|3
7469009|NCT01917968|11770125|FG001|Overall Study|36M Missed Visit|2
7257180|NCT00329420|11469035|FG002|Re-induction Phase|Lack of Efficacy|0
7257181|NCT00329420|11469033|FG000|Re-induction Phase|Withdrawal of Consent|0
7257182|NCT00329420|11469034|FG001|Re-induction Phase|Withdrawal of Consent|0
7257183|NCT00329420|11469035|FG002|Re-induction Phase|Withdrawal of Consent|1
7257184|NCT00329420|11469033|FG000|Re-induction Phase|Did not respond to re-induction|6
7257185|NCT00329420|11469034|FG001|Re-induction Phase|Did not respond to re-induction|5
7257186|NCT00329420|11469035|FG002|Re-induction Phase|Did not respond to re-induction|7
7257187|NCT00329420|11469033|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
7257188|NCT00329420|11469034|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7257189|NCT00329420|11469035|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
7257190|NCT00329420|11469033|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7257191|NCT00329420|11469034|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
7257192|NCT00329420|11469035|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
7257193|NCT00329420|11469033|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
7257194|NCT00329420|11469034|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7257195|NCT00329420|11469035|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
7257196|NCT00329550|11469061|FG000|Overall Study|Adverse Event|3
7257197|NCT00329550|11469062|FG001|Overall Study|Adverse Event|4
7257198|NCT00329550|11469063|FG002|Overall Study|Adverse Event|2
7257199|NCT00329550|11469061|FG000|Overall Study|Withdrawal of Consent|1
7257200|NCT00329550|11469062|FG001|Overall Study|Withdrawal of Consent|0
7257201|NCT00329550|11469063|FG002|Overall Study|Withdrawal of Consent|1
7257202|NCT00329550|11469061|FG000|Overall Study|Due to Relocation|0
7257203|NCT00329550|11469062|FG001|Overall Study|Due to Relocation|0
7257204|NCT00329550|11469063|FG002|Overall Study|Due to Relocation|1
7469010|NCT01917968|11770124|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
7469011|NCT01917968|11770125|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
7469012|NCT01917968|11770124|FG000|Overall Study|Change in Family Circumstances|0
7469013|NCT01917968|11770125|FG001|Overall Study|Change in Family Circumstances|1
7469014|NCT01917968|11770124|FG000|Overall Study|No Data Available|0
7469015|NCT01917968|11770125|FG001|Overall Study|No Data Available|2
7469016|NCT01918085|11770152|FG000|Test Period 1: Strata Strip|Adverse Event|0
7469017|NCT01918085|11770153|FG001|Test Period 1: Strata Strip|Adverse Event|1
7469018|NCT01918306|11770168|FG000|Overall Study|progresive disease|4
7469019|NCT01918306|11770169|FG001|Overall Study|progresive disease|0
7469020|NCT01918306|11770170|FG002|Overall Study|progresive disease|1
7469021|NCT01918306|11770171|FG003|Overall Study|progresive disease|1
7469022|NCT01918306|11770168|FG000|Overall Study|Withdrawal by Subject|0
7469023|NCT01918306|11770169|FG001|Overall Study|Withdrawal by Subject|0
7469024|NCT01918306|11770170|FG002|Overall Study|Withdrawal by Subject|0
7469025|NCT01918306|11770171|FG003|Overall Study|Withdrawal by Subject|2
7469026|NCT01918306|11770168|FG000|Overall Study|neutropenia|1
7469027|NCT01918306|11770169|FG001|Overall Study|neutropenia|0
7469028|NCT01918306|11770170|FG002|Overall Study|neutropenia|0
7469029|NCT01918306|11770171|FG003|Overall Study|neutropenia|0
7469030|NCT01918306|11770168|FG000|Overall Study|Lack of Efficacy|1
7469031|NCT01918306|11770169|FG001|Overall Study|Lack of Efficacy|0
7469032|NCT01918306|11770170|FG002|Overall Study|Lack of Efficacy|0
7469033|NCT01918306|11770171|FG003|Overall Study|Lack of Efficacy|0
7469034|NCT01918306|11770168|FG000|Overall Study|progress disease, crossover|0
7469035|NCT01918306|11770169|FG001|Overall Study|progress disease, crossover|0
7469036|NCT01918306|11770170|FG002|Overall Study|progress disease, crossover|1
7469037|NCT01918306|11770171|FG003|Overall Study|progress disease, crossover|0
7469038|NCT01918332|11770195|FG000|Overall Study|Adverse Event|0
7469039|NCT01918332|11770196|FG001|Overall Study|Adverse Event|0
7469040|NCT01918332|11770197|FG002|Overall Study|Adverse Event|0
7469041|NCT01918332|11770198|FG003|Overall Study|Adverse Event|1
7469042|NCT01918332|11770195|FG000|Overall Study|Withdrawal by Subject|2
7469043|NCT01918332|11770196|FG001|Overall Study|Withdrawal by Subject|3
7469044|NCT01918332|11770197|FG002|Overall Study|Withdrawal by Subject|2
7469045|NCT01918332|11770198|FG003|Overall Study|Withdrawal by Subject|3
7469046|NCT01918332|11770195|FG000|Overall Study|Protocol Violation|6
7469047|NCT01918332|11770196|FG001|Overall Study|Protocol Violation|2
7469048|NCT01918332|11770197|FG002|Overall Study|Protocol Violation|6
7469049|NCT01918332|11770198|FG003|Overall Study|Protocol Violation|3
7469050|NCT01918332|11770195|FG000|Overall Study|lipid result by central lab did not meet|0
7469051|NCT01918332|11770196|FG001|Overall Study|lipid result by central lab did not meet|0
7469052|NCT01918332|11770197|FG002|Overall Study|lipid result by central lab did not meet|1
7469053|NCT01918332|11770198|FG003|Overall Study|lipid result by central lab did not meet|0
7469054|NCT01918371|11770210|FG000|Overall Study|Missing Data|1
7469055|NCT01918371|11770211|FG001|Overall Study|Missing Data|1
7469056|NCT01918774|11770221|FG000|Overall Study|Lost prior to first CBTw session|4
7469057|NCT01918774|11770221|FG000|Overall Study|Lost to Follow-up|1
7469058|NCT01919112|11770237|FG000|Secondary Analysis-day 30|Death|1
7469059|NCT01919112|11770238|FG001|Secondary Analysis-day 30|Death|1
7469060|NCT01919112|11770239|FG002|Secondary Analysis-day 30|Death|1
7469061|NCT01919112|11770237|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
7469062|NCT01919112|11770238|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
7469063|NCT01919112|11770239|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
7469064|NCT01919164|11770252|FG000|Overall Study|Adverse Event|6
7469065|NCT01919164|11770253|FG001|Overall Study|Adverse Event|4
7469066|NCT01919164|11770254|FG002|Overall Study|Adverse Event|9
7469067|NCT01919164|11770255|FG003|Overall Study|Adverse Event|3
7469068|NCT01919164|11770256|FG004|Overall Study|Adverse Event|2
7469069|NCT01919164|11770252|FG000|Overall Study|Lost to Follow-up|2
7469070|NCT01919164|11770253|FG001|Overall Study|Lost to Follow-up|2
7257205|NCT00329602|11469075|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
7257206|NCT00329602|11469076|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
7257207|NCT00329602|11469077|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
7257208|NCT00329602|11469075|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
7257209|NCT00329602|11469076|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
7257210|NCT00329602|11469077|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
7257211|NCT00329602|11469075|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7257212|NCT00329602|11469076|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
7257213|NCT00329602|11469077|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
7257214|NCT00329602|11469075|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
7257215|NCT00329602|11469076|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
7257216|NCT00329602|11469077|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
7257217|NCT00329602|11469075|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7257218|NCT00329602|11469076|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
7257219|NCT00329602|11469077|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
7257220|NCT00329602|11469075|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
7257221|NCT00329602|11469076|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
7257222|NCT00329602|11469077|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
7257223|NCT00329641|11469093|FG000|Overall Study|Did not start treatment|1
7257224|NCT00329641|11469093|FG000|Overall Study|Not eligible|1
7257225|NCT00329641|11469093|FG000|Overall Study|Adverse Event|3
7257226|NCT00329641|11469093|FG000|Overall Study|Other reason, not protocol specified|1
7257227|NCT00329719|11469102|FG000|Overall Study|Lost to Follow-up|0
7257228|NCT00329719|11469103|FG001|Overall Study|Lost to Follow-up|0
7257229|NCT00329719|11469104|FG002|Overall Study|Lost to Follow-up|0
7257230|NCT00329719|11469105|FG003|Overall Study|Lost to Follow-up|1
7257231|NCT00329745|11469117|FG000|Overall Study|Protocol Violation|1
7257232|NCT00329745|11469118|FG001|Overall Study|Protocol Violation|0
7257233|NCT00329745|11469117|FG000|Overall Study|Withdrawal by Subject|0
7257234|NCT00329745|11469118|FG001|Overall Study|Withdrawal by Subject|1
7257235|NCT00329745|11469117|FG000|Overall Study|Lost to Follow-up|86
7257236|NCT00329745|11469118|FG001|Overall Study|Lost to Follow-up|101
7257237|NCT00329784|11469132|FG000|Overall Study|Lost to Follow-up|0
7257238|NCT00329784|11469133|FG001|Overall Study|Lost to Follow-up|1
7257239|NCT00329784|11469134|FG002|Overall Study|Lost to Follow-up|0
7257240|NCT00329784|11469135|FG003|Overall Study|Lost to Follow-up|0
7257241|NCT00329784|11469132|FG000|Overall Study|Withdrawal by Subject|4
7469071|NCT01919164|11770254|FG002|Overall Study|Lost to Follow-up|2
7469072|NCT01919164|11770255|FG003|Overall Study|Lost to Follow-up|0
7575501|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
7575502|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
7575503|NCT03739840|11959101|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7257242|NCT00329784|11469133|FG001|Overall Study|Withdrawal by Subject|2
7257243|NCT00329784|11469134|FG002|Overall Study|Withdrawal by Subject|0
7257244|NCT00329784|11469135|FG003|Overall Study|Withdrawal by Subject|0
7257245|NCT00329784|11469132|FG000|Overall Study|Other|1
7257246|NCT00329784|11469133|FG001|Overall Study|Other|2
7257247|NCT00329784|11469134|FG002|Overall Study|Other|0
7257248|NCT00329784|11469135|FG003|Overall Study|Other|0
7257249|NCT00329797|11469149|FG000|Overall Study|Protocol Violation|1
7257250|NCT00329797|11469150|FG001|Overall Study|Protocol Violation|0
7257251|NCT00329797|11469149|FG000|Overall Study|Withdrawal by Subject|6
7575504|NCT03739840|11959102|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7575505|NCT03739840|11959103|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
7575506|NCT03739840|11959104|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
7575507|NCT03753763|11959163|FG000|Overall Study|Adverse Event|2
7575508|NCT03753763|11959164|FG001|Overall Study|Adverse Event|0
7575509|NCT03753763|11959163|FG000|Overall Study|Withdrawal by Subject|3
7575510|NCT03753763|11959164|FG001|Overall Study|Withdrawal by Subject|1
7575511|NCT03753763|11959163|FG000|Overall Study|clinical deterioration|1
7575512|NCT03753763|11959164|FG001|Overall Study|clinical deterioration|0
7575513|NCT03756571|11959172|FG000|Overall Study|Lost to Follow-up|1
7257252|NCT00329797|11469150|FG001|Overall Study|Withdrawal by Subject|6
7257253|NCT00329849|11469162|FG000|Overall Study|Withdrawal by Subject|6
7257254|NCT00329849|11469163|FG001|Overall Study|Withdrawal by Subject|4
7469073|NCT01919164|11770256|FG004|Overall Study|Lost to Follow-up|4
7469074|NCT01919164|11770252|FG000|Overall Study|Death|1
7469075|NCT01919164|11770253|FG001|Overall Study|Death|0
7469076|NCT01919164|11770254|FG002|Overall Study|Death|0
7469077|NCT01919164|11770255|FG003|Overall Study|Death|0
7469078|NCT01919164|11770256|FG004|Overall Study|Death|0
7469079|NCT01919164|11770252|FG000|Overall Study|Protocol Violation|6
7469080|NCT01919164|11770253|FG001|Overall Study|Protocol Violation|0
7469081|NCT01919164|11770254|FG002|Overall Study|Protocol Violation|3
7469082|NCT01919164|11770255|FG003|Overall Study|Protocol Violation|2
7469083|NCT01919164|11770256|FG004|Overall Study|Protocol Violation|2
7469084|NCT01919164|11770252|FG000|Overall Study|Disease progression|2
7469085|NCT01919164|11770253|FG001|Overall Study|Disease progression|2
7469086|NCT01919164|11770254|FG002|Overall Study|Disease progression|1
7257255|NCT00329901|11469176|FG000|Overall Study|Withdrawal by Subject|4
7257256|NCT00329901|11469177|FG001|Overall Study|Withdrawal by Subject|3
7257257|NCT00329901|11469178|FG002|Overall Study|Withdrawal by Subject|2
7257258|NCT00329901|11469176|FG000|Overall Study|Lost to Follow-up|2
7257259|NCT00329901|11469177|FG001|Overall Study|Lost to Follow-up|0
7257260|NCT00329901|11469178|FG002|Overall Study|Lost to Follow-up|1
7257261|NCT00329901|11469176|FG000|Overall Study|Protocol Violation|1
7257262|NCT00329901|11469177|FG001|Overall Study|Protocol Violation|0
7257263|NCT00329901|11469178|FG002|Overall Study|Protocol Violation|1
7257264|NCT00329901|11469176|FG000|Overall Study|Unable to classify|2
7257265|NCT00329901|11469177|FG001|Overall Study|Unable to classify|2
7257266|NCT00329901|11469178|FG002|Overall Study|Unable to classify|0
7257267|NCT00330174|11469196|FG000|Overall Study|Withdrawal by Subject|7
7257268|NCT00330174|11469197|FG001|Overall Study|Withdrawal by Subject|7
7257269|NCT00330174|11469196|FG000|Overall Study|Lost to Follow-up|4
7257270|NCT00330174|11469197|FG001|Overall Study|Lost to Follow-up|1
7257271|NCT00330174|11469196|FG000|Overall Study|Clinical deterioration|1
7257272|NCT00330174|11469197|FG001|Overall Study|Clinical deterioration|2
7257273|NCT00330174|11469196|FG000|Overall Study|Excessive missed visits|3
7257274|NCT00330174|11469197|FG001|Overall Study|Excessive missed visits|8
7257275|NCT00330174|11469196|FG000|Overall Study|Miscellaneous reasons|7
7257276|NCT00330174|11469197|FG001|Overall Study|Miscellaneous reasons|1
7257277|NCT00330187|11469207|FG000|Overall Study|Lost to Follow-up|12
7257278|NCT00330187|11469208|FG001|Overall Study|Lost to Follow-up|13
7257279|NCT00330187|11469209|FG002|Overall Study|Lost to Follow-up|14
7257280|NCT00330187|11469210|FG003|Overall Study|Lost to Follow-up|10
7257281|NCT00330187|11469207|FG000|Overall Study|Withdrawal by Subject|8
7257282|NCT00330187|11469208|FG001|Overall Study|Withdrawal by Subject|5
7257283|NCT00330187|11469209|FG002|Overall Study|Withdrawal by Subject|4
7257284|NCT00330187|11469210|FG003|Overall Study|Withdrawal by Subject|4
7257285|NCT00330343|11469220|FG000|Overall Study|Lost to Follow-up|5
7257286|NCT00330460|11469241|FG000|Overall Study|Physician Decision|1
7257287|NCT00330460|11469242|FG001|Overall Study|Physician Decision|0
7257288|NCT00330460|11469241|FG000|Overall Study|Adverse Event|10
7257289|NCT00330460|11469242|FG001|Overall Study|Adverse Event|8
7257290|NCT00330460|11469241|FG000|Overall Study|Withdrawal by Subject|18
7257291|NCT00330460|11469242|FG001|Overall Study|Withdrawal by Subject|17
7257292|NCT00330460|11469241|FG000|Overall Study|Death|1
7257293|NCT00330460|11469242|FG001|Overall Study|Death|1
7257294|NCT00330460|11469241|FG000|Overall Study|Ineligibility determined|1
7257295|NCT00330460|11469242|FG001|Overall Study|Ineligibility determined|3
7257296|NCT00330460|11469241|FG000|Overall Study|Lost to Follow-up|8
7257297|NCT00330460|11469242|FG001|Overall Study|Lost to Follow-up|3
7257298|NCT00330460|11469241|FG000|Overall Study|Noncompliance|2
7257299|NCT00330460|11469242|FG001|Overall Study|Noncompliance|1
7257300|NCT00330460|11469241|FG000|Overall Study|Other|1
7257301|NCT00330460|11469242|FG001|Overall Study|Other|0
7257302|NCT00330616|11469263|FG000|Overall Study|Adverse Event|13
7257303|NCT00330616|11469263|FG000|Overall Study|Lack of Efficacy|1
7257304|NCT00330616|11469263|FG000|Overall Study|Lost to Follow-up|2
7257305|NCT00330616|11469263|FG000|Overall Study|Withdrawal by Subject|4
7257306|NCT00330616|11469263|FG000|Overall Study|Other|1
7257307|NCT00330668|11469267|FG000|BID Dosing Period|Adverse Event|1
7257308|NCT00330668|11469267|FG000|BID Dosing Period|Lost to Follow-up|7
7257309|NCT00330668|11469267|FG000|BID Dosing Period|Non-Compliance|5
7257310|NCT00330668|11469267|FG000|BID Dosing Period|Withdrawal by Subject|19
7257311|NCT00330668|11469267|FG000|BID Dosing Period|Sponsor's decision|1
7257312|NCT00330668|11469267|FG000|BID Dosing Period|Other|3
7257313|NCT00330668|11469267|FG000|QD Dosing Period|Sponsor decision to terminate study|74
7257314|NCT00330668|11469267|FG000|QD Dosing Period|Other|1
7257315|NCT00330668|11469267|FG000|QD Dosing Period|Withdrawal by Subject|1
7257316|NCT00330668|11469267|FG000|QD Dosing Period|Lost to Follow-up|2
7257317|NCT00330681|11469273|FG000|Overall Study|Adverse Event|3
7257318|NCT00330681|11469274|FG001|Overall Study|Adverse Event|6
7257319|NCT00330681|11469273|FG000|Overall Study|Protocol Violation|0
7257320|NCT00330681|11469274|FG001|Overall Study|Protocol Violation|1
7257321|NCT00330681|11469273|FG000|Overall Study|Withdrawal by Subject|5
7257322|NCT00330681|11469274|FG001|Overall Study|Withdrawal by Subject|5
7257323|NCT00330681|11469273|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
7257324|NCT00330681|11469274|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
7257325|NCT00330759|11469291|FG000|Overall Study|Death|316
7257326|NCT00330759|11469292|FG001|Overall Study|Death|310
7257327|NCT00330759|11469291|FG000|Overall Study|Disease progression|104
7257328|NCT00330759|11469292|FG001|Overall Study|Disease progression|126
7257329|NCT00330759|11469291|FG000|Overall Study|Withdrawal by Subject|143
7257330|NCT00330759|11469292|FG001|Overall Study|Withdrawal by Subject|124
7257331|NCT00330759|11469291|FG000|Overall Study|Adverse Event|48
7257332|NCT00330759|11469292|FG001|Overall Study|Adverse Event|36
7257333|NCT00330759|11469291|FG000|Overall Study|Participant request|31
7257334|NCT00330759|11469292|FG001|Overall Study|Participant request|22
7257335|NCT00330759|11469291|FG000|Overall Study|Lost to Follow-up|16
7257336|NCT00330759|11469292|FG001|Overall Study|Lost to Follow-up|22
7257337|NCT00330759|11469291|FG000|Overall Study|Noncompliance|15
7257338|NCT00330759|11469292|FG001|Overall Study|Noncompliance|17
7257339|NCT00330759|11469291|FG000|Overall Study|Physician Decision|1
7257340|NCT00330759|11469292|FG001|Overall Study|Physician Decision|2
7257341|NCT00330759|11469291|FG000|Overall Study|Protocol deviation|0
7257342|NCT00330759|11469292|FG001|Overall Study|Protocol deviation|2
7257343|NCT00330759|11469291|FG000|Overall Study|Ineligibility determined|2
7257344|NCT00330759|11469292|FG001|Overall Study|Ineligibility determined|1
7257345|NCT00330759|11469291|FG000|Overall Study|Other|36
7257346|NCT00330759|11469292|FG001|Overall Study|Other|44
7257347|NCT00330928|11469318|FG000|Overall Study|Lost to Follow-up|6
7257348|NCT00330928|11469318|FG000|Overall Study|Physician Decision|9
7257349|NCT00330928|11469318|FG000|Overall Study|Death|1
7257350|NCT00330928|11469318|FG000|Overall Study|IVUS could not be performed.|1
7257351|NCT00330967|11469324|FG000|Overall Study|Withdrawal by Subject|0
7257352|NCT00330967|11469325|FG001|Overall Study|Withdrawal by Subject|5
7257353|NCT00330967|11469324|FG000|Overall Study|Physician Decision|0
7257354|NCT00330967|11469325|FG001|Overall Study|Physician Decision|9
7257355|NCT00331006|11469331|FG000|Screening Phase|Withdrawal by Subject|1
7257356|NCT00331006|11469331|FG000|Screening Phase|enrollment halted|1
7257357|NCT00331006|11469331|FG000|Screening Phase|Lost to Follow-up|1
7257358|NCT00331006|11469331|FG000|Screening Phase|Ineligible for treatment phase|4
7257359|NCT00331006|11469331|FG000|Treatment Phase|Withdrawal by Subject|1
7257360|NCT00331006|11469331|FG000|Follow-Up Phase I|Lost to Follow-up|1
7257361|NCT00331006|11469331|FG000|Follow-Up Phase II|Lost to Follow-up|3
7257362|NCT00331136|11469339|FG000|Overall Study|Adverse Event|3
7257363|NCT00331136|11469340|FG001|Overall Study|Adverse Event|5
7257364|NCT00331136|11469341|FG002|Overall Study|Adverse Event|0
7257365|NCT00331136|11469342|FG003|Overall Study|Adverse Event|1
7257366|NCT00331136|11469339|FG000|Overall Study|Withdrawal by Subject|0
7257367|NCT00331136|11469340|FG001|Overall Study|Withdrawal by Subject|1
7257368|NCT00331136|11469341|FG002|Overall Study|Withdrawal by Subject|0
7257369|NCT00331136|11469342|FG003|Overall Study|Withdrawal by Subject|0
7257370|NCT00331136|11469339|FG000|Overall Study|Lost to Follow-up|0
7257371|NCT00331136|11469340|FG001|Overall Study|Lost to Follow-up|1
7257372|NCT00331136|11469341|FG002|Overall Study|Lost to Follow-up|0
7257373|NCT00331136|11469342|FG003|Overall Study|Lost to Follow-up|0
7257374|NCT00331136|11469339|FG000|Overall Study|Protocol Violation|1
7257375|NCT00331136|11469340|FG001|Overall Study|Protocol Violation|0
7257376|NCT00331136|11469341|FG002|Overall Study|Protocol Violation|0
7257377|NCT00331136|11469342|FG003|Overall Study|Protocol Violation|0
7257378|NCT00331136|11469339|FG000|Overall Study|Not treated|1
7257379|NCT00331136|11469340|FG001|Overall Study|Not treated|0
7257380|NCT00331136|11469341|FG002|Overall Study|Not treated|0
7257381|NCT00331136|11469342|FG003|Overall Study|Not treated|0
7257382|NCT00331344|11469361|FG000|Phase I|Adverse Event|0
7257383|NCT00331344|11469362|FG001|Phase I|Adverse Event|0
7257384|NCT00331344|11469363|FG002|Phase I|Adverse Event|0
7257385|NCT00331344|11469364|FG003|Phase I|Adverse Event|1
7257386|NCT00331344|11469365|FG004|Phase I|Adverse Event|2
7257387|NCT00331344|11469366|FG005|Phase I|Adverse Event|2
7257388|NCT00331344|11469367|FG006|Phase I|Adverse Event|0
7257389|NCT00331344|11469368|FG007|Phase I|Adverse Event|1
7257390|NCT00331344|11469369|FG008|Phase I|Adverse Event|0
7469087|NCT01919164|11770255|FG003|Overall Study|Disease progression|2
7469088|NCT01919164|11770256|FG004|Overall Study|Disease progression|1
7469089|NCT01919164|11770252|FG000|Overall Study|Withdrew consent|13
7575514|NCT03756571|11959173|FG001|Overall Study|Lost to Follow-up|1
7469090|NCT01919164|11770253|FG001|Overall Study|Withdrew consent|13
7469091|NCT01919164|11770254|FG002|Overall Study|Withdrew consent|14
7469092|NCT01919164|11770255|FG003|Overall Study|Withdrew consent|14
7469093|NCT01919164|11770256|FG004|Overall Study|Withdrew consent|9
7469094|NCT01919164|11770252|FG000|Overall Study|Other Un-specified|13
7469095|NCT01919164|11770253|FG001|Overall Study|Other Un-specified|9
7469096|NCT01919164|11770254|FG002|Overall Study|Other Un-specified|8
7469097|NCT01919164|11770255|FG003|Overall Study|Other Un-specified|7
7469098|NCT01919164|11770256|FG004|Overall Study|Other Un-specified|15
7469099|NCT01919190|11770270|FG000|Overall Study|Intra-op findings, etc.|3
7469100|NCT01919190|11770271|FG001|Overall Study|Intra-op findings, etc.|0
7469101|NCT01919229|11770294|FG000|Overall Study|Subject/guardian decision|0
7469102|NCT01919229|11770295|FG001|Overall Study|Subject/guardian decision|0
7469103|NCT01919229|11770296|FG002|Overall Study|Subject/guardian decision|1
7469104|NCT01919307|11770304|FG000|Overall Study|Withdrawal by Subject|9
7469105|NCT01919398|11770311|FG000|Overall Study|Progressive Disease|0
7469106|NCT01919398|11770312|FG001|Overall Study|Progressive Disease|0
7257391|NCT00331344|11469361|FG000|Phase II|Death|0
7257392|NCT00331344|11469362|FG001|Phase II|Death|0
7257393|NCT00331344|11469363|FG002|Phase II|Death|0
7257394|NCT00331344|11469364|FG003|Phase II|Death|0
7469107|NCT01919398|11770313|FG002|Overall Study|Progressive Disease|4
7469108|NCT01919411|11770323|FG000|Overall Study|Lost to Follow-up|2
7469109|NCT01919411|11770324|FG001|Overall Study|Lost to Follow-up|4
7469110|NCT01919411|11770323|FG000|Overall Study|Physician Decision|1
7469111|NCT01919411|11770324|FG001|Overall Study|Physician Decision|0
7469112|NCT01919411|11770323|FG000|Overall Study|Protocol Violation|2
7257395|NCT00331344|11469365|FG004|Phase II|Death|0
7257396|NCT00331344|11469366|FG005|Phase II|Death|0
7257397|NCT00331344|11469367|FG006|Phase II|Death|0
7257398|NCT00331344|11469368|FG007|Phase II|Death|0
7257399|NCT00331344|11469369|FG008|Phase II|Death|4
7257400|NCT00331409|11469382|FG000|Overall Study|Lack of Efficacy|4
7257401|NCT00331422|11469386|FG000|Overall Study|Did not receive entire study regimen|5
7257402|NCT00331552|11469393|FG000|Period 3: Phase II|Neurological Symptoms|1
7257403|NCT00331552|11469394|FG001|Period 3: Phase II|Neurological Symptoms|0
7257404|NCT00331552|11469393|FG000|Period 3: Phase II|Severe Nausea|1
7257405|NCT00331552|11469394|FG001|Period 3: Phase II|Severe Nausea|0
7257406|NCT00331630|11469405|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
7469113|NCT01919411|11770324|FG001|Overall Study|Protocol Violation|1
7469114|NCT01919489|11770349|FG000|Overall Study|Rejected the need of injections|4
7469115|NCT01919489|11770350|FG001|Overall Study|Rejected the need of injections|7
7469116|NCT01919489|11770349|FG000|Overall Study|Adverse Event|10
7469117|NCT01919489|11770350|FG001|Overall Study|Adverse Event|0
7469118|NCT01919489|11770349|FG000|Overall Study|Hospital readmission|2
7469119|NCT01919489|11770350|FG001|Overall Study|Hospital readmission|9
7469120|NCT01919489|11770349|FG000|Overall Study|Death|2
7469121|NCT01919489|11770350|FG001|Overall Study|Death|1
7469122|NCT01919489|11770349|FG000|Overall Study|Lost to Follow-up|38
7469123|NCT01919489|11770350|FG001|Overall Study|Lost to Follow-up|27
7469124|NCT01919723|11770377|FG000|Overall Study|Blood Samples Hemolyzed|2
7469125|NCT01919723|11770378|FG001|Overall Study|Blood Samples Hemolyzed|2
7469126|NCT01919801|11770386|FG000|Overall Study|Withdrawal by Subject|1
7469127|NCT01919801|11770387|FG001|Overall Study|Withdrawal by Subject|0
7469128|NCT01919801|11770386|FG000|Overall Study|Physician Decision|0
7469129|NCT01919801|11770387|FG001|Overall Study|Physician Decision|1
7469130|NCT01919801|11770386|FG000|Overall Study|Lost to Follow-up|0
7469131|NCT01919801|11770387|FG001|Overall Study|Lost to Follow-up|1
7469132|NCT01919801|11770386|FG000|Overall Study|Other|0
7469133|NCT01919801|11770387|FG001|Overall Study|Other|1
7469134|NCT01919814|11770393|FG000|Overall Study|Adverse Event|1
7469135|NCT01919814|11770394|FG001|Overall Study|Adverse Event|0
7469136|NCT01919814|11770393|FG000|Overall Study|Protocol Violation|1
7469137|NCT01919814|11770394|FG001|Overall Study|Protocol Violation|0
7469138|NCT01919814|11770393|FG000|Overall Study|Withdrawal by Subject|1
7469139|NCT01919814|11770394|FG001|Overall Study|Withdrawal by Subject|0
7469140|NCT01919970|11770402|FG000|Overall Study|Withdrawal by Subject|3
7469141|NCT01919970|11770403|FG001|Overall Study|Withdrawal by Subject|0
7257407|NCT00331630|11469405|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
7257408|NCT00331630|11469405|FG000|Follow up for 5 Years|Death|5
7257409|NCT00331630|11469405|FG000|Follow up for 5 Years|Data collection was stopped|24
7257410|NCT00331682|11469409|FG000|Overall Study|Adverse Event|1
7257411|NCT00331760|11469415|FG000|Overall Study|Ineligible / no protocol treatment|15
7257412|NCT00331760|11469416|FG001|Overall Study|Ineligible / no protocol treatment|8
7257413|NCT00331799|11469423|FG000|Overall Study|Withdrawal by Subject|2
7257414|NCT00331799|11469423|FG000|Overall Study|Sedation|1
7257415|NCT00331864|11469429|FG000|Overall Study|Adverse Event|30
7257416|NCT00331864|11469430|FG001|Overall Study|Adverse Event|1
7257417|NCT00331864|11469429|FG000|Overall Study|Lack of Efficacy|4
7257418|NCT00331864|11469430|FG001|Overall Study|Lack of Efficacy|0
7257419|NCT00331864|11469429|FG000|Overall Study|Protocol Violation|3
7575515|NCT03763877|11959200|FG000|Overall Study|Withdrawal by Subject|3
7575516|NCT03763877|11959201|FG001|Overall Study|Withdrawal by Subject|1
7575517|NCT03763877|11959202|FG002|Overall Study|Withdrawal by Subject|3
7575518|NCT03763877|11959203|FG003|Overall Study|Withdrawal by Subject|4
7575519|NCT03763877|11959200|FG000|Overall Study|Adverse Event|1
7575520|NCT03763877|11959201|FG001|Overall Study|Adverse Event|1
7575521|NCT03763877|11959202|FG002|Overall Study|Adverse Event|3
7575522|NCT03763877|11959203|FG003|Overall Study|Adverse Event|1
7575523|NCT03763877|11959200|FG000|Overall Study|Protocol Violation|1
7575524|NCT03763877|11959201|FG001|Overall Study|Protocol Violation|1
7575525|NCT03763877|11959202|FG002|Overall Study|Protocol Violation|0
7575526|NCT03763877|11959203|FG003|Overall Study|Protocol Violation|0
7575527|NCT03763877|11959200|FG000|Overall Study|Lost to Follow-up|0
7575528|NCT03763877|11959201|FG001|Overall Study|Lost to Follow-up|1
7575529|NCT03763877|11959202|FG002|Overall Study|Lost to Follow-up|1
7575530|NCT03763877|11959203|FG003|Overall Study|Lost to Follow-up|0
7575531|NCT03772587|11959226|FG000|Overall Study|COVID-19|0
7575532|NCT03772587|11959227|FG001|Overall Study|COVID-19|0
7257420|NCT00331864|11469430|FG001|Overall Study|Protocol Violation|0
7257421|NCT00331864|11469429|FG000|Overall Study|Withdrawal by Subject|10
7575533|NCT03772587|11959228|FG002|Overall Study|COVID-19|1
7575534|NCT03772587|11959229|FG003|Overall Study|COVID-19|1
7575535|NCT03772587|11959230|FG004|Overall Study|COVID-19|0
7575536|NCT03772587|11959226|FG000|Overall Study|Withdrawal by Subject|1
7575537|NCT03772587|11959227|FG001|Overall Study|Withdrawal by Subject|0
7575538|NCT03772587|11959228|FG002|Overall Study|Withdrawal by Subject|0
7575539|NCT03772587|11959229|FG003|Overall Study|Withdrawal by Subject|0
7575540|NCT03772587|11959230|FG004|Overall Study|Withdrawal by Subject|0
7575541|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
7575542|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
7257422|NCT00331864|11469430|FG001|Overall Study|Withdrawal by Subject|0
7257423|NCT00331864|11469429|FG000|Overall Study|Lost to Follow-up|4
7257424|NCT00331864|11469430|FG001|Overall Study|Lost to Follow-up|3
7257425|NCT00331864|11469429|FG000|Overall Study|Administrative Problems|1
7257426|NCT00331864|11469430|FG001|Overall Study|Administrative Problems|0
7257427|NCT00331864|11469429|FG000|Overall Study|Death|6
7257428|NCT00331864|11469430|FG001|Overall Study|Death|0
7257429|NCT00332189|11469445|FG000|Overall Study|Adverse Event|3
7257430|NCT00332189|11469445|FG000|Overall Study|Uncooperative/Noncompliant|3
7257431|NCT00332189|11469445|FG000|Overall Study|Withdrawal by Subject|9
7257432|NCT00332189|11469445|FG000|Overall Study|Lack of Efficacy|4
7257433|NCT00332189|11469445|FG000|Overall Study|Moved out of country|2
7257434|NCT00332202|11469452|FG000|Overall Study|Adverse Event|72
7257435|NCT00332202|11469453|FG001|Overall Study|Adverse Event|28
7257436|NCT00332202|11469452|FG000|Overall Study|Lost to Follow-up|2
7257437|NCT00332202|11469453|FG001|Overall Study|Lost to Follow-up|1
7257438|NCT00332202|11469452|FG000|Overall Study|Physician Decision|6
7257439|NCT00332202|11469453|FG001|Overall Study|Physician Decision|8
7257440|NCT00332202|11469452|FG000|Overall Study|Protocol Entry Criteria Not Met|6
7257441|NCT00332202|11469453|FG001|Overall Study|Protocol Entry Criteria Not Met|5
7257442|NCT00332202|11469452|FG000|Overall Study|Protocol Violation|7
7257443|NCT00332202|11469453|FG001|Overall Study|Protocol Violation|2
7257444|NCT00332202|11469452|FG000|Overall Study|Sponsor Decision|1
7257445|NCT00332202|11469453|FG001|Overall Study|Sponsor Decision|2
7257446|NCT00332202|11469452|FG000|Overall Study|Withdrawal by Subject|36
7257447|NCT00332202|11469453|FG001|Overall Study|Withdrawal by Subject|17
7257448|NCT00332202|11469452|FG000|Overall Study|Progressive Disease|106
7257449|NCT00332202|11469453|FG001|Overall Study|Progressive Disease|60
7257450|NCT00332202|11469452|FG000|Overall Study|Death|5
7257451|NCT00332202|11469453|FG001|Overall Study|Death|2
7257452|NCT00332241|11469470|FG000|Overall Study|Lack of Efficacy|6
7257453|NCT00332241|11469471|FG001|Overall Study|Lack of Efficacy|1
7257454|NCT00332241|11469470|FG000|Overall Study|Adverse Event|3
7257455|NCT00332241|11469471|FG001|Overall Study|Adverse Event|5
7257456|NCT00332241|11469470|FG000|Overall Study|Withdrawal by Subject|2
7257457|NCT00332241|11469471|FG001|Overall Study|Withdrawal by Subject|1
7257458|NCT00332241|11469470|FG000|Overall Study|Lost to Follow-up|4
7257459|NCT00332241|11469471|FG001|Overall Study|Lost to Follow-up|1
7257460|NCT00332332|11469477|FG000|Overall Study|Adverse Event|13
7257461|NCT00332332|11469477|FG000|Overall Study|Death|1
7257462|NCT00332332|11469477|FG000|Overall Study|Withdrawal by Subject|8
7257463|NCT00332332|11469477|FG000|Overall Study|Physician Decision|1
7257464|NCT00332332|11469477|FG000|Overall Study|Lost to Follow-up|3
7257465|NCT00332332|11469477|FG000|Overall Study|Protocol deviation|4
7257466|NCT00332332|11469477|FG000|Overall Study|Noncompliance|2
7257467|NCT00332332|11469477|FG000|Overall Study|Disease progression|2
7257468|NCT00332332|11469477|FG000|Overall Study|Other|18
7257469|NCT00332332|11469477|FG000|Overall Study|Did not receive study treatment|16
7257470|NCT00332462|11469481|FG000|Overall Study|Adverse Event|5
7257471|NCT00332462|11469481|FG000|Overall Study|Abnormal Lab Value|1
7257472|NCT00332462|11469481|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7257473|NCT00332462|11469481|FG000|Overall Study|no longer requires study drug|1
7257474|NCT00332462|11469481|FG000|Overall Study|Death|3
7257475|NCT00332462|11469481|FG000|Overall Study|Graft Loss|2
7257476|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
7257477|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
7257478|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
7257479|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
7257480|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
7257481|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
7257482|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
7257483|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
7257484|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
7257485|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
7257486|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
7257487|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
7257488|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
7257489|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
7257490|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
7257491|NCT00332488|11469491|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
7257492|NCT00332488|11469492|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
7257493|NCT00332488|11469493|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
7257494|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7257495|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
7257496|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
7257497|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7257498|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
7257499|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
7257500|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7257501|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
7257502|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
7257503|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7257504|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
7257505|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
7257506|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7257507|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
7257508|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
7257509|NCT00332488|11469491|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7257510|NCT00332488|11469492|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
7257511|NCT00332488|11469493|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
7257512|NCT00332696|11469552|FG000|Overall Study|Death|24
7257513|NCT00332696|11469553|FG001|Overall Study|Death|14
7257514|NCT00332696|11469552|FG000|Overall Study|Insufficient therapeutic effect|4
7257515|NCT00332696|11469553|FG001|Overall Study|Insufficient therapeutic effect|11
7257516|NCT00332696|11469552|FG000|Overall Study|Adverse Event|1
7257517|NCT00332696|11469553|FG001|Overall Study|Adverse Event|2
7257549|NCT00333138|11469590|FG001|Core Study (6 Months)|Adverse Event|5
7469222|NCT01920152|11770517|FG000|Overall Study|Withdrawal by Subject|1
7469223|NCT01920152|11770518|FG001|Overall Study|Withdrawal by Subject|2
7469224|NCT01920178|11770526|FG000|Overall Study|Lost to Follow-up|2
7469225|NCT01920178|11770527|FG001|Overall Study|Lost to Follow-up|1
7575543|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
7537884|NCT02120469|11886991|FG000|Overall Study|HER-2/neu-amplified|1
7537885|NCT02120469|11886992|FG001|Overall Study|HER-2/neu-amplified|0
7537886|NCT02120469|11886993|FG002|Overall Study|HER-2/neu-amplified|1
7537887|NCT02109744|11887006|FG000|Overall Study|Death|1
7537888|NCT02109744|11887007|FG001|Overall Study|Death|1
7537889|NCT02109744|11887006|FG000|Overall Study|no marrow exam|1
7537890|NCT02109744|11887007|FG001|Overall Study|no marrow exam|0
7537891|NCT02008396|11887015|FG000|Overall Study|Protocol Violation|0
7537892|NCT02008396|11887016|FG001|Overall Study|Protocol Violation|1
7537893|NCT02000622|11887025|FG000|Overall Study|Withdrawal by Subject|5
7537894|NCT02000622|11887026|FG001|Overall Study|Withdrawal by Subject|7
7537895|NCT02000622|11887025|FG000|Overall Study|Lost to Follow-up|4
7537896|NCT02000622|11887026|FG001|Overall Study|Lost to Follow-up|0
7537897|NCT02000622|11887025|FG000|Overall Study|Death|159
7537898|NCT02000622|11887026|FG001|Overall Study|Death|73
7537899|NCT02000622|11887025|FG000|Overall Study|Withdrawn due to site closure|1
7537900|NCT02000622|11887026|FG001|Overall Study|Withdrawn due to site closure|0
7257518|NCT00332696|11469552|FG000|Overall Study|Condition does not justify treatment|0
7257519|NCT00332696|11469553|FG001|Overall Study|Condition does not justify treatment|2
7257520|NCT00332696|11469552|FG000|Overall Study|Lost to Follow-up|0
7257521|NCT00332696|11469553|FG001|Overall Study|Lost to Follow-up|1
7257522|NCT00332696|11469552|FG000|Overall Study|Withdrawal by Subject|1
7257523|NCT00332696|11469553|FG001|Overall Study|Withdrawal by Subject|0
7257524|NCT00332709|11469561|FG000|Overall Study|Adverse Event|11
7257525|NCT00332709|11469562|FG001|Overall Study|Adverse Event|14
7257526|NCT00332709|11469561|FG000|Overall Study|Withdrawal by Subject|2
7257527|NCT00332709|11469562|FG001|Overall Study|Withdrawal by Subject|3
7257528|NCT00332709|11469561|FG000|Overall Study|Lost to Follow-up|2
7257529|NCT00332709|11469562|FG001|Overall Study|Lost to Follow-up|0
7257530|NCT00332709|11469561|FG000|Overall Study|Administrative Problems|0
7257531|NCT00332709|11469562|FG001|Overall Study|Administrative Problems|3
7257532|NCT00332709|11469561|FG000|Overall Study|Abnormal test procedure result|1
7257533|NCT00332709|11469562|FG001|Overall Study|Abnormal test procedure result|0
7257534|NCT00332839|11469579|FG000|Core (Months 0 - 12)|Administrative problems|1
7257535|NCT00332839|11469580|FG001|Core (Months 0 - 12)|Administrative problems|1
7257536|NCT00332839|11469579|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
7257537|NCT00332839|11469580|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
7257538|NCT00332839|11469579|FG000|Core (Months 0 - 12)|Protocol deviation|1
7257539|NCT00332839|11469580|FG001|Core (Months 0 - 12)|Protocol deviation|1
7257540|NCT00332839|11469579|FG000|Core (Months 0 - 12)|Adverse Event|5
7257541|NCT00332839|11469580|FG001|Core (Months 0 - 12)|Adverse Event|15
7257542|NCT00332839|11469579|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7257543|NCT00332839|11469580|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
7257544|NCT00332839|11469579|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
7257545|NCT00332839|11469580|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
7257546|NCT00332839|11469579|FG000|Follow-up (Months 12 - 60)|Death|1
7257547|NCT00332839|11469580|FG001|Follow-up (Months 12 - 60)|Death|1
7257548|NCT00333138|11469589|FG000|Core Study (6 Months)|Adverse Event|4
7257550|NCT00333138|11469591|FG002|Core Study (6 Months)|Adverse Event|8
7257551|NCT00333138|11469589|FG000|Core Study (6 Months)|Withdrawal by Subject|1
7257552|NCT00333138|11469590|FG001|Core Study (6 Months)|Withdrawal by Subject|1
7257553|NCT00333138|11469591|FG002|Core Study (6 Months)|Withdrawal by Subject|2
7257554|NCT00333138|11469589|FG000|Core Study (6 Months)|Lack of Efficacy|1
7257555|NCT00333138|11469590|FG001|Core Study (6 Months)|Lack of Efficacy|0
7257556|NCT00333138|11469591|FG002|Core Study (6 Months)|Lack of Efficacy|0
7257557|NCT00333138|11469589|FG000|Core Study (6 Months)|Protocol Violation|1
7257558|NCT00333138|11469590|FG001|Core Study (6 Months)|Protocol Violation|0
7257559|NCT00333138|11469591|FG002|Core Study (6 Months)|Protocol Violation|1
7469226|NCT01920477|11770548|FG000|Overall Study|Adverse Event|0
7469227|NCT01920477|11770549|FG001|Overall Study|Adverse Event|1
7469228|NCT01920477|11770548|FG000|Overall Study|Lack of Efficacy|1
7469229|NCT01920477|11770549|FG001|Overall Study|Lack of Efficacy|0
7469230|NCT01920477|11770548|FG000|Overall Study|Study closed/terminated|14
7469231|NCT01920477|11770549|FG001|Overall Study|Study closed/terminated|15
7469232|NCT01920477|11770548|FG000|Overall Study|Withdrawal by Subject|0
7469233|NCT01920477|11770549|FG001|Overall Study|Withdrawal by Subject|1
7469234|NCT01920555|11770560|FG000|Overall Study|Physician Decision|1
7469235|NCT01920555|11770561|FG001|Overall Study|Physician Decision|2
7469236|NCT01920555|11770562|FG002|Overall Study|Physician Decision|1
7469237|NCT01920555|11770563|FG003|Overall Study|Physician Decision|2
7469238|NCT01920555|11770564|FG004|Overall Study|Physician Decision|0
7469239|NCT01920555|11770560|FG000|Overall Study|Lack of Efficacy|2
7469240|NCT01920555|11770561|FG001|Overall Study|Lack of Efficacy|0
7469241|NCT01920555|11770562|FG002|Overall Study|Lack of Efficacy|0
7469242|NCT01920555|11770563|FG003|Overall Study|Lack of Efficacy|0
7469243|NCT01920555|11770564|FG004|Overall Study|Lack of Efficacy|0
7469244|NCT01920555|11770560|FG000|Overall Study|Travel Difficulties|1
7469245|NCT01920555|11770561|FG001|Overall Study|Travel Difficulties|1
7469246|NCT01920555|11770562|FG002|Overall Study|Travel Difficulties|0
7469247|NCT01920555|11770563|FG003|Overall Study|Travel Difficulties|0
7469248|NCT01920555|11770564|FG004|Overall Study|Travel Difficulties|1
7469249|NCT01920555|11770560|FG000|Overall Study|Lost to Follow-up|0
7469250|NCT01920555|11770561|FG001|Overall Study|Lost to Follow-up|1
7469251|NCT01920555|11770562|FG002|Overall Study|Lost to Follow-up|0
7469252|NCT01920555|11770563|FG003|Overall Study|Lost to Follow-up|1
7469253|NCT01920555|11770564|FG004|Overall Study|Lost to Follow-up|0
7469254|NCT01920568|11770578|FG000|Overall Study|Adverse Event|27
7469255|NCT01920568|11770579|FG001|Overall Study|Adverse Event|8
7469256|NCT01920568|11770578|FG000|Overall Study|Protocol Violation|5
7469257|NCT01920568|11770579|FG001|Overall Study|Protocol Violation|3
7469258|NCT01920568|11770578|FG000|Overall Study|Lost to Follow-up|2
7469259|NCT01920568|11770579|FG001|Overall Study|Lost to Follow-up|2
7469260|NCT01920568|11770578|FG000|Overall Study|Physician Decision|13
7469261|NCT01920568|11770579|FG001|Overall Study|Physician Decision|4
7469262|NCT01920568|11770578|FG000|Overall Study|Withdrawal by Subject|79
7469263|NCT01920568|11770579|FG001|Overall Study|Withdrawal by Subject|55
7469264|NCT01920568|11770578|FG000|Overall Study|Death due to disease progression|25
7469265|NCT01920568|11770579|FG001|Overall Study|Death due to disease progression|12
7469266|NCT01920594|11770588|FG000|Overall Study|Adverse Event|4
7469267|NCT01920594|11770589|FG001|Overall Study|Adverse Event|2
7469268|NCT01920594|11770588|FG000|Overall Study|Lost to Follow-up|1
7469269|NCT01920594|11770589|FG001|Overall Study|Lost to Follow-up|0
7469270|NCT01920594|11770588|FG000|Overall Study|Recovery|2
7257560|NCT00333138|11469589|FG000|Core Study (6 Months)|Laboratory abnormality|0
7257561|NCT00333138|11469590|FG001|Core Study (6 Months)|Laboratory abnormality|0
7257562|NCT00333138|11469591|FG002|Core Study (6 Months)|Laboratory abnormality|1
7257563|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
7257564|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7575544|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
7575545|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
7575546|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
7575547|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
7575548|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
7575549|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
7575550|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
7575551|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
7575552|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
7257565|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
7257566|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
7257567|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
7257568|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
7257569|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
7257570|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
7257571|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
7257572|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
7257573|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
7257574|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
7469271|NCT01920594|11770589|FG001|Overall Study|Recovery|0
7469272|NCT01920594|11770588|FG000|Overall Study|Investigator discretion|0
7469273|NCT01920594|11770589|FG001|Overall Study|Investigator discretion|1
7469274|NCT01920711|11770597|FG000|Overall Study|Death|347
7469275|NCT01920711|11770598|FG001|Overall Study|Death|356
7469276|NCT01920711|11770597|FG000|Overall Study|Lost to Follow-up|13
7469277|NCT01920711|11770598|FG001|Overall Study|Lost to Follow-up|14
7469278|NCT01920711|11770597|FG000|Overall Study|Withdrawal by Subject|4
7469279|NCT01920711|11770598|FG001|Overall Study|Withdrawal by Subject|3
7469280|NCT01920854|11770625|FG000|Overall Study|Withdrawal by Subject|1
7469281|NCT01920854|11770626|FG001|Overall Study|Withdrawal by Subject|0
7469282|NCT01920854|11770627|FG002|Overall Study|Withdrawal by Subject|0
7469283|NCT01920854|11770628|FG003|Overall Study|Withdrawal by Subject|0
7469284|NCT01920854|11770629|FG004|Overall Study|Withdrawal by Subject|1
7469285|NCT01920854|11770630|FG005|Overall Study|Withdrawal by Subject|0
7469286|NCT01920854|11770631|FG006|Overall Study|Withdrawal by Subject|1
7469287|NCT01920893|11770668|FG000|Overall Study|Adverse Event|5
7469288|NCT01920893|11770669|FG001|Overall Study|Adverse Event|2
7469289|NCT01920893|11770668|FG000|Overall Study|Lack of Efficacy|2
7469290|NCT01920893|11770669|FG001|Overall Study|Lack of Efficacy|0
7469291|NCT01920958|11770676|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
7469292|NCT01921101|11770682|FG000|Overall Study|Death|16
7469293|NCT01921101|11770683|FG001|Overall Study|Death|6
7469294|NCT01921179|11770691|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7469295|NCT01921179|11770692|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
7469296|NCT01921179|11770691|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
7469297|NCT01921179|11770692|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
7469298|NCT01921205|11770701|FG000|Overall Study|Adverse Event|12
7469299|NCT01921205|11770702|FG001|Overall Study|Adverse Event|7
7469300|NCT01921205|11770701|FG000|Overall Study|Lack of Efficacy|1
7469301|NCT01921205|11770702|FG001|Overall Study|Lack of Efficacy|0
7469302|NCT01921205|11770701|FG000|Overall Study|Protocol Violation|1
7469303|NCT01921205|11770702|FG001|Overall Study|Protocol Violation|3
7469304|NCT01921205|11770701|FG000|Overall Study|Lost to Follow-up|1
7469305|NCT01921205|11770702|FG001|Overall Study|Lost to Follow-up|1
7469306|NCT01921205|11770701|FG000|Overall Study|Withdrawal by Subject|6
7469307|NCT01921205|11770702|FG001|Overall Study|Withdrawal by Subject|5
7469308|NCT01921205|11770701|FG000|Overall Study|Use Of Prohibited Medication|0
7469309|NCT01921205|11770702|FG001|Overall Study|Use Of Prohibited Medication|1
7469310|NCT01921205|11770701|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
7469311|NCT01921205|11770702|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
7469312|NCT01921205|11770701|FG000|Overall Study|Non Compliance Of The Parent|0
7469313|NCT01921205|11770702|FG001|Overall Study|Non Compliance Of The Parent|1
7469314|NCT01921205|11770701|FG000|Overall Study|Non Compliance Of Child|0
7469315|NCT01921205|11770702|FG001|Overall Study|Non Compliance Of Child|1
7537930|NCT01940341|11887070|FG000|Double-Blind Phase|Randomized but Never Treated|0
7537931|NCT01940341|11887071|FG001|Double-Blind Phase|Randomized but Never Treated|1
7537932|NCT01940341|11887070|FG000|Double-Blind Phase|Adverse Event|3
7537933|NCT01940341|11887071|FG001|Double-Blind Phase|Adverse Event|2
7537934|NCT01940341|11887070|FG000|Double-Blind Phase|Withdrew Consent|3
7537935|NCT01940341|11887071|FG001|Double-Blind Phase|Withdrew Consent|2
7537936|NCT01940341|11887070|FG000|Double-Blind Phase|Lost to Follow-up|4
7537937|NCT01940341|11887071|FG001|Double-Blind Phase|Lost to Follow-up|1
7537938|NCT01940341|11887070|FG000|Double-Blind Phase|Pregnancy|0
7537939|NCT01940341|11887071|FG001|Double-Blind Phase|Pregnancy|1
7537940|NCT01940341|11887070|FG000|Double-Blind Phase|Investigator's Discretion|1
7537941|NCT01940341|11887071|FG001|Double-Blind Phase|Investigator's Discretion|0
7537942|NCT01940341|11887070|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
7537943|NCT01940341|11887071|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7537944|NCT01940341|11887070|FG000|Double-Blind Phase|Protocol Specified Criteria|1
7537945|NCT01940341|11887071|FG001|Double-Blind Phase|Protocol Specified Criteria|0
7537946|NCT01940341|11887070|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
7537947|NCT01940341|11887071|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
7537948|NCT01940341|11887070|FG000|Open-label Extension Phase|Still on Study|4
7537949|NCT01940341|11887071|FG001|Open-label Extension Phase|Still on Study|1
7537964|NCT01866657|11887099|FG000|Overall Study|Surgery canceled|2
7537965|NCT01866657|11887100|FG001|Overall Study|Surgery canceled|0
7537975|NCT01705977|11887121|FG000|Overall Study|Withdrawal by Subject|128
7537976|NCT01705977|11887122|FG001|Overall Study|Withdrawal by Subject|128
7537977|NCT01705977|11887121|FG000|Overall Study|Adverse Event|57
7537978|NCT01705977|11887122|FG001|Overall Study|Adverse Event|49
7537979|NCT01705977|11887121|FG000|Overall Study|Protocol Violation|2
7537980|NCT01705977|11887122|FG001|Overall Study|Protocol Violation|4
7537981|NCT01705977|11887121|FG000|Overall Study|Site closure|3
7257575|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7257576|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
7257577|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
7257578|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7257579|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
7257580|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
7257581|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
7257582|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
7257583|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
7257584|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7257585|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
7257586|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
7257587|NCT00333138|11469589|FG000|Extension Study (Month6 to End of Study)|Death|0
7257588|NCT00333138|11469590|FG001|Extension Study (Month6 to End of Study)|Death|1
7257589|NCT00333138|11469591|FG002|Extension Study (Month6 to End of Study)|Death|0
7257590|NCT00333359|11469622|FG000|Overall Study|Adverse Event|29
7257591|NCT00333359|11469623|FG001|Overall Study|Adverse Event|35
7257592|NCT00333359|11469622|FG000|Overall Study|Withdrawal by Subject|19
7257593|NCT00333359|11469623|FG001|Overall Study|Withdrawal by Subject|37
7257594|NCT00333359|11469622|FG000|Overall Study|Physician Decision|2
7257595|NCT00333359|11469623|FG001|Overall Study|Physician Decision|2
7257596|NCT00333359|11469622|FG000|Overall Study|Protocol Non-compliance|2
7257597|NCT00333359|11469623|FG001|Overall Study|Protocol Non-compliance|8
7257598|NCT00333359|11469622|FG000|Overall Study|Lost to Follow-up|15
7257599|NCT00333359|11469623|FG001|Overall Study|Lost to Follow-up|25
7257600|NCT00333359|11469622|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
7257601|NCT00333359|11469623|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
7257602|NCT00333359|11469622|FG000|Overall Study|Treatment Failure|3
7257603|NCT00333359|11469623|FG001|Overall Study|Treatment Failure|8
7257604|NCT00333359|11469622|FG000|Overall Study|Withdrew before Receiving One Dose|2
7257605|NCT00333359|11469623|FG001|Overall Study|Withdrew before Receiving One Dose|6
7257606|NCT00333619|11469649|FG000|Overall Study|Death|12
7469316|NCT01921257|11770708|FG000|Overall Study|Adverse Event|1
7469317|NCT01921257|11770708|FG000|Overall Study|Protocol Violation|1
7469318|NCT01921257|11770708|FG000|Overall Study|Withdrawal by Subject|1
7469319|NCT01921270|11770713|FG000|Overall Study|Withdrawal by Subject|1
7469320|NCT01921348|11770732|FG000|Overall Study|Withdrawal by Subject|1
7469321|NCT01921348|11770733|FG001|Overall Study|Withdrawal by Subject|0
7469322|NCT01921348|11770732|FG000|Overall Study|Lost to Follow-up|0
7469323|NCT01921348|11770733|FG001|Overall Study|Lost to Follow-up|2
7469324|NCT01921387|11770739|FG000|Overall Study|Adverse Event|1
7469325|NCT01921517|11770750|FG000|Overall Study|Lost to Follow-up|5
7469326|NCT01921517|11770751|FG001|Overall Study|Lost to Follow-up|0
7469327|NCT01921517|11770750|FG000|Overall Study|Newly diagnosed health concern|2
7469328|NCT01921517|11770751|FG001|Overall Study|Newly diagnosed health concern|0
7469329|NCT01921517|11770750|FG000|Overall Study|Physician Decision|0
7469330|NCT01921517|11770751|FG001|Overall Study|Physician Decision|2
7469331|NCT01921517|11770750|FG000|Overall Study|Withdrawal by Subject|7
7469332|NCT01921517|11770751|FG001|Overall Study|Withdrawal by Subject|3
7469333|NCT01921517|11770750|FG000|Overall Study|Subject missed final imaging|1
7469334|NCT01921517|11770751|FG001|Overall Study|Subject missed final imaging|4
7469335|NCT01921829|11770778|FG000|Overall Study|Withdrawal by Subject|0
7469336|NCT01921829|11770779|FG001|Overall Study|Withdrawal by Subject|1
7469337|NCT01922011|11770812|FG000|Overall Study|Protocol Violation|0
7469338|NCT01922011|11770813|FG001|Overall Study|Protocol Violation|1
7469339|NCT01922011|11770812|FG000|Overall Study|Physician Decision|0
7469340|NCT01922011|11770813|FG001|Overall Study|Physician Decision|1
7469341|NCT01922011|11770812|FG000|Overall Study|Parent/Guardian Decision|3
7469342|NCT01922011|11770813|FG001|Overall Study|Parent/Guardian Decision|0
7469343|NCT01922011|11770812|FG000|Overall Study|Lost to Follow-up|0
7469344|NCT01922011|11770813|FG001|Overall Study|Lost to Follow-up|1
7469345|NCT01922011|11770812|FG000|Overall Study|Missed Test-of-Cure Visit|0
7469346|NCT01922011|11770813|FG001|Overall Study|Missed Test-of-Cure Visit|2
7469347|NCT01922011|11770812|FG000|Overall Study|Not Treated|1
7469348|NCT01922011|11770813|FG001|Overall Study|Not Treated|0
7469349|NCT01922011|11770812|FG000|Overall Study|Lack of willing home health agency|1
7469350|NCT01922011|11770813|FG001|Overall Study|Lack of willing home health agency|0
7469351|NCT01922011|11770812|FG000|Overall Study|Randomized in error|1
7257607|NCT00333619|11469650|FG001|Overall Study|Death|6
7257608|NCT00333619|11469649|FG000|Overall Study|Withdrawal by Subject|6
7257609|NCT00333619|11469650|FG001|Overall Study|Withdrawal by Subject|1
7469352|NCT01922011|11770813|FG001|Overall Study|Randomized in error|0
7469353|NCT01922037|11770836|FG000|Overall Study|Withdrawal by Subject|2
7469354|NCT01922037|11770837|FG001|Overall Study|Withdrawal by Subject|44
7469355|NCT01922037|11770836|FG000|Overall Study|Adverse Event|1
7469356|NCT01922037|11770837|FG001|Overall Study|Adverse Event|7
7469357|NCT01922037|11770836|FG000|Overall Study|Death|0
7469358|NCT01922037|11770837|FG001|Overall Study|Death|5
7469359|NCT01922037|11770836|FG000|Overall Study|Pregnancy|0
7469360|NCT01922037|11770837|FG001|Overall Study|Pregnancy|2
7257610|NCT00333619|11469649|FG000|Overall Study|Lost to Follow-up|3
7257611|NCT00333619|11469650|FG001|Overall Study|Lost to Follow-up|3
7257612|NCT00333775|11469674|FG000|Overall Study|Death|144
7257613|NCT00333775|11469675|FG001|Overall Study|Death|149
7257614|NCT00333775|11469676|FG002|Overall Study|Death|143
7257615|NCT00333775|11469674|FG000|Overall Study|In Follow-up When Study Stopped|87
7257616|NCT00333775|11469675|FG001|Overall Study|In Follow-up When Study Stopped|92
7257617|NCT00333775|11469676|FG002|Overall Study|In Follow-up When Study Stopped|96
7257618|NCT00333775|11469674|FG000|Overall Study|Lost to Follow-up|10
7257619|NCT00333775|11469675|FG001|Overall Study|Lost to Follow-up|7
7257620|NCT00333775|11469676|FG002|Overall Study|Lost to Follow-up|8
7257621|NCT00333788|11469684|FG000|Overall Study|Adverse Event|44
7257622|NCT00333788|11469684|FG000|Overall Study|Lack of Efficacy|80
7257623|NCT00333788|11469684|FG000|Overall Study|Lost to Follow-up|2
7257624|NCT00333788|11469684|FG000|Overall Study|Withdrawal by Subject|24
7257625|NCT00333788|11469684|FG000|Overall Study|Other: Non-compliance|2
7257626|NCT00333788|11469684|FG000|Overall Study|Other: Moved|2
7257627|NCT00333788|11469684|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
7257628|NCT00333788|11469684|FG000|Overall Study|Other: Investigator decision|1
7257629|NCT00333788|11469684|FG000|Overall Study|Other: Quality of life concern|1
7257630|NCT00333788|11469684|FG000|Overall Study|Other: Sponsor decision|1
7257631|NCT00333788|11469684|FG000|Overall Study|Other: Subject in need of an Entocort|1
7469361|NCT01922037|11770836|FG000|Overall Study|Participant non-compliance|4
7469362|NCT01922037|11770837|FG001|Overall Study|Participant non-compliance|46
7469363|NCT01922037|11770836|FG000|Overall Study|Investigator/Sponsor decision|1
7469364|NCT01922037|11770837|FG001|Overall Study|Investigator/Sponsor decision|4
7469365|NCT01922037|11770836|FG000|Overall Study|Other unspecified|2
7469366|NCT01922037|11770837|FG001|Overall Study|Other unspecified|66
7469367|NCT01922089|11770904|FG000|Overall Study|Adverse Event|18
7469368|NCT01922089|11770905|FG001|Overall Study|Adverse Event|13
7469369|NCT01922089|11770904|FG000|Overall Study|Protocol Deviation|10
7469370|NCT01922089|11770905|FG001|Overall Study|Protocol Deviation|7
7469371|NCT01922089|11770904|FG000|Overall Study|Withdrawal by Subject|3
7469372|NCT01922089|11770905|FG001|Overall Study|Withdrawal by Subject|4
7469373|NCT01922089|11770904|FG000|Overall Study|administrative problems|4
7469374|NCT01922089|11770905|FG001|Overall Study|administrative problems|1
7469375|NCT01922089|11770904|FG000|Overall Study|Physician Decision|2
7469376|NCT01922089|11770905|FG001|Overall Study|Physician Decision|3
7469377|NCT01922089|11770904|FG000|Overall Study|Death|2
7469378|NCT01922089|11770905|FG001|Overall Study|Death|1
7257632|NCT00333788|11469684|FG000|Overall Study|Other: Medical monitor decision|1
7257633|NCT00333788|11469684|FG000|Overall Study|Other: Physician decision|1
7257634|NCT00333788|11469684|FG000|Overall Study|Other: Signed consent for another study|1
7257635|NCT00333801|11469690|FG000|Overall Study|Moved to another state|5
7257636|NCT00333801|11469691|FG001|Overall Study|Moved to another state|3
7469379|NCT01922089|11770904|FG000|Overall Study|Lost to Follow-up|0
7469380|NCT01922089|11770905|FG001|Overall Study|Lost to Follow-up|1
7469381|NCT01922102|11770914|FG000|Overall Study|Withdrawal by Subject|7
7469382|NCT01922102|11770915|FG001|Overall Study|Withdrawal by Subject|3
7469383|NCT01922102|11770916|FG002|Overall Study|Withdrawal by Subject|7
7469384|NCT01922102|11770914|FG000|Overall Study|Physician Decision|0
7469385|NCT01922102|11770915|FG001|Overall Study|Physician Decision|2
7469386|NCT01922102|11770916|FG002|Overall Study|Physician Decision|1
7469387|NCT01922102|11770914|FG000|Overall Study|Adverse Event|1
7469388|NCT01922102|11770915|FG001|Overall Study|Adverse Event|2
7469389|NCT01922102|11770916|FG002|Overall Study|Adverse Event|0
7469390|NCT01922102|11770914|FG000|Overall Study|Lost to Follow-up|1
7469391|NCT01922102|11770915|FG001|Overall Study|Lost to Follow-up|0
7469392|NCT01922102|11770916|FG002|Overall Study|Lost to Follow-up|0
7469393|NCT01922102|11770914|FG000|Overall Study|Administrative problems|0
7257637|NCT00333801|11469690|FG000|Overall Study|Lost to Follow-up|2
7257638|NCT00333801|11469691|FG001|Overall Study|Lost to Follow-up|0
7257639|NCT00333801|11469690|FG000|Overall Study|Incarcerated|1
7257640|NCT00333801|11469691|FG001|Overall Study|Incarcerated|2
7257641|NCT00333801|11469690|FG000|Overall Study|Withdrawal by Subject|0
7257642|NCT00333801|11469691|FG001|Overall Study|Withdrawal by Subject|1
7257643|NCT00333840|11469712|FG000|First-line Treatment Period|Adverse Event|38
7257644|NCT00333840|11469713|FG001|First-line Treatment Period|Adverse Event|37
7257645|NCT00333840|11469714|FG002|First-line Treatment Period|Adverse Event|0
7257646|NCT00333840|11469715|FG003|First-line Treatment Period|Adverse Event|0
7257647|NCT00333840|11469712|FG000|First-line Treatment Period|Abnormal laboratory values|3
7257648|NCT00333840|11469713|FG001|First-line Treatment Period|Abnormal laboratory values|1
7257649|NCT00333840|11469714|FG002|First-line Treatment Period|Abnormal laboratory values|0
7257650|NCT00333840|11469715|FG003|First-line Treatment Period|Abnormal laboratory values|0
7257651|NCT00333840|11469712|FG000|First-line Treatment Period|Abnormal procedure|2
7257652|NCT00333840|11469713|FG001|First-line Treatment Period|Abnormal procedure|0
7257653|NCT00333840|11469714|FG002|First-line Treatment Period|Abnormal procedure|0
7257654|NCT00333840|11469715|FG003|First-line Treatment Period|Abnormal procedure|0
7469394|NCT01922102|11770915|FG001|Overall Study|Administrative problems|2
7469395|NCT01922102|11770916|FG002|Overall Study|Administrative problems|0
7469396|NCT01922258|11770943|FG000|Overall Study|Lost to Follow-up|1
7469397|NCT01922258|11770944|FG001|Overall Study|Lost to Follow-up|1
7469398|NCT01922258|11770943|FG000|Overall Study|Adverse Event|9
7469399|NCT01922258|11770944|FG001|Overall Study|Adverse Event|2
7469400|NCT01922258|11770943|FG000|Overall Study|Met Withdrawal Criteria|0
7469401|NCT01922258|11770944|FG001|Overall Study|Met Withdrawal Criteria|4
7469402|NCT01922258|11770943|FG000|Overall Study|Withdrawn by the Investigator|1
7469403|NCT01922258|11770944|FG001|Overall Study|Withdrawn by the Investigator|4
7469404|NCT01922258|11770943|FG000|Overall Study|Withdrawal by participant|5
7575553|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
7575554|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
7575555|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
7575556|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
7575557|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
7575558|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
7469405|NCT01922258|11770944|FG001|Overall Study|Withdrawal by participant|5
7469406|NCT01922271|11770952|FG000|WASHOUT Period|Withdrawal by Subject|1
7469407|NCT01922271|11770953|FG001|WASHOUT Period|Withdrawal by Subject|0
7469408|NCT01922349|11770976|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
7469409|NCT01922349|11770977|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
7469410|NCT01922349|11770978|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
7469411|NCT01922349|11770979|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
7469412|NCT01922739|11771015|FG000|Titration/Adjustment Period|Adverse Event|3
7469413|NCT01922739|11771015|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
7469414|NCT01922739|11771015|FG000|Titration/Adjustment Period|Lost to Follow-up|1
7469415|NCT01922739|11771015|FG000|Titration/Adjustment Period|Lack of Efficacy|3
7469416|NCT01922739|11771015|FG000|Open-label Treatment Period|Adverse Event|6
7469417|NCT01922739|11771015|FG000|Open-label Treatment Period|Withdrawal by Subject|14
7469418|NCT01922739|11771015|FG000|Open-label Treatment Period|Noncompliance to study medication|3
7469419|NCT01922739|11771015|FG000|Open-label Treatment Period|Protocol Violation|5
7469420|NCT01922739|11771015|FG000|Open-label Treatment Period|Pregnancy|1
7469421|NCT01922739|11771015|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
7469422|NCT01922739|11771015|FG000|Open-label Treatment Period|Lost to Follow-up|2
7469423|NCT01922739|11771015|FG000|Open-label Treatment Period|Physician Decision|1
7469424|NCT01922739|11771015|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
7469425|NCT01922934|11771033|FG000|Eligible Patients|Death|0
7469426|NCT01922934|11771034|FG001|Eligible Patients|Death|7
7469427|NCT01922934|11771033|FG000|Eligible Patients|Physician Decision|17
7469428|NCT01922934|11771034|FG001|Eligible Patients|Physician Decision|0
7469429|NCT01922934|11771033|FG000|Eligible Patients|Did not meet inclusion criteria|36
7469430|NCT01922934|11771034|FG001|Eligible Patients|Did not meet inclusion criteria|81
7469431|NCT01922934|11771033|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
7469432|NCT01922934|11771034|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
7469433|NCT01922934|11771033|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
7469434|NCT01922934|11771034|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
7257655|NCT00333840|11469712|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
7257656|NCT00333840|11469713|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
7257657|NCT00333840|11469714|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7257658|NCT00333840|11469715|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
7257659|NCT00333840|11469712|FG000|First-line Treatment Period|No longer required study drug|21
7257660|NCT00333840|11469713|FG001|First-line Treatment Period|No longer required study drug|8
7257661|NCT00333840|11469714|FG002|First-line Treatment Period|No longer required study drug|0
7257662|NCT00333840|11469715|FG003|First-line Treatment Period|No longer required study drug|0
7257663|NCT00333840|11469712|FG000|First-line Treatment Period|Protocol Violation|17
7257664|NCT00333840|11469713|FG001|First-line Treatment Period|Protocol Violation|17
7257665|NCT00333840|11469714|FG002|First-line Treatment Period|Protocol Violation|0
7257666|NCT00333840|11469715|FG003|First-line Treatment Period|Protocol Violation|0
7257667|NCT00333840|11469712|FG000|First-line Treatment Period|Subject withdrew consent|57
7257668|NCT00333840|11469713|FG001|First-line Treatment Period|Subject withdrew consent|77
7257669|NCT00333840|11469714|FG002|First-line Treatment Period|Subject withdrew consent|0
7257670|NCT00333840|11469715|FG003|First-line Treatment Period|Subject withdrew consent|0
7257671|NCT00333840|11469712|FG000|First-line Treatment Period|Lost to Follow-up|15
7257672|NCT00333840|11469713|FG001|First-line Treatment Period|Lost to Follow-up|6
7257673|NCT00333840|11469714|FG002|First-line Treatment Period|Lost to Follow-up|0
7469435|NCT01922934|11771033|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
7469436|NCT01922934|11771034|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
7469437|NCT01923181|11771069|FG000|Overall Study|Protocol Violation|2
7469438|NCT01923181|11771070|FG001|Overall Study|Protocol Violation|2
7469439|NCT01923181|11771071|FG002|Overall Study|Protocol Violation|0
7469440|NCT01923181|11771072|FG003|Overall Study|Protocol Violation|2
7469441|NCT01923181|11771073|FG004|Overall Study|Protocol Violation|2
7469442|NCT01923181|11771074|FG005|Overall Study|Protocol Violation|1
7469443|NCT01923181|11771075|FG006|Overall Study|Protocol Violation|1
7469444|NCT01923181|11771076|FG007|Overall Study|Protocol Violation|2
7469445|NCT01923181|11771077|FG008|Overall Study|Protocol Violation|1
7469446|NCT01923181|11771069|FG000|Overall Study|Withdrawal by Subject|0
7469447|NCT01923181|11771070|FG001|Overall Study|Withdrawal by Subject|1
7469448|NCT01923181|11771071|FG002|Overall Study|Withdrawal by Subject|0
7469449|NCT01923181|11771072|FG003|Overall Study|Withdrawal by Subject|1
7469450|NCT01923181|11771073|FG004|Overall Study|Withdrawal by Subject|4
7469451|NCT01923181|11771074|FG005|Overall Study|Withdrawal by Subject|2
7469452|NCT01923181|11771075|FG006|Overall Study|Withdrawal by Subject|4
7469453|NCT01923181|11771076|FG007|Overall Study|Withdrawal by Subject|3
7469454|NCT01923181|11771077|FG008|Overall Study|Withdrawal by Subject|1
7469455|NCT01923181|11771069|FG000|Overall Study|Other|1
7469456|NCT01923181|11771070|FG001|Overall Study|Other|0
7469457|NCT01923181|11771071|FG002|Overall Study|Other|0
7469458|NCT01923181|11771072|FG003|Overall Study|Other|1
7469459|NCT01923181|11771073|FG004|Overall Study|Other|0
7469460|NCT01923181|11771074|FG005|Overall Study|Other|0
7469461|NCT01923181|11771075|FG006|Overall Study|Other|0
7469462|NCT01923181|11771076|FG007|Overall Study|Other|0
7469463|NCT01923181|11771077|FG008|Overall Study|Other|0
7469464|NCT01923181|11771069|FG000|Overall Study|Lost to Follow-up|0
7469465|NCT01923181|11771070|FG001|Overall Study|Lost to Follow-up|3
7469466|NCT01923181|11771071|FG002|Overall Study|Lost to Follow-up|2
7469467|NCT01923181|11771072|FG003|Overall Study|Lost to Follow-up|1
7469468|NCT01923181|11771073|FG004|Overall Study|Lost to Follow-up|2
7469469|NCT01923181|11771074|FG005|Overall Study|Lost to Follow-up|1
7469470|NCT01923181|11771075|FG006|Overall Study|Lost to Follow-up|3
7469471|NCT01923181|11771076|FG007|Overall Study|Lost to Follow-up|3
7469472|NCT01923181|11771077|FG008|Overall Study|Lost to Follow-up|1
7469473|NCT01923285|11771102|FG000|Overall Study|Withdrawal by Subject|7
7469474|NCT01923285|11771103|FG001|Overall Study|Withdrawal by Subject|6
7469475|NCT01923311|11771111|FG000|Overall Study|Pregnancy|1
7469476|NCT01923311|11771112|FG001|Overall Study|Pregnancy|0
7469477|NCT01923311|11771111|FG000|Overall Study|Investigator's Discretion|1
7469478|NCT01923311|11771112|FG001|Overall Study|Investigator's Discretion|0
7469479|NCT01923311|11771111|FG000|Overall Study|Non-Compliance with Study Drug|2
7469480|NCT01923311|11771112|FG001|Overall Study|Non-Compliance with Study Drug|1
7469481|NCT01923311|11771111|FG000|Overall Study|Withdrew Consent|1
7469482|NCT01923311|11771112|FG001|Overall Study|Withdrew Consent|0
7469483|NCT01923311|11771111|FG000|Overall Study|Study Terminated by Sponsor|12
7469484|NCT01923311|11771112|FG001|Overall Study|Study Terminated by Sponsor|0
7469485|NCT01923363|11771119|FG000|Overall Study|Protocol Violation|1
7469486|NCT01923389|11771125|FG000|Overall Study|Protocol Violation|1
7469487|NCT01923389|11771126|FG001|Overall Study|Protocol Violation|0
7469488|NCT01923428|11771137|FG000|Overall Study|Adverse Event|8
7469489|NCT01923428|11771138|FG001|Overall Study|Adverse Event|6
7469490|NCT01923428|11771139|FG002|Overall Study|Adverse Event|3
7469491|NCT01923428|11771140|FG003|Overall Study|Adverse Event|3
7469492|NCT01923428|11771137|FG000|Overall Study|Withdrawal by Subject|5
7469493|NCT01923428|11771138|FG001|Overall Study|Withdrawal by Subject|3
7469494|NCT01923428|11771139|FG002|Overall Study|Withdrawal by Subject|0
7469495|NCT01923428|11771140|FG003|Overall Study|Withdrawal by Subject|4
7469496|NCT01923428|11771137|FG000|Overall Study|Lost to Follow-up|2
7257674|NCT00333840|11469715|FG003|First-line Treatment Period|Lost to Follow-up|0
7257675|NCT00333840|11469712|FG000|First-line Treatment Period|Administrative problems|12
7257676|NCT00333840|11469713|FG001|First-line Treatment Period|Administrative problems|6
7257677|NCT00333840|11469714|FG002|First-line Treatment Period|Administrative problems|0
7257678|NCT00333840|11469715|FG003|First-line Treatment Period|Administrative problems|0
7257679|NCT00333840|11469712|FG000|First-line Treatment Period|Death|19
7257680|NCT00333840|11469713|FG001|First-line Treatment Period|Death|2
7257681|NCT00333840|11469714|FG002|First-line Treatment Period|Death|0
7257682|NCT00333840|11469715|FG003|First-line Treatment Period|Death|0
7257683|NCT00333840|11469712|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
7257684|NCT00333840|11469713|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
7257685|NCT00333840|11469714|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
7257686|NCT00333840|11469715|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
7257687|NCT00333840|11469712|FG000|Second-line Treatment Period|Adverse Event|0
7257688|NCT00333840|11469713|FG001|Second-line Treatment Period|Adverse Event|0
7257689|NCT00333840|11469714|FG002|Second-line Treatment Period|Adverse Event|3
7257690|NCT00333840|11469715|FG003|Second-line Treatment Period|Adverse Event|34
7257691|NCT00333840|11469712|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
7257692|NCT00333840|11469713|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
7257693|NCT00333840|11469714|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
7257694|NCT00333840|11469715|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
7257695|NCT00333840|11469712|FG000|Second-line Treatment Period|Abnormal procedure|0
7257696|NCT00333840|11469713|FG001|Second-line Treatment Period|Abnormal procedure|0
7257697|NCT00333840|11469714|FG002|Second-line Treatment Period|Abnormal procedure|0
7257698|NCT00333840|11469715|FG003|Second-line Treatment Period|Abnormal procedure|1
7257699|NCT00333840|11469712|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7257700|NCT00333840|11469713|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
7257701|NCT00333840|11469714|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
7257702|NCT00333840|11469715|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
7257703|NCT00333840|11469712|FG000|Second-line Treatment Period|No longer required study drug|0
7257704|NCT00333840|11469713|FG001|Second-line Treatment Period|No longer required study drug|0
7257705|NCT00333840|11469714|FG002|Second-line Treatment Period|No longer required study drug|1
7469497|NCT01923428|11771138|FG001|Overall Study|Lost to Follow-up|1
7469498|NCT01923428|11771139|FG002|Overall Study|Lost to Follow-up|5
7469499|NCT01923428|11771140|FG003|Overall Study|Lost to Follow-up|0
7469500|NCT01923428|11771137|FG000|Overall Study|Protocol Violation|3
7469501|NCT01923428|11771138|FG001|Overall Study|Protocol Violation|0
7469502|NCT01923428|11771139|FG002|Overall Study|Protocol Violation|2
7469503|NCT01923428|11771140|FG003|Overall Study|Protocol Violation|1
7469504|NCT01923428|11771137|FG000|Overall Study|Non Compliance to treatment|1
7469505|NCT01923428|11771138|FG001|Overall Study|Non Compliance to treatment|2
7469506|NCT01923428|11771139|FG002|Overall Study|Non Compliance to treatment|0
7469507|NCT01923428|11771140|FG003|Overall Study|Non Compliance to treatment|1
7469508|NCT01923428|11771137|FG000|Overall Study|Lack of Efficacy|0
7469509|NCT01923428|11771138|FG001|Overall Study|Lack of Efficacy|0
7469510|NCT01923428|11771139|FG002|Overall Study|Lack of Efficacy|1
7469511|NCT01923428|11771140|FG003|Overall Study|Lack of Efficacy|1
7469512|NCT01923467|11771150|FG000|Overall Study|Lost to Follow-up|62
7469513|NCT01923467|11771150|FG000|Overall Study|Subject non-interest|479
7469514|NCT01923740|11771156|FG000|Overall Study|Lost to Follow-up|4
7469515|NCT01923740|11771157|FG001|Overall Study|Lost to Follow-up|9
7469516|NCT01923740|11771156|FG000|Overall Study|Withdrawal by Subject|2
7469517|NCT01923740|11771157|FG001|Overall Study|Withdrawal by Subject|0
7469518|NCT01923896|11771174|FG000|Overall Study|Adverse Event|1
7469519|NCT01923896|11771175|FG001|Overall Study|Adverse Event|0
7469520|NCT01924182|11771200|FG000|Overall Study|Withdrawal by Subject|1
7469521|NCT01924182|11771201|FG001|Overall Study|Withdrawal by Subject|0
7469522|NCT01924299|11771209|FG000|Period 2|Withdrawal by Subject|1
7469523|NCT01924299|11771210|FG001|Period 2|Withdrawal by Subject|0
7469524|NCT01924299|11771209|FG000|Period 2|Adverse Event|0
7469525|NCT01924299|11771210|FG001|Period 2|Adverse Event|1
7469526|NCT01924364|11771222|FG000|Overall Study|Physician Decision|3
7469527|NCT01924429|11771248|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
7469528|NCT01924429|11771249|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
7469529|NCT01924689|11771286|FG000|Overall Study|Death|0
7469530|NCT01924689|11771287|FG001|Overall Study|Death|1
7469531|NCT01924689|11771288|FG002|Overall Study|Death|0
7469532|NCT01924689|11771289|FG003|Overall Study|Death|1
7469533|NCT01924689|11771290|FG004|Overall Study|Death|0
7469534|NCT01924689|11771291|FG005|Overall Study|Death|0
7469535|NCT01924689|11771286|FG000|Overall Study|Disease progression|0
7469536|NCT01924689|11771287|FG001|Overall Study|Disease progression|0
7469537|NCT01924689|11771288|FG002|Overall Study|Disease progression|2
7469538|NCT01924689|11771289|FG003|Overall Study|Disease progression|0
7469539|NCT01924689|11771290|FG004|Overall Study|Disease progression|3
7469540|NCT01924689|11771291|FG005|Overall Study|Disease progression|2
7469541|NCT01924689|11771286|FG000|Overall Study|New therapy or study|3
7469542|NCT01924689|11771287|FG001|Overall Study|New therapy or study|2
7469543|NCT01924689|11771288|FG002|Overall Study|New therapy or study|1
7469544|NCT01924689|11771289|FG003|Overall Study|New therapy or study|4
7257706|NCT00333840|11469715|FG003|Second-line Treatment Period|No longer required study drug|14
7257707|NCT00333840|11469712|FG000|Second-line Treatment Period|Protocol Violation|0
7257708|NCT00333840|11469713|FG001|Second-line Treatment Period|Protocol Violation|0
7257709|NCT00333840|11469714|FG002|Second-line Treatment Period|Protocol Violation|1
7257710|NCT00333840|11469715|FG003|Second-line Treatment Period|Protocol Violation|10
7257711|NCT00333840|11469712|FG000|Second-line Treatment Period|Subject withdrew consent|0
7257712|NCT00333840|11469713|FG001|Second-line Treatment Period|Subject withdrew consent|0
7257713|NCT00333840|11469714|FG002|Second-line Treatment Period|Subject withdrew consent|0
7257714|NCT00333840|11469715|FG003|Second-line Treatment Period|Subject withdrew consent|34
7257715|NCT00333840|11469712|FG000|Second-line Treatment Period|Lost to Follow-up|0
7257716|NCT00333840|11469713|FG001|Second-line Treatment Period|Lost to Follow-up|0
7257717|NCT00333840|11469714|FG002|Second-line Treatment Period|Lost to Follow-up|0
7257718|NCT00333840|11469715|FG003|Second-line Treatment Period|Lost to Follow-up|6
7257719|NCT00333840|11469712|FG000|Second-line Treatment Period|Administrative problems|0
7257720|NCT00333840|11469713|FG001|Second-line Treatment Period|Administrative problems|0
7257721|NCT00333840|11469714|FG002|Second-line Treatment Period|Administrative problems|0
7257722|NCT00333840|11469715|FG003|Second-line Treatment Period|Administrative problems|7
7257723|NCT00333840|11469712|FG000|Second-line Treatment Period|Death|0
7257724|NCT00333840|11469713|FG001|Second-line Treatment Period|Death|0
7257725|NCT00333840|11469714|FG002|Second-line Treatment Period|Death|0
7257726|NCT00333840|11469715|FG003|Second-line Treatment Period|Death|9
7257727|NCT00333866|11469733|FG000|Overall Study|Adverse Event|23
7257728|NCT00333866|11469734|FG001|Overall Study|Adverse Event|37
7257729|NCT00333866|11469735|FG002|Overall Study|Adverse Event|38
7257730|NCT00333866|11469736|FG003|Overall Study|Adverse Event|47
7257731|NCT00333866|11469733|FG000|Overall Study|Other|3
7257732|NCT00333866|11469734|FG001|Overall Study|Other|2
7257733|NCT00333866|11469735|FG002|Overall Study|Other|2
7257734|NCT00333866|11469736|FG003|Overall Study|Other|2
7257735|NCT00333866|11469733|FG000|Overall Study|Lack of Efficacy|8
7257736|NCT00333866|11469734|FG001|Overall Study|Lack of Efficacy|6
7257737|NCT00333866|11469735|FG002|Overall Study|Lack of Efficacy|3
7257738|NCT00333866|11469736|FG003|Overall Study|Lack of Efficacy|5
7257739|NCT00333866|11469733|FG000|Overall Study|Lost to Follow-up|1
7257740|NCT00333866|11469734|FG001|Overall Study|Lost to Follow-up|2
7257741|NCT00333866|11469735|FG002|Overall Study|Lost to Follow-up|2
7257742|NCT00333866|11469736|FG003|Overall Study|Lost to Follow-up|2
7257743|NCT00333866|11469733|FG000|Overall Study|Withdrawal by Subject|8
7257744|NCT00333866|11469734|FG001|Overall Study|Withdrawal by Subject|14
7257745|NCT00333866|11469735|FG002|Overall Study|Withdrawal by Subject|4
7469545|NCT01924689|11771290|FG004|Overall Study|New therapy or study|2
7469546|NCT01924689|11771291|FG005|Overall Study|New therapy or study|0
7469547|NCT01924689|11771286|FG000|Overall Study|Withdrawal of consent|0
7469548|NCT01924689|11771287|FG001|Overall Study|Withdrawal of consent|0
7469549|NCT01924689|11771288|FG002|Overall Study|Withdrawal of consent|1
7469550|NCT01924689|11771289|FG003|Overall Study|Withdrawal of consent|1
7469551|NCT01924689|11771290|FG004|Overall Study|Withdrawal of consent|0
7469552|NCT01924689|11771291|FG005|Overall Study|Withdrawal of consent|0
7469553|NCT01924689|11771286|FG000|Overall Study|Other|0
7469554|NCT01924689|11771287|FG001|Overall Study|Other|0
7469555|NCT01924689|11771288|FG002|Overall Study|Other|0
7469556|NCT01924689|11771289|FG003|Overall Study|Other|0
7469557|NCT01924689|11771290|FG004|Overall Study|Other|1
7469558|NCT01924689|11771291|FG005|Overall Study|Other|0
7469559|NCT01924754|11771312|FG000|Overall Study|Lost to Follow-up|1
7469560|NCT01924754|11771313|FG001|Overall Study|Lost to Follow-up|2
7257746|NCT00333866|11469736|FG003|Overall Study|Withdrawal by Subject|9
7257747|NCT00333866|11469733|FG000|Overall Study|Randomized but not Treated|5
7257748|NCT00333866|11469734|FG001|Overall Study|Randomized but not Treated|3
7257749|NCT00333866|11469735|FG002|Overall Study|Randomized but not Treated|2
7257750|NCT00333866|11469736|FG003|Overall Study|Randomized but not Treated|1
7257751|NCT00333970|11469752|FG000|Overall Study|Withdrawal by Subject|13
7257752|NCT00333970|11469753|FG001|Overall Study|Withdrawal by Subject|7
7469561|NCT01924754|11771314|FG002|Overall Study|Lost to Follow-up|1
7469562|NCT01924754|11771312|FG000|Overall Study|Pregnancy|0
7469563|NCT01924754|11771313|FG001|Overall Study|Pregnancy|1
7469564|NCT01924754|11771314|FG002|Overall Study|Pregnancy|2
7469565|NCT01924767|11771330|FG000|Overall Study|Adverse Event|1
7469566|NCT01924767|11771331|FG001|Overall Study|Adverse Event|0
7469567|NCT01924767|11771332|FG002|Overall Study|Adverse Event|1
7257753|NCT00333983|11469762|FG000|Overall Study|Lost to Follow-up|2
7257754|NCT00333983|11469763|FG001|Overall Study|Lost to Follow-up|1
7257755|NCT00333983|11469764|FG002|Overall Study|Lost to Follow-up|0
7257756|NCT00333983|11469762|FG000|Overall Study|Adverse Event|1
7257757|NCT00333983|11469763|FG001|Overall Study|Adverse Event|1
7257758|NCT00333983|11469764|FG002|Overall Study|Adverse Event|1
7257759|NCT00333983|11469762|FG000|Overall Study|Withdrawal by Subject|0
7257760|NCT00333983|11469763|FG001|Overall Study|Withdrawal by Subject|3
7257761|NCT00333983|11469764|FG002|Overall Study|Withdrawal by Subject|1
7387825|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
7387826|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
7387827|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
7387828|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
7387829|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
7387830|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
7387831|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
7387832|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
7387833|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
7387834|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
7387835|NCT01216072|11646542|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
7387836|NCT01216072|11646543|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
7387837|NCT01216072|11646542|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
7387838|NCT01216072|11646543|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
7387839|NCT01216072|11646542|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
7257792|NCT00334802|11469848|FG000|Overall Study|Lack of Efficacy|1
7387840|NCT01216072|11646543|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
7387841|NCT01216072|11646542|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
7387842|NCT01216072|11646543|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
7387843|NCT01216163|11646555|FG000|Overall Study|Withdrawal by Subject|1
7469568|NCT01924767|11771333|FG003|Overall Study|Adverse Event|0
7469569|NCT01924767|11771334|FG004|Overall Study|Adverse Event|0
7469570|NCT01924806|11771353|FG000|Overall Study|Physician Decision|2
7469571|NCT01924806|11771354|FG001|Overall Study|Physician Decision|1
7469572|NCT01924845|11771360|FG000|Overall Study|Adverse Event|3
7469573|NCT01924845|11771360|FG000|Overall Study|Withdrawal by Subject|2
7469574|NCT01924845|11771360|FG000|Overall Study|Protocol Violation|1
7469575|NCT01925014|11771395|FG000|Overall Study|Inappropriate enrollment|4
7469576|NCT01925014|11771396|FG001|Overall Study|Inappropriate enrollment|6
7469577|NCT01925014|11771395|FG000|Overall Study|Withdrawal by Subject|5
7469578|NCT01925014|11771396|FG001|Overall Study|Withdrawal by Subject|13
7575559|NCT03789292|11959254|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
7575560|NCT03789292|11959255|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
7575561|NCT03789292|11959256|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
7575562|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
7575563|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
7575564|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
7575565|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
7575566|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
7575567|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
7575568|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
7575569|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
7575570|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
7575571|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
7575572|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
7575573|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
7575574|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
7575575|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
7387844|NCT01216163|11646556|FG001|Overall Study|Withdrawal by Subject|1
7387845|NCT01216163|11646557|FG002|Overall Study|Withdrawal by Subject|0
7387846|NCT01216176|11646568|FG000|Overall Study|Adverse Event|0
7387847|NCT01216176|11646569|FG001|Overall Study|Adverse Event|8
7387848|NCT01216176|11646570|FG002|Overall Study|Adverse Event|0
7387849|NCT01216176|11646568|FG000|Overall Study|Physician Decision|0
7469579|NCT01925170|11771409|FG000|Overall Study|Unverified cancer status|53
7469580|NCT01925183|11771417|FG000|Overall Study|Adverse Event|1
7469581|NCT01925183|11771418|FG001|Overall Study|Adverse Event|0
7469582|NCT01925209|11771428|FG000|Treatment Epoch|Physician Decision|1
7469583|NCT01925209|11771429|FG001|Treatment Epoch|Physician Decision|0
7469584|NCT01925209|11771430|FG002|Treatment Epoch|Physician Decision|0
7469585|NCT01925209|11771431|FG003|Treatment Epoch|Physician Decision|0
7469586|NCT01925209|11771428|FG000|Treatment Epoch|Non-compliance with study treatment|0
7469587|NCT01925209|11771429|FG001|Treatment Epoch|Non-compliance with study treatment|0
7469588|NCT01925209|11771430|FG002|Treatment Epoch|Non-compliance with study treatment|0
7469589|NCT01925209|11771431|FG003|Treatment Epoch|Non-compliance with study treatment|1
7257762|NCT00334113|11469783|FG000|Overall Study|Lost to Follow-up|2
7257763|NCT00334113|11469784|FG001|Overall Study|Lost to Follow-up|2
7257764|NCT00334113|11469783|FG000|Overall Study|Withdrawal by Subject|0
7257765|NCT00334113|11469784|FG001|Overall Study|Withdrawal by Subject|1
7257766|NCT00334282|11469797|FG000|Overall Study|Lost to Follow-up|11
7257767|NCT00334282|11469798|FG001|Overall Study|Lost to Follow-up|5
7257768|NCT00334282|11469797|FG000|Overall Study|Withdrawal by Subject|17
7257769|NCT00334282|11469798|FG001|Overall Study|Withdrawal by Subject|3
7257770|NCT00334282|11469797|FG000|Overall Study|Death|194
7257771|NCT00334282|11469798|FG001|Overall Study|Death|100
7257772|NCT00334295|11469808|FG000|Overall Study|Patients received fewer than 3 injection|5
7257773|NCT00334542|11469812|FG000|Overall Study|Adverse Event|3
7257774|NCT00334542|11469812|FG000|Overall Study|Withdrawal by Subject|1
7257775|NCT00334542|11469812|FG000|Overall Study|New cancer diagnosis|1
7257776|NCT00334737|11469836|FG000|Hospital Phase|Death|1
7257777|NCT00334737|11469837|FG001|Hospital Phase|Death|2
7257778|NCT00334737|11469838|FG002|Hospital Phase|Death|3
7257779|NCT00334737|11469836|FG000|Hospital Phase|Withdrawal by Subject|0
7257780|NCT00334737|11469837|FG001|Hospital Phase|Withdrawal by Subject|0
7257781|NCT00334737|11469838|FG002|Hospital Phase|Withdrawal by Subject|1
7257782|NCT00334737|11469836|FG000|Hospital Phase|Did not receive study drug|1
7257783|NCT00334737|11469837|FG001|Hospital Phase|Did not receive study drug|0
7257784|NCT00334737|11469838|FG002|Hospital Phase|Did not receive study drug|0
7257785|NCT00334737|11469836|FG000|Follow up Phase|Lost to Follow-up|5
7257786|NCT00334737|11469837|FG001|Follow up Phase|Lost to Follow-up|3
7257787|NCT00334737|11469838|FG002|Follow up Phase|Lost to Follow-up|6
7257788|NCT00334802|11469848|FG000|Overall Study|Progressive Disease|2
7257789|NCT00334802|11469849|FG001|Overall Study|Progressive Disease|24
7257790|NCT00334802|11469848|FG000|Overall Study|Toxicity|1
7257791|NCT00334802|11469849|FG001|Overall Study|Toxicity|5
7257793|NCT00334802|11469849|FG001|Overall Study|Lack of Efficacy|3
7257794|NCT00334802|11469848|FG000|Overall Study|Patient Condition Aggrevated|1
7257795|NCT00334802|11469849|FG001|Overall Study|Patient Condition Aggrevated|0
7469590|NCT01925209|11771428|FG000|Treatment Epoch|Death|1
7469591|NCT01925209|11771429|FG001|Treatment Epoch|Death|0
7469592|NCT01925209|11771430|FG002|Treatment Epoch|Death|0
7469593|NCT01925209|11771431|FG003|Treatment Epoch|Death|0
7469594|NCT01925209|11771428|FG000|Treatment Epoch|Protocol deviation|0
7469595|NCT01925209|11771429|FG001|Treatment Epoch|Protocol deviation|0
7537982|NCT01705977|11887122|FG001|Overall Study|Site closure|2
7537983|NCT01705977|11887121|FG000|Overall Study|Lost to Follow-up|33
7537984|NCT01705977|11887122|FG001|Overall Study|Lost to Follow-up|37
7537985|NCT01705977|11887121|FG000|Overall Study|Physician Decision|48
7537986|NCT01705977|11887122|FG001|Overall Study|Physician Decision|38
7537987|NCT01705977|11887121|FG000|Overall Study|Missing study conclusion form|2
7537988|NCT01705977|11887122|FG001|Overall Study|Missing study conclusion form|2
7575576|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
7575577|NCT03789292|11959254|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
7575578|NCT03789292|11959255|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
7575579|NCT03789292|11959256|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
7575580|NCT03805438|11959283|FG000|Overall Study|Lack of Efficacy|1
7575581|NCT03805438|11959283|FG000|Overall Study|Protocol Violation|1
7575582|NCT03817528|11959295|FG000|Overall Study|Withdrawal by Subject|1
7575583|NCT03817528|11959295|FG000|Overall Study|Adverse Event|2
7257796|NCT00334802|11469848|FG000|Overall Study|Physician Decision|1
7257797|NCT00334802|11469849|FG001|Overall Study|Physician Decision|0
7257798|NCT00334802|11469848|FG000|Overall Study|Withdrawal by Subject|0
7257799|NCT00334802|11469849|FG001|Overall Study|Withdrawal by Subject|4
7469596|NCT01925209|11771430|FG002|Treatment Epoch|Protocol deviation|1
7469597|NCT01925209|11771431|FG003|Treatment Epoch|Protocol deviation|1
7469598|NCT01925209|11771428|FG000|Treatment Epoch|Withdrawal by Subject|4
7469599|NCT01925209|11771429|FG001|Treatment Epoch|Withdrawal by Subject|3
7469600|NCT01925209|11771430|FG002|Treatment Epoch|Withdrawal by Subject|3
7469601|NCT01925209|11771431|FG003|Treatment Epoch|Withdrawal by Subject|2
7469602|NCT01925209|11771428|FG000|Treatment Epoch|Adverse Event|3
7469603|NCT01925209|11771429|FG001|Treatment Epoch|Adverse Event|5
7469604|NCT01925209|11771430|FG002|Treatment Epoch|Adverse Event|3
7469605|NCT01925209|11771431|FG003|Treatment Epoch|Adverse Event|1
7469606|NCT01925209|11771428|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
7469607|NCT01925209|11771429|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
7469608|NCT01925209|11771430|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
7469609|NCT01925209|11771431|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
7469610|NCT01925209|11771428|FG000|Maintenance Treatment Epoch|Adverse Event|0
7469611|NCT01925209|11771429|FG001|Maintenance Treatment Epoch|Adverse Event|0
7469612|NCT01925209|11771430|FG002|Maintenance Treatment Epoch|Adverse Event|1
7469613|NCT01925209|11771431|FG003|Maintenance Treatment Epoch|Adverse Event|0
7538005|NCT01366092|11887161|FG000|Overall Study|Progressive cGVHD|2
7538006|NCT01366092|11887161|FG000|Overall Study|Physician Decision|1
7538007|NCT01366092|11887161|FG000|Overall Study|Withdrawal by Subject|1
7538016|NCT01222247|11887171|FG000|Overall Study|Lost to Follow-up|2
7538017|NCT01222247|11887172|FG001|Overall Study|Lost to Follow-up|2
7538045|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
7538046|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
7538047|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
7538048|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
7538049|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Adverse Event|198
7538050|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Adverse Event|0
7538051|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Adverse Event|0
7538052|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Adverse Event|0
7538053|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Death|62
7538054|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Death|0
7538055|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Death|0
7538056|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Death|0
7538057|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
7538058|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
7538059|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
7538060|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
7538061|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Complicating disease|13
7538062|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Complicating disease|0
7538063|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Complicating disease|0
7538064|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Complicating disease|0
7538065|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Alternative therapy|12
7538066|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Alternative therapy|0
7538067|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Alternative therapy|0
7538068|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Alternative therapy|0
7538069|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
7538070|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
7538071|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
7538072|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
7538073|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Non-compliance|4
7538074|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Non-compliance|0
7538075|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Non-compliance|0
7538076|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Non-compliance|0
7538077|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Pain|4
7538078|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Pain|0
7538079|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Pain|0
7538080|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Pain|0
7538081|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Protocol Violation|1
7538082|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Protocol Violation|0
7538083|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Protocol Violation|0
7538084|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Protocol Violation|0
7538085|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Hospice care|1
7538086|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Hospice care|0
7538087|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Hospice care|0
7538088|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Hospice care|0
7538089|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Physician Decision|1
7538090|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Physician Decision|0
7538091|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Physician Decision|0
7538092|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Physician Decision|0
7538093|NCT01107626|11887215|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
7538094|NCT01107626|11887216|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
7538095|NCT01107626|11887217|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
7538096|NCT01107626|11887218|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
7538097|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
7538098|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
7538099|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
7538100|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
7538101|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Adverse Event|0
7538102|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Adverse Event|32
7538103|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Adverse Event|29
7538104|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Adverse Event|46
7538105|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Death|0
7538106|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Death|8
7538107|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Death|2
7538108|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Death|13
7538109|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
7538110|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
7538111|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
7538112|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
7538113|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
7538114|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
7538115|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
7538116|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
7538117|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
7538118|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
7538119|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
7538120|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
7538121|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
7538122|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
7538123|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
7538124|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
7575584|NCT03829228|11959322|FG000|Overall Study|Protocol Violation|1
7575585|NCT03830333|11959341|FG000|Overall Study|Death|0
7575586|NCT03830333|11959342|FG001|Overall Study|Death|1
7575587|NCT03830333|11959341|FG000|Overall Study|Withdrawal by Subject|5
7575588|NCT03830333|11959342|FG001|Overall Study|Withdrawal by Subject|1
7575589|NCT03830333|11959341|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
7575590|NCT03830333|11959342|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
7575591|NCT03831880|11959350|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
7575592|NCT03831880|11959351|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
7575593|NCT03831880|11959350|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
7538125|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
7538126|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7538127|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
7538128|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
7538129|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7538130|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7538131|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
7538132|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
7538133|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Financial reason|0
7538134|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Financial reason|2
7538135|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Financial reason|0
7538136|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Financial reason|0
7538137|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Physician Decision|0
7538138|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Physician Decision|2
7538139|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Physician Decision|3
7538140|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Physician Decision|3
7538141|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Hospice care|0
7538142|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Hospice care|1
7538143|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Hospice care|2
7538144|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Hospice care|0
7538145|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Non-compliance|0
7538146|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Non-compliance|0
7575594|NCT03831880|11959351|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
7538147|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Non-compliance|0
7538148|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Non-compliance|2
7538149|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Pain|0
7538150|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Pain|0
7538151|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Pain|0
7538152|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Pain|1
7538153|NCT01107626|11887215|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
7538154|NCT01107626|11887216|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7538155|NCT01107626|11887217|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
7538156|NCT01107626|11887218|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
7538167|NCT00920387|11887233|FG000|Stage 1|Adverse Event|1
7538168|NCT00920387|11887234|FG001|Stage 1|Adverse Event|0
7538169|NCT00920387|11887235|FG002|Stage 1|Adverse Event|0
7552105|NCT02980692|11911737|FG002|Overall Study|RELOCATION|0
7552106|NCT02980692|11911738|FG003|Overall Study|RELOCATION|0
7552107|NCT02980692|11911739|FG004|Overall Study|RELOCATION|1
7538216|NCT04526574|11887332|FG000|Overall Study|Protocol Violation|3
7538217|NCT04526574|11887333|FG001|Overall Study|Protocol Violation|1
7538218|NCT04526574|11887332|FG000|Overall Study|Withdrawal by Subject|12
7538219|NCT04526574|11887333|FG001|Overall Study|Withdrawal by Subject|9
7538220|NCT04526574|11887332|FG000|Overall Study|Other|1
7538221|NCT04526574|11887333|FG001|Overall Study|Other|2
7538222|NCT04526574|11887332|FG000|Overall Study|Adverse Event|1
7538223|NCT04526574|11887333|FG001|Overall Study|Adverse Event|1
7538224|NCT04526574|11887332|FG000|Overall Study|Death|2
7538225|NCT04526574|11887333|FG001|Overall Study|Death|3
7538226|NCT04526574|11887332|FG000|Overall Study|Lost to Follow-up|9
7538227|NCT04526574|11887333|FG001|Overall Study|Lost to Follow-up|9
7538228|NCT04526574|11887332|FG000|Overall Study|No longer meets eligibility criteria|8
7538229|NCT04526574|11887333|FG001|Overall Study|No longer meets eligibility criteria|8
7538230|NCT04345367|11887349|FG000|Overall Study|Other|3
7538231|NCT04345367|11887350|FG001|Overall Study|Other|4
7538232|NCT04345367|11887349|FG000|Overall Study|Medication Error Without Associated Adverse Event|1
7538233|NCT04345367|11887350|FG001|Overall Study|Medication Error Without Associated Adverse Event|0
7538234|NCT04345367|11887349|FG000|Overall Study|Withdrawal by Subject|11
7538235|NCT04345367|11887350|FG001|Overall Study|Withdrawal by Subject|11
7538236|NCT04345367|11887349|FG000|Overall Study|Protocol Violation|4
7538237|NCT04345367|11887350|FG001|Overall Study|Protocol Violation|3
7538238|NCT04345367|11887349|FG000|Overall Study|Lost to Follow-up|2
7538239|NCT04345367|11887350|FG001|Overall Study|Lost to Follow-up|4
7538240|NCT04345367|11887349|FG000|Overall Study|Lack of Efficacy|2
7538241|NCT04345367|11887350|FG001|Overall Study|Lack of Efficacy|0
7538242|NCT04345367|11887349|FG000|Overall Study|Death|2
7538243|NCT04345367|11887350|FG001|Overall Study|Death|0
7538244|NCT04345367|11887349|FG000|Overall Study|Adverse Event|10
7538245|NCT04345367|11887350|FG001|Overall Study|Adverse Event|9
7538260|NCT04048382|11887417|FG000|3-Month Follow Up|Enrolled but did not complete survey|2
7538261|NCT04048382|11887418|FG001|3-Month Follow Up|Enrolled but did not complete survey|0
7538262|NCT04048382|11887417|FG000|3-Month Follow Up|Withdrawal by Subject|0
7538263|NCT04048382|11887418|FG001|3-Month Follow Up|Withdrawal by Subject|1
7538264|NCT04048382|11887417|FG000|6-Month Follow up|Enrolled but did not complete survey|2
7538265|NCT04048382|11887418|FG001|6-Month Follow up|Enrolled but did not complete survey|0
7538266|NCT03928821|11887428|FG000|Overall Study|Death|0
7538267|NCT03928821|11887429|FG001|Overall Study|Death|1
7538268|NCT03928821|11887430|FG002|Overall Study|Death|0
7538269|NCT03928821|11887431|FG003|Overall Study|Death|0
7538270|NCT03928821|11887428|FG000|Overall Study|Lost to Follow-up|0
7538271|NCT03928821|11887429|FG001|Overall Study|Lost to Follow-up|2
7538272|NCT03928821|11887430|FG002|Overall Study|Lost to Follow-up|3
7538273|NCT03928821|11887431|FG003|Overall Study|Lost to Follow-up|0
7538274|NCT03928821|11887428|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7538275|NCT03928821|11887429|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7538276|NCT03928821|11887430|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
7538277|NCT03928821|11887431|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
7538278|NCT03856996|11887443|FG000|Overall Study|Withdrawal by Subject|1
7538279|NCT03856996|11887444|FG001|Overall Study|Withdrawal by Subject|0
7538280|NCT03856996|11887443|FG000|Overall Study|Lost to Follow-up|0
7538281|NCT03856996|11887444|FG001|Overall Study|Lost to Follow-up|1
7538282|NCT03856996|11887443|FG000|Overall Study|Adverse Event|1
7538283|NCT03856996|11887444|FG001|Overall Study|Adverse Event|1
7538284|NCT03856996|11887443|FG000|Overall Study|Other|1
7538285|NCT03856996|11887444|FG001|Overall Study|Other|0
7575595|NCT03831945|11959361|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7575596|NCT03831945|11959362|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
7575597|NCT03831945|11959361|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7575598|NCT03831945|11959362|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
7575599|NCT03831945|11959361|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
7575600|NCT03831945|11959362|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
7575601|NCT03840174|11959381|FG000|Overall Study|Withdrawal by Subject|1
7575602|NCT03840174|11959382|FG001|Overall Study|Withdrawal by Subject|0
7575603|NCT03840174|11959383|FG002|Overall Study|Withdrawal by Subject|0
7575604|NCT03840174|11959384|FG003|Overall Study|Withdrawal by Subject|0
7575605|NCT03857841|11959413|FG000|Overall Study|Death|1
7575606|NCT03857841|11959414|FG001|Overall Study|Death|0
7575607|NCT03857841|11959415|FG002|Overall Study|Death|0
7575608|NCT03857841|11959416|FG003|Overall Study|Death|0
7575609|NCT03857841|11959413|FG000|Overall Study|Study Terminated by Sponsor|1
7575610|NCT03857841|11959414|FG001|Overall Study|Study Terminated by Sponsor|0
7575611|NCT03857841|11959415|FG002|Overall Study|Study Terminated by Sponsor|0
7575612|NCT03857841|11959416|FG003|Overall Study|Study Terminated by Sponsor|0
7575613|NCT03862625|11959441|FG000|Overall Study|Lost to Follow-up|0
7575614|NCT03862625|11959442|FG001|Overall Study|Lost to Follow-up|1
7575615|NCT03877224|11959470|FG000|Overall Study|Death|3
7575616|NCT03877224|11959471|FG001|Overall Study|Death|2
7575617|NCT03877224|11959470|FG000|Overall Study|Withdrawal by Subject|1
7575618|NCT03877224|11959471|FG001|Overall Study|Withdrawal by Subject|6
7575619|NCT03877224|11959470|FG000|Overall Study|Participant is alive, just unable to come for visits|1
7575620|NCT03877224|11959471|FG001|Overall Study|Participant is alive, just unable to come for visits|0
7575621|NCT03885596|11959490|FG000|Overall Study|Withdrawal by Subject|2
7575622|NCT03885596|11959491|FG001|Overall Study|Withdrawal by Subject|1
7575623|NCT03885596|11959492|FG002|Overall Study|Withdrawal by Subject|0
7575624|NCT03885596|11959493|FG003|Overall Study|Withdrawal by Subject|0
7575625|NCT03885661|11959508|FG000|Overall Study|Withdrawal by Subject|0
7575626|NCT03885661|11959509|FG001|Overall Study|Withdrawal by Subject|1
7575627|NCT03885661|11959508|FG000|Overall Study|Unwilling to undergo required study procedure|1
7575628|NCT03885661|11959509|FG001|Overall Study|Unwilling to undergo required study procedure|0
7575629|NCT03886493|11959515|FG000|Overall Study|Adverse Event|1
7575630|NCT03888235|11959522|FG000|Overall Study|Lost to Follow-up|1
7575631|NCT03888235|11959523|FG001|Overall Study|Lost to Follow-up|1
7575632|NCT03888235|11959524|FG002|Overall Study|Lost to Follow-up|0
7575633|NCT03900416|11959580|FG000|Six Week Follow-up|Lost to Follow-up|1
7575634|NCT03900416|11959581|FG001|Six Week Follow-up|Lost to Follow-up|0
7575635|NCT03900416|11959580|FG000|Six Week Follow-up|Withdrawal by Subject|1
7575636|NCT03900416|11959581|FG001|Six Week Follow-up|Withdrawal by Subject|0
7575637|NCT03900416|11959580|FG000|Twelve Week Follow-up|Lost to Follow-up|0
7575638|NCT03900416|11959581|FG001|Twelve Week Follow-up|Lost to Follow-up|2
7575639|NCT03900416|11959580|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
7575640|NCT03900416|11959581|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
7575641|NCT03900416|11959580|FG000|Twelve Week Follow-up|Adverse Event|1
7575642|NCT03900416|11959581|FG001|Twelve Week Follow-up|Adverse Event|1
7575643|NCT03900416|11959580|FG000|Six Month Follow-up|Lost to Follow-up|4
7575644|NCT03900416|11959581|FG001|Six Month Follow-up|Lost to Follow-up|3
7575645|NCT03900416|11959580|FG000|Six Month Follow-up|Withdrawal by Subject|1
7575646|NCT03900416|11959581|FG001|Six Month Follow-up|Withdrawal by Subject|1
7575647|NCT03905863|11959589|FG000|Overall Study|Adverse Event|2
7575648|NCT03905863|11959590|FG001|Overall Study|Adverse Event|4
7575649|NCT03905863|11959589|FG000|Overall Study|Withdrawal by Subject|2
7575650|NCT03905863|11959590|FG001|Overall Study|Withdrawal by Subject|2
7575651|NCT03905863|11959589|FG000|Overall Study|Physician Decision|0
7575652|NCT03905863|11959590|FG001|Overall Study|Physician Decision|3
7575653|NCT03905863|11959589|FG000|Overall Study|Lost to Follow-up|1
7575654|NCT03905863|11959590|FG001|Overall Study|Lost to Follow-up|0
7575655|NCT03905863|11959589|FG000|Overall Study|Protocol Violation|0
7575656|NCT03905863|11959590|FG001|Overall Study|Protocol Violation|2
7575657|NCT03905863|11959589|FG000|Overall Study|Death|0
7575658|NCT03905863|11959590|FG001|Overall Study|Death|1
7575659|NCT03909971|11959607|FG000|Overall Study|Other Reasons Not Specified|0
7575660|NCT03909971|11959608|FG001|Overall Study|Other Reasons Not Specified|1
7575661|NCT03909971|11959607|FG000|Overall Study|Global Deterioration of Health Status|2
7538358|NCT03282123|11887583|FG000|Overall Study|Withdrawal by Subject|5
7538359|NCT03199391|11887588|FG000|Overall Study|Death|1
7538360|NCT03199391|11887588|FG000|Overall Study|Lost to Follow-up|3
7538361|NCT03199391|11887588|FG000|Overall Study|Adverse Event|2
7538362|NCT03199391|11887588|FG000|Overall Study|Withdrawal by Subject|10
7538371|NCT03122886|11887598|FG000|Overall Study|Withdrawal by Subject|1
7538372|NCT03122886|11887599|FG001|Overall Study|Withdrawal by Subject|2
7538373|NCT03042611|11887607|FG000|Core Phase|Withdrawal by Subject|13
7538374|NCT03042611|11887608|FG001|Core Phase|Withdrawal by Subject|4
7538375|NCT03042611|11887609|FG002|Core Phase|Withdrawal by Subject|0
7538376|NCT03042611|11887610|FG003|Core Phase|Withdrawal by Subject|0
7538377|NCT03042611|11887607|FG000|Core Phase|Death|232
7538378|NCT03042611|11887608|FG001|Core Phase|Death|110
7538379|NCT03042611|11887609|FG002|Core Phase|Death|0
7538380|NCT03042611|11887610|FG003|Core Phase|Death|0
7257800|NCT00334802|11469848|FG000|Overall Study|Adverse Event|0
7538381|NCT03042611|11887607|FG000|Core Phase|Lost to Follow-up|4
7538382|NCT03042611|11887608|FG001|Core Phase|Lost to Follow-up|7
7538383|NCT03042611|11887609|FG002|Core Phase|Lost to Follow-up|0
7538384|NCT03042611|11887610|FG003|Core Phase|Lost to Follow-up|0
7538385|NCT03042611|11887607|FG000|Core Phase|Physician Decision|7
7538386|NCT03042611|11887608|FG001|Core Phase|Physician Decision|2
7538387|NCT03042611|11887609|FG002|Core Phase|Physician Decision|0
7538388|NCT03042611|11887610|FG003|Core Phase|Physician Decision|0
7538389|NCT03042611|11887607|FG000|Core Phase|Study Closed|0
7538390|NCT03042611|11887608|FG001|Core Phase|Study Closed|1
7538391|NCT03042611|11887609|FG002|Core Phase|Study Closed|0
7538392|NCT03042611|11887610|FG003|Core Phase|Study Closed|0
7538393|NCT03042611|11887607|FG000|Extension Phase|Death|0
7538394|NCT03042611|11887608|FG001|Extension Phase|Death|0
7538395|NCT03042611|11887609|FG002|Extension Phase|Death|34
7538396|NCT03042611|11887610|FG003|Extension Phase|Death|16
7538397|NCT03042611|11887607|FG000|Extension Phase|Lost to Follow-up|0
7538398|NCT03042611|11887608|FG001|Extension Phase|Lost to Follow-up|0
7538399|NCT03042611|11887609|FG002|Extension Phase|Lost to Follow-up|1
7538400|NCT03042611|11887610|FG003|Extension Phase|Lost to Follow-up|1
7538401|NCT03042611|11887607|FG000|Extension Phase|Study Closed|0
7538402|NCT03042611|11887608|FG001|Extension Phase|Study Closed|0
7538403|NCT03042611|11887609|FG002|Extension Phase|Study Closed|17
7538404|NCT03042611|11887610|FG003|Extension Phase|Study Closed|11
7538405|NCT03041181|11887618|FG000|Overall Study|Disease Progression|1
7538406|NCT03041181|11887619|FG001|Overall Study|Disease Progression|2
7538407|NCT03017742|11887625|FG000|Overall Study|Protocol Violation|36
7538408|NCT03017742|11887625|FG000|Overall Study|Withdrawal by Subject|37
7538409|NCT02941926|11887633|FG000|Overall Study|Progressive disease|1109
7538410|NCT02941926|11887633|FG000|Overall Study|Adverse Event|504
7538411|NCT02941926|11887633|FG000|Overall Study|Subject/guardian decision|127
7538412|NCT02941926|11887633|FG000|Overall Study|Physician Decision|112
7538413|NCT02941926|11887633|FG000|Overall Study|Death|46
7538414|NCT02941926|11887633|FG000|Overall Study|Protocol deviation|34
7538415|NCT02941926|11887633|FG000|Overall Study|Lost to Follow-up|8
7538416|NCT02941926|11887633|FG000|Overall Study|Technical problems|5
7538417|NCT02879448|11887641|FG000|Overall Study|No implant attempt|17
7538418|NCT02879448|11887642|FG001|Overall Study|No implant attempt|28
7538419|NCT02879448|11887641|FG000|Overall Study|Withdrawal by Subject|20
7538420|NCT02879448|11887642|FG001|Overall Study|Withdrawal by Subject|46
7538421|NCT02879448|11887641|FG000|Overall Study|Death|63
7538422|NCT02879448|11887642|FG001|Overall Study|Death|85
7538423|NCT02879448|11887641|FG000|Overall Study|Lost to Follow-up|3
7538424|NCT02879448|11887642|FG001|Overall Study|Lost to Follow-up|4
7538425|NCT02879448|11887641|FG000|Overall Study|Missing visit|34
7538426|NCT02879448|11887642|FG001|Overall Study|Missing visit|39
7538427|NCT02879448|11887641|FG000|Overall Study|Pending evaluation|1
7538428|NCT02879448|11887642|FG001|Overall Study|Pending evaluation|0
7538429|NCT02739347|11887650|FG000|Overall Study|Adverse Event|3
7538430|NCT02739347|11887651|FG001|Overall Study|Adverse Event|0
7538431|NCT02739347|11887650|FG000|Overall Study|Protocol Violation|0
7538432|NCT02739347|11887651|FG001|Overall Study|Protocol Violation|1
7538433|NCT02739347|11887650|FG000|Overall Study|Lost to Follow-up|0
7538434|NCT02739347|11887651|FG001|Overall Study|Lost to Follow-up|2
7538465|NCT02582749|11887668|FG000|Overall Study|Study terminated by funder|5
7538466|NCT02582749|11887669|FG001|Overall Study|Study terminated by funder|10
7538467|NCT02582749|11887668|FG000|Overall Study|Withdrawal by Subject|0
7538468|NCT02582749|11887669|FG001|Overall Study|Withdrawal by Subject|1
7538481|NCT02499952|11887693|FG000|Overall Study|Lost to Follow-up|1
7538482|NCT02499952|11887693|FG000|Overall Study|Death|9
7575662|NCT03909971|11959608|FG001|Overall Study|Global Deterioration of Health Status|1
7575663|NCT03909971|11959607|FG000|Overall Study|Progressive Disease|6
7575664|NCT03909971|11959608|FG001|Overall Study|Progressive Disease|14
7575665|NCT03909971|11959607|FG000|Overall Study|Death|2
7575666|NCT03909971|11959608|FG001|Overall Study|Death|6
7575667|NCT03920215|11959619|FG000|Overall Study|Lost to Follow-up|1
7575668|NCT03920215|11959620|FG001|Overall Study|Lost to Follow-up|2
7575669|NCT03920215|11959621|FG002|Overall Study|Lost to Follow-up|0
7575670|NCT03920215|11959622|FG003|Overall Study|Lost to Follow-up|0
7575671|NCT03920215|11959619|FG000|Overall Study|Death|0
7575672|NCT03920215|11959620|FG001|Overall Study|Death|0
7575673|NCT03920215|11959621|FG002|Overall Study|Death|0
7575674|NCT03920215|11959622|FG003|Overall Study|Death|1
7575675|NCT03921151|11959634|FG000|Overall Study|Withdrawal by Subject|11
7575676|NCT03921151|11959635|FG001|Overall Study|Withdrawal by Subject|16
7624423|NCT04052620|12035476|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1
7624424|NCT04052620|12035477|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0
7538537|NCT02450331|11887724|FG000|Overall Study|Death|120
7538538|NCT02450331|11887725|FG001|Overall Study|Death|114
7538539|NCT02450331|11887724|FG000|Overall Study|Lost to Follow-up|9
7538540|NCT02450331|11887725|FG001|Overall Study|Lost to Follow-up|7
7538541|NCT02450331|11887724|FG000|Overall Study|Withdrawal by Subject|50
7538542|NCT02450331|11887725|FG001|Overall Study|Withdrawal by Subject|39
7538543|NCT02450331|11887724|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
7538544|NCT02450331|11887725|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
7538545|NCT02450331|11887724|FG000|Overall Study|On-Study Status: In Survival follow-up|45
7538546|NCT02450331|11887725|FG001|Overall Study|On-Study Status: In Survival follow-up|38
7538567|NCT01984346|11887752|FG000|Overall Study|Physician Decision|4
7538568|NCT01984346|11887753|FG001|Overall Study|Physician Decision|2
7538569|NCT01984346|11887752|FG000|Overall Study|Withdrawal by Subject|2
7538570|NCT01984346|11887753|FG001|Overall Study|Withdrawal by Subject|2
7538571|NCT01984346|11887752|FG000|Overall Study|Enrollment Closed|8
7538572|NCT01984346|11887753|FG001|Overall Study|Enrollment Closed|1
7538573|NCT01984346|11887752|FG000|Overall Study|Insurance Coverage|1
7538574|NCT01984346|11887753|FG001|Overall Study|Insurance Coverage|0
7538575|NCT01984346|11887752|FG000|Overall Study|Intra-operative Exclusion|2
7538576|NCT01984346|11887753|FG001|Overall Study|Intra-operative Exclusion|0
7538577|NCT01963780|11887759|FG000|Overall Study|Death|7
7538578|NCT01793610|11887776|FG000|Overall Study|Withdrawal by Subject|1
7538579|NCT01793610|11887777|FG001|Overall Study|Withdrawal by Subject|0
7538580|NCT01793610|11887778|FG002|Overall Study|Withdrawal by Subject|1
7538581|NCT01780545|11887792|FG000|Overall Study|Withdrawal by Subject|3
7538582|NCT01780545|11887793|FG001|Overall Study|Withdrawal by Subject|1
7538583|NCT01780545|11887792|FG000|Overall Study|Lost to Follow-up|1
7538584|NCT01780545|11887793|FG001|Overall Study|Lost to Follow-up|1
7538597|NCT01732107|11887811|FG000|Overall Study|Adverse Event|2
7538598|NCT01732107|11887811|FG000|Overall Study|Disease Progression|8
7538599|NCT01732107|11887811|FG000|Overall Study|Physician Decision|1
7538600|NCT01732107|11887811|FG000|Overall Study|Withdrawal by Subject|2
7538601|NCT01681433|11887817|FG000|Overall Study|Lack of Efficacy|23
7538602|NCT01681433|11887818|FG001|Overall Study|Lack of Efficacy|23
7538603|NCT01681433|11887817|FG000|Overall Study|Withdrawal by Subject|5
7538604|NCT01681433|11887818|FG001|Overall Study|Withdrawal by Subject|5
7538605|NCT01681433|11887817|FG000|Overall Study|Protocol Violation|2
7538606|NCT01681433|11887818|FG001|Overall Study|Protocol Violation|0
7538607|NCT01681433|11887817|FG000|Overall Study|Adverse Event|2
7538608|NCT01681433|11887818|FG001|Overall Study|Adverse Event|4
7538609|NCT01681433|11887817|FG000|Overall Study|Lost to Follow-up|0
7538610|NCT01681433|11887818|FG001|Overall Study|Lost to Follow-up|1
7538635|NCT01630434|11887840|FG000|Overall Study|Donor lungs turned down|1
7538636|NCT01630434|11887841|FG001|Overall Study|Donor lungs turned down|0
7538637|NCT01630434|11887840|FG000|Overall Study|Protocol Violation|9
7538638|NCT01630434|11887841|FG001|Overall Study|Protocol Violation|4
7538639|NCT01630434|11887840|FG000|Overall Study|Death|20
7538640|NCT01630434|11887841|FG001|Overall Study|Death|26
7538709|NCT01524991|11887893|FG000|Overall Study|Adverse Event|12
7538710|NCT01524991|11887893|FG000|Overall Study|Death|1
7538711|NCT01524991|11887893|FG000|Overall Study|Disease ProgressionDu|17
7538712|NCT01524991|11887893|FG000|Overall Study|Other complicating disease|1
7538713|NCT01524991|11887893|FG000|Overall Study|Withdrawal by Subject|2
7538714|NCT01524991|11887893|FG000|Overall Study|Symptomatic Deterioration|1
7538715|NCT01085084|11887917|FG000|Overall Study|Withdrawal by Subject|1
7538716|NCT01085084|11887918|FG001|Overall Study|Withdrawal by Subject|0
7538717|NCT01085084|11887919|FG002|Overall Study|Withdrawal by Subject|0
7538718|NCT01085084|11887917|FG000|Overall Study|Lost to Follow-up|2
7538719|NCT01085084|11887918|FG001|Overall Study|Lost to Follow-up|1
7538720|NCT01085084|11887919|FG002|Overall Study|Lost to Follow-up|1
7538721|NCT01085084|11887917|FG000|Overall Study|Adverse Event|4
7538722|NCT01085084|11887918|FG001|Overall Study|Adverse Event|3
7538723|NCT01085084|11887919|FG002|Overall Study|Adverse Event|6
7538724|NCT01085084|11887917|FG000|Overall Study|Treatment Failure|0
7538725|NCT01085084|11887918|FG001|Overall Study|Treatment Failure|1
7538726|NCT01085084|11887919|FG002|Overall Study|Treatment Failure|2
7538727|NCT01084252|11887941|FG000|Phase 1 (120 Weeks)|Adverse Event|0
7538728|NCT01084252|11887942|FG001|Phase 1 (120 Weeks)|Adverse Event|0
7538729|NCT01084252|11887943|FG002|Phase 1 (120 Weeks)|Adverse Event|1
7538730|NCT01084252|11887944|FG003|Phase 1 (120 Weeks)|Adverse Event|1
7538731|NCT01084252|11887945|FG004|Phase 1 (120 Weeks)|Adverse Event|1
7538732|NCT01084252|11887946|FG005|Phase 1 (120 Weeks)|Adverse Event|0
7538733|NCT01084252|11887947|FG006|Phase 1 (120 Weeks)|Adverse Event|1
7538734|NCT01084252|11887948|FG007|Phase 1 (120 Weeks)|Adverse Event|0
7538735|NCT01084252|11887949|FG008|Phase 1 (120 Weeks)|Adverse Event|0
7538736|NCT01084252|11887950|FG009|Phase 1 (120 Weeks)|Adverse Event|0
7538737|NCT01084252|11887951|FG010|Phase 1 (120 Weeks)|Adverse Event|0
7538738|NCT01084252|11887952|FG011|Phase 1 (120 Weeks)|Adverse Event|0
7538739|NCT01084252|11887953|FG012|Phase 1 (120 Weeks)|Adverse Event|0
7538740|NCT01084252|11887954|FG013|Phase 1 (120 Weeks)|Adverse Event|0
7538741|NCT01084252|11887941|FG000|Phase 1 (120 Weeks)|Progressive disease|15
7538742|NCT01084252|11887942|FG001|Phase 1 (120 Weeks)|Progressive disease|5
7538743|NCT01084252|11887943|FG002|Phase 1 (120 Weeks)|Progressive disease|2
7538744|NCT01084252|11887944|FG003|Phase 1 (120 Weeks)|Progressive disease|22
7538745|NCT01084252|11887945|FG004|Phase 1 (120 Weeks)|Progressive disease|16
7538746|NCT01084252|11887946|FG005|Phase 1 (120 Weeks)|Progressive disease|6
7538747|NCT01084252|11887947|FG006|Phase 1 (120 Weeks)|Progressive disease|5
7538748|NCT01084252|11887948|FG007|Phase 1 (120 Weeks)|Progressive disease|6
7538749|NCT01084252|11887949|FG008|Phase 1 (120 Weeks)|Progressive disease|0
7538750|NCT01084252|11887950|FG009|Phase 1 (120 Weeks)|Progressive disease|0
7538751|NCT01084252|11887951|FG010|Phase 1 (120 Weeks)|Progressive disease|0
7538752|NCT01084252|11887952|FG011|Phase 1 (120 Weeks)|Progressive disease|0
7538753|NCT01084252|11887953|FG012|Phase 1 (120 Weeks)|Progressive disease|0
7538754|NCT01084252|11887954|FG013|Phase 1 (120 Weeks)|Progressive disease|0
7538755|NCT01084252|11887941|FG000|Phase 1 (120 Weeks)|Other than specified above|1
7538756|NCT01084252|11887942|FG001|Phase 1 (120 Weeks)|Other than specified above|1
7538757|NCT01084252|11887943|FG002|Phase 1 (120 Weeks)|Other than specified above|0
7538758|NCT01084252|11887944|FG003|Phase 1 (120 Weeks)|Other than specified above|3
7538759|NCT01084252|11887945|FG004|Phase 1 (120 Weeks)|Other than specified above|1
7538760|NCT01084252|11887946|FG005|Phase 1 (120 Weeks)|Other than specified above|0
7538761|NCT01084252|11887947|FG006|Phase 1 (120 Weeks)|Other than specified above|1
7538762|NCT01084252|11887948|FG007|Phase 1 (120 Weeks)|Other than specified above|1
7538763|NCT01084252|11887949|FG008|Phase 1 (120 Weeks)|Other than specified above|0
7538764|NCT01084252|11887950|FG009|Phase 1 (120 Weeks)|Other than specified above|0
7538765|NCT01084252|11887951|FG010|Phase 1 (120 Weeks)|Other than specified above|0
7538766|NCT01084252|11887952|FG011|Phase 1 (120 Weeks)|Other than specified above|0
7538767|NCT01084252|11887953|FG012|Phase 1 (120 Weeks)|Other than specified above|0
7538768|NCT01084252|11887954|FG013|Phase 1 (120 Weeks)|Other than specified above|0
7538769|NCT01084252|11887941|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538770|NCT01084252|11887942|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538771|NCT01084252|11887943|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538772|NCT01084252|11887944|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538773|NCT01084252|11887945|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538774|NCT01084252|11887946|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538775|NCT01084252|11887947|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538776|NCT01084252|11887948|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538777|NCT01084252|11887949|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538778|NCT01084252|11887950|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7538779|NCT01084252|11887951|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
7538780|NCT01084252|11887952|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
7538781|NCT01084252|11887953|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7575677|NCT03927911|11959656|FG000|Overall Study|problems with eDiary|0
7538782|NCT01084252|11887954|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
7538783|NCT01084252|11887941|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538784|NCT01084252|11887942|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538785|NCT01084252|11887943|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538786|NCT01084252|11887944|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538787|NCT01084252|11887945|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538788|NCT01084252|11887946|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538789|NCT01084252|11887947|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538790|NCT01084252|11887948|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538791|NCT01084252|11887949|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
7538792|NCT01084252|11887950|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
7538793|NCT01084252|11887951|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
7538794|NCT01084252|11887952|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
7538795|NCT01084252|11887953|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538796|NCT01084252|11887954|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
7538797|NCT01084252|11887941|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538798|NCT01084252|11887942|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538799|NCT01084252|11887943|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538800|NCT01084252|11887944|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538801|NCT01084252|11887945|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538802|NCT01084252|11887946|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538803|NCT01084252|11887947|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538804|NCT01084252|11887948|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538805|NCT01084252|11887949|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
7538806|NCT01084252|11887950|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538807|NCT01084252|11887951|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
7538808|NCT01084252|11887952|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
7538809|NCT01084252|11887953|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538810|NCT01084252|11887954|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
7538811|NCT01084252|11887941|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538812|NCT01084252|11887942|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538813|NCT01084252|11887943|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538814|NCT01084252|11887944|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538815|NCT01084252|11887945|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538816|NCT01084252|11887946|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538817|NCT01084252|11887947|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538818|NCT01084252|11887948|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538819|NCT01084252|11887949|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
7538820|NCT01084252|11887950|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
7538821|NCT01084252|11887951|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7538822|NCT01084252|11887952|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
7538823|NCT01084252|11887953|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538824|NCT01084252|11887954|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
7538825|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538826|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538827|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538828|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538829|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538830|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538831|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538832|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538833|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538834|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538835|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538836|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
7538837|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
7538838|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
7538839|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538840|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538841|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538842|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538843|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538844|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538845|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538846|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538847|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538848|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538849|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538850|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
7538851|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
7538852|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
7538853|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538854|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538855|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538856|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538857|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538858|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538859|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538860|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538861|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538862|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538863|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538864|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538865|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
7538866|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
7538867|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538868|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538869|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538870|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538871|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538872|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538873|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538874|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538875|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538876|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538877|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538878|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
7538879|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
7538880|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
7538881|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538882|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538883|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538884|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538885|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538886|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538887|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538888|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538889|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538890|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538891|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538892|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
7538893|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
7538894|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
7538895|NCT01084252|11887941|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538896|NCT01084252|11887942|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538897|NCT01084252|11887943|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538898|NCT01084252|11887944|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538899|NCT01084252|11887945|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538900|NCT01084252|11887946|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538901|NCT01084252|11887947|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538902|NCT01084252|11887948|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538903|NCT01084252|11887949|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538904|NCT01084252|11887950|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538905|NCT01084252|11887951|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538906|NCT01084252|11887952|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538907|NCT01084252|11887953|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
7538908|NCT01084252|11887954|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
7538909|NCT01034631|11888021|FG000|Phase I|Symptomatic Deterioration before Treatme|3
7538910|NCT01034631|11888022|FG001|Phase I|Symptomatic Deterioration before Treatme|0
7538911|NCT01034631|11888023|FG002|Phase I|Symptomatic Deterioration before Treatme|0
7538912|NCT01034631|11888021|FG000|Phase II|Not Evaluable per protocol|0
7538913|NCT01034631|11888022|FG001|Phase II|Not Evaluable per protocol|0
7538914|NCT01034631|11888023|FG002|Phase II|Not Evaluable per protocol|2
7538915|NCT01034631|11888021|FG000|Phase II|Determined Ineligible per protocol|0
7538916|NCT01034631|11888022|FG001|Phase II|Determined Ineligible per protocol|1
7538917|NCT01034631|11888023|FG002|Phase II|Determined Ineligible per protocol|0
7538918|NCT00402298|11888035|FG000|Overall Study|Withdrawal by Subject|1
7538919|NCT00402298|11888036|FG001|Overall Study|Withdrawal by Subject|0
7552108|NCT02980692|11911735|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7538920|NCT04320745|11888059|FG000|Overall Study|Adverse Event|26
7538921|NCT04320745|11888059|FG000|Overall Study|Withdrawal by Subject|4
7538922|NCT04320745|11888059|FG000|Overall Study|Lost to Follow-up|12
7538923|NCT04320745|11888059|FG000|Overall Study|Protocol Deviation|2
7538924|NCT04320745|11888059|FG000|Overall Study|Non-compliance With Study Drug|2
7538925|NCT04320745|11888059|FG000|Overall Study|Reason Not Specified|1
7575678|NCT03927911|11959657|FG001|Overall Study|problems with eDiary|1
7575679|NCT03927911|11959658|FG002|Overall Study|problems with eDiary|0
7538928|NCT04016779|11888089|FG000|Overall Study|Adverse Event|9
7538929|NCT04016779|11888090|FG001|Overall Study|Adverse Event|17
7538930|NCT04016779|11888089|FG000|Overall Study|Lack of Efficacy|4
7538931|NCT04016779|11888090|FG001|Overall Study|Lack of Efficacy|1
7538932|NCT04016779|11888089|FG000|Overall Study|Lost to Follow-up|5
7538933|NCT04016779|11888090|FG001|Overall Study|Lost to Follow-up|14
7538934|NCT04016779|11888089|FG000|Overall Study|Physician Decision|1
7538935|NCT04016779|11888090|FG001|Overall Study|Physician Decision|3
7538936|NCT04016779|11888089|FG000|Overall Study|Withdrawal by Subject|6
7538937|NCT04016779|11888090|FG001|Overall Study|Withdrawal by Subject|8
7538938|NCT04016779|11888089|FG000|Overall Study|Non-compliance with Study Drug|2
7538939|NCT04016779|11888090|FG001|Overall Study|Non-compliance with Study Drug|3
7538940|NCT04016779|11888089|FG000|Overall Study|Other, Multiple categories|17
7538941|NCT04016779|11888090|FG001|Overall Study|Other, Multiple categories|17
7538942|NCT04000165|11888098|FG000|Overall Study|Physician Decision|1
7538943|NCT04000165|11888098|FG000|Overall Study|Withdrawal by Subject|1
7538944|NCT03952650|11888109|FG000|Overall Study|TRAVEL|0
7538945|NCT03952650|11888110|FG001|Overall Study|TRAVEL|4
7538946|NCT03952650|11888111|FG002|Overall Study|TRAVEL|0
7538947|NCT03952650|11888112|FG003|Overall Study|TRAVEL|4
7538948|NCT03952650|11888113|FG004|Overall Study|TRAVEL|0
7538949|NCT03952650|11888114|FG005|Overall Study|TRAVEL|3
7538950|NCT03952650|11888115|FG006|Overall Study|TRAVEL|2
7538951|NCT03952650|11888109|FG000|Overall Study|Withdrawal by Subject|0
7538952|NCT03952650|11888110|FG001|Overall Study|Withdrawal by Subject|2
7538953|NCT03952650|11888111|FG002|Overall Study|Withdrawal by Subject|0
7538954|NCT03952650|11888112|FG003|Overall Study|Withdrawal by Subject|3
7538955|NCT03952650|11888113|FG004|Overall Study|Withdrawal by Subject|0
7538956|NCT03952650|11888114|FG005|Overall Study|Withdrawal by Subject|1
7538957|NCT03952650|11888115|FG006|Overall Study|Withdrawal by Subject|1
7538958|NCT03952650|11888109|FG000|Overall Study|Lost to Follow-up|0
7538959|NCT03952650|11888110|FG001|Overall Study|Lost to Follow-up|1
7538960|NCT03952650|11888111|FG002|Overall Study|Lost to Follow-up|0
7538961|NCT03952650|11888112|FG003|Overall Study|Lost to Follow-up|0
7538962|NCT03952650|11888113|FG004|Overall Study|Lost to Follow-up|0
7538963|NCT03952650|11888114|FG005|Overall Study|Lost to Follow-up|1
7538964|NCT03952650|11888115|FG006|Overall Study|Lost to Follow-up|1
7538965|NCT03952650|11888109|FG000|Overall Study|Received wrong vaccine and travelled|0
7538966|NCT03952650|11888110|FG001|Overall Study|Received wrong vaccine and travelled|0
7538967|NCT03952650|11888111|FG002|Overall Study|Received wrong vaccine and travelled|0
7538968|NCT03952650|11888112|FG003|Overall Study|Received wrong vaccine and travelled|0
7538969|NCT03952650|11888113|FG004|Overall Study|Received wrong vaccine and travelled|0
7538970|NCT03952650|11888114|FG005|Overall Study|Received wrong vaccine and travelled|1
7538971|NCT03952650|11888115|FG006|Overall Study|Received wrong vaccine and travelled|0
7538972|NCT03952650|11888109|FG000|Overall Study|Unable to make study visit|0
7538973|NCT03952650|11888110|FG001|Overall Study|Unable to make study visit|0
7538974|NCT03952650|11888111|FG002|Overall Study|Unable to make study visit|0
7538975|NCT03952650|11888112|FG003|Overall Study|Unable to make study visit|0
7538976|NCT03952650|11888113|FG004|Overall Study|Unable to make study visit|0
7538977|NCT03952650|11888114|FG005|Overall Study|Unable to make study visit|1
7538978|NCT03952650|11888115|FG006|Overall Study|Unable to make study visit|0
7538979|NCT03794089|11888133|FG000|Overall Study|Lost to Follow-up|4
7538980|NCT03794089|11888134|FG001|Overall Study|Lost to Follow-up|1
7538981|NCT03794089|11888133|FG000|Overall Study|Withdrawal by Subject|2
7538982|NCT03794089|11888134|FG001|Overall Study|Withdrawal by Subject|0
7538983|NCT03713021|11888149|FG000|Overall Study|Did not have CT sim scan available|6
7538984|NCT03713021|11888149|FG000|Overall Study|Not eligible|4
7538985|NCT03713021|11888149|FG000|Overall Study|Issues with TraceIT markers|5
7538986|NCT03631407|11888164|FG000|Overall Study|Withdrawal by Subject|3
7538987|NCT03631407|11888165|FG001|Overall Study|Withdrawal by Subject|2
7538988|NCT03631407|11888164|FG000|Overall Study|Sponsor Decision|0
7538989|NCT03631407|11888165|FG001|Overall Study|Sponsor Decision|2
7538990|NCT03631407|11888164|FG000|Overall Study|Death|16
7538991|NCT03631407|11888165|FG001|Overall Study|Death|16
7538992|NCT03631407|11888164|FG000|Overall Study|Randomized by mistake without study treatment|1
7538993|NCT03631407|11888165|FG001|Overall Study|Randomized by mistake without study treatment|0
7538994|NCT03531827|11888171|FG000|Overall Study|Adverse Event|2
7538995|NCT03531827|11888172|FG001|Overall Study|Adverse Event|0
7538996|NCT03531827|11888171|FG000|Overall Study|Progressive disease|1
7538997|NCT03531827|11888172|FG001|Overall Study|Progressive disease|0
7538998|NCT03368664|11888210|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1
7538999|NCT03368664|11888210|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1
7575680|NCT03927911|11959659|FG003|Overall Study|problems with eDiary|1
7575681|NCT03927911|11959660|FG004|Overall Study|problems with eDiary|0
7539000|NCT03368664|11888210|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1
7539001|NCT03368664|11888210|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1
7539025|NCT02998671|11888274|FG000|Period 1|Study Terminated By Sponsor|2
7539026|NCT02998671|11888275|FG001|Period 1|Study Terminated By Sponsor|1
7539027|NCT02998671|11888276|FG002|Period 1|Study Terminated By Sponsor|0
7539028|NCT02998671|11888277|FG003|Period 1|Study Terminated By Sponsor|0
7539029|NCT02998671|11888278|FG004|Period 1|Study Terminated By Sponsor|1
7539030|NCT02998671|11888274|FG000|Period 1|Withdrawal by Subject|1
7539031|NCT02998671|11888275|FG001|Period 1|Withdrawal by Subject|2
7539032|NCT02998671|11888276|FG002|Period 1|Withdrawal by Subject|0
7539033|NCT02998671|11888277|FG003|Period 1|Withdrawal by Subject|0
7539034|NCT02998671|11888278|FG004|Period 1|Withdrawal by Subject|2
7539035|NCT02998671|11888274|FG000|Period 1|Pregnancy|1
7539036|NCT02998671|11888275|FG001|Period 1|Pregnancy|0
7539037|NCT02998671|11888276|FG002|Period 1|Pregnancy|0
7539038|NCT02998671|11888277|FG003|Period 1|Pregnancy|0
7539039|NCT02998671|11888278|FG004|Period 1|Pregnancy|0
7539040|NCT02998671|11888274|FG000|Period 1|Adverse Event|0
7539041|NCT02998671|11888275|FG001|Period 1|Adverse Event|0
7539042|NCT02998671|11888276|FG002|Period 1|Adverse Event|0
7539043|NCT02998671|11888277|FG003|Period 1|Adverse Event|0
7539044|NCT02998671|11888278|FG004|Period 1|Adverse Event|1
7539045|NCT02998671|11888274|FG000|Period 2|Adverse Event|0
7539046|NCT02998671|11888275|FG001|Period 2|Adverse Event|1
7539047|NCT02998671|11888276|FG002|Period 2|Adverse Event|0
7539048|NCT02998671|11888277|FG003|Period 2|Adverse Event|0
7539049|NCT02998671|11888278|FG004|Period 2|Adverse Event|0
7539050|NCT02998671|11888274|FG000|Period 2|Study Terminated By Sponsor|3
7539051|NCT02998671|11888275|FG001|Period 2|Study Terminated By Sponsor|5
7539052|NCT02998671|11888276|FG002|Period 2|Study Terminated By Sponsor|1
7539053|NCT02998671|11888277|FG003|Period 2|Study Terminated By Sponsor|3
7539054|NCT02998671|11888278|FG004|Period 2|Study Terminated By Sponsor|0
7539055|NCT02998671|11888274|FG000|Period 2|Withdrawal by Subject|0
7539056|NCT02998671|11888275|FG001|Period 2|Withdrawal by Subject|1
7539057|NCT02998671|11888276|FG002|Period 2|Withdrawal by Subject|0
7539058|NCT02998671|11888277|FG003|Period 2|Withdrawal by Subject|0
7539059|NCT02998671|11888278|FG004|Period 2|Withdrawal by Subject|0
7539060|NCT02998671|11888274|FG000|Period 2|Lost to Follow-up|0
7539061|NCT02998671|11888275|FG001|Period 2|Lost to Follow-up|0
7539062|NCT02998671|11888276|FG002|Period 2|Lost to Follow-up|0
7539063|NCT02998671|11888277|FG003|Period 2|Lost to Follow-up|1
7539064|NCT02998671|11888278|FG004|Period 2|Lost to Follow-up|0
7539076|NCT02860039|11888315|FG000|Overall Study|Death|4
7539077|NCT02860039|11888316|FG001|Overall Study|Death|0
7539078|NCT02860039|11888315|FG000|Overall Study|Lost to Follow-up|2
7539079|NCT02860039|11888316|FG001|Overall Study|Lost to Follow-up|2
7539080|NCT02860039|11888315|FG000|Overall Study|Protocol Violation|3
7539081|NCT02860039|11888316|FG001|Overall Study|Protocol Violation|1
7539082|NCT02860039|11888315|FG000|Overall Study|Withdrawal by Subject|1
7539083|NCT02860039|11888316|FG001|Overall Study|Withdrawal by Subject|0
7539084|NCT02860039|11888315|FG000|Overall Study|Not otherwise eligible|1
7539085|NCT02860039|11888316|FG001|Overall Study|Not otherwise eligible|1
7539086|NCT02499146|11888326|FG000|Overall Study|Lost to Follow-up|1
7539087|NCT02499146|11888326|FG000|Overall Study|Withdrawal by Subject|1
7539088|NCT02499146|11888326|FG000|Overall Study|Other|2
7539089|NCT02499146|11888326|FG000|Overall Study|Ongoing at date of cut-off|9
7539090|NCT02499146|11888326|FG000|Overall Study|Began other treatment/therapy|13
7539091|NCT02499120|11888332|FG000|Overall Study|Death|45
7539092|NCT02499120|11888333|FG001|Overall Study|Death|42
7539093|NCT02499120|11888332|FG000|Overall Study|Lost to Follow-up|1
7539094|NCT02499120|11888333|FG001|Overall Study|Lost to Follow-up|2
7539095|NCT02499120|11888332|FG000|Overall Study|Participant refused further follow-up|1
7539096|NCT02499120|11888333|FG001|Overall Study|Participant refused further follow-up|0
7539097|NCT02499120|11888332|FG000|Overall Study|Withdrawal by Subject|2
7539098|NCT02499120|11888333|FG001|Overall Study|Withdrawal by Subject|5
7539099|NCT02499120|11888332|FG000|Overall Study|Other|1
7539100|NCT02499120|11888333|FG001|Overall Study|Other|0
7539101|NCT02499120|11888332|FG000|Overall Study|Ongoing on study|15
7539102|NCT02499120|11888333|FG001|Overall Study|Ongoing on study|11
7539103|NCT02340221|11888367|FG000|Overall Study|Death|100
7539104|NCT02340221|11888368|FG001|Overall Study|Death|197
7539105|NCT02340221|11888367|FG000|Overall Study|Withdrawal by Participant|24
7539106|NCT02340221|11888368|FG001|Overall Study|Withdrawal by Participant|37
7539107|NCT02340221|11888367|FG000|Overall Study|Lost to Follow-up|4
7539108|NCT02340221|11888368|FG001|Overall Study|Lost to Follow-up|15
7539109|NCT02340221|11888367|FG000|Overall Study|Reason Not Specified|85
7539110|NCT02340221|11888368|FG001|Overall Study|Reason Not Specified|165
7539111|NCT02340221|11888367|FG000|Overall Study|Study Terminated by Sponsor|1
7539112|NCT02340221|11888368|FG001|Overall Study|Study Terminated by Sponsor|3
7539113|NCT02332915|11888377|FG000|Overall Study|Moved out of region|3
7539114|NCT02332915|11888378|FG001|Overall Study|Moved out of region|0
7539115|NCT02332915|11888377|FG000|Overall Study|Unrelated illness|1
7539116|NCT02332915|11888378|FG001|Overall Study|Unrelated illness|1
7539117|NCT02332915|11888377|FG000|Overall Study|Travel distance prohibitive|0
7539118|NCT02332915|11888378|FG001|Overall Study|Travel distance prohibitive|1
7539119|NCT02332915|11888377|FG000|Overall Study|did not meet inclusion criteria|2
7539120|NCT02332915|11888378|FG001|Overall Study|did not meet inclusion criteria|4
7539121|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
7539122|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
7539123|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
7539124|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
7539274|NCT01306331|11888471|FG000|Overall Study|Pregnancy|136
7539125|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
7539126|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
7539127|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
7539128|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
7539129|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
7539130|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
7539131|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
7539132|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
7539133|NCT02288247|11888398|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
7539134|NCT02288247|11888399|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
7539135|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
7539136|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
7539137|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
7539138|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
7539139|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
7539140|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
7539141|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
7539142|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
7539143|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
7539144|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
7539145|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7539146|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
7539147|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
7539148|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
7539149|NCT02288247|11888398|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
7539150|NCT02288247|11888399|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
7575682|NCT03927911|11959661|FG005|Overall Study|problems with eDiary|4
7539184|NCT02177175|11888419|FG000|Overall Study|stopped trastuzumab so was taken off study|1
7539185|NCT02177175|11888420|FG001|Overall Study|stopped trastuzumab so was taken off study|0
7539186|NCT02049138|11888437|FG000|Overall Study|Adverse Event|46
7539187|NCT02049138|11888438|FG001|Overall Study|Adverse Event|25
7539188|NCT02049138|11888439|FG002|Overall Study|Adverse Event|1
7539189|NCT02049138|11888437|FG000|Overall Study|Withdrawal by Subject|57
7539190|NCT02049138|11888438|FG001|Overall Study|Withdrawal by Subject|21
7539191|NCT02049138|11888439|FG002|Overall Study|Withdrawal by Subject|5
7539192|NCT02049138|11888437|FG000|Overall Study|Lost to Follow-up|18
7539193|NCT02049138|11888438|FG001|Overall Study|Lost to Follow-up|5
7539194|NCT02049138|11888439|FG002|Overall Study|Lost to Follow-up|1
7539195|NCT02049138|11888437|FG000|Overall Study|Lack of Efficacy|10
7539196|NCT02049138|11888438|FG001|Overall Study|Lack of Efficacy|26
7539197|NCT02049138|11888439|FG002|Overall Study|Lack of Efficacy|1
7539198|NCT02049138|11888437|FG000|Overall Study|Non-Compliance|15
7539199|NCT02049138|11888438|FG001|Overall Study|Non-Compliance|6
7539200|NCT02049138|11888439|FG002|Overall Study|Non-Compliance|0
7539201|NCT02049138|11888437|FG000|Overall Study|Required Alternative / Prohibited Therapy|1
7539202|NCT02049138|11888438|FG001|Overall Study|Required Alternative / Prohibited Therapy|1
7539203|NCT02049138|11888439|FG002|Overall Study|Required Alternative / Prohibited Therapy|0
7539204|NCT02049138|11888437|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1
7539205|NCT02049138|11888438|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0
7539206|NCT02049138|11888439|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0
7539207|NCT02049138|11888437|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7539208|NCT02049138|11888438|FG001|Overall Study|COVID-19 Logistical Restrictions|0
7539209|NCT02049138|11888439|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7539210|NCT02049138|11888437|FG000|Overall Study|Other|15
7539211|NCT02049138|11888438|FG001|Overall Study|Other|13
7539212|NCT02049138|11888439|FG002|Overall Study|Other|0
7539213|NCT02049138|11888437|FG000|Overall Study|Missing|0
7539214|NCT02049138|11888438|FG001|Overall Study|Missing|1
7539215|NCT02049138|11888439|FG002|Overall Study|Missing|0
7539216|NCT01721772|11888452|FG000|Pre-Treatment|Participant no longer meets study criteria|3
7539217|NCT01721772|11888453|FG001|Pre-Treatment|Participant no longer meets study criteria|1
7539218|NCT01721772|11888452|FG000|Pre-Treatment|Poor/non-compliance|0
7539219|NCT01721772|11888453|FG001|Pre-Treatment|Poor/non-compliance|1
7539220|NCT01721772|11888452|FG000|Pre-Treatment|Participant withdrew consent|0
7539221|NCT01721772|11888453|FG001|Pre-Treatment|Participant withdrew consent|1
7539222|NCT01721772|11888452|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7539223|NCT01721772|11888453|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
7539224|NCT01721772|11888452|FG000|Treatment|Disease progression|119
7539225|NCT01721772|11888453|FG001|Treatment|Disease progression|168
7539226|NCT01721772|11888452|FG000|Treatment|Study drug toxicity|19
7539227|NCT01721772|11888453|FG001|Treatment|Study drug toxicity|10
7539228|NCT01721772|11888452|FG000|Treatment|Adverse event unrelated to study drug|7
7539229|NCT01721772|11888453|FG001|Treatment|Adverse event unrelated to study drug|7
7539230|NCT01721772|11888452|FG000|Treatment|Maximum clinical benefit|16
7539231|NCT01721772|11888453|FG001|Treatment|Maximum clinical benefit|4
7539232|NCT01721772|11888452|FG000|Treatment|Other|19
7539233|NCT01721772|11888453|FG001|Treatment|Other|2
7539234|NCT01721772|11888452|FG000|Treatment|Participant withdrew consent|2
7539235|NCT01721772|11888453|FG001|Treatment|Participant withdrew consent|5
7539236|NCT01721772|11888452|FG000|Treatment|Participant request to discontinue study treatment|21
7539237|NCT01721772|11888453|FG001|Treatment|Participant request to discontinue study treatment|8
7539238|NCT01721772|11888452|FG000|Treatment|Death|1
7539239|NCT01721772|11888453|FG001|Treatment|Death|0
7539240|NCT01721772|11888452|FG000|Treatment|Not reported|1
7539241|NCT01721772|11888453|FG001|Treatment|Not reported|0
7539242|NCT01721772|11888452|FG000|Treatment|Poor/non-compliance|1
7539243|NCT01721772|11888453|FG001|Treatment|Poor/non-compliance|0
7539244|NCT01721772|11888452|FG000|Treatment|Lost to Follow-up|0
7539245|NCT01721772|11888453|FG001|Treatment|Lost to Follow-up|1
7539246|NCT01412333|11888461|FG000|Overall Study|Death|1
7539247|NCT01412333|11888462|FG001|Overall Study|Death|1
7539248|NCT01412333|11888461|FG000|Overall Study|Physician Decision|0
7539249|NCT01412333|11888462|FG001|Overall Study|Physician Decision|1
7539250|NCT01412333|11888461|FG000|Overall Study|Reason not specified|16
7539251|NCT01412333|11888462|FG001|Overall Study|Reason not specified|10
7539252|NCT01412333|11888461|FG000|Overall Study|Non-compliance with study drug|1
7539253|NCT01412333|11888462|FG001|Overall Study|Non-compliance with study drug|1
7539254|NCT01412333|11888461|FG000|Overall Study|Protocol Violation|1
7539255|NCT01412333|11888462|FG001|Overall Study|Protocol Violation|1
7539256|NCT01412333|11888461|FG000|Overall Study|Non-compliance|1
7539257|NCT01412333|11888462|FG001|Overall Study|Non-compliance|3
7539258|NCT01412333|11888461|FG000|Overall Study|Lack of Efficacy|15
7539259|NCT01412333|11888462|FG001|Overall Study|Lack of Efficacy|6
7539260|NCT01412333|11888461|FG000|Overall Study|Pregnancy|3
7539261|NCT01412333|11888462|FG001|Overall Study|Pregnancy|0
7539262|NCT01412333|11888461|FG000|Overall Study|Consent withdrawn by participant|25
7539263|NCT01412333|11888462|FG001|Overall Study|Consent withdrawn by participant|12
7539264|NCT01412333|11888461|FG000|Overall Study|Adverse Event|25
7539265|NCT01412333|11888462|FG001|Overall Study|Adverse Event|16
7539266|NCT01412333|11888461|FG000|Overall Study|Lost to Follow-up|10
7539267|NCT01412333|11888462|FG001|Overall Study|Lost to Follow-up|6
7539268|NCT01306331|11888471|FG000|Overall Study|Adverse Event|28
7539269|NCT01306331|11888472|FG001|Overall Study|Adverse Event|25
7539270|NCT01306331|11888471|FG000|Overall Study|Lost to Follow-up|321
7539271|NCT01306331|11888472|FG001|Overall Study|Lost to Follow-up|323
7539272|NCT01306331|11888471|FG000|Overall Study|Physician Decision|26
7539273|NCT01306331|11888472|FG001|Overall Study|Physician Decision|22
7575683|NCT03927911|11959656|FG000|Overall Study|Adverse Event|0
7575684|NCT03927911|11959657|FG001|Overall Study|Adverse Event|0
7575685|NCT03927911|11959658|FG002|Overall Study|Adverse Event|0
7575686|NCT03927911|11959659|FG003|Overall Study|Adverse Event|0
7575687|NCT03927911|11959660|FG004|Overall Study|Adverse Event|0
7575688|NCT03927911|11959661|FG005|Overall Study|Adverse Event|1
7575689|NCT03927911|11959656|FG000|Overall Study|not treated -study terminated by sponsor|0
7575690|NCT03927911|11959657|FG001|Overall Study|not treated -study terminated by sponsor|1
7575691|NCT03927911|11959658|FG002|Overall Study|not treated -study terminated by sponsor|0
7575692|NCT03927911|11959659|FG003|Overall Study|not treated -study terminated by sponsor|0
7624431|NCT03826667|12035492|FG000|Overall Study|Protocol deviation|21
7539275|NCT01306331|11888472|FG001|Overall Study|Pregnancy|151
7539276|NCT01306331|11888471|FG000|Overall Study|Protocol Violation|154
7539277|NCT01306331|11888472|FG001|Overall Study|Protocol Violation|124
7539278|NCT01306331|11888471|FG000|Overall Study|Withdrawal by Subject|163
7539279|NCT01306331|11888472|FG001|Overall Study|Withdrawal by Subject|152
7539280|NCT01306331|11888471|FG000|Overall Study|Not sexually active|29
7539281|NCT01306331|11888472|FG001|Overall Study|Not sexually active|28
7539282|NCT01306331|11888471|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
7539283|NCT01306331|11888472|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
7539284|NCT01306331|11888471|FG000|Overall Study|Other|34
7539285|NCT01306331|11888472|FG001|Overall Study|Other|32
7539286|NCT01247324|11888480|FG000|Overall Study|Death|1
7539287|NCT01247324|11888481|FG001|Overall Study|Death|0
7539288|NCT01247324|11888480|FG000|Overall Study|Physician Decision|0
7539289|NCT01247324|11888481|FG001|Overall Study|Physician Decision|1
7539290|NCT01247324|11888480|FG000|Overall Study|Non-compliance with study drug|3
7539291|NCT01247324|11888481|FG001|Overall Study|Non-compliance with study drug|0
7539292|NCT01247324|11888480|FG000|Overall Study|Lack of Efficacy|12
7539293|NCT01247324|11888481|FG001|Overall Study|Lack of Efficacy|8
7539294|NCT01247324|11888480|FG000|Overall Study|Non-compliance|2
7539295|NCT01247324|11888481|FG001|Overall Study|Non-compliance|0
7539296|NCT01247324|11888480|FG000|Overall Study|Pregnancy|2
7539297|NCT01247324|11888481|FG001|Overall Study|Pregnancy|3
7539298|NCT01247324|11888480|FG000|Overall Study|Protocol Violation|1
7539299|NCT01247324|11888481|FG001|Overall Study|Protocol Violation|2
7539300|NCT01247324|11888480|FG000|Overall Study|Reason not specified|11
7539301|NCT01247324|11888481|FG001|Overall Study|Reason not specified|8
7539302|NCT01247324|11888480|FG000|Overall Study|Consent withdrawn by participant|13
7539303|NCT01247324|11888481|FG001|Overall Study|Consent withdrawn by participant|8
7539304|NCT01247324|11888480|FG000|Overall Study|Adverse Event|25
7539305|NCT01247324|11888481|FG001|Overall Study|Adverse Event|13
7539306|NCT01247324|11888480|FG000|Overall Study|Lost to Follow-up|1
7539307|NCT01247324|11888481|FG001|Overall Study|Lost to Follow-up|1
7539308|NCT01194570|11888490|FG000|Overall Study|Death|1
7539309|NCT01194570|11888491|FG001|Overall Study|Death|3
7539310|NCT01194570|11888490|FG000|Overall Study|Ongoing at CCOD|162
7539311|NCT01194570|11888491|FG001|Overall Study|Ongoing at CCOD|387
7539312|NCT01194570|11888490|FG000|Overall Study|Physician Decision|2
7539313|NCT01194570|11888491|FG001|Overall Study|Physician Decision|6
7539314|NCT01194570|11888490|FG000|Overall Study|Reason not specified|13
7539315|NCT01194570|11888491|FG001|Overall Study|Reason not specified|20
7539316|NCT01194570|11888490|FG000|Overall Study|Protocol Violation|0
7539317|NCT01194570|11888491|FG001|Overall Study|Protocol Violation|2
7539318|NCT01194570|11888490|FG000|Overall Study|Non-compliance with study drug|2
7539319|NCT01194570|11888491|FG001|Overall Study|Non-compliance with study drug|2
7539320|NCT01194570|11888490|FG000|Overall Study|Adverse Event|12
7539321|NCT01194570|11888491|FG001|Overall Study|Adverse Event|18
7539322|NCT01194570|11888490|FG000|Overall Study|Non-compliance|2
7539323|NCT01194570|11888491|FG001|Overall Study|Non-compliance|2
7539324|NCT01194570|11888490|FG000|Overall Study|Lack of Efficacy|27
7539325|NCT01194570|11888491|FG001|Overall Study|Lack of Efficacy|21
7539326|NCT01194570|11888490|FG000|Overall Study|Withdrawal by Subject|21
7539327|NCT01194570|11888491|FG001|Overall Study|Withdrawal by Subject|22
7539328|NCT01194570|11888490|FG000|Overall Study|Pregnancy|1
7539329|NCT01194570|11888491|FG001|Overall Study|Pregnancy|1
7539330|NCT01194570|11888490|FG000|Overall Study|Lost to Follow-up|1
7539331|NCT01194570|11888491|FG001|Overall Study|Lost to Follow-up|4
7539332|NCT01190930|11888499|FG000|Induction|Adverse Event|17
7539333|NCT01190930|11888500|FG001|Induction|Adverse Event|0
7539334|NCT01190930|11888501|FG002|Induction|Adverse Event|0
7539335|NCT01190930|11888502|FG003|Induction|Adverse Event|0
7539336|NCT01190930|11888503|FG004|Induction|Adverse Event|0
7539337|NCT01190930|11888504|FG005|Induction|Adverse Event|0
7539338|NCT01190930|11888505|FG006|Induction|Adverse Event|0
7539339|NCT01190930|11888506|FG007|Induction|Adverse Event|0
7539340|NCT01190930|11888507|FG008|Induction|Adverse Event|0
7539341|NCT01190930|11888508|FG009|Induction|Adverse Event|0
7539342|NCT01190930|11888499|FG000|Induction|Death|34
7539343|NCT01190930|11888500|FG001|Induction|Death|0
7539344|NCT01190930|11888501|FG002|Induction|Death|0
7539345|NCT01190930|11888502|FG003|Induction|Death|0
7539346|NCT01190930|11888503|FG004|Induction|Death|0
7539347|NCT01190930|11888504|FG005|Induction|Death|0
7539348|NCT01190930|11888505|FG006|Induction|Death|0
7539349|NCT01190930|11888506|FG007|Induction|Death|0
7539350|NCT01190930|11888507|FG008|Induction|Death|0
7539351|NCT01190930|11888508|FG009|Induction|Death|0
7539352|NCT01190930|11888499|FG000|Induction|Lost to Follow-up|1
7539353|NCT01190930|11888500|FG001|Induction|Lost to Follow-up|0
7539354|NCT01190930|11888501|FG002|Induction|Lost to Follow-up|0
7539355|NCT01190930|11888502|FG003|Induction|Lost to Follow-up|0
7539356|NCT01190930|11888503|FG004|Induction|Lost to Follow-up|0
7539357|NCT01190930|11888504|FG005|Induction|Lost to Follow-up|0
7539358|NCT01190930|11888505|FG006|Induction|Lost to Follow-up|0
7539359|NCT01190930|11888506|FG007|Induction|Lost to Follow-up|0
7539360|NCT01190930|11888507|FG008|Induction|Lost to Follow-up|0
7539361|NCT01190930|11888508|FG009|Induction|Lost to Follow-up|0
7539362|NCT01190930|11888499|FG000|Induction|Physician Decision|125
7539363|NCT01190930|11888500|FG001|Induction|Physician Decision|3
7539364|NCT01190930|11888501|FG002|Induction|Physician Decision|0
7539365|NCT01190930|11888502|FG003|Induction|Physician Decision|0
7539366|NCT01190930|11888503|FG004|Induction|Physician Decision|0
7539367|NCT01190930|11888504|FG005|Induction|Physician Decision|0
7539368|NCT01190930|11888505|FG006|Induction|Physician Decision|0
7539369|NCT01190930|11888506|FG007|Induction|Physician Decision|0
7539370|NCT01190930|11888507|FG008|Induction|Physician Decision|0
7539371|NCT01190930|11888508|FG009|Induction|Physician Decision|0
7539372|NCT01190930|11888499|FG000|Induction|Withdrawal by Subject|9
7539373|NCT01190930|11888500|FG001|Induction|Withdrawal by Subject|0
7539374|NCT01190930|11888501|FG002|Induction|Withdrawal by Subject|0
7539375|NCT01190930|11888502|FG003|Induction|Withdrawal by Subject|0
7539376|NCT01190930|11888503|FG004|Induction|Withdrawal by Subject|0
7539377|NCT01190930|11888504|FG005|Induction|Withdrawal by Subject|0
7539378|NCT01190930|11888505|FG006|Induction|Withdrawal by Subject|0
7539379|NCT01190930|11888506|FG007|Induction|Withdrawal by Subject|0
7539380|NCT01190930|11888507|FG008|Induction|Withdrawal by Subject|0
7539381|NCT01190930|11888508|FG009|Induction|Withdrawal by Subject|0
7539382|NCT01190930|11888499|FG000|Induction|Refusal|235
7539383|NCT01190930|11888500|FG001|Induction|Refusal|0
7575693|NCT03927911|11959660|FG004|Overall Study|not treated -study terminated by sponsor|0
7575694|NCT03927911|11959661|FG005|Overall Study|not treated -study terminated by sponsor|0
7575695|NCT03927911|11959656|FG000|Overall Study|Surgery cancelled|0
7575696|NCT03927911|11959657|FG001|Overall Study|Surgery cancelled|0
7575697|NCT03927911|11959658|FG002|Overall Study|Surgery cancelled|0
7575698|NCT03927911|11959659|FG003|Overall Study|Surgery cancelled|1
7575699|NCT03927911|11959660|FG004|Overall Study|Surgery cancelled|0
7575700|NCT03927911|11959661|FG005|Overall Study|Surgery cancelled|1
7575701|NCT03927911|11959656|FG000|Overall Study|Protocol Violation|0
7575702|NCT03927911|11959657|FG001|Overall Study|Protocol Violation|0
7575703|NCT03927911|11959658|FG002|Overall Study|Protocol Violation|0
7575704|NCT03927911|11959659|FG003|Overall Study|Protocol Violation|0
7575705|NCT03927911|11959660|FG004|Overall Study|Protocol Violation|0
7539384|NCT01190930|11888501|FG002|Induction|Refusal|0
7539385|NCT01190930|11888502|FG003|Induction|Refusal|0
7539386|NCT01190930|11888503|FG004|Induction|Refusal|0
7539387|NCT01190930|11888504|FG005|Induction|Refusal|0
7539388|NCT01190930|11888505|FG006|Induction|Refusal|0
7539389|NCT01190930|11888506|FG007|Induction|Refusal|0
7539390|NCT01190930|11888507|FG008|Induction|Refusal|0
7539391|NCT01190930|11888508|FG009|Induction|Refusal|0
7539392|NCT01190930|11888499|FG000|Induction|Inevaluable|23
7539393|NCT01190930|11888500|FG001|Induction|Inevaluable|1
7539394|NCT01190930|11888501|FG002|Induction|Inevaluable|0
7539395|NCT01190930|11888502|FG003|Induction|Inevaluable|0
7539396|NCT01190930|11888503|FG004|Induction|Inevaluable|0
7539397|NCT01190930|11888504|FG005|Induction|Inevaluable|0
7539398|NCT01190930|11888505|FG006|Induction|Inevaluable|0
7539399|NCT01190930|11888506|FG007|Induction|Inevaluable|0
7539400|NCT01190930|11888507|FG008|Induction|Inevaluable|0
7539401|NCT01190930|11888508|FG009|Induction|Inevaluable|0
7539402|NCT01190930|11888499|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
7539403|NCT01190930|11888500|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539404|NCT01190930|11888501|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539405|NCT01190930|11888502|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539406|NCT01190930|11888503|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539407|NCT01190930|11888504|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539408|NCT01190930|11888505|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539409|NCT01190930|11888506|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539410|NCT01190930|11888507|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539411|NCT01190930|11888508|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
7539412|NCT01190930|11888499|FG000|Induction|High Risk Downs|80
7539413|NCT01190930|11888500|FG001|Induction|High Risk Downs|0
7539414|NCT01190930|11888501|FG002|Induction|High Risk Downs|0
7539415|NCT01190930|11888502|FG003|Induction|High Risk Downs|0
7539416|NCT01190930|11888503|FG004|Induction|High Risk Downs|0
7539417|NCT01190930|11888504|FG005|Induction|High Risk Downs|0
7539418|NCT01190930|11888505|FG006|Induction|High Risk Downs|0
7539419|NCT01190930|11888506|FG007|Induction|High Risk Downs|0
7539420|NCT01190930|11888507|FG008|Induction|High Risk Downs|0
7539421|NCT01190930|11888508|FG009|Induction|High Risk Downs|0
7539422|NCT01190930|11888499|FG000|Induction|Enrollment onto another COG Protocol|1
7539423|NCT01190930|11888500|FG001|Induction|Enrollment onto another COG Protocol|0
7539424|NCT01190930|11888501|FG002|Induction|Enrollment onto another COG Protocol|0
7539425|NCT01190930|11888502|FG003|Induction|Enrollment onto another COG Protocol|0
7539426|NCT01190930|11888503|FG004|Induction|Enrollment onto another COG Protocol|0
7539427|NCT01190930|11888504|FG005|Induction|Enrollment onto another COG Protocol|0
7539428|NCT01190930|11888505|FG006|Induction|Enrollment onto another COG Protocol|0
7539429|NCT01190930|11888506|FG007|Induction|Enrollment onto another COG Protocol|0
7539430|NCT01190930|11888507|FG008|Induction|Enrollment onto another COG Protocol|0
7539431|NCT01190930|11888508|FG009|Induction|Enrollment onto another COG Protocol|0
7539432|NCT01190930|11888499|FG000|Induction|Average Risk|1847
7539433|NCT01190930|11888500|FG001|Induction|Average Risk|0
7539434|NCT01190930|11888501|FG002|Induction|Average Risk|0
7539435|NCT01190930|11888502|FG003|Induction|Average Risk|0
7539436|NCT01190930|11888503|FG004|Induction|Average Risk|0
7539437|NCT01190930|11888504|FG005|Induction|Average Risk|0
7539438|NCT01190930|11888505|FG006|Induction|Average Risk|0
7539439|NCT01190930|11888506|FG007|Induction|Average Risk|0
7539440|NCT01190930|11888507|FG008|Induction|Average Risk|0
7539441|NCT01190930|11888508|FG009|Induction|Average Risk|0
7539442|NCT01190930|11888499|FG000|Induction|High Risk|1227
7539443|NCT01190930|11888500|FG001|Induction|High Risk|0
7539444|NCT01190930|11888501|FG002|Induction|High Risk|0
7539445|NCT01190930|11888502|FG003|Induction|High Risk|0
7539446|NCT01190930|11888503|FG004|Induction|High Risk|0
7539447|NCT01190930|11888504|FG005|Induction|High Risk|0
7539448|NCT01190930|11888505|FG006|Induction|High Risk|0
7539449|NCT01190930|11888506|FG007|Induction|High Risk|0
7539450|NCT01190930|11888507|FG008|Induction|High Risk|0
7539451|NCT01190930|11888508|FG009|Induction|High Risk|0
7539452|NCT01190930|11888499|FG000|Induction|Low Risk|443
7539453|NCT01190930|11888500|FG001|Induction|Low Risk|0
7539454|NCT01190930|11888501|FG002|Induction|Low Risk|0
7539455|NCT01190930|11888502|FG003|Induction|Low Risk|0
7539456|NCT01190930|11888503|FG004|Induction|Low Risk|0
7539457|NCT01190930|11888504|FG005|Induction|Low Risk|0
7539458|NCT01190930|11888505|FG006|Induction|Low Risk|0
7539459|NCT01190930|11888506|FG007|Induction|Low Risk|0
7539460|NCT01190930|11888507|FG008|Induction|Low Risk|0
7539461|NCT01190930|11888508|FG009|Induction|Low Risk|0
7539462|NCT01190930|11888499|FG000|Induction|Very High Risk|1012
7539463|NCT01190930|11888500|FG001|Induction|Very High Risk|0
7539464|NCT01190930|11888501|FG002|Induction|Very High Risk|0
7539465|NCT01190930|11888502|FG003|Induction|Very High Risk|0
7539466|NCT01190930|11888503|FG004|Induction|Very High Risk|0
7539467|NCT01190930|11888504|FG005|Induction|Very High Risk|0
7539468|NCT01190930|11888505|FG006|Induction|Very High Risk|0
7539469|NCT01190930|11888506|FG007|Induction|Very High Risk|0
7539470|NCT01190930|11888507|FG008|Induction|Very High Risk|0
7539471|NCT01190930|11888508|FG009|Induction|Very High Risk|0
7539472|NCT01190930|11888499|FG000|Induction|Philadelphia chromosome-positive|99
7539473|NCT01190930|11888500|FG001|Induction|Philadelphia chromosome-positive|0
7539474|NCT01190930|11888501|FG002|Induction|Philadelphia chromosome-positive|0
7539475|NCT01190930|11888502|FG003|Induction|Philadelphia chromosome-positive|0
7539476|NCT01190930|11888503|FG004|Induction|Philadelphia chromosome-positive|0
7539477|NCT01190930|11888504|FG005|Induction|Philadelphia chromosome-positive|0
7539478|NCT01190930|11888505|FG006|Induction|Philadelphia chromosome-positive|0
7539479|NCT01190930|11888506|FG007|Induction|Philadelphia chromosome-positive|0
7539480|NCT01190930|11888507|FG008|Induction|Philadelphia chromosome-positive|0
7539481|NCT01190930|11888508|FG009|Induction|Philadelphia chromosome-positive|0
7539482|NCT01190930|11888499|FG000|Induction|Incomplete Induction data|63
7539483|NCT01190930|11888500|FG001|Induction|Incomplete Induction data|0
7539484|NCT01190930|11888501|FG002|Induction|Incomplete Induction data|0
7539485|NCT01190930|11888502|FG003|Induction|Incomplete Induction data|0
7539486|NCT01190930|11888503|FG004|Induction|Incomplete Induction data|0
7539487|NCT01190930|11888504|FG005|Induction|Incomplete Induction data|0
7539488|NCT01190930|11888505|FG006|Induction|Incomplete Induction data|0
7539489|NCT01190930|11888506|FG007|Induction|Incomplete Induction data|0
7539490|NCT01190930|11888507|FG008|Induction|Incomplete Induction data|0
7539491|NCT01190930|11888508|FG009|Induction|Incomplete Induction data|0
7539492|NCT01190930|11888499|FG000|Induction|Progressive disease|0
7539493|NCT01190930|11888500|FG001|Induction|Progressive disease|1
7539494|NCT01190930|11888501|FG002|Induction|Progressive disease|0
7539495|NCT01190930|11888502|FG003|Induction|Progressive disease|0
7539496|NCT01190930|11888503|FG004|Induction|Progressive disease|0
7539497|NCT01190930|11888504|FG005|Induction|Progressive disease|0
7539498|NCT01190930|11888505|FG006|Induction|Progressive disease|0
7539499|NCT01190930|11888506|FG007|Induction|Progressive disease|0
7539500|NCT01190930|11888507|FG008|Induction|Progressive disease|0
7539501|NCT01190930|11888508|FG009|Induction|Progressive disease|0
7539502|NCT01190930|11888499|FG000|Induction|No treatment|3
7539503|NCT01190930|11888500|FG001|Induction|No treatment|0
7539504|NCT01190930|11888501|FG002|Induction|No treatment|0
7539505|NCT01190930|11888502|FG003|Induction|No treatment|0
7539506|NCT01190930|11888503|FG004|Induction|No treatment|0
7539507|NCT01190930|11888504|FG005|Induction|No treatment|0
7539508|NCT01190930|11888505|FG006|Induction|No treatment|0
7539509|NCT01190930|11888506|FG007|Induction|No treatment|0
7539510|NCT01190930|11888507|FG008|Induction|No treatment|0
7539511|NCT01190930|11888508|FG009|Induction|No treatment|0
7539512|NCT01190930|11888499|FG000|Induction|Ineligible|69
7539513|NCT01190930|11888500|FG001|Induction|Ineligible|4
7539514|NCT01190930|11888501|FG002|Induction|Ineligible|0
7539515|NCT01190930|11888502|FG003|Induction|Ineligible|0
7539516|NCT01190930|11888503|FG004|Induction|Ineligible|0
7539517|NCT01190930|11888504|FG005|Induction|Ineligible|0
7539518|NCT01190930|11888505|FG006|Induction|Ineligible|0
7539519|NCT01190930|11888506|FG007|Induction|Ineligible|0
7539520|NCT01190930|11888507|FG008|Induction|Ineligible|0
7539521|NCT01190930|11888508|FG009|Induction|Ineligible|0
7539522|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Adverse Event|0
7539523|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Adverse Event|0
7539524|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Adverse Event|8
7539525|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Adverse Event|0
7539526|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Adverse Event|0
7539527|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Adverse Event|0
7539528|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Adverse Event|0
7539529|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Adverse Event|0
7539530|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Adverse Event|0
7539531|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Adverse Event|0
7539532|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Death|0
7539533|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Death|0
7539534|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Death|8
7539535|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Death|4
7539536|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Death|0
7539537|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Death|0
7539538|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Death|0
7539539|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Death|0
7539540|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Death|0
7539541|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Death|0
7539542|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Physician Decision|0
7539543|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Physician Decision|2
7539544|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Physician Decision|35
7539545|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Physician Decision|7
7539546|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Physician Decision|5
7539547|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Physician Decision|3
7539548|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Physician Decision|0
7539549|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Physician Decision|0
7539550|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Physician Decision|0
7539551|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Physician Decision|0
7539552|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539553|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
7539554|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
7539555|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
7539556|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539557|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539558|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539559|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539560|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539561|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
7539562|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Refusal|0
7539563|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Refusal|2
7539564|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Refusal|694
7539565|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Refusal|4
7539566|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Refusal|0
7539567|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Refusal|3
7539568|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Refusal|0
7539569|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Refusal|0
7539570|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Refusal|0
7539571|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Refusal|0
7539572|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Inevaluable|0
7539573|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Inevaluable|0
7539574|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Inevaluable|6
7539575|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Inevaluable|0
7539576|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Inevaluable|0
7539577|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Inevaluable|0
7539578|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Inevaluable|0
7539579|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Inevaluable|0
7539580|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Inevaluable|0
7539581|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Inevaluable|0
7539582|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539583|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
7539584|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539585|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539586|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539587|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539588|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539589|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539590|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539591|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
7539592|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Progressive disease|0
7539593|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Progressive disease|0
7539594|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Progressive disease|1
7539595|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Progressive disease|0
7539596|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Progressive disease|0
7539597|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Progressive disease|0
7539598|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Progressive disease|0
7539599|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Progressive disease|0
7539600|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Progressive disease|0
7539601|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Progressive disease|0
7539602|NCT01190930|11888499|FG000|Post Induction Pre-Maintenance|Relapse|0
7539603|NCT01190930|11888500|FG001|Post Induction Pre-Maintenance|Relapse|0
7539604|NCT01190930|11888501|FG002|Post Induction Pre-Maintenance|Relapse|1
7539605|NCT01190930|11888502|FG003|Post Induction Pre-Maintenance|Relapse|0
7539606|NCT01190930|11888503|FG004|Post Induction Pre-Maintenance|Relapse|0
7539607|NCT01190930|11888504|FG005|Post Induction Pre-Maintenance|Relapse|0
7539608|NCT01190930|11888505|FG006|Post Induction Pre-Maintenance|Relapse|0
7539609|NCT01190930|11888506|FG007|Post Induction Pre-Maintenance|Relapse|0
7539610|NCT01190930|11888507|FG008|Post Induction Pre-Maintenance|Relapse|0
7539611|NCT01190930|11888508|FG009|Post Induction Pre-Maintenance|Relapse|0
7539612|NCT01190930|11888499|FG000|Maintenance|Adverse Event|0
7539613|NCT01190930|11888500|FG001|Maintenance|Adverse Event|0
7539614|NCT01190930|11888501|FG002|Maintenance|Adverse Event|0
7539615|NCT01190930|11888502|FG003|Maintenance|Adverse Event|0
7539616|NCT01190930|11888503|FG004|Maintenance|Adverse Event|0
7539617|NCT01190930|11888504|FG005|Maintenance|Adverse Event|1
7539618|NCT01190930|11888505|FG006|Maintenance|Adverse Event|1
7539619|NCT01190930|11888506|FG007|Maintenance|Adverse Event|3
7539620|NCT01190930|11888507|FG008|Maintenance|Adverse Event|3
7539621|NCT01190930|11888508|FG009|Maintenance|Adverse Event|0
7539622|NCT01190930|11888499|FG000|Maintenance|Death|0
7539623|NCT01190930|11888500|FG001|Maintenance|Death|0
7539624|NCT01190930|11888501|FG002|Maintenance|Death|0
7539625|NCT01190930|11888502|FG003|Maintenance|Death|1
7539626|NCT01190930|11888503|FG004|Maintenance|Death|0
7575706|NCT03927911|11959661|FG005|Overall Study|Protocol Violation|1
7575707|NCT03938857|11959688|FG000|Overall Study|Physician Decision|1
7575708|NCT03938857|11959689|FG001|Overall Study|Physician Decision|0
7575709|NCT03938857|11959690|FG002|Overall Study|Physician Decision|0
7575710|NCT03938857|11959691|FG003|Overall Study|Physician Decision|0
7575711|NCT03945981|11959705|FG000|Overall Study|Lost to Follow-up|12
7575712|NCT03945981|11959705|FG000|Overall Study|Physician Decision|4
7575713|NCT03945981|11959705|FG000|Overall Study|Withdrawal by Subject|6
7575714|NCT03945981|11959705|FG000|Overall Study|Protocol Violation|1
7575715|NCT03954834|11959722|FG000|Overall Study|Adverse Event|1
7575716|NCT03954834|11959723|FG001|Overall Study|Adverse Event|3
7575717|NCT03954834|11959724|FG002|Overall Study|Adverse Event|1
7575718|NCT03954834|11959725|FG003|Overall Study|Adverse Event|1
7575719|NCT03954834|11959722|FG000|Overall Study|Death|0
7575720|NCT03954834|11959723|FG001|Overall Study|Death|0
7575721|NCT03954834|11959724|FG002|Overall Study|Death|0
7575722|NCT03954834|11959725|FG003|Overall Study|Death|1
7539627|NCT01190930|11888504|FG005|Maintenance|Death|0
7539628|NCT01190930|11888505|FG006|Maintenance|Death|2
7539629|NCT01190930|11888506|FG007|Maintenance|Death|2
7539630|NCT01190930|11888507|FG008|Maintenance|Death|2
7539631|NCT01190930|11888508|FG009|Maintenance|Death|2
7539632|NCT01190930|11888499|FG000|Maintenance|Lost to Follow-up|0
7539633|NCT01190930|11888500|FG001|Maintenance|Lost to Follow-up|0
7539634|NCT01190930|11888501|FG002|Maintenance|Lost to Follow-up|0
7539635|NCT01190930|11888502|FG003|Maintenance|Lost to Follow-up|0
7539636|NCT01190930|11888503|FG004|Maintenance|Lost to Follow-up|0
7539637|NCT01190930|11888504|FG005|Maintenance|Lost to Follow-up|0
7539638|NCT01190930|11888505|FG006|Maintenance|Lost to Follow-up|1
7539639|NCT01190930|11888506|FG007|Maintenance|Lost to Follow-up|1
7539640|NCT01190930|11888507|FG008|Maintenance|Lost to Follow-up|1
7539641|NCT01190930|11888508|FG009|Maintenance|Lost to Follow-up|0
7539642|NCT01190930|11888499|FG000|Maintenance|Physician Decision|0
7539643|NCT01190930|11888500|FG001|Maintenance|Physician Decision|1
7539644|NCT01190930|11888501|FG002|Maintenance|Physician Decision|0
7539645|NCT01190930|11888502|FG003|Maintenance|Physician Decision|5
7539646|NCT01190930|11888503|FG004|Maintenance|Physician Decision|9
7539647|NCT01190930|11888504|FG005|Maintenance|Physician Decision|4
7539648|NCT01190930|11888505|FG006|Maintenance|Physician Decision|8
7539649|NCT01190930|11888506|FG007|Maintenance|Physician Decision|8
7539650|NCT01190930|11888507|FG008|Maintenance|Physician Decision|10
7539651|NCT01190930|11888508|FG009|Maintenance|Physician Decision|17
7539652|NCT01190930|11888499|FG000|Maintenance|Withdrawal by Subject|0
7539653|NCT01190930|11888500|FG001|Maintenance|Withdrawal by Subject|0
7539654|NCT01190930|11888501|FG002|Maintenance|Withdrawal by Subject|0
7539655|NCT01190930|11888502|FG003|Maintenance|Withdrawal by Subject|0
7539656|NCT01190930|11888503|FG004|Maintenance|Withdrawal by Subject|0
7539657|NCT01190930|11888504|FG005|Maintenance|Withdrawal by Subject|0
7539658|NCT01190930|11888505|FG006|Maintenance|Withdrawal by Subject|2
7539659|NCT01190930|11888506|FG007|Maintenance|Withdrawal by Subject|1
7539660|NCT01190930|11888507|FG008|Maintenance|Withdrawal by Subject|4
7539661|NCT01190930|11888508|FG009|Maintenance|Withdrawal by Subject|1
7539662|NCT01190930|11888499|FG000|Maintenance|Refusal|0
7539663|NCT01190930|11888500|FG001|Maintenance|Refusal|1
7539664|NCT01190930|11888501|FG002|Maintenance|Refusal|0
7539665|NCT01190930|11888502|FG003|Maintenance|Refusal|2
7539666|NCT01190930|11888503|FG004|Maintenance|Refusal|0
7539667|NCT01190930|11888504|FG005|Maintenance|Refusal|4
7539668|NCT01190930|11888505|FG006|Maintenance|Refusal|5
7539669|NCT01190930|11888506|FG007|Maintenance|Refusal|17
7539670|NCT01190930|11888507|FG008|Maintenance|Refusal|13
7539671|NCT01190930|11888508|FG009|Maintenance|Refusal|6
7539672|NCT01190930|11888499|FG000|Maintenance|second malignant neoplasm|0
7539673|NCT01190930|11888500|FG001|Maintenance|second malignant neoplasm|0
7539674|NCT01190930|11888501|FG002|Maintenance|second malignant neoplasm|0
7539675|NCT01190930|11888502|FG003|Maintenance|second malignant neoplasm|1
7539676|NCT01190930|11888503|FG004|Maintenance|second malignant neoplasm|0
7539677|NCT01190930|11888504|FG005|Maintenance|second malignant neoplasm|1
7539678|NCT01190930|11888505|FG006|Maintenance|second malignant neoplasm|0
7539679|NCT01190930|11888506|FG007|Maintenance|second malignant neoplasm|0
7539680|NCT01190930|11888507|FG008|Maintenance|second malignant neoplasm|1
7539681|NCT01190930|11888508|FG009|Maintenance|second malignant neoplasm|0
7539682|NCT01190930|11888499|FG000|Maintenance|Inevaluable|0
7539683|NCT01190930|11888500|FG001|Maintenance|Inevaluable|0
7539684|NCT01190930|11888501|FG002|Maintenance|Inevaluable|0
7539685|NCT01190930|11888502|FG003|Maintenance|Inevaluable|0
7539686|NCT01190930|11888503|FG004|Maintenance|Inevaluable|0
7539687|NCT01190930|11888504|FG005|Maintenance|Inevaluable|1
7539688|NCT01190930|11888505|FG006|Maintenance|Inevaluable|1
7539689|NCT01190930|11888506|FG007|Maintenance|Inevaluable|1
7539690|NCT01190930|11888507|FG008|Maintenance|Inevaluable|0
7539691|NCT01190930|11888508|FG009|Maintenance|Inevaluable|0
7539692|NCT01190930|11888499|FG000|Maintenance|Enrollment onto another COG Protocol|0
7539693|NCT01190930|11888500|FG001|Maintenance|Enrollment onto another COG Protocol|0
7539694|NCT01190930|11888501|FG002|Maintenance|Enrollment onto another COG Protocol|0
7539695|NCT01190930|11888502|FG003|Maintenance|Enrollment onto another COG Protocol|0
7539696|NCT01190930|11888503|FG004|Maintenance|Enrollment onto another COG Protocol|0
7539697|NCT01190930|11888504|FG005|Maintenance|Enrollment onto another COG Protocol|0
7539698|NCT01190930|11888505|FG006|Maintenance|Enrollment onto another COG Protocol|0
7539699|NCT01190930|11888506|FG007|Maintenance|Enrollment onto another COG Protocol|0
7539700|NCT01190930|11888507|FG008|Maintenance|Enrollment onto another COG Protocol|1
7539701|NCT01190930|11888508|FG009|Maintenance|Enrollment onto another COG Protocol|0
7539702|NCT01190930|11888499|FG000|Maintenance|Relapse|0
7539703|NCT01190930|11888500|FG001|Maintenance|Relapse|0
7539704|NCT01190930|11888501|FG002|Maintenance|Relapse|0
7539705|NCT01190930|11888502|FG003|Maintenance|Relapse|2
7539706|NCT01190930|11888503|FG004|Maintenance|Relapse|0
7539707|NCT01190930|11888504|FG005|Maintenance|Relapse|1
7539708|NCT01190930|11888505|FG006|Maintenance|Relapse|6
7539709|NCT01190930|11888506|FG007|Maintenance|Relapse|13
7539710|NCT01190930|11888507|FG008|Maintenance|Relapse|11
7539711|NCT01190930|11888508|FG009|Maintenance|Relapse|11
7539712|NCT01190930|11888499|FG000|Maintenance|Still on therapy|0
7539713|NCT01190930|11888500|FG001|Maintenance|Still on therapy|8
7539714|NCT01190930|11888501|FG002|Maintenance|Still on therapy|0
7539715|NCT01190930|11888502|FG003|Maintenance|Still on therapy|29
7539716|NCT01190930|11888503|FG004|Maintenance|Still on therapy|0
7539717|NCT01190930|11888504|FG005|Maintenance|Still on therapy|0
7539718|NCT01190930|11888505|FG006|Maintenance|Still on therapy|0
7539719|NCT01190930|11888506|FG007|Maintenance|Still on therapy|0
7539720|NCT01190930|11888507|FG008|Maintenance|Still on therapy|0
7539721|NCT01190930|11888508|FG009|Maintenance|Still on therapy|0
7539722|NCT00779324|11888543|FG000|Overall Study|Lost to Follow-up|2
7539723|NCT00779324|11888544|FG001|Overall Study|Lost to Follow-up|1
7539724|NCT00779324|11888543|FG000|Overall Study|Withdrawal by Subject|4
7539725|NCT00779324|11888544|FG001|Overall Study|Withdrawal by Subject|2
7539726|NCT00779324|11888543|FG000|Overall Study|Missed visit|1
7539727|NCT00779324|11888544|FG001|Overall Study|Missed visit|1
7539728|NCT00554788|11888553|FG000|Overall Study|Adverse Event|0
7539729|NCT00554788|11888554|FG001|Overall Study|Adverse Event|1
7539730|NCT00554788|11888555|FG002|Overall Study|Adverse Event|2
7539731|NCT00554788|11888553|FG000|Overall Study|Lost to Follow-up|4
7539732|NCT00554788|11888554|FG001|Overall Study|Lost to Follow-up|3
7539733|NCT00554788|11888555|FG002|Overall Study|Lost to Follow-up|3
7539734|NCT00554788|11888553|FG000|Overall Study|Physician Decision|1
7539735|NCT00554788|11888554|FG001|Overall Study|Physician Decision|1
7539736|NCT00554788|11888555|FG002|Overall Study|Physician Decision|3
7539737|NCT00554788|11888553|FG000|Overall Study|Withdrawal by Subject|0
7539738|NCT00554788|11888554|FG001|Overall Study|Withdrawal by Subject|0
7539739|NCT00554788|11888555|FG002|Overall Study|Withdrawal by Subject|1
7257801|NCT00334802|11469849|FG001|Overall Study|Adverse Event|3
7539740|NCT00554788|11888553|FG000|Overall Study|Refusal of further protocol therapy|0
7539741|NCT00554788|11888554|FG001|Overall Study|Refusal of further protocol therapy|1
7539742|NCT00554788|11888555|FG002|Overall Study|Refusal of further protocol therapy|1
7539743|NCT00554788|11888553|FG000|Overall Study|Progressive disease|0
7539744|NCT00554788|11888554|FG001|Overall Study|Progressive disease|0
7539745|NCT00554788|11888555|FG002|Overall Study|Progressive disease|3
7539746|NCT00554788|11888553|FG000|Overall Study|Ineligible|2
7539747|NCT00554788|11888554|FG001|Overall Study|Ineligible|0
7539748|NCT00554788|11888555|FG002|Overall Study|Ineligible|1
7539749|NCT00336024|11888570|FG000|Overall Study|Death|2
7539750|NCT00336024|11888571|FG001|Overall Study|Death|1
7539751|NCT00336024|11888570|FG000|Overall Study|Physician Decision|4
7539752|NCT00336024|11888571|FG001|Overall Study|Physician Decision|1
7539753|NCT00336024|11888570|FG000|Overall Study|Protocol Violation|1
7539754|NCT00336024|11888571|FG001|Overall Study|Protocol Violation|0
7539755|NCT00336024|11888570|FG000|Overall Study|Withdrawal by Subject|1
7539756|NCT00336024|11888571|FG001|Overall Study|Withdrawal by Subject|2
7539757|NCT00336024|11888570|FG000|Overall Study|Failure to fulfill consolidation|1
7539758|NCT00336024|11888571|FG001|Overall Study|Failure to fulfill consolidation|1
7539759|NCT00336024|11888570|FG000|Overall Study|Progressive Disease|4
7539760|NCT00336024|11888571|FG001|Overall Study|Progressive Disease|7
7539761|NCT00336024|11888570|FG000|Overall Study|Ineligible|7
7539762|NCT00336024|11888571|FG001|Overall Study|Ineligible|7
7539763|NCT00274937|11888577|FG000|Overall Study|Physician Decision|10
7539764|NCT00274937|11888577|FG000|Overall Study|Withdrawal by Subject|6
7539765|NCT00274937|11888577|FG000|Overall Study|Progressive Disease|4
7552109|NCT02980692|11911736|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7552110|NCT02980692|11911737|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7552111|NCT02980692|11911738|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
7552112|NCT02980692|11911739|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
7552113|NCT02980705|11911754|FG000|Overall Study|Adverse Event|0
7552114|NCT02980705|11911755|FG001|Overall Study|Adverse Event|1
7552115|NCT02980705|11911754|FG000|Overall Study|Withdrawal by Subject|6
7552116|NCT02980705|11911755|FG001|Overall Study|Withdrawal by Subject|9
7552117|NCT02980705|11911754|FG000|Overall Study|withdrew participation|0
7552118|NCT02980705|11911755|FG001|Overall Study|withdrew participation|1
7552119|NCT02980705|11911754|FG000|Overall Study|Lost to Follow-up|2
7552120|NCT02980705|11911755|FG001|Overall Study|Lost to Follow-up|0
7552121|NCT02980783|11911762|FG000|Overall Study|Lost to Follow-up|1
7552122|NCT02980874|11911768|FG000|Overall Study|Adverse Event|2
7552123|NCT02980874|11911769|FG001|Overall Study|Adverse Event|7
7552124|NCT02980874|11911768|FG000|Overall Study|Withdrawal by Subject|7
7552125|NCT02980874|11911769|FG001|Overall Study|Withdrawal by Subject|2
7552126|NCT02980874|11911768|FG000|Overall Study|Lost to Follow-up|5
7552127|NCT02980874|11911769|FG001|Overall Study|Lost to Follow-up|5
7552128|NCT02980874|11911768|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
7539766|NCT02737722|11888585|FG000|Overall Study|Physician Decision|0
7539767|NCT02737722|11888586|FG001|Overall Study|Physician Decision|0
7539768|NCT02737722|11888587|FG002|Overall Study|Physician Decision|1
7539769|NCT02737722|11888588|FG003|Overall Study|Physician Decision|0
7539770|NCT02737826|11888598|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
7539771|NCT02737826|11888599|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
7539772|NCT02737826|11888600|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
7539773|NCT02737852|11888609|FG000|Overall Study|Withdrawal by Subject|2
7539774|NCT02737930|11888633|FG000|Overall Study|Withdrawal by Subject|0
7539775|NCT02737930|11888634|FG001|Overall Study|Withdrawal by Subject|1
7575723|NCT03954834|11959722|FG000|Overall Study|Physician Decision|0
7575724|NCT03954834|11959723|FG001|Overall Study|Physician Decision|1
7539776|NCT02738008|11888643|FG000|Overall Study|Study Terminated by Sponsor|1
7539777|NCT02738008|11888644|FG001|Overall Study|Study Terminated by Sponsor|5
7539778|NCT02738008|11888645|FG002|Overall Study|Study Terminated by Sponsor|3
7539779|NCT02738008|11888643|FG000|Overall Study|Adverse Event|0
7539780|NCT02738008|11888644|FG001|Overall Study|Adverse Event|1
7539781|NCT02738008|11888645|FG002|Overall Study|Adverse Event|2
7539782|NCT02738138|11888667|FG000|Overall Study|Adverse Event|0
7539783|NCT02738138|11888668|FG001|Overall Study|Adverse Event|1
7539784|NCT02738138|11888667|FG000|Overall Study|Lost to Follow-up|2
7539785|NCT02738138|11888668|FG001|Overall Study|Lost to Follow-up|0
7539786|NCT02738138|11888667|FG000|Overall Study|Other - not further specified|1
7539787|NCT02738138|11888668|FG001|Overall Study|Other - not further specified|0
7539788|NCT02738151|11888675|FG000|Overall Study|Randomized but not treated|4
7539789|NCT02738151|11888676|FG001|Overall Study|Randomized but not treated|1
7539790|NCT02738151|11888675|FG000|Overall Study|Adverse Event|4
7539791|NCT02738151|11888676|FG001|Overall Study|Adverse Event|5
7539792|NCT02738151|11888675|FG000|Overall Study|Hypoglycemia|0
7539793|NCT02738151|11888676|FG001|Overall Study|Hypoglycemia|1
7539794|NCT02738151|11888675|FG000|Overall Study|Poor Compliance to Protocol|4
7539795|NCT02738151|11888676|FG001|Overall Study|Poor Compliance to Protocol|3
7539796|NCT02738151|11888675|FG000|Overall Study|Other than specified above|11
7539797|NCT02738151|11888676|FG001|Overall Study|Other than specified above|21
7539798|NCT02738203|11888684|FG000|Overall Study|Failed IUD Insertion|2
7539799|NCT02738203|11888685|FG001|Overall Study|Failed IUD Insertion|2
7539800|NCT02738203|11888684|FG000|Overall Study|Protocol Violation|0
7539801|NCT02738203|11888685|FG001|Overall Study|Protocol Violation|1
7539802|NCT02738333|11888694|FG000|Overall Study|Death|1
7539803|NCT02738333|11888695|FG001|Overall Study|Death|0
7539804|NCT02738333|11888696|FG002|Overall Study|Death|0
7539805|NCT02738333|11888694|FG000|Overall Study|Lost to Follow-up|1
7539806|NCT02738333|11888695|FG001|Overall Study|Lost to Follow-up|0
7539807|NCT02738333|11888696|FG002|Overall Study|Lost to Follow-up|0
7539808|NCT02738450|11888708|FG000|Overall Study|Withdrawal by Subject|0
7539809|NCT02738450|11888709|FG001|Overall Study|Withdrawal by Subject|2
7539810|NCT02738450|11888710|FG002|Overall Study|Withdrawal by Subject|0
7539811|NCT02738580|11888721|FG000|Overall Study|Adverse Event|1
7539812|NCT02738580|11888722|FG001|Overall Study|Adverse Event|0
7539813|NCT02738580|11888721|FG000|Overall Study|Lack of Efficacy|3
7539814|NCT02738580|11888722|FG001|Overall Study|Lack of Efficacy|2
7539815|NCT02738580|11888721|FG000|Overall Study|Withdrawal by Subject|0
7539816|NCT02738580|11888722|FG001|Overall Study|Withdrawal by Subject|1
7539817|NCT02738580|11888721|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
7539818|NCT02738580|11888722|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
7539819|NCT02738775|11888734|FG000|Overall Study|Withdrawal by Subject|0
7539820|NCT02738775|11888735|FG001|Overall Study|Withdrawal by Subject|1
7539821|NCT02738775|11888736|FG002|Overall Study|Withdrawal by Subject|0
7539822|NCT02738775|11888737|FG003|Overall Study|Withdrawal by Subject|0
7539823|NCT02738775|11888738|FG004|Overall Study|Withdrawal by Subject|0
7539824|NCT02738775|11888739|FG005|Overall Study|Withdrawal by Subject|0
7539825|NCT02738775|11888734|FG000|Overall Study|Adverse Event|0
7539826|NCT02738775|11888735|FG001|Overall Study|Adverse Event|0
7539827|NCT02738775|11888736|FG002|Overall Study|Adverse Event|0
7539828|NCT02738775|11888737|FG003|Overall Study|Adverse Event|1
7539829|NCT02738775|11888738|FG004|Overall Study|Adverse Event|0
7539830|NCT02738775|11888739|FG005|Overall Study|Adverse Event|0
7539831|NCT02738775|11888734|FG000|Overall Study|Pregnancy|0
7539832|NCT02738775|11888735|FG001|Overall Study|Pregnancy|1
7539833|NCT02738775|11888736|FG002|Overall Study|Pregnancy|0
7539834|NCT02738775|11888737|FG003|Overall Study|Pregnancy|0
7539835|NCT02738775|11888738|FG004|Overall Study|Pregnancy|0
7539836|NCT02738775|11888739|FG005|Overall Study|Pregnancy|0
7539837|NCT02738775|11888734|FG000|Overall Study|Missing|0
7539838|NCT02738775|11888735|FG001|Overall Study|Missing|0
7539839|NCT02738775|11888736|FG002|Overall Study|Missing|0
7539840|NCT02738775|11888737|FG003|Overall Study|Missing|0
7539841|NCT02738775|11888738|FG004|Overall Study|Missing|0
7539842|NCT02738775|11888739|FG005|Overall Study|Missing|1
7539843|NCT02738801|11888759|FG000|Overall Study|Adverse Event|1
7539844|NCT02738801|11888760|FG001|Overall Study|Adverse Event|1
7539845|NCT02738801|11888759|FG000|Overall Study|Withdrawal by Subject|0
7539846|NCT02738801|11888760|FG001|Overall Study|Withdrawal by Subject|1
7539847|NCT02738840|11888767|FG000|Overall Study|MRI Scan not Performed|5
7539848|NCT02738840|11888767|FG000|Overall Study|Lost to Follow-up|1
7539849|NCT02738840|11888767|FG000|Overall Study|Subject Participation Terminated by Investigator|1
7539850|NCT02738840|11888767|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
7539851|NCT02738879|11888773|FG000|Overall Study|Adverse Event|1
7539852|NCT02738879|11888774|FG001|Overall Study|Adverse Event|1
7539853|NCT02738879|11888773|FG000|Overall Study|Death|0
7539854|NCT02738879|11888774|FG001|Overall Study|Death|2
7539855|NCT02738879|11888773|FG000|Overall Study|Lost to Follow-up|1
7539856|NCT02738879|11888774|FG001|Overall Study|Lost to Follow-up|5
7539857|NCT02738879|11888773|FG000|Overall Study|Protocol Violation|1
7539858|NCT02738879|11888774|FG001|Overall Study|Protocol Violation|3
7539859|NCT02738879|11888773|FG000|Overall Study|Physician Decision|3
7539860|NCT02738879|11888774|FG001|Overall Study|Physician Decision|4
7539861|NCT02738879|11888773|FG000|Overall Study|Pregnancy|0
7539862|NCT02738879|11888774|FG001|Overall Study|Pregnancy|1
7539863|NCT02738879|11888773|FG000|Overall Study|Screen Failure|1
7539864|NCT02738879|11888774|FG001|Overall Study|Screen Failure|2
7539865|NCT02738879|11888773|FG000|Overall Study|Site Discontinued Study Participation|1
7539866|NCT02738879|11888774|FG001|Overall Study|Site Discontinued Study Participation|0
7539867|NCT02738879|11888773|FG000|Overall Study|Withdrawal by Subject|5
7539868|NCT02738879|11888774|FG001|Overall Study|Withdrawal by Subject|7
7539869|NCT02739269|11888790|FG000|Overall Study|Protocol Violation|5
7539870|NCT02739269|11888791|FG001|Overall Study|Protocol Violation|0
7539871|NCT02739269|11888790|FG000|Overall Study|Cycle cancellation|2
7539872|NCT02739269|11888791|FG001|Overall Study|Cycle cancellation|2
7539873|NCT02739269|11888790|FG000|Overall Study|Withdrawal by Subject|0
7539874|NCT02739269|11888791|FG001|Overall Study|Withdrawal by Subject|2
7539875|NCT02739321|11888799|FG000|Overall Study|Lack of Efficacy|1
7539876|NCT02739321|11888800|FG001|Overall Study|Lack of Efficacy|1
7539877|NCT02739321|11888799|FG000|Overall Study|Lost to Follow-up|1
7539878|NCT02739321|11888800|FG001|Overall Study|Lost to Follow-up|1
7539879|NCT02739321|11888799|FG000|Overall Study|Withdrawal by Subject|1
7539880|NCT02739321|11888800|FG001|Overall Study|Withdrawal by Subject|2
7539881|NCT02739360|11888815|FG000|Overall Study|Adverse Event|1
7539882|NCT02739360|11888815|FG000|Overall Study|Study terminated by Sponsor|2
7539883|NCT02739594|11888821|FG000|Overall Study|Undesired Event|3
7539884|NCT02739594|11888822|FG001|Overall Study|Undesired Event|4
7539885|NCT02739594|11888821|FG000|Overall Study|Violation of Eligibility Criteria|1
7539886|NCT02739594|11888822|FG001|Overall Study|Violation of Eligibility Criteria|2
7539887|NCT02739594|11888821|FG000|Overall Study|Protocol Violation|5
7575725|NCT03954834|11959724|FG002|Overall Study|Physician Decision|0
7575726|NCT03954834|11959725|FG003|Overall Study|Physician Decision|2
7575727|NCT03954834|11959722|FG000|Overall Study|Protocol Violation|1
7575728|NCT03954834|11959723|FG001|Overall Study|Protocol Violation|0
7575729|NCT03954834|11959724|FG002|Overall Study|Protocol Violation|0
7575730|NCT03954834|11959725|FG003|Overall Study|Protocol Violation|1
7575731|NCT03954834|11959722|FG000|Overall Study|Withdrawal by Subject|2
7539888|NCT02739594|11888822|FG001|Overall Study|Protocol Violation|6
7539889|NCT02739594|11888821|FG000|Overall Study|Death|4
7539890|NCT02739594|11888822|FG001|Overall Study|Death|2
7539891|NCT02739594|11888821|FG000|Overall Study|Renal Insufficiency|4
7539892|NCT02739594|11888822|FG001|Overall Study|Renal Insufficiency|6
7539893|NCT02739594|11888821|FG000|Overall Study|Administrative Reasons|1
7539894|NCT02739594|11888822|FG001|Overall Study|Administrative Reasons|3
7539895|NCT02739594|11888821|FG000|Overall Study|Withdrawal by Subject|1
7539896|NCT02739594|11888822|FG001|Overall Study|Withdrawal by Subject|1
7539897|NCT02739594|11888821|FG000|Overall Study|Lost to Follow-up|0
7539898|NCT02739594|11888822|FG001|Overall Study|Lost to Follow-up|1
7539899|NCT02739594|11888821|FG000|Overall Study|Elevated Serum Creatinine|0
7539900|NCT02739594|11888822|FG001|Overall Study|Elevated Serum Creatinine|1
7539901|NCT02739594|11888821|FG000|Overall Study|Other|6
7539902|NCT02739594|11888822|FG001|Overall Study|Other|2
7539903|NCT02739828|11888847|FG000|Overall Study|Adverse Event|1
7539904|NCT02739828|11888847|FG000|Overall Study|Lost to Follow-up|4
7539905|NCT02739984|11888853|FG000|Overall Study|Sponsor Decision|1
7539906|NCT02739984|11888854|FG001|Overall Study|Sponsor Decision|0
7539907|NCT02739984|11888853|FG000|Overall Study|Withdrawal by Subject|1
7539908|NCT02739984|11888854|FG001|Overall Study|Withdrawal by Subject|1
7539909|NCT02739984|11888853|FG000|Overall Study|Death|0
7539910|NCT02739984|11888854|FG001|Overall Study|Death|1
7539911|NCT02739984|11888853|FG000|Overall Study|Lost to Follow-up|3
7539912|NCT02739984|11888854|FG001|Overall Study|Lost to Follow-up|0
7539913|NCT02739997|11888860|FG000|Overall Study|Death|1
7539914|NCT02739997|11888860|FG000|Overall Study|Withdrawal by Subject|1
7539915|NCT02740049|11888864|FG000|Overall Study|Isolated cells did not grow sufficiently|1
7539916|NCT02740478|11888896|FG000|Overall Study|Withdrawal by Subject|1
7539917|NCT02741076|11888952|FG000|Overall Study|Adverse Event|0
7539918|NCT02741076|11888953|FG001|Overall Study|Adverse Event|1
7539919|NCT02741076|11888954|FG002|Overall Study|Adverse Event|1
7539920|NCT02741076|11888955|FG003|Overall Study|Adverse Event|0
7539921|NCT02741076|11888952|FG000|Overall Study|Lack of Efficacy|1
7539922|NCT02741076|11888953|FG001|Overall Study|Lack of Efficacy|0
7539923|NCT02741076|11888954|FG002|Overall Study|Lack of Efficacy|0
7539924|NCT02741076|11888955|FG003|Overall Study|Lack of Efficacy|0
7539925|NCT02741076|11888952|FG000|Overall Study|Withdrawal by Subject|0
7575732|NCT03954834|11959723|FG001|Overall Study|Withdrawal by Subject|3
7539926|NCT02741076|11888953|FG001|Overall Study|Withdrawal by Subject|1
7539927|NCT02741076|11888954|FG002|Overall Study|Withdrawal by Subject|0
7539928|NCT02741076|11888955|FG003|Overall Study|Withdrawal by Subject|0
7539929|NCT02741076|11888952|FG000|Overall Study|Sponsor Request|2
7539930|NCT02741076|11888953|FG001|Overall Study|Sponsor Request|3
7539931|NCT02741076|11888954|FG002|Overall Study|Sponsor Request|0
7539932|NCT02741076|11888955|FG003|Overall Study|Sponsor Request|1
7539933|NCT02741076|11888952|FG000|Overall Study|No additional information available|0
7539934|NCT02741076|11888953|FG001|Overall Study|No additional information available|0
7539935|NCT02741076|11888954|FG002|Overall Study|No additional information available|1
7539936|NCT02741076|11888955|FG003|Overall Study|No additional information available|1
7539937|NCT02741310|11888983|FG000|Overall Study|Sponsor Decision|2
7539938|NCT02741310|11888984|FG001|Overall Study|Sponsor Decision|2
7539939|NCT02741518|11889000|FG000|Overall Study|Withdrawal by Subject|1
7539940|NCT02741518|11889001|FG001|Overall Study|Withdrawal by Subject|1
7539941|NCT02741596|11889009|FG000|Overall Study|Adverse Event|1
7539942|NCT02741596|11889010|FG001|Overall Study|Adverse Event|5
7575733|NCT03954834|11959724|FG002|Overall Study|Withdrawal by Subject|13
7575734|NCT03954834|11959725|FG003|Overall Study|Withdrawal by Subject|6
7575735|NCT03954834|11959722|FG000|Overall Study|Participant left the country|0
7575736|NCT03954834|11959723|FG001|Overall Study|Participant left the country|0
7575737|NCT03954834|11959724|FG002|Overall Study|Participant left the country|1
7575738|NCT03954834|11959725|FG003|Overall Study|Participant left the country|0
7575739|NCT03954834|11959722|FG000|Overall Study|Lost to Follow-up|3
7575740|NCT03954834|11959723|FG001|Overall Study|Lost to Follow-up|2
7575741|NCT03954834|11959724|FG002|Overall Study|Lost to Follow-up|3
7575742|NCT03954834|11959725|FG003|Overall Study|Lost to Follow-up|5
7575743|NCT03961529|11959752|FG000|Overall Study|Adverse Event|13
7575744|NCT03961529|11959753|FG001|Overall Study|Adverse Event|5
7575745|NCT03961529|11959754|FG002|Overall Study|Adverse Event|2
7575746|NCT03961529|11959752|FG000|Overall Study|Withdrawal by Subject|17
7575747|NCT03961529|11959753|FG001|Overall Study|Withdrawal by Subject|2
7575748|NCT03961529|11959754|FG002|Overall Study|Withdrawal by Subject|1
7575749|NCT03961529|11959752|FG000|Overall Study|Withdrawal by parent/guardian|0
7575750|NCT03961529|11959753|FG001|Overall Study|Withdrawal by parent/guardian|7
7575751|NCT03961529|11959754|FG002|Overall Study|Withdrawal by parent/guardian|0
7575752|NCT03961529|11959752|FG000|Overall Study|Physician Decision|2
7575753|NCT03961529|11959753|FG001|Overall Study|Physician Decision|1
7575754|NCT03961529|11959754|FG002|Overall Study|Physician Decision|1
7575755|NCT03961529|11959752|FG000|Overall Study|Lost to Follow-up|2
7575756|NCT03961529|11959753|FG001|Overall Study|Lost to Follow-up|1
7575757|NCT03961529|11959754|FG002|Overall Study|Lost to Follow-up|0
7575758|NCT03961529|11959752|FG000|Overall Study|Lack of Efficacy|2
7575759|NCT03961529|11959753|FG001|Overall Study|Lack of Efficacy|0
7575760|NCT03961529|11959754|FG002|Overall Study|Lack of Efficacy|1
7575761|NCT03961529|11959752|FG000|Overall Study|Other|6
7575762|NCT03961529|11959753|FG001|Overall Study|Other|1
7575763|NCT03961529|11959754|FG002|Overall Study|Other|0
7575764|NCT03968159|11959764|FG000|Overall Study|Adverse Event|4
7575765|NCT03968159|11959765|FG001|Overall Study|Adverse Event|4
7575766|NCT03968159|11959764|FG000|Overall Study|Lost to Follow-up|1
7575767|NCT03968159|11959765|FG001|Overall Study|Lost to Follow-up|1
7575768|NCT03968159|11959764|FG000|Overall Study|Use of prohibited medication|0
7575769|NCT03968159|11959765|FG001|Overall Study|Use of prohibited medication|1
7575770|NCT03968159|11959764|FG000|Overall Study|Protocol Violation|2
7575771|NCT03968159|11959765|FG001|Overall Study|Protocol Violation|2
7575772|NCT03968159|11959764|FG000|Overall Study|Withdrawal by Subject|4
7575773|NCT03968159|11959765|FG001|Overall Study|Withdrawal by Subject|6
7575774|NCT03968159|11959764|FG000|Overall Study|Lack of Efficacy|0
7575775|NCT03968159|11959765|FG001|Overall Study|Lack of Efficacy|1
7575776|NCT03968159|11959764|FG000|Overall Study|Not further specified|2
7575777|NCT03968159|11959765|FG001|Overall Study|Not further specified|0
7575778|NCT03970824|11959783|FG000|Overall Study|Withdrawal by Subject|1
7575779|NCT03970824|11959784|FG001|Overall Study|Withdrawal by Subject|1
7539943|NCT02741596|11889009|FG000|Overall Study|Lost to Follow-up|1
7539944|NCT02741596|11889010|FG001|Overall Study|Lost to Follow-up|1
7539945|NCT02741596|11889009|FG000|Overall Study|Physician Decision|2
7539946|NCT02741596|11889010|FG001|Overall Study|Physician Decision|1
7539947|NCT02741596|11889009|FG000|Overall Study|Pregnancy|3
7539948|NCT02741596|11889010|FG001|Overall Study|Pregnancy|1
7539949|NCT02741596|11889009|FG000|Overall Study|Other (Unspecified)|0
7539950|NCT02741596|11889010|FG001|Overall Study|Other (Unspecified)|3
7539951|NCT02741596|11889009|FG000|Overall Study|Subject withdrawn-Other|17
7539952|NCT02741596|11889010|FG001|Overall Study|Subject withdrawn-Other|4
7539953|NCT02741596|11889009|FG000|Overall Study|Subject withdrawn-to commercial product|54
7539954|NCT02741596|11889010|FG001|Overall Study|Subject withdrawn-to commercial product|63
7539955|NCT02741635|11889016|FG000|Overall Study|Withdrawal by Subject|1
7539956|NCT02741713|11889032|FG000|Overall Study|Surgery type changed intra-operatively|2
7539957|NCT02741713|11889033|FG001|Overall Study|Surgery type changed intra-operatively|1
7539958|NCT02742103|11889046|FG000|Overall Study|Protocol Violation|1
7539959|NCT02742103|11889047|FG001|Overall Study|Protocol Violation|0
7539960|NCT02742103|11889046|FG000|Overall Study|Death|2
7539961|NCT02742103|11889047|FG001|Overall Study|Death|2
7539962|NCT02742103|11889046|FG000|Overall Study|Adverse Event|1
7539963|NCT02742103|11889047|FG001|Overall Study|Adverse Event|0
7539964|NCT02742103|11889046|FG000|Overall Study|Moved to another town|0
7539965|NCT02742103|11889047|FG001|Overall Study|Moved to another town|1
7539966|NCT02742103|11889046|FG000|Overall Study|Withdrawal by Subject|5
7539967|NCT02742103|11889047|FG001|Overall Study|Withdrawal by Subject|2
7539968|NCT02742441|11889067|FG000|Overall Study|Lost to Follow-up|4
7539969|NCT02742441|11889068|FG001|Overall Study|Lost to Follow-up|4
7539970|NCT02742441|11889067|FG000|Overall Study|Withdrawal by Subject|2
7539971|NCT02742441|11889068|FG001|Overall Study|Withdrawal by Subject|2
7539972|NCT02742441|11889067|FG000|Overall Study|Adverse Event|0
7539973|NCT02742441|11889068|FG001|Overall Study|Adverse Event|2
7539974|NCT02742519|11889076|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7539975|NCT02742519|11889077|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
7539976|NCT02742519|11889078|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
7539977|NCT02742519|11889076|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7539978|NCT02742519|11889077|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
7539979|NCT02742519|11889078|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
7539980|NCT02742519|11889076|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
7539981|NCT02742519|11889077|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
7539982|NCT02742519|11889078|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
7539983|NCT02742649|11889098|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
7539984|NCT02742649|11889099|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7539985|NCT02742649|11889100|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7539986|NCT02742649|11889101|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7539987|NCT02742649|11889102|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
7539988|NCT02742649|11889098|FG000|Double-Blind Treatment Period|Adverse Event|0
7539989|NCT02742649|11889099|FG001|Double-Blind Treatment Period|Adverse Event|1
7539990|NCT02742649|11889100|FG002|Double-Blind Treatment Period|Adverse Event|0
7539991|NCT02742649|11889101|FG003|Double-Blind Treatment Period|Adverse Event|0
7539992|NCT02742649|11889102|FG004|Double-Blind Treatment Period|Adverse Event|0
7539993|NCT02742649|11889098|FG000|Open-Label Period|Lost to Follow-up|0
7539994|NCT02742649|11889099|FG001|Open-Label Period|Lost to Follow-up|0
7539995|NCT02742649|11889100|FG002|Open-Label Period|Lost to Follow-up|0
7539996|NCT02742649|11889101|FG003|Open-Label Period|Lost to Follow-up|0
7539997|NCT02742649|11889102|FG004|Open-Label Period|Lost to Follow-up|1
7539998|NCT02742766|11889132|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7539999|NCT02742766|11889133|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540000|NCT02742766|11889134|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540001|NCT02742766|11889135|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540002|NCT02742766|11889136|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540003|NCT02742766|11889137|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540004|NCT02742766|11889138|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540005|NCT02742766|11889139|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540006|NCT02742766|11889140|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540007|NCT02742766|11889141|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540008|NCT02742766|11889142|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540009|NCT02742766|11889143|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540010|NCT02742766|11889144|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540011|NCT02742766|11889145|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
7540012|NCT02742766|11889146|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540013|NCT02742766|11889147|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540014|NCT02742766|11889148|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540015|NCT02742766|11889149|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540016|NCT02742766|11889150|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
7540017|NCT02742766|11889132|FG000|Part 2 (Up to 22 Days)|Physician Decision|0
7540018|NCT02742766|11889133|FG001|Part 2 (Up to 22 Days)|Physician Decision|0
7540019|NCT02742766|11889134|FG002|Part 2 (Up to 22 Days)|Physician Decision|0
7540020|NCT02742766|11889135|FG003|Part 2 (Up to 22 Days)|Physician Decision|0
7540021|NCT02742766|11889136|FG004|Part 2 (Up to 22 Days)|Physician Decision|0
7540022|NCT02742766|11889137|FG005|Part 2 (Up to 22 Days)|Physician Decision|0
7540023|NCT02742766|11889138|FG006|Part 2 (Up to 22 Days)|Physician Decision|0
7540024|NCT02742766|11889139|FG007|Part 2 (Up to 22 Days)|Physician Decision|0
7540025|NCT02742766|11889140|FG008|Part 2 (Up to 22 Days)|Physician Decision|0
7540026|NCT02742766|11889141|FG009|Part 2 (Up to 22 Days)|Physician Decision|0
7540027|NCT02742766|11889142|FG010|Part 2 (Up to 22 Days)|Physician Decision|0
7540028|NCT02742766|11889143|FG011|Part 2 (Up to 22 Days)|Physician Decision|0
7540029|NCT02742766|11889144|FG012|Part 2 (Up to 22 Days)|Physician Decision|2
7540030|NCT02742766|11889145|FG013|Part 2 (Up to 22 Days)|Physician Decision|5
7540031|NCT02742766|11889146|FG014|Part 2 (Up to 22 Days)|Physician Decision|0
7540032|NCT02742766|11889147|FG015|Part 2 (Up to 22 Days)|Physician Decision|1
7540033|NCT02742766|11889148|FG016|Part 2 (Up to 22 Days)|Physician Decision|0
7540034|NCT02742766|11889149|FG017|Part 2 (Up to 22 Days)|Physician Decision|0
7540035|NCT02742766|11889150|FG018|Part 2 (Up to 22 Days)|Physician Decision|0
7540036|NCT02742818|11889212|FG000|Overall Study|Adverse Event|0
7540037|NCT02742818|11889213|FG001|Overall Study|Adverse Event|1
7540038|NCT02742818|11889212|FG000|Overall Study|Protocol Violation|0
7540039|NCT02742818|11889213|FG001|Overall Study|Protocol Violation|1
7540040|NCT02743117|11889236|FG000|Overall Study|Lost to Follow-up|0
7540041|NCT02743117|11889237|FG001|Overall Study|Lost to Follow-up|1
7540042|NCT02743117|11889236|FG000|Overall Study|Other|1
7540043|NCT02743117|11889237|FG001|Overall Study|Other|0
7540044|NCT02743221|11889245|FG000|Overall Study|Progressive disease|29
7540045|NCT02743221|11889246|FG001|Overall Study|Progressive disease|38
7540046|NCT02743221|11889245|FG000|Overall Study|Adverse Event|17
7540047|NCT02743221|11889246|FG001|Overall Study|Adverse Event|14
7540048|NCT02743221|11889245|FG000|Overall Study|non medical reason|8
7540049|NCT02743221|11889246|FG001|Overall Study|non medical reason|2
7540050|NCT02743221|11889245|FG000|Overall Study|Physician Decision|2
7540051|NCT02743221|11889246|FG001|Overall Study|Physician Decision|5
7540052|NCT02743221|11889245|FG000|Overall Study|Patient not eligible, not treated|0
7540053|NCT02743221|11889246|FG001|Overall Study|Patient not eligible, not treated|1
7540054|NCT02743520|11889284|FG000|Overall Study|Withdrawal by Subject|1
7575780|NCT03970824|11959785|FG002|Overall Study|Withdrawal by Subject|3
7575781|NCT03970824|11959783|FG000|Overall Study|Lost to Follow-up|0
7575782|NCT03970824|11959784|FG001|Overall Study|Lost to Follow-up|2
7575783|NCT03970824|11959785|FG002|Overall Study|Lost to Follow-up|1
7575784|NCT03970824|11959783|FG000|Overall Study|Adverse Event|1
7575785|NCT03970824|11959784|FG001|Overall Study|Adverse Event|0
7575786|NCT03970824|11959785|FG002|Overall Study|Adverse Event|0
7575787|NCT03982069|11959831|FG000|Overall Study|Lost to Follow-up|5
7575788|NCT03982069|11959832|FG001|Overall Study|Lost to Follow-up|5
7575789|NCT03982069|11959833|FG002|Overall Study|Lost to Follow-up|3
7575790|NCT03982069|11959834|FG003|Overall Study|Lost to Follow-up|5
7575791|NCT03982069|11959831|FG000|Overall Study|Physician Decision|0
7575792|NCT03982069|11959832|FG001|Overall Study|Physician Decision|1
7575793|NCT03982069|11959833|FG002|Overall Study|Physician Decision|0
7575794|NCT03982069|11959834|FG003|Overall Study|Physician Decision|0
7575795|NCT03982069|11959831|FG000|Overall Study|Withdrawal by Subject|2
7575796|NCT03982069|11959832|FG001|Overall Study|Withdrawal by Subject|1
7257802|NCT00334802|11469848|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
7257803|NCT00334802|11469849|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
7257804|NCT00334893|11469860|FG000|Overall Study|Not Treated|1
7257805|NCT00334893|11469861|FG001|Overall Study|Not Treated|0
7257806|NCT00334958|11469871|FG000|Overall Study|Medication Noncompliance|0
7257807|NCT00334958|11469872|FG001|Overall Study|Medication Noncompliance|3
7257808|NCT00334958|11469871|FG000|Overall Study|Protocol Violation|2
7257809|NCT00334958|11469872|FG001|Overall Study|Protocol Violation|2
7257810|NCT00334958|11469871|FG000|Overall Study|Request of the investigator or sponsor|0
7257811|NCT00334958|11469872|FG001|Overall Study|Request of the investigator or sponsor|1
7575797|NCT03982069|11959833|FG002|Overall Study|Withdrawal by Subject|5
7575798|NCT03982069|11959834|FG003|Overall Study|Withdrawal by Subject|2
7575799|NCT03982069|11959831|FG000|Overall Study|Specimen loss|3
7575800|NCT03982069|11959832|FG001|Overall Study|Specimen loss|3
7575801|NCT03982069|11959833|FG002|Overall Study|Specimen loss|1
7575802|NCT03982069|11959834|FG003|Overall Study|Specimen loss|1
7575803|NCT03984812|11959853|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575804|NCT03984812|11959854|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575805|NCT03984812|11959855|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1
7540055|NCT02743780|11889302|FG000|Part 3 (7 Days)|Adverse Event|0
7540056|NCT02743780|11889303|FG001|Part 3 (7 Days)|Adverse Event|0
7540057|NCT02743780|11889304|FG002|Part 3 (7 Days)|Adverse Event|1
7540058|NCT02743780|11889305|FG003|Part 3 (7 Days)|Adverse Event|0
7540059|NCT02743780|11889306|FG004|Part 3 (7 Days)|Adverse Event|0
7540060|NCT02743793|11889328|FG000|Overall Study|Death|1
7540061|NCT02743793|11889329|FG001|Overall Study|Death|1
7540062|NCT02743793|11889328|FG000|Overall Study|Withdrawal by Subject|0
7540063|NCT02743793|11889329|FG001|Overall Study|Withdrawal by Subject|1
7540064|NCT02743793|11889328|FG000|Overall Study|Screen Failure|4
7540065|NCT02743793|11889329|FG001|Overall Study|Screen Failure|0
7540066|NCT02743793|11889328|FG000|Overall Study|No Primary Care Physician|0
7540067|NCT02743793|11889329|FG001|Overall Study|No Primary Care Physician|1
7540068|NCT02743793|11889328|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
7540069|NCT02743793|11889329|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
7540070|NCT02743793|11889328|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
7540071|NCT02743793|11889329|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
7540072|NCT02743949|11889346|FG000|Overall Study|Adverse Event|0
7540073|NCT02743949|11889347|FG001|Overall Study|Adverse Event|0
7540074|NCT02743949|11889348|FG002|Overall Study|Adverse Event|2
7540075|NCT02743949|11889346|FG000|Overall Study|Significant Protocol Deviation|2
7540076|NCT02743949|11889347|FG001|Overall Study|Significant Protocol Deviation|0
7540077|NCT02743949|11889348|FG002|Overall Study|Significant Protocol Deviation|1
7540078|NCT02743949|11889346|FG000|Overall Study|Voluntary Withdrawal|2
7540079|NCT02743949|11889347|FG001|Overall Study|Voluntary Withdrawal|1
7540080|NCT02743949|11889348|FG002|Overall Study|Voluntary Withdrawal|0
7540081|NCT02743962|11889358|FG000|Overall Study|Atrophic vaginitis diagnosed|1
7540082|NCT02743962|11889359|FG001|Overall Study|Atrophic vaginitis diagnosed|0
7540083|NCT02744066|11889370|FG000|Overall Study|Withdrawal by parent|0
7540084|NCT02744066|11889371|FG001|Overall Study|Withdrawal by parent|1
7540085|NCT02744066|11889370|FG000|Overall Study|Discharged from NICU prior to completion|0
7540086|NCT02744066|11889371|FG001|Overall Study|Discharged from NICU prior to completion|4
7540087|NCT02744391|11889379|FG000|Overall Study|Lost to Follow-up|9
7540088|NCT02744391|11889379|FG000|Overall Study|Physician Decision|2
7540089|NCT02744391|11889379|FG000|Overall Study|Withdrawal by Subject|3
7540090|NCT02744755|11889391|FG000|Study Period 1|Protocol Violation|2
7540091|NCT02744755|11889392|FG001|Study Period 1|Protocol Violation|1
7540092|NCT02744755|11889391|FG000|Study Period 1|not defined|0
7540093|NCT02744755|11889392|FG001|Study Period 1|not defined|1
7540094|NCT02744755|11889391|FG000|Study Period 1|Pregnancy|1
7540095|NCT02744755|11889392|FG001|Study Period 1|Pregnancy|0
7540096|NCT02744755|11889391|FG000|Study Period 1|Adverse Event|1
7540097|NCT02744755|11889392|FG001|Study Period 1|Adverse Event|1
7540098|NCT02744755|11889391|FG000|Study Period 1|Lost to Follow-up|1
7540099|NCT02744755|11889392|FG001|Study Period 1|Lost to Follow-up|1
7540100|NCT02744755|11889391|FG000|Study Period 1|Lack of Efficacy|1
7540101|NCT02744755|11889392|FG001|Study Period 1|Lack of Efficacy|0
7540102|NCT02744755|11889391|FG000|Study Period 1|Withdrawal by Subject|8
7540103|NCT02744755|11889392|FG001|Study Period 1|Withdrawal by Subject|4
7540104|NCT02744755|11889391|FG000|Study Period 2|Adverse Event|5
7540105|NCT02744755|11889392|FG001|Study Period 2|Adverse Event|0
7540106|NCT02744755|11889391|FG000|Study Period 2|Protocol Violation|1
7540107|NCT02744755|11889392|FG001|Study Period 2|Protocol Violation|0
7540108|NCT02744755|11889391|FG000|Study Period 2|not defined|3
7540109|NCT02744755|11889392|FG001|Study Period 2|not defined|2
7540110|NCT02744755|11889391|FG000|Study Period 2|Lost to Follow-up|0
7540111|NCT02744755|11889392|FG001|Study Period 2|Lost to Follow-up|2
7540112|NCT02744755|11889391|FG000|Study Period 2|Withdrawal by Subject|2
7540113|NCT02744755|11889392|FG001|Study Period 2|Withdrawal by Subject|2
7540114|NCT02744755|11889391|FG000|Study Period 2|Lack of Efficacy|3
7540115|NCT02744755|11889392|FG001|Study Period 2|Lack of Efficacy|2
7540116|NCT02744898|11889410|FG000|Overall Study|Progressive Disease|2
7540117|NCT02744898|11889410|FG000|Overall Study|Physician Decision|1
7540118|NCT02744898|11889410|FG000|Overall Study|Toxicity|1
7540119|NCT02745080|11889416|FG000|Overall Study|Adverse Event|13
7540120|NCT02745080|11889417|FG001|Overall Study|Adverse Event|21
7540121|NCT02745080|11889416|FG000|Overall Study|Lack of Efficacy|11
7540122|NCT02745080|11889417|FG001|Overall Study|Lack of Efficacy|23
7540123|NCT02745080|11889416|FG000|Overall Study|Lost to Follow-up|3
7540124|NCT02745080|11889417|FG001|Overall Study|Lost to Follow-up|3
7540125|NCT02745080|11889416|FG000|Overall Study|Physician Decision|3
7540126|NCT02745080|11889417|FG001|Overall Study|Physician Decision|0
7540127|NCT02745080|11889416|FG000|Overall Study|Protocol Violation|3
7540128|NCT02745080|11889417|FG001|Overall Study|Protocol Violation|1
7540129|NCT02745080|11889416|FG000|Overall Study|Withdrawal by Subject|22
7540130|NCT02745080|11889417|FG001|Overall Study|Withdrawal by Subject|41
7540131|NCT02745119|11889428|FG000|Overall Study|Adverse Event|1
7540132|NCT02745119|11889429|FG001|Overall Study|Adverse Event|0
7540133|NCT02745119|11889430|FG002|Overall Study|Adverse Event|1
7540134|NCT02745119|11889431|FG003|Overall Study|Adverse Event|3
7540135|NCT02745119|11889428|FG000|Overall Study|Death|3
7540136|NCT02745119|11889429|FG001|Overall Study|Death|3
7540137|NCT02745119|11889430|FG002|Overall Study|Death|0
7540138|NCT02745119|11889431|FG003|Overall Study|Death|4
7540139|NCT02745119|11889428|FG000|Overall Study|Lost to Follow-up|0
7540140|NCT02745119|11889429|FG001|Overall Study|Lost to Follow-up|0
7540141|NCT02745119|11889430|FG002|Overall Study|Lost to Follow-up|0
7540142|NCT02745119|11889431|FG003|Overall Study|Lost to Follow-up|1
7540143|NCT02745119|11889428|FG000|Overall Study|Protocol Deviation|0
7540144|NCT02745119|11889429|FG001|Overall Study|Protocol Deviation|0
7540145|NCT02745119|11889430|FG002|Overall Study|Protocol Deviation|0
7540146|NCT02745119|11889431|FG003|Overall Study|Protocol Deviation|1
7540147|NCT02745119|11889428|FG000|Overall Study|Withdrawal by Subject|7
7540148|NCT02745119|11889429|FG001|Overall Study|Withdrawal by Subject|15
7540149|NCT02745119|11889430|FG002|Overall Study|Withdrawal by Subject|8
7540150|NCT02745119|11889431|FG003|Overall Study|Withdrawal by Subject|14
7540151|NCT02745119|11889428|FG000|Overall Study|Study Terminated by Sponsor|134
7540152|NCT02745119|11889429|FG001|Overall Study|Study Terminated by Sponsor|252
7540153|NCT02745119|11889430|FG002|Overall Study|Study Terminated by Sponsor|135
7540154|NCT02745119|11889431|FG003|Overall Study|Study Terminated by Sponsor|251
7540155|NCT02745119|11889428|FG000|Overall Study|Physician Decision|0
7540156|NCT02745119|11889429|FG001|Overall Study|Physician Decision|2
7540157|NCT02745119|11889430|FG002|Overall Study|Physician Decision|2
7540158|NCT02745119|11889431|FG003|Overall Study|Physician Decision|2
7540159|NCT02745119|11889428|FG000|Overall Study|Reason Not Specified|0
7540160|NCT02745119|11889429|FG001|Overall Study|Reason Not Specified|2
7540161|NCT02745119|11889430|FG002|Overall Study|Reason Not Specified|0
7540162|NCT02745119|11889431|FG003|Overall Study|Reason Not Specified|1
7540163|NCT02745145|11889446|FG000|Overall Study|Adverse Event|1
7540164|NCT02745145|11889447|FG001|Overall Study|Adverse Event|0
7540165|NCT02745145|11889448|FG002|Overall Study|Adverse Event|0
7540166|NCT02745145|11889446|FG000|Overall Study|Death|0
7540167|NCT02745145|11889447|FG001|Overall Study|Death|1
7540168|NCT02745145|11889448|FG002|Overall Study|Death|0
7540169|NCT02745145|11889446|FG000|Overall Study|Progressive disease|0
7540170|NCT02745145|11889447|FG001|Overall Study|Progressive disease|0
7540171|NCT02745145|11889448|FG002|Overall Study|Progressive disease|1
7540172|NCT02745145|11889446|FG000|Overall Study|Withdrew consent|1
7540173|NCT02745145|11889447|FG001|Overall Study|Withdrew consent|1
7540174|NCT02745145|11889448|FG002|Overall Study|Withdrew consent|1
7540175|NCT02745145|11889446|FG000|Overall Study|Study Termination|8
7540176|NCT02745145|11889447|FG001|Overall Study|Study Termination|3
7540177|NCT02745145|11889448|FG002|Overall Study|Study Termination|7
7540178|NCT02745392|11889469|FG000|Overall Study|Lost to Follow-up|0
7540179|NCT02745392|11889470|FG001|Overall Study|Lost to Follow-up|1
7540180|NCT02745392|11889471|FG002|Overall Study|Lost to Follow-up|0
7540181|NCT02745392|11889472|FG003|Overall Study|Lost to Follow-up|0
7540182|NCT02746575|11889514|FG000|Overall Study|Surgery cancelled or time chaned|13
7540183|NCT02746575|11889514|FG000|Overall Study|Received epidural|10
7540184|NCT02746575|11889514|FG000|Overall Study|Withdrawal by Subject|3
7540185|NCT02746575|11889514|FG000|Overall Study|Bradycardia/hypotension|9
7540186|NCT02746575|11889514|FG000|Overall Study|Study paused|8
7540187|NCT02746575|11889514|FG000|Overall Study|put on beta-blocker|3
7540188|NCT02746575|11889514|FG000|Overall Study|type of surgery|1
7540189|NCT02746575|11889514|FG000|Overall Study|typ of surgery|1
7540190|NCT02746575|11889514|FG000|Overall Study|PI unavailable|1
7540191|NCT02746575|11889514|FG000|Overall Study|Unknown history of CVA|1
7540192|NCT02746627|11889521|FG000|Overall Study|Withdrawal by Subject|1
7540193|NCT02746627|11889522|FG001|Overall Study|Withdrawal by Subject|1
7540194|NCT02746627|11889523|FG002|Overall Study|Withdrawal by Subject|1
7540195|NCT02746679|11889533|FG000|Overall Study|Lost to Follow-up|4
7540196|NCT02746679|11889534|FG001|Overall Study|Lost to Follow-up|6
7540197|NCT02746705|11889542|FG000|Overall Study|Physician Decision|1
7540198|NCT02746705|11889543|FG001|Overall Study|Physician Decision|1
7540199|NCT02746705|11889542|FG000|Overall Study|Lost to Follow-up|1
7540200|NCT02746705|11889543|FG001|Overall Study|Lost to Follow-up|0
7540201|NCT02746705|11889542|FG000|Overall Study|outlier scores deemed not valid|0
7540202|NCT02746705|11889543|FG001|Overall Study|outlier scores deemed not valid|1
7540203|NCT02746874|11889551|FG000|Overall Study|Withdrawal by Subject|0
7540204|NCT02746874|11889552|FG001|Overall Study|Withdrawal by Subject|1
7540205|NCT02746874|11889551|FG000|Overall Study|Surgery Date Changed|0
7540206|NCT02746874|11889552|FG001|Overall Study|Surgery Date Changed|2
7575806|NCT03984812|11959856|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575807|NCT03984812|11959857|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575808|NCT03984812|11959858|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575809|NCT03984812|11959859|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575810|NCT03984812|11959860|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575811|NCT03984812|11959861|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575812|NCT03984812|11959862|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575813|NCT03984812|11959863|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0
7575814|NCT04006171|11959926|FG000|Overall Study|Withdrawal by Subject|8
7575815|NCT04006171|11959927|FG001|Overall Study|Withdrawal by Subject|7
7575816|NCT04006171|11959926|FG000|Overall Study|missing serum samples|2
7575817|NCT04006171|11959927|FG001|Overall Study|missing serum samples|2
7575818|NCT04006171|11959926|FG000|Overall Study|insufficient sample volume|2
7575819|NCT04006171|11959927|FG001|Overall Study|insufficient sample volume|3
7575820|NCT04013529|11959954|FG000|Overall Study|Withdrawal by Subject|1
7575821|NCT04013529|11959955|FG001|Overall Study|Withdrawal by Subject|1
7540228|NCT02747108|11889593|FG000|Overall Study|Death|2
7540229|NCT02747108|11889594|FG001|Overall Study|Death|2
7540230|NCT02747108|11889593|FG000|Overall Study|Withdrawal by Subject|1
7540231|NCT02747108|11889594|FG001|Overall Study|Withdrawal by Subject|0
7540232|NCT02747108|11889593|FG000|Overall Study|Protocol Violation|2
7540233|NCT02747108|11889594|FG001|Overall Study|Protocol Violation|0
7540234|NCT02747238|11889616|FG000|Overall Study|Lack of Efficacy|0
7540235|NCT02747238|11889617|FG001|Overall Study|Lack of Efficacy|1
7540236|NCT02747238|11889616|FG000|Overall Study|Data lost|3
7540237|NCT02747238|11889617|FG001|Overall Study|Data lost|5
7540238|NCT02747420|11889625|FG000|Overall Study|Lost to Follow-up|4
7540239|NCT02747420|11889626|FG001|Overall Study|Lost to Follow-up|2
7540240|NCT02747420|11889625|FG000|Overall Study|Withdrawal by Subject|3
7540241|NCT02747420|11889626|FG001|Overall Study|Withdrawal by Subject|2
7540242|NCT02747875|11889656|FG000|Overall Study|Physician Decision|1
7540243|NCT02747875|11889657|FG001|Overall Study|Physician Decision|0
7540244|NCT02747875|11889656|FG000|Overall Study|Adverse Event|0
7540245|NCT02747875|11889657|FG001|Overall Study|Adverse Event|1
7552129|NCT02980874|11911769|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
7552130|NCT02980874|11911768|FG000|Overall Study|Unknown study completion status|1
7552131|NCT02980874|11911769|FG001|Overall Study|Unknown study completion status|0
7552132|NCT02981342|11911788|FG000|Overall Study|Adverse Event|0
7552133|NCT02981342|11911789|FG001|Overall Study|Adverse Event|0
7552134|NCT02981342|11911790|FG002|Overall Study|Adverse Event|0
7552135|NCT02981342|11911791|FG003|Overall Study|Adverse Event|1
7552136|NCT02981342|11911788|FG000|Overall Study|Death|0
7552137|NCT02981342|11911789|FG001|Overall Study|Death|9
7552138|NCT02981342|11911790|FG002|Overall Study|Death|9
7552139|NCT02981342|11911791|FG003|Overall Study|Death|4
7552140|NCT02981342|11911788|FG000|Overall Study|Withdrawal by Subject|0
7552141|NCT02981342|11911789|FG001|Overall Study|Withdrawal by Subject|0
7552142|NCT02981342|11911790|FG002|Overall Study|Withdrawal by Subject|3
7552143|NCT02981342|11911791|FG003|Overall Study|Withdrawal by Subject|1
7552144|NCT02981342|11911788|FG000|Overall Study|Study closed by sponsor|0
7552145|NCT02981342|11911789|FG001|Overall Study|Study closed by sponsor|0
7552146|NCT02981342|11911790|FG002|Overall Study|Study closed by sponsor|1
7552147|NCT02981342|11911791|FG003|Overall Study|Study closed by sponsor|1
7552148|NCT02981342|11911788|FG000|Overall Study|Randomized, Never Treated|0
7552149|NCT02981342|11911789|FG001|Overall Study|Randomized, Never Treated|1
7552150|NCT02981342|11911790|FG002|Overall Study|Randomized, Never Treated|0
7552151|NCT02981342|11911791|FG003|Overall Study|Randomized, Never Treated|7
7552152|NCT02981342|11911788|FG000|Overall Study|Lost to Follow-up|0
7575822|NCT04018066|11959970|FG000|Overall Study|participants started taking medications during the study period|3
7575823|NCT04018066|11959970|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
7575824|NCT04041440|11960015|FG000|Overall Study|Withdrawal by Subject|0
7540258|NCT02748213|11889692|FG000|Overall Study|Withdrawal Prior to Treatment|1
7540259|NCT02748213|11889693|FG001|Overall Study|Withdrawal Prior to Treatment|2
7540260|NCT02748213|11889692|FG000|Overall Study|Abnormal Laboratory Test|1
7540261|NCT02748213|11889693|FG001|Overall Study|Abnormal Laboratory Test|0
7540262|NCT02748213|11889692|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
7540263|NCT02748213|11889693|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
7540264|NCT02748213|11889692|FG000|Overall Study|Death|5
7540265|NCT02748213|11889693|FG001|Overall Study|Death|3
7540266|NCT02748213|11889692|FG000|Overall Study|Insufficient Therapeutic Response|56
7540267|NCT02748213|11889693|FG001|Overall Study|Insufficient Therapeutic Response|57
7540268|NCT02748213|11889692|FG000|Overall Study|Violation of Selection Criteria|2
7540269|NCT02748213|11889693|FG001|Overall Study|Violation of Selection Criteria|0
7575825|NCT04041440|11960016|FG001|Overall Study|Withdrawal by Subject|1
7575826|NCT04041440|11960015|FG000|Overall Study|Lost to Follow-up|0
7575827|NCT04041440|11960016|FG001|Overall Study|Lost to Follow-up|1
7575828|NCT04041570|11960025|FG000|Overall Study|Moved from Area|0
7540270|NCT02748213|11889692|FG000|Overall Study|Protocol Violation|6
7540271|NCT02748213|11889693|FG001|Overall Study|Protocol Violation|4
7540272|NCT02748213|11889692|FG000|Overall Study|Refused Treatment*|6
7540273|NCT02748213|11889693|FG001|Overall Study|Refused Treatment*|6
7540274|NCT02748213|11889692|FG000|Overall Study|Failure to Return|1
7540275|NCT02748213|11889693|FG001|Overall Study|Failure to Return|0
7540276|NCT02748213|11889692|FG000|Overall Study|Other|30
7540277|NCT02748213|11889693|FG001|Overall Study|Other|29
7540278|NCT02748317|11889699|FG000|Overall Study|Withdrawal by Subject|14
7540279|NCT02748317|11889699|FG000|Overall Study|Lost to Follow-up|8
7540280|NCT02748317|11889699|FG000|Overall Study|Death|1
7540281|NCT02748356|11889703|FG000|Overall Study|Withdrawal by Subject|1
7540282|NCT02748512|11889709|FG000|Overall Study|Lost to Follow-up|1
7540283|NCT02748512|11889710|FG001|Overall Study|Lost to Follow-up|1
7540284|NCT02748694|11889735|FG000|Overall Study|Voluntary Withdrawal|0
7540285|NCT02748694|11889736|FG001|Overall Study|Voluntary Withdrawal|0
7540286|NCT02748694|11889737|FG002|Overall Study|Voluntary Withdrawal|0
7540287|NCT02748694|11889738|FG003|Overall Study|Voluntary Withdrawal|0
7540288|NCT02748694|11889739|FG004|Overall Study|Voluntary Withdrawal|0
7540289|NCT02748694|11889740|FG005|Overall Study|Voluntary Withdrawal|0
7540290|NCT02748694|11889741|FG006|Overall Study|Voluntary Withdrawal|0
7540291|NCT02748694|11889742|FG007|Overall Study|Voluntary Withdrawal|0
7540292|NCT02748694|11889743|FG008|Overall Study|Voluntary Withdrawal|0
7540293|NCT02748694|11889744|FG009|Overall Study|Voluntary Withdrawal|0
7540294|NCT02748694|11889745|FG010|Overall Study|Voluntary Withdrawal|0
7540295|NCT02748694|11889746|FG011|Overall Study|Voluntary Withdrawal|0
7540296|NCT02748694|11889747|FG012|Overall Study|Voluntary Withdrawal|0
7540297|NCT02748694|11889748|FG013|Overall Study|Voluntary Withdrawal|0
7540298|NCT02748694|11889749|FG014|Overall Study|Voluntary Withdrawal|2
7540299|NCT02748863|11889825|FG000|Treatment Period 1|Adverse Event|0
7540300|NCT02748863|11889826|FG001|Treatment Period 1|Adverse Event|1
7540301|NCT02748863|11889827|FG002|Treatment Period 1|Adverse Event|0
7540302|NCT02748863|11889828|FG003|Treatment Period 1|Adverse Event|0
7575829|NCT04041570|11960026|FG001|Overall Study|Moved from Area|2
7575830|NCT04043143|11960035|FG000|Overall Study|Lost to Follow-up|5
7575831|NCT04043143|11960036|FG001|Overall Study|Lost to Follow-up|5
7575832|NCT04043143|11960035|FG000|Overall Study|screen failure|1
7575833|NCT04043143|11960036|FG001|Overall Study|screen failure|0
7575834|NCT04052204|11960061|FG000|Overall Study|Death|1
7575835|NCT04052204|11960062|FG001|Overall Study|Death|0
7575836|NCT04052204|11960063|FG002|Overall Study|Death|0
7540303|NCT02748863|11889829|FG004|Treatment Period 1|Adverse Event|0
7540304|NCT02748863|11889825|FG000|Treatment Period 1|Lack of Efficacy|0
7540305|NCT02748863|11889826|FG001|Treatment Period 1|Lack of Efficacy|0
7540306|NCT02748863|11889827|FG002|Treatment Period 1|Lack of Efficacy|1
7540307|NCT02748863|11889828|FG003|Treatment Period 1|Lack of Efficacy|0
7540308|NCT02748863|11889829|FG004|Treatment Period 1|Lack of Efficacy|0
7540309|NCT02748863|11889825|FG000|Treatment Period 1|Withdrawal by Subject|0
7575837|NCT04052204|11960061|FG000|Overall Study|Progressive disease|1
7540310|NCT02748863|11889826|FG001|Treatment Period 1|Withdrawal by Subject|1
7540311|NCT02748863|11889827|FG002|Treatment Period 1|Withdrawal by Subject|1
7540312|NCT02748863|11889828|FG003|Treatment Period 1|Withdrawal by Subject|0
7540313|NCT02748863|11889829|FG004|Treatment Period 1|Withdrawal by Subject|0
7575838|NCT04052204|11960062|FG001|Overall Study|Progressive disease|0
7575839|NCT04052204|11960063|FG002|Overall Study|Progressive disease|0
7575840|NCT04052204|11960061|FG000|Overall Study|Other|1
7540314|NCT02748863|11889825|FG000|Treatment Period 2|Lost to Follow-up|2
7540315|NCT02748863|11889826|FG001|Treatment Period 2|Lost to Follow-up|0
7540316|NCT02748863|11889827|FG002|Treatment Period 2|Lost to Follow-up|0
7540317|NCT02748863|11889828|FG003|Treatment Period 2|Lost to Follow-up|0
7540318|NCT02748863|11889829|FG004|Treatment Period 2|Lost to Follow-up|0
7540319|NCT02748863|11889825|FG000|Treatment Period 2|Adverse Event|3
7540320|NCT02748863|11889826|FG001|Treatment Period 2|Adverse Event|2
7540321|NCT02748863|11889827|FG002|Treatment Period 2|Adverse Event|0
7540322|NCT02748863|11889828|FG003|Treatment Period 2|Adverse Event|2
7540323|NCT02748863|11889829|FG004|Treatment Period 2|Adverse Event|0
7540324|NCT02748863|11889825|FG000|Treatment Period 2|Lack of Efficacy|0
7540325|NCT02748863|11889826|FG001|Treatment Period 2|Lack of Efficacy|1
7540326|NCT02748863|11889827|FG002|Treatment Period 2|Lack of Efficacy|0
7540327|NCT02748863|11889828|FG003|Treatment Period 2|Lack of Efficacy|0
7540328|NCT02748863|11889829|FG004|Treatment Period 2|Lack of Efficacy|0
7540329|NCT02748863|11889825|FG000|Treatment Period 2|Pregnancy|0
7540330|NCT02748863|11889826|FG001|Treatment Period 2|Pregnancy|0
7540331|NCT02748863|11889827|FG002|Treatment Period 2|Pregnancy|0
7540332|NCT02748863|11889828|FG003|Treatment Period 2|Pregnancy|0
7540333|NCT02748863|11889829|FG004|Treatment Period 2|Pregnancy|1
7540334|NCT02749370|11889860|FG000|Overall Study|Withdrawal by Subject|11
7540335|NCT02749370|11889860|FG000|Overall Study|Lost to Follow-up|3
7540336|NCT02749721|11889864|FG000|Screening|Withdrawal by Subject|1
7540337|NCT02749721|11889864|FG000|Screening|Lost to Follow-up|2
7540338|NCT02749721|11889864|FG000|Screening|Protocol Violation|3
7540339|NCT02749721|11889864|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
7540340|NCT02749721|11889864|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
7540341|NCT02749799|11889870|FG000|Overall Study|Adverse Event|2
7540342|NCT02749799|11889870|FG000|Overall Study|Lost to Follow-up|4
7540343|NCT02749799|11889870|FG000|Overall Study|Protocol Violation|1
7540344|NCT02749799|11889870|FG000|Overall Study|Withdrawal by Subject|1
7540345|NCT02750306|11889891|FG000|Overall Study|Withdrawal by Subject|5
7540346|NCT02750306|11889892|FG001|Overall Study|Withdrawal by Subject|2
7540347|NCT02750306|11889891|FG000|Overall Study|Protocol Violation|1
7540348|NCT02750306|11889892|FG001|Overall Study|Protocol Violation|0
7540349|NCT02750332|11889898|FG000|Treatment Period 1|Withdrawal by Subject|0
7540350|NCT02750332|11889899|FG001|Treatment Period 1|Withdrawal by Subject|1
7540351|NCT02750345|11889905|FG000|Intervention 1|Adverse Event|0
7540352|NCT02750345|11889906|FG001|Intervention 1|Adverse Event|0
7540353|NCT02750345|11889907|FG002|Intervention 1|Adverse Event|0
7540354|NCT02750345|11889908|FG003|Intervention 1|Adverse Event|0
7540355|NCT02750345|11889909|FG004|Intervention 1|Adverse Event|1
7540356|NCT02750345|11889910|FG005|Intervention 1|Adverse Event|0
7540357|NCT02750410|11889922|FG000|Double-Blind Treatment Period|Adverse Event|2
7540358|NCT02750410|11889923|FG001|Double-Blind Treatment Period|Adverse Event|2
7540359|NCT02750410|11889922|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7540360|NCT02750410|11889923|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7540361|NCT02750410|11889922|FG000|Open-Label Extension Period|Adverse Event|5
7540362|NCT02750410|11889923|FG001|Open-Label Extension Period|Adverse Event|3
7540363|NCT02750410|11889922|FG000|Open-Label Extension Period|Protocol Violation|0
7540364|NCT02750410|11889923|FG001|Open-Label Extension Period|Protocol Violation|1
7540365|NCT02750410|11889922|FG000|Open-Label Extension Period|Withdrawal by Subject|1
7540366|NCT02750410|11889923|FG001|Open-Label Extension Period|Withdrawal by Subject|2
7540367|NCT02750501|11889933|FG000|Overall Study|Adverse Event|4
7540368|NCT02750501|11889933|FG000|Overall Study|Physician Decision|1
7540369|NCT02750501|11889933|FG000|Overall Study|Protocol Violation|1
7540370|NCT02750501|11889933|FG000|Overall Study|G-tube came out|1
7540371|NCT02750501|11889933|FG000|Overall Study|Non-compliant use of PERT|1
7540372|NCT02750514|11889946|FG000|Track 1|Disease progression|20
7540373|NCT02750514|11889947|FG001|Track 1|Disease progression|1
7540374|NCT02750514|11889948|FG002|Track 1|Disease progression|0
7540375|NCT02750514|11889949|FG003|Track 1|Disease progression|1
7540376|NCT02750514|11889950|FG004|Track 1|Disease progression|0
7540377|NCT02750514|11889946|FG000|Track 1|Adverse event unrelated to study drug|1
7540378|NCT02750514|11889947|FG001|Track 1|Adverse event unrelated to study drug|0
7540379|NCT02750514|11889948|FG002|Track 1|Adverse event unrelated to study drug|0
7540380|NCT02750514|11889949|FG003|Track 1|Adverse event unrelated to study drug|0
7540381|NCT02750514|11889950|FG004|Track 1|Adverse event unrelated to study drug|0
7540382|NCT02750514|11889946|FG000|Track 1|Study drug toxicity|4
7540383|NCT02750514|11889947|FG001|Track 1|Study drug toxicity|1
7540384|NCT02750514|11889948|FG002|Track 1|Study drug toxicity|0
7540385|NCT02750514|11889949|FG003|Track 1|Study drug toxicity|1
7540386|NCT02750514|11889950|FG004|Track 1|Study drug toxicity|0
7540387|NCT02750514|11889946|FG000|Track 1|Participant request to discontinue|1
7540388|NCT02750514|11889947|FG001|Track 1|Participant request to discontinue|0
7540389|NCT02750514|11889948|FG002|Track 1|Participant request to discontinue|0
7540390|NCT02750514|11889949|FG003|Track 1|Participant request to discontinue|0
7540391|NCT02750514|11889950|FG004|Track 1|Participant request to discontinue|0
7540392|NCT02750514|11889946|FG000|Track 1|Other reasons|1
7540393|NCT02750514|11889947|FG001|Track 1|Other reasons|0
7540394|NCT02750514|11889948|FG002|Track 1|Other reasons|0
7540395|NCT02750514|11889949|FG003|Track 1|Other reasons|0
7540396|NCT02750514|11889950|FG004|Track 1|Other reasons|0
7540397|NCT02750514|11889946|FG000|Track 2|Disease progression|4
7540398|NCT02750514|11889947|FG001|Track 2|Disease progression|5
7540399|NCT02750514|11889948|FG002|Track 2|Disease progression|2
7540400|NCT02750514|11889949|FG003|Track 2|Disease progression|5
7540401|NCT02750514|11889950|FG004|Track 2|Disease progression|0
7540402|NCT02750514|11889946|FG000|Track 2|Adverse event unrelated to study drug|1
7540403|NCT02750514|11889947|FG001|Track 2|Adverse event unrelated to study drug|0
7540404|NCT02750514|11889948|FG002|Track 2|Adverse event unrelated to study drug|0
7540405|NCT02750514|11889949|FG003|Track 2|Adverse event unrelated to study drug|0
7540406|NCT02750514|11889950|FG004|Track 2|Adverse event unrelated to study drug|0
7540407|NCT02750514|11889946|FG000|Track 2|Study drug toxicity|1
7540408|NCT02750514|11889947|FG001|Track 2|Study drug toxicity|2
7540409|NCT02750514|11889948|FG002|Track 2|Study drug toxicity|0
7540410|NCT02750514|11889949|FG003|Track 2|Study drug toxicity|2
7540411|NCT02750514|11889950|FG004|Track 2|Study drug toxicity|0
7540412|NCT02750514|11889946|FG000|Track 2|Participant withdrew consent|0
7540413|NCT02750514|11889947|FG001|Track 2|Participant withdrew consent|1
7540414|NCT02750514|11889948|FG002|Track 2|Participant withdrew consent|0
7540415|NCT02750514|11889949|FG003|Track 2|Participant withdrew consent|0
7540416|NCT02750514|11889950|FG004|Track 2|Participant withdrew consent|0
7540417|NCT02750514|11889946|FG000|Track 3|Disease progression|0
7540418|NCT02750514|11889947|FG001|Track 3|Disease progression|24
7540419|NCT02750514|11889948|FG002|Track 3|Disease progression|13
7540420|NCT02750514|11889949|FG003|Track 3|Disease progression|14
7540421|NCT02750514|11889950|FG004|Track 3|Disease progression|0
7540422|NCT02750514|11889946|FG000|Track 3|Adverse event unrelated to study drug|0
7540423|NCT02750514|11889947|FG001|Track 3|Adverse event unrelated to study drug|1
7540424|NCT02750514|11889948|FG002|Track 3|Adverse event unrelated to study drug|1
7540425|NCT02750514|11889949|FG003|Track 3|Adverse event unrelated to study drug|1
7540426|NCT02750514|11889950|FG004|Track 3|Adverse event unrelated to study drug|0
7540427|NCT02750514|11889946|FG000|Track 3|Study drug toxicity|0
7540428|NCT02750514|11889947|FG001|Track 3|Study drug toxicity|3
7540429|NCT02750514|11889948|FG002|Track 3|Study drug toxicity|0
7540430|NCT02750514|11889949|FG003|Track 3|Study drug toxicity|1
7540431|NCT02750514|11889950|FG004|Track 3|Study drug toxicity|0
7540432|NCT02750514|11889946|FG000|Track 3|Participant request to discontinue|0
7540433|NCT02750514|11889947|FG001|Track 3|Participant request to discontinue|2
7540434|NCT02750514|11889948|FG002|Track 3|Participant request to discontinue|0
7540435|NCT02750514|11889949|FG003|Track 3|Participant request to discontinue|0
7540436|NCT02750514|11889950|FG004|Track 3|Participant request to discontinue|0
7540437|NCT02750514|11889946|FG000|Track 3|Participant withdrew consent|0
7540438|NCT02750514|11889947|FG001|Track 3|Participant withdrew consent|3
7540439|NCT02750514|11889948|FG002|Track 3|Participant withdrew consent|1
7540440|NCT02750514|11889949|FG003|Track 3|Participant withdrew consent|0
7540441|NCT02750514|11889950|FG004|Track 3|Participant withdrew consent|0
7540442|NCT02750514|11889946|FG000|Track 3|Other reasons|0
7540443|NCT02750514|11889947|FG001|Track 3|Other reasons|3
7540444|NCT02750514|11889948|FG002|Track 3|Other reasons|0
7540445|NCT02750514|11889949|FG003|Track 3|Other reasons|0
7540446|NCT02750514|11889950|FG004|Track 3|Other reasons|0
7540447|NCT02750514|11889946|FG000|Track 4|Study drug toxicity|0
7575841|NCT04052204|11960062|FG001|Overall Study|Other|0
7575842|NCT04052204|11960063|FG002|Overall Study|Other|0
7575843|NCT04067011|11960083|FG000|Overall Study|Not Treated|8
7575844|NCT04067011|11960084|FG001|Overall Study|Not Treated|7
7575845|NCT04067011|11960085|FG002|Overall Study|Not Treated|5
7575846|NCT04067011|11960083|FG000|Overall Study|Adverse Event|2
7575847|NCT04067011|11960084|FG001|Overall Study|Adverse Event|1
7575848|NCT04067011|11960085|FG002|Overall Study|Adverse Event|0
7575849|NCT04067011|11960083|FG000|Overall Study|Withdrawal by Subject|6
7575850|NCT04067011|11960084|FG001|Overall Study|Withdrawal by Subject|2
7575851|NCT04067011|11960085|FG002|Overall Study|Withdrawal by Subject|1
7575852|NCT04067011|11960083|FG000|Overall Study|Lost to Follow-up|0
7575853|NCT04067011|11960084|FG001|Overall Study|Lost to Follow-up|0
7575854|NCT04067011|11960085|FG002|Overall Study|Lost to Follow-up|1
7575855|NCT04067011|11960083|FG000|Overall Study|Physician Decision|1
7575856|NCT04067011|11960084|FG001|Overall Study|Physician Decision|1
7575857|NCT04067011|11960085|FG002|Overall Study|Physician Decision|0
7575858|NCT04067011|11960083|FG000|Overall Study|Other Reasons|2
7575859|NCT04067011|11960084|FG001|Overall Study|Other Reasons|0
7575860|NCT04067011|11960085|FG002|Overall Study|Other Reasons|1
7575861|NCT04067011|11960083|FG000|Overall Study|Missing|0
7575862|NCT04067011|11960084|FG001|Overall Study|Missing|2
7575863|NCT04067011|11960085|FG002|Overall Study|Missing|0
7575864|NCT04072159|11960097|FG000|Overall Study|Lost to Follow-up|6
7257812|NCT00334958|11469871|FG000|Overall Study|Withdrawal by Subject|7
7540448|NCT02750514|11889947|FG001|Track 4|Study drug toxicity|6
7540449|NCT02750514|11889948|FG002|Track 4|Study drug toxicity|0
7540450|NCT02750514|11889949|FG003|Track 4|Study drug toxicity|5
7540451|NCT02750514|11889950|FG004|Track 4|Study drug toxicity|0
7540452|NCT02750514|11889946|FG000|Track 4|Participant request to discontinue|0
7540453|NCT02750514|11889947|FG001|Track 4|Participant request to discontinue|1
7575865|NCT04072159|11960098|FG001|Overall Study|Lost to Follow-up|6
7575866|NCT04072159|11960097|FG000|Overall Study|Withdrawal by Subject|2
7575867|NCT04072159|11960098|FG001|Overall Study|Withdrawal by Subject|0
7540454|NCT02750514|11889948|FG002|Track 4|Participant request to discontinue|0
7540455|NCT02750514|11889949|FG003|Track 4|Participant request to discontinue|1
7540456|NCT02750514|11889950|FG004|Track 4|Participant request to discontinue|0
7540457|NCT02750514|11889946|FG000|Track 4|Participant withdrew consent|0
7540458|NCT02750514|11889947|FG001|Track 4|Participant withdrew consent|1
7540459|NCT02750514|11889948|FG002|Track 4|Participant withdrew consent|0
7540460|NCT02750514|11889949|FG003|Track 4|Participant withdrew consent|0
7540461|NCT02750514|11889950|FG004|Track 4|Participant withdrew consent|0
7540462|NCT02750514|11889946|FG000|Track 4|Other reasons|0
7540463|NCT02750514|11889947|FG001|Track 4|Other reasons|5
7540464|NCT02750514|11889948|FG002|Track 4|Other reasons|0
7540465|NCT02750514|11889949|FG003|Track 4|Other reasons|3
7540466|NCT02750514|11889950|FG004|Track 4|Other reasons|0
7540467|NCT02750514|11889946|FG000|Track 4|Disease progression|0
7540468|NCT02750514|11889947|FG001|Track 4|Disease progression|33
7540469|NCT02750514|11889948|FG002|Track 4|Disease progression|0
7540470|NCT02750514|11889949|FG003|Track 4|Disease progression|32
7540471|NCT02750514|11889950|FG004|Track 4|Disease progression|0
7540472|NCT02750514|11889946|FG000|Track 4|Adverse event unrelated to study drug|0
7540473|NCT02750514|11889947|FG001|Track 4|Adverse event unrelated to study drug|5
7540474|NCT02750514|11889948|FG002|Track 4|Adverse event unrelated to study drug|0
7540475|NCT02750514|11889949|FG003|Track 4|Adverse event unrelated to study drug|0
7540476|NCT02750514|11889950|FG004|Track 4|Adverse event unrelated to study drug|0
7540477|NCT02750514|11889946|FG000|Track 4|Death|0
7540478|NCT02750514|11889947|FG001|Track 4|Death|0
7540479|NCT02750514|11889948|FG002|Track 4|Death|0
7540480|NCT02750514|11889949|FG003|Track 4|Death|1
7540481|NCT02750514|11889950|FG004|Track 4|Death|0
7540482|NCT02750514|11889946|FG000|Track 5|Disease progression|0
7540483|NCT02750514|11889947|FG001|Track 5|Disease progression|0
7540484|NCT02750514|11889948|FG002|Track 5|Disease progression|0
7540485|NCT02750514|11889949|FG003|Track 5|Disease progression|0
7540486|NCT02750514|11889950|FG004|Track 5|Disease progression|34
7540487|NCT02750514|11889946|FG000|Track 5|Adverse event unrelated to study drug|0
7540488|NCT02750514|11889947|FG001|Track 5|Adverse event unrelated to study drug|0
7540489|NCT02750514|11889948|FG002|Track 5|Adverse event unrelated to study drug|0
7540490|NCT02750514|11889949|FG003|Track 5|Adverse event unrelated to study drug|0
7540491|NCT02750514|11889950|FG004|Track 5|Adverse event unrelated to study drug|2
7540492|NCT02750514|11889946|FG000|Track 5|Study drug toxicity|0
7540493|NCT02750514|11889947|FG001|Track 5|Study drug toxicity|0
7540494|NCT02750514|11889948|FG002|Track 5|Study drug toxicity|0
7540495|NCT02750514|11889949|FG003|Track 5|Study drug toxicity|0
7540496|NCT02750514|11889950|FG004|Track 5|Study drug toxicity|2
7540497|NCT02750514|11889946|FG000|Track 5|Participant request to discontinue|0
7540498|NCT02750514|11889947|FG001|Track 5|Participant request to discontinue|0
7540499|NCT02750514|11889948|FG002|Track 5|Participant request to discontinue|0
7540500|NCT02750514|11889949|FG003|Track 5|Participant request to discontinue|0
7540501|NCT02750514|11889950|FG004|Track 5|Participant request to discontinue|3
7540502|NCT02750514|11889946|FG000|Track 5|Other reasons|0
7540503|NCT02750514|11889947|FG001|Track 5|Other reasons|0
7540504|NCT02750514|11889948|FG002|Track 5|Other reasons|0
7540505|NCT02750514|11889949|FG003|Track 5|Other reasons|0
7540506|NCT02750514|11889950|FG004|Track 5|Other reasons|2
7540507|NCT02750592|11889970|FG000|Overall Study|Adverse Event|3
7540508|NCT02750592|11889970|FG000|Overall Study|Lack of Efficacy|2
7540509|NCT02750618|11889974|FG000|Overall Study|Withdrawal by Subject|1
7540510|NCT02750709|11889978|FG000|Treatment Period 1|Adverse Event|0
7540511|NCT02750709|11889979|FG001|Treatment Period 1|Adverse Event|0
7540512|NCT02750709|11889980|FG002|Treatment Period 1|Adverse Event|0
7540513|NCT02750709|11889981|FG003|Treatment Period 1|Adverse Event|0
7540514|NCT02750709|11889982|FG004|Treatment Period 1|Adverse Event|0
7540515|NCT02750709|11889983|FG005|Treatment Period 1|Adverse Event|1
7540516|NCT02750761|11889997|FG000|Overall Study|Lost to Follow-up|0
7540517|NCT02750761|11889998|FG001|Overall Study|Lost to Follow-up|0
7540518|NCT02750761|11889999|FG002|Overall Study|Lost to Follow-up|1
7540519|NCT02750761|11890000|FG003|Overall Study|Lost to Follow-up|0
7540520|NCT02750761|11890001|FG004|Overall Study|Lost to Follow-up|0
7540521|NCT02750761|11890002|FG005|Overall Study|Lost to Follow-up|0
7540522|NCT02750800|11890026|FG000|Overall Study|Adverse Event|18
7540523|NCT02750800|11890026|FG000|Overall Study|Lost to Follow-up|12
7540524|NCT02750800|11890026|FG000|Overall Study|Investigator decision|53
7540525|NCT02750800|11890026|FG000|Overall Study|Patient request|12
7540526|NCT02750800|11890026|FG000|Overall Study|Other, not specified|3
7540527|NCT02750813|11890044|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
7540528|NCT02750813|11890045|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
7540529|NCT02750813|11890044|FG000|Period 1, First 14 Days of Wear|Reason not given|0
7540530|NCT02750813|11890045|FG001|Period 1, First 14 Days of Wear|Reason not given|1
7540531|NCT02750930|11890052|FG000|Overall Study|Study closed/terminated|8
7540532|NCT02750943|11890058|FG000|Overall Study|Lost to Follow-up|1
7540533|NCT02750943|11890059|FG001|Overall Study|Lost to Follow-up|2
7540534|NCT02750943|11890058|FG000|Overall Study|Withdrawal by Subject|5
7540535|NCT02750943|11890059|FG001|Overall Study|Withdrawal by Subject|7
7540536|NCT02751320|11890065|FG000|Overall Study|Adverse Event|2
7540537|NCT02751320|11890065|FG000|Overall Study|Withdrawal by Subject|1
7540538|NCT02751359|11890090|FG000|Overall Study|Lost to Follow-up|1
7540539|NCT02751424|11890118|FG000|Part 2|Adverse Event|0
7540540|NCT02751424|11890119|FG001|Part 2|Adverse Event|0
7540541|NCT02751424|11890120|FG002|Part 2|Adverse Event|0
7540542|NCT02751424|11890121|FG003|Part 2|Adverse Event|0
7540543|NCT02751424|11890122|FG004|Part 2|Adverse Event|0
7540544|NCT02751424|11890123|FG005|Part 2|Adverse Event|0
7540545|NCT02751424|11890124|FG006|Part 2|Adverse Event|0
7540546|NCT02751424|11890125|FG007|Part 2|Adverse Event|5
7540547|NCT02751424|11890126|FG008|Part 2|Adverse Event|0
7540548|NCT02751450|11890151|FG000|Overall Study|Adverse Event|1
7540549|NCT02751450|11890152|FG001|Overall Study|Adverse Event|0
7540550|NCT02751580|11890160|FG000|Overall Study|Lost to Follow-up|4
7540551|NCT02751580|11890160|FG000|Overall Study|Death|2
7540552|NCT02751827|11890167|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7540553|NCT02751827|11890168|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
7575868|NCT04094870|11960117|FG000|Overall Study|Lost to Follow-up|1
7575869|NCT04094870|11960118|FG001|Overall Study|Lost to Follow-up|1
7575870|NCT04123405|11960159|FG000|Overall Study|Adverse Event|1
7575871|NCT04123405|11960160|FG001|Overall Study|Adverse Event|2
7575872|NCT04123405|11960161|FG002|Overall Study|Adverse Event|3
7575873|NCT04123405|11960162|FG003|Overall Study|Adverse Event|3
7575874|NCT04123405|11960159|FG000|Overall Study|Exclusion criteria met|1
7575875|NCT04123405|11960160|FG001|Overall Study|Exclusion criteria met|2
7575876|NCT04123405|11960161|FG002|Overall Study|Exclusion criteria met|0
7575877|NCT04123405|11960162|FG003|Overall Study|Exclusion criteria met|2
7575878|NCT04123405|11960159|FG000|Overall Study|Withdrawal by Subject|1
7575879|NCT04123405|11960160|FG001|Overall Study|Withdrawal by Subject|3
7575880|NCT04123405|11960161|FG002|Overall Study|Withdrawal by Subject|0
7575881|NCT04123405|11960162|FG003|Overall Study|Withdrawal by Subject|2
7575882|NCT04123405|11960159|FG000|Overall Study|Contact to subject lost|0
7575883|NCT04123405|11960160|FG001|Overall Study|Contact to subject lost|0
7575884|NCT04123405|11960161|FG002|Overall Study|Contact to subject lost|0
7575885|NCT04123405|11960162|FG003|Overall Study|Contact to subject lost|1
7575886|NCT04123405|11960159|FG000|Overall Study|screening failure|1
7575887|NCT04123405|11960160|FG001|Overall Study|screening failure|0
7575888|NCT04123405|11960161|FG002|Overall Study|screening failure|0
7575889|NCT04123405|11960162|FG003|Overall Study|screening failure|0
7575890|NCT04147715|11960205|FG000|Overall Study|Adverse Event|0
7575891|NCT04147715|11960206|FG001|Overall Study|Adverse Event|0
7575892|NCT04147715|11960207|FG002|Overall Study|Adverse Event|0
7575893|NCT04147715|11960208|FG003|Overall Study|Adverse Event|0
7575894|NCT04147715|11960209|FG004|Overall Study|Adverse Event|0
7575895|NCT04147715|11960210|FG005|Overall Study|Adverse Event|0
7575896|NCT04147715|11960211|FG006|Overall Study|Adverse Event|0
7575897|NCT04147715|11960212|FG007|Overall Study|Adverse Event|2
7575898|NCT04147715|11960213|FG008|Overall Study|Adverse Event|1
7575899|NCT04147715|11960214|FG009|Overall Study|Adverse Event|0
7575900|NCT04147715|11960215|FG010|Overall Study|Adverse Event|0
7575901|NCT04147715|11960216|FG011|Overall Study|Adverse Event|0
7575902|NCT04154605|11960290|FG000|Overall Study|Procedure Canceled|1
7575903|NCT04154605|11960291|FG001|Overall Study|Procedure Canceled|1
7575904|NCT04154605|11960290|FG000|Overall Study|Missed follow up|1
7575905|NCT04154605|11960291|FG001|Overall Study|Missed follow up|1
7540554|NCT02751827|11890169|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
7540555|NCT02751931|11890191|FG000|Overall Study|Adverse Event|3
7540556|NCT02751931|11890192|FG001|Overall Study|Adverse Event|0
7540557|NCT02751931|11890191|FG000|Overall Study|Other: Miscelleneous|10
7540558|NCT02751931|11890192|FG001|Overall Study|Other: Miscelleneous|8
7540559|NCT02751983|11890206|FG000|Treatment|Stopped ACT, but Remained in study|2
7540560|NCT02751983|11890207|FG001|Treatment|Stopped ACT, but Remained in study|0
7540561|NCT02751983|11890206|FG000|Treatment|Discharged prior to beginning ACT|2
7540562|NCT02751983|11890207|FG001|Treatment|Discharged prior to beginning ACT|0
7540563|NCT02751983|11890206|FG000|Post-Treatment Assessment|Lost to Follow-up|5
7540564|NCT02751983|11890207|FG001|Post-Treatment Assessment|Lost to Follow-up|0
7540565|NCT02751983|11890206|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
7540566|NCT02751983|11890207|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
7540567|NCT02751983|11890206|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
7540568|NCT02751983|11890207|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
7540569|NCT02752048|11890216|FG000|Overall Study|Withdrawal by Subject|0
7540570|NCT02752048|11890217|FG001|Overall Study|Withdrawal by Subject|0
7540571|NCT02752048|11890218|FG002|Overall Study|Withdrawal by Subject|3
7540572|NCT02752074|11890228|FG000|Overall Study|Lost to Follow-up|1
7540573|NCT02752074|11890229|FG001|Overall Study|Lost to Follow-up|4
7540574|NCT02752074|11890228|FG000|Overall Study|Death|146
7540575|NCT02752074|11890229|FG001|Overall Study|Death|129
7540576|NCT02752074|11890228|FG000|Overall Study|Withdrawal by Subject|9
7540577|NCT02752074|11890229|FG001|Overall Study|Withdrawal by Subject|10
7540578|NCT02752087|11890235|FG000|Washout|Physician Decision|1
7540579|NCT02752087|11890236|FG001|Washout|Physician Decision|0
7540580|NCT02752633|11890260|FG000|Overall Study|Withdrawal by Subject|1
7540581|NCT02752776|11890267|FG000|Overall Study|Adverse Event|15
7540582|NCT02752776|11890268|FG001|Overall Study|Adverse Event|23
7540583|NCT02752776|11890269|FG002|Overall Study|Adverse Event|11
7540584|NCT02752776|11890267|FG000|Overall Study|Lack of Efficacy|2
7540585|NCT02752776|11890268|FG001|Overall Study|Lack of Efficacy|6
7540586|NCT02752776|11890269|FG002|Overall Study|Lack of Efficacy|14
7540587|NCT02752776|11890267|FG000|Overall Study|Lost to Follow-up|11
7540588|NCT02752776|11890268|FG001|Overall Study|Lost to Follow-up|12
7540589|NCT02752776|11890269|FG002|Overall Study|Lost to Follow-up|4
7540590|NCT02752776|11890267|FG000|Overall Study|Non-compliance with study treatment|0
7540591|NCT02752776|11890268|FG001|Overall Study|Non-compliance with study treatment|0
7540592|NCT02752776|11890269|FG002|Overall Study|Non-compliance with study treatment|1
7540593|NCT02752776|11890267|FG000|Overall Study|Physician Decision|2
7540594|NCT02752776|11890268|FG001|Overall Study|Physician Decision|6
7540595|NCT02752776|11890269|FG002|Overall Study|Physician Decision|2
7540596|NCT02752776|11890267|FG000|Overall Study|Pregnancy|1
7540597|NCT02752776|11890268|FG001|Overall Study|Pregnancy|6
7540598|NCT02752776|11890269|FG002|Overall Study|Pregnancy|3
7540599|NCT02752776|11890267|FG000|Overall Study|Protocol Violation|10
7540600|NCT02752776|11890268|FG001|Overall Study|Protocol Violation|13
7540601|NCT02752776|11890269|FG002|Overall Study|Protocol Violation|6
7540602|NCT02752776|11890267|FG000|Overall Study|Subject/guardian decision|8
7540603|NCT02752776|11890268|FG001|Overall Study|Subject/guardian decision|6
7540604|NCT02752776|11890269|FG002|Overall Study|Subject/guardian decision|4
7540605|NCT02752776|11890267|FG000|Overall Study|Death|0
7540606|NCT02752776|11890268|FG001|Overall Study|Death|0
7540607|NCT02752776|11890269|FG002|Overall Study|Death|1
7540608|NCT02752776|11890267|FG000|Overall Study|Withdrawal by Subject|3
7540609|NCT02752776|11890268|FG001|Overall Study|Withdrawal by Subject|4
7540610|NCT02752776|11890269|FG002|Overall Study|Withdrawal by Subject|2
7540611|NCT02752802|11890281|FG000|Overall Study|Contrast Volume Not Collected|1
7540612|NCT02752802|11890282|FG001|Overall Study|Contrast Volume Not Collected|0
7540613|NCT02752958|11890300|FG000|Overall Study|Adverse Event|3
7540614|NCT02752958|11890300|FG000|Overall Study|Lost to Follow-up|1
7540615|NCT02752958|11890300|FG000|Overall Study|Protocol Violation|1
7540616|NCT02752958|11890300|FG000|Overall Study|Withdrawal by Subject|2
7540617|NCT02752958|11890300|FG000|Overall Study|Other (Reason not specified)|2
7540618|NCT02753075|11890309|FG000|Overall Study|Adverse Event|2
7540619|NCT02753075|11890310|FG001|Overall Study|Adverse Event|1
7540620|NCT02753075|11890311|FG002|Overall Study|Adverse Event|0
7540621|NCT02753075|11890309|FG000|Overall Study|Lost to Follow-up|2
7540622|NCT02753075|11890310|FG001|Overall Study|Lost to Follow-up|0
7540623|NCT02753075|11890311|FG002|Overall Study|Lost to Follow-up|0
7540624|NCT02753075|11890309|FG000|Overall Study|Withdrawal of Consent|1
7540625|NCT02753075|11890310|FG001|Overall Study|Withdrawal of Consent|1
7540626|NCT02753075|11890311|FG002|Overall Study|Withdrawal of Consent|3
7540627|NCT02753075|11890309|FG000|Overall Study|Physician Decision|3
7540628|NCT02753075|11890310|FG001|Overall Study|Physician Decision|1
7540629|NCT02753075|11890311|FG002|Overall Study|Physician Decision|0
7540630|NCT02753400|11890322|FG000|Overall Study|Adverse Event|3
7540631|NCT02753400|11890323|FG001|Overall Study|Adverse Event|0
7540632|NCT02753400|11890322|FG000|Overall Study|Withdrawal by Subject|2
7540633|NCT02753400|11890323|FG001|Overall Study|Withdrawal by Subject|1
7540634|NCT02753595|11890340|FG000|Overall Study|Sponsor termination|2
7540635|NCT02753595|11890341|FG001|Overall Study|Sponsor termination|2
7540636|NCT02753816|11890364|FG000|Overall Study|Protocol Violation|0
7540637|NCT02753816|11890365|FG001|Overall Study|Protocol Violation|1
7540638|NCT02753816|11890366|FG002|Overall Study|Protocol Violation|0
7540639|NCT02753946|11890425|FG000|Overall Study|Adverse Event|7
7540640|NCT02753946|11890426|FG001|Overall Study|Adverse Event|6
7540641|NCT02753946|11890425|FG000|Overall Study|Withdrawal by Subject|6
7540642|NCT02753946|11890426|FG001|Overall Study|Withdrawal by Subject|1
7540643|NCT02753946|11890425|FG000|Overall Study|Lack of Efficacy|1
7540644|NCT02753946|11890426|FG001|Overall Study|Lack of Efficacy|0
7540645|NCT02753946|11890425|FG000|Overall Study|Physician Decision|0
7540646|NCT02753946|11890426|FG001|Overall Study|Physician Decision|2
7540647|NCT02754440|11890454|FG000|Overall Study|Protocol Violation|3
7540648|NCT02754440|11890455|FG001|Overall Study|Protocol Violation|2
7540649|NCT02754440|11890456|FG002|Overall Study|Protocol Violation|2
7540650|NCT02754440|11890457|FG003|Overall Study|Protocol Violation|6
7540651|NCT02754440|11890454|FG000|Overall Study|Adverse Event|3
7540652|NCT02754440|11890455|FG001|Overall Study|Adverse Event|1
7575906|NCT04154605|11960290|FG000|Overall Study|Withdrawal by Subject|1
7540653|NCT02754440|11890456|FG002|Overall Study|Adverse Event|0
7540654|NCT02754440|11890457|FG003|Overall Study|Adverse Event|9
7540655|NCT02754440|11890454|FG000|Overall Study|Withdrawal by Subject|0
7540656|NCT02754440|11890455|FG001|Overall Study|Withdrawal by Subject|0
7540657|NCT02754440|11890456|FG002|Overall Study|Withdrawal by Subject|0
7540658|NCT02754440|11890457|FG003|Overall Study|Withdrawal by Subject|1
7540659|NCT02754440|11890454|FG000|Overall Study|Equipment failure|0
7540660|NCT02754440|11890455|FG001|Overall Study|Equipment failure|5
7540661|NCT02754440|11890456|FG002|Overall Study|Equipment failure|5
7540662|NCT02754440|11890457|FG003|Overall Study|Equipment failure|7
7540663|NCT02754440|11890454|FG000|Overall Study|Subject issues not resulting in AE|0
7540664|NCT02754440|11890455|FG001|Overall Study|Subject issues not resulting in AE|0
7540665|NCT02754440|11890456|FG002|Overall Study|Subject issues not resulting in AE|0
7540666|NCT02754440|11890457|FG003|Overall Study|Subject issues not resulting in AE|12
7540667|NCT02754492|11890470|FG000|Overall Study|Protocol Violation|2
7540668|NCT02754492|11890471|FG001|Overall Study|Protocol Violation|2
7540669|NCT02754492|11890472|FG002|Overall Study|Protocol Violation|0
7540670|NCT02754492|11890473|FG003|Overall Study|Protocol Violation|1
7540671|NCT02754492|11890470|FG000|Overall Study|Withdrawal by Subject|2
7540672|NCT02754492|11890471|FG001|Overall Study|Withdrawal by Subject|0
7540673|NCT02754492|11890472|FG002|Overall Study|Withdrawal by Subject|0
7540674|NCT02754492|11890473|FG003|Overall Study|Withdrawal by Subject|0
7540675|NCT02754492|11890470|FG000|Overall Study|Equipment malfuntion|0
7540676|NCT02754492|11890471|FG001|Overall Study|Equipment malfuntion|0
7540677|NCT02754492|11890472|FG002|Overall Study|Equipment malfuntion|2
7540678|NCT02754492|11890473|FG003|Overall Study|Equipment malfuntion|5
7575907|NCT04154605|11960291|FG001|Overall Study|Withdrawal by Subject|0
7575908|NCT04160091|11960301|FG000|Overall Study|Terminated by Sponsor|7
7575909|NCT04160091|11960302|FG001|Overall Study|Terminated by Sponsor|3
7575910|NCT04160091|11960303|FG002|Overall Study|Terminated by Sponsor|5
7575911|NCT04160091|11960304|FG003|Overall Study|Terminated by Sponsor|2
7575912|NCT04160091|11960301|FG000|Overall Study|Noncompliance|0
7575913|NCT04160091|11960302|FG001|Overall Study|Noncompliance|0
7575914|NCT04160091|11960303|FG002|Overall Study|Noncompliance|0
7575915|NCT04160091|11960304|FG003|Overall Study|Noncompliance|1
7575916|NCT04160091|11960301|FG000|Overall Study|Withdrawal by Subject|0
7575917|NCT04160091|11960302|FG001|Overall Study|Withdrawal by Subject|0
7575918|NCT04160091|11960303|FG002|Overall Study|Withdrawal by Subject|0
7575919|NCT04160091|11960304|FG003|Overall Study|Withdrawal by Subject|1
7575920|NCT04164758|11960321|FG000|Overall Study|COVID-19 withdrawal of consent|1
7575921|NCT04164758|11960322|FG001|Overall Study|COVID-19 withdrawal of consent|0
7575922|NCT04164758|11960323|FG002|Overall Study|COVID-19 withdrawal of consent|0
7575923|NCT04164758|11960321|FG000|Overall Study|Adverse Event|0
7575924|NCT04164758|11960322|FG001|Overall Study|Adverse Event|1
7575925|NCT04164758|11960323|FG002|Overall Study|Adverse Event|0
7575926|NCT04165031|11960337|FG000|Overall Study|Adverse Event|1
7575927|NCT04165031|11960338|FG001|Overall Study|Adverse Event|1
7575928|NCT04165031|11960339|FG002|Overall Study|Adverse Event|0
7540679|NCT02754492|11890470|FG000|Overall Study|Adverse Event|0
7540680|NCT02754492|11890471|FG001|Overall Study|Adverse Event|0
7540681|NCT02754492|11890472|FG002|Overall Study|Adverse Event|0
7540682|NCT02754492|11890473|FG003|Overall Study|Adverse Event|13
7540683|NCT02754492|11890470|FG000|Overall Study|Venous access issues not resulting in AE|0
7540684|NCT02754492|11890471|FG001|Overall Study|Venous access issues not resulting in AE|0
7575929|NCT04165031|11960340|FG003|Overall Study|Adverse Event|0
7575930|NCT04165031|11960341|FG004|Overall Study|Adverse Event|0
7575931|NCT04165031|11960342|FG005|Overall Study|Adverse Event|0
7575932|NCT04165031|11960337|FG000|Overall Study|Withdrawal by Subject|0
7575933|NCT04165031|11960338|FG001|Overall Study|Withdrawal by Subject|0
7540685|NCT02754492|11890472|FG002|Overall Study|Venous access issues not resulting in AE|0
7540686|NCT02754492|11890473|FG003|Overall Study|Venous access issues not resulting in AE|4
7540687|NCT02755090|11890514|FG000|Overall Study|equipment malfunction|1
7540688|NCT02755090|11890515|FG001|Overall Study|equipment malfunction|0
7540689|NCT02755116|11890523|FG000|Overall Study|surgery converted to open, pt admitted|3
7540690|NCT02755116|11890524|FG001|Overall Study|surgery converted to open, pt admitted|1
7540691|NCT02755649|11890544|FG000|Overall Study|Transitioned into OLE study|99
7540692|NCT02755649|11890545|FG001|Overall Study|Transitioned into OLE study|98
7540693|NCT02755649|11890546|FG002|Overall Study|Transitioned into OLE study|100
7540694|NCT02755649|11890544|FG000|Overall Study|Did Not Complete Follow-up Visits|1
7540695|NCT02755649|11890545|FG001|Overall Study|Did Not Complete Follow-up Visits|0
7540696|NCT02755649|11890546|FG002|Overall Study|Did Not Complete Follow-up Visits|0
7540697|NCT02755649|11890544|FG000|Overall Study|Physician Decision|0
7540698|NCT02755649|11890545|FG001|Overall Study|Physician Decision|0
7540699|NCT02755649|11890546|FG002|Overall Study|Physician Decision|2
7540700|NCT02755649|11890544|FG000|Overall Study|Withdrawal by Subject|0
7540701|NCT02755649|11890545|FG001|Overall Study|Withdrawal by Subject|1
7540702|NCT02755649|11890546|FG002|Overall Study|Withdrawal by Subject|0
7540703|NCT02755649|11890544|FG000|Overall Study|Undecided|1
7540704|NCT02755649|11890545|FG001|Overall Study|Undecided|0
7540705|NCT02755649|11890546|FG002|Overall Study|Undecided|0
7540706|NCT02755805|11890556|FG000|Overall Study|Lost to Follow-up|1
7540707|NCT02755805|11890557|FG001|Overall Study|Lost to Follow-up|2
7540708|NCT02755805|11890556|FG000|Overall Study|Refused assessments|1
7540709|NCT02755805|11890557|FG001|Overall Study|Refused assessments|0
7540710|NCT02755805|11890556|FG000|Overall Study|Withdrawal by Subject|0
7540711|NCT02755805|11890557|FG001|Overall Study|Withdrawal by Subject|2
7540712|NCT02755818|11890567|FG000|Overall Study|Withdrawal by Subject|0
7540713|NCT02755818|11890568|FG001|Overall Study|Withdrawal by Subject|0
7540714|NCT02755818|11890569|FG002|Overall Study|Withdrawal by Subject|0
7540715|NCT02755818|11890570|FG003|Overall Study|Withdrawal by Subject|2
7540716|NCT02755818|11890567|FG000|Overall Study|withdrawal by PI|0
7540717|NCT02755818|11890568|FG001|Overall Study|withdrawal by PI|0
7540718|NCT02755818|11890569|FG002|Overall Study|withdrawal by PI|1
7540719|NCT02755818|11890570|FG003|Overall Study|withdrawal by PI|1
7540720|NCT02755831|11890584|FG000|Overall Study|Lost to Follow-up|3
7540721|NCT02755831|11890585|FG001|Overall Study|Lost to Follow-up|3
7540722|NCT02756078|11890595|FG000|Period 1|Unsatisfactory Lens Fitting|0
7540723|NCT02756078|11890596|FG001|Period 1|Unsatisfactory Lens Fitting|1
7540724|NCT02756078|11890595|FG000|Period 1|Lost to Follow-up|0
7540725|NCT02756078|11890596|FG001|Period 1|Lost to Follow-up|2
7540726|NCT02756078|11890595|FG000|Period 1|Protocol Violation|0
7540727|NCT02756078|11890596|FG001|Period 1|Protocol Violation|1
7540728|NCT02756078|11890595|FG000|Period 1|Adverse Event|1
7540729|NCT02756078|11890596|FG001|Period 1|Adverse Event|10
7540730|NCT02756078|11890595|FG000|Period 1|Withdrawal by Subject|6
7540731|NCT02756078|11890596|FG001|Period 1|Withdrawal by Subject|6
7540732|NCT02756078|11890595|FG000|Period 1|Lens Discomfort|2
7540733|NCT02756078|11890596|FG001|Period 1|Lens Discomfort|2
7540734|NCT02756078|11890595|FG000|Period 2|Adverse Event|3
7540735|NCT02756078|11890596|FG001|Period 2|Adverse Event|5
7540736|NCT02756078|11890595|FG000|Period 2|Unsatisfactory Lens Fitting|0
7540737|NCT02756078|11890596|FG001|Period 2|Unsatisfactory Lens Fitting|1
7540738|NCT02756078|11890595|FG000|Period 2|Withdrawal by Subject|3
7540739|NCT02756078|11890596|FG001|Period 2|Withdrawal by Subject|1
7540740|NCT02756182|11890602|FG000|Overall Study|StudyTechnical Difficulties|4
7540741|NCT02756338|11890608|FG000|Overall Study|Withdrawn by Investigator|1
7540742|NCT02756338|11890608|FG000|Overall Study|Device Replaced with Pacemaker|4
7540743|NCT02756364|11890624|FG000|Overall Study|Site Terminated by Sponsor|24
7540744|NCT02756364|11890625|FG001|Overall Study|Site Terminated by Sponsor|30
7540745|NCT02756364|11890626|FG002|Overall Study|Site Terminated by Sponsor|21
7540746|NCT02756364|11890624|FG000|Overall Study|Death|20
7540747|NCT02756364|11890625|FG001|Overall Study|Death|15
7540748|NCT02756364|11890626|FG002|Overall Study|Death|18
7540749|NCT02756364|11890624|FG000|Overall Study|Withdrawal by Patient|2
7540750|NCT02756364|11890625|FG001|Overall Study|Withdrawal by Patient|1
7540751|NCT02756364|11890626|FG002|Overall Study|Withdrawal by Patient|8
7540752|NCT02756364|11890624|FG000|Overall Study|Lost to Follow-up|0
7540753|NCT02756364|11890625|FG001|Overall Study|Lost to Follow-up|1
7540754|NCT02756364|11890626|FG002|Overall Study|Lost to Follow-up|1
7540755|NCT02756637|11890654|FG000|Overall Study|Not eligible for initial SWOG study|10
7540756|NCT02756637|11890655|FG001|Overall Study|Not eligible for initial SWOG study|10
7540757|NCT02756637|11890654|FG000|Overall Study|No available NLR value|44
7540758|NCT02756637|11890655|FG001|Overall Study|No available NLR value|44
7540759|NCT02756637|11890654|FG000|Overall Study|Did not complete curative therapy|33
7540760|NCT02756637|11890655|FG001|Overall Study|Did not complete curative therapy|0
7540761|NCT02756650|11890661|FG000|Overall Study|Physician Decision|1
7540762|NCT02756650|11890661|FG000|Overall Study|Adverse Event|1
7540763|NCT02756819|11890708|FG000|Overall Study|Lost for observation|23
7540764|NCT02756819|11890708|FG000|Overall Study|Patient's unwillingness|16
7540765|NCT02756819|11890708|FG000|Overall Study|Insufficient efficacy|2
7540766|NCT02756819|11890708|FG000|Overall Study|Adverse Event|2
7540767|NCT02756819|11890708|FG000|Overall Study|Reason not Specified|9
7540768|NCT02756832|11890712|FG000|Overall Study|Lost for Observation after Baseline|6
7540769|NCT02756832|11890712|FG000|Overall Study|Lost for Observation|13
7540770|NCT02756832|11890712|FG000|Overall Study|Patient's Unwillingness|12
7540771|NCT02756832|11890712|FG000|Overall Study|Insufficient Efficacy|2
7540772|NCT02756832|11890712|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
7540773|NCT02756832|11890712|FG000|Overall Study|Reason not Specified|9
7540774|NCT02756832|11890712|FG000|Overall Study|Protocol Deviation|10
7540775|NCT02757352|11890826|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
7540776|NCT02757352|11890827|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540777|NCT02757352|11890828|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
7540778|NCT02757352|11890829|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540779|NCT02757352|11890830|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540780|NCT02757352|11890831|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540781|NCT02757352|11890832|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540782|NCT02757352|11890833|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540783|NCT02757352|11890834|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540784|NCT02757352|11890835|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
7540785|NCT02757352|11890826|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540786|NCT02757352|11890827|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540787|NCT02757352|11890828|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
7552153|NCT02981342|11911789|FG001|Overall Study|Lost to Follow-up|1
7540788|NCT02757352|11890829|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540789|NCT02757352|11890830|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540790|NCT02757352|11890831|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540791|NCT02757352|11890832|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540792|NCT02757352|11890833|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540793|NCT02757352|11890834|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540794|NCT02757352|11890835|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
7540795|NCT02757352|11890826|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
7540796|NCT02757352|11890827|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
7540797|NCT02757352|11890828|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
7540798|NCT02757352|11890829|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540799|NCT02757352|11890830|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540800|NCT02757352|11890831|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540801|NCT02757352|11890832|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540802|NCT02757352|11890833|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540803|NCT02757352|11890834|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540804|NCT02757352|11890835|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
7540805|NCT02757352|11890826|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540806|NCT02757352|11890827|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
7540807|NCT02757352|11890828|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540808|NCT02757352|11890829|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540809|NCT02757352|11890830|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540810|NCT02757352|11890831|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540811|NCT02757352|11890832|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540812|NCT02757352|11890833|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540813|NCT02757352|11890834|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540814|NCT02757352|11890835|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
7540815|NCT02757352|11890826|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540816|NCT02757352|11890827|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
7540817|NCT02757352|11890828|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540818|NCT02757352|11890829|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540819|NCT02757352|11890830|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540820|NCT02757352|11890831|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540821|NCT02757352|11890832|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540822|NCT02757352|11890833|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540823|NCT02757352|11890834|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540824|NCT02757352|11890835|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
7540825|NCT02757352|11890826|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7540826|NCT02757352|11890827|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
7540827|NCT02757352|11890828|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
7540828|NCT02757352|11890829|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540829|NCT02757352|11890830|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540830|NCT02757352|11890831|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540831|NCT02757352|11890832|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540832|NCT02757352|11890833|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540833|NCT02757352|11890834|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540834|NCT02757352|11890835|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540835|NCT02757352|11890826|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
7540836|NCT02757352|11890827|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
7540837|NCT02757352|11890828|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
7540838|NCT02757352|11890829|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540839|NCT02757352|11890830|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540840|NCT02757352|11890831|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540841|NCT02757352|11890832|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540842|NCT02757352|11890833|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540843|NCT02757352|11890834|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540844|NCT02757352|11890835|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
7540845|NCT02757352|11890826|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540846|NCT02757352|11890827|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540847|NCT02757352|11890828|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540848|NCT02757352|11890829|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
7540849|NCT02757352|11890830|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540850|NCT02757352|11890831|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
7540851|NCT02757352|11890832|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540852|NCT02757352|11890833|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540853|NCT02757352|11890834|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540854|NCT02757352|11890835|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
7540855|NCT02757352|11890826|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540856|NCT02757352|11890827|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540857|NCT02757352|11890828|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540858|NCT02757352|11890829|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
7540859|NCT02757352|11890830|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
7540860|NCT02757352|11890831|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
7540861|NCT02757352|11890832|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540862|NCT02757352|11890833|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540863|NCT02757352|11890834|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540864|NCT02757352|11890835|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
7540865|NCT02757352|11890826|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540866|NCT02757352|11890827|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540867|NCT02757352|11890828|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540868|NCT02757352|11890829|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540869|NCT02757352|11890830|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
7540870|NCT02757352|11890831|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540871|NCT02757352|11890832|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540872|NCT02757352|11890833|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540873|NCT02757352|11890834|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540874|NCT02757352|11890835|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
7540875|NCT02757352|11890826|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540876|NCT02757352|11890827|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540877|NCT02757352|11890828|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540878|NCT02757352|11890829|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540879|NCT02757352|11890830|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540880|NCT02757352|11890831|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
7540881|NCT02757352|11890832|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540882|NCT02757352|11890833|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540883|NCT02757352|11890834|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540884|NCT02757352|11890835|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
7540885|NCT02757352|11890826|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540886|NCT02757352|11890827|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540887|NCT02757352|11890828|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540888|NCT02757352|11890829|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
7540889|NCT02757352|11890830|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7540890|NCT02757352|11890831|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
7540891|NCT02757352|11890832|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540892|NCT02757352|11890833|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540893|NCT02757352|11890834|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540894|NCT02757352|11890835|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
7540895|NCT02757352|11890826|FG000|Follow-Up Period|Adverse Event|0
7540896|NCT02757352|11890827|FG001|Follow-Up Period|Adverse Event|0
7540897|NCT02757352|11890828|FG002|Follow-Up Period|Adverse Event|0
7540898|NCT02757352|11890829|FG003|Follow-Up Period|Adverse Event|0
7540899|NCT02757352|11890830|FG004|Follow-Up Period|Adverse Event|0
7540900|NCT02757352|11890831|FG005|Follow-Up Period|Adverse Event|0
7540901|NCT02757352|11890832|FG006|Follow-Up Period|Adverse Event|1
7540902|NCT02757352|11890833|FG007|Follow-Up Period|Adverse Event|0
7540903|NCT02757352|11890834|FG008|Follow-Up Period|Adverse Event|2
7540904|NCT02757352|11890835|FG009|Follow-Up Period|Adverse Event|0
7540905|NCT02757352|11890826|FG000|Follow-Up Period|Lost to Follow-up|0
7540906|NCT02757352|11890827|FG001|Follow-Up Period|Lost to Follow-up|0
7540907|NCT02757352|11890828|FG002|Follow-Up Period|Lost to Follow-up|0
7540908|NCT02757352|11890829|FG003|Follow-Up Period|Lost to Follow-up|0
7540909|NCT02757352|11890830|FG004|Follow-Up Period|Lost to Follow-up|0
7540910|NCT02757352|11890831|FG005|Follow-Up Period|Lost to Follow-up|0
7540911|NCT02757352|11890832|FG006|Follow-Up Period|Lost to Follow-up|0
7540912|NCT02757352|11890833|FG007|Follow-Up Period|Lost to Follow-up|0
7540913|NCT02757352|11890834|FG008|Follow-Up Period|Lost to Follow-up|1
7540914|NCT02757352|11890835|FG009|Follow-Up Period|Lost to Follow-up|0
7540915|NCT02757352|11890826|FG000|Follow-Up Period|Lack of Efficacy|0
7540916|NCT02757352|11890827|FG001|Follow-Up Period|Lack of Efficacy|0
7540917|NCT02757352|11890828|FG002|Follow-Up Period|Lack of Efficacy|0
7540918|NCT02757352|11890829|FG003|Follow-Up Period|Lack of Efficacy|0
7540919|NCT02757352|11890830|FG004|Follow-Up Period|Lack of Efficacy|0
7540920|NCT02757352|11890831|FG005|Follow-Up Period|Lack of Efficacy|0
7540921|NCT02757352|11890832|FG006|Follow-Up Period|Lack of Efficacy|0
7540922|NCT02757352|11890833|FG007|Follow-Up Period|Lack of Efficacy|0
7540923|NCT02757352|11890834|FG008|Follow-Up Period|Lack of Efficacy|1
7540924|NCT02757352|11890835|FG009|Follow-Up Period|Lack of Efficacy|1
7540925|NCT02757352|11890826|FG000|Follow-Up Period|Withdrawal by Subject|0
7540926|NCT02757352|11890827|FG001|Follow-Up Period|Withdrawal by Subject|0
7540927|NCT02757352|11890828|FG002|Follow-Up Period|Withdrawal by Subject|0
7540928|NCT02757352|11890829|FG003|Follow-Up Period|Withdrawal by Subject|0
7540929|NCT02757352|11890830|FG004|Follow-Up Period|Withdrawal by Subject|0
7540930|NCT02757352|11890831|FG005|Follow-Up Period|Withdrawal by Subject|0
7540931|NCT02757352|11890832|FG006|Follow-Up Period|Withdrawal by Subject|0
7540932|NCT02757352|11890833|FG007|Follow-Up Period|Withdrawal by Subject|1
7540933|NCT02757352|11890834|FG008|Follow-Up Period|Withdrawal by Subject|6
7540934|NCT02757352|11890835|FG009|Follow-Up Period|Withdrawal by Subject|2
7540935|NCT02757430|11890866|FG000|Overall Study|Physician Decision|6
7540936|NCT02757430|11890866|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
7540937|NCT02757430|11890866|FG000|Overall Study|No informed consent|1
7540938|NCT02757430|11890866|FG000|Overall Study|No procedure performed|2
7540939|NCT02757625|11890883|FG000|Overall Study|Investigator's discretion|0
7540940|NCT02757625|11890884|FG001|Overall Study|Investigator's discretion|0
7540941|NCT02757625|11890885|FG002|Overall Study|Investigator's discretion|1
7540942|NCT02757625|11890886|FG003|Overall Study|Investigator's discretion|0
7540943|NCT02757625|11890883|FG000|Overall Study|Adverse Event|0
7540944|NCT02757625|11890884|FG001|Overall Study|Adverse Event|0
7540945|NCT02757625|11890885|FG002|Overall Study|Adverse Event|1
7540946|NCT02757625|11890886|FG003|Overall Study|Adverse Event|0
7552154|NCT02981342|11911790|FG002|Overall Study|Lost to Follow-up|0
7552155|NCT02981342|11911791|FG003|Overall Study|Lost to Follow-up|0
7552156|NCT02981524|11911839|FG000|Overall Study|Progressive Disease|14
7552157|NCT02981524|11911839|FG000|Overall Study|Death (unrelated)|1
7552158|NCT02981524|11911839|FG000|Overall Study|Treatment Related Toxicity|1
7552159|NCT02981524|11911839|FG000|Overall Study|Withdrawal by Subject|1
7552160|NCT02981602|11911848|FG000|Overall Study|Adverse Event|0
7552161|NCT02981602|11911849|FG001|Overall Study|Adverse Event|0
7552162|NCT02981602|11911850|FG002|Overall Study|Adverse Event|0
7552163|NCT02981602|11911851|FG003|Overall Study|Adverse Event|1
7552164|NCT02981602|11911852|FG004|Overall Study|Adverse Event|0
7552165|NCT02981953|11911865|FG000|Overall Study|Death|9
7552166|NCT02981953|11911865|FG000|Overall Study|Withdrawal by Subject|1
7552167|NCT02981953|11911865|FG000|Overall Study|Withdrawal to non-compliance|1
7257813|NCT00334958|11469872|FG001|Overall Study|Withdrawal by Subject|4
7552168|NCT02982018|11911871|FG000|Overall Study|Incorrect Lens Dispensed|1
7552169|NCT02982018|11911872|FG001|Overall Study|Incorrect Lens Dispensed|0
7552170|NCT02982018|11911871|FG000|Overall Study|Protocol Violation|1
7552171|NCT02982018|11911872|FG001|Overall Study|Protocol Violation|1
7540947|NCT02757768|11890900|FG000|Overall Study|Randomized Never Received Study Drug|3
7540948|NCT02757768|11890901|FG001|Overall Study|Randomized Never Received Study Drug|4
7540949|NCT02757768|11890900|FG000|Overall Study|Adverse Event|5
7540950|NCT02757768|11890901|FG001|Overall Study|Adverse Event|3
7540951|NCT02757768|11890900|FG000|Overall Study|Lack of Efficacy|2
7540952|NCT02757768|11890901|FG001|Overall Study|Lack of Efficacy|1
7540953|NCT02757768|11890900|FG000|Overall Study|Lost to Follow-up|1
7540954|NCT02757768|11890901|FG001|Overall Study|Lost to Follow-up|0
7540955|NCT02757768|11890900|FG000|Overall Study|Protocol Deviation|2
7540956|NCT02757768|11890901|FG001|Overall Study|Protocol Deviation|9
7540957|NCT02757768|11890900|FG000|Overall Study|Withdrawal by Subject|16
7540958|NCT02757768|11890901|FG001|Overall Study|Withdrawal by Subject|9
7540959|NCT02757768|11890900|FG000|Overall Study|Miscellaneous|4
7540960|NCT02757768|11890901|FG001|Overall Study|Miscellaneous|2
7540961|NCT02757963|11890919|FG000|Overall Study|Adverse Event|3
7540962|NCT02757963|11890919|FG000|Overall Study|Reached Stopping Criteria|1054
7540963|NCT02757963|11890919|FG000|Overall Study|Lost to Follow-up|5
7540964|NCT02757963|11890919|FG000|Overall Study|Physician Decision|1
7540965|NCT02757963|11890919|FG000|Overall Study|Withdrawal by Subject|34
7540966|NCT02758171|11890947|FG000|Wash-out|Withdrawal by Subject|1
7540967|NCT02758171|11890948|FG001|Wash-out|Withdrawal by Subject|0
7540968|NCT02758171|11890947|FG000|Wash-out|Other reason|1
7540969|NCT02758171|11890948|FG001|Wash-out|Other reason|0
7540970|NCT02758301|11890960|FG000|Overall Study|Death|12
7540971|NCT02758301|11890961|FG001|Overall Study|Death|0
7540972|NCT02758301|11890960|FG000|Overall Study|Physician Decision|10
7540973|NCT02758301|11890961|FG001|Overall Study|Physician Decision|1
7540974|NCT02758301|11890960|FG000|Overall Study|Withdrawal by Subject|5
7540975|NCT02758301|11890961|FG001|Overall Study|Withdrawal by Subject|6
7575934|NCT04165031|11960339|FG002|Overall Study|Withdrawal by Subject|1
7575935|NCT04165031|11960340|FG003|Overall Study|Withdrawal by Subject|0
7575936|NCT04165031|11960341|FG004|Overall Study|Withdrawal by Subject|0
7575937|NCT04165031|11960342|FG005|Overall Study|Withdrawal by Subject|0
7575938|NCT04171414|11960361|FG000|Overall Study|Death|1
7575939|NCT04171414|11960361|FG000|Overall Study|Withdrawal by Subject|1
7575940|NCT04175808|11960365|FG000|Part A|Miscellaneous|2
7575941|NCT04175808|11960366|FG001|Part A|Miscellaneous|0
7575942|NCT04175808|11960367|FG002|Part A|Miscellaneous|0
7575943|NCT04175808|11960368|FG003|Part A|Miscellaneous|0
7575944|NCT04175808|11960369|FG004|Part A|Miscellaneous|0
7257814|NCT00334958|11469871|FG000|Overall Study|Adverse Event|27
7257815|NCT00334958|11469872|FG001|Overall Study|Adverse Event|12
7257816|NCT00334958|11469871|FG000|Overall Study|Other|1
7540976|NCT02758301|11890960|FG000|Overall Study|Lost to Follow-up|7
7540977|NCT02758301|11890961|FG001|Overall Study|Lost to Follow-up|0
7540978|NCT02758301|11890960|FG000|Overall Study|Protocol Violation|0
7540979|NCT02758301|11890961|FG001|Overall Study|Protocol Violation|1
7540980|NCT02758613|11890971|FG000|Treatment|Physician and Sponsor Decision|1
7540981|NCT02758613|11890972|FG001|Treatment|Physician and Sponsor Decision|0
7540982|NCT02758613|11890973|FG002|Treatment|Physician and Sponsor Decision|0
7540983|NCT02758613|11890974|FG003|Treatment|Physician and Sponsor Decision|0
7540984|NCT02758613|11890971|FG000|Treatment|Withdrawal by Subject|1
7540985|NCT02758613|11890972|FG001|Treatment|Withdrawal by Subject|0
7540986|NCT02758613|11890973|FG002|Treatment|Withdrawal by Subject|1
7540987|NCT02758613|11890974|FG003|Treatment|Withdrawal by Subject|0
7540988|NCT02759016|11890998|FG000|Overall Study|Not treated with BI 836826|1
7540989|NCT02759016|11890999|FG001|Overall Study|Not treated with BI 836826|0
7540990|NCT02759016|11890998|FG000|Overall Study|Progressive disease|1
7540991|NCT02759016|11890999|FG001|Overall Study|Progressive disease|0
7540992|NCT02759016|11890998|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
7540993|NCT02759016|11890999|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
7540994|NCT02759016|11890998|FG000|Overall Study|Other not defined above|2
7540995|NCT02759016|11890999|FG001|Overall Study|Other not defined above|1
7540996|NCT02759055|11891008|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
7540997|NCT02759055|11891009|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
7540998|NCT02759120|11891017|FG000|Overall Study|Death|34
7575945|NCT04175808|11960370|FG005|Part A|Miscellaneous|0
7575946|NCT04175808|11960371|FG006|Part A|Miscellaneous|0
7540999|NCT02759120|11891018|FG001|Overall Study|Death|36
7541000|NCT02759120|11891017|FG000|Overall Study|Lost to Follow-up|4
7575947|NCT04178720|11960389|FG000|Overall Study|Withdrawal by Subject|2
7575948|NCT04178720|11960390|FG001|Overall Study|Withdrawal by Subject|0
7575949|NCT04178720|11960389|FG000|Overall Study|Relocation|0
7575950|NCT04178720|11960390|FG001|Overall Study|Relocation|1
7575951|NCT04218110|11960433|FG000|Overall Study|Withdrawal by Subject|0
7575952|NCT04218110|11960434|FG001|Overall Study|Withdrawal by Subject|0
7575953|NCT04218110|11960435|FG002|Overall Study|Withdrawal by Subject|0
7575954|NCT04218110|11960436|FG003|Overall Study|Withdrawal by Subject|1
7575955|NCT04222725|11960450|FG000|Overall Study|Adverse Event|0
7575956|NCT04222725|11960451|FG001|Overall Study|Adverse Event|1
7575957|NCT04222725|11960452|FG002|Overall Study|Adverse Event|0
7575958|NCT04222725|11960453|FG003|Overall Study|Adverse Event|0
7575959|NCT04258995|11960539|FG000|Overall Study|Lost to Follow-up|1
7575960|NCT04258995|11960540|FG001|Overall Study|Lost to Follow-up|1
7575961|NCT04317040|11960579|FG000|Overall Study|Lost to Follow-up|2
7575962|NCT04317040|11960580|FG001|Overall Study|Lost to Follow-up|0
7575963|NCT04317040|11960579|FG000|Overall Study|Death|16
7575964|NCT04317040|11960580|FG001|Overall Study|Death|18
7575965|NCT04317040|11960579|FG000|Overall Study|Withdrawal by Subject|0
7575966|NCT04317040|11960580|FG001|Overall Study|Withdrawal by Subject|1
7575967|NCT04317040|11960579|FG000|Overall Study|Incomplete assessments|0
7575968|NCT04317040|11960580|FG001|Overall Study|Incomplete assessments|1
7575969|NCT04319159|11960597|FG000|Overall Study|Screening failure|13
7575970|NCT04319159|11960597|FG000|Overall Study|Re-screening due to COVID-19 implications|2
7575971|NCT04319159|11960597|FG000|Overall Study|Withdrawal by Subject|1
7575972|NCT04331899|11960627|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
7575973|NCT04331899|11960628|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
7575974|NCT04334148|11960636|FG000|Overall Study|positive nasal swab at baseline|0
7575975|NCT04334148|11960637|FG001|Overall Study|positive nasal swab at baseline|1
7575976|NCT04347954|11960657|FG000|Overall Study|Did not present to study site for allocated intervention|3
7575977|NCT04347954|11960658|FG001|Overall Study|Did not present to study site for allocated intervention|0
7575978|NCT04347954|11960659|FG002|Overall Study|Did not present to study site for allocated intervention|3
7575979|NCT04347954|11960657|FG000|Overall Study|Lost to Follow-up|0
7575980|NCT04347954|11960658|FG001|Overall Study|Lost to Follow-up|1
7575981|NCT04347954|11960659|FG002|Overall Study|Lost to Follow-up|0
7575982|NCT04349098|11960669|FG000|Overall Study|Death|16
7575983|NCT04349098|11960670|FG001|Overall Study|Death|8
7575984|NCT04349098|11960669|FG000|Overall Study|Lost to Follow-up|11
7575985|NCT04349098|11960670|FG001|Overall Study|Lost to Follow-up|8
7575986|NCT04349098|11960669|FG000|Overall Study|Withdrawal by Subject|8
7575987|NCT04349098|11960670|FG001|Overall Study|Withdrawal by Subject|5
7575988|NCT04349098|11960669|FG000|Overall Study|Other|3
7575989|NCT04349098|11960670|FG001|Overall Study|Other|5
7575990|NCT04353037|11960680|FG000|Overall Study|Lost to Follow-up|0
7575991|NCT04353037|11960681|FG001|Overall Study|Lost to Follow-up|1
7575992|NCT04353037|11960682|FG002|Overall Study|Lost to Follow-up|2
7575993|NCT04353037|11960683|FG003|Overall Study|Lost to Follow-up|3
7575994|NCT04353037|11960680|FG000|Overall Study|Withdrawal by Subject|0
7575995|NCT04353037|11960681|FG001|Overall Study|Withdrawal by Subject|2
7575996|NCT04353037|11960682|FG002|Overall Study|Withdrawal by Subject|3
7575997|NCT04353037|11960683|FG003|Overall Study|Withdrawal by Subject|5
7575998|NCT04353037|11960680|FG000|Overall Study|Adverse Event|0
7575999|NCT04353037|11960681|FG001|Overall Study|Adverse Event|0
7576000|NCT04353037|11960682|FG002|Overall Study|Adverse Event|2
7576001|NCT04353037|11960683|FG003|Overall Study|Adverse Event|0
7576002|NCT04353037|11960680|FG000|Overall Study|Exposure Change|0
7576003|NCT04353037|11960681|FG001|Overall Study|Exposure Change|0
7576004|NCT04353037|11960682|FG002|Overall Study|Exposure Change|0
7576005|NCT04353037|11960683|FG003|Overall Study|Exposure Change|2
7576006|NCT04355767|11960703|FG000|Overall Study|Withdrawal by Subject|2
7576007|NCT04355767|11960704|FG001|Overall Study|Withdrawal by Subject|2
7576008|NCT04355767|11960703|FG000|Overall Study|Death|5
7576009|NCT04355767|11960704|FG001|Overall Study|Death|1
7576010|NCT04356573|11960712|FG000|Overall Study|Didn't Qualify|1
7576011|NCT04356573|11960713|FG001|Overall Study|Didn't Qualify|0
7576012|NCT04358068|11960725|FG000|Overall Study|Did not initiate study treatment|2
7541001|NCT02759120|11891018|FG001|Overall Study|Lost to Follow-up|7
7541002|NCT02759120|11891017|FG000|Overall Study|Physician Decision|3
7541003|NCT02759120|11891018|FG001|Overall Study|Physician Decision|0
7541004|NCT02759120|11891017|FG000|Overall Study|Withdrawal by Subject|28
7541005|NCT02759120|11891018|FG001|Overall Study|Withdrawal by Subject|15
7541006|NCT02759120|11891017|FG000|Overall Study|Moved out of area|3
7541007|NCT02759120|11891018|FG001|Overall Study|Moved out of area|4
7541008|NCT02759120|11891017|FG000|Overall Study|Lung transplant|3
7541009|NCT02759120|11891018|FG001|Overall Study|Lung transplant|5
7541010|NCT02759120|11891017|FG000|Overall Study|Other reason not completed|10
7541011|NCT02759120|11891018|FG001|Overall Study|Other reason not completed|12
7541012|NCT02759315|11891057|FG000|Overall Study|Adverse Event|0
7541013|NCT02759315|11891058|FG001|Overall Study|Adverse Event|0
7541014|NCT02759315|11891059|FG002|Overall Study|Adverse Event|0
7541015|NCT02759315|11891060|FG003|Overall Study|Adverse Event|1
7541016|NCT02759315|11891061|FG004|Overall Study|Adverse Event|0
7541017|NCT02759315|11891057|FG000|Overall Study|Death|0
7541018|NCT02759315|11891058|FG001|Overall Study|Death|0
7541019|NCT02759315|11891059|FG002|Overall Study|Death|1
7541020|NCT02759315|11891060|FG003|Overall Study|Death|0
7541021|NCT02759315|11891061|FG004|Overall Study|Death|0
7541022|NCT02759315|11891057|FG000|Overall Study|Lost to Follow-up|2
7541023|NCT02759315|11891058|FG001|Overall Study|Lost to Follow-up|0
7541024|NCT02759315|11891059|FG002|Overall Study|Lost to Follow-up|4
7541025|NCT02759315|11891060|FG003|Overall Study|Lost to Follow-up|0
7541026|NCT02759315|11891061|FG004|Overall Study|Lost to Follow-up|0
7541027|NCT02759315|11891057|FG000|Overall Study|Protocol Violation|0
7541028|NCT02759315|11891058|FG001|Overall Study|Protocol Violation|1
7541029|NCT02759315|11891059|FG002|Overall Study|Protocol Violation|0
7541030|NCT02759315|11891060|FG003|Overall Study|Protocol Violation|0
7541031|NCT02759315|11891061|FG004|Overall Study|Protocol Violation|0
7541032|NCT02759315|11891057|FG000|Overall Study|Study terminated prior to completion|2
7541033|NCT02759315|11891058|FG001|Overall Study|Study terminated prior to completion|0
7541034|NCT02759315|11891059|FG002|Overall Study|Study terminated prior to completion|5
7576013|NCT04358068|11960726|FG001|Overall Study|Did not initiate study treatment|2
7576014|NCT04366349|11960738|FG000|Overall Study|Withdrawal by Subject|1
7541035|NCT02759315|11891060|FG003|Overall Study|Study terminated prior to completion|0
7541036|NCT02759315|11891061|FG004|Overall Study|Study terminated prior to completion|1
7541037|NCT02759471|11891094|FG000|Overall Study|discomfort|2
7541038|NCT02759562|11891102|FG000|Open-Label Treatment Period|Withdrew Consent|1
7541039|NCT02759562|11891103|FG001|Open-Label Treatment Period|Withdrew Consent|0
7541040|NCT02759562|11891102|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
7541041|NCT02759562|11891103|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
7541042|NCT02759692|11891114|FG000|Period 1|Test article no longer available|1
7541043|NCT02759692|11891115|FG001|Period 1|Test article no longer available|1
7541044|NCT02759692|11891114|FG000|Period 1|No longer meets eligibility criteria.|1
7541045|NCT02759692|11891115|FG001|Period 1|No longer meets eligibility criteria.|0
7541046|NCT02759692|11891114|FG000|Period 1|Miss-Randomized|1
7541047|NCT02759692|11891115|FG001|Period 1|Miss-Randomized|1
7541048|NCT02759692|11891114|FG000|Period 2|Lost to Follow-up|1
7541049|NCT02759692|11891115|FG001|Period 2|Lost to Follow-up|0
7541050|NCT02759692|11891114|FG000|Period 2|Test article no longer available|0
7576015|NCT04366349|11960739|FG001|Overall Study|Withdrawal by Subject|0
7576016|NCT04366349|11960740|FG002|Overall Study|Withdrawal by Subject|0
7576017|NCT04366349|11960741|FG003|Overall Study|Withdrawal by Subject|0
7576018|NCT04366349|11960742|FG004|Overall Study|Withdrawal by Subject|0
7576019|NCT04366349|11960743|FG005|Overall Study|Withdrawal by Subject|0
7624432|NCT03600909|12035505|FG000|Overall Study|Not treated|0
7624433|NCT03600909|12035506|FG001|Overall Study|Not treated|3
7624434|NCT03600909|12035507|FG002|Overall Study|Not treated|0
7541051|NCT02759692|11891115|FG001|Period 2|Test article no longer available|1
7541052|NCT02759939|11891125|FG000|Overall Study|Missing data on first outcome assessed|11
7541053|NCT02759939|11891126|FG001|Overall Study|Missing data on first outcome assessed|2
7541054|NCT02759939|11891127|FG002|Overall Study|Missing data on first outcome assessed|5
7541055|NCT02759939|11891128|FG003|Overall Study|Missing data on first outcome assessed|2
7541056|NCT02759939|11891125|FG000|Overall Study|Ineligible for T2 and T3|310
7541057|NCT02759939|11891126|FG001|Overall Study|Ineligible for T2 and T3|179
7541058|NCT02759939|11891127|FG002|Overall Study|Ineligible for T2 and T3|366
7541059|NCT02759939|11891128|FG003|Overall Study|Ineligible for T2 and T3|391
7541060|NCT02759939|11891125|FG000|Overall Study|Lost to Follow-up|735
7541061|NCT02759939|11891126|FG001|Overall Study|Lost to Follow-up|791
7541062|NCT02759939|11891127|FG002|Overall Study|Lost to Follow-up|783
7541063|NCT02759939|11891128|FG003|Overall Study|Lost to Follow-up|650
7541064|NCT02760069|11891151|FG000|Overall Study|Withdrawal by Subject|0
7541065|NCT02760069|11891152|FG001|Overall Study|Withdrawal by Subject|1
7541066|NCT02760069|11891153|FG002|Overall Study|Withdrawal by Subject|1
7541067|NCT02760368|11891199|FG000|Overall Study|Withdrawal by Subject|12
7541068|NCT02760368|11891200|FG001|Overall Study|Withdrawal by Subject|8
7541069|NCT02760368|11891201|FG002|Overall Study|Withdrawal by Subject|9
7541070|NCT02760368|11891199|FG000|Overall Study|Screen Failure|0
7541071|NCT02760368|11891200|FG001|Overall Study|Screen Failure|0
7541072|NCT02760368|11891201|FG002|Overall Study|Screen Failure|1
7541073|NCT02760368|11891199|FG000|Overall Study|Death|1
7541074|NCT02760368|11891200|FG001|Overall Study|Death|0
7541075|NCT02760368|11891201|FG002|Overall Study|Death|0
7541076|NCT02760368|11891199|FG000|Overall Study|Withdrawal by Sponsor|0
7541077|NCT02760368|11891200|FG001|Overall Study|Withdrawal by Sponsor|0
7541078|NCT02760368|11891201|FG002|Overall Study|Withdrawal by Sponsor|1
7541079|NCT02760407|11891213|FG000|Overall Study|Death|2
7541080|NCT02760407|11891214|FG001|Overall Study|Death|3
7541081|NCT02760407|11891215|FG002|Overall Study|Death|1
7541082|NCT02760407|11891216|FG003|Overall Study|Death|1
7541083|NCT02760407|11891213|FG000|Overall Study|Lost to Follow-up|1
7541084|NCT02760407|11891214|FG001|Overall Study|Lost to Follow-up|7
7541085|NCT02760407|11891215|FG002|Overall Study|Lost to Follow-up|4
7541086|NCT02760407|11891216|FG003|Overall Study|Lost to Follow-up|6
7541087|NCT02760407|11891213|FG000|Overall Study|Withdrawal by Subject|25
7541088|NCT02760407|11891214|FG001|Overall Study|Withdrawal by Subject|31
7541089|NCT02760407|11891215|FG002|Overall Study|Withdrawal by Subject|37
7541090|NCT02760407|11891216|FG003|Overall Study|Withdrawal by Subject|25
7541091|NCT02760407|11891213|FG000|Overall Study|Violation of Eligibility criteria|0
7541092|NCT02760407|11891214|FG001|Overall Study|Violation of Eligibility criteria|0
7541093|NCT02760407|11891215|FG002|Overall Study|Violation of Eligibility criteria|1
7541094|NCT02760407|11891216|FG003|Overall Study|Violation of Eligibility criteria|1
7541095|NCT02760407|11891213|FG000|Overall Study|Personal reasons|0
7541096|NCT02760407|11891214|FG001|Overall Study|Personal reasons|0
7541097|NCT02760407|11891215|FG002|Overall Study|Personal reasons|0
7541098|NCT02760407|11891216|FG003|Overall Study|Personal reasons|1
7541099|NCT02760407|11891213|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
7541100|NCT02760407|11891214|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7541101|NCT02760407|11891215|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7541102|NCT02760407|11891216|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
7541103|NCT02760407|11891213|FG000|Overall Study|Use of prohibited Medication|0
7541104|NCT02760407|11891214|FG001|Overall Study|Use of prohibited Medication|0
7541105|NCT02760407|11891215|FG002|Overall Study|Use of prohibited Medication|1
7541106|NCT02760407|11891216|FG003|Overall Study|Use of prohibited Medication|0
7541107|NCT02760407|11891213|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7541108|NCT02760407|11891214|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7541109|NCT02760407|11891215|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
7541110|NCT02760407|11891216|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
7541111|NCT02760407|11891213|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
7552172|NCT02982018|11911871|FG000|Overall Study|Adverse Event|1
7552173|NCT02982018|11911872|FG001|Overall Study|Adverse Event|1
7552174|NCT02982018|11911871|FG000|Overall Study|Lens Discomfort|2
7552175|NCT02982018|11911872|FG001|Overall Study|Lens Discomfort|0
7552176|NCT02982018|11911871|FG000|Overall Study|Withdrawal by Subject|0
7552177|NCT02982018|11911872|FG001|Overall Study|Withdrawal by Subject|1
7552178|NCT02982187|11911880|FG000|Overall Study|Withdrawal by Subject|0
7257817|NCT00334958|11469872|FG001|Overall Study|Other|2
7552179|NCT02982187|11911881|FG001|Overall Study|Withdrawal by Subject|0
7552180|NCT02982187|11911882|FG002|Overall Study|Withdrawal by Subject|0
7552181|NCT02982187|11911883|FG003|Overall Study|Withdrawal by Subject|0
7552182|NCT02982187|11911884|FG004|Overall Study|Withdrawal by Subject|0
7552183|NCT02982187|11911885|FG005|Overall Study|Withdrawal by Subject|0
7552184|NCT02982187|11911886|FG006|Overall Study|Withdrawal by Subject|1
7552185|NCT02982187|11911887|FG007|Overall Study|Withdrawal by Subject|0
7552186|NCT02982213|11911899|FG000|Overall Study|Did not complete follow up questionnaire|5
7552187|NCT02982213|11911900|FG001|Overall Study|Did not complete follow up questionnaire|1
7552188|NCT02982239|11911908|FG000|Overall Study|Lost to Follow-up|3
7552189|NCT02982239|11911909|FG001|Overall Study|Lost to Follow-up|2
7552190|NCT02982590|11911918|FG000|Overall Study|Lost to Follow-up|0
7552191|NCT02982590|11911919|FG001|Overall Study|Lost to Follow-up|1
7552192|NCT02982590|11911918|FG000|Overall Study|Death|4
7552193|NCT02982590|11911919|FG001|Overall Study|Death|0
7552194|NCT02982772|11911927|FG000|Intervention|Lost to Follow-up|19
7552195|NCT02982772|11911928|FG001|Intervention|Lost to Follow-up|13
7552196|NCT02982772|11911927|FG000|1M Follow-Up|Lost to Follow-up|21
7552197|NCT02982772|11911928|FG001|1M Follow-Up|Lost to Follow-up|18
7552198|NCT02982772|11911927|FG000|3M Follow-Up|Lost to Follow-up|17
7552199|NCT02982772|11911928|FG001|3M Follow-Up|Lost to Follow-up|11
7552200|NCT02982772|11911927|FG000|6M Follow-Up|Lost to Follow-up|11
7552201|NCT02982772|11911928|FG001|6M Follow-Up|Lost to Follow-up|9
7552202|NCT02982772|11911927|FG000|12M Follow-Up|Lost to Follow-up|11
7552203|NCT02982772|11911928|FG001|12M Follow-Up|Lost to Follow-up|5
7552204|NCT02982863|11911941|FG000|Overall Study|Not eligible patients|809
7552205|NCT02982863|11911942|FG001|Overall Study|Not eligible patients|4261
7552206|NCT02982863|11911943|FG002|Overall Study|Not eligible patients|1852
7552207|NCT02982863|11911944|FG003|Overall Study|Not eligible patients|1400
7552208|NCT02982863|11911945|FG004|Overall Study|Not eligible patients|492
7541112|NCT02760407|11891214|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7541113|NCT02760407|11891215|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7541114|NCT02760407|11891216|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
7541115|NCT02760407|11891213|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
7541116|NCT02760407|11891214|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
7541117|NCT02760407|11891215|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
7541118|NCT02760407|11891216|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
7541119|NCT02760407|11891213|FG000|Overall Study|Inadequately Enrolled|0
7541120|NCT02760407|11891214|FG001|Overall Study|Inadequately Enrolled|0
7541121|NCT02760407|11891215|FG002|Overall Study|Inadequately Enrolled|0
7541122|NCT02760407|11891216|FG003|Overall Study|Inadequately Enrolled|1
7541123|NCT02760407|11891213|FG000|Overall Study|Withdrawal By PI's Decision|0
7541124|NCT02760407|11891214|FG001|Overall Study|Withdrawal By PI's Decision|1
7541125|NCT02760407|11891215|FG002|Overall Study|Withdrawal By PI's Decision|0
7541126|NCT02760407|11891216|FG003|Overall Study|Withdrawal By PI's Decision|0
7541127|NCT02760407|11891213|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7541128|NCT02760407|11891214|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7541129|NCT02760407|11891215|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
7541130|NCT02760407|11891216|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
7541131|NCT02760407|11891213|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7541132|NCT02760407|11891214|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7541133|NCT02760407|11891215|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
7541134|NCT02760407|11891216|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
7541135|NCT02760407|11891213|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
7541136|NCT02760407|11891214|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7541137|NCT02760407|11891215|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7541138|NCT02760407|11891216|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
7541139|NCT02760407|11891213|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
7541140|NCT02760407|11891214|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
7541141|NCT02760407|11891215|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
7541142|NCT02760407|11891216|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
7541143|NCT02760407|11891213|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
7541144|NCT02760407|11891214|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7541145|NCT02760407|11891215|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7541146|NCT02760407|11891216|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
7541219|NCT02761629|11891315|FG000|Overall Study|Lost to Follow-up|4
7541147|NCT02760407|11891213|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
7541148|NCT02760407|11891214|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7541149|NCT02760407|11891215|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7541150|NCT02760407|11891216|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
7541151|NCT02760407|11891213|FG000|Overall Study|Lack Of Efficacy Per PI|0
7541152|NCT02760407|11891214|FG001|Overall Study|Lack Of Efficacy Per PI|0
7541153|NCT02760407|11891215|FG002|Overall Study|Lack Of Efficacy Per PI|0
7541154|NCT02760407|11891216|FG003|Overall Study|Lack Of Efficacy Per PI|1
7541155|NCT02760407|11891213|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
7541156|NCT02760407|11891214|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7541157|NCT02760407|11891215|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7541158|NCT02760407|11891216|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
7541159|NCT02760407|11891213|FG000|Overall Study|Investigator recorded as Adverse Event|1
7541160|NCT02760407|11891214|FG001|Overall Study|Investigator recorded as Adverse Event|0
7541161|NCT02760407|11891215|FG002|Overall Study|Investigator recorded as Adverse Event|2
7541162|NCT02760407|11891216|FG003|Overall Study|Investigator recorded as Adverse Event|0
7541163|NCT02760433|11891232|FG000|Overall Study|Lost to Follow-up|1
7541164|NCT02760433|11891233|FG001|Overall Study|Lost to Follow-up|0
7541165|NCT02760433|11891234|FG002|Overall Study|Lost to Follow-up|1
7541166|NCT02760433|11891235|FG003|Overall Study|Lost to Follow-up|0
7541167|NCT02760433|11891236|FG004|Overall Study|Lost to Follow-up|0
7541168|NCT02760433|11891232|FG000|Overall Study|Withdrawal by Subject|23
7541169|NCT02760433|11891233|FG001|Overall Study|Withdrawal by Subject|9
7541170|NCT02760433|11891234|FG002|Overall Study|Withdrawal by Subject|0
7541171|NCT02760433|11891235|FG003|Overall Study|Withdrawal by Subject|2
7541172|NCT02760433|11891236|FG004|Overall Study|Withdrawal by Subject|9
7541173|NCT02760433|11891232|FG000|Overall Study|Lack of Response At Week 14|0
7541174|NCT02760433|11891233|FG001|Overall Study|Lack of Response At Week 14|0
7541175|NCT02760433|11891234|FG002|Overall Study|Lack of Response At Week 14|0
7541176|NCT02760433|11891235|FG003|Overall Study|Lack of Response At Week 14|0
7541177|NCT02760433|11891236|FG004|Overall Study|Lack of Response At Week 14|1
7541178|NCT02760433|11891232|FG000|Overall Study|Subject refused to continue the study|1
7541179|NCT02760433|11891233|FG001|Overall Study|Subject refused to continue the study|0
7541180|NCT02760433|11891234|FG002|Overall Study|Subject refused to continue the study|0
7541181|NCT02760433|11891235|FG003|Overall Study|Subject refused to continue the study|0
7541182|NCT02760433|11891236|FG004|Overall Study|Subject refused to continue the study|0
7541183|NCT02760433|11891232|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
7541184|NCT02760433|11891233|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7541185|NCT02760433|11891234|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7541186|NCT02760433|11891235|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7541187|NCT02760433|11891236|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
7541188|NCT02760433|11891232|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7541189|NCT02760433|11891233|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
7541190|NCT02760433|11891234|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7541191|NCT02760433|11891235|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7541192|NCT02760433|11891236|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
7541193|NCT02760654|11891255|FG000|Overall Study|Lost to Follow-up|3
7541194|NCT02760654|11891256|FG001|Overall Study|Lost to Follow-up|3
7541195|NCT02760654|11891255|FG000|Overall Study|Withdrawal by Subject|4
7541196|NCT02760654|11891256|FG001|Overall Study|Withdrawal by Subject|3
7541197|NCT02760810|11891262|FG000|Overall Study|Protocol Violation|1
7541198|NCT02760927|11891275|FG000|Overall Study|Tube Slippage from Device|1
7541199|NCT02761330|11891294|FG000|Treatment Week 1|Withdrawal by Subject|0
7541200|NCT02761330|11891295|FG001|Treatment Week 1|Withdrawal by Subject|0
7541201|NCT02761330|11891296|FG002|Treatment Week 1|Withdrawal by Subject|0
7541202|NCT02761330|11891297|FG003|Treatment Week 1|Withdrawal by Subject|1
7541203|NCT02761330|11891298|FG004|Treatment Week 1|Withdrawal by Subject|0
7541204|NCT02761330|11891299|FG005|Treatment Week 1|Withdrawal by Subject|1
7541205|NCT02761629|11891315|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
7541206|NCT02761629|11891316|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
7541207|NCT02761629|11891315|FG000|Overall Study|Insufficient Therapeutic Response|2
7541208|NCT02761629|11891316|FG001|Overall Study|Insufficient Therapeutic Response|7
7541209|NCT02761629|11891315|FG000|Overall Study|Failure to Return|2
7541210|NCT02761629|11891316|FG001|Overall Study|Failure to Return|4
7541211|NCT02761629|11891315|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
7541212|NCT02761629|11891316|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
7541213|NCT02761629|11891315|FG000|Overall Study|Protocol Violation|2
7541214|NCT02761629|11891316|FG001|Overall Study|Protocol Violation|2
7541215|NCT02761629|11891315|FG000|Overall Study|Withdrawal by Subject|0
7541216|NCT02761629|11891316|FG001|Overall Study|Withdrawal by Subject|3
7541217|NCT02761629|11891315|FG000|Overall Study|Other|0
7541218|NCT02761629|11891316|FG001|Overall Study|Other|2
7541220|NCT02761629|11891316|FG001|Overall Study|Lost to Follow-up|1
7541221|NCT02761629|11891315|FG000|Overall Study|Randomized But Not Treated|8
7541222|NCT02761629|11891316|FG001|Overall Study|Randomized But Not Treated|4
7541223|NCT02761642|11891322|FG000|Overall Study|Did not Receive Study Treatment|3
7541224|NCT02761642|11891322|FG000|Overall Study|Adverse Event|13
7576024|NCT04398732|11960800|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
7576025|NCT04401293|11960808|FG000|Overall Study|Withdrawal by Subject|1
7576026|NCT04401293|11960809|FG001|Overall Study|Withdrawal by Subject|3
7576027|NCT04411628|11960819|FG000|Overall Study|Withdrawal by Subject|1
7576028|NCT04411628|11960820|FG001|Overall Study|Withdrawal by Subject|1
7576029|NCT04411628|11960821|FG002|Overall Study|Withdrawal by Subject|2
7576030|NCT04411628|11960822|FG003|Overall Study|Withdrawal by Subject|0
7576031|NCT04411628|11960819|FG000|Overall Study|Lost to Follow-up|0
7576032|NCT04411628|11960820|FG001|Overall Study|Lost to Follow-up|1
7541225|NCT02761642|11891322|FG000|Overall Study|Withdrawal by Subject|2
7541226|NCT02761642|11891322|FG000|Overall Study|Non-compliant|7
7541227|NCT02761642|11891322|FG000|Overall Study|Death|3
7541228|NCT02761642|11891322|FG000|Overall Study|Lack of Efficacy|20
7541229|NCT02761642|11891322|FG000|Overall Study|Physician Decision|1
7541230|NCT02761642|11891322|FG000|Overall Study|Reason Unspecified|21
7541231|NCT02761733|11891330|FG000|Overall Study|Death|3
7541232|NCT02761733|11891331|FG001|Overall Study|Death|5
7541233|NCT02761733|11891332|FG002|Overall Study|Death|1
7541234|NCT02761733|11891333|FG003|Overall Study|Death|1
7541235|NCT02761733|11891330|FG000|Overall Study|Lost to Follow-up|6
7541236|NCT02761733|11891331|FG001|Overall Study|Lost to Follow-up|7
7541237|NCT02761733|11891332|FG002|Overall Study|Lost to Follow-up|0
7541238|NCT02761733|11891333|FG003|Overall Study|Lost to Follow-up|3
7541239|NCT02761733|11891330|FG000|Overall Study|Physician Decision|4
7541240|NCT02761733|11891331|FG001|Overall Study|Physician Decision|0
7576033|NCT04411628|11960821|FG002|Overall Study|Lost to Follow-up|0
7576034|NCT04411628|11960822|FG003|Overall Study|Lost to Follow-up|0
7576035|NCT04428411|11960874|FG000|Overall Study|Lost to Follow-up|114
7576036|NCT04435184|11960883|FG000|Overall Study|follow-up blood draws missing|3
7541241|NCT02761733|11891332|FG002|Overall Study|Physician Decision|0
7541242|NCT02761733|11891333|FG003|Overall Study|Physician Decision|0
7541243|NCT02761733|11891330|FG000|Overall Study|Withdrawal by Subject|2
7541244|NCT02761733|11891331|FG001|Overall Study|Withdrawal by Subject|0
7541245|NCT02761733|11891332|FG002|Overall Study|Withdrawal by Subject|0
7541246|NCT02761733|11891333|FG003|Overall Study|Withdrawal by Subject|0
7541247|NCT02761733|11891330|FG000|Overall Study|Discharged from Study Site|10
7541248|NCT02761733|11891331|FG001|Overall Study|Discharged from Study Site|9
7541249|NCT02761733|11891332|FG002|Overall Study|Discharged from Study Site|25
7541250|NCT02761733|11891333|FG003|Overall Study|Discharged from Study Site|11
7541251|NCT02761733|11891330|FG000|Overall Study|Cognitive Impairment|5
7541252|NCT02761733|11891331|FG001|Overall Study|Cognitive Impairment|0
7541253|NCT02761733|11891332|FG002|Overall Study|Cognitive Impairment|1
7541254|NCT02761733|11891333|FG003|Overall Study|Cognitive Impairment|0
7541255|NCT02761915|11891349|FG000|Overall Study|Death|3
7541256|NCT02761915|11891350|FG001|Overall Study|Death|1
7541257|NCT02761915|11891351|FG002|Overall Study|Death|1
7541258|NCT02761915|11891352|FG003|Overall Study|Death|1
7541259|NCT02761915|11891353|FG004|Overall Study|Death|0
7541260|NCT02761915|11891354|FG005|Overall Study|Death|1
7541261|NCT02761915|11891349|FG000|Overall Study|Withdrawal by Subject|1
7541262|NCT02761915|11891350|FG001|Overall Study|Withdrawal by Subject|0
7541263|NCT02761915|11891351|FG002|Overall Study|Withdrawal by Subject|0
7541264|NCT02761915|11891352|FG003|Overall Study|Withdrawal by Subject|0
7541265|NCT02761915|11891353|FG004|Overall Study|Withdrawal by Subject|1
7541266|NCT02761915|11891354|FG005|Overall Study|Withdrawal by Subject|2
7541267|NCT02761915|11891349|FG000|Overall Study|Disease Progression|0
7541268|NCT02761915|11891350|FG001|Overall Study|Disease Progression|0
7541269|NCT02761915|11891351|FG002|Overall Study|Disease Progression|0
7541270|NCT02761915|11891352|FG003|Overall Study|Disease Progression|2
7541271|NCT02761915|11891353|FG004|Overall Study|Disease Progression|2
7541272|NCT02761915|11891354|FG005|Overall Study|Disease Progression|2
7541273|NCT02761980|11891388|FG000|Overall Study|Adverse Event|4
7541274|NCT02761980|11891389|FG001|Overall Study|Adverse Event|6
7541275|NCT02761980|11891390|FG002|Overall Study|Adverse Event|5
7541276|NCT02761980|11891391|FG003|Overall Study|Adverse Event|6
7541277|NCT02761980|11891388|FG000|Overall Study|Withdrawal by Subject|0
7541278|NCT02761980|11891389|FG001|Overall Study|Withdrawal by Subject|1
7541279|NCT02761980|11891390|FG002|Overall Study|Withdrawal by Subject|0
7541280|NCT02761980|11891391|FG003|Overall Study|Withdrawal by Subject|0
7541281|NCT02761980|11891388|FG000|Overall Study|Other|0
7541282|NCT02761980|11891389|FG001|Overall Study|Other|0
7541283|NCT02761980|11891390|FG002|Overall Study|Other|1
7541284|NCT02761980|11891391|FG003|Overall Study|Other|0
7541285|NCT02761993|11891404|FG000|Overall Study|Adverse Event|0
7541286|NCT02761993|11891405|FG001|Overall Study|Adverse Event|2
7541287|NCT02761993|11891406|FG002|Overall Study|Adverse Event|0
7541288|NCT02761993|11891404|FG000|Overall Study|Lost to Follow-up|1
7541289|NCT02761993|11891405|FG001|Overall Study|Lost to Follow-up|3
7541290|NCT02761993|11891406|FG002|Overall Study|Lost to Follow-up|2
7541291|NCT02761993|11891404|FG000|Overall Study|Withdrawal by Subject|1
7541292|NCT02761993|11891405|FG001|Overall Study|Withdrawal by Subject|1
7541293|NCT02761993|11891406|FG002|Overall Study|Withdrawal by Subject|2
7541294|NCT02762084|11891427|FG000|Overall Study|Withdrawal by Subject|1
7541295|NCT02762084|11891428|FG001|Overall Study|Withdrawal by Subject|0
7541296|NCT02762084|11891429|FG002|Overall Study|Withdrawal by Subject|0
7541297|NCT02762084|11891427|FG000|Overall Study|Adverse Event|0
7541298|NCT02762084|11891428|FG001|Overall Study|Adverse Event|0
7541299|NCT02762084|11891429|FG002|Overall Study|Adverse Event|1
7541300|NCT02762370|11891450|FG000|Overall Study|Protocol Violation|1
7541301|NCT02762370|11891451|FG001|Overall Study|Protocol Violation|0
7541302|NCT02762500|11891461|FG000|Overall Study|Lack of Efficacy|1
7541303|NCT02762500|11891462|FG001|Overall Study|Lack of Efficacy|0
7541304|NCT02762500|11891461|FG000|Overall Study|Withdrawal by Subject|1
7541305|NCT02762500|11891462|FG001|Overall Study|Withdrawal by Subject|1
7541306|NCT02762500|11891461|FG000|Overall Study|Adverse Event|0
7541307|NCT02762500|11891462|FG001|Overall Study|Adverse Event|2
7541308|NCT02762565|11891472|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
7541309|NCT02762578|11891478|FG000|Overall Study|Adverse Event|1
7541310|NCT02762578|11891479|FG001|Overall Study|Adverse Event|6
7257818|NCT00335140|11469878|FG000|Overall Study|Ineligible|1
7541311|NCT02762578|11891478|FG000|Overall Study|Protocol Violation|4
7541312|NCT02762578|11891479|FG001|Overall Study|Protocol Violation|2
7576037|NCT04435184|11960884|FG001|Overall Study|follow-up blood draws missing|5
7541313|NCT02762578|11891478|FG000|Overall Study|Withdrawal by Subject|4
7541314|NCT02762578|11891479|FG001|Overall Study|Withdrawal by Subject|2
7541315|NCT02762578|11891478|FG000|Overall Study|Unclassified|6
7541316|NCT02762578|11891479|FG001|Overall Study|Unclassified|0
7541317|NCT02762994|11891518|FG000|Overall Study|Withdrawal by Subject|0
7541318|NCT02762994|11891519|FG001|Overall Study|Withdrawal by Subject|1
7541319|NCT02762994|11891520|FG002|Overall Study|Withdrawal by Subject|2
7541320|NCT02762994|11891521|FG003|Overall Study|Withdrawal by Subject|0
7541321|NCT02762994|11891518|FG000|Overall Study|Protocol Violation|1
7541322|NCT02762994|11891519|FG001|Overall Study|Protocol Violation|0
7541323|NCT02762994|11891520|FG002|Overall Study|Protocol Violation|0
7541324|NCT02762994|11891521|FG003|Overall Study|Protocol Violation|2
7541325|NCT02763046|11891538|FG000|Overall Study|Adverse Event|5
7541326|NCT02763046|11891539|FG001|Overall Study|Adverse Event|4
7541327|NCT02763046|11891540|FG002|Overall Study|Adverse Event|0
7541328|NCT02763046|11891538|FG000|Overall Study|Lack of Efficacy|1
7541329|NCT02763046|11891539|FG001|Overall Study|Lack of Efficacy|1
7541330|NCT02763046|11891540|FG002|Overall Study|Lack of Efficacy|3
7541331|NCT02763046|11891538|FG000|Overall Study|Physician Decision|1
7541332|NCT02763046|11891539|FG001|Overall Study|Physician Decision|0
7541333|NCT02763046|11891540|FG002|Overall Study|Physician Decision|1
7541334|NCT02763046|11891538|FG000|Overall Study|Subject/guardian decision|2
7541335|NCT02763046|11891539|FG001|Overall Study|Subject/guardian decision|0
7541336|NCT02763046|11891540|FG002|Overall Study|Subject/guardian decision|4
7541337|NCT02763215|11891558|FG000|Overall Study|Participants withdrew from study|3
7541338|NCT02763215|11891558|FG000|Overall Study|Missed visit|1
7541339|NCT02763215|11891558|FG000|Overall Study|Visit outside visit-window|1
7541340|NCT02763215|11891558|FG000|Overall Study|Death|1
7541341|NCT02763215|11891558|FG000|Overall Study|Lost to Follow-up|1
7541342|NCT02763254|11891562|FG000|Overall Study|Adverse Event|1
7576038|NCT04476784|11960892|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
7576039|NCT04476784|11960893|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
7576040|NCT04495283|11960925|FG000|Overall Study|Physician Decision|0
7576041|NCT04495283|11960926|FG001|Overall Study|Physician Decision|0
7576042|NCT04495283|11960927|FG002|Overall Study|Physician Decision|1
7576043|NCT04495283|11960925|FG000|Overall Study|Withdrawal by Subject|0
7576044|NCT04495283|11960926|FG001|Overall Study|Withdrawal by Subject|1
7576045|NCT04495283|11960927|FG002|Overall Study|Withdrawal by Subject|1
7576046|NCT04495283|11960925|FG000|Overall Study|Other|1
7576047|NCT04495283|11960926|FG001|Overall Study|Other|0
7576048|NCT04495283|11960927|FG002|Overall Study|Other|1
7576049|NCT04497948|11960938|FG000|Overall Study|Death|2
7576050|NCT04501952|11960965|FG000|Overall Study|Adverse Event|0
7576051|NCT04501952|11960966|FG001|Overall Study|Adverse Event|3
7576052|NCT04501952|11960965|FG000|Overall Study|Investigator's Discretion|0
7576053|NCT04501952|11960966|FG001|Overall Study|Investigator's Discretion|1
7576054|NCT04501952|11960965|FG000|Overall Study|Protocol Violation|1
7576055|NCT04501952|11960966|FG001|Overall Study|Protocol Violation|1
7576056|NCT04501952|11960965|FG000|Overall Study|Withdrew Consent|5
7576057|NCT04501952|11960966|FG001|Overall Study|Withdrew Consent|4
7576058|NCT04501952|11960965|FG000|Overall Study|Lost to Follow-up|7
7576059|NCT04501952|11960966|FG001|Overall Study|Lost to Follow-up|2
7576060|NCT04501952|11960965|FG000|Overall Study|Randomized and Never Treated|13
7576061|NCT04501952|11960966|FG001|Overall Study|Randomized and Never Treated|9
7576062|NCT04504032|11960975|FG000|Overall Study|Adverse Event|1
7576063|NCT04504032|11960976|FG001|Overall Study|Adverse Event|2
7576064|NCT04504032|11960975|FG000|Overall Study|Lost to Follow-up|6
7576065|NCT04504032|11960976|FG001|Overall Study|Lost to Follow-up|9
7576066|NCT04504032|11960975|FG000|Overall Study|Protocol Violation|2
7576067|NCT04504032|11960976|FG001|Overall Study|Protocol Violation|0
7576068|NCT04504032|11960975|FG000|Overall Study|Study terminated by sponsor|1
7576069|NCT04504032|11960976|FG001|Overall Study|Study terminated by sponsor|2
7576070|NCT04504032|11960975|FG000|Overall Study|Withdrawal by Subject|9
7576071|NCT04504032|11960976|FG001|Overall Study|Withdrawal by Subject|11
7576072|NCT04504032|11960975|FG000|Overall Study|Disease progression prior to dosing|15
7576073|NCT04504032|11960976|FG001|Overall Study|Disease progression prior to dosing|3
7576074|NCT04504032|11960975|FG000|Overall Study|Drug supply issues|1
7576075|NCT04504032|11960976|FG001|Overall Study|Drug supply issues|1
7576076|NCT04504032|11960975|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
7576077|NCT04504032|11960976|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
7576078|NCT04507763|11960982|FG000|Overall Study|Participants did not meet entrance criteria|201
7576079|NCT04507867|11960991|FG000|Overall Study|Death|7
7576080|NCT04507867|11960992|FG001|Overall Study|Death|1
7576081|NCT04527978|11961037|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7576082|NCT04527978|11961038|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7576083|NCT04529109|11961059|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
7576084|NCT04529109|11961060|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
7541355|NCT02763644|11891589|FG000|Overall Study|Patient/guardian decision|1
7541356|NCT02763644|11891590|FG001|Overall Study|Patient/guardian decision|0
7541357|NCT02763644|11891589|FG000|Overall Study|Death|1
7576085|NCT04601103|11961175|FG000|Overall Study|Needed crown & cleaning|0
7576086|NCT04601103|11961176|FG001|Overall Study|Needed crown & cleaning|0
7541358|NCT02763644|11891590|FG001|Overall Study|Death|1
7541359|NCT02763644|11891589|FG000|Overall Study|Adverse Event|1
7541360|NCT02763644|11891590|FG001|Overall Study|Adverse Event|1
7541361|NCT02764151|11891645|FG000|Overall Study|Subject refused further follow-up|0
7541362|NCT02764151|11891646|FG001|Overall Study|Subject refused further follow-up|0
7541363|NCT02764151|11891647|FG002|Overall Study|Subject refused further follow-up|0
7541364|NCT02764151|11891648|FG003|Overall Study|Subject refused further follow-up|1
7541365|NCT02764151|11891645|FG000|Overall Study|Other|0
7541366|NCT02764151|11891646|FG001|Overall Study|Other|0
7541367|NCT02764151|11891647|FG002|Overall Study|Other|0
7541368|NCT02764151|11891648|FG003|Overall Study|Other|2
7541369|NCT02764190|11891664|FG000|Overall Study|Lost to Follow-up|17
7541370|NCT02764190|11891665|FG001|Overall Study|Lost to Follow-up|13
7541371|NCT02764229|11891671|FG000|Overall Study|Withdrawal by Subject|15
7541372|NCT02764229|11891671|FG000|Overall Study|Adverse Event|9
7541373|NCT02764229|11891671|FG000|Overall Study|Physician Decision|5
7541374|NCT02764229|11891671|FG000|Overall Study|Lost to Follow-up|3
7541375|NCT02764229|11891671|FG000|Overall Study|Lack of Efficacy|1
7541376|NCT02764229|11891671|FG000|Overall Study|Study Stopped by Sponsor|69
7541377|NCT02764320|11891677|FG000|Overall Study|Withdrawal by Subject|35
7541378|NCT02764320|11891678|FG001|Overall Study|Withdrawal by Subject|38
7541379|NCT02764320|11891677|FG000|Overall Study|Protocol Violation|11
7541380|NCT02764320|11891678|FG001|Overall Study|Protocol Violation|6
7541381|NCT02764320|11891677|FG000|Overall Study|Adverse Event|2
7541382|NCT02764320|11891678|FG001|Overall Study|Adverse Event|0
7541383|NCT02764320|11891677|FG000|Overall Study|Health Issues unable to continue|2
7541384|NCT02764320|11891678|FG001|Overall Study|Health Issues unable to continue|0
7541385|NCT02764320|11891677|FG000|Overall Study|Did not meet inclusion criteria|1
7541386|NCT02764320|11891678|FG001|Overall Study|Did not meet inclusion criteria|0
7541387|NCT02764320|11891677|FG000|Overall Study|Subject moved|0
7541388|NCT02764320|11891678|FG001|Overall Study|Subject moved|2
7541389|NCT02764320|11891677|FG000|Overall Study|Overused medication unavailable|0
7541390|NCT02764320|11891678|FG001|Overall Study|Overused medication unavailable|1
7541391|NCT02764320|11891677|FG000|Overall Study|Seeking care outside site|0
7541392|NCT02764320|11891678|FG001|Overall Study|Seeking care outside site|1
7541393|NCT02764320|11891677|FG000|Overall Study|Technology barriers|0
7541394|NCT02764320|11891678|FG001|Overall Study|Technology barriers|1
7541395|NCT02764333|11891684|FG000|Overall Study|Ineligible|1
7541396|NCT02764697|11891697|FG000|Overall Study|Lack of Efficacy|3
7541400|NCT02764775|11891705|FG000|Overall Study|Death|1
7541401|NCT02764775|11891705|FG000|Overall Study|Lost to Follow-up|2
7541402|NCT02764775|11891705|FG000|Overall Study|Withdrawal by Subject|3
7541403|NCT02765035|11891720|FG000|First Intervention (90 Days)|Adverse Event|1
7541404|NCT02765035|11891721|FG001|First Intervention (90 Days)|Adverse Event|1
7541405|NCT02765035|11891720|FG000|Second Intervention (30 Days)|Protocol Violation|2
7541406|NCT02765035|11891721|FG001|Second Intervention (30 Days)|Protocol Violation|2
7541407|NCT02765100|11891730|FG000|Overall Study|subject found ineligible after baseline|1
7541408|NCT02765100|11891731|FG001|Overall Study|subject found ineligible after baseline|1
7541409|NCT02765100|11891730|FG000|Overall Study|Lost to Follow-up|0
7541410|NCT02765100|11891731|FG001|Overall Study|Lost to Follow-up|1
7541411|NCT02765165|11891744|FG000|Treatment Period|Progressive disease|3
7541412|NCT02765165|11891745|FG001|Treatment Period|Progressive disease|2
7541413|NCT02765165|11891746|FG002|Treatment Period|Progressive disease|3
7541414|NCT02765165|11891747|FG003|Treatment Period|Progressive disease|3
7541415|NCT02765165|11891748|FG004|Treatment Period|Progressive disease|4
7541416|NCT02765165|11891749|FG005|Treatment Period|Progressive disease|2
7541417|NCT02765165|11891750|FG006|Treatment Period|Progressive disease|2
7541418|NCT02765165|11891744|FG000|Treatment Period|Physician Decision|0
7541419|NCT02765165|11891745|FG001|Treatment Period|Physician Decision|1
7541420|NCT02765165|11891746|FG002|Treatment Period|Physician Decision|0
7541421|NCT02765165|11891747|FG003|Treatment Period|Physician Decision|0
7541422|NCT02765165|11891748|FG004|Treatment Period|Physician Decision|0
7541423|NCT02765165|11891749|FG005|Treatment Period|Physician Decision|0
7541424|NCT02765165|11891750|FG006|Treatment Period|Physician Decision|0
7541425|NCT02765165|11891744|FG000|Treatment Period|Adverse Event|0
7541426|NCT02765165|11891745|FG001|Treatment Period|Adverse Event|1
7541427|NCT02765165|11891746|FG002|Treatment Period|Adverse Event|0
7541428|NCT02765165|11891747|FG003|Treatment Period|Adverse Event|0
7541429|NCT02765165|11891748|FG004|Treatment Period|Adverse Event|0
7541430|NCT02765165|11891749|FG005|Treatment Period|Adverse Event|0
7541431|NCT02765165|11891750|FG006|Treatment Period|Adverse Event|0
7541432|NCT02765165|11891744|FG000|Treatment Period|Withdrawal by Subject|0
7541433|NCT02765165|11891745|FG001|Treatment Period|Withdrawal by Subject|0
7257819|NCT00335153|11469882|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
7541434|NCT02765165|11891746|FG002|Treatment Period|Withdrawal by Subject|0
7541435|NCT02765165|11891747|FG003|Treatment Period|Withdrawal by Subject|0
7541436|NCT02765165|11891748|FG004|Treatment Period|Withdrawal by Subject|2
7541437|NCT02765165|11891749|FG005|Treatment Period|Withdrawal by Subject|0
7541438|NCT02765165|11891750|FG006|Treatment Period|Withdrawal by Subject|0
7541439|NCT02765165|11891744|FG000|Treatment Period|Study terminated|0
7541440|NCT02765165|11891745|FG001|Treatment Period|Study terminated|0
7541441|NCT02765165|11891746|FG002|Treatment Period|Study terminated|0
7541442|NCT02765165|11891747|FG003|Treatment Period|Study terminated|0
7541443|NCT02765165|11891748|FG004|Treatment Period|Study terminated|0
7541444|NCT02765165|11891749|FG005|Treatment Period|Study terminated|1
7541445|NCT02765165|11891750|FG006|Treatment Period|Study terminated|2
7541446|NCT02765165|11891744|FG000|Post-treatment Follow-up|Death|1
7541447|NCT02765165|11891745|FG001|Post-treatment Follow-up|Death|2
7541448|NCT02765165|11891746|FG002|Post-treatment Follow-up|Death|1
7541449|NCT02765165|11891747|FG003|Post-treatment Follow-up|Death|1
7541450|NCT02765165|11891748|FG004|Post-treatment Follow-up|Death|1
7541451|NCT02765165|11891749|FG005|Post-treatment Follow-up|Death|1
7541452|NCT02765165|11891750|FG006|Post-treatment Follow-up|Death|0
7541453|NCT02765165|11891744|FG000|Post-treatment Follow-up|Lost to Follow-up|0
7541454|NCT02765165|11891745|FG001|Post-treatment Follow-up|Lost to Follow-up|0
7541455|NCT02765165|11891746|FG002|Post-treatment Follow-up|Lost to Follow-up|0
7541456|NCT02765165|11891747|FG003|Post-treatment Follow-up|Lost to Follow-up|1
7541457|NCT02765165|11891748|FG004|Post-treatment Follow-up|Lost to Follow-up|0
7541458|NCT02765165|11891749|FG005|Post-treatment Follow-up|Lost to Follow-up|0
7541459|NCT02765165|11891750|FG006|Post-treatment Follow-up|Lost to Follow-up|0
7541460|NCT02765165|11891744|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
7541461|NCT02765165|11891745|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
7541462|NCT02765165|11891746|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
7541463|NCT02765165|11891747|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
7541464|NCT02765165|11891748|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
7541465|NCT02765165|11891749|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
7541466|NCT02765165|11891750|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
7541467|NCT02765165|11891744|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
7541468|NCT02765165|11891745|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
7541469|NCT02765165|11891746|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
7541470|NCT02765165|11891747|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
7541471|NCT02765165|11891748|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
7541472|NCT02765165|11891749|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
7541473|NCT02765165|11891750|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
7541474|NCT02765165|11891744|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
7541475|NCT02765165|11891745|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
7541476|NCT02765165|11891746|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
7541477|NCT02765165|11891747|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
7541478|NCT02765165|11891748|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
7541479|NCT02765165|11891749|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
7541480|NCT02765165|11891750|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
7541481|NCT02765165|11891744|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
7541482|NCT02765165|11891745|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
7541483|NCT02765165|11891746|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
7541484|NCT02765165|11891747|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
7541485|NCT02765165|11891748|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
7541486|NCT02765165|11891749|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
7541487|NCT02765165|11891750|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
7541488|NCT02765490|11891790|FG000|Overall Study|Lost to Follow-up|1
7541489|NCT02765490|11891791|FG001|Overall Study|Lost to Follow-up|1
7541490|NCT02765490|11891790|FG000|Overall Study|Other|0
7541491|NCT02765490|11891791|FG001|Overall Study|Other|1
7541492|NCT02765490|11891790|FG000|Overall Study|Death|0
7541493|NCT02765490|11891791|FG001|Overall Study|Death|1
7541494|NCT02766023|11891799|FG000|Overall Study|Lost to Follow-up|23
7541495|NCT02766023|11891800|FG001|Overall Study|Lost to Follow-up|11
7541496|NCT02766023|11891799|FG000|Overall Study|Pregnancy|1
7541497|NCT02766023|11891800|FG001|Overall Study|Pregnancy|0
7541498|NCT02766023|11891799|FG000|Overall Study|Adverse Event|1
7541499|NCT02766023|11891800|FG001|Overall Study|Adverse Event|0
7541500|NCT02766023|11891799|FG000|Overall Study|Withdrawal by Subject|4
7541501|NCT02766023|11891800|FG001|Overall Study|Withdrawal by Subject|5
7541502|NCT02766023|11891799|FG000|Overall Study|Physician Decision|1
7541503|NCT02766023|11891800|FG001|Overall Study|Physician Decision|0
7541504|NCT02766023|11891799|FG000|Overall Study|Not Eligible at Enrollment|0
7541505|NCT02766023|11891800|FG001|Overall Study|Not Eligible at Enrollment|1
7541506|NCT02766088|11891806|FG000|Overall Study|Sponsor study termination|498
7541507|NCT02766088|11891806|FG000|Overall Study|Migrated/moved from the study area|1
7541508|NCT02766088|11891806|FG000|Overall Study|Lost to Follow-up|5
7541509|NCT02766088|11891806|FG000|Overall Study|Other|1
7541510|NCT02766088|11891806|FG000|Overall Study|Death|1
7541511|NCT02766283|11891819|FG000|Overall Study|Lost to Follow-up|27
7541512|NCT02766400|11891838|FG000|Overall Study|Death|1
7541513|NCT02766400|11891839|FG001|Overall Study|Death|2
7541514|NCT02766400|11891838|FG000|Overall Study|Withdrawal by Subject|1
7541515|NCT02766400|11891839|FG001|Overall Study|Withdrawal by Subject|0
7541516|NCT02766608|11891863|FG000|Overall Study|Adverse Event|27
7541517|NCT02766608|11891864|FG001|Overall Study|Adverse Event|22
7541518|NCT02766608|11891865|FG002|Overall Study|Adverse Event|17
7541519|NCT02766608|11891866|FG003|Overall Study|Adverse Event|13
7541520|NCT02766608|11891867|FG004|Overall Study|Adverse Event|12
7541521|NCT02766608|11891863|FG000|Overall Study|Withdrawal by Subject|21
7541522|NCT02766608|11891864|FG001|Overall Study|Withdrawal by Subject|20
7541523|NCT02766608|11891865|FG002|Overall Study|Withdrawal by Subject|24
7541524|NCT02766608|11891866|FG003|Overall Study|Withdrawal by Subject|13
7541525|NCT02766608|11891867|FG004|Overall Study|Withdrawal by Subject|10
7541526|NCT02766608|11891863|FG000|Overall Study|Lack of Efficacy|16
7541527|NCT02766608|11891864|FG001|Overall Study|Lack of Efficacy|15
7541528|NCT02766608|11891865|FG002|Overall Study|Lack of Efficacy|32
7541529|NCT02766608|11891866|FG003|Overall Study|Lack of Efficacy|8
7541530|NCT02766608|11891867|FG004|Overall Study|Lack of Efficacy|2
7541531|NCT02766608|11891863|FG000|Overall Study|Lost to Follow-up|6
7541532|NCT02766608|11891864|FG001|Overall Study|Lost to Follow-up|3
7576087|NCT04601103|11961177|FG002|Overall Study|Needed crown & cleaning|1
7576088|NCT04601103|11961175|FG000|Overall Study|study was terminated|18
7576089|NCT04601103|11961176|FG001|Overall Study|study was terminated|18
7541533|NCT02766608|11891865|FG002|Overall Study|Lost to Follow-up|5
7541534|NCT02766608|11891866|FG003|Overall Study|Lost to Follow-up|2
7541535|NCT02766608|11891867|FG004|Overall Study|Lost to Follow-up|2
7541536|NCT02766608|11891863|FG000|Overall Study|Physician Decision|3
7541537|NCT02766608|11891864|FG001|Overall Study|Physician Decision|2
7541538|NCT02766608|11891865|FG002|Overall Study|Physician Decision|3
7541539|NCT02766608|11891866|FG003|Overall Study|Physician Decision|1
7541540|NCT02766608|11891867|FG004|Overall Study|Physician Decision|2
7541541|NCT02766608|11891863|FG000|Overall Study|Protocol disc criteria|3
7541542|NCT02766608|11891864|FG001|Overall Study|Protocol disc criteria|3
7541543|NCT02766608|11891865|FG002|Overall Study|Protocol disc criteria|4
7541544|NCT02766608|11891866|FG003|Overall Study|Protocol disc criteria|0
7541545|NCT02766608|11891867|FG004|Overall Study|Protocol disc criteria|0
7541546|NCT02766608|11891863|FG000|Overall Study|Protocol Violation|0
7541547|NCT02766608|11891864|FG001|Overall Study|Protocol Violation|4
7541548|NCT02766608|11891865|FG002|Overall Study|Protocol Violation|4
7541549|NCT02766608|11891866|FG003|Overall Study|Protocol Violation|0
7541550|NCT02766608|11891867|FG004|Overall Study|Protocol Violation|1
7541551|NCT02766608|11891863|FG000|Overall Study|Administrative Reasons|3
7541552|NCT02766608|11891864|FG001|Overall Study|Administrative Reasons|1
7541553|NCT02766608|11891865|FG002|Overall Study|Administrative Reasons|1
7541554|NCT02766608|11891866|FG003|Overall Study|Administrative Reasons|0
7541555|NCT02766608|11891867|FG004|Overall Study|Administrative Reasons|0
7541556|NCT02766777|11891895|FG000|Overall Study|Adverse Event|12
7541557|NCT02766777|11891895|FG000|Overall Study|Lost to Follow-up|16
7541558|NCT02766777|11891895|FG000|Overall Study|Non-Compliance With Study Drug|1
7541559|NCT02766777|11891895|FG000|Overall Study|Protocol Violation|1
7541560|NCT02766777|11891895|FG000|Overall Study|Withdrawal by Subject|4
7576090|NCT04601103|11961177|FG002|Overall Study|study was terminated|16
7576091|NCT04664855|11961205|FG000|Overall Study|Withdrawal by Subject|0
7576092|NCT04664855|11961206|FG001|Overall Study|Withdrawal by Subject|2
7576093|NCT04701658|11961212|FG000|Overall Study|Lost to Follow-up|6
7576094|NCT04706416|11961218|FG000|Overall Study|Lost to Follow-up|2
7576095|NCT04706416|11961219|FG001|Overall Study|Lost to Follow-up|0
7576096|NCT04727749|11961239|FG000|Overall Study|Lost to Follow-up|10
7576097|NCT04727749|11961240|FG001|Overall Study|Lost to Follow-up|3
7576098|NCT04854707|11961262|FG000|Overall Study|Lack of Efficacy|78
7541561|NCT02767323|11891944|FG000|Overall Study|Withdrawal by Subject|17
7541562|NCT02767323|11891945|FG001|Overall Study|Withdrawal by Subject|5
7541563|NCT02767323|11891946|FG002|Overall Study|Withdrawal by Subject|13
7541564|NCT02767323|11891947|FG003|Overall Study|Withdrawal by Subject|0
7576099|NCT04854707|11961263|FG001|Overall Study|Lack of Efficacy|59
7576100|NCT04854707|11961264|FG002|Overall Study|Lack of Efficacy|30
7576101|NCT04947436|11961359|FG000|Overall Study|Lost to Follow-up|3
7576102|NCT04947436|11961360|FG001|Overall Study|Lost to Follow-up|7
7576103|NCT04947436|11961361|FG002|Overall Study|Lost to Follow-up|5
7576104|NCT04947436|11961359|FG000|Overall Study|Death|1
7576105|NCT04947436|11961360|FG001|Overall Study|Death|1
7576106|NCT04947436|11961361|FG002|Overall Study|Death|1
7576107|NCT05002972|11961369|FG000|Overall Study|Withdrawal by Subject|2
7576108|NCT05002985|11961373|FG000|Overall Study|Withdrawal by Subject|1
7576109|NCT04512482|11961379|FG000|Second Intervention (1 Day)|Protocol Violation|2
7576110|NCT04512482|11961380|FG001|Second Intervention (1 Day)|Protocol Violation|1
7541565|NCT02767323|11891944|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7541566|NCT02767323|11891945|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
7541567|NCT02767323|11891946|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
7541568|NCT02767323|11891947|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
7541569|NCT02767765|11891995|FG000|Overall Study|Adverse Event|4
7541570|NCT02767765|11891995|FG000|Overall Study|Death|1
7541571|NCT02767765|11891995|FG000|Overall Study|Insufficient response|1
7541572|NCT02767765|11891995|FG000|Overall Study|Lost to Follow-up|2
7541573|NCT02767765|11891995|FG000|Overall Study|Investigator decision|1
7541574|NCT02767765|11891995|FG000|Overall Study|Non-Compliance|1
7541575|NCT02767765|11891995|FG000|Overall Study|Withdrawal by Subject|1
7552209|NCT02983227|11911976|FG000|Overall Study|Adverse Event|21
7552210|NCT02983227|11911977|FG001|Overall Study|Adverse Event|3
7552211|NCT02983227|11911976|FG000|Overall Study|Death|3
7552212|NCT02983227|11911977|FG001|Overall Study|Death|0
7576111|NCT04523831|11961405|FG000|Overall Study|Lost to Follow-up|15
7576112|NCT04523831|11961406|FG001|Overall Study|Lost to Follow-up|17
7576113|NCT04523831|11961405|FG000|Overall Study|Death|0
7576114|NCT04523831|11961406|FG001|Overall Study|Death|3
7576115|NCT04523831|11961405|FG000|Overall Study|Adverse Event|2
7576116|NCT04523831|11961406|FG001|Overall Study|Adverse Event|0
7576117|NCT04521777|11961415|FG000|Overall Study|Death|2
7576118|NCT04521777|11961415|FG000|Overall Study|Withdrawal by Subject|2
7576119|NCT04507776|11961445|FG000|Overall Study|Participants did not meet the entrance criteria|201
7576120|NCT04502979|11961456|FG000|Overall Study|Lost to Follow-up|1
7576121|NCT04502979|11961457|FG001|Overall Study|Lost to Follow-up|3
7576122|NCT04502979|11961456|FG000|Overall Study|Withdrawal by Subject|2
7576123|NCT04502979|11961457|FG001|Overall Study|Withdrawal by Subject|1
7576124|NCT04498403|11961500|FG000|Overall Study|Adverse Event|1
7576125|NCT04498403|11961501|FG001|Overall Study|Adverse Event|0
7576126|NCT04498403|11961500|FG000|Overall Study|Study Terminated By Sponsor|29
7576127|NCT04498403|11961501|FG001|Overall Study|Study Terminated By Sponsor|10
7576128|NCT04495374|11961509|FG000|Overall Study|Protocol Violation|2
7576129|NCT04495374|11961510|FG001|Overall Study|Protocol Violation|1
7576130|NCT04491994|11961534|FG000|Overall Study|Withdrawal by Subject|10
7576131|NCT04491994|11961535|FG001|Overall Study|Withdrawal by Subject|5
7576132|NCT04491994|11961534|FG000|Overall Study|developed fever > 3 days|4
7576133|NCT04491994|11961535|FG001|Overall Study|developed fever > 3 days|1
7576134|NCT04491994|11961534|FG000|Overall Study|Protocol Violation|11
7576135|NCT04491994|11961535|FG001|Overall Study|Protocol Violation|2
7576136|NCT04491994|11961534|FG000|Overall Study|Lost to Follow-up|4
7576137|NCT04491994|11961535|FG001|Overall Study|Lost to Follow-up|3
7576139|NCT04486235|11961568|FG000|Overall Study|Pregnancy|1
7576140|NCT04486235|11961569|FG001|Overall Study|Pregnancy|0
7576141|NCT04486235|11961568|FG000|Overall Study|Lost to Follow-up|1
7576142|NCT04486235|11961569|FG001|Overall Study|Lost to Follow-up|0
7576143|NCT04483011|11961578|FG000|Washout (7 Days)|Withdrawal by Subject|0
7576144|NCT04483011|11961579|FG001|Washout (7 Days)|Withdrawal by Subject|1
7576145|NCT04475588|11961589|FG000|Overall Study|Adverse Event|2
7576146|NCT04475588|11961590|FG001|Overall Study|Adverse Event|0
7576147|NCT04474405|11961616|FG000|Overall Study|Withdrawal by Subject|0
7576148|NCT04474405|11961617|FG001|Overall Study|Withdrawal by Subject|0
7576149|NCT04474405|11961618|FG002|Overall Study|Withdrawal by Subject|1
7576150|NCT04474405|11961619|FG003|Overall Study|Withdrawal by Subject|0
7576151|NCT04474405|11961620|FG004|Overall Study|Withdrawal by Subject|1
7576152|NCT04474405|11961621|FG005|Overall Study|Withdrawal by Subject|0
7576153|NCT04474405|11961616|FG000|Overall Study|Other|0
7576154|NCT04474405|11961617|FG001|Overall Study|Other|0
7576155|NCT04474405|11961618|FG002|Overall Study|Other|0
7576156|NCT04474405|11961619|FG003|Overall Study|Other|0
7257820|NCT00335153|11469882|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
7552213|NCT02983227|11911976|FG000|Overall Study|Lack of Efficacy|8
7552214|NCT02983227|11911977|FG001|Overall Study|Lack of Efficacy|1
7552215|NCT02983227|11911976|FG000|Overall Study|Lost to Follow-up|3
7552216|NCT02983227|11911977|FG001|Overall Study|Lost to Follow-up|0
7552217|NCT02983227|11911976|FG000|Overall Study|Multiple Reasons|2
7552218|NCT02983227|11911977|FG001|Overall Study|Multiple Reasons|1
7552219|NCT02983227|11911976|FG000|Overall Study|Physician Decision|3
7552220|NCT02983227|11911977|FG001|Overall Study|Physician Decision|1
7552221|NCT02983227|11911976|FG000|Overall Study|Withdrawal by Subject|19
7552222|NCT02983227|11911977|FG001|Overall Study|Withdrawal by Subject|8
7552223|NCT02983305|11911985|FG000|Overall Study|incomplete data|2
7552224|NCT02983305|11911986|FG001|Overall Study|incomplete data|0
7541576|NCT02768103|11892028|FG000|Overall Study|1 participant did not fit in the fMRI|1
7541577|NCT02768194|11892041|FG000|Period 1|Adverse Event|0
7541578|NCT02768194|11892042|FG001|Period 1|Adverse Event|0
7541579|NCT02768194|11892043|FG002|Period 1|Adverse Event|0
7541580|NCT02768194|11892044|FG003|Period 1|Adverse Event|1
7541581|NCT02768194|11892045|FG004|Period 1|Adverse Event|0
7541582|NCT02768194|11892046|FG005|Period 1|Adverse Event|0
7541583|NCT02768194|11892041|FG000|Period 2|Other (Reason not specified)|1
7541584|NCT02768194|11892042|FG001|Period 2|Other (Reason not specified)|0
7541585|NCT02768194|11892043|FG002|Period 2|Other (Reason not specified)|0
7541586|NCT02768194|11892044|FG003|Period 2|Other (Reason not specified)|0
7541587|NCT02768194|11892045|FG004|Period 2|Other (Reason not specified)|0
7541588|NCT02768194|11892046|FG005|Period 2|Other (Reason not specified)|0
7541589|NCT02768194|11892041|FG000|Period 3|Other (Reason not specified)|0
7541590|NCT02768194|11892042|FG001|Period 3|Other (Reason not specified)|1
7541591|NCT02768194|11892043|FG002|Period 3|Other (Reason not specified)|0
7541592|NCT02768194|11892044|FG003|Period 3|Other (Reason not specified)|0
7541593|NCT02768194|11892045|FG004|Period 3|Other (Reason not specified)|0
7541594|NCT02768194|11892046|FG005|Period 3|Other (Reason not specified)|0
7541595|NCT02768298|11892056|FG000|Overall Study|Adverse Event|1
7541596|NCT02768298|11892057|FG001|Overall Study|Adverse Event|4
7541597|NCT02768298|11892056|FG000|Overall Study|Death|2
7541598|NCT02768298|11892057|FG001|Overall Study|Death|1
7541599|NCT02768298|11892056|FG000|Overall Study|Non-compliance with study treatment|0
7541600|NCT02768298|11892057|FG001|Overall Study|Non-compliance with study treatment|1
7541601|NCT02768298|11892056|FG000|Overall Study|Subject/guardian decision|1
7541602|NCT02768298|11892057|FG001|Overall Study|Subject/guardian decision|0
7541603|NCT02768298|11892056|FG000|Overall Study|Withdrawal of informed consent|0
7541604|NCT02768298|11892057|FG001|Overall Study|Withdrawal of informed consent|1
7541606|NCT02769065|11892115|FG000|Overall Study|Voluntary Withdrawal|1
7541607|NCT02769065|11892116|FG001|Overall Study|Voluntary Withdrawal|0
7541608|NCT02769065|11892117|FG002|Overall Study|Voluntary Withdrawal|0
7541609|NCT02769065|11892118|FG003|Overall Study|Voluntary Withdrawal|0
7541610|NCT02769065|11892119|FG004|Overall Study|Voluntary Withdrawal|0
7541611|NCT02769065|11892120|FG005|Overall Study|Voluntary Withdrawal|0
7541612|NCT02769065|11892121|FG006|Overall Study|Voluntary Withdrawal|0
7541613|NCT02769065|11892122|FG007|Overall Study|Voluntary Withdrawal|0
7541614|NCT02769065|11892123|FG008|Overall Study|Voluntary Withdrawal|0
7541615|NCT02769065|11892124|FG009|Overall Study|Voluntary Withdrawal|0
7541616|NCT02769065|11892125|FG010|Overall Study|Voluntary Withdrawal|0
7541617|NCT02769065|11892126|FG011|Overall Study|Voluntary Withdrawal|0
7541618|NCT02769065|11892127|FG012|Overall Study|Voluntary Withdrawal|0
7541619|NCT02769065|11892128|FG013|Overall Study|Voluntary Withdrawal|0
7541620|NCT02769065|11892129|FG014|Overall Study|Voluntary Withdrawal|0
7541621|NCT02769065|11892130|FG015|Overall Study|Voluntary Withdrawal|0
7541622|NCT02769065|11892131|FG016|Overall Study|Voluntary Withdrawal|0
7541623|NCT02769065|11892132|FG017|Overall Study|Voluntary Withdrawal|0
7541624|NCT02769065|11892133|FG018|Overall Study|Voluntary Withdrawal|0
7541625|NCT02769065|11892134|FG019|Overall Study|Voluntary Withdrawal|0
7541626|NCT02769065|11892135|FG020|Overall Study|Voluntary Withdrawal|0
7541627|NCT02769065|11892136|FG021|Overall Study|Voluntary Withdrawal|0
7541628|NCT02769065|11892137|FG022|Overall Study|Voluntary Withdrawal|0
7541629|NCT02769065|11892138|FG023|Overall Study|Voluntary Withdrawal|0
7541630|NCT02769065|11892139|FG024|Overall Study|Voluntary Withdrawal|0
7541631|NCT02769065|11892140|FG025|Overall Study|Voluntary Withdrawal|0
7541632|NCT02769065|11892141|FG026|Overall Study|Voluntary Withdrawal|0
7541633|NCT02769065|11892142|FG027|Overall Study|Voluntary Withdrawal|0
7541634|NCT02769065|11892143|FG028|Overall Study|Voluntary Withdrawal|0
7541635|NCT02769065|11892144|FG029|Overall Study|Voluntary Withdrawal|0
7541636|NCT02769065|11892115|FG000|Overall Study|Reason Not Specified|0
7541637|NCT02769065|11892116|FG001|Overall Study|Reason Not Specified|0
7541638|NCT02769065|11892117|FG002|Overall Study|Reason Not Specified|0
7541639|NCT02769065|11892118|FG003|Overall Study|Reason Not Specified|0
7541640|NCT02769065|11892119|FG004|Overall Study|Reason Not Specified|0
7541641|NCT02769065|11892120|FG005|Overall Study|Reason Not Specified|0
7541642|NCT02769065|11892121|FG006|Overall Study|Reason Not Specified|1
7541643|NCT02769065|11892122|FG007|Overall Study|Reason Not Specified|0
7541644|NCT02769065|11892123|FG008|Overall Study|Reason Not Specified|0
7541645|NCT02769065|11892124|FG009|Overall Study|Reason Not Specified|0
7541646|NCT02769065|11892125|FG010|Overall Study|Reason Not Specified|0
7541647|NCT02769065|11892126|FG011|Overall Study|Reason Not Specified|0
7541648|NCT02769065|11892127|FG012|Overall Study|Reason Not Specified|0
7541649|NCT02769065|11892128|FG013|Overall Study|Reason Not Specified|0
7541650|NCT02769065|11892129|FG014|Overall Study|Reason Not Specified|0
7541651|NCT02769065|11892130|FG015|Overall Study|Reason Not Specified|0
7541652|NCT02769065|11892131|FG016|Overall Study|Reason Not Specified|0
7541653|NCT02769065|11892132|FG017|Overall Study|Reason Not Specified|0
7541654|NCT02769065|11892133|FG018|Overall Study|Reason Not Specified|0
7541655|NCT02769065|11892134|FG019|Overall Study|Reason Not Specified|0
7541656|NCT02769065|11892135|FG020|Overall Study|Reason Not Specified|0
7257821|NCT00335153|11469882|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
7541657|NCT02769065|11892136|FG021|Overall Study|Reason Not Specified|0
7541658|NCT02769065|11892137|FG022|Overall Study|Reason Not Specified|0
7541659|NCT02769065|11892138|FG023|Overall Study|Reason Not Specified|0
7541660|NCT02769065|11892139|FG024|Overall Study|Reason Not Specified|0
7541661|NCT02769065|11892140|FG025|Overall Study|Reason Not Specified|0
7541662|NCT02769065|11892141|FG026|Overall Study|Reason Not Specified|0
7541663|NCT02769065|11892142|FG027|Overall Study|Reason Not Specified|0
7541664|NCT02769065|11892143|FG028|Overall Study|Reason Not Specified|0
7541665|NCT02769065|11892144|FG029|Overall Study|Reason Not Specified|0
7541666|NCT02769065|11892115|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
7541667|NCT02769065|11892116|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
7541668|NCT02769065|11892117|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
7541669|NCT02769065|11892118|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
7541670|NCT02769065|11892119|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
7541671|NCT02769065|11892120|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
7541672|NCT02769065|11892121|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
7257822|NCT00335153|11469882|FG000|Nasojejunal (NJ) Test Period|Administrative|1
7257823|NCT00335153|11469882|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
7541673|NCT02769065|11892122|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
7541674|NCT02769065|11892123|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
7541675|NCT02769065|11892124|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
7541676|NCT02769065|11892125|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
7541677|NCT02769065|11892126|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
7541678|NCT02769065|11892127|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
7541679|NCT02769065|11892128|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
7541680|NCT02769065|11892129|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
7541681|NCT02769065|11892130|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
7541682|NCT02769065|11892131|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
7541683|NCT02769065|11892132|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
7541684|NCT02769065|11892133|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
7541685|NCT02769065|11892134|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
7257824|NCT00335153|11469882|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
7257825|NCT00335153|11469882|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
7257826|NCT00335153|11469882|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
7257827|NCT00335153|11469882|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
7257828|NCT00335153|11469882|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
7257829|NCT00335322|11469917|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
7257830|NCT00335322|11469918|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
7257831|NCT00335322|11469919|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
7257832|NCT00335452|11469934|FG000|Overall Study|Death|156
7257833|NCT00335452|11469935|FG001|Overall Study|Death|144
7257834|NCT00335452|11469936|FG002|Overall Study|Death|158
7257835|NCT00335452|11469937|FG003|Overall Study|Death|129
7257836|NCT00335452|11469934|FG000|Overall Study|Lost to Follow-up|2
7257837|NCT00335452|11469935|FG001|Overall Study|Lost to Follow-up|3
7257838|NCT00335452|11469936|FG002|Overall Study|Lost to Follow-up|1
7257839|NCT00335452|11469937|FG003|Overall Study|Lost to Follow-up|2
7257840|NCT00335556|11469983|FG000|Overall Study|Death|0
7257841|NCT00335556|11469984|FG001|Overall Study|Death|5
7257842|NCT00335556|11469985|FG002|Overall Study|Death|0
7257843|NCT00335556|11469986|FG003|Overall Study|Death|0
7257844|NCT00335556|11469987|FG004|Overall Study|Death|1
7257845|NCT00335556|11469988|FG005|Overall Study|Death|0
7541686|NCT02769065|11892135|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
7541687|NCT02769065|11892136|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
7541688|NCT02769065|11892137|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
7541689|NCT02769065|11892138|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
7541690|NCT02769065|11892139|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
7541691|NCT02769065|11892140|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
7541692|NCT02769065|11892141|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
7541693|NCT02769065|11892142|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
7541694|NCT02769065|11892143|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
7541695|NCT02769065|11892144|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
7541696|NCT02769247|11892241|FG000|Overall Study|Withdrawal by Subject|1
7541697|NCT02769247|11892242|FG001|Overall Study|Withdrawal by Subject|0
7541698|NCT02769247|11892243|FG002|Overall Study|Withdrawal by Subject|0
7541699|NCT02769247|11892244|FG003|Overall Study|Withdrawal by Subject|1
7541700|NCT02769247|11892241|FG000|Overall Study|Protocol Violation|0
7541701|NCT02769247|11892242|FG001|Overall Study|Protocol Violation|0
7541702|NCT02769247|11892243|FG002|Overall Study|Protocol Violation|1
7541703|NCT02769247|11892244|FG003|Overall Study|Protocol Violation|0
7541704|NCT02769247|11892241|FG000|Overall Study|Physician Decision|1
7541705|NCT02769247|11892242|FG001|Overall Study|Physician Decision|0
7541706|NCT02769247|11892243|FG002|Overall Study|Physician Decision|0
7541707|NCT02769247|11892244|FG003|Overall Study|Physician Decision|0
7541708|NCT02769312|11892260|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7541709|NCT02769312|11892261|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
7541710|NCT02769312|11892260|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
7541711|NCT02769312|11892261|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
7541712|NCT02769312|11892260|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
7541713|NCT02769312|11892261|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
7541714|NCT02769312|11892260|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
7541715|NCT02769312|11892261|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
7541716|NCT02769312|11892260|FG000|Follow-up|Lost to Follow-up|1
7541717|NCT02769312|11892261|FG001|Follow-up|Lost to Follow-up|1
7541718|NCT02769481|11892284|FG000|Overall Study|Protocol Violation|1
7541719|NCT02769481|11892285|FG001|Overall Study|Protocol Violation|0
7541720|NCT02769481|11892284|FG000|Overall Study|Adverse Event|3
7541721|NCT02769481|11892285|FG001|Overall Study|Adverse Event|6
7541722|NCT02769481|11892284|FG000|Overall Study|Entry Criteria Not Met|1
7541723|NCT02769481|11892285|FG001|Overall Study|Entry Criteria Not Met|2
7541724|NCT02769481|11892284|FG000|Overall Study|Withdrawal by Subject|14
7541725|NCT02769481|11892285|FG001|Overall Study|Withdrawal by Subject|16
7541726|NCT02769481|11892284|FG000|Overall Study|Lost to Follow-up|9
7541727|NCT02769481|11892285|FG001|Overall Study|Lost to Follow-up|9
7541728|NCT02769481|11892284|FG000|Overall Study|Physician Decision|0
7541729|NCT02769481|11892285|FG001|Overall Study|Physician Decision|1
7541730|NCT02769481|11892284|FG000|Overall Study|Terminated by Sponsor|1
7541731|NCT02769481|11892285|FG001|Overall Study|Terminated by Sponsor|0
7541732|NCT02769481|11892284|FG000|Overall Study|Death|0
7541733|NCT02769481|11892285|FG001|Overall Study|Death|1
7541734|NCT02769481|11892284|FG000|Overall Study|Undefined|4
7541735|NCT02769481|11892285|FG001|Overall Study|Undefined|1
7541736|NCT02769624|11892291|FG000|Overall Study|Lost to Follow-up|0
7541737|NCT02769624|11892292|FG001|Overall Study|Lost to Follow-up|1
7541738|NCT02769858|11892302|FG000|Overall Study|Withdrawal by Subject|2
7541739|NCT02770170|11892315|FG000|Overall Study|Withdrawal by Subject|0
7541740|NCT02770170|11892316|FG001|Overall Study|Withdrawal by Subject|0
7541741|NCT02770170|11892317|FG002|Overall Study|Withdrawal by Subject|0
7541742|NCT02770170|11892318|FG003|Overall Study|Withdrawal by Subject|2
7541743|NCT02770170|11892315|FG000|Overall Study|due to pregnancy|1
7541744|NCT02770170|11892316|FG001|Overall Study|due to pregnancy|0
7541745|NCT02770170|11892317|FG002|Overall Study|due to pregnancy|0
7541746|NCT02770170|11892318|FG003|Overall Study|due to pregnancy|0
7541747|NCT02770170|11892315|FG000|Overall Study|Lack of Efficacy|2
7541748|NCT02770170|11892316|FG001|Overall Study|Lack of Efficacy|0
7541749|NCT02770170|11892317|FG002|Overall Study|Lack of Efficacy|0
7541750|NCT02770170|11892318|FG003|Overall Study|Lack of Efficacy|1
7541751|NCT02770170|11892315|FG000|Overall Study|Adverse Event|4
7576157|NCT04474405|11961620|FG004|Overall Study|Other|3
7541752|NCT02770170|11892316|FG001|Overall Study|Adverse Event|3
7541753|NCT02770170|11892317|FG002|Overall Study|Adverse Event|5
7541754|NCT02770170|11892318|FG003|Overall Study|Adverse Event|3
7576158|NCT04474405|11961621|FG005|Overall Study|Other|0
7576159|NCT04468347|11961643|FG000|Overall Study|Withdrawal by Subject|0
7576160|NCT04468347|11961644|FG001|Overall Study|Withdrawal by Subject|1
7576161|NCT04468347|11961645|FG002|Overall Study|Withdrawal by Subject|3
7576162|NCT04468347|11961646|FG003|Overall Study|Withdrawal by Subject|3
7576163|NCT04468347|11961643|FG000|Overall Study|Lost to Follow-up|0
7576164|NCT04468347|11961644|FG001|Overall Study|Lost to Follow-up|0
7576165|NCT04468347|11961645|FG002|Overall Study|Lost to Follow-up|1
7576166|NCT04468347|11961646|FG003|Overall Study|Lost to Follow-up|1
7576167|NCT04468347|11961643|FG000|Overall Study|Physician Decision|1
7576168|NCT04468347|11961644|FG001|Overall Study|Physician Decision|0
7576169|NCT04468347|11961645|FG002|Overall Study|Physician Decision|2
7576170|NCT04468347|11961646|FG003|Overall Study|Physician Decision|0
7576171|NCT04468347|11961643|FG000|Overall Study|Protocol Violation|1
7576172|NCT04468347|11961644|FG001|Overall Study|Protocol Violation|0
7576173|NCT04468347|11961645|FG002|Overall Study|Protocol Violation|0
7541755|NCT02770170|11892315|FG000|Overall Study|due to disease worsening|0
7541756|NCT02770170|11892316|FG001|Overall Study|due to disease worsening|0
7576174|NCT04468347|11961646|FG003|Overall Study|Protocol Violation|0
7576175|NCT04465422|11961671|FG000|Overall Study|Lost to Follow-up|0
7576176|NCT04465422|11961672|FG001|Overall Study|Lost to Follow-up|2
7576177|NCT04448561|11961691|FG000|Overall Study|Noncompliance|1
7576178|NCT04448561|11961692|FG001|Overall Study|Noncompliance|0
7541757|NCT02770170|11892317|FG002|Overall Study|due to disease worsening|0
7541758|NCT02770170|11892318|FG003|Overall Study|due to disease worsening|1
7541759|NCT02770248|11892330|FG000|Overall Study|Adverse Event|0
7541760|NCT02770248|11892331|FG001|Overall Study|Adverse Event|1
7541761|NCT02770248|11892330|FG000|Overall Study|Randomized in error, prior to treatment|0
7541762|NCT02770248|11892331|FG001|Overall Study|Randomized in error, prior to treatment|1
7541763|NCT02770547|11892384|FG000|Overall Study|Patient non-compliant|1
7541764|NCT02770547|11892385|FG001|Overall Study|Patient non-compliant|0
7541765|NCT02770547|11892384|FG000|Overall Study|Adverse Event|0
7541766|NCT02770547|11892385|FG001|Overall Study|Adverse Event|1
7541767|NCT02770612|11892391|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
7541768|NCT02770820|11892399|FG000|Overall Study|Death|1
7541769|NCT02770820|11892399|FG000|Overall Study|Physician Decision|2
7541770|NCT02771145|11892423|FG000|Overall Study|Adverse Event|3
7541771|NCT02771145|11892423|FG000|Overall Study|Lost to Follow-up|1
7541772|NCT02771210|11892445|FG000|Period 1|Adverse Event|5
7541773|NCT02771210|11892446|FG001|Period 1|Adverse Event|3
7541774|NCT02771210|11892445|FG000|Period 1|Lack of Efficacy|3
7541775|NCT02771210|11892446|FG001|Period 1|Lack of Efficacy|6
7541776|NCT02771210|11892445|FG000|Period 1|Lost to Follow-up|2
7541777|NCT02771210|11892446|FG001|Period 1|Lost to Follow-up|0
7541778|NCT02771210|11892445|FG000|Period 1|Physician Decision|0
7541779|NCT02771210|11892446|FG001|Period 1|Physician Decision|1
7541780|NCT02771210|11892445|FG000|Period 1|Withdrawal by Subject|0
7576179|NCT04450381|11961767|FG000|Overall Study|Protocol Violation|4
7576180|NCT04450381|11961767|FG000|Overall Study|Wrong device setting|2
7576181|NCT04449341|11961773|FG000|Overall Study|Protocol Violation|1
7576182|NCT04449341|11961774|FG001|Overall Study|Protocol Violation|0
7576183|NCT04439214|11961789|FG000|Overall Study|Adverse Event|13
7576184|NCT04439214|11961789|FG000|Overall Study|Disease progression|16
7576185|NCT04439214|11961789|FG000|Overall Study|Death|1
7576186|NCT04439214|11961789|FG000|Overall Study|Withdrawal by Subject|2
7576187|NCT04439214|11961789|FG000|Overall Study|Declining health|1
7576188|NCT04439214|11961789|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
7576189|NCT04439214|11961789|FG000|Overall Study|Ineligible|5
7576190|NCT04439240|11961793|FG000|Overall Study|Ineligible|2
7576191|NCT04439240|11961793|FG000|Overall Study|Never started treatment|2
7576192|NCT04439240|11961793|FG000|Overall Study|Adverse Event|12
7576193|NCT04439240|11961793|FG000|Overall Study|Death|2
7576194|NCT04439240|11961793|FG000|Overall Study|Disease progression|25
7576195|NCT04439240|11961793|FG000|Overall Study|Other diseases|2
7576196|NCT04439240|11961793|FG000|Overall Study|Withdrawal by Subject|3
7576197|NCT04439240|11961793|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
7576198|NCT04439240|11961793|FG000|Overall Study|Symptomatic decline|1
7576199|NCT04439240|11961793|FG000|Overall Study|Pogression of the lymphadenopathy|1
7576200|NCT04439240|11961793|FG000|Overall Study|Clinical progression|1
7576201|NCT04438785|11961799|FG000|Overall Study|change of weight, give up intervention|2
7576202|NCT04438785|11961800|FG001|Overall Study|change of weight, give up intervention|10
7576203|NCT04428502|11961889|FG000|Overall Study|Did not meet entrance criteria|14
7576204|NCT04428424|11961894|FG000|Overall Study|Does not meet entrance criteria|132
7576205|NCT04428424|11961894|FG000|Overall Study|Lost to Follow-up|115
7576206|NCT04425863|11961938|FG000|Overall Study|Death|0
7576207|NCT04425863|11961939|FG001|Overall Study|Death|0
7576208|NCT04425863|11961940|FG002|Overall Study|Death|1
7624435|NCT03366428|12035523|FG000|Overall Study|Progressive disease per RECIST v1.1|33
7624436|NCT03366428|12035523|FG000|Overall Study|Adverse Event|12
7624437|NCT03366428|12035523|FG000|Overall Study|Clinical progression|2
7624438|NCT03366428|12035523|FG000|Overall Study|Withdrawal by Subject|4
7624446|NCT02756611|12035546|FG000|Overall Study|Death|39
7624447|NCT02756611|12035546|FG000|Overall Study|Withdrawal by Subject|1
7624448|NCT02756611|12035546|FG000|Overall Study|Lost to Follow-up|2
7624449|NCT02756611|12035546|FG000|Overall Study|Other|7
7624450|NCT02756611|12035546|FG000|Overall Study|Missing|2
7624451|NCT02756611|12035546|FG000|Overall Study|Active on Study|205
7257846|NCT00335556|11469983|FG000|Overall Study|Lack of Efficacy|0
7541781|NCT02771210|11892446|FG001|Period 1|Withdrawal by Subject|3
7624452|NCT02724878|12035550|FG000|Overall Study|Still on Active Therapy|15
7624453|NCT02724878|12035550|FG000|Overall Study|Disease Progression|31
7624454|NCT02724878|12035550|FG000|Overall Study|Toxicity|5
7624455|NCT02724878|12035550|FG000|Overall Study|Death|1
7624456|NCT02724878|12035550|FG000|Overall Study|Withdrawal by Subject|4
7624457|NCT02724878|12035550|FG000|Overall Study|Lost to Follow-up|2
7624458|NCT02724878|12035550|FG000|Overall Study|Protocol Violation|1
7624459|NCT02724878|12035550|FG000|Overall Study|Ineligible for Study Drug|5
7624460|NCT02724878|12035550|FG000|Overall Study|not started|1
7624461|NCT02487095|12035576|FG000|Dose Expansion|Unable to scan/restage participant|0
7541782|NCT02771210|11892445|FG000|Period 1|Withdrawal of informed consent|1
7541783|NCT02771210|11892446|FG001|Period 1|Withdrawal of informed consent|5
7541784|NCT02771210|11892445|FG000|Period 2|Adverse Event|1
7541785|NCT02771210|11892446|FG001|Period 2|Adverse Event|0
7541786|NCT02771210|11892445|FG000|Period 2|Lack of Efficacy|0
7541787|NCT02771210|11892446|FG001|Period 2|Lack of Efficacy|1
7541788|NCT02771210|11892445|FG000|Period 2|Withdrawal by Subject|1
7541789|NCT02771210|11892446|FG001|Period 2|Withdrawal by Subject|0
7541790|NCT02771210|11892445|FG000|Period 2|Withdrawal of informed consent|0
7541791|NCT02771210|11892446|FG001|Period 2|Withdrawal of informed consent|2
7541792|NCT02771366|11892467|FG000|Period 1|Withdrawal by Subject|0
7541793|NCT02771366|11892468|FG001|Period 1|Withdrawal by Subject|2
7541794|NCT02771366|11892467|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
7541795|NCT02771366|11892468|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
7541796|NCT02771522|11892475|FG000|Overall Study|Lost to Follow-up|3
7541797|NCT02771522|11892475|FG000|Overall Study|Withdrawal by Subject|2
7541798|NCT02771522|11892475|FG000|Overall Study|No white spot lesions|3
7541799|NCT02772757|11892534|FG000|Overall Study|Withdrawal by Subject|1
7541800|NCT02772757|11892535|FG001|Overall Study|Withdrawal by Subject|0
7541801|NCT02772757|11892536|FG002|Overall Study|Withdrawal by Subject|1
7541802|NCT02772757|11892534|FG000|Overall Study|Protocol Violation|0
7541803|NCT02772757|11892535|FG001|Overall Study|Protocol Violation|0
7541804|NCT02772757|11892536|FG002|Overall Study|Protocol Violation|1
7541805|NCT02772757|11892534|FG000|Overall Study|Physician Decision|0
7541806|NCT02772757|11892535|FG001|Overall Study|Physician Decision|3
7541807|NCT02772757|11892536|FG002|Overall Study|Physician Decision|3
7541808|NCT02772809|11892554|FG000|Overall Study|not completed some tasks|6
7541809|NCT02772978|11892563|FG000|Overall Study|Withdrawal by Subject|1
7541810|NCT02772978|11892564|FG001|Overall Study|Withdrawal by Subject|1
7541811|NCT02773368|11892571|FG000|Overall Study|Lost to Follow-up|4
7541812|NCT02773368|11892572|FG001|Overall Study|Lost to Follow-up|1
7541813|NCT02773368|11892571|FG000|Overall Study|Withdrawal by Subject|5
7541814|NCT02773368|11892572|FG001|Overall Study|Withdrawal by Subject|1
7541815|NCT02773368|11892571|FG000|Overall Study|Unclassified|1
7541816|NCT02773368|11892572|FG001|Overall Study|Unclassified|1
7541817|NCT02773368|11892571|FG000|Overall Study|Missing|0
7541818|NCT02773368|11892572|FG001|Overall Study|Missing|1
7541819|NCT02773446|11892584|FG000|First Admission|Withdrawal by Subject|0
7541820|NCT02773446|11892585|FG001|First Admission|Withdrawal by Subject|0
7541821|NCT02773446|11892586|FG002|First Admission|Withdrawal by Subject|0
7541822|NCT02773446|11892587|FG003|First Admission|Withdrawal by Subject|1
7541823|NCT02773446|11892588|FG004|First Admission|Withdrawal by Subject|0
7541824|NCT02773446|11892589|FG005|First Admission|Withdrawal by Subject|0
7541825|NCT02773446|11892584|FG000|First Admission|Lost to Follow-up|1
7541826|NCT02773446|11892585|FG001|First Admission|Lost to Follow-up|0
7541827|NCT02773446|11892586|FG002|First Admission|Lost to Follow-up|0
7541828|NCT02773446|11892587|FG003|First Admission|Lost to Follow-up|0
7541829|NCT02773446|11892588|FG004|First Admission|Lost to Follow-up|0
7541830|NCT02773446|11892589|FG005|First Admission|Lost to Follow-up|0
7541831|NCT02773537|11892609|FG000|Overall Study|Lost to Follow-up|0
7541832|NCT02773537|11892610|FG001|Overall Study|Lost to Follow-up|1
7541833|NCT02773537|11892611|FG002|Overall Study|Lost to Follow-up|4
7541834|NCT02774278|11892672|FG000|Overall Study|Lack of Efficacy|199
7541835|NCT02774278|11892672|FG000|Overall Study|Death|29
7541836|NCT02774278|11892672|FG000|Overall Study|Adverse event/intercurrent illness|16
7541837|NCT02774278|11892672|FG000|Overall Study|Refused treatment/did not cooperate|9
7541838|NCT02774278|11892672|FG000|Overall Study|Administrative reasons|6
7541839|NCT02774278|11892672|FG000|Overall Study|Withdrawal by Subject|3
7541840|NCT02774278|11892672|FG000|Overall Study|Protocol Violation|2
7541841|NCT02774681|11892700|FG000|Treatment on Study|Progressive Disease|7
7541842|NCT02774681|11892700|FG000|Follow-Up for 3 Years|Death|11
7541843|NCT02774681|11892700|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
7541844|NCT02775344|11892743|FG000|Overall Study|No ovarian cyst identified|3
7541845|NCT02775344|11892744|FG001|Overall Study|No ovarian cyst identified|2
7541846|NCT02775864|11892763|FG000|Overall Study|Data ended end of 2010|1764
7541847|NCT02775864|11892764|FG001|Overall Study|Data ended end of 2010|2880
7541848|NCT02775864|11892765|FG002|Overall Study|Data ended end of 2010|1140
7541849|NCT02775864|11892766|FG003|Overall Study|Data ended end of 2010|1194
7541850|NCT02775864|11892763|FG000|Overall Study|Medicaid eligibility discontinued|1478
7541851|NCT02775864|11892764|FG001|Overall Study|Medicaid eligibility discontinued|2019
7541852|NCT02775864|11892765|FG002|Overall Study|Medicaid eligibility discontinued|720
7541853|NCT02775864|11892766|FG003|Overall Study|Medicaid eligibility discontinued|890
7541854|NCT02775916|11892779|FG000|Overall Study|Adverse Event|1
7541855|NCT02775916|11892780|FG001|Overall Study|Adverse Event|0
7541856|NCT02775916|11892779|FG000|Overall Study|Subject/Guardian Decision|2
7541857|NCT02775916|11892780|FG001|Overall Study|Subject/Guardian Decision|0
7541858|NCT02776033|11892789|FG000|Overall Study|Withdrawal by Subject|0
7541859|NCT02776033|11892790|FG001|Overall Study|Withdrawal by Subject|0
7541860|NCT02776033|11892791|FG002|Overall Study|Withdrawal by Subject|2
7541861|NCT02776033|11892789|FG000|Overall Study|Physician Decision|2
7541862|NCT02776033|11892790|FG001|Overall Study|Physician Decision|0
7541863|NCT02776033|11892791|FG002|Overall Study|Physician Decision|0
7541864|NCT02776033|11892789|FG000|Overall Study|Lost to Follow-up|1
7541865|NCT02776033|11892790|FG001|Overall Study|Lost to Follow-up|0
7541866|NCT02776033|11892791|FG002|Overall Study|Lost to Follow-up|0
7541867|NCT02776033|11892789|FG000|Overall Study|Adverse Event|1
7541868|NCT02776033|11892790|FG001|Overall Study|Adverse Event|2
7541869|NCT02776033|11892791|FG002|Overall Study|Adverse Event|0
7541870|NCT02776553|11892807|FG000|Overall Study|Lost to Follow-up|1
7541871|NCT02776553|11892808|FG001|Overall Study|Lost to Follow-up|0
7541872|NCT02776553|11892807|FG000|Overall Study|got liver transplant|1
7541873|NCT02776553|11892808|FG001|Overall Study|got liver transplant|2
7541874|NCT02776553|11892807|FG000|Overall Study|had other surgery|1
7541875|NCT02776553|11892808|FG001|Overall Study|had other surgery|0
7541876|NCT02776553|11892807|FG000|Overall Study|Protocol Violation|0
7541877|NCT02776553|11892808|FG001|Overall Study|Protocol Violation|1
7541878|NCT02776670|11892825|FG000|Overall Study|Adverse Event|0
7541879|NCT02776670|11892826|FG001|Overall Study|Adverse Event|2
7541880|NCT02776670|11892825|FG000|Overall Study|Protocol Violation|0
7541881|NCT02776670|11892826|FG001|Overall Study|Protocol Violation|2
7541882|NCT02776670|11892825|FG000|Overall Study|Withdrawal by Subject|0
7541883|NCT02776670|11892826|FG001|Overall Study|Withdrawal by Subject|1
7541884|NCT02776670|11892825|FG000|Overall Study|Other - Reason not given|0
7541885|NCT02776670|11892826|FG001|Overall Study|Other - Reason not given|1
7541886|NCT02776683|11892832|FG000|Pre-switch Period|Protocol Violation|1
7541887|NCT02776683|11892833|FG001|Pre-switch Period|Protocol Violation|0
7541888|NCT02776683|11892832|FG000|Pre-switch Period|Adverse Event|21
7541889|NCT02776683|11892833|FG001|Pre-switch Period|Adverse Event|0
7541890|NCT02776683|11892832|FG000|Pre-switch Period|Withdrawal by Subject|9
7541891|NCT02776683|11892833|FG001|Pre-switch Period|Withdrawal by Subject|0
7541892|NCT02776683|11892832|FG000|Pre-switch Period|Physician Decision|7
7541893|NCT02776683|11892833|FG001|Pre-switch Period|Physician Decision|0
7541894|NCT02776683|11892832|FG000|Pre-switch Period|Progressive disease|39
7541895|NCT02776683|11892833|FG001|Pre-switch Period|Progressive disease|0
7541896|NCT02776683|11892832|FG000|Pre-switch Period|Other than listed|3
7541897|NCT02776683|11892833|FG001|Pre-switch Period|Other than listed|0
7541898|NCT02776683|11892832|FG000|Post-switch Period|Adverse Event|0
7541899|NCT02776683|11892833|FG001|Post-switch Period|Adverse Event|3
7541900|NCT02776683|11892832|FG000|Post-switch Period|Withdrawal by Subject|0
7541901|NCT02776683|11892833|FG001|Post-switch Period|Withdrawal by Subject|2
7541902|NCT02776683|11892832|FG000|Post-switch Period|Physician Decision|0
7541903|NCT02776683|11892833|FG001|Post-switch Period|Physician Decision|3
7541904|NCT02776683|11892832|FG000|Post-switch Period|Progressive disease|0
7541905|NCT02776683|11892833|FG001|Post-switch Period|Progressive disease|20
7541906|NCT02776683|11892832|FG000|Post-switch Period|Other than listed|0
7541907|NCT02776683|11892833|FG001|Post-switch Period|Other than listed|15
7541908|NCT02777086|11892868|FG000|Overall Study|Lost to Follow-up|96
7541909|NCT02777086|11892869|FG001|Overall Study|Lost to Follow-up|99
7541910|NCT02777125|11892877|FG000|Overall Study|Consent form violation|14
7541911|NCT02777125|11892878|FG001|Overall Study|Consent form violation|12
7541912|NCT02777125|11892877|FG000|Overall Study|Assent form violation|21
7541913|NCT02777125|11892878|FG001|Overall Study|Assent form violation|23
7541914|NCT02777125|11892877|FG000|Overall Study|Protocol Violation|8
7541915|NCT02777125|11892878|FG001|Overall Study|Protocol Violation|12
7541916|NCT02777242|11892885|FG000|Overall Study|Other|2
7541917|NCT02777242|11892885|FG000|Overall Study|Lost to Follow-up|1
7541918|NCT02777242|11892885|FG000|Overall Study|Multiple|1
7541919|NCT02777242|11892885|FG000|Overall Study|Sponsor's request|1
7541920|NCT02777242|11892885|FG000|Overall Study|Withdrawal by Subject|1
7541921|NCT02777333|11892913|FG000|Overall Study|Withdrawal by Subject|0
7541922|NCT02777333|11892914|FG001|Overall Study|Withdrawal by Subject|1
7541923|NCT02777333|11892913|FG000|Overall Study|Lost to Follow-up|0
7541924|NCT02777333|11892914|FG001|Overall Study|Lost to Follow-up|1
7552225|NCT02983604|11912026|FG000|Overall Study|Enrolled but not Treated|0
7552226|NCT02983604|11912027|FG001|Overall Study|Enrolled but not Treated|0
7552227|NCT02983604|11912028|FG002|Overall Study|Enrolled but not Treated|1
7552228|NCT02983604|11912029|FG003|Overall Study|Enrolled but not Treated|0
7552229|NCT02984267|11912054|FG000|Overall Study|Protocol Violation|1
7552230|NCT02984267|11912055|FG001|Overall Study|Protocol Violation|0
7552231|NCT02984267|11912054|FG000|Overall Study|Withdrawal by Subject|0
7552232|NCT02984267|11912055|FG001|Overall Study|Withdrawal by Subject|1
7552233|NCT02984683|11912093|FG000|Overall Study|Adverse Event|3
7552234|NCT02984683|11912094|FG001|Overall Study|Adverse Event|3
7552235|NCT02984683|11912093|FG000|Overall Study|Withdrawal by Subject|1
7552236|NCT02984683|11912094|FG001|Overall Study|Withdrawal by Subject|0
7552237|NCT02984683|11912093|FG000|Overall Study|Disease progression|7
7552238|NCT02984683|11912094|FG001|Overall Study|Disease progression|9
7552239|NCT02984943|11912123|FG000|Overall Study|Withdrawal by Subject|3
7552240|NCT02984943|11912123|FG000|Overall Study|Physician Decision|1
7552241|NCT02984982|11912129|FG000|Overall Study|Adverse Event|2
7552242|NCT02984982|11912130|FG001|Overall Study|Adverse Event|5
7552243|NCT02984982|11912129|FG000|Overall Study|Poor Compliance to Protocol|4
7552244|NCT02984982|11912130|FG001|Overall Study|Poor Compliance to Protocol|4
7552245|NCT02984982|11912129|FG000|Overall Study|Withdrawal by Subject|2
7552246|NCT02984982|11912130|FG001|Overall Study|Withdrawal by Subject|0
7552247|NCT02984982|11912129|FG000|Overall Study|Randomized but not treated|0
7552248|NCT02984982|11912130|FG001|Overall Study|Randomized but not treated|1
7552249|NCT02984995|11912139|FG000|Overall Study|Required stem cell transplant|13
7552250|NCT02984995|11912140|FG001|Overall Study|Required stem cell transplant|2
7541925|NCT05283499|11892922|FG000|Overall Study|Did not receive intervention|1
7541926|NCT05283499|11892923|FG001|Overall Study|Did not receive intervention|2
7541927|NCT04919317|11892931|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0
7541928|NCT04919317|11892932|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5
7541929|NCT04919317|11892931|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12
7541930|NCT04919317|11892932|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6
7541931|NCT04537949|11893020|FG000|Overall Study|personal reasons not related to the IMP|1
7541932|NCT04537949|11893021|FG001|Overall Study|personal reasons not related to the IMP|0
7541933|NCT04537949|11893022|FG002|Overall Study|personal reasons not related to the IMP|0
7541934|NCT04537949|11893023|FG003|Overall Study|personal reasons not related to the IMP|0
7541935|NCT04537949|11893024|FG004|Overall Study|personal reasons not related to the IMP|0
7541936|NCT04537949|11893025|FG005|Overall Study|personal reasons not related to the IMP|0
7541937|NCT04537949|11893026|FG006|Overall Study|personal reasons not related to the IMP|0
7541938|NCT04537949|11893027|FG007|Overall Study|personal reasons not related to the IMP|0
7541939|NCT04346628|11893047|FG000|Overall Study|Lost to Follow-up|4
7541940|NCT04346628|11893048|FG001|Overall Study|Lost to Follow-up|4
7541941|NCT04346628|11893047|FG000|Overall Study|Withdrew (had personal reasons)|2
7541942|NCT04346628|11893048|FG001|Overall Study|Withdrew (had personal reasons)|5
7541943|NCT04346628|11893047|FG000|Overall Study|Withdrew (medication intolerant)|0
7541944|NCT04346628|11893048|FG001|Overall Study|Withdrew (medication intolerant)|3
7541945|NCT04346628|11893047|FG000|Overall Study|Withdrew (declined intervention)|0
7541946|NCT04346628|11893048|FG001|Overall Study|Withdrew (declined intervention)|1
7541949|NCT04040933|11893093|FG000|Overall Study|Protocol Violation|1
7541950|NCT04040933|11893093|FG000|Overall Study|Withdrawal by Subject|2
7541951|NCT03428997|11893160|FG000|Overall Study|Sponsor decision.|1
7541952|NCT03428997|11893160|FG000|Overall Study|Withdrawal by Subject|3
7541953|NCT03428997|11893160|FG000|Overall Study|Lost to Follow-up|4
7541954|NCT03385564|11893170|FG000|Overall Study|Adverse Event|0
7541955|NCT03385564|11893171|FG001|Overall Study|Adverse Event|0
7541956|NCT03385564|11893172|FG002|Overall Study|Adverse Event|3
7541957|NCT03385564|11893173|FG003|Overall Study|Adverse Event|3
7541958|NCT03385564|11893170|FG000|Overall Study|Other than listed|0
7541959|NCT03385564|11893171|FG001|Overall Study|Other than listed|0
7541960|NCT03385564|11893172|FG002|Overall Study|Other than listed|0
7541961|NCT03385564|11893173|FG003|Overall Study|Other than listed|5
7541962|NCT03385564|11893170|FG000|Overall Study|Withdrawal by Subject|0
7541963|NCT03385564|11893171|FG001|Overall Study|Withdrawal by Subject|1
7541964|NCT03385564|11893172|FG002|Overall Study|Withdrawal by Subject|1
7541965|NCT03385564|11893173|FG003|Overall Study|Withdrawal by Subject|0
7541966|NCT03385564|11893170|FG000|Overall Study|Lack of Efficacy|0
7541967|NCT03385564|11893171|FG001|Overall Study|Lack of Efficacy|0
7541968|NCT03385564|11893172|FG002|Overall Study|Lack of Efficacy|0
7257847|NCT00335556|11469984|FG001|Overall Study|Lack of Efficacy|19
7541969|NCT03385564|11893173|FG003|Overall Study|Lack of Efficacy|1
7541970|NCT03385564|11893170|FG000|Overall Study|Death|0
7541971|NCT03385564|11893171|FG001|Overall Study|Death|0
7541972|NCT03385564|11893172|FG002|Overall Study|Death|1
7541973|NCT03385564|11893173|FG003|Overall Study|Death|0
7541974|NCT03335163|11893183|FG000|Overall Study|Not eligible due to laboratory criteria|3
7541975|NCT03335163|11893183|FG000|Overall Study|Withdrawal by Subject|18
7541976|NCT03235544|11893191|FG000|Overall Study|Participants Still Ongoing in the Study|1
7541977|NCT03235544|11893192|FG001|Overall Study|Participants Still Ongoing in the Study|13
7541978|NCT03235544|11893193|FG002|Overall Study|Participants Still Ongoing in the Study|19
7541979|NCT03235544|11893194|FG003|Overall Study|Participants Still Ongoing in the Study|55
7541980|NCT03235544|11893191|FG000|Overall Study|Death|11
7541981|NCT03235544|11893192|FG001|Overall Study|Death|23
7541982|NCT03235544|11893193|FG002|Overall Study|Death|11
7541983|NCT03235544|11893194|FG003|Overall Study|Death|20
7541984|NCT03235544|11893191|FG000|Overall Study|Lost to Follow-up|0
7541985|NCT03235544|11893192|FG001|Overall Study|Lost to Follow-up|1
7541986|NCT03235544|11893193|FG002|Overall Study|Lost to Follow-up|0
7541987|NCT03235544|11893194|FG003|Overall Study|Lost to Follow-up|1
7541988|NCT03235544|11893191|FG000|Overall Study|Withdrawal by Participant|0
7541989|NCT03235544|11893192|FG001|Overall Study|Withdrawal by Participant|0
7541990|NCT03235544|11893193|FG002|Overall Study|Withdrawal by Participant|1
7541991|NCT03235544|11893194|FG003|Overall Study|Withdrawal by Participant|0
7541992|NCT03235544|11893191|FG000|Overall Study|Reason not Specified|0
7541993|NCT03235544|11893192|FG001|Overall Study|Reason not Specified|4
7541994|NCT03235544|11893193|FG002|Overall Study|Reason not Specified|0
7541995|NCT03235544|11893194|FG003|Overall Study|Reason not Specified|1
7541997|NCT03023046|11893209|FG000|Overall Study|Withdrawal by Subject|1
7542017|NCT02421172|11893271|FG000|Period 1|Adverse Event|1
7542018|NCT02421172|11893272|FG001|Period 1|Adverse Event|0
7542019|NCT02421172|11893273|FG002|Period 1|Adverse Event|0
7542020|NCT02421172|11893274|FG003|Period 1|Adverse Event|0
7542021|NCT02421172|11893275|FG004|Period 1|Adverse Event|0
7542022|NCT02421172|11893271|FG000|Period 1|Lost to Follow-up|3
7542023|NCT02421172|11893272|FG001|Period 1|Lost to Follow-up|1
7542024|NCT02421172|11893273|FG002|Period 1|Lost to Follow-up|0
7542025|NCT02421172|11893274|FG003|Period 1|Lost to Follow-up|0
7542026|NCT02421172|11893275|FG004|Period 1|Lost to Follow-up|0
7542027|NCT02421172|11893271|FG000|Period 1|Patient/guardian decision|0
7542028|NCT02421172|11893272|FG001|Period 1|Patient/guardian decision|1
7542029|NCT02421172|11893273|FG002|Period 1|Patient/guardian decision|0
7542030|NCT02421172|11893274|FG003|Period 1|Patient/guardian decision|0
7542031|NCT02421172|11893275|FG004|Period 1|Patient/guardian decision|0
7542032|NCT02421172|11893271|FG000|Period 2|Adverse Event|0
7542033|NCT02421172|11893272|FG001|Period 2|Adverse Event|0
7542034|NCT02421172|11893273|FG002|Period 2|Adverse Event|4
7542035|NCT02421172|11893274|FG003|Period 2|Adverse Event|0
7542036|NCT02421172|11893275|FG004|Period 2|Adverse Event|0
7542037|NCT02421172|11893271|FG000|Period 2|Lost to Follow-up|0
7542038|NCT02421172|11893272|FG001|Period 2|Lost to Follow-up|0
7542039|NCT02421172|11893273|FG002|Period 2|Lost to Follow-up|0
7542040|NCT02421172|11893274|FG003|Period 2|Lost to Follow-up|1
7542041|NCT02421172|11893275|FG004|Period 2|Lost to Follow-up|0
7542042|NCT02421172|11893271|FG000|Period 2|Patient/guardian decision|0
7542043|NCT02421172|11893272|FG001|Period 2|Patient/guardian decision|0
7542044|NCT02421172|11893273|FG002|Period 2|Patient/guardian decision|3
7542045|NCT02421172|11893274|FG003|Period 2|Patient/guardian decision|2
7542046|NCT02421172|11893275|FG004|Period 2|Patient/guardian decision|1
7542047|NCT02012296|11893310|FG000|Overall Study|Lack of Efficacy|0
7542048|NCT02012296|11893311|FG001|Overall Study|Lack of Efficacy|0
7542049|NCT02012296|11893312|FG002|Overall Study|Lack of Efficacy|15
7542050|NCT02012296|11893310|FG000|Overall Study|Adverse Event|0
7542051|NCT02012296|11893311|FG001|Overall Study|Adverse Event|0
7542052|NCT02012296|11893312|FG002|Overall Study|Adverse Event|2
7542053|NCT02012296|11893310|FG000|Overall Study|Early study closure|0
7542054|NCT02012296|11893311|FG001|Overall Study|Early study closure|0
7542055|NCT02012296|11893312|FG002|Overall Study|Early study closure|5
7542056|NCT02012296|11893310|FG000|Overall Study|Protocol Violation|0
7542057|NCT02012296|11893311|FG001|Overall Study|Protocol Violation|1
7542058|NCT02012296|11893312|FG002|Overall Study|Protocol Violation|0
7542059|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542060|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542061|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542062|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7542063|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7542064|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542065|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542066|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542067|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542068|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7542069|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542070|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542071|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7542072|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7542073|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
7542074|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7542075|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
7542076|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
7542077|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
7542078|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7542079|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7542080|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542081|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542082|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7542083|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7542084|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542085|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7542086|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542087|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7542088|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542089|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542090|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7542091|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7542092|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
7542093|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
7542094|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
7542095|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
7542096|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
7542097|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
7542098|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7542099|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7542100|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7542101|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7542102|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7257848|NCT00335556|11469985|FG002|Overall Study|Lack of Efficacy|3
7257849|NCT00335556|11469986|FG003|Overall Study|Lack of Efficacy|3
7257850|NCT00335556|11469987|FG004|Overall Study|Lack of Efficacy|0
7257851|NCT00335556|11469988|FG005|Overall Study|Lack of Efficacy|1
7257852|NCT00335556|11469983|FG000|Overall Study|Physician Decision|0
7257853|NCT00335556|11469984|FG001|Overall Study|Physician Decision|6
7257854|NCT00335556|11469985|FG002|Overall Study|Physician Decision|2
7257855|NCT00335556|11469986|FG003|Overall Study|Physician Decision|1
7257856|NCT00335556|11469987|FG004|Overall Study|Physician Decision|0
7257857|NCT00335556|11469988|FG005|Overall Study|Physician Decision|0
7257858|NCT00335556|11469983|FG000|Overall Study|Ineligible|2
7257859|NCT00335556|11469984|FG001|Overall Study|Ineligible|0
7257860|NCT00335556|11469985|FG002|Overall Study|Ineligible|0
7257861|NCT00335556|11469986|FG003|Overall Study|Ineligible|0
7257862|NCT00335556|11469987|FG004|Overall Study|Ineligible|0
7257863|NCT00335556|11469988|FG005|Overall Study|Ineligible|0
7257864|NCT00335556|11469983|FG000|Overall Study|Refusal of further protocol therapy|0
7257865|NCT00335556|11469984|FG001|Overall Study|Refusal of further protocol therapy|4
7257866|NCT00335556|11469985|FG002|Overall Study|Refusal of further protocol therapy|0
7257867|NCT00335556|11469986|FG003|Overall Study|Refusal of further protocol therapy|1
7542103|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
7542104|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
7542105|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
7542106|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
7542107|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7542108|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
7542109|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
7542110|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
7542111|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
7542112|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
7542113|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
7542114|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
7542115|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
7542116|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542117|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542118|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542119|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542120|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542121|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542122|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542123|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542124|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542125|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542126|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
7542127|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542128|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542129|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542130|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542131|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542132|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542133|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542134|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
7542135|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7542136|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542137|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542138|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542139|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542140|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7542141|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542142|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542143|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542144|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542145|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2
7542146|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542147|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542148|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7542149|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1
7542150|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4
7542151|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3
7542152|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16
7542153|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0
7542154|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542155|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542156|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542157|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542158|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7542159|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542160|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542161|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542162|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542163|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
7542164|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542165|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542166|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542167|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542168|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542169|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542170|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542171|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542172|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
7542173|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542174|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542175|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
7542176|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542177|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542178|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542179|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542180|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542181|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542182|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542183|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542184|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542185|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542186|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542187|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542188|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
7542189|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
7542190|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
7542191|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
7542192|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7542193|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7542194|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542195|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7542196|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542197|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542198|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7542199|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542200|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542201|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542202|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7542203|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542204|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
7542205|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
7542206|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
7542207|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7542208|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
7542209|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
7542210|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
7542211|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542212|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542213|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542214|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542215|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542216|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542217|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542218|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542219|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542220|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7257868|NCT00335556|11469987|FG004|Overall Study|Refusal of further protocol therapy|0
7257869|NCT00335556|11469988|FG005|Overall Study|Refusal of further protocol therapy|0
7257870|NCT00335738|11470019|FG000|Overall Study|Physician Decision|6
7257871|NCT00335738|11470020|FG001|Overall Study|Physician Decision|0
7257872|NCT00335738|11470019|FG000|Overall Study|Withdrawal by Subject|2
7257873|NCT00335738|11470020|FG001|Overall Study|Withdrawal by Subject|0
7257874|NCT00335738|11470019|FG000|Overall Study|Ineligible|3
7257875|NCT00335738|11470020|FG001|Overall Study|Ineligible|4
7257876|NCT00335764|11470032|FG000|Overall Study|wrong histology|1
7257877|NCT00335764|11470033|FG001|Overall Study|wrong histology|0
7257878|NCT00335764|11470034|FG002|Overall Study|wrong histology|0
7257879|NCT00335764|11470035|FG003|Overall Study|wrong histology|0
7257880|NCT00335764|11470036|FG004|Overall Study|wrong histology|1
7257881|NCT00335829|11470072|FG000|Overall Study|Withdrawal by Subject|1
7257882|NCT00335829|11470072|FG000|Overall Study|Lost to Follow-up|1
7257883|NCT00335829|11470072|FG000|Overall Study|Adverse Event|1
7257884|NCT00335959|11470076|FG000|Overall Study|Adverse Event|2
7257885|NCT00335959|11470076|FG000|Overall Study|Ineligible|1
7257886|NCT00335972|11470083|FG000|Overall Study|not given treatments|0
7257887|NCT00335972|11470084|FG001|Overall Study|not given treatments|3
7576209|NCT04422561|11961973|FG000|Overall Study|Lost to Follow-up|25
7576210|NCT04422561|11961974|FG001|Overall Study|Lost to Follow-up|11
7576211|NCT04419311|11961991|FG000|Overall Study|Lost to Follow-up|1
7576212|NCT04419311|11961992|FG001|Overall Study|Lost to Follow-up|0
7576213|NCT04411667|11962012|FG000|Overall Study|Physician Decision|1
7542221|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7542222|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542223|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542224|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7542225|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542226|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542227|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7542228|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
7542229|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
7542230|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7542231|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542232|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542233|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542234|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542235|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7542236|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542237|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542238|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542239|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542240|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542241|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542242|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542243|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542244|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
7542245|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7576214|NCT04411667|11962013|FG001|Overall Study|Physician Decision|0
7576215|NCT04407507|11962025|FG000|Overall Study|Withdrawal by Subject|0
7576216|NCT04407507|11962026|FG001|Overall Study|Withdrawal by Subject|1
7542246|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542247|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
7542248|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
7542249|NCT01915498|11893342|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542250|NCT01915498|11893343|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542251|NCT01915498|11893344|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542252|NCT01915498|11893345|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542253|NCT01915498|11893346|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7576217|NCT04406194|11962034|FG000|Period 1|Withdrawal by Subject|0
7576218|NCT04406194|11962035|FG001|Period 1|Withdrawal by Subject|1
7257902|NCT00336284|11470105|FG000|Overall Study|Death|52
7257903|NCT00336284|11470106|FG001|Overall Study|Death|26
7257904|NCT00336284|11470105|FG000|Overall Study|Lost to Follow-up|82
7257905|NCT00336284|11470106|FG001|Overall Study|Lost to Follow-up|61
7257906|NCT00336284|11470105|FG000|Overall Study|Withdrawal by Physician or Subject|102
7257907|NCT00336284|11470106|FG001|Overall Study|Withdrawal by Physician or Subject|64
7257908|NCT00336479|11470141|FG000|Overall Study|Adverse Event|8
7257909|NCT00336479|11470142|FG001|Overall Study|Adverse Event|11
7257910|NCT00336479|11470143|FG002|Overall Study|Adverse Event|18
7257911|NCT00336479|11470144|FG003|Overall Study|Adverse Event|4
7257912|NCT00336479|11470141|FG000|Overall Study|Noncompliant|1
7257913|NCT00336479|11470142|FG001|Overall Study|Noncompliant|7
7257914|NCT00336479|11470143|FG002|Overall Study|Noncompliant|3
7257915|NCT00336479|11470144|FG003|Overall Study|Noncompliant|0
7257916|NCT00336479|11470141|FG000|Overall Study|Physician Decision|2
7257917|NCT00336479|11470142|FG001|Overall Study|Physician Decision|3
7257918|NCT00336479|11470143|FG002|Overall Study|Physician Decision|1
7257919|NCT00336479|11470144|FG003|Overall Study|Physician Decision|0
7257920|NCT00336479|11470141|FG000|Overall Study|Lost to Follow-up|3
7257921|NCT00336479|11470142|FG001|Overall Study|Lost to Follow-up|2
7257922|NCT00336479|11470143|FG002|Overall Study|Lost to Follow-up|0
7257923|NCT00336479|11470144|FG003|Overall Study|Lost to Follow-up|0
7257924|NCT00336479|11470141|FG000|Overall Study|Withdrawal by Subject|3
7257925|NCT00336479|11470142|FG001|Overall Study|Withdrawal by Subject|2
7257926|NCT00336479|11470143|FG002|Overall Study|Withdrawal by Subject|3
7257927|NCT00336479|11470144|FG003|Overall Study|Withdrawal by Subject|0
7257928|NCT00336479|11470141|FG000|Overall Study|Other|0
7257929|NCT00336479|11470142|FG001|Overall Study|Other|0
7257930|NCT00336479|11470143|FG002|Overall Study|Other|1
7257931|NCT00336479|11470144|FG003|Overall Study|Other|0
7257932|NCT00336479|11470141|FG000|Overall Study|Virologic Stopping Rule|20
7257933|NCT00336479|11470142|FG001|Overall Study|Virologic Stopping Rule|0
7257934|NCT00336479|11470143|FG002|Overall Study|Virologic Stopping Rule|0
7257935|NCT00336479|11470144|FG003|Overall Study|Virologic Stopping Rule|0
7257936|NCT00336492|11470158|FG000|Overall Study|Adverse Event|4
7257937|NCT00336492|11470159|FG001|Overall Study|Adverse Event|3
7257938|NCT00336492|11470160|FG002|Overall Study|Adverse Event|6
7257939|NCT00336492|11470158|FG000|Overall Study|Lack of Efficacy|6
7257940|NCT00336492|11470159|FG001|Overall Study|Lack of Efficacy|1
7257941|NCT00336492|11470160|FG002|Overall Study|Lack of Efficacy|4
7257942|NCT00336492|11470158|FG000|Overall Study|Other|5
7257943|NCT00336492|11470159|FG001|Overall Study|Other|0
7257944|NCT00336492|11470160|FG002|Overall Study|Other|1
7257945|NCT00336505|11470170|FG000|Overall Study|Adverse Event|10
7542254|NCT01915498|11893347|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7542255|NCT01915498|11893348|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542256|NCT01915498|11893349|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542257|NCT01915498|11893350|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542258|NCT01915498|11893351|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7257946|NCT00336505|11470171|FG001|Overall Study|Adverse Event|9
7257947|NCT00336505|11470170|FG000|Overall Study|Lack of Efficacy|8
7257948|NCT00336505|11470171|FG001|Overall Study|Lack of Efficacy|4
7257949|NCT00336505|11470170|FG000|Overall Study|Lost to Follow-up|7
7257950|NCT00336505|11470171|FG001|Overall Study|Lost to Follow-up|4
7257951|NCT00336505|11470170|FG000|Overall Study|Withdrawal by Subject|5
7257952|NCT00336505|11470171|FG001|Overall Study|Withdrawal by Subject|3
7257953|NCT00336505|11470170|FG000|Overall Study|Other|7
7257954|NCT00336505|11470171|FG001|Overall Study|Other|7
7257955|NCT00336544|11470179|FG000|Overall Study|Lack of Efficacy|8
7542259|NCT01915498|11893352|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542260|NCT01915498|11893353|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542261|NCT01915498|11893354|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542262|NCT01915498|11893355|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7542263|NCT01915498|11893356|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7542264|NCT01915498|11893357|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
7542265|NCT01915498|11893358|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7542266|NCT01915498|11893359|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
7542267|NCT01915498|11893360|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
7542268|NCT01915498|11893342|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542269|NCT01915498|11893343|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542270|NCT01915498|11893344|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542271|NCT01915498|11893345|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542272|NCT01915498|11893346|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542273|NCT01915498|11893347|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542274|NCT01915498|11893348|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542275|NCT01915498|11893349|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542276|NCT01915498|11893350|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542277|NCT01915498|11893351|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542278|NCT01915498|11893352|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542279|NCT01915498|11893353|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542280|NCT01915498|11893354|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542281|NCT01915498|11893355|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542282|NCT01915498|11893356|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542283|NCT01915498|11893357|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542284|NCT01915498|11893358|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542285|NCT01915498|11893359|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
7542286|NCT01915498|11893360|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
7542288|NCT00033631|11893454|FG000|Overall Study|Protocol Violation|14
7542289|NCT00033631|11893455|FG001|Overall Study|Protocol Violation|11
7542290|NCT00033631|11893454|FG000|Overall Study|Withdrawal by Subject|4
7542291|NCT00033631|11893455|FG001|Overall Study|Withdrawal by Subject|4
7552251|NCT02984995|11912139|FG000|Overall Study|Progressive disease|11
7552252|NCT02984995|11912140|FG001|Overall Study|Progressive disease|1
7552253|NCT02984995|11912139|FG000|Overall Study|Adverse Event|1
7552254|NCT02984995|11912140|FG001|Overall Study|Adverse Event|0
7552255|NCT02985021|11912152|FG000|Overall Study|Inability to comply with study procedures|1
7552256|NCT02985398|11912156|FG000|Overall Study|Adverse Event|1
7552257|NCT02985398|11912156|FG000|Overall Study|Lost to Follow-up|4
7552258|NCT02985398|11912156|FG000|Overall Study|Withdrawal by Subject|8
7552259|NCT02985398|11912156|FG000|Overall Study|Study Burden|9
7552260|NCT02985450|11912160|FG000|Overall Study|Lost to Follow-up|7
7552261|NCT02985879|11912188|FG000|Overall Study|Adverse Event|7
7257956|NCT00336544|11470180|FG001|Overall Study|Lack of Efficacy|5
7257957|NCT00336544|11470179|FG000|Overall Study|Adverse Event|4
7257958|NCT00336544|11470180|FG001|Overall Study|Adverse Event|9
7257959|NCT00336544|11470179|FG000|Overall Study|Withdrawal by Subject|4
7257960|NCT00336544|11470180|FG001|Overall Study|Withdrawal by Subject|3
7257961|NCT00336544|11470179|FG000|Overall Study|Other|3
7257962|NCT00336544|11470180|FG001|Overall Study|Other|5
7257963|NCT00336583|11470186|FG000|Overall Study|Lost to Follow-up|1
7257964|NCT00336583|11470186|FG000|Overall Study|Death|1
7257965|NCT00336856|11470205|FG000|Overall Study|Withdrawal by Subject|3
7257966|NCT00336856|11470205|FG000|Overall Study|Found ineligible at time of analysis|1
7257967|NCT00336895|11470209|FG000|Overall Study|diarrhea|1
7257968|NCT00336895|11470209|FG000|Overall Study|nausea and upset stomach|1
7257969|NCT00336895|11470209|FG000|Overall Study|Physician Decision|1
7542292|NCT04952701|11893462|FG000|Control Lens|Physician Decision|4
7542293|NCT04952701|11893462|FG000|Test Lens|Physician Decision|1
7542294|NCT04074161|11893475|FG000|Overall Study|Withdrawal by Subject|2
7542295|NCT04074161|11893476|FG001|Overall Study|Withdrawal by Subject|4
7542296|NCT04074161|11893477|FG002|Overall Study|Withdrawal by Subject|1
7542297|NCT04074161|11893475|FG000|Overall Study|Lost to Follow-up|4
7542298|NCT04074161|11893476|FG001|Overall Study|Lost to Follow-up|5
7542299|NCT04074161|11893477|FG002|Overall Study|Lost to Follow-up|3
7257970|NCT00336895|11470209|FG000|Overall Study|screen failed|1
7257971|NCT00337077|11470216|FG000|Overall Study|Progressive disease|25
7257972|NCT00337077|11470217|FG001|Overall Study|Progressive disease|37
7257973|NCT00337077|11470218|FG002|Overall Study|Progressive disease|19
7257974|NCT00337077|11470216|FG000|Overall Study|Adverse Event|7
7257975|NCT00337077|11470217|FG001|Overall Study|Adverse Event|7
7257976|NCT00337077|11470218|FG002|Overall Study|Adverse Event|1
7257977|NCT00337077|11470216|FG000|Overall Study|Death|0
7257978|NCT00337077|11470217|FG001|Overall Study|Death|1
7257979|NCT00337077|11470218|FG002|Overall Study|Death|0
7257980|NCT00337077|11470216|FG000|Overall Study|Withdrawal by Subject|7
7257981|NCT00337077|11470217|FG001|Overall Study|Withdrawal by Subject|2
7257982|NCT00337077|11470218|FG002|Overall Study|Withdrawal by Subject|2
7257983|NCT00337077|11470216|FG000|Overall Study|Alternative therapy|1
7257984|NCT00337077|11470217|FG001|Overall Study|Alternative therapy|0
7257985|NCT00337077|11470218|FG002|Overall Study|Alternative therapy|0
7257986|NCT00337077|11470216|FG000|Overall Study|Physician Decision|1
7257987|NCT00337077|11470217|FG001|Overall Study|Physician Decision|4
7257988|NCT00337077|11470218|FG002|Overall Study|Physician Decision|2
7257989|NCT00337077|11470216|FG000|Overall Study|Never started treatment|1
7257990|NCT00337077|11470217|FG001|Overall Study|Never started treatment|1
7257991|NCT00337077|11470218|FG002|Overall Study|Never started treatment|0
7257992|NCT00337077|11470216|FG000|Overall Study|Ineligible|1
7257993|NCT00337077|11470217|FG001|Overall Study|Ineligible|1
7257994|NCT00337077|11470218|FG002|Overall Study|Ineligible|1
7257995|NCT00337103|11470226|FG000|Overall Study|Progressive Disease|414
7257996|NCT00337103|11470227|FG001|Overall Study|Progressive Disease|410
7257997|NCT00337103|11470226|FG000|Overall Study|Adverse Event|45
7257998|NCT00337103|11470227|FG001|Overall Study|Adverse Event|59
7257999|NCT00337103|11470226|FG000|Overall Study|Subject Choice|34
7258000|NCT00337103|11470227|FG001|Overall Study|Subject Choice|27
7542300|NCT04033432|11893485|FG000|Overall Study|Progressive Disease|8
7542301|NCT04033432|11893485|FG000|Overall Study|Adverse Event|4
7258001|NCT00337103|11470226|FG000|Overall Study|Clinical Progression|27
7258002|NCT00337103|11470227|FG001|Overall Study|Clinical Progression|24
7258003|NCT00337103|11470226|FG000|Overall Study|Physician Decision|15
7258004|NCT00337103|11470227|FG001|Overall Study|Physician Decision|14
7258005|NCT00337103|11470226|FG000|Overall Study|Withdrawal by Subject|8
7542302|NCT04033432|11893485|FG000|Overall Study|Death|1
7542303|NCT04030247|11893490|FG000|Overall Study|Withdrawal by Subject|4
7542304|NCT04030247|11893490|FG000|Overall Study|Lost to Follow-up|13
7258006|NCT00337103|11470227|FG001|Overall Study|Withdrawal by Subject|5
7258007|NCT00337103|11470226|FG000|Overall Study|Other|5
7258008|NCT00337103|11470227|FG001|Overall Study|Other|6
7258009|NCT00337103|11470226|FG000|Overall Study|Entry Criteria Not Met|4
7258010|NCT00337103|11470227|FG001|Overall Study|Entry Criteria Not Met|1
7258011|NCT00337103|11470226|FG000|Overall Study|Lost to Follow-up|1
7258012|NCT00337103|11470227|FG001|Overall Study|Lost to Follow-up|2
7258013|NCT00337103|11470226|FG000|Overall Study|Death|1
7258014|NCT00337103|11470227|FG001|Overall Study|Death|0
7258015|NCT00337129|11470234|FG000|Overall Study|Adverse Event|4
7258016|NCT00337129|11470234|FG000|Overall Study|Withdrawal by Subject|1
7258017|NCT00337129|11470234|FG000|Overall Study|Lack of Efficacy|32
7258018|NCT00337129|11470234|FG000|Overall Study|Death|2
7258019|NCT00337129|11470234|FG000|Overall Study|not protocol specified|1
7258020|NCT00337168|11470238|FG000|Overall Study|Death|5
7258021|NCT00337168|11470238|FG000|Overall Study|Not protocol specified|2
7258022|NCT00337168|11470238|FG000|Overall Study|Did not start therapy|1
7258023|NCT00337194|11470254|FG000|Overall Study|Adverse Event|5
7258024|NCT00337194|11470255|FG001|Overall Study|Adverse Event|1
7258025|NCT00337194|11470254|FG000|Overall Study|Death|2
7258026|NCT00337194|11470255|FG001|Overall Study|Death|0
7258027|NCT00337194|11470254|FG000|Overall Study|Withdrawal by Subject|1
7258028|NCT00337194|11470255|FG001|Overall Study|Withdrawal by Subject|0
7258029|NCT00337194|11470254|FG000|Overall Study|Disease progression|1
7258030|NCT00337194|11470255|FG001|Overall Study|Disease progression|2
7258031|NCT00337194|11470254|FG000|Overall Study|Subsequent non-protocol therapy|3
7258032|NCT00337194|11470255|FG001|Overall Study|Subsequent non-protocol therapy|1
7258033|NCT00337207|11470263|FG000|Overall Study|Withdrawal by Subject|3
7258034|NCT00337272|11470270|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
7258035|NCT00337272|11470271|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
7258036|NCT00337272|11470270|FG000|Screening Period (Pre-randomization)|Non-compliance|1
7258037|NCT00337272|11470271|FG001|Screening Period (Pre-randomization)|Non-compliance|0
7258038|NCT00337272|11470270|FG000|Screening Period (Pre-randomization)|Screen failure|3
7258039|NCT00337272|11470271|FG001|Screening Period (Pre-randomization)|Screen failure|0
7258040|NCT00337272|11470270|FG000|Treatment Period|Non-compliance|1
7258041|NCT00337272|11470271|FG001|Treatment Period|Non-compliance|1
7258042|NCT00337272|11470270|FG000|Treatment Period|Withdrawal by Subject|0
7258043|NCT00337272|11470271|FG001|Treatment Period|Withdrawal by Subject|1
7258044|NCT00337272|11470270|FG000|Withdrawal Period|Non-compliance|0
7258045|NCT00337272|11470271|FG001|Withdrawal Period|Non-compliance|1
7258046|NCT00337285|11470277|FG000|Overall Study|Withdrawal by Subject|42
7258047|NCT00337285|11470277|FG000|Overall Study|Lost to Follow-up|41
7258048|NCT00337285|11470277|FG000|Overall Study|Adverse Event|28
7258049|NCT00337285|11470277|FG000|Overall Study|Protocol Violation|27
7258050|NCT00337285|11470277|FG000|Overall Study|Lack of Efficacy|11
7258051|NCT00337285|11470277|FG000|Overall Study|Death|1
7258052|NCT00337285|11470277|FG000|Overall Study|Physician Decision|1
7258053|NCT00337285|11470277|FG000|Overall Study|Lack of protocol compliance|7
7258054|NCT00337428|11470292|FG000|Overall Study|Withdrawal by Subject|1
7258055|NCT00337428|11470293|FG001|Overall Study|Withdrawal by Subject|2
7542305|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Other|1
7542306|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Other|3
7542307|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Other|0
7542308|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Other|0
7542309|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Other|1
7542310|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Other|0
7542311|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Other|0
7542312|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Other|0
7542313|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Other|0
7542314|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542315|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1
7542316|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542317|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542318|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542319|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542320|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542321|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542322|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
7542323|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542324|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2
7542325|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542326|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1
7542327|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542328|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542329|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7576221|NCT04403399|11962066|FG000|Period 2|Physician Decision|0
7576222|NCT04403399|11962067|FG001|Period 2|Physician Decision|1
7576223|NCT04401202|11962097|FG000|Overall Study|Lost to Follow-up|2
7576224|NCT04401202|11962098|FG001|Overall Study|Lost to Follow-up|2
7576225|NCT04401202|11962097|FG000|Overall Study|Adverse Event|0
7576226|NCT04401202|11962098|FG001|Overall Study|Adverse Event|1
7576227|NCT04401202|11962097|FG000|Overall Study|Hospitalized|4
7576228|NCT04401202|11962098|FG001|Overall Study|Hospitalized|1
7576229|NCT04400682|11962107|FG000|Period 1|Withdrawal by Subject|1
7576230|NCT04400682|11962108|FG001|Period 1|Withdrawal by Subject|4
7576231|NCT04399161|11962117|FG000|Overall Study|Withdrawal by Subject|1
7258056|NCT00337428|11470292|FG000|Overall Study|Lack of Time|1
7258057|NCT00337428|11470293|FG001|Overall Study|Lack of Time|1
7258058|NCT00337428|11470292|FG000|Overall Study|Unwilling to Continue|1
7258059|NCT00337428|11470293|FG001|Overall Study|Unwilling to Continue|0
7258060|NCT00337428|11470292|FG000|Overall Study|Anorexia|1
7258061|NCT00337428|11470293|FG001|Overall Study|Anorexia|0
7258062|NCT00337467|11470299|FG000|Overall Study|Adverse Event|3
7258063|NCT00337467|11470299|FG000|Overall Study|Subject Withdrew Consent|2
7258064|NCT00337467|11470299|FG000|Overall Study|Pregnancy|1
7258065|NCT00337467|11470299|FG000|Overall Study|Lost to Follow-up|2
7258066|NCT00337467|11470299|FG000|Overall Study|Subject No Longer Met Study Criteria|2
7258067|NCT00337571|11470310|FG000|Overall Study|Lack of Efficacy|3
7258068|NCT00337571|11470311|FG001|Overall Study|Lack of Efficacy|0
7258069|NCT00337571|11470312|FG002|Overall Study|Lack of Efficacy|0
7258070|NCT00337571|11470313|FG003|Overall Study|Lack of Efficacy|0
7258071|NCT00337571|11470310|FG000|Overall Study|Adverse Event|4
7258072|NCT00337571|11470311|FG001|Overall Study|Adverse Event|5
7258073|NCT00337571|11470312|FG002|Overall Study|Adverse Event|8
7258074|NCT00337571|11470313|FG003|Overall Study|Adverse Event|4
7258075|NCT00337571|11470310|FG000|Overall Study|Withdrawal by Subject|2
7258076|NCT00337571|11470311|FG001|Overall Study|Withdrawal by Subject|2
7258077|NCT00337571|11470312|FG002|Overall Study|Withdrawal by Subject|1
7576232|NCT04399161|11962118|FG001|Overall Study|Withdrawal by Subject|0
7576233|NCT04399161|11962119|FG002|Overall Study|Withdrawal by Subject|2
7576234|NCT04399161|11962117|FG000|Overall Study|Protocol Violation|1
7576235|NCT04399161|11962118|FG001|Overall Study|Protocol Violation|2
7576236|NCT04399161|11962119|FG002|Overall Study|Protocol Violation|0
7258078|NCT00337571|11470313|FG003|Overall Study|Withdrawal by Subject|0
7542330|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542331|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542332|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542333|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1
7542334|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542335|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6
7542336|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542337|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542338|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542339|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542340|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
7542341|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7542342|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
7542343|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9
7542344|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542345|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6
7542346|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542347|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542348|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542349|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542350|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542351|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2
7542352|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542353|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542354|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542355|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542356|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542357|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542358|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
7542359|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542360|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542361|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542362|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1
7542363|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542364|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542365|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7258079|NCT00337571|11470310|FG000|Overall Study|Lost to Follow-up|3
7258080|NCT00337571|11470311|FG001|Overall Study|Lost to Follow-up|1
7258081|NCT00337571|11470312|FG002|Overall Study|Lost to Follow-up|0
7258082|NCT00337571|11470313|FG003|Overall Study|Lost to Follow-up|1
7258083|NCT00337571|11470310|FG000|Overall Study|Poor/noncompliance|1
7258084|NCT00337571|11470311|FG001|Overall Study|Poor/noncompliance|1
7258085|NCT00337571|11470312|FG002|Overall Study|Poor/noncompliance|1
7258086|NCT00337571|11470313|FG003|Overall Study|Poor/noncompliance|1
7258087|NCT00337571|11470310|FG000|Overall Study|No longer met study criteria|1
7258088|NCT00337571|11470311|FG001|Overall Study|No longer met study criteria|0
7258089|NCT00337571|11470312|FG002|Overall Study|No longer met study criteria|0
7258090|NCT00337571|11470313|FG003|Overall Study|No longer met study criteria|0
7258091|NCT00337571|11470310|FG000|Overall Study|High Potassium level|0
7258092|NCT00337571|11470311|FG001|Overall Study|High Potassium level|0
7542366|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7258093|NCT00337571|11470312|FG002|Overall Study|High Potassium level|0
7542367|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
7542368|NCT03893565|11893499|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542369|NCT03893565|11893500|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2
7542370|NCT03893565|11893501|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7542371|NCT03893565|11893502|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
7542372|NCT03893565|11893503|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542373|NCT03893565|11893504|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542374|NCT03893565|11893505|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542375|NCT03893565|11893506|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542376|NCT03893565|11893507|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
7542377|NCT03893565|11893499|FG000|Double-blind Extended Treatment(20weeks)|Other|0
7542378|NCT03893565|11893500|FG001|Double-blind Extended Treatment(20weeks)|Other|0
7542379|NCT03893565|11893501|FG002|Double-blind Extended Treatment(20weeks)|Other|0
7542380|NCT03893565|11893502|FG003|Double-blind Extended Treatment(20weeks)|Other|0
7542381|NCT03893565|11893503|FG004|Double-blind Extended Treatment(20weeks)|Other|0
7542382|NCT03893565|11893504|FG005|Double-blind Extended Treatment(20weeks)|Other|1
7542383|NCT03893565|11893505|FG006|Double-blind Extended Treatment(20weeks)|Other|1
7542384|NCT03893565|11893506|FG007|Double-blind Extended Treatment(20weeks)|Other|0
7542385|NCT03893565|11893507|FG008|Double-blind Extended Treatment(20weeks)|Other|0
7542386|NCT03893565|11893499|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542387|NCT03893565|11893500|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542388|NCT03893565|11893501|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542389|NCT03893565|11893502|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542390|NCT03893565|11893503|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542391|NCT03893565|11893504|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7258094|NCT00337571|11470313|FG003|Overall Study|High Potassium level|1
7258095|NCT00337610|11470325|FG000|Overall Study|Adverse Event|2
7258096|NCT00337610|11470326|FG001|Overall Study|Adverse Event|2
7258097|NCT00337610|11470325|FG000|Overall Study|Death|0
7258098|NCT00337610|11470326|FG001|Overall Study|Death|1
7258099|NCT00337610|11470325|FG000|Overall Study|Lack of Efficacy|6
7258100|NCT00337610|11470326|FG001|Overall Study|Lack of Efficacy|3
7258101|NCT00337610|11470325|FG000|Overall Study|Lost to Follow-up|3
7258102|NCT00337610|11470326|FG001|Overall Study|Lost to Follow-up|3
7258103|NCT00337610|11470325|FG000|Overall Study|Withdrawal by Subject|6
7258104|NCT00337610|11470326|FG001|Overall Study|Withdrawal by Subject|5
7258105|NCT00337662|11470335|FG000|Study Period II|Lost to Follow-up|0
7258106|NCT00337662|11470336|FG001|Study Period II|Lost to Follow-up|0
7258107|NCT00337662|11470337|FG002|Study Period II|Lost to Follow-up|0
7258108|NCT00337662|11470338|FG003|Study Period II|Lost to Follow-up|35
7258109|NCT00337662|11470335|FG000|Study Period II|Withdrawal by Subject|0
7258110|NCT00337662|11470336|FG001|Study Period II|Withdrawal by Subject|0
7258111|NCT00337662|11470337|FG002|Study Period II|Withdrawal by Subject|0
7258112|NCT00337662|11470338|FG003|Study Period II|Withdrawal by Subject|20
7258113|NCT00337662|11470335|FG000|Study Period II|Adverse Event|0
7258114|NCT00337662|11470336|FG001|Study Period II|Adverse Event|0
7258115|NCT00337662|11470337|FG002|Study Period II|Adverse Event|0
7258116|NCT00337662|11470338|FG003|Study Period II|Adverse Event|16
7258117|NCT00337662|11470335|FG000|Study Period II|Physician Decision|0
7258118|NCT00337662|11470336|FG001|Study Period II|Physician Decision|0
7258119|NCT00337662|11470337|FG002|Study Period II|Physician Decision|0
7258120|NCT00337662|11470338|FG003|Study Period II|Physician Decision|13
7258121|NCT00337662|11470335|FG000|Study Period II|Entry Criteria Not Met|0
7258122|NCT00337662|11470336|FG001|Study Period II|Entry Criteria Not Met|0
7258123|NCT00337662|11470337|FG002|Study Period II|Entry Criteria Not Met|0
7258124|NCT00337662|11470338|FG003|Study Period II|Entry Criteria Not Met|6
7258125|NCT00337662|11470335|FG000|Study Period II|Protocol Violation|0
7258126|NCT00337662|11470336|FG001|Study Period II|Protocol Violation|0
7258127|NCT00337662|11470337|FG002|Study Period II|Protocol Violation|0
7258128|NCT00337662|11470338|FG003|Study Period II|Protocol Violation|6
7258129|NCT00337662|11470335|FG000|Study Period II|Lack of Efficacy|0
7258130|NCT00337662|11470336|FG001|Study Period II|Lack of Efficacy|0
7258131|NCT00337662|11470337|FG002|Study Period II|Lack of Efficacy|0
7258132|NCT00337662|11470338|FG003|Study Period II|Lack of Efficacy|7
7258133|NCT00337662|11470335|FG000|Study Period II|Sponsor Decision|0
7258134|NCT00337662|11470336|FG001|Study Period II|Sponsor Decision|0
7542392|NCT03893565|11893505|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1
7542393|NCT03893565|11893506|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542394|NCT03893565|11893507|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
7542395|NCT03893565|11893499|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542396|NCT03893565|11893500|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542397|NCT03893565|11893501|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542398|NCT03893565|11893502|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542399|NCT03893565|11893503|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542400|NCT03893565|11893504|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7542401|NCT03893565|11893505|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
7542402|NCT03893565|11893506|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542403|NCT03893565|11893507|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
7542404|NCT03893565|11893499|FG000|Open-label Induction Phase (10 Weeks)|Other|0
7542405|NCT03893565|11893500|FG001|Open-label Induction Phase (10 Weeks)|Other|0
7542406|NCT03893565|11893501|FG002|Open-label Induction Phase (10 Weeks)|Other|0
7542407|NCT03893565|11893502|FG003|Open-label Induction Phase (10 Weeks)|Other|0
7542408|NCT03893565|11893503|FG004|Open-label Induction Phase (10 Weeks)|Other|0
7542409|NCT03893565|11893504|FG005|Open-label Induction Phase (10 Weeks)|Other|0
7542410|NCT03893565|11893505|FG006|Open-label Induction Phase (10 Weeks)|Other|0
7542411|NCT03893565|11893506|FG007|Open-label Induction Phase (10 Weeks)|Other|3
7542412|NCT03893565|11893507|FG008|Open-label Induction Phase (10 Weeks)|Other|0
7542413|NCT03893565|11893499|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542414|NCT03893565|11893500|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542415|NCT03893565|11893501|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542416|NCT03893565|11893502|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542417|NCT03893565|11893503|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542418|NCT03893565|11893504|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542419|NCT03893565|11893505|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542420|NCT03893565|11893506|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5
7542421|NCT03893565|11893507|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
7542422|NCT03893565|11893499|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542423|NCT03893565|11893500|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542424|NCT03893565|11893501|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542425|NCT03893565|11893502|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542426|NCT03893565|11893503|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542427|NCT03893565|11893504|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542428|NCT03893565|11893505|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7576237|NCT04399122|11962138|FG000|Overall Study|Lost to Follow-up|2
7576238|NCT04399122|11962139|FG001|Overall Study|Lost to Follow-up|0
7542429|NCT03893565|11893506|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15
7542430|NCT03893565|11893507|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
7542431|NCT03893565|11893499|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542432|NCT03893565|11893500|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542433|NCT03893565|11893501|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542434|NCT03893565|11893502|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542435|NCT03893565|11893503|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542436|NCT03893565|11893504|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542437|NCT03893565|11893505|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542438|NCT03893565|11893506|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7
7542439|NCT03893565|11893507|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
7542440|NCT03893565|11893499|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542441|NCT03893565|11893500|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542442|NCT03893565|11893501|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7258135|NCT00337662|11470337|FG002|Study Period II|Sponsor Decision|0
7258136|NCT00337662|11470338|FG003|Study Period II|Sponsor Decision|2
7258137|NCT00337662|11470335|FG000|Study Period II|Parent/Caregiver Decision|0
7258138|NCT00337662|11470336|FG001|Study Period II|Parent/Caregiver Decision|0
7258139|NCT00337662|11470337|FG002|Study Period II|Parent/Caregiver Decision|0
7258140|NCT00337662|11470338|FG003|Study Period II|Parent/Caregiver Decision|1
7258141|NCT00337662|11470335|FG000|Study Period III|Lost to Follow-up|14
7258142|NCT00337662|11470336|FG001|Study Period III|Lost to Follow-up|16
7258143|NCT00337662|11470337|FG002|Study Period III|Lost to Follow-up|14
7258144|NCT00337662|11470338|FG003|Study Period III|Lost to Follow-up|0
7258145|NCT00337662|11470335|FG000|Study Period III|Withdrawal by Subject|18
7258146|NCT00337662|11470336|FG001|Study Period III|Withdrawal by Subject|14
7258147|NCT00337662|11470337|FG002|Study Period III|Withdrawal by Subject|12
7258148|NCT00337662|11470338|FG003|Study Period III|Withdrawal by Subject|0
7258149|NCT00337662|11470335|FG000|Study Period III|Adverse Event|9
7258150|NCT00337662|11470336|FG001|Study Period III|Adverse Event|10
7258151|NCT00337662|11470337|FG002|Study Period III|Adverse Event|8
7258152|NCT00337662|11470338|FG003|Study Period III|Adverse Event|0
7258153|NCT00337662|11470335|FG000|Study Period III|Protocol Violation|3
7258154|NCT00337662|11470336|FG001|Study Period III|Protocol Violation|8
7258155|NCT00337662|11470337|FG002|Study Period III|Protocol Violation|2
7258156|NCT00337662|11470338|FG003|Study Period III|Protocol Violation|0
7258157|NCT00337662|11470335|FG000|Study Period III|Physician Decision|6
7258158|NCT00337662|11470336|FG001|Study Period III|Physician Decision|5
7258159|NCT00337662|11470337|FG002|Study Period III|Physician Decision|0
7258160|NCT00337662|11470338|FG003|Study Period III|Physician Decision|0
7258161|NCT00337662|11470335|FG000|Study Period III|Entry Criteria Not Met|4
7258162|NCT00337662|11470336|FG001|Study Period III|Entry Criteria Not Met|1
7258163|NCT00337662|11470337|FG002|Study Period III|Entry Criteria Not Met|3
7258164|NCT00337662|11470338|FG003|Study Period III|Entry Criteria Not Met|0
7258165|NCT00337662|11470335|FG000|Study Period III|Lack of Efficacy|4
7258166|NCT00337662|11470336|FG001|Study Period III|Lack of Efficacy|4
7258167|NCT00337662|11470337|FG002|Study Period III|Lack of Efficacy|2
7258168|NCT00337662|11470338|FG003|Study Period III|Lack of Efficacy|0
7258169|NCT00337662|11470335|FG000|Study Period III|Parent/Caregiver Decision|0
7258170|NCT00337662|11470336|FG001|Study Period III|Parent/Caregiver Decision|0
7258171|NCT00337662|11470337|FG002|Study Period III|Parent/Caregiver Decision|2
7258172|NCT00337662|11470338|FG003|Study Period III|Parent/Caregiver Decision|0
7258173|NCT00337662|11470335|FG000|Study Period III|Sponsor Decision|1
7258174|NCT00337662|11470336|FG001|Study Period III|Sponsor Decision|0
7258175|NCT00337662|11470337|FG002|Study Period III|Sponsor Decision|1
7542443|NCT03893565|11893502|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542444|NCT03893565|11893503|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542445|NCT03893565|11893504|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542446|NCT03893565|11893505|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542447|NCT03893565|11893506|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
7542448|NCT03893565|11893507|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4
7542449|NCT03701516|11893526|FG000|Period 1|Lost to Follow-up|0
7542450|NCT03701516|11893527|FG001|Period 1|Lost to Follow-up|1
7542451|NCT03701516|11893526|FG000|Period 1|Adverse Event|0
7542452|NCT03701516|11893527|FG001|Period 1|Adverse Event|2
7542453|NCT03701516|11893526|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2
7542454|NCT03701516|11893527|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
7542455|NCT03701516|11893526|FG000|Period 1|Non Compliance to Protocol|2
7542456|NCT03701516|11893527|FG001|Period 1|Non Compliance to Protocol|1
7542457|NCT03701516|11893526|FG000|Period 1|Withdrawal by Subject|0
7542458|NCT03701516|11893527|FG001|Period 1|Withdrawal by Subject|1
7542459|NCT03701516|11893526|FG000|Period 2|failed to meet all eligibility creiteria|1
7542460|NCT03701516|11893527|FG001|Period 2|failed to meet all eligibility creiteria|0
7542461|NCT03701516|11893526|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
7542462|NCT03701516|11893527|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
7542463|NCT03650556|11893533|FG000|Overall Study|Death|2
7542464|NCT03650556|11893533|FG000|Overall Study|Withdrawal by Subject|20
7542465|NCT03650556|11893533|FG000|Overall Study|Physician Decision|2
7542466|NCT03650556|11893533|FG000|Overall Study|Lost to Follow-up|8
7542467|NCT03650556|11893533|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4
7542468|NCT03650556|11893533|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1
7542469|NCT03628716|11893540|FG000|Overall Study|Adverse Event|1
7542470|NCT03628716|11893541|FG001|Overall Study|Adverse Event|1
7542471|NCT03628716|11893540|FG000|Overall Study|Death|1
7542472|NCT03628716|11893541|FG001|Overall Study|Death|0
7542473|NCT03628716|11893540|FG000|Overall Study|Lack of Efficacy|15
7542474|NCT03628716|11893541|FG001|Overall Study|Lack of Efficacy|20
7542475|NCT03628716|11893540|FG000|Overall Study|Withdrawal by Subject|1
7542476|NCT03628716|11893541|FG001|Overall Study|Withdrawal by Subject|2
7542477|NCT03628716|11893540|FG000|Overall Study|Study Terminated by Sponsor|1
7542478|NCT03628716|11893541|FG001|Overall Study|Study Terminated by Sponsor|0
7552262|NCT02985879|11912189|FG001|Overall Study|Adverse Event|9
7552263|NCT02985879|11912190|FG002|Overall Study|Adverse Event|7
7552264|NCT02985879|11912188|FG000|Overall Study|Withdrew consent|6
7552265|NCT02985879|11912189|FG001|Overall Study|Withdrew consent|8
7552266|NCT02985879|11912190|FG002|Overall Study|Withdrew consent|10
7552267|NCT02985879|11912188|FG000|Overall Study|Lost to Follow-up|1
7552268|NCT02985879|11912189|FG001|Overall Study|Lost to Follow-up|0
7552269|NCT02985879|11912190|FG002|Overall Study|Lost to Follow-up|2
7552270|NCT02985879|11912188|FG000|Overall Study|Other, not specified|62
7552271|NCT02985879|11912189|FG001|Overall Study|Other, not specified|58
7258176|NCT00337662|11470338|FG003|Study Period III|Sponsor Decision|0
7552272|NCT02985879|11912190|FG002|Overall Study|Other, not specified|58
7552273|NCT02985996|11912209|FG000|Overall Study|Withdrawal by Subject|0
7552274|NCT02985996|11912210|FG001|Overall Study|Withdrawal by Subject|0
7552275|NCT02985996|11912211|FG002|Overall Study|Withdrawal by Subject|1
7552276|NCT02985996|11912212|FG003|Overall Study|Withdrawal by Subject|0
7552277|NCT02985996|11912213|FG004|Overall Study|Withdrawal by Subject|0
7552278|NCT02985996|11912209|FG000|Overall Study|Protocol Violation|0
7552279|NCT02985996|11912210|FG001|Overall Study|Protocol Violation|1
7552280|NCT02985996|11912211|FG002|Overall Study|Protocol Violation|0
7552281|NCT02985996|11912212|FG003|Overall Study|Protocol Violation|0
7552282|NCT02985996|11912213|FG004|Overall Study|Protocol Violation|0
7552283|NCT02986074|11912229|FG000|First Trial Period|Adverse Event|1
7552284|NCT02986074|11912230|FG001|First Trial Period|Adverse Event|0
7552285|NCT02986074|11912231|FG002|First Trial Period|Adverse Event|0
7552286|NCT02986074|11912232|FG003|First Trial Period|Adverse Event|0
7552287|NCT02986074|11912229|FG000|Follow up Period|system explant|0
7552288|NCT02986074|11912230|FG001|Follow up Period|system explant|0
7542479|NCT03377699|11893551|FG000|Overall Study|Withdrawal by Subject|2
7542480|NCT03377699|11893552|FG001|Overall Study|Withdrawal by Subject|9
7542481|NCT03377699|11893551|FG000|Overall Study|Lost to Follow-up|1
7542482|NCT03377699|11893552|FG001|Overall Study|Lost to Follow-up|1
7542483|NCT03377699|11893551|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1
7542484|NCT03377699|11893552|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0
7542485|NCT03377699|11893551|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7542486|NCT03377699|11893552|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
7542487|NCT03377699|11893551|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11
7542488|NCT03377699|11893552|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8
7542489|NCT03377699|11893551|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7542490|NCT03377699|11893552|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
7542491|NCT03275350|11893562|FG000|Overall Study|Lost to Follow-up|4
7542492|NCT03275350|11893563|FG001|Overall Study|Lost to Follow-up|6
7542493|NCT03275350|11893562|FG000|Overall Study|Death|2
7542494|NCT03275350|11893563|FG001|Overall Study|Death|1
7542495|NCT03275350|11893562|FG000|Overall Study|Physician Decision|1
7542496|NCT03275350|11893563|FG001|Overall Study|Physician Decision|0
7542497|NCT03275350|11893562|FG000|Overall Study|Incarcerated|1
7542498|NCT03275350|11893563|FG001|Overall Study|Incarcerated|1
7576239|NCT04399122|11962138|FG000|Overall Study|Withdrawal by Subject|1
7576240|NCT04399122|11962139|FG001|Overall Study|Withdrawal by Subject|0
7576241|NCT04397445|11962145|FG000|Overall Study|Withdrawal by Subject|1
7258177|NCT00337662|11470335|FG000|Study Period III|Clinical Relapse|1
7258178|NCT00337662|11470336|FG001|Study Period III|Clinical Relapse|0
7258179|NCT00337662|11470337|FG002|Study Period III|Clinical Relapse|0
7258180|NCT00337662|11470338|FG003|Study Period III|Clinical Relapse|0
7258181|NCT00337727|11470351|FG000|Overall Study|Adverse Event|5
7258182|NCT00337727|11470352|FG001|Overall Study|Adverse Event|3
7258183|NCT00337727|11470351|FG000|Overall Study|Lost to Follow-up|5
7258184|NCT00337727|11470352|FG001|Overall Study|Lost to Follow-up|4
7258185|NCT00337727|11470351|FG000|Overall Study|Physician Decision|1
7258186|NCT00337727|11470352|FG001|Overall Study|Physician Decision|0
7258187|NCT00337727|11470351|FG000|Overall Study|Protocol Violation|4
7258188|NCT00337727|11470352|FG001|Overall Study|Protocol Violation|0
7258189|NCT00337727|11470351|FG000|Overall Study|Withdrawal by Subject|3
7258190|NCT00337727|11470352|FG001|Overall Study|Withdrawal by Subject|5
7258191|NCT00337779|11470360|FG000|Overall Study|Withdrawal by Subject|10
7258192|NCT00337779|11470361|FG001|Overall Study|Withdrawal by Subject|12
7258193|NCT00337779|11470360|FG000|Overall Study|Sponsor decision|1
7258194|NCT00337779|11470361|FG001|Overall Study|Sponsor decision|1
7258195|NCT00337779|11470360|FG000|Overall Study|Physician Decision|3
7258196|NCT00337779|11470361|FG001|Overall Study|Physician Decision|6
7258197|NCT00337779|11470360|FG000|Overall Study|Protocol Violation|1
7258198|NCT00337779|11470361|FG001|Overall Study|Protocol Violation|1
7258199|NCT00337779|11470360|FG000|Overall Study|Lost to Follow-up|6
7258200|NCT00337779|11470361|FG001|Overall Study|Lost to Follow-up|5
7258201|NCT00337779|11470360|FG000|Overall Study|Adverse Event|28
7258202|NCT00337779|11470361|FG001|Overall Study|Adverse Event|51
7258203|NCT00337779|11470360|FG000|Overall Study|Pregnancy|3
7258204|NCT00337779|11470361|FG001|Overall Study|Pregnancy|2
7258205|NCT00337779|11470360|FG000|Overall Study|Death|0
7258206|NCT00337779|11470361|FG001|Overall Study|Death|1
7258207|NCT00337818|11470370|FG000|Overall Study|Lost to Follow-up|289
7258208|NCT00337818|11470371|FG001|Overall Study|Lost to Follow-up|91
7258209|NCT00337818|11470372|FG002|Overall Study|Lost to Follow-up|107
7258210|NCT00337935|11470382|FG000|Overall Study|Adverse Event|2
7258211|NCT00337935|11470383|FG001|Overall Study|Adverse Event|5
7258212|NCT00337935|11470382|FG000|Overall Study|Death|2
7542499|NCT03272347|11893574|FG000|Overall Study|Death|0
7542500|NCT03272347|11893575|FG001|Overall Study|Death|0
7258213|NCT00337935|11470383|FG001|Overall Study|Death|8
7258214|NCT00337935|11470382|FG000|Overall Study|Physician Decision|1
7542501|NCT03272347|11893576|FG002|Overall Study|Death|0
7542502|NCT03272347|11893577|FG003|Overall Study|Death|1
7542503|NCT03272347|11893574|FG000|Overall Study|Lost to Follow-up|1
7542504|NCT03272347|11893575|FG001|Overall Study|Lost to Follow-up|0
7542505|NCT03272347|11893576|FG002|Overall Study|Lost to Follow-up|5
7542506|NCT03272347|11893577|FG003|Overall Study|Lost to Follow-up|1
7542507|NCT03272347|11893574|FG000|Overall Study|Physician Decision|4
7542508|NCT03272347|11893575|FG001|Overall Study|Physician Decision|2
7542509|NCT03272347|11893576|FG002|Overall Study|Physician Decision|5
7542510|NCT03272347|11893577|FG003|Overall Study|Physician Decision|4
7542511|NCT03272347|11893574|FG000|Overall Study|Screen Failure|1
7542512|NCT03272347|11893575|FG001|Overall Study|Screen Failure|0
7542513|NCT03272347|11893576|FG002|Overall Study|Screen Failure|0
7542514|NCT03272347|11893577|FG003|Overall Study|Screen Failure|0
7542515|NCT03272347|11893574|FG000|Overall Study|Withdrawal by Subject|3
7542516|NCT03272347|11893575|FG001|Overall Study|Withdrawal by Subject|1
7576242|NCT04397445|11962146|FG001|Overall Study|Withdrawal by Subject|0
7576243|NCT04397445|11962147|FG002|Overall Study|Withdrawal by Subject|0
7576244|NCT04397445|11962148|FG003|Overall Study|Withdrawal by Subject|0
7576245|NCT04396639|11962174|FG000|Overall Study|Withdrawal by Subject|1
7258215|NCT00337935|11470383|FG001|Overall Study|Physician Decision|1
7258216|NCT00337935|11470382|FG000|Overall Study|Lost to Follow-up|0
7258217|NCT00337935|11470383|FG001|Overall Study|Lost to Follow-up|1
7258218|NCT00337935|11470382|FG000|Overall Study|Protocol Violation|4
7258219|NCT00337935|11470383|FG001|Overall Study|Protocol Violation|3
7258220|NCT00337935|11470382|FG000|Overall Study|Withdrawal by Subject|1
7258221|NCT00337935|11470383|FG001|Overall Study|Withdrawal by Subject|7
7258222|NCT00337935|11470382|FG000|Overall Study|Other|0
7258223|NCT00337935|11470383|FG001|Overall Study|Other|1
7258224|NCT00337935|11470382|FG000|Overall Study|Lack of Efficacy|0
7258225|NCT00337935|11470383|FG001|Overall Study|Lack of Efficacy|1
7258226|NCT00338286|11470400|FG000|Overall Study|Withdrawal by Subject|50
7258227|NCT00338286|11470401|FG001|Overall Study|Withdrawal by Subject|54
7258228|NCT00338286|11470400|FG000|Overall Study|Lost to Follow-up|80
7258229|NCT00338286|11470401|FG001|Overall Study|Lost to Follow-up|66
7258230|NCT00338286|11470400|FG000|Overall Study|Other|103
7258231|NCT00338286|11470401|FG001|Overall Study|Other|93
7258232|NCT00338728|11470416|FG000|Overall Study|Screen Failure|14
7258233|NCT00338741|11470422|FG000|Overall Study|Lost to Follow-up|2
7258234|NCT00338741|11470423|FG001|Overall Study|Lost to Follow-up|0
7258235|NCT00338806|11470431|FG000|Acute Phase|Withdrawal by Subject|0
7258236|NCT00338806|11470432|FG001|Acute Phase|Withdrawal by Subject|1
7258237|NCT00338806|11470431|FG000|Follow-up|Lost to Follow-up|1
7258238|NCT00338806|11470432|FG001|Follow-up|Lost to Follow-up|3
7258239|NCT00338884|11470440|FG000|Overall Study|Objective Disease Progression or Relapse|44
7258240|NCT00338884|11470440|FG000|Overall Study|Adverse Event|14
7258241|NCT00338884|11470440|FG000|Overall Study|Death|8
7258242|NCT00338884|11470440|FG000|Overall Study|Other|4
7258243|NCT00338884|11470440|FG000|Overall Study|Global Deterioration of Health Status|3
7258244|NCT00338884|11470440|FG000|Overall Study|Withdrawal by Subject|3
7258245|NCT00338884|11470440|FG000|Overall Study|Lost to Follow-up|1
7258246|NCT00338884|11470440|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
7258247|NCT00338949|11470446|FG000|Subject Screening|Screen failures|11
7258248|NCT00338949|11470447|FG001|Subject Screening|Screen failures|11
7258249|NCT00338949|11470446|FG000|Randomization|Withdrawal by Subject|1
7542517|NCT03272347|11893576|FG002|Overall Study|Withdrawal by Subject|2
7542518|NCT03272347|11893577|FG003|Overall Study|Withdrawal by Subject|1
7542519|NCT03272347|11893574|FG000|Overall Study|Status Not Recorded|22
7542520|NCT03272347|11893575|FG001|Overall Study|Status Not Recorded|26
7542521|NCT03272347|11893576|FG002|Overall Study|Status Not Recorded|19
7542522|NCT03272347|11893577|FG003|Overall Study|Status Not Recorded|22
7258250|NCT00338949|11470447|FG001|Randomization|Withdrawal by Subject|0
7258251|NCT00338949|11470446|FG000|Randomization|Adverse Event|0
7258252|NCT00338949|11470447|FG001|Randomization|Adverse Event|5
7258253|NCT00338962|11470457|FG000|Overall Study|Lost to Follow-up|3
7258254|NCT00338962|11470458|FG001|Overall Study|Lost to Follow-up|3
7552289|NCT02986074|11912231|FG002|Follow up Period|system explant|1
7552290|NCT02986074|11912232|FG003|Follow up Period|system explant|2
7552291|NCT02986074|11912229|FG000|Follow up Period|Physician Decision|0
7552292|NCT02986074|11912230|FG001|Follow up Period|Physician Decision|0
7552293|NCT02986074|11912231|FG002|Follow up Period|Physician Decision|0
7552294|NCT02986074|11912232|FG003|Follow up Period|Physician Decision|1
7552295|NCT02986139|11912239|FG000|Overall Study|Sponsor Decision|1
7542523|NCT02674750|11893618|FG000|Overall Study|Death|4
7542524|NCT02674750|11893619|FG001|Overall Study|Death|5
7542525|NCT02674750|11893620|FG002|Overall Study|Death|8
7542526|NCT02674750|11893618|FG000|Overall Study|Lost to Follow-up|0
7258255|NCT00338962|11470459|FG002|Overall Study|Lost to Follow-up|2
7258256|NCT00338962|11470460|FG003|Overall Study|Lost to Follow-up|3
7258257|NCT00338962|11470457|FG000|Overall Study|Withdrawal by Subject|1
7258258|NCT00338962|11470458|FG001|Overall Study|Withdrawal by Subject|0
7258259|NCT00338962|11470459|FG002|Overall Study|Withdrawal by Subject|0
7258260|NCT00338962|11470460|FG003|Overall Study|Withdrawal by Subject|0
7258261|NCT00338962|11470457|FG000|Overall Study|No Transportation|2
7258262|NCT00338962|11470458|FG001|Overall Study|No Transportation|0
7258263|NCT00338962|11470459|FG002|Overall Study|No Transportation|0
7258264|NCT00338962|11470460|FG003|Overall Study|No Transportation|0
7258265|NCT00338962|11470457|FG000|Overall Study|Time Constraint|2
7542527|NCT02674750|11893619|FG001|Overall Study|Lost to Follow-up|8
7258266|NCT00338962|11470458|FG001|Overall Study|Time Constraint|0
7258267|NCT00338962|11470459|FG002|Overall Study|Time Constraint|0
7258268|NCT00338962|11470460|FG003|Overall Study|Time Constraint|0
7258269|NCT00338962|11470457|FG000|Overall Study|Moved|0
7258270|NCT00338962|11470458|FG001|Overall Study|Moved|1
7258271|NCT00338962|11470459|FG002|Overall Study|Moved|0
7258272|NCT00338962|11470460|FG003|Overall Study|Moved|0
7258273|NCT00338962|11470457|FG000|Overall Study|Adverse Event|0
7542528|NCT02674750|11893620|FG002|Overall Study|Lost to Follow-up|0
7542529|NCT02674750|11893618|FG000|Overall Study|Lack of Efficacy|1
7542530|NCT02674750|11893619|FG001|Overall Study|Lack of Efficacy|17
7542531|NCT02674750|11893620|FG002|Overall Study|Lack of Efficacy|3
7258274|NCT00338962|11470458|FG001|Overall Study|Adverse Event|0
7258275|NCT00338962|11470459|FG002|Overall Study|Adverse Event|2
7258276|NCT00338962|11470460|FG003|Overall Study|Adverse Event|0
7258277|NCT00338962|11470457|FG000|Overall Study|Poor Compliance|0
7258278|NCT00338962|11470458|FG001|Overall Study|Poor Compliance|0
7258279|NCT00338962|11470459|FG002|Overall Study|Poor Compliance|2
7258280|NCT00338962|11470460|FG003|Overall Study|Poor Compliance|0
7258281|NCT00339040|11470477|FG000|Stage I|Not able to attend clinic|1
7258282|NCT00339040|11470478|FG001|Stage I|Not able to attend clinic|0
7258283|NCT00339040|11470477|FG000|Stage I|Protocol Violation|1
7258284|NCT00339040|11470478|FG001|Stage I|Protocol Violation|1
7258285|NCT00339040|11470477|FG000|Stage II|Lost to Follow-up|3
7258286|NCT00339040|11470478|FG001|Stage II|Lost to Follow-up|0
7258287|NCT00339040|11470477|FG000|Stage II|Withdrawal by Subject|1
7258288|NCT00339040|11470478|FG001|Stage II|Withdrawal by Subject|2
7258289|NCT00339040|11470477|FG000|Stage II|Protocol Violation|3
7258290|NCT00339040|11470478|FG001|Stage II|Protocol Violation|0
7258291|NCT00339040|11470477|FG000|Stage II|Not able to attend clinic|1
7258292|NCT00339040|11470478|FG001|Stage II|Not able to attend clinic|0
7258293|NCT00339040|11470477|FG000|Stage II|Site closing|2
7258294|NCT00339040|11470478|FG001|Stage II|Site closing|0
7258295|NCT00339144|11470508|FG000|Overall Study|Disease progression|5
7258296|NCT00339144|11470509|FG001|Overall Study|Disease progression|2
7258297|NCT00339144|11470510|FG002|Overall Study|Disease progression|2
7258298|NCT00339144|11470508|FG000|Overall Study|Study drug toxicity|3
7258299|NCT00339144|11470509|FG001|Overall Study|Study drug toxicity|1
7258300|NCT00339144|11470510|FG002|Overall Study|Study drug toxicity|1
7258301|NCT00339144|11470508|FG000|Overall Study|Participant's request to discontinuation|1
7258302|NCT00339144|11470509|FG001|Overall Study|Participant's request to discontinuation|0
7258303|NCT00339144|11470510|FG002|Overall Study|Participant's request to discontinuation|1
7258320|NCT00339833|11470534|FG000|Overall Study|Withdrawal by Subject|1
7258321|NCT00339833|11470535|FG001|Overall Study|Withdrawal by Subject|2
7258322|NCT00339833|11470534|FG000|Overall Study|toothache|0
7258323|NCT00339833|11470535|FG001|Overall Study|toothache|1
7258324|NCT00339833|11470534|FG000|Overall Study|indigestion|0
7258325|NCT00339833|11470535|FG001|Overall Study|indigestion|1
7258326|NCT00339833|11470534|FG000|Overall Study|Chest pain|0
7258327|NCT00339833|11470535|FG001|Overall Study|Chest pain|1
7542532|NCT02674750|11893618|FG000|Overall Study|Withdrawal by Subject|0
7542533|NCT02674750|11893619|FG001|Overall Study|Withdrawal by Subject|7
7542534|NCT02674750|11893620|FG002|Overall Study|Withdrawal by Subject|1
7542535|NCT02674750|11893618|FG000|Overall Study|Other|0
7542536|NCT02674750|11893619|FG001|Overall Study|Other|8
7542537|NCT02674750|11893620|FG002|Overall Study|Other|0
7542538|NCT02440854|11893627|FG000|Overall Study|Relocation of patient|1
7542539|NCT02440854|11893627|FG000|Overall Study|Death|6
7542540|NCT02440854|11893627|FG000|Overall Study|Lost to Follow-up|10
7542541|NCT02440854|11893627|FG000|Overall Study|Afatinib discontinuation|46
7542542|NCT02440854|11893627|FG000|Overall Study|stopped study at earlier timepoint|14
7542543|NCT02440854|11893627|FG000|Overall Study|Study medication not received|1
7542544|NCT02440854|11893627|FG000|Overall Study|Violation of inclusion criteria|2
7542545|NCT02154529|11893646|FG000|Overall Study|Death|1
7542546|NCT02154529|11893647|FG001|Overall Study|Death|1
7542547|NCT02154529|11893648|FG002|Overall Study|Death|5
7542548|NCT02154529|11893649|FG003|Overall Study|Death|1
7542549|NCT02154529|11893646|FG000|Overall Study|Termination of study by sponsor|2
7258328|NCT00339833|11470534|FG000|Overall Study|minor infection|0
7258329|NCT00339833|11470535|FG001|Overall Study|minor infection|1
7542550|NCT02154529|11893647|FG001|Overall Study|Termination of study by sponsor|2
7542551|NCT02154529|11893648|FG002|Overall Study|Termination of study by sponsor|3
7542552|NCT02154529|11893649|FG003|Overall Study|Termination of study by sponsor|1
7542553|NCT02154529|11893646|FG000|Overall Study|Lost to Follow-up|1
7542554|NCT02154529|11893647|FG001|Overall Study|Lost to Follow-up|0
7542555|NCT02154529|11893648|FG002|Overall Study|Lost to Follow-up|0
7542556|NCT02154529|11893649|FG003|Overall Study|Lost to Follow-up|0
7542557|NCT00788125|11893661|FG000|Overall Study|Death|6
7542558|NCT02777554|11893667|FG000|Overall Study|Adverse Event|4
7542559|NCT02777554|11893668|FG001|Overall Study|Adverse Event|4
7542560|NCT02777554|11893669|FG002|Overall Study|Adverse Event|0
7576246|NCT04396639|11962174|FG000|Overall Study|Other|1
7576247|NCT04393493|11962193|FG000|First 4 Days of Intervention|Early improvement|5
7258330|NCT00339833|11470534|FG000|Overall Study|Poor venous access|2
7258331|NCT00339833|11470535|FG001|Overall Study|Poor venous access|2
7258332|NCT00339833|11470534|FG000|Overall Study|anaemia or excess drop in glycaemia|2
7258333|NCT00339833|11470535|FG001|Overall Study|anaemia or excess drop in glycaemia|0
7258334|NCT00339833|11470534|FG000|Overall Study|Error in data records|1
7258335|NCT00339833|11470535|FG001|Overall Study|Error in data records|0
7258336|NCT00340678|11470554|FG000|Overall Study|Lost to Follow-up|1
7258337|NCT00340678|11470555|FG001|Overall Study|Lost to Follow-up|0
7258338|NCT00340678|11470556|FG002|Overall Study|Lost to Follow-up|0
7258339|NCT00340678|11470557|FG003|Overall Study|Lost to Follow-up|0
7258340|NCT00340704|11470574|FG000|PK Study|Adverse Event|0
7258341|NCT00340704|11470575|FG001|PK Study|Adverse Event|1
7258342|NCT00340704|11470576|FG002|PK Study|Adverse Event|0
7258343|NCT00340704|11470577|FG003|PK Study|Adverse Event|0
7258344|NCT00340704|11470578|FG004|PK Study|Adverse Event|0
7258345|NCT00340704|11470579|FG005|PK Study|Adverse Event|0
7258346|NCT00340704|11470580|FG006|PK Study|Adverse Event|0
7258347|NCT00340704|11470581|FG007|PK Study|Adverse Event|0
7258348|NCT00340704|11470582|FG008|PK Study|Adverse Event|0
7258349|NCT00340704|11470574|FG000|PK Study|Not treated|0
7258350|NCT00340704|11470575|FG001|PK Study|Not treated|0
7258351|NCT00340704|11470576|FG002|PK Study|Not treated|1
7258352|NCT00340704|11470577|FG003|PK Study|Not treated|0
7258353|NCT00340704|11470578|FG004|PK Study|Not treated|0
7258354|NCT00340704|11470579|FG005|PK Study|Not treated|0
7258355|NCT00340704|11470580|FG006|PK Study|Not treated|0
7258356|NCT00340704|11470581|FG007|PK Study|Not treated|0
7258357|NCT00340704|11470582|FG008|PK Study|Not treated|0
7258358|NCT00340704|11470574|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7258359|NCT00340704|11470575|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7258360|NCT00340704|11470576|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7258361|NCT00340704|11470577|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
7258362|NCT00340704|11470578|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
7258363|NCT00340704|11470579|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7258364|NCT00340704|11470580|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
7258365|NCT00340704|11470581|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7258366|NCT00340704|11470582|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
7258367|NCT00340704|11470574|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258368|NCT00340704|11470575|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258369|NCT00340704|11470576|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258370|NCT00340704|11470577|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258371|NCT00340704|11470578|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258372|NCT00340704|11470579|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
7258373|NCT00340704|11470580|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258374|NCT00340704|11470581|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258375|NCT00340704|11470582|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
7258376|NCT00340704|11470574|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258377|NCT00340704|11470575|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258378|NCT00340704|11470576|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258379|NCT00340704|11470577|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258380|NCT00340704|11470578|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
7542561|NCT02777554|11893670|FG003|Overall Study|Adverse Event|1
7542562|NCT02777554|11893671|FG004|Overall Study|Adverse Event|0
7542563|NCT02777554|11893672|FG005|Overall Study|Adverse Event|0
7542564|NCT02777554|11893667|FG000|Overall Study|Withdrawal by Subject|3
7542565|NCT02777554|11893668|FG001|Overall Study|Withdrawal by Subject|1
7542566|NCT02777554|11893669|FG002|Overall Study|Withdrawal by Subject|1
7542567|NCT02777554|11893670|FG003|Overall Study|Withdrawal by Subject|0
7576248|NCT04393493|11962194|FG001|First 4 Days of Intervention|Early improvement|7
7258381|NCT00340704|11470579|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
7258382|NCT00340704|11470580|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258383|NCT00340704|11470581|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7542568|NCT02777554|11893671|FG004|Overall Study|Withdrawal by Subject|0
7542569|NCT02777554|11893672|FG005|Overall Study|Withdrawal by Subject|0
7542570|NCT02777554|11893667|FG000|Overall Study|Discharged early due to hurricane|22
7542571|NCT02777554|11893668|FG001|Overall Study|Discharged early due to hurricane|20
7542572|NCT02777554|11893669|FG002|Overall Study|Discharged early due to hurricane|0
7542573|NCT02777554|11893670|FG003|Overall Study|Discharged early due to hurricane|0
7542574|NCT02777554|11893671|FG004|Overall Study|Discharged early due to hurricane|0
7542575|NCT02777554|11893672|FG005|Overall Study|Discharged early due to hurricane|0
7542576|NCT02777554|11893667|FG000|Overall Study|Other - Miscellaneous|1
7542577|NCT02777554|11893668|FG001|Overall Study|Other - Miscellaneous|0
7542578|NCT02777554|11893669|FG002|Overall Study|Other - Miscellaneous|0
7542579|NCT02777554|11893670|FG003|Overall Study|Other - Miscellaneous|0
7258384|NCT00340704|11470582|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
7258385|NCT00340704|11470574|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7258386|NCT00340704|11470575|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7258387|NCT00340704|11470576|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7258388|NCT00340704|11470577|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7258389|NCT00340704|11470578|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
7258390|NCT00340704|11470579|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
7258391|NCT00340704|11470580|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
7258392|NCT00340704|11470581|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
7258393|NCT00340704|11470582|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
7258394|NCT00340834|11470613|FG000|Core Phase of Study|Adverse Event|26
7258395|NCT00340834|11470614|FG001|Core Phase of Study|Adverse Event|9
7258396|NCT00340834|11470615|FG002|Core Phase of Study|Adverse Event|9
7258397|NCT00340834|11470616|FG003|Core Phase of Study|Adverse Event|0
7542580|NCT02777554|11893671|FG004|Overall Study|Other - Miscellaneous|0
7542581|NCT02777554|11893672|FG005|Overall Study|Other - Miscellaneous|0
7552296|NCT02986139|11912240|FG001|Overall Study|Sponsor Decision|2
7552297|NCT02986139|11912239|FG000|Overall Study|Withdrawal by Subject|0
7552298|NCT02986139|11912240|FG001|Overall Study|Withdrawal by Subject|1
7552299|NCT02986139|11912239|FG000|Overall Study|Lost to Follow-up|0
7552300|NCT02986139|11912240|FG001|Overall Study|Lost to Follow-up|1
7552301|NCT02986373|11912254|FG000|Overall Study|Adverse Event|4
7552302|NCT02986373|11912254|FG000|Overall Study|Lost to Follow-up|1
7552303|NCT02986373|11912254|FG000|Overall Study|Withdrawal by Subject|10
7552304|NCT02986373|11912254|FG000|Overall Study|Other|24
7552305|NCT02986854|11912287|FG000|Overall Study|Withdrawal by Subject|0
7552306|NCT02986854|11912288|FG001|Overall Study|Withdrawal by Subject|1
7552307|NCT02986854|11912289|FG002|Overall Study|Withdrawal by Subject|1
7552308|NCT02986854|11912287|FG000|Overall Study|Lost to Follow-up|3
7552309|NCT02986854|11912288|FG001|Overall Study|Lost to Follow-up|11
7552310|NCT02986854|11912289|FG002|Overall Study|Lost to Follow-up|2
7552311|NCT02987205|11912308|FG000|Overall Study|Adverse Event|1
7552312|NCT02987205|11912308|FG000|Overall Study|Withdrawal by Subject|3
7552313|NCT02987660|11912338|FG000|Overall Study|Study terminated by sponsor|10
7552314|NCT02987660|11912339|FG001|Overall Study|Study terminated by sponsor|10
7552315|NCT02987972|11912383|FG000|Overall Study|Adverse Event|1
7552316|NCT02987972|11912384|FG001|Overall Study|Adverse Event|1
7552317|NCT02987972|11912385|FG002|Overall Study|Adverse Event|0
7552318|NCT02987972|11912383|FG000|Overall Study|Death|1
7552319|NCT02987972|11912384|FG001|Overall Study|Death|0
7552320|NCT02987972|11912385|FG002|Overall Study|Death|0
7542582|NCT02777827|11893709|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
7542583|NCT02777827|11893710|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
7542584|NCT02777827|11893711|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
7542585|NCT02777827|11893712|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
7258398|NCT00340834|11470617|FG004|Core Phase of Study|Adverse Event|0
7258399|NCT00340834|11470613|FG000|Core Phase of Study|Withdrawal by Subject|11
7258400|NCT00340834|11470614|FG001|Core Phase of Study|Withdrawal by Subject|9
7258401|NCT00340834|11470615|FG002|Core Phase of Study|Withdrawal by Subject|16
7258402|NCT00340834|11470616|FG003|Core Phase of Study|Withdrawal by Subject|0
7258403|NCT00340834|11470617|FG004|Core Phase of Study|Withdrawal by Subject|0
7258404|NCT00340834|11470613|FG000|Core Phase of Study|Administrative Problems|6
7258405|NCT00340834|11470614|FG001|Core Phase of Study|Administrative Problems|2
7258406|NCT00340834|11470615|FG002|Core Phase of Study|Administrative Problems|7
7258407|NCT00340834|11470616|FG003|Core Phase of Study|Administrative Problems|0
7258408|NCT00340834|11470617|FG004|Core Phase of Study|Administrative Problems|0
7258409|NCT00340834|11470613|FG000|Core Phase of Study|Lack of Efficacy|3
7542586|NCT02777827|11893713|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
7542587|NCT02777827|11893714|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
7542588|NCT02777918|11893730|FG000|Overall Study|Medical reasons|1
7542589|NCT02777918|11893731|FG001|Overall Study|Medical reasons|2
7542590|NCT02777918|11893730|FG000|Overall Study|Too busy / stressed|1
7542591|NCT02777918|11893731|FG001|Overall Study|Too busy / stressed|1
7542592|NCT02777918|11893730|FG000|Overall Study|Withdrawal by Subject|1
7542593|NCT02777918|11893731|FG001|Overall Study|Withdrawal by Subject|1
7542594|NCT02777970|11893758|FG000|Overall Study|Lost to Follow-up|0
7542595|NCT02777970|11893759|FG001|Overall Study|Lost to Follow-up|1
7542596|NCT02777970|11893760|FG002|Overall Study|Lost to Follow-up|0
7542597|NCT02777970|11893758|FG000|Overall Study|Protocol Violation|1
7542598|NCT02777970|11893759|FG001|Overall Study|Protocol Violation|0
7542599|NCT02777970|11893760|FG002|Overall Study|Protocol Violation|0
7542600|NCT02778074|11893772|FG000|Overall Study|Lost to Follow-up|7
7542601|NCT02778074|11893773|FG001|Overall Study|Lost to Follow-up|10
7542602|NCT02778100|11893781|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
7542603|NCT02778100|11893782|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
7542604|NCT02778555|11893812|FG000|Overall Study|Withdrawal by Subject|55
7542605|NCT02778555|11893813|FG001|Overall Study|Withdrawal by Subject|32
7542606|NCT02778555|11893814|FG002|Overall Study|Withdrawal by Subject|107
7542607|NCT02778867|11893824|FG000|Phase 1|Withdrawal by Subject|2
7542608|NCT02778867|11893825|FG001|Phase 1|Withdrawal by Subject|3
7542609|NCT02778867|11893826|FG002|Phase 1|Withdrawal by Subject|0
7542610|NCT02778867|11893827|FG003|Phase 1|Withdrawal by Subject|0
7542611|NCT02778867|11893824|FG000|Phase 2|Withdrawal by Subject|0
7542612|NCT02778867|11893825|FG001|Phase 2|Withdrawal by Subject|0
7542613|NCT02778867|11893826|FG002|Phase 2|Withdrawal by Subject|1
7542614|NCT02778867|11893827|FG003|Phase 2|Withdrawal by Subject|0
7542615|NCT02778867|11893824|FG000|Phase 2|Physician Decision|0
7542616|NCT02778867|11893825|FG001|Phase 2|Physician Decision|0
7542617|NCT02778867|11893826|FG002|Phase 2|Physician Decision|0
7542618|NCT02778867|11893827|FG003|Phase 2|Physician Decision|1
7542619|NCT02778867|11893824|FG000|Phase 2|Adverse Event|0
7542620|NCT02778867|11893825|FG001|Phase 2|Adverse Event|0
7542621|NCT02778867|11893826|FG002|Phase 2|Adverse Event|0
7542622|NCT02778867|11893827|FG003|Phase 2|Adverse Event|1
7542623|NCT02779075|11893857|FG000|Overall Study|Withdrawal by Subject|1
7542624|NCT02779075|11893858|FG001|Overall Study|Withdrawal by Subject|3
7542625|NCT02779075|11893857|FG000|Overall Study|IV lost during 2nd study|1
7542626|NCT02779075|11893858|FG001|Overall Study|IV lost during 2nd study|0
7542627|NCT02780115|11893905|FG000|Overall Study|Withdrawal by Subject|0
7542628|NCT02780115|11893906|FG001|Overall Study|Withdrawal by Subject|1
7542629|NCT02780115|11893907|FG002|Overall Study|Withdrawal by Subject|1
7542630|NCT02780115|11893908|FG003|Overall Study|Withdrawal by Subject|0
7542631|NCT02780115|11893909|FG004|Overall Study|Withdrawal by Subject|0
7542632|NCT02780115|11893905|FG000|Overall Study|Adverse Event|0
7542633|NCT02780115|11893906|FG001|Overall Study|Adverse Event|0
7542634|NCT02780115|11893907|FG002|Overall Study|Adverse Event|0
7542635|NCT02780115|11893908|FG003|Overall Study|Adverse Event|1
7542636|NCT02780115|11893909|FG004|Overall Study|Adverse Event|1
7542637|NCT02780167|11893926|FG000|Overall Study|Adverse Event|9
7542638|NCT02780167|11893927|FG001|Overall Study|Adverse Event|8
7542639|NCT02780167|11893928|FG002|Overall Study|Adverse Event|8
7542640|NCT02780167|11893929|FG003|Overall Study|Adverse Event|12
7542641|NCT02780167|11893930|FG004|Overall Study|Adverse Event|8
7542642|NCT02780167|11893926|FG000|Overall Study|Lack of Efficacy|6
7542643|NCT02780167|11893927|FG001|Overall Study|Lack of Efficacy|5
7542644|NCT02780167|11893928|FG002|Overall Study|Lack of Efficacy|6
7258410|NCT00340834|11470614|FG001|Core Phase of Study|Lack of Efficacy|3
7258411|NCT00340834|11470615|FG002|Core Phase of Study|Lack of Efficacy|7
7258412|NCT00340834|11470616|FG003|Core Phase of Study|Lack of Efficacy|0
7258413|NCT00340834|11470617|FG004|Core Phase of Study|Lack of Efficacy|0
7258414|NCT00340834|11470613|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
7258415|NCT00340834|11470614|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
7258416|NCT00340834|11470615|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
7258417|NCT00340834|11470616|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
7258418|NCT00340834|11470617|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
7258419|NCT00340834|11470613|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
7258420|NCT00340834|11470614|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
7258421|NCT00340834|11470615|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
7258422|NCT00340834|11470616|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
7258423|NCT00340834|11470617|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
7258424|NCT00340834|11470613|FG000|Core Phase of Study|Lost to Follow-up|1
7258425|NCT00340834|11470614|FG001|Core Phase of Study|Lost to Follow-up|1
7258426|NCT00340834|11470615|FG002|Core Phase of Study|Lost to Follow-up|4
7258427|NCT00340834|11470616|FG003|Core Phase of Study|Lost to Follow-up|0
7258428|NCT00340834|11470617|FG004|Core Phase of Study|Lost to Follow-up|0
7258429|NCT00340834|11470613|FG000|Core Phase of Study|Death|2
7258430|NCT00340834|11470614|FG001|Core Phase of Study|Death|0
7258431|NCT00340834|11470615|FG002|Core Phase of Study|Death|0
7258432|NCT00340834|11470616|FG003|Core Phase of Study|Death|0
7258433|NCT00340834|11470617|FG004|Core Phase of Study|Death|0
7258434|NCT00340834|11470613|FG000|Core Phase of Study|Protocol Violation|0
7258435|NCT00340834|11470614|FG001|Core Phase of Study|Protocol Violation|0
7258436|NCT00340834|11470615|FG002|Core Phase of Study|Protocol Violation|2
7258437|NCT00340834|11470616|FG003|Core Phase of Study|Protocol Violation|0
7542645|NCT02780167|11893929|FG003|Overall Study|Lack of Efficacy|1
7542646|NCT02780167|11893930|FG004|Overall Study|Lack of Efficacy|0
7258438|NCT00340834|11470617|FG004|Core Phase of Study|Protocol Violation|0
7258439|NCT00340834|11470613|FG000|Extension Phase of Study|Subject did not receive study drug|0
7258440|NCT00340834|11470614|FG001|Extension Phase of Study|Subject did not receive study drug|1
7258441|NCT00340834|11470615|FG002|Extension Phase of Study|Subject did not receive study drug|0
7542647|NCT02780167|11893926|FG000|Overall Study|Lost to Follow-up|2
7542648|NCT02780167|11893927|FG001|Overall Study|Lost to Follow-up|0
7542649|NCT02780167|11893928|FG002|Overall Study|Lost to Follow-up|1
7542650|NCT02780167|11893929|FG003|Overall Study|Lost to Follow-up|0
7542651|NCT02780167|11893930|FG004|Overall Study|Lost to Follow-up|0
7542652|NCT02780167|11893926|FG000|Overall Study|Does not meet entrance criteria|0
7542653|NCT02780167|11893927|FG001|Overall Study|Does not meet entrance criteria|0
7542654|NCT02780167|11893928|FG002|Overall Study|Does not meet entrance criteria|1
7542655|NCT02780167|11893929|FG003|Overall Study|Does not meet entrance criteria|0
7542656|NCT02780167|11893930|FG004|Overall Study|Does not meet entrance criteria|0
7542657|NCT02780167|11893926|FG000|Overall Study|No longer meets eligibility criteria|0
7542658|NCT02780167|11893927|FG001|Overall Study|No longer meets eligibility criteria|0
7542659|NCT02780167|11893928|FG002|Overall Study|No longer meets eligibility criteria|0
7576249|NCT04391842|11962293|FG000|Overall Study|Withdrawal by Subject|2
7576250|NCT04386902|11962306|FG000|Overall Study|Withdrawal by Subject|5
7258442|NCT00340834|11470616|FG003|Extension Phase of Study|Subject did not receive study drug|2
7258558|NCT00343291|11470697|FG001|Overall Study|Adverse Event|13
7258443|NCT00340834|11470617|FG004|Extension Phase of Study|Subject did not receive study drug|0
7258444|NCT00340834|11470613|FG000|Extension Phase of Study|Subject withdrew consent|26
7258445|NCT00340834|11470614|FG001|Extension Phase of Study|Subject withdrew consent|31
7258446|NCT00340834|11470615|FG002|Extension Phase of Study|Subject withdrew consent|0
7258447|NCT00340834|11470616|FG003|Extension Phase of Study|Subject withdrew consent|12
7542660|NCT02780167|11893929|FG003|Overall Study|No longer meets eligibility criteria|1
7542661|NCT02780167|11893930|FG004|Overall Study|No longer meets eligibility criteria|1
7542662|NCT02780167|11893926|FG000|Overall Study|Protocol Violation|5
7542663|NCT02780167|11893927|FG001|Overall Study|Protocol Violation|5
7542664|NCT02780167|11893928|FG002|Overall Study|Protocol Violation|1
7542665|NCT02780167|11893929|FG003|Overall Study|Protocol Violation|1
7542666|NCT02780167|11893930|FG004|Overall Study|Protocol Violation|2
7542667|NCT02780167|11893926|FG000|Overall Study|Withdrawal by Subject|6
7542668|NCT02780167|11893927|FG001|Overall Study|Withdrawal by Subject|4
7542669|NCT02780167|11893928|FG002|Overall Study|Withdrawal by Subject|4
7542670|NCT02780167|11893929|FG003|Overall Study|Withdrawal by Subject|3
7542671|NCT02780167|11893930|FG004|Overall Study|Withdrawal by Subject|4
7542672|NCT02780167|11893926|FG000|Overall Study|Other|0
7542673|NCT02780167|11893927|FG001|Overall Study|Other|0
7542674|NCT02780167|11893928|FG002|Overall Study|Other|3
7542675|NCT02780167|11893929|FG003|Overall Study|Other|1
7542676|NCT02780167|11893930|FG004|Overall Study|Other|2
7542677|NCT02780388|11893951|FG000|Overall Study|Lost to Follow-up|0
7542678|NCT02780388|11893952|FG001|Overall Study|Lost to Follow-up|1
7542679|NCT02780388|11893953|FG002|Overall Study|Lost to Follow-up|0
7542680|NCT02780388|11893954|FG003|Overall Study|Lost to Follow-up|0
7542681|NCT02780388|11893955|FG004|Overall Study|Lost to Follow-up|0
7542682|NCT02780388|11893951|FG000|Overall Study|Withdrawal by Subject|1
7542683|NCT02780388|11893952|FG001|Overall Study|Withdrawal by Subject|1
7542684|NCT02780388|11893953|FG002|Overall Study|Withdrawal by Subject|0
7542685|NCT02780388|11893954|FG003|Overall Study|Withdrawal by Subject|0
7542686|NCT02780388|11893955|FG004|Overall Study|Withdrawal by Subject|0
7542687|NCT02780687|11893989|FG000|Overall Study|Adverse Event|1
7542688|NCT02780687|11893990|FG001|Overall Study|Adverse Event|1
7542689|NCT02780687|11893989|FG000|Overall Study|Withdrawal by Subject|2
7542690|NCT02780687|11893990|FG001|Overall Study|Withdrawal by Subject|1
7542691|NCT02780687|11893989|FG000|Overall Study|Switched to commercial program (in CTP)|2
7542692|NCT02780687|11893990|FG001|Overall Study|Switched to commercial program (in CTP)|0
7542693|NCT02780687|11893989|FG000|Overall Study|progressive disease|29
7542694|NCT02780687|11893990|FG001|Overall Study|progressive disease|6
7542695|NCT02780700|11893995|FG000|Overall Study|Progressive disease|1
7542696|NCT02780713|11893999|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7542697|NCT02780713|11894000|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7542698|NCT02780713|11894001|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2
7542699|NCT02780713|11894002|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7542700|NCT02780713|11894003|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0
7542701|NCT02780856|11894031|FG000|Overall Study|Lost to Follow-up|1
7542702|NCT02781311|11894055|FG000|Overall Study|Adverse Event|2
7542703|NCT02781311|11894056|FG001|Overall Study|Adverse Event|6
7542704|NCT02781311|11894057|FG002|Overall Study|Adverse Event|1
7542705|NCT02781311|11894055|FG000|Overall Study|Withdrawal of Consent|11
7542706|NCT02781311|11894056|FG001|Overall Study|Withdrawal of Consent|12
7542707|NCT02781311|11894057|FG002|Overall Study|Withdrawal of Consent|2
7542708|NCT02781311|11894055|FG000|Overall Study|Lost to Follow-up|11
7542709|NCT02781311|11894056|FG001|Overall Study|Lost to Follow-up|8
7576251|NCT04386902|11962306|FG000|Overall Study|Technical problems in the recording|5
7576252|NCT04384523|11962325|FG000|Overall Study|Lost to Follow-up|0
7542710|NCT02781311|11894057|FG002|Overall Study|Lost to Follow-up|1
7542711|NCT02781311|11894055|FG000|Overall Study|Non-Compliance with Study Drug|2
7542712|NCT02781311|11894056|FG001|Overall Study|Non-Compliance with Study Drug|0
7542713|NCT02781311|11894057|FG002|Overall Study|Non-Compliance with Study Drug|0
7542714|NCT02781324|11894066|FG000|Overall Study|Withdrawal by Subject|1
7542715|NCT02781324|11894067|FG001|Overall Study|Withdrawal by Subject|0
7542716|NCT02781324|11894066|FG000|Overall Study|Physician Decision|1
7542717|NCT02781324|11894067|FG001|Overall Study|Physician Decision|2
7576253|NCT04384523|11962326|FG001|Overall Study|Lost to Follow-up|0
7542718|NCT02781558|11894103|FG000|Overall Study|Lost to Follow-up|2
7542719|NCT02781558|11894104|FG001|Overall Study|Lost to Follow-up|2
7542720|NCT02781558|11894103|FG000|Overall Study|Adverse Event|1
7542721|NCT02781558|11894104|FG001|Overall Study|Adverse Event|0
7542722|NCT02781818|11894148|FG000|Overall Study|Lost to Follow-up|4
7258448|NCT00340834|11470617|FG004|Extension Phase of Study|Subject withdrew consent|15
7258449|NCT00340834|11470613|FG000|Extension Phase of Study|Adverse Event|21
7258450|NCT00340834|11470614|FG001|Extension Phase of Study|Adverse Event|22
7258451|NCT00340834|11470615|FG002|Extension Phase of Study|Adverse Event|0
7258452|NCT00340834|11470616|FG003|Extension Phase of Study|Adverse Event|19
7258453|NCT00340834|11470617|FG004|Extension Phase of Study|Adverse Event|7
7258454|NCT00340834|11470613|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
7258455|NCT00340834|11470614|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
7258456|NCT00340834|11470615|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
7258457|NCT00340834|11470616|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
7258458|NCT00340834|11470617|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
7258459|NCT00340834|11470613|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
7258460|NCT00340834|11470614|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
7258461|NCT00340834|11470615|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
7258462|NCT00340834|11470616|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
7258463|NCT00340834|11470617|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
7258464|NCT00340834|11470613|FG000|Extension Phase of Study|Lost to Follow-up|1
7258465|NCT00340834|11470614|FG001|Extension Phase of Study|Lost to Follow-up|1
7258466|NCT00340834|11470615|FG002|Extension Phase of Study|Lost to Follow-up|0
7258467|NCT00340834|11470616|FG003|Extension Phase of Study|Lost to Follow-up|2
7258468|NCT00340834|11470617|FG004|Extension Phase of Study|Lost to Follow-up|3
7258469|NCT00340834|11470613|FG000|Extension Phase of Study|Subject no longer requires study drug|4
7258470|NCT00340834|11470614|FG001|Extension Phase of Study|Subject no longer requires study drug|0
7258471|NCT00340834|11470615|FG002|Extension Phase of Study|Subject no longer requires study drug|0
7258472|NCT00340834|11470616|FG003|Extension Phase of Study|Subject no longer requires study drug|0
7258473|NCT00340834|11470617|FG004|Extension Phase of Study|Subject no longer requires study drug|2
7258474|NCT00340834|11470613|FG000|Extension Phase of Study|Administrative problems|3
7258475|NCT00340834|11470614|FG001|Extension Phase of Study|Administrative problems|0
7258476|NCT00340834|11470615|FG002|Extension Phase of Study|Administrative problems|0
7542723|NCT02781818|11894149|FG001|Overall Study|Lost to Follow-up|2
7542724|NCT02781818|11894150|FG002|Overall Study|Lost to Follow-up|1
7542725|NCT02781844|11894162|FG000|Treatment Period 1|Adverse Event|0
7542726|NCT02781844|11894163|FG001|Treatment Period 1|Adverse Event|0
7542727|NCT02781844|11894164|FG002|Treatment Period 1|Adverse Event|0
7542728|NCT02781844|11894165|FG003|Treatment Period 1|Adverse Event|0
7542729|NCT02781844|11894166|FG004|Treatment Period 1|Adverse Event|0
7542730|NCT02781844|11894167|FG005|Treatment Period 1|Adverse Event|1
7542731|NCT02781844|11894168|FG006|Treatment Period 1|Adverse Event|0
7542732|NCT02781844|11894169|FG007|Treatment Period 1|Adverse Event|0
7258477|NCT00340834|11470616|FG003|Extension Phase of Study|Administrative problems|1
7258478|NCT00340834|11470617|FG004|Extension Phase of Study|Administrative problems|1
7258479|NCT00340834|11470613|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
7258480|NCT00340834|11470614|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
7258481|NCT00340834|11470615|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
7258482|NCT00340834|11470616|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
7258483|NCT00340834|11470617|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
7258484|NCT00340834|11470613|FG000|Extension Phase of Study|Protocol Violation|3
7258485|NCT00340834|11470614|FG001|Extension Phase of Study|Protocol Violation|0
7258486|NCT00340834|11470615|FG002|Extension Phase of Study|Protocol Violation|0
7258487|NCT00340834|11470616|FG003|Extension Phase of Study|Protocol Violation|0
7258488|NCT00340834|11470617|FG004|Extension Phase of Study|Protocol Violation|0
7258489|NCT00340834|11470613|FG000|Extension Phase of Study|Death|0
7258490|NCT00340834|11470614|FG001|Extension Phase of Study|Death|0
7258491|NCT00340834|11470615|FG002|Extension Phase of Study|Death|0
7258492|NCT00340834|11470616|FG003|Extension Phase of Study|Death|0
7258493|NCT00340834|11470617|FG004|Extension Phase of Study|Death|1
7258494|NCT00342628|11470666|FG000|Overall Study|Withdrawal by Subject|19
7258495|NCT00342628|11470667|FG001|Overall Study|Withdrawal by Subject|19
7258496|NCT00342628|11470668|FG002|Overall Study|Withdrawal by Subject|18
7258497|NCT00342628|11470666|FG000|Overall Study|Death|1
7258498|NCT00342628|11470667|FG001|Overall Study|Death|1
7258499|NCT00342628|11470668|FG002|Overall Study|Death|0
7258500|NCT00342628|11470666|FG000|Overall Study|moved residence|0
7258501|NCT00342628|11470667|FG001|Overall Study|moved residence|1
7258502|NCT00342628|11470668|FG002|Overall Study|moved residence|1
7258503|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Adverse Event|17
7258504|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Adverse Event|11
7258505|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Death|0
7258506|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Death|2
7258507|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
7258508|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
7258509|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
7258510|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
7258511|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
7258512|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
7258513|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Physician Decision|1
7258514|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Physician Decision|3
7258515|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Protocol Violation|2
7258516|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Protocol Violation|2
7258517|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
7258518|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
7258519|NCT00343252|11470687|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
7542733|NCT02782169|11894192|FG000|Overall Study|Lost to Follow-up|1
7542734|NCT02782169|11894193|FG001|Overall Study|Lost to Follow-up|2
7258520|NCT00343252|11470688|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
7542735|NCT02782325|11894201|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
7542736|NCT02782325|11894202|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
7542737|NCT02782325|11894203|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
7258521|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Adverse Event|22
7258522|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Adverse Event|20
7258523|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Death|3
7258524|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Death|3
7258525|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7258526|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
7258527|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
7258528|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
7258529|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
7258530|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
7258531|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Physician Decision|4
7258532|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Physician Decision|5
7258533|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Protocol Violation|3
7258534|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Protocol Violation|2
7258535|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
7258536|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
7258537|NCT00343252|11470687|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
7258538|NCT00343252|11470688|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
7258539|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Adverse Event|31
7258540|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Adverse Event|23
7258541|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Death|4
7258542|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Death|5
7258543|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
7258544|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
7258545|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
7258546|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
7258547|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
7258548|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
7258549|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Physician Decision|4
7258550|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Physician Decision|7
7258551|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Protocol Violation|3
7542738|NCT02782325|11894201|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7542739|NCT02782325|11894202|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
7542740|NCT02782325|11894203|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
7542741|NCT02782377|11894219|FG000|Overall Study|Physician Decision|5
7542742|NCT02782676|11894224|FG000|Overall Study|Lost to Follow-up|0
7542743|NCT02782676|11894225|FG001|Overall Study|Lost to Follow-up|1
7542744|NCT02782780|11894233|FG000|Overall Study|dropped out after randomization.|7
7542745|NCT02782780|11894234|FG001|Overall Study|dropped out after randomization.|5
7542746|NCT02782780|11894233|FG000|Overall Study|Protocol Violation|0
7542747|NCT02782780|11894234|FG001|Overall Study|Protocol Violation|2
7542748|NCT02782923|11894240|FG000|Overall Study|Lost to Follow-up|15
7542749|NCT02783066|11894253|FG000|Overall Study|Withdrawal by Subject|13
7542750|NCT02783170|11894260|FG000|Overall Study|Randomized but not Vaccinated|1
7542751|NCT02783170|11894261|FG001|Overall Study|Randomized but not Vaccinated|0
7542752|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
7542753|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
7542754|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
7542755|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Death|4
7542756|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Death|2
7542757|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Death|3
7542758|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7542759|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
7542760|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
7542761|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7542762|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
7542763|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
7258552|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Protocol Violation|3
7542764|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
7542765|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
7542766|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
7542767|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
7542768|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
7542769|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
7542770|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
7542771|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
7258553|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
7258554|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
7258555|NCT00343252|11470687|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
7258556|NCT00343252|11470688|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
7258557|NCT00343291|11470696|FG000|Overall Study|Adverse Event|13
7258559|NCT00343291|11470696|FG000|Overall Study|Death|3
7258560|NCT00343291|11470697|FG001|Overall Study|Death|2
7258561|NCT00343291|11470696|FG000|Overall Study|Progressive disease|33
7258562|NCT00343291|11470697|FG001|Overall Study|Progressive disease|34
7258563|NCT00343291|11470696|FG000|Overall Study|Withdrawal by Subject|0
7258564|NCT00343291|11470697|FG001|Overall Study|Withdrawal by Subject|2
7258565|NCT00343291|11470696|FG000|Overall Study|Other|8
7258566|NCT00343291|11470697|FG001|Overall Study|Other|5
7258567|NCT00343382|11470706|FG000|Overall Study|Adverse Event|2
7258568|NCT00343382|11470707|FG001|Overall Study|Adverse Event|10
7258569|NCT00343382|11470708|FG002|Overall Study|Adverse Event|7
7258570|NCT00343382|11470706|FG000|Overall Study|Withdrawal by Subject|1
7258571|NCT00343382|11470707|FG001|Overall Study|Withdrawal by Subject|2
7258572|NCT00343382|11470708|FG002|Overall Study|Withdrawal by Subject|6
7258573|NCT00343382|11470706|FG000|Overall Study|Other Reason Not Specified|1
7258574|NCT00343382|11470707|FG001|Overall Study|Other Reason Not Specified|2
7258575|NCT00343382|11470708|FG002|Overall Study|Other Reason Not Specified|4
7258576|NCT00343512|11470742|FG000|Overall Study|Withdrawal by Subject|2
7258577|NCT00343642|11470866|FG000|Overall Study|Lost to Follow-up|0
7258578|NCT00343642|11470867|FG001|Overall Study|Lost to Follow-up|1
7258579|NCT00343642|11470868|FG002|Overall Study|Lost to Follow-up|0
7258580|NCT00343642|11470866|FG000|Overall Study|Pregnancy|1
7258581|NCT00343642|11470867|FG001|Overall Study|Pregnancy|0
7258582|NCT00343642|11470868|FG002|Overall Study|Pregnancy|2
7258583|NCT00343642|11470866|FG000|Overall Study|Withdrawal by Subject|2
7258584|NCT00343642|11470867|FG001|Overall Study|Withdrawal by Subject|3
7258585|NCT00343642|11470868|FG002|Overall Study|Withdrawal by Subject|4
7258586|NCT00343642|11470866|FG000|Overall Study|Adverse Event|0
7258587|NCT00343642|11470867|FG001|Overall Study|Adverse Event|0
7258588|NCT00343642|11470868|FG002|Overall Study|Adverse Event|1
7258589|NCT00343642|11470866|FG000|Overall Study|Flare up|6
7258590|NCT00343642|11470867|FG001|Overall Study|Flare up|4
7258591|NCT00343642|11470868|FG002|Overall Study|Flare up|0
7258592|NCT00343889|11470897|FG000|Overall Study|Lost to Follow-up|2
7258593|NCT00343889|11470898|FG001|Overall Study|Lost to Follow-up|0
7258594|NCT00343889|11470897|FG000|Overall Study|Withdrawal by Subject|0
7258595|NCT00343889|11470898|FG001|Overall Study|Withdrawal by Subject|1
7258596|NCT00343889|11470897|FG000|Overall Study|Protocol Violation|1
7258597|NCT00343889|11470898|FG001|Overall Study|Protocol Violation|0
7258598|NCT00343915|11470906|FG000|Primary Study|Withdrawal by Subject|1
7258599|NCT00343915|11470907|FG001|Primary Study|Withdrawal by Subject|0
7258600|NCT00343915|11470906|FG000|Primary Study|Lost to Follow-up|2
7258601|NCT00343915|11470907|FG001|Primary Study|Lost to Follow-up|3
7258602|NCT00343915|11470906|FG000|Primary Study|Other|1
7258603|NCT00343915|11470907|FG001|Primary Study|Other|0
7258604|NCT00344032|11470918|FG000|Overall Study|Adverse Event|0
7258605|NCT00344032|11470919|FG001|Overall Study|Adverse Event|1
7258606|NCT00344032|11470918|FG000|Overall Study|Withdrawal by Subject|6
7542772|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
7542773|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
7258607|NCT00344032|11470919|FG001|Overall Study|Withdrawal by Subject|2
7258608|NCT00344032|11470918|FG000|Overall Study|Lost to Follow-up|4
7258609|NCT00344032|11470919|FG001|Overall Study|Lost to Follow-up|6
7258610|NCT00344032|11470918|FG000|Overall Study|Physician Decision|4
7258611|NCT00344032|11470919|FG001|Overall Study|Physician Decision|1
7258612|NCT00344305|11470936|FG000|Overall Study|Lost to Follow-up|2
7258613|NCT00344305|11470937|FG001|Overall Study|Lost to Follow-up|0
7258614|NCT00344305|11470936|FG000|Overall Study|Participant was not contacted in window|0
7258615|NCT00344305|11470937|FG001|Overall Study|Participant was not contacted in window|1
7258616|NCT00344318|11470948|FG000|Overall Study|Adverse Event|0
7258617|NCT00344318|11470949|FG001|Overall Study|Adverse Event|3
7258618|NCT00344318|11470950|FG002|Overall Study|Adverse Event|0
7258619|NCT00344318|11470951|FG003|Overall Study|Adverse Event|1
7258620|NCT00344318|11470948|FG000|Overall Study|Withdrawal by Subject|2
7258621|NCT00344318|11470949|FG001|Overall Study|Withdrawal by Subject|2
7258622|NCT00344318|11470950|FG002|Overall Study|Withdrawal by Subject|0
7258623|NCT00344318|11470951|FG003|Overall Study|Withdrawal by Subject|2
7258624|NCT00344318|11470948|FG000|Overall Study|Lost to Follow-up|2
7258625|NCT00344318|11470949|FG001|Overall Study|Lost to Follow-up|0
7258626|NCT00344318|11470950|FG002|Overall Study|Lost to Follow-up|1
7258627|NCT00344318|11470951|FG003|Overall Study|Lost to Follow-up|0
7387850|NCT01216176|11646569|FG001|Overall Study|Physician Decision|0
7387851|NCT01216176|11646570|FG002|Overall Study|Physician Decision|1
7387852|NCT01216189|11646581|FG000|Overall Study|Lost to Follow-up|21
7387853|NCT01216189|11646582|FG001|Overall Study|Lost to Follow-up|3
7387854|NCT01216189|11646581|FG000|Overall Study|Death|4
7387855|NCT01216189|11646582|FG001|Overall Study|Death|2
7387856|NCT01216202|11646590|FG000|Overall Study|Withdrawal by Subject|8
7387857|NCT01216202|11646591|FG001|Overall Study|Withdrawal by Subject|0
7387858|NCT01216202|11646590|FG000|Overall Study|Death|0
7387859|NCT01216202|11646591|FG001|Overall Study|Death|2
7387860|NCT01216202|11646590|FG000|Overall Study|Lost to Follow-up|14
7387861|NCT01216202|11646591|FG001|Overall Study|Lost to Follow-up|0
7387862|NCT01216319|11646608|FG000|Overall Study|Lost to Follow-up|2
7387863|NCT01216319|11646608|FG000|Overall Study|Unanticipated chemo for breast cancer|2
7387864|NCT01216332|11646614|FG000|Overall Study|Withdrawal by Subject|4
7387865|NCT01216332|11646615|FG001|Overall Study|Withdrawal by Subject|0
7387866|NCT01217073|11646674|FG000|Base Period|Adverse Event|1
7387867|NCT01217073|11646675|FG001|Base Period|Adverse Event|0
7387868|NCT01217073|11646676|FG002|Base Period|Adverse Event|1
7387869|NCT01217073|11646677|FG003|Base Period|Adverse Event|0
7387870|NCT01217073|11646678|FG004|Base Period|Adverse Event|4
7387871|NCT01217073|11646679|FG005|Base Period|Adverse Event|1
7387872|NCT01217073|11646680|FG006|Base Period|Adverse Event|0
7387873|NCT01217073|11646681|FG007|Base Period|Adverse Event|0
7387874|NCT01217073|11646674|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
7387875|NCT01217073|11646675|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
7387876|NCT01217073|11646676|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
7387877|NCT01217073|11646677|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
7387878|NCT01217073|11646678|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
7387879|NCT01217073|11646679|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
7387880|NCT01217073|11646680|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
7387881|NCT01217073|11646681|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
7258628|NCT00344448|11470974|FG000|Screening|Withdrawal by Subject|0
7258629|NCT00344448|11470975|FG001|Screening|Withdrawal by Subject|1
7258630|NCT00344448|11470974|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
7258631|NCT00344448|11470975|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
7258632|NCT00344448|11470974|FG000|Double Blind, Placebo Controlled|Study terminated|1
7258633|NCT00344448|11470975|FG001|Double Blind, Placebo Controlled|Study terminated|0
7258634|NCT00344448|11470974|FG000|Open Label|Withdrawal by Subject|1
7258635|NCT00344448|11470975|FG001|Open Label|Withdrawal by Subject|1
7258636|NCT00344448|11470974|FG000|Open Label|Study terminated|1
7258637|NCT00344448|11470975|FG001|Open Label|Study terminated|0
7258638|NCT00344461|11470981|FG000|Overall Study|Adverse Event|6
7258639|NCT00344461|11470981|FG000|Overall Study|Death|1
7258640|NCT00344461|11470981|FG000|Overall Study|Lack of Efficacy|2
7542774|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
7542775|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
7542776|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
7542777|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
7542778|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
7542779|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7542780|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
7542781|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
7542782|NCT02783573|11894284|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
7542783|NCT02783573|11894285|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
7542784|NCT02783573|11894286|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
7542785|NCT02783573|11894284|FG000|Delayed-Start Period|Sponsor Decision|0
7542786|NCT02783573|11894285|FG001|Delayed-Start Period|Sponsor Decision|17
7542787|NCT02783573|11894286|FG002|Delayed-Start Period|Sponsor Decision|12
7542788|NCT02783599|11894297|FG000|Overall Study|Progressive disease|23
7542789|NCT02783599|11894297|FG000|Overall Study|Surgical Resection|10
7542790|NCT02783599|11894297|FG000|Overall Study|Adverse Event|4
7542791|NCT02783599|11894297|FG000|Overall Study|Physician Decision|2
7542792|NCT02783599|11894297|FG000|Overall Study|Death|1
7542793|NCT02783729|11894312|FG000|Overall Study|Lack of Efficacy|1
7258641|NCT00344461|11470981|FG000|Overall Study|Lost to Follow-up|2
7258642|NCT00344461|11470981|FG000|Overall Study|Physician Decision|2
7258643|NCT00344461|11470981|FG000|Overall Study|Protocol Violation|6
7258644|NCT00344461|11470981|FG000|Overall Study|Withdrawal by Subject|2
7258645|NCT00344500|11470988|FG000|Overall Study|Adverse Event|6
7258646|NCT00344500|11470989|FG001|Overall Study|Adverse Event|2
7258647|NCT00344500|11470990|FG002|Overall Study|Adverse Event|0
7258648|NCT00344500|11470988|FG000|Overall Study|Lost to Follow-up|5
7258649|NCT00344500|11470989|FG001|Overall Study|Lost to Follow-up|13
7258650|NCT00344500|11470990|FG002|Overall Study|Lost to Follow-up|1
7258651|NCT00344500|11470988|FG000|Overall Study|Withdrawal by Subject|7
7258652|NCT00344500|11470989|FG001|Overall Study|Withdrawal by Subject|10
7258653|NCT00344500|11470990|FG002|Overall Study|Withdrawal by Subject|0
7258654|NCT00344500|11470988|FG000|Overall Study|Protocol Violation|4
7258655|NCT00344500|11470989|FG001|Overall Study|Protocol Violation|7
7258656|NCT00344500|11470990|FG002|Overall Study|Protocol Violation|1
7258657|NCT00344500|11470988|FG000|Overall Study|Not Noted|1
7258658|NCT00344500|11470989|FG001|Overall Study|Not Noted|3
7258659|NCT00344500|11470990|FG002|Overall Study|Not Noted|0
7258660|NCT00344773|11471006|FG000|Overall Study|Adverse Event|2
7258661|NCT00344773|11471006|FG000|Overall Study|Objective Disease Progression|16
7258662|NCT00344773|11471006|FG000|Overall Study|Withdrawal by Subject|1
7258663|NCT00344773|11471006|FG000|Overall Study|Not Eligible for the study|2
7258664|NCT00344968|11471013|FG000|Overall Study|Adverse Event|5
7258665|NCT00344968|11471014|FG001|Overall Study|Adverse Event|4
7258666|NCT00344968|11471015|FG002|Overall Study|Adverse Event|15
7258667|NCT00344968|11471013|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
7258668|NCT00344968|11471014|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
7258669|NCT00344968|11471015|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
7258670|NCT00344968|11471013|FG000|Overall Study|Protocol Violation|2
7258671|NCT00344968|11471014|FG001|Overall Study|Protocol Violation|2
7258672|NCT00344968|11471015|FG002|Overall Study|Protocol Violation|5
7258673|NCT00344968|11471013|FG000|Overall Study|Withdrawal by Subject|14
7258674|NCT00344968|11471014|FG001|Overall Study|Withdrawal by Subject|31
7258675|NCT00344968|11471015|FG002|Overall Study|Withdrawal by Subject|27
7258676|NCT00344968|11471013|FG000|Overall Study|Lost to Follow-up|24
7258677|NCT00344968|11471014|FG001|Overall Study|Lost to Follow-up|37
7258678|NCT00344968|11471015|FG002|Overall Study|Lost to Follow-up|37
7258679|NCT00344968|11471013|FG000|Overall Study|Death|11
7258680|NCT00344968|11471014|FG001|Overall Study|Death|27
7258681|NCT00344968|11471015|FG002|Overall Study|Death|31
7258682|NCT00344968|11471013|FG000|Overall Study|Other|0
7258683|NCT00344968|11471014|FG001|Overall Study|Other|1
7258684|NCT00344968|11471015|FG002|Overall Study|Other|0
7258685|NCT00345046|11471036|FG000|Overall Study|Protocol Violation|1
7258686|NCT00345046|11471037|FG001|Overall Study|Protocol Violation|1
7258687|NCT00345046|11471038|FG002|Overall Study|Protocol Violation|2
7542794|NCT02783729|11894313|FG001|Overall Study|Lack of Efficacy|0
7542795|NCT02783729|11894314|FG002|Overall Study|Lack of Efficacy|0
7542796|NCT02783729|11894315|FG003|Overall Study|Lack of Efficacy|0
7542797|NCT02783729|11894312|FG000|Overall Study|Adverse Event|2
7542798|NCT02783729|11894313|FG001|Overall Study|Adverse Event|6
7542799|NCT02783729|11894314|FG002|Overall Study|Adverse Event|2
7258688|NCT00345293|11471074|FG000|Overall Study|Unable to access line for sample|1
7258689|NCT00345293|11471075|FG001|Overall Study|Unable to access line for sample|0
7258690|NCT00345293|11471074|FG000|Overall Study|Withdrawal by Subject|1
7258691|NCT00345293|11471075|FG001|Overall Study|Withdrawal by Subject|0
7258692|NCT00345397|11471110|FG000|Overall Study|Death|1
7258693|NCT00345540|11471115|FG000|Overall Study|Withdrawal by Subject|1
7258694|NCT00345579|11471121|FG000|Overall Study|Adverse Event|9
7258695|NCT00345579|11471122|FG001|Overall Study|Adverse Event|6
7258696|NCT00345579|11471121|FG000|Overall Study|Protocol Violation|14
7258697|NCT00345579|11471122|FG001|Overall Study|Protocol Violation|5
7258698|NCT00345579|11471121|FG000|Overall Study|Withdrawal by Subject|50
7258699|NCT00345579|11471122|FG001|Overall Study|Withdrawal by Subject|17
7258700|NCT00345579|11471121|FG000|Overall Study|Lost to Follow-up|82
7258701|NCT00345579|11471122|FG001|Overall Study|Lost to Follow-up|36
7258702|NCT00345579|11471121|FG000|Overall Study|Other|9
7258703|NCT00345579|11471122|FG001|Overall Study|Other|1
7258704|NCT00345592|11471131|FG000|Overall Study|Death|14
7258705|NCT00345592|11471132|FG001|Overall Study|Death|16
7258706|NCT00345592|11471131|FG000|Overall Study|Withdrawal by Subject|11
7258707|NCT00345592|11471132|FG001|Overall Study|Withdrawal by Subject|8
7258708|NCT00345605|11471138|FG000|Arm 1|Adverse Event|0
7258709|NCT00345605|11471139|FG001|Arm 1|Adverse Event|1
7258710|NCT00345605|11471138|FG000|Arm 2, Opposite Treatment|Adverse Event|1
7258711|NCT00345605|11471139|FG001|Arm 2, Opposite Treatment|Adverse Event|0
7258712|NCT00345631|11471150|FG000|Overall Study|Withdrawal by Subject|1
7258713|NCT00345631|11471151|FG001|Overall Study|Withdrawal by Subject|0
7258714|NCT00345631|11471152|FG002|Overall Study|Withdrawal by Subject|1
7258715|NCT00345631|11471150|FG000|Overall Study|Adverse Event|0
7258716|NCT00345631|11471151|FG001|Overall Study|Adverse Event|1
7258717|NCT00345631|11471152|FG002|Overall Study|Adverse Event|0
7258718|NCT00345631|11471150|FG000|Overall Study|Lost to Follow-up|3
7258719|NCT00345631|11471151|FG001|Overall Study|Lost to Follow-up|7
7258720|NCT00345631|11471152|FG002|Overall Study|Lost to Follow-up|4
7258721|NCT00345631|11471150|FG000|Overall Study|Other reasons|0
7258722|NCT00345631|11471151|FG001|Overall Study|Other reasons|0
7258723|NCT00345631|11471152|FG002|Overall Study|Other reasons|1
7258724|NCT00345683|11471164|FG000|Overall Study|Lost to Follow-up|19
7258725|NCT00345683|11471165|FG001|Overall Study|Lost to Follow-up|7
7258726|NCT00345683|11471164|FG000|Overall Study|Other|6
7258727|NCT00345683|11471165|FG001|Overall Study|Other|2
7258732|NCT00345878|11471203|FG000|Overall Study|Adverse Event|1
7258733|NCT00345878|11471204|FG001|Overall Study|Adverse Event|0
7258734|NCT00345878|11471203|FG000|Overall Study|Lost to Follow-up|2
7258735|NCT00345878|11471204|FG001|Overall Study|Lost to Follow-up|1
7258736|NCT00345878|11471203|FG000|Overall Study|Other|1
7258737|NCT00345878|11471204|FG001|Overall Study|Other|0
7258738|NCT00346034|11471219|FG000|Overall Study|Adverse Event|34
7258739|NCT00346034|11471219|FG000|Overall Study|Lack of Efficacy|8
7258740|NCT00346034|11471219|FG000|Overall Study|Withdrawal by Subject|13
7258741|NCT00346034|11471219|FG000|Overall Study|Patient Stopped Taking Study Drug|1
7258742|NCT00346034|11471219|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
7258743|NCT00346073|11471225|FG000|Overall Study|Serious Adverse Event|2
7258744|NCT00346073|11471226|FG001|Overall Study|Serious Adverse Event|0
7258745|NCT00346073|11471225|FG000|Overall Study|Lost to Follow-up|39
7258746|NCT00346073|11471226|FG001|Overall Study|Lost to Follow-up|24
7258747|NCT00346151|11471232|FG000|Overall Study|Withdrawal by Subject|3
7258748|NCT00346216|11471239|FG000|Overall Study|Other|181
7258749|NCT00346216|11471240|FG001|Overall Study|Other|231
7258750|NCT00346216|11471241|FG002|Overall Study|Other|205
7542800|NCT02783729|11894315|FG003|Overall Study|Adverse Event|3
7542801|NCT02783729|11894312|FG000|Overall Study|Other|1
7542802|NCT02783729|11894313|FG001|Overall Study|Other|6
7542803|NCT02783729|11894314|FG002|Overall Study|Other|2
7258751|NCT00346216|11471239|FG000|Overall Study|No longer willing to participate|600
7258752|NCT00346216|11471240|FG001|Overall Study|No longer willing to participate|606
7258753|NCT00346216|11471241|FG002|Overall Study|No longer willing to participate|585
7258754|NCT00346216|11471239|FG000|Overall Study|Withdrawal by Subject|661
7258755|NCT00346216|11471240|FG001|Overall Study|Withdrawal by Subject|692
7258756|NCT00346216|11471241|FG002|Overall Study|Withdrawal by Subject|651
7542804|NCT02783729|11894315|FG003|Overall Study|Other|3
7542805|NCT02783729|11894312|FG000|Overall Study|Withdrawal by Subject|2
7542806|NCT02783729|11894313|FG001|Overall Study|Withdrawal by Subject|3
7542807|NCT02783729|11894314|FG002|Overall Study|Withdrawal by Subject|1
7542808|NCT02783729|11894315|FG003|Overall Study|Withdrawal by Subject|2
7542809|NCT02783729|11894312|FG000|Overall Study|Participant's choice|2
7542810|NCT02783729|11894313|FG001|Overall Study|Participant's choice|1
7258757|NCT00346216|11471239|FG000|Overall Study|Lost to Follow-up|611
7258758|NCT00346216|11471240|FG001|Overall Study|Lost to Follow-up|588
7542811|NCT02783729|11894314|FG002|Overall Study|Participant's choice|2
7542812|NCT02783729|11894315|FG003|Overall Study|Participant's choice|1
7542813|NCT02783729|11894312|FG000|Overall Study|Lost to Follow-up|2
7542814|NCT02783729|11894313|FG001|Overall Study|Lost to Follow-up|1
7542815|NCT02783729|11894314|FG002|Overall Study|Lost to Follow-up|1
7258759|NCT00346216|11471241|FG002|Overall Study|Lost to Follow-up|542
7258760|NCT00346216|11471239|FG000|Overall Study|Physician Decision|80
7258761|NCT00346216|11471240|FG001|Overall Study|Physician Decision|76
7258762|NCT00346216|11471241|FG002|Overall Study|Physician Decision|59
7258763|NCT00346216|11471239|FG000|Overall Study|Does not meet entrance criteria|13
7258764|NCT00346216|11471240|FG001|Overall Study|Does not meet entrance criteria|10
7258765|NCT00346216|11471241|FG002|Overall Study|Does not meet entrance criteria|8
7258766|NCT00346216|11471239|FG000|Overall Study|Death|189
7258767|NCT00346216|11471240|FG001|Overall Study|Death|192
7258768|NCT00346216|11471241|FG002|Overall Study|Death|228
7258769|NCT00346216|11471239|FG000|Overall Study|Study terminated by sponsor|11
7258770|NCT00346216|11471240|FG001|Overall Study|Study terminated by sponsor|4
7258771|NCT00346216|11471241|FG002|Overall Study|Study terminated by sponsor|8
7258772|NCT00346216|11471239|FG000|Overall Study|Missing Subject Summary Status|62
7258773|NCT00346216|11471240|FG001|Overall Study|Missing Subject Summary Status|61
7258774|NCT00346216|11471241|FG002|Overall Study|Missing Subject Summary Status|62
7258775|NCT00346268|11471251|FG000|Overall Study|Adverse Event|1
7258776|NCT00346268|11471252|FG001|Overall Study|Adverse Event|0
7258777|NCT00346268|11471251|FG000|Overall Study|Protocol Violation|1
7258778|NCT00346268|11471252|FG001|Overall Study|Protocol Violation|0
7258779|NCT00346268|11471251|FG000|Overall Study|Participant refused|0
7258780|NCT00346268|11471252|FG001|Overall Study|Participant refused|3
7258781|NCT00346333|11471260|FG000|Overall Study|Death|1
7258782|NCT00346333|11471261|FG001|Overall Study|Death|0
7542816|NCT02783729|11894315|FG003|Overall Study|Lost to Follow-up|0
7542817|NCT02783768|11894330|FG000|Overall Study|Lost to Follow-up|1
7542818|NCT02783768|11894331|FG001|Overall Study|Lost to Follow-up|0
7542819|NCT02783911|11894367|FG000|Overall Study|Lost to Follow-up|3
7542820|NCT02783911|11894368|FG001|Overall Study|Lost to Follow-up|32
7542821|NCT02784106|11894385|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
7542822|NCT02784106|11894386|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
7258783|NCT00346333|11471260|FG000|Overall Study|unwilling or unable to continue|4
7258784|NCT00346333|11471261|FG001|Overall Study|unwilling or unable to continue|8
7258785|NCT00346398|11471271|FG000|Overall Study|Lost to Follow-up|3
7258786|NCT00346398|11471272|FG001|Overall Study|Lost to Follow-up|0
7258787|NCT00346398|11471271|FG000|Overall Study|Withdrawal by Subject|0
7258788|NCT00346398|11471272|FG001|Overall Study|Withdrawal by Subject|2
7258789|NCT00346632|11471284|FG000|Overall Study|Progressive Disease|2
7258790|NCT00346632|11471285|FG001|Overall Study|Progressive Disease|2
7258791|NCT00346632|11471286|FG002|Overall Study|Progressive Disease|4
7258792|NCT00346632|11471287|FG003|Overall Study|Progressive Disease|3
7258793|NCT00346632|11471288|FG004|Overall Study|Progressive Disease|3
7542823|NCT02784106|11894387|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7258794|NCT00346632|11471289|FG005|Overall Study|Progressive Disease|1
7258795|NCT00346632|11471290|FG006|Overall Study|Progressive Disease|2
7258796|NCT00346632|11471291|FG007|Overall Study|Progressive Disease|2
7258797|NCT00346632|11471292|FG008|Overall Study|Progressive Disease|2
7258798|NCT00346632|11471293|FG009|Overall Study|Progressive Disease|2
7258799|NCT00346632|11471284|FG000|Overall Study|Adverse Event|0
7258800|NCT00346632|11471285|FG001|Overall Study|Adverse Event|0
7258801|NCT00346632|11471286|FG002|Overall Study|Adverse Event|0
7258802|NCT00346632|11471287|FG003|Overall Study|Adverse Event|0
7258803|NCT00346632|11471288|FG004|Overall Study|Adverse Event|1
7258804|NCT00346632|11471289|FG005|Overall Study|Adverse Event|1
7258805|NCT00346632|11471290|FG006|Overall Study|Adverse Event|1
7258806|NCT00346632|11471291|FG007|Overall Study|Adverse Event|0
7258807|NCT00346632|11471292|FG008|Overall Study|Adverse Event|0
7258808|NCT00346632|11471293|FG009|Overall Study|Adverse Event|0
7258809|NCT00346632|11471284|FG000|Overall Study|Death|0
7258810|NCT00346632|11471285|FG001|Overall Study|Death|0
7258811|NCT00346632|11471286|FG002|Overall Study|Death|1
7258812|NCT00346632|11471287|FG003|Overall Study|Death|0
7258813|NCT00346632|11471288|FG004|Overall Study|Death|0
7258814|NCT00346632|11471289|FG005|Overall Study|Death|0
7258815|NCT00346632|11471290|FG006|Overall Study|Death|0
7258816|NCT00346632|11471291|FG007|Overall Study|Death|0
7258817|NCT00346632|11471292|FG008|Overall Study|Death|0
7258818|NCT00346632|11471293|FG009|Overall Study|Death|0
7258819|NCT00346632|11471284|FG000|Overall Study|Protocol Violation|0
7258820|NCT00346632|11471285|FG001|Overall Study|Protocol Violation|0
7542824|NCT02784106|11894388|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
7542825|NCT02784106|11894385|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
7542826|NCT02784106|11894386|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
7542827|NCT02784106|11894387|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7542828|NCT02784106|11894388|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
7542829|NCT02784106|11894385|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
7542830|NCT02784106|11894386|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
7542831|NCT02784106|11894387|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
7542832|NCT02784106|11894388|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
7542833|NCT02784106|11894385|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
7542834|NCT02784106|11894386|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7542835|NCT02784106|11894387|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7542836|NCT02784106|11894388|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
7258821|NCT00346632|11471286|FG002|Overall Study|Protocol Violation|0
7258822|NCT00346632|11471287|FG003|Overall Study|Protocol Violation|0
7258823|NCT00346632|11471288|FG004|Overall Study|Protocol Violation|0
7258824|NCT00346632|11471289|FG005|Overall Study|Protocol Violation|0
7258825|NCT00346632|11471290|FG006|Overall Study|Protocol Violation|1
7258826|NCT00346632|11471291|FG007|Overall Study|Protocol Violation|0
7542837|NCT02784106|11894385|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7258827|NCT00346632|11471292|FG008|Overall Study|Protocol Violation|0
7258828|NCT00346632|11471293|FG009|Overall Study|Protocol Violation|0
7258829|NCT00346632|11471284|FG000|Overall Study|Withdrawal by Subject|0
7258830|NCT00346632|11471285|FG001|Overall Study|Withdrawal by Subject|0
7258831|NCT00346632|11471286|FG002|Overall Study|Withdrawal by Subject|0
7258832|NCT00346632|11471287|FG003|Overall Study|Withdrawal by Subject|0
7258833|NCT00346632|11471288|FG004|Overall Study|Withdrawal by Subject|0
7258834|NCT00346632|11471289|FG005|Overall Study|Withdrawal by Subject|0
7258835|NCT00346632|11471290|FG006|Overall Study|Withdrawal by Subject|1
7258836|NCT00346632|11471291|FG007|Overall Study|Withdrawal by Subject|0
7258837|NCT00346632|11471292|FG008|Overall Study|Withdrawal by Subject|0
7258838|NCT00346632|11471293|FG009|Overall Study|Withdrawal by Subject|0
7258839|NCT00346632|11471284|FG000|Overall Study|Switched to alternative treatment|0
7258840|NCT00346632|11471285|FG001|Overall Study|Switched to alternative treatment|0
7258841|NCT00346632|11471286|FG002|Overall Study|Switched to alternative treatment|1
7258842|NCT00346632|11471287|FG003|Overall Study|Switched to alternative treatment|0
7258843|NCT00346632|11471288|FG004|Overall Study|Switched to alternative treatment|0
7258844|NCT00346632|11471289|FG005|Overall Study|Switched to alternative treatment|0
7258845|NCT00346632|11471290|FG006|Overall Study|Switched to alternative treatment|0
7258846|NCT00346632|11471291|FG007|Overall Study|Switched to alternative treatment|0
7258847|NCT00346632|11471292|FG008|Overall Study|Switched to alternative treatment|0
7258848|NCT00346632|11471293|FG009|Overall Study|Switched to alternative treatment|0
7258849|NCT00346632|11471284|FG000|Overall Study|Not Stated|1
7258850|NCT00346632|11471285|FG001|Overall Study|Not Stated|1
7258851|NCT00346632|11471286|FG002|Overall Study|Not Stated|0
7258852|NCT00346632|11471287|FG003|Overall Study|Not Stated|0
7258853|NCT00346632|11471288|FG004|Overall Study|Not Stated|0
7258854|NCT00346632|11471289|FG005|Overall Study|Not Stated|0
7258855|NCT00346632|11471290|FG006|Overall Study|Not Stated|0
7258856|NCT00346632|11471291|FG007|Overall Study|Not Stated|2
7258857|NCT00346632|11471292|FG008|Overall Study|Not Stated|2
7258858|NCT00346632|11471293|FG009|Overall Study|Not Stated|1
7258859|NCT00346697|11471357|FG000|Overall Study|Lost to Follow-up|0
7258860|NCT00346697|11471358|FG001|Overall Study|Lost to Follow-up|1
7258861|NCT00346775|11471366|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
7258862|NCT00346775|11471367|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
7258863|NCT00346775|11471366|FG000|Period 1: Intervention Period 1|Protocol Violation|3
7258864|NCT00346775|11471367|FG001|Period 1: Intervention Period 1|Protocol Violation|2
7258865|NCT00346775|11471366|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
7258866|NCT00346775|11471367|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
7258867|NCT00347009|11471381|FG000|Overall Study|Death|1
7258868|NCT00347009|11471381|FG000|Overall Study|Adverse Event|6
7258869|NCT00347009|11471381|FG000|Overall Study|Withdrawal by Subject|3
7258870|NCT00347009|11471381|FG000|Overall Study|Physician Decision|5
7258871|NCT00347009|11471381|FG000|Overall Study|Lost to Follow-up|4
7258872|NCT00347009|11471381|FG000|Overall Study|Protocol Violation|2
7258873|NCT00347009|11471381|FG000|Overall Study|Adverse Laboratory Experience|1
7258874|NCT00347009|11471381|FG000|Overall Study|Insufficient Viral Suppression|3
7258875|NCT00347009|11471381|FG000|Overall Study|Increased ALT/HBV DNA|1
7258876|NCT00347009|11471381|FG000|Overall Study|Serious Adverse Event|1
7258877|NCT00347269|11471396|FG000|Overall Study|Lost to Follow-up|74
7258878|NCT00347269|11471397|FG001|Overall Study|Lost to Follow-up|65
7258879|NCT00347269|11471396|FG000|Overall Study|Withdrawal by Subject|18
7258880|NCT00347269|11471397|FG001|Overall Study|Withdrawal by Subject|38
7258881|NCT00347269|11471396|FG000|Overall Study|Death|2
7258882|NCT00347269|11471397|FG001|Overall Study|Death|3
7258883|NCT00347360|11471422|FG000|Overall Study|Adverse Event|1
7258884|NCT00347360|11471423|FG001|Overall Study|Adverse Event|2
7258885|NCT00347360|11471424|FG002|Overall Study|Adverse Event|0
7258886|NCT00347360|11471425|FG003|Overall Study|Adverse Event|4
7258887|NCT00347360|11471426|FG004|Overall Study|Adverse Event|1
7258888|NCT00347360|11471427|FG005|Overall Study|Adverse Event|2
7258889|NCT00347360|11471428|FG006|Overall Study|Adverse Event|2
7258890|NCT00347360|11471429|FG007|Overall Study|Adverse Event|0
7258891|NCT00347360|11471430|FG008|Overall Study|Adverse Event|2
7258892|NCT00347360|11471431|FG009|Overall Study|Adverse Event|3
7258893|NCT00347360|11471432|FG010|Overall Study|Adverse Event|3
7258894|NCT00347360|11471433|FG011|Overall Study|Adverse Event|1
7258895|NCT00347360|11471434|FG012|Overall Study|Adverse Event|3
7258896|NCT00347360|11471435|FG013|Overall Study|Adverse Event|2
7258897|NCT00347360|11471436|FG014|Overall Study|Adverse Event|2
7258898|NCT00347360|11471422|FG000|Overall Study|Lost to Follow-up|0
7258899|NCT00347360|11471423|FG001|Overall Study|Lost to Follow-up|0
7258900|NCT00347360|11471424|FG002|Overall Study|Lost to Follow-up|0
7258901|NCT00347360|11471425|FG003|Overall Study|Lost to Follow-up|2
7258902|NCT00347360|11471426|FG004|Overall Study|Lost to Follow-up|1
7258903|NCT00347360|11471427|FG005|Overall Study|Lost to Follow-up|1
7258904|NCT00347360|11471428|FG006|Overall Study|Lost to Follow-up|0
7258905|NCT00347360|11471429|FG007|Overall Study|Lost to Follow-up|1
7258906|NCT00347360|11471430|FG008|Overall Study|Lost to Follow-up|1
7258907|NCT00347360|11471431|FG009|Overall Study|Lost to Follow-up|2
7258908|NCT00347360|11471432|FG010|Overall Study|Lost to Follow-up|0
7258909|NCT00347360|11471433|FG011|Overall Study|Lost to Follow-up|0
7258910|NCT00347360|11471434|FG012|Overall Study|Lost to Follow-up|1
7542838|NCT02784106|11894386|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
7542839|NCT02784106|11894387|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
7542840|NCT02784106|11894388|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
7542841|NCT02784106|11894385|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7542842|NCT02784106|11894386|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
7542843|NCT02784106|11894387|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7542844|NCT02784106|11894388|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
7542847|NCT02784834|11894448|FG000|Overall Study|Lack of Efficacy|1
7542848|NCT02785458|11894541|FG000|1 Month|Withdrawal by Subject|2
7542849|NCT02785458|11894542|FG001|1 Month|Withdrawal by Subject|1
7542850|NCT02785458|11894541|FG000|1 Month|Lost to Follow-up|38
7542851|NCT02785458|11894542|FG001|1 Month|Lost to Follow-up|31
7542852|NCT02785458|11894541|FG000|1 Month|Deemed Ineligible|1
7542853|NCT02785458|11894542|FG001|1 Month|Deemed Ineligible|0
7542854|NCT02785458|11894541|FG000|1 Month|Completed Evaluation by Baseline|42
7542855|NCT02785458|11894542|FG001|1 Month|Completed Evaluation by Baseline|39
7542856|NCT02785458|11894541|FG000|1 Month|Partial Interview|0
7542857|NCT02785458|11894542|FG001|1 Month|Partial Interview|4
7542858|NCT02785458|11894541|FG000|3 Months|Withdrawal by Subject|3
7542859|NCT02785458|11894542|FG001|3 Months|Withdrawal by Subject|1
7542860|NCT02785458|11894541|FG000|3 Months|Lost to Follow-up|25
7542861|NCT02785458|11894542|FG001|3 Months|Lost to Follow-up|21
7542862|NCT02785458|11894541|FG000|3 Months|Completed Evaluation at 1 Month|100
7542863|NCT02785458|11894542|FG001|3 Months|Completed Evaluation at 1 Month|89
7542864|NCT02785588|11894548|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
7542865|NCT02785588|11894548|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
7542866|NCT02785770|11894552|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
7542867|NCT02785770|11894553|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
7542868|NCT02785770|11894554|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
7542869|NCT02785770|11894555|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
7542870|NCT02785770|11894552|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
7542871|NCT02785770|11894553|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
7542872|NCT02785770|11894554|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
7542873|NCT02785770|11894555|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
7542874|NCT02785770|11894552|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
7542875|NCT02785770|11894553|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
7542876|NCT02785770|11894554|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
7542877|NCT02785770|11894555|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
7542878|NCT02785900|11894570|FG000|Overall Study|Study Termination by Sponsor|64
7258911|NCT00347360|11471435|FG013|Overall Study|Lost to Follow-up|0
7258912|NCT00347360|11471436|FG014|Overall Study|Lost to Follow-up|0
7258913|NCT00347360|11471422|FG000|Overall Study|Protocol Violation|2
7258914|NCT00347360|11471423|FG001|Overall Study|Protocol Violation|3
7542879|NCT02785900|11894571|FG001|Overall Study|Study Termination by Sponsor|81
7258915|NCT00347360|11471424|FG002|Overall Study|Protocol Violation|1
7258916|NCT00347360|11471425|FG003|Overall Study|Protocol Violation|2
7258917|NCT00347360|11471426|FG004|Overall Study|Protocol Violation|1
7258918|NCT00347360|11471427|FG005|Overall Study|Protocol Violation|2
7258919|NCT00347360|11471428|FG006|Overall Study|Protocol Violation|0
7258920|NCT00347360|11471429|FG007|Overall Study|Protocol Violation|0
7258921|NCT00347360|11471430|FG008|Overall Study|Protocol Violation|1
7258922|NCT00347360|11471431|FG009|Overall Study|Protocol Violation|2
7258923|NCT00347360|11471432|FG010|Overall Study|Protocol Violation|0
7258924|NCT00347360|11471433|FG011|Overall Study|Protocol Violation|0
7258925|NCT00347360|11471434|FG012|Overall Study|Protocol Violation|0
7258926|NCT00347360|11471435|FG013|Overall Study|Protocol Violation|1
7258927|NCT00347360|11471436|FG014|Overall Study|Protocol Violation|0
7258928|NCT00347360|11471422|FG000|Overall Study|Withdrawal by Subject|0
7258929|NCT00347360|11471423|FG001|Overall Study|Withdrawal by Subject|1
7258930|NCT00347360|11471424|FG002|Overall Study|Withdrawal by Subject|2
7258931|NCT00347360|11471425|FG003|Overall Study|Withdrawal by Subject|4
7258932|NCT00347360|11471426|FG004|Overall Study|Withdrawal by Subject|1
7258933|NCT00347360|11471427|FG005|Overall Study|Withdrawal by Subject|2
7258934|NCT00347360|11471428|FG006|Overall Study|Withdrawal by Subject|1
7258935|NCT00347360|11471429|FG007|Overall Study|Withdrawal by Subject|1
7258936|NCT00347360|11471430|FG008|Overall Study|Withdrawal by Subject|1
7258937|NCT00347360|11471431|FG009|Overall Study|Withdrawal by Subject|1
7258938|NCT00347360|11471432|FG010|Overall Study|Withdrawal by Subject|0
7258939|NCT00347360|11471433|FG011|Overall Study|Withdrawal by Subject|3
7258940|NCT00347360|11471434|FG012|Overall Study|Withdrawal by Subject|4
7258941|NCT00347360|11471435|FG013|Overall Study|Withdrawal by Subject|2
7258942|NCT00347360|11471436|FG014|Overall Study|Withdrawal by Subject|1
7258943|NCT00347360|11471422|FG000|Overall Study|Lack of Efficacy|1
7258944|NCT00347360|11471423|FG001|Overall Study|Lack of Efficacy|1
7258945|NCT00347360|11471424|FG002|Overall Study|Lack of Efficacy|3
7258946|NCT00347360|11471425|FG003|Overall Study|Lack of Efficacy|1
7258947|NCT00347360|11471426|FG004|Overall Study|Lack of Efficacy|0
7258948|NCT00347360|11471427|FG005|Overall Study|Lack of Efficacy|1
7258949|NCT00347360|11471428|FG006|Overall Study|Lack of Efficacy|0
7258950|NCT00347360|11471429|FG007|Overall Study|Lack of Efficacy|1
7258951|NCT00347360|11471430|FG008|Overall Study|Lack of Efficacy|1
7258952|NCT00347360|11471431|FG009|Overall Study|Lack of Efficacy|0
7258953|NCT00347360|11471432|FG010|Overall Study|Lack of Efficacy|0
7258954|NCT00347360|11471433|FG011|Overall Study|Lack of Efficacy|0
7258955|NCT00347360|11471434|FG012|Overall Study|Lack of Efficacy|0
7258956|NCT00347360|11471435|FG013|Overall Study|Lack of Efficacy|0
7258957|NCT00347360|11471436|FG014|Overall Study|Lack of Efficacy|0
7258958|NCT00347360|11471422|FG000|Overall Study|Reason not listed/blank|1
7258959|NCT00347360|11471423|FG001|Overall Study|Reason not listed/blank|0
7542880|NCT02785900|11894570|FG000|Overall Study|Death|46
7542881|NCT02785900|11894571|FG001|Overall Study|Death|32
7542882|NCT02785900|11894570|FG000|Overall Study|Withdrawal by Subject|4
7542883|NCT02785900|11894571|FG001|Overall Study|Withdrawal by Subject|8
7542884|NCT02785900|11894570|FG000|Overall Study|Physician Decision|3
7542885|NCT02785900|11894571|FG001|Overall Study|Physician Decision|2
7542886|NCT02785913|11894577|FG000|Overall Study|Adverse Event|5
7542887|NCT02785913|11894577|FG000|Overall Study|Death|2
7542888|NCT02785913|11894577|FG000|Overall Study|Progression|18
7542889|NCT02785913|11894577|FG000|Overall Study|Not protocol specified|1
7542890|NCT02785939|11894584|FG000|Overall Study|Progression|25
7258960|NCT00347360|11471424|FG002|Overall Study|Reason not listed/blank|0
7258961|NCT00347360|11471425|FG003|Overall Study|Reason not listed/blank|0
7258962|NCT00347360|11471426|FG004|Overall Study|Reason not listed/blank|0
7258963|NCT00347360|11471427|FG005|Overall Study|Reason not listed/blank|0
7258964|NCT00347360|11471428|FG006|Overall Study|Reason not listed/blank|1
7258965|NCT00347360|11471429|FG007|Overall Study|Reason not listed/blank|0
7258966|NCT00347360|11471430|FG008|Overall Study|Reason not listed/blank|0
7258967|NCT00347360|11471431|FG009|Overall Study|Reason not listed/blank|0
7542891|NCT02785939|11894585|FG001|Overall Study|Progression|8
7258968|NCT00347360|11471432|FG010|Overall Study|Reason not listed/blank|0
7258969|NCT00347360|11471433|FG011|Overall Study|Reason not listed/blank|0
7258970|NCT00347360|11471434|FG012|Overall Study|Reason not listed/blank|0
7258971|NCT00347360|11471435|FG013|Overall Study|Reason not listed/blank|1
7258972|NCT00347360|11471436|FG014|Overall Study|Reason not listed/blank|0
7258973|NCT00347360|11471422|FG000|Overall Study|Per sponsors instruction|0
7258974|NCT00347360|11471423|FG001|Overall Study|Per sponsors instruction|1
7258975|NCT00347360|11471424|FG002|Overall Study|Per sponsors instruction|0
7258976|NCT00347360|11471425|FG003|Overall Study|Per sponsors instruction|0
7542892|NCT02785939|11894584|FG000|Overall Study|Adverse Event|3
7542893|NCT02785939|11894585|FG001|Overall Study|Adverse Event|1
7542894|NCT02785939|11894584|FG000|Overall Study|Death|1
7542895|NCT02785939|11894585|FG001|Overall Study|Death|0
7542896|NCT02785939|11894584|FG000|Overall Study|Refusal|1
7542897|NCT02785939|11894585|FG001|Overall Study|Refusal|0
7542898|NCT02785939|11894584|FG000|Overall Study|Deteriorating health|1
7542899|NCT02785939|11894585|FG001|Overall Study|Deteriorating health|0
7542900|NCT02785939|11894584|FG000|Overall Study|Not protocol specified|0
7542901|NCT02785939|11894585|FG001|Overall Study|Not protocol specified|1
7542902|NCT02786004|11894593|FG000|Overall Study|Withdrawal by Subject|0
7542903|NCT02786004|11894594|FG001|Overall Study|Withdrawal by Subject|1
7542904|NCT02786836|11894635|FG000|Overall Study|Death|1
7542905|NCT02786836|11894635|FG000|Overall Study|Lack of Efficacy|2
7542906|NCT02786836|11894635|FG000|Overall Study|Protocol Violation|3
7542907|NCT02786836|11894635|FG000|Overall Study|Withdrawal by Subject|3
7542908|NCT02786836|11894635|FG000|Overall Study|Liver Transplantation|2
7542909|NCT02786836|11894635|FG000|Overall Study|Device or Pharmacy Issues|3
7542910|NCT02786901|11894643|FG000|Overall Study|Adverse Event|1
7542911|NCT02786901|11894644|FG001|Overall Study|Adverse Event|1
7542912|NCT02786901|11894645|FG002|Overall Study|Adverse Event|2
7542913|NCT02786901|11894643|FG000|Overall Study|Physician Decision|1
7542914|NCT02786901|11894644|FG001|Overall Study|Physician Decision|0
7542915|NCT02786901|11894645|FG002|Overall Study|Physician Decision|0
7542916|NCT02786901|11894643|FG000|Overall Study|Rescue Therapy Use|71
7542917|NCT02786901|11894644|FG001|Overall Study|Rescue Therapy Use|49
7542918|NCT02786901|11894645|FG002|Overall Study|Rescue Therapy Use|33
7258977|NCT00347360|11471426|FG004|Overall Study|Per sponsors instruction|0
7258978|NCT00347360|11471427|FG005|Overall Study|Per sponsors instruction|0
7542919|NCT02786901|11894643|FG000|Overall Study|Subject Request/Lost to Follow up|1
7542920|NCT02786901|11894644|FG001|Overall Study|Subject Request/Lost to Follow up|5
7542921|NCT02786901|11894645|FG002|Overall Study|Subject Request/Lost to Follow up|5
7542922|NCT02786901|11894643|FG000|Overall Study|Disallowed medication|1
7258979|NCT00347360|11471428|FG006|Overall Study|Per sponsors instruction|0
7258980|NCT00347360|11471429|FG007|Overall Study|Per sponsors instruction|0
7258981|NCT00347360|11471430|FG008|Overall Study|Per sponsors instruction|0
7258982|NCT00347360|11471431|FG009|Overall Study|Per sponsors instruction|0
7258983|NCT00347360|11471432|FG010|Overall Study|Per sponsors instruction|0
7258984|NCT00347360|11471433|FG011|Overall Study|Per sponsors instruction|0
7258985|NCT00347360|11471434|FG012|Overall Study|Per sponsors instruction|0
7258986|NCT00347360|11471435|FG013|Overall Study|Per sponsors instruction|0
7258987|NCT00347360|11471436|FG014|Overall Study|Per sponsors instruction|0
7258988|NCT00347360|11471422|FG000|Overall Study|P.I. recommended due to blood pressure|0
7258989|NCT00347360|11471423|FG001|Overall Study|P.I. recommended due to blood pressure|0
7258990|NCT00347360|11471424|FG002|Overall Study|P.I. recommended due to blood pressure|0
7258991|NCT00347360|11471425|FG003|Overall Study|P.I. recommended due to blood pressure|0
7258992|NCT00347360|11471426|FG004|Overall Study|P.I. recommended due to blood pressure|1
7258993|NCT00347360|11471427|FG005|Overall Study|P.I. recommended due to blood pressure|0
7258994|NCT00347360|11471428|FG006|Overall Study|P.I. recommended due to blood pressure|0
7258995|NCT00347360|11471429|FG007|Overall Study|P.I. recommended due to blood pressure|0
7258996|NCT00347360|11471430|FG008|Overall Study|P.I. recommended due to blood pressure|0
7258997|NCT00347360|11471431|FG009|Overall Study|P.I. recommended due to blood pressure|0
7258998|NCT00347360|11471432|FG010|Overall Study|P.I. recommended due to blood pressure|0
7258999|NCT00347360|11471433|FG011|Overall Study|P.I. recommended due to blood pressure|0
7259000|NCT00347360|11471434|FG012|Overall Study|P.I. recommended due to blood pressure|0
7259001|NCT00347360|11471435|FG013|Overall Study|P.I. recommended due to blood pressure|0
7259002|NCT00347360|11471436|FG014|Overall Study|P.I. recommended due to blood pressure|0
7259003|NCT00347360|11471422|FG000|Overall Study|Subject did not meet end of study ABPM|0
7259004|NCT00347360|11471423|FG001|Overall Study|Subject did not meet end of study ABPM|0
7259005|NCT00347360|11471424|FG002|Overall Study|Subject did not meet end of study ABPM|0
7259006|NCT00347360|11471425|FG003|Overall Study|Subject did not meet end of study ABPM|0
7259007|NCT00347360|11471426|FG004|Overall Study|Subject did not meet end of study ABPM|0
7259008|NCT00347360|11471427|FG005|Overall Study|Subject did not meet end of study ABPM|0
7259009|NCT00347360|11471428|FG006|Overall Study|Subject did not meet end of study ABPM|1
7259010|NCT00347360|11471429|FG007|Overall Study|Subject did not meet end of study ABPM|0
7259011|NCT00347360|11471430|FG008|Overall Study|Subject did not meet end of study ABPM|0
7259012|NCT00347360|11471431|FG009|Overall Study|Subject did not meet end of study ABPM|0
7259013|NCT00347360|11471432|FG010|Overall Study|Subject did not meet end of study ABPM|1
7259014|NCT00347360|11471433|FG011|Overall Study|Subject did not meet end of study ABPM|0
7259015|NCT00347360|11471434|FG012|Overall Study|Subject did not meet end of study ABPM|1
7259016|NCT00347360|11471435|FG013|Overall Study|Subject did not meet end of study ABPM|1
7259017|NCT00347360|11471436|FG014|Overall Study|Subject did not meet end of study ABPM|0
7259018|NCT00347360|11471422|FG000|Overall Study|Abnormal lab values|0
7259019|NCT00347360|11471423|FG001|Overall Study|Abnormal lab values|0
7259020|NCT00347360|11471424|FG002|Overall Study|Abnormal lab values|0
7259021|NCT00347360|11471425|FG003|Overall Study|Abnormal lab values|0
7259022|NCT00347360|11471426|FG004|Overall Study|Abnormal lab values|0
7259023|NCT00347360|11471427|FG005|Overall Study|Abnormal lab values|0
7259024|NCT00347360|11471428|FG006|Overall Study|Abnormal lab values|1
7259025|NCT00347360|11471429|FG007|Overall Study|Abnormal lab values|0
7259026|NCT00347360|11471430|FG008|Overall Study|Abnormal lab values|0
7259027|NCT00347360|11471431|FG009|Overall Study|Abnormal lab values|0
7259028|NCT00347360|11471432|FG010|Overall Study|Abnormal lab values|0
7259029|NCT00347360|11471433|FG011|Overall Study|Abnormal lab values|0
7259030|NCT00347360|11471434|FG012|Overall Study|Abnormal lab values|0
7259031|NCT00347360|11471435|FG013|Overall Study|Abnormal lab values|0
7259032|NCT00347360|11471436|FG014|Overall Study|Abnormal lab values|0
7259033|NCT00347360|11471422|FG000|Overall Study|PI recommended early withdrawal|0
7259034|NCT00347360|11471423|FG001|Overall Study|PI recommended early withdrawal|0
7259035|NCT00347360|11471424|FG002|Overall Study|PI recommended early withdrawal|0
7259036|NCT00347360|11471425|FG003|Overall Study|PI recommended early withdrawal|0
7576254|NCT04384523|11962327|FG002|Overall Study|Lost to Follow-up|0
7259037|NCT00347360|11471426|FG004|Overall Study|PI recommended early withdrawal|0
7259038|NCT00347360|11471427|FG005|Overall Study|PI recommended early withdrawal|0
7576255|NCT04384523|11962328|FG003|Overall Study|Lost to Follow-up|0
7259039|NCT00347360|11471428|FG006|Overall Study|PI recommended early withdrawal|0
7259040|NCT00347360|11471429|FG007|Overall Study|PI recommended early withdrawal|0
7259041|NCT00347360|11471430|FG008|Overall Study|PI recommended early withdrawal|0
7259042|NCT00347360|11471431|FG009|Overall Study|PI recommended early withdrawal|1
7259043|NCT00347360|11471432|FG010|Overall Study|PI recommended early withdrawal|0
7259044|NCT00347360|11471433|FG011|Overall Study|PI recommended early withdrawal|0
7259045|NCT00347360|11471434|FG012|Overall Study|PI recommended early withdrawal|0
7259046|NCT00347360|11471435|FG013|Overall Study|PI recommended early withdrawal|0
7259047|NCT00347360|11471436|FG014|Overall Study|PI recommended early withdrawal|0
7259048|NCT00347360|11471422|FG000|Overall Study|Did not meet criteria before ABPM|0
7259049|NCT00347360|11471423|FG001|Overall Study|Did not meet criteria before ABPM|0
7259050|NCT00347360|11471424|FG002|Overall Study|Did not meet criteria before ABPM|0
7259051|NCT00347360|11471425|FG003|Overall Study|Did not meet criteria before ABPM|0
7259052|NCT00347360|11471426|FG004|Overall Study|Did not meet criteria before ABPM|0
7259053|NCT00347360|11471427|FG005|Overall Study|Did not meet criteria before ABPM|0
7259054|NCT00347360|11471428|FG006|Overall Study|Did not meet criteria before ABPM|0
7259055|NCT00347360|11471429|FG007|Overall Study|Did not meet criteria before ABPM|0
7259056|NCT00347360|11471430|FG008|Overall Study|Did not meet criteria before ABPM|0
7259057|NCT00347360|11471431|FG009|Overall Study|Did not meet criteria before ABPM|0
7259058|NCT00347360|11471432|FG010|Overall Study|Did not meet criteria before ABPM|1
7259059|NCT00347360|11471433|FG011|Overall Study|Did not meet criteria before ABPM|0
7259060|NCT00347360|11471434|FG012|Overall Study|Did not meet criteria before ABPM|0
7259061|NCT00347360|11471435|FG013|Overall Study|Did not meet criteria before ABPM|0
7259062|NCT00347360|11471436|FG014|Overall Study|Did not meet criteria before ABPM|0
7259063|NCT00347360|11471422|FG000|Overall Study|Randomized in error|0
7259064|NCT00347360|11471423|FG001|Overall Study|Randomized in error|0
7259065|NCT00347360|11471424|FG002|Overall Study|Randomized in error|0
7259066|NCT00347360|11471425|FG003|Overall Study|Randomized in error|0
7259067|NCT00347360|11471426|FG004|Overall Study|Randomized in error|0
7259068|NCT00347360|11471427|FG005|Overall Study|Randomized in error|0
7259069|NCT00347360|11471428|FG006|Overall Study|Randomized in error|0
7259070|NCT00347360|11471429|FG007|Overall Study|Randomized in error|0
7259071|NCT00347360|11471430|FG008|Overall Study|Randomized in error|0
7259072|NCT00347360|11471431|FG009|Overall Study|Randomized in error|0
7259073|NCT00347360|11471432|FG010|Overall Study|Randomized in error|0
7259074|NCT00347360|11471433|FG011|Overall Study|Randomized in error|1
7259075|NCT00347360|11471434|FG012|Overall Study|Randomized in error|0
7259076|NCT00347360|11471435|FG013|Overall Study|Randomized in error|0
7259077|NCT00347360|11471436|FG014|Overall Study|Randomized in error|0
7259078|NCT00347360|11471422|FG000|Overall Study|Failed inclusion criteria #4|0
7259079|NCT00347360|11471423|FG001|Overall Study|Failed inclusion criteria #4|0
7259080|NCT00347360|11471424|FG002|Overall Study|Failed inclusion criteria #4|0
7259081|NCT00347360|11471425|FG003|Overall Study|Failed inclusion criteria #4|0
7259082|NCT00347360|11471426|FG004|Overall Study|Failed inclusion criteria #4|0
7259083|NCT00347360|11471427|FG005|Overall Study|Failed inclusion criteria #4|0
7259084|NCT00347360|11471428|FG006|Overall Study|Failed inclusion criteria #4|0
7259085|NCT00347360|11471429|FG007|Overall Study|Failed inclusion criteria #4|0
7259086|NCT00347360|11471430|FG008|Overall Study|Failed inclusion criteria #4|0
7259087|NCT00347360|11471431|FG009|Overall Study|Failed inclusion criteria #4|0
7259088|NCT00347360|11471432|FG010|Overall Study|Failed inclusion criteria #4|0
7259089|NCT00347360|11471433|FG011|Overall Study|Failed inclusion criteria #4|1
7259090|NCT00347360|11471434|FG012|Overall Study|Failed inclusion criteria #4|0
7259091|NCT00347360|11471435|FG013|Overall Study|Failed inclusion criteria #4|0
7259092|NCT00347360|11471436|FG014|Overall Study|Failed inclusion criteria #4|0
7259093|NCT00347360|11471422|FG000|Overall Study|Prolonged duration between visits|0
7259094|NCT00347360|11471423|FG001|Overall Study|Prolonged duration between visits|0
7259095|NCT00347360|11471424|FG002|Overall Study|Prolonged duration between visits|0
7259096|NCT00347360|11471425|FG003|Overall Study|Prolonged duration between visits|0
7259097|NCT00347360|11471426|FG004|Overall Study|Prolonged duration between visits|0
7259098|NCT00347360|11471427|FG005|Overall Study|Prolonged duration between visits|0
7259099|NCT00347360|11471428|FG006|Overall Study|Prolonged duration between visits|0
7259100|NCT00347360|11471429|FG007|Overall Study|Prolonged duration between visits|0
7259101|NCT00347360|11471430|FG008|Overall Study|Prolonged duration between visits|0
7259102|NCT00347360|11471431|FG009|Overall Study|Prolonged duration between visits|0
7259103|NCT00347360|11471432|FG010|Overall Study|Prolonged duration between visits|0
7259104|NCT00347360|11471433|FG011|Overall Study|Prolonged duration between visits|0
7259105|NCT00347360|11471434|FG012|Overall Study|Prolonged duration between visits|1
7542923|NCT02786901|11894644|FG001|Overall Study|Disallowed medication|1
7542924|NCT02786901|11894645|FG002|Overall Study|Disallowed medication|0
7542925|NCT02786901|11894643|FG000|Overall Study|Randomized in error|2
7542926|NCT02786901|11894644|FG001|Overall Study|Randomized in error|0
7542927|NCT02786901|11894645|FG002|Overall Study|Randomized in error|1
7542928|NCT02786927|11894653|FG000|Overall Study|Adverse Event|1
7542929|NCT02786927|11894653|FG000|Overall Study|Protocol Violation|4
7542930|NCT02786953|11894660|FG000|Overall Study|Withdrawal by Subject|3
7542931|NCT02786953|11894661|FG001|Overall Study|Withdrawal by Subject|0
7542932|NCT02786953|11894660|FG000|Overall Study|Physician Decision|0
7542933|NCT02786953|11894661|FG001|Overall Study|Physician Decision|1
7542934|NCT02787083|11894678|FG000|Overall Study|Adverse Event|1
7542935|NCT02787083|11894679|FG001|Overall Study|Adverse Event|0
7542936|NCT02787083|11894678|FG000|Overall Study|Withdrawal by Subject|2
7542937|NCT02787083|11894679|FG001|Overall Study|Withdrawal by Subject|2
7542938|NCT02787304|11894693|FG000|Overall Study|Adverse Event|9
7542939|NCT02787304|11894694|FG001|Overall Study|Adverse Event|3
7542940|NCT02787304|11894695|FG002|Overall Study|Adverse Event|8
7259106|NCT00347360|11471435|FG013|Overall Study|Prolonged duration between visits|0
7259107|NCT00347360|11471436|FG014|Overall Study|Prolonged duration between visits|0
7259108|NCT00347360|11471422|FG000|Overall Study|Subject left town, ran out of study drug|0
7259109|NCT00347360|11471423|FG001|Overall Study|Subject left town, ran out of study drug|0
7259110|NCT00347360|11471424|FG002|Overall Study|Subject left town, ran out of study drug|0
7259111|NCT00347360|11471425|FG003|Overall Study|Subject left town, ran out of study drug|0
7259112|NCT00347360|11471426|FG004|Overall Study|Subject left town, ran out of study drug|0
7259113|NCT00347360|11471427|FG005|Overall Study|Subject left town, ran out of study drug|0
7259114|NCT00347360|11471428|FG006|Overall Study|Subject left town, ran out of study drug|0
7259115|NCT00347360|11471429|FG007|Overall Study|Subject left town, ran out of study drug|0
7259116|NCT00347360|11471430|FG008|Overall Study|Subject left town, ran out of study drug|0
7259117|NCT00347360|11471431|FG009|Overall Study|Subject left town, ran out of study drug|0
7542941|NCT02787304|11894696|FG003|Overall Study|Adverse Event|1
7542942|NCT02787304|11894693|FG000|Overall Study|Withdrawal by Subject|1
7542943|NCT02787304|11894694|FG001|Overall Study|Withdrawal by Subject|4
7542944|NCT02787304|11894695|FG002|Overall Study|Withdrawal by Subject|0
7542945|NCT02787304|11894696|FG003|Overall Study|Withdrawal by Subject|0
7542946|NCT02787304|11894693|FG000|Overall Study|Lost to Follow-up|1
7542947|NCT02787304|11894694|FG001|Overall Study|Lost to Follow-up|0
7542948|NCT02787304|11894695|FG002|Overall Study|Lost to Follow-up|0
7542949|NCT02787304|11894696|FG003|Overall Study|Lost to Follow-up|1
7542950|NCT02787304|11894693|FG000|Overall Study|Noncompliance with study drug|0
7542951|NCT02787304|11894694|FG001|Overall Study|Noncompliance with study drug|0
7542952|NCT02787304|11894695|FG002|Overall Study|Noncompliance with study drug|1
7542953|NCT02787304|11894696|FG003|Overall Study|Noncompliance with study drug|0
7542954|NCT02787304|11894693|FG000|Overall Study|Physician Decision|0
7542955|NCT02787304|11894694|FG001|Overall Study|Physician Decision|0
7542956|NCT02787304|11894695|FG002|Overall Study|Physician Decision|1
7542957|NCT02787304|11894696|FG003|Overall Study|Physician Decision|0
7542958|NCT02787304|11894693|FG000|Overall Study|Study terminated by sponsor|25
7542959|NCT02787304|11894694|FG001|Overall Study|Study terminated by sponsor|31
7542960|NCT02787304|11894695|FG002|Overall Study|Study terminated by sponsor|31
7542961|NCT02787304|11894696|FG003|Overall Study|Study terminated by sponsor|32
7552321|NCT02987972|11912383|FG000|Overall Study|Lack of Efficacy|9
7552322|NCT02987972|11912384|FG001|Overall Study|Lack of Efficacy|12
7552323|NCT02987972|11912385|FG002|Overall Study|Lack of Efficacy|12
7552324|NCT02987972|11912383|FG000|Overall Study|Lost to Follow-up|7
7552325|NCT02987972|11912384|FG001|Overall Study|Lost to Follow-up|8
7552326|NCT02987972|11912385|FG002|Overall Study|Lost to Follow-up|4
7552327|NCT02987972|11912383|FG000|Overall Study|Physician Decision|1
7552328|NCT02987972|11912384|FG001|Overall Study|Physician Decision|6
7552329|NCT02987972|11912385|FG002|Overall Study|Physician Decision|0
7552330|NCT02987972|11912383|FG000|Overall Study|Protocol Violation|2
7552331|NCT02987972|11912384|FG001|Overall Study|Protocol Violation|1
7552332|NCT02987972|11912385|FG002|Overall Study|Protocol Violation|5
7552333|NCT02987972|11912383|FG000|Overall Study|Withdrawal by Subject|22
7552334|NCT02987972|11912384|FG001|Overall Study|Withdrawal by Subject|17
7552335|NCT02987972|11912385|FG002|Overall Study|Withdrawal by Subject|21
7552336|NCT02988115|11912404|FG000|Overall Study|Adverse Event|6
7552337|NCT02988115|11912405|FG001|Overall Study|Adverse Event|1
7552338|NCT02988115|11912404|FG000|Overall Study|Sponsor Decision|5
7552339|NCT02988115|11912405|FG001|Overall Study|Sponsor Decision|2
7259118|NCT00347360|11471432|FG010|Overall Study|Subject left town, ran out of study drug|0
7259119|NCT00347360|11471433|FG011|Overall Study|Subject left town, ran out of study drug|0
7259120|NCT00347360|11471434|FG012|Overall Study|Subject left town, ran out of study drug|0
7259121|NCT00347360|11471435|FG013|Overall Study|Subject left town, ran out of study drug|1
7259122|NCT00347360|11471436|FG014|Overall Study|Subject left town, ran out of study drug|0
7259123|NCT00347360|11471422|FG000|Overall Study|Subject refuse to sign updated consent|0
7259124|NCT00347360|11471423|FG001|Overall Study|Subject refuse to sign updated consent|0
7259125|NCT00347360|11471424|FG002|Overall Study|Subject refuse to sign updated consent|0
7259126|NCT00347360|11471425|FG003|Overall Study|Subject refuse to sign updated consent|0
7259127|NCT00347360|11471426|FG004|Overall Study|Subject refuse to sign updated consent|0
7259128|NCT00347360|11471427|FG005|Overall Study|Subject refuse to sign updated consent|0
7259129|NCT00347360|11471428|FG006|Overall Study|Subject refuse to sign updated consent|0
7576256|NCT04384523|11962329|FG004|Overall Study|Lost to Follow-up|0
7259130|NCT00347360|11471429|FG007|Overall Study|Subject refuse to sign updated consent|0
7259131|NCT00347360|11471430|FG008|Overall Study|Subject refuse to sign updated consent|0
7259132|NCT00347360|11471431|FG009|Overall Study|Subject refuse to sign updated consent|0
7259133|NCT00347360|11471432|FG010|Overall Study|Subject refuse to sign updated consent|0
7259134|NCT00347360|11471433|FG011|Overall Study|Subject refuse to sign updated consent|0
7259135|NCT00347360|11471434|FG012|Overall Study|Subject refuse to sign updated consent|0
7259136|NCT00347360|11471435|FG013|Overall Study|Subject refuse to sign updated consent|0
7259137|NCT00347360|11471436|FG014|Overall Study|Subject refuse to sign updated consent|1
7542962|NCT02787863|11894740|FG000|Overall Study|Death|1
7542963|NCT02787863|11894741|FG001|Overall Study|Death|0
7542964|NCT02787863|11894742|FG002|Overall Study|Death|1
7542965|NCT02787863|11894743|FG003|Overall Study|Death|0
7542966|NCT02787863|11894744|FG004|Overall Study|Death|0
7542967|NCT02787863|11894745|FG005|Overall Study|Death|0
7542968|NCT02787863|11894746|FG006|Overall Study|Death|0
7542969|NCT02787863|11894747|FG007|Overall Study|Death|0
7542970|NCT02787863|11894740|FG000|Overall Study|Withdrawal by Subject|0
7542971|NCT02787863|11894741|FG001|Overall Study|Withdrawal by Subject|1
7542972|NCT02787863|11894742|FG002|Overall Study|Withdrawal by Subject|1
7542973|NCT02787863|11894743|FG003|Overall Study|Withdrawal by Subject|0
7259138|NCT00347360|11471422|FG000|Overall Study|Visits conflicted with new job|0
7259139|NCT00347360|11471423|FG001|Overall Study|Visits conflicted with new job|0
7259140|NCT00347360|11471424|FG002|Overall Study|Visits conflicted with new job|0
7259141|NCT00347360|11471425|FG003|Overall Study|Visits conflicted with new job|0
7259142|NCT00347360|11471426|FG004|Overall Study|Visits conflicted with new job|0
7259143|NCT00347360|11471427|FG005|Overall Study|Visits conflicted with new job|0
7259144|NCT00347360|11471428|FG006|Overall Study|Visits conflicted with new job|1
7259145|NCT00347360|11471429|FG007|Overall Study|Visits conflicted with new job|0
7259146|NCT00347360|11471430|FG008|Overall Study|Visits conflicted with new job|0
7259147|NCT00347360|11471431|FG009|Overall Study|Visits conflicted with new job|0
7259148|NCT00347360|11471432|FG010|Overall Study|Visits conflicted with new job|0
7259149|NCT00347360|11471433|FG011|Overall Study|Visits conflicted with new job|0
7259150|NCT00347360|11471434|FG012|Overall Study|Visits conflicted with new job|0
7259151|NCT00347360|11471435|FG013|Overall Study|Visits conflicted with new job|0
7259152|NCT00347360|11471436|FG014|Overall Study|Visits conflicted with new job|0
7259153|NCT00347438|11471468|FG000|Overall Study|Withdrawal by Subject|1
7259154|NCT00347438|11471468|FG000|Overall Study|Physician Decision|1
7259155|NCT00347776|11471475|FG000|1.5 Month Follow-up|Death|2
7259156|NCT00347776|11471476|FG001|1.5 Month Follow-up|Death|0
7259157|NCT00347776|11471477|FG002|1.5 Month Follow-up|Death|0
7259158|NCT00347776|11471475|FG000|1.5 Month Follow-up|reached the endpoint|12
7259159|NCT00347776|11471476|FG001|1.5 Month Follow-up|reached the endpoint|8
7259160|NCT00347776|11471477|FG002|1.5 Month Follow-up|reached the endpoint|12
7259161|NCT00347776|11471475|FG000|6 Month Follow-up|Death|2
7259162|NCT00347776|11471476|FG001|6 Month Follow-up|Death|1
7259163|NCT00347776|11471477|FG002|6 Month Follow-up|Death|3
7259164|NCT00347776|11471475|FG000|6 Month Follow-up|reached endpont|20
7259165|NCT00347776|11471476|FG001|6 Month Follow-up|reached endpont|12
7259166|NCT00347776|11471477|FG002|6 Month Follow-up|reached endpont|15
7259167|NCT00347776|11471475|FG000|12 Month Follow-up|Lost to Follow-up|7
7259168|NCT00347776|11471476|FG001|12 Month Follow-up|Lost to Follow-up|6
7259169|NCT00347776|11471477|FG002|12 Month Follow-up|Lost to Follow-up|6
7259170|NCT00347776|11471475|FG000|12 Month Follow-up|Death|3
7259171|NCT00347776|11471476|FG001|12 Month Follow-up|Death|4
7259172|NCT00347776|11471477|FG002|12 Month Follow-up|Death|4
7259173|NCT00347776|11471475|FG000|12 Month Follow-up|Reached endpoint|13
7259174|NCT00347776|11471476|FG001|12 Month Follow-up|Reached endpoint|6
7259175|NCT00347776|11471477|FG002|12 Month Follow-up|Reached endpoint|9
7259176|NCT00347919|11471488|FG000|Overall Study|Lost to Follow-up|11
7259177|NCT00347919|11471489|FG001|Overall Study|Lost to Follow-up|13
7259178|NCT00347919|11471490|FG002|Overall Study|Lost to Follow-up|0
7259179|NCT00347919|11471488|FG000|Overall Study|Withdrawal by Subject|6
7259180|NCT00347919|11471489|FG001|Overall Study|Withdrawal by Subject|8
7259181|NCT00347919|11471490|FG002|Overall Study|Withdrawal by Subject|0
7259182|NCT00347919|11471488|FG000|Overall Study|Physician Decision|1
7259183|NCT00347919|11471489|FG001|Overall Study|Physician Decision|1
7259184|NCT00347919|11471490|FG002|Overall Study|Physician Decision|0
7259185|NCT00347919|11471488|FG000|Overall Study|Sponsor terminated study|15
7259186|NCT00347919|11471489|FG001|Overall Study|Sponsor terminated study|10
7576257|NCT04384523|11962330|FG005|Overall Study|Lost to Follow-up|1
7576258|NCT04384523|11962325|FG000|Overall Study|Protocol Violation|0
7576259|NCT04384523|11962326|FG001|Overall Study|Protocol Violation|1
7576260|NCT04384523|11962327|FG002|Overall Study|Protocol Violation|0
7576261|NCT04384523|11962328|FG003|Overall Study|Protocol Violation|0
7576262|NCT04384523|11962329|FG004|Overall Study|Protocol Violation|0
7576263|NCT04384523|11962330|FG005|Overall Study|Protocol Violation|0
7576264|NCT04384523|11962325|FG000|Overall Study|Withdrawal by Subject|1
7576265|NCT04384523|11962326|FG001|Overall Study|Withdrawal by Subject|0
7576266|NCT04384523|11962327|FG002|Overall Study|Withdrawal by Subject|0
7576267|NCT04384523|11962328|FG003|Overall Study|Withdrawal by Subject|0
7576268|NCT04384523|11962329|FG004|Overall Study|Withdrawal by Subject|0
7259187|NCT00347919|11471490|FG002|Overall Study|Sponsor terminated study|16
7259188|NCT00347919|11471488|FG000|Overall Study|Death|35
7259189|NCT00347919|11471489|FG001|Overall Study|Death|42
7259190|NCT00347919|11471490|FG002|Overall Study|Death|19
7259191|NCT00347919|11471488|FG000|Overall Study|Par. Started Other Treatment|1
7259192|NCT00347919|11471489|FG001|Overall Study|Par. Started Other Treatment|1
7542974|NCT02787863|11894744|FG004|Overall Study|Withdrawal by Subject|0
7542975|NCT02787863|11894745|FG005|Overall Study|Withdrawal by Subject|0
7542976|NCT02787863|11894746|FG006|Overall Study|Withdrawal by Subject|0
7542977|NCT02787863|11894747|FG007|Overall Study|Withdrawal by Subject|0
7542978|NCT02788175|11894806|FG000|Overall Study|Protocol Violation|3
7542979|NCT02788175|11894806|FG000|Overall Study|Withdrawal by Subject|4
7542980|NCT02788175|11894806|FG000|Overall Study|Ineligible prior to study agent|6
7542981|NCT02788201|11894845|FG000|Overall Study|Death|1
7542982|NCT02788201|11894846|FG001|Overall Study|Death|1
7542983|NCT02788201|11894847|FG002|Overall Study|Death|1
7542984|NCT02788201|11894848|FG003|Overall Study|Death|1
7542985|NCT02788201|11894849|FG004|Overall Study|Death|0
7542986|NCT02788201|11894850|FG005|Overall Study|Death|1
7542987|NCT02788201|11894845|FG000|Overall Study|Ineligible|0
7542988|NCT02788201|11894846|FG001|Overall Study|Ineligible|0
7542989|NCT02788201|11894847|FG002|Overall Study|Ineligible|0
7542990|NCT02788201|11894848|FG003|Overall Study|Ineligible|0
7542991|NCT02788201|11894849|FG004|Overall Study|Ineligible|0
7542992|NCT02788201|11894850|FG005|Overall Study|Ineligible|1
7542993|NCT02788201|11894845|FG000|Overall Study|Withdrawal by Subject|0
7259193|NCT00347919|11471490|FG002|Overall Study|Par. Started Other Treatment|1
7542994|NCT02788201|11894846|FG001|Overall Study|Withdrawal by Subject|0
7542995|NCT02788201|11894847|FG002|Overall Study|Withdrawal by Subject|0
7542996|NCT02788201|11894848|FG003|Overall Study|Withdrawal by Subject|0
7259194|NCT00347919|11471488|FG000|Overall Study|Missing|2
7259195|NCT00347919|11471489|FG001|Overall Study|Missing|1
7259196|NCT00347919|11471490|FG002|Overall Study|Missing|2
7259197|NCT00347932|11471502|FG000|Overall Study|Adverse Event|4
7259198|NCT00347932|11471503|FG001|Overall Study|Adverse Event|5
7259199|NCT00347932|11471502|FG000|Overall Study|Lack of Efficacy|3
7259200|NCT00347932|11471503|FG001|Overall Study|Lack of Efficacy|14
7259201|NCT00347932|11471502|FG000|Overall Study|Lost to Follow-up|10
7259202|NCT00347932|11471503|FG001|Overall Study|Lost to Follow-up|9
7259203|NCT00347932|11471502|FG000|Overall Study|Withdrawal by Subject|10
7259204|NCT00347932|11471503|FG001|Overall Study|Withdrawal by Subject|16
7259205|NCT00347932|11471502|FG000|Overall Study|Did not meet inclusion criteria|4
7259206|NCT00347932|11471503|FG001|Overall Study|Did not meet inclusion criteria|8
7259207|NCT00347958|11471509|FG000|Overall Study|Adverse Event|1
7259208|NCT00347958|11471509|FG000|Overall Study|Protocol Violation|2
7259209|NCT00347958|11471509|FG000|Overall Study|Withdrawal by Subject|1
7259210|NCT00348140|11471516|FG000|Overall Study|Adverse Event|46
7259211|NCT00348140|11471517|FG001|Overall Study|Adverse Event|49
7259212|NCT00348140|11471518|FG002|Overall Study|Adverse Event|78
7259213|NCT00348140|11471516|FG000|Overall Study|Lost to Follow-up|4
7259214|NCT00348140|11471517|FG001|Overall Study|Lost to Follow-up|4
7259215|NCT00348140|11471518|FG002|Overall Study|Lost to Follow-up|4
7259216|NCT00348140|11471516|FG000|Overall Study|Protocol Violation|12
7259217|NCT00348140|11471517|FG001|Overall Study|Protocol Violation|13
7259218|NCT00348140|11471518|FG002|Overall Study|Protocol Violation|14
7259219|NCT00348140|11471516|FG000|Overall Study|Withdrawal by Subject|32
7259220|NCT00348140|11471517|FG001|Overall Study|Withdrawal by Subject|40
7259221|NCT00348140|11471518|FG002|Overall Study|Withdrawal by Subject|40
7259222|NCT00348140|11471516|FG000|Overall Study|Non-compliance|8
7259223|NCT00348140|11471517|FG001|Overall Study|Non-compliance|13
7542997|NCT02788201|11894849|FG004|Overall Study|Withdrawal by Subject|0
7542998|NCT02788201|11894850|FG005|Overall Study|Withdrawal by Subject|1
7542999|NCT02788279|11894869|FG000|Overall Study|Death|62
7543000|NCT02788279|11894870|FG001|Overall Study|Death|136
7543001|NCT02788279|11894871|FG002|Overall Study|Death|72
7543002|NCT02788279|11894869|FG000|Overall Study|Withdrawal by Subject|10
7543003|NCT02788279|11894870|FG001|Overall Study|Withdrawal by Subject|15
7543004|NCT02788279|11894871|FG002|Overall Study|Withdrawal by Subject|5
7543005|NCT02788279|11894869|FG000|Overall Study|Lost to Follow-up|0
7543006|NCT02788279|11894870|FG001|Overall Study|Lost to Follow-up|3
7543007|NCT02788279|11894871|FG002|Overall Study|Lost to Follow-up|2
7543008|NCT02788279|11894869|FG000|Overall Study|Sponsor decision|18
7543009|NCT02788279|11894870|FG001|Overall Study|Sponsor decision|29
7543010|NCT02788279|11894871|FG002|Overall Study|Sponsor decision|11
7543011|NCT02788357|11894884|FG000|Overall Study|Lost to Follow-up|3
7543012|NCT02788357|11894885|FG001|Overall Study|Lost to Follow-up|0
7543013|NCT02788474|11894893|FG000|Double Blind Treatment Period|Not treated|1
7543014|NCT02788474|11894894|FG001|Double Blind Treatment Period|Not treated|0
7543015|NCT02788474|11894893|FG000|Double Blind Treatment Period|Patient's refusal|3
7576269|NCT04384523|11962330|FG005|Overall Study|Withdrawal by Subject|0
7576276|NCT04380688|11962438|FG000|Overall Study|Death|2
7576277|NCT04380688|11962439|FG001|Overall Study|Death|2
7576278|NCT04380688|11962438|FG000|Overall Study|Lost to Follow-up|2
7576279|NCT04380688|11962439|FG001|Overall Study|Lost to Follow-up|4
7259224|NCT00348140|11471518|FG002|Overall Study|Non-compliance|5
7576280|NCT04380688|11962438|FG000|Overall Study|Withdrawal by Subject|3
7259225|NCT00348140|11471516|FG000|Overall Study|Participant at risk due to study drug|2
7259226|NCT00348140|11471517|FG001|Overall Study|Participant at risk due to study drug|0
7576281|NCT04380688|11962439|FG001|Overall Study|Withdrawal by Subject|3
7259227|NCT00348140|11471518|FG002|Overall Study|Participant at risk due to study drug|0
7259228|NCT00348140|11471516|FG000|Overall Study|Conditional medication increased dose|1
7259229|NCT00348140|11471517|FG001|Overall Study|Conditional medication increased dose|0
7259230|NCT00348140|11471518|FG002|Overall Study|Conditional medication increased dose|0
7259231|NCT00348140|11471516|FG000|Overall Study|Caregiver related|4
7259232|NCT00348140|11471517|FG001|Overall Study|Caregiver related|7
7259233|NCT00348140|11471518|FG002|Overall Study|Caregiver related|3
7259234|NCT00348140|11471516|FG000|Overall Study|Participant hospitalised|3
7259235|NCT00348140|11471517|FG001|Overall Study|Participant hospitalised|0
7259236|NCT00348140|11471518|FG002|Overall Study|Participant hospitalised|0
7259237|NCT00348140|11471516|FG000|Overall Study|Efficacy related|1
7259238|NCT00348140|11471517|FG001|Overall Study|Efficacy related|1
7259239|NCT00348140|11471518|FG002|Overall Study|Efficacy related|0
7259240|NCT00348140|11471516|FG000|Overall Study|Administration related|3
7259241|NCT00348140|11471517|FG001|Overall Study|Administration related|1
7259242|NCT00348140|11471518|FG002|Overall Study|Administration related|1
7259243|NCT00348140|11471516|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
7259244|NCT00348140|11471517|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
7259245|NCT00348140|11471518|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
7259246|NCT00348140|11471516|FG000|Overall Study|Participant unwell|1
7259247|NCT00348140|11471517|FG001|Overall Study|Participant unwell|0
7259248|NCT00348140|11471518|FG002|Overall Study|Participant unwell|0
7259249|NCT00348140|11471516|FG000|Overall Study|Screen failure|1
7259250|NCT00348140|11471517|FG001|Overall Study|Screen failure|0
7259251|NCT00348140|11471518|FG002|Overall Study|Screen failure|0
7259252|NCT00348140|11471516|FG000|Overall Study|Investigator decided to discontinue|4
7259253|NCT00348140|11471517|FG001|Overall Study|Investigator decided to discontinue|1
7259254|NCT00348140|11471518|FG002|Overall Study|Investigator decided to discontinue|4
7259255|NCT00348140|11471516|FG000|Overall Study|Decided to discontinue on their own|1
7259256|NCT00348140|11471517|FG001|Overall Study|Decided to discontinue on their own|4
7259257|NCT00348140|11471518|FG002|Overall Study|Decided to discontinue on their own|1
7259258|NCT00348140|11471516|FG000|Overall Study|Use of prohibited drug|1
7259259|NCT00348140|11471517|FG001|Overall Study|Use of prohibited drug|0
7259260|NCT00348140|11471518|FG002|Overall Study|Use of prohibited drug|2
7259261|NCT00348140|11471516|FG000|Overall Study|Disease progression|1
7259262|NCT00348140|11471517|FG001|Overall Study|Disease progression|2
7259263|NCT00348140|11471518|FG002|Overall Study|Disease progression|5
7259264|NCT00348140|11471516|FG000|Overall Study|Increased risk of cardiac infarction|0
7259265|NCT00348140|11471517|FG001|Overall Study|Increased risk of cardiac infarction|1
7259266|NCT00348140|11471518|FG002|Overall Study|Increased risk of cardiac infarction|0
7259267|NCT00348140|11471516|FG000|Overall Study|Serious adverse event|0
7259268|NCT00348140|11471517|FG001|Overall Study|Serious adverse event|1
7259269|NCT00348140|11471518|FG002|Overall Study|Serious adverse event|0
7259270|NCT00348140|11471516|FG000|Overall Study|Abnormal ECG|0
7259271|NCT00348140|11471517|FG001|Overall Study|Abnormal ECG|1
7259272|NCT00348140|11471518|FG002|Overall Study|Abnormal ECG|3
7259273|NCT00348140|11471516|FG000|Overall Study|Participant died|0
7259274|NCT00348140|11471517|FG001|Overall Study|Participant died|1
7259275|NCT00348140|11471518|FG002|Overall Study|Participant died|0
7259276|NCT00348140|11471516|FG000|Overall Study|Exclusion criteria met|0
7259277|NCT00348140|11471517|FG001|Overall Study|Exclusion criteria met|0
7259278|NCT00348140|11471518|FG002|Overall Study|Exclusion criteria met|1
7259279|NCT00348140|11471516|FG000|Overall Study|Memory declined|0
7259280|NCT00348140|11471517|FG001|Overall Study|Memory declined|0
7259281|NCT00348140|11471518|FG002|Overall Study|Memory declined|1
7259282|NCT00348283|11471533|FG000|Induction|Adverse Event|0
7259283|NCT00348283|11471534|FG001|Induction|Adverse Event|2
7259284|NCT00348283|11471533|FG000|Induction|Protocol Violation|0
7259285|NCT00348283|11471534|FG001|Induction|Protocol Violation|4
7259286|NCT00348283|11471533|FG000|Double Blind|Adverse Event|2
7259287|NCT00348283|11471534|FG001|Double Blind|Adverse Event|5
7259288|NCT00348283|11471533|FG000|Double Blind|Withdrawal by Subject|1
7259289|NCT00348283|11471534|FG001|Double Blind|Withdrawal by Subject|1
7259290|NCT00348283|11471533|FG000|Double Blind|Protocol Violation|0
7576282|NCT04376060|11962445|FG000|Overall Study|Physician Decision|1
7576283|NCT04372186|11962464|FG000|Overall Study|Death|24
7259291|NCT00348283|11471534|FG001|Double Blind|Protocol Violation|1
7259292|NCT00348283|11471533|FG000|Double Blind|Lack of Efficacy|2
7576284|NCT04372186|11962465|FG001|Overall Study|Death|11
7259293|NCT00348283|11471534|FG001|Double Blind|Lack of Efficacy|2
7259294|NCT00348283|11471533|FG000|Double Blind|Pregnancy|0
7259295|NCT00348283|11471534|FG001|Double Blind|Pregnancy|1
7259296|NCT00348283|11471533|FG000|Open Label|Adverse Event|0
7259297|NCT00348283|11471534|FG001|Open Label|Adverse Event|8
7259298|NCT00348283|11471533|FG000|Open Label|Withdrawal by Subject|0
7259299|NCT00348283|11471534|FG001|Open Label|Withdrawal by Subject|4
7259300|NCT00348283|11471533|FG000|Open Label|Lost to Follow-up|0
7259301|NCT00348283|11471534|FG001|Open Label|Lost to Follow-up|1
7259302|NCT00348283|11471533|FG000|Open Label|Lack of Efficacy|0
7259303|NCT00348283|11471534|FG001|Open Label|Lack of Efficacy|13
7259304|NCT00348283|11471533|FG000|Open Label|Administrative reasons|0
7259305|NCT00348283|11471534|FG001|Open Label|Administrative reasons|5
7259306|NCT00348283|11471533|FG000|Open Label|Subject moved to the United States|0
7259307|NCT00348283|11471534|FG001|Open Label|Subject moved to the United States|1
7259308|NCT00348283|11471533|FG000|Open Label|Pregnancy|0
7259309|NCT00348283|11471534|FG001|Open Label|Pregnancy|1
7259310|NCT00348283|11471533|FG000|Open Label|Sponsor decision|0
7259311|NCT00348283|11471534|FG001|Open Label|Sponsor decision|1
7259312|NCT00348309|11471543|FG000|Overall Study|Adverse Event|56
7259313|NCT00348309|11471544|FG001|Overall Study|Adverse Event|28
7259314|NCT00348309|11471545|FG002|Overall Study|Adverse Event|63
7259315|NCT00348309|11471543|FG000|Overall Study|Lost to Follow-up|6
7259316|NCT00348309|11471544|FG001|Overall Study|Lost to Follow-up|7
7259317|NCT00348309|11471545|FG002|Overall Study|Lost to Follow-up|4
7259318|NCT00348309|11471543|FG000|Overall Study|Protocol Violation|7
7259319|NCT00348309|11471544|FG001|Overall Study|Protocol Violation|12
7259320|NCT00348309|11471545|FG002|Overall Study|Protocol Violation|7
7259321|NCT00348309|11471543|FG000|Overall Study|Withdrawal by Subject|33
7259322|NCT00348309|11471544|FG001|Overall Study|Withdrawal by Subject|37
7259323|NCT00348309|11471545|FG002|Overall Study|Withdrawal by Subject|40
7259324|NCT00348309|11471543|FG000|Overall Study|Non-compliance|8
7259325|NCT00348309|11471544|FG001|Overall Study|Non-compliance|6
7259326|NCT00348309|11471545|FG002|Overall Study|Non-compliance|8
7259327|NCT00348309|11471543|FG000|Overall Study|Death of caregiver|1
7259328|NCT00348309|11471544|FG001|Overall Study|Death of caregiver|0
7259329|NCT00348309|11471545|FG002|Overall Study|Death of caregiver|1
7259330|NCT00348309|11471543|FG000|Overall Study|Lack of insight, dementia|1
7259331|NCT00348309|11471544|FG001|Overall Study|Lack of insight, dementia|0
7259332|NCT00348309|11471545|FG002|Overall Study|Lack of insight, dementia|0
7259333|NCT00348309|11471543|FG000|Overall Study|Wrong bottle allocated|1
7259334|NCT00348309|11471544|FG001|Overall Study|Wrong bottle allocated|0
7259335|NCT00348309|11471545|FG002|Overall Study|Wrong bottle allocated|0
7259336|NCT00348309|11471543|FG000|Overall Study|Caregiver sick|1
7543016|NCT02788474|11894894|FG001|Double Blind Treatment Period|Patient's refusal|0
7543017|NCT02788474|11894893|FG000|Double Blind Treatment Period|Adverse Event|6
7543018|NCT02788474|11894894|FG001|Double Blind Treatment Period|Adverse Event|4
7543019|NCT02788474|11894893|FG000|Open Label Treatment Period|Adverse Event|29
7543020|NCT02788474|11894894|FG001|Open Label Treatment Period|Adverse Event|9
7543021|NCT02788474|11894893|FG000|Open Label Treatment Period|Other than reason specified|1
7543022|NCT02788474|11894894|FG001|Open Label Treatment Period|Other than reason specified|0
7543023|NCT02788474|11894893|FG000|Open Label Treatment Period|Patient's refusal|1
7543024|NCT02788474|11894894|FG001|Open Label Treatment Period|Patient's refusal|3
7543025|NCT02788474|11894893|FG000|Open Label Treatment Period|Non-compliance|1
7543026|NCT02788474|11894894|FG001|Open Label Treatment Period|Non-compliance|0
7543027|NCT02788513|11894906|FG000|Overall Study|Withdrawal by Subject|3
7259337|NCT00348309|11471544|FG001|Overall Study|Caregiver sick|0
7259338|NCT00348309|11471545|FG002|Overall Study|Caregiver sick|0
7259339|NCT00348309|11471543|FG000|Overall Study|Use of prohibited medication|5
7259340|NCT00348309|11471544|FG001|Overall Study|Use of prohibited medication|2
7259341|NCT00348309|11471545|FG002|Overall Study|Use of prohibited medication|2
7259342|NCT00348309|11471543|FG000|Overall Study|Caregiver withdrawal|3
7259343|NCT00348309|11471544|FG001|Overall Study|Caregiver withdrawal|0
7259344|NCT00348309|11471545|FG002|Overall Study|Caregiver withdrawal|7
7259345|NCT00348309|11471543|FG000|Overall Study|Unable to complete ET visit|1
7259346|NCT00348309|11471544|FG001|Overall Study|Unable to complete ET visit|0
7259347|NCT00348309|11471545|FG002|Overall Study|Unable to complete ET visit|0
7259348|NCT00348309|11471543|FG000|Overall Study|PI closing medical practice|1
7259349|NCT00348309|11471544|FG001|Overall Study|PI closing medical practice|0
7259350|NCT00348309|11471545|FG002|Overall Study|PI closing medical practice|0
7259351|NCT00348309|11471543|FG000|Overall Study|Principal investigator's decision|1
7259352|NCT00348309|11471544|FG001|Overall Study|Principal investigator's decision|0
7259353|NCT00348309|11471545|FG002|Overall Study|Principal investigator's decision|0
7259354|NCT00348309|11471543|FG000|Overall Study|No disponibility of medication|1
7259355|NCT00348309|11471544|FG001|Overall Study|No disponibility of medication|0
7259356|NCT00348309|11471545|FG002|Overall Study|No disponibility of medication|0
7259357|NCT00348309|11471543|FG000|Overall Study|Worsened neurodegenerative disease|1
7259358|NCT00348309|11471544|FG001|Overall Study|Worsened neurodegenerative disease|0
7259359|NCT00348309|11471545|FG002|Overall Study|Worsened neurodegenerative disease|0
7259360|NCT00348309|11471543|FG000|Overall Study|Cognitive and behaviour worsening|2
7259361|NCT00348309|11471544|FG001|Overall Study|Cognitive and behaviour worsening|0
7259362|NCT00348309|11471545|FG002|Overall Study|Cognitive and behaviour worsening|0
7259363|NCT00348309|11471543|FG000|Overall Study|Worsening of alzheimer|1
7259364|NCT00348309|11471544|FG001|Overall Study|Worsening of alzheimer|0
7259365|NCT00348309|11471545|FG002|Overall Study|Worsening of alzheimer|1
7259366|NCT00348309|11471543|FG000|Overall Study|Did not appear in time for Visit 3|1
7259367|NCT00348309|11471544|FG001|Overall Study|Did not appear in time for Visit 3|0
7259368|NCT00348309|11471545|FG002|Overall Study|Did not appear in time for Visit 3|0
7259369|NCT00348309|11471543|FG000|Overall Study|Participant died|2
7259370|NCT00348309|11471544|FG001|Overall Study|Participant died|1
7259371|NCT00348309|11471545|FG002|Overall Study|Participant died|1
7259372|NCT00348309|11471543|FG000|Overall Study|Decision of sponsor|1
7259373|NCT00348309|11471544|FG001|Overall Study|Decision of sponsor|0
7259374|NCT00348309|11471545|FG002|Overall Study|Decision of sponsor|0
7259375|NCT00348309|11471543|FG000|Overall Study|Ineffectiveness of treatment|0
7259376|NCT00348309|11471544|FG001|Overall Study|Ineffectiveness of treatment|1
7259377|NCT00348309|11471545|FG002|Overall Study|Ineffectiveness of treatment|0
7259378|NCT00348309|11471543|FG000|Overall Study|A foul of exclusion criteria|0
7259379|NCT00348309|11471544|FG001|Overall Study|A foul of exclusion criteria|1
7259380|NCT00348309|11471545|FG002|Overall Study|A foul of exclusion criteria|0
7259381|NCT00348309|11471543|FG000|Overall Study|Participant was hospitalized|0
7259382|NCT00348309|11471544|FG001|Overall Study|Participant was hospitalized|1
7259383|NCT00348309|11471545|FG002|Overall Study|Participant was hospitalized|0
7259384|NCT00348309|11471543|FG000|Overall Study|Sponsor refuseal|0
7259385|NCT00348309|11471544|FG001|Overall Study|Sponsor refuseal|1
7259386|NCT00348309|11471545|FG002|Overall Study|Sponsor refuseal|1
7259387|NCT00348309|11471543|FG000|Overall Study|Forgot often medication|0
7259388|NCT00348309|11471544|FG001|Overall Study|Forgot often medication|1
7259389|NCT00348309|11471545|FG002|Overall Study|Forgot often medication|0
7259390|NCT00348309|11471543|FG000|Overall Study|Medical Monitor decision|0
7259391|NCT00348309|11471544|FG001|Overall Study|Medical Monitor decision|0
7259392|NCT00348309|11471545|FG002|Overall Study|Medical Monitor decision|1
7259393|NCT00348309|11471543|FG000|Overall Study|Increased dose of Aricept|0
7259394|NCT00348309|11471544|FG001|Overall Study|Increased dose of Aricept|0
7259395|NCT00348309|11471545|FG002|Overall Study|Increased dose of Aricept|1
7259396|NCT00348309|11471543|FG000|Overall Study|Site closure|0
7259397|NCT00348309|11471544|FG001|Overall Study|Site closure|0
7259398|NCT00348309|11471545|FG002|Overall Study|Site closure|1
7259399|NCT00348309|11471543|FG000|Overall Study|Adverse event not attended|0
7259400|NCT00348309|11471544|FG001|Overall Study|Adverse event not attended|0
7259401|NCT00348309|11471545|FG002|Overall Study|Adverse event not attended|1
7259402|NCT00348309|11471543|FG000|Overall Study|ECG abnormal|0
7259403|NCT00348309|11471544|FG001|Overall Study|ECG abnormal|0
7259404|NCT00348309|11471545|FG002|Overall Study|ECG abnormal|2
7259405|NCT00348309|11471543|FG000|Overall Study|Cardiologist recommendations|0
7259406|NCT00348309|11471544|FG001|Overall Study|Cardiologist recommendations|0
7259407|NCT00348309|11471545|FG002|Overall Study|Cardiologist recommendations|1
7259408|NCT00348309|11471543|FG000|Overall Study|HCV career|0
7259409|NCT00348309|11471544|FG001|Overall Study|HCV career|0
7259410|NCT00348309|11471545|FG002|Overall Study|HCV career|1
7259411|NCT00348348|11471556|FG000|Overall Study|Adverse event - unrelated to study drug|0
7259412|NCT00348348|11471557|FG001|Overall Study|Adverse event - unrelated to study drug|1
7259413|NCT00348348|11471556|FG000|Overall Study|Lack of Efficacy|1
7259414|NCT00348348|11471557|FG001|Overall Study|Lack of Efficacy|1
7259415|NCT00348348|11471556|FG000|Overall Study|Lost to Follow-up|8
7259416|NCT00348348|11471557|FG001|Overall Study|Lost to Follow-up|10
7259417|NCT00348348|11471556|FG000|Overall Study|Withdrawal by Subject|4
7259418|NCT00348348|11471557|FG001|Overall Study|Withdrawal by Subject|1
7259419|NCT00348348|11471556|FG000|Overall Study|Other|7
7259420|NCT00348348|11471557|FG001|Overall Study|Other|4
7576285|NCT04372186|11962464|FG000|Overall Study|Transferred to a different facility for care|0
7576286|NCT04372186|11962465|FG001|Overall Study|Transferred to a different facility for care|2
7576287|NCT04370028|11962539|FG000|Overall Study|Withdrawal by Subject|695
7576288|NCT04370028|11962539|FG000|Overall Study|Protocol Violation|9
7576289|NCT04370028|11962539|FG000|Overall Study|Adverse Event|3
7576296|NCT04365699|11962571|FG000|Overall Study|Death|2
7576297|NCT04365699|11962572|FG001|Overall Study|Death|5
7576298|NCT04365699|11962573|FG002|Overall Study|Death|15
7259421|NCT00348348|11471556|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
7259422|NCT00348348|11471557|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
7259423|NCT00348348|11471556|FG000|Overall Study|Dissallowed Meds - unlikley related|1
7259424|NCT00348348|11471557|FG001|Overall Study|Dissallowed Meds - unlikley related|1
7259425|NCT00348348|11471556|FG000|Overall Study|Dissallowed Meds - possibly releated|1
7259426|NCT00348348|11471557|FG001|Overall Study|Dissallowed Meds - possibly releated|1
7259427|NCT00348348|11471556|FG000|Overall Study|Worsening of BC - Unrelated to study|0
7259428|NCT00348348|11471557|FG001|Overall Study|Worsening of BC - Unrelated to study|3
7259429|NCT00348348|11471556|FG000|Overall Study|Worsening of BC - Unlikely related|1
7259430|NCT00348348|11471557|FG001|Overall Study|Worsening of BC - Unlikely related|2
7259431|NCT00348348|11471556|FG000|Overall Study|Adverse event probably related to study|1
7259432|NCT00348348|11471557|FG001|Overall Study|Adverse event probably related to study|0
7259433|NCT00348374|11471565|FG000|Overall Study|Adverse Event|1
7259434|NCT00348374|11471566|FG001|Overall Study|Adverse Event|4
7259435|NCT00348374|11471565|FG000|Overall Study|Lost to Follow-up|1
7259436|NCT00348374|11471566|FG001|Overall Study|Lost to Follow-up|3
7259437|NCT00348374|11471565|FG000|Overall Study|Withdrawal by Subject|5
7259438|NCT00348374|11471566|FG001|Overall Study|Withdrawal by Subject|5
7259439|NCT00348374|11471565|FG000|Overall Study|Other|11
7259440|NCT00348374|11471566|FG001|Overall Study|Other|12
7259441|NCT00348374|11471565|FG000|Overall Study|ongoing at date of cutoff|1
7259442|NCT00348374|11471566|FG001|Overall Study|ongoing at date of cutoff|1
7259443|NCT00348374|11471565|FG000|Overall Study|randomized but did not receive treatment|0
7259444|NCT00348374|11471566|FG001|Overall Study|randomized but did not receive treatment|7
7259445|NCT00348595|11471575|FG000|Overall Study|Adverse Event|5
7259446|NCT00348595|11471576|FG001|Overall Study|Adverse Event|8
7259447|NCT00348673|11471590|FG000|Stage 1|Randomized but not Treated|0
7259448|NCT00348673|11471591|FG001|Stage 1|Randomized but not Treated|0
7259449|NCT00348673|11471592|FG002|Stage 1|Randomized but not Treated|1
7259450|NCT00348673|11471593|FG003|Stage 1|Randomized but not Treated|0
7259451|NCT00348673|11471594|FG004|Stage 1|Randomized but not Treated|0
7259452|NCT00348673|11471595|FG005|Stage 1|Randomized but not Treated|0
7259453|NCT00348673|11471596|FG006|Stage 1|Randomized but not Treated|0
7259454|NCT00348673|11471597|FG007|Stage 1|Randomized but not Treated|0
7259455|NCT00348673|11471598|FG008|Stage 1|Randomized but not Treated|0
7259456|NCT00348686|11471616|FG000|Overall Study|Withdrawal by Subject|45
7259457|NCT00348686|11471616|FG000|Overall Study|Adverse Event|5
7543028|NCT02788513|11894907|FG001|Overall Study|Withdrawal by Subject|0
7543029|NCT02788513|11894908|FG002|Overall Study|Withdrawal by Subject|2
7543030|NCT02788513|11894909|FG003|Overall Study|Withdrawal by Subject|3
7543031|NCT02788513|11894910|FG004|Overall Study|Withdrawal by Subject|1
7543032|NCT02788513|11894906|FG000|Overall Study|Lost to Follow-up|1
7543033|NCT02788513|11894907|FG001|Overall Study|Lost to Follow-up|0
7543034|NCT02788513|11894908|FG002|Overall Study|Lost to Follow-up|0
7259458|NCT00348686|11471616|FG000|Overall Study|Protocol Violation|6
7259459|NCT00348686|11471616|FG000|Overall Study|Lost to Follow-up|2
7259460|NCT00348686|11471616|FG000|Overall Study|Multiple Reasons|8
7259461|NCT00348790|11471620|FG000|Completed Treatment|Withdrawal by Subject|4
7259462|NCT00348790|11471620|FG000|Completed Treatment|Disease progression|14
7259463|NCT00348790|11471620|FG000|Completed Treatment|Adverse Event|4
7259464|NCT00348790|11471620|FG000|Completed Treatment|Required surgery|2
7259465|NCT00348790|11471620|FG000|Completed Treatment|Unable to travel to study site|1
7259466|NCT00348816|11471625|FG000|Overall Study|Noncompliance with radiation treatment|1
7259467|NCT00348881|11471633|FG000|Overall Study|Lost to Follow-up|12
7259468|NCT00348881|11471634|FG001|Overall Study|Lost to Follow-up|6
7259469|NCT00348881|11471633|FG000|Overall Study|Withdrawal by Subject|3
7259470|NCT00348881|11471634|FG001|Overall Study|Withdrawal by Subject|4
7259471|NCT00348881|11471633|FG000|Overall Study|Adverse Event|2
7259472|NCT00348881|11471634|FG001|Overall Study|Adverse Event|0
7259473|NCT00348881|11471633|FG000|Overall Study|Serious Adverse Event|0
7543035|NCT02788513|11894909|FG003|Overall Study|Lost to Follow-up|0
7259474|NCT00348881|11471634|FG001|Overall Study|Serious Adverse Event|2
7259475|NCT00348933|11471644|FG000|Overall Study|Withdrawal by Subject|10
7259476|NCT00348933|11471644|FG000|Overall Study|Lost to Follow-up|6
7259477|NCT00348933|11471644|FG000|Overall Study|Protocol Violation|2
7259478|NCT00348933|11471644|FG000|Overall Study|Adverse Event|7
7259479|NCT00349349|11471672|FG000|Overall Study|Adverse Event|5
7259480|NCT00349349|11471673|FG001|Overall Study|Adverse Event|6
7259481|NCT00349349|11471674|FG002|Overall Study|Adverse Event|2
7259482|NCT00349349|11471672|FG000|Overall Study|Withdrawal by Subject|5
7259483|NCT00349349|11471673|FG001|Overall Study|Withdrawal by Subject|2
7259484|NCT00349349|11471674|FG002|Overall Study|Withdrawal by Subject|1
7259485|NCT00349349|11471672|FG000|Overall Study|Withdrawn due to Disease Progression|27
7259486|NCT00349349|11471673|FG001|Overall Study|Withdrawn due to Disease Progression|37
7259487|NCT00349349|11471674|FG002|Overall Study|Withdrawn due to Disease Progression|1
7259488|NCT00349349|11471672|FG000|Overall Study|Death|13
7259489|NCT00349349|11471673|FG001|Overall Study|Death|10
7259490|NCT00349349|11471674|FG002|Overall Study|Death|1
7259491|NCT00349349|11471672|FG000|Overall Study|Other Treatment Selected|2
7259492|NCT00349349|11471673|FG001|Overall Study|Other Treatment Selected|0
7259493|NCT00349349|11471674|FG002|Overall Study|Other Treatment Selected|0
7259494|NCT00349349|11471672|FG000|Overall Study|Participant Reduced General Condition|0
7259495|NCT00349349|11471673|FG001|Overall Study|Participant Reduced General Condition|1
7259496|NCT00349349|11471674|FG002|Overall Study|Participant Reduced General Condition|0
7259497|NCT00349349|11471672|FG000|Overall Study|Physician Decision|1
7259498|NCT00349349|11471673|FG001|Overall Study|Physician Decision|2
7259499|NCT00349349|11471674|FG002|Overall Study|Physician Decision|1
7259500|NCT00349349|11471672|FG000|Overall Study|No Response|0
7259501|NCT00349349|11471673|FG001|Overall Study|No Response|3
7259502|NCT00349349|11471674|FG002|Overall Study|No Response|0
7259503|NCT00349349|11471672|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
7259504|NCT00349349|11471673|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
7259505|NCT00349349|11471674|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
7259506|NCT00349622|11471695|FG000|Overall Study|Death|168
7543036|NCT02788513|11894910|FG004|Overall Study|Lost to Follow-up|1
7543037|NCT02788513|11894906|FG000|Overall Study|Adverse Event|5
7543038|NCT02788513|11894907|FG001|Overall Study|Adverse Event|8
7259507|NCT00349622|11471696|FG001|Overall Study|Death|86
7259508|NCT00349622|11471695|FG000|Overall Study|Lost to Follow-up|5
7543039|NCT02788513|11894908|FG002|Overall Study|Adverse Event|4
7543040|NCT02788513|11894909|FG003|Overall Study|Adverse Event|2
7543041|NCT02788513|11894910|FG004|Overall Study|Adverse Event|2
7543042|NCT02788513|11894906|FG000|Overall Study|Protocol Violation|0
7543043|NCT02788513|11894907|FG001|Overall Study|Protocol Violation|0
7543044|NCT02788513|11894908|FG002|Overall Study|Protocol Violation|1
7543045|NCT02788513|11894909|FG003|Overall Study|Protocol Violation|1
7543046|NCT02788513|11894910|FG004|Overall Study|Protocol Violation|0
7543047|NCT02788513|11894906|FG000|Overall Study|Subject decided to stop taking treatment|0
7543048|NCT02788513|11894907|FG001|Overall Study|Subject decided to stop taking treatment|0
7543049|NCT02788513|11894908|FG002|Overall Study|Subject decided to stop taking treatment|1
7543050|NCT02788513|11894909|FG003|Overall Study|Subject decided to stop taking treatment|0
7543051|NCT02788513|11894910|FG004|Overall Study|Subject decided to stop taking treatment|0
7543052|NCT02788513|11894906|FG000|Overall Study|Decision by the study team|0
7259509|NCT00349622|11471696|FG001|Overall Study|Lost to Follow-up|1
7259510|NCT00349622|11471695|FG000|Overall Study|Withdrawal by Subject|5
7259511|NCT00349622|11471696|FG001|Overall Study|Withdrawal by Subject|9
7543053|NCT02788513|11894907|FG001|Overall Study|Decision by the study team|0
7543054|NCT02788513|11894908|FG002|Overall Study|Decision by the study team|0
7543055|NCT02788513|11894909|FG003|Overall Study|Decision by the study team|0
7543056|NCT02788513|11894910|FG004|Overall Study|Decision by the study team|1
7543057|NCT02788656|11894924|FG000|Overall Study|Withdrawal by Subject|1
7543058|NCT02788656|11894925|FG001|Overall Study|Withdrawal by Subject|0
7543059|NCT02788747|11894934|FG000|Overall Study|Adverse Event|1
7576299|NCT04362137|11962606|FG000|Overall Study|Death|9
7576300|NCT04362137|11962607|FG001|Overall Study|Death|3
7576301|NCT04362137|11962606|FG000|Overall Study|Patient decision|6
7576302|NCT04362137|11962607|FG001|Overall Study|Patient decision|3
7576303|NCT04362137|11962606|FG000|Overall Study|Adverse Event|1
7576304|NCT04362137|11962607|FG001|Overall Study|Adverse Event|0
7576305|NCT04362137|11962606|FG000|Overall Study|Lost to Follow-up|1
7576306|NCT04362137|11962607|FG001|Overall Study|Lost to Follow-up|0
7576307|NCT04362137|11962606|FG000|Overall Study|Protocol deviation|1
7576308|NCT04362137|11962607|FG001|Overall Study|Protocol deviation|0
7576309|NCT04359771|11962615|FG000|Overall Study|Lack of Efficacy|2
7576310|NCT04359771|11962616|FG001|Overall Study|Lack of Efficacy|2
7576311|NCT04358081|11962629|FG000|Treatment Phase of Study|Withdrawal by Subject|0
7576312|NCT04358081|11962630|FG001|Treatment Phase of Study|Withdrawal by Subject|1
7576313|NCT04358081|11962631|FG002|Treatment Phase of Study|Withdrawal by Subject|1
7576314|NCT04358081|11962629|FG000|Treatment Phase of Study|Adverse Event|1
7576315|NCT04358081|11962630|FG001|Treatment Phase of Study|Adverse Event|0
7576316|NCT04358081|11962631|FG002|Treatment Phase of Study|Adverse Event|1
7576317|NCT04358081|11962629|FG000|Treatment Phase of Study|Physician Decision|2
7576318|NCT04358081|11962630|FG001|Treatment Phase of Study|Physician Decision|0
7576319|NCT04358081|11962631|FG002|Treatment Phase of Study|Physician Decision|1
7576320|NCT04358081|11962629|FG000|Treatment Phase of Study|Protocol Violation|1
7576321|NCT04358081|11962630|FG001|Treatment Phase of Study|Protocol Violation|0
7543060|NCT02788747|11894935|FG001|Overall Study|Adverse Event|0
7543061|NCT02788747|11894936|FG002|Overall Study|Adverse Event|0
7543062|NCT02789111|11894977|FG000|Overall Study|Withdrawal by Subject|1
7576322|NCT04358081|11962631|FG002|Treatment Phase of Study|Protocol Violation|0
7576323|NCT04358081|11962629|FG000|Study Completion Phase|Death|0
7576324|NCT04358081|11962630|FG001|Study Completion Phase|Death|0
7576325|NCT04358081|11962631|FG002|Study Completion Phase|Death|1
7576326|NCT04358081|11962629|FG000|Study Completion Phase|Lost to Follow-up|1
7576327|NCT04358081|11962630|FG001|Study Completion Phase|Lost to Follow-up|0
7576328|NCT04358081|11962631|FG002|Study Completion Phase|Lost to Follow-up|1
7576329|NCT04356937|11962643|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
7576330|NCT04356937|11962644|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
7576331|NCT04355663|11962653|FG000|Overall Study|Physician Decision|2
7576332|NCT04355663|11962654|FG001|Overall Study|Physician Decision|7
7576333|NCT04355663|11962655|FG002|Overall Study|Physician Decision|0
7576334|NCT04355663|11962653|FG000|Overall Study|Adverse Event|0
7576335|NCT04355663|11962654|FG001|Overall Study|Adverse Event|0
7576336|NCT04355663|11962655|FG002|Overall Study|Adverse Event|1
7576337|NCT04355663|11962653|FG000|Overall Study|Withdrawal by Subject|0
7576338|NCT04355663|11962654|FG001|Overall Study|Withdrawal by Subject|8
7576339|NCT04355663|11962655|FG002|Overall Study|Withdrawal by Subject|3
7576340|NCT04354870|11962665|FG000|Overall Study|Lost to Follow-up|32
7576341|NCT04354870|11962666|FG001|Overall Study|Lost to Follow-up|12
7576342|NCT04354870|11962665|FG000|Overall Study|Withdrawal by Subject|10
7576343|NCT04354870|11962666|FG001|Overall Study|Withdrawal by Subject|16
7576344|NCT04354870|11962665|FG000|Overall Study|Did not complete all study visits|6
7576345|NCT04354870|11962666|FG001|Overall Study|Did not complete all study visits|5
7259512|NCT00349752|11471717|FG000|Overall Study|Adverse Event|8
7259513|NCT00349752|11471718|FG001|Overall Study|Adverse Event|12
7259514|NCT00349752|11471717|FG000|Overall Study|Lack of Efficacy|37
7259515|NCT00349752|11471718|FG001|Overall Study|Lack of Efficacy|42
7259516|NCT00349752|11471717|FG000|Overall Study|Lost to Follow-up|4
7259517|NCT00349752|11471718|FG001|Overall Study|Lost to Follow-up|2
7259518|NCT00349752|11471717|FG000|Overall Study|Personal reasons|6
7259519|NCT00349752|11471718|FG001|Overall Study|Personal reasons|5
7259520|NCT00349752|11471717|FG000|Overall Study|Other: Required exclusionary medication|0
7259521|NCT00349752|11471718|FG001|Overall Study|Other: Required exclusionary medication|1
7259522|NCT00349752|11471717|FG000|Overall Study|Other: Non compliance|0
7259523|NCT00349752|11471718|FG001|Overall Study|Other: Non compliance|1
7259524|NCT00349752|11471717|FG000|Overall Study|Other: Patient stopped steroids|0
7259525|NCT00349752|11471718|FG001|Overall Study|Other: Patient stopped steroids|1
7259526|NCT00349752|11471717|FG000|Overall Study|Other: Patient's steroid use|1
7259527|NCT00349752|11471718|FG001|Overall Study|Other: Patient's steroid use|0
7259528|NCT00349752|11471717|FG000|Overall Study|Other: Ineligible|1
7259529|NCT00349752|11471718|FG001|Overall Study|Other: Ineligible|0
7259530|NCT00349752|11471717|FG000|Overall Study|Other: Inadvertently unblinded|1
7259531|NCT00349752|11471718|FG001|Overall Study|Other: Inadvertently unblinded|0
7259532|NCT00349752|11471717|FG000|Overall Study|Other:History of squamous cell carcinoma|1
7259533|NCT00349752|11471718|FG001|Overall Study|Other:History of squamous cell carcinoma|0
7259534|NCT00349908|11471730|FG000|Overall Study|Withdrawal by Subject|0
7259535|NCT00349908|11471731|FG001|Overall Study|Withdrawal by Subject|4
7259536|NCT00349921|11471742|FG000|First Spinal Injection|Physician Decision|1
7259537|NCT00349921|11471743|FG001|First Spinal Injection|Physician Decision|0
7259538|NCT00349921|11471744|FG002|First Spinal Injection|Physician Decision|0
7259539|NCT00349921|11471745|FG003|First Spinal Injection|Physician Decision|0
7259540|NCT00349921|11471742|FG000|First Spinal Injection|Adverse Event|0
7259541|NCT00349921|11471743|FG001|First Spinal Injection|Adverse Event|0
7259542|NCT00349921|11471744|FG002|First Spinal Injection|Adverse Event|1
7259543|NCT00349921|11471745|FG003|First Spinal Injection|Adverse Event|0
7259544|NCT00349973|11471756|FG000|Overall Study|Adverse Event|3
7259545|NCT00349973|11471757|FG001|Overall Study|Adverse Event|3
7259546|NCT00349973|11471756|FG000|Overall Study|Withdrawal by Subject|1
7259547|NCT00349973|11471757|FG001|Overall Study|Withdrawal by Subject|0
7259548|NCT00350207|11471780|FG000|Overall Study|Adverse Event|5
7259549|NCT00350207|11471781|FG001|Overall Study|Adverse Event|2
7259550|NCT00350207|11471782|FG002|Overall Study|Adverse Event|2
7259551|NCT00350207|11471780|FG000|Overall Study|Lack of Efficacy|1
7259552|NCT00350207|11471781|FG001|Overall Study|Lack of Efficacy|0
7259553|NCT00350207|11471782|FG002|Overall Study|Lack of Efficacy|2
7259554|NCT00350207|11471780|FG000|Overall Study|Lost to Follow-up|1
7259555|NCT00350207|11471781|FG001|Overall Study|Lost to Follow-up|0
7259556|NCT00350207|11471782|FG002|Overall Study|Lost to Follow-up|1
7259557|NCT00350207|11471780|FG000|Overall Study|Withdrawal by Subject|0
7259558|NCT00350207|11471781|FG001|Overall Study|Withdrawal by Subject|1
7259559|NCT00350207|11471782|FG002|Overall Study|Withdrawal by Subject|1
7259560|NCT00350207|11471780|FG000|Overall Study|Other|1
7259561|NCT00350207|11471781|FG001|Overall Study|Other|3
7259562|NCT00350207|11471782|FG002|Overall Study|Other|1
7543063|NCT02789111|11894978|FG001|Overall Study|Withdrawal by Subject|4
7259563|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Adverse Event|1
7259564|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Adverse Event|0
7259565|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Death|1
7259566|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Death|0
7259567|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
7259568|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
7259569|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
7259570|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
7259571|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Physician Decision|2
7259572|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Physician Decision|1
7259573|NCT00350272|11471801|FG000|Blinded 12 Week Treatment|Sponsor decision|0
7259574|NCT00350272|11471802|FG001|Blinded 12 Week Treatment|Sponsor decision|1
7259575|NCT00350272|11471801|FG000|Open-Label 84 Week Treatment|Adverse Event|2
7259576|NCT00350272|11471802|FG001|Open-Label 84 Week Treatment|Adverse Event|1
7259577|NCT00350272|11471801|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
7259578|NCT00350272|11471802|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
7259579|NCT00350272|11471801|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
7259580|NCT00350272|11471802|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
7259581|NCT00350272|11471801|FG000|Open-Label 84 Week Treatment|Physician Decision|1
7259582|NCT00350272|11471802|FG001|Open-Label 84 Week Treatment|Physician Decision|2
7259583|NCT00350272|11471801|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
7259584|NCT00350272|11471802|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
7259585|NCT00350298|11471812|FG000|Overall Study|Death|7
7259586|NCT00350298|11471813|FG001|Overall Study|Death|8
7543064|NCT02789137|11894986|FG000|Overall Study|Dropped out/Died|58
7543065|NCT02789176|11894995|FG000|Overall Study|Death|0
7543066|NCT02789176|11894996|FG001|Overall Study|Death|0
7543067|NCT02789176|11894997|FG002|Overall Study|Death|3
7543068|NCT02789176|11894998|FG003|Overall Study|Death|0
7543069|NCT02789176|11894995|FG000|Overall Study|Withdrawal by Subject|0
7543070|NCT02789176|11894996|FG001|Overall Study|Withdrawal by Subject|0
7543071|NCT02789176|11894997|FG002|Overall Study|Withdrawal by Subject|1
7543072|NCT02789176|11894998|FG003|Overall Study|Withdrawal by Subject|0
7543073|NCT02789176|11894995|FG000|Overall Study|Lost to Follow-up|8
7543074|NCT02789176|11894996|FG001|Overall Study|Lost to Follow-up|2
7543075|NCT02789176|11894997|FG002|Overall Study|Lost to Follow-up|6
7543076|NCT02789176|11894998|FG003|Overall Study|Lost to Follow-up|1
7543077|NCT02790073|11895017|FG000|Overall Study|Death|1
7543078|NCT02790073|11895017|FG000|Overall Study|Withdrawal from HD|1
7543079|NCT02790073|11895017|FG000|Overall Study|Withdrawal by Subject|1
7543080|NCT02790437|11895027|FG000|Overall Study|Patient graft failure - nephrectomy|1
7543081|NCT02790437|11895028|FG001|Overall Study|Patient graft failure - nephrectomy|0
7543082|NCT02790437|11895027|FG000|Overall Study|Adverse Event|1
7543083|NCT02790437|11895028|FG001|Overall Study|Adverse Event|0
7543084|NCT02790437|11895027|FG000|Overall Study|Withdrawal by Subject|1
7543085|NCT02790437|11895028|FG001|Overall Study|Withdrawal by Subject|0
7543086|NCT02790606|11895050|FG000|Overall Study|Death|27
7543087|NCT02790606|11895050|FG000|Overall Study|Lost to Follow-up|4
7543088|NCT02790606|11895050|FG000|Overall Study|Physician Decision|3
7543089|NCT02790606|11895050|FG000|Overall Study|Withdrawal by Subject|1
7543090|NCT02791191|11895077|FG000|Overall Study|Adverse Event|2
7576346|NCT04350788|11962692|FG000|Overall Study|Lost to Follow-up|6
7576347|NCT04350788|11962693|FG001|Overall Study|Lost to Follow-up|2
7576348|NCT04350788|11962692|FG000|Overall Study|Withdrawal by Subject|2
7576349|NCT04350788|11962693|FG001|Overall Study|Withdrawal by Subject|4
7259587|NCT00350298|11471812|FG000|Overall Study|Lost to Follow-up|1
7259588|NCT00350298|11471813|FG001|Overall Study|Lost to Follow-up|2
7543091|NCT02791191|11895078|FG001|Overall Study|Adverse Event|4
7543092|NCT02791191|11895079|FG002|Overall Study|Adverse Event|5
7543093|NCT02791191|11895077|FG000|Overall Study|Lack of Efficacy|0
7543094|NCT02791191|11895078|FG001|Overall Study|Lack of Efficacy|1
7543095|NCT02791191|11895079|FG002|Overall Study|Lack of Efficacy|0
7543096|NCT02791191|11895077|FG000|Overall Study|Study Drug Non-Compliance|0
7543097|NCT02791191|11895078|FG001|Overall Study|Study Drug Non-Compliance|2
7543098|NCT02791191|11895079|FG002|Overall Study|Study Drug Non-Compliance|0
7259589|NCT00350298|11471812|FG000|Overall Study|Withdrawal by Subject|1
7543099|NCT02791191|11895077|FG000|Overall Study|Site Closed by Sponsor|1
7576350|NCT04350788|11962692|FG000|Overall Study|Protocol Violation|4
7543100|NCT02791191|11895078|FG001|Overall Study|Site Closed by Sponsor|1
7576351|NCT04350788|11962693|FG001|Overall Study|Protocol Violation|0
7576352|NCT04349917|11962706|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
7576353|NCT04349917|11962707|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
7576354|NCT04349917|11962706|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
7576355|NCT04349917|11962707|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
7576356|NCT04348851|11962718|FG000|Post-Test 1|Withdrawal by Subject|0
7576357|NCT04348851|11962719|FG001|Post-Test 1|Withdrawal by Subject|1
7576358|NCT04348851|11962720|FG002|Post-Test 1|Withdrawal by Subject|0
7576359|NCT04348851|11962721|FG003|Post-Test 1|Withdrawal by Subject|0
7576360|NCT04348851|11962718|FG000|Post-Test 1|Lost to Follow-up|0
7576361|NCT04348851|11962719|FG001|Post-Test 1|Lost to Follow-up|1
7576362|NCT04348851|11962720|FG002|Post-Test 1|Lost to Follow-up|0
7576363|NCT04348851|11962721|FG003|Post-Test 1|Lost to Follow-up|0
7576364|NCT04348851|11962718|FG000|Post-Test 2|Stroke survivor death|0
7576365|NCT04348851|11962719|FG001|Post-Test 2|Stroke survivor death|1
7576366|NCT04348851|11962720|FG002|Post-Test 2|Stroke survivor death|0
7576367|NCT04348851|11962721|FG003|Post-Test 2|Stroke survivor death|1
7576368|NCT04346199|11962742|FG000|Overall Study|Death|8
7576369|NCT04346199|11962743|FG001|Overall Study|Death|9
7576370|NCT04346199|11962742|FG000|Overall Study|Lost to Follow-up|0
7576371|NCT04346199|11962743|FG001|Overall Study|Lost to Follow-up|1
7576372|NCT04346199|11962742|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
7576373|NCT04346199|11962743|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
7576374|NCT04346199|11962742|FG000|Overall Study|Withdrawal by Subject|5
7576375|NCT04346199|11962743|FG001|Overall Study|Withdrawal by Subject|1
7576376|NCT04345653|11962749|FG000|Overall Study|Withdrawal by Subject|2
7576377|NCT04343261|11962754|FG000|Overall Study|Adverse Event|1
7576378|NCT04343261|11962754|FG000|Overall Study|received inadequate amount of antibodies|7
7576379|NCT04342897|11962786|FG000|Overall Study|Death|7
7576380|NCT04342897|11962787|FG001|Overall Study|Death|4
7576381|NCT04342897|11962786|FG000|Overall Study|Lost to Follow-up|6
7576382|NCT04342897|11962787|FG001|Overall Study|Lost to Follow-up|6
7576383|NCT04342897|11962786|FG000|Overall Study|Withdrawal by Subject|1
7576384|NCT04342897|11962787|FG001|Overall Study|Withdrawal by Subject|2
7576385|NCT04340557|11962799|FG000|Overall Study|Transferred to ICU and/or death|1
7576386|NCT04340557|11962800|FG001|Overall Study|Transferred to ICU and/or death|2
7576387|NCT04339972|11962808|FG000|Overall Study|Scheduling Issues|3
7576388|NCT04339972|11962809|FG001|Overall Study|Scheduling Issues|3
7576389|NCT04339972|11962808|FG000|Overall Study|dropout|1
7259590|NCT00350298|11471813|FG001|Overall Study|Withdrawal by Subject|3
7259591|NCT00350402|11471843|FG000|Overall Study|Lost to Follow-up|1
7259592|NCT00350402|11471844|FG001|Overall Study|Lost to Follow-up|1
7259593|NCT00350519|11471858|FG000|Overall Study|Death|0
7259594|NCT00350519|11471859|FG001|Overall Study|Death|1
7259595|NCT00350519|11471858|FG000|Overall Study|Physician Decision|0
7259596|NCT00350519|11471859|FG001|Overall Study|Physician Decision|1
7259597|NCT00350519|11471858|FG000|Overall Study|Protocol Violation|1
7259598|NCT00350519|11471859|FG001|Overall Study|Protocol Violation|2
7259599|NCT00350519|11471858|FG000|Overall Study|Withdrawal by Subject|3
7259600|NCT00350519|11471859|FG001|Overall Study|Withdrawal by Subject|2
7259601|NCT00350545|11471874|FG000|Overall Study|Withdrawal by Subject|2
7259602|NCT00350636|11471880|FG000|Overall Study|Adverse Event|19
7259603|NCT00350636|11471881|FG001|Overall Study|Adverse Event|13
7259604|NCT00350636|11471880|FG000|Overall Study|Protocol Violation|1
7259605|NCT00350636|11471881|FG001|Overall Study|Protocol Violation|3
7259606|NCT00350636|11471880|FG000|Overall Study|Withdrawal by Subject|13
7259607|NCT00350636|11471881|FG001|Overall Study|Withdrawal by Subject|17
7259608|NCT00350636|11471880|FG000|Overall Study|Lost to Follow-up|9
7259609|NCT00350636|11471881|FG001|Overall Study|Lost to Follow-up|8
7259610|NCT00350636|11471880|FG000|Overall Study|Physician Decision|0
7259611|NCT00350636|11471881|FG001|Overall Study|Physician Decision|2
7259612|NCT00350636|11471880|FG000|Overall Study|Other|1
7259613|NCT00350636|11471881|FG001|Overall Study|Other|2
7259614|NCT00350727|11471890|FG000|Phase I: Dose Escalation|Adverse Event|4
7259615|NCT00350727|11471891|FG001|Phase I: Dose Escalation|Adverse Event|0
7259616|NCT00350727|11471892|FG002|Phase I: Dose Escalation|Adverse Event|0
7259617|NCT00350727|11471890|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
7259618|NCT00350727|11471891|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
7259619|NCT00350727|11471892|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
7259620|NCT00350727|11471890|FG000|Phase I: Dose Escalation|Death|1
7259621|NCT00350727|11471891|FG001|Phase I: Dose Escalation|Death|0
7543101|NCT02791191|11895079|FG002|Overall Study|Site Closed by Sponsor|3
7543102|NCT02791191|11895077|FG000|Overall Study|Progressive Disease|1
7543103|NCT02791191|11895078|FG001|Overall Study|Progressive Disease|0
7543104|NCT02791191|11895079|FG002|Overall Study|Progressive Disease|0
7543105|NCT02791191|11895077|FG000|Overall Study|Study Terminated by Sponsor|29
7543106|NCT02791191|11895078|FG001|Overall Study|Study Terminated by Sponsor|101
7543107|NCT02791191|11895079|FG002|Overall Study|Study Terminated by Sponsor|109
7543108|NCT02791191|11895077|FG000|Overall Study|Withdrawal by Subject|3
7543109|NCT02791191|11895078|FG001|Overall Study|Withdrawal by Subject|1
7543110|NCT02791191|11895079|FG002|Overall Study|Withdrawal by Subject|3
7543111|NCT02791191|11895077|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
7543112|NCT02791191|11895078|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
7259622|NCT00350727|11471892|FG002|Phase I: Dose Escalation|Death|0
7259623|NCT00350727|11471890|FG000|Phase I: Dose Escalation|Physician Decision|1
7259624|NCT00350727|11471891|FG001|Phase I: Dose Escalation|Physician Decision|0
7259625|NCT00350727|11471892|FG002|Phase I: Dose Escalation|Physician Decision|0
7543113|NCT02791191|11895079|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
7543114|NCT02791269|11895089|FG000|Overall Study|Lost to Follow-up|0
7543115|NCT02791269|11895090|FG001|Overall Study|Lost to Follow-up|1
7543116|NCT02791438|11895122|FG000|Treatment Period|Adverse Event|1
7543117|NCT02791438|11895123|FG001|Treatment Period|Adverse Event|0
7543118|NCT02791438|11895122|FG000|Treatment Period|Withdrawal by Subject|0
7543119|NCT02791438|11895123|FG001|Treatment Period|Withdrawal by Subject|1
7543120|NCT02791438|11895122|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
7543121|NCT02791438|11895123|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
7543122|NCT02791490|11895131|FG000|Overall Study|Lost to Follow-up|1
7543123|NCT02791490|11895132|FG001|Overall Study|Lost to Follow-up|2
7543124|NCT02791490|11895131|FG000|Overall Study|Withdrawal by Subject|2
7259626|NCT00350727|11471890|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
7259627|NCT00350727|11471891|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
7259628|NCT00350727|11471892|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
7259629|NCT00350727|11471890|FG000|Phase II|Disease Progression|0
7259630|NCT00350727|11471891|FG001|Phase II|Disease Progression|15
7259631|NCT00350727|11471892|FG002|Phase II|Disease Progression|16
7259632|NCT00350727|11471890|FG000|Phase II|Clinical Deterioration|0
7259633|NCT00350727|11471891|FG001|Phase II|Clinical Deterioration|1
7259634|NCT00350727|11471892|FG002|Phase II|Clinical Deterioration|0
7259635|NCT00350727|11471890|FG000|Phase II|Withdrawal by Subject|0
7259636|NCT00350727|11471891|FG001|Phase II|Withdrawal by Subject|2
7259637|NCT00350727|11471892|FG002|Phase II|Withdrawal by Subject|1
7259638|NCT00350727|11471890|FG000|Phase II|Adverse Event|0
7259639|NCT00350727|11471891|FG001|Phase II|Adverse Event|1
7259640|NCT00350727|11471892|FG002|Phase II|Adverse Event|1
7259641|NCT00350727|11471890|FG000|Phase II|Death|0
7259642|NCT00350727|11471891|FG001|Phase II|Death|0
7259643|NCT00350727|11471892|FG002|Phase II|Death|2
7259644|NCT00350727|11471890|FG000|Phase II|Sponsor Terminated Study|0
7259645|NCT00350727|11471891|FG001|Phase II|Sponsor Terminated Study|0
7259646|NCT00350727|11471892|FG002|Phase II|Sponsor Terminated Study|1
7259647|NCT00350727|11471890|FG000|Phase II|Enrolled in Rollover Study|0
7259648|NCT00350727|11471891|FG001|Phase II|Enrolled in Rollover Study|0
7259649|NCT00350727|11471892|FG002|Phase II|Enrolled in Rollover Study|1
7259650|NCT00350779|11471913|FG000|Overall Study|Adverse Event|4
7259651|NCT00350779|11471914|FG001|Overall Study|Adverse Event|2
7259652|NCT00350779|11471913|FG000|Overall Study|Lack of Efficacy|0
7259653|NCT00350779|11471914|FG001|Overall Study|Lack of Efficacy|4
7259654|NCT00350779|11471913|FG000|Overall Study|Lost to Follow-up|2
7259655|NCT00350779|11471914|FG001|Overall Study|Lost to Follow-up|0
7259656|NCT00350779|11471913|FG000|Overall Study|Physician Decision|2
7259657|NCT00350779|11471914|FG001|Overall Study|Physician Decision|4
7259658|NCT00350779|11471913|FG000|Overall Study|Protocol Violation|3
7259659|NCT00350779|11471914|FG001|Overall Study|Protocol Violation|1
7259660|NCT00350779|11471913|FG000|Overall Study|Withdrawal by Subject|9
7259661|NCT00350779|11471914|FG001|Overall Study|Withdrawal by Subject|8
7259662|NCT00350779|11471913|FG000|Overall Study|Patient Moved|2
7259663|NCT00350779|11471914|FG001|Overall Study|Patient Moved|1
7259664|NCT00350779|11471913|FG000|Overall Study|Non-compliance with study procedures|0
7543125|NCT02791490|11895132|FG001|Overall Study|Withdrawal by Subject|6
7259665|NCT00350779|11471914|FG001|Overall Study|Non-compliance with study procedures|1
7259666|NCT00350792|11471922|FG000|Overall Study|Adverse Event|11
7259667|NCT00350792|11471922|FG000|Overall Study|Death from Study Disease|1
7259668|NCT00350792|11471922|FG000|Overall Study|Death from Study Drug Toxicity|1
7259669|NCT00350792|11471922|FG000|Overall Study|Death Not Study Drug Related|2
7259670|NCT00350792|11471922|FG000|Overall Study|Protocol Violation|1
7259671|NCT00350792|11471922|FG000|Overall Study|Withdrawal by Subject|4
7259672|NCT00350792|11471922|FG000|Overall Study|Physician Decision|2
7259673|NCT00350792|11471922|FG000|Overall Study|Lack of Efficacy|11
7259674|NCT00350870|11471930|FG000|Overall Study|Withdrawal by Subject|21
7259675|NCT00350870|11471931|FG001|Overall Study|Withdrawal by Subject|17
7259676|NCT00350870|11471932|FG002|Overall Study|Withdrawal by Subject|15
7259677|NCT00350870|11471933|FG003|Overall Study|Withdrawal by Subject|14
7259678|NCT00350870|11471930|FG000|Overall Study|Physician Decision|1
7259679|NCT00350870|11471931|FG001|Overall Study|Physician Decision|0
7259680|NCT00350870|11471932|FG002|Overall Study|Physician Decision|1
7259681|NCT00350870|11471933|FG003|Overall Study|Physician Decision|1
7259682|NCT00351273|11471958|FG000|Overall Study|Lost to Follow-up|1
7259683|NCT00351273|11471959|FG001|Overall Study|Lost to Follow-up|2
7259684|NCT00351273|11471960|FG002|Overall Study|Lost to Follow-up|5
7259685|NCT00351351|11471988|FG000|Overall Study|surgical access pbs; device issues|9
7259686|NCT00351351|11471989|FG001|Overall Study|surgical access pbs; device issues|4
7259687|NCT00351377|11471995|FG000|Overall Study|Adverse Event|5
7259688|NCT00351377|11471995|FG000|Overall Study|Death|1
7259689|NCT00351377|11471995|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7259690|NCT00351468|11472008|FG000|Overall Study|Adverse Event|42
7259691|NCT00351468|11472008|FG000|Overall Study|Withdrawal by Subject|39
7259692|NCT00351468|11472008|FG000|Overall Study|Various -follow up w clinical team|39
7259693|NCT00351468|11472008|FG000|Overall Study|Lack of Efficacy|32
7543126|NCT02791516|11895140|FG000|Overall Study|Withdrawal by Subject|1
7543127|NCT02791516|11895141|FG001|Overall Study|Withdrawal by Subject|1
7543128|NCT02791659|11895149|FG000|Overall Study|Protocol Violation|0
7543129|NCT02791659|11895150|FG001|Overall Study|Protocol Violation|1
7543130|NCT02791763|11895159|FG000|Overall Study|Protocol Violation|0
7543131|NCT02791763|11895160|FG001|Overall Study|Protocol Violation|0
7543132|NCT02791763|11895161|FG002|Overall Study|Protocol Violation|1
7543133|NCT02791763|11895159|FG000|Overall Study|Withdrawal by Subject|5
7543134|NCT02791763|11895160|FG001|Overall Study|Withdrawal by Subject|1
7543135|NCT02791763|11895161|FG002|Overall Study|Withdrawal by Subject|0
7543136|NCT02791763|11895159|FG000|Overall Study|Physician Decision|0
7543137|NCT02791763|11895160|FG001|Overall Study|Physician Decision|1
7543138|NCT02791763|11895161|FG002|Overall Study|Physician Decision|0
7543139|NCT02791763|11895159|FG000|Overall Study|Needs maintenance/changes in dialysis|16
7543140|NCT02791763|11895160|FG001|Overall Study|Needs maintenance/changes in dialysis|19
7259694|NCT00351468|11472008|FG000|Overall Study|Non-compliance|8
7543141|NCT02791763|11895161|FG002|Overall Study|Needs maintenance/changes in dialysis|5
7543142|NCT02791763|11895159|FG000|Overall Study|Cancer event|1
7543143|NCT02791763|11895160|FG001|Overall Study|Cancer event|3
7259695|NCT00351468|11472008|FG000|Overall Study|Lost to Follow-up|4
7259696|NCT00351468|11472008|FG000|Overall Study|Protocol Violation|3
7259697|NCT00351533|11472015|FG000|Overall Study|Extubated before first BAL|1
7543144|NCT02791763|11895161|FG002|Overall Study|Cancer event|0
7543145|NCT02791763|11895159|FG000|Overall Study|Participant had renal transplant|3
7543146|NCT02791763|11895160|FG001|Overall Study|Participant had renal transplant|0
7543147|NCT02791763|11895161|FG002|Overall Study|Participant had renal transplant|0
7543148|NCT02791763|11895159|FG000|Overall Study|Met hemoglobin stopping criteria|1
7259698|NCT00351533|11472016|FG001|Overall Study|Extubated before first BAL|0
7259699|NCT00351533|11472015|FG000|Overall Study|Lost to Follow-up|1
7259700|NCT00351533|11472016|FG001|Overall Study|Lost to Follow-up|3
7259701|NCT00351533|11472015|FG000|Overall Study|Physician Decision|0
7259702|NCT00351533|11472016|FG001|Overall Study|Physician Decision|1
7259703|NCT00351533|11472015|FG000|Overall Study|Withdrawal by Subject|0
7259704|NCT00351533|11472016|FG001|Overall Study|Withdrawal by Subject|1
7259705|NCT00351611|11472024|FG000|Overall Study|Adverse Event|11
7259706|NCT00351611|11472025|FG001|Overall Study|Adverse Event|3
7259707|NCT00351611|11472024|FG000|Overall Study|Death|1
7259708|NCT00351611|11472025|FG001|Overall Study|Death|0
7259709|NCT00351611|11472024|FG000|Overall Study|Lost to Follow-up|1
7259710|NCT00351611|11472025|FG001|Overall Study|Lost to Follow-up|0
7259711|NCT00351611|11472024|FG000|Overall Study|No Longer Willing to Participate in Study|0
7259712|NCT00351611|11472025|FG001|Overall Study|No Longer Willing to Participate in Study|5
7259713|NCT00351611|11472024|FG000|Overall Study|Other|1
7259714|NCT00351611|11472025|FG001|Overall Study|Other|0
7259715|NCT00351611|11472024|FG000|Overall Study|Protocol Violation|0
7259716|NCT00351611|11472025|FG001|Overall Study|Protocol Violation|2
7543149|NCT02791763|11895160|FG001|Overall Study|Met hemoglobin stopping criteria|0
7543150|NCT02791763|11895161|FG002|Overall Study|Met hemoglobin stopping criteria|0
7543151|NCT02791763|11895159|FG000|Overall Study|Adverse Event|12
7543152|NCT02791763|11895160|FG001|Overall Study|Adverse Event|13
7543153|NCT02791763|11895161|FG002|Overall Study|Adverse Event|7
7543154|NCT02791893|11895180|FG000|Blinded Phase|Lost to Follow-up|2
7543155|NCT02791893|11895181|FG001|Blinded Phase|Lost to Follow-up|2
7543156|NCT02791893|11895180|FG000|Blinded Phase|Withdrawal by Subject|1
7543157|NCT02791893|11895181|FG001|Blinded Phase|Withdrawal by Subject|2
7543158|NCT02791893|11895180|FG000|Open Label Phase|Lost to Follow-up|3
7543159|NCT02791893|11895181|FG001|Open Label Phase|Lost to Follow-up|0
7543160|NCT02791893|11895180|FG000|Open Label Phase|Withdrawal by Subject|0
7543161|NCT02791893|11895181|FG001|Open Label Phase|Withdrawal by Subject|2
7543162|NCT02792062|11895224|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
7543163|NCT02792062|11895225|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7543164|NCT02792062|11895226|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7543165|NCT02792062|11895227|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7543166|NCT02792062|11895228|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7543167|NCT02792062|11895229|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
7543168|NCT02792192|11895241|FG000|Overall Study|Death|1
7543169|NCT02792192|11895242|FG001|Overall Study|Death|0
7543170|NCT02792192|11895243|FG002|Overall Study|Death|0
7543171|NCT02792192|11895244|FG003|Overall Study|Death|0
7543172|NCT02792192|11895241|FG000|Overall Study|Informed Consent Withdrawn|4
7543173|NCT02792192|11895242|FG001|Overall Study|Informed Consent Withdrawn|0
7543174|NCT02792192|11895243|FG002|Overall Study|Informed Consent Withdrawn|0
7543175|NCT02792192|11895244|FG003|Overall Study|Informed Consent Withdrawn|0
7543176|NCT02792192|11895241|FG000|Overall Study|Physician Decision|1
7543177|NCT02792192|11895242|FG001|Overall Study|Physician Decision|0
7543178|NCT02792192|11895243|FG002|Overall Study|Physician Decision|0
7543179|NCT02792192|11895244|FG003|Overall Study|Physician Decision|0
7543180|NCT02792192|11895241|FG000|Overall Study|Progressive Disease|0
7543181|NCT02792192|11895242|FG001|Overall Study|Progressive Disease|1
7543182|NCT02792192|11895243|FG002|Overall Study|Progressive Disease|0
7543183|NCT02792192|11895244|FG003|Overall Study|Progressive Disease|0
7543184|NCT02792192|11895241|FG000|Overall Study|Study Terminated By Sponsor|6
7543185|NCT02792192|11895242|FG001|Overall Study|Study Terminated By Sponsor|10
7543186|NCT02792192|11895243|FG002|Overall Study|Study Terminated By Sponsor|0
7543187|NCT02792192|11895244|FG003|Overall Study|Study Terminated By Sponsor|0
7543188|NCT02792218|11895257|FG000|Overall Study|Patient/guardian decision|15
7259717|NCT00351819|11472042|FG000|Overall Study|Lost to Follow-up|4
7259718|NCT00351819|11472043|FG001|Overall Study|Lost to Follow-up|4
7259719|NCT00351819|11472042|FG000|Overall Study|Withdrawal by Subject|0
7259720|NCT00351819|11472043|FG001|Overall Study|Withdrawal by Subject|4
7259721|NCT00351819|11472042|FG000|Overall Study|Elevated PSA|1
7259722|NCT00351819|11472043|FG001|Overall Study|Elevated PSA|1
7259723|NCT00351819|11472042|FG000|Overall Study|Traumatic ankle fracture|1
7259724|NCT00351819|11472043|FG001|Overall Study|Traumatic ankle fracture|0
7259725|NCT00351819|11472042|FG000|Overall Study|Unprofessional behavior|1
7259726|NCT00351819|11472043|FG001|Overall Study|Unprofessional behavior|0
7259727|NCT00351819|11472042|FG000|Overall Study|Non-compliance|0
7259728|NCT00351819|11472043|FG001|Overall Study|Non-compliance|1
7259729|NCT00351819|11472042|FG000|Overall Study|Incarcerated|0
7259730|NCT00351819|11472043|FG001|Overall Study|Incarcerated|1
7259731|NCT00351819|11472042|FG000|Overall Study|Enrolled in another trial|0
7259732|NCT00351819|11472043|FG001|Overall Study|Enrolled in another trial|1
7387882|NCT01217073|11646674|FG000|Base Period|Excluded medication|0
7387883|NCT01217073|11646675|FG001|Base Period|Excluded medication|0
7387884|NCT01217073|11646676|FG002|Base Period|Excluded medication|0
7387885|NCT01217073|11646677|FG003|Base Period|Excluded medication|0
7387886|NCT01217073|11646678|FG004|Base Period|Excluded medication|1
7387887|NCT01217073|11646679|FG005|Base Period|Excluded medication|0
7387888|NCT01217073|11646680|FG006|Base Period|Excluded medication|0
7387889|NCT01217073|11646681|FG007|Base Period|Excluded medication|0
7387890|NCT01217073|11646674|FG000|Base Period|Lack of Efficacy|0
7387891|NCT01217073|11646675|FG001|Base Period|Lack of Efficacy|0
7387892|NCT01217073|11646676|FG002|Base Period|Lack of Efficacy|0
7387893|NCT01217073|11646677|FG003|Base Period|Lack of Efficacy|0
7387894|NCT01217073|11646678|FG004|Base Period|Lack of Efficacy|0
7387895|NCT01217073|11646679|FG005|Base Period|Lack of Efficacy|1
7387896|NCT01217073|11646680|FG006|Base Period|Lack of Efficacy|0
7387897|NCT01217073|11646681|FG007|Base Period|Lack of Efficacy|0
7387898|NCT01217073|11646674|FG000|Base Period|Lost to Follow-up|0
7387899|NCT01217073|11646675|FG001|Base Period|Lost to Follow-up|0
7387900|NCT01217073|11646676|FG002|Base Period|Lost to Follow-up|1
7387901|NCT01217073|11646677|FG003|Base Period|Lost to Follow-up|1
7387902|NCT01217073|11646678|FG004|Base Period|Lost to Follow-up|3
7387903|NCT01217073|11646679|FG005|Base Period|Lost to Follow-up|0
7387904|NCT01217073|11646680|FG006|Base Period|Lost to Follow-up|0
7387905|NCT01217073|11646681|FG007|Base Period|Lost to Follow-up|0
7387906|NCT01217073|11646674|FG000|Base Period|Physician Decision|0
7387907|NCT01217073|11646675|FG001|Base Period|Physician Decision|0
7387908|NCT01217073|11646676|FG002|Base Period|Physician Decision|0
7387909|NCT01217073|11646677|FG003|Base Period|Physician Decision|0
7387910|NCT01217073|11646678|FG004|Base Period|Physician Decision|1
7387911|NCT01217073|11646679|FG005|Base Period|Physician Decision|0
7387912|NCT01217073|11646680|FG006|Base Period|Physician Decision|0
7387913|NCT01217073|11646681|FG007|Base Period|Physician Decision|0
7387914|NCT01217073|11646674|FG000|Base Period|Protocol Violation|1
7387915|NCT01217073|11646675|FG001|Base Period|Protocol Violation|0
7387916|NCT01217073|11646676|FG002|Base Period|Protocol Violation|0
7387917|NCT01217073|11646677|FG003|Base Period|Protocol Violation|0
7387918|NCT01217073|11646678|FG004|Base Period|Protocol Violation|1
7387919|NCT01217073|11646679|FG005|Base Period|Protocol Violation|2
7387920|NCT01217073|11646680|FG006|Base Period|Protocol Violation|0
7387921|NCT01217073|11646681|FG007|Base Period|Protocol Violation|0
7387922|NCT01217073|11646674|FG000|Base Period|Withdrawal by Subject|4
7387923|NCT01217073|11646675|FG001|Base Period|Withdrawal by Subject|5
7387924|NCT01217073|11646676|FG002|Base Period|Withdrawal by Subject|5
7387925|NCT01217073|11646677|FG003|Base Period|Withdrawal by Subject|1
7387926|NCT01217073|11646678|FG004|Base Period|Withdrawal by Subject|5
7387927|NCT01217073|11646679|FG005|Base Period|Withdrawal by Subject|5
7387928|NCT01217073|11646680|FG006|Base Period|Withdrawal by Subject|0
7387929|NCT01217073|11646681|FG007|Base Period|Withdrawal by Subject|0
7387930|NCT01217073|11646674|FG000|Extension Period|Adverse Event|0
7387931|NCT01217073|11646675|FG001|Extension Period|Adverse Event|0
7387932|NCT01217073|11646676|FG002|Extension Period|Adverse Event|0
7387933|NCT01217073|11646677|FG003|Extension Period|Adverse Event|0
7387934|NCT01217073|11646678|FG004|Extension Period|Adverse Event|0
7387935|NCT01217073|11646679|FG005|Extension Period|Adverse Event|0
7387936|NCT01217073|11646680|FG006|Extension Period|Adverse Event|19
7387937|NCT01217073|11646681|FG007|Extension Period|Adverse Event|5
7387938|NCT01217073|11646674|FG000|Extension Period|ALT/AST|0
7387939|NCT01217073|11646675|FG001|Extension Period|ALT/AST|0
7387940|NCT01217073|11646676|FG002|Extension Period|ALT/AST|0
7387941|NCT01217073|11646677|FG003|Extension Period|ALT/AST|0
7387942|NCT01217073|11646678|FG004|Extension Period|ALT/AST|0
7387943|NCT01217073|11646679|FG005|Extension Period|ALT/AST|0
7387944|NCT01217073|11646680|FG006|Extension Period|ALT/AST|2
7259733|NCT00352053|11472060|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
7259734|NCT00352053|11472061|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
7259735|NCT00352053|11472060|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
7259736|NCT00352053|11472061|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
7259737|NCT00352053|11472060|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
7259738|NCT00352053|11472061|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
7259739|NCT00352053|11472060|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
7259740|NCT00352053|11472061|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
7259741|NCT00352053|11472060|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
7259742|NCT00352053|11472061|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
7259743|NCT00352053|11472060|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
7259744|NCT00352053|11472061|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
7543189|NCT02792218|11895258|FG001|Overall Study|Patient/guardian decision|42
7543190|NCT02792218|11895257|FG000|Overall Study|Adverse Event|15
7543191|NCT02792218|11895258|FG001|Overall Study|Adverse Event|14
7543192|NCT02792218|11895257|FG000|Overall Study|Lost to Follow-up|10
7543193|NCT02792218|11895258|FG001|Overall Study|Lost to Follow-up|5
7543194|NCT02792218|11895257|FG000|Overall Study|Lack of Efficacy|1
7543195|NCT02792218|11895258|FG001|Overall Study|Lack of Efficacy|12
7543196|NCT02792218|11895257|FG000|Overall Study|Physician Decision|4
7543197|NCT02792218|11895258|FG001|Overall Study|Physician Decision|4
7543198|NCT02792218|11895257|FG000|Overall Study|Protocol deviation|3
7543199|NCT02792218|11895258|FG001|Overall Study|Protocol deviation|2
7543200|NCT02792218|11895257|FG000|Overall Study|New therapy for study indication|0
7543201|NCT02792218|11895258|FG001|Overall Study|New therapy for study indication|1
7543202|NCT02792218|11895257|FG000|Overall Study|Non-compliance with study treatment|0
7543203|NCT02792218|11895258|FG001|Overall Study|Non-compliance with study treatment|1
7543204|NCT02792218|11895257|FG000|Overall Study|Pregnancy|1
7543205|NCT02792218|11895258|FG001|Overall Study|Pregnancy|0
7543206|NCT02792231|11895266|FG000|Overall Study|Patient/guardian decision|32
7543207|NCT02792231|11895267|FG001|Overall Study|Patient/guardian decision|42
7543208|NCT02792231|11895266|FG000|Overall Study|Adverse Event|15
7543209|NCT02792231|11895267|FG001|Overall Study|Adverse Event|11
7543210|NCT02792231|11895266|FG000|Overall Study|Physician Decision|14
7543211|NCT02792231|11895267|FG001|Overall Study|Physician Decision|12
7543212|NCT02792231|11895266|FG000|Overall Study|Lack of Efficacy|7
7543213|NCT02792231|11895267|FG001|Overall Study|Lack of Efficacy|9
7543214|NCT02792231|11895266|FG000|Overall Study|Lost to Follow-up|9
7543215|NCT02792231|11895267|FG001|Overall Study|Lost to Follow-up|5
7543216|NCT02792231|11895266|FG000|Overall Study|Pregnancy|1
7543217|NCT02792231|11895267|FG001|Overall Study|Pregnancy|3
7543218|NCT02792231|11895266|FG000|Overall Study|Non-compliance with study treatment|2
7543219|NCT02792231|11895267|FG001|Overall Study|Non-compliance with study treatment|1
7543220|NCT02792231|11895266|FG000|Overall Study|Protocol deviation|2
7543221|NCT02792231|11895267|FG001|Overall Study|Protocol deviation|0
7543222|NCT02792231|11895266|FG000|Overall Study|Technical problems|0
7543223|NCT02792231|11895267|FG001|Overall Study|Technical problems|1
7543224|NCT02792504|11895273|FG000|Overall Study|Lost to Follow-up|24
7543225|NCT02792504|11895273|FG000|Overall Study|Violated inclusion/exclusion criteria|6
7543226|NCT02792517|11895277|FG000|Overall Study|Withdrawal by Subject|10
7543227|NCT02792517|11895277|FG000|Overall Study|Decision by Sponsor|7
7543228|NCT02792517|11895277|FG000|Overall Study|Lost to Follow-up|3
7543229|NCT02792699|11895284|FG000|Overall Study|Adverse Event|1
7259745|NCT00352053|11472060|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
7259746|NCT00352053|11472061|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
7259747|NCT00352053|11472060|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
7259748|NCT00352053|11472061|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
7259749|NCT00352053|11472060|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
7259750|NCT00352053|11472061|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
7259751|NCT00352053|11472060|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7259752|NCT00352053|11472061|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
7259753|NCT00352053|11472060|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7259754|NCT00352053|11472061|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
7259755|NCT00352053|11472060|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7259756|NCT00352053|11472061|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
7259757|NCT00352053|11472060|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
7259758|NCT00352053|11472061|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
7259759|NCT00352105|11472075|FG000|Overall Study|Death|5
7259760|NCT00352105|11472075|FG000|Overall Study|Withdrawal by Subject|5
7259761|NCT00352105|11472075|FG000|Overall Study|Lack of Efficacy|9
7259762|NCT00352105|11472075|FG000|Overall Study|Adverse Event|19
7259763|NCT00352105|11472075|FG000|Overall Study|Protocol Violation|2
7259764|NCT00352365|11472079|FG000|Induction Therapy|Adverse Event|7
7259765|NCT00352365|11472079|FG000|Induction Therapy|Progression/Relapse|8
7259766|NCT00352365|11472079|FG000|Induction Therapy|Death|7
7259767|NCT00352365|11472079|FG000|Induction Therapy|Not protocol specified|1
7259768|NCT00352365|11472079|FG000|Induction Therapy|Not eligible|3
7259769|NCT00352365|11472079|FG000|Induction Therapy|Death before starting protocol therapy|1
7259770|NCT00352365|11472079|FG000|Maintenance Therapy|Progression/Relapse|3
7259771|NCT00352365|11472079|FG000|Maintenance Therapy|Death|2
7259772|NCT00352365|11472079|FG000|Maintenance Therapy|Not protocol specified|3
7259773|NCT00352365|11472079|FG000|Maintenance Therapy|Not eligible|4
7259774|NCT00352417|11472089|FG000|Overall Study|Adverse Event|1
7259775|NCT00352417|11472090|FG001|Overall Study|Adverse Event|0
7259776|NCT00352417|11472089|FG000|Overall Study|Protocol Violation|0
7259777|NCT00352417|11472090|FG001|Overall Study|Protocol Violation|2
7259778|NCT00352417|11472089|FG000|Overall Study|Withdrawal by Subject|1
7259779|NCT00352417|11472090|FG001|Overall Study|Withdrawal by Subject|2
7259780|NCT00352417|11472089|FG000|Overall Study|Lost to Follow-up|1
7259781|NCT00352417|11472090|FG001|Overall Study|Lost to Follow-up|0
7259782|NCT00352417|11472089|FG000|Overall Study|Schedule Change|2
7259783|NCT00352417|11472090|FG001|Overall Study|Schedule Change|1
7259784|NCT00352664|11472107|FG000|Overall Study|Withdrawal by Subject|7
7259785|NCT00352664|11472108|FG001|Overall Study|Withdrawal by Subject|0
7259786|NCT00352690|11472116|FG000|Overall Study|Determined to be ineligible|2
7259787|NCT00352690|11472117|FG001|Overall Study|Determined to be ineligible|0
7259788|NCT00352755|11472123|FG000|Overall Study|Physician Decision|1
7259789|NCT00352755|11472123|FG000|Overall Study|Adverse Event|1
7259790|NCT00352846|11472137|FG000|Overall Study|Disease progression|0
7259791|NCT00352846|11472138|FG001|Overall Study|Disease progression|2
7259792|NCT00352846|11472137|FG000|Overall Study|Withdrawal by Subject|3
7259793|NCT00352846|11472138|FG001|Overall Study|Withdrawal by Subject|8
7259794|NCT00352846|11472137|FG000|Overall Study|Ineligible|3
7259795|NCT00352846|11472138|FG001|Overall Study|Ineligible|2
7259796|NCT00352846|11472137|FG000|Overall Study|Non-compliance|2
7259797|NCT00352846|11472138|FG001|Overall Study|Non-compliance|0
7259798|NCT00352846|11472137|FG000|Overall Study|Death|0
7259799|NCT00352846|11472138|FG001|Overall Study|Death|1
7259800|NCT00352885|11472146|FG000|Overall Study|Withdrawal by Subject|0
7259801|NCT00352885|11472147|FG001|Overall Study|Withdrawal by Subject|3
7259802|NCT00352885|11472146|FG000|Overall Study|Development of major depression|0
7259803|NCT00352885|11472147|FG001|Overall Study|Development of major depression|1
7259804|NCT00352885|11472146|FG000|Overall Study|Progression of metastatic melanoma|5
7259805|NCT00352885|11472147|FG001|Overall Study|Progression of metastatic melanoma|3
7259806|NCT00352885|11472146|FG000|Overall Study|Side effects of IL-2 administration|1
7259807|NCT00352885|11472147|FG001|Overall Study|Side effects of IL-2 administration|0
7259808|NCT00353262|11472179|FG000|Overall Study|Adverse Event|8
7259809|NCT00353262|11472179|FG000|Overall Study|Withdrawal by Subject|2
7259810|NCT00353262|11472179|FG000|Overall Study|Insufficient Therapeutic Response|13
7259811|NCT00353262|11472179|FG000|Overall Study|Progression|1
7259812|NCT00353262|11472179|FG000|Overall Study|Surgery|4
7259813|NCT00353262|11472179|FG000|Overall Study|Break from Chemotherapy|1
7259814|NCT00353366|11472187|FG000|Overall Study|Adverse Event|8
7259815|NCT00353366|11472187|FG000|Overall Study|Protocol Violation|12
7259816|NCT00353366|11472187|FG000|Overall Study|Withdrawal by Subject|12
7259817|NCT00353366|11472187|FG000|Overall Study|Lost to Follow-up|92
7259818|NCT00353366|11472187|FG000|Overall Study|Other|19
7259819|NCT00353496|11472211|FG000|Overall Study|Adverse Event|1
7259820|NCT00353496|11472212|FG001|Overall Study|Adverse Event|0
7259821|NCT00353496|11472211|FG000|Overall Study|Protocol Violation|2
7259822|NCT00353496|11472212|FG001|Overall Study|Protocol Violation|2
7259823|NCT00353496|11472211|FG000|Overall Study|Withdrawal by Subject|3
7259824|NCT00353496|11472212|FG001|Overall Study|Withdrawal by Subject|4
7259825|NCT00353496|11472211|FG000|Overall Study|Physician Decision|6
7259826|NCT00353496|11472212|FG001|Overall Study|Physician Decision|9
7259827|NCT00353496|11472211|FG000|Overall Study|Not otherwise specified|4
7259828|NCT00353496|11472212|FG001|Overall Study|Not otherwise specified|2
7259829|NCT00353704|11472254|FG000|Overall Study|Protocol Violation|3
7259830|NCT00353704|11472255|FG001|Overall Study|Protocol Violation|1
7259831|NCT00353873|11472276|FG000|Overall Study|Protocol Violation|1
7259832|NCT00353873|11472277|FG001|Overall Study|Protocol Violation|2
7259833|NCT00353873|11472276|FG000|Overall Study|Exacerbation|1
7259834|NCT00353873|11472277|FG001|Overall Study|Exacerbation|0
7259835|NCT00353873|11472276|FG000|Overall Study|Adverse Event|1
7259836|NCT00353873|11472277|FG001|Overall Study|Adverse Event|0
7259837|NCT00353873|11472276|FG000|Overall Study|Physician Decision|2
7259838|NCT00353873|11472277|FG001|Overall Study|Physician Decision|0
7259839|NCT00353873|11472276|FG000|Overall Study|Withdrawal by Subject|1
7543230|NCT02792699|11895285|FG001|Overall Study|Adverse Event|2
7259840|NCT00353873|11472277|FG001|Overall Study|Withdrawal by Subject|1
7259841|NCT00354029|11472289|FG000|Overall Study|Protocol Violation|4
7259842|NCT00354029|11472290|FG001|Overall Study|Protocol Violation|2
7259843|NCT00354107|11472296|FG000|Overall Study|Adverse Event|2
7259844|NCT00354107|11472296|FG000|Overall Study|Physician Decision|2
7259845|NCT00354107|11472296|FG000|Overall Study|Withdrawal by Subject|1
7259846|NCT00354159|11472302|FG000|Randomized Study Period|Withdrawal by Subject|5
7259847|NCT00354159|11472303|FG001|Randomized Study Period|Withdrawal by Subject|3
7259848|NCT00354159|11472302|FG000|Randomized Study Period|Physician Decision|6
7543231|NCT02792699|11895286|FG002|Overall Study|Adverse Event|4
7259849|NCT00354159|11472303|FG001|Randomized Study Period|Physician Decision|10
7259850|NCT00354159|11472302|FG000|Randomized Study Period|Lost to Follow-up|4
7259851|NCT00354159|11472303|FG001|Randomized Study Period|Lost to Follow-up|0
7259852|NCT00354159|11472302|FG000|Randomized Study Period|Death|7
7259853|NCT00354159|11472303|FG001|Randomized Study Period|Death|9
7259854|NCT00354159|11472302|FG000|Long-term Follow-up|Withdrawal by Subject|9
7259855|NCT00354159|11472303|FG001|Long-term Follow-up|Withdrawal by Subject|9
7259856|NCT00354159|11472302|FG000|Long-term Follow-up|Physician Decision|127
7259857|NCT00354159|11472303|FG001|Long-term Follow-up|Physician Decision|122
7259858|NCT00354159|11472302|FG000|Long-term Follow-up|Lost to Follow-up|1
7259859|NCT00354159|11472303|FG001|Long-term Follow-up|Lost to Follow-up|0
7259860|NCT00354159|11472302|FG000|Long-term Follow-up|Death|14
7259861|NCT00354159|11472303|FG001|Long-term Follow-up|Death|11
7259862|NCT00354159|11472302|FG000|Long-term Follow-up|Study Closed|29
7259863|NCT00354159|11472303|FG001|Long-term Follow-up|Study Closed|34
7259864|NCT00354172|11472316|FG000|Overall Study|Did not receive transplant|1
7259865|NCT00354341|11472326|FG000|Overall Study|Adverse Event|1
7259866|NCT00354341|11472327|FG001|Overall Study|Adverse Event|0
7259867|NCT00354341|11472326|FG000|Overall Study|Death|0
7259868|NCT00354341|11472327|FG001|Overall Study|Death|2
7259869|NCT00354341|11472326|FG000|Overall Study|Refused treatment|1
7259870|NCT00354341|11472327|FG001|Overall Study|Refused treatment|2
7259871|NCT00354341|11472326|FG000|Overall Study|Failure to return|0
7259872|NCT00354341|11472327|FG001|Overall Study|Failure to return|1
7259873|NCT00354341|11472326|FG000|Overall Study|Other|1
7259874|NCT00354341|11472327|FG001|Overall Study|Other|2
7259875|NCT00354432|11472337|FG000|Overall Study|Adverse Event|3
7259876|NCT00354432|11472338|FG001|Overall Study|Adverse Event|1
7259877|NCT00354432|11472339|FG002|Overall Study|Adverse Event|5
7259878|NCT00354432|11472340|FG003|Overall Study|Adverse Event|5
7259879|NCT00354432|11472337|FG000|Overall Study|Off/Toxicity|3
7259880|NCT00354432|11472338|FG001|Overall Study|Off/Toxicity|7
7259881|NCT00354432|11472339|FG002|Overall Study|Off/Toxicity|5
7259882|NCT00354432|11472340|FG003|Overall Study|Off/Toxicity|5
7259883|NCT00354601|11472359|FG000|Overall Study|Protocol Violation|1
7259884|NCT00354601|11472359|FG000|Overall Study|progression|1
7259885|NCT00354614|11472363|FG000|Overall Study|Lack of Efficacy|28
7259886|NCT00354679|11472371|FG000|Overall Study|Patient Not Treated|1
7259887|NCT00354744|11472375|FG000|Overall Study|Adverse Event|2
7259888|NCT00354744|11472375|FG000|Overall Study|Death|2
7259889|NCT00354744|11472375|FG000|Overall Study|Lack of Efficacy|11
7259890|NCT00354744|11472375|FG000|Overall Study|Lost to Follow-up|2
7259891|NCT00354744|11472375|FG000|Overall Study|Physician Decision|11
7259892|NCT00354744|11472375|FG000|Overall Study|Withdrawal by Subject|14
7259893|NCT00355030|11472404|FG000|Study Period 1 Treatment|Adverse Event|1
7259894|NCT00355030|11472405|FG001|Study Period 1 Treatment|Adverse Event|1
7259895|NCT00355030|11472404|FG000|Study Period 1 Treatment|Lost to Follow-up|3
7259896|NCT00355030|11472405|FG001|Study Period 1 Treatment|Lost to Follow-up|0
7259897|NCT00355030|11472404|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
7259898|NCT00355030|11472405|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
7259899|NCT00355030|11472404|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
7259900|NCT00355030|11472405|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
7259901|NCT00355030|11472404|FG000|Study Period 1 Treatment|Physician Decision|0
7259902|NCT00355030|11472405|FG001|Study Period 1 Treatment|Physician Decision|1
7259903|NCT00355030|11472404|FG000|Study Period 1 Treatment|Sponsor Decision|34
7259904|NCT00355030|11472405|FG001|Study Period 1 Treatment|Sponsor Decision|32
7259905|NCT00355030|11472404|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
7259906|NCT00355030|11472405|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
7259907|NCT00355030|11472404|FG000|Study Period 1 Treatment|Other|2
7259908|NCT00355030|11472405|FG001|Study Period 1 Treatment|Other|6
7259909|NCT00355030|11472404|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
7259910|NCT00355030|11472405|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
7259911|NCT00355030|11472404|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7259912|NCT00355030|11472405|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
7259913|NCT00355056|11472413|FG000|Randomization Period|Early Termination|4
7259914|NCT00355056|11472414|FG001|Randomization Period|Early Termination|6
7259915|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
7259916|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
7259917|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
7259918|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
7387945|NCT01217073|11646681|FG007|Extension Period|ALT/AST|0
7259919|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
7259920|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
7259921|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
7259922|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
7259923|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
7259924|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7259925|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
7259926|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
7259927|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7259928|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
7259929|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
7543232|NCT02792699|11895284|FG000|Overall Study|Withdrawal by Subject|4
7543233|NCT02792699|11895285|FG001|Overall Study|Withdrawal by Subject|4
7543234|NCT02792699|11895286|FG002|Overall Study|Withdrawal by Subject|3
7543235|NCT02792699|11895284|FG000|Overall Study|Lost to Follow-up|0
7543236|NCT02792699|11895285|FG001|Overall Study|Lost to Follow-up|1
7543237|NCT02792699|11895286|FG002|Overall Study|Lost to Follow-up|2
7543238|NCT02792699|11895284|FG000|Overall Study|Physician Decision|2
7543239|NCT02792699|11895285|FG001|Overall Study|Physician Decision|0
7543240|NCT02792699|11895286|FG002|Overall Study|Physician Decision|0
7543241|NCT02792699|11895284|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
7543242|NCT02792699|11895285|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
7543243|NCT02792699|11895286|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
7543244|NCT02792699|11895284|FG000|Overall Study|Other|1
7543245|NCT02792699|11895285|FG001|Overall Study|Other|0
7543246|NCT02792699|11895286|FG002|Overall Study|Other|0
7543247|NCT02792777|11895303|FG000|Overall Study|Withdrawal by Subject|2
7543248|NCT02792777|11895304|FG001|Overall Study|Withdrawal by Subject|0
7543249|NCT02792777|11895303|FG000|Overall Study|Recording malfunction|2
7543250|NCT02792777|11895304|FG001|Overall Study|Recording malfunction|0
7543251|NCT02792777|11895303|FG000|Overall Study|Later determined to be ineligible|2
7543252|NCT02792777|11895304|FG001|Overall Study|Later determined to be ineligible|0
7543253|NCT02792777|11895303|FG000|Overall Study|Participant interviewed twice|1
7543254|NCT02792777|11895304|FG001|Overall Study|Participant interviewed twice|0
7543255|NCT02792829|11895319|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
7543256|NCT02792829|11895320|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
7543257|NCT02792829|11895321|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
7543258|NCT02792829|11895322|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
7543259|NCT02792829|11895323|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
7543260|NCT02792829|11895324|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
7543261|NCT02792829|11895325|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
7543262|NCT02792829|11895326|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
7543263|NCT02792829|11895319|FG000|Treatment Period 2|Adverse Event|0
7543264|NCT02792829|11895320|FG001|Treatment Period 2|Adverse Event|0
7543265|NCT02792829|11895321|FG002|Treatment Period 2|Adverse Event|0
7543266|NCT02792829|11895322|FG003|Treatment Period 2|Adverse Event|0
7543267|NCT02792829|11895323|FG004|Treatment Period 2|Adverse Event|1
7543268|NCT02792829|11895324|FG005|Treatment Period 2|Adverse Event|0
7543269|NCT02792829|11895325|FG006|Treatment Period 2|Adverse Event|1
7543270|NCT02792829|11895326|FG007|Treatment Period 2|Adverse Event|1
7543271|NCT02792829|11895319|FG000|Treatment Period 2|Use of proscribed medications|0
7543272|NCT02792829|11895320|FG001|Treatment Period 2|Use of proscribed medications|0
7543273|NCT02792829|11895321|FG002|Treatment Period 2|Use of proscribed medications|0
7543274|NCT02792829|11895322|FG003|Treatment Period 2|Use of proscribed medications|0
7543275|NCT02792829|11895323|FG004|Treatment Period 2|Use of proscribed medications|0
7543276|NCT02792829|11895324|FG005|Treatment Period 2|Use of proscribed medications|0
7543277|NCT02792829|11895325|FG006|Treatment Period 2|Use of proscribed medications|0
7543278|NCT02792829|11895326|FG007|Treatment Period 2|Use of proscribed medications|1
7543279|NCT02792959|11895352|FG000|Overall Study|Protocol Violation|1
7543280|NCT02793128|11895356|FG000|Overall Study|Death|4
7576390|NCT04339972|11962809|FG001|Overall Study|dropout|1
7576391|NCT04339972|11962808|FG000|Overall Study|Technical issues|1
7576392|NCT04339972|11962809|FG001|Overall Study|Technical issues|0
7576393|NCT04339972|11962808|FG000|Overall Study|Claustraphobia|0
7576394|NCT04339972|11962809|FG001|Overall Study|Claustraphobia|1
7576395|NCT04339296|11962817|FG000|Overall Study|Refuse to participate after allocation|1
7576396|NCT04339296|11962818|FG001|Overall Study|Refuse to participate after allocation|1
7576397|NCT04339296|11962817|FG000|Overall Study|Withdrew after completion of baseline|2
7576398|NCT04339296|11962818|FG001|Overall Study|Withdrew after completion of baseline|1
7576399|NCT04339296|11962817|FG000|Overall Study|Lost to Follow-up|0
7576400|NCT04339296|11962818|FG001|Overall Study|Lost to Follow-up|4
7576401|NCT04339296|11962817|FG000|Overall Study|Discontinued intervention|5
7576402|NCT04339296|11962818|FG001|Overall Study|Discontinued intervention|3
7576403|NCT04336475|11962848|FG000|Overall Study|pain|1
7576404|NCT04336475|11962849|FG001|Overall Study|pain|0
7576405|NCT04336475|11962848|FG000|Overall Study|upper respiratory infection|1
7576406|NCT04336475|11962849|FG001|Overall Study|upper respiratory infection|0
7576407|NCT04336475|11962848|FG000|Overall Study|Lost to Follow-up|0
7576408|NCT04336475|11962849|FG001|Overall Study|Lost to Follow-up|2
7576409|NCT04335929|11962855|FG000|Overall Study|Lost to Follow-up|10
7576410|NCT04335812|11962861|FG000|Overall Study|Withdrawal by Subject|1
7576411|NCT04335812|11962862|FG001|Overall Study|Withdrawal by Subject|3
7576412|NCT04335812|11962861|FG000|Overall Study|Lost to Follow-up|12
7576413|NCT04335812|11962862|FG001|Overall Study|Lost to Follow-up|12
7576414|NCT04335812|11962861|FG000|Overall Study|Did not engage in the intervention|22
7576415|NCT04335812|11962862|FG001|Overall Study|Did not engage in the intervention|18
7576416|NCT04335136|11962870|FG000|Overall Study|Death|8
7576417|NCT04335136|11962871|FG001|Overall Study|Death|4
7576418|NCT04335136|11962870|FG000|Overall Study|Lost to Follow-up|2
7576419|NCT04335136|11962871|FG001|Overall Study|Lost to Follow-up|0
7576420|NCT04335136|11962870|FG000|Overall Study|Protocol Violation|1
7576421|NCT04335136|11962871|FG001|Overall Study|Protocol Violation|0
7576422|NCT04335136|11962870|FG000|Overall Study|Withdrawal by Subject|1
7576423|NCT04335136|11962871|FG001|Overall Study|Withdrawal by Subject|1
7259930|NCT00355082|11472430|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
7259931|NCT00355082|11472431|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
7259932|NCT00355082|11472432|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
7259933|NCT00355082|11472430|FG000|Continuation Phase|Adverse Event|2
7259934|NCT00355082|11472431|FG001|Continuation Phase|Adverse Event|0
7259935|NCT00355082|11472432|FG002|Continuation Phase|Adverse Event|1
7259936|NCT00355082|11472430|FG000|Continuation Phase|Lost to Follow-up|2
7259937|NCT00355082|11472431|FG001|Continuation Phase|Lost to Follow-up|0
7259938|NCT00355082|11472432|FG002|Continuation Phase|Lost to Follow-up|1
7259939|NCT00355082|11472430|FG000|Continuation Phase|Protocol Violation|1
7259940|NCT00355082|11472431|FG001|Continuation Phase|Protocol Violation|0
7259941|NCT00355082|11472432|FG002|Continuation Phase|Protocol Violation|1
7259942|NCT00355082|11472430|FG000|Continuation Phase|Withdrawal by Subject|4
7259943|NCT00355082|11472431|FG001|Continuation Phase|Withdrawal by Subject|0
7259944|NCT00355082|11472432|FG002|Continuation Phase|Withdrawal by Subject|0
7259945|NCT00355082|11472430|FG000|Continuation Phase|Lack of Efficacy|5
7259946|NCT00355082|11472431|FG001|Continuation Phase|Lack of Efficacy|0
7259947|NCT00355082|11472432|FG002|Continuation Phase|Lack of Efficacy|0
7259948|NCT00355082|11472430|FG000|Continuation Phase|Site Closed by Sponsor|8
7543281|NCT02793128|11895356|FG000|Overall Study|Withdrawal by Subject|2
7543282|NCT02793128|11895356|FG000|Overall Study|Physician Decision|1
7543283|NCT02793128|11895356|FG000|Overall Study|Comorbid conditions and noncompliance|1
7543284|NCT02793128|11895356|FG000|Overall Study|Patient elected nephroureterectomy|1
7543285|NCT02793232|11895390|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543286|NCT02793232|11895391|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543287|NCT02793232|11895392|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543288|NCT02793232|11895393|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543289|NCT02793232|11895394|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7543290|NCT02793232|11895395|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543291|NCT02793232|11895396|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
7543292|NCT02793232|11895397|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543293|NCT02793232|11895398|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
7543294|NCT02793622|11895434|FG000|Overall Study|Lost to Follow-up|31
7543295|NCT02793622|11895435|FG001|Overall Study|Lost to Follow-up|19
7543296|NCT02793622|11895434|FG000|Overall Study|Withdrawal by Subject|21
7543297|NCT02793622|11895435|FG001|Overall Study|Withdrawal by Subject|17
7543298|NCT02793622|11895434|FG000|Overall Study|Adverse Event|0
7543299|NCT02793622|11895435|FG001|Overall Study|Adverse Event|1
7543300|NCT02793622|11895434|FG000|Overall Study|Protocol Violation|1
7543301|NCT02793622|11895435|FG001|Overall Study|Protocol Violation|5
7543302|NCT02793947|11895512|FG000|Overall Study|Death|1
7543303|NCT02793947|11895513|FG001|Overall Study|Death|0
7543304|NCT02793947|11895512|FG000|Overall Study|Physician Decision|1
7543305|NCT02793947|11895513|FG001|Overall Study|Physician Decision|5
7543306|NCT02794103|11895519|FG000|Overall Study|Loss to follow up due to high sedation|3
7543307|NCT02794246|11895531|FG000|Overall Study|Withdrawal by Subject|2
7543308|NCT02794246|11895531|FG000|Overall Study|Physician Decision|4
7259949|NCT00355082|11472431|FG001|Continuation Phase|Site Closed by Sponsor|0
7259950|NCT00355082|11472432|FG002|Continuation Phase|Site Closed by Sponsor|0
7259951|NCT00355082|11472430|FG000|Continuation Phase|Scheduling Error|1
7259952|NCT00355082|11472431|FG001|Continuation Phase|Scheduling Error|0
7259953|NCT00355082|11472432|FG002|Continuation Phase|Scheduling Error|0
7259954|NCT00355082|11472430|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
7259955|NCT00355082|11472431|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
7259956|NCT00355082|11472432|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
7259957|NCT00355121|11472446|FG000|Overall Study|Did not receive study vaccine|1
7259958|NCT00355121|11472447|FG001|Overall Study|Did not receive study vaccine|0
7259959|NCT00355121|11472448|FG002|Overall Study|Did not receive study vaccine|1
7259960|NCT00355121|11472446|FG000|Overall Study|Adverse Event|0
7259961|NCT00355121|11472447|FG001|Overall Study|Adverse Event|1
7259962|NCT00355121|11472448|FG002|Overall Study|Adverse Event|0
7259963|NCT00355121|11472446|FG000|Overall Study|Protocol Violation|7
7259964|NCT00355121|11472447|FG001|Overall Study|Protocol Violation|9
7259965|NCT00355121|11472448|FG002|Overall Study|Protocol Violation|1
7259966|NCT00355121|11472446|FG000|Overall Study|Lost to Follow-up|4
7259967|NCT00355121|11472447|FG001|Overall Study|Lost to Follow-up|7
7259968|NCT00355121|11472448|FG002|Overall Study|Lost to Follow-up|1
7259969|NCT00355121|11472446|FG000|Overall Study|Withdrawal by Subject|9
7259970|NCT00355121|11472447|FG001|Overall Study|Withdrawal by Subject|10
7259971|NCT00355121|11472448|FG002|Overall Study|Withdrawal by Subject|2
7259972|NCT00355121|11472446|FG000|Overall Study|Serious adverse events|0
7259973|NCT00355121|11472447|FG001|Overall Study|Serious adverse events|2
7259974|NCT00355121|11472448|FG002|Overall Study|Serious adverse events|0
7259975|NCT00355134|11472464|FG000|Core Phase|Withdrawal by Subject|35
7259976|NCT00355134|11472465|FG001|Core Phase|Withdrawal by Subject|24
7259977|NCT00355134|11472466|FG002|Core Phase|Withdrawal by Subject|35
7259978|NCT00355134|11472467|FG003|Core Phase|Withdrawal by Subject|0
7259979|NCT00355134|11472468|FG004|Core Phase|Withdrawal by Subject|0
7259980|NCT00355134|11472464|FG000|Core Phase|Adverse Event|28
7259981|NCT00355134|11472465|FG001|Core Phase|Adverse Event|22
7259982|NCT00355134|11472466|FG002|Core Phase|Adverse Event|16
7259983|NCT00355134|11472467|FG003|Core Phase|Adverse Event|0
7259984|NCT00355134|11472468|FG004|Core Phase|Adverse Event|0
7259985|NCT00355134|11472464|FG000|Core Phase|Lost to Follow-up|17
7259986|NCT00355134|11472465|FG001|Core Phase|Lost to Follow-up|13
7259987|NCT00355134|11472466|FG002|Core Phase|Lost to Follow-up|21
7259988|NCT00355134|11472467|FG003|Core Phase|Lost to Follow-up|0
7259989|NCT00355134|11472468|FG004|Core Phase|Lost to Follow-up|0
7259990|NCT00355134|11472464|FG000|Core Phase|Abnormal laboratory value(s)|19
7259991|NCT00355134|11472465|FG001|Core Phase|Abnormal laboratory value(s)|14
7259992|NCT00355134|11472466|FG002|Core Phase|Abnormal laboratory value(s)|2
7259993|NCT00355134|11472467|FG003|Core Phase|Abnormal laboratory value(s)|0
7259994|NCT00355134|11472468|FG004|Core Phase|Abnormal laboratory value(s)|0
7259995|NCT00355134|11472464|FG000|Core Phase|Unsatisfactory therapeutic effect|10
7259996|NCT00355134|11472465|FG001|Core Phase|Unsatisfactory therapeutic effect|6
7259997|NCT00355134|11472466|FG002|Core Phase|Unsatisfactory therapeutic effect|17
7259998|NCT00355134|11472467|FG003|Core Phase|Unsatisfactory therapeutic effect|0
7259999|NCT00355134|11472468|FG004|Core Phase|Unsatisfactory therapeutic effect|0
7260000|NCT00355134|11472464|FG000|Core Phase|Administrative problems|5
7260001|NCT00355134|11472465|FG001|Core Phase|Administrative problems|3
7260002|NCT00355134|11472466|FG002|Core Phase|Administrative problems|5
7260003|NCT00355134|11472467|FG003|Core Phase|Administrative problems|0
7260004|NCT00355134|11472468|FG004|Core Phase|Administrative problems|0
7260005|NCT00355134|11472464|FG000|Core Phase|Protocol Violation|3
7260006|NCT00355134|11472465|FG001|Core Phase|Protocol Violation|2
7260007|NCT00355134|11472466|FG002|Core Phase|Protocol Violation|2
7260008|NCT00355134|11472467|FG003|Core Phase|Protocol Violation|0
7260009|NCT00355134|11472468|FG004|Core Phase|Protocol Violation|0
7260010|NCT00355134|11472464|FG000|Core Phase|Abnormal test procedure result(s)|1
7260011|NCT00355134|11472465|FG001|Core Phase|Abnormal test procedure result(s)|2
7260012|NCT00355134|11472466|FG002|Core Phase|Abnormal test procedure result(s)|1
7260013|NCT00355134|11472467|FG003|Core Phase|Abnormal test procedure result(s)|0
7260014|NCT00355134|11472468|FG004|Core Phase|Abnormal test procedure result(s)|0
7260015|NCT00355134|11472464|FG000|Core Phase|Condition no longer requires study drug|1
7260016|NCT00355134|11472465|FG001|Core Phase|Condition no longer requires study drug|0
7260017|NCT00355134|11472466|FG002|Core Phase|Condition no longer requires study drug|1
7260018|NCT00355134|11472467|FG003|Core Phase|Condition no longer requires study drug|0
7260019|NCT00355134|11472468|FG004|Core Phase|Condition no longer requires study drug|0
7260020|NCT00355134|11472464|FG000|Extension Phase|Withdrawal by Subject|7
7260021|NCT00355134|11472465|FG001|Extension Phase|Withdrawal by Subject|11
7260022|NCT00355134|11472466|FG002|Extension Phase|Withdrawal by Subject|0
7260023|NCT00355134|11472467|FG003|Extension Phase|Withdrawal by Subject|7
7260024|NCT00355134|11472468|FG004|Extension Phase|Withdrawal by Subject|5
7260025|NCT00355134|11472464|FG000|Extension Phase|Adverse Event|13
7260026|NCT00355134|11472465|FG001|Extension Phase|Adverse Event|9
7260027|NCT00355134|11472466|FG002|Extension Phase|Adverse Event|0
7260028|NCT00355134|11472467|FG003|Extension Phase|Adverse Event|3
7260029|NCT00355134|11472468|FG004|Extension Phase|Adverse Event|5
7260030|NCT00355134|11472464|FG000|Extension Phase|Lost to Follow-up|2
7260031|NCT00355134|11472465|FG001|Extension Phase|Lost to Follow-up|6
7260032|NCT00355134|11472466|FG002|Extension Phase|Lost to Follow-up|0
7260033|NCT00355134|11472467|FG003|Extension Phase|Lost to Follow-up|2
7260034|NCT00355134|11472468|FG004|Extension Phase|Lost to Follow-up|4
7260035|NCT00355134|11472464|FG000|Extension Phase|Abnormal laboratory value(s)|4
7260036|NCT00355134|11472465|FG001|Extension Phase|Abnormal laboratory value(s)|2
7260037|NCT00355134|11472466|FG002|Extension Phase|Abnormal laboratory value(s)|0
7260038|NCT00355134|11472467|FG003|Extension Phase|Abnormal laboratory value(s)|2
7260039|NCT00355134|11472468|FG004|Extension Phase|Abnormal laboratory value(s)|2
7260040|NCT00355134|11472464|FG000|Extension Phase|Administrative problems|2
7260041|NCT00355134|11472465|FG001|Extension Phase|Administrative problems|4
7260042|NCT00355134|11472466|FG002|Extension Phase|Administrative problems|0
7260043|NCT00355134|11472467|FG003|Extension Phase|Administrative problems|1
7260044|NCT00355134|11472468|FG004|Extension Phase|Administrative problems|1
7260045|NCT00355134|11472464|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
7260046|NCT00355134|11472465|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
7260047|NCT00355134|11472466|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7260048|NCT00355134|11472467|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
7260049|NCT00355134|11472468|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
7260050|NCT00355134|11472464|FG000|Extension Phase|Abnormal test procedure result(s)|0
7260051|NCT00355134|11472465|FG001|Extension Phase|Abnormal test procedure result(s)|1
7260052|NCT00355134|11472466|FG002|Extension Phase|Abnormal test procedure result(s)|0
7260053|NCT00355134|11472467|FG003|Extension Phase|Abnormal test procedure result(s)|0
7260054|NCT00355134|11472468|FG004|Extension Phase|Abnormal test procedure result(s)|1
7260055|NCT00355134|11472464|FG000|Extension Phase|Protocol Violation|0
7260056|NCT00355134|11472465|FG001|Extension Phase|Protocol Violation|0
7260057|NCT00355134|11472466|FG002|Extension Phase|Protocol Violation|0
7260058|NCT00355134|11472467|FG003|Extension Phase|Protocol Violation|1
7260059|NCT00355134|11472468|FG004|Extension Phase|Protocol Violation|0
7260060|NCT00355147|11472480|FG000|Overall Study|Lost to Follow-up|10
7260061|NCT00355147|11472481|FG001|Overall Study|Lost to Follow-up|8
7260062|NCT00355147|11472480|FG000|Overall Study|Withdrawal by Subject|8
7260063|NCT00355147|11472481|FG001|Overall Study|Withdrawal by Subject|12
7260064|NCT00355264|11472500|FG000|Extension (Variable Duration)|Adverse Event|1
7260065|NCT00355264|11472500|FG000|Extension (Variable Duration)|Withdrew Consent|1
7260066|NCT00355342|11472511|FG000|Overall Study|Adverse Event|13
7260067|NCT00355342|11472512|FG001|Overall Study|Adverse Event|15
7260068|NCT00355342|11472511|FG000|Overall Study|Lost to Follow-up|4
7260069|NCT00355342|11472512|FG001|Overall Study|Lost to Follow-up|2
7260070|NCT00355342|11472511|FG000|Overall Study|Withdrawal by Subject|14
7260071|NCT00355342|11472512|FG001|Overall Study|Withdrawal by Subject|11
7260072|NCT00355342|11472511|FG000|Overall Study|Sponsor terminated study|2
7260073|NCT00355342|11472512|FG001|Overall Study|Sponsor terminated study|2
7260074|NCT00355342|11472511|FG000|Overall Study|Overcompliant-PI discretion|1
7260075|NCT00355342|11472512|FG001|Overall Study|Overcompliant-PI discretion|0
7260076|NCT00355342|11472511|FG000|Overall Study|Use of prohibited medication|1
7260077|NCT00355342|11472512|FG001|Overall Study|Use of prohibited medication|0
7260078|NCT00355342|11472511|FG000|Overall Study|COPD exacerbation|1
7260079|NCT00355342|11472512|FG001|Overall Study|COPD exacerbation|1
7260080|NCT00355342|11472511|FG000|Overall Study|Dispensed wrong study drug kit|1
7260081|NCT00355342|11472512|FG001|Overall Study|Dispensed wrong study drug kit|0
7260082|NCT00355342|11472511|FG000|Overall Study|Non-compliance with Dexa scans|1
7260083|NCT00355342|11472512|FG001|Overall Study|Non-compliance with Dexa scans|0
7260084|NCT00355342|11472511|FG000|Overall Study|Withdrawal by participant and physician|1
7260085|NCT00355342|11472512|FG001|Overall Study|Withdrawal by participant and physician|0
7260086|NCT00355342|11472511|FG000|Overall Study|Participant relocated|0
7260087|NCT00355342|11472512|FG001|Overall Study|Participant relocated|1
7260088|NCT00355342|11472511|FG000|Overall Study|Participant discontinued study drug|0
7260089|NCT00355342|11472512|FG001|Overall Study|Participant discontinued study drug|1
7260090|NCT00355342|11472511|FG000|Overall Study|Study management|0
7260091|NCT00355342|11472512|FG001|Overall Study|Study management|1
7260092|NCT00355342|11472511|FG000|Overall Study|Protocol Violation|0
7260093|NCT00355342|11472512|FG001|Overall Study|Protocol Violation|1
7260094|NCT00355342|11472511|FG000|Overall Study|Use of protocol excluded medication|0
7260095|NCT00355342|11472512|FG001|Overall Study|Use of protocol excluded medication|1
7260096|NCT00355368|11472520|FG000|Overall Study|Protocol Violation|8
7260097|NCT00355368|11472521|FG001|Overall Study|Protocol Violation|7
7260098|NCT00355368|11472520|FG000|Overall Study|cardiac arrest prior to intubation|2
7260099|NCT00355368|11472521|FG001|Overall Study|cardiac arrest prior to intubation|2
7260100|NCT00355472|11472538|FG000|Overall Study|Physician Decision|1
7260101|NCT00355615|11472554|FG000|Randomized Double Blind Period|Adverse Event|1
7260102|NCT00355615|11472555|FG001|Randomized Double Blind Period|Adverse Event|0
7260103|NCT00355615|11472556|FG002|Randomized Double Blind Period|Adverse Event|0
7260104|NCT00355615|11472557|FG003|Randomized Double Blind Period|Adverse Event|0
7260105|NCT00355615|11472558|FG004|Randomized Double Blind Period|Adverse Event|0
7260106|NCT00355615|11472554|FG000|Randomized Double Blind Period|Protocol Violation|0
7260107|NCT00355615|11472555|FG001|Randomized Double Blind Period|Protocol Violation|0
7260108|NCT00355615|11472556|FG002|Randomized Double Blind Period|Protocol Violation|1
7260109|NCT00355615|11472557|FG003|Randomized Double Blind Period|Protocol Violation|1
7260110|NCT00355615|11472558|FG004|Randomized Double Blind Period|Protocol Violation|0
7260111|NCT00355615|11472554|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
7260112|NCT00355615|11472555|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
7260113|NCT00355615|11472556|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
7260114|NCT00355615|11472557|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
7260115|NCT00355615|11472558|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
7260116|NCT00355615|11472554|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7260117|NCT00355615|11472555|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7260118|NCT00355615|11472556|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7260119|NCT00355615|11472557|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
7260120|NCT00355615|11472558|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
7260121|NCT00355615|11472554|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7260122|NCT00355615|11472555|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7260123|NCT00355615|11472556|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7260124|NCT00355615|11472557|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
7260125|NCT00355615|11472558|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
7260126|NCT00355615|11472554|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
7260127|NCT00355615|11472555|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
7260128|NCT00355615|11472556|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
7260129|NCT00355615|11472557|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
7260130|NCT00355615|11472558|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
7260131|NCT00355784|11472583|FG000|Overall Study|Withdrawal by Subject|0
7260132|NCT00355784|11472584|FG001|Overall Study|Withdrawal by Subject|0
7260133|NCT00355784|11472585|FG002|Overall Study|Withdrawal by Subject|2
7260134|NCT00356122|11472641|FG000|TREATMENT|Lack of Efficacy|26
7260135|NCT00356122|11472641|FG000|TREATMENT|Adverse Event|10
7260136|NCT00356122|11472641|FG000|TREATMENT|Subject's request|4
7260137|NCT00356122|11472641|FG000|TREATMENT|Other|4
7260138|NCT00356122|11472641|FG000|TREATMENT|Did not receive study medication|1
7260139|NCT00356122|11472641|FG000|FOLLOW-UP|Death|37
7260140|NCT00356122|11472641|FG000|FOLLOW-UP|Lost to Follow-up|2
7260141|NCT00356122|11472641|FG000|FOLLOW-UP|Other|2
7260142|NCT00356135|11472648|FG000|Overall Study|Protocol Violation|1
7260143|NCT00356135|11472649|FG001|Overall Study|Protocol Violation|0
7260144|NCT00356135|11472650|FG002|Overall Study|Protocol Violation|0
7260145|NCT00356135|11472648|FG000|Overall Study|Adverse Event|1
7260146|NCT00356135|11472649|FG001|Overall Study|Adverse Event|0
7260147|NCT00356135|11472650|FG002|Overall Study|Adverse Event|0
7260148|NCT00356135|11472648|FG000|Overall Study|Lost to Follow-up|0
7260149|NCT00356135|11472649|FG001|Overall Study|Lost to Follow-up|0
7260150|NCT00356135|11472650|FG002|Overall Study|Lost to Follow-up|1
7260151|NCT00356135|11472648|FG000|Overall Study|Physician Decision|1
7260152|NCT00356135|11472649|FG001|Overall Study|Physician Decision|1
7260153|NCT00356135|11472650|FG002|Overall Study|Physician Decision|1
7260154|NCT00356135|11472648|FG000|Overall Study|Subject non-compliance|1
7260155|NCT00356135|11472649|FG001|Overall Study|Subject non-compliance|1
7260156|NCT00356135|11472650|FG002|Overall Study|Subject non-compliance|3
7260157|NCT00356148|11472662|FG000|Overall Study|Reoperation within 30 days|2
7543309|NCT02794480|11895546|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7543310|NCT02794480|11895547|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7543311|NCT02794480|11895548|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
7543312|NCT02794480|11895549|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
7543313|NCT02794480|11895546|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7543314|NCT02794480|11895547|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7543315|NCT02794480|11895548|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
7543316|NCT02794480|11895549|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
7543317|NCT02794480|11895546|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7543318|NCT02794480|11895547|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7543319|NCT02794480|11895548|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
7543320|NCT02794480|11895549|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
7543321|NCT02794480|11895546|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7543322|NCT02794480|11895547|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
7543323|NCT02794480|11895548|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
7543324|NCT02794480|11895549|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
7543325|NCT02794480|11895546|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7543326|NCT02794480|11895547|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7543327|NCT02794480|11895548|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
7543328|NCT02794480|11895549|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
7543329|NCT02794870|11895597|FG000|Overall Study|Withdrawal by Subject|2
7543330|NCT02794870|11895598|FG001|Overall Study|Withdrawal by Subject|0
7543331|NCT02794974|11895606|FG000|Overall Study|Physician Decision|0
7543332|NCT02794974|11895607|FG001|Overall Study|Physician Decision|1
7543333|NCT02795767|11895629|FG000|Overall Study|Received Commercial Emicizumab|1
7543334|NCT02795767|11895630|FG001|Overall Study|Received Commercial Emicizumab|0
7543335|NCT02795767|11895631|FG002|Overall Study|Received Commercial Emicizumab|0
7543336|NCT02795832|11895676|FG000|Overall Study|Adverse Event|0
7543337|NCT02795832|11895677|FG001|Overall Study|Adverse Event|0
7543338|NCT02795832|11895678|FG002|Overall Study|Adverse Event|0
7543339|NCT02795832|11895679|FG003|Overall Study|Adverse Event|0
7543340|NCT02795832|11895680|FG004|Overall Study|Adverse Event|0
7543341|NCT02795832|11895681|FG005|Overall Study|Adverse Event|3
7543342|NCT02796560|11895746|FG000|Overall Study|Adverse Event|2
7543343|NCT02796560|11895747|FG001|Overall Study|Adverse Event|0
7543344|NCT02796560|11895746|FG000|Overall Study|Withdrawal by Subject|2
7543345|NCT02796560|11895747|FG001|Overall Study|Withdrawal by Subject|2
7543346|NCT02796651|11895757|FG000|Overall Study|Adverse Event|6
7543347|NCT02796651|11895757|FG000|Overall Study|Lost to Follow-up|1
7543348|NCT02796651|11895757|FG000|Overall Study|Withdrawal by Subject|4
7543349|NCT02796651|11895757|FG000|Overall Study|Protocol Violation|4
7543350|NCT02796651|11895757|FG000|Overall Study|Lack of Efficacy|1
7543351|NCT02796651|11895757|FG000|Overall Study|Other|10
7543352|NCT02796664|11895774|FG000|Overall Study|Withdrawal by Subject|0
7543353|NCT02796664|11895775|FG001|Overall Study|Withdrawal by Subject|3
7543354|NCT02796664|11895774|FG000|Overall Study|Noncompliance|1
7543355|NCT02796664|11895775|FG001|Overall Study|Noncompliance|1
7543356|NCT02796664|11895774|FG000|Overall Study|Death|0
7543357|NCT02796664|11895775|FG001|Overall Study|Death|1
7543358|NCT02796677|11895787|FG000|Overall Study|Adverse Event|11
7543359|NCT02796677|11895788|FG001|Overall Study|Adverse Event|22
7543360|NCT02796677|11895789|FG002|Overall Study|Adverse Event|14
7543361|NCT02796677|11895790|FG003|Overall Study|Adverse Event|14
7543362|NCT02796677|11895787|FG000|Overall Study|Protocol Violation|7
7543363|NCT02796677|11895788|FG001|Overall Study|Protocol Violation|5
7543364|NCT02796677|11895789|FG002|Overall Study|Protocol Violation|4
7543365|NCT02796677|11895790|FG003|Overall Study|Protocol Violation|8
7260158|NCT00356148|11472663|FG001|Overall Study|Reoperation within 30 days|1
7260159|NCT00356200|11472672|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
7260160|NCT00356200|11472673|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
7260161|NCT00356200|11472672|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
7260162|NCT00356200|11472673|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
7260163|NCT00356265|11472688|FG000|Overall Study|Withdrawal by Subject|0
7260164|NCT00356265|11472689|FG001|Overall Study|Withdrawal by Subject|0
7260165|NCT00356265|11472690|FG002|Overall Study|Withdrawal by Subject|1
7260166|NCT00356278|11472702|FG000|Overall Study|Withdrawal by Subject|25
7260167|NCT00356278|11472703|FG001|Overall Study|Withdrawal by Subject|15
7260168|NCT00356278|11472704|FG002|Overall Study|Withdrawal by Subject|19
7260169|NCT00356369|11472723|FG000|Active Phase|Withdrawal by Subject|2
7260170|NCT00356369|11472724|FG001|Active Phase|Withdrawal by Subject|1
7260171|NCT00356408|11472734|FG000|Overall Study|Adverse Event|9
7260172|NCT00356408|11472734|FG000|Overall Study|Lack of Efficacy|36
7260173|NCT00356408|11472734|FG000|Overall Study|Lost to Follow-up|2
7260174|NCT00356408|11472734|FG000|Overall Study|Withdrawal by Subject|6
7260175|NCT00356408|11472734|FG000|Overall Study|Other: Principal investigator discretion|3
7260176|NCT00356408|11472734|FG000|Overall Study|Other: Sponsor request|1
7260177|NCT00356408|11472734|FG000|Overall Study|Other: Azathioprine stopped|1
7543366|NCT02796677|11895787|FG000|Overall Study|Lost to Follow-up|1
7543367|NCT02796677|11895788|FG001|Overall Study|Lost to Follow-up|5
7543368|NCT02796677|11895789|FG002|Overall Study|Lost to Follow-up|2
7543369|NCT02796677|11895790|FG003|Overall Study|Lost to Follow-up|2
7543370|NCT02796677|11895787|FG000|Overall Study|Lack of Efficacy|7
7543371|NCT02796677|11895788|FG001|Overall Study|Lack of Efficacy|9
7543372|NCT02796677|11895789|FG002|Overall Study|Lack of Efficacy|14
7260178|NCT00356408|11472734|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
7260179|NCT00356408|11472734|FG000|Overall Study|Other: Subject chose commerical dosing|1
7260180|NCT00356525|11472759|FG000|Overall Study|Progressive Disease|8
7543373|NCT02796677|11895790|FG003|Overall Study|Lack of Efficacy|20
7543374|NCT02796677|11895787|FG000|Overall Study|Withdrawal by Subject|4
7543375|NCT02796677|11895788|FG001|Overall Study|Withdrawal by Subject|14
7260181|NCT00356525|11472760|FG001|Overall Study|Progressive Disease|5
7260182|NCT00356525|11472761|FG002|Overall Study|Progressive Disease|4
7260183|NCT00356525|11472762|FG003|Overall Study|Progressive Disease|2
7260184|NCT00356525|11472759|FG000|Overall Study|Adverse Event|1
7260185|NCT00356525|11472760|FG001|Overall Study|Adverse Event|3
7260186|NCT00356525|11472761|FG002|Overall Study|Adverse Event|1
7260187|NCT00356525|11472762|FG003|Overall Study|Adverse Event|1
7260188|NCT00356525|11472759|FG000|Overall Study|Lost to Follow-up|1
7260189|NCT00356525|11472760|FG001|Overall Study|Lost to Follow-up|0
7260190|NCT00356525|11472761|FG002|Overall Study|Lost to Follow-up|0
7260191|NCT00356525|11472762|FG003|Overall Study|Lost to Follow-up|0
7260192|NCT00356525|11472759|FG000|Overall Study|Physician Decision|2
7260193|NCT00356525|11472760|FG001|Overall Study|Physician Decision|2
7260194|NCT00356525|11472761|FG002|Overall Study|Physician Decision|2
7260195|NCT00356525|11472762|FG003|Overall Study|Physician Decision|1
7260196|NCT00356525|11472759|FG000|Overall Study|Protocol Entry Criteria Not Met|1
7260197|NCT00356525|11472760|FG001|Overall Study|Protocol Entry Criteria Not Met|0
7260198|NCT00356525|11472761|FG002|Overall Study|Protocol Entry Criteria Not Met|0
7260199|NCT00356525|11472762|FG003|Overall Study|Protocol Entry Criteria Not Met|0
7260200|NCT00356525|11472759|FG000|Overall Study|Withdrawal by Subject|1
7260201|NCT00356525|11472760|FG001|Overall Study|Withdrawal by Subject|1
7260202|NCT00356525|11472761|FG002|Overall Study|Withdrawal by Subject|0
7260203|NCT00356525|11472762|FG003|Overall Study|Withdrawal by Subject|3
7260204|NCT00356525|11472759|FG000|Overall Study|Death|0
7260205|NCT00356525|11472760|FG001|Overall Study|Death|0
7260206|NCT00356525|11472761|FG002|Overall Study|Death|0
7260207|NCT00356525|11472762|FG003|Overall Study|Death|1
7260208|NCT00356525|11472759|FG000|Overall Study|Sponsor Decision|0
7260209|NCT00356525|11472760|FG001|Overall Study|Sponsor Decision|0
7260210|NCT00356525|11472761|FG002|Overall Study|Sponsor Decision|0
7260211|NCT00356525|11472762|FG003|Overall Study|Sponsor Decision|1
7260212|NCT00356590|11472772|FG000|Overall Study|Adverse Event|54
7260213|NCT00356590|11472772|FG000|Overall Study|Death|10
7260214|NCT00356590|11472772|FG000|Overall Study|Lost to Follow-up|35
7260215|NCT00356590|11472772|FG000|Overall Study|Physician Decision|46
7260216|NCT00356590|11472772|FG000|Overall Study|Withdrawal by Subject|41
7260217|NCT00356590|11472772|FG000|Overall Study|Completed month 12 only|2
7260218|NCT00356590|11472772|FG000|Overall Study|Protocol issues|6
7260219|NCT00356590|11472772|FG000|Overall Study|Response status|28
7260220|NCT00356590|11472772|FG000|Overall Study|Other|52
7260221|NCT00356603|11472778|FG000|Overall Study|Other|6
7260222|NCT00356603|11472779|FG001|Overall Study|Other|3
7260223|NCT00356759|11472789|FG000|Overall Study|Death|5
7260224|NCT00356759|11472790|FG001|Overall Study|Death|2
7260225|NCT00356759|11472789|FG000|Overall Study|Withdrawal by Subject|2
7260226|NCT00356759|11472790|FG001|Overall Study|Withdrawal by Subject|2
7260227|NCT00356759|11472789|FG000|Overall Study|Adverse Event|1
7260228|NCT00356759|11472790|FG001|Overall Study|Adverse Event|3
7260229|NCT00356759|11472789|FG000|Overall Study|Lost to Follow-up|1
7260230|NCT00356759|11472790|FG001|Overall Study|Lost to Follow-up|1
7260231|NCT00356759|11472789|FG000|Overall Study|Intercurrent disease or persistent extre|5
7260232|NCT00356759|11472790|FG001|Overall Study|Intercurrent disease or persistent extre|2
7260233|NCT00356811|11472796|FG000|Overall Study|Death|35
7260234|NCT00356811|11472796|FG000|Overall Study|Lost to Follow-up|2
7260235|NCT00356811|11472796|FG000|Overall Study|Withdrawal by Subject|6
7260236|NCT00356811|11472796|FG000|Overall Study|Participant Could Not Make a Checkup|1
7260237|NCT00356811|11472796|FG000|Overall Study|Study Is Terminating|3
7260238|NCT00356811|11472796|FG000|Overall Study|Site Closed during Follow-up|2
7260239|NCT00356863|11472803|FG000|Overall Study|Death|16
7260240|NCT00356863|11472804|FG001|Overall Study|Death|32
7260241|NCT00356863|11472803|FG000|Overall Study|Lost to Follow-up|76
7260242|NCT00356863|11472804|FG001|Overall Study|Lost to Follow-up|43
7260243|NCT00356889|11472814|FG000|Overall Study|Protocol Violation|2
7260244|NCT00356889|11472814|FG000|Overall Study|Adverse Event|1
7260245|NCT00356915|11472822|FG000|Overall Study|Non compliance|1
7260246|NCT00356915|11472823|FG001|Overall Study|Non compliance|2
7260247|NCT00356915|11472824|FG002|Overall Study|Non compliance|1
7260248|NCT00356915|11472822|FG000|Overall Study|Protocol Violation|2
7260249|NCT00356915|11472823|FG001|Overall Study|Protocol Violation|3
7260250|NCT00356915|11472824|FG002|Overall Study|Protocol Violation|2
7260251|NCT00356915|11472822|FG000|Overall Study|Withdrawal by Subject|14
7260252|NCT00356915|11472823|FG001|Overall Study|Withdrawal by Subject|14
7543376|NCT02796677|11895789|FG002|Overall Study|Withdrawal by Subject|6
7543377|NCT02796677|11895790|FG003|Overall Study|Withdrawal by Subject|7
7543378|NCT02796677|11895787|FG000|Overall Study|Progressive disease|6
7543379|NCT02796677|11895788|FG001|Overall Study|Progressive disease|15
7543380|NCT02796677|11895789|FG002|Overall Study|Progressive disease|13
7543381|NCT02796677|11895790|FG003|Overall Study|Progressive disease|18
7543382|NCT02796677|11895787|FG000|Overall Study|Reason not mentioned|2
7543383|NCT02796677|11895788|FG001|Overall Study|Reason not mentioned|3
7543384|NCT02796677|11895789|FG002|Overall Study|Reason not mentioned|0
7543385|NCT02796677|11895790|FG003|Overall Study|Reason not mentioned|5
7543386|NCT02796755|11895804|FG000|Overall Study|Adverse Event|2
7543387|NCT02796755|11895805|FG001|Overall Study|Adverse Event|0
7543388|NCT02796963|11895819|FG000|Overall Study|Lost to Follow-up|89
7543389|NCT02796963|11895820|FG001|Overall Study|Lost to Follow-up|76
7543390|NCT02796963|11895821|FG002|Overall Study|Lost to Follow-up|69
7543391|NCT02796963|11895822|FG003|Overall Study|Lost to Follow-up|72
7543392|NCT02797080|11895845|FG000|Overall Study|Lost to Follow-up|1
7543393|NCT02797080|11895845|FG000|Overall Study|Withdrawal by Subject|1
7543394|NCT02797132|11895849|FG000|Part A (15 Days)|Adverse Event|1
7260253|NCT00356915|11472824|FG002|Overall Study|Withdrawal by Subject|10
7543395|NCT02797132|11895849|FG000|Part B (24 Weeks)|Adverse Event|3
7543396|NCT02797171|11895868|FG000|Overall Study|Lost to Follow-up|2
7260254|NCT00356915|11472822|FG000|Overall Study|Lack of Efficacy|0
7260255|NCT00356915|11472823|FG001|Overall Study|Lack of Efficacy|0
7260256|NCT00356915|11472824|FG002|Overall Study|Lack of Efficacy|3
7260257|NCT00356915|11472822|FG000|Overall Study|Lost to Follow-up|27
7260258|NCT00356915|11472823|FG001|Overall Study|Lost to Follow-up|34
7260259|NCT00356915|11472824|FG002|Overall Study|Lost to Follow-up|14
7260260|NCT00356915|11472822|FG000|Overall Study|Administrative Decision|0
7260261|NCT00356915|11472823|FG001|Overall Study|Administrative Decision|0
7260262|NCT00356915|11472824|FG002|Overall Study|Administrative Decision|1
7260263|NCT00356915|11472822|FG000|Overall Study|Physician Decision|0
7260264|NCT00356915|11472823|FG001|Overall Study|Physician Decision|2
7260265|NCT00356915|11472824|FG002|Overall Study|Physician Decision|0
7260266|NCT00356915|11472822|FG000|Overall Study|Adverse Event|21
7260267|NCT00356915|11472823|FG001|Overall Study|Adverse Event|31
7260268|NCT00356915|11472824|FG002|Overall Study|Adverse Event|8
7260269|NCT00356915|11472822|FG000|Overall Study|Miscellaneous reasons|11
7260270|NCT00356915|11472823|FG001|Overall Study|Miscellaneous reasons|8
7260271|NCT00356915|11472824|FG002|Overall Study|Miscellaneous reasons|3
7260272|NCT00357006|11472845|FG000|Overall Study|Lost to Follow-up|1
7260273|NCT00357006|11472846|FG001|Overall Study|Lost to Follow-up|2
7260274|NCT00357006|11472847|FG002|Overall Study|Lost to Follow-up|1
7260275|NCT00357006|11472845|FG000|Overall Study|Withdrawal by Subject|1
7260276|NCT00357006|11472846|FG001|Overall Study|Withdrawal by Subject|3
7260277|NCT00357006|11472847|FG002|Overall Study|Withdrawal by Subject|2
7260278|NCT00357097|11472861|FG000|Overall Study|Did not meet inclusion criteria|5
7260279|NCT00357097|11472862|FG001|Overall Study|Did not meet inclusion criteria|3
7260280|NCT00357097|11472861|FG000|Overall Study|Adverse Event|34
7260281|NCT00357097|11472862|FG001|Overall Study|Adverse Event|6
7260282|NCT00357097|11472861|FG000|Overall Study|Withdrawal by Subject|8
7260283|NCT00357097|11472862|FG001|Overall Study|Withdrawal by Subject|7
7260284|NCT00357097|11472861|FG000|Overall Study|Non-compliance|1
7260285|NCT00357097|11472862|FG001|Overall Study|Non-compliance|2
7260286|NCT00357097|11472861|FG000|Overall Study|Lack of Efficacy|2
7260287|NCT00357097|11472862|FG001|Overall Study|Lack of Efficacy|8
7260288|NCT00357097|11472861|FG000|Overall Study|Met Exclusion Criteria|3
7260289|NCT00357097|11472862|FG001|Overall Study|Met Exclusion Criteria|1
7260290|NCT00357097|11472861|FG000|Overall Study|Other|1
7260291|NCT00357097|11472862|FG001|Overall Study|Other|1
7260292|NCT00357097|11472861|FG000|Overall Study|Increase of RLS Symptoms|0
7260293|NCT00357097|11472862|FG001|Overall Study|Increase of RLS Symptoms|1
7260294|NCT00357110|11472870|FG000|Overall Study|Early study termination|5
7260295|NCT00357110|11472871|FG001|Overall Study|Early study termination|5
7260296|NCT00357370|11472910|FG000|Cohort 2|Lack of Efficacy|0
7260297|NCT00357370|11472911|FG001|Cohort 2|Lack of Efficacy|2
7260298|NCT00357370|11472912|FG002|Cohort 2|Lack of Efficacy|1
7260299|NCT00357370|11472910|FG000|Cohort 2|Adverse Event|1
7260300|NCT00357370|11472911|FG001|Cohort 2|Adverse Event|1
7260301|NCT00357370|11472912|FG002|Cohort 2|Adverse Event|1
7260302|NCT00357370|11472910|FG000|Cohort 2|Lost to Follow-up|0
7260303|NCT00357370|11472911|FG001|Cohort 2|Lost to Follow-up|1
7260304|NCT00357370|11472912|FG002|Cohort 2|Lost to Follow-up|0
7260305|NCT00357370|11472910|FG000|Cohort 2|non-compliance, not met criteria, etc|1
7260306|NCT00357370|11472911|FG001|Cohort 2|non-compliance, not met criteria, etc|1
7260307|NCT00357370|11472912|FG002|Cohort 2|non-compliance, not met criteria, etc|0
7260308|NCT00357370|11472910|FG000|Cohort 2|Withdrawal by Subject|0
7260309|NCT00357370|11472911|FG001|Cohort 2|Withdrawal by Subject|2
7260310|NCT00357370|11472912|FG002|Cohort 2|Withdrawal by Subject|0
7260311|NCT00357396|11472922|FG000|Overall Study|Adverse Event|1
7260312|NCT00357396|11472923|FG001|Overall Study|Adverse Event|0
7260313|NCT00357500|11472928|FG000|Overall Study|Adverse Event|3
7260314|NCT00357500|11472928|FG000|Overall Study|Withdrawal by Subject|5
7260315|NCT00357500|11472928|FG000|Overall Study|Progressive Disease|65
7260316|NCT00357500|11472928|FG000|Overall Study|Not Started Protocol Therapy|4
7260317|NCT00357552|11472932|FG000|Screening|Did not meet eligibility criteria|84
7260318|NCT00357552|11472932|FG000|Weeks 0 to 24|Death|1
7260319|NCT00357552|11472932|FG000|Weeks 24 to 104|Death|3
7260320|NCT00357552|11472932|FG000|Weeks 24 to 104|Not able to get to clinic|2
7260321|NCT00357656|11472942|FG000|Overall Study|Other, No surgery performed|0
7260322|NCT00357656|11472943|FG001|Overall Study|Other, No surgery performed|3
7260323|NCT00357760|11472967|FG000|Overall Study|Disease progression|44
7260324|NCT00357760|11472968|FG001|Overall Study|Disease progression|17
7260325|NCT00357760|11472967|FG000|Overall Study|Adverse Event|10
7260326|NCT00357760|11472968|FG001|Overall Study|Adverse Event|7
7260327|NCT00357760|11472967|FG000|Overall Study|Death|0
7260328|NCT00357760|11472968|FG001|Overall Study|Death|3
7260329|NCT00357760|11472967|FG000|Overall Study|Alternative therapy|1
7260330|NCT00357760|11472968|FG001|Overall Study|Alternative therapy|0
7260331|NCT00357760|11472967|FG000|Overall Study|Withdrawal by Subject|0
7260332|NCT00357760|11472968|FG001|Overall Study|Withdrawal by Subject|2
7260333|NCT00357760|11472967|FG000|Overall Study|Never started treatment|2
7260334|NCT00357760|11472968|FG001|Overall Study|Never started treatment|1
7260335|NCT00357760|11472967|FG000|Overall Study|Ineligible|0
7260336|NCT00357760|11472968|FG001|Overall Study|Ineligible|2
7260337|NCT00357760|11472967|FG000|Overall Study|Physician Decision|2
7260338|NCT00357760|11472968|FG001|Overall Study|Physician Decision|1
7260339|NCT00357760|11472967|FG000|Overall Study|Protocol Violation|0
7260340|NCT00357760|11472968|FG001|Overall Study|Protocol Violation|1
7260341|NCT00357760|11472967|FG000|Overall Study|To receive hospice care|0
7260342|NCT00357760|11472968|FG001|Overall Study|To receive hospice care|1
7260343|NCT00357877|11472976|FG000|Overall Study|Death|2
7260344|NCT00357877|11472977|FG001|Overall Study|Death|1
7260345|NCT00357877|11472976|FG000|Overall Study|Lost to Follow-up|20
7260346|NCT00357877|11472977|FG001|Overall Study|Lost to Follow-up|23
7260347|NCT00357877|11472976|FG000|Overall Study|Withdrawal by Subject|3
7260348|NCT00357877|11472977|FG001|Overall Study|Withdrawal by Subject|3
7260349|NCT00357877|11472976|FG000|Overall Study|Administrative withdrawal|1
7260350|NCT00357877|11472977|FG001|Overall Study|Administrative withdrawal|1
7260351|NCT00357877|11472976|FG000|Overall Study|Other|0
7260352|NCT00357877|11472977|FG001|Overall Study|Other|2
7543397|NCT02797171|11895869|FG001|Overall Study|Lost to Follow-up|0
7543398|NCT02797171|11895870|FG002|Overall Study|Lost to Follow-up|2
7543399|NCT02797171|11895871|FG003|Overall Study|Lost to Follow-up|1
7543400|NCT02797171|11895872|FG004|Overall Study|Lost to Follow-up|2
7543401|NCT02797171|11895873|FG005|Overall Study|Lost to Follow-up|0
7543402|NCT02797171|11895868|FG000|Overall Study|Withdrawal by Subject|1
7543403|NCT02797171|11895869|FG001|Overall Study|Withdrawal by Subject|1
7543404|NCT02797171|11895870|FG002|Overall Study|Withdrawal by Subject|0
7543405|NCT02797171|11895871|FG003|Overall Study|Withdrawal by Subject|0
7543406|NCT02797171|11895872|FG004|Overall Study|Withdrawal by Subject|0
7543407|NCT02797171|11895873|FG005|Overall Study|Withdrawal by Subject|0
7260353|NCT00357903|11472987|FG000|Overall Study|Adverse Event|87
7260354|NCT00357903|11472988|FG001|Overall Study|Adverse Event|4
7260355|NCT00357903|11472987|FG000|Overall Study|Death|33
7260356|NCT00357903|11472988|FG001|Overall Study|Death|0
7543408|NCT02797171|11895868|FG000|Overall Study|Protocol Violation|1
7543409|NCT02797171|11895869|FG001|Overall Study|Protocol Violation|0
7543410|NCT02797171|11895870|FG002|Overall Study|Protocol Violation|0
7543411|NCT02797171|11895871|FG003|Overall Study|Protocol Violation|0
7543412|NCT02797171|11895872|FG004|Overall Study|Protocol Violation|0
7543413|NCT02797171|11895873|FG005|Overall Study|Protocol Violation|0
7543414|NCT02797171|11895868|FG000|Overall Study|Participant unable to adhere|0
7543415|NCT02797171|11895869|FG001|Overall Study|Participant unable to adhere|1
7260357|NCT00357903|11472987|FG000|Overall Study|Lost to Follow-up|23
7260358|NCT00357903|11472988|FG001|Overall Study|Lost to Follow-up|4
7260359|NCT00357903|11472987|FG000|Overall Study|Physician Decision|39
7260360|NCT00357903|11472988|FG001|Overall Study|Physician Decision|5
7260361|NCT00357903|11472987|FG000|Overall Study|Withdrawal by Subject|57
7260362|NCT00357903|11472988|FG001|Overall Study|Withdrawal by Subject|7
7260363|NCT00357903|11472987|FG000|Overall Study|Completed month 12 only|0
7260364|NCT00357903|11472988|FG001|Overall Study|Completed month 12 only|1
7260365|NCT00357903|11472987|FG000|Overall Study|Protocol issues|14
7260366|NCT00357903|11472988|FG001|Overall Study|Protocol issues|3
7260367|NCT00357903|11472987|FG000|Overall Study|Response status|61
7260368|NCT00357903|11472988|FG001|Overall Study|Response status|9
7260369|NCT00357903|11472987|FG000|Overall Study|Other|49
7260370|NCT00357903|11472988|FG001|Overall Study|Other|10
7260371|NCT00357968|11473006|FG000|First Maintenance Dose Phase|Not a PCI patient|47
7260372|NCT00357968|11473007|FG001|First Maintenance Dose Phase|Not a PCI patient|42
7260373|NCT00357968|11473006|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
7260374|NCT00357968|11473007|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
7260375|NCT00357994|11473030|FG000|Overall Study|Adverse Event|1
7260376|NCT00357994|11473031|FG001|Overall Study|Adverse Event|2
7260377|NCT00357994|11473030|FG000|Overall Study|Lack of Efficacy|0
7260378|NCT00357994|11473031|FG001|Overall Study|Lack of Efficacy|1
7260379|NCT00357994|11473030|FG000|Overall Study|Protocol Violation|1
7260380|NCT00357994|11473031|FG001|Overall Study|Protocol Violation|0
7260381|NCT00358150|11473041|FG000|Overall Study|Adverse Event|3
7260382|NCT00358150|11473041|FG000|Overall Study|Withdrawal by Subject|1
7260383|NCT00358150|11473041|FG000|Overall Study|Undefined|3
7260384|NCT00358215|11473050|FG000|Overall Study|Ineligibility determined|4
7260385|NCT00358215|11473051|FG001|Overall Study|Ineligibility determined|3
7260386|NCT00358215|11473050|FG000|Overall Study|Adverse Event|83
7260387|NCT00358215|11473051|FG001|Overall Study|Adverse Event|65
7260388|NCT00358215|11473050|FG000|Overall Study|Withdrawal by Subject|111
7260389|NCT00358215|11473051|FG001|Overall Study|Withdrawal by Subject|102
7260390|NCT00358215|11473050|FG000|Overall Study|Participant request|65
7260391|NCT00358215|11473051|FG001|Overall Study|Participant request|64
7260392|NCT00358215|11473050|FG000|Overall Study|Physician Decision|47
7260393|NCT00358215|11473051|FG001|Overall Study|Physician Decision|39
7260394|NCT00358215|11473050|FG000|Overall Study|Lost to Follow-up|16
7543416|NCT02797171|11895870|FG002|Overall Study|Participant unable to adhere|0
7543417|NCT02797171|11895871|FG003|Overall Study|Participant unable to adhere|0
7543418|NCT02797171|11895872|FG004|Overall Study|Participant unable to adhere|0
7543419|NCT02797171|11895873|FG005|Overall Study|Participant unable to adhere|0
7543420|NCT02797171|11895868|FG000|Overall Study|Not Randomized|0
7543421|NCT02797171|11895869|FG001|Overall Study|Not Randomized|0
7543422|NCT02797171|11895870|FG002|Overall Study|Not Randomized|0
7543423|NCT02797171|11895871|FG003|Overall Study|Not Randomized|0
7543424|NCT02797171|11895872|FG004|Overall Study|Not Randomized|0
7543425|NCT02797171|11895873|FG005|Overall Study|Not Randomized|1
7543426|NCT02797522|11895898|FG000|Overall Study|Study Terminated by Sponsor|0
7543427|NCT02797522|11895899|FG001|Overall Study|Study Terminated by Sponsor|0
7543428|NCT02797522|11895900|FG002|Overall Study|Study Terminated by Sponsor|0
7543429|NCT02797522|11895901|FG003|Overall Study|Study Terminated by Sponsor|0
7543430|NCT02797522|11895902|FG004|Overall Study|Study Terminated by Sponsor|0
7543431|NCT02797522|11895903|FG005|Overall Study|Study Terminated by Sponsor|0
7543432|NCT02797522|11895904|FG006|Overall Study|Study Terminated by Sponsor|0
7543433|NCT02797522|11895905|FG007|Overall Study|Study Terminated by Sponsor|4
7543434|NCT02797522|11895906|FG008|Overall Study|Study Terminated by Sponsor|2
7543435|NCT02797522|11895907|FG009|Overall Study|Study Terminated by Sponsor|4
7543436|NCT02797522|11895908|FG010|Overall Study|Study Terminated by Sponsor|1
7543437|NCT02797678|11895945|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
7543438|NCT02797678|11895946|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7543439|NCT02797678|11895947|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7543440|NCT02797678|11895948|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7543441|NCT02797678|11895945|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
7543442|NCT02797678|11895946|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
7543443|NCT02797678|11895947|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
7543444|NCT02797678|11895948|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
7543445|NCT02797678|11895945|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
7543446|NCT02797678|11895946|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
7543447|NCT02797678|11895947|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
7576424|NCT04335136|11962870|FG000|Overall Study|Health-threatening condition|0
7260395|NCT00358215|11473051|FG001|Overall Study|Lost to Follow-up|22
7543448|NCT02797678|11895948|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
7543449|NCT02797808|11895963|FG000|Overall Study|Withdrawal by Subject|1
7543450|NCT02797808|11895964|FG001|Overall Study|Withdrawal by Subject|1
7543451|NCT02797808|11895963|FG000|Overall Study|Physician Decision|6
7543452|NCT02797808|11895964|FG001|Overall Study|Physician Decision|2
7260396|NCT00358215|11473050|FG000|Overall Study|Death|265
7543453|NCT02798211|11895986|FG000|Period 1|Adverse Event|1
7260397|NCT00358215|11473051|FG001|Overall Study|Death|281
7543454|NCT02798211|11895987|FG001|Period 1|Adverse Event|1
7543455|NCT02798211|11895988|FG002|Period 1|Adverse Event|0
7543456|NCT02798211|11895989|FG003|Period 1|Adverse Event|0
7543457|NCT02798211|11895990|FG004|Period 1|Adverse Event|0
7260398|NCT00358215|11473050|FG000|Overall Study|Protocol Violation|64
7260399|NCT00358215|11473051|FG001|Overall Study|Protocol Violation|59
7576425|NCT04335136|11962871|FG001|Overall Study|Health-threatening condition|1
7576426|NCT04335136|11962870|FG000|Overall Study|Adverse Event|0
7576427|NCT04335136|11962871|FG001|Overall Study|Adverse Event|1
7576428|NCT04335136|11962870|FG000|Overall Study|Erroneously randomized|2
7576429|NCT04335136|11962871|FG001|Overall Study|Erroneously randomized|0
7260400|NCT00358215|11473050|FG000|Overall Study|Pregnancy|1
7260401|NCT00358215|11473051|FG001|Overall Study|Pregnancy|0
7260402|NCT00358215|11473050|FG000|Overall Study|Other|21
7260403|NCT00358215|11473051|FG001|Overall Study|Other|14
7260404|NCT00358215|11473050|FG000|Overall Study|Did not receive investigational product|2
7260405|NCT00358215|11473051|FG001|Overall Study|Did not receive investigational product|3
7260406|NCT00358436|11473076|FG000|Overall Study|Adverse Event|29
7260407|NCT00358436|11473077|FG001|Overall Study|Adverse Event|13
7260408|NCT00358436|11473076|FG000|Overall Study|Lack of Efficacy|34
7260409|NCT00358436|11473077|FG001|Overall Study|Lack of Efficacy|36
7260410|NCT00358436|11473076|FG000|Overall Study|Lost to Follow-up|11
7260411|NCT00358436|11473077|FG001|Overall Study|Lost to Follow-up|6
7260412|NCT00358436|11473076|FG000|Overall Study|Protocol Violation|8
7260413|NCT00358436|11473077|FG001|Overall Study|Protocol Violation|3
7260414|NCT00358436|11473076|FG000|Overall Study|Withdrawal by Subject|40
7260415|NCT00358436|11473077|FG001|Overall Study|Withdrawal by Subject|17
7260416|NCT00358436|11473076|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
7260417|NCT00358436|11473077|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
7260418|NCT00358436|11473076|FG000|Overall Study|COPD exacerbation|22
7260419|NCT00358436|11473077|FG001|Overall Study|COPD exacerbation|10
7260420|NCT00358436|11473076|FG000|Overall Study|Other|6
7260421|NCT00358436|11473077|FG001|Overall Study|Other|1
7260422|NCT00358449|11473088|FG000|Overall Study|Adverse Event|1
7260423|NCT00358449|11473089|FG001|Overall Study|Adverse Event|0
7260424|NCT00358449|11473090|FG002|Overall Study|Adverse Event|1
7260425|NCT00358449|11473088|FG000|Overall Study|Lost to Follow-up|1
7260426|NCT00358449|11473089|FG001|Overall Study|Lost to Follow-up|0
7260427|NCT00358449|11473090|FG002|Overall Study|Lost to Follow-up|0
7260428|NCT00358449|11473088|FG000|Overall Study|Withdrawal by Subject|2
7260429|NCT00358449|11473089|FG001|Overall Study|Withdrawal by Subject|0
7543458|NCT02798211|11895991|FG005|Period 1|Adverse Event|0
7260430|NCT00358449|11473090|FG002|Overall Study|Withdrawal by Subject|0
7260431|NCT00358449|11473088|FG000|Overall Study|Lack of Efficacy|0
7260432|NCT00358449|11473089|FG001|Overall Study|Lack of Efficacy|1
7260433|NCT00358449|11473090|FG002|Overall Study|Lack of Efficacy|0
7260434|NCT00358449|11473088|FG000|Overall Study|Steriod Inhaler was Increased|0
7543459|NCT02798211|11895986|FG000|Period 1|Lost to Follow-up|2
7543460|NCT02798211|11895987|FG001|Period 1|Lost to Follow-up|1
7543461|NCT02798211|11895988|FG002|Period 1|Lost to Follow-up|0
7543462|NCT02798211|11895989|FG003|Period 1|Lost to Follow-up|0
7543463|NCT02798211|11895990|FG004|Period 1|Lost to Follow-up|0
7543464|NCT02798211|11895991|FG005|Period 1|Lost to Follow-up|0
7543465|NCT02798211|11895986|FG000|Period 1|Protocol Violation|0
7543466|NCT02798211|11895987|FG001|Period 1|Protocol Violation|0
7543467|NCT02798211|11895988|FG002|Period 1|Protocol Violation|2
7543468|NCT02798211|11895989|FG003|Period 1|Protocol Violation|0
7543469|NCT02798211|11895990|FG004|Period 1|Protocol Violation|0
7543470|NCT02798211|11895991|FG005|Period 1|Protocol Violation|0
7543471|NCT02798211|11895986|FG000|Period 1|Withdrawal by Subject|1
7543472|NCT02798211|11895987|FG001|Period 1|Withdrawal by Subject|1
7543473|NCT02798211|11895988|FG002|Period 1|Withdrawal by Subject|0
7543474|NCT02798211|11895989|FG003|Period 1|Withdrawal by Subject|0
7576430|NCT04333199|11962921|FG000|Evaluated Patients|Lost to Follow-up|0
7576431|NCT04333199|11962922|FG001|Evaluated Patients|Lost to Follow-up|1
7576432|NCT04333199|11962923|FG002|Evaluated Patients|Lost to Follow-up|2
7260435|NCT00358449|11473089|FG001|Overall Study|Steriod Inhaler was Increased|0
7260436|NCT00358449|11473090|FG002|Overall Study|Steriod Inhaler was Increased|1
7260437|NCT00358644|11473138|FG000|Overall Study|Progressive Disease|21
7260438|NCT00358644|11473138|FG000|Overall Study|Adverse Event|7
7260439|NCT00358644|11473138|FG000|Overall Study|Death|11
7260440|NCT00358644|11473138|FG000|Overall Study|Withdrawal by Subject|4
7260441|NCT00358644|11473138|FG000|Overall Study|Physician Decision|6
7260442|NCT00358644|11473138|FG000|Overall Study|Patient not eligible for study|1
7260443|NCT00358670|11473148|FG000|Overall Study|Adverse Event|26
7543475|NCT02798211|11895990|FG004|Period 1|Withdrawal by Subject|0
7543476|NCT02798211|11895991|FG005|Period 1|Withdrawal by Subject|0
7543477|NCT02798211|11895986|FG000|Period 1|Death|0
7543478|NCT02798211|11895987|FG001|Period 1|Death|0
7543479|NCT02798211|11895988|FG002|Period 1|Death|1
7543480|NCT02798211|11895989|FG003|Period 1|Death|0
7543481|NCT02798211|11895990|FG004|Period 1|Death|0
7543482|NCT02798211|11895991|FG005|Period 1|Death|0
7543483|NCT02798211|11895986|FG000|Period 1|Withdrawal of Informed Consent|2
7543484|NCT02798211|11895987|FG001|Period 1|Withdrawal of Informed Consent|7
7543485|NCT02798211|11895988|FG002|Period 1|Withdrawal of Informed Consent|3
7543486|NCT02798211|11895989|FG003|Period 1|Withdrawal of Informed Consent|0
7543487|NCT02798211|11895990|FG004|Period 1|Withdrawal of Informed Consent|0
7543488|NCT02798211|11895991|FG005|Period 1|Withdrawal of Informed Consent|0
7543489|NCT02798211|11895986|FG000|Period 2|Withdrawal by Subject|2
7543490|NCT02798211|11895987|FG001|Period 2|Withdrawal by Subject|0
7543491|NCT02798211|11895988|FG002|Period 2|Withdrawal by Subject|0
7543492|NCT02798211|11895989|FG003|Period 2|Withdrawal by Subject|0
7543493|NCT02798211|11895990|FG004|Period 2|Withdrawal by Subject|2
7543494|NCT02798211|11895991|FG005|Period 2|Withdrawal by Subject|2
7543495|NCT02798211|11895986|FG000|Period 2|Adverse Event|5
7543496|NCT02798211|11895987|FG001|Period 2|Adverse Event|0
7543497|NCT02798211|11895988|FG002|Period 2|Adverse Event|0
7543498|NCT02798211|11895989|FG003|Period 2|Adverse Event|0
7543499|NCT02798211|11895990|FG004|Period 2|Adverse Event|1
7543500|NCT02798211|11895991|FG005|Period 2|Adverse Event|0
7543501|NCT02798211|11895986|FG000|Period 2|Lack of Efficacy|1
7543502|NCT02798211|11895987|FG001|Period 2|Lack of Efficacy|0
7543503|NCT02798211|11895988|FG002|Period 2|Lack of Efficacy|0
7543504|NCT02798211|11895989|FG003|Period 2|Lack of Efficacy|1
7543505|NCT02798211|11895990|FG004|Period 2|Lack of Efficacy|0
7543506|NCT02798211|11895991|FG005|Period 2|Lack of Efficacy|1
7543507|NCT02798211|11895986|FG000|Period 2|Lost to Follow-up|3
7543508|NCT02798211|11895987|FG001|Period 2|Lost to Follow-up|0
7543509|NCT02798211|11895988|FG002|Period 2|Lost to Follow-up|0
7543510|NCT02798211|11895989|FG003|Period 2|Lost to Follow-up|0
7543511|NCT02798211|11895990|FG004|Period 2|Lost to Follow-up|2
7543512|NCT02798211|11895991|FG005|Period 2|Lost to Follow-up|0
7543513|NCT02798211|11895986|FG000|Period 2|Physician Decision|1
7543514|NCT02798211|11895987|FG001|Period 2|Physician Decision|0
7543515|NCT02798211|11895988|FG002|Period 2|Physician Decision|0
7543516|NCT02798211|11895989|FG003|Period 2|Physician Decision|1
7543517|NCT02798211|11895990|FG004|Period 2|Physician Decision|1
7543518|NCT02798211|11895991|FG005|Period 2|Physician Decision|0
7543519|NCT02798211|11895986|FG000|Period 2|Pregnancy|0
7543520|NCT02798211|11895987|FG001|Period 2|Pregnancy|0
7543521|NCT02798211|11895988|FG002|Period 2|Pregnancy|0
7543522|NCT02798211|11895989|FG003|Period 2|Pregnancy|2
7543523|NCT02798211|11895990|FG004|Period 2|Pregnancy|0
7543524|NCT02798211|11895991|FG005|Period 2|Pregnancy|0
7543525|NCT02798211|11895986|FG000|Period 2|Technical problems|1
7543526|NCT02798211|11895987|FG001|Period 2|Technical problems|0
7543527|NCT02798211|11895988|FG002|Period 2|Technical problems|0
7543528|NCT02798211|11895989|FG003|Period 2|Technical problems|1
7543529|NCT02798211|11895990|FG004|Period 2|Technical problems|0
7543530|NCT02798211|11895991|FG005|Period 2|Technical problems|0
7543531|NCT02798211|11895986|FG000|Period 2|Withdrawal of Informed Consent|1
7543532|NCT02798211|11895987|FG001|Period 2|Withdrawal of Informed Consent|0
7543533|NCT02798211|11895988|FG002|Period 2|Withdrawal of Informed Consent|0
7543534|NCT02798211|11895989|FG003|Period 2|Withdrawal of Informed Consent|2
7543535|NCT02798211|11895990|FG004|Period 2|Withdrawal of Informed Consent|2
7543536|NCT02798211|11895991|FG005|Period 2|Withdrawal of Informed Consent|3
7543537|NCT02798315|11896007|FG000|Overall Study|Failure to return|1
7552340|NCT02988115|11912404|FG000|Overall Study|Withdrawal by Subject|1
7260444|NCT00358670|11473149|FG001|Overall Study|Adverse Event|29
7260445|NCT00358670|11473148|FG000|Overall Study|Lack of Efficacy|20
7260446|NCT00358670|11473149|FG001|Overall Study|Lack of Efficacy|23
7260447|NCT00358670|11473148|FG000|Overall Study|Protocol Violation|6
7260448|NCT00358670|11473149|FG001|Overall Study|Protocol Violation|9
7260449|NCT00358670|11473148|FG000|Overall Study|Lost to Follow-up|4
7260450|NCT00358670|11473149|FG001|Overall Study|Lost to Follow-up|5
7260451|NCT00358670|11473148|FG000|Overall Study|Withdrawal by Subject|13
7260452|NCT00358670|11473149|FG001|Overall Study|Withdrawal by Subject|24
7260453|NCT00358670|11473148|FG000|Overall Study|Protocol Defined Clinical Event|0
7260454|NCT00358670|11473149|FG001|Overall Study|Protocol Defined Clinical Event|1
7260455|NCT00358670|11473148|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7260456|NCT00358670|11473149|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
7260457|NCT00358670|11473148|FG000|Overall Study|Administrative|153
7260458|NCT00358670|11473149|FG001|Overall Study|Administrative|125
7260459|NCT00358826|11473168|FG000|Core Study|Adverse Event|1
7260460|NCT00358826|11473169|FG001|Core Study|Adverse Event|3
7260461|NCT00358826|11473170|FG002|Core Study|Adverse Event|1
7260462|NCT00358826|11473171|FG003|Core Study|Adverse Event|1
7260463|NCT00358826|11473172|FG004|Core Study|Adverse Event|0
7260464|NCT00358826|11473173|FG005|Core Study|Adverse Event|0
7260465|NCT00358826|11473174|FG006|Core Study|Adverse Event|0
7260466|NCT00358826|11473175|FG007|Core Study|Adverse Event|0
7260467|NCT00358826|11473168|FG000|Core Study|Withdrawal by Subject|2
7260468|NCT00358826|11473169|FG001|Core Study|Withdrawal by Subject|2
7260469|NCT00358826|11473170|FG002|Core Study|Withdrawal by Subject|0
7260470|NCT00358826|11473171|FG003|Core Study|Withdrawal by Subject|0
7260471|NCT00358826|11473172|FG004|Core Study|Withdrawal by Subject|0
7260472|NCT00358826|11473173|FG005|Core Study|Withdrawal by Subject|0
7260473|NCT00358826|11473174|FG006|Core Study|Withdrawal by Subject|0
7260474|NCT00358826|11473175|FG007|Core Study|Withdrawal by Subject|0
7543538|NCT02798835|11896046|FG000|Overall Study|Protocol Violation|0
7543539|NCT02798835|11896047|FG001|Overall Study|Protocol Violation|0
7543540|NCT02798835|11896048|FG002|Overall Study|Protocol Violation|3
7543541|NCT02798861|11896056|FG000|Overall Study|Lost to Follow-up|22
7543542|NCT02798861|11896056|FG000|Overall Study|Withdrawal by Subject|1
7543543|NCT02799069|11896102|FG000|Overall Study|Adverse Event|0
7543544|NCT02799069|11896103|FG001|Overall Study|Adverse Event|2
7543545|NCT02799069|11896104|FG002|Overall Study|Adverse Event|2
7543546|NCT02799069|11896102|FG000|Overall Study|Lack of Efficacy|2
7543547|NCT02799069|11896103|FG001|Overall Study|Lack of Efficacy|0
7543548|NCT02799069|11896104|FG002|Overall Study|Lack of Efficacy|0
7543549|NCT02799069|11896102|FG000|Overall Study|Lost to Follow-up|1
7543550|NCT02799069|11896103|FG001|Overall Study|Lost to Follow-up|1
7543551|NCT02799069|11896104|FG002|Overall Study|Lost to Follow-up|0
7543552|NCT02799069|11896102|FG000|Overall Study|Withdrawal by Subject|4
7543553|NCT02799069|11896103|FG001|Overall Study|Withdrawal by Subject|4
7543554|NCT02799069|11896104|FG002|Overall Study|Withdrawal by Subject|3
7543555|NCT02799069|11896102|FG000|Overall Study|Protocol Violation|1
7260475|NCT00358826|11473168|FG000|Core Study|Lost to Follow-up|0
7260476|NCT00358826|11473169|FG001|Core Study|Lost to Follow-up|0
7260477|NCT00358826|11473170|FG002|Core Study|Lost to Follow-up|0
7260478|NCT00358826|11473171|FG003|Core Study|Lost to Follow-up|1
7260479|NCT00358826|11473172|FG004|Core Study|Lost to Follow-up|0
7543556|NCT02799069|11896103|FG001|Overall Study|Protocol Violation|0
7260480|NCT00358826|11473173|FG005|Core Study|Lost to Follow-up|0
7260481|NCT00358826|11473174|FG006|Core Study|Lost to Follow-up|0
7260482|NCT00358826|11473175|FG007|Core Study|Lost to Follow-up|0
7260483|NCT00358826|11473168|FG000|Core Study|Physician Decision|0
7260484|NCT00358826|11473169|FG001|Core Study|Physician Decision|0
7260485|NCT00358826|11473170|FG002|Core Study|Physician Decision|1
7260486|NCT00358826|11473171|FG003|Core Study|Physician Decision|0
7260487|NCT00358826|11473172|FG004|Core Study|Physician Decision|0
7260488|NCT00358826|11473173|FG005|Core Study|Physician Decision|0
7260489|NCT00358826|11473174|FG006|Core Study|Physician Decision|0
7260490|NCT00358826|11473175|FG007|Core Study|Physician Decision|0
7260491|NCT00358826|11473168|FG000|MDCT Substudy|Adverse Event|0
7260492|NCT00358826|11473169|FG001|MDCT Substudy|Adverse Event|0
7260493|NCT00358826|11473170|FG002|MDCT Substudy|Adverse Event|0
7260494|NCT00358826|11473171|FG003|MDCT Substudy|Adverse Event|0
7260495|NCT00358826|11473172|FG004|MDCT Substudy|Adverse Event|1
7260496|NCT00358826|11473173|FG005|MDCT Substudy|Adverse Event|0
7260497|NCT00358826|11473174|FG006|MDCT Substudy|Adverse Event|0
7260498|NCT00358826|11473175|FG007|MDCT Substudy|Adverse Event|0
7260499|NCT00358826|11473168|FG000|MDCT Substudy|Lost to Follow-up|0
7260500|NCT00358826|11473169|FG001|MDCT Substudy|Lost to Follow-up|0
7260501|NCT00358826|11473170|FG002|MDCT Substudy|Lost to Follow-up|0
7260502|NCT00358826|11473171|FG003|MDCT Substudy|Lost to Follow-up|0
7260503|NCT00358826|11473172|FG004|MDCT Substudy|Lost to Follow-up|0
7260504|NCT00358826|11473173|FG005|MDCT Substudy|Lost to Follow-up|1
7260505|NCT00358826|11473174|FG006|MDCT Substudy|Lost to Follow-up|0
7543557|NCT02799069|11896104|FG002|Overall Study|Protocol Violation|2
7543558|NCT02799082|11896114|FG000|Overall Study|Refused second PDT or withdraw consent|4
7543559|NCT02799082|11896115|FG001|Overall Study|Refused second PDT or withdraw consent|3
7543560|NCT02799082|11896114|FG000|Overall Study|Protocol Violation|0
7543561|NCT02799082|11896115|FG001|Overall Study|Protocol Violation|1
7543562|NCT02799381|11896140|FG000|Overall Study|Withdrew consent|3
7543563|NCT02799381|11896141|FG001|Overall Study|Withdrew consent|2
7543564|NCT02799381|11896140|FG000|Overall Study|Adverse Event|0
7543565|NCT02799381|11896141|FG001|Overall Study|Adverse Event|1
7543566|NCT02799381|11896140|FG000|Overall Study|Participant did not take any study drug|1
7260506|NCT00358826|11473175|FG007|MDCT Substudy|Lost to Follow-up|0
7260507|NCT00358826|11473168|FG000|MDCT Substudy|Withdrawal by Subject|0
7260508|NCT00358826|11473169|FG001|MDCT Substudy|Withdrawal by Subject|0
7260509|NCT00358826|11473170|FG002|MDCT Substudy|Withdrawal by Subject|0
7260510|NCT00358826|11473171|FG003|MDCT Substudy|Withdrawal by Subject|0
7260511|NCT00358826|11473172|FG004|MDCT Substudy|Withdrawal by Subject|0
7260512|NCT00358826|11473173|FG005|MDCT Substudy|Withdrawal by Subject|1
7260513|NCT00358826|11473174|FG006|MDCT Substudy|Withdrawal by Subject|0
7260514|NCT00358826|11473175|FG007|MDCT Substudy|Withdrawal by Subject|0
7260515|NCT00358917|11473191|FG000|Overall Study|Adverse Event|14
7260516|NCT00358917|11473192|FG001|Overall Study|Adverse Event|21
7260517|NCT00358917|11473191|FG000|Overall Study|Withdrawal by Subject|5
7260518|NCT00358917|11473192|FG001|Overall Study|Withdrawal by Subject|7
7260519|NCT00358917|11473191|FG000|Overall Study|Lost to Follow-up|20
7260520|NCT00358917|11473192|FG001|Overall Study|Lost to Follow-up|17
7260521|NCT00358917|11473191|FG000|Overall Study|Noncompliance|12
7260522|NCT00358917|11473192|FG001|Overall Study|Noncompliance|11
7260523|NCT00358917|11473191|FG000|Overall Study|Death|2
7260524|NCT00358917|11473192|FG001|Overall Study|Death|3
7260525|NCT00358917|11473191|FG000|Overall Study|Virologic failure|11
7260526|NCT00358917|11473192|FG001|Overall Study|Virologic failure|8
7260527|NCT00358917|11473191|FG000|Overall Study|Unable to Continue Participation|2
7260528|NCT00358917|11473192|FG001|Overall Study|Unable to Continue Participation|2
7260529|NCT00358956|11473200|FG000|Overall Study|Adverse Event|3
7260530|NCT00358956|11473200|FG000|Overall Study|condition under investigation worsened|4
7260531|NCT00358956|11473200|FG000|Overall Study|Withdrawal by Subject|1
7260532|NCT00359021|11473206|FG000|Overall Study|Adverse Event|26
7260533|NCT00359021|11473207|FG001|Overall Study|Adverse Event|8
7260534|NCT00359021|11473206|FG000|Overall Study|Subject Non-Compliant|1
7260535|NCT00359021|11473207|FG001|Overall Study|Subject Non-Compliant|2
7260536|NCT00359021|11473206|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
7260537|NCT00359021|11473207|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
7260538|NCT00359021|11473206|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
7260539|NCT00359021|11473207|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
7260540|NCT00359021|11473206|FG000|Overall Study|Withdrawal by Subject|2
7260541|NCT00359021|11473207|FG001|Overall Study|Withdrawal by Subject|9
7260542|NCT00359021|11473206|FG000|Overall Study|Lost to Follow-up|1
7260543|NCT00359021|11473207|FG001|Overall Study|Lost to Follow-up|0
7260544|NCT00359021|11473206|FG000|Overall Study|Other|4
7260545|NCT00359021|11473207|FG001|Overall Study|Other|1
7260546|NCT00359021|11473206|FG000|Overall Study|Pregnancy|1
7260547|NCT00359021|11473207|FG001|Overall Study|Pregnancy|0
7260548|NCT00359073|11473217|FG000|Overall Study|Withdrawal by Subject|1
7260549|NCT00359073|11473218|FG001|Overall Study|Withdrawal by Subject|1
7260550|NCT00359073|11473217|FG000|Overall Study|Eligibility criteria no longer met|3
7260551|NCT00359073|11473218|FG001|Overall Study|Eligibility criteria no longer met|0
7260552|NCT00359073|11473217|FG000|Overall Study|developed RV16 antibody|0
7260553|NCT00359073|11473218|FG001|Overall Study|developed RV16 antibody|1
7260554|NCT00359281|11473244|FG000|Overall Study|Adverse Event|1
7260555|NCT00359281|11473245|FG001|Overall Study|Adverse Event|0
7260556|NCT00359281|11473246|FG002|Overall Study|Adverse Event|0
7260557|NCT00359281|11473247|FG003|Overall Study|Adverse Event|0
7260558|NCT00359281|11473248|FG004|Overall Study|Adverse Event|0
7260559|NCT00359281|11473249|FG005|Overall Study|Adverse Event|0
7260560|NCT00359281|11473250|FG006|Overall Study|Adverse Event|1
7260561|NCT00359281|11473251|FG007|Overall Study|Adverse Event|0
7260562|NCT00359281|11473252|FG008|Overall Study|Adverse Event|0
7260563|NCT00359281|11473244|FG000|Overall Study|Withdrawal by Subject|0
7260564|NCT00359281|11473245|FG001|Overall Study|Withdrawal by Subject|0
7260565|NCT00359281|11473246|FG002|Overall Study|Withdrawal by Subject|0
7260566|NCT00359281|11473247|FG003|Overall Study|Withdrawal by Subject|0
7260567|NCT00359281|11473248|FG004|Overall Study|Withdrawal by Subject|0
7260568|NCT00359281|11473249|FG005|Overall Study|Withdrawal by Subject|0
7260569|NCT00359281|11473250|FG006|Overall Study|Withdrawal by Subject|1
7260570|NCT00359281|11473251|FG007|Overall Study|Withdrawal by Subject|0
7260571|NCT00359281|11473252|FG008|Overall Study|Withdrawal by Subject|0
7260572|NCT00359294|11473284|FG000|Overall Study|Progressive disease|1
7260573|NCT00359294|11473285|FG001|Overall Study|Progressive disease|1
7260574|NCT00359294|11473286|FG002|Overall Study|Progressive disease|2
7260575|NCT00359294|11473287|FG003|Overall Study|Progressive disease|3
7260576|NCT00359294|11473288|FG004|Overall Study|Progressive disease|2
7260577|NCT00359294|11473284|FG000|Overall Study|Withdrawal by Subject|0
7260578|NCT00359294|11473285|FG001|Overall Study|Withdrawal by Subject|0
7260579|NCT00359294|11473286|FG002|Overall Study|Withdrawal by Subject|0
7260580|NCT00359294|11473287|FG003|Overall Study|Withdrawal by Subject|0
7260581|NCT00359294|11473288|FG004|Overall Study|Withdrawal by Subject|1
7260582|NCT00359294|11473284|FG000|Overall Study|Not treated|0
7260583|NCT00359294|11473285|FG001|Overall Study|Not treated|0
7260584|NCT00359294|11473286|FG002|Overall Study|Not treated|0
7260585|NCT00359294|11473287|FG003|Overall Study|Not treated|1
7260586|NCT00359294|11473288|FG004|Overall Study|Not treated|0
7260587|NCT00359294|11473284|FG000|Overall Study|Physician Decision|0
7260588|NCT00359294|11473285|FG001|Overall Study|Physician Decision|0
7260589|NCT00359294|11473286|FG002|Overall Study|Physician Decision|1
7260590|NCT00359294|11473287|FG003|Overall Study|Physician Decision|0
7260591|NCT00359294|11473288|FG004|Overall Study|Physician Decision|0
7260592|NCT00359424|11473298|FG000|Overall Study|Death|99
7260593|NCT00359424|11473299|FG001|Overall Study|Death|58
7260594|NCT00359424|11473298|FG000|Overall Study|Lost to Follow-up|19
7260595|NCT00359424|11473299|FG001|Overall Study|Lost to Follow-up|7
7260596|NCT00359424|11473298|FG000|Overall Study|Withdrawal by Subject|10
7260597|NCT00359424|11473299|FG001|Overall Study|Withdrawal by Subject|2
7260598|NCT00359424|11473298|FG000|Overall Study|follow up not conducted|2
7260599|NCT00359424|11473299|FG001|Overall Study|follow up not conducted|0
7260600|NCT00359619|11473312|FG000|Overall Study|Adverse Event|0
7260601|NCT00359619|11473313|FG001|Overall Study|Adverse Event|0
7260602|NCT00359619|11473314|FG002|Overall Study|Adverse Event|1
7260603|NCT00359619|11473315|FG003|Overall Study|Adverse Event|0
7260604|NCT00359619|11473316|FG004|Overall Study|Adverse Event|0
7260605|NCT00359619|11473317|FG005|Overall Study|Adverse Event|0
7260606|NCT00359619|11473318|FG006|Overall Study|Adverse Event|1
7543567|NCT02799381|11896141|FG001|Overall Study|Participant did not take any study drug|0
7543568|NCT02799472|11896149|FG000|Overall Study|Withdrawal by Subject|2
7543569|NCT02799472|11896150|FG001|Overall Study|Withdrawal by Subject|4
7543570|NCT02799472|11896149|FG000|Overall Study|Lack of Efficacy|2
7543571|NCT02799472|11896150|FG001|Overall Study|Lack of Efficacy|0
7543572|NCT02799472|11896149|FG000|Overall Study|Lost to Follow-up|0
7543573|NCT02799472|11896150|FG001|Overall Study|Lost to Follow-up|1
7543574|NCT02799745|11896167|FG000|Overall Study|Participant moved out of state|1
7543575|NCT02799745|11896168|FG001|Overall Study|Participant moved out of state|0
7543576|NCT02799745|11896167|FG000|Overall Study|Discontinued due to planned surgery|1
7543577|NCT02799745|11896168|FG001|Overall Study|Discontinued due to planned surgery|0
7543578|NCT02799745|11896167|FG000|Overall Study|Withdrawal by Subject|16
7543579|NCT02799745|11896168|FG001|Overall Study|Withdrawal by Subject|25
7543580|NCT02799745|11896167|FG000|Overall Study|Protocol Deviation|4
7543581|NCT02799745|11896168|FG001|Overall Study|Protocol Deviation|5
7260607|NCT00359619|11473312|FG000|Overall Study|Withdrawal by Subject|3
7260608|NCT00359619|11473313|FG001|Overall Study|Withdrawal by Subject|1
7260609|NCT00359619|11473314|FG002|Overall Study|Withdrawal by Subject|4
7260610|NCT00359619|11473315|FG003|Overall Study|Withdrawal by Subject|2
7260611|NCT00359619|11473316|FG004|Overall Study|Withdrawal by Subject|2
7260612|NCT00359619|11473317|FG005|Overall Study|Withdrawal by Subject|0
7260613|NCT00359619|11473318|FG006|Overall Study|Withdrawal by Subject|3
7260614|NCT00359619|11473312|FG000|Overall Study|Other|1
7260615|NCT00359619|11473313|FG001|Overall Study|Other|0
7260616|NCT00359619|11473314|FG002|Overall Study|Other|0
7260617|NCT00359619|11473315|FG003|Overall Study|Other|0
7260618|NCT00359619|11473316|FG004|Overall Study|Other|0
7260619|NCT00359619|11473317|FG005|Overall Study|Other|0
7260620|NCT00359619|11473318|FG006|Overall Study|Other|0
7260621|NCT00359619|11473312|FG000|Overall Study|Lost to Follow-up|4
7260622|NCT00359619|11473313|FG001|Overall Study|Lost to Follow-up|4
7260623|NCT00359619|11473314|FG002|Overall Study|Lost to Follow-up|2
7260624|NCT00359619|11473315|FG003|Overall Study|Lost to Follow-up|1
7260625|NCT00359619|11473316|FG004|Overall Study|Lost to Follow-up|1
7260626|NCT00359619|11473317|FG005|Overall Study|Lost to Follow-up|5
7260627|NCT00359619|11473318|FG006|Overall Study|Lost to Follow-up|0
7260628|NCT00359632|11473336|FG000|Overall Study|Death|2
7260629|NCT00359632|11473337|FG001|Overall Study|Death|0
7260630|NCT00359632|11473336|FG000|Overall Study|Adverse Event|1
7260631|NCT00359632|11473337|FG001|Overall Study|Adverse Event|0
7260632|NCT00359632|11473336|FG000|Overall Study|Non-compliance with visit schedule|1
7260633|NCT00359632|11473337|FG001|Overall Study|Non-compliance with visit schedule|0
7543582|NCT02799745|11896167|FG000|Overall Study|Progressive Disease|28
7543583|NCT02799745|11896168|FG001|Overall Study|Progressive Disease|38
7543584|NCT02799745|11896167|FG000|Overall Study|Lost to Follow-up|3
7543585|NCT02799745|11896168|FG001|Overall Study|Lost to Follow-up|2
7260634|NCT00359762|11473356|FG000|Period II|Adverse Event|17
7260635|NCT00359762|11473357|FG001|Period II|Adverse Event|0
7260636|NCT00359762|11473358|FG002|Period II|Adverse Event|0
7260637|NCT00359762|11473359|FG003|Period II|Adverse Event|0
7260638|NCT00359762|11473360|FG004|Period II|Adverse Event|49
7260639|NCT00359762|11473356|FG000|Period II|Protocol Violation|18
7260640|NCT00359762|11473357|FG001|Period II|Protocol Violation|0
7260641|NCT00359762|11473358|FG002|Period II|Protocol Violation|0
7260642|NCT00359762|11473359|FG003|Period II|Protocol Violation|0
7260643|NCT00359762|11473360|FG004|Period II|Protocol Violation|11
7260644|NCT00359762|11473356|FG000|Period II|Physician Decision|17
7260645|NCT00359762|11473357|FG001|Period II|Physician Decision|0
7260646|NCT00359762|11473358|FG002|Period II|Physician Decision|0
7260647|NCT00359762|11473359|FG003|Period II|Physician Decision|0
7260648|NCT00359762|11473360|FG004|Period II|Physician Decision|23
7260649|NCT00359762|11473356|FG000|Period II|Death|2
7260650|NCT00359762|11473357|FG001|Period II|Death|0
7260651|NCT00359762|11473358|FG002|Period II|Death|0
7260652|NCT00359762|11473359|FG003|Period II|Death|0
7543586|NCT02799745|11896167|FG000|Overall Study|Death|3
7543587|NCT02799745|11896168|FG001|Overall Study|Death|0
7543588|NCT02799745|11896167|FG000|Overall Study|Adverse Event|0
7543589|NCT02799745|11896168|FG001|Overall Study|Adverse Event|1
7543590|NCT02799784|11896174|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7543591|NCT02799784|11896175|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7543592|NCT02799784|11896174|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
7543593|NCT02799784|11896175|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
7543594|NCT02799784|11896174|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
7543595|NCT02799784|11896175|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
7543596|NCT02799784|11896174|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
7543597|NCT02799784|11896175|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
7543598|NCT02799784|11896174|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
7543599|NCT02799784|11896175|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
7543600|NCT02799784|11896174|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
7543601|NCT02799784|11896175|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
7543602|NCT02800642|11896207|FG000|Overall Study|Death|3
7543603|NCT02800642|11896207|FG000|Overall Study|Other|10
7543604|NCT02800642|11896207|FG000|Overall Study|Physician Decision|2
7543605|NCT02800642|11896207|FG000|Overall Study|Adverse Event|6
7543606|NCT02800642|11896207|FG000|Overall Study|Withdrawal by Subject|3
7543607|NCT02800642|11896207|FG000|Overall Study|Lost to Follow-up|1
7543608|NCT02800928|11896211|FG000|Overall Study|Withdrawal by Subject|1
7543609|NCT02800928|11896212|FG001|Overall Study|Withdrawal by Subject|1
7543610|NCT02800928|11896211|FG000|Overall Study|Protocol Violation|1
7543611|NCT02800928|11896212|FG001|Overall Study|Protocol Violation|1
7543612|NCT02801396|11896237|FG000|Period 1|Withdrawal by Subject|0
7543613|NCT02801396|11896238|FG001|Period 1|Withdrawal by Subject|0
7543614|NCT02801396|11896239|FG002|Period 1|Withdrawal by Subject|0
7543615|NCT02801396|11896240|FG003|Period 1|Withdrawal by Subject|0
7543616|NCT02801396|11896241|FG004|Period 1|Withdrawal by Subject|1
7543617|NCT02801396|11896242|FG005|Period 1|Withdrawal by Subject|0
7543618|NCT02801578|11896250|FG000|Overall Study|Adverse Event|2
7543619|NCT02801617|11896256|FG000|Overall Study|Protocol Violation|2
7543620|NCT02801617|11896257|FG001|Overall Study|Protocol Violation|6
7543621|NCT02801669|11896269|FG000|Overall Study|Death|66
7543622|NCT02801669|11896270|FG001|Overall Study|Death|69
7543623|NCT02801669|11896269|FG000|Overall Study|Withdrawal by Subject|81
7543624|NCT02801669|11896270|FG001|Overall Study|Withdrawal by Subject|77
7543625|NCT02801669|11896269|FG000|Overall Study|Other|4
7543626|NCT02801669|11896270|FG001|Overall Study|Other|6
7543627|NCT02801877|11896280|FG000|Overall Study|Lost to Follow-up|1
7543628|NCT02801877|11896281|FG001|Overall Study|Lost to Follow-up|1
7543629|NCT02801877|11896282|FG002|Overall Study|Lost to Follow-up|2
7543630|NCT02801877|11896283|FG003|Overall Study|Lost to Follow-up|0
7543631|NCT02801877|11896280|FG000|Overall Study|Never Started Treatment|2
7543632|NCT02801877|11896281|FG001|Overall Study|Never Started Treatment|0
7543633|NCT02801877|11896282|FG002|Overall Study|Never Started Treatment|4
7543634|NCT02801877|11896283|FG003|Overall Study|Never Started Treatment|0
7543635|NCT02802319|11896330|FG000|Overall Study|Physician Decision|2
7543636|NCT02802319|11896331|FG001|Overall Study|Physician Decision|1
7543637|NCT02802319|11896330|FG000|Overall Study|Lost to Follow-up|0
7543638|NCT02802319|11896331|FG001|Overall Study|Lost to Follow-up|4
7260653|NCT00359762|11473360|FG004|Period II|Death|4
7260654|NCT00359762|11473356|FG000|Period II|Lack of Efficacy|11
7260655|NCT00359762|11473357|FG001|Period II|Lack of Efficacy|0
7260656|NCT00359762|11473358|FG002|Period II|Lack of Efficacy|0
7576433|NCT04332107|11962995|FG000|Day 3|Lost to Follow-up|23
7576434|NCT04332107|11962996|FG001|Day 3|Lost to Follow-up|14
7576435|NCT04332107|11962995|FG000|Day 3|Missing outcome data|3
7576436|NCT04332107|11962996|FG001|Day 3|Missing outcome data|6
7260657|NCT00359762|11473359|FG003|Period II|Lack of Efficacy|0
7260658|NCT00359762|11473360|FG004|Period II|Lack of Efficacy|8
7260659|NCT00359762|11473356|FG000|Period II|Lost to follow up|5
7260660|NCT00359762|11473357|FG001|Period II|Lost to follow up|0
7260661|NCT00359762|11473358|FG002|Period II|Lost to follow up|0
7260662|NCT00359762|11473359|FG003|Period II|Lost to follow up|0
7260663|NCT00359762|11473360|FG004|Period II|Lost to follow up|5
7260664|NCT00359762|11473356|FG000|Period II|Entry Criteria Not Met|8
7260665|NCT00359762|11473357|FG001|Period II|Entry Criteria Not Met|0
7260666|NCT00359762|11473358|FG002|Period II|Entry Criteria Not Met|0
7260667|NCT00359762|11473359|FG003|Period II|Entry Criteria Not Met|0
7260668|NCT00359762|11473360|FG004|Period II|Entry Criteria Not Met|4
7260669|NCT00359762|11473356|FG000|Period II|Subject Decision|50
7260670|NCT00359762|11473357|FG001|Period II|Subject Decision|0
7260671|NCT00359762|11473358|FG002|Period II|Subject Decision|0
7260672|NCT00359762|11473359|FG003|Period II|Subject Decision|0
7260673|NCT00359762|11473360|FG004|Period II|Subject Decision|70
7260674|NCT00359762|11473356|FG000|Period III|Protocol Violation|0
7260675|NCT00359762|11473357|FG001|Period III|Protocol Violation|5
7260676|NCT00359762|11473358|FG002|Period III|Protocol Violation|3
7260677|NCT00359762|11473359|FG003|Period III|Protocol Violation|8
7260678|NCT00359762|11473360|FG004|Period III|Protocol Violation|0
7260679|NCT00359762|11473356|FG000|Period III|Adverse Event|0
7260680|NCT00359762|11473357|FG001|Period III|Adverse Event|3
7260681|NCT00359762|11473358|FG002|Period III|Adverse Event|4
7260682|NCT00359762|11473359|FG003|Period III|Adverse Event|10
7260683|NCT00359762|11473360|FG004|Period III|Adverse Event|0
7260684|NCT00359762|11473356|FG000|Period III|Physician Decision|0
7260685|NCT00359762|11473357|FG001|Period III|Physician Decision|5
7260686|NCT00359762|11473358|FG002|Period III|Physician Decision|9
7260687|NCT00359762|11473359|FG003|Period III|Physician Decision|15
7260688|NCT00359762|11473360|FG004|Period III|Physician Decision|0
7260689|NCT00359762|11473356|FG000|Period III|Lack of Efficacy|0
7260690|NCT00359762|11473357|FG001|Period III|Lack of Efficacy|7
7260691|NCT00359762|11473358|FG002|Period III|Lack of Efficacy|5
7260692|NCT00359762|11473359|FG003|Period III|Lack of Efficacy|9
7260693|NCT00359762|11473360|FG004|Period III|Lack of Efficacy|0
7260694|NCT00359762|11473356|FG000|Period III|Lost to follow up|0
7260695|NCT00359762|11473357|FG001|Period III|Lost to follow up|1
7260696|NCT00359762|11473358|FG002|Period III|Lost to follow up|1
7260697|NCT00359762|11473359|FG003|Period III|Lost to follow up|2
7260698|NCT00359762|11473360|FG004|Period III|Lost to follow up|0
7260699|NCT00359762|11473356|FG000|Period III|Entry Criteria Not Met|0
7260700|NCT00359762|11473357|FG001|Period III|Entry Criteria Not Met|1
7260701|NCT00359762|11473358|FG002|Period III|Entry Criteria Not Met|0
7260702|NCT00359762|11473359|FG003|Period III|Entry Criteria Not Met|1
7260703|NCT00359762|11473360|FG004|Period III|Entry Criteria Not Met|0
7260704|NCT00359762|11473356|FG000|Period III|Subject Decision|0
7260705|NCT00359762|11473357|FG001|Period III|Subject Decision|7
7260706|NCT00359762|11473358|FG002|Period III|Subject Decision|8
7260707|NCT00359762|11473359|FG003|Period III|Subject Decision|20
7260708|NCT00359762|11473360|FG004|Period III|Subject Decision|0
7260709|NCT00359788|11473376|FG000|Overall Study|Adverse Event|11
7260710|NCT00359788|11473377|FG001|Overall Study|Adverse Event|10
7576437|NCT04332107|11962995|FG000|Day 14|Lost to Follow-up|13
7576438|NCT04332107|11962996|FG001|Day 14|Lost to Follow-up|4
7576439|NCT04332107|11962995|FG000|Day 14|Missing outcome data|4
7260711|NCT00359788|11473376|FG000|Overall Study|Lack of Efficacy|1
7260712|NCT00359788|11473377|FG001|Overall Study|Lack of Efficacy|2
7260713|NCT00359788|11473376|FG000|Overall Study|Lost to Follow-up|3
7260714|NCT00359788|11473377|FG001|Overall Study|Lost to Follow-up|2
7260715|NCT00359788|11473376|FG000|Overall Study|Withdrawal by Subject|4
7260716|NCT00359788|11473377|FG001|Overall Study|Withdrawal by Subject|1
7260717|NCT00359788|11473376|FG000|Overall Study|Protocol Violation|4
7260718|NCT00359788|11473377|FG001|Overall Study|Protocol Violation|2
7260719|NCT00359801|11473385|FG000|Overall Study|Lost to Follow-up|72
7260720|NCT00359801|11473386|FG001|Overall Study|Lost to Follow-up|58
7260721|NCT00359801|11473385|FG000|Overall Study|Withdrawal by Subject|143
7260722|NCT00359801|11473386|FG001|Overall Study|Withdrawal by Subject|96
7260723|NCT00359801|11473385|FG000|Overall Study|Other|66
7260724|NCT00359801|11473386|FG001|Overall Study|Other|46
7260725|NCT00359801|11473385|FG000|Overall Study|Final Status Unknown: missing data|7
7260726|NCT00359801|11473386|FG001|Overall Study|Final Status Unknown: missing data|4
7260727|NCT00359801|11473385|FG000|Overall Study|Sponsor Decision|17
7260728|NCT00359801|11473386|FG001|Overall Study|Sponsor Decision|16
7260729|NCT00360230|11473442|FG000|Overall Study|Withdrawal by Subject|1
7260730|NCT00360230|11473443|FG001|Overall Study|Withdrawal by Subject|1
7260731|NCT00360230|11473444|FG002|Overall Study|Withdrawal by Subject|0
7260732|NCT00360230|11473445|FG003|Overall Study|Withdrawal by Subject|1
7260733|NCT00360230|11473446|FG004|Overall Study|Withdrawal by Subject|1
7260734|NCT00360230|11473447|FG005|Overall Study|Withdrawal by Subject|1
7260735|NCT00360230|11473448|FG006|Overall Study|Withdrawal by Subject|0
7260736|NCT00360230|11473442|FG000|Overall Study|Migrated|4
7260737|NCT00360230|11473443|FG001|Overall Study|Migrated|1
7260738|NCT00360230|11473444|FG002|Overall Study|Migrated|3
7260739|NCT00360230|11473445|FG003|Overall Study|Migrated|1
7260740|NCT00360230|11473446|FG004|Overall Study|Migrated|4
7260741|NCT00360230|11473447|FG005|Overall Study|Migrated|1
7260742|NCT00360230|11473448|FG006|Overall Study|Migrated|1
7260743|NCT00360230|11473442|FG000|Overall Study|Other|1
7260744|NCT00360230|11473443|FG001|Overall Study|Other|0
7260745|NCT00360230|11473444|FG002|Overall Study|Other|0
7260746|NCT00360230|11473445|FG003|Overall Study|Other|0
7260747|NCT00360230|11473446|FG004|Overall Study|Other|0
7260748|NCT00360230|11473447|FG005|Overall Study|Other|0
7260749|NCT00360230|11473448|FG006|Overall Study|Other|0
7260750|NCT00360230|11473442|FG000|Overall Study|Protocol Violation|0
7260751|NCT00360230|11473443|FG001|Overall Study|Protocol Violation|0
7260752|NCT00360230|11473444|FG002|Overall Study|Protocol Violation|0
7260753|NCT00360230|11473445|FG003|Overall Study|Protocol Violation|0
7260754|NCT00360230|11473446|FG004|Overall Study|Protocol Violation|0
7260755|NCT00360230|11473447|FG005|Overall Study|Protocol Violation|1
7260756|NCT00360230|11473448|FG006|Overall Study|Protocol Violation|0
7260757|NCT00360230|11473442|FG000|Overall Study|Death|0
7260758|NCT00360230|11473443|FG001|Overall Study|Death|1
7260759|NCT00360230|11473444|FG002|Overall Study|Death|0
7260760|NCT00360230|11473445|FG003|Overall Study|Death|0
7260761|NCT00360230|11473446|FG004|Overall Study|Death|0
7260762|NCT00360230|11473447|FG005|Overall Study|Death|1
7260763|NCT00360230|11473448|FG006|Overall Study|Death|1
7260764|NCT00360269|11473485|FG000|Overall Study|Lost to Follow-up|7
7260765|NCT00360269|11473486|FG001|Overall Study|Lost to Follow-up|9
7260766|NCT00360269|11473485|FG000|Overall Study|Physician Decision|1
7260767|NCT00360269|11473486|FG001|Overall Study|Physician Decision|2
7260768|NCT00360269|11473485|FG000|Overall Study|Adverse Event|1
7260769|NCT00360269|11473486|FG001|Overall Study|Adverse Event|0
7260770|NCT00360269|11473485|FG000|Overall Study|Withdrawal by Subject|1
7260771|NCT00360269|11473486|FG001|Overall Study|Withdrawal by Subject|1
7260772|NCT00360282|11473492|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
7260773|NCT00360282|11473493|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
7260774|NCT00360282|11473494|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
7260775|NCT00360282|11473495|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
7260776|NCT00360282|11473492|FG000|Second Intervention|Adverse Event|0
7260777|NCT00360282|11473493|FG001|Second Intervention|Adverse Event|1
7260778|NCT00360282|11473494|FG002|Second Intervention|Adverse Event|0
7260779|NCT00360282|11473495|FG003|Second Intervention|Adverse Event|0
7260780|NCT00360308|11473506|FG000|Overall Study|Adverse Event|15
7260781|NCT00360308|11473507|FG001|Overall Study|Adverse Event|14
7260782|NCT00360308|11473508|FG002|Overall Study|Adverse Event|25
7260783|NCT00360308|11473506|FG000|Overall Study|Abnormal Laboratory Value(s)|0
7260784|NCT00360308|11473507|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7260785|NCT00360308|11473508|FG002|Overall Study|Abnormal Laboratory Value(s)|0
7260786|NCT00360308|11473506|FG000|Overall Study|Protocol Violation|2
7260787|NCT00360308|11473507|FG001|Overall Study|Protocol Violation|1
7260788|NCT00360308|11473508|FG002|Overall Study|Protocol Violation|2
7260789|NCT00360308|11473506|FG000|Overall Study|Withdrawal by Subject|11
7260790|NCT00360308|11473507|FG001|Overall Study|Withdrawal by Subject|7
7260791|NCT00360308|11473508|FG002|Overall Study|Withdrawal by Subject|14
7260792|NCT00360308|11473506|FG000|Overall Study|Lack of Efficacy|3
7260793|NCT00360308|11473507|FG001|Overall Study|Lack of Efficacy|0
7260794|NCT00360308|11473508|FG002|Overall Study|Lack of Efficacy|2
7260795|NCT00360308|11473506|FG000|Overall Study|Other|2
7260796|NCT00360308|11473507|FG001|Overall Study|Other|1
7260797|NCT00360308|11473508|FG002|Overall Study|Other|1
7260798|NCT00360308|11473506|FG000|Overall Study|Study termination by sponsor|43
7260799|NCT00360308|11473507|FG001|Overall Study|Study termination by sponsor|55
7260800|NCT00360308|11473508|FG002|Overall Study|Study termination by sponsor|44
7260801|NCT00360334|11473522|FG000|Overall Study|Adverse Event|7
7260802|NCT00360334|11473523|FG001|Overall Study|Adverse Event|4
7260803|NCT00360334|11473522|FG000|Overall Study|Protocol Violation|1
7260804|NCT00360334|11473523|FG001|Overall Study|Protocol Violation|1
7260805|NCT00360334|11473522|FG000|Overall Study|Physician Decision|2
7260806|NCT00360334|11473523|FG001|Overall Study|Physician Decision|3
7260807|NCT00360334|11473522|FG000|Overall Study|Lack of Efficacy|0
7543639|NCT02802345|11896339|FG000|Overall Study|Not Treated|0
7543640|NCT02802345|11896340|FG001|Overall Study|Not Treated|1
7543641|NCT02802345|11896339|FG000|Overall Study|Adverse Event|28
7543642|NCT02802345|11896340|FG001|Overall Study|Adverse Event|20
7543643|NCT02802345|11896339|FG000|Overall Study|Withdrawal by Subject|3
7543644|NCT02802345|11896340|FG001|Overall Study|Withdrawal by Subject|3
7543645|NCT02802345|11896339|FG000|Overall Study|Protocol Violation|0
7543646|NCT02802345|11896340|FG001|Overall Study|Protocol Violation|1
7543647|NCT02802345|11896339|FG000|Overall Study|Other than listed|1
7543648|NCT02802345|11896340|FG001|Overall Study|Other than listed|5
7543649|NCT02802735|11896392|FG000|Overall Study|Withdrawal by Subject|0
7260808|NCT00360334|11473523|FG001|Overall Study|Lack of Efficacy|1
7260809|NCT00360334|11473522|FG000|Overall Study|Entry criterion not met|1
7260810|NCT00360334|11473523|FG001|Overall Study|Entry criterion not met|2
7260811|NCT00360334|11473522|FG000|Overall Study|Subject decision|8
7260812|NCT00360334|11473523|FG001|Overall Study|Subject decision|2
7260813|NCT00360412|11473548|FG000|Overall Study|Adverse Event|37
7260814|NCT00360412|11473549|FG001|Overall Study|Adverse Event|65
7260815|NCT00360412|11473548|FG000|Overall Study|Protocol Violation|2
7260816|NCT00360412|11473549|FG001|Overall Study|Protocol Violation|5
7260817|NCT00360412|11473548|FG000|Overall Study|Patient withdrew consent|27
7260818|NCT00360412|11473549|FG001|Overall Study|Patient withdrew consent|52
7260819|NCT00360412|11473548|FG000|Overall Study|Lack of therapeutic efficacy|46
7260820|NCT00360412|11473549|FG001|Overall Study|Lack of therapeutic efficacy|61
7260821|NCT00360412|11473548|FG000|Overall Study|Physician Decision|2
7260822|NCT00360412|11473549|FG001|Overall Study|Physician Decision|4
7260823|NCT00360412|11473548|FG000|Overall Study|Other|5
7260824|NCT00360412|11473549|FG001|Overall Study|Other|6
7260825|NCT00360412|11473548|FG000|Overall Study|Study termination by Sponsor|214
7260826|NCT00360412|11473549|FG001|Overall Study|Study termination by Sponsor|469
7260827|NCT00360490|11473557|FG000|Overall Study|Adverse Event|4
7260828|NCT00360490|11473558|FG001|Overall Study|Adverse Event|2
7260829|NCT00360490|11473557|FG000|Overall Study|Lost to Follow-up|2
7260830|NCT00360490|11473558|FG001|Overall Study|Lost to Follow-up|1
7260831|NCT00360490|11473557|FG000|Overall Study|Physician Decision|2
7260832|NCT00360490|11473558|FG001|Overall Study|Physician Decision|1
7260833|NCT00360490|11473557|FG000|Overall Study|Protocol Violation|0
7260834|NCT00360490|11473558|FG001|Overall Study|Protocol Violation|4
7260835|NCT00360490|11473557|FG000|Overall Study|Withdrawal by Subject|1
7260836|NCT00360490|11473558|FG001|Overall Study|Withdrawal by Subject|3
7260837|NCT00360529|11473567|FG000|Overall Study|Adverse Event|10
7260838|NCT00360529|11473568|FG001|Overall Study|Adverse Event|23
7260839|NCT00360529|11473569|FG002|Overall Study|Adverse Event|33
7260840|NCT00360529|11473567|FG000|Overall Study|Protocol Violation|3
7260841|NCT00360529|11473568|FG001|Overall Study|Protocol Violation|3
7260842|NCT00360529|11473569|FG002|Overall Study|Protocol Violation|11
7260843|NCT00360529|11473567|FG000|Overall Study|Lost to Follow-up|14
7260844|NCT00360529|11473568|FG001|Overall Study|Lost to Follow-up|10
7260845|NCT00360529|11473569|FG002|Overall Study|Lost to Follow-up|13
7260846|NCT00360529|11473567|FG000|Overall Study|Withdrawal by Subject|22
7260847|NCT00360529|11473568|FG001|Overall Study|Withdrawal by Subject|14
7260848|NCT00360529|11473569|FG002|Overall Study|Withdrawal by Subject|18
7260849|NCT00360529|11473567|FG000|Overall Study|Lack of Efficacy|8
7260850|NCT00360529|11473568|FG001|Overall Study|Lack of Efficacy|6
7260851|NCT00360529|11473569|FG002|Overall Study|Lack of Efficacy|5
7260852|NCT00360529|11473567|FG000|Overall Study|Reason discontinued not explained above|4
7260853|NCT00360529|11473568|FG001|Overall Study|Reason discontinued not explained above|9
7260854|NCT00360529|11473569|FG002|Overall Study|Reason discontinued not explained above|11
7260855|NCT00360568|11473596|FG000|Overall Study|Adverse Event|1
7260856|NCT00360568|11473597|FG001|Overall Study|Adverse Event|2
7260857|NCT00360568|11473596|FG000|Overall Study|Lack of Efficacy|1
7260858|NCT00360568|11473597|FG001|Overall Study|Lack of Efficacy|0
7260859|NCT00360568|11473596|FG000|Overall Study|Withdrawal by Subject|0
7260860|NCT00360568|11473597|FG001|Overall Study|Withdrawal by Subject|3
7260861|NCT00360698|11473621|FG000|Run-In|Physician Decision|0
7260862|NCT00360698|11473622|FG001|Run-In|Physician Decision|1
7260863|NCT00360698|11473621|FG000|Run-In|Withdrawal by Subject|0
7260864|NCT00360698|11473622|FG001|Run-In|Withdrawal by Subject|2
7260865|NCT00360698|11473621|FG000|Run-In|Non compliance with treatment procedure|0
7260866|NCT00360698|11473622|FG001|Run-In|Non compliance with treatment procedure|1
7260867|NCT00360698|11473621|FG000|Run-In|Sponsor request|0
7260868|NCT00360698|11473622|FG001|Run-In|Sponsor request|2
7260869|NCT00360698|11473621|FG000|Run-In|Patient did not meet inclusion criteria|0
7260870|NCT00360698|11473622|FG001|Run-In|Patient did not meet inclusion criteria|1
7260871|NCT00360698|11473621|FG000|Run-In|Patient personal reasons|0
7260872|NCT00360698|11473622|FG001|Run-In|Patient personal reasons|2
7260873|NCT00360698|11473621|FG000|Run-In|Need of insulin with meals|0
7260874|NCT00360698|11473622|FG001|Run-In|Need of insulin with meals|1
7543650|NCT02802735|11896393|FG001|Overall Study|Withdrawal by Subject|1
7543651|NCT02802735|11896394|FG002|Overall Study|Withdrawal by Subject|0
7543652|NCT02802735|11896395|FG003|Overall Study|Withdrawal by Subject|0
7543653|NCT02802735|11896396|FG004|Overall Study|Withdrawal by Subject|0
7543654|NCT02802865|11896413|FG000|Overall Study|Pregnancy|1
7543655|NCT02802865|11896414|FG001|Overall Study|Pregnancy|1
7543656|NCT02802865|11896413|FG000|Overall Study|Ineliegible due to tuberculosis|0
7543657|NCT02802865|11896414|FG001|Overall Study|Ineliegible due to tuberculosis|1
7543658|NCT02802878|11896422|FG000|Overall Study|Withdrawal by Subject|3
7543659|NCT02802878|11896423|FG001|Overall Study|Withdrawal by Subject|3
7543660|NCT02802878|11896422|FG000|Overall Study|Protocol Violation|1
7543661|NCT02802878|11896423|FG001|Overall Study|Protocol Violation|0
7543662|NCT02803138|11896429|FG000|Overall Study|Failure to return|38
7543663|NCT02803138|11896429|FG000|Overall Study|Insufficient virological response|2
7543664|NCT02803138|11896429|FG000|Overall Study|Withdrawn consent|1
7543665|NCT02803138|11896429|FG000|Overall Study|Death|1
7543666|NCT02803138|11896429|FG000|Overall Study|Other, not specified|28
7543667|NCT02803580|11896455|FG000|Overall Study|Death|13
7543668|NCT02803580|11896455|FG000|Overall Study|Lost to Follow-up|19
7543669|NCT02803580|11896455|FG000|Overall Study|Withdrawal by Subject|3
7543670|NCT02803580|11896455|FG000|Overall Study|Inclusion in clinical trial|1
7543671|NCT02804178|11896468|FG000|Overall Study|Adverse Event|1
7543672|NCT02804399|11896472|FG000|Period 2|Adverse Event|0
7543673|NCT02804399|11896473|FG001|Period 2|Adverse Event|1
7543674|NCT02804750|11896493|FG000|Period 1|Adverse Event|0
7543675|NCT02804750|11896494|FG001|Period 1|Adverse Event|2
7543676|NCT02804750|11896493|FG000|Period 1|Withdrawal by Subject|0
7543677|NCT02804750|11896494|FG001|Period 1|Withdrawal by Subject|1
7543678|NCT02804750|11896493|FG000|Period 2|Adverse Event|1
7543679|NCT02804750|11896494|FG001|Period 2|Adverse Event|0
7543680|NCT02804750|11896493|FG000|Period 3|Adverse Event|0
7543681|NCT02804750|11896494|FG001|Period 3|Adverse Event|2
7543682|NCT02804750|11896493|FG000|Period 4|Adverse Event|0
7543683|NCT02804750|11896494|FG001|Period 4|Adverse Event|5
7543684|NCT02804763|11896506|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
7543685|NCT02804763|11896507|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7543686|NCT02804763|11896508|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7543687|NCT02804763|11896509|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
7543688|NCT02804763|11896506|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7543689|NCT02804763|11896507|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
7543690|NCT02804763|11896508|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
7543691|NCT02804763|11896509|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
7543692|NCT02804763|11896506|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7543693|NCT02804763|11896507|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
7543694|NCT02804763|11896508|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7543695|NCT02804763|11896509|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
7260875|NCT00360698|11473621|FG000|Treatment Period|Non compliance with treatment procedure|1
7543696|NCT02804763|11896506|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
7543697|NCT02804763|11896507|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
7543698|NCT02804763|11896508|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7543699|NCT02804763|11896509|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
7543700|NCT02804763|11896506|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
7576440|NCT04332107|11962996|FG001|Day 14|Missing outcome data|4
7576441|NCT04332107|11962995|FG000|Day 21|Lost to Follow-up|10
7576442|NCT04332107|11962996|FG001|Day 21|Lost to Follow-up|2
7576443|NCT04329923|11963030|FG000|Overall Study|Withdrawal by Subject|1
7576444|NCT04329923|11963031|FG001|Overall Study|Withdrawal by Subject|4
7576445|NCT04329923|11963032|FG002|Overall Study|Withdrawal by Subject|1
7576446|NCT04329923|11963033|FG003|Overall Study|Withdrawal by Subject|1
7576447|NCT04329923|11963034|FG004|Overall Study|Withdrawal by Subject|1
7576448|NCT04329923|11963035|FG005|Overall Study|Withdrawal by Subject|1
7576449|NCT04329923|11963030|FG000|Overall Study|early termination of study|0
7576450|NCT04329923|11963031|FG001|Overall Study|early termination of study|0
7576451|NCT04329923|11963032|FG002|Overall Study|early termination of study|0
7576452|NCT04329923|11963033|FG003|Overall Study|early termination of study|0
7576453|NCT04329923|11963034|FG004|Overall Study|early termination of study|1
7576454|NCT04329923|11963035|FG005|Overall Study|early termination of study|2
7576455|NCT04329923|11963030|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
7576456|NCT04329923|11963031|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
7576457|NCT04329923|11963032|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
7576458|NCT04329923|11963033|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
7576459|NCT04329923|11963034|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
7576460|NCT04329923|11963035|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
7576461|NCT04328467|11963052|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
7576462|NCT04328467|11963053|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
7576463|NCT04328467|11963054|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
7576464|NCT04322526|11963064|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
7576465|NCT04322526|11963065|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
7576466|NCT04322526|11963064|FG000|Washout (1 Week)|Lost to Follow-up|1
7576467|NCT04322526|11963065|FG001|Washout (1 Week)|Lost to Follow-up|2
7576468|NCT04322682|11963082|FG000|Overall Study|Withdrawal by Subject|33
7576469|NCT04322682|11963083|FG001|Overall Study|Withdrawal by Subject|47
7576470|NCT04322682|11963082|FG000|Overall Study|Death|5
7576471|NCT04322682|11963083|FG001|Overall Study|Death|9
7576472|NCT04322682|11963082|FG000|Overall Study|Lost to Follow-up|4
7576473|NCT04322682|11963083|FG001|Overall Study|Lost to Follow-up|8
7576474|NCT04322682|11963082|FG000|Overall Study|Admitted to Hospital and Intubated|1
7576475|NCT04322682|11963083|FG001|Overall Study|Admitted to Hospital and Intubated|0
7260876|NCT00360698|11473622|FG001|Treatment Period|Non compliance with treatment procedure|0
7260877|NCT00360698|11473621|FG000|Treatment Period|Early termination by error|0
7260878|NCT00360698|11473622|FG001|Treatment Period|Early termination by error|1
7260879|NCT00361218|11473666|FG000|Overall Study|Lost to Follow-up|11
7260880|NCT00361218|11473666|FG000|Overall Study|Personal Reasons|7
7260881|NCT00361218|11473666|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
7260882|NCT00361231|11473670|FG000|Overall Study|Physician Decision|3
7260883|NCT00361231|11473670|FG000|Overall Study|Symptomatic deterioration|5
7260884|NCT00361231|11473670|FG000|Overall Study|Radiographic disease progression|16
7260885|NCT00361231|11473670|FG000|Overall Study|Withdrawal by Subject|4
7260886|NCT00361231|11473670|FG000|Overall Study|Adverse Event|6
7260887|NCT00361270|11473689|FG000|Overall Study|Death|0
7260888|NCT00361270|11473690|FG001|Overall Study|Death|0
7260889|NCT00361270|11473691|FG002|Overall Study|Death|0
7260890|NCT00361270|11473692|FG003|Overall Study|Death|2
7260891|NCT00361270|11473689|FG000|Overall Study|Lost to Follow-up|4
7260892|NCT00361270|11473690|FG001|Overall Study|Lost to Follow-up|1
7260893|NCT00361270|11473691|FG002|Overall Study|Lost to Follow-up|0
7260894|NCT00361270|11473692|FG003|Overall Study|Lost to Follow-up|0
7260895|NCT00361270|11473689|FG000|Overall Study|Physician Decision|0
7260896|NCT00361270|11473690|FG001|Overall Study|Physician Decision|0
7260897|NCT00361270|11473691|FG002|Overall Study|Physician Decision|1
7260898|NCT00361270|11473692|FG003|Overall Study|Physician Decision|0
7260899|NCT00361270|11473689|FG000|Overall Study|Protocol Violation|9
7260900|NCT00361270|11473690|FG001|Overall Study|Protocol Violation|4
7260901|NCT00361270|11473691|FG002|Overall Study|Protocol Violation|5
7260902|NCT00361270|11473692|FG003|Overall Study|Protocol Violation|4
7260903|NCT00361270|11473689|FG000|Overall Study|Withdrawal by Subject|6
7624462|NCT02487095|12035577|FG001|Dose Expansion|Unable to scan/restage participant|0
7624463|NCT02487095|12035578|FG002|Dose Expansion|Unable to scan/restage participant|0
7260904|NCT00361270|11473690|FG001|Overall Study|Withdrawal by Subject|6
7260905|NCT00361270|11473691|FG002|Overall Study|Withdrawal by Subject|3
7260906|NCT00361270|11473692|FG003|Overall Study|Withdrawal by Subject|7
7260907|NCT00361270|11473689|FG000|Overall Study|Afraid of Hypnosis|1
7260908|NCT00361270|11473690|FG001|Overall Study|Afraid of Hypnosis|2
7260909|NCT00361270|11473691|FG002|Overall Study|Afraid of Hypnosis|0
7260910|NCT00361270|11473692|FG003|Overall Study|Afraid of Hypnosis|0
7260911|NCT00361270|11473689|FG000|Overall Study|Problems with Transportation|4
7260912|NCT00361270|11473690|FG001|Overall Study|Problems with Transportation|0
7624464|NCT02487095|12035579|FG003|Dose Expansion|Unable to scan/restage participant|0
7624465|NCT02487095|12035580|FG004|Dose Expansion|Unable to scan/restage participant|1
7624466|NCT02335658|12035627|FG000|Overall Study|Adverse Event|18
7624467|NCT02335658|12035628|FG001|Overall Study|Adverse Event|12
7624468|NCT02335658|12035627|FG000|Overall Study|Lack of Efficacy|4
7624469|NCT02335658|12035628|FG001|Overall Study|Lack of Efficacy|5
7624470|NCT02335658|12035627|FG000|Overall Study|Pregnancy|1
7624471|NCT02335658|12035628|FG001|Overall Study|Pregnancy|0
7624472|NCT02335658|12035627|FG000|Overall Study|Withdrawal by Subject|13
7624473|NCT02335658|12035628|FG001|Overall Study|Withdrawal by Subject|21
7624474|NCT02335658|12035627|FG000|Overall Study|non-compliance|2
7624475|NCT02335658|12035628|FG001|Overall Study|non-compliance|3
7624476|NCT02335658|12035627|FG000|Overall Study|other reason|2
7624477|NCT02335658|12035628|FG001|Overall Study|other reason|3
7624478|NCT02287584|12035639|FG000|the Double-blind Phase|Adverse Event|17
7624479|NCT02287584|12035640|FG001|the Double-blind Phase|Adverse Event|17
7624480|NCT02287584|12035641|FG002|the Double-blind Phase|Adverse Event|12
7624481|NCT02287584|12035642|FG003|the Double-blind Phase|Adverse Event|0
7260913|NCT00361270|11473691|FG002|Overall Study|Problems with Transportation|0
7260914|NCT00361270|11473692|FG003|Overall Study|Problems with Transportation|0
7260915|NCT00361270|11473689|FG000|Overall Study|Adverse Event|0
7260916|NCT00361270|11473690|FG001|Overall Study|Adverse Event|1
7260917|NCT00361270|11473691|FG002|Overall Study|Adverse Event|1
7260918|NCT00361270|11473692|FG003|Overall Study|Adverse Event|0
7543701|NCT02804763|11896507|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
7543702|NCT02804763|11896508|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7543703|NCT02804763|11896509|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
7543704|NCT02804763|11896506|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7543705|NCT02804763|11896507|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
7543706|NCT02804763|11896508|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7543707|NCT02804763|11896509|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
7543708|NCT02805309|11896530|FG000|Overall Study|Lost to Follow-up|2
7543709|NCT02805309|11896531|FG001|Overall Study|Lost to Follow-up|2
7543710|NCT02805309|11896532|FG002|Overall Study|Lost to Follow-up|2
7543711|NCT02805309|11896530|FG000|Overall Study|Post-Randomization Exclusion|0
7543712|NCT02805309|11896531|FG001|Overall Study|Post-Randomization Exclusion|2
7543713|NCT02805309|11896532|FG002|Overall Study|Post-Randomization Exclusion|1
7543714|NCT02805660|11896556|FG000|Overall Study|Death|5
7543715|NCT02805660|11896557|FG001|Overall Study|Death|2
7543716|NCT02805660|11896558|FG002|Overall Study|Death|9
7543717|NCT02805660|11896559|FG003|Overall Study|Death|5
7543718|NCT02805660|11896560|FG004|Overall Study|Death|0
7543719|NCT02805660|11896561|FG005|Overall Study|Death|14
7543720|NCT02805660|11896562|FG006|Overall Study|Death|12
7576476|NCT04320615|11963134|FG000|Overall Study|Withdrawal by Subject|4
7576477|NCT04320615|11963135|FG001|Overall Study|Withdrawal by Subject|10
7576478|NCT04320615|11963134|FG000|Overall Study|Physician Decision|2
7576479|NCT04320615|11963135|FG001|Overall Study|Physician Decision|0
7576480|NCT04320615|11963134|FG000|Overall Study|Other|2
7576481|NCT04320615|11963135|FG001|Overall Study|Other|0
7576482|NCT04320615|11963134|FG000|Overall Study|Lost to Follow-up|5
7576483|NCT04320615|11963135|FG001|Overall Study|Lost to Follow-up|23
7576484|NCT04320615|11963134|FG000|Overall Study|Death|35
7576485|NCT04320615|11963135|FG001|Overall Study|Death|71
7576486|NCT04318535|11963145|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7576487|NCT04318535|11963146|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
7576488|NCT04318535|11963147|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
7576489|NCT04314037|11963168|FG000|Treatment Period 2|Adverse Event|1
7576490|NCT04314037|11963169|FG001|Treatment Period 2|Adverse Event|0
7576491|NCT04314037|11963168|FG000|Treatment Period 3|Protocol Violation|1
7576492|NCT04314037|11963169|FG001|Treatment Period 3|Protocol Violation|0
7576493|NCT04314037|11963168|FG000|Treatment Period 3|Adverse Event|0
7576494|NCT04314037|11963169|FG001|Treatment Period 3|Adverse Event|1
7576495|NCT04315298|11963200|FG000|Overall Study|Withdrawal by Subject|0
7576496|NCT04315298|11963201|FG001|Overall Study|Withdrawal by Subject|0
7576497|NCT04315298|11963202|FG002|Overall Study|Withdrawal by Subject|0
7576498|NCT04315298|11963203|FG003|Overall Study|Withdrawal by Subject|2
7576499|NCT04315298|11963204|FG004|Overall Study|Withdrawal by Subject|2
7576500|NCT04315298|11963205|FG005|Overall Study|Withdrawal by Subject|2
7576501|NCT04315298|11963206|FG006|Overall Study|Withdrawal by Subject|0
7576502|NCT04315298|11963207|FG007|Overall Study|Withdrawal by Subject|1
7576503|NCT04315298|11963208|FG008|Overall Study|Withdrawal by Subject|1
7576504|NCT04315298|11963209|FG009|Overall Study|Withdrawal by Subject|1
7576505|NCT04315298|11963210|FG010|Overall Study|Withdrawal by Subject|0
7576506|NCT04315298|11963211|FG011|Overall Study|Withdrawal by Subject|0
7576507|NCT04315298|11963212|FG012|Overall Study|Withdrawal by Subject|0
7260919|NCT00361283|11473709|FG000|Overall Study|Lost to Follow-up|27
7260920|NCT00361296|11473713|FG000|Overall Study|Physician Decision|1
7260921|NCT00361296|11473713|FG000|Overall Study|Lack of Efficacy|2
7260922|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Adverse Event|9
7260923|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Adverse Event|4
7260924|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Adverse Event|5
7260925|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Adverse Event|9
7260926|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Adverse Event|8
7260927|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Adverse Event|0
7260928|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Adverse Event|0
7260929|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
7260930|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
7260931|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
7260932|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
7260933|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
7260934|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
7260935|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
7260936|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Death|1
7260937|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Death|1
7260938|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Death|1
7260939|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Death|1
7260940|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Death|0
7260941|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Death|0
7260942|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Death|0
7260943|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
7260944|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
7260945|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
7260946|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
7260947|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
7260948|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
7260949|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
7260950|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
7543721|NCT02805660|11896556|FG000|Overall Study|Lost to Follow-up|0
7543722|NCT02805660|11896557|FG001|Overall Study|Lost to Follow-up|1
7543723|NCT02805660|11896558|FG002|Overall Study|Lost to Follow-up|1
7543724|NCT02805660|11896559|FG003|Overall Study|Lost to Follow-up|2
7543725|NCT02805660|11896560|FG004|Overall Study|Lost to Follow-up|0
7543726|NCT02805660|11896561|FG005|Overall Study|Lost to Follow-up|0
7543727|NCT02805660|11896562|FG006|Overall Study|Lost to Follow-up|0
7543728|NCT02805660|11896556|FG000|Overall Study|Withdrawal by Subject|0
7543729|NCT02805660|11896557|FG001|Overall Study|Withdrawal by Subject|0
7543730|NCT02805660|11896558|FG002|Overall Study|Withdrawal by Subject|0
7543731|NCT02805660|11896559|FG003|Overall Study|Withdrawal by Subject|3
7543732|NCT02805660|11896560|FG004|Overall Study|Withdrawal by Subject|1
7543733|NCT02805660|11896561|FG005|Overall Study|Withdrawal by Subject|0
7543734|NCT02805660|11896562|FG006|Overall Study|Withdrawal by Subject|2
7543735|NCT02805660|11896556|FG000|Overall Study|Study terminated by Sponsor|0
7543736|NCT02805660|11896557|FG001|Overall Study|Study terminated by Sponsor|0
7543737|NCT02805660|11896558|FG002|Overall Study|Study terminated by Sponsor|1
7543738|NCT02805660|11896559|FG003|Overall Study|Study terminated by Sponsor|4
7543739|NCT02805660|11896560|FG004|Overall Study|Study terminated by Sponsor|2
7543740|NCT02805660|11896561|FG005|Overall Study|Study terminated by Sponsor|3
7543741|NCT02805660|11896562|FG006|Overall Study|Study terminated by Sponsor|1
7543742|NCT02805660|11896556|FG000|Overall Study|Miscellaneous|0
7543743|NCT02805660|11896557|FG001|Overall Study|Miscellaneous|1
7543744|NCT02805660|11896558|FG002|Overall Study|Miscellaneous|0
7543745|NCT02805660|11896559|FG003|Overall Study|Miscellaneous|4
7543746|NCT02805660|11896560|FG004|Overall Study|Miscellaneous|0
7543747|NCT02805660|11896561|FG005|Overall Study|Miscellaneous|6
7543748|NCT02805660|11896562|FG006|Overall Study|Miscellaneous|4
7543749|NCT02805790|11896593|FG000|Second Intervention (4 Weeks)|Physician Decision|0
7260951|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
7260952|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
7260953|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
7260954|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
7260955|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
7543750|NCT02805790|11896594|FG001|Second Intervention (4 Weeks)|Physician Decision|1
7543751|NCT02805907|11896602|FG000|Overall Study|Lost to Follow-up|3
7543752|NCT02805907|11896603|FG001|Overall Study|Lost to Follow-up|3
7543753|NCT02805972|11896611|FG000|Washout Period|Lost to Follow-up|3
7543754|NCT02805972|11896612|FG001|Washout Period|Lost to Follow-up|0
7543755|NCT02806024|11896630|FG000|Overall Study|Night Delivery|1
7543756|NCT02806024|11896631|FG001|Overall Study|Night Delivery|1
7543757|NCT02806024|11896630|FG000|Overall Study|DVT during antepartum admission|0
7543758|NCT02806024|11896631|FG001|Overall Study|DVT during antepartum admission|1
7543759|NCT02806232|11896646|FG000|Overall Study|Lost to Follow-up|1
7260956|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
7260957|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Worsening of RA|0
7260958|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Worsening of RA|5
7260959|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Worsening of RA|1
7260960|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Worsening of RA|4
7260961|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Worsening of RA|2
7260962|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Worsening of RA|0
7260963|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Worsening of RA|0
7260964|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Other|2
7260965|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Other|9
7260966|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Other|9
7260967|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Other|3
7260968|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Other|2
7260969|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Other|0
7260970|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Other|0
7260971|NCT00361335|11473722|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
7260972|NCT00361335|11473723|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
7260973|NCT00361335|11473724|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
7260974|NCT00361335|11473725|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
7260975|NCT00361335|11473726|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
7260976|NCT00361335|11473727|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
7260977|NCT00361335|11473728|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
7260978|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
7260979|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
7260980|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
7260981|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
7260982|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
7260983|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
7260984|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
7260985|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7543760|NCT02806232|11896647|FG001|Overall Study|Lost to Follow-up|2
7543761|NCT02806232|11896648|FG002|Overall Study|Lost to Follow-up|1
7543762|NCT02806232|11896649|FG003|Overall Study|Lost to Follow-up|0
7543763|NCT02806232|11896650|FG004|Overall Study|Lost to Follow-up|0
7543764|NCT02806232|11896651|FG005|Overall Study|Lost to Follow-up|1
7543765|NCT02806232|11896652|FG006|Overall Study|Lost to Follow-up|0
7543766|NCT02806232|11896653|FG007|Overall Study|Lost to Follow-up|0
7543767|NCT02806232|11896654|FG008|Overall Study|Lost to Follow-up|0
7543768|NCT02806232|11896646|FG000|Overall Study|Withdrawal by Subject|0
7543769|NCT02806232|11896647|FG001|Overall Study|Withdrawal by Subject|2
7543770|NCT02806232|11896648|FG002|Overall Study|Withdrawal by Subject|0
7543771|NCT02806232|11896649|FG003|Overall Study|Withdrawal by Subject|0
7543772|NCT02806232|11896650|FG004|Overall Study|Withdrawal by Subject|2
7543773|NCT02806232|11896651|FG005|Overall Study|Withdrawal by Subject|1
7543774|NCT02806232|11896652|FG006|Overall Study|Withdrawal by Subject|0
7543775|NCT02806232|11896653|FG007|Overall Study|Withdrawal by Subject|0
7543776|NCT02806232|11896654|FG008|Overall Study|Withdrawal by Subject|0
7543777|NCT02806414|11896674|FG000|Overall Study|Lost to Follow-up|2
7543778|NCT02806505|11896680|FG000|Overall Study|Adverse event/intercurrent illness|1
7543779|NCT02806505|11896681|FG001|Overall Study|Adverse event/intercurrent illness|3
7543780|NCT02806505|11896680|FG000|Overall Study|Death|4
7543781|NCT02806505|11896681|FG001|Overall Study|Death|0
7543782|NCT02806505|11896680|FG000|Overall Study|Did not cooperate/refused treatment|3
7543783|NCT02806505|11896681|FG001|Overall Study|Did not cooperate/refused treatment|3
7543784|NCT02806505|11896680|FG000|Overall Study|Failure to return|0
7543785|NCT02806505|11896681|FG001|Overall Study|Failure to return|1
7543786|NCT02806505|11896680|FG000|Overall Study|Insufficient therapeutic response|2
7576508|NCT04315298|11963213|FG013|Overall Study|Withdrawal by Subject|0
7543787|NCT02806505|11896681|FG001|Overall Study|Insufficient therapeutic response|4
7260986|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7260987|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7260988|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7260989|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7260990|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
7260991|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
7260992|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Death|0
7260993|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Death|0
7260994|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Death|0
7260995|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Death|0
7260996|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Death|0
7260997|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Death|0
7260998|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Death|1
7260999|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
7261000|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
7261001|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
7261002|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
7543788|NCT02806713|11896693|FG000|Overall Study|Urethral injury during procedure|1
7543789|NCT02806713|11896694|FG001|Overall Study|Urethral injury during procedure|0
7543790|NCT02806713|11896693|FG000|Overall Study|cancelled surgery|1
7543791|NCT02806713|11896694|FG001|Overall Study|cancelled surgery|2
7543792|NCT02806726|11896700|FG000|Overall Study|Lost to Follow-up|1
7543793|NCT02806947|11896736|FG000|Overall Study|Withdrawal by Subject|5
7543794|NCT02806947|11896737|FG001|Overall Study|Withdrawal by Subject|1
7543795|NCT02806973|11896743|FG000|Period 1|Withdrawal by Subject|0
7543796|NCT02806973|11896744|FG001|Period 1|Withdrawal by Subject|2
7576509|NCT04315298|11963214|FG014|Overall Study|Withdrawal by Subject|0
7576510|NCT04315298|11963215|FG015|Overall Study|Withdrawal by Subject|0
7576511|NCT04315298|11963216|FG016|Overall Study|Withdrawal by Subject|0
7576512|NCT04315298|11963217|FG017|Overall Study|Withdrawal by Subject|0
7576513|NCT04315298|11963218|FG018|Overall Study|Withdrawal by Subject|0
7576514|NCT04315298|11963200|FG000|Overall Study|Physician Decision|0
7576515|NCT04315298|11963201|FG001|Overall Study|Physician Decision|0
7543797|NCT02806973|11896745|FG002|Period 1|Withdrawal by Subject|1
7543798|NCT02806973|11896746|FG003|Period 1|Withdrawal by Subject|1
7543799|NCT02806973|11896743|FG000|Period 1|Adverse Event|0
7543800|NCT02806973|11896744|FG001|Period 1|Adverse Event|0
7543801|NCT02806973|11896745|FG002|Period 1|Adverse Event|0
7543802|NCT02806973|11896746|FG003|Period 1|Adverse Event|1
7543803|NCT02806973|11896743|FG000|Period 3|Withdrawal by Subject|0
7543804|NCT02806973|11896744|FG001|Period 3|Withdrawal by Subject|0
7543805|NCT02806973|11896745|FG002|Period 3|Withdrawal by Subject|0
7543806|NCT02806973|11896746|FG003|Period 3|Withdrawal by Subject|3
7543807|NCT02806973|11896743|FG000|Period 3|Adverse Event|0
7543808|NCT02806973|11896744|FG001|Period 3|Adverse Event|0
7543809|NCT02806973|11896745|FG002|Period 3|Adverse Event|1
7543810|NCT02806973|11896746|FG003|Period 3|Adverse Event|0
7543811|NCT02806986|11896756|FG000|Treatment Stage 1|Adverse Event|1
7543812|NCT02806986|11896756|FG000|Treatment Stage 2|Adverse Event|3
7543813|NCT02806986|11896756|FG000|Treatment Stage 2|Withdrawal by Subject|2
7576516|NCT04315298|11963202|FG002|Overall Study|Physician Decision|0
7261003|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
7261004|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
7261005|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
7543814|NCT02807259|11896766|FG000|Baseline (3 Months)|migration, refusal, not available|77
7543815|NCT02807259|11896767|FG001|Baseline (3 Months)|migration, refusal, not available|112
7543816|NCT02807259|11896766|FG000|Midline (3 Months)|migration, refusal, not available|30
7543817|NCT02807259|11896767|FG001|Midline (3 Months)|migration, refusal, not available|34
7543818|NCT02807259|11896766|FG000|Endline (3 Months)|migration, refusal, not available|35
7576517|NCT04315298|11963203|FG003|Overall Study|Physician Decision|0
7261006|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Other|1
7261007|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Other|0
7261008|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Other|0
7261009|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Other|1
7261010|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Other|0
7261011|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Other|1
7261012|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Other|2
7261013|NCT00361335|11473722|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7261014|NCT00361335|11473723|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7261015|NCT00361335|11473724|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
7261016|NCT00361335|11473725|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7261017|NCT00361335|11473726|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7261018|NCT00361335|11473727|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
7261019|NCT00361335|11473728|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
7261020|NCT00361504|11473768|FG000|Overall Study|Withdrawal by Subject|94
7261021|NCT00361504|11473769|FG001|Overall Study|Withdrawal by Subject|31
7261022|NCT00361504|11473768|FG000|Overall Study|Lost to Follow-up|40
7261023|NCT00361504|11473769|FG001|Overall Study|Lost to Follow-up|7
7261024|NCT00361504|11473768|FG000|Overall Study|Adverse Event|203
7261025|NCT00361504|11473769|FG001|Overall Study|Adverse Event|82
7261026|NCT00361504|11473768|FG000|Overall Study|Lack of Efficacy|72
7261027|NCT00361504|11473769|FG001|Overall Study|Lack of Efficacy|7
7261028|NCT00361504|11473768|FG000|Overall Study|Resolution of Pain|2
7261029|NCT00361504|11473769|FG001|Overall Study|Resolution of Pain|0
7261030|NCT00361504|11473768|FG000|Overall Study|Study medication non compliant|42
7261031|NCT00361504|11473769|FG001|Overall Study|Study medication non compliant|15
7261032|NCT00361504|11473768|FG000|Overall Study|All other|28
7261033|NCT00361504|11473769|FG001|Overall Study|All other|3
7261034|NCT00361569|11473779|FG000|Overall Study|Protocol Violation|3
7261035|NCT00361569|11473780|FG001|Overall Study|Protocol Violation|2
7261036|NCT00361569|11473781|FG002|Overall Study|Protocol Violation|4
7261037|NCT00361569|11473782|FG003|Overall Study|Protocol Violation|2
7261038|NCT00361569|11473779|FG000|Overall Study|Withdrawal by Subject|2
7261039|NCT00361569|11473780|FG001|Overall Study|Withdrawal by Subject|1
7261040|NCT00361569|11473781|FG002|Overall Study|Withdrawal by Subject|9
7543819|NCT02807259|11896767|FG001|Endline (3 Months)|migration, refusal, not available|87
7543820|NCT02807376|11896777|FG000|Overall Study|Intra-operative exclusion criteria|3
7543821|NCT02807376|11896778|FG001|Overall Study|Intra-operative exclusion criteria|0
7543822|NCT02807376|11896777|FG000|Overall Study|Lost to Follow-up|0
7543823|NCT02807376|11896778|FG001|Overall Study|Lost to Follow-up|1
7543824|NCT02807402|11896784|FG000|Overall Study|Failure to Return|1
7543825|NCT02807402|11896784|FG000|Overall Study|Death|3
7543826|NCT02807402|11896784|FG000|Overall Study|Other|2
7543827|NCT02807623|11896799|FG000|Overall Study|Lost to Follow-up|23
7543828|NCT02807623|11896800|FG001|Overall Study|Lost to Follow-up|18
7543829|NCT02807623|11896801|FG002|Overall Study|Lost to Follow-up|22
7543830|NCT02807623|11896799|FG000|Overall Study|Drug intolerance|0
7261041|NCT00361569|11473782|FG003|Overall Study|Withdrawal by Subject|14
7261042|NCT00361569|11473779|FG000|Overall Study|Adverse Event|3
7261043|NCT00361569|11473780|FG001|Overall Study|Adverse Event|5
7261044|NCT00361569|11473781|FG002|Overall Study|Adverse Event|2
7261045|NCT00361569|11473782|FG003|Overall Study|Adverse Event|2
7261046|NCT00361569|11473779|FG000|Overall Study|Lost to Follow-up|2
7261047|NCT00361569|11473780|FG001|Overall Study|Lost to Follow-up|3
7261048|NCT00361569|11473781|FG002|Overall Study|Lost to Follow-up|3
7261049|NCT00361569|11473782|FG003|Overall Study|Lost to Follow-up|2
7261050|NCT00361569|11473779|FG000|Overall Study|Not specified by investigator|2
7261051|NCT00361569|11473780|FG001|Overall Study|Not specified by investigator|0
7261052|NCT00361569|11473781|FG002|Overall Study|Not specified by investigator|0
7261053|NCT00361569|11473782|FG003|Overall Study|Not specified by investigator|1
7261054|NCT00361634|11473796|FG000|Overall Study|Lost to Follow-up|1
7261055|NCT00361634|11473796|FG000|Overall Study|Withdrawal by Subject|1
7261056|NCT00361842|11473811|FG000|Overall Study|Withdrawal by Subject|2
7261057|NCT00361842|11473812|FG001|Overall Study|Withdrawal by Subject|3
7261058|NCT00361842|11473811|FG000|Overall Study|Death|2
7261059|NCT00361842|11473812|FG001|Overall Study|Death|1
7261060|NCT00361842|11473811|FG000|Overall Study|Disease progression|19
7543831|NCT02807623|11896800|FG001|Overall Study|Drug intolerance|1
7543832|NCT02807623|11896801|FG002|Overall Study|Drug intolerance|0
7261061|NCT00361842|11473812|FG001|Overall Study|Disease progression|20
7261062|NCT00361842|11473811|FG000|Overall Study|Adverse Event|2
7261063|NCT00361842|11473812|FG001|Overall Study|Adverse Event|3
7261064|NCT00361842|11473811|FG000|Overall Study|Occurrence of unacceptable toxicity|1
7261065|NCT00361842|11473812|FG001|Overall Study|Occurrence of unacceptable toxicity|5
7261066|NCT00361842|11473811|FG000|Overall Study|Other|1
7261067|NCT00361842|11473812|FG001|Overall Study|Other|0
7261068|NCT00361842|11473811|FG000|Overall Study|Other|0
7261069|NCT00361842|11473812|FG001|Overall Study|Other|2
7261070|NCT00362115|11473837|FG000|Overall Study|Adverse Event|0
7261071|NCT00362115|11473838|FG001|Overall Study|Adverse Event|1
7261072|NCT00362115|11473839|FG002|Overall Study|Adverse Event|1
7261073|NCT00362115|11473840|FG003|Overall Study|Adverse Event|1
7261074|NCT00362115|11473841|FG004|Overall Study|Adverse Event|2
7261075|NCT00362115|11473842|FG005|Overall Study|Adverse Event|2
7261076|NCT00362115|11473843|FG006|Overall Study|Adverse Event|1
7261077|NCT00362115|11473837|FG000|Overall Study|Protocol Violation|0
7261078|NCT00362115|11473838|FG001|Overall Study|Protocol Violation|0
7261079|NCT00362115|11473839|FG002|Overall Study|Protocol Violation|0
7261080|NCT00362115|11473840|FG003|Overall Study|Protocol Violation|0
7261081|NCT00362115|11473841|FG004|Overall Study|Protocol Violation|0
7261082|NCT00362115|11473842|FG005|Overall Study|Protocol Violation|1
7261083|NCT00362115|11473843|FG006|Overall Study|Protocol Violation|0
7261084|NCT00362115|11473837|FG000|Overall Study|Lost to Follow-up|0
7261085|NCT00362115|11473838|FG001|Overall Study|Lost to Follow-up|1
7261086|NCT00362115|11473839|FG002|Overall Study|Lost to Follow-up|0
7261087|NCT00362115|11473840|FG003|Overall Study|Lost to Follow-up|0
7261088|NCT00362115|11473841|FG004|Overall Study|Lost to Follow-up|2
7261089|NCT00362115|11473842|FG005|Overall Study|Lost to Follow-up|0
7261090|NCT00362115|11473843|FG006|Overall Study|Lost to Follow-up|1
7261091|NCT00362115|11473837|FG000|Overall Study|Withdrawal by Subject|1
7261092|NCT00362115|11473838|FG001|Overall Study|Withdrawal by Subject|3
7261093|NCT00362115|11473839|FG002|Overall Study|Withdrawal by Subject|1
7261094|NCT00362115|11473840|FG003|Overall Study|Withdrawal by Subject|0
7261095|NCT00362115|11473841|FG004|Overall Study|Withdrawal by Subject|1
7261096|NCT00362115|11473842|FG005|Overall Study|Withdrawal by Subject|3
7261097|NCT00362115|11473843|FG006|Overall Study|Withdrawal by Subject|4
7261098|NCT00362115|11473837|FG000|Overall Study|Lack of Efficacy|1
7261099|NCT00362115|11473838|FG001|Overall Study|Lack of Efficacy|0
7261100|NCT00362115|11473839|FG002|Overall Study|Lack of Efficacy|5
7261101|NCT00362115|11473840|FG003|Overall Study|Lack of Efficacy|2
7261102|NCT00362115|11473841|FG004|Overall Study|Lack of Efficacy|2
7261103|NCT00362115|11473842|FG005|Overall Study|Lack of Efficacy|0
7261104|NCT00362115|11473843|FG006|Overall Study|Lack of Efficacy|3
7261105|NCT00362115|11473837|FG000|Overall Study|Physician Decision|0
7261106|NCT00362115|11473838|FG001|Overall Study|Physician Decision|0
7261107|NCT00362115|11473839|FG002|Overall Study|Physician Decision|0
7261108|NCT00362115|11473840|FG003|Overall Study|Physician Decision|0
7261109|NCT00362115|11473841|FG004|Overall Study|Physician Decision|0
7543833|NCT02807623|11896799|FG000|Overall Study|incomplete blood draw|0
7543834|NCT02807623|11896800|FG001|Overall Study|incomplete blood draw|2
7543835|NCT02807623|11896801|FG002|Overall Study|incomplete blood draw|1
7543836|NCT02807844|11896828|FG000|Overall Study|Physician Decision|0
7543837|NCT02807844|11896829|FG001|Overall Study|Physician Decision|0
7543838|NCT02807844|11896830|FG002|Overall Study|Physician Decision|0
7543839|NCT02807844|11896831|FG003|Overall Study|Physician Decision|0
7261110|NCT00362115|11473842|FG005|Overall Study|Physician Decision|0
7261111|NCT00362115|11473843|FG006|Overall Study|Physician Decision|3
7261112|NCT00362115|11473837|FG000|Overall Study|Other|0
7261113|NCT00362115|11473838|FG001|Overall Study|Other|1
7261114|NCT00362115|11473839|FG002|Overall Study|Other|0
7261115|NCT00362115|11473840|FG003|Overall Study|Other|1
7543840|NCT02807844|11896832|FG004|Overall Study|Physician Decision|0
7261116|NCT00362115|11473841|FG004|Overall Study|Other|0
7261117|NCT00362115|11473842|FG005|Overall Study|Other|1
7261118|NCT00362115|11473843|FG006|Overall Study|Other|0
7261119|NCT00362180|11473872|FG000|Treated Period|Withdrawal by Subject|1
7261120|NCT00362180|11473873|FG001|Treated Period|Withdrawal by Subject|0
7261121|NCT00362180|11473874|FG002|Treated Period|Withdrawal by Subject|0
7261122|NCT00362180|11473875|FG003|Treated Period|Withdrawal by Subject|0
7261123|NCT00362180|11473876|FG004|Treated Period|Withdrawal by Subject|0
7261124|NCT00362180|11473877|FG005|Treated Period|Withdrawal by Subject|0
7261125|NCT00362180|11473878|FG006|Treated Period|Withdrawal by Subject|0
7576518|NCT04315298|11963204|FG004|Overall Study|Physician Decision|1
7576519|NCT04315298|11963205|FG005|Overall Study|Physician Decision|0
7576520|NCT04315298|11963206|FG006|Overall Study|Physician Decision|0
7576521|NCT04315298|11963207|FG007|Overall Study|Physician Decision|0
7576522|NCT04315298|11963208|FG008|Overall Study|Physician Decision|0
7261126|NCT00362180|11473879|FG007|Treated Period|Withdrawal by Subject|0
7261127|NCT00362180|11473880|FG008|Treated Period|Withdrawal by Subject|0
7261128|NCT00362180|11473872|FG000|Treated Period|Adverse Event|0
7261129|NCT00362180|11473873|FG001|Treated Period|Adverse Event|0
7576523|NCT04315298|11963209|FG009|Overall Study|Physician Decision|0
7576524|NCT04315298|11963210|FG010|Overall Study|Physician Decision|0
7543841|NCT02807844|11896833|FG005|Overall Study|Physician Decision|0
7543842|NCT02807844|11896834|FG006|Overall Study|Physician Decision|3
7543843|NCT02807844|11896835|FG007|Overall Study|Physician Decision|0
7543844|NCT02807844|11896836|FG008|Overall Study|Physician Decision|1
7543845|NCT02807844|11896837|FG009|Overall Study|Physician Decision|2
7543846|NCT02807844|11896828|FG000|Overall Study|Death|0
7576525|NCT04315298|11963211|FG011|Overall Study|Physician Decision|0
7576526|NCT04315298|11963212|FG012|Overall Study|Physician Decision|0
7576527|NCT04315298|11963213|FG013|Overall Study|Physician Decision|0
7576528|NCT04315298|11963214|FG014|Overall Study|Physician Decision|0
7576529|NCT04315298|11963215|FG015|Overall Study|Physician Decision|0
7576530|NCT04315298|11963216|FG016|Overall Study|Physician Decision|0
7576531|NCT04315298|11963217|FG017|Overall Study|Physician Decision|0
7576532|NCT04315298|11963218|FG018|Overall Study|Physician Decision|0
7576533|NCT04315298|11963200|FG000|Overall Study|Lost to Follow-up|5
7576534|NCT04315298|11963201|FG001|Overall Study|Lost to Follow-up|10
7576535|NCT04315298|11963202|FG002|Overall Study|Lost to Follow-up|6
7576536|NCT04315298|11963203|FG003|Overall Study|Lost to Follow-up|8
7576537|NCT04315298|11963204|FG004|Overall Study|Lost to Follow-up|12
7576538|NCT04315298|11963205|FG005|Overall Study|Lost to Follow-up|13
7576539|NCT04315298|11963206|FG006|Overall Study|Lost to Follow-up|9
7576540|NCT04315298|11963207|FG007|Overall Study|Lost to Follow-up|16
7261130|NCT00362180|11473874|FG002|Treated Period|Adverse Event|0
7261131|NCT00362180|11473875|FG003|Treated Period|Adverse Event|0
7261132|NCT00362180|11473876|FG004|Treated Period|Adverse Event|0
7261133|NCT00362180|11473877|FG005|Treated Period|Adverse Event|1
7261134|NCT00362180|11473878|FG006|Treated Period|Adverse Event|0
7261135|NCT00362180|11473879|FG007|Treated Period|Adverse Event|1
7261136|NCT00362180|11473880|FG008|Treated Period|Adverse Event|0
7261137|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
7261138|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
7543847|NCT02807844|11896829|FG001|Overall Study|Death|0
7543848|NCT02807844|11896830|FG002|Overall Study|Death|2
7543849|NCT02807844|11896831|FG003|Overall Study|Death|4
7543850|NCT02807844|11896832|FG004|Overall Study|Death|1
7543851|NCT02807844|11896833|FG005|Overall Study|Death|2
7543852|NCT02807844|11896834|FG006|Overall Study|Death|1
7543853|NCT02807844|11896835|FG007|Overall Study|Death|2
7543854|NCT02807844|11896836|FG008|Overall Study|Death|0
7543855|NCT02807844|11896837|FG009|Overall Study|Death|1
7543856|NCT02807844|11896828|FG000|Overall Study|Withdrawal by Subject|0
7543857|NCT02807844|11896829|FG001|Overall Study|Withdrawal by Subject|0
7543858|NCT02807844|11896830|FG002|Overall Study|Withdrawal by Subject|2
7543859|NCT02807844|11896831|FG003|Overall Study|Withdrawal by Subject|1
7543860|NCT02807844|11896832|FG004|Overall Study|Withdrawal by Subject|1
7576541|NCT04315298|11963208|FG008|Overall Study|Lost to Follow-up|14
7576542|NCT04315298|11963209|FG009|Overall Study|Lost to Follow-up|0
7576543|NCT04315298|11963210|FG010|Overall Study|Lost to Follow-up|2
7576544|NCT04315298|11963211|FG011|Overall Study|Lost to Follow-up|1
7576545|NCT04315298|11963212|FG012|Overall Study|Lost to Follow-up|0
7576546|NCT04315298|11963213|FG013|Overall Study|Lost to Follow-up|0
7576547|NCT04315298|11963214|FG014|Overall Study|Lost to Follow-up|0
7261139|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Death|1
7261140|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Death|3
7261141|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
7261142|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
7261143|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
7261144|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
7576548|NCT04315298|11963215|FG015|Overall Study|Lost to Follow-up|2
7576549|NCT04315298|11963216|FG016|Overall Study|Lost to Follow-up|0
7261145|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
7261146|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
7261147|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
7261148|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
7261149|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
7261150|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
7261151|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
7261152|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
7261153|NCT00362232|11473900|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
7261154|NCT00362232|11473901|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
7261155|NCT00362232|11473900|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
7261156|NCT00362232|11473901|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
7261157|NCT00362232|11473900|FG000|Follow-up (30 (+ 5) Days)|Death|1
7261158|NCT00362232|11473901|FG001|Follow-up (30 (+ 5) Days)|Death|1
7261159|NCT00362232|11473900|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
7261160|NCT00362232|11473901|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
7261161|NCT00362232|11473900|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
7261162|NCT00362232|11473901|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
7261163|NCT00362297|11473909|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
7261164|NCT00362297|11473910|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
7261165|NCT00362336|11473919|FG000|Overall Study|Serious Adverse Event|1
7261166|NCT00362336|11473920|FG001|Overall Study|Serious Adverse Event|0
7261167|NCT00362336|11473921|FG002|Overall Study|Serious Adverse Event|1
7261168|NCT00362336|11473919|FG000|Overall Study|Protocol Violation|0
7261169|NCT00362336|11473920|FG001|Overall Study|Protocol Violation|0
7261170|NCT00362336|11473921|FG002|Overall Study|Protocol Violation|1
7261171|NCT00362336|11473919|FG000|Overall Study|Lost to Follow-up|6
7261172|NCT00362336|11473920|FG001|Overall Study|Lost to Follow-up|4
7261173|NCT00362336|11473921|FG002|Overall Study|Lost to Follow-up|0
7261174|NCT00362336|11473919|FG000|Overall Study|Withdrawal by Subject|3
7261175|NCT00362336|11473920|FG001|Overall Study|Withdrawal by Subject|3
7261176|NCT00362336|11473921|FG002|Overall Study|Withdrawal by Subject|1
7261177|NCT00362375|11473938|FG000|Overall Study|Lost to Follow-up|40
7261178|NCT00362375|11473939|FG001|Overall Study|Lost to Follow-up|35
7261179|NCT00362414|11473945|FG000|Overall Study|Death|2
7261180|NCT00362414|11473945|FG000|Overall Study|Adverse Event|1
7261181|NCT00362609|11473981|FG000|Overall Study|Withdrawal by Subject|0
7261182|NCT00362609|11473982|FG001|Overall Study|Withdrawal by Subject|1
7261183|NCT00362609|11473981|FG000|Overall Study|Protocol Violation|0
7261184|NCT00362609|11473982|FG001|Overall Study|Protocol Violation|1
7261185|NCT00362648|11473992|FG000|Overall Study|Adverse Event|12
7261186|NCT00362648|11473993|FG001|Overall Study|Adverse Event|21
7261187|NCT00362648|11473994|FG002|Overall Study|Adverse Event|1
7261188|NCT00362648|11473995|FG003|Overall Study|Adverse Event|0
7543861|NCT02807844|11896833|FG005|Overall Study|Withdrawal by Subject|0
7261189|NCT00362648|11473992|FG000|Overall Study|Lost to Follow-up|62
7261190|NCT00362648|11473993|FG001|Overall Study|Lost to Follow-up|69
7261191|NCT00362648|11473994|FG002|Overall Study|Lost to Follow-up|4
7261192|NCT00362648|11473995|FG003|Overall Study|Lost to Follow-up|3
7261193|NCT00362648|11473992|FG000|Overall Study|Protocol Violation|4
7261194|NCT00362648|11473993|FG001|Overall Study|Protocol Violation|2
7261195|NCT00362648|11473994|FG002|Overall Study|Protocol Violation|2
7261196|NCT00362648|11473995|FG003|Overall Study|Protocol Violation|2
7261197|NCT00362648|11473992|FG000|Overall Study|Withdrawal by Subject|48
7543862|NCT02807844|11896834|FG006|Overall Study|Withdrawal by Subject|1
7576550|NCT04315298|11963217|FG017|Overall Study|Lost to Follow-up|0
7576551|NCT04315298|11963218|FG018|Overall Study|Lost to Follow-up|0
7576552|NCT04315298|11963200|FG000|Overall Study|Death|24
7576553|NCT04315298|11963201|FG001|Overall Study|Death|60
7576554|NCT04315298|11963202|FG002|Overall Study|Death|49
7261198|NCT00362648|11473993|FG001|Overall Study|Withdrawal by Subject|42
7261199|NCT00362648|11473994|FG002|Overall Study|Withdrawal by Subject|2
7261200|NCT00362648|11473995|FG003|Overall Study|Withdrawal by Subject|6
7261201|NCT00363051|11474025|FG000|Overall Study|Adminstrative problems|1
7261202|NCT00363051|11474026|FG001|Overall Study|Adminstrative problems|1
7261203|NCT00363051|11474025|FG000|Overall Study|Adverse Event|21
7261204|NCT00363051|11474026|FG001|Overall Study|Adverse Event|12
7261205|NCT00363051|11474025|FG000|Overall Study|New Cancer Therapy|2
7261206|NCT00363051|11474026|FG001|Overall Study|New Cancer Therapy|1
7261207|NCT00363051|11474025|FG000|Overall Study|Withdrawal by Subject|11
7261208|NCT00363051|11474026|FG001|Overall Study|Withdrawal by Subject|3
7261209|NCT00363051|11474025|FG000|Overall Study|Lost to Follow-up|0
7261210|NCT00363051|11474026|FG001|Overall Study|Lost to Follow-up|1
7261211|NCT00363051|11474025|FG000|Overall Study|Protocol Violation|0
7261212|NCT00363051|11474026|FG001|Overall Study|Protocol Violation|2
7261213|NCT00363051|11474025|FG000|Overall Study|Death|3
7261214|NCT00363051|11474026|FG001|Overall Study|Death|2
7261215|NCT00363129|11474045|FG000|Overall Study|Withdrawal by Subject|11
7261216|NCT00363129|11474046|FG001|Overall Study|Withdrawal by Subject|18
7261217|NCT00363129|11474045|FG000|Overall Study|Adverse Event|8
7261218|NCT00363129|11474046|FG001|Overall Study|Adverse Event|3
7261219|NCT00363129|11474045|FG000|Overall Study|Alternate Treatment|2
7261220|NCT00363129|11474046|FG001|Overall Study|Alternate Treatment|4
7261221|NCT00363129|11474045|FG000|Overall Study|Other Medical Problems|2
7261222|NCT00363129|11474046|FG001|Overall Study|Other Medical Problems|4
7261223|NCT00363129|11474045|FG000|Overall Study|Death|0
7261224|NCT00363129|11474046|FG001|Overall Study|Death|1
7261225|NCT00363129|11474045|FG000|Overall Study|Other Reasons|6
7261226|NCT00363129|11474046|FG001|Overall Study|Other Reasons|3
7261227|NCT00363142|11474054|FG000|Overall Study|Adverse Event|2
7576555|NCT04315298|11963203|FG003|Overall Study|Death|59
7261228|NCT00363142|11474055|FG001|Overall Study|Adverse Event|0
7261229|NCT00363142|11474054|FG000|Overall Study|Lack of Efficacy|0
7261230|NCT00363142|11474055|FG001|Overall Study|Lack of Efficacy|1
7261231|NCT00363142|11474054|FG000|Overall Study|Lost to Follow-up|1
7261232|NCT00363142|11474055|FG001|Overall Study|Lost to Follow-up|0
7261233|NCT00363142|11474054|FG000|Overall Study|Non-compliance|1
7261234|NCT00363142|11474055|FG001|Overall Study|Non-compliance|1
7261235|NCT00363142|11474054|FG000|Overall Study|Withdrawal by Subject|3
7261236|NCT00363142|11474055|FG001|Overall Study|Withdrawal by Subject|1
7261237|NCT00363246|11474073|FG000|Overall Study|Death|40
7261238|NCT00363246|11474073|FG000|Overall Study|Withdrawal by Subject|19
7261239|NCT00363246|11474073|FG000|Overall Study|Lost to Follow-up|14
7576556|NCT04315298|11963204|FG004|Overall Study|Death|70
7576557|NCT04315298|11963205|FG005|Overall Study|Death|114
7261240|NCT00363246|11474073|FG000|Overall Study|Bad health|6
7261241|NCT00363246|11474073|FG000|Overall Study|Stopped using wheelchair|11
7261242|NCT00363246|11474073|FG000|Overall Study|Subject expressed security concerns|2
7261243|NCT00363246|11474073|FG000|Overall Study|Eligibility changed due to Hospice move|5
7261244|NCT00363298|11474080|FG000|First Study Week|Lack of Efficacy|6
7261245|NCT00363298|11474081|FG001|First Study Week|Lack of Efficacy|5
7261246|NCT00363298|11474080|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
7261247|NCT00363298|11474081|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
7261248|NCT00363311|11474090|FG000|Overall Study|Adverse Event|6
7261249|NCT00363311|11474091|FG001|Overall Study|Adverse Event|4
7261250|NCT00363311|11474090|FG000|Overall Study|Lost to Follow-up|3
7261251|NCT00363311|11474091|FG001|Overall Study|Lost to Follow-up|0
7261252|NCT00363311|11474090|FG000|Overall Study|Protocol Violation|1
7543863|NCT02807844|11896835|FG007|Overall Study|Withdrawal by Subject|0
7543864|NCT02807844|11896836|FG008|Overall Study|Withdrawal by Subject|0
7543865|NCT02807844|11896837|FG009|Overall Study|Withdrawal by Subject|0
7543866|NCT02807844|11896828|FG000|Overall Study|Progressive disease|5
7543867|NCT02807844|11896829|FG001|Overall Study|Progressive disease|12
7543868|NCT02807844|11896830|FG002|Overall Study|Progressive disease|8
7543869|NCT02807844|11896831|FG003|Overall Study|Progressive disease|8
7543870|NCT02807844|11896832|FG004|Overall Study|Progressive disease|3
7543871|NCT02807844|11896833|FG005|Overall Study|Progressive disease|8
7543872|NCT02807844|11896834|FG006|Overall Study|Progressive disease|14
7543873|NCT02807844|11896835|FG007|Overall Study|Progressive disease|17
7543874|NCT02807844|11896836|FG008|Overall Study|Progressive disease|19
7543875|NCT02807844|11896837|FG009|Overall Study|Progressive disease|15
7543876|NCT02807844|11896828|FG000|Overall Study|Adverse Event|1
7543877|NCT02807844|11896829|FG001|Overall Study|Adverse Event|0
7543878|NCT02807844|11896830|FG002|Overall Study|Adverse Event|0
7543879|NCT02807844|11896831|FG003|Overall Study|Adverse Event|0
7543880|NCT02807844|11896832|FG004|Overall Study|Adverse Event|1
7543881|NCT02807844|11896833|FG005|Overall Study|Adverse Event|1
7543882|NCT02807844|11896834|FG006|Overall Study|Adverse Event|1
7543883|NCT02807844|11896835|FG007|Overall Study|Adverse Event|1
7543884|NCT02807844|11896836|FG008|Overall Study|Adverse Event|1
7543885|NCT02807844|11896837|FG009|Overall Study|Adverse Event|2
7543886|NCT02807857|11896863|FG000|Enrolled Set|Patients not suitable for follow-up.|551
7543887|NCT02807857|11896863|FG000|Follow-Up Set|Study Terminated By Sponsor|131
7543888|NCT02807857|11896863|FG000|Follow-Up Set|Withdrawal by Subject|8
7543889|NCT02807857|11896863|FG000|Follow-Up Set|Lost to Follow-up|7
7543890|NCT02807857|11896863|FG000|Follow-Up Set|Physician Decision|6
7543891|NCT02807857|11896863|FG000|Follow-Up Set|Adverse Event|3
7543892|NCT02807857|11896863|FG000|Follow-Up Set|Death|27
7543893|NCT02807857|11896863|FG000|Follow-Up Set|Relocation|2
7543894|NCT02807948|11896873|FG000|Overall Study|Physician Decision|1
7543895|NCT02807948|11896874|FG001|Overall Study|Physician Decision|0
7543896|NCT02808312|11896925|FG000|Overall Study|Enrolled but Never Treated|0
7543897|NCT02808312|11896926|FG001|Overall Study|Enrolled but Never Treated|0
7543898|NCT02808312|11896927|FG002|Overall Study|Enrolled but Never Treated|1
7543899|NCT02808312|11896928|FG003|Overall Study|Enrolled but Never Treated|0
7543900|NCT02808312|11896929|FG004|Overall Study|Enrolled but Never Treated|0
7261253|NCT00363311|11474091|FG001|Overall Study|Protocol Violation|2
7261254|NCT00363311|11474090|FG000|Overall Study|Withdrawal by Subject|12
7543901|NCT02808338|11896946|FG000|Screening|Screen Failure|10
7543902|NCT02808338|11896946|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
7261255|NCT00363311|11474091|FG001|Overall Study|Withdrawal by Subject|6
7261256|NCT00363311|11474090|FG000|Overall Study|Physician Decision|1
7261257|NCT00363311|11474091|FG001|Overall Study|Physician Decision|1
7261258|NCT00363311|11474090|FG000|Overall Study|Sponsor Terminated Study|2
7543903|NCT02808338|11896946|FG000|Overnight In-lab Polysomonography|Reason not given|1
7543904|NCT02808429|11896960|FG000|Overall Study|Lost to Follow-up|1
7543905|NCT02808429|11896961|FG001|Overall Study|Lost to Follow-up|0
7543906|NCT02808429|11896962|FG002|Overall Study|Lost to Follow-up|0
7543907|NCT02808429|11896960|FG000|Overall Study|Protocol Violation|0
7543908|NCT02808429|11896961|FG001|Overall Study|Protocol Violation|1
7543909|NCT02808429|11896962|FG002|Overall Study|Protocol Violation|0
7543910|NCT02808429|11896960|FG000|Overall Study|Premature study termination by sponsor|2
7543911|NCT02808429|11896961|FG001|Overall Study|Premature study termination by sponsor|0
7543912|NCT02808429|11896962|FG002|Overall Study|Premature study termination by sponsor|1
7543913|NCT02808429|11896960|FG000|Overall Study|Relocation|0
7543914|NCT02808429|11896961|FG001|Overall Study|Relocation|0
7543915|NCT02808429|11896962|FG002|Overall Study|Relocation|1
7543916|NCT02808819|11896972|FG000|Overall Study|eg. no treatment efficacy on asthma|5
7543917|NCT02808819|11896973|FG001|Overall Study|eg. no treatment efficacy on asthma|4
7543918|NCT02808819|11896972|FG000|Overall Study|Withdrawal by Subject|10
7543919|NCT02808819|11896973|FG001|Overall Study|Withdrawal by Subject|13
7543920|NCT02808819|11896972|FG000|Overall Study|Site terminated by sponsor|2
7543921|NCT02808819|11896973|FG001|Overall Study|Site terminated by sponsor|0
7543922|NCT02808819|11896972|FG000|Overall Study|Pregnancy|1
7543923|NCT02808819|11896973|FG001|Overall Study|Pregnancy|0
7543924|NCT02808819|11896972|FG000|Overall Study|Lost to Follow-up|1
7543925|NCT02808819|11896973|FG001|Overall Study|Lost to Follow-up|6
7543926|NCT02808819|11896972|FG000|Overall Study|Protocol Violation|0
7543927|NCT02808819|11896973|FG001|Overall Study|Protocol Violation|1
7543928|NCT02808819|11896972|FG000|Overall Study|Development of study-specific withdrawal criteria|8
7543929|NCT02808819|11896973|FG001|Overall Study|Development of study-specific withdrawal criteria|3
7543930|NCT02808819|11896972|FG000|Overall Study|Death|1
7543931|NCT02808819|11896973|FG001|Overall Study|Death|0
7543932|NCT02808819|11896972|FG000|Overall Study|Adverse Event|3
7543933|NCT02808819|11896973|FG001|Overall Study|Adverse Event|4
7543934|NCT02808975|11896982|FG000|Overall Study|Adverse Event|3
7543935|NCT02808975|11896983|FG001|Overall Study|Adverse Event|4
7543936|NCT02808975|11896982|FG000|Overall Study|Withdrew consent|9
7543937|NCT02808975|11896983|FG001|Overall Study|Withdrew consent|8
7543938|NCT02808975|11896982|FG000|Overall Study|Lost to Follow-up|4
7543939|NCT02808975|11896983|FG001|Overall Study|Lost to Follow-up|6
7543940|NCT02808975|11896982|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
7543941|NCT02808975|11896983|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
7543942|NCT02808975|11896982|FG000|Overall Study|Other, not specified|5
7543943|NCT02808975|11896983|FG001|Overall Study|Other, not specified|1
7543944|NCT02809053|11896991|FG000|Overall Study|Death|0
7543945|NCT02809053|11896992|FG001|Overall Study|Death|1
7543946|NCT02809053|11896991|FG000|Overall Study|Lost to Follow-up|3
7543947|NCT02809053|11896992|FG001|Overall Study|Lost to Follow-up|1
7543948|NCT02809053|11896991|FG000|Overall Study|Withdrawal by Subject|2
7543949|NCT02809053|11896992|FG001|Overall Study|Withdrawal by Subject|3
7543950|NCT02809053|11896991|FG000|Overall Study|Disease Progression|2
7543951|NCT02809053|11896992|FG001|Overall Study|Disease Progression|1
7543952|NCT02809833|11897032|FG000|Overall Study|Death|3
7543953|NCT02809833|11897032|FG000|Overall Study|Intolerance|54
7543954|NCT02809833|11897032|FG000|Overall Study|Lack of Efficacy|89
7543955|NCT02809833|11897032|FG000|Overall Study|Remission/Treatment No Longer Needed|3
7543956|NCT02809833|11897032|FG000|Overall Study|Noncompliance|1
7543957|NCT02809833|11897032|FG000|Overall Study|Withdrawal by Subject|34
7543958|NCT02809833|11897032|FG000|Overall Study|Lost to Follow-up|35
7543959|NCT02809833|11897032|FG000|Overall Study|Adverse Event (AE)|24
7543960|NCT02809833|11897032|FG000|Overall Study|Other|5
7543961|NCT02809833|11897032|FG000|Overall Study|Missing Information|52
7543962|NCT02809976|11897058|FG000|Overall Study|Lost to Follow-up|1
7543963|NCT02809976|11897058|FG000|Overall Study|Withdrawal by Subject|1
7543964|NCT02810340|11897074|FG000|Overall Study|Withdrawal by Subject|1
7543965|NCT02810340|11897075|FG001|Overall Study|Withdrawal by Subject|0
7543966|NCT02810340|11897076|FG002|Overall Study|Withdrawal by Subject|0
7261259|NCT00363311|11474091|FG001|Overall Study|Sponsor Terminated Study|2
7261260|NCT00363311|11474090|FG000|Overall Study|Disease Progression|46
7261261|NCT00363311|11474091|FG001|Overall Study|Disease Progression|26
7261262|NCT00363311|11474090|FG000|Overall Study|Non-Compliance|1
7261263|NCT00363311|11474091|FG001|Overall Study|Non-Compliance|1
7261264|NCT00363311|11474090|FG000|Overall Study|Participant Refused Biopsy|1
7261265|NCT00363311|11474091|FG001|Overall Study|Participant Refused Biopsy|0
7261266|NCT00363311|11474090|FG000|Overall Study|Prostate Volume/PSA Doubled|1
7261267|NCT00363311|11474091|FG001|Overall Study|Prostate Volume/PSA Doubled|0
7261268|NCT00363311|11474090|FG000|Overall Study|Participant Opted for Treatment|1
7261269|NCT00363311|11474091|FG001|Overall Study|Participant Opted for Treatment|0
7261270|NCT00363311|11474090|FG000|Overall Study|Participant Moved to Another Country|1
7261271|NCT00363311|11474091|FG001|Overall Study|Participant Moved to Another Country|0
7261272|NCT00363311|11474090|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
7261273|NCT00363311|11474091|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
7261274|NCT00363311|11474090|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
7261275|NCT00363311|11474091|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
7261276|NCT00363311|11474090|FG000|Overall Study|Participant Moved to Louisiana|0
7261277|NCT00363311|11474091|FG001|Overall Study|Participant Moved to Louisiana|1
7261278|NCT00363415|11474099|FG000|Overall Study|Progressive Disease|196
7261279|NCT00363415|11474100|FG001|Overall Study|Progressive Disease|107
7261280|NCT00363415|11474099|FG000|Overall Study|Sponsor Decision|67
7261281|NCT00363415|11474100|FG001|Overall Study|Sponsor Decision|31
7261282|NCT00363415|11474099|FG000|Overall Study|Death|32
7261283|NCT00363415|11474100|FG001|Overall Study|Death|29
7261284|NCT00363415|11474099|FG000|Overall Study|Adverse Event|24
7261285|NCT00363415|11474100|FG001|Overall Study|Adverse Event|15
7261286|NCT00363415|11474099|FG000|Overall Study|Physician Decision|18
7261287|NCT00363415|11474100|FG001|Overall Study|Physician Decision|35
7261288|NCT00363415|11474099|FG000|Overall Study|Entry Criteria Not Met|11
7261289|NCT00363415|11474100|FG001|Overall Study|Entry Criteria Not Met|10
7261290|NCT00363415|11474099|FG000|Overall Study|Withdrawal by Subject|9
7261291|NCT00363415|11474100|FG001|Overall Study|Withdrawal by Subject|15
7261292|NCT00363415|11474099|FG000|Overall Study|Lost to Follow-up|3
7261293|NCT00363415|11474100|FG001|Overall Study|Lost to Follow-up|3
7261294|NCT00363415|11474099|FG000|Overall Study|Protocol Violation|1
7261295|NCT00363415|11474100|FG001|Overall Study|Protocol Violation|4
7261296|NCT00363467|11474106|FG000|Overall Study|Physician Decision|1
7261297|NCT00363480|11474110|FG000|Overall Study|Criteria for treatment period not fulfil|1
7261298|NCT00363480|11474110|FG000|Overall Study|Adverse Event|4
7261299|NCT00363480|11474110|FG000|Overall Study|Lost to Follow-up|5
7261300|NCT00363480|11474110|FG000|Overall Study|Withdrawal by Subject|5
7261301|NCT00363480|11474110|FG000|Overall Study|Non-compliance of subject|1
7261302|NCT00363480|11474110|FG000|Overall Study|Participant discontinued on its own|1
7261303|NCT00363545|11474116|FG000|Overall Study|Serious Adverse Event|0
7261304|NCT00363545|11474117|FG001|Overall Study|Serious Adverse Event|1
7261305|NCT00363545|11474116|FG000|Overall Study|Withdrawal by Subject|12
7261306|NCT00363545|11474117|FG001|Overall Study|Withdrawal by Subject|15
7261307|NCT00363545|11474116|FG000|Overall Study|Migrated/moved from study area|3
7261308|NCT00363545|11474117|FG001|Overall Study|Migrated/moved from study area|6
7261309|NCT00363545|11474116|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
7261310|NCT00363545|11474117|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
7261311|NCT00363545|11474116|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
7543967|NCT02810340|11897074|FG000|Overall Study|Incarceration|0
7543968|NCT02810340|11897075|FG001|Overall Study|Incarceration|1
7543969|NCT02810340|11897076|FG002|Overall Study|Incarceration|0
7261312|NCT00363545|11474117|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
7261313|NCT00363545|11474116|FG000|Overall Study|Others|1
7261314|NCT00363545|11474117|FG001|Overall Study|Others|0
7261315|NCT00363649|11474125|FG000|Overall Study|Withdrawal by Subject|1
7543970|NCT02810340|11897074|FG000|Overall Study|Lost to Follow-up|0
7261316|NCT00363649|11474126|FG001|Overall Study|Withdrawal by Subject|1
7261317|NCT00363649|11474125|FG000|Overall Study|Adverse Event|6
7261318|NCT00363649|11474126|FG001|Overall Study|Adverse Event|0
7387946|NCT01217073|11646674|FG000|Extension Period|Contraindication to study medication|0
7387947|NCT01217073|11646675|FG001|Extension Period|Contraindication to study medication|0
7387948|NCT01217073|11646676|FG002|Extension Period|Contraindication to study medication|0
7387949|NCT01217073|11646677|FG003|Extension Period|Contraindication to study medication|0
7387950|NCT01217073|11646678|FG004|Extension Period|Contraindication to study medication|0
7387951|NCT01217073|11646679|FG005|Extension Period|Contraindication to study medication|0
7387952|NCT01217073|11646680|FG006|Extension Period|Contraindication to study medication|1
7387953|NCT01217073|11646681|FG007|Extension Period|Contraindication to study medication|0
7387954|NCT01217073|11646674|FG000|Extension Period|Creatinine/eGFR|0
7387955|NCT01217073|11646675|FG001|Extension Period|Creatinine/eGFR|0
7387956|NCT01217073|11646676|FG002|Extension Period|Creatinine/eGFR|0
7387957|NCT01217073|11646677|FG003|Extension Period|Creatinine/eGFR|0
7387958|NCT01217073|11646678|FG004|Extension Period|Creatinine/eGFR|0
7387959|NCT01217073|11646679|FG005|Extension Period|Creatinine/eGFR|0
7387960|NCT01217073|11646680|FG006|Extension Period|Creatinine/eGFR|11
7387961|NCT01217073|11646681|FG007|Extension Period|Creatinine/eGFR|1
7387962|NCT01217073|11646674|FG000|Extension Period|Death|0
7543971|NCT02810340|11897075|FG001|Overall Study|Lost to Follow-up|0
7543972|NCT02810340|11897076|FG002|Overall Study|Lost to Follow-up|1
7261319|NCT00363766|11474139|FG000|Overall Study|Progressive Disease|15
7261320|NCT00363766|11474140|FG001|Overall Study|Progressive Disease|9
7543973|NCT02810392|11897086|FG000|Overall Study|Subject too ill to continue|1
7543974|NCT02810392|11897087|FG001|Overall Study|Subject too ill to continue|0
7543975|NCT02810392|11897086|FG000|Overall Study|COVID 19 research restrictions|0
7543976|NCT02810392|11897087|FG001|Overall Study|COVID 19 research restrictions|1
7543977|NCT02810951|11897114|FG000|Overall Study|Adverse Event|1
7543978|NCT02810964|11897122|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
7543979|NCT02810964|11897123|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
7543980|NCT02810964|11897122|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
7543981|NCT02810964|11897123|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
7543982|NCT02810964|11897122|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
7543983|NCT02810964|11897123|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
7543984|NCT02810964|11897122|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
7543985|NCT02810964|11897123|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
7543986|NCT02811159|11897129|FG000|Treatment Course 1|Lost to Follow-up|1
7543987|NCT02811640|11897156|FG000|Overall Study|Technology malfunction|2
7552341|NCT02988115|11912405|FG001|Overall Study|Withdrawal by Subject|1
7552342|NCT02988115|11912404|FG000|Overall Study|Withdrawn by Mistake|1
7552343|NCT02988115|11912405|FG001|Overall Study|Withdrawn by Mistake|0
7552344|NCT02988115|11912404|FG000|Overall Study|Lost to Follow-up|1
7552345|NCT02988115|11912405|FG001|Overall Study|Lost to Follow-up|0
7552346|NCT02988219|11912422|FG000|Overall Study|Lack of Efficacy|1
7552347|NCT02988219|11912423|FG001|Overall Study|Lack of Efficacy|1
7552348|NCT02988219|11912422|FG000|Overall Study|Withdrawal by Subject|0
7552349|NCT02988219|11912423|FG001|Overall Study|Withdrawal by Subject|2
7552350|NCT02988622|11912438|FG000|Overall Study|Lost to Follow-up|17
7552351|NCT02989168|11912468|FG000|Overall Study|Withdrawal by Subject|2
7552352|NCT02989168|11912469|FG001|Overall Study|Withdrawal by Subject|0
7552353|NCT02989168|11912468|FG000|Overall Study|Physician Decision|0
7552354|NCT02989168|11912469|FG001|Overall Study|Physician Decision|1
7552355|NCT02989168|11912468|FG000|Overall Study|Adverse Event|1
7552356|NCT02989168|11912469|FG001|Overall Study|Adverse Event|2
7552357|NCT02989168|11912468|FG000|Overall Study|Sponsor stopped study.|1
7552358|NCT02989168|11912469|FG001|Overall Study|Sponsor stopped study.|0
7576558|NCT04315298|11963206|FG006|Overall Study|Death|9
7576559|NCT04315298|11963207|FG007|Overall Study|Death|12
7576560|NCT04315298|11963208|FG008|Overall Study|Death|21
7576561|NCT04315298|11963209|FG009|Overall Study|Death|16
7576562|NCT04315298|11963210|FG010|Overall Study|Death|40
7576563|NCT04315298|11963211|FG011|Overall Study|Death|40
7576564|NCT04315298|11963212|FG012|Overall Study|Death|3
7576565|NCT04315298|11963213|FG013|Overall Study|Death|4
7576566|NCT04315298|11963214|FG014|Overall Study|Death|6
7576567|NCT04315298|11963215|FG015|Overall Study|Death|4
7576568|NCT04315298|11963216|FG016|Overall Study|Death|3
7576569|NCT04315298|11963217|FG017|Overall Study|Death|1
7576570|NCT04315298|11963218|FG018|Overall Study|Death|0
7576571|NCT04308239|11963328|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
7576572|NCT04308239|11963329|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
7576573|NCT04308239|11963328|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
7576574|NCT04308239|11963329|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
7576575|NCT04308239|11963328|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
7576576|NCT04308239|11963329|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
7576577|NCT04308239|11963328|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
7576578|NCT04308239|11963329|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
7576579|NCT04308668|11963341|FG000|Overall Study|Lost to Follow-up|32
7576580|NCT04308668|11963342|FG001|Overall Study|Lost to Follow-up|38
7576581|NCT04308668|11963341|FG000|Overall Study|Withdrawal by Subject|4
7576582|NCT04308668|11963342|FG001|Overall Study|Withdrawal by Subject|4
7576583|NCT04307940|11963351|FG000|Overall Study|Adverse Event|1
7576584|NCT04307940|11963352|FG001|Overall Study|Adverse Event|0
7576585|NCT04307940|11963353|FG002|Overall Study|Adverse Event|0
7576586|NCT04307940|11963351|FG000|Overall Study|Withdrawal by Subject|2
7576587|NCT04307940|11963352|FG001|Overall Study|Withdrawal by Subject|3
7576588|NCT04307940|11963353|FG002|Overall Study|Withdrawal by Subject|1
7576589|NCT04307940|11963351|FG000|Overall Study|Lost to Follow-up|2
7576590|NCT04307940|11963352|FG001|Overall Study|Lost to Follow-up|0
7261321|NCT00363766|11474139|FG000|Overall Study|Adverse Event|10
7261322|NCT00363766|11474140|FG001|Overall Study|Adverse Event|2
7261323|NCT00363766|11474139|FG000|Overall Study|Disease Related Death|1
7261324|NCT00363766|11474140|FG001|Overall Study|Disease Related Death|3
7261325|NCT00363766|11474139|FG000|Overall Study|Not Disease Related Death|3
7261326|NCT00363766|11474140|FG001|Overall Study|Not Disease Related Death|4
7261327|NCT00363766|11474139|FG000|Overall Study|Withdrawal by Subject|2
7261328|NCT00363766|11474140|FG001|Overall Study|Withdrawal by Subject|0
7261329|NCT00363766|11474139|FG000|Overall Study|Physician Decision|1
7261330|NCT00363766|11474140|FG001|Overall Study|Physician Decision|2
7261331|NCT00363896|11474170|FG000|Overall Study|Withdrawal by Subject|29
7261332|NCT00363896|11474171|FG001|Overall Study|Withdrawal by Subject|16
7261333|NCT00363896|11474170|FG000|Overall Study|Adverse Event|24
7261334|NCT00363896|11474171|FG001|Overall Study|Adverse Event|13
7261335|NCT00363896|11474170|FG000|Overall Study|COPD exacerbation|13
7261336|NCT00363896|11474171|FG001|Overall Study|COPD exacerbation|7
7261337|NCT00363896|11474170|FG000|Overall Study|Lack of Efficacy|12
7261338|NCT00363896|11474171|FG001|Overall Study|Lack of Efficacy|8
7261339|NCT00363896|11474170|FG000|Overall Study|Protocol Violation|6
7261340|NCT00363896|11474171|FG001|Overall Study|Protocol Violation|1
7261341|NCT00363896|11474170|FG000|Overall Study|Lost to Follow-up|3
7261342|NCT00363896|11474171|FG001|Overall Study|Lost to Follow-up|0
7261343|NCT00363896|11474170|FG000|Overall Study|Non-fulfilment of entry criteria|1
7261344|NCT00363896|11474171|FG001|Overall Study|Non-fulfilment of entry criteria|0
7261345|NCT00363896|11474170|FG000|Overall Study|Other|1
7261346|NCT00363896|11474171|FG001|Overall Study|Other|2
7543988|NCT02812186|11897187|FG000|Period 1|Post randomization screen failure|5
7543989|NCT02812186|11897188|FG001|Period 1|Post randomization screen failure|9
7543990|NCT02812186|11897187|FG000|Period 1|nonevaluable data sets|6
7543991|NCT02812186|11897188|FG001|Period 1|nonevaluable data sets|6
7543992|NCT02813421|11897235|FG000|Overall Study|Withdrawal by Subject|1
7543993|NCT02813421|11897236|FG001|Overall Study|Withdrawal by Subject|2
7543994|NCT02813421|11897235|FG000|Overall Study|Lost to Follow-up|1
7543995|NCT02813421|11897236|FG001|Overall Study|Lost to Follow-up|1
7543996|NCT02813577|11897255|FG000|Overall Study|Study terminated|4
7543997|NCT02813681|11897262|FG000|Overall Study|Physician Decision|5
7543998|NCT02813681|11897263|FG001|Overall Study|Physician Decision|5
7543999|NCT02813681|11897264|FG002|Overall Study|Physician Decision|0
7544000|NCT02813681|11897262|FG000|Overall Study|Lost to Follow-up|0
7544001|NCT02813681|11897263|FG001|Overall Study|Lost to Follow-up|1
7544002|NCT02813681|11897264|FG002|Overall Study|Lost to Follow-up|0
7544003|NCT02813694|11897276|FG000|Overall Study|Physician Decision|0
7544004|NCT02813694|11897277|FG001|Overall Study|Physician Decision|1
7544005|NCT02813694|11897276|FG000|Overall Study|Withdrawal by Subject|10
7544006|NCT02813694|11897277|FG001|Overall Study|Withdrawal by Subject|9
7544007|NCT02813694|11897276|FG000|Overall Study|Lost to Follow-up|1
7544008|NCT02813694|11897277|FG001|Overall Study|Lost to Follow-up|1
7544009|NCT02813694|11897276|FG000|Overall Study|Death|3
7544010|NCT02813694|11897277|FG001|Overall Study|Death|3
7544011|NCT02813694|11897276|FG000|Overall Study|Randomized- did not receive study drug|2
7576591|NCT04307940|11963353|FG002|Overall Study|Lost to Follow-up|1
7544012|NCT02813694|11897277|FG001|Overall Study|Randomized- did not receive study drug|0
7544013|NCT02813694|11897276|FG000|Overall Study|Patient hospitalized|1
7576592|NCT04302545|11963363|FG000|Overall Study|Lost to Follow-up|3
7576593|NCT04302545|11963364|FG001|Overall Study|Lost to Follow-up|4
7576594|NCT04297241|11963386|FG000|Overall Study|Withdrawal by Subject|1
7576595|NCT04297241|11963386|FG000|Overall Study|Adverse Event|1
7576596|NCT04297241|11963386|FG000|Overall Study|Physician Decision|3
7576597|NCT04295356|11963415|FG000|Overall Study|Physician Decision|1
7576598|NCT04295356|11963416|FG001|Overall Study|Physician Decision|0
7576599|NCT04295356|11963415|FG000|Overall Study|Lost to Follow-up|0
7576600|NCT04295356|11963416|FG001|Overall Study|Lost to Follow-up|3
7576601|NCT04295356|11963415|FG000|Overall Study|Protocol Violation|0
7576602|NCT04295356|11963416|FG001|Overall Study|Protocol Violation|1
7261363|NCT00364130|11474195|FG000|Intervention Period|Lost to Follow-up|4
7261364|NCT00364130|11474196|FG001|Intervention Period|Lost to Follow-up|3
7261365|NCT00364130|11474195|FG000|Intervention Period|Pregnancy|1
7261366|NCT00364130|11474196|FG001|Intervention Period|Pregnancy|0
7261367|NCT00364130|11474195|FG000|Intervention Period|Withdrawal by Subject|4
7261368|NCT00364130|11474196|FG001|Intervention Period|Withdrawal by Subject|5
7261369|NCT00364130|11474195|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
7261370|NCT00364130|11474196|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
7261371|NCT00364156|11474206|FG000|Overall Study|Withdrawal by Subject|73
7261372|NCT00364156|11474207|FG001|Overall Study|Withdrawal by Subject|80
7261373|NCT00364156|11474206|FG000|Overall Study|Protocol Violation|6
7261374|NCT00364156|11474207|FG001|Overall Study|Protocol Violation|1
7261375|NCT00364182|11474216|FG000|First Intervention|Secondary prophylaxis|1
7261376|NCT00364182|11474217|FG001|First Intervention|Secondary prophylaxis|0
7261377|NCT00364182|11474218|FG002|First Intervention|Secondary prophylaxis|0
7261378|NCT00364182|11474216|FG000|First Intervention|Withdrawal by Subject|2
7261379|NCT00364182|11474217|FG001|First Intervention|Withdrawal by Subject|0
7261380|NCT00364182|11474218|FG002|First Intervention|Withdrawal by Subject|0
7261381|NCT00364182|11474216|FG000|Second Intervention|non-compliance|0
7261382|NCT00364182|11474217|FG001|Second Intervention|non-compliance|1
7261383|NCT00364182|11474218|FG002|Second Intervention|non-compliance|1
7261384|NCT00364182|11474216|FG000|Second Intervention|Protocol Violation|0
7261385|NCT00364182|11474217|FG001|Second Intervention|Protocol Violation|1
7261386|NCT00364182|11474218|FG002|Second Intervention|Protocol Violation|0
7261387|NCT00364182|11474216|FG000|Second Intervention|Adverse Event|0
7261388|NCT00364182|11474217|FG001|Second Intervention|Adverse Event|0
7261389|NCT00364182|11474218|FG002|Second Intervention|Adverse Event|1
7261390|NCT00364182|11474216|FG000|Third Intervention|non-compliance|0
7261391|NCT00364182|11474217|FG001|Third Intervention|non-compliance|1
7261392|NCT00364182|11474218|FG002|Third Intervention|non-compliance|0
7261393|NCT00364182|11474216|FG000|Third Intervention|Lost to Follow-up|0
7261394|NCT00364182|11474217|FG001|Third Intervention|Lost to Follow-up|0
7261395|NCT00364182|11474218|FG002|Third Intervention|Lost to Follow-up|1
7261396|NCT00364286|11474228|FG000|Overall Study|Withdrawal by Subject|1
7261397|NCT00364286|11474228|FG000|Overall Study|Adverse Event|2
7261398|NCT00364351|11474234|FG000|Overall Study|Adverse Event|90
7261399|NCT00364351|11474235|FG001|Overall Study|Adverse Event|44
7261400|NCT00364351|11474234|FG000|Overall Study|Condition under investigation worsened|469
7261401|NCT00364351|11474235|FG001|Overall Study|Condition under investigation worsened|497
7261402|NCT00364351|11474234|FG000|Overall Study|Prohibited concomitant medication|0
7261403|NCT00364351|11474235|FG001|Overall Study|Prohibited concomitant medication|2
7261404|NCT00364351|11474234|FG000|Overall Study|Lost to Follow-up|1
7261405|NCT00364351|11474235|FG001|Overall Study|Lost to Follow-up|1
7261406|NCT00364351|11474234|FG000|Overall Study|Withdrawal by Subject|30
7261407|NCT00364351|11474235|FG001|Overall Study|Withdrawal by Subject|29
7261408|NCT00364351|11474234|FG000|Overall Study|Incorrect enrollment|1
7261409|NCT00364351|11474235|FG001|Overall Study|Incorrect enrollment|1
7261410|NCT00364351|11474234|FG000|Overall Study|Sponsor decision|1
7261411|NCT00364351|11474235|FG001|Overall Study|Sponsor decision|0
7261412|NCT00364351|11474234|FG000|Overall Study|Poor treatment compliance|0
7261413|NCT00364351|11474235|FG001|Overall Study|Poor treatment compliance|3
7544014|NCT02813694|11897277|FG001|Overall Study|Patient hospitalized|0
7261414|NCT00364351|11474234|FG000|Overall Study|Investigator error|0
7261415|NCT00364351|11474235|FG001|Overall Study|Investigator error|2
7261416|NCT00364351|11474234|FG000|Overall Study|Patient could not travel to site|0
7261417|NCT00364351|11474235|FG001|Overall Study|Patient could not travel to site|1
7261418|NCT00364351|11474234|FG000|Overall Study|Randomised treatment not started|0
7261419|NCT00364351|11474235|FG001|Overall Study|Randomised treatment not started|3
7261420|NCT00364533|11474255|FG000|Overall Study|Adverse Event|8
7261421|NCT00364533|11474256|FG001|Overall Study|Adverse Event|7
7261422|NCT00364533|11474257|FG002|Overall Study|Adverse Event|15
7261423|NCT00364533|11474258|FG003|Overall Study|Adverse Event|5
7261424|NCT00364533|11474259|FG004|Overall Study|Adverse Event|2
7261425|NCT00364533|11474255|FG000|Overall Study|Withdrawal by Subject|4
7261426|NCT00364533|11474256|FG001|Overall Study|Withdrawal by Subject|8
7261427|NCT00364533|11474257|FG002|Overall Study|Withdrawal by Subject|6
7261428|NCT00364533|11474258|FG003|Overall Study|Withdrawal by Subject|6
7261429|NCT00364533|11474259|FG004|Overall Study|Withdrawal by Subject|6
7261430|NCT00364533|11474255|FG000|Overall Study|Lack of Efficacy|22
7261431|NCT00364533|11474256|FG001|Overall Study|Lack of Efficacy|22
7261432|NCT00364533|11474257|FG002|Overall Study|Lack of Efficacy|21
7261433|NCT00364533|11474258|FG003|Overall Study|Lack of Efficacy|17
7261434|NCT00364533|11474259|FG004|Overall Study|Lack of Efficacy|42
7261435|NCT00364533|11474255|FG000|Overall Study|Subject discharged from hospital|4
7261436|NCT00364533|11474256|FG001|Overall Study|Subject discharged from hospital|1
7261437|NCT00364533|11474257|FG002|Overall Study|Subject discharged from hospital|2
7261438|NCT00364533|11474258|FG003|Overall Study|Subject discharged from hospital|3
7261439|NCT00364533|11474259|FG004|Overall Study|Subject discharged from hospital|1
7261440|NCT00364533|11474255|FG000|Overall Study|Variations in drug compliance|2
7261441|NCT00364533|11474256|FG001|Overall Study|Variations in drug compliance|1
7261442|NCT00364533|11474257|FG002|Overall Study|Variations in drug compliance|1
7261443|NCT00364533|11474258|FG003|Overall Study|Variations in drug compliance|0
7261444|NCT00364533|11474259|FG004|Overall Study|Variations in drug compliance|0
7261445|NCT00364533|11474255|FG000|Overall Study|Non-compliance|1
7261446|NCT00364533|11474256|FG001|Overall Study|Non-compliance|0
7261447|NCT00364533|11474257|FG002|Overall Study|Non-compliance|0
7261448|NCT00364533|11474258|FG003|Overall Study|Non-compliance|0
7261449|NCT00364533|11474259|FG004|Overall Study|Non-compliance|0
7261450|NCT00364533|11474255|FG000|Overall Study|Protocol Violation|1
7261451|NCT00364533|11474256|FG001|Overall Study|Protocol Violation|1
7261452|NCT00364533|11474257|FG002|Overall Study|Protocol Violation|0
7261453|NCT00364533|11474258|FG003|Overall Study|Protocol Violation|0
7261454|NCT00364533|11474259|FG004|Overall Study|Protocol Violation|0
7261455|NCT00364611|11474273|FG000|Overall Study|Did not receive study medication|0
7261456|NCT00364611|11474274|FG001|Overall Study|Did not receive study medication|1
7261457|NCT00364611|11474273|FG000|Overall Study|Adverse Event|7
7261458|NCT00364611|11474274|FG001|Overall Study|Adverse Event|4
7261459|NCT00364611|11474273|FG000|Overall Study|Participant's Request|3
7261460|NCT00364611|11474274|FG001|Overall Study|Participant's Request|4
7261461|NCT00364611|11474273|FG000|Overall Study|Disease Progression|38
7261462|NCT00364611|11474274|FG001|Overall Study|Disease Progression|8
7261463|NCT00364611|11474273|FG000|Overall Study|Investigator decision|2
7261464|NCT00364611|11474274|FG001|Overall Study|Investigator decision|2
7261465|NCT00364611|11474273|FG000|Overall Study|Found Ineligible|1
7261466|NCT00364611|11474274|FG001|Overall Study|Found Ineligible|0
7261467|NCT00364611|11474273|FG000|Overall Study|Presumed CR on Study|0
7261468|NCT00364611|11474274|FG001|Overall Study|Presumed CR on Study|1
7261469|NCT00364611|11474273|FG000|Overall Study|Receiving Liver Ablation|0
7261470|NCT00364611|11474274|FG001|Overall Study|Receiving Liver Ablation|1
7261471|NCT00364793|11474284|FG000|Overall Study|Adverse Event|2
7261472|NCT00364793|11474285|FG001|Overall Study|Adverse Event|0
7261473|NCT00364793|11474286|FG002|Overall Study|Adverse Event|0
7261474|NCT00364793|11474287|FG003|Overall Study|Adverse Event|0
7261475|NCT00364793|11474284|FG000|Overall Study|Death|1
7261476|NCT00364793|11474285|FG001|Overall Study|Death|0
7261477|NCT00364793|11474286|FG002|Overall Study|Death|1
7261478|NCT00364793|11474287|FG003|Overall Study|Death|0
7261479|NCT00364793|11474284|FG000|Overall Study|Lack of Efficacy|3
7261480|NCT00364793|11474285|FG001|Overall Study|Lack of Efficacy|3
7261481|NCT00364793|11474286|FG002|Overall Study|Lack of Efficacy|1
7261482|NCT00364793|11474287|FG003|Overall Study|Lack of Efficacy|1
7261483|NCT00364793|11474284|FG000|Overall Study|Lost to Follow-up|1
7261484|NCT00364793|11474285|FG001|Overall Study|Lost to Follow-up|0
7261485|NCT00364793|11474286|FG002|Overall Study|Lost to Follow-up|2
7261486|NCT00364793|11474287|FG003|Overall Study|Lost to Follow-up|0
7261487|NCT00364793|11474284|FG000|Overall Study|Poor or non-compliance|1
7261488|NCT00364793|11474285|FG001|Overall Study|Poor or non-compliance|1
7261489|NCT00364793|11474286|FG002|Overall Study|Poor or non-compliance|0
7261490|NCT00364793|11474287|FG003|Overall Study|Poor or non-compliance|1
7261491|NCT00364793|11474284|FG000|Overall Study|No longer meets criteria|0
7261492|NCT00364793|11474285|FG001|Overall Study|No longer meets criteria|0
7261493|NCT00364793|11474286|FG002|Overall Study|No longer meets criteria|0
7261494|NCT00364793|11474287|FG003|Overall Study|No longer meets criteria|1
7261495|NCT00364793|11474284|FG000|Overall Study|Withdrawal by Subject|0
7261496|NCT00364793|11474285|FG001|Overall Study|Withdrawal by Subject|1
7261497|NCT00364793|11474286|FG002|Overall Study|Withdrawal by Subject|0
7261498|NCT00364793|11474287|FG003|Overall Study|Withdrawal by Subject|0
7261499|NCT00364832|11474313|FG000|Core Period|Early Withdrawals|2
7576603|NCT04292535|11963440|FG000|Overall Study|Withdrawal by Subject|0
7261500|NCT00364832|11474314|FG001|Core Period|Early Withdrawals|2
7261501|NCT00364832|11474315|FG002|Core Period|Early Withdrawals|1
7261502|NCT00364832|11474316|FG003|Core Period|Early Withdrawals|1
7261503|NCT00364832|11474317|FG004|Core Period|Early Withdrawals|0
7261504|NCT00364832|11474318|FG005|Core Period|Early Withdrawals|0
7261505|NCT00364832|11474319|FG006|Core Period|Early Withdrawals|4
7261506|NCT00364832|11474320|FG007|Core Period|Early Withdrawals|1
7261507|NCT00364832|11474321|FG008|Core Period|Early Withdrawals|0
7261508|NCT00364832|11474322|FG009|Core Period|Early Withdrawals|0
7261509|NCT00364832|11474323|FG010|Core Period|Early Withdrawals|0
7261510|NCT00364832|11474324|FG011|Core Period|Early Withdrawals|0
7261511|NCT00364832|11474313|FG000|Extension Year 1|Early Withdrawals|0
7261512|NCT00364832|11474314|FG001|Extension Year 1|Early Withdrawals|0
7261513|NCT00364832|11474315|FG002|Extension Year 1|Early Withdrawals|0
7261514|NCT00364832|11474316|FG003|Extension Year 1|Early Withdrawals|0
7261515|NCT00364832|11474317|FG004|Extension Year 1|Early Withdrawals|0
7261516|NCT00364832|11474318|FG005|Extension Year 1|Early Withdrawals|0
7261517|NCT00364832|11474319|FG006|Extension Year 1|Early Withdrawals|0
7261518|NCT00364832|11474320|FG007|Extension Year 1|Early Withdrawals|0
7261519|NCT00364832|11474321|FG008|Extension Year 1|Early Withdrawals|0
7261520|NCT00364832|11474322|FG009|Extension Year 1|Early Withdrawals|4
7261521|NCT00364832|11474323|FG010|Extension Year 1|Early Withdrawals|2
7261522|NCT00364832|11474324|FG011|Extension Year 1|Early Withdrawals|10
7261523|NCT00364832|11474313|FG000|Extension Year 2|Early Withdrawals|0
7261524|NCT00364832|11474314|FG001|Extension Year 2|Early Withdrawals|0
7261525|NCT00364832|11474315|FG002|Extension Year 2|Early Withdrawals|0
7261526|NCT00364832|11474316|FG003|Extension Year 2|Early Withdrawals|0
7261527|NCT00364832|11474317|FG004|Extension Year 2|Early Withdrawals|0
7261528|NCT00364832|11474318|FG005|Extension Year 2|Early Withdrawals|0
7261529|NCT00364832|11474319|FG006|Extension Year 2|Early Withdrawals|0
7261530|NCT00364832|11474320|FG007|Extension Year 2|Early Withdrawals|0
7261531|NCT00364832|11474321|FG008|Extension Year 2|Early Withdrawals|0
7261532|NCT00364832|11474322|FG009|Extension Year 2|Early Withdrawals|5
7261533|NCT00364832|11474323|FG010|Extension Year 2|Early Withdrawals|5
7261534|NCT00364832|11474324|FG011|Extension Year 2|Early Withdrawals|3
7261535|NCT00364845|11474343|FG000|Overall Study|Adverse Event|1
7261536|NCT00364845|11474344|FG001|Overall Study|Adverse Event|0
7261537|NCT00364845|11474343|FG000|Overall Study|Withdrawal by Subject|2
7261538|NCT00364845|11474344|FG001|Overall Study|Withdrawal by Subject|1
7261539|NCT00364845|11474343|FG000|Overall Study|Physician Decision|8
7261540|NCT00364845|11474344|FG001|Overall Study|Physician Decision|8
7261541|NCT00364845|11474343|FG000|Overall Study|Lost to Follow-up|0
7261542|NCT00364845|11474344|FG001|Overall Study|Lost to Follow-up|1
7261543|NCT00364845|11474343|FG000|Overall Study|Death|0
7261544|NCT00364845|11474344|FG001|Overall Study|Death|1
7261545|NCT00364858|11474352|FG000|Overall Study|Adverse Event|1
7261546|NCT00364858|11474353|FG001|Overall Study|Adverse Event|5
7261547|NCT00364858|11474352|FG000|Overall Study|Withdrawal by Subject|1
7261548|NCT00364858|11474353|FG001|Overall Study|Withdrawal by Subject|1
7261549|NCT00364858|11474352|FG000|Overall Study|Pregnancy|1
7261550|NCT00364858|11474353|FG001|Overall Study|Pregnancy|1
7261551|NCT00364858|11474352|FG000|Overall Study|Clinical failure|2
7261552|NCT00364858|11474353|FG001|Overall Study|Clinical failure|13
7261553|NCT00364858|11474352|FG000|Overall Study|Discontinuation at baseline|1
7261554|NCT00364858|11474353|FG001|Overall Study|Discontinuation at baseline|0
7261555|NCT00364858|11474352|FG000|Overall Study|Non-compliant|1
7261556|NCT00364858|11474353|FG001|Overall Study|Non-compliant|0
7261557|NCT00364858|11474352|FG000|Overall Study|Return to Q2 regimen|0
7261558|NCT00364858|11474353|FG001|Overall Study|Return to Q2 regimen|1
7261559|NCT00364858|11474352|FG000|Overall Study|Clinical baseline issue|0
7261560|NCT00364858|11474353|FG001|Overall Study|Clinical baseline issue|1
7261561|NCT00364923|11474360|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
7261562|NCT00364923|11474360|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
7261563|NCT00365105|11474379|FG000|Overall Study|Protocol Violation|5
7261564|NCT00365105|11474380|FG001|Overall Study|Protocol Violation|8
7261565|NCT00365300|11474413|FG000|Open-label Phase|Adverse Event|4
7261566|NCT00365300|11474414|FG001|Open-label Phase|Adverse Event|0
7261567|NCT00365300|11474413|FG000|Open-label Phase|Failed to Return|1
7261568|NCT00365300|11474414|FG001|Open-label Phase|Failed to Return|0
7261569|NCT00365300|11474413|FG000|Open-label Phase|Physician Decision|1
7261570|NCT00365300|11474414|FG001|Open-label Phase|Physician Decision|0
7261571|NCT00365300|11474413|FG000|Open-label Phase|Noncompliance|9
7261572|NCT00365300|11474414|FG001|Open-label Phase|Noncompliance|0
7261573|NCT00365300|11474413|FG000|Open-label Phase|Parent/Legal Guardian Request|4
7261574|NCT00365300|11474414|FG001|Open-label Phase|Parent/Legal Guardian Request|0
7261575|NCT00365300|11474413|FG000|Open-label Phase|Protocol Violation|1
7261576|NCT00365300|11474414|FG001|Open-label Phase|Protocol Violation|0
7261577|NCT00365300|11474413|FG000|Open-label Phase|Lack of Efficacy|1
7261578|NCT00365300|11474414|FG001|Open-label Phase|Lack of Efficacy|0
7261579|NCT00365300|11474413|FG000|Open-label Phase|Patient skipped open label phase|1
7261580|NCT00365300|11474414|FG001|Open-label Phase|Patient skipped open label phase|0
7261581|NCT00365300|11474413|FG000|Double-blind Phase|Failed to return|1
7261582|NCT00365300|11474414|FG001|Double-blind Phase|Failed to return|0
7261583|NCT00365300|11474413|FG000|Double-blind Phase|Noncompliance|1
7261584|NCT00365300|11474414|FG001|Double-blind Phase|Noncompliance|1
7261585|NCT00365300|11474413|FG000|Double-blind Phase|Withdrawal by Subject|0
7261586|NCT00365300|11474414|FG001|Double-blind Phase|Withdrawal by Subject|1
7261587|NCT00365300|11474413|FG000|Double-blind Phase|Protocol Violation|3
7261588|NCT00365300|11474414|FG001|Double-blind Phase|Protocol Violation|1
7261589|NCT00365300|11474413|FG000|Double-blind Phase|Lack of Efficacy|6
7261590|NCT00365300|11474414|FG001|Double-blind Phase|Lack of Efficacy|6
7261591|NCT00365352|11474426|FG000|Overall Study|Adverse Event|6
7261592|NCT00365352|11474427|FG001|Overall Study|Adverse Event|7
7261593|NCT00365352|11474428|FG002|Overall Study|Adverse Event|8
7261594|NCT00365352|11474426|FG000|Overall Study|Participant Withdrew Consent|8
7261595|NCT00365352|11474427|FG001|Overall Study|Participant Withdrew Consent|3
7261596|NCT00365352|11474428|FG002|Overall Study|Participant Withdrew Consent|4
7261597|NCT00365352|11474426|FG000|Overall Study|Lack of Efficacy|3
7261598|NCT00365352|11474427|FG001|Overall Study|Lack of Efficacy|0
7544015|NCT02814175|11897285|FG000|Part 1|Adverse Event|2
7544016|NCT02814175|11897286|FG001|Part 1|Adverse Event|3
7544017|NCT02814175|11897287|FG002|Part 1|Adverse Event|0
7544018|NCT02814175|11897288|FG003|Part 1|Adverse Event|0
7544019|NCT02814175|11897289|FG004|Part 1|Adverse Event|0
7544020|NCT02814175|11897290|FG005|Part 1|Adverse Event|0
7544021|NCT02814175|11897285|FG000|Part 1|Withdrawal Consent|8
7544022|NCT02814175|11897286|FG001|Part 1|Withdrawal Consent|1
7544023|NCT02814175|11897287|FG002|Part 1|Withdrawal Consent|0
7544024|NCT02814175|11897288|FG003|Part 1|Withdrawal Consent|0
7544025|NCT02814175|11897289|FG004|Part 1|Withdrawal Consent|0
7544026|NCT02814175|11897290|FG005|Part 1|Withdrawal Consent|0
7544027|NCT02814175|11897285|FG000|Part 1|Lost to Follow-up|1
7544028|NCT02814175|11897286|FG001|Part 1|Lost to Follow-up|0
7544029|NCT02814175|11897287|FG002|Part 1|Lost to Follow-up|0
7576604|NCT04292535|11963441|FG001|Overall Study|Withdrawal by Subject|0
7576605|NCT04292535|11963442|FG002|Overall Study|Withdrawal by Subject|0
7576606|NCT04292535|11963443|FG003|Overall Study|Withdrawal by Subject|0
7576607|NCT04292535|11963444|FG004|Overall Study|Withdrawal by Subject|0
7576608|NCT04292535|11963445|FG005|Overall Study|Withdrawal by Subject|0
7576609|NCT04292535|11963446|FG006|Overall Study|Withdrawal by Subject|0
7576610|NCT04292535|11963447|FG007|Overall Study|Withdrawal by Subject|1
7576611|NCT04292535|11963448|FG008|Overall Study|Withdrawal by Subject|0
7576612|NCT04292535|11963449|FG009|Overall Study|Withdrawal by Subject|0
7576613|NCT04292535|11963450|FG010|Overall Study|Withdrawal by Subject|0
7576614|NCT04292535|11963451|FG011|Overall Study|Withdrawal by Subject|0
7576615|NCT04292535|11963452|FG012|Overall Study|Withdrawal by Subject|0
7576616|NCT04292535|11963453|FG013|Overall Study|Withdrawal by Subject|0
7576617|NCT04292535|11963440|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576618|NCT04292535|11963441|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576619|NCT04292535|11963442|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576620|NCT04292535|11963443|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576621|NCT04292535|11963444|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576622|NCT04292535|11963445|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576623|NCT04292535|11963446|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576624|NCT04292535|11963447|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7576625|NCT04292535|11963448|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576626|NCT04292535|11963449|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576627|NCT04292535|11963450|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576628|NCT04292535|11963451|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
7576629|NCT04292535|11963452|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7576630|NCT04292535|11963453|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
7576631|NCT04292535|11963440|FG000|Overall Study|Report of Dizziness|0
7576632|NCT04292535|11963441|FG001|Overall Study|Report of Dizziness|0
7576633|NCT04292535|11963442|FG002|Overall Study|Report of Dizziness|0
7576634|NCT04292535|11963443|FG003|Overall Study|Report of Dizziness|0
7576635|NCT04292535|11963444|FG004|Overall Study|Report of Dizziness|0
7261599|NCT00365352|11474428|FG002|Overall Study|Lack of Efficacy|0
7261600|NCT00365352|11474426|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7544030|NCT02814175|11897288|FG003|Part 1|Lost to Follow-up|0
7544031|NCT02814175|11897289|FG004|Part 1|Lost to Follow-up|0
7544032|NCT02814175|11897290|FG005|Part 1|Lost to Follow-up|0
7544033|NCT02814175|11897285|FG000|Part 1|Lack of Efficacy|1
7544034|NCT02814175|11897286|FG001|Part 1|Lack of Efficacy|2
7576636|NCT04292535|11963445|FG005|Overall Study|Report of Dizziness|0
7261601|NCT00365352|11474427|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
7261602|NCT00365352|11474428|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
7261603|NCT00365352|11474426|FG000|Overall Study|Non-Compliance (after Randomization)|1
7261604|NCT00365352|11474427|FG001|Overall Study|Non-Compliance (after Randomization)|0
7261605|NCT00365352|11474428|FG002|Overall Study|Non-Compliance (after Randomization)|1
7261606|NCT00365352|11474426|FG000|Overall Study|Lost to Follow-up|1
7261607|NCT00365352|11474427|FG001|Overall Study|Lost to Follow-up|1
7261608|NCT00365352|11474428|FG002|Overall Study|Lost to Follow-up|0
7261609|NCT00365352|11474426|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
7261610|NCT00365352|11474427|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
7261611|NCT00365352|11474428|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
7261612|NCT00365365|11474442|FG000|Overall Study|Randomized but not treated|0
7261613|NCT00365365|11474443|FG001|Overall Study|Randomized but not treated|2
7261614|NCT00365365|11474444|FG002|Overall Study|Randomized but not treated|0
7261615|NCT00365365|11474442|FG000|Overall Study|Poor compliance to protocol|0
7261616|NCT00365365|11474443|FG001|Overall Study|Poor compliance to protocol|1
7261617|NCT00365365|11474444|FG002|Overall Study|Poor compliance to protocol|0
7261618|NCT00365365|11474442|FG000|Overall Study|Lost to Follow-up|3
7261619|NCT00365365|11474443|FG001|Overall Study|Lost to Follow-up|3
7261620|NCT00365365|11474444|FG002|Overall Study|Lost to Follow-up|3
7261621|NCT00365365|11474442|FG000|Overall Study|Death|1
7261622|NCT00365365|11474443|FG001|Overall Study|Death|3
7261623|NCT00365365|11474444|FG002|Overall Study|Death|0
7261624|NCT00365365|11474442|FG000|Overall Study|Subject's request|11
7261625|NCT00365365|11474443|FG001|Overall Study|Subject's request|13
7261626|NCT00365365|11474444|FG002|Overall Study|Subject's request|1
7261627|NCT00365365|11474442|FG000|Overall Study|Disease progression/relapse|9
7261628|NCT00365365|11474443|FG001|Overall Study|Disease progression/relapse|6
7261629|NCT00365365|11474444|FG002|Overall Study|Disease progression/relapse|7
7261630|NCT00365365|11474442|FG000|Overall Study|Adverse Event|6
7261631|NCT00365365|11474443|FG001|Overall Study|Adverse Event|6
7261632|NCT00365365|11474444|FG002|Overall Study|Adverse Event|3
7261633|NCT00365365|11474442|FG000|Overall Study|Moved|2
7261634|NCT00365365|11474443|FG001|Overall Study|Moved|0
7261635|NCT00365365|11474444|FG002|Overall Study|Moved|0
7261636|NCT00365365|11474442|FG000|Overall Study|New cancer|1
7261637|NCT00365365|11474443|FG001|Overall Study|New cancer|0
7261638|NCT00365365|11474444|FG002|Overall Study|New cancer|0
7261639|NCT00365365|11474442|FG000|Overall Study|Withdrew consent|1
7261640|NCT00365365|11474443|FG001|Overall Study|Withdrew consent|1
7261641|NCT00365365|11474444|FG002|Overall Study|Withdrew consent|0
7261642|NCT00365365|11474442|FG000|Overall Study|Second malignancy|0
7261643|NCT00365365|11474443|FG001|Overall Study|Second malignancy|1
7261644|NCT00365365|11474444|FG002|Overall Study|Second malignancy|0
7261645|NCT00365365|11474442|FG000|Overall Study|Patient/physician decision|0
7261646|NCT00365365|11474443|FG001|Overall Study|Patient/physician decision|0
7261647|NCT00365365|11474444|FG002|Overall Study|Patient/physician decision|1
7261648|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
7261649|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
7261650|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261651|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
7261652|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
7261653|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
7261654|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
7261655|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
7261656|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
7261657|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
7261658|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
7261659|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
7261660|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
7261661|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
7261662|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
7261663|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
7261664|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
7261665|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
7261666|NCT00365378|11474454|FG000|Vaccination (Day 1 to Month 7)|Other|17
7261667|NCT00365378|11474455|FG001|Vaccination (Day 1 to Month 7)|Other|9
7261668|NCT00365378|11474456|FG002|Vaccination (Day 1 to Month 7)|Other|0
7261669|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
7261670|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
7261671|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
7261672|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
7261673|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
7261674|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
7261675|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7261676|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
7261677|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
7576637|NCT04292535|11963446|FG006|Overall Study|Report of Dizziness|0
7576638|NCT04292535|11963447|FG007|Overall Study|Report of Dizziness|0
7576639|NCT04292535|11963448|FG008|Overall Study|Report of Dizziness|0
7576640|NCT04292535|11963449|FG009|Overall Study|Report of Dizziness|0
7576641|NCT04292535|11963450|FG010|Overall Study|Report of Dizziness|0
7576642|NCT04292535|11963451|FG011|Overall Study|Report of Dizziness|0
7576643|NCT04292535|11963452|FG012|Overall Study|Report of Dizziness|0
7576644|NCT04292535|11963453|FG013|Overall Study|Report of Dizziness|1
7576645|NCT04292535|11963440|FG000|Overall Study|Equipment Failure|0
7576646|NCT04292535|11963441|FG001|Overall Study|Equipment Failure|0
7261678|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
7261679|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
7261680|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
7261681|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
7576647|NCT04292535|11963442|FG002|Overall Study|Equipment Failure|0
7576648|NCT04292535|11963443|FG003|Overall Study|Equipment Failure|0
7261682|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
7261683|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
7261684|NCT00365378|11474454|FG000|Follow-up (Month 7 Though Month 48)|Other|11
7261685|NCT00365378|11474455|FG001|Follow-up (Month 7 Though Month 48)|Other|21
7261686|NCT00365378|11474456|FG002|Follow-up (Month 7 Though Month 48)|Other|0
7261687|NCT00365378|11474454|FG000|Extension|Adverse Event|0
7261688|NCT00365378|11474455|FG001|Extension|Adverse Event|0
7261689|NCT00365378|11474456|FG002|Extension|Adverse Event|1
7261690|NCT00365378|11474454|FG000|Extension|Moved|0
7261691|NCT00365378|11474455|FG001|Extension|Moved|0
7544035|NCT02814175|11897287|FG002|Part 1|Lack of Efficacy|0
7544036|NCT02814175|11897288|FG003|Part 1|Lack of Efficacy|0
7544037|NCT02814175|11897289|FG004|Part 1|Lack of Efficacy|0
7544038|NCT02814175|11897290|FG005|Part 1|Lack of Efficacy|0
7544039|NCT02814175|11897285|FG000|Part 2|Adverse Event|0
7544040|NCT02814175|11897286|FG001|Part 2|Adverse Event|0
7544041|NCT02814175|11897287|FG002|Part 2|Adverse Event|0
7544042|NCT02814175|11897288|FG003|Part 2|Adverse Event|1
7544043|NCT02814175|11897289|FG004|Part 2|Adverse Event|1
7544044|NCT02814175|11897290|FG005|Part 2|Adverse Event|2
7544045|NCT02814175|11897285|FG000|Part 2|Withdrawal Consent|0
7544046|NCT02814175|11897286|FG001|Part 2|Withdrawal Consent|0
7544047|NCT02814175|11897287|FG002|Part 2|Withdrawal Consent|0
7544048|NCT02814175|11897288|FG003|Part 2|Withdrawal Consent|2
7544049|NCT02814175|11897289|FG004|Part 2|Withdrawal Consent|1
7544050|NCT02814175|11897290|FG005|Part 2|Withdrawal Consent|1
7544051|NCT02814175|11897285|FG000|Part 2|Lost to Follow-up|0
7544052|NCT02814175|11897286|FG001|Part 2|Lost to Follow-up|0
7576649|NCT04292535|11963444|FG004|Overall Study|Equipment Failure|0
7576650|NCT04292535|11963445|FG005|Overall Study|Equipment Failure|0
7261692|NCT00365378|11474456|FG002|Extension|Moved|8
7544053|NCT02814175|11897287|FG002|Part 2|Lost to Follow-up|0
7544054|NCT02814175|11897288|FG003|Part 2|Lost to Follow-up|1
7576651|NCT04292535|11963446|FG006|Overall Study|Equipment Failure|0
7576652|NCT04292535|11963447|FG007|Overall Study|Equipment Failure|0
7261693|NCT00365378|11474454|FG000|Extension|Lost to Follow-up|0
7261694|NCT00365378|11474455|FG001|Extension|Lost to Follow-up|0
7261695|NCT00365378|11474456|FG002|Extension|Lost to Follow-up|57
7261696|NCT00365378|11474454|FG000|Extension|Protocol Violation|0
7261697|NCT00365378|11474455|FG001|Extension|Protocol Violation|0
7261698|NCT00365378|11474456|FG002|Extension|Protocol Violation|2
7261699|NCT00365378|11474454|FG000|Extension|Withdrawal by Subject|0
7261700|NCT00365378|11474455|FG001|Extension|Withdrawal by Subject|0
7261701|NCT00365378|11474456|FG002|Extension|Withdrawal by Subject|98
7261702|NCT00365378|11474454|FG000|Extension|Other|0
7261703|NCT00365378|11474455|FG001|Extension|Other|0
7261704|NCT00365378|11474456|FG002|Extension|Other|31
7261705|NCT00365456|11474472|FG000|Trial Period I (12 Months)|Adverse Event|84
7261706|NCT00365456|11474473|FG001|Trial Period I (12 Months)|Adverse Event|0
7261707|NCT00365456|11474472|FG000|Trial Period I (12 Months)|Non-compliance|3
7261708|NCT00365456|11474473|FG001|Trial Period I (12 Months)|Non-compliance|0
7261709|NCT00365456|11474472|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
7261710|NCT00365456|11474473|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
7261711|NCT00365456|11474472|FG000|Trial Period I (12 Months)|Other|11
7261712|NCT00365456|11474473|FG001|Trial Period I (12 Months)|Other|0
7261713|NCT00365456|11474472|FG000|Trial Period II (12 Months)|Adverse Event|0
7261714|NCT00365456|11474473|FG001|Trial Period II (12 Months)|Adverse Event|6
7261715|NCT00365456|11474472|FG000|Trial Period II (12 Months)|Non-compliance|0
7261716|NCT00365456|11474473|FG001|Trial Period II (12 Months)|Non-compliance|2
7261717|NCT00365456|11474472|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
7261718|NCT00365456|11474473|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
7261719|NCT00365456|11474472|FG000|Trial Period II (12 Months)|Other|0
7261720|NCT00365456|11474473|FG001|Trial Period II (12 Months)|Other|1
7261721|NCT00365456|11474472|FG000|Trial Period III (12 Months)|Adverse Event|13
7261722|NCT00365456|11474473|FG001|Trial Period III (12 Months)|Adverse Event|3
7261723|NCT00365456|11474472|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
7261724|NCT00365456|11474473|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
7261725|NCT00365456|11474472|FG000|Trial Period III (12 Months)|Other|1
7261726|NCT00365456|11474473|FG001|Trial Period III (12 Months)|Other|1
7261727|NCT00365508|11474481|FG000|Overall Study|Lost to Follow-up|139
7261728|NCT00365508|11474482|FG001|Overall Study|Lost to Follow-up|154
7261729|NCT00365547|11474488|FG000|Overall Study|Insurance did not cover Avastin|1
7261730|NCT00365547|11474488|FG000|Overall Study|Screen failure|1
7261731|NCT00365547|11474488|FG000|Overall Study|Withdrawal by Subject|1
7261732|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
7261733|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
7261734|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261735|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261736|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261737|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261738|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
7261739|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
7261740|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
7261741|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
7261742|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
7261743|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
7261744|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
7261745|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
7261746|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7261747|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7261748|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
7261749|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
7261750|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7261751|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7261752|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
7261753|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Other|0
7261754|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Other|1
7261755|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Other|0
7261756|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Other|0
7261757|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Other|0
7261758|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Other|0
7261759|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Other|0
7261760|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
7261761|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
7261762|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
7261763|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
7261764|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
7261765|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
7261766|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
7261767|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
7261768|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
7261769|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
7261770|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
7261771|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
7261772|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
7261773|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
7261774|NCT00365716|11474504|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7261775|NCT00365716|11474505|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
7261776|NCT00365716|11474506|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
7261777|NCT00365716|11474507|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
7261778|NCT00365716|11474508|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
7261779|NCT00365716|11474509|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7261780|NCT00365716|11474510|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
7261781|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
7261782|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7261783|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7261784|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
7261785|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
7261786|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7261787|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
7261788|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
7261789|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
7261790|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
7261791|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
7261792|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
7261793|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7261794|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
7261795|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
7261796|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7261797|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
7261798|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
7261799|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7261800|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7261801|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
7261802|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
7261803|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7261804|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7261805|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7261806|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
7261807|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7261808|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
7261809|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7261810|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7261811|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
7261812|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7261813|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7261814|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7576653|NCT04292535|11963448|FG008|Overall Study|Equipment Failure|0
7576654|NCT04292535|11963449|FG009|Overall Study|Equipment Failure|0
7576655|NCT04292535|11963450|FG010|Overall Study|Equipment Failure|0
7576656|NCT04292535|11963451|FG011|Overall Study|Equipment Failure|1
7576657|NCT04292535|11963452|FG012|Overall Study|Equipment Failure|0
7576658|NCT04292535|11963453|FG013|Overall Study|Equipment Failure|0
7576659|NCT04292171|11963485|FG000|Overall Study|Pharmacy error|2
7576660|NCT04292171|11963486|FG001|Overall Study|Pharmacy error|0
7576661|NCT04292171|11963485|FG000|Overall Study|Delivered prior to procedure|0
7576662|NCT04292171|11963486|FG001|Overall Study|Delivered prior to procedure|1
7576663|NCT04292899|11963496|FG000|Overall Study|Death|21
7576664|NCT04292899|11963497|FG001|Overall Study|Death|28
7576665|NCT04292899|11963498|FG002|Overall Study|Death|188
7576666|NCT04292899|11963499|FG003|Overall Study|Death|371
7576667|NCT04292899|11963496|FG000|Overall Study|Lost to Follow-up|8
7576668|NCT04292899|11963497|FG001|Overall Study|Lost to Follow-up|4
7576669|NCT04292899|11963498|FG002|Overall Study|Lost to Follow-up|22
7261815|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
7261816|NCT00365716|11474504|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
7261817|NCT00365716|11474505|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7261818|NCT00365716|11474506|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
7261819|NCT00365716|11474507|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
7261820|NCT00365716|11474508|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
7261821|NCT00365716|11474509|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7261822|NCT00365716|11474510|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
7261823|NCT00365716|11474504|FG000|Extension 1|Lost to Follow-up|0
7261824|NCT00365716|11474505|FG001|Extension 1|Lost to Follow-up|0
7261825|NCT00365716|11474506|FG002|Extension 1|Lost to Follow-up|0
7261826|NCT00365716|11474507|FG003|Extension 1|Lost to Follow-up|0
7261827|NCT00365716|11474508|FG004|Extension 1|Lost to Follow-up|0
7261828|NCT00365716|11474509|FG005|Extension 1|Lost to Follow-up|1
7261829|NCT00365716|11474510|FG006|Extension 1|Lost to Follow-up|0
7261830|NCT00365716|11474504|FG000|Extension 1|Other|0
7261831|NCT00365716|11474505|FG001|Extension 1|Other|0
7261832|NCT00365716|11474506|FG002|Extension 1|Other|0
7261833|NCT00365716|11474507|FG003|Extension 1|Other|0
7261834|NCT00365716|11474508|FG004|Extension 1|Other|0
7261835|NCT00365716|11474509|FG005|Extension 1|Other|9
7261836|NCT00365716|11474510|FG006|Extension 1|Other|0
7261837|NCT00365716|11474504|FG000|Extension 1|Moved|0
7261838|NCT00365716|11474505|FG001|Extension 1|Moved|0
7261839|NCT00365716|11474506|FG002|Extension 1|Moved|0
7261840|NCT00365716|11474507|FG003|Extension 1|Moved|0
7261841|NCT00365716|11474508|FG004|Extension 1|Moved|0
7261842|NCT00365716|11474509|FG005|Extension 1|Moved|4
7261843|NCT00365716|11474510|FG006|Extension 1|Moved|0
7261844|NCT00365716|11474504|FG000|Extension 1|Withdrawal by Subject|0
7261845|NCT00365716|11474505|FG001|Extension 1|Withdrawal by Subject|0
7261846|NCT00365716|11474506|FG002|Extension 1|Withdrawal by Subject|0
7261847|NCT00365716|11474507|FG003|Extension 1|Withdrawal by Subject|0
7261848|NCT00365716|11474508|FG004|Extension 1|Withdrawal by Subject|0
7261849|NCT00365716|11474509|FG005|Extension 1|Withdrawal by Subject|3
7261850|NCT00365716|11474510|FG006|Extension 1|Withdrawal by Subject|0
7261851|NCT00365716|11474504|FG000|Extension 1|Pregnancy|0
7261852|NCT00365716|11474505|FG001|Extension 1|Pregnancy|0
7261853|NCT00365716|11474506|FG002|Extension 1|Pregnancy|0
7261854|NCT00365716|11474507|FG003|Extension 1|Pregnancy|0
7261855|NCT00365716|11474508|FG004|Extension 1|Pregnancy|0
7261856|NCT00365716|11474509|FG005|Extension 1|Pregnancy|4
7576670|NCT04292899|11963499|FG003|Overall Study|Lost to Follow-up|235
7576671|NCT04292899|11963496|FG000|Overall Study|Withdrew consent|1
7576672|NCT04292899|11963497|FG001|Overall Study|Withdrew consent|0
7261857|NCT00365716|11474510|FG006|Extension 1|Pregnancy|0
7261858|NCT00365716|11474504|FG000|Extension 1|Protocol Violation|0
7261859|NCT00365716|11474505|FG001|Extension 1|Protocol Violation|0
7261860|NCT00365716|11474506|FG002|Extension 1|Protocol Violation|0
7261861|NCT00365716|11474507|FG003|Extension 1|Protocol Violation|0
7261862|NCT00365716|11474508|FG004|Extension 1|Protocol Violation|0
7261863|NCT00365716|11474509|FG005|Extension 1|Protocol Violation|1
7261864|NCT00365716|11474510|FG006|Extension 1|Protocol Violation|0
7576673|NCT04292899|11963498|FG002|Overall Study|Withdrew consent|11
7576674|NCT04292899|11963499|FG003|Overall Study|Withdrew consent|32
7576675|NCT04292899|11963496|FG000|Overall Study|Adverse Event|2
7261865|NCT00365716|11474504|FG000|Extension 2|Lost to Follow-up|0
7261866|NCT00365716|11474505|FG001|Extension 2|Lost to Follow-up|0
7261867|NCT00365716|11474506|FG002|Extension 2|Lost to Follow-up|0
7261868|NCT00365716|11474507|FG003|Extension 2|Lost to Follow-up|0
7261869|NCT00365716|11474508|FG004|Extension 2|Lost to Follow-up|0
7261870|NCT00365716|11474509|FG005|Extension 2|Lost to Follow-up|0
7261871|NCT00365716|11474510|FG006|Extension 2|Lost to Follow-up|2
7261872|NCT00365716|11474504|FG000|Extension 2|Other|0
7261873|NCT00365716|11474505|FG001|Extension 2|Other|0
7261874|NCT00365716|11474506|FG002|Extension 2|Other|0
7261875|NCT00365716|11474507|FG003|Extension 2|Other|0
7261876|NCT00365716|11474508|FG004|Extension 2|Other|0
7261877|NCT00365716|11474509|FG005|Extension 2|Other|0
7261878|NCT00365716|11474510|FG006|Extension 2|Other|3
7261879|NCT00365716|11474504|FG000|Extension 2|Withdrawal by Subject|0
7261880|NCT00365716|11474505|FG001|Extension 2|Withdrawal by Subject|0
7261881|NCT00365716|11474506|FG002|Extension 2|Withdrawal by Subject|0
7544055|NCT02814175|11897289|FG004|Part 2|Lost to Follow-up|0
7544056|NCT02814175|11897290|FG005|Part 2|Lost to Follow-up|0
7544057|NCT02814175|11897285|FG000|Part 2|Lack of Efficacy|0
7544058|NCT02814175|11897286|FG001|Part 2|Lack of Efficacy|0
7544059|NCT02814175|11897287|FG002|Part 2|Lack of Efficacy|0
7544060|NCT02814175|11897288|FG003|Part 2|Lack of Efficacy|0
7544061|NCT02814175|11897289|FG004|Part 2|Lack of Efficacy|0
7544062|NCT02814175|11897290|FG005|Part 2|Lack of Efficacy|3
7544063|NCT02814565|11897340|FG000|Overall Study|Lack of Efficacy|0
7544064|NCT02814565|11897341|FG001|Overall Study|Lack of Efficacy|1
7544065|NCT02814565|11897340|FG000|Overall Study|Subject decision, caused by AE Influenza|1
7544066|NCT02814565|11897341|FG001|Overall Study|Subject decision, caused by AE Influenza|1
7544067|NCT02814643|11897349|FG000|Overall Study|Lost to Follow-up|0
7544068|NCT02814643|11897350|FG001|Overall Study|Lost to Follow-up|1
7544069|NCT02814643|11897349|FG000|Overall Study|Withdrawal by Subject|1
7544070|NCT02814643|11897350|FG001|Overall Study|Withdrawal by Subject|2
7544071|NCT02814838|11897375|FG000|Overall Study|3 agreed dates for the final visit missed|1
7544072|NCT02814838|11897376|FG001|Overall Study|3 agreed dates for the final visit missed|0
7544073|NCT02814838|11897375|FG000|Overall Study|Consent withdrawal|1
7544074|NCT02814838|11897376|FG001|Overall Study|Consent withdrawal|1
7544075|NCT02815293|11897400|FG000|Overall Study|Study termination by sponsor|10
7544076|NCT02815293|11897401|FG001|Overall Study|Study termination by sponsor|7
7544077|NCT02815293|11897402|FG002|Overall Study|Study termination by sponsor|0
7544078|NCT02815293|11897400|FG000|Overall Study|Participants not randomized|0
7544079|NCT02815293|11897401|FG001|Overall Study|Participants not randomized|0
7544080|NCT02815293|11897402|FG002|Overall Study|Participants not randomized|18
7544081|NCT02815293|11897400|FG000|Overall Study|Adverse Event|0
7544082|NCT02815293|11897401|FG001|Overall Study|Adverse Event|1
7544083|NCT02815293|11897402|FG002|Overall Study|Adverse Event|0
7544084|NCT02815670|11897417|FG000|Overall Study|Prematurely discontinued of the trial|1
7544085|NCT02815735|11897443|FG000|First Intervention (4 Weeks)|Discomfort|1
7544086|NCT02815735|11897444|FG001|First Intervention (4 Weeks)|Discomfort|0
7544087|NCT02815735|11897443|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
7544088|NCT02815735|11897444|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
7544089|NCT02815735|11897443|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
7544090|NCT02815735|11897444|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
7544091|NCT02815735|11897443|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
7544092|NCT02815735|11897444|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
7544093|NCT02816138|11897478|FG000|Overall Study|Adverse Event|1
7544094|NCT02816398|11897503|FG000|Overall Study|Death|5
7544095|NCT02816398|11897503|FG000|Overall Study|Lack of Efficacy|8
7544096|NCT02816398|11897503|FG000|Overall Study|Lost to Follow-up|1
7544097|NCT02817087|11897534|FG000|Overall Study|Withdrawal by Subject|2
7544098|NCT02817087|11897535|FG001|Overall Study|Withdrawal by Subject|0
7544099|NCT02817516|11897545|FG000|Overall Study|Other|0
7544100|NCT02817516|11897546|FG001|Overall Study|Other|0
7544101|NCT02817516|11897547|FG002|Overall Study|Other|1
7544102|NCT02817516|11897548|FG003|Overall Study|Other|0
7544103|NCT02817555|11897563|FG000|Overall Study|Death|1
7544104|NCT02817555|11897564|FG001|Overall Study|Death|3
7544105|NCT02817555|11897563|FG000|Overall Study|moved away|1
7544106|NCT02817555|11897564|FG001|Overall Study|moved away|0
7261882|NCT00365716|11474507|FG003|Extension 2|Withdrawal by Subject|0
7261883|NCT00365716|11474508|FG004|Extension 2|Withdrawal by Subject|0
7261884|NCT00365716|11474509|FG005|Extension 2|Withdrawal by Subject|0
7261885|NCT00365716|11474510|FG006|Extension 2|Withdrawal by Subject|5
7261886|NCT00365794|11474533|FG000|Overall Study|Withdrawal by Subject|2
7544107|NCT02817555|11897563|FG000|Overall Study|transplant|1
7261887|NCT00365846|11474538|FG000|Overall Study|Lost to Follow-up|1
7261888|NCT00365976|11474573|FG000|Overall Study|Withdrawal by Subject|1
7261889|NCT00365976|11474574|FG001|Overall Study|Withdrawal by Subject|5
7261890|NCT00365989|11474580|FG000|Overall Study|Withdrawal by Subject|1
7261891|NCT00365989|11474580|FG000|Overall Study|Non-compliance|1
7261892|NCT00366249|11474602|FG000|Overall Study|Adverse Event|53
7261893|NCT00366249|11474603|FG001|Overall Study|Adverse Event|28
7261894|NCT00366249|11474602|FG000|Overall Study|Death|0
7261895|NCT00366249|11474603|FG001|Overall Study|Death|1
7261896|NCT00366249|11474602|FG000|Overall Study|Physician Decision|5
7261897|NCT00366249|11474603|FG001|Overall Study|Physician Decision|2
7261898|NCT00366249|11474602|FG000|Overall Study|Lost to Follow-up|2
7261899|NCT00366249|11474603|FG001|Overall Study|Lost to Follow-up|0
7261900|NCT00366249|11474602|FG000|Overall Study|Protocol Violation|1
7261901|NCT00366249|11474603|FG001|Overall Study|Protocol Violation|2
7261902|NCT00366249|11474602|FG000|Overall Study|Withdrawal by Subject|18
7261903|NCT00366249|11474603|FG001|Overall Study|Withdrawal by Subject|4
7261904|NCT00366249|11474602|FG000|Overall Study|Lack of Efficacy|21
7261905|NCT00366249|11474603|FG001|Overall Study|Lack of Efficacy|21
7261906|NCT00366249|11474602|FG000|Overall Study|Most due to osteomylitis status|31
7261907|NCT00366249|11474603|FG001|Overall Study|Most due to osteomylitis status|20
7261908|NCT00366301|11474617|FG000|Overall Study|Lost to Follow-up|4
7261909|NCT00366301|11474618|FG001|Overall Study|Lost to Follow-up|4
7261910|NCT00366301|11474619|FG002|Overall Study|Lost to Follow-up|3
7261911|NCT00366301|11474620|FG003|Overall Study|Lost to Follow-up|7
7261912|NCT00366301|11474617|FG000|Overall Study|Withdrawal by Subject|4
7261913|NCT00366301|11474618|FG001|Overall Study|Withdrawal by Subject|2
7261914|NCT00366301|11474619|FG002|Overall Study|Withdrawal by Subject|1
7261915|NCT00366301|11474620|FG003|Overall Study|Withdrawal by Subject|1
7261916|NCT00366340|11474632|FG000|Infant Series|Protocol Violation|3
7261917|NCT00366340|11474633|FG001|Infant Series|Protocol Violation|4
7261918|NCT00366340|11474632|FG000|Infant Series|Withdrawal by Subject|3
7261919|NCT00366340|11474633|FG001|Infant Series|Withdrawal by Subject|3
7261920|NCT00366340|11474632|FG000|Infant Series|Adverse Event|0
7261921|NCT00366340|11474633|FG001|Infant Series|Adverse Event|2
7261922|NCT00366340|11474632|FG000|Infant Series|Lost to Follow-up|1
7261923|NCT00366340|11474633|FG001|Infant Series|Lost to Follow-up|1
7261924|NCT00366340|11474632|FG000|Infant Series|Failure to return|1
7261925|NCT00366340|11474633|FG001|Infant Series|Failure to return|0
7261926|NCT00366340|11474632|FG000|After the Infant Series|Parent/legal guardian request|1
7261927|NCT00366340|11474633|FG001|After the Infant Series|Parent/legal guardian request|1
7261928|NCT00366340|11474632|FG000|After the Infant Series|Failed to return|0
7261929|NCT00366340|11474633|FG001|After the Infant Series|Failed to return|1
7261930|NCT00366340|11474632|FG000|After the Infant Series|Protocol Violation|2
7261931|NCT00366340|11474633|FG001|After the Infant Series|Protocol Violation|2
7261932|NCT00366340|11474632|FG000|After the Infant Series|Adverse Event|0
7261933|NCT00366340|11474633|FG001|After the Infant Series|Adverse Event|1
7261934|NCT00366340|11474632|FG000|After the Infant Series|Lost to Follow-up|0
7261935|NCT00366340|11474633|FG001|After the Infant Series|Lost to Follow-up|1
7261936|NCT00366340|11474632|FG000|Toddler Dose|Failed to return|1
7261937|NCT00366340|11474633|FG001|Toddler Dose|Failed to return|0
7261938|NCT00366340|11474632|FG000|Toddler Dose|Parent/legal guardian request|0
7261939|NCT00366340|11474633|FG001|Toddler Dose|Parent/legal guardian request|1
7261940|NCT00366444|11474665|FG000|Overall Study|Withdrawal by Subject|1
7261941|NCT00366444|11474666|FG001|Overall Study|Withdrawal by Subject|1
7261942|NCT00366444|11474665|FG000|Overall Study|Lack of Efficacy|0
7261943|NCT00366444|11474666|FG001|Overall Study|Lack of Efficacy|1
7261944|NCT00366457|11474672|FG000|Overall Study|never began study therapy|2
7261945|NCT00366535|11474678|FG000|First Phase: 12 Weeks|Adverse Event|1
7261946|NCT00366535|11474679|FG001|First Phase: 12 Weeks|Adverse Event|3
7261947|NCT00366535|11474678|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
7261948|NCT00366535|11474679|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
7261949|NCT00366535|11474678|FG000|Second Phase: 12 Weeks|Adverse Event|1
7261950|NCT00366535|11474679|FG001|Second Phase: 12 Weeks|Adverse Event|1
7261951|NCT00366535|11474678|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
7261952|NCT00366535|11474679|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
7261953|NCT00366548|11474695|FG000|Infant Series|Adverse Event|1
7261954|NCT00366548|11474696|FG001|Infant Series|Adverse Event|3
7544108|NCT02817555|11897564|FG001|Overall Study|transplant|1
7544109|NCT02817555|11897563|FG000|Overall Study|changed to Peritoneal Dialysis|0
7544110|NCT02817555|11897564|FG001|Overall Study|changed to Peritoneal Dialysis|1
7544111|NCT02817594|11897570|FG000|Overall Study|Withdrawal by Subject|1
7544112|NCT02817594|11897570|FG000|Overall Study|Other|1
7544113|NCT02817594|11897570|FG000|Overall Study|Did Not Receive Treatment|1
7544114|NCT02817776|11897587|FG000|Overall Study|Excluded|33
7544115|NCT02817776|11897587|FG000|Overall Study|Lost to Follow-up|20
7544116|NCT02817776|11897587|FG000|Overall Study|Withdrawal by Subject|33
7544117|NCT02817776|11897587|FG000|Overall Study|Death|2
7576676|NCT04292899|11963497|FG001|Overall Study|Adverse Event|1
7576677|NCT04292899|11963498|FG002|Overall Study|Adverse Event|2
7576678|NCT04292899|11963499|FG003|Overall Study|Adverse Event|2
7576679|NCT04292899|11963496|FG000|Overall Study|Investigator's Discretion|0
7576680|NCT04292899|11963497|FG001|Overall Study|Investigator's Discretion|0
7576681|NCT04292899|11963498|FG002|Overall Study|Investigator's Discretion|0
7576682|NCT04292899|11963499|FG003|Overall Study|Investigator's Discretion|3
7576683|NCT04292899|11963496|FG000|Overall Study|Non-compliance With Study Drug|0
7576684|NCT04292899|11963497|FG001|Overall Study|Non-compliance With Study Drug|0
7576685|NCT04292899|11963498|FG002|Overall Study|Non-compliance With Study Drug|0
7576686|NCT04292899|11963499|FG003|Overall Study|Non-compliance With Study Drug|1
7544118|NCT02817828|11897591|FG000|Overall Study|Lost to Follow-up|41
7544119|NCT02817828|11897591|FG000|Overall Study|Adverse event not related to bleeding|104
7544120|NCT02817828|11897591|FG000|Overall Study|Adverse event related to bleeding|53
7544121|NCT02817828|11897591|FG000|Overall Study|Protocol Violation|11
7544122|NCT02817828|11897591|FG000|Overall Study|Pregnancy|7
7544123|NCT02817828|11897591|FG000|Overall Study|Pregnancy wish|15
7544124|NCT02817828|11897591|FG000|Overall Study|Withdrawal by Subject|78
7544125|NCT02817828|11897591|FG000|Overall Study|Other|26
7544126|NCT02817841|11897600|FG000|Overall Study|Lost to Follow-up|287
7544127|NCT02817841|11897600|FG000|Overall Study|Withdrawal by Subject|183
7544128|NCT02817841|11897600|FG000|Overall Study|Adverse event not related to bleeding|131
7544129|NCT02817841|11897600|FG000|Overall Study|Adverse event related to bleeding|51
7544130|NCT02817841|11897600|FG000|Overall Study|Pregnancy|32
7544131|NCT02817841|11897600|FG000|Overall Study|Pregnancy wish|17
7544132|NCT02817841|11897600|FG000|Overall Study|Other reasons|53
7544133|NCT02817841|11897600|FG000|Overall Study|Protocol Violation|94
7544134|NCT02817906|11897610|FG000|Overall Study|Adverse Event|3
7544135|NCT02817906|11897611|FG001|Overall Study|Adverse Event|0
7544136|NCT02817906|11897610|FG000|Overall Study|Lack of Efficacy|1
7544137|NCT02817906|11897611|FG001|Overall Study|Lack of Efficacy|0
7544138|NCT02817906|11897610|FG000|Overall Study|Protocol Violation|1
7544139|NCT02817906|11897611|FG001|Overall Study|Protocol Violation|1
7544140|NCT02817906|11897610|FG000|Overall Study|Study Terminated by Sponsor|2
7544141|NCT02817906|11897611|FG001|Overall Study|Study Terminated by Sponsor|2
7544142|NCT02817906|11897610|FG000|Overall Study|Withdrawal by Subject|7
7544143|NCT02817906|11897611|FG001|Overall Study|Withdrawal by Subject|0
7544144|NCT02817906|11897610|FG000|Overall Study|Other|2
7544145|NCT02817906|11897611|FG001|Overall Study|Other|2
7544146|NCT02818036|11897619|FG000|Overall Study|head did not fit in fMRI scanner headres|1
7544147|NCT02818036|11897620|FG001|Overall Study|head did not fit in fMRI scanner headres|0
7544148|NCT02818036|11897619|FG000|Overall Study|Withdrawal by Subject|1
7576687|NCT04292899|11963496|FG000|Overall Study|Protocol Violation|0
7576688|NCT04292899|11963497|FG001|Overall Study|Protocol Violation|0
7261955|NCT00366548|11474695|FG000|Infant Series|Protocol Violation|0
7576689|NCT04292899|11963498|FG002|Overall Study|Protocol Violation|0
7261956|NCT00366548|11474696|FG001|Infant Series|Protocol Violation|1
7261957|NCT00366548|11474695|FG000|Infant Series|Withdrawal by Subject|3
7261958|NCT00366548|11474696|FG001|Infant Series|Withdrawal by Subject|1
7261959|NCT00366548|11474695|FG000|After Infant Series|Withdrawal by Subject|3
7261960|NCT00366548|11474696|FG001|After Infant Series|Withdrawal by Subject|1
7261961|NCT00366548|11474695|FG000|After Infant Series|Adverse Event|2
7261962|NCT00366548|11474696|FG001|After Infant Series|Adverse Event|0
7261963|NCT00366548|11474695|FG000|After Infant Series|Lost to Follow-up|1
7261964|NCT00366548|11474696|FG001|After Infant Series|Lost to Follow-up|0
7261965|NCT00366678|11474733|FG000|Infant Series|Withdrawal by Subject|8
7261966|NCT00366678|11474734|FG001|Infant Series|Withdrawal by Subject|6
7261967|NCT00366678|11474735|FG002|Infant Series|Withdrawal by Subject|0
7261968|NCT00366678|11474733|FG000|Infant Series|Protocol Violation|4
7261969|NCT00366678|11474734|FG001|Infant Series|Protocol Violation|3
7261970|NCT00366678|11474735|FG002|Infant Series|Protocol Violation|0
7261971|NCT00366678|11474733|FG000|Infant Series|Failed to return|1
7261972|NCT00366678|11474734|FG001|Infant Series|Failed to return|1
7261973|NCT00366678|11474735|FG002|Infant Series|Failed to return|0
7261974|NCT00366678|11474733|FG000|Infant Series|Adverse Event|1
7261975|NCT00366678|11474734|FG001|Infant Series|Adverse Event|0
7261976|NCT00366678|11474735|FG002|Infant Series|Adverse Event|0
7261977|NCT00366678|11474733|FG000|After Infant|Withdrawal by Subject|8
7261978|NCT00366678|11474734|FG001|After Infant|Withdrawal by Subject|4
7261979|NCT00366678|11474735|FG002|After Infant|Withdrawal by Subject|0
7261980|NCT00366678|11474733|FG000|After Infant|Lost to Follow-up|2
7261981|NCT00366678|11474734|FG001|After Infant|Lost to Follow-up|1
7261982|NCT00366678|11474735|FG002|After Infant|Lost to Follow-up|0
7261983|NCT00366678|11474733|FG000|After Infant|Failed to return|5
7261984|NCT00366678|11474734|FG001|After Infant|Failed to return|5
7261985|NCT00366678|11474735|FG002|After Infant|Failed to return|0
7261986|NCT00366678|11474733|FG000|After Infant|Adverse Event|1
7261987|NCT00366678|11474734|FG001|After Infant|Adverse Event|0
7261988|NCT00366678|11474735|FG002|After Infant|Adverse Event|0
7261989|NCT00366678|11474733|FG000|After Infant|Protocol Violation|1
7261990|NCT00366678|11474734|FG001|After Infant|Protocol Violation|0
7261991|NCT00366678|11474735|FG002|After Infant|Protocol Violation|0
7261992|NCT00366678|11474733|FG000|Toddler Dose|Protocol Violation|2
7261993|NCT00366678|11474734|FG001|Toddler Dose|Protocol Violation|1
7544149|NCT02818036|11897620|FG001|Overall Study|Withdrawal by Subject|0
7544150|NCT02818777|11897658|FG000|Overall Study|Adverse Event|3
7261994|NCT00366678|11474735|FG002|Toddler Dose|Protocol Violation|0
7261995|NCT00366678|11474733|FG000|Toddler Dose|Failed to return|1
7261996|NCT00366678|11474734|FG001|Toddler Dose|Failed to return|0
7261997|NCT00366678|11474735|FG002|Toddler Dose|Failed to return|0
7261998|NCT00366678|11474733|FG000|Toddler Dose|Withdrawal by Subject|1
7261999|NCT00366678|11474734|FG001|Toddler Dose|Withdrawal by Subject|0
7262000|NCT00366678|11474735|FG002|Toddler Dose|Withdrawal by Subject|0
7262001|NCT00366678|11474733|FG000|Toddler Dose|protocol deviation|1
7262002|NCT00366678|11474734|FG001|Toddler Dose|protocol deviation|0
7262003|NCT00366678|11474735|FG002|Toddler Dose|protocol deviation|0
7262004|NCT00366899|11474782|FG000|Infant Series|Withdrawal by Subject|4
7262005|NCT00366899|11474783|FG001|Infant Series|Withdrawal by Subject|7
7262006|NCT00366899|11474782|FG000|Infant Series|Protocol Violation|2
7262007|NCT00366899|11474783|FG001|Infant Series|Protocol Violation|1
7262008|NCT00366899|11474782|FG000|Infant Series|Failed to return|1
7262009|NCT00366899|11474783|FG001|Infant Series|Failed to return|1
7262010|NCT00366899|11474782|FG000|Infant Series|Lost to Follow-up|0
7262011|NCT00366899|11474783|FG001|Infant Series|Lost to Follow-up|2
7262012|NCT00366899|11474782|FG000|Infant Series|Adverse Event|0
7262013|NCT00366899|11474783|FG001|Infant Series|Adverse Event|1
7262014|NCT00366899|11474782|FG000|Infant Series|Physician Decision|1
7262015|NCT00366899|11474783|FG001|Infant Series|Physician Decision|0
7262016|NCT00366899|11474782|FG000|Infant Series|Randomized but not consented|1
7262017|NCT00366899|11474783|FG001|Infant Series|Randomized but not consented|0
7262018|NCT00366899|11474782|FG000|After Infant Series|Lost to Follow-up|4
7262019|NCT00366899|11474783|FG001|After Infant Series|Lost to Follow-up|3
7262020|NCT00366899|11474782|FG000|After Infant Series|Withdrawal by Subject|1
7262021|NCT00366899|11474783|FG001|After Infant Series|Withdrawal by Subject|4
7262022|NCT00366899|11474782|FG000|After Infant Series|Adverse Event|1
7262023|NCT00366899|11474783|FG001|After Infant Series|Adverse Event|2
7262024|NCT00366899|11474782|FG000|After Infant Series|Protocol Violation|1
7262025|NCT00366899|11474783|FG001|After Infant Series|Protocol Violation|0
7262026|NCT00366899|11474782|FG000|Toddler Dose|Withdrawal by Subject|1
7262027|NCT00366899|11474783|FG001|Toddler Dose|Withdrawal by Subject|1
7262028|NCT00366899|11474782|FG000|Toddler Dose|Protocol Violation|1
7262029|NCT00366899|11474783|FG001|Toddler Dose|Protocol Violation|0
7262030|NCT00367055|11474828|FG000|Overall Study|Adverse Event|6
7262031|NCT00367055|11474829|FG001|Overall Study|Adverse Event|3
7262032|NCT00367055|11474828|FG000|Overall Study|Patient's Willing|3
7262033|NCT00367055|11474829|FG001|Overall Study|Patient's Willing|2
7262034|NCT00367055|11474828|FG000|Overall Study|Lack of Efficacy|1
7262035|NCT00367055|11474829|FG001|Overall Study|Lack of Efficacy|2
7262036|NCT00367055|11474828|FG000|Overall Study|Lost to Follow-up|1
7262037|NCT00367055|11474829|FG001|Overall Study|Lost to Follow-up|1
7262038|NCT00367055|11474828|FG000|Overall Study|Protocol Violation|0
7262039|NCT00367055|11474829|FG001|Overall Study|Protocol Violation|1
7262040|NCT00367055|11474828|FG000|Overall Study|Stopping Criterion Met|0
7262041|NCT00367055|11474829|FG001|Overall Study|Stopping Criterion Met|1
7262042|NCT00367055|11474828|FG000|Overall Study|Participant Living too Far from Hospital|0
7262043|NCT00367055|11474829|FG001|Overall Study|Participant Living too Far from Hospital|1
7262044|NCT00367133|11474838|FG000|2 Years|Death|20
7262045|NCT00367133|11474839|FG001|2 Years|Death|12
7262046|NCT00367133|11474840|FG002|2 Years|Death|12
7262047|NCT00367133|11474838|FG000|2 Years|Dropped|34
7262048|NCT00367133|11474839|FG001|2 Years|Dropped|19
7262049|NCT00367133|11474840|FG002|2 Years|Dropped|33
7262050|NCT00367133|11474838|FG000|2 Years|Missed visit|4
7262051|NCT00367133|11474839|FG001|2 Years|Missed visit|5
7262052|NCT00367133|11474840|FG002|2 Years|Missed visit|4
7262053|NCT00367237|11474850|FG000|Overall Study|Adverse Event|7
7262054|NCT00367237|11474851|FG001|Overall Study|Adverse Event|2
7262055|NCT00367237|11474850|FG000|Overall Study|Lost to Follow-up|1
7262056|NCT00367237|11474851|FG001|Overall Study|Lost to Follow-up|0
7262057|NCT00367237|11474850|FG000|Overall Study|Withdrawal by Subject|0
7262058|NCT00367237|11474851|FG001|Overall Study|Withdrawal by Subject|4
7262059|NCT00367237|11474850|FG000|Overall Study|Protocol Violation|2
7262060|NCT00367237|11474851|FG001|Overall Study|Protocol Violation|5
7262061|NCT00367341|11474859|FG000|Overall Study|Physician Decision|1
7262062|NCT00367341|11474860|FG001|Overall Study|Physician Decision|0
7262063|NCT00367341|11474859|FG000|Overall Study|Protocol Violation|1
7262064|NCT00367341|11474860|FG001|Overall Study|Protocol Violation|0
7262065|NCT00367432|11474879|FG000|First Period (16 Weeks)|Adverse Event|6
7262066|NCT00367432|11474880|FG001|First Period (16 Weeks)|Adverse Event|0
7262067|NCT00367432|11474879|FG000|First Period (16 Weeks)|Lack of Efficacy|24
7262068|NCT00367432|11474880|FG001|First Period (16 Weeks)|Lack of Efficacy|0
7262069|NCT00367432|11474879|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
7262070|NCT00367432|11474880|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
7262071|NCT00367432|11474879|FG000|First Period (16 Weeks)|Other Reason|2
7262072|NCT00367432|11474880|FG001|First Period (16 Weeks)|Other Reason|0
7262073|NCT00367432|11474879|FG000|Second Period (up to 54 Months)|Adverse Event|14
7262074|NCT00367432|11474880|FG001|Second Period (up to 54 Months)|Adverse Event|3
7262075|NCT00367432|11474879|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
7262076|NCT00367432|11474880|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
7262077|NCT00367432|11474879|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
7262078|NCT00367432|11474880|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
7262079|NCT00367432|11474879|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
7262080|NCT00367432|11474880|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
7262081|NCT00367432|11474879|FG000|Second Period (up to 54 Months)|Other Reason|6
7262082|NCT00367432|11474880|FG001|Second Period (up to 54 Months)|Other Reason|2
7262083|NCT00367458|11474886|FG000|First Intervention - 8 Weeks|Adverse Event|2
7262084|NCT00367458|11474887|FG001|First Intervention - 8 Weeks|Adverse Event|0
7262085|NCT00367484|11474893|FG000|Overall Study|Adverse Event|7
7262086|NCT00367484|11474893|FG000|Overall Study|Withdrew informed consent|5
7262087|NCT00367484|11474893|FG000|Overall Study|Travel to USA|1
7262088|NCT00367484|11474893|FG000|Overall Study|Lost to Follow-up|1
7262089|NCT00367484|11474893|FG000|Overall Study|Protocol Violation|1
7262090|NCT00367484|11474893|FG000|Overall Study|The choice of the patient|1
7544151|NCT02818998|11897671|FG000|Overall Study|Adverse Event|3
7544152|NCT02818998|11897672|FG001|Overall Study|Adverse Event|2
7544153|NCT02818998|11897673|FG002|Overall Study|Adverse Event|1
7544154|NCT02818998|11897671|FG000|Overall Study|Lost to Follow-up|4
7544155|NCT02818998|11897672|FG001|Overall Study|Lost to Follow-up|1
7544156|NCT02818998|11897673|FG002|Overall Study|Lost to Follow-up|2
7544157|NCT02818998|11897671|FG000|Overall Study|Withdrawal by sponsor|0
7544158|NCT02818998|11897672|FG001|Overall Study|Withdrawal by sponsor|1
7544159|NCT02818998|11897673|FG002|Overall Study|Withdrawal by sponsor|1
7544160|NCT02818998|11897671|FG000|Overall Study|Death|3
7544161|NCT02818998|11897672|FG001|Overall Study|Death|6
7544162|NCT02818998|11897673|FG002|Overall Study|Death|8
7544163|NCT02818998|11897671|FG000|Overall Study|Withdrawal by Subject|7
7544164|NCT02818998|11897672|FG001|Overall Study|Withdrawal by Subject|6
7544165|NCT02818998|11897673|FG002|Overall Study|Withdrawal by Subject|6
7544166|NCT02818998|11897671|FG000|Overall Study|Physician Decision|1
7544167|NCT02818998|11897672|FG001|Overall Study|Physician Decision|0
7544168|NCT02818998|11897673|FG002|Overall Study|Physician Decision|0
7544169|NCT02819297|11897702|FG000|Overall Study|Withdrawal by Subject|25
7544170|NCT02819297|11897703|FG001|Overall Study|Withdrawal by Subject|13
7262091|NCT00367484|11474893|FG000|Overall Study|Lack of Efficacy|1
7262092|NCT00367640|11474906|FG000|Overall Study|Adverse Event|3
7262093|NCT00367640|11474907|FG001|Overall Study|Adverse Event|6
7262094|NCT00367640|11474908|FG002|Overall Study|Adverse Event|8
7262095|NCT00367640|11474909|FG003|Overall Study|Adverse Event|0
7262096|NCT00367640|11474906|FG000|Overall Study|Withdrawal by Subject|8
7262097|NCT00367640|11474907|FG001|Overall Study|Withdrawal by Subject|11
7262098|NCT00367640|11474908|FG002|Overall Study|Withdrawal by Subject|8
7262099|NCT00367640|11474909|FG003|Overall Study|Withdrawal by Subject|6
7262100|NCT00367640|11474906|FG000|Overall Study|Any other reason not above-mentioned|7
7262101|NCT00367640|11474907|FG001|Overall Study|Any other reason not above-mentioned|5
7262102|NCT00367640|11474908|FG002|Overall Study|Any other reason not above-mentioned|3
7262103|NCT00367640|11474909|FG003|Overall Study|Any other reason not above-mentioned|4
7262104|NCT00367744|11474927|FG000|Overall Study|Lost to Follow-up|4
7262105|NCT00367744|11474928|FG001|Overall Study|Lost to Follow-up|5
7262106|NCT00367770|11474935|FG000|Overall Study|Adverse Event|1
7262107|NCT00367770|11474935|FG000|Overall Study|Withdrawal by Subject|1
7262108|NCT00367835|11474941|FG000|Overall Study|Adverse Event|14
7262109|NCT00367835|11474942|FG001|Overall Study|Adverse Event|1
7262110|NCT00367835|11474941|FG000|Overall Study|Protocol Violation|1
7262111|NCT00367835|11474942|FG001|Overall Study|Protocol Violation|7
7262112|NCT00367835|11474941|FG000|Overall Study|Withdrawal by Subject|7
7262113|NCT00367835|11474942|FG001|Overall Study|Withdrawal by Subject|6
7262114|NCT00367835|11474941|FG000|Overall Study|Lost to Follow-up|1
7262115|NCT00367835|11474942|FG001|Overall Study|Lost to Follow-up|4
7262116|NCT00367835|11474941|FG000|Overall Study|Lack of Efficacy|3
7262117|NCT00367835|11474942|FG001|Overall Study|Lack of Efficacy|12
7262118|NCT00367835|11474941|FG000|Overall Study|Subject in juvenile detention center|1
7262119|NCT00367835|11474942|FG001|Overall Study|Subject in juvenile detention center|0
7262120|NCT00367835|11474941|FG000|Overall Study|refused blood collection|1
7262121|NCT00367835|11474942|FG001|Overall Study|refused blood collection|0
7262122|NCT00367835|11474941|FG000|Overall Study|Did not respond to calls|1
7262123|NCT00367835|11474942|FG001|Overall Study|Did not respond to calls|0
7262124|NCT00367835|11474941|FG000|Overall Study|History of lead poisoning|0
7262125|NCT00367835|11474942|FG001|Overall Study|History of lead poisoning|1
7262126|NCT00367991|11474950|FG000|Overall Study|Withdrawal by Subject|1
7262127|NCT00367991|11474951|FG001|Overall Study|Withdrawal by Subject|1
7262128|NCT00367991|11474950|FG000|Overall Study|Adverse Event|1
7262129|NCT00367991|11474951|FG001|Overall Study|Adverse Event|1
7262130|NCT00368069|11474959|FG000|Overall Study|Adverse Event|5
7262131|NCT00368069|11474960|FG001|Overall Study|Adverse Event|2
7262132|NCT00368069|11474959|FG000|Overall Study|Lack of Efficacy|0
7262133|NCT00368069|11474960|FG001|Overall Study|Lack of Efficacy|1
7262134|NCT00368069|11474959|FG000|Overall Study|Lost to Follow-up|1
7262135|NCT00368069|11474960|FG001|Overall Study|Lost to Follow-up|0
7262136|NCT00368069|11474959|FG000|Overall Study|Protocol Violation|0
7262137|NCT00368069|11474960|FG001|Overall Study|Protocol Violation|2
7262138|NCT00368069|11474959|FG000|Overall Study|Withdrawal of Consent|2
7262139|NCT00368069|11474960|FG001|Overall Study|Withdrawal of Consent|1
7262140|NCT00368069|11474959|FG000|Overall Study|no blood sampling possible|0
7262141|NCT00368069|11474960|FG001|Overall Study|no blood sampling possible|1
7262142|NCT00368108|11474969|FG000|Overall Study|Adverse Event|38
7262143|NCT00368108|11474970|FG001|Overall Study|Adverse Event|26
7262144|NCT00368108|11474971|FG002|Overall Study|Adverse Event|44
7262145|NCT00368108|11474969|FG000|Overall Study|Abnormal Laboratory Value|0
7262146|NCT00368108|11474970|FG001|Overall Study|Abnormal Laboratory Value|0
7262147|NCT00368108|11474971|FG002|Overall Study|Abnormal Laboratory Value|3
7262148|NCT00368108|11474969|FG000|Overall Study|Protocol Violation|5
7262149|NCT00368108|11474970|FG001|Overall Study|Protocol Violation|9
7262150|NCT00368108|11474971|FG002|Overall Study|Protocol Violation|9
7262151|NCT00368108|11474969|FG000|Overall Study|Withdrawal by Subject|9
7262152|NCT00368108|11474970|FG001|Overall Study|Withdrawal by Subject|3
7262153|NCT00368108|11474971|FG002|Overall Study|Withdrawal by Subject|5
7262154|NCT00368108|11474969|FG000|Overall Study|Lack of Efficacy|7
7262155|NCT00368108|11474970|FG001|Overall Study|Lack of Efficacy|8
7262156|NCT00368108|11474971|FG002|Overall Study|Lack of Efficacy|5
7262157|NCT00368108|11474969|FG000|Overall Study|Physician Decision|2
7262158|NCT00368108|11474970|FG001|Overall Study|Physician Decision|0
7262159|NCT00368108|11474971|FG002|Overall Study|Physician Decision|1
7262160|NCT00368108|11474969|FG000|Overall Study|Other|3
7262161|NCT00368108|11474970|FG001|Overall Study|Other|7
7262162|NCT00368108|11474971|FG002|Overall Study|Other|1
7262163|NCT00368251|11474982|FG000|Overall Study|SAE, non-fatal|1
7262164|NCT00368251|11474983|FG001|Overall Study|SAE, non-fatal|0
7262165|NCT00368251|11474984|FG002|Overall Study|SAE, non-fatal|0
7262166|NCT00368251|11474982|FG000|Overall Study|AE, non-serious non-fatal|0
7262167|NCT00368251|11474983|FG001|Overall Study|AE, non-serious non-fatal|0
7262168|NCT00368251|11474984|FG002|Overall Study|AE, non-serious non-fatal|1
7262169|NCT00368277|11474994|FG000|Overall Study|Adverse Event|33
7262170|NCT00368277|11474995|FG001|Overall Study|Adverse Event|49
7262171|NCT00368277|11474994|FG000|Overall Study|Death|2
7262172|NCT00368277|11474995|FG001|Overall Study|Death|1
7262173|NCT00368277|11474994|FG000|Overall Study|Unsatisfactory therapeutic effect|31
7262174|NCT00368277|11474995|FG001|Overall Study|Unsatisfactory therapeutic effect|24
7262175|NCT00368277|11474994|FG000|Overall Study|Protocol deviation|7
7262176|NCT00368277|11474995|FG001|Overall Study|Protocol deviation|0
7262177|NCT00368277|11474994|FG000|Overall Study|Patient withdrew consent|32
7262178|NCT00368277|11474995|FG001|Overall Study|Patient withdrew consent|28
7262179|NCT00368277|11474994|FG000|Overall Study|Lost to Follow-up|8
7262180|NCT00368277|11474995|FG001|Overall Study|Lost to Follow-up|6
7262181|NCT00368355|11475021|FG000|Overall Study|Adverse Event|1
7262182|NCT00368355|11475022|FG001|Overall Study|Adverse Event|0
7262183|NCT00368355|11475021|FG000|Overall Study|Death|2
7262184|NCT00368355|11475022|FG001|Overall Study|Death|4
7262185|NCT00368355|11475021|FG000|Overall Study|Relapse|6
7262186|NCT00368355|11475022|FG001|Overall Study|Relapse|10
7262187|NCT00368355|11475021|FG000|Overall Study|Subsequent transplant|0
7262188|NCT00368355|11475022|FG001|Overall Study|Subsequent transplant|3
7262189|NCT00368355|11475021|FG000|Overall Study|Treatment - hematopoietic cell product|2
7262190|NCT00368355|11475022|FG001|Overall Study|Treatment - hematopoietic cell product|0
7262191|NCT00368472|11475037|FG000|Overall Study|Adverse Event|22
7262192|NCT00368472|11475037|FG000|Overall Study|Medication non-compliance|4
7262193|NCT00368472|11475037|FG000|Overall Study|Protocol Violation|2
7262194|NCT00368472|11475037|FG000|Overall Study|Request of Investigator or Sponsor|3
7262195|NCT00368472|11475037|FG000|Overall Study|Withdrawal by Subject|40
7262196|NCT00368472|11475037|FG000|Overall Study|Diary non-compliance|1
7262197|NCT00368472|11475037|FG000|Overall Study|Other|32
7262198|NCT00368472|11475037|FG000|Overall Study|Missing Final Disposition Date|1
7262199|NCT00368537|11475043|FG000|Randomization|No study drug dosed|13
7544171|NCT02819297|11897702|FG000|Overall Study|Lost to Follow-up|12
7544172|NCT02819297|11897703|FG001|Overall Study|Lost to Follow-up|14
7544173|NCT02819297|11897702|FG000|Overall Study|Adverse Event|12
7544174|NCT02819297|11897703|FG001|Overall Study|Adverse Event|10
7544175|NCT02819297|11897702|FG000|Overall Study|Physician Decision|5
7544176|NCT02819297|11897703|FG001|Overall Study|Physician Decision|5
7544177|NCT02819297|11897702|FG000|Overall Study|Lack of Efficacy|5
7544178|NCT02819297|11897703|FG001|Overall Study|Lack of Efficacy|8
7544179|NCT02819297|11897702|FG000|Overall Study|Protocol Violation|1
7544180|NCT02819297|11897703|FG001|Overall Study|Protocol Violation|2
7262200|NCT00368537|11475044|FG001|Randomization|No study drug dosed|6
7262201|NCT00368537|11475043|FG000|Baseline Participants|Lost to Follow-up|16
7262202|NCT00368537|11475044|FG001|Baseline Participants|Lost to Follow-up|17
7262203|NCT00368537|11475043|FG000|Baseline Participants|Withdrawal by Subject|6
7262204|NCT00368537|11475044|FG001|Baseline Participants|Withdrawal by Subject|4
7262205|NCT00368537|11475043|FG000|Baseline Participants|Death|1
7262206|NCT00368537|11475044|FG001|Baseline Participants|Death|2
7262207|NCT00368537|11475043|FG000|Baseline Participants|No susceptibility|1
7262208|NCT00368537|11475044|FG001|Baseline Participants|No susceptibility|0
7262209|NCT00368537|11475043|FG000|Baseline Participants|Patient uncompliant|0
7262210|NCT00368537|11475044|FG001|Baseline Participants|Patient uncompliant|1
7262211|NCT00368550|11475052|FG000|Overall Study|Adverse Event|7
7262212|NCT00368550|11475053|FG001|Overall Study|Adverse Event|4
7262213|NCT00368550|11475052|FG000|Overall Study|Lack of Efficacy|4
7262214|NCT00368550|11475053|FG001|Overall Study|Lack of Efficacy|9
7262215|NCT00368550|11475052|FG000|Overall Study|Withdrawal by Subject|17
7262216|NCT00368550|11475053|FG001|Overall Study|Withdrawal by Subject|10
7262217|NCT00368641|11475061|FG000|Overall Study|Adverse Event|2
7262218|NCT00368641|11475062|FG001|Overall Study|Adverse Event|1
7262219|NCT00368641|11475061|FG000|Overall Study|Death|1
7262220|NCT00368641|11475062|FG001|Overall Study|Death|0
7262221|NCT00368641|11475061|FG000|Overall Study|Withdrawal by Subject|1
7262222|NCT00368641|11475062|FG001|Overall Study|Withdrawal by Subject|0
7262223|NCT00368641|11475061|FG000|Overall Study|Sponsor decision to terminate study|2
7262224|NCT00368641|11475062|FG001|Overall Study|Sponsor decision to terminate study|5
7262225|NCT00368745|11475070|FG000|Double-blind Treatment Period|Adverse Event|6
7262226|NCT00368745|11475071|FG001|Double-blind Treatment Period|Adverse Event|6
7262227|NCT00368745|11475070|FG000|Double-blind Treatment Period|Lack of Efficacy|7
7262228|NCT00368745|11475071|FG001|Double-blind Treatment Period|Lack of Efficacy|16
7262229|NCT00368745|11475070|FG000|Double-blind Treatment Period|Lost to Follow-up|1
7262230|NCT00368745|11475071|FG001|Double-blind Treatment Period|Lost to Follow-up|0
7262231|NCT00368745|11475070|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
7262232|NCT00368745|11475071|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
7262233|NCT00368745|11475070|FG000|Double-blind Treatment Period|Other|7
7262234|NCT00368745|11475071|FG001|Double-blind Treatment Period|Other|6
7262235|NCT00368849|11475077|FG000|Overall Study|Withdrawal by Subject|0
7262236|NCT00368849|11475078|FG001|Overall Study|Withdrawal by Subject|1
7262237|NCT00368849|11475077|FG000|Overall Study|Physician Decision|0
7262238|NCT00368849|11475078|FG001|Overall Study|Physician Decision|1
7262239|NCT00368875|11475085|FG000|Overall Study|Adverse Event|0
7262240|NCT00368875|11475086|FG001|Overall Study|Adverse Event|12
7262241|NCT00368875|11475085|FG000|Overall Study|Progressive disease|3
7262242|NCT00368875|11475086|FG001|Overall Study|Progressive disease|27
7262243|NCT00368875|11475085|FG000|Overall Study|Withdrawal by Subject|2
7262244|NCT00368875|11475086|FG001|Overall Study|Withdrawal by Subject|6
7262245|NCT00368875|11475085|FG000|Overall Study|Other Reason|0
7262246|NCT00368875|11475086|FG001|Overall Study|Other Reason|2
7262247|NCT00368875|11475085|FG000|Overall Study|Alternative Therapy|1
7262248|NCT00368875|11475086|FG001|Overall Study|Alternative Therapy|1
7262249|NCT00368927|11475094|FG000|Overall Study|Lost to Follow-up|2
7262250|NCT00368927|11475095|FG001|Overall Study|Lost to Follow-up|0
7262251|NCT00368927|11475094|FG000|Overall Study|Adverse Event|1
7262252|NCT00368927|11475095|FG001|Overall Study|Adverse Event|1
7262253|NCT00368927|11475094|FG000|Overall Study|Withdrawal by Subject|1
7262254|NCT00368927|11475095|FG001|Overall Study|Withdrawal by Subject|2
7262255|NCT00368927|11475094|FG000|Overall Study|Physician Decision|1
7262256|NCT00368927|11475095|FG001|Overall Study|Physician Decision|0
7262257|NCT00368966|11475113|FG000|Infant Series|Withdrawal by Subject|11
7262258|NCT00368966|11475114|FG001|Infant Series|Withdrawal by Subject|6
7262259|NCT00368966|11475113|FG000|Infant Series|Protocol Violation|2
7262260|NCT00368966|11475114|FG001|Infant Series|Protocol Violation|1
7262261|NCT00368966|11475113|FG000|Infant Series|Lost to Follow-up|2
7544181|NCT02819310|11897709|FG000|Overall Study|Withdrawal by Subject|37
7544182|NCT02819310|11897709|FG000|Overall Study|Lost to Follow-up|16
7544183|NCT02819310|11897709|FG000|Overall Study|Adverse Event|13
7544184|NCT02819310|11897709|FG000|Overall Study|Lack of Efficacy|5
7544185|NCT02819310|11897709|FG000|Overall Study|Physician Decision|8
7544186|NCT02819310|11897709|FG000|Overall Study|Protocol Violation|30
7544187|NCT02819726|11897733|FG000|Part A (All Participants)|Lost to Follow-up|0
7544188|NCT02819726|11897734|FG001|Part A (All Participants)|Lost to Follow-up|1
7544189|NCT02819726|11897735|FG002|Part A (All Participants)|Lost to Follow-up|0
7544190|NCT02819726|11897736|FG003|Part A (All Participants)|Lost to Follow-up|0
7262262|NCT00368966|11475114|FG001|Infant Series|Lost to Follow-up|0
7262263|NCT00368966|11475113|FG000|Infant Series|Randomization error|0
7262264|NCT00368966|11475114|FG001|Infant Series|Randomization error|1
7262265|NCT00368966|11475113|FG000|Infant Series|Failed to meet eligibility criteria|0
7576690|NCT04292899|11963499|FG003|Overall Study|Protocol Violation|1
7262266|NCT00368966|11475114|FG001|Infant Series|Failed to meet eligibility criteria|1
7262267|NCT00368966|11475113|FG000|Infant Series|Adverse Event|0
7262268|NCT00368966|11475114|FG001|Infant Series|Adverse Event|1
7262269|NCT00368966|11475113|FG000|Infant Series|Failed to return|1
7262270|NCT00368966|11475114|FG001|Infant Series|Failed to return|0
7262271|NCT00368966|11475113|FG000|After Infant|Failed to return|3
7262272|NCT00368966|11475114|FG001|After Infant|Failed to return|1
7262273|NCT00368966|11475113|FG000|After Infant|Adverse Event|1
7262274|NCT00368966|11475114|FG001|After Infant|Adverse Event|2
7262275|NCT00368966|11475113|FG000|After Infant|Withdrawal by Subject|1
7262276|NCT00368966|11475114|FG001|After Infant|Withdrawal by Subject|1
7262277|NCT00368966|11475113|FG000|After Infant|Death|1
7262278|NCT00368966|11475114|FG001|After Infant|Death|0
7262279|NCT00368966|11475113|FG000|After Infant|Lost to Follow-up|0
7262280|NCT00368966|11475114|FG001|After Infant|Lost to Follow-up|1
7262281|NCT00368966|11475113|FG000|Toddler Dose|Withdrawal by Subject|1
7262282|NCT00368966|11475114|FG001|Toddler Dose|Withdrawal by Subject|1
7262283|NCT00368966|11475113|FG000|Toddler Dose|Lost to Follow-up|0
7262284|NCT00368966|11475114|FG001|Toddler Dose|Lost to Follow-up|2
7262285|NCT00368979|11475147|FG000|Overall Study|Adverse Event|9
7262286|NCT00368979|11475148|FG001|Overall Study|Adverse Event|16
7262287|NCT00368979|11475147|FG000|Overall Study|Lack of Efficacy|5
7262288|NCT00368979|11475148|FG001|Overall Study|Lack of Efficacy|3
7262289|NCT00368979|11475147|FG000|Overall Study|Other|3
7262290|NCT00368979|11475148|FG001|Overall Study|Other|1
7262291|NCT00368979|11475147|FG000|Overall Study|Lost to Follow-up|1
7262292|NCT00368979|11475148|FG001|Overall Study|Lost to Follow-up|0
7262293|NCT00368979|11475147|FG000|Overall Study|Protocol Violation|2
7262294|NCT00368979|11475148|FG001|Overall Study|Protocol Violation|1
7262295|NCT00368979|11475147|FG000|Overall Study|Withdrawal by Subject|5
7262296|NCT00368979|11475148|FG001|Overall Study|Withdrawal by Subject|9
7262297|NCT00368992|11475154|FG000|Overall Study|Ineligible|5
7262298|NCT00368992|11475154|FG000|Overall Study|Refused treatment|3
7262299|NCT00368992|11475154|FG000|Overall Study|Lack of Efficacy|63
7262300|NCT00368992|11475154|FG000|Overall Study|Adverse Event|26
7544191|NCT02819726|11897733|FG000|Part A (All Participants)|Withdrawal by Subject|3
7544192|NCT02819726|11897734|FG001|Part A (All Participants)|Withdrawal by Subject|5
7544193|NCT02819726|11897735|FG002|Part A (All Participants)|Withdrawal by Subject|6
7544194|NCT02819726|11897736|FG003|Part A (All Participants)|Withdrawal by Subject|0
7544195|NCT02819726|11897733|FG000|Part A (All Participants)|Protocol non-compliance|3
7544196|NCT02819726|11897734|FG001|Part A (All Participants)|Protocol non-compliance|4
7544197|NCT02819726|11897735|FG002|Part A (All Participants)|Protocol non-compliance|5
7544198|NCT02819726|11897736|FG003|Part A (All Participants)|Protocol non-compliance|0
7544199|NCT02819726|11897733|FG000|Part B (All Participants)|Lost to Follow-up|1
7544200|NCT02819726|11897734|FG001|Part B (All Participants)|Lost to Follow-up|1
7544201|NCT02819726|11897735|FG002|Part B (All Participants)|Lost to Follow-up|2
7544202|NCT02819726|11897736|FG003|Part B (All Participants)|Lost to Follow-up|2
7544203|NCT02819726|11897733|FG000|Part B (All Participants)|Withdrawal by Subject|2
7576691|NCT04292730|11963511|FG000|Overall Study|Lost to Follow-up|8
7262301|NCT00368992|11475154|FG000|Overall Study|Death|4
7262302|NCT00368992|11475154|FG000|Overall Study|Other|9
7262303|NCT00369122|11475159|FG000|Overall Study|Ineligible|10
7262304|NCT00369122|11475159|FG000|Overall Study|No protocol treatment|1
7262305|NCT00369161|11475165|FG000|Overall Study|Adverse Event|15
7262306|NCT00369161|11475166|FG001|Overall Study|Adverse Event|13
7262307|NCT00369161|11475165|FG000|Overall Study|Abnormal laboratory value|0
7262308|NCT00369161|11475166|FG001|Overall Study|Abnormal laboratory value|1
7262309|NCT00369161|11475165|FG000|Overall Study|Lack of Efficacy|3
7262310|NCT00369161|11475166|FG001|Overall Study|Lack of Efficacy|1
7262311|NCT00369161|11475165|FG000|Overall Study|Protocol Violation|0
7262312|NCT00369161|11475166|FG001|Overall Study|Protocol Violation|2
7262313|NCT00369161|11475165|FG000|Overall Study|Withdrawal by Subject|2
7262314|NCT00369161|11475166|FG001|Overall Study|Withdrawal by Subject|3
7262315|NCT00369161|11475165|FG000|Overall Study|Death|1
7262316|NCT00369161|11475166|FG001|Overall Study|Death|2
7262317|NCT00369161|11475165|FG000|Overall Study|Graft loss|4
7262318|NCT00369161|11475166|FG001|Overall Study|Graft loss|0
7262319|NCT00369161|11475165|FG000|Overall Study|Administrative Problem|2
7262320|NCT00369161|11475166|FG001|Overall Study|Administrative Problem|2
7262321|NCT00369278|11475186|FG000|Overall Study|Adverse Event|14
7262322|NCT00369278|11475187|FG001|Overall Study|Adverse Event|11
7262323|NCT00369278|11475186|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7262324|NCT00369278|11475187|FG001|Overall Study|Unsatisfactory therapeutic effect|5
7262325|NCT00369278|11475186|FG000|Overall Study|Protocol Violation|2
7262326|NCT00369278|11475187|FG001|Overall Study|Protocol Violation|1
7262327|NCT00369278|11475186|FG000|Overall Study|Withdrawal by Subject|2
7262328|NCT00369278|11475187|FG001|Overall Study|Withdrawal by Subject|2
7262329|NCT00369278|11475186|FG000|Overall Study|Lost to Follow-up|1
7262330|NCT00369278|11475187|FG001|Overall Study|Lost to Follow-up|0
7262331|NCT00369278|11475186|FG000|Overall Study|Graft loss|1
7262332|NCT00369278|11475187|FG001|Overall Study|Graft loss|2
7262333|NCT00369343|11475195|FG000|Double-blind Phase|Adverse Event|19
7262334|NCT00369343|11475196|FG001|Double-blind Phase|Adverse Event|4
7262335|NCT00369343|11475195|FG000|Double-blind Phase|Failed to return|2
7262336|NCT00369343|11475196|FG001|Double-blind Phase|Failed to return|0
7262337|NCT00369343|11475195|FG000|Double-blind Phase|Lost to Follow-up|9
7262338|NCT00369343|11475196|FG001|Double-blind Phase|Lost to Follow-up|2
7262339|NCT00369343|11475195|FG000|Double-blind Phase|Protocol Violation|2
7262340|NCT00369343|11475196|FG001|Double-blind Phase|Protocol Violation|0
7262341|NCT00369343|11475195|FG000|Double-blind Phase|Withdrawal by Subject|8
7262342|NCT00369343|11475196|FG001|Double-blind Phase|Withdrawal by Subject|6
7262343|NCT00369343|11475195|FG000|Double-blind Phase|Lack of Efficacy|0
7262344|NCT00369343|11475196|FG001|Double-blind Phase|Lack of Efficacy|4
7262345|NCT00369343|11475195|FG000|Double-blind Phase|Protocol deviation|4
7262346|NCT00369343|11475196|FG001|Double-blind Phase|Protocol deviation|0
7262347|NCT00369343|11475195|FG000|Open-label Phase|Adverse Event|19
7262348|NCT00369343|11475196|FG001|Open-label Phase|Adverse Event|7
7262349|NCT00369343|11475195|FG000|Open-label Phase|Failed to return|4
7262350|NCT00369343|11475196|FG001|Open-label Phase|Failed to return|0
7262351|NCT00369343|11475195|FG000|Open-label Phase|Physician Decision|2
7262352|NCT00369343|11475196|FG001|Open-label Phase|Physician Decision|0
7262353|NCT00369343|11475195|FG000|Open-label Phase|Lost to Follow-up|5
7262354|NCT00369343|11475196|FG001|Open-label Phase|Lost to Follow-up|3
7262355|NCT00369343|11475195|FG000|Open-label Phase|inadvertently reported study completers|3
7262356|NCT00369343|11475196|FG001|Open-label Phase|inadvertently reported study completers|2
7262357|NCT00369343|11475195|FG000|Open-label Phase|Protocol Violation|1
7262358|NCT00369343|11475196|FG001|Open-label Phase|Protocol Violation|3
7262359|NCT00369343|11475195|FG000|Open-label Phase|Withdrawal by Subject|15
7262360|NCT00369343|11475196|FG001|Open-label Phase|Withdrawal by Subject|6
7262361|NCT00369343|11475195|FG000|Open-label Phase|Lack of Efficacy|4
7262362|NCT00369343|11475196|FG001|Open-label Phase|Lack of Efficacy|3
7262363|NCT00369343|11475195|FG000|Open-label Phase|Lack of continuance tolerability|3
7262364|NCT00369343|11475196|FG001|Open-label Phase|Lack of continuance tolerability|4
7262365|NCT00369343|11475195|FG000|Open-label Phase|did not take study drug|1
7262366|NCT00369343|11475196|FG001|Open-label Phase|did not take study drug|2
7387963|NCT01217073|11646675|FG001|Extension Period|Death|0
7387964|NCT01217073|11646676|FG002|Extension Period|Death|0
7544204|NCT02819726|11897734|FG001|Part B (All Participants)|Withdrawal by Subject|1
7544205|NCT02819726|11897735|FG002|Part B (All Participants)|Withdrawal by Subject|1
7544206|NCT02819726|11897736|FG003|Part B (All Participants)|Withdrawal by Subject|0
7544207|NCT02819726|11897733|FG000|Part B (All Participants)|Protocol non-compliance|0
7544208|NCT02819726|11897734|FG001|Part B (All Participants)|Protocol non-compliance|0
7544209|NCT02819726|11897735|FG002|Part B (All Participants)|Protocol non-compliance|1
7544210|NCT02819726|11897736|FG003|Part B (All Participants)|Protocol non-compliance|0
7544211|NCT02820038|11897767|FG000|Overall Study|Lost to Follow-up|7
7387965|NCT01217073|11646677|FG003|Extension Period|Death|0
7387966|NCT01217073|11646678|FG004|Extension Period|Death|0
7387967|NCT01217073|11646679|FG005|Extension Period|Death|0
7262367|NCT00369382|11475211|FG000|Overall Study|Death|0
7262368|NCT00369382|11475212|FG001|Overall Study|Death|2
7262369|NCT00369382|11475211|FG000|Overall Study|Physician Decision|2
7262370|NCT00369382|11475212|FG001|Overall Study|Physician Decision|1
7262371|NCT00369382|11475211|FG000|Overall Study|Withdrawal by Subject|5
7262372|NCT00369382|11475212|FG001|Overall Study|Withdrawal by Subject|0
7262373|NCT00369382|11475211|FG000|Overall Study|Randomized, not treated|2
7262374|NCT00369382|11475212|FG001|Overall Study|Randomized, not treated|0
7262375|NCT00369382|11475211|FG000|Overall Study|Other|1
7262376|NCT00369382|11475212|FG001|Overall Study|Other|0
7262377|NCT00369486|11475224|FG000|4-Week Visit|Missed visit|2
7262378|NCT00369486|11475225|FG001|4-Week Visit|Missed visit|2
7262379|NCT00369486|11475226|FG002|4-Week Visit|Missed visit|0
7544212|NCT02820038|11897768|FG001|Overall Study|Lost to Follow-up|11
7544213|NCT02820038|11897769|FG002|Overall Study|Lost to Follow-up|2
7544214|NCT02820038|11897770|FG003|Overall Study|Lost to Follow-up|9
7544215|NCT02820038|11897767|FG000|Overall Study|Withdrawal by Subject|3
7544216|NCT02820038|11897768|FG001|Overall Study|Withdrawal by Subject|14
7544217|NCT02820038|11897769|FG002|Overall Study|Withdrawal by Subject|3
7544218|NCT02820038|11897770|FG003|Overall Study|Withdrawal by Subject|13
7544219|NCT02820298|11897792|FG000|Overall Study|Withdrawal by Subject|0
7544220|NCT02820298|11897793|FG001|Overall Study|Withdrawal by Subject|1
7544221|NCT02820298|11897792|FG000|Overall Study|Physician Decision|1
7544222|NCT02820298|11897793|FG001|Overall Study|Physician Decision|0
7544223|NCT02820298|11897792|FG000|Overall Study|Protocol Violation|0
7544224|NCT02820298|11897793|FG001|Overall Study|Protocol Violation|1
7544225|NCT02820597|11897826|FG000|Overall Study|Lost to Follow-up|12
7544226|NCT02820844|11897832|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
7544227|NCT02820844|11897833|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
7544228|NCT02820844|11897834|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7544229|NCT02820844|11897835|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7544230|NCT02820844|11897836|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7544231|NCT02820844|11897837|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7544232|NCT02820844|11897832|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
7544233|NCT02820844|11897833|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
7544234|NCT02820844|11897834|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7544235|NCT02820844|11897835|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7544236|NCT02820844|11897836|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7262380|NCT00369486|11475227|FG003|4-Week Visit|Missed visit|2
7262381|NCT00369486|11475228|FG004|4-Week Visit|Missed visit|1
7262382|NCT00369486|11475224|FG000|4-Week Visit|Dropped|0
7262383|NCT00369486|11475225|FG001|4-Week Visit|Dropped|0
7262384|NCT00369486|11475226|FG002|4-Week Visit|Dropped|1
7262385|NCT00369486|11475227|FG003|4-Week Visit|Dropped|0
7262386|NCT00369486|11475228|FG004|4-Week Visit|Dropped|0
7262387|NCT00369486|11475224|FG000|8-Week Visit|Missed visit|0
7262388|NCT00369486|11475225|FG001|8-Week Visit|Missed visit|1
7262389|NCT00369486|11475226|FG002|8-Week Visit|Missed visit|0
7262390|NCT00369486|11475227|FG003|8-Week Visit|Missed visit|0
7262391|NCT00369486|11475228|FG004|8-Week Visit|Missed visit|1
7262392|NCT00369486|11475224|FG000|8-Week Visit|Dropped|0
7262393|NCT00369486|11475225|FG001|8-Week Visit|Dropped|0
7262394|NCT00369486|11475226|FG002|8-Week Visit|Dropped|0
7262395|NCT00369486|11475227|FG003|8-Week Visit|Dropped|1
7262396|NCT00369486|11475228|FG004|8-Week Visit|Dropped|0
7262397|NCT00369486|11475224|FG000|17-Week Visit|Missed visit|0
7262398|NCT00369486|11475225|FG001|17-Week Visit|Missed visit|0
7262399|NCT00369486|11475226|FG002|17-Week Visit|Missed visit|1
7262400|NCT00369486|11475227|FG003|17-Week Visit|Missed visit|1
7262401|NCT00369486|11475228|FG004|17-Week Visit|Missed visit|1
7262402|NCT00369486|11475224|FG000|34-Week Visit|Dropped|0
7262403|NCT00369486|11475225|FG001|34-Week Visit|Dropped|1
7262404|NCT00369486|11475226|FG002|34-Week Visit|Dropped|1
7262405|NCT00369486|11475227|FG003|34-Week Visit|Dropped|3
7262406|NCT00369486|11475228|FG004|34-Week Visit|Dropped|3
7262407|NCT00369577|11475260|FG000|Overall Study|Withdrawal by Subject|0
7262408|NCT00369577|11475261|FG001|Overall Study|Withdrawal by Subject|0
7262409|NCT00369577|11475262|FG002|Overall Study|Withdrawal by Subject|1
7262410|NCT00369629|11475278|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
7262411|NCT00369629|11475279|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
7262412|NCT00369629|11475280|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
7262413|NCT00369629|11475281|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
7262414|NCT00369629|11475278|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
7262415|NCT00369629|11475279|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
7262416|NCT00369629|11475280|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
7262417|NCT00369629|11475281|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
7262418|NCT00369629|11475278|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
7262419|NCT00369629|11475279|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
7262420|NCT00369629|11475280|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
7262421|NCT00369629|11475281|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
7262422|NCT00369629|11475278|FG000|Moved on to 4 More Cycles|Progressive Disease|0
7262423|NCT00369629|11475279|FG001|Moved on to 4 More Cycles|Progressive Disease|0
7262424|NCT00369629|11475280|FG002|Moved on to 4 More Cycles|Progressive Disease|1
7262425|NCT00369629|11475281|FG003|Moved on to 4 More Cycles|Progressive Disease|0
7262426|NCT00369629|11475278|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
7262427|NCT00369629|11475279|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
7262428|NCT00369629|11475280|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
7262429|NCT00369629|11475281|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
7262430|NCT00369629|11475278|FG000|Completed 4 More Cycles|Progressive disease|2
7262431|NCT00369629|11475279|FG001|Completed 4 More Cycles|Progressive disease|1
7262432|NCT00369629|11475280|FG002|Completed 4 More Cycles|Progressive disease|2
7262433|NCT00369629|11475281|FG003|Completed 4 More Cycles|Progressive disease|0
7262434|NCT00369629|11475278|FG000|Follow up for 1 Year|Death|2
7262435|NCT00369629|11475279|FG001|Follow up for 1 Year|Death|1
7262436|NCT00369629|11475280|FG002|Follow up for 1 Year|Death|1
7262437|NCT00369629|11475281|FG003|Follow up for 1 Year|Death|0
7262438|NCT00369629|11475278|FG000|Follow up for 1 Year|Lost to Follow-up|0
7262439|NCT00369629|11475279|FG001|Follow up for 1 Year|Lost to Follow-up|1
7262440|NCT00369629|11475280|FG002|Follow up for 1 Year|Lost to Follow-up|0
7262441|NCT00369629|11475281|FG003|Follow up for 1 Year|Lost to Follow-up|0
7262442|NCT00369629|11475278|FG000|Follow up for 1 Year|stopped being followed as study closed|0
7262443|NCT00369629|11475279|FG001|Follow up for 1 Year|stopped being followed as study closed|0
7262444|NCT00369629|11475280|FG002|Follow up for 1 Year|stopped being followed as study closed|2
7262445|NCT00369629|11475281|FG003|Follow up for 1 Year|stopped being followed as study closed|0
7262446|NCT00369655|11475291|FG000|Overall Study|Refusal of further treatment|2
7262447|NCT00369668|11475298|FG000|Overall Study|Lack of Efficacy|4
7262448|NCT00369668|11475299|FG001|Overall Study|Lack of Efficacy|5
7262449|NCT00369668|11475300|FG002|Overall Study|Lack of Efficacy|7
7262450|NCT00369681|11475311|FG000|Overall Study|Death|1
7262451|NCT00369707|11475315|FG000|Induction Part B (2 Cycles)|Adverse Event|3
7262452|NCT00369707|11475315|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
7262453|NCT00369707|11475315|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
7262454|NCT00369707|11475315|FG000|Induction Part B (2 Cycles)|Progressive disease|1
7262455|NCT00369707|11475315|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
7262456|NCT00369707|11475315|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
7262457|NCT00369707|11475315|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
7262458|NCT00369707|11475315|FG000|Follow up for 2 Years After Treatment|Death|1
7262459|NCT00369707|11475315|FG000|Follow up for 2 Years After Treatment|Other|2
7262460|NCT00369785|11475330|FG000|Overall Study|Physician Decision|3
7262461|NCT00369785|11475331|FG001|Overall Study|Physician Decision|2
7262462|NCT00369785|11475330|FG000|Overall Study|Death|1
7262463|NCT00369785|11475331|FG001|Overall Study|Death|2
7262464|NCT00369785|11475330|FG000|Overall Study|Withdrawal by Subject|7
7262465|NCT00369785|11475331|FG001|Overall Study|Withdrawal by Subject|6
7262466|NCT00369785|11475330|FG000|Overall Study|Toxicity|6
7262467|NCT00369785|11475331|FG001|Overall Study|Toxicity|4
7262468|NCT00369785|11475330|FG000|Overall Study|Never started|0
7262469|NCT00369785|11475331|FG001|Overall Study|Never started|2
7262470|NCT00369785|11475330|FG000|Overall Study|Progression|4
7262471|NCT00369785|11475331|FG001|Overall Study|Progression|4
7262472|NCT00369785|11475330|FG000|Overall Study|Multiple reasons|6
7262473|NCT00369785|11475331|FG001|Overall Study|Multiple reasons|5
7262474|NCT00369824|11475343|FG000|Overall Study|Adverse Event|0
7262475|NCT00369824|11475344|FG001|Overall Study|Adverse Event|2
7262476|NCT00369824|11475345|FG002|Overall Study|Adverse Event|0
7576692|NCT04292730|11963512|FG001|Overall Study|Lost to Follow-up|12
7576693|NCT04292730|11963513|FG002|Overall Study|Lost to Follow-up|12
7576694|NCT04292730|11963514|FG003|Overall Study|Lost to Follow-up|48
7576695|NCT04292730|11963511|FG000|Overall Study|Death|2
7576696|NCT04292730|11963512|FG001|Overall Study|Death|2
7576697|NCT04292730|11963513|FG002|Overall Study|Death|4
7576698|NCT04292730|11963514|FG003|Overall Study|Death|12
7576699|NCT04292730|11963511|FG000|Overall Study|Withdrew Consent|2
7576700|NCT04292730|11963512|FG001|Overall Study|Withdrew Consent|2
7576701|NCT04292730|11963513|FG002|Overall Study|Withdrew Consent|5
7576702|NCT04292730|11963514|FG003|Overall Study|Withdrew Consent|6
7576703|NCT04292730|11963511|FG000|Overall Study|Non-Compliance with Study Drug|0
7576704|NCT04292730|11963512|FG001|Overall Study|Non-Compliance with Study Drug|1
7576705|NCT04292730|11963513|FG002|Overall Study|Non-Compliance with Study Drug|0
7576706|NCT04292730|11963514|FG003|Overall Study|Non-Compliance with Study Drug|0
7576707|NCT04292730|11963511|FG000|Overall Study|Protocol Violation|0
7576708|NCT04292730|11963512|FG001|Overall Study|Protocol Violation|0
7576709|NCT04292730|11963513|FG002|Overall Study|Protocol Violation|1
7576710|NCT04292730|11963514|FG003|Overall Study|Protocol Violation|0
7576711|NCT04292730|11963511|FG000|Overall Study|Randomized but not Treated|8
7576712|NCT04292730|11963512|FG001|Overall Study|Randomized but not Treated|4
7576713|NCT04292730|11963513|FG002|Overall Study|Randomized but not Treated|0
7576714|NCT04292730|11963514|FG003|Overall Study|Randomized but not Treated|14
7262477|NCT00369824|11475346|FG003|Overall Study|Adverse Event|0
7262478|NCT00369824|11475347|FG004|Overall Study|Adverse Event|1
7262479|NCT00369824|11475348|FG005|Overall Study|Adverse Event|0
7262480|NCT00369824|11475343|FG000|Overall Study|Protocol Violation|0
7262481|NCT00369824|11475344|FG001|Overall Study|Protocol Violation|1
7262482|NCT00369824|11475345|FG002|Overall Study|Protocol Violation|0
7262483|NCT00369824|11475346|FG003|Overall Study|Protocol Violation|1
7262484|NCT00369824|11475347|FG004|Overall Study|Protocol Violation|1
7262485|NCT00369824|11475348|FG005|Overall Study|Protocol Violation|0
7262486|NCT00369824|11475343|FG000|Overall Study|Withdrawal by Subject|9
7262487|NCT00369824|11475344|FG001|Overall Study|Withdrawal by Subject|5
7262488|NCT00369824|11475345|FG002|Overall Study|Withdrawal by Subject|5
7262489|NCT00369824|11475346|FG003|Overall Study|Withdrawal by Subject|4
7262490|NCT00369824|11475347|FG004|Overall Study|Withdrawal by Subject|6
7262491|NCT00369824|11475348|FG005|Overall Study|Withdrawal by Subject|2
7262492|NCT00369824|11475343|FG000|Overall Study|Lost to Follow-up|6
7262493|NCT00369824|11475344|FG001|Overall Study|Lost to Follow-up|11
7262494|NCT00369824|11475345|FG002|Overall Study|Lost to Follow-up|7
7262495|NCT00369824|11475346|FG003|Overall Study|Lost to Follow-up|8
7262496|NCT00369824|11475347|FG004|Overall Study|Lost to Follow-up|9
7262497|NCT00369824|11475348|FG005|Overall Study|Lost to Follow-up|6
7262498|NCT00369824|11475343|FG000|Overall Study|Other|0
7262499|NCT00369824|11475344|FG001|Overall Study|Other|0
7262500|NCT00369824|11475345|FG002|Overall Study|Other|0
7262501|NCT00369824|11475346|FG003|Overall Study|Other|2
7262502|NCT00369824|11475347|FG004|Overall Study|Other|1
7262503|NCT00369824|11475348|FG005|Overall Study|Other|3
7576715|NCT04289623|11963547|FG000|Wave 1 Emails|Email was not delivered|268
7576716|NCT04289623|11963548|FG001|Wave 1 Emails|Email was not delivered|257
7576717|NCT04289623|11963549|FG002|Wave 1 Emails|Email was not delivered|0
7576718|NCT04289623|11963550|FG003|Wave 1 Emails|Email was not delivered|0
7576719|NCT04289623|11963551|FG004|Wave 1 Emails|Email was not delivered|0
7262504|NCT00369915|11475364|FG000|Overall Study|expected side effects|2
7262505|NCT00369915|11475365|FG001|Overall Study|expected side effects|1
7576720|NCT04289623|11963552|FG005|Wave 1 Emails|Email was not delivered|0
7576721|NCT04276207|11963566|FG000|Period 1|Withdrawal by Subject|0
7262506|NCT00369915|11475364|FG000|Overall Study|Withdrawal by Subject|4
7262507|NCT00369915|11475365|FG001|Overall Study|Withdrawal by Subject|1
7262508|NCT00369915|11475364|FG000|Overall Study|W/drawl by investigators|0
7262509|NCT00369915|11475365|FG001|Overall Study|W/drawl by investigators|1
7262510|NCT00369941|11475386|FG000|Overall Study|Never Treated|1
7262511|NCT00369941|11475387|FG001|Overall Study|Never Treated|2
7262512|NCT00369941|11475386|FG000|Overall Study|Adverse Event|14
7262513|NCT00369941|11475387|FG001|Overall Study|Adverse Event|28
7262514|NCT00369941|11475386|FG000|Overall Study|Lack of Efficacy|6
7576722|NCT04276207|11963567|FG001|Period 1|Withdrawal by Subject|1
7576723|NCT04287517|11963597|FG000|Overall Study|Withdrawal by Subject|1
7576724|NCT04287517|11963598|FG001|Overall Study|Withdrawal by Subject|1
7262515|NCT00369941|11475387|FG001|Overall Study|Lack of Efficacy|10
7262516|NCT00369941|11475386|FG000|Overall Study|Lost to Follow-up|12
7262517|NCT00369941|11475387|FG001|Overall Study|Lost to Follow-up|22
7262518|NCT00369941|11475386|FG000|Overall Study|Protocol Violation|5
7262519|NCT00369941|11475387|FG001|Overall Study|Protocol Violation|3
7262520|NCT00369941|11475386|FG000|Overall Study|Withdrawal by Subject|5
7262521|NCT00369941|11475387|FG001|Overall Study|Withdrawal by Subject|18
7262522|NCT00369941|11475386|FG000|Overall Study|Pregnancy|4
7262523|NCT00369941|11475387|FG001|Overall Study|Pregnancy|2
7262524|NCT00369941|11475386|FG000|Overall Study|Completed, Did Not Enter Extension|5
7262525|NCT00369941|11475387|FG001|Overall Study|Completed, Did Not Enter Extension|6
7262526|NCT00369941|11475386|FG000|Overall Study|Moved|11
7262527|NCT00369941|11475387|FG001|Overall Study|Moved|5
7262528|NCT00369941|11475386|FG000|Overall Study|Treatment with Prohibited Medication|3
7262529|NCT00369941|11475387|FG001|Overall Study|Treatment with Prohibited Medication|1
7576725|NCT04275336|11963664|FG000|Overall Study|First venipuncture failed|4
7576726|NCT04275336|11963665|FG001|Overall Study|First venipuncture failed|6
7576727|NCT04275336|11963666|FG002|Overall Study|First venipuncture failed|5
7576728|NCT04275336|11963664|FG000|Overall Study|Unscheduled venipuncture|9
7576729|NCT04275336|11963665|FG001|Overall Study|Unscheduled venipuncture|13
7576730|NCT04275336|11963666|FG002|Overall Study|Unscheduled venipuncture|7
7576731|NCT04275336|11963664|FG000|Overall Study|Failed specimen of saliva|4
7576732|NCT04275336|11963665|FG001|Overall Study|Failed specimen of saliva|3
7576733|NCT04275336|11963666|FG002|Overall Study|Failed specimen of saliva|4
7576734|NCT04272775|11963679|FG000|Overall Study|Study Terminated by Sponsor|1
7576735|NCT04272775|11963680|FG001|Overall Study|Study Terminated by Sponsor|0
7576736|NCT04272775|11963679|FG000|Overall Study|Protocol Violation|0
7262530|NCT00369941|11475386|FG000|Overall Study|Employment Interfered with Study Visits|1
7262531|NCT00369941|11475387|FG001|Overall Study|Employment Interfered with Study Visits|0
7262532|NCT00369941|11475386|FG000|Overall Study|Study Site Terminated|2
7262533|NCT00369941|11475387|FG001|Overall Study|Study Site Terminated|0
7262534|NCT00369941|11475386|FG000|Overall Study|Miscellaneous|3
7576737|NCT04272775|11963680|FG001|Overall Study|Protocol Violation|1
7576738|NCT04272775|11963679|FG000|Overall Study|Symptomatic Deterioration|1
7576739|NCT04272775|11963680|FG001|Overall Study|Symptomatic Deterioration|1
7576740|NCT04272775|11963679|FG000|Overall Study|Withdrawal by Subject|1
7576741|NCT04272775|11963680|FG001|Overall Study|Withdrawal by Subject|2
7576742|NCT04272775|11963679|FG000|Overall Study|Adverse Event|1
7576743|NCT04272775|11963680|FG001|Overall Study|Adverse Event|2
7576744|NCT04272775|11963679|FG000|Overall Study|Progressive Disease|3
7262535|NCT00369941|11475387|FG001|Overall Study|Miscellaneous|3
7262536|NCT00369967|11475396|FG000|Overall Study|Lost to Follow-up|23
7544237|NCT02820844|11897837|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7544238|NCT02820844|11897832|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7544239|NCT02820844|11897833|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
7544240|NCT02820844|11897834|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7544241|NCT02820844|11897835|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7544242|NCT02820844|11897836|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7544243|NCT02820844|11897837|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7544244|NCT02820844|11897832|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
7544245|NCT02820844|11897833|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
7544246|NCT02820844|11897834|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7544247|NCT02820844|11897835|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7576745|NCT04272775|11963680|FG001|Overall Study|Progressive Disease|1
7576746|NCT04271605|11963712|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
7576747|NCT04268316|11963723|FG000|Overall Study|Withdrawal by Subject|2
7576748|NCT04268316|11963724|FG001|Overall Study|Withdrawal by Subject|1
7262537|NCT00369967|11475397|FG001|Overall Study|Lost to Follow-up|12
7262538|NCT00370032|11475409|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
7262539|NCT00370032|11475410|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
7262540|NCT00370032|11475409|FG000|Washout Period|Withdrawal by Subject|0
7262541|NCT00370032|11475410|FG001|Washout Period|Withdrawal by Subject|1
7262542|NCT00370032|11475409|FG000|Washout Period|Lost to Follow-up|0
7262543|NCT00370032|11475410|FG001|Washout Period|Lost to Follow-up|1
7262544|NCT00370032|11475409|FG000|Washout Period|Adverse Event|1
7262545|NCT00370032|11475410|FG001|Washout Period|Adverse Event|0
7262546|NCT00370032|11475409|FG000|Follow-up Period|Withdrawal by Subject|1
7262547|NCT00370032|11475410|FG001|Follow-up Period|Withdrawal by Subject|0
7262548|NCT00370071|11475425|FG000|Overall Study|Withdrawal by Subject|2
7262549|NCT00370149|11475431|FG000|Overall Study|Physician Decision|16
7262550|NCT00370149|11475432|FG001|Overall Study|Physician Decision|16
7262551|NCT00370149|11475431|FG000|Overall Study|Protocol Violation|1
7262552|NCT00370149|11475432|FG001|Overall Study|Protocol Violation|0
7262553|NCT00370149|11475431|FG000|Overall Study|Catheter inserted in wrong vessel-|2
7262554|NCT00370149|11475432|FG001|Overall Study|Catheter inserted in wrong vessel-|1
7262555|NCT00370149|11475431|FG000|Overall Study|Pre-existing infection|0
7262556|NCT00370149|11475432|FG001|Overall Study|Pre-existing infection|1
7262557|NCT00370149|11475431|FG000|Overall Study|Antibiotic coated dressing placed|0
7262558|NCT00370149|11475432|FG001|Overall Study|Antibiotic coated dressing placed|1
7262559|NCT00370292|11475443|FG000|Overall Study|Disease Progression|4
7262560|NCT00370292|11475443|FG000|Overall Study|Adverse Event|7
7262561|NCT00370292|11475443|FG000|Overall Study|Physician Decision|2
7387968|NCT01217073|11646680|FG006|Extension Period|Death|1
7387969|NCT01217073|11646681|FG007|Extension Period|Death|0
7387970|NCT01217073|11646674|FG000|Extension Period|Excluded medication|0
7387971|NCT01217073|11646675|FG001|Extension Period|Excluded medication|0
7387972|NCT01217073|11646676|FG002|Extension Period|Excluded medication|0
7387973|NCT01217073|11646677|FG003|Extension Period|Excluded medication|0
7387974|NCT01217073|11646678|FG004|Extension Period|Excluded medication|0
7387975|NCT01217073|11646679|FG005|Extension Period|Excluded medication|0
7387976|NCT01217073|11646680|FG006|Extension Period|Excluded medication|2
7387977|NCT01217073|11646681|FG007|Extension Period|Excluded medication|0
7387978|NCT01217073|11646674|FG000|Extension Period|Lack of Efficacy|0
7387979|NCT01217073|11646675|FG001|Extension Period|Lack of Efficacy|0
7387980|NCT01217073|11646676|FG002|Extension Period|Lack of Efficacy|0
7387981|NCT01217073|11646677|FG003|Extension Period|Lack of Efficacy|0
7387982|NCT01217073|11646678|FG004|Extension Period|Lack of Efficacy|0
7387983|NCT01217073|11646679|FG005|Extension Period|Lack of Efficacy|0
7387984|NCT01217073|11646680|FG006|Extension Period|Lack of Efficacy|3
7387985|NCT01217073|11646681|FG007|Extension Period|Lack of Efficacy|0
7387986|NCT01217073|11646674|FG000|Extension Period|Lost to Follow-up|0
7387987|NCT01217073|11646675|FG001|Extension Period|Lost to Follow-up|0
7387988|NCT01217073|11646676|FG002|Extension Period|Lost to Follow-up|0
7387989|NCT01217073|11646677|FG003|Extension Period|Lost to Follow-up|0
7387990|NCT01217073|11646678|FG004|Extension Period|Lost to Follow-up|0
7387991|NCT01217073|11646679|FG005|Extension Period|Lost to Follow-up|0
7387992|NCT01217073|11646680|FG006|Extension Period|Lost to Follow-up|9
7387993|NCT01217073|11646681|FG007|Extension Period|Lost to Follow-up|1
7387994|NCT01217073|11646674|FG000|Extension Period|Non-compliance with study drug|0
7387995|NCT01217073|11646675|FG001|Extension Period|Non-compliance with study drug|0
7387996|NCT01217073|11646676|FG002|Extension Period|Non-compliance with study drug|0
7387997|NCT01217073|11646677|FG003|Extension Period|Non-compliance with study drug|0
7387998|NCT01217073|11646678|FG004|Extension Period|Non-compliance with study drug|0
7387999|NCT01217073|11646679|FG005|Extension Period|Non-compliance with study drug|0
7388000|NCT01217073|11646680|FG006|Extension Period|Non-compliance with study drug|0
7388001|NCT01217073|11646681|FG007|Extension Period|Non-compliance with study drug|1
7388002|NCT01217073|11646674|FG000|Extension Period|Physician Decision|0
7388003|NCT01217073|11646675|FG001|Extension Period|Physician Decision|0
7576749|NCT04268316|11963725|FG002|Overall Study|Withdrawal by Subject|0
7388004|NCT01217073|11646676|FG002|Extension Period|Physician Decision|0
7388005|NCT01217073|11646677|FG003|Extension Period|Physician Decision|0
7388006|NCT01217073|11646678|FG004|Extension Period|Physician Decision|0
7388007|NCT01217073|11646679|FG005|Extension Period|Physician Decision|0
7388008|NCT01217073|11646680|FG006|Extension Period|Physician Decision|4
7388009|NCT01217073|11646681|FG007|Extension Period|Physician Decision|1
7388010|NCT01217073|11646674|FG000|Extension Period|Protocol Violation|0
7388011|NCT01217073|11646675|FG001|Extension Period|Protocol Violation|0
7388012|NCT01217073|11646676|FG002|Extension Period|Protocol Violation|0
7388013|NCT01217073|11646677|FG003|Extension Period|Protocol Violation|0
7388014|NCT01217073|11646678|FG004|Extension Period|Protocol Violation|0
7576750|NCT04263142|11963768|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
7576751|NCT04263142|11963769|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
7576752|NCT04263142|11963770|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
7576753|NCT04263142|11963771|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
7576754|NCT04263142|11963772|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
7576755|NCT04263142|11963768|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
7576756|NCT04263142|11963769|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
7262562|NCT04876274|11475456|FG000|Overall Study|Lost to Follow-up|9
7262563|NCT04876274|11475457|FG001|Overall Study|Lost to Follow-up|12
7262564|NCT04656691|11475463|FG000|Overall Study|Adverse Event|1
7262565|NCT04555096|11475478|FG000|Overall Study|Death|4
7262566|NCT04555096|11475479|FG001|Overall Study|Death|4
7262567|NCT04555096|11475478|FG000|Overall Study|Withdrawal by Subject|1
7262568|NCT04555096|11475479|FG001|Overall Study|Withdrawal by Subject|0
7262569|NCT04555096|11475478|FG000|Overall Study|Other|0
7262570|NCT04555096|11475479|FG001|Overall Study|Other|1
7262571|NCT04150341|11475485|FG000|Overall Study|Physician Decision|0
7262572|NCT04150341|11475486|FG001|Overall Study|Physician Decision|0
7262573|NCT04150341|11475487|FG002|Overall Study|Physician Decision|1
7262574|NCT04150341|11475488|FG003|Overall Study|Physician Decision|0
7262575|NCT04150341|11475489|FG004|Overall Study|Physician Decision|0
7262576|NCT04150341|11475490|FG005|Overall Study|Physician Decision|0
7262577|NCT04150341|11475485|FG000|Overall Study|Adverse Event|0
7544248|NCT02820844|11897836|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7544249|NCT02820844|11897837|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7544250|NCT02820844|11897832|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
7544251|NCT02820844|11897833|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7544252|NCT02820844|11897834|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7544253|NCT02820844|11897835|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7544254|NCT02820844|11897836|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7544255|NCT02820844|11897837|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7544256|NCT02820844|11897832|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7544257|NCT02820844|11897833|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7544258|NCT02820844|11897834|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
7544259|NCT02820844|11897835|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
7544260|NCT02820844|11897836|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7544261|NCT02820844|11897837|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7544262|NCT02820844|11897832|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7544263|NCT02820844|11897833|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7544264|NCT02820844|11897834|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
7544265|NCT02820844|11897835|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7544266|NCT02820844|11897836|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7544267|NCT02820844|11897837|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7544268|NCT02820844|11897832|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544269|NCT02820844|11897833|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544270|NCT02820844|11897834|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
7544271|NCT02820844|11897835|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
7544272|NCT02820844|11897836|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544273|NCT02820844|11897837|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544274|NCT02820844|11897832|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7262578|NCT04150341|11475486|FG001|Overall Study|Adverse Event|0
7262579|NCT04150341|11475487|FG002|Overall Study|Adverse Event|0
7262580|NCT04150341|11475488|FG003|Overall Study|Adverse Event|0
7262581|NCT04150341|11475489|FG004|Overall Study|Adverse Event|1
7262582|NCT04150341|11475490|FG005|Overall Study|Adverse Event|0
7262583|NCT04115839|11475503|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
7262584|NCT04115839|11475504|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13
7262585|NCT04115839|11475505|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
7262586|NCT04115839|11475506|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7262587|NCT04115839|11475507|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7262588|NCT04115839|11475508|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7262589|NCT04115839|11475509|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
7262590|NCT04115839|11475503|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2
7262591|NCT04115839|11475504|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1
7262592|NCT04115839|11475505|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3
7262593|NCT04115839|11475506|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7262594|NCT04115839|11475507|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7262595|NCT04115839|11475508|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7262596|NCT04115839|11475509|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0
7262597|NCT04115839|11475503|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2
7262598|NCT04115839|11475504|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0
7262599|NCT04115839|11475505|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0
7262600|NCT04115839|11475506|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0
7262601|NCT04115839|11475507|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0
7262602|NCT04115839|11475508|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0
7262603|NCT04115839|11475509|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0
7262604|NCT04115839|11475503|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262605|NCT04115839|11475504|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262606|NCT04115839|11475505|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1
7262607|NCT04115839|11475506|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262608|NCT04115839|11475507|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262609|NCT04115839|11475508|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262610|NCT04115839|11475509|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
7262611|NCT04115839|11475503|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7262612|NCT04115839|11475504|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7262613|NCT04115839|11475505|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
7262614|NCT04115839|11475506|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17
7262615|NCT04115839|11475507|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19
7262616|NCT04115839|11475508|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10
7262617|NCT04115839|11475509|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8
7262618|NCT04115839|11475503|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7262619|NCT04115839|11475504|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7262620|NCT04115839|11475505|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7262621|NCT04115839|11475506|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
7262622|NCT04115839|11475507|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
7262623|NCT04115839|11475508|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7262624|NCT04115839|11475509|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
7262625|NCT04078126|11475534|FG000|Washout|Study put on hold due to COVID-19|0
7262626|NCT04078126|11475535|FG001|Washout|Study put on hold due to COVID-19|2
7262627|NCT04078126|11475534|FG000|Period 2|Study put on hold due to COVID-19|1
7262628|NCT04078126|11475535|FG001|Period 2|Study put on hold due to COVID-19|1
7262629|NCT03825341|11475543|FG000|Overall Study|Withdrawal by Subject|0
7262630|NCT03825341|11475544|FG001|Overall Study|Withdrawal by Subject|1
7388015|NCT01217073|11646679|FG005|Extension Period|Protocol Violation|0
7388016|NCT01217073|11646680|FG006|Extension Period|Protocol Violation|2
7388017|NCT01217073|11646681|FG007|Extension Period|Protocol Violation|1
7388018|NCT01217073|11646674|FG000|Extension Period|Site discontinued study participation|0
7388019|NCT01217073|11646675|FG001|Extension Period|Site discontinued study participation|0
7388020|NCT01217073|11646676|FG002|Extension Period|Site discontinued study participation|0
7388021|NCT01217073|11646677|FG003|Extension Period|Site discontinued study participation|0
7388022|NCT01217073|11646678|FG004|Extension Period|Site discontinued study participation|0
7388023|NCT01217073|11646679|FG005|Extension Period|Site discontinued study participation|0
7388024|NCT01217073|11646680|FG006|Extension Period|Site discontinued study participation|7
7388025|NCT01217073|11646681|FG007|Extension Period|Site discontinued study participation|2
7388026|NCT01217073|11646674|FG000|Extension Period|Withdrawal by Subject|0
7388027|NCT01217073|11646675|FG001|Extension Period|Withdrawal by Subject|0
7388028|NCT01217073|11646676|FG002|Extension Period|Withdrawal by Subject|0
7388029|NCT01217073|11646677|FG003|Extension Period|Withdrawal by Subject|0
7388030|NCT01217073|11646678|FG004|Extension Period|Withdrawal by Subject|0
7388031|NCT01217073|11646679|FG005|Extension Period|Withdrawal by Subject|0
7388032|NCT01217073|11646680|FG006|Extension Period|Withdrawal by Subject|30
7388033|NCT01217073|11646681|FG007|Extension Period|Withdrawal by Subject|8
7388034|NCT01217112|11646710|FG000|Overall Study|Adverse Event|0
7262631|NCT03751631|11475552|FG000|Overall Study|Withdrawal by Subject|0
7262632|NCT03751631|11475553|FG001|Overall Study|Withdrawal by Subject|0
7262633|NCT03751631|11475554|FG002|Overall Study|Withdrawal by Subject|1
7262634|NCT03751631|11475555|FG003|Overall Study|Withdrawal by Subject|1
7262635|NCT03751631|11475556|FG004|Overall Study|Withdrawal by Subject|0
7262636|NCT03751631|11475557|FG005|Overall Study|Withdrawal by Subject|0
7262637|NCT03751098|11475568|FG000|Overall Study|Withdrawal by Subject|0
7262638|NCT03751098|11475569|FG001|Overall Study|Withdrawal by Subject|1
7262639|NCT03673345|11475585|FG000|Overall Study|Lost to Follow-up|1
7262640|NCT03673345|11475586|FG001|Overall Study|Lost to Follow-up|0
7262641|NCT03673345|11475587|FG002|Overall Study|Lost to Follow-up|3
7262642|NCT03673345|11475588|FG003|Overall Study|Lost to Follow-up|3
7262643|NCT03673345|11475589|FG004|Overall Study|Lost to Follow-up|2
7262644|NCT03673345|11475590|FG005|Overall Study|Lost to Follow-up|1
7262645|NCT03673345|11475591|FG006|Overall Study|Lost to Follow-up|0
7262646|NCT03673345|11475592|FG007|Overall Study|Lost to Follow-up|0
7262647|NCT03673345|11475585|FG000|Overall Study|Withdrawal by Subject|1
7262648|NCT03673345|11475586|FG001|Overall Study|Withdrawal by Subject|0
7262649|NCT03673345|11475587|FG002|Overall Study|Withdrawal by Subject|4
7262650|NCT03673345|11475588|FG003|Overall Study|Withdrawal by Subject|2
7262651|NCT03673345|11475589|FG004|Overall Study|Withdrawal by Subject|0
7262652|NCT03673345|11475590|FG005|Overall Study|Withdrawal by Subject|0
7262653|NCT03673345|11475591|FG006|Overall Study|Withdrawal by Subject|0
7262654|NCT03673345|11475592|FG007|Overall Study|Withdrawal by Subject|0
7262655|NCT03673345|11475585|FG000|Overall Study|Physician Decision|0
7262656|NCT03673345|11475586|FG001|Overall Study|Physician Decision|0
7262657|NCT03673345|11475587|FG002|Overall Study|Physician Decision|2
7262658|NCT03673345|11475588|FG003|Overall Study|Physician Decision|0
7262659|NCT03673345|11475589|FG004|Overall Study|Physician Decision|0
7262660|NCT03673345|11475590|FG005|Overall Study|Physician Decision|0
7262661|NCT03673345|11475591|FG006|Overall Study|Physician Decision|0
7576757|NCT04263142|11963770|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
7576758|NCT04263142|11963771|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
7262662|NCT03673345|11475592|FG007|Overall Study|Physician Decision|0
7262663|NCT03418675|11475612|FG000|Overall Study|Lost to Follow-up|13
7262664|NCT03418675|11475613|FG001|Overall Study|Lost to Follow-up|10
7262665|NCT03418675|11475612|FG000|Overall Study|Adverse Event|2
7262666|NCT03418675|11475613|FG001|Overall Study|Adverse Event|0
7262667|NCT03329690|11475628|FG000|Overall Study|Progressive disease per RECIST|85
7262668|NCT03329690|11475629|FG001|Overall Study|Progressive disease per RECIST|44
7262669|NCT03329690|11475630|FG002|Overall Study|Progressive disease per RECIST|6
7262670|NCT03329690|11475631|FG003|Overall Study|Progressive disease per RECIST|16
7262671|NCT03329690|11475632|FG004|Overall Study|Progressive disease per RECIST|20
7262672|NCT03329690|11475628|FG000|Overall Study|Clinical progression|7
7262673|NCT03329690|11475629|FG001|Overall Study|Clinical progression|4
7262674|NCT03329690|11475630|FG002|Overall Study|Clinical progression|1
7262675|NCT03329690|11475631|FG003|Overall Study|Clinical progression|1
7262676|NCT03329690|11475632|FG004|Overall Study|Clinical progression|1
7262677|NCT03329690|11475628|FG000|Overall Study|Adverse Event|22
7262678|NCT03329690|11475629|FG001|Overall Study|Adverse Event|4
7262679|NCT03329690|11475630|FG002|Overall Study|Adverse Event|0
7262680|NCT03329690|11475631|FG003|Overall Study|Adverse Event|1
7262681|NCT03329690|11475632|FG004|Overall Study|Adverse Event|2
7262682|NCT03329690|11475628|FG000|Overall Study|Death|2
7262683|NCT03329690|11475629|FG001|Overall Study|Death|0
7262684|NCT03329690|11475630|FG002|Overall Study|Death|0
7262685|NCT03329690|11475631|FG003|Overall Study|Death|1
7262686|NCT03329690|11475632|FG004|Overall Study|Death|0
7262687|NCT03329690|11475628|FG000|Overall Study|Withdrawal by Subject|2
7262688|NCT03329690|11475629|FG001|Overall Study|Withdrawal by Subject|3
7262689|NCT03329690|11475630|FG002|Overall Study|Withdrawal by Subject|0
7262690|NCT03329690|11475631|FG003|Overall Study|Withdrawal by Subject|1
7262691|NCT03329690|11475632|FG004|Overall Study|Withdrawal by Subject|0
7262692|NCT03329690|11475628|FG000|Overall Study|Physician Decision|1
7262693|NCT03329690|11475629|FG001|Overall Study|Physician Decision|0
7262694|NCT03329690|11475630|FG002|Overall Study|Physician Decision|0
7262695|NCT03329690|11475631|FG003|Overall Study|Physician Decision|0
7262696|NCT03329690|11475632|FG004|Overall Study|Physician Decision|1
7262697|NCT03329690|11475628|FG000|Overall Study|Miscellaneous|6
7262698|NCT03329690|11475629|FG001|Overall Study|Miscellaneous|0
7262699|NCT03329690|11475630|FG002|Overall Study|Miscellaneous|0
7262700|NCT03329690|11475631|FG003|Overall Study|Miscellaneous|0
7262701|NCT03329690|11475632|FG004|Overall Study|Miscellaneous|0
7262702|NCT03329690|11475628|FG000|Overall Study|Did not receive treatment|1
7262703|NCT03329690|11475629|FG001|Overall Study|Did not receive treatment|0
7262704|NCT03329690|11475630|FG002|Overall Study|Did not receive treatment|0
7262705|NCT03329690|11475631|FG003|Overall Study|Did not receive treatment|1
7262706|NCT03329690|11475632|FG004|Overall Study|Did not receive treatment|0
7262707|NCT03320564|11475650|FG000|Overall Study|Protocol Violation|1
7262708|NCT03165955|11475668|FG000|Treatment|Withdrawal by Subject|3
7262709|NCT03165955|11475668|FG000|Treatment|Death|1
7262710|NCT03165955|11475668|FG000|Treatment|Adverse Event|1
7262711|NCT03165955|11475668|FG000|Treatment|Progressive disease|3
7262712|NCT03133793|11475676|FG000|Overall Study|Withdrawal by Subject|0
7262713|NCT03133793|11475677|FG001|Overall Study|Withdrawal by Subject|4
7262714|NCT03133793|11475678|FG002|Overall Study|Withdrawal by Subject|2
7262715|NCT03133793|11475679|FG003|Overall Study|Withdrawal by Subject|4
7262716|NCT03133793|11475676|FG000|Overall Study|Lost to Follow-up|1
7262717|NCT03133793|11475677|FG001|Overall Study|Lost to Follow-up|0
7262718|NCT03133793|11475678|FG002|Overall Study|Lost to Follow-up|2
7262719|NCT03133793|11475679|FG003|Overall Study|Lost to Follow-up|0
7262720|NCT03133793|11475676|FG000|Overall Study|Death|0
7262721|NCT03133793|11475677|FG001|Overall Study|Death|0
7262722|NCT03133793|11475678|FG002|Overall Study|Death|0
7262723|NCT03133793|11475679|FG003|Overall Study|Death|1
7262724|NCT03103542|11475693|FG000|Overall Study|Physician Decision|2
7262725|NCT03103542|11475693|FG000|Overall Study|Adverse Event|2
7262726|NCT03103542|11475693|FG000|Overall Study|Other|2
7262727|NCT03103542|11475693|FG000|Overall Study|Withdrawal by Subject|1
7262728|NCT02676765|11475709|FG000|Overall Study|Lost to Follow-up|0
7262729|NCT02676765|11475710|FG001|Overall Study|Lost to Follow-up|1
7262730|NCT02362451|11475736|FG000|Overall Study|Withdrawal by Subject|0
7262731|NCT02362451|11475737|FG001|Overall Study|Withdrawal by Subject|1
7262732|NCT02362451|11475736|FG000|Overall Study|Lack of Efficacy|2
7262733|NCT02362451|11475737|FG001|Overall Study|Lack of Efficacy|0
7262734|NCT02362451|11475736|FG000|Overall Study|Progression|1
7262735|NCT02362451|11475737|FG001|Overall Study|Progression|0
7262736|NCT02362451|11475736|FG000|Overall Study|Participant chose other therapy.|1
7262737|NCT02362451|11475737|FG001|Overall Study|Participant chose other therapy.|0
7388035|NCT01217112|11646711|FG001|Overall Study|Adverse Event|2
7388036|NCT01217112|11646712|FG002|Overall Study|Adverse Event|0
7388037|NCT01217112|11646713|FG003|Overall Study|Adverse Event|2
7388038|NCT01217112|11646714|FG004|Overall Study|Adverse Event|0
7388039|NCT01217112|11646710|FG000|Overall Study|Withdrawal by Subject|0
7388040|NCT01217112|11646711|FG001|Overall Study|Withdrawal by Subject|0
7388041|NCT01217112|11646712|FG002|Overall Study|Withdrawal by Subject|1
7388042|NCT01217112|11646713|FG003|Overall Study|Withdrawal by Subject|0
7388043|NCT01217112|11646714|FG004|Overall Study|Withdrawal by Subject|0
7388044|NCT01217112|11646710|FG000|Overall Study|Physician Decision|0
7388045|NCT01217112|11646711|FG001|Overall Study|Physician Decision|0
7388046|NCT01217112|11646712|FG002|Overall Study|Physician Decision|0
7544275|NCT02820844|11897833|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7388047|NCT01217112|11646713|FG003|Overall Study|Physician Decision|0
7388048|NCT01217112|11646714|FG004|Overall Study|Physician Decision|1
7388049|NCT01217190|11646728|FG000|Second Dosing|Withdrawal by Subject|0
7388050|NCT01217190|11646729|FG001|Second Dosing|Withdrawal by Subject|2
7388051|NCT01217229|11646738|FG000|Overall Study|Adverse Event|1
7262752|NCT02180724|11475771|FG000|Overall Study|Death|12
7262753|NCT02180724|11475772|FG001|Overall Study|Death|1
7262754|NCT02180724|11475771|FG000|Overall Study|Lost to Follow-up|1
7262755|NCT02180724|11475772|FG001|Overall Study|Lost to Follow-up|0
7262756|NCT02180724|11475771|FG000|Overall Study|Withdrawal by Subject|1
7262757|NCT02180724|11475772|FG001|Overall Study|Withdrawal by Subject|2
7262758|NCT02180724|11475771|FG000|Overall Study|Ongoing Study|78
7262759|NCT02180724|11475772|FG001|Overall Study|Ongoing Study|11
7262760|NCT02038777|11475786|FG000|Overall Study|Death|0
7262761|NCT02038777|11475787|FG001|Overall Study|Death|2
7262762|NCT02038777|11475788|FG002|Overall Study|Death|0
7262763|NCT02038777|11475789|FG003|Overall Study|Death|1
7262764|NCT02038777|11475790|FG004|Overall Study|Death|2
7262765|NCT02038777|11475791|FG005|Overall Study|Death|4
7262766|NCT02038777|11475792|FG006|Overall Study|Death|0
7544276|NCT02820844|11897834|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7544277|NCT02820844|11897835|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7544278|NCT02820844|11897836|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
7544279|NCT02820844|11897837|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7544280|NCT02820844|11897832|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544281|NCT02820844|11897833|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7576759|NCT04263142|11963772|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
7576760|NCT04256785|11963787|FG000|Overall Study|Adverse Event|8
7576761|NCT04256785|11963788|FG001|Overall Study|Adverse Event|6
7576762|NCT04256785|11963787|FG000|Overall Study|Lack of Efficacy|3
7576763|NCT04256785|11963788|FG001|Overall Study|Lack of Efficacy|4
7576764|NCT04256785|11963787|FG000|Overall Study|Lost to Follow-up|7
7576765|NCT04256785|11963788|FG001|Overall Study|Lost to Follow-up|7
7576766|NCT04256785|11963787|FG000|Overall Study|Protocol Violation|1
7576767|NCT04256785|11963788|FG001|Overall Study|Protocol Violation|0
7576768|NCT04256785|11963787|FG000|Overall Study|Withdrawal by Subject|4
7576769|NCT04256785|11963788|FG001|Overall Study|Withdrawal by Subject|1
7576770|NCT04256785|11963787|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
7544282|NCT02820844|11897834|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544283|NCT02820844|11897835|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544284|NCT02820844|11897836|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7544285|NCT02820844|11897837|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
7624482|NCT02287584|12035643|FG004|the Double-blind Phase|Adverse Event|0
7624483|NCT02287584|12035644|FG005|the Double-blind Phase|Adverse Event|0
7624484|NCT02287584|12035639|FG000|the Double-blind Phase|Lack of Efficacy|18
7624485|NCT02287584|12035640|FG001|the Double-blind Phase|Lack of Efficacy|8
7624486|NCT02287584|12035641|FG002|the Double-blind Phase|Lack of Efficacy|8
7624487|NCT02287584|12035642|FG003|the Double-blind Phase|Lack of Efficacy|0
7624488|NCT02287584|12035643|FG004|the Double-blind Phase|Lack of Efficacy|0
7624489|NCT02287584|12035644|FG005|the Double-blind Phase|Lack of Efficacy|0
7624490|NCT02287584|12035639|FG000|the Double-blind Phase|Lost to Follow-up|0
7624491|NCT02287584|12035640|FG001|the Double-blind Phase|Lost to Follow-up|1
7624492|NCT02287584|12035641|FG002|the Double-blind Phase|Lost to Follow-up|1
7624493|NCT02287584|12035642|FG003|the Double-blind Phase|Lost to Follow-up|0
7624494|NCT02287584|12035643|FG004|the Double-blind Phase|Lost to Follow-up|0
7624495|NCT02287584|12035644|FG005|the Double-blind Phase|Lost to Follow-up|0
7624496|NCT02287584|12035639|FG000|the Double-blind Phase|Withdrawal by Subject|17
7624497|NCT02287584|12035640|FG001|the Double-blind Phase|Withdrawal by Subject|17
7624498|NCT02287584|12035641|FG002|the Double-blind Phase|Withdrawal by Subject|11
7624499|NCT02287584|12035642|FG003|the Double-blind Phase|Withdrawal by Subject|0
7624500|NCT02287584|12035643|FG004|the Double-blind Phase|Withdrawal by Subject|0
7624501|NCT02287584|12035644|FG005|the Double-blind Phase|Withdrawal by Subject|0
7624502|NCT02287584|12035639|FG000|the Double-blind Phase|Pregnancy|0
7624503|NCT02287584|12035640|FG001|the Double-blind Phase|Pregnancy|1
7624504|NCT02287584|12035641|FG002|the Double-blind Phase|Pregnancy|0
7624505|NCT02287584|12035642|FG003|the Double-blind Phase|Pregnancy|0
7624506|NCT02287584|12035643|FG004|the Double-blind Phase|Pregnancy|0
7624507|NCT02287584|12035644|FG005|the Double-blind Phase|Pregnancy|0
7576771|NCT04256785|11963788|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
7576772|NCT04249336|11963813|FG000|Overall Study|Lost to Follow-up|3
7576773|NCT04249336|11963814|FG001|Overall Study|Lost to Follow-up|3
7576774|NCT04249336|11963815|FG002|Overall Study|Lost to Follow-up|3
7576775|NCT04249336|11963816|FG003|Overall Study|Lost to Follow-up|3
7576776|NCT04247061|11963835|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
7576777|NCT04247061|11963835|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
7576778|NCT04247061|11963835|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
7576779|NCT04245202|11963841|FG000|Overall Study|Lack of Efficacy|10
7576780|NCT04245202|11963842|FG001|Overall Study|Lack of Efficacy|1
7576781|NCT04238650|11963873|FG000|Overall Study|Withdrawal by Subject|0
7576782|NCT04238650|11963874|FG001|Overall Study|Withdrawal by Subject|1
7576783|NCT04238663|11963883|FG000|Overall Study|Lost to Follow-up|0
7576784|NCT04238663|11963884|FG001|Overall Study|Lost to Follow-up|1
7576785|NCT04238663|11963885|FG002|Overall Study|Lost to Follow-up|0
7576786|NCT04222699|11963959|FG000|Overall Study|Lost to Follow-up|2
7576787|NCT04206293|11963982|FG000|Overall Study|Consent withdrawal|1
7576788|NCT04228302|11963993|FG000|Overall Study|Adverse Event|0
7576789|NCT04228302|11963994|FG001|Overall Study|Adverse Event|0
7576790|NCT04228302|11963995|FG002|Overall Study|Adverse Event|0
7576791|NCT04228302|11963996|FG003|Overall Study|Adverse Event|0
7576792|NCT04228302|11963997|FG004|Overall Study|Adverse Event|1
7576793|NCT04228302|11963998|FG005|Overall Study|Adverse Event|0
7576794|NCT04223687|11964036|FG000|Overall Study|Missing primary outcome|1
7576795|NCT04223687|11964037|FG001|Overall Study|Missing primary outcome|0
7576796|NCT04223232|11964043|FG000|Overall Study|Withdrawal by Subject|1
7576797|NCT04189224|11964047|FG000|Period 2|Adverse Event|0
7576798|NCT04189224|11964048|FG001|Period 2|Adverse Event|1
7576799|NCT04214600|11964056|FG000|Overall Study|Lost to Follow-up|9
7576800|NCT04214600|11964057|FG001|Overall Study|Lost to Follow-up|14
7576801|NCT04202497|11964064|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
7576802|NCT04202497|11964065|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7576803|NCT04202497|11964066|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7576804|NCT04202497|11964067|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
7576805|NCT04209530|11964094|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
7576806|NCT04209530|11964095|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
7576807|NCT04209530|11964094|FG000|Overall Study|Withdrawal by Subject|0
7576808|NCT04209530|11964095|FG001|Overall Study|Withdrawal by Subject|1
7576809|NCT04207840|11964115|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7576810|NCT04207840|11964116|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
7576811|NCT04207840|11964117|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
7576812|NCT04207840|11964115|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7576813|NCT04207840|11964116|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
7576814|NCT04207840|11964117|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
7576815|NCT04206384|11964152|FG000|Overall Study|Withdrawal by Subject|8
7576816|NCT04206384|11964152|FG000|Overall Study|Adverse Event|2
7576817|NCT04195893|11964173|FG000|Second Intervention|Withdrawal by Subject|1
7576818|NCT04195893|11964174|FG001|Second Intervention|Withdrawal by Subject|0
7576819|NCT04195581|11964189|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
7576820|NCT04195581|11964189|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
7576821|NCT04195581|11964189|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
7576822|NCT04195581|11964189|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
7576823|NCT04195581|11964189|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
7576824|NCT04195581|11964189|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
7576825|NCT04194151|11964213|FG000|Overall Study|Physician Decision|1
7576826|NCT04194151|11964214|FG001|Overall Study|Physician Decision|1
7576827|NCT04194151|11964215|FG002|Overall Study|Physician Decision|1
7576828|NCT04194151|11964216|FG003|Overall Study|Physician Decision|1
7576829|NCT04194151|11964217|FG004|Overall Study|Physician Decision|0
7576830|NCT04194151|11964218|FG005|Overall Study|Physician Decision|1
7576831|NCT04194151|11964213|FG000|Overall Study|Monitorization problem|0
7576832|NCT04194151|11964214|FG001|Overall Study|Monitorization problem|1
7576833|NCT04194151|11964215|FG002|Overall Study|Monitorization problem|0
7576834|NCT04194151|11964216|FG003|Overall Study|Monitorization problem|0
7576835|NCT04194151|11964217|FG004|Overall Study|Monitorization problem|0
7576836|NCT04194151|11964218|FG005|Overall Study|Monitorization problem|0
7576837|NCT04194008|11964232|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
7576838|NCT04194008|11964232|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
7576839|NCT04194008|11964232|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
7576840|NCT04194008|11964232|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
7576841|NCT04194008|11964232|FG000|Treatment Phase With Nerivio|Missing data|4
7576842|NCT04194008|11964232|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
7576843|NCT04189081|11964243|FG000|Overall Study|Lost to Follow-up|1
7576844|NCT04189081|11964244|FG001|Overall Study|Lost to Follow-up|0
7576845|NCT04189081|11964245|FG002|Overall Study|Lost to Follow-up|0
7576846|NCT04189081|11964243|FG000|Overall Study|Withdrawal by Subject|0
7576847|NCT04189081|11964244|FG001|Overall Study|Withdrawal by Subject|0
7576848|NCT04189081|11964245|FG002|Overall Study|Withdrawal by Subject|1
7624508|NCT02287584|12035639|FG000|the Double-blind Phase|Protocol Violation|0
7624509|NCT02287584|12035640|FG001|the Double-blind Phase|Protocol Violation|3
7624510|NCT02287584|12035641|FG002|the Double-blind Phase|Protocol Violation|0
7624511|NCT02287584|12035642|FG003|the Double-blind Phase|Protocol Violation|0
7624512|NCT02287584|12035643|FG004|the Double-blind Phase|Protocol Violation|0
7624513|NCT02287584|12035644|FG005|the Double-blind Phase|Protocol Violation|0
7624514|NCT02287584|12035639|FG000|the Double-blind Phase|other reasons|0
7624515|NCT02287584|12035640|FG001|the Double-blind Phase|other reasons|0
7624516|NCT02287584|12035641|FG002|the Double-blind Phase|other reasons|1
7624517|NCT02287584|12035642|FG003|the Double-blind Phase|other reasons|0
7624518|NCT02287584|12035643|FG004|the Double-blind Phase|other reasons|0
7624519|NCT02287584|12035644|FG005|the Double-blind Phase|other reasons|0
7624520|NCT02287584|12035639|FG000|the Open-label Phase|Did not receive drug|0
7624521|NCT02287584|12035640|FG001|the Open-label Phase|Did not receive drug|0
7624522|NCT02287584|12035641|FG002|the Open-label Phase|Did not receive drug|0
7624523|NCT02287584|12035642|FG003|the Open-label Phase|Did not receive drug|7
7624524|NCT02287584|12035643|FG004|the Open-label Phase|Did not receive drug|6
7624525|NCT02287584|12035644|FG005|the Open-label Phase|Did not receive drug|4
7624526|NCT02287584|12035639|FG000|the Open-label Phase|Adverse Event|0
7624527|NCT02287584|12035640|FG001|the Open-label Phase|Adverse Event|0
7624528|NCT02287584|12035641|FG002|the Open-label Phase|Adverse Event|0
7624529|NCT02287584|12035642|FG003|the Open-label Phase|Adverse Event|15
7624530|NCT02287584|12035643|FG004|the Open-label Phase|Adverse Event|12
7624531|NCT02287584|12035644|FG005|the Open-label Phase|Adverse Event|16
7624532|NCT02287584|12035639|FG000|the Open-label Phase|Lack of Efficacy|0
7624533|NCT02287584|12035640|FG001|the Open-label Phase|Lack of Efficacy|0
7624534|NCT02287584|12035641|FG002|the Open-label Phase|Lack of Efficacy|0
7624535|NCT02287584|12035642|FG003|the Open-label Phase|Lack of Efficacy|8
7624536|NCT02287584|12035643|FG004|the Open-label Phase|Lack of Efficacy|3
7624537|NCT02287584|12035644|FG005|the Open-label Phase|Lack of Efficacy|7
7624538|NCT02287584|12035639|FG000|the Open-label Phase|Lost to Follow-up|0
7624539|NCT02287584|12035640|FG001|the Open-label Phase|Lost to Follow-up|0
7262767|NCT02038777|11475793|FG007|Overall Study|Death|10
7262768|NCT02038777|11475786|FG000|Overall Study|Lost to Follow-up|0
7262769|NCT02038777|11475787|FG001|Overall Study|Lost to Follow-up|0
7262770|NCT02038777|11475788|FG002|Overall Study|Lost to Follow-up|0
7262771|NCT02038777|11475789|FG003|Overall Study|Lost to Follow-up|1
7262772|NCT02038777|11475790|FG004|Overall Study|Lost to Follow-up|0
7262773|NCT02038777|11475791|FG005|Overall Study|Lost to Follow-up|0
7262774|NCT02038777|11475792|FG006|Overall Study|Lost to Follow-up|0
7624540|NCT02287584|12035641|FG002|the Open-label Phase|Lost to Follow-up|0
7624541|NCT02287584|12035642|FG003|the Open-label Phase|Lost to Follow-up|4
7624542|NCT02287584|12035643|FG004|the Open-label Phase|Lost to Follow-up|1
7624543|NCT02287584|12035644|FG005|the Open-label Phase|Lost to Follow-up|2
7624544|NCT02287584|12035639|FG000|the Open-label Phase|Withdrawal by Subject|0
7624545|NCT02287584|12035640|FG001|the Open-label Phase|Withdrawal by Subject|0
7624546|NCT02287584|12035641|FG002|the Open-label Phase|Withdrawal by Subject|0
7624547|NCT02287584|12035642|FG003|the Open-label Phase|Withdrawal by Subject|18
7624548|NCT02287584|12035643|FG004|the Open-label Phase|Withdrawal by Subject|29
7624549|NCT02287584|12035644|FG005|the Open-label Phase|Withdrawal by Subject|21
7624550|NCT02287584|12035639|FG000|the Open-label Phase|non-compliance|0
7624551|NCT02287584|12035640|FG001|the Open-label Phase|non-compliance|0
7624552|NCT02287584|12035641|FG002|the Open-label Phase|non-compliance|0
7624553|NCT02287584|12035642|FG003|the Open-label Phase|non-compliance|2
7624554|NCT02287584|12035643|FG004|the Open-label Phase|non-compliance|5
7624555|NCT02287584|12035644|FG005|the Open-label Phase|non-compliance|1
7624556|NCT02287584|12035639|FG000|the Open-label Phase|other reasons|0
7624557|NCT02287584|12035640|FG001|the Open-label Phase|other reasons|0
7624558|NCT02287584|12035641|FG002|the Open-label Phase|other reasons|0
7624559|NCT02287584|12035642|FG003|the Open-label Phase|other reasons|3
7624560|NCT02287584|12035643|FG004|the Open-label Phase|other reasons|6
7624561|NCT02287584|12035644|FG005|the Open-label Phase|other reasons|6
7624562|NCT02178566|12035660|FG000|Overall Study|patient did not complete due to noncompliance|0
7624563|NCT02178566|12035661|FG001|Overall Study|patient did not complete due to noncompliance|1
7624564|NCT02173301|12035671|FG000|Overall Study|Adverse Event|7
7624565|NCT02173301|12035672|FG001|Overall Study|Adverse Event|8
7262775|NCT02038777|11475793|FG007|Overall Study|Lost to Follow-up|0
7262776|NCT02038777|11475786|FG000|Overall Study|Other|0
7262777|NCT02038777|11475787|FG001|Overall Study|Other|1
7262778|NCT02038777|11475788|FG002|Overall Study|Other|0
7262779|NCT02038777|11475789|FG003|Overall Study|Other|2
7262780|NCT02038777|11475790|FG004|Overall Study|Other|1
7262781|NCT02038777|11475791|FG005|Overall Study|Other|0
7262782|NCT02038777|11475792|FG006|Overall Study|Other|0
7262783|NCT02038777|11475793|FG007|Overall Study|Other|0
7262784|NCT02038777|11475786|FG000|Overall Study|Randomized but not treated|0
7262785|NCT02038777|11475787|FG001|Overall Study|Randomized but not treated|1
7262786|NCT02038777|11475788|FG002|Overall Study|Randomized but not treated|0
7262787|NCT02038777|11475789|FG003|Overall Study|Randomized but not treated|0
7262788|NCT02038777|11475790|FG004|Overall Study|Randomized but not treated|0
7262789|NCT02038777|11475791|FG005|Overall Study|Randomized but not treated|0
7262790|NCT02038777|11475792|FG006|Overall Study|Randomized but not treated|0
7262791|NCT02038777|11475793|FG007|Overall Study|Randomized but not treated|0
7262792|NCT02038777|11475786|FG000|Overall Study|Started Chemotherapy|1
7262793|NCT02038777|11475787|FG001|Overall Study|Started Chemotherapy|0
7262794|NCT02038777|11475788|FG002|Overall Study|Started Chemotherapy|3
7262795|NCT02038777|11475789|FG003|Overall Study|Started Chemotherapy|0
7262796|NCT02038777|11475790|FG004|Overall Study|Started Chemotherapy|0
7262797|NCT02038777|11475791|FG005|Overall Study|Started Chemotherapy|0
7262798|NCT02038777|11475792|FG006|Overall Study|Started Chemotherapy|0
7262799|NCT02038777|11475793|FG007|Overall Study|Started Chemotherapy|0
7262800|NCT01927419|11475823|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0
7262801|NCT01927419|11475824|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1
7262802|NCT01927419|11475823|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1
7262803|NCT01927419|11475824|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0
7262804|NCT01927419|11475823|FG000|Treatment Period|Disease progression|17
7262805|NCT01927419|11475824|FG001|Treatment Period|Disease progression|20
7262806|NCT01927419|11475823|FG000|Treatment Period|Study drug toxicity|48
7262807|NCT01927419|11475824|FG001|Treatment Period|Study drug toxicity|10
7262808|NCT01927419|11475823|FG000|Treatment Period|Death|0
7262809|NCT01927419|11475824|FG001|Treatment Period|Death|1
7262810|NCT01927419|11475823|FG000|Treatment Period|Adverse event unrelated to study drug|6
7262811|NCT01927419|11475824|FG001|Treatment Period|Adverse event unrelated to study drug|3
7262812|NCT01927419|11475823|FG000|Treatment Period|Participant request to discontinue|12
7262813|NCT01927419|11475824|FG001|Treatment Period|Participant request to discontinue|4
7262814|NCT01927419|11475823|FG000|Treatment Period|Withdrawal by Subject|1
7544286|NCT02821416|11897896|FG000|Overall Study|Adverse Event|0
7544287|NCT02821416|11897897|FG001|Overall Study|Adverse Event|1
7544288|NCT02821416|11897896|FG000|Overall Study|Withdrawal by Subject|2
7544289|NCT02821416|11897897|FG001|Overall Study|Withdrawal by Subject|0
7544290|NCT02821416|11897896|FG000|Overall Study|Lost to Follow-up|1
7544291|NCT02821416|11897897|FG001|Overall Study|Lost to Follow-up|0
7544292|NCT02821715|11897908|FG000|Overall Study|Protocol Violation|1
7544293|NCT02821715|11897909|FG001|Overall Study|Protocol Violation|0
7544294|NCT02821715|11897910|FG002|Overall Study|Protocol Violation|0
7544295|NCT02821715|11897911|FG003|Overall Study|Protocol Violation|0
7544296|NCT02821715|11897912|FG004|Overall Study|Protocol Violation|0
7544297|NCT02821715|11897913|FG005|Overall Study|Protocol Violation|0
7544298|NCT02821819|11897921|FG000|Overall Study|Protocol Violation|1
7544299|NCT02821910|11897931|FG000|Overall Study|Withdrawal by Subject|0
7544300|NCT02821910|11897932|FG001|Overall Study|Withdrawal by Subject|0
7544301|NCT02821910|11897933|FG002|Overall Study|Withdrawal by Subject|1
7544302|NCT02821910|11897934|FG003|Overall Study|Withdrawal by Subject|0
7544303|NCT02821910|11897935|FG004|Overall Study|Withdrawal by Subject|0
7544304|NCT02821910|11897936|FG005|Overall Study|Withdrawal by Subject|1
7262815|NCT01927419|11475824|FG001|Treatment Period|Withdrawal by Subject|1
7262816|NCT01927419|11475823|FG000|Treatment Period|Maximum Clinical Benefit|6
7262817|NCT01927419|11475824|FG001|Treatment Period|Maximum Clinical Benefit|2
7262818|NCT01927419|11475823|FG000|Treatment Period|Other reasons|3
7544305|NCT02821910|11897931|FG000|Overall Study|Other than specified|1
7544306|NCT02821910|11897932|FG001|Overall Study|Other than specified|0
7544307|NCT02821910|11897933|FG002|Overall Study|Other than specified|1
7544308|NCT02821910|11897934|FG003|Overall Study|Other than specified|0
7544309|NCT02821910|11897935|FG004|Overall Study|Other than specified|0
7544310|NCT02821910|11897936|FG005|Overall Study|Other than specified|0
7544311|NCT02821962|11897952|FG000|Overall Study|Lost to Follow-up|2
7544312|NCT02821962|11897953|FG001|Overall Study|Lost to Follow-up|0
7544313|NCT02822222|11897961|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
7544314|NCT02822222|11897962|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
7544315|NCT02822235|11897970|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
7544316|NCT02822235|11897971|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
7544317|NCT02822235|11897970|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
7544318|NCT02822235|11897971|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
7544319|NCT02822235|11897970|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
7544320|NCT02822235|11897971|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
7544321|NCT02822235|11897970|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
7576849|NCT04186806|11964266|FG000|Period 1: 7 Days|Adverse Event|1
7576850|NCT04186806|11964267|FG001|Period 1: 7 Days|Adverse Event|0
7576851|NCT04179838|11964301|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
7576852|NCT04179838|11964302|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
7576853|NCT04179838|11964301|FG000|Second Intervention (1 Day)|Protocol Violation|0
7576854|NCT04179838|11964302|FG001|Second Intervention (1 Day)|Protocol Violation|1
7576855|NCT04179461|11964308|FG000|Overall Study|Lost to Follow-up|4
7576856|NCT04178590|11964336|FG000|Overall Study|Pregnancy|1
7576857|NCT04178590|11964336|FG000|Overall Study|Lost to Follow-up|1
7576858|NCT04177862|11964364|FG000|Overall Study|Protocol Violation|2
7576859|NCT04177862|11964365|FG001|Overall Study|Protocol Violation|7
7576860|NCT04173741|11964440|FG000|Overall Study|IVC measurement cannot be done|1
7576861|NCT04173741|11964441|FG001|Overall Study|IVC measurement cannot be done|1
7576862|NCT04169061|11964447|FG000|Overall Study|Adverse Event|2
7576863|NCT04169061|11964447|FG000|Overall Study|Death|1
7576864|NCT04169061|11964447|FG000|Overall Study|Withdrawal by Subject|1
7576865|NCT04169061|11964447|FG000|Overall Study|Protocol Violation|1
7576866|NCT04157738|11964453|FG000|Overall Study|Moved out of state|0
7576867|NCT04157738|11964454|FG001|Overall Study|Moved out of state|2
7576868|NCT04157738|11964453|FG000|Overall Study|Did not show up to the Follow-up appointment|1
7576869|NCT04157738|11964454|FG001|Overall Study|Did not show up to the Follow-up appointment|0
7576870|NCT04156646|11964462|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
7576871|NCT04156646|11964463|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
7576872|NCT04170686|11964474|FG000|Screening|Physician Decision|12
7576873|NCT04170686|11964475|FG001|Screening|Physician Decision|13
7576874|NCT04170686|11964474|FG000|Randomization and Treatment|Lost to Follow-up|26
7576875|NCT04170686|11964475|FG001|Randomization and Treatment|Lost to Follow-up|15
7576876|NCT04162795|11964527|FG000|Overall Study|Other|16
7576877|NCT04162795|11964527|FG000|Overall Study|Screen failures|10
7576878|NCT04161807|11964531|FG000|Overall Study|Withdrawal by Subject|2
7576879|NCT04161807|11964531|FG000|Overall Study|Performed only 1 treatment|2
7576880|NCT04161144|11964537|FG000|Overall Study|Withdrawal by Subject|0
7576881|NCT04161144|11964538|FG001|Overall Study|Withdrawal by Subject|1
7576882|NCT04161144|11964537|FG000|Overall Study|Protocol Violation|1
7262819|NCT01927419|11475824|FG001|Treatment Period|Other reasons|4
7262820|NCT01927419|11475823|FG000|Treatment Period|Not Reported|1
7262821|NCT01927419|11475824|FG001|Treatment Period|Not Reported|1
7576883|NCT04161144|11964538|FG001|Overall Study|Protocol Violation|0
7576884|NCT04161079|11964544|FG000|Clinical Investigation 2010-040|Adverse Event|1
7576885|NCT04152083|11964563|FG000|Overall Study|Lost to Follow-up|2
7576886|NCT04152083|11964564|FG001|Overall Study|Lost to Follow-up|1
7576887|NCT04152083|11964563|FG000|Overall Study|Adverse Event|1
7576888|NCT04152083|11964564|FG001|Overall Study|Adverse Event|0
7576889|NCT04152083|11964563|FG000|Overall Study|Randomized but not treated|3
7576890|NCT04152083|11964564|FG001|Overall Study|Randomized but not treated|2
7262830|NCT01711879|11475859|FG000|Overall Study|Death|1
7262831|NCT01711879|11475860|FG001|Overall Study|Death|0
7262832|NCT01697267|11475870|FG000|Overall Study|Death|3
7262833|NCT01697267|11475871|FG001|Overall Study|Death|1
7262834|NCT01697267|11475870|FG000|Overall Study|Withdrawal by Subject|5
7262835|NCT01697267|11475871|FG001|Overall Study|Withdrawal by Subject|5
7262836|NCT01697267|11475870|FG000|Overall Study|Adverse Event|2
7262837|NCT01697267|11475871|FG001|Overall Study|Adverse Event|1
7262838|NCT01697267|11475870|FG000|Overall Study|Lost to Follow-up|2
7262839|NCT01697267|11475871|FG001|Overall Study|Lost to Follow-up|4
7262840|NCT01697267|11475870|FG000|Overall Study|Physician Decision|2
7262841|NCT01697267|11475871|FG001|Overall Study|Physician Decision|4
7262842|NCT01527149|11475877|FG000|Overall Study|Death|2
7262843|NCT00554840|11475907|FG000|Overall Study|Physician Decision|0
7262844|NCT00554840|11475908|FG001|Overall Study|Physician Decision|1
7262845|NCT00003656|11475918|FG000|Overall Study|Adverse Event|0
7262846|NCT00003656|11475919|FG001|Overall Study|Adverse Event|1
7262847|NCT00370331|11475928|FG000|Overall Study|Adverse Event|4
7262848|NCT00370331|11475929|FG001|Overall Study|Adverse Event|13
7262849|NCT00370331|11475928|FG000|Overall Study|Withdrawal by Subject|2
7262850|NCT00370331|11475929|FG001|Overall Study|Withdrawal by Subject|4
7262851|NCT00370331|11475928|FG000|Overall Study|Lost to Follow-up|0
7262852|NCT00370331|11475929|FG001|Overall Study|Lost to Follow-up|3
7262853|NCT00370331|11475928|FG000|Overall Study|Lack of Efficacy|0
7262854|NCT00370331|11475929|FG001|Overall Study|Lack of Efficacy|1
7262855|NCT00370331|11475928|FG000|Overall Study|Non-compliance|0
7262856|NCT00370331|11475929|FG001|Overall Study|Non-compliance|1
7262857|NCT00370331|11475928|FG000|Overall Study|Protocol Violation|1
7262858|NCT00370331|11475929|FG001|Overall Study|Protocol Violation|1
7262859|NCT00370396|11475938|FG000|Overall Study|Withdrawal by Subject|0
7262860|NCT00370396|11475939|FG001|Overall Study|Withdrawal by Subject|0
7262861|NCT00370396|11475940|FG002|Overall Study|Withdrawal by Subject|1
7262862|NCT00370396|11475938|FG000|Overall Study|Lost to Follow-up|11
7262863|NCT00370396|11475939|FG001|Overall Study|Lost to Follow-up|1
7262864|NCT00370396|11475940|FG002|Overall Study|Lost to Follow-up|0
7544322|NCT02822235|11897971|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
7544323|NCT02822235|11897970|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
7544324|NCT02822235|11897971|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
7262865|NCT00370552|11475951|FG000|Overall Study|Adverse Event|2
7262866|NCT00370552|11475952|FG001|Overall Study|Adverse Event|2
7262867|NCT00370552|11475953|FG002|Overall Study|Adverse Event|2
7262868|NCT00370552|11475951|FG000|Overall Study|Disease progression|23
7544325|NCT02822235|11897970|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
7544326|NCT02822235|11897971|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
7544327|NCT02822794|11898022|FG000|Overall Study|Withdrew Consent|1
7544328|NCT02822794|11898023|FG001|Overall Study|Withdrew Consent|0
7544329|NCT02823470|11898065|FG000|Overall Study|Adverse Event|1
7544330|NCT02823470|11898066|FG001|Overall Study|Adverse Event|0
7544331|NCT02823470|11898065|FG000|Overall Study|Study terminated by sponsor|8
7544332|NCT02823470|11898066|FG001|Overall Study|Study terminated by sponsor|15
7544333|NCT02823964|11898081|FG000|Overall Study|Adverse Event|2
7544334|NCT02823964|11898081|FG000|Overall Study|Physician Decision|1
7544335|NCT02823964|11898081|FG000|Overall Study|Lack of Efficacy|1
7544336|NCT02823964|11898081|FG000|Overall Study|Withdrawal by Subject|1
7544337|NCT02824224|11898087|FG000|Overall Study|Discontinued, IUS expulsion|0
7544338|NCT02824224|11898088|FG001|Overall Study|Discontinued, IUS expulsion|1
7544339|NCT02824224|11898087|FG000|Overall Study|Did not show up for allocation visit|2
7544340|NCT02824224|11898088|FG001|Overall Study|Did not show up for allocation visit|0
7544341|NCT02824432|11898096|FG000|Overall Study|Major Protocol Deviation|1
7262869|NCT00370552|11475952|FG001|Overall Study|Disease progression|23
7262870|NCT00370552|11475953|FG002|Overall Study|Disease progression|15
7262871|NCT00370552|11475951|FG000|Overall Study|Maximum clinical benefit|3
7262872|NCT00370552|11475952|FG001|Overall Study|Maximum clinical benefit|5
7262873|NCT00370552|11475953|FG002|Overall Study|Maximum clinical benefit|5
7262874|NCT00370552|11475951|FG000|Overall Study|Poor or noncompliance|0
7262875|NCT00370552|11475952|FG001|Overall Study|Poor or noncompliance|0
7262876|NCT00370552|11475953|FG002|Overall Study|Poor or noncompliance|1
7262877|NCT00370552|11475951|FG000|Overall Study|Study drug toxicity|11
7262878|NCT00370552|11475952|FG001|Overall Study|Study drug toxicity|8
7262879|NCT00370552|11475953|FG002|Overall Study|Study drug toxicity|6
7262880|NCT00370552|11475951|FG000|Overall Study|Withdrawal by Subject|2
7262881|NCT00370552|11475952|FG001|Overall Study|Withdrawal by Subject|0
7262882|NCT00370552|11475953|FG002|Overall Study|Withdrawal by Subject|1
7262883|NCT00370552|11475951|FG000|Overall Study|Still on treatment|1
7262884|NCT00370552|11475952|FG001|Overall Study|Still on treatment|3
7262885|NCT00370552|11475953|FG002|Overall Study|Still on treatment|2
7262886|NCT00370552|11475951|FG000|Overall Study|Never treated|1
7262887|NCT00370552|11475952|FG001|Overall Study|Never treated|0
7262888|NCT00370552|11475953|FG002|Overall Study|Never treated|0
7262889|NCT00370552|11475951|FG000|Overall Study|Physician Decision|1
7262890|NCT00370552|11475952|FG001|Overall Study|Physician Decision|1
7262891|NCT00370552|11475953|FG002|Overall Study|Physician Decision|0
7262892|NCT00370552|11475951|FG000|Overall Study|Investigator decision|2
7262893|NCT00370552|11475952|FG001|Overall Study|Investigator decision|1
7262894|NCT00370552|11475953|FG002|Overall Study|Investigator decision|0
7262895|NCT00370552|11475951|FG000|Overall Study|High risk of allergic reaction|0
7262896|NCT00370552|11475952|FG001|Overall Study|High risk of allergic reaction|1
7262897|NCT00370552|11475953|FG002|Overall Study|High risk of allergic reaction|0
7262898|NCT00370552|11475951|FG000|Overall Study|Planned radiation for palliation|0
7262899|NCT00370552|11475952|FG001|Overall Study|Planned radiation for palliation|1
7262900|NCT00370552|11475953|FG002|Overall Study|Planned radiation for palliation|0
7262901|NCT00370682|11475964|FG000|Overall Study|Moved from area|0
7262902|NCT00370682|11475965|FG001|Overall Study|Moved from area|2
7262903|NCT00370682|11475966|FG002|Overall Study|Moved from area|0
7262904|NCT00370682|11475964|FG000|Overall Study|Lost to Follow-up|0
7262905|NCT00370682|11475965|FG001|Overall Study|Lost to Follow-up|1
7262906|NCT00370682|11475966|FG002|Overall Study|Lost to Follow-up|1
7262907|NCT00371137|11475999|FG000|Overall Study|Adverse Event|20
7262908|NCT00371137|11476000|FG001|Overall Study|Adverse Event|35
7262909|NCT00371137|11476001|FG002|Overall Study|Adverse Event|42
7262910|NCT00371137|11475999|FG000|Overall Study|Withdrawal by Subject|11
7262911|NCT00371137|11476000|FG001|Overall Study|Withdrawal by Subject|10
7262912|NCT00371137|11476001|FG002|Overall Study|Withdrawal by Subject|15
7262913|NCT00371137|11475999|FG000|Overall Study|Lost to Follow-up|6
7262914|NCT00371137|11476000|FG001|Overall Study|Lost to Follow-up|3
7262915|NCT00371137|11476001|FG002|Overall Study|Lost to Follow-up|5
7262916|NCT00371137|11475999|FG000|Overall Study|Lack of Efficacy|30
7262917|NCT00371137|11476000|FG001|Overall Study|Lack of Efficacy|12
7262918|NCT00371137|11476001|FG002|Overall Study|Lack of Efficacy|13
7262919|NCT00371137|11475999|FG000|Overall Study|Sponsor Decision|2
7262920|NCT00371137|11476000|FG001|Overall Study|Sponsor Decision|1
7262921|NCT00371137|11476001|FG002|Overall Study|Sponsor Decision|2
7262922|NCT00371137|11475999|FG000|Overall Study|Physician Decision|1
7262923|NCT00371137|11476000|FG001|Overall Study|Physician Decision|1
7544342|NCT02824432|11898097|FG001|Overall Study|Major Protocol Deviation|0
7262924|NCT00371137|11476001|FG002|Overall Study|Physician Decision|1
7262925|NCT00371137|11475999|FG000|Overall Study|Protocol Violation|2
7262926|NCT00371137|11476000|FG001|Overall Study|Protocol Violation|1
7262927|NCT00371137|11476001|FG002|Overall Study|Protocol Violation|1
7262928|NCT00371150|11476011|FG000|Overall Study|Lost to Follow-up|3
7262929|NCT00371150|11476012|FG001|Overall Study|Lost to Follow-up|2
7262930|NCT00371254|11476033|FG000|Overall Study|Disease progression|13
7262931|NCT00371254|11476034|FG001|Overall Study|Disease progression|13
7262932|NCT00371254|11476033|FG000|Overall Study|Study drug toxicity|3
7262933|NCT00371254|11476034|FG001|Overall Study|Study drug toxicity|5
7262934|NCT00371254|11476033|FG000|Overall Study|Subject request|5
7262935|NCT00371254|11476034|FG001|Overall Study|Subject request|0
7262936|NCT00371254|11476033|FG000|Overall Study|Investigator Decision|2
7262937|NCT00371254|11476034|FG001|Overall Study|Investigator Decision|0
7262938|NCT00371254|11476033|FG000|Overall Study|Adverse event unrelated to study drug|0
7262939|NCT00371254|11476034|FG001|Overall Study|Adverse event unrelated to study drug|1
7262940|NCT00371254|11476033|FG000|Overall Study|Lost to Follow-up|0
7262941|NCT00371254|11476034|FG001|Overall Study|Lost to Follow-up|1
7262942|NCT00371254|11476033|FG000|Overall Study|Withdrawal by Subject|0
7262943|NCT00371254|11476034|FG001|Overall Study|Withdrawal by Subject|1
7262944|NCT00371345|11476065|FG000|Overall Study|Disease Progression|21
7262945|NCT00371345|11476066|FG001|Overall Study|Disease Progression|35
7262946|NCT00371345|11476065|FG000|Overall Study|Study Drug Toxicity|1
7262947|NCT00371345|11476066|FG001|Overall Study|Study Drug Toxicity|7
7262948|NCT00371345|11476065|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
7262949|NCT00371345|11476066|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
7262950|NCT00371345|11476065|FG000|Overall Study|Participant Request|1
7262951|NCT00371345|11476066|FG001|Overall Study|Participant Request|1
7262952|NCT00371345|11476065|FG000|Overall Study|Participant Withdrew Consent|0
7262953|NCT00371345|11476066|FG001|Overall Study|Participant Withdrew Consent|1
7262954|NCT00371397|11476086|FG000|Session 1|Withdrawal by Subject|1
7262955|NCT00371397|11476087|FG001|Session 1|Withdrawal by Subject|0
7262956|NCT00371397|11476088|FG002|Session 1|Withdrawal by Subject|0
7262957|NCT00371397|11476089|FG003|Session 1|Withdrawal by Subject|0
7262958|NCT00371397|11476090|FG004|Session 1|Withdrawal by Subject|0
7262959|NCT00371397|11476091|FG005|Session 1|Withdrawal by Subject|0
7262960|NCT00371397|11476092|FG006|Session 1|Withdrawal by Subject|0
7262961|NCT00371397|11476093|FG007|Session 1|Withdrawal by Subject|1
7262962|NCT00371397|11476094|FG008|Session 1|Withdrawal by Subject|0
7262963|NCT00371397|11476095|FG009|Session 1|Withdrawal by Subject|0
7262964|NCT00371397|11476096|FG010|Session 1|Withdrawal by Subject|0
7262965|NCT00371397|11476097|FG011|Session 1|Withdrawal by Subject|0
7262966|NCT00371566|11476129|FG000|Treatment Phase|Withdrawal by Subject|0
7262967|NCT00371566|11476130|FG001|Treatment Phase|Withdrawal by Subject|1
7262968|NCT00371566|11476129|FG000|Treatment Phase|Adverse Event|0
7262969|NCT00371566|11476130|FG001|Treatment Phase|Adverse Event|1
7262970|NCT00371566|11476129|FG000|Treatment Phase|Protocol Violation|0
7262971|NCT00371566|11476130|FG001|Treatment Phase|Protocol Violation|1
7262972|NCT00371566|11476129|FG000|Chemoradiation Phase|Physician Decision|2
7262973|NCT00371566|11476130|FG001|Chemoradiation Phase|Physician Decision|0
7262974|NCT00371566|11476129|FG000|Chemoradiation Phase|Withdrawal by Subject|0
7262975|NCT00371566|11476130|FG001|Chemoradiation Phase|Withdrawal by Subject|1
7262976|NCT00371566|11476129|FG000|Chemoradiation Phase|Non compliant|0
7262977|NCT00371566|11476130|FG001|Chemoradiation Phase|Non compliant|1
7262978|NCT00371566|11476129|FG000|Chemoradiation Phase|Progressive Disease|1
7262979|NCT00371566|11476130|FG001|Chemoradiation Phase|Progressive Disease|1
7262980|NCT00371566|11476129|FG000|Chemoradiation Phase|Death|2
7262981|NCT00371566|11476130|FG001|Chemoradiation Phase|Death|0
7262982|NCT00371566|11476129|FG000|Follow Up Phase|Death|0
7262983|NCT00371566|11476130|FG001|Follow Up Phase|Death|5
7262984|NCT00371566|11476129|FG000|Follow Up Phase|Disease progression|1
7262985|NCT00371566|11476130|FG001|Follow Up Phase|Disease progression|0
7262986|NCT00371566|11476129|FG000|Follow Up Phase|Withdrawal by Subject|0
7262987|NCT00371566|11476130|FG001|Follow Up Phase|Withdrawal by Subject|1
7262988|NCT00371566|11476129|FG000|Follow Up Phase|Physician Decision|1
7262989|NCT00371566|11476130|FG001|Follow Up Phase|Physician Decision|1
7262990|NCT00371566|11476129|FG000|Follow Up Phase|Lost to Follow-up|1
7262991|NCT00371566|11476130|FG001|Follow Up Phase|Lost to Follow-up|0
7262992|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|Death|1
7262993|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|Death|1
7262994|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
7262995|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
7262996|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
7262997|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
7262998|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
7262999|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
7263000|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
7263001|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
7263002|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
7263003|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
7263004|NCT00371683|11476151|FG000|DB Treatment Period-Randomized Patients|non-specified|9
7263005|NCT00371683|11476152|FG001|DB Treatment Period-Randomized Patients|non-specified|8
7263006|NCT00371683|11476151|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
7263007|NCT00371683|11476152|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
7263008|NCT00371683|11476151|FG000|Follow-Up Period - Randomized Patients|Death|0
7263009|NCT00371683|11476152|FG001|Follow-Up Period - Randomized Patients|Death|2
7263010|NCT00371683|11476151|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
7263011|NCT00371683|11476152|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
7263012|NCT00371683|11476151|FG000|Follow-Up Period - Randomized Patients|non-specified|6
7263013|NCT00371683|11476152|FG001|Follow-Up Period - Randomized Patients|non-specified|12
7263014|NCT00371761|11476170|FG000|Overall Study|Adverse Event|1
7263015|NCT00371761|11476171|FG001|Overall Study|Adverse Event|1
7263016|NCT00371761|11476170|FG000|Overall Study|Withdrawal by Subject|1
7263017|NCT00371761|11476171|FG001|Overall Study|Withdrawal by Subject|3
7263018|NCT00371761|11476170|FG000|Overall Study|Investigator Judgment|2
7263019|NCT00371761|11476171|FG001|Overall Study|Investigator Judgment|3
7263020|NCT00371761|11476170|FG000|Overall Study|Study termination|4
7263021|NCT00371761|11476171|FG001|Overall Study|Study termination|3
7263022|NCT00371787|11476179|FG000|Overall Study|Withdrawal by Subject|3
7263023|NCT00371787|11476180|FG001|Overall Study|Withdrawal by Subject|1
7263024|NCT00371826|11476189|FG000|Core Phase (12 Months)|Adverse Event|15
7263025|NCT00371826|11476190|FG001|Core Phase (12 Months)|Adverse Event|4
7263026|NCT00371826|11476191|FG002|Core Phase (12 Months)|Adverse Event|9
7263027|NCT00371826|11476189|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7263028|NCT00371826|11476190|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
7263029|NCT00371826|11476191|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
7263030|NCT00371826|11476189|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
7263031|NCT00371826|11476190|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
7263032|NCT00371826|11476191|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
7263033|NCT00371826|11476189|FG000|Core Phase (12 Months)|Protocol Violation|1
7263034|NCT00371826|11476190|FG001|Core Phase (12 Months)|Protocol Violation|0
7263035|NCT00371826|11476191|FG002|Core Phase (12 Months)|Protocol Violation|1
7263036|NCT00371826|11476189|FG000|Core Phase (12 Months)|Subject withdrew consent|0
7263037|NCT00371826|11476190|FG001|Core Phase (12 Months)|Subject withdrew consent|0
7263038|NCT00371826|11476191|FG002|Core Phase (12 Months)|Subject withdrew consent|3
7263039|NCT00371826|11476189|FG000|Core Phase (12 Months)|Administrative problems|1
7263040|NCT00371826|11476190|FG001|Core Phase (12 Months)|Administrative problems|0
7263041|NCT00371826|11476191|FG002|Core Phase (12 Months)|Administrative problems|8
7263042|NCT00371826|11476189|FG000|Core Phase (12 Months)|Graft Loss|0
7263043|NCT00371826|11476190|FG001|Core Phase (12 Months)|Graft Loss|1
7263044|NCT00371826|11476191|FG002|Core Phase (12 Months)|Graft Loss|0
7263045|NCT00371826|11476189|FG000|Extension Phase (24 Months)|Adverse Event|4
7263046|NCT00371826|11476190|FG001|Extension Phase (24 Months)|Adverse Event|5
7263047|NCT00371826|11476191|FG002|Extension Phase (24 Months)|Adverse Event|0
7263048|NCT00371826|11476189|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7263049|NCT00371826|11476190|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
7263050|NCT00371826|11476191|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
7263051|NCT00371826|11476189|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7263052|NCT00371826|11476190|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
7263053|NCT00371826|11476191|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
7263054|NCT00371826|11476189|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
7263055|NCT00371826|11476190|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
7263056|NCT00371826|11476191|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
7263057|NCT00371826|11476189|FG000|Extension Phase (24 Months)|Administrative problems|0
7263058|NCT00371826|11476190|FG001|Extension Phase (24 Months)|Administrative problems|0
7263059|NCT00371826|11476191|FG002|Extension Phase (24 Months)|Administrative problems|2
7263060|NCT00371839|11476202|FG000|Overall Study|Death|4
7263061|NCT00371839|11476203|FG001|Overall Study|Death|0
7263062|NCT00371839|11476204|FG002|Overall Study|Death|0
7263063|NCT00371839|11476202|FG000|Overall Study|Withdrawal by Subject|7
7263064|NCT00371839|11476203|FG001|Overall Study|Withdrawal by Subject|4
7263065|NCT00371839|11476204|FG002|Overall Study|Withdrawal by Subject|0
7263066|NCT00371839|11476202|FG000|Overall Study|Lost to Follow-up|6
7544343|NCT02824562|11898105|FG000|Overall Study|Lost to Follow-up|3
7544344|NCT02824562|11898106|FG001|Overall Study|Lost to Follow-up|4
7544345|NCT02824562|11898105|FG000|Overall Study|Death|0
7544346|NCT02824562|11898106|FG001|Overall Study|Death|1
7544347|NCT02825251|11898129|FG000|Overall Study|Adverse Event|0
7544348|NCT02825251|11898130|FG001|Overall Study|Adverse Event|1
7544349|NCT02825251|11898129|FG000|Overall Study|Lost to Follow-up|0
7544350|NCT02825251|11898130|FG001|Overall Study|Lost to Follow-up|1
7544351|NCT02825251|11898129|FG000|Overall Study|Withdrawal by Subject|1
7544352|NCT02825251|11898130|FG001|Overall Study|Withdrawal by Subject|4
7544353|NCT02825251|11898129|FG000|Overall Study|Unclassified|2
7544354|NCT02825251|11898130|FG001|Overall Study|Unclassified|0
7544355|NCT02825420|11898138|FG000|Overall Study|Death|30
7544356|NCT02825420|11898139|FG001|Overall Study|Death|12
7544357|NCT02825420|11898138|FG000|Overall Study|Progressive disease|6
7544358|NCT02825420|11898139|FG001|Overall Study|Progressive disease|1
7544359|NCT02825420|11898138|FG000|Overall Study|Lost to Follow-up|2
7544360|NCT02825420|11898139|FG001|Overall Study|Lost to Follow-up|2
7576891|NCT04155047|11964576|FG000|Overall Study|Adverse Event|1
7576892|NCT04155047|11964577|FG001|Overall Study|Adverse Event|0
7576893|NCT04155047|11964576|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
7576894|NCT04155047|11964577|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
7576895|NCT04150250|11964606|FG000|Overall Study|Lost to Follow-up|0
7576896|NCT04150250|11964607|FG001|Overall Study|Lost to Follow-up|2
7576897|NCT04149353|11964692|FG000|Overall Study|Study terminated|1
7576898|NCT04136444|11964712|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
7576899|NCT04136444|11964713|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
7576900|NCT04147611|11964747|FG000|Overall Study|Physician Decision|0
7576901|NCT04147611|11964748|FG001|Overall Study|Physician Decision|1
7576902|NCT04142216|11964817|FG000|Overall Study|Hospitalization|0
7576903|NCT04142216|11964818|FG001|Overall Study|Hospitalization|2
7576904|NCT04142216|11964817|FG000|Overall Study|Death|3
7576905|NCT04142216|11964818|FG001|Overall Study|Death|1
7576906|NCT04142216|11964817|FG000|Overall Study|Referral to another hemodialysis unit|3
7576907|NCT04142216|11964818|FG001|Overall Study|Referral to another hemodialysis unit|2
7576908|NCT04142216|11964817|FG000|Overall Study|Use of clove|0
7576909|NCT04142216|11964818|FG001|Overall Study|Use of clove|1
7576910|NCT04142450|11964829|FG000|Overall Study|Screen Failure|1
7576911|NCT04142450|11964829|FG000|Overall Study|Lost to Follow-up|1
7576912|NCT04140890|11964835|FG000|Overall Study|Withdrawal by Subject|0
7576913|NCT04140890|11964836|FG001|Overall Study|Withdrawal by Subject|1
7576914|NCT04139018|11964847|FG000|Overall Study|Screen fail|1
7576915|NCT04139018|11964848|FG001|Overall Study|Screen fail|0
7576916|NCT04139018|11964847|FG000|Overall Study|Withdrawal by Subject|2
7576917|NCT04139018|11964848|FG001|Overall Study|Withdrawal by Subject|0
7576918|NCT04139018|11964847|FG000|Overall Study|Lost to Follow-up|0
7576919|NCT04139018|11964848|FG001|Overall Study|Lost to Follow-up|1
7576920|NCT04138810|11964856|FG000|Overall Study|Withdrawal by Subject|0
7576921|NCT04138810|11964857|FG001|Overall Study|Withdrawal by Subject|1
7576922|NCT04138810|11964856|FG000|Overall Study|Subject cancelled surgery|1
7576923|NCT04138810|11964857|FG001|Overall Study|Subject cancelled surgery|0
7576924|NCT04131556|11964863|FG000|Overall Study|Adverse Event|1
7576925|NCT04131556|11964863|FG000|Overall Study|Withdrawal by Subject|1
7576926|NCT04126174|11964870|FG000|Overall Study|Lost to Follow-up|3
7576927|NCT04126174|11964871|FG001|Overall Study|Lost to Follow-up|3
7576928|NCT04138043|11964915|FG000|Overall Study|Withdrawal by Subject|0
7576929|NCT04138043|11964916|FG001|Overall Study|Withdrawal by Subject|1
7576930|NCT04132336|11964949|FG000|Overall Study|Investigator Decision|0
7576931|NCT04132336|11964950|FG001|Overall Study|Investigator Decision|1
7576932|NCT04132336|11964951|FG002|Overall Study|Investigator Decision|0
7576933|NCT04132336|11964952|FG003|Overall Study|Investigator Decision|0
7576934|NCT04132336|11964953|FG004|Overall Study|Investigator Decision|0
7544361|NCT02825420|11898138|FG000|Overall Study|Withdrawal by Subject|1
7576935|NCT04132336|11964954|FG005|Overall Study|Investigator Decision|0
7576936|NCT04132336|11964955|FG006|Overall Study|Investigator Decision|0
7576937|NCT04128293|11964995|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7263067|NCT00371839|11476203|FG001|Overall Study|Lost to Follow-up|3
7544362|NCT02825420|11898139|FG001|Overall Study|Withdrawal by Subject|1
7263068|NCT00371839|11476204|FG002|Overall Study|Lost to Follow-up|2
7263069|NCT00371865|11476212|FG000|Overall Study|Lack of Efficacy|0
7263070|NCT00371865|11476213|FG001|Overall Study|Lack of Efficacy|2
7263071|NCT00371865|11476212|FG000|Overall Study|Protocol Violation|3
7263072|NCT00371865|11476213|FG001|Overall Study|Protocol Violation|2
7263073|NCT00371865|11476212|FG000|Overall Study|Withdrawal by Subject|12
7263074|NCT00371865|11476213|FG001|Overall Study|Withdrawal by Subject|10
7263075|NCT00372060|11476221|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
7263076|NCT00372060|11476222|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
7263077|NCT00372060|11476221|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
7263078|NCT00372060|11476222|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
7263079|NCT00372060|11476221|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
7263080|NCT00372060|11476222|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
7263081|NCT00372060|11476221|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
7263082|NCT00372060|11476222|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
7263083|NCT00372060|11476221|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
7263084|NCT00372060|11476222|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
7263085|NCT00372060|11476221|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
7263086|NCT00372060|11476222|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
7263087|NCT00372112|11476235|FG000|Overall Study|Adverse Event|0
7263088|NCT00372112|11476236|FG001|Overall Study|Adverse Event|1
7263089|NCT00372112|11476237|FG002|Overall Study|Adverse Event|1
7263090|NCT00372112|11476238|FG003|Overall Study|Adverse Event|1
7263091|NCT00372112|11476235|FG000|Overall Study|Withdrawal by Subject|0
7263092|NCT00372112|11476236|FG001|Overall Study|Withdrawal by Subject|0
7263093|NCT00372112|11476237|FG002|Overall Study|Withdrawal by Subject|2
7263094|NCT00372112|11476238|FG003|Overall Study|Withdrawal by Subject|1
7263095|NCT00372112|11476235|FG000|Overall Study|Exacerbation|0
7263096|NCT00372112|11476236|FG001|Overall Study|Exacerbation|0
7263097|NCT00372112|11476237|FG002|Overall Study|Exacerbation|0
7263098|NCT00372112|11476238|FG003|Overall Study|Exacerbation|1
7263099|NCT00372112|11476235|FG000|Overall Study|PR >240 at Visit 3|0
7263100|NCT00372112|11476236|FG001|Overall Study|PR >240 at Visit 3|0
7263101|NCT00372112|11476237|FG002|Overall Study|PR >240 at Visit 3|0
7263102|NCT00372112|11476238|FG003|Overall Study|PR >240 at Visit 3|1
7263103|NCT00372112|11476235|FG000|Overall Study|Hepatitis B|1
7263104|NCT00372112|11476236|FG001|Overall Study|Hepatitis B|0
7263105|NCT00372112|11476237|FG002|Overall Study|Hepatitis B|0
7263106|NCT00372112|11476238|FG003|Overall Study|Hepatitis B|0
7263107|NCT00372112|11476235|FG000|Overall Study|Other-protocol violation|0
7263108|NCT00372112|11476236|FG001|Overall Study|Other-protocol violation|0
7263109|NCT00372112|11476237|FG002|Overall Study|Other-protocol violation|1
7263110|NCT00372112|11476238|FG003|Overall Study|Other-protocol violation|0
7263111|NCT00372190|11476253|FG000|Overall Study|Lost to Follow-up|3
7263112|NCT00372190|11476254|FG001|Overall Study|Lost to Follow-up|1
7263113|NCT00372255|11476264|FG000|Overall Study|Withdrawn for other reasons|2
7263114|NCT00372255|11476265|FG001|Overall Study|Withdrawn for other reasons|1
7263115|NCT00372385|11476276|FG000|Overall Study|Adverse Event|6
7263116|NCT00372385|11476277|FG001|Overall Study|Adverse Event|11
7263117|NCT00372385|11476278|FG002|Overall Study|Adverse Event|9
7263118|NCT00372385|11476279|FG003|Overall Study|Adverse Event|7
7263119|NCT00372385|11476276|FG000|Overall Study|Noncompliance|0
7263120|NCT00372385|11476277|FG001|Overall Study|Noncompliance|1
7263121|NCT00372385|11476278|FG002|Overall Study|Noncompliance|1
7263122|NCT00372385|11476279|FG003|Overall Study|Noncompliance|1
7263123|NCT00372385|11476276|FG000|Overall Study|Physician Decision|1
7263124|NCT00372385|11476277|FG001|Overall Study|Physician Decision|0
7263125|NCT00372385|11476278|FG002|Overall Study|Physician Decision|0
7263126|NCT00372385|11476279|FG003|Overall Study|Physician Decision|0
7263127|NCT00372385|11476276|FG000|Overall Study|Lost to Follow-up|2
7263128|NCT00372385|11476277|FG001|Overall Study|Lost to Follow-up|0
7263129|NCT00372385|11476278|FG002|Overall Study|Lost to Follow-up|0
7263130|NCT00372385|11476279|FG003|Overall Study|Lost to Follow-up|0
7263131|NCT00372385|11476276|FG000|Overall Study|Withdrawal by Subject|2
7263132|NCT00372385|11476277|FG001|Overall Study|Withdrawal by Subject|1
7263133|NCT00372385|11476278|FG002|Overall Study|Withdrawal by Subject|0
7263134|NCT00372385|11476279|FG003|Overall Study|Withdrawal by Subject|0
7263135|NCT00372385|11476276|FG000|Overall Study|Refusal of Treatment|3
7263136|NCT00372385|11476277|FG001|Overall Study|Refusal of Treatment|6
7544363|NCT02825420|11898138|FG000|Overall Study|Protocol amendment not signed|1
7544364|NCT02825420|11898139|FG001|Overall Study|Protocol amendment not signed|1
7544365|NCT02825420|11898138|FG000|Overall Study|Physician Decision|1
7544366|NCT02825420|11898139|FG001|Overall Study|Physician Decision|0
7544367|NCT02825420|11898138|FG000|Overall Study|Did not receive PLD|2
7544368|NCT02825420|11898139|FG001|Overall Study|Did not receive PLD|0
7544369|NCT02825550|11898150|FG000|Overall Study|Physician Decision|1
7544370|NCT02825992|11898181|FG000|Overall Study|Withdrawal by Subject|4
7544371|NCT02825992|11898181|FG000|Overall Study|Lost to Follow-up|2
7544372|NCT02825992|11898181|FG000|Overall Study|Procedure terminated|2
7544373|NCT02826421|11898195|FG000|Overall Study|Adverse Event|1
7544374|NCT02826421|11898196|FG001|Overall Study|Adverse Event|0
7544375|NCT02826421|11898197|FG002|Overall Study|Adverse Event|0
7544376|NCT02826421|11898198|FG003|Overall Study|Adverse Event|1
7544377|NCT02826421|11898195|FG000|Overall Study|Withdrawal by Subject|1
7544378|NCT02826421|11898196|FG001|Overall Study|Withdrawal by Subject|3
7544379|NCT02826421|11898197|FG002|Overall Study|Withdrawal by Subject|1
7544380|NCT02826421|11898198|FG003|Overall Study|Withdrawal by Subject|1
7544381|NCT02826421|11898195|FG000|Overall Study|Reason not given|1
7544382|NCT02826421|11898196|FG001|Overall Study|Reason not given|0
7544383|NCT02826421|11898197|FG002|Overall Study|Reason not given|1
7544384|NCT02826421|11898198|FG003|Overall Study|Reason not given|0
7544385|NCT02826603|11898211|FG000|Overall Study|Adverse Event|17
7544386|NCT02826603|11898212|FG001|Overall Study|Adverse Event|9
7544387|NCT02826603|11898211|FG000|Overall Study|Lack of Efficacy|4
7544388|NCT02826603|11898212|FG001|Overall Study|Lack of Efficacy|9
7544389|NCT02826603|11898211|FG000|Overall Study|Lost to Follow-up|13
7544390|NCT02826603|11898212|FG001|Overall Study|Lost to Follow-up|12
7263208|NCT00372593|11476331|FG000|Overall Study|Lack of Efficacy|82
7544391|NCT02826603|11898211|FG000|Overall Study|Noncompliance with treatment|0
7544392|NCT02826603|11898212|FG001|Overall Study|Noncompliance with treatment|2
7544393|NCT02826603|11898211|FG000|Overall Study|Physician Decision|1
7544394|NCT02826603|11898212|FG001|Overall Study|Physician Decision|7
7544395|NCT02826603|11898211|FG000|Overall Study|Pregnancy|1
7544396|NCT02826603|11898212|FG001|Overall Study|Pregnancy|2
7263137|NCT00372385|11476278|FG002|Overall Study|Refusal of Treatment|0
7263138|NCT00372385|11476279|FG003|Overall Study|Refusal of Treatment|0
7263139|NCT00372385|11476276|FG000|Overall Study|No Response|1
7263140|NCT00372385|11476277|FG001|Overall Study|No Response|1
7544397|NCT02826603|11898211|FG000|Overall Study|Protocol Violation|3
7544398|NCT02826603|11898212|FG001|Overall Study|Protocol Violation|3
7544399|NCT02826603|11898211|FG000|Overall Study|Withdrawal by Subject|20
7263141|NCT00372385|11476278|FG002|Overall Study|No Response|0
7263142|NCT00372385|11476279|FG003|Overall Study|No Response|0
7544400|NCT02826603|11898212|FG001|Overall Study|Withdrawal by Subject|19
7544401|NCT02826603|11898211|FG000|Overall Study|Death|2
7544402|NCT02826603|11898212|FG001|Overall Study|Death|0
7544403|NCT02826603|11898211|FG000|Overall Study|New therapy for study indication|0
7544404|NCT02826603|11898212|FG001|Overall Study|New therapy for study indication|1
7263143|NCT00372385|11476276|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
7263144|NCT00372385|11476277|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
7263145|NCT00372385|11476278|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
7263146|NCT00372385|11476279|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
7263147|NCT00372385|11476276|FG000|Overall Study|Virologic Stopping Rule|17
7263148|NCT00372385|11476277|FG001|Overall Study|Virologic Stopping Rule|0
7263149|NCT00372385|11476278|FG002|Overall Study|Virologic Stopping Rule|0
7263150|NCT00372385|11476279|FG003|Overall Study|Virologic Stopping Rule|0
7263151|NCT00372411|11476293|FG000|Overall Study|Withdrawal by Subject|3
7263152|NCT00372411|11476294|FG001|Overall Study|Withdrawal by Subject|4
7263153|NCT00372411|11476295|FG002|Overall Study|Withdrawal by Subject|1
7263154|NCT00372411|11476293|FG000|Overall Study|Death|0
7263155|NCT00372411|11476294|FG001|Overall Study|Death|2
7263156|NCT00372411|11476295|FG002|Overall Study|Death|1
7263157|NCT00372411|11476293|FG000|Overall Study|Lost to Follow-up|1
7263158|NCT00372411|11476294|FG001|Overall Study|Lost to Follow-up|1
7263159|NCT00372411|11476295|FG002|Overall Study|Lost to Follow-up|1
7263160|NCT00372411|11476293|FG000|Overall Study|Adverse Event|1
7263161|NCT00372411|11476294|FG001|Overall Study|Adverse Event|1
7263162|NCT00372411|11476295|FG002|Overall Study|Adverse Event|0
7263163|NCT00372424|11476303|FG000|Overall Study|Adverse Event|2
7263164|NCT00372424|11476303|FG000|Overall Study|Withdrawal by Subject|1
7263165|NCT00372424|11476303|FG000|Overall Study|Death|1
7263166|NCT00372424|11476303|FG000|Overall Study|Objective Progression or Relapse|14
7263167|NCT00372424|11476303|FG000|Overall Study|Other|7
7263168|NCT00372424|11476303|FG000|Overall Study|Enrolled, Not Treated|1
7263169|NCT00372489|11476307|FG000|Overall Study|Adverse Event|18
7263170|NCT00372489|11476307|FG000|Overall Study|Lack of Efficacy|1
7263171|NCT00372489|11476307|FG000|Overall Study|Lost to Follow-up|3
7263172|NCT00372489|11476307|FG000|Overall Study|Physician Decision|3
7263173|NCT00372489|11476307|FG000|Overall Study|Withdrawal by Subject|5
7263174|NCT00372489|11476307|FG000|Overall Study|Patient Relocation|2
7263175|NCT00372489|11476307|FG000|Overall Study|Renal transplant|6
7263176|NCT00372489|11476307|FG000|Overall Study|Sponsor Decision to Terminate Study|41
7263177|NCT00372528|11476311|FG000|Overall Study|Lack of Efficacy|1
7263178|NCT00372528|11476311|FG000|Overall Study|Adverse Event|1
7263179|NCT00372528|11476311|FG000|Overall Study|Study Terminated by Sponsor|18
7263180|NCT00372528|11476311|FG000|Overall Study|Other|1
7263181|NCT00372567|11476318|FG000|Phase 3 Study|Adverse Event|5
7263182|NCT00372567|11476319|FG001|Phase 3 Study|Adverse Event|1
7263183|NCT00372567|11476320|FG002|Phase 3 Study|Adverse Event|1
7263184|NCT00372567|11476318|FG000|Phase 3 Study|Death|1
7263185|NCT00372567|11476319|FG001|Phase 3 Study|Death|1
7263186|NCT00372567|11476320|FG002|Phase 3 Study|Death|0
7263187|NCT00372567|11476318|FG000|Phase 3 Study|Protocol Violation|0
7263188|NCT00372567|11476319|FG001|Phase 3 Study|Protocol Violation|0
7263189|NCT00372567|11476320|FG002|Phase 3 Study|Protocol Violation|1
7263190|NCT00372567|11476318|FG000|Phase 3 Study|Objective progression or relapse|10
7263191|NCT00372567|11476319|FG001|Phase 3 Study|Objective progression or relapse|13
7263192|NCT00372567|11476320|FG002|Phase 3 Study|Objective progression or relapse|4
7263193|NCT00372567|11476318|FG000|Phase 3 Study|Global deterioration of health status|0
7263194|NCT00372567|11476319|FG001|Phase 3 Study|Global deterioration of health status|1
7263195|NCT00372567|11476320|FG002|Phase 3 Study|Global deterioration of health status|0
7263196|NCT00372567|11476318|FG000|Phase 3 Study|Other|2
7263197|NCT00372567|11476319|FG001|Phase 3 Study|Other|2
7263198|NCT00372567|11476320|FG002|Phase 3 Study|Other|1
7263199|NCT00372567|11476318|FG000|Phase 3 Study|study terminated by sponsor|13
7263200|NCT00372567|11476319|FG001|Phase 3 Study|study terminated by sponsor|8
7263201|NCT00372567|11476320|FG002|Phase 3 Study|study terminated by sponsor|5
7263202|NCT00372593|11476331|FG000|Overall Study|Adverse Event|43
7263203|NCT00372593|11476332|FG001|Overall Study|Adverse Event|45
7263204|NCT00372593|11476333|FG002|Overall Study|Adverse Event|0
7263205|NCT00372593|11476331|FG000|Overall Study|Death|16
7263206|NCT00372593|11476332|FG001|Overall Study|Death|20
7263207|NCT00372593|11476333|FG002|Overall Study|Death|1
7263209|NCT00372593|11476332|FG001|Overall Study|Lack of Efficacy|71
7263210|NCT00372593|11476333|FG002|Overall Study|Lack of Efficacy|2
7263211|NCT00372593|11476331|FG000|Overall Study|Lost to Follow-up|1
7544405|NCT02826798|11898235|FG000|Overall Study|Withdrawal by Subject|0
7544406|NCT02826798|11898236|FG001|Overall Study|Withdrawal by Subject|1
7544407|NCT02826798|11898237|FG002|Overall Study|Withdrawal by Subject|0
7544408|NCT02826798|11898238|FG003|Overall Study|Withdrawal by Subject|1
7544409|NCT02826798|11898239|FG004|Overall Study|Withdrawal by Subject|0
7544410|NCT02827500|11898253|FG000|Overall Study|Death|7
7544411|NCT02827500|11898254|FG001|Overall Study|Death|3
7544412|NCT02827500|11898253|FG000|Overall Study|Lost to Follow-up|1
7544413|NCT02827500|11898254|FG001|Overall Study|Lost to Follow-up|1
7544414|NCT02827500|11898253|FG000|Overall Study|Withdrawal by Subject|3
7544415|NCT02827500|11898254|FG001|Overall Study|Withdrawal by Subject|1
7544416|NCT02827500|11898253|FG000|Overall Study|Missing primary endpoint data|3
7544417|NCT02827500|11898254|FG001|Overall Study|Missing primary endpoint data|1
7544418|NCT02827500|11898253|FG000|Overall Study|Other|5
7544419|NCT02827500|11898254|FG001|Overall Study|Other|1
7544420|NCT02827708|11898262|FG000|Overall Study|Lost to Follow-up|3
7544421|NCT02827708|11898263|FG001|Overall Study|Lost to Follow-up|1
7544422|NCT02827708|11898262|FG000|Overall Study|Withdrawal by Subject|1
7544423|NCT02827708|11898263|FG001|Overall Study|Withdrawal by Subject|2
7544424|NCT02827708|11898262|FG000|Overall Study|Death|1
7544425|NCT02827708|11898263|FG001|Overall Study|Death|2
7544426|NCT02828020|11898272|FG000|Treatment Period|Adverse Event|3
7544427|NCT02828020|11898273|FG001|Treatment Period|Adverse Event|1
7544428|NCT02828020|11898274|FG002|Treatment Period|Adverse Event|1
7544429|NCT02828020|11898272|FG000|Treatment Period|Withdrawal of Consent|10
7544430|NCT02828020|11898273|FG001|Treatment Period|Withdrawal of Consent|14
7544431|NCT02828020|11898274|FG002|Treatment Period|Withdrawal of Consent|9
7544432|NCT02828020|11898272|FG000|Treatment Period|Lost to Follow-up|21
7544433|NCT02828020|11898273|FG001|Treatment Period|Lost to Follow-up|24
7544434|NCT02828020|11898274|FG002|Treatment Period|Lost to Follow-up|18
7544435|NCT02828020|11898272|FG000|Treatment Period|Lack of Qualifying Event|44
7544436|NCT02828020|11898273|FG001|Treatment Period|Lack of Qualifying Event|53
7544437|NCT02828020|11898274|FG002|Treatment Period|Lack of Qualifying Event|43
7544438|NCT02828020|11898272|FG000|Treatment Period|Pregnancy|0
7544439|NCT02828020|11898273|FG001|Treatment Period|Pregnancy|2
7544440|NCT02828020|11898274|FG002|Treatment Period|Pregnancy|0
7544441|NCT02828020|11898272|FG000|Treatment Period|Protocol Violation|2
7544442|NCT02828020|11898273|FG001|Treatment Period|Protocol Violation|4
7544443|NCT02828020|11898274|FG002|Treatment Period|Protocol Violation|7
7263212|NCT00372593|11476332|FG001|Overall Study|Lost to Follow-up|0
7263213|NCT00372593|11476333|FG002|Overall Study|Lost to Follow-up|0
7544444|NCT02828020|11898272|FG000|Treatment Period|Other Miscellaneous Reasons|0
7544445|NCT02828020|11898273|FG001|Treatment Period|Other Miscellaneous Reasons|1
7544446|NCT02828020|11898274|FG002|Treatment Period|Other Miscellaneous Reasons|0
7544447|NCT02828020|11898272|FG000|Safety Follow-up Period|Withdrawal of Consent|10
7544448|NCT02828020|11898273|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7263214|NCT00372593|11476331|FG000|Overall Study|Physician Decision|42
7469614|NCT01925209|11771428|FG000|Follow-up|Adverse Event|1
7469615|NCT01925209|11771429|FG001|Follow-up|Adverse Event|4
7469616|NCT01925209|11771430|FG002|Follow-up|Adverse Event|0
7469617|NCT01925209|11771431|FG003|Follow-up|Adverse Event|1
7469618|NCT01925209|11771428|FG000|Follow-up|Physician Decision|0
7469619|NCT01925209|11771429|FG001|Follow-up|Physician Decision|0
7469620|NCT01925209|11771430|FG002|Follow-up|Physician Decision|1
7469621|NCT01925209|11771431|FG003|Follow-up|Physician Decision|0
7263215|NCT00372593|11476332|FG001|Overall Study|Physician Decision|41
7263216|NCT00372593|11476333|FG002|Overall Study|Physician Decision|0
7263217|NCT00372593|11476331|FG000|Overall Study|Ineligible|20
7263218|NCT00372593|11476332|FG001|Overall Study|Ineligible|21
7263219|NCT00372593|11476333|FG002|Overall Study|Ineligible|1
7263220|NCT00372619|11476349|FG000|Overall Study|Ineligible|0
7263221|NCT00372619|11476350|FG001|Overall Study|Ineligible|0
7263222|NCT00372619|11476351|FG002|Overall Study|Ineligible|0
7263223|NCT00372619|11476352|FG003|Overall Study|Ineligible|0
7263224|NCT00372619|11476353|FG004|Overall Study|Ineligible|0
7263225|NCT00372619|11476354|FG005|Overall Study|Ineligible|2
7263226|NCT00372619|11476355|FG006|Overall Study|Ineligible|0
7263227|NCT00372619|11476349|FG000|Overall Study|Inevaluable|0
7263228|NCT00372619|11476350|FG001|Overall Study|Inevaluable|0
7263229|NCT00372619|11476351|FG002|Overall Study|Inevaluable|0
7263230|NCT00372619|11476352|FG003|Overall Study|Inevaluable|0
7263231|NCT00372619|11476353|FG004|Overall Study|Inevaluable|0
7263232|NCT00372619|11476354|FG005|Overall Study|Inevaluable|1
7263233|NCT00372619|11476355|FG006|Overall Study|Inevaluable|0
7263234|NCT00372697|11476373|FG000|Overall Study|Protocol Violation|1
7263235|NCT00372697|11476374|FG001|Overall Study|Protocol Violation|1
7263236|NCT00372775|11476380|FG000|Overall Study|Adverse Event|8
7263237|NCT00372775|11476380|FG000|Overall Study|Death|15
7263238|NCT00372775|11476380|FG000|Overall Study|Objective progression or relapse|30
7263239|NCT00372775|11476380|FG000|Overall Study|Global deterioration of health status|6
7263240|NCT00372775|11476380|FG000|Overall Study|Withdrawal by Subject|1
7263241|NCT00372775|11476380|FG000|Overall Study|Other|1
7263242|NCT00372775|11476380|FG000|Overall Study|Not Treated|2
7263243|NCT00372905|11476384|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
7263244|NCT00372905|11476385|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7263245|NCT00372905|11476386|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7263246|NCT00372905|11476387|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
7263247|NCT00372905|11476384|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7263248|NCT00372905|11476385|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7263249|NCT00372905|11476386|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
7263250|NCT00372905|11476387|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
7263251|NCT00372905|11476384|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7263252|NCT00372905|11476385|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7263253|NCT00372905|11476386|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
7263254|NCT00372905|11476387|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
7263255|NCT00372905|11476384|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7263256|NCT00372905|11476385|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7263257|NCT00372905|11476386|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
7263258|NCT00372905|11476387|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
7263259|NCT00372905|11476384|FG000|Follow up Until Relapse or Progression|Study closed|0
7544449|NCT02828020|11898274|FG002|Safety Follow-up Period|Withdrawal of Consent|7
7544450|NCT02828020|11898272|FG000|Safety Follow-up Period|Lost to Follow-up|9
7544451|NCT02828020|11898273|FG001|Safety Follow-up Period|Lost to Follow-up|8
7544452|NCT02828020|11898274|FG002|Safety Follow-up Period|Lost to Follow-up|11
7544453|NCT02828020|11898272|FG000|Safety Follow-up Period|Protocol Violation|0
7544454|NCT02828020|11898273|FG001|Safety Follow-up Period|Protocol Violation|2
7544455|NCT02828020|11898274|FG002|Safety Follow-up Period|Protocol Violation|1
7263260|NCT00372905|11476385|FG001|Follow up Until Relapse or Progression|Study closed|0
7263261|NCT00372905|11476386|FG002|Follow up Until Relapse or Progression|Study closed|0
7263262|NCT00372905|11476387|FG003|Follow up Until Relapse or Progression|Study closed|3
7544456|NCT02828020|11898272|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
7544457|NCT02828020|11898273|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
7263263|NCT00372905|11476384|FG000|Follow up Until Relapse or Progression|Other|0
7263264|NCT00372905|11476385|FG001|Follow up Until Relapse or Progression|Other|1
7263265|NCT00372905|11476386|FG002|Follow up Until Relapse or Progression|Other|0
7263266|NCT00372905|11476387|FG003|Follow up Until Relapse or Progression|Other|0
7469622|NCT01925209|11771428|FG000|Follow-up|Non-compliance with study treatment|0
7469623|NCT01925209|11771429|FG001|Follow-up|Non-compliance with study treatment|0
7469624|NCT01925209|11771430|FG002|Follow-up|Non-compliance with study treatment|0
7469625|NCT01925209|11771431|FG003|Follow-up|Non-compliance with study treatment|1
7469626|NCT01925209|11771428|FG000|Follow-up|Withdrawal by Subject|0
7469627|NCT01925209|11771429|FG001|Follow-up|Withdrawal by Subject|2
7469628|NCT01925209|11771430|FG002|Follow-up|Withdrawal by Subject|0
7469629|NCT01925209|11771431|FG003|Follow-up|Withdrawal by Subject|2
7469630|NCT01925274|11771444|FG000|Overall Study|Death|1
7469631|NCT01925274|11771445|FG001|Overall Study|Death|0
7469632|NCT01925274|11771446|FG002|Overall Study|Death|0
7469633|NCT01925274|11771444|FG000|Overall Study|Lost to Follow-up|0
7469634|NCT01925274|11771445|FG001|Overall Study|Lost to Follow-up|1
7469635|NCT01925274|11771446|FG002|Overall Study|Lost to Follow-up|0
7544458|NCT02828020|11898274|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7263267|NCT00372996|11476423|FG000|Overall Study|Death|11
7263268|NCT00372996|11476424|FG001|Overall Study|Death|4
7263269|NCT00372996|11476425|FG002|Overall Study|Death|8
7263270|NCT00372996|11476426|FG003|Overall Study|Death|7
7263271|NCT00372996|11476423|FG000|Overall Study|Lost to Follow-up|0
7263272|NCT00372996|11476424|FG001|Overall Study|Lost to Follow-up|2
7263273|NCT00372996|11476425|FG002|Overall Study|Lost to Follow-up|0
7263274|NCT00372996|11476426|FG003|Overall Study|Lost to Follow-up|1
7263275|NCT00372996|11476423|FG000|Overall Study|Withdrawal by Subject|12
7263276|NCT00372996|11476424|FG001|Overall Study|Withdrawal by Subject|6
7263277|NCT00372996|11476425|FG002|Overall Study|Withdrawal by Subject|9
7263278|NCT00372996|11476426|FG003|Overall Study|Withdrawal by Subject|5
7263279|NCT00372996|11476423|FG000|Overall Study|Study Terminated by Sponsor|4
7263280|NCT00372996|11476424|FG001|Overall Study|Study Terminated by Sponsor|0
7263281|NCT00372996|11476425|FG002|Overall Study|Study Terminated by Sponsor|4
7263282|NCT00372996|11476426|FG003|Overall Study|Study Terminated by Sponsor|0
7263283|NCT00372996|11476423|FG000|Overall Study|Other|10
7263284|NCT00372996|11476424|FG001|Overall Study|Other|2
7263285|NCT00372996|11476425|FG002|Overall Study|Other|7
7263286|NCT00372996|11476426|FG003|Overall Study|Other|7
7263287|NCT00373113|11476438|FG000|Overall Study|Death|1
7263288|NCT00373113|11476439|FG001|Overall Study|Death|7
7263289|NCT00373113|11476438|FG000|Overall Study|Adverse Event|38
7263290|NCT00373113|11476439|FG001|Overall Study|Adverse Event|24
7263291|NCT00373113|11476438|FG000|Overall Study|Study terminated by sponsor|9
7263292|NCT00373113|11476439|FG001|Overall Study|Study terminated by sponsor|1
7263293|NCT00373113|11476438|FG000|Overall Study|Global deterioration of health status|10
7263294|NCT00373113|11476439|FG001|Overall Study|Global deterioration of health status|7
7544459|NCT02828111|11898287|FG000|Overall Study|Withdrawal by Subject|0
7544460|NCT02828111|11898288|FG001|Overall Study|Withdrawal by Subject|0
7544461|NCT02828111|11898289|FG002|Overall Study|Withdrawal by Subject|2
7544462|NCT02828111|11898290|FG003|Overall Study|Withdrawal by Subject|0
7544463|NCT02828111|11898291|FG004|Overall Study|Withdrawal by Subject|0
7544464|NCT02828111|11898287|FG000|Overall Study|Lost to Follow-up|0
7544465|NCT02828111|11898288|FG001|Overall Study|Lost to Follow-up|0
7544466|NCT02828111|11898289|FG002|Overall Study|Lost to Follow-up|0
7544467|NCT02828111|11898290|FG003|Overall Study|Lost to Follow-up|1
7544468|NCT02828111|11898291|FG004|Overall Study|Lost to Follow-up|1
7544469|NCT02828241|11898327|FG000|Overall Study|Adverse Event|7
7544470|NCT02828241|11898328|FG001|Overall Study|Adverse Event|2
7544471|NCT02828241|11898327|FG000|Overall Study|Protocol Violation|1
7544472|NCT02828241|11898328|FG001|Overall Study|Protocol Violation|0
7544473|NCT02828358|11898356|FG000|Overall Study|Physician Decision|7
7544474|NCT02828358|11898357|FG001|Overall Study|Physician Decision|1
7544475|NCT02828358|11898356|FG000|Overall Study|Treatment Failure|6
7544476|NCT02828358|11898357|FG001|Overall Study|Treatment Failure|0
7544477|NCT02828358|11898356|FG000|Overall Study|Patients without KMT2A rearrangement|0
7544478|NCT02828358|11898357|FG001|Overall Study|Patients without KMT2A rearrangement|21
7544479|NCT02828358|11898356|FG000|Overall Study|Refusal of further protocol therapy|2
7544480|NCT02828358|11898357|FG001|Overall Study|Refusal of further protocol therapy|0
7544481|NCT02828358|11898356|FG000|Overall Study|Relapse|25
7263295|NCT00373113|11476438|FG000|Overall Study|Lost to Follow-up|1
7263296|NCT00373113|11476439|FG001|Overall Study|Lost to Follow-up|3
7263297|NCT00373113|11476438|FG000|Overall Study|Objective progression or relapse|150
7263298|NCT00373113|11476439|FG001|Overall Study|Objective progression or relapse|169
7263299|NCT00373113|11476438|FG000|Overall Study|Other|14
7263300|NCT00373113|11476439|FG001|Overall Study|Other|17
7263301|NCT00373113|11476438|FG000|Overall Study|Protocol Violation|5
7263302|NCT00373113|11476439|FG001|Overall Study|Protocol Violation|1
7263303|NCT00373113|11476438|FG000|Overall Study|Withdrawal by Subject|10
7263304|NCT00373113|11476439|FG001|Overall Study|Withdrawal by Subject|15
7263305|NCT00373256|11476447|FG000|Overall Study|Adverse Event (AE)|1
7263306|NCT00373256|11476448|FG001|Overall Study|Adverse Event (AE)|5
7263307|NCT00373256|11476447|FG000|Overall Study|Lost to Follow-up|2
7263308|NCT00373256|11476448|FG001|Overall Study|Lost to Follow-up|1
7263309|NCT00373256|11476447|FG000|Overall Study|Death|9
7263310|NCT00373256|11476448|FG001|Overall Study|Death|8
7263311|NCT00373256|11476447|FG000|Overall Study|Objective Progression or Relapse|111
7263312|NCT00373256|11476448|FG001|Overall Study|Objective Progression or Relapse|104
7263313|NCT00373256|11476447|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
7263314|NCT00373256|11476448|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
7263315|NCT00373256|11476447|FG000|Overall Study|Other|73
7263316|NCT00373256|11476448|FG001|Overall Study|Other|107
7263317|NCT00373256|11476447|FG000|Overall Study|Protocol Violation|0
7263318|NCT00373256|11476448|FG001|Overall Study|Protocol Violation|2
7263319|NCT00373256|11476447|FG000|Overall Study|Study Terminated by Sponsor|41
7263320|NCT00373256|11476448|FG001|Overall Study|Study Terminated by Sponsor|13
7263321|NCT00373295|11476463|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
7263322|NCT00373295|11476464|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
7263323|NCT00373295|11476465|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
7263324|NCT00373295|11476466|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
7263325|NCT00373295|11476467|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
7263326|NCT00373295|11476468|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
7388052|NCT01217229|11646738|FG000|Overall Study|Disease progression, deterioration|2
7388053|NCT01217229|11646738|FG000|Overall Study|Disease progression, Cheson criteria|14
7388054|NCT01217229|11646738|FG000|Overall Study|Protocol Violation|1
7388055|NCT01217229|11646738|FG000|Overall Study|Disease progression not confirmed|2
7388056|NCT01217307|11646744|FG000|Overall Study|Withdrawal by Subject|0
7388057|NCT01217307|11646745|FG001|Overall Study|Withdrawal by Subject|1
7388058|NCT01217385|11646751|FG000|Overall Study|Withdrawal by Subject|3
7388059|NCT01217385|11646751|FG000|Overall Study|DOSI not performed/not eval|12
7388060|NCT01217385|11646751|FG000|Overall Study|Central Path not Available|1
7388061|NCT01217385|11646751|FG000|Overall Study|Normal Breast TOI not available|10
7388062|NCT01217437|11646774|FG000|Overall Study|Adverse Event|0
7388063|NCT01217437|11646775|FG001|Overall Study|Adverse Event|8
7388064|NCT01217437|11646774|FG000|Overall Study|Death|5
7388065|NCT01217437|11646775|FG001|Overall Study|Death|0
7388066|NCT01217437|11646774|FG000|Overall Study|Lack of Efficacy|29
7388067|NCT01217437|11646775|FG001|Overall Study|Lack of Efficacy|25
7388068|NCT01217437|11646774|FG000|Overall Study|Physician Decision|8
7388069|NCT01217437|11646775|FG001|Overall Study|Physician Decision|5
7388070|NCT01217437|11646774|FG000|Overall Study|Withdrawal by Subject|0
7388071|NCT01217437|11646775|FG001|Overall Study|Withdrawal by Subject|2
7388072|NCT01217437|11646774|FG000|Overall Study|Ineligible|1
7388073|NCT01217437|11646775|FG001|Overall Study|Ineligible|1
7388074|NCT01217463|11646783|FG000|Overall Study|Adverse Event|8
7388075|NCT01217463|11646784|FG001|Overall Study|Adverse Event|5
7388076|NCT01217463|11646783|FG000|Overall Study|Physician Decision|0
7388077|NCT01217463|11646784|FG001|Overall Study|Physician Decision|1
7388078|NCT01217463|11646783|FG000|Overall Study|Withdrawal by Subject|3
7388079|NCT01217463|11646784|FG001|Overall Study|Withdrawal by Subject|0
7388080|NCT01217463|11646783|FG000|Overall Study|Surgery on the Target Limb|0
7388081|NCT01217463|11646784|FG001|Overall Study|Surgery on the Target Limb|1
7388082|NCT01217463|11646783|FG000|Overall Study|Patient Non-compliant|1
7263327|NCT00373425|11476517|FG000|Overall Study|Relapse of NSCLC|116
7263328|NCT00373425|11476518|FG001|Overall Study|Relapse of NSCLC|104
7263329|NCT00373425|11476519|FG002|Overall Study|Relapse of NSCLC|19
7263330|NCT00373425|11476520|FG003|Overall Study|Relapse of NSCLC|2
7263331|NCT00373425|11476521|FG004|Overall Study|Relapse of NSCLC|26
7263332|NCT00373425|11476517|FG000|Overall Study|Adverse Event|191
7263333|NCT00373425|11476518|FG001|Overall Study|Adverse Event|22
7263334|NCT00373425|11476519|FG002|Overall Study|Adverse Event|59
7263335|NCT00373425|11476520|FG003|Overall Study|Adverse Event|0
7263336|NCT00373425|11476521|FG004|Overall Study|Adverse Event|34
7263337|NCT00373425|11476517|FG000|Overall Study|Patient request|35
7263338|NCT00373425|11476518|FG001|Overall Study|Patient request|18
7263339|NCT00373425|11476519|FG002|Overall Study|Patient request|43
7263340|NCT00373425|11476520|FG003|Overall Study|Patient request|6
7263341|NCT00373425|11476521|FG004|Overall Study|Patient request|7
7544482|NCT02828358|11898357|FG001|Overall Study|Relapse|0
7544483|NCT02828358|11898356|FG000|Overall Study|Still on therapy|5
7544484|NCT02828358|11898357|FG001|Overall Study|Still on therapy|0
7544485|NCT02828436|11898362|FG000|Period 1|Did Not Meet Inclusion Criteria|0
7544486|NCT02828436|11898363|FG001|Period 1|Did Not Meet Inclusion Criteria|3
7544487|NCT02828436|11898362|FG000|Period 1|Lost to Follow-up|0
7544488|NCT02828436|11898363|FG001|Period 1|Lost to Follow-up|1
7544489|NCT02828436|11898362|FG000|Period 2|Withdrawal by Subject|4
7544490|NCT02828436|11898363|FG001|Period 2|Withdrawal by Subject|0
7544491|NCT02828436|11898362|FG000|Period 2|Did Not Meet Inclusion Criteria|3
7544492|NCT02828436|11898363|FG001|Period 2|Did Not Meet Inclusion Criteria|0
7544493|NCT02828436|11898362|FG000|Period 2|Lost to Follow-up|1
7544494|NCT02828436|11898363|FG001|Period 2|Lost to Follow-up|0
7544495|NCT02828644|11898371|FG000|Overall Study|Lost to Follow-up|23
7544496|NCT02828644|11898372|FG001|Overall Study|Lost to Follow-up|22
7544497|NCT02829138|11898390|FG000|Overall Study|Withdrawal by Subject|1
7544498|NCT02829138|11898391|FG001|Overall Study|Withdrawal by Subject|0
7544499|NCT02829775|11898427|FG000|Overall Study|Death|1
7544500|NCT02829775|11898427|FG000|Overall Study|Withdrawal by Subject|3
7263342|NCT00373425|11476517|FG000|Overall Study|Medical/ethical/noncompliance reason|21
7263343|NCT00373425|11476518|FG001|Overall Study|Medical/ethical/noncompliance reason|9
7263344|NCT00373425|11476519|FG002|Overall Study|Medical/ethical/noncompliance reason|10
7263345|NCT00373425|11476520|FG003|Overall Study|Medical/ethical/noncompliance reason|2
7263346|NCT00373425|11476521|FG004|Overall Study|Medical/ethical/noncompliance reason|5
7263347|NCT00373425|11476517|FG000|Overall Study|Death|7
7263348|NCT00373425|11476518|FG001|Overall Study|Death|0
7263349|NCT00373425|11476519|FG002|Overall Study|Death|3
7263350|NCT00373425|11476520|FG003|Overall Study|Death|1
7263351|NCT00373425|11476521|FG004|Overall Study|Death|0
7263352|NCT00373490|11476532|FG000|Overall Study|Adverse Event|0
7263353|NCT00373490|11476533|FG001|Overall Study|Adverse Event|1
7263354|NCT00373490|11476532|FG000|Overall Study|Lack of Efficacy|9
7263355|NCT00373490|11476533|FG001|Overall Study|Lack of Efficacy|4
7263356|NCT00373490|11476532|FG000|Overall Study|Withdrawal by Subject|0
7263357|NCT00373490|11476533|FG001|Overall Study|Withdrawal by Subject|1
7263358|NCT00373529|11476539|FG000|Overall Study|Physician Decision|19
7263359|NCT00373529|11476539|FG000|Overall Study|Withdrawal by Subject|7
7263360|NCT00373529|11476539|FG000|Overall Study|Adverse Event|7
7263361|NCT00373529|11476539|FG000|Overall Study|Treatment failure|36
7263362|NCT00373529|11476539|FG000|Overall Study|Disease recurrence|10
7263363|NCT00373529|11476539|FG000|Overall Study|Death|16
7263364|NCT00373529|11476539|FG000|Overall Study|Need for treatment prohibited by study|1
7263365|NCT00373529|11476539|FG000|Overall Study|Other|8
7263366|NCT00373529|11476539|FG000|Overall Study|Failed independent confirmation of AML|3
7263367|NCT00373529|11476539|FG000|Overall Study|Consent violation|1
7263368|NCT00373685|11476545|FG000|Overall Study|Death|2
7263369|NCT00373685|11476546|FG001|Overall Study|Death|1
7263370|NCT00373685|11476545|FG000|Overall Study|Adverse Event|278
7263371|NCT00373685|11476546|FG001|Overall Study|Adverse Event|253
7263372|NCT00373685|11476545|FG000|Overall Study|Insufficient clinical response|169
7263373|NCT00373685|11476546|FG001|Overall Study|Insufficient clinical response|119
7263374|NCT00373685|11476545|FG000|Overall Study|Did not meet entrance criteria|167
7544501|NCT02829775|11898427|FG000|Overall Study|Disease remission|1
7544502|NCT02829944|11898434|FG000|Overall Study|Physician Decision|0
7544503|NCT02829944|11898435|FG001|Overall Study|Physician Decision|1
7263375|NCT00373685|11476546|FG001|Overall Study|Did not meet entrance criteria|184
7544504|NCT02829944|11898434|FG000|Overall Study|Screen Failure|2
7263376|NCT00373685|11476545|FG000|Overall Study|Lost to follow up|83
7263377|NCT00373685|11476546|FG001|Overall Study|Lost to follow up|103
7263378|NCT00373685|11476545|FG000|Overall Study|No longer willing to participate|337
7263379|NCT00373685|11476546|FG001|Overall Study|No longer willing to participate|352
7263380|NCT00373685|11476545|FG000|Overall Study|Other|149
7263381|NCT00373685|11476546|FG001|Overall Study|Other|146
7263382|NCT00373685|11476545|FG000|Overall Study|Protocol Violation|191
7263383|NCT00373685|11476546|FG001|Overall Study|Protocol Violation|182
7263384|NCT00373685|11476545|FG000|Overall Study|Final Status Unknown|12
7263385|NCT00373685|11476546|FG001|Overall Study|Final Status Unknown|4
7263386|NCT00373685|11476545|FG000|Overall Study|Randomized, not treated|51
7263387|NCT00373685|11476546|FG001|Overall Study|Randomized, not treated|77
7263388|NCT00373880|11476563|FG000|Overall Study|Physician Decision|3
7263389|NCT00373880|11476563|FG000|Overall Study|Arrested|1
7263390|NCT00373880|11476563|FG000|Overall Study|Protocol Violation|14
7263391|NCT00373958|11476577|FG000|Infant Series|Withdrawal by Subject|13
7263392|NCT00373958|11476578|FG001|Infant Series|Withdrawal by Subject|15
7263393|NCT00373958|11476577|FG000|Infant Series|Failed to return|8
7263394|NCT00373958|11476578|FG001|Infant Series|Failed to return|13
7263395|NCT00373958|11476577|FG000|Infant Series|Lost to Follow-up|6
7263396|NCT00373958|11476578|FG001|Infant Series|Lost to Follow-up|5
7263397|NCT00373958|11476577|FG000|Infant Series|Protocol Violation|3
7263398|NCT00373958|11476578|FG001|Infant Series|Protocol Violation|7
7263399|NCT00373958|11476577|FG000|Infant Series|Lost Kaiser coverage|4
7544505|NCT02829944|11898435|FG001|Overall Study|Screen Failure|2
7544506|NCT02829944|11898434|FG000|Overall Study|Inadequate Neuraxial Block|1
7544507|NCT02829944|11898435|FG001|Overall Study|Inadequate Neuraxial Block|1
7544508|NCT02829944|11898434|FG000|Overall Study|Withdrawal by Subject|2
7544509|NCT02829944|11898435|FG001|Overall Study|Withdrawal by Subject|1
7544510|NCT02829944|11898434|FG000|Overall Study|Catheter Displacement|1
7544511|NCT02829944|11898435|FG001|Overall Study|Catheter Displacement|0
7544512|NCT02829944|11898434|FG000|Overall Study|Catheter broke|0
7544513|NCT02829944|11898435|FG001|Overall Study|Catheter broke|1
7544514|NCT02829944|11898434|FG000|Overall Study|Staff unavailable|0
7544515|NCT02829944|11898435|FG001|Overall Study|Staff unavailable|1
7544516|NCT02829996|11898455|FG000|Overall Study|Withdrawal by Subject|1
7544517|NCT02829996|11898456|FG001|Overall Study|Withdrawal by Subject|0
7544518|NCT02829996|11898457|FG002|Overall Study|Withdrawal by Subject|0
7544519|NCT02829996|11898458|FG003|Overall Study|Withdrawal by Subject|0
7544520|NCT02829996|11898459|FG004|Overall Study|Withdrawal by Subject|0
7544521|NCT02830087|11898487|FG000|Overall Study|No study staff to follow-up patients|4
7544522|NCT02830087|11898488|FG001|Overall Study|No study staff to follow-up patients|4
7544523|NCT02830087|11898489|FG002|Overall Study|No study staff to follow-up patients|4
7544524|NCT02830087|11898490|FG003|Overall Study|No study staff to follow-up patients|3
7544525|NCT02830087|11898491|FG004|Overall Study|No study staff to follow-up patients|3
7544526|NCT02830087|11898492|FG005|Overall Study|No study staff to follow-up patients|3
7544527|NCT02830776|11898510|FG000|Overall Study|Lost to Follow-up|1
7544528|NCT02830880|11898515|FG000|Overall Study|Adverse reaction to chemotherapy|1
7544529|NCT02830880|11898515|FG000|Overall Study|Death|1
7544530|NCT02830880|11898515|FG000|Overall Study|Physician Decision|1
7544531|NCT02830893|11898521|FG000|Overall Study|Relocation to out of the country|1
7544532|NCT02830893|11898522|FG001|Overall Study|Relocation to out of the country|0
7544533|NCT02830893|11898521|FG000|Overall Study|Lost to Follow-up|0
7544534|NCT02830893|11898522|FG001|Overall Study|Lost to Follow-up|2
7544535|NCT02830893|11898521|FG000|Overall Study|Discharged to SNF, no transportation.|0
7544536|NCT02830893|11898522|FG001|Overall Study|Discharged to SNF, no transportation.|1
7544537|NCT02831387|11898530|FG000|Overall Study|Withdrawal by Subject|1
7544538|NCT02831387|11898531|FG001|Overall Study|Withdrawal by Subject|1
7544539|NCT02831387|11898530|FG000|Overall Study|Discontinued due to stock recovery|0
7624566|NCT02173301|12035673|FG002|Overall Study|Adverse Event|13
7624567|NCT02173301|12035674|FG003|Overall Study|Adverse Event|5
7624568|NCT02173301|12035671|FG000|Overall Study|Withdrawal by Subject|8
7263400|NCT00373958|11476578|FG001|Infant Series|Lost Kaiser coverage|0
7263401|NCT00373958|11476577|FG000|Infant Series|Child relocated|1
7263402|NCT00373958|11476578|FG001|Infant Series|Child relocated|0
7624569|NCT02173301|12035672|FG001|Overall Study|Withdrawal by Subject|10
7263403|NCT00373958|11476577|FG000|Infant Series|Consent was not received|1
7624570|NCT02173301|12035673|FG002|Overall Study|Withdrawal by Subject|4
7624571|NCT02173301|12035674|FG003|Overall Study|Withdrawal by Subject|8
7624572|NCT02173301|12035671|FG000|Overall Study|Lost to Follow-up|4
7624573|NCT02173301|12035672|FG001|Overall Study|Lost to Follow-up|4
7624574|NCT02173301|12035673|FG002|Overall Study|Lost to Follow-up|2
7624575|NCT02173301|12035674|FG003|Overall Study|Lost to Follow-up|2
7624576|NCT02173301|12035671|FG000|Overall Study|Protocol Violation|0
7624577|NCT02173301|12035672|FG001|Overall Study|Protocol Violation|1
7624578|NCT02173301|12035673|FG002|Overall Study|Protocol Violation|0
7624579|NCT02173301|12035674|FG003|Overall Study|Protocol Violation|0
7624580|NCT02173301|12035671|FG000|Overall Study|Physician Decision|0
7624581|NCT02173301|12035672|FG001|Overall Study|Physician Decision|0
7263404|NCT00373958|11476578|FG001|Infant Series|Consent was not received|0
7263405|NCT00373958|11476577|FG000|Infant Series|Adverse Event|3
7544540|NCT02831387|11898531|FG001|Overall Study|Discontinued due to stock recovery|1
7544541|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
7544542|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
7544543|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
7544544|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
7544545|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7544546|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
7544547|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
7544548|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7544549|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
7544550|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
7544551|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7544552|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
7544553|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
7544554|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
7544555|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
7544556|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
7544557|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7544558|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
7544559|NCT02831855|11898556|FG000|Open Label Phase (24 Weeks)|Other|4
7576938|NCT04128293|11964996|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7576939|NCT04128293|11964997|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7576940|NCT04128293|11964998|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
7576941|NCT04126343|11965019|FG000|Overall Study|Adverse Event|0
7576942|NCT04126343|11965020|FG001|Overall Study|Adverse Event|0
7576943|NCT04126343|11965021|FG002|Overall Study|Adverse Event|0
7544560|NCT02831855|11898557|FG001|Open Label Phase (24 Weeks)|Other|0
7544561|NCT02831855|11898558|FG002|Open Label Phase (24 Weeks)|Other|0
7544562|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
7544563|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
7544564|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
7544565|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Death|0
7544566|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Death|0
7544567|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Death|2
7544568|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
7544569|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7544570|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
7544571|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
7544572|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
7544573|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
7544574|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
7544575|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
7544576|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
7544577|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Other|0
7544578|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Other|2
7544579|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Other|5
7544580|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
7544581|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
7544582|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
7544583|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
7544584|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
7544585|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
7576944|NCT04126343|11965022|FG003|Overall Study|Adverse Event|0
7576945|NCT04126343|11965023|FG004|Overall Study|Adverse Event|0
7576946|NCT04126343|11965024|FG005|Overall Study|Adverse Event|1
7263406|NCT00373958|11476578|FG001|Infant Series|Adverse Event|1
7263407|NCT00373958|11476577|FG000|Infant Series|Physician Decision|1
7263408|NCT00373958|11476578|FG001|Infant Series|Physician Decision|1
7263409|NCT00373958|11476577|FG000|Toddler Dose|Lost to Follow-up|5
7263410|NCT00373958|11476578|FG001|Toddler Dose|Lost to Follow-up|8
7263411|NCT00373958|11476577|FG000|Toddler Dose|Withdrawal by Subject|2
7263412|NCT00373958|11476578|FG001|Toddler Dose|Withdrawal by Subject|2
7263413|NCT00373958|11476577|FG000|Toddler Dose|Failed to return|1
7576947|NCT04126343|11965019|FG000|Overall Study|Withdrawal by Subject|0
7576948|NCT04126343|11965020|FG001|Overall Study|Withdrawal by Subject|0
7263414|NCT00373958|11476578|FG001|Toddler Dose|Failed to return|2
7263415|NCT00373958|11476577|FG000|Toddler Dose|Protocol Violation|0
7263416|NCT00373958|11476578|FG001|Toddler Dose|Protocol Violation|1
7263417|NCT00373958|11476577|FG000|Toddler Dose|Withdrawn after infant series|22
7263418|NCT00373958|11476578|FG001|Toddler Dose|Withdrawn after infant series|25
7263419|NCT00374127|11476616|FG000|Overall Study|Did not inhale during smoking procedure.|3
7263420|NCT00374127|11476616|FG000|Overall Study|Blood could not be drawn.|2
7263421|NCT00374127|11476616|FG000|Overall Study|Protocol Violation|5
7263422|NCT00374127|11476616|FG000|Overall Study|Pregnancy|1
7263423|NCT00374140|11476626|FG000|Overall Study|Lost to Follow-up|1
7263424|NCT00374140|11476626|FG000|Overall Study|Protocol Violation|1
7263425|NCT00374322|11476646|FG000|Overall Study|Lost to Follow-up|92
7263426|NCT00374322|11476647|FG001|Overall Study|Lost to Follow-up|90
7263427|NCT00374322|11476646|FG000|Overall Study|Protocol Violation|8
7263428|NCT00374322|11476647|FG001|Overall Study|Protocol Violation|3
7263429|NCT00374322|11476646|FG000|Overall Study|Withdrawal by Subject|235
7263430|NCT00374322|11476647|FG001|Overall Study|Withdrawal by Subject|167
7263431|NCT00374322|11476646|FG000|Overall Study|Sponsor Terminated Study|866
7263432|NCT00374322|11476647|FG001|Overall Study|Sponsor Terminated Study|990
7263433|NCT00374322|11476646|FG000|Overall Study|Physician Decision|36
7263434|NCT00374322|11476647|FG001|Overall Study|Physician Decision|32
7263435|NCT00374322|11476646|FG000|Overall Study|Par. Consented to Survival FU Only|3
7263436|NCT00374322|11476647|FG001|Overall Study|Par. Consented to Survival FU Only|1
7263437|NCT00374322|11476646|FG000|Overall Study|Sponsor Decision|2
7263438|NCT00374322|11476647|FG001|Overall Study|Sponsor Decision|3
7263439|NCT00374322|11476646|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
7263440|NCT00374322|11476647|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
7263441|NCT00374322|11476646|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
7263442|NCT00374322|11476647|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
7263443|NCT00374322|11476646|FG000|Overall Study|Severe Toxicity|1
7263444|NCT00374322|11476647|FG001|Overall Study|Severe Toxicity|0
7263445|NCT00374322|11476646|FG000|Overall Study|Site Closed|2
7263446|NCT00374322|11476647|FG001|Overall Study|Site Closed|2
7263447|NCT00374322|11476646|FG000|Overall Study|Participant Changed Physician|1
7263448|NCT00374322|11476647|FG001|Overall Study|Participant Changed Physician|0
7263449|NCT00374322|11476646|FG000|Overall Study|Started Another Chemotherapy Regimen|0
7263450|NCT00374322|11476647|FG001|Overall Study|Started Another Chemotherapy Regimen|1
7263451|NCT00374322|11476646|FG000|Overall Study|Noncompliance with Study Requirements|0
7263452|NCT00374322|11476647|FG001|Overall Study|Noncompliance with Study Requirements|1
7263453|NCT00374322|11476646|FG000|Overall Study|Withdrew Consent During Follow-up|0
7263454|NCT00374322|11476647|FG001|Overall Study|Withdrew Consent During Follow-up|5
7263455|NCT00374322|11476646|FG000|Overall Study|Did Not Receive Study Medication|8
7263456|NCT00374322|11476647|FG001|Overall Study|Did Not Receive Study Medication|6
7263457|NCT00374452|11476660|FG000|Overall Study|Left clinic before intervention started|4
7263458|NCT00374452|11476661|FG001|Overall Study|Left clinic before intervention started|1
7263459|NCT00374452|11476660|FG000|Overall Study|Change in job role before intervention|0
7263460|NCT00374452|11476661|FG001|Overall Study|Change in job role before intervention|1
7263461|NCT00374452|11476660|FG000|Overall Study|Left clinic after intervention started|1
7263462|NCT00374452|11476661|FG001|Overall Study|Left clinic after intervention started|1
7263463|NCT00374452|11476660|FG000|Overall Study|Withdrawal by Subject|0
7263464|NCT00374452|11476661|FG001|Overall Study|Withdrawal by Subject|2
7263465|NCT00374556|11476669|FG000|Overall Study|Lost to Follow-up|1
7263466|NCT00374556|11476670|FG001|Overall Study|Lost to Follow-up|0
7263467|NCT00374556|11476669|FG000|Overall Study|Removed at baseline due to medical cond|0
7263468|NCT00374556|11476670|FG001|Overall Study|Removed at baseline due to medical cond|1
7263469|NCT00374868|11476702|FG000|Overall Study|Adverse Event|12
7263470|NCT00374868|11476702|FG000|Overall Study|Progressive Disease|7
7263471|NCT00374868|11476702|FG000|Overall Study|Physician Decision|13
7263472|NCT00374868|11476702|FG000|Overall Study|Lost to Follow-up|1
7263473|NCT00374868|11476702|FG000|Overall Study|Death|2
7263474|NCT00374868|11476702|FG000|Overall Study|Other - Not Specified|1
7263475|NCT00374907|11476708|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
7263476|NCT00374907|11476709|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
7263477|NCT00374907|11476708|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
7263478|NCT00374907|11476709|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
7263479|NCT00374907|11476708|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
7263480|NCT00374907|11476709|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
7263481|NCT00374907|11476708|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
7263482|NCT00374907|11476709|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
7263483|NCT00374907|11476708|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7263484|NCT00374907|11476709|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
7263485|NCT00375219|11476731|FG000|Overall Study|Failure to achieve a response|16
7263486|NCT00375219|11476732|FG001|Overall Study|Failure to achieve a response|2
7263487|NCT00375219|11476733|FG002|Overall Study|Failure to achieve a response|0
7263488|NCT00375219|11476731|FG000|Overall Study|Adverse Event|8
7263489|NCT00375219|11476732|FG001|Overall Study|Adverse Event|2
7263490|NCT00375219|11476733|FG002|Overall Study|Adverse Event|1
7263491|NCT00375219|11476731|FG000|Overall Study|Protocol Violation|1
7263492|NCT00375219|11476732|FG001|Overall Study|Protocol Violation|0
7263493|NCT00375219|11476733|FG002|Overall Study|Protocol Violation|1
7263494|NCT00375219|11476731|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
7263495|NCT00375219|11476732|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
7263496|NCT00375219|11476733|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
7263497|NCT00375219|11476731|FG000|Overall Study|Lost to Follow-up|1
7263498|NCT00375219|11476732|FG001|Overall Study|Lost to Follow-up|1
7263499|NCT00375219|11476733|FG002|Overall Study|Lost to Follow-up|0
7263500|NCT00375219|11476731|FG000|Overall Study|Disease progression|18
7263501|NCT00375219|11476732|FG001|Overall Study|Disease progression|9
7263502|NCT00375219|11476733|FG002|Overall Study|Disease progression|12
7263503|NCT00375219|11476731|FG000|Overall Study|Death|4
7263504|NCT00375219|11476732|FG001|Overall Study|Death|3
7263505|NCT00375219|11476733|FG002|Overall Study|Death|7
7576949|NCT04126343|11965021|FG002|Overall Study|Withdrawal by Subject|0
7263506|NCT00375219|11476731|FG000|Overall Study|Hematologic resistance|1
7263507|NCT00375219|11476732|FG001|Overall Study|Hematologic resistance|0
7263508|NCT00375219|11476733|FG002|Overall Study|Hematologic resistance|0
7263509|NCT00375219|11476731|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
7263510|NCT00375219|11476732|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
7263511|NCT00375219|11476733|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
7263512|NCT00375219|11476731|FG000|Overall Study|Allograft|2
7263513|NCT00375219|11476732|FG001|Overall Study|Allograft|0
7263514|NCT00375219|11476733|FG002|Overall Study|Allograft|0
7263515|NCT00375219|11476731|FG000|Overall Study|Cord blood transplantation|1
7263516|NCT00375219|11476732|FG001|Overall Study|Cord blood transplantation|0
7263517|NCT00375219|11476733|FG002|Overall Study|Cord blood transplantation|0
7263518|NCT00375219|11476731|FG000|Overall Study|Withdrawal by Subject|1
7263519|NCT00375219|11476732|FG001|Overall Study|Withdrawal by Subject|0
7263520|NCT00375219|11476733|FG002|Overall Study|Withdrawal by Subject|0
7263521|NCT00375427|11476742|FG000|Overall Study|Adverse Event|21
7263522|NCT00375427|11476743|FG001|Overall Study|Adverse Event|27
7263523|NCT00375427|11476742|FG000|Overall Study|Abnormal test procedure result(s)|0
7263524|NCT00375427|11476743|FG001|Overall Study|Abnormal test procedure result(s)|1
7544586|NCT02831855|11898556|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7544587|NCT02831855|11898557|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
7544588|NCT02831855|11898558|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
7544589|NCT02832037|11898584|FG000|Overall Study|Administrative reasons|0
7544590|NCT02832037|11898585|FG001|Overall Study|Administrative reasons|0
7544591|NCT02832037|11898586|FG002|Overall Study|Administrative reasons|1
7544592|NCT02832037|11898587|FG003|Overall Study|Administrative reasons|0
7544593|NCT02832037|11898588|FG004|Overall Study|Administrative reasons|0
7544594|NCT02832037|11898584|FG000|Overall Study|Protocol Violation|3
7544595|NCT02832037|11898585|FG001|Overall Study|Protocol Violation|0
7544596|NCT02832037|11898586|FG002|Overall Study|Protocol Violation|4
7544597|NCT02832037|11898587|FG003|Overall Study|Protocol Violation|1
7544598|NCT02832037|11898588|FG004|Overall Study|Protocol Violation|2
7576950|NCT04126343|11965022|FG003|Overall Study|Withdrawal by Subject|1
7263525|NCT00375427|11476742|FG000|Overall Study|Abnormal laboratory value(s)|1
7263526|NCT00375427|11476743|FG001|Overall Study|Abnormal laboratory value(s)|2
7263527|NCT00375427|11476742|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7263528|NCT00375427|11476743|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7263529|NCT00375427|11476742|FG000|Overall Study|Patient no longer requires study drug|3
7263530|NCT00375427|11476743|FG001|Overall Study|Patient no longer requires study drug|7
7263531|NCT00375427|11476742|FG000|Overall Study|Protocol Violation|10
7263532|NCT00375427|11476743|FG001|Overall Study|Protocol Violation|8
7263533|NCT00375427|11476742|FG000|Overall Study|Withdrawal by Subject|9
7263534|NCT00375427|11476743|FG001|Overall Study|Withdrawal by Subject|13
7263535|NCT00375427|11476742|FG000|Overall Study|Lost to Follow-up|1
7263536|NCT00375427|11476743|FG001|Overall Study|Lost to Follow-up|1
7263537|NCT00375427|11476742|FG000|Overall Study|Administrative reasons|0
7263538|NCT00375427|11476743|FG001|Overall Study|Administrative reasons|1
7263539|NCT00375427|11476742|FG000|Overall Study|Death|11
7263540|NCT00375427|11476743|FG001|Overall Study|Death|10
7263541|NCT00375492|11476751|FG000|Overall Study|Adverse Event|4
7263542|NCT00375492|11476752|FG001|Overall Study|Adverse Event|5
7263543|NCT00375492|11476751|FG000|Overall Study|Entry Criteria Not Met|0
7263544|NCT00375492|11476752|FG001|Overall Study|Entry Criteria Not Met|1
7263545|NCT00375492|11476751|FG000|Overall Study|Loss of Glucose Control|0
7263546|NCT00375492|11476752|FG001|Overall Study|Loss of Glucose Control|1
7263547|NCT00375492|11476751|FG000|Overall Study|Lost to Follow-up|10
7263548|NCT00375492|11476752|FG001|Overall Study|Lost to Follow-up|5
7263549|NCT00375492|11476751|FG000|Overall Study|Physician Decision|0
7263550|NCT00375492|11476752|FG001|Overall Study|Physician Decision|4
7263551|NCT00375492|11476751|FG000|Overall Study|Protocol Violation|6
7263552|NCT00375492|11476752|FG001|Overall Study|Protocol Violation|3
7263553|NCT00375492|11476751|FG000|Overall Study|Sponsor Decision|0
7263554|NCT00375492|11476752|FG001|Overall Study|Sponsor Decision|1
7263555|NCT00375492|11476751|FG000|Overall Study|Withdrawal by Subject|6
7263556|NCT00375492|11476752|FG001|Overall Study|Withdrawal by Subject|6
7263557|NCT00375505|11476760|FG000|Overall Study|Adverse Event|1
7263558|NCT00375505|11476761|FG001|Overall Study|Adverse Event|2
7263559|NCT00375518|11476769|FG000|Overall Study|Withdrawal by Subject|2
7263560|NCT00375518|11476770|FG001|Overall Study|Withdrawal by Subject|10
7263561|NCT00375518|11476769|FG000|Overall Study|Patient Not Treated|6
7263562|NCT00375518|11476770|FG001|Overall Study|Patient Not Treated|6
7263563|NCT00375518|11476769|FG000|Overall Study|Death|0
7263564|NCT00375518|11476770|FG001|Overall Study|Death|1
7263565|NCT00375609|11476779|FG000|Overall Study|Did not receive treatment|1
7263566|NCT00375609|11476780|FG001|Overall Study|Did not receive treatment|0
7263567|NCT00375609|11476781|FG002|Overall Study|Did not receive treatment|0
7263568|NCT00375609|11476779|FG000|Overall Study|Adverse Event|0
7263569|NCT00375609|11476780|FG001|Overall Study|Adverse Event|3
7263570|NCT00375609|11476781|FG002|Overall Study|Adverse Event|0
7263571|NCT00375609|11476779|FG000|Overall Study|Lost to Follow-up|1
7263572|NCT00375609|11476780|FG001|Overall Study|Lost to Follow-up|0
7263573|NCT00375609|11476781|FG002|Overall Study|Lost to Follow-up|0
7263574|NCT00375609|11476779|FG000|Overall Study|Physician Decision|0
7263575|NCT00375609|11476780|FG001|Overall Study|Physician Decision|0
7263576|NCT00375609|11476781|FG002|Overall Study|Physician Decision|1
7544599|NCT02832037|11898584|FG000|Overall Study|Lost to Follow-up|2
7544600|NCT02832037|11898585|FG001|Overall Study|Lost to Follow-up|0
7544601|NCT02832037|11898586|FG002|Overall Study|Lost to Follow-up|3
7544602|NCT02832037|11898587|FG003|Overall Study|Lost to Follow-up|0
7544603|NCT02832037|11898588|FG004|Overall Study|Lost to Follow-up|5
7544604|NCT02832037|11898584|FG000|Overall Study|Withdrawal by Subject|9
7544605|NCT02832037|11898585|FG001|Overall Study|Withdrawal by Subject|8
7544606|NCT02832037|11898586|FG002|Overall Study|Withdrawal by Subject|0
7544607|NCT02832037|11898587|FG003|Overall Study|Withdrawal by Subject|4
7544608|NCT02832037|11898588|FG004|Overall Study|Withdrawal by Subject|8
7544609|NCT02832037|11898584|FG000|Overall Study|Adverse Event|5
7544610|NCT02832037|11898585|FG001|Overall Study|Adverse Event|4
7544611|NCT02832037|11898586|FG002|Overall Study|Adverse Event|0
7544612|NCT02832037|11898587|FG003|Overall Study|Adverse Event|2
7544613|NCT02832037|11898588|FG004|Overall Study|Adverse Event|4
7544614|NCT02832375|11898619|FG000|Overall Study|Lost to Follow-up|1
7544615|NCT02832375|11898620|FG001|Overall Study|Lost to Follow-up|0
7544616|NCT02832375|11898619|FG000|Overall Study|Withdrawal of Consent|1
7544617|NCT02832375|11898620|FG001|Overall Study|Withdrawal of Consent|0
7544618|NCT02832622|11898627|FG000|Overall Study|MPP not programmed|1259
7544619|NCT02832622|11898627|FG000|Overall Study|Withdrawal by Subject|123
7544620|NCT02832622|11898627|FG000|Overall Study|Death|119
7263577|NCT00375609|11476779|FG000|Overall Study|Withdrawal by Subject|1
7263578|NCT00375609|11476780|FG001|Overall Study|Withdrawal by Subject|4
7263579|NCT00375609|11476781|FG002|Overall Study|Withdrawal by Subject|0
7544621|NCT02832622|11898627|FG000|Overall Study|Unsuccessful CRT implant|93
7576951|NCT04126343|11965023|FG004|Overall Study|Withdrawal by Subject|0
7263580|NCT00375609|11476779|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
7263581|NCT00375609|11476780|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
7544622|NCT02832622|11898627|FG000|Overall Study|Lost to Follow-up|45
7544623|NCT02832622|11898627|FG000|Overall Study|Patient non-compliance|42
7263582|NCT00375609|11476781|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
7263583|NCT00375674|11476791|FG000|Overall Study|Other|26
7263584|NCT00375674|11476792|FG001|Overall Study|Other|18
7263585|NCT00375674|11476791|FG000|Overall Study|Death|67
7263586|NCT00375674|11476792|FG001|Overall Study|Death|76
7263587|NCT00375674|11476791|FG000|Overall Study|Participants refused further follow-up|31
7263588|NCT00375674|11476792|FG001|Overall Study|Participants refused further follow-up|30
7263589|NCT00375674|11476791|FG000|Overall Study|Lost to Follow-up|17
7263590|NCT00375674|11476792|FG001|Overall Study|Lost to Follow-up|15
7263591|NCT00375674|11476791|FG000|Overall Study|Enrolled but not treated|3
7263592|NCT00375674|11476792|FG001|Overall Study|Enrolled but not treated|2
7263593|NCT00375752|11476809|FG000|Overall Study|Lack of Efficacy|4
7263594|NCT00375752|11476810|FG001|Overall Study|Lack of Efficacy|4
7263595|NCT00375752|11476809|FG000|Overall Study|Adverse Event|1
7263596|NCT00375752|11476810|FG001|Overall Study|Adverse Event|6
7263597|NCT00375752|11476809|FG000|Overall Study|Withdrawal by Subject|6
7263598|NCT00375752|11476810|FG001|Overall Study|Withdrawal by Subject|1
7263599|NCT00375752|11476809|FG000|Overall Study|Abnormal Laboratory Value(s)|1
7263600|NCT00375752|11476810|FG001|Overall Study|Abnormal Laboratory Value(s)|1
7263601|NCT00375752|11476809|FG000|Overall Study|Protocol Violation|0
7263602|NCT00375752|11476810|FG001|Overall Study|Protocol Violation|2
7263603|NCT00375752|11476809|FG000|Overall Study|Administrative Problems|0
7263604|NCT00375752|11476810|FG001|Overall Study|Administrative Problems|1
7263605|NCT00375934|11476843|FG000|Overall Study|Adverse Event|1
7263606|NCT00375934|11476844|FG001|Overall Study|Adverse Event|1
7263607|NCT00375934|11476843|FG000|Overall Study|Withdrawal by Subject|2
7263608|NCT00375934|11476844|FG001|Overall Study|Withdrawal by Subject|2
7263609|NCT00375934|11476843|FG000|Overall Study|Lack of Efficacy|0
7263610|NCT00375934|11476844|FG001|Overall Study|Lack of Efficacy|2
7263611|NCT00375934|11476843|FG000|Overall Study|Physician Decision|0
7263612|NCT00375934|11476844|FG001|Overall Study|Physician Decision|1
7263613|NCT00376168|11476865|FG000|Overall Study|Adverse Event|1
7263614|NCT00376168|11476866|FG001|Overall Study|Adverse Event|1
7263615|NCT00376168|11476865|FG000|Overall Study|Pregnancy|1
7263616|NCT00376168|11476866|FG001|Overall Study|Pregnancy|0
7263617|NCT00376220|11476874|FG000|Overall Study|Lost to Follow-up|7
7263618|NCT00376220|11476875|FG001|Overall Study|Lost to Follow-up|10
7263619|NCT00376220|11476874|FG000|Overall Study|Withdrawal by Subject|3
7263620|NCT00376220|11476875|FG001|Overall Study|Withdrawal by Subject|2
7263621|NCT00376246|11476881|FG000|First Intervention (2 Weeks)|Adverse Event|2
7544624|NCT02832622|11898627|FG000|Overall Study|Withdrawal by other reasons|25
7544625|NCT02832622|11898627|FG000|Overall Study|System explant|24
7544626|NCT02832622|11898627|FG000|Overall Study|Physician Decision|6
7544627|NCT02833077|11898638|FG000|Overall Study|Adverse Event|1
7263622|NCT00376246|11476882|FG001|First Intervention (2 Weeks)|Adverse Event|0
7263623|NCT00376246|11476881|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
7263624|NCT00376246|11476882|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
7263625|NCT00376246|11476881|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
7263626|NCT00376246|11476882|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
7263627|NCT00376259|11476892|FG000|Overall Study|Sponsor request - study termination|21
7263628|NCT00376259|11476893|FG001|Overall Study|Sponsor request - study termination|21
7263629|NCT00376259|11476892|FG000|Overall Study|Patient request|1
7263630|NCT00376259|11476893|FG001|Overall Study|Patient request|0
7263631|NCT00376506|11476910|FG000|Overall Study|Death|0
7263632|NCT00376506|11476911|FG001|Overall Study|Death|2
7544628|NCT02833077|11898639|FG001|Overall Study|Adverse Event|2
7263633|NCT00376532|11476922|FG000|Overall Study|Lack sufficient blood sample|6
7263634|NCT00376532|11476923|FG001|Overall Study|Lack sufficient blood sample|6
7263635|NCT00376675|11476952|FG000|Overall Study|Withdrawal by Subject|9
7263636|NCT00376675|11476953|FG001|Overall Study|Withdrawal by Subject|2
7263637|NCT00376675|11476952|FG000|Overall Study|Adverse Event|10
7263638|NCT00376675|11476953|FG001|Overall Study|Adverse Event|5
7263639|NCT00376675|11476952|FG000|Overall Study|Other Reason|1
7263640|NCT00376675|11476953|FG001|Overall Study|Other Reason|7
7263641|NCT00376688|11476959|FG000|Overall Study|Adverse Event|3
7263642|NCT00376688|11476959|FG000|Overall Study|Death|1
7263643|NCT00376961|11476988|FG000|Initial Registration|Adverse Event|1
7263644|NCT00376961|11476989|FG001|Initial Registration|Adverse Event|0
7263645|NCT00376961|11476988|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
7263646|NCT00376961|11476989|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
7263647|NCT00376961|11476988|FG000|Initial Registration|Progression/relapse|1
7263648|NCT00376961|11476989|FG001|Initial Registration|Progression/relapse|0
7263649|NCT00376961|11476988|FG000|Initial Registration|Ineligible|3
7263650|NCT00376961|11476989|FG001|Initial Registration|Ineligible|0
7263651|NCT00376961|11476988|FG000|Maintenance|Adverse Event|0
7263652|NCT00376961|11476989|FG001|Maintenance|Adverse Event|1
7263653|NCT00376961|11476988|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
7263654|NCT00376961|11476989|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
7263655|NCT00376961|11476988|FG000|Maintenance|Progression/relapse|0
7263656|NCT00376961|11476989|FG001|Maintenance|Progression/relapse|18
7263657|NCT00376961|11476988|FG000|Maintenance|Ineligible|0
7263658|NCT00376961|11476989|FG001|Maintenance|Ineligible|3
7263675|NCT00377234|11477010|FG000|Overall Study|Adverse Event|14
7263676|NCT00377234|11477011|FG001|Overall Study|Adverse Event|17
7263677|NCT00377234|11477010|FG000|Overall Study|Withdrawal by Subject|11
7263678|NCT00377234|11477011|FG001|Overall Study|Withdrawal by Subject|9
7263679|NCT00377234|11477010|FG000|Overall Study|Lost to Follow-up|4
7263680|NCT00377234|11477011|FG001|Overall Study|Lost to Follow-up|2
7263681|NCT00377234|11477010|FG000|Overall Study|Administrative|2
7263682|NCT00377234|11477011|FG001|Overall Study|Administrative|1
7263683|NCT00377234|11477010|FG000|Overall Study|Not assigned|3
7263684|NCT00377234|11477011|FG001|Overall Study|Not assigned|2
7263685|NCT00377260|11477025|FG000|Overall Study|Lost to Follow-up|0
7263686|NCT00377260|11477026|FG001|Overall Study|Lost to Follow-up|1
7263687|NCT00377260|11477025|FG000|Overall Study|Withdrawal by Subject|2
7263688|NCT00377260|11477026|FG001|Overall Study|Withdrawal by Subject|4
7263689|NCT00377299|11477034|FG000|Overall Study|Lost to Follow-up|14
7263690|NCT00377299|11477035|FG001|Overall Study|Lost to Follow-up|19
7263691|NCT00377299|11477034|FG000|Overall Study|Adverse Event|0
7263692|NCT00377299|11477035|FG001|Overall Study|Adverse Event|1
7263693|NCT00377299|11477034|FG000|Overall Study|Withdrawal by Subject|5
7263694|NCT00377299|11477035|FG001|Overall Study|Withdrawal by Subject|4
7263695|NCT00377312|11477044|FG000|Overall Study|Adverse Event|1
7263696|NCT00377312|11477045|FG001|Overall Study|Adverse Event|1
7263697|NCT00377364|11477053|FG000|Overall Study|Lost to Follow-up|1
7263698|NCT00377364|11477054|FG001|Overall Study|Lost to Follow-up|0
7263699|NCT00377364|11477053|FG000|Overall Study|Withdrawal by Subject|1
7263700|NCT00377364|11477054|FG001|Overall Study|Withdrawal by Subject|0
7263701|NCT00377403|11477064|FG000|Overall Study|Unable to contact for telephone intervie|4
7263702|NCT00377403|11477065|FG001|Overall Study|Unable to contact for telephone intervie|7
7263703|NCT00377429|11477071|FG000|Overall Study|Withdrawal by Subject|5
7263704|NCT00377429|11477071|FG000|Overall Study|Adverse Event|8
7263705|NCT00377429|11477071|FG000|Overall Study|Physician Decision|1
7263706|NCT00377429|11477071|FG000|Overall Study|Patient non-compliance|1
7263707|NCT00377520|11477075|FG000|Overall Study|Ineligible (Prior radiation)|1
7263708|NCT00377611|11477090|FG000|Overall Study|Adverse Event|2
7576952|NCT04126343|11965024|FG005|Overall Study|Withdrawal by Subject|0
7263709|NCT00377611|11477091|FG001|Overall Study|Adverse Event|9
7263710|NCT00377611|11477090|FG000|Overall Study|Protocol Violation|2
7263711|NCT00377611|11477091|FG001|Overall Study|Protocol Violation|0
7263712|NCT00377611|11477090|FG000|Overall Study|Withdrawal by Subject|0
7263713|NCT00377611|11477091|FG001|Overall Study|Withdrawal by Subject|5
7263714|NCT00377611|11477090|FG000|Overall Study|Lost to Follow-up|18
7263715|NCT00377611|11477091|FG001|Overall Study|Lost to Follow-up|16
7263716|NCT00377611|11477090|FG000|Overall Study|Other|0
7263717|NCT00377611|11477091|FG001|Overall Study|Other|3
7263718|NCT00377637|11477102|FG000|Induction Phase|Adverse Event|12
7263719|NCT00377637|11477103|FG001|Induction Phase|Adverse Event|21
7263720|NCT00377637|11477104|FG002|Induction Phase|Adverse Event|0
7263721|NCT00377637|11477105|FG003|Induction Phase|Adverse Event|0
7263722|NCT00377637|11477102|FG000|Induction Phase|Deterioration/serum creatinine|2
7263723|NCT00377637|11477103|FG001|Induction Phase|Deterioration/serum creatinine|0
7263724|NCT00377637|11477104|FG002|Induction Phase|Deterioration/serum creatinine|0
7576953|NCT04126343|11965019|FG000|Overall Study|Related to COVID-19 pandemic|3
7576954|NCT04126343|11965020|FG001|Overall Study|Related to COVID-19 pandemic|4
7576955|NCT04126343|11965021|FG002|Overall Study|Related to COVID-19 pandemic|3
7576956|NCT04126343|11965022|FG003|Overall Study|Related to COVID-19 pandemic|3
7576957|NCT04126343|11965023|FG004|Overall Study|Related to COVID-19 pandemic|3
7576958|NCT04126343|11965024|FG005|Overall Study|Related to COVID-19 pandemic|3
7576959|NCT04124952|11965043|FG000|Overall Study|Lost to Follow-up|1
7576960|NCT04123665|11965049|FG000|Overall Study|Withdrawal by Subject|7
7576961|NCT04123665|11965050|FG001|Overall Study|Withdrawal by Subject|0
7576962|NCT04123665|11965049|FG000|Overall Study|Lost to Follow-up|1
7576963|NCT04123665|11965050|FG001|Overall Study|Lost to Follow-up|0
7576964|NCT04122534|11965056|FG000|Overall Study|Lost to Follow-up|4
7576965|NCT04117607|11965072|FG000|Overall Study|Early Termination|0
7576966|NCT04117607|11965073|FG001|Overall Study|Early Termination|1
7576967|NCT04117607|11965074|FG002|Overall Study|Early Termination|0
7263725|NCT00377637|11477105|FG003|Induction Phase|Deterioration/serum creatinine|0
7263726|NCT00377637|11477102|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7263727|NCT00377637|11477103|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
7263728|NCT00377637|11477104|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7263729|NCT00377637|11477105|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
7263730|NCT00377637|11477102|FG000|Induction Phase|Lost to Follow-up|2
7263731|NCT00377637|11477103|FG001|Induction Phase|Lost to Follow-up|1
7263732|NCT00377637|11477104|FG002|Induction Phase|Lost to Follow-up|0
7263733|NCT00377637|11477105|FG003|Induction Phase|Lost to Follow-up|0
7263734|NCT00377637|11477102|FG000|Induction Phase|Death|1
7544629|NCT02833077|11898638|FG000|Overall Study|Lost to Follow-up|10
7544630|NCT02833077|11898639|FG001|Overall Study|Lost to Follow-up|1
7544631|NCT02833077|11898638|FG000|Overall Study|Personal Reasons|6
7544632|NCT02833077|11898639|FG001|Overall Study|Personal Reasons|4
7544633|NCT02833077|11898638|FG000|Overall Study|Protocol Deviation|0
7544634|NCT02833077|11898639|FG001|Overall Study|Protocol Deviation|1
7544635|NCT02833350|11898657|FG000|Overall Study|Adverse Event|0
7544636|NCT02833350|11898658|FG001|Overall Study|Adverse Event|3
7544637|NCT02833350|11898659|FG002|Overall Study|Adverse Event|4
7544638|NCT02833350|11898660|FG003|Overall Study|Adverse Event|4
7544639|NCT02833350|11898661|FG004|Overall Study|Adverse Event|1
7544640|NCT02833350|11898662|FG005|Overall Study|Adverse Event|0
7544641|NCT02833350|11898663|FG006|Overall Study|Adverse Event|1
7544642|NCT02833350|11898657|FG000|Overall Study|Death|0
7544643|NCT02833350|11898658|FG001|Overall Study|Death|0
7544644|NCT02833350|11898659|FG002|Overall Study|Death|1
7544645|NCT02833350|11898660|FG003|Overall Study|Death|0
7544646|NCT02833350|11898661|FG004|Overall Study|Death|0
7576968|NCT04117607|11965075|FG003|Overall Study|Early Termination|0
7576969|NCT04117607|11965076|FG004|Overall Study|Early Termination|0
7576970|NCT04117607|11965077|FG005|Overall Study|Early Termination|0
7263735|NCT00377637|11477103|FG001|Induction Phase|Death|3
7263736|NCT00377637|11477104|FG002|Induction Phase|Death|0
7263737|NCT00377637|11477105|FG003|Induction Phase|Death|0
7263738|NCT00377637|11477102|FG000|Induction Phase|Withdrawal by Subject|5
7263739|NCT00377637|11477103|FG001|Induction Phase|Withdrawal by Subject|6
7576971|NCT04117607|11965078|FG006|Overall Study|Early Termination|1
7263740|NCT00377637|11477104|FG002|Induction Phase|Withdrawal by Subject|0
7263741|NCT00377637|11477105|FG003|Induction Phase|Withdrawal by Subject|0
7263742|NCT00377637|11477102|FG000|Induction Phase|Physician Decision|3
7263743|NCT00377637|11477103|FG001|Induction Phase|Physician Decision|1
7544647|NCT02833350|11898662|FG005|Overall Study|Death|0
7544648|NCT02833350|11898663|FG006|Overall Study|Death|0
7544649|NCT02833350|11898657|FG000|Overall Study|Lack of Efficacy|0
7544650|NCT02833350|11898658|FG001|Overall Study|Lack of Efficacy|2
7576972|NCT04117607|11965079|FG007|Overall Study|Early Termination|0
7576973|NCT04117607|11965080|FG008|Overall Study|Early Termination|0
7263744|NCT00377637|11477104|FG002|Induction Phase|Physician Decision|0
7263745|NCT00377637|11477105|FG003|Induction Phase|Physician Decision|0
7263746|NCT00377637|11477102|FG000|Induction Phase|Sponsor decision|1
7263747|NCT00377637|11477103|FG001|Induction Phase|Sponsor decision|2
7263748|NCT00377637|11477104|FG002|Induction Phase|Sponsor decision|0
7263749|NCT00377637|11477105|FG003|Induction Phase|Sponsor decision|0
7263750|NCT00377637|11477102|FG000|Induction Phase|Non-Compliance|1
7263751|NCT00377637|11477103|FG001|Induction Phase|Non-Compliance|0
7263752|NCT00377637|11477104|FG002|Induction Phase|Non-Compliance|0
7263753|NCT00377637|11477105|FG003|Induction Phase|Non-Compliance|0
7263754|NCT00377637|11477102|FG000|Induction Phase|Reason for withdrawal is not noted|2
7263755|NCT00377637|11477103|FG001|Induction Phase|Reason for withdrawal is not noted|0
7263756|NCT00377637|11477104|FG002|Induction Phase|Reason for withdrawal is not noted|0
7263757|NCT00377637|11477105|FG003|Induction Phase|Reason for withdrawal is not noted|0
7263758|NCT00377637|11477102|FG000|Maintenance Phase|Adverse Event|0
7263759|NCT00377637|11477103|FG001|Maintenance Phase|Adverse Event|0
7263760|NCT00377637|11477104|FG002|Maintenance Phase|Adverse Event|29
7263761|NCT00377637|11477105|FG003|Maintenance Phase|Adverse Event|43
7263762|NCT00377637|11477102|FG000|Maintenance Phase|Physician Decision|0
7263763|NCT00377637|11477103|FG001|Maintenance Phase|Physician Decision|0
7263764|NCT00377637|11477104|FG002|Maintenance Phase|Physician Decision|5
7263765|NCT00377637|11477105|FG003|Maintenance Phase|Physician Decision|4
7263766|NCT00377637|11477102|FG000|Maintenance Phase|Lost to Follow-up|0
7263767|NCT00377637|11477103|FG001|Maintenance Phase|Lost to Follow-up|0
7263768|NCT00377637|11477104|FG002|Maintenance Phase|Lost to Follow-up|3
7263769|NCT00377637|11477105|FG003|Maintenance Phase|Lost to Follow-up|1
7263770|NCT00377637|11477102|FG000|Maintenance Phase|Withdrawal by Subject|0
7263771|NCT00377637|11477103|FG001|Maintenance Phase|Withdrawal by Subject|0
7263772|NCT00377637|11477104|FG002|Maintenance Phase|Withdrawal by Subject|3
7263773|NCT00377637|11477105|FG003|Maintenance Phase|Withdrawal by Subject|3
7263774|NCT00377637|11477102|FG000|Maintenance Phase|Sponsor decision|0
7263775|NCT00377637|11477103|FG001|Maintenance Phase|Sponsor decision|0
7263776|NCT00377637|11477104|FG002|Maintenance Phase|Sponsor decision|2
7263777|NCT00377637|11477105|FG003|Maintenance Phase|Sponsor decision|3
7263778|NCT00377637|11477102|FG000|Maintenance Phase|Non-compliance|0
7263779|NCT00377637|11477103|FG001|Maintenance Phase|Non-compliance|0
7263780|NCT00377637|11477104|FG002|Maintenance Phase|Non-compliance|1
7263781|NCT00377637|11477105|FG003|Maintenance Phase|Non-compliance|1
7263782|NCT00377637|11477102|FG000|Maintenance Phase|Study medication stopped > 14 days|0
7263783|NCT00377637|11477103|FG001|Maintenance Phase|Study medication stopped > 14 days|0
7263784|NCT00377637|11477104|FG002|Maintenance Phase|Study medication stopped > 14 days|0
7263785|NCT00377637|11477105|FG003|Maintenance Phase|Study medication stopped > 14 days|1
7263786|NCT00377637|11477102|FG000|Maintenance Phase|Death|0
7263787|NCT00377637|11477103|FG001|Maintenance Phase|Death|0
7263788|NCT00377637|11477104|FG002|Maintenance Phase|Death|0
7263789|NCT00377637|11477105|FG003|Maintenance Phase|Death|1
7263790|NCT00377676|11477121|FG000|Overall Study|Adverse Event|498
7263791|NCT00377676|11477122|FG001|Overall Study|Adverse Event|107
7263792|NCT00377676|11477121|FG000|Overall Study|Protocol Violation|33
7263793|NCT00377676|11477122|FG001|Overall Study|Protocol Violation|27
7263794|NCT00377676|11477121|FG000|Overall Study|Death|5
7263795|NCT00377676|11477122|FG001|Overall Study|Death|2
7263796|NCT00377676|11477121|FG000|Overall Study|Withdrawal by Subject|187
7263797|NCT00377676|11477122|FG001|Overall Study|Withdrawal by Subject|72
7263798|NCT00377676|11477121|FG000|Overall Study|Lost to Follow-up|120
7263799|NCT00377676|11477122|FG001|Overall Study|Lost to Follow-up|56
7263800|NCT00377676|11477121|FG000|Overall Study|Other|118
7263801|NCT00377676|11477122|FG001|Overall Study|Other|58
7263802|NCT00377819|11477139|FG000|Overall Study|Adverse Event|2
7544651|NCT02833350|11898659|FG002|Overall Study|Lack of Efficacy|1
7544652|NCT02833350|11898660|FG003|Overall Study|Lack of Efficacy|4
7544653|NCT02833350|11898661|FG004|Overall Study|Lack of Efficacy|0
7544654|NCT02833350|11898662|FG005|Overall Study|Lack of Efficacy|1
7544655|NCT02833350|11898663|FG006|Overall Study|Lack of Efficacy|1
7544656|NCT02833350|11898657|FG000|Overall Study|Lost to Follow-up|0
7544657|NCT02833350|11898658|FG001|Overall Study|Lost to Follow-up|1
7544658|NCT02833350|11898659|FG002|Overall Study|Lost to Follow-up|0
7544659|NCT02833350|11898660|FG003|Overall Study|Lost to Follow-up|0
7544660|NCT02833350|11898661|FG004|Overall Study|Lost to Follow-up|0
7544661|NCT02833350|11898662|FG005|Overall Study|Lost to Follow-up|0
7544662|NCT02833350|11898663|FG006|Overall Study|Lost to Follow-up|1
7544663|NCT02833350|11898657|FG000|Overall Study|Withdrawal by Subject|3
7544664|NCT02833350|11898658|FG001|Overall Study|Withdrawal by Subject|3
7544665|NCT02833350|11898659|FG002|Overall Study|Withdrawal by Subject|2
7544666|NCT02833350|11898660|FG003|Overall Study|Withdrawal by Subject|0
7544667|NCT02833350|11898661|FG004|Overall Study|Withdrawal by Subject|2
7263803|NCT00377819|11477140|FG001|Overall Study|Adverse Event|3
7544668|NCT02833350|11898662|FG005|Overall Study|Withdrawal by Subject|0
7544669|NCT02833350|11898663|FG006|Overall Study|Withdrawal by Subject|2
7544670|NCT02833948|11898701|FG000|Overall Study|Death|2
7263804|NCT00377819|11477139|FG000|Overall Study|Withdrawal by Subject|10
7263805|NCT00377819|11477140|FG001|Overall Study|Withdrawal by Subject|4
7263806|NCT00377819|11477139|FG000|Overall Study|Death|0
7263807|NCT00377819|11477140|FG001|Overall Study|Death|1
7263808|NCT00377819|11477139|FG000|Overall Study|Lost to Follow-up|0
7263809|NCT00377819|11477140|FG001|Overall Study|Lost to Follow-up|1
7263810|NCT00377819|11477139|FG000|Overall Study|Protocol Violation|1
7263811|NCT00377819|11477140|FG001|Overall Study|Protocol Violation|1
7263812|NCT00377858|11477160|FG000|Overall Study|Withdrawal by Subject|12
7263813|NCT00377858|11477161|FG001|Overall Study|Withdrawal by Subject|11
7263814|NCT00377858|11477160|FG000|Overall Study|Lost to Follow-up|6
7263815|NCT00377858|11477161|FG001|Overall Study|Lost to Follow-up|1
7263816|NCT00377858|11477160|FG000|Overall Study|Physician Decision|5
7263817|NCT00377858|11477161|FG001|Overall Study|Physician Decision|5
7263818|NCT00377858|11477160|FG000|Overall Study|Protocol Violation|3
7263819|NCT00377858|11477161|FG001|Overall Study|Protocol Violation|4
7263820|NCT00377858|11477160|FG000|Overall Study|Adverse Event|2
7263821|NCT00377858|11477161|FG001|Overall Study|Adverse Event|1
7263822|NCT00377858|11477160|FG000|Overall Study|Entry Criteria Not Met|2
7263823|NCT00377858|11477161|FG001|Overall Study|Entry Criteria Not Met|0
7263824|NCT00377858|11477160|FG000|Overall Study|Sponsor Decision|1
7263825|NCT00377858|11477161|FG001|Overall Study|Sponsor Decision|2
7263826|NCT00377858|11477160|FG000|Overall Study|Death|0
7263827|NCT00377858|11477161|FG001|Overall Study|Death|3
7263828|NCT00377962|11477169|FG000|Core Study: 0-12 Months|Adverse Event|18
7263829|NCT00377962|11477170|FG001|Core Study: 0-12 Months|Adverse Event|2
7263830|NCT00377962|11477169|FG000|Core Study: 0-12 Months|Death|3
7263831|NCT00377962|11477170|FG001|Core Study: 0-12 Months|Death|0
7263832|NCT00377962|11477169|FG000|Core Study: 0-12 Months|Withdrew Consent|5
7263833|NCT00377962|11477170|FG001|Core Study: 0-12 Months|Withdrew Consent|2
7263834|NCT00377962|11477169|FG000|Core Study: 0-12 Months|Administrative Reason|1
7263835|NCT00377962|11477170|FG001|Core Study: 0-12 Months|Administrative Reason|1
7263836|NCT00377962|11477169|FG000|Core Study: 0-12 Months|Unspecified reasons|1
7263837|NCT00377962|11477170|FG001|Core Study: 0-12 Months|Unspecified reasons|4
7263838|NCT00377962|11477169|FG000|Extension Study: 12-24 Months|Death|1
7263839|NCT00377962|11477170|FG001|Extension Study: 12-24 Months|Death|1
7263840|NCT00377962|11477169|FG000|Extension Study: 12-24 Months|Adverse Event|8
7544671|NCT02833948|11898702|FG001|Overall Study|Death|3
7544672|NCT02833948|11898701|FG000|Overall Study|were not scanned|8
7544673|NCT02833948|11898702|FG001|Overall Study|were not scanned|13
7263841|NCT00377962|11477170|FG001|Extension Study: 12-24 Months|Adverse Event|0
7263842|NCT00377962|11477169|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
7263843|NCT00377962|11477170|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
7263844|NCT00377962|11477169|FG000|Extension Study: 12-24 Months|Unspecified reason|0
7263845|NCT00377962|11477170|FG001|Extension Study: 12-24 Months|Unspecified reason|3
7263846|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Adverse Event|1
7576974|NCT04117607|11965081|FG009|Overall Study|Early Termination|0
7263847|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Adverse Event|0
7263848|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Graft loss|1
7263849|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Graft loss|2
7263850|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Death|5
7263851|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Death|3
7263852|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Administrative Problems|2
7263853|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Administrative Problems|2
7263854|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
7263855|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
7263856|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
7263857|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
7263858|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Protocol deviation|0
7263859|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Protocol deviation|1
7263860|NCT00378014|11477184|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
7263861|NCT00378014|11477185|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
7263862|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
7263863|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
7263864|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Death|1
7263865|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Death|2
7263866|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
7263867|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
7263868|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7263869|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
7263870|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
7263871|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
7263872|NCT00378014|11477184|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
7263873|NCT00378014|11477185|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
7263874|NCT00378079|11477196|FG000|Overall Study|Lost to Follow-up|6
7263875|NCT00378079|11477197|FG001|Overall Study|Lost to Follow-up|1
7263876|NCT00378079|11477198|FG002|Overall Study|Lost to Follow-up|0
7263877|NCT00378105|11477208|FG000|Overall Study|Adverse Event|3
7263878|NCT00378105|11477209|FG001|Overall Study|Adverse Event|1
7263879|NCT00378105|11477208|FG000|Overall Study|Withdrawal by Subject|3
7263880|NCT00378105|11477209|FG001|Overall Study|Withdrawal by Subject|3
7263881|NCT00378105|11477208|FG000|Overall Study|Death|1
7263882|NCT00378105|11477209|FG001|Overall Study|Death|0
7263883|NCT00378105|11477208|FG000|Overall Study|Going to transplant|7
7263884|NCT00378105|11477209|FG001|Overall Study|Going to transplant|8
7263885|NCT00378105|11477208|FG000|Overall Study|Progressive disease|3
7263886|NCT00378105|11477209|FG001|Overall Study|Progressive disease|3
7263887|NCT00378105|11477208|FG000|Overall Study|remain on study|3
7263888|NCT00378105|11477209|FG001|Overall Study|remain on study|11
7263889|NCT00378105|11477208|FG000|Overall Study|Physician Decision|0
7263890|NCT00378105|11477209|FG001|Overall Study|Physician Decision|2
7263891|NCT00378105|11477208|FG000|Overall Study|Going non-protocol therapy|0
7263892|NCT00378105|11477209|FG001|Overall Study|Going non-protocol therapy|1
7263893|NCT00378105|11477208|FG000|Overall Study|necessity to increase lenalidomide dose|0
7263894|NCT00378105|11477209|FG001|Overall Study|necessity to increase lenalidomide dose|1
7263895|NCT00378209|11477216|FG000|Overall Study|Progressive disease|11
7263896|NCT00378209|11477216|FG000|Overall Study|Adverse Event|3
7263897|NCT00378209|11477216|FG000|Overall Study|Initiation of non-protocol therapy|3
7263898|NCT00378209|11477216|FG000|Overall Study|Physician Decision|3
7263899|NCT00378209|11477216|FG000|Overall Study|Death|1
7263900|NCT00378209|11477216|FG000|Overall Study|Treatment delay|1
7263901|NCT00378508|11477244|FG000|Overall Study|Withdrawal by Subject|1
7263902|NCT00378508|11477245|FG001|Overall Study|Withdrawal by Subject|3
7263903|NCT00378508|11477244|FG000|Overall Study|Lost to Follow-up|1
7263904|NCT00378508|11477245|FG001|Overall Study|Lost to Follow-up|0
7263905|NCT00378534|11477254|FG000|Overall Study|Participants did not receive transplant|3
7263906|NCT00378534|11477255|FG001|Overall Study|Participants did not receive transplant|0
7544674|NCT02833948|11898701|FG000|Overall Study|scans could not be evaluated|5
7544675|NCT02833948|11898702|FG001|Overall Study|scans could not be evaluated|2
7544676|NCT02833974|11898714|FG000|Overall Study|Lost to Follow-up|1
7544677|NCT02833974|11898715|FG001|Overall Study|Lost to Follow-up|0
7544678|NCT02833974|11898714|FG000|Overall Study|Adverse Event|0
7263907|NCT00378560|11477262|FG000|Overall Study|Adverse Event|1
7263908|NCT00378560|11477263|FG001|Overall Study|Adverse Event|0
7263909|NCT00378560|11477262|FG000|Overall Study|Lost to Follow-up|24
7263910|NCT00378560|11477263|FG001|Overall Study|Lost to Follow-up|29
7263911|NCT00378560|11477262|FG000|Overall Study|Protocol Violation|2
7263912|NCT00378560|11477263|FG001|Overall Study|Protocol Violation|0
7263913|NCT00378560|11477262|FG000|Overall Study|Withdrawal by Subject|17
7263914|NCT00378560|11477263|FG001|Overall Study|Withdrawal by Subject|21
7263915|NCT00378560|11477262|FG000|Overall Study|Moved|4
7263916|NCT00378560|11477263|FG001|Overall Study|Moved|3
7263917|NCT00378560|11477262|FG000|Overall Study|Pregnancy|7
7263918|NCT00378560|11477263|FG001|Overall Study|Pregnancy|5
7263919|NCT00378560|11477262|FG000|Overall Study|Laboratory test values abnormal|1
7263920|NCT00378560|11477263|FG001|Overall Study|Laboratory test values abnormal|0
7263921|NCT00378573|11477269|FG000|Treatment Period|Adverse Event|9
7263922|NCT00378573|11477269|FG000|Treatment Period|Physician Decision|1
7263923|NCT00378573|11477269|FG000|Treatment Period|Withdrawal by Subject|2
7263924|NCT00378573|11477269|FG000|Treatment Period|Disease Progression|4
7263925|NCT00378573|11477269|FG000|Treatment Period|Sponsor decision to close study|1
7263926|NCT00378573|11477269|FG000|Follow-up|Death|12
7263927|NCT00378573|11477269|FG000|Follow-up|Lost to Follow-up|1
7263928|NCT00378573|11477269|FG000|Follow-up|Withdrawal by Subject|1
7263929|NCT00378599|11477273|FG000|Overall Study|Adverse Event|38
7263930|NCT00378599|11477273|FG000|Overall Study|Protocol Violation|2
7263931|NCT00378599|11477273|FG000|Overall Study|Treatment failure|7
7263932|NCT00378599|11477273|FG000|Overall Study|Withdrawal by Subject|5
7263933|NCT00378703|11477281|FG000|Overall Study|Disease progression|59
7263934|NCT00378703|11477282|FG001|Overall Study|Disease progression|43
7263935|NCT00378703|11477283|FG002|Overall Study|Disease progression|48
7263936|NCT00378703|11477284|FG003|Overall Study|Disease progression|49
7263937|NCT00378703|11477281|FG000|Overall Study|Adverse Event|11
7263938|NCT00378703|11477282|FG001|Overall Study|Adverse Event|17
7263939|NCT00378703|11477283|FG002|Overall Study|Adverse Event|20
7263940|NCT00378703|11477284|FG003|Overall Study|Adverse Event|18
7263941|NCT00378703|11477281|FG000|Overall Study|Death|2
7263942|NCT00378703|11477282|FG001|Overall Study|Death|2
7263943|NCT00378703|11477283|FG002|Overall Study|Death|4
7263944|NCT00378703|11477284|FG003|Overall Study|Death|3
7263945|NCT00378703|11477281|FG000|Overall Study|Withdrawal by Subject|4
7263946|NCT00378703|11477282|FG001|Overall Study|Withdrawal by Subject|8
7263947|NCT00378703|11477283|FG002|Overall Study|Withdrawal by Subject|5
7263948|NCT00378703|11477284|FG003|Overall Study|Withdrawal by Subject|7
7263949|NCT00378703|11477281|FG000|Overall Study|Physician Decision|1
7263950|NCT00378703|11477282|FG001|Overall Study|Physician Decision|4
7263951|NCT00378703|11477283|FG002|Overall Study|Physician Decision|1
7263952|NCT00378703|11477284|FG003|Overall Study|Physician Decision|0
7263953|NCT00378703|11477281|FG000|Overall Study|Alternative therapy|4
7263954|NCT00378703|11477282|FG001|Overall Study|Alternative therapy|2
7263955|NCT00378703|11477283|FG002|Overall Study|Alternative therapy|0
7263956|NCT00378703|11477284|FG003|Overall Study|Alternative therapy|0
7263957|NCT00378703|11477281|FG000|Overall Study|Other complicated disease|0
7263958|NCT00378703|11477282|FG001|Overall Study|Other complicated disease|2
7263959|NCT00378703|11477283|FG002|Overall Study|Other complicated disease|2
7263960|NCT00378703|11477284|FG003|Overall Study|Other complicated disease|0
7263961|NCT00378703|11477281|FG000|Overall Study|Symptomatic deterioration|0
7263962|NCT00378703|11477282|FG001|Overall Study|Symptomatic deterioration|1
7263963|NCT00378703|11477283|FG002|Overall Study|Symptomatic deterioration|0
7263964|NCT00378703|11477284|FG003|Overall Study|Symptomatic deterioration|2
7263965|NCT00378703|11477281|FG000|Overall Study|Surgery|1
7263966|NCT00378703|11477282|FG001|Overall Study|Surgery|0
7263967|NCT00378703|11477283|FG002|Overall Study|Surgery|0
7263968|NCT00378703|11477284|FG003|Overall Study|Surgery|1
7263969|NCT00378703|11477281|FG000|Overall Study|Joint decision of physician and patient|1
7263970|NCT00378703|11477282|FG001|Overall Study|Joint decision of physician and patient|0
7263971|NCT00378703|11477283|FG002|Overall Study|Joint decision of physician and patient|0
7263972|NCT00378703|11477284|FG003|Overall Study|Joint decision of physician and patient|0
7263973|NCT00378703|11477281|FG000|Overall Study|Adverse events and progressive disease|0
7263974|NCT00378703|11477282|FG001|Overall Study|Adverse events and progressive disease|0
7263975|NCT00378703|11477283|FG002|Overall Study|Adverse events and progressive disease|0
7263976|NCT00378703|11477284|FG003|Overall Study|Adverse events and progressive disease|1
7263977|NCT00378703|11477281|FG000|Overall Study|Relocation|0
7263978|NCT00378703|11477282|FG001|Overall Study|Relocation|0
7263979|NCT00378703|11477283|FG002|Overall Study|Relocation|1
7263980|NCT00378703|11477284|FG003|Overall Study|Relocation|0
7544679|NCT02833974|11898715|FG001|Overall Study|Adverse Event|3
7544680|NCT02834247|11898725|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
7544681|NCT02834247|11898726|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
7544682|NCT02834247|11898727|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
7544683|NCT02834247|11898728|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
7544684|NCT02834247|11898725|FG000|Dose Escalation Phase|Death|5
7544685|NCT02834247|11898726|FG001|Dose Escalation Phase|Death|6
7544686|NCT02834247|11898727|FG002|Dose Escalation Phase|Death|5
7544687|NCT02834247|11898728|FG003|Dose Escalation Phase|Death|0
7263981|NCT00378703|11477281|FG000|Overall Study|Ineligible|4
7263982|NCT00378703|11477282|FG001|Overall Study|Ineligible|7
7263983|NCT00378703|11477283|FG002|Overall Study|Ineligible|7
7263984|NCT00378703|11477284|FG003|Overall Study|Ineligible|7
7263985|NCT00378703|11477281|FG000|Overall Study|Never started treatment|1
7263986|NCT00378703|11477282|FG001|Overall Study|Never started treatment|4
7263987|NCT00378703|11477283|FG002|Overall Study|Never started treatment|0
7263988|NCT00378703|11477284|FG003|Overall Study|Never started treatment|0
7544688|NCT02834247|11898725|FG000|Dose Escalation Phase|Lost to Follow-up|0
7544689|NCT02834247|11898726|FG001|Dose Escalation Phase|Lost to Follow-up|1
7544690|NCT02834247|11898727|FG002|Dose Escalation Phase|Lost to Follow-up|0
7263989|NCT00378703|11477281|FG000|Overall Study|Other|1
7263990|NCT00378703|11477282|FG001|Overall Study|Other|1
7263991|NCT00378703|11477283|FG002|Overall Study|Other|2
7263992|NCT00378703|11477284|FG003|Overall Study|Other|3
7263993|NCT00378898|11477296|FG000|Overall Study|Withdrawal by Subject|10
7263994|NCT00378898|11477297|FG001|Overall Study|Withdrawal by Subject|5
7263995|NCT00378898|11477296|FG000|Overall Study|Protocol Violation|1
7263996|NCT00378898|11477297|FG001|Overall Study|Protocol Violation|1
7263997|NCT00379080|11477308|FG000|Overall Study|Withdrawal by Subject|0
7263998|NCT00379080|11477309|FG001|Overall Study|Withdrawal by Subject|4
7263999|NCT00379080|11477310|FG002|Overall Study|Withdrawal by Subject|0
7264000|NCT00379210|11477349|FG000|Overall Study|Withdrawal by Subject|10
7264001|NCT00379210|11477350|FG001|Overall Study|Withdrawal by Subject|7
7264002|NCT00379236|11477358|FG000|Double-blind|Adverse Event|11
7264003|NCT00379236|11477359|FG001|Double-blind|Adverse Event|6
7264004|NCT00379236|11477360|FG002|Double-blind|Adverse Event|0
7264005|NCT00379236|11477358|FG000|Double-blind|Protocol Violation|3
7264006|NCT00379236|11477359|FG001|Double-blind|Protocol Violation|3
7264007|NCT00379236|11477360|FG002|Double-blind|Protocol Violation|0
7264008|NCT00379236|11477358|FG000|Double-blind|Withdrawal by Subject|12
7264009|NCT00379236|11477359|FG001|Double-blind|Withdrawal by Subject|13
7264010|NCT00379236|11477360|FG002|Double-blind|Withdrawal by Subject|0
7264011|NCT00379236|11477358|FG000|Double-blind|Lost to Follow-up|4
7264012|NCT00379236|11477359|FG001|Double-blind|Lost to Follow-up|3
7264013|NCT00379236|11477360|FG002|Double-blind|Lost to Follow-up|0
7264014|NCT00379236|11477358|FG000|Double-blind|Use of exclusionary medication|1
7264015|NCT00379236|11477359|FG001|Double-blind|Use of exclusionary medication|2
7264016|NCT00379236|11477360|FG002|Double-blind|Use of exclusionary medication|0
7264017|NCT00379236|11477358|FG000|Double-blind|Other|3
7264018|NCT00379236|11477359|FG001|Double-blind|Other|7
7264019|NCT00379236|11477360|FG002|Double-blind|Other|0
7264020|NCT00379236|11477358|FG000|Double-blind|Data could not be retrieved|2
7264021|NCT00379236|11477359|FG001|Double-blind|Data could not be retrieved|2
7264022|NCT00379236|11477360|FG002|Double-blind|Data could not be retrieved|0
7264023|NCT00379236|11477358|FG000|Open-label Extension|Adverse Event|0
7264024|NCT00379236|11477359|FG001|Open-label Extension|Adverse Event|0
7264025|NCT00379236|11477360|FG002|Open-label Extension|Adverse Event|13
7264026|NCT00379236|11477358|FG000|Open-label Extension|Protocol Violation|0
7264027|NCT00379236|11477359|FG001|Open-label Extension|Protocol Violation|0
7264028|NCT00379236|11477360|FG002|Open-label Extension|Protocol Violation|7
7264029|NCT00379236|11477358|FG000|Open-label Extension|Withdrawal by Subject|0
7264030|NCT00379236|11477359|FG001|Open-label Extension|Withdrawal by Subject|0
7264031|NCT00379236|11477360|FG002|Open-label Extension|Withdrawal by Subject|13
7264032|NCT00379236|11477358|FG000|Open-label Extension|Lost to Follow-up|0
7264033|NCT00379236|11477359|FG001|Open-label Extension|Lost to Follow-up|0
7264034|NCT00379236|11477360|FG002|Open-label Extension|Lost to Follow-up|12
7264035|NCT00379236|11477358|FG000|Open-label Extension|Use of exclusionary medication|0
7264036|NCT00379236|11477359|FG001|Open-label Extension|Use of exclusionary medication|0
7544691|NCT02834247|11898728|FG003|Dose Escalation Phase|Lost to Follow-up|0
7544692|NCT02834247|11898725|FG000|Dose Escalation Phase|Withdrawal by Subject|2
7544693|NCT02834247|11898726|FG001|Dose Escalation Phase|Withdrawal by Subject|2
7544694|NCT02834247|11898727|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7544695|NCT02834247|11898728|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7544696|NCT02834247|11898725|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
7264037|NCT00379236|11477360|FG002|Open-label Extension|Use of exclusionary medication|3
7264038|NCT00379236|11477358|FG000|Open-label Extension|Other|0
7264039|NCT00379236|11477359|FG001|Open-label Extension|Other|0
7264040|NCT00379236|11477360|FG002|Open-label Extension|Other|7
7264041|NCT00379353|11477374|FG000|Overall Study|Hospitalization|3
7264042|NCT00379353|11477375|FG001|Overall Study|Hospitalization|3
7264043|NCT00379353|11477374|FG000|Overall Study|Withdrawal by Subject|5
7264044|NCT00379353|11477375|FG001|Overall Study|Withdrawal by Subject|2
7264045|NCT00379353|11477374|FG000|Overall Study|Death|1
7264046|NCT00379353|11477375|FG001|Overall Study|Death|0
7264047|NCT00379353|11477374|FG000|Overall Study|Cardiac Tamponade|1
7264048|NCT00379353|11477375|FG001|Overall Study|Cardiac Tamponade|0
7264049|NCT00379353|11477374|FG000|Overall Study|Non-compliance|1
7264050|NCT00379353|11477375|FG001|Overall Study|Non-compliance|0
7264051|NCT00379353|11477374|FG000|Overall Study|Conflicting drug treatment|0
7264052|NCT00379353|11477375|FG001|Overall Study|Conflicting drug treatment|1
7264053|NCT00379587|11477395|FG000|Overall Study|Lost to Follow-up|2
7264054|NCT00379639|11477404|FG000|Overall Study|Disease Progression|3
7264055|NCT00379639|11477405|FG001|Overall Study|Disease Progression|3
7264056|NCT00379639|11477406|FG002|Overall Study|Disease Progression|3
7264057|NCT00379639|11477407|FG003|Overall Study|Disease Progression|4
7264058|NCT00379639|11477408|FG004|Overall Study|Disease Progression|4
7264059|NCT00379639|11477404|FG000|Overall Study|Physician Decision|0
7264060|NCT00379639|11477405|FG001|Overall Study|Physician Decision|2
7264061|NCT00379639|11477406|FG002|Overall Study|Physician Decision|1
7264062|NCT00379639|11477407|FG003|Overall Study|Physician Decision|1
7264063|NCT00379639|11477408|FG004|Overall Study|Physician Decision|0
7264064|NCT00379639|11477404|FG000|Overall Study|Symptomatic Deterioration|0
7264065|NCT00379639|11477405|FG001|Overall Study|Symptomatic Deterioration|0
7264066|NCT00379639|11477406|FG002|Overall Study|Symptomatic Deterioration|1
7264067|NCT00379639|11477407|FG003|Overall Study|Symptomatic Deterioration|0
7264068|NCT00379639|11477408|FG004|Overall Study|Symptomatic Deterioration|1
7264069|NCT00379639|11477404|FG000|Overall Study|Adverse Event|0
7264070|NCT00379639|11477405|FG001|Overall Study|Adverse Event|0
7264071|NCT00379639|11477406|FG002|Overall Study|Adverse Event|1
7264072|NCT00379639|11477407|FG003|Overall Study|Adverse Event|0
7264073|NCT00379639|11477408|FG004|Overall Study|Adverse Event|1
7264074|NCT00379639|11477404|FG000|Overall Study|Lost to Follow-up|0
7544697|NCT02834247|11898726|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
7264075|NCT00379639|11477405|FG001|Overall Study|Lost to Follow-up|0
7264076|NCT00379639|11477406|FG002|Overall Study|Lost to Follow-up|0
7264077|NCT00379639|11477407|FG003|Overall Study|Lost to Follow-up|1
7264078|NCT00379639|11477408|FG004|Overall Study|Lost to Follow-up|0
7264079|NCT00379639|11477404|FG000|Overall Study|Other|0
7264080|NCT00379639|11477405|FG001|Overall Study|Other|0
7264081|NCT00379639|11477406|FG002|Overall Study|Other|3
7264082|NCT00379639|11477407|FG003|Overall Study|Other|0
7264083|NCT00379639|11477408|FG004|Overall Study|Other|0
7264084|NCT00379769|11477424|FG000|Main Study|Death|57
7264085|NCT00379769|11477425|FG001|Main Study|Death|67
7264086|NCT00379769|11477426|FG002|Main Study|Death|54
7544698|NCT02834247|11898727|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
7544699|NCT02834247|11898728|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
7544700|NCT02834247|11898725|FG000|Dose Expansion Phase|Death|0
7544701|NCT02834247|11898726|FG001|Dose Expansion Phase|Death|0
7544702|NCT02834247|11898727|FG002|Dose Expansion Phase|Death|0
7544703|NCT02834247|11898728|FG003|Dose Expansion Phase|Death|8
7544704|NCT02834247|11898725|FG000|Dose Expansion Phase|Lost to Follow-up|0
7544705|NCT02834247|11898726|FG001|Dose Expansion Phase|Lost to Follow-up|0
7544706|NCT02834247|11898727|FG002|Dose Expansion Phase|Lost to Follow-up|0
7544707|NCT02834247|11898728|FG003|Dose Expansion Phase|Lost to Follow-up|1
7544708|NCT02834247|11898725|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7544709|NCT02834247|11898726|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7544710|NCT02834247|11898727|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7544711|NCT02834247|11898728|FG003|Dose Expansion Phase|Withdrawal by Subject|1
7544712|NCT02834390|11898742|FG000|Induction Phase|Progressive disease|0
7544713|NCT02834390|11898743|FG001|Induction Phase|Progressive disease|1
7544714|NCT02834390|11898742|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
7544715|NCT02834390|11898743|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
7544716|NCT02834390|11898742|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
7544717|NCT02834390|11898743|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
7544718|NCT02834390|11898742|FG000|Consolidation Phase|Physician Decision|1
7544719|NCT02834390|11898743|FG001|Consolidation Phase|Physician Decision|1
7544720|NCT02834819|11898783|FG000|Overall Study|Did not complete 7 day follow up call.|5
7544721|NCT02834819|11898784|FG001|Overall Study|Did not complete 7 day follow up call.|0
7544722|NCT02835092|11898793|FG000|Overall Study|Withdrawal by Subject|3
7544723|NCT02835092|11898794|FG001|Overall Study|Withdrawal by Subject|6
7544724|NCT02835092|11898795|FG002|Overall Study|Withdrawal by Subject|3
7544725|NCT02835092|11898793|FG000|Overall Study|Lost to Follow-up|0
7544726|NCT02835092|11898794|FG001|Overall Study|Lost to Follow-up|2
7544727|NCT02835092|11898795|FG002|Overall Study|Lost to Follow-up|0
7544728|NCT02835339|11898814|FG000|Overall Study|Did not receive allocated intervention|13
7544729|NCT02835339|11898815|FG001|Overall Study|Did not receive allocated intervention|16
7544730|NCT02835495|11898823|FG000|Overall Study|Cancer diagnosis prior intervention|1
7544731|NCT02835495|11898824|FG001|Overall Study|Cancer diagnosis prior intervention|0
7544732|NCT02835495|11898823|FG000|Overall Study|Declined in-person follow-up visit|4
7544733|NCT02835495|11898824|FG001|Overall Study|Declined in-person follow-up visit|2
7544734|NCT02835820|11898848|FG000|Overall Study|Baseline Screen Failure|0
7544735|NCT02835820|11898849|FG001|Overall Study|Baseline Screen Failure|3
7544736|NCT02836496|11898861|FG000|Overall Study|Adverse Event|2
7544737|NCT02836496|11898862|FG001|Overall Study|Adverse Event|1
7544738|NCT02836496|11898861|FG000|Overall Study|Withdrawal by Subject|0
7544739|NCT02836496|11898862|FG001|Overall Study|Withdrawal by Subject|1
7544740|NCT02836613|11898870|FG000|Overall Study|Accidental drowning|1
7544741|NCT02836613|11898871|FG001|Overall Study|Accidental drowning|0
7544742|NCT02836613|11898870|FG000|Overall Study|Lost to Follow-up|0
7544743|NCT02836613|11898871|FG001|Overall Study|Lost to Follow-up|1
7544744|NCT02836613|11898870|FG000|Overall Study|Withdrawal by Subject|0
7544745|NCT02836613|11898871|FG001|Overall Study|Withdrawal by Subject|2
7544746|NCT02836652|11898879|FG000|Overall Study|Death|3
7544747|NCT02836652|11898880|FG001|Overall Study|Death|3
7544748|NCT02836652|11898879|FG000|Overall Study|Transplant/Explant|3
7544749|NCT02836652|11898880|FG001|Overall Study|Transplant/Explant|4
7544750|NCT02836652|11898879|FG000|Overall Study|Withdrawn|9
7544751|NCT02836652|11898880|FG001|Overall Study|Withdrawn|9
7264087|NCT00379769|11477427|FG003|Main Study|Death|72
7544752|NCT02836652|11898879|FG000|Overall Study|Not on treatment regimen post-op day 15|3
7544753|NCT02836652|11898880|FG001|Overall Study|Not on treatment regimen post-op day 15|3
7544754|NCT02836769|11898886|FG000|Overall Study|Lost to Follow-up|10
7544755|NCT02836769|11898886|FG000|Overall Study|Medical withdrawal|2
7264088|NCT00379769|11477428|FG004|Main Study|Death|0
7264089|NCT00379769|11477429|FG005|Main Study|Death|0
7264090|NCT00379769|11477424|FG000|Main Study|Adverse Event|5
7264091|NCT00379769|11477425|FG001|Main Study|Adverse Event|8
7264092|NCT00379769|11477426|FG002|Main Study|Adverse Event|10
7264093|NCT00379769|11477427|FG003|Main Study|Adverse Event|11
7264094|NCT00379769|11477428|FG004|Main Study|Adverse Event|0
7264095|NCT00379769|11477429|FG005|Main Study|Adverse Event|0
7264096|NCT00379769|11477424|FG000|Main Study|Lost to Follow-up|29
7264097|NCT00379769|11477425|FG001|Main Study|Lost to Follow-up|29
7264098|NCT00379769|11477426|FG002|Main Study|Lost to Follow-up|25
7264099|NCT00379769|11477427|FG003|Main Study|Lost to Follow-up|26
7264100|NCT00379769|11477428|FG004|Main Study|Lost to Follow-up|0
7264101|NCT00379769|11477429|FG005|Main Study|Lost to Follow-up|0
7264102|NCT00379769|11477424|FG000|Main Study|Withdrawal by Subject|46
7264103|NCT00379769|11477425|FG001|Main Study|Withdrawal by Subject|56
7264104|NCT00379769|11477426|FG002|Main Study|Withdrawal by Subject|72
7264105|NCT00379769|11477427|FG003|Main Study|Withdrawal by Subject|70
7264106|NCT00379769|11477428|FG004|Main Study|Withdrawal by Subject|0
7264107|NCT00379769|11477429|FG005|Main Study|Withdrawal by Subject|0
7264108|NCT00379769|11477424|FG000|Main Study|Moved to survival status follow-up only|27
7264109|NCT00379769|11477425|FG001|Main Study|Moved to survival status follow-up only|25
7264110|NCT00379769|11477426|FG002|Main Study|Moved to survival status follow-up only|32
7264111|NCT00379769|11477427|FG003|Main Study|Moved to survival status follow-up only|36
7264112|NCT00379769|11477428|FG004|Main Study|Moved to survival status follow-up only|0
7264113|NCT00379769|11477429|FG005|Main Study|Moved to survival status follow-up only|0
7264114|NCT00379769|11477424|FG000|Main Study|Participant moved|3
7264115|NCT00379769|11477425|FG001|Main Study|Participant moved|2
7264116|NCT00379769|11477426|FG002|Main Study|Participant moved|3
7264117|NCT00379769|11477427|FG003|Main Study|Participant moved|3
7264118|NCT00379769|11477428|FG004|Main Study|Participant moved|0
7264119|NCT00379769|11477429|FG005|Main Study|Participant moved|0
7264120|NCT00379769|11477424|FG000|Main Study|Poor compliance|3
7264121|NCT00379769|11477425|FG001|Main Study|Poor compliance|2
7264122|NCT00379769|11477426|FG002|Main Study|Poor compliance|2
7264123|NCT00379769|11477427|FG003|Main Study|Poor compliance|1
7264124|NCT00379769|11477428|FG004|Main Study|Poor compliance|0
7264125|NCT00379769|11477429|FG005|Main Study|Poor compliance|0
7264126|NCT00379769|11477424|FG000|Main Study|Prohibited glucose lowering medication|0
7264127|NCT00379769|11477425|FG001|Main Study|Prohibited glucose lowering medication|3
7264128|NCT00379769|11477426|FG002|Main Study|Prohibited glucose lowering medication|0
7264129|NCT00379769|11477427|FG003|Main Study|Prohibited glucose lowering medication|1
7264130|NCT00379769|11477428|FG004|Main Study|Prohibited glucose lowering medication|0
7264131|NCT00379769|11477429|FG005|Main Study|Prohibited glucose lowering medication|0
7264132|NCT00379769|11477424|FG000|Main Study|Site closed|4
7264133|NCT00379769|11477425|FG001|Main Study|Site closed|4
7264134|NCT00379769|11477426|FG002|Main Study|Site closed|4
7264135|NCT00379769|11477427|FG003|Main Study|Site closed|8
7264136|NCT00379769|11477428|FG004|Main Study|Site closed|0
7264137|NCT00379769|11477429|FG005|Main Study|Site closed|0
7264138|NCT00379769|11477424|FG000|Main Study|Entry criteria violation|0
7264139|NCT00379769|11477425|FG001|Main Study|Entry criteria violation|0
7264140|NCT00379769|11477426|FG002|Main Study|Entry criteria violation|1
7264141|NCT00379769|11477427|FG003|Main Study|Entry criteria violation|1
7264142|NCT00379769|11477428|FG004|Main Study|Entry criteria violation|0
7264143|NCT00379769|11477429|FG005|Main Study|Entry criteria violation|0
7264144|NCT00379769|11477424|FG000|Main Study|Participant did not take study drug|0
7264145|NCT00379769|11477425|FG001|Main Study|Participant did not take study drug|0
7264146|NCT00379769|11477426|FG002|Main Study|Participant did not take study drug|1
7264147|NCT00379769|11477427|FG003|Main Study|Participant did not take study drug|0
7264148|NCT00379769|11477428|FG004|Main Study|Participant did not take study drug|0
7264149|NCT00379769|11477429|FG005|Main Study|Participant did not take study drug|0
7264150|NCT00379769|11477424|FG000|Main Study|Physician Decision|2
7264151|NCT00379769|11477425|FG001|Main Study|Physician Decision|2
7264152|NCT00379769|11477426|FG002|Main Study|Physician Decision|1
7264153|NCT00379769|11477427|FG003|Main Study|Physician Decision|1
7264154|NCT00379769|11477428|FG004|Main Study|Physician Decision|0
7264155|NCT00379769|11477429|FG005|Main Study|Physician Decision|0
7264156|NCT00379769|11477424|FG000|Main Study|Participant completed study at visit 27|1
7264157|NCT00379769|11477425|FG001|Main Study|Participant completed study at visit 27|0
7264158|NCT00379769|11477426|FG002|Main Study|Participant completed study at visit 27|0
7264159|NCT00379769|11477427|FG003|Main Study|Participant completed study at visit 27|0
7264160|NCT00379769|11477428|FG004|Main Study|Participant completed study at visit 27|0
7264161|NCT00379769|11477429|FG005|Main Study|Participant completed study at visit 27|0
7264162|NCT00379769|11477424|FG000|Main Study|Personal reasons|1
7264163|NCT00379769|11477425|FG001|Main Study|Personal reasons|0
7264164|NCT00379769|11477426|FG002|Main Study|Personal reasons|0
7264165|NCT00379769|11477427|FG003|Main Study|Personal reasons|0
7264166|NCT00379769|11477428|FG004|Main Study|Personal reasons|0
7264167|NCT00379769|11477429|FG005|Main Study|Personal reasons|0
7264168|NCT00379769|11477424|FG000|Main Study|Risk of heart failure|0
7264169|NCT00379769|11477425|FG001|Main Study|Risk of heart failure|1
7264170|NCT00379769|11477426|FG002|Main Study|Risk of heart failure|0
7264171|NCT00379769|11477427|FG003|Main Study|Risk of heart failure|0
7264172|NCT00379769|11477428|FG004|Main Study|Risk of heart failure|0
7264173|NCT00379769|11477429|FG005|Main Study|Risk of heart failure|0
7264174|NCT00379769|11477424|FG000|Main Study|Investigator refused to log temperature|0
7264175|NCT00379769|11477425|FG001|Main Study|Investigator refused to log temperature|0
7264176|NCT00379769|11477426|FG002|Main Study|Investigator refused to log temperature|1
7264177|NCT00379769|11477427|FG003|Main Study|Investigator refused to log temperature|0
7264178|NCT00379769|11477428|FG004|Main Study|Investigator refused to log temperature|0
7264179|NCT00379769|11477429|FG005|Main Study|Investigator refused to log temperature|0
7264180|NCT00379769|11477424|FG000|Main Study|Reason unspecified|0
7264181|NCT00379769|11477425|FG001|Main Study|Reason unspecified|0
7264182|NCT00379769|11477426|FG002|Main Study|Reason unspecified|1
7264183|NCT00379769|11477427|FG003|Main Study|Reason unspecified|0
7264184|NCT00379769|11477428|FG004|Main Study|Reason unspecified|0
7264185|NCT00379769|11477429|FG005|Main Study|Reason unspecified|0
7264186|NCT00379769|11477424|FG000|Observational Follow-up|Death|0
7264187|NCT00379769|11477425|FG001|Observational Follow-up|Death|0
7264188|NCT00379769|11477426|FG002|Observational Follow-up|Death|0
7264189|NCT00379769|11477427|FG003|Observational Follow-up|Death|0
7264190|NCT00379769|11477428|FG004|Observational Follow-up|Death|78
7264191|NCT00379769|11477429|FG005|Observational Follow-up|Death|70
7264192|NCT00379769|11477424|FG000|Observational Follow-up|Adverse Event|0
7264193|NCT00379769|11477425|FG001|Observational Follow-up|Adverse Event|0
7264194|NCT00379769|11477426|FG002|Observational Follow-up|Adverse Event|0
7264195|NCT00379769|11477427|FG003|Observational Follow-up|Adverse Event|0
7264196|NCT00379769|11477428|FG004|Observational Follow-up|Adverse Event|1
7264197|NCT00379769|11477429|FG005|Observational Follow-up|Adverse Event|0
7264198|NCT00379769|11477424|FG000|Observational Follow-up|Lost to Follow-up|0
7264199|NCT00379769|11477425|FG001|Observational Follow-up|Lost to Follow-up|0
7264200|NCT00379769|11477426|FG002|Observational Follow-up|Lost to Follow-up|0
7264201|NCT00379769|11477427|FG003|Observational Follow-up|Lost to Follow-up|0
7264202|NCT00379769|11477428|FG004|Observational Follow-up|Lost to Follow-up|25
7264203|NCT00379769|11477429|FG005|Observational Follow-up|Lost to Follow-up|27
7264204|NCT00379769|11477424|FG000|Observational Follow-up|Withdrawal by Subject|0
7264205|NCT00379769|11477425|FG001|Observational Follow-up|Withdrawal by Subject|0
7264206|NCT00379769|11477426|FG002|Observational Follow-up|Withdrawal by Subject|0
7264207|NCT00379769|11477427|FG003|Observational Follow-up|Withdrawal by Subject|0
7264208|NCT00379769|11477428|FG004|Observational Follow-up|Withdrawal by Subject|12
7264209|NCT00379769|11477429|FG005|Observational Follow-up|Withdrawal by Subject|12
7264210|NCT00379769|11477424|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
7264211|NCT00379769|11477425|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
7264212|NCT00379769|11477426|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
7264213|NCT00379769|11477427|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
7264214|NCT00379769|11477428|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
7264215|NCT00379769|11477429|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
7264216|NCT00379769|11477424|FG000|Observational Follow-up|Physician Decision|0
7264217|NCT00379769|11477425|FG001|Observational Follow-up|Physician Decision|0
7544756|NCT02836769|11898886|FG000|Overall Study|Withdrawal by Subject|3
7544757|NCT02836873|11898892|FG000|Overall Study|Protocol Violation|0
7544758|NCT02836873|11898893|FG001|Overall Study|Protocol Violation|1
7544759|NCT02836873|11898892|FG000|Overall Study|Adverse Event|1
7544760|NCT02836873|11898893|FG001|Overall Study|Adverse Event|4
7544761|NCT02836873|11898892|FG000|Overall Study|Withdrawal by Subject|2
7544762|NCT02836873|11898893|FG001|Overall Study|Withdrawal by Subject|2
7544763|NCT02836873|11898892|FG000|Overall Study|Lost to Follow-up|1
7544764|NCT02836873|11898893|FG001|Overall Study|Lost to Follow-up|3
7544765|NCT02836873|11898892|FG000|Overall Study|Physician Decision|0
7544766|NCT02836873|11898893|FG001|Overall Study|Physician Decision|1
7544767|NCT02836873|11898892|FG000|Overall Study|Other|1
7544768|NCT02836873|11898893|FG001|Overall Study|Other|0
7544769|NCT02837731|11898925|FG000|Allocation|Admitted to General Floor|3
7544770|NCT02837731|11898926|FG001|Allocation|Admitted to General Floor|4
7544771|NCT02837731|11898925|FG000|Allocation|Immediate surgery/withdrew|2
7544772|NCT02837731|11898926|FG001|Allocation|Immediate surgery/withdrew|0
7544773|NCT02837731|11898925|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
7544774|NCT02837731|11898926|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
7544775|NCT02837731|11898925|FG000|Allocation|Withdrawal by Subject|2
7544776|NCT02837731|11898926|FG001|Allocation|Withdrawal by Subject|0
7544777|NCT02837731|11898925|FG000|Allocation|Device not available|1
7544778|NCT02837731|11898926|FG001|Allocation|Device not available|0
7544779|NCT02837731|11898925|FG000|Allocation|Protocol not implemented|7
7544780|NCT02837731|11898926|FG001|Allocation|Protocol not implemented|0
7544781|NCT02837731|11898925|FG000|Allocation|Moribund/Do not resuscitate|2
7544782|NCT02837731|11898926|FG001|Allocation|Moribund/Do not resuscitate|0
7544783|NCT02837731|11898925|FG000|Allocation|Did not meet sepsis criteria|1
7544784|NCT02837731|11898926|FG001|Allocation|Did not meet sepsis criteria|2
7544785|NCT02837731|11898925|FG000|Allocation|Known aortic abnormalities|0
7544786|NCT02837731|11898926|FG001|Allocation|Known aortic abnormalities|1
7544787|NCT02837952|11898947|FG000|Overall Study|Adverse Event|0
7544788|NCT02837952|11898948|FG001|Overall Study|Adverse Event|1
7544789|NCT02837952|11898947|FG000|Overall Study|Withdrawal by Subject|4
7264218|NCT00379769|11477426|FG002|Observational Follow-up|Physician Decision|0
7264219|NCT00379769|11477427|FG003|Observational Follow-up|Physician Decision|0
7544790|NCT02837952|11898948|FG001|Overall Study|Withdrawal by Subject|5
7544791|NCT02837952|11898947|FG000|Overall Study|Medication Error|1
7544792|NCT02837952|11898948|FG001|Overall Study|Medication Error|0
7544793|NCT02838017|11898956|FG000|Overall Study|Lost to Follow-up|14
7544794|NCT02838017|11898957|FG001|Overall Study|Lost to Follow-up|11
7544795|NCT02838134|11898965|FG000|Overall Study|Lost to Follow-up|1
7544796|NCT02838134|11898966|FG001|Overall Study|Lost to Follow-up|2
7544797|NCT02838134|11898965|FG000|Overall Study|logistic problems|1
7544798|NCT02838134|11898966|FG001|Overall Study|logistic problems|1
7544799|NCT02838420|11898978|FG000|Overall Study|Ongoing in Study|113
7264220|NCT00379769|11477428|FG004|Observational Follow-up|Physician Decision|8
7264221|NCT00379769|11477429|FG005|Observational Follow-up|Physician Decision|8
7264222|NCT00379769|11477424|FG000|Observational Follow-up|Site Closed Early|0
7264223|NCT00379769|11477425|FG001|Observational Follow-up|Site Closed Early|0
7264224|NCT00379769|11477426|FG002|Observational Follow-up|Site Closed Early|0
7264225|NCT00379769|11477427|FG003|Observational Follow-up|Site Closed Early|0
7264226|NCT00379769|11477428|FG004|Observational Follow-up|Site Closed Early|6
7264227|NCT00379769|11477429|FG005|Observational Follow-up|Site Closed Early|7
7264228|NCT00379769|11477424|FG000|Observational Follow-up|Participant Moved|0
7264229|NCT00379769|11477425|FG001|Observational Follow-up|Participant Moved|0
7264230|NCT00379769|11477426|FG002|Observational Follow-up|Participant Moved|0
7264231|NCT00379769|11477427|FG003|Observational Follow-up|Participant Moved|0
7264232|NCT00379769|11477428|FG004|Observational Follow-up|Participant Moved|0
7264233|NCT00379769|11477429|FG005|Observational Follow-up|Participant Moved|1
7264234|NCT00379769|11477424|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
7264235|NCT00379769|11477425|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
7264236|NCT00379769|11477426|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
7264237|NCT00379769|11477427|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
7264238|NCT00379769|11477428|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
7264239|NCT00379769|11477429|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
7264240|NCT00379795|11477461|FG000|Overall Study|Death|31
7264241|NCT00379795|11477462|FG001|Overall Study|Death|8
7264242|NCT00379795|11477463|FG002|Overall Study|Death|6
7264243|NCT00379795|11477464|FG003|Overall Study|Death|4
7264244|NCT00379795|11477465|FG004|Overall Study|Death|7
7264245|NCT00379795|11477461|FG000|Overall Study|Adverse Event|17
7264246|NCT00379795|11477462|FG001|Overall Study|Adverse Event|3
7264247|NCT00379795|11477463|FG002|Overall Study|Adverse Event|3
7264248|NCT00379795|11477464|FG003|Overall Study|Adverse Event|1
7264249|NCT00379795|11477465|FG004|Overall Study|Adverse Event|4
7264250|NCT00379795|11477461|FG000|Overall Study|Lost to Follow-up|8
7264251|NCT00379795|11477462|FG001|Overall Study|Lost to Follow-up|1
7264252|NCT00379795|11477463|FG002|Overall Study|Lost to Follow-up|2
7264253|NCT00379795|11477464|FG003|Overall Study|Lost to Follow-up|1
7264254|NCT00379795|11477465|FG004|Overall Study|Lost to Follow-up|4
7264255|NCT00379795|11477461|FG000|Overall Study|Physician Decision|25
7264256|NCT00379795|11477462|FG001|Overall Study|Physician Decision|0
7264257|NCT00379795|11477463|FG002|Overall Study|Physician Decision|2
7264258|NCT00379795|11477464|FG003|Overall Study|Physician Decision|2
7264259|NCT00379795|11477465|FG004|Overall Study|Physician Decision|2
7264260|NCT00379795|11477461|FG000|Overall Study|Withdrawal by Subject|94
7264261|NCT00379795|11477462|FG001|Overall Study|Withdrawal by Subject|11
7264262|NCT00379795|11477463|FG002|Overall Study|Withdrawal by Subject|19
7264263|NCT00379795|11477464|FG003|Overall Study|Withdrawal by Subject|7
7264264|NCT00379795|11477465|FG004|Overall Study|Withdrawal by Subject|14
7264265|NCT00379795|11477461|FG000|Overall Study|Subject non-compliance|7
7264266|NCT00379795|11477462|FG001|Overall Study|Subject non-compliance|2
7264267|NCT00379795|11477463|FG002|Overall Study|Subject non-compliance|0
7264268|NCT00379795|11477464|FG003|Overall Study|Subject non-compliance|0
7264269|NCT00379795|11477465|FG004|Overall Study|Subject non-compliance|1
7264270|NCT00379795|11477461|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
7264271|NCT00379795|11477462|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
7264272|NCT00379795|11477463|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
7264273|NCT00379795|11477464|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
7264274|NCT00379795|11477465|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
7264275|NCT00379795|11477461|FG000|Overall Study|Subjects condition mandated intervention|34
7264276|NCT00379795|11477462|FG001|Overall Study|Subjects condition mandated intervention|9
7264277|NCT00379795|11477463|FG002|Overall Study|Subjects condition mandated intervention|7
7264278|NCT00379795|11477464|FG003|Overall Study|Subjects condition mandated intervention|5
7264279|NCT00379795|11477465|FG004|Overall Study|Subjects condition mandated intervention|7
7264280|NCT00379795|11477461|FG000|Overall Study|Sponsor's decision|257
7264281|NCT00379795|11477462|FG001|Overall Study|Sponsor's decision|17
7264282|NCT00379795|11477463|FG002|Overall Study|Sponsor's decision|54
7264283|NCT00379795|11477464|FG003|Overall Study|Sponsor's decision|47
7264284|NCT00379795|11477465|FG004|Overall Study|Sponsor's decision|10
7264285|NCT00379808|11477480|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
7264286|NCT00379808|11477481|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
7264287|NCT00379834|11477511|FG000|Overall Study|Time constraints|2
7544800|NCT02838420|11898979|FG001|Overall Study|Ongoing in Study|45
7544801|NCT02838420|11898978|FG000|Overall Study|Lost to Follow-up|1
7544802|NCT02838420|11898979|FG001|Overall Study|Lost to Follow-up|0
7544803|NCT02838420|11898978|FG000|Overall Study|Withdrawal by Subject|3
7544804|NCT02838420|11898979|FG001|Overall Study|Withdrawal by Subject|4
7544805|NCT02838420|11898978|FG000|Overall Study|Death|8
7544806|NCT02838420|11898979|FG001|Overall Study|Death|13
7544807|NCT02838628|11898987|FG000|Recurrence Follow-up Period|AK Recurrence|18
7544808|NCT02838628|11898988|FG001|Recurrence Follow-up Period|AK Recurrence|13
7544809|NCT02838628|11898987|FG000|Recurrence Follow-up Period|Adverse Event|1
7544810|NCT02838628|11898988|FG001|Recurrence Follow-up Period|Adverse Event|0
7544811|NCT02838628|11898987|FG000|Recurrence Follow-up Period|Non-compliance|0
7544812|NCT02838628|11898988|FG001|Recurrence Follow-up Period|Non-compliance|1
7264288|NCT00379899|11477517|FG000|Overall Study|Adverse Event|7
7264289|NCT00379899|11477518|FG001|Overall Study|Adverse Event|3
7264290|NCT00379899|11477517|FG000|Overall Study|Death|10
7544813|NCT02838628|11898987|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
7544814|NCT02838628|11898988|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
7544815|NCT02838628|11898987|FG000|Recurrence Follow-up Period|Other un-specified|1
7544816|NCT02838628|11898988|FG001|Recurrence Follow-up Period|Other un-specified|1
7544817|NCT02838901|11898997|FG000|Overall Study|Withdrawal by Subject|1
7544818|NCT02838901|11898998|FG001|Overall Study|Withdrawal by Subject|1
7544819|NCT02838901|11898997|FG000|Overall Study|Lost to Follow-up|1
7544820|NCT02838901|11898998|FG001|Overall Study|Lost to Follow-up|1
7544821|NCT02839200|11899012|FG000|Overall Study|Withdrawal by Subject|2
7544822|NCT02839200|11899013|FG001|Overall Study|Withdrawal by Subject|0
7544823|NCT02839200|11899014|FG002|Overall Study|Withdrawal by Subject|1
7544824|NCT02839200|11899015|FG003|Overall Study|Withdrawal by Subject|0
7544825|NCT02839200|11899016|FG004|Overall Study|Withdrawal by Subject|0
7264291|NCT00379899|11477518|FG001|Overall Study|Death|10
7264292|NCT00379899|11477517|FG000|Overall Study|Lost to Follow-up|2
7264293|NCT00379899|11477518|FG001|Overall Study|Lost to Follow-up|4
7264294|NCT00379899|11477517|FG000|Overall Study|Physician Decision|3
7264295|NCT00379899|11477518|FG001|Overall Study|Physician Decision|4
7264296|NCT00379899|11477517|FG000|Overall Study|Withdrawal by Subject|5
7264297|NCT00379899|11477518|FG001|Overall Study|Withdrawal by Subject|5
7264298|NCT00379899|11477517|FG000|Overall Study|Ineligibility determined|0
7264299|NCT00379899|11477518|FG001|Overall Study|Ineligibility determined|1
7264300|NCT00379899|11477517|FG000|Overall Study|Noncompliance|1
7264301|NCT00379899|11477518|FG001|Overall Study|Noncompliance|1
7264302|NCT00379899|11477517|FG000|Overall Study|Parathyroidectomy|0
7264303|NCT00379899|11477518|FG001|Overall Study|Parathyroidectomy|2
7264304|NCT00379899|11477517|FG000|Overall Study|Renal transplantation|5
7264305|NCT00379899|11477518|FG001|Overall Study|Renal transplantation|4
7264306|NCT00379899|11477517|FG000|Overall Study|Coronary artery bypass graft|1
7544826|NCT02839200|11899017|FG005|Overall Study|Withdrawal by Subject|1
7544827|NCT02839200|11899012|FG000|Overall Study|Lost to Follow-up|2
7544828|NCT02839200|11899013|FG001|Overall Study|Lost to Follow-up|0
7544829|NCT02839200|11899014|FG002|Overall Study|Lost to Follow-up|0
7544830|NCT02839200|11899015|FG003|Overall Study|Lost to Follow-up|0
7544831|NCT02839200|11899016|FG004|Overall Study|Lost to Follow-up|1
7544832|NCT02839200|11899017|FG005|Overall Study|Lost to Follow-up|0
7544833|NCT02839200|11899012|FG000|Overall Study|Adverse Event|0
7544834|NCT02839200|11899013|FG001|Overall Study|Adverse Event|0
7544835|NCT02839200|11899014|FG002|Overall Study|Adverse Event|0
7544836|NCT02839200|11899015|FG003|Overall Study|Adverse Event|0
7544837|NCT02839200|11899016|FG004|Overall Study|Adverse Event|1
7544838|NCT02839200|11899017|FG005|Overall Study|Adverse Event|0
7544839|NCT02839200|11899012|FG000|Overall Study|Randomized in error|0
7544840|NCT02839200|11899013|FG001|Overall Study|Randomized in error|1
7544841|NCT02839200|11899014|FG002|Overall Study|Randomized in error|0
7544842|NCT02839200|11899015|FG003|Overall Study|Randomized in error|0
7544843|NCT02839200|11899016|FG004|Overall Study|Randomized in error|0
7544844|NCT02839200|11899017|FG005|Overall Study|Randomized in error|0
7544845|NCT02839330|11899035|FG000|Overall Study|Adverse Event|0
7544846|NCT02839330|11899036|FG001|Overall Study|Adverse Event|1
7544847|NCT02839330|11899037|FG002|Overall Study|Adverse Event|2
7544848|NCT02839330|11899038|FG003|Overall Study|Adverse Event|2
7544849|NCT02839330|11899035|FG000|Overall Study|Death|4
7544850|NCT02839330|11899036|FG001|Overall Study|Death|6
7544851|NCT02839330|11899037|FG002|Overall Study|Death|1
7544852|NCT02839330|11899038|FG003|Overall Study|Death|1
7544853|NCT02839330|11899035|FG000|Overall Study|Withdrawal by Subject|27
7544854|NCT02839330|11899036|FG001|Overall Study|Withdrawal by Subject|19
7544855|NCT02839330|11899037|FG002|Overall Study|Withdrawal by Subject|11
7544856|NCT02839330|11899038|FG003|Overall Study|Withdrawal by Subject|13
7544857|NCT02839330|11899035|FG000|Overall Study|Lost to Follow-up|22
7544858|NCT02839330|11899036|FG001|Overall Study|Lost to Follow-up|27
7544859|NCT02839330|11899037|FG002|Overall Study|Lost to Follow-up|29
7544860|NCT02839330|11899038|FG003|Overall Study|Lost to Follow-up|25
7544861|NCT02839330|11899035|FG000|Overall Study|Administrative Reason|0
7576975|NCT04117607|11965082|FG010|Overall Study|Early Termination|0
7576976|NCT04117607|11965083|FG011|Overall Study|Early Termination|0
7544862|NCT02839330|11899036|FG001|Overall Study|Administrative Reason|0
7544863|NCT02839330|11899037|FG002|Overall Study|Administrative Reason|0
7544864|NCT02839330|11899038|FG003|Overall Study|Administrative Reason|1
7544865|NCT02839330|11899035|FG000|Overall Study|Protocol Violation|1
7544866|NCT02839330|11899036|FG001|Overall Study|Protocol Violation|2
7544867|NCT02839330|11899037|FG002|Overall Study|Protocol Violation|2
7544868|NCT02839330|11899038|FG003|Overall Study|Protocol Violation|3
7544869|NCT02839330|11899035|FG000|Overall Study|Other reason, not specified|4
7544870|NCT02839330|11899036|FG001|Overall Study|Other reason, not specified|3
7544871|NCT02839330|11899037|FG002|Overall Study|Other reason, not specified|3
7544872|NCT02839330|11899038|FG003|Overall Study|Other reason, not specified|6
7544873|NCT02839681|11899049|FG000|Overall Study|Death|2
7544874|NCT02839746|11899053|FG000|Overall Study|Not met selection criteria|12
7544875|NCT02839798|11899080|FG000|Overall Study|Withdrawal by Subject|2
7544876|NCT02839876|11899086|FG000|Overall Study|Protocol Violation|10
7544877|NCT02839876|11899087|FG001|Overall Study|Protocol Violation|11
7576977|NCT04117607|11965084|FG012|Overall Study|Early Termination|0
7264307|NCT00379899|11477518|FG001|Overall Study|Coronary artery bypass graft|1
7264308|NCT00379899|11477517|FG000|Overall Study|Other protocol-specified criteria|3
7264309|NCT00379899|11477518|FG001|Overall Study|Other protocol-specified criteria|4
7264310|NCT00379899|11477517|FG000|Overall Study|Other|3
7264311|NCT00379899|11477518|FG001|Overall Study|Other|1
7264312|NCT00379912|11477526|FG000|Overall Study|Lack of Efficacy|1
7264313|NCT00379912|11477527|FG001|Overall Study|Lack of Efficacy|0
7264314|NCT00380068|11477547|FG000|Overall Study|Adverse Event|40
7264315|NCT00380068|11477547|FG000|Overall Study|Withdrawal by Subject|10
7264316|NCT00380068|11477547|FG000|Overall Study|Not compliant|6
7264317|NCT00380068|11477547|FG000|Overall Study|Lost to Follow-up|1
7264318|NCT00380068|11477547|FG000|Overall Study|Addition of other PAH therapeutic agent|1
7264319|NCT00380068|11477547|FG000|Overall Study|Lung transplant|3
7264320|NCT00380068|11477547|FG000|Overall Study|Physician Decision|2
7264321|NCT00380068|11477547|FG000|Overall Study|Partipant moved away|1
7264322|NCT00380068|11477547|FG000|Overall Study|Lack of Efficacy|5
7388083|NCT01217463|11646784|FG001|Overall Study|Patient Non-compliant|0
7388084|NCT01217463|11646783|FG000|Overall Study|Other|1
7388085|NCT01217463|11646784|FG001|Overall Study|Other|1
7388086|NCT01217476|11646794|FG000|Overall Study|Adverse Event|6
7388087|NCT01217476|11646795|FG001|Overall Study|Adverse Event|1
7388088|NCT01217476|11646794|FG000|Overall Study|Physician Decision|0
7388089|NCT01217476|11646795|FG001|Overall Study|Physician Decision|1
7388090|NCT01217476|11646794|FG000|Overall Study|Withdrawal by Subject|3
7388091|NCT01217476|11646795|FG001|Overall Study|Withdrawal by Subject|3
7388092|NCT01217476|11646794|FG000|Overall Study|Surgery on the Target Limb|0
7388093|NCT01217476|11646795|FG001|Overall Study|Surgery on the Target Limb|2
7388094|NCT01217476|11646794|FG000|Overall Study|Protocol Deviation|1
7388095|NCT01217476|11646795|FG001|Overall Study|Protocol Deviation|0
7388096|NCT01217476|11646794|FG000|Overall Study|Other|2
7388097|NCT01217476|11646795|FG001|Overall Study|Other|0
7388098|NCT01217606|11646816|FG000|Initial Treatment Phase|Other Reasons|0
7388099|NCT01217606|11646817|FG001|Initial Treatment Phase|Other Reasons|2
7544878|NCT02840253|11899127|FG000|Overall Study|Unsuccessful block|4
7544879|NCT02840461|11899134|FG000|Overall Study|Adverse Event|1
7544880|NCT02840461|11899135|FG001|Overall Study|Adverse Event|5
7544881|NCT02840461|11899136|FG002|Overall Study|Adverse Event|3
7544882|NCT02840461|11899134|FG000|Overall Study|Lost to Follow-up|10
7544883|NCT02840461|11899135|FG001|Overall Study|Lost to Follow-up|7
7544884|NCT02840461|11899136|FG002|Overall Study|Lost to Follow-up|6
7544885|NCT02840461|11899134|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
7544886|NCT02840461|11899135|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
7544887|NCT02840461|11899136|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
7544888|NCT02840461|11899134|FG000|Overall Study|Protocol Violation|2
7544889|NCT02840461|11899135|FG001|Overall Study|Protocol Violation|3
7544890|NCT02840461|11899136|FG002|Overall Study|Protocol Violation|1
7544891|NCT02840461|11899134|FG000|Overall Study|Withdrawal by Subject|10
7544892|NCT02840461|11899135|FG001|Overall Study|Withdrawal by Subject|6
7544893|NCT02840461|11899136|FG002|Overall Study|Withdrawal by Subject|2
7544894|NCT02840461|11899134|FG000|Overall Study|Worsening of Symptom & Kit Error|0
7544895|NCT02840461|11899135|FG001|Overall Study|Worsening of Symptom & Kit Error|0
7544896|NCT02840461|11899136|FG002|Overall Study|Worsening of Symptom & Kit Error|2
7544897|NCT02840474|11899147|FG000|Overall Study|Lost to Follow-up|1
7544898|NCT02840474|11899148|FG001|Overall Study|Lost to Follow-up|0
7544899|NCT02840721|11899154|FG000|Treatment Period|Adverse Event|1
7544900|NCT02840721|11899154|FG000|Follow-Up|Lack of Efficacy|1
7544901|NCT02840721|11899154|FG000|Follow-Up|Withdrawal by Subject|4
7544902|NCT02840721|11899154|FG000|Follow-Up|Withdrawal of Consent|2
7576978|NCT04117607|11965085|FG013|Overall Study|Early Termination|0
7576979|NCT04096365|11965110|FG000|Overall Study|Adverse Event|1
7576980|NCT04080297|11965116|FG000|Overall Study|Adverse Event|1
7576981|NCT04080297|11965117|FG001|Overall Study|Adverse Event|3
7576982|NCT04080297|11965116|FG000|Overall Study|concurrent illness|1
7576983|NCT04080297|11965117|FG001|Overall Study|concurrent illness|0
7576984|NCT04115358|11965126|FG000|Overall Study|exfoliation|0
7576985|NCT04115358|11965127|FG001|Overall Study|exfoliation|0
7576986|NCT04115358|11965128|FG002|Overall Study|exfoliation|1
7388100|NCT01217606|11646816|FG000|Initial Treatment Phase|Protocol Violation|3
7576987|NCT04113694|11965152|FG000|Overall Study|Adverse Event|2
7576988|NCT04113694|11965152|FG000|Overall Study|Lost to Follow-up|2
7576989|NCT04113694|11965152|FG000|Overall Study|Withdrawal by Subject|6
7388101|NCT01217606|11646817|FG001|Initial Treatment Phase|Protocol Violation|2
7388102|NCT01217606|11646816|FG000|Initial Treatment Phase|Personal Reasons|0
7264323|NCT00380081|11477557|FG000|Overall Study|Withdrawal by Subject|0
7264324|NCT00380081|11477558|FG001|Overall Study|Withdrawal by Subject|0
7264325|NCT00380081|11477559|FG002|Overall Study|Withdrawal by Subject|0
7264326|NCT00380081|11477560|FG003|Overall Study|Withdrawal by Subject|0
7264327|NCT00380081|11477561|FG004|Overall Study|Withdrawal by Subject|1
7264328|NCT00380081|11477562|FG005|Overall Study|Withdrawal by Subject|0
7264329|NCT00380081|11477557|FG000|Overall Study|Family Emergency|0
7264330|NCT00380081|11477558|FG001|Overall Study|Family Emergency|0
7264331|NCT00380081|11477559|FG002|Overall Study|Family Emergency|0
7264332|NCT00380081|11477560|FG003|Overall Study|Family Emergency|0
7264333|NCT00380081|11477561|FG004|Overall Study|Family Emergency|0
7264334|NCT00380081|11477562|FG005|Overall Study|Family Emergency|1
7264335|NCT00380250|11477572|FG000|Overall Study|Withdrawal by Subject|39
7576990|NCT04113694|11965152|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
7576991|NCT04106817|11965208|FG000|Overall Study|Lost to Follow-up|1
7576992|NCT04106817|11965209|FG001|Overall Study|Lost to Follow-up|0
7576993|NCT04106817|11965210|FG002|Overall Study|Lost to Follow-up|0
7264336|NCT00380250|11477573|FG001|Overall Study|Withdrawal by Subject|28
7264337|NCT00380250|11477572|FG000|Overall Study|Adverse Event|20
7264338|NCT00380250|11477573|FG001|Overall Study|Adverse Event|9
7264339|NCT00380250|11477572|FG000|Overall Study|Lack of Efficacy|10
7264340|NCT00380250|11477573|FG001|Overall Study|Lack of Efficacy|8
7264341|NCT00380250|11477572|FG000|Overall Study|Protocol Violation|15
7264342|NCT00380250|11477573|FG001|Overall Study|Protocol Violation|5
7264343|NCT00380250|11477572|FG000|Overall Study|Lost to Follow-up|14
7264344|NCT00380250|11477573|FG001|Overall Study|Lost to Follow-up|5
7264345|NCT00380250|11477572|FG000|Overall Study|Physician Decision|1
7264346|NCT00380250|11477573|FG001|Overall Study|Physician Decision|0
7264347|NCT00380367|11477579|FG000|Overall Study|Lost to Follow-up|1
7264348|NCT00380367|11477579|FG000|Overall Study|Withdrawal by Subject|1
7264349|NCT00380393|11477585|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
7264350|NCT00380393|11477586|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
7544903|NCT02841709|11899222|FG000|5th Intervention|Adverse Event|2
7544904|NCT02841709|11899223|FG001|5th Intervention|Adverse Event|0
7544905|NCT02841709|11899224|FG002|5th Intervention|Adverse Event|0
7544906|NCT02841709|11899225|FG003|5th Intervention|Adverse Event|0
7544907|NCT02841709|11899226|FG004|5th Intervention|Adverse Event|2
7544908|NCT02841787|11899242|FG000|Overall Study|Lost to Follow-up|1
7544909|NCT02841787|11899243|FG001|Overall Study|Lost to Follow-up|0
7544910|NCT02841787|11899244|FG002|Overall Study|Lost to Follow-up|0
7544911|NCT02841787|11899242|FG000|Overall Study|Symptoms dropped below threshold|1
7544912|NCT02841787|11899243|FG001|Overall Study|Symptoms dropped below threshold|0
7544913|NCT02841787|11899244|FG002|Overall Study|Symptoms dropped below threshold|0
7544914|NCT02841787|11899242|FG000|Overall Study|Withdrawal by Subject|1
7544915|NCT02841787|11899243|FG001|Overall Study|Withdrawal by Subject|4
7544916|NCT02841787|11899244|FG002|Overall Study|Withdrawal by Subject|0
7544917|NCT02842073|11899261|FG000|Overall Study|Withdrawal by Subject|1
7544938|NCT02842151|11899274|FG000|Overall Study|Adverse Event|1
7544939|NCT02842151|11899274|FG000|Overall Study|Subject moved too far away|1
7544940|NCT02842736|11899289|FG000|Overall Study|Lost to Follow-up|13
7544941|NCT02842736|11899289|FG000|Overall Study|Intervention for menstrual bleeding|17
7544942|NCT02842736|11899289|FG000|Overall Study|Withdrawal by Subject|4
7544943|NCT02842736|11899289|FG000|Overall Study|Pregnancy|3
7544944|NCT02842736|11899289|FG000|Overall Study|Hysterectomy for fibroids|2
7544945|NCT02842736|11899289|FG000|Overall Study|Hysterectomy for uterine prolapse|1
7544946|NCT02842736|11899289|FG000|Overall Study|IUD: Mirena|1
7544947|NCT02843178|11899297|FG000|Overall Study|Lost to Follow-up|8
7544948|NCT02843178|11899298|FG001|Overall Study|Lost to Follow-up|8
7544949|NCT02843178|11899299|FG002|Overall Study|Lost to Follow-up|6
7264351|NCT00380393|11477585|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
7264352|NCT00380393|11477586|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
7264353|NCT00380393|11477585|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
7264354|NCT00380393|11477586|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
7264355|NCT00380393|11477585|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7264356|NCT00380393|11477586|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
7264357|NCT00380393|11477585|FG000|Month 8 (Cross-sectional Visit)|Others|5
7264358|NCT00380393|11477586|FG001|Month 8 (Cross-sectional Visit)|Others|4
7264359|NCT00380393|11477585|FG000|Month 14|Withdrawal by Subject|9
7264360|NCT00380393|11477586|FG001|Month 14|Withdrawal by Subject|7
7264361|NCT00380393|11477585|FG000|Month 14|Death|1
7264362|NCT00380393|11477586|FG001|Month 14|Death|0
7264363|NCT00380393|11477585|FG000|Month 14|Lost to Follow-up|0
7264364|NCT00380393|11477586|FG001|Month 14|Lost to Follow-up|1
7264365|NCT00380393|11477585|FG000|Month 14|Migrated/moved from study area|39
7264366|NCT00380393|11477586|FG001|Month 14|Migrated/moved from study area|42
7264367|NCT00380393|11477585|FG000|Month 14|Protocol Violation|2
7264368|NCT00380393|11477586|FG001|Month 14|Protocol Violation|0
7264369|NCT00380393|11477585|FG000|Month 14|Others|6
7264370|NCT00380393|11477586|FG001|Month 14|Others|6
7264371|NCT00380588|11477594|FG000|Overall Study|Unequivocal Disease Progression|25
7264372|NCT00380588|11477595|FG001|Overall Study|Unequivocal Disease Progression|34
7264373|NCT00380588|11477594|FG000|Overall Study|Next Cycle Not Started|4
7264374|NCT00380588|11477595|FG001|Overall Study|Next Cycle Not Started|0
7264375|NCT00380588|11477594|FG000|Overall Study|Adverse Event|7
7264376|NCT00380588|11477595|FG001|Overall Study|Adverse Event|3
7264377|NCT00380588|11477594|FG000|Overall Study|Withdrawal by Subject|1
7264378|NCT00380588|11477595|FG001|Overall Study|Withdrawal by Subject|3
7264379|NCT00380588|11477594|FG000|Overall Study|Physician Decision|2
7264380|NCT00380588|11477595|FG001|Overall Study|Physician Decision|0
7264381|NCT00380692|11477603|FG000|Study Period II - Double Blind|Adverse Event|1
7264382|NCT00380692|11477604|FG001|Study Period II - Double Blind|Adverse Event|0
7264383|NCT00380692|11477603|FG000|Study Period II - Double Blind|Protocol Violation|2
7264384|NCT00380692|11477604|FG001|Study Period II - Double Blind|Protocol Violation|2
7264385|NCT00380692|11477603|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
7264386|NCT00380692|11477604|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
7264387|NCT00380692|11477603|FG000|Study Period II - Double Blind|Physician Decision|0
7264388|NCT00380692|11477604|FG001|Study Period II - Double Blind|Physician Decision|1
7264389|NCT00380692|11477603|FG000|Study Period II - Double Blind|Lack of Efficacy|1
7264390|NCT00380692|11477604|FG001|Study Period II - Double Blind|Lack of Efficacy|0
7264391|NCT00380692|11477603|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
7264392|NCT00380692|11477604|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
7264393|NCT00380692|11477603|FG000|Study Period III - Open Label|Adverse Event|5
7264394|NCT00380692|11477604|FG001|Study Period III - Open Label|Adverse Event|3
7264395|NCT00380692|11477603|FG000|Study Period III - Open Label|Protocol Violation|0
7264396|NCT00380692|11477604|FG001|Study Period III - Open Label|Protocol Violation|0
7264397|NCT00380692|11477603|FG000|Study Period III - Open Label|Withdrawal by Subject|0
7264398|NCT00380692|11477604|FG001|Study Period III - Open Label|Withdrawal by Subject|1
7264399|NCT00380692|11477603|FG000|Study Period III - Open Label|Physician Decision|0
7264400|NCT00380692|11477604|FG001|Study Period III - Open Label|Physician Decision|3
7264401|NCT00380692|11477603|FG000|Study Period III - Open Label|Lack of Efficacy|0
7264402|NCT00380692|11477604|FG001|Study Period III - Open Label|Lack of Efficacy|4
7264403|NCT00380692|11477603|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
7264404|NCT00380692|11477604|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
7264405|NCT00380718|11477610|FG000|Overall Study|Adverse Event|1
7264406|NCT00380718|11477610|FG000|Overall Study|Death after 30-day post-therapy followup|17
7264407|NCT00380744|11477621|FG000|Overall Study|Death|0
7264408|NCT00380744|11477622|FG001|Overall Study|Death|0
7264409|NCT00380744|11477623|FG002|Overall Study|Death|0
7264410|NCT00380744|11477624|FG003|Overall Study|Death|0
7264411|NCT00380744|11477625|FG004|Overall Study|Death|0
7544950|NCT02843178|11899300|FG003|Overall Study|Lost to Follow-up|3
7544951|NCT02843178|11899297|FG000|Overall Study|Withdrawal by Subject|0
7544952|NCT02843178|11899298|FG001|Overall Study|Withdrawal by Subject|0
7544953|NCT02843178|11899299|FG002|Overall Study|Withdrawal by Subject|1
7544954|NCT02843178|11899300|FG003|Overall Study|Withdrawal by Subject|1
7544955|NCT02843659|11899322|FG000|Overall Study|Subject Withdrew Consent|0
7544956|NCT02843659|11899323|FG001|Overall Study|Subject Withdrew Consent|0
7544957|NCT02843659|11899324|FG002|Overall Study|Subject Withdrew Consent|1
7544958|NCT02843659|11899322|FG000|Overall Study|Administrative Reason by Sponsor|4
7544959|NCT02843659|11899323|FG001|Overall Study|Administrative Reason by Sponsor|5
7544960|NCT02843659|11899324|FG002|Overall Study|Administrative Reason by Sponsor|4
7544961|NCT02843659|11899322|FG000|Overall Study|Adverse Event|0
7544962|NCT02843659|11899323|FG001|Overall Study|Adverse Event|1
7544963|NCT02843659|11899324|FG002|Overall Study|Adverse Event|0
7544964|NCT02844439|11899332|FG000|Overall Study|Withdrawal by Subject|1
7544965|NCT02844439|11899332|FG000|Overall Study|Lost to Follow-up|2
7544966|NCT02844439|11899332|FG000|Overall Study|Termination by Sponsor|4
7264412|NCT00380744|11477626|FG005|Overall Study|Death|0
7264413|NCT00380744|11477627|FG006|Overall Study|Death|1
7264414|NCT00380744|11477621|FG000|Overall Study|Withdrawal by Subject|1
7264415|NCT00380744|11477622|FG001|Overall Study|Withdrawal by Subject|0
7264416|NCT00380744|11477623|FG002|Overall Study|Withdrawal by Subject|0
7264417|NCT00380744|11477624|FG003|Overall Study|Withdrawal by Subject|0
7544967|NCT02844439|11899332|FG000|Overall Study|Death|28
7544968|NCT02844439|11899332|FG000|Overall Study|Other|5
7544969|NCT02844543|11899343|FG000|Overall Study|Withdrawal by Subject|4
7544970|NCT02844543|11899343|FG000|Overall Study|Did not meet eligibility criteria|1
7544971|NCT02844920|11899360|FG000|Overall Study|Lost to Follow-up|2
7544972|NCT02845336|11899379|FG000|Overall Study|Lost to Follow-up|3
7544973|NCT02845336|11899380|FG001|Overall Study|Lost to Follow-up|1
7544974|NCT02845336|11899379|FG000|Overall Study|Inability to get medication|2
7544975|NCT02845336|11899380|FG001|Overall Study|Inability to get medication|0
7544976|NCT02845375|11899389|FG000|Overall Study|upper airway obstruction|1
7544977|NCT02845375|11899390|FG001|Overall Study|upper airway obstruction|2
7544978|NCT02845375|11899391|FG002|Overall Study|upper airway obstruction|1
7544979|NCT02846324|11899439|FG000|Overall Study|Other|1
7544980|NCT02846324|11899440|FG001|Overall Study|Other|0
7544981|NCT02846324|11899441|FG002|Overall Study|Other|0
7544982|NCT02846324|11899442|FG003|Overall Study|Other|0
7544983|NCT02846324|11899439|FG000|Overall Study|Withdrawal by Subject|1
7544984|NCT02846324|11899440|FG001|Overall Study|Withdrawal by Subject|0
7544985|NCT02846324|11899441|FG002|Overall Study|Withdrawal by Subject|4
7544986|NCT02846324|11899442|FG003|Overall Study|Withdrawal by Subject|0
7544987|NCT02846415|11899463|FG000|Overall Study|Lost to Follow-up|2
7544988|NCT02846415|11899464|FG001|Overall Study|Lost to Follow-up|0
7544989|NCT02846415|11899463|FG000|Overall Study|Withdrawal by Subject|1
7544990|NCT02846415|11899464|FG001|Overall Study|Withdrawal by Subject|1
7544991|NCT02846558|11899474|FG000|Overall Study|Adverse Event|1
7544992|NCT02846558|11899475|FG001|Overall Study|Adverse Event|0
7544993|NCT02846558|11899476|FG002|Overall Study|Adverse Event|0
7544994|NCT02846558|11899477|FG003|Overall Study|Adverse Event|0
7544995|NCT02846558|11899474|FG000|Overall Study|Withdrawal by Subject|5
7544996|NCT02846558|11899475|FG001|Overall Study|Withdrawal by Subject|4
7544997|NCT02846558|11899476|FG002|Overall Study|Withdrawal by Subject|2
7544998|NCT02846558|11899477|FG003|Overall Study|Withdrawal by Subject|2
7544999|NCT02846558|11899474|FG000|Overall Study|Lost to Follow-up|2
7545000|NCT02846558|11899475|FG001|Overall Study|Lost to Follow-up|0
7545001|NCT02846558|11899476|FG002|Overall Study|Lost to Follow-up|0
7264418|NCT00380744|11477625|FG004|Overall Study|Withdrawal by Subject|0
7264419|NCT00380744|11477626|FG005|Overall Study|Withdrawal by Subject|0
7545002|NCT02846558|11899477|FG003|Overall Study|Lost to Follow-up|0
7545003|NCT02846779|11899510|FG000|Overall Study|Lost Enrollment|83
7545004|NCT02846779|11899511|FG001|Overall Study|Lost Enrollment|82
7545005|NCT02846779|11899512|FG002|Overall Study|Lost Enrollment|86
7545006|NCT02846779|11899510|FG000|Overall Study|Less than 31 days of follow-up|56
7264420|NCT00380744|11477627|FG006|Overall Study|Withdrawal by Subject|0
7264421|NCT00380874|11477655|FG000|Overall Study|Adverse Event|7
7264422|NCT00380874|11477656|FG001|Overall Study|Adverse Event|7
7264423|NCT00380874|11477655|FG000|Overall Study|Death|1
7264424|NCT00380874|11477656|FG001|Overall Study|Death|0
7264425|NCT00380874|11477655|FG000|Overall Study|Withdrawal by Subject|2
7264426|NCT00380874|11477656|FG001|Overall Study|Withdrawal by Subject|1
7264427|NCT00380874|11477655|FG000|Overall Study|Not related to study drug|3
7264428|NCT00380874|11477656|FG001|Overall Study|Not related to study drug|2
7264429|NCT00380978|11477664|FG000|Overall Study|Refused allocated intervention|0
7264430|NCT00380978|11477665|FG001|Overall Study|Refused allocated intervention|6
7264431|NCT00380978|11477664|FG000|Overall Study|Wrong study envelope|0
7264432|NCT00380978|11477665|FG001|Overall Study|Wrong study envelope|2
7264433|NCT00380978|11477664|FG000|Overall Study|Allocation prior to analgesia request|1
7264434|NCT00380978|11477665|FG001|Overall Study|Allocation prior to analgesia request|2
7264435|NCT00380978|11477664|FG000|Overall Study|Parous patient|1
7264436|NCT00380978|11477665|FG001|Overall Study|Parous patient|0
7264437|NCT00381043|11477677|FG000|Overall Study|Lost to Follow-up|8
7264438|NCT00381043|11477678|FG001|Overall Study|Lost to Follow-up|6
7264439|NCT00381043|11477677|FG000|Overall Study|Withdrawal by Subject|3
7264440|NCT00381043|11477678|FG001|Overall Study|Withdrawal by Subject|1
7264441|NCT00381043|11477677|FG000|Overall Study|wanted more care|0
7264442|NCT00381043|11477678|FG001|Overall Study|wanted more care|1
7264443|NCT00381043|11477677|FG000|Overall Study|incarcerated|1
7264444|NCT00381043|11477678|FG001|Overall Study|incarcerated|0
7264445|NCT00381095|11477686|FG000|Overall Study|Death|3
7264446|NCT00381095|11477687|FG001|Overall Study|Death|4
7264447|NCT00381095|11477686|FG000|Overall Study|Lack of Efficacy|2
7264448|NCT00381095|11477687|FG001|Overall Study|Lack of Efficacy|4
7264449|NCT00381095|11477686|FG000|Overall Study|Other|2
7264450|NCT00381095|11477687|FG001|Overall Study|Other|2
7264451|NCT00381095|11477686|FG000|Overall Study|Protocol Violation|1
7264452|NCT00381095|11477687|FG001|Overall Study|Protocol Violation|1
7264453|NCT00381095|11477686|FG000|Overall Study|Withdrawal by Subject|3
7264454|NCT00381095|11477687|FG001|Overall Study|Withdrawal by Subject|3
7264455|NCT00381095|11477686|FG000|Overall Study|Adverse Event|2
7264456|NCT00381095|11477687|FG001|Overall Study|Adverse Event|7
7264457|NCT00381238|11477693|FG000|Overall Study|Adverse Event|3
7264458|NCT00381238|11477693|FG000|Overall Study|Protocol Violation|1
7264459|NCT00381238|11477693|FG000|Overall Study|Withdrawal by Subject|4
7264460|NCT00381238|11477693|FG000|Overall Study|Lack of Efficacy|2
7264461|NCT00381238|11477693|FG000|Overall Study|Withdrew by physician|1
7264462|NCT00381238|11477693|FG000|Overall Study|Disease progression|1
7264463|NCT00381303|11477699|FG000|Overall Study|Lost to Follow-up|25
7264464|NCT00381303|11477700|FG001|Overall Study|Lost to Follow-up|9
7264465|NCT00381303|11477699|FG000|Overall Study|AE/HIV-related event|22
7264466|NCT00381303|11477700|FG001|Overall Study|AE/HIV-related event|6
7264467|NCT00381303|11477699|FG000|Overall Study|Non-Adherence|13
7264468|NCT00381303|11477700|FG001|Overall Study|Non-Adherence|6
7264469|NCT00381303|11477699|FG000|Overall Study|Withdrawal by Subject|13
7264470|NCT00381303|11477700|FG001|Overall Study|Withdrawal by Subject|6
7264471|NCT00381303|11477699|FG000|Overall Study|Virologic failure|6
7264472|NCT00381303|11477700|FG001|Overall Study|Virologic failure|4
7264473|NCT00381303|11477699|FG000|Overall Study|Ineligible to continue the trial|2
7264474|NCT00381303|11477700|FG001|Overall Study|Ineligible to continue the trial|1
7264475|NCT00381303|11477699|FG000|Overall Study|Pregnancy|2
7264476|NCT00381303|11477700|FG001|Overall Study|Pregnancy|0
7264477|NCT00381303|11477699|FG000|Overall Study|Physician Decision|1
7264478|NCT00381303|11477700|FG001|Overall Study|Physician Decision|0
7264479|NCT00381303|11477699|FG000|Overall Study|Physician's decision to close the site|3
7264480|NCT00381303|11477700|FG001|Overall Study|Physician's decision to close the site|1
7264481|NCT00381303|11477699|FG000|Overall Study|Subject moved out of state|2
7264482|NCT00381303|11477700|FG001|Overall Study|Subject moved out of state|0
7264483|NCT00381303|11477699|FG000|Overall Study|Subject taking too many different meds|1
7264484|NCT00381303|11477700|FG001|Overall Study|Subject taking too many different meds|0
7264485|NCT00381303|11477699|FG000|Overall Study|No virologic response by week 12|1
7264486|NCT00381303|11477700|FG001|Overall Study|No virologic response by week 12|0
7264487|NCT00381303|11477699|FG000|Overall Study|Subject was too busy for appointments|1
7264488|NCT00381303|11477700|FG001|Overall Study|Subject was too busy for appointments|0
7264489|NCT00381303|11477699|FG000|Overall Study|Subject did not continue visits|1
7264490|NCT00381303|11477700|FG001|Overall Study|Subject did not continue visits|0
7264491|NCT00381303|11477699|FG000|Overall Study|Subject primary physician's decision|1
7264492|NCT00381303|11477700|FG001|Overall Study|Subject primary physician's decision|0
7264493|NCT00381563|11477724|FG000|Overall Study|Withdrawal by Subject|5
7264494|NCT00381563|11477725|FG001|Overall Study|Withdrawal by Subject|5
7264495|NCT00381563|11477724|FG000|Overall Study|Lost to Follow-up|2
7264496|NCT00381563|11477725|FG001|Overall Study|Lost to Follow-up|0
7264497|NCT00381563|11477724|FG000|Overall Study|Protocol Violation|0
7264498|NCT00381563|11477725|FG001|Overall Study|Protocol Violation|1
7264499|NCT00381615|11477734|FG000|Overall Study|Withdrawal by Subject|1
7264500|NCT00381615|11477735|FG001|Overall Study|Withdrawal by Subject|3
7264501|NCT00381615|11477736|FG002|Overall Study|Withdrawal by Subject|0
7264502|NCT00381615|11477737|FG003|Overall Study|Withdrawal by Subject|1
7264503|NCT00381615|11477734|FG000|Overall Study|Lost to Follow-up|3
7264504|NCT00381615|11477735|FG001|Overall Study|Lost to Follow-up|2
7264505|NCT00381615|11477736|FG002|Overall Study|Lost to Follow-up|0
7264506|NCT00381615|11477737|FG003|Overall Study|Lost to Follow-up|1
7264507|NCT00381615|11477734|FG000|Overall Study|Protocol Violation|0
7264508|NCT00381615|11477735|FG001|Overall Study|Protocol Violation|0
7264509|NCT00381615|11477736|FG002|Overall Study|Protocol Violation|1
7264510|NCT00381615|11477737|FG003|Overall Study|Protocol Violation|0
7264511|NCT00381680|11477768|FG000|Overall Study|Adverse Event|9
7264512|NCT00381680|11477769|FG001|Overall Study|Adverse Event|3
7264513|NCT00381680|11477768|FG000|Overall Study|Death|10
7264514|NCT00381680|11477769|FG001|Overall Study|Death|7
7264515|NCT00381680|11477768|FG000|Overall Study|Lost to Follow-up|3
7264516|NCT00381680|11477769|FG001|Overall Study|Lost to Follow-up|2
7264517|NCT00381680|11477768|FG000|Overall Study|Physician Decision|25
7264518|NCT00381680|11477769|FG001|Overall Study|Physician Decision|6
7264519|NCT00381680|11477768|FG000|Overall Study|Withdrawal by Subject|3
7264520|NCT00381680|11477769|FG001|Overall Study|Withdrawal by Subject|1
7264521|NCT00381680|11477768|FG000|Overall Study|Entry onto another COG Trial|1
7264522|NCT00381680|11477769|FG001|Overall Study|Entry onto another COG Trial|2
7264523|NCT00381680|11477768|FG000|Overall Study|Alternative Therapy|11
7264524|NCT00381680|11477769|FG001|Overall Study|Alternative Therapy|5
7264525|NCT00381680|11477768|FG000|Overall Study|Secondary Malignancy|3
7264526|NCT00381680|11477769|FG001|Overall Study|Secondary Malignancy|0
7264527|NCT00381680|11477768|FG000|Overall Study|Delay initiation|1
7264528|NCT00381680|11477769|FG001|Overall Study|Delay initiation|0
7264529|NCT00381680|11477768|FG000|Overall Study|Stem Cell Transplant|26
7264530|NCT00381680|11477769|FG001|Overall Study|Stem Cell Transplant|10
7264531|NCT00381680|11477768|FG000|Overall Study|Relapse|18
7264532|NCT00381680|11477769|FG001|Overall Study|Relapse|9
7264533|NCT00381680|11477768|FG000|Overall Study|Induction Failure|4
7545007|NCT02846779|11899511|FG001|Overall Study|Less than 31 days of follow-up|45
7545008|NCT02846779|11899512|FG002|Overall Study|Less than 31 days of follow-up|52
7545009|NCT02847182|11899548|FG000|Overall Study|Withdrawal by Subject|0
7264534|NCT00381680|11477769|FG001|Overall Study|Induction Failure|1
7264535|NCT00381680|11477768|FG000|Overall Study|Progression|1
7264536|NCT00381680|11477769|FG001|Overall Study|Progression|1
7264537|NCT00381680|11477768|FG000|Overall Study|Other not otherwise specified|7
7264538|NCT00381680|11477769|FG001|Overall Study|Other not otherwise specified|2
7545010|NCT02847182|11899549|FG001|Overall Study|Withdrawal by Subject|1
7264539|NCT00381680|11477768|FG000|Overall Study|Ineligible|3
7264540|NCT00381680|11477769|FG001|Overall Study|Ineligible|1
7264541|NCT00381693|11477779|FG000|Overall Study|Death|1
7264542|NCT00381693|11477779|FG000|Overall Study|Adverse Event|4
7264543|NCT00381693|11477779|FG000|Overall Study|Patient Choice|1
7264544|NCT00381693|11477779|FG000|Overall Study|Progression|2
7264545|NCT00381706|11477789|FG000|Overall Study|Never treated|7
7264546|NCT00381706|11477790|FG001|Overall Study|Never treated|2
7264547|NCT00381706|11477791|FG002|Overall Study|Never treated|1
7264548|NCT00381797|11477810|FG000|Overall Study|Withdrawal by Subject|1
7264549|NCT00381797|11477811|FG001|Overall Study|Withdrawal by Subject|1
7264550|NCT00381797|11477812|FG002|Overall Study|Withdrawal by Subject|0
7576994|NCT04105972|11965220|FG000|Overall Study|Adverse Event|2
7264551|NCT00381797|11477813|FG003|Overall Study|Withdrawal by Subject|0
7264552|NCT00381797|11477814|FG004|Overall Study|Withdrawal by Subject|2
7264553|NCT00381797|11477810|FG000|Overall Study|Ineligible|0
7264554|NCT00381797|11477811|FG001|Overall Study|Ineligible|0
7264555|NCT00381797|11477812|FG002|Overall Study|Ineligible|0
7264556|NCT00381797|11477813|FG003|Overall Study|Ineligible|1
7264557|NCT00381797|11477814|FG004|Overall Study|Ineligible|0
7264558|NCT00381849|11477853|FG000|Wash Out|Withdrawal by Subject|0
7264559|NCT00381849|11477854|FG001|Wash Out|Withdrawal by Subject|1
7264560|NCT00381888|11477864|FG000|Overall Study|Death|1
7264561|NCT00381888|11477864|FG000|Overall Study|Withdrawal by Subject|1
7264562|NCT00381888|11477864|FG000|Overall Study|Physician Decision|1
7264563|NCT00381888|11477864|FG000|Overall Study|Protocol Violation|9
7264564|NCT00381888|11477864|FG000|Overall Study|Had laparoscopic surgery|2
7264565|NCT00381888|11477864|FG000|Overall Study|Surgery was cancelled|2
7264566|NCT00381888|11477864|FG000|Overall Study|Adverse Event|1
7264567|NCT00381940|11477868|FG000|Overall Study|Lack of Efficacy|3
7264568|NCT00381940|11477868|FG000|Overall Study|Protocol Violation|1
7264569|NCT00381940|11477868|FG000|Overall Study|Ineligible|1
7264570|NCT00382018|11477880|FG000|Overall Study|Progression|0
7264571|NCT00382018|11477881|FG001|Overall Study|Progression|136
7264572|NCT00382018|11477882|FG002|Overall Study|Progression|51
7264573|NCT00382018|11477883|FG003|Overall Study|Progression|43
7264574|NCT00382018|11477880|FG000|Overall Study|Death|0
7264575|NCT00382018|11477881|FG001|Overall Study|Death|9
7264576|NCT00382018|11477882|FG002|Overall Study|Death|7
7264577|NCT00382018|11477883|FG003|Overall Study|Death|11
7264578|NCT00382018|11477880|FG000|Overall Study|Withdrawal by Subject|0
7264579|NCT00382018|11477881|FG001|Overall Study|Withdrawal by Subject|4
7264580|NCT00382018|11477882|FG002|Overall Study|Withdrawal by Subject|3
7264581|NCT00382018|11477883|FG003|Overall Study|Withdrawal by Subject|4
7264582|NCT00382018|11477880|FG000|Overall Study|Other, not protocol specified|0
7264583|NCT00382018|11477881|FG001|Overall Study|Other, not protocol specified|16
7264584|NCT00382018|11477882|FG002|Overall Study|Other, not protocol specified|3
7264585|NCT00382018|11477883|FG003|Overall Study|Other, not protocol specified|1
7264586|NCT00382070|11477907|FG000|Overall Study|No follow up data mapped to Other|17
7264587|NCT00382070|11477908|FG001|Overall Study|No follow up data mapped to Other|19
7264588|NCT00382070|11477907|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
7264589|NCT00382070|11477908|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
7264590|NCT00382070|11477907|FG000|Overall Study|No clinical assessment|9
7264591|NCT00382070|11477908|FG001|Overall Study|No clinical assessment|11
7264592|NCT00382109|11477916|FG000|Overall Study|Adverse Event|3
7264593|NCT00382109|11477917|FG001|Overall Study|Adverse Event|0
7264594|NCT00382109|11477916|FG000|Overall Study|Physician Decision|6
7264595|NCT00382109|11477917|FG001|Overall Study|Physician Decision|1
7264596|NCT00382109|11477916|FG000|Overall Study|Withdrawal by Subject|1
7264597|NCT00382109|11477917|FG001|Overall Study|Withdrawal by Subject|0
7264598|NCT00382109|11477916|FG000|Overall Study|ineligible|2
7264599|NCT00382109|11477917|FG001|Overall Study|ineligible|0
7264600|NCT00382109|11477916|FG000|Overall Study|Other|0
7264601|NCT00382109|11477917|FG001|Overall Study|Other|2
7264602|NCT00382109|11477916|FG000|Overall Study|consent withdrawal|0
7264603|NCT00382109|11477917|FG001|Overall Study|consent withdrawal|1
7264604|NCT00382174|11477937|FG000|Overall Study|Lost to Follow-up|1
7264605|NCT00382174|11477938|FG001|Overall Study|Lost to Follow-up|4
7264606|NCT00382174|11477939|FG002|Overall Study|Lost to Follow-up|5
7264607|NCT00382174|11477937|FG000|Overall Study|Adverse Event|1
7264608|NCT00382174|11477938|FG001|Overall Study|Adverse Event|4
7264609|NCT00382174|11477939|FG002|Overall Study|Adverse Event|5
7264610|NCT00382174|11477937|FG000|Overall Study|Withdrawal by Subject|1
7576995|NCT04105972|11965221|FG001|Overall Study|Adverse Event|1
7576996|NCT04105218|11965229|FG000|Overall Study|Withdrawal by Subject|3
7576997|NCT04105218|11965230|FG001|Overall Study|Withdrawal by Subject|2
7576998|NCT04105218|11965229|FG000|Overall Study|Study was terminated; unable to complete study visits|1
7576999|NCT04105218|11965230|FG001|Overall Study|Study was terminated; unable to complete study visits|3
7577000|NCT04105218|11965229|FG000|Overall Study|Failed screening tests|2
7577001|NCT04105218|11965230|FG001|Overall Study|Failed screening tests|1
7577002|NCT04102540|11965245|FG000|Overall Study|Withdrawn by PI|2
7264611|NCT00382174|11477938|FG001|Overall Study|Withdrawal by Subject|4
7264612|NCT00382174|11477939|FG002|Overall Study|Withdrawal by Subject|5
7264613|NCT00382174|11477937|FG000|Overall Study|Non compliance|1
7264614|NCT00382174|11477938|FG001|Overall Study|Non compliance|0
7264615|NCT00382174|11477939|FG002|Overall Study|Non compliance|1
7264616|NCT00382174|11477937|FG000|Overall Study|Physician Decision|0
7264617|NCT00382174|11477938|FG001|Overall Study|Physician Decision|2
7577003|NCT04102540|11965245|FG000|Overall Study|Lost to Follow-up|6
7264618|NCT00382174|11477939|FG002|Overall Study|Physician Decision|2
7264619|NCT00382174|11477937|FG000|Overall Study|Failed to meet criteria|0
7264620|NCT00382174|11477938|FG001|Overall Study|Failed to meet criteria|1
7264621|NCT00382174|11477939|FG002|Overall Study|Failed to meet criteria|1
7264622|NCT00382174|11477937|FG000|Overall Study|Wounds merged|0
7264623|NCT00382174|11477938|FG001|Overall Study|Wounds merged|2
7264624|NCT00382174|11477939|FG002|Overall Study|Wounds merged|2
7264625|NCT00382291|11477963|FG000|Overall Study|Adverse Event|1
7264626|NCT00382291|11477964|FG001|Overall Study|Adverse Event|2
7264627|NCT00382291|11477965|FG002|Overall Study|Adverse Event|2
7264628|NCT00382291|11477963|FG000|Overall Study|Protocol Violation|1
7264629|NCT00382291|11477964|FG001|Overall Study|Protocol Violation|0
7264630|NCT00382291|11477965|FG002|Overall Study|Protocol Violation|0
7264631|NCT00382291|11477963|FG000|Overall Study|Temporary study suspension|2
7264632|NCT00382291|11477964|FG001|Overall Study|Temporary study suspension|2
7264633|NCT00382291|11477965|FG002|Overall Study|Temporary study suspension|5
7264634|NCT00382291|11477963|FG000|Overall Study|Withdrawal by Subject|0
7264635|NCT00382291|11477964|FG001|Overall Study|Withdrawal by Subject|2
7264636|NCT00382291|11477965|FG002|Overall Study|Withdrawal by Subject|0
7264637|NCT00382291|11477963|FG000|Overall Study|Physician Decision|0
7264638|NCT00382291|11477964|FG001|Overall Study|Physician Decision|1
7264639|NCT00382291|11477965|FG002|Overall Study|Physician Decision|0
7264640|NCT00382291|11477963|FG000|Overall Study|Lack of Efficacy|0
7264641|NCT00382291|11477964|FG001|Overall Study|Lack of Efficacy|0
7264642|NCT00382291|11477965|FG002|Overall Study|Lack of Efficacy|1
7264643|NCT00382408|11477977|FG000|Overall Study|Did not meet protocol requirement|3
7264644|NCT00382408|11477978|FG001|Overall Study|Did not meet protocol requirement|3
7264645|NCT00382408|11477977|FG000|Overall Study|Protocol Violation|2
7264646|NCT00382408|11477978|FG001|Overall Study|Protocol Violation|2
7264647|NCT00382408|11477977|FG000|Overall Study|Physician Decision|1
7264648|NCT00382408|11477978|FG001|Overall Study|Physician Decision|0
7264649|NCT00382408|11477977|FG000|Overall Study|Withdrawal by Subject|17
7264650|NCT00382408|11477978|FG001|Overall Study|Withdrawal by Subject|6
7264651|NCT00382408|11477977|FG000|Overall Study|Pregnancy|2
7264652|NCT00382408|11477978|FG001|Overall Study|Pregnancy|0
7264653|NCT00382408|11477977|FG000|Overall Study|Lost to Follow-up|19
7264654|NCT00382408|11477978|FG001|Overall Study|Lost to Follow-up|8
7264655|NCT00382408|11477977|FG000|Overall Study|Other|100
7264656|NCT00382408|11477978|FG001|Overall Study|Other|35
7264657|NCT00382720|11477996|FG000|Overall Study|Adverse Event|21
7264658|NCT00382720|11477997|FG001|Overall Study|Adverse Event|23
7264659|NCT00382720|11477998|FG002|Overall Study|Adverse Event|15
7264660|NCT00382720|11477996|FG000|Overall Study|Protocol Violation|2
7264661|NCT00382720|11477997|FG001|Overall Study|Protocol Violation|5
7264662|NCT00382720|11477998|FG002|Overall Study|Protocol Violation|1
7264663|NCT00382720|11477996|FG000|Overall Study|Death|0
7264664|NCT00382720|11477997|FG001|Overall Study|Death|1
7264665|NCT00382720|11477998|FG002|Overall Study|Death|2
7264666|NCT00382720|11477996|FG000|Overall Study|Progressive disease|37
7264667|NCT00382720|11477997|FG001|Overall Study|Progressive disease|28
7264668|NCT00382720|11477998|FG002|Overall Study|Progressive disease|38
7264669|NCT00382720|11477996|FG000|Overall Study|Withdrew consent|1
7264670|NCT00382720|11477997|FG001|Overall Study|Withdrew consent|1
7264671|NCT00382720|11477998|FG002|Overall Study|Withdrew consent|2
7264672|NCT00382720|11477996|FG000|Overall Study|Withdrawal by Subject|11
7264673|NCT00382720|11477997|FG001|Overall Study|Withdrawal by Subject|20
7264674|NCT00382720|11477998|FG002|Overall Study|Withdrawal by Subject|12
7264675|NCT00382720|11477996|FG000|Overall Study|Surgery|1
7264676|NCT00382720|11477997|FG001|Overall Study|Surgery|1
7264677|NCT00382720|11477998|FG002|Overall Study|Surgery|4
7264678|NCT00382720|11477996|FG000|Overall Study|Patient did not receive study medication|1
7264679|NCT00382720|11477997|FG001|Overall Study|Patient did not receive study medication|1
7264680|NCT00382720|11477998|FG002|Overall Study|Patient did not receive study medication|4
7264681|NCT00382720|11477996|FG000|Overall Study|Clinically progressive disease|0
7264682|NCT00382720|11477997|FG001|Overall Study|Clinically progressive disease|1
7264683|NCT00382720|11477998|FG002|Overall Study|Clinically progressive disease|0
7264684|NCT00382720|11477996|FG000|Overall Study|Good prognosis|0
7264685|NCT00382720|11477997|FG001|Overall Study|Good prognosis|1
7264686|NCT00382720|11477998|FG002|Overall Study|Good prognosis|0
7264687|NCT00382720|11477996|FG000|Overall Study|Investigator/Clinical decision|5
7264688|NCT00382720|11477997|FG001|Overall Study|Investigator/Clinical decision|6
7264689|NCT00382720|11477998|FG002|Overall Study|Investigator/Clinical decision|6
7264690|NCT00382720|11477996|FG000|Overall Study|Discontinued at end of study|0
7264691|NCT00382720|11477997|FG001|Overall Study|Discontinued at end of study|1
7264692|NCT00382720|11477998|FG002|Overall Study|Discontinued at end of study|2
7264693|NCT00382733|11478006|FG000|Overall Study|Withdrawal by Subject|0
7264694|NCT00382733|11478007|FG001|Overall Study|Withdrawal by Subject|1
7264695|NCT00382733|11478008|FG002|Overall Study|Withdrawal by Subject|0
7264696|NCT00382733|11478009|FG003|Overall Study|Withdrawal by Subject|0
7264697|NCT00382733|11478010|FG004|Overall Study|Withdrawal by Subject|0
7264698|NCT00382863|11478043|FG000|Overall Study|Death|9
7264699|NCT00382863|11478044|FG001|Overall Study|Death|9
7264700|NCT00382863|11478043|FG000|Overall Study|Lost to Follow-up|1
7264701|NCT00382863|11478044|FG001|Overall Study|Lost to Follow-up|2
7264702|NCT00382863|11478043|FG000|Overall Study|Withdrawal by Subject|5
7264703|NCT00382863|11478044|FG001|Overall Study|Withdrawal by Subject|25
7264704|NCT00382967|11478066|FG000|Overall Study|Protocol Violation|1
7264705|NCT00382967|11478067|FG001|Overall Study|Protocol Violation|1
7264706|NCT00382993|11478073|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7264707|NCT00382993|11478074|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
7264708|NCT00382993|11478073|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
7264709|NCT00382993|11478074|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
7264710|NCT00382993|11478073|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
7264711|NCT00382993|11478074|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
7264712|NCT00382993|11478073|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7264713|NCT00382993|11478074|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
7264714|NCT00382993|11478073|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
7264715|NCT00382993|11478074|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
7264716|NCT00382993|11478073|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7264717|NCT00382993|11478074|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7264718|NCT00382993|11478073|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
7264719|NCT00382993|11478074|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
7264720|NCT00382993|11478073|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
7264721|NCT00382993|11478074|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
7264722|NCT00382993|11478073|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
7264723|NCT00382993|11478074|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
7264724|NCT00382993|11478073|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7264725|NCT00382993|11478074|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
7264726|NCT00383019|11478082|FG000|Overall Study|Adverse Event|5
7264727|NCT00383019|11478083|FG001|Overall Study|Adverse Event|1
7264728|NCT00383019|11478082|FG000|Overall Study|Withdrawal by Subject|0
7264729|NCT00383019|11478083|FG001|Overall Study|Withdrawal by Subject|1
7264730|NCT00383084|11478108|FG000|Overall Study|Withdrawal by Subject|12
7264731|NCT00383084|11478109|FG001|Overall Study|Withdrawal by Subject|10
7264732|NCT00383123|11478127|FG000|Overall Study|Adverse Event|1
7264733|NCT00383123|11478128|FG001|Overall Study|Adverse Event|0
7264734|NCT00383123|11478127|FG000|Overall Study|Lost to Follow-up|68
7264735|NCT00383123|11478128|FG001|Overall Study|Lost to Follow-up|61
7264736|NCT00383123|11478127|FG000|Overall Study|Protocol Violation|5
7264737|NCT00383123|11478128|FG001|Overall Study|Protocol Violation|1
7264738|NCT00383123|11478127|FG000|Overall Study|Withdrawal by Subject|27
7264739|NCT00383123|11478128|FG001|Overall Study|Withdrawal by Subject|18
7264740|NCT00383123|11478127|FG000|Overall Study|Other reason|10
7264741|NCT00383123|11478128|FG001|Overall Study|Other reason|6
7264742|NCT00383149|11478134|FG000|Overall Study|Adverse Event not Related to Study Drug|3
7264743|NCT00383149|11478134|FG000|Overall Study|Death|2
7264744|NCT00383149|11478134|FG000|Overall Study|Disease Progression|38
7264745|NCT00383149|11478134|FG000|Overall Study|Lost to Follow-up|1
7264746|NCT00383149|11478134|FG000|Overall Study|Other|1
7264747|NCT00383149|11478134|FG000|Overall Study|Study Drug Toxicity|4
7264748|NCT00383149|11478134|FG000|Overall Study|Request to Discontinue Treatment|4
7264749|NCT00383149|11478134|FG000|Overall Study|Participant Withdrew Consent|1
7264750|NCT00383162|11478140|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
7264751|NCT00383162|11478141|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
7264752|NCT00383162|11478140|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
7264753|NCT00383162|11478141|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
7264754|NCT00383162|11478140|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
7264755|NCT00383162|11478141|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
7264756|NCT00383162|11478140|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
7264757|NCT00383162|11478141|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
7264758|NCT00383162|11478140|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
7264759|NCT00383162|11478141|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
7264760|NCT00383162|11478140|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
7264761|NCT00383162|11478141|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
7264762|NCT00383162|11478140|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
7264763|NCT00383162|11478141|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
7264764|NCT00383162|11478140|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
7264765|NCT00383162|11478141|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
7264766|NCT00383162|11478140|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
7264767|NCT00383162|11478141|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
7264768|NCT00383188|11478152|FG000|Overall Study|Adverse Event|4
7264769|NCT00383188|11478153|FG001|Overall Study|Adverse Event|7
7264770|NCT00383188|11478154|FG002|Overall Study|Adverse Event|9
7264771|NCT00383188|11478155|FG003|Overall Study|Adverse Event|8
7264772|NCT00383188|11478156|FG004|Overall Study|Adverse Event|8
7264773|NCT00383188|11478152|FG000|Overall Study|Lack of Efficacy|9
7264774|NCT00383188|11478153|FG001|Overall Study|Lack of Efficacy|3
7264775|NCT00383188|11478154|FG002|Overall Study|Lack of Efficacy|3
7264776|NCT00383188|11478155|FG003|Overall Study|Lack of Efficacy|2
7264777|NCT00383188|11478156|FG004|Overall Study|Lack of Efficacy|6
7545011|NCT02847260|11899561|FG000|Overall Study|Adverse Event|3
7545012|NCT02847260|11899561|FG000|Overall Study|Withdrawal by Subject|2
7545013|NCT02847260|11899561|FG000|Overall Study|Clinical Deterioration|1
7545014|NCT02847260|11899561|FG000|Overall Study|Physician Decision|1
7264778|NCT00383188|11478152|FG000|Overall Study|Other|3
7264779|NCT00383188|11478153|FG001|Overall Study|Other|1
7264780|NCT00383188|11478154|FG002|Overall Study|Other|0
7264781|NCT00383188|11478155|FG003|Overall Study|Other|2
7264782|NCT00383188|11478156|FG004|Overall Study|Other|6
7264783|NCT00383188|11478152|FG000|Overall Study|No longer willing to participate|1
7264784|NCT00383188|11478153|FG001|Overall Study|No longer willing to participate|0
7264785|NCT00383188|11478154|FG002|Overall Study|No longer willing to participate|1
7264786|NCT00383188|11478155|FG003|Overall Study|No longer willing to participate|0
7264787|NCT00383188|11478156|FG004|Overall Study|No longer willing to participate|2
7264788|NCT00383188|11478152|FG000|Overall Study|Lost to Follow-up|0
7264789|NCT00383188|11478153|FG001|Overall Study|Lost to Follow-up|0
7264790|NCT00383188|11478154|FG002|Overall Study|Lost to Follow-up|0
7264791|NCT00383188|11478155|FG003|Overall Study|Lost to Follow-up|0
7264792|NCT00383188|11478156|FG004|Overall Study|Lost to Follow-up|1
7264793|NCT00383292|11478177|FG000|Overall Study|Adverse Event|4
7545015|NCT02847494|11899567|FG000|Overall Study|Lost to Follow-up|8
7545016|NCT02847494|11899568|FG001|Overall Study|Lost to Follow-up|5
7545017|NCT02847650|11899576|FG000|Overall Study|Adverse Event|2
7545018|NCT02847650|11899577|FG001|Overall Study|Adverse Event|4
7545019|NCT02847650|11899576|FG000|Overall Study|Lost to Follow-up|1
7545020|NCT02847650|11899577|FG001|Overall Study|Lost to Follow-up|0
7545021|NCT02847650|11899576|FG000|Overall Study|Protocol Violation|0
7545022|NCT02847650|11899577|FG001|Overall Study|Protocol Violation|1
7545023|NCT02847650|11899576|FG000|Overall Study|Withdrawal by Subject|1
7545024|NCT02847650|11899577|FG001|Overall Study|Withdrawal by Subject|1
7545025|NCT02847858|11899585|FG000|Overall Study|Lost to Follow-up|401
7545026|NCT02847858|11899586|FG001|Overall Study|Lost to Follow-up|269
7545027|NCT02848313|11899616|FG000|Overall Study|Adverse Event|1
7545028|NCT02848313|11899617|FG001|Overall Study|Adverse Event|2
7545029|NCT02848313|11899616|FG000|Overall Study|Lack of Efficacy|0
7545030|NCT02848313|11899617|FG001|Overall Study|Lack of Efficacy|1
7545031|NCT02848313|11899616|FG000|Overall Study|Withdrawal by Subject|1
7545032|NCT02848313|11899617|FG001|Overall Study|Withdrawal by Subject|1
7545033|NCT02848313|11899616|FG000|Overall Study|Lost to follow up|1
7545034|NCT02848313|11899617|FG001|Overall Study|Lost to follow up|0
7545035|NCT02848326|11899629|FG000|Treatment Period|Adverse Event|5
7545036|NCT02848326|11899630|FG001|Treatment Period|Adverse Event|4
7545037|NCT02848326|11899631|FG002|Treatment Period|Adverse Event|11
7545038|NCT02848326|11899632|FG003|Treatment Period|Adverse Event|6
7545039|NCT02848326|11899633|FG004|Treatment Period|Adverse Event|5
7545040|NCT02848326|11899634|FG005|Treatment Period|Adverse Event|7
7545041|NCT02848326|11899629|FG000|Treatment Period|Withdrawal of Consent|20
7545042|NCT02848326|11899630|FG001|Treatment Period|Withdrawal of Consent|6
7545043|NCT02848326|11899631|FG002|Treatment Period|Withdrawal of Consent|9
7545044|NCT02848326|11899632|FG003|Treatment Period|Withdrawal of Consent|6
7545045|NCT02848326|11899633|FG004|Treatment Period|Withdrawal of Consent|9
7545046|NCT02848326|11899634|FG005|Treatment Period|Withdrawal of Consent|6
7545047|NCT02848326|11899629|FG000|Treatment Period|Lost to Follow-up|5
7545048|NCT02848326|11899630|FG001|Treatment Period|Lost to Follow-up|1
7545049|NCT02848326|11899631|FG002|Treatment Period|Lost to Follow-up|11
7545050|NCT02848326|11899632|FG003|Treatment Period|Lost to Follow-up|7
7545051|NCT02848326|11899633|FG004|Treatment Period|Lost to Follow-up|2
7545052|NCT02848326|11899634|FG005|Treatment Period|Lost to Follow-up|3
7545053|NCT02848326|11899629|FG000|Treatment Period|Pregnancy|0
7545054|NCT02848326|11899630|FG001|Treatment Period|Pregnancy|0
7545055|NCT02848326|11899631|FG002|Treatment Period|Pregnancy|1
7545056|NCT02848326|11899632|FG003|Treatment Period|Pregnancy|1
7545057|NCT02848326|11899633|FG004|Treatment Period|Pregnancy|0
7545058|NCT02848326|11899634|FG005|Treatment Period|Pregnancy|1
7545059|NCT02848326|11899629|FG000|Treatment Period|Protocol Violation|4
7545060|NCT02848326|11899630|FG001|Treatment Period|Protocol Violation|3
7545061|NCT02848326|11899631|FG002|Treatment Period|Protocol Violation|4
7545062|NCT02848326|11899632|FG003|Treatment Period|Protocol Violation|2
7545063|NCT02848326|11899633|FG004|Treatment Period|Protocol Violation|3
7264794|NCT00383292|11478178|FG001|Overall Study|Adverse Event|1
7264795|NCT00383292|11478179|FG002|Overall Study|Adverse Event|2
7545064|NCT02848326|11899634|FG005|Treatment Period|Protocol Violation|3
7545065|NCT02848326|11899629|FG000|Treatment Period|Non-compliance with Study Drug|4
7545066|NCT02848326|11899630|FG001|Treatment Period|Non-compliance with Study Drug|0
7545067|NCT02848326|11899631|FG002|Treatment Period|Non-compliance with Study Drug|0
7545068|NCT02848326|11899632|FG003|Treatment Period|Non-compliance with Study Drug|1
7545069|NCT02848326|11899633|FG004|Treatment Period|Non-compliance with Study Drug|0
7545070|NCT02848326|11899634|FG005|Treatment Period|Non-compliance with Study Drug|0
7545071|NCT02848326|11899629|FG000|Safety Follow-up Period|Withdrawal of Consent|0
7545072|NCT02848326|11899630|FG001|Safety Follow-up Period|Withdrawal of Consent|1
7545073|NCT02848326|11899631|FG002|Safety Follow-up Period|Withdrawal of Consent|1
7545074|NCT02848326|11899632|FG003|Safety Follow-up Period|Withdrawal of Consent|0
7545075|NCT02848326|11899633|FG004|Safety Follow-up Period|Withdrawal of Consent|0
7545076|NCT02848326|11899634|FG005|Safety Follow-up Period|Withdrawal of Consent|2
7264796|NCT00383292|11478177|FG000|Overall Study|Death|3
7264797|NCT00383292|11478178|FG001|Overall Study|Death|3
7264798|NCT00383292|11478179|FG002|Overall Study|Death|3
7264799|NCT00383292|11478177|FG000|Overall Study|Physician Decision|4
7264800|NCT00383292|11478178|FG001|Overall Study|Physician Decision|0
7264801|NCT00383292|11478179|FG002|Overall Study|Physician Decision|1
7264802|NCT00383292|11478177|FG000|Overall Study|Withdrawal by Subject|3
7264803|NCT00383292|11478178|FG001|Overall Study|Withdrawal by Subject|2
7264804|NCT00383292|11478179|FG002|Overall Study|Withdrawal by Subject|2
7264805|NCT00383292|11478177|FG000|Overall Study|Other|1
7264806|NCT00383292|11478178|FG001|Overall Study|Other|0
7264807|NCT00383292|11478179|FG002|Overall Study|Other|0
7264808|NCT00383331|11478190|FG000|Overall Study|Protocol Violation|0
7264809|NCT00383331|11478191|FG001|Overall Study|Protocol Violation|1
7264810|NCT00383500|11478205|FG000|Overall Study|Withdrawal by Subject|8
7264811|NCT00383500|11478206|FG001|Overall Study|Withdrawal by Subject|3
7264812|NCT00383500|11478207|FG002|Overall Study|Withdrawal by Subject|0
7264813|NCT00383500|11478205|FG000|Overall Study|Lost to Follow-up|0
7264814|NCT00383500|11478206|FG001|Overall Study|Lost to Follow-up|0
7264815|NCT00383500|11478207|FG002|Overall Study|Lost to Follow-up|2
7264816|NCT00383786|11478258|FG000|Overall Study|Protocol Violation|2
7264817|NCT00383786|11478259|FG001|Overall Study|Protocol Violation|6
7264818|NCT00383786|11478258|FG000|Overall Study|Withdrawal by Subject|2
7264819|NCT00383786|11478259|FG001|Overall Study|Withdrawal by Subject|5
7264820|NCT00383786|11478258|FG000|Overall Study|Physician Decision|0
7264821|NCT00383786|11478259|FG001|Overall Study|Physician Decision|1
7264822|NCT00384033|11478278|FG000|Overall Study|Adverse Event|10
7264823|NCT00384033|11478279|FG001|Overall Study|Adverse Event|8
7264824|NCT00384033|11478280|FG002|Overall Study|Adverse Event|11
7264825|NCT00384033|11478281|FG003|Overall Study|Adverse Event|20
7264826|NCT00384033|11478278|FG000|Overall Study|Failed to return|1
7264827|NCT00384033|11478279|FG001|Overall Study|Failed to return|3
7264828|NCT00384033|11478280|FG002|Overall Study|Failed to return|2
7264829|NCT00384033|11478281|FG003|Overall Study|Failed to return|2
7264830|NCT00384033|11478278|FG000|Overall Study|Physician Decision|1
7264831|NCT00384033|11478279|FG001|Overall Study|Physician Decision|0
7264832|NCT00384033|11478280|FG002|Overall Study|Physician Decision|0
7264833|NCT00384033|11478281|FG003|Overall Study|Physician Decision|0
7264834|NCT00384033|11478278|FG000|Overall Study|Lost to Follow-up|6
7264835|NCT00384033|11478279|FG001|Overall Study|Lost to Follow-up|12
7264836|NCT00384033|11478280|FG002|Overall Study|Lost to Follow-up|7
7264837|NCT00384033|11478281|FG003|Overall Study|Lost to Follow-up|7
7264838|NCT00384033|11478278|FG000|Overall Study|Other|2
7264839|NCT00384033|11478279|FG001|Overall Study|Other|0
7264840|NCT00384033|11478280|FG002|Overall Study|Other|0
7264841|NCT00384033|11478281|FG003|Overall Study|Other|0
7264842|NCT00384033|11478278|FG000|Overall Study|Protocol Violation|5
7264843|NCT00384033|11478279|FG001|Overall Study|Protocol Violation|0
7264844|NCT00384033|11478280|FG002|Overall Study|Protocol Violation|5
7264845|NCT00384033|11478281|FG003|Overall Study|Protocol Violation|6
7264846|NCT00384033|11478278|FG000|Overall Study|Withdrawal by Subject|6
7264847|NCT00384033|11478279|FG001|Overall Study|Withdrawal by Subject|2
7264848|NCT00384033|11478280|FG002|Overall Study|Withdrawal by Subject|5
7264849|NCT00384033|11478281|FG003|Overall Study|Withdrawal by Subject|2
7264850|NCT00384033|11478278|FG000|Overall Study|Lack of Efficacy|7
7545077|NCT02848326|11899629|FG000|Safety Follow-up Period|Lost to Follow-up|4
7545078|NCT02848326|11899630|FG001|Safety Follow-up Period|Lost to Follow-up|0
7545079|NCT02848326|11899631|FG002|Safety Follow-up Period|Lost to Follow-up|2
7545080|NCT02848326|11899632|FG003|Safety Follow-up Period|Lost to Follow-up|0
7545081|NCT02848326|11899633|FG004|Safety Follow-up Period|Lost to Follow-up|1
7545082|NCT02848326|11899634|FG005|Safety Follow-up Period|Lost to Follow-up|3
7545083|NCT02848599|11899650|FG000|Overall Study|Protocol Violation|7
7545084|NCT02848599|11899651|FG001|Overall Study|Protocol Violation|9
7545085|NCT02848651|11899659|FG000|Overall Study|Death|85
7545086|NCT02848651|11899659|FG000|Overall Study|Lost to Follow-up|1
7545087|NCT02848651|11899659|FG000|Overall Study|Non-Compliance|1
7545088|NCT02848651|11899659|FG000|Overall Study|Symptomatic Deterioration|1
7545089|NCT02848651|11899659|FG000|Overall Study|Physician Decision|4
7545090|NCT02848651|11899659|FG000|Overall Study|Withdrawal by Subject|14
7545091|NCT02848664|11899679|FG000|Overall Study|Withdrawal by Subject|2
7545092|NCT02848664|11899679|FG000|Overall Study|Adverse Event|1
7545093|NCT02848664|11899679|FG000|Overall Study|no assistance for device training|1
7264851|NCT00384033|11478279|FG001|Overall Study|Lack of Efficacy|3
7264852|NCT00384033|11478280|FG002|Overall Study|Lack of Efficacy|3
7264853|NCT00384033|11478281|FG003|Overall Study|Lack of Efficacy|1
7264854|NCT00384033|11478278|FG000|Overall Study|Randomized but not treated|3
7264855|NCT00384033|11478279|FG001|Overall Study|Randomized but not treated|7
7264856|NCT00384033|11478280|FG002|Overall Study|Randomized but not treated|10
7545094|NCT02848729|11899689|FG000|Overall Study|Withdrawal by Subject|1
7545095|NCT02848729|11899690|FG001|Overall Study|Withdrawal by Subject|0
7545096|NCT02848729|11899689|FG000|Overall Study|Emesis|15
7545097|NCT02848729|11899690|FG001|Overall Study|Emesis|11
7545098|NCT02848833|11899703|FG000|Overall Study|subject who are duplicated|1
7264857|NCT00384033|11478281|FG003|Overall Study|Randomized but not treated|2
7264858|NCT00384059|11478293|FG000|Infant Series|Not consented|2
7264859|NCT00384059|11478294|FG001|Infant Series|Not consented|6
7264860|NCT00384059|11478293|FG000|Infant Series|Withdrawal by Subject|2
7264861|NCT00384059|11478294|FG001|Infant Series|Withdrawal by Subject|2
7264862|NCT00384059|11478293|FG000|Infant Series|Adverse Event|1
7264863|NCT00384059|11478294|FG001|Infant Series|Adverse Event|2
7264864|NCT00384059|11478293|FG000|Infant Series|Protocol Violation|1
7264865|NCT00384059|11478294|FG001|Infant Series|Protocol Violation|2
7264866|NCT00384059|11478293|FG000|Infant Series|Lost to Follow-up|0
7264867|NCT00384059|11478294|FG001|Infant Series|Lost to Follow-up|1
7264868|NCT00384059|11478293|FG000|After Infant Series|Protocol Violation|2
7264869|NCT00384059|11478294|FG001|After Infant Series|Protocol Violation|3
7264870|NCT00384059|11478293|FG000|After Infant Series|Withdrawal by Subject|2
7264871|NCT00384059|11478294|FG001|After Infant Series|Withdrawal by Subject|2
7264872|NCT00384059|11478293|FG000|After Infant Series|Failed to Return|0
7264873|NCT00384059|11478294|FG001|After Infant Series|Failed to Return|2
7264874|NCT00384059|11478293|FG000|After Infant Series|Adverse Event|0
7264875|NCT00384059|11478294|FG001|After Infant Series|Adverse Event|1
7264876|NCT00384059|11478293|FG000|After Infant Series|Physician Decision|0
7264877|NCT00384059|11478294|FG001|After Infant Series|Physician Decision|1
7264878|NCT00384059|11478293|FG000|After Infant Series|Lost to Follow-up|0
7264879|NCT00384059|11478294|FG001|After Infant Series|Lost to Follow-up|1
7264880|NCT00384059|11478293|FG000|Toddler Dose|Lost to Follow-up|1
7264881|NCT00384059|11478294|FG001|Toddler Dose|Lost to Follow-up|1
7264882|NCT00384059|11478293|FG000|Toddler Dose|Failed to return|0
7264883|NCT00384059|11478294|FG001|Toddler Dose|Failed to return|1
7264884|NCT00384085|11478324|FG000|Overall Study|Adverse Event|5
7264885|NCT00384085|11478325|FG001|Overall Study|Adverse Event|5
7264886|NCT00384085|11478326|FG002|Overall Study|Adverse Event|4
7264887|NCT00384085|11478324|FG000|Overall Study|Lack of Efficacy|0
7264888|NCT00384085|11478325|FG001|Overall Study|Lack of Efficacy|3
7264889|NCT00384085|11478326|FG002|Overall Study|Lack of Efficacy|2
7264890|NCT00384085|11478324|FG000|Overall Study|No longer Requires Study Treatment|1
7264891|NCT00384085|11478325|FG001|Overall Study|No longer Requires Study Treatment|0
7264892|NCT00384085|11478326|FG002|Overall Study|No longer Requires Study Treatment|1
7264893|NCT00384085|11478324|FG000|Overall Study|Protocol Violation|2
7264894|NCT00384085|11478325|FG001|Overall Study|Protocol Violation|2
7264895|NCT00384085|11478326|FG002|Overall Study|Protocol Violation|2
7264896|NCT00384085|11478324|FG000|Overall Study|Lost to Follow-up|9
7264897|NCT00384085|11478325|FG001|Overall Study|Lost to Follow-up|9
7264898|NCT00384085|11478326|FG002|Overall Study|Lost to Follow-up|10
7264899|NCT00384085|11478324|FG000|Overall Study|Progressive Disease|0
7264900|NCT00384085|11478325|FG001|Overall Study|Progressive Disease|1
7264901|NCT00384085|11478326|FG002|Overall Study|Progressive Disease|0
7264902|NCT00384085|11478324|FG000|Overall Study|Withdrawal by Subject|14
7264903|NCT00384085|11478325|FG001|Overall Study|Withdrawal by Subject|19
7264904|NCT00384085|11478326|FG002|Overall Study|Withdrawal by Subject|29
7545099|NCT02848833|11899703|FG000|Overall Study|have not taken the study drug|11
7545100|NCT02848833|11899703|FG000|Overall Study|follow-up failure|6
7545101|NCT02848833|11899703|FG000|Overall Study|Protocol Violation|119
7545126|NCT02849509|11899759|FG000|Overall Study|Worsening of disease under study|1
7545127|NCT02849509|11899760|FG001|Overall Study|Worsening of disease under study|1
7264905|NCT00384085|11478324|FG000|Overall Study|Patient non-compliant|4
7264906|NCT00384085|11478325|FG001|Overall Study|Patient non-compliant|4
7264907|NCT00384085|11478326|FG002|Overall Study|Patient non-compliant|5
7545128|NCT02849509|11899761|FG002|Overall Study|Worsening of disease under study|1
7545129|NCT02849509|11899759|FG000|Overall Study|Worsening of other pre-existing disease|0
7545130|NCT02849509|11899760|FG001|Overall Study|Worsening of other pre-existing disease|1
7264908|NCT00384085|11478324|FG000|Overall Study|Physician Decision|1
7264909|NCT00384085|11478325|FG001|Overall Study|Physician Decision|0
7264910|NCT00384085|11478326|FG002|Overall Study|Physician Decision|0
7264911|NCT00384085|11478324|FG000|Overall Study|Loss of site personnel|1
7264912|NCT00384085|11478325|FG001|Overall Study|Loss of site personnel|0
7264913|NCT00384085|11478326|FG002|Overall Study|Loss of site personnel|1
7264914|NCT00384085|11478324|FG000|Overall Study|Sponsor decision|1
7264915|NCT00384085|11478325|FG001|Overall Study|Sponsor decision|2
7264916|NCT00384085|11478326|FG002|Overall Study|Sponsor decision|1
7264917|NCT00384085|11478324|FG000|Overall Study|Patient moved|1
7264918|NCT00384085|11478325|FG001|Overall Study|Patient moved|0
7264919|NCT00384085|11478326|FG002|Overall Study|Patient moved|1
7264920|NCT00384085|11478324|FG000|Overall Study|Patient required surgery|0
7264921|NCT00384085|11478325|FG001|Overall Study|Patient required surgery|1
7264922|NCT00384085|11478326|FG002|Overall Study|Patient required surgery|0
7264923|NCT00384176|11478339|FG000|Overall Study|Death|239
7264924|NCT00384176|11478340|FG001|Overall Study|Death|247
7264925|NCT00384176|11478341|FG002|Overall Study|Death|105
7264926|NCT00384176|11478339|FG000|Overall Study|Withdrawal by Subject|52
7264927|NCT00384176|11478340|FG001|Overall Study|Withdrawal by Subject|48
7264928|NCT00384176|11478341|FG002|Overall Study|Withdrawal by Subject|22
7264929|NCT00384176|11478339|FG000|Overall Study|Lost to Follow-up|16
7264930|NCT00384176|11478340|FG001|Overall Study|Lost to Follow-up|18
7264931|NCT00384176|11478341|FG002|Overall Study|Lost to Follow-up|4
7264932|NCT00384176|11478339|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
7264933|NCT00384176|11478340|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
7264934|NCT00384176|11478341|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
7545131|NCT02849509|11899761|FG002|Overall Study|Worsening of other pre-existing disease|2
7545132|NCT02849509|11899759|FG000|Overall Study|Other adverse event|36
7545133|NCT02849509|11899760|FG001|Overall Study|Other adverse event|41
7545134|NCT02849509|11899761|FG002|Overall Study|Other adverse event|8
7545135|NCT02849509|11899759|FG000|Overall Study|Withdrawal by Subject|6
7545136|NCT02849509|11899760|FG001|Overall Study|Withdrawal by Subject|17
7545137|NCT02849509|11899761|FG002|Overall Study|Withdrawal by Subject|12
7545138|NCT02849509|11899759|FG000|Overall Study|Lost to Follow-up|27
7545139|NCT02849509|11899760|FG001|Overall Study|Lost to Follow-up|67
7545140|NCT02849509|11899761|FG002|Overall Study|Lost to Follow-up|36
7545141|NCT02849509|11899759|FG000|Overall Study|Other, reason not specified|14
7545142|NCT02849509|11899760|FG001|Overall Study|Other, reason not specified|29
7545143|NCT02849509|11899761|FG002|Overall Study|Other, reason not specified|25
7577004|NCT04102345|11965251|FG000|Overall Study|Withdrawal by Subject|1
7577005|NCT04102345|11965252|FG001|Overall Study|Withdrawal by Subject|0
7577006|NCT04099277|11965292|FG000|Overall Study|Physician Decision|1
7577007|NCT04099277|11965292|FG000|Overall Study|Withdrawal by Subject|1
7577008|NCT04098809|11965298|FG000|Overall Study|Withdrawal by Subject|1
7577009|NCT04098809|11965299|FG001|Overall Study|Withdrawal by Subject|3
7577010|NCT04098809|11965298|FG000|Overall Study|Physician Decision|2
7577011|NCT04098809|11965299|FG001|Overall Study|Physician Decision|1
7624582|NCT02173301|12035673|FG002|Overall Study|Physician Decision|1
7264935|NCT00384176|11478339|FG000|Overall Study|Longer QTC as Visit 1|1
7264936|NCT00384176|11478340|FG001|Overall Study|Longer QTC as Visit 1|0
7264937|NCT00384176|11478341|FG002|Overall Study|Longer QTC as Visit 1|0
7264938|NCT00384176|11478339|FG000|Overall Study|Toxicity of treatment|1
7545144|NCT02849509|11899759|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
7624583|NCT02173301|12035674|FG003|Overall Study|Physician Decision|0
7624584|NCT02173301|12035671|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1
7624585|NCT02173301|12035672|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624586|NCT02173301|12035673|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624587|NCT02173301|12035674|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
7624588|NCT01986114|12035684|FG000|Overall Study|Adverse Event|59
7264939|NCT00384176|11478340|FG001|Overall Study|Toxicity of treatment|0
7264940|NCT00384176|11478341|FG002|Overall Study|Toxicity of treatment|0
7264941|NCT00384176|11478339|FG000|Overall Study|Did not receive study treatment|0
7264942|NCT00384176|11478340|FG001|Overall Study|Did not receive study treatment|1
7264943|NCT00384176|11478341|FG002|Overall Study|Did not receive study treatment|1
7264944|NCT00384176|11478339|FG000|Overall Study|Physician Decision|0
7264945|NCT00384176|11478340|FG001|Overall Study|Physician Decision|2
7264946|NCT00384176|11478341|FG002|Overall Study|Physician Decision|0
7264947|NCT00384176|11478339|FG000|Overall Study|Liver metastases, colon resec. planned|1
7264948|NCT00384176|11478340|FG001|Overall Study|Liver metastases, colon resec. planned|0
7264949|NCT00384176|11478341|FG002|Overall Study|Liver metastases, colon resec. planned|0
7264950|NCT00384189|11478353|FG000|Overall Study|Reason Not Specified|50
7264951|NCT00384189|11478354|FG001|Overall Study|Reason Not Specified|57
7264952|NCT00384189|11478355|FG002|Overall Study|Reason Not Specified|58
7264953|NCT00384189|11478356|FG003|Overall Study|Reason Not Specified|40
7264954|NCT00384332|11478376|FG000|Overall Study|Lost to Follow-up|4
7264955|NCT00384332|11478377|FG001|Overall Study|Lost to Follow-up|0
7264956|NCT00384397|11478388|FG000|Overall Study|Adverse Event|0
7264957|NCT00384397|11478389|FG001|Overall Study|Adverse Event|1
7264958|NCT00384397|11478390|FG002|Overall Study|Adverse Event|2
7264959|NCT00384397|11478388|FG000|Overall Study|Protocol Violation|7
7264960|NCT00384397|11478389|FG001|Overall Study|Protocol Violation|15
7264961|NCT00384397|11478390|FG002|Overall Study|Protocol Violation|13
7264962|NCT00384397|11478388|FG000|Overall Study|Lost to Follow-up|11
7264963|NCT00384397|11478389|FG001|Overall Study|Lost to Follow-up|13
7264964|NCT00384397|11478390|FG002|Overall Study|Lost to Follow-up|3
7264965|NCT00384397|11478388|FG000|Overall Study|Withdrawal by Subject|14
7264966|NCT00384397|11478389|FG001|Overall Study|Withdrawal by Subject|17
7264967|NCT00384397|11478390|FG002|Overall Study|Withdrawal by Subject|15
7264968|NCT00384839|11478453|FG000|Overall Study|Adverse Event|4
7264969|NCT00384839|11478453|FG000|Overall Study|Investigator Request|1
7264970|NCT00384839|11478453|FG000|Overall Study|Patient Request|1
7264971|NCT00384839|11478453|FG000|Overall Study|Ineligible|2
7264972|NCT00384930|11478479|FG000|Overall Study|Adverse Event|5
7264973|NCT00384930|11478480|FG001|Overall Study|Adverse Event|4
7264974|NCT00384930|11478481|FG002|Overall Study|Adverse Event|12
7264975|NCT00384930|11478482|FG003|Overall Study|Adverse Event|11
7264976|NCT00384930|11478483|FG004|Overall Study|Adverse Event|14
7264977|NCT00384930|11478479|FG000|Overall Study|Entry Criteria Not Met|2
7264978|NCT00384930|11478480|FG001|Overall Study|Entry Criteria Not Met|6
7264979|NCT00384930|11478481|FG002|Overall Study|Entry Criteria Not Met|7
7264980|NCT00384930|11478482|FG003|Overall Study|Entry Criteria Not Met|8
7264981|NCT00384930|11478483|FG004|Overall Study|Entry Criteria Not Met|4
7264982|NCT00384930|11478479|FG000|Overall Study|Lack of Efficacy|1
7264983|NCT00384930|11478480|FG001|Overall Study|Lack of Efficacy|1
7264984|NCT00384930|11478481|FG002|Overall Study|Lack of Efficacy|2
7264985|NCT00384930|11478482|FG003|Overall Study|Lack of Efficacy|1
7264986|NCT00384930|11478483|FG004|Overall Study|Lack of Efficacy|2
7264987|NCT00384930|11478479|FG000|Overall Study|Lost to Follow-up|5
7264988|NCT00384930|11478480|FG001|Overall Study|Lost to Follow-up|3
7264989|NCT00384930|11478481|FG002|Overall Study|Lost to Follow-up|0
7264990|NCT00384930|11478482|FG003|Overall Study|Lost to Follow-up|4
7264991|NCT00384930|11478483|FG004|Overall Study|Lost to Follow-up|6
7264992|NCT00384930|11478479|FG000|Overall Study|Physician Decision|0
7264993|NCT00384930|11478480|FG001|Overall Study|Physician Decision|1
7264994|NCT00384930|11478481|FG002|Overall Study|Physician Decision|1
7264995|NCT00384930|11478482|FG003|Overall Study|Physician Decision|0
7264996|NCT00384930|11478483|FG004|Overall Study|Physician Decision|1
7264997|NCT00384930|11478479|FG000|Overall Study|Protocol Violation|1
7264998|NCT00384930|11478480|FG001|Overall Study|Protocol Violation|0
7264999|NCT00384930|11478481|FG002|Overall Study|Protocol Violation|1
7265000|NCT00384930|11478482|FG003|Overall Study|Protocol Violation|6
7265001|NCT00384930|11478483|FG004|Overall Study|Protocol Violation|4
7265002|NCT00384930|11478479|FG000|Overall Study|Sponsor Decision|3
7265003|NCT00384930|11478480|FG001|Overall Study|Sponsor Decision|4
7265004|NCT00384930|11478481|FG002|Overall Study|Sponsor Decision|0
7265005|NCT00384930|11478482|FG003|Overall Study|Sponsor Decision|5
7265006|NCT00384930|11478483|FG004|Overall Study|Sponsor Decision|0
7265007|NCT00384930|11478479|FG000|Overall Study|Withdrawal by Subject|9
7265008|NCT00384930|11478480|FG001|Overall Study|Withdrawal by Subject|7
7265009|NCT00384930|11478481|FG002|Overall Study|Withdrawal by Subject|7
7265010|NCT00384930|11478482|FG003|Overall Study|Withdrawal by Subject|6
7265011|NCT00384930|11478483|FG004|Overall Study|Withdrawal by Subject|16
7265012|NCT00384930|11478479|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
7265013|NCT00384930|11478480|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
7265014|NCT00384930|11478481|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
7265015|NCT00384930|11478482|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
7265016|NCT00384930|11478483|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
7265017|NCT00384956|11478498|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
7265018|NCT00385203|11478523|FG000|Overall Study|Adverse Event|5
7265019|NCT00385203|11478524|FG001|Overall Study|Adverse Event|4
7265020|NCT00385203|11478523|FG000|Overall Study|Death|1
7265021|NCT00385203|11478524|FG001|Overall Study|Death|0
7265022|NCT00385203|11478523|FG000|Overall Study|Condition under investigation worsened|18
7265023|NCT00385203|11478524|FG001|Overall Study|Condition under investigation worsened|3
7265024|NCT00385203|11478523|FG000|Overall Study|Incorrect enrollment|2
7265025|NCT00385203|11478524|FG001|Overall Study|Incorrect enrollment|0
7265026|NCT00385255|11478540|FG000|Overall Study|Serious Adverse Event|1
7265027|NCT00385255|11478541|FG001|Overall Study|Serious Adverse Event|2
7265028|NCT00385255|11478540|FG000|Overall Study|Protocol Violation|0
7265029|NCT00385255|11478541|FG001|Overall Study|Protocol Violation|4
7265030|NCT00385255|11478540|FG000|Overall Study|Withdrawal by Subject|0
7265031|NCT00385255|11478541|FG001|Overall Study|Withdrawal by Subject|8
7265032|NCT00385255|11478540|FG000|Overall Study|Migrated/moved from study area|0
7265033|NCT00385255|11478541|FG001|Overall Study|Migrated/moved from study area|1
7265034|NCT00385255|11478540|FG000|Overall Study|Lost to Follow-up|20
7265035|NCT00385255|11478541|FG001|Overall Study|Lost to Follow-up|58
7265036|NCT00385541|11478562|FG000|Overall Study|severe pain, clinician requested unblind|0
7265037|NCT00385541|11478563|FG001|Overall Study|severe pain, clinician requested unblind|1
7265038|NCT00385593|11478590|FG000|Overall Study|Adverse Event|3
7265039|NCT00385593|11478591|FG001|Overall Study|Adverse Event|2
7265040|NCT00385593|11478590|FG000|Overall Study|Withdrawal by Subject|17
7545145|NCT02849509|11899760|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
7545146|NCT02849509|11899761|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
7545147|NCT02849678|11899773|FG000|Overall Study|Protocol Violation|3
7545148|NCT02849678|11899774|FG001|Overall Study|Protocol Violation|6
7545149|NCT02849704|11899782|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
7545150|NCT02849704|11899783|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
7545151|NCT02849704|11899782|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
7545152|NCT02849704|11899783|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
7545153|NCT02849704|11899782|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
7545154|NCT02849704|11899783|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
7545155|NCT02850276|11899815|FG000|Overall Study|screen failure|43
7545156|NCT02850276|11899815|FG000|Overall Study|Withdrawal by Subject|14
7545157|NCT02850276|11899815|FG000|Overall Study|Physician Decision|2
7545158|NCT02850276|11899815|FG000|Overall Study|Lost to Follow-up|2
7545159|NCT02850965|11899831|FG000|Overall Study|Other than listed|3
7545160|NCT02850965|11899832|FG001|Overall Study|Other than listed|4
7545161|NCT02850965|11899831|FG000|Overall Study|Protocol Violation|0
7545162|NCT02850965|11899832|FG001|Overall Study|Protocol Violation|2
7545163|NCT02850965|11899831|FG000|Overall Study|Lost to Follow-up|5
7545164|NCT02850965|11899832|FG001|Overall Study|Lost to Follow-up|3
7545165|NCT02850965|11899831|FG000|Overall Study|Lack of Efficacy|4
7545166|NCT02850965|11899832|FG001|Overall Study|Lack of Efficacy|8
7545167|NCT02850965|11899831|FG000|Overall Study|Adverse Event|3
7545168|NCT02850965|11899832|FG001|Overall Study|Adverse Event|2
7545169|NCT02850965|11899831|FG000|Overall Study|Withdrawal by Subject|3
7545170|NCT02850965|11899832|FG001|Overall Study|Withdrawal by Subject|4
7545171|NCT02850965|11899831|FG000|Overall Study|Physician Decision|0
7545172|NCT02850965|11899832|FG001|Overall Study|Physician Decision|1
7545173|NCT02850965|11899831|FG000|Overall Study|Randomized but not treated|0
7545174|NCT02850965|11899832|FG001|Overall Study|Randomized but not treated|1
7545175|NCT02850978|11899838|FG000|Overall Study|Uncollectable CRF|27
7545176|NCT02850978|11899838|FG000|Overall Study|No visit since the first visit|35
7545177|NCT02850978|11899838|FG000|Overall Study|Adverse Event|81
7545178|NCT02850978|11899838|FG000|Overall Study|Lack of Efficacy|40
7545179|NCT02850978|11899838|FG000|Overall Study|Improvement in condition|34
7545180|NCT02850978|11899838|FG000|Overall Study|Lost to Follow-up|121
7545181|NCT02850978|11899838|FG000|Overall Study|Reason not listed|88
7545182|NCT02851069|11899842|FG000|Overall Study|Failure to Return|3
7545183|NCT02851069|11899842|FG000|Overall Study|Other|3
7545184|NCT02851615|11899858|FG000|Overall Study|Cognitive Issue|1
7545185|NCT02851615|11899859|FG001|Overall Study|Cognitive Issue|0
7545186|NCT02851615|11899858|FG000|Overall Study|Lost to Follow-up|0
7545187|NCT02851615|11899859|FG001|Overall Study|Lost to Follow-up|4
7545198|NCT02852265|11899897|FG000|3-month Follow-up|Lost to Follow-up|1
7545199|NCT02852265|11899898|FG001|3-month Follow-up|Lost to Follow-up|1
7545200|NCT02852434|11899914|FG000|Overall Study|Withdrawal by Subject|0
7545201|NCT02852434|11899915|FG001|Overall Study|Withdrawal by Subject|1
7545202|NCT02852434|11899914|FG000|Overall Study|Unsuccessful Dilator Procedure|2
7545203|NCT02852434|11899915|FG001|Overall Study|Unsuccessful Dilator Procedure|0
7545204|NCT02853032|11899923|FG000|Overall Study|Adverse Event|4
7545205|NCT02853032|11899924|FG001|Overall Study|Adverse Event|0
7545206|NCT02853032|11899923|FG000|Overall Study|Withdrawal by Subject|3
7545207|NCT02853032|11899924|FG001|Overall Study|Withdrawal by Subject|1
7265041|NCT00385593|11478591|FG001|Overall Study|Withdrawal by Subject|7
7265042|NCT00385593|11478590|FG000|Overall Study|Lost to Follow-up|12
7265043|NCT00385593|11478591|FG001|Overall Study|Lost to Follow-up|8
7265044|NCT00385593|11478590|FG000|Overall Study|Protocol Violation|7
7265045|NCT00385593|11478591|FG001|Overall Study|Protocol Violation|4
7265046|NCT00385593|11478590|FG000|Overall Study|Several reasons|17
7265047|NCT00385593|11478591|FG001|Overall Study|Several reasons|15
7265048|NCT00385593|11478590|FG000|Overall Study|Incorrect inclusion|2
7265049|NCT00385593|11478591|FG001|Overall Study|Incorrect inclusion|0
7265050|NCT00385593|11478590|FG000|Overall Study|Incorrect randomization|0
7265051|NCT00385593|11478591|FG001|Overall Study|Incorrect randomization|1
7265052|NCT00385671|11478600|FG000|Overall Study|Adverse Event|14
7265053|NCT00385671|11478601|FG001|Overall Study|Adverse Event|27
7265054|NCT00385671|11478602|FG002|Overall Study|Adverse Event|18
7265055|NCT00385671|11478600|FG000|Overall Study|Lack of Efficacy|5
7265056|NCT00385671|11478601|FG001|Overall Study|Lack of Efficacy|9
7265057|NCT00385671|11478602|FG002|Overall Study|Lack of Efficacy|5
7265058|NCT00385671|11478600|FG000|Overall Study|Lost to Follow-up|6
7265059|NCT00385671|11478601|FG001|Overall Study|Lost to Follow-up|6
7265060|NCT00385671|11478602|FG002|Overall Study|Lost to Follow-up|5
7265061|NCT00385671|11478600|FG000|Overall Study|Physician Decision|2
7265062|NCT00385671|11478601|FG001|Overall Study|Physician Decision|1
7265063|NCT00385671|11478602|FG002|Overall Study|Physician Decision|2
7265064|NCT00385671|11478600|FG000|Overall Study|Protocol Violation|5
7265065|NCT00385671|11478601|FG001|Overall Study|Protocol Violation|2
7265066|NCT00385671|11478602|FG002|Overall Study|Protocol Violation|1
7265067|NCT00385671|11478600|FG000|Overall Study|Sponsor Decision|2
7265068|NCT00385671|11478601|FG001|Overall Study|Sponsor Decision|2
7545208|NCT02853032|11899923|FG000|Overall Study|Requested to withdraw from all treatment|2
7545209|NCT02853032|11899924|FG001|Overall Study|Requested to withdraw from all treatment|2
7545210|NCT02853123|11899932|FG000|Treatment Period 1|Adverse Event|0
7545211|NCT02853123|11899933|FG001|Treatment Period 1|Adverse Event|3
7545212|NCT02853123|11899932|FG000|Washout Period|Worsening of COPD|0
7545213|NCT02853123|11899933|FG001|Washout Period|Worsening of COPD|3
7545214|NCT02853123|11899932|FG000|Washout Period|Adverse Event|1
7545215|NCT02853123|11899933|FG001|Washout Period|Adverse Event|0
7545216|NCT02853318|11899940|FG000|Overall Study|Withdrawal by Subject|1
7545217|NCT02853435|11899947|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7545218|NCT02853435|11899948|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7545219|NCT02853435|11899949|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7545220|NCT02853435|11899950|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7545221|NCT02853435|11899951|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
7545222|NCT02853435|11899952|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7545223|NCT02853929|11899984|FG000|Overall Study|Lost to Follow-up|3
7545224|NCT02853929|11899985|FG001|Overall Study|Lost to Follow-up|0
7545225|NCT02853929|11899984|FG000|Overall Study|Withdrawal by Subject|1
7545226|NCT02853929|11899985|FG001|Overall Study|Withdrawal by Subject|0
7545227|NCT02853929|11899984|FG000|Overall Study|Subjects enrolled but not vaccinated|7
7545228|NCT02853929|11899985|FG001|Overall Study|Subjects enrolled but not vaccinated|4
7545229|NCT02854527|11900010|FG000|Overall Study|Adverse Event|0
7545230|NCT02854527|11900011|FG001|Overall Study|Adverse Event|0
7545231|NCT02854527|11900012|FG002|Overall Study|Adverse Event|0
7545232|NCT02854527|11900013|FG003|Overall Study|Adverse Event|0
7545233|NCT02854527|11900014|FG004|Overall Study|Adverse Event|1
7545234|NCT02854527|11900015|FG005|Overall Study|Adverse Event|0
7545235|NCT02854527|11900016|FG006|Overall Study|Adverse Event|0
7545236|NCT02854527|11900017|FG007|Overall Study|Adverse Event|0
7545237|NCT02854527|11900018|FG008|Overall Study|Adverse Event|0
7545238|NCT02854527|11900019|FG009|Overall Study|Adverse Event|0
7545239|NCT02854527|11900010|FG000|Overall Study|Lost to Follow-up|0
7545240|NCT02854527|11900011|FG001|Overall Study|Lost to Follow-up|0
7545241|NCT02854527|11900012|FG002|Overall Study|Lost to Follow-up|0
7545242|NCT02854527|11900013|FG003|Overall Study|Lost to Follow-up|1
7545243|NCT02854527|11900014|FG004|Overall Study|Lost to Follow-up|0
7545244|NCT02854527|11900015|FG005|Overall Study|Lost to Follow-up|0
7545245|NCT02854527|11900016|FG006|Overall Study|Lost to Follow-up|0
7545246|NCT02854527|11900017|FG007|Overall Study|Lost to Follow-up|0
7545247|NCT02854527|11900018|FG008|Overall Study|Lost to Follow-up|0
7545248|NCT02854527|11900019|FG009|Overall Study|Lost to Follow-up|0
7545249|NCT02854605|11900040|FG000|Overall Study|Adverse Event|1
7545250|NCT02854605|11900041|FG001|Overall Study|Adverse Event|5
7545251|NCT02854605|11900042|FG002|Overall Study|Adverse Event|2
7545252|NCT02854605|11900040|FG000|Overall Study|Lost to Follow-up|0
7545253|NCT02854605|11900041|FG001|Overall Study|Lost to Follow-up|2
7545254|NCT02854605|11900042|FG002|Overall Study|Lost to Follow-up|0
7545255|NCT02854605|11900040|FG000|Overall Study|Withdrew Consent|1
7545256|NCT02854605|11900041|FG001|Overall Study|Withdrew Consent|0
7545257|NCT02854605|11900042|FG002|Overall Study|Withdrew Consent|1
7545258|NCT02854605|11900040|FG000|Overall Study|Investigator's Discretion|1
7545259|NCT02854605|11900041|FG001|Overall Study|Investigator's Discretion|0
7265069|NCT00385671|11478602|FG002|Overall Study|Sponsor Decision|1
7265070|NCT00385671|11478600|FG000|Overall Study|Withdrawal by Subject|4
7265071|NCT00385671|11478601|FG001|Overall Study|Withdrawal by Subject|4
7265072|NCT00385671|11478602|FG002|Overall Study|Withdrawal by Subject|4
7545260|NCT02854605|11900042|FG002|Overall Study|Investigator's Discretion|0
7265073|NCT00385684|11478612|FG000|FIRST INTERVENTION OF PHASE A|Death|1
7265074|NCT00385684|11478613|FG001|FIRST INTERVENTION OF PHASE A|Death|0
7265075|NCT00385684|11478612|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
7265076|NCT00385684|11478613|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
7265077|NCT00385684|11478612|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
7265078|NCT00385684|11478613|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
7265079|NCT00385723|11478622|FG000|Overall Study|Lost to Follow-up|1
7265080|NCT00385723|11478623|FG001|Overall Study|Lost to Follow-up|1
7265081|NCT00385723|11478624|FG002|Overall Study|Lost to Follow-up|0
7265082|NCT00385723|11478622|FG000|Overall Study|Withdrawal by Subject|1
7265083|NCT00385723|11478623|FG001|Overall Study|Withdrawal by Subject|0
7265084|NCT00385723|11478624|FG002|Overall Study|Withdrawal by Subject|2
7265085|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
7265086|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
7265087|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
7265088|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
7265089|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
7265090|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
7265091|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7265092|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
7265093|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
7265094|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
7265095|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
7265096|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
7265097|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
7265098|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
7265099|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
7265100|NCT00385736|11478635|FG000|Efficacy Analysis Set - Induction|Other|0
7265101|NCT00385736|11478636|FG001|Efficacy Analysis Set - Induction|Other|0
7265102|NCT00385736|11478637|FG002|Efficacy Analysis Set - Induction|Other|1
7545261|NCT02854605|11900040|FG000|Overall Study|Protocol Violation|0
7545262|NCT02854605|11900041|FG001|Overall Study|Protocol Violation|0
7545263|NCT02854605|11900042|FG002|Overall Study|Protocol Violation|1
7545264|NCT02854631|11900052|FG000|Overall Study|Adverse Event|1
7545265|NCT02854631|11900053|FG001|Overall Study|Adverse Event|2
7545266|NCT02854631|11900052|FG000|Overall Study|Withdrew Consent|3
7545267|NCT02854631|11900053|FG001|Overall Study|Withdrew Consent|2
7545268|NCT02854631|11900052|FG000|Overall Study|Investigator's Discretion|2
7545269|NCT02854631|11900053|FG001|Overall Study|Investigator's Discretion|0
7545270|NCT02854631|11900052|FG000|Overall Study|Death|12
7545271|NCT02854631|11900053|FG001|Overall Study|Death|8
7545272|NCT02854631|11900052|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
7545273|NCT02854631|11900053|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
7545274|NCT02854631|11900052|FG000|Overall Study|Protocol Violation|0
7545275|NCT02854631|11900053|FG001|Overall Study|Protocol Violation|1
7545276|NCT02854631|11900052|FG000|Overall Study|Subjects Randomized but Never Treated|2
7545277|NCT02854631|11900053|FG001|Overall Study|Subjects Randomized but Never Treated|0
7545278|NCT02854631|11900052|FG000|Overall Study|Lost to Follow-up|4
7545279|NCT02854631|11900053|FG001|Overall Study|Lost to Follow-up|2
7545280|NCT02854800|11900062|FG000|Overall Study|Protocol Violation|16
7545281|NCT02854800|11900063|FG001|Overall Study|Protocol Violation|11
7545282|NCT02854800|11900064|FG002|Overall Study|Protocol Violation|3
7545283|NCT02854800|11900062|FG000|Overall Study|Withdrawal by Subject|4
7545284|NCT02854800|11900063|FG001|Overall Study|Withdrawal by Subject|2
7545285|NCT02854800|11900064|FG002|Overall Study|Withdrawal by Subject|3
7545286|NCT02855164|11900092|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7545287|NCT02855164|11900093|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7545288|NCT02855164|11900094|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7545289|NCT02855164|11900095|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
7545290|NCT02855164|11900096|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
7545291|NCT02855164|11900097|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7545292|NCT02855164|11900098|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7469637|NCT01925274|11771445|FG001|Overall Study|Withdrawal by Subject|2
7545293|NCT02855164|11900099|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
7545294|NCT02855164|11900092|FG000|Parts A + B (Randomized Set)|Physician Decision|0
7545295|NCT02855164|11900093|FG001|Parts A + B (Randomized Set)|Physician Decision|0
7545296|NCT02855164|11900094|FG002|Parts A + B (Randomized Set)|Physician Decision|0
7545297|NCT02855164|11900095|FG003|Parts A + B (Randomized Set)|Physician Decision|2
7545298|NCT02855164|11900096|FG004|Parts A + B (Randomized Set)|Physician Decision|0
7545299|NCT02855164|11900097|FG005|Parts A + B (Randomized Set)|Physician Decision|0
7545300|NCT02855164|11900098|FG006|Parts A + B (Randomized Set)|Physician Decision|0
7545301|NCT02855164|11900099|FG007|Parts A + B (Randomized Set)|Physician Decision|0
7545302|NCT02855164|11900092|FG000|Parts A + B (Randomized Set)|Adverse Event|0
7545303|NCT02855164|11900093|FG001|Parts A + B (Randomized Set)|Adverse Event|0
7545304|NCT02855164|11900094|FG002|Parts A + B (Randomized Set)|Adverse Event|0
7545305|NCT02855164|11900095|FG003|Parts A + B (Randomized Set)|Adverse Event|4
7265103|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
7265104|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
7265105|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
7265106|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7265107|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
7265108|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
7265109|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
7265110|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7265111|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
7265112|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
7265113|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
7265114|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
7265115|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
7265116|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
7265117|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
7265118|NCT00385736|11478635|FG000|Efficacy Analysis Set - Maintenance|Other|0
7265119|NCT00385736|11478636|FG001|Efficacy Analysis Set - Maintenance|Other|4
7265120|NCT00385736|11478637|FG002|Efficacy Analysis Set - Maintenance|Other|4
7265121|NCT00385736|11478635|FG000|Safety Analysis Set|Adverse Event|23
7265122|NCT00385736|11478636|FG001|Safety Analysis Set|Adverse Event|15
7265123|NCT00385736|11478637|FG002|Safety Analysis Set|Adverse Event|23
7265124|NCT00385736|11478635|FG000|Safety Analysis Set|Withdrawal by Subject|6
7265125|NCT00385736|11478636|FG001|Safety Analysis Set|Withdrawal by Subject|6
7265126|NCT00385736|11478637|FG002|Safety Analysis Set|Withdrawal by Subject|14
7265127|NCT00385736|11478635|FG000|Safety Analysis Set|Lost to Follow-up|0
7265128|NCT00385736|11478636|FG001|Safety Analysis Set|Lost to Follow-up|2
7265129|NCT00385736|11478637|FG002|Safety Analysis Set|Lost to Follow-up|2
7265130|NCT00385736|11478635|FG000|Safety Analysis Set|Lack of Efficacy|38
7265131|NCT00385736|11478636|FG001|Safety Analysis Set|Lack of Efficacy|16
7265132|NCT00385736|11478637|FG002|Safety Analysis Set|Lack of Efficacy|31
7265133|NCT00385736|11478635|FG000|Safety Analysis Set|Protocol Violation|2
7265134|NCT00385736|11478636|FG001|Safety Analysis Set|Protocol Violation|1
7265135|NCT00385736|11478637|FG002|Safety Analysis Set|Protocol Violation|6
7265136|NCT00385736|11478635|FG000|Safety Analysis Set|Other|1
7265137|NCT00385736|11478636|FG001|Safety Analysis Set|Other|4
7265138|NCT00385736|11478637|FG002|Safety Analysis Set|Other|4
7265139|NCT00385762|11478648|FG000|Overall Study|Adverse Event|1
7265140|NCT00385762|11478648|FG000|Overall Study|Lost to Follow-up|1
7388103|NCT01217606|11646817|FG001|Initial Treatment Phase|Personal Reasons|2
7388104|NCT01217606|11646816|FG000|Initial Treatment Phase|Lack of Efficacy|1
7388105|NCT01217606|11646817|FG001|Initial Treatment Phase|Lack of Efficacy|0
7388106|NCT01217606|11646816|FG000|Initial Treatment Phase|Adverse Event|10
7388107|NCT01217606|11646817|FG001|Initial Treatment Phase|Adverse Event|6
7388108|NCT01217606|11646816|FG000|9-Month Masked Extension|Adverse Event|3
7388109|NCT01217606|11646817|FG001|9-Month Masked Extension|Adverse Event|6
7388110|NCT01217606|11646816|FG000|9-Month Masked Extension|Other Reasons|4
7388111|NCT01217606|11646817|FG001|9-Month Masked Extension|Other Reasons|4
7388112|NCT01217606|11646816|FG000|9-Month Masked Extension|Personal Reasons|2
7388113|NCT01217606|11646817|FG001|9-Month Masked Extension|Personal Reasons|1
7388114|NCT01217606|11646816|FG000|9-Month Masked Extension|Lost to Follow-up|1
7388115|NCT01217606|11646817|FG001|9-Month Masked Extension|Lost to Follow-up|0
7388116|NCT01217606|11646816|FG000|9-Month Masked Extension|Pregnancy|1
7388117|NCT01217606|11646817|FG001|9-Month Masked Extension|Pregnancy|0
7388118|NCT01217606|11646816|FG000|9-Month Masked Extension|Lack of Efficacy|2
7388119|NCT01217606|11646817|FG001|9-Month Masked Extension|Lack of Efficacy|0
7388120|NCT01217801|11646840|FG000|Period 1|Protocol Violation|1
7388121|NCT01217801|11646841|FG001|Period 1|Protocol Violation|1
7388122|NCT01217801|11646840|FG000|Period 1|Withdrawal by Subject|0
7388123|NCT01217801|11646841|FG001|Period 1|Withdrawal by Subject|1
7388124|NCT01217814|11646850|FG000|Overall Study|Adverse Event|1
7388125|NCT01217814|11646851|FG001|Overall Study|Adverse Event|1
7388126|NCT01217814|11646852|FG002|Overall Study|Adverse Event|0
7388127|NCT01217814|11646850|FG000|Overall Study|Lack of Efficacy|0
7388128|NCT01217814|11646851|FG001|Overall Study|Lack of Efficacy|0
7388129|NCT01217814|11646852|FG002|Overall Study|Lack of Efficacy|1
7469636|NCT01925274|11771444|FG000|Overall Study|Withdrawal by Subject|1
7469638|NCT01925274|11771446|FG002|Overall Study|Withdrawal by Subject|0
7469639|NCT01925274|11771444|FG000|Overall Study|Study terminated by sponsor|4
7469640|NCT01925274|11771445|FG001|Overall Study|Study terminated by sponsor|0
7469641|NCT01925274|11771446|FG002|Overall Study|Study terminated by sponsor|0
7469642|NCT01925274|11771444|FG000|Overall Study|Protocol amendment|1
7469643|NCT01925274|11771445|FG001|Overall Study|Protocol amendment|3
7469644|NCT01925274|11771446|FG002|Overall Study|Protocol amendment|6
7469645|NCT01925339|11771458|FG000|Overall Study|Adverse Event|2
7469646|NCT01925339|11771459|FG001|Overall Study|Adverse Event|0
7469647|NCT01925417|11771482|FG000|Overall Study|Withdrawal by Subject|2
7469648|NCT01925417|11771482|FG000|Overall Study|Death|1
7469649|NCT01925612|11771501|FG000|Overall Study|Progressive Disease|1
7469650|NCT01925612|11771502|FG001|Overall Study|Progressive Disease|1
7469651|NCT01925612|11771503|FG002|Overall Study|Progressive Disease|1
7469652|NCT01925612|11771504|FG003|Overall Study|Progressive Disease|0
7265141|NCT00385827|11478674|FG000|Part 1|Adverse Event|1
7265142|NCT00385827|11478675|FG001|Part 1|Adverse Event|0
7265143|NCT00385827|11478676|FG002|Part 1|Adverse Event|0
7265144|NCT00385827|11478674|FG000|Part 1|Death|2
7265145|NCT00385827|11478675|FG001|Part 1|Death|0
7265146|NCT00385827|11478676|FG002|Part 1|Death|0
7265147|NCT00385827|11478674|FG000|Part 1|Lack of Efficacy|5
7265148|NCT00385827|11478675|FG001|Part 1|Lack of Efficacy|0
7265149|NCT00385827|11478676|FG002|Part 1|Lack of Efficacy|0
7265150|NCT00385827|11478674|FG000|Part 1|Other|1
7265151|NCT00385827|11478675|FG001|Part 1|Other|0
7265152|NCT00385827|11478676|FG002|Part 1|Other|0
7265153|NCT00385827|11478674|FG000|Part 2|Adverse Event|0
7265154|NCT00385827|11478675|FG001|Part 2|Adverse Event|6
7265155|NCT00385827|11478676|FG002|Part 2|Adverse Event|10
7265156|NCT00385827|11478674|FG000|Part 2|Death|0
7265157|NCT00385827|11478675|FG001|Part 2|Death|0
7265158|NCT00385827|11478676|FG002|Part 2|Death|2
7265159|NCT00385827|11478674|FG000|Part 2|Lack of Efficacy|0
7265160|NCT00385827|11478675|FG001|Part 2|Lack of Efficacy|14
7265161|NCT00385827|11478676|FG002|Part 2|Lack of Efficacy|13
7265162|NCT00385827|11478674|FG000|Part 2|Randomized but not treated|0
7265163|NCT00385827|11478675|FG001|Part 2|Randomized but not treated|2
7265164|NCT00385827|11478676|FG002|Part 2|Randomized but not treated|2
7265165|NCT00385827|11478674|FG000|Part 2|Other|0
7265166|NCT00385827|11478675|FG001|Part 2|Other|11
7265167|NCT00385827|11478676|FG002|Part 2|Other|21
7265168|NCT00385840|11478688|FG000|Overall Study|Adverse Event|1
7265169|NCT00385840|11478689|FG001|Overall Study|Adverse Event|1
7265170|NCT00385840|11478688|FG000|Overall Study|Lost to Follow-up|3
7265171|NCT00385840|11478689|FG001|Overall Study|Lost to Follow-up|13
7265172|NCT00385918|11478697|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7265173|NCT00385918|11478698|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
7265174|NCT00385918|11478699|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
7265175|NCT00385918|11478697|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7265176|NCT00385918|11478698|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
7265177|NCT00385918|11478699|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
7265178|NCT00385918|11478697|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
7265179|NCT00385918|11478698|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
7265180|NCT00385918|11478699|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
7265181|NCT00385918|11478697|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
7265182|NCT00385918|11478698|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
7265183|NCT00385918|11478699|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
7265184|NCT00385918|11478697|FG000|Intervention Phase After Randomization|Physician Decision|1
7265185|NCT00385918|11478698|FG001|Intervention Phase After Randomization|Physician Decision|0
7265186|NCT00385918|11478699|FG002|Intervention Phase After Randomization|Physician Decision|0
7265187|NCT00385918|11478697|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
7265188|NCT00385918|11478698|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
7265189|NCT00385918|11478699|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
7265190|NCT00385944|11478708|FG000|1st Maintenance Dose Period|Physician Decision|1
7265191|NCT00385944|11478709|FG001|1st Maintenance Dose Period|Physician Decision|0
7265192|NCT00385944|11478710|FG002|1st Maintenance Dose Period|Physician Decision|0
7265193|NCT00385944|11478708|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7265194|NCT00385944|11478709|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
7265195|NCT00385944|11478710|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
7265196|NCT00385944|11478708|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
7265197|NCT00385944|11478709|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7265198|NCT00385944|11478710|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
7265199|NCT00385944|11478708|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
7265200|NCT00385944|11478709|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
7265201|NCT00385944|11478710|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
7265202|NCT00386009|11478732|FG000|Overall Study|Adverse Event|0
7265203|NCT00386009|11478733|FG001|Overall Study|Adverse Event|2
7265204|NCT00386009|11478732|FG000|Overall Study|Death|1
7265205|NCT00386009|11478733|FG001|Overall Study|Death|0
7545306|NCT02855164|11900096|FG004|Parts A + B (Randomized Set)|Adverse Event|0
7545307|NCT02855164|11900097|FG005|Parts A + B (Randomized Set)|Adverse Event|0
7545308|NCT02855164|11900098|FG006|Parts A + B (Randomized Set)|Adverse Event|0
7545309|NCT02855164|11900099|FG007|Parts A + B (Randomized Set)|Adverse Event|0
7545310|NCT02855164|11900092|FG000|Part C (Randomized Set)|Adverse Event|0
7545311|NCT02855164|11900093|FG001|Part C (Randomized Set)|Adverse Event|0
7545312|NCT02855164|11900094|FG002|Part C (Randomized Set)|Adverse Event|0
7265206|NCT00386009|11478732|FG000|Overall Study|Entry Criteria Not Met|0
7265207|NCT00386009|11478733|FG001|Overall Study|Entry Criteria Not Met|2
7265208|NCT00386009|11478732|FG000|Overall Study|Lost to Follow-up|1
7265209|NCT00386009|11478733|FG001|Overall Study|Lost to Follow-up|1
7265210|NCT00386009|11478732|FG000|Overall Study|Protocol Violation|1
7265211|NCT00386009|11478733|FG001|Overall Study|Protocol Violation|0
7265212|NCT00386009|11478732|FG000|Overall Study|Sponsor Decision|1
7265213|NCT00386009|11478733|FG001|Overall Study|Sponsor Decision|1
7265214|NCT00386009|11478732|FG000|Overall Study|Withdrawal by Subject|5
7265215|NCT00386009|11478733|FG001|Overall Study|Withdrawal by Subject|4
7265216|NCT00386022|11478741|FG000|Plus Estrogen|Lost to Follow-up|2
7265217|NCT00386022|11478742|FG001|Plus Estrogen|Lost to Follow-up|0
7545313|NCT02855164|11900095|FG003|Part C (Randomized Set)|Adverse Event|0
7545314|NCT02855164|11900096|FG004|Part C (Randomized Set)|Adverse Event|0
7545315|NCT02855164|11900097|FG005|Part C (Randomized Set)|Adverse Event|5
7545316|NCT02855164|11900098|FG006|Part C (Randomized Set)|Adverse Event|9
7545317|NCT02855164|11900099|FG007|Part C (Randomized Set)|Adverse Event|2
7545318|NCT02855164|11900092|FG000|Part C (Randomized Set)|Lost to Follow-up|0
7545319|NCT02855164|11900093|FG001|Part C (Randomized Set)|Lost to Follow-up|0
7545320|NCT02855164|11900094|FG002|Part C (Randomized Set)|Lost to Follow-up|0
7545321|NCT02855164|11900095|FG003|Part C (Randomized Set)|Lost to Follow-up|0
7545322|NCT02855164|11900096|FG004|Part C (Randomized Set)|Lost to Follow-up|0
7545323|NCT02855164|11900097|FG005|Part C (Randomized Set)|Lost to Follow-up|1
7545324|NCT02855164|11900098|FG006|Part C (Randomized Set)|Lost to Follow-up|1
7545325|NCT02855164|11900099|FG007|Part C (Randomized Set)|Lost to Follow-up|1
7545326|NCT02855164|11900092|FG000|Part C (Randomized Set)|Physician Decision|0
7545327|NCT02855164|11900093|FG001|Part C (Randomized Set)|Physician Decision|0
7545328|NCT02855164|11900094|FG002|Part C (Randomized Set)|Physician Decision|0
7545329|NCT02855164|11900095|FG003|Part C (Randomized Set)|Physician Decision|0
7545330|NCT02855164|11900096|FG004|Part C (Randomized Set)|Physician Decision|0
7545331|NCT02855164|11900097|FG005|Part C (Randomized Set)|Physician Decision|1
7545332|NCT02855164|11900098|FG006|Part C (Randomized Set)|Physician Decision|0
7545333|NCT02855164|11900099|FG007|Part C (Randomized Set)|Physician Decision|1
7545334|NCT02855164|11900092|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
7545335|NCT02855164|11900093|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
7545336|NCT02855164|11900094|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
7545337|NCT02855164|11900095|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
7545338|NCT02855164|11900096|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
7545339|NCT02855164|11900097|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
7545340|NCT02855164|11900098|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
7545341|NCT02855164|11900099|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
7545342|NCT02855359|11900147|FG000|Overall Study|Death|2
7545343|NCT02855359|11900148|FG001|Overall Study|Death|2
7545344|NCT02855359|11900149|FG002|Overall Study|Death|0
7545345|NCT02855359|11900150|FG003|Overall Study|Death|0
7545346|NCT02855359|11900147|FG000|Overall Study|Study Termination by Sponsor|9
7545347|NCT02855359|11900148|FG001|Overall Study|Study Termination by Sponsor|11
7545348|NCT02855359|11900149|FG002|Overall Study|Study Termination by Sponsor|0
7545349|NCT02855359|11900150|FG003|Overall Study|Study Termination by Sponsor|0
7545350|NCT02855450|11900168|FG000|Overall Study|Adverse Event|1
7545351|NCT02855450|11900169|FG001|Overall Study|Adverse Event|0
7545352|NCT02855450|11900168|FG000|Overall Study|Lost to Follow-up|4
7545353|NCT02855450|11900169|FG001|Overall Study|Lost to Follow-up|0
7545354|NCT02855541|11900175|FG000|Overall Study|Change in health status|2
7545355|NCT02855541|11900175|FG000|Overall Study|Withdrawal by Subject|2
7545356|NCT02856282|11900192|FG000|Overall Study|Withdrawal by Subject|1
7545357|NCT02856555|11900212|FG000|Overall Study|Adverse Event|1
7545358|NCT02856555|11900213|FG001|Overall Study|Adverse Event|0
7545359|NCT02856555|11900214|FG002|Overall Study|Adverse Event|0
7545360|NCT02856555|11900212|FG000|Overall Study|Lost to Follow-up|1
7545361|NCT02856555|11900213|FG001|Overall Study|Lost to Follow-up|3
7545362|NCT02856555|11900214|FG002|Overall Study|Lost to Follow-up|0
7545363|NCT02856555|11900212|FG000|Overall Study|Withdrawal by Subject|3
7545364|NCT02856555|11900213|FG001|Overall Study|Withdrawal by Subject|0
7545365|NCT02856555|11900214|FG002|Overall Study|Withdrawal by Subject|0
7545366|NCT02856555|11900212|FG000|Overall Study|Randomized but Never Treated|0
7545367|NCT02856555|11900213|FG001|Overall Study|Randomized but Never Treated|1
7545368|NCT02856555|11900214|FG002|Overall Study|Randomized but Never Treated|0
7545369|NCT02856802|11900224|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7545370|NCT02856802|11900225|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
7545371|NCT02856802|11900224|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
7545372|NCT02856802|11900225|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
7545373|NCT02856802|11900224|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
7545374|NCT02856802|11900225|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
7545375|NCT02856802|11900224|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
7265218|NCT00386022|11478741|FG000|Plus Estrogen|Adverse Event|0
7265219|NCT00386022|11478742|FG001|Plus Estrogen|Adverse Event|1
7265220|NCT00386100|11478752|FG000|Overall Study|Did not receive study medication|6
7265221|NCT00386100|11478753|FG001|Overall Study|Did not receive study medication|4
7265222|NCT00386100|11478752|FG000|Overall Study|Adverse Event|15
7265223|NCT00386100|11478753|FG001|Overall Study|Adverse Event|25
7265224|NCT00386100|11478752|FG000|Overall Study|Death|0
7265225|NCT00386100|11478753|FG001|Overall Study|Death|1
7265226|NCT00386100|11478752|FG000|Overall Study|Insufficient therapeutic effect|30
7265227|NCT00386100|11478753|FG001|Overall Study|Insufficient therapeutic effect|6
7545376|NCT02856802|11900225|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
7265228|NCT00386100|11478752|FG000|Overall Study|Lost to Follow-up|29
7265229|NCT00386100|11478753|FG001|Overall Study|Lost to Follow-up|29
7265230|NCT00386100|11478752|FG000|Overall Study|Non-compliance|18
7265231|NCT00386100|11478753|FG001|Overall Study|Non-compliance|19
7265232|NCT00386100|11478752|FG000|Overall Study|Protocol Violation|5
7265233|NCT00386100|11478753|FG001|Overall Study|Protocol Violation|3
7265234|NCT00386100|11478752|FG000|Overall Study|Withdrawal by Subject|32
7265235|NCT00386100|11478753|FG001|Overall Study|Withdrawal by Subject|31
7265236|NCT00386100|11478752|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
7265237|NCT00386100|11478753|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
7265238|NCT00386100|11478752|FG000|Overall Study|BMD <2.5|1
7265239|NCT00386100|11478753|FG001|Overall Study|BMD <2.5|0
7265240|NCT00386100|11478752|FG000|Overall Study|Consecutive elevated Hba1C|1
7265241|NCT00386100|11478753|FG001|Overall Study|Consecutive elevated Hba1C|0
7265242|NCT00386100|11478752|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
7265243|NCT00386100|11478753|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
7265244|NCT00386100|11478752|FG000|Overall Study|Laboratory findings|1
7265245|NCT00386100|11478753|FG001|Overall Study|Laboratory findings|0
7545377|NCT02856802|11900224|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
7545378|NCT02856802|11900225|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
7545379|NCT02856802|11900224|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
7545380|NCT02856802|11900225|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
7545381|NCT02856880|11900252|FG000|Overall Study|Withdrawal of consent|1
7545382|NCT02857283|11900273|FG000|First Exposure|Withdrawal by Subject|1
7545383|NCT02857283|11900274|FG001|First Exposure|Withdrawal by Subject|0
7545384|NCT02857816|11900281|FG000|Overall Study|Screen Failure|33
7545385|NCT02857816|11900281|FG000|Overall Study|Withdrawal by Subject|4
7545386|NCT02857816|11900281|FG000|Overall Study|Lost to Follow-up|1
7545387|NCT02858076|11900297|FG000|Overall Study|Death|6
7545388|NCT02858076|11900298|FG001|Overall Study|Death|3
7545389|NCT02858076|11900297|FG000|Overall Study|Withdrawal by Subject|1
7545390|NCT02858076|11900298|FG001|Overall Study|Withdrawal by Subject|5
7545391|NCT02858076|11900297|FG000|Overall Study|Lost to Follow-up|2
7545392|NCT02858076|11900298|FG001|Overall Study|Lost to Follow-up|7
7545393|NCT02858076|11900297|FG000|Overall Study|Completed Out of Window|1
7545394|NCT02858076|11900298|FG001|Overall Study|Completed Out of Window|3
7545395|NCT02858180|11900308|FG000|Overall Study|Lost to Follow-up|0
7545396|NCT02858180|11900309|FG001|Overall Study|Lost to Follow-up|2
7577012|NCT04098458|11965318|FG000|Overall Study|Death|1
7577013|NCT04098458|11965318|FG000|Overall Study|did not meet study inclusion criteria|3
7577014|NCT04095286|11965323|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577015|NCT04095286|11965324|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
7577016|NCT04095286|11965325|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577017|NCT04095286|11965326|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577018|NCT04095286|11965327|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577019|NCT04095286|11965328|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577020|NCT04095286|11965323|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
7577021|NCT04095286|11965324|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7577022|NCT04095286|11965325|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7577023|NCT04095286|11965326|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7577024|NCT04095286|11965327|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7577025|NCT04095286|11965328|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
7577026|NCT04095286|11965323|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7577027|NCT04095286|11965324|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7577028|NCT04095286|11965325|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
7577029|NCT04095286|11965326|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7577030|NCT04095286|11965327|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7577031|NCT04095286|11965328|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
7577032|NCT04095286|11965323|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577033|NCT04095286|11965324|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577034|NCT04095286|11965325|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
7577035|NCT04095286|11965326|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577036|NCT04095286|11965327|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577037|NCT04095286|11965328|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
7577038|NCT04095286|11965323|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7577039|NCT04095286|11965324|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7577040|NCT04095286|11965325|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7577041|NCT04095286|11965326|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7577042|NCT04095286|11965327|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
7577043|NCT04095286|11965328|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
7577044|NCT04094883|11965336|FG000|Overall Study|Withdrawal by Subject|1
7577045|NCT04091659|11965342|FG000|Overall Study|Protocol Violation|3
7577046|NCT04091659|11965343|FG001|Overall Study|Protocol Violation|0
7577047|NCT04091659|11965342|FG000|Overall Study|Lost to Follow-up|0
7577048|NCT04091659|11965343|FG001|Overall Study|Lost to Follow-up|1
7577049|NCT04090242|11965368|FG000|Overall Study|Withdrawal by Subject|1
7577050|NCT04090242|11965369|FG001|Overall Study|Withdrawal by Subject|0
7577051|NCT04089761|11965376|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
7265246|NCT00386100|11478752|FG000|Overall Study|Participant's concern due to CPK levels|1
7265247|NCT00386100|11478753|FG001|Overall Study|Participant's concern due to CPK levels|0
7265248|NCT00386100|11478752|FG000|Overall Study|Participant moving out of state|2
7265249|NCT00386100|11478753|FG001|Overall Study|Participant moving out of state|0
7265250|NCT00386100|11478752|FG000|Overall Study|Excessive bone loss vs. baseline value|0
7265251|NCT00386100|11478753|FG001|Overall Study|Excessive bone loss vs. baseline value|1
7265252|NCT00386100|11478752|FG000|Overall Study|Didn't meet entry criteria|1
7265253|NCT00386100|11478753|FG001|Overall Study|Didn't meet entry criteria|1
7265254|NCT00386100|11478752|FG000|Overall Study|Participant's PCP wanted to stop drug|1
7265255|NCT00386100|11478753|FG001|Overall Study|Participant's PCP wanted to stop drug|0
7265256|NCT00386100|11478752|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
7265257|NCT00386100|11478753|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
7265258|NCT00386100|11478752|FG000|Overall Study|Bad metabolic control & patient security|1
7265259|NCT00386100|11478753|FG001|Overall Study|Bad metabolic control & patient security|0
7265260|NCT00386100|11478752|FG000|Overall Study|Bone loss by DXA bone scan|1
7265261|NCT00386100|11478753|FG001|Overall Study|Bone loss by DXA bone scan|0
7265262|NCT00386100|11478752|FG000|Overall Study|DBP 93 mmHg at randomization|1
7265263|NCT00386100|11478753|FG001|Overall Study|DBP 93 mmHg at randomization|0
7265264|NCT00386100|11478752|FG000|Overall Study|7.6% bone loss|1
7265265|NCT00386100|11478753|FG001|Overall Study|7.6% bone loss|0
7545397|NCT02858362|11900322|FG000|Overall Study|Protocol Violation|0
7545398|NCT02858362|11900323|FG001|Overall Study|Protocol Violation|1
7545399|NCT02858362|11900324|FG002|Overall Study|Protocol Violation|0
7545400|NCT02858362|11900322|FG000|Overall Study|Withdrawal by Subject|1
7545401|NCT02858362|11900323|FG001|Overall Study|Withdrawal by Subject|0
7545402|NCT02858362|11900324|FG002|Overall Study|Withdrawal by Subject|0
7545403|NCT02858362|11900322|FG000|Overall Study|Early Study Termination|0
7545404|NCT02858362|11900323|FG001|Overall Study|Early Study Termination|0
7545405|NCT02858362|11900324|FG002|Overall Study|Early Study Termination|3
7545406|NCT02858362|11900322|FG000|Overall Study|Lost to Follow-up|1
7545407|NCT02858362|11900323|FG001|Overall Study|Lost to Follow-up|0
7545408|NCT02858362|11900324|FG002|Overall Study|Lost to Follow-up|0
7545409|NCT02858401|11900344|FG000|Overall Study|Withdrew Consent|0
7545410|NCT02858401|11900345|FG001|Overall Study|Withdrew Consent|0
7545411|NCT02858401|11900346|FG002|Overall Study|Withdrew Consent|0
7545412|NCT02858401|11900347|FG003|Overall Study|Withdrew Consent|0
7545413|NCT02858401|11900348|FG004|Overall Study|Withdrew Consent|0
7545414|NCT02858401|11900349|FG005|Overall Study|Withdrew Consent|1
7545415|NCT02858401|11900350|FG006|Overall Study|Withdrew Consent|0
7545416|NCT02858401|11900344|FG000|Overall Study|Lost to Follow-up|0
7545417|NCT02858401|11900345|FG001|Overall Study|Lost to Follow-up|1
7545418|NCT02858401|11900346|FG002|Overall Study|Lost to Follow-up|0
7545419|NCT02858401|11900347|FG003|Overall Study|Lost to Follow-up|0
7545420|NCT02858401|11900348|FG004|Overall Study|Lost to Follow-up|0
7545421|NCT02858401|11900349|FG005|Overall Study|Lost to Follow-up|0
7545422|NCT02858401|11900350|FG006|Overall Study|Lost to Follow-up|0
7545423|NCT02858440|11900375|FG000|Overall Study|Lost to Follow-up|3
7545424|NCT02858440|11900375|FG000|Overall Study|Protocol Violation|2
7545425|NCT02858440|11900375|FG000|Overall Study|Consent withdrawal|3
7545426|NCT02858440|11900375|FG000|Overall Study|Migrated/moved from study area|4
7545427|NCT02858492|11900383|FG000|Overall Study|Withdrawal by Subject|0
7545428|NCT02858492|11900384|FG001|Overall Study|Withdrawal by Subject|1
7545429|NCT02858492|11900385|FG002|Overall Study|Withdrawal by Subject|0
7545430|NCT02858492|11900386|FG003|Overall Study|Withdrawal by Subject|1
7545431|NCT02858492|11900383|FG000|Overall Study|Adverse Event|0
7545432|NCT02858492|11900384|FG001|Overall Study|Adverse Event|0
7545433|NCT02858492|11900385|FG002|Overall Study|Adverse Event|0
7545434|NCT02858492|11900386|FG003|Overall Study|Adverse Event|3
7545435|NCT02858492|11900383|FG000|Overall Study|Lack of Efficacy|0
7545436|NCT02858492|11900384|FG001|Overall Study|Lack of Efficacy|0
7545437|NCT02858492|11900385|FG002|Overall Study|Lack of Efficacy|0
7545438|NCT02858492|11900386|FG003|Overall Study|Lack of Efficacy|1
7545439|NCT02858492|11900383|FG000|Overall Study|Protocol defined stopping criteria|0
7545440|NCT02858492|11900384|FG001|Overall Study|Protocol defined stopping criteria|0
7545441|NCT02858492|11900385|FG002|Overall Study|Protocol defined stopping criteria|0
7545442|NCT02858492|11900386|FG003|Overall Study|Protocol defined stopping criteria|1
7545443|NCT02858726|11900415|FG000|Overall Study|Adverse Event|4
7545444|NCT02858726|11900416|FG001|Overall Study|Adverse Event|4
7545445|NCT02858726|11900417|FG002|Overall Study|Adverse Event|9
7545446|NCT02858726|11900418|FG003|Overall Study|Adverse Event|1
7545447|NCT02858726|11900415|FG000|Overall Study|Physician Decision|0
7545448|NCT02858726|11900416|FG001|Overall Study|Physician Decision|0
7265266|NCT00386100|11478752|FG000|Overall Study|Osteoporosis|0
7545449|NCT02858726|11900417|FG002|Overall Study|Physician Decision|1
7545450|NCT02858726|11900418|FG003|Overall Study|Physician Decision|0
7545451|NCT02858726|11900415|FG000|Overall Study|Protocol Violation|0
7545452|NCT02858726|11900416|FG001|Overall Study|Protocol Violation|0
7545453|NCT02858726|11900417|FG002|Overall Study|Protocol Violation|0
7545454|NCT02858726|11900418|FG003|Overall Study|Protocol Violation|1
7545455|NCT02858726|11900415|FG000|Overall Study|Study Terminated by Sponsor|0
7545456|NCT02858726|11900416|FG001|Overall Study|Study Terminated by Sponsor|0
7545457|NCT02858726|11900417|FG002|Overall Study|Study Terminated by Sponsor|0
7265267|NCT00386100|11478753|FG001|Overall Study|Osteoporosis|1
7265268|NCT00386100|11478752|FG000|Overall Study|Positive pregnancy test|1
7265269|NCT00386100|11478753|FG001|Overall Study|Positive pregnancy test|3
7265270|NCT00386100|11478752|FG000|Overall Study|Out of country for 5 months|1
7265271|NCT00386100|11478753|FG001|Overall Study|Out of country for 5 months|0
7265272|NCT00386100|11478752|FG000|Overall Study|Hb1Ac >8%|0
7265273|NCT00386100|11478753|FG001|Overall Study|Hb1Ac >8%|1
7265274|NCT00386100|11478752|FG000|Overall Study|Participant randomized in error|1
7265275|NCT00386100|11478753|FG001|Overall Study|Participant randomized in error|0
7265276|NCT00386152|11478762|FG000|Overall Study|Adverse Event|6
7265277|NCT00386152|11478763|FG001|Overall Study|Adverse Event|5
7265278|NCT00386152|11478764|FG002|Overall Study|Adverse Event|4
7265279|NCT00386152|11478762|FG000|Overall Study|Chang from original chemo stratification|4
7265280|NCT00386152|11478763|FG001|Overall Study|Chang from original chemo stratification|5
7265281|NCT00386152|11478764|FG002|Overall Study|Chang from original chemo stratification|6
7265282|NCT00386152|11478762|FG000|Overall Study|Death|3
7265283|NCT00386152|11478763|FG001|Overall Study|Death|0
7265284|NCT00386152|11478764|FG002|Overall Study|Death|1
7265285|NCT00386152|11478762|FG000|Overall Study|Disease progression|7
7265286|NCT00386152|11478763|FG001|Overall Study|Disease progression|4
7265287|NCT00386152|11478764|FG002|Overall Study|Disease progression|5
7265288|NCT00386152|11478762|FG000|Overall Study|Physician Decision|13
7265289|NCT00386152|11478763|FG001|Overall Study|Physician Decision|10
7265290|NCT00386152|11478764|FG002|Overall Study|Physician Decision|4
7265291|NCT00386152|11478762|FG000|Overall Study|Lost to Follow-up|1
7265292|NCT00386152|11478763|FG001|Overall Study|Lost to Follow-up|0
7265293|NCT00386152|11478764|FG002|Overall Study|Lost to Follow-up|0
7265294|NCT00386152|11478762|FG000|Overall Study|Completed chemotherapy|4
7265295|NCT00386152|11478763|FG001|Overall Study|Completed chemotherapy|5
7265296|NCT00386152|11478764|FG002|Overall Study|Completed chemotherapy|1
7265297|NCT00386152|11478762|FG000|Overall Study|Protocol Violation|3
7265298|NCT00386152|11478763|FG001|Overall Study|Protocol Violation|5
7265299|NCT00386152|11478764|FG002|Overall Study|Protocol Violation|2
7265300|NCT00386152|11478762|FG000|Overall Study|Withdrawal by Subject|3
7265301|NCT00386152|11478763|FG001|Overall Study|Withdrawal by Subject|6
7265302|NCT00386152|11478764|FG002|Overall Study|Withdrawal by Subject|10
7265303|NCT00386308|11478800|FG000|Overall Study|Adverse Event|3
7265304|NCT00386308|11478801|FG001|Overall Study|Adverse Event|3
7265305|NCT00386308|11478800|FG000|Overall Study|Protocol Violation|2
7265306|NCT00386308|11478801|FG001|Overall Study|Protocol Violation|5
7265307|NCT00386308|11478800|FG000|Overall Study|Lack of Efficacy|0
7265308|NCT00386308|11478801|FG001|Overall Study|Lack of Efficacy|2
7265309|NCT00386308|11478800|FG000|Overall Study|Lost to Follow-up|10
7265310|NCT00386308|11478801|FG001|Overall Study|Lost to Follow-up|6
7265311|NCT00386308|11478800|FG000|Overall Study|Withdrawal by Subject|6
7265312|NCT00386308|11478801|FG001|Overall Study|Withdrawal by Subject|2
7265313|NCT00386308|11478800|FG000|Overall Study|Other Event|8
7265314|NCT00386308|11478801|FG001|Overall Study|Other Event|1
7265315|NCT00386334|11478809|FG000|Double Blind Period|Adverse Event|9
7265316|NCT00386334|11478810|FG001|Double Blind Period|Adverse Event|14
7265317|NCT00386334|11478809|FG000|Double Blind Period|Protocol Violation|1
7265318|NCT00386334|11478810|FG001|Double Blind Period|Protocol Violation|1
7265319|NCT00386334|11478809|FG000|Double Blind Period|Withdrawal by Subject|9
7265320|NCT00386334|11478810|FG001|Double Blind Period|Withdrawal by Subject|13
7265321|NCT00386334|11478809|FG000|Double Blind Period|Lack of Efficacy|20
7265322|NCT00386334|11478810|FG001|Double Blind Period|Lack of Efficacy|11
7265323|NCT00386334|11478809|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
7265324|NCT00386334|11478810|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
7265325|NCT00386334|11478809|FG000|Double Blind Period|Other|3
7265326|NCT00386334|11478810|FG001|Double Blind Period|Other|3
7265327|NCT00386334|11478809|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
7265328|NCT00386334|11478810|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
7265329|NCT00386360|11478818|FG000|Overall Study|Adverse Event|4
7265330|NCT00386360|11478819|FG001|Overall Study|Adverse Event|2
7545458|NCT02858726|11900418|FG003|Overall Study|Study Terminated by Sponsor|1
7545459|NCT02858726|11900415|FG000|Overall Study|Withdrawal by Subject|1
7545460|NCT02858726|11900416|FG001|Overall Study|Withdrawal by Subject|2
7545461|NCT02858726|11900417|FG002|Overall Study|Withdrawal by Subject|1
7545462|NCT02858726|11900418|FG003|Overall Study|Withdrawal by Subject|0
7545463|NCT02858726|11900415|FG000|Overall Study|Noncompliance|0
7545464|NCT02858726|11900416|FG001|Overall Study|Noncompliance|1
7265331|NCT00386360|11478818|FG000|Overall Study|Physician Decision|2
7265332|NCT00386360|11478819|FG001|Overall Study|Physician Decision|2
7265333|NCT00386360|11478818|FG000|Overall Study|Lost to Follow-up|0
7265334|NCT00386360|11478819|FG001|Overall Study|Lost to Follow-up|2
7265335|NCT00386360|11478818|FG000|Overall Study|Protocol Violation|0
7265336|NCT00386360|11478819|FG001|Overall Study|Protocol Violation|3
7265337|NCT00386360|11478818|FG000|Overall Study|Withdrawal by Subject|3
7265338|NCT00386360|11478819|FG001|Overall Study|Withdrawal by Subject|6
7545465|NCT02858726|11900417|FG002|Overall Study|Noncompliance|0
7265339|NCT00386360|11478818|FG000|Overall Study|Did not take any study medication|0
7265340|NCT00386360|11478819|FG001|Overall Study|Did not take any study medication|2
7265341|NCT00386425|11478828|FG000|Overall Study|Physician Decision|3
7545466|NCT02858726|11900418|FG003|Overall Study|Noncompliance|0
7265342|NCT00386425|11478829|FG001|Overall Study|Physician Decision|0
7265343|NCT00386425|11478830|FG002|Overall Study|Physician Decision|0
7265344|NCT00386425|11478828|FG000|Overall Study|Withdrawal by Subject|0
7265345|NCT00386425|11478829|FG001|Overall Study|Withdrawal by Subject|1
7265346|NCT00386425|11478830|FG002|Overall Study|Withdrawal by Subject|0
7265347|NCT00386607|11478851|FG000|Core|Adverse Event|40
7265348|NCT00386607|11478852|FG001|Core|Adverse Event|0
7265349|NCT00386607|11478851|FG000|Core|Abnormal laboratory value(s)|3
7265350|NCT00386607|11478852|FG001|Core|Abnormal laboratory value(s)|0
7265351|NCT00386607|11478851|FG000|Core|Unsatisfactory therapeutic effect|23
7265352|NCT00386607|11478852|FG001|Core|Unsatisfactory therapeutic effect|0
7265353|NCT00386607|11478851|FG000|Core|Condition no longer requires study drug|4
7265354|NCT00386607|11478852|FG001|Core|Condition no longer requires study drug|0
7265355|NCT00386607|11478851|FG000|Core|Patient withdrew consent|15
7265356|NCT00386607|11478852|FG001|Core|Patient withdrew consent|0
7265357|NCT00386607|11478851|FG000|Core|Lost to Follow-up|23
7265358|NCT00386607|11478852|FG001|Core|Lost to Follow-up|0
7265359|NCT00386607|11478851|FG000|Core|Administrative problems|1
7265360|NCT00386607|11478852|FG001|Core|Administrative problems|0
7265361|NCT00386607|11478851|FG000|Core|Protocol Deviation|6
7265362|NCT00386607|11478852|FG001|Core|Protocol Deviation|0
7265363|NCT00386607|11478851|FG000|Extension|Adverse Event|0
7265364|NCT00386607|11478852|FG001|Extension|Adverse Event|6
7265365|NCT00386607|11478851|FG000|Extension|Abnormal laboratory value(s)|0
7265366|NCT00386607|11478852|FG001|Extension|Abnormal laboratory value(s)|1
7265367|NCT00386607|11478851|FG000|Extension|Administrative problems|0
7265368|NCT00386607|11478852|FG001|Extension|Administrative problems|1
7265369|NCT00386607|11478851|FG000|Extension|Lost to Follow-up|0
7265370|NCT00386607|11478852|FG001|Extension|Lost to Follow-up|3
7265371|NCT00386607|11478851|FG000|Extension|Patient withdrew consent|0
7265372|NCT00386607|11478852|FG001|Extension|Patient withdrew consent|5
7265373|NCT00386607|11478851|FG000|Extension|Unsatisfactory therapeutic effect|0
7265374|NCT00386607|11478852|FG001|Extension|Unsatisfactory therapeutic effect|1
7265375|NCT00386776|11478864|FG000|Overall Study|Withdrawal by Subject|8
7265376|NCT00387010|11478876|FG000|Dose Titration Period|Adverse Event|12
7265377|NCT00387010|11478876|FG000|Dose Titration Period|Lack of Efficacy|5
7265378|NCT00387010|11478876|FG000|Dose Titration Period|Withdrawal by Subject|3
7265379|NCT00387010|11478876|FG000|Dose Titration Period|Protocol Violation|1
7265380|NCT00387010|11478876|FG000|Dose Titration Period|Lost to Follow-up|2
7545467|NCT02859142|11900434|FG000|Overall Study|Adverse Event|1
7545468|NCT02859142|11900435|FG001|Overall Study|Adverse Event|2
7545469|NCT02859142|11900434|FG000|Overall Study|Lost to Follow-up|1
7545470|NCT02859142|11900435|FG001|Overall Study|Lost to Follow-up|4
7545471|NCT02859142|11900434|FG000|Overall Study|Withdrawal by Subject|2
7545472|NCT02859142|11900435|FG001|Overall Study|Withdrawal by Subject|0
7545473|NCT02859142|11900434|FG000|Overall Study|Scheduling difficulties|0
7545474|NCT02859142|11900435|FG001|Overall Study|Scheduling difficulties|3
7545475|NCT02859246|11900441|FG000|Overall Study|Screen fails|3
7545476|NCT02859246|11900441|FG000|Overall Study|Adverse Event|1
7545477|NCT02859246|11900441|FG000|Overall Study|Withdrawal by Subject|1
7545478|NCT02859324|11900449|FG000|Overall Study|Death|4
7545479|NCT02859324|11900450|FG001|Overall Study|Death|6
7545480|NCT02859324|11900451|FG002|Overall Study|Death|5
7545481|NCT02859324|11900449|FG000|Overall Study|Other reasons|3
7545482|NCT02859324|11900450|FG001|Overall Study|Other reasons|3
7545483|NCT02859324|11900451|FG002|Overall Study|Other reasons|0
7545484|NCT02859454|11900480|FG000|Overall Study|PI discretion/off study prior to trtmt|1
7545485|NCT02860130|11900500|FG000|Overall Study|Adverse Event|2
7545486|NCT02860130|11900501|FG001|Overall Study|Adverse Event|3
7545487|NCT02860130|11900500|FG000|Overall Study|Protocol Violation|1
7545488|NCT02860130|11900501|FG001|Overall Study|Protocol Violation|1
7545489|NCT02860130|11900500|FG000|Overall Study|Withdrawal by Subject|0
7545490|NCT02860130|11900501|FG001|Overall Study|Withdrawal by Subject|2
7545491|NCT02860130|11900500|FG000|Overall Study|Physician Decision|2
7545492|NCT02860130|11900501|FG001|Overall Study|Physician Decision|2
7545493|NCT02860130|11900500|FG000|Overall Study|Other|2
7545494|NCT02860130|11900501|FG001|Overall Study|Other|1
7265381|NCT00387010|11478876|FG000|Dose Titration Period|Noncompliance with study medication|8
7265382|NCT00387010|11478876|FG000|Dose Titration Period|Noncompliance with study procedures|7
7545495|NCT02860546|11900534|FG000|Overall Study|Clinical Progression|6
7545496|NCT02860546|11900534|FG000|Overall Study|Radiological Progression|12
7545497|NCT02861534|11900582|FG000|Overall Study|Death|541
7545498|NCT02861534|11900583|FG001|Overall Study|Death|552
7265383|NCT00387010|11478876|FG000|Treatment Period|Adverse Event|4
7265384|NCT00387010|11478876|FG000|Treatment Period|Withdrawal by Subject|1
7265385|NCT00387010|11478876|FG000|Treatment Period|Noncompliance with study medication|2
7265386|NCT00387010|11478876|FG000|Treatment Period|Noncompliance with study procedures|3
7265387|NCT00387010|11478876|FG000|Treatment Period|Participant reported study drug stolen|1
7265388|NCT00387088|11478893|FG000|Overall Study|Adverse Event|143
7265389|NCT00387088|11478894|FG001|Overall Study|Adverse Event|156
7265390|NCT00387088|11478893|FG000|Overall Study|Protocol Violation|47
7265391|NCT00387088|11478894|FG001|Overall Study|Protocol Violation|35
7265392|NCT00387088|11478893|FG000|Overall Study|Withdrawal by Subject|20
7265393|NCT00387088|11478894|FG001|Overall Study|Withdrawal by Subject|35
7265394|NCT00387088|11478893|FG000|Overall Study|Lack of Efficacy|28
7265395|NCT00387088|11478894|FG001|Overall Study|Lack of Efficacy|67
7265396|NCT00387088|11478893|FG000|Overall Study|Lost to Follow-up|22
7265397|NCT00387088|11478894|FG001|Overall Study|Lost to Follow-up|28
7265398|NCT00387088|11478893|FG000|Overall Study|Other|58
7265399|NCT00387088|11478894|FG001|Overall Study|Other|52
7265400|NCT00387127|11478902|FG000|Overall Study|Lost to Follow-up|0
7265401|NCT00387127|11478903|FG001|Overall Study|Lost to Follow-up|4
7265402|NCT00387127|11478902|FG000|Overall Study|Death|16
7265403|NCT00387127|11478903|FG001|Overall Study|Death|16
7265404|NCT00387127|11478902|FG000|Overall Study|Physician Decision|0
7265405|NCT00387127|11478903|FG001|Overall Study|Physician Decision|1
7265406|NCT00387127|11478902|FG000|Overall Study|Withdrawal by Subject|3
7265407|NCT00387127|11478903|FG001|Overall Study|Withdrawal by Subject|2
7265408|NCT00387127|11478902|FG000|Overall Study|Required by Protocol Amendment #4|12
7265409|NCT00387127|11478903|FG001|Overall Study|Required by Protocol Amendment #4|10
7265410|NCT00387127|11478902|FG000|Overall Study|Serious Adverse Event|1
7265411|NCT00387127|11478903|FG001|Overall Study|Serious Adverse Event|1
7265412|NCT00387127|11478902|FG000|Overall Study|Sponsor Unblinded|1
7265413|NCT00387127|11478903|FG001|Overall Study|Sponsor Unblinded|0
7265414|NCT00387153|11478911|FG000|Overall Study|Adverse Event|1
7265415|NCT00387153|11478911|FG000|Overall Study|Disease Progression|3
7265416|NCT00387153|11478911|FG000|Overall Study|Lack of Response|4
7265417|NCT00387348|11478927|FG000|Overall Study|Death|1
7265418|NCT00387348|11478928|FG001|Overall Study|Death|1
7265419|NCT00387348|11478929|FG002|Overall Study|Death|0
7265420|NCT00387348|11478927|FG000|Overall Study|Physician Decision|1
7265421|NCT00387348|11478928|FG001|Overall Study|Physician Decision|0
7265422|NCT00387348|11478929|FG002|Overall Study|Physician Decision|1
7265423|NCT00387348|11478927|FG000|Overall Study|Withdrawal by Subject|0
7265424|NCT00387348|11478928|FG001|Overall Study|Withdrawal by Subject|2
7265425|NCT00387348|11478929|FG002|Overall Study|Withdrawal by Subject|2
7265426|NCT00387348|11478927|FG000|Overall Study|Adverse Event|1
7265427|NCT00387348|11478928|FG001|Overall Study|Adverse Event|0
7265428|NCT00387348|11478929|FG002|Overall Study|Adverse Event|1
7265429|NCT00387426|11478942|FG000|Overall Study|Lack of Response|7
7265430|NCT00387426|11478942|FG000|Overall Study|Toxicities|4
7265431|NCT00387426|11478942|FG000|Overall Study|Disease Progression|3
7265432|NCT00387465|11478949|FG000|Overall Study|Withdrawal by Subject|0
7265433|NCT00387465|11478950|FG001|Overall Study|Withdrawal by Subject|1
7265434|NCT00387465|11478951|FG002|Overall Study|Withdrawal by Subject|0
7265435|NCT00387647|11478975|FG000|Overall Study|Death|18
7265436|NCT00387712|11478990|FG000|Overall Study|Physician Decision|6
7265437|NCT00387712|11478991|FG001|Overall Study|Physician Decision|4
7265438|NCT00387712|11478990|FG000|Overall Study|Lost to Follow-up|17
7265439|NCT00387712|11478991|FG001|Overall Study|Lost to Follow-up|20
7265440|NCT00387712|11478990|FG000|Overall Study|Withdrawal by Subject|6
7265441|NCT00387712|11478991|FG001|Overall Study|Withdrawal by Subject|12
7265442|NCT00387725|11479001|FG000|Overall Study|Adverse Event|0
7265443|NCT00387725|11479002|FG001|Overall Study|Adverse Event|0
7265444|NCT00387725|11479003|FG002|Overall Study|Adverse Event|0
7265445|NCT00387725|11479004|FG003|Overall Study|Adverse Event|1
7265446|NCT00387725|11479001|FG000|Overall Study|Protocol Violation|0
7265447|NCT00387725|11479002|FG001|Overall Study|Protocol Violation|1
7265448|NCT00387725|11479003|FG002|Overall Study|Protocol Violation|0
7265449|NCT00387725|11479004|FG003|Overall Study|Protocol Violation|0
7265450|NCT00387725|11479001|FG000|Overall Study|Withdrawal by Subject|1
7265451|NCT00387725|11479002|FG001|Overall Study|Withdrawal by Subject|0
7265452|NCT00387725|11479003|FG002|Overall Study|Withdrawal by Subject|1
7265453|NCT00387725|11479004|FG003|Overall Study|Withdrawal by Subject|0
7545499|NCT02861534|11900582|FG000|Overall Study|Lost to Follow-up|14
7545500|NCT02861534|11900583|FG001|Overall Study|Lost to Follow-up|14
7545501|NCT02861534|11900582|FG000|Overall Study|Site Terminated by Sponsor|4
7545502|NCT02861534|11900583|FG001|Overall Study|Site Terminated by Sponsor|3
7545503|NCT02861534|11900582|FG000|Overall Study|Withdrawal by Subject|15
7545504|NCT02861534|11900583|FG001|Overall Study|Withdrawal by Subject|18
7265454|NCT00387725|11479001|FG000|Overall Study|Parent/legal guardian request|0
7265455|NCT00387725|11479002|FG001|Overall Study|Parent/legal guardian request|0
7265456|NCT00387725|11479003|FG002|Overall Study|Parent/legal guardian request|1
7265457|NCT00387725|11479004|FG003|Overall Study|Parent/legal guardian request|1
7265458|NCT00387764|11479020|FG000|Overall Study|Adverse Event|12
7265459|NCT00387764|11479020|FG000|Overall Study|Withdrawal by Subject|8
7265460|NCT00387764|11479020|FG000|Overall Study|Sponsor Terminated Study|1
7545505|NCT02861586|11900597|FG000|Overall Study|Withdrawal by Subject|1
7265461|NCT00387764|11479020|FG000|Overall Study|Physician Decision|1
7265462|NCT00387764|11479020|FG000|Overall Study|Other|2
7265463|NCT00387764|11479020|FG000|Overall Study|Death|7
7265464|NCT00387790|11479024|FG000|Overall Study|Adverse Event|5
7265465|NCT00387790|11479024|FG000|Overall Study|Lack of Efficacy|2
7265466|NCT00387790|11479024|FG000|Overall Study|Physician Decision|2
7265467|NCT00387790|11479024|FG000|Overall Study|Withdrawal by Subject|3
7265468|NCT00387790|11479024|FG000|Overall Study|Ineligible for study|2
7265469|NCT00387881|11479039|FG000|Overall Study|Lost to Follow-up|23
7265470|NCT00387881|11479040|FG001|Overall Study|Lost to Follow-up|23
7265471|NCT00387881|11479039|FG000|Overall Study|Protocol Violation|2
7265472|NCT00387881|11479040|FG001|Overall Study|Protocol Violation|12
7265473|NCT00387881|11479039|FG000|Overall Study|Withdrawal by Subject|15
7265474|NCT00387881|11479040|FG001|Overall Study|Withdrawal by Subject|18
7265475|NCT00387881|11479039|FG000|Overall Study|Sponsor terminated Study|0
7265476|NCT00387881|11479040|FG001|Overall Study|Sponsor terminated Study|1
7265477|NCT00387881|11479039|FG000|Overall Study|Not eligible|6
7265478|NCT00387881|11479040|FG001|Overall Study|Not eligible|7
7265479|NCT00387881|11479039|FG000|Overall Study|No opportunity to treat headache|32
7265480|NCT00387881|11479040|FG001|Overall Study|No opportunity to treat headache|34
7265481|NCT00387881|11479039|FG000|Overall Study|Not otherwise specified|11
7265482|NCT00387881|11479040|FG001|Overall Study|Not otherwise specified|7
7265483|NCT00387894|11479046|FG000|Overall Study|Withdrawal by Subject|1
7265484|NCT00388037|11479054|FG000|Overall Study|Protocol Violation|1
7265485|NCT00388154|11479058|FG000|Overall Study|Withdrawal by Subject|1
7265486|NCT00388297|11479066|FG000|Overall Study|Lost to Follow-up|16
7545506|NCT02861586|11900598|FG001|Overall Study|Withdrawal by Subject|2
7545507|NCT02861586|11900599|FG002|Overall Study|Withdrawal by Subject|0
7545508|NCT02861586|11900600|FG003|Overall Study|Withdrawal by Subject|0
7545509|NCT02861586|11900601|FG004|Overall Study|Withdrawal by Subject|0
7545510|NCT02861586|11900602|FG005|Overall Study|Withdrawal by Subject|1
7545511|NCT02861586|11900603|FG006|Overall Study|Withdrawal by Subject|1
7545512|NCT02861586|11900604|FG007|Overall Study|Withdrawal by Subject|0
7545513|NCT02861586|11900597|FG000|Overall Study|Lost to Follow-up|3
7545514|NCT02861586|11900598|FG001|Overall Study|Lost to Follow-up|1
7545515|NCT02861586|11900599|FG002|Overall Study|Lost to Follow-up|1
7545516|NCT02861586|11900600|FG003|Overall Study|Lost to Follow-up|0
7545517|NCT02861586|11900601|FG004|Overall Study|Lost to Follow-up|0
7545518|NCT02861586|11900602|FG005|Overall Study|Lost to Follow-up|3
7545519|NCT02861586|11900603|FG006|Overall Study|Lost to Follow-up|0
7545520|NCT02861586|11900604|FG007|Overall Study|Lost to Follow-up|0
7545521|NCT02861586|11900597|FG000|Overall Study|Adverse Event|0
7545522|NCT02861586|11900598|FG001|Overall Study|Adverse Event|0
7545523|NCT02861586|11900599|FG002|Overall Study|Adverse Event|0
7545524|NCT02861586|11900600|FG003|Overall Study|Adverse Event|0
7545525|NCT02861586|11900601|FG004|Overall Study|Adverse Event|0
7545526|NCT02861586|11900602|FG005|Overall Study|Adverse Event|1
7545527|NCT02861586|11900603|FG006|Overall Study|Adverse Event|0
7545528|NCT02861586|11900604|FG007|Overall Study|Adverse Event|0
7545529|NCT02861664|11900629|FG000|Overall Study|Withdrawal of Consent|0
7545530|NCT02861664|11900630|FG001|Overall Study|Withdrawal of Consent|1
7545531|NCT02861807|11900638|FG000|Overall Study|Lost to Follow-up|7
7545532|NCT02861807|11900639|FG001|Overall Study|Lost to Follow-up|6
7545533|NCT02861807|11900638|FG000|Overall Study|Withdrawal by Subject|5
7545534|NCT02861807|11900639|FG001|Overall Study|Withdrawal by Subject|8
7545535|NCT02862106|11900680|FG000|Overall Study|Adverse Event|4
7545536|NCT02862106|11900681|FG001|Overall Study|Adverse Event|0
7545537|NCT02862106|11900680|FG000|Overall Study|Protocol Violation|16
7545538|NCT02862106|11900681|FG001|Overall Study|Protocol Violation|1
7545539|NCT02862106|11900680|FG000|Overall Study|Lost to Follow-up|15
7545540|NCT02862106|11900681|FG001|Overall Study|Lost to Follow-up|5
7545541|NCT02862106|11900680|FG000|Overall Study|Withdrawal by Subject|2
7545542|NCT02862106|11900681|FG001|Overall Study|Withdrawal by Subject|0
7545543|NCT02862106|11900680|FG000|Overall Study|Subjects moved to other city|1
7545544|NCT02862106|11900681|FG001|Overall Study|Subjects moved to other city|0
7545545|NCT02862535|11900697|FG000|Overall Study|Death|7
7545546|NCT02862535|11900698|FG001|Overall Study|Death|3
7545547|NCT02862535|11900699|FG002|Overall Study|Death|2
7545548|NCT02862535|11900700|FG003|Overall Study|Death|5
7545549|NCT02862535|11900697|FG000|Overall Study|Study Terminated by Sponsor|1
7545550|NCT02862535|11900698|FG001|Overall Study|Study Terminated by Sponsor|3
7545551|NCT02862535|11900699|FG002|Overall Study|Study Terminated by Sponsor|8
7545552|NCT02862535|11900700|FG003|Overall Study|Study Terminated by Sponsor|5
7265487|NCT00388297|11479067|FG001|Overall Study|Lost to Follow-up|12
7265488|NCT00388297|11479068|FG002|Overall Study|Lost to Follow-up|11
7545553|NCT02862535|11900697|FG000|Overall Study|Enrolled, not Treated|1
7545554|NCT02862535|11900698|FG001|Overall Study|Enrolled, not Treated|0
7545555|NCT02862535|11900699|FG002|Overall Study|Enrolled, not Treated|0
7545556|NCT02862535|11900700|FG003|Overall Study|Enrolled, not Treated|1
7545557|NCT02862574|11900713|FG000|Double-Blind Treatment Period|Adverse Event|0
7545558|NCT02862574|11900714|FG001|Double-Blind Treatment Period|Adverse Event|1
7545559|NCT02862574|11900715|FG002|Double-Blind Treatment Period|Adverse Event|0
7265570|NCT00388674|11479136|FG000|End of Study|No Off-Treatment Status Data|22
7545560|NCT02862574|11900713|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
7545561|NCT02862574|11900714|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
7265489|NCT00388297|11479069|FG003|Overall Study|Lost to Follow-up|8
7265490|NCT00388349|11479079|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
7265491|NCT00388349|11479080|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
7265492|NCT00388362|11479088|FG000|Enrolled|Ineligible|1
7265493|NCT00388362|11479088|FG000|Enrolled|Adverse Event|9
7265494|NCT00388362|11479088|FG000|Enrolled|Death|1
7265495|NCT00388362|11479088|FG000|Enrolled|Loss insurance|1
7265496|NCT00388362|11479088|FG000|Enrolled|Withdrawal by Subject|1
7265497|NCT00388362|11479088|FG000|Remained on Study Median of 514 Days|Death|2
7265498|NCT00388505|11479118|FG000|Overall Study|Adverse Event or Death|43
7265499|NCT00388505|11479119|FG001|Overall Study|Adverse Event or Death|17
7265500|NCT00388505|11479118|FG000|Overall Study|Withdrawal by Subject|24
7265501|NCT00388505|11479119|FG001|Overall Study|Withdrawal by Subject|9
7265502|NCT00388505|11479118|FG000|Overall Study|Lost to Follow-up|5
7265503|NCT00388505|11479119|FG001|Overall Study|Lost to Follow-up|3
7265504|NCT00388505|11479118|FG000|Overall Study|Inappropriate Enrollment|0
7265505|NCT00388505|11479119|FG001|Overall Study|Inappropriate Enrollment|1
7265506|NCT00388505|11479118|FG000|Overall Study|Administrative Reason|1
7265507|NCT00388505|11479119|FG001|Overall Study|Administrative Reason|0
7265508|NCT00388505|11479118|FG000|Overall Study|Protocol Violation|6
7265509|NCT00388505|11479119|FG001|Overall Study|Protocol Violation|5
7265510|NCT00388505|11479118|FG000|Overall Study|Unable to classify|4
7265511|NCT00388505|11479119|FG001|Overall Study|Unable to classify|3
7265512|NCT00388583|11479127|FG000|Overall Study|Protocol Violation|1
7265513|NCT00388583|11479128|FG001|Overall Study|Protocol Violation|0
7265514|NCT00388583|11479127|FG000|Overall Study|Withdrawal by Subject|3
7265515|NCT00388583|11479128|FG001|Overall Study|Withdrawal by Subject|3
7265516|NCT00388583|11479127|FG000|Overall Study|Serious Adverse Event|2
7265517|NCT00388583|11479128|FG001|Overall Study|Serious Adverse Event|0
7265518|NCT00388583|11479127|FG000|Overall Study|Did not receive vaccine|0
7265519|NCT00388583|11479128|FG001|Overall Study|Did not receive vaccine|1
7265520|NCT00388674|11479136|FG000|Initial Treatment|Administrative Reason by Sponsor|241
7265521|NCT00388674|11479137|FG001|Initial Treatment|Administrative Reason by Sponsor|158
7265522|NCT00388674|11479136|FG000|Initial Treatment|Adverse Event|22
7265523|NCT00388674|11479137|FG001|Initial Treatment|Adverse Event|87
7265524|NCT00388674|11479136|FG000|Initial Treatment|Death|215
7265525|NCT00388674|11479137|FG001|Initial Treatment|Death|216
7265526|NCT00388674|11479136|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
7265527|NCT00388674|11479137|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
7265528|NCT00388674|11479136|FG000|Initial Treatment|HCC|12
7265529|NCT00388674|11479137|FG001|Initial Treatment|HCC|20
7265530|NCT00388674|11479136|FG000|Initial Treatment|Lost to Follow-up|526
7265531|NCT00388674|11479137|FG001|Initial Treatment|Lost to Follow-up|624
7265532|NCT00388674|11479136|FG000|Initial Treatment|Malignancy (Non-HCC)|7
7265533|NCT00388674|11479137|FG001|Initial Treatment|Malignancy (Non-HCC)|3
7265534|NCT00388674|11479136|FG000|Initial Treatment|Never Treated with Study Medication|1
7265535|NCT00388674|11479137|FG001|Initial Treatment|Never Treated with Study Medication|7
7265536|NCT00388674|11479136|FG000|Initial Treatment|Non-Study related Comorbidities|3
7265537|NCT00388674|11479137|FG001|Initial Treatment|Non-Study related Comorbidities|4
7265538|NCT00388674|11479136|FG000|Initial Treatment|Not Defined|125
7265539|NCT00388674|11479137|FG001|Initial Treatment|Not Defined|172
7265540|NCT00388674|11479136|FG000|Initial Treatment|Partial or inadequate Treatment|112
7265541|NCT00388674|11479137|FG001|Initial Treatment|Partial or inadequate Treatment|472
7265542|NCT00388674|11479136|FG000|Initial Treatment|Pregnancy|26
7265543|NCT00388674|11479137|FG001|Initial Treatment|Pregnancy|16
7265544|NCT00388674|11479136|FG000|Initial Treatment|Study Drug Toxicity|5
7265545|NCT00388674|11479137|FG001|Initial Treatment|Study Drug Toxicity|92
7265546|NCT00388674|11479136|FG000|Initial Treatment|Participant Request|501
7265547|NCT00388674|11479137|FG001|Initial Treatment|Participant Request|673
7265548|NCT00388674|11479136|FG000|Initial Treatment|No Off-Treatment Status Data|11
7265549|NCT00388674|11479137|FG001|Initial Treatment|No Off-Treatment Status Data|13
7265550|NCT00388674|11479136|FG000|Initial Treatment|Not Reported|10
7265551|NCT00388674|11479137|FG001|Initial Treatment|Not Reported|12
7265552|NCT00388674|11479136|FG000|End of Study|Administrative Reason By Sponsor|299
7265553|NCT00388674|11479137|FG001|End of Study|Administrative Reason By Sponsor|253
7265554|NCT00388674|11479136|FG000|End of Study|Death|239
7265555|NCT00388674|11479137|FG001|End of Study|Death|262
7265556|NCT00388674|11479136|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
7265557|NCT00388674|11479137|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
7265558|NCT00388674|11479136|FG000|End of Study|HCC|8
7265559|NCT00388674|11479137|FG001|End of Study|HCC|7
7265560|NCT00388674|11479136|FG000|End of Study|Lost to Follow-up|587
7265561|NCT00388674|11479137|FG001|End of Study|Lost to Follow-up|715
7265562|NCT00388674|11479136|FG000|End of Study|Malignancy (Non-HCC)|1
7265563|NCT00388674|11479137|FG001|End of Study|Malignancy (Non-HCC)|1
7265564|NCT00388674|11479136|FG000|End of Study|Non-Study Related Comorbidities|3
7265565|NCT00388674|11479137|FG001|End of Study|Non-Study Related Comorbidities|4
7265566|NCT00388674|11479136|FG000|End of Study|Not Defined|135
7265567|NCT00388674|11479137|FG001|End of Study|Not Defined|214
7265568|NCT00388674|11479136|FG000|End of Study|Participant Withdrew Consent|437
7265569|NCT00388674|11479137|FG001|End of Study|Participant Withdrew Consent|673
7265571|NCT00388674|11479137|FG001|End of Study|No Off-Treatment Status Data|30
7265572|NCT00388674|11479136|FG000|End of Study|Not Reported|0
7265573|NCT00388674|11479137|FG001|End of Study|Not Reported|1
7265574|NCT00388726|11479145|FG000|Overall Study|Adverse Event|50
7265575|NCT00388726|11479146|FG001|Overall Study|Adverse Event|24
7265576|NCT00388726|11479145|FG000|Overall Study|Progressive Disease|336
7265577|NCT00388726|11479146|FG001|Overall Study|Progressive Disease|153
7265578|NCT00388726|11479145|FG000|Overall Study|Clinical Progression|61
7265579|NCT00388726|11479146|FG001|Overall Study|Clinical Progression|36
7265580|NCT00388726|11479145|FG000|Overall Study|Withdrawal by Subject|10
7265581|NCT00388726|11479146|FG001|Overall Study|Withdrawal by Subject|7
7265582|NCT00388726|11479145|FG000|Overall Study|Administrative|6
7265583|NCT00388726|11479146|FG001|Overall Study|Administrative|9
7265584|NCT00388726|11479145|FG000|Overall Study|Physician Decision|18
7265585|NCT00388726|11479146|FG001|Overall Study|Physician Decision|13
7265586|NCT00388726|11479145|FG000|Overall Study|Death|3
7545562|NCT02862574|11900715|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
7545563|NCT02862574|11900713|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
7545564|NCT02862574|11900714|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
7545565|NCT02862574|11900715|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
7545566|NCT02862600|11900724|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
7545567|NCT02862600|11900724|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
7545568|NCT02862600|11900724|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
7545569|NCT02862600|11900724|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
7545570|NCT02862730|11900730|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545571|NCT02862730|11900731|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545572|NCT02862730|11900732|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
7545573|NCT02862730|11900733|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545574|NCT02862730|11900734|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545575|NCT02862730|11900735|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545576|NCT02862730|11900736|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
7545577|NCT02862730|11900730|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
7577052|NCT04089761|11965376|FG000|"Run In Phase"|Lost to Follow-up|1
7577053|NCT04089761|11965376|FG000|"Treatment Phase"|No evaluable data|5
7577054|NCT04089761|11965376|FG000|"Treatment Phase"|Lost to Follow-up|1
7577055|NCT04079803|11965383|FG000|Overall Study|Withdrawal by Subject|0
7577056|NCT04079803|11965384|FG001|Overall Study|Withdrawal by Subject|0
7577057|NCT04079803|11965385|FG002|Overall Study|Withdrawal by Subject|1
7577058|NCT04086641|11965428|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
7577059|NCT04086641|11965429|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
7577060|NCT04085289|11965447|FG000|Overall Study|Withdrawal by Subject|0
7577061|NCT04085289|11965448|FG001|Overall Study|Withdrawal by Subject|0
7577062|NCT04085289|11965449|FG002|Overall Study|Withdrawal by Subject|1
7577063|NCT04082663|11965460|FG000|Overall Study|Adverse Event|6
7577064|NCT04082663|11965460|FG000|Overall Study|Lost to Follow-up|1
7577065|NCT04079790|11965541|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
7577066|NCT04079790|11965542|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7577067|NCT04079790|11965543|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7577068|NCT04079790|11965544|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
7577069|NCT04079790|11965541|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7577070|NCT04079790|11965542|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7577071|NCT04079790|11965543|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
7577072|NCT04079790|11965544|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
7577073|NCT04079790|11965541|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7577074|NCT04079790|11965542|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7577075|NCT04079790|11965543|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
7577076|NCT04079790|11965544|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
7577077|NCT04073407|11965635|FG000|Part 1|Withdrawal by Subject|1
7577078|NCT04073407|11965636|FG001|Part 1|Withdrawal by Subject|0
7577079|NCT04073407|11965635|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
7577080|NCT04073407|11965636|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
7577081|NCT04073407|11965635|FG000|Part 2|Withdrawal by Subject|0
7577082|NCT04073407|11965636|FG001|Part 2|Withdrawal by Subject|1
7577083|NCT04073368|11965646|FG000|Overall Study|Adverse Event|2
7577084|NCT04073368|11965647|FG001|Overall Study|Adverse Event|0
7577085|NCT04073368|11965648|FG002|Overall Study|Adverse Event|1
7577086|NCT04073368|11965649|FG003|Overall Study|Adverse Event|1
7577087|NCT04073368|11965646|FG000|Overall Study|Withdrawal by Subject|2
7577088|NCT04073368|11965647|FG001|Overall Study|Withdrawal by Subject|2
7577089|NCT04073368|11965648|FG002|Overall Study|Withdrawal by Subject|1
7577090|NCT04073368|11965649|FG003|Overall Study|Withdrawal by Subject|1
7577091|NCT04073368|11965646|FG000|Overall Study|Lost to Follow-up|1
7577092|NCT04073368|11965647|FG001|Overall Study|Lost to Follow-up|1
7577093|NCT04073368|11965648|FG002|Overall Study|Lost to Follow-up|1
7577094|NCT04073368|11965649|FG003|Overall Study|Lost to Follow-up|0
7265587|NCT00388726|11479146|FG001|Overall Study|Death|2
7265588|NCT00388947|11479161|FG000|Overall Study|Protocol Violation|47
7265589|NCT00388973|11479167|FG000|Overall Study|Adverse Event|16
7265590|NCT00388973|11479168|FG001|Overall Study|Adverse Event|6
7265591|NCT00388973|11479167|FG000|Overall Study|Lack of Efficacy|1
7265592|NCT00388973|11479168|FG001|Overall Study|Lack of Efficacy|12
7265593|NCT00388973|11479167|FG000|Overall Study|Protocol Violation|3
7265594|NCT00388973|11479168|FG001|Overall Study|Protocol Violation|0
7265595|NCT00388973|11479167|FG000|Overall Study|Withdrawal by Subject|14
7265596|NCT00388973|11479168|FG001|Overall Study|Withdrawal by Subject|17
7265597|NCT00388973|11479167|FG000|Overall Study|Study specific Discontinuation Criteria|0
7265598|NCT00388973|11479168|FG001|Overall Study|Study specific Discontinuation Criteria|1
7265599|NCT00388973|11479167|FG000|Overall Study|Did not complete 61 days of treatment|5
7265600|NCT00388973|11479168|FG001|Overall Study|Did not complete 61 days of treatment|4
7265601|NCT00388973|11479167|FG000|Overall Study|Left region|0
7265602|NCT00388973|11479168|FG001|Overall Study|Left region|1
7265603|NCT00388973|11479167|FG000|Overall Study|Did not complete 2-week follow-up visit|17
7265604|NCT00388973|11479168|FG001|Overall Study|Did not complete 2-week follow-up visit|17
7265605|NCT00389064|11479176|FG000|Overall Study|Adverse Event|11
7265606|NCT00389064|11479177|FG001|Overall Study|Adverse Event|3
7265607|NCT00389064|11479176|FG000|Overall Study|Lack of Efficacy|3
7265608|NCT00389064|11479177|FG001|Overall Study|Lack of Efficacy|14
7265609|NCT00389064|11479176|FG000|Overall Study|Withdrawal by Subject|17
7265610|NCT00389064|11479177|FG001|Overall Study|Withdrawal by Subject|27
7265611|NCT00389064|11479176|FG000|Overall Study|Physician Decision|2
7265612|NCT00389064|11479177|FG001|Overall Study|Physician Decision|2
7265613|NCT00389064|11479176|FG000|Overall Study|Lost to Follow-up|1
7265614|NCT00389064|11479177|FG001|Overall Study|Lost to Follow-up|2
7265615|NCT00389064|11479176|FG000|Overall Study|Protocol Violation|2
7265616|NCT00389064|11479177|FG001|Overall Study|Protocol Violation|0
7265617|NCT00389064|11479176|FG000|Overall Study|Multiple Reasons|9
7265618|NCT00389064|11479177|FG001|Overall Study|Multiple Reasons|11
7265619|NCT00389207|11479195|FG000|Overall Study|Adverse Event|26
7265620|NCT00389207|11479196|FG001|Overall Study|Adverse Event|32
7265621|NCT00389207|11479197|FG002|Overall Study|Adverse Event|10
7265622|NCT00389207|11479195|FG000|Overall Study|Protocol Violation|3
7265623|NCT00389207|11479196|FG001|Overall Study|Protocol Violation|1
7265624|NCT00389207|11479197|FG002|Overall Study|Protocol Violation|4
7265625|NCT00389207|11479195|FG000|Overall Study|Lost to Follow-up|12
7265626|NCT00389207|11479196|FG001|Overall Study|Lost to Follow-up|9
7265627|NCT00389207|11479197|FG002|Overall Study|Lost to Follow-up|7
7265628|NCT00389207|11479195|FG000|Overall Study|Withdrawal by Subject|5
7265629|NCT00389207|11479196|FG001|Overall Study|Withdrawal by Subject|7
7265630|NCT00389207|11479197|FG002|Overall Study|Withdrawal by Subject|11
7265631|NCT00389207|11479195|FG000|Overall Study|Other|17
7545578|NCT02862730|11900731|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545579|NCT02862730|11900732|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545580|NCT02862730|11900733|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545581|NCT02862730|11900734|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545582|NCT02862730|11900735|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545583|NCT02862730|11900736|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
7545584|NCT02862730|11900730|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7545585|NCT02862730|11900731|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7545586|NCT02862730|11900732|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7545587|NCT02862730|11900733|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7545588|NCT02862730|11900734|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
7545589|NCT02862730|11900735|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7545590|NCT02862730|11900736|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
7545591|NCT02862730|11900730|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7545592|NCT02862730|11900731|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7545593|NCT02862730|11900732|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7545594|NCT02862730|11900733|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
7545595|NCT02862730|11900734|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7545596|NCT02862730|11900735|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7545597|NCT02862730|11900736|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
7265632|NCT00389207|11479196|FG001|Overall Study|Other|23
7265633|NCT00389207|11479197|FG002|Overall Study|Other|9
7265634|NCT00389324|11479210|FG000|Run-In Phase|Adverse Event|1
7265635|NCT00389324|11479210|FG000|Run-In Phase|Lost to Follow-up|1
7265636|NCT00389324|11479210|FG000|Run-In Phase|Withdrawal by Subject|1
7265637|NCT00389324|11479210|FG000|Subcutaneous Phase|Adverse Event|2
7265638|NCT00389324|11479210|FG000|Subcutaneous Phase|Non-compliance with study medication|2
7265639|NCT00389324|11479210|FG000|Subcutaneous Phase|Withdrawal by Subject|2
7265640|NCT00389324|11479210|FG000|Subcutaneous Phase|Lost to Follow-up|1
7265641|NCT00389441|11479217|FG000|Overall Study|Adverse Event|7
7265642|NCT00389441|11479217|FG000|Overall Study|Death|4
7265643|NCT00389441|11479217|FG000|Overall Study|Lost to Follow-up|2
7265644|NCT00389441|11479217|FG000|Overall Study|Withdrawal by Subject|4
7265645|NCT00389441|11479217|FG000|Overall Study|Physician Decision|1
7265646|NCT00389441|11479217|FG000|Overall Study|Protocol Violation|1
7265647|NCT00389441|11479217|FG000|Overall Study|Global deterioration of health status|4
7265648|NCT00389441|11479217|FG000|Overall Study|Objective progression or relapse|26
7265649|NCT00389441|11479217|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
7265650|NCT00389441|11479217|FG000|Overall Study|Clinical progression|1
7265651|NCT00389519|11479259|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
7265652|NCT00389519|11479260|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
7265653|NCT00389519|11479261|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
7265654|NCT00389519|11479262|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
7265655|NCT00389519|11479259|FG000|Placebo Run-In|Withdrawal by Subject|19
7545604|NCT02863354|11900796|FG000|Year 1|Lost to Follow-up|1
7545605|NCT02863354|11900797|FG001|Year 1|Lost to Follow-up|1
7545606|NCT02863354|11900796|FG000|Year 1|Withdrawal by Subject|3
7545607|NCT02863354|11900797|FG001|Year 1|Withdrawal by Subject|0
7545608|NCT02863354|11900796|FG000|Year 1|Death|0
7545609|NCT02863354|11900797|FG001|Year 1|Death|1
7545610|NCT02863354|11900796|FG000|Year 2|Lost to Follow-up|2
7545611|NCT02863354|11900797|FG001|Year 2|Lost to Follow-up|2
7545621|NCT02863575|11900819|FG000|Overall Study|Participants Unable To Swallow Capsule|1
7545622|NCT02863575|11900820|FG001|Overall Study|Participants Unable To Swallow Capsule|0
7545623|NCT02863575|11900821|FG002|Overall Study|Participants Unable To Swallow Capsule|0
7545624|NCT02863575|11900819|FG000|Overall Study|Withdrawal by Subject|0
7545625|NCT02863575|11900820|FG001|Overall Study|Withdrawal by Subject|1
7545626|NCT02863575|11900821|FG002|Overall Study|Withdrawal by Subject|1
7545627|NCT02863575|11900819|FG000|Overall Study|Adverse Event|0
7545628|NCT02863575|11900820|FG001|Overall Study|Adverse Event|1
7545629|NCT02863575|11900821|FG002|Overall Study|Adverse Event|0
7545630|NCT02864082|11900844|FG000|Overall Study|Adverse Event|1
7545631|NCT02864082|11900845|FG001|Overall Study|Adverse Event|1
7545632|NCT02864082|11900844|FG000|Overall Study|Lost to Follow-up|0
7545633|NCT02864082|11900845|FG001|Overall Study|Lost to Follow-up|1
7545634|NCT02864082|11900844|FG000|Overall Study|Withdrawal by Subject|2
7545635|NCT02864082|11900845|FG001|Overall Study|Withdrawal by Subject|2
7545636|NCT02864316|11900867|FG000|Overall Study|Progressive Disease|2
7545637|NCT02864316|11900868|FG001|Overall Study|Progressive Disease|1
7545638|NCT02864316|11900867|FG000|Overall Study|Adverse Event|0
7545639|NCT02864316|11900868|FG001|Overall Study|Adverse Event|1
7545640|NCT02864342|11900876|FG000|Overall Study|Eligibility Criteria Deviation|2
7545641|NCT02864342|11900877|FG001|Overall Study|Eligibility Criteria Deviation|3
7545642|NCT02864342|11900876|FG000|Overall Study|Withdrawal by Subject|4
7545643|NCT02864342|11900877|FG001|Overall Study|Withdrawal by Subject|2
7545644|NCT02864342|11900876|FG000|Overall Study|Device Technology Issue|6
7545645|NCT02864342|11900877|FG001|Overall Study|Device Technology Issue|7
7545646|NCT02864342|11900876|FG000|Overall Study|Death|0
7545647|NCT02864342|11900877|FG001|Overall Study|Death|1
7545648|NCT02864342|11900876|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
7545649|NCT02864342|11900877|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
7545650|NCT02864342|11900876|FG000|Overall Study|Lost to Follow-up|1
7545651|NCT02864342|11900877|FG001|Overall Study|Lost to Follow-up|5
7545652|NCT02864342|11900876|FG000|Overall Study|Lost Device|1
7545653|NCT02864342|11900877|FG001|Overall Study|Lost Device|0
7545654|NCT02864342|11900876|FG000|Overall Study|Adverse Event|1
7545655|NCT02864342|11900877|FG001|Overall Study|Adverse Event|0
7545656|NCT02864381|11900895|FG000|Overall Study|Death|58
7545657|NCT02864381|11900896|FG001|Overall Study|Death|61
7545658|NCT02864381|11900895|FG000|Overall Study|Withdrew Consent|5
7545659|NCT02864381|11900896|FG001|Overall Study|Withdrew Consent|6
7545660|NCT02864381|11900895|FG000|Overall Study|Reason Unknown|7
7545661|NCT02864381|11900896|FG001|Overall Study|Reason Unknown|3
7545662|NCT02864381|11900895|FG000|Overall Study|Lost to Follow-up|1
7545663|NCT02864381|11900896|FG001|Overall Study|Lost to Follow-up|1
7545664|NCT02864381|11900895|FG000|Overall Study|Investigator's Discretion|1
7545665|NCT02864381|11900896|FG001|Overall Study|Investigator's Discretion|0
7545666|NCT02864381|11900895|FG000|Overall Study|Protocol Violation|0
7545667|NCT02864381|11900896|FG001|Overall Study|Protocol Violation|1
7545674|NCT02865499|11900992|FG000|Baseline|Adverse Event|1
7545675|NCT02865499|11900992|FG000|Baseline|Withdrawal by Subject|1
7545676|NCT02865538|11901001|FG000|Overall Study|Withdrawal by Subject|0
7545677|NCT02865538|11901002|FG001|Overall Study|Withdrawal by Subject|0
7545678|NCT02865538|11901003|FG002|Overall Study|Withdrawal by Subject|1
7545679|NCT02865538|11901004|FG003|Overall Study|Withdrawal by Subject|0
7577095|NCT04073368|11965646|FG000|Overall Study|Protocol Violation|0
7577096|NCT04073368|11965647|FG001|Overall Study|Protocol Violation|1
7577097|NCT04073368|11965648|FG002|Overall Study|Protocol Violation|0
7577098|NCT04073368|11965649|FG003|Overall Study|Protocol Violation|0
7577099|NCT04073368|11965646|FG000|Overall Study|Subject noncompliance|7
7577100|NCT04073368|11965647|FG001|Overall Study|Subject noncompliance|4
7577101|NCT04073368|11965648|FG002|Overall Study|Subject noncompliance|0
7577102|NCT04073368|11965649|FG003|Overall Study|Subject noncompliance|0
7577109|NCT04071301|11965727|FG000|Overall Study|Withdrawal by Subject|6
7577110|NCT04071301|11965727|FG000|Overall Study|Death|1
7545680|NCT02865538|11901005|FG004|Overall Study|Withdrawal by Subject|0
7545681|NCT02865538|11901001|FG000|Overall Study|Lost to Follow-up|1
7545682|NCT02865538|11901002|FG001|Overall Study|Lost to Follow-up|0
7545683|NCT02865538|11901003|FG002|Overall Study|Lost to Follow-up|0
7577111|NCT04071158|11965736|FG000|Overall Study|Lost to Follow-up|1
7577112|NCT04071158|11965737|FG001|Overall Study|Lost to Follow-up|2
7577113|NCT04071158|11965738|FG002|Overall Study|Lost to Follow-up|3
7545684|NCT02865538|11901004|FG003|Overall Study|Lost to Follow-up|0
7545685|NCT02865538|11901005|FG004|Overall Study|Lost to Follow-up|0
7545686|NCT02866175|11901041|FG000|Overall Study|Adverse Event|56
7545687|NCT02866175|11901042|FG001|Overall Study|Adverse Event|54
7545688|NCT02866175|11901041|FG000|Overall Study|Withdrawal by Subject|31
7545689|NCT02866175|11901042|FG001|Overall Study|Withdrawal by Subject|52
7545690|NCT02866175|11901041|FG000|Overall Study|Death|30
7545691|NCT02866175|11901042|FG001|Overall Study|Death|23
7545692|NCT02866175|11901041|FG000|Overall Study|Other|7
7545693|NCT02866175|11901042|FG001|Overall Study|Other|14
7545694|NCT02866175|11901041|FG000|Overall Study|Progressive disease|1
7545695|NCT02866175|11901042|FG001|Overall Study|Progressive disease|1
7545696|NCT02866175|11901041|FG000|Overall Study|Lost to Follow-up|2
7545697|NCT02866175|11901042|FG001|Overall Study|Lost to Follow-up|0
7545698|NCT02866175|11901041|FG000|Overall Study|Lack of Efficacy|0
7545699|NCT02866175|11901042|FG001|Overall Study|Lack of Efficacy|1
7545700|NCT02866175|11901041|FG000|Overall Study|Physician Decision|3
7545701|NCT02866175|11901042|FG001|Overall Study|Physician Decision|15
7545702|NCT02866175|11901041|FG000|Overall Study|Did not receive treatment|5
7545703|NCT02866175|11901042|FG001|Overall Study|Did not receive treatment|15
7545704|NCT02866942|11901058|FG000|Overall Study|Invalid consent|1
7545705|NCT02867709|11901112|FG000|Treatment Period|Adverse Event|1
7545706|NCT02867709|11901113|FG001|Treatment Period|Adverse Event|1
7545707|NCT02867709|11901114|FG002|Treatment Period|Adverse Event|2
7545708|NCT02867709|11901112|FG000|Treatment Period|Withdrawal of Consent|7
7545709|NCT02867709|11901113|FG001|Treatment Period|Withdrawal of Consent|9
7545710|NCT02867709|11901114|FG002|Treatment Period|Withdrawal of Consent|8
7545711|NCT02867709|11901112|FG000|Treatment Period|Lost to Follow-up|17
7545712|NCT02867709|11901113|FG001|Treatment Period|Lost to Follow-up|20
7545713|NCT02867709|11901114|FG002|Treatment Period|Lost to Follow-up|20
7545714|NCT02867709|11901112|FG000|Treatment Period|Lack of Qualifying Event|42
7577114|NCT04071158|11965739|FG003|Overall Study|Lost to Follow-up|3
7577115|NCT04071158|11965740|FG004|Overall Study|Lost to Follow-up|5
7265656|NCT00389519|11479260|FG001|Placebo Run-In|Withdrawal by Subject|0
7265657|NCT00389519|11479261|FG002|Placebo Run-In|Withdrawal by Subject|0
7265658|NCT00389519|11479262|FG003|Placebo Run-In|Withdrawal by Subject|0
7265659|NCT00389519|11479259|FG000|Placebo Run-In|Reason not specified|40
7265660|NCT00389519|11479260|FG001|Placebo Run-In|Reason not specified|0
7265661|NCT00389519|11479261|FG002|Placebo Run-In|Reason not specified|0
7265662|NCT00389519|11479262|FG003|Placebo Run-In|Reason not specified|0
7265663|NCT00389519|11479259|FG000|Randomized|Did not receive study drug|2
7265664|NCT00389519|11479260|FG001|Randomized|Did not receive study drug|0
7265665|NCT00389519|11479261|FG002|Randomized|Did not receive study drug|0
7265666|NCT00389519|11479262|FG003|Randomized|Did not receive study drug|0
7265667|NCT00389519|11479259|FG000|Treated|Adverse Event|1
7265668|NCT00389519|11479260|FG001|Treated|Adverse Event|0
7265669|NCT00389519|11479261|FG002|Treated|Adverse Event|0
7265670|NCT00389519|11479262|FG003|Treated|Adverse Event|2
7265671|NCT00389519|11479259|FG000|Treated|Reason not specified|1
7265672|NCT00389519|11479260|FG001|Treated|Reason not specified|1
7265673|NCT00389519|11479261|FG002|Treated|Reason not specified|0
7265674|NCT00389519|11479262|FG003|Treated|Reason not specified|2
7265675|NCT00389597|11479285|FG000|Overall Study|Lost to Follow-up|8
7265676|NCT00389597|11479286|FG001|Overall Study|Lost to Follow-up|6
7265677|NCT00389597|11479287|FG002|Overall Study|Lost to Follow-up|4
7265678|NCT00389597|11479288|FG003|Overall Study|Lost to Follow-up|6
7265679|NCT00389831|11479313|FG000|Overall Study|Lack of Efficacy|0
7265680|NCT00389831|11479314|FG001|Overall Study|Lack of Efficacy|2
7265681|NCT00389831|11479313|FG000|Overall Study|Did not receive treatment.|0
7265682|NCT00389831|11479314|FG001|Overall Study|Did not receive treatment.|2
7265683|NCT00389831|11479313|FG000|Overall Study|Other reasons|0
7265684|NCT00389831|11479314|FG001|Overall Study|Other reasons|2
7265685|NCT00389831|11479313|FG000|Overall Study|Lost to Follow-up|0
7265686|NCT00389831|11479314|FG001|Overall Study|Lost to Follow-up|1
7265687|NCT00390013|11479348|FG000|Phase 1|tired|0
7265688|NCT00390013|11479349|FG001|Phase 1|tired|0
7265689|NCT00390013|11479350|FG002|Phase 1|tired|0
7265690|NCT00390013|11479351|FG003|Phase 1|tired|1
7545715|NCT02867709|11901113|FG001|Treatment Period|Lack of Qualifying Event|55
7545716|NCT02867709|11901114|FG002|Treatment Period|Lack of Qualifying Event|42
7545717|NCT02867709|11901112|FG000|Treatment Period|Protocol Violation|3
7545718|NCT02867709|11901113|FG001|Treatment Period|Protocol Violation|2
7545719|NCT02867709|11901114|FG002|Treatment Period|Protocol Violation|3
7545720|NCT02867709|11901112|FG000|Safety Follow-up Period|Withdrawal of Consent|1
7545721|NCT02867709|11901113|FG001|Safety Follow-up Period|Withdrawal of Consent|8
7545722|NCT02867709|11901114|FG002|Safety Follow-up Period|Withdrawal of Consent|6
7577116|NCT04071158|11965736|FG000|Overall Study|Randomized but not treated|2
7577117|NCT04071158|11965737|FG001|Overall Study|Randomized but not treated|2
7577118|NCT04071158|11965738|FG002|Overall Study|Randomized but not treated|0
7577119|NCT04071158|11965739|FG003|Overall Study|Randomized but not treated|0
7577120|NCT04071158|11965740|FG004|Overall Study|Randomized but not treated|0
7577121|NCT04069715|11965781|FG000|Overall Study|Lost to Follow-up|1
7577122|NCT04069715|11965782|FG001|Overall Study|Lost to Follow-up|1
7577123|NCT04069715|11965781|FG000|Overall Study|Physician Decision|1
7577124|NCT04069715|11965782|FG001|Overall Study|Physician Decision|1
7577125|NCT04069715|11965781|FG000|Overall Study|Withdrawal by Subject|3
7577126|NCT04069715|11965782|FG001|Overall Study|Withdrawal by Subject|3
7577127|NCT04050722|11965790|FG000|Overall Study|Withdrawal by Subject|1
7577128|NCT04050722|11965791|FG001|Overall Study|Withdrawal by Subject|0
7577129|NCT04067141|11965812|FG000|First Intervention|Withdrawal by Subject|0
7545723|NCT02867709|11901112|FG000|Safety Follow-up Period|Lost to Follow-up|10
7545724|NCT02867709|11901113|FG001|Safety Follow-up Period|Lost to Follow-up|5
7545725|NCT02867709|11901114|FG002|Safety Follow-up Period|Lost to Follow-up|7
7545726|NCT02867709|11901112|FG000|Safety Follow-up Period|Pregnancy|0
7545727|NCT02867709|11901113|FG001|Safety Follow-up Period|Pregnancy|1
7545728|NCT02867709|11901114|FG002|Safety Follow-up Period|Pregnancy|0
7545729|NCT02867709|11901112|FG000|Safety Follow-up Period|Protocol Violation|0
7545730|NCT02867709|11901113|FG001|Safety Follow-up Period|Protocol Violation|1
7545731|NCT02867709|11901114|FG002|Safety Follow-up Period|Protocol Violation|1
7545732|NCT02867995|11901124|FG000|Overall Study|Withdrawal by Subject|0
7545733|NCT02867995|11901125|FG001|Overall Study|Withdrawal by Subject|1
7545734|NCT02867995|11901124|FG000|Overall Study|Lost to Follow-up|0
7545735|NCT02867995|11901125|FG001|Overall Study|Lost to Follow-up|2
7545736|NCT02868216|11901137|FG000|Overall Study|Death|0
7545737|NCT02868216|11901138|FG001|Overall Study|Death|1
7545738|NCT02868216|11901137|FG000|Overall Study|coronary artery bypass|1
7545739|NCT02868216|11901138|FG001|Overall Study|coronary artery bypass|0
7577130|NCT04067141|11965813|FG001|First Intervention|Withdrawal by Subject|1
7545740|NCT02868216|11901137|FG000|Overall Study|Withdrawal by Subject|7
7545741|NCT02868216|11901138|FG001|Overall Study|Withdrawal by Subject|5
7545742|NCT02868229|11901148|FG000|Overall Study|Adverse Event|1
7545743|NCT02868229|11901149|FG001|Overall Study|Adverse Event|0
7577131|NCT04067141|11965812|FG000|Second Intervention|Adverse Event|0
7265691|NCT00390013|11479348|FG000|Phase 2 First Treatment|tired|1
7265692|NCT00390013|11479349|FG001|Phase 2 First Treatment|tired|0
7265693|NCT00390013|11479350|FG002|Phase 2 First Treatment|tired|0
7265694|NCT00390013|11479351|FG003|Phase 2 First Treatment|tired|0
7388130|NCT01217892|11646884|FG000|Overall Study|Adverse Event|1
7577132|NCT04067141|11965813|FG001|Second Intervention|Adverse Event|2
7577133|NCT04049578|11965819|FG000|Overall Study|Physician Decision|1
7577134|NCT04067401|11965825|FG000|Overall Study|Withdrawal by Subject|7
7577135|NCT04067401|11965826|FG001|Overall Study|Withdrawal by Subject|0
7577136|NCT04067401|11965825|FG000|Overall Study|no data provided|1
7577137|NCT04067401|11965826|FG001|Overall Study|no data provided|0
7577138|NCT04067050|11965834|FG000|One Month|Lost to Follow-up|4
7577139|NCT04067050|11965835|FG001|One Month|Lost to Follow-up|0
7577140|NCT04067050|11965834|FG000|Two Month|Lost to Follow-up|1
7577141|NCT04067050|11965835|FG001|Two Month|Lost to Follow-up|0
7577142|NCT04067050|11965834|FG000|Two Month|Adverse Event|1
7577143|NCT04067050|11965835|FG001|Two Month|Adverse Event|0
7577144|NCT04060654|11965871|FG000|Overall Study|Withdrawal by Subject|1
7577145|NCT04060654|11965871|FG000|Overall Study|Lost to Follow-up|5
7577146|NCT04058353|11965884|FG000|Overall Study|Adverse Event|2
7577147|NCT04058353|11965885|FG001|Overall Study|Adverse Event|1
7577148|NCT04058353|11965884|FG000|Overall Study|Physician Decision|1
7577149|NCT04058353|11965885|FG001|Overall Study|Physician Decision|0
7577150|NCT04058353|11965884|FG000|Overall Study|Other|1
7577151|NCT04058353|11965885|FG001|Overall Study|Other|0
7265695|NCT00390013|11479348|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
7265696|NCT00390013|11479349|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
7265697|NCT00390013|11479350|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
7265698|NCT00390013|11479351|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
7265699|NCT00390221|11479364|FG000|Overall Study|Lost to Follow-up|0
7265700|NCT00390221|11479365|FG001|Overall Study|Lost to Follow-up|3
7265701|NCT00390221|11479366|FG002|Overall Study|Lost to Follow-up|0
7265702|NCT00390221|11479364|FG000|Overall Study|Adverse Event|1
7265703|NCT00390221|11479365|FG001|Overall Study|Adverse Event|4
7265704|NCT00390221|11479366|FG002|Overall Study|Adverse Event|3
7265705|NCT00390221|11479364|FG000|Overall Study|Investigator Decision|0
7265706|NCT00390221|11479365|FG001|Overall Study|Investigator Decision|0
7265707|NCT00390221|11479366|FG002|Overall Study|Investigator Decision|1
7265708|NCT00390221|11479364|FG000|Overall Study|Withdrawal by Subject|13
7265709|NCT00390221|11479365|FG001|Overall Study|Withdrawal by Subject|9
7265710|NCT00390221|11479366|FG002|Overall Study|Withdrawal by Subject|7
7265711|NCT00390221|11479364|FG000|Overall Study|Subject Non-compliance|1
7265712|NCT00390221|11479365|FG001|Overall Study|Subject Non-compliance|0
7265713|NCT00390221|11479366|FG002|Overall Study|Subject Non-compliance|2
7265714|NCT00390221|11479364|FG000|Overall Study|Other|3
7265715|NCT00390221|11479365|FG001|Overall Study|Other|4
7265716|NCT00390221|11479366|FG002|Overall Study|Other|2
7265717|NCT00390299|11479385|FG000|Overall Study|Cancellation|1
7265718|NCT00390299|11479386|FG001|Overall Study|Cancellation|0
7265719|NCT00390299|11479387|FG002|Overall Study|Cancellation|0
7265720|NCT00390299|11479388|FG003|Overall Study|Cancellation|0
7265721|NCT00390299|11479389|FG004|Overall Study|Cancellation|0
7545744|NCT02868229|11901150|FG002|Overall Study|Adverse Event|0
7545745|NCT02868229|11901151|FG003|Overall Study|Adverse Event|1
7545746|NCT02868229|11901148|FG000|Overall Study|Death|0
7545747|NCT02868229|11901149|FG001|Overall Study|Death|0
7545748|NCT02868229|11901150|FG002|Overall Study|Death|1
7545749|NCT02868229|11901151|FG003|Overall Study|Death|1
7545750|NCT02868229|11901148|FG000|Overall Study|Missed dose|0
7545751|NCT02868229|11901149|FG001|Overall Study|Missed dose|0
7545752|NCT02868229|11901150|FG002|Overall Study|Missed dose|0
7545753|NCT02868229|11901151|FG003|Overall Study|Missed dose|3
7265722|NCT00390416|11479407|FG000|Overall Study|Withdrawal by Subject|1
7265723|NCT00390416|11479407|FG000|Overall Study|Not treated|3
7265724|NCT00390455|11479430|FG000|Overall Study|Adverse Event|17
7545754|NCT02868281|11901174|FG000|Overall Study|Adverse Event|2
7545755|NCT02868281|11901175|FG001|Overall Study|Adverse Event|2
7545756|NCT02868281|11901174|FG000|Overall Study|Protocol Violation|13
7545757|NCT02868281|11901175|FG001|Overall Study|Protocol Violation|10
7545758|NCT02868281|11901174|FG000|Overall Study|Lost to Follow-up|3
7545759|NCT02868281|11901175|FG001|Overall Study|Lost to Follow-up|6
7545760|NCT02868281|11901174|FG000|Overall Study|Withdrawal by Subject|11
7545761|NCT02868281|11901175|FG001|Overall Study|Withdrawal by Subject|15
7545762|NCT02868281|11901174|FG000|Overall Study|Physician Decision|2
7545763|NCT02868281|11901175|FG001|Overall Study|Physician Decision|0
7545764|NCT02868281|11901174|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
7545765|NCT02868281|11901175|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
7545766|NCT02868281|11901174|FG000|Overall Study|Inclusion/exclusion criteria violation|3
7545767|NCT02868281|11901175|FG001|Overall Study|Inclusion/exclusion criteria violation|2
7577152|NCT04054765|11965917|FG000|Baseline|Withdrawal by Subject|5
7265725|NCT00390455|11479431|FG001|Overall Study|Adverse Event|3
7265726|NCT00390455|11479430|FG000|Overall Study|Withdrawal by Subject|8
7265727|NCT00390455|11479431|FG001|Overall Study|Withdrawal by Subject|8
7265728|NCT00390455|11479430|FG000|Overall Study|Alternate Treatment|0
7265729|NCT00390455|11479431|FG001|Overall Study|Alternate Treatment|1
7265730|NCT00390455|11479430|FG000|Overall Study|Other Medical Reasons|7
7265731|NCT00390455|11479431|FG001|Overall Study|Other Medical Reasons|11
7265732|NCT00390468|11479437|FG000|Overall Study|Protocol Violation|2
7265733|NCT00390468|11479437|FG000|Overall Study|Lack of Efficacy|1
7265734|NCT00390546|11479443|FG000|Overall Study|Renal impairment|1
7265735|NCT00390546|11479444|FG001|Overall Study|Renal impairment|0
7265736|NCT00390546|11479443|FG000|Overall Study|Physician Decision|5
7265737|NCT00390546|11479444|FG001|Overall Study|Physician Decision|5
7265738|NCT00390572|11479463|FG000|Overall Study|Lost to Follow-up|8
7265739|NCT00390572|11479464|FG001|Overall Study|Lost to Follow-up|4
7265740|NCT00390572|11479463|FG000|Overall Study|health condition|0
7265741|NCT00390572|11479464|FG001|Overall Study|health condition|1
7265742|NCT00390689|11479484|FG000|Overall Study|Adverse Event|2
7265743|NCT00390689|11479485|FG001|Overall Study|Adverse Event|5
7265744|NCT00390689|11479486|FG002|Overall Study|Adverse Event|2
7265745|NCT00390689|11479484|FG000|Overall Study|Lack of Efficacy|0
7265746|NCT00390689|11479485|FG001|Overall Study|Lack of Efficacy|0
7265747|NCT00390689|11479486|FG002|Overall Study|Lack of Efficacy|1
7265748|NCT00390689|11479484|FG000|Overall Study|Protocol Violation|1
7265749|NCT00390689|11479485|FG001|Overall Study|Protocol Violation|0
7265750|NCT00390689|11479486|FG002|Overall Study|Protocol Violation|0
7265751|NCT00390689|11479484|FG000|Overall Study|Investigator's judgement|2
7265752|NCT00390689|11479485|FG001|Overall Study|Investigator's judgement|0
7265753|NCT00390689|11479486|FG002|Overall Study|Investigator's judgement|0
7265754|NCT00390780|11479505|FG000|Overall Study|Not completed|10
7265755|NCT00390780|11479506|FG001|Overall Study|Not completed|4
7265756|NCT00390780|11479505|FG000|Overall Study|Protocol Violation|6
7265757|NCT00390780|11479506|FG001|Overall Study|Protocol Violation|4
7265758|NCT00390780|11479505|FG000|Overall Study|Lost to Follow-up|3
7265759|NCT00390780|11479506|FG001|Overall Study|Lost to Follow-up|6
7265760|NCT00390780|11479505|FG000|Overall Study|Adverse Event|2
7265761|NCT00390780|11479506|FG001|Overall Study|Adverse Event|3
7265762|NCT00390780|11479505|FG000|Overall Study|Death|1
7265763|NCT00390780|11479506|FG001|Overall Study|Death|3
7265764|NCT00390780|11479505|FG000|Overall Study|Withdrawal by Subject|1
7265765|NCT00390780|11479506|FG001|Overall Study|Withdrawal by Subject|2
7265766|NCT00390780|11479505|FG000|Overall Study|Inclusion criteria not satisfied|0
7265767|NCT00390780|11479506|FG001|Overall Study|Inclusion criteria not satisfied|2
7265768|NCT00390780|11479505|FG000|Overall Study|Lost to follow up and other reasons|0
7265769|NCT00390780|11479506|FG001|Overall Study|Lost to follow up and other reasons|1
7265770|NCT00390780|11479505|FG000|Overall Study|Investigator decision, SAE, other reason|0
7265771|NCT00390780|11479506|FG001|Overall Study|Investigator decision, SAE, other reason|1
7265772|NCT00390780|11479505|FG000|Overall Study|SAE, death|0
7265773|NCT00390780|11479506|FG001|Overall Study|SAE, death|1
7265774|NCT00390806|11479514|FG000|Overall Study|Lost to Follow-up|7
7265775|NCT00390806|11479515|FG001|Overall Study|Lost to Follow-up|6
7265776|NCT00390806|11479514|FG000|Overall Study|Protocol Violation|2
7265777|NCT00390806|11479515|FG001|Overall Study|Protocol Violation|2
7265778|NCT00390806|11479514|FG000|Overall Study|Withdrawal by Subject|12
7265779|NCT00390806|11479515|FG001|Overall Study|Withdrawal by Subject|15
7265780|NCT00390806|11479514|FG000|Overall Study|Investigator Decision|4
7265781|NCT00390806|11479515|FG001|Overall Study|Investigator Decision|6
7265782|NCT00390806|11479514|FG000|Overall Study|Death|1
7265783|NCT00390806|11479515|FG001|Overall Study|Death|0
7265784|NCT00390806|11479514|FG000|Overall Study|Physician Decision|0
7265785|NCT00390806|11479515|FG001|Overall Study|Physician Decision|1
7265786|NCT00390806|11479514|FG000|Overall Study|Ongoing|4
7265787|NCT00390806|11479515|FG001|Overall Study|Ongoing|2
7265788|NCT00390858|11479523|FG000|Overall Study|Adverse Event|6
7265789|NCT00390858|11479524|FG001|Overall Study|Adverse Event|2
7265790|NCT00390858|11479523|FG000|Overall Study|Lack of Efficacy|0
7265791|NCT00390858|11479524|FG001|Overall Study|Lack of Efficacy|1
7265792|NCT00390858|11479523|FG000|Overall Study|Withdrawal by Subject|3
7265793|NCT00390858|11479524|FG001|Overall Study|Withdrawal by Subject|4
7265794|NCT00390884|11479532|FG000|Overall Study|Withdrawal by Subject|2
7265795|NCT00390884|11479533|FG001|Overall Study|Withdrawal by Subject|2
7265796|NCT00390910|11479542|FG000|Overall Study|Adverse Event|1
7265797|NCT00390910|11479543|FG001|Overall Study|Adverse Event|0
7265798|NCT00390910|11479544|FG002|Overall Study|Adverse Event|0
7265799|NCT00390910|11479542|FG000|Overall Study|Lost to Follow-up|0
7265800|NCT00390910|11479543|FG001|Overall Study|Lost to Follow-up|1
7265801|NCT00390910|11479544|FG002|Overall Study|Lost to Follow-up|5
7265802|NCT00390910|11479542|FG000|Overall Study|Withdrawal by Subject|1
7265803|NCT00390910|11479543|FG001|Overall Study|Withdrawal by Subject|3
7265804|NCT00390910|11479544|FG002|Overall Study|Withdrawal by Subject|2
7265805|NCT00390910|11479542|FG000|Overall Study|Migrated/moved from study area|0
7265806|NCT00390910|11479543|FG001|Overall Study|Migrated/moved from study area|0
7265807|NCT00390910|11479544|FG002|Overall Study|Migrated/moved from study area|3
7265808|NCT00391027|11479565|FG000|Overall Study|Adverse Event|8
7265809|NCT00391027|11479566|FG001|Overall Study|Adverse Event|8
7265810|NCT00391027|11479565|FG000|Overall Study|Lack of Efficacy|3
7265811|NCT00391027|11479566|FG001|Overall Study|Lack of Efficacy|0
7265812|NCT00391027|11479565|FG000|Overall Study|Withdrawal by Subject|10
7265813|NCT00391027|11479566|FG001|Overall Study|Withdrawal by Subject|1
7265814|NCT00391027|11479565|FG000|Overall Study|Other|4
7265815|NCT00391027|11479566|FG001|Overall Study|Other|3
7265816|NCT00391053|11479576|FG000|Overall Study|Serious Adverse Events|1
7265817|NCT00391053|11479577|FG001|Overall Study|Serious Adverse Events|0
7265818|NCT00391053|11479578|FG002|Overall Study|Serious Adverse Events|1
7265819|NCT00391053|11479579|FG003|Overall Study|Serious Adverse Events|4
7265820|NCT00391053|11479576|FG000|Overall Study|Protocol Violation|2
7265821|NCT00391053|11479577|FG001|Overall Study|Protocol Violation|0
7265822|NCT00391053|11479578|FG002|Overall Study|Protocol Violation|0
7545768|NCT02868281|11901174|FG000|Overall Study|Long journey/moving away|1
7545769|NCT02868281|11901175|FG001|Overall Study|Long journey/moving away|1
7545770|NCT02868554|11901184|FG000|Overall Study|Lost to Follow-up|3
7545771|NCT02868554|11901185|FG001|Overall Study|Lost to Follow-up|0
7545772|NCT02868554|11901186|FG002|Overall Study|Lost to Follow-up|1
7545773|NCT02869438|11901226|FG000|Overall Study|Lost to Follow-up|1
7545774|NCT02869438|11901227|FG001|Overall Study|Lost to Follow-up|0
7545775|NCT02869438|11901226|FG000|Overall Study|Adverse Event|1
7545776|NCT02869438|11901227|FG001|Overall Study|Adverse Event|0
7545777|NCT02869438|11901226|FG000|Overall Study|Withdrawal by Subject|1
7545778|NCT02869438|11901227|FG001|Overall Study|Withdrawal by Subject|2
7545779|NCT02869893|11901237|FG000|Overall Study|participant aversion to IV|5
7545780|NCT02869893|11901237|FG000|Overall Study|participant fear of MRI scanner|2
7545781|NCT02870933|11901293|FG000|Overall Study|Death|2
7545782|NCT02870933|11901294|FG001|Overall Study|Death|1
7545783|NCT02870933|11901293|FG000|Overall Study|Withdrawal by Subject|0
7545784|NCT02870933|11901294|FG001|Overall Study|Withdrawal by Subject|1
7545785|NCT02870972|11901306|FG000|Overall Study|Adverse Event|1
7545786|NCT02870972|11901307|FG001|Overall Study|Adverse Event|0
7545787|NCT02870972|11901308|FG002|Overall Study|Adverse Event|0
7545788|NCT02870972|11901309|FG003|Overall Study|Adverse Event|0
7545789|NCT02870972|11901310|FG004|Overall Study|Adverse Event|0
7545790|NCT02871375|11901346|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
7545791|NCT02871375|11901347|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
7545792|NCT02871492|11901387|FG000|Overall Study|Lost to Follow-up|6
7545793|NCT02871492|11901388|FG001|Overall Study|Lost to Follow-up|3
7545794|NCT02871492|11901389|FG002|Overall Study|Lost to Follow-up|5
7545795|NCT02871492|11901387|FG000|Overall Study|Withdrawal by Subject|0
7545796|NCT02871492|11901388|FG001|Overall Study|Withdrawal by Subject|0
7545797|NCT02871492|11901389|FG002|Overall Study|Withdrawal by Subject|1
7545798|NCT02871635|11901408|FG000|Overall Study|Primary lack of efficacy|4
7545799|NCT02871635|11901409|FG001|Overall Study|Primary lack of efficacy|4
7545800|NCT02871635|11901408|FG000|Overall Study|Protocol Violation|3
7545801|NCT02871635|11901409|FG001|Overall Study|Protocol Violation|1
7545802|NCT02871635|11901408|FG000|Overall Study|Lost to Follow-up|1
7545803|NCT02871635|11901409|FG001|Overall Study|Lost to Follow-up|2
7545804|NCT02871635|11901408|FG000|Overall Study|Pregnancy|0
7545805|NCT02871635|11901409|FG001|Overall Study|Pregnancy|2
7545806|NCT02871635|11901408|FG000|Overall Study|Physician Decision|1
7545807|NCT02871635|11901409|FG001|Overall Study|Physician Decision|1
7545808|NCT02871635|11901408|FG000|Overall Study|Withdrawal by Subject|3
7545809|NCT02871635|11901409|FG001|Overall Study|Withdrawal by Subject|4
7545810|NCT02871635|11901408|FG000|Overall Study|Adverse Event|4
7545811|NCT02871635|11901409|FG001|Overall Study|Adverse Event|4
7545812|NCT02871635|11901408|FG000|Overall Study|Secondary lack of efficacy|2
7545813|NCT02871635|11901409|FG001|Overall Study|Secondary lack of efficacy|1
7545814|NCT02871739|11901421|FG000|Overall Study|Lost to Follow-up|3
7545815|NCT02871739|11901422|FG001|Overall Study|Lost to Follow-up|2
7545816|NCT02871739|11901423|FG002|Overall Study|Lost to Follow-up|0
7545817|NCT02871739|11901424|FG003|Overall Study|Lost to Follow-up|2
7545818|NCT02872012|11901439|FG000|Overall Study|Withdrawal by Subject|1
7545819|NCT02872012|11901440|FG001|Overall Study|Withdrawal by Subject|0
7545820|NCT02872012|11901441|FG002|Overall Study|Withdrawal by Subject|0
7545821|NCT02872012|11901442|FG003|Overall Study|Withdrawal by Subject|0
7545822|NCT02872012|11901443|FG004|Overall Study|Withdrawal by Subject|0
7545823|NCT02872142|11901468|FG000|Overall Study|Adverse Event|2
7545824|NCT02872142|11901468|FG000|Overall Study|Death|1
7545825|NCT02872142|11901468|FG000|Overall Study|Participant Decision|3
7265823|NCT00391053|11479579|FG003|Overall Study|Protocol Violation|0
7265824|NCT00391053|11479576|FG000|Overall Study|Lost to Follow-up|1
7545826|NCT02872285|11901474|FG000|Overall Study|Withdrawal by Subject|2
7545827|NCT02872285|11901475|FG001|Overall Study|Withdrawal by Subject|0
7545828|NCT02872285|11901474|FG000|Overall Study|Lost to Follow-up|2
7545829|NCT02872285|11901475|FG001|Overall Study|Lost to Follow-up|2
7545830|NCT02872285|11901474|FG000|Overall Study|Discontinued due to back surgery|1
7545831|NCT02872285|11901475|FG001|Overall Study|Discontinued due to back surgery|0
7545832|NCT02872311|11901486|FG000|Overall Study|Death|2
7545833|NCT02872311|11901487|FG001|Overall Study|Death|0
7545834|NCT02872311|11901488|FG002|Overall Study|Death|0
7545835|NCT02872311|11901489|FG003|Overall Study|Death|0
7545836|NCT02872311|11901490|FG004|Overall Study|Death|0
7545837|NCT02872311|11901486|FG000|Overall Study|Lost to Follow-up|2
7265825|NCT00391053|11479577|FG001|Overall Study|Lost to Follow-up|0
7265826|NCT00391053|11479578|FG002|Overall Study|Lost to Follow-up|0
7265827|NCT00391053|11479579|FG003|Overall Study|Lost to Follow-up|5
7265828|NCT00391053|11479576|FG000|Overall Study|Withdrawal by Subject|5
7265829|NCT00391053|11479577|FG001|Overall Study|Withdrawal by Subject|1
7545838|NCT02872311|11901487|FG001|Overall Study|Lost to Follow-up|0
7545839|NCT02872311|11901488|FG002|Overall Study|Lost to Follow-up|0
7545840|NCT02872311|11901489|FG003|Overall Study|Lost to Follow-up|0
7545841|NCT02872311|11901490|FG004|Overall Study|Lost to Follow-up|0
7545842|NCT02872311|11901486|FG000|Overall Study|Protocol Violation|0
7545843|NCT02872311|11901487|FG001|Overall Study|Protocol Violation|2
7545844|NCT02872311|11901488|FG002|Overall Study|Protocol Violation|1
7545845|NCT02872311|11901489|FG003|Overall Study|Protocol Violation|0
7545846|NCT02872311|11901490|FG004|Overall Study|Protocol Violation|0
7545847|NCT02872935|11901540|FG000|Overall Study|Other|0
7545848|NCT02872935|11901541|FG001|Overall Study|Other|1
7577153|NCT04054765|11965918|FG001|Baseline|Withdrawal by Subject|3
7577154|NCT04054765|11965917|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
7577155|NCT04054765|11965918|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
7577156|NCT04054765|11965917|FG000|3-month Follow up|Withdrawal by Subject|0
7577157|NCT04054765|11965918|FG001|3-month Follow up|Withdrawal by Subject|3
7577158|NCT04054765|11965917|FG000|6-month Follow up|Lost to Follow-up|32
7577159|NCT04054765|11965918|FG001|6-month Follow up|Lost to Follow-up|32
7577160|NCT04054011|11965924|FG000|Overall Study|COVID|3
7577161|NCT04059094|11965935|FG000|Overall Study|Adverse Event|0
7577162|NCT04059094|11965936|FG001|Overall Study|Adverse Event|0
7577163|NCT04059094|11965937|FG002|Overall Study|Adverse Event|0
7577164|NCT04059094|11965938|FG003|Overall Study|Adverse Event|0
7577165|NCT04059094|11965939|FG004|Overall Study|Adverse Event|1
7577166|NCT04059094|11965935|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7577167|NCT04059094|11965936|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
7577168|NCT04059094|11965937|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7577169|NCT04059094|11965938|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7577170|NCT04059094|11965939|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
7577171|NCT04046341|11965964|FG000|Overall Study|Lost to Follow-up|2
7577172|NCT04046341|11965964|FG000|Overall Study|Withdrawal by Subject|1
7577173|NCT04043416|11965979|FG000|Washout|Change in health condition|0
7577174|NCT04043416|11965980|FG001|Washout|Change in health condition|1
7577175|NCT04054193|11966042|FG000|Cycle 1|Physician Decision|1
7577176|NCT04054193|11966042|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
7577177|NCT04054193|11966042|FG000|Cycle 1|Allocated but not treated|3
7577178|NCT04054193|11966042|FG000|Cycles 2-3|Physician Decision|2
7577179|NCT04054193|11966042|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
7577180|NCT04054193|11966042|FG000|Cycles 2-3|Various reasons|17
7577181|NCT04050618|11966049|FG000|First Intervention|Withdrawal by Subject|2
7577182|NCT04050618|11966050|FG001|First Intervention|Withdrawal by Subject|0
7577183|NCT04050618|11966049|FG000|Second Intervention|Withdrawal by Subject|1
7577184|NCT04050618|11966050|FG001|Second Intervention|Withdrawal by Subject|0
7577185|NCT04053465|11966063|FG000|Overall Study|Withdrawal by Subject|4
7577186|NCT04053465|11966064|FG001|Overall Study|Withdrawal by Subject|4
7577187|NCT04049552|11966083|FG000|Overall Study|Lost to Follow-up|1
7577188|NCT04053023|11966091|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
7577189|NCT04053023|11966092|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
7577190|NCT04050865|11966117|FG000|Overall Study|Adverse Event|1
7577191|NCT04050865|11966118|FG001|Overall Study|Adverse Event|0
7577192|NCT04050865|11966117|FG000|Overall Study|no insert|1
7577193|NCT04050865|11966118|FG001|Overall Study|no insert|0
7577194|NCT04050865|11966117|FG000|Overall Study|Only 1 insert|2
7577195|NCT04050865|11966118|FG001|Overall Study|Only 1 insert|3
7577196|NCT04050865|11966117|FG000|Overall Study|Physician Decision|0
7577197|NCT04050865|11966118|FG001|Overall Study|Physician Decision|1
7577198|NCT04050865|11966117|FG000|Overall Study|Withdrawal by Subject|0
7577199|NCT04050865|11966118|FG001|Overall Study|Withdrawal by Subject|1
7577200|NCT04050371|11966136|FG000|Overall Study|Withdrawal by Subject|1
7265830|NCT00391053|11479578|FG002|Overall Study|Withdrawal by Subject|1
7265831|NCT00391053|11479579|FG003|Overall Study|Withdrawal by Subject|1
7265832|NCT00391092|11479600|FG000|Overall Study|Death|78
7265833|NCT00391092|11479601|FG001|Overall Study|Death|81
7265834|NCT00391092|11479600|FG000|Overall Study|Lost to Follow-up|13
7265835|NCT00391092|11479601|FG001|Overall Study|Lost to Follow-up|18
7265836|NCT00391092|11479600|FG000|Overall Study|Alive on treatment|29
7265837|NCT00391092|11479601|FG001|Overall Study|Alive on treatment|33
7577201|NCT04050371|11966137|FG001|Overall Study|Withdrawal by Subject|0
7577202|NCT04048681|11966147|FG000|Overall Study|family emergency|0
7265838|NCT00391092|11479600|FG000|Overall Study|Alive in follow-up|88
7265839|NCT00391092|11479601|FG001|Overall Study|Alive in follow-up|84
7577203|NCT04048681|11966148|FG001|Overall Study|family emergency|0
7577204|NCT04048681|11966149|FG002|Overall Study|family emergency|0
7577205|NCT04048681|11966150|FG003|Overall Study|family emergency|1
7577206|NCT04048681|11966151|FG004|Overall Study|family emergency|0
7577207|NCT04046250|11966161|FG000|Overall Study|Death|0
7265840|NCT00391118|11479610|FG000|Overall Study|Adverse Event|3
7265841|NCT00391118|11479611|FG001|Overall Study|Adverse Event|10
7265842|NCT00391118|11479612|FG002|Overall Study|Adverse Event|7
7265843|NCT00391118|11479610|FG000|Overall Study|Lost to Follow-up|0
7265844|NCT00391118|11479611|FG001|Overall Study|Lost to Follow-up|2
7265845|NCT00391118|11479612|FG002|Overall Study|Lost to Follow-up|3
7265846|NCT00391118|11479610|FG000|Overall Study|Withdrawal by Subject|0
7265847|NCT00391118|11479611|FG001|Overall Study|Withdrawal by Subject|9
7265848|NCT00391118|11479612|FG002|Overall Study|Withdrawal by Subject|1
7265849|NCT00391118|11479610|FG000|Overall Study|Death|0
7265850|NCT00391118|11479611|FG001|Overall Study|Death|1
7265851|NCT00391118|11479612|FG002|Overall Study|Death|0
7265852|NCT00391118|11479610|FG000|Overall Study|Physician Decision|0
7265853|NCT00391118|11479611|FG001|Overall Study|Physician Decision|3
7545849|NCT02873208|11901556|FG000|Overall Study|Withdrawal by Subject|36
7545850|NCT02873208|11901556|FG000|Overall Study|Lost to Follow-up|22
7545851|NCT02873208|11901556|FG000|Overall Study|Adverse Event|15
7545852|NCT02873208|11901556|FG000|Overall Study|Non-compliance with study drug|12
7545853|NCT02873208|11901556|FG000|Overall Study|Protocol Violation|8
7545854|NCT02873208|11901556|FG000|Overall Study|Pregnancy|2
7545855|NCT02873208|11901556|FG000|Overall Study|Incarceration|1
7545856|NCT02873208|11901556|FG000|Overall Study|Lack of Efficacy|1
7545857|NCT02873208|11901556|FG000|Overall Study|Physician Decision|1
7545858|NCT02873221|11901563|FG000|Treatment Period|Other Miscellaneous Reasons|0
7545859|NCT02873221|11901564|FG001|Treatment Period|Other Miscellaneous Reasons|2
7545860|NCT02873221|11901565|FG002|Treatment Period|Other Miscellaneous Reasons|1
7545861|NCT02873221|11901563|FG000|Treatment Period|Non-Compliance with Study Drug|0
7545862|NCT02873221|11901564|FG001|Treatment Period|Non-Compliance with Study Drug|3
7545863|NCT02873221|11901565|FG002|Treatment Period|Non-Compliance with Study Drug|2
7545864|NCT02873221|11901563|FG000|Treatment Period|Protocol Violation|2
7545865|NCT02873221|11901564|FG001|Treatment Period|Protocol Violation|5
7545866|NCT02873221|11901565|FG002|Treatment Period|Protocol Violation|8
7545867|NCT02873221|11901563|FG000|Treatment Period|Pregnancy|4
7545868|NCT02873221|11901564|FG001|Treatment Period|Pregnancy|6
7545869|NCT02873221|11901565|FG002|Treatment Period|Pregnancy|3
7545870|NCT02873221|11901563|FG000|Treatment Period|Lack of Qualifying Event|0
7545871|NCT02873221|11901564|FG001|Treatment Period|Lack of Qualifying Event|3
7545872|NCT02873221|11901565|FG002|Treatment Period|Lack of Qualifying Event|1
7545873|NCT02873221|11901563|FG000|Treatment Period|Withdrawal of Consent|52
7545874|NCT02873221|11901564|FG001|Treatment Period|Withdrawal of Consent|51
7545875|NCT02873221|11901565|FG002|Treatment Period|Withdrawal of Consent|41
7577208|NCT04046250|11966162|FG001|Overall Study|Death|1
7265854|NCT00391118|11479612|FG002|Overall Study|Physician Decision|0
7545876|NCT02873221|11901563|FG000|Treatment Period|Lack of Efficacy|0
7545877|NCT02873221|11901564|FG001|Treatment Period|Lack of Efficacy|17
7545878|NCT02873221|11901565|FG002|Treatment Period|Lack of Efficacy|12
7545879|NCT02873221|11901563|FG000|Treatment Period|Adverse Event|4
7545880|NCT02873221|11901564|FG001|Treatment Period|Adverse Event|9
7545881|NCT02873221|11901565|FG002|Treatment Period|Adverse Event|11
7545882|NCT02873221|11901563|FG000|Treatment Period|Lost to Follow-up|26
7545883|NCT02873221|11901564|FG001|Treatment Period|Lost to Follow-up|30
7545884|NCT02873221|11901565|FG002|Treatment Period|Lost to Follow-up|26
7545885|NCT02873221|11901563|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
7545886|NCT02873221|11901564|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
7545887|NCT02873221|11901565|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
7545888|NCT02873221|11901563|FG000|Safety Follow-up Period|Protocol Violation|0
7545889|NCT02873221|11901564|FG001|Safety Follow-up Period|Protocol Violation|0
7545890|NCT02873221|11901565|FG002|Safety Follow-up Period|Protocol Violation|1
7545891|NCT02873221|11901563|FG000|Safety Follow-up Period|Lost to Follow-up|3
7545892|NCT02873221|11901564|FG001|Safety Follow-up Period|Lost to Follow-up|5
7545893|NCT02873221|11901565|FG002|Safety Follow-up Period|Lost to Follow-up|5
7545894|NCT02873221|11901563|FG000|Safety Follow-up Period|Withdrawal of Consent|4
7545895|NCT02873221|11901564|FG001|Safety Follow-up Period|Withdrawal of Consent|10
7545896|NCT02873221|11901565|FG002|Safety Follow-up Period|Withdrawal of Consent|8
7545897|NCT02873338|11901597|FG000|Overall Study|Adverse Event|0
7545898|NCT02873338|11901598|FG001|Overall Study|Adverse Event|2
7545899|NCT02873338|11901599|FG002|Overall Study|Adverse Event|1
7545900|NCT02873338|11901597|FG000|Overall Study|Death|2
7545901|NCT02873338|11901598|FG001|Overall Study|Death|1
7545902|NCT02873338|11901599|FG002|Overall Study|Death|1
7545903|NCT02873338|11901597|FG000|Overall Study|Withdrawal by Subject|2
7545904|NCT02873338|11901598|FG001|Overall Study|Withdrawal by Subject|1
7545905|NCT02873338|11901599|FG002|Overall Study|Withdrawal by Subject|3
7545906|NCT02873338|11901597|FG000|Overall Study|Lack of Efficacy|0
7545907|NCT02873338|11901598|FG001|Overall Study|Lack of Efficacy|2
7545908|NCT02873338|11901599|FG002|Overall Study|Lack of Efficacy|0
7545909|NCT02873338|11901597|FG000|Overall Study|Other or Missing|14
7545910|NCT02873338|11901598|FG001|Overall Study|Other or Missing|15
7545911|NCT02873338|11901599|FG002|Overall Study|Other or Missing|13
7545912|NCT02873377|11901609|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7545913|NCT02873377|11901610|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
7545914|NCT02873377|11901609|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
7545915|NCT02873377|11901610|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
7265855|NCT00391118|11479610|FG000|Overall Study|Protocol Entry Criteria Not Met|0
7265856|NCT00391118|11479611|FG001|Overall Study|Protocol Entry Criteria Not Met|3
7265857|NCT00391118|11479612|FG002|Overall Study|Protocol Entry Criteria Not Met|1
7265858|NCT00391118|11479610|FG000|Overall Study|Progressive Disease|7
7265859|NCT00391118|11479611|FG001|Overall Study|Progressive Disease|26
7265860|NCT00391118|11479612|FG002|Overall Study|Progressive Disease|43
7265861|NCT00391118|11479610|FG000|Overall Study|Sponsor Decision|0
7265862|NCT00391118|11479611|FG001|Overall Study|Sponsor Decision|1
7265863|NCT00391118|11479612|FG002|Overall Study|Sponsor Decision|3
7265864|NCT00391118|11479610|FG000|Overall Study|Protocol Violation|1
7265865|NCT00391118|11479611|FG001|Overall Study|Protocol Violation|0
7265866|NCT00391118|11479612|FG002|Overall Study|Protocol Violation|0
7265867|NCT00391222|11479626|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7265868|NCT00391222|11479627|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7265869|NCT00391222|11479628|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
7265870|NCT00391222|11479629|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
7265871|NCT00391222|11479626|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7265872|NCT00391222|11479627|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7265873|NCT00391222|11479628|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
7265874|NCT00391222|11479629|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
7265875|NCT00391222|11479626|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
7265876|NCT00391222|11479627|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
7265877|NCT00391222|11479628|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
7265878|NCT00391222|11479629|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
7545916|NCT02873429|11901619|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
7545917|NCT02873429|11901620|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
7545918|NCT02873429|11901619|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
7545919|NCT02873429|11901620|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
7545920|NCT02873429|11901619|FG000|16 Weeks|Lost to Follow-up|3
7545921|NCT02873429|11901620|FG001|16 Weeks|Lost to Follow-up|0
7545922|NCT02873689|11901645|FG000|Overall Study|Lack of Efficacy|1
7545923|NCT02873689|11901646|FG001|Overall Study|Lack of Efficacy|0
7545924|NCT02873689|11901645|FG000|Overall Study|Withdrawal by Subject|2
7545925|NCT02873689|11901646|FG001|Overall Study|Withdrawal by Subject|2
7545926|NCT02873689|11901645|FG000|Overall Study|Protocol Violation|1
7545927|NCT02873689|11901646|FG001|Overall Study|Protocol Violation|0
7545928|NCT02873689|11901645|FG000|Overall Study|Adverse Event|2
7545929|NCT02873689|11901646|FG001|Overall Study|Adverse Event|2
7545930|NCT02873689|11901645|FG000|Overall Study|Randomized but not Treated|1
7545931|NCT02873689|11901646|FG001|Overall Study|Randomized but not Treated|1
7545932|NCT02873702|11901654|FG000|Healing Period (up to Week 8)|Adverse Event|1
7545933|NCT02873702|11901655|FG001|Healing Period (up to Week 8)|Adverse Event|0
7545934|NCT02873702|11901656|FG002|Healing Period (up to Week 8)|Adverse Event|0
7545935|NCT02873702|11901657|FG003|Healing Period (up to Week 8)|Adverse Event|0
7545936|NCT02873702|11901654|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
7545937|NCT02873702|11901655|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
7545938|NCT02873702|11901656|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
7545939|NCT02873702|11901657|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
7545940|NCT02873702|11901654|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
7545941|NCT02873702|11901655|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
7545942|NCT02873702|11901656|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
7545943|NCT02873702|11901657|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
7545944|NCT02873702|11901654|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
7545945|NCT02873702|11901655|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
7577209|NCT04046250|11966161|FG000|Overall Study|Withdrawal by Subject|3
7577210|NCT04046250|11966162|FG001|Overall Study|Withdrawal by Subject|3
7577211|NCT04044352|11966177|FG000|Overall Study|Lost to Follow-up|9
7577212|NCT04044352|11966177|FG000|Overall Study|Withdrawal by Subject|2
7577213|NCT04043728|11966185|FG000|Overall Study|Lost to Follow-up|1
7577214|NCT04043728|11966186|FG001|Overall Study|Lost to Follow-up|2
7577215|NCT04043728|11966187|FG002|Overall Study|Lost to Follow-up|0
7577216|NCT04041414|11966216|FG000|Overall Study|Lost to Follow-up|1
7577217|NCT04041414|11966217|FG001|Overall Study|Lost to Follow-up|2
7577218|NCT04041700|11966230|FG000|Overall Study|Pregnancy|1
7577219|NCT04041700|11966230|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
7577220|NCT04029519|11966264|FG000|Overall Study|Protocol Violation|1
7577221|NCT04029519|11966264|FG000|Overall Study|Withdrawal by Subject|3
7577222|NCT04029519|11966264|FG000|Overall Study|Lost to Follow-up|1
7577223|NCT04039919|11966273|FG000|Treatment Period 1|Withdrawal by Subject|1
7577224|NCT04039919|11966274|FG001|Treatment Period 1|Withdrawal by Subject|0
7577225|NCT04039919|11966275|FG002|Treatment Period 1|Withdrawal by Subject|0
7577226|NCT04039919|11966276|FG003|Treatment Period 1|Withdrawal by Subject|0
7577227|NCT04039919|11966277|FG004|Treatment Period 1|Withdrawal by Subject|0
7577228|NCT04039919|11966273|FG000|Treatment Period 1|Sponsor's decision|0
7577229|NCT04039919|11966274|FG001|Treatment Period 1|Sponsor's decision|0
7577230|NCT04039919|11966275|FG002|Treatment Period 1|Sponsor's decision|0
7577231|NCT04039919|11966276|FG003|Treatment Period 1|Sponsor's decision|0
7577232|NCT04039919|11966277|FG004|Treatment Period 1|Sponsor's decision|16
7577233|NCT04039919|11966273|FG000|Treatment Period 5|Withdrawal by Subject|1
7265879|NCT00391222|11479626|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
7265880|NCT00391222|11479627|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
7265881|NCT00391222|11479628|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
7265882|NCT00391222|11479629|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
7265883|NCT00391222|11479626|FG000|Period II (Open-label Risperidone LAI)|Other|0
7265884|NCT00391222|11479627|FG001|Period II (Open-label Risperidone LAI)|Other|0
7265885|NCT00391222|11479628|FG002|Period II (Open-label Risperidone LAI)|Other|0
7265886|NCT00391222|11479629|FG003|Period II (Open-label Risperidone LAI)|Other|24
7265887|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
7265888|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
7265889|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
7265890|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
7265891|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
7265892|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7265893|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
7265894|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
7265895|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
7265896|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
7265897|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
7265898|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
7265899|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
7265900|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
7265901|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
7265902|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
7265903|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7265904|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
7265905|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
7265906|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
7265907|NCT00391222|11479626|FG000|Period III (Double-Blind Treatment)|Other|6
7265908|NCT00391222|11479627|FG001|Period III (Double-Blind Treatment)|Other|1
7265909|NCT00391222|11479628|FG002|Period III (Double-Blind Treatment)|Other|6
7265910|NCT00391222|11479629|FG003|Period III (Double-Blind Treatment)|Other|0
7265911|NCT00391274|11479641|FG000|Overall Study|Death Due to Study Disease|55
7265912|NCT00391274|11479642|FG001|Overall Study|Death Due to Study Disease|45
7265913|NCT00391274|11479641|FG000|Overall Study|Lost to Follow-up|0
7265914|NCT00391274|11479642|FG001|Overall Study|Lost to Follow-up|3
7265915|NCT00391274|11479641|FG000|Overall Study|Physician Decision|4
7265916|NCT00391274|11479642|FG001|Overall Study|Physician Decision|2
7265917|NCT00391274|11479641|FG000|Overall Study|Withdrawal by Subject|0
7265918|NCT00391274|11479642|FG001|Overall Study|Withdrawal by Subject|3
7265919|NCT00391274|11479641|FG000|Overall Study|Death Due to Adverse Event|1
7265920|NCT00391274|11479642|FG001|Overall Study|Death Due to Adverse Event|3
7545946|NCT02873702|11901656|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
7545947|NCT02873702|11901657|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
7545948|NCT02873702|11901654|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7577234|NCT04039919|11966274|FG001|Treatment Period 5|Withdrawal by Subject|0
7577235|NCT04039919|11966275|FG002|Treatment Period 5|Withdrawal by Subject|0
7577236|NCT04039919|11966276|FG003|Treatment Period 5|Withdrawal by Subject|0
7577237|NCT04039919|11966277|FG004|Treatment Period 5|Withdrawal by Subject|0
7577238|NCT04037748|11966326|FG000|Treatment Period 1|Withdrawal by Subject|3
7577239|NCT04037748|11966327|FG001|Treatment Period 1|Withdrawal by Subject|0
7577240|NCT04037748|11966326|FG000|Treatment Period 1|Adverse Event|1
7577241|NCT04037748|11966327|FG001|Treatment Period 1|Adverse Event|1
7577242|NCT04037748|11966326|FG000|Treatment Period 1|Protocol Violation|4
7577243|NCT04037748|11966327|FG001|Treatment Period 1|Protocol Violation|5
7577244|NCT04037748|11966326|FG000|Treatment Period 2|Adverse Event|0
7577245|NCT04037748|11966327|FG001|Treatment Period 2|Adverse Event|1
7577246|NCT04037748|11966326|FG000|Treatment Period 2|Protocol Violation|2
7577247|NCT04037748|11966327|FG001|Treatment Period 2|Protocol Violation|0
7577248|NCT04027686|11966344|FG000|Overall Study|Lost to Follow-up|2
7577249|NCT04027686|11966345|FG001|Overall Study|Lost to Follow-up|0
7265921|NCT00391274|11479641|FG000|Overall Study|Death Due to Indeterminate Cause|1
7545949|NCT02873702|11901655|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
7545950|NCT02873702|11901656|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
7545951|NCT02873702|11901657|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
7545952|NCT02873754|11901667|FG000|Overall Study|Lost to Follow-up|5
7545953|NCT02873754|11901667|FG000|Overall Study|Couldn't complete study procedures|1
7545954|NCT02873936|11901678|FG000|Overall Study|Withdrew Consent|4
7545955|NCT02873936|11901679|FG001|Overall Study|Withdrew Consent|11
7545956|NCT02873936|11901680|FG002|Overall Study|Withdrew Consent|20
7545957|NCT02873936|11901678|FG000|Overall Study|Investigator's Discretion|3
7545958|NCT02873936|11901679|FG001|Overall Study|Investigator's Discretion|5
7545959|NCT02873936|11901680|FG002|Overall Study|Investigator's Discretion|4
7577250|NCT04027686|11966344|FG000|Overall Study|Withdrawal by Subject|0
7577251|NCT04027686|11966345|FG001|Overall Study|Withdrawal by Subject|1
7577252|NCT04036110|11966375|FG000|Overall Study|Lost to Follow-up|3
7577253|NCT04036110|11966376|FG001|Overall Study|Lost to Follow-up|2
7265922|NCT00391274|11479642|FG001|Overall Study|Death Due to Indeterminate Cause|0
7265923|NCT00391274|11479641|FG000|Overall Study|Death Not Study Related|0
7265924|NCT00391274|11479642|FG001|Overall Study|Death Not Study Related|1
7265925|NCT00391391|11479652|FG000|Overall Study|Adverse Event|0
7265926|NCT00391391|11479653|FG001|Overall Study|Adverse Event|0
7265927|NCT00391391|11479654|FG002|Overall Study|Adverse Event|0
7265928|NCT00391391|11479655|FG003|Overall Study|Adverse Event|1
7265929|NCT00391391|11479652|FG000|Overall Study|Lost to Follow-up|1
7265930|NCT00391391|11479653|FG001|Overall Study|Lost to Follow-up|3
7265931|NCT00391391|11479654|FG002|Overall Study|Lost to Follow-up|7
7265932|NCT00391391|11479655|FG003|Overall Study|Lost to Follow-up|4
7265933|NCT00391391|11479652|FG000|Overall Study|Protocol Violation|2
7265934|NCT00391391|11479653|FG001|Overall Study|Protocol Violation|3
7265935|NCT00391391|11479654|FG002|Overall Study|Protocol Violation|6
7265936|NCT00391391|11479655|FG003|Overall Study|Protocol Violation|7
7265937|NCT00391391|11479652|FG000|Overall Study|Withdrawal by Subject|6
7545960|NCT02873936|11901678|FG000|Overall Study|Adverse Event|3
7545961|NCT02873936|11901679|FG001|Overall Study|Adverse Event|5
7545962|NCT02873936|11901680|FG002|Overall Study|Adverse Event|3
7545963|NCT02873936|11901678|FG000|Overall Study|Protocol Violation|0
7545964|NCT02873936|11901679|FG001|Overall Study|Protocol Violation|1
7545965|NCT02873936|11901680|FG002|Overall Study|Protocol Violation|3
7545966|NCT02873936|11901678|FG000|Overall Study|Lost to Follow-up|1
7545967|NCT02873936|11901679|FG001|Overall Study|Lost to Follow-up|1
7545968|NCT02873936|11901680|FG002|Overall Study|Lost to Follow-up|1
7545969|NCT02873936|11901678|FG000|Overall Study|Non-compliance With Study Drug|1
7545970|NCT02873936|11901679|FG001|Overall Study|Non-compliance With Study Drug|0
7545971|NCT02873936|11901680|FG002|Overall Study|Non-compliance With Study Drug|1
7545972|NCT02873936|11901678|FG000|Overall Study|Randomized but not Dosed|1
7545973|NCT02873936|11901679|FG001|Overall Study|Randomized but not Dosed|0
7545974|NCT02873936|11901680|FG002|Overall Study|Randomized but not Dosed|0
7545975|NCT02874534|11901707|FG000|Overall Study|Withdrawal by Subject|5
7545976|NCT02874534|11901708|FG001|Overall Study|Withdrawal by Subject|8
7545977|NCT02874534|11901707|FG000|Overall Study|Lost to Follow-up|2
7545978|NCT02874534|11901708|FG001|Overall Study|Lost to Follow-up|2
7545979|NCT02874534|11901707|FG000|Overall Study|Ongoing in study|1
7545980|NCT02874534|11901708|FG001|Overall Study|Ongoing in study|1
7545981|NCT02874794|11901716|FG000|Overall Study|Physician Decision|3
7545982|NCT02874794|11901717|FG001|Overall Study|Physician Decision|2
7545983|NCT02874794|11901716|FG000|Overall Study|Withdrawal by Subject|2
7545984|NCT02874794|11901717|FG001|Overall Study|Withdrawal by Subject|8
7545985|NCT02874794|11901716|FG000|Overall Study|Death|2
7545986|NCT02874794|11901717|FG001|Overall Study|Death|1
7545987|NCT02874924|11901739|FG000|Overall Study|Adverse Event|2
7545988|NCT02874924|11901740|FG001|Overall Study|Adverse Event|0
7545989|NCT02874924|11901741|FG002|Overall Study|Adverse Event|0
7545990|NCT02874924|11901739|FG000|Overall Study|Withdrawal by Subject|1
7545991|NCT02874924|11901740|FG001|Overall Study|Withdrawal by Subject|0
7545992|NCT02874924|11901741|FG002|Overall Study|Withdrawal by Subject|0
7545993|NCT02875028|11901751|FG000|Washout Period|Withdrawal by Subject|0
7545994|NCT02875028|11901752|FG001|Washout Period|Withdrawal by Subject|1
7545995|NCT02875080|11901763|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
7545996|NCT02875080|11901764|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7545997|NCT02875080|11901765|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
7545998|NCT02875340|11901773|FG000|Overall Study|Death|2
7545999|NCT02875340|11901773|FG000|Overall Study|Withdrawal by Subject|2
7546000|NCT02875340|11901773|FG000|Overall Study|Physician Decision|3
7546001|NCT02875340|11901773|FG000|Overall Study|Adverse Event|1
7546002|NCT02875366|11901785|FG000|Overall Study|Adverse Event|0
7546003|NCT02875366|11901786|FG001|Overall Study|Adverse Event|2
7546004|NCT02875366|11901785|FG000|Overall Study|Noncompliance|0
7546005|NCT02875366|11901786|FG001|Overall Study|Noncompliance|1
7546006|NCT02875392|11901794|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
7546007|NCT02875392|11901795|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
7546008|NCT02875613|11901801|FG000|Overall Study|Withdrawal by Subject|1
7265938|NCT00391391|11479653|FG001|Overall Study|Withdrawal by Subject|4
7265939|NCT00391391|11479654|FG002|Overall Study|Withdrawal by Subject|10
7265940|NCT00391391|11479655|FG003|Overall Study|Withdrawal by Subject|7
7546009|NCT02875834|11901809|FG000|Open-label Phase|Withdrawal by Subject|3
7546010|NCT02875834|11901810|FG001|Open-label Phase|Withdrawal by Subject|0
7546011|NCT02875834|11901811|FG002|Open-label Phase|Withdrawal by Subject|0
7546012|NCT02875834|11901812|FG003|Open-label Phase|Withdrawal by Subject|0
7546013|NCT02875834|11901809|FG000|Open-label Phase|(Not collected)|4
7546014|NCT02875834|11901810|FG001|Open-label Phase|(Not collected)|0
7546015|NCT02875834|11901811|FG002|Open-label Phase|(Not collected)|0
7546016|NCT02875834|11901812|FG003|Open-label Phase|(Not collected)|0
7388131|NCT01217892|11646885|FG001|Overall Study|Adverse Event|1
7388132|NCT01217892|11646886|FG002|Overall Study|Adverse Event|1
7546017|NCT02875834|11901809|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
7546018|NCT02875834|11901810|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
7546019|NCT02875834|11901811|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
7265941|NCT00391586|11479687|FG000|Overall Study|Progressive disease|13
7265942|NCT00391586|11479687|FG000|Overall Study|Adverse Event|5
7265943|NCT00391586|11479687|FG000|Overall Study|Physician Decision|2
7265944|NCT00391586|11479687|FG000|Overall Study|Death|4
7265945|NCT00391625|11479702|FG000|Month 14|Withdrawal by Subject|1
7265946|NCT00391625|11479702|FG000|Month 50|Physician Decision|1
7265947|NCT00391768|11479749|FG000|Overall Study|Withdrawal by Subject|0
7265948|NCT00391768|11479750|FG001|Overall Study|Withdrawal by Subject|0
7265949|NCT00391768|11479751|FG002|Overall Study|Withdrawal by Subject|1
7265950|NCT00391768|11479752|FG003|Overall Study|Withdrawal by Subject|0
7265951|NCT00391768|11479753|FG004|Overall Study|Withdrawal by Subject|0
7265952|NCT00391768|11479754|FG005|Overall Study|Withdrawal by Subject|1
7265953|NCT00391768|11479755|FG006|Overall Study|Withdrawal by Subject|1
7265954|NCT00391768|11479749|FG000|Overall Study|Lost to Follow-up|0
7265955|NCT00391768|11479750|FG001|Overall Study|Lost to Follow-up|0
7265956|NCT00391768|11479751|FG002|Overall Study|Lost to Follow-up|0
7265957|NCT00391768|11479752|FG003|Overall Study|Lost to Follow-up|1
7265958|NCT00391768|11479753|FG004|Overall Study|Lost to Follow-up|2
7265959|NCT00391768|11479754|FG005|Overall Study|Lost to Follow-up|2
7265960|NCT00391768|11479755|FG006|Overall Study|Lost to Follow-up|3
7265961|NCT00391807|11479789|FG000|Overall Study|Did not receive study medication|23
7265962|NCT00391807|11479789|FG000|Overall Study|Adverse Event|177
7265963|NCT00391807|11479789|FG000|Overall Study|Pregnancy|25
7265964|NCT00391807|11479789|FG000|Overall Study|Lost to Follow-up|227
7265965|NCT00391807|11479789|FG000|Overall Study|Withdrawal by Subject|147
7265966|NCT00391807|11479789|FG000|Overall Study|Protocol Violation|20
7265967|NCT00391807|11479789|FG000|Overall Study|Various|96
7265968|NCT00391846|11479795|FG000|Overall Study|Adverse Event|4
7265969|NCT00391846|11479796|FG001|Overall Study|Adverse Event|1
7265970|NCT00391846|11479795|FG000|Overall Study|Did not meet the required elig. crit|2
7265971|NCT00391846|11479796|FG001|Overall Study|Did not meet the required elig. crit|2
7265972|NCT00391846|11479795|FG000|Overall Study|Withdrawal by Subject|2
7265973|NCT00391846|11479796|FG001|Overall Study|Withdrawal by Subject|3
7265974|NCT00391846|11479795|FG000|Overall Study|Developed study specific DC criteria|0
7265975|NCT00391846|11479796|FG001|Overall Study|Developed study specific DC criteria|1
7265976|NCT00391872|11479804|FG000|Overall Study|Protocol Violation|7
7265977|NCT00391872|11479805|FG001|Overall Study|Protocol Violation|2
7265978|NCT00391872|11479804|FG000|Overall Study|Withdrawal by Subject|296
7265979|NCT00391872|11479805|FG001|Overall Study|Withdrawal by Subject|249
7265980|NCT00391872|11479804|FG000|Overall Study|Reason unknown|2
7265981|NCT00391872|11479805|FG001|Overall Study|Reason unknown|4
7265982|NCT00391872|11479804|FG000|Overall Study|Lost to Follow-up|2
7265983|NCT00391872|11479805|FG001|Overall Study|Lost to Follow-up|0
7265984|NCT00391898|11479813|FG000|Overall Study|Adverse Event|3
7265985|NCT00391898|11479814|FG001|Overall Study|Adverse Event|0
7265986|NCT00391898|11479813|FG000|Overall Study|Other|8
7265987|NCT00391898|11479814|FG001|Overall Study|Other|10
7265988|NCT00391976|11479823|FG000|Overall Study|Adverse Event|0
7265989|NCT00391976|11479824|FG001|Overall Study|Adverse Event|0
7265990|NCT00391976|11479825|FG002|Overall Study|Adverse Event|1
7265991|NCT00391976|11479823|FG000|Overall Study|Withdrawal of consent|0
7265992|NCT00391976|11479824|FG001|Overall Study|Withdrawal of consent|1
7265993|NCT00391976|11479825|FG002|Overall Study|Withdrawal of consent|1
7265994|NCT00391976|11479823|FG000|Overall Study|Lost to Follow-up|1
7265995|NCT00391976|11479824|FG001|Overall Study|Lost to Follow-up|2
7546020|NCT02875834|11901812|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
7546021|NCT02875834|11901809|FG000|Randomized Treatment Phase|Protocol Violation|0
7546022|NCT02875834|11901810|FG001|Randomized Treatment Phase|Protocol Violation|2
7546023|NCT02875834|11901811|FG002|Randomized Treatment Phase|Protocol Violation|0
7546024|NCT02875834|11901812|FG003|Randomized Treatment Phase|Protocol Violation|0
7546025|NCT02875834|11901809|FG000|Randomized Treatment Phase|(Not collected)|0
7546026|NCT02875834|11901810|FG001|Randomized Treatment Phase|(Not collected)|9
7546027|NCT02875834|11901811|FG002|Randomized Treatment Phase|(Not collected)|10
7546028|NCT02875834|11901812|FG003|Randomized Treatment Phase|(Not collected)|9
7546029|NCT02875977|11901824|FG000|Overall Study|Lost to Follow-up|42
7546030|NCT02875977|11901825|FG001|Overall Study|Lost to Follow-up|29
7546031|NCT02876601|11901865|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7546032|NCT02876601|11901866|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7546033|NCT02876601|11901867|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
7546034|NCT02876601|11901868|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
7546035|NCT02877004|11901960|FG000|Overall Study|Pregnancy|0
7265996|NCT00391976|11479825|FG002|Overall Study|Lost to Follow-up|0
7265997|NCT00391976|11479823|FG000|Overall Study|Inappropriate enrollment|1
7265998|NCT00391976|11479824|FG001|Overall Study|Inappropriate enrollment|1
7265999|NCT00391976|11479825|FG002|Overall Study|Inappropriate enrollment|0
7266000|NCT00391976|11479823|FG000|Overall Study|Protocol deviation/violation|4
7266001|NCT00391976|11479824|FG001|Overall Study|Protocol deviation/violation|2
7266002|NCT00391976|11479825|FG002|Overall Study|Protocol deviation/violation|1
7266003|NCT00391976|11479823|FG000|Overall Study|Recurrence/no eradication of infection|21
7266004|NCT00391976|11479824|FG001|Overall Study|Recurrence/no eradication of infection|19
7266005|NCT00391976|11479825|FG002|Overall Study|Recurrence/no eradication of infection|0
7266006|NCT00391976|11479823|FG000|Overall Study|Unable to classify|0
7266007|NCT00391976|11479824|FG001|Overall Study|Unable to classify|0
7266008|NCT00391976|11479825|FG002|Overall Study|Unable to classify|1
7388133|NCT01217892|11646887|FG003|Overall Study|Adverse Event|0
7546036|NCT02877004|11901961|FG001|Overall Study|Pregnancy|0
7546037|NCT02877004|11901962|FG002|Overall Study|Pregnancy|1
7546038|NCT02877082|11901970|FG000|Overall Study|Trial was closed early|5
7546039|NCT02877680|11901995|FG000|Overall Study|Lost to Follow-up|1
7546040|NCT02877680|11901996|FG001|Overall Study|Lost to Follow-up|1
7546041|NCT02877927|11902008|FG000|Overall Study|Adverse Event|1
7546042|NCT02877927|11902009|FG001|Overall Study|Adverse Event|0
7546043|NCT02877927|11902008|FG000|Overall Study|Lost to Follow-up|37
7546044|NCT02877927|11902009|FG001|Overall Study|Lost to Follow-up|38
7546045|NCT02877927|11902008|FG000|Overall Study|Withdrawal by Subject|11
7546046|NCT02877927|11902009|FG001|Overall Study|Withdrawal by Subject|12
7546047|NCT02877927|11902008|FG000|Overall Study|Physician Decision|0
7546048|NCT02877927|11902009|FG001|Overall Study|Physician Decision|1
7546049|NCT02877927|11902008|FG000|Overall Study|Missed EOT/PTE Visit|5
7546050|NCT02877927|11902009|FG001|Overall Study|Missed EOT/PTE Visit|6
7546051|NCT02878213|11902019|FG000|Overall Study|Withdrawal by Subject|2
7546052|NCT02878213|11902019|FG000|Overall Study|Adverse Event|1
7546053|NCT02878330|11902026|FG000|Overall Study|Death|3
7546054|NCT02878330|11902027|FG001|Overall Study|Death|2
7546055|NCT02878330|11902026|FG000|Overall Study|Lost to Follow-up|11
7546056|NCT02878330|11902027|FG001|Overall Study|Lost to Follow-up|26
7546057|NCT02878330|11902026|FG000|Overall Study|Withdrawal by Subject|11
7546058|NCT02878330|11902027|FG001|Overall Study|Withdrawal by Subject|21
7546059|NCT02878330|11902026|FG000|Overall Study|Other|4
7546060|NCT02878330|11902027|FG001|Overall Study|Other|7
7546061|NCT02878590|11902052|FG000|Overall Study|Withdrawal by Subject|2
7546062|NCT02879383|11902066|FG000|First 24 Weeks|Physician Decision|0
7546063|NCT02879383|11902067|FG001|First 24 Weeks|Physician Decision|1
7546064|NCT02879383|11902068|FG002|First 24 Weeks|Physician Decision|0
7546065|NCT02879383|11902069|FG003|First 24 Weeks|Physician Decision|0
7546066|NCT02879578|11902084|FG000|Overall Study|Adverse Event|1
7546067|NCT02879578|11902085|FG001|Overall Study|Adverse Event|2
7546068|NCT02879578|11902086|FG002|Overall Study|Adverse Event|14
7546069|NCT02879578|11902084|FG000|Overall Study|Protocol Violation|0
7546070|NCT02879578|11902085|FG001|Overall Study|Protocol Violation|1
7546071|NCT02879578|11902086|FG002|Overall Study|Protocol Violation|1
7546072|NCT02879578|11902084|FG000|Overall Study|Withdrawal by Subject|8
7546073|NCT02879578|11902085|FG001|Overall Study|Withdrawal by Subject|6
7546074|NCT02879578|11902086|FG002|Overall Study|Withdrawal by Subject|9
7546075|NCT02879578|11902084|FG000|Overall Study|Lost to Follow-up|1
7546076|NCT02879578|11902085|FG001|Overall Study|Lost to Follow-up|0
7546077|NCT02879578|11902086|FG002|Overall Study|Lost to Follow-up|4
7546078|NCT02879578|11902084|FG000|Overall Study|Physician Decision|0
7546079|NCT02879578|11902085|FG001|Overall Study|Physician Decision|0
7546080|NCT02879578|11902086|FG002|Overall Study|Physician Decision|4
7546081|NCT02879994|11902125|FG000|Overall Study|off treatment early|7
7546082|NCT02879994|11902125|FG000|Overall Study|Adverse Event|2
7546083|NCT02879994|11902125|FG000|Overall Study|Death|2
7546084|NCT02880761|11902176|FG000|Overall Study|Death|6
7546085|NCT02880761|11902177|FG001|Overall Study|Death|8
7546086|NCT02880761|11902176|FG000|Overall Study|Withdrawal by Subject|3
7546087|NCT02880761|11902177|FG001|Overall Study|Withdrawal by Subject|6
7546088|NCT02880761|11902176|FG000|Overall Study|Protocol Violation|4
7546089|NCT02880761|11902177|FG001|Overall Study|Protocol Violation|3
7546090|NCT02880761|11902176|FG000|Overall Study|Lost to Follow-up|3
7546091|NCT02880761|11902177|FG001|Overall Study|Lost to Follow-up|4
7546092|NCT02880865|11902189|FG000|Overall Study|Adverse Event|1
7546093|NCT02880865|11902190|FG001|Overall Study|Adverse Event|0
7546094|NCT02880865|11902189|FG000|Overall Study|Withdrawal by Subject|0
7546095|NCT02880865|11902190|FG001|Overall Study|Withdrawal by Subject|2
7546096|NCT02880865|11902189|FG000|Overall Study|Physician Decision|0
7546097|NCT02880865|11902190|FG001|Overall Study|Physician Decision|1
7546098|NCT02881047|11902245|FG000|Overall Study|Adverse Event|1
7546099|NCT02881047|11902245|FG000|Overall Study|Withdrawal by Subject|1
7577254|NCT04036110|11966377|FG002|Overall Study|Lost to Follow-up|1
7577255|NCT04036110|11966375|FG000|Overall Study|Study Suspended|4
7577256|NCT04036110|11966376|FG001|Overall Study|Study Suspended|5
7577257|NCT04036110|11966377|FG002|Overall Study|Study Suspended|1
7577258|NCT04035577|11966394|FG000|Overall Study|Lost to Follow-up|1
7577259|NCT04035577|11966394|FG000|Overall Study|Withdrawal by Subject|1
7577260|NCT04035564|11966402|FG000|Overall Study|Protocol Violation|1
7577261|NCT04035564|11966403|FG001|Overall Study|Protocol Violation|2
7577262|NCT04035564|11966402|FG000|Overall Study|No laboratory available|2
7577263|NCT04035564|11966403|FG001|Overall Study|No laboratory available|2
7577264|NCT04035564|11966402|FG000|Overall Study|Guardian declined consent|1
7577265|NCT04035564|11966403|FG001|Overall Study|Guardian declined consent|2
7577266|NCT04032977|11966411|FG000|Overall Study|Withdrawal by Subject|6
7577267|NCT04032977|11966412|FG001|Overall Study|Withdrawal by Subject|1
7577268|NCT04032977|11966411|FG000|Overall Study|Lost to Follow-up|2
7577269|NCT04032977|11966412|FG001|Overall Study|Lost to Follow-up|7
7577270|NCT04032977|11966411|FG000|Overall Study|Pregnancy|1
7577271|NCT04032977|11966412|FG001|Overall Study|Pregnancy|0
7577272|NCT04032652|11966420|FG000|Overall Study|The study was terminated and the PI has|1
7577273|NCT04032652|11966421|FG001|Overall Study|The study was terminated and the PI has|1
7266009|NCT00391976|11479823|FG000|Overall Study|Positive P. aeruginosa antibody test|0
7266010|NCT00391976|11479824|FG001|Overall Study|Positive P. aeruginosa antibody test|0
7266011|NCT00391976|11479825|FG002|Overall Study|Positive P. aeruginosa antibody test|31
7266012|NCT00392015|11479845|FG000|Overall Study|Lost to Follow-up|2
7266013|NCT00392015|11479846|FG001|Overall Study|Lost to Follow-up|0
7266014|NCT00392015|11479847|FG002|Overall Study|Lost to Follow-up|2
7266015|NCT00392015|11479848|FG003|Overall Study|Lost to Follow-up|1
7266016|NCT00392015|11479849|FG004|Overall Study|Lost to Follow-up|1
7266017|NCT00392015|11479850|FG005|Overall Study|Lost to Follow-up|0
7266018|NCT00392015|11479845|FG000|Overall Study|Withdrawal by Subject|0
7266019|NCT00392015|11479846|FG001|Overall Study|Withdrawal by Subject|0
7266020|NCT00392015|11479847|FG002|Overall Study|Withdrawal by Subject|2
7266021|NCT00392015|11479848|FG003|Overall Study|Withdrawal by Subject|0
7266022|NCT00392015|11479849|FG004|Overall Study|Withdrawal by Subject|0
7266023|NCT00392015|11479850|FG005|Overall Study|Withdrawal by Subject|0
7266024|NCT00392015|11479845|FG000|Overall Study|Adverse Event|0
7266025|NCT00392015|11479846|FG001|Overall Study|Adverse Event|0
7266026|NCT00392015|11479847|FG002|Overall Study|Adverse Event|0
7266027|NCT00392015|11479848|FG003|Overall Study|Adverse Event|0
7266028|NCT00392015|11479849|FG004|Overall Study|Adverse Event|1
7266029|NCT00392015|11479850|FG005|Overall Study|Adverse Event|0
7266030|NCT00392015|11479845|FG000|Overall Study|Previous trial recipient|0
7266031|NCT00392015|11479846|FG001|Overall Study|Previous trial recipient|0
7266032|NCT00392015|11479847|FG002|Overall Study|Previous trial recipient|0
7266033|NCT00392015|11479848|FG003|Overall Study|Previous trial recipient|0
7266034|NCT00392015|11479849|FG004|Overall Study|Previous trial recipient|1
7266035|NCT00392015|11479850|FG005|Overall Study|Previous trial recipient|0
7266036|NCT00392171|11479891|FG000|Overall Study|Did not meet inclusion criteria|4
7266037|NCT00392171|11479891|FG000|Overall Study|Disease progression|101
7266038|NCT00392197|11479897|FG000|Overall Study|Adverse Event|4
7266039|NCT00392197|11479898|FG001|Overall Study|Adverse Event|12
7266040|NCT00392197|11479897|FG000|Overall Study|Lack of Efficacy|3
7266041|NCT00392197|11479898|FG001|Overall Study|Lack of Efficacy|4
7266042|NCT00392197|11479897|FG000|Overall Study|Lost to Follow-up|0
7266043|NCT00392197|11479898|FG001|Overall Study|Lost to Follow-up|1
7266044|NCT00392197|11479897|FG000|Overall Study|Physician Decision|3
7266045|NCT00392197|11479898|FG001|Overall Study|Physician Decision|2
7266046|NCT00392197|11479897|FG000|Overall Study|Protocol Violation|7
7266047|NCT00392197|11479898|FG001|Overall Study|Protocol Violation|5
7266048|NCT00392197|11479897|FG000|Overall Study|Withdrawal by Subject|4
7266049|NCT00392197|11479898|FG001|Overall Study|Withdrawal by Subject|6
7266050|NCT00392210|11479906|FG000|First Voiding Trial|Physician Decision|2
7266051|NCT00392210|11479907|FG001|First Voiding Trial|Physician Decision|2
7266052|NCT00392223|11479915|FG000|Overall Study|Adverse Event|5
7266053|NCT00392223|11479916|FG001|Overall Study|Adverse Event|4
7266054|NCT00392223|11479915|FG000|Overall Study|Lost to Follow-up|1
7266055|NCT00392223|11479916|FG001|Overall Study|Lost to Follow-up|4
7266056|NCT00392223|11479915|FG000|Overall Study|Protocol Violation|0
7266057|NCT00392223|11479916|FG001|Overall Study|Protocol Violation|3
7266058|NCT00392223|11479915|FG000|Overall Study|Withdrawal by Subject|3
7266059|NCT00392223|11479916|FG001|Overall Study|Withdrawal by Subject|2
7266060|NCT00392288|11479934|FG000|Overall Study|Adverse Event|17
7266061|NCT00392288|11479935|FG001|Overall Study|Adverse Event|7
7266062|NCT00392288|11479936|FG002|Overall Study|Adverse Event|8
7266063|NCT00392288|11479934|FG000|Overall Study|Lack of Efficacy|8
7266064|NCT00392288|11479935|FG001|Overall Study|Lack of Efficacy|5
7266065|NCT00392288|11479936|FG002|Overall Study|Lack of Efficacy|3
7266066|NCT00392288|11479934|FG000|Overall Study|Protocol Violation|1
7266067|NCT00392288|11479935|FG001|Overall Study|Protocol Violation|3
7266068|NCT00392288|11479936|FG002|Overall Study|Protocol Violation|1
7266069|NCT00392288|11479934|FG000|Overall Study|Lost to Follow-up|1
7266070|NCT00392288|11479935|FG001|Overall Study|Lost to Follow-up|1
7266071|NCT00392288|11479936|FG002|Overall Study|Lost to Follow-up|1
7266072|NCT00392288|11479934|FG000|Overall Study|Withdrawal by Subject|1
7266073|NCT00392288|11479935|FG001|Overall Study|Withdrawal by Subject|0
7266074|NCT00392288|11479936|FG002|Overall Study|Withdrawal by Subject|2
7266075|NCT00392288|11479934|FG000|Overall Study|Parent/legal guardian withdrawal|1
7266076|NCT00392288|11479935|FG001|Overall Study|Parent/legal guardian withdrawal|2
7266077|NCT00392288|11479936|FG002|Overall Study|Parent/legal guardian withdrawal|1
7266078|NCT00392288|11479934|FG000|Overall Study|Other|3
7266079|NCT00392288|11479935|FG001|Overall Study|Other|4
7266080|NCT00392288|11479936|FG002|Overall Study|Other|1
7266081|NCT00392379|11479946|FG000|Overall Study|Withdrawal by Subject|17
7266082|NCT00392379|11479947|FG001|Overall Study|Withdrawal by Subject|28
7266083|NCT00392379|11479946|FG000|Overall Study|Lost to Follow-up|4
7266084|NCT00392379|11479947|FG001|Overall Study|Lost to Follow-up|9
7266085|NCT00392379|11479946|FG000|Overall Study|Adverse Event|1
7266086|NCT00392379|11479947|FG001|Overall Study|Adverse Event|1
7266087|NCT00392665|11479967|FG000|Overall Study|Death|16
7266088|NCT00392665|11479968|FG001|Overall Study|Death|14
7266089|NCT00392665|11479967|FG000|Overall Study|Lost to Follow-up|1
7266090|NCT00392665|11479968|FG001|Overall Study|Lost to Follow-up|1
7266091|NCT00392769|11480004|FG000|Overall Study|Clinical Deterioration|9
7266092|NCT00392769|11480004|FG000|Overall Study|Adverse Event|1
7266093|NCT00392808|11480016|FG000|Overall Study|Lost to Follow-up|3
7266094|NCT00392808|11480017|FG001|Overall Study|Lost to Follow-up|2
7266095|NCT00392808|11480018|FG002|Overall Study|Lost to Follow-up|1
7266096|NCT00392808|11480019|FG003|Overall Study|Lost to Follow-up|2
7266097|NCT00392808|11480016|FG000|Overall Study|Unable to withdraw blood|3
7266098|NCT00392808|11480017|FG001|Overall Study|Unable to withdraw blood|1
7266099|NCT00392808|11480018|FG002|Overall Study|Unable to withdraw blood|1
7266100|NCT00392808|11480019|FG003|Overall Study|Unable to withdraw blood|2
7266101|NCT00392925|11480042|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
7266102|NCT00392925|11480043|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7266103|NCT00392925|11480044|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7266104|NCT00392925|11480045|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
7266105|NCT00392925|11480042|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
7266106|NCT00392925|11480043|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7266107|NCT00392925|11480044|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7266108|NCT00392925|11480045|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
7266109|NCT00392925|11480042|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
7266110|NCT00392925|11480043|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7266111|NCT00392925|11480044|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7266112|NCT00392925|11480045|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
7266113|NCT00392925|11480042|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
7266114|NCT00392925|11480043|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7266115|NCT00392925|11480044|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7266116|NCT00392925|11480045|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
7546100|NCT02881567|11902253|FG000|Overall Study|Adverse Event|1
7546101|NCT02881567|11902253|FG000|Overall Study|Lost to Follow-up|3
7546102|NCT02881567|11902253|FG000|Overall Study|Consent withdrawn|1
7546103|NCT02881567|11902253|FG000|Overall Study|Investigator decision|1
7546104|NCT02881567|11902253|FG000|Overall Study|Study terminated by sponsor|9
7546105|NCT02881567|11902253|FG000|Overall Study|Reason not Specified|3
7546106|NCT02882152|11902290|FG000|Overall Study|Lost to Follow-up|1
7546107|NCT02882152|11902291|FG001|Overall Study|Lost to Follow-up|0
7546108|NCT02882854|11902316|FG000|Overall Study|Lost to Follow-up|1
7546109|NCT02882854|11902317|FG001|Overall Study|Lost to Follow-up|2
7546110|NCT02882854|11902316|FG000|Overall Study|Physician Decision|0
7546111|NCT02882854|11902317|FG001|Overall Study|Physician Decision|1
7546112|NCT02883244|11902325|FG000|Overall Study|Lost to Follow-up|0
7546113|NCT02883244|11902326|FG001|Overall Study|Lost to Follow-up|1
7546114|NCT02883452|11902338|FG000|Overall Study|Withdrawal by Subject|1
7546115|NCT02883452|11902339|FG001|Overall Study|Withdrawal by Subject|1
7546116|NCT02883452|11902340|FG002|Overall Study|Withdrawal by Subject|3
7546117|NCT02883452|11902341|FG003|Overall Study|Withdrawal by Subject|0
7546118|NCT02883452|11902342|FG004|Overall Study|Withdrawal by Subject|2
7546119|NCT02883452|11902343|FG005|Overall Study|Withdrawal by Subject|5
7546120|NCT02883452|11902338|FG000|Overall Study|Disease progression|1
7546121|NCT02883452|11902339|FG001|Overall Study|Disease progression|0
7546122|NCT02883452|11902340|FG002|Overall Study|Disease progression|0
7546123|NCT02883452|11902341|FG003|Overall Study|Disease progression|1
7546124|NCT02883452|11902342|FG004|Overall Study|Disease progression|4
7546125|NCT02883452|11902343|FG005|Overall Study|Disease progression|5
7546126|NCT02883452|11902338|FG000|Overall Study|Adverse Event|2
7546127|NCT02883452|11902339|FG001|Overall Study|Adverse Event|1
7546128|NCT02883452|11902340|FG002|Overall Study|Adverse Event|1
7546129|NCT02883452|11902341|FG003|Overall Study|Adverse Event|1
7546130|NCT02883452|11902342|FG004|Overall Study|Adverse Event|1
7546131|NCT02883452|11902343|FG005|Overall Study|Adverse Event|3
7546132|NCT02883452|11902338|FG000|Overall Study|Physician Decision|0
7546133|NCT02883452|11902339|FG001|Overall Study|Physician Decision|0
7546134|NCT02883452|11902340|FG002|Overall Study|Physician Decision|0
7546135|NCT02883452|11902341|FG003|Overall Study|Physician Decision|0
7546136|NCT02883452|11902342|FG004|Overall Study|Physician Decision|4
7546137|NCT02883452|11902343|FG005|Overall Study|Physician Decision|1
7546138|NCT02883452|11902338|FG000|Overall Study|Death|1
7546139|NCT02883452|11902339|FG001|Overall Study|Death|0
7546140|NCT02883452|11902340|FG002|Overall Study|Death|1
7546141|NCT02883452|11902341|FG003|Overall Study|Death|0
7546142|NCT02883452|11902342|FG004|Overall Study|Death|0
7546143|NCT02883452|11902343|FG005|Overall Study|Death|0
7546144|NCT02883452|11902338|FG000|Overall Study|Other|0
7546145|NCT02883452|11902339|FG001|Overall Study|Other|0
7546146|NCT02883452|11902340|FG002|Overall Study|Other|0
7546147|NCT02883452|11902341|FG003|Overall Study|Other|0
7546148|NCT02883452|11902342|FG004|Overall Study|Other|0
7546149|NCT02883452|11902343|FG005|Overall Study|Other|1
7546150|NCT02884089|11902358|FG000|Period 1|Dosing error|2
7546151|NCT02884089|11902359|FG001|Period 1|Dosing error|2
7546152|NCT02884089|11902360|FG002|Period 1|Dosing error|0
7546153|NCT02884089|11902361|FG003|Period 1|Dosing error|0
7546154|NCT02884089|11902358|FG000|Washout Period 1|Lost to Follow-up|0
7546155|NCT02884089|11902359|FG001|Washout Period 1|Lost to Follow-up|1
7546156|NCT02884089|11902360|FG002|Washout Period 1|Lost to Follow-up|0
7546157|NCT02884089|11902361|FG003|Washout Period 1|Lost to Follow-up|1
7546158|NCT02884089|11902358|FG000|Washout Period 1|Withdrawal by Subject|0
7546159|NCT02884089|11902359|FG001|Washout Period 1|Withdrawal by Subject|1
7266117|NCT00392925|11480042|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
7266118|NCT00392925|11480043|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7266119|NCT00392925|11480044|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7266120|NCT00392925|11480045|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
7266121|NCT00392925|11480042|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
7266122|NCT00392925|11480043|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
7266123|NCT00392925|11480044|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
7266124|NCT00392925|11480045|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
7266125|NCT00392925|11480042|FG000|Randomization to Treatment Group Period|Adverse Event|0
7266126|NCT00392925|11480043|FG001|Randomization to Treatment Group Period|Adverse Event|3
7266127|NCT00392925|11480044|FG002|Randomization to Treatment Group Period|Adverse Event|3
7266128|NCT00392925|11480045|FG003|Randomization to Treatment Group Period|Adverse Event|5
7266129|NCT00392925|11480042|FG000|Randomization to Treatment Group Period|Protocol Violation|0
7266130|NCT00392925|11480043|FG001|Randomization to Treatment Group Period|Protocol Violation|0
7266131|NCT00392925|11480044|FG002|Randomization to Treatment Group Period|Protocol Violation|2
7266132|NCT00392925|11480045|FG003|Randomization to Treatment Group Period|Protocol Violation|1
7266133|NCT00392925|11480042|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
7266134|NCT00392925|11480043|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
7266135|NCT00392925|11480044|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
7266136|NCT00392925|11480045|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
7266137|NCT00392990|11480067|FG000|Treatment on Study|Adverse Event|3
7266138|NCT00392990|11480068|FG001|Treatment on Study|Adverse Event|1
7266139|NCT00392990|11480067|FG000|Follow up for 2 Years|Death|4
7266140|NCT00392990|11480068|FG001|Follow up for 2 Years|Death|0
7266141|NCT00393029|11480076|FG000|Overall Study|Not treated|0
7266142|NCT00393029|11480077|FG001|Overall Study|Not treated|1
7266143|NCT00393042|11480084|FG000|First Intervention|Withdrawal by Subject|1
7266144|NCT00393042|11480085|FG001|First Intervention|Withdrawal by Subject|2
7266145|NCT00393042|11480084|FG000|First Intervention|Lost to Follow-up|3
7266146|NCT00393042|11480085|FG001|First Intervention|Lost to Follow-up|3
7266147|NCT00393042|11480084|FG000|First Intervention|Protocol Violation|1
7266148|NCT00393042|11480085|FG001|First Intervention|Protocol Violation|0
7266149|NCT00393042|11480084|FG000|First Intervention|Adverse Event|0
7266150|NCT00393042|11480085|FG001|First Intervention|Adverse Event|1
7266151|NCT00393042|11480084|FG000|Second Intervetion|Adverse Event|0
7266152|NCT00393042|11480085|FG001|Second Intervetion|Adverse Event|3
7546160|NCT02884089|11902360|FG002|Washout Period 1|Withdrawal by Subject|0
7546161|NCT02884089|11902361|FG003|Washout Period 1|Withdrawal by Subject|0
7546162|NCT02884089|11902358|FG000|Period 2|Adverse Event|1
7546163|NCT02884089|11902359|FG001|Period 2|Adverse Event|0
7546164|NCT02884089|11902360|FG002|Period 2|Adverse Event|0
7546165|NCT02884089|11902361|FG003|Period 2|Adverse Event|0
7546166|NCT02884089|11902358|FG000|Period 3|Withdrawal by Subject|0
7546167|NCT02884089|11902359|FG001|Period 3|Withdrawal by Subject|0
7546168|NCT02884089|11902360|FG002|Period 3|Withdrawal by Subject|1
7546169|NCT02884089|11902361|FG003|Period 3|Withdrawal by Subject|0
7546170|NCT02884089|11902358|FG000|Washout Period 3|Withdrawal by Subject|0
7546171|NCT02884089|11902359|FG001|Washout Period 3|Withdrawal by Subject|0
7546172|NCT02884089|11902360|FG002|Washout Period 3|Withdrawal by Subject|1
7546173|NCT02884089|11902361|FG003|Washout Period 3|Withdrawal by Subject|0
7546174|NCT02884089|11902358|FG000|Washout Period 3|Lost to Follow-up|0
7546175|NCT02884089|11902359|FG001|Washout Period 3|Lost to Follow-up|0
7546176|NCT02884089|11902360|FG002|Washout Period 3|Lost to Follow-up|0
7546177|NCT02884089|11902361|FG003|Washout Period 3|Lost to Follow-up|1
7546178|NCT02884089|11902358|FG000|Period 4|Withdrawal by Subject|0
7546179|NCT02884089|11902359|FG001|Period 4|Withdrawal by Subject|1
7546180|NCT02884089|11902360|FG002|Period 4|Withdrawal by Subject|0
7546181|NCT02884089|11902361|FG003|Period 4|Withdrawal by Subject|0
7546182|NCT02884089|11902358|FG000|Period 4|Lost to Follow-up|1
7546183|NCT02884089|11902359|FG001|Period 4|Lost to Follow-up|0
7546184|NCT02884089|11902360|FG002|Period 4|Lost to Follow-up|0
7546185|NCT02884089|11902361|FG003|Period 4|Lost to Follow-up|0
7546186|NCT02884089|11902358|FG000|Follow-up Visit|Withdrawal by Subject|1
7546187|NCT02884089|11902359|FG001|Follow-up Visit|Withdrawal by Subject|0
7546188|NCT02884089|11902360|FG002|Follow-up Visit|Withdrawal by Subject|0
7546189|NCT02884089|11902361|FG003|Follow-up Visit|Withdrawal by Subject|1
7546190|NCT02885181|11902431|FG000|Overall Study|Investigator's Discretion|0
7546191|NCT02885181|11902432|FG001|Overall Study|Investigator's Discretion|1
7546192|NCT02885181|11902433|FG002|Overall Study|Investigator's Discretion|0
7546193|NCT02885181|11902434|FG003|Overall Study|Investigator's Discretion|1
7546194|NCT02885181|11902431|FG000|Overall Study|Adverse Event|0
7266153|NCT00393042|11480084|FG000|Second Intervetion|Withdrawal by Subject|0
7266154|NCT00393042|11480085|FG001|Second Intervetion|Withdrawal by Subject|2
7266155|NCT00393042|11480084|FG000|Second Intervetion|Lack of Efficacy|1
7266156|NCT00393042|11480085|FG001|Second Intervetion|Lack of Efficacy|0
7266157|NCT00393042|11480084|FG000|Second Intervetion|Lost to Follow-up|0
7266158|NCT00393042|11480085|FG001|Second Intervetion|Lost to Follow-up|2
7266159|NCT00393042|11480084|FG000|Second Intervetion|Protocol Violation|1
7266160|NCT00393042|11480085|FG001|Second Intervetion|Protocol Violation|1
7266161|NCT00393094|11480139|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
7266162|NCT00393094|11480139|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
7266163|NCT00393367|11480147|FG000|Overall Study|Protocol Violation|2
7266164|NCT00393367|11480148|FG001|Overall Study|Protocol Violation|5
7266165|NCT00393367|11480147|FG000|Overall Study|Withdrawal by Subject|0
7266166|NCT00393367|11480148|FG001|Overall Study|Withdrawal by Subject|2
7266167|NCT00393458|11480164|FG000|Overall Study|Adverse Event|35
7266168|NCT00393458|11480165|FG001|Overall Study|Adverse Event|24
7266169|NCT00393458|11480166|FG002|Overall Study|Adverse Event|40
7266170|NCT00393458|11480167|FG003|Overall Study|Adverse Event|35
7266171|NCT00393458|11480164|FG000|Overall Study|Subject withdrew consent|27
7266172|NCT00393458|11480165|FG001|Overall Study|Subject withdrew consent|40
7266173|NCT00393458|11480166|FG002|Overall Study|Subject withdrew consent|33
7266174|NCT00393458|11480167|FG003|Overall Study|Subject withdrew consent|50
7266175|NCT00393458|11480164|FG000|Overall Study|Unsatisfactory therapeutic effect|12
7266176|NCT00393458|11480165|FG001|Overall Study|Unsatisfactory therapeutic effect|9
7266177|NCT00393458|11480166|FG002|Overall Study|Unsatisfactory therapeutic effect|12
7266178|NCT00393458|11480167|FG003|Overall Study|Unsatisfactory therapeutic effect|30
7266179|NCT00393458|11480164|FG000|Overall Study|Protocol deviation|11
7266180|NCT00393458|11480165|FG001|Overall Study|Protocol deviation|11
7266181|NCT00393458|11480166|FG002|Overall Study|Protocol deviation|11
7266182|NCT00393458|11480167|FG003|Overall Study|Protocol deviation|10
7266183|NCT00393458|11480164|FG000|Overall Study|Administrative problems|7
7266184|NCT00393458|11480165|FG001|Overall Study|Administrative problems|8
7266185|NCT00393458|11480166|FG002|Overall Study|Administrative problems|5
7266186|NCT00393458|11480167|FG003|Overall Study|Administrative problems|2
7266187|NCT00393458|11480164|FG000|Overall Study|Lost to Follow-up|5
7266188|NCT00393458|11480165|FG001|Overall Study|Lost to Follow-up|6
7266189|NCT00393458|11480166|FG002|Overall Study|Lost to Follow-up|5
7266190|NCT00393458|11480167|FG003|Overall Study|Lost to Follow-up|3
7266191|NCT00393458|11480164|FG000|Overall Study|Abnormal laboratory value(s)|1
7266192|NCT00393458|11480165|FG001|Overall Study|Abnormal laboratory value(s)|1
7266193|NCT00393458|11480166|FG002|Overall Study|Abnormal laboratory value(s)|0
7266194|NCT00393458|11480167|FG003|Overall Study|Abnormal laboratory value(s)|0
7266195|NCT00393458|11480164|FG000|Overall Study|Death|1
7266196|NCT00393458|11480165|FG001|Overall Study|Death|1
7266197|NCT00393458|11480166|FG002|Overall Study|Death|5
7266198|NCT00393458|11480167|FG003|Overall Study|Death|5
7266199|NCT00393458|11480164|FG000|Overall Study|Abnormal test procedure result(s)|0
7266200|NCT00393458|11480165|FG001|Overall Study|Abnormal test procedure result(s)|1
7266201|NCT00393458|11480166|FG002|Overall Study|Abnormal test procedure result(s)|1
7266202|NCT00393458|11480167|FG003|Overall Study|Abnormal test procedure result(s)|2
7266203|NCT00393458|11480164|FG000|Overall Study|Subject no longer requires study drug|0
7266204|NCT00393458|11480165|FG001|Overall Study|Subject no longer requires study drug|1
7266205|NCT00393458|11480166|FG002|Overall Study|Subject no longer requires study drug|0
7546195|NCT02885181|11902432|FG001|Overall Study|Adverse Event|0
7546196|NCT02885181|11902433|FG002|Overall Study|Adverse Event|0
7546197|NCT02885181|11902434|FG003|Overall Study|Adverse Event|1
7546198|NCT02885181|11902431|FG000|Overall Study|Withdrawal by Subject|0
7546199|NCT02885181|11902432|FG001|Overall Study|Withdrawal by Subject|0
7546200|NCT02885181|11902433|FG002|Overall Study|Withdrawal by Subject|0
7546201|NCT02885181|11902434|FG003|Overall Study|Withdrawal by Subject|1
7546202|NCT02886338|11902530|FG000|Overall Study|Withdrawal by Subject|1
7546203|NCT02886494|11902536|FG000|Overall Study|Adverse Event|1
7546204|NCT02886494|11902537|FG001|Overall Study|Adverse Event|0
7546205|NCT02886494|11902536|FG000|Overall Study|Withdrawal by Subject|12
7546206|NCT02886494|11902537|FG001|Overall Study|Withdrawal by Subject|3
7546207|NCT02886494|11902536|FG000|Overall Study|Protocol Violation|4
7546208|NCT02886494|11902537|FG001|Overall Study|Protocol Violation|1
7266206|NCT00393458|11480167|FG003|Overall Study|Subject no longer requires study drug|0
7546209|NCT02886624|11902546|FG000|12-week Post Treatment Follow-up|Death|1
7546210|NCT02886624|11902546|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
7266207|NCT00393484|11480179|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
7266208|NCT00393484|11480180|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
7266209|NCT00393484|11480179|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
7266210|NCT00393484|11480180|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
7546211|NCT02886702|11902553|FG000|Overall Study|Other|4
7546212|NCT02886702|11902554|FG001|Overall Study|Other|3
7546213|NCT02886702|11902555|FG002|Overall Study|Other|9
7546214|NCT02886702|11902553|FG000|Overall Study|Withdrawal by Subject|24
7546215|NCT02886702|11902554|FG001|Overall Study|Withdrawal by Subject|18
7546216|NCT02886702|11902555|FG002|Overall Study|Withdrawal by Subject|22
7546217|NCT02886702|11902553|FG000|Overall Study|Significant Worsening of Condition|0
7546218|NCT02886702|11902554|FG001|Overall Study|Significant Worsening of Condition|1
7546219|NCT02886702|11902555|FG002|Overall Study|Significant Worsening of Condition|0
7546220|NCT02886702|11902553|FG000|Overall Study|Protocol Violation|2
7546221|NCT02886702|11902554|FG001|Overall Study|Protocol Violation|2
7546222|NCT02886702|11902555|FG002|Overall Study|Protocol Violation|1
7546223|NCT02886702|11902553|FG000|Overall Study|Non-Compliance With Study Drug|0
7546224|NCT02886702|11902554|FG001|Overall Study|Non-Compliance With Study Drug|1
7546225|NCT02886702|11902555|FG002|Overall Study|Non-Compliance With Study Drug|4
7546226|NCT02886702|11902553|FG000|Overall Study|Lost to Follow-up|11
7546227|NCT02886702|11902554|FG001|Overall Study|Lost to Follow-up|13
7546228|NCT02886702|11902555|FG002|Overall Study|Lost to Follow-up|8
7546229|NCT02886702|11902553|FG000|Overall Study|Lack of Efficacy|3
7546230|NCT02886702|11902554|FG001|Overall Study|Lack of Efficacy|4
7546231|NCT02886702|11902555|FG002|Overall Study|Lack of Efficacy|5
7546232|NCT02886702|11902553|FG000|Overall Study|Adverse Event|4
7546233|NCT02886702|11902554|FG001|Overall Study|Adverse Event|9
7546234|NCT02886702|11902555|FG002|Overall Study|Adverse Event|3
7546235|NCT02886702|11902553|FG000|Overall Study|Administrative Reasons|0
7546236|NCT02886702|11902554|FG001|Overall Study|Administrative Reasons|0
7546237|NCT02886702|11902555|FG002|Overall Study|Administrative Reasons|1
7546238|NCT02886715|11902566|FG000|Overall Study|Non-Compliance With Study Drug|0
7546239|NCT02886715|11902567|FG001|Overall Study|Non-Compliance With Study Drug|2
7546240|NCT02886715|11902568|FG002|Overall Study|Non-Compliance With Study Drug|0
7546241|NCT02886715|11902566|FG000|Overall Study|Adverse Event|4
7546242|NCT02886715|11902567|FG001|Overall Study|Adverse Event|2
7546243|NCT02886715|11902568|FG002|Overall Study|Adverse Event|0
7546244|NCT02886715|11902566|FG000|Overall Study|Lack of Efficacy|0
7546245|NCT02886715|11902567|FG001|Overall Study|Lack of Efficacy|2
7546246|NCT02886715|11902568|FG002|Overall Study|Lack of Efficacy|1
7546247|NCT02886715|11902566|FG000|Overall Study|Lost to Follow-up|29
7546248|NCT02886715|11902567|FG001|Overall Study|Lost to Follow-up|26
7546249|NCT02886715|11902568|FG002|Overall Study|Lost to Follow-up|10
7546250|NCT02886715|11902566|FG000|Overall Study|Pregnancy|1
7546251|NCT02886715|11902567|FG001|Overall Study|Pregnancy|1
7546252|NCT02886715|11902568|FG002|Overall Study|Pregnancy|1
7546253|NCT02886715|11902566|FG000|Overall Study|Protocol Violation|3
7546254|NCT02886715|11902567|FG001|Overall Study|Protocol Violation|2
7546255|NCT02886715|11902568|FG002|Overall Study|Protocol Violation|1
7546256|NCT02886715|11902566|FG000|Overall Study|Withdrawal by Subject|20
7546257|NCT02886715|11902567|FG001|Overall Study|Withdrawal by Subject|18
7546258|NCT02886715|11902568|FG002|Overall Study|Withdrawal by Subject|5
7546259|NCT02886715|11902566|FG000|Overall Study|missing|7
7546260|NCT02886715|11902567|FG001|Overall Study|missing|2
7546261|NCT02886715|11902568|FG002|Overall Study|missing|2
7546262|NCT02886728|11902580|FG000|Overall Study|Withdrew Consent|31
7546263|NCT02886728|11902581|FG001|Overall Study|Withdrew Consent|13
7546264|NCT02886728|11902582|FG002|Overall Study|Withdrew Consent|11
7546265|NCT02886728|11902583|FG003|Overall Study|Withdrew Consent|47
7546266|NCT02886728|11902580|FG000|Overall Study|Lost to Follow-up|12
7546267|NCT02886728|11902581|FG001|Overall Study|Lost to Follow-up|6
7546268|NCT02886728|11902582|FG002|Overall Study|Lost to Follow-up|13
7546269|NCT02886728|11902583|FG003|Overall Study|Lost to Follow-up|12
7546270|NCT02886728|11902580|FG000|Overall Study|Adverse Event|13
7546271|NCT02886728|11902581|FG001|Overall Study|Adverse Event|5
7546272|NCT02886728|11902582|FG002|Overall Study|Adverse Event|5
7546273|NCT02886728|11902583|FG003|Overall Study|Adverse Event|11
7546274|NCT02886728|11902580|FG000|Overall Study|Investigator's Discretion|11
7546275|NCT02886728|11902581|FG001|Overall Study|Investigator's Discretion|7
7546276|NCT02886728|11902582|FG002|Overall Study|Investigator's Discretion|5
7266211|NCT00393484|11480179|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
7266212|NCT00393484|11480180|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
7546277|NCT02886728|11902583|FG003|Overall Study|Investigator's Discretion|11
7546278|NCT02886728|11902580|FG000|Overall Study|Death|3
7546279|NCT02886728|11902581|FG001|Overall Study|Death|1
7546280|NCT02886728|11902582|FG002|Overall Study|Death|0
7546281|NCT02886728|11902583|FG003|Overall Study|Death|0
7546282|NCT02886728|11902580|FG000|Overall Study|Protocol Violation|0
7546283|NCT02886728|11902581|FG001|Overall Study|Protocol Violation|0
7546284|NCT02886728|11902582|FG002|Overall Study|Protocol Violation|0
7546285|NCT02886728|11902583|FG003|Overall Study|Protocol Violation|4
7546286|NCT02886728|11902580|FG000|Overall Study|Non-Compliance with Study Drug|1
7546287|NCT02886728|11902581|FG001|Overall Study|Non-Compliance with Study Drug|0
7546288|NCT02886728|11902582|FG002|Overall Study|Non-Compliance with Study Drug|1
7266213|NCT00393484|11480179|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
7266214|NCT00393484|11480180|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
7266215|NCT00393484|11480179|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
7266216|NCT00393484|11480180|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
7266217|NCT00393484|11480179|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
7266218|NCT00393484|11480180|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
7266219|NCT00393484|11480179|FG000|Open-label Period (Weeks 96 to 240)|Death|1
7266220|NCT00393484|11480180|FG001|Open-label Period (Weeks 96 to 240)|Death|0
7546289|NCT02886728|11902583|FG003|Overall Study|Non-Compliance with Study Drug|0
7546290|NCT02886728|11902580|FG000|Overall Study|Pregnancy|0
7546291|NCT02886728|11902581|FG001|Overall Study|Pregnancy|0
7546292|NCT02886728|11902582|FG002|Overall Study|Pregnancy|1
7546293|NCT02886728|11902583|FG003|Overall Study|Pregnancy|0
7546294|NCT02886728|11902580|FG000|Overall Study|Randomized but Not Dosed|1
7546295|NCT02886728|11902581|FG001|Overall Study|Randomized but Not Dosed|0
7546296|NCT02886728|11902582|FG002|Overall Study|Randomized but Not Dosed|0
7546297|NCT02886728|11902583|FG003|Overall Study|Randomized but Not Dosed|2
7546298|NCT02887183|11902600|FG000|Overall Study|Adverse Event|44
7546299|NCT02887183|11902600|FG000|Overall Study|Death|30
7546300|NCT02887183|11902600|FG000|Overall Study|Pregnancy|1
7546301|NCT02887183|11902600|FG000|Overall Study|Protocol Violation|6
7546302|NCT02887183|11902600|FG000|Overall Study|Technical Problems|2
7546303|NCT02887183|11902600|FG000|Overall Study|Lost to Follow-up|13
7546304|NCT02887183|11902600|FG000|Overall Study|Physician Decision|10
7266221|NCT00393484|11480179|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
7266222|NCT00393484|11480180|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
7266223|NCT00393484|11480179|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7266224|NCT00393484|11480180|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
7266225|NCT00393484|11480179|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
7266226|NCT00393484|11480180|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
7266227|NCT00393510|11480190|FG000|Overall Study|Physician Decision|3
7266228|NCT00393510|11480191|FG001|Overall Study|Physician Decision|9
7266229|NCT00393523|11480202|FG000|Overall Study|Lost to Follow-up|0
7266230|NCT00393523|11480203|FG001|Overall Study|Lost to Follow-up|0
7266231|NCT00393523|11480204|FG002|Overall Study|Lost to Follow-up|0
7266232|NCT00393523|11480205|FG003|Overall Study|Lost to Follow-up|2
7266233|NCT00393523|11480206|FG004|Overall Study|Lost to Follow-up|1
7266234|NCT00393523|11480202|FG000|Overall Study|Protocol Violation|6
7266235|NCT00393523|11480203|FG001|Overall Study|Protocol Violation|2
7266236|NCT00393523|11480204|FG002|Overall Study|Protocol Violation|0
7266237|NCT00393523|11480205|FG003|Overall Study|Protocol Violation|1
7266238|NCT00393523|11480206|FG004|Overall Study|Protocol Violation|0
7266239|NCT00393523|11480202|FG000|Overall Study|Withdrawal by Subject|6
7546305|NCT02887183|11902600|FG000|Overall Study|Withdrawal by Subject|35
7546306|NCT02887521|11902616|FG000|Overall Study|Withdrawal by Subject|0
7546307|NCT02887521|11902617|FG001|Overall Study|Withdrawal by Subject|3
7577274|NCT04032613|11966441|FG000|Overall Study|Did not complete post-program assessment|5
7577275|NCT04032613|11966442|FG001|Overall Study|Did not complete post-program assessment|2
7266240|NCT00393523|11480203|FG001|Overall Study|Withdrawal by Subject|7
7266241|NCT00393523|11480204|FG002|Overall Study|Withdrawal by Subject|2
7266242|NCT00393523|11480205|FG003|Overall Study|Withdrawal by Subject|3
7266243|NCT00393523|11480206|FG004|Overall Study|Withdrawal by Subject|0
7266244|NCT00393523|11480202|FG000|Overall Study|Difficulties in specimen collection|0
7266245|NCT00393523|11480203|FG001|Overall Study|Difficulties in specimen collection|0
7266246|NCT00393523|11480204|FG002|Overall Study|Difficulties in specimen collection|1
7266247|NCT00393523|11480205|FG003|Overall Study|Difficulties in specimen collection|0
7266248|NCT00393523|11480206|FG004|Overall Study|Difficulties in specimen collection|0
7266249|NCT00393523|11480202|FG000|Overall Study|Vaccine supply issue|0
7266250|NCT00393523|11480203|FG001|Overall Study|Vaccine supply issue|0
7266251|NCT00393523|11480204|FG002|Overall Study|Vaccine supply issue|1
7266252|NCT00393523|11480205|FG003|Overall Study|Vaccine supply issue|0
7266253|NCT00393523|11480206|FG004|Overall Study|Vaccine supply issue|0
7266254|NCT00393705|11480219|FG000|Overall Study|Adverse Event|0
7266255|NCT00393705|11480220|FG001|Overall Study|Adverse Event|2
7266256|NCT00393705|11480219|FG000|Overall Study|Death|0
7266257|NCT00393705|11480220|FG001|Overall Study|Death|1
7266258|NCT00393705|11480219|FG000|Overall Study|Lost to Follow-up|2
7266259|NCT00393705|11480220|FG001|Overall Study|Lost to Follow-up|2
7266260|NCT00393705|11480219|FG000|Overall Study|Entry Criteria Not Met|10
7266261|NCT00393705|11480220|FG001|Overall Study|Entry Criteria Not Met|10
7266262|NCT00393705|11480219|FG000|Overall Study|Protocol Violation|4
7546308|NCT02887989|11902625|FG000|Overall Study|Withdrawal by Subject|8
7546309|NCT02887989|11902626|FG001|Overall Study|Withdrawal by Subject|11
7546310|NCT02887989|11902625|FG000|Overall Study|Death|1
7546311|NCT02887989|11902626|FG001|Overall Study|Death|0
7546312|NCT02888080|11902634|FG000|Overall Study|Subject / Guardian decision|1
7546313|NCT02888080|11902635|FG001|Overall Study|Subject / Guardian decision|3
7546314|NCT02888080|11902634|FG000|Overall Study|New Therapy for study indication|1
7546315|NCT02888080|11902635|FG001|Overall Study|New Therapy for study indication|0
7546316|NCT02888080|11902634|FG000|Overall Study|Lack of Efficacy|0
7546317|NCT02888080|11902635|FG001|Overall Study|Lack of Efficacy|1
7546318|NCT02888080|11902634|FG000|Overall Study|Adverse Event|0
7546319|NCT02888080|11902635|FG001|Overall Study|Adverse Event|1
7546320|NCT02888106|11902658|FG000|Overall Study|Withdrawal by Subject|1
7546321|NCT02888106|11902659|FG001|Overall Study|Withdrawal by Subject|2
7546322|NCT02888106|11902660|FG002|Overall Study|Withdrawal by Subject|0
7546323|NCT02888106|11902661|FG003|Overall Study|Withdrawal by Subject|1
7546324|NCT02888106|11902662|FG004|Overall Study|Withdrawal by Subject|0
7546325|NCT02888106|11902663|FG005|Overall Study|Withdrawal by Subject|0
7546326|NCT02888106|11902658|FG000|Overall Study|Lost to Follow-up|1
7546327|NCT02888106|11902659|FG001|Overall Study|Lost to Follow-up|0
7546328|NCT02888106|11902660|FG002|Overall Study|Lost to Follow-up|0
7546329|NCT02888106|11902661|FG003|Overall Study|Lost to Follow-up|1
7546330|NCT02888106|11902662|FG004|Overall Study|Lost to Follow-up|0
7546331|NCT02888106|11902663|FG005|Overall Study|Lost to Follow-up|1
7546332|NCT02888106|11902658|FG000|Overall Study|Adverse Event|2
7546333|NCT02888106|11902659|FG001|Overall Study|Adverse Event|0
7546334|NCT02888106|11902660|FG002|Overall Study|Adverse Event|0
7546335|NCT02888106|11902661|FG003|Overall Study|Adverse Event|0
7266263|NCT00393705|11480220|FG001|Overall Study|Protocol Violation|3
7266264|NCT00393705|11480219|FG000|Overall Study|Withdrawal by Subject|5
7266265|NCT00393705|11480220|FG001|Overall Study|Withdrawal by Subject|3
7546336|NCT02888106|11902662|FG004|Overall Study|Adverse Event|0
7546337|NCT02888106|11902663|FG005|Overall Study|Adverse Event|0
7546338|NCT02888106|11902658|FG000|Overall Study|Withdrawal of consent|0
7546339|NCT02888106|11902659|FG001|Overall Study|Withdrawal of consent|0
7546340|NCT02888106|11902660|FG002|Overall Study|Withdrawal of consent|0
7546341|NCT02888106|11902661|FG003|Overall Study|Withdrawal of consent|0
7546342|NCT02888106|11902662|FG004|Overall Study|Withdrawal of consent|1
7546343|NCT02888106|11902663|FG005|Overall Study|Withdrawal of consent|0
7546344|NCT02888106|11902658|FG000|Overall Study|Pregnancy|1
7546345|NCT02888106|11902659|FG001|Overall Study|Pregnancy|0
7546346|NCT02888106|11902660|FG002|Overall Study|Pregnancy|0
7546347|NCT02888106|11902661|FG003|Overall Study|Pregnancy|0
7546348|NCT02888106|11902662|FG004|Overall Study|Pregnancy|0
7266266|NCT00393705|11480219|FG000|Overall Study|Physician Decision|2
7266267|NCT00393705|11480220|FG001|Overall Study|Physician Decision|2
7266268|NCT00393718|11480228|FG000|Overall Study|Adverse Event|20
7266269|NCT00393718|11480229|FG001|Overall Study|Adverse Event|8
7546349|NCT02888106|11902663|FG005|Overall Study|Pregnancy|0
7546350|NCT02888171|11902685|FG000|Overall Study|Lost to Follow-up|2
7546351|NCT02888171|11902686|FG001|Overall Study|Lost to Follow-up|1
7546352|NCT02888171|11902685|FG000|Overall Study|Withdrawal by Subject|3
7546353|NCT02888171|11902686|FG001|Overall Study|Withdrawal by Subject|2
7546354|NCT02888171|11902685|FG000|Overall Study|Adverse Event|0
7546355|NCT02888171|11902686|FG001|Overall Study|Adverse Event|1
7546356|NCT02888756|11902716|FG000|Analytical Treatment Interruption|Physician Decision|10
7546357|NCT02888756|11902717|FG001|Analytical Treatment Interruption|Physician Decision|6
7546358|NCT02888756|11902718|FG002|Analytical Treatment Interruption|Physician Decision|5
7546359|NCT02889562|11902749|FG000|Overall Study|Physician Decision|0
7546360|NCT02889562|11902750|FG001|Overall Study|Physician Decision|1
7546361|NCT02889562|11902749|FG000|Overall Study|Withdrawal by Subject|0
7266270|NCT00393718|11480228|FG000|Overall Study|Protocol Violation|1
7266271|NCT00393718|11480229|FG001|Overall Study|Protocol Violation|2
7266272|NCT00393718|11480228|FG000|Overall Study|Lack of Efficacy|10
7266273|NCT00393718|11480229|FG001|Overall Study|Lack of Efficacy|9
7266274|NCT00393718|11480228|FG000|Overall Study|Hypoglycaemia|3
7266275|NCT00393718|11480229|FG001|Overall Study|Hypoglycaemia|2
7577276|NCT04032171|11966450|FG000|Overall Study|Study Termination|1
7577277|NCT04032171|11966451|FG001|Overall Study|Study Termination|0
7577278|NCT04032158|11966459|FG000|Overall Study|Study Termination|2
7577279|NCT04032158|11966460|FG001|Overall Study|Study Termination|1
7546362|NCT02889562|11902750|FG001|Overall Study|Withdrawal by Subject|1
7546363|NCT02889796|11902760|FG000|Overall Study|Withdrew Consent|18
7546364|NCT02889796|11902761|FG001|Overall Study|Withdrew Consent|29
7546365|NCT02889796|11902762|FG002|Overall Study|Withdrew Consent|20
7546366|NCT02889796|11902763|FG003|Overall Study|Withdrew Consent|1
7546367|NCT02889796|11902764|FG004|Overall Study|Withdrew Consent|2
7546368|NCT02889796|11902765|FG005|Overall Study|Withdrew Consent|35
7546369|NCT02889796|11902760|FG000|Overall Study|Investigator's Discretion|10
7546370|NCT02889796|11902761|FG001|Overall Study|Investigator's Discretion|9
7546371|NCT02889796|11902762|FG002|Overall Study|Investigator's Discretion|10
7546372|NCT02889796|11902763|FG003|Overall Study|Investigator's Discretion|3
7546373|NCT02889796|11902764|FG004|Overall Study|Investigator's Discretion|0
7546374|NCT02889796|11902765|FG005|Overall Study|Investigator's Discretion|15
7546375|NCT02889796|11902760|FG000|Overall Study|Adverse Event|17
7546376|NCT02889796|11902761|FG001|Overall Study|Adverse Event|8
7546377|NCT02889796|11902762|FG002|Overall Study|Adverse Event|8
7546378|NCT02889796|11902763|FG003|Overall Study|Adverse Event|4
7546379|NCT02889796|11902764|FG004|Overall Study|Adverse Event|1
7546380|NCT02889796|11902765|FG005|Overall Study|Adverse Event|7
7546381|NCT02889796|11902760|FG000|Overall Study|Lost to Follow-up|5
7546382|NCT02889796|11902761|FG001|Overall Study|Lost to Follow-up|7
7546383|NCT02889796|11902762|FG002|Overall Study|Lost to Follow-up|2
7546384|NCT02889796|11902763|FG003|Overall Study|Lost to Follow-up|0
7546385|NCT02889796|11902764|FG004|Overall Study|Lost to Follow-up|2
7546386|NCT02889796|11902765|FG005|Overall Study|Lost to Follow-up|6
7546387|NCT02889796|11902760|FG000|Overall Study|Protocol Violation|0
7546388|NCT02889796|11902761|FG001|Overall Study|Protocol Violation|1
7546389|NCT02889796|11902762|FG002|Overall Study|Protocol Violation|3
7546390|NCT02889796|11902763|FG003|Overall Study|Protocol Violation|0
7546391|NCT02889796|11902764|FG004|Overall Study|Protocol Violation|0
7546392|NCT02889796|11902765|FG005|Overall Study|Protocol Violation|4
7546393|NCT02889796|11902760|FG000|Overall Study|Non-compliance With Study Drug|0
7546394|NCT02889796|11902761|FG001|Overall Study|Non-compliance With Study Drug|2
7546395|NCT02889796|11902762|FG002|Overall Study|Non-compliance With Study Drug|0
7546396|NCT02889796|11902763|FG003|Overall Study|Non-compliance With Study Drug|0
7546397|NCT02889796|11902764|FG004|Overall Study|Non-compliance With Study Drug|1
7546398|NCT02889796|11902765|FG005|Overall Study|Non-compliance With Study Drug|2
7546399|NCT02889796|11902760|FG000|Overall Study|Death|1
7546400|NCT02889796|11902761|FG001|Overall Study|Death|1
7546401|NCT02889796|11902762|FG002|Overall Study|Death|0
7546402|NCT02889796|11902763|FG003|Overall Study|Death|1
7546403|NCT02889796|11902764|FG004|Overall Study|Death|0
7546404|NCT02889796|11902765|FG005|Overall Study|Death|1
7546405|NCT02889796|11902760|FG000|Overall Study|Pregnancy|0
7546406|NCT02889796|11902761|FG001|Overall Study|Pregnancy|1
7546407|NCT02889796|11902762|FG002|Overall Study|Pregnancy|1
7546408|NCT02889796|11902763|FG003|Overall Study|Pregnancy|0
7546409|NCT02889796|11902764|FG004|Overall Study|Pregnancy|0
7546410|NCT02889796|11902765|FG005|Overall Study|Pregnancy|0
7546411|NCT02889796|11902760|FG000|Overall Study|Randomized but not Dosed|2
7546412|NCT02889796|11902761|FG001|Overall Study|Randomized but not Dosed|0
7546413|NCT02889796|11902762|FG002|Overall Study|Randomized but not Dosed|0
7546414|NCT02889796|11902763|FG003|Overall Study|Randomized but not Dosed|0
7546415|NCT02889796|11902764|FG004|Overall Study|Randomized but not Dosed|0
7546416|NCT02889796|11902765|FG005|Overall Study|Randomized but not Dosed|2
7546417|NCT02889861|11902788|FG000|Overall Study|Ongoing in Survival Follow-up|2
7546418|NCT02890992|11902818|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
7546419|NCT02890992|11902819|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
7546420|NCT02890992|11902820|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
7546421|NCT02890992|11902821|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
7546422|NCT02890992|11902822|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
7546423|NCT02890992|11902823|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
7546424|NCT02890992|11902824|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
7577280|NCT04031404|11966466|FG000|Baseline|Lost to Follow-up|0
7266276|NCT00393718|11480228|FG000|Overall Study|Subject decision|5
7266277|NCT00393718|11480229|FG001|Overall Study|Subject decision|0
7266278|NCT00393718|11480228|FG000|Overall Study|Withdrawal of consent|2
7546425|NCT02890992|11902825|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
7546426|NCT02890992|11902818|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
7546427|NCT02890992|11902819|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
7546428|NCT02890992|11902820|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
7266279|NCT00393718|11480229|FG001|Overall Study|Withdrawal of consent|1
7266280|NCT00393718|11480228|FG000|Overall Study|Missed measurement|1
7266281|NCT00393718|11480229|FG001|Overall Study|Missed measurement|0
7266282|NCT00393718|11480228|FG000|Overall Study|Move|1
7266283|NCT00393718|11480229|FG001|Overall Study|Move|0
7266284|NCT00393848|11480248|FG000|Overall Study|Surgical schedule|0
7266285|NCT00393848|11480249|FG001|Overall Study|Surgical schedule|0
7266286|NCT00393848|11480250|FG002|Overall Study|Surgical schedule|0
7266287|NCT00393848|11480251|FG003|Overall Study|Surgical schedule|1
7266288|NCT00393848|11480248|FG000|Overall Study|Personal reasons|0
7266289|NCT00393848|11480249|FG001|Overall Study|Personal reasons|0
7266290|NCT00393848|11480250|FG002|Overall Study|Personal reasons|2
7266291|NCT00393848|11480251|FG003|Overall Study|Personal reasons|0
7266292|NCT00393861|11480262|FG000|Overall Study|Adverse Event|2
7266293|NCT00393861|11480262|FG000|Overall Study|Disease Progression|24
7266294|NCT00393887|11480284|FG000|Overall Study|Physician Decision|5
7266295|NCT00393887|11480285|FG001|Overall Study|Physician Decision|0
7266296|NCT00393887|11480284|FG000|Overall Study|Lost to Follow-up|11
7266297|NCT00393887|11480285|FG001|Overall Study|Lost to Follow-up|9
7266298|NCT00393913|11480291|FG000|Initial Assessment|diagnosed with other sleep disorder|21
7266299|NCT00393913|11480291|FG000|Initial Assessment|Withdrawal by Subject|16
7266300|NCT00393913|11480291|FG000|CPAP|Withdrawal by Subject|3
7266301|NCT00393913|11480291|FG000|CPAP|Physician Decision|1
7266302|NCT00393913|11480291|FG000|CPAP|TEchnical problem with CPAP|3
7266303|NCT00393939|11480298|FG000|Overall Study|Protocol Violation|1
7266304|NCT00393939|11480299|FG001|Overall Study|Protocol Violation|1
7266305|NCT00393939|11480298|FG000|Overall Study|Lost to Follow-up|2
7266306|NCT00393939|11480299|FG001|Overall Study|Lost to Follow-up|4
7266307|NCT00393939|11480298|FG000|Overall Study|Death|10
7266308|NCT00393939|11480299|FG001|Overall Study|Death|4
7266309|NCT00393939|11480298|FG000|Overall Study|Sponsor|5
7266310|NCT00393939|11480299|FG001|Overall Study|Sponsor|13
7266311|NCT00393939|11480298|FG000|Overall Study|Objective progression or relapse|239
7266312|NCT00393939|11480299|FG001|Overall Study|Objective progression or relapse|223
7266313|NCT00393939|11480298|FG000|Overall Study|Withdrawal by Subject|2
7266314|NCT00393939|11480299|FG001|Overall Study|Withdrawal by Subject|7
7266315|NCT00393939|11480298|FG000|Overall Study|Other|37
7266316|NCT00393939|11480299|FG001|Overall Study|Other|45
7266317|NCT00394082|11480314|FG000|Overall Study|Unacceptable toxicity|15
7266318|NCT00394082|11480314|FG000|Overall Study|Adverse Event|4
7266319|NCT00394082|11480314|FG000|Overall Study|Physician Decision|4
7266320|NCT00394082|11480314|FG000|Overall Study|Withdrawal by Subject|2
7266321|NCT00394082|11480314|FG000|Overall Study|Other|1
7266322|NCT00394095|11480320|FG000|Overall Study|Adverse Event|1
7266323|NCT00394095|11480321|FG001|Overall Study|Adverse Event|0
7266324|NCT00394212|11480330|FG000|Overall Study|Lost to Follow-up|3
7266325|NCT00394212|11480331|FG001|Overall Study|Lost to Follow-up|0
7266326|NCT00394212|11480330|FG000|Overall Study|Withdrawal by Subject|4
7266327|NCT00394212|11480331|FG001|Overall Study|Withdrawal by Subject|1
7266328|NCT00394251|11480339|FG000|Overall Study|Adverse Event|7
7546429|NCT02890992|11902821|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
7546430|NCT02890992|11902822|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
7546431|NCT02890992|11902823|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
7546432|NCT02890992|11902824|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
7546433|NCT02890992|11902825|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
7546434|NCT02890992|11902818|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
7546435|NCT02890992|11902819|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
7546436|NCT02890992|11902820|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
7546437|NCT02890992|11902821|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
7546438|NCT02890992|11902822|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
7546439|NCT02890992|11902823|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
7546440|NCT02890992|11902824|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
7546441|NCT02890992|11902825|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
7546442|NCT02891070|11902852|FG000|Overall Study|Adverse Event|1
7546443|NCT02891070|11902853|FG001|Overall Study|Adverse Event|0
7546444|NCT02891070|11902852|FG000|Overall Study|Physician Decision|0
7546445|NCT02891070|11902853|FG001|Overall Study|Physician Decision|1
7546446|NCT02891070|11902852|FG000|Overall Study|Lost to Follow-up|4
7546447|NCT02891070|11902853|FG001|Overall Study|Lost to Follow-up|4
7546448|NCT02891070|11902852|FG000|Overall Study|Other|1
7546449|NCT02891070|11902853|FG001|Overall Study|Other|0
7546450|NCT02891070|11902852|FG000|Overall Study|Protocol Violation|0
7546451|NCT02891070|11902853|FG001|Overall Study|Protocol Violation|1
7266329|NCT00394251|11480340|FG001|Overall Study|Adverse Event|5
7266330|NCT00394251|11480339|FG000|Overall Study|Unacceptable Toxicity|20
7266331|NCT00394251|11480340|FG001|Overall Study|Unacceptable Toxicity|18
7266332|NCT00394251|11480339|FG000|Overall Study|Physician Decision|1
7266333|NCT00394251|11480340|FG001|Overall Study|Physician Decision|1
7266334|NCT00394251|11480339|FG000|Overall Study|Protocol Violation|0
7546452|NCT02891070|11902852|FG000|Overall Study|Withdrawal by Subject|1
7546453|NCT02891070|11902853|FG001|Overall Study|Withdrawal by Subject|2
7266335|NCT00394251|11480340|FG001|Overall Study|Protocol Violation|1
7266336|NCT00394251|11480339|FG000|Overall Study|Withdrawal by Subject|7
7266337|NCT00394251|11480340|FG001|Overall Study|Withdrawal by Subject|11
7266338|NCT00394251|11480339|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7266339|NCT00394251|11480340|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
7266340|NCT00394433|11480390|FG000|Overall Study|Adverse Event|2
7266341|NCT00394433|11480390|FG000|Overall Study|Alternative Therapy|1
7266342|NCT00394472|11480396|FG000|Overall Study|Protocol Violation|1
7266343|NCT00394472|11480397|FG001|Overall Study|Protocol Violation|3
7266344|NCT00394472|11480396|FG000|Overall Study|incorrect enrolment|4
7266345|NCT00394472|11480397|FG001|Overall Study|incorrect enrolment|2
7266346|NCT00394472|11480396|FG000|Overall Study|Adverse Event|4
7266347|NCT00394472|11480397|FG001|Overall Study|Adverse Event|2
7266348|NCT00394472|11480396|FG000|Overall Study|Withdrawal by Subject|0
7266349|NCT00394472|11480397|FG001|Overall Study|Withdrawal by Subject|2
7266350|NCT00394472|11480396|FG000|Overall Study|Physician Decision|0
7266351|NCT00394472|11480397|FG001|Overall Study|Physician Decision|1
7266352|NCT00394472|11480396|FG000|Overall Study|Lost to Follow-up|0
7266353|NCT00394472|11480397|FG001|Overall Study|Lost to Follow-up|1
7266354|NCT00394524|11480405|FG000|Overall Study|Protocol Violation|2
7266355|NCT00394524|11480406|FG001|Overall Study|Protocol Violation|3
7266356|NCT00394524|11480405|FG000|Overall Study|Death|1
7266357|NCT00394524|11480406|FG001|Overall Study|Death|0
7266358|NCT00394524|11480405|FG000|Overall Study|Withdrawal by Subject|0
7266359|NCT00394524|11480406|FG001|Overall Study|Withdrawal by Subject|1
7266360|NCT00394589|11480417|FG000|Overall Study|Adverse Event|2
7266361|NCT00394589|11480418|FG001|Overall Study|Adverse Event|1
7266362|NCT00394589|11480419|FG002|Overall Study|Adverse Event|2
7266363|NCT00394589|11480417|FG000|Overall Study|Lack of Efficacy|2
7266364|NCT00394589|11480418|FG001|Overall Study|Lack of Efficacy|2
7266365|NCT00394589|11480419|FG002|Overall Study|Lack of Efficacy|3
7266366|NCT00394589|11480417|FG000|Overall Study|Protocol Violation|4
7266367|NCT00394589|11480418|FG001|Overall Study|Protocol Violation|0
7266368|NCT00394589|11480419|FG002|Overall Study|Protocol Violation|2
7266369|NCT00394654|11480429|FG000|Overall Study|Lost to Follow-up|1
7266370|NCT00394654|11480430|FG001|Overall Study|Lost to Follow-up|0
7266371|NCT00394654|11480429|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
7266372|NCT00394654|11480430|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
7266373|NCT00394706|11480444|FG000|Overall Study|Withdrawal by Subject|2
7266374|NCT00394706|11480445|FG001|Overall Study|Withdrawal by Subject|0
7266375|NCT00394706|11480446|FG002|Overall Study|Withdrawal by Subject|1
7266376|NCT00394706|11480447|FG003|Overall Study|Withdrawal by Subject|0
7266377|NCT00394706|11480448|FG004|Overall Study|Withdrawal by Subject|0
7266378|NCT00394706|11480449|FG005|Overall Study|Withdrawal by Subject|2
7266379|NCT00394706|11480450|FG006|Overall Study|Withdrawal by Subject|1
7266380|NCT00394706|11480451|FG007|Overall Study|Withdrawal by Subject|0
7266381|NCT00394706|11480444|FG000|Overall Study|Lost to Follow-up|2
7266382|NCT00394706|11480445|FG001|Overall Study|Lost to Follow-up|2
7266383|NCT00394706|11480446|FG002|Overall Study|Lost to Follow-up|8
7266384|NCT00394706|11480447|FG003|Overall Study|Lost to Follow-up|1
7266385|NCT00394706|11480448|FG004|Overall Study|Lost to Follow-up|2
7266386|NCT00394706|11480449|FG005|Overall Study|Lost to Follow-up|5
7266387|NCT00394706|11480450|FG006|Overall Study|Lost to Follow-up|2
7266388|NCT00394706|11480451|FG007|Overall Study|Lost to Follow-up|0
7266389|NCT00394771|11480469|FG000|Overall Study|Did not meet protocol requirements|1
7266390|NCT00394771|11480470|FG001|Overall Study|Did not meet protocol requirements|0
7266391|NCT00394771|11480471|FG002|Overall Study|Did not meet protocol requirements|2
7266392|NCT00394771|11480472|FG003|Overall Study|Did not meet protocol requirements|0
7546454|NCT02891070|11902852|FG000|Overall Study|Death|3
7546455|NCT02891070|11902853|FG001|Overall Study|Death|0
7546456|NCT02891174|11902861|FG000|First Intervention (24 Hours)|Declined any study medication|1
7546457|NCT02891174|11902862|FG001|First Intervention (24 Hours)|Declined any study medication|5
7546458|NCT02891174|11902861|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
7546459|NCT02891174|11902862|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
7546460|NCT02891174|11902861|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
7546461|NCT02891174|11902862|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
7546462|NCT02891174|11902861|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
7546463|NCT02891174|11902862|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
7546464|NCT02891174|11902861|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
7546465|NCT02891174|11902862|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
7546466|NCT02891174|11902861|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
7546467|NCT02891174|11902862|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
7546468|NCT02891174|11902861|FG000|Second Intervention (24 Hours)|Protocol Violation|0
7546469|NCT02891174|11902862|FG001|Second Intervention (24 Hours)|Protocol Violation|1
7546470|NCT02891200|11902874|FG000|Overall Study|Lost to Follow-up|31
7546471|NCT02891200|11902875|FG001|Overall Study|Lost to Follow-up|36
7546472|NCT02891200|11902874|FG000|Overall Study|Death|10
7266393|NCT00394771|11480469|FG000|Overall Study|Protocol Violation|2
7266394|NCT00394771|11480470|FG001|Overall Study|Protocol Violation|4
7266395|NCT00394771|11480471|FG002|Overall Study|Protocol Violation|9
7266396|NCT00394771|11480472|FG003|Overall Study|Protocol Violation|7
7266397|NCT00394771|11480469|FG000|Overall Study|Withdrawal by Subject|10
7266398|NCT00394771|11480470|FG001|Overall Study|Withdrawal by Subject|6
7266399|NCT00394771|11480471|FG002|Overall Study|Withdrawal by Subject|8
7266400|NCT00394771|11480472|FG003|Overall Study|Withdrawal by Subject|12
7266401|NCT00394771|11480469|FG000|Overall Study|Adverse Event|10
7266402|NCT00394771|11480470|FG001|Overall Study|Adverse Event|5
7266403|NCT00394771|11480471|FG002|Overall Study|Adverse Event|12
7266404|NCT00394771|11480472|FG003|Overall Study|Adverse Event|8
7546473|NCT02891200|11902875|FG001|Overall Study|Death|9
7546474|NCT02891200|11902874|FG000|Overall Study|Withdrawal by Subject|1
7546475|NCT02891200|11902875|FG001|Overall Study|Withdrawal by Subject|4
7546476|NCT02891408|11902888|FG000|Overall Study|Lost to Follow-up|0
7546477|NCT02891408|11902889|FG001|Overall Study|Lost to Follow-up|0
7546478|NCT02891408|11902890|FG002|Overall Study|Lost to Follow-up|1
7546479|NCT02891408|11902891|FG003|Overall Study|Lost to Follow-up|0
7546480|NCT02891408|11902892|FG004|Overall Study|Lost to Follow-up|0
7546481|NCT02891408|11902893|FG005|Overall Study|Lost to Follow-up|0
7546482|NCT02891408|11902894|FG006|Overall Study|Lost to Follow-up|0
7546483|NCT02891681|11902932|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7546484|NCT02891681|11902933|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
7546485|NCT02891681|11902934|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
7546486|NCT02891681|11902932|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
7546487|NCT02891681|11902933|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7546488|NCT02891681|11902934|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
7546489|NCT02891681|11902932|FG000|Overall Study|Taken off study after first imaging appointment|1
7546490|NCT02891681|11902933|FG001|Overall Study|Taken off study after first imaging appointment|0
7546491|NCT02891681|11902934|FG002|Overall Study|Taken off study after first imaging appointment|0
7546492|NCT02891850|11902944|FG000|Overall Study|Adverse Event|3
7546493|NCT02891850|11902945|FG001|Overall Study|Adverse Event|0
7546494|NCT02891850|11902944|FG000|Overall Study|Death|0
7546495|NCT02891850|11902945|FG001|Overall Study|Death|4
7546496|NCT02891850|11902944|FG000|Overall Study|Physician Decision|1
7546497|NCT02891850|11902945|FG001|Overall Study|Physician Decision|0
7546498|NCT02891850|11902944|FG000|Overall Study|Pregnancy|1
7546499|NCT02891850|11902945|FG001|Overall Study|Pregnancy|0
7546500|NCT02891850|11902944|FG000|Overall Study|Withdrawal by Subject|2
7546501|NCT02891850|11902945|FG001|Overall Study|Withdrawal by Subject|3
7546502|NCT02891915|11902957|FG000|Overall Study|Enrolled but Treatment Not Administered|6
7546503|NCT02891915|11902958|FG001|Overall Study|Enrolled but Treatment Not Administered|4
7546504|NCT02891915|11902957|FG000|Overall Study|Withdrawal by Subject|3
7546505|NCT02891915|11902958|FG001|Overall Study|Withdrawal by Subject|3
7546506|NCT02891915|11902957|FG000|Overall Study|Became Ineligible After Enrollment|2
7546507|NCT02891915|11902958|FG001|Overall Study|Became Ineligible After Enrollment|1
7546508|NCT02891915|11902957|FG000|Overall Study|Lost to Follow-up|1
7546509|NCT02891915|11902958|FG001|Overall Study|Lost to Follow-up|4
7546510|NCT02891915|11902957|FG000|Overall Study|Physician Decision|1
7546511|NCT02891915|11902958|FG001|Overall Study|Physician Decision|0
7546512|NCT02892019|11902966|FG000|Overall Study|randomized but not treated|0
7546513|NCT02892019|11902967|FG001|Overall Study|randomized but not treated|1
7546514|NCT02892019|11902966|FG000|Overall Study|Withdrawal by Subject|0
7546515|NCT02892019|11902967|FG001|Overall Study|Withdrawal by Subject|1
7546516|NCT02892019|11902966|FG000|Overall Study|Adverse Event|1
7546517|NCT02892019|11902967|FG001|Overall Study|Adverse Event|1
7546518|NCT02892344|11902984|FG000|Overall Study|Protocol deviation|3
7546519|NCT02892344|11902985|FG001|Overall Study|Protocol deviation|4
7546520|NCT02892344|11902984|FG000|Overall Study|Adverse Event|1
7546521|NCT02892344|11902985|FG001|Overall Study|Adverse Event|8
7546522|NCT02892344|11902984|FG000|Overall Study|Lost to Follow-up|0
7546523|NCT02892344|11902985|FG001|Overall Study|Lost to Follow-up|1
7546524|NCT02892344|11902984|FG000|Overall Study|Non-compliance with study treatment|0
7546525|NCT02892344|11902985|FG001|Overall Study|Non-compliance with study treatment|1
7546526|NCT02892344|11902984|FG000|Overall Study|Physician Decision|0
7546527|NCT02892344|11902985|FG001|Overall Study|Physician Decision|2
7546528|NCT02892344|11902984|FG000|Overall Study|Subject/guardian decision|0
7546529|NCT02892344|11902985|FG001|Overall Study|Subject/guardian decision|4
7546530|NCT02892344|11902984|FG000|Overall Study|Technical problems|0
7546531|NCT02892344|11902985|FG001|Overall Study|Technical problems|1
7546532|NCT02892409|11902993|FG000|Overall Study|Adverse Event|1
7546533|NCT02892409|11902994|FG001|Overall Study|Adverse Event|0
7546534|NCT02892409|11902993|FG000|Overall Study|Withdrawal by Subject|2
7546535|NCT02892409|11902994|FG001|Overall Study|Withdrawal by Subject|1
7546536|NCT02892422|11903000|FG000|Overall Study|Enrolled not treated|4
7546537|NCT02892422|11903000|FG000|Overall Study|Adverse Event|38
7546538|NCT02892422|11903000|FG000|Overall Study|Lack of Efficacy|32
7546539|NCT02892422|11903000|FG000|Overall Study|Non-compliance with study drug|11
7546540|NCT02892422|11903000|FG000|Overall Study|Protocol Violation|4
7546541|NCT02892422|11903000|FG000|Overall Study|Withdrawal by Subject|56
7546542|NCT02892422|11903000|FG000|Overall Study|Lost to Follow-up|5
7546543|NCT02892422|11903000|FG000|Overall Study|sponsor information 16159A results|21
7546544|NCT02892422|11903000|FG000|Overall Study|withdrawal of consent|13
7546545|NCT02892422|11903000|FG000|Overall Study|exclusion criteria met|3
7546546|NCT02892422|11903000|FG000|Overall Study|moving elsewhere|4
7546547|NCT02892422|11903000|FG000|Overall Study|non-compliance|10
7266405|NCT00394771|11480469|FG000|Overall Study|Participant pregnant|0
7266406|NCT00394771|11480470|FG001|Overall Study|Participant pregnant|1
7266407|NCT00394771|11480471|FG002|Overall Study|Participant pregnant|2
7266408|NCT00394771|11480472|FG003|Overall Study|Participant pregnant|2
7266409|NCT00394771|11480469|FG000|Overall Study|Lost to Follow-up|15
7266410|NCT00394771|11480470|FG001|Overall Study|Lost to Follow-up|15
7266411|NCT00394771|11480471|FG002|Overall Study|Lost to Follow-up|13
7266412|NCT00394771|11480472|FG003|Overall Study|Lost to Follow-up|10
7266413|NCT00394771|11480469|FG000|Overall Study|Other|3
7266414|NCT00394771|11480470|FG001|Overall Study|Other|3
7266415|NCT00394771|11480471|FG002|Overall Study|Other|1
7266416|NCT00394771|11480472|FG003|Overall Study|Other|0
7266417|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Adverse Event|0
7266418|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Adverse Event|2
7266419|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Protocol Violation|0
7266420|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Protocol Violation|2
7266421|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Disease Progression|27
7266422|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Disease Progression|60
7266423|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Patient Refusal|1
7266424|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Patient Refusal|2
7266425|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Death|0
7266426|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Death|1
7266427|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
7266428|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
7266429|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
7266430|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
7266431|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
7266432|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
7266433|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Physician Decision|0
7266434|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Physician Decision|1
7266435|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
7266436|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
7266437|NCT00394836|11480484|FG000|Teatment or Follow-up Phase|Non compliance|0
7266438|NCT00394836|11480485|FG001|Teatment or Follow-up Phase|Non compliance|1
7266439|NCT00394836|11480484|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
7266440|NCT00394836|11480485|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
7266441|NCT00394836|11480484|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
7266442|NCT00394836|11480485|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
7266443|NCT00394836|11480484|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
7266444|NCT00394836|11480485|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
7388134|NCT01217892|11646884|FG000|Overall Study|Withdrawal by Subject|0
7546548|NCT02892422|11903000|FG000|Overall Study|patient legally incapable|1
7546549|NCT02892422|11903000|FG000|Overall Study|patient decision|7
7546550|NCT02892422|11903000|FG000|Overall Study|Investigator decision|1
7546551|NCT02892448|11903007|FG000|Overall Study|Screening failure|2
7546552|NCT02892448|11903008|FG001|Overall Study|Screening failure|2
7546553|NCT02892448|11903009|FG002|Overall Study|Screening failure|1
7546554|NCT02892513|11903019|FG000|Overall Study|Withdrawal by Subject|0
7546555|NCT02892513|11903020|FG001|Overall Study|Withdrawal by Subject|1
7546556|NCT02892734|11903026|FG000|Treatment on Study|Progressive Disease|2
7546557|NCT02892734|11903026|FG000|Follow up for 2 Years|Death|2
7546558|NCT02892734|11903026|FG000|Follow up for 2 Years|Study closed early|1
7546559|NCT02892760|11903030|FG000|Overall Study|Withdrawal by Subject|3
7546560|NCT02894502|11903053|FG000|Baseline|Withdrawal by Subject|24
7546561|NCT02894502|11903054|FG001|Baseline|Withdrawal by Subject|31
7546562|NCT02894502|11903055|FG002|Baseline|Withdrawal by Subject|36
7546563|NCT02894502|11903053|FG000|Baseline|Death|3
7546564|NCT02894502|11903054|FG001|Baseline|Death|1
7546565|NCT02894502|11903055|FG002|Baseline|Death|9
7546566|NCT02894502|11903053|FG000|First Follow up|Withdrawal by Subject|32
7546567|NCT02894502|11903054|FG001|First Follow up|Withdrawal by Subject|29
7546568|NCT02894502|11903055|FG002|First Follow up|Withdrawal by Subject|37
7546569|NCT02894502|11903053|FG000|First Follow up|Death|2
7546570|NCT02894502|11903054|FG001|First Follow up|Death|2
7546571|NCT02894502|11903055|FG002|First Follow up|Death|3
7546572|NCT02894502|11903053|FG000|Second Follow up|Withdrawal by Subject|13
7577281|NCT04031404|11966467|FG001|Baseline|Lost to Follow-up|1
7577282|NCT04031404|11966466|FG000|Baseline|Did not meet full inclusion/exclusion.|2
7577283|NCT04031404|11966467|FG001|Baseline|Did not meet full inclusion/exclusion.|4
7577284|NCT04031404|11966466|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
7577285|NCT04031404|11966467|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
7577286|NCT04031404|11966466|FG000|Pre-randomization|Disqualified by TMS safety screening|1
7577287|NCT04031404|11966467|FG001|Pre-randomization|Disqualified by TMS safety screening|0
7577288|NCT04031404|11966466|FG000|Washout (5 Day Min)|Lost to Follow-up|1
7577289|NCT04031404|11966467|FG001|Washout (5 Day Min)|Lost to Follow-up|0
7577290|NCT04029961|11966512|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
7624589|NCT01986114|12035684|FG000|Overall Study|Lack of Efficacy|23
7546573|NCT02894502|11903054|FG001|Second Follow up|Withdrawal by Subject|15
7266445|NCT00394836|11480484|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
7266446|NCT00394836|11480485|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
7388135|NCT01217892|11646885|FG001|Overall Study|Withdrawal by Subject|2
7388136|NCT01217892|11646886|FG002|Overall Study|Withdrawal by Subject|1
7388137|NCT01217892|11646887|FG003|Overall Study|Withdrawal by Subject|0
7388138|NCT01217892|11646884|FG000|Overall Study|Lab value|1
7388139|NCT01217892|11646885|FG001|Overall Study|Lab value|0
7388140|NCT01217892|11646886|FG002|Overall Study|Lab value|1
7388141|NCT01217892|11646887|FG003|Overall Study|Lab value|0
7388142|NCT01217892|11646884|FG000|Overall Study|Subject no longer meets study criteria|5
7546574|NCT02894502|11903055|FG002|Second Follow up|Withdrawal by Subject|13
7546575|NCT02894502|11903053|FG000|Second Follow up|Death|2
7546576|NCT02894502|11903054|FG001|Second Follow up|Death|3
7546577|NCT02894502|11903055|FG002|Second Follow up|Death|1
7546578|NCT02894502|11903053|FG000|Third Follow up|Withdrawal by Subject|5
7546579|NCT02894502|11903054|FG001|Third Follow up|Withdrawal by Subject|6
7546580|NCT02894502|11903055|FG002|Third Follow up|Withdrawal by Subject|3
7546581|NCT02894502|11903053|FG000|Third Follow up|Death|1
7546582|NCT02894502|11903054|FG001|Third Follow up|Death|1
7546583|NCT02894502|11903055|FG002|Third Follow up|Death|0
7546584|NCT02894840|11903070|FG000|Overall Study|Lost to Follow-up|1
7546585|NCT02894840|11903071|FG001|Overall Study|Lost to Follow-up|0
7546586|NCT02894840|11903072|FG002|Overall Study|Lost to Follow-up|3
7546587|NCT02894840|11903073|FG003|Overall Study|Lost to Follow-up|0
7546588|NCT02895295|11903115|FG000|Overall Study|Survey Non-response|71
7546589|NCT02895295|11903116|FG001|Overall Study|Survey Non-response|94
7546590|NCT02895295|11903117|FG002|Overall Study|Survey Non-response|92
7546591|NCT02895347|11903127|FG000|Overall Study|Withdrawal by Subject|3
7546592|NCT02895347|11903128|FG001|Overall Study|Withdrawal by Subject|1
7546593|NCT02895360|11903141|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
7546594|NCT02895360|11903142|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7546595|NCT02895360|11903143|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7546596|NCT02895360|11903144|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7546597|NCT02895360|11903145|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7546598|NCT02895360|11903146|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
7546599|NCT02895360|11903141|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7546600|NCT02895360|11903142|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
7546601|NCT02895360|11903143|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7546602|NCT02895360|11903144|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7546603|NCT02895360|11903145|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7546604|NCT02895360|11903146|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
7546605|NCT02895360|11903141|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7546606|NCT02895360|11903142|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7546607|NCT02895360|11903143|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
7546608|NCT02895360|11903144|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7546609|NCT02895360|11903145|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7546610|NCT02895360|11903146|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
7546611|NCT02895360|11903141|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7546612|NCT02895360|11903142|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7546613|NCT02895360|11903143|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
7546614|NCT02895360|11903144|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7546615|NCT02895360|11903145|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7546616|NCT02895360|11903146|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
7546617|NCT02895360|11903141|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7546618|NCT02895360|11903142|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7546619|NCT02895360|11903143|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7546620|NCT02895360|11903144|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
7546621|NCT02895360|11903145|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7546622|NCT02895360|11903146|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
7546623|NCT02895360|11903141|FG000|Phase 2a|Adverse Event|0
7546624|NCT02895360|11903142|FG001|Phase 2a|Adverse Event|0
7546625|NCT02895360|11903143|FG002|Phase 2a|Adverse Event|0
7546626|NCT02895360|11903144|FG003|Phase 2a|Adverse Event|0
7546627|NCT02895360|11903145|FG004|Phase 2a|Adverse Event|0
7546628|NCT02895360|11903146|FG005|Phase 2a|Adverse Event|1
7546629|NCT02895360|11903141|FG000|Phase 2a|Progressive disease|0
7546630|NCT02895360|11903142|FG001|Phase 2a|Progressive disease|0
7546631|NCT02895360|11903143|FG002|Phase 2a|Progressive disease|0
7546632|NCT02895360|11903144|FG003|Phase 2a|Progressive disease|0
7546633|NCT02895360|11903145|FG004|Phase 2a|Progressive disease|11
7546634|NCT02895360|11903146|FG005|Phase 2a|Progressive disease|11
7546635|NCT02895945|11903180|FG000|Overall Study|Physician Decision|2
7546636|NCT02895945|11903181|FG001|Overall Study|Physician Decision|1
7546637|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Adverse Event|9
7546638|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Adverse Event|2
7546639|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
7546640|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
7546641|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
7546642|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
7546643|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Physician Decision|1
7546644|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Physician Decision|1
7546645|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Pregnancy|2
7546646|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Pregnancy|0
7266447|NCT00394901|11480508|FG000|Baseline Phase|Protocol Violation|0
7266448|NCT00394901|11480509|FG001|Baseline Phase|Protocol Violation|0
7266449|NCT00394901|11480510|FG002|Baseline Phase|Protocol Violation|1
7266450|NCT00394901|11480511|FG003|Baseline Phase|Protocol Violation|0
7266451|NCT00394901|11480508|FG000|Double-blind Phase|Adverse Event|5
7266452|NCT00394901|11480509|FG001|Double-blind Phase|Adverse Event|7
7266453|NCT00394901|11480510|FG002|Double-blind Phase|Adverse Event|16
7266454|NCT00394901|11480511|FG003|Double-blind Phase|Adverse Event|20
7266455|NCT00394901|11480508|FG000|Double-blind Phase|Lack of Efficacy|6
7266456|NCT00394901|11480509|FG001|Double-blind Phase|Lack of Efficacy|4
7266457|NCT00394901|11480510|FG002|Double-blind Phase|Lack of Efficacy|1
7266458|NCT00394901|11480511|FG003|Double-blind Phase|Lack of Efficacy|3
7266459|NCT00394901|11480508|FG000|Double-blind Phase|Withdrawal by Subject|2
7266460|NCT00394901|11480509|FG001|Double-blind Phase|Withdrawal by Subject|0
7266461|NCT00394901|11480510|FG002|Double-blind Phase|Withdrawal by Subject|0
7266462|NCT00394901|11480511|FG003|Double-blind Phase|Withdrawal by Subject|0
7266463|NCT00394901|11480508|FG000|Double-blind Phase|Lost to Follow-up|0
7266464|NCT00394901|11480509|FG001|Double-blind Phase|Lost to Follow-up|0
7266465|NCT00394901|11480510|FG002|Double-blind Phase|Lost to Follow-up|0
7266466|NCT00394901|11480511|FG003|Double-blind Phase|Lost to Follow-up|1
7266467|NCT00394901|11480508|FG000|Double-blind Phase|Protocol Violation|0
7266468|NCT00394901|11480509|FG001|Double-blind Phase|Protocol Violation|0
7266469|NCT00394901|11480510|FG002|Double-blind Phase|Protocol Violation|0
7266470|NCT00394901|11480511|FG003|Double-blind Phase|Protocol Violation|1
7266471|NCT00394901|11480508|FG000|Double-blind Phase|Death|1
7266472|NCT00394901|11480509|FG001|Double-blind Phase|Death|0
7266473|NCT00394901|11480510|FG002|Double-blind Phase|Death|0
7266474|NCT00394901|11480511|FG003|Double-blind Phase|Death|0
7266475|NCT00394901|11480508|FG000|Double-blind Phase|Subject's Personal Reason|1
7266476|NCT00394901|11480509|FG001|Double-blind Phase|Subject's Personal Reason|0
7266477|NCT00394901|11480510|FG002|Double-blind Phase|Subject's Personal Reason|0
7266478|NCT00394901|11480511|FG003|Double-blind Phase|Subject's Personal Reason|1
7266479|NCT00394901|11480508|FG000|Double-blind Phase|Lack of Compliance|0
7266480|NCT00394901|11480509|FG001|Double-blind Phase|Lack of Compliance|3
7266481|NCT00394901|11480510|FG002|Double-blind Phase|Lack of Compliance|0
7266482|NCT00394901|11480511|FG003|Double-blind Phase|Lack of Compliance|0
7266483|NCT00394901|11480508|FG000|Double-blind Phase|Entry into another study was found|0
7266484|NCT00394901|11480509|FG001|Double-blind Phase|Entry into another study was found|0
7266485|NCT00394901|11480510|FG002|Double-blind Phase|Entry into another study was found|1
7266486|NCT00394901|11480511|FG003|Double-blind Phase|Entry into another study was found|0
7266487|NCT00394901|11480508|FG000|Double-blind Phase|Found not to meet entrance criteria|0
7266488|NCT00394901|11480509|FG001|Double-blind Phase|Found not to meet entrance criteria|0
7266489|NCT00394901|11480510|FG002|Double-blind Phase|Found not to meet entrance criteria|0
7266490|NCT00394901|11480511|FG003|Double-blind Phase|Found not to meet entrance criteria|1
7266491|NCT00394914|11480526|FG000|Treatment Period|Adverse Event|0
7266492|NCT00394914|11480527|FG001|Treatment Period|Adverse Event|3
7546647|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
7546648|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
7546649|NCT02896127|11903196|FG000|COMPLETED WEEK 52|Technical problems|1
7546650|NCT02896127|11903197|FG001|COMPLETED WEEK 52|Technical problems|0
7546651|NCT02896127|11903196|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
7546652|NCT02896127|11903197|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
7546653|NCT02896127|11903196|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
7546654|NCT02896127|11903197|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
7546655|NCT02896127|11903196|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
7546656|NCT02896127|11903197|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
7546657|NCT02896127|11903196|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
7546658|NCT02896127|11903197|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
7546659|NCT02896127|11903196|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
7546660|NCT02896127|11903197|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
7546661|NCT02896296|11903203|FG000|Overall Study|Adverse Event|1
7546662|NCT02896296|11903203|FG000|Overall Study|Lost to Follow-up|19
7546663|NCT02896296|11903203|FG000|Overall Study|Pregnancy|1
7546664|NCT02896296|11903203|FG000|Overall Study|Physician Decision|2
7546665|NCT02896296|11903203|FG000|Overall Study|Withdrawal by Subject|10
7546666|NCT02896296|11903203|FG000|Overall Study|Site closing|7
7546667|NCT02896296|11903203|FG000|Overall Study|Incarceration|1
7546668|NCT02896296|11903203|FG000|Overall Study|Relocation|1
7546669|NCT02896361|11903207|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
7546670|NCT02896361|11903208|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
7546671|NCT02896361|11903209|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
7546672|NCT02896361|11903207|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7546673|NCT02896361|11903208|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
7546674|NCT02896361|11903209|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
7266493|NCT00394914|11480528|FG002|Treatment Period|Adverse Event|1
7266494|NCT00394914|11480526|FG000|Treatment Period|Lost to Follow-up|0
7266495|NCT00394914|11480527|FG001|Treatment Period|Lost to Follow-up|1
7266496|NCT00394914|11480528|FG002|Treatment Period|Lost to Follow-up|0
7266497|NCT00394914|11480526|FG000|Treatment Period|Withdrawal by Subject|0
7266498|NCT00394914|11480527|FG001|Treatment Period|Withdrawal by Subject|2
7266499|NCT00394914|11480528|FG002|Treatment Period|Withdrawal by Subject|2
7266500|NCT00394914|11480526|FG000|Treatment Period|Noncompliance with protocol|0
7266501|NCT00394914|11480527|FG001|Treatment Period|Noncompliance with protocol|3
7266502|NCT00394914|11480528|FG002|Treatment Period|Noncompliance with protocol|2
7266503|NCT00394914|11480526|FG000|Treatment Period|Did not meet protocol eligibility|0
7266504|NCT00394914|11480527|FG001|Treatment Period|Did not meet protocol eligibility|1
7266505|NCT00394914|11480528|FG002|Treatment Period|Did not meet protocol eligibility|1
7266506|NCT00394953|11480536|FG000|First Treatment Period|Adverse Event|1
7266507|NCT00394953|11480537|FG001|First Treatment Period|Adverse Event|2
7266508|NCT00394953|11480536|FG000|First Treatment Period|Death|6
7266509|NCT00394953|11480537|FG001|First Treatment Period|Death|7
7266510|NCT00394953|11480536|FG000|First Treatment Period|Lack of Efficacy|1
7266511|NCT00394953|11480537|FG001|First Treatment Period|Lack of Efficacy|1
7266512|NCT00394953|11480536|FG000|First Treatment Period|Withdrawal by Subject|6
7266513|NCT00394953|11480537|FG001|First Treatment Period|Withdrawal by Subject|3
7266514|NCT00394953|11480536|FG000|First Treatment Period|Lost to Follow-up|0
7266515|NCT00394953|11480537|FG001|First Treatment Period|Lost to Follow-up|1
7266516|NCT00394953|11480536|FG000|First Treatment Period|Renal transplant|11
7266517|NCT00394953|11480537|FG001|First Treatment Period|Renal transplant|7
7266518|NCT00394953|11480536|FG000|First Treatment Period|Not defined|4
7266519|NCT00394953|11480537|FG001|First Treatment Period|Not defined|1
7266520|NCT00394953|11480536|FG000|Second Treatment Period|Adverse Event|2
7266521|NCT00394953|11480537|FG001|Second Treatment Period|Adverse Event|5
7266522|NCT00394953|11480536|FG000|Second Treatment Period|Death|8
7266523|NCT00394953|11480537|FG001|Second Treatment Period|Death|4
7266524|NCT00394953|11480536|FG000|Second Treatment Period|Lack of Efficacy|9
7266525|NCT00394953|11480537|FG001|Second Treatment Period|Lack of Efficacy|47
7266526|NCT00394953|11480536|FG000|Second Treatment Period|Withdrawal by Subject|3
7266527|NCT00394953|11480537|FG001|Second Treatment Period|Withdrawal by Subject|3
7266528|NCT00394953|11480536|FG000|Second Treatment Period|Lost to Follow-up|0
7266529|NCT00394953|11480537|FG001|Second Treatment Period|Lost to Follow-up|1
7266530|NCT00394953|11480536|FG000|Second Treatment Period|Renal transplant|4
7266531|NCT00394953|11480537|FG001|Second Treatment Period|Renal transplant|6
7266532|NCT00394953|11480536|FG000|Second Treatment Period|Not defined|3
7266533|NCT00394953|11480537|FG001|Second Treatment Period|Not defined|8
7266534|NCT00395018|11480543|FG000|On-Treatment|Death|4
7266535|NCT00395018|11480543|FG000|On-Treatment|Other Reason|2
7266536|NCT00395018|11480543|FG000|On-Treatment|Poor/non-compliance|2
7266537|NCT00395018|11480543|FG000|On-Treatment|Subject no longer meets study criteria|2
7266538|NCT00395018|11480543|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
7266539|NCT00395018|11480543|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
7266540|NCT00395018|11480543|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
7266541|NCT00395083|11480575|FG000|Overall Study|Withdrawal by Subject|6
7546675|NCT02896400|11903237|FG000|1 Month Follow-up|Lost to Follow-up|7
7546676|NCT02896400|11903238|FG001|1 Month Follow-up|Lost to Follow-up|7
7546677|NCT02896400|11903239|FG002|1 Month Follow-up|Lost to Follow-up|5
7546678|NCT02896400|11903240|FG003|1 Month Follow-up|Lost to Follow-up|8
7546679|NCT02896400|11903241|FG004|1 Month Follow-up|Lost to Follow-up|9
7546680|NCT02896400|11903242|FG005|1 Month Follow-up|Lost to Follow-up|6
7546681|NCT02896400|11903243|FG006|1 Month Follow-up|Lost to Follow-up|5
7546682|NCT02896400|11903244|FG007|1 Month Follow-up|Lost to Follow-up|6
7546683|NCT02896400|11903245|FG008|1 Month Follow-up|Lost to Follow-up|4
7546684|NCT02896400|11903246|FG009|1 Month Follow-up|Lost to Follow-up|7
7546685|NCT02896400|11903247|FG010|1 Month Follow-up|Lost to Follow-up|5
7546686|NCT02896400|11903248|FG011|1 Month Follow-up|Lost to Follow-up|5
7546687|NCT02896400|11903249|FG012|1 Month Follow-up|Lost to Follow-up|3
7546688|NCT02896400|11903250|FG013|1 Month Follow-up|Lost to Follow-up|4
7546689|NCT02896400|11903251|FG014|1 Month Follow-up|Lost to Follow-up|1
7546690|NCT02896400|11903252|FG015|1 Month Follow-up|Lost to Follow-up|2
7546691|NCT02896400|11903237|FG000|1 Month Follow-up|Death|0
7546692|NCT02896400|11903238|FG001|1 Month Follow-up|Death|0
7546693|NCT02896400|11903239|FG002|1 Month Follow-up|Death|0
7546694|NCT02896400|11903240|FG003|1 Month Follow-up|Death|0
7546695|NCT02896400|11903241|FG004|1 Month Follow-up|Death|0
7546696|NCT02896400|11903242|FG005|1 Month Follow-up|Death|0
7546697|NCT02896400|11903243|FG006|1 Month Follow-up|Death|0
7266542|NCT00395083|11480576|FG001|Overall Study|Withdrawal by Subject|5
7266543|NCT00395083|11480575|FG000|Overall Study|Developed another disease|4
7266544|NCT00395083|11480576|FG001|Overall Study|Developed another disease|3
7266545|NCT00395226|11480615|FG000|Overall Study|Adverse Event|4
7266546|NCT00395226|11480616|FG001|Overall Study|Adverse Event|3
7266547|NCT00395226|11480615|FG000|Overall Study|Withdrawal by Subject|0
7266548|NCT00395226|11480616|FG001|Overall Study|Withdrawal by Subject|1
7266549|NCT00395226|11480615|FG000|Overall Study|Lost to Follow-up|0
7266550|NCT00395226|11480616|FG001|Overall Study|Lost to Follow-up|1
7266551|NCT00395304|11480629|FG000|Treatment Period 1|Withdrawal by Subject|0
7266552|NCT00395304|11480630|FG001|Treatment Period 1|Withdrawal by Subject|3
7266553|NCT00395304|11480631|FG002|Treatment Period 1|Withdrawal by Subject|0
7266554|NCT00395304|11480632|FG003|Treatment Period 1|Withdrawal by Subject|2
7266555|NCT00395304|11480633|FG004|Treatment Period 1|Withdrawal by Subject|1
7266556|NCT00395304|11480634|FG005|Treatment Period 1|Withdrawal by Subject|1
7266557|NCT00395304|11480629|FG000|Treatment Period 1|Lost to Follow-up|1
7266558|NCT00395304|11480630|FG001|Treatment Period 1|Lost to Follow-up|0
7266559|NCT00395304|11480631|FG002|Treatment Period 1|Lost to Follow-up|0
7266560|NCT00395304|11480632|FG003|Treatment Period 1|Lost to Follow-up|1
7266561|NCT00395304|11480633|FG004|Treatment Period 1|Lost to Follow-up|0
7266562|NCT00395304|11480634|FG005|Treatment Period 1|Lost to Follow-up|1
7266563|NCT00395304|11480629|FG000|Treatment Period 1|Physician Decision|0
7266564|NCT00395304|11480630|FG001|Treatment Period 1|Physician Decision|1
7266565|NCT00395304|11480631|FG002|Treatment Period 1|Physician Decision|0
7266566|NCT00395304|11480632|FG003|Treatment Period 1|Physician Decision|0
7266567|NCT00395304|11480633|FG004|Treatment Period 1|Physician Decision|0
7266568|NCT00395304|11480634|FG005|Treatment Period 1|Physician Decision|0
7266569|NCT00395304|11480629|FG000|Treatment Period 2|Withdrawal by Subject|0
7266570|NCT00395304|11480630|FG001|Treatment Period 2|Withdrawal by Subject|0
7266571|NCT00395304|11480631|FG002|Treatment Period 2|Withdrawal by Subject|0
7266572|NCT00395304|11480632|FG003|Treatment Period 2|Withdrawal by Subject|1
7266573|NCT00395304|11480633|FG004|Treatment Period 2|Withdrawal by Subject|0
7266574|NCT00395304|11480634|FG005|Treatment Period 2|Withdrawal by Subject|2
7266575|NCT00395304|11480629|FG000|Treatment Period 2|Lost to Follow-up|0
7266576|NCT00395304|11480630|FG001|Treatment Period 2|Lost to Follow-up|3
7266577|NCT00395304|11480631|FG002|Treatment Period 2|Lost to Follow-up|0
7266578|NCT00395304|11480632|FG003|Treatment Period 2|Lost to Follow-up|0
7546698|NCT02896400|11903244|FG007|1 Month Follow-up|Death|0
7546699|NCT02896400|11903245|FG008|1 Month Follow-up|Death|0
7546700|NCT02896400|11903246|FG009|1 Month Follow-up|Death|0
7546701|NCT02896400|11903247|FG010|1 Month Follow-up|Death|0
7546702|NCT02896400|11903248|FG011|1 Month Follow-up|Death|0
7546703|NCT02896400|11903249|FG012|1 Month Follow-up|Death|0
7546704|NCT02896400|11903250|FG013|1 Month Follow-up|Death|0
7546705|NCT02896400|11903251|FG014|1 Month Follow-up|Death|0
7546706|NCT02896400|11903252|FG015|1 Month Follow-up|Death|1
7546707|NCT02896400|11903237|FG000|3 Month Follow-up|Lost to Follow-up|6
7546708|NCT02896400|11903238|FG001|3 Month Follow-up|Lost to Follow-up|3
7546709|NCT02896400|11903239|FG002|3 Month Follow-up|Lost to Follow-up|6
7546710|NCT02896400|11903240|FG003|3 Month Follow-up|Lost to Follow-up|11
7546711|NCT02896400|11903241|FG004|3 Month Follow-up|Lost to Follow-up|12
7546712|NCT02896400|11903242|FG005|3 Month Follow-up|Lost to Follow-up|6
7546713|NCT02896400|11903243|FG006|3 Month Follow-up|Lost to Follow-up|4
7546714|NCT02896400|11903244|FG007|3 Month Follow-up|Lost to Follow-up|3
7546715|NCT02896400|11903245|FG008|3 Month Follow-up|Lost to Follow-up|6
7546716|NCT02896400|11903246|FG009|3 Month Follow-up|Lost to Follow-up|5
7546717|NCT02896400|11903247|FG010|3 Month Follow-up|Lost to Follow-up|6
7546718|NCT02896400|11903248|FG011|3 Month Follow-up|Lost to Follow-up|6
7546719|NCT02896400|11903249|FG012|3 Month Follow-up|Lost to Follow-up|3
7546720|NCT02896400|11903250|FG013|3 Month Follow-up|Lost to Follow-up|5
7546721|NCT02896400|11903251|FG014|3 Month Follow-up|Lost to Follow-up|3
7546722|NCT02896400|11903252|FG015|3 Month Follow-up|Lost to Follow-up|2
7546723|NCT02896400|11903237|FG000|3 Month Follow-up|Death|0
7546724|NCT02896400|11903238|FG001|3 Month Follow-up|Death|0
7546725|NCT02896400|11903239|FG002|3 Month Follow-up|Death|0
7546726|NCT02896400|11903240|FG003|3 Month Follow-up|Death|0
7266579|NCT00395304|11480633|FG004|Treatment Period 2|Lost to Follow-up|0
7266580|NCT00395304|11480634|FG005|Treatment Period 2|Lost to Follow-up|0
7266581|NCT00395304|11480629|FG000|Treatment Period 2|Physician Decision|0
7266582|NCT00395304|11480630|FG001|Treatment Period 2|Physician Decision|0
7266583|NCT00395304|11480631|FG002|Treatment Period 2|Physician Decision|1
7266584|NCT00395304|11480632|FG003|Treatment Period 2|Physician Decision|0
7266585|NCT00395304|11480633|FG004|Treatment Period 2|Physician Decision|0
7266586|NCT00395304|11480634|FG005|Treatment Period 2|Physician Decision|0
7266587|NCT00395304|11480629|FG000|Treatment Period 2|Other|0
7266588|NCT00395304|11480630|FG001|Treatment Period 2|Other|1
7266589|NCT00395304|11480631|FG002|Treatment Period 2|Other|0
7266590|NCT00395304|11480632|FG003|Treatment Period 2|Other|0
7266591|NCT00395304|11480633|FG004|Treatment Period 2|Other|0
7266592|NCT00395304|11480634|FG005|Treatment Period 2|Other|0
7266593|NCT00395304|11480629|FG000|Treatment Period 3|Withdrawal by Subject|0
7266594|NCT00395304|11480630|FG001|Treatment Period 3|Withdrawal by Subject|0
7266595|NCT00395304|11480631|FG002|Treatment Period 3|Withdrawal by Subject|0
7266596|NCT00395304|11480632|FG003|Treatment Period 3|Withdrawal by Subject|1
7546727|NCT02896400|11903241|FG004|3 Month Follow-up|Death|0
7266597|NCT00395304|11480633|FG004|Treatment Period 3|Withdrawal by Subject|0
7266598|NCT00395304|11480634|FG005|Treatment Period 3|Withdrawal by Subject|1
7266599|NCT00395304|11480629|FG000|Treatment Period 3|Lost to Follow-up|1
7266600|NCT00395304|11480630|FG001|Treatment Period 3|Lost to Follow-up|1
7266601|NCT00395304|11480631|FG002|Treatment Period 3|Lost to Follow-up|0
7266602|NCT00395304|11480632|FG003|Treatment Period 3|Lost to Follow-up|0
7266603|NCT00395304|11480633|FG004|Treatment Period 3|Lost to Follow-up|0
7266604|NCT00395304|11480634|FG005|Treatment Period 3|Lost to Follow-up|0
7266605|NCT00395304|11480629|FG000|Treatment Period 3|Physician Decision|0
7266606|NCT00395304|11480630|FG001|Treatment Period 3|Physician Decision|1
7266607|NCT00395304|11480631|FG002|Treatment Period 3|Physician Decision|0
7266608|NCT00395304|11480632|FG003|Treatment Period 3|Physician Decision|0
7266609|NCT00395304|11480633|FG004|Treatment Period 3|Physician Decision|0
7266610|NCT00395304|11480634|FG005|Treatment Period 3|Physician Decision|0
7266611|NCT00395304|11480629|FG000|Treatment Period 3|Other|0
7266612|NCT00395304|11480630|FG001|Treatment Period 3|Other|0
7266613|NCT00395304|11480631|FG002|Treatment Period 3|Other|0
7266614|NCT00395304|11480632|FG003|Treatment Period 3|Other|1
7266615|NCT00395304|11480633|FG004|Treatment Period 3|Other|0
7266616|NCT00395304|11480634|FG005|Treatment Period 3|Other|0
7266617|NCT00395343|11480643|FG000|Overall Study|Adverse Event|13
7266618|NCT00395343|11480644|FG001|Overall Study|Adverse Event|5
7266619|NCT00395343|11480643|FG000|Overall Study|Lack of Efficacy|0
7266620|NCT00395343|11480644|FG001|Overall Study|Lack of Efficacy|1
7266621|NCT00395343|11480643|FG000|Overall Study|Lost to Follow-up|4
7266622|NCT00395343|11480644|FG001|Overall Study|Lost to Follow-up|4
7266623|NCT00395343|11480643|FG000|Overall Study|Physician Decision|2
7266624|NCT00395343|11480644|FG001|Overall Study|Physician Decision|4
7266625|NCT00395343|11480643|FG000|Overall Study|Protocol Violation|6
7266626|NCT00395343|11480644|FG001|Overall Study|Protocol Violation|8
7266627|NCT00395343|11480643|FG000|Overall Study|Withdrawal by Subject|11
7266628|NCT00395343|11480644|FG001|Overall Study|Withdrawal by Subject|12
7266629|NCT00395343|11480643|FG000|Overall Study|Other|5
7266630|NCT00395343|11480644|FG001|Overall Study|Other|2
7266631|NCT00395447|11480652|FG000|Overall Study|Death|37
7266632|NCT00395447|11480653|FG001|Overall Study|Death|32
7266633|NCT00395447|11480652|FG000|Overall Study|Lost to Follow-up|52
7266634|NCT00395447|11480653|FG001|Overall Study|Lost to Follow-up|43
7266635|NCT00395447|11480652|FG000|Overall Study|Withdrawal by Subject|24
7266636|NCT00395447|11480653|FG001|Overall Study|Withdrawal by Subject|19
7266637|NCT00395447|11480652|FG000|Overall Study|Withdrawl - Other (not subject)|8
7266638|NCT00395447|11480653|FG001|Overall Study|Withdrawl - Other (not subject)|17
7266639|NCT00395460|11480661|FG000|Overall Study|Withdrawal by Subject|1
7266640|NCT00395460|11480662|FG001|Overall Study|Withdrawal by Subject|0
7266641|NCT00395486|11480670|FG000|Overall Study|Adverse Event|1
7266642|NCT00395486|11480671|FG001|Overall Study|Adverse Event|2
7266643|NCT00395486|11480670|FG000|Overall Study|Withdrawal by Subject|5
7266644|NCT00395486|11480671|FG001|Overall Study|Withdrawal by Subject|2
7266645|NCT00395486|11480670|FG000|Overall Study|Lost to Follow-up|0
7266646|NCT00395486|11480671|FG001|Overall Study|Lost to Follow-up|1
7266647|NCT00395512|11480681|FG000|Overall Study|Adverse Event|3
7546728|NCT02896400|11903242|FG005|3 Month Follow-up|Death|0
7546729|NCT02896400|11903243|FG006|3 Month Follow-up|Death|0
7546730|NCT02896400|11903244|FG007|3 Month Follow-up|Death|0
7546731|NCT02896400|11903245|FG008|3 Month Follow-up|Death|0
7546732|NCT02896400|11903246|FG009|3 Month Follow-up|Death|0
7546733|NCT02896400|11903247|FG010|3 Month Follow-up|Death|0
7546734|NCT02896400|11903248|FG011|3 Month Follow-up|Death|0
7546735|NCT02896400|11903249|FG012|3 Month Follow-up|Death|0
7546736|NCT02896400|11903250|FG013|3 Month Follow-up|Death|1
7546737|NCT02896400|11903251|FG014|3 Month Follow-up|Death|1
7546738|NCT02896400|11903252|FG015|3 Month Follow-up|Death|0
7546739|NCT02896400|11903237|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546740|NCT02896400|11903238|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
7546741|NCT02896400|11903239|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546742|NCT02896400|11903240|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546743|NCT02896400|11903241|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
7546744|NCT02896400|11903242|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546745|NCT02896400|11903243|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
7546746|NCT02896400|11903244|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
7546747|NCT02896400|11903245|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546748|NCT02896400|11903246|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546749|NCT02896400|11903247|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
7266648|NCT00395512|11480682|FG001|Overall Study|Adverse Event|8
7266649|NCT00395512|11480683|FG002|Overall Study|Adverse Event|6
7266650|NCT00395512|11480684|FG003|Overall Study|Adverse Event|6
7266651|NCT00395512|11480681|FG000|Overall Study|Protocol Violation|2
7266652|NCT00395512|11480682|FG001|Overall Study|Protocol Violation|3
7266653|NCT00395512|11480683|FG002|Overall Study|Protocol Violation|6
7266654|NCT00395512|11480684|FG003|Overall Study|Protocol Violation|7
7266655|NCT00395512|11480681|FG000|Overall Study|Lost to Follow-up|2
7266656|NCT00395512|11480682|FG001|Overall Study|Lost to Follow-up|6
7266657|NCT00395512|11480683|FG002|Overall Study|Lost to Follow-up|5
7546750|NCT02896400|11903248|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
7266658|NCT00395512|11480684|FG003|Overall Study|Lost to Follow-up|5
7266659|NCT00395512|11480681|FG000|Overall Study|Withdrawal by Subject|6
7266660|NCT00395512|11480682|FG001|Overall Study|Withdrawal by Subject|5
7266661|NCT00395512|11480683|FG002|Overall Study|Withdrawal by Subject|5
7266662|NCT00395512|11480684|FG003|Overall Study|Withdrawal by Subject|12
7266663|NCT00395512|11480681|FG000|Overall Study|Physician Decision|6
7266664|NCT00395512|11480682|FG001|Overall Study|Physician Decision|4
7266665|NCT00395512|11480683|FG002|Overall Study|Physician Decision|2
7266666|NCT00395512|11480684|FG003|Overall Study|Physician Decision|2
7266667|NCT00395512|11480681|FG000|Overall Study|Other|1
7266668|NCT00395512|11480682|FG001|Overall Study|Other|1
7266669|NCT00395512|11480683|FG002|Overall Study|Other|0
7266670|NCT00395512|11480684|FG003|Overall Study|Other|0
7266671|NCT00395512|11480681|FG000|Overall Study|Hyperglycemic Rescue|18
7266672|NCT00395512|11480682|FG001|Overall Study|Hyperglycemic Rescue|10
7266673|NCT00395512|11480683|FG002|Overall Study|Hyperglycemic Rescue|4
7266674|NCT00395512|11480684|FG003|Overall Study|Hyperglycemic Rescue|6
7266675|NCT00395538|11480697|FG000|Overall Study|Did not re-consent to revised protocol|1
7266676|NCT00395538|11480698|FG001|Overall Study|Did not re-consent to revised protocol|10
7266677|NCT00395538|11480699|FG002|Overall Study|Did not re-consent to revised protocol|0
7266678|NCT00395538|11480697|FG000|Overall Study|FDA partial hold on PTH|0
7266679|NCT00395538|11480698|FG001|Overall Study|FDA partial hold on PTH|0
7266680|NCT00395538|11480699|FG002|Overall Study|FDA partial hold on PTH|11
7266681|NCT00395538|11480697|FG000|Overall Study|Failed screening|0
7266682|NCT00395538|11480698|FG001|Overall Study|Failed screening|0
7266683|NCT00395538|11480699|FG002|Overall Study|Failed screening|4
7266684|NCT00395538|11480697|FG000|Overall Study|Switch to Natpara|0
7266685|NCT00395538|11480698|FG001|Overall Study|Switch to Natpara|0
7266686|NCT00395538|11480699|FG002|Overall Study|Switch to Natpara|3
7266687|NCT00395538|11480697|FG000|Overall Study|Adverse Event|1
7266688|NCT00395538|11480698|FG001|Overall Study|Adverse Event|0
7266689|NCT00395538|11480699|FG002|Overall Study|Adverse Event|2
7266690|NCT00395538|11480697|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
7266691|NCT00395538|11480698|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
7266692|NCT00395538|11480699|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
7266693|NCT00395538|11480697|FG000|Overall Study|Non-compliance with study protocol|0
7266694|NCT00395538|11480698|FG001|Overall Study|Non-compliance with study protocol|1
7266695|NCT00395538|11480699|FG002|Overall Study|Non-compliance with study protocol|0
7266696|NCT00395538|11480697|FG000|Overall Study|PTH resistance|0
7266697|NCT00395538|11480698|FG001|Overall Study|PTH resistance|0
7266698|NCT00395538|11480699|FG002|Overall Study|PTH resistance|1
7266699|NCT00395538|11480697|FG000|Overall Study|Pregnancy|1
7266700|NCT00395538|11480698|FG001|Overall Study|Pregnancy|0
7266701|NCT00395538|11480699|FG002|Overall Study|Pregnancy|0
7266702|NCT00395538|11480697|FG000|Overall Study|Partial recovery of parathyroid function|0
7266703|NCT00395538|11480698|FG001|Overall Study|Partial recovery of parathyroid function|0
7266704|NCT00395538|11480699|FG002|Overall Study|Partial recovery of parathyroid function|1
7266705|NCT00395538|11480697|FG000|Overall Study|Participant elected to discontinue|0
7266706|NCT00395538|11480698|FG001|Overall Study|Participant elected to discontinue|0
7266707|NCT00395538|11480699|FG002|Overall Study|Participant elected to discontinue|1
7266708|NCT00395629|11480710|FG000|Core Study|Adverse Event|0
7266709|NCT00395629|11480711|FG001|Core Study|Adverse Event|3
7266710|NCT00395629|11480712|FG002|Core Study|Adverse Event|4
7266711|NCT00395629|11480710|FG000|Core Study|Abnormal laboratory value(s)|0
7266712|NCT00395629|11480711|FG001|Core Study|Abnormal laboratory value(s)|0
7266713|NCT00395629|11480712|FG002|Core Study|Abnormal laboratory value(s)|1
7266714|NCT00395629|11480710|FG000|Core Study|Protocol Violation|1
7266715|NCT00395629|11480711|FG001|Core Study|Protocol Violation|0
7266716|NCT00395629|11480712|FG002|Core Study|Protocol Violation|0
7266717|NCT00395629|11480710|FG000|Core Study|Withdrawal by Subject|0
7266718|NCT00395629|11480711|FG001|Core Study|Withdrawal by Subject|1
7266719|NCT00395629|11480712|FG002|Core Study|Withdrawal by Subject|1
7266720|NCT00395629|11480710|FG000|Core Study|Lost to Follow-up|0
7266721|NCT00395629|11480711|FG001|Core Study|Lost to Follow-up|0
7266722|NCT00395629|11480712|FG002|Core Study|Lost to Follow-up|1
7266723|NCT00395629|11480710|FG000|Extension Study|Adverse Event|0
7266724|NCT00395629|11480711|FG001|Extension Study|Adverse Event|0
7546751|NCT02896400|11903249|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
7546752|NCT02896400|11903250|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
7546753|NCT02896400|11903251|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
7266725|NCT00395629|11480712|FG002|Extension Study|Adverse Event|2
7266726|NCT00395629|11480710|FG000|Extension Study|Administrative problems|0
7266727|NCT00395629|11480711|FG001|Extension Study|Administrative problems|0
7266728|NCT00395629|11480712|FG002|Extension Study|Administrative problems|1
7546754|NCT02896400|11903252|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
7266729|NCT00395642|11480723|FG000|Overall Study|Death|4
7266730|NCT00395642|11480723|FG000|Overall Study|Lost to Follow-up|1
7266731|NCT00395642|11480723|FG000|Overall Study|Physician Decision|7
7266732|NCT00395642|11480723|FG000|Overall Study|Withdrawal by Subject|1
7624590|NCT01986114|12035684|FG000|Overall Study|Withdrawal by Subject|58
7266733|NCT00395694|11480729|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
7266734|NCT00395694|11480730|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
7266735|NCT00395694|11480729|FG000|Continuation Phase|Adverse Event|1
7266736|NCT00395694|11480730|FG001|Continuation Phase|Adverse Event|0
7266737|NCT00395694|11480729|FG000|Continuation Phase|Lack of Efficacy|12
7266738|NCT00395694|11480730|FG001|Continuation Phase|Lack of Efficacy|11
7266739|NCT00395694|11480729|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
7266740|NCT00395694|11480730|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
7266741|NCT00395694|11480729|FG000|Continuation Phase|Poor Compliance|1
7266742|NCT00395694|11480730|FG001|Continuation Phase|Poor Compliance|0
7266743|NCT00395694|11480729|FG000|Continuation Phase|Withdrawal by Subject|0
7266744|NCT00395694|11480730|FG001|Continuation Phase|Withdrawal by Subject|2
7266745|NCT00395733|11480741|FG000|Period 2|Withdrawal by Subject|1
7266746|NCT00395733|11480742|FG001|Period 2|Withdrawal by Subject|2
7266747|NCT00395733|11480741|FG000|Period 2|Protocol Violation|0
7266748|NCT00395733|11480742|FG001|Period 2|Protocol Violation|1
7266749|NCT00395733|11480741|FG000|Period 2|Adverse Event|0
7266750|NCT00395733|11480742|FG001|Period 2|Adverse Event|2
7266751|NCT00395733|11480741|FG000|Period 2|Technical problems|1
7266752|NCT00395733|11480742|FG001|Period 2|Technical problems|0
7266753|NCT00395746|11480751|FG000|Overall Study|Adverse Event|5
7546755|NCT02896400|11903237|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7546756|NCT02896400|11903238|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7546757|NCT02896400|11903239|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
7546758|NCT02896400|11903240|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
7266754|NCT00395746|11480752|FG001|Overall Study|Adverse Event|2
7546759|NCT02896400|11903241|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
7546760|NCT02896400|11903242|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7546761|NCT02896400|11903243|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7266755|NCT00395746|11480753|FG002|Overall Study|Adverse Event|2
7266756|NCT00395746|11480751|FG000|Overall Study|Protocol Violation|0
7266757|NCT00395746|11480752|FG001|Overall Study|Protocol Violation|1
7266758|NCT00395746|11480753|FG002|Overall Study|Protocol Violation|0
7266759|NCT00395746|11480751|FG000|Overall Study|Lack of Efficacy|2
7266760|NCT00395746|11480752|FG001|Overall Study|Lack of Efficacy|0
7266761|NCT00395746|11480753|FG002|Overall Study|Lack of Efficacy|17
7266762|NCT00395746|11480751|FG000|Overall Study|Hypoglycaemia|2
7266763|NCT00395746|11480752|FG001|Overall Study|Hypoglycaemia|1
7266764|NCT00395746|11480753|FG002|Overall Study|Hypoglycaemia|0
7546762|NCT02896400|11903244|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
7546763|NCT02896400|11903245|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
7546764|NCT02896400|11903246|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7546765|NCT02896400|11903247|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
7546766|NCT02896400|11903248|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
7546767|NCT02896400|11903249|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7546768|NCT02896400|11903250|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
7546769|NCT02896400|11903251|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
7546770|NCT02896400|11903252|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
7546771|NCT02896569|11903280|FG000|Overall Study|Lost to Follow-up|2
7546772|NCT02896569|11903281|FG001|Overall Study|Lost to Follow-up|1
7546773|NCT02896569|11903280|FG000|Overall Study|Physician Decision|1
7546774|NCT02896569|11903281|FG001|Overall Study|Physician Decision|3
7546775|NCT02896569|11903280|FG000|Overall Study|Adverse Event|0
7546776|NCT02896569|11903281|FG001|Overall Study|Adverse Event|1
7546777|NCT02896569|11903280|FG000|Overall Study|Withdrawal by Subject|1
7546778|NCT02896569|11903281|FG001|Overall Study|Withdrawal by Subject|0
7546779|NCT02897115|11903302|FG000|Overall Study|Early termination of study by sponsor|11
7546780|NCT02897115|11903303|FG001|Overall Study|Early termination of study by sponsor|8
7546781|NCT02897349|11903331|FG000|Overall Study|Lost to Follow-up|2
7546782|NCT02897349|11903332|FG001|Overall Study|Lost to Follow-up|2
7546783|NCT02897349|11903331|FG000|Overall Study|Adverse Event|3
7546784|NCT02897349|11903332|FG001|Overall Study|Adverse Event|3
7546785|NCT02897349|11903331|FG000|Overall Study|Other than listed above|0
7546786|NCT02897349|11903332|FG001|Overall Study|Other than listed above|1
7546787|NCT02898116|11903351|FG000|Overall Study|Adverse Event|1
7546788|NCT02898116|11903351|FG000|Overall Study|Progressive disease|1
7546789|NCT02898454|11903358|FG000|Overall Study|Adverse Event|4
7546790|NCT02898454|11903359|FG001|Overall Study|Adverse Event|1
7546791|NCT02898454|11903360|FG002|Overall Study|Adverse Event|2
7546792|NCT02898454|11903358|FG000|Overall Study|Protocol Violation|1
7546793|NCT02898454|11903359|FG001|Overall Study|Protocol Violation|0
7546794|NCT02898454|11903360|FG002|Overall Study|Protocol Violation|1
7546795|NCT02898454|11903358|FG000|Overall Study|Lack of Efficacy|4
7546796|NCT02898454|11903359|FG001|Overall Study|Lack of Efficacy|1
7546797|NCT02898454|11903360|FG002|Overall Study|Lack of Efficacy|0
7546798|NCT02898454|11903358|FG000|Overall Study|Withdrawal by Subject|6
7546799|NCT02898454|11903359|FG001|Overall Study|Withdrawal by Subject|3
7546800|NCT02898454|11903360|FG002|Overall Study|Withdrawal by Subject|3
7546801|NCT02898454|11903358|FG000|Overall Study|Lost to Follow-up|1
7546802|NCT02898454|11903359|FG001|Overall Study|Lost to Follow-up|0
7546803|NCT02898454|11903360|FG002|Overall Study|Lost to Follow-up|0
7546804|NCT02898454|11903358|FG000|Overall Study|Did Not Met Eligibility Criteria|1
7546805|NCT02898454|11903359|FG001|Overall Study|Did Not Met Eligibility Criteria|0
7546806|NCT02898454|11903360|FG002|Overall Study|Did Not Met Eligibility Criteria|0
7546807|NCT02898597|11903375|FG000|Overall Study|Protocol Violation|4
7546808|NCT02898597|11903376|FG001|Overall Study|Protocol Violation|2
7546809|NCT02898597|11903375|FG000|Overall Study|Lost to Follow-up|0
7546810|NCT02898597|11903376|FG001|Overall Study|Lost to Follow-up|9
7546811|NCT02898597|11903375|FG000|Overall Study|Death|0
7546812|NCT02898597|11903376|FG001|Overall Study|Death|1
7546813|NCT02898662|11903384|FG000|Overall Study|Adverse Event|1
7546814|NCT02898662|11903385|FG001|Overall Study|Adverse Event|0
7546815|NCT02898662|11903384|FG000|Overall Study|Loss of asthma control|23
7546816|NCT02898662|11903385|FG001|Overall Study|Loss of asthma control|24
7546817|NCT02898662|11903384|FG000|Overall Study|Withdrawal by Subject|4
7546818|NCT02898662|11903385|FG001|Overall Study|Withdrawal by Subject|1
7546819|NCT02898662|11903384|FG000|Overall Study|Technical issue|0
7546820|NCT02898662|11903385|FG001|Overall Study|Technical issue|1
7577291|NCT04029961|11966513|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
7577292|NCT04029961|11966512|FG000|Overall Study|Change in Treatment Course|0
7577293|NCT04029961|11966513|FG001|Overall Study|Change in Treatment Course|1
7577294|NCT04025684|11966523|FG000|Overall Study|Withdrawal by Subject|1
7577295|NCT04025684|11966524|FG001|Overall Study|Withdrawal by Subject|1
7577296|NCT04025684|11966525|FG002|Overall Study|Withdrawal by Subject|0
7577297|NCT04025684|11966526|FG003|Overall Study|Withdrawal by Subject|0
7577298|NCT04025684|11966523|FG000|Overall Study|Multiple reasons|1
7577299|NCT04025684|11966524|FG001|Overall Study|Multiple reasons|3
7577300|NCT04025684|11966525|FG002|Overall Study|Multiple reasons|0
7577301|NCT04025684|11966526|FG003|Overall Study|Multiple reasons|1
7624591|NCT01986114|12035684|FG000|Overall Study|Noncompliance|3
7266765|NCT00395746|11480751|FG000|Overall Study|Subject decision|0
7546821|NCT02898662|11903384|FG000|Overall Study|Randomized in error|0
7266766|NCT00395746|11480752|FG001|Overall Study|Subject decision|0
7266767|NCT00395746|11480753|FG002|Overall Study|Subject decision|1
7266768|NCT00395746|11480751|FG000|Overall Study|Withdrawal of consent|0
7266769|NCT00395746|11480752|FG001|Overall Study|Withdrawal of consent|0
7266770|NCT00395746|11480753|FG002|Overall Study|Withdrawal of consent|1
7266771|NCT00395746|11480751|FG000|Overall Study|Difficultulty in use of device|0
7266772|NCT00395746|11480752|FG001|Overall Study|Difficultulty in use of device|0
7266773|NCT00395746|11480753|FG002|Overall Study|Difficultulty in use of device|1
7266774|NCT00395746|11480751|FG000|Overall Study|Unable to visit site on schedule|1
7266775|NCT00395746|11480752|FG001|Overall Study|Unable to visit site on schedule|0
7266776|NCT00395746|11480753|FG002|Overall Study|Unable to visit site on schedule|0
7266777|NCT00395850|11480765|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
7266778|NCT00395850|11480766|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7266779|NCT00395850|11480767|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7546822|NCT02898662|11903385|FG001|Overall Study|Randomized in error|1
7546823|NCT02898662|11903384|FG000|Overall Study|Subject decision|1
7546824|NCT02898662|11903385|FG001|Overall Study|Subject decision|0
7546825|NCT02898662|11903384|FG000|Overall Study|Other|0
7546826|NCT02898662|11903385|FG001|Overall Study|Other|1
7546827|NCT02899156|11903411|FG000|Overall Study|Death|1
7546828|NCT02899156|11903412|FG001|Overall Study|Death|0
7577302|NCT04019054|11966538|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
7577303|NCT04019054|11966539|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
7577304|NCT04019054|11966538|FG000|Overall Study|Withdrawal by Subject|3
7577305|NCT04019054|11966539|FG001|Overall Study|Withdrawal by Subject|1
7577306|NCT04016311|11966672|FG000|Overall Study|Withdrawal by Subject|1
7577307|NCT04016311|11966673|FG001|Overall Study|Withdrawal by Subject|0
7577308|NCT04023682|11966766|FG000|Overall Study|Clinical schedules did not allow continued participation|6
7577309|NCT04023994|11966813|FG000|Overall Study|Lost to Follow-up|0
7577310|NCT04023994|11966814|FG001|Overall Study|Lost to Follow-up|1
7577311|NCT04023994|11966815|FG002|Overall Study|Lost to Follow-up|2
7546829|NCT02899156|11903411|FG000|Overall Study|Physician Decision|0
7546830|NCT02899156|11903412|FG001|Overall Study|Physician Decision|1
7546831|NCT02899195|11903418|FG000|Concurrent Durvalumab|Adverse Event|4
7546832|NCT02899195|11903418|FG000|Concurrent Durvalumab|Physician Decision|1
7546833|NCT02899195|11903418|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
7546834|NCT02899195|11903418|FG000|Concurrent Durvalumab|Progressive Disease|5
7546835|NCT02899195|11903418|FG000|Maintenance Durvalumab|Adverse Event|1
7546836|NCT02899195|11903418|FG000|Maintenance Durvalumab|Physician Decision|1
7546837|NCT02899195|11903418|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
7546838|NCT02899195|11903418|FG000|Maintenance Durvalumab|Progressive Disease|31
7546839|NCT02899338|11903424|FG000|Overall Study|Adverse Event|1
7546840|NCT02899338|11903425|FG001|Overall Study|Adverse Event|2
7546841|NCT02899338|11903424|FG000|Overall Study|Withdrawal by Subject|2
7546842|NCT02899338|11903425|FG001|Overall Study|Withdrawal by Subject|0
7546843|NCT02899377|11903433|FG000|Overall Study|Adverse Event|1
7546844|NCT02899377|11903434|FG001|Overall Study|Adverse Event|0
7546845|NCT02899962|11903470|FG000|Open-label Phase|Adverse Event|2
7546846|NCT02899962|11903471|FG001|Open-label Phase|Adverse Event|0
7546847|NCT02899962|11903472|FG002|Open-label Phase|Adverse Event|0
7546848|NCT02899962|11903470|FG000|Open-label Phase|Lost to Follow-up|9
7546849|NCT02899962|11903471|FG001|Open-label Phase|Lost to Follow-up|0
7546850|NCT02899962|11903472|FG002|Open-label Phase|Lost to Follow-up|0
7546851|NCT02899962|11903470|FG000|Open-label Phase|Other reasons|9
7546852|NCT02899962|11903471|FG001|Open-label Phase|Other reasons|0
7546853|NCT02899962|11903472|FG002|Open-label Phase|Other reasons|0
7546854|NCT02899962|11903470|FG000|Open-label Phase|Withdrawal by Subject|7
7546855|NCT02899962|11903471|FG001|Open-label Phase|Withdrawal by Subject|0
7546856|NCT02899962|11903472|FG002|Open-label Phase|Withdrawal by Subject|0
7546857|NCT02899962|11903470|FG000|Maintenance Phase|Adverse Event|0
7546858|NCT02899962|11903471|FG001|Maintenance Phase|Adverse Event|2
7546859|NCT02899962|11903472|FG002|Maintenance Phase|Adverse Event|1
7546860|NCT02899962|11903470|FG000|Maintenance Phase|Death|0
7546861|NCT02899962|11903471|FG001|Maintenance Phase|Death|0
7546862|NCT02899962|11903472|FG002|Maintenance Phase|Death|1
7546863|NCT02899962|11903470|FG000|Maintenance Phase|Lack of Efficacy|0
7546864|NCT02899962|11903471|FG001|Maintenance Phase|Lack of Efficacy|20
7546865|NCT02899962|11903472|FG002|Maintenance Phase|Lack of Efficacy|16
7546866|NCT02899962|11903470|FG000|Maintenance Phase|Lost to Follow-up|0
7546867|NCT02899962|11903471|FG001|Maintenance Phase|Lost to Follow-up|12
7546868|NCT02899962|11903472|FG002|Maintenance Phase|Lost to Follow-up|14
7546869|NCT02899962|11903470|FG000|Maintenance Phase|Other reasons|0
7546870|NCT02899962|11903471|FG001|Maintenance Phase|Other reasons|9
7546871|NCT02899962|11903472|FG002|Maintenance Phase|Other reasons|13
7546872|NCT02899962|11903470|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
7546873|NCT02899962|11903471|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
7546874|NCT02899962|11903472|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
7546875|NCT02899962|11903470|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
7546876|NCT02899962|11903471|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
7266780|NCT00395850|11480768|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
7266781|NCT00395850|11480765|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
7266782|NCT00395850|11480766|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7266783|NCT00395850|11480767|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7266784|NCT00395850|11480768|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
7266785|NCT00395850|11480765|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
7266786|NCT00395850|11480766|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7266787|NCT00395850|11480767|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7266788|NCT00395850|11480768|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
7266789|NCT00395850|11480765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7266790|NCT00395850|11480766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
7266791|NCT00395850|11480767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
7266792|NCT00395850|11480768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
7266793|NCT00395850|11480765|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
7266794|NCT00395850|11480766|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7266795|NCT00395850|11480767|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7266796|NCT00395850|11480768|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
7266797|NCT00395850|11480765|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
7266798|NCT00395850|11480766|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7266799|NCT00395850|11480767|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7266800|NCT00395850|11480768|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
7266801|NCT00395850|11480765|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
7266802|NCT00395850|11480766|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7266803|NCT00395850|11480767|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7266804|NCT00395850|11480768|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
7266805|NCT00395863|11480780|FG000|Overall Study|Patients did not complete both exams|2
7266806|NCT00395863|11480781|FG001|Overall Study|Patients did not complete both exams|3
7266807|NCT00395967|11480799|FG000|Treatment Period|Failed Mobilization|1
7266808|NCT00395967|11480799|FG000|Follow-up Period|Death|1
7266809|NCT00395967|11480799|FG000|Follow-up Period|Lost to Follow-up|1
7388143|NCT01217892|11646885|FG001|Overall Study|Subject no longer meets study criteria|2
7388144|NCT01217892|11646886|FG002|Overall Study|Subject no longer meets study criteria|4
7388145|NCT01217892|11646887|FG003|Overall Study|Subject no longer meets study criteria|8
7388146|NCT01217892|11646884|FG000|Overall Study|Incorrect enrollment|0
7388147|NCT01217892|11646885|FG001|Overall Study|Incorrect enrollment|1
7388148|NCT01217892|11646886|FG002|Overall Study|Incorrect enrollment|1
7388149|NCT01217892|11646887|FG003|Overall Study|Incorrect enrollment|0
7388150|NCT01217892|11646884|FG000|Overall Study|Poor/Non-Compliance|0
7388151|NCT01217892|11646885|FG001|Overall Study|Poor/Non-Compliance|0
7388152|NCT01217892|11646886|FG002|Overall Study|Poor/Non-Compliance|1
7388153|NCT01217892|11646887|FG003|Overall Study|Poor/Non-Compliance|0
7388154|NCT01217944|11646900|FG000|Overall Study|Protocol Violation|1
7388155|NCT01217944|11646901|FG001|Overall Study|Protocol Violation|1
7388156|NCT01217944|11646902|FG002|Overall Study|Protocol Violation|0
7388157|NCT01217944|11646900|FG000|Overall Study|Lost to Follow-up|3
7388158|NCT01217944|11646901|FG001|Overall Study|Lost to Follow-up|1
7388159|NCT01217944|11646902|FG002|Overall Study|Lost to Follow-up|0
7388160|NCT01217944|11646900|FG000|Overall Study|Withdrawal by Subject|1
7388161|NCT01217944|11646901|FG001|Overall Study|Withdrawal by Subject|2
7388162|NCT01217944|11646902|FG002|Overall Study|Withdrawal by Subject|0
7388163|NCT01217944|11646900|FG000|Overall Study|Lack of Efficacy|1
7388164|NCT01217944|11646901|FG001|Overall Study|Lack of Efficacy|0
7388165|NCT01217944|11646902|FG002|Overall Study|Lack of Efficacy|0
7388166|NCT01217957|11646917|FG000|Phase 1|Withdrawal by Patient|1
7546877|NCT02899962|11903472|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
7546878|NCT02899962|11903470|FG000|Maintenance Phase|Withdrawal by Subject|0
7546879|NCT02899962|11903471|FG001|Maintenance Phase|Withdrawal by Subject|30
7546880|NCT02899962|11903472|FG002|Maintenance Phase|Withdrawal by Subject|36
7546881|NCT02899988|11903483|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
7546882|NCT02899988|11903484|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
7546883|NCT02899988|11903485|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
7577312|NCT04023994|11966816|FG003|Overall Study|Lost to Follow-up|0
7546884|NCT02899988|11903486|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546885|NCT02899988|11903487|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546886|NCT02899988|11903488|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546887|NCT02899988|11903489|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546888|NCT02899988|11903490|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546889|NCT02899988|11903491|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546890|NCT02899988|11903492|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546891|NCT02899988|11903493|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
7546892|NCT02899988|11903483|FG000|Induction Period (16 Weeks)|Adverse Event|0
7546893|NCT02899988|11903484|FG001|Induction Period (16 Weeks)|Adverse Event|0
7577313|NCT04023994|11966817|FG004|Overall Study|Lost to Follow-up|0
7388167|NCT01217957|11646918|FG001|Phase 1|Withdrawal by Patient|0
7266810|NCT00396084|11480846|FG000|Overall Study|Adverse Event|0
7266811|NCT00396084|11480847|FG001|Overall Study|Adverse Event|0
7266812|NCT00396084|11480848|FG002|Overall Study|Adverse Event|0
7266813|NCT00396084|11480849|FG003|Overall Study|Adverse Event|0
7266814|NCT00396084|11480850|FG004|Overall Study|Adverse Event|1
7266815|NCT00396084|11480851|FG005|Overall Study|Adverse Event|2
7266816|NCT00396084|11480846|FG000|Overall Study|Withdrawal by Subject|0
7266817|NCT00396084|11480847|FG001|Overall Study|Withdrawal by Subject|0
7266818|NCT00396084|11480848|FG002|Overall Study|Withdrawal by Subject|0
7266819|NCT00396084|11480849|FG003|Overall Study|Withdrawal by Subject|1
7266820|NCT00396084|11480850|FG004|Overall Study|Withdrawal by Subject|0
7266821|NCT00396084|11480851|FG005|Overall Study|Withdrawal by Subject|0
7266822|NCT00396097|11480871|FG000|Overall Study|Withdrawal by Subject|17
7266823|NCT00396097|11480872|FG001|Overall Study|Withdrawal by Subject|17
7266824|NCT00396097|11480871|FG000|Overall Study|Lost to Follow-up|4
7266825|NCT00396097|11480872|FG001|Overall Study|Lost to Follow-up|9
7266826|NCT00396097|11480871|FG000|Overall Study|Other|3
7266827|NCT00396097|11480872|FG001|Overall Study|Other|5
7266828|NCT00396097|11480871|FG000|Overall Study|Protocol Violation|0
7266829|NCT00396097|11480872|FG001|Overall Study|Protocol Violation|6
7266830|NCT00396097|11480871|FG000|Overall Study|Adverse Event|1
7266831|NCT00396097|11480872|FG001|Overall Study|Adverse Event|5
7266832|NCT00396097|11480871|FG000|Overall Study|Insufficient Clinical Response|1
7266833|NCT00396097|11480872|FG001|Overall Study|Insufficient Clinical Response|4
7266834|NCT00396136|11480882|FG000|Overall Study|Death|43
7266835|NCT00396136|11480882|FG000|Overall Study|Withdrawal by Subject|59
7266836|NCT00396136|11480882|FG000|Overall Study|Lost to Follow-up|15
7266837|NCT00396136|11480882|FG000|Overall Study|Study device explanted|8
7266838|NCT00396162|11480888|FG000|Overall Study|Withdrawal by Subject|2
7266839|NCT00396162|11480889|FG001|Overall Study|Withdrawal by Subject|3
7266840|NCT00396253|11480904|FG000|Overall Study|Protocol Violation|1
7266841|NCT00396253|11480904|FG000|Overall Study|Withdrawal by Subject|7
7266842|NCT00396253|11480904|FG000|Overall Study|Death|3
7266843|NCT00396253|11480904|FG000|Overall Study|Physician Decision|1
7266844|NCT00396253|11480904|FG000|Overall Study|Change in eligibility status|1
7266845|NCT00396279|11480921|FG000|Overall Study|Ongoing in study|26
7266846|NCT00396279|11480921|FG000|Overall Study|Disease progression|2
7266847|NCT00396279|11480921|FG000|Overall Study|Withdrawal by Subject|1
7266848|NCT00396279|11480921|FG000|Overall Study|Physician Decision|1
7266849|NCT00396318|11480934|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
7266850|NCT00396331|11480942|FG000|Overall Study|Failed to mobilize - no transplant|8
7266851|NCT00396331|11480942|FG000|Overall Study|Did not go on to transplant|5
7266852|NCT00396331|11480942|FG000|Overall Study|Lost to Follow-up|3
7266853|NCT00396331|11480942|FG000|Overall Study|Death|16
7266854|NCT00396383|11480954|FG000|Overall Study|Death|2
7266855|NCT00396383|11480954|FG000|Overall Study|Lost to Follow-up|1
7266856|NCT00396409|11480960|FG000|Period 1 - 2007|Adverse Event|0
7266857|NCT00396409|11480961|FG001|Period 1 - 2007|Adverse Event|1
7266858|NCT00396409|11480960|FG000|Period 1 - 2007|Lack of Efficacy|0
7266859|NCT00396409|11480961|FG001|Period 1 - 2007|Lack of Efficacy|1
7266860|NCT00396409|11480960|FG000|Period 1 - 2007|Withdrawal by Subject|1
7266861|NCT00396409|11480961|FG001|Period 1 - 2007|Withdrawal by Subject|1
7266862|NCT00396409|11480960|FG000|Period 1 - 2007|Lost to Follow-up|2
7266863|NCT00396409|11480961|FG001|Period 1 - 2007|Lost to Follow-up|3
7266864|NCT00396409|11480960|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
7266865|NCT00396409|11480961|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
7266866|NCT00396409|11480960|FG000|Period 2 - 2008|Protocol Violation|1
7266867|NCT00396409|11480961|FG001|Period 2 - 2008|Protocol Violation|0
7266868|NCT00396409|11480960|FG000|Period 2 - 2008|Withdrawal by Subject|3
7266869|NCT00396409|11480961|FG001|Period 2 - 2008|Withdrawal by Subject|1
7266870|NCT00396409|11480960|FG000|Period 2 - 2008|Lost to Follow-up|3
7266871|NCT00396409|11480961|FG001|Period 2 - 2008|Lost to Follow-up|1
7266872|NCT00396565|11480972|FG000|Overall Study|Physician Decision|3
7266873|NCT00396565|11480973|FG001|Overall Study|Physician Decision|1
7266874|NCT00396565|11480974|FG002|Overall Study|Physician Decision|2
7266875|NCT00396565|11480972|FG000|Overall Study|Adverse Event|5
7266876|NCT00396565|11480973|FG001|Overall Study|Adverse Event|13
7266877|NCT00396565|11480974|FG002|Overall Study|Adverse Event|3
7266878|NCT00396565|11480972|FG000|Overall Study|Withdrawal by Subject|8
7266879|NCT00396565|11480973|FG001|Overall Study|Withdrawal by Subject|13
7266880|NCT00396565|11480974|FG002|Overall Study|Withdrawal by Subject|1
7266881|NCT00396565|11480972|FG000|Overall Study|Lack of Efficacy|32
7266882|NCT00396565|11480973|FG001|Overall Study|Lack of Efficacy|64
7266883|NCT00396565|11480974|FG002|Overall Study|Lack of Efficacy|11
7266884|NCT00396591|11480982|FG000|Overall Study|Disease Progression|13
7266885|NCT00396591|11480982|FG000|Overall Study|Adverse Event|2
7266886|NCT00396591|11480982|FG000|Overall Study|Participant request|1
7266887|NCT00396630|11480988|FG000|Overall Study|Lost to Follow-up|1
7266888|NCT00396630|11480989|FG001|Overall Study|Lost to Follow-up|1
7266889|NCT00396630|11480988|FG000|Overall Study|Withdrawal by Subject|1
7266890|NCT00396630|11480989|FG001|Overall Study|Withdrawal by Subject|1
7266891|NCT00396630|11480988|FG000|Overall Study|Not vaccinated at Visit 3|3
7266892|NCT00396630|11480989|FG001|Overall Study|Not vaccinated at Visit 3|3
7266893|NCT00396656|11480996|FG000|First Treatment Period|Withdrawal by Subject|0
7266894|NCT00396656|11480997|FG001|First Treatment Period|Withdrawal by Subject|2
7546894|NCT02899988|11903485|FG002|Induction Period (16 Weeks)|Adverse Event|0
7546895|NCT02899988|11903486|FG003|Induction Period (16 Weeks)|Adverse Event|2
7546896|NCT02899988|11903487|FG004|Induction Period (16 Weeks)|Adverse Event|0
7546897|NCT02899988|11903488|FG005|Induction Period (16 Weeks)|Adverse Event|0
7546898|NCT02899988|11903489|FG006|Induction Period (16 Weeks)|Adverse Event|0
7546899|NCT02899988|11903490|FG007|Induction Period (16 Weeks)|Adverse Event|0
7546900|NCT02899988|11903491|FG008|Induction Period (16 Weeks)|Adverse Event|0
7546901|NCT02899988|11903492|FG009|Induction Period (16 Weeks)|Adverse Event|0
7546902|NCT02899988|11903493|FG010|Induction Period (16 Weeks)|Adverse Event|0
7546903|NCT02899988|11903483|FG000|Induction Period (16 Weeks)|Physician Decision|0
7546904|NCT02899988|11903484|FG001|Induction Period (16 Weeks)|Physician Decision|1
7546905|NCT02899988|11903485|FG002|Induction Period (16 Weeks)|Physician Decision|0
7546906|NCT02899988|11903486|FG003|Induction Period (16 Weeks)|Physician Decision|0
7546907|NCT02899988|11903487|FG004|Induction Period (16 Weeks)|Physician Decision|0
7546908|NCT02899988|11903488|FG005|Induction Period (16 Weeks)|Physician Decision|0
7546909|NCT02899988|11903489|FG006|Induction Period (16 Weeks)|Physician Decision|0
7546910|NCT02899988|11903490|FG007|Induction Period (16 Weeks)|Physician Decision|0
7546911|NCT02899988|11903491|FG008|Induction Period (16 Weeks)|Physician Decision|0
7546912|NCT02899988|11903492|FG009|Induction Period (16 Weeks)|Physician Decision|0
7546913|NCT02899988|11903493|FG010|Induction Period (16 Weeks)|Physician Decision|0
7546914|NCT02899988|11903483|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
7546915|NCT02899988|11903484|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
7546916|NCT02899988|11903485|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
7546917|NCT02899988|11903486|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
7546918|NCT02899988|11903487|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
7546919|NCT02899988|11903488|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
7546920|NCT02899988|11903489|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
7546921|NCT02899988|11903490|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
7546922|NCT02899988|11903491|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
7546923|NCT02899988|11903492|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
7546924|NCT02899988|11903493|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
7546925|NCT02899988|11903483|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546926|NCT02899988|11903484|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546927|NCT02899988|11903485|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546928|NCT02899988|11903486|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546929|NCT02899988|11903487|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546930|NCT02899988|11903488|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7546931|NCT02899988|11903489|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546932|NCT02899988|11903490|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
7546933|NCT02899988|11903491|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546934|NCT02899988|11903492|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546935|NCT02899988|11903493|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
7546936|NCT02899988|11903483|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546937|NCT02899988|11903484|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546938|NCT02899988|11903485|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546939|NCT02899988|11903486|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546940|NCT02899988|11903487|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7546941|NCT02899988|11903488|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546942|NCT02899988|11903489|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
7546943|NCT02899988|11903490|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7546944|NCT02899988|11903491|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
7546945|NCT02899988|11903492|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
7546946|NCT02899988|11903493|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
7546947|NCT02900092|11903525|FG000|Overall Study|Adverse Event|1
7546948|NCT02900170|11903529|FG000|Overall Study|Lost to Follow-up|8
7546949|NCT02900378|11903535|FG000|Randomization (Visit 2)|Adverse Event|14
7546950|NCT02900378|11903536|FG001|Randomization (Visit 2)|Adverse Event|11
7546951|NCT02900378|11903535|FG000|Randomization (Visit 2)|Death|1
7546952|NCT02900378|11903536|FG001|Randomization (Visit 2)|Death|4
7266895|NCT00396656|11480996|FG000|Second Treatment Period|Adverse Event|0
7266896|NCT00396656|11480997|FG001|Second Treatment Period|Adverse Event|1
7266897|NCT00396812|11481003|FG000|Overall Study|Physician Decision|1
7266898|NCT00396877|11481009|FG000|Overall Study|Lost to Follow-up|2
7266899|NCT00396877|11481010|FG001|Overall Study|Lost to Follow-up|1
7266900|NCT00396877|11481009|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
7546953|NCT02900378|11903535|FG000|Randomization (Visit 2)|Lost to Follow-up|1
7546954|NCT02900378|11903536|FG001|Randomization (Visit 2)|Lost to Follow-up|0
7546955|NCT02900378|11903535|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
7546956|NCT02900378|11903536|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
7546957|NCT02900378|11903535|FG000|Randomization (Visit 2)|Protocol Deviation|1
7546958|NCT02900378|11903536|FG001|Randomization (Visit 2)|Protocol Deviation|7
7546959|NCT02900378|11903535|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
7266901|NCT00396877|11481010|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
7266902|NCT00397033|11481037|FG000|Overall Study|Adverse Event|7
7266903|NCT00397033|11481038|FG001|Overall Study|Adverse Event|10
7266904|NCT00397033|11481039|FG002|Overall Study|Adverse Event|4
7266905|NCT00397033|11481037|FG000|Overall Study|Lack of Efficacy|22
7266906|NCT00397033|11481038|FG001|Overall Study|Lack of Efficacy|12
7266907|NCT00397033|11481039|FG002|Overall Study|Lack of Efficacy|9
7266908|NCT00397033|11481037|FG000|Overall Study|Lost to Follow-up|3
7266909|NCT00397033|11481038|FG001|Overall Study|Lost to Follow-up|3
7266910|NCT00397033|11481039|FG002|Overall Study|Lost to Follow-up|3
7266911|NCT00397033|11481037|FG000|Overall Study|Withdrawal by Subject|12
7266912|NCT00397033|11481038|FG001|Overall Study|Withdrawal by Subject|7
7266913|NCT00397033|11481039|FG002|Overall Study|Withdrawal by Subject|5
7266914|NCT00397033|11481037|FG000|Overall Study|Other|0
7266915|NCT00397033|11481038|FG001|Overall Study|Other|5
7266916|NCT00397033|11481039|FG002|Overall Study|Other|2
7266917|NCT00397046|11481051|FG000|Overall Study|Disease Progression|3
7266918|NCT00397046|11481052|FG001|Overall Study|Disease Progression|3
7266919|NCT00397046|11481053|FG002|Overall Study|Disease Progression|10
7266920|NCT00397046|11481054|FG003|Overall Study|Disease Progression|5
7266921|NCT00397189|11481076|FG000|3 Weeks Period|Lost to Follow-up|5
7266922|NCT00397189|11481077|FG001|3 Weeks Period|Lost to Follow-up|4
7266923|NCT00397189|11481076|FG000|3 Weeks Period|Adverse Event|3
7266924|NCT00397189|11481077|FG001|3 Weeks Period|Adverse Event|2
7266925|NCT00397189|11481076|FG000|3 Weeks Period|Withdrawal by Subject|13
7266926|NCT00397189|11481077|FG001|3 Weeks Period|Withdrawal by Subject|9
7266927|NCT00397189|11481076|FG000|3 Weeks Period|Physician Decision|0
7266928|NCT00397189|11481077|FG001|3 Weeks Period|Physician Decision|2
7266929|NCT00397189|11481076|FG000|3 Weeks Period|Protocol Violation|0
7266930|NCT00397189|11481077|FG001|3 Weeks Period|Protocol Violation|3
7266931|NCT00397189|11481076|FG000|3 Weeks Period|Other|0
7266932|NCT00397189|11481077|FG001|3 Weeks Period|Other|2
7266933|NCT00397215|11481089|FG000|Month 0 (Day 0)|Adverse Event|0
7266934|NCT00397215|11481090|FG001|Month 0 (Day 0)|Adverse Event|1
7266935|NCT00397215|11481091|FG002|Month 0 (Day 0)|Adverse Event|0
7266936|NCT00397215|11481092|FG003|Month 0 (Day 0)|Adverse Event|0
7266937|NCT00397215|11481089|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
7266938|NCT00397215|11481090|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
7266939|NCT00397215|11481091|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
7266940|NCT00397215|11481092|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
7266941|NCT00397215|11481089|FG000|Month 0 (Day 0)|Other|4
7266942|NCT00397215|11481090|FG001|Month 0 (Day 0)|Other|1
7266943|NCT00397215|11481091|FG002|Month 0 (Day 0)|Other|3
7266944|NCT00397215|11481092|FG003|Month 0 (Day 0)|Other|3
7266945|NCT00397215|11481089|FG000|Month 6 (Day 180)|Adverse Event|0
7266946|NCT00397215|11481090|FG001|Month 6 (Day 180)|Adverse Event|3
7266947|NCT00397215|11481091|FG002|Month 6 (Day 180)|Adverse Event|2
7266948|NCT00397215|11481092|FG003|Month 6 (Day 180)|Adverse Event|0
7266949|NCT00397215|11481089|FG000|Month 6 (Day 180)|Other|2
7266950|NCT00397215|11481090|FG001|Month 6 (Day 180)|Other|0
7266951|NCT00397215|11481091|FG002|Month 6 (Day 180)|Other|3
7266952|NCT00397215|11481092|FG003|Month 6 (Day 180)|Other|0
7266953|NCT00397488|11481118|FG000|Overall Study|Withdrawal by Subject|3
7266954|NCT00397488|11481118|FG000|Overall Study|Adverse Event|3
7266955|NCT00397488|11481118|FG000|Overall Study|Death|1
7266956|NCT00397514|11481122|FG000|Overall Study|Withdrawal by Subject|1
7266957|NCT00397514|11481122|FG000|Overall Study|Pacing wire malfunction|1
7266958|NCT00397514|11481122|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
7266959|NCT00397514|11481122|FG000|Overall Study|early extubation|2
7266960|NCT00397514|11481122|FG000|Overall Study|poor echocardiographic windows|1
7546960|NCT02900378|11903536|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
7546961|NCT02900378|11903535|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
7546962|NCT02900378|11903536|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
7546963|NCT02901054|11903542|FG000|Overall Study|Physician Decision|1
7546964|NCT02901054|11903542|FG000|Overall Study|Withdrawal by Subject|3
7546965|NCT02901431|11903576|FG000|PK Part|Adverse Event|0
7546966|NCT02901431|11903577|FG001|PK Part|Adverse Event|1
7546967|NCT02901431|11903578|FG002|PK Part|Adverse Event|0
7546968|NCT02901431|11903579|FG003|PK Part|Adverse Event|0
7546969|NCT02901431|11903580|FG004|PK Part|Adverse Event|0
7546970|NCT02901431|11903581|FG005|PK Part|Adverse Event|0
7546971|NCT02901431|11903582|FG006|PK Part|Adverse Event|0
7546972|NCT02901431|11903583|FG007|PK Part|Adverse Event|0
7546973|NCT02901431|11903584|FG008|PK Part|Adverse Event|0
7546974|NCT02901431|11903585|FG009|PK Part|Adverse Event|0
7546975|NCT02901431|11903586|FG010|PK Part|Adverse Event|0
7546976|NCT02901431|11903587|FG011|PK Part|Adverse Event|0
7546977|NCT02901431|11903588|FG012|PK Part|Adverse Event|0
7546978|NCT02901431|11903576|FG000|PK Part|Lost to Follow-up|0
7266961|NCT00397540|11481134|FG000|Overall Study|short follow-up duration < 12 months|1
7266962|NCT00397540|11481135|FG001|Overall Study|short follow-up duration < 12 months|0
7266963|NCT00397631|11481148|FG000|Overall Study|Adverse Event|5
7266964|NCT00397631|11481149|FG001|Overall Study|Adverse Event|6
7546979|NCT02901431|11903577|FG001|PK Part|Lost to Follow-up|0
7546980|NCT02901431|11903578|FG002|PK Part|Lost to Follow-up|1
7546981|NCT02901431|11903579|FG003|PK Part|Lost to Follow-up|0
7546982|NCT02901431|11903580|FG004|PK Part|Lost to Follow-up|0
7546983|NCT02901431|11903581|FG005|PK Part|Lost to Follow-up|0
7577314|NCT04023994|11966818|FG005|Overall Study|Lost to Follow-up|0
7266965|NCT00397631|11481148|FG000|Overall Study|Lack of Efficacy|7
7266966|NCT00397631|11481149|FG001|Overall Study|Lack of Efficacy|10
7266967|NCT00397631|11481148|FG000|Overall Study|Lost to Follow-up|8
7266968|NCT00397631|11481149|FG001|Overall Study|Lost to Follow-up|9
7266969|NCT00397631|11481148|FG000|Overall Study|Physician Decision|2
7266970|NCT00397631|11481149|FG001|Overall Study|Physician Decision|0
7266971|NCT00397631|11481148|FG000|Overall Study|Protocol Violation|0
7266972|NCT00397631|11481149|FG001|Overall Study|Protocol Violation|1
7266973|NCT00397631|11481148|FG000|Overall Study|Withdrawal by Subject|7
7266974|NCT00397631|11481149|FG001|Overall Study|Withdrawal by Subject|14
7266975|NCT00397631|11481148|FG000|Overall Study|protocol discontinuation criteria|1
7266976|NCT00397631|11481149|FG001|Overall Study|protocol discontinuation criteria|4
7266977|NCT00397891|11481198|FG000|Overall Study|Withdrawal by Subject|1
7266978|NCT00397891|11481199|FG001|Overall Study|Withdrawal by Subject|0
7266979|NCT00397891|11481200|FG002|Overall Study|Withdrawal by Subject|0
7266980|NCT00397891|11481201|FG003|Overall Study|Withdrawal by Subject|0
7577315|NCT04023994|11966813|FG000|Overall Study|Withdrawal by Subject|0
7577316|NCT04023994|11966814|FG001|Overall Study|Withdrawal by Subject|0
7577317|NCT04023994|11966815|FG002|Overall Study|Withdrawal by Subject|0
7577318|NCT04023994|11966816|FG003|Overall Study|Withdrawal by Subject|1
7577319|NCT04023994|11966817|FG004|Overall Study|Withdrawal by Subject|0
7577320|NCT04023994|11966818|FG005|Overall Study|Withdrawal by Subject|0
7577321|NCT04017611|11966861|FG000|Overall Study|Withdrawn prior to completion|1
7577322|NCT04015232|11966867|FG000|Overall Study|Withdrawal by Subject|7
7577323|NCT04015232|11966868|FG001|Overall Study|Withdrawal by Subject|4
7577324|NCT04015232|11966867|FG000|Overall Study|Protocol Violation|1
7577325|NCT04015232|11966868|FG001|Overall Study|Protocol Violation|0
7577326|NCT04015232|11966867|FG000|Overall Study|Medical Grounds|3
7266981|NCT00397891|11481202|FG004|Overall Study|Withdrawal by Subject|1
7266982|NCT00397930|11481220|FG000|Overall Study|Personal reasons|14
7546984|NCT02901431|11903582|FG006|PK Part|Lost to Follow-up|0
7546985|NCT02901431|11903583|FG007|PK Part|Lost to Follow-up|0
7546986|NCT02901431|11903584|FG008|PK Part|Lost to Follow-up|0
7546987|NCT02901431|11903585|FG009|PK Part|Lost to Follow-up|0
7546988|NCT02901431|11903586|FG010|PK Part|Lost to Follow-up|0
7546989|NCT02901431|11903587|FG011|PK Part|Lost to Follow-up|0
7546990|NCT02901431|11903588|FG012|PK Part|Lost to Follow-up|0
7546991|NCT02901431|11903576|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
7546992|NCT02901431|11903577|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
7546993|NCT02901431|11903578|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
7546994|NCT02901431|11903579|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
7546995|NCT02901431|11903580|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
7546996|NCT02901431|11903581|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
7546997|NCT02901431|11903582|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
7546998|NCT02901431|11903583|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
7546999|NCT02901431|11903584|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
7547000|NCT02901431|11903585|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
7547001|NCT02901431|11903586|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
7547002|NCT02901431|11903587|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
7547003|NCT02901431|11903588|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
7547004|NCT02901431|11903576|FG000|PK Part|Pending dose confirmation|0
7547005|NCT02901431|11903577|FG001|PK Part|Pending dose confirmation|1
7547006|NCT02901431|11903578|FG002|PK Part|Pending dose confirmation|0
7547007|NCT02901431|11903579|FG003|PK Part|Pending dose confirmation|0
7547008|NCT02901431|11903580|FG004|PK Part|Pending dose confirmation|0
7547009|NCT02901431|11903581|FG005|PK Part|Pending dose confirmation|0
7547010|NCT02901431|11903582|FG006|PK Part|Pending dose confirmation|0
7547011|NCT02901431|11903583|FG007|PK Part|Pending dose confirmation|0
7547012|NCT02901431|11903584|FG008|PK Part|Pending dose confirmation|0
7547013|NCT02901431|11903585|FG009|PK Part|Pending dose confirmation|0
7547014|NCT02901431|11903586|FG010|PK Part|Pending dose confirmation|0
7547015|NCT02901431|11903587|FG011|PK Part|Pending dose confirmation|0
7547016|NCT02901431|11903588|FG012|PK Part|Pending dose confirmation|0
7547017|NCT02901431|11903576|FG000|PK Part|8 weeks of treatment ran out|2
7547018|NCT02901431|11903577|FG001|PK Part|8 weeks of treatment ran out|0
7547019|NCT02901431|11903578|FG002|PK Part|8 weeks of treatment ran out|0
7547020|NCT02901431|11903579|FG003|PK Part|8 weeks of treatment ran out|0
7547021|NCT02901431|11903580|FG004|PK Part|8 weeks of treatment ran out|0
7547022|NCT02901431|11903581|FG005|PK Part|8 weeks of treatment ran out|0
7547023|NCT02901431|11903582|FG006|PK Part|8 weeks of treatment ran out|0
7547024|NCT02901431|11903583|FG007|PK Part|8 weeks of treatment ran out|0
7547025|NCT02901431|11903584|FG008|PK Part|8 weeks of treatment ran out|0
7547026|NCT02901431|11903585|FG009|PK Part|8 weeks of treatment ran out|0
7547027|NCT02901431|11903586|FG010|PK Part|8 weeks of treatment ran out|0
7547028|NCT02901431|11903587|FG011|PK Part|8 weeks of treatment ran out|0
7547029|NCT02901431|11903588|FG012|PK Part|8 weeks of treatment ran out|0
7547030|NCT02901431|11903576|FG000|PK Part|Stopped treatment after 8 weeks|1
7547031|NCT02901431|11903577|FG001|PK Part|Stopped treatment after 8 weeks|0
7547032|NCT02901431|11903578|FG002|PK Part|Stopped treatment after 8 weeks|1
7547033|NCT02901431|11903579|FG003|PK Part|Stopped treatment after 8 weeks|0
7577327|NCT04015232|11966868|FG001|Overall Study|Medical Grounds|3
7547034|NCT02901431|11903580|FG004|PK Part|Stopped treatment after 8 weeks|0
7547035|NCT02901431|11903581|FG005|PK Part|Stopped treatment after 8 weeks|0
7547036|NCT02901431|11903582|FG006|PK Part|Stopped treatment after 8 weeks|0
7577328|NCT04014062|11966908|FG000|Period I: Dosing|Medical Grounds|4
7577329|NCT04014062|11966909|FG001|Period I: Dosing|Medical Grounds|5
7547037|NCT02901431|11903583|FG007|PK Part|Stopped treatment after 8 weeks|0
7547038|NCT02901431|11903584|FG008|PK Part|Stopped treatment after 8 weeks|0
7547039|NCT02901431|11903585|FG009|PK Part|Stopped treatment after 8 weeks|0
7547040|NCT02901431|11903586|FG010|PK Part|Stopped treatment after 8 weeks|0
7547041|NCT02901431|11903587|FG011|PK Part|Stopped treatment after 8 weeks|0
7547042|NCT02901431|11903588|FG012|PK Part|Stopped treatment after 8 weeks|0
7547043|NCT02901431|11903576|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
7547044|NCT02901431|11903577|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547045|NCT02901431|11903578|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
7547046|NCT02901431|11903579|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547047|NCT02901431|11903580|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547048|NCT02901431|11903581|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547049|NCT02901431|11903582|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547050|NCT02901431|11903583|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547051|NCT02901431|11903584|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547052|NCT02901431|11903585|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547053|NCT02901431|11903586|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547054|NCT02901431|11903587|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547055|NCT02901431|11903588|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
7547056|NCT02901431|11903576|FG000|PK Part|Discontinued per Sponsor|0
7266983|NCT00397930|11481221|FG001|Overall Study|Personal reasons|8
7266984|NCT00397930|11481220|FG000|Overall Study|Other medical|9
7266985|NCT00397930|11481221|FG001|Overall Study|Other medical|4
7266986|NCT00397930|11481220|FG000|Overall Study|Unknown reasons|9
7266987|NCT00397930|11481221|FG001|Overall Study|Unknown reasons|14
7266988|NCT00397930|11481220|FG000|Overall Study|Noncompliant|3
7266989|NCT00397930|11481221|FG001|Overall Study|Noncompliant|2
7266990|NCT00397930|11481220|FG000|Overall Study|Too time-consuming|2
7266991|NCT00397930|11481221|FG001|Overall Study|Too time-consuming|9
7266992|NCT00397930|11481220|FG000|Overall Study|Started own yoga program|1
7266993|NCT00397930|11481221|FG001|Overall Study|Started own yoga program|1
7266994|NCT00397930|11481220|FG000|Overall Study|Did not want to be in control group|0
7266995|NCT00397930|11481221|FG001|Overall Study|Did not want to be in control group|1
7266996|NCT00397930|11481220|FG000|Overall Study|Withdrawal by Subject|0
7266997|NCT00397930|11481221|FG001|Overall Study|Withdrawal by Subject|8
7266998|NCT00397930|11481220|FG000|Overall Study|Missing data|0
7266999|NCT00397930|11481221|FG001|Overall Study|Missing data|4
7267000|NCT00397943|11481232|FG000|Overall Study|Unspecified reasons|12
7267001|NCT00397943|11481233|FG001|Overall Study|Unspecified reasons|9
7267002|NCT00397943|11481234|FG002|Overall Study|Unspecified reasons|0
7267003|NCT00397943|11481235|FG003|Overall Study|Unspecified reasons|0
7547057|NCT02901431|11903577|FG001|PK Part|Discontinued per Sponsor|3
7547058|NCT02901431|11903578|FG002|PK Part|Discontinued per Sponsor|0
7267004|NCT00397943|11481236|FG004|Overall Study|Unspecified reasons|0
7267005|NCT00397982|11481248|FG000|Overall Study|Withdrawal by Subject|1
7547059|NCT02901431|11903579|FG003|PK Part|Discontinued per Sponsor|0
7547060|NCT02901431|11903580|FG004|PK Part|Discontinued per Sponsor|0
7547061|NCT02901431|11903581|FG005|PK Part|Discontinued per Sponsor|0
7547062|NCT02901431|11903582|FG006|PK Part|Discontinued per Sponsor|0
7547063|NCT02901431|11903583|FG007|PK Part|Discontinued per Sponsor|0
7547064|NCT02901431|11903584|FG008|PK Part|Discontinued per Sponsor|0
7547065|NCT02901431|11903585|FG009|PK Part|Discontinued per Sponsor|0
7267006|NCT00397982|11481248|FG000|Overall Study|Adverse Event|1
7267007|NCT00397982|11481248|FG000|Overall Study|noncompliance|1
7267008|NCT00397982|11481248|FG000|Overall Study|Unrelated health issues|1
7267009|NCT00398047|11481253|FG000|Overall Study|all patient progressed before completion|3
7267010|NCT00398073|11481260|FG000|Overall Study|Withdrawal by Subject|1
7267011|NCT00398073|11481261|FG001|Overall Study|Withdrawal by Subject|0
7267012|NCT00398086|11481270|FG000|Overall Study|Unacceptable Toxicity|2
7267013|NCT00398086|11481271|FG001|Overall Study|Unacceptable Toxicity|8
7267014|NCT00398086|11481272|FG002|Overall Study|Unacceptable Toxicity|2
7267015|NCT00398086|11481270|FG000|Overall Study|Adverse Event|1
7267016|NCT00398086|11481271|FG001|Overall Study|Adverse Event|4
7267017|NCT00398086|11481272|FG002|Overall Study|Adverse Event|0
7267018|NCT00398086|11481270|FG000|Overall Study|Physician Decision|1
7267019|NCT00398086|11481271|FG001|Overall Study|Physician Decision|4
7267020|NCT00398086|11481272|FG002|Overall Study|Physician Decision|0
7267021|NCT00398086|11481270|FG000|Overall Study|Withdrawal by Subject|5
7267022|NCT00398086|11481271|FG001|Overall Study|Withdrawal by Subject|7
7267023|NCT00398086|11481272|FG002|Overall Study|Withdrawal by Subject|0
7267024|NCT00398112|11481280|FG000|Overall Study|Adverse Event|4
7267025|NCT00398112|11481280|FG000|Overall Study|Disease progression|9
7267026|NCT00398112|11481280|FG000|Overall Study|Alternative treatment|1
7267027|NCT00398112|11481280|FG000|Overall Study|Withdrawal by Subject|3
7267028|NCT00398112|11481280|FG000|Overall Study|Death|1
7267029|NCT00398138|11481284|FG000|Overall Study|Adverse Event|2
7267030|NCT00398216|11481293|FG000|Overall Study|Adverse Event|4
7267031|NCT00398216|11481294|FG001|Overall Study|Adverse Event|2
7267032|NCT00398216|11481295|FG002|Overall Study|Adverse Event|5
7267033|NCT00398216|11481296|FG003|Overall Study|Adverse Event|7
7547066|NCT02901431|11903586|FG010|PK Part|Discontinued per Sponsor|0
7547067|NCT02901431|11903587|FG011|PK Part|Discontinued per Sponsor|0
7547068|NCT02901431|11903588|FG012|PK Part|Discontinued per Sponsor|0
7547069|NCT02901431|11903576|FG000|PK Part|Withdrawal by Subject|1
7267034|NCT00398216|11481297|FG004|Overall Study|Adverse Event|2
7267035|NCT00398216|11481293|FG000|Overall Study|Protocol Violation|2
7267036|NCT00398216|11481294|FG001|Overall Study|Protocol Violation|4
7267037|NCT00398216|11481295|FG002|Overall Study|Protocol Violation|5
7267038|NCT00398216|11481296|FG003|Overall Study|Protocol Violation|7
7267039|NCT00398216|11481297|FG004|Overall Study|Protocol Violation|5
7267040|NCT00398216|11481293|FG000|Overall Study|Lost to Follow-up|1
7267041|NCT00398216|11481294|FG001|Overall Study|Lost to Follow-up|6
7267042|NCT00398216|11481295|FG002|Overall Study|Lost to Follow-up|4
7267043|NCT00398216|11481296|FG003|Overall Study|Lost to Follow-up|4
7267044|NCT00398216|11481297|FG004|Overall Study|Lost to Follow-up|1
7267045|NCT00398216|11481293|FG000|Overall Study|Death|0
7267046|NCT00398216|11481294|FG001|Overall Study|Death|3
7267047|NCT00398216|11481295|FG002|Overall Study|Death|0
7267048|NCT00398216|11481296|FG003|Overall Study|Death|0
7267049|NCT00398216|11481297|FG004|Overall Study|Death|0
7267050|NCT00398216|11481293|FG000|Overall Study|Withdrawal by Subject|1
7267051|NCT00398216|11481294|FG001|Overall Study|Withdrawal by Subject|0
7267052|NCT00398216|11481295|FG002|Overall Study|Withdrawal by Subject|3
7267053|NCT00398216|11481296|FG003|Overall Study|Withdrawal by Subject|1
7267054|NCT00398216|11481297|FG004|Overall Study|Withdrawal by Subject|2
7267055|NCT00398216|11481293|FG000|Overall Study|administrative reasons|3
7267056|NCT00398216|11481294|FG001|Overall Study|administrative reasons|4
7267057|NCT00398216|11481295|FG002|Overall Study|administrative reasons|4
7267058|NCT00398216|11481296|FG003|Overall Study|administrative reasons|3
7267059|NCT00398216|11481297|FG004|Overall Study|administrative reasons|3
7267060|NCT00398216|11481293|FG000|Overall Study|entrance criteria|0
7267061|NCT00398216|11481294|FG001|Overall Study|entrance criteria|0
7267062|NCT00398216|11481295|FG002|Overall Study|entrance criteria|0
7267063|NCT00398216|11481296|FG003|Overall Study|entrance criteria|0
7267064|NCT00398216|11481297|FG004|Overall Study|entrance criteria|2
7267065|NCT00398320|11481309|FG000|Overall Study|Death|1
7267066|NCT00398320|11481309|FG000|Overall Study|Adverse Event|4
7267067|NCT00398320|11481309|FG000|Overall Study|Physician Decision|1
7267068|NCT00398411|11481319|FG000|Overall Study|Death|0
7267069|NCT00398411|11481320|FG001|Overall Study|Death|1
7267070|NCT00398567|11481338|FG000|Overall Study|Disease Progression|3
7267071|NCT00398567|11481339|FG001|Overall Study|Disease Progression|4
7267072|NCT00398567|11481340|FG002|Overall Study|Disease Progression|27
7267073|NCT00398567|11481338|FG000|Overall Study|Withdrawal by Subject|1
7267074|NCT00398567|11481339|FG001|Overall Study|Withdrawal by Subject|0
7267075|NCT00398567|11481340|FG002|Overall Study|Withdrawal by Subject|4
7267076|NCT00398567|11481338|FG000|Overall Study|Adverse Event|0
7267077|NCT00398567|11481339|FG001|Overall Study|Adverse Event|0
7267078|NCT00398567|11481340|FG002|Overall Study|Adverse Event|2
7267079|NCT00398567|11481338|FG000|Overall Study|Protocol Violation|0
7267080|NCT00398567|11481339|FG001|Overall Study|Protocol Violation|0
7267081|NCT00398567|11481340|FG002|Overall Study|Protocol Violation|1
7267082|NCT00398632|11481346|FG000|Overall Study|Withdrawal by Subject|1
7267083|NCT00398632|11481346|FG000|Overall Study|Lack of Efficacy|1
7267084|NCT00398866|11481354|FG000|Overall Study|Adverse Event|1
7267085|NCT00398866|11481355|FG001|Overall Study|Adverse Event|0
7267086|NCT00398866|11481356|FG002|Overall Study|Adverse Event|0
7267087|NCT00398866|11481354|FG000|Overall Study|Lack of Efficacy|0
7267088|NCT00398866|11481355|FG001|Overall Study|Lack of Efficacy|0
7267089|NCT00398866|11481356|FG002|Overall Study|Lack of Efficacy|1
7267090|NCT00398866|11481354|FG000|Overall Study|Lost to Follow-up|7
7267091|NCT00398866|11481355|FG001|Overall Study|Lost to Follow-up|6
7267092|NCT00398866|11481356|FG002|Overall Study|Lost to Follow-up|4
7267093|NCT00398866|11481354|FG000|Overall Study|Withdrawal by Subject|5
7267094|NCT00398866|11481355|FG001|Overall Study|Withdrawal by Subject|1
7267095|NCT00398866|11481356|FG002|Overall Study|Withdrawal by Subject|2
7267096|NCT00398866|11481354|FG000|Overall Study|Unable to complete requirements of study|1
7267097|NCT00398866|11481355|FG001|Overall Study|Unable to complete requirements of study|1
7267098|NCT00398866|11481356|FG002|Overall Study|Unable to complete requirements of study|1
7267099|NCT00399035|11481381|FG000|Overall Study|Death|289
7267100|NCT00399035|11481382|FG001|Overall Study|Death|141
7267101|NCT00399035|11481383|FG002|Overall Study|Death|234
7267102|NCT00399035|11481381|FG000|Overall Study|Lost to Follow-up|2
7267103|NCT00399035|11481382|FG001|Overall Study|Lost to Follow-up|1
7267104|NCT00399035|11481383|FG002|Overall Study|Lost to Follow-up|5
7267105|NCT00399035|11481381|FG000|Overall Study|Withdrawal by Subject|19
7267106|NCT00399035|11481382|FG001|Overall Study|Withdrawal by Subject|15
7267107|NCT00399035|11481383|FG002|Overall Study|Withdrawal by Subject|12
7267108|NCT00399035|11481381|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7267109|NCT00399035|11481382|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
7267110|NCT00399035|11481383|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
7267111|NCT00399035|11481381|FG000|Overall Study|Severe non-compliance with protocol|2
7267112|NCT00399035|11481382|FG001|Overall Study|Severe non-compliance with protocol|1
7267113|NCT00399035|11481383|FG002|Overall Study|Severe non-compliance with protocol|0
7267114|NCT00399360|11481407|FG000|Overall Study|Lost to Follow-up|2
7267115|NCT00399360|11481408|FG001|Overall Study|Lost to Follow-up|1
7267116|NCT00399360|11481409|FG002|Overall Study|Lost to Follow-up|2
7267117|NCT00399360|11481410|FG003|Overall Study|Lost to Follow-up|4
7267118|NCT00399360|11481407|FG000|Overall Study|Adverse Event|0
7267119|NCT00399360|11481408|FG001|Overall Study|Adverse Event|0
7267120|NCT00399360|11481409|FG002|Overall Study|Adverse Event|1
7267121|NCT00399360|11481410|FG003|Overall Study|Adverse Event|0
7267122|NCT00399360|11481407|FG000|Overall Study|Withdrawal by Subject|0
7267123|NCT00399360|11481408|FG001|Overall Study|Withdrawal by Subject|2
7267124|NCT00399360|11481409|FG002|Overall Study|Withdrawal by Subject|0
7267125|NCT00399360|11481410|FG003|Overall Study|Withdrawal by Subject|2
7267126|NCT00399490|11481425|FG000|Overall Study|Adverse Event|19
7267127|NCT00399490|11481425|FG000|Overall Study|Lack of Efficacy|31
7267128|NCT00399490|11481425|FG000|Overall Study|Lost to Follow-up|5
7267129|NCT00399490|11481425|FG000|Overall Study|Withdrawal by Subject|18
7267130|NCT00399490|11481425|FG000|Overall Study|Other|25
7267131|NCT00399516|11481431|FG000|Overall Study|Lost to Follow-up|2
7267132|NCT00399529|11481435|FG000|Overall Study|Off Study Prior to Treatment|2
7267133|NCT00399542|11481442|FG000|Overall Study|Adverse Event|18
7267134|NCT00399542|11481443|FG001|Overall Study|Adverse Event|15
7267135|NCT00399542|11481442|FG000|Overall Study|Protocol Violation|13
7267136|NCT00399542|11481443|FG001|Overall Study|Protocol Violation|3
7267137|NCT00399542|11481442|FG000|Overall Study|Withdrawal by Subject|28
7267138|NCT00399542|11481443|FG001|Overall Study|Withdrawal by Subject|10
7547070|NCT02901431|11903577|FG001|PK Part|Withdrawal by Subject|1
7547071|NCT02901431|11903578|FG002|PK Part|Withdrawal by Subject|3
7547072|NCT02901431|11903579|FG003|PK Part|Withdrawal by Subject|0
7547073|NCT02901431|11903580|FG004|PK Part|Withdrawal by Subject|0
7547074|NCT02901431|11903581|FG005|PK Part|Withdrawal by Subject|0
7547075|NCT02901431|11903582|FG006|PK Part|Withdrawal by Subject|0
7547076|NCT02901431|11903583|FG007|PK Part|Withdrawal by Subject|0
7547077|NCT02901431|11903584|FG008|PK Part|Withdrawal by Subject|0
7547078|NCT02901431|11903585|FG009|PK Part|Withdrawal by Subject|0
7547079|NCT02901431|11903586|FG010|PK Part|Withdrawal by Subject|0
7547080|NCT02901431|11903587|FG011|PK Part|Withdrawal by Subject|0
7547081|NCT02901431|11903588|FG012|PK Part|Withdrawal by Subject|0
7547082|NCT02901431|11903576|FG000|Main Treatment Part|Adverse Event|0
7547083|NCT02901431|11903577|FG001|Main Treatment Part|Adverse Event|0
7547084|NCT02901431|11903578|FG002|Main Treatment Part|Adverse Event|0
7547085|NCT02901431|11903579|FG003|Main Treatment Part|Adverse Event|3
7547086|NCT02901431|11903580|FG004|Main Treatment Part|Adverse Event|3
7547087|NCT02901431|11903581|FG005|Main Treatment Part|Adverse Event|4
7547088|NCT02901431|11903582|FG006|Main Treatment Part|Adverse Event|1
7547089|NCT02901431|11903583|FG007|Main Treatment Part|Adverse Event|0
7547090|NCT02901431|11903584|FG008|Main Treatment Part|Adverse Event|0
7547091|NCT02901431|11903585|FG009|Main Treatment Part|Adverse Event|0
7547092|NCT02901431|11903586|FG010|Main Treatment Part|Adverse Event|0
7547093|NCT02901431|11903587|FG011|Main Treatment Part|Adverse Event|0
7547094|NCT02901431|11903588|FG012|Main Treatment Part|Adverse Event|0
7547095|NCT02901431|11903576|FG000|Main Treatment Part|Lack of Efficacy|0
7547096|NCT02901431|11903577|FG001|Main Treatment Part|Lack of Efficacy|0
7547097|NCT02901431|11903578|FG002|Main Treatment Part|Lack of Efficacy|0
7547098|NCT02901431|11903579|FG003|Main Treatment Part|Lack of Efficacy|1
7547099|NCT02901431|11903580|FG004|Main Treatment Part|Lack of Efficacy|0
7547100|NCT02901431|11903581|FG005|Main Treatment Part|Lack of Efficacy|0
7547101|NCT02901431|11903582|FG006|Main Treatment Part|Lack of Efficacy|0
7547102|NCT02901431|11903583|FG007|Main Treatment Part|Lack of Efficacy|0
7547103|NCT02901431|11903584|FG008|Main Treatment Part|Lack of Efficacy|0
7547104|NCT02901431|11903585|FG009|Main Treatment Part|Lack of Efficacy|0
7547105|NCT02901431|11903586|FG010|Main Treatment Part|Lack of Efficacy|0
7547106|NCT02901431|11903587|FG011|Main Treatment Part|Lack of Efficacy|0
7547107|NCT02901431|11903588|FG012|Main Treatment Part|Lack of Efficacy|0
7547108|NCT02901431|11903576|FG000|Main Treatment Part|Lost to Follow-up|0
7547109|NCT02901431|11903577|FG001|Main Treatment Part|Lost to Follow-up|0
7547110|NCT02901431|11903578|FG002|Main Treatment Part|Lost to Follow-up|0
7547111|NCT02901431|11903579|FG003|Main Treatment Part|Lost to Follow-up|3
7547112|NCT02901431|11903580|FG004|Main Treatment Part|Lost to Follow-up|1
7547113|NCT02901431|11903581|FG005|Main Treatment Part|Lost to Follow-up|2
7547114|NCT02901431|11903582|FG006|Main Treatment Part|Lost to Follow-up|3
7267139|NCT00399542|11481442|FG000|Overall Study|Lack of Efficacy|18
7267140|NCT00399542|11481443|FG001|Overall Study|Lack of Efficacy|8
7547115|NCT02901431|11903583|FG007|Main Treatment Part|Lost to Follow-up|0
7547116|NCT02901431|11903584|FG008|Main Treatment Part|Lost to Follow-up|0
7547117|NCT02901431|11903585|FG009|Main Treatment Part|Lost to Follow-up|0
7547118|NCT02901431|11903586|FG010|Main Treatment Part|Lost to Follow-up|0
7547119|NCT02901431|11903587|FG011|Main Treatment Part|Lost to Follow-up|0
7267141|NCT00399542|11481442|FG000|Overall Study|Lost to Follow-up|6
7547120|NCT02901431|11903588|FG012|Main Treatment Part|Lost to Follow-up|0
7547121|NCT02901431|11903576|FG000|Main Treatment Part|Withdrawal by Caregiver|0
7547122|NCT02901431|11903577|FG001|Main Treatment Part|Withdrawal by Caregiver|0
7547123|NCT02901431|11903578|FG002|Main Treatment Part|Withdrawal by Caregiver|0
7267142|NCT00399542|11481443|FG001|Overall Study|Lost to Follow-up|6
7267143|NCT00399542|11481442|FG000|Overall Study|Other|1
7267144|NCT00399542|11481443|FG001|Overall Study|Other|0
7267145|NCT00399542|11481442|FG000|Overall Study|Physician Decision|0
7267146|NCT00399542|11481443|FG001|Overall Study|Physician Decision|1
7267147|NCT00399568|11481451|FG000|Overall Study|Adverse Event|1
7267148|NCT00399568|11481452|FG001|Overall Study|Adverse Event|2
7267149|NCT00399568|11481451|FG000|Overall Study|Withdrawal by Subject|7
7267150|NCT00399568|11481452|FG001|Overall Study|Withdrawal by Subject|3
7267151|NCT00399568|11481451|FG000|Overall Study|Protocol non-compliance|2
7267152|NCT00399568|11481452|FG001|Overall Study|Protocol non-compliance|2
7267153|NCT00399568|11481451|FG000|Overall Study|Lost to Follow-up|2
7267154|NCT00399568|11481452|FG001|Overall Study|Lost to Follow-up|2
7267155|NCT00399763|11481462|FG000|Overall Study|Lost to Follow-up|2
7267156|NCT00399763|11481463|FG001|Overall Study|Lost to Follow-up|3
7267157|NCT00399802|11481471|FG000|Overall Study|Adverse Event|0
7267158|NCT00399802|11481472|FG001|Overall Study|Adverse Event|2
7267159|NCT00399802|11481471|FG000|Overall Study|Participant discontinued by mistake|0
7267160|NCT00399802|11481472|FG001|Overall Study|Participant discontinued by mistake|1
7267161|NCT00399893|11481489|FG000|Overall Study|Withdrawal by Subject|1
7267162|NCT00399893|11481490|FG001|Overall Study|Withdrawal by Subject|0
7267163|NCT00400153|11481499|FG000|Overall Study|AE due to study disease worsening|14
7267164|NCT00400153|11481500|FG001|Overall Study|AE due to study disease worsening|19
7267165|NCT00400153|11481501|FG002|Overall Study|AE due to study disease worsening|20
7267166|NCT00400153|11481499|FG000|Overall Study|AE due to other disease worsening|2
7267167|NCT00400153|11481500|FG001|Overall Study|AE due to other disease worsening|1
7267168|NCT00400153|11481501|FG002|Overall Study|AE due to other disease worsening|0
7267169|NCT00400153|11481499|FG000|Overall Study|AE due to other condition|3
7267170|NCT00400153|11481500|FG001|Overall Study|AE due to other condition|14
7267171|NCT00400153|11481501|FG002|Overall Study|AE due to other condition|15
7267172|NCT00400153|11481499|FG000|Overall Study|Protocol Violation|7
7267173|NCT00400153|11481500|FG001|Overall Study|Protocol Violation|4
7267174|NCT00400153|11481501|FG002|Overall Study|Protocol Violation|9
7267175|NCT00400153|11481499|FG000|Overall Study|Lost to Follow-up|2
7267176|NCT00400153|11481500|FG001|Overall Study|Lost to Follow-up|1
7267177|NCT00400153|11481501|FG002|Overall Study|Lost to Follow-up|4
7267178|NCT00400153|11481499|FG000|Overall Study|Withdrawal by Subject|12
7267179|NCT00400153|11481500|FG001|Overall Study|Withdrawal by Subject|11
7267180|NCT00400153|11481501|FG002|Overall Study|Withdrawal by Subject|10
7267181|NCT00400153|11481499|FG000|Overall Study|Other reasons - not mentioned above|8
7267182|NCT00400153|11481500|FG001|Overall Study|Other reasons - not mentioned above|5
7267183|NCT00400153|11481501|FG002|Overall Study|Other reasons - not mentioned above|3
7267184|NCT00400179|11481516|FG000|Overall Study|Adverse Event|2
7267185|NCT00400179|11481517|FG001|Overall Study|Adverse Event|2
7267186|NCT00400179|11481516|FG000|Overall Study|Death|1
7267187|NCT00400179|11481517|FG001|Overall Study|Death|2
7267188|NCT00400179|11481516|FG000|Overall Study|Withdrew Consent|1
7267189|NCT00400179|11481517|FG001|Overall Study|Withdrew Consent|5
7267190|NCT00400179|11481516|FG000|Overall Study|Disease progression|1
7267191|NCT00400179|11481517|FG001|Overall Study|Disease progression|1
7267192|NCT00400179|11481516|FG000|Overall Study|Intercurrent illness|0
7267193|NCT00400179|11481517|FG001|Overall Study|Intercurrent illness|1
7267194|NCT00400179|11481516|FG000|Overall Study|Investigator judgment|0
7267195|NCT00400179|11481517|FG001|Overall Study|Investigator judgment|1
7267196|NCT00400179|11481516|FG000|Overall Study|Randomization error/patient ineligible|1
7267197|NCT00400179|11481517|FG001|Overall Study|Randomization error/patient ineligible|6
7267198|NCT00400400|11481530|FG000|Overall Study|Adverse Event|9
7267199|NCT00400400|11481531|FG001|Overall Study|Adverse Event|8
7267200|NCT00400400|11481530|FG000|Overall Study|Protocol Violation|2
7267201|NCT00400400|11481531|FG001|Overall Study|Protocol Violation|0
7267202|NCT00400400|11481530|FG000|Overall Study|Withdrawal by Subject|1
7267203|NCT00400400|11481531|FG001|Overall Study|Withdrawal by Subject|3
7267204|NCT00400400|11481530|FG000|Overall Study|Administrative Problem|1
7547124|NCT02901431|11903579|FG003|Main Treatment Part|Withdrawal by Caregiver|0
7547125|NCT02901431|11903580|FG004|Main Treatment Part|Withdrawal by Caregiver|0
7547126|NCT02901431|11903581|FG005|Main Treatment Part|Withdrawal by Caregiver|1
7547127|NCT02901431|11903582|FG006|Main Treatment Part|Withdrawal by Caregiver|0
7547128|NCT02901431|11903583|FG007|Main Treatment Part|Withdrawal by Caregiver|0
7547129|NCT02901431|11903584|FG008|Main Treatment Part|Withdrawal by Caregiver|0
7547130|NCT02901431|11903585|FG009|Main Treatment Part|Withdrawal by Caregiver|0
7547131|NCT02901431|11903586|FG010|Main Treatment Part|Withdrawal by Caregiver|0
7547132|NCT02901431|11903587|FG011|Main Treatment Part|Withdrawal by Caregiver|0
7547133|NCT02901431|11903588|FG012|Main Treatment Part|Withdrawal by Caregiver|0
7547134|NCT02901431|11903576|FG000|Main Treatment Part|Physician Decision|0
7547135|NCT02901431|11903577|FG001|Main Treatment Part|Physician Decision|0
7547136|NCT02901431|11903578|FG002|Main Treatment Part|Physician Decision|0
7547137|NCT02901431|11903579|FG003|Main Treatment Part|Physician Decision|1
7547138|NCT02901431|11903580|FG004|Main Treatment Part|Physician Decision|0
7547139|NCT02901431|11903581|FG005|Main Treatment Part|Physician Decision|0
7547140|NCT02901431|11903582|FG006|Main Treatment Part|Physician Decision|1
7267205|NCT00400400|11481531|FG001|Overall Study|Administrative Problem|0
7267206|NCT00400400|11481530|FG000|Overall Study|Lost to Follow-up|0
7267207|NCT00400400|11481531|FG001|Overall Study|Lost to Follow-up|1
7267208|NCT00400400|11481530|FG000|Overall Study|Did not receive study drug|1
7267209|NCT00400400|11481531|FG001|Overall Study|Did not receive study drug|3
7267210|NCT00400517|11481546|FG000|Overall Study|Withdrawal by Subject|1
7267211|NCT00400517|11481546|FG000|Overall Study|Physician Decision|1
7267212|NCT00400569|11481550|FG000|Overall Study|Death|1
7267213|NCT00400712|11481572|FG000|Overall Study|Death|1
7267214|NCT00400712|11481573|FG001|Overall Study|Death|0
7267215|NCT00400712|11481572|FG000|Overall Study|Withdrawal by Subject|11
7267216|NCT00400712|11481573|FG001|Overall Study|Withdrawal by Subject|12
7267217|NCT00400712|11481572|FG000|Overall Study|Physician Decision|5
7547141|NCT02901431|11903583|FG007|Main Treatment Part|Physician Decision|0
7547142|NCT02901431|11903584|FG008|Main Treatment Part|Physician Decision|0
7547143|NCT02901431|11903585|FG009|Main Treatment Part|Physician Decision|0
7547144|NCT02901431|11903586|FG010|Main Treatment Part|Physician Decision|0
7547145|NCT02901431|11903587|FG011|Main Treatment Part|Physician Decision|0
7547146|NCT02901431|11903588|FG012|Main Treatment Part|Physician Decision|0
7547147|NCT02901431|11903576|FG000|Main Treatment Part|Withdrawal by Subject|0
7547148|NCT02901431|11903577|FG001|Main Treatment Part|Withdrawal by Subject|0
7547149|NCT02901431|11903578|FG002|Main Treatment Part|Withdrawal by Subject|0
7547150|NCT02901431|11903579|FG003|Main Treatment Part|Withdrawal by Subject|18
7547151|NCT02901431|11903580|FG004|Main Treatment Part|Withdrawal by Subject|3
7547152|NCT02901431|11903581|FG005|Main Treatment Part|Withdrawal by Subject|5
7547153|NCT02901431|11903582|FG006|Main Treatment Part|Withdrawal by Subject|6
7547154|NCT02901431|11903583|FG007|Main Treatment Part|Withdrawal by Subject|0
7547155|NCT02901431|11903584|FG008|Main Treatment Part|Withdrawal by Subject|0
7547156|NCT02901431|11903585|FG009|Main Treatment Part|Withdrawal by Subject|0
7547157|NCT02901431|11903586|FG010|Main Treatment Part|Withdrawal by Subject|0
7547158|NCT02901431|11903587|FG011|Main Treatment Part|Withdrawal by Subject|0
7547159|NCT02901431|11903588|FG012|Main Treatment Part|Withdrawal by Subject|0
7547160|NCT02901431|11903576|FG000|Open Label Part|Adverse Event|0
7547161|NCT02901431|11903577|FG001|Open Label Part|Adverse Event|0
7547162|NCT02901431|11903578|FG002|Open Label Part|Adverse Event|0
7547163|NCT02901431|11903579|FG003|Open Label Part|Adverse Event|0
7547164|NCT02901431|11903580|FG004|Open Label Part|Adverse Event|0
7547165|NCT02901431|11903581|FG005|Open Label Part|Adverse Event|0
7547166|NCT02901431|11903582|FG006|Open Label Part|Adverse Event|0
7547167|NCT02901431|11903583|FG007|Open Label Part|Adverse Event|0
7547168|NCT02901431|11903584|FG008|Open Label Part|Adverse Event|4
7547169|NCT02901431|11903585|FG009|Open Label Part|Adverse Event|4
7547170|NCT02901431|11903586|FG010|Open Label Part|Adverse Event|0
7547171|NCT02901431|11903587|FG011|Open Label Part|Adverse Event|4
7547172|NCT02901431|11903588|FG012|Open Label Part|Adverse Event|1
7547173|NCT02901431|11903576|FG000|Open Label Part|Lost to Follow-up|0
7547174|NCT02901431|11903577|FG001|Open Label Part|Lost to Follow-up|0
7547175|NCT02901431|11903578|FG002|Open Label Part|Lost to Follow-up|0
7547176|NCT02901431|11903579|FG003|Open Label Part|Lost to Follow-up|0
7547177|NCT02901431|11903580|FG004|Open Label Part|Lost to Follow-up|0
7547178|NCT02901431|11903581|FG005|Open Label Part|Lost to Follow-up|0
7547179|NCT02901431|11903582|FG006|Open Label Part|Lost to Follow-up|0
7547180|NCT02901431|11903583|FG007|Open Label Part|Lost to Follow-up|0
7547181|NCT02901431|11903584|FG008|Open Label Part|Lost to Follow-up|2
7267218|NCT00400712|11481573|FG001|Overall Study|Physician Decision|4
7547182|NCT02901431|11903585|FG009|Open Label Part|Lost to Follow-up|2
7547183|NCT02901431|11903586|FG010|Open Label Part|Lost to Follow-up|1
7547184|NCT02901431|11903587|FG011|Open Label Part|Lost to Follow-up|1
7547185|NCT02901431|11903588|FG012|Open Label Part|Lost to Follow-up|1
7547186|NCT02901431|11903576|FG000|Open Label Part|Physician Decision|0
7547187|NCT02901431|11903577|FG001|Open Label Part|Physician Decision|0
7547188|NCT02901431|11903578|FG002|Open Label Part|Physician Decision|0
7547189|NCT02901431|11903579|FG003|Open Label Part|Physician Decision|0
7547190|NCT02901431|11903580|FG004|Open Label Part|Physician Decision|0
7547191|NCT02901431|11903581|FG005|Open Label Part|Physician Decision|0
7547192|NCT02901431|11903582|FG006|Open Label Part|Physician Decision|0
7547193|NCT02901431|11903583|FG007|Open Label Part|Physician Decision|0
7547194|NCT02901431|11903584|FG008|Open Label Part|Physician Decision|1
7547195|NCT02901431|11903585|FG009|Open Label Part|Physician Decision|1
7267219|NCT00400764|11481586|FG000|Phase Ib|Adverse Event|1
7267220|NCT00400764|11481587|FG001|Phase Ib|Adverse Event|0
7267221|NCT00400764|11481588|FG002|Phase Ib|Adverse Event|0
7267222|NCT00400764|11481589|FG003|Phase Ib|Adverse Event|0
7267223|NCT00400764|11481590|FG004|Phase Ib|Adverse Event|0
7267224|NCT00400764|11481586|FG000|Phase Ib|Death|1
7267225|NCT00400764|11481587|FG001|Phase Ib|Death|0
7267226|NCT00400764|11481588|FG002|Phase Ib|Death|0
7267227|NCT00400764|11481589|FG003|Phase Ib|Death|0
7267228|NCT00400764|11481590|FG004|Phase Ib|Death|0
7267229|NCT00400764|11481586|FG000|Phase Ib|Disease Progression|4
7267230|NCT00400764|11481587|FG001|Phase Ib|Disease Progression|4
7547196|NCT02901431|11903586|FG010|Open Label Part|Physician Decision|0
7547197|NCT02901431|11903587|FG011|Open Label Part|Physician Decision|0
7547198|NCT02901431|11903588|FG012|Open Label Part|Physician Decision|0
7267231|NCT00400764|11481588|FG002|Phase Ib|Disease Progression|0
7267232|NCT00400764|11481589|FG003|Phase Ib|Disease Progression|0
7267233|NCT00400764|11481590|FG004|Phase Ib|Disease Progression|0
7547199|NCT02901431|11903576|FG000|Open Label Part|Study Terminated By Sponsor|0
7547200|NCT02901431|11903577|FG001|Open Label Part|Study Terminated By Sponsor|0
7547201|NCT02901431|11903578|FG002|Open Label Part|Study Terminated By Sponsor|0
7267234|NCT00400764|11481586|FG000|Phase II|Death|0
7267235|NCT00400764|11481587|FG001|Phase II|Death|0
7267236|NCT00400764|11481588|FG002|Phase II|Death|1
7267237|NCT00400764|11481589|FG003|Phase II|Death|2
7267238|NCT00400764|11481590|FG004|Phase II|Death|0
7267239|NCT00400764|11481586|FG000|Phase II|Lost to Follow-up|0
7267240|NCT00400764|11481587|FG001|Phase II|Lost to Follow-up|0
7267241|NCT00400764|11481588|FG002|Phase II|Lost to Follow-up|1
7267242|NCT00400764|11481589|FG003|Phase II|Lost to Follow-up|0
7267243|NCT00400764|11481590|FG004|Phase II|Lost to Follow-up|0
7267244|NCT00400764|11481586|FG000|Phase II|Physician Decision|0
7267245|NCT00400764|11481587|FG001|Phase II|Physician Decision|0
7267246|NCT00400764|11481588|FG002|Phase II|Physician Decision|1
7267247|NCT00400764|11481589|FG003|Phase II|Physician Decision|1
7267248|NCT00400764|11481590|FG004|Phase II|Physician Decision|0
7267249|NCT00400764|11481586|FG000|Phase II|Sponsor's decision to terminate|0
7267250|NCT00400764|11481587|FG001|Phase II|Sponsor's decision to terminate|0
7267251|NCT00400764|11481588|FG002|Phase II|Sponsor's decision to terminate|18
7267252|NCT00400764|11481589|FG003|Phase II|Sponsor's decision to terminate|22
7267253|NCT00400764|11481590|FG004|Phase II|Sponsor's decision to terminate|11
7267254|NCT00400764|11481586|FG000|Phase II|Patient began new, non-protocol, therapy|0
7267255|NCT00400764|11481587|FG001|Phase II|Patient began new, non-protocol, therapy|0
7267256|NCT00400764|11481588|FG002|Phase II|Patient began new, non-protocol, therapy|1
7267257|NCT00400764|11481589|FG003|Phase II|Patient began new, non-protocol, therapy|0
7267258|NCT00400764|11481590|FG004|Phase II|Patient began new, non-protocol, therapy|0
7267259|NCT00400764|11481586|FG000|Phase II|Withdrawal by Subject|0
7267260|NCT00400764|11481587|FG001|Phase II|Withdrawal by Subject|0
7547202|NCT02901431|11903579|FG003|Open Label Part|Study Terminated By Sponsor|0
7547203|NCT02901431|11903580|FG004|Open Label Part|Study Terminated By Sponsor|0
7547204|NCT02901431|11903581|FG005|Open Label Part|Study Terminated By Sponsor|0
7547205|NCT02901431|11903582|FG006|Open Label Part|Study Terminated By Sponsor|0
7547206|NCT02901431|11903583|FG007|Open Label Part|Study Terminated By Sponsor|0
7547207|NCT02901431|11903584|FG008|Open Label Part|Study Terminated By Sponsor|35
7547208|NCT02901431|11903585|FG009|Open Label Part|Study Terminated By Sponsor|12
7547209|NCT02901431|11903586|FG010|Open Label Part|Study Terminated By Sponsor|21
7547210|NCT02901431|11903587|FG011|Open Label Part|Study Terminated By Sponsor|31
7547211|NCT02901431|11903588|FG012|Open Label Part|Study Terminated By Sponsor|0
7547212|NCT02901431|11903576|FG000|Open Label Part|Withdrawal by Subject|0
7547213|NCT02901431|11903577|FG001|Open Label Part|Withdrawal by Subject|0
7547214|NCT02901431|11903578|FG002|Open Label Part|Withdrawal by Subject|0
7547215|NCT02901431|11903579|FG003|Open Label Part|Withdrawal by Subject|0
7547216|NCT02901431|11903580|FG004|Open Label Part|Withdrawal by Subject|0
7547217|NCT02901431|11903581|FG005|Open Label Part|Withdrawal by Subject|0
7547218|NCT02901431|11903582|FG006|Open Label Part|Withdrawal by Subject|0
7547219|NCT02901431|11903583|FG007|Open Label Part|Withdrawal by Subject|0
7547220|NCT02901431|11903584|FG008|Open Label Part|Withdrawal by Subject|6
7547221|NCT02901431|11903585|FG009|Open Label Part|Withdrawal by Subject|5
7547222|NCT02901431|11903586|FG010|Open Label Part|Withdrawal by Subject|7
7547223|NCT02901431|11903587|FG011|Open Label Part|Withdrawal by Subject|3
7547224|NCT02901431|11903588|FG012|Open Label Part|Withdrawal by Subject|1
7547225|NCT02902809|11903672|FG000|Overall Study|Discontinuation of asthma program|28
7547226|NCT02902965|11903684|FG000|Overall Study|Withdrawal by Subject|10
7547227|NCT02903030|11903691|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
7547228|NCT02903030|11903692|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
7547229|NCT02903238|11903710|FG000|Overall Study|Lost to Follow-up|4
7547230|NCT02903368|11903717|FG000|Overall Study|Not sprcified|4
7547231|NCT02903368|11903718|FG001|Overall Study|Not sprcified|0
7547232|NCT02903420|11903746|FG000|Overall Study|Death|3
7547233|NCT02903511|11903761|FG000|Overall Study|Withdrawal by Subject|1
7547234|NCT02903511|11903762|FG001|Overall Study|Withdrawal by Subject|0
7547235|NCT02903511|11903761|FG000|Overall Study|Lost to Follow-up|3
7547236|NCT02903511|11903762|FG001|Overall Study|Lost to Follow-up|2
7547237|NCT02903966|11903783|FG000|Part A (Day 1 to 43)|Adverse Event|1
7547238|NCT02903966|11903784|FG001|Part A (Day 1 to 43)|Adverse Event|0
7547239|NCT02903966|11903783|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
7547240|NCT02903966|11903784|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
7547241|NCT02903966|11903783|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
7547242|NCT02903966|11903784|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
7577330|NCT04014062|11966908|FG000|Period I: Dosing|Withdrawal by Subject|3
7577331|NCT04014062|11966909|FG001|Period I: Dosing|Withdrawal by Subject|1
7577332|NCT04013191|11966946|FG000|Overall Study|Adverse Event|1
7577333|NCT04013191|11966947|FG001|Overall Study|Adverse Event|0
7577334|NCT04011735|11966964|FG000|Overall Study|Withdrawal by Subject|1
7577335|NCT04011735|11966965|FG001|Overall Study|Withdrawal by Subject|0
7577336|NCT04011735|11966966|FG002|Overall Study|Withdrawal by Subject|1
7577337|NCT04011735|11966964|FG000|Overall Study|Met exclusion criteria after study entry|0
7577338|NCT04011735|11966965|FG001|Overall Study|Met exclusion criteria after study entry|1
7577339|NCT04011735|11966966|FG002|Overall Study|Met exclusion criteria after study entry|0
7577340|NCT04009577|11966980|FG000|Core Study|Adverse Event|1
7577341|NCT04009577|11966981|FG001|Core Study|Adverse Event|0
7267261|NCT00400764|11481588|FG002|Phase II|Withdrawal by Subject|1
7577342|NCT04009577|11966982|FG002|Core Study|Adverse Event|2
7267262|NCT00400764|11481589|FG003|Phase II|Withdrawal by Subject|1
7267263|NCT00400764|11481590|FG004|Phase II|Withdrawal by Subject|0
7267264|NCT00400985|11481629|FG000|Overall Study|Withdrawal by Subject|5
7267265|NCT00400985|11481629|FG000|Overall Study|system modification|8
7267266|NCT00400985|11481629|FG000|Overall Study|Death|30
7267267|NCT00400985|11481629|FG000|Overall Study|Lost to Follow-up|9
7267268|NCT00401193|11481640|FG000|Overall Study|Adverse Event|1
7267269|NCT00401193|11481641|FG001|Overall Study|Adverse Event|3
7267270|NCT00401193|11481642|FG002|Overall Study|Adverse Event|1
7267271|NCT00401193|11481640|FG000|Overall Study|Protocol Violation|3
7267272|NCT00401193|11481641|FG001|Overall Study|Protocol Violation|1
7267273|NCT00401193|11481642|FG002|Overall Study|Protocol Violation|1
7267274|NCT00401193|11481640|FG000|Overall Study|Lost to Follow-up|6
7267275|NCT00401193|11481641|FG001|Overall Study|Lost to Follow-up|5
7267276|NCT00401193|11481642|FG002|Overall Study|Lost to Follow-up|1
7577343|NCT04009577|11966983|FG003|Core Study|Adverse Event|4
7577344|NCT04009577|11966980|FG000|Core Study|Withdrawal by Subject|0
7577345|NCT04009577|11966981|FG001|Core Study|Withdrawal by Subject|0
7577346|NCT04009577|11966982|FG002|Core Study|Withdrawal by Subject|2
7577347|NCT04009577|11966983|FG003|Core Study|Withdrawal by Subject|0
7577348|NCT04009577|11966980|FG000|Core Study|Other|0
7577349|NCT04009577|11966981|FG001|Core Study|Other|0
7577350|NCT04009577|11966982|FG002|Core Study|Other|0
7577351|NCT04009577|11966983|FG003|Core Study|Other|1
7577352|NCT04009577|11966980|FG000|Extension Phase|Adverse Event|0
7577353|NCT04009577|11966981|FG001|Extension Phase|Adverse Event|0
7577354|NCT04009577|11966982|FG002|Extension Phase|Adverse Event|0
7577355|NCT04009577|11966983|FG003|Extension Phase|Adverse Event|1
7577356|NCT04009577|11966980|FG000|Extension Phase|Inadequate therapeutic effect|0
7577357|NCT04009577|11966981|FG001|Extension Phase|Inadequate therapeutic effect|0
7577358|NCT04009577|11966982|FG002|Extension Phase|Inadequate therapeutic effect|1
7577359|NCT04009577|11966983|FG003|Extension Phase|Inadequate therapeutic effect|0
7577360|NCT04009577|11966980|FG000|Extension Phase|Withdrawal by Subject|0
7577361|NCT04009577|11966981|FG001|Extension Phase|Withdrawal by Subject|0
7577362|NCT04009577|11966982|FG002|Extension Phase|Withdrawal by Subject|1
7577363|NCT04009577|11966983|FG003|Extension Phase|Withdrawal by Subject|0
7577364|NCT04009577|11966980|FG000|Extension Phase|Not Treated|0
7577365|NCT04009577|11966981|FG001|Extension Phase|Not Treated|0
7577366|NCT04009577|11966982|FG002|Extension Phase|Not Treated|2
7267277|NCT00401193|11481640|FG000|Overall Study|Withdrawal by Subject|2
7267278|NCT00401193|11481641|FG001|Overall Study|Withdrawal by Subject|0
7267279|NCT00401193|11481642|FG002|Overall Study|Withdrawal by Subject|1
7267280|NCT00401193|11481640|FG000|Overall Study|Other Event|3
7267281|NCT00401193|11481641|FG001|Overall Study|Other Event|2
7267282|NCT00401193|11481642|FG002|Overall Study|Other Event|2
7267283|NCT00401245|11481655|FG000|Double Blind Titration Phase|Adverse Event|3
7267284|NCT00401245|11481656|FG001|Double Blind Titration Phase|Adverse Event|2
7547243|NCT02904096|11903807|FG000|Overall Study|Adverse Event|1
7547244|NCT02904096|11903808|FG001|Overall Study|Adverse Event|0
7547245|NCT02904096|11903807|FG000|Overall Study|Withdrawal by Subject|4
7547246|NCT02904096|11903808|FG001|Overall Study|Withdrawal by Subject|3
7547247|NCT02904096|11903807|FG000|Overall Study|Lost to Follow-up|10
7547248|NCT02904096|11903808|FG001|Overall Study|Lost to Follow-up|17
7547249|NCT02904096|11903807|FG000|Overall Study|Non-compliant|3
7547250|NCT02904096|11903808|FG001|Overall Study|Non-compliant|1
7547251|NCT02904096|11903807|FG000|Overall Study|Sponsor instructed|1
7577367|NCT04009577|11966983|FG003|Extension Phase|Not Treated|0
7577368|NCT04007159|11967009|FG000|Induction Phase|(missed study visits)|16
7547252|NCT02904096|11903808|FG001|Overall Study|Sponsor instructed|0
7547253|NCT02904200|11903814|FG000|Overall Study|Withdrawal by Subject|1
7547254|NCT02904200|11903815|FG001|Overall Study|Withdrawal by Subject|0
7547255|NCT02904265|11903852|FG000|Overall Study|Physician Decision|1
7547256|NCT02904265|11903853|FG001|Overall Study|Physician Decision|2
7547257|NCT02904512|11903861|FG000|Overall Study|Withdrawal by Subject|1
7547258|NCT02904512|11903862|FG001|Overall Study|Withdrawal by Subject|0
7547259|NCT02904512|11903861|FG000|Overall Study|Transferred to ICU|1
7547260|NCT02904512|11903862|FG001|Overall Study|Transferred to ICU|0
7547261|NCT02904512|11903861|FG000|Overall Study|Minor Bleeding at site of device insertion|1
7577369|NCT04007159|11967009|FG000|Induction Phase|Withdrawal by Subject|4
7577370|NCT04007159|11967009|FG000|Induction Phase|Adverse Event|2
7577371|NCT04007159|11967009|FG000|Challenge Phase|missed study visits|3
7577372|NCT04007107|11967020|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7577373|NCT04007107|11967021|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
7577374|NCT04007107|11967022|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7577375|NCT04007107|11967023|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
7577376|NCT04005885|11967039|FG000|First Intervention|Withdrawal by Subject|1
7577377|NCT04005885|11967040|FG001|First Intervention|Withdrawal by Subject|1
7577378|NCT04005885|11967039|FG000|Second Intervention|Withdrawal by Subject|0
7547262|NCT02904512|11903862|FG001|Overall Study|Minor Bleeding at site of device insertion|0
7547263|NCT02904902|11903868|FG000|Overall Study|Withdrawal by Subject|1
7267285|NCT00401245|11481657|FG002|Double Blind Titration Phase|Adverse Event|5
7267286|NCT00401245|11481658|FG003|Double Blind Titration Phase|Adverse Event|12
7267287|NCT00401245|11481659|FG004|Double Blind Titration Phase|Adverse Event|0
7267288|NCT00401245|11481660|FG005|Double Blind Titration Phase|Adverse Event|0
7577379|NCT04005885|11967040|FG001|Second Intervention|Withdrawal by Subject|2
7577380|NCT04000815|11967054|FG000|Overall Study|Lost to Follow-up|9
7577381|NCT04000815|11967055|FG001|Overall Study|Lost to Follow-up|2
7577382|NCT04000815|11967056|FG002|Overall Study|Lost to Follow-up|3
7577383|NCT04000815|11967054|FG000|Overall Study|Withdrawal by Subject|4
7577384|NCT04000815|11967055|FG001|Overall Study|Withdrawal by Subject|3
7267289|NCT00401245|11481661|FG006|Double Blind Titration Phase|Adverse Event|0
7267290|NCT00401245|11481662|FG007|Double Blind Titration Phase|Adverse Event|0
7267291|NCT00401245|11481655|FG000|Double Blind Titration Phase|Other|0
7267292|NCT00401245|11481656|FG001|Double Blind Titration Phase|Other|0
7267293|NCT00401245|11481657|FG002|Double Blind Titration Phase|Other|1
7267294|NCT00401245|11481658|FG003|Double Blind Titration Phase|Other|0
7267295|NCT00401245|11481659|FG004|Double Blind Titration Phase|Other|0
7267296|NCT00401245|11481660|FG005|Double Blind Titration Phase|Other|0
7267297|NCT00401245|11481661|FG006|Double Blind Titration Phase|Other|0
7267298|NCT00401245|11481662|FG007|Double Blind Titration Phase|Other|0
7267299|NCT00401245|11481655|FG000|Double Blind Titration Phase|Protocol Violation|0
7267300|NCT00401245|11481656|FG001|Double Blind Titration Phase|Protocol Violation|0
7267301|NCT00401245|11481657|FG002|Double Blind Titration Phase|Protocol Violation|0
7267302|NCT00401245|11481658|FG003|Double Blind Titration Phase|Protocol Violation|1
7267303|NCT00401245|11481659|FG004|Double Blind Titration Phase|Protocol Violation|0
7267304|NCT00401245|11481660|FG005|Double Blind Titration Phase|Protocol Violation|0
7267305|NCT00401245|11481661|FG006|Double Blind Titration Phase|Protocol Violation|0
7577385|NCT04000815|11967056|FG002|Overall Study|Withdrawal by Subject|2
7577386|NCT04000815|11967054|FG000|Overall Study|Right ovarian cyst occured|1
7267306|NCT00401245|11481662|FG007|Double Blind Titration Phase|Protocol Violation|0
7267307|NCT00401245|11481655|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
7267308|NCT00401245|11481656|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
7267309|NCT00401245|11481657|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
7267310|NCT00401245|11481658|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
7267311|NCT00401245|11481659|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
7267312|NCT00401245|11481660|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
7267313|NCT00401245|11481661|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
7267314|NCT00401245|11481662|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
7267315|NCT00401245|11481655|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267316|NCT00401245|11481656|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
7267317|NCT00401245|11481657|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267318|NCT00401245|11481658|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
7267319|NCT00401245|11481659|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267320|NCT00401245|11481660|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267321|NCT00401245|11481661|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267322|NCT00401245|11481662|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
7267323|NCT00401245|11481655|FG000|Open Label Phase|Adverse Event|5
7267324|NCT00401245|11481656|FG001|Open Label Phase|Adverse Event|14
7577387|NCT04000815|11967055|FG001|Overall Study|Right ovarian cyst occured|0
7577388|NCT04000815|11967056|FG002|Overall Study|Right ovarian cyst occured|0
7577389|NCT04000815|11967054|FG000|Overall Study|Hypertension occured on follow up|0
7577390|NCT04000815|11967055|FG001|Overall Study|Hypertension occured on follow up|0
7577391|NCT04000815|11967056|FG002|Overall Study|Hypertension occured on follow up|2
7577392|NCT04006366|11967081|FG000|Overall Study|Withdrawal by Subject|1
7577393|NCT04006145|11967087|FG000|Overall Study|Lost to Follow-up|0
7577394|NCT04006145|11967088|FG001|Overall Study|Lost to Follow-up|1
7267325|NCT00401245|11481657|FG002|Open Label Phase|Adverse Event|6
7267326|NCT00401245|11481658|FG003|Open Label Phase|Adverse Event|7
7267327|NCT00401245|11481659|FG004|Open Label Phase|Adverse Event|0
7267328|NCT00401245|11481660|FG005|Open Label Phase|Adverse Event|0
7267329|NCT00401245|11481661|FG006|Open Label Phase|Adverse Event|0
7577395|NCT04006145|11967087|FG000|Overall Study|Other|1
7577396|NCT04006145|11967088|FG001|Overall Study|Other|2
7577397|NCT04005755|11967094|FG000|Overall Study|Adverse Event|6
7577398|NCT04005755|11967094|FG000|Overall Study|Physician Decision|3
7577399|NCT04005755|11967094|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
7577400|NCT04005755|11967094|FG000|Overall Study|Withdrawal by Subject|3
7577401|NCT04005755|11967094|FG000|Overall Study|Lost to Follow-up|1
7577402|NCT03993288|11967117|FG000|Overall Study|Lost to Follow-up|2
7577403|NCT03993288|11967118|FG001|Overall Study|Lost to Follow-up|1
7577404|NCT03993288|11967117|FG000|Overall Study|non-compliance to the inclusion criteria|0
7577405|NCT03993288|11967118|FG001|Overall Study|non-compliance to the inclusion criteria|1
7577406|NCT03993288|11967117|FG000|Overall Study|wrong randomization|0
7577407|NCT03993288|11967118|FG001|Overall Study|wrong randomization|1
7577408|NCT03993288|11967117|FG000|Overall Study|improper enrollment|0
7577409|NCT03993288|11967118|FG001|Overall Study|improper enrollment|1
7577410|NCT03993288|11967117|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
7577411|NCT03993288|11967118|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
7577412|NCT03993288|11967117|FG000|Overall Study|developed SAE|2
7577413|NCT03993288|11967118|FG001|Overall Study|developed SAE|0
7577414|NCT03993288|11967117|FG000|Overall Study|consent withdrawal|1
7577415|NCT03993288|11967118|FG001|Overall Study|consent withdrawal|0
7577416|NCT03993288|11967117|FG000|Overall Study|did not follow the treatment schedule|1
7577417|NCT03993288|11967118|FG001|Overall Study|did not follow the treatment schedule|0
7577418|NCT03993288|11967117|FG000|Overall Study|did not follow the treatment regimen|1
7577419|NCT03993288|11967118|FG001|Overall Study|did not follow the treatment regimen|0
7577420|NCT03993288|11967117|FG000|Overall Study|Adverse Event|1
7267330|NCT00401245|11481662|FG007|Open Label Phase|Adverse Event|0
7267331|NCT00401245|11481655|FG000|Open Label Phase|Lost to Follow-up|5
7267332|NCT00401245|11481656|FG001|Open Label Phase|Lost to Follow-up|7
7267333|NCT00401245|11481657|FG002|Open Label Phase|Lost to Follow-up|5
7267334|NCT00401245|11481658|FG003|Open Label Phase|Lost to Follow-up|4
7267335|NCT00401245|11481659|FG004|Open Label Phase|Lost to Follow-up|0
7267336|NCT00401245|11481660|FG005|Open Label Phase|Lost to Follow-up|0
7267337|NCT00401245|11481661|FG006|Open Label Phase|Lost to Follow-up|0
7267338|NCT00401245|11481662|FG007|Open Label Phase|Lost to Follow-up|0
7267339|NCT00401245|11481655|FG000|Open Label Phase|Other|4
7267340|NCT00401245|11481656|FG001|Open Label Phase|Other|8
7267341|NCT00401245|11481657|FG002|Open Label Phase|Other|7
7267342|NCT00401245|11481658|FG003|Open Label Phase|Other|8
7267343|NCT00401245|11481659|FG004|Open Label Phase|Other|0
7267344|NCT00401245|11481660|FG005|Open Label Phase|Other|0
7267345|NCT00401245|11481661|FG006|Open Label Phase|Other|0
7267346|NCT00401245|11481662|FG007|Open Label Phase|Other|0
7267347|NCT00401245|11481655|FG000|Open Label Phase|Protocol Violation|0
7267348|NCT00401245|11481656|FG001|Open Label Phase|Protocol Violation|1
7267349|NCT00401245|11481657|FG002|Open Label Phase|Protocol Violation|0
7267350|NCT00401245|11481658|FG003|Open Label Phase|Protocol Violation|1
7267351|NCT00401245|11481659|FG004|Open Label Phase|Protocol Violation|0
7267352|NCT00401245|11481660|FG005|Open Label Phase|Protocol Violation|0
7267353|NCT00401245|11481661|FG006|Open Label Phase|Protocol Violation|0
7267354|NCT00401245|11481662|FG007|Open Label Phase|Protocol Violation|0
7267355|NCT00401245|11481655|FG000|Open Label Phase|Withdrawal by Subject|3
7267356|NCT00401245|11481656|FG001|Open Label Phase|Withdrawal by Subject|3
7267357|NCT00401245|11481657|FG002|Open Label Phase|Withdrawal by Subject|2
7267358|NCT00401245|11481658|FG003|Open Label Phase|Withdrawal by Subject|1
7267359|NCT00401245|11481659|FG004|Open Label Phase|Withdrawal by Subject|0
7267360|NCT00401245|11481660|FG005|Open Label Phase|Withdrawal by Subject|0
7267361|NCT00401245|11481661|FG006|Open Label Phase|Withdrawal by Subject|0
7267362|NCT00401245|11481662|FG007|Open Label Phase|Withdrawal by Subject|0
7267363|NCT00401245|11481655|FG000|Open Label Phase|Lack of Efficacy|4
7267364|NCT00401245|11481656|FG001|Open Label Phase|Lack of Efficacy|2
7267365|NCT00401245|11481657|FG002|Open Label Phase|Lack of Efficacy|3
7267366|NCT00401245|11481658|FG003|Open Label Phase|Lack of Efficacy|0
7267367|NCT00401245|11481659|FG004|Open Label Phase|Lack of Efficacy|0
7267368|NCT00401245|11481660|FG005|Open Label Phase|Lack of Efficacy|0
7267369|NCT00401245|11481661|FG006|Open Label Phase|Lack of Efficacy|0
7267370|NCT00401245|11481662|FG007|Open Label Phase|Lack of Efficacy|0
7267371|NCT00401245|11481655|FG000|Double Blind Tapering Phase|Adverse Event|0
7267372|NCT00401245|11481656|FG001|Double Blind Tapering Phase|Adverse Event|0
7267373|NCT00401245|11481657|FG002|Double Blind Tapering Phase|Adverse Event|0
7267374|NCT00401245|11481658|FG003|Double Blind Tapering Phase|Adverse Event|0
7547352|NCT02905149|11903943|FG000|Overall Study|Lost to Follow-up|2
7547353|NCT02905149|11903944|FG001|Overall Study|Lost to Follow-up|0
7547354|NCT02905266|11903952|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
7547355|NCT02905266|11903953|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
7547356|NCT02905266|11903952|FG000|Treatment Phase Part 1|Disease Progression|6
7547357|NCT02905266|11903953|FG001|Treatment Phase Part 1|Disease Progression|7
7547358|NCT02905266|11903952|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
7547359|NCT02905266|11903953|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
7547360|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
7547361|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
7577421|NCT03993288|11967118|FG001|Overall Study|Adverse Event|0
7267375|NCT00401245|11481659|FG004|Double Blind Tapering Phase|Adverse Event|1
7267376|NCT00401245|11481660|FG005|Double Blind Tapering Phase|Adverse Event|1
7267377|NCT00401245|11481661|FG006|Double Blind Tapering Phase|Adverse Event|2
7267378|NCT00401245|11481662|FG007|Double Blind Tapering Phase|Adverse Event|4
7267379|NCT00401245|11481655|FG000|Double Blind Tapering Phase|Investigator request|0
7267380|NCT00401245|11481656|FG001|Double Blind Tapering Phase|Investigator request|0
7267381|NCT00401245|11481657|FG002|Double Blind Tapering Phase|Investigator request|0
7267382|NCT00401245|11481658|FG003|Double Blind Tapering Phase|Investigator request|0
7267383|NCT00401245|11481659|FG004|Double Blind Tapering Phase|Investigator request|0
7267384|NCT00401245|11481660|FG005|Double Blind Tapering Phase|Investigator request|0
7267385|NCT00401245|11481661|FG006|Double Blind Tapering Phase|Investigator request|0
7577422|NCT03993288|11967117|FG000|Overall Study|Withdrawal by Subject|1
7577423|NCT03993288|11967118|FG001|Overall Study|Withdrawal by Subject|1
7577424|NCT03978832|11967149|FG000|Overall Study|Adverse Event|1
7577425|NCT03978832|11967149|FG000|Overall Study|Lost to Follow-up|1
7577426|NCT03978832|11967149|FG000|Overall Study|Withdrawal by Subject|6
7577427|NCT03978832|11967149|FG000|Overall Study|Physician Decision|2
7577428|NCT03978832|11967149|FG000|Overall Study|did not pass screening criteria|44
7577429|NCT04004260|11967190|FG000|Overall Study|Withdrawal by Subject|7
7577430|NCT04004260|11967191|FG001|Overall Study|Withdrawal by Subject|3
7577431|NCT04004260|11967190|FG000|Overall Study|Lost to Follow-up|22
7577432|NCT04004260|11967191|FG001|Overall Study|Lost to Follow-up|12
7577433|NCT04004260|11967190|FG000|Overall Study|Did not engage in intervention|13
7577434|NCT04004260|11967191|FG001|Overall Study|Did not engage in intervention|17
7577435|NCT04002960|11967224|FG000|Overall Study|Withdrawn prior to Completion|2
7577436|NCT04002648|11967234|FG000|Overall Study|Lost to Follow-up|2
7577437|NCT04002648|11967235|FG001|Overall Study|Lost to Follow-up|0
7577438|NCT03990649|11967264|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7577439|NCT03990649|11967265|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
7577440|NCT03990649|11967266|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
7577441|NCT03990649|11967264|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
7577442|NCT03990649|11967265|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
7577443|NCT03990649|11967266|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
7267386|NCT00401245|11481662|FG007|Double Blind Tapering Phase|Investigator request|1
7577444|NCT03990649|11967264|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
7577445|NCT03990649|11967265|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7267387|NCT00401245|11481655|FG000|Double Blind Tapering Phase|Other|0
7267388|NCT00401245|11481656|FG001|Double Blind Tapering Phase|Other|0
7267389|NCT00401245|11481657|FG002|Double Blind Tapering Phase|Other|0
7267390|NCT00401245|11481658|FG003|Double Blind Tapering Phase|Other|0
7267391|NCT00401245|11481659|FG004|Double Blind Tapering Phase|Other|1
7267392|NCT00401245|11481660|FG005|Double Blind Tapering Phase|Other|0
7267393|NCT00401245|11481661|FG006|Double Blind Tapering Phase|Other|2
7267394|NCT00401245|11481662|FG007|Double Blind Tapering Phase|Other|2
7267395|NCT00401245|11481655|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
7267396|NCT00401245|11481656|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
7267397|NCT00401245|11481657|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
7267398|NCT00401245|11481658|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
7267399|NCT00401245|11481659|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
7267400|NCT00401245|11481660|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
7267401|NCT00401245|11481661|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
7267402|NCT00401245|11481662|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
7267403|NCT00401245|11481655|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
7267404|NCT00401245|11481656|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
7267405|NCT00401245|11481657|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
7267406|NCT00401245|11481658|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
7267407|NCT00401245|11481659|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
7267408|NCT00401245|11481660|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
7267409|NCT00401245|11481661|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
7267410|NCT00401245|11481662|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
7267411|NCT00401258|11481682|FG000|Overall Study|Adverse Event|7
7267412|NCT00401375|11481689|FG000|Overall Study|Protocol Violation|2
7267413|NCT00401375|11481690|FG001|Overall Study|Protocol Violation|2
7267414|NCT00401375|11481691|FG002|Overall Study|Protocol Violation|1
7267415|NCT00401375|11481689|FG000|Overall Study|Adverse Event|6
7267416|NCT00401375|11481690|FG001|Overall Study|Adverse Event|11
7267417|NCT00401375|11481691|FG002|Overall Study|Adverse Event|10
7267418|NCT00401375|11481689|FG000|Overall Study|Withdrawal by Subject|9
7267419|NCT00401375|11481690|FG001|Overall Study|Withdrawal by Subject|7
7267420|NCT00401375|11481691|FG002|Overall Study|Withdrawal by Subject|7
7267421|NCT00401375|11481689|FG000|Overall Study|Lost to Follow-up|0
7267422|NCT00401375|11481690|FG001|Overall Study|Lost to Follow-up|1
7267423|NCT00401375|11481691|FG002|Overall Study|Lost to Follow-up|1
7267424|NCT00401375|11481689|FG000|Overall Study|Other than specified|2
7267425|NCT00401375|11481690|FG001|Overall Study|Other than specified|1
7267426|NCT00401375|11481691|FG002|Overall Study|Other than specified|3
7267427|NCT00401375|11481689|FG000|Overall Study|Randomized but not treated|3
7267428|NCT00401375|11481690|FG001|Overall Study|Randomized but not treated|3
7267429|NCT00401375|11481691|FG002|Overall Study|Randomized but not treated|3
7267430|NCT00401531|11481750|FG000|Overall Study|Adverse Event|2
7267431|NCT00401531|11481751|FG001|Overall Study|Adverse Event|0
7547362|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Disease progression|2
7547363|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Disease progression|1
7547364|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
7547365|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
7547366|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Death|0
7547367|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Death|1
7547368|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
7547369|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
7547370|NCT02905266|11903952|FG000|Transition From Part 1 to Part 2|Adverse Event|1
7547371|NCT02905266|11903953|FG001|Transition From Part 1 to Part 2|Adverse Event|1
7547372|NCT02905266|11903952|FG000|Maintenance Phase Part 2|Disease Progression|9
7547373|NCT02905266|11903953|FG001|Maintenance Phase Part 2|Disease Progression|2
7547374|NCT02905266|11903952|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
7547375|NCT02905266|11903953|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
7547376|NCT02905266|11903952|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
7547377|NCT02905266|11903953|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
7547378|NCT02905331|11903961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
7547379|NCT02905331|11903962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7547380|NCT02905331|11903963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
7547381|NCT02905331|11903961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
7547382|NCT02905331|11903962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7547383|NCT02905331|11903963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
7547384|NCT02905331|11903961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7547385|NCT02905331|11903962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
7547386|NCT02905331|11903963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
7547387|NCT02905331|11903961|FG000|Active Treatment and Follow up (wk16-40)|Other|0
7547388|NCT02905331|11903962|FG001|Active Treatment and Follow up (wk16-40)|Other|6
7547389|NCT02905331|11903963|FG002|Active Treatment and Follow up (wk16-40)|Other|0
7547390|NCT02905331|11903961|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7547391|NCT02905331|11903962|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
7547392|NCT02905331|11903963|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
7547393|NCT02905435|11903971|FG000|Overall Study|Death|2
7547394|NCT02905435|11903971|FG000|Overall Study|Physician Decision|1
7547395|NCT02905435|11903971|FG000|Overall Study|Lost to Follow-up|4
7547396|NCT02905825|11903976|FG000|Overall Study|Protocol Violation|11
7547397|NCT02905825|11903976|FG000|Overall Study|Device Malfunction|1
7547398|NCT02906358|11903986|FG000|Overall Study|Withdrawal by Subject|10
7547399|NCT02906358|11903987|FG001|Overall Study|Withdrawal by Subject|7
7547400|NCT02906358|11903986|FG000|Overall Study|Lost to Follow-up|12
7267432|NCT00401531|11481750|FG000|Overall Study|Protocol Violation|3
7267433|NCT00401531|11481751|FG001|Overall Study|Protocol Violation|7
7267434|NCT00401531|11481750|FG000|Overall Study|Lost to Follow-up|1
7267435|NCT00401531|11481751|FG001|Overall Study|Lost to Follow-up|1
7267436|NCT00401531|11481750|FG000|Overall Study|Withdrawal by Subject|3
7267437|NCT00401531|11481751|FG001|Overall Study|Withdrawal by Subject|2
7267438|NCT00401544|11481761|FG000|Overall Study|Adverse Event|5
7267439|NCT00401544|11481762|FG001|Overall Study|Adverse Event|1
7267440|NCT00401544|11481763|FG002|Overall Study|Adverse Event|1
7267441|NCT00401544|11481764|FG003|Overall Study|Adverse Event|1
7267442|NCT00401544|11481761|FG000|Overall Study|Death|3
7267443|NCT00401544|11481762|FG001|Overall Study|Death|6
7267444|NCT00401544|11481763|FG002|Overall Study|Death|2
7267445|NCT00401544|11481764|FG003|Overall Study|Death|5
7267446|NCT00401544|11481761|FG000|Overall Study|Lost to Follow-up|2
7267447|NCT00401544|11481762|FG001|Overall Study|Lost to Follow-up|0
7267448|NCT00401544|11481763|FG002|Overall Study|Lost to Follow-up|1
7267449|NCT00401544|11481764|FG003|Overall Study|Lost to Follow-up|1
7267450|NCT00401544|11481761|FG000|Overall Study|Withdrawal by Subject|7
7267451|NCT00401544|11481762|FG001|Overall Study|Withdrawal by Subject|6
7267452|NCT00401544|11481763|FG002|Overall Study|Withdrawal by Subject|6
7267453|NCT00401544|11481764|FG003|Overall Study|Withdrawal by Subject|5
7267454|NCT00401544|11481761|FG000|Overall Study|Physician Decision|1
7267455|NCT00401544|11481762|FG001|Overall Study|Physician Decision|3
7267456|NCT00401544|11481763|FG002|Overall Study|Physician Decision|0
7267457|NCT00401544|11481764|FG003|Overall Study|Physician Decision|0
7267458|NCT00401544|11481761|FG000|Overall Study|Ineligibility determined|0
7267459|NCT00401544|11481762|FG001|Overall Study|Ineligibility determined|1
7267460|NCT00401544|11481763|FG002|Overall Study|Ineligibility determined|0
7267461|NCT00401544|11481764|FG003|Overall Study|Ineligibility determined|2
7267462|NCT00401544|11481761|FG000|Overall Study|Disease progression|0
7267463|NCT00401544|11481762|FG001|Overall Study|Disease progression|1
7267464|NCT00401544|11481763|FG002|Overall Study|Disease progression|0
7267465|NCT00401544|11481764|FG003|Overall Study|Disease progression|0
7267466|NCT00401544|11481761|FG000|Overall Study|Other|0
7267467|NCT00401544|11481762|FG001|Overall Study|Other|0
7267468|NCT00401544|11481763|FG002|Overall Study|Other|2
7267469|NCT00401544|11481764|FG003|Overall Study|Other|2
7267470|NCT00401726|11481790|FG000|Overall Study|Adverse Event|34
7267471|NCT00401726|11481791|FG001|Overall Study|Adverse Event|45
7267472|NCT00401726|11481790|FG000|Overall Study|Death|0
7267473|NCT00401726|11481791|FG001|Overall Study|Death|3
7267474|NCT00401726|11481790|FG000|Overall Study|Sponsor Request|0
7267475|NCT00401726|11481791|FG001|Overall Study|Sponsor Request|1
7267476|NCT00401726|11481790|FG000|Overall Study|Physician Decision|3
7267477|NCT00401726|11481791|FG001|Overall Study|Physician Decision|6
7267478|NCT00401726|11481790|FG000|Overall Study|Lost to Follow-up|23
7267479|NCT00401726|11481791|FG001|Overall Study|Lost to Follow-up|20
7267480|NCT00401726|11481790|FG000|Overall Study|Protocol Violation|6
7267481|NCT00401726|11481791|FG001|Overall Study|Protocol Violation|3
7547401|NCT02906358|11903987|FG001|Overall Study|Lost to Follow-up|15
7547402|NCT02906579|11904004|FG000|Overall Study|Adverse Event|1
7547403|NCT02906579|11904004|FG000|Overall Study|Physician Decision|1
7547404|NCT02906644|11904026|FG000|First 2 Weeks|Withdrawal by Subject|0
7547405|NCT02906644|11904027|FG001|First 2 Weeks|Withdrawal by Subject|2
7547406|NCT02906644|11904026|FG000|First 2 Weeks|Physician Decision|1
7547407|NCT02906644|11904027|FG001|First 2 Weeks|Physician Decision|1
7547408|NCT02906644|11904026|FG000|Weeks 3 to 14|Withdrawal by Subject|13
7547409|NCT02906644|11904027|FG001|Weeks 3 to 14|Withdrawal by Subject|7
7547410|NCT02906644|11904026|FG000|Weeks 3 to 14|Lost to Follow-up|3
7547411|NCT02906644|11904027|FG001|Weeks 3 to 14|Lost to Follow-up|4
7547412|NCT02906670|11904044|FG000|Cohort 1, QW|Radiological Progression|1
7547413|NCT02906670|11904045|FG001|Cohort 1, QW|Radiological Progression|0
7547414|NCT02906670|11904046|FG002|Cohort 1, QW|Radiological Progression|0
7547415|NCT02906670|11904047|FG003|Cohort 1, QW|Radiological Progression|0
7547416|NCT02906670|11904048|FG004|Cohort 1, QW|Radiological Progression|0
7547417|NCT02906670|11904049|FG005|Cohort 1, QW|Radiological Progression|0
7547418|NCT02906670|11904050|FG006|Cohort 1, QW|Radiological Progression|0
7547419|NCT02906670|11904051|FG007|Cohort 1, QW|Radiological Progression|0
7547420|NCT02906670|11904052|FG008|Cohort 1, QW|Radiological Progression|0
7547421|NCT02906670|11904053|FG009|Cohort 1, QW|Radiological Progression|0
7547422|NCT02906670|11904044|FG000|Cohort 2, QW|Radiological Progression|0
7547423|NCT02906670|11904045|FG001|Cohort 2, QW|Radiological Progression|1
7547424|NCT02906670|11904046|FG002|Cohort 2, QW|Radiological Progression|0
7547425|NCT02906670|11904047|FG003|Cohort 2, QW|Radiological Progression|0
7547426|NCT02906670|11904048|FG004|Cohort 2, QW|Radiological Progression|0
7547427|NCT02906670|11904049|FG005|Cohort 2, QW|Radiological Progression|0
7547428|NCT02906670|11904050|FG006|Cohort 2, QW|Radiological Progression|0
7547429|NCT02906670|11904051|FG007|Cohort 2, QW|Radiological Progression|0
7547430|NCT02906670|11904052|FG008|Cohort 2, QW|Radiological Progression|0
7547431|NCT02906670|11904053|FG009|Cohort 2, QW|Radiological Progression|0
7267482|NCT00401726|11481790|FG000|Overall Study|Withdrawal by Subject|18
7267483|NCT00401726|11481791|FG001|Overall Study|Withdrawal by Subject|24
7547432|NCT02906670|11904044|FG000|Cohort 3, QW|Radiological Progression|0
7577446|NCT03990649|11967266|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
7267484|NCT00401726|11481790|FG000|Overall Study|Lack of Efficacy|4
7267485|NCT00401726|11481791|FG001|Overall Study|Lack of Efficacy|6
7267486|NCT00401726|11481790|FG000|Overall Study|Protocol Deviation|9
7267487|NCT00401726|11481791|FG001|Overall Study|Protocol Deviation|4
7267488|NCT00401752|11481799|FG000|Overall Study|Adverse Event|2
7267489|NCT00401752|11481800|FG001|Overall Study|Adverse Event|5
7267490|NCT00401752|11481799|FG000|Overall Study|Withdrawal by Subject|2
7267491|NCT00401752|11481800|FG001|Overall Study|Withdrawal by Subject|6
7267492|NCT00401752|11481799|FG000|Overall Study|Lost to Follow-up|1
7267493|NCT00401752|11481800|FG001|Overall Study|Lost to Follow-up|4
7267494|NCT00401752|11481799|FG000|Overall Study|Development of any exclusion criteria|4
7267495|NCT00401752|11481800|FG001|Overall Study|Development of any exclusion criteria|2
7267496|NCT00401752|11481799|FG000|Overall Study|Physician Decision|1
7267497|NCT00401752|11481800|FG001|Overall Study|Physician Decision|1
7267498|NCT00401830|11481826|FG000|Overall Study|Adverse Event|10
7267499|NCT00401830|11481827|FG001|Overall Study|Adverse Event|18
7267500|NCT00401830|11481826|FG000|Overall Study|Lack of Efficacy|11
7267501|NCT00401830|11481827|FG001|Overall Study|Lack of Efficacy|5
7267502|NCT00401830|11481826|FG000|Overall Study|Withdrawal by Subject|4
7267503|NCT00401830|11481827|FG001|Overall Study|Withdrawal by Subject|3
7267504|NCT00401830|11481826|FG000|Overall Study|Protocol Violation|3
7267505|NCT00401830|11481827|FG001|Overall Study|Protocol Violation|3
7267506|NCT00401830|11481826|FG000|Overall Study|Non-compliance with drug study|1
7267507|NCT00401830|11481827|FG001|Overall Study|Non-compliance with drug study|0
7267508|NCT00401830|11481826|FG000|Overall Study|Lost to Follow-up|1
7547433|NCT02906670|11904045|FG001|Cohort 3, QW|Radiological Progression|0
7547434|NCT02906670|11904046|FG002|Cohort 3, QW|Radiological Progression|2
7547435|NCT02906670|11904047|FG003|Cohort 3, QW|Radiological Progression|0
7547436|NCT02906670|11904048|FG004|Cohort 3, QW|Radiological Progression|0
7547437|NCT02906670|11904049|FG005|Cohort 3, QW|Radiological Progression|0
7547438|NCT02906670|11904050|FG006|Cohort 3, QW|Radiological Progression|0
7547439|NCT02906670|11904051|FG007|Cohort 3, QW|Radiological Progression|0
7547440|NCT02906670|11904052|FG008|Cohort 3, QW|Radiological Progression|0
7547441|NCT02906670|11904053|FG009|Cohort 3, QW|Radiological Progression|0
7547442|NCT02906670|11904044|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
7547443|NCT02906670|11904045|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
7547444|NCT02906670|11904046|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
7547445|NCT02906670|11904047|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
7547446|NCT02906670|11904048|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
7547447|NCT02906670|11904049|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
7547448|NCT02906670|11904050|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
7547449|NCT02906670|11904051|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
7547450|NCT02906670|11904052|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
7547451|NCT02906670|11904053|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
7547452|NCT02906670|11904044|FG000|Cohort 4, Q2W|Radiological Progression|0
7547453|NCT02906670|11904045|FG001|Cohort 4, Q2W|Radiological Progression|0
7547454|NCT02906670|11904046|FG002|Cohort 4, Q2W|Radiological Progression|0
7547455|NCT02906670|11904047|FG003|Cohort 4, Q2W|Radiological Progression|0
7547456|NCT02906670|11904048|FG004|Cohort 4, Q2W|Radiological Progression|0
7547457|NCT02906670|11904049|FG005|Cohort 4, Q2W|Radiological Progression|1
7547458|NCT02906670|11904050|FG006|Cohort 4, Q2W|Radiological Progression|0
7547459|NCT02906670|11904051|FG007|Cohort 4, Q2W|Radiological Progression|0
7547460|NCT02906670|11904052|FG008|Cohort 4, Q2W|Radiological Progression|0
7547461|NCT02906670|11904053|FG009|Cohort 4, Q2W|Radiological Progression|0
7547462|NCT02906670|11904044|FG000|Cohort 4, Q2W|Clinical Progression|0
7547463|NCT02906670|11904045|FG001|Cohort 4, Q2W|Clinical Progression|0
7547464|NCT02906670|11904046|FG002|Cohort 4, Q2W|Clinical Progression|0
7547465|NCT02906670|11904047|FG003|Cohort 4, Q2W|Clinical Progression|0
7547466|NCT02906670|11904048|FG004|Cohort 4, Q2W|Clinical Progression|0
7547467|NCT02906670|11904049|FG005|Cohort 4, Q2W|Clinical Progression|2
7547468|NCT02906670|11904050|FG006|Cohort 4, Q2W|Clinical Progression|0
7547469|NCT02906670|11904051|FG007|Cohort 4, Q2W|Clinical Progression|0
7547470|NCT02906670|11904052|FG008|Cohort 4, Q2W|Clinical Progression|0
7547471|NCT02906670|11904053|FG009|Cohort 4, Q2W|Clinical Progression|0
7547472|NCT02906670|11904044|FG000|Cohort 5, Q2W|Radiological Progression|0
7547473|NCT02906670|11904045|FG001|Cohort 5, Q2W|Radiological Progression|0
7547474|NCT02906670|11904046|FG002|Cohort 5, Q2W|Radiological Progression|0
7547475|NCT02906670|11904047|FG003|Cohort 5, Q2W|Radiological Progression|0
7547476|NCT02906670|11904048|FG004|Cohort 5, Q2W|Radiological Progression|0
7547477|NCT02906670|11904049|FG005|Cohort 5, Q2W|Radiological Progression|0
7547478|NCT02906670|11904050|FG006|Cohort 5, Q2W|Radiological Progression|4
7267509|NCT00401830|11481827|FG001|Overall Study|Lost to Follow-up|3
7267510|NCT00401830|11481826|FG000|Overall Study|Other: Personal / Family problems|1
7267511|NCT00401830|11481827|FG001|Overall Study|Other: Personal / Family problems|0
7267512|NCT00401843|11481836|FG000|Overall Study|Achieved Complete Response|1
7267513|NCT00401843|11481837|FG001|Overall Study|Achieved Complete Response|5
7267514|NCT00401843|11481838|FG002|Overall Study|Achieved Complete Response|11
7267515|NCT00401843|11481836|FG000|Overall Study|Adverse Event|7
7267516|NCT00401843|11481837|FG001|Overall Study|Adverse Event|26
7267517|NCT00401843|11481838|FG002|Overall Study|Adverse Event|27
7267518|NCT00401843|11481836|FG000|Overall Study|Death|0
7267519|NCT00401843|11481837|FG001|Overall Study|Death|8
7267520|NCT00401843|11481838|FG002|Overall Study|Death|10
7547479|NCT02906670|11904051|FG007|Cohort 5, Q2W|Radiological Progression|0
7547480|NCT02906670|11904052|FG008|Cohort 5, Q2W|Radiological Progression|0
7547481|NCT02906670|11904053|FG009|Cohort 5, Q2W|Radiological Progression|0
7547482|NCT02906670|11904044|FG000|Cohort 5, Q2W|Clinical Progression|0
7547483|NCT02906670|11904045|FG001|Cohort 5, Q2W|Clinical Progression|0
7267521|NCT00401843|11481836|FG000|Overall Study|Disease progression|10
7267522|NCT00401843|11481837|FG001|Overall Study|Disease progression|60
7267523|NCT00401843|11481838|FG002|Overall Study|Disease progression|49
7267524|NCT00401843|11481836|FG000|Overall Study|End of Study|1
7267525|NCT00401843|11481837|FG001|Overall Study|End of Study|1
7267526|NCT00401843|11481838|FG002|Overall Study|End of Study|2
7267527|NCT00401843|11481836|FG000|Overall Study|Lost to Follow-up|0
7267528|NCT00401843|11481837|FG001|Overall Study|Lost to Follow-up|0
7267529|NCT00401843|11481838|FG002|Overall Study|Lost to Follow-up|2
7267530|NCT00401843|11481836|FG000|Overall Study|Other Unspecified|0
7267531|NCT00401843|11481837|FG001|Overall Study|Other Unspecified|3
7267532|NCT00401843|11481838|FG002|Overall Study|Other Unspecified|5
7267533|NCT00401843|11481836|FG000|Overall Study|Physician Decision|0
7267534|NCT00401843|11481837|FG001|Overall Study|Physician Decision|16
7577447|NCT03990649|11967264|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7577448|NCT03990649|11967265|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
7577449|NCT03990649|11967266|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
7577450|NCT03990649|11967264|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7577451|NCT03990649|11967265|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
7577452|NCT03990649|11967266|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
7577453|NCT03990649|11967264|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7577454|NCT03990649|11967265|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
7577455|NCT03990649|11967266|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
7577456|NCT03990649|11967264|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7577457|NCT03990649|11967265|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
7577458|NCT03990649|11967266|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
7577461|NCT03996694|11967291|FG000|First Washout (7 Days)|positive urine drug screen|0
7577462|NCT03996694|11967292|FG001|First Washout (7 Days)|positive urine drug screen|0
7577463|NCT03996694|11967293|FG002|First Washout (7 Days)|positive urine drug screen|1
7577464|NCT03996694|11967294|FG003|First Washout (7 Days)|positive urine drug screen|0
7577465|NCT03996694|11967295|FG004|First Washout (7 Days)|positive urine drug screen|0
7577466|NCT03996694|11967296|FG005|First Washout (7 Days)|positive urine drug screen|0
7577467|NCT03996694|11967291|FG000|First Washout (7 Days)|Adverse Event|0
7577468|NCT03996694|11967292|FG001|First Washout (7 Days)|Adverse Event|1
7577469|NCT03996694|11967293|FG002|First Washout (7 Days)|Adverse Event|0
7577470|NCT03996694|11967294|FG003|First Washout (7 Days)|Adverse Event|0
7577471|NCT03996694|11967295|FG004|First Washout (7 Days)|Adverse Event|0
7577472|NCT03996694|11967296|FG005|First Washout (7 Days)|Adverse Event|0
7577473|NCT03996694|11967291|FG000|First Washout (7 Days)|Lost to Follow-up|0
7577474|NCT03996694|11967292|FG001|First Washout (7 Days)|Lost to Follow-up|0
7577475|NCT03996694|11967293|FG002|First Washout (7 Days)|Lost to Follow-up|1
7577476|NCT03996694|11967294|FG003|First Washout (7 Days)|Lost to Follow-up|0
7577477|NCT03996694|11967295|FG004|First Washout (7 Days)|Lost to Follow-up|0
7577478|NCT03996694|11967296|FG005|First Washout (7 Days)|Lost to Follow-up|0
7577479|NCT03996694|11967291|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
7577480|NCT03996694|11967292|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
7577481|NCT03996694|11967293|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
7577482|NCT03996694|11967294|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
7577483|NCT03996694|11967295|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
7577484|NCT03996694|11967296|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
7577485|NCT03988907|11967312|FG000|Overall Study|Unable to complete visit|0
7577486|NCT03988907|11967313|FG001|Overall Study|Unable to complete visit|1
7577487|NCT03988088|11967327|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
7577488|NCT03988088|11967328|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
7267535|NCT00401843|11481838|FG002|Overall Study|Physician Decision|10
7267536|NCT00401843|11481836|FG000|Overall Study|Protocol Violation|0
7267537|NCT00401843|11481837|FG001|Overall Study|Protocol Violation|0
7267538|NCT00401843|11481838|FG002|Overall Study|Protocol Violation|1
7267539|NCT00401843|11481836|FG000|Overall Study|Withdrawal by Subject|1
7267540|NCT00401843|11481837|FG001|Overall Study|Withdrawal by Subject|5
7267541|NCT00401843|11481838|FG002|Overall Study|Withdrawal by Subject|5
7267542|NCT00401843|11481836|FG000|Overall Study|Withdrawal of consent to study agent|1
7267543|NCT00401843|11481837|FG001|Overall Study|Withdrawal of consent to study agent|15
7267544|NCT00401843|11481838|FG002|Overall Study|Withdrawal of consent to study agent|17
7267545|NCT00401843|11481836|FG000|Overall Study|Randomized but not Treated|0
7547484|NCT02906670|11904046|FG002|Cohort 5, Q2W|Clinical Progression|0
7547485|NCT02906670|11904047|FG003|Cohort 5, Q2W|Clinical Progression|0
7547486|NCT02906670|11904048|FG004|Cohort 5, Q2W|Clinical Progression|0
7547487|NCT02906670|11904049|FG005|Cohort 5, Q2W|Clinical Progression|0
7547488|NCT02906670|11904050|FG006|Cohort 5, Q2W|Clinical Progression|1
7267546|NCT00401843|11481837|FG001|Overall Study|Randomized but not Treated|2
7547489|NCT02906670|11904051|FG007|Cohort 5, Q2W|Clinical Progression|0
7547490|NCT02906670|11904052|FG008|Cohort 5, Q2W|Clinical Progression|0
7547491|NCT02906670|11904053|FG009|Cohort 5, Q2W|Clinical Progression|0
7547492|NCT02906670|11904044|FG000|Cohort 5, Q2W|Adverse Event|0
7547493|NCT02906670|11904045|FG001|Cohort 5, Q2W|Adverse Event|0
7267547|NCT00401843|11481838|FG002|Overall Study|Randomized but not Treated|3
7267548|NCT00401843|11481836|FG000|Overall Study|Received incorrect treatment|0
7267549|NCT00401843|11481837|FG001|Overall Study|Received incorrect treatment|3
7267550|NCT00401843|11481838|FG002|Overall Study|Received incorrect treatment|0
7388168|NCT01217957|11646919|FG002|Phase 1|Withdrawal by Patient|1
7388169|NCT01217957|11646920|FG003|Phase 1|Withdrawal by Patient|1
7388170|NCT01217957|11646921|FG004|Phase 1|Withdrawal by Patient|0
7388171|NCT01217957|11646917|FG000|Phase 2|Withdrawal by Patient|0
7388172|NCT01217957|11646918|FG001|Phase 2|Withdrawal by Patient|0
7388173|NCT01217957|11646919|FG002|Phase 2|Withdrawal by Patient|0
7388174|NCT01217957|11646920|FG003|Phase 2|Withdrawal by Patient|0
7388175|NCT01217957|11646921|FG004|Phase 2|Withdrawal by Patient|1
7388176|NCT01218009|11646944|FG000|Overall Study|Protocol Violation|2
7388177|NCT01218009|11646945|FG001|Overall Study|Protocol Violation|1
7388178|NCT01218009|11646944|FG000|Overall Study|Withdrawal by Subject|3
7388179|NCT01218009|11646945|FG001|Overall Study|Withdrawal by Subject|1
7388180|NCT01218009|11646944|FG000|Overall Study|Sponsor terminated study|161
7388181|NCT01218009|11646945|FG001|Overall Study|Sponsor terminated study|163
7547494|NCT02906670|11904046|FG002|Cohort 5, Q2W|Adverse Event|0
7547495|NCT02906670|11904047|FG003|Cohort 5, Q2W|Adverse Event|0
7547496|NCT02906670|11904048|FG004|Cohort 5, Q2W|Adverse Event|0
7547497|NCT02906670|11904049|FG005|Cohort 5, Q2W|Adverse Event|0
7547498|NCT02906670|11904050|FG006|Cohort 5, Q2W|Adverse Event|1
7547499|NCT02906670|11904051|FG007|Cohort 5, Q2W|Adverse Event|0
7547500|NCT02906670|11904052|FG008|Cohort 5, Q2W|Adverse Event|0
7547501|NCT02906670|11904053|FG009|Cohort 5, Q2W|Adverse Event|0
7547502|NCT02906670|11904044|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547503|NCT02906670|11904045|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547504|NCT02906670|11904046|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547505|NCT02906670|11904047|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547506|NCT02906670|11904048|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547507|NCT02906670|11904049|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547508|NCT02906670|11904050|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
7547509|NCT02906670|11904051|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547510|NCT02906670|11904052|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547511|NCT02906670|11904053|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
7547512|NCT02906670|11904044|FG000|Cohort 5P, Q2W|Radiological Progression|0
7547513|NCT02906670|11904045|FG001|Cohort 5P, Q2W|Radiological Progression|0
7547514|NCT02906670|11904046|FG002|Cohort 5P, Q2W|Radiological Progression|0
7547515|NCT02906670|11904047|FG003|Cohort 5P, Q2W|Radiological Progression|0
7547516|NCT02906670|11904048|FG004|Cohort 5P, Q2W|Radiological Progression|0
7547517|NCT02906670|11904049|FG005|Cohort 5P, Q2W|Radiological Progression|0
7547518|NCT02906670|11904050|FG006|Cohort 5P, Q2W|Radiological Progression|0
7547519|NCT02906670|11904051|FG007|Cohort 5P, Q2W|Radiological Progression|2
7547520|NCT02906670|11904052|FG008|Cohort 5P, Q2W|Radiological Progression|0
7547521|NCT02906670|11904053|FG009|Cohort 5P, Q2W|Radiological Progression|0
7547522|NCT02906670|11904044|FG000|Cohort 5P, Q2W|Adverse Event|0
7547523|NCT02906670|11904045|FG001|Cohort 5P, Q2W|Adverse Event|0
7547524|NCT02906670|11904046|FG002|Cohort 5P, Q2W|Adverse Event|0
7547525|NCT02906670|11904047|FG003|Cohort 5P, Q2W|Adverse Event|0
7547526|NCT02906670|11904048|FG004|Cohort 5P, Q2W|Adverse Event|0
7547527|NCT02906670|11904049|FG005|Cohort 5P, Q2W|Adverse Event|0
7547528|NCT02906670|11904050|FG006|Cohort 5P, Q2W|Adverse Event|0
7547529|NCT02906670|11904051|FG007|Cohort 5P, Q2W|Adverse Event|1
7547530|NCT02906670|11904052|FG008|Cohort 5P, Q2W|Adverse Event|0
7547531|NCT02906670|11904053|FG009|Cohort 5P, Q2W|Adverse Event|0
7547532|NCT02906670|11904044|FG000|Cohort 6P, Q2W|Radiological Progression|0
7547533|NCT02906670|11904045|FG001|Cohort 6P, Q2W|Radiological Progression|0
7547534|NCT02906670|11904046|FG002|Cohort 6P, Q2W|Radiological Progression|0
7547535|NCT02906670|11904047|FG003|Cohort 6P, Q2W|Radiological Progression|0
7547536|NCT02906670|11904048|FG004|Cohort 6P, Q2W|Radiological Progression|0
7547537|NCT02906670|11904049|FG005|Cohort 6P, Q2W|Radiological Progression|0
7388182|NCT01218087|11646958|FG000|Overall Study|Death|2
7388183|NCT01218087|11646959|FG001|Overall Study|Death|1
7388184|NCT01218087|11646958|FG000|Overall Study|Withdrawal by Subject|5
7388185|NCT01218087|11646959|FG001|Overall Study|Withdrawal by Subject|0
7388186|NCT01218087|11646958|FG000|Overall Study|Transferred|8
7388187|NCT01218087|11646959|FG001|Overall Study|Transferred|5
7388188|NCT01218100|11646969|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
7388189|NCT01218100|11646970|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
7388190|NCT01218100|11646971|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
7388191|NCT01218100|11646972|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
7388192|NCT01218100|11646969|FG000|Overall Study|Adverse Event|4
7388193|NCT01218100|11646970|FG001|Overall Study|Adverse Event|6
7388194|NCT01218100|11646971|FG002|Overall Study|Adverse Event|6
7388195|NCT01218100|11646972|FG003|Overall Study|Adverse Event|7
7547538|NCT02906670|11904050|FG006|Cohort 6P, Q2W|Radiological Progression|0
7547539|NCT02906670|11904051|FG007|Cohort 6P, Q2W|Radiological Progression|0
7547540|NCT02906670|11904052|FG008|Cohort 6P, Q2W|Radiological Progression|1
7547541|NCT02906670|11904053|FG009|Cohort 6P, Q2W|Radiological Progression|0
7547542|NCT02906670|11904044|FG000|Cohort 6P, Q2W|Clinical Progression|0
7388196|NCT01218100|11646969|FG000|Overall Study|Lack of Efficacy|9
7547543|NCT02906670|11904045|FG001|Cohort 6P, Q2W|Clinical Progression|0
7267551|NCT00401960|11481865|FG000|Overall Study|Lost to Follow-up|3
7267552|NCT00401960|11481866|FG001|Overall Study|Lost to Follow-up|0
7267553|NCT00401960|11481865|FG000|Overall Study|Death|2
7267554|NCT00401960|11481866|FG001|Overall Study|Death|0
7267555|NCT00401973|11481877|FG000|Overall Study|Adverse Event|2
7267556|NCT00401973|11481878|FG001|Overall Study|Adverse Event|8
7267557|NCT00401973|11481879|FG002|Overall Study|Adverse Event|4
7547544|NCT02906670|11904046|FG002|Cohort 6P, Q2W|Clinical Progression|0
7547545|NCT02906670|11904047|FG003|Cohort 6P, Q2W|Clinical Progression|0
7547546|NCT02906670|11904048|FG004|Cohort 6P, Q2W|Clinical Progression|0
7547547|NCT02906670|11904049|FG005|Cohort 6P, Q2W|Clinical Progression|0
7547548|NCT02906670|11904050|FG006|Cohort 6P, Q2W|Clinical Progression|0
7547549|NCT02906670|11904051|FG007|Cohort 6P, Q2W|Clinical Progression|0
7547550|NCT02906670|11904052|FG008|Cohort 6P, Q2W|Clinical Progression|3
7547551|NCT02906670|11904053|FG009|Cohort 6P, Q2W|Clinical Progression|0
7547552|NCT02906670|11904044|FG000|Cohort 4P, QW|Radiological Progression|0
7547553|NCT02906670|11904045|FG001|Cohort 4P, QW|Radiological Progression|0
7547554|NCT02906670|11904046|FG002|Cohort 4P, QW|Radiological Progression|0
7547555|NCT02906670|11904047|FG003|Cohort 4P, QW|Radiological Progression|3
7547556|NCT02906670|11904048|FG004|Cohort 4P, QW|Radiological Progression|0
7547557|NCT02906670|11904049|FG005|Cohort 4P, QW|Radiological Progression|0
7547558|NCT02906670|11904050|FG006|Cohort 4P, QW|Radiological Progression|0
7547559|NCT02906670|11904051|FG007|Cohort 4P, QW|Radiological Progression|0
7547560|NCT02906670|11904052|FG008|Cohort 4P, QW|Radiological Progression|0
7547561|NCT02906670|11904053|FG009|Cohort 4P, QW|Radiological Progression|0
7547562|NCT02906670|11904044|FG000|Cohort 7P, Q2W|Adverse Event|0
7547563|NCT02906670|11904045|FG001|Cohort 7P, Q2W|Adverse Event|0
7547564|NCT02906670|11904046|FG002|Cohort 7P, Q2W|Adverse Event|0
7547565|NCT02906670|11904047|FG003|Cohort 7P, Q2W|Adverse Event|0
7547566|NCT02906670|11904048|FG004|Cohort 7P, Q2W|Adverse Event|0
7547567|NCT02906670|11904049|FG005|Cohort 7P, Q2W|Adverse Event|0
7547568|NCT02906670|11904050|FG006|Cohort 7P, Q2W|Adverse Event|0
7547569|NCT02906670|11904051|FG007|Cohort 7P, Q2W|Adverse Event|0
7547570|NCT02906670|11904052|FG008|Cohort 7P, Q2W|Adverse Event|0
7547571|NCT02906670|11904053|FG009|Cohort 7P, Q2W|Adverse Event|1
7547572|NCT02906670|11904044|FG000|Cohort 7P, Q2W|Physician Decision|0
7547573|NCT02906670|11904045|FG001|Cohort 7P, Q2W|Physician Decision|0
7547574|NCT02906670|11904046|FG002|Cohort 7P, Q2W|Physician Decision|0
7547575|NCT02906670|11904047|FG003|Cohort 7P, Q2W|Physician Decision|0
7547576|NCT02906670|11904048|FG004|Cohort 7P, Q2W|Physician Decision|0
7547577|NCT02906670|11904049|FG005|Cohort 7P, Q2W|Physician Decision|0
7547578|NCT02906670|11904050|FG006|Cohort 7P, Q2W|Physician Decision|0
7547579|NCT02906670|11904051|FG007|Cohort 7P, Q2W|Physician Decision|0
7547580|NCT02906670|11904052|FG008|Cohort 7P, Q2W|Physician Decision|0
7547581|NCT02906670|11904053|FG009|Cohort 7P, Q2W|Physician Decision|1
7547582|NCT02906670|11904044|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547583|NCT02906670|11904045|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547584|NCT02906670|11904046|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547585|NCT02906670|11904047|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547586|NCT02906670|11904048|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547587|NCT02906670|11904049|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547588|NCT02906670|11904050|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547589|NCT02906670|11904051|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547590|NCT02906670|11904052|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
7547591|NCT02906670|11904053|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
7547592|NCT02906670|11904044|FG000|Cohort 5P, QW|Radiological Progression|0
7547593|NCT02906670|11904045|FG001|Cohort 5P, QW|Radiological Progression|0
7547594|NCT02906670|11904046|FG002|Cohort 5P, QW|Radiological Progression|0
7547595|NCT02906670|11904047|FG003|Cohort 5P, QW|Radiological Progression|0
7547596|NCT02906670|11904048|FG004|Cohort 5P, QW|Radiological Progression|3
7547597|NCT02906670|11904049|FG005|Cohort 5P, QW|Radiological Progression|0
7547598|NCT02906670|11904050|FG006|Cohort 5P, QW|Radiological Progression|0
7547599|NCT02906670|11904051|FG007|Cohort 5P, QW|Radiological Progression|0
7547600|NCT02906670|11904052|FG008|Cohort 5P, QW|Radiological Progression|0
7547601|NCT02906670|11904053|FG009|Cohort 5P, QW|Radiological Progression|0
7547602|NCT02906709|11904109|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
7547603|NCT02906709|11904110|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
7547604|NCT02906709|11904109|FG000|Phase A (Week 0 to Week 16)|Death|0
7547605|NCT02906709|11904110|FG001|Phase A (Week 0 to Week 16)|Death|1
7547606|NCT02906709|11904109|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
7547607|NCT02906709|11904110|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
7547608|NCT02906709|11904109|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
7267558|NCT00401973|11481877|FG000|Overall Study|Clinical Relapse|0
7267559|NCT00401973|11481878|FG001|Overall Study|Clinical Relapse|1
7267560|NCT00401973|11481879|FG002|Overall Study|Clinical Relapse|1
7547609|NCT02906709|11904110|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
7547610|NCT02906917|11904137|FG000|Initiation Period (Week 0-26)|Unclassified|1
7547611|NCT02906917|11904138|FG001|Initiation Period (Week 0-26)|Unclassified|3
7547612|NCT02906917|11904137|FG000|Initiation Period (Week 0-26)|Adverse Event|1
7547613|NCT02906917|11904138|FG001|Initiation Period (Week 0-26)|Adverse Event|0
7267561|NCT00401973|11481877|FG000|Overall Study|Lack of Efficacy|0
7267562|NCT00401973|11481878|FG001|Overall Study|Lack of Efficacy|0
7267563|NCT00401973|11481879|FG002|Overall Study|Lack of Efficacy|3
7267564|NCT00401973|11481877|FG000|Overall Study|Lost to Follow-up|2
7267565|NCT00401973|11481878|FG001|Overall Study|Lost to Follow-up|2
7267566|NCT00401973|11481879|FG002|Overall Study|Lost to Follow-up|2
7267567|NCT00401973|11481877|FG000|Overall Study|Physician Decision|2
7267568|NCT00401973|11481878|FG001|Overall Study|Physician Decision|0
7267569|NCT00401973|11481879|FG002|Overall Study|Physician Decision|1
7267570|NCT00401973|11481877|FG000|Overall Study|Protocol Violation|1
7267571|NCT00401973|11481878|FG001|Overall Study|Protocol Violation|2
7267572|NCT00401973|11481879|FG002|Overall Study|Protocol Violation|3
7267573|NCT00401973|11481877|FG000|Overall Study|Sponsor Decision|0
7267574|NCT00401973|11481878|FG001|Overall Study|Sponsor Decision|1
7267575|NCT00401973|11481879|FG002|Overall Study|Sponsor Decision|0
7267576|NCT00401973|11481877|FG000|Overall Study|Withdrawal by Subject|4
7267577|NCT00401973|11481878|FG001|Overall Study|Withdrawal by Subject|12
7267578|NCT00401973|11481879|FG002|Overall Study|Withdrawal by Subject|9
7267579|NCT00402025|11481901|FG000|Overall Study|Adverse Event|0
7267580|NCT00402025|11481902|FG001|Overall Study|Adverse Event|0
7267581|NCT00402025|11481903|FG002|Overall Study|Adverse Event|2
7267582|NCT00402025|11481901|FG000|Overall Study|Death|0
7267583|NCT00402025|11481902|FG001|Overall Study|Death|1
7267584|NCT00402025|11481903|FG002|Overall Study|Death|5
7267585|NCT00402025|11481901|FG000|Overall Study|Disease Progression|1
7267586|NCT00402025|11481902|FG001|Overall Study|Disease Progression|1
7267587|NCT00402025|11481903|FG002|Overall Study|Disease Progression|2
7267588|NCT00402025|11481901|FG000|Overall Study|Physician Decision|1
7267589|NCT00402025|11481902|FG001|Overall Study|Physician Decision|1
7267590|NCT00402025|11481903|FG002|Overall Study|Physician Decision|0
7267591|NCT00402025|11481901|FG000|Overall Study|Participant Decision|0
7267592|NCT00402025|11481902|FG001|Overall Study|Participant Decision|0
7267593|NCT00402025|11481903|FG002|Overall Study|Participant Decision|1
7267594|NCT00402051|11481913|FG000|Overall Study|Progressive Disease|13
7267595|NCT00402051|11481914|FG001|Overall Study|Progressive Disease|20
7267596|NCT00402051|11481913|FG000|Overall Study|Adverse Event|11
7267597|NCT00402051|11481914|FG001|Overall Study|Adverse Event|4
7267598|NCT00402051|11481913|FG000|Overall Study|Physician Decision|7
7267599|NCT00402051|11481914|FG001|Overall Study|Physician Decision|3
7267600|NCT00402051|11481913|FG000|Overall Study|Withdrawal by Subject|3
7267601|NCT00402051|11481914|FG001|Overall Study|Withdrawal by Subject|3
7267602|NCT00402051|11481913|FG000|Overall Study|Death - Related to Study Drug|1
7267603|NCT00402051|11481914|FG001|Overall Study|Death - Related to Study Drug|2
7267604|NCT00402051|11481913|FG000|Overall Study|Death Due to Study Disease|2
7267605|NCT00402051|11481914|FG001|Overall Study|Death Due to Study Disease|1
7267606|NCT00402051|11481913|FG000|Overall Study|Death Due to Adverse Event|0
7267607|NCT00402051|11481914|FG001|Overall Study|Death Due to Adverse Event|2
7267608|NCT00402051|11481913|FG000|Overall Study|Lost to Follow-up|1
7267609|NCT00402051|11481914|FG001|Overall Study|Lost to Follow-up|0
7267610|NCT00402103|11481922|FG000|Overall Study|Adverse Event|60
7267611|NCT00402103|11481923|FG001|Overall Study|Adverse Event|7
7267612|NCT00402103|11481922|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7267613|NCT00402103|11481923|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7267614|NCT00402103|11481922|FG000|Overall Study|Condition no longer requires study drug|2
7267615|NCT00402103|11481923|FG001|Overall Study|Condition no longer requires study drug|0
7267616|NCT00402103|11481922|FG000|Overall Study|Protocol Deviation|8
7267617|NCT00402103|11481923|FG001|Overall Study|Protocol Deviation|0
7267618|NCT00402103|11481922|FG000|Overall Study|Patient withdrew consent|12
7267619|NCT00402103|11481923|FG001|Overall Study|Patient withdrew consent|1
7267620|NCT00402103|11481922|FG000|Overall Study|Lost to Follow-up|6
7267621|NCT00402103|11481923|FG001|Overall Study|Lost to Follow-up|3
7267622|NCT00402103|11481922|FG000|Overall Study|Administrative problems|2
7267623|NCT00402103|11481923|FG001|Overall Study|Administrative problems|0
7547614|NCT02906917|11904137|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
7267624|NCT00402116|11481936|FG000|Overall Study|Jaw infection after surgery-other|1
7267625|NCT00402116|11481937|FG001|Overall Study|Jaw infection after surgery-other|0
7267626|NCT00402116|11481938|FG002|Overall Study|Jaw infection after surgery-other|0
7267627|NCT00402116|11481936|FG000|Overall Study|Withdrawal by Subject|1
7267628|NCT00402116|11481937|FG001|Overall Study|Withdrawal by Subject|0
7267629|NCT00402116|11481938|FG002|Overall Study|Withdrawal by Subject|5
7267630|NCT00402116|11481936|FG000|Overall Study|Treatment completed per protocol|1
7267631|NCT00402116|11481937|FG001|Overall Study|Treatment completed per protocol|1
7267632|NCT00402116|11481938|FG002|Overall Study|Treatment completed per protocol|2
7267633|NCT00402116|11481936|FG000|Overall Study|other complicating disease|0
7547615|NCT02906917|11904138|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
7267634|NCT00402116|11481937|FG001|Overall Study|other complicating disease|0
7267635|NCT00402116|11481938|FG002|Overall Study|other complicating disease|2
7267636|NCT00402116|11481936|FG000|Overall Study|Disease Progression|0
7267637|NCT00402116|11481937|FG001|Overall Study|Disease Progression|4
7267638|NCT00402116|11481938|FG002|Overall Study|Disease Progression|38
7267639|NCT00402116|11481936|FG000|Overall Study|mistaken thrombocytopenia|0
7267640|NCT00402116|11481937|FG001|Overall Study|mistaken thrombocytopenia|0
7267641|NCT00402116|11481938|FG002|Overall Study|mistaken thrombocytopenia|1
7267642|NCT00402116|11481936|FG000|Overall Study|decline related hyponatremia/tumor|0
7267643|NCT00402116|11481937|FG001|Overall Study|decline related hyponatremia/tumor|0
7267644|NCT00402116|11481938|FG002|Overall Study|decline related hyponatremia/tumor|1
7267645|NCT00402116|11481936|FG000|Overall Study|Adverse Event|0
7267646|NCT00402116|11481937|FG001|Overall Study|Adverse Event|1
7267647|NCT00402116|11481938|FG002|Overall Study|Adverse Event|6
7267648|NCT00402168|11481968|FG000|Randomized|Lost to Follow-up|1
7267649|NCT00402168|11481969|FG001|Randomized|Lost to Follow-up|0
7267650|NCT00402168|11481968|FG000|Randomized|Withdrawal by Subject|0
7267651|NCT00402168|11481969|FG001|Randomized|Withdrawal by Subject|1
7267652|NCT00402168|11481968|FG000|Treatment (up to 12 Months)|Death|0
7267653|NCT00402168|11481969|FG001|Treatment (up to 12 Months)|Death|1
7267654|NCT00402168|11481968|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
7267655|NCT00402168|11481969|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
7267656|NCT00402168|11481968|FG000|Treatment (up to 12 Months)|non-specified|0
7267657|NCT00402168|11481969|FG001|Treatment (up to 12 Months)|non-specified|1
7267658|NCT00402168|11481968|FG000|Long Term (LT)|Adverse Event|1
7267659|NCT00402168|11481969|FG001|Long Term (LT)|Adverse Event|5
7267660|NCT00402168|11481968|FG000|Long Term (LT)|Withdrawal by Subject|4
7267661|NCT00402168|11481969|FG001|Long Term (LT)|Withdrawal by Subject|7
7267662|NCT00402168|11481968|FG000|Long Term (LT)|Pregnancy|0
7267663|NCT00402168|11481969|FG001|Long Term (LT)|Pregnancy|1
7267664|NCT00402168|11481968|FG000|Long Term (LT)|Lost to Follow-up|1
7267665|NCT00402168|11481969|FG001|Long Term (LT)|Lost to Follow-up|0
7267666|NCT00402168|11481968|FG000|Long Term (LT)|Death|4
7267667|NCT00402168|11481969|FG001|Long Term (LT)|Death|0
7267668|NCT00402168|11481968|FG000|Long Term (LT)|Lack of Efficacy|0
7547616|NCT02906917|11904137|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
7547617|NCT02906917|11904138|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
7547618|NCT02906917|11904137|FG000|Intensification Period (Week 26-38)|Unclassified|3
7547619|NCT02906917|11904138|FG001|Intensification Period (Week 26-38)|Unclassified|2
7547620|NCT02906917|11904137|FG000|Intensification Period (Week 26-38)|Adverse Event|0
7547621|NCT02906917|11904138|FG001|Intensification Period (Week 26-38)|Adverse Event|2
7547622|NCT02906917|11904137|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
7547623|NCT02906917|11904138|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
7547624|NCT02906917|11904137|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
7547625|NCT02906917|11904138|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
7547642|NCT02907177|11904176|FG000|Overall Study|Death|0
7547643|NCT02907177|11904177|FG001|Overall Study|Death|1
7547644|NCT02907177|11904176|FG000|Overall Study|Physician Decision|3
7547645|NCT02907177|11904177|FG001|Overall Study|Physician Decision|3
7547646|NCT02907177|11904176|FG000|Overall Study|Withdrawal by Subject|15
7547647|NCT02907177|11904177|FG001|Overall Study|Withdrawal by Subject|7
7547648|NCT02907177|11904176|FG000|Overall Study|Sponsor's Decision|50
7547649|NCT02907177|11904177|FG001|Overall Study|Sponsor's Decision|57
7547650|NCT02907216|11904185|FG000|Overall Study|No benefit to be obtained by continuing|0
7547651|NCT02907216|11904186|FG001|Overall Study|No benefit to be obtained by continuing|1
7547652|NCT02907216|11904185|FG000|Overall Study|Withdrawal by Subject|1
7547653|NCT02907216|11904186|FG001|Overall Study|Withdrawal by Subject|0
7547654|NCT02907463|11904200|FG000|Overall Study|Lost to Follow-up|17
7547655|NCT02907463|11904200|FG000|Overall Study|Death|10
7547656|NCT02907463|11904200|FG000|Overall Study|Withdrawal by Subject|4
7547657|NCT02907463|11904200|FG000|Overall Study|MIS Approach was not used|2
7547658|NCT02907463|11904200|FG000|Overall Study|Not Implanted with Study Device|2
7547659|NCT02907463|11904200|FG000|Overall Study|Device Explanted|1
7547660|NCT02907463|11904200|FG000|Overall Study|Missing Exit Form|1
7547661|NCT02907619|11904224|FG000|Overall Study|Study terminated by sponsor|18
7267669|NCT00402168|11481969|FG001|Long Term (LT)|Lack of Efficacy|2
7267670|NCT00402168|11481968|FG000|Long Term (LT)|non-specified|1
7267671|NCT00402168|11481969|FG001|Long Term (LT)|non-specified|2
7267672|NCT00402168|11481968|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
7267673|NCT00402168|11481969|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
7547662|NCT02907619|11904225|FG001|Overall Study|Study terminated by sponsor|18
7547663|NCT02907619|11904226|FG002|Overall Study|Study terminated by sponsor|19
7547664|NCT02907619|11904224|FG000|Overall Study|Death|0
7547665|NCT02907619|11904225|FG001|Overall Study|Death|0
7267674|NCT00402168|11481968|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
7267675|NCT00402168|11481969|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
7267676|NCT00402233|11481996|FG000|Overall Study|Adverse Event|1
7267677|NCT00402233|11481997|FG001|Overall Study|Adverse Event|7
7267678|NCT00402233|11481998|FG002|Overall Study|Adverse Event|9
7267679|NCT00402233|11481999|FG003|Overall Study|Adverse Event|9
7267680|NCT00402233|11481996|FG000|Overall Study|Protocol Violation|0
7267681|NCT00402233|11481997|FG001|Overall Study|Protocol Violation|1
7547666|NCT02907619|11904226|FG002|Overall Study|Death|1
7547667|NCT02907619|11904224|FG000|Overall Study|Withdrawal by Subject|1
7547668|NCT02907619|11904225|FG001|Overall Study|Withdrawal by Subject|1
7547669|NCT02907619|11904226|FG002|Overall Study|Withdrawal by Subject|0
7547670|NCT02907619|11904224|FG000|Overall Study|Other|0
7547671|NCT02907619|11904225|FG001|Overall Study|Other|1
7547672|NCT02907619|11904226|FG002|Overall Study|Other|0
7547673|NCT02907892|11904247|FG000|Overall Study|Lost to Follow-up|27
7547674|NCT02907892|11904248|FG001|Overall Study|Lost to Follow-up|40
7547675|NCT02908100|11904264|FG000|Overall Study|Adverse Event|7
7547676|NCT02908100|11904265|FG001|Overall Study|Adverse Event|6
7547677|NCT02908100|11904266|FG002|Overall Study|Adverse Event|9
7267682|NCT00402233|11481998|FG002|Overall Study|Protocol Violation|0
7267683|NCT00402233|11481999|FG003|Overall Study|Protocol Violation|0
7267684|NCT00402233|11481996|FG000|Overall Study|Withdrawal by Subject|2
7267685|NCT00402233|11481997|FG001|Overall Study|Withdrawal by Subject|1
7267686|NCT00402233|11481998|FG002|Overall Study|Withdrawal by Subject|2
7267687|NCT00402233|11481999|FG003|Overall Study|Withdrawal by Subject|2
7547678|NCT02908100|11904264|FG000|Overall Study|Death|2
7547679|NCT02908100|11904265|FG001|Overall Study|Death|0
7547680|NCT02908100|11904266|FG002|Overall Study|Death|0
7547681|NCT02908100|11904264|FG000|Overall Study|Lack of Efficacy|2
7547682|NCT02908100|11904265|FG001|Overall Study|Lack of Efficacy|3
7547683|NCT02908100|11904266|FG002|Overall Study|Lack of Efficacy|3
7547684|NCT02908100|11904264|FG000|Overall Study|Lost to Follow-up|0
7547685|NCT02908100|11904265|FG001|Overall Study|Lost to Follow-up|1
7547686|NCT02908100|11904266|FG002|Overall Study|Lost to Follow-up|2
7547687|NCT02908100|11904264|FG000|Overall Study|Non-Compliance With Study Drug|1
7547688|NCT02908100|11904265|FG001|Overall Study|Non-Compliance With Study Drug|1
7547689|NCT02908100|11904266|FG002|Overall Study|Non-Compliance With Study Drug|2
7547690|NCT02908100|11904264|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
7547691|NCT02908100|11904265|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
7547692|NCT02908100|11904266|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
7547693|NCT02908100|11904264|FG000|Overall Study|Physician Decision|0
7547694|NCT02908100|11904265|FG001|Overall Study|Physician Decision|1
7547695|NCT02908100|11904266|FG002|Overall Study|Physician Decision|0
7547696|NCT02908100|11904264|FG000|Overall Study|Pregnancy|1
7547697|NCT02908100|11904265|FG001|Overall Study|Pregnancy|2
7547698|NCT02908100|11904266|FG002|Overall Study|Pregnancy|0
7547699|NCT02908100|11904264|FG000|Overall Study|Withdrawal by Subject|8
7547700|NCT02908100|11904265|FG001|Overall Study|Withdrawal by Subject|7
7547701|NCT02908100|11904266|FG002|Overall Study|Withdrawal by Subject|5
7547702|NCT02908100|11904264|FG000|Overall Study|Randomised in Error|1
7547703|NCT02908100|11904265|FG001|Overall Study|Randomised in Error|0
7547704|NCT02908100|11904266|FG002|Overall Study|Randomised in Error|0
7547705|NCT02908347|11904294|FG000|Overall Study|Adverse Event|0
7547706|NCT02908347|11904295|FG001|Overall Study|Adverse Event|1
7547707|NCT02908347|11904294|FG000|Overall Study|Lost to Follow-up|1
7547708|NCT02908347|11904295|FG001|Overall Study|Lost to Follow-up|0
7547709|NCT02908464|11904317|FG000|Overall Study|Withdrawal by Subject|2
7547710|NCT02908464|11904318|FG001|Overall Study|Withdrawal by Subject|1
7547711|NCT02908464|11904317|FG000|Overall Study|Found ineligible after randomization|0
7547712|NCT02908464|11904318|FG001|Overall Study|Found ineligible after randomization|2
7547713|NCT02908529|11904334|FG000|Overall Study|Lost to Follow-up|0
7547714|NCT02908529|11904335|FG001|Overall Study|Lost to Follow-up|2
7547715|NCT02908841|11904366|FG000|Overall Study|Physician Decision|4
7547716|NCT02908841|11904367|FG001|Overall Study|Physician Decision|0
7547717|NCT02908880|11904373|FG000|Overall Study|Lost to Follow-up|4
7547718|NCT02908880|11904373|FG000|Overall Study|Explantation of the device|1
7547719|NCT02908880|11904373|FG000|Overall Study|Withdrawal by Subject|17
7547720|NCT02908880|11904373|FG000|Overall Study|Death|5
7547721|NCT02909101|11904379|FG000|Overall Study|Lost to Follow-up|1
7547722|NCT02909101|11904380|FG001|Overall Study|Lost to Follow-up|1
7547723|NCT02909153|11904404|FG000|Overall Study|Withdrawal by Subject|0
7547724|NCT02909153|11904405|FG001|Overall Study|Withdrawal by Subject|1
7547725|NCT02909153|11904406|FG002|Overall Study|Withdrawal by Subject|0
7547726|NCT02909153|11904407|FG003|Overall Study|Withdrawal by Subject|0
7547727|NCT02909153|11904408|FG004|Overall Study|Withdrawal by Subject|0
7577489|NCT03988088|11967329|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
7577490|NCT03988088|11967330|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
7267688|NCT00402233|11481996|FG000|Overall Study|Worsening of disease under study|2
7267689|NCT00402233|11481997|FG001|Overall Study|Worsening of disease under study|0
7547728|NCT02909504|11904429|FG000|Overall Study|Adverse Event|2
7547729|NCT02909504|11904429|FG000|Overall Study|Lack of Efficacy|3
7547730|NCT02909504|11904429|FG000|Overall Study|Withdrawal by Subject|4
7547731|NCT02909504|11904429|FG000|Overall Study|Pregnancy|1
7547732|NCT02909504|11904429|FG000|Overall Study|Subject moved|1
7547733|NCT02909504|11904429|FG000|Overall Study|Lost to Follow-up|1
7547734|NCT02909907|11904448|FG000|Overall Study|Withdrawal by Subject|0
7267690|NCT00402233|11481998|FG002|Overall Study|Worsening of disease under study|0
7267691|NCT00402233|11481999|FG003|Overall Study|Worsening of disease under study|0
7267692|NCT00402233|11481996|FG000|Overall Study|Worsening of other pre-existing disease|0
7267693|NCT00402233|11481997|FG001|Overall Study|Worsening of other pre-existing disease|1
7267694|NCT00402233|11481998|FG002|Overall Study|Worsening of other pre-existing disease|0
7267695|NCT00402233|11481999|FG003|Overall Study|Worsening of other pre-existing disease|0
7267696|NCT00402246|11482011|FG000|Overall Study|Death|62
7267697|NCT00402246|11482012|FG001|Overall Study|Death|58
7267698|NCT00402246|11482011|FG000|Overall Study|Lost to Follow-up|20
7267699|NCT00402246|11482012|FG001|Overall Study|Lost to Follow-up|28
7267700|NCT00402246|11482011|FG000|Overall Study|Withdrawal by Subject|72
7267701|NCT00402246|11482012|FG001|Overall Study|Withdrawal by Subject|87
7267702|NCT00402246|11482011|FG000|Overall Study|Physician Decision|24
7267703|NCT00402246|11482012|FG001|Overall Study|Physician Decision|26
7267704|NCT00402246|11482011|FG000|Overall Study|Protocol Violation|25
7267705|NCT00402246|11482012|FG001|Overall Study|Protocol Violation|24
7267706|NCT00402246|11482011|FG000|Overall Study|Missed Final Visit|1
7267707|NCT00402246|11482012|FG001|Overall Study|Missed Final Visit|2
7267708|NCT00402246|11482011|FG000|Overall Study|Insurance Issues|2
7267709|NCT00402246|11482012|FG001|Overall Study|Insurance Issues|1
7267710|NCT00402246|11482011|FG000|Overall Study|Heart Transplant|0
7267711|NCT00402246|11482012|FG001|Overall Study|Heart Transplant|1
7267712|NCT00402246|11482011|FG000|Overall Study|Patient's device explanted|6
7267713|NCT00402246|11482012|FG001|Overall Study|Patient's device explanted|2
7267714|NCT00402246|11482011|FG000|Overall Study|Center Closure|5
7267715|NCT00402246|11482012|FG001|Overall Study|Center Closure|3
7267716|NCT00402246|11482011|FG000|Overall Study|Deterioriating Condition|3
7267717|NCT00402246|11482012|FG001|Overall Study|Deterioriating Condition|2
7267718|NCT00402285|11482023|FG000|Overall Study|insufficient RNA quality|7
7267719|NCT00402285|11482024|FG001|Overall Study|insufficient RNA quality|6
7267720|NCT00402285|11482025|FG002|Overall Study|insufficient RNA quality|2
7577491|NCT03988088|11967327|FG000|Open-Label Addendum|Lost to Follow-up|0
7577492|NCT03988088|11967328|FG001|Open-Label Addendum|Lost to Follow-up|0
7267723|NCT00402324|11482042|FG000|Overall Study|Lost to Follow-up|11
7267724|NCT00402324|11482043|FG001|Overall Study|Lost to Follow-up|11
7267725|NCT00402324|11482042|FG000|Overall Study|Protocol Entry Criteria Not Met|5
7267726|NCT00402324|11482043|FG001|Overall Study|Protocol Entry Criteria Not Met|4
7267727|NCT00402324|11482042|FG000|Overall Study|Protocol Violation|8
7267728|NCT00402324|11482043|FG001|Overall Study|Protocol Violation|7
7267729|NCT00402324|11482042|FG000|Overall Study|Withdrawal by Subject|5
7267730|NCT00402324|11482043|FG001|Overall Study|Withdrawal by Subject|2
7267731|NCT00402324|11482042|FG000|Overall Study|Physician Decision|2
7267732|NCT00402324|11482043|FG001|Overall Study|Physician Decision|4
7267733|NCT00402324|11482042|FG000|Overall Study|Sponsor Decision|4
7267734|NCT00402324|11482043|FG001|Overall Study|Sponsor Decision|5
7267735|NCT00402324|11482042|FG000|Overall Study|Lack of Efficacy|1
7267736|NCT00402324|11482043|FG001|Overall Study|Lack of Efficacy|4
7267737|NCT00402324|11482042|FG000|Overall Study|Adverse Event|6
7267738|NCT00402324|11482043|FG001|Overall Study|Adverse Event|4
7267739|NCT00402324|11482042|FG000|Overall Study|Death|1
7267740|NCT00402324|11482043|FG001|Overall Study|Death|0
7267741|NCT00402337|11482054|FG000|Overall Study|Adverse Event|0
7267742|NCT00402337|11482055|FG001|Overall Study|Adverse Event|2
7547735|NCT02909907|11904449|FG001|Overall Study|Withdrawal by Subject|1
7547736|NCT02910011|11904464|FG000|Overall Study|Physician Decision|2
7547737|NCT02910037|11904470|FG000|Overall Study|Withdrawal by Subject|4
7547738|NCT02910037|11904470|FG000|Overall Study|Lost to Follow-up|6
7547739|NCT02910063|11904490|FG000|Phase 2|Withdrawal by Subject|3
7267743|NCT00402337|11482056|FG002|Overall Study|Adverse Event|2
7267744|NCT00402337|11482057|FG003|Overall Study|Adverse Event|3
7267745|NCT00402337|11482058|FG004|Overall Study|Adverse Event|2
7267746|NCT00402337|11482054|FG000|Overall Study|Noncompliance|0
7267747|NCT00402337|11482055|FG001|Overall Study|Noncompliance|0
7267748|NCT00402337|11482056|FG002|Overall Study|Noncompliance|0
7267749|NCT00402337|11482057|FG003|Overall Study|Noncompliance|0
7267750|NCT00402337|11482058|FG004|Overall Study|Noncompliance|2
7267751|NCT00402337|11482054|FG000|Overall Study|Withdrawal by Subject|5
7267752|NCT00402337|11482055|FG001|Overall Study|Withdrawal by Subject|3
7547740|NCT02910063|11904491|FG001|Phase 2|Withdrawal by Subject|0
7547741|NCT02910063|11904492|FG002|Phase 2|Withdrawal by Subject|0
7547742|NCT02910063|11904490|FG000|Phase 2|Lost to Follow-up|1
7547743|NCT02910063|11904491|FG001|Phase 2|Lost to Follow-up|0
7267753|NCT00402337|11482056|FG002|Overall Study|Withdrawal by Subject|1
7267754|NCT00402337|11482057|FG003|Overall Study|Withdrawal by Subject|6
7267755|NCT00402337|11482058|FG004|Overall Study|Withdrawal by Subject|4
7267756|NCT00402337|11482054|FG000|Overall Study|Lost to Follow-up|0
7267757|NCT00402337|11482055|FG001|Overall Study|Lost to Follow-up|0
7267758|NCT00402337|11482056|FG002|Overall Study|Lost to Follow-up|1
7267759|NCT00402337|11482057|FG003|Overall Study|Lost to Follow-up|2
7267760|NCT00402337|11482058|FG004|Overall Study|Lost to Follow-up|0
7267761|NCT00402337|11482054|FG000|Overall Study|Physician Decision|0
7267762|NCT00402337|11482055|FG001|Overall Study|Physician Decision|0
7267763|NCT00402337|11482056|FG002|Overall Study|Physician Decision|0
7547744|NCT02910063|11904492|FG002|Phase 2|Lost to Follow-up|0
7547745|NCT02910063|11904490|FG000|Phase 2|Death|24
7547746|NCT02910063|11904491|FG001|Phase 2|Death|0
7547747|NCT02910063|11904492|FG002|Phase 2|Death|0
7547748|NCT02910089|11904503|FG000|Overall Study|Lost insurance eligibility|22
7547749|NCT02910089|11904504|FG001|Overall Study|Lost insurance eligibility|16
7547750|NCT02910167|11904524|FG000|Overall Study|Adverse Event|1
7547751|NCT02910167|11904524|FG000|Overall Study|Lost to Follow-up|18
7547752|NCT02910466|11904537|FG000|Overall Study|Adverse Event|1
7547753|NCT02910466|11904537|FG000|Overall Study|Withdrawal by Subject|3
7547754|NCT02910466|11904537|FG000|Overall Study|Lost to Follow-up|5
7547755|NCT02910466|11904537|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29
7547756|NCT02910466|11904537|FG000|Overall Study|Participant didn't meet inclusion criteria|1
7547757|NCT02910713|11904546|FG000|Overall Study|Protocol Violation|2
7547758|NCT02910713|11904546|FG000|Overall Study|Subject Choice|4
7547759|NCT02910713|11904546|FG000|Overall Study|Received One Application|10
7547760|NCT02910713|11904546|FG000|Overall Study|Received Neither Application|18
7547761|NCT02910713|11904546|FG000|Overall Study|Enrollment cap|7
7547762|NCT02910713|11904546|FG000|Overall Study|Investigator Discretion|1
7547763|NCT02910739|11904553|FG000|Overall Study|Adverse Event|1
7547764|NCT02910739|11904554|FG001|Overall Study|Adverse Event|0
7547765|NCT02910739|11904555|FG002|Overall Study|Adverse Event|0
7547766|NCT02910739|11904556|FG003|Overall Study|Adverse Event|0
7547767|NCT02911025|11904562|FG000|Overall Study|Lost to Follow-up|3
7547768|NCT02911116|11904568|FG000|Overall Study|Insufficient Therapeutic Response|1
7547769|NCT02911116|11904569|FG001|Overall Study|Insufficient Therapeutic Response|0
7547770|NCT02911116|11904568|FG000|Overall Study|Lost to Follow-up|0
7547771|NCT02911116|11904569|FG001|Overall Study|Lost to Follow-up|1
7547772|NCT02911285|11904577|FG000|Overall Study|Lost to Follow-up|8
7547773|NCT02911285|11904578|FG001|Overall Study|Lost to Follow-up|5
7547774|NCT02911285|11904577|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
7547775|NCT02911285|11904578|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
7547776|NCT02911519|11904600|FG000|Overall Study|Lost to Follow-up|2
7547777|NCT02911519|11904601|FG001|Overall Study|Lost to Follow-up|2
7547778|NCT02911519|11904600|FG000|Overall Study|Death|0
7547779|NCT02911519|11904601|FG001|Overall Study|Death|2
7547780|NCT02911688|11904609|FG000|Washout|Lost to Follow-up|1
7547781|NCT02911688|11904610|FG001|Washout|Lost to Follow-up|1
7547782|NCT02911688|11904609|FG000|Washout|Withdrawal by Subject|0
7547783|NCT02911688|11904610|FG001|Washout|Withdrawal by Subject|1
7547784|NCT02911948|11904709|FG000|Overall Study|Protocol Violation|0
7547785|NCT02911948|11904710|FG001|Overall Study|Protocol Violation|1
7547786|NCT02911948|11904709|FG000|Overall Study|Withdrawal by Subject|0
7547787|NCT02911948|11904710|FG001|Overall Study|Withdrawal by Subject|2
7547788|NCT02911948|11904709|FG000|Overall Study|Lack of Efficacy|0
7547789|NCT02911948|11904710|FG001|Overall Study|Lack of Efficacy|1
7547790|NCT02911948|11904709|FG000|Overall Study|Unclassified|0
7267764|NCT00402337|11482057|FG003|Overall Study|Physician Decision|1
7547791|NCT02911948|11904710|FG001|Overall Study|Unclassified|3
7547792|NCT02912455|11904737|FG000|Overall Study|Withdrawal by Subject|0
7547793|NCT02912455|11904738|FG001|Overall Study|Withdrawal by Subject|1
7547794|NCT02912455|11904737|FG000|Overall Study|Lack of Efficacy|0
7547795|NCT02912455|11904738|FG001|Overall Study|Lack of Efficacy|1
7547796|NCT02912455|11904737|FG000|Overall Study|Lost to Follow-up|2
7547797|NCT02912455|11904738|FG001|Overall Study|Lost to Follow-up|1
7547798|NCT02912468|11904746|FG000|Overall Study|Adverse Event|3
7547799|NCT02912468|11904747|FG001|Overall Study|Adverse Event|2
7547800|NCT02912468|11904746|FG000|Overall Study|Withdrawal by Subject|6
7547801|NCT02912468|11904747|FG001|Overall Study|Withdrawal by Subject|2
7547802|NCT02912468|11904746|FG000|Overall Study|Randomized and not treated|0
7547803|NCT02912468|11904747|FG001|Overall Study|Randomized and not treated|1
7547804|NCT02912650|11904758|FG000|Overall Study|Withdrawal by Subject|1
7547805|NCT02912650|11904759|FG001|Overall Study|Withdrawal by Subject|0
7547806|NCT02912650|11904760|FG002|Overall Study|Withdrawal by Subject|1
7547807|NCT02912650|11904761|FG003|Overall Study|Withdrawal by Subject|5
7547808|NCT02912650|11904758|FG000|Overall Study|Adverse Event|0
7547809|NCT02912650|11904759|FG001|Overall Study|Adverse Event|0
7547810|NCT02912650|11904760|FG002|Overall Study|Adverse Event|1
7547811|NCT02912650|11904761|FG003|Overall Study|Adverse Event|0
7547812|NCT02913105|11904774|FG000|Overall Study|Adverse Event|11
7547813|NCT02913105|11904775|FG001|Overall Study|Adverse Event|0
7547814|NCT02913105|11904776|FG002|Overall Study|Adverse Event|4
7547815|NCT02913105|11904774|FG000|Overall Study|Non-Compliance With Study Drug|0
7547816|NCT02913105|11904775|FG001|Overall Study|Non-Compliance With Study Drug|0
7547817|NCT02913105|11904776|FG002|Overall Study|Non-Compliance With Study Drug|1
7547818|NCT02913105|11904774|FG000|Overall Study|Reason Not Specified|3
7547819|NCT02913105|11904775|FG001|Overall Study|Reason Not Specified|1
7547820|NCT02913105|11904776|FG002|Overall Study|Reason Not Specified|1
7547821|NCT02913105|11904774|FG000|Overall Study|Physician Decision|1
7547822|NCT02913105|11904775|FG001|Overall Study|Physician Decision|1
7547823|NCT02913105|11904776|FG002|Overall Study|Physician Decision|0
7547824|NCT02913105|11904774|FG000|Overall Study|Withdrawal by Subject|0
7547825|NCT02913105|11904775|FG001|Overall Study|Withdrawal by Subject|3
7547826|NCT02913105|11904776|FG002|Overall Study|Withdrawal by Subject|1
7547827|NCT02913326|11904787|FG000|Overall Study|Reason not listed|0
7267765|NCT00402337|11482058|FG004|Overall Study|Physician Decision|0
7267766|NCT00402337|11482054|FG000|Overall Study|Other Reason|0
7267767|NCT00402337|11482055|FG001|Overall Study|Other Reason|1
7267768|NCT00402337|11482056|FG002|Overall Study|Other Reason|0
7267769|NCT00402337|11482057|FG003|Overall Study|Other Reason|0
7267770|NCT00402337|11482058|FG004|Overall Study|Other Reason|0
7267771|NCT00402363|11482074|FG000|Overall Study|Adverse Event|9
7547828|NCT02913326|11904788|FG001|Overall Study|Reason not listed|1
7547829|NCT02913326|11904787|FG000|Overall Study|Lost to Follow-up|0
7547830|NCT02913326|11904788|FG001|Overall Study|Lost to Follow-up|1
7547831|NCT02913326|11904787|FG000|Overall Study|Adverse Event|1
7547832|NCT02913326|11904788|FG001|Overall Study|Adverse Event|0
7547833|NCT02914184|11904828|FG000|Overall Study|Lost to Follow-up|7
7547834|NCT02914184|11904829|FG001|Overall Study|Lost to Follow-up|10
7547835|NCT02914184|11904830|FG002|Overall Study|Lost to Follow-up|8
7547836|NCT02914184|11904831|FG003|Overall Study|Lost to Follow-up|7
7547837|NCT02914184|11904828|FG000|Overall Study|Withdrawal by Subject|4
7547838|NCT02914184|11904829|FG001|Overall Study|Withdrawal by Subject|2
7547839|NCT02914184|11904830|FG002|Overall Study|Withdrawal by Subject|7
7547840|NCT02914184|11904831|FG003|Overall Study|Withdrawal by Subject|3
7547841|NCT02914184|11904828|FG000|Overall Study|Other|1
7547842|NCT02914184|11904829|FG001|Overall Study|Other|0
7547843|NCT02914184|11904830|FG002|Overall Study|Other|0
7547844|NCT02914184|11904831|FG003|Overall Study|Other|0
7547845|NCT02914184|11904828|FG000|Overall Study|Migrated/moved from the study area|2
7547846|NCT02914184|11904829|FG001|Overall Study|Migrated/moved from the study area|1
7547847|NCT02914184|11904830|FG002|Overall Study|Migrated/moved from the study area|2
7547848|NCT02914184|11904831|FG003|Overall Study|Migrated/moved from the study area|1
7547849|NCT02914236|11904852|FG000|Overall Study|Lost to Follow-up|1
7547850|NCT02914275|11904858|FG000|Overall Study|Lost to Follow-up|84
7547851|NCT02914275|11904859|FG001|Overall Study|Lost to Follow-up|29
7547852|NCT02914275|11904858|FG000|Overall Study|Withdrawal by Subject|26
7547853|NCT02914275|11904859|FG001|Overall Study|Withdrawal by Subject|10
7547854|NCT02914275|11904858|FG000|Overall Study|Protocol Violation|1
7547855|NCT02914275|11904859|FG001|Overall Study|Protocol Violation|1
7547856|NCT02914275|11904858|FG000|Overall Study|Physician Decision|3
7547857|NCT02914275|11904859|FG001|Overall Study|Physician Decision|1
7547858|NCT02914275|11904858|FG000|Overall Study|Other|4
7547859|NCT02914275|11904859|FG001|Overall Study|Other|1
7577493|NCT03988088|11967329|FG002|Open-Label Addendum|Lost to Follow-up|1
7577494|NCT03988088|11967330|FG003|Open-Label Addendum|Lost to Follow-up|0
7577495|NCT03980522|11967343|FG000|Treatment Period|Adverse Event|1
7577496|NCT03980522|11967344|FG001|Treatment Period|Adverse Event|0
7577497|NCT03980522|11967345|FG002|Treatment Period|Adverse Event|0
7577498|NCT03980522|11967346|FG003|Treatment Period|Adverse Event|0
7577499|NCT03980522|11967347|FG004|Treatment Period|Adverse Event|0
7577500|NCT03995784|11967363|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
7577501|NCT03993392|11967374|FG000|Overall Study|Withdrawal by Subject|3
7577502|NCT03993392|11967374|FG000|Overall Study|Lost to Follow-up|2
7577503|NCT03993392|11967374|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
7577504|NCT03981822|11967397|FG000|Overall Study|Lost to Follow-up|0
7577505|NCT03981822|11967398|FG001|Overall Study|Lost to Follow-up|1
7577506|NCT03981822|11967399|FG002|Overall Study|Lost to Follow-up|1
7577507|NCT03981822|11967400|FG003|Overall Study|Lost to Follow-up|0
7577508|NCT03981822|11967401|FG004|Overall Study|Lost to Follow-up|6
7577509|NCT03981822|11967402|FG005|Overall Study|Lost to Follow-up|4
7577510|NCT03981822|11967403|FG006|Overall Study|Lost to Follow-up|4
7577511|NCT03981822|11967404|FG007|Overall Study|Lost to Follow-up|2
7577512|NCT03981822|11967397|FG000|Overall Study|Withdrawal by Subject|0
7577513|NCT03981822|11967398|FG001|Overall Study|Withdrawal by Subject|1
7577514|NCT03981822|11967399|FG002|Overall Study|Withdrawal by Subject|0
7577515|NCT03981822|11967400|FG003|Overall Study|Withdrawal by Subject|0
7577516|NCT03981822|11967401|FG004|Overall Study|Withdrawal by Subject|0
7577517|NCT03981822|11967402|FG005|Overall Study|Withdrawal by Subject|1
7577518|NCT03981822|11967403|FG006|Overall Study|Withdrawal by Subject|0
7577519|NCT03981822|11967404|FG007|Overall Study|Withdrawal by Subject|2
7577520|NCT03981822|11967397|FG000|Overall Study|COVID-19 Related|0
7577521|NCT03981822|11967398|FG001|Overall Study|COVID-19 Related|0
7577522|NCT03981822|11967399|FG002|Overall Study|COVID-19 Related|0
7577523|NCT03981822|11967400|FG003|Overall Study|COVID-19 Related|0
7577524|NCT03981822|11967401|FG004|Overall Study|COVID-19 Related|2
7267772|NCT00402363|11482075|FG001|Overall Study|Adverse Event|14
7267773|NCT00402363|11482076|FG002|Overall Study|Adverse Event|2
7577525|NCT03981822|11967402|FG005|Overall Study|COVID-19 Related|1
7267774|NCT00402363|11482077|FG003|Overall Study|Adverse Event|2
7577526|NCT03981822|11967403|FG006|Overall Study|COVID-19 Related|2
7577527|NCT03981822|11967404|FG007|Overall Study|COVID-19 Related|1
7577528|NCT03991494|11967457|FG000|Overall Study|Progressive Disease|4
7577529|NCT03988803|11967476|FG000|Period 2|Prematurely discontinued from medication|2
7577530|NCT03988803|11967476|FG000|Period 2|Adverse Event|1
7577531|NCT03987932|11967487|FG000|Overall Study|Lost to Follow-up|2
7577532|NCT03987932|11967488|FG001|Overall Study|Lost to Follow-up|1
7577533|NCT03987932|11967489|FG002|Overall Study|Lost to Follow-up|1
7267775|NCT00402363|11482074|FG000|Overall Study|Withdrew Consent|10
7577534|NCT03987932|11967487|FG000|Overall Study|Non-study related elective surgery|0
7267776|NCT00402363|11482075|FG001|Overall Study|Withdrew Consent|5
7577535|NCT03987932|11967488|FG001|Overall Study|Non-study related elective surgery|0
7577536|NCT03987932|11967489|FG002|Overall Study|Non-study related elective surgery|1
7577537|NCT03987191|11967499|FG000|Overall Study|COVID-19 related research disruption|0
7577538|NCT03987191|11967500|FG001|Overall Study|COVID-19 related research disruption|2
7577539|NCT03988842|11967506|FG000|Overall Study|Death|1
7577540|NCT03981861|11967511|FG000|Overall Study|Withdrawal by Subject|3
7267777|NCT00402363|11482076|FG002|Overall Study|Withdrew Consent|2
7267778|NCT00402363|11482077|FG003|Overall Study|Withdrew Consent|1
7267779|NCT00402363|11482074|FG000|Overall Study|Protocol Violation|3
7267780|NCT00402363|11482075|FG001|Overall Study|Protocol Violation|5
7267781|NCT00402363|11482076|FG002|Overall Study|Protocol Violation|0
7267782|NCT00402363|11482077|FG003|Overall Study|Protocol Violation|3
7267783|NCT00402363|11482074|FG000|Overall Study|Lost to Follow-up|5
7267784|NCT00402363|11482075|FG001|Overall Study|Lost to Follow-up|4
7267785|NCT00402363|11482076|FG002|Overall Study|Lost to Follow-up|0
7267786|NCT00402363|11482077|FG003|Overall Study|Lost to Follow-up|2
7267787|NCT00402363|11482074|FG000|Overall Study|"Captured as Other"|6
7267788|NCT00402363|11482075|FG001|Overall Study|"Captured as Other"|2
7267789|NCT00402363|11482076|FG002|Overall Study|"Captured as Other"|2
7267790|NCT00402363|11482077|FG003|Overall Study|"Captured as Other"|2
7267791|NCT00402597|11482098|FG000|Overall Study|Death|15
7267792|NCT00402597|11482099|FG001|Overall Study|Death|7
7267793|NCT00402597|11482100|FG002|Overall Study|Death|6
7547860|NCT02914275|11904858|FG000|Overall Study|Excluded due to invalid informed consent|3
7547861|NCT02914275|11904859|FG001|Overall Study|Excluded due to invalid informed consent|0
7547862|NCT02914457|11904869|FG000|Overall Study|Withdrawal by Subject|1
7547863|NCT02914457|11904869|FG000|Overall Study|Physician Decision|1
7547864|NCT02914457|11904869|FG000|Overall Study|No veins available for lead placement|1
7547865|NCT02914457|11904869|FG000|Overall Study|Electrical instability of patient|1
7267794|NCT00402597|11482101|FG003|Overall Study|Death|4
7267795|NCT00402597|11482102|FG004|Overall Study|Death|6
7267796|NCT00402597|11482098|FG000|Overall Study|Adverse Event|81
7267797|NCT00402597|11482099|FG001|Overall Study|Adverse Event|18
7267798|NCT00402597|11482100|FG002|Overall Study|Adverse Event|106
7267799|NCT00402597|11482101|FG003|Overall Study|Adverse Event|39
7267800|NCT00402597|11482102|FG004|Overall Study|Adverse Event|71
7267801|NCT00402597|11482098|FG000|Overall Study|Lost to Follow-up|8
7267802|NCT00402597|11482099|FG001|Overall Study|Lost to Follow-up|1
7267803|NCT00402597|11482100|FG002|Overall Study|Lost to Follow-up|8
7267804|NCT00402597|11482101|FG003|Overall Study|Lost to Follow-up|2
7267805|NCT00402597|11482102|FG004|Overall Study|Lost to Follow-up|3
7267806|NCT00402597|11482098|FG000|Overall Study|Withdrawal by Subject|57
7267807|NCT00402597|11482099|FG001|Overall Study|Withdrawal by Subject|16
7267808|NCT00402597|11482100|FG002|Overall Study|Withdrawal by Subject|65
7267809|NCT00402597|11482101|FG003|Overall Study|Withdrawal by Subject|15
7267810|NCT00402597|11482102|FG004|Overall Study|Withdrawal by Subject|24
7267811|NCT00402597|11482098|FG000|Overall Study|reason not specified|30
7267812|NCT00402597|11482099|FG001|Overall Study|reason not specified|4
7267813|NCT00402597|11482100|FG002|Overall Study|reason not specified|27
7267814|NCT00402597|11482101|FG003|Overall Study|reason not specified|14
7267815|NCT00402597|11482102|FG004|Overall Study|reason not specified|20
7267816|NCT00402649|11482114|FG000|Overall Study|Lost to Follow-up|1
7267817|NCT00402649|11482114|FG000|Overall Study|Withdrawal by Subject|1
7267818|NCT00402688|11482121|FG000|Overall Study|Adverse Event|12
7267819|NCT00402688|11482122|FG001|Overall Study|Adverse Event|9
7267820|NCT00402688|11482123|FG002|Overall Study|Adverse Event|3
7267821|NCT00402688|11482121|FG000|Overall Study|Withdrawal by Subject|3
7267822|NCT00402688|11482122|FG001|Overall Study|Withdrawal by Subject|1
7267823|NCT00402688|11482123|FG002|Overall Study|Withdrawal by Subject|1
7267824|NCT00402688|11482121|FG000|Overall Study|Physician Decision|0
7267825|NCT00402688|11482122|FG001|Overall Study|Physician Decision|0
7267826|NCT00402688|11482123|FG002|Overall Study|Physician Decision|1
7267827|NCT00402688|11482121|FG000|Overall Study|Lack of Efficacy|4
7267828|NCT00402688|11482122|FG001|Overall Study|Lack of Efficacy|4
7267829|NCT00402688|11482123|FG002|Overall Study|Lack of Efficacy|5
7547866|NCT02914457|11904869|FG000|Overall Study|ECG acquisition error due to sweating|1
7547867|NCT02914457|11904869|FG000|Overall Study|Protocol Violation|1
7547868|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Adverse Event|5
7547869|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Adverse Event|6
7547870|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Adverse Event|4
7547871|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Adverse Event|18
7547872|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Adverse Event|14
7547873|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Adverse Event|10
7547874|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Adverse Event|0
7547875|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Adverse Event|0
7547876|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Adverse Event|0
7267830|NCT00402688|11482121|FG000|Overall Study|Protocol Violation|1
7267831|NCT00402688|11482122|FG001|Overall Study|Protocol Violation|1
7267832|NCT00402688|11482123|FG002|Overall Study|Protocol Violation|1
7267833|NCT00402688|11482121|FG000|Overall Study|Lost to Follow-up|1
7267834|NCT00402688|11482122|FG001|Overall Study|Lost to Follow-up|0
7267835|NCT00402688|11482123|FG002|Overall Study|Lost to Follow-up|2
7267836|NCT00402688|11482121|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
7267837|NCT00402688|11482122|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
7267838|NCT00402688|11482123|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
7267839|NCT00402688|11482121|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7267840|NCT00402688|11482122|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
7267841|NCT00402688|11482123|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
7547877|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Adverse Event|0
7547878|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Adverse Event|0
7547879|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
7547880|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
7547881|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
7547882|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
7267842|NCT00402688|11482121|FG000|Overall Study|Patient Left Town and Forgot Medication|0
7267843|NCT00402688|11482122|FG001|Overall Study|Patient Left Town and Forgot Medication|0
7267844|NCT00402688|11482123|FG002|Overall Study|Patient Left Town and Forgot Medication|1
7267845|NCT00402727|11482144|FG000|Overall Study|Adverse Event|10
7267846|NCT00402727|11482145|FG001|Overall Study|Adverse Event|6
7267847|NCT00402727|11482144|FG000|Overall Study|Death|1
7267848|NCT00402727|11482145|FG001|Overall Study|Death|0
7267849|NCT00402727|11482144|FG000|Overall Study|Lack of Efficacy|1
7267850|NCT00402727|11482145|FG001|Overall Study|Lack of Efficacy|3
7267851|NCT00402727|11482144|FG000|Overall Study|Lost to Follow-up|24
7267852|NCT00402727|11482145|FG001|Overall Study|Lost to Follow-up|11
7267853|NCT00402727|11482144|FG000|Overall Study|Physician Decision|1
7267854|NCT00402727|11482145|FG001|Overall Study|Physician Decision|1
7267855|NCT00402727|11482144|FG000|Overall Study|Protocol Violation|0
7267856|NCT00402727|11482145|FG001|Overall Study|Protocol Violation|4
7267857|NCT00402727|11482144|FG000|Overall Study|Withdrawal by Subject|3
7267858|NCT00402727|11482145|FG001|Overall Study|Withdrawal by Subject|7
7267859|NCT00402727|11482144|FG000|Overall Study|supply problems|2
7267860|NCT00402727|11482145|FG001|Overall Study|supply problems|1
7267861|NCT00402727|11482144|FG000|Overall Study|non-compliance|0
7267862|NCT00402727|11482145|FG001|Overall Study|non-compliance|1
7267863|NCT00402740|11482151|FG000|Overall Study|Withdrawal by Subject|18
7267864|NCT00402740|11482151|FG000|Overall Study|Death|50
7267865|NCT00402740|11482151|FG000|Overall Study|Lost to Follow-up|6
7267866|NCT00402740|11482151|FG000|Overall Study|No stent. Completed FU at 30 days.|5
7267867|NCT00402740|11482151|FG000|Overall Study|Subject disposition unknown.|1
7267868|NCT00402779|11482161|FG000|Overall Study|Screen Failure|77
7267869|NCT00402779|11482162|FG001|Overall Study|Screen Failure|76
7267870|NCT00402831|11482170|FG000|Overall Study|Lost to Follow-up|1
7267871|NCT00402831|11482171|FG001|Overall Study|Lost to Follow-up|2
7267872|NCT00402831|11482170|FG000|Overall Study|Non-compliance with protocol|0
7267873|NCT00402831|11482171|FG001|Overall Study|Non-compliance with protocol|1
7267874|NCT00402987|11482187|FG000|Overall Study|Lack of Efficacy|0
7267875|NCT00402987|11482188|FG001|Overall Study|Lack of Efficacy|0
7267876|NCT00402987|11482189|FG002|Overall Study|Lack of Efficacy|1
7267877|NCT00402987|11482190|FG003|Overall Study|Lack of Efficacy|0
7267878|NCT00403130|11482245|FG000|2 Years From Start of Treatment|Not Eligible|3
7267879|NCT00403130|11482245|FG000|2 Years From Start of Treatment|Lost to Follow up|1
7267880|NCT00403130|11482245|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
7267881|NCT00403130|11482245|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
7267882|NCT00403234|11482253|FG000|Overall Study|Withdrawal by Subject|0
7267883|NCT00403234|11482254|FG001|Overall Study|Withdrawal by Subject|1
7267884|NCT00403234|11482255|FG002|Overall Study|Withdrawal by Subject|0
7267885|NCT00403234|11482256|FG003|Overall Study|Withdrawal by Subject|0
7267886|NCT00403234|11482253|FG000|Overall Study|Adverse Event|1
7267887|NCT00403234|11482254|FG001|Overall Study|Adverse Event|0
7267888|NCT00403234|11482255|FG002|Overall Study|Adverse Event|1
7267889|NCT00403234|11482256|FG003|Overall Study|Adverse Event|0
7547883|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
7547884|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
7547885|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
7547886|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
7547887|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
7547888|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
7547889|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
7547890|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Protocol Violation|0
7547891|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Protocol Violation|2
7267890|NCT00403260|11482268|FG000|Overall Study|Adverse Event|5
7267891|NCT00403260|11482269|FG001|Overall Study|Adverse Event|4
7267892|NCT00403260|11482268|FG000|Overall Study|Withdrawal by Subject|5
7267893|NCT00403260|11482269|FG001|Overall Study|Withdrawal by Subject|6
7267894|NCT00403260|11482268|FG000|Overall Study|Lost to Follow-up|49
7267895|NCT00403260|11482269|FG001|Overall Study|Lost to Follow-up|25
7267896|NCT00403260|11482268|FG000|Overall Study|Re-appearance of P. falciparum|34
7267897|NCT00403260|11482269|FG001|Overall Study|Re-appearance of P. falciparum|25
7267898|NCT00403260|11482268|FG000|Overall Study|P. vivax infection|26
7267899|NCT00403260|11482269|FG001|Overall Study|P. vivax infection|4
7267900|NCT00403260|11482268|FG000|Overall Study|Mixed infection with P. vivax|2
7267901|NCT00403260|11482269|FG001|Overall Study|Mixed infection with P. vivax|0
7267902|NCT00403260|11482268|FG000|Overall Study|Mixed infection with P. falciparum|1
7267903|NCT00403260|11482269|FG001|Overall Study|Mixed infection with P. falciparum|0
7267904|NCT00403260|11482268|FG000|Overall Study|P. vivax infection at screening|1
7267905|NCT00403260|11482269|FG001|Overall Study|P. vivax infection at screening|0
7267906|NCT00403260|11482268|FG000|Overall Study|P. ovale infection|1
7267907|NCT00403260|11482269|FG001|Overall Study|P. ovale infection|0
7267908|NCT00403260|11482268|FG000|Overall Study|Gametocyte re-appearance|1
7267909|NCT00403260|11482269|FG001|Overall Study|Gametocyte re-appearance|1
7267910|NCT00403260|11482268|FG000|Overall Study|Withdrawn from study accidentally|0
7267911|NCT00403260|11482269|FG001|Overall Study|Withdrawn from study accidentally|1
7267912|NCT00403273|11482277|FG000|Overall Study|Lost to Follow-up|3
7267913|NCT00403273|11482278|FG001|Overall Study|Lost to Follow-up|2
7267914|NCT00403273|11482277|FG000|Overall Study|Physician Decision|0
7267915|NCT00403273|11482278|FG001|Overall Study|Physician Decision|1
7267916|NCT00403273|11482277|FG000|Overall Study|pt. wanted to have a surgical procedure|0
7267917|NCT00403273|11482278|FG001|Overall Study|pt. wanted to have a surgical procedure|1
7267918|NCT00403390|11482288|FG000|Overall Study|Withdrawal by Subject|1
7267919|NCT00403390|11482289|FG001|Overall Study|Withdrawal by Subject|0
7267920|NCT00403390|11482288|FG000|Overall Study|samples lost|1
7267921|NCT00403390|11482289|FG001|Overall Study|samples lost|0
7267922|NCT00403390|11482288|FG000|Overall Study|non-compliant|1
7267923|NCT00403390|11482289|FG001|Overall Study|non-compliant|0
7267924|NCT00403455|11482304|FG000|Overall Study|Withdrawal by Subject|1
7267925|NCT00403481|11482308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
7267926|NCT00403481|11482308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
7267927|NCT00403481|11482308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
7267928|NCT00403481|11482308|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
7267929|NCT00403481|11482308|FG000|Olm 40 mg|Adverse Event|2
7267930|NCT00403481|11482308|FG000|Olm 40 mg|Protocol Violation|1
7267931|NCT00403481|11482308|FG000|Olm 40 mg|Withdrawal by Subject|1
7267932|NCT00403481|11482308|FG000|Olm 40 mg|Other|1
7267933|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
7267934|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
7267935|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
7267936|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
7267937|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
7267938|NCT00403481|11482308|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7267939|NCT00403494|11482317|FG000|Overall Study|Adverse Event|10
7267940|NCT00403494|11482318|FG001|Overall Study|Adverse Event|8
7267941|NCT00403494|11482317|FG000|Overall Study|Withdrew Consent|3
7267942|NCT00403494|11482318|FG001|Overall Study|Withdrew Consent|2
7267943|NCT00403494|11482317|FG000|Overall Study|Inappropriately enrolled|0
7267944|NCT00403494|11482318|FG001|Overall Study|Inappropriately enrolled|1
7267945|NCT00403494|11482317|FG000|Overall Study|Lost to Follow-up|0
7547892|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Protocol Violation|1
7547893|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Protocol Violation|3
7547894|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Protocol Violation|4
7547895|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Protocol Violation|2
7547896|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Protocol Violation|0
7547897|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Protocol Violation|0
7547898|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Protocol Violation|0
7547899|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Protocol Violation|0
7547900|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Protocol Violation|0
7547901|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
7547902|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
7547903|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
7547904|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
7547905|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
7547906|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
7547907|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
7547908|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
7547909|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
7547910|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
7547911|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
7547912|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
7547913|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
7547914|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
7547915|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
7547916|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
7547917|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
7547918|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
7624592|NCT01986114|12035684|FG000|Overall Study|Protocol Violation|1
7547919|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
7547920|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
7547921|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
7577541|NCT03974334|11967515|FG000|Overall Study|Lost to Follow-up|1
7267946|NCT00403494|11482318|FG001|Overall Study|Lost to Follow-up|2
7267947|NCT00403494|11482317|FG000|Overall Study|Protocol noncompliance|0
7267948|NCT00403494|11482318|FG001|Overall Study|Protocol noncompliance|1
7267949|NCT00403494|11482317|FG000|Overall Study|Death|1
7267950|NCT00403494|11482318|FG001|Overall Study|Death|0
7267951|NCT00403494|11482317|FG000|Overall Study|Sponsor Request|1
7267952|NCT00403494|11482318|FG001|Overall Study|Sponsor Request|0
7267953|NCT00403546|11482328|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
7267954|NCT00403546|11482329|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
7267955|NCT00403546|11482330|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
7267956|NCT00403546|11482328|FG000|Signed Informed Consent/Open-Label|Early Termination|8
7267957|NCT00403546|11482329|FG001|Signed Informed Consent/Open-Label|Early Termination|0
7267958|NCT00403546|11482330|FG002|Signed Informed Consent/Open-Label|Early Termination|0
7267959|NCT00403546|11482328|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
7267960|NCT00403546|11482329|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7267961|NCT00403546|11482330|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
7267962|NCT00403546|11482328|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
7267963|NCT00403546|11482329|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
7267964|NCT00403546|11482330|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
7267965|NCT00403546|11482328|FG000|Screening Phase|Screening Failure|22
7267966|NCT00403546|11482329|FG001|Screening Phase|Screening Failure|0
7267967|NCT00403546|11482330|FG002|Screening Phase|Screening Failure|0
7267968|NCT00403546|11482328|FG000|Screening Phase|Adverse Event|1
7267969|NCT00403546|11482329|FG001|Screening Phase|Adverse Event|0
7267970|NCT00403546|11482330|FG002|Screening Phase|Adverse Event|0
7267971|NCT00403546|11482328|FG000|Screening Phase|Terminated Prior to Randomization|5
7267972|NCT00403546|11482329|FG001|Screening Phase|Terminated Prior to Randomization|0
7267973|NCT00403546|11482330|FG002|Screening Phase|Terminated Prior to Randomization|0
7267974|NCT00403546|11482328|FG000|Randomized Trial|Early Terminations|0
7267975|NCT00403546|11482329|FG001|Randomized Trial|Early Terminations|17
7267976|NCT00403546|11482330|FG002|Randomized Trial|Early Terminations|16
7267977|NCT00403585|11482339|FG000|Initial Treatment Phase|Lost to Follow-up|2
7267978|NCT00403585|11482339|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
7267979|NCT00403585|11482339|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
7267980|NCT00403754|11482343|FG000|Core Treatment Period 1|Withdrawal by Subject|0
7267981|NCT00403754|11482344|FG001|Core Treatment Period 1|Withdrawal by Subject|1
7267982|NCT00403754|11482345|FG002|Core Treatment Period 1|Withdrawal by Subject|0
7267983|NCT00403754|11482346|FG003|Core Treatment Period 1|Withdrawal by Subject|0
7267984|NCT00403754|11482343|FG000|Core Treatment Period 2|Lack of Efficacy|0
7267985|NCT00403754|11482344|FG001|Core Treatment Period 2|Lack of Efficacy|0
7267986|NCT00403754|11482345|FG002|Core Treatment Period 2|Lack of Efficacy|1
7267987|NCT00403754|11482346|FG003|Core Treatment Period 2|Lack of Efficacy|0
7267988|NCT00403767|11482360|FG000|Overall Study|Adverse Event|993
7267989|NCT00403767|11482361|FG001|Overall Study|Adverse Event|919
7267990|NCT00403767|11482360|FG000|Overall Study|Non-compliant with study medication|134
7577542|NCT03987074|11967543|FG000|Overall Study|Withdrew Consent|1
7577543|NCT03987074|11967544|FG001|Overall Study|Withdrew Consent|1
7577544|NCT03987074|11967545|FG002|Overall Study|Withdrew Consent|0
7577545|NCT03987074|11967546|FG003|Overall Study|Withdrew Consent|2
7577546|NCT03987074|11967547|FG004|Overall Study|Withdrew Consent|1
7577547|NCT03987074|11967543|FG000|Overall Study|Adverse Event|2
7577548|NCT03987074|11967544|FG001|Overall Study|Adverse Event|1
7577549|NCT03987074|11967545|FG002|Overall Study|Adverse Event|0
7577550|NCT03987074|11967546|FG003|Overall Study|Adverse Event|0
7577551|NCT03987074|11967547|FG004|Overall Study|Adverse Event|1
7577552|NCT03987074|11967543|FG000|Overall Study|Lost to Follow-up|0
7577553|NCT03987074|11967544|FG001|Overall Study|Lost to Follow-up|0
7577554|NCT03987074|11967545|FG002|Overall Study|Lost to Follow-up|1
7577555|NCT03987074|11967546|FG003|Overall Study|Lost to Follow-up|1
7577556|NCT03987074|11967547|FG004|Overall Study|Lost to Follow-up|0
7577557|NCT03987074|11967543|FG000|Overall Study|Investigator's Discretion|0
7577558|NCT03987074|11967544|FG001|Overall Study|Investigator's Discretion|0
7267991|NCT00403767|11482361|FG001|Overall Study|Non-compliant with study medication|164
7267992|NCT00403767|11482360|FG000|Overall Study|Consent withdrawn|671
7267993|NCT00403767|11482361|FG001|Overall Study|Consent withdrawn|673
7267994|NCT00403767|11482360|FG000|Overall Study|Investigator dec./not protocol-related|191
7267995|NCT00403767|11482361|FG001|Overall Study|Investigator dec./not protocol-related|178
7267996|NCT00403767|11482360|FG000|Overall Study|Lost to Follow-up|6
7267997|NCT00403767|11482361|FG001|Overall Study|Lost to Follow-up|8
7267998|NCT00403767|11482360|FG000|Overall Study|Protocol Violation|142
7267999|NCT00403767|11482361|FG001|Overall Study|Protocol Violation|124
7268000|NCT00403767|11482360|FG000|Overall Study|Clinical efficacy endpoint reached|300
7268001|NCT00403767|11482361|FG001|Overall Study|Clinical efficacy endpoint reached|332
7577559|NCT03987074|11967545|FG002|Overall Study|Investigator's Discretion|0
7577560|NCT03987074|11967546|FG003|Overall Study|Investigator's Discretion|1
7577561|NCT03987074|11967547|FG004|Overall Study|Investigator's Discretion|0
7268002|NCT00403767|11482360|FG000|Overall Study|Study terminated by sponsor|82
7268003|NCT00403767|11482361|FG001|Overall Study|Study terminated by sponsor|69
7624593|NCT01986114|12035684|FG000|Overall Study|Lost to Follow-up|5
7268004|NCT00403767|11482360|FG000|Overall Study|Missing/incomplete data|1
7268005|NCT00403767|11482361|FG001|Overall Study|Missing/incomplete data|1
7268006|NCT00403845|11482367|FG000|Treatment Period 1|Subject withdrew consent|1
7268007|NCT00403845|11482368|FG001|Treatment Period 1|Subject withdrew consent|0
7268008|NCT00403845|11482369|FG002|Treatment Period 1|Subject withdrew consent|0
7268009|NCT00403845|11482370|FG003|Treatment Period 1|Subject withdrew consent|0
7268010|NCT00403845|11482367|FG000|Treatment Period 1|Subject no longer needs study drug|0
7268011|NCT00403845|11482368|FG001|Treatment Period 1|Subject no longer needs study drug|0
7268012|NCT00403845|11482369|FG002|Treatment Period 1|Subject no longer needs study drug|0
7268013|NCT00403845|11482370|FG003|Treatment Period 1|Subject no longer needs study drug|1
7268014|NCT00403845|11482367|FG000|Treatment Period 2|Subject withdrew consent|1
7268015|NCT00403845|11482368|FG001|Treatment Period 2|Subject withdrew consent|0
7268016|NCT00403845|11482369|FG002|Treatment Period 2|Subject withdrew consent|0
7268017|NCT00403845|11482370|FG003|Treatment Period 2|Subject withdrew consent|0
7268018|NCT00403845|11482367|FG000|Treatment Period 3|Subject withdrew consent|0
7268019|NCT00403845|11482368|FG001|Treatment Period 3|Subject withdrew consent|0
7268020|NCT00403845|11482369|FG002|Treatment Period 3|Subject withdrew consent|0
7547922|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
7547923|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
7547924|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547925|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547926|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547927|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547928|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547929|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547930|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547931|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547932|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547933|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
7547934|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Pregnancy|0
7547935|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Pregnancy|0
7547936|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Pregnancy|0
7547937|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Pregnancy|0
7547938|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Pregnancy|1
7547939|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Pregnancy|0
7547940|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Pregnancy|0
7577562|NCT03979820|11967581|FG000|Overall Study|Protocol Violation|1
7577563|NCT03979820|11967582|FG001|Overall Study|Protocol Violation|0
7577564|NCT03979820|11967583|FG002|Overall Study|Protocol Violation|0
7577565|NCT03979820|11967584|FG003|Overall Study|Protocol Violation|0
7577566|NCT03979820|11967581|FG000|Overall Study|Withdrawal by Subject|0
7577567|NCT03979820|11967582|FG001|Overall Study|Withdrawal by Subject|0
7577568|NCT03979820|11967583|FG002|Overall Study|Withdrawal by Subject|1
7577569|NCT03979820|11967584|FG003|Overall Study|Withdrawal by Subject|0
7577570|NCT03979820|11967581|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
7577571|NCT03979820|11967582|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7577572|NCT03979820|11967583|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
7577573|NCT03979820|11967584|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
7577574|NCT03972137|11967598|FG000|Overall Study|Lost to Follow-up|2
7577575|NCT03972137|11967598|FG000|Overall Study|Withdrawal by Subject|4
7577576|NCT03970395|11967616|FG000|Overall Study|Withdrawal by Subject|3
7577577|NCT03970395|11967617|FG001|Overall Study|Withdrawal by Subject|4
7577578|NCT03970395|11967616|FG000|Overall Study|Lost to Follow-up|4
7577579|NCT03970395|11967617|FG001|Overall Study|Lost to Follow-up|8
7577580|NCT03987620|11967629|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
7577581|NCT03987620|11967630|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
7577582|NCT03987620|11967629|FG000|Overall Study|Adverse Event|3
7577583|NCT03987620|11967630|FG001|Overall Study|Adverse Event|0
7577584|NCT03987620|11967629|FG000|Overall Study|Lost to Follow-up|1
7577585|NCT03987620|11967630|FG001|Overall Study|Lost to Follow-up|2
7577586|NCT03987620|11967629|FG000|Overall Study|Physician Decision|0
7577587|NCT03987620|11967630|FG001|Overall Study|Physician Decision|1
7577588|NCT03987620|11967629|FG000|Overall Study|Pregnancy|1
7577589|NCT03987620|11967630|FG001|Overall Study|Pregnancy|0
7577590|NCT03987620|11967629|FG000|Overall Study|Withdrawal by Subject|7
7577591|NCT03987620|11967630|FG001|Overall Study|Withdrawal by Subject|1
7577592|NCT03987620|11967629|FG000|Overall Study|Other|2
7577593|NCT03987620|11967630|FG001|Overall Study|Other|5
7577594|NCT03983317|11967636|FG000|Overall Study|Physician Decision|5
7577595|NCT03984825|11967699|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
7577596|NCT03984825|11967699|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
7577597|NCT03984825|11967699|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
7577598|NCT03982433|11967712|FG000|Overall Study|Lost to Follow-up|1
7577599|NCT03976466|11967722|FG000|Overall Study|Lost to Follow-up|1
7577600|NCT03976466|11967723|FG001|Overall Study|Lost to Follow-up|3
7577601|NCT03979638|11967733|FG000|Period 1|Physician Decision|1
7268021|NCT00403845|11482370|FG003|Treatment Period 3|Subject withdrew consent|1
7268022|NCT00403845|11482367|FG000|Treatment Period 3|Adverse Event|0
7268023|NCT00403845|11482368|FG001|Treatment Period 3|Adverse Event|0
7268024|NCT00403845|11482369|FG002|Treatment Period 3|Adverse Event|0
7268025|NCT00403845|11482370|FG003|Treatment Period 3|Adverse Event|1
7268026|NCT00404066|11482380|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
7547941|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Pregnancy|0
7547942|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Pregnancy|0
7547943|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Pregnancy|0
7547944|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Pregnancy|0
7547945|NCT02914522|11904890|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547946|NCT02914522|11904891|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7547947|NCT02914522|11904892|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547948|NCT02914522|11904893|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547949|NCT02914522|11904894|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7547950|NCT02914522|11904895|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
7547951|NCT02914522|11904896|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547952|NCT02914522|11904897|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547953|NCT02914522|11904898|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547954|NCT02914522|11904899|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547955|NCT02914522|11904900|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
7547956|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547957|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547958|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547959|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547960|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547961|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
7547962|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
7547963|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
7547964|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
7547965|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
7547966|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
7547967|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547968|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547969|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547970|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547971|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547972|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
7547973|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
7547974|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
7547975|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
7547976|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
7547977|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
7547978|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547979|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547980|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547981|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547982|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547983|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547984|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7547985|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
7547986|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
7547987|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
7547988|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
7547989|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547990|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547991|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547992|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547993|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547994|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
7547995|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7268027|NCT00404066|11482380|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
7268028|NCT00404079|11482386|FG000|Overall Study|Lost to follow up, adverse event etc|22
7268029|NCT00404079|11482387|FG001|Overall Study|Lost to follow up, adverse event etc|20
7268030|NCT00404092|11482397|FG000|Overall Study|Death|1
7268031|NCT00404092|11482398|FG001|Overall Study|Death|0
7268032|NCT00404092|11482399|FG002|Overall Study|Death|0
7268033|NCT00404092|11482400|FG003|Overall Study|Death|0
7268034|NCT00404092|11482397|FG000|Overall Study|Adverse Event|0
7268035|NCT00404092|11482398|FG001|Overall Study|Adverse Event|0
7268036|NCT00404092|11482399|FG002|Overall Study|Adverse Event|1
7268037|NCT00404092|11482400|FG003|Overall Study|Adverse Event|0
7268038|NCT00404235|11482412|FG000|Overall Study|Withdrawal by Subject|1
7268039|NCT00404235|11482413|FG001|Overall Study|Withdrawal by Subject|2
7268040|NCT00404248|11482422|FG000|Overall Study|pts declining status|0
7268041|NCT00404248|11482423|FG001|Overall Study|pts declining status|1
7268042|NCT00404248|11482424|FG002|Overall Study|pts declining status|0
7268043|NCT00404248|11482425|FG003|Overall Study|pts declining status|0
7268044|NCT00404248|11482426|FG004|Overall Study|pts declining status|0
7268045|NCT00404248|11482427|FG005|Overall Study|pts declining status|0
7268046|NCT00404248|11482428|FG006|Overall Study|pts declining status|0
7268047|NCT00404248|11482429|FG007|Overall Study|pts declining status|0
7268048|NCT00404248|11482430|FG008|Overall Study|pts declining status|0
7268049|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Adverse Event|5
7268050|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Adverse Event|4
7268051|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Adverse Event|6
7268052|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Adverse Event|0
7268053|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Adverse Event|0
7268054|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Adverse Event|0
7268055|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Adverse Event|0
7268056|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Adverse Event|0
7268057|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Adverse Event|0
7268058|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Pregnancy|0
7268059|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Pregnancy|0
7268060|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Pregnancy|2
7268061|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Pregnancy|0
7268062|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Pregnancy|0
7268063|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Pregnancy|0
7268064|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Pregnancy|0
7268065|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Pregnancy|0
7268066|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Pregnancy|0
7268067|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Death|0
7268068|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Death|0
7268069|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Death|1
7268070|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Death|0
7268071|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Death|0
7268072|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Death|0
7268073|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Death|0
7547996|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
7547997|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
7547998|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
7547999|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
7548000|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Death|0
7548001|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Death|0
7548002|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Death|0
7548003|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Death|0
7548004|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Death|0
7548005|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Death|0
7268074|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Death|0
7268075|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Death|0
7268076|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
7268077|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
7268078|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
7268079|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268080|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268081|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268082|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268083|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268084|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
7268085|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
7268086|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
7268087|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
7268088|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268089|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268090|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268091|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268092|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268093|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
7268094|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Disease progression|3
7268095|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Disease progression|0
7268096|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Disease progression|2
7268097|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Disease progression|0
7268098|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Disease progression|0
7268099|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Disease progression|0
7268100|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Disease progression|0
7268101|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Disease progression|0
7268102|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Disease progression|0
7268103|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Poor compliance|1
7268104|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Poor compliance|0
7268105|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Poor compliance|0
7268106|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Poor compliance|0
7268107|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Poor compliance|0
7268108|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Poor compliance|0
7268109|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Poor compliance|0
7268110|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Poor compliance|0
7268111|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Poor compliance|0
7268112|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
7268113|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
7268114|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
7268115|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
7268116|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
7268117|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
7268118|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
7268119|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
7268120|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
7268121|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
7268122|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
7268123|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
7268124|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
7268125|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
7268126|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
7268127|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
7268128|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
7268129|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
7268130|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Physician Decision|0
7268131|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Physician Decision|0
7268132|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Physician Decision|1
7268133|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Physician Decision|0
7268134|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Physician Decision|0
7268135|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Physician Decision|0
7268136|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Physician Decision|0
7268137|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Physician Decision|0
7268138|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Physician Decision|0
7268139|NCT00404352|11482459|FG000|Double Blind (up to 24 Month)|Other|0
7268140|NCT00404352|11482460|FG001|Double Blind (up to 24 Month)|Other|1
7268141|NCT00404352|11482461|FG002|Double Blind (up to 24 Month)|Other|0
7268142|NCT00404352|11482462|FG003|Double Blind (up to 24 Month)|Other|0
7268143|NCT00404352|11482463|FG004|Double Blind (up to 24 Month)|Other|0
7268144|NCT00404352|11482464|FG005|Double Blind (up to 24 Month)|Other|0
7268145|NCT00404352|11482465|FG006|Double Blind (up to 24 Month)|Other|0
7268146|NCT00404352|11482466|FG007|Double Blind (up to 24 Month)|Other|0
7268147|NCT00404352|11482467|FG008|Double Blind (up to 24 Month)|Other|0
7268148|NCT00404352|11482459|FG000|Open Label (up to 24 Month)|Adverse Event|0
7268149|NCT00404352|11482460|FG001|Open Label (up to 24 Month)|Adverse Event|0
7268150|NCT00404352|11482461|FG002|Open Label (up to 24 Month)|Adverse Event|0
7268151|NCT00404352|11482462|FG003|Open Label (up to 24 Month)|Adverse Event|2
7268152|NCT00404352|11482463|FG004|Open Label (up to 24 Month)|Adverse Event|1
7268153|NCT00404352|11482464|FG005|Open Label (up to 24 Month)|Adverse Event|1
7268154|NCT00404352|11482465|FG006|Open Label (up to 24 Month)|Adverse Event|0
7268155|NCT00404352|11482466|FG007|Open Label (up to 24 Month)|Adverse Event|0
7268156|NCT00404352|11482467|FG008|Open Label (up to 24 Month)|Adverse Event|0
7268157|NCT00404352|11482459|FG000|Open Label (up to 24 Month)|Pregnancy|0
7268158|NCT00404352|11482460|FG001|Open Label (up to 24 Month)|Pregnancy|0
7268159|NCT00404352|11482461|FG002|Open Label (up to 24 Month)|Pregnancy|0
7268160|NCT00404352|11482462|FG003|Open Label (up to 24 Month)|Pregnancy|0
7268161|NCT00404352|11482463|FG004|Open Label (up to 24 Month)|Pregnancy|0
7268162|NCT00404352|11482464|FG005|Open Label (up to 24 Month)|Pregnancy|1
7268163|NCT00404352|11482465|FG006|Open Label (up to 24 Month)|Pregnancy|0
7268164|NCT00404352|11482466|FG007|Open Label (up to 24 Month)|Pregnancy|0
7268165|NCT00404352|11482467|FG008|Open Label (up to 24 Month)|Pregnancy|0
7268166|NCT00404352|11482459|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
7268167|NCT00404352|11482460|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
7268168|NCT00404352|11482461|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
7268169|NCT00404352|11482462|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
7268170|NCT00404352|11482463|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
7268171|NCT00404352|11482464|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
7268172|NCT00404352|11482465|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
7268173|NCT00404352|11482466|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
7268174|NCT00404352|11482467|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
7268175|NCT00404352|11482459|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268176|NCT00404352|11482460|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268177|NCT00404352|11482461|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268178|NCT00404352|11482462|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268179|NCT00404352|11482463|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268180|NCT00404352|11482464|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
7268181|NCT00404352|11482465|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268182|NCT00404352|11482466|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268183|NCT00404352|11482467|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
7268184|NCT00404352|11482459|FG000|Open Label (up to 24 Month)|Disease progression|0
7268185|NCT00404352|11482460|FG001|Open Label (up to 24 Month)|Disease progression|0
7268186|NCT00404352|11482461|FG002|Open Label (up to 24 Month)|Disease progression|0
7268187|NCT00404352|11482462|FG003|Open Label (up to 24 Month)|Disease progression|1
7268188|NCT00404352|11482463|FG004|Open Label (up to 24 Month)|Disease progression|0
7268189|NCT00404352|11482464|FG005|Open Label (up to 24 Month)|Disease progression|0
7548006|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Death|2
7548007|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Death|0
7548008|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Death|0
7548009|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Death|0
7548010|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Death|0
7548011|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548012|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548013|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548014|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548015|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548016|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548017|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548018|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
7548019|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
7548020|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548021|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
7548022|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548023|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548024|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548025|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548026|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548027|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548028|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548029|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7548030|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
7548031|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
7548032|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
7577602|NCT03979638|11967734|FG001|Period 1|Physician Decision|1
7577603|NCT03979638|11967733|FG000|Period 1|Withdrawal by Subject|4
7577604|NCT03979638|11967734|FG001|Period 1|Withdrawal by Subject|3
7577605|NCT03979638|11967733|FG000|Period 1|Study terminated by Sponsor|1
7577606|NCT03979638|11967734|FG001|Period 1|Study terminated by Sponsor|3
7268190|NCT00404352|11482465|FG006|Open Label (up to 24 Month)|Disease progression|0
7268191|NCT00404352|11482466|FG007|Open Label (up to 24 Month)|Disease progression|0
7268192|NCT00404352|11482467|FG008|Open Label (up to 24 Month)|Disease progression|0
7268193|NCT00404352|11482459|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
7268194|NCT00404352|11482460|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
7268195|NCT00404352|11482461|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
7268196|NCT00404352|11482462|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
7548033|NCT02914522|11904890|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548034|NCT02914522|11904891|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548035|NCT02914522|11904892|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548036|NCT02914522|11904893|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548037|NCT02914522|11904894|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548038|NCT02914522|11904895|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548039|NCT02914522|11904896|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548040|NCT02914522|11904897|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548041|NCT02914522|11904898|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548042|NCT02914522|11904899|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
7548043|NCT02914522|11904900|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
7548044|NCT02914548|11904930|FG000|Overall Study|Adverse Event|15
7548045|NCT02914548|11904931|FG001|Overall Study|Adverse Event|7
7548046|NCT02914548|11904932|FG002|Overall Study|Adverse Event|15
7548047|NCT02914548|11904930|FG000|Overall Study|Physician Decision|2
7548048|NCT02914548|11904931|FG001|Overall Study|Physician Decision|2
7548049|NCT02914548|11904932|FG002|Overall Study|Physician Decision|0
7268197|NCT00404352|11482463|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
7268198|NCT00404352|11482464|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
7268199|NCT00404352|11482465|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
7268200|NCT00404352|11482466|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
7268201|NCT00404352|11482467|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
7268202|NCT00404352|11482459|FG000|Open Label Extension (up to 36 Months)|Other|0
7268203|NCT00404352|11482460|FG001|Open Label Extension (up to 36 Months)|Other|0
7268204|NCT00404352|11482461|FG002|Open Label Extension (up to 36 Months)|Other|0
7268205|NCT00404352|11482462|FG003|Open Label Extension (up to 36 Months)|Other|0
7268206|NCT00404352|11482463|FG004|Open Label Extension (up to 36 Months)|Other|0
7268207|NCT00404352|11482464|FG005|Open Label Extension (up to 36 Months)|Other|0
7268208|NCT00404352|11482465|FG006|Open Label Extension (up to 36 Months)|Other|0
7268209|NCT00404352|11482466|FG007|Open Label Extension (up to 36 Months)|Other|0
7268210|NCT00404352|11482467|FG008|Open Label Extension (up to 36 Months)|Other|2
7268211|NCT00404495|11482486|FG000|Overall Study|Death|37
7268212|NCT00404495|11482487|FG001|Overall Study|Death|11
7268213|NCT00404495|11482486|FG000|Overall Study|Lost to Follow-up|5
7268214|NCT00404495|11482487|FG001|Overall Study|Lost to Follow-up|0
7268215|NCT00404495|11482486|FG000|Overall Study|Other|1
7268216|NCT00404495|11482487|FG001|Overall Study|Other|0
7268217|NCT00404495|11482486|FG000|Overall Study|Withdrawal by Subject|1
7268218|NCT00404495|11482487|FG001|Overall Study|Withdrawal by Subject|0
7268219|NCT00404547|11482495|FG000|Overall Study|Adverse Event|39
7268220|NCT00404547|11482496|FG001|Overall Study|Adverse Event|6
7268221|NCT00404547|11482495|FG000|Overall Study|Withdrawal by Subject|19
7268222|NCT00404547|11482496|FG001|Overall Study|Withdrawal by Subject|2
7268223|NCT00404547|11482495|FG000|Overall Study|Protocol Violation|0
7268224|NCT00404547|11482496|FG001|Overall Study|Protocol Violation|1
7268225|NCT00404547|11482495|FG000|Overall Study|Lost to Follow-up|20
7268226|NCT00404547|11482496|FG001|Overall Study|Lost to Follow-up|9
7268227|NCT00404547|11482495|FG000|Overall Study|Lack of compliance|5
7268228|NCT00404547|11482496|FG001|Overall Study|Lack of compliance|1
7268229|NCT00404547|11482495|FG000|Overall Study|Other|4
7268230|NCT00404547|11482496|FG001|Overall Study|Other|0
7268231|NCT00404547|11482495|FG000|Overall Study|Reason not stated|3
7268232|NCT00404547|11482496|FG001|Overall Study|Reason not stated|6
7268233|NCT00404651|11482506|FG000|Overall Study|Serious Adverse Event|0
7268234|NCT00404651|11482507|FG001|Overall Study|Serious Adverse Event|0
7268235|NCT00404651|11482508|FG002|Overall Study|Serious Adverse Event|2
7268236|NCT00404651|11482509|FG003|Overall Study|Serious Adverse Event|0
7268237|NCT00404651|11482506|FG000|Overall Study|Protocol Violation|10
7268238|NCT00404651|11482507|FG001|Overall Study|Protocol Violation|5
7268239|NCT00404651|11482508|FG002|Overall Study|Protocol Violation|14
7268240|NCT00404651|11482509|FG003|Overall Study|Protocol Violation|5
7268241|NCT00404651|11482506|FG000|Overall Study|Lost to Follow-up|15
7268242|NCT00404651|11482507|FG001|Overall Study|Lost to Follow-up|11
7268243|NCT00404651|11482508|FG002|Overall Study|Lost to Follow-up|13
7268244|NCT00404651|11482509|FG003|Overall Study|Lost to Follow-up|10
7268245|NCT00404651|11482506|FG000|Overall Study|Withdrawal by Subject|14
7268246|NCT00404651|11482507|FG001|Overall Study|Withdrawal by Subject|12
7268247|NCT00404651|11482508|FG002|Overall Study|Withdrawal by Subject|16
7268248|NCT00404651|11482509|FG003|Overall Study|Withdrawal by Subject|6
7268249|NCT00404755|11482519|FG000|Phase I (Bupropion)|Adverse Event|3
7268250|NCT00404755|11482519|FG000|Phase I (Bupropion)|Other|1
7268251|NCT00404755|11482519|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
7268252|NCT00404768|11482531|FG000|Part A and B|Withdrawn due to labor progression|1
7268253|NCT00404768|11482532|FG001|Part A and B|Withdrawn due to labor progression|0
7268254|NCT00404768|11482533|FG002|Part A and B|Withdrawn due to labor progression|0
7268255|NCT00404768|11482534|FG003|Part A and B|Withdrawn due to labor progression|0
7268256|NCT00404768|11482531|FG000|Part A and B|Withdrawn as delivery imminemnt|0
7548050|NCT02914548|11904930|FG000|Overall Study|Protocol Violation|1
7548051|NCT02914548|11904931|FG001|Overall Study|Protocol Violation|0
7548052|NCT02914548|11904932|FG002|Overall Study|Protocol Violation|0
7548053|NCT02914548|11904930|FG000|Overall Study|Withdrawal by Subject|3
7548054|NCT02914548|11904931|FG001|Overall Study|Withdrawal by Subject|4
7548055|NCT02914548|11904932|FG002|Overall Study|Withdrawal by Subject|4
7548056|NCT02914548|11904930|FG000|Overall Study|>40% of body surface area|0
7548057|NCT02914548|11904931|FG001|Overall Study|>40% of body surface area|1
7268257|NCT00404768|11482532|FG001|Part A and B|Withdrawn as delivery imminemnt|1
7268258|NCT00404768|11482533|FG002|Part A and B|Withdrawn as delivery imminemnt|0
7268259|NCT00404768|11482534|FG003|Part A and B|Withdrawn as delivery imminemnt|0
7268260|NCT00404768|11482531|FG000|Part C|Adverse Event|0
7268261|NCT00404768|11482532|FG001|Part C|Adverse Event|0
7268262|NCT00404768|11482533|FG002|Part C|Adverse Event|0
7268263|NCT00404768|11482534|FG003|Part C|Adverse Event|3
7268264|NCT00404768|11482531|FG000|Part C|Lost to Follow-up|0
7548058|NCT02914548|11904932|FG002|Overall Study|>40% of body surface area|1
7548059|NCT02914834|11904953|FG000|Overall Study|Study halted due to COVID|1
7268265|NCT00404768|11482532|FG001|Part C|Lost to Follow-up|0
7268266|NCT00404768|11482533|FG002|Part C|Lost to Follow-up|3
7268267|NCT00404768|11482534|FG003|Part C|Lost to Follow-up|1
7268268|NCT00404768|11482531|FG000|Part C|Withdrawal by Subject|0
7268269|NCT00404768|11482532|FG001|Part C|Withdrawal by Subject|0
7268270|NCT00404768|11482533|FG002|Part C|Withdrawal by Subject|2
7268271|NCT00404768|11482534|FG003|Part C|Withdrawal by Subject|1
7268272|NCT00404768|11482531|FG000|Part C|Early withdrawal from study medication|0
7268273|NCT00404768|11482532|FG001|Part C|Early withdrawal from study medication|0
7268274|NCT00404768|11482533|FG002|Part C|Early withdrawal from study medication|1
7268275|NCT00404768|11482534|FG003|Part C|Early withdrawal from study medication|0
7268276|NCT00404768|11482531|FG000|Part C|Participant did not respond to therapy|0
7268277|NCT00404768|11482532|FG001|Part C|Participant did not respond to therapy|0
7268278|NCT00404768|11482533|FG002|Part C|Participant did not respond to therapy|1
7268279|NCT00404768|11482534|FG003|Part C|Participant did not respond to therapy|1
7268280|NCT00404768|11482531|FG000|Part C|Physician withdrew the study medication|0
7268281|NCT00404768|11482532|FG001|Part C|Physician withdrew the study medication|0
7268282|NCT00404768|11482533|FG002|Part C|Physician withdrew the study medication|1
7268283|NCT00404768|11482534|FG003|Part C|Physician withdrew the study medication|0
7268284|NCT00404768|11482531|FG000|Part C|Participant delivered baby|0
7268285|NCT00404768|11482532|FG001|Part C|Participant delivered baby|0
7268286|NCT00404768|11482533|FG002|Part C|Participant delivered baby|0
7268287|NCT00404768|11482534|FG003|Part C|Participant delivered baby|1
7268288|NCT00404768|11482531|FG000|Part C|Unsatisfactory uterine response to IP|0
7268289|NCT00404768|11482532|FG001|Part C|Unsatisfactory uterine response to IP|0
7268290|NCT00404768|11482533|FG002|Part C|Unsatisfactory uterine response to IP|0
7268291|NCT00404768|11482534|FG003|Part C|Unsatisfactory uterine response to IP|1
7268292|NCT00404768|11482531|FG000|Part C|Active labor|0
7268293|NCT00404768|11482532|FG001|Part C|Active labor|0
7268294|NCT00404768|11482533|FG002|Part C|Active labor|0
7268295|NCT00404768|11482534|FG003|Part C|Active labor|1
7268296|NCT00404768|11482531|FG000|Part C|Lack of Efficacy|0
7268297|NCT00404768|11482532|FG001|Part C|Lack of Efficacy|0
7268298|NCT00404768|11482533|FG002|Part C|Lack of Efficacy|0
7268299|NCT00404768|11482534|FG003|Part C|Lack of Efficacy|2
7268300|NCT00404768|11482531|FG000|Part C|Treatment failure|0
7268301|NCT00404768|11482532|FG001|Part C|Treatment failure|0
7548060|NCT02914834|11904954|FG001|Overall Study|Study halted due to COVID|1
7548061|NCT02914834|11904953|FG000|Overall Study|1 subject withdrew|0
7548062|NCT02914834|11904954|FG001|Overall Study|1 subject withdrew|1
7548063|NCT02915159|11904971|FG000|Overall Study|Participant no longer meets criteria|2
7548064|NCT02915159|11904972|FG001|Overall Study|Participant no longer meets criteria|0
7548065|NCT02915159|11904971|FG000|Overall Study|poor/non-compliance|1
7548066|NCT02915159|11904972|FG001|Overall Study|poor/non-compliance|0
7548067|NCT02915159|11904971|FG000|Overall Study|Participant withdrew consent|5
7548068|NCT02915159|11904972|FG001|Overall Study|Participant withdrew consent|1
7548069|NCT02915159|11904971|FG000|Overall Study|Request to discontinue treatment|1
7548070|NCT02915159|11904972|FG001|Overall Study|Request to discontinue treatment|2
7548071|NCT02915159|11904971|FG000|Overall Study|Adverse Event|2
7548072|NCT02915159|11904972|FG001|Overall Study|Adverse Event|2
7548073|NCT02915159|11904971|FG000|Overall Study|Lack of Efficacy|0
7548074|NCT02915159|11904972|FG001|Overall Study|Lack of Efficacy|3
7577607|NCT03979638|11967733|FG000|Period 1|Protocol Violation|1
7577608|NCT03979638|11967734|FG001|Period 1|Protocol Violation|0
7577609|NCT03979638|11967733|FG000|Period 2|Study terminated by Sponsor|1
7577610|NCT03979638|11967734|FG001|Period 2|Study terminated by Sponsor|1
7577611|NCT03979274|11967749|FG000|Treatment Period 2|Withdrawal by Subject|0
7577612|NCT03979274|11967750|FG001|Treatment Period 2|Withdrawal by Subject|1
7577613|NCT03977727|11967767|FG000|Second Treatment|Lost to Follow-up|0
7577614|NCT03977727|11967768|FG001|Second Treatment|Lost to Follow-up|3
7577615|NCT03977155|11967777|FG000|Overall Study|Adverse Event|3
7577616|NCT03977155|11967778|FG001|Overall Study|Adverse Event|0
7577617|NCT03977155|11967779|FG002|Overall Study|Adverse Event|0
7577618|NCT03977155|11967777|FG000|Overall Study|Lost to Follow-up|0
7577619|NCT03977155|11967778|FG001|Overall Study|Lost to Follow-up|1
7577620|NCT03977155|11967779|FG002|Overall Study|Lost to Follow-up|0
7577621|NCT03977155|11967777|FG000|Overall Study|Withdrawal by Subject|1
7577622|NCT03977155|11967778|FG001|Overall Study|Withdrawal by Subject|1
7268302|NCT00404768|11482533|FG002|Part C|Treatment failure|0
7268303|NCT00404768|11482534|FG003|Part C|Treatment failure|1
7268304|NCT00404768|11482531|FG000|Part C|Investigator discretion|0
7268305|NCT00404768|11482532|FG001|Part C|Investigator discretion|0
7268306|NCT00404768|11482533|FG002|Part C|Investigator discretion|0
7268307|NCT00404768|11482534|FG003|Part C|Investigator discretion|1
7268308|NCT00404768|11482531|FG000|Part C|Researcher suspended study medication|0
7268309|NCT00404768|11482532|FG001|Part C|Researcher suspended study medication|0
7577623|NCT03977155|11967779|FG002|Overall Study|Withdrawal by Subject|2
7577624|NCT03977155|11967777|FG000|Overall Study|Participant was unable to come in for the Visit|1
7577625|NCT03977155|11967778|FG001|Overall Study|Participant was unable to come in for the Visit|0
7268310|NCT00404768|11482533|FG002|Part C|Researcher suspended study medication|0
7268311|NCT00404768|11482534|FG003|Part C|Researcher suspended study medication|1
7268312|NCT00404820|11482551|FG000|Overall Study|Adverse Event|4
7268313|NCT00404820|11482552|FG001|Overall Study|Adverse Event|16
7268314|NCT00404820|11482551|FG000|Overall Study|Withdrawal by Subject|5
7268315|NCT00404820|11482552|FG001|Overall Study|Withdrawal by Subject|3
7268316|NCT00404820|11482551|FG000|Overall Study|Lost to Follow-up|7
7268317|NCT00404820|11482552|FG001|Overall Study|Lost to Follow-up|3
7268318|NCT00404820|11482551|FG000|Overall Study|Administrative problems|2
7268319|NCT00404820|11482552|FG001|Overall Study|Administrative problems|0
7268320|NCT00404820|11482551|FG000|Overall Study|Death|1
7268321|NCT00404820|11482552|FG001|Overall Study|Death|0
7268322|NCT00404820|11482551|FG000|Overall Study|Other|0
7268323|NCT00404820|11482552|FG001|Overall Study|Other|2
7548075|NCT02915835|11905007|FG000|Overall Study|Physician Decision|1
7548076|NCT02915835|11905008|FG001|Overall Study|Physician Decision|0
7548077|NCT02915835|11905007|FG000|Overall Study|Withdrawal by Subject|0
7548078|NCT02915835|11905008|FG001|Overall Study|Withdrawal by Subject|1
7548079|NCT02915874|11905016|FG000|Overall Study|Lost to Follow-up|5
7548080|NCT02915874|11905017|FG001|Overall Study|Lost to Follow-up|4
7548081|NCT02915874|11905016|FG000|Overall Study|Withdrawal by Subject|1
7548082|NCT02915874|11905017|FG001|Overall Study|Withdrawal by Subject|1
7548083|NCT02915874|11905016|FG000|Overall Study|Started New Anxiety Medication|0
7548084|NCT02915874|11905017|FG001|Overall Study|Started New Anxiety Medication|1
7548085|NCT02915978|11905026|FG000|Overall Study|Adverse Event|2
7548086|NCT02915978|11905027|FG001|Overall Study|Adverse Event|1
7548087|NCT02915978|11905028|FG002|Overall Study|Adverse Event|0
7548088|NCT02916056|11905036|FG000|Overall Study|Adverse Event|6
7548089|NCT02916056|11905036|FG000|Overall Study|Lost to Follow-up|1
7548090|NCT02916056|11905036|FG000|Overall Study|Other|12
7548091|NCT02916056|11905036|FG000|Overall Study|Protocol Violation|1
7548092|NCT02916056|11905036|FG000|Overall Study|Withdrawal by Subject|8
7548093|NCT02916056|11905036|FG000|Overall Study|Study Terminated by Sponsor|269
7548094|NCT02916433|11905051|FG000|Overall Study|Withdrawal by Subject|1
7548095|NCT02916433|11905052|FG001|Overall Study|Withdrawal by Subject|0
7548096|NCT02916433|11905051|FG000|Overall Study|Physician Decision|1
7548097|NCT02916433|11905052|FG001|Overall Study|Physician Decision|0
7548098|NCT02916693|11905074|FG000|Overall Study|Lost to Follow-up|7
7548099|NCT02916927|11905088|FG000|Overall Study|Discharged prior to study drug receipt|0
7548100|NCT02916927|11905089|FG001|Overall Study|Discharged prior to study drug receipt|2
7548101|NCT02916927|11905088|FG000|Overall Study|At radiology for 45 & 60 min time points|0
7548102|NCT02916927|11905089|FG001|Overall Study|At radiology for 45 & 60 min time points|1
7548103|NCT02916927|11905088|FG000|Overall Study|Withdrawal before first time point|1
7577626|NCT03977155|11967779|FG002|Overall Study|Participant was unable to come in for the Visit|0
7577627|NCT03970733|11967801|FG000|Overall Study|Withdrawal by Subject|0
7577628|NCT03970733|11967802|FG001|Overall Study|Withdrawal by Subject|5
7577629|NCT03970733|11967803|FG002|Overall Study|Withdrawal by Subject|1
7577630|NCT03970733|11967801|FG000|Overall Study|e.g.: moved from study area|1
7577631|NCT03970733|11967802|FG001|Overall Study|e.g.: moved from study area|0
7577632|NCT03970733|11967803|FG002|Overall Study|e.g.: moved from study area|0
7577633|NCT03970733|11967801|FG000|Overall Study|Lost to Follow-up|2
7577634|NCT03970733|11967802|FG001|Overall Study|Lost to Follow-up|1
7577635|NCT03970733|11967803|FG002|Overall Study|Lost to Follow-up|1
7577636|NCT03970733|11967801|FG000|Overall Study|Other|1
7577637|NCT03970733|11967802|FG001|Overall Study|Other|0
7577638|NCT03970733|11967803|FG002|Overall Study|Other|0
7577639|NCT03968978|11967813|FG000|Overall Study|Adverse Event|1
7577640|NCT03968978|11967814|FG001|Overall Study|Adverse Event|0
7577643|NCT03966911|11967844|FG000|Overall Study|Adverse Event|1
7577644|NCT03966911|11967845|FG001|Overall Study|Adverse Event|1
7268324|NCT00404924|11482560|FG000|Overall Study|Adverse Event|75
7268325|NCT00404924|11482561|FG001|Overall Study|Adverse Event|16
7268326|NCT00404924|11482560|FG000|Overall Study|Condition under investigation worsened|475
7268327|NCT00404924|11482561|FG001|Overall Study|Condition under investigation worsened|264
7268328|NCT00404924|11482560|FG000|Overall Study|Lost to Follow-up|1
7268329|NCT00404924|11482561|FG001|Overall Study|Lost to Follow-up|1
7268330|NCT00404924|11482560|FG000|Overall Study|Withdrawal by Subject|26
7268331|NCT00404924|11482561|FG001|Overall Study|Withdrawal by Subject|13
7268332|NCT00404924|11482560|FG000|Overall Study|Other|25
7548104|NCT02916927|11905089|FG001|Overall Study|Withdrawal before first time point|0
7548105|NCT02917031|11905098|FG000|Overall Study|Reason not specified|7
7548106|NCT02917031|11905099|FG001|Overall Study|Reason not specified|5
7268333|NCT00404924|11482561|FG001|Overall Study|Other|11
7268334|NCT00404924|11482560|FG000|Overall Study|Randomised but not received treatment|1
7268335|NCT00404924|11482561|FG001|Overall Study|Randomised but not received treatment|1
7268336|NCT00405067|11482570|FG000|Overall Study|Adverse Event|4
7268337|NCT00405067|11482571|FG001|Overall Study|Adverse Event|9
7268338|NCT00405067|11482572|FG002|Overall Study|Adverse Event|4
7268339|NCT00405067|11482570|FG000|Overall Study|Lost to Follow-up|0
7548107|NCT02917031|11905100|FG002|Overall Study|Reason not specified|6
7577645|NCT03966911|11967844|FG000|Overall Study|Withdrawal by Subject|8
7268340|NCT00405067|11482571|FG001|Overall Study|Lost to Follow-up|0
7268341|NCT00405067|11482572|FG002|Overall Study|Lost to Follow-up|1
7268342|NCT00405275|11482582|FG000|Overall Study|Death|1
7268343|NCT00405275|11482583|FG001|Overall Study|Death|0
7268344|NCT00405275|11482582|FG000|Overall Study|Lost to Follow-up|5
7268345|NCT00405275|11482583|FG001|Overall Study|Lost to Follow-up|1
7268346|NCT00405275|11482582|FG000|Overall Study|Withdrawal by Subject|7
7268347|NCT00405275|11482583|FG001|Overall Study|Withdrawal by Subject|9
7268348|NCT00405275|11482582|FG000|Overall Study|Unwilling to continue|10
7268349|NCT00405275|11482583|FG001|Overall Study|Unwilling to continue|9
7268350|NCT00405392|11482604|FG000|Overall Study|Adverse Event|15
7268351|NCT00405392|11482605|FG001|Overall Study|Adverse Event|14
7268352|NCT00405392|11482604|FG000|Overall Study|Did not meet Eligibility criteria|7
7268353|NCT00405392|11482605|FG001|Overall Study|Did not meet Eligibility criteria|2
7268354|NCT00405392|11482604|FG000|Overall Study|Withdrawal by Subject|4
7268355|NCT00405392|11482605|FG001|Overall Study|Withdrawal by Subject|3
7268356|NCT00405392|11482604|FG000|Overall Study|Lost to Follow-up|1
7268357|NCT00405392|11482605|FG001|Overall Study|Lost to Follow-up|2
7268358|NCT00405392|11482604|FG000|Overall Study|Data missing|2
7268359|NCT00405392|11482605|FG001|Overall Study|Data missing|0
7268360|NCT00405392|11482604|FG000|Overall Study|Non-compliance|0
7268361|NCT00405392|11482605|FG001|Overall Study|Non-compliance|1
7268362|NCT00405392|11482604|FG000|Overall Study|Other|1
7268363|NCT00405392|11482605|FG001|Overall Study|Other|5
7268364|NCT00405548|11482631|FG000|Overall Study|Cognitive Memory problems on study day|1
7268365|NCT00405548|11482632|FG001|Overall Study|Cognitive Memory problems on study day|0
7268366|NCT00405548|11482631|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
7268367|NCT00405548|11482632|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
7268368|NCT00405548|11482631|FG000|Overall Study|Unable to self-administer shots|1
7268369|NCT00405548|11482632|FG001|Overall Study|Unable to self-administer shots|0
7268370|NCT00405548|11482631|FG000|Overall Study|Venous access failed during study day|1
7268371|NCT00405548|11482632|FG001|Overall Study|Venous access failed during study day|0
7268372|NCT00405548|11482631|FG000|Overall Study|Withdrawal by Subject|1
7268373|NCT00405548|11482632|FG001|Overall Study|Withdrawal by Subject|0
7268374|NCT00405587|11482642|FG000|Overall Study|Death|0
7268375|NCT00405587|11482643|FG001|Overall Study|Death|0
7268376|NCT00405587|11482644|FG002|Overall Study|Death|0
7548108|NCT02917031|11905098|FG000|Overall Study|Development of study-specific withdrawal criteria|1
7548109|NCT02917031|11905099|FG001|Overall Study|Development of study-specific withdrawal criteria|1
7548110|NCT02917031|11905100|FG002|Overall Study|Development of study-specific withdrawal criteria|0
7548111|NCT02917031|11905098|FG000|Overall Study|Withdrawal by Subject|3
7548112|NCT02917031|11905099|FG001|Overall Study|Withdrawal by Subject|3
7548113|NCT02917031|11905100|FG002|Overall Study|Withdrawal by Subject|0
7548114|NCT02917031|11905098|FG000|Overall Study|Physician Decision|1
7548115|NCT02917031|11905099|FG001|Overall Study|Physician Decision|0
7548116|NCT02917031|11905100|FG002|Overall Study|Physician Decision|0
7548117|NCT02917031|11905098|FG000|Overall Study|Adverse Event|4
7548118|NCT02917031|11905099|FG001|Overall Study|Adverse Event|1
7548119|NCT02917031|11905100|FG002|Overall Study|Adverse Event|5
7548120|NCT02917031|11905098|FG000|Overall Study|Death|2
7548121|NCT02917031|11905099|FG001|Overall Study|Death|3
7548122|NCT02917031|11905100|FG002|Overall Study|Death|4
7548123|NCT02917265|11905120|FG000|Overall Study|Physician Decision|1
7548124|NCT02917265|11905121|FG001|Overall Study|Physician Decision|0
7548125|NCT02917265|11905120|FG000|Overall Study|Withdrawal by Subject|1
7548126|NCT02917265|11905121|FG001|Overall Study|Withdrawal by Subject|0
7548127|NCT02917941|11905166|FG000|Treatment Period|Adverse Event|11
7548128|NCT02917941|11905166|FG000|Treatment Period|Progressive Disease|11
7548129|NCT02917941|11905166|FG000|Treatment Period|Reason not Specified|2
7548130|NCT02917941|11905166|FG000|Survival Follow-up Period|Lost to Follow-up|1
7548131|NCT02917941|11905166|FG000|Survival Follow-up Period|Withdrawal by Subject|4
7548132|NCT02918071|11905170|FG000|Overall Study|Withdrawal by Subject|2
7548133|NCT02918071|11905170|FG000|Overall Study|Lost to Follow-up|1
7548134|NCT02918266|11905189|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
7548135|NCT02918266|11905190|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548136|NCT02918266|11905191|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548137|NCT02918266|11905192|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548138|NCT02918266|11905193|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548139|NCT02918266|11905194|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548140|NCT02918266|11905195|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7548141|NCT02918266|11905196|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548142|NCT02918266|11905197|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
7548143|NCT02918266|11905198|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7548144|NCT02918266|11905199|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
7268377|NCT00405587|11482645|FG003|Overall Study|Death|1
7268378|NCT00405587|11482642|FG000|Overall Study|Disease Progression|22
7268379|NCT00405587|11482643|FG001|Overall Study|Disease Progression|23
7268380|NCT00405587|11482644|FG002|Overall Study|Disease Progression|21
7268381|NCT00405587|11482645|FG003|Overall Study|Disease Progression|17
7268382|NCT00405587|11482642|FG000|Overall Study|Physician Decision|3
7268383|NCT00405587|11482643|FG001|Overall Study|Physician Decision|2
7268384|NCT00405587|11482644|FG002|Overall Study|Physician Decision|0
7268385|NCT00405587|11482645|FG003|Overall Study|Physician Decision|0
7268386|NCT00405587|11482642|FG000|Overall Study|Adverse Event|1
7268387|NCT00405587|11482643|FG001|Overall Study|Adverse Event|0
7268388|NCT00405587|11482644|FG002|Overall Study|Adverse Event|0
7268389|NCT00405587|11482645|FG003|Overall Study|Adverse Event|0
7268390|NCT00405587|11482642|FG000|Overall Study|Lost to Follow-up|0
7268391|NCT00405587|11482643|FG001|Overall Study|Lost to Follow-up|1
7268392|NCT00405587|11482644|FG002|Overall Study|Lost to Follow-up|1
7268393|NCT00405587|11482645|FG003|Overall Study|Lost to Follow-up|0
7268394|NCT00405587|11482642|FG000|Overall Study|Radiation induced necrosis|0
7268395|NCT00405587|11482643|FG001|Overall Study|Radiation induced necrosis|1
7268396|NCT00405587|11482644|FG002|Overall Study|Radiation induced necrosis|0
7268397|NCT00405587|11482645|FG003|Overall Study|Radiation induced necrosis|0
7268398|NCT00405587|11482642|FG000|Overall Study|Withdrawal by Subject|0
7268399|NCT00405587|11482643|FG001|Overall Study|Withdrawal by Subject|0
7268400|NCT00405587|11482644|FG002|Overall Study|Withdrawal by Subject|0
7268401|NCT00405587|11482645|FG003|Overall Study|Withdrawal by Subject|2
7268402|NCT00405587|11482642|FG000|Overall Study|Participant not dosed|0
7268403|NCT00405587|11482643|FG001|Overall Study|Participant not dosed|1
7268404|NCT00405587|11482644|FG002|Overall Study|Participant not dosed|0
7268405|NCT00405587|11482645|FG003|Overall Study|Participant not dosed|0
7268406|NCT00405639|11482683|FG000|Overall Study|Withdrawal by Subject|1
7268407|NCT00405639|11482684|FG001|Overall Study|Withdrawal by Subject|0
7268408|NCT00405639|11482683|FG000|Overall Study|Adverse Event|1
7268409|NCT00405639|11482684|FG001|Overall Study|Adverse Event|0
7268410|NCT00405639|11482683|FG000|Overall Study|Seizure prior to receiving BNP|1
7577646|NCT03966911|11967845|FG001|Overall Study|Withdrawal by Subject|2
7577647|NCT03966911|11967844|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
7577648|NCT03966911|11967845|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
7577649|NCT03966365|11967855|FG000|Overall Study|Protocol Violation|1
7577650|NCT03966365|11967856|FG001|Overall Study|Protocol Violation|0
7577651|NCT03965403|11967862|FG000|Overall Study|Subject not meeting eligibility criteria|1
7577652|NCT03965351|11967919|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
7577653|NCT03965351|11967920|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
7577654|NCT03965351|11967919|FG000|Second Intervention (4 Weeks)|Adverse Event|0
7577655|NCT03965351|11967920|FG001|Second Intervention (4 Weeks)|Adverse Event|1
7577656|NCT03958955|11967935|FG000|Overall Study|Adverse Event|1
7577657|NCT03965052|11967943|FG000|Overall Study|Protocol Violation|1
7577658|NCT03965052|11967944|FG001|Overall Study|Protocol Violation|0
7577659|NCT03963401|11967973|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
7577660|NCT03963401|11967974|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
7577661|NCT03963401|11967975|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
7577662|NCT03963401|11967976|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
7577663|NCT03963401|11967977|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
7577664|NCT03963401|11967978|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
7577665|NCT03963401|11967973|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7577666|NCT03963401|11967974|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7577667|NCT03963401|11967975|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7577668|NCT03963401|11967976|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
7577669|NCT03963401|11967977|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7577670|NCT03963401|11967978|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
7577671|NCT03963401|11967973|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7577672|NCT03963401|11967974|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7268411|NCT00405639|11482684|FG001|Overall Study|Seizure prior to receiving BNP|0
7268412|NCT00405652|11482690|FG000|Overall Study|Adverse Event|4
7268413|NCT00405756|11482707|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
7268414|NCT00405756|11482708|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
7268415|NCT00405756|11482709|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
7268416|NCT00405756|11482707|FG000|Double-blind Treatment|Adverse Event|31
7268417|NCT00405756|11482708|FG001|Double-blind Treatment|Adverse Event|27
7268418|NCT00405756|11482709|FG002|Double-blind Treatment|Adverse Event|12
7268419|NCT00405756|11482707|FG000|Double-blind Treatment|Disease Progression|47
7268420|NCT00405756|11482708|FG001|Double-blind Treatment|Disease Progression|81
7268421|NCT00405756|11482709|FG002|Double-blind Treatment|Disease Progression|102
7268422|NCT00405756|11482707|FG000|Double-blind Treatment|Lack of Efficacy|1
7548145|NCT02918279|11905221|FG000|Overall Study|Lost to Follow-up|3
7548146|NCT02918279|11905222|FG001|Overall Study|Lost to Follow-up|6
7548147|NCT02918279|11905221|FG000|Overall Study|Withdrawal by Subject|5
7548148|NCT02918279|11905222|FG001|Overall Study|Withdrawal by Subject|15
7548149|NCT02918279|11905221|FG000|Overall Study|Withdrawal by parent/guardian|2
7548150|NCT02918279|11905222|FG001|Overall Study|Withdrawal by parent/guardian|1
7548151|NCT02918279|11905221|FG000|Overall Study|Other|3
7548152|NCT02918279|11905222|FG001|Overall Study|Other|1
7548153|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
7548154|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
7548155|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
7548156|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
7548157|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
7548158|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7548159|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7548160|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7548161|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
7548162|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
7548163|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7548164|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7548165|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7548166|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
7548167|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
7548240|NCT02918968|11905404|FG001|1st Line AAT|Lost to Follow-up|1
7548168|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7548169|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
7548170|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7548171|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7548172|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
7548173|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7548174|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7548175|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7548176|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
7548177|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
7548178|NCT02918318|11905232|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
7548179|NCT02918318|11905233|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
7548180|NCT02918318|11905234|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
7548181|NCT02918318|11905235|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
7548182|NCT02918318|11905236|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
7548183|NCT02918318|11905232|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7548184|NCT02918318|11905233|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7548185|NCT02918318|11905234|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7548186|NCT02918318|11905235|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
7548187|NCT02918318|11905236|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
7548188|NCT02918318|11905232|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7548189|NCT02918318|11905233|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7548190|NCT02918318|11905234|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7624594|NCT01986114|12035684|FG000|Overall Study|Other reason|7
7268423|NCT00405756|11482708|FG001|Double-blind Treatment|Lack of Efficacy|4
7268424|NCT00405756|11482709|FG002|Double-blind Treatment|Lack of Efficacy|2
7268425|NCT00405756|11482707|FG000|Double-blind Treatment|Withdrawal by Subject|15
7268426|NCT00405756|11482708|FG001|Double-blind Treatment|Withdrawal by Subject|9
7268427|NCT00405756|11482709|FG002|Double-blind Treatment|Withdrawal by Subject|10
7268428|NCT00405756|11482707|FG000|Double-blind Treatment|Lost to Follow-up|1
7268429|NCT00405756|11482708|FG001|Double-blind Treatment|Lost to Follow-up|0
7268430|NCT00405756|11482709|FG002|Double-blind Treatment|Lost to Follow-up|0
7268431|NCT00405756|11482707|FG000|Double-blind Treatment|Death|4
7268432|NCT00405756|11482708|FG001|Double-blind Treatment|Death|4
7268433|NCT00405756|11482709|FG002|Double-blind Treatment|Death|4
7268434|NCT00405756|11482707|FG000|Double-blind Treatment|Protocol Violation|1
7268435|NCT00405756|11482708|FG001|Double-blind Treatment|Protocol Violation|0
7268436|NCT00405756|11482709|FG002|Double-blind Treatment|Protocol Violation|2
7268437|NCT00405756|11482707|FG000|Double-blind Treatment|Other|7
7268438|NCT00405756|11482708|FG001|Double-blind Treatment|Other|4
7268439|NCT00405756|11482709|FG002|Double-blind Treatment|Other|4
7268440|NCT00405756|11482707|FG000|Open-label Extension|Ongoing in Open Label Period|7
7268441|NCT00405756|11482708|FG001|Open-label Extension|Ongoing in Open Label Period|15
7268442|NCT00405756|11482709|FG002|Open-label Extension|Ongoing in Open Label Period|25
7268443|NCT00405756|11482707|FG000|Open-label Extension|Adverse Event|1
7268444|NCT00405756|11482708|FG001|Open-label Extension|Adverse Event|3
7268445|NCT00405756|11482709|FG002|Open-label Extension|Adverse Event|7
7268446|NCT00405756|11482707|FG000|Open-label Extension|Disease Progression|8
7268447|NCT00405756|11482708|FG001|Open-label Extension|Disease Progression|23
7268448|NCT00405756|11482709|FG002|Open-label Extension|Disease Progression|26
7268449|NCT00405756|11482707|FG000|Open-label Extension|Withdrawal by Subject|2
7268450|NCT00405756|11482708|FG001|Open-label Extension|Withdrawal by Subject|3
7268451|NCT00405756|11482709|FG002|Open-label Extension|Withdrawal by Subject|3
7268452|NCT00405756|11482707|FG000|Open-label Extension|Death|1
7268453|NCT00405756|11482708|FG001|Open-label Extension|Death|2
7548191|NCT02918318|11905235|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
7548192|NCT02918318|11905236|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
7548193|NCT02918318|11905232|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7548194|NCT02918318|11905233|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7548195|NCT02918318|11905234|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7548196|NCT02918318|11905235|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
7548197|NCT02918318|11905236|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
7548198|NCT02918318|11905232|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
7548199|NCT02918318|11905233|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
7548200|NCT02918318|11905234|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
7548201|NCT02918318|11905235|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
7548202|NCT02918318|11905236|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
7548203|NCT02918318|11905232|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7548204|NCT02918318|11905233|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7548205|NCT02918318|11905234|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7548206|NCT02918318|11905235|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
7548207|NCT02918318|11905236|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
7548208|NCT02918318|11905232|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7548209|NCT02918318|11905233|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7548210|NCT02918318|11905234|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7548211|NCT02918318|11905235|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
7548212|NCT02918318|11905236|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
7548213|NCT02918552|11905294|FG000|Overall Study|Failed Pharmacokinetics|1
7548214|NCT02918552|11905295|FG001|Overall Study|Failed Pharmacokinetics|0
7548215|NCT02918552|11905294|FG000|Overall Study|Withdrawal by Subject|0
7548216|NCT02918552|11905295|FG001|Overall Study|Withdrawal by Subject|1
7548217|NCT02918552|11905294|FG000|Overall Study|Lost to Follow-up|0
7548218|NCT02918552|11905295|FG001|Overall Study|Lost to Follow-up|1
7268454|NCT00405756|11482709|FG002|Open-label Extension|Death|4
7268455|NCT00405756|11482707|FG000|Open-label Extension|Other|0
7268456|NCT00405756|11482708|FG001|Open-label Extension|Other|1
7268457|NCT00405756|11482709|FG002|Open-label Extension|Other|7
7268458|NCT00405756|11482707|FG000|Follow-up|Ongoing in Follow-up Period|52
7268459|NCT00405756|11482708|FG001|Follow-up|Ongoing in Follow-up Period|51
7268460|NCT00405756|11482709|FG002|Follow-up|Ongoing in Follow-up Period|60
7268461|NCT00405756|11482707|FG000|Follow-up|Death|21
7268462|NCT00405756|11482708|FG001|Follow-up|Death|31
7268463|NCT00405756|11482709|FG002|Follow-up|Death|24
7268464|NCT00405756|11482707|FG000|Follow-up|Lost to Follow-up|2
7268465|NCT00405756|11482708|FG001|Follow-up|Lost to Follow-up|8
7268466|NCT00405756|11482709|FG002|Follow-up|Lost to Follow-up|4
7268467|NCT00405821|11482719|FG000|Overall Study|Death|5
7268468|NCT00405821|11482720|FG001|Overall Study|Death|7
7268469|NCT00405821|11482719|FG000|Overall Study|Lost to Follow-up|7
7268470|NCT00405821|11482720|FG001|Overall Study|Lost to Follow-up|7
7268471|NCT00405821|11482719|FG000|Overall Study|Protocol Violation|1
7268472|NCT00405821|11482720|FG001|Overall Study|Protocol Violation|0
7268473|NCT00405821|11482719|FG000|Overall Study|initiated ART|9
7268474|NCT00405821|11482720|FG001|Overall Study|initiated ART|8
7268475|NCT00405912|11482729|FG000|Overall Study|Withdrawal by Subject|12
7268476|NCT00405912|11482730|FG001|Overall Study|Withdrawal by Subject|11
7268477|NCT00405912|11482731|FG002|Overall Study|Withdrawal by Subject|12
7268478|NCT00405912|11482729|FG000|Overall Study|Lost to Follow-up|4
7268479|NCT00405912|11482730|FG001|Overall Study|Lost to Follow-up|8
7268480|NCT00405912|11482731|FG002|Overall Study|Lost to Follow-up|4
7268481|NCT00406029|11482753|FG000|Overall Study|Adverse Event|12
7268482|NCT00406029|11482754|FG001|Overall Study|Adverse Event|2
7548219|NCT02918877|11905394|FG000|Overall Study|Withdrawal by Subject|2
7548220|NCT02918877|11905395|FG001|Overall Study|Withdrawal by Subject|2
7548221|NCT02918877|11905394|FG000|Overall Study|Surgery cancelled|1
7548222|NCT02918877|11905395|FG001|Overall Study|Surgery cancelled|0
7548223|NCT02918877|11905394|FG000|Overall Study|Physician Decision|1
7268483|NCT00406029|11482755|FG002|Overall Study|Adverse Event|5
7268484|NCT00406029|11482756|FG003|Overall Study|Adverse Event|10
7268485|NCT00406029|11482757|FG004|Overall Study|Adverse Event|7
7268486|NCT00406029|11482753|FG000|Overall Study|Withdrawal by Subject|3
7268487|NCT00406029|11482754|FG001|Overall Study|Withdrawal by Subject|4
7268488|NCT00406029|11482755|FG002|Overall Study|Withdrawal by Subject|2
7268489|NCT00406029|11482756|FG003|Overall Study|Withdrawal by Subject|2
7268490|NCT00406029|11482757|FG004|Overall Study|Withdrawal by Subject|0
7268491|NCT00406029|11482753|FG000|Overall Study|Protocol Violation|1
7268492|NCT00406029|11482754|FG001|Overall Study|Protocol Violation|2
7268493|NCT00406029|11482755|FG002|Overall Study|Protocol Violation|0
7268494|NCT00406029|11482756|FG003|Overall Study|Protocol Violation|2
7268495|NCT00406029|11482757|FG004|Overall Study|Protocol Violation|0
7268496|NCT00406029|11482753|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
7268497|NCT00406029|11482754|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7268498|NCT00406029|11482755|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
7268499|NCT00406029|11482756|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
7268500|NCT00406029|11482757|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
7268501|NCT00406029|11482753|FG000|Overall Study|Randomized in Error|0
7268502|NCT00406029|11482754|FG001|Overall Study|Randomized in Error|0
7268503|NCT00406029|11482755|FG002|Overall Study|Randomized in Error|2
7268504|NCT00406029|11482756|FG003|Overall Study|Randomized in Error|3
7268505|NCT00406029|11482757|FG004|Overall Study|Randomized in Error|1
7268506|NCT00406315|11482806|FG000|Overall Study|Death|1
7268507|NCT00406315|11482806|FG000|Overall Study|Adverse Event|39
7268508|NCT00406315|11482806|FG000|Overall Study|Laboratory Abnormality|4
7268509|NCT00406315|11482806|FG000|Overall Study|Lack of Efficacy|13
7548224|NCT02918877|11905395|FG001|Overall Study|Physician Decision|0
7548225|NCT02918877|11905394|FG000|Overall Study|Received intraoperative steroids|1
7548226|NCT02918877|11905395|FG001|Overall Study|Received intraoperative steroids|0
7548227|NCT02918877|11905394|FG000|Overall Study|Unable to obtain lab samples|1
7548228|NCT02918877|11905395|FG001|Overall Study|Unable to obtain lab samples|0
7548229|NCT02918877|11905394|FG000|Overall Study|Unsafe to perform BAL|0
7548230|NCT02918877|11905395|FG001|Overall Study|Unsafe to perform BAL|1
7548231|NCT02918968|11905403|FG000|1st Line AAT|Progressive disease|9
7548232|NCT02918968|11905404|FG001|1st Line AAT|Progressive disease|4
7548233|NCT02918968|11905403|FG000|1st Line AAT|Adverse Event|12
7548234|NCT02918968|11905404|FG001|1st Line AAT|Adverse Event|3
7548235|NCT02918968|11905403|FG000|1st Line AAT|Physician Decision|4
7548236|NCT02918968|11905404|FG001|1st Line AAT|Physician Decision|2
7548237|NCT02918968|11905403|FG000|1st Line AAT|Withdrawal by Subject|2
7548238|NCT02918968|11905404|FG001|1st Line AAT|Withdrawal by Subject|1
7548239|NCT02918968|11905403|FG000|1st Line AAT|Lost to Follow-up|0
7548241|NCT02918968|11905403|FG000|1st Line AAT|Death|1
7548242|NCT02918968|11905404|FG001|1st Line AAT|Death|0
7548243|NCT02918968|11905403|FG000|1st Line AAT|Miscellaneous|1
7548244|NCT02918968|11905404|FG001|1st Line AAT|Miscellaneous|0
7548245|NCT02918968|11905403|FG000|2nd Line AAT|Progressive disease|21
7577673|NCT03963401|11967975|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7577674|NCT03963401|11967976|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
7577675|NCT03963401|11967977|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
7577676|NCT03963401|11967978|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
7577677|NCT03963401|11967973|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7577678|NCT03963401|11967974|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
7577679|NCT03963401|11967975|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7577680|NCT03963401|11967976|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7577681|NCT03963401|11967977|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7577682|NCT03963401|11967978|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
7577683|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
7268510|NCT00406315|11482806|FG000|Overall Study|Other|33
7548246|NCT02918968|11905404|FG001|2nd Line AAT|Progressive disease|3
7548247|NCT02918968|11905403|FG000|2nd Line AAT|Adverse Event|2
7548248|NCT02918968|11905404|FG001|2nd Line AAT|Adverse Event|5
7548249|NCT02918968|11905403|FG000|2nd Line AAT|Physician Decision|0
7548250|NCT02918968|11905404|FG001|2nd Line AAT|Physician Decision|1
7548251|NCT02918968|11905403|FG000|2nd Line AAT|Withdrawal by Subject|2
7548252|NCT02918968|11905404|FG001|2nd Line AAT|Withdrawal by Subject|2
7548253|NCT02918968|11905403|FG000|2nd Line AAT|Death|0
7548254|NCT02918968|11905404|FG001|2nd Line AAT|Death|1
7548255|NCT02919267|11905424|FG000|Overall Study|Protocol Violation|0
7548256|NCT02919267|11905425|FG001|Overall Study|Protocol Violation|3
7268511|NCT00406315|11482806|FG000|Overall Study|Lost to Follow-up|21
7268512|NCT00406315|11482806|FG000|Overall Study|Withdrawal by Subject|30
7268513|NCT00406354|11482813|FG000|All Randomized Patients|Protocol Violation|0
7548257|NCT02919267|11905426|FG002|Overall Study|Protocol Violation|3
7548258|NCT02919267|11905427|FG003|Overall Study|Protocol Violation|4
7548259|NCT02919475|11905451|FG000|Overall Study|Adverse Event|3
7548260|NCT02919475|11905452|FG001|Overall Study|Adverse Event|3
7268514|NCT00406354|11482814|FG001|All Randomized Patients|Protocol Violation|0
7268515|NCT00406354|11482815|FG002|All Randomized Patients|Protocol Violation|1
7268516|NCT00406354|11482813|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
7268517|NCT00406354|11482814|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
7548261|NCT02919475|11905453|FG002|Overall Study|Adverse Event|3
7548262|NCT02919475|11905454|FG003|Overall Study|Adverse Event|9
7548263|NCT02919475|11905455|FG004|Overall Study|Adverse Event|2
7268518|NCT00406354|11482815|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
7268519|NCT00406354|11482813|FG000|All Randomized and Treated Patients|Adverse Event|6
7548264|NCT02919475|11905451|FG000|Overall Study|Death|0
7548265|NCT02919475|11905452|FG001|Overall Study|Death|1
7548266|NCT02919475|11905453|FG002|Overall Study|Death|0
7548267|NCT02919475|11905454|FG003|Overall Study|Death|0
7548268|NCT02919475|11905455|FG004|Overall Study|Death|0
7548269|NCT02919475|11905451|FG000|Overall Study|Lost to Follow-up|0
7548270|NCT02919475|11905452|FG001|Overall Study|Lost to Follow-up|0
7548271|NCT02919475|11905453|FG002|Overall Study|Lost to Follow-up|0
7548272|NCT02919475|11905454|FG003|Overall Study|Lost to Follow-up|1
7548273|NCT02919475|11905455|FG004|Overall Study|Lost to Follow-up|0
7548274|NCT02919475|11905451|FG000|Overall Study|Withdrawal by Subject|2
7548275|NCT02919475|11905452|FG001|Overall Study|Withdrawal by Subject|3
7548276|NCT02919475|11905453|FG002|Overall Study|Withdrawal by Subject|1
7548277|NCT02919475|11905454|FG003|Overall Study|Withdrawal by Subject|2
7548278|NCT02919475|11905455|FG004|Overall Study|Withdrawal by Subject|2
7548279|NCT02919475|11905451|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7548280|NCT02919475|11905452|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7548281|NCT02919475|11905453|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7548282|NCT02919475|11905454|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
7548283|NCT02919475|11905455|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7548284|NCT02919696|11905476|FG000|Overall Study|Adverse Event|1
7548285|NCT02919696|11905477|FG001|Overall Study|Adverse Event|2
7548286|NCT02919696|11905476|FG000|Overall Study|Withdrawal by Subject|2
7548287|NCT02919696|11905477|FG001|Overall Study|Withdrawal by Subject|1
7548288|NCT02919696|11905476|FG000|Overall Study|Sponsor Decision|1
7548289|NCT02919696|11905477|FG001|Overall Study|Sponsor Decision|1
7548290|NCT02919696|11905476|FG000|Overall Study|Never Treated|0
7548291|NCT02919696|11905477|FG001|Overall Study|Never Treated|1
7548292|NCT02919761|11905489|FG000|Part 1: Open Label|Withdrawal by Subject|12
7548293|NCT02919761|11905490|FG001|Part 1: Open Label|Withdrawal by Subject|0
7548294|NCT02919761|11905491|FG002|Part 1: Open Label|Withdrawal by Subject|0
7548295|NCT02919761|11905489|FG000|Part 1: Open Label|Adverse Event|1
7548296|NCT02919761|11905490|FG001|Part 1: Open Label|Adverse Event|0
7548297|NCT02919761|11905491|FG002|Part 1: Open Label|Adverse Event|0
7548298|NCT02919761|11905489|FG000|Part 1: Open Label|Lost to Follow-up|1
7548299|NCT02919761|11905490|FG001|Part 1: Open Label|Lost to Follow-up|0
7548300|NCT02919761|11905491|FG002|Part 1: Open Label|Lost to Follow-up|0
7268576|NCT00406419|11482845|FG001|Overall Study|Adverse Event|12
7548301|NCT02919761|11905489|FG000|Part 1: Open Label|Met withdrawal criteria|5
7548302|NCT02919761|11905490|FG001|Part 1: Open Label|Met withdrawal criteria|0
7548303|NCT02919761|11905491|FG002|Part 1: Open Label|Met withdrawal criteria|0
7548304|NCT02919761|11905489|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
7548305|NCT02919761|11905490|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7548306|NCT02919761|11905491|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
7548307|NCT02919761|11905489|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
7548308|NCT02919761|11905490|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7548309|NCT02919761|11905491|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
7548310|NCT02919761|11905489|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
7548311|NCT02919761|11905490|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
7548312|NCT02919761|11905491|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
7548313|NCT02919761|11905489|FG000|Part 1: Open Label|Termination by Sponsor|1
7548314|NCT02919761|11905490|FG001|Part 1: Open Label|Termination by Sponsor|0
7548315|NCT02919761|11905491|FG002|Part 1: Open Label|Termination by Sponsor|0
7548316|NCT02919761|11905489|FG000|Part 2: Double-blind|Withdrawal by Subject|0
7548317|NCT02919761|11905490|FG001|Part 2: Double-blind|Withdrawal by Subject|0
7548318|NCT02919761|11905491|FG002|Part 2: Double-blind|Withdrawal by Subject|2
7548319|NCT02919761|11905489|FG000|Part 2: Double-blind|Adverse Event|0
7548320|NCT02919761|11905490|FG001|Part 2: Double-blind|Adverse Event|1
7548321|NCT02919761|11905491|FG002|Part 2: Double-blind|Adverse Event|0
7548322|NCT02919761|11905489|FG000|Part 2: Double-blind|Lost to Follow-up|0
7268520|NCT00406354|11482814|FG001|All Randomized and Treated Patients|Adverse Event|2
7268521|NCT00406354|11482815|FG002|All Randomized and Treated Patients|Adverse Event|1
7268522|NCT00406354|11482813|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
7268523|NCT00406354|11482814|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
7268524|NCT00406354|11482815|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
7268525|NCT00406354|11482813|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
7268526|NCT00406354|11482814|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
7548323|NCT02919761|11905490|FG001|Part 2: Double-blind|Lost to Follow-up|0
7548324|NCT02919761|11905491|FG002|Part 2: Double-blind|Lost to Follow-up|3
7548325|NCT02919761|11905489|FG000|Part 2: Double-blind|Met withdrawal criteria|0
7388197|NCT01218100|11646970|FG001|Overall Study|Lack of Efficacy|6
7268527|NCT00406354|11482815|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
7268528|NCT00406354|11482813|FG000|All Randomized and Treated Patients|Physician Decision|0
7268529|NCT00406354|11482814|FG001|All Randomized and Treated Patients|Physician Decision|0
7268530|NCT00406354|11482815|FG002|All Randomized and Treated Patients|Physician Decision|1
7268531|NCT00406367|11482825|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
7268532|NCT00406367|11482826|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
7268533|NCT00406367|11482825|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
7268534|NCT00406367|11482826|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
7548326|NCT02919761|11905490|FG001|Part 2: Double-blind|Met withdrawal criteria|1
7548327|NCT02919761|11905491|FG002|Part 2: Double-blind|Met withdrawal criteria|2
7548328|NCT02919761|11905489|FG000|Part 2: Double-blind|Worsening of disease activity|0
7548329|NCT02919761|11905490|FG001|Part 2: Double-blind|Worsening of disease activity|4
7548330|NCT02919761|11905491|FG002|Part 2: Double-blind|Worsening of disease activity|10
7548331|NCT02919761|11905489|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
7548332|NCT02919761|11905490|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
7548333|NCT02919761|11905491|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
7548334|NCT02919761|11905489|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
7548335|NCT02919761|11905490|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
7548336|NCT02919761|11905491|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
7548337|NCT02919761|11905489|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
7548338|NCT02919761|11905490|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
7548339|NCT02919761|11905491|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
7548340|NCT02919995|11905528|FG000|Overall Study|Adverse Event|0
7548341|NCT02919995|11905529|FG001|Overall Study|Adverse Event|0
7548342|NCT02919995|11905530|FG002|Overall Study|Adverse Event|0
7548343|NCT02919995|11905531|FG003|Overall Study|Adverse Event|0
7548344|NCT02919995|11905532|FG004|Overall Study|Adverse Event|0
7548345|NCT02919995|11905533|FG005|Overall Study|Adverse Event|1
7548346|NCT02920528|11905544|FG000|Overall Study|Incomplete Data|1
7548347|NCT02920528|11905545|FG001|Overall Study|Incomplete Data|1
7548348|NCT02920528|11905546|FG002|Overall Study|Incomplete Data|1
7577684|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
7577685|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
7577686|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
7577687|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
7577688|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
7577689|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7577690|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7577691|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
7577692|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7577693|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7577694|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
7577695|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7577696|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7577697|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
7577698|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7577699|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7577700|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
7577701|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
7577702|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7577703|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7577704|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7577705|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7577706|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
7577707|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
7577708|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7577709|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7577710|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
7577711|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7577712|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
7577713|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
7577714|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7268535|NCT00406367|11482825|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
7268536|NCT00406367|11482826|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
7268537|NCT00406367|11482825|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
7388198|NCT01218100|11646971|FG002|Overall Study|Lack of Efficacy|5
7548349|NCT02920528|11905544|FG000|Overall Study|Adverse Event|0
7548350|NCT02920528|11905545|FG001|Overall Study|Adverse Event|0
7548351|NCT02920528|11905546|FG002|Overall Study|Adverse Event|3
7548352|NCT02920528|11905544|FG000|Overall Study|Did not meet inclusion criteria|2
7548353|NCT02920528|11905545|FG001|Overall Study|Did not meet inclusion criteria|0
7548354|NCT02920528|11905546|FG002|Overall Study|Did not meet inclusion criteria|1
7268538|NCT00406367|11482826|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
7268539|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
7268540|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
7268541|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
7268542|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
7268543|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7268544|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7268545|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
7268546|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
7268547|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
7268548|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
7268549|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
7268550|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
7268551|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
7268552|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
7268553|NCT00406367|11482825|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
7268554|NCT00406367|11482826|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
7268555|NCT00406393|11482834|FG000|Overall Study|Did not undergo transplantation|2
7268556|NCT00406393|11482835|FG001|Overall Study|Did not undergo transplantation|1
7577715|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7577716|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7577717|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7268557|NCT00406419|11482844|FG000|Overall Study|Death|3
7268558|NCT00406419|11482845|FG001|Overall Study|Death|1
7268559|NCT00406419|11482846|FG002|Overall Study|Death|4
7268560|NCT00406419|11482844|FG000|Overall Study|Protocol Violation|6
7268561|NCT00406419|11482845|FG001|Overall Study|Protocol Violation|2
7268562|NCT00406419|11482846|FG002|Overall Study|Protocol Violation|5
7268563|NCT00406419|11482844|FG000|Overall Study|Study Terminated by Sponsor|260
7268564|NCT00406419|11482845|FG001|Overall Study|Study Terminated by Sponsor|288
7268565|NCT00406419|11482846|FG002|Overall Study|Study Terminated by Sponsor|282
7268566|NCT00406419|11482844|FG000|Overall Study|Withdrawal by Subject|17
7268567|NCT00406419|11482845|FG001|Overall Study|Withdrawal by Subject|24
7268568|NCT00406419|11482846|FG002|Overall Study|Withdrawal by Subject|26
7268569|NCT00406419|11482844|FG000|Overall Study|Lack of Efficacy|12
7268570|NCT00406419|11482845|FG001|Overall Study|Lack of Efficacy|1
7268571|NCT00406419|11482846|FG002|Overall Study|Lack of Efficacy|6
7268572|NCT00406419|11482844|FG000|Overall Study|Non-Compliance with Study Drug|5
7268573|NCT00406419|11482845|FG001|Overall Study|Non-Compliance with Study Drug|6
7268574|NCT00406419|11482846|FG002|Overall Study|Non-Compliance with Study Drug|3
7268575|NCT00406419|11482844|FG000|Overall Study|Adverse Event|10
7268577|NCT00406419|11482846|FG002|Overall Study|Adverse Event|16
7268578|NCT00406419|11482844|FG000|Overall Study|Lost to Follow-up|11
7268579|NCT00406419|11482845|FG001|Overall Study|Lost to Follow-up|10
7268580|NCT00406419|11482846|FG002|Overall Study|Lost to Follow-up|5
7268581|NCT00406640|11482856|FG000|Acute Phase|Adverse Event|18
7268582|NCT00406640|11482857|FG001|Acute Phase|Adverse Event|13
7268583|NCT00406640|11482856|FG000|Acute Phase|Failed to Return|5
7268584|NCT00406640|11482857|FG001|Acute Phase|Failed to Return|1
7268585|NCT00406640|11482856|FG000|Acute Phase|Physician Decision|0
7268586|NCT00406640|11482857|FG001|Acute Phase|Physician Decision|1
7268587|NCT00406640|11482856|FG000|Acute Phase|Lost to Follow-up|7
7268588|NCT00406640|11482857|FG001|Acute Phase|Lost to Follow-up|4
7268589|NCT00406640|11482856|FG000|Acute Phase|Protocol deviation|4
7268590|NCT00406640|11482857|FG001|Acute Phase|Protocol deviation|10
7268591|NCT00406640|11482856|FG000|Acute Phase|Protocol Violation|3
7548355|NCT02920957|11905584|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
7548356|NCT02920957|11905585|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
7548357|NCT02920957|11905584|FG000|First Intervention : 1 Month|Lost to Follow-up|1
7548358|NCT02920957|11905585|FG001|First Intervention : 1 Month|Lost to Follow-up|0
7548359|NCT02920957|11905584|FG000|First Intervention : 1 Month|Adverse Event|1
7548360|NCT02920957|11905585|FG001|First Intervention : 1 Month|Adverse Event|0
7548361|NCT02920957|11905584|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
7548362|NCT02920957|11905585|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
7548363|NCT02920970|11905602|FG000|First Intervention|Protocol Violation|0
7548364|NCT02920970|11905603|FG001|First Intervention|Protocol Violation|1
7548365|NCT02920970|11905602|FG000|First Intervention|Adverse Event|0
7548366|NCT02920970|11905603|FG001|First Intervention|Adverse Event|1
7548367|NCT02920970|11905602|FG000|Second Intervention|Poor Lens Fit|1
7268592|NCT00406640|11482857|FG001|Acute Phase|Protocol Violation|2
7268593|NCT00406640|11482856|FG000|Acute Phase|Withdrawal by Subject|11
7548368|NCT02920970|11905603|FG001|Second Intervention|Poor Lens Fit|0
7548369|NCT02920983|11905611|FG000|Dispense 1|Unacceptable Lens Fit|0
7548370|NCT02920983|11905612|FG001|Dispense 1|Unacceptable Lens Fit|0
7548371|NCT02920983|11905613|FG002|Dispense 1|Unacceptable Lens Fit|0
7548372|NCT02920983|11905614|FG003|Dispense 1|Unacceptable Lens Fit|0
7268594|NCT00406640|11482857|FG001|Acute Phase|Withdrawal by Subject|9
7268595|NCT00406640|11482856|FG000|Acute Phase|Lack of Efficacy|3
7268596|NCT00406640|11482857|FG001|Acute Phase|Lack of Efficacy|3
7268597|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Adverse Event|11
7268598|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Adverse Event|11
7268599|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Death|1
7268600|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Death|0
7268601|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Failed to Return|0
7268602|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Failed to Return|2
7268603|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Physician Decision|2
7268604|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Physician Decision|3
7268605|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
7268606|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
7268607|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|non-compliance|7
7268608|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|non-compliance|5
7268609|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Protocol Violation|2
7268610|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Protocol Violation|2
7268611|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
7268612|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
7268613|NCT00406640|11482856|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
7268614|NCT00406640|11482857|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
7268615|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
7268616|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
7268617|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
7268618|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
7268619|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
7268620|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
7268621|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
7268622|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
7268623|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|non-compliance|3
7268624|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|non-compliance|2
7268625|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
7268626|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
7268627|NCT00406640|11482856|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
7268628|NCT00406640|11482857|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
7268629|NCT00406653|11482873|FG000|Induction Period|Adverse Event|1
7268630|NCT00406653|11482874|FG001|Induction Period|Adverse Event|10
7268631|NCT00406653|11482875|FG002|Induction Period|Adverse Event|4
7268632|NCT00406653|11482876|FG003|Induction Period|Adverse Event|11
7268633|NCT00406653|11482877|FG004|Induction Period|Adverse Event|0
7268634|NCT00406653|11482878|FG005|Induction Period|Adverse Event|0
7268635|NCT00406653|11482879|FG006|Induction Period|Adverse Event|0
7268636|NCT00406653|11482873|FG000|Induction Period|Lack of Efficacy|11
7548373|NCT02920983|11905615|FG004|Dispense 1|Unacceptable Lens Fit|1
7548374|NCT02920983|11905616|FG005|Dispense 1|Unacceptable Lens Fit|0
7548375|NCT02920983|11905611|FG000|Dispense 2|Unscceptable lens fit|1
7548376|NCT02920983|11905612|FG001|Dispense 2|Unscceptable lens fit|0
7548377|NCT02920983|11905613|FG002|Dispense 2|Unscceptable lens fit|0
7548378|NCT02920983|11905614|FG003|Dispense 2|Unscceptable lens fit|0
7548379|NCT02920983|11905615|FG004|Dispense 2|Unscceptable lens fit|1
7548380|NCT02920983|11905616|FG005|Dispense 2|Unscceptable lens fit|0
7548381|NCT02920983|11905611|FG000|Dispense 3|Unacceptable Lens Fit|1
7548382|NCT02920983|11905612|FG001|Dispense 3|Unacceptable Lens Fit|1
7548383|NCT02920983|11905613|FG002|Dispense 3|Unacceptable Lens Fit|0
7548384|NCT02920983|11905614|FG003|Dispense 3|Unacceptable Lens Fit|0
7548385|NCT02920983|11905615|FG004|Dispense 3|Unacceptable Lens Fit|1
7548386|NCT02920983|11905616|FG005|Dispense 3|Unacceptable Lens Fit|0
7548387|NCT02921087|11905630|FG000|Overall Study|Withdrawal by Subject|0
7548388|NCT02921087|11905631|FG001|Overall Study|Withdrawal by Subject|1
7548389|NCT02921425|11905675|FG000|Overall Study|Protocol Violation|9
7548390|NCT02921750|11905689|FG000|Overall Study|Adverse Event|1
7548391|NCT02921750|11905690|FG001|Overall Study|Adverse Event|2
7548392|NCT02921750|11905689|FG000|Overall Study|Withdrawal by Subject|1
7548393|NCT02921750|11905690|FG001|Overall Study|Withdrawal by Subject|1
7548394|NCT02921750|11905689|FG000|Overall Study|Lost to Follow-up|3
7548395|NCT02921750|11905690|FG001|Overall Study|Lost to Follow-up|3
7268637|NCT00406653|11482874|FG001|Induction Period|Lack of Efficacy|14
7268638|NCT00406653|11482875|FG002|Induction Period|Lack of Efficacy|8
7268639|NCT00406653|11482876|FG003|Induction Period|Lack of Efficacy|10
7268640|NCT00406653|11482877|FG004|Induction Period|Lack of Efficacy|0
7268641|NCT00406653|11482878|FG005|Induction Period|Lack of Efficacy|0
7268642|NCT00406653|11482879|FG006|Induction Period|Lack of Efficacy|0
7268643|NCT00406653|11482873|FG000|Induction Period|Lost to Follow-up|0
7268644|NCT00406653|11482874|FG001|Induction Period|Lost to Follow-up|2
7268645|NCT00406653|11482875|FG002|Induction Period|Lost to Follow-up|0
7268646|NCT00406653|11482876|FG003|Induction Period|Lost to Follow-up|0
7268647|NCT00406653|11482877|FG004|Induction Period|Lost to Follow-up|0
7268648|NCT00406653|11482878|FG005|Induction Period|Lost to Follow-up|0
7268649|NCT00406653|11482879|FG006|Induction Period|Lost to Follow-up|0
7268650|NCT00406653|11482873|FG000|Induction Period|Withdrawal of Consent|2
7268651|NCT00406653|11482874|FG001|Induction Period|Withdrawal of Consent|5
7268652|NCT00406653|11482875|FG002|Induction Period|Withdrawal of Consent|1
7268653|NCT00406653|11482876|FG003|Induction Period|Withdrawal of Consent|2
7268654|NCT00406653|11482877|FG004|Induction Period|Withdrawal of Consent|0
7268655|NCT00406653|11482878|FG005|Induction Period|Withdrawal of Consent|0
7268656|NCT00406653|11482879|FG006|Induction Period|Withdrawal of Consent|0
7268657|NCT00406653|11482873|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
7268658|NCT00406653|11482874|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
7268659|NCT00406653|11482875|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
7268660|NCT00406653|11482876|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
7268661|NCT00406653|11482877|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
7268662|NCT00406653|11482878|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
7268663|NCT00406653|11482879|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
7268664|NCT00406653|11482873|FG000|Induction Period|Pregnancy|1
7268665|NCT00406653|11482874|FG001|Induction Period|Pregnancy|0
7268666|NCT00406653|11482875|FG002|Induction Period|Pregnancy|0
7268667|NCT00406653|11482876|FG003|Induction Period|Pregnancy|0
7268668|NCT00406653|11482877|FG004|Induction Period|Pregnancy|0
7268669|NCT00406653|11482878|FG005|Induction Period|Pregnancy|0
7268670|NCT00406653|11482879|FG006|Induction Period|Pregnancy|0
7268671|NCT00406653|11482873|FG000|Induction Period|Declined participation but followup done|0
7268672|NCT00406653|11482874|FG001|Induction Period|Declined participation but followup done|2
7268673|NCT00406653|11482875|FG002|Induction Period|Declined participation but followup done|1
7268674|NCT00406653|11482876|FG003|Induction Period|Declined participation but followup done|1
7268675|NCT00406653|11482877|FG004|Induction Period|Declined participation but followup done|0
7268676|NCT00406653|11482878|FG005|Induction Period|Declined participation but followup done|0
7268677|NCT00406653|11482879|FG006|Induction Period|Declined participation but followup done|0
7268678|NCT00406653|11482873|FG000|Induction Period|Given prohibited drug|0
7268679|NCT00406653|11482874|FG001|Induction Period|Given prohibited drug|1
7268680|NCT00406653|11482875|FG002|Induction Period|Given prohibited drug|2
7268681|NCT00406653|11482876|FG003|Induction Period|Given prohibited drug|0
7268682|NCT00406653|11482877|FG004|Induction Period|Given prohibited drug|0
7268683|NCT00406653|11482878|FG005|Induction Period|Given prohibited drug|0
7268684|NCT00406653|11482879|FG006|Induction Period|Given prohibited drug|0
7268685|NCT00406653|11482873|FG000|Induction Period|Incarcerated|0
7268686|NCT00406653|11482874|FG001|Induction Period|Incarcerated|0
7268687|NCT00406653|11482875|FG002|Induction Period|Incarcerated|1
7268688|NCT00406653|11482876|FG003|Induction Period|Incarcerated|0
7268689|NCT00406653|11482877|FG004|Induction Period|Incarcerated|0
7268690|NCT00406653|11482878|FG005|Induction Period|Incarcerated|0
7268691|NCT00406653|11482879|FG006|Induction Period|Incarcerated|0
7268692|NCT00406653|11482873|FG000|Induction Period|Patient relocated|0
7268693|NCT00406653|11482874|FG001|Induction Period|Patient relocated|0
7268694|NCT00406653|11482875|FG002|Induction Period|Patient relocated|1
7268695|NCT00406653|11482876|FG003|Induction Period|Patient relocated|0
7268696|NCT00406653|11482877|FG004|Induction Period|Patient relocated|0
7268697|NCT00406653|11482878|FG005|Induction Period|Patient relocated|0
7268698|NCT00406653|11482879|FG006|Induction Period|Patient relocated|0
7268699|NCT00406653|11482873|FG000|Maintenance Period|Adverse Event|0
7268700|NCT00406653|11482874|FG001|Maintenance Period|Adverse Event|0
7268701|NCT00406653|11482875|FG002|Maintenance Period|Adverse Event|0
7268702|NCT00406653|11482876|FG003|Maintenance Period|Adverse Event|0
7268703|NCT00406653|11482877|FG004|Maintenance Period|Adverse Event|1
7268704|NCT00406653|11482878|FG005|Maintenance Period|Adverse Event|1
7268705|NCT00406653|11482879|FG006|Maintenance Period|Adverse Event|0
7268706|NCT00406653|11482873|FG000|Maintenance Period|Lack of Efficacy|0
7268707|NCT00406653|11482874|FG001|Maintenance Period|Lack of Efficacy|0
7268708|NCT00406653|11482875|FG002|Maintenance Period|Lack of Efficacy|0
7268709|NCT00406653|11482876|FG003|Maintenance Period|Lack of Efficacy|0
7268710|NCT00406653|11482877|FG004|Maintenance Period|Lack of Efficacy|20
7268711|NCT00406653|11482878|FG005|Maintenance Period|Lack of Efficacy|26
7268712|NCT00406653|11482879|FG006|Maintenance Period|Lack of Efficacy|0
7268713|NCT00406653|11482873|FG000|Maintenance Period|Lost to Follow-up|0
7268714|NCT00406653|11482874|FG001|Maintenance Period|Lost to Follow-up|0
7268715|NCT00406653|11482875|FG002|Maintenance Period|Lost to Follow-up|0
7268716|NCT00406653|11482876|FG003|Maintenance Period|Lost to Follow-up|0
7268717|NCT00406653|11482877|FG004|Maintenance Period|Lost to Follow-up|2
7268718|NCT00406653|11482878|FG005|Maintenance Period|Lost to Follow-up|1
7268719|NCT00406653|11482879|FG006|Maintenance Period|Lost to Follow-up|0
7548396|NCT02921750|11905689|FG000|Overall Study|Wound healed|3
7548397|NCT02921750|11905690|FG001|Overall Study|Wound healed|3
7548398|NCT02921750|11905689|FG000|Overall Study|Serious Adverse Event|1
7548399|NCT02921750|11905690|FG001|Overall Study|Serious Adverse Event|2
7548400|NCT02922153|11905710|FG000|Overall Study|Death|8
7548401|NCT02922153|11905711|FG001|Overall Study|Death|1
7548402|NCT02922153|11905710|FG000|Overall Study|Lost to Follow-up|1
7548403|NCT02922153|11905711|FG001|Overall Study|Lost to Follow-up|0
7548404|NCT02922153|11905710|FG000|Overall Study|Physician Decision|1
7548405|NCT02922153|11905711|FG001|Overall Study|Physician Decision|1
7548406|NCT02922634|11905734|FG000|Overall Study|Withdrawal by Subject|5
7548407|NCT02922634|11905734|FG000|Overall Study|Did not have their surgery|5
7548408|NCT02923115|11905780|FG000|Overall Study|Lost to Follow-up|0
7548409|NCT02923115|11905781|FG001|Overall Study|Lost to Follow-up|0
7548410|NCT02923115|11905782|FG002|Overall Study|Lost to Follow-up|0
7548411|NCT02923115|11905783|FG003|Overall Study|Lost to Follow-up|1
7548412|NCT02923115|11905784|FG004|Overall Study|Lost to Follow-up|0
7548413|NCT02923115|11905785|FG005|Overall Study|Lost to Follow-up|0
7548414|NCT02923115|11905780|FG000|Overall Study|Withdrawal by Subject|0
7548415|NCT02923115|11905781|FG001|Overall Study|Withdrawal by Subject|1
7548416|NCT02923115|11905782|FG002|Overall Study|Withdrawal by Subject|0
7548417|NCT02923115|11905783|FG003|Overall Study|Withdrawal by Subject|0
7548418|NCT02923115|11905784|FG004|Overall Study|Withdrawal by Subject|0
7548419|NCT02923115|11905785|FG005|Overall Study|Withdrawal by Subject|0
7548420|NCT02923115|11905780|FG000|Overall Study|Randomized, but not dosed|0
7548421|NCT02923115|11905781|FG001|Overall Study|Randomized, but not dosed|0
7548422|NCT02923115|11905782|FG002|Overall Study|Randomized, but not dosed|3
7548423|NCT02923115|11905783|FG003|Overall Study|Randomized, but not dosed|1
7548424|NCT02923115|11905784|FG004|Overall Study|Randomized, but not dosed|5
7548425|NCT02923115|11905785|FG005|Overall Study|Randomized, but not dosed|0
7548428|NCT02923245|11905810|FG000|Overall Study|ultrasound order was cancelled|2
7548429|NCT02923245|11905811|FG001|Overall Study|ultrasound order was cancelled|1
7548430|NCT02923349|11905834|FG000|Overall Study|Other|1
7548431|NCT02923349|11905835|FG001|Overall Study|Other|2
7548432|NCT02923349|11905836|FG002|Overall Study|Other|4
7548433|NCT02923349|11905837|FG003|Overall Study|Other|1
7577718|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
7577719|NCT03963401|11967973|FG000|Extension Period (Week 17 - Week 52)|Other|1
7577720|NCT03963401|11967974|FG001|Extension Period (Week 17 - Week 52)|Other|1
7577721|NCT03963401|11967975|FG002|Extension Period (Week 17 - Week 52)|Other|0
7577722|NCT03963401|11967976|FG003|Extension Period (Week 17 - Week 52)|Other|1
7577723|NCT03963401|11967977|FG004|Extension Period (Week 17 - Week 52)|Other|1
7577724|NCT03963401|11967978|FG005|Extension Period (Week 17 - Week 52)|Other|1
7577725|NCT03962790|11968005|FG000|Period 1|Adverse Event|0
7577726|NCT03962790|11968006|FG001|Period 1|Adverse Event|1
7577727|NCT03962790|11968005|FG000|Period 1|Failed to meet all eligibility criteria|1
7577728|NCT03962790|11968006|FG001|Period 1|Failed to meet all eligibility criteria|1
7577729|NCT03962790|11968005|FG000|Period 1|No Longer Meets Eligibility Criteria|1
7577730|NCT03962790|11968006|FG001|Period 1|No Longer Meets Eligibility Criteria|0
7577731|NCT03962790|11968005|FG000|Period 1|Withdrawal by Subject|1
7577732|NCT03962790|11968006|FG001|Period 1|Withdrawal by Subject|0
7577733|NCT03956225|11968014|FG000|Overall Study|Lack of Efficacy|1
7577734|NCT03956225|11968015|FG001|Overall Study|Lack of Efficacy|1
7577735|NCT03956225|11968014|FG000|Overall Study|Lost to Follow-up|0
7577736|NCT03956225|11968015|FG001|Overall Study|Lost to Follow-up|1
7577737|NCT03956225|11968014|FG000|Overall Study|Withdrawal by Subject|2
7577738|NCT03956225|11968015|FG001|Overall Study|Withdrawal by Subject|1
7577739|NCT03956225|11968014|FG000|Overall Study|Other Reasons|2
7577740|NCT03956225|11968015|FG001|Overall Study|Other Reasons|1
7577741|NCT03958149|11968033|FG000|Overall Study|Withdrawal by Subject|0
7268720|NCT00406653|11482873|FG000|Maintenance Period|Withdrawal of Consent|0
7268721|NCT00406653|11482874|FG001|Maintenance Period|Withdrawal of Consent|0
7577742|NCT03958149|11968034|FG001|Overall Study|Withdrawal by Subject|1
7577743|NCT03953183|11968046|FG000|Overall Study|Physician Decision|0
7577744|NCT03953183|11968047|FG001|Overall Study|Physician Decision|1
7577745|NCT03953183|11968046|FG000|Overall Study|Withdrawal by Subject|0
7577746|NCT03953183|11968047|FG001|Overall Study|Withdrawal by Subject|1
7577747|NCT03962738|11968068|FG000|Overall Study|Protocol Deviation|3
7577748|NCT03962738|11968069|FG001|Overall Study|Protocol Deviation|0
7577749|NCT03962738|11968070|FG002|Overall Study|Protocol Deviation|1
7577750|NCT03962738|11968071|FG003|Overall Study|Protocol Deviation|1
7577751|NCT03962738|11968068|FG000|Overall Study|Withdrawal by Subject|4
7577752|NCT03962738|11968069|FG001|Overall Study|Withdrawal by Subject|0
7577753|NCT03962738|11968070|FG002|Overall Study|Withdrawal by Subject|0
7577754|NCT03962738|11968071|FG003|Overall Study|Withdrawal by Subject|0
7577755|NCT03962738|11968068|FG000|Overall Study|Lost to Follow-up|0
7577756|NCT03962738|11968069|FG001|Overall Study|Lost to Follow-up|0
7577757|NCT03962738|11968070|FG002|Overall Study|Lost to Follow-up|1
7577758|NCT03962738|11968071|FG003|Overall Study|Lost to Follow-up|0
7268722|NCT00406653|11482875|FG002|Maintenance Period|Withdrawal of Consent|0
7268723|NCT00406653|11482876|FG003|Maintenance Period|Withdrawal of Consent|0
7268724|NCT00406653|11482877|FG004|Maintenance Period|Withdrawal of Consent|2
7268725|NCT00406653|11482878|FG005|Maintenance Period|Withdrawal of Consent|0
7268726|NCT00406653|11482879|FG006|Maintenance Period|Withdrawal of Consent|0
7268727|NCT00406653|11482873|FG000|Maintenance Period|Pregnancy|0
7268728|NCT00406653|11482874|FG001|Maintenance Period|Pregnancy|0
7268729|NCT00406653|11482875|FG002|Maintenance Period|Pregnancy|0
7268730|NCT00406653|11482876|FG003|Maintenance Period|Pregnancy|0
7268731|NCT00406653|11482877|FG004|Maintenance Period|Pregnancy|0
7268732|NCT00406653|11482878|FG005|Maintenance Period|Pregnancy|1
7268733|NCT00406653|11482879|FG006|Maintenance Period|Pregnancy|0
7268734|NCT00406653|11482873|FG000|Maintenance Period|Administrative Reason By Sponsor|0
7268735|NCT00406653|11482874|FG001|Maintenance Period|Administrative Reason By Sponsor|0
7268736|NCT00406653|11482875|FG002|Maintenance Period|Administrative Reason By Sponsor|0
7268737|NCT00406653|11482876|FG003|Maintenance Period|Administrative Reason By Sponsor|0
7268738|NCT00406653|11482877|FG004|Maintenance Period|Administrative Reason By Sponsor|4
7268739|NCT00406653|11482878|FG005|Maintenance Period|Administrative Reason By Sponsor|7
7268740|NCT00406653|11482879|FG006|Maintenance Period|Administrative Reason By Sponsor|0
7268741|NCT00406653|11482873|FG000|Maintenance Period|Error in disease score evaluation|0
7268742|NCT00406653|11482874|FG001|Maintenance Period|Error in disease score evaluation|0
7268743|NCT00406653|11482875|FG002|Maintenance Period|Error in disease score evaluation|0
7268744|NCT00406653|11482876|FG003|Maintenance Period|Error in disease score evaluation|0
7268745|NCT00406653|11482877|FG004|Maintenance Period|Error in disease score evaluation|1
7268746|NCT00406653|11482878|FG005|Maintenance Period|Error in disease score evaluation|0
7268747|NCT00406653|11482879|FG006|Maintenance Period|Error in disease score evaluation|0
7268748|NCT00406653|11482873|FG000|Open-Label Period|Death|0
7268749|NCT00406653|11482874|FG001|Open-Label Period|Death|0
7268750|NCT00406653|11482875|FG002|Open-Label Period|Death|0
7268751|NCT00406653|11482876|FG003|Open-Label Period|Death|0
7268752|NCT00406653|11482877|FG004|Open-Label Period|Death|0
7268753|NCT00406653|11482878|FG005|Open-Label Period|Death|0
7268754|NCT00406653|11482879|FG006|Open-Label Period|Death|1
7268755|NCT00406653|11482873|FG000|Open-Label Period|Adverse Event|0
7268756|NCT00406653|11482874|FG001|Open-Label Period|Adverse Event|0
7548434|NCT02923349|11905838|FG004|Overall Study|Other|3
7548435|NCT02923349|11905839|FG005|Overall Study|Other|0
7548436|NCT02923349|11905840|FG006|Overall Study|Other|1
7548437|NCT02923349|11905834|FG000|Overall Study|Withdrawal by Subject|2
7548438|NCT02923349|11905835|FG001|Overall Study|Withdrawal by Subject|2
7548439|NCT02923349|11905836|FG002|Overall Study|Withdrawal by Subject|8
7548440|NCT02923349|11905837|FG003|Overall Study|Withdrawal by Subject|10
7548441|NCT02923349|11905838|FG004|Overall Study|Withdrawal by Subject|12
7548442|NCT02923349|11905839|FG005|Overall Study|Withdrawal by Subject|3
7548443|NCT02923349|11905840|FG006|Overall Study|Withdrawal by Subject|0
7548444|NCT02923349|11905834|FG000|Overall Study|Physician Decision|0
7548445|NCT02923349|11905835|FG001|Overall Study|Physician Decision|0
7548446|NCT02923349|11905836|FG002|Overall Study|Physician Decision|0
7548447|NCT02923349|11905837|FG003|Overall Study|Physician Decision|1
7548448|NCT02923349|11905838|FG004|Overall Study|Physician Decision|1
7548449|NCT02923349|11905839|FG005|Overall Study|Physician Decision|0
7548450|NCT02923349|11905840|FG006|Overall Study|Physician Decision|2
7548451|NCT02923349|11905834|FG000|Overall Study|Lost to Follow-up|0
7548452|NCT02923349|11905835|FG001|Overall Study|Lost to Follow-up|0
7548453|NCT02923349|11905836|FG002|Overall Study|Lost to Follow-up|3
7548454|NCT02923349|11905837|FG003|Overall Study|Lost to Follow-up|0
7548455|NCT02923349|11905838|FG004|Overall Study|Lost to Follow-up|1
7548456|NCT02923349|11905839|FG005|Overall Study|Lost to Follow-up|1
7548457|NCT02923349|11905840|FG006|Overall Study|Lost to Follow-up|0
7548458|NCT02923349|11905834|FG000|Overall Study|Death|1
7548459|NCT02923349|11905835|FG001|Overall Study|Death|0
7548460|NCT02923349|11905836|FG002|Overall Study|Death|2
7548461|NCT02923349|11905837|FG003|Overall Study|Death|4
7548462|NCT02923349|11905838|FG004|Overall Study|Death|2
7548463|NCT02923349|11905839|FG005|Overall Study|Death|3
7548464|NCT02923349|11905840|FG006|Overall Study|Death|0
7548465|NCT02923427|11905858|FG000|Overall Study|convert to laparatomy|2
7548466|NCT02923427|11905859|FG001|Overall Study|convert to laparatomy|2
7548467|NCT02923427|11905858|FG000|Overall Study|destaturation|1
7548468|NCT02923427|11905859|FG001|Overall Study|destaturation|0
7548469|NCT02923427|11905858|FG000|Overall Study|can not replace LMA|1
7548470|NCT02923427|11905859|FG001|Overall Study|can not replace LMA|0
7548471|NCT02923921|11905876|FG000|Overall Study|Sponsor Decision|39
7548472|NCT02923921|11905877|FG001|Overall Study|Sponsor Decision|38
7548473|NCT02923921|11905876|FG000|Overall Study|Lost to Follow-up|1
7548474|NCT02923921|11905877|FG001|Overall Study|Lost to Follow-up|0
7548475|NCT02923921|11905876|FG000|Overall Study|Withdrawal by Subject|6
7548476|NCT02923921|11905877|FG001|Overall Study|Withdrawal by Subject|13
7548477|NCT02923921|11905876|FG000|Overall Study|Unknown, Not Collected|7
7548478|NCT02923921|11905877|FG001|Overall Study|Unknown, Not Collected|6
7548479|NCT02924051|11905885|FG000|Overall Study|Withdrawal by Subject|1
7548480|NCT02924051|11905886|FG001|Overall Study|Withdrawal by Subject|9
7548481|NCT02924428|11905905|FG000|Overall Study|Adverse Event|1
7548482|NCT02924428|11905906|FG001|Overall Study|Adverse Event|0
7268757|NCT00406653|11482875|FG002|Open-Label Period|Adverse Event|0
7268758|NCT00406653|11482876|FG003|Open-Label Period|Adverse Event|0
7268759|NCT00406653|11482877|FG004|Open-Label Period|Adverse Event|0
7268760|NCT00406653|11482878|FG005|Open-Label Period|Adverse Event|0
7268761|NCT00406653|11482879|FG006|Open-Label Period|Adverse Event|18
7268762|NCT00406653|11482873|FG000|Open-Label Period|Lack of Efficacy|0
7268763|NCT00406653|11482874|FG001|Open-Label Period|Lack of Efficacy|0
7268764|NCT00406653|11482875|FG002|Open-Label Period|Lack of Efficacy|0
7268765|NCT00406653|11482876|FG003|Open-Label Period|Lack of Efficacy|0
7268766|NCT00406653|11482877|FG004|Open-Label Period|Lack of Efficacy|0
7268767|NCT00406653|11482878|FG005|Open-Label Period|Lack of Efficacy|0
7268768|NCT00406653|11482879|FG006|Open-Label Period|Lack of Efficacy|160
7268769|NCT00406653|11482873|FG000|Open-Label Period|Lost to Follow-up|0
7268770|NCT00406653|11482874|FG001|Open-Label Period|Lost to Follow-up|0
7268771|NCT00406653|11482875|FG002|Open-Label Period|Lost to Follow-up|0
7268772|NCT00406653|11482876|FG003|Open-Label Period|Lost to Follow-up|0
7268773|NCT00406653|11482877|FG004|Open-Label Period|Lost to Follow-up|0
7268774|NCT00406653|11482878|FG005|Open-Label Period|Lost to Follow-up|0
7268775|NCT00406653|11482879|FG006|Open-Label Period|Lost to Follow-up|6
7268776|NCT00406653|11482873|FG000|Open-Label Period|Withdrawal of Consent|0
7268777|NCT00406653|11482874|FG001|Open-Label Period|Withdrawal of Consent|0
7268778|NCT00406653|11482875|FG002|Open-Label Period|Withdrawal of Consent|0
7268779|NCT00406653|11482876|FG003|Open-Label Period|Withdrawal of Consent|0
7268780|NCT00406653|11482877|FG004|Open-Label Period|Withdrawal of Consent|0
7268781|NCT00406653|11482878|FG005|Open-Label Period|Withdrawal of Consent|0
7268782|NCT00406653|11482879|FG006|Open-Label Period|Withdrawal of Consent|11
7268783|NCT00406653|11482873|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268784|NCT00406653|11482874|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268785|NCT00406653|11482875|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268786|NCT00406653|11482876|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268787|NCT00406653|11482877|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268788|NCT00406653|11482878|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
7268789|NCT00406653|11482879|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
7268790|NCT00406653|11482873|FG000|Open-Label Period|Pregnancy|0
7268791|NCT00406653|11482874|FG001|Open-Label Period|Pregnancy|0
7268792|NCT00406653|11482875|FG002|Open-Label Period|Pregnancy|0
7268793|NCT00406653|11482876|FG003|Open-Label Period|Pregnancy|0
7268794|NCT00406653|11482877|FG004|Open-Label Period|Pregnancy|0
7268795|NCT00406653|11482878|FG005|Open-Label Period|Pregnancy|0
7268796|NCT00406653|11482879|FG006|Open-Label Period|Pregnancy|2
7548483|NCT02924428|11905905|FG000|Overall Study|Physician Decision|1
7548484|NCT02924428|11905906|FG001|Overall Study|Physician Decision|0
7548485|NCT02924428|11905905|FG000|Overall Study|Lost to Follow-up|2
7548486|NCT02924428|11905906|FG001|Overall Study|Lost to Follow-up|4
7548487|NCT02924428|11905905|FG000|Overall Study|Pregnancy|0
7548488|NCT02924428|11905906|FG001|Overall Study|Pregnancy|1
7548489|NCT02924688|11905918|FG000|Overall Study|Adverse Event|9
7548490|NCT02924688|11905919|FG001|Overall Study|Adverse Event|3
7548491|NCT02924688|11905920|FG002|Overall Study|Adverse Event|2
7548492|NCT02924688|11905921|FG003|Overall Study|Adverse Event|2
7548493|NCT02924688|11905922|FG004|Overall Study|Adverse Event|3
7548494|NCT02924688|11905923|FG005|Overall Study|Adverse Event|2
7548495|NCT02924688|11905918|FG000|Overall Study|Lack of Efficacy|2
7548496|NCT02924688|11905919|FG001|Overall Study|Lack of Efficacy|3
7548497|NCT02924688|11905920|FG002|Overall Study|Lack of Efficacy|4
7548498|NCT02924688|11905921|FG003|Overall Study|Lack of Efficacy|2
7548499|NCT02924688|11905922|FG004|Overall Study|Lack of Efficacy|1
7548500|NCT02924688|11905923|FG005|Overall Study|Lack of Efficacy|1
7548501|NCT02924688|11905918|FG000|Overall Study|Protocol Violation|3
7548502|NCT02924688|11905919|FG001|Overall Study|Protocol Violation|7
7548503|NCT02924688|11905920|FG002|Overall Study|Protocol Violation|5
7548504|NCT02924688|11905921|FG003|Overall Study|Protocol Violation|6
7548505|NCT02924688|11905922|FG004|Overall Study|Protocol Violation|2
7548506|NCT02924688|11905923|FG005|Overall Study|Protocol Violation|2
7548507|NCT02924688|11905918|FG000|Overall Study|Protocol defined withdrawal criteria met|1
7548508|NCT02924688|11905919|FG001|Overall Study|Protocol defined withdrawal criteria met|0
7548509|NCT02924688|11905920|FG002|Overall Study|Protocol defined withdrawal criteria met|1
7548510|NCT02924688|11905921|FG003|Overall Study|Protocol defined withdrawal criteria met|1
7548511|NCT02924688|11905922|FG004|Overall Study|Protocol defined withdrawal criteria met|1
7548512|NCT02924688|11905923|FG005|Overall Study|Protocol defined withdrawal criteria met|0
7548513|NCT02924688|11905918|FG000|Overall Study|Lost to Follow-up|2
7548514|NCT02924688|11905919|FG001|Overall Study|Lost to Follow-up|4
7548515|NCT02924688|11905920|FG002|Overall Study|Lost to Follow-up|2
7548516|NCT02924688|11905921|FG003|Overall Study|Lost to Follow-up|4
7548517|NCT02924688|11905922|FG004|Overall Study|Lost to Follow-up|2
7548518|NCT02924688|11905923|FG005|Overall Study|Lost to Follow-up|4
7548519|NCT02924688|11905918|FG000|Overall Study|Physician Decision|2
7548520|NCT02924688|11905919|FG001|Overall Study|Physician Decision|1
7548521|NCT02924688|11905920|FG002|Overall Study|Physician Decision|0
7548522|NCT02924688|11905921|FG003|Overall Study|Physician Decision|1
7548523|NCT02924688|11905922|FG004|Overall Study|Physician Decision|1
7548524|NCT02924688|11905923|FG005|Overall Study|Physician Decision|1
7548525|NCT02924688|11905918|FG000|Overall Study|Withdrawal by Subject|14
7268797|NCT00406653|11482873|FG000|Open-Label Period|Administrative Reason By Sponsor|0
7268798|NCT00406653|11482874|FG001|Open-Label Period|Administrative Reason By Sponsor|0
7268799|NCT00406653|11482875|FG002|Open-Label Period|Administrative Reason By Sponsor|0
7268800|NCT00406653|11482876|FG003|Open-Label Period|Administrative Reason By Sponsor|0
7268801|NCT00406653|11482877|FG004|Open-Label Period|Administrative Reason By Sponsor|0
7268802|NCT00406653|11482878|FG005|Open-Label Period|Administrative Reason By Sponsor|0
7268803|NCT00406653|11482879|FG006|Open-Label Period|Administrative Reason By Sponsor|115
7268804|NCT00406653|11482873|FG000|Open-Label Period|Declined participation but followup done|0
7268805|NCT00406653|11482874|FG001|Open-Label Period|Declined participation but followup done|0
7268806|NCT00406653|11482875|FG002|Open-Label Period|Declined participation but followup done|0
7268807|NCT00406653|11482876|FG003|Open-Label Period|Declined participation but followup done|0
7268808|NCT00406653|11482877|FG004|Open-Label Period|Declined participation but followup done|0
7268809|NCT00406653|11482878|FG005|Open-Label Period|Declined participation but followup done|0
7268810|NCT00406653|11482879|FG006|Open-Label Period|Declined participation but followup done|8
7268811|NCT00406653|11482873|FG000|Open-Label Period|Discontinued by Sponsor|0
7268812|NCT00406653|11482874|FG001|Open-Label Period|Discontinued by Sponsor|0
7268813|NCT00406653|11482875|FG002|Open-Label Period|Discontinued by Sponsor|0
7268814|NCT00406653|11482876|FG003|Open-Label Period|Discontinued by Sponsor|0
7268815|NCT00406653|11482877|FG004|Open-Label Period|Discontinued by Sponsor|0
7268816|NCT00406653|11482878|FG005|Open-Label Period|Discontinued by Sponsor|0
7268817|NCT00406653|11482879|FG006|Open-Label Period|Discontinued by Sponsor|1
7548526|NCT02924688|11905919|FG001|Overall Study|Withdrawal by Subject|13
7548527|NCT02924688|11905920|FG002|Overall Study|Withdrawal by Subject|9
7548528|NCT02924688|11905921|FG003|Overall Study|Withdrawal by Subject|12
7548529|NCT02924688|11905922|FG004|Overall Study|Withdrawal by Subject|13
7548530|NCT02924688|11905923|FG005|Overall Study|Withdrawal by Subject|14
7548531|NCT02924883|11905942|FG000|Overall Study|Death|39
7548532|NCT02924883|11905943|FG001|Overall Study|Death|20
7548533|NCT02924883|11905942|FG000|Overall Study|Lost to Follow-up|1
7548534|NCT02924883|11905943|FG001|Overall Study|Lost to Follow-up|0
7548535|NCT02924883|11905942|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
7548536|NCT02924883|11905943|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
7548537|NCT02924883|11905942|FG000|Overall Study|Protocol Violation|1
7548538|NCT02924883|11905943|FG001|Overall Study|Protocol Violation|0
7548539|NCT02924883|11905942|FG000|Overall Study|Withdrawal by Subject|22
7548540|NCT02924883|11905943|FG001|Overall Study|Withdrawal by Subject|16
7548541|NCT02924883|11905942|FG000|Overall Study|Progressive Disease|1
7548542|NCT02924883|11905943|FG001|Overall Study|Progressive Disease|0
7548543|NCT02924883|11905942|FG000|Overall Study|Study Terminated by Sponsor|69
7548544|NCT02924883|11905943|FG001|Overall Study|Study Terminated by Sponsor|32
7548545|NCT02925117|11905964|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
7548546|NCT02925117|11905965|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
7548547|NCT02925117|11905966|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
7548548|NCT02925117|11905967|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
7548549|NCT02925117|11905968|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548550|NCT02925117|11905969|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548551|NCT02925117|11905970|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548552|NCT02925117|11905971|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548553|NCT02925117|11905972|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548554|NCT02925117|11905973|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548555|NCT02925117|11905974|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548556|NCT02925117|11905975|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
7548557|NCT02925117|11905964|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
7577759|NCT03962101|11968089|FG000|Overall Study|Adverse Event|1
7577760|NCT03962101|11968089|FG000|Overall Study|Physician Decision|2
7577761|NCT03962101|11968089|FG000|Overall Study|Not related to medical events|1
7577762|NCT03959137|11968094|FG000|Overall Study|Protocol Violation|6
7577763|NCT03946124|11968098|FG000|Overall Study|Withdrawal by Subject|19
7577764|NCT03961308|11968104|FG000|Overall Study|Withdrawal by Subject|1
7577765|NCT03961308|11968105|FG001|Overall Study|Withdrawal by Subject|0
7577766|NCT03961308|11968104|FG000|Overall Study|Other|1
7577767|NCT03961308|11968105|FG001|Overall Study|Other|0
7577768|NCT03961308|11968104|FG000|Overall Study|Lost to Follow-up|0
7577769|NCT03961308|11968105|FG001|Overall Study|Lost to Follow-up|1
7577770|NCT03961308|11968104|FG000|Overall Study|Adverse Event|0
7577771|NCT03961308|11968105|FG001|Overall Study|Adverse Event|1
7577772|NCT03956862|11968131|FG000|Overall Study|Lost to Follow-up|1
7577773|NCT03956862|11968132|FG001|Overall Study|Lost to Follow-up|1
7577774|NCT03956862|11968131|FG000|Overall Study|Withdrawal by Subject|1
7577775|NCT03956862|11968132|FG001|Overall Study|Withdrawal by Subject|1
7577776|NCT03954444|11968141|FG000|Overall Study|Withdrawal by Subject|5
7577777|NCT03954444|11968142|FG001|Overall Study|Withdrawal by Subject|5
7577778|NCT03954444|11968143|FG002|Overall Study|Withdrawal by Subject|5
7577779|NCT03954444|11968141|FG000|Overall Study|Adverse Event|1
7268818|NCT00406653|11482873|FG000|Open-Label Period|Refused followup|0
7268819|NCT00406653|11482874|FG001|Open-Label Period|Refused followup|0
7577780|NCT03954444|11968142|FG001|Overall Study|Adverse Event|3
7577781|NCT03954444|11968143|FG002|Overall Study|Adverse Event|2
7577782|NCT03954444|11968141|FG000|Overall Study|Protocol Violation|0
7268820|NCT00406653|11482875|FG002|Open-Label Period|Refused followup|0
7268821|NCT00406653|11482876|FG003|Open-Label Period|Refused followup|0
7268822|NCT00406653|11482877|FG004|Open-Label Period|Refused followup|0
7268823|NCT00406653|11482878|FG005|Open-Label Period|Refused followup|0
7268824|NCT00406653|11482879|FG006|Open-Label Period|Refused followup|1
7268825|NCT00406692|11482899|FG000|Overall Study|Withdrawal by Subject|4
7268826|NCT00406692|11482899|FG000|Overall Study|Physician Decision|1
7268827|NCT00406692|11482899|FG000|Overall Study|Adverse Event|1
7268828|NCT00406692|11482899|FG000|Overall Study|Lack of Efficacy|1
7268829|NCT00406718|11482906|FG000|Overall Study|Withdrawal by Subject|2
7268830|NCT00406718|11482907|FG001|Overall Study|Withdrawal by Subject|9
7268831|NCT00406718|11482908|FG002|Overall Study|Withdrawal by Subject|4
7268832|NCT00406718|11482906|FG000|Overall Study|Lost to Follow-up|2
7268833|NCT00406718|11482907|FG001|Overall Study|Lost to Follow-up|5
7268834|NCT00406718|11482908|FG002|Overall Study|Lost to Follow-up|4
7268835|NCT00406848|11482920|FG000|Overall Study|Withdrawal by Subject|27
7268836|NCT00406848|11482921|FG001|Overall Study|Withdrawal by Subject|22
7268837|NCT00406848|11482920|FG000|Overall Study|Adverse Event|38
7268838|NCT00406848|11482921|FG001|Overall Study|Adverse Event|7
7268839|NCT00406848|11482920|FG000|Overall Study|Lack of Efficacy|9
7268840|NCT00406848|11482921|FG001|Overall Study|Lack of Efficacy|14
7268841|NCT00406848|11482920|FG000|Overall Study|Protocol Violation|10
7268842|NCT00406848|11482921|FG001|Overall Study|Protocol Violation|6
7268843|NCT00406848|11482920|FG000|Overall Study|Lost to Follow-up|6
7268844|NCT00406848|11482921|FG001|Overall Study|Lost to Follow-up|2
7268845|NCT00406848|11482920|FG000|Overall Study|Physician Decision|2
7268846|NCT00406848|11482921|FG001|Overall Study|Physician Decision|2
7548558|NCT02925117|11905965|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7548559|NCT02925117|11905966|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
7548560|NCT02925117|11905967|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548561|NCT02925117|11905968|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548562|NCT02925117|11905969|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548563|NCT02925117|11905970|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548564|NCT02925117|11905971|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548565|NCT02925117|11905972|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548566|NCT02925117|11905973|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548567|NCT02925117|11905974|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548568|NCT02925117|11905975|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
7548569|NCT02925117|11905964|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
7548570|NCT02925117|11905965|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
7548571|NCT02925117|11905966|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548572|NCT02925117|11905967|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548573|NCT02925117|11905968|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548574|NCT02925117|11905969|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548575|NCT02925117|11905970|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548576|NCT02925117|11905971|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548577|NCT02925117|11905972|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548578|NCT02925117|11905973|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548579|NCT02925117|11905974|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548580|NCT02925117|11905975|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
7548581|NCT02925117|11905964|FG000|Period 1 (Weeks 0 - 16)|Other|5
7548582|NCT02925117|11905965|FG001|Period 1 (Weeks 0 - 16)|Other|4
7548583|NCT02925117|11905966|FG002|Period 1 (Weeks 0 - 16)|Other|1
7548584|NCT02925117|11905967|FG003|Period 1 (Weeks 0 - 16)|Other|1
7548585|NCT02925117|11905968|FG004|Period 1 (Weeks 0 - 16)|Other|0
7548586|NCT02925117|11905969|FG005|Period 1 (Weeks 0 - 16)|Other|0
7548587|NCT02925117|11905970|FG006|Period 1 (Weeks 0 - 16)|Other|0
7548588|NCT02925117|11905971|FG007|Period 1 (Weeks 0 - 16)|Other|0
7548589|NCT02925117|11905972|FG008|Period 1 (Weeks 0 - 16)|Other|0
7548590|NCT02925117|11905973|FG009|Period 1 (Weeks 0 - 16)|Other|0
7577783|NCT03954444|11968142|FG001|Overall Study|Protocol Violation|3
7577784|NCT03954444|11968143|FG002|Overall Study|Protocol Violation|5
7577785|NCT03954444|11968141|FG000|Overall Study|Use of prohibited therapy|1
7577786|NCT03954444|11968142|FG001|Overall Study|Use of prohibited therapy|1
7577787|NCT03954444|11968143|FG002|Overall Study|Use of prohibited therapy|2
7577788|NCT03954444|11968141|FG000|Overall Study|Lost to Follow-up|1
7268847|NCT00406848|11482920|FG000|Overall Study|Sponsor Decision|1
7577789|NCT03954444|11968142|FG001|Overall Study|Lost to Follow-up|0
7577790|NCT03954444|11968143|FG002|Overall Study|Lost to Follow-up|1
7577791|NCT03954444|11968141|FG000|Overall Study|Non-compliant with study drug application|2
7577792|NCT03954444|11968142|FG001|Overall Study|Non-compliant with study drug application|2
7577793|NCT03954444|11968143|FG002|Overall Study|Non-compliant with study drug application|0
7577794|NCT03954444|11968141|FG000|Overall Study|Administrative reasons|0
7577795|NCT03954444|11968142|FG001|Overall Study|Administrative reasons|0
7577796|NCT03954444|11968143|FG002|Overall Study|Administrative reasons|1
7268848|NCT00406848|11482921|FG001|Overall Study|Sponsor Decision|1
7268849|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
7268850|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
7268851|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
7268852|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7268853|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
7268854|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
7268855|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7268856|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7268857|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
7268858|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7268859|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7268860|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
7268861|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7268862|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
7268863|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
7268864|NCT00407030|11482933|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
7268865|NCT00407030|11482934|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
7268866|NCT00407030|11482935|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
7268867|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
7268868|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
7268869|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
7268870|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7268871|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
7268872|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
7268873|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
7268874|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
7268875|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
7268876|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7268877|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
7268878|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
7268879|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7268880|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
7268881|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
7268882|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
7268883|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
7268884|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
7268885|NCT00407030|11482933|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
7268886|NCT00407030|11482934|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
7268887|NCT00407030|11482935|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
7548591|NCT02925117|11905974|FG010|Period 1 (Weeks 0 - 16)|Other|0
7548592|NCT02925117|11905975|FG011|Period 1 (Weeks 0 - 16)|Other|0
7548593|NCT02925117|11905964|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548594|NCT02925117|11905965|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548595|NCT02925117|11905966|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548596|NCT02925117|11905967|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548597|NCT02925117|11905968|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548598|NCT02925117|11905969|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
7548599|NCT02925117|11905970|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548600|NCT02925117|11905971|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548601|NCT02925117|11905972|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548602|NCT02925117|11905973|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
7548603|NCT02925117|11905974|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
7548604|NCT02925117|11905975|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
7548605|NCT02925117|11905964|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7548606|NCT02925117|11905965|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7548607|NCT02925117|11905966|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7548608|NCT02925117|11905967|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7548609|NCT02925117|11905968|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
7548610|NCT02925117|11905969|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
7548611|NCT02925117|11905970|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
7548612|NCT02925117|11905971|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
7548613|NCT02925117|11905972|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7548614|NCT02925117|11905973|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7268888|NCT00407511|11482983|FG000|Overall Study|Adverse Event|9
7268889|NCT00407511|11482983|FG000|Overall Study|Lost to Follow-up|4
7268890|NCT00407511|11482983|FG000|Overall Study|Other|5
7268891|NCT00407511|11482983|FG000|Overall Study|Withdrawal by Subject|4
7268892|NCT00407537|11482989|FG000|Overall Study|Death|5
7268893|NCT00407537|11482990|FG001|Overall Study|Death|2
7268894|NCT00407537|11482989|FG000|Overall Study|Adverse Event|36
7268895|NCT00407537|11482990|FG001|Overall Study|Adverse Event|0
7268896|NCT00407537|11482989|FG000|Overall Study|Lost to Follow-up|12
7268897|NCT00407537|11482990|FG001|Overall Study|Lost to Follow-up|19
7268898|NCT00407537|11482989|FG000|Overall Study|Other|6
7268899|NCT00407537|11482990|FG001|Overall Study|Other|7
7548615|NCT02925117|11905974|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7548616|NCT02925117|11905975|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
7548617|NCT02925117|11905964|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7548618|NCT02925117|11905965|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7268900|NCT00407537|11482989|FG000|Overall Study|Withdrawal by Subject|34
7268901|NCT00407537|11482990|FG001|Overall Study|Withdrawal by Subject|16
7268902|NCT00407550|11482998|FG000|Overall Study|Adverse Event|0
7268903|NCT00407550|11482999|FG001|Overall Study|Adverse Event|1
7268904|NCT00407550|11482998|FG000|Overall Study|Withdrawal by Subject|0
7268905|NCT00407550|11482999|FG001|Overall Study|Withdrawal by Subject|2
7268906|NCT00407550|11482998|FG000|Overall Study|Death|1
7268907|NCT00407550|11482999|FG001|Overall Study|Death|0
7268908|NCT00407550|11482998|FG000|Overall Study|Insurance or Other medical condition|2
7268909|NCT00407550|11482999|FG001|Overall Study|Insurance or Other medical condition|1
7268910|NCT00407563|11483005|FG000|Overall Study|Patient continues on treatment|1
7268911|NCT00407745|11483016|FG000|Overall Study|Lack of Efficacy|1
7268912|NCT00407745|11483017|FG001|Overall Study|Lack of Efficacy|2
7268913|NCT00407745|11483016|FG000|Overall Study|Withdrawal by Subject|3
7268914|NCT00407745|11483017|FG001|Overall Study|Withdrawal by Subject|3
7268915|NCT00407745|11483016|FG000|Overall Study|Protocol Violation|5
7268916|NCT00407745|11483017|FG001|Overall Study|Protocol Violation|3
7268917|NCT00407745|11483016|FG000|Overall Study|Adverse Event|8
7268918|NCT00407745|11483017|FG001|Overall Study|Adverse Event|8
7268919|NCT00407745|11483016|FG000|Overall Study|Other|2
7268920|NCT00407745|11483017|FG001|Overall Study|Other|0
7268921|NCT00407745|11483016|FG000|Overall Study|Randomized, unknown if treated|0
7268922|NCT00407745|11483017|FG001|Overall Study|Randomized, unknown if treated|1
7268923|NCT00407758|11483023|FG000|Overall Study|ineligible -improper prior treatment|1
7268924|NCT00407797|11483027|FG000|Overall Study|Lost to Follow-up|2
7268925|NCT00407797|11483027|FG000|Overall Study|Adverse Event|6
7268926|NCT00407797|11483027|FG000|Overall Study|Other|7
7268927|NCT00407797|11483027|FG000|Overall Study|Withdrawal by Subject|3
7388199|NCT01218100|11646972|FG003|Overall Study|Lack of Efficacy|12
7388200|NCT01218100|11646969|FG000|Overall Study|Protocol Violation|0
7388201|NCT01218100|11646970|FG001|Overall Study|Protocol Violation|0
7388202|NCT01218100|11646971|FG002|Overall Study|Protocol Violation|1
7388203|NCT01218100|11646972|FG003|Overall Study|Protocol Violation|1
7388204|NCT01218100|11646969|FG000|Overall Study|Withdrawal by Subject|5
7388205|NCT01218100|11646970|FG001|Overall Study|Withdrawal by Subject|2
7548619|NCT02925117|11905966|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7548620|NCT02925117|11905967|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7548621|NCT02925117|11905968|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7548622|NCT02925117|11905969|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
7548623|NCT02925117|11905970|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7548624|NCT02925117|11905971|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7548625|NCT02925117|11905972|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7548626|NCT02925117|11905973|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7548627|NCT02925117|11905974|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
7548628|NCT02925117|11905975|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
7548629|NCT02925117|11905964|FG000|Period 2 (Weeks 16 - 88)|Other|0
7548630|NCT02925117|11905965|FG001|Period 2 (Weeks 16 - 88)|Other|0
7548631|NCT02925117|11905966|FG002|Period 2 (Weeks 16 - 88)|Other|0
7548632|NCT02925117|11905967|FG003|Period 2 (Weeks 16 - 88)|Other|0
7548633|NCT02925117|11905968|FG004|Period 2 (Weeks 16 - 88)|Other|1
7548634|NCT02925117|11905969|FG005|Period 2 (Weeks 16 - 88)|Other|1
7548635|NCT02925117|11905970|FG006|Period 2 (Weeks 16 - 88)|Other|1
7548636|NCT02925117|11905971|FG007|Period 2 (Weeks 16 - 88)|Other|1
7548637|NCT02925117|11905972|FG008|Period 2 (Weeks 16 - 88)|Other|3
7548638|NCT02925117|11905973|FG009|Period 2 (Weeks 16 - 88)|Other|4
7548639|NCT02925117|11905974|FG010|Period 2 (Weeks 16 - 88)|Other|3
7548640|NCT02925117|11905975|FG011|Period 2 (Weeks 16 - 88)|Other|0
7548641|NCT02925312|11906003|FG000|Overall Study|Lost to Follow-up|25
7548642|NCT02925312|11906004|FG001|Overall Study|Lost to Follow-up|0
7548643|NCT02925312|11906003|FG000|Overall Study|Adverse Event|2
7388206|NCT01218100|11646971|FG002|Overall Study|Withdrawal by Subject|6
7388207|NCT01218100|11646972|FG003|Overall Study|Withdrawal by Subject|7
7388208|NCT01218100|11646969|FG000|Overall Study|Lost to Follow-up|3
7388209|NCT01218100|11646970|FG001|Overall Study|Lost to Follow-up|8
7388210|NCT01218100|11646971|FG002|Overall Study|Lost to Follow-up|2
7388211|NCT01218100|11646972|FG003|Overall Study|Lost to Follow-up|1
7388212|NCT01218100|11646969|FG000|Overall Study|Other Reason|2
7388213|NCT01218100|11646970|FG001|Overall Study|Other Reason|2
7548644|NCT02925312|11906004|FG001|Overall Study|Adverse Event|0
7548645|NCT02925403|11906012|FG000|Overall Study|Lost to Follow-up|0
7548646|NCT02925403|11906013|FG001|Overall Study|Lost to Follow-up|1
7548647|NCT02925455|11906021|FG000|Overall Study|Withdrawal by Subject|2
7548648|NCT02925455|11906022|FG001|Overall Study|Withdrawal by Subject|0
7388214|NCT01218100|11646971|FG002|Overall Study|Other Reason|6
7388215|NCT01218100|11646972|FG003|Overall Study|Other Reason|4
7388216|NCT01218113|11646985|FG000|Overall Study|Withdrawal by Subject|1
7388217|NCT01218113|11646986|FG001|Overall Study|Withdrawal by Subject|0
7388218|NCT01218113|11646987|FG002|Overall Study|Withdrawal by Subject|1
7388219|NCT01218113|11646985|FG000|Overall Study|Lost to Follow-up|4
7548649|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7388220|NCT01218113|11646986|FG001|Overall Study|Lost to Follow-up|1
7388221|NCT01218113|11646987|FG002|Overall Study|Lost to Follow-up|4
7388222|NCT01218113|11646985|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
7388223|NCT01218113|11646986|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
7388224|NCT01218113|11646987|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
7548650|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
7548651|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
7548652|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
7548653|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
7548654|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7548655|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
7548656|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
7548657|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Other|1
7548658|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Other|4
7548659|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Other|3
7548660|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Other|6
7577797|NCT03954444|11968141|FG000|Overall Study|Miscellaneous|3
7577798|NCT03954444|11968142|FG001|Overall Study|Miscellaneous|2
7577799|NCT03954444|11968143|FG002|Overall Study|Miscellaneous|1
7577800|NCT03953820|11968151|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
7548661|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
7548662|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7548663|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
7548664|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
7548665|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
7548666|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
7548667|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
7548668|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
7548669|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
7548670|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
7548671|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
7548672|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
7548673|NCT02925494|11906032|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
7548674|NCT02925494|11906033|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
7548675|NCT02925494|11906034|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
7548676|NCT02925494|11906035|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
7548677|NCT02925741|11906057|FG000|Overall Study|Withdrawal by Subject|11
7548678|NCT02925741|11906058|FG001|Overall Study|Withdrawal by Subject|0
7548679|NCT02925923|11906078|FG000|Overall Study|blood samples hemolyzed|0
7548680|NCT02925923|11906079|FG001|Overall Study|blood samples hemolyzed|2
7548681|NCT02926209|11906094|FG000|Study Cohort|Poor Bowel Preparation|1
7548682|NCT02926209|11906095|FG001|Study Cohort|Poor Bowel Preparation|0
7548683|NCT02926573|11906104|FG000|Overall Study|Nausea|1
7548684|NCT02926573|11906105|FG001|Overall Study|Nausea|0
7548685|NCT02926573|11906104|FG000|Overall Study|Remain intubated|2
7548686|NCT02926573|11906105|FG001|Overall Study|Remain intubated|2
7548687|NCT02926573|11906104|FG000|Overall Study|Change in surgery plan|3
7548688|NCT02926573|11906105|FG001|Overall Study|Change in surgery plan|1
7548689|NCT02926573|11906104|FG000|Overall Study|Change to outpatient status|5
7548690|NCT02926573|11906105|FG001|Overall Study|Change to outpatient status|1
7548691|NCT02926573|11906104|FG000|Overall Study|Withdrawal by Subject|0
7548692|NCT02926573|11906105|FG001|Overall Study|Withdrawal by Subject|2
7548693|NCT02926573|11906104|FG000|Overall Study|Return to operating room|0
7548694|NCT02926573|11906105|FG001|Overall Study|Return to operating room|2
7548695|NCT02926573|11906104|FG000|Overall Study|Delirium|0
7548696|NCT02926573|11906105|FG001|Overall Study|Delirium|1
7577801|NCT03953820|11968152|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
7577802|NCT03953820|11968153|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
7577803|NCT03953820|11968151|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
7577804|NCT03953820|11968152|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
7577805|NCT03953820|11968153|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
7577808|NCT03950856|11968196|FG000|Overall Study|Death|1
7577809|NCT03950856|11968197|FG001|Overall Study|Death|2
7577810|NCT03950856|11968198|FG002|Overall Study|Death|0
7577811|NCT03950856|11968199|FG003|Overall Study|Death|0
7577812|NCT03950856|11968196|FG000|Overall Study|Lost to Follow-up|5
7577813|NCT03950856|11968197|FG001|Overall Study|Lost to Follow-up|6
7577814|NCT03950856|11968198|FG002|Overall Study|Lost to Follow-up|8
7577815|NCT03950856|11968199|FG003|Overall Study|Lost to Follow-up|2
7577816|NCT03950856|11968196|FG000|Overall Study|Protocol Violation|2
7577817|NCT03950856|11968197|FG001|Overall Study|Protocol Violation|0
7577818|NCT03950856|11968198|FG002|Overall Study|Protocol Violation|0
7577819|NCT03950856|11968199|FG003|Overall Study|Protocol Violation|1
7577820|NCT03950856|11968196|FG000|Overall Study|Withdrawal by Subject|4
7577821|NCT03950856|11968197|FG001|Overall Study|Withdrawal by Subject|1
7577822|NCT03950856|11968198|FG002|Overall Study|Withdrawal by Subject|3
7577823|NCT03950856|11968199|FG003|Overall Study|Withdrawal by Subject|1
7577824|NCT03950856|11968196|FG000|Overall Study|Unable to phone|7
7577825|NCT03950856|11968197|FG001|Overall Study|Unable to phone|6
7577826|NCT03950856|11968198|FG002|Overall Study|Unable to phone|7
7577827|NCT03950856|11968199|FG003|Overall Study|Unable to phone|2
7577828|NCT03956550|11968252|FG000|Overall Study|Sponsor decision|65
7577829|NCT03956550|11968253|FG001|Overall Study|Sponsor decision|66
7577830|NCT03956550|11968254|FG002|Overall Study|Sponsor decision|64
7577831|NCT03956550|11968252|FG000|Overall Study|Adverse Event|0
7577832|NCT03956550|11968253|FG001|Overall Study|Adverse Event|1
7577833|NCT03956550|11968254|FG002|Overall Study|Adverse Event|0
7577834|NCT03956550|11968252|FG000|Overall Study|Withdrawal by Subject|5
7577835|NCT03956550|11968253|FG001|Overall Study|Withdrawal by Subject|5
7577836|NCT03956550|11968254|FG002|Overall Study|Withdrawal by Subject|6
7577837|NCT03958656|11968306|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
7577838|NCT03958656|11968307|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
7577839|NCT03958656|11968308|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
7577840|NCT03958656|11968309|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
7577841|NCT03958656|11968306|FG000|Overall Study|No longer meets eligibility criteria|0
7577842|NCT03958656|11968307|FG001|Overall Study|No longer meets eligibility criteria|0
7577843|NCT03958656|11968308|FG002|Overall Study|No longer meets eligibility criteria|1
7577844|NCT03958656|11968309|FG003|Overall Study|No longer meets eligibility criteria|0
7577845|NCT03958656|11968306|FG000|Overall Study|Started anti-cancer treatment|0
7577846|NCT03958656|11968307|FG001|Overall Study|Started anti-cancer treatment|0
7577847|NCT03958656|11968308|FG002|Overall Study|Started anti-cancer treatment|1
7577848|NCT03958656|11968309|FG003|Overall Study|Started anti-cancer treatment|0
7577849|NCT03951805|11968332|FG000|Overall Study|Adverse Event|1
7577850|NCT03951805|11968333|FG001|Overall Study|Adverse Event|0
7577851|NCT03951805|11968334|FG002|Overall Study|Adverse Event|0
7577852|NCT03951805|11968335|FG003|Overall Study|Adverse Event|0
7577853|NCT03950622|11968360|FG000|Overall Study|Withdrawal by Subject|1
7268928|NCT00408317|11483052|FG000|First Intervention Period|Adverse Event|0
7268929|NCT00408317|11483053|FG001|First Intervention Period|Adverse Event|1
7548697|NCT02926937|11906128|FG000|Overall Study|Adverse Event|0
7548698|NCT02926937|11906129|FG001|Overall Study|Adverse Event|1
7268930|NCT00408317|11483052|FG000|Second Intervention Period|Adverse Event|2
7268931|NCT00408317|11483053|FG001|Second Intervention Period|Adverse Event|0
7268932|NCT00408317|11483052|FG000|Second Intervention Period|Protocol Violation|0
7268933|NCT00408317|11483053|FG001|Second Intervention Period|Protocol Violation|1
7268934|NCT00408317|11483052|FG000|Second Intervention Period|Withdrawal of consent|0
7268935|NCT00408317|11483053|FG001|Second Intervention Period|Withdrawal of consent|1
7268936|NCT00408408|11483065|FG000|Overall Study|No follow up data|2
7268937|NCT00408408|11483066|FG001|Overall Study|No follow up data|3
7268938|NCT00408408|11483067|FG002|Overall Study|No follow up data|0
7268939|NCT00408408|11483068|FG003|Overall Study|No follow up data|7
7268940|NCT00408408|11483069|FG004|Overall Study|No follow up data|5
7268941|NCT00408408|11483070|FG005|Overall Study|No follow up data|3
7268942|NCT00408421|11483086|FG000|Treatment Initial Randomization|Adverse Event|5
7268943|NCT00408421|11483087|FG001|Treatment Initial Randomization|Adverse Event|9
7268944|NCT00408421|11483088|FG002|Treatment Initial Randomization|Adverse Event|0
7268945|NCT00408421|11483086|FG000|Treatment Initial Randomization|Lack of Efficacy|2
7268946|NCT00408421|11483087|FG001|Treatment Initial Randomization|Lack of Efficacy|2
7268947|NCT00408421|11483088|FG002|Treatment Initial Randomization|Lack of Efficacy|0
7268948|NCT00408421|11483086|FG000|Treatment Initial Randomization|Lost to Follow-up|0
7268949|NCT00408421|11483087|FG001|Treatment Initial Randomization|Lost to Follow-up|3
7268950|NCT00408421|11483088|FG002|Treatment Initial Randomization|Lost to Follow-up|0
7268951|NCT00408421|11483086|FG000|Treatment Initial Randomization|Physician Decision|1
7268952|NCT00408421|11483087|FG001|Treatment Initial Randomization|Physician Decision|0
7268953|NCT00408421|11483088|FG002|Treatment Initial Randomization|Physician Decision|0
7268954|NCT00408421|11483086|FG000|Treatment Initial Randomization|Protocol Violation|0
7268955|NCT00408421|11483087|FG001|Treatment Initial Randomization|Protocol Violation|1
7268956|NCT00408421|11483088|FG002|Treatment Initial Randomization|Protocol Violation|0
7268957|NCT00408421|11483086|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
7268958|NCT00408421|11483087|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
7268959|NCT00408421|11483088|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
7268960|NCT00408421|11483086|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
7268961|NCT00408421|11483087|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
7268962|NCT00408421|11483088|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
7268963|NCT00408421|11483086|FG000|Treatment Initial Randomization|Sponsor Decision|1
7268964|NCT00408421|11483087|FG001|Treatment Initial Randomization|Sponsor Decision|0
7268965|NCT00408421|11483088|FG002|Treatment Initial Randomization|Sponsor Decision|0
7268966|NCT00408421|11483086|FG000|Treatment Re-Randomization|Adverse Event|2
7268967|NCT00408421|11483087|FG001|Treatment Re-Randomization|Adverse Event|2
7268968|NCT00408421|11483088|FG002|Treatment Re-Randomization|Adverse Event|4
7268969|NCT00408421|11483086|FG000|Treatment Re-Randomization|Lack of Efficacy|1
7268970|NCT00408421|11483087|FG001|Treatment Re-Randomization|Lack of Efficacy|0
7268971|NCT00408421|11483088|FG002|Treatment Re-Randomization|Lack of Efficacy|0
7268972|NCT00408421|11483086|FG000|Treatment Re-Randomization|Lost to Follow-up|0
7268973|NCT00408421|11483087|FG001|Treatment Re-Randomization|Lost to Follow-up|0
7548699|NCT02926937|11906130|FG002|Overall Study|Adverse Event|1
7548700|NCT02926937|11906128|FG000|Overall Study|Poor Compliance to Protocol|1
7548701|NCT02926937|11906129|FG001|Overall Study|Poor Compliance to Protocol|0
7548702|NCT02926937|11906130|FG002|Overall Study|Poor Compliance to Protocol|0
7548703|NCT02926937|11906128|FG000|Overall Study|Lost to Follow-up|4
7548704|NCT02926937|11906129|FG001|Overall Study|Lost to Follow-up|5
7548705|NCT02926937|11906130|FG002|Overall Study|Lost to Follow-up|0
7548706|NCT02926937|11906128|FG000|Overall Study|At the Participant's own Request|11
7548707|NCT02926937|11906129|FG001|Overall Study|At the Participant's own Request|5
7548708|NCT02926937|11906130|FG002|Overall Study|At the Participant's own Request|8
7548709|NCT02926937|11906128|FG000|Overall Study|Reason not Specified|3
7548710|NCT02926937|11906129|FG001|Overall Study|Reason not Specified|4
7548711|NCT02926937|11906130|FG002|Overall Study|Reason not Specified|2
7548712|NCT02926950|11906141|FG000|Overall Study|Adverse Event|4
7548713|NCT02926950|11906142|FG001|Overall Study|Adverse Event|6
7548714|NCT02926950|11906141|FG000|Overall Study|At the participant's own request|21
7548715|NCT02926950|11906142|FG001|Overall Study|At the participant's own request|25
7548716|NCT02926950|11906141|FG000|Overall Study|Reason not Specified|17
7548717|NCT02926950|11906142|FG001|Overall Study|Reason not Specified|9
7548718|NCT02926950|11906141|FG000|Overall Study|Lost to Follow-up|7
7548719|NCT02926950|11906142|FG001|Overall Study|Lost to Follow-up|8
7268974|NCT00408421|11483088|FG002|Treatment Re-Randomization|Lost to Follow-up|1
7268975|NCT00408421|11483086|FG000|Treatment Re-Randomization|Physician Decision|1
7268976|NCT00408421|11483087|FG001|Treatment Re-Randomization|Physician Decision|3
7268977|NCT00408421|11483088|FG002|Treatment Re-Randomization|Physician Decision|0
7268978|NCT00408421|11483086|FG000|Treatment Re-Randomization|Protocol Violation|1
7268979|NCT00408421|11483087|FG001|Treatment Re-Randomization|Protocol Violation|1
7268980|NCT00408421|11483088|FG002|Treatment Re-Randomization|Protocol Violation|0
7268981|NCT00408421|11483086|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
7268982|NCT00408421|11483087|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
7268983|NCT00408421|11483088|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
7268984|NCT00408434|11483103|FG000|Overall Study|Adverse Event|0
7268985|NCT00408434|11483104|FG001|Overall Study|Adverse Event|0
7268986|NCT00408434|11483105|FG002|Overall Study|Adverse Event|1
7268987|NCT00408434|11483106|FG003|Overall Study|Adverse Event|0
7268988|NCT00408434|11483107|FG004|Overall Study|Adverse Event|0
7268989|NCT00408434|11483108|FG005|Overall Study|Adverse Event|0
7577854|NCT03950622|11968361|FG001|Overall Study|Withdrawal by Subject|0
7577855|NCT03950622|11968360|FG000|Overall Study|Protocol Deviation|0
7577856|NCT03950622|11968361|FG001|Overall Study|Protocol Deviation|1
7577857|NCT03950622|11968360|FG000|Overall Study|Physician Decision|1
7577858|NCT03950622|11968361|FG001|Overall Study|Physician Decision|0
7577859|NCT03950622|11968360|FG000|Overall Study|Lost to Follow-up|5
7577860|NCT03950622|11968361|FG001|Overall Study|Lost to Follow-up|5
7577861|NCT03950622|11968360|FG000|Overall Study|Death|1
7577862|NCT03950622|11968361|FG001|Overall Study|Death|1
7577865|NCT03948334|11968413|FG000|Overall Study|Adverse Event|1
7577866|NCT03948334|11968414|FG001|Overall Study|Adverse Event|4
7577867|NCT03948334|11968413|FG000|Overall Study|Lack of Efficacy|2
7577868|NCT03948334|11968414|FG001|Overall Study|Lack of Efficacy|0
7577869|NCT03948334|11968413|FG000|Overall Study|Lost to Follow-up|1
7577870|NCT03948334|11968414|FG001|Overall Study|Lost to Follow-up|0
7577871|NCT03948334|11968413|FG000|Overall Study|Physician Decision|1
7577872|NCT03948334|11968414|FG001|Overall Study|Physician Decision|0
7577873|NCT03948334|11968413|FG000|Overall Study|Pregnancy|0
7577874|NCT03948334|11968414|FG001|Overall Study|Pregnancy|1
7577875|NCT03948334|11968413|FG000|Overall Study|Protocol Deviation|1
7577876|NCT03948334|11968414|FG001|Overall Study|Protocol Deviation|0
7577877|NCT03948334|11968413|FG000|Overall Study|Study terminated by Sponsor|50
7577878|NCT03948334|11968414|FG001|Overall Study|Study terminated by Sponsor|51
7577879|NCT03948334|11968413|FG000|Overall Study|Subject Decision /Guardian Decision|4
7577880|NCT03948334|11968414|FG001|Overall Study|Subject Decision /Guardian Decision|7
7548770|NCT02927171|11906215|FG000|Overall Study|Lost to Follow-up|0
7548771|NCT02927171|11906216|FG001|Overall Study|Lost to Follow-up|1
7548775|NCT02927366|11906243|FG000|Overall Study|Adverse Event|1
7548776|NCT02927366|11906244|FG001|Overall Study|Adverse Event|0
7548777|NCT02927366|11906243|FG000|Overall Study|Patient schedule|1
7548778|NCT02927366|11906244|FG001|Overall Study|Patient schedule|0
7548779|NCT02927431|11906253|FG000|Overall Study|Withdrawal by Subject|0
7548780|NCT02927431|11906254|FG001|Overall Study|Withdrawal by Subject|0
7548781|NCT02927431|11906255|FG002|Overall Study|Withdrawal by Subject|1
7548782|NCT02927795|11906287|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
7548783|NCT02927795|11906287|FG000|Overall Study|Not Treated|4
7548784|NCT02927834|11906294|FG000|Overall Study|Lost to Follow-up|1
7548785|NCT02927834|11906295|FG001|Overall Study|Lost to Follow-up|2
7548786|NCT02927834|11906296|FG002|Overall Study|Lost to Follow-up|2
7548787|NCT02927873|11906310|FG000|Overall Study|Lost to Follow-up|0
7548788|NCT02927873|11906311|FG001|Overall Study|Lost to Follow-up|1
7548789|NCT02927873|11906312|FG002|Overall Study|Lost to Follow-up|0
7548790|NCT02927873|11906313|FG003|Overall Study|Lost to Follow-up|0
7548791|NCT02927873|11906314|FG004|Overall Study|Lost to Follow-up|0
7548792|NCT02927873|11906315|FG005|Overall Study|Lost to Follow-up|0
7548793|NCT02927873|11906310|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7548794|NCT02927873|11906311|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
7548795|NCT02927873|11906312|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7548796|NCT02927873|11906313|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7548797|NCT02927873|11906314|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7548798|NCT02927873|11906315|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
7548799|NCT02927873|11906310|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7548800|NCT02927873|11906311|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7548801|NCT02927873|11906312|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7548802|NCT02927873|11906313|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7548803|NCT02927873|11906314|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7548804|NCT02927873|11906315|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7548805|NCT02927873|11906310|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7548806|NCT02927873|11906311|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
7268990|NCT00408434|11483109|FG006|Overall Study|Adverse Event|0
7268991|NCT00408434|11483103|FG000|Overall Study|Progressive disease|6
7268992|NCT00408434|11483104|FG001|Overall Study|Progressive disease|3
7268993|NCT00408434|11483105|FG002|Overall Study|Progressive disease|4
7268994|NCT00408434|11483106|FG003|Overall Study|Progressive disease|3
7268995|NCT00408434|11483107|FG004|Overall Study|Progressive disease|3
7268996|NCT00408434|11483108|FG005|Overall Study|Progressive disease|1
7268997|NCT00408434|11483109|FG006|Overall Study|Progressive disease|4
7268998|NCT00408434|11483103|FG000|Overall Study|Other|0
7268999|NCT00408434|11483104|FG001|Overall Study|Other|0
7269000|NCT00408434|11483105|FG002|Overall Study|Other|1
7269001|NCT00408434|11483106|FG003|Overall Study|Other|0
7269002|NCT00408434|11483107|FG004|Overall Study|Other|2
7269003|NCT00408434|11483108|FG005|Overall Study|Other|1
7269004|NCT00408434|11483109|FG006|Overall Study|Other|0
7269005|NCT00408434|11483103|FG000|Overall Study|Terminated by Investigator|0
7269006|NCT00408434|11483104|FG001|Overall Study|Terminated by Investigator|0
7269007|NCT00408434|11483105|FG002|Overall Study|Terminated by Investigator|0
7269008|NCT00408434|11483106|FG003|Overall Study|Terminated by Investigator|0
7269009|NCT00408434|11483107|FG004|Overall Study|Terminated by Investigator|1
7269010|NCT00408434|11483108|FG005|Overall Study|Terminated by Investigator|1
7269011|NCT00408434|11483109|FG006|Overall Study|Terminated by Investigator|0
7269012|NCT00408499|11483130|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
7269013|NCT00408499|11483131|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
7269014|NCT00408499|11483132|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
7269015|NCT00408499|11483133|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
7269016|NCT00408499|11483134|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
7269017|NCT00408499|11483130|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7269018|NCT00408499|11483131|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
7269019|NCT00408499|11483132|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7269020|NCT00408499|11483133|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7269021|NCT00408499|11483134|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
7269022|NCT00408499|11483130|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
7269023|NCT00408499|11483131|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
7269024|NCT00408499|11483132|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
7269025|NCT00408499|11483133|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
7269026|NCT00408499|11483134|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
7269027|NCT00408499|11483130|FG000|Phase II- MTD Expansion|Adverse Event|0
7269028|NCT00408499|11483131|FG001|Phase II- MTD Expansion|Adverse Event|0
7269029|NCT00408499|11483132|FG002|Phase II- MTD Expansion|Adverse Event|0
7269030|NCT00408499|11483133|FG003|Phase II- MTD Expansion|Adverse Event|0
7269031|NCT00408499|11483134|FG004|Phase II- MTD Expansion|Adverse Event|9
7269032|NCT00408499|11483130|FG000|Phase II- MTD Expansion|Death|0
7577881|NCT03944707|11968441|FG000|Overall Study|Adverse Event|0
7577882|NCT03944707|11968442|FG001|Overall Study|Adverse Event|2
7577883|NCT03944707|11968441|FG000|Overall Study|Study terminated by sponsor|12
7577884|NCT03944707|11968442|FG001|Overall Study|Study terminated by sponsor|7
7577885|NCT03944707|11968441|FG000|Overall Study|Subject decision|0
7577886|NCT03944707|11968442|FG001|Overall Study|Subject decision|1
7577887|NCT03943095|11968459|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
7577888|NCT03943095|11968460|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
7577889|NCT03943095|11968459|FG000|Overall Study|Withdrawal by Subject|1
7269033|NCT00408499|11483131|FG001|Phase II- MTD Expansion|Death|0
7269034|NCT00408499|11483132|FG002|Phase II- MTD Expansion|Death|0
7269035|NCT00408499|11483133|FG003|Phase II- MTD Expansion|Death|0
7269036|NCT00408499|11483134|FG004|Phase II- MTD Expansion|Death|2
7269037|NCT00408499|11483130|FG000|Phase II- MTD Expansion|Physician Decision|0
7269038|NCT00408499|11483131|FG001|Phase II- MTD Expansion|Physician Decision|0
7269039|NCT00408499|11483132|FG002|Phase II- MTD Expansion|Physician Decision|0
7269040|NCT00408499|11483133|FG003|Phase II- MTD Expansion|Physician Decision|0
7548807|NCT02927873|11906312|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7548808|NCT02927873|11906313|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7548809|NCT02927873|11906314|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7548810|NCT02927873|11906315|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
7548811|NCT02927873|11906310|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
7548812|NCT02927873|11906311|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7548813|NCT02927873|11906312|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7548814|NCT02927873|11906313|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7548815|NCT02927873|11906314|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7548816|NCT02927873|11906315|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
7548817|NCT02927873|11906310|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
7548818|NCT02927873|11906311|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7548819|NCT02927873|11906312|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7548820|NCT02927873|11906313|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7548821|NCT02927873|11906314|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7548822|NCT02927873|11906315|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
7548823|NCT02927925|11906329|FG000|Overall Study|Death|16
7548824|NCT02927925|11906329|FG000|Overall Study|Physician Decision|1
7548825|NCT02927925|11906329|FG000|Overall Study|Withdrawal by Subject|11
7548826|NCT02927925|11906329|FG000|Overall Study|Other|3
7548827|NCT02927925|11906329|FG000|Overall Study|Disease progression at clinical cutoff|1
7548828|NCT02928029|11906335|FG000|Overall Study|Withdrawal by Subject|0
7548829|NCT02928029|11906336|FG001|Overall Study|Withdrawal by Subject|1
7548830|NCT02928029|11906335|FG000|Overall Study|Radiological progression|1
7548831|NCT02928029|11906336|FG001|Overall Study|Radiological progression|0
7548832|NCT02928029|11906335|FG000|Overall Study|Clinical progression|1
7548833|NCT02928029|11906336|FG001|Overall Study|Clinical progression|2
7548834|NCT02928029|11906335|FG000|Overall Study|AE not related to clinical progression|1
7548835|NCT02928029|11906336|FG001|Overall Study|AE not related to clinical progression|1
7548836|NCT02928770|11906375|FG000|Overall Study|Withdrawal by Subject|2
7548837|NCT02928848|11906381|FG000|Arm 2|Withdrawal by Subject|1
7548838|NCT02928848|11906382|FG001|Arm 2|Withdrawal by Subject|0
7548839|NCT02928952|11906392|FG000|Overall Study|Lost to Follow-up|5
7548840|NCT02928952|11906393|FG001|Overall Study|Lost to Follow-up|5
7548841|NCT02928952|11906392|FG000|Overall Study|Withdrawal by Subject|5
7548842|NCT02928952|11906393|FG001|Overall Study|Withdrawal by Subject|1
7548843|NCT02928952|11906392|FG000|Overall Study|Physician Decision|0
7548844|NCT02928952|11906393|FG001|Overall Study|Physician Decision|1
7548845|NCT02929329|11906401|FG000|Overall Study|Withdrawal by Subject|24
7548846|NCT02929329|11906402|FG001|Overall Study|Withdrawal by Subject|21
7548847|NCT02929329|11906401|FG000|Overall Study|Lost to Follow-up|26
7548848|NCT02929329|11906402|FG001|Overall Study|Lost to Follow-up|20
7548849|NCT02929329|11906401|FG000|Overall Study|Death|1054
7548850|NCT02929329|11906402|FG001|Overall Study|Death|1051
7548851|NCT02929407|11906412|FG000|Overall Study|Adverse Event|1
7548852|NCT02929498|11906419|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
7548853|NCT02929498|11906420|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7548854|NCT02929498|11906421|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
7548855|NCT02929498|11906419|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
7548856|NCT02929498|11906420|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7548857|NCT02929498|11906421|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
7548858|NCT02930005|11906463|FG000|Overall Study|Lost to Follow-up|1
7548859|NCT02930005|11906464|FG001|Overall Study|Lost to Follow-up|5
7548860|NCT02930018|11906472|FG000|Overall Study|Lost to Follow-up|1
7548861|NCT02930018|11906473|FG001|Overall Study|Lost to Follow-up|1
7548862|NCT02930018|11906472|FG000|Overall Study|Withdrawal by Subject|5
7548863|NCT02930018|11906473|FG001|Overall Study|Withdrawal by Subject|2
7548864|NCT02930226|11906496|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
7548865|NCT02930226|11906497|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
7548866|NCT02930226|11906498|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
7548867|NCT02930226|11906499|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
7548868|NCT02930226|11906500|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
7548869|NCT02930226|11906501|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
7548870|NCT02930343|11906519|FG000|Overall Study|Lost to Follow-up|9
7548871|NCT02930343|11906520|FG001|Overall Study|Lost to Follow-up|7
7548872|NCT02930837|11906549|FG000|Overall Study|Adverse Event|6
7548873|NCT02930837|11906549|FG000|Overall Study|Lost to Follow-up|5
7548874|NCT02930837|11906549|FG000|Overall Study|Withdrawal by Subject|1
7548875|NCT02930941|11906555|FG000|Overall Study|Lost to Follow-up|1
7548876|NCT02930941|11906556|FG001|Overall Study|Lost to Follow-up|2
7548877|NCT02931396|11906590|FG000|Overall Study|Lost to Follow-up|3
7548878|NCT02931396|11906591|FG001|Overall Study|Lost to Follow-up|0
7548879|NCT02931396|11906590|FG000|Overall Study|Withdrawal by Subject|2
7548880|NCT02931396|11906591|FG001|Overall Study|Withdrawal by Subject|0
7548881|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Investigator discretion|1
7548882|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Investigator discretion|1
7548883|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Investigator discretion|0
7548884|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Adverse Event|5
7548885|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Adverse Event|1
7548886|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Adverse Event|0
7548887|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
7548888|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
7548889|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
7548890|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Death|8
7548891|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Death|24
7548892|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Death|0
7548893|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
7577890|NCT03943095|11968460|FG001|Overall Study|Withdrawal by Subject|0
7577918|NCT03942042|11968519|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
7577919|NCT03942042|11968520|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
7577920|NCT03942042|11968519|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
7269041|NCT00408499|11483134|FG004|Phase II- MTD Expansion|Physician Decision|1
7269042|NCT00408499|11483130|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
7269043|NCT00408499|11483131|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
7269044|NCT00408499|11483132|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
7269045|NCT00408499|11483133|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
7269046|NCT00408499|11483134|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
7269047|NCT00408499|11483130|FG000|Phase II- MTD Expansion|treatment delay|0
7269048|NCT00408499|11483131|FG001|Phase II- MTD Expansion|treatment delay|0
7269049|NCT00408499|11483132|FG002|Phase II- MTD Expansion|treatment delay|0
7269050|NCT00408499|11483133|FG003|Phase II- MTD Expansion|treatment delay|0
7548894|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
7548895|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
7548896|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Protocol Violation|6
7548897|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Protocol Violation|0
7548898|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Protocol Violation|0
7548899|NCT02931539|11906599|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
7548900|NCT02931539|11906600|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7548901|NCT02931539|11906601|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
7548902|NCT02931539|11906599|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7548903|NCT02931539|11906600|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
7548904|NCT02931539|11906601|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
7548905|NCT02931838|11906630|FG000|Overall Study|Reason not provided by investigator|1
7548906|NCT02931838|11906631|FG001|Overall Study|Reason not provided by investigator|0
7548907|NCT02931838|11906632|FG002|Overall Study|Reason not provided by investigator|1
7548908|NCT02931838|11906633|FG003|Overall Study|Reason not provided by investigator|0
7548909|NCT02931838|11906634|FG004|Overall Study|Reason not provided by investigator|0
7548910|NCT02931838|11906635|FG005|Overall Study|Reason not provided by investigator|0
7548911|NCT02931838|11906630|FG000|Overall Study|Poor/non-compliance|0
7548912|NCT02931838|11906631|FG001|Overall Study|Poor/non-compliance|0
7548913|NCT02931838|11906632|FG002|Overall Study|Poor/non-compliance|1
7548914|NCT02931838|11906633|FG003|Overall Study|Poor/non-compliance|0
7548915|NCT02931838|11906634|FG004|Overall Study|Poor/non-compliance|0
7548916|NCT02931838|11906635|FG005|Overall Study|Poor/non-compliance|0
7548917|NCT02931838|11906630|FG000|Overall Study|Lack of Efficacy|5
7577921|NCT03942042|11968520|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
7577922|NCT03923530|11968539|FG000|Overall Study|Withdrawal by Subject|1
7577923|NCT03923530|11968539|FG000|Overall Study|screen failure|3
7577924|NCT03914417|11968543|FG000|Overall Study|Withdrawal by Subject|2
7577925|NCT03913377|11968549|FG000|Period 1|Test Article no longer available|0
7548918|NCT02931838|11906631|FG001|Overall Study|Lack of Efficacy|4
7548919|NCT02931838|11906632|FG002|Overall Study|Lack of Efficacy|0
7548920|NCT02931838|11906633|FG003|Overall Study|Lack of Efficacy|0
7548921|NCT02931838|11906634|FG004|Overall Study|Lack of Efficacy|0
7548922|NCT02931838|11906635|FG005|Overall Study|Lack of Efficacy|1
7548923|NCT02931838|11906630|FG000|Overall Study|Lost to Follow-up|1
7548924|NCT02931838|11906631|FG001|Overall Study|Lost to Follow-up|0
7548925|NCT02931838|11906632|FG002|Overall Study|Lost to Follow-up|1
7548926|NCT02931838|11906633|FG003|Overall Study|Lost to Follow-up|1
7548927|NCT02931838|11906634|FG004|Overall Study|Lost to Follow-up|2
7548928|NCT02931838|11906635|FG005|Overall Study|Lost to Follow-up|0
7548929|NCT02931838|11906630|FG000|Overall Study|Subject request to discontinue treatment|4
7548930|NCT02931838|11906631|FG001|Overall Study|Subject request to discontinue treatment|3
7548931|NCT02931838|11906632|FG002|Overall Study|Subject request to discontinue treatment|3
7548932|NCT02931838|11906633|FG003|Overall Study|Subject request to discontinue treatment|0
7548933|NCT02931838|11906634|FG004|Overall Study|Subject request to discontinue treatment|1
7548934|NCT02931838|11906635|FG005|Overall Study|Subject request to discontinue treatment|0
7548935|NCT02931838|11906630|FG000|Overall Study|Withdrawal by Subject|1
7548936|NCT02931838|11906631|FG001|Overall Study|Withdrawal by Subject|2
7548937|NCT02931838|11906632|FG002|Overall Study|Withdrawal by Subject|0
7548938|NCT02931838|11906633|FG003|Overall Study|Withdrawal by Subject|1
7548939|NCT02931838|11906634|FG004|Overall Study|Withdrawal by Subject|0
7548940|NCT02931838|11906635|FG005|Overall Study|Withdrawal by Subject|0
7548941|NCT02931838|11906630|FG000|Overall Study|Adverse Event|2
7548942|NCT02931838|11906631|FG001|Overall Study|Adverse Event|1
7548943|NCT02931838|11906632|FG002|Overall Study|Adverse Event|2
7548944|NCT02931838|11906633|FG003|Overall Study|Adverse Event|1
7548945|NCT02931838|11906634|FG004|Overall Study|Adverse Event|3
7548946|NCT02931838|11906635|FG005|Overall Study|Adverse Event|1
7548947|NCT02932228|11906656|FG000|Overall Study|Death|8
7548948|NCT02932228|11906657|FG001|Overall Study|Death|23
7548949|NCT02932228|11906656|FG000|Overall Study|not eligible upon chart review|2
7548950|NCT02932228|11906657|FG001|Overall Study|not eligible upon chart review|5
7548951|NCT02932267|11906665|FG000|Overall Study|Withdrawal by Subject|3
7548952|NCT02932267|11906665|FG000|Overall Study|Lost to Follow-up|4
7548953|NCT02932267|11906665|FG000|Overall Study|Pregnancy|1
7548954|NCT02932306|11906671|FG000|Overall Study|Withdrawal by Subject|16
7548955|NCT02932306|11906672|FG001|Overall Study|Withdrawal by Subject|25
7577926|NCT03913377|11968550|FG001|Period 1|Test Article no longer available|1
7548956|NCT02932306|11906671|FG000|Overall Study|Adverse Event|3
7269051|NCT00408499|11483134|FG004|Phase II- MTD Expansion|treatment delay|3
7269052|NCT00408629|11483190|FG000|Overall Study|Adverse Event|13
7269053|NCT00408629|11483191|FG001|Overall Study|Adverse Event|27
7269054|NCT00408629|11483190|FG000|Overall Study|Withdrawal by Subject|8
7269055|NCT00408629|11483191|FG001|Overall Study|Withdrawal by Subject|4
7269056|NCT00408629|11483190|FG000|Overall Study|Lost to Follow-up|1
7269057|NCT00408629|11483191|FG001|Overall Study|Lost to Follow-up|1
7269058|NCT00408629|11483190|FG000|Overall Study|Lack of Efficacy|63
7269059|NCT00408629|11483191|FG001|Overall Study|Lack of Efficacy|73
7269060|NCT00408629|11483190|FG000|Overall Study|Protocol Violation|1
7269061|NCT00408629|11483191|FG001|Overall Study|Protocol Violation|5
7269062|NCT00408629|11483190|FG000|Overall Study|Miscellaneous|11
7548957|NCT02932306|11906672|FG001|Overall Study|Adverse Event|0
7548958|NCT02932306|11906671|FG000|Overall Study|Pregnancy|2
7548959|NCT02932306|11906672|FG001|Overall Study|Pregnancy|0
7548960|NCT02932306|11906671|FG000|Overall Study|Protocol Violation|1
7548961|NCT02932306|11906672|FG001|Overall Study|Protocol Violation|1
7548962|NCT02932306|11906671|FG000|Overall Study|Noncompliance with Study Drug|1
7548963|NCT02932306|11906672|FG001|Overall Study|Noncompliance with Study Drug|1
7548964|NCT02932306|11906671|FG000|Overall Study|Lost to Follow-up|36
7548965|NCT02932306|11906672|FG001|Overall Study|Lost to Follow-up|40
7548966|NCT02932306|11906671|FG000|Overall Study|Withdrawal by Parent or Guardian|6
7548967|NCT02932306|11906672|FG001|Overall Study|Withdrawal by Parent or Guardian|8
7548968|NCT02932306|11906671|FG000|Overall Study|Lack of Efficacy|0
7548969|NCT02932306|11906672|FG001|Overall Study|Lack of Efficacy|2
7548970|NCT02932306|11906671|FG000|Overall Study|Worsening condition|2
7548971|NCT02932306|11906672|FG001|Overall Study|Worsening condition|0
7548972|NCT02932306|11906671|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
7548973|NCT02932306|11906672|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
7548974|NCT02932462|11906680|FG000|Overall Study|Adverse Event|1
7548975|NCT02932462|11906681|FG001|Overall Study|Adverse Event|2
7548976|NCT02932462|11906680|FG000|Overall Study|Lost to Follow-up|4
7548977|NCT02932462|11906681|FG001|Overall Study|Lost to Follow-up|1
7548978|NCT02932462|11906680|FG000|Overall Study|Protocol Violation|0
7548979|NCT02932462|11906681|FG001|Overall Study|Protocol Violation|5
7548980|NCT02932462|11906680|FG000|Overall Study|Withdrawal by Subject|1
7548981|NCT02932462|11906681|FG001|Overall Study|Withdrawal by Subject|4
7548982|NCT02932462|11906680|FG000|Overall Study|Non-Compliance With Study Drug|0
7548983|NCT02932462|11906681|FG001|Overall Study|Non-Compliance With Study Drug|1
7548984|NCT02932462|11906680|FG000|Overall Study|Progressive Disease|1
7548985|NCT02932462|11906681|FG001|Overall Study|Progressive Disease|0
7548986|NCT02932878|11906701|FG000|Overall Study|Due to Lab Results|2
7548987|NCT02932878|11906702|FG001|Overall Study|Due to Lab Results|1
7548988|NCT02932891|11906708|FG000|Overall Study|Lost to Follow-up|2
7577927|NCT03913377|11968551|FG002|Period 1|Test Article no longer available|0
7577928|NCT03913377|11968549|FG000|Period 1|No Longer Meets Eligibility Criteria|0
7548989|NCT02932891|11906708|FG000|Overall Study|HPA Suppress|2
7548990|NCT02932904|11906716|FG000|Overall Study|Reason not Specified|1
7548991|NCT02932904|11906717|FG001|Overall Study|Reason not Specified|0
7548992|NCT02932904|11906718|FG002|Overall Study|Reason not Specified|2
7548993|NCT02932904|11906719|FG003|Overall Study|Reason not Specified|2
7548994|NCT02932904|11906716|FG000|Overall Study|Noncompliance with Study Drug|2
7548995|NCT02932904|11906717|FG001|Overall Study|Noncompliance with Study Drug|3
7548996|NCT02932904|11906718|FG002|Overall Study|Noncompliance with Study Drug|3
7548997|NCT02932904|11906719|FG003|Overall Study|Noncompliance with Study Drug|4
7548998|NCT02932904|11906716|FG000|Overall Study|Pregnancy|0
7548999|NCT02932904|11906717|FG001|Overall Study|Pregnancy|1
7549000|NCT02932904|11906718|FG002|Overall Study|Pregnancy|1
7549001|NCT02932904|11906719|FG003|Overall Study|Pregnancy|0
7549002|NCT02932904|11906716|FG000|Overall Study|Study Termination|0
7549003|NCT02932904|11906717|FG001|Overall Study|Study Termination|1
7549004|NCT02932904|11906718|FG002|Overall Study|Study Termination|0
7549005|NCT02932904|11906719|FG003|Overall Study|Study Termination|0
7549006|NCT02932904|11906716|FG000|Overall Study|Voluntary Withdrawal|2
7549007|NCT02932904|11906717|FG001|Overall Study|Voluntary Withdrawal|1
7549008|NCT02932904|11906718|FG002|Overall Study|Voluntary Withdrawal|4
7549009|NCT02932904|11906719|FG003|Overall Study|Voluntary Withdrawal|2
7549010|NCT02932904|11906716|FG000|Overall Study|Lost to Follow-up|5
7549011|NCT02932904|11906717|FG001|Overall Study|Lost to Follow-up|3
7549012|NCT02932904|11906718|FG002|Overall Study|Lost to Follow-up|6
7577929|NCT03913377|11968550|FG001|Period 1|No Longer Meets Eligibility Criteria|0
7549013|NCT02932904|11906719|FG003|Overall Study|Lost to Follow-up|0
7549014|NCT02932904|11906716|FG000|Overall Study|Significant Protocol Deviation|2
7549015|NCT02932904|11906717|FG001|Overall Study|Significant Protocol Deviation|3
7549016|NCT02932904|11906718|FG002|Overall Study|Significant Protocol Deviation|6
7549017|NCT02932904|11906719|FG003|Overall Study|Significant Protocol Deviation|1
7549018|NCT02932904|11906716|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7549019|NCT02932904|11906717|FG001|Overall Study|Pretreatment Event/Adverse Event|5
7549020|NCT02932904|11906718|FG002|Overall Study|Pretreatment Event/Adverse Event|1
7549021|NCT02932904|11906719|FG003|Overall Study|Pretreatment Event/Adverse Event|3
7577930|NCT03913377|11968551|FG002|Period 1|No Longer Meets Eligibility Criteria|1
7549022|NCT02932904|11906716|FG000|Overall Study|Randomized But Not Treated|1
7549023|NCT02932904|11906717|FG001|Overall Study|Randomized But Not Treated|1
7269063|NCT00408629|11483191|FG001|Overall Study|Miscellaneous|15
7269064|NCT00408681|11483198|FG000|Overall Study|Lack of Efficacy|2
7269065|NCT00408681|11483198|FG000|Overall Study|Adverse Event|7
7269066|NCT00408694|11483203|FG000|Overall Study|Ineligible|1
7269067|NCT00408694|11483203|FG000|Overall Study|No protocol treatment|1
7269068|NCT00408876|11483211|FG000|Overall Study|Adverse Event|9
7269069|NCT00408876|11483212|FG001|Overall Study|Adverse Event|17
7269070|NCT00408876|11483213|FG002|Overall Study|Adverse Event|27
7269071|NCT00408876|11483214|FG003|Overall Study|Adverse Event|10
7549024|NCT02932904|11906718|FG002|Overall Study|Randomized But Not Treated|0
7549025|NCT02932904|11906719|FG003|Overall Study|Randomized But Not Treated|2
7549026|NCT02932943|11906734|FG000|Overall Study|Lost to Follow-up|0
7549027|NCT02932943|11906735|FG001|Overall Study|Lost to Follow-up|2
7549028|NCT02932943|11906734|FG000|Overall Study|Adverse Event|2
7549029|NCT02932943|11906735|FG001|Overall Study|Adverse Event|2
7549030|NCT02932943|11906734|FG000|Overall Study|Withdrawal by Subject|3
7549031|NCT02932943|11906735|FG001|Overall Study|Withdrawal by Subject|3
7549032|NCT02933060|11906747|FG000|Overall Study|Withdrawal by Subject|0
7549033|NCT02933060|11906748|FG001|Overall Study|Withdrawal by Subject|1
7577931|NCT03937778|11968562|FG000|Overall Study|Withdrawal by Subject|1
7577932|NCT03937778|11968562|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
7577933|NCT03937479|11968571|FG000|Overall Study|Adverse Event|2
7577934|NCT03937479|11968572|FG001|Overall Study|Adverse Event|3
7577935|NCT03937479|11968573|FG002|Overall Study|Adverse Event|0
7577936|NCT03937479|11968574|FG003|Overall Study|Adverse Event|0
7577937|NCT03937479|11968575|FG004|Overall Study|Adverse Event|1
7577938|NCT03937479|11968571|FG000|Overall Study|Withdrawal by Subject|3
7577939|NCT03937479|11968572|FG001|Overall Study|Withdrawal by Subject|5
7269072|NCT00408876|11483211|FG000|Overall Study|Withdrawal by Subject|3
7269073|NCT00408876|11483212|FG001|Overall Study|Withdrawal by Subject|6
7269074|NCT00408876|11483213|FG002|Overall Study|Withdrawal by Subject|6
7269075|NCT00408876|11483214|FG003|Overall Study|Withdrawal by Subject|14
7269076|NCT00408876|11483211|FG000|Overall Study|Lack of Efficacy|2
7269077|NCT00408876|11483212|FG001|Overall Study|Lack of Efficacy|4
7269078|NCT00408876|11483213|FG002|Overall Study|Lack of Efficacy|5
7269079|NCT00408876|11483214|FG003|Overall Study|Lack of Efficacy|6
7269080|NCT00408876|11483211|FG000|Overall Study|Lost to Follow-up|1
7269081|NCT00408876|11483212|FG001|Overall Study|Lost to Follow-up|6
7269082|NCT00408876|11483213|FG002|Overall Study|Lost to Follow-up|5
7269083|NCT00408876|11483214|FG003|Overall Study|Lost to Follow-up|2
7269084|NCT00408876|11483211|FG000|Overall Study|Protocol Violation|0
7269085|NCT00408876|11483212|FG001|Overall Study|Protocol Violation|3
7269086|NCT00408876|11483213|FG002|Overall Study|Protocol Violation|4
7269087|NCT00408876|11483214|FG003|Overall Study|Protocol Violation|3
7577940|NCT03937479|11968573|FG002|Overall Study|Withdrawal by Subject|2
7577941|NCT03937479|11968574|FG003|Overall Study|Withdrawal by Subject|2
7577942|NCT03937479|11968575|FG004|Overall Study|Withdrawal by Subject|1
7577943|NCT03937479|11968571|FG000|Overall Study|Protocol Violation|5
7577944|NCT03937479|11968572|FG001|Overall Study|Protocol Violation|6
7577945|NCT03937479|11968573|FG002|Overall Study|Protocol Violation|4
7577946|NCT03937479|11968574|FG003|Overall Study|Protocol Violation|3
7577947|NCT03937479|11968575|FG004|Overall Study|Protocol Violation|2
7577948|NCT03937479|11968571|FG000|Overall Study|Lost to Follow-up|0
7577949|NCT03937479|11968572|FG001|Overall Study|Lost to Follow-up|1
7577950|NCT03937479|11968573|FG002|Overall Study|Lost to Follow-up|0
7577951|NCT03937479|11968574|FG003|Overall Study|Lost to Follow-up|1
7577952|NCT03937479|11968575|FG004|Overall Study|Lost to Follow-up|0
7577953|NCT03937479|11968571|FG000|Overall Study|Physician Decision|0
7577954|NCT03937479|11968572|FG001|Overall Study|Physician Decision|0
7577955|NCT03937479|11968573|FG002|Overall Study|Physician Decision|1
7577956|NCT03937479|11968574|FG003|Overall Study|Physician Decision|0
7577957|NCT03937479|11968575|FG004|Overall Study|Physician Decision|1
7577958|NCT03936244|11968611|FG000|Overall Study|Lost to Follow-up|5
7577959|NCT03936244|11968612|FG001|Overall Study|Lost to Follow-up|1
7577960|NCT03936244|11968611|FG000|Overall Study|Physician Decision|7
7577961|NCT03936244|11968612|FG001|Overall Study|Physician Decision|3
7577962|NCT03935126|11968619|FG000|Overall Study|Study termination by sponsor|3
7577963|NCT03933462|11968638|FG000|Overall Study|Adverse Event|2
7577964|NCT03933462|11968639|FG001|Overall Study|Adverse Event|0
7577965|NCT03931330|11968654|FG000|Overall Study|Physician Decision|1
7269088|NCT00408876|11483211|FG000|Overall Study|Physician Decision|1
7624595|NCT01813305|12035749|FG000|Overall Study|Withdrawal by Subject|12
7269089|NCT00408876|11483212|FG001|Overall Study|Physician Decision|0
7269090|NCT00408876|11483213|FG002|Overall Study|Physician Decision|3
7269091|NCT00408876|11483214|FG003|Overall Study|Physician Decision|0
7269092|NCT00408902|11483224|FG000|Overall Study|Lack of Efficacy|7
7269093|NCT00408902|11483224|FG000|Overall Study|Adverse Event|3
7269094|NCT00408928|11483229|FG000|Overall Study|Withdrawal by Subject|1
7269095|NCT00408928|11483229|FG000|Overall Study|Death|1
7269096|NCT00408928|11483229|FG000|Overall Study|Infection indistinguishable from GVHD|1
7624596|NCT01813305|12035750|FG001|Overall Study|Withdrawal by Subject|5
7269097|NCT00408993|11483235|FG000|Overall Study|Adverse Event|15
7269098|NCT00408993|11483236|FG001|Overall Study|Adverse Event|4
7269099|NCT00408993|11483235|FG000|Overall Study|Protocol Violation|1
7269100|NCT00408993|11483236|FG001|Overall Study|Protocol Violation|6
7269101|NCT00408993|11483235|FG000|Overall Study|Lack of Efficacy|1
7269102|NCT00408993|11483236|FG001|Overall Study|Lack of Efficacy|4
7269103|NCT00408993|11483235|FG000|Overall Study|Withdrawal by Subject|2
7269104|NCT00408993|11483236|FG001|Overall Study|Withdrawal by Subject|3
7269105|NCT00409006|11483248|FG000|Overall Study|Death|15
7269106|NCT00409006|11483249|FG001|Overall Study|Death|6
7269107|NCT00409006|11483248|FG000|Overall Study|Lost to Follow-up|1
7269108|NCT00409006|11483249|FG001|Overall Study|Lost to Follow-up|2
7269109|NCT00409006|11483248|FG000|Overall Study|Withdrawal by Subject|3
7269110|NCT00409006|11483249|FG001|Overall Study|Withdrawal by Subject|2
7269111|NCT00409006|11483248|FG000|Overall Study|Physician Decision|1
7269112|NCT00409006|11483249|FG001|Overall Study|Physician Decision|2
7269113|NCT00409175|11483257|FG000|Overall Study|Adverse Event|4
7269114|NCT00409175|11483258|FG001|Overall Study|Adverse Event|3
7269115|NCT00409175|11483257|FG000|Overall Study|Withdrawal by Subject|1
7269116|NCT00409175|11483258|FG001|Overall Study|Withdrawal by Subject|2
7269117|NCT00409175|11483257|FG000|Overall Study|Negative genotype|0
7269118|NCT00409175|11483258|FG001|Overall Study|Negative genotype|1
7269119|NCT00409175|11483257|FG000|Overall Study|Liver transplantation|13
7269120|NCT00409175|11483258|FG001|Overall Study|Liver transplantation|13
7269121|NCT00409188|11483266|FG000|Overall Study|Ongoing at data cut-off|383
7269122|NCT00409188|11483267|FG001|Overall Study|Ongoing at data cut-off|175
7269123|NCT00409409|11483290|FG000|Overall Study|Adverse Event|7
7269124|NCT00409409|11483291|FG001|Overall Study|Adverse Event|2
7269125|NCT00409409|11483290|FG000|Overall Study|Withdrawal by Subject|1
7269126|NCT00409409|11483291|FG001|Overall Study|Withdrawal by Subject|1
7269127|NCT00409409|11483290|FG000|Overall Study|Any other reason not above-mentioned|0
7269128|NCT00409409|11483291|FG001|Overall Study|Any other reason not above-mentioned|1
7269129|NCT00409578|11483326|FG000|Overall Study|Adverse Event|27
7269130|NCT00409578|11483327|FG001|Overall Study|Adverse Event|37
7269131|NCT00409578|11483328|FG002|Overall Study|Adverse Event|25
7269132|NCT00409578|11483329|FG003|Overall Study|Adverse Event|33
7269133|NCT00409578|11483326|FG000|Overall Study|Abnormal laboratory value(s)|2
7269134|NCT00409578|11483327|FG001|Overall Study|Abnormal laboratory value(s)|2
7269135|NCT00409578|11483328|FG002|Overall Study|Abnormal laboratory value(s)|2
7269136|NCT00409578|11483329|FG003|Overall Study|Abnormal laboratory value(s)|4
7269137|NCT00409578|11483326|FG000|Overall Study|Lack of Efficacy|0
7269138|NCT00409578|11483327|FG001|Overall Study|Lack of Efficacy|0
7269139|NCT00409578|11483328|FG002|Overall Study|Lack of Efficacy|0
7269140|NCT00409578|11483329|FG003|Overall Study|Lack of Efficacy|2
7269141|NCT00409578|11483326|FG000|Overall Study|Subject no longer requires study drug|0
7269142|NCT00409578|11483327|FG001|Overall Study|Subject no longer requires study drug|0
7549040|NCT02933528|11906811|FG000|Overall Study|Lost to Follow-up|2
7549041|NCT02934178|11906841|FG000|Received Vaccination 2|Death|0
7549042|NCT02934178|11906842|FG001|Received Vaccination 2|Death|1
7549043|NCT02934178|11906841|FG000|Received Vaccination 3|Withdrawal by Subject|1
7549044|NCT02934178|11906842|FG001|Received Vaccination 3|Withdrawal by Subject|0
7549045|NCT02935192|11906924|FG000|Overall Study|Withdrawal by Subject|8
7549046|NCT02935192|11906925|FG001|Overall Study|Withdrawal by Subject|4
7549047|NCT02935452|11906933|FG000|Overall Study|work and life commintment|3
7549048|NCT02935452|11906934|FG001|Overall Study|work and life commintment|1
7549049|NCT02935673|11906947|FG000|Overall Study|Adverse Event|0
7549050|NCT02935673|11906948|FG001|Overall Study|Adverse Event|1
7549051|NCT02935673|11906949|FG002|Overall Study|Adverse Event|0
7549052|NCT02935673|11906947|FG000|Overall Study|Withdrawal by Subject|1
7549053|NCT02935673|11906948|FG001|Overall Study|Withdrawal by Subject|2
7549054|NCT02935673|11906949|FG002|Overall Study|Withdrawal by Subject|0
7549055|NCT02935842|11906989|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
7549056|NCT02935842|11906990|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
7549057|NCT02935842|11906991|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
7549058|NCT02935842|11906992|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
7549059|NCT02935842|11906989|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
7549060|NCT02935842|11906990|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7549061|NCT02935842|11906991|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
7549062|NCT02935842|11906992|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
7577966|NCT03931785|11968697|FG000|Overall Study|Lost to Follow-up|4
7269143|NCT00409578|11483328|FG002|Overall Study|Subject no longer requires study drug|0
7269144|NCT00409578|11483329|FG003|Overall Study|Subject no longer requires study drug|1
7269145|NCT00409578|11483326|FG000|Overall Study|Withdrawal by Subject|8
7269146|NCT00409578|11483327|FG001|Overall Study|Withdrawal by Subject|15
7269147|NCT00409578|11483328|FG002|Overall Study|Withdrawal by Subject|16
7269148|NCT00409578|11483329|FG003|Overall Study|Withdrawal by Subject|17
7269149|NCT00409578|11483326|FG000|Overall Study|Lost to Follow-up|2
7269150|NCT00409578|11483327|FG001|Overall Study|Lost to Follow-up|0
7269151|NCT00409578|11483328|FG002|Overall Study|Lost to Follow-up|2
7269152|NCT00409578|11483329|FG003|Overall Study|Lost to Follow-up|2
7269153|NCT00409578|11483326|FG000|Overall Study|Administrative problems|8
7269154|NCT00409578|11483327|FG001|Overall Study|Administrative problems|9
7269155|NCT00409578|11483328|FG002|Overall Study|Administrative problems|2
7269156|NCT00409578|11483329|FG003|Overall Study|Administrative problems|4
7269157|NCT00409578|11483326|FG000|Overall Study|Death|2
7269158|NCT00409578|11483327|FG001|Overall Study|Death|4
7269159|NCT00409578|11483328|FG002|Overall Study|Death|4
7269160|NCT00409578|11483329|FG003|Overall Study|Death|2
7269161|NCT00409578|11483326|FG000|Overall Study|Protocol Violation|3
7269162|NCT00409578|11483327|FG001|Overall Study|Protocol Violation|2
7269163|NCT00409578|11483328|FG002|Overall Study|Protocol Violation|3
7269164|NCT00409578|11483329|FG003|Overall Study|Protocol Violation|1
7269165|NCT00409578|11483326|FG000|Overall Study|Missing|0
7269166|NCT00409578|11483327|FG001|Overall Study|Missing|1
7269167|NCT00409578|11483328|FG002|Overall Study|Missing|0
7269168|NCT00409578|11483329|FG003|Overall Study|Missing|1
7269169|NCT00409617|11483339|FG000|Overall Study|Adverse Event|57
7269170|NCT00409617|11483339|FG000|Overall Study|Lack of Efficacy|54
7269171|NCT00409617|11483339|FG000|Overall Study|Lost to Follow-up|2
7269172|NCT00409617|11483339|FG000|Overall Study|Protocol Violation|24
7269173|NCT00409617|11483339|FG000|Overall Study|Withdrawal by Subject|8
7269174|NCT00409617|11483339|FG000|Overall Study|Administrative reasons|1
7269175|NCT00409617|11483339|FG000|Overall Study|Not described|14
7269176|NCT00409682|11483346|FG000|Open-label Induction Period|Adverse Event|1
7269177|NCT00409682|11483347|FG001|Open-label Induction Period|Adverse Event|0
7269178|NCT00409682|11483348|FG002|Open-label Induction Period|Adverse Event|0
7269179|NCT00409682|11483346|FG000|Open-label Induction Period|Lack of Efficacy|1
7269180|NCT00409682|11483347|FG001|Open-label Induction Period|Lack of Efficacy|0
7549063|NCT02935842|11906989|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
7549064|NCT02935842|11906990|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
7549065|NCT02935842|11906991|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
7549066|NCT02935842|11906992|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
7549067|NCT02935842|11906989|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
7549068|NCT02935842|11906990|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
7549069|NCT02935842|11906991|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
7549070|NCT02935842|11906992|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
7549071|NCT02935842|11906989|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
7549072|NCT02935842|11906990|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
7549073|NCT02935842|11906991|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
7549074|NCT02935842|11906992|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
7549075|NCT02935894|11907009|FG000|Overall Study|Subject dismissed|1
7549076|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Protocol Violation|1
7549077|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Protocol Violation|4
7549078|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
7549079|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
7549080|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
7549081|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
7549082|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Death|0
7549083|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Death|1
7549084|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Adverse Event|11
7549085|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Adverse Event|11
7549086|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
7549087|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
7549088|NCT02936037|11907015|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7549089|NCT02936037|11907016|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
7549090|NCT02936037|11907015|FG000|Open Label Extension|Adverse Event|0
7549091|NCT02936037|11907016|FG001|Open Label Extension|Adverse Event|3
7549092|NCT02936037|11907015|FG000|Open Label Extension|Other|0
7549093|NCT02936037|11907016|FG001|Open Label Extension|Other|3
7549094|NCT02936037|11907015|FG000|Open Label Extension|Withdrawal by Subject|0
7549095|NCT02936037|11907016|FG001|Open Label Extension|Withdrawal by Subject|4
7549096|NCT02936635|11907037|FG000|Overall Study|Adverse Event|43
7549097|NCT02936635|11907038|FG001|Overall Study|Adverse Event|25
7549098|NCT02936635|11907037|FG000|Overall Study|Progressive Disease|10
7549099|NCT02936635|11907038|FG001|Overall Study|Progressive Disease|18
7549100|NCT02936635|11907037|FG000|Overall Study|Sponsor Discretion|10
7549101|NCT02936635|11907038|FG001|Overall Study|Sponsor Discretion|16
7549102|NCT02936635|11907037|FG000|Overall Study|Death|9
7549103|NCT02936635|11907038|FG001|Overall Study|Death|15
7269181|NCT00409682|11483348|FG002|Open-label Induction Period|Lack of Efficacy|0
7269182|NCT00409682|11483346|FG000|Open-label Induction Period|Protocol Violation|1
7269183|NCT00409682|11483347|FG001|Open-label Induction Period|Protocol Violation|0
7269184|NCT00409682|11483348|FG002|Open-label Induction Period|Protocol Violation|0
7269185|NCT00409682|11483346|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
7269186|NCT00409682|11483347|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
7269187|NCT00409682|11483348|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
7269188|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
7269189|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
7269190|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
7269191|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
7269192|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
7269193|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
7269194|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7269195|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
7269196|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
7269197|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
7269198|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
7269199|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
7269200|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
7269201|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
7269202|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
7269203|NCT00409682|11483346|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
7269204|NCT00409682|11483347|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
7269205|NCT00409682|11483348|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
7269206|NCT00409708|11483357|FG000|Treatment|Abnormal test procedure result(s)|1
7269207|NCT00409708|11483358|FG001|Treatment|Abnormal test procedure result(s)|0
7269208|NCT00409708|11483357|FG000|Treatment|Lack of Efficacy|0
7269209|NCT00409708|11483358|FG001|Treatment|Lack of Efficacy|1
7269210|NCT00409708|11483357|FG000|Treatment|Protocol Violation|6
7269211|NCT00409708|11483358|FG001|Treatment|Protocol Violation|2
7269212|NCT00409708|11483357|FG000|Treatment|Withdrawal by Subject|3
7269213|NCT00409708|11483358|FG001|Treatment|Withdrawal by Subject|8
7269214|NCT00409708|11483357|FG000|Treatment|Lost to Follow-up|0
7269215|NCT00409708|11483358|FG001|Treatment|Lost to Follow-up|6
7549104|NCT02936635|11907037|FG000|Overall Study|Withdrawal by Subject|8
7549105|NCT02936635|11907038|FG001|Overall Study|Withdrawal by Subject|15
7549106|NCT02936635|11907037|FG000|Overall Study|Physician Decision|2
7549107|NCT02936635|11907038|FG001|Overall Study|Physician Decision|9
7549108|NCT02936635|11907037|FG000|Overall Study|Lost to Follow-up|1
7549109|NCT02936635|11907038|FG001|Overall Study|Lost to Follow-up|2
7549110|NCT02936635|11907037|FG000|Overall Study|Protocol Violation|1
7549111|NCT02936635|11907038|FG001|Overall Study|Protocol Violation|0
7549112|NCT02936635|11907037|FG000|Overall Study|Lack of effect/Entry into other study|31
7549113|NCT02936635|11907038|FG001|Overall Study|Lack of effect/Entry into other study|65
7549114|NCT02936869|11907050|FG000|Overall Study|Lost to Follow-up|1
7549115|NCT02936869|11907051|FG001|Overall Study|Lost to Follow-up|3
7549116|NCT02936869|11907050|FG000|Overall Study|Death|0
7549117|NCT02936869|11907051|FG001|Overall Study|Death|1
7549118|NCT02936869|11907050|FG000|Overall Study|Legal Case|0
7549119|NCT02936869|11907051|FG001|Overall Study|Legal Case|1
7549120|NCT02936869|11907050|FG000|Overall Study|Protocol Violation|1
7549121|NCT02936869|11907051|FG001|Overall Study|Protocol Violation|0
7549122|NCT02937350|11907127|FG000|Overall Study|Withdrawal by Subject|0
7549123|NCT02937350|11907128|FG001|Overall Study|Withdrawal by Subject|1
7549124|NCT02937350|11907129|FG002|Overall Study|Withdrawal by Subject|0
7549125|NCT02937454|11907137|FG000|Overall Study|Adverse Event|0
7549126|NCT02937454|11907138|FG001|Overall Study|Adverse Event|1
7549127|NCT02937454|11907137|FG000|Overall Study|Death|98
7549128|NCT02937454|11907138|FG001|Overall Study|Death|95
7549129|NCT02937454|11907137|FG000|Overall Study|Lost to Follow-up|1
7549130|NCT02937454|11907138|FG001|Overall Study|Lost to Follow-up|1
7549131|NCT02937454|11907137|FG000|Overall Study|Physician Decision|0
7549132|NCT02937454|11907138|FG001|Overall Study|Physician Decision|1
7549133|NCT02937454|11907137|FG000|Overall Study|Protocol Violation|6
7549134|NCT02937454|11907138|FG001|Overall Study|Protocol Violation|10
7549135|NCT02937454|11907137|FG000|Overall Study|Withdrawal by Subject|27
7549136|NCT02937454|11907138|FG001|Overall Study|Withdrawal by Subject|15
7549137|NCT02937454|11907137|FG000|Overall Study|Other|8
7549138|NCT02937454|11907138|FG001|Overall Study|Other|5
7549139|NCT02937545|11907156|FG000|Overall Study|Withdrawal by Subject|1
7549140|NCT02937545|11907157|FG001|Overall Study|Withdrawal by Subject|2
7549141|NCT02937545|11907158|FG002|Overall Study|Withdrawal by Subject|6
7549142|NCT02937545|11907159|FG003|Overall Study|Withdrawal by Subject|7
7549143|NCT02937545|11907156|FG000|Overall Study|Lost to Follow-up|1
7549144|NCT02937545|11907157|FG001|Overall Study|Lost to Follow-up|0
7549145|NCT02937545|11907158|FG002|Overall Study|Lost to Follow-up|0
7549146|NCT02937545|11907159|FG003|Overall Study|Lost to Follow-up|0
7549147|NCT02937584|11907180|FG000|Period 1|Adverse Event|1
7549148|NCT02937584|11907181|FG001|Period 1|Adverse Event|2
7269216|NCT00409708|11483357|FG000|Treatment|Administrative problems|5
7269217|NCT00409708|11483358|FG001|Treatment|Administrative problems|0
7269218|NCT00409708|11483357|FG000|Washout|Lack of Efficacy|9
7269219|NCT00409708|11483358|FG001|Washout|Lack of Efficacy|1
7269220|NCT00409708|11483357|FG000|Washout|Protocol Violation|0
7549149|NCT02937584|11907180|FG000|Washout|Adverse Event|0
7549150|NCT02937584|11907181|FG001|Washout|Adverse Event|1
7549151|NCT02937636|11907198|FG000|Overall Study|Other (Not specified)|3
7549152|NCT02937636|11907199|FG001|Overall Study|Other (Not specified)|2
7549153|NCT02937701|11907208|FG000|Day 1 to Week 22|Adverse Event|11
7549154|NCT02937701|11907209|FG001|Day 1 to Week 22|Adverse Event|14
7549155|NCT02937701|11907210|FG002|Day 1 to Week 22|Adverse Event|0
7549156|NCT02937701|11907211|FG003|Day 1 to Week 22|Adverse Event|0
7549157|NCT02937701|11907212|FG004|Day 1 to Week 22|Adverse Event|0
7549158|NCT02937701|11907208|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
7549159|NCT02937701|11907209|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
7549160|NCT02937701|11907210|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
7549161|NCT02937701|11907211|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
7549162|NCT02937701|11907212|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
7549163|NCT02937701|11907208|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
7549164|NCT02937701|11907209|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
7549165|NCT02937701|11907210|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7549166|NCT02937701|11907211|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7577967|NCT03931785|11968698|FG001|Overall Study|Lost to Follow-up|1
7577968|NCT03931785|11968699|FG002|Overall Study|Lost to Follow-up|4
7577969|NCT03931785|11968700|FG003|Overall Study|Lost to Follow-up|3
7577970|NCT03931785|11968697|FG000|Overall Study|Adverse Event|1
7577971|NCT03931785|11968698|FG001|Overall Study|Adverse Event|0
7577972|NCT03931785|11968699|FG002|Overall Study|Adverse Event|3
7577973|NCT03931785|11968700|FG003|Overall Study|Adverse Event|4
7577974|NCT03931785|11968697|FG000|Overall Study|Protocol Violation|0
7577975|NCT03931785|11968698|FG001|Overall Study|Protocol Violation|1
7577976|NCT03931785|11968699|FG002|Overall Study|Protocol Violation|0
7577977|NCT03931785|11968700|FG003|Overall Study|Protocol Violation|0
7577978|NCT03931785|11968697|FG000|Overall Study|Noncompliance With Study drug|0
7577979|NCT03931785|11968698|FG001|Overall Study|Noncompliance With Study drug|1
7577980|NCT03931785|11968699|FG002|Overall Study|Noncompliance With Study drug|0
7577981|NCT03931785|11968700|FG003|Overall Study|Noncompliance With Study drug|0
7577982|NCT03931785|11968697|FG000|Overall Study|Other Not specified|0
7577983|NCT03931785|11968698|FG001|Overall Study|Other Not specified|2
7577984|NCT03931785|11968699|FG002|Overall Study|Other Not specified|2
7577985|NCT03931785|11968700|FG003|Overall Study|Other Not specified|2
7577986|NCT03931785|11968697|FG000|Overall Study|Withdrawal by Subject|0
7577987|NCT03931785|11968698|FG001|Overall Study|Withdrawal by Subject|2
7577988|NCT03931785|11968699|FG002|Overall Study|Withdrawal by Subject|4
7577989|NCT03931785|11968700|FG003|Overall Study|Withdrawal by Subject|1
7577990|NCT03931785|11968697|FG000|Overall Study|Pregnancy|0
7577991|NCT03931785|11968698|FG001|Overall Study|Pregnancy|0
7577992|NCT03931785|11968699|FG002|Overall Study|Pregnancy|0
7577993|NCT03931785|11968700|FG003|Overall Study|Pregnancy|1
7577994|NCT03927846|11968716|FG000|Overall Study|Lost to Follow-up|10
7577995|NCT03927846|11968717|FG001|Overall Study|Lost to Follow-up|11
7577996|NCT03927105|11968723|FG000|Overall Study|Death|1
7577997|NCT03927105|11968723|FG000|Overall Study|In observation for potential re-treatment|2
7577998|NCT03927105|11968723|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
7577999|NCT03923933|11968729|FG000|Overall Study|Lost to Follow-up|1
7578000|NCT03923933|11968730|FG001|Overall Study|Lost to Follow-up|0
7578001|NCT03923933|11968729|FG000|Overall Study|Withdrawal by Subject|0
7578002|NCT03923933|11968730|FG001|Overall Study|Withdrawal by Subject|1
7578003|NCT03909295|11968736|FG000|Overall Study|Adverse Event|2
7578004|NCT03909295|11968736|FG000|Overall Study|Study terminated by sponsor|50
7578005|NCT03908970|11968742|FG000|Overall Study|Adverse Event|7
7578006|NCT03908970|11968743|FG001|Overall Study|Adverse Event|21
7578007|NCT03908970|11968742|FG000|Overall Study|Physician Decision|1
7578008|NCT03908970|11968743|FG001|Overall Study|Physician Decision|4
7578009|NCT03908970|11968742|FG000|Overall Study|Withdrawal by Subject|9
7578010|NCT03908970|11968743|FG001|Overall Study|Withdrawal by Subject|22
7578011|NCT03897179|11968749|FG000|Overall Study|Withdrawal by Subject|1
7578012|NCT03927950|11968813|FG000|Overall Study|Adverse Event|9
7578013|NCT03920670|11968835|FG000|Overall Study|Protocol Violation|2
7269221|NCT00409708|11483358|FG001|Washout|Protocol Violation|1
7269222|NCT00409708|11483357|FG000|Washout|Withdrawal by Subject|11
7269223|NCT00409708|11483358|FG001|Washout|Withdrawal by Subject|5
7269224|NCT00409708|11483357|FG000|Washout|Lost to Follow-up|1
7269225|NCT00409708|11483358|FG001|Washout|Lost to Follow-up|3
7269226|NCT00409747|11483364|FG000|Overall Study|Withdrawal by Subject|1
7269227|NCT00409786|11483368|FG000|Overall Study|Withdrawal by Subject|3
7269228|NCT00409838|11483378|FG000|Short-term Period|Adverse Event|0
7269229|NCT00409838|11483379|FG001|Short-term Period|Adverse Event|1
7269230|NCT00409838|11483378|FG000|Short-term Period|Lost to Follow-up|0
7269231|NCT00409838|11483379|FG001|Short-term Period|Lost to Follow-up|1
7269232|NCT00409838|11483378|FG000|Short-term Period|Withdrawal by Subject|2
7269233|NCT00409838|11483379|FG001|Short-term Period|Withdrawal by Subject|3
7269234|NCT00409838|11483378|FG000|Short-term Period|Never Treated|1
7269235|NCT00409838|11483379|FG001|Short-term Period|Never Treated|0
7269236|NCT00409838|11483378|FG000|Long-term Extension Period|Adverse Event|10
7269237|NCT00409838|11483379|FG001|Long-term Extension Period|Adverse Event|0
7269238|NCT00409838|11483378|FG000|Long-term Extension Period|Death|1
7269239|NCT00409838|11483379|FG001|Long-term Extension Period|Death|0
7269240|NCT00409838|11483378|FG000|Long-term Extension Period|Lack of Efficacy|2
7269241|NCT00409838|11483379|FG001|Long-term Extension Period|Lack of Efficacy|0
7269242|NCT00409838|11483378|FG000|Long-term Extension Period|Withdrawal by Subject|3
7269243|NCT00409838|11483379|FG001|Long-term Extension Period|Withdrawal by Subject|0
7269244|NCT00409838|11483378|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
7269245|NCT00409838|11483379|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
7269246|NCT00409838|11483378|FG000|Long-term Extension Period|Pregnancy|1
7269247|NCT00409838|11483379|FG001|Long-term Extension Period|Pregnancy|0
7269248|NCT00410046|11483402|FG000|Overall Study|Adverse Event|3
7269249|NCT00410046|11483402|FG000|Overall Study|Withdrawal by Subject|1
7269250|NCT00410046|11483402|FG000|Overall Study|Lost to Follow-up|1
7269251|NCT00410072|11483413|FG000|Day 1 to Week 48|Adverse Event|1
7269252|NCT00410072|11483414|FG001|Day 1 to Week 48|Adverse Event|2
7269253|NCT00410072|11483413|FG000|Day 1 to Week 48|Lost to Follow-up|5
7269254|NCT00410072|11483414|FG001|Day 1 to Week 48|Lost to Follow-up|2
7269255|NCT00410072|11483413|FG000|Day 1 to Week 48|Other|0
7269256|NCT00410072|11483414|FG001|Day 1 to Week 48|Other|1
7269257|NCT00410072|11483413|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
7269258|NCT00410072|11483414|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
7269259|NCT00410072|11483413|FG000|Day 1 to Week 48|Pregnancy|0
7269260|NCT00410072|11483414|FG001|Day 1 to Week 48|Pregnancy|2
7269261|NCT00410072|11483413|FG000|Day 1 to Week 48|Withdrawal by Subject|0
7269262|NCT00410072|11483414|FG001|Day 1 to Week 48|Withdrawal by Subject|2
7269263|NCT00410072|11483413|FG000|After Week 48 to Week 96|Adverse Event|1
7269264|NCT00410072|11483414|FG001|After Week 48 to Week 96|Adverse Event|2
7269265|NCT00410072|11483413|FG000|After Week 48 to Week 96|Death|0
7269266|NCT00410072|11483414|FG001|After Week 48 to Week 96|Death|1
7269267|NCT00410072|11483413|FG000|After Week 48 to Week 96|Lack of Efficacy|1
7269268|NCT00410072|11483414|FG001|After Week 48 to Week 96|Lack of Efficacy|0
7269269|NCT00410072|11483413|FG000|After Week 48 to Week 96|Lost to Follow-up|2
7269270|NCT00410072|11483414|FG001|After Week 48 to Week 96|Lost to Follow-up|4
7269271|NCT00410072|11483413|FG000|After Week 48 to Week 96|Other|2
7269272|NCT00410072|11483414|FG001|After Week 48 to Week 96|Other|0
7269273|NCT00410072|11483413|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
7269274|NCT00410072|11483414|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
7269275|NCT00410072|11483413|FG000|After Week 48 to Week 96|Pregnancy|0
7269276|NCT00410072|11483414|FG001|After Week 48 to Week 96|Pregnancy|2
7269277|NCT00410072|11483413|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
7269278|NCT00410072|11483414|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
7269279|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
7269280|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
7269281|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
7269282|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
7269283|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
7269284|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
7269285|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
7269286|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
7269287|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
7269288|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
7269289|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
7269290|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
7269291|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Death|7
7269292|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Death|4
7269293|NCT00410124|11483422|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
7269294|NCT00410124|11483423|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
7269295|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
7269296|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
7269297|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
7269298|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
7269299|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
7269300|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
7269301|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7269302|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
7269303|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Death|2
7269304|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Death|10
7269305|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
7269306|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
7269307|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
7269381|NCT00410384|11483485|FG000|Overall Study|Lost to Follow-up|4
7269308|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
7269309|NCT00410124|11483422|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
7269310|NCT00410124|11483423|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
7269311|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
7269312|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
7269313|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
7269314|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
7269315|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
7269316|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
7269317|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
7269318|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
7269319|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
7269320|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
7269321|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
7269322|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
7269323|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7269324|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
7269325|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
7269326|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
7269327|NCT00410163|11483444|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
7269328|NCT00410163|11483445|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
7269329|NCT00410163|11483444|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
7269330|NCT00410163|11483445|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
7269331|NCT00410163|11483444|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7269332|NCT00410163|11483445|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
7269333|NCT00410163|11483444|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
7269334|NCT00410163|11483445|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
7269335|NCT00410163|11483444|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
7269336|NCT00410163|11483445|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
7269337|NCT00410163|11483444|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
7269338|NCT00410163|11483445|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
7269339|NCT00410202|11483462|FG000|On-Treatment|Continuing treatment|69
7269340|NCT00410202|11483463|FG001|On-Treatment|Continuing treatment|71
7269341|NCT00410202|11483464|FG002|On-Treatment|Continuing treatment|66
7269342|NCT00410202|11483462|FG000|On-Treatment|Adverse Event|1
7269343|NCT00410202|11483463|FG001|On-Treatment|Adverse Event|3
7269344|NCT00410202|11483464|FG002|On-Treatment|Adverse Event|2
7269345|NCT00410202|11483462|FG000|On-Treatment|Death|1
7269346|NCT00410202|11483463|FG001|On-Treatment|Death|0
7269347|NCT00410202|11483464|FG002|On-Treatment|Death|0
7269348|NCT00410202|11483462|FG000|On-Treatment|Lost to Follow-up|1
7269349|NCT00410202|11483463|FG001|On-Treatment|Lost to Follow-up|0
7269350|NCT00410202|11483464|FG002|On-Treatment|Lost to Follow-up|1
7269351|NCT00410202|11483462|FG000|On-Treatment|Lack of Efficacy|1
7269352|NCT00410202|11483463|FG001|On-Treatment|Lack of Efficacy|4
7269353|NCT00410202|11483464|FG002|On-Treatment|Lack of Efficacy|0
7269354|NCT00410202|11483462|FG000|On-Treatment|Withdrawal by Subject|2
7269355|NCT00410202|11483463|FG001|On-Treatment|Withdrawal by Subject|1
7269356|NCT00410202|11483464|FG002|On-Treatment|Withdrawal by Subject|1
7269357|NCT00410202|11483462|FG000|On-Treatment|Other Reason|0
7269358|NCT00410202|11483463|FG001|On-Treatment|Other Reason|0
7269359|NCT00410202|11483464|FG002|On-Treatment|Other Reason|1
7269360|NCT00410202|11483462|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
7269361|NCT00410202|11483463|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
7269362|NCT00410202|11483464|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
7269363|NCT00410202|11483462|FG000|Off-treatment Follow up|Follow up not required per protocol|3
7269364|NCT00410202|11483463|FG001|Off-treatment Follow up|Follow up not required per protocol|0
7269365|NCT00410202|11483464|FG002|Off-treatment Follow up|Follow up not required per protocol|1
7269366|NCT00410202|11483462|FG000|Off-treatment Follow up|Lost to Follow-up|1
7269367|NCT00410202|11483463|FG001|Off-treatment Follow up|Lost to Follow-up|0
7549167|NCT02937701|11907212|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
7549168|NCT02937701|11907208|FG000|Day 1 to Week 22|Withdrawal by Subject|6
7269368|NCT00410202|11483464|FG002|Off-treatment Follow up|Lost to Follow-up|0
7269369|NCT00410384|11483485|FG000|Overall Study|Withdrawal by Subject|28
7269370|NCT00410384|11483486|FG001|Overall Study|Withdrawal by Subject|17
7269371|NCT00410384|11483487|FG002|Overall Study|Withdrawal by Subject|20
7269372|NCT00410384|11483485|FG000|Overall Study|Adverse Event|23
7269373|NCT00410384|11483486|FG001|Overall Study|Adverse Event|18
7269374|NCT00410384|11483487|FG002|Overall Study|Adverse Event|23
7269375|NCT00410384|11483485|FG000|Overall Study|Lack of Efficacy|20
7269376|NCT00410384|11483486|FG001|Overall Study|Lack of Efficacy|12
7269377|NCT00410384|11483487|FG002|Overall Study|Lack of Efficacy|17
7269378|NCT00410384|11483485|FG000|Overall Study|Lack of Compliance|2
7269379|NCT00410384|11483486|FG001|Overall Study|Lack of Compliance|2
7269380|NCT00410384|11483487|FG002|Overall Study|Lack of Compliance|2
7269382|NCT00410384|11483486|FG001|Overall Study|Lost to Follow-up|6
7269383|NCT00410384|11483487|FG002|Overall Study|Lost to Follow-up|6
7269384|NCT00410384|11483485|FG000|Overall Study|Protocol Violation|6
7269385|NCT00410384|11483486|FG001|Overall Study|Protocol Violation|6
7269386|NCT00410384|11483487|FG002|Overall Study|Protocol Violation|6
7269387|NCT00410384|11483485|FG000|Overall Study|Physician Decision|3
7269388|NCT00410384|11483486|FG001|Overall Study|Physician Decision|3
7269389|NCT00410384|11483487|FG002|Overall Study|Physician Decision|4
7269390|NCT00410384|11483485|FG000|Overall Study|Other|3
7269391|NCT00410384|11483486|FG001|Overall Study|Other|8
7269392|NCT00410384|11483487|FG002|Overall Study|Other|4
7269393|NCT00410410|11483501|FG000|Induction Period (IP)|Death|1
7269394|NCT00410410|11483502|FG001|Induction Period (IP)|Death|0
7269395|NCT00410410|11483503|FG002|Induction Period (IP)|Death|0
7269396|NCT00410410|11483504|FG003|Induction Period (IP)|Death|0
7269397|NCT00410410|11483505|FG004|Induction Period (IP)|Death|0
7269398|NCT00410410|11483506|FG005|Induction Period (IP)|Death|0
7269399|NCT00410410|11483507|FG006|Induction Period (IP)|Death|0
7269400|NCT00410410|11483508|FG007|Induction Period (IP)|Death|0
7269401|NCT00410410|11483509|FG008|Induction Period (IP)|Death|0
7269402|NCT00410410|11483501|FG000|Induction Period (IP)|Adverse Event|3
7269403|NCT00410410|11483502|FG001|Induction Period (IP)|Adverse Event|4
7269404|NCT00410410|11483503|FG002|Induction Period (IP)|Adverse Event|2
7269405|NCT00410410|11483504|FG003|Induction Period (IP)|Adverse Event|4
7269406|NCT00410410|11483505|FG004|Induction Period (IP)|Adverse Event|1
7269407|NCT00410410|11483506|FG005|Induction Period (IP)|Adverse Event|0
7269408|NCT00410410|11483507|FG006|Induction Period (IP)|Adverse Event|0
7269409|NCT00410410|11483508|FG007|Induction Period (IP)|Adverse Event|0
7269410|NCT00410410|11483509|FG008|Induction Period (IP)|Adverse Event|0
7269411|NCT00410410|11483501|FG000|Induction Period (IP)|Lack of Efficacy|26
7269412|NCT00410410|11483502|FG001|Induction Period (IP)|Lack of Efficacy|24
7269413|NCT00410410|11483503|FG002|Induction Period (IP)|Lack of Efficacy|8
7269414|NCT00410410|11483504|FG003|Induction Period (IP)|Lack of Efficacy|8
7269415|NCT00410410|11483505|FG004|Induction Period (IP)|Lack of Efficacy|7
7269416|NCT00410410|11483506|FG005|Induction Period (IP)|Lack of Efficacy|7
7269417|NCT00410410|11483507|FG006|Induction Period (IP)|Lack of Efficacy|0
7269418|NCT00410410|11483508|FG007|Induction Period (IP)|Lack of Efficacy|0
7269419|NCT00410410|11483509|FG008|Induction Period (IP)|Lack of Efficacy|0
7269420|NCT00410410|11483501|FG000|Induction Period (IP)|Lost to Follow-up|2
7269421|NCT00410410|11483502|FG001|Induction Period (IP)|Lost to Follow-up|2
7269422|NCT00410410|11483503|FG002|Induction Period (IP)|Lost to Follow-up|2
7269423|NCT00410410|11483504|FG003|Induction Period (IP)|Lost to Follow-up|3
7269424|NCT00410410|11483505|FG004|Induction Period (IP)|Lost to Follow-up|0
7269425|NCT00410410|11483506|FG005|Induction Period (IP)|Lost to Follow-up|1
7269426|NCT00410410|11483507|FG006|Induction Period (IP)|Lost to Follow-up|0
7269427|NCT00410410|11483508|FG007|Induction Period (IP)|Lost to Follow-up|0
7269428|NCT00410410|11483509|FG008|Induction Period (IP)|Lost to Follow-up|0
7269429|NCT00410410|11483501|FG000|Induction Period (IP)|Withdrawal by Subject|3
7269430|NCT00410410|11483502|FG001|Induction Period (IP)|Withdrawal by Subject|5
7269431|NCT00410410|11483503|FG002|Induction Period (IP)|Withdrawal by Subject|3
7269432|NCT00410410|11483504|FG003|Induction Period (IP)|Withdrawal by Subject|5
7269433|NCT00410410|11483505|FG004|Induction Period (IP)|Withdrawal by Subject|2
7269434|NCT00410410|11483506|FG005|Induction Period (IP)|Withdrawal by Subject|0
7269435|NCT00410410|11483507|FG006|Induction Period (IP)|Withdrawal by Subject|0
7269436|NCT00410410|11483508|FG007|Induction Period (IP)|Withdrawal by Subject|0
7269437|NCT00410410|11483509|FG008|Induction Period (IP)|Withdrawal by Subject|0
7269438|NCT00410410|11483501|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269439|NCT00410410|11483502|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269440|NCT00410410|11483503|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
7269441|NCT00410410|11483504|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269442|NCT00410410|11483505|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269443|NCT00410410|11483506|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269444|NCT00410410|11483507|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269445|NCT00410410|11483508|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269446|NCT00410410|11483509|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
7269447|NCT00410410|11483501|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
7269448|NCT00410410|11483502|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
7269449|NCT00410410|11483503|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
7269450|NCT00410410|11483504|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
7269451|NCT00410410|11483505|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
7549169|NCT02937701|11907209|FG001|Day 1 to Week 22|Withdrawal by Subject|6
7549170|NCT02937701|11907210|FG002|Day 1 to Week 22|Withdrawal by Subject|0
7549171|NCT02937701|11907211|FG003|Day 1 to Week 22|Withdrawal by Subject|0
7549172|NCT02937701|11907212|FG004|Day 1 to Week 22|Withdrawal by Subject|0
7549173|NCT02937701|11907208|FG000|Day 1 to Week 22|Death|1
7549174|NCT02937701|11907209|FG001|Day 1 to Week 22|Death|1
7549175|NCT02937701|11907210|FG002|Day 1 to Week 22|Death|0
7549176|NCT02937701|11907211|FG003|Day 1 to Week 22|Death|0
7549177|NCT02937701|11907212|FG004|Day 1 to Week 22|Death|0
7549178|NCT02937701|11907208|FG000|Day 1 to Week 22|Protocol Violation|1
7269452|NCT00410410|11483506|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
7269453|NCT00410410|11483507|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
7269454|NCT00410410|11483508|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
7269455|NCT00410410|11483509|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
7269456|NCT00410410|11483501|FG000|Induction Period (IP)|Other|0
7269457|NCT00410410|11483502|FG001|Induction Period (IP)|Other|0
7269458|NCT00410410|11483503|FG002|Induction Period (IP)|Other|1
7269459|NCT00410410|11483504|FG003|Induction Period (IP)|Other|0
7269460|NCT00410410|11483505|FG004|Induction Period (IP)|Other|0
7269461|NCT00410410|11483506|FG005|Induction Period (IP)|Other|0
7269462|NCT00410410|11483507|FG006|Induction Period (IP)|Other|0
7549179|NCT02937701|11907209|FG001|Day 1 to Week 22|Protocol Violation|1
7549180|NCT02937701|11907210|FG002|Day 1 to Week 22|Protocol Violation|0
7549181|NCT02937701|11907211|FG003|Day 1 to Week 22|Protocol Violation|0
7549182|NCT02937701|11907212|FG004|Day 1 to Week 22|Protocol Violation|0
7549183|NCT02937701|11907208|FG000|Day 1 to Week 22|Lost to Follow-up|1
7549184|NCT02937701|11907209|FG001|Day 1 to Week 22|Lost to Follow-up|1
7549185|NCT02937701|11907210|FG002|Day 1 to Week 22|Lost to Follow-up|0
7549186|NCT02937701|11907211|FG003|Day 1 to Week 22|Lost to Follow-up|0
7549187|NCT02937701|11907212|FG004|Day 1 to Week 22|Lost to Follow-up|0
7549188|NCT02937701|11907208|FG000|Day 1 to Week 22|Physician Decision|2
7549189|NCT02937701|11907209|FG001|Day 1 to Week 22|Physician Decision|0
7549190|NCT02937701|11907210|FG002|Day 1 to Week 22|Physician Decision|0
7549191|NCT02937701|11907211|FG003|Day 1 to Week 22|Physician Decision|0
7549192|NCT02937701|11907212|FG004|Day 1 to Week 22|Physician Decision|0
7549193|NCT02937701|11907208|FG000|Day 1 to Week 22|Other|1
7549194|NCT02937701|11907209|FG001|Day 1 to Week 22|Other|0
7549195|NCT02937701|11907210|FG002|Day 1 to Week 22|Other|0
7549196|NCT02937701|11907211|FG003|Day 1 to Week 22|Other|0
7549197|NCT02937701|11907212|FG004|Day 1 to Week 22|Other|0
7549198|NCT02937701|11907208|FG000|Week 22 to Week 50|Adverse Event|0
7549199|NCT02937701|11907209|FG001|Week 22 to Week 50|Adverse Event|0
7578014|NCT03920670|11968836|FG001|Overall Study|Protocol Violation|2
7578015|NCT03920670|11968835|FG000|Overall Study|Adverse Event|1
7578016|NCT03920670|11968836|FG001|Overall Study|Adverse Event|0
7578017|NCT03898063|11968857|FG000|Overall Study|Withdrawal by Subject|10
7578018|NCT03898063|11968858|FG001|Overall Study|Withdrawal by Subject|8
7578019|NCT03909100|11968904|FG000|Overall Study|Protocol Deviation|2
7578020|NCT03909100|11968904|FG000|Overall Study|Technical Problems|4
7578021|NCT03909100|11968904|FG000|Overall Study|Withdrawal by Subject|4
7578022|NCT03909100|11968904|FG000|Overall Study|Lost to Follow-up|1
7578023|NCT03909100|11968904|FG000|Overall Study|Reason not Specified|4
7578024|NCT03905642|11968911|FG000|Overall Study|Withdrawal by Subject|3
7578025|NCT03905642|11968911|FG000|Overall Study|Pregnancy|1
7578026|NCT03905642|11968911|FG000|Overall Study|Adverse Event|1
7578027|NCT03905642|11968911|FG000|Overall Study|Lack of Efficacy|1
7578028|NCT03905642|11968911|FG000|Overall Study|Completed study but not 24 of 28 days|2
7578029|NCT03892889|11968915|FG000|Overall Study|Adverse Event|17
7578030|NCT03892889|11968915|FG000|Overall Study|Lack of Efficacy|1
7578031|NCT03892889|11968915|FG000|Overall Study|Lost to Follow-up|46
7578032|NCT03892889|11968915|FG000|Overall Study|Non-compliance with study drug|22
7578033|NCT03892889|11968915|FG000|Overall Study|Pregnancy|1
7269463|NCT00410410|11483508|FG007|Induction Period (IP)|Other|0
7269464|NCT00410410|11483509|FG008|Induction Period (IP)|Other|0
7269465|NCT00410410|11483501|FG000|Maintenance Period (MP)|Death|0
7578034|NCT03892889|11968915|FG000|Overall Study|Protocol Deviation|3
7578035|NCT03892889|11968915|FG000|Overall Study|Withdrawal by Subject|50
7578036|NCT03892889|11968915|FG000|Overall Study|Withdrawal by Caregiver|1
7578037|NCT03892889|11968915|FG000|Overall Study|Study Terminated by Sponsor|50
7578038|NCT03892889|11968915|FG000|Overall Study|Physician Decision|8
7578039|NCT03892889|11968915|FG000|Overall Study|Reason not Specified|5
7578040|NCT03921723|11968919|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
7578041|NCT03921723|11968919|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
7578042|NCT03918239|11968963|FG000|Overall Study|Lost to Follow-up|3
7549200|NCT02937701|11907210|FG002|Week 22 to Week 50|Adverse Event|10
7549201|NCT02937701|11907211|FG003|Week 22 to Week 50|Adverse Event|3
7549202|NCT02937701|11907212|FG004|Week 22 to Week 50|Adverse Event|3
7578043|NCT03918239|11968964|FG001|Overall Study|Lost to Follow-up|1
7578044|NCT03918239|11968963|FG000|Overall Study|Pregnancy|0
7269466|NCT00410410|11483502|FG001|Maintenance Period (MP)|Death|0
7269467|NCT00410410|11483503|FG002|Maintenance Period (MP)|Death|0
7269468|NCT00410410|11483504|FG003|Maintenance Period (MP)|Death|0
7269469|NCT00410410|11483505|FG004|Maintenance Period (MP)|Death|0
7269470|NCT00410410|11483506|FG005|Maintenance Period (MP)|Death|0
7269471|NCT00410410|11483507|FG006|Maintenance Period (MP)|Death|1
7269472|NCT00410410|11483508|FG007|Maintenance Period (MP)|Death|0
7269473|NCT00410410|11483509|FG008|Maintenance Period (MP)|Death|0
7269474|NCT00410410|11483501|FG000|Maintenance Period (MP)|Adverse Event|0
7269475|NCT00410410|11483502|FG001|Maintenance Period (MP)|Adverse Event|0
7269476|NCT00410410|11483503|FG002|Maintenance Period (MP)|Adverse Event|0
7269477|NCT00410410|11483504|FG003|Maintenance Period (MP)|Adverse Event|0
7269478|NCT00410410|11483505|FG004|Maintenance Period (MP)|Adverse Event|0
7269479|NCT00410410|11483506|FG005|Maintenance Period (MP)|Adverse Event|0
7269480|NCT00410410|11483507|FG006|Maintenance Period (MP)|Adverse Event|1
7269481|NCT00410410|11483508|FG007|Maintenance Period (MP)|Adverse Event|3
7269482|NCT00410410|11483509|FG008|Maintenance Period (MP)|Adverse Event|0
7269483|NCT00410410|11483501|FG000|Maintenance Period (MP)|Lack of Efficacy|0
7269484|NCT00410410|11483502|FG001|Maintenance Period (MP)|Lack of Efficacy|0
7269485|NCT00410410|11483503|FG002|Maintenance Period (MP)|Lack of Efficacy|0
7269486|NCT00410410|11483504|FG003|Maintenance Period (MP)|Lack of Efficacy|0
7269487|NCT00410410|11483505|FG004|Maintenance Period (MP)|Lack of Efficacy|0
7269488|NCT00410410|11483506|FG005|Maintenance Period (MP)|Lack of Efficacy|0
7269489|NCT00410410|11483507|FG006|Maintenance Period (MP)|Lack of Efficacy|25
7269490|NCT00410410|11483508|FG007|Maintenance Period (MP)|Lack of Efficacy|24
7269491|NCT00410410|11483509|FG008|Maintenance Period (MP)|Lack of Efficacy|0
7269492|NCT00410410|11483501|FG000|Maintenance Period (MP)|Lost to Follow-up|0
7269493|NCT00410410|11483502|FG001|Maintenance Period (MP)|Lost to Follow-up|0
7269494|NCT00410410|11483503|FG002|Maintenance Period (MP)|Lost to Follow-up|0
7269495|NCT00410410|11483504|FG003|Maintenance Period (MP)|Lost to Follow-up|0
7269496|NCT00410410|11483505|FG004|Maintenance Period (MP)|Lost to Follow-up|0
7269497|NCT00410410|11483506|FG005|Maintenance Period (MP)|Lost to Follow-up|0
7269498|NCT00410410|11483507|FG006|Maintenance Period (MP)|Lost to Follow-up|1
7269499|NCT00410410|11483508|FG007|Maintenance Period (MP)|Lost to Follow-up|2
7269500|NCT00410410|11483509|FG008|Maintenance Period (MP)|Lost to Follow-up|0
7269501|NCT00410410|11483501|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
7269502|NCT00410410|11483502|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
7269503|NCT00410410|11483503|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
7269504|NCT00410410|11483504|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
7269505|NCT00410410|11483505|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
7269506|NCT00410410|11483506|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
7269507|NCT00410410|11483507|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
7269508|NCT00410410|11483508|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
7269509|NCT00410410|11483509|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
7269510|NCT00410410|11483501|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269511|NCT00410410|11483502|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269512|NCT00410410|11483503|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269513|NCT00410410|11483504|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269514|NCT00410410|11483505|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269515|NCT00410410|11483506|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7549203|NCT02937701|11907208|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7549204|NCT02937701|11907209|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
7549205|NCT02937701|11907210|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
7549206|NCT02937701|11907211|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
7549207|NCT02937701|11907212|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
7549208|NCT02937701|11907208|FG000|Week 22 to Week 50|Withdrawal by Subject|0
7549209|NCT02937701|11907209|FG001|Week 22 to Week 50|Withdrawal by Subject|0
7549210|NCT02937701|11907210|FG002|Week 22 to Week 50|Withdrawal by Subject|8
7549211|NCT02937701|11907211|FG003|Week 22 to Week 50|Withdrawal by Subject|2
7549212|NCT02937701|11907212|FG004|Week 22 to Week 50|Withdrawal by Subject|1
7549213|NCT02937701|11907208|FG000|Week 22 to Week 50|Lost to Follow-up|0
7549214|NCT02937701|11907209|FG001|Week 22 to Week 50|Lost to Follow-up|0
7549215|NCT02937701|11907210|FG002|Week 22 to Week 50|Lost to Follow-up|2
7549216|NCT02937701|11907211|FG003|Week 22 to Week 50|Lost to Follow-up|0
7549217|NCT02937701|11907212|FG004|Week 22 to Week 50|Lost to Follow-up|1
7549218|NCT02937701|11907208|FG000|Week 22 to Week 50|Physician Decision|0
7549219|NCT02937701|11907209|FG001|Week 22 to Week 50|Physician Decision|0
7549220|NCT02937701|11907210|FG002|Week 22 to Week 50|Physician Decision|2
7549221|NCT02937701|11907211|FG003|Week 22 to Week 50|Physician Decision|0
7549222|NCT02937701|11907212|FG004|Week 22 to Week 50|Physician Decision|1
7549223|NCT02937701|11907208|FG000|Week 22 to Week 50|Other|0
7549224|NCT02937701|11907209|FG001|Week 22 to Week 50|Other|0
7549225|NCT02937701|11907210|FG002|Week 22 to Week 50|Other|0
7549226|NCT02937701|11907211|FG003|Week 22 to Week 50|Other|0
7549227|NCT02937701|11907212|FG004|Week 22 to Week 50|Other|1
7549228|NCT02937740|11907226|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
7549229|NCT02937740|11907227|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
7549230|NCT02937740|11907226|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
7549231|NCT02937740|11907227|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
7388225|NCT01218126|11647006|FG000|Overall Study|Adverse Event|8
7269516|NCT00410410|11483507|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
7269517|NCT00410410|11483508|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
7269518|NCT00410410|11483509|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
7269519|NCT00410410|11483501|FG000|Open-Label Period (OL)|Death|0
7269520|NCT00410410|11483502|FG001|Open-Label Period (OL)|Death|0
7269521|NCT00410410|11483503|FG002|Open-Label Period (OL)|Death|0
7269522|NCT00410410|11483504|FG003|Open-Label Period (OL)|Death|0
7269523|NCT00410410|11483505|FG004|Open-Label Period (OL)|Death|0
7269524|NCT00410410|11483506|FG005|Open-Label Period (OL)|Death|0
7269525|NCT00410410|11483507|FG006|Open-Label Period (OL)|Death|0
7269526|NCT00410410|11483508|FG007|Open-Label Period (OL)|Death|0
7269527|NCT00410410|11483509|FG008|Open-Label Period (OL)|Death|1
7269528|NCT00410410|11483501|FG000|Open-Label Period (OL)|Adverse Event|0
7269529|NCT00410410|11483502|FG001|Open-Label Period (OL)|Adverse Event|0
7269530|NCT00410410|11483503|FG002|Open-Label Period (OL)|Adverse Event|0
7269531|NCT00410410|11483504|FG003|Open-Label Period (OL)|Adverse Event|0
7269532|NCT00410410|11483505|FG004|Open-Label Period (OL)|Adverse Event|0
7269533|NCT00410410|11483506|FG005|Open-Label Period (OL)|Adverse Event|0
7269534|NCT00410410|11483507|FG006|Open-Label Period (OL)|Adverse Event|0
7269535|NCT00410410|11483508|FG007|Open-Label Period (OL)|Adverse Event|0
7269536|NCT00410410|11483509|FG008|Open-Label Period (OL)|Adverse Event|10
7269537|NCT00410410|11483501|FG000|Open-Label Period (OL)|Lack of Efficacy|0
7269538|NCT00410410|11483502|FG001|Open-Label Period (OL)|Lack of Efficacy|0
7269539|NCT00410410|11483503|FG002|Open-Label Period (OL)|Lack of Efficacy|0
7269540|NCT00410410|11483504|FG003|Open-Label Period (OL)|Lack of Efficacy|0
7269541|NCT00410410|11483505|FG004|Open-Label Period (OL)|Lack of Efficacy|0
7269542|NCT00410410|11483506|FG005|Open-Label Period (OL)|Lack of Efficacy|0
7269543|NCT00410410|11483507|FG006|Open-Label Period (OL)|Lack of Efficacy|0
7269544|NCT00410410|11483508|FG007|Open-Label Period (OL)|Lack of Efficacy|0
7269545|NCT00410410|11483509|FG008|Open-Label Period (OL)|Lack of Efficacy|161
7269546|NCT00410410|11483501|FG000|Open-Label Period (OL)|Lost to Follow-up|0
7269547|NCT00410410|11483502|FG001|Open-Label Period (OL)|Lost to Follow-up|0
7269548|NCT00410410|11483503|FG002|Open-Label Period (OL)|Lost to Follow-up|0
7269549|NCT00410410|11483504|FG003|Open-Label Period (OL)|Lost to Follow-up|0
7269550|NCT00410410|11483505|FG004|Open-Label Period (OL)|Lost to Follow-up|0
7269551|NCT00410410|11483506|FG005|Open-Label Period (OL)|Lost to Follow-up|0
7269552|NCT00410410|11483507|FG006|Open-Label Period (OL)|Lost to Follow-up|0
7269553|NCT00410410|11483508|FG007|Open-Label Period (OL)|Lost to Follow-up|0
7269554|NCT00410410|11483509|FG008|Open-Label Period (OL)|Lost to Follow-up|4
7269555|NCT00410410|11483501|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
7269556|NCT00410410|11483502|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
7269557|NCT00410410|11483503|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
7269558|NCT00410410|11483504|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
7269559|NCT00410410|11483505|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
7269560|NCT00410410|11483506|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
7269561|NCT00410410|11483507|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
7269562|NCT00410410|11483508|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
7269563|NCT00410410|11483509|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
7269564|NCT00410410|11483501|FG000|Open-Label Period (OL)|Pregnancy|0
7269565|NCT00410410|11483502|FG001|Open-Label Period (OL)|Pregnancy|0
7269566|NCT00410410|11483503|FG002|Open-Label Period (OL)|Pregnancy|0
7269567|NCT00410410|11483504|FG003|Open-Label Period (OL)|Pregnancy|0
7269568|NCT00410410|11483505|FG004|Open-Label Period (OL)|Pregnancy|0
7269569|NCT00410410|11483506|FG005|Open-Label Period (OL)|Pregnancy|0
7269570|NCT00410410|11483507|FG006|Open-Label Period (OL)|Pregnancy|0
7269571|NCT00410410|11483508|FG007|Open-Label Period (OL)|Pregnancy|0
7269572|NCT00410410|11483509|FG008|Open-Label Period (OL)|Pregnancy|1
7269573|NCT00410410|11483501|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269574|NCT00410410|11483502|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269575|NCT00410410|11483503|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269576|NCT00410410|11483504|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269577|NCT00410410|11483505|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269578|NCT00410410|11483506|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269579|NCT00410410|11483507|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7549232|NCT02937740|11907226|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
7549233|NCT02937740|11907227|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
7549234|NCT02937740|11907226|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
7549235|NCT02937740|11907227|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
7549236|NCT02937740|11907226|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
7549237|NCT02937740|11907227|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
7549238|NCT02937740|11907226|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
7549239|NCT02937740|11907227|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
7549240|NCT02937870|11907239|FG000|Overall Study|Adverse Event|1
7269580|NCT00410410|11483508|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
7269581|NCT00410410|11483509|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
7269582|NCT00410410|11483501|FG000|Open-Label Period (OL)|Other|0
7269583|NCT00410410|11483502|FG001|Open-Label Period (OL)|Other|0
7269584|NCT00410410|11483503|FG002|Open-Label Period (OL)|Other|0
7269585|NCT00410410|11483504|FG003|Open-Label Period (OL)|Other|0
7269586|NCT00410410|11483505|FG004|Open-Label Period (OL)|Other|0
7269587|NCT00410410|11483506|FG005|Open-Label Period (OL)|Other|0
7269588|NCT00410410|11483507|FG006|Open-Label Period (OL)|Other|0
7269589|NCT00410410|11483508|FG007|Open-Label Period (OL)|Other|0
7269590|NCT00410410|11483509|FG008|Open-Label Period (OL)|Other|7
7269591|NCT00410514|11483565|FG000|Overall Study|Adverse Event|2
7269592|NCT00410514|11483566|FG001|Overall Study|Adverse Event|2
7269593|NCT00410514|11483567|FG002|Overall Study|Adverse Event|2
7269594|NCT00410514|11483565|FG000|Overall Study|Protocol Violation|0
7269595|NCT00410514|11483566|FG001|Overall Study|Protocol Violation|1
7269596|NCT00410514|11483567|FG002|Overall Study|Protocol Violation|1
7269597|NCT00410514|11483565|FG000|Overall Study|Lost to Follow-up|0
7269598|NCT00410514|11483566|FG001|Overall Study|Lost to Follow-up|0
7269599|NCT00410514|11483567|FG002|Overall Study|Lost to Follow-up|2
7269600|NCT00410514|11483565|FG000|Overall Study|Non-compliant with study procedures|0
7269601|NCT00410514|11483566|FG001|Overall Study|Non-compliant with study procedures|0
7269602|NCT00410514|11483567|FG002|Overall Study|Non-compliant with study procedures|2
7549241|NCT02937870|11907239|FG000|Overall Study|Protocol Deviation|2
7578045|NCT03918239|11968964|FG001|Overall Study|Pregnancy|2
7578046|NCT03918239|11968963|FG000|Overall Study|Withdrawal by Subject|3
7578047|NCT03918239|11968964|FG001|Overall Study|Withdrawal by Subject|3
7578048|NCT03918239|11968963|FG000|Overall Study|positive urine drug screening results|4
7578049|NCT03918239|11968964|FG001|Overall Study|positive urine drug screening results|1
7578050|NCT03917823|11968972|FG000|Overall Study|Lost to Follow-up|1
7578051|NCT03917823|11968973|FG001|Overall Study|Lost to Follow-up|1
7578052|NCT03917823|11968972|FG000|Overall Study|Withdrawal by Subject|0
7578053|NCT03917823|11968973|FG001|Overall Study|Withdrawal by Subject|1
7578054|NCT03902613|11968994|FG000|Overall Study|Physician Decision|1
7578055|NCT03902574|11969001|FG000|Overall Study|Urinary drug test was positive on Day 20|0
7578056|NCT03902574|11969002|FG001|Overall Study|Urinary drug test was positive on Day 20|0
7578057|NCT03902574|11969003|FG002|Overall Study|Urinary drug test was positive on Day 20|1
7578058|NCT03914950|11969011|FG000|Overall Study|Physician Decision|54
7578059|NCT03911843|11969023|FG000|Overall Study|Adverse Event|2
7578060|NCT03911843|11969024|FG001|Overall Study|Adverse Event|0
7578061|NCT03911843|11969023|FG000|Overall Study|Protocol Violation|2
7578062|NCT03911843|11969024|FG001|Overall Study|Protocol Violation|0
7578063|NCT03911843|11969023|FG000|Overall Study|Lost to Follow-up|0
7578064|NCT03911843|11969024|FG001|Overall Study|Lost to Follow-up|1
7578065|NCT03894813|11969041|FG000|Overall Study|Adverse Event|1
7578066|NCT03894813|11969042|FG001|Overall Study|Adverse Event|1
7578067|NCT03894813|11969041|FG000|Overall Study|Lack of Efficacy|3
7578068|NCT03894813|11969042|FG001|Overall Study|Lack of Efficacy|3
7578069|NCT03894813|11969041|FG000|Overall Study|Lost to Follow-up|1
7578070|NCT03894813|11969042|FG001|Overall Study|Lost to Follow-up|0
7578071|NCT03894813|11969041|FG000|Overall Study|Pregnancy|2
7578072|NCT03894813|11969042|FG001|Overall Study|Pregnancy|1
7578073|NCT03894813|11969041|FG000|Overall Study|Protocol Violation|3
7578074|NCT03894813|11969042|FG001|Overall Study|Protocol Violation|7
7578075|NCT03894813|11969041|FG000|Overall Study|Withdrawal by Subject|1
7578076|NCT03894813|11969042|FG001|Overall Study|Withdrawal by Subject|3
7578077|NCT03894813|11969041|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
7578078|NCT03894813|11969042|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
7578079|NCT03911960|11969050|FG000|Overall Study|Lost to Follow-up|5
7578080|NCT03911960|11969051|FG001|Overall Study|Lost to Follow-up|3
7578081|NCT03907072|11969061|FG000|Overall Study|Study Terminated by Sponsor|2
7578082|NCT03907072|11969062|FG001|Overall Study|Study Terminated by Sponsor|2
7578083|NCT03907072|11969063|FG002|Overall Study|Study Terminated by Sponsor|2
7578084|NCT03911401|11969083|FG000|Overall Study|Adverse Event|1
7578085|NCT03911401|11969084|FG001|Overall Study|Adverse Event|2
7578086|NCT03911401|11969085|FG002|Overall Study|Adverse Event|5
7578087|NCT03911401|11969083|FG000|Overall Study|Lack of Efficacy|1
7578088|NCT03911401|11969084|FG001|Overall Study|Lack of Efficacy|1
7578089|NCT03911401|11969085|FG002|Overall Study|Lack of Efficacy|8
7578090|NCT03911401|11969083|FG000|Overall Study|Physician Decision|0
7578091|NCT03911401|11969084|FG001|Overall Study|Physician Decision|0
7578092|NCT03911401|11969085|FG002|Overall Study|Physician Decision|1
7578093|NCT03911401|11969083|FG000|Overall Study|Withdrawal by Subject|1
7578094|NCT03911401|11969084|FG001|Overall Study|Withdrawal by Subject|2
7578095|NCT03911401|11969085|FG002|Overall Study|Withdrawal by Subject|0
7578096|NCT03911401|11969083|FG000|Overall Study|Withdrawal by parent/guardian|4
7578097|NCT03911401|11969084|FG001|Overall Study|Withdrawal by parent/guardian|4
7578098|NCT03911401|11969085|FG002|Overall Study|Withdrawal by parent/guardian|11
7578099|NCT03904420|11969112|FG000|Overall Study|Study terminated|2
7578100|NCT03904420|11969113|FG001|Overall Study|Study terminated|2
7578101|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
7269603|NCT00410605|11483575|FG000|Overall Study|Adverse Event|12
7269604|NCT00410605|11483575|FG000|Overall Study|Physician Decision|3
7269605|NCT00410605|11483575|FG000|Overall Study|Withdrawal by Subject|5
7269606|NCT00410605|11483575|FG000|Overall Study|Started Non-Protocol Therapy|3
7269607|NCT00410605|11483575|FG000|Overall Study|Stopped treatmen to collect stem cells|1
7578102|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
7578103|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
7578104|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
7269608|NCT00410605|11483575|FG000|Overall Study|Transferred to another Institution|1
7269609|NCT00410761|11483581|FG000|Overall Study|Adverse Event|29
7269610|NCT00410761|11483582|FG001|Overall Study|Adverse Event|3
7269611|NCT00410761|11483581|FG000|Overall Study|objective disease progression|71
7269612|NCT00410761|11483582|FG001|Overall Study|objective disease progression|55
7549242|NCT02938585|11907302|FG000|Overall Study|Withdrawal by parent or guardian|0
7549243|NCT02938585|11907303|FG001|Overall Study|Withdrawal by parent or guardian|1
7549244|NCT02938585|11907304|FG002|Overall Study|Withdrawal by parent or guardian|0
7549245|NCT02938585|11907305|FG003|Overall Study|Withdrawal by parent or guardian|0
7549246|NCT02938585|11907302|FG000|Overall Study|Withdrawal by Subject|0
7549247|NCT02938585|11907303|FG001|Overall Study|Withdrawal by Subject|0
7549248|NCT02938585|11907304|FG002|Overall Study|Withdrawal by Subject|0
7549249|NCT02938585|11907305|FG003|Overall Study|Withdrawal by Subject|5
7549250|NCT02939014|11907340|FG000|Overall Study|Lost to Follow-up|1
7549251|NCT02939014|11907341|FG001|Overall Study|Lost to Follow-up|0
7549252|NCT02939014|11907340|FG000|Overall Study|Death|4
7549253|NCT02939014|11907341|FG001|Overall Study|Death|3
7549254|NCT02939079|11907350|FG000|Overall Study|Adverse Event|2
7549255|NCT02939079|11907351|FG001|Overall Study|Adverse Event|1
7549256|NCT02939079|11907350|FG000|Overall Study|Lost to Follow-up|0
7549257|NCT02939079|11907351|FG001|Overall Study|Lost to Follow-up|2
7549258|NCT02939079|11907350|FG000|Overall Study|Protocol Violation|1
7549259|NCT02939079|11907351|FG001|Overall Study|Protocol Violation|0
7549260|NCT02939079|11907350|FG000|Overall Study|Withdrawal by Subject|0
7549261|NCT02939079|11907351|FG001|Overall Study|Withdrawal by Subject|1
7549262|NCT02939079|11907350|FG000|Overall Study|relapse during the study|1
7549263|NCT02939079|11907351|FG001|Overall Study|relapse during the study|1
7269613|NCT00410761|11483581|FG000|Overall Study|Withdrawal by Subject|8
7269614|NCT00410761|11483582|FG001|Overall Study|Withdrawal by Subject|4
7269615|NCT00410761|11483581|FG000|Overall Study|Other|12
7269616|NCT00410761|11483582|FG001|Overall Study|Other|9
7269617|NCT00410761|11483581|FG000|Overall Study|Never received randomised treatment|0
7269618|NCT00410761|11483582|FG001|Overall Study|Never received randomised treatment|1
7549264|NCT02939131|11907364|FG000|Overall Study|Unable to get to clinic|6
7549265|NCT02939131|11907365|FG001|Overall Study|Unable to get to clinic|4
7549266|NCT02939131|11907364|FG000|Overall Study|Lost to Follow-up|2
7549267|NCT02939131|11907365|FG001|Overall Study|Lost to Follow-up|4
7549268|NCT02939131|11907364|FG000|Overall Study|severe debilitation|1
7549269|NCT02939131|11907365|FG001|Overall Study|severe debilitation|0
7578105|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
7578106|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
7578107|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
7578108|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
7578109|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578110|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578111|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578112|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578113|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7578114|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
7578115|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578116|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
7578117|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578118|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578119|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578120|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578121|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578122|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
7578123|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7578124|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
7578125|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
7578126|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
7578127|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
7578128|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
7578129|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
7578130|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
7578131|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
7578132|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
7578133|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
7578134|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
7269619|NCT00410813|11483590|FG000|Overall Study|Adverse Event|6
7269620|NCT00410813|11483591|FG001|Overall Study|Adverse Event|11
7269621|NCT00410813|11483590|FG000|Overall Study|Progression|32
7269622|NCT00410813|11483591|FG001|Overall Study|Progression|21
7269623|NCT00410813|11483590|FG000|Overall Study|Not protocol specified|3
7269624|NCT00410813|11483591|FG001|Overall Study|Not protocol specified|4
7549270|NCT02939131|11907364|FG000|Overall Study|Other|0
7549271|NCT02939131|11907365|FG001|Overall Study|Other|1
7549272|NCT02939131|11907364|FG000|Overall Study|not willing to adhere to protocol|2
7578135|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
7578136|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
7269625|NCT00410813|11483590|FG000|Overall Study|Ineligible|2
7269626|NCT00410813|11483591|FG001|Overall Study|Ineligible|4
7269627|NCT00410813|11483590|FG000|Overall Study|Death|0
7269628|NCT00410813|11483591|FG001|Overall Study|Death|2
7269629|NCT00411151|11483647|FG000|Overall Study|Death|38
7269630|NCT00411151|11483647|FG000|Overall Study|Withdrawal by Subject|2
7269631|NCT00411151|11483647|FG000|Overall Study|Lost to Follow-up|2
7269632|NCT00411151|11483647|FG000|Overall Study|Protocol Violation|1
7269633|NCT00411151|11483647|FG000|Overall Study|Trial prematurely closed|4
7269634|NCT00411216|11483653|FG000|Overall Study|Ten participants were entered into the c|0
7269635|NCT00411216|11483654|FG001|Overall Study|Ten participants were entered into the c|2
7269636|NCT00411450|11483674|FG000|Overall Study|Ongoing at time of data cut-off.|3
7269637|NCT00411554|11483694|FG000|Overall Study|Adverse Event|2
7269638|NCT00411554|11483695|FG001|Overall Study|Adverse Event|4
7269639|NCT00411554|11483694|FG000|Overall Study|Lack of Efficacy|2
7269640|NCT00411554|11483695|FG001|Overall Study|Lack of Efficacy|5
7269641|NCT00411554|11483694|FG000|Overall Study|Withdrawal by Subject|3
7269642|NCT00411554|11483695|FG001|Overall Study|Withdrawal by Subject|0
7269643|NCT00411554|11483694|FG000|Overall Study|Patient Moved|1
7269644|NCT00411554|11483695|FG001|Overall Study|Patient Moved|0
7269645|NCT00411632|11483706|FG000|Overall Study|Death|1
7269646|NCT00411645|11483712|FG000|Overall Study|Consent Withdrawn|13
7269647|NCT00411645|11483713|FG001|Overall Study|Consent Withdrawn|22
7269648|NCT00411645|11483712|FG000|Overall Study|Death|56
7269649|NCT00411645|11483713|FG001|Overall Study|Death|135
7269650|NCT00411645|11483712|FG000|Overall Study|Investigator/Sponsor Decision|10
7269651|NCT00411645|11483713|FG001|Overall Study|Investigator/Sponsor Decision|7
7269652|NCT00411645|11483712|FG000|Overall Study|Lost to Follow-up|2
7269653|NCT00411645|11483713|FG001|Overall Study|Lost to Follow-up|0
7269654|NCT00411671|11483720|FG000|Overall Study|Adverse Event|15
7269655|NCT00411671|11483720|FG000|Overall Study|Death|2
7269656|NCT00411671|11483720|FG000|Overall Study|Lost to Follow-up|3
7269657|NCT00411762|11483741|FG000|Overall Study|Withdrawal by Subject|5
7269658|NCT00411788|11483745|FG000|Overall Study|Protocol Violation|1
7269659|NCT00411788|11483745|FG000|Overall Study|Adverse Event|1
7269660|NCT00412061|11483751|FG000|Double Blind Phase|Disease Progression|101
7269661|NCT00412061|11483752|FG001|Double Blind Phase|Disease Progression|154
7269662|NCT00412061|11483751|FG000|Double Blind Phase|Adverse Event|61
7269663|NCT00412061|11483752|FG001|Double Blind Phase|Adverse Event|16
7269664|NCT00412061|11483751|FG000|Double Blind Phase|Final Primary Analysis|26
7269665|NCT00412061|11483752|FG001|Double Blind Phase|Final Primary Analysis|14
7269666|NCT00412061|11483751|FG000|Double Blind Phase|Withdrawal by Subject|18
7269667|NCT00412061|11483752|FG001|Double Blind Phase|Withdrawal by Subject|20
7269668|NCT00412061|11483751|FG000|Double Blind Phase|Death|6
7269669|NCT00412061|11483752|FG001|Double Blind Phase|Death|3
7269670|NCT00412061|11483751|FG000|Double Blind Phase|Protocol Violation|3
7269671|NCT00412061|11483752|FG001|Double Blind Phase|Protocol Violation|4
7269672|NCT00412061|11483751|FG000|Double Blind Phase|New Cander Therapy|1
7549273|NCT02939131|11907365|FG001|Overall Study|not willing to adhere to protocol|0
7549274|NCT02939560|11907415|FG000|Overall Study|Withdrawal by Subject|2
7549275|NCT02939560|11907415|FG000|Overall Study|Protocol Violation|1
7549276|NCT02939599|11907421|FG000|Overall Study|Adverse Event|1
7549277|NCT02939599|11907422|FG001|Overall Study|Adverse Event|0
7549278|NCT02939599|11907421|FG000|Overall Study|Study Terminated By Sponsor|2
7549279|NCT02939599|11907422|FG001|Overall Study|Study Terminated By Sponsor|2
7549280|NCT02939716|11907433|FG000|Overall Study|scanner failure|0
7549281|NCT02939716|11907434|FG001|Overall Study|scanner failure|0
7549282|NCT02939716|11907435|FG002|Overall Study|scanner failure|0
7549283|NCT02939716|11907436|FG003|Overall Study|scanner failure|1
7549284|NCT02939716|11907437|FG004|Overall Study|scanner failure|1
7549285|NCT02939716|11907438|FG005|Overall Study|scanner failure|1
7549286|NCT02939781|11907455|FG000|Overall Study|Protocol Violation|8
7549287|NCT02939781|11907455|FG000|Overall Study|Withdrawal by Subject|1
7549288|NCT02939937|11907462|FG000|Overall Study|Adverse Event|5
7549289|NCT02939937|11907463|FG001|Overall Study|Adverse Event|0
7549290|NCT02939937|11907462|FG000|Overall Study|Lost to Follow-up|1
7549291|NCT02939937|11907463|FG001|Overall Study|Lost to Follow-up|3
7549292|NCT02939950|11907471|FG000|Overall Study|Lost to Follow-up|13
7549293|NCT02939950|11907472|FG001|Overall Study|Lost to Follow-up|16
7549294|NCT02939950|11907471|FG000|Overall Study|Positive slit lamp findings|0
7549295|NCT02939950|11907472|FG001|Overall Study|Positive slit lamp findings|1
7269673|NCT00412061|11483752|FG001|Double Blind Phase|New Cander Therapy|1
7269674|NCT00412061|11483751|FG000|Double Blind Phase|Lost to Follow-up|0
7269675|NCT00412061|11483752|FG001|Double Blind Phase|Lost to Follow-up|1
7269676|NCT00412061|11483751|FG000|Open Label Phase|Disease Progression|0
7269677|NCT00412061|11483752|FG001|Open Label Phase|Disease Progression|86
7269678|NCT00412061|11483751|FG000|Open Label Phase|Adverse Event|0
7269679|NCT00412061|11483752|FG001|Open Label Phase|Adverse Event|46
7269680|NCT00412061|11483751|FG000|Open Label Phase|Withdrawal by Subject|0
7549296|NCT02939950|11907471|FG000|Overall Study|Chalazion upper lid|0
7549297|NCT02939950|11907472|FG001|Overall Study|Chalazion upper lid|1
7549298|NCT02939950|11907471|FG000|Overall Study|Lack of motivation|0
7549299|NCT02939950|11907472|FG001|Overall Study|Lack of motivation|2
7549300|NCT02939950|11907471|FG000|Overall Study|Unacceptable distance lens visual acuity|1
7549301|NCT02939950|11907472|FG001|Overall Study|Unacceptable distance lens visual acuity|1
7269681|NCT00412061|11483752|FG001|Open Label Phase|Withdrawal by Subject|15
7269682|NCT00412061|11483751|FG000|Open Label Phase|Administrative Problems|0
7269683|NCT00412061|11483752|FG001|Open Label Phase|Administrative Problems|13
7269684|NCT00412061|11483751|FG000|Open Label Phase|Death|0
7269685|NCT00412061|11483752|FG001|Open Label Phase|Death|7
7269686|NCT00412061|11483751|FG000|Open Label Phase|Lost to Follow-up|0
7269687|NCT00412061|11483752|FG001|Open Label Phase|Lost to Follow-up|2
7269688|NCT00412061|11483751|FG000|Open Label Phase|New Cancer Therapy|0
7269689|NCT00412061|11483752|FG001|Open Label Phase|New Cancer Therapy|1
7269690|NCT00412113|11483788|FG000|Overall Study|Adverse Event|11
7269691|NCT00412113|11483789|FG001|Overall Study|Adverse Event|15
7269692|NCT00412113|11483788|FG000|Overall Study|did not receive treatment|1
7269693|NCT00412113|11483789|FG001|Overall Study|did not receive treatment|0
7269694|NCT00412217|11483797|FG000|Overall Study|Insufficient Data Available|8
7269695|NCT00412217|11483798|FG001|Overall Study|Insufficient Data Available|3
7269696|NCT00412217|11483797|FG000|Overall Study|Death|5
7269697|NCT00412217|11483798|FG001|Overall Study|Death|4
7269698|NCT00412217|11483797|FG000|Overall Study|Disease Progression|2
7549302|NCT02939950|11907471|FG000|Overall Study|Military orders|1
7549303|NCT02939950|11907472|FG001|Overall Study|Military orders|0
7549304|NCT02939950|11907471|FG000|Overall Study|Participant Relocated|5
7549305|NCT02939950|11907472|FG001|Overall Study|Participant Relocated|3
7549306|NCT02939950|11907471|FG000|Overall Study|Study related symptoms|8
7549307|NCT02939950|11907472|FG001|Overall Study|Study related symptoms|8
7549308|NCT02939950|11907471|FG000|Overall Study|Unacceptable lens movement|2
7549309|NCT02939950|11907472|FG001|Overall Study|Unacceptable lens movement|0
7549310|NCT02939950|11907471|FG000|Overall Study|Protocol Violation|6
7549311|NCT02939950|11907472|FG001|Overall Study|Protocol Violation|3
7549312|NCT02939950|11907471|FG000|Overall Study|Physician Decision|2
7549313|NCT02939950|11907472|FG001|Overall Study|Physician Decision|0
7549314|NCT02939950|11907471|FG000|Overall Study|Pregnancy|6
7549315|NCT02939950|11907472|FG001|Overall Study|Pregnancy|7
7549316|NCT02939950|11907471|FG000|Overall Study|Withdrawal by Subject|12
7549317|NCT02939950|11907472|FG001|Overall Study|Withdrawal by Subject|28
7549318|NCT02939950|11907471|FG000|Overall Study|Adverse Event|7
7549319|NCT02939950|11907472|FG001|Overall Study|Adverse Event|3
7549320|NCT02939950|11907471|FG000|Overall Study|Randomized, not dispensed|1
7549321|NCT02939950|11907472|FG001|Overall Study|Randomized, not dispensed|0
7549322|NCT02939950|11907471|FG000|Overall Study|Ineligible at Baseline|2
7549323|NCT02939950|11907472|FG001|Overall Study|Ineligible at Baseline|8
7549324|NCT02940392|11907493|FG000|Overall Study|Lost to Follow-up|3
7549325|NCT02940392|11907493|FG000|Overall Study|Retreatment|3
7549326|NCT02940392|11907493|FG000|Overall Study|Death|2
7549327|NCT02940574|11907499|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
7549328|NCT02940574|11907500|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
7549329|NCT02940574|11907499|FG000|1-year Follow-up|Lost to Follow-up|3
7549330|NCT02940574|11907500|FG001|1-year Follow-up|Lost to Follow-up|4
7578137|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
7578138|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
7578139|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
7578140|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
7578141|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
7578142|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
7578143|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
7578144|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
7578145|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
7578146|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
7578147|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
7578148|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
7578149|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7578150|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
7578151|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7578152|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7578153|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
7578154|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
7578155|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7578156|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
7578157|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
7578158|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7578159|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7269699|NCT00412217|11483798|FG001|Overall Study|Disease Progression|3
7269700|NCT00412217|11483797|FG000|Overall Study|Investigator Decision|1
7269701|NCT00412217|11483798|FG001|Overall Study|Investigator Decision|0
7269702|NCT00412217|11483797|FG000|Overall Study|Withdrawal by Subject|2
7549331|NCT02940626|11907512|FG000|Overall Study|Death|40
7549332|NCT02940626|11907513|FG001|Overall Study|Death|32
7549333|NCT02940626|11907512|FG000|Overall Study|Lost to Follow-up|5
7549334|NCT02940626|11907513|FG001|Overall Study|Lost to Follow-up|2
7549335|NCT02940626|11907512|FG000|Overall Study|Withdrawal by Subject|1
7549336|NCT02940626|11907513|FG001|Overall Study|Withdrawal by Subject|0
7549337|NCT02940626|11907512|FG000|Overall Study|Transfer to Hospice Care|1
7269703|NCT00412217|11483798|FG001|Overall Study|Withdrawal by Subject|0
7269704|NCT00412217|11483797|FG000|Overall Study|Lost to Follow-up|1
7269705|NCT00412217|11483798|FG001|Overall Study|Lost to Follow-up|4
7269706|NCT00412217|11483797|FG000|Overall Study|Study Terminated by Sponsor|26
7269707|NCT00412217|11483798|FG001|Overall Study|Study Terminated by Sponsor|33
7269708|NCT00412217|11483797|FG000|Overall Study|Other|1
7269709|NCT00412217|11483798|FG001|Overall Study|Other|1
7269710|NCT00412360|11483810|FG000|Overall Study|Lost to Follow-up|0
7269711|NCT00412360|11483811|FG001|Overall Study|Lost to Follow-up|1
7269712|NCT00412360|11483810|FG000|Overall Study|Not Transplanted|1
7269713|NCT00412360|11483811|FG001|Overall Study|Not Transplanted|2
7269714|NCT00412373|11483819|FG000|Overall Study|Adverse Event|8
7269715|NCT00412373|11483820|FG001|Overall Study|Adverse Event|13
7269716|NCT00412373|11483819|FG000|Overall Study|Lack of Efficacy|16
7269717|NCT00412373|11483820|FG001|Overall Study|Lack of Efficacy|22
7269718|NCT00412373|11483819|FG000|Overall Study|Lost to Follow-up|7
7269719|NCT00412373|11483820|FG001|Overall Study|Lost to Follow-up|13
7269720|NCT00412373|11483819|FG000|Overall Study|Withdrawal by Subject|8
7269721|NCT00412373|11483820|FG001|Overall Study|Withdrawal by Subject|27
7269722|NCT00412373|11483819|FG000|Overall Study|Other|2
7269723|NCT00412373|11483820|FG001|Overall Study|Other|2
7549338|NCT02940626|11907513|FG001|Overall Study|Transfer to Hospice Care|0
7549339|NCT02940626|11907512|FG000|Overall Study|Prohibited Concomitant Medication|0
7549340|NCT02940626|11907513|FG001|Overall Study|Prohibited Concomitant Medication|1
7549341|NCT02940691|11907521|FG000|Overall Study|Lost to Follow-up|5
7549342|NCT02940691|11907521|FG000|Overall Study|Incarceration|1
7549343|NCT02940730|11907528|FG000|Intervention 2|Physician Decision|7
7549344|NCT02940730|11907529|FG001|Intervention 2|Physician Decision|0
7549345|NCT02940860|11907537|FG000|Overall Study|Non-serious AE|1
7549346|NCT02940860|11907538|FG001|Overall Study|Non-serious AE|2
7549347|NCT02940860|11907537|FG000|Overall Study|Serious AE|7
7549348|NCT02940860|11907538|FG001|Overall Study|Serious AE|3
7549349|NCT02940860|11907537|FG000|Overall Study|Withdrawal by Subject|19
7549350|NCT02940860|11907538|FG001|Overall Study|Withdrawal by Subject|9
7549351|NCT02940860|11907537|FG000|Overall Study|Lost to Follow-up|13
7549352|NCT02940860|11907538|FG001|Overall Study|Lost to Follow-up|7
7549353|NCT02940860|11907537|FG000|Overall Study|Physician Decision|5
7549354|NCT02940860|11907538|FG001|Overall Study|Physician Decision|3
7549355|NCT02940860|11907537|FG000|Overall Study|Sponsor Decision|0
7578160|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7578161|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7578162|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
7578163|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7578164|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
7578165|NCT03903822|11969127|FG000|Treatment Phase (6 Weeks)|Other|2
7578166|NCT03903822|11969128|FG001|Treatment Phase (6 Weeks)|Other|1
7578167|NCT03903822|11969129|FG002|Treatment Phase (6 Weeks)|Other|0
7578168|NCT03903822|11969130|FG003|Treatment Phase (6 Weeks)|Other|0
7578169|NCT03903822|11969131|FG004|Treatment Phase (6 Weeks)|Other|1
7578170|NCT03903822|11969132|FG005|Treatment Phase (6 Weeks)|Other|1
7578171|NCT03903822|11969133|FG006|Treatment Phase (6 Weeks)|Other|0
7578172|NCT03903822|11969134|FG007|Treatment Phase (6 Weeks)|Other|0
7578173|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
7578174|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
7578175|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
7578176|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
7578177|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
7578178|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
7578179|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
7578180|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
7578181|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578182|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578183|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578184|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578185|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
7578186|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578187|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578188|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
7578189|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
7578190|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7578191|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7578192|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7578193|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7578194|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
7578195|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
7578196|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
7578197|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
7578198|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
7578199|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
7578200|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
7578201|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
7549356|NCT02940860|11907538|FG001|Overall Study|Sponsor Decision|1
7269724|NCT00412542|11483880|FG000|Overall Study|Withdrawal by Subject|0
7269725|NCT00412542|11483881|FG001|Overall Study|Withdrawal by Subject|2
7269726|NCT00412542|11483880|FG000|Overall Study|Not Eligible|0
7269727|NCT00412542|11483881|FG001|Overall Study|Not Eligible|1
7269728|NCT00412607|11483885|FG000|Overall Study|Withdrawal by Subject|9
7269729|NCT00412607|11483885|FG000|Overall Study|Lost to Follow-up|19
7269730|NCT00412607|11483885|FG000|Overall Study|Death|61
7269731|NCT00412607|11483885|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
7269732|NCT00412737|11483894|FG000|Overall Study|Death|1
7269733|NCT00412737|11483895|FG001|Overall Study|Death|0
7269734|NCT00412737|11483894|FG000|Overall Study|Adverse Event|3
7269735|NCT00412737|11483895|FG001|Overall Study|Adverse Event|2
7269736|NCT00412737|11483894|FG000|Overall Study|Refused Treatment|6
7269737|NCT00412737|11483895|FG001|Overall Study|Refused Treatment|2
7269738|NCT00412737|11483894|FG000|Overall Study|Failure to Return|6
7269739|NCT00412737|11483895|FG001|Overall Study|Failure to Return|2
7549357|NCT02940860|11907537|FG000|Overall Study|Protocol Violation|0
7549358|NCT02940860|11907538|FG001|Overall Study|Protocol Violation|2
7549359|NCT02940860|11907537|FG000|Overall Study|Death|3
7549360|NCT02940860|11907538|FG001|Overall Study|Death|2
7549361|NCT02940860|11907537|FG000|Overall Study|Moved, poor venous access, transport|6
7549362|NCT02940860|11907538|FG001|Overall Study|Moved, poor venous access, transport|4
7549363|NCT02940860|11907537|FG000|Overall Study|Not treated|2
7549364|NCT02940860|11907538|FG001|Overall Study|Not treated|2
7549365|NCT02940886|11907548|FG000|Overall Study|Adverse Event|7
7549366|NCT02940886|11907549|FG001|Overall Study|Adverse Event|3
7549367|NCT02940886|11907548|FG000|Overall Study|Protocol Violation|0
7549368|NCT02940886|11907549|FG001|Overall Study|Protocol Violation|2
7549369|NCT02940886|11907548|FG000|Overall Study|Withdrawal by Subject|28
7549370|NCT02940886|11907549|FG001|Overall Study|Withdrawal by Subject|20
7549371|NCT02940886|11907548|FG000|Overall Study|Death|1
7549372|NCT02940886|11907549|FG001|Overall Study|Death|0
7549373|NCT02940886|11907548|FG000|Overall Study|Lack of Efficacy|1
7549374|NCT02940886|11907549|FG001|Overall Study|Lack of Efficacy|0
7549375|NCT02940886|11907548|FG000|Overall Study|Lost to Follow-up|49
7549376|NCT02940886|11907549|FG001|Overall Study|Lost to Follow-up|21
7549377|NCT02940886|11907548|FG000|Overall Study|Physician Decision|9
7549378|NCT02940886|11907549|FG001|Overall Study|Physician Decision|4
7549379|NCT02940886|11907548|FG000|Overall Study|Sponsor decision|0
7549380|NCT02940886|11907549|FG001|Overall Study|Sponsor decision|1
7549381|NCT02940886|11907548|FG000|Overall Study|No treatment|7
7549382|NCT02940886|11907549|FG001|Overall Study|No treatment|2
7549383|NCT02940886|11907548|FG000|Overall Study|Enrolment error|0
7549384|NCT02940886|11907549|FG001|Overall Study|Enrolment error|1
7549385|NCT02941523|11907559|FG000|Monotherapy|Withdrawal by Subject|0
7549386|NCT02941523|11907560|FG001|Monotherapy|Withdrawal by Subject|1
7549387|NCT02941523|11907559|FG000|Carboplatin Combination Therapy|Adverse Event|0
7549388|NCT02941523|11907560|FG001|Carboplatin Combination Therapy|Adverse Event|1
7549389|NCT02941523|11907559|FG000|Carboplatin Combination Therapy|Death|1
7549390|NCT02941523|11907560|FG001|Carboplatin Combination Therapy|Death|2
7549391|NCT02941523|11907559|FG000|Carboplatin Combination Therapy|Disease progression|2
7549392|NCT02941523|11907560|FG001|Carboplatin Combination Therapy|Disease progression|0
7549393|NCT02941523|11907559|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
7549394|NCT02941523|11907560|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
7549395|NCT02941627|11907585|FG000|Overall Study|Death|1
7549396|NCT02941627|11907585|FG000|Overall Study|Surgical failure|1
7549397|NCT02941627|11907585|FG000|Overall Study|cholesteatoma prevented implantation|1
7549398|NCT02942264|11907638|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549399|NCT02942264|11907639|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7549400|NCT02942264|11907640|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549401|NCT02942264|11907641|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549402|NCT02942264|11907642|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549403|NCT02942264|11907643|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549404|NCT02942264|11907644|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
7549405|NCT02942264|11907645|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7549406|NCT02942264|11907646|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
7578202|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
7578203|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
7269740|NCT00412750|11483904|FG000|Overall Study|Abnormal laboratory value(s)|1
7269741|NCT00412750|11483905|FG001|Overall Study|Abnormal laboratory value(s)|0
7269742|NCT00412750|11483906|FG002|Overall Study|Abnormal laboratory value(s)|0
7549407|NCT02942264|11907638|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549408|NCT02942264|11907639|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549409|NCT02942264|11907640|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549410|NCT02942264|11907641|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549411|NCT02942264|11907642|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549412|NCT02942264|11907643|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549413|NCT02942264|11907644|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549414|NCT02942264|11907645|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
7549415|NCT02942264|11907646|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
7549416|NCT02942407|11907673|FG000|Overall Study|Lost to Follow-up|3
7269743|NCT00412750|11483904|FG000|Overall Study|Administrative problems|21
7269744|NCT00412750|11483905|FG001|Overall Study|Administrative problems|17
7269745|NCT00412750|11483906|FG002|Overall Study|Administrative problems|14
7269746|NCT00412750|11483904|FG000|Overall Study|Adverse Event|8
7269747|NCT00412750|11483905|FG001|Overall Study|Adverse Event|3
7269748|NCT00412750|11483906|FG002|Overall Study|Adverse Event|3
7269749|NCT00412750|11483904|FG000|Overall Study|Lost to Follow-up|1
7269750|NCT00412750|11483905|FG001|Overall Study|Lost to Follow-up|0
7269751|NCT00412750|11483906|FG002|Overall Study|Lost to Follow-up|1
7269752|NCT00412750|11483904|FG000|Overall Study|Withdrawal by Subject|0
7269753|NCT00412750|11483905|FG001|Overall Study|Withdrawal by Subject|1
7269754|NCT00412750|11483906|FG002|Overall Study|Withdrawal by Subject|2
7269755|NCT00412750|11483904|FG000|Overall Study|Lack of Efficacy|0
7269756|NCT00412750|11483905|FG001|Overall Study|Lack of Efficacy|0
7269757|NCT00412750|11483906|FG002|Overall Study|Lack of Efficacy|3
7269758|NCT00412854|11483928|FG000|Overall Study|Withdrawn due to adverse events|1
7269759|NCT00412854|11483929|FG001|Overall Study|Withdrawn due to adverse events|5
7269760|NCT00412854|11483928|FG000|Overall Study|Withdrawn for other reasons|13
7269761|NCT00412854|11483929|FG001|Overall Study|Withdrawn for other reasons|11
7269762|NCT00412893|11483942|FG000|Overall Study|Adverse Event|31
7269763|NCT00412893|11483943|FG001|Overall Study|Adverse Event|53
7269764|NCT00412893|11483942|FG000|Overall Study|Death|17
7269765|NCT00412893|11483943|FG001|Overall Study|Death|21
7269766|NCT00412893|11483942|FG000|Overall Study|Insufficient Therapeutic Response|39
7269767|NCT00412893|11483943|FG001|Overall Study|Insufficient Therapeutic Response|23
7269768|NCT00412893|11483942|FG000|Overall Study|Lost to Follow-up|2
7269769|NCT00412893|11483943|FG001|Overall Study|Lost to Follow-up|1
7269770|NCT00412893|11483942|FG000|Overall Study|Violation of Selection at Entry|17
7269771|NCT00412893|11483943|FG001|Overall Study|Violation of Selection at Entry|10
7269772|NCT00412893|11483942|FG000|Overall Study|Other Protocol Violation|10
7269773|NCT00412893|11483943|FG001|Overall Study|Other Protocol Violation|6
7269774|NCT00412893|11483942|FG000|Overall Study|Did Not Cooperate|12
7269775|NCT00412893|11483943|FG001|Overall Study|Did Not Cooperate|9
7269776|NCT00412893|11483942|FG000|Overall Study|Administrative Reason|12
7269777|NCT00412893|11483943|FG001|Overall Study|Administrative Reason|15
7269778|NCT00412893|11483942|FG000|Overall Study|Randomized but Never Received Study Drug|5
7269779|NCT00412893|11483943|FG001|Overall Study|Randomized but Never Received Study Drug|6
7269780|NCT00412958|11483953|FG000|Overall Study|Withdrawal by Subject|3
7269781|NCT00412958|11483954|FG001|Overall Study|Withdrawal by Subject|0
7269782|NCT00412958|11483955|FG002|Overall Study|Withdrawal by Subject|0
7269783|NCT00412958|11483956|FG003|Overall Study|Withdrawal by Subject|1
7269784|NCT00412958|11483953|FG000|Overall Study|Adverse Event|0
7269785|NCT00412958|11483954|FG001|Overall Study|Adverse Event|1
7269786|NCT00412958|11483955|FG002|Overall Study|Adverse Event|0
7269787|NCT00412958|11483956|FG003|Overall Study|Adverse Event|0
7269788|NCT00412958|11483953|FG000|Overall Study|Lost to Follow-up|0
7269789|NCT00412958|11483954|FG001|Overall Study|Lost to Follow-up|1
7269790|NCT00412958|11483955|FG002|Overall Study|Lost to Follow-up|0
7269791|NCT00412958|11483956|FG003|Overall Study|Lost to Follow-up|0
7269792|NCT00412958|11483953|FG000|Overall Study|Death|0
7269793|NCT00412958|11483954|FG001|Overall Study|Death|1
7269794|NCT00412958|11483955|FG002|Overall Study|Death|0
7269795|NCT00412958|11483956|FG003|Overall Study|Death|0
7269796|NCT00412958|11483953|FG000|Overall Study|Transport issue|0
7549417|NCT02942407|11907674|FG001|Overall Study|Lost to Follow-up|2
7549418|NCT02942407|11907673|FG000|Overall Study|Withdrawal by Subject|7
7549419|NCT02942407|11907674|FG001|Overall Study|Withdrawal by Subject|9
7549420|NCT02942407|11907673|FG000|Overall Study|Death|16
7549421|NCT02942407|11907674|FG001|Overall Study|Death|13
7549422|NCT02942485|11907690|FG000|Overall Study|Lost to Follow-up|1
7549423|NCT02942485|11907691|FG001|Overall Study|Lost to Follow-up|0
7549424|NCT02942576|11907699|FG000|Overall Study|Adverse Event|28
7549425|NCT02942576|11907700|FG001|Overall Study|Adverse Event|6
7549426|NCT02942576|11907699|FG000|Overall Study|Withdrawal by Subject|7
7549427|NCT02942576|11907700|FG001|Overall Study|Withdrawal by Subject|5
7549428|NCT02942576|11907699|FG000|Overall Study|Physician Decision|1
7549429|NCT02942576|11907700|FG001|Overall Study|Physician Decision|4
7549430|NCT02942576|11907699|FG000|Overall Study|Other|10
7549431|NCT02942576|11907700|FG001|Overall Study|Other|8
7549432|NCT02942771|11907718|FG000|Overall Study|Adverse Event|1
7549433|NCT02942771|11907719|FG001|Overall Study|Adverse Event|0
7549434|NCT02942771|11907720|FG002|Overall Study|Adverse Event|0
7269797|NCT00412958|11483954|FG001|Overall Study|Transport issue|1
7269798|NCT00412958|11483955|FG002|Overall Study|Transport issue|0
7269799|NCT00412958|11483956|FG003|Overall Study|Transport issue|0
7269800|NCT00412971|11483968|FG000|Overall Study|Lost to Follow-up|17
7269801|NCT00412971|11483969|FG001|Overall Study|Lost to Follow-up|9
7269802|NCT00412971|11483968|FG000|Overall Study|Protocol Violation|13
7269803|NCT00412971|11483969|FG001|Overall Study|Protocol Violation|1
7549435|NCT02942771|11907721|FG003|Overall Study|Adverse Event|0
7549436|NCT02942771|11907722|FG004|Overall Study|Adverse Event|2
7549437|NCT02942771|11907718|FG000|Overall Study|Lost to Follow-up|1
7549438|NCT02942771|11907719|FG001|Overall Study|Lost to Follow-up|0
7549439|NCT02942771|11907720|FG002|Overall Study|Lost to Follow-up|0
7549440|NCT02942771|11907721|FG003|Overall Study|Lost to Follow-up|0
7549441|NCT02942771|11907722|FG004|Overall Study|Lost to Follow-up|0
7269804|NCT00412984|11483977|FG000|Overall Study|Death|331
7269805|NCT00412984|11483978|FG001|Overall Study|Death|349
7549442|NCT02942771|11907718|FG000|Overall Study|Withdrawal by Subject|1
7549443|NCT02942771|11907719|FG001|Overall Study|Withdrawal by Subject|0
7549444|NCT02942771|11907720|FG002|Overall Study|Withdrawal by Subject|0
7549445|NCT02942771|11907721|FG003|Overall Study|Withdrawal by Subject|0
7549446|NCT02942771|11907722|FG004|Overall Study|Withdrawal by Subject|2
7549447|NCT02943070|11907743|FG000|Overall Study|Physician Decision|1
7549448|NCT02943070|11907743|FG000|Overall Study|Adverse Event|2
7549449|NCT02943070|11907743|FG000|Overall Study|Death|2
7549450|NCT02943070|11907743|FG000|Overall Study|Withdrawal by Subject|3
7549451|NCT02943070|11907743|FG000|Overall Study|Lost to Follow-up|4
7549452|NCT02943070|11907743|FG000|Overall Study|Retreatment or TURP|13
7549453|NCT02943070|11907743|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
7549454|NCT02943096|11907756|FG000|Overall Study|Lack of Efficacy|0
7549455|NCT02943096|11907757|FG001|Overall Study|Lack of Efficacy|1
7549456|NCT02943447|11907781|FG000|Blinded Study Phase|Withdrew Consent|1
7549457|NCT02943447|11907782|FG001|Blinded Study Phase|Withdrew Consent|2
7549458|NCT02943447|11907783|FG002|Blinded Study Phase|Withdrew Consent|1
7549459|NCT02943447|11907781|FG000|Blinded Study Phase|Adverse Event|3
7549460|NCT02943447|11907782|FG001|Blinded Study Phase|Adverse Event|0
7578204|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
7578205|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7578206|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
7578207|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7578208|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7578209|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7578210|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
7578211|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7578212|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
7578213|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578214|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578215|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578216|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578217|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578218|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
7578219|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578220|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
7578221|NCT03903822|11969127|FG000|Follow up Phase (4 Weeks)|Other|1
7578222|NCT03903822|11969128|FG001|Follow up Phase (4 Weeks)|Other|1
7578223|NCT03903822|11969129|FG002|Follow up Phase (4 Weeks)|Other|0
7578224|NCT03903822|11969130|FG003|Follow up Phase (4 Weeks)|Other|0
7578225|NCT03903822|11969131|FG004|Follow up Phase (4 Weeks)|Other|0
7578226|NCT03903822|11969132|FG005|Follow up Phase (4 Weeks)|Other|0
7578227|NCT03903822|11969133|FG006|Follow up Phase (4 Weeks)|Other|0
7578228|NCT03903822|11969134|FG007|Follow up Phase (4 Weeks)|Other|0
7578229|NCT03905096|11969154|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
7578230|NCT03905096|11969155|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
7578231|NCT03899064|11969168|FG000|Overall Study|Lost to Follow-up|1
7578232|NCT03899064|11969168|FG000|Overall Study|Protocol Violation|2
7578233|NCT03899064|11969168|FG000|Overall Study|Withdrawal by Subject|2
7578234|NCT03899064|11969168|FG000|Overall Study|Other|2
7578235|NCT03903159|11969172|FG000|Overall Study|Discharged with Staff Approval|2
7269806|NCT00412984|11483977|FG000|Overall Study|Adverse Event|679
7269807|NCT00412984|11483978|FG001|Overall Study|Adverse Event|738
7269808|NCT00412984|11483977|FG000|Overall Study|Withdrawal by Subject|921
7269809|NCT00412984|11483978|FG001|Overall Study|Withdrawal by Subject|989
7269810|NCT00412984|11483977|FG000|Overall Study|Lost to Follow-up|51
7269811|NCT00412984|11483978|FG001|Overall Study|Lost to Follow-up|39
7269812|NCT00412984|11483977|FG000|Overall Study|Poor/Noncompliance|57
7269813|NCT00412984|11483978|FG001|Overall Study|Poor/Noncompliance|77
7269814|NCT00412984|11483977|FG000|Overall Study|Pregnancy|1
7269815|NCT00412984|11483978|FG001|Overall Study|Pregnancy|0
7269816|NCT00412984|11483977|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
7269817|NCT00412984|11483978|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
7549461|NCT02943447|11907783|FG002|Blinded Study Phase|Adverse Event|0
7549462|NCT02943447|11907781|FG000|Blinded Study Phase|Investigator's discretion|1
7549463|NCT02943447|11907782|FG001|Blinded Study Phase|Investigator's discretion|0
7549464|NCT02943447|11907783|FG002|Blinded Study Phase|Investigator's discretion|0
7549465|NCT02943447|11907781|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
7549466|NCT02943447|11907782|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
7549467|NCT02943447|11907783|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
7549468|NCT02943447|11907781|FG000|Open-Label Extension Phase|Adverse Event|4
7578236|NCT03903159|11969172|FG000|Overall Study|Discharged at Staff Request|2
7549469|NCT02943447|11907782|FG001|Open-Label Extension Phase|Adverse Event|7
7269818|NCT00412984|11483977|FG000|Overall Study|Administrative Reason by Sponsor|11
7549470|NCT02943447|11907783|FG002|Open-Label Extension Phase|Adverse Event|3
7549471|NCT02943447|11907781|FG000|Open-Label Extension Phase|Lack of Efficacy|3
7549472|NCT02943447|11907782|FG001|Open-Label Extension Phase|Lack of Efficacy|4
7578237|NCT03903159|11969172|FG000|Overall Study|Discharged Against Staff Advice|1
7578238|NCT03902392|11969178|FG000|Overall Study|Lost to Follow-up|7
7578239|NCT03902392|11969179|FG001|Overall Study|Lost to Follow-up|7
7578240|NCT03900728|11969235|FG000|Overall Study|No text responses|0
7578241|NCT03900728|11969236|FG001|Overall Study|No text responses|0
7578242|NCT03900728|11969237|FG002|Overall Study|No text responses|4
7578243|NCT03895372|11969276|FG000|Investigational Treatment Period|Adverse Event|1
7578244|NCT03895372|11969277|FG001|Investigational Treatment Period|Adverse Event|0
7578245|NCT03895372|11969278|FG002|Investigational Treatment Period|Adverse Event|0
7578246|NCT03895372|11969279|FG003|Investigational Treatment Period|Adverse Event|0
7578247|NCT03895372|11969280|FG004|Investigational Treatment Period|Adverse Event|0
7578248|NCT03895372|11969281|FG005|Investigational Treatment Period|Adverse Event|0
7578249|NCT03895372|11969282|FG006|Investigational Treatment Period|Adverse Event|4
7578250|NCT03895372|11969283|FG007|Investigational Treatment Period|Adverse Event|3
7578251|NCT03895372|11969276|FG000|Investigational Treatment Period|Lack of Efficacy|1
7578252|NCT03895372|11969277|FG001|Investigational Treatment Period|Lack of Efficacy|0
7578253|NCT03895372|11969278|FG002|Investigational Treatment Period|Lack of Efficacy|0
7269819|NCT00412984|11483978|FG001|Overall Study|Administrative Reason by Sponsor|8
7269820|NCT00412984|11483977|FG000|Overall Study|Physician Refused to Continue Treatment|81
7269821|NCT00412984|11483978|FG001|Overall Study|Physician Refused to Continue Treatment|89
7269822|NCT00412984|11483977|FG000|Overall Study|Other Reason|80
7269823|NCT00412984|11483978|FG001|Overall Study|Other Reason|92
7269824|NCT00412984|11483977|FG000|Overall Study|Not Reported|11
7269825|NCT00412984|11483978|FG001|Overall Study|Not Reported|12
7269826|NCT00413010|11483986|FG000|Overall Study|Adverse Event|8
7269827|NCT00413010|11483987|FG001|Overall Study|Adverse Event|4
7269828|NCT00413010|11483986|FG000|Overall Study|Laboratory abnormality|0
7269829|NCT00413010|11483987|FG001|Overall Study|Laboratory abnormality|2
7269830|NCT00413010|11483986|FG000|Overall Study|Lack of Efficacy|0
7269831|NCT00413010|11483987|FG001|Overall Study|Lack of Efficacy|3
7269832|NCT00413010|11483986|FG000|Overall Study|Lost to Follow-up|3
7269833|NCT00413010|11483987|FG001|Overall Study|Lost to Follow-up|0
7269834|NCT00413010|11483986|FG000|Overall Study|Withdrawal by Subject|7
7269835|NCT00413010|11483987|FG001|Overall Study|Withdrawal by Subject|2
7269836|NCT00413010|11483986|FG000|Overall Study|Due to termination of the study|54
7269837|NCT00413010|11483987|FG001|Overall Study|Due to termination of the study|52
7269838|NCT00413036|11483993|FG000|Overall Study|Adverse Event|44
7269839|NCT00413036|11483993|FG000|Overall Study|Lack of Efficacy|129
7269840|NCT00413036|11483993|FG000|Overall Study|Withdrawal by Subject|7
7269841|NCT00413036|11483993|FG000|Overall Study|Death|9
7269842|NCT00413036|11483993|FG000|Overall Study|Other|26
7269843|NCT00413036|11483993|FG000|Overall Study|Missing|2
7269844|NCT00413049|11483999|FG000|Overall Study|Adverse Event|10
7269845|NCT00413049|11484000|FG001|Overall Study|Adverse Event|8
7269846|NCT00413049|11483999|FG000|Overall Study|Withdrawal by Subject|7
7269847|NCT00413049|11484000|FG001|Overall Study|Withdrawal by Subject|5
7549473|NCT02943447|11907783|FG002|Open-Label Extension Phase|Lack of Efficacy|0
7549474|NCT02943447|11907781|FG000|Open-Label Extension Phase|Withdrew consent|1
7549475|NCT02943447|11907782|FG001|Open-Label Extension Phase|Withdrew consent|1
7549476|NCT02943447|11907783|FG002|Open-Label Extension Phase|Withdrew consent|1
7549477|NCT02943447|11907781|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7549478|NCT02943447|11907782|FG001|Open-Label Extension Phase|Lost to Follow-up|1
7549479|NCT02943447|11907783|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7549480|NCT02943460|11907803|FG000|Blinded Study Phase|Adverse Event|3
7549481|NCT02943460|11907804|FG001|Blinded Study Phase|Adverse Event|0
7549482|NCT02943460|11907805|FG002|Blinded Study Phase|Adverse Event|0
7549483|NCT02943460|11907803|FG000|Blinded Study Phase|Withdrew Consent|0
7549484|NCT02943460|11907804|FG001|Blinded Study Phase|Withdrew Consent|1
7549485|NCT02943460|11907805|FG002|Blinded Study Phase|Withdrew Consent|0
7549486|NCT02943460|11907803|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
7549487|NCT02943460|11907804|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
7549488|NCT02943460|11907805|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
7549489|NCT02943460|11907803|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
7549490|NCT02943460|11907804|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
7549491|NCT02943460|11907805|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
7549492|NCT02943460|11907803|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7549493|NCT02943460|11907804|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
7549494|NCT02943460|11907805|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
7549495|NCT02943473|11907814|FG000|Overall Study|enrolled but not dosed|1
7549496|NCT02943473|11907814|FG000|Overall Study|screen failure|1
7549497|NCT02943473|11907814|FG000|Overall Study|Physician Decision|4
7578254|NCT03895372|11969279|FG003|Investigational Treatment Period|Lack of Efficacy|0
7578255|NCT03895372|11969280|FG004|Investigational Treatment Period|Lack of Efficacy|0
7578256|NCT03895372|11969281|FG005|Investigational Treatment Period|Lack of Efficacy|0
7269848|NCT00413049|11483999|FG000|Overall Study|Lost to Follow-up|2
7269849|NCT00413049|11484000|FG001|Overall Study|Lost to Follow-up|3
7269850|NCT00413049|11483999|FG000|Overall Study|Protocol Violation|3
7269851|NCT00413049|11484000|FG001|Overall Study|Protocol Violation|1
7269852|NCT00413049|11483999|FG000|Overall Study|Subject no longer requires study drug|0
7269853|NCT00413049|11484000|FG001|Overall Study|Subject no longer requires study drug|1
7269854|NCT00413049|11483999|FG000|Overall Study|Abnormal laboratory value(s)|1
7269855|NCT00413049|11484000|FG001|Overall Study|Abnormal laboratory value(s)|0
7269856|NCT00413049|11483999|FG000|Overall Study|Lack of Efficacy|1
7269857|NCT00413049|11484000|FG001|Overall Study|Lack of Efficacy|0
7269858|NCT00413153|11484008|FG000|Overall Study|Withdrawal by Subject|1
7269859|NCT00413153|11484009|FG001|Overall Study|Withdrawal by Subject|1
7269860|NCT00413153|11484008|FG000|Overall Study|Adverse Event|1
7269861|NCT00413153|11484009|FG001|Overall Study|Adverse Event|0
7269862|NCT00413192|11484032|FG000|Overall Study|Disease progression|26
7269863|NCT00413192|11484033|FG001|Overall Study|Disease progression|31
7269864|NCT00413192|11484034|FG002|Overall Study|Disease progression|16
7269865|NCT00413192|11484035|FG003|Overall Study|Disease progression|25
7269866|NCT00413192|11484032|FG000|Overall Study|Toxicity|3
7269867|NCT00413192|11484033|FG001|Overall Study|Toxicity|2
7269868|NCT00413192|11484034|FG002|Overall Study|Toxicity|2
7269869|NCT00413192|11484035|FG003|Overall Study|Toxicity|2
7269870|NCT00413192|11484032|FG000|Overall Study|Withdrawal by Subject|3
7269871|NCT00413192|11484033|FG001|Overall Study|Withdrawal by Subject|5
7269872|NCT00413192|11484034|FG002|Overall Study|Withdrawal by Subject|0
7269873|NCT00413192|11484035|FG003|Overall Study|Withdrawal by Subject|1
7269874|NCT00413192|11484032|FG000|Overall Study|Intercurrent illness|0
7269875|NCT00413192|11484033|FG001|Overall Study|Intercurrent illness|0
7269876|NCT00413192|11484034|FG002|Overall Study|Intercurrent illness|0
7578257|NCT03895372|11969282|FG006|Investigational Treatment Period|Lack of Efficacy|0
7578258|NCT03895372|11969283|FG007|Investigational Treatment Period|Lack of Efficacy|0
7578259|NCT03895372|11969276|FG000|Investigational Treatment Period|Lost to Follow-up|0
7578260|NCT03895372|11969277|FG001|Investigational Treatment Period|Lost to Follow-up|0
7578261|NCT03895372|11969278|FG002|Investigational Treatment Period|Lost to Follow-up|0
7578262|NCT03895372|11969279|FG003|Investigational Treatment Period|Lost to Follow-up|0
7578263|NCT03895372|11969280|FG004|Investigational Treatment Period|Lost to Follow-up|0
7578264|NCT03895372|11969281|FG005|Investigational Treatment Period|Lost to Follow-up|0
7578265|NCT03895372|11969282|FG006|Investigational Treatment Period|Lost to Follow-up|1
7578266|NCT03895372|11969283|FG007|Investigational Treatment Period|Lost to Follow-up|0
7578267|NCT03895372|11969276|FG000|Investigational Treatment Period|Other|0
7578268|NCT03895372|11969277|FG001|Investigational Treatment Period|Other|0
7269877|NCT00413192|11484035|FG003|Overall Study|Intercurrent illness|1
7269878|NCT00413192|11484032|FG000|Overall Study|Intercurrent death|0
7269879|NCT00413192|11484033|FG001|Overall Study|Intercurrent death|1
7269880|NCT00413192|11484034|FG002|Overall Study|Intercurrent death|0
7269881|NCT00413192|11484035|FG003|Overall Study|Intercurrent death|0
7269882|NCT00413192|11484032|FG000|Overall Study|Other|5
7269883|NCT00413192|11484033|FG001|Overall Study|Other|1
7269884|NCT00413192|11484034|FG002|Overall Study|Other|1
7269885|NCT00413192|11484035|FG003|Overall Study|Other|2
7269886|NCT00413192|11484032|FG000|Overall Study|Not treated|0
7269887|NCT00413192|11484033|FG001|Overall Study|Not treated|0
7269888|NCT00413192|11484034|FG002|Overall Study|Not treated|0
7269889|NCT00413192|11484035|FG003|Overall Study|Not treated|1
7269890|NCT00413218|11484047|FG000|Overall Study|Randomized but didn't receive study drug|2
7269891|NCT00413218|11484048|FG001|Overall Study|Randomized but didn't receive study drug|8
7269892|NCT00413218|11484047|FG000|Overall Study|Death|57
7269893|NCT00413218|11484048|FG001|Overall Study|Death|56
7269894|NCT00413218|11484047|FG000|Overall Study|Lost to Follow-up|14
7269895|NCT00413218|11484048|FG001|Overall Study|Lost to Follow-up|17
7269896|NCT00413218|11484047|FG000|Overall Study|Admin|20
7269897|NCT00413218|11484048|FG001|Overall Study|Admin|14
7269898|NCT00413218|11484047|FG000|Overall Study|Missing|1
7269899|NCT00413218|11484048|FG001|Overall Study|Missing|0
7269900|NCT00413218|11484047|FG000|Overall Study|Withdrawal by Subject|9
7269901|NCT00413218|11484048|FG001|Overall Study|Withdrawal by Subject|1
7388226|NCT01218126|11647007|FG001|Overall Study|Adverse Event|10
7388227|NCT01218126|11647008|FG002|Overall Study|Adverse Event|12
7388228|NCT01218126|11647009|FG003|Overall Study|Adverse Event|16
7388229|NCT01218126|11647006|FG000|Overall Study|Lack of Efficacy|7
7388230|NCT01218126|11647007|FG001|Overall Study|Lack of Efficacy|2
7388231|NCT01218126|11647008|FG002|Overall Study|Lack of Efficacy|2
7388232|NCT01218126|11647009|FG003|Overall Study|Lack of Efficacy|6
7578269|NCT03895372|11969278|FG002|Investigational Treatment Period|Other|0
7388233|NCT01218126|11647006|FG000|Overall Study|Protocol Violation|5
7388234|NCT01218126|11647007|FG001|Overall Study|Protocol Violation|2
7388235|NCT01218126|11647008|FG002|Overall Study|Protocol Violation|2
7388236|NCT01218126|11647009|FG003|Overall Study|Protocol Violation|3
7388237|NCT01218126|11647006|FG000|Overall Study|Protocol-defined stopping criteria|1
7388238|NCT01218126|11647007|FG001|Overall Study|Protocol-defined stopping criteria|1
7388239|NCT01218126|11647008|FG002|Overall Study|Protocol-defined stopping criteria|0
7388240|NCT01218126|11647009|FG003|Overall Study|Protocol-defined stopping criteria|0
7388241|NCT01218126|11647006|FG000|Overall Study|Lost to Follow-up|0
7388242|NCT01218126|11647007|FG001|Overall Study|Lost to Follow-up|0
7388243|NCT01218126|11647008|FG002|Overall Study|Lost to Follow-up|0
7388244|NCT01218126|11647009|FG003|Overall Study|Lost to Follow-up|2
7388245|NCT01218126|11647006|FG000|Overall Study|Physician Decision|1
7388246|NCT01218126|11647007|FG001|Overall Study|Physician Decision|2
7388247|NCT01218126|11647008|FG002|Overall Study|Physician Decision|4
7388248|NCT01218126|11647009|FG003|Overall Study|Physician Decision|2
7269902|NCT00413231|11484055|FG000|0 to 30-day Post Treatment|Death|5
7269903|NCT00413231|11484055|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
7269904|NCT00413231|11484055|FG000|30-day to 365-day Post Treatment|Death|13
7269905|NCT00413231|11484055|FG000|365-day to 60-month Post Treatment|Death|36
7269906|NCT00413231|11484055|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
7269907|NCT00413231|11484055|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
7269908|NCT00413231|11484055|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
7269909|NCT00413244|11484062|FG000|Overall Study|Withdrawal by Subject|10
7269910|NCT00413244|11484063|FG001|Overall Study|Withdrawal by Subject|1
7269911|NCT00413283|11484073|FG000|Overall Study|Withdrawal by Subject|1
7269912|NCT00413283|11484074|FG001|Overall Study|Withdrawal by Subject|0
7269913|NCT00413283|11484075|FG002|Overall Study|Withdrawal by Subject|0
7269914|NCT00413283|11484076|FG003|Overall Study|Withdrawal by Subject|1
7269915|NCT00413283|11484073|FG000|Overall Study|Death|0
7269916|NCT00413283|11484074|FG001|Overall Study|Death|0
7269917|NCT00413283|11484075|FG002|Overall Study|Death|1
7269918|NCT00413283|11484076|FG003|Overall Study|Death|1
7269919|NCT00413283|11484073|FG000|Overall Study|Adverse Event|0
7269920|NCT00413283|11484074|FG001|Overall Study|Adverse Event|0
7269921|NCT00413283|11484075|FG002|Overall Study|Adverse Event|0
7549498|NCT02943564|11907830|FG000|Overall Study|Miscellaneous Reasons|0
7549499|NCT02943564|11907831|FG001|Overall Study|Miscellaneous Reasons|0
7549500|NCT02943564|11907832|FG002|Overall Study|Miscellaneous Reasons|3
7549501|NCT02943564|11907830|FG000|Overall Study|Site terminated by sponsor|0
7549502|NCT02943564|11907831|FG001|Overall Study|Site terminated by sponsor|1
7549503|NCT02943564|11907832|FG002|Overall Study|Site terminated by sponsor|0
7549504|NCT02943564|11907830|FG000|Overall Study|Non-compliance with study drug|0
7549505|NCT02943564|11907831|FG001|Overall Study|Non-compliance with study drug|1
7549506|NCT02943564|11907832|FG002|Overall Study|Non-compliance with study drug|0
7549507|NCT02943564|11907830|FG000|Overall Study|Pregnancy|0
7578270|NCT03895372|11969279|FG003|Investigational Treatment Period|Other|0
7578271|NCT03895372|11969280|FG004|Investigational Treatment Period|Other|0
7578272|NCT03895372|11969281|FG005|Investigational Treatment Period|Other|1
7578273|NCT03895372|11969282|FG006|Investigational Treatment Period|Other|0
7578274|NCT03895372|11969283|FG007|Investigational Treatment Period|Other|2
7578275|NCT03895372|11969276|FG000|Investigational Treatment Period|Protocol Violation|0
7578276|NCT03895372|11969277|FG001|Investigational Treatment Period|Protocol Violation|0
7578277|NCT03895372|11969278|FG002|Investigational Treatment Period|Protocol Violation|0
7578278|NCT03895372|11969279|FG003|Investigational Treatment Period|Protocol Violation|1
7578279|NCT03895372|11969280|FG004|Investigational Treatment Period|Protocol Violation|0
7578280|NCT03895372|11969281|FG005|Investigational Treatment Period|Protocol Violation|0
7578281|NCT03895372|11969282|FG006|Investigational Treatment Period|Protocol Violation|0
7578282|NCT03895372|11969283|FG007|Investigational Treatment Period|Protocol Violation|0
7578283|NCT03895372|11969276|FG000|Investigational Treatment Period|Withdrawal by Subject|2
7578284|NCT03895372|11969277|FG001|Investigational Treatment Period|Withdrawal by Subject|3
7578285|NCT03895372|11969278|FG002|Investigational Treatment Period|Withdrawal by Subject|1
7578286|NCT03895372|11969279|FG003|Investigational Treatment Period|Withdrawal by Subject|1
7578287|NCT03895372|11969280|FG004|Investigational Treatment Period|Withdrawal by Subject|0
7578288|NCT03895372|11969281|FG005|Investigational Treatment Period|Withdrawal by Subject|1
7578289|NCT03895372|11969282|FG006|Investigational Treatment Period|Withdrawal by Subject|3
7578290|NCT03895372|11969283|FG007|Investigational Treatment Period|Withdrawal by Subject|0
7578291|NCT03895372|11969276|FG000|Extension Treatment Period|Adverse Event|0
7578292|NCT03895372|11969277|FG001|Extension Treatment Period|Adverse Event|1
7578293|NCT03895372|11969278|FG002|Extension Treatment Period|Adverse Event|0
7578294|NCT03895372|11969279|FG003|Extension Treatment Period|Adverse Event|1
7578295|NCT03895372|11969280|FG004|Extension Treatment Period|Adverse Event|0
7578296|NCT03895372|11969281|FG005|Extension Treatment Period|Adverse Event|0
7578297|NCT03895372|11969282|FG006|Extension Treatment Period|Adverse Event|3
7578298|NCT03895372|11969283|FG007|Extension Treatment Period|Adverse Event|3
7578299|NCT03895372|11969276|FG000|Extension Treatment Period|Other|1
7578300|NCT03895372|11969277|FG001|Extension Treatment Period|Other|3
7578301|NCT03895372|11969278|FG002|Extension Treatment Period|Other|0
7578302|NCT03895372|11969279|FG003|Extension Treatment Period|Other|0
7578303|NCT03895372|11969280|FG004|Extension Treatment Period|Other|1
7578304|NCT03895372|11969281|FG005|Extension Treatment Period|Other|0
7578305|NCT03895372|11969282|FG006|Extension Treatment Period|Other|0
7578306|NCT03895372|11969283|FG007|Extension Treatment Period|Other|2
7578307|NCT03895372|11969276|FG000|Extension Treatment Period|Pregnancy|0
7578308|NCT03895372|11969277|FG001|Extension Treatment Period|Pregnancy|0
7578309|NCT03895372|11969278|FG002|Extension Treatment Period|Pregnancy|0
7549508|NCT02943564|11907831|FG001|Overall Study|Pregnancy|1
7578310|NCT03895372|11969279|FG003|Extension Treatment Period|Pregnancy|0
7578311|NCT03895372|11969280|FG004|Extension Treatment Period|Pregnancy|1
7578312|NCT03895372|11969281|FG005|Extension Treatment Period|Pregnancy|0
7269922|NCT00413283|11484076|FG003|Overall Study|Adverse Event|1
7269923|NCT00413283|11484073|FG000|Overall Study|Ineligibility determined|0
7269924|NCT00413283|11484074|FG001|Overall Study|Ineligibility determined|0
7269925|NCT00413283|11484075|FG002|Overall Study|Ineligibility determined|0
7269926|NCT00413283|11484076|FG003|Overall Study|Ineligibility determined|1
7269927|NCT00413283|11484073|FG000|Overall Study|Protocol deviation|0
7269928|NCT00413283|11484074|FG001|Overall Study|Protocol deviation|1
7269929|NCT00413283|11484075|FG002|Overall Study|Protocol deviation|0
7269930|NCT00413283|11484076|FG003|Overall Study|Protocol deviation|0
7269931|NCT00413283|11484073|FG000|Overall Study|Requirement for alternative therapy|0
7269932|NCT00413283|11484074|FG001|Overall Study|Requirement for alternative therapy|2
7269933|NCT00413283|11484075|FG002|Overall Study|Requirement for alternative therapy|0
7269934|NCT00413283|11484076|FG003|Overall Study|Requirement for alternative therapy|0
7269935|NCT00413283|11484073|FG000|Overall Study|Other|0
7269936|NCT00413283|11484074|FG001|Overall Study|Other|0
7269937|NCT00413283|11484075|FG002|Overall Study|Other|1
7269938|NCT00413283|11484076|FG003|Overall Study|Other|0
7269939|NCT00413374|11484097|FG000|Overall Study|Ineligible due to screening criteria.|3
7269940|NCT00413374|11484098|FG001|Overall Study|Ineligible due to screening criteria.|0
7269941|NCT00413374|11484097|FG000|Overall Study|Adverse Event|1
7269942|NCT00413374|11484098|FG001|Overall Study|Adverse Event|0
7269943|NCT00413374|11484097|FG000|Overall Study|Lost to Follow-up|1
7269944|NCT00413374|11484098|FG001|Overall Study|Lost to Follow-up|0
7269945|NCT00413374|11484097|FG000|Overall Study|Surgery|1
7269946|NCT00413374|11484098|FG001|Overall Study|Surgery|0
7269947|NCT00413413|11484119|FG000|Single-Blind|Adverse Event|0
7269948|NCT00413413|11484120|FG001|Single-Blind|Adverse Event|9
7269949|NCT00413413|11484121|FG002|Single-Blind|Adverse Event|0
7269950|NCT00413413|11484119|FG000|Single-Blind|Lack of Efficacy|0
7269951|NCT00413413|11484120|FG001|Single-Blind|Lack of Efficacy|5
7269952|NCT00413413|11484121|FG002|Single-Blind|Lack of Efficacy|0
7269953|NCT00413413|11484119|FG000|Single-Blind|Subject no longer requires study drug|0
7269954|NCT00413413|11484120|FG001|Single-Blind|Subject no longer requires study drug|151
7269955|NCT00413413|11484121|FG002|Single-Blind|Subject no longer requires study drug|0
7269956|NCT00413413|11484119|FG000|Single-Blind|Protocol Violation|0
7269957|NCT00413413|11484120|FG001|Single-Blind|Protocol Violation|16
7269958|NCT00413413|11484121|FG002|Single-Blind|Protocol Violation|0
7269959|NCT00413413|11484119|FG000|Single-Blind|Withdrawal by Subject|0
7269960|NCT00413413|11484120|FG001|Single-Blind|Withdrawal by Subject|27
7269961|NCT00413413|11484121|FG002|Single-Blind|Withdrawal by Subject|0
7269962|NCT00413413|11484119|FG000|Single-Blind|Lost to Follow-up|0
7269963|NCT00413413|11484120|FG001|Single-Blind|Lost to Follow-up|8
7269964|NCT00413413|11484121|FG002|Single-Blind|Lost to Follow-up|0
7269965|NCT00413413|11484119|FG000|Double-Blind|Adverse Event|6
7269966|NCT00413413|11484120|FG001|Double-Blind|Adverse Event|0
7269967|NCT00413413|11484121|FG002|Double-Blind|Adverse Event|5
7269968|NCT00413413|11484119|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
7549509|NCT02943564|11907832|FG002|Overall Study|Pregnancy|1
7549510|NCT02943564|11907830|FG000|Overall Study|Protocol Violation|2
7549511|NCT02943564|11907831|FG001|Overall Study|Protocol Violation|2
7549512|NCT02943564|11907832|FG002|Overall Study|Protocol Violation|2
7549513|NCT02943564|11907830|FG000|Overall Study|Lost to Follow-up|1
7549514|NCT02943564|11907831|FG001|Overall Study|Lost to Follow-up|0
7549515|NCT02943564|11907832|FG002|Overall Study|Lost to Follow-up|0
7549516|NCT02943564|11907830|FG000|Overall Study|Withdrawal by Subject|6
7549517|NCT02943564|11907831|FG001|Overall Study|Withdrawal by Subject|5
7549518|NCT02943564|11907832|FG002|Overall Study|Withdrawal by Subject|2
7549519|NCT02943564|11907830|FG000|Overall Study|Adverse Event|1
7549520|NCT02943564|11907831|FG001|Overall Study|Adverse Event|2
7549521|NCT02943564|11907832|FG002|Overall Study|Adverse Event|1
7549522|NCT02943564|11907830|FG000|Overall Study|Lack of Efficacy|0
7549523|NCT02943564|11907831|FG001|Overall Study|Lack of Efficacy|1
7549524|NCT02943564|11907832|FG002|Overall Study|Lack of Efficacy|0
7549525|NCT02943577|11907842|FG000|Overall Study|Protocol Violation|0
7549526|NCT02943577|11907843|FG001|Overall Study|Protocol Violation|1
7549527|NCT02943577|11907842|FG000|Overall Study|Adverse Event|3
7549528|NCT02943577|11907843|FG001|Overall Study|Adverse Event|2
7578313|NCT03895372|11969282|FG006|Extension Treatment Period|Pregnancy|0
7578314|NCT03895372|11969283|FG007|Extension Treatment Period|Pregnancy|0
7578315|NCT03895372|11969276|FG000|Extension Treatment Period|Withdrawal by Subject|2
7578316|NCT03895372|11969277|FG001|Extension Treatment Period|Withdrawal by Subject|1
7578317|NCT03895372|11969278|FG002|Extension Treatment Period|Withdrawal by Subject|0
7578318|NCT03895372|11969279|FG003|Extension Treatment Period|Withdrawal by Subject|0
7578319|NCT03895372|11969280|FG004|Extension Treatment Period|Withdrawal by Subject|1
7578320|NCT03895372|11969281|FG005|Extension Treatment Period|Withdrawal by Subject|1
7578321|NCT03895372|11969282|FG006|Extension Treatment Period|Withdrawal by Subject|1
7578322|NCT03895372|11969283|FG007|Extension Treatment Period|Withdrawal by Subject|1
7578323|NCT03896022|11969309|FG000|Overall Study|Withdrawal by Subject|1
7578324|NCT03896022|11969310|FG001|Overall Study|Withdrawal by Subject|0
7269969|NCT00413413|11484120|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
7269970|NCT00413413|11484121|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
7549529|NCT02943577|11907842|FG000|Overall Study|Lost to Follow-up|0
7549530|NCT02943577|11907843|FG001|Overall Study|Lost to Follow-up|1
7549531|NCT02943577|11907842|FG000|Overall Study|Withdrawal by Subject|1
7549532|NCT02943577|11907843|FG001|Overall Study|Withdrawal by Subject|1
7549533|NCT02943577|11907842|FG000|Overall Study|Pregnancy|1
7269971|NCT00413413|11484119|FG000|Double-Blind|Protocol deviation|1
7269972|NCT00413413|11484120|FG001|Double-Blind|Protocol deviation|2
7269973|NCT00413413|11484121|FG002|Double-Blind|Protocol deviation|1
7269974|NCT00413413|11484119|FG000|Double-Blind|Subject withdrew consent|4
7269975|NCT00413413|11484120|FG001|Double-Blind|Subject withdrew consent|6
7269976|NCT00413413|11484121|FG002|Double-Blind|Subject withdrew consent|9
7269977|NCT00413413|11484119|FG000|Double-Blind|Lost to Follow-up|3
7269978|NCT00413413|11484120|FG001|Double-Blind|Lost to Follow-up|4
7269979|NCT00413413|11484121|FG002|Double-Blind|Lost to Follow-up|2
7269980|NCT00413660|11484160|FG000|Up To Week 12|Adverse Event|1
7269981|NCT00413660|11484161|FG001|Up To Week 12|Adverse Event|3
7269982|NCT00413660|11484162|FG002|Up To Week 12|Adverse Event|1
7269983|NCT00413660|11484163|FG003|Up To Week 12|Adverse Event|4
7549534|NCT02943577|11907843|FG001|Overall Study|Pregnancy|0
7549535|NCT02943668|11907849|FG000|Overall Study|Disease Progression|1
7549536|NCT02944383|11907864|FG000|Overall Study|Lost to Follow-up|0
7549537|NCT02944383|11907865|FG001|Overall Study|Lost to Follow-up|0
7549538|NCT02944383|11907866|FG002|Overall Study|Lost to Follow-up|1
7549539|NCT02944383|11907864|FG000|Overall Study|Withdrawal by Subject|1
7578325|NCT03896022|11969311|FG002|Overall Study|Withdrawal by Subject|0
7578326|NCT03896022|11969309|FG000|Overall Study|Did not have procedure|3
7578327|NCT03896022|11969310|FG001|Overall Study|Did not have procedure|0
7578328|NCT03896022|11969311|FG002|Overall Study|Did not have procedure|0
7578329|NCT03891862|11969323|FG000|Open-label Period|Adverse Event|2
7578330|NCT03891862|11969324|FG001|Open-label Period|Adverse Event|0
7578331|NCT03891862|11969325|FG002|Open-label Period|Adverse Event|0
7578332|NCT03891862|11969323|FG000|Open-label Period|Protocol Violation|5
7578333|NCT03891862|11969324|FG001|Open-label Period|Protocol Violation|0
7578334|NCT03891862|11969325|FG002|Open-label Period|Protocol Violation|0
7578335|NCT03891862|11969323|FG000|Open-label Period|Withdrawal by Subject|6
7578336|NCT03891862|11969324|FG001|Open-label Period|Withdrawal by Subject|0
7578337|NCT03891862|11969325|FG002|Open-label Period|Withdrawal by Subject|0
7578338|NCT03891862|11969323|FG000|Open-label Period|Death|1
7578339|NCT03891862|11969324|FG001|Open-label Period|Death|0
7578340|NCT03891862|11969325|FG002|Open-label Period|Death|0
7578341|NCT03891862|11969323|FG000|Open-label Period|Lost to Follow-up|2
7578342|NCT03891862|11969324|FG001|Open-label Period|Lost to Follow-up|0
7578343|NCT03891862|11969325|FG002|Open-label Period|Lost to Follow-up|0
7578344|NCT03891862|11969323|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
7578345|NCT03891862|11969324|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
7578346|NCT03891862|11969325|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
7578347|NCT03891862|11969323|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
7578348|NCT03891862|11969324|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
7578349|NCT03891862|11969325|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
7578350|NCT03891862|11969323|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
7578351|NCT03891862|11969324|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
7269984|NCT00413660|11484164|FG004|Up To Week 12|Adverse Event|6
7549540|NCT02944383|11907865|FG001|Overall Study|Withdrawal by Subject|0
7549541|NCT02944383|11907866|FG002|Overall Study|Withdrawal by Subject|0
7549542|NCT02944448|11907878|FG000|Overall Study|Adverse Event|37
7549543|NCT02944448|11907879|FG001|Overall Study|Adverse Event|6
7549544|NCT02944448|11907878|FG000|Overall Study|Lack of Efficacy|8
7549545|NCT02944448|11907879|FG001|Overall Study|Lack of Efficacy|5
7549546|NCT02944448|11907878|FG000|Overall Study|Lost to Follow-up|3
7549547|NCT02944448|11907879|FG001|Overall Study|Lost to Follow-up|1
7549548|NCT02944448|11907878|FG000|Overall Study|Protocol Violation|25
7549549|NCT02944448|11907879|FG001|Overall Study|Protocol Violation|7
7549550|NCT02944448|11907878|FG000|Overall Study|Withdrawal by Subject|14
7549551|NCT02944448|11907879|FG001|Overall Study|Withdrawal by Subject|4
7549552|NCT02944448|11907878|FG000|Overall Study|Sponsor did not supply drug in time|0
7549553|NCT02944448|11907879|FG001|Overall Study|Sponsor did not supply drug in time|1
7549554|NCT02944448|11907878|FG000|Overall Study|Noncompliant with dosing|1
7549555|NCT02944448|11907879|FG001|Overall Study|Noncompliant with dosing|0
7549556|NCT02944448|11907878|FG000|Overall Study|Abnormal laboratory values|1
7549557|NCT02944448|11907879|FG001|Overall Study|Abnormal laboratory values|0
7549558|NCT02944656|11907897|FG000|Overall Study|No longer eligible|3
7549559|NCT02944656|11907898|FG001|Overall Study|No longer eligible|0
7549560|NCT02944656|11907897|FG000|Overall Study|Lost to Follow-up|7
7549561|NCT02944656|11907898|FG001|Overall Study|Lost to Follow-up|10
7549562|NCT02944968|11907904|FG000|Overall Study|Subject excluded before study procedure|1
7549563|NCT02944968|11907904|FG000|Overall Study|Subject didn't meet eligibility criteria|2
7549564|NCT02945046|11907911|FG000|Overall Study|Adverse Event|1
7549565|NCT02945046|11907912|FG001|Overall Study|Adverse Event|0
7549566|NCT02945046|11907913|FG002|Overall Study|Adverse Event|2
7549567|NCT02945046|11907911|FG000|Overall Study|Withdrawal by Subject|3
7549568|NCT02945046|11907912|FG001|Overall Study|Withdrawal by Subject|3
7549569|NCT02945046|11907913|FG002|Overall Study|Withdrawal by Subject|3
7549570|NCT02945046|11907911|FG000|Overall Study|Protocol Violation|2
7549571|NCT02945046|11907912|FG001|Overall Study|Protocol Violation|3
7549572|NCT02945046|11907913|FG002|Overall Study|Protocol Violation|2
7549573|NCT02945046|11907911|FG000|Overall Study|Lost to Follow-up|1
7549574|NCT02945046|11907912|FG001|Overall Study|Lost to Follow-up|1
7549575|NCT02945046|11907913|FG002|Overall Study|Lost to Follow-up|0
7269985|NCT00413660|11484165|FG005|Up To Week 12|Adverse Event|4
7269986|NCT00413660|11484166|FG006|Up To Week 12|Adverse Event|1
7269987|NCT00413660|11484167|FG007|Up To Week 12|Adverse Event|0
7269988|NCT00413660|11484168|FG008|Up To Week 12|Adverse Event|0
7269989|NCT00413660|11484169|FG009|Up To Week 12|Adverse Event|0
7269990|NCT00413660|11484170|FG010|Up To Week 12|Adverse Event|0
7269991|NCT00413660|11484160|FG000|Up To Week 12|Lack of Efficacy|2
7269992|NCT00413660|11484161|FG001|Up To Week 12|Lack of Efficacy|0
7269993|NCT00413660|11484162|FG002|Up To Week 12|Lack of Efficacy|0
7269994|NCT00413660|11484163|FG003|Up To Week 12|Lack of Efficacy|0
7269995|NCT00413660|11484164|FG004|Up To Week 12|Lack of Efficacy|0
7269996|NCT00413660|11484165|FG005|Up To Week 12|Lack of Efficacy|0
7269997|NCT00413660|11484166|FG006|Up To Week 12|Lack of Efficacy|5
7269998|NCT00413660|11484167|FG007|Up To Week 12|Lack of Efficacy|0
7269999|NCT00413660|11484168|FG008|Up To Week 12|Lack of Efficacy|0
7270000|NCT00413660|11484169|FG009|Up To Week 12|Lack of Efficacy|0
7270001|NCT00413660|11484170|FG010|Up To Week 12|Lack of Efficacy|0
7270002|NCT00413660|11484160|FG000|Up To Week 12|Lost to Follow-up|0
7270003|NCT00413660|11484161|FG001|Up To Week 12|Lost to Follow-up|1
7270004|NCT00413660|11484162|FG002|Up To Week 12|Lost to Follow-up|0
7270005|NCT00413660|11484163|FG003|Up To Week 12|Lost to Follow-up|0
7270006|NCT00413660|11484164|FG004|Up To Week 12|Lost to Follow-up|1
7270007|NCT00413660|11484165|FG005|Up To Week 12|Lost to Follow-up|0
7270008|NCT00413660|11484166|FG006|Up To Week 12|Lost to Follow-up|0
7270009|NCT00413660|11484167|FG007|Up To Week 12|Lost to Follow-up|0
7270010|NCT00413660|11484168|FG008|Up To Week 12|Lost to Follow-up|0
7270011|NCT00413660|11484169|FG009|Up To Week 12|Lost to Follow-up|0
7270012|NCT00413660|11484170|FG010|Up To Week 12|Lost to Follow-up|0
7270013|NCT00413660|11484160|FG000|Up To Week 12|Withdrawal by Subject|0
7270014|NCT00413660|11484161|FG001|Up To Week 12|Withdrawal by Subject|2
7270015|NCT00413660|11484162|FG002|Up To Week 12|Withdrawal by Subject|0
7270016|NCT00413660|11484163|FG003|Up To Week 12|Withdrawal by Subject|2
7270017|NCT00413660|11484164|FG004|Up To Week 12|Withdrawal by Subject|0
7270018|NCT00413660|11484165|FG005|Up To Week 12|Withdrawal by Subject|2
7270019|NCT00413660|11484166|FG006|Up To Week 12|Withdrawal by Subject|2
7270020|NCT00413660|11484167|FG007|Up To Week 12|Withdrawal by Subject|0
7270021|NCT00413660|11484168|FG008|Up To Week 12|Withdrawal by Subject|0
7270022|NCT00413660|11484169|FG009|Up To Week 12|Withdrawal by Subject|0
7549576|NCT02945046|11907911|FG000|Overall Study|Lack of Efficacy|1
7549577|NCT02945046|11907912|FG001|Overall Study|Lack of Efficacy|2
7549578|NCT02945046|11907913|FG002|Overall Study|Lack of Efficacy|1
7549579|NCT02945046|11907911|FG000|Overall Study|Other than specified|5
7549580|NCT02945046|11907912|FG001|Overall Study|Other than specified|4
7549581|NCT02945046|11907913|FG002|Overall Study|Other than specified|7
7549582|NCT02945254|11907927|FG000|Overall Study|Lost to Follow-up|1
7549583|NCT02945254|11907928|FG001|Overall Study|Lost to Follow-up|0
7549584|NCT02945254|11907927|FG000|Overall Study|Withdrawal by Subject|1
7549585|NCT02945254|11907928|FG001|Overall Study|Withdrawal by Subject|0
7549586|NCT02945410|11907940|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
7549587|NCT02945410|11907941|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
7549588|NCT02945410|11907942|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
7549589|NCT02945410|11907943|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
7549590|NCT02945410|11907944|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
7549591|NCT02945410|11907945|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
7549592|NCT02945410|11907940|FG000|Intervention 1 (5 Days)|Adverse Event|1
7549593|NCT02945410|11907941|FG001|Intervention 1 (5 Days)|Adverse Event|0
7549594|NCT02945410|11907942|FG002|Intervention 1 (5 Days)|Adverse Event|0
7549595|NCT02945410|11907943|FG003|Intervention 1 (5 Days)|Adverse Event|0
7549596|NCT02945410|11907944|FG004|Intervention 1 (5 Days)|Adverse Event|0
7549597|NCT02945410|11907945|FG005|Intervention 1 (5 Days)|Adverse Event|1
7549598|NCT02945410|11907940|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
7549599|NCT02945410|11907941|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
7549600|NCT02945410|11907942|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
7549601|NCT02945410|11907943|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
7549602|NCT02945410|11907944|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
7549603|NCT02945410|11907945|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
7549604|NCT02945657|11907966|FG000|Overall Study|Adverse Event|1
7549605|NCT02945657|11907966|FG000|Overall Study|Withdrawal by Parent/Guardian|3
7549606|NCT02946385|11908022|FG000|Overall Study|Lost to Follow-up|0
7578352|NCT03891862|11969325|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
7578353|NCT03891862|11969323|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7578354|NCT03891862|11969324|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
7578355|NCT03891862|11969325|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
7549607|NCT02946385|11908023|FG001|Overall Study|Lost to Follow-up|0
7549608|NCT02946385|11908024|FG002|Overall Study|Lost to Follow-up|3
7549609|NCT02946385|11908025|FG003|Overall Study|Lost to Follow-up|0
7549610|NCT02946385|11908026|FG004|Overall Study|Lost to Follow-up|2
7270023|NCT00413660|11484170|FG010|Up To Week 12|Withdrawal by Subject|0
7270024|NCT00413660|11484160|FG000|Up To Week 12|Randomized, Not Treated|1
7270025|NCT00413660|11484161|FG001|Up To Week 12|Randomized, Not Treated|0
7270026|NCT00413660|11484162|FG002|Up To Week 12|Randomized, Not Treated|0
7270027|NCT00413660|11484163|FG003|Up To Week 12|Randomized, Not Treated|1
7270028|NCT00413660|11484164|FG004|Up To Week 12|Randomized, Not Treated|0
7270029|NCT00413660|11484165|FG005|Up To Week 12|Randomized, Not Treated|0
7549611|NCT02946385|11908027|FG005|Overall Study|Lost to Follow-up|1
7549616|NCT02946515|11908062|FG000|Overall Study|Lost to Follow-up|2
7549617|NCT02946515|11908063|FG001|Overall Study|Lost to Follow-up|1
7549618|NCT02946580|11908071|FG000|Overall Study|Withdrawal by Subject|1
7549619|NCT02946580|11908072|FG001|Overall Study|Withdrawal by Subject|2
7549620|NCT02946580|11908071|FG000|Overall Study|Adverse Event|0
7549621|NCT02946580|11908072|FG001|Overall Study|Adverse Event|2
7549622|NCT02946580|11908071|FG000|Overall Study|Did not undergo posterior spinal fusion|0
7549623|NCT02946580|11908072|FG001|Overall Study|Did not undergo posterior spinal fusion|1
7549624|NCT02946918|11908087|FG000|Overall Study|Patient unblinded himself|1
7549625|NCT02946918|11908088|FG001|Overall Study|Patient unblinded himself|0
7549626|NCT02946918|11908087|FG000|Overall Study|Physician Decision|0
7549627|NCT02946918|11908088|FG001|Overall Study|Physician Decision|2
7549628|NCT02946918|11908087|FG000|Overall Study|Ran out of study medication|0
7549629|NCT02946918|11908088|FG001|Overall Study|Ran out of study medication|1
7549630|NCT02948582|11908130|FG000|Washout Period 1|Adverse Event|0
7549631|NCT02948582|11908131|FG001|Washout Period 1|Adverse Event|2
7549632|NCT02948582|11908132|FG002|Washout Period 1|Adverse Event|0
7549633|NCT02948582|11908133|FG003|Washout Period 1|Adverse Event|0
7549634|NCT02948582|11908134|FG004|Washout Period 1|Adverse Event|0
7549635|NCT02948582|11908135|FG005|Washout Period 1|Adverse Event|0
7549636|NCT02948582|11908130|FG000|Washout Period 1|Protocol Violation|0
7549637|NCT02948582|11908131|FG001|Washout Period 1|Protocol Violation|0
7549638|NCT02948582|11908132|FG002|Washout Period 1|Protocol Violation|0
7549639|NCT02948582|11908133|FG003|Washout Period 1|Protocol Violation|0
7549640|NCT02948582|11908134|FG004|Washout Period 1|Protocol Violation|0
7549641|NCT02948582|11908135|FG005|Washout Period 1|Protocol Violation|1
7549642|NCT02948582|11908130|FG000|Washout Period 2|Adverse Event|0
7549643|NCT02948582|11908131|FG001|Washout Period 2|Adverse Event|1
7549644|NCT02948582|11908132|FG002|Washout Period 2|Adverse Event|0
7549645|NCT02948582|11908133|FG003|Washout Period 2|Adverse Event|0
7549646|NCT02948582|11908134|FG004|Washout Period 2|Adverse Event|0
7549647|NCT02948582|11908135|FG005|Washout Period 2|Adverse Event|0
7549648|NCT02948582|11908130|FG000|Washout Period 2|personal reasons|0
7549649|NCT02948582|11908131|FG001|Washout Period 2|personal reasons|0
7549650|NCT02948582|11908132|FG002|Washout Period 2|personal reasons|0
7549651|NCT02948582|11908133|FG003|Washout Period 2|personal reasons|1
7549652|NCT02948582|11908134|FG004|Washout Period 2|personal reasons|0
7549653|NCT02948582|11908135|FG005|Washout Period 2|personal reasons|0
7549654|NCT02948582|11908130|FG000|Washout Period 4|Adverse Event|1
7549655|NCT02948582|11908131|FG001|Washout Period 4|Adverse Event|0
7549656|NCT02948582|11908132|FG002|Washout Period 4|Adverse Event|1
7549657|NCT02948582|11908133|FG003|Washout Period 4|Adverse Event|0
7549658|NCT02948582|11908134|FG004|Washout Period 4|Adverse Event|0
7549659|NCT02948582|11908135|FG005|Washout Period 4|Adverse Event|0
7549660|NCT02948634|11908151|FG000|Overall Study|Lack of efficacy and study suspended|10
7549661|NCT02948634|11908152|FG001|Overall Study|Lack of efficacy and study suspended|2
7549662|NCT02948777|11908158|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
7549666|NCT02949011|11908185|FG000|Overall Study|Adverse Event|6
7549667|NCT02949011|11908186|FG001|Overall Study|Adverse Event|7
7549668|NCT02949011|11908187|FG002|Overall Study|Adverse Event|3
7549669|NCT02949011|11908185|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7549670|NCT02949011|11908186|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
7549671|NCT02949011|11908187|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
7549672|NCT02949011|11908185|FG000|Overall Study|Protocol Deviation|5
7549673|NCT02949011|11908186|FG001|Overall Study|Protocol Deviation|3
7549674|NCT02949011|11908187|FG002|Overall Study|Protocol Deviation|3
7549675|NCT02949011|11908185|FG000|Overall Study|Lack of Efficacy|0
7549676|NCT02949011|11908186|FG001|Overall Study|Lack of Efficacy|2
7549677|NCT02949011|11908187|FG002|Overall Study|Lack of Efficacy|0
7549678|NCT02949011|11908185|FG000|Overall Study|Withdrawal by Subject|13
7549679|NCT02949011|11908186|FG001|Overall Study|Withdrawal by Subject|13
7549680|NCT02949011|11908187|FG002|Overall Study|Withdrawal by Subject|21
7549681|NCT02949011|11908185|FG000|Overall Study|Lost to Follow-up|7
7549682|NCT02949011|11908186|FG001|Overall Study|Lost to Follow-up|5
7549683|NCT02949011|11908187|FG002|Overall Study|Lost to Follow-up|5
7549684|NCT02949011|11908185|FG000|Overall Study|Death|0
7549685|NCT02949011|11908186|FG001|Overall Study|Death|0
7549686|NCT02949011|11908187|FG002|Overall Study|Death|1
7549687|NCT02949011|11908185|FG000|Overall Study|Miscellaneous|2
7549688|NCT02949011|11908186|FG001|Overall Study|Miscellaneous|4
7549689|NCT02949011|11908187|FG002|Overall Study|Miscellaneous|6
7549690|NCT02949024|11908197|FG000|Overall Study|Withdrawal by Subject|0
7549691|NCT02949024|11908198|FG001|Overall Study|Withdrawal by Subject|1
7549692|NCT02949271|11908215|FG000|Overall Study|Lack of Efficacy|5
7549693|NCT02949271|11908216|FG001|Overall Study|Lack of Efficacy|4
7549694|NCT02949271|11908215|FG000|Overall Study|Lost to Follow-up|3
7549695|NCT02949271|11908216|FG001|Overall Study|Lost to Follow-up|6
7549696|NCT02949271|11908215|FG000|Overall Study|Physician Decision|5
7549697|NCT02949271|11908216|FG001|Overall Study|Physician Decision|5
7549698|NCT02949271|11908215|FG000|Overall Study|Protocol Violation|6
7549699|NCT02949271|11908216|FG001|Overall Study|Protocol Violation|3
7549700|NCT02949271|11908215|FG000|Overall Study|Withdrawal by Subject|1
7549701|NCT02949271|11908216|FG001|Overall Study|Withdrawal by Subject|0
7549702|NCT02949271|11908215|FG000|Overall Study|Delivered prior to intervention|7
7549703|NCT02949271|11908216|FG001|Overall Study|Delivered prior to intervention|9
7549704|NCT02949271|11908215|FG000|Overall Study|Outside the window for cervical dilation|2
7549705|NCT02949271|11908216|FG001|Overall Study|Outside the window for cervical dilation|3
7549706|NCT02949362|11908224|FG000|Retrospective Period|Inform consent not signed by participant|4
7549707|NCT02949362|11908225|FG001|Retrospective Period|Inform consent not signed by participant|1
7549708|NCT02949362|11908226|FG002|Retrospective Period|Inform consent not signed by participant|0
7549709|NCT02949362|11908227|FG003|Retrospective Period|Inform consent not signed by participant|0
7549710|NCT02949362|11908224|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7549711|NCT02949362|11908225|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7549712|NCT02949362|11908226|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
7549713|NCT02949362|11908227|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
7549714|NCT02949362|11908224|FG000|Prospective Period|Other|0
7549715|NCT02949362|11908225|FG001|Prospective Period|Other|0
7549716|NCT02949362|11908226|FG002|Prospective Period|Other|0
7549717|NCT02949362|11908227|FG003|Prospective Period|Other|4
7549718|NCT02949908|11908263|FG000|Overall Study|Study termination|2
7549719|NCT02949973|11908276|FG000|Overall Study|Physician Decision|1
7549720|NCT02950545|11908299|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
7549721|NCT02950545|11908300|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
7549722|NCT02950545|11908301|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
7549723|NCT02950545|11908302|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
7549724|NCT02950545|11908303|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
7549725|NCT02950545|11908304|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
7549726|NCT02950545|11908299|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7549727|NCT02950545|11908300|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7549728|NCT02950545|11908301|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7549729|NCT02950545|11908302|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7578356|NCT03892564|11969353|FG000|Overall Study|Withdrawal by Subject|2
7578357|NCT03892707|11969360|FG000|Overall Study|Screen failure|6
7578358|NCT03892707|11969361|FG001|Overall Study|Screen failure|0
7578359|NCT03892707|11969360|FG000|Overall Study|Pain resolution|0
7578360|NCT03892707|11969361|FG001|Overall Study|Pain resolution|4
7578361|NCT03892707|11969360|FG000|Overall Study|Withdrawal by Subject|0
7578362|NCT03892707|11969361|FG001|Overall Study|Withdrawal by Subject|1
7578363|NCT03892707|11969360|FG000|Overall Study|Other (long business trip)|0
7578364|NCT03892707|11969361|FG001|Overall Study|Other (long business trip)|1
7578365|NCT03891641|11969380|FG000|Overall Study|Study Stoppage Due to COVID-19|2
7578366|NCT03891641|11969381|FG001|Overall Study|Study Stoppage Due to COVID-19|2
7578367|NCT03889704|11969387|FG000|Overall Study|Study terminated due to pandemic|1
7578368|NCT03888391|11969401|FG000|Overall Study|Lost to Follow-up|15
7578369|NCT03888482|11969407|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
7578370|NCT03888482|11969408|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
7578371|NCT03888482|11969407|FG000|Second Wear (8 -1/+2 Days)|Other|1
7578372|NCT03888482|11969408|FG001|Second Wear (8 -1/+2 Days)|Other|0
7578373|NCT03887442|11969443|FG000|Overall Study|Adverse Event|1
7578374|NCT03887442|11969444|FG001|Overall Study|Adverse Event|0
7578375|NCT03878602|11969468|FG000|Overall Study|cord blood donation|7
7578376|NCT03878602|11969469|FG001|Overall Study|cord blood donation|1
7578377|NCT03878602|11969468|FG000|Overall Study|incomplete data collection|2
7578378|NCT03878602|11969469|FG001|Overall Study|incomplete data collection|0
7578379|NCT03875118|11969479|FG000|Overall Study|Withdrawal by Subject|4
7578380|NCT03875118|11969480|FG001|Overall Study|Withdrawal by Subject|4
7578381|NCT03873987|11969488|FG000|Overall Study|Adverse Event|1
7578382|NCT03873987|11969489|FG001|Overall Study|Adverse Event|0
7578383|NCT03873987|11969488|FG000|Overall Study|staff was unable to start a new IV line|1
7578384|NCT03873987|11969489|FG001|Overall Study|staff was unable to start a new IV line|0
7578385|NCT03873987|11969488|FG000|Overall Study|Lost to Follow-up|0
7578386|NCT03873987|11969489|FG001|Overall Study|Lost to Follow-up|1
7578387|NCT03878758|11969515|FG000|Overall Study|Withdrawal by Subject|1
7549730|NCT02950545|11908303|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
7549731|NCT02950545|11908304|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
7549732|NCT02950545|11908299|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
7549733|NCT02950545|11908300|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
7549734|NCT02950545|11908301|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
7549735|NCT02950545|11908302|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
7549736|NCT02950545|11908303|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
7578388|NCT03878758|11969515|FG000|Overall Study|Protocol defined|2
7549737|NCT02950545|11908304|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
7549738|NCT02950545|11908299|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
7549739|NCT02950545|11908300|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7549740|NCT02950545|11908301|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7549741|NCT02950545|11908302|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7549742|NCT02950545|11908303|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7549743|NCT02950545|11908304|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
7549744|NCT02950545|11908299|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
7549745|NCT02950545|11908300|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
7549746|NCT02950545|11908301|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
7549747|NCT02950545|11908302|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
7549748|NCT02950545|11908303|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
7549749|NCT02950545|11908304|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
7549750|NCT02950558|11908312|FG000|Overall Study|Lost to Follow-up|2
7549751|NCT02950558|11908313|FG001|Overall Study|Lost to Follow-up|0
7549752|NCT02950831|11908329|FG000|Overall Study|Lost to Follow-up|1
7549753|NCT02950831|11908329|FG000|Overall Study|Withdrawal by Subject|3
7549754|NCT02950831|11908329|FG000|Overall Study|stimulation trail failure|5
7578389|NCT03878758|11969515|FG000|Overall Study|Improper consent documentation|1
7578390|NCT03849300|11969532|FG000|Overall Study|move out to different area|1
7578391|NCT03849300|11969533|FG001|Overall Study|move out to different area|3
7578392|NCT03849300|11969534|FG002|Overall Study|move out to different area|1
7578393|NCT03849300|11969535|FG003|Overall Study|move out to different area|4
7578394|NCT03849300|11969532|FG000|Overall Study|scheduling/transportation conflict|4
7578395|NCT03849300|11969533|FG001|Overall Study|scheduling/transportation conflict|4
7578396|NCT03849300|11969534|FG002|Overall Study|scheduling/transportation conflict|3
7578397|NCT03849300|11969535|FG003|Overall Study|scheduling/transportation conflict|2
7578398|NCT03883113|11969577|FG000|Overall Study|Physician Decision|4
7578399|NCT03883113|11969578|FG001|Overall Study|Physician Decision|2
7578400|NCT03883113|11969577|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
7578401|NCT03883113|11969578|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
7578402|NCT03883113|11969577|FG000|Overall Study|Pregnancy|1
7578403|NCT03883113|11969578|FG001|Overall Study|Pregnancy|0
7578404|NCT03883113|11969577|FG000|Overall Study|Adverse Event|0
7578405|NCT03883113|11969578|FG001|Overall Study|Adverse Event|1
7578406|NCT03883113|11969577|FG000|Overall Study|Withdrawal by Subject|1
7578407|NCT03883113|11969578|FG001|Overall Study|Withdrawal by Subject|2
7578408|NCT03883113|11969577|FG000|Overall Study|Lost to Follow-up|1
7578409|NCT03883113|11969578|FG001|Overall Study|Lost to Follow-up|0
7578410|NCT03880227|11969600|FG000|First Visit|Withdrawal by Subject|1
7578411|NCT03880227|11969601|FG001|First Visit|Withdrawal by Subject|0
7578412|NCT03880227|11969602|FG002|First Visit|Withdrawal by Subject|0
7578413|NCT03880227|11969603|FG003|First Visit|Withdrawal by Subject|0
7578414|NCT03880227|11969600|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
7578415|NCT03880227|11969601|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
7578416|NCT03880227|11969602|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
7578417|NCT03880227|11969603|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
7578418|NCT03880227|11969600|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
7578419|NCT03880227|11969601|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
7578420|NCT03880227|11969602|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
7578421|NCT03880227|11969603|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
7578422|NCT03880227|11969600|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7578423|NCT03880227|11969601|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7578424|NCT03880227|11969602|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
7578425|NCT03880227|11969603|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
7578426|NCT03876743|11969617|FG000|Overall Study|Lost to Follow-up|6
7578427|NCT03876743|11969618|FG001|Overall Study|Lost to Follow-up|4
7578428|NCT03876743|11969619|FG002|Overall Study|Lost to Follow-up|4
7578429|NCT03876743|11969620|FG003|Overall Study|Lost to Follow-up|7
7578430|NCT03885934|11969640|FG000|Overall Study|Withdrawn by Parent/Guardian|1
7578431|NCT03885934|11969641|FG001|Overall Study|Withdrawn by Parent/Guardian|0
7578432|NCT03885934|11969642|FG002|Overall Study|Withdrawn by Parent/Guardian|0
7578433|NCT03885934|11969643|FG003|Overall Study|Withdrawn by Parent/Guardian|0
7578434|NCT03885934|11969644|FG004|Overall Study|Withdrawn by Parent/Guardian|0
7624597|NCT01813305|12035749|FG000|Overall Study|Safety Concern|4
7624598|NCT01813305|12035750|FG001|Overall Study|Safety Concern|0
7624599|NCT01813305|12035749|FG000|Overall Study|Ulcer became worse|4
7624600|NCT01813305|12035750|FG001|Overall Study|Ulcer became worse|0
7624601|NCT01813305|12035749|FG000|Overall Study|Physician Decision|4
7624602|NCT01813305|12035750|FG001|Overall Study|Physician Decision|0
7624603|NCT01813305|12035749|FG000|Overall Study|Lost to Follow-up|3
7624604|NCT01813305|12035750|FG001|Overall Study|Lost to Follow-up|1
7624605|NCT01813305|12035749|FG000|Overall Study|Protocol Violation|1
7624606|NCT01813305|12035750|FG001|Overall Study|Protocol Violation|0
7624607|NCT01813305|12035749|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7
7624608|NCT01813305|12035750|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2
7624609|NCT01680965|12035762|FG000|Overall Study|Death|0
7624610|NCT01680965|12035763|FG001|Overall Study|Death|0
7549755|NCT02951156|11908361|FG000|Overall Study|Death|3
7549756|NCT02951156|11908362|FG001|Overall Study|Death|8
7549757|NCT02951156|11908363|FG002|Overall Study|Death|5
7549758|NCT02951156|11908361|FG000|Overall Study|Progressive disease|1
7549759|NCT02951156|11908362|FG001|Overall Study|Progressive disease|0
7549760|NCT02951156|11908363|FG002|Overall Study|Progressive disease|1
7549761|NCT02951156|11908361|FG000|Overall Study|Withdrawal by Subject|0
7549762|NCT02951156|11908362|FG001|Overall Study|Withdrawal by Subject|0
7549763|NCT02951156|11908363|FG002|Overall Study|Withdrawal by Subject|1
7549764|NCT02951156|11908361|FG000|Overall Study|Study terminated by sponsor|0
7549765|NCT02951156|11908362|FG001|Overall Study|Study terminated by sponsor|0
7549766|NCT02951156|11908363|FG002|Overall Study|Study terminated by sponsor|1
7549767|NCT02951156|11908361|FG000|Overall Study|Other|5
7549768|NCT02951156|11908362|FG001|Overall Study|Other|1
7549769|NCT02951156|11908363|FG002|Overall Study|Other|2
7549770|NCT02951429|11908488|FG000|Overall Study|Adverse Event|3
7549771|NCT02951429|11908489|FG001|Overall Study|Adverse Event|7
7549772|NCT02951429|11908488|FG000|Overall Study|Death|28
7549773|NCT02951429|11908489|FG001|Overall Study|Death|36
7549774|NCT02951429|11908488|FG000|Overall Study|Lack of Efficacy|0
7549775|NCT02951429|11908489|FG001|Overall Study|Lack of Efficacy|1
7549776|NCT02951429|11908488|FG000|Overall Study|Lost to Follow-up|0
7549777|NCT02951429|11908489|FG001|Overall Study|Lost to Follow-up|1
7549778|NCT02951429|11908488|FG000|Overall Study|Lung Transplantation|9
7549779|NCT02951429|11908489|FG001|Overall Study|Lung Transplantation|6
7549780|NCT02951429|11908488|FG000|Overall Study|Other|1
7549781|NCT02951429|11908489|FG001|Overall Study|Other|3
7549782|NCT02951429|11908488|FG000|Overall Study|Progressive Disease|1
7549783|NCT02951429|11908489|FG001|Overall Study|Progressive Disease|1
7549784|NCT02951429|11908488|FG000|Overall Study|Withdrawal by Subject|7
7549785|NCT02951429|11908489|FG001|Overall Study|Withdrawal by Subject|11
7549786|NCT02951429|11908488|FG000|Overall Study|Participant ongoing in the study|23
7549787|NCT02951429|11908489|FG001|Overall Study|Participant ongoing in the study|17
7549788|NCT02951533|11908497|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
7549789|NCT02951533|11908498|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
7549790|NCT02951533|11908499|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
7549791|NCT02951533|11908497|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7549792|NCT02951533|11908498|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
7549793|NCT02951533|11908499|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
7549794|NCT02951533|11908497|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
7549795|NCT02951533|11908498|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
7549796|NCT02951533|11908499|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
7549797|NCT02951533|11908497|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7549798|NCT02951533|11908498|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
7549799|NCT02951533|11908499|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
7549800|NCT02951533|11908497|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7549801|NCT02951533|11908498|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
7549802|NCT02951533|11908499|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
7549803|NCT02951533|11908497|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
7549804|NCT02951533|11908498|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7549805|NCT02951533|11908499|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
7549806|NCT02951533|11908497|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7549807|NCT02951533|11908498|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
7549808|NCT02951533|11908499|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
7549809|NCT02951533|11908497|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
7549810|NCT02951533|11908498|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
7549811|NCT02951533|11908499|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
7549812|NCT02951533|11908497|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
7549813|NCT02951533|11908498|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7549814|NCT02951533|11908499|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
7549815|NCT02951533|11908497|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
7549816|NCT02951533|11908498|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7549817|NCT02951533|11908499|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
7549818|NCT02951533|11908497|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7549819|NCT02951533|11908498|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
7549820|NCT02951533|11908499|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
7549821|NCT02951780|11908534|FG000|Period 1|Adverse Event|0
7549822|NCT02951780|11908535|FG001|Period 1|Adverse Event|0
7549823|NCT02951780|11908536|FG002|Period 1|Adverse Event|0
7549824|NCT02951780|11908537|FG003|Period 1|Adverse Event|1
7549825|NCT02951780|11908538|FG004|Period 1|Adverse Event|0
7549826|NCT02951780|11908539|FG005|Period 1|Adverse Event|0
7549827|NCT02951780|11908540|FG006|Period 1|Adverse Event|0
7549828|NCT02951780|11908541|FG007|Period 1|Adverse Event|0
7549829|NCT02951780|11908542|FG008|Period 1|Adverse Event|0
7549830|NCT02951780|11908534|FG000|Period 1|Scheduling Conflicts|0
7549831|NCT02951780|11908535|FG001|Period 1|Scheduling Conflicts|0
7549832|NCT02951780|11908536|FG002|Period 1|Scheduling Conflicts|0
7549833|NCT02951780|11908537|FG003|Period 1|Scheduling Conflicts|0
7549834|NCT02951780|11908538|FG004|Period 1|Scheduling Conflicts|0
7549835|NCT02951780|11908539|FG005|Period 1|Scheduling Conflicts|0
7549836|NCT02951780|11908540|FG006|Period 1|Scheduling Conflicts|0
7549837|NCT02951780|11908541|FG007|Period 1|Scheduling Conflicts|1
7549838|NCT02951780|11908542|FG008|Period 1|Scheduling Conflicts|0
7549839|NCT02951780|11908534|FG000|Period 2|Scheduling Conflicts|0
7549840|NCT02951780|11908535|FG001|Period 2|Scheduling Conflicts|0
7549841|NCT02951780|11908536|FG002|Period 2|Scheduling Conflicts|0
7549842|NCT02951780|11908537|FG003|Period 2|Scheduling Conflicts|0
7549843|NCT02951780|11908538|FG004|Period 2|Scheduling Conflicts|0
7549844|NCT02951780|11908539|FG005|Period 2|Scheduling Conflicts|0
7549845|NCT02951780|11908540|FG006|Period 2|Scheduling Conflicts|0
7549846|NCT02951780|11908541|FG007|Period 2|Scheduling Conflicts|1
7549847|NCT02951780|11908542|FG008|Period 2|Scheduling Conflicts|0
7549848|NCT02951819|11908564|FG000|Overall Study|Death|9
7549849|NCT02951819|11908565|FG001|Overall Study|Death|7
7549850|NCT02951819|11908564|FG000|Overall Study|Withdrawal by Subject|3
7549851|NCT02951819|11908565|FG001|Overall Study|Withdrawal by Subject|0
7549852|NCT02951819|11908564|FG000|Overall Study|Adverse Event|1
7549853|NCT02951819|11908565|FG001|Overall Study|Adverse Event|0
7549854|NCT02951819|11908564|FG000|Overall Study|Lack of Efficacy|4
7549855|NCT02951819|11908565|FG001|Overall Study|Lack of Efficacy|0
7549856|NCT02951819|11908564|FG000|Overall Study|Lost to Follow-up|1
7549857|NCT02951819|11908565|FG001|Overall Study|Lost to Follow-up|0
7549858|NCT02951819|11908564|FG000|Overall Study|Progressive Disease|1
7549859|NCT02951819|11908565|FG001|Overall Study|Progressive Disease|0
7549860|NCT02951819|11908564|FG000|Overall Study|Other|9
7549861|NCT02951819|11908565|FG001|Overall Study|Other|0
7549862|NCT02951988|11908587|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
7549863|NCT02951988|11908588|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
7549864|NCT02951988|11908589|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
7549865|NCT02951988|11908590|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
7549866|NCT02951988|11908587|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
7549867|NCT02951988|11908588|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
7549868|NCT02951988|11908589|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
7549869|NCT02951988|11908590|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
7549870|NCT02951988|11908587|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
7549871|NCT02951988|11908588|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
7549872|NCT02951988|11908589|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
7549873|NCT02951988|11908590|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
7549874|NCT02951988|11908587|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
7549875|NCT02951988|11908588|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
7549876|NCT02951988|11908589|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
7549877|NCT02951988|11908590|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
7549878|NCT02951988|11908587|FG000|Open-Label Treatment Period|Protocol Violation|22
7549879|NCT02951988|11908588|FG001|Open-Label Treatment Period|Protocol Violation|0
7549880|NCT02951988|11908589|FG002|Open-Label Treatment Period|Protocol Violation|0
7549881|NCT02951988|11908590|FG003|Open-Label Treatment Period|Protocol Violation|0
7549882|NCT02951988|11908587|FG000|Open-Label Treatment Period|Pregnancy|2
7549883|NCT02951988|11908588|FG001|Open-Label Treatment Period|Pregnancy|0
7549884|NCT02951988|11908589|FG002|Open-Label Treatment Period|Pregnancy|0
7549885|NCT02951988|11908590|FG003|Open-Label Treatment Period|Pregnancy|0
7549886|NCT02951988|11908587|FG000|Open-Label Treatment Period|Lost to Follow-up|28
7549887|NCT02951988|11908588|FG001|Open-Label Treatment Period|Lost to Follow-up|0
7549888|NCT02951988|11908589|FG002|Open-Label Treatment Period|Lost to Follow-up|0
7549889|NCT02951988|11908590|FG003|Open-Label Treatment Period|Lost to Follow-up|0
7549890|NCT02951988|11908587|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
7549891|NCT02951988|11908588|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
7549892|NCT02951988|11908589|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
7549893|NCT02951988|11908590|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
7549894|NCT02951988|11908587|FG000|Open-Label Treatment Period|Lack of Efficacy|49
7549895|NCT02951988|11908588|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7549896|NCT02951988|11908589|FG002|Open-Label Treatment Period|Lack of Efficacy|0
7549897|NCT02951988|11908590|FG003|Open-Label Treatment Period|Lack of Efficacy|0
7549898|NCT02951988|11908587|FG000|Open-Label Treatment Period|Adverse Event|45
7549899|NCT02951988|11908588|FG001|Open-Label Treatment Period|Adverse Event|0
7549900|NCT02951988|11908589|FG002|Open-Label Treatment Period|Adverse Event|0
7549901|NCT02951988|11908590|FG003|Open-Label Treatment Period|Adverse Event|0
7549902|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
7549903|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
7549904|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
7549905|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
7549906|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
7549907|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
7549908|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
7549909|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
7624611|NCT01680965|12035764|FG002|Overall Study|Death|0
7549910|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
7549911|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
7549912|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
7549913|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
7549914|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Protocol Violation|0
7549915|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Protocol Violation|4
7549916|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Protocol Violation|4
7549917|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Protocol Violation|8
7549918|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Pregnancy|0
7549919|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Pregnancy|1
7578435|NCT03885934|11969645|FG005|Overall Study|Withdrawn by Parent/Guardian|0
7578436|NCT03885726|11969659|FG000|Overall Study|Staffing issues/lost interest|1
7578437|NCT03885726|11969659|FG000|Overall Study|Early discharge from hospital|3
7578438|NCT03883386|11969684|FG000|First Assignment|Lost to Follow-up|1
7578439|NCT03883386|11969685|FG001|First Assignment|Lost to Follow-up|0
7578440|NCT03883386|11969684|FG000|First Assignment|Withdrawal by Subject|1
7578441|NCT03883386|11969685|FG001|First Assignment|Withdrawal by Subject|1
7578442|NCT03882801|11969697|FG000|Period 1|Adverse Event|0
7578443|NCT03882801|11969698|FG001|Period 1|Adverse Event|1
7578444|NCT03882801|11969697|FG000|Period 1|Non-compliance with study drug|1
7578445|NCT03882801|11969698|FG001|Period 1|Non-compliance with study drug|1
7578446|NCT03882801|11969697|FG000|Period 1|Never treated with study drug|1
7578447|NCT03882801|11969698|FG001|Period 1|Never treated with study drug|0
7578448|NCT03882801|11969697|FG000|Washout Period|Physician Decision|0
7578449|NCT03882801|11969698|FG001|Washout Period|Physician Decision|1
7578450|NCT03882801|11969697|FG000|Period 2|Non-compliance with study drug|0
7578451|NCT03882801|11969698|FG001|Period 2|Non-compliance with study drug|1
7578452|NCT03882424|11969709|FG000|Overall Study|Lost to Follow-up|3
7578453|NCT03882424|11969710|FG001|Overall Study|Lost to Follow-up|0
7578454|NCT03882424|11969711|FG002|Overall Study|Lost to Follow-up|0
7578455|NCT03882424|11969709|FG000|Overall Study|schedule conflict|1
7578456|NCT03882424|11969710|FG001|Overall Study|schedule conflict|0
7578457|NCT03882424|11969711|FG002|Overall Study|schedule conflict|0
7624612|NCT01680965|12035765|FG003|Overall Study|Death|6
7549920|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Pregnancy|1
7549921|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Pregnancy|0
7549922|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7549923|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
7549924|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
7549925|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
7549926|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7549927|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
7549928|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
7549929|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
7549930|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Adverse Event|0
7549931|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Adverse Event|8
7549932|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Adverse Event|3
7549933|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Adverse Event|6
7549934|NCT02951988|11908587|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
7549935|NCT02951988|11908588|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
7549936|NCT02951988|11908589|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
7549937|NCT02951988|11908590|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
7549938|NCT02952001|11908602|FG000|Overall Study|Adverse Event|3
7549939|NCT02952001|11908603|FG001|Overall Study|Adverse Event|0
7549940|NCT02952001|11908602|FG000|Overall Study|Prohibited therapy|10
7549941|NCT02952001|11908603|FG001|Overall Study|Prohibited therapy|3
7549942|NCT02952001|11908602|FG000|Overall Study|Due to Posterior Capsular Opacity|1
7549943|NCT02952001|11908603|FG001|Overall Study|Due to Posterior Capsular Opacity|0
7549944|NCT02952261|11908612|FG000|Overall Study|Withdrawal by Subject|4
7549945|NCT02952261|11908613|FG001|Overall Study|Withdrawal by Subject|5
7549946|NCT02952261|11908612|FG000|Overall Study|Protocol Violation|1
7549947|NCT02952261|11908613|FG001|Overall Study|Protocol Violation|0
7549948|NCT02952313|11908619|FG000|Primary Endpoint|Lost to Follow-up|4
7549949|NCT02952313|11908619|FG000|Primary Endpoint|Withdrawal by Subject|1
7549950|NCT02952313|11908619|FG000|Primary Endpoint|Lack of Efficacy|1
7549951|NCT02952313|11908619|FG000|Primary Endpoint|Missed visit|1
7549952|NCT02952313|11908619|FG000|Long-term Follow-up|Lost to Follow-up|12
7549953|NCT02952313|11908619|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
7549954|NCT02952313|11908619|FG000|Long-term Follow-up|Lack of Efficacy|6
7549955|NCT02952313|11908619|FG000|Long-term Follow-up|Withdrawal by Subject|5
7549956|NCT02952313|11908619|FG000|Long-term Follow-up|Physician Decision|1
7549957|NCT02952313|11908619|FG000|Long-term Follow-up|Death|1
7549958|NCT02952586|11908626|FG000|Lead-In Phase (7 Days)|Death|0
7549959|NCT02952586|11908627|FG001|Lead-In Phase (7 Days)|Death|1
7549960|NCT02952586|11908626|FG000|Lead-In Phase (7 Days)|Adverse Event|3
7549961|NCT02952586|11908627|FG001|Lead-In Phase (7 Days)|Adverse Event|0
7549962|NCT02952586|11908626|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
7549963|NCT02952586|11908627|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
7624613|NCT00152477|12035811|FG000|Chemotherapy Period|Adverse Event|9
7549964|NCT02952586|11908626|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7549965|NCT02952586|11908627|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
7549966|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
7549967|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
7549968|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7549969|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
7549970|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
7549971|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
7549972|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
7549973|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
7549974|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
7549975|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
7549976|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7549977|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
7549978|NCT02952586|11908626|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
7549979|NCT02952586|11908627|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
7549980|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Death|3
7549981|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Death|8
7549982|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
7549983|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
7549984|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
7549985|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
7549986|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
7549987|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
7549988|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
7549989|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
7549990|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7549991|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
7549992|NCT02952586|11908626|FG000|CRT for Cisplatin (63 Days)|Other|1
7549993|NCT02952586|11908627|FG001|CRT for Cisplatin (63 Days)|Other|1
7549994|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Death|5
7549995|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Death|8
7549996|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Adverse Event|5
7549997|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Adverse Event|5
7549998|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
7549999|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
7550000|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
7550001|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
7550002|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
7550003|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
7550004|NCT02952586|11908626|FG000|CRT for IMRT (63 Days)|Other|1
7550005|NCT02952586|11908627|FG001|CRT for IMRT (63 Days)|Other|0
7550006|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Death|17
7550007|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Death|11
7550008|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Progressive disease|60
7550009|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Progressive disease|54
7550010|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Adverse Event|24
7550011|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Adverse Event|21
7550012|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7550013|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
7550014|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Physician Decision|1
7550015|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Physician Decision|1
7550016|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
7550017|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
7550018|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
7550019|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
7550020|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
7550021|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
7550022|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Other|2
7550023|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Other|1
7550024|NCT02952586|11908626|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
7550025|NCT02952586|11908627|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
7550026|NCT02952586|11908626|FG000|Follow-Up Phase (90 Days)|Death|12
7550027|NCT02952586|11908627|FG001|Follow-Up Phase (90 Days)|Death|10
7550028|NCT02952586|11908626|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
7550029|NCT02952586|11908627|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
7550030|NCT02952586|11908626|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7550031|NCT02952586|11908627|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
7550032|NCT02952586|11908626|FG000|Follow-Up Phase (90 Days)|Other|7
7550033|NCT02952586|11908627|FG001|Follow-Up Phase (90 Days)|Other|5
7550034|NCT02952586|11908626|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
7550035|NCT02952586|11908627|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
7550036|NCT02952586|11908626|FG000|LT Follow-up (up to 45 Months)|Death|51
7550037|NCT02952586|11908627|FG001|LT Follow-up (up to 45 Months)|Death|31
7550038|NCT02952586|11908626|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
7550039|NCT02952586|11908627|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
7550040|NCT02952586|11908626|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
7550041|NCT02952586|11908627|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
7550042|NCT02952586|11908626|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
7550043|NCT02952586|11908627|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
7550044|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
7550045|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
7550046|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
7550047|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7550048|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
7550049|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
7550050|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
7550051|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
7550052|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
7550053|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
7550054|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
7550055|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
7550056|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
7550057|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
7550058|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
7550059|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
7550060|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
7550061|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
7550062|NCT02952820|11908637|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
7550063|NCT02952820|11908638|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
7550064|NCT02952820|11908639|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
7550065|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Adverse Event|0
7550066|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Adverse Event|6
7550067|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Adverse Event|5
7550068|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
7550069|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
7550070|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
7550071|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Subject choice|0
7550072|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Subject choice|10
7550073|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Subject choice|7
7550074|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
7550075|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
7550076|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
7550077|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
7550078|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
7550079|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
7550080|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Other than specified|0
7550081|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Other than specified|6
7550082|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Other than specified|2
7550083|NCT02952820|11908637|FG000|Active Treatment Period (6 Months)|Not treated|0
7550084|NCT02952820|11908638|FG001|Active Treatment Period (6 Months)|Not treated|0
7550085|NCT02952820|11908639|FG002|Active Treatment Period (6 Months)|Not treated|1
7550086|NCT02952898|11908718|FG000|Overall Study|Withdrawal by Subject|10
7550087|NCT02952898|11908719|FG001|Overall Study|Withdrawal by Subject|8
7550088|NCT02952898|11908720|FG002|Overall Study|Withdrawal by Subject|8
7550089|NCT02952898|11908718|FG000|Overall Study|Adverse Event|8
7550090|NCT02952898|11908719|FG001|Overall Study|Adverse Event|8
7550091|NCT02952898|11908720|FG002|Overall Study|Adverse Event|3
7550092|NCT02952898|11908718|FG000|Overall Study|Lost to Follow-up|3
7550093|NCT02952898|11908719|FG001|Overall Study|Lost to Follow-up|2
7550094|NCT02952898|11908720|FG002|Overall Study|Lost to Follow-up|2
7550095|NCT02952898|11908718|FG000|Overall Study|Non-compliance with study drug|1
7550096|NCT02952898|11908719|FG001|Overall Study|Non-compliance with study drug|1
7550097|NCT02952898|11908720|FG002|Overall Study|Non-compliance with study drug|2
7550098|NCT02953262|11908732|FG000|Overall Study|Used portal during 6 months prior to randomization|3
7550099|NCT02953262|11908733|FG001|Overall Study|Used portal during 6 months prior to randomization|6
7550100|NCT02953262|11908734|FG002|Overall Study|Used portal during 6 months prior to randomization|3
7550101|NCT02953262|11908735|FG003|Overall Study|Used portal during 6 months prior to randomization|3
7550102|NCT02953314|11908751|FG000|Overall Study|Adverse Event|0
7550103|NCT02953314|11908752|FG001|Overall Study|Adverse Event|1
7550104|NCT02953314|11908751|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
7550105|NCT02953314|11908752|FG001|Overall Study|Withdrawal of consent (not due to AE)|2
7550106|NCT02953639|11908777|FG000|Overall Study|Adverse Event|2
7550107|NCT02953639|11908778|FG001|Overall Study|Adverse Event|0
7550108|NCT02953639|11908779|FG002|Overall Study|Adverse Event|1
7550109|NCT02953639|11908777|FG000|Overall Study|Lost to Follow-up|8
7550110|NCT02953639|11908778|FG001|Overall Study|Lost to Follow-up|4
7550111|NCT02953639|11908779|FG002|Overall Study|Lost to Follow-up|3
7550112|NCT02953639|11908777|FG000|Overall Study|Non-Compliance With Study Drug|0
7550113|NCT02953639|11908778|FG001|Overall Study|Non-Compliance With Study Drug|2
7550114|NCT02953639|11908779|FG002|Overall Study|Non-Compliance With Study Drug|1
7550115|NCT02953639|11908777|FG000|Overall Study|Multiple Reasons|1
7550116|NCT02953639|11908778|FG001|Overall Study|Multiple Reasons|0
7550117|NCT02953639|11908779|FG002|Overall Study|Multiple Reasons|1
7550118|NCT02953639|11908777|FG000|Overall Study|Physician Decision|1
7550119|NCT02953639|11908778|FG001|Overall Study|Physician Decision|0
7550120|NCT02953639|11908779|FG002|Overall Study|Physician Decision|0
7550121|NCT02953639|11908777|FG000|Overall Study|Withdrawal by Subject|7
7550122|NCT02953639|11908778|FG001|Overall Study|Withdrawal by Subject|8
7550123|NCT02953639|11908779|FG002|Overall Study|Withdrawal by Subject|10
7550124|NCT02953639|11908777|FG000|Overall Study|Completed or Discontinued information is missing|1
7550125|NCT02953639|11908778|FG001|Overall Study|Completed or Discontinued information is missing|0
7550126|NCT02953639|11908779|FG002|Overall Study|Completed or Discontinued information is missing|0
7550127|NCT02953678|11908789|FG000|Overall Study|Adverse Event|20
7550128|NCT02953678|11908789|FG000|Overall Study|Death|7
7550129|NCT02953678|11908789|FG000|Overall Study|Physician Decision|23
7550130|NCT02953678|11908789|FG000|Overall Study|Progressive Disease of GVHD|7
7550131|NCT02953678|11908789|FG000|Overall Study|Relapse of Underlying Malignancy|3
7550132|NCT02953678|11908789|FG000|Overall Study|Withdrawal by participant|3
7550133|NCT02953678|11908789|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
7550134|NCT02953678|11908789|FG000|Overall Study|Participants were transferred to commercial product.|3
7550135|NCT02953782|11908802|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
7550136|NCT02953782|11908803|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
7550137|NCT02953782|11908804|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7550138|NCT02953782|11908805|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
7550139|NCT02953782|11908806|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
7550140|NCT02953782|11908807|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7550141|NCT02953782|11908808|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7550142|NCT02953782|11908809|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
7550143|NCT02953782|11908802|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7550144|NCT02953782|11908803|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7550145|NCT02953782|11908804|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
7550146|NCT02953782|11908805|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7550147|NCT02953782|11908806|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
7550148|NCT02953782|11908807|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7550149|NCT02953782|11908808|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7550150|NCT02953782|11908809|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
7550151|NCT02953782|11908802|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7550152|NCT02953782|11908803|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7550153|NCT02953782|11908804|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7550154|NCT02953782|11908805|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7550155|NCT02953782|11908806|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
7550156|NCT02953782|11908807|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7550157|NCT02953782|11908808|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7550158|NCT02953782|11908809|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
7578458|NCT03880266|11969744|FG000|Overall Study|Withdrawal by Subject|0
7578459|NCT03880266|11969745|FG001|Overall Study|Withdrawal by Subject|1
7578460|NCT03880266|11969746|FG002|Overall Study|Withdrawal by Subject|1
7578461|NCT03880266|11969747|FG003|Overall Study|Withdrawal by Subject|0
7578462|NCT03880266|11969748|FG004|Overall Study|Withdrawal by Subject|0
7578463|NCT03880266|11969749|FG005|Overall Study|Withdrawal by Subject|0
7578464|NCT03880266|11969750|FG006|Overall Study|Withdrawal by Subject|0
7578465|NCT03880266|11969751|FG007|Overall Study|Withdrawal by Subject|0
7578466|NCT03878160|11969794|FG000|Overall Study|Lost to Follow-up|1
7578467|NCT03878160|11969795|FG001|Overall Study|Lost to Follow-up|1
7578468|NCT03878160|11969796|FG002|Overall Study|Lost to Follow-up|1
7578469|NCT03878160|11969794|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
7578470|NCT03878160|11969795|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7578471|NCT03878160|11969796|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
7578472|NCT03864627|11969806|FG000|Overall Study|Adverse Event|0
7578473|NCT03864627|11969807|FG001|Overall Study|Adverse Event|1
7550159|NCT02953782|11908802|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550160|NCT02953782|11908803|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550161|NCT02953782|11908804|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7550162|NCT02953782|11908805|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
7550163|NCT02953782|11908806|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550164|NCT02953782|11908807|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550165|NCT02953782|11908808|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550166|NCT02953782|11908809|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
7550167|NCT02953782|11908802|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7550168|NCT02953782|11908803|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7550169|NCT02953782|11908804|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7550170|NCT02953782|11908805|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7550171|NCT02953782|11908806|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
7550172|NCT02953782|11908807|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
7550173|NCT02953782|11908808|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
7550174|NCT02953782|11908809|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
7550175|NCT02953782|11908802|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7550176|NCT02953782|11908803|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7550177|NCT02953782|11908804|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7550178|NCT02953782|11908805|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7550179|NCT02953782|11908806|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
7550180|NCT02953782|11908807|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
7550181|NCT02953782|11908808|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
7550182|NCT02953782|11908809|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
7550183|NCT02953782|11908802|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7550184|NCT02953782|11908803|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7550185|NCT02953782|11908804|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7550186|NCT02953782|11908805|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7550187|NCT02953782|11908806|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
7550188|NCT02953782|11908807|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7550189|NCT02953782|11908808|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
7550190|NCT02953782|11908809|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
7550191|NCT02953782|11908802|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550192|NCT02953782|11908803|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550193|NCT02953782|11908804|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550194|NCT02953782|11908805|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7270030|NCT00413660|11484166|FG006|Up To Week 12|Randomized, Not Treated|0
7270031|NCT00413660|11484167|FG007|Up To Week 12|Randomized, Not Treated|0
7270032|NCT00413660|11484168|FG008|Up To Week 12|Randomized, Not Treated|0
7270033|NCT00413660|11484169|FG009|Up To Week 12|Randomized, Not Treated|0
7270034|NCT00413660|11484170|FG010|Up To Week 12|Randomized, Not Treated|0
7270035|NCT00413660|11484160|FG000|Up To Week 12|Other|3
7550195|NCT02953782|11908806|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550196|NCT02953782|11908807|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550197|NCT02953782|11908808|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
7270036|NCT00413660|11484161|FG001|Up To Week 12|Other|1
7270037|NCT00413660|11484162|FG002|Up To Week 12|Other|6
7270038|NCT00413660|11484163|FG003|Up To Week 12|Other|1
7550198|NCT02953782|11908809|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
7550199|NCT02953821|11908832|FG000|Overall Study|Adverse Event|0
7550200|NCT02953821|11908833|FG001|Overall Study|Adverse Event|4
7550201|NCT02953821|11908832|FG000|Overall Study|Death|1
7550202|NCT02953821|11908833|FG001|Overall Study|Death|0
7550203|NCT02953821|11908832|FG000|Overall Study|Progressive Disease|5
7550204|NCT02953821|11908833|FG001|Overall Study|Progressive Disease|1
7550205|NCT02953821|11908832|FG000|Overall Study|Lost to Follow-up|2
7550206|NCT02953821|11908833|FG001|Overall Study|Lost to Follow-up|0
7550207|NCT02953821|11908832|FG000|Overall Study|Physician Decision|1
7550208|NCT02953821|11908833|FG001|Overall Study|Physician Decision|1
7550209|NCT02953821|11908832|FG000|Overall Study|Withdrawal by Subject|3
7550210|NCT02953821|11908833|FG001|Overall Study|Withdrawal by Subject|3
7550211|NCT02953821|11908832|FG000|Overall Study|Change of address|0
7550212|NCT02953821|11908833|FG001|Overall Study|Change of address|1
7550213|NCT02953821|11908832|FG000|Overall Study|Lack of Efficacy|1
7550214|NCT02953821|11908833|FG001|Overall Study|Lack of Efficacy|0
7550215|NCT02953821|11908832|FG000|Overall Study|Out of state for indeterminate time|0
7550216|NCT02953821|11908833|FG001|Overall Study|Out of state for indeterminate time|1
7550217|NCT02953821|11908832|FG000|Overall Study|No improvement|0
7550218|NCT02953821|11908833|FG001|Overall Study|No improvement|1
7270039|NCT00413660|11484164|FG004|Up To Week 12|Other|2
7270040|NCT00413660|11484165|FG005|Up To Week 12|Other|4
7270041|NCT00413660|11484166|FG006|Up To Week 12|Other|3
7270042|NCT00413660|11484167|FG007|Up To Week 12|Other|0
7550219|NCT02953821|11908832|FG000|Overall Study|Refused follow-up visit|2
7550220|NCT02953821|11908833|FG001|Overall Study|Refused follow-up visit|1
7550221|NCT02953938|11908855|FG000|Overall Study|Adverse Event|0
7550222|NCT02953938|11908856|FG001|Overall Study|Adverse Event|1
7550223|NCT02953938|11908855|FG000|Overall Study|Withdrawal by Subject|1
7550224|NCT02953938|11908856|FG001|Overall Study|Withdrawal by Subject|1
7550225|NCT02954172|11908865|FG000|Overall Study|Protocol Violation|3
7550226|NCT02954172|11908866|FG001|Overall Study|Protocol Violation|0
7550227|NCT02954172|11908865|FG000|Overall Study|allergic reaction|2
7550228|NCT02954172|11908866|FG001|Overall Study|allergic reaction|1
7550229|NCT02954172|11908865|FG000|Overall Study|non-measurable lesions at baseline|1
7550230|NCT02954172|11908866|FG001|Overall Study|non-measurable lesions at baseline|2
7550231|NCT02954354|11908885|FG000|Overall Study|Adverse Event|2
7550232|NCT02954354|11908886|FG001|Overall Study|Adverse Event|2
7550233|NCT02954354|11908887|FG002|Overall Study|Adverse Event|4
7550234|NCT02954354|11908885|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
7550235|NCT02954354|11908886|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
7550236|NCT02954354|11908887|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
7550237|NCT02954354|11908885|FG000|Overall Study|Lack of Efficacy|0
7550238|NCT02954354|11908886|FG001|Overall Study|Lack of Efficacy|2
7550239|NCT02954354|11908887|FG002|Overall Study|Lack of Efficacy|0
7550240|NCT02954354|11908885|FG000|Overall Study|Withdrawal by Subject|17
7550241|NCT02954354|11908886|FG001|Overall Study|Withdrawal by Subject|9
7550242|NCT02954354|11908887|FG002|Overall Study|Withdrawal by Subject|11
7550243|NCT02954354|11908885|FG000|Overall Study|Lost to Follow-up|12
7550244|NCT02954354|11908886|FG001|Overall Study|Lost to Follow-up|5
7550245|NCT02954354|11908887|FG002|Overall Study|Lost to Follow-up|0
7550246|NCT02954354|11908885|FG000|Overall Study|Miscellaneous|2
7550247|NCT02954354|11908886|FG001|Overall Study|Miscellaneous|2
7550248|NCT02954354|11908887|FG002|Overall Study|Miscellaneous|1
7550249|NCT02954458|11908901|FG000|Overall Study|Adverse Event|0
7550250|NCT02954458|11908902|FG001|Overall Study|Adverse Event|0
7550251|NCT02954458|11908903|FG002|Overall Study|Adverse Event|0
7550252|NCT02954458|11908904|FG003|Overall Study|Adverse Event|1
7550253|NCT02954458|11908901|FG000|Overall Study|Withdrawal by Subject|0
7550254|NCT02954458|11908902|FG001|Overall Study|Withdrawal by Subject|0
7550255|NCT02954458|11908903|FG002|Overall Study|Withdrawal by Subject|0
7550256|NCT02954458|11908904|FG003|Overall Study|Withdrawal by Subject|1
7550257|NCT02954458|11908901|FG000|Overall Study|Physician Decision|0
7550258|NCT02954458|11908902|FG001|Overall Study|Physician Decision|0
7550259|NCT02954458|11908903|FG002|Overall Study|Physician Decision|1
7550260|NCT02954458|11908904|FG003|Overall Study|Physician Decision|1
7550261|NCT02954458|11908901|FG000|Overall Study|Lost to Follow-up|1
7550262|NCT02954458|11908902|FG001|Overall Study|Lost to Follow-up|0
7550263|NCT02954458|11908903|FG002|Overall Study|Lost to Follow-up|0
7550264|NCT02954458|11908904|FG003|Overall Study|Lost to Follow-up|1
7550265|NCT02954458|11908901|FG000|Overall Study|Death|0
7550266|NCT02954458|11908902|FG001|Overall Study|Death|0
7550267|NCT02954458|11908903|FG002|Overall Study|Death|0
7550268|NCT02954458|11908904|FG003|Overall Study|Death|1
7550269|NCT02954458|11908901|FG000|Overall Study|Other|0
7550270|NCT02954458|11908902|FG001|Overall Study|Other|0
7550271|NCT02954458|11908903|FG002|Overall Study|Other|0
7550272|NCT02954458|11908904|FG003|Overall Study|Other|7
7550273|NCT02954575|11908918|FG000|Overall Study|Withdrawal by Subject|2
7550274|NCT02954575|11908918|FG000|Overall Study|Adverse Event|1
7550275|NCT02954601|11908930|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
7550276|NCT02954601|11908931|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
7550277|NCT02954601|11908932|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
7550278|NCT02954601|11908933|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
7550279|NCT02954653|11908945|FG000|Overall Study|Death|3
7550280|NCT02954653|11908946|FG001|Overall Study|Death|1
7550281|NCT02954653|11908947|FG002|Overall Study|Death|0
7550282|NCT02954653|11908948|FG003|Overall Study|Death|0
7550283|NCT02954653|11908949|FG004|Overall Study|Death|0
7550284|NCT02954653|11908950|FG005|Overall Study|Death|0
7550285|NCT02954653|11908951|FG006|Overall Study|Death|0
7550286|NCT02954653|11908952|FG007|Overall Study|Death|0
7550287|NCT02954653|11908953|FG008|Overall Study|Death|0
7550288|NCT02954653|11908945|FG000|Overall Study|Randomized but did not receive treatment|1
7550289|NCT02954653|11908946|FG001|Overall Study|Randomized but did not receive treatment|0
7550290|NCT02954653|11908947|FG002|Overall Study|Randomized but did not receive treatment|0
7550291|NCT02954653|11908948|FG003|Overall Study|Randomized but did not receive treatment|0
7550292|NCT02954653|11908949|FG004|Overall Study|Randomized but did not receive treatment|0
7550293|NCT02954653|11908950|FG005|Overall Study|Randomized but did not receive treatment|0
7550294|NCT02954653|11908951|FG006|Overall Study|Randomized but did not receive treatment|0
7550295|NCT02954653|11908952|FG007|Overall Study|Randomized but did not receive treatment|0
7550296|NCT02954653|11908953|FG008|Overall Study|Randomized but did not receive treatment|0
7550297|NCT02954653|11908945|FG000|Overall Study|Started another anti-cancer therapy|0
7550298|NCT02954653|11908946|FG001|Overall Study|Started another anti-cancer therapy|1
7550299|NCT02954653|11908947|FG002|Overall Study|Started another anti-cancer therapy|0
7550300|NCT02954653|11908948|FG003|Overall Study|Started another anti-cancer therapy|0
7550301|NCT02954653|11908949|FG004|Overall Study|Started another anti-cancer therapy|0
7550302|NCT02954653|11908950|FG005|Overall Study|Started another anti-cancer therapy|0
7550303|NCT02954653|11908951|FG006|Overall Study|Started another anti-cancer therapy|0
7550304|NCT02954653|11908952|FG007|Overall Study|Started another anti-cancer therapy|0
7550305|NCT02954653|11908953|FG008|Overall Study|Started another anti-cancer therapy|0
7550306|NCT02954653|11908945|FG000|Overall Study|Treatment failure and consent withdrawal|0
7550307|NCT02954653|11908946|FG001|Overall Study|Treatment failure and consent withdrawal|1
7550308|NCT02954653|11908947|FG002|Overall Study|Treatment failure and consent withdrawal|0
7550309|NCT02954653|11908948|FG003|Overall Study|Treatment failure and consent withdrawal|0
7550310|NCT02954653|11908949|FG004|Overall Study|Treatment failure and consent withdrawal|0
7550311|NCT02954653|11908950|FG005|Overall Study|Treatment failure and consent withdrawal|0
7550312|NCT02954653|11908951|FG006|Overall Study|Treatment failure and consent withdrawal|0
7550313|NCT02954653|11908952|FG007|Overall Study|Treatment failure and consent withdrawal|0
7550314|NCT02954653|11908953|FG008|Overall Study|Treatment failure and consent withdrawal|0
7550315|NCT02954848|11908967|FG000|Overall Study|Randomized but Not Treated|0
7550316|NCT02954848|11908968|FG001|Overall Study|Randomized but Not Treated|1
7550317|NCT02954848|11908967|FG000|Overall Study|Adverse Event|2
7550318|NCT02954848|11908968|FG001|Overall Study|Adverse Event|3
7550319|NCT02954848|11908967|FG000|Overall Study|Withdrawal by Participant|0
7550320|NCT02954848|11908968|FG001|Overall Study|Withdrawal by Participant|1
7550324|NCT02955069|11908980|FG000|Overall Study|Adverse Event|7
7550325|NCT02955069|11908981|FG001|Overall Study|Adverse Event|2
7550326|NCT02955069|11908980|FG000|Overall Study|Death|7
7550327|NCT02955069|11908981|FG001|Overall Study|Death|3
7550328|NCT02955069|11908980|FG000|Overall Study|Physician Decision|10
7550329|NCT02955069|11908981|FG001|Overall Study|Physician Decision|2
7550330|NCT02955069|11908980|FG000|Overall Study|Progressive disease|64
7550331|NCT02955069|11908981|FG001|Overall Study|Progressive disease|13
7550332|NCT02955069|11908980|FG000|Overall Study|Study terminated by sponsor|4
7550333|NCT02955069|11908981|FG001|Overall Study|Study terminated by sponsor|0
7550334|NCT02955069|11908980|FG000|Overall Study|Subject/Guardian decision|3
7550335|NCT02955069|11908981|FG001|Overall Study|Subject/Guardian decision|1
7550336|NCT02955186|11908995|FG000|Overall Study|Withdrawal by Subject|6
7550337|NCT02955186|11908996|FG001|Overall Study|Withdrawal by Subject|2
7550338|NCT02955186|11908995|FG000|Overall Study|Protocol Violation|1
7550339|NCT02955186|11908996|FG001|Overall Study|Protocol Violation|0
7550340|NCT02955212|11909004|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
7550341|NCT02955212|11909005|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
7550342|NCT02955212|11909004|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
7550427|NCT02956837|11909183|FG000|Overall Study|Withdrawal by Subject|0
7550343|NCT02955212|11909005|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
7550344|NCT02955212|11909004|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
7550345|NCT02955212|11909005|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
7550346|NCT02955212|11909004|FG000|Period 1: Double-blind Treatment Period|Other|3
7550347|NCT02955212|11909005|FG001|Period 1: Double-blind Treatment Period|Other|2
7550348|NCT02955212|11909004|FG000|Period 2: Open-label Extension|Adverse Event|11
7550349|NCT02955212|11909005|FG001|Period 2: Open-label Extension|Adverse Event|7
7550350|NCT02955212|11909004|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
7550351|NCT02955212|11909005|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
7550352|NCT02955212|11909004|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
7550353|NCT02955212|11909005|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
7550354|NCT02955212|11909004|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
7550355|NCT02955212|11909005|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
7550356|NCT02955212|11909004|FG000|Period 2: Open-label Extension|Other|2
7550357|NCT02955212|11909005|FG001|Period 2: Open-label Extension|Other|4
7550358|NCT02956057|11909053|FG000|Overall Study|Discontinued intervention|14
7550359|NCT02956057|11909054|FG001|Overall Study|Discontinued intervention|10
7550360|NCT02956057|11909055|FG002|Overall Study|Discontinued intervention|7
7550361|NCT02956057|11909056|FG003|Overall Study|Discontinued intervention|14
7550362|NCT02956057|11909057|FG004|Overall Study|Discontinued intervention|4
7550363|NCT02956057|11909058|FG005|Overall Study|Discontinued intervention|17
7550364|NCT02956057|11909053|FG000|Overall Study|Lost to Follow-up|0
7550365|NCT02956057|11909054|FG001|Overall Study|Lost to Follow-up|2
7550366|NCT02956057|11909055|FG002|Overall Study|Lost to Follow-up|1
7550367|NCT02956057|11909056|FG003|Overall Study|Lost to Follow-up|1
7550368|NCT02956057|11909057|FG004|Overall Study|Lost to Follow-up|1
7550369|NCT02956057|11909058|FG005|Overall Study|Lost to Follow-up|0
7550370|NCT02956278|11909095|FG000|Overall Study|Withdrawal by Subject|6
7550371|NCT02956278|11909096|FG001|Overall Study|Withdrawal by Subject|2
7550372|NCT02956278|11909097|FG002|Overall Study|Withdrawal by Subject|0
7550373|NCT02956460|11909107|FG000|Lens 1|Lost to Follow-up|1
7550374|NCT02956460|11909108|FG001|Lens 1|Lost to Follow-up|0
7550375|NCT02956486|11909116|FG000|Core Phase|Adverse Event|51
7550376|NCT02956486|11909117|FG001|Core Phase|Adverse Event|88
7550377|NCT02956486|11909118|FG002|Core Phase|Adverse Event|0
7550378|NCT02956486|11909116|FG000|Core Phase|Lost to Follow-up|8
7550379|NCT02956486|11909117|FG001|Core Phase|Lost to Follow-up|6
7550380|NCT02956486|11909118|FG002|Core Phase|Lost to Follow-up|0
7550381|NCT02956486|11909116|FG000|Core Phase|Inadequate therapeutic effect|4
7550382|NCT02956486|11909117|FG001|Core Phase|Inadequate therapeutic effect|5
7550383|NCT02956486|11909118|FG002|Core Phase|Inadequate therapeutic effect|0
7550384|NCT02956486|11909116|FG000|Core Phase|Withdrawal by Subject|101
7550385|NCT02956486|11909117|FG001|Core Phase|Withdrawal by Subject|104
7550386|NCT02956486|11909118|FG002|Core Phase|Withdrawal by Subject|0
7550387|NCT02956486|11909116|FG000|Core Phase|Study terminated by sponsor|888
7550388|NCT02956486|11909117|FG001|Core Phase|Study terminated by sponsor|848
7550389|NCT02956486|11909118|FG002|Core Phase|Study terminated by sponsor|0
7550390|NCT02956486|11909116|FG000|Core Phase|Other|27
7550391|NCT02956486|11909117|FG001|Core Phase|Other|18
7550392|NCT02956486|11909118|FG002|Core Phase|Other|0
7550393|NCT02956486|11909116|FG000|Core Phase|Not treated|0
7550394|NCT02956486|11909117|FG001|Core Phase|Not treated|3
7550395|NCT02956486|11909118|FG002|Core Phase|Not treated|0
7550396|NCT02956486|11909116|FG000|Extension Phase|Adverse Event|0
7550397|NCT02956486|11909117|FG001|Extension Phase|Adverse Event|0
7550398|NCT02956486|11909118|FG002|Extension Phase|Adverse Event|2
7550399|NCT02956486|11909116|FG000|Extension Phase|Study terminated by sponsor|0
7550400|NCT02956486|11909117|FG001|Extension Phase|Study terminated by sponsor|0
7550401|NCT02956486|11909118|FG002|Extension Phase|Study terminated by sponsor|16
7550402|NCT02956486|11909116|FG000|Extension Phase|Not Treated|0
7550403|NCT02956486|11909117|FG001|Extension Phase|Not Treated|0
7550404|NCT02956486|11909118|FG002|Extension Phase|Not Treated|1
7550405|NCT02956629|11909142|FG000|Overall Study|Adverse Event|0
7550406|NCT02956629|11909143|FG001|Overall Study|Adverse Event|0
7550407|NCT02956629|11909144|FG002|Overall Study|Adverse Event|1
7550408|NCT02956629|11909145|FG003|Overall Study|Adverse Event|0
7550409|NCT02956629|11909146|FG004|Overall Study|Adverse Event|0
7550410|NCT02956629|11909147|FG005|Overall Study|Adverse Event|0
7550411|NCT02956629|11909142|FG000|Overall Study|Lost to Follow-up|2
7550412|NCT02956629|11909143|FG001|Overall Study|Lost to Follow-up|5
7550413|NCT02956629|11909144|FG002|Overall Study|Lost to Follow-up|3
7550414|NCT02956629|11909145|FG003|Overall Study|Lost to Follow-up|1
7550415|NCT02956629|11909146|FG004|Overall Study|Lost to Follow-up|0
7550416|NCT02956629|11909147|FG005|Overall Study|Lost to Follow-up|1
7550417|NCT02956629|11909142|FG000|Overall Study|Withdrawal by Subject|3
7550418|NCT02956629|11909143|FG001|Overall Study|Withdrawal by Subject|1
7550419|NCT02956629|11909144|FG002|Overall Study|Withdrawal by Subject|0
7550420|NCT02956629|11909145|FG003|Overall Study|Withdrawal by Subject|0
7550421|NCT02956629|11909146|FG004|Overall Study|Withdrawal by Subject|0
7550422|NCT02956629|11909147|FG005|Overall Study|Withdrawal by Subject|0
7550423|NCT02956837|11909183|FG000|Overall Study|Serious Adverse Events|0
7550424|NCT02956837|11909184|FG001|Overall Study|Serious Adverse Events|1
7550425|NCT02956837|11909185|FG002|Overall Study|Serious Adverse Events|0
7550426|NCT02956837|11909186|FG003|Overall Study|Serious Adverse Events|0
7550428|NCT02956837|11909184|FG001|Overall Study|Withdrawal by Subject|1
7550429|NCT02956837|11909185|FG002|Overall Study|Withdrawal by Subject|0
7550430|NCT02956837|11909186|FG003|Overall Study|Withdrawal by Subject|3
7550431|NCT02956837|11909183|FG000|Overall Study|Lost to Follow-up|0
7550432|NCT02956837|11909184|FG001|Overall Study|Lost to Follow-up|1
7550433|NCT02956837|11909185|FG002|Overall Study|Lost to Follow-up|2
7550434|NCT02956837|11909186|FG003|Overall Study|Lost to Follow-up|0
7550435|NCT02956967|11909199|FG000|Overall Study|Adverse Event|3
7550436|NCT02956967|11909199|FG000|Overall Study|Reason non-related to neutropenia|10
7550437|NCT02956967|11909199|FG000|Overall Study|Lost to Follow-up|5
7550438|NCT02956967|11909199|FG000|Overall Study|Missing|1
7550439|NCT02956967|11909199|FG000|Overall Study|Termination of Nivestim administration|29
7550440|NCT02957136|11909209|FG000|Overall Study|Withdrawal by Subject|2
7550441|NCT02957136|11909210|FG001|Overall Study|Withdrawal by Subject|1
7550442|NCT02957331|11909227|FG000|Overall Study|Protocol Violation|1
7550443|NCT02957331|11909228|FG001|Overall Study|Protocol Violation|0
7550444|NCT02957682|11909252|FG000|Overall Study|Adverse Event|64
7550445|NCT02957682|11909253|FG001|Overall Study|Adverse Event|67
7550446|NCT02957682|11909252|FG000|Overall Study|Poor Compliance to Protocol|30
7550447|NCT02957682|11909253|FG001|Overall Study|Poor Compliance to Protocol|26
7550448|NCT02957682|11909252|FG000|Overall Study|Physician Decision|4
7550449|NCT02957682|11909253|FG001|Overall Study|Physician Decision|4
7550450|NCT02957682|11909252|FG000|Overall Study|Study Terminated by Sponsor|4
7550451|NCT02957682|11909253|FG001|Overall Study|Study Terminated by Sponsor|3
7550452|NCT02957682|11909252|FG000|Overall Study|Subject Moved|10
7550453|NCT02957682|11909253|FG001|Overall Study|Subject Moved|16
7550454|NCT02957682|11909252|FG000|Overall Study|Withdrawal by Subject|64
7550455|NCT02957682|11909253|FG001|Overall Study|Withdrawal by Subject|33
7550456|NCT02957682|11909252|FG000|Overall Study|Related to IMP Administration|3
7550457|NCT02957682|11909253|FG001|Overall Study|Related to IMP Administration|6
7550458|NCT02957682|11909252|FG000|Overall Study|Non-disclosed|16
7550459|NCT02957682|11909253|FG001|Overall Study|Non-disclosed|12
7550460|NCT02957682|11909252|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
7550461|NCT02957682|11909253|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
7550462|NCT02957747|11909261|FG000|Overall Study|Withdrawal by Subject|0
7550463|NCT02957747|11909262|FG001|Overall Study|Withdrawal by Subject|3
7550464|NCT02957747|11909261|FG000|Overall Study|Lost to Follow-up|10
7550465|NCT02957747|11909262|FG001|Overall Study|Lost to Follow-up|5
7550466|NCT02957942|11909271|FG000|Overall Study|Withdrawal by Subject|0
7550467|NCT02957942|11909272|FG001|Overall Study|Withdrawal by Subject|1
7550468|NCT02957942|11909271|FG000|Overall Study|Practicing experiment protocol|0
7550469|NCT02957942|11909272|FG001|Overall Study|Practicing experiment protocol|6
7550470|NCT02958267|11909280|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
7550471|NCT02958267|11909281|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
7550472|NCT02958267|11909280|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
7550473|NCT02958267|11909281|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
7550474|NCT02958267|11909280|FG000|Follow-up Visits|Additional treatment pursued|2
7550475|NCT02958267|11909281|FG001|Follow-up Visits|Additional treatment pursued|1
7550476|NCT02958527|11909296|FG000|Overall Study|Not collected CRFs|12
7550477|NCT02958553|11909309|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
7550478|NCT02958553|11909309|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
7550479|NCT02959138|11909409|FG000|Overall Study|Enrolled but Never Treated|0
7550480|NCT02959138|11909410|FG001|Overall Study|Enrolled but Never Treated|1
7550481|NCT02959138|11909411|FG002|Overall Study|Enrolled but Never Treated|0
7550482|NCT02959177|11909426|FG000|Double-Blind Treatment Phase|Adverse Event|5
7550483|NCT02959177|11909427|FG001|Double-Blind Treatment Phase|Adverse Event|2
7550484|NCT02959177|11909428|FG002|Double-Blind Treatment Phase|Adverse Event|0
7550485|NCT02959177|11909426|FG000|Double-Blind Treatment Phase|Physician Decision|1
7550486|NCT02959177|11909427|FG001|Double-Blind Treatment Phase|Physician Decision|0
7550487|NCT02959177|11909428|FG002|Double-Blind Treatment Phase|Physician Decision|0
7550488|NCT02959177|11909426|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7550489|NCT02959177|11909427|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7550490|NCT02959177|11909428|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7550491|NCT02959177|11909426|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
7550492|NCT02959177|11909427|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
7550493|NCT02959177|11909428|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
7550494|NCT02959177|11909426|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
7550495|NCT02959177|11909427|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
7550496|NCT02959177|11909428|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
7550497|NCT02959177|11909426|FG000|Follow-up Post Treatment Phase|Adverse Event|0
7550498|NCT02959177|11909427|FG001|Follow-up Post Treatment Phase|Adverse Event|1
7550499|NCT02959177|11909428|FG002|Follow-up Post Treatment Phase|Adverse Event|0
7550500|NCT02959177|11909426|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7550501|NCT02959177|11909427|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
7550502|NCT02959177|11909428|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
7550503|NCT02959190|11909446|FG000|Open Label|Adverse Event|5
7550504|NCT02959190|11909447|FG001|Open Label|Adverse Event|7
7550505|NCT02959190|11909448|FG002|Open Label|Adverse Event|3
7550506|NCT02959190|11909449|FG003|Open Label|Adverse Event|4
7550507|NCT02959190|11909446|FG000|Open Label|Pregnancy|0
7550508|NCT02959190|11909447|FG001|Open Label|Pregnancy|1
7550509|NCT02959190|11909448|FG002|Open Label|Pregnancy|0
7550510|NCT02959190|11909449|FG003|Open Label|Pregnancy|0
7550511|NCT02959190|11909446|FG000|Open Label|Withdrawal by Subject|2
7550512|NCT02959190|11909447|FG001|Open Label|Withdrawal by Subject|8
7550513|NCT02959190|11909448|FG002|Open Label|Withdrawal by Subject|0
7550514|NCT02959190|11909449|FG003|Open Label|Withdrawal by Subject|0
7550515|NCT02959190|11909446|FG000|Open Label|Physician Decision|0
7550516|NCT02959190|11909447|FG001|Open Label|Physician Decision|0
7550517|NCT02959190|11909448|FG002|Open Label|Physician Decision|1
7550518|NCT02959190|11909449|FG003|Open Label|Physician Decision|0
7550519|NCT02959190|11909446|FG000|Open Label|Protocol Violation|0
7550520|NCT02959190|11909447|FG001|Open Label|Protocol Violation|0
7550521|NCT02959190|11909448|FG002|Open Label|Protocol Violation|0
7550522|NCT02959190|11909449|FG003|Open Label|Protocol Violation|2
7550523|NCT02959190|11909446|FG000|Post Treatment Follow Up|Adverse Event|1
7550524|NCT02959190|11909447|FG001|Post Treatment Follow Up|Adverse Event|1
7550525|NCT02959190|11909448|FG002|Post Treatment Follow Up|Adverse Event|0
7550526|NCT02959190|11909449|FG003|Post Treatment Follow Up|Adverse Event|0
7550527|NCT02959190|11909446|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
7550528|NCT02959190|11909447|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
7550529|NCT02959190|11909448|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
7550530|NCT02959190|11909449|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
7550531|NCT02959437|11909481|FG000|Overall Study|Death|33
7550532|NCT02959437|11909482|FG001|Overall Study|Death|3
7550533|NCT02959437|11909483|FG002|Overall Study|Death|0
7550534|NCT02959437|11909484|FG003|Overall Study|Death|0
7550535|NCT02959437|11909481|FG000|Overall Study|Lost to Follow-up|3
7550536|NCT02959437|11909482|FG001|Overall Study|Lost to Follow-up|1
7550537|NCT02959437|11909483|FG002|Overall Study|Lost to Follow-up|0
7550538|NCT02959437|11909484|FG003|Overall Study|Lost to Follow-up|0
7550539|NCT02959437|11909481|FG000|Overall Study|Withdrawal by Subject|11
7550540|NCT02959437|11909482|FG001|Overall Study|Withdrawal by Subject|3
7550541|NCT02959437|11909483|FG002|Overall Study|Withdrawal by Subject|0
7550542|NCT02959437|11909484|FG003|Overall Study|Withdrawal by Subject|0
7550543|NCT02959437|11909481|FG000|Overall Study|Progressive Disease|9
7550544|NCT02959437|11909482|FG001|Overall Study|Progressive Disease|1
7550545|NCT02959437|11909483|FG002|Overall Study|Progressive Disease|0
7550546|NCT02959437|11909484|FG003|Overall Study|Progressive Disease|0
7550547|NCT02959437|11909481|FG000|Overall Study|Study Terminated by Sponsor|4
7550548|NCT02959437|11909482|FG001|Overall Study|Study Terminated by Sponsor|0
7550549|NCT02959437|11909483|FG002|Overall Study|Study Terminated by Sponsor|0
7550550|NCT02959437|11909484|FG003|Overall Study|Study Terminated by Sponsor|0
7550551|NCT02959437|11909481|FG000|Overall Study|Other Unspecified|2
7550552|NCT02959437|11909482|FG001|Overall Study|Other Unspecified|0
7550553|NCT02959437|11909483|FG002|Overall Study|Other Unspecified|0
7550554|NCT02959437|11909484|FG003|Overall Study|Other Unspecified|0
7550555|NCT02959671|11909495|FG000|Overall Study|Adverse Event|2
7550556|NCT02959671|11909495|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
7550557|NCT02959814|11909499|FG000|Overall Study|Excluded based on diagnostic angiography|16
7550558|NCT02959814|11909499|FG000|Overall Study|Excluded based on anatomical criteria|2
7550559|NCT02959814|11909499|FG000|Overall Study|Protocol Violation|7
7550560|NCT02959814|11909499|FG000|Overall Study|FFR not measured|2
7550561|NCT02959814|11909499|FG000|Overall Study|In-procedure QFR not computed|6
7550562|NCT02959814|11909499|FG000|Overall Study|Excluded by FFR core-lab|24
7550563|NCT02959866|11909535|FG000|Overall Study|Withdrawal by Subject|1
7550564|NCT02959892|11909542|FG000|Overall Study|PET tracer synthesis failure|1
7550565|NCT02959892|11909543|FG001|Overall Study|PET tracer synthesis failure|0
7550566|NCT02959892|11909542|FG000|Overall Study|Study termination|0
7550567|NCT02959892|11909543|FG001|Overall Study|Study termination|1
7550568|NCT02959970|11909551|FG000|Overall Study|Adverse Event|1
7550569|NCT02959970|11909552|FG001|Overall Study|Adverse Event|0
7550570|NCT02959970|11909551|FG000|Overall Study|Withdrawal by Subject|0
7550571|NCT02959970|11909552|FG001|Overall Study|Withdrawal by Subject|2
7550572|NCT02959970|11909551|FG000|Overall Study|Lost to Follow-up|1
7550573|NCT02959970|11909552|FG001|Overall Study|Lost to Follow-up|5
7550574|NCT02959983|11909562|FG000|Overall Study|Protocol Violation|0
7550575|NCT02959983|11909563|FG001|Overall Study|Protocol Violation|1
7550576|NCT02959983|11909562|FG000|Overall Study|Lack of Efficacy|0
7550577|NCT02959983|11909563|FG001|Overall Study|Lack of Efficacy|1
7550578|NCT02959983|11909562|FG000|Overall Study|Lost to Follow-up|12
7550579|NCT02959983|11909563|FG001|Overall Study|Lost to Follow-up|9
7550580|NCT02959983|11909562|FG000|Overall Study|Other|1
7550581|NCT02959983|11909563|FG001|Overall Study|Other|1
7550582|NCT02959983|11909562|FG000|Overall Study|Physician Decision|1
7550583|NCT02959983|11909563|FG001|Overall Study|Physician Decision|0
7550584|NCT02959983|11909562|FG000|Overall Study|Adverse Event|5
7550585|NCT02959983|11909563|FG001|Overall Study|Adverse Event|1
7550586|NCT02959983|11909562|FG000|Overall Study|Withdrawal by Subject|7
7550587|NCT02959983|11909563|FG001|Overall Study|Withdrawal by Subject|12
7550588|NCT02960217|11909580|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
7550589|NCT02960217|11909581|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
7550590|NCT02960217|11909580|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
7550591|NCT02960217|11909581|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
7550592|NCT02960217|11909580|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
7550593|NCT02960217|11909581|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
7550594|NCT02960217|11909580|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
7550595|NCT02960217|11909581|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
7550596|NCT02960217|11909580|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
7550597|NCT02960217|11909581|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
7550598|NCT02960217|11909580|FG000|Open-Label Extension Phase|Adverse Event|1
7550599|NCT02960217|11909581|FG001|Open-Label Extension Phase|Adverse Event|0
7550600|NCT02960217|11909580|FG000|Open-Label Extension Phase|Sponsor Decision|18
7550601|NCT02960217|11909581|FG001|Open-Label Extension Phase|Sponsor Decision|11
7550602|NCT02960217|11909580|FG000|Open-Label Extension Phase|Lack of Efficacy|1
7550603|NCT02960217|11909581|FG001|Open-Label Extension Phase|Lack of Efficacy|1
7550604|NCT02960217|11909580|FG000|Open-Label Extension Phase|Other, Not Specified|0
7550605|NCT02960217|11909581|FG001|Open-Label Extension Phase|Other, Not Specified|1
7550606|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7550607|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
7550608|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
7550609|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
7550610|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
7550611|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
7550612|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
7550613|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
7550614|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
7550615|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7550616|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7550617|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
7550618|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7550619|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7550620|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
7550621|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
7550622|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
7550623|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
7550624|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
7550625|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
7550626|NCT02960438|11909600|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
7550627|NCT02960438|11909601|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7550628|NCT02960438|11909602|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
7550629|NCT02960438|11909603|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
7550630|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7550631|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
7550632|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
7550633|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
7550634|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7550635|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7550636|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
7550637|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
7550638|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7550639|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7550640|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
7550641|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
7550642|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7550643|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
7550644|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
7550645|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
7550646|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7550647|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7550648|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
7550649|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
7550650|NCT02960438|11909600|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
7550651|NCT02960438|11909601|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
7550652|NCT02960438|11909602|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
7550653|NCT02960438|11909603|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
7550654|NCT02960490|11909623|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
7550655|NCT02960490|11909624|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
7550656|NCT02960490|11909625|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550657|NCT02960490|11909626|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550658|NCT02960490|11909627|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550659|NCT02960490|11909628|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550660|NCT02960490|11909629|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550661|NCT02960490|11909630|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550662|NCT02960490|11909631|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7550663|NCT02960490|11909632|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
7578474|NCT03864627|11969806|FG000|Overall Study|Lack of Efficacy|0
7578475|NCT03864627|11969807|FG001|Overall Study|Lack of Efficacy|1
7578476|NCT03864627|11969806|FG000|Overall Study|Lost to Follow-up|0
7578477|NCT03864627|11969807|FG001|Overall Study|Lost to Follow-up|1
7578478|NCT03864627|11969806|FG000|Overall Study|Withdrawal by Subject|4
7578479|NCT03864627|11969807|FG001|Overall Study|Withdrawal by Subject|8
7578480|NCT03864627|11969806|FG000|Overall Study|Study terminated by sponsor|0
7578481|NCT03864627|11969807|FG001|Overall Study|Study terminated by sponsor|1
7578482|NCT03848403|11969822|FG000|Period 2 (Day 8)|Adverse Event|1
7578483|NCT03848403|11969823|FG001|Period 2 (Day 8)|Adverse Event|2
7578484|NCT03848403|11969824|FG002|Period 2 (Day 8)|Adverse Event|2
7578485|NCT03848403|11969822|FG000|Period 2 (Day 8)|Physician Decision|0
7578486|NCT03848403|11969823|FG001|Period 2 (Day 8)|Physician Decision|1
7578487|NCT03848403|11969824|FG002|Period 2 (Day 8)|Physician Decision|0
7578488|NCT03848403|11969822|FG000|Period 2 (Day 8)|Sponsor Decision|8
7578489|NCT03848403|11969823|FG001|Period 2 (Day 8)|Sponsor Decision|6
7578490|NCT03848403|11969824|FG002|Period 2 (Day 8)|Sponsor Decision|5
7578491|NCT03878108|11969891|FG000|Overall Study|Adverse Event|1
7578492|NCT03878108|11969892|FG001|Overall Study|Adverse Event|0
7578493|NCT03877237|11969908|FG000|Overall Study|Adverse Event|1
7578494|NCT03877237|11969909|FG001|Overall Study|Adverse Event|2
7578495|NCT03877237|11969908|FG000|Overall Study|Death|3
7578496|NCT03877237|11969909|FG001|Overall Study|Death|2
7578497|NCT03877237|11969908|FG000|Overall Study|Physician Decision|1
7578498|NCT03877237|11969909|FG001|Overall Study|Physician Decision|0
7578499|NCT03877237|11969908|FG000|Overall Study|Withdrawal by Subject|0
7578500|NCT03877237|11969909|FG001|Overall Study|Withdrawal by Subject|2
7578501|NCT03859323|11969938|FG000|Overall Study|Lost to Follow-up|0
7578502|NCT03859323|11969939|FG001|Overall Study|Lost to Follow-up|0
7578503|NCT03859323|11969940|FG002|Overall Study|Lost to Follow-up|0
7578504|NCT03859323|11969941|FG003|Overall Study|Lost to Follow-up|0
7578505|NCT03859323|11969942|FG004|Overall Study|Lost to Follow-up|0
7578506|NCT03859323|11969943|FG005|Overall Study|Lost to Follow-up|0
7578507|NCT03859323|11969944|FG006|Overall Study|Lost to Follow-up|1
7578508|NCT03859323|11969945|FG007|Overall Study|Lost to Follow-up|0
7578509|NCT03859323|11969946|FG008|Overall Study|Lost to Follow-up|0
7578510|NCT03859323|11969947|FG009|Overall Study|Lost to Follow-up|0
7578511|NCT03859323|11969948|FG010|Overall Study|Lost to Follow-up|0
7578512|NCT03859323|11969949|FG011|Overall Study|Lost to Follow-up|0
7578513|NCT03859323|11969950|FG012|Overall Study|Lost to Follow-up|0
7578514|NCT03859323|11969938|FG000|Overall Study|Withdrawal by Subject|0
7578515|NCT03859323|11969939|FG001|Overall Study|Withdrawal by Subject|0
7578516|NCT03859323|11969940|FG002|Overall Study|Withdrawal by Subject|1
7578517|NCT03859323|11969941|FG003|Overall Study|Withdrawal by Subject|0
7578518|NCT03859323|11969942|FG004|Overall Study|Withdrawal by Subject|0
7578519|NCT03859323|11969943|FG005|Overall Study|Withdrawal by Subject|1
7578520|NCT03859323|11969944|FG006|Overall Study|Withdrawal by Subject|0
7578521|NCT03859323|11969945|FG007|Overall Study|Withdrawal by Subject|0
7578522|NCT03859323|11969946|FG008|Overall Study|Withdrawal by Subject|0
7578523|NCT03859323|11969947|FG009|Overall Study|Withdrawal by Subject|1
7578524|NCT03859323|11969948|FG010|Overall Study|Withdrawal by Subject|1
7578525|NCT03859323|11969949|FG011|Overall Study|Withdrawal by Subject|2
7578526|NCT03859323|11969950|FG012|Overall Study|Withdrawal by Subject|1
7578527|NCT03859323|11969938|FG000|Overall Study|Pregnancy|0
7270043|NCT00413660|11484168|FG008|Up To Week 12|Other|0
7270044|NCT00413660|11484169|FG009|Up To Week 12|Other|0
7270045|NCT00413660|11484170|FG010|Up To Week 12|Other|0
7270046|NCT00413660|11484160|FG000|Post Week 12|Adverse Event|2
7270047|NCT00413660|11484161|FG001|Post Week 12|Adverse Event|0
7270048|NCT00413660|11484162|FG002|Post Week 12|Adverse Event|2
7270049|NCT00413660|11484163|FG003|Post Week 12|Adverse Event|1
7270050|NCT00413660|11484164|FG004|Post Week 12|Adverse Event|4
7270051|NCT00413660|11484165|FG005|Post Week 12|Adverse Event|2
7578528|NCT03859323|11969939|FG001|Overall Study|Pregnancy|0
7578529|NCT03859323|11969940|FG002|Overall Study|Pregnancy|0
7578530|NCT03859323|11969941|FG003|Overall Study|Pregnancy|0
7578531|NCT03859323|11969942|FG004|Overall Study|Pregnancy|0
7550664|NCT02960490|11909623|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550665|NCT02960490|11909624|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
7550666|NCT02960490|11909625|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550667|NCT02960490|11909626|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550668|NCT02960490|11909627|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550669|NCT02960490|11909628|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550670|NCT02960490|11909629|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550671|NCT02960490|11909630|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550672|NCT02960490|11909631|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550673|NCT02960490|11909632|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
7550674|NCT02960490|11909623|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
7550675|NCT02960490|11909624|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
7550676|NCT02960490|11909625|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550677|NCT02960490|11909626|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550678|NCT02960490|11909627|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550679|NCT02960490|11909628|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550680|NCT02960490|11909629|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550681|NCT02960490|11909630|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550682|NCT02960490|11909631|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550683|NCT02960490|11909632|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
7550684|NCT02960490|11909623|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7550685|NCT02960490|11909624|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
7550686|NCT02960490|11909625|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550687|NCT02960490|11909626|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550688|NCT02960490|11909627|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550689|NCT02960490|11909628|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550690|NCT02960490|11909629|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550691|NCT02960490|11909630|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550692|NCT02960490|11909631|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550693|NCT02960490|11909632|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
7550694|NCT02960490|11909623|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550695|NCT02960490|11909624|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550696|NCT02960490|11909625|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7550697|NCT02960490|11909626|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
7550698|NCT02960490|11909627|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550699|NCT02960490|11909628|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
7550700|NCT02960490|11909629|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550701|NCT02960490|11909630|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550702|NCT02960490|11909631|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550703|NCT02960490|11909632|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
7550704|NCT02960490|11909623|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550705|NCT02960490|11909624|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550706|NCT02960490|11909625|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
7550707|NCT02960490|11909626|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550708|NCT02960490|11909627|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
7550709|NCT02960490|11909628|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550710|NCT02960490|11909629|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550711|NCT02960490|11909630|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550712|NCT02960490|11909631|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550713|NCT02960490|11909632|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
7550714|NCT02960490|11909623|FG000|Re-randomized Participants: 12 Weeks|Other|0
7550715|NCT02960490|11909624|FG001|Re-randomized Participants: 12 Weeks|Other|0
7550716|NCT02960490|11909625|FG002|Re-randomized Participants: 12 Weeks|Other|0
7550717|NCT02960490|11909626|FG003|Re-randomized Participants: 12 Weeks|Other|1
7550718|NCT02960490|11909627|FG004|Re-randomized Participants: 12 Weeks|Other|0
7550719|NCT02960490|11909628|FG005|Re-randomized Participants: 12 Weeks|Other|0
7550720|NCT02960490|11909629|FG006|Re-randomized Participants: 12 Weeks|Other|0
7550721|NCT02960490|11909630|FG007|Re-randomized Participants: 12 Weeks|Other|0
7550722|NCT02960490|11909631|FG008|Re-randomized Participants: 12 Weeks|Other|0
7550723|NCT02960490|11909632|FG009|Re-randomized Participants: 12 Weeks|Other|0
7550724|NCT02960490|11909623|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550725|NCT02960490|11909624|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550726|NCT02960490|11909625|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550727|NCT02960490|11909626|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550728|NCT02960490|11909627|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550729|NCT02960490|11909628|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550730|NCT02960490|11909629|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
7550731|NCT02960490|11909630|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7550732|NCT02960490|11909631|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
7550733|NCT02960490|11909632|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
7550734|NCT02960490|11909623|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550735|NCT02960490|11909624|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550736|NCT02960490|11909625|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550737|NCT02960490|11909626|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550738|NCT02960490|11909627|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550739|NCT02960490|11909628|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550740|NCT02960490|11909629|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550741|NCT02960490|11909630|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
7550742|NCT02960490|11909631|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550743|NCT02960490|11909632|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
7550744|NCT02960490|11909623|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550816|NCT02961790|11909711|FG002|Overall Study|without baseline data|1
7550745|NCT02960490|11909624|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550746|NCT02960490|11909625|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550747|NCT02960490|11909626|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550748|NCT02960490|11909627|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550749|NCT02960490|11909628|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
7550750|NCT02960490|11909629|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
7550751|NCT02960490|11909630|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7550752|NCT02960490|11909631|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
7550753|NCT02960490|11909632|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
7550754|NCT02960490|11909623|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550755|NCT02960490|11909624|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550756|NCT02960490|11909625|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550757|NCT02960490|11909626|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550758|NCT02960490|11909627|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550759|NCT02960490|11909628|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550760|NCT02960490|11909629|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
7550761|NCT02960490|11909630|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550762|NCT02960490|11909631|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550763|NCT02960490|11909632|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
7550764|NCT02960490|11909623|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
7550765|NCT02960490|11909624|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
7550766|NCT02960490|11909625|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
7550767|NCT02960490|11909626|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
7550768|NCT02960490|11909627|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
7550769|NCT02960490|11909628|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
7550770|NCT02960490|11909629|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
7550771|NCT02960490|11909630|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
7550772|NCT02960490|11909631|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
7550773|NCT02960490|11909632|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
7550774|NCT02960854|11909656|FG000|Overall Study|Not Disclosed|2
7550775|NCT02960854|11909657|FG001|Overall Study|Not Disclosed|2
7550776|NCT02960854|11909656|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
7550777|NCT02960854|11909657|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
7550778|NCT02960854|11909656|FG000|Overall Study|Subject Withdrew Consent|0
7550779|NCT02960854|11909657|FG001|Overall Study|Subject Withdrew Consent|1
7550780|NCT02960854|11909656|FG000|Overall Study|Death|4
7550781|NCT02960854|11909657|FG001|Overall Study|Death|6
7550782|NCT02961218|11909674|FG000|Overall Study|Lost to Follow-up|0
7550783|NCT02961218|11909675|FG001|Overall Study|Lost to Follow-up|2
7550784|NCT02961218|11909674|FG000|Overall Study|Physician Decision|0
7550785|NCT02961218|11909675|FG001|Overall Study|Physician Decision|2
7550786|NCT02961218|11909674|FG000|Overall Study|Subject/Guardian Decision|3
7550787|NCT02961218|11909675|FG001|Overall Study|Subject/Guardian Decision|1
7550788|NCT02961244|11909685|FG000|Overall Study|Protocol Violation|0
7550789|NCT02961244|11909686|FG001|Overall Study|Protocol Violation|1
7550790|NCT02961244|11909685|FG000|Overall Study|Withdrawal by Subject|1
7550791|NCT02961244|11909686|FG001|Overall Study|Withdrawal by Subject|2
7550792|NCT02961244|11909685|FG000|Overall Study|Surgery plan change after study approval|0
7550793|NCT02961244|11909686|FG001|Overall Study|Surgery plan change after study approval|2
7550794|NCT02961244|11909685|FG000|Overall Study|Lost to Follow-up|0
7550795|NCT02961244|11909686|FG001|Overall Study|Lost to Follow-up|2
7550796|NCT02961244|11909685|FG000|Overall Study|İnadequate data|0
7550797|NCT02961244|11909686|FG001|Overall Study|İnadequate data|2
7578532|NCT03859323|11969943|FG005|Overall Study|Pregnancy|0
7578533|NCT03859323|11969944|FG006|Overall Study|Pregnancy|0
7578534|NCT03859323|11969945|FG007|Overall Study|Pregnancy|0
7578535|NCT03859323|11969946|FG008|Overall Study|Pregnancy|0
7578536|NCT03859323|11969947|FG009|Overall Study|Pregnancy|1
7578537|NCT03859323|11969948|FG010|Overall Study|Pregnancy|0
7578538|NCT03859323|11969949|FG011|Overall Study|Pregnancy|0
7578539|NCT03859323|11969950|FG012|Overall Study|Pregnancy|0
7578540|NCT03875508|11970015|FG000|Overall Study|Adverse Event|1
7578541|NCT03875508|11970015|FG000|Overall Study|Lost to Follow-up|8
7550798|NCT02961751|11909692|FG000|Overall Study|Lost to Follow-up|11
7550799|NCT02961751|11909692|FG000|Overall Study|Physician Decision|2
7550800|NCT02961751|11909692|FG000|Overall Study|Not Eligible at Enrollment|1
7550801|NCT02961751|11909692|FG000|Overall Study|Protocol Violation|1
7550802|NCT02961764|11909698|FG000|Overall Study|Protocol Violation|0
7550803|NCT02961764|11909699|FG001|Overall Study|Protocol Violation|1
7550804|NCT02961764|11909698|FG000|Overall Study|Death|2
7550805|NCT02961764|11909699|FG001|Overall Study|Death|0
7550806|NCT02961764|11909698|FG000|Overall Study|Lost to Follow-up|35
7550807|NCT02961764|11909699|FG001|Overall Study|Lost to Follow-up|24
7550808|NCT02961764|11909698|FG000|Overall Study|Withdrawal by Subject|2
7550809|NCT02961764|11909699|FG001|Overall Study|Withdrawal by Subject|0
7550810|NCT02961790|11909709|FG000|Overall Study|Canceled|4
7550811|NCT02961790|11909710|FG001|Overall Study|Canceled|5
7550812|NCT02961790|11909711|FG002|Overall Study|Canceled|1
7550813|NCT02961790|11909712|FG003|Overall Study|Canceled|4
7550814|NCT02961790|11909709|FG000|Overall Study|without baseline data|4
7550815|NCT02961790|11909710|FG001|Overall Study|without baseline data|0
7550817|NCT02961790|11909712|FG003|Overall Study|without baseline data|0
7550818|NCT02961790|11909709|FG000|Overall Study|without post baseline data|7
7550819|NCT02961790|11909710|FG001|Overall Study|without post baseline data|6
7550820|NCT02961790|11909711|FG002|Overall Study|without post baseline data|4
7550821|NCT02961790|11909712|FG003|Overall Study|without post baseline data|1
7550822|NCT02961920|11909729|FG000|Overall Study|did not achive stydy protocol schedule|1
7550823|NCT02961920|11909730|FG001|Overall Study|did not achive stydy protocol schedule|1
7550824|NCT02962284|11909751|FG000|Overall Study|Death|2
7550825|NCT02962284|11909752|FG001|Overall Study|Death|0
7550826|NCT02962284|11909751|FG000|Overall Study|Progressive disease|2
7550827|NCT02962284|11909752|FG001|Overall Study|Progressive disease|3
7550828|NCT02962284|11909751|FG000|Overall Study|Withdrawal by Subject|1
7550829|NCT02962284|11909752|FG001|Overall Study|Withdrawal by Subject|0
7550830|NCT02962648|11909780|FG000|Overall Study|Withdrawal by Subject|3
7550831|NCT02962648|11909780|FG000|Overall Study|Lost to Follow-up|3
7550832|NCT02962648|11909780|FG000|Overall Study|Physician Decision|1
7550833|NCT02962648|11909780|FG000|Overall Study|Subject had problems with transportation|2
7550834|NCT02962674|11909784|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
7550835|NCT02962739|11909801|FG000|Overall Study|Withdrawal by Subject|0
7550836|NCT02962739|11909802|FG001|Overall Study|Withdrawal by Subject|1
7550837|NCT02962739|11909803|FG002|Overall Study|Withdrawal by Subject|0
7550838|NCT02962739|11909804|FG003|Overall Study|Withdrawal by Subject|0
7550839|NCT02962739|11909805|FG004|Overall Study|Withdrawal by Subject|0
7550840|NCT02962739|11909806|FG005|Overall Study|Withdrawal by Subject|0
7550841|NCT02962739|11909801|FG000|Overall Study|Protocol Violation|0
7550842|NCT02962739|11909802|FG001|Overall Study|Protocol Violation|0
7550843|NCT02962739|11909803|FG002|Overall Study|Protocol Violation|1
7550844|NCT02962739|11909804|FG003|Overall Study|Protocol Violation|0
7550845|NCT02962739|11909805|FG004|Overall Study|Protocol Violation|1
7550846|NCT02962739|11909806|FG005|Overall Study|Protocol Violation|0
7550847|NCT02962765|11909812|FG000|Overall Study|Protocol Violation|9
7550848|NCT02962765|11909812|FG000|Overall Study|Withdrawal by Subject|3
7550849|NCT02962765|11909812|FG000|Overall Study|Lost to Follow-up|1
7550850|NCT02962765|11909812|FG000|Overall Study|Death|1
7550851|NCT02962765|11909812|FG000|Overall Study|Limited access to study medication|3
7550852|NCT02962882|11909823|FG000|Overall Study|Adverse Event|2
7550853|NCT02962882|11909823|FG000|Overall Study|Withdrawal by Subject|2
7550854|NCT02962882|11909823|FG000|Overall Study|Transfer from ICU|32
7550855|NCT02962908|11909832|FG000|Overall Study|Lost to Follow-up|0
7550856|NCT02962908|11909833|FG001|Overall Study|Lost to Follow-up|3
7550857|NCT02962908|11909834|FG002|Overall Study|Lost to Follow-up|0
7550858|NCT02962908|11909835|FG003|Overall Study|Lost to Follow-up|1
7550859|NCT02962908|11909832|FG000|Overall Study|Withdrawal by Subject|0
7550860|NCT02962908|11909833|FG001|Overall Study|Withdrawal by Subject|3
7550861|NCT02962908|11909834|FG002|Overall Study|Withdrawal by Subject|0
7550862|NCT02962908|11909835|FG003|Overall Study|Withdrawal by Subject|2
7550863|NCT02962908|11909832|FG000|Overall Study|Protocol Violation|0
7550864|NCT02962908|11909833|FG001|Overall Study|Protocol Violation|1
7550865|NCT02962908|11909834|FG002|Overall Study|Protocol Violation|0
7550866|NCT02962908|11909835|FG003|Overall Study|Protocol Violation|0
7550867|NCT02962908|11909832|FG000|Overall Study|Physician Decision|0
7550868|NCT02962908|11909833|FG001|Overall Study|Physician Decision|1
7550869|NCT02962908|11909834|FG002|Overall Study|Physician Decision|0
7550870|NCT02962908|11909835|FG003|Overall Study|Physician Decision|0
7550871|NCT02962960|11909863|FG000|Overall Study|Withdrawal by Subject|1
7550872|NCT02962960|11909864|FG001|Overall Study|Withdrawal by Subject|1
7550873|NCT02962960|11909865|FG002|Overall Study|Withdrawal by Subject|0
7550874|NCT02962960|11909863|FG000|Overall Study|Adverse Event|1
7550875|NCT02962960|11909864|FG001|Overall Study|Adverse Event|1
7550876|NCT02962960|11909865|FG002|Overall Study|Adverse Event|0
7550877|NCT02962960|11909863|FG000|Overall Study|Protocol Violation|1
7550878|NCT02962960|11909864|FG001|Overall Study|Protocol Violation|0
7550879|NCT02962960|11909865|FG002|Overall Study|Protocol Violation|0
7550880|NCT02963311|11909875|FG000|Overall Study|Withdrawal by Subject|1
7550881|NCT02963311|11909875|FG000|Overall Study|Screen Failure|4
7550882|NCT02963441|11909910|FG000|Overall Study|Protocol violation or withdrawn|8
7550883|NCT02963441|11909910|FG000|Overall Study|Ungradeable by FPRC or IDx|40
7550884|NCT02963441|11909910|FG000|Overall Study|IDx-DR insufficient quality|33
7578542|NCT03875508|11970015|FG000|Overall Study|Lack of Efficacy|1
7551041|NCT02963701|11909960|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
7551042|NCT02963701|11909961|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
7551043|NCT02963922|11909969|FG000|Overall Study|Adverse Event|15
7551044|NCT02963922|11909970|FG001|Overall Study|Adverse Event|6
7551045|NCT02963922|11909969|FG000|Overall Study|Protocol deviation|6
7551046|NCT02963922|11909970|FG001|Overall Study|Protocol deviation|6
7551047|NCT02963922|11909969|FG000|Overall Study|Lack of Efficacy|1
7551048|NCT02963922|11909970|FG001|Overall Study|Lack of Efficacy|1
7551049|NCT02963922|11909969|FG000|Overall Study|Lost to Follow-up|2
7551050|NCT02963922|11909970|FG001|Overall Study|Lost to Follow-up|3
7551051|NCT02963922|11909969|FG000|Overall Study|Other|8
7551052|NCT02963922|11909970|FG001|Overall Study|Other|14
7551053|NCT02963935|11909978|FG000|Overall Study|Adverse Event|12
7551054|NCT02963935|11909979|FG001|Overall Study|Adverse Event|6
7551055|NCT02963935|11909978|FG000|Overall Study|Protocol Violation|2
7551056|NCT02963935|11909979|FG001|Overall Study|Protocol Violation|1
7551057|NCT02963935|11909978|FG000|Overall Study|Lack of Efficacy|0
7551058|NCT02963935|11909979|FG001|Overall Study|Lack of Efficacy|2
7551059|NCT02963935|11909978|FG000|Overall Study|Lost to Follow-up|1
7551060|NCT02963935|11909979|FG001|Overall Study|Lost to Follow-up|6
7551061|NCT02963935|11909978|FG000|Overall Study|Unclassified|13
7551062|NCT02963935|11909979|FG001|Overall Study|Unclassified|22
7551063|NCT02964234|11910000|FG000|Overall Study|Lost to Follow-up|22
7551064|NCT02964234|11910001|FG001|Overall Study|Lost to Follow-up|13
7551065|NCT02964247|11910009|FG000|Overall Study|Lost to Follow-up|2
7551066|NCT02964247|11910010|FG001|Overall Study|Lost to Follow-up|0
7551067|NCT02964247|11910009|FG000|Overall Study|Withdrawal by Subject|1
7551068|NCT02964247|11910010|FG001|Overall Study|Withdrawal by Subject|2
7551069|NCT02964312|11910016|FG000|Overall Study|Lost to Follow-up|28
7551070|NCT02964312|11910016|FG000|Overall Study|Withdrawal by Subject|11
7551071|NCT02964312|11910016|FG000|Overall Study|Lack of Efficacy|10
7551072|NCT02964312|11910016|FG000|Overall Study|Did not consent to long-term FU|14
7551073|NCT02964312|11910016|FG000|Overall Study|Death|1
7551074|NCT02964325|11910025|FG000|Overall Study|Lost to Follow-up|3
7551075|NCT02964325|11910026|FG001|Overall Study|Lost to Follow-up|3
7551076|NCT02964325|11910025|FG000|Overall Study|Physician Decision|5
7551077|NCT02964325|11910026|FG001|Overall Study|Physician Decision|4
7551078|NCT02964325|11910025|FG000|Overall Study|Death|1
7551079|NCT02964325|11910026|FG001|Overall Study|Death|3
7551080|NCT02964325|11910025|FG000|Overall Study|Withdrawal by Subject|2
7551081|NCT02964325|11910026|FG001|Overall Study|Withdrawal by Subject|1
7551082|NCT02964325|11910025|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
7551083|NCT02964325|11910026|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
7551084|NCT02964338|11910035|FG000|Overall Study|Sponsor terminated study for futility|12
7551085|NCT02964338|11910036|FG001|Overall Study|Sponsor terminated study for futility|15
7551086|NCT02964338|11910037|FG002|Overall Study|Sponsor terminated study for futility|14
7551087|NCT02964338|11910035|FG000|Overall Study|Lack of Efficacy|0
7551088|NCT02964338|11910036|FG001|Overall Study|Lack of Efficacy|3
7551089|NCT02964338|11910037|FG002|Overall Study|Lack of Efficacy|0
7551090|NCT02964338|11910035|FG000|Overall Study|Lost to Follow-up|1
7551091|NCT02964338|11910036|FG001|Overall Study|Lost to Follow-up|0
7551092|NCT02964338|11910037|FG002|Overall Study|Lost to Follow-up|3
7551093|NCT02964338|11910035|FG000|Overall Study|Protocol Violation|0
7551094|NCT02964338|11910036|FG001|Overall Study|Protocol Violation|1
7551095|NCT02964338|11910037|FG002|Overall Study|Protocol Violation|0
7551096|NCT02964338|11910035|FG000|Overall Study|Withdrawal by Subject|1
7551097|NCT02964338|11910036|FG001|Overall Study|Withdrawal by Subject|3
7551098|NCT02964338|11910037|FG002|Overall Study|Withdrawal by Subject|1
7551099|NCT02964338|11910035|FG000|Overall Study|Adverse Event|2
7551100|NCT02964338|11910036|FG001|Overall Study|Adverse Event|1
7551101|NCT02964338|11910037|FG002|Overall Study|Adverse Event|1
7551102|NCT02964338|11910035|FG000|Overall Study|Non-compliant with e-diary|0
7551103|NCT02964338|11910036|FG001|Overall Study|Non-compliant with e-diary|1
7551104|NCT02964338|11910037|FG002|Overall Study|Non-compliant with e-diary|0
7551105|NCT02964338|11910035|FG000|Overall Study|Did not meet criteria|1
7551106|NCT02964338|11910036|FG001|Overall Study|Did not meet criteria|0
7551107|NCT02964338|11910037|FG002|Overall Study|Did not meet criteria|0
7551108|NCT02965378|11910085|FG000|Overall Study|Progression|16
7551109|NCT02965378|11910086|FG001|Overall Study|Progression|4
7551110|NCT02965378|11910085|FG000|Overall Study|Adverse Event|5
7551111|NCT02965378|11910086|FG001|Overall Study|Adverse Event|2
7551112|NCT02965378|11910085|FG000|Overall Study|Death|2
7551113|NCT02965378|11910086|FG001|Overall Study|Death|0
7551114|NCT02965378|11910085|FG000|Overall Study|Refusal|2
7551115|NCT02965378|11910086|FG001|Overall Study|Refusal|1
7551116|NCT02965378|11910085|FG000|Overall Study|Not protocol specified|0
7551117|NCT02965378|11910086|FG001|Overall Study|Not protocol specified|2
7551118|NCT02965456|11910094|FG000|Overall Study|Lost to Follow-up|40
7551119|NCT02965456|11910095|FG001|Overall Study|Lost to Follow-up|18
7551120|NCT02965456|11910094|FG000|Overall Study|Subject Request|22
7551121|NCT02965456|11910095|FG001|Overall Study|Subject Request|13
7551122|NCT02965456|11910094|FG000|Overall Study|Withdrawal by Parent or Guardian|3
7551123|NCT02965456|11910095|FG001|Overall Study|Withdrawal by Parent or Guardian|6
7551124|NCT02965456|11910094|FG000|Overall Study|Adverse Event|3
7551125|NCT02965456|11910095|FG001|Overall Study|Adverse Event|0
7551126|NCT02965456|11910094|FG000|Overall Study|Noncompliance with Study Drug|1
7551127|NCT02965456|11910095|FG001|Overall Study|Noncompliance with Study Drug|1
7551128|NCT02965456|11910094|FG000|Overall Study|Worsening Condition|0
7551129|NCT02965456|11910095|FG001|Overall Study|Worsening Condition|2
7551130|NCT02965456|11910094|FG000|Overall Study|Lack of Efficacy|1
7551131|NCT02965456|11910095|FG001|Overall Study|Lack of Efficacy|0
7551132|NCT02965456|11910094|FG000|Overall Study|Physician Decision|0
7551133|NCT02965456|11910095|FG001|Overall Study|Physician Decision|1
7551134|NCT02965456|11910094|FG000|Overall Study|Pregnancy|1
7551135|NCT02965456|11910095|FG001|Overall Study|Pregnancy|0
7551136|NCT02965456|11910094|FG000|Overall Study|Protocol Violation|0
7551137|NCT02965456|11910095|FG001|Overall Study|Protocol Violation|1
7551138|NCT02965456|11910094|FG000|Overall Study|Participant ran out of study drug|0
7551139|NCT02965456|11910095|FG001|Overall Study|Participant ran out of study drug|1
7551140|NCT02965573|11910111|FG000|Overall Study|Lack of Efficacy|1
7551141|NCT02965573|11910112|FG001|Overall Study|Lack of Efficacy|0
7551142|NCT02965599|11910120|FG000|Overall Study|Protocol-defined stop criteria reached|1
7551143|NCT02965599|11910121|FG001|Overall Study|Protocol-defined stop criteria reached|0
7551144|NCT02965820|11910141|FG000|Period 2, Second 30 Days|Adverse Event|1
7551145|NCT02965820|11910142|FG001|Period 2, Second 30 Days|Adverse Event|1
7551146|NCT02965833|11910148|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
7551147|NCT02965833|11910149|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
7551148|NCT02965833|11910148|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7551149|NCT02965833|11910149|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
7551150|NCT02965833|11910148|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
7551151|NCT02965833|11910149|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
7551152|NCT02965833|11910148|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
7551153|NCT02965833|11910149|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
7551154|NCT02965833|11910148|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
7551155|NCT02965833|11910149|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
7551156|NCT02966002|11910174|FG000|Overall Study|Withdrawal by Subject|2
7551157|NCT02966002|11910174|FG000|Overall Study|Adverse Event|1
7551158|NCT02966002|11910174|FG000|Overall Study|Lost to Follow-up|1
7551159|NCT02966015|11910180|FG000|Inclusion Visit|did not answer questionnaire|8
7551160|NCT02966015|11910181|FG001|Inclusion Visit|did not answer questionnaire|3
7551161|NCT02966028|11910190|FG000|Overall Study|Adverse Event|7
7551162|NCT02966028|11910191|FG001|Overall Study|Adverse Event|13
7551163|NCT02966028|11910192|FG002|Overall Study|Adverse Event|10
7551164|NCT02966028|11910190|FG000|Overall Study|Physician Decision|1
7551165|NCT02966028|11910191|FG001|Overall Study|Physician Decision|0
7551166|NCT02966028|11910192|FG002|Overall Study|Physician Decision|2
7551167|NCT02966028|11910190|FG000|Overall Study|Withdrawal by Subject|7
7551168|NCT02966028|11910191|FG001|Overall Study|Withdrawal by Subject|5
7551169|NCT02966028|11910192|FG002|Overall Study|Withdrawal by Subject|5
7551170|NCT02966028|11910190|FG000|Overall Study|Kidney transplant Changed dialysis units|9
7551171|NCT02966028|11910191|FG001|Overall Study|Kidney transplant Changed dialysis units|16
7551172|NCT02966028|11910192|FG002|Overall Study|Kidney transplant Changed dialysis units|14
7551173|NCT02966314|11910213|FG000|Overall Study|Lost to Follow-up|1
7551174|NCT02966314|11910214|FG001|Overall Study|Lost to Follow-up|0
7551175|NCT02966340|11910220|FG000|Overall Study|Adverse Event|0
7551176|NCT02966340|11910221|FG001|Overall Study|Adverse Event|1
7551177|NCT02966340|11910220|FG000|Overall Study|Lost to Follow-up|0
7551178|NCT02966340|11910221|FG001|Overall Study|Lost to Follow-up|1
7551179|NCT02966340|11910220|FG000|Overall Study|Withdrawal by Subject|1
7551180|NCT02966340|11910221|FG001|Overall Study|Withdrawal by Subject|0
7551181|NCT02966340|11910220|FG000|Overall Study|data acquisition error|1
7551182|NCT02966340|11910221|FG001|Overall Study|data acquisition error|0
7551183|NCT02966340|11910220|FG000|Overall Study|startle non-responder|1
7551184|NCT02966340|11910221|FG001|Overall Study|startle non-responder|1
7551185|NCT02966353|11910227|FG000|Overall Study|Withdrawal by Subject|7
7551186|NCT02966353|11910227|FG000|Overall Study|Adverse Event|4
7551187|NCT02966353|11910227|FG000|Overall Study|Death|4
7551188|NCT02966353|11910227|FG000|Overall Study|Physician Decision|3
7551189|NCT02966353|11910227|FG000|Overall Study|Progressive disease|2
7551190|NCT02966353|11910227|FG000|Overall Study|Protocol deviation|2
7551191|NCT02966509|11910233|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
7551192|NCT02966509|11910234|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
7551193|NCT02966509|11910233|FG000|Baseline Satisfaction Survey|Death|0
7551194|NCT02966509|11910234|FG001|Baseline Satisfaction Survey|Death|1
7551195|NCT02966509|11910233|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
7551196|NCT02966509|11910234|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
7551197|NCT02966509|11910233|FG000|Baseline Satisfaction Survey|Refused to Answer|1
7551198|NCT02966509|11910234|FG001|Baseline Satisfaction Survey|Refused to Answer|2
7551199|NCT02966509|11910233|FG000|6 Month Satisfaction Decision Survey|Death|22
7551200|NCT02966509|11910234|FG001|6 Month Satisfaction Decision Survey|Death|25
7551201|NCT02966509|11910233|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
7551202|NCT02966509|11910234|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
7551203|NCT02966509|11910233|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7551204|NCT02966509|11910234|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
7551205|NCT02966509|11910233|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
7551206|NCT02966509|11910234|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
7551207|NCT02966509|11910233|FG000|6 Month Satisfaction Survey|Death|36
7551208|NCT02966509|11910234|FG001|6 Month Satisfaction Survey|Death|33
7551209|NCT02966509|11910233|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
7551210|NCT02966509|11910234|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
7551211|NCT02966509|11910233|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
7551212|NCT02966509|11910234|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
7551213|NCT02966509|11910233|FG000|6 Month Satisfaction Survey|Refused to Answer|8
7551214|NCT02966509|11910234|FG001|6 Month Satisfaction Survey|Refused to Answer|11
7551215|NCT02966509|11910233|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
7551216|NCT02966509|11910234|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
7551217|NCT02966509|11910233|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
7551218|NCT02966509|11910234|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
7551219|NCT02966795|11910242|FG000|Overall Study|Patient Left the Country|0
7551220|NCT02966795|11910243|FG001|Overall Study|Patient Left the Country|1
7551221|NCT02966834|11910254|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7551222|NCT02966834|11910255|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7551223|NCT02966834|11910256|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7551224|NCT02966834|11910257|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7551225|NCT02966834|11910258|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
7551226|NCT02966834|11910259|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
7578702|NCT03837028|11970753|FG000|Overall Study|Withdrawal by Subject|12
7551227|NCT02966834|11910254|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
7551228|NCT02966834|11910255|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7578543|NCT03875508|11970015|FG000|Overall Study|Other, not specified|2
7578544|NCT03869333|11970023|FG000|Overall Study|Lost to Follow-up|1
7578545|NCT03869333|11970024|FG001|Overall Study|Lost to Follow-up|0
7578546|NCT03869333|11970025|FG002|Overall Study|Lost to Follow-up|0
7578547|NCT03869333|11970026|FG003|Overall Study|Lost to Follow-up|0
7578548|NCT03869333|11970023|FG000|Overall Study|Pregnancy|1
7578549|NCT03869333|11970024|FG001|Overall Study|Pregnancy|0
7578550|NCT03869333|11970025|FG002|Overall Study|Pregnancy|0
7578551|NCT03869333|11970026|FG003|Overall Study|Pregnancy|0
7578552|NCT03869333|11970023|FG000|Overall Study|Physician Decision|0
7578553|NCT03869333|11970024|FG001|Overall Study|Physician Decision|1
7578554|NCT03869333|11970025|FG002|Overall Study|Physician Decision|0
7578555|NCT03869333|11970026|FG003|Overall Study|Physician Decision|0
7578556|NCT03864900|11970038|FG000|Overall Study|Withdrawal by Subject|1
7578557|NCT03864900|11970039|FG001|Overall Study|Withdrawal by Subject|1
7578558|NCT03864900|11970038|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
7578559|NCT03864900|11970039|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
7578560|NCT03875482|11970064|FG000|Overall Study|Adverse Event|0
7578561|NCT03875482|11970065|FG001|Overall Study|Adverse Event|1
7578562|NCT03875482|11970064|FG000|Overall Study|Withdrew consent|5
7578563|NCT03875482|11970065|FG001|Overall Study|Withdrew consent|6
7578564|NCT03875482|11970064|FG000|Overall Study|Lost to Follow-up|8
7578565|NCT03875482|11970065|FG001|Overall Study|Lost to Follow-up|2
7578566|NCT03875482|11970064|FG000|Overall Study|Lack of Efficacy|0
7578567|NCT03875482|11970065|FG001|Overall Study|Lack of Efficacy|11
7578568|NCT03874013|11970083|FG000|Overall Study|Adverse Event|0
7578569|NCT03874013|11970084|FG001|Overall Study|Adverse Event|1
7578570|NCT03873116|11970093|FG000|Overall Study|Study drug discontinuation due to rash|0
7578571|NCT03873116|11970094|FG001|Overall Study|Study drug discontinuation due to rash|0
7578572|NCT03873116|11970095|FG002|Overall Study|Study drug discontinuation due to rash|1
7578573|NCT03872843|11970105|FG000|Overall Study|Lost to Follow-up|5
7578574|NCT03872843|11970106|FG001|Overall Study|Lost to Follow-up|7
7578575|NCT03870997|11970118|FG000|Overall Study|Did not complete mid-study/final survey|10544
7578576|NCT03870997|11970119|FG001|Overall Study|Did not complete mid-study/final survey|10431
7578577|NCT03870997|11970120|FG002|Overall Study|Did not complete mid-study/final survey|10978
7578578|NCT03870997|11970121|FG003|Overall Study|Did not complete mid-study/final survey|10947
7578579|NCT03870997|11970122|FG004|Overall Study|Did not complete mid-study/final survey|10588
7578580|NCT03870997|11970123|FG005|Overall Study|Did not complete mid-study/final survey|10531
7578581|NCT03869684|11970135|FG000|Overall Study|Adverse Event|0
7578582|NCT03869684|11970136|FG001|Overall Study|Adverse Event|3
7578583|NCT03869684|11970137|FG002|Overall Study|Adverse Event|1
7578584|NCT03869684|11970135|FG000|Overall Study|Withdrawal by Subject|1
7578585|NCT03869684|11970136|FG001|Overall Study|Withdrawal by Subject|0
7578586|NCT03869684|11970137|FG002|Overall Study|Withdrawal by Subject|0
7578587|NCT03869684|11970135|FG000|Overall Study|Lost to Follow-up|1
7578588|NCT03869684|11970136|FG001|Overall Study|Lost to Follow-up|0
7578589|NCT03869684|11970137|FG002|Overall Study|Lost to Follow-up|0
7578590|NCT03869684|11970135|FG000|Overall Study|Study prematurely terminated by sponsor|0
7578591|NCT03869684|11970136|FG001|Overall Study|Study prematurely terminated by sponsor|0
7578592|NCT03869684|11970137|FG002|Overall Study|Study prematurely terminated by sponsor|2
7578593|NCT03848416|11970191|FG000|Overall Study|Withdrawal by Subject|1
7578594|NCT03848416|11970192|FG001|Overall Study|Withdrawal by Subject|0
7578595|NCT03848416|11970193|FG002|Overall Study|Withdrawal by Subject|0
7578596|NCT03848416|11970191|FG000|Overall Study|Death|0
7578597|NCT03848416|11970192|FG001|Overall Study|Death|0
7578598|NCT03848416|11970193|FG002|Overall Study|Death|1
7578599|NCT03847987|11970203|FG000|Overall Study|Lost to Follow-up|1
7578600|NCT03847987|11970204|FG001|Overall Study|Lost to Follow-up|0
7578601|NCT03847987|11970203|FG000|Overall Study|Adverse Event|2
7578602|NCT03847987|11970204|FG001|Overall Study|Adverse Event|0
7578603|NCT03853551|11970266|FG000|Overall Study|Death|2
7578604|NCT03853551|11970266|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
7578605|NCT03870555|11970273|FG000|Period 3 (2 Days)|Adverse Event|1
7578606|NCT03870555|11970274|FG001|Period 3 (2 Days)|Adverse Event|0
7578607|NCT03870555|11970275|FG002|Period 3 (2 Days)|Adverse Event|0
7578608|NCT03851094|11970301|FG000|Overall Study|Withdrawal by Subject|0
7578609|NCT03851094|11970302|FG001|Overall Study|Withdrawal by Subject|1
7578610|NCT03851094|11970301|FG000|Overall Study|Participant lost device|0
7578611|NCT03851094|11970302|FG001|Overall Study|Participant lost device|1
7578612|NCT03851094|11970301|FG000|Overall Study|Participant returned device|0
7578613|NCT03851094|11970302|FG001|Overall Study|Participant returned device|2
7578614|NCT03868631|11970325|FG000|Baseline to Week 6|Adverse Event|0
7578615|NCT03868631|11970326|FG001|Baseline to Week 6|Adverse Event|3
7578616|NCT03868631|11970325|FG000|Baseline to Week 6|Protocol Violation|1
7578617|NCT03868631|11970326|FG001|Baseline to Week 6|Protocol Violation|1
7578618|NCT03868631|11970325|FG000|Baseline to Week 6|Withdrawal by Subject|3
7578619|NCT03868631|11970326|FG001|Baseline to Week 6|Withdrawal by Subject|0
7578620|NCT03868631|11970325|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
7578621|NCT03868631|11970326|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
7578703|NCT03837028|11970754|FG001|Overall Study|Withdrawal by Subject|11
7578622|NCT03868631|11970325|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
7578623|NCT03868631|11970326|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
7578624|NCT03868631|11970325|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7578625|NCT03868631|11970326|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
7578626|NCT03865953|11970334|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
7578627|NCT03865953|11970335|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
7578628|NCT03865953|11970334|FG000|First Intervention (4 Weeks)|Protocol Violation|0
7578629|NCT03865953|11970335|FG001|First Intervention (4 Weeks)|Protocol Violation|1
7578630|NCT03865953|11970334|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
7578631|NCT03865953|11970335|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
7578632|NCT03865381|11970341|FG000|Overall Study|Protocol Violation/Non-Compliance|3
7578633|NCT03865381|11970341|FG000|Overall Study|Withdrawal by Subject|2
7578634|NCT03868059|11970369|FG000|Overall Study|Adverse Event|3
7578635|NCT03868059|11970369|FG000|Overall Study|Lost to Follow-up|3
7578636|NCT03868059|11970369|FG000|Overall Study|Withdrawal by Subject|6
7578637|NCT03865407|11970384|FG000|Overall Study|Adverse Event|1
7578638|NCT03865407|11970385|FG001|Overall Study|Adverse Event|0
7578639|NCT03865407|11970384|FG000|Overall Study|Withdrawal by Subject|1
7578640|NCT03865407|11970385|FG001|Overall Study|Withdrawal by Subject|0
7578641|NCT03865407|11970384|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
7578642|NCT03865407|11970385|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
7578643|NCT03864653|11970404|FG000|Overall Study|Withdrawal by Subject|1
7578644|NCT03853213|11970421|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
7578645|NCT03853213|11970422|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
7578646|NCT03853213|11970421|FG000|Overall Study|Other (e.g., too busy)|0
7578647|NCT03853213|11970422|FG001|Overall Study|Other (e.g., too busy)|2
7578648|NCT03847610|11970428|FG000|Overall Study|Withdrawal by Subject|1
7578649|NCT03850093|11970435|FG000|Overall Study|Withdrawal by Subject|1
7578650|NCT03850093|11970436|FG001|Overall Study|Withdrawal by Subject|0
7578651|NCT03850093|11970437|FG002|Overall Study|Withdrawal by Subject|2
7578652|NCT03861936|11970518|FG000|Overall Study|Withdrawal by Subject|4
7578653|NCT03861936|11970519|FG001|Overall Study|Withdrawal by Subject|1
7578654|NCT03861936|11970520|FG002|Overall Study|Withdrawal by Subject|3
7578655|NCT03861936|11970518|FG000|Overall Study|Lost to Follow-up|5
7578656|NCT03861936|11970519|FG001|Overall Study|Lost to Follow-up|3
7578657|NCT03861936|11970520|FG002|Overall Study|Lost to Follow-up|3
7578658|NCT03861936|11970518|FG000|Overall Study|Physician Decision|0
7578659|NCT03861936|11970519|FG001|Overall Study|Physician Decision|1
7578660|NCT03861936|11970520|FG002|Overall Study|Physician Decision|0
7578661|NCT03861936|11970518|FG000|Overall Study|Protocol Deviation|0
7578662|NCT03861936|11970519|FG001|Overall Study|Protocol Deviation|0
7578663|NCT03861936|11970520|FG002|Overall Study|Protocol Deviation|1
7578664|NCT03861936|11970518|FG000|Overall Study|Reason not Specified|5
7578665|NCT03861936|11970519|FG001|Overall Study|Reason not Specified|5
7578666|NCT03861936|11970520|FG002|Overall Study|Reason not Specified|3
7578667|NCT03850509|11970560|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
7578668|NCT03850509|11970561|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
7578669|NCT03851016|11970646|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7578670|NCT03851016|11970647|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
7578671|NCT03850496|11970656|FG000|Overall Study|Withdrawal by Subject|1
7578672|NCT03850496|11970657|FG001|Overall Study|Withdrawal by Subject|0
7578673|NCT03850496|11970658|FG002|Overall Study|Withdrawal by Subject|0
7578674|NCT03850496|11970656|FG000|Overall Study|Lost to Follow-up|0
7578675|NCT03850496|11970657|FG001|Overall Study|Lost to Follow-up|1
7578676|NCT03850496|11970658|FG002|Overall Study|Lost to Follow-up|4
7578677|NCT03848949|11970668|FG000|Overall Study|Lost to Follow-up|5
7578678|NCT03848949|11970669|FG001|Overall Study|Lost to Follow-up|7
7578679|NCT03844945|11970697|FG000|Overall Study|Adverse Event|1
7578680|NCT03844945|11970698|FG001|Overall Study|Adverse Event|1
7578681|NCT03844945|11970699|FG002|Overall Study|Adverse Event|4
7578682|NCT03844945|11970700|FG003|Overall Study|Adverse Event|0
7578683|NCT03844945|11970697|FG000|Overall Study|Withdrawal by Subject|0
7578684|NCT03844945|11970698|FG001|Overall Study|Withdrawal by Subject|0
7578685|NCT03844945|11970699|FG002|Overall Study|Withdrawal by Subject|1
7578686|NCT03844945|11970700|FG003|Overall Study|Withdrawal by Subject|0
7578687|NCT03844945|11970697|FG000|Overall Study|Lack of Efficacy|0
7578688|NCT03844945|11970698|FG001|Overall Study|Lack of Efficacy|0
7578689|NCT03844945|11970699|FG002|Overall Study|Lack of Efficacy|0
7578690|NCT03844945|11970700|FG003|Overall Study|Lack of Efficacy|1
7578691|NCT03843632|11970723|FG000|Overall Study|Withdrawal by Subject|1
7578692|NCT03843632|11970724|FG001|Overall Study|Withdrawal by Subject|0
7578693|NCT03843632|11970725|FG002|Overall Study|Withdrawal by Subject|0
7578694|NCT03843632|11970726|FG003|Overall Study|Withdrawal by Subject|0
7578695|NCT03840811|11970739|FG000|Overall Study|Lost to Follow-up|0
7578696|NCT03840811|11970740|FG001|Overall Study|Lost to Follow-up|0
7578697|NCT03840811|11970741|FG002|Overall Study|Lost to Follow-up|1
7578698|NCT03837028|11970753|FG000|Overall Study|Lost to Follow-up|4
7578699|NCT03837028|11970754|FG001|Overall Study|Lost to Follow-up|0
7578700|NCT03837028|11970755|FG002|Overall Study|Lost to Follow-up|2
7578701|NCT03837028|11970756|FG003|Overall Study|Lost to Follow-up|0
7578704|NCT03837028|11970755|FG002|Overall Study|Withdrawal by Subject|11
7578705|NCT03837028|11970756|FG003|Overall Study|Withdrawal by Subject|7
7578706|NCT03841331|11970799|FG000|Overall Study|Withdrawal by Subject|4
7578707|NCT03841331|11970800|FG001|Overall Study|Withdrawal by Subject|9
7578708|NCT03841331|11970799|FG000|Overall Study|Lost to Follow-up|5
7578709|NCT03841331|11970800|FG001|Overall Study|Lost to Follow-up|1
7578710|NCT03840135|11970815|FG000|Overall Study|Protocol Violation|6
7578711|NCT03840135|11970816|FG001|Overall Study|Protocol Violation|1
7578712|NCT03840135|11970815|FG000|Overall Study|Withdrawal by Subject|1
7578713|NCT03840135|11970816|FG001|Overall Study|Withdrawal by Subject|0
7578714|NCT03839641|11970828|FG000|Overall Study|Withdrawal by Subject|1
7578715|NCT03839641|11970829|FG001|Overall Study|Withdrawal by Subject|1
7578716|NCT03839212|11970837|FG000|Overall Study|COVID-19 related suspension of research activities.|4
7578717|NCT03839355|11970843|FG000|Overall Study|Withdrawal by Subject|1
7578718|NCT03839355|11970844|FG001|Overall Study|Withdrawal by Subject|0
7578719|NCT03838731|11970861|FG000|Overall Study|Pregnancy|0
7578720|NCT03838731|11970862|FG001|Overall Study|Pregnancy|1
7578721|NCT03838731|11970861|FG000|Overall Study|Withdrawal of consent|1
7578722|NCT03838731|11970862|FG001|Overall Study|Withdrawal of consent|0
7624614|NCT00152477|12035812|FG001|Chemotherapy Period|Adverse Event|4
7624615|NCT00152477|12035813|FG002|Chemotherapy Period|Adverse Event|5
7624616|NCT00152477|12035811|FG000|Chemotherapy Period|Death|1
7624617|NCT00152477|12035812|FG001|Chemotherapy Period|Death|3
7624618|NCT00152477|12035813|FG002|Chemotherapy Period|Death|3
7624619|NCT00152477|12035811|FG000|Chemotherapy Period|Lack of Efficacy|4
7624620|NCT00152477|12035812|FG001|Chemotherapy Period|Lack of Efficacy|5
7624621|NCT00152477|12035813|FG002|Chemotherapy Period|Lack of Efficacy|6
7624622|NCT00152477|12035811|FG000|Chemotherapy Period|Lost to Follow-up|1
7624623|NCT00152477|12035812|FG001|Chemotherapy Period|Lost to Follow-up|0
7624624|NCT00152477|12035813|FG002|Chemotherapy Period|Lost to Follow-up|1
7624625|NCT00152477|12035811|FG000|Chemotherapy Period|Protocol Violation|1
7624626|NCT00152477|12035812|FG001|Chemotherapy Period|Protocol Violation|1
7624627|NCT00152477|12035813|FG002|Chemotherapy Period|Protocol Violation|0
7624628|NCT00152477|12035811|FG000|Chemotherapy Period|Withdrawal by Subject|5
7624629|NCT00152477|12035812|FG001|Chemotherapy Period|Withdrawal by Subject|1
7624630|NCT00152477|12035813|FG002|Chemotherapy Period|Withdrawal by Subject|0
7624631|NCT00152477|12035811|FG000|Chemotherapy Period|Progression of Disease|6
7624632|NCT00152477|12035812|FG001|Chemotherapy Period|Progression of Disease|8
7624633|NCT00152477|12035813|FG002|Chemotherapy Period|Progression of Disease|4
7624634|NCT00152477|12035811|FG000|Chemotherapy Period|Investigator decision|0
7624635|NCT00152477|12035812|FG001|Chemotherapy Period|Investigator decision|0
7624636|NCT00152477|12035813|FG002|Chemotherapy Period|Investigator decision|1
7624637|NCT00152477|12035811|FG000|Chemotherapy Period|Patient condition worsened|1
7578723|NCT03838198|11970870|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7578724|NCT03838198|11970871|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7578725|NCT03838198|11970872|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
7578726|NCT03838198|11970873|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
7578727|NCT03838198|11970870|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7578728|NCT03838198|11970871|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7578729|NCT03838198|11970872|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
7578730|NCT03838198|11970873|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
7578731|NCT03836677|11970992|FG000|Period 1|Adverse Event|0
7578732|NCT03836677|11970993|FG001|Period 1|Adverse Event|1
7578733|NCT03836677|11970992|FG000|Period 2|Severe non-compliance to protocol|1
7578734|NCT03836677|11970993|FG001|Period 2|Severe non-compliance to protocol|0
7578735|NCT03827564|11971013|FG000|Overall Study|Discontinued due to Study Termination|1
7578736|NCT03827564|11971014|FG001|Overall Study|Discontinued due to Study Termination|0
7578737|NCT03824236|11971023|FG000|Overall Study|Lost to Follow-up|0
7578738|NCT03824236|11971024|FG001|Overall Study|Lost to Follow-up|0
7578739|NCT03824236|11971025|FG002|Overall Study|Lost to Follow-up|1
7578740|NCT03810235|11971046|FG000|Overall Study|Withdrawal by Subject|2
7578741|NCT03810235|11971047|FG001|Overall Study|Withdrawal by Subject|0
7578742|NCT03836664|11971066|FG000|Overall Study|Didn't complete forms and lost drug|3
7578743|NCT03836664|11971067|FG001|Overall Study|Didn't complete forms and lost drug|3
7578744|NCT03832738|11971080|FG000|Overall Study|Withdrawal by Subject|6
7578745|NCT03832738|11971081|FG001|Overall Study|Withdrawal by Subject|7
7578746|NCT03832738|11971082|FG002|Overall Study|Withdrawal by Subject|16
7578747|NCT03832738|11971080|FG000|Overall Study|Physician Decision|0
7578748|NCT03832738|11971081|FG001|Overall Study|Physician Decision|1
7578749|NCT03832738|11971082|FG002|Overall Study|Physician Decision|2
7578750|NCT03832738|11971080|FG000|Overall Study|Adverse Event|2
7578751|NCT03832738|11971081|FG001|Overall Study|Adverse Event|3
7578752|NCT03832738|11971082|FG002|Overall Study|Adverse Event|1
7578753|NCT03832738|11971080|FG000|Overall Study|Pregnancy|0
7578754|NCT03832738|11971081|FG001|Overall Study|Pregnancy|1
7578755|NCT03832738|11971082|FG002|Overall Study|Pregnancy|0
7578756|NCT03823391|11971092|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
7578757|NCT03823391|11971093|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
7578758|NCT03823391|11971092|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
7578759|NCT03823391|11971093|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
7578760|NCT03808298|11971115|FG000|Overall Study|Adverse Event|3
7578761|NCT03808298|11971115|FG000|Overall Study|Physician Decision|1
7578762|NCT03808298|11971115|FG000|Overall Study|Withdrawal by Subject|1
7578763|NCT03808298|11971115|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
7578764|NCT03836729|11971144|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
7578765|NCT03835975|11971157|FG000|Overall Study|Lost to Follow-up|1
7578766|NCT03835975|11971158|FG001|Overall Study|Lost to Follow-up|1
7578767|NCT03835975|11971159|FG002|Overall Study|Lost to Follow-up|0
7578768|NCT03835975|11971160|FG003|Overall Study|Lost to Follow-up|0
7578769|NCT03835975|11971161|FG004|Overall Study|Lost to Follow-up|0
7578770|NCT03835975|11971157|FG000|Overall Study|No longer met eligibility criteria|0
7578771|NCT03835975|11971158|FG001|Overall Study|No longer met eligibility criteria|1
7578772|NCT03835975|11971159|FG002|Overall Study|No longer met eligibility criteria|0
7578773|NCT03835975|11971160|FG003|Overall Study|No longer met eligibility criteria|0
7578774|NCT03835975|11971161|FG004|Overall Study|No longer met eligibility criteria|0
7578775|NCT03835975|11971157|FG000|Overall Study|Protocol Violation|1
7578776|NCT03835975|11971158|FG001|Overall Study|Protocol Violation|1
7578777|NCT03835975|11971159|FG002|Overall Study|Protocol Violation|2
7578778|NCT03835975|11971160|FG003|Overall Study|Protocol Violation|0
7578779|NCT03835975|11971161|FG004|Overall Study|Protocol Violation|0
7578780|NCT03835975|11971157|FG000|Overall Study|Withdrawal by Subject|1
7578781|NCT03835975|11971158|FG001|Overall Study|Withdrawal by Subject|0
7578782|NCT03835975|11971159|FG002|Overall Study|Withdrawal by Subject|1
7578783|NCT03835975|11971160|FG003|Overall Study|Withdrawal by Subject|1
7578784|NCT03835975|11971161|FG004|Overall Study|Withdrawal by Subject|0
7578785|NCT03835221|11971216|FG000|Methafilcon A|Withdrawal by Subject|1
7578786|NCT03819634|11971222|FG000|Overall Study|Physician Decision|2
7578787|NCT03812679|11971226|FG000|Overall Study|Adverse Event|2
7578788|NCT03812679|11971226|FG000|Overall Study|Missed >4 consecutive therapy days|1
7578789|NCT03812679|11971226|FG000|Overall Study|Renal transplant|1
7578790|NCT03812679|11971226|FG000|Overall Study|Withdrawal by Subject|1
7578791|NCT03812679|11971226|FG000|Overall Study|Termination of study|2
7578792|NCT03812679|11971226|FG000|Overall Study|Water device replacement|1
7578793|NCT03801148|11971281|FG000|Period 1 (2 Days)|Adverse Event|1
7578794|NCT03801148|11971282|FG001|Period 1 (2 Days)|Adverse Event|1
7578795|NCT03801148|11971283|FG002|Period 1 (2 Days)|Adverse Event|0
7578796|NCT03801148|11971284|FG003|Period 1 (2 Days)|Adverse Event|0
7578797|NCT03801148|11971281|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7578798|NCT03801148|11971282|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7578799|NCT03801148|11971283|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
7578800|NCT03801148|11971284|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
7578801|NCT03801148|11971281|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7578802|NCT03801148|11971282|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7578803|NCT03801148|11971283|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
7578804|NCT03801148|11971284|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
7578805|NCT03801148|11971281|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
7578806|NCT03801148|11971282|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
7578807|NCT03801148|11971283|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
7578808|NCT03801148|11971284|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
7578809|NCT03832322|11971300|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
7578810|NCT03832322|11971301|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
7578811|NCT03832387|11971311|FG000|Overall Study|Protocol Violation|2
7578812|NCT03832387|11971312|FG001|Overall Study|Protocol Violation|6
7578813|NCT03832387|11971311|FG000|Overall Study|EXCLUSION CRITERIA|3
7578814|NCT03832387|11971312|FG001|Overall Study|EXCLUSION CRITERIA|1
7578815|NCT03807739|11971335|FG000|Overall Study|Adverse Event|1
7578816|NCT03807739|11971336|FG001|Overall Study|Adverse Event|0
7578817|NCT03807739|11971337|FG002|Overall Study|Adverse Event|0
7578818|NCT03807739|11971338|FG003|Overall Study|Adverse Event|0
7578819|NCT03807739|11971335|FG000|Overall Study|Withdrawal by Subject|1
7578820|NCT03807739|11971336|FG001|Overall Study|Withdrawal by Subject|0
7578821|NCT03807739|11971337|FG002|Overall Study|Withdrawal by Subject|0
7578822|NCT03807739|11971338|FG003|Overall Study|Withdrawal by Subject|0
7578823|NCT03831282|11971348|FG000|Overall Study|Could not place sensor|1
7578824|NCT03824912|11971355|FG000|Overall Study|Lost to Follow-up|18
7578825|NCT03824912|11971356|FG001|Overall Study|Lost to Follow-up|15
7578826|NCT03824912|11971357|FG002|Overall Study|Lost to Follow-up|8
7578827|NCT03824912|11971355|FG000|Overall Study|Negative Baseline Culture Result|118
7578828|NCT03824912|11971356|FG001|Overall Study|Negative Baseline Culture Result|112
7578829|NCT03824912|11971357|FG002|Overall Study|Negative Baseline Culture Result|57
7578830|NCT03824912|11971355|FG000|Overall Study|Non-Compliance with Study Drug|0
7578831|NCT03824912|11971356|FG001|Overall Study|Non-Compliance with Study Drug|0
7578832|NCT03824912|11971357|FG002|Overall Study|Non-Compliance with Study Drug|1
7578833|NCT03824912|11971355|FG000|Overall Study|Protocol Violation|1
7578834|NCT03824912|11971356|FG001|Overall Study|Protocol Violation|4
7578835|NCT03824912|11971357|FG002|Overall Study|Protocol Violation|1
7578836|NCT03824912|11971355|FG000|Overall Study|Withdrawal by Subject|3
7578837|NCT03824912|11971356|FG001|Overall Study|Withdrawal by Subject|2
7578838|NCT03824912|11971357|FG002|Overall Study|Withdrawal by Subject|1
7578839|NCT03824912|11971355|FG000|Overall Study|Participation in another study|0
7578840|NCT03824912|11971356|FG001|Overall Study|Participation in another study|1
7578841|NCT03824912|11971357|FG002|Overall Study|Participation in another study|0
7578842|NCT03822884|11971371|FG000|Overall Study|Withdrawal by Subject|0
7578843|NCT03822884|11971372|FG001|Overall Study|Withdrawal by Subject|0
7578844|NCT03822884|11971373|FG002|Overall Study|Withdrawal by Subject|0
7578845|NCT03822884|11971374|FG003|Overall Study|Withdrawal by Subject|0
7578846|NCT03822884|11971375|FG004|Overall Study|Withdrawal by Subject|1
7578847|NCT03822884|11971376|FG005|Overall Study|Withdrawal by Subject|0
7578848|NCT03810014|11971392|FG000|Overall Study|Pregnancy|2
7578849|NCT03810014|11971393|FG001|Overall Study|Pregnancy|2
7578850|NCT03810014|11971394|FG002|Overall Study|Pregnancy|0
7578851|NCT03810014|11971395|FG003|Overall Study|Pregnancy|2
7578852|NCT03830892|11971420|FG000|Overall Study|Physician Decision|2
7578853|NCT03830892|11971421|FG001|Overall Study|Physician Decision|3
7578854|NCT03830892|11971420|FG000|Overall Study|Study terminated due to COVID|4
7578855|NCT03830892|11971421|FG001|Overall Study|Study terminated due to COVID|0
7578856|NCT03830892|11971420|FG000|Overall Study|Protocol Violation|0
7578857|NCT03830892|11971421|FG001|Overall Study|Protocol Violation|1
7578858|NCT03830892|11971420|FG000|Overall Study|Withdrawal by Subject|0
7578859|NCT03830892|11971421|FG001|Overall Study|Withdrawal by Subject|2
7578860|NCT03825042|11971433|FG000|Overall Study|Adverse Event|1
7578861|NCT03825042|11971434|FG001|Overall Study|Adverse Event|0
7578862|NCT03825042|11971433|FG000|Overall Study|Withdrawal by Subject|1
7578863|NCT03825042|11971434|FG001|Overall Study|Withdrawal by Subject|0
7578864|NCT03823378|11971446|FG000|Overall Study|Adverse Event|2
7578865|NCT03823378|11971447|FG001|Overall Study|Adverse Event|2
7578866|NCT03823378|11971448|FG002|Overall Study|Adverse Event|0
7578867|NCT03823378|11971449|FG003|Overall Study|Adverse Event|0
7578868|NCT03823378|11971450|FG004|Overall Study|Adverse Event|0
7578869|NCT03823378|11971451|FG005|Overall Study|Adverse Event|0
7578870|NCT03823378|11971446|FG000|Overall Study|Lost to Follow-up|0
7578871|NCT03823378|11971447|FG001|Overall Study|Lost to Follow-up|1
7578872|NCT03823378|11971448|FG002|Overall Study|Lost to Follow-up|0
7578873|NCT03823378|11971449|FG003|Overall Study|Lost to Follow-up|0
7578874|NCT03823378|11971450|FG004|Overall Study|Lost to Follow-up|1
7578875|NCT03823378|11971451|FG005|Overall Study|Lost to Follow-up|0
7578876|NCT03823378|11971446|FG000|Overall Study|Withdrawal by Subject|0
7578877|NCT03823378|11971447|FG001|Overall Study|Withdrawal by Subject|1
7578878|NCT03823378|11971448|FG002|Overall Study|Withdrawal by Subject|4
7578879|NCT03823378|11971449|FG003|Overall Study|Withdrawal by Subject|2
7578880|NCT03823378|11971450|FG004|Overall Study|Withdrawal by Subject|0
7578881|NCT03823378|11971451|FG005|Overall Study|Withdrawal by Subject|1
7578882|NCT03823378|11971446|FG000|Overall Study|Other, not specified|19
7578883|NCT03823378|11971447|FG001|Overall Study|Other, not specified|12
7578884|NCT03823378|11971448|FG002|Overall Study|Other, not specified|6
7578885|NCT03823378|11971449|FG003|Overall Study|Other, not specified|8
7578886|NCT03823378|11971450|FG004|Overall Study|Other, not specified|17
7578887|NCT03823378|11971451|FG005|Overall Study|Other, not specified|7
7578888|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Adverse Event|2
7578889|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Adverse Event|1
7578890|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Adverse Event|3
7578891|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Adverse Event|4
7578892|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Adverse Event|0
7578893|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Adverse Event|0
7578894|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Adverse Event|0
7578895|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Adverse Event|0
7578896|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Adverse Event|0
7578897|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Adverse Event|0
7578898|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Adverse Event|0
7578899|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Adverse Event|0
7578900|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Adverse Event|0
7578901|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Adverse Event|0
7578902|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Adverse Event|0
7578903|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
7578904|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
7578905|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
7578906|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
7578907|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
7578908|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
7578909|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
7578910|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
7578911|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
7578912|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
7578913|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
7578914|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
7578915|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
7578916|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
7578917|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
7578918|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Pregnancy|0
7578919|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Pregnancy|0
7578920|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Pregnancy|1
7578921|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Pregnancy|0
7578922|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Pregnancy|0
7578923|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Pregnancy|0
7578924|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Pregnancy|0
7578925|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Pregnancy|0
7578926|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Pregnancy|0
7578927|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Pregnancy|0
7578928|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Pregnancy|0
7578929|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Pregnancy|0
7578930|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Pregnancy|0
7578931|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Pregnancy|0
7578932|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Pregnancy|0
7578933|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Protocol Violation|0
7578934|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Protocol Violation|0
7578935|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Protocol Violation|0
7578936|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Protocol Violation|2
7578937|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Protocol Violation|0
7578938|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Protocol Violation|0
7578939|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Protocol Violation|0
7578940|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Protocol Violation|0
7578941|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Protocol Violation|0
7578942|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Protocol Violation|0
7578943|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Protocol Violation|0
7578944|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Protocol Violation|0
7578945|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Protocol Violation|0
7578946|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Protocol Violation|0
7578947|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Protocol Violation|0
7578948|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
7578949|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
7578950|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
7578951|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
7578952|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578953|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578954|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578955|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578956|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578957|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578958|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578959|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578960|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578961|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578962|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
7578963|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
7578964|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
7578965|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
7578966|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
7578967|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578968|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578969|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578970|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578971|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578972|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578973|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578974|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578975|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578976|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578977|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
7578978|NCT03831191|11971469|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
7578979|NCT03831191|11971470|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
7578980|NCT03831191|11971471|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
7578981|NCT03831191|11971472|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
7578982|NCT03831191|11971473|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
7578983|NCT03831191|11971474|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
7578984|NCT03831191|11971475|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
7578985|NCT03831191|11971476|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
7578986|NCT03831191|11971477|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
7578987|NCT03831191|11971478|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
7578988|NCT03831191|11971479|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
7578989|NCT03831191|11971480|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
7578990|NCT03831191|11971481|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
7578991|NCT03831191|11971482|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
7578992|NCT03831191|11971483|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
7578993|NCT03831191|11971469|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7578994|NCT03831191|11971470|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7578995|NCT03831191|11971471|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7578996|NCT03831191|11971472|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
7578997|NCT03831191|11971473|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7578998|NCT03831191|11971474|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
7578999|NCT03831191|11971475|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
7579000|NCT03831191|11971476|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7579001|NCT03831191|11971477|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
7579002|NCT03831191|11971478|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7579003|NCT03831191|11971479|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
7579004|NCT03831191|11971480|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
7579005|NCT03831191|11971481|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7579006|NCT03831191|11971482|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
7579007|NCT03831191|11971483|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
7579008|NCT03831191|11971469|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579009|NCT03831191|11971470|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579010|NCT03831191|11971471|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579011|NCT03831191|11971472|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579012|NCT03831191|11971473|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579013|NCT03831191|11971474|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579014|NCT03831191|11971475|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579015|NCT03831191|11971476|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579016|NCT03831191|11971477|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579017|NCT03831191|11971478|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579018|NCT03831191|11971479|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579019|NCT03831191|11971480|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579020|NCT03831191|11971481|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579021|NCT03831191|11971482|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
7579022|NCT03831191|11971483|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
7579023|NCT03831191|11971469|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579024|NCT03831191|11971470|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579025|NCT03831191|11971471|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579026|NCT03831191|11971472|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579027|NCT03831191|11971473|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579028|NCT03831191|11971474|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579029|NCT03831191|11971475|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579030|NCT03831191|11971476|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579031|NCT03831191|11971477|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579032|NCT03831191|11971478|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579033|NCT03831191|11971479|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579034|NCT03831191|11971480|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579035|NCT03831191|11971481|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579036|NCT03831191|11971482|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
7579037|NCT03831191|11971483|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
7579038|NCT03830281|11971518|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
7579039|NCT03830281|11971519|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
7579040|NCT03830281|11971518|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
7579041|NCT03830281|11971519|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
7579042|NCT03830281|11971518|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
7579043|NCT03830281|11971519|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
7579044|NCT03830281|11971518|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
7579045|NCT03830281|11971519|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
7579046|NCT03830281|11971518|FG000|Treatment Period (16 Weeks)|Adverse Event|1
7579047|NCT03830281|11971519|FG001|Treatment Period (16 Weeks)|Adverse Event|7
7579048|NCT03830281|11971518|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
7579049|NCT03830281|11971519|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
7579050|NCT03830281|11971518|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
7579051|NCT03830281|11971519|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
7579052|NCT03830281|11971518|FG000|Treatment Period (16 Weeks)|Physician Decision|1
7579053|NCT03830281|11971519|FG001|Treatment Period (16 Weeks)|Physician Decision|0
7579054|NCT03830281|11971518|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
7579055|NCT03830281|11971519|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
7579056|NCT03827395|11971535|FG000|Overall Study|Lost to Follow-up|1
7579057|NCT03827395|11971536|FG001|Overall Study|Lost to Follow-up|0
7579058|NCT03827395|11971535|FG000|Overall Study|Protocol Violation|1
7579059|NCT03827395|11971536|FG001|Overall Study|Protocol Violation|0
7579060|NCT03827395|11971535|FG000|Overall Study|Became ineligible after enrollment|1
7579061|NCT03827395|11971536|FG001|Overall Study|Became ineligible after enrollment|2
7579062|NCT03819218|11971542|FG000|Overall Study|Protocol Violation|1
7579063|NCT03828487|11971555|FG000|Overall Study|Physician Decision|1
7579064|NCT03828617|11971563|FG000|Overall Study|Lost to Follow-up|22
7579065|NCT03828617|11971564|FG001|Overall Study|Lost to Follow-up|12
7579066|NCT03828617|11971565|FG002|Overall Study|Lost to Follow-up|23
7579067|NCT03828617|11971566|FG003|Overall Study|Lost to Follow-up|7
7579068|NCT03828617|11971563|FG000|Overall Study|No longer met eligibility criteria|0
7579069|NCT03828617|11971564|FG001|Overall Study|No longer met eligibility criteria|1
7579070|NCT03828617|11971565|FG002|Overall Study|No longer met eligibility criteria|1
7579071|NCT03828617|11971566|FG003|Overall Study|No longer met eligibility criteria|3
7579072|NCT03828617|11971563|FG000|Overall Study|Protocol Violation|0
7270052|NCT00413660|11484166|FG006|Post Week 12|Adverse Event|2
7270053|NCT00413660|11484167|FG007|Post Week 12|Adverse Event|0
7270054|NCT00413660|11484168|FG008|Post Week 12|Adverse Event|0
7270055|NCT00413660|11484169|FG009|Post Week 12|Adverse Event|0
7270056|NCT00413660|11484170|FG010|Post Week 12|Adverse Event|0
7579073|NCT03828617|11971564|FG001|Overall Study|Protocol Violation|2
7579074|NCT03828617|11971565|FG002|Overall Study|Protocol Violation|0
7579075|NCT03828617|11971566|FG003|Overall Study|Protocol Violation|0
7579076|NCT03828617|11971563|FG000|Overall Study|Withdrawal by Subject|2
7579077|NCT03828617|11971564|FG001|Overall Study|Withdrawal by Subject|0
7579078|NCT03828617|11971565|FG002|Overall Study|Withdrawal by Subject|2
7579079|NCT03828617|11971566|FG003|Overall Study|Withdrawal by Subject|0
7579080|NCT03828539|11971577|FG000|Overall Study|Adverse Event|3
7579081|NCT03828539|11971578|FG001|Overall Study|Adverse Event|12
7579082|NCT03828539|11971577|FG000|Overall Study|Patient's/guardian's decision|3
7579083|NCT03828539|11971578|FG001|Overall Study|Patient's/guardian's decision|5
7579084|NCT03828539|11971577|FG000|Overall Study|Lost to Follow-up|4
7579085|NCT03828539|11971578|FG001|Overall Study|Lost to Follow-up|2
7579086|NCT03828539|11971577|FG000|Overall Study|Protocol Violation|3
7579087|NCT03828539|11971578|FG001|Overall Study|Protocol Violation|2
7579088|NCT03828539|11971577|FG000|Overall Study|Withdrawal of informed consent|2
7579089|NCT03828539|11971578|FG001|Overall Study|Withdrawal of informed consent|1
7579090|NCT03828539|11971577|FG000|Overall Study|New therapy for study indication|1
7579091|NCT03828539|11971578|FG001|Overall Study|New therapy for study indication|0
7579092|NCT03824704|11971584|FG000|Overall Study|Study Terminated by Sponsor|1
7579093|NCT03817879|11971599|FG000|Overall Study|Drop out|5
7579094|NCT03817879|11971600|FG001|Overall Study|Drop out|12
7579095|NCT03817879|11971599|FG000|Overall Study|Withdrawal by Subject|0
7579096|NCT03817879|11971600|FG001|Overall Study|Withdrawal by Subject|1
7579097|NCT03811834|11971606|FG000|Period 1 ( 7 Days)|Adverse Event|1
7579098|NCT03806127|11971621|FG000|Overall Study|Withdrawal by Subject|4
7270057|NCT00413660|11484160|FG000|Post Week 12|Lack of Efficacy|0
7579099|NCT03806127|11971622|FG001|Overall Study|Withdrawal by Subject|5
7579100|NCT03806127|11971621|FG000|Overall Study|Protocol Violation|3
7579101|NCT03806127|11971622|FG001|Overall Study|Protocol Violation|1
7579102|NCT03806127|11971621|FG000|Overall Study|Adverse Event|3
7579103|NCT03806127|11971622|FG001|Overall Study|Adverse Event|0
7579104|NCT03806127|11971621|FG000|Overall Study|Unable to Complete Procedures|0
7579105|NCT03806127|11971622|FG001|Overall Study|Unable to Complete Procedures|1
7579106|NCT03806127|11971621|FG000|Overall Study|Pregnancy|0
7579107|NCT03806127|11971622|FG001|Overall Study|Pregnancy|1
7579108|NCT03806127|11971621|FG000|Overall Study|Lost to Follow-up|5
7579109|NCT03806127|11971622|FG001|Overall Study|Lost to Follow-up|1
7579110|NCT03806127|11971621|FG000|Overall Study|Physician Decision|1
7579111|NCT03806127|11971622|FG001|Overall Study|Physician Decision|1
7579112|NCT03806127|11971621|FG000|Overall Study|Could Not Come Due to Covid|1
7579113|NCT03806127|11971622|FG001|Overall Study|Could Not Come Due to Covid|0
7579114|NCT03806127|11971621|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
7579115|NCT03806127|11971622|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
7579116|NCT03806127|11971621|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
7579117|NCT03806127|11971622|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
7579118|NCT03806127|11971621|FG000|Overall Study|Covid 19 Restrictions|2
7579119|NCT03806127|11971622|FG001|Overall Study|Covid 19 Restrictions|0
7579120|NCT03806127|11971621|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
7579121|NCT03806127|11971622|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
7579122|NCT03806127|11971621|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
7579123|NCT03806127|11971622|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
7579124|NCT03827473|11971630|FG000|Overall Study|Withdrawal by Subject|1
7579125|NCT03827473|11971631|FG001|Overall Study|Withdrawal by Subject|0
7579126|NCT03826914|11971639|FG000|Overall Study|Withdrawal by Subject|1
7579127|NCT03826914|11971640|FG001|Overall Study|Withdrawal by Subject|1
7579128|NCT03808688|11971663|FG000|Overall Study|Adverse Event|13
7579129|NCT03808688|11971664|FG001|Overall Study|Adverse Event|17
7579130|NCT03808688|11971663|FG000|Overall Study|Lack of Efficacy|2
7579131|NCT03808688|11971664|FG001|Overall Study|Lack of Efficacy|0
7579132|NCT03808688|11971663|FG000|Overall Study|Lost to Follow-up|0
7579133|NCT03808688|11971664|FG001|Overall Study|Lost to Follow-up|2
7579134|NCT03808688|11971663|FG000|Overall Study|Withdrawal by Subject|1
7579135|NCT03808688|11971664|FG001|Overall Study|Withdrawal by Subject|0
7579136|NCT03808688|11971663|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
7579137|NCT03808688|11971664|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
7579138|NCT03808688|11971663|FG000|Overall Study|IOP Too High|1
7579139|NCT03808688|11971664|FG001|Overall Study|IOP Too High|1
7579140|NCT03808688|11971663|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
7579141|NCT03808688|11971664|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
7579142|NCT03808688|11971663|FG000|Overall Study|Visit Out of Window|0
7579143|NCT03808688|11971664|FG001|Overall Study|Visit Out of Window|1
7579144|NCT03808688|11971663|FG000|Overall Study|Medication Non-Compliance|0
7579145|NCT03808688|11971664|FG001|Overall Study|Medication Non-Compliance|1
7579150|NCT03822182|11971687|FG000|Overall Study|Protocol Violation|0
7579151|NCT03822182|11971688|FG001|Overall Study|Protocol Violation|1
7579152|NCT03822182|11971689|FG002|Overall Study|Protocol Violation|1
7579153|NCT03822416|11971700|FG000|Overall Study|Lost to Follow-up|1
7579154|NCT03822416|11971701|FG001|Overall Study|Lost to Follow-up|0
7579155|NCT03822416|11971700|FG000|Overall Study|Withdrawal by Subject|0
7579156|NCT03822416|11971701|FG001|Overall Study|Withdrawal by Subject|1
7579157|NCT03809104|11971707|FG000|Overall Study|Withdrawal by Subject|3
7579158|NCT03806231|11971722|FG000|Overall Study|Physician Decision|1
7579159|NCT03806231|11971723|FG001|Overall Study|Physician Decision|0
7579160|NCT03806231|11971722|FG000|Overall Study|Withdrawal by Subject|1
7579161|NCT03806231|11971723|FG001|Overall Study|Withdrawal by Subject|0
7579162|NCT03804710|11971731|FG000|Overall Study|Adverse Event|0
7579163|NCT03804710|11971732|FG001|Overall Study|Adverse Event|3
7579164|NCT03804710|11971731|FG000|Overall Study|Withdrawal by Subject|2
7579165|NCT03804710|11971732|FG001|Overall Study|Withdrawal by Subject|1
7579166|NCT03804710|11971731|FG000|Overall Study|Other|0
7579167|NCT03804710|11971732|FG001|Overall Study|Other|1
7579168|NCT03821064|11971776|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
7579169|NCT03820024|11971791|FG000|Overall Study|Physician Decision|1
7579170|NCT03820024|11971792|FG001|Overall Study|Physician Decision|2
7579171|NCT03816761|11971817|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
7579172|NCT03816761|11971818|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
7579173|NCT03816761|11971819|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
7579174|NCT03816761|11971820|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
7579175|NCT03816761|11971821|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
7579176|NCT03816761|11971822|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
7579177|NCT03816761|11971817|FG000|Second Treatment Period (7 Days)|Unclassified|0
7579178|NCT03816761|11971818|FG001|Second Treatment Period (7 Days)|Unclassified|0
7579179|NCT03816761|11971819|FG002|Second Treatment Period (7 Days)|Unclassified|0
7579180|NCT03816761|11971820|FG003|Second Treatment Period (7 Days)|Unclassified|1
7579181|NCT03816761|11971821|FG004|Second Treatment Period (7 Days)|Unclassified|0
7579182|NCT03816761|11971822|FG005|Second Treatment Period (7 Days)|Unclassified|0
7579183|NCT03812510|11971887|FG000|Overall Study|Lost to Follow-up|39
7579184|NCT03812510|11971887|FG000|Overall Study|Withdrawal by Subject|42
7579185|NCT03812510|11971887|FG000|Overall Study|Physician Decision|2
7579186|NCT03812510|11971887|FG000|Overall Study|Study Terminated by Sponsor|9
7579187|NCT03812510|11971887|FG000|Overall Study|Did Not Start Study Medication|55
7579188|NCT03812510|11971887|FG000|Overall Study|Adverse Event|5
7579189|NCT03802994|11971897|FG000|Overall Study|Lost to Follow-up|0
7579190|NCT03802994|11971898|FG001|Overall Study|Lost to Follow-up|2
7579191|NCT03802994|11971899|FG002|Overall Study|Lost to Follow-up|3
7579192|NCT03802994|11971900|FG003|Overall Study|Lost to Follow-up|2
7579193|NCT03802994|11971901|FG004|Overall Study|Lost to Follow-up|2
7579194|NCT03810183|11971926|FG000|Overall Study|Study terminated by Sponsor|2
7579195|NCT03810183|11971927|FG001|Overall Study|Study terminated by Sponsor|1
7579196|NCT03805971|11971967|FG000|Overall Study|Withdrawal by Subject|1
7579197|NCT03805971|11971967|FG000|Overall Study|Protocol Violation|2
7579198|NCT03802916|11971974|FG000|Overall Study|Adverse Event|0
7579199|NCT03802916|11971975|FG001|Overall Study|Adverse Event|1
7579200|NCT03802916|11971974|FG000|Overall Study|Withdrawal by Subject|0
7579201|NCT03802916|11971975|FG001|Overall Study|Withdrawal by Subject|1
7579202|NCT03809039|11971992|FG000|Part 1|Withdrawal by Subject|1
7579203|NCT03809039|11971993|FG001|Part 1|Withdrawal by Subject|0
7579204|NCT03809039|11971994|FG002|Part 1|Withdrawal by Subject|0
7579205|NCT03809039|11971995|FG003|Part 1|Withdrawal by Subject|1
7579206|NCT03809039|11971996|FG004|Part 1|Withdrawal by Subject|0
7579207|NCT03809039|11971997|FG005|Part 1|Withdrawal by Subject|0
7579208|NCT03809039|11971998|FG006|Part 1|Withdrawal by Subject|0
7579209|NCT03809039|11971999|FG007|Part 1|Withdrawal by Subject|0
7579210|NCT03809039|11972000|FG008|Part 1|Withdrawal by Subject|0
7579211|NCT03809039|11971992|FG000|Part 3|Withdrawn by study termination|0
7579212|NCT03809039|11971993|FG001|Part 3|Withdrawn by study termination|0
7579213|NCT03809039|11971994|FG002|Part 3|Withdrawn by study termination|0
7579214|NCT03809039|11971995|FG003|Part 3|Withdrawn by study termination|0
7579215|NCT03809039|11971996|FG004|Part 3|Withdrawn by study termination|0
7579216|NCT03809039|11971997|FG005|Part 3|Withdrawn by study termination|0
7579217|NCT03809039|11971998|FG006|Part 3|Withdrawn by study termination|0
7579218|NCT03809039|11971999|FG007|Part 3|Withdrawn by study termination|2
7579219|NCT03809039|11972000|FG008|Part 3|Withdrawn by study termination|6
7579220|NCT03807700|11972035|FG000|Overall Study|Withdrawal by Subject|2
7579221|NCT03807700|11972036|FG001|Overall Study|Withdrawal by Subject|1
7579222|NCT03804918|11972043|FG000|Overall Study|Participant did not use the app|1
7579223|NCT03803475|11972059|FG000|Overall Study|Physician Decision|1
7624638|NCT00152477|12035812|FG001|Chemotherapy Period|Patient condition worsened|0
7624639|NCT00152477|12035813|FG002|Chemotherapy Period|Patient condition worsened|0
7624640|NCT00152477|12035811|FG000|Monotherapy Period|Adverse Event|1
7624641|NCT00152477|12035812|FG001|Monotherapy Period|Adverse Event|0
7624642|NCT00152477|12035813|FG002|Monotherapy Period|Adverse Event|5
7624643|NCT00152477|12035811|FG000|Monotherapy Period|Death|2
7624644|NCT00152477|12035812|FG001|Monotherapy Period|Death|0
7624645|NCT00152477|12035813|FG002|Monotherapy Period|Death|1
7624646|NCT00152477|12035811|FG000|Monotherapy Period|Lack of Efficacy|7
7579224|NCT03801928|11972112|FG000|Overall Study|Adverse Event|1
7579225|NCT03801928|11972113|FG001|Overall Study|Adverse Event|0
7579226|NCT03801928|11972114|FG002|Overall Study|Adverse Event|1
7579227|NCT03801928|11972115|FG003|Overall Study|Adverse Event|2
7579228|NCT03801928|11972116|FG004|Overall Study|Adverse Event|0
7579229|NCT03801928|11972117|FG005|Overall Study|Adverse Event|2
7579230|NCT03801928|11972112|FG000|Overall Study|Lack of Efficacy|0
7579231|NCT03801928|11972113|FG001|Overall Study|Lack of Efficacy|0
7579232|NCT03801928|11972114|FG002|Overall Study|Lack of Efficacy|1
7579233|NCT03801928|11972115|FG003|Overall Study|Lack of Efficacy|0
7579234|NCT03801928|11972116|FG004|Overall Study|Lack of Efficacy|0
7579235|NCT03801928|11972117|FG005|Overall Study|Lack of Efficacy|0
7579236|NCT03801928|11972112|FG000|Overall Study|Lost to Follow-up|5
7579237|NCT03801928|11972113|FG001|Overall Study|Lost to Follow-up|1
7579238|NCT03801928|11972114|FG002|Overall Study|Lost to Follow-up|1
7579239|NCT03801928|11972115|FG003|Overall Study|Lost to Follow-up|4
7579240|NCT03801928|11972116|FG004|Overall Study|Lost to Follow-up|4
7579241|NCT03801928|11972117|FG005|Overall Study|Lost to Follow-up|2
7579242|NCT03801928|11972112|FG000|Overall Study|Withdrawal by Subject|0
7579243|NCT03801928|11972113|FG001|Overall Study|Withdrawal by Subject|0
7579244|NCT03801928|11972114|FG002|Overall Study|Withdrawal by Subject|2
7579245|NCT03801928|11972115|FG003|Overall Study|Withdrawal by Subject|1
7579246|NCT03801928|11972116|FG004|Overall Study|Withdrawal by Subject|0
7579247|NCT03801928|11972117|FG005|Overall Study|Withdrawal by Subject|0
7579248|NCT03801928|11972112|FG000|Overall Study|Other|0
7579249|NCT03801928|11972113|FG001|Overall Study|Other|2
7579250|NCT03801928|11972114|FG002|Overall Study|Other|0
7579251|NCT03801928|11972115|FG003|Overall Study|Other|1
7579252|NCT03801928|11972116|FG004|Overall Study|Other|0
7579253|NCT03801928|11972117|FG005|Overall Study|Other|1
7579254|NCT03800173|11972139|FG000|Overall Study|Lost to Follow-up|0
7579255|NCT03800173|11972140|FG001|Overall Study|Lost to Follow-up|0
7579256|NCT03800173|11972141|FG002|Overall Study|Lost to Follow-up|0
7579257|NCT03800173|11972142|FG003|Overall Study|Lost to Follow-up|0
7579258|NCT03800173|11972143|FG004|Overall Study|Lost to Follow-up|1
7579259|NCT03799211|11972178|FG000|Overall Study|Lost to Follow-up|2
7579260|NCT03799211|11972179|FG001|Overall Study|Lost to Follow-up|13
7579261|NCT03799211|11972178|FG000|Overall Study|Withdrawal by Subject|2
7579262|NCT03799211|11972179|FG001|Overall Study|Withdrawal by Subject|0
7579263|NCT03798717|11972193|FG000|Overall Study|Failed Screening|0
7579264|NCT03798717|11972194|FG001|Overall Study|Failed Screening|0
7579265|NCT03798717|11972195|FG002|Overall Study|Failed Screening|0
7579266|NCT03798717|11972196|FG003|Overall Study|Failed Screening|0
7579267|NCT03798717|11972197|FG004|Overall Study|Failed Screening|0
7579268|NCT03798717|11972198|FG005|Overall Study|Failed Screening|1
7579269|NCT03798717|11972193|FG000|Overall Study|Physician Decision|1
7579270|NCT03798717|11972194|FG001|Overall Study|Physician Decision|0
7579271|NCT03798717|11972195|FG002|Overall Study|Physician Decision|1
7579272|NCT03798717|11972196|FG003|Overall Study|Physician Decision|0
7579273|NCT03798717|11972197|FG004|Overall Study|Physician Decision|0
7579274|NCT03798717|11972198|FG005|Overall Study|Physician Decision|0
7579275|NCT03798717|11972193|FG000|Overall Study|Withdrawal by Subject|0
7579276|NCT03798717|11972194|FG001|Overall Study|Withdrawal by Subject|0
7579277|NCT03798717|11972195|FG002|Overall Study|Withdrawal by Subject|0
7579278|NCT03798717|11972196|FG003|Overall Study|Withdrawal by Subject|1
7579279|NCT03798717|11972197|FG004|Overall Study|Withdrawal by Subject|0
7579280|NCT03798717|11972198|FG005|Overall Study|Withdrawal by Subject|0
7579281|NCT03798717|11972193|FG000|Overall Study|Lost to Follow-up|1
7579282|NCT03798717|11972194|FG001|Overall Study|Lost to Follow-up|0
7579283|NCT03798717|11972195|FG002|Overall Study|Lost to Follow-up|0
7579284|NCT03798717|11972196|FG003|Overall Study|Lost to Follow-up|1
7579285|NCT03798717|11972197|FG004|Overall Study|Lost to Follow-up|0
7579286|NCT03798717|11972198|FG005|Overall Study|Lost to Follow-up|0
7579287|NCT03798717|11972193|FG000|Overall Study|Adverse Event|0
7579288|NCT03798717|11972194|FG001|Overall Study|Adverse Event|1
7579289|NCT03798717|11972195|FG002|Overall Study|Adverse Event|0
7579290|NCT03798717|11972196|FG003|Overall Study|Adverse Event|0
7579291|NCT03798717|11972197|FG004|Overall Study|Adverse Event|0
7579292|NCT03798717|11972198|FG005|Overall Study|Adverse Event|0
7579293|NCT03798717|11972193|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7579294|NCT03798717|11972194|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7579295|NCT03798717|11972195|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7579296|NCT03798717|11972196|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7579297|NCT03798717|11972197|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
7579298|NCT03798717|11972198|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
7579299|NCT03798483|11972207|FG000|Overall Study|Lost to Follow-up|2
7579300|NCT03798366|11972217|FG000|Overall Study|Lost to Follow-up|0
7579301|NCT03798366|11972218|FG001|Overall Study|Lost to Follow-up|1
7579302|NCT03799952|11972226|FG000|Overall Study|Program was too easy, discontinued|1
7579303|NCT03799952|11972227|FG001|Overall Study|Program was too easy, discontinued|0
7579304|NCT03799952|11972226|FG000|Overall Study|Lost to Follow-up|0
7579305|NCT03799952|11972227|FG001|Overall Study|Lost to Follow-up|2
7579306|NCT03796728|11972261|FG000|Overall Study|Lost to Follow-up|8
7579307|NCT03796728|11972261|FG000|Overall Study|Reason not Specified|16
7270058|NCT00413660|11484161|FG001|Post Week 12|Lack of Efficacy|0
7579308|NCT03797144|11972267|FG000|Enrollment|Protocol Violation|4
7579309|NCT03797144|11972268|FG001|Enrollment|Protocol Violation|1
7579310|NCT03797144|11972267|FG000|Surgery|Protocol Violation|1
7579311|NCT03797144|11972268|FG001|Surgery|Protocol Violation|0
7579312|NCT03797144|11972267|FG000|3 Month|Early termination cut-off date|2
7579313|NCT03797144|11972268|FG001|3 Month|Early termination cut-off date|0
7579314|NCT03797144|11972267|FG000|12 Month|Early termination cut-off date|8
7579315|NCT03797144|11972268|FG001|12 Month|Early termination cut-off date|9
7579316|NCT03797144|11972267|FG000|24 Month|Early termination cut-off date|1
7579317|NCT03797144|11972268|FG001|24 Month|Early termination cut-off date|1
7579318|NCT03782571|11972275|FG000|Period 1|Withdrawal by Subject|1
7579319|NCT03782571|11972276|FG001|Period 1|Withdrawal by Subject|0
7579320|NCT03782571|11972277|FG002|Period 1|Withdrawal by Subject|0
7579321|NCT03782571|11972278|FG003|Period 1|Withdrawal by Subject|0
7579322|NCT03782571|11972275|FG000|Period 3|Subject Unable to Attend V5|1
7579323|NCT03782571|11972276|FG001|Period 3|Subject Unable to Attend V5|0
7579324|NCT03782571|11972277|FG002|Period 3|Subject Unable to Attend V5|0
7579325|NCT03782571|11972278|FG003|Period 3|Subject Unable to Attend V5|0
7579326|NCT03782571|11972275|FG000|Period 3|Adverse Event|1
7579327|NCT03782571|11972276|FG001|Period 3|Adverse Event|0
7579328|NCT03782571|11972277|FG002|Period 3|Adverse Event|0
7579329|NCT03782571|11972278|FG003|Period 3|Adverse Event|0
7579330|NCT03796039|11972301|FG000|Overall Study|Death|2
7579331|NCT03796039|11972302|FG001|Overall Study|Death|1
7579332|NCT03796039|11972301|FG000|Overall Study|Withdrawal by Subject|7
7579333|NCT03796039|11972302|FG001|Overall Study|Withdrawal by Subject|4
7579334|NCT03783780|11972308|FG000|Overall Study|Withdrawn prior to completion|1
7579335|NCT03780959|11972316|FG000|Part 1|Adverse Event|1
7579336|NCT03780959|11972317|FG001|Part 1|Adverse Event|0
7579337|NCT03780959|11972318|FG002|Part 1|Adverse Event|0
7579338|NCT03780959|11972316|FG000|Part 1|Withdrawal by Subject|1
7579339|NCT03780959|11972317|FG001|Part 1|Withdrawal by Subject|0
7579340|NCT03780959|11972318|FG002|Part 1|Withdrawal by Subject|0
7579341|NCT03780959|11972316|FG000|Part 1|Withdrawal by Parent/Guardian|1
7579342|NCT03780959|11972317|FG001|Part 1|Withdrawal by Parent/Guardian|0
7579343|NCT03780959|11972318|FG002|Part 1|Withdrawal by Parent/Guardian|0
7579344|NCT03780959|11972316|FG000|Part 1|Response Status|2
7579345|NCT03780959|11972317|FG001|Part 1|Response Status|0
7579346|NCT03780959|11972318|FG002|Part 1|Response Status|0
7579347|NCT03780959|11972316|FG000|Part 2|Withdrawal by Parent/Guardian|0
7579348|NCT03780959|11972317|FG001|Part 2|Withdrawal by Parent/Guardian|1
7579349|NCT03780959|11972318|FG002|Part 2|Withdrawal by Parent/Guardian|0
7579350|NCT03780959|11972316|FG000|Part 2|Response Status|0
7579351|NCT03780959|11972317|FG001|Part 2|Response Status|18
7579352|NCT03780959|11972318|FG002|Part 2|Response Status|6
7579353|NCT03792477|11972358|FG000|Overall Study|Adverse Event|0
7579354|NCT03792477|11972359|FG001|Overall Study|Adverse Event|0
7579355|NCT03792477|11972360|FG002|Overall Study|Adverse Event|0
7579356|NCT03792477|11972361|FG003|Overall Study|Adverse Event|1
7579357|NCT03792477|11972362|FG004|Overall Study|Adverse Event|0
7579358|NCT03792477|11972358|FG000|Overall Study|Lost to Follow-up|0
7579359|NCT03792477|11972359|FG001|Overall Study|Lost to Follow-up|0
7579360|NCT03792477|11972360|FG002|Overall Study|Lost to Follow-up|2
7579361|NCT03792477|11972361|FG003|Overall Study|Lost to Follow-up|0
7579362|NCT03792477|11972362|FG004|Overall Study|Lost to Follow-up|0
7579363|NCT03792477|11972358|FG000|Overall Study|Other|0
7579364|NCT03792477|11972359|FG001|Overall Study|Other|0
7579365|NCT03792477|11972360|FG002|Overall Study|Other|0
7579366|NCT03792477|11972361|FG003|Overall Study|Other|0
7579367|NCT03792477|11972362|FG004|Overall Study|Other|1
7579368|NCT03783962|11972370|FG000|Overall Study|Lost to Follow-up|3
7579369|NCT03783962|11972371|FG001|Overall Study|Lost to Follow-up|6
7579370|NCT03783962|11972370|FG000|Overall Study|Protocol Violation|0
7579371|NCT03783962|11972371|FG001|Overall Study|Protocol Violation|1
7579372|NCT03793556|11972426|FG000|Overall Study|Withdrawal by Subject|12
7579373|NCT03793556|11972427|FG001|Overall Study|Withdrawal by Subject|1
7579374|NCT03793556|11972426|FG000|Overall Study|Lost to Follow-up|1
7579375|NCT03793556|11972427|FG001|Overall Study|Lost to Follow-up|1
7579376|NCT03785548|11972438|FG000|Overall Study|age > 80|1
7579377|NCT03785548|11972439|FG001|Overall Study|age > 80|0
7579378|NCT03785548|11972438|FG000|Overall Study|no Postop queries|1
7579379|NCT03785548|11972439|FG001|Overall Study|no Postop queries|0
7579381|NCT03792672|11972456|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
7579382|NCT03792672|11972457|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7579383|NCT03792672|11972458|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7579384|NCT03792672|11972459|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
7579385|NCT03792672|11972460|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7579386|NCT03792672|11972461|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
7579387|NCT03792672|11972456|FG000|Washout Period 3 (10 Days)|Physician Decision|0
7579388|NCT03792672|11972457|FG001|Washout Period 3 (10 Days)|Physician Decision|0
7579389|NCT03792672|11972458|FG002|Washout Period 3 (10 Days)|Physician Decision|1
7579390|NCT03792672|11972459|FG003|Washout Period 3 (10 Days)|Physician Decision|0
7579391|NCT03792672|11972460|FG004|Washout Period 3 (10 Days)|Physician Decision|0
7579392|NCT03792672|11972461|FG005|Washout Period 3 (10 Days)|Physician Decision|0
7579393|NCT03792672|11972456|FG000|Treatment Period 4 (2 Days)|Other|1
7579394|NCT03792672|11972457|FG001|Treatment Period 4 (2 Days)|Other|0
7579395|NCT03792672|11972458|FG002|Treatment Period 4 (2 Days)|Other|0
7579396|NCT03792672|11972459|FG003|Treatment Period 4 (2 Days)|Other|0
7579397|NCT03792672|11972460|FG004|Treatment Period 4 (2 Days)|Other|0
7579398|NCT03792672|11972461|FG005|Treatment Period 4 (2 Days)|Other|0
7579399|NCT03787615|11972570|FG000|Overall Study|Withdrawal by Subject|2
7579400|NCT03787615|11972570|FG000|Overall Study|Lost to Follow-up|2
7579401|NCT03786718|11972575|FG000|Overall Study|Lost to Follow-up|3
7579402|NCT03786718|11972575|FG000|Overall Study|Withdrawal by Subject|1
7579403|NCT03786718|11972575|FG000|Overall Study|Did not use the intervention|2
7579404|NCT03786718|11972575|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
7579405|NCT03784963|11972584|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
7579406|NCT03784963|11972585|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
7579407|NCT03784963|11972586|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
7579408|NCT03784963|11972587|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
7579409|NCT03787212|11972608|FG000|Period 1|Study Termination|2
7579410|NCT03787212|11972609|FG001|Period 1|Study Termination|2
7579411|NCT03783702|11972630|FG000|Overall Study|Lost to Follow-up|6
7579412|NCT03783702|11972631|FG001|Overall Study|Lost to Follow-up|8
7579413|NCT03783702|11972630|FG000|Overall Study|Protocol Violation|1
7579414|NCT03783702|11972631|FG001|Overall Study|Protocol Violation|3
7579415|NCT03783039|11972689|FG000|Overall Study|Death|2
7579416|NCT03783039|11972690|FG001|Overall Study|Death|1
7579417|NCT03776175|11972718|FG000|Treatment Period (42 Days)|Adverse Event|0
7579418|NCT03776175|11972719|FG001|Treatment Period (42 Days)|Adverse Event|1
7579419|NCT03776175|11972720|FG002|Treatment Period (42 Days)|Adverse Event|1
7579420|NCT03776175|11972721|FG003|Treatment Period (42 Days)|Adverse Event|0
7579421|NCT03776175|11972718|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
7579422|NCT03776175|11972719|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
7579423|NCT03776175|11972720|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
7579424|NCT03776175|11972721|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
7579425|NCT03776175|11972718|FG000|Treatment Period (42 Days)|Participants screened at other site|0
7579426|NCT03776175|11972719|FG001|Treatment Period (42 Days)|Participants screened at other site|2
7579427|NCT03776175|11972720|FG002|Treatment Period (42 Days)|Participants screened at other site|0
7579428|NCT03776175|11972721|FG003|Treatment Period (42 Days)|Participants screened at other site|0
7579429|NCT03776175|11972718|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
7579430|NCT03776175|11972719|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
7579431|NCT03776175|11972720|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
7579432|NCT03776175|11972721|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
7579433|NCT03776175|11972718|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
7579434|NCT03776175|11972719|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
7579435|NCT03776175|11972720|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
7579436|NCT03776175|11972721|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
7579437|NCT03776175|11972718|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
7579438|NCT03776175|11972719|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
7579439|NCT03776175|11972720|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
7579440|NCT03776175|11972721|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
7579441|NCT03771963|11972731|FG000|Overall Study|Lost to Follow-up|22
7579442|NCT03771963|11972731|FG000|Overall Study|Withdrawal of Consent|10
7579443|NCT03771352|11972735|FG000|Overall Study|Screen failure|2
7579444|NCT03771352|11972735|FG000|Overall Study|Withdrawal by Subject|2
7579445|NCT03773796|11972739|FG000|Overall Study|Adverse Event|1
7579446|NCT03773796|11972739|FG000|Overall Study|Withdrawal by Subject|1
7579447|NCT03773796|11972739|FG000|Overall Study|Lack of Efficacy|1
7579448|NCT03781375|11972756|FG000|Double-blind Phase|Adverse Event|0
7579449|NCT03781375|11972757|FG001|Double-blind Phase|Adverse Event|1
7579450|NCT03781375|11972756|FG000|Double-blind Phase|Lack of Response|6
7579451|NCT03781375|11972757|FG001|Double-blind Phase|Lack of Response|2
7579452|NCT03781375|11972756|FG000|Double-blind Phase|Other|1
7579453|NCT03781375|11972757|FG001|Double-blind Phase|Other|3
7579454|NCT03781375|11972756|FG000|Open-label Phase|Protocol Issues|0
7579455|NCT03781375|11972757|FG001|Open-label Phase|Protocol Issues|1
7579456|NCT03781375|11972756|FG000|Open-label Phase|Suboptimal Clinical Response|1
7579457|NCT03781375|11972757|FG001|Open-label Phase|Suboptimal Clinical Response|0
7579458|NCT03781375|11972756|FG000|Open-label Phase|Other|2
7579459|NCT03781375|11972757|FG001|Open-label Phase|Other|2
7579460|NCT03781336|11972766|FG000|Overall Study|Withdrawal by Subject|2
7579461|NCT03781336|11972767|FG001|Overall Study|Withdrawal by Subject|2
7579462|NCT03780400|11972773|FG000|Overall Study|Lost to Follow-up|5
7579463|NCT03780400|11972773|FG000|Overall Study|Withdrawal by Subject|2
7579464|NCT03779503|11972786|FG000|First Intervention|Adverse Event|0
7579465|NCT03779503|11972787|FG001|First Intervention|Adverse Event|1
7579466|NCT03779503|11972786|FG000|First Intervention|Withdrawal by Subject|1
7579467|NCT03779503|11972787|FG001|First Intervention|Withdrawal by Subject|0
7579468|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
7579469|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
7579470|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
7579471|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
7579472|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7579473|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7579474|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
7579475|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
7579476|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7579477|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
7579478|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
7579479|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
7579480|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7579481|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
7579482|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
7579483|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
7579484|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
7579485|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
7579486|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
7579487|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
7579488|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
7579489|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
7579490|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
7579491|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
7579492|NCT03777059|11972821|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7579493|NCT03777059|11972822|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
7579494|NCT03777059|11972823|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
7270059|NCT00413660|11484162|FG002|Post Week 12|Lack of Efficacy|1
7270060|NCT00413660|11484163|FG003|Post Week 12|Lack of Efficacy|0
7270061|NCT00413660|11484164|FG004|Post Week 12|Lack of Efficacy|0
7270062|NCT00413660|11484165|FG005|Post Week 12|Lack of Efficacy|0
7270063|NCT00413660|11484166|FG006|Post Week 12|Lack of Efficacy|0
7270064|NCT00413660|11484167|FG007|Post Week 12|Lack of Efficacy|0
7270065|NCT00413660|11484168|FG008|Post Week 12|Lack of Efficacy|0
7270066|NCT00413660|11484169|FG009|Post Week 12|Lack of Efficacy|1
7270067|NCT00413660|11484170|FG010|Post Week 12|Lack of Efficacy|0
7270068|NCT00413660|11484160|FG000|Post Week 12|Lost to Follow-up|0
7270069|NCT00413660|11484161|FG001|Post Week 12|Lost to Follow-up|1
7579495|NCT03777059|11972824|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
7579496|NCT03777059|11972821|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7579497|NCT03777059|11972822|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
7579498|NCT03777059|11972823|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
7579499|NCT03777059|11972824|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
7579500|NCT03777059|11972821|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7579501|NCT03777059|11972822|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
7579502|NCT03777059|11972823|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
7579503|NCT03777059|11972824|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
7579504|NCT03777059|11972821|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7579505|NCT03777059|11972822|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7579506|NCT03777059|11972823|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
7579507|NCT03777059|11972824|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
7579508|NCT03777059|11972821|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7579509|NCT03777059|11972822|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
7579510|NCT03777059|11972823|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7579511|NCT03777059|11972824|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
7579512|NCT03772522|11972836|FG000|Pre-intervention|Withdrawal by Subject|3
7579513|NCT03772522|11972837|FG001|Pre-intervention|Withdrawal by Subject|4
7579514|NCT03772522|11972836|FG000|Intervention|Withdrawal by Subject|1
7579515|NCT03772522|11972837|FG001|Intervention|Withdrawal by Subject|0
7579516|NCT03772522|11972836|FG000|Post-intervention Follow-up|Lost to Follow-up|1
7579517|NCT03772522|11972837|FG001|Post-intervention Follow-up|Lost to Follow-up|0
7579518|NCT03772327|11972849|FG000|Overall Study|Lost to Follow-up|3
7579519|NCT03772327|11972850|FG001|Overall Study|Lost to Follow-up|4
7579520|NCT03772327|11972849|FG000|Overall Study|Withdrawal by Subject|2
7579521|NCT03772327|11972850|FG001|Overall Study|Withdrawal by Subject|3
7579522|NCT03774576|11972860|FG000|Period 2|Adverse Event|1
7579523|NCT03772041|11972888|FG000|Overall Study|Adverse Event|8
7579524|NCT03772041|11972889|FG001|Overall Study|Adverse Event|3
7579525|NCT03772041|11972888|FG000|Overall Study|Withdrawal by Subject|0
7579526|NCT03772041|11972889|FG001|Overall Study|Withdrawal by Subject|2
7579527|NCT03772041|11972888|FG000|Overall Study|Protocol Violation|4
7579528|NCT03772041|11972889|FG001|Overall Study|Protocol Violation|2
7579529|NCT03772041|11972888|FG000|Overall Study|Physician Decision|2
7579530|NCT03772041|11972889|FG001|Overall Study|Physician Decision|3
7579531|NCT03775681|11972895|FG000|Overall Study|Physician Decision|3
7579532|NCT03774823|11972901|FG000|Overall Study|Withdrawal by Subject|1
7579533|NCT03774823|11972902|FG001|Overall Study|Withdrawal by Subject|1
7579534|NCT03774433|11972917|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
7579535|NCT03769896|11972940|FG000|Open-label Phase|Lack of Efficacy|5
7579536|NCT03769896|11972941|FG001|Open-label Phase|Lack of Efficacy|0
7579537|NCT03769896|11972940|FG000|Open-label Phase|Adverse Event|3
7579538|NCT03769896|11972941|FG001|Open-label Phase|Adverse Event|0
7579539|NCT03769896|11972940|FG000|Open-label Phase|Withdrawal by Subject|1
7579540|NCT03769896|11972941|FG001|Open-label Phase|Withdrawal by Subject|0
7579541|NCT03768726|11972958|FG000|Treatment Phase|Adverse Event|2
7579542|NCT03768726|11972959|FG001|Treatment Phase|Adverse Event|2
7579543|NCT03768726|11972958|FG000|Treatment Phase|Lost to Follow-up|1
7579544|NCT03768726|11972959|FG001|Treatment Phase|Lost to Follow-up|0
7579545|NCT03768726|11972958|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
7579546|NCT03768726|11972959|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
7579547|NCT03768726|11972958|FG000|Treatment Phase|Withdrawal by Subject|3
7579548|NCT03768726|11972959|FG001|Treatment Phase|Withdrawal by Subject|1
7579549|NCT03768726|11972958|FG000|Follow-Up|Adverse Event|2
7579550|NCT03768726|11972959|FG001|Follow-Up|Adverse Event|2
7579551|NCT03768726|11972958|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
7579552|NCT03768726|11972959|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
7579553|NCT03768726|11972958|FG000|Follow-Up|Withdrawal by Subject|2
7579554|NCT03768726|11972959|FG001|Follow-Up|Withdrawal by Subject|0
7579555|NCT03768726|11972958|FG000|Follow-Up|Other|1
7579556|NCT03768726|11972959|FG001|Follow-Up|Other|0
7579557|NCT03768206|11972967|FG000|Overall Study|Lost to Follow-up|2
7579558|NCT03768206|11972968|FG001|Overall Study|Lost to Follow-up|1
7579559|NCT03768206|11972967|FG000|Overall Study|Withdrawal by Subject|0
7579560|NCT03768206|11972968|FG001|Overall Study|Withdrawal by Subject|1
7579561|NCT03767894|11972975|FG000|Overall Study|Withdrawal by Subject|1
7579562|NCT03766646|11973008|FG000|Overall Study|Withdrawal by Subject|1
7579563|NCT03766646|11973009|FG001|Overall Study|Withdrawal by Subject|0
7579564|NCT03766646|11973008|FG000|Overall Study|Protocol Violation|0
7579565|NCT03766646|11973009|FG001|Overall Study|Protocol Violation|3
7579566|NCT03765164|11973081|FG000|Pre-intervention|Withdrawal by Subject|5
7579567|NCT03765164|11973082|FG001|Pre-intervention|Withdrawal by Subject|6
7624647|NCT00152477|12035812|FG001|Monotherapy Period|Lack of Efficacy|16
7624648|NCT00152477|12035813|FG002|Monotherapy Period|Lack of Efficacy|10
7624649|NCT00152477|12035811|FG000|Monotherapy Period|Protocol Violation|0
7624650|NCT00152477|12035812|FG001|Monotherapy Period|Protocol Violation|1
7624651|NCT00152477|12035813|FG002|Monotherapy Period|Protocol Violation|0
7624652|NCT00152477|12035811|FG000|Monotherapy Period|Withdrawal by Subject|0
7624653|NCT00152477|12035812|FG001|Monotherapy Period|Withdrawal by Subject|0
7624654|NCT00152477|12035813|FG002|Monotherapy Period|Withdrawal by Subject|4
7624655|NCT00152477|12035811|FG000|Monotherapy Period|Progression of Disease|5
7624656|NCT00152477|12035812|FG001|Monotherapy Period|Progression of Disease|11
7624657|NCT00152477|12035813|FG002|Monotherapy Period|Progression of Disease|12
7624658|NCT00152477|12035811|FG000|Monotherapy Period|Patient decision|0
7624659|NCT00152477|12035812|FG001|Monotherapy Period|Patient decision|1
7624660|NCT00152477|12035813|FG002|Monotherapy Period|Patient decision|1
7624661|NCT00152477|12035811|FG000|Monotherapy Period|Study personel decision|0
7624662|NCT00152477|12035812|FG001|Monotherapy Period|Study personel decision|0
7624663|NCT00152477|12035813|FG002|Monotherapy Period|Study personel decision|1
7579568|NCT03765138|11973088|FG000|Overall Study|Lost to Follow-up|1
7579569|NCT03762681|11973143|FG000|Part 1|Withdrawal by Subject|0
7579570|NCT03762681|11973144|FG001|Part 1|Withdrawal by Subject|0
7579571|NCT03762681|11973145|FG002|Part 1|Withdrawal by Subject|0
7579572|NCT03762681|11973146|FG003|Part 1|Withdrawal by Subject|1
7579573|NCT03762681|11973147|FG004|Part 1|Withdrawal by Subject|0
7579574|NCT03762681|11973148|FG005|Part 1|Withdrawal by Subject|0
7579575|NCT03762681|11973149|FG006|Part 1|Withdrawal by Subject|0
7579576|NCT03762681|11973150|FG007|Part 1|Withdrawal by Subject|0
7579577|NCT03762681|11973143|FG000|Part 2a|Pandemic Travel Restrictions|0
7579578|NCT03762681|11973144|FG001|Part 2a|Pandemic Travel Restrictions|0
7579579|NCT03762681|11973145|FG002|Part 2a|Pandemic Travel Restrictions|0
7579580|NCT03762681|11973146|FG003|Part 2a|Pandemic Travel Restrictions|0
7579581|NCT03762681|11973147|FG004|Part 2a|Pandemic Travel Restrictions|0
7579582|NCT03762681|11973148|FG005|Part 2a|Pandemic Travel Restrictions|0
7579583|NCT03762681|11973149|FG006|Part 2a|Pandemic Travel Restrictions|0
7579584|NCT03762681|11973150|FG007|Part 2a|Pandemic Travel Restrictions|1
7579585|NCT03762668|11973179|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
7579586|NCT03762668|11973180|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
7579587|NCT03762616|11973186|FG000|Overall Study|Protocol Violation|2
7579588|NCT03762200|11973201|FG000|Overall Study|Death|2
7579589|NCT03761147|11973216|FG000|Overall Study|Withdrawal by Subject|6
7579590|NCT03761147|11973217|FG001|Overall Study|Withdrawal by Subject|1
7579591|NCT03761147|11973216|FG000|Overall Study|Adverse Event|1
7579592|NCT03761147|11973217|FG001|Overall Study|Adverse Event|3
7579593|NCT03760510|11973331|FG000|Overall Study|Not ventilated for 24 hours|105
7579594|NCT03760510|11973332|FG001|Overall Study|Not ventilated for 24 hours|97
7579595|NCT03760250|11973338|FG000|Overall Study|Withdrawal by Subject|1
7579596|NCT03760250|11973338|FG000|Overall Study|Physician Decision|1
7579597|NCT03759600|11973342|FG000|Overall Study|Ongoing at Data Cut-off|16
7579598|NCT03759600|11973342|FG000|Overall Study|Adverse Event|1
7579599|NCT03759600|11973342|FG000|Overall Study|Progressive Disease|3
7579600|NCT03759340|11973346|FG000|Overall Study|Adverse Event|2
7579601|NCT03759340|11973346|FG000|Overall Study|Lost to Follow-up|1
7579602|NCT03759340|11973346|FG000|Overall Study|Withdrawal by Subject|15
7579603|NCT03759340|11973346|FG000|Overall Study|Study Terminated by Sponsor|38
7579604|NCT03757988|11973369|FG000|Overall Study|Withdrawal by Subject|1
7579605|NCT03757234|11973390|FG000|Overall Study|Adverse Event|0
7579606|NCT03757234|11973391|FG001|Overall Study|Adverse Event|0
7579607|NCT03757234|11973392|FG002|Overall Study|Adverse Event|0
7579608|NCT03757234|11973393|FG003|Overall Study|Adverse Event|0
7579609|NCT03757234|11973394|FG004|Overall Study|Adverse Event|1
7579610|NCT03757234|11973390|FG000|Overall Study|Lost to Follow-up|1
7579611|NCT03757234|11973391|FG001|Overall Study|Lost to Follow-up|0
7579612|NCT03757234|11973392|FG002|Overall Study|Lost to Follow-up|0
7579613|NCT03757234|11973393|FG003|Overall Study|Lost to Follow-up|0
7579614|NCT03757234|11973394|FG004|Overall Study|Lost to Follow-up|1
7579615|NCT03757234|11973390|FG000|Overall Study|Withdrawal by Subject|1
7579616|NCT03757234|11973391|FG001|Overall Study|Withdrawal by Subject|1
7579617|NCT03757234|11973392|FG002|Overall Study|Withdrawal by Subject|0
7579618|NCT03757234|11973393|FG003|Overall Study|Withdrawal by Subject|1
7579619|NCT03757234|11973394|FG004|Overall Study|Withdrawal by Subject|2
7579620|NCT03757234|11973390|FG000|Overall Study|Other|1
7579621|NCT03757234|11973391|FG001|Overall Study|Other|1
7579622|NCT03757234|11973392|FG002|Overall Study|Other|0
7579623|NCT03757234|11973393|FG003|Overall Study|Other|0
7579624|NCT03757234|11973394|FG004|Overall Study|Other|0
7579625|NCT03756883|11973422|FG000|Overall Study|Adverse Event|2
7579626|NCT03756883|11973423|FG001|Overall Study|Adverse Event|2
7579627|NCT03756883|11973424|FG002|Overall Study|Adverse Event|2
7579628|NCT03756883|11973422|FG000|Overall Study|Lack of Efficacy|0
7579629|NCT03756883|11973423|FG001|Overall Study|Lack of Efficacy|1
7579630|NCT03756883|11973424|FG002|Overall Study|Lack of Efficacy|2
7579631|NCT03756883|11973422|FG000|Overall Study|Lost to Follow-up|3
7579632|NCT03756883|11973423|FG001|Overall Study|Lost to Follow-up|3
7579633|NCT03756883|11973424|FG002|Overall Study|Lost to Follow-up|0
7579634|NCT03756883|11973422|FG000|Overall Study|Protocol Violation|2
7579635|NCT03756883|11973423|FG001|Overall Study|Protocol Violation|0
7579636|NCT03756883|11973424|FG002|Overall Study|Protocol Violation|1
7579637|NCT03756883|11973422|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
7579638|NCT03756883|11973423|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
7579639|NCT03756883|11973424|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
7579640|NCT03756883|11973422|FG000|Overall Study|Withdrawal by Subject|4
7579641|NCT03756883|11973423|FG001|Overall Study|Withdrawal by Subject|1
7579642|NCT03756883|11973424|FG002|Overall Study|Withdrawal by Subject|0
7579643|NCT03756883|11973422|FG000|Overall Study|Other Reasons|2
7579644|NCT03756883|11973423|FG001|Overall Study|Other Reasons|4
7579645|NCT03756883|11973424|FG002|Overall Study|Other Reasons|0
7579646|NCT03756285|11973443|FG000|Overall Study|Lost to Follow-up|0
7579647|NCT03756285|11973444|FG001|Overall Study|Lost to Follow-up|1
7579648|NCT03756285|11973443|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
7579649|NCT03756285|11973444|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
7624664|NCT04585646|12035824|FG000|First Intervention|Physician Decision|1
7579650|NCT03756285|11973443|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7579651|NCT03756285|11973444|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
7579652|NCT03756129|11973457|FG000|Overall Study|Adverse Event|1
7579653|NCT03756129|11973458|FG001|Overall Study|Adverse Event|1
7579654|NCT03756129|11973459|FG002|Overall Study|Adverse Event|0
7579655|NCT03756129|11973460|FG003|Overall Study|Adverse Event|2
7579656|NCT03756129|11973461|FG004|Overall Study|Adverse Event|0
7579657|NCT03756129|11973462|FG005|Overall Study|Adverse Event|0
7579658|NCT03756129|11973457|FG000|Overall Study|Withdrawal by Subject|2
7579659|NCT03756129|11973458|FG001|Overall Study|Withdrawal by Subject|1
7579660|NCT03756129|11973459|FG002|Overall Study|Withdrawal by Subject|3
7579661|NCT03756129|11973460|FG003|Overall Study|Withdrawal by Subject|1
7579662|NCT03756129|11973461|FG004|Overall Study|Withdrawal by Subject|1
7579663|NCT03756129|11973462|FG005|Overall Study|Withdrawal by Subject|3
7579664|NCT03756129|11973457|FG000|Overall Study|Lost to Follow-up|0
7579665|NCT03756129|11973458|FG001|Overall Study|Lost to Follow-up|0
7579666|NCT03756129|11973459|FG002|Overall Study|Lost to Follow-up|0
7579667|NCT03756129|11973460|FG003|Overall Study|Lost to Follow-up|0
7579668|NCT03756129|11973461|FG004|Overall Study|Lost to Follow-up|0
7579669|NCT03756129|11973462|FG005|Overall Study|Lost to Follow-up|1
7579670|NCT03756129|11973457|FG000|Overall Study|Physician Decision|0
7579671|NCT03756129|11973458|FG001|Overall Study|Physician Decision|0
7579672|NCT03756129|11973459|FG002|Overall Study|Physician Decision|0
7579673|NCT03756129|11973460|FG003|Overall Study|Physician Decision|0
7579674|NCT03756129|11973461|FG004|Overall Study|Physician Decision|0
7579675|NCT03756129|11973462|FG005|Overall Study|Physician Decision|1
7579676|NCT03755882|11973498|FG000|Period 1|Protocol Violation|1
7579677|NCT03755882|11973499|FG001|Period 1|Protocol Violation|0
7579678|NCT03755882|11973498|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
7579679|NCT03755882|11973499|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
7579680|NCT03755661|11973507|FG000|Overall Study|Lost to Follow-up|1
7579681|NCT03755661|11973508|FG001|Overall Study|Lost to Follow-up|0
7579682|NCT03754582|11973514|FG000|Treatment Phase|Adverse Event|0
7579683|NCT03754582|11973515|FG001|Treatment Phase|Adverse Event|1
7579684|NCT03754582|11973516|FG002|Treatment Phase|Adverse Event|0
7579685|NCT03754582|11973514|FG000|Follow-up Phase|Other|0
7579686|NCT03754582|11973515|FG001|Follow-up Phase|Other|0
7579687|NCT03754582|11973516|FG002|Follow-up Phase|Other|1
7579688|NCT03752528|11973549|FG000|Part A|Lost to Follow-up|1
7579689|NCT03752528|11973549|FG000|Part A|Protocol Violation|1
7579690|NCT03752528|11973549|FG000|Part B|Protocol Violation|1
7579691|NCT03752528|11973549|FG000|Part B|Study terminated by sponsor|3
7579692|NCT03752151|11973556|FG000|Overall Study|Withdrawal by Subject|1
7579693|NCT03752151|11973556|FG000|Overall Study|Protocol Violation|1
7579694|NCT03751657|11973563|FG000|Overall Study|Physician Decision|0
7579695|NCT03751657|11973564|FG001|Overall Study|Physician Decision|1
7579696|NCT03751657|11973563|FG000|Overall Study|Withdrawal by Subject|1
7579697|NCT03751657|11973564|FG001|Overall Study|Withdrawal by Subject|1
7579698|NCT03751657|11973563|FG000|Overall Study|Lost to Follow-up|2
7579699|NCT03751657|11973564|FG001|Overall Study|Lost to Follow-up|1
7579700|NCT03751280|11973572|FG000|Overall Study|Adverse Event|0
7579701|NCT03751280|11973573|FG001|Overall Study|Adverse Event|1
7579702|NCT03751280|11973572|FG000|Overall Study|Lost to Follow-up|3
7579703|NCT03751280|11973573|FG001|Overall Study|Lost to Follow-up|5
7579704|NCT03751280|11973572|FG000|Overall Study|Physician Decision|0
7579705|NCT03751280|11973573|FG001|Overall Study|Physician Decision|2
7579706|NCT03751280|11973572|FG000|Overall Study|Protocol Violation|0
7579707|NCT03751280|11973573|FG001|Overall Study|Protocol Violation|2
7579708|NCT03751280|11973572|FG000|Overall Study|Withdrawal by Subject|5
7579709|NCT03751280|11973573|FG001|Overall Study|Withdrawal by Subject|2
7579710|NCT03751020|11973583|FG000|Overall Study|Withdrawal by Subject|2
7579711|NCT03751020|11973584|FG001|Overall Study|Withdrawal by Subject|0
7579712|NCT03751020|11973585|FG002|Overall Study|Withdrawal by Subject|0
7579713|NCT03751020|11973583|FG000|Overall Study|Lost to Follow-up|7
7579714|NCT03751020|11973584|FG001|Overall Study|Lost to Follow-up|4
7579715|NCT03751020|11973585|FG002|Overall Study|Lost to Follow-up|10
7579716|NCT03750955|11973595|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7579717|NCT03750955|11973596|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
7579718|NCT03750955|11973595|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7579719|NCT03750955|11973596|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
7579720|NCT03750695|11973604|FG000|Overall Study|Lost to Follow-up|0
7579721|NCT03750695|11973605|FG001|Overall Study|Lost to Follow-up|1
7579722|NCT03748706|11973713|FG000|Overall Study|Lost to Follow-up|1
7579723|NCT03746405|11973741|FG000|Overall Study|Withdrawal by Subject|3
7579724|NCT03746405|11973742|FG001|Overall Study|Withdrawal by Subject|0
7579725|NCT03746405|11973741|FG000|Overall Study|technical difficulties|0
7579726|NCT03746405|11973742|FG001|Overall Study|technical difficulties|2
7579727|NCT03745937|11973752|FG000|Overall Study|Withdrawal by Subject|0
7579728|NCT03745937|11973753|FG001|Overall Study|Withdrawal by Subject|0
7579729|NCT03745937|11973754|FG002|Overall Study|Withdrawal by Subject|0
7579730|NCT03745937|11973755|FG003|Overall Study|Withdrawal by Subject|1
7579731|NCT03745937|11973752|FG000|Overall Study|Not-specifed|0
7579732|NCT03745937|11973753|FG001|Overall Study|Not-specifed|1
7579733|NCT03745937|11973754|FG002|Overall Study|Not-specifed|0
7579734|NCT03745937|11973755|FG003|Overall Study|Not-specifed|1
7579735|NCT03745222|11973769|FG000|Overall Study|Withdrawal by Subject|0
7579736|NCT03745222|11973770|FG001|Overall Study|Withdrawal by Subject|1
7579737|NCT03745222|11973771|FG002|Overall Study|Withdrawal by Subject|0
7579738|NCT03743038|11973806|FG000|Overall Study|Physician Decision|1
7579739|NCT03742271|11973829|FG000|Overall Study|Unsatisfactory Visual Response|1
7579740|NCT03742271|11973829|FG000|Overall Study|Withdrawal by Subject|3
7579741|NCT03742271|11973829|FG000|Overall Study|Lost to Follow-up|4
7579742|NCT03742271|11973829|FG000|Overall Study|Failed Insertion & removal|3
7579743|NCT03742271|11973829|FG000|Overall Study|Protocol Violation|1
7579744|NCT03741062|11973864|FG000|Overall Study|Protocol Violation|1
7579745|NCT03741062|11973865|FG001|Overall Study|Protocol Violation|0
7579746|NCT03739866|11973896|FG000|Overall Study|Lost to Follow-up|0
7579747|NCT03739866|11973897|FG001|Overall Study|Lost to Follow-up|0
7579748|NCT03739866|11973898|FG002|Overall Study|Lost to Follow-up|0
7579749|NCT03739866|11973899|FG003|Overall Study|Lost to Follow-up|1
7579750|NCT03739866|11973900|FG004|Overall Study|Lost to Follow-up|0
7579751|NCT03739866|11973901|FG005|Overall Study|Lost to Follow-up|0
7579752|NCT03739866|11973902|FG006|Overall Study|Lost to Follow-up|0
7579753|NCT03739866|11973903|FG007|Overall Study|Lost to Follow-up|0
7579754|NCT03739866|11973896|FG000|Overall Study|Enrolled but not treated|0
7579755|NCT03739866|11973897|FG001|Overall Study|Enrolled but not treated|0
7579756|NCT03739866|11973898|FG002|Overall Study|Enrolled but not treated|1
7579757|NCT03739866|11973899|FG003|Overall Study|Enrolled but not treated|0
7579758|NCT03739866|11973900|FG004|Overall Study|Enrolled but not treated|1
7579759|NCT03739866|11973901|FG005|Overall Study|Enrolled but not treated|0
7579760|NCT03739866|11973902|FG006|Overall Study|Enrolled but not treated|0
7579761|NCT03739866|11973903|FG007|Overall Study|Enrolled but not treated|0
7579762|NCT03739528|11973931|FG000|Overall Study|Not treated|8
7579763|NCT03739528|11973932|FG001|Overall Study|Not treated|12
7579764|NCT03739528|11973931|FG000|Overall Study|Treatment and study discontinued|6
7579765|NCT03739528|11973932|FG001|Overall Study|Treatment and study discontinued|2
7579766|NCT03739528|11973931|FG000|Overall Study|Treatment discontinued + study completed|1
7579767|NCT03739528|11973932|FG001|Overall Study|Treatment discontinued + study completed|3
7579768|NCT03739242|11973943|FG000|Overall Study|Withdrawal by Subject|1
7579769|NCT03739242|11973944|FG001|Overall Study|Withdrawal by Subject|1
7579770|NCT03739242|11973943|FG000|Overall Study|Protocol Violation|0
7579771|NCT03739242|11973944|FG001|Overall Study|Protocol Violation|1
7579772|NCT03738865|11973952|FG000|Overall Study|Withdrawal by Subject|3
7579773|NCT03738865|11973953|FG001|Overall Study|Withdrawal by Subject|3
7579774|NCT03738865|11973952|FG000|Overall Study|Adverse Event|2
7579775|NCT03738865|11973953|FG001|Overall Study|Adverse Event|0
7579776|NCT03738865|11973952|FG000|Overall Study|Physician Decision|0
7579777|NCT03738865|11973953|FG001|Overall Study|Physician Decision|1
7579778|NCT03738475|11973970|FG000|Overall Study|Participant Non-Compliance|1
7579779|NCT03738475|11973971|FG001|Overall Study|Participant Non-Compliance|0
7579780|NCT03738241|11973987|FG000|Overall Study|Withdrawal by Subject|0
7579781|NCT03738241|11973988|FG001|Overall Study|Withdrawal by Subject|0
7579782|NCT03738241|11973989|FG002|Overall Study|Withdrawal by Subject|0
7579783|NCT03738241|11973990|FG003|Overall Study|Withdrawal by Subject|0
7579784|NCT03738241|11973991|FG004|Overall Study|Withdrawal by Subject|0
7579785|NCT03738241|11973992|FG005|Overall Study|Withdrawal by Subject|0
7579786|NCT03738241|11973993|FG006|Overall Study|Withdrawal by Subject|0
7579787|NCT03738241|11973994|FG007|Overall Study|Withdrawal by Subject|0
7579788|NCT03738241|11973995|FG008|Overall Study|Withdrawal by Subject|0
7579789|NCT03738241|11973996|FG009|Overall Study|Withdrawal by Subject|1
7579790|NCT03738241|11973987|FG000|Overall Study|Physician Decision|0
7579791|NCT03738241|11973988|FG001|Overall Study|Physician Decision|0
7579792|NCT03738241|11973989|FG002|Overall Study|Physician Decision|0
7579793|NCT03738241|11973990|FG003|Overall Study|Physician Decision|0
7579794|NCT03738241|11973991|FG004|Overall Study|Physician Decision|0
7579795|NCT03738241|11973992|FG005|Overall Study|Physician Decision|0
7579796|NCT03738241|11973993|FG006|Overall Study|Physician Decision|0
7579797|NCT03738241|11973994|FG007|Overall Study|Physician Decision|0
7579798|NCT03738241|11973995|FG008|Overall Study|Physician Decision|1
7579799|NCT03738241|11973996|FG009|Overall Study|Physician Decision|0
7579800|NCT03738241|11973987|FG000|Overall Study|Adverse Event|1
7579801|NCT03738241|11973988|FG001|Overall Study|Adverse Event|0
7579802|NCT03738241|11973989|FG002|Overall Study|Adverse Event|0
7579803|NCT03738241|11973990|FG003|Overall Study|Adverse Event|0
7579804|NCT03738241|11973991|FG004|Overall Study|Adverse Event|0
7579805|NCT03738241|11973992|FG005|Overall Study|Adverse Event|0
7579806|NCT03738241|11973993|FG006|Overall Study|Adverse Event|0
7579807|NCT03738241|11973994|FG007|Overall Study|Adverse Event|0
7579808|NCT03738241|11973995|FG008|Overall Study|Adverse Event|0
7579809|NCT03738241|11973996|FG009|Overall Study|Adverse Event|0
7579810|NCT03736785|11974053|FG000|Overall Study|Adverse Event|1
7579811|NCT03736785|11974054|FG001|Overall Study|Adverse Event|1
7579812|NCT03736785|11974055|FG002|Overall Study|Adverse Event|1
7579813|NCT03736785|11974053|FG000|Overall Study|Death|1
7579814|NCT03736785|11974054|FG001|Overall Study|Death|0
7579815|NCT03736785|11974055|FG002|Overall Study|Death|1
7579816|NCT03736785|11974053|FG000|Overall Study|Lost to Follow-up|0
7579817|NCT03736785|11974054|FG001|Overall Study|Lost to Follow-up|2
7579818|NCT03736785|11974055|FG002|Overall Study|Lost to Follow-up|3
7579819|NCT03736785|11974053|FG000|Overall Study|Non compliance with study drug|1
7579820|NCT03736785|11974054|FG001|Overall Study|Non compliance with study drug|1
7579821|NCT03736785|11974055|FG002|Overall Study|Non compliance with study drug|0
7579822|NCT03736785|11974053|FG000|Overall Study|Physician Decision|0
7579823|NCT03736785|11974054|FG001|Overall Study|Physician Decision|1
7579824|NCT03736785|11974055|FG002|Overall Study|Physician Decision|1
7579825|NCT03736785|11974053|FG000|Overall Study|Protocol Violation|1
7579826|NCT03736785|11974054|FG001|Overall Study|Protocol Violation|4
7579827|NCT03736785|11974055|FG002|Overall Study|Protocol Violation|3
7579828|NCT03736785|11974053|FG000|Overall Study|Sponsor Decision|1
7579829|NCT03736785|11974054|FG001|Overall Study|Sponsor Decision|0
7579830|NCT03736785|11974055|FG002|Overall Study|Sponsor Decision|0
7579831|NCT03736785|11974053|FG000|Overall Study|Unknown/Missing data|3
7579832|NCT03736785|11974054|FG001|Overall Study|Unknown/Missing data|2
7579833|NCT03736785|11974055|FG002|Overall Study|Unknown/Missing data|1
7579834|NCT03736785|11974053|FG000|Overall Study|Withdrawal by Subject|9
7579835|NCT03736785|11974054|FG001|Overall Study|Withdrawal by Subject|6
7579836|NCT03736785|11974055|FG002|Overall Study|Withdrawal by Subject|4
7579837|NCT03736031|11974066|FG000|Overall Study|Death|2
7579838|NCT03736031|11974067|FG001|Overall Study|Death|4
7579839|NCT03736031|11974066|FG000|Overall Study|Lost to Follow-up|21
7579840|NCT03736031|11974067|FG001|Overall Study|Lost to Follow-up|2
7579841|NCT03736031|11974066|FG000|Overall Study|Withdrawal by Subject|9
7579842|NCT03736031|11974067|FG001|Overall Study|Withdrawal by Subject|0
7579843|NCT03734991|11974079|FG000|Overall Study|Adverse Event|4
7579844|NCT03734991|11974080|FG001|Overall Study|Adverse Event|0
7579845|NCT03734991|11974079|FG000|Overall Study|Lost to Follow-up|4
7579846|NCT03734991|11974080|FG001|Overall Study|Lost to Follow-up|0
7579847|NCT03734991|11974079|FG000|Overall Study|Physician Decision|0
7579848|NCT03734991|11974080|FG001|Overall Study|Physician Decision|1
7579849|NCT03734991|11974079|FG000|Overall Study|Pregnancy|1
7579850|NCT03734991|11974080|FG001|Overall Study|Pregnancy|0
7579851|NCT03734991|11974079|FG000|Overall Study|Withdrawal by Subject|6
7579852|NCT03734991|11974080|FG001|Overall Study|Withdrawal by Subject|3
7579853|NCT03734991|11974079|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
7579854|NCT03734991|11974080|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
7579855|NCT03734991|11974079|FG000|Overall Study|Other|2
7579856|NCT03734991|11974080|FG001|Overall Study|Other|2
7579857|NCT03733899|11974094|FG000|Period 1|Protocol Violation|0
7579858|NCT03733899|11974095|FG001|Period 1|Protocol Violation|0
7579859|NCT03733899|11974096|FG002|Period 1|Protocol Violation|0
7579860|NCT03733899|11974097|FG003|Period 1|Protocol Violation|0
7579861|NCT03733899|11974098|FG004|Period 1|Protocol Violation|0
7579862|NCT03733899|11974099|FG005|Period 1|Protocol Violation|1
7579863|NCT03733899|11974094|FG000|Period 2|Unscuccessful Treatment|0
7579864|NCT03733899|11974095|FG001|Period 2|Unscuccessful Treatment|1
7579865|NCT03733899|11974096|FG002|Period 2|Unscuccessful Treatment|0
7579866|NCT03733899|11974097|FG003|Period 2|Unscuccessful Treatment|0
7579867|NCT03733899|11974098|FG004|Period 2|Unscuccessful Treatment|0
7579868|NCT03733899|11974099|FG005|Period 2|Unscuccessful Treatment|0
7579869|NCT03733899|11974094|FG000|Period 3|Withdrawal by Subject|1
7579870|NCT03733899|11974095|FG001|Period 3|Withdrawal by Subject|0
7579871|NCT03733899|11974096|FG002|Period 3|Withdrawal by Subject|0
7579872|NCT03733899|11974097|FG003|Period 3|Withdrawal by Subject|0
7579873|NCT03733899|11974098|FG004|Period 3|Withdrawal by Subject|0
7579874|NCT03733899|11974099|FG005|Period 3|Withdrawal by Subject|0
7579875|NCT03733470|11974118|FG000|Overall Study|PI Decision|1
7579876|NCT03733470|11974119|FG001|Overall Study|PI Decision|1
7579877|NCT03733301|11974128|FG000|Overall Study|Screen Fail|1
7579878|NCT03733301|11974129|FG001|Overall Study|Screen Fail|0
7579879|NCT03733301|11974130|FG002|Overall Study|Screen Fail|0
7579880|NCT03733301|11974128|FG000|Overall Study|Non-compliance|1
7579881|NCT03733301|11974129|FG001|Overall Study|Non-compliance|0
7579882|NCT03733301|11974130|FG002|Overall Study|Non-compliance|0
7579883|NCT03733301|11974128|FG000|Overall Study|Lack of Efficacy|2
7579884|NCT03733301|11974129|FG001|Overall Study|Lack of Efficacy|3
7579885|NCT03733301|11974130|FG002|Overall Study|Lack of Efficacy|0
7579886|NCT03733301|11974128|FG000|Overall Study|Adverse Event|0
7579887|NCT03733301|11974129|FG001|Overall Study|Adverse Event|1
7579888|NCT03733301|11974130|FG002|Overall Study|Adverse Event|3
7579889|NCT03733301|11974128|FG000|Overall Study|Withdrawal by Subject|3
7579890|NCT03733301|11974129|FG001|Overall Study|Withdrawal by Subject|5
7579891|NCT03733301|11974130|FG002|Overall Study|Withdrawal by Subject|1
7579892|NCT03732638|11974141|FG000|Overall Study|Adverse Event|5
7579893|NCT03732638|11974142|FG001|Overall Study|Adverse Event|2
7579894|NCT03732638|11974141|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
7579895|NCT03732638|11974142|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
7579896|NCT03732638|11974141|FG000|Overall Study|Lack of Efficacy|1
7579897|NCT03732638|11974142|FG001|Overall Study|Lack of Efficacy|1
7579898|NCT03732638|11974141|FG000|Overall Study|Lost to Follow-up|19
7579899|NCT03732638|11974142|FG001|Overall Study|Lost to Follow-up|12
7579900|NCT03732638|11974141|FG000|Overall Study|Non-compliance|6
7579901|NCT03732638|11974142|FG001|Overall Study|Non-compliance|5
7579902|NCT03732638|11974141|FG000|Overall Study|Physician Decision|0
7579903|NCT03732638|11974142|FG001|Overall Study|Physician Decision|1
7579904|NCT03732638|11974141|FG000|Overall Study|Protocol deviation|4
7579905|NCT03732638|11974142|FG001|Overall Study|Protocol deviation|5
7579906|NCT03732638|11974141|FG000|Overall Study|Withdrawal by Subject|11
7579907|NCT03732638|11974142|FG001|Overall Study|Withdrawal by Subject|22
7579908|NCT03732248|11974151|FG000|Overall Study|Withdrawal by Subject|1
7579909|NCT03732248|11974152|FG001|Overall Study|Withdrawal by Subject|0
7579910|NCT03731182|11974160|FG000|Overall Study|Lost to Follow-up|2
7579911|NCT03731182|11974161|FG001|Overall Study|Lost to Follow-up|0
7579912|NCT03731182|11974160|FG000|Overall Study|Physician Decision|1
7579913|NCT03731182|11974161|FG001|Overall Study|Physician Decision|0
7579914|NCT03731182|11974160|FG000|Overall Study|Withdrawal By Parent/Guardian|2
7579915|NCT03731182|11974161|FG001|Overall Study|Withdrawal By Parent/Guardian|0
7579916|NCT03730961|11974170|FG000|Overall Study|Adverse Event|0
7579917|NCT03730961|11974171|FG001|Overall Study|Adverse Event|1
7579918|NCT03730103|11974187|FG000|Overall Study|Did not meet inclusion criteria|0
7579919|NCT03730103|11974188|FG001|Overall Study|Did not meet inclusion criteria|5
7624665|NCT04585646|12035825|FG001|First Intervention|Physician Decision|0
7624666|NCT04585646|12035824|FG000|First Intervention|Lost to Follow-up|0
7624667|NCT04585646|12035825|FG001|First Intervention|Lost to Follow-up|3
7624668|NCT04585646|12035824|FG000|First Intervention|Withdrawal by Subject|0
7624669|NCT04585646|12035825|FG001|First Intervention|Withdrawal by Subject|1
7624670|NCT04451330|12035834|FG000|Overall Study|Adverse Event|1
7624671|NCT04451330|12035835|FG001|Overall Study|Adverse Event|2
7624672|NCT04451330|12035834|FG000|Overall Study|Lost to Follow-up|5
7624673|NCT04451330|12035835|FG001|Overall Study|Lost to Follow-up|0
7624674|NCT04451330|12035834|FG000|Overall Study|Withdrawal by Subject|3
7624675|NCT04451330|12035835|FG001|Overall Study|Withdrawal by Subject|1
7624676|NCT04451330|12035834|FG000|Overall Study|Withdrawal by parent/guardian|1
7624677|NCT04451330|12035835|FG001|Overall Study|Withdrawal by parent/guardian|0
7624678|NCT04451330|12035834|FG000|Overall Study|Other than specified|0
7624679|NCT04451330|12035835|FG001|Overall Study|Other than specified|1
7579920|NCT03728140|11974218|FG000|Overall Study|Abnormal embryo transfer operation|10
7579921|NCT03728140|11974219|FG001|Overall Study|Abnormal embryo transfer operation|7
7579922|NCT03727347|11974238|FG000|Overall Study|Withdrawal by Subject|2
7579923|NCT03727347|11974238|FG000|Overall Study|Lost to Follow-up|1
7579924|NCT03726996|11974251|FG000|Overall Study|Parent's decision|2
7579925|NCT03726996|11974251|FG000|Overall Study|Study early termination|2
7579926|NCT03725852|11974266|FG000|Overall Study|Death|1
7579927|NCT03725852|11974267|FG001|Overall Study|Death|0
7579928|NCT03725852|11974266|FG000|Overall Study|Withdrawal by Subject|1
7579929|NCT03725852|11974267|FG001|Overall Study|Withdrawal by Subject|0
7579930|NCT03725852|11974266|FG000|Overall Study|Travel restrictions due to COVID-19|2
7579931|NCT03725852|11974267|FG001|Overall Study|Travel restrictions due to COVID-19|0
7579932|NCT03725722|11974278|FG000|Overall Study|Lack of Efficacy|2
7579933|NCT03725722|11974279|FG001|Overall Study|Lack of Efficacy|1
7579934|NCT03725722|11974280|FG002|Overall Study|Lack of Efficacy|2
7579935|NCT03725722|11974281|FG003|Overall Study|Lack of Efficacy|0
7579936|NCT03725722|11974282|FG004|Overall Study|Lack of Efficacy|2
7579937|NCT03725722|11974278|FG000|Overall Study|Adverse Event|2
7579938|NCT03725722|11974279|FG001|Overall Study|Adverse Event|2
7579939|NCT03725722|11974280|FG002|Overall Study|Adverse Event|1
7579940|NCT03725722|11974281|FG003|Overall Study|Adverse Event|0
7579941|NCT03725722|11974282|FG004|Overall Study|Adverse Event|6
7579942|NCT03725722|11974278|FG000|Overall Study|Withdrawal by Subject|4
7579943|NCT03725722|11974279|FG001|Overall Study|Withdrawal by Subject|1
7579944|NCT03725722|11974280|FG002|Overall Study|Withdrawal by Subject|0
7579945|NCT03725722|11974281|FG003|Overall Study|Withdrawal by Subject|4
7579946|NCT03725722|11974282|FG004|Overall Study|Withdrawal by Subject|4
7579947|NCT03725722|11974278|FG000|Overall Study|Lost to Follow-up|3
7579948|NCT03725722|11974279|FG001|Overall Study|Lost to Follow-up|1
7579949|NCT03725722|11974280|FG002|Overall Study|Lost to Follow-up|2
7579950|NCT03725722|11974281|FG003|Overall Study|Lost to Follow-up|2
7579951|NCT03725722|11974282|FG004|Overall Study|Lost to Follow-up|1
7579952|NCT03725722|11974278|FG000|Overall Study|Personal reasons|0
7579953|NCT03725722|11974279|FG001|Overall Study|Personal reasons|0
7579954|NCT03725722|11974280|FG002|Overall Study|Personal reasons|1
7579955|NCT03725722|11974281|FG003|Overall Study|Personal reasons|0
7579956|NCT03725722|11974282|FG004|Overall Study|Personal reasons|1
7579957|NCT03725722|11974278|FG000|Overall Study|COVID-19 situation|0
7579958|NCT03725722|11974279|FG001|Overall Study|COVID-19 situation|1
7579959|NCT03725722|11974280|FG002|Overall Study|COVID-19 situation|0
7579960|NCT03725722|11974281|FG003|Overall Study|COVID-19 situation|0
7579961|NCT03725722|11974282|FG004|Overall Study|COVID-19 situation|0
7579962|NCT03725085|11974303|FG000|Overall Study|Lost to Follow-up|2
7579963|NCT03724981|11974319|FG000|First Device|Protocol Violation|1
7579964|NCT03724981|11974320|FG001|First Device|Protocol Violation|1
7579965|NCT03724968|11974330|FG000|Overall Study|Insurance issues|0
7579966|NCT03724968|11974331|FG001|Overall Study|Insurance issues|1
7579967|NCT03724968|11974330|FG000|Overall Study|Study closed|0
7579968|NCT03724968|11974331|FG001|Overall Study|Study closed|1
7579969|NCT03723070|11974395|FG000|Overall Study|Lost to Follow-up|2
7579970|NCT03723070|11974395|FG000|Overall Study|Physician Decision|1
7579971|NCT03723070|11974395|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
7579972|NCT03720210|11974399|FG000|Overall Study|Lost to Follow-up|1
7579973|NCT03718143|11974407|FG000|Overall Study|Death|1
7579974|NCT03718143|11974408|FG001|Overall Study|Death|0
7579975|NCT03718143|11974409|FG002|Overall Study|Death|0
7579976|NCT03718143|11974407|FG000|Overall Study|Progression of Disease|1
7579977|NCT03718143|11974408|FG001|Overall Study|Progression of Disease|0
7579978|NCT03718143|11974409|FG002|Overall Study|Progression of Disease|0
7579979|NCT03718143|11974407|FG000|Overall Study|Withdrawal of Informed Consent|1
7579980|NCT03718143|11974408|FG001|Overall Study|Withdrawal of Informed Consent|2
7579981|NCT03718143|11974409|FG002|Overall Study|Withdrawal of Informed Consent|1
7579982|NCT03709576|11974417|FG000|Overall Study|progression prior to enrollment|1
7579983|NCT03704636|11974422|FG000|Overall Study|Inadequate Venous Flow|3
7579984|NCT03694821|11974446|FG000|Overall Study|Study terminated|4
7579985|NCT03694821|11974447|FG001|Overall Study|Study terminated|8
7579986|NCT03694821|11974448|FG002|Overall Study|Study terminated|4
7579987|NCT03686969|11974458|FG000|Overall Study|Study terminated|1
7579988|NCT03686969|11974459|FG001|Overall Study|Study terminated|0
7579989|NCT03682367|11974467|FG000|Overall Study|Protocol Violation|2
7579990|NCT03682367|11974468|FG001|Overall Study|Protocol Violation|1
7579991|NCT03682367|11974467|FG000|Overall Study|Closed Study Early|0
7579992|NCT03682367|11974468|FG001|Overall Study|Closed Study Early|3
7579993|NCT03680911|11974476|FG000|At Home Treatment|Study Termination|3
7579994|NCT03680911|11974477|FG001|At Home Treatment|Study Termination|0
7579995|NCT03680911|11974476|FG000|At Home Treatment|Lost to Follow-up|0
7579996|NCT03680911|11974477|FG001|At Home Treatment|Lost to Follow-up|1
7579997|NCT03680911|11974476|FG000|At Home Treatment|Withdrawal by Subject|0
7579998|NCT03680911|11974477|FG001|At Home Treatment|Withdrawal by Subject|2
7579999|NCT03680911|11974476|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
7580000|NCT03680911|11974477|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
7580001|NCT03656692|11974483|FG000|Overall Study|Worsening of disease activity|2
7580002|NCT03656692|11974483|FG000|Overall Study|Physician Decision|1
7580003|NCT03648983|11974487|FG000|Overall Study|Study was terminated due to PI departure|95
7580004|NCT03643159|11974494|FG000|Overall Study|Adverse Event|1
7580005|NCT03643159|11974494|FG000|Overall Study|Withdrawal by Subject|1
7580006|NCT03630120|11974512|FG000|Overall Study|Disease progression|0
7580007|NCT03630120|11974513|FG001|Overall Study|Disease progression|1
7580008|NCT03630120|11974514|FG002|Overall Study|Disease progression|1
7580009|NCT03630120|11974515|FG003|Overall Study|Disease progression|1
7580010|NCT03615144|11974542|FG000|Overall Study|Participant no longer eligible for this protocol|1
7580011|NCT03615144|11974543|FG001|Overall Study|Participant no longer eligible for this protocol|0
7580012|NCT03605303|11974549|FG000|Period 1|Study Terminated|2
7580013|NCT03605303|11974550|FG001|Period 1|Study Terminated|1
7580014|NCT03600740|11974556|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
7580015|NCT03598140|11974562|FG000|Overall Study|enrolled but didn't start|1
7580016|NCT03598140|11974563|FG001|Overall Study|enrolled but didn't start|0
7580017|NCT03598036|11974571|FG000|Overall Study|Withdrawal by Subject|1
7580018|NCT03598036|11974572|FG001|Overall Study|Withdrawal by Subject|0
7580019|NCT03590743|11974591|FG000|Overall Study|Withdrawal by Subject|0
7580020|NCT03590743|11974592|FG001|Overall Study|Withdrawal by Subject|1
7580021|NCT03580382|11974600|FG000|Overall Study|Early Termination of Study|0
7580022|NCT03580382|11974601|FG001|Overall Study|Early Termination of Study|3
7580023|NCT03571646|11974608|FG000|Overall Study|Adverse Event|1
7580024|NCT03571646|11974609|FG001|Overall Study|Adverse Event|0
7580025|NCT03571646|11974608|FG000|Overall Study|Withdrawal by Subject|1
7580026|NCT03571646|11974609|FG001|Overall Study|Withdrawal by Subject|1
7580027|NCT03543358|11974632|FG000|Overall Study|Death|1
7580028|NCT03543358|11974633|FG001|Overall Study|Death|0
7580029|NCT03543358|11974632|FG000|Overall Study|Disease Progression|1
7580030|NCT03543358|11974633|FG001|Overall Study|Disease Progression|0
7580031|NCT03543358|11974632|FG000|Overall Study|Parent Study Closure|1
7580032|NCT03543358|11974633|FG001|Overall Study|Parent Study Closure|0
7580033|NCT03509207|11974661|FG000|Overall Study|Death|2
7580034|NCT03500341|11974678|FG000|Overall Study|Withdrawn prior to Completion|2
7580035|NCT03500159|11974684|FG000|Overall Study|Study Terminated|2
7580036|NCT03500159|11974685|FG001|Overall Study|Study Terminated|1
7580037|NCT03477903|11974711|FG000|Overall Study|Study Terminated by Sponsor|1
7580038|NCT03469258|11974715|FG000|Overall Study|Upon surgery, did not meet criteria|4
7580039|NCT03466658|11974719|FG000|Overall Study|Withdrawal by Subject|3
7580040|NCT03465891|11974727|FG000|Overall Study|Withdrawal by Subject|0
7580041|NCT03465891|11974728|FG001|Overall Study|Withdrawal by Subject|1
7580042|NCT03465891|11974727|FG000|Overall Study|Disease progression|1
7580043|NCT03465891|11974728|FG001|Overall Study|Disease progression|0
7580044|NCT03387059|11974806|FG000|Overall Study|Study termination|5
7580045|NCT03387059|11974807|FG001|Overall Study|Study termination|4
7580046|NCT03379233|11974824|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
7580047|NCT03379233|11974825|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
7580048|NCT03361228|11974841|FG000|Overall Study|Other|1
7580049|NCT03361228|11974842|FG001|Overall Study|Other|1
7580050|NCT03361228|11974841|FG000|Overall Study|Death|3
7580051|NCT03361228|11974842|FG001|Overall Study|Death|0
7580052|NCT03359174|11974857|FG000|Overall Study|Adverse Event|1
7580053|NCT03348904|11974868|FG000|Overall Study|Administrative reason by the sponsor|0
7580054|NCT03348904|11974869|FG001|Overall Study|Administrative reason by the sponsor|1
7580055|NCT03348904|11974870|FG002|Overall Study|Administrative reason by the sponsor|0
7580056|NCT03345901|11974878|FG000|Overall Study|The study was terminated|18
7580057|NCT03344562|11974885|FG000|Overall Study|Withdrawal by Subject|2
7580058|NCT03344562|11974886|FG001|Overall Study|Withdrawal by Subject|0
7580059|NCT03342638|11974894|FG000|Overall Study|Withdrawal by Subject|1
7580060|NCT03342638|11974895|FG001|Overall Study|Withdrawal by Subject|0
7580061|NCT03342638|11974894|FG000|Overall Study|Physician Decision|0
7580062|NCT03342638|11974895|FG001|Overall Study|Physician Decision|1
7580063|NCT03339401|11974912|FG000|Overall Study|Death|2
7580064|NCT03339401|11974913|FG001|Overall Study|Death|1
7580065|NCT03339401|11974912|FG000|Overall Study|Withdrawal by Subject|2
7580066|NCT03339401|11974913|FG001|Overall Study|Withdrawal by Subject|0
7580067|NCT03339401|11974912|FG000|Overall Study|Study terminated|4
7580068|NCT03339401|11974913|FG001|Overall Study|Study terminated|3
7580069|NCT03339401|11974912|FG000|Overall Study|Investigator Decision|1
7580070|NCT03339401|11974913|FG001|Overall Study|Investigator Decision|0
7580071|NCT03339245|11974921|FG000|Overall Study|Adverse Event|1
7580072|NCT03339245|11974922|FG001|Overall Study|Adverse Event|1
7580073|NCT03339245|11974921|FG000|Overall Study|Withdrawal by Subject|1
7580074|NCT03339245|11974922|FG001|Overall Study|Withdrawal by Subject|0
7580075|NCT03329404|11974934|FG000|Overall Study|The study was suspended.|1
7580076|NCT03329404|11974935|FG001|Overall Study|The study was suspended.|4
7580077|NCT03326869|11974943|FG000|Overall Study|Study data has been lost to natural disa|1
7580078|NCT03326869|11974944|FG001|Overall Study|Study data has been lost to natural disa|1
7580079|NCT03305055|11974969|FG000|Overall Study|Withdrawal by Subject|0
7580080|NCT03305055|11974970|FG001|Overall Study|Withdrawal by Subject|1
7580081|NCT03305055|11974969|FG000|Overall Study|Adverse Event|1
7580082|NCT03305055|11974970|FG001|Overall Study|Adverse Event|1
7580083|NCT03303469|11974976|FG000|Overall Study|Lost to Follow-up|2
7580084|NCT03302247|11974980|FG000|Overall Study|the study has closed prematurely|2
7580085|NCT03302247|11974980|FG000|Overall Study|Death|1
7580086|NCT03300024|11974986|FG000|Overall Study|Physician Decision|4
7580087|NCT03300024|11974987|FG001|Overall Study|Physician Decision|6
7580088|NCT03283709|11974997|FG000|Overall Study|trial terminated|0
7580089|NCT03283709|11974998|FG001|Overall Study|trial terminated|1
7624680|NCT04003623|12035895|FG000|Overall Study|Withdrawal by Subject|1
7624681|NCT04003623|12035896|FG001|Overall Study|Withdrawal by Subject|0
7624682|NCT03828383|12035914|FG000|Overall Study|Lost to Follow-up|3
7624683|NCT03828383|12035915|FG001|Overall Study|Lost to Follow-up|2
7624684|NCT03828383|12035914|FG000|Overall Study|Withdrawal by Subject|4
7624685|NCT03828383|12035915|FG001|Overall Study|Withdrawal by Subject|5
7624719|NCT03717480|12035931|FG000|Overall Study|Never received investigational product due to product viability limitations.|1
7624720|NCT03615066|12035938|FG000|Main Study|Withdrew Consent|0
7624721|NCT03615066|12035939|FG001|Main Study|Withdrew Consent|1
7624722|NCT03615066|12035940|FG002|Main Study|Withdrew Consent|1
7624723|NCT03615066|12035938|FG000|Main Study|Lost to Follow-up|0
7624724|NCT03615066|12035939|FG001|Main Study|Lost to Follow-up|0
7624725|NCT03615066|12035940|FG002|Main Study|Lost to Follow-up|1
7624726|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1
7624727|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
7624728|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0
7624729|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1
7624730|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
7624731|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0
7624732|NCT03615066|12035938|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
7624733|NCT03615066|12035939|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1
7624734|NCT03615066|12035940|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0
7624735|NCT03557931|12035955|FG000|Overall Study|Adverse Event|4
7624736|NCT03557931|12035956|FG001|Overall Study|Adverse Event|6
7624737|NCT03557931|12035957|FG002|Overall Study|Adverse Event|1
7624738|NCT03557931|12035955|FG000|Overall Study|Lost to Follow-up|4
7624739|NCT03557931|12035956|FG001|Overall Study|Lost to Follow-up|4
7624740|NCT03557931|12035957|FG002|Overall Study|Lost to Follow-up|1
7624741|NCT03557931|12035955|FG000|Overall Study|Protocol Violation|1
7624742|NCT03557931|12035956|FG001|Overall Study|Protocol Violation|4
7624743|NCT03557931|12035957|FG002|Overall Study|Protocol Violation|1
7624744|NCT03557931|12035955|FG000|Overall Study|Withdrawal by Subject|14
7624745|NCT03557931|12035956|FG001|Overall Study|Withdrawal by Subject|0
7624746|NCT03557931|12035957|FG002|Overall Study|Withdrawal by Subject|7
7624747|NCT03557931|12035955|FG000|Overall Study|Miscellaneous|8
7624748|NCT03557931|12035956|FG001|Overall Study|Miscellaneous|5
7624749|NCT03557931|12035957|FG002|Overall Study|Miscellaneous|3
7624750|NCT02596035|12035979|FG000|Overall Study|Disease Progression|62
7624751|NCT02596035|12035980|FG001|Overall Study|Disease Progression|32
7624752|NCT02596035|12035981|FG002|Overall Study|Disease Progression|1
7624753|NCT02596035|12035979|FG000|Overall Study|Study Drug Toxicity|11
7624754|NCT02596035|12035980|FG001|Overall Study|Study Drug Toxicity|3
7580090|NCT03263806|11975033|FG000|Overall Study|Elevated Troponin (failed screen)|1
7580091|NCT03263806|11975034|FG001|Overall Study|Elevated Troponin (failed screen)|0
7580092|NCT03263806|11975033|FG000|Overall Study|Withdrawal by Subject|0
7580093|NCT03263806|11975034|FG001|Overall Study|Withdrawal by Subject|1
7580094|NCT03263806|11975033|FG000|Overall Study|Study Termination|5
7580095|NCT03263806|11975034|FG001|Overall Study|Study Termination|6
7580096|NCT03261531|11975040|FG000|Overall Study|Withdrawal by Subject|4
7580097|NCT03219372|11975046|FG000|Overall Study|Withdrawal by Subject|1
7580098|NCT03219372|11975047|FG001|Overall Study|Withdrawal by Subject|0
7580099|NCT03217175|11975053|FG000|Overall Study|Physician Decision|4
7580100|NCT03217175|11975054|FG001|Overall Study|Physician Decision|1
7580101|NCT03223662|11975081|FG000|Overall Study|Physician Decision|1
7580102|NCT03223662|11975081|FG000|Overall Study|Study closure|1
7580103|NCT03212144|11975087|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
7580104|NCT03212144|11975088|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
7580105|NCT03212144|11975087|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
7580106|NCT03212144|11975088|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
7580107|NCT03204539|11975104|FG000|Overall Study|Loss of funding|0
7580108|NCT03204539|11975105|FG001|Overall Study|Loss of funding|1
7580109|NCT03206216|11975113|FG000|Overall Study|Withdrawal by Subject|0
7580110|NCT03206216|11975114|FG001|Overall Study|Withdrawal by Subject|1
7580111|NCT03195660|11975120|FG000|Overall Study|The study was terminated|2
7580112|NCT03166618|11975130|FG000|Overall Study|Study was Terminated|0
7580113|NCT03166618|11975131|FG001|Overall Study|Study was Terminated|1
7580114|NCT03169530|11975139|FG000|Overall Study|Study ended by NIH|15
7580115|NCT03169530|11975140|FG001|Overall Study|Study ended by NIH|17
7580116|NCT03151226|11975155|FG000|Overall Study|Withdrawal by Subject|2
7580117|NCT03151226|11975155|FG000|Overall Study|not wear device correctly|1
7580118|NCT03168906|11975170|FG000|Overall Study|Lack of Efficacy|6
7580119|NCT03168906|11975171|FG001|Overall Study|Lack of Efficacy|6
7580120|NCT03178201|11975178|FG000|Overall Study|Off study|5
7580121|NCT03172026|11975184|FG000|Overall Study|Withdrawal by Subject|1
7580122|NCT03172026|11975185|FG001|Overall Study|Withdrawal by Subject|0
7580123|NCT03172026|11975184|FG000|Overall Study|COVID restrictions|1
7580124|NCT03172026|11975185|FG001|Overall Study|COVID restrictions|0
7580125|NCT03152526|11975194|FG000|Overall Study|Withdrawal by Subject|0
7580126|NCT03152526|11975195|FG001|Overall Study|Withdrawal by Subject|1
7580127|NCT03123393|11975230|FG000|Overall Study|Study Terminated by Sponsor|6
7580128|NCT03123393|11975231|FG001|Overall Study|Study Terminated by Sponsor|9
7580129|NCT03123393|11975230|FG000|Overall Study|Withdrawal by Subject|2
7580130|NCT03123393|11975231|FG001|Overall Study|Withdrawal by Subject|1
7580131|NCT03123393|11975230|FG000|Overall Study|Reason not Specified|13
7580132|NCT03123393|11975231|FG001|Overall Study|Reason not Specified|13
7580133|NCT03119662|11975243|FG000|Overall Study|Withdrawal by Subject|0
7580134|NCT03119662|11975244|FG001|Overall Study|Withdrawal by Subject|1
7580135|NCT03120676|11975259|FG000|Overall Study|Not treated|1
7580136|NCT03113071|11975284|FG000|Overall Study|Withdrawal by Subject|1
7580137|NCT03113071|11975285|FG001|Overall Study|Withdrawal by Subject|0
7580138|NCT03110900|11975293|FG000|Overall Study|Sponsor withdrew|1
7580139|NCT03110900|11975294|FG001|Overall Study|Sponsor withdrew|1
7580140|NCT03078868|11975300|FG000|Overall Study|Physician Decision|3
7580141|NCT03065933|11975313|FG000|Overall Study|study terminated|5
7580142|NCT03070002|11975317|FG000|Follow up for 2 Years|Death|1
7580143|NCT03058705|11975321|FG000|Overall Study|Withdrawal by Subject|2
7580144|NCT03058705|11975321|FG000|Overall Study|Physician Decision|2
7580145|NCT03053518|11975343|FG000|Overall Study|Withdrawal by Subject|3
7580146|NCT03053518|11975343|FG000|Overall Study|Lost to Follow-up|2
7580147|NCT03053518|11975343|FG000|Overall Study|Ineligible|5
7580148|NCT03050398|11975347|FG000|Overall Study|Study terminated by sponsor|8
7580149|NCT03029832|11975365|FG000|Overall Study|Safety Follow-Up Completed|2
7580150|NCT03029832|11975366|FG001|Overall Study|Safety Follow-Up Completed|0
7580151|NCT03029832|11975365|FG000|Overall Study|Death due to Disease Progression|1
7580152|NCT03029832|11975366|FG001|Overall Study|Death due to Disease Progression|0
7580153|NCT03029832|11975365|FG000|Overall Study|Study Terminated By Sponsor|1
7580154|NCT03029832|11975366|FG001|Overall Study|Study Terminated By Sponsor|1
7580155|NCT03010423|11975401|FG000|Overall Study|Study termination|8
7580156|NCT02991430|11975417|FG000|Treatment Period 1|Adverse Event|1
7580157|NCT02991430|11975418|FG001|Treatment Period 1|Adverse Event|0
7580158|NCT02991430|11975419|FG002|Treatment Period 1|Adverse Event|2
7580159|NCT02991430|11975417|FG000|Treatment Period 1|Withdrawal by Subject|0
7580160|NCT02991430|11975418|FG001|Treatment Period 1|Withdrawal by Subject|4
7580161|NCT02991430|11975419|FG002|Treatment Period 1|Withdrawal by Subject|0
7580162|NCT02991430|11975417|FG000|Treatment Period 2|Study Termination|6
7580163|NCT02991430|11975418|FG001|Treatment Period 2|Study Termination|3
7580164|NCT02991430|11975419|FG002|Treatment Period 2|Study Termination|3
7580165|NCT02991430|11975417|FG000|Treatment Period 2|Lost to Follow-up|0
7580166|NCT02991430|11975418|FG001|Treatment Period 2|Lost to Follow-up|0
7580167|NCT02991430|11975419|FG002|Treatment Period 2|Lost to Follow-up|1
7580168|NCT02991430|11975417|FG000|Post-treatment Observation Period|Study Termination|3
7580169|NCT02991430|11975418|FG001|Post-treatment Observation Period|Study Termination|6
7580170|NCT02991430|11975419|FG002|Post-treatment Observation Period|Study Termination|5
7580171|NCT02978833|11975452|FG000|Overall Study|Study terminated|1
7580172|NCT02978833|11975453|FG001|Overall Study|Study terminated|1
7580173|NCT02966223|11975490|FG000|Overall Study|Physician Decision|3
7580174|NCT02966223|11975490|FG000|Overall Study|Withdrawal by Subject|11
7580175|NCT02966223|11975490|FG000|Overall Study|Lost to Follow-up|1
7580176|NCT02965846|11975497|FG000|Overall Study|Lost to Follow-up|1
7580177|NCT02965846|11975498|FG001|Overall Study|Lost to Follow-up|0
7580178|NCT02965846|11975499|FG002|Overall Study|Lost to Follow-up|0
7580179|NCT02965846|11975497|FG000|Overall Study|Withdrawal by Subject|0
7580180|NCT02965846|11975498|FG001|Overall Study|Withdrawal by Subject|1
7580181|NCT02965846|11975499|FG002|Overall Study|Withdrawal by Subject|0
7580182|NCT02965846|11975497|FG000|Overall Study|Study Terminated By Sponsor|4
7580183|NCT02965846|11975498|FG001|Overall Study|Study Terminated By Sponsor|4
7580184|NCT02965846|11975499|FG002|Overall Study|Study Terminated By Sponsor|0
7580185|NCT02965846|11975497|FG000|Overall Study|Participants not randomized|0
7580186|NCT02965846|11975498|FG001|Overall Study|Participants not randomized|0
7580187|NCT02965846|11975499|FG002|Overall Study|Participants not randomized|33
7580188|NCT02956005|11975520|FG000|Overall Study|Not eligible|1
7580189|NCT02956005|11975520|FG000|Overall Study|Withdrawal by Subject|3
7580190|NCT02956005|11975520|FG000|Overall Study|Physician Decision|12
7580191|NCT02940223|11975535|FG000|Overall Study|Failed Requirement|2
7580192|NCT02940223|11975536|FG001|Overall Study|Failed Requirement|0
7580193|NCT02954159|11975544|FG000|Overall Study|Study ended prematurely due to low enrol|1
7580194|NCT02954159|11975545|FG001|Overall Study|Study ended prematurely due to low enrol|0
7580195|NCT02954159|11975544|FG000|Overall Study|Withdrawal by Subject|0
7580196|NCT02954159|11975545|FG001|Overall Study|Withdrawal by Subject|1
7580197|NCT02954952|11975554|FG000|Overall Study|Withdrawal by Subject|1
7580198|NCT02954952|11975555|FG001|Overall Study|Withdrawal by Subject|0
7580199|NCT02954952|11975556|FG002|Overall Study|Withdrawal by Subject|0
7580200|NCT02954952|11975554|FG000|Overall Study|No data collected|0
7580201|NCT02954952|11975555|FG001|Overall Study|No data collected|1
7580202|NCT02954952|11975556|FG002|Overall Study|No data collected|0
7580203|NCT02947022|11975568|FG000|Overall Study|Study Stopped|1
7580204|NCT02950480|11975583|FG000|Overall Study|Withdrawal by Subject|1
7580205|NCT02950480|11975584|FG001|Overall Study|Withdrawal by Subject|0
7580206|NCT02949947|11975592|FG000|Overall Study|Non Compliance|0
7580207|NCT02949947|11975593|FG001|Overall Study|Non Compliance|1
7580208|NCT02949947|11975592|FG000|Overall Study|Insurance change|1
7580209|NCT02949947|11975593|FG001|Overall Study|Insurance change|0
7580210|NCT02947100|11975599|FG000|Overall Study|study terminated early|3
7580211|NCT02947100|11975599|FG000|Overall Study|did not meet inclusion criteria|1
7580212|NCT02908516|11975620|FG000|Overall Study|Study Terminated|3
7580213|NCT02908516|11975621|FG001|Overall Study|Study Terminated|3
7580214|NCT02923830|11975629|FG000|Overall Study|Physician Decision|13
7580215|NCT02923830|11975630|FG001|Overall Study|Physician Decision|15
7580216|NCT02920450|11975636|FG000|Overall Study|Death|1
7580217|NCT02920450|11975637|FG001|Overall Study|Death|0
7580218|NCT02920450|11975638|FG002|Overall Study|Death|0
7580219|NCT02920450|11975639|FG003|Overall Study|Death|0
7580220|NCT02920450|11975636|FG000|Overall Study|Withdrawal by Subject|1
7580221|NCT02920450|11975637|FG001|Overall Study|Withdrawal by Subject|0
7580222|NCT02920450|11975638|FG002|Overall Study|Withdrawal by Subject|0
7580223|NCT02920450|11975639|FG003|Overall Study|Withdrawal by Subject|0
7580224|NCT02920177|11975648|FG000|Overall Study|Withdrawal by Subject|1
7580225|NCT02920177|11975649|FG001|Overall Study|Withdrawal by Subject|1
7580226|NCT02920177|11975648|FG000|Overall Study|Physician Decision|1
7580227|NCT02920177|11975649|FG001|Overall Study|Physician Decision|0
7580228|NCT02920177|11975648|FG000|Overall Study|Lost to Follow-up|0
7580229|NCT02920177|11975649|FG001|Overall Study|Lost to Follow-up|1
7580230|NCT02926638|11975657|FG000|Overall Study|Progression|2
7580231|NCT02926638|11975658|FG001|Overall Study|Progression|5
7580232|NCT02926638|11975657|FG000|Overall Study|Ineligible|1
7580233|NCT02926638|11975658|FG001|Overall Study|Ineligible|0
7580234|NCT02926638|11975657|FG000|Overall Study|Not protocol specified|1
7580235|NCT02926638|11975658|FG001|Overall Study|Not protocol specified|0
7580236|NCT02920242|11975667|FG000|Overall Study|Withdrawal by Subject|1
7580237|NCT02920242|11975668|FG001|Overall Study|Withdrawal by Subject|0
7580238|NCT02920242|11975669|FG002|Overall Study|Withdrawal by Subject|1
7580239|NCT02920242|11975667|FG000|Overall Study|Did not meet inc./exc. criteria|1
7580240|NCT02920242|11975668|FG001|Overall Study|Did not meet inc./exc. criteria|0
7580241|NCT02920242|11975669|FG002|Overall Study|Did not meet inc./exc. criteria|0
7580242|NCT02899728|11975701|FG000|Overall Study|Withdrawal by Subject|1
7580243|NCT02899728|11975702|FG001|Overall Study|Withdrawal by Subject|1
7580244|NCT02875067|11975708|FG000|Overall Study|Withdrawal by Subject|1
7580245|NCT02875067|11975708|FG000|Overall Study|Withdrawal by Termination of Study|5
7580246|NCT02860169|11975723|FG000|Part A|Withdrawal by Subject|1
7580247|NCT02860169|11975723|FG000|Part A|Other (Screening failure)|6
7580248|NCT02860169|11975723|FG000|Part A|Other (Survey not completed)|3
7580249|NCT02860169|11975723|FG000|Part A|Other (did not completed consent)|1
7580250|NCT02860169|11975723|FG000|Part B|Other (Screening failure)|10
7580251|NCT02860169|11975723|FG000|Part B|Withdrawal by Subject|1
7580252|NCT02860169|11975723|FG000|Part C|Other (Screening failure)|1
7580253|NCT02865395|11975732|FG000|Overall Study|Physician Decision|6
7580254|NCT02865395|11975733|FG001|Overall Study|Physician Decision|10
7580255|NCT02865395|11975734|FG002|Overall Study|Physician Decision|7
7580256|NCT02868892|11975742|FG000|Overall Study|Investigator left site and no follow-up|6
7580257|NCT02865083|11975748|FG000|Overall Study|Early Termination|3
7580258|NCT02865083|11975749|FG001|Overall Study|Early Termination|1
7580259|NCT02865122|11975758|FG000|Overall Study|Adverse Event|1
7580260|NCT02865122|11975759|FG001|Overall Study|Adverse Event|0
7580261|NCT02865122|11975760|FG002|Overall Study|Adverse Event|0
7580262|NCT02865915|11975770|FG000|Overall Study|Pregnancy|1
7580263|NCT02865915|11975771|FG001|Overall Study|Pregnancy|0
7580264|NCT02865915|11975770|FG000|Overall Study|Withdrawal by Subject|1
7580265|NCT02865915|11975771|FG001|Overall Study|Withdrawal by Subject|1
7580266|NCT02865915|11975770|FG000|Overall Study|Adverse Event|0
7580267|NCT02865915|11975771|FG001|Overall Study|Adverse Event|4
7580268|NCT02865915|11975770|FG000|Overall Study|Lost to Follow-up|0
7580269|NCT02865915|11975771|FG001|Overall Study|Lost to Follow-up|1
7580270|NCT02865915|11975770|FG000|Overall Study|Protocol Violation|0
7580271|NCT02865915|11975771|FG001|Overall Study|Protocol Violation|1
7580272|NCT02865915|11975770|FG000|Overall Study|Study terminated by sponsor|23
7580273|NCT02865915|11975771|FG001|Overall Study|Study terminated by sponsor|18
7580274|NCT02865915|11975770|FG000|Overall Study|Dosing group discontinued|0
7580275|NCT02865915|11975771|FG001|Overall Study|Dosing group discontinued|5
7580276|NCT02855411|11975777|FG000|Overall Study|Study terminated by sponsor|21
7580277|NCT02855411|11975777|FG000|Overall Study|Does not meet entrance criteria|14
7580278|NCT02828124|11975785|FG000|Overall Study|Disease Progression|1
7580279|NCT02828124|11975786|FG001|Overall Study|Disease Progression|2
7580280|NCT02828124|11975787|FG002|Overall Study|Disease Progression|1
7580281|NCT02828124|11975788|FG003|Overall Study|Disease Progression|4
7580282|NCT02828124|11975785|FG000|Overall Study|AE Unrelated to Study Drug|0
7580283|NCT02828124|11975786|FG001|Overall Study|AE Unrelated to Study Drug|0
7580284|NCT02828124|11975787|FG002|Overall Study|AE Unrelated to Study Drug|0
7580285|NCT02828124|11975788|FG003|Overall Study|AE Unrelated to Study Drug|1
7580286|NCT02828124|11975785|FG000|Overall Study|Subject Withdrew Consent|0
7580287|NCT02828124|11975786|FG001|Overall Study|Subject Withdrew Consent|0
7580288|NCT02828124|11975787|FG002|Overall Study|Subject Withdrew Consent|0
7580289|NCT02828124|11975788|FG003|Overall Study|Subject Withdrew Consent|1
7624755|NCT02596035|12035981|FG002|Overall Study|Study Drug Toxicity|0
7624756|NCT02596035|12035979|FG000|Overall Study|Adverse Event|6
7624757|NCT02596035|12035980|FG001|Overall Study|Adverse Event|2
7624758|NCT02596035|12035981|FG002|Overall Study|Adverse Event|0
7624759|NCT02596035|12035979|FG000|Overall Study|Withdrawal by Subject|4
7624760|NCT02596035|12035980|FG001|Overall Study|Withdrawal by Subject|2
7624761|NCT02596035|12035981|FG002|Overall Study|Withdrawal by Subject|0
7624762|NCT02596035|12035979|FG000|Overall Study|Poor/Non-Compliance|0
7624763|NCT02596035|12035980|FG001|Overall Study|Poor/Non-Compliance|1
7624764|NCT02596035|12035981|FG002|Overall Study|Poor/Non-Compliance|0
7624765|NCT02596035|12035979|FG000|Overall Study|Other Reasons|3
7624766|NCT02596035|12035980|FG001|Overall Study|Other Reasons|4
7624767|NCT02596035|12035981|FG002|Overall Study|Other Reasons|0
7580290|NCT02825043|11975807|FG000|Overall Study|Lost to Follow-up|4
7580291|NCT02819804|11975811|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
7580292|NCT02809118|11975818|FG000|Overall Study|Withdrawal by Subject|0
7580293|NCT02809118|11975819|FG001|Overall Study|Withdrawal by Subject|1
7580294|NCT02809118|11975820|FG002|Overall Study|Withdrawal by Subject|1
7580295|NCT02806960|11975856|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
7580296|NCT02806960|11975857|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
7580297|NCT02806960|11975858|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
7580298|NCT02806960|11975859|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
7580299|NCT02815397|11975869|FG000|Overall Study|Physician Decision|2
7580300|NCT02802592|11975873|FG000|Overall Study|Study terminated due to loss of funding|4
7580301|NCT02730793|11975898|FG000|Overall Study|Physician Decision|0
7580302|NCT02730793|11975899|FG001|Overall Study|Physician Decision|1
7580303|NCT02730793|11975898|FG000|Overall Study|Withdrawal by Subject|0
7580304|NCT02730793|11975899|FG001|Overall Study|Withdrawal by Subject|1
7580305|NCT02760602|11975916|FG000|Overall Study|Withdrawal by Subject|1
7580306|NCT02760602|11975917|FG001|Overall Study|Withdrawal by Subject|0
7580307|NCT02760602|11975916|FG000|Overall Study|Terminated by sponsor|12
7580308|NCT02760602|11975917|FG001|Overall Study|Terminated by sponsor|13
7580309|NCT02757521|11975925|FG000|Overall Study|Adverse Event|1
7580310|NCT02757521|11975926|FG001|Overall Study|Adverse Event|0
7580311|NCT02725671|11975979|FG000|Overall Study|Lost to Follow-up|1
7580312|NCT02732327|11976000|FG000|Overall Study|Protocol Violation|0
7580313|NCT02732327|11976001|FG001|Overall Study|Protocol Violation|1
7580314|NCT02726399|11976007|FG000|Overall Study|Participant Non-Compliance|1
7580315|NCT02726399|11976007|FG000|Overall Study|Adverse Event|2
7580316|NCT02726399|11976007|FG000|Overall Study|Progression of disease|4
7580317|NCT02720510|11976013|FG000|Overall Study|Study Terminated by the sponsor|2
7580318|NCT02720510|11976014|FG001|Overall Study|Study Terminated by the sponsor|0
7580319|NCT02720510|11976013|FG000|Overall Study|Adverse Event|0
7580320|NCT02720510|11976014|FG001|Overall Study|Adverse Event|1
7580321|NCT02720510|11976013|FG000|Overall Study|Physician Decision|1
7580322|NCT02720510|11976014|FG001|Overall Study|Physician Decision|2
7580323|NCT02715765|11976023|FG000|Overall Study|Study Termination|3
7580324|NCT02715765|11976024|FG001|Overall Study|Study Termination|0
7580325|NCT02715765|11976025|FG002|Overall Study|Study Termination|0
7580326|NCT02717130|11976044|FG000|Overall Study|Withdrawal by Subject|1
7580327|NCT02717130|11976044|FG000|Overall Study|Adverse Event|1
7580328|NCT02717130|11976044|FG000|Overall Study|Physician Decision|1
7580329|NCT02717130|11976044|FG000|Overall Study|Study Closure|4
7580330|NCT02685202|11976048|FG000|Overall Study|Lost to Follow-up|9
7580331|NCT02709083|11976052|FG000|Overall Study|Original PI left institution|7
7580332|NCT02693171|11976056|FG000|Overall Study|Adverse Event|1
7580333|NCT02693171|11976056|FG000|Overall Study|Discontinuation of Study by Sponsor|8
7580334|NCT02696226|11976064|FG000|Overall Study|Study terminated - lack of enrollment|1
7580335|NCT02696226|11976065|FG001|Overall Study|Study terminated - lack of enrollment|0
7580336|NCT02696226|11976066|FG002|Overall Study|Study terminated - lack of enrollment|2
7580337|NCT02696226|11976067|FG003|Overall Study|Study terminated - lack of enrollment|0
7580338|NCT02693743|11976079|FG000|Overall Study|Physician Decision|1
7580339|NCT02693743|11976080|FG001|Overall Study|Physician Decision|0
7580340|NCT02706691|11976086|FG000|Overall Study|Adverse Event|1
7580341|NCT02694757|11976104|FG000|Overall Study|Lack of Efficacy|3
7580342|NCT02693002|11976110|FG000|Overall Study|Withdrawal by Subject|1
7580343|NCT02693002|11976111|FG001|Overall Study|Withdrawal by Subject|0
7580344|NCT02689518|11976117|FG000|Overall Study|Withdrawal by Subject|3
7580345|NCT02673684|11976148|FG000|Overall Study|Study not completed d/t loss of funding|9
7580346|NCT02673684|11976149|FG001|Overall Study|Study not completed d/t loss of funding|8
7580347|NCT02674204|11976159|FG000|Overall Study|Adverse Event|1
7580348|NCT02674204|11976160|FG001|Overall Study|Adverse Event|0
7580349|NCT02671461|11976182|FG000|Treatment|Adverse Event|0
7580350|NCT02671461|11976183|FG001|Treatment|Adverse Event|0
7580351|NCT02671461|11976184|FG002|Treatment|Adverse Event|1
7580352|NCT02671461|11976182|FG000|Treatment|Administrative Reason by Sponsor|1
7580353|NCT02671461|11976183|FG001|Treatment|Administrative Reason by Sponsor|3
7580354|NCT02671461|11976184|FG002|Treatment|Administrative Reason by Sponsor|4
7580355|NCT02671461|11976182|FG000|Treatment|Randomized, not treated|1
7580356|NCT02671461|11976183|FG001|Treatment|Randomized, not treated|0
7580357|NCT02671461|11976184|FG002|Treatment|Randomized, not treated|0
7580358|NCT02671461|11976182|FG000|Follow-up|Withdrawal by Subject|1
7580359|NCT02671461|11976183|FG001|Follow-up|Withdrawal by Subject|0
7580360|NCT02671461|11976184|FG002|Follow-up|Withdrawal by Subject|0
7580361|NCT02671461|11976182|FG000|Follow-up|Lost to Follow-up|0
7580362|NCT02671461|11976183|FG001|Follow-up|Lost to Follow-up|0
7580363|NCT02671461|11976184|FG002|Follow-up|Lost to Follow-up|1
7580364|NCT02671461|11976182|FG000|Follow-up|Administrative Reason by Sponsor|0
7580365|NCT02671461|11976183|FG001|Follow-up|Administrative Reason by Sponsor|1
7580366|NCT02671461|11976184|FG002|Follow-up|Administrative Reason by Sponsor|0
7580367|NCT02653495|11976255|FG000|Overall Study|Lost to Follow-up|2
7580368|NCT02653495|11976256|FG001|Overall Study|Lost to Follow-up|0
7580369|NCT02653495|11976255|FG000|Overall Study|Screening Failure|10
7580370|NCT02653495|11976256|FG001|Overall Study|Screening Failure|0
7580371|NCT02639390|11976268|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
7580372|NCT02639390|11976269|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
7580373|NCT02634606|11976275|FG000|Overall Study|unable to obtain the drug at start|13
7580374|NCT02636283|11976289|FG000|Overall Study|Adverse Event|2
7580375|NCT02636283|11976290|FG001|Overall Study|Adverse Event|0
7580376|NCT02636283|11976289|FG000|Overall Study|Trial Terminated Prematurely|0
7580377|NCT02636283|11976290|FG001|Overall Study|Trial Terminated Prematurely|3
7580378|NCT02638129|11976298|FG000|Overall Study|Study terminated|28
7580379|NCT02638129|11976299|FG001|Overall Study|Study terminated|30
7580380|NCT02615990|11976307|FG000|Overall Study|study terminated|1
7580381|NCT02615990|11976308|FG001|Overall Study|study terminated|1
7580382|NCT02640677|11976314|FG000|Overall Study|Lost to Follow-up|1
7270070|NCT00413660|11484162|FG002|Post Week 12|Lost to Follow-up|1
7580383|NCT02640677|11976314|FG000|Overall Study|Withdrawal by Subject|1
7580384|NCT02623959|11976324|FG000|Overall Study|Progression|0
7580385|NCT02623959|11976325|FG001|Overall Study|Progression|1
7580386|NCT02631148|11976335|FG000|Overall Study|8 were ineligible|8
7580387|NCT02631148|11976336|FG001|Overall Study|8 were ineligible|0
7580388|NCT02631148|11976335|FG000|Overall Study|Withdrawal by Subject|1
7580389|NCT02631148|11976336|FG001|Overall Study|Withdrawal by Subject|0
7580390|NCT02631148|11976335|FG000|Overall Study|PAH not available to study participant|1
7580391|NCT02631148|11976336|FG001|Overall Study|PAH not available to study participant|0
7580392|NCT02630472|11976344|FG000|Overall Study|Physician Decision|10
7580393|NCT02630472|11976345|FG001|Overall Study|Physician Decision|0
7580394|NCT02626520|11976354|FG000|Overall Study|Physician Decision|1
7580395|NCT02626520|11976355|FG001|Overall Study|Physician Decision|1
7580396|NCT02626520|11976354|FG000|Overall Study|Adverse Event|0
7580397|NCT02626520|11976355|FG001|Overall Study|Adverse Event|4
7580398|NCT02626520|11976354|FG000|Overall Study|Lack of Efficacy|0
7580399|NCT02626520|11976355|FG001|Overall Study|Lack of Efficacy|2
7580400|NCT02626520|11976354|FG000|Overall Study|Did not start protocol therapy|0
7580401|NCT02626520|11976355|FG001|Overall Study|Did not start protocol therapy|2
7580402|NCT02626520|11976354|FG000|Overall Study|Study terminated|0
7580403|NCT02626520|11976355|FG001|Overall Study|Study terminated|1
7580404|NCT02614898|11976363|FG000|Overall Study|Participated until study termination|10
7580405|NCT02614898|11976364|FG001|Overall Study|Participated until study termination|26
7580406|NCT02614898|11976363|FG000|Overall Study|Lost to Follow-up|0
7580407|NCT02614898|11976364|FG001|Overall Study|Lost to Follow-up|2
7580408|NCT02614898|11976363|FG000|Overall Study|Physician Decision|1
7580409|NCT02614898|11976364|FG001|Overall Study|Physician Decision|8
7580410|NCT02614898|11976363|FG000|Overall Study|Study Terminated by Sponsor|3
7580411|NCT02614898|11976364|FG001|Overall Study|Study Terminated by Sponsor|0
7580412|NCT02614898|11976363|FG000|Overall Study|Withdrawal by Subject|0
7580413|NCT02614898|11976364|FG001|Overall Study|Withdrawal by Subject|2
7580414|NCT02614898|11976363|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7580415|NCT02614898|11976364|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7624807|NCT02318095|12036004|FG000|Overall Study|Adverse Event|1
7624808|NCT02155647|12036011|FG000|Overall Study|Still on Treatment|26
7624809|NCT02155647|12036012|FG001|Overall Study|Still on Treatment|26
7624810|NCT02155647|12036011|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
7624811|NCT02155647|12036012|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
7624812|NCT01904903|12036035|FG000|Overall Study|Withdrawal by Subject|1
7624813|NCT01827384|12036053|FG000|Overall Study|Switched to alternative treatment|0
7624814|NCT01827384|12036054|FG001|Overall Study|Switched to alternative treatment|0
7624815|NCT01827384|12036055|FG002|Overall Study|Switched to alternative treatment|0
7624816|NCT01827384|12036056|FG003|Overall Study|Switched to alternative treatment|0
7624817|NCT01827384|12036057|FG004|Overall Study|Switched to alternative treatment|0
7624818|NCT01827384|12036058|FG005|Overall Study|Switched to alternative treatment|0
7624819|NCT01827384|12036059|FG006|Overall Study|Switched to alternative treatment|0
7624820|NCT01827384|12036060|FG007|Overall Study|Switched to alternative treatment|0
7624821|NCT01827384|12036061|FG008|Overall Study|Switched to alternative treatment|0
7624822|NCT01827384|12036062|FG009|Overall Study|Switched to alternative treatment|0
7624823|NCT01827384|12036063|FG010|Overall Study|Switched to alternative treatment|0
7624824|NCT01827384|12036064|FG011|Overall Study|Switched to alternative treatment|0
7624825|NCT01827384|12036065|FG012|Overall Study|Switched to alternative treatment|0
7624826|NCT01827384|12036066|FG013|Overall Study|Switched to alternative treatment|2
7624827|NCT01827384|12036053|FG000|Overall Study|Disease progression before treatment|0
7624828|NCT01827384|12036054|FG001|Overall Study|Disease progression before treatment|0
7624829|NCT01827384|12036055|FG002|Overall Study|Disease progression before treatment|0
7624830|NCT01827384|12036056|FG003|Overall Study|Disease progression before treatment|0
7624831|NCT01827384|12036057|FG004|Overall Study|Disease progression before treatment|0
7624832|NCT01827384|12036058|FG005|Overall Study|Disease progression before treatment|0
7624833|NCT01827384|12036059|FG006|Overall Study|Disease progression before treatment|0
7624834|NCT01827384|12036060|FG007|Overall Study|Disease progression before treatment|0
7624835|NCT01827384|12036061|FG008|Overall Study|Disease progression before treatment|0
7580416|NCT02614898|11976363|FG000|Overall Study|Other-Additional Information Unavailable|0
7580417|NCT02614898|11976364|FG001|Overall Study|Other-Additional Information Unavailable|11
7580418|NCT02614898|11976363|FG000|Overall Study|Missing|0
7580419|NCT02614898|11976364|FG001|Overall Study|Missing|1
7580420|NCT02622828|11976371|FG000|Overall Study|participant withdrew|3
7580421|NCT02619812|11976397|FG000|Overall Study|Withdrawal by Subject|0
7580422|NCT02619812|11976398|FG001|Overall Study|Withdrawal by Subject|0
7580423|NCT02619812|11976399|FG002|Overall Study|Withdrawal by Subject|1
7580424|NCT02619812|11976400|FG003|Overall Study|Withdrawal by Subject|2
7580425|NCT02612285|11976410|FG000|Overall Study|Withdrawal by Subject|1
7580426|NCT02606279|11976420|FG000|Overall Study|Lost to Follow-up|0
7580427|NCT02606279|11976421|FG001|Overall Study|Lost to Follow-up|1
7580428|NCT02605824|11976429|FG000|Overall Study|Physician Decision|1
7580429|NCT02605824|11976430|FG001|Overall Study|Physician Decision|0
7580430|NCT02598622|11976438|FG000|Overall Study|Withdrawal by Subject|3
7580431|NCT02598622|11976439|FG001|Overall Study|Withdrawal by Subject|0
7580432|NCT02598622|11976438|FG000|Overall Study|Physician Decision|3
7580433|NCT02598622|11976439|FG001|Overall Study|Physician Decision|0
7580434|NCT02569957|11976485|FG000|Overall Study|Withdrawal by Subject|0
7580435|NCT02569957|11976486|FG001|Overall Study|Withdrawal by Subject|1
7580436|NCT02575365|11976505|FG000|Overall Study|Lost to Follow-up|4
7580437|NCT02547129|11976515|FG000|Overall Study|Difficulty with ongoing infection|1
7580438|NCT02547129|11976516|FG001|Overall Study|Difficulty with ongoing infection|0
7580439|NCT02533531|11976555|FG000|Overall Study|Device did not turn on|1
7580440|NCT02520726|11976571|FG000|Overall Study|Lost to Follow-up|3
7580441|NCT02520726|11976572|FG001|Overall Study|Lost to Follow-up|2
7624836|NCT01827384|12036062|FG009|Overall Study|Disease progression before treatment|0
7624837|NCT01827384|12036063|FG010|Overall Study|Disease progression before treatment|0
7624838|NCT01827384|12036064|FG011|Overall Study|Disease progression before treatment|0
7624839|NCT01827384|12036065|FG012|Overall Study|Disease progression before treatment|0
7624840|NCT01827384|12036066|FG013|Overall Study|Disease progression before treatment|4
7624841|NCT01827384|12036053|FG000|Overall Study|Ineligible|0
7624842|NCT01827384|12036054|FG001|Overall Study|Ineligible|0
7624843|NCT01827384|12036055|FG002|Overall Study|Ineligible|0
7624844|NCT01827384|12036056|FG003|Overall Study|Ineligible|0
7624845|NCT01827384|12036057|FG004|Overall Study|Ineligible|0
7624846|NCT01827384|12036058|FG005|Overall Study|Ineligible|0
7624847|NCT01827384|12036059|FG006|Overall Study|Ineligible|0
7624848|NCT01827384|12036060|FG007|Overall Study|Ineligible|0
7624849|NCT01827384|12036061|FG008|Overall Study|Ineligible|0
7624850|NCT01827384|12036062|FG009|Overall Study|Ineligible|0
7624851|NCT01827384|12036063|FG010|Overall Study|Ineligible|0
7624852|NCT01827384|12036064|FG011|Overall Study|Ineligible|0
7624853|NCT01827384|12036065|FG012|Overall Study|Ineligible|0
7624854|NCT01827384|12036066|FG013|Overall Study|Ineligible|19
7624855|NCT01827384|12036053|FG000|Overall Study|Participant died before treatment|0
7624856|NCT01827384|12036054|FG001|Overall Study|Participant died before treatment|0
7624857|NCT01827384|12036055|FG002|Overall Study|Participant died before treatment|0
7624858|NCT01827384|12036056|FG003|Overall Study|Participant died before treatment|0
7624859|NCT01827384|12036057|FG004|Overall Study|Participant died before treatment|0
7624860|NCT01827384|12036058|FG005|Overall Study|Participant died before treatment|0
7624861|NCT01827384|12036059|FG006|Overall Study|Participant died before treatment|0
7624862|NCT01827384|12036060|FG007|Overall Study|Participant died before treatment|0
7624863|NCT01827384|12036061|FG008|Overall Study|Participant died before treatment|0
7624864|NCT01827384|12036062|FG009|Overall Study|Participant died before treatment|0
7624865|NCT01827384|12036063|FG010|Overall Study|Participant died before treatment|0
7624866|NCT01827384|12036064|FG011|Overall Study|Participant died before treatment|0
7624867|NCT01827384|12036065|FG012|Overall Study|Participant died before treatment|0
7624868|NCT01827384|12036066|FG013|Overall Study|Participant died before treatment|5
7624869|NCT01827384|12036053|FG000|Overall Study|Insufficient tumor cells|0
7624870|NCT01827384|12036054|FG001|Overall Study|Insufficient tumor cells|0
7624871|NCT01827384|12036055|FG002|Overall Study|Insufficient tumor cells|0
7624872|NCT01827384|12036056|FG003|Overall Study|Insufficient tumor cells|0
7624873|NCT01827384|12036057|FG004|Overall Study|Insufficient tumor cells|0
7624874|NCT01827384|12036058|FG005|Overall Study|Insufficient tumor cells|0
7624875|NCT01827384|12036059|FG006|Overall Study|Insufficient tumor cells|0
7624876|NCT01827384|12036060|FG007|Overall Study|Insufficient tumor cells|0
7624877|NCT01827384|12036061|FG008|Overall Study|Insufficient tumor cells|0
7624878|NCT01827384|12036062|FG009|Overall Study|Insufficient tumor cells|0
7624879|NCT01827384|12036063|FG010|Overall Study|Insufficient tumor cells|0
7624880|NCT01827384|12036064|FG011|Overall Study|Insufficient tumor cells|0
7624881|NCT01827384|12036065|FG012|Overall Study|Insufficient tumor cells|0
7624882|NCT01827384|12036066|FG013|Overall Study|Insufficient tumor cells|13
7624883|NCT01827384|12036053|FG000|Overall Study|No actionable mutation|0
7624884|NCT01827384|12036054|FG001|Overall Study|No actionable mutation|0
7624885|NCT01827384|12036055|FG002|Overall Study|No actionable mutation|0
7624886|NCT01827384|12036056|FG003|Overall Study|No actionable mutation|0
7624887|NCT01827384|12036057|FG004|Overall Study|No actionable mutation|0
7624888|NCT01827384|12036058|FG005|Overall Study|No actionable mutation|0
7624889|NCT01827384|12036059|FG006|Overall Study|No actionable mutation|0
7624890|NCT01827384|12036060|FG007|Overall Study|No actionable mutation|0
7624891|NCT01827384|12036061|FG008|Overall Study|No actionable mutation|0
7580442|NCT02519712|11976582|FG000|Overall Study|Disease Relapse|1
7580443|NCT02519712|11976582|FG000|Overall Study|Disease Progression|1
7580444|NCT02519712|11976582|FG000|Overall Study|Accruals are donors|2
7580445|NCT02516228|11976590|FG000|Overall Study|Lost to Follow-up|1
7580446|NCT02516228|11976590|FG000|Overall Study|Withdrawal by Subject|1
7580447|NCT02516228|11976590|FG000|Overall Study|Physician Decision|1
7580448|NCT02506101|11976630|FG000|Overall Study|Transportation issues|1
7580449|NCT02506101|11976631|FG001|Overall Study|Transportation issues|0
7580450|NCT02506101|11976630|FG000|Overall Study|No enrollment and staff unavailability|1
7580451|NCT02506101|11976631|FG001|Overall Study|No enrollment and staff unavailability|0
7580452|NCT02500901|11976650|FG000|Overall Study|Disease ProgressionDD|2
7580453|NCT02483533|11976656|FG000|Overall Study|Lack of Efficacy|50
7580454|NCT02483533|11976657|FG001|Overall Study|Lack of Efficacy|50
7580455|NCT02496039|11976663|FG000|Overall Study|Adverse Event|3
7580456|NCT02496039|11976663|FG000|Overall Study|Protocol Violation|1
7580457|NCT02494206|11976672|FG000|Overall Study|Adverse Event|1
7580458|NCT02494206|11976672|FG000|Overall Study|Disease Progression|1
7580459|NCT02473445|11976676|FG000|Overall Study|Withdrawal by Subject|2
7580460|NCT02473445|11976676|FG000|Overall Study|Sponsor Decision|20
7580461|NCT02491411|11976680|FG000|Overall Study|Physician Decision|4
7580462|NCT02476994|11976686|FG000|Overall Study|Based on feedback from FDA|1
7580463|NCT02476994|11976687|FG001|Overall Study|Based on feedback from FDA|0
7580464|NCT02473523|11976693|FG000|Overall Study|Death|1
7580465|NCT02473523|11976693|FG000|Overall Study|Lost to Follow-up|1
7580466|NCT02472639|11976712|FG000|Overall Study|Physician Decision|4
7580467|NCT02472639|11976713|FG001|Overall Study|Physician Decision|3
7580468|NCT02469415|11976719|FG000|Overall Study|Withdrawal by Subject|1
7580469|NCT02469415|11976719|FG000|Overall Study|Investigational agent placed on hold|2
7580470|NCT02452359|11976731|FG000|Overall Study|Adverse Event|1
7580471|NCT02452359|11976731|FG000|Overall Study|Lost to Follow-up|15
7580472|NCT02452359|11976731|FG000|Overall Study|Pregnancy|1
7580473|NCT02452359|11976731|FG000|Overall Study|Withdrawal by Subject|4
7580474|NCT02452398|11976739|FG000|Overall Study|Adverse Event|1
7580475|NCT02452398|11976739|FG000|Overall Study|Lost to Follow-up|28
7580476|NCT02452398|11976739|FG000|Overall Study|Physician Decision|2
7580477|NCT02452398|11976739|FG000|Overall Study|Withdrawal by Subject|6
7580478|NCT02452398|11976739|FG000|Overall Study|Moved away|4
7580479|NCT02447887|11976743|FG000|Overall Study|Study was terminated|3
7580480|NCT02439970|11976764|FG000|Overall Study|Study Terminated|2
7580481|NCT02439970|11976765|FG001|Overall Study|Study Terminated|3
7580482|NCT02439957|11976773|FG000|Overall Study|Study Terminated|3
7580483|NCT02439957|11976774|FG001|Overall Study|Study Terminated|3
7580484|NCT02441036|11976785|FG000|Overall Study|No tissue resected|0
7580485|NCT02441036|11976786|FG001|Overall Study|No tissue resected|1
7580486|NCT02441036|11976787|FG002|Overall Study|No tissue resected|0
7580487|NCT02441036|11976788|FG003|Overall Study|No tissue resected|1
7580488|NCT02441036|11976789|FG004|Overall Study|No tissue resected|0
7580489|NCT02430532|11976826|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
7580490|NCT02430532|11976827|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
7580491|NCT02430532|11976826|FG000|Overall Study|Consent Withdrawn|0
7580492|NCT02430532|11976827|FG001|Overall Study|Consent Withdrawn|2
7580493|NCT02430532|11976826|FG000|Overall Study|Adverse Event|0
7580494|NCT02430532|11976827|FG001|Overall Study|Adverse Event|1
7580495|NCT02428231|11976837|FG000|Overall Study|Other|10
7580496|NCT02428231|11976838|FG001|Overall Study|Other|16
7580497|NCT02428231|11976837|FG000|Overall Study|Required Symptomatic Therapy|0
7580498|NCT02428231|11976838|FG001|Overall Study|Required Symptomatic Therapy|1
7580499|NCT02428231|11976837|FG000|Overall Study|Adverse Event|3
7580500|NCT02428231|11976838|FG001|Overall Study|Adverse Event|0
7580501|NCT02424565|11976844|FG000|Period 1 (D0)|Protocol Violation|0
7580502|NCT02424565|11976845|FG001|Period 1 (D0)|Protocol Violation|1
7580503|NCT02422303|11976866|FG000|Overall Study|Lost to Follow-up|1
7580504|NCT02422303|11976867|FG001|Overall Study|Lost to Follow-up|1
7580505|NCT02414152|11976890|FG000|Overall Study|Withdrawal by Subject|1
7580506|NCT02414152|11976890|FG000|Overall Study|Lack of Efficacy|1
7580507|NCT02410551|11976894|FG000|Overall Study|Adverse Event|1
7580508|NCT02410551|11976894|FG000|Overall Study|Withdrawal by Subject|1
7580509|NCT02410551|11976894|FG000|Overall Study|FDA Clinical hold-patients taken off|2
7580510|NCT02410954|11976905|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
7580511|NCT02410954|11976906|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
7580512|NCT02410954|11976905|FG000|Overall Study|Instrument malfunction generated unusable data|8
7580513|NCT02410954|11976906|FG001|Overall Study|Instrument malfunction generated unusable data|0
7580514|NCT02409355|11976918|FG000|Overall Study|Withdrawal by Subject|1
7580515|NCT02409355|11976919|FG001|Overall Study|Withdrawal by Subject|0
7580516|NCT02409355|11976918|FG000|Overall Study|Death|1
7580517|NCT02409355|11976919|FG001|Overall Study|Death|1
7580518|NCT02409355|11976918|FG000|Overall Study|Study terminated by Sponsor|2
7580519|NCT02409355|11976919|FG001|Overall Study|Study terminated by Sponsor|3
7580520|NCT02404545|11976944|FG000|Overall Study|Sponsor Termination|6
7580521|NCT02404545|11976945|FG001|Overall Study|Sponsor Termination|6
7580522|NCT02392377|11976954|FG000|Overall Study|Withdrawal by Subject|0
7580523|NCT02392377|11976955|FG001|Overall Study|Withdrawal by Subject|1
7580524|NCT02394665|11976989|FG000|Overall Study|Physician Decision|1
7580525|NCT02394665|11976990|FG001|Overall Study|Physician Decision|0
7580526|NCT02394665|11976991|FG002|Overall Study|Physician Decision|0
7580527|NCT02390362|11977010|FG000|Overall Study|Withdrawal by Subject|0
7580528|NCT02390362|11977011|FG001|Overall Study|Withdrawal by Subject|1
7580529|NCT02388776|11977017|FG000|Overall Study|Death|1
7580530|NCT02388776|11977017|FG000|Overall Study|Lost to Follow-up|1
7580531|NCT02383433|11977022|FG000|Overall Study|Disease progression|2
7580532|NCT02379390|11977050|FG000|Overall Study|Adverse Event|1
7580533|NCT02379390|11977051|FG001|Overall Study|Adverse Event|1
7580534|NCT02379390|11977050|FG000|Overall Study|Investigator's decision|1
7580535|NCT02379390|11977051|FG001|Overall Study|Investigator's decision|0
7580536|NCT02379390|11977050|FG000|Overall Study|Study Termination|0
7580537|NCT02379390|11977051|FG001|Overall Study|Study Termination|1
7580538|NCT02361580|11977075|FG000|Overall Study|Lost to Follow-up|6
7580539|NCT02361580|11977076|FG001|Overall Study|Lost to Follow-up|3
7580540|NCT02370888|11977107|FG000|Overall Study|disease progression|2
7580541|NCT02370888|11977107|FG000|Overall Study|did not meet chimerism criteria|6
7580542|NCT02365233|11977131|FG000|Overall Study|IRB withheld the data|1
7580543|NCT02365233|11977132|FG001|Overall Study|IRB withheld the data|2
7580544|NCT02365233|11977133|FG002|Overall Study|IRB withheld the data|2
7580545|NCT02347943|11977144|FG000|Overall Study|Study was cancelled|140
7580546|NCT02347943|11977145|FG001|Overall Study|Study was cancelled|67
7580547|NCT02347943|11977146|FG002|Overall Study|Study was cancelled|45
7580548|NCT02365207|11977154|FG000|Overall Study|Withdrawal by Subject|1
7580549|NCT02365207|11977154|FG000|Overall Study|Physician Decision|1
7580550|NCT02360111|11977158|FG000|Overall Study|Death|2
7580551|NCT02353468|11977162|FG000|Overall Study|Study terminated|3
7580552|NCT02346877|11977190|FG000|Overall Study|Adverse Event|1
7580553|NCT02346877|11977191|FG001|Overall Study|Adverse Event|0
7580554|NCT02346877|11977190|FG000|Overall Study|Administrative Decision|1
7580555|NCT02346877|11977191|FG001|Overall Study|Administrative Decision|0
7580556|NCT02346877|11977190|FG000|Overall Study|Sponsor Decision|12
7580557|NCT02346877|11977191|FG001|Overall Study|Sponsor Decision|0
7580558|NCT02346877|11977190|FG000|Overall Study|Missing|5
7580559|NCT02346877|11977191|FG001|Overall Study|Missing|0
7580560|NCT02353572|11977214|FG000|Overall Study|Withdrawal by Subject|1
7580561|NCT02353572|11977214|FG000|Overall Study|Study terminated|2
7580562|NCT02343263|11977230|FG000|Overall Study|Physician Decision|5
7580563|NCT02343263|11977231|FG001|Overall Study|Physician Decision|3
7580564|NCT02343263|11977232|FG002|Overall Study|Physician Decision|1
7580565|NCT02343159|11977247|FG000|Overall Study|Early Study Termination|16
7580566|NCT02343159|11977248|FG001|Overall Study|Early Study Termination|19
7580567|NCT02343159|11977249|FG002|Overall Study|Early Study Termination|23
7580568|NCT02343159|11977247|FG000|Overall Study|Physician Decision|2
7580569|NCT02343159|11977248|FG001|Overall Study|Physician Decision|0
7580570|NCT02343159|11977249|FG002|Overall Study|Physician Decision|1
7580571|NCT02343159|11977247|FG000|Overall Study|Withdrawal by Subject|3
7580572|NCT02343159|11977248|FG001|Overall Study|Withdrawal by Subject|0
7580573|NCT02343159|11977249|FG002|Overall Study|Withdrawal by Subject|2
7580574|NCT02343159|11977247|FG000|Overall Study|Lost to Follow-up|0
7580575|NCT02343159|11977248|FG001|Overall Study|Lost to Follow-up|2
7580576|NCT02343159|11977249|FG002|Overall Study|Lost to Follow-up|2
7580577|NCT02343159|11977247|FG000|Overall Study|Adverse Event|4
7580578|NCT02343159|11977248|FG001|Overall Study|Adverse Event|4
7580579|NCT02343159|11977249|FG002|Overall Study|Adverse Event|2
7580580|NCT02343159|11977247|FG000|Overall Study|Sponsor Decision|0
7580581|NCT02343159|11977248|FG001|Overall Study|Sponsor Decision|1
7580582|NCT02343159|11977249|FG002|Overall Study|Sponsor Decision|0
7580583|NCT02343159|11977247|FG000|Overall Study|Enrollment Error|1
7580584|NCT02343159|11977248|FG001|Overall Study|Enrollment Error|0
7580585|NCT02343159|11977249|FG002|Overall Study|Enrollment Error|0
7580586|NCT02336425|11977266|FG000|Overall Study|Study terminated.|2
7580587|NCT02336425|11977267|FG001|Overall Study|Study terminated.|2
7580588|NCT02336425|11977268|FG002|Overall Study|Study terminated.|3
7580589|NCT02336425|11977269|FG003|Overall Study|Study terminated.|3
7580590|NCT02308735|11977330|FG000|Overall Study|Physician Decision|2
7580591|NCT02308735|11977331|FG001|Overall Study|Physician Decision|0
7580592|NCT02308735|11977332|FG002|Overall Study|Physician Decision|0
7580593|NCT02308735|11977333|FG003|Overall Study|Physician Decision|2
7580594|NCT02299206|11977343|FG000|Overall Study|Lost to Follow-up|1
7580595|NCT02299206|11977343|FG000|Overall Study|Withdrawal by Subject|1
7580596|NCT02302859|11977349|FG000|Overall Study|Lost Phone|1
7580597|NCT02302859|11977350|FG001|Overall Study|Lost Phone|1
7580598|NCT02302859|11977349|FG000|Overall Study|Withdrawal by Subject|0
7580599|NCT02302859|11977350|FG001|Overall Study|Withdrawal by Subject|1
7624892|NCT01827384|12036062|FG009|Overall Study|No actionable mutation|0
7624893|NCT01827384|12036063|FG010|Overall Study|No actionable mutation|0
7624894|NCT01827384|12036064|FG011|Overall Study|No actionable mutation|0
7624895|NCT01827384|12036065|FG012|Overall Study|No actionable mutation|0
7624896|NCT01827384|12036066|FG013|Overall Study|No actionable mutation|73
7624897|NCT01827384|12036053|FG000|Overall Study|Participant declined to participate (before treatment started)|0
7624898|NCT01827384|12036054|FG001|Overall Study|Participant declined to participate (before treatment started)|0
7624899|NCT01827384|12036055|FG002|Overall Study|Participant declined to participate (before treatment started)|0
7624900|NCT01827384|12036056|FG003|Overall Study|Participant declined to participate (before treatment started)|0
7624901|NCT01827384|12036057|FG004|Overall Study|Participant declined to participate (before treatment started)|0
7624902|NCT01827384|12036058|FG005|Overall Study|Participant declined to participate (before treatment started)|0
7624903|NCT01827384|12036059|FG006|Overall Study|Participant declined to participate (before treatment started)|0
7624904|NCT01827384|12036060|FG007|Overall Study|Participant declined to participate (before treatment started)|0
7624905|NCT01827384|12036061|FG008|Overall Study|Participant declined to participate (before treatment started)|0
7580600|NCT02299934|11977356|FG000|Overall Study|Termination of study|13
7580601|NCT02294981|11977383|FG000|Overall Study|Lost to Follow-up|1
7580602|NCT02284906|11977390|FG000|Overall Study|Pretreatment Event/Adverse Event|0
7580603|NCT02284906|11977391|FG001|Overall Study|Pretreatment Event/Adverse Event|1
7580604|NCT02284906|11977392|FG002|Overall Study|Pretreatment Event/Adverse Event|0
7580605|NCT02284906|11977390|FG000|Overall Study|Major Protocol Deviation|0
7580606|NCT02284906|11977391|FG001|Overall Study|Major Protocol Deviation|1
7580607|NCT02284906|11977392|FG002|Overall Study|Major Protocol Deviation|0
7580608|NCT02284906|11977390|FG000|Overall Study|Voluntary Withdrawal|2
7580609|NCT02284906|11977391|FG001|Overall Study|Voluntary Withdrawal|4
7580610|NCT02284906|11977392|FG002|Overall Study|Voluntary Withdrawal|5
7580611|NCT02284906|11977390|FG000|Overall Study|Study Termination|0
7580612|NCT02284906|11977391|FG001|Overall Study|Study Termination|11
7580613|NCT02284906|11977392|FG002|Overall Study|Study Termination|14
7580614|NCT02284906|11977390|FG000|Overall Study|Reason not Specified|1
7580615|NCT02284906|11977391|FG001|Overall Study|Reason not Specified|1
7580616|NCT02284906|11977392|FG002|Overall Study|Reason not Specified|0
7270071|NCT00413660|11484163|FG003|Post Week 12|Lost to Follow-up|0
7270072|NCT00413660|11484164|FG004|Post Week 12|Lost to Follow-up|0
7270073|NCT00413660|11484165|FG005|Post Week 12|Lost to Follow-up|0
7270074|NCT00413660|11484166|FG006|Post Week 12|Lost to Follow-up|0
7270075|NCT00413660|11484167|FG007|Post Week 12|Lost to Follow-up|0
7270076|NCT00413660|11484168|FG008|Post Week 12|Lost to Follow-up|0
7270077|NCT00413660|11484169|FG009|Post Week 12|Lost to Follow-up|0
7270078|NCT00413660|11484170|FG010|Post Week 12|Lost to Follow-up|0
7580617|NCT02287025|11977402|FG000|Overall Study|Not treated|2
7580618|NCT02287025|11977403|FG001|Overall Study|Not treated|0
7580619|NCT02287025|11977402|FG000|Overall Study|Progression of disease|3
7580620|NCT02287025|11977403|FG001|Overall Study|Progression of disease|2
7580621|NCT02287025|11977402|FG000|Overall Study|Adverse Event|2
7580622|NCT02287025|11977403|FG001|Overall Study|Adverse Event|4
7580623|NCT02287025|11977402|FG000|Overall Study|Withdrawal by Subject|2
7580624|NCT02287025|11977403|FG001|Overall Study|Withdrawal by Subject|2
7580625|NCT02287025|11977402|FG000|Overall Study|Screening failed|1
7580626|NCT02287025|11977403|FG001|Overall Study|Screening failed|1
7580627|NCT02276560|11977418|FG000|Overall Study|Adverse Event|1
7270079|NCT00413660|11484160|FG000|Post Week 12|Withdrawal by Subject|0
7270080|NCT00413660|11484161|FG001|Post Week 12|Withdrawal by Subject|1
7270081|NCT00413660|11484162|FG002|Post Week 12|Withdrawal by Subject|1
7580628|NCT02276560|11977419|FG001|Overall Study|Adverse Event|0
7580629|NCT02276560|11977420|FG002|Overall Study|Adverse Event|0
7580630|NCT02284373|11977435|FG000|Overall Study|Withdrawal by Subject|0
7580631|NCT02284373|11977436|FG001|Overall Study|Withdrawal by Subject|1
7580632|NCT02284373|11977437|FG002|Overall Study|Withdrawal by Subject|0
7580633|NCT02284373|11977435|FG000|Overall Study|Other|0
7580634|NCT02284373|11977436|FG001|Overall Study|Other|1
7580635|NCT02284373|11977437|FG002|Overall Study|Other|0
7580636|NCT02284373|11977435|FG000|Overall Study|Lost to Follow-up|0
7580637|NCT02284373|11977436|FG001|Overall Study|Lost to Follow-up|1
7580638|NCT02284373|11977437|FG002|Overall Study|Lost to Follow-up|0
7580639|NCT02285270|11977445|FG000|Overall Study|Lost to Follow-up|1
7580640|NCT02285270|11977445|FG000|Overall Study|Physician Decision|3
7580641|NCT02285270|11977445|FG000|Overall Study|Determined to be ineligible|1
7580642|NCT02275481|11977451|FG000|Overall Study|Death|2
7580643|NCT02275481|11977452|FG001|Overall Study|Death|1
7580644|NCT02275481|11977451|FG000|Overall Study|Lost to Follow-up|2
7580645|NCT02275481|11977452|FG001|Overall Study|Lost to Follow-up|0
7580646|NCT02275481|11977451|FG000|Overall Study|Withdrawal by Subject|3
7580647|NCT02275481|11977452|FG001|Overall Study|Withdrawal by Subject|0
7580648|NCT02275481|11977451|FG000|Overall Study|all other reasons combined|2
7580649|NCT02275481|11977452|FG001|Overall Study|all other reasons combined|1
7580650|NCT02275481|11977451|FG000|Overall Study|Physician Decision|0
7580651|NCT02275481|11977452|FG001|Overall Study|Physician Decision|1
7580652|NCT02273752|11977462|FG000|Overall Study|Trial was terminated early|2
7580653|NCT02270684|11977468|FG000|Overall Study|Lost to Follow-up|0
7580654|NCT02270684|11977469|FG001|Overall Study|Lost to Follow-up|3
7580655|NCT02270684|11977468|FG000|Overall Study|Study terminated|1
7580656|NCT02270684|11977469|FG001|Overall Study|Study terminated|0
7580657|NCT02271594|11977486|FG000|Overall Study|Study closed; recruiting failure|19
7580658|NCT02271594|11977487|FG001|Overall Study|Study closed; recruiting failure|12
7580659|NCT02263365|11977497|FG000|Overall Study|Physician Decision|22
7580660|NCT02263365|11977498|FG001|Overall Study|Physician Decision|18
7580661|NCT02241551|11977532|FG000|Overall Study|Adverse Event|1
7580662|NCT02241551|11977533|FG001|Overall Study|Adverse Event|0
7580663|NCT02246114|11977543|FG000|Overall Study|miscarriage|1
7580664|NCT02246114|11977544|FG001|Overall Study|miscarriage|0
7580665|NCT02232880|11977550|FG000|Overall Study|study stopped prior to randomization|1
7580666|NCT02244944|11977572|FG000|Overall Study|Withdrawal by Subject|1
7580667|NCT02244944|11977572|FG000|Overall Study|Study Terminated|1
7580668|NCT02241187|11977576|FG000|Overall Study|Protocol closed due to lack of accrual.|2
7580669|NCT02239926|11977582|FG000|Overall Study|Withdrawal by Subject|0
7580670|NCT02239926|11977583|FG001|Overall Study|Withdrawal by Subject|1
7580671|NCT02231892|11977592|FG000|Overall Study|Lost to Follow-up|1
7580672|NCT02231892|11977593|FG001|Overall Study|Lost to Follow-up|0
7580673|NCT02231892|11977594|FG002|Overall Study|Lost to Follow-up|3
7580674|NCT02231892|11977592|FG000|Overall Study|Withdrawal by Subject|4
7580675|NCT02231892|11977593|FG001|Overall Study|Withdrawal by Subject|3
7580676|NCT02231892|11977594|FG002|Overall Study|Withdrawal by Subject|15
7580677|NCT02231892|11977592|FG000|Overall Study|Physician Decision|0
7580678|NCT02231892|11977593|FG001|Overall Study|Physician Decision|2
7580679|NCT02231892|11977594|FG002|Overall Study|Physician Decision|4
7580680|NCT02231892|11977592|FG000|Overall Study|Motor activity when stimulating ante ACC|4
7580681|NCT02231892|11977593|FG001|Overall Study|Motor activity when stimulating ante ACC|7
7580682|NCT02231892|11977594|FG002|Overall Study|Motor activity when stimulating ante ACC|12
7580683|NCT02231892|11977592|FG000|Overall Study|Participant motor threshold was >83%|0
7580684|NCT02231892|11977593|FG001|Overall Study|Participant motor threshold was >83%|0
7580685|NCT02231892|11977594|FG002|Overall Study|Participant motor threshold was >83%|9
7580686|NCT02231892|11977592|FG000|Overall Study|Could not find motor threshold|2
7580687|NCT02231892|11977593|FG001|Overall Study|Could not find motor threshold|0
7580688|NCT02231892|11977594|FG002|Overall Study|Could not find motor threshold|1
7580689|NCT02231892|11977592|FG000|Overall Study|Could not find reliable motor hotspot|0
7580690|NCT02231892|11977593|FG001|Overall Study|Could not find reliable motor hotspot|0
7580691|NCT02231892|11977594|FG002|Overall Study|Could not find reliable motor hotspot|1
7580692|NCT02241343|11977608|FG000|Overall Study|Adverse Event|1
7580693|NCT02224599|11977643|FG000|Overall Study|Physician Decision|1
7580694|NCT02224599|11977643|FG000|Overall Study|Progression of Disease|1
7580695|NCT02201472|11977647|FG000|Overall Study|Lack of Efficacy|2
7580696|NCT02200042|11977670|FG000|Overall Study|Withdrawal by Subject|0
7580697|NCT02200042|11977671|FG001|Overall Study|Withdrawal by Subject|1
7580698|NCT02181790|11977679|FG000|Overall Study|study terminated|2
7580699|NCT02181790|11977680|FG001|Overall Study|study terminated|0
7580700|NCT02177266|11977708|FG000|Overall Study|Adverse Event|0
7580701|NCT02177266|11977709|FG001|Overall Study|Adverse Event|1
7580702|NCT02177266|11977708|FG000|Overall Study|Withdrawal by Subject|1
7580703|NCT02177266|11977709|FG001|Overall Study|Withdrawal by Subject|0
7580704|NCT02170298|11977726|FG000|Overall Study|Withdrawal by Subject|0
7580705|NCT02170298|11977727|FG001|Overall Study|Withdrawal by Subject|1
7580706|NCT02170298|11977726|FG000|Overall Study|unblinded, rerandomized to intervention|1
7580707|NCT02170298|11977727|FG001|Overall Study|unblinded, rerandomized to intervention|0
7580708|NCT02169830|11977749|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7580709|NCT02169830|11977750|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
7580710|NCT02169830|11977751|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
7580711|NCT02169830|11977749|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
7580712|NCT02169830|11977750|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
7580713|NCT02169830|11977751|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
7580714|NCT02169830|11977749|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
7580715|NCT02169830|11977750|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
7580716|NCT02169830|11977751|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
7580717|NCT02169830|11977749|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
7580718|NCT02169830|11977750|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
7580719|NCT02169830|11977751|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
7580720|NCT02169830|11977749|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7580721|NCT02169830|11977750|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
7580722|NCT02169830|11977751|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
7580723|NCT02163187|11977761|FG000|Overall Study|Device removed|1
7580724|NCT02163187|11977762|FG001|Overall Study|Device removed|0
7580725|NCT02163187|11977761|FG000|Overall Study|Progressive disease|1
7580726|NCT02163187|11977762|FG001|Overall Study|Progressive disease|0
7580727|NCT02161016|11977768|FG000|Overall Study|withdrawn by IRB|1
7580728|NCT02159040|11977772|FG000|Overall Study|Death|1
7580729|NCT02168270|11977776|FG000|Overall Study|Lack of Efficacy|4
7580730|NCT02157116|11977780|FG000|Overall Study|Withdrawal by Subject|4
7580731|NCT02157116|11977780|FG000|Overall Study|Physician Decision|3
7580732|NCT02157116|11977780|FG000|Overall Study|Failed Screening|2
7580733|NCT02154087|11977784|FG000|Overall Study|Study Termination|1
7580734|NCT02152566|11977792|FG000|Overall Study|Lost to Follow-up|1
7580735|NCT02152566|11977792|FG000|Overall Study|Withdrawal by Subject|2
7580736|NCT02145390|11977809|FG000|Overall Study|Withdrawal by Subject|1
7580737|NCT02150863|11977842|FG000|Overall Study|Lost to Follow-up|0
7580738|NCT02150863|11977843|FG001|Overall Study|Lost to Follow-up|1
7580739|NCT02150863|11977844|FG002|Overall Study|Lost to Follow-up|0
7580740|NCT02131155|11977880|FG000|Overall Study|Adverse Event|1
7580741|NCT02131155|11977881|FG001|Overall Study|Adverse Event|0
7580742|NCT02131155|11977880|FG000|Overall Study|Treatment completed|1
7580743|NCT02131155|11977881|FG001|Overall Study|Treatment completed|0
7580744|NCT02131155|11977880|FG000|Overall Study|Primary tumour recurrence|2
7580745|NCT02131155|11977881|FG001|Overall Study|Primary tumour recurrence|1
7580746|NCT02131155|11977880|FG000|Overall Study|Refused to continue study medication|1
7580747|NCT02131155|11977881|FG001|Overall Study|Refused to continue study medication|0
7580748|NCT02131155|11977880|FG000|Overall Study|Study early termination|20
7580749|NCT02131155|11977881|FG001|Overall Study|Study early termination|10
7580750|NCT02117050|11977887|FG000|Overall Study|Subject Enrolled but not Dosed|1
7580751|NCT02105116|11977909|FG000|Overall Study|not eligible for step 2 of trial|5
7580752|NCT02105116|11977909|FG000|Overall Study|Death|1
7580753|NCT02099344|11977926|FG000|Overall Study|Physician Decision|1
7580754|NCT02099344|11977927|FG001|Overall Study|Physician Decision|0
7580755|NCT02096042|11977944|FG000|Overall Study|Disease Progression|1
7580756|NCT02096042|11977945|FG001|Overall Study|Disease Progression|0
7580757|NCT02096042|11977946|FG002|Overall Study|Disease Progression|0
7580758|NCT02088957|11977953|FG000|Overall Study|Lack of Efficacy|1
7580759|NCT02088957|11977954|FG001|Overall Study|Lack of Efficacy|0
7580760|NCT02093689|11977963|FG000|Overall Study|Physician Decision|4
7580761|NCT02093689|11977964|FG001|Overall Study|Physician Decision|0
7580762|NCT02093689|11977965|FG002|Overall Study|Physician Decision|0
7580763|NCT02091752|11977971|FG000|Overall Study|Study terminated by Sponsor|2
7580764|NCT02091752|11977971|FG000|Overall Study|Adverse Event|1
7580765|NCT02068547|11977977|FG000|Overall Study|Lost to Follow-up|3
7580766|NCT02068547|11977978|FG001|Overall Study|Lost to Follow-up|3
7580767|NCT02068547|11977977|FG000|Overall Study|Physician Decision|1
7580768|NCT02068547|11977978|FG001|Overall Study|Physician Decision|0
7580769|NCT02081183|11978016|FG000|Overall Study|Lost to Follow-up|0
7580770|NCT02081183|11978017|FG001|Overall Study|Lost to Follow-up|1
7580771|NCT02081183|11978016|FG000|Overall Study|Protocol Violation|1
7580772|NCT02081183|11978017|FG001|Overall Study|Protocol Violation|0
7580773|NCT02081183|11978016|FG000|Overall Study|Other|3
7580774|NCT02081183|11978017|FG001|Overall Study|Other|3
7580775|NCT02067104|11978037|FG000|Overall Study|Study termination due to low accrual|4
7580776|NCT02067104|11978038|FG001|Overall Study|Study termination due to low accrual|5
7580777|NCT02057874|11978048|FG000|Overall Study|participant did not return for scan|1
7580778|NCT02058537|11978062|FG000|Overall Study|Withdrawal by Subject|1
7580779|NCT02038153|11978075|FG000|Overall Study|Withdrawal by Subject|1
7580780|NCT02054910|11978081|FG000|Overall Study|Lost to Follow-up|4
7580781|NCT02054910|11978082|FG001|Overall Study|Lost to Follow-up|1
7580782|NCT02044302|11978092|FG000|Overall Study|study terminated|2
7580783|NCT02044302|11978093|FG001|Overall Study|study terminated|0
7580784|NCT02046226|11978097|FG000|Overall Study|Lost to Follow-up|7
7580785|NCT02044848|11978104|FG000|Overall Study|Administrative Problems|2
7580786|NCT02044848|11978105|FG001|Overall Study|Administrative Problems|3
7624906|NCT01827384|12036062|FG009|Overall Study|Participant declined to participate (before treatment started)|0
7624907|NCT01827384|12036063|FG010|Overall Study|Participant declined to participate (before treatment started)|0
7624908|NCT01827384|12036064|FG011|Overall Study|Participant declined to participate (before treatment started)|0
7624909|NCT01827384|12036065|FG012|Overall Study|Participant declined to participate (before treatment started)|0
7580787|NCT02042950|11978111|FG000|Overall Study|Progressive Disease|4
7580788|NCT02048904|11978115|FG000|Overall Study|Withdrawal by Subject|7
7580789|NCT02048904|11978115|FG000|Overall Study|Physician Decision|70
7580790|NCT02044822|11978119|FG000|Overall Study|Study Terminated by Sponsor|77
7580791|NCT02044822|11978119|FG000|Overall Study|Investigator's Discretion|10
7580792|NCT02044822|11978119|FG000|Overall Study|Withdrew Consent|3
7580793|NCT02044822|11978119|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
7580794|NCT02044822|11978119|FG000|Overall Study|Lost to Follow-up|1
7580795|NCT02042924|11978123|FG000|Overall Study|Early Death|1
7580796|NCT02017522|11978131|FG000|Overall Study|Withdrawal by Subject|1
7580797|NCT02030015|11978136|FG000|Overall Study|Withdrawal by Subject|3
7580798|NCT02030015|11978136|FG000|Overall Study|Death|13
7580799|NCT02015663|11978142|FG000|Overall Study|unsatisfactory therapeutic effect|1
7580800|NCT02015663|11978143|FG001|Overall Study|unsatisfactory therapeutic effect|0
7580801|NCT02015663|11978142|FG000|Overall Study|Withdrawal by Subject|1
7580802|NCT02015663|11978143|FG001|Overall Study|Withdrawal by Subject|0
7580803|NCT02015663|11978142|FG000|Overall Study|Protocol Violation|0
7580804|NCT02015663|11978143|FG001|Overall Study|Protocol Violation|1
7580805|NCT02015663|11978142|FG000|Overall Study|Adverse Event|3
7580806|NCT02015663|11978143|FG001|Overall Study|Adverse Event|0
7580807|NCT02015663|11978142|FG000|Overall Study|Administrative problems|10
7580808|NCT02015663|11978143|FG001|Overall Study|Administrative problems|11
7580809|NCT02029846|11978152|FG000|Overall Study|n=1 each arm|1
7580810|NCT02029846|11978153|FG001|Overall Study|n=1 each arm|1
7580811|NCT02011542|11978190|FG000|Overall Study|Physician Decision|1
7580812|NCT02008370|11978194|FG000|Overall Study|Lost to Follow-up|7
7580813|NCT02005445|11978215|FG000|Overall Study|Dual study enrollment|0
7580814|NCT02005445|11978216|FG001|Overall Study|Dual study enrollment|1
7580815|NCT02006927|11978235|FG000|Overall Study|Adverse Event|2
7580816|NCT02006927|11978235|FG000|Overall Study|Withdrawal by Subject|1
7580817|NCT01996982|11978239|FG000|Overall Study|PI/team left institution|7
7580818|NCT01986751|11978249|FG000|Overall Study|improperly consented|10
7580819|NCT01986751|11978250|FG001|Overall Study|improperly consented|2
7580820|NCT01977729|11978309|FG000|Overall Study|Study terminated|1
7580821|NCT01982253|11978322|FG000|Overall Study|Withdrawal by Subject|1
7580822|NCT01982253|11978323|FG001|Overall Study|Withdrawal by Subject|0
7580823|NCT01982253|11978324|FG002|Overall Study|Withdrawal by Subject|0
7580824|NCT01982253|11978322|FG000|Overall Study|Study terminated by sponsor|1
7580825|NCT01982253|11978323|FG001|Overall Study|Study terminated by sponsor|4
7580826|NCT01982253|11978324|FG002|Overall Study|Study terminated by sponsor|4
7580827|NCT01984268|11978332|FG000|Overall Study|Study Terminated|15
7580828|NCT01980875|11978352|FG000|Overall Study|Withdrew Consent|1
7580829|NCT01980875|11978353|FG001|Overall Study|Withdrew Consent|1
7580830|NCT01980875|11978354|FG002|Overall Study|Withdrew Consent|1
7580831|NCT01980875|11978352|FG000|Overall Study|Study Terminated by Sponsor|7
7580832|NCT01980875|11978353|FG001|Overall Study|Study Terminated by Sponsor|24
7580833|NCT01980875|11978354|FG002|Overall Study|Study Terminated by Sponsor|22
7580834|NCT01980875|11978352|FG000|Overall Study|Lost to Follow-up|0
7580835|NCT01980875|11978353|FG001|Overall Study|Lost to Follow-up|0
7580836|NCT01980875|11978354|FG002|Overall Study|Lost to Follow-up|1
7580837|NCT01970462|11978400|FG000|Overall Study|Lost to Follow-up|0
7580838|NCT01970462|11978401|FG001|Overall Study|Lost to Follow-up|2
7580839|NCT01969565|11978407|FG000|Overall Study|Withdrawal by Subject|1
7580840|NCT01968226|11978412|FG000|Overall Study|[F-18] RDG-K5 was not available|2
7580841|NCT01962974|11978431|FG000|Overall Study|Study termination|7
7580842|NCT01951378|11978448|FG000|Overall Study|Study Terminated-Not completed|23
7580843|NCT01951378|11978449|FG001|Overall Study|Study Terminated-Not completed|17
7580844|NCT01944059|11978472|FG000|Overall Study|Lost to Follow-up|1
7580845|NCT01944059|11978472|FG000|Overall Study|Physician Decision|3
7580846|NCT01944059|11978472|FG000|Overall Study|Withdrawal by Subject|1
7580847|NCT01944059|11978472|FG000|Overall Study|Adverse Event|2
7580848|NCT01935947|11978480|FG000|Overall Study|Adverse Event|0
7580849|NCT01935947|11978481|FG001|Overall Study|Adverse Event|2
7580850|NCT01935947|11978482|FG002|Overall Study|Adverse Event|0
7580851|NCT01935947|11978480|FG000|Overall Study|Diease Progression|2
7580852|NCT01935947|11978481|FG001|Overall Study|Diease Progression|2
7580853|NCT01935947|11978482|FG002|Overall Study|Diease Progression|2
7580854|NCT01935947|11978480|FG000|Overall Study|Death|1
7580855|NCT01935947|11978481|FG001|Overall Study|Death|0
7580856|NCT01935947|11978482|FG002|Overall Study|Death|0
7580857|NCT01939223|11978495|FG000|Overall Study|AE not assoc. with disease recurrence|1
7580858|NCT01939223|11978496|FG001|Overall Study|AE not assoc. with disease recurrence|1
7580859|NCT01939223|11978495|FG000|Overall Study|Disease recurrence (radiological)|1
7580860|NCT01939223|11978496|FG001|Overall Study|Disease recurrence (radiological)|3
7270082|NCT00413660|11484163|FG003|Post Week 12|Withdrawal by Subject|0
7580861|NCT01939223|11978495|FG000|Overall Study|Study stopped by Sponsor|5
7580862|NCT01939223|11978496|FG001|Overall Study|Study stopped by Sponsor|7
7580863|NCT01939223|11978495|FG000|Overall Study|Withdrawal by Subject|6
7580864|NCT01939223|11978496|FG001|Overall Study|Withdrawal by Subject|0
7580865|NCT01938716|11978502|FG000|Overall Study|Physician Decision|2
7580866|NCT01938716|11978502|FG000|Overall Study|Withdrawal by Subject|2
7580867|NCT01936974|11978508|FG000|Overall Study|Physician Decision|2
7580868|NCT01936974|11978509|FG001|Overall Study|Physician Decision|5
7580869|NCT01934504|11978536|FG000|Overall Study|Protocol Deviation|0
7580870|NCT01934504|11978537|FG001|Overall Study|Protocol Deviation|0
7580871|NCT01934504|11978538|FG002|Overall Study|Protocol Deviation|0
7580872|NCT01934504|11978539|FG003|Overall Study|Protocol Deviation|2
7580873|NCT01934504|11978536|FG000|Overall Study|Study Terminated by Sponsor|1
7580874|NCT01934504|11978537|FG001|Overall Study|Study Terminated by Sponsor|0
7580875|NCT01934504|11978538|FG002|Overall Study|Study Terminated by Sponsor|5
7580876|NCT01934504|11978539|FG003|Overall Study|Study Terminated by Sponsor|5
7580877|NCT01928082|11978549|FG000|Overall Study|Study terminated.|1
7580878|NCT01928615|11978553|FG000|Overall Study|Study Terminated by Sponsor|2
7580879|NCT01911793|11978560|FG000|Overall Study|Physician Decision|1
7580880|NCT01911793|11978561|FG001|Overall Study|Physician Decision|5
7580881|NCT01912404|11978569|FG000|Overall Study|Due to personal reasons|1
7580882|NCT01912404|11978570|FG001|Overall Study|Due to personal reasons|0
7580883|NCT01910389|11978578|FG000|Overall Study|Withdrawal by Subject|2
7580884|NCT01910389|11978579|FG001|Overall Study|Withdrawal by Subject|0
7580885|NCT01910389|11978578|FG000|Overall Study|Study Closed|13
7580886|NCT01910389|11978579|FG001|Overall Study|Study Closed|8
7580887|NCT01913327|11978605|FG000|Overall Study|Withdrawal by Subject|0
7580888|NCT01913327|11978606|FG001|Overall Study|Withdrawal by Subject|1
7580889|NCT01902888|11978612|FG000|Overall Study|Study Terminated|3
7580890|NCT01901224|11978616|FG000|Overall Study|study was not funded and terminated|2
7580891|NCT01910441|11978622|FG000|Overall Study|Sponsor decision|0
7580892|NCT01910441|11978623|FG001|Overall Study|Sponsor decision|2
7580893|NCT01910441|11978622|FG000|Overall Study|Lost to Follow-up|6
7580894|NCT01910441|11978623|FG001|Overall Study|Lost to Follow-up|5
7580895|NCT01910441|11978622|FG000|Overall Study|Withdrawal by Subject|0
7580896|NCT01910441|11978623|FG001|Overall Study|Withdrawal by Subject|1
7580897|NCT01910441|11978622|FG000|Overall Study|Non-compliance|0
7580898|NCT01910441|11978623|FG001|Overall Study|Non-compliance|1
7580899|NCT01910441|11978622|FG000|Overall Study|Adverse Event|1
7580900|NCT01910441|11978623|FG001|Overall Study|Adverse Event|0
7580901|NCT01910441|11978622|FG000|Overall Study|Physician Decision|0
7580902|NCT01910441|11978623|FG001|Overall Study|Physician Decision|1
7580903|NCT01902966|11978629|FG000|Overall Study|Death|1
7580904|NCT01902966|11978629|FG000|Overall Study|Physician Decision|1
7580905|NCT01902966|11978629|FG000|Overall Study|Withdrawal by Subject|1
7580906|NCT01900730|11978644|FG000|Overall Study|Withdrawal by Subject|1
7580907|NCT01900730|11978645|FG001|Overall Study|Withdrawal by Subject|0
7580908|NCT01900730|11978644|FG000|Overall Study|Screen Failure|1
7580909|NCT01900730|11978645|FG001|Overall Study|Screen Failure|0
7580910|NCT01900626|11978673|FG000|Overall Study|study was closed due to low enrollment|1
7580911|NCT01900626|11978674|FG001|Overall Study|study was closed due to low enrollment|1
7580912|NCT01884077|11978696|FG000|Overall Study|screen fail|0
7580913|NCT01884077|11978697|FG001|Overall Study|screen fail|2
7580914|NCT01884077|11978696|FG000|Overall Study|canceled surgery|2
7580915|NCT01884077|11978697|FG001|Overall Study|canceled surgery|0
7580916|NCT01884077|11978696|FG000|Overall Study|Lost to Follow-up|0
7580917|NCT01884077|11978697|FG001|Overall Study|Lost to Follow-up|4
7580918|NCT01884077|11978696|FG000|Overall Study|study closed|6
7580919|NCT01884077|11978697|FG001|Overall Study|study closed|4
7580920|NCT01887288|11978729|FG000|Overall Study|The study was terminated and the PI has|16
7580921|NCT01861717|11978772|FG000|Overall Study|Lost to Follow-up|1
7580922|NCT01861717|11978772|FG000|Overall Study|Withdrawal by Subject|1
7580923|NCT01866709|11978779|FG000|Overall Study|Adverse Event|1
7580924|NCT01866709|11978780|FG001|Overall Study|Adverse Event|0
7580925|NCT01860040|11978788|FG000|Overall Study|Withdrawal by Subject|1
7580926|NCT01860040|11978789|FG001|Overall Study|Withdrawal by Subject|0
7580927|NCT01856322|11978834|FG000|Overall Study|off study due to lack of accrual|0
7580928|NCT01856322|11978835|FG001|Overall Study|off study due to lack of accrual|0
7580929|NCT01856322|11978836|FG002|Overall Study|off study due to lack of accrual|3
7580930|NCT01853176|11978845|FG000|Overall Study|Study terminated|4
7580931|NCT01853176|11978846|FG001|Overall Study|Study terminated|0
7580932|NCT01857271|11978852|FG000|Overall Study|Lost to Follow-up|1
7580933|NCT01853982|11978867|FG000|Overall Study|Withdrawal by Subject|1
7580934|NCT01853982|11978868|FG001|Overall Study|Withdrawal by Subject|0
7580935|NCT01853982|11978867|FG000|Overall Study|Death|1
7580936|NCT01853982|11978868|FG001|Overall Study|Death|0
7580937|NCT01853982|11978867|FG000|Overall Study|Lost to Follow-up|0
7580938|NCT01853982|11978868|FG001|Overall Study|Lost to Follow-up|1
7624910|NCT01827384|12036066|FG013|Overall Study|Participant declined to participate (before treatment started)|15
7624911|NCT01636258|12036102|FG000|Overall Study|Lost to Follow-up|1
7624912|NCT01636258|12036103|FG001|Overall Study|Lost to Follow-up|0
7624913|NCT01517802|12036164|FG000|Overall Study|Death|1
7624914|NCT00455325|12036168|FG000|Cohort 1: Placebo|Started exclusionary drug|1
7624915|NCT00455325|12036169|FG001|Cohort 1: Placebo|Started exclusionary drug|0
7624916|NCT00455325|12036170|FG002|Cohort 1: Placebo|Started exclusionary drug|0
7624917|NCT00455325|12036171|FG003|Cohort 1: Placebo|Started exclusionary drug|0
7624918|NCT00455325|12036168|FG000|Cohort 1: Placebo|Withdrawal by Subject|4
7624919|NCT00455325|12036169|FG001|Cohort 1: Placebo|Withdrawal by Subject|0
7624920|NCT00455325|12036170|FG002|Cohort 1: Placebo|Withdrawal by Subject|0
7624921|NCT00455325|12036171|FG003|Cohort 1: Placebo|Withdrawal by Subject|0
7624922|NCT00455325|12036168|FG000|Cohort 1: Placebo|Lost to Follow-up|1
7580940|NCT01821963|11978912|FG000|Overall Study|Adverse Event|1
7580941|NCT01821898|11978918|FG000|Overall Study|Withdrawal by Subject|2
7580942|NCT01821898|11978919|FG001|Overall Study|Withdrawal by Subject|1
7580943|NCT01829477|11978950|FG000|Overall Study|Study Terminated by Sponsor|15
7580944|NCT01829477|11978951|FG001|Overall Study|Study Terminated by Sponsor|15
7580945|NCT01829477|11978950|FG000|Overall Study|Withdrawal by Subject|1
7580946|NCT01829477|11978951|FG001|Overall Study|Withdrawal by Subject|0
7580947|NCT01803711|11978959|FG000|Overall Study|Adverse Event|1
7580948|NCT01803711|11978960|FG001|Overall Study|Adverse Event|1
7580949|NCT01806051|11978988|FG000|Overall Study|Withdrawal by Subject|6
7580950|NCT01810302|11979015|FG000|Overall Study|Death|1
7580951|NCT01810302|11979016|FG001|Overall Study|Death|0
7580952|NCT01810302|11979015|FG000|Overall Study|Physician Decision|0
7580953|NCT01810302|11979016|FG001|Overall Study|Physician Decision|1
7580954|NCT01806961|11979022|FG000|Overall Study|sponsor decision|16
7580955|NCT01783015|11979032|FG000|Blinded Treatment|Adverse Event|0
7580956|NCT01783015|11979033|FG001|Blinded Treatment|Adverse Event|1
7580957|NCT01783015|11979034|FG002|Blinded Treatment|Adverse Event|0
7580958|NCT01783015|11979032|FG000|Blinded Treatment|Protocol Violation|0
7580959|NCT01783015|11979033|FG001|Blinded Treatment|Protocol Violation|1
7580960|NCT01783015|11979034|FG002|Blinded Treatment|Protocol Violation|0
7580961|NCT01783015|11979032|FG000|Blinded Treatment|Withdrawal by Subject|0
7580962|NCT01783015|11979033|FG001|Blinded Treatment|Withdrawal by Subject|1
7580963|NCT01783015|11979034|FG002|Blinded Treatment|Withdrawal by Subject|0
7580964|NCT01783015|11979032|FG000|Blinded Treatment|Study Terminated by Sponsor|2
7580965|NCT01783015|11979033|FG001|Blinded Treatment|Study Terminated by Sponsor|0
7580966|NCT01783015|11979034|FG002|Blinded Treatment|Study Terminated by Sponsor|0
7580967|NCT01783015|11979032|FG000|Open Label Treatment|Study Terminated by Sponsor|0
7580968|NCT01783015|11979033|FG001|Open Label Treatment|Study Terminated by Sponsor|0
7580969|NCT01783015|11979034|FG002|Open Label Treatment|Study Terminated by Sponsor|6
7580970|NCT01781026|11979068|FG000|Overall Study|Lack of Efficacy|2
7580971|NCT01777854|11979094|FG000|Overall Study|Physician Decision|3
7580972|NCT01777854|11979095|FG001|Overall Study|Physician Decision|3
7580973|NCT01772719|11979103|FG000|Overall Study|Withdrawal by Subject|3
7580974|NCT01772719|11979103|FG000|Overall Study|Adverse Event|2
7580975|NCT01772719|11979103|FG000|Overall Study|Protocol Violation|1
7580976|NCT01772719|11979103|FG000|Overall Study|Lost to Follow-up|1
7580977|NCT01764997|11979115|FG000|Run-in Period|Adverse Event|15
7580978|NCT01764997|11979116|FG001|Run-in Period|Adverse Event|0
7580979|NCT01764997|11979117|FG002|Run-in Period|Adverse Event|0
7580980|NCT01764997|11979118|FG003|Run-in Period|Adverse Event|0
7580981|NCT01764997|11979119|FG004|Run-in Period|Adverse Event|0
7580982|NCT01764997|11979115|FG000|Run-in Period|Lack of Efficacy|5
7580983|NCT01764997|11979116|FG001|Run-in Period|Lack of Efficacy|0
7580984|NCT01764997|11979117|FG002|Run-in Period|Lack of Efficacy|0
7580985|NCT01764997|11979118|FG003|Run-in Period|Lack of Efficacy|0
7580986|NCT01764997|11979119|FG004|Run-in Period|Lack of Efficacy|0
7580987|NCT01764997|11979115|FG000|Run-in Period|Poor compliance to protocol|1
7580988|NCT01764997|11979116|FG001|Run-in Period|Poor compliance to protocol|0
7580989|NCT01764997|11979117|FG002|Run-in Period|Poor compliance to protocol|0
7580990|NCT01764997|11979118|FG003|Run-in Period|Poor compliance to protocol|0
7580991|NCT01764997|11979119|FG004|Run-in Period|Poor compliance to protocol|0
7580992|NCT01764997|11979115|FG000|Run-in Period|Other than specified above|17
7580993|NCT01764997|11979116|FG001|Run-in Period|Other than specified above|0
7580994|NCT01764997|11979117|FG002|Run-in Period|Other than specified above|0
7580995|NCT01764997|11979118|FG003|Run-in Period|Other than specified above|0
7580996|NCT01764997|11979119|FG004|Run-in Period|Other than specified above|0
7580997|NCT01764997|11979115|FG000|Study Drug Treatment Period|Adverse Event|0
7580998|NCT01764997|11979116|FG001|Study Drug Treatment Period|Adverse Event|1
7580999|NCT01764997|11979117|FG002|Study Drug Treatment Period|Adverse Event|0
7581000|NCT01764997|11979118|FG003|Study Drug Treatment Period|Adverse Event|0
7581001|NCT01764997|11979119|FG004|Study Drug Treatment Period|Adverse Event|24
7581002|NCT01764997|11979115|FG000|Study Drug Treatment Period|Lack of Efficacy|0
7581003|NCT01764997|11979116|FG001|Study Drug Treatment Period|Lack of Efficacy|0
7581004|NCT01764997|11979117|FG002|Study Drug Treatment Period|Lack of Efficacy|0
7581005|NCT01764997|11979118|FG003|Study Drug Treatment Period|Lack of Efficacy|0
7581006|NCT01764997|11979119|FG004|Study Drug Treatment Period|Lack of Efficacy|2
7581007|NCT01764997|11979115|FG000|Study Drug Treatment Period|Other than specified above|0
7581008|NCT01764997|11979116|FG001|Study Drug Treatment Period|Other than specified above|0
7581009|NCT01764997|11979117|FG002|Study Drug Treatment Period|Other than specified above|0
7581010|NCT01764997|11979118|FG003|Study Drug Treatment Period|Other than specified above|0
7581011|NCT01764997|11979119|FG004|Study Drug Treatment Period|Other than specified above|10
7581012|NCT01769443|11979135|FG000|Overall Study|Study closure|1
7581013|NCT01769443|11979136|FG001|Overall Study|Study closure|0
7581014|NCT01749826|11979158|FG000|Overall Study|Study Terminated|20
7581015|NCT01749826|11979159|FG001|Overall Study|Study Terminated|0
7581016|NCT01752023|11979220|FG000|Overall Study|Physician Decision|2
7581017|NCT01752023|11979221|FG001|Overall Study|Physician Decision|1
7581018|NCT01740154|11979231|FG000|Overall Study|Adverse Event|1
7581019|NCT01748890|11979235|FG000|Overall Study|Insufficient recruitment for analysis|4
7581020|NCT01748162|11979241|FG000|Overall Study|no additional croup episodes to evaluate|2
7581021|NCT01748162|11979242|FG001|Overall Study|no additional croup episodes to evaluate|2
7581022|NCT01748162|11979241|FG000|Overall Study|participant consented but did not begin|0
7581023|NCT01748162|11979242|FG001|Overall Study|participant consented but did not begin|1
7581024|NCT01748162|11979241|FG000|Overall Study|reasons not available|3
7581025|NCT01748162|11979242|FG001|Overall Study|reasons not available|2
7581026|NCT01732926|11979267|FG000|Overall Study|Study Terminated by Sponsor|168
7581027|NCT01732926|11979268|FG001|Overall Study|Study Terminated by Sponsor|80
7581028|NCT01732926|11979267|FG000|Overall Study|Withdrawal by Subject|46
7581029|NCT01732926|11979268|FG001|Overall Study|Withdrawal by Subject|8
7581030|NCT01732926|11979267|FG000|Overall Study|Physician Decision|24
7581031|NCT01732926|11979268|FG001|Overall Study|Physician Decision|11
7581032|NCT01732926|11979267|FG000|Overall Study|Other Reason|21
7581033|NCT01732926|11979268|FG001|Overall Study|Other Reason|4
7581034|NCT01732926|11979267|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
7581035|NCT01732926|11979268|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
7581036|NCT01732926|11979267|FG000|Overall Study|Blind Broken by Subject or Study Site|1
7581037|NCT01732926|11979268|FG001|Overall Study|Blind Broken by Subject or Study Site|1
7581038|NCT01732913|11979285|FG000|Overall Study|Study Terminated by Sponsor|105
7581039|NCT01732913|11979286|FG001|Overall Study|Study Terminated by Sponsor|55
7581040|NCT01732913|11979285|FG000|Overall Study|Withdrawal by Subject|27
7581041|NCT01732913|11979286|FG001|Overall Study|Withdrawal by Subject|4
7581042|NCT01732913|11979285|FG000|Overall Study|Physician Decision|14
7581043|NCT01732913|11979286|FG001|Overall Study|Physician Decision|7
7581044|NCT01732913|11979285|FG000|Overall Study|Other|7
7581045|NCT01732913|11979286|FG001|Overall Study|Other|1
7581046|NCT01732913|11979285|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
7581047|NCT01732913|11979286|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
7581048|NCT01716052|11979298|FG000|Overall Study|Withdrawal of funding|1
7581049|NCT01716052|11979299|FG001|Overall Study|Withdrawal of funding|1
7581050|NCT01712854|11979314|FG000|Overall Study|Physician Decision|1
7581051|NCT01708057|11979341|FG000|Overall Study|Withdrawal due to study termination.|1
7581052|NCT01708057|11979342|FG001|Overall Study|Withdrawal due to study termination.|1
7581053|NCT01708057|11979343|FG002|Overall Study|Withdrawal due to study termination.|1
7581054|NCT01693367|11979363|FG000|Overall Study|Withdrawal by Subject|1
7581055|NCT01693367|11979364|FG001|Overall Study|Withdrawal by Subject|1
7581056|NCT01693367|11979363|FG000|Overall Study|Physician Decision|0
7581057|NCT01693367|11979364|FG001|Overall Study|Physician Decision|1
7581058|NCT01697800|11979385|FG000|Overall Study|Death|0
7581059|NCT01697800|11979386|FG001|Overall Study|Death|1
7581060|NCT01700348|11979392|FG000|Overall Study|Withdrawal by Subject|22
7581061|NCT01700348|11979392|FG000|Overall Study|Lost to Follow-up|1
7581062|NCT01689974|11979437|FG000|Overall Study|Termination of Study|5
7581063|NCT01689974|11979438|FG001|Overall Study|Termination of Study|5
7581064|NCT01676961|11979444|FG000|Overall Study|Death|3
7581065|NCT01676961|11979444|FG000|Overall Study|Lost to Follow-up|1
7581066|NCT01676961|11979444|FG000|Overall Study|Withdrawal by Subject|1
7581067|NCT01675011|11979512|FG000|Overall Study|Trial terminated by Sponsor|3
7581068|NCT01675011|11979513|FG001|Overall Study|Trial terminated by Sponsor|1
7581069|NCT01668147|11979541|FG000|Overall Study|Withdrawal by Subject|6
7581070|NCT01676701|11979551|FG000|Overall Study|Protocol Violation|1
7581071|NCT01676701|11979552|FG001|Overall Study|Protocol Violation|0
7581072|NCT01676701|11979551|FG000|Overall Study|Sponsor Decision|3
7581073|NCT01676701|11979552|FG001|Overall Study|Sponsor Decision|4
7581074|NCT01662102|11979567|FG000|Overall Study|Sponsor's decision|1
7581075|NCT01662102|11979568|FG001|Overall Study|Sponsor's decision|0
7581076|NCT01659554|11979575|FG000|Overall Study|Study Termination|4
7581077|NCT01658813|11979579|FG000|Overall Study|Disease progression|3
7581078|NCT01642732|11979607|FG000|Overall Study|Withdrawal by Subject|1
7581079|NCT01648270|11979620|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
7581080|NCT01641601|11979636|FG000|Overall Study|Study discontinued.|3
7581081|NCT01641601|11979637|FG001|Overall Study|Study discontinued.|5
7581082|NCT01627899|11979665|FG000|Overall Study|Study terminated early by sponsor.|5
7581083|NCT01632020|11979671|FG000|Overall Study|Withdrawal by Subject|1
7581084|NCT01632020|11979672|FG001|Overall Study|Withdrawal by Subject|0
7581085|NCT01632020|11979671|FG000|Overall Study|Adverse Event|1
7581086|NCT01632020|11979672|FG001|Overall Study|Adverse Event|0
7581087|NCT01619800|11979684|FG000|Overall Study|study terminated|2
7581088|NCT01619800|11979685|FG001|Overall Study|study terminated|0
7581089|NCT01614067|11979702|FG000|Overall Study|Pregnancy|1
7581090|NCT01614067|11979703|FG001|Overall Study|Pregnancy|0
7581091|NCT01614067|11979702|FG000|Overall Study|Physician Decision|6
7581092|NCT01614067|11979703|FG001|Overall Study|Physician Decision|5
7581093|NCT01614067|11979702|FG000|Overall Study|Withdrawal by Subject|0
7581094|NCT01614067|11979703|FG001|Overall Study|Withdrawal by Subject|1
7581095|NCT01614067|11979702|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
7581096|NCT01614067|11979703|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
7581097|NCT01605019|11979716|FG000|Overall Study|pt did not meet transplant endpoint|3
7581098|NCT01605019|11979717|FG001|Overall Study|pt did not meet transplant endpoint|0
7624923|NCT00455325|12036169|FG001|Cohort 1: Placebo|Lost to Follow-up|0
7624924|NCT00455325|12036170|FG002|Cohort 1: Placebo|Lost to Follow-up|0
7624925|NCT00455325|12036171|FG003|Cohort 1: Placebo|Lost to Follow-up|0
7581099|NCT01609231|11979725|FG000|Overall Study|Adverse Event|1
7581100|NCT01609231|11979726|FG001|Overall Study|Adverse Event|3
7581101|NCT01609231|11979725|FG000|Overall Study|Physician Decision|1
7581102|NCT01609231|11979726|FG001|Overall Study|Physician Decision|0
7581103|NCT01609231|11979725|FG000|Overall Study|Withdrawal by Subject|1
7581104|NCT01609231|11979726|FG001|Overall Study|Withdrawal by Subject|0
7581105|NCT01603043|11979752|FG000|Overall Study|Study Futility|7
7581106|NCT01603043|11979753|FG001|Overall Study|Study Futility|3
7581107|NCT01605370|11979761|FG000|Overall Study|Adverse Event|1
7581108|NCT01605370|11979762|FG001|Overall Study|Adverse Event|0
7581109|NCT01605617|11979770|FG000|First Intervention|Adverse Event|0
7581110|NCT01605617|11979771|FG001|First Intervention|Adverse Event|1
7581111|NCT01605617|11979770|FG000|Washout Period of 4 Weeks|Study Terminated|2
7581112|NCT01605617|11979771|FG001|Washout Period of 4 Weeks|Study Terminated|1
7581113|NCT01603121|11979788|FG000|Second Intervention, 10 Hours|Adverse Event|1
7581114|NCT01603121|11979789|FG001|Second Intervention, 10 Hours|Adverse Event|0
7581115|NCT01603394|11979802|FG000|Overall Study|Adverse Event|1
7581116|NCT01592383|11979806|FG000|Overall Study|Adverse Event|1
7581117|NCT01591096|11979828|FG000|Overall Study|Adverse Event|1
7581118|NCT01576575|11979845|FG000|Buprenorphine Control|Withdrawal by Subject|3
7581119|NCT01576575|11979845|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
7581120|NCT01576575|11979845|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
7581121|NCT01582100|11979869|FG000|Overall Study|Adverse Event|1
7581122|NCT01582100|11979869|FG000|Overall Study|Withdrawal by Subject|1
7581123|NCT01575028|11979882|FG000|Overall Study|Physician Decision|0
7581124|NCT01575028|11979883|FG001|Overall Study|Physician Decision|1
7581125|NCT01578785|11979891|FG000|Overall Study|Withdrawal by Subject|0
7581126|NCT01578785|11979892|FG001|Overall Study|Withdrawal by Subject|1
7581127|NCT01578785|11979891|FG000|Overall Study|Study terminated by sponsor|59
7581128|NCT01578785|11979892|FG001|Overall Study|Study terminated by sponsor|118
7581129|NCT01576549|11979898|FG000|Overall Study|Sponsor Decision|2
7581130|NCT01561989|11979918|FG000|Overall Study|accural target not met.|5
7581131|NCT01561989|11979919|FG001|Overall Study|accural target not met.|6
7581132|NCT01564732|11979927|FG000|Overall Study|Early termination by the study sponsor|6
7581133|NCT01564732|11979928|FG001|Overall Study|Early termination by the study sponsor|5
7581134|NCT01560507|11979937|FG000|Overall Study|Lost to Follow-up|3
7581135|NCT01560507|11979938|FG001|Overall Study|Lost to Follow-up|1
7581136|NCT01560507|11979939|FG002|Overall Study|Lost to Follow-up|2
7581137|NCT01560507|11979937|FG000|Overall Study|Withdrawal by Subject|1
7581138|NCT01560507|11979938|FG001|Overall Study|Withdrawal by Subject|1
7581139|NCT01560507|11979939|FG002|Overall Study|Withdrawal by Subject|0
7581140|NCT01555073|11979983|FG000|Overall Study|Lost to Follow-up|1
7581141|NCT01555073|11979984|FG001|Overall Study|Lost to Follow-up|2
7581142|NCT01555073|11979985|FG002|Overall Study|Lost to Follow-up|0
7581143|NCT01555073|11979986|FG003|Overall Study|Lost to Follow-up|5
7581144|NCT01541397|11980021|FG000|Overall Study|Study ended prior to data collection|4
7581145|NCT01541397|11980022|FG001|Overall Study|Study ended prior to data collection|2
7581146|NCT01546207|11980028|FG000|Overall Study|Death|1
7581147|NCT01547728|11980036|FG000|Overall Study|Change in procedure and equipment|1
7581148|NCT01547728|11980036|FG000|Overall Study|Drug not ready for subject|1
7581149|NCT01547728|11980036|FG000|Overall Study|Screen failure|39
7581150|NCT01546883|11980053|FG000|Overall Study|Withdrawal by Subject|3
7581151|NCT01546883|11980053|FG000|Overall Study|Adverse Event|4
7581152|NCT01546883|11980053|FG000|Overall Study|Lost to Follow-up|2
7581153|NCT01546883|11980053|FG000|Overall Study|early closure of study|2
7581154|NCT01546883|11980053|FG000|Overall Study|other unrelated illness|1
7581155|NCT01536015|11980063|FG000|Overall Study|Adverse Event|1
7581156|NCT01536015|11980064|FG001|Overall Study|Adverse Event|4
7581157|NCT01536015|11980063|FG000|Overall Study|Lost to Follow-up|0
7581158|NCT01536015|11980064|FG001|Overall Study|Lost to Follow-up|1
7581159|NCT01536015|11980063|FG000|Overall Study|Inclusion Criterion not met|2
7581160|NCT01536015|11980064|FG001|Overall Study|Inclusion Criterion not met|0
7581161|NCT01536015|11980063|FG000|Overall Study|Study closure|5
7581162|NCT01536015|11980064|FG001|Overall Study|Study closure|5
7581163|NCT01534676|11980090|FG000|Overall Study|Study closed due to poor enrollment|2
7581164|NCT01534676|11980091|FG001|Overall Study|Study closed due to poor enrollment|1
7581165|NCT01530087|11980115|FG000|Overall Study|Physician Decision|2
7581166|NCT01531387|11980152|FG000|Overall Study|Early termination of study|11
7581167|NCT01531387|11980153|FG001|Overall Study|Early termination of study|11
7581168|NCT01527292|11980172|FG000|Overall Study|Physician Decision|0
7581169|NCT01527292|11980173|FG001|Overall Study|Physician Decision|3
7581170|NCT01528696|11980192|FG000|Overall Study|See detailed description|18
7581171|NCT01528696|11980193|FG001|Overall Study|See detailed description|19
7581172|NCT01520714|11980227|FG000|Overall Study|Protocol Violation|0
7581173|NCT01520714|11980228|FG001|Overall Study|Protocol Violation|3
7581174|NCT01520714|11980227|FG000|Overall Study|Adverse Event|0
7581175|NCT01520714|11980228|FG001|Overall Study|Adverse Event|2
7581176|NCT01520714|11980227|FG000|Overall Study|Lack of Efficacy|0
7581177|NCT01520714|11980228|FG001|Overall Study|Lack of Efficacy|1
7581178|NCT01516034|11980243|FG000|Overall Study|Physician Decision|1
7581179|NCT01516034|11980243|FG000|Overall Study|Lack of Efficacy|7
7581180|NCT01510756|11980268|FG000|Overall Study|Death|1
7581181|NCT01510756|11980268|FG000|Overall Study|Lack of Efficacy|2
7581182|NCT01510756|11980268|FG000|Overall Study|Physician Decision|1
7581183|NCT01509053|11980294|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
7581184|NCT01509053|11980294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
7581185|NCT01509053|11980294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
7581186|NCT01509053|11980294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
7581187|NCT01509053|11980294|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
7581188|NCT01509053|11980294|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
7581189|NCT01478113|11980343|FG000|Overall Study|Withdrawal by Subject|0
7581190|NCT01478113|11980344|FG001|Overall Study|Withdrawal by Subject|1
7581191|NCT01478113|11980343|FG000|Overall Study|Physician Decision|1
7581192|NCT01478113|11980344|FG001|Overall Study|Physician Decision|0
7581193|NCT01482598|11980362|FG000|Overall Study|Death|7
7581194|NCT01482598|11980363|FG001|Overall Study|Death|10
7581195|NCT01482598|11980362|FG000|Overall Study|Physician Decision|0
7581196|NCT01482598|11980363|FG001|Overall Study|Physician Decision|3
7581197|NCT01482598|11980362|FG000|Overall Study|Withdrawal by Subject|4
7581198|NCT01482598|11980363|FG001|Overall Study|Withdrawal by Subject|5
7581199|NCT01482598|11980362|FG000|Overall Study|Lost to Follow-up|5
7581200|NCT01482598|11980363|FG001|Overall Study|Lost to Follow-up|4
7581201|NCT01473732|11980383|FG000|Overall Study|Adverse Event|1
7581202|NCT01473732|11980384|FG001|Overall Study|Adverse Event|0
7581203|NCT01473732|11980383|FG000|Overall Study|Death|1
7581204|NCT01473732|11980384|FG001|Overall Study|Death|0
7581205|NCT01465230|11980399|FG000|Overall Study|Withdrawal by Subject|2
7581206|NCT01463293|11980421|FG000|Overall Study|Lost to Follow-up|1
7581207|NCT01463293|11980422|FG001|Overall Study|Lost to Follow-up|4
7581208|NCT01463293|11980423|FG002|Overall Study|Lost to Follow-up|5
7581209|NCT01463293|11980421|FG000|Overall Study|Adverse Event|1
7581210|NCT01463293|11980422|FG001|Overall Study|Adverse Event|2
7581211|NCT01463293|11980423|FG002|Overall Study|Adverse Event|0
7581212|NCT01463293|11980421|FG000|Overall Study|Withdrawal by Subject|4
7581213|NCT01463293|11980422|FG001|Overall Study|Withdrawal by Subject|10
7581214|NCT01463293|11980423|FG002|Overall Study|Withdrawal by Subject|5
7581215|NCT01463293|11980421|FG000|Overall Study|Other|0
7581216|NCT01463293|11980422|FG001|Overall Study|Other|0
7581217|NCT01463293|11980423|FG002|Overall Study|Other|2
7581218|NCT01457053|11980431|FG000|Overall Study|Unable to undergo selected treatment|1
7581219|NCT01457053|11980432|FG001|Overall Study|Unable to undergo selected treatment|1
7581220|NCT01451723|11980440|FG000|Overall Study|study halted|6
7581221|NCT01451723|11980441|FG001|Overall Study|study halted|5
7581222|NCT01440517|11980447|FG000|Overall Study|Subject withdrawn prior to dosing|1
7581223|NCT01440595|11980453|FG000|Overall Study|Lost to Follow-up|0
7581224|NCT01440595|11980454|FG001|Overall Study|Lost to Follow-up|1
7581225|NCT01440595|11980455|FG002|Overall Study|Lost to Follow-up|0
7581226|NCT01440595|11980453|FG000|Overall Study|Study terminated by sponsor.|1
7581227|NCT01440595|11980454|FG001|Overall Study|Study terminated by sponsor.|2
7581228|NCT01440595|11980455|FG002|Overall Study|Study terminated by sponsor.|1
7581229|NCT01446796|11980461|FG000|Overall Study|Withdrawal by Subject|1
7581230|NCT01446796|11980462|FG001|Overall Study|Withdrawal by Subject|0
7581231|NCT01443923|11980472|FG000|Overall Study|Adverse Event|1
7581232|NCT01443923|11980473|FG001|Overall Study|Adverse Event|0
7624926|NCT00455325|12036168|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1
7624927|NCT00455325|12036169|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624928|NCT00455325|12036170|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624929|NCT00455325|12036171|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0
7624930|NCT00455325|12036168|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1
7624931|NCT00455325|12036169|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624932|NCT00455325|12036170|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624933|NCT00455325|12036171|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0
7624934|NCT00455325|12036168|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624935|NCT00455325|12036169|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1
7624936|NCT00455325|12036170|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624937|NCT00455325|12036171|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0
7624938|NCT00455325|12036168|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624939|NCT00455325|12036169|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624940|NCT00455325|12036170|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1
7624941|NCT00455325|12036171|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0
7624942|NCT00321555|12036182|FG000|Overall Study|Developed antibodies|1
7624943|NCT00321555|12036182|FG000|Overall Study|Switched to alternative treatment|3
7624944|NCT00321555|12036182|FG000|Overall Study|Physician Decision|1
7624945|NCT00321555|12036182|FG000|Overall Study|Disease progression on study|1
7270083|NCT00413660|11484164|FG004|Post Week 12|Withdrawal by Subject|1
7581233|NCT01439347|11980481|FG000|Overall Study|Death|10
7581234|NCT01439347|11980482|FG001|Overall Study|Death|9
7581235|NCT01439347|11980481|FG000|Overall Study|Withdrawal by Subject|0
7581236|NCT01439347|11980482|FG001|Overall Study|Withdrawal by Subject|1
7581237|NCT01439347|11980481|FG000|Overall Study|Physician Decision|1
7581238|NCT01439347|11980482|FG001|Overall Study|Physician Decision|0
7581239|NCT01439347|11980481|FG000|Overall Study|Sponsor Terminated Study|2
7581240|NCT01439347|11980482|FG001|Overall Study|Sponsor Terminated Study|3
7581241|NCT01433471|11980507|FG000|Overall Study|Withdrawal by Subject|0
7581242|NCT01433471|11980508|FG001|Overall Study|Withdrawal by Subject|1
7581243|NCT01436084|11980516|FG000|Overall Study|Disease Progression|2
7581244|NCT01436084|11980516|FG000|Overall Study|Withdrawal by Subject|1
7581245|NCT01436084|11980516|FG000|Overall Study|Early Closure of Study|1
7581246|NCT01415986|11980544|FG000|Overall Study|Lost to Follow-up|1
7581247|NCT01410799|11980549|FG000|Overall Study|PI decision|13
7581248|NCT01426113|11980555|FG000|Overall Study|Study Discontinued|1
7581249|NCT01426113|11980556|FG001|Overall Study|Study Discontinued|1
7581250|NCT01426113|11980555|FG000|Overall Study|Adverse Event|0
7581251|NCT01426113|11980556|FG001|Overall Study|Adverse Event|1
7581252|NCT01420965|11980574|FG000|Overall Study|Withdrawal by Subject|1
7581253|NCT01420965|11980575|FG001|Overall Study|Withdrawal by Subject|0
7581254|NCT01420965|11980576|FG002|Overall Study|Withdrawal by Subject|0
7581255|NCT01420965|11980574|FG000|Overall Study|Adverse Event|0
7581256|NCT01420965|11980575|FG001|Overall Study|Adverse Event|1
7581257|NCT01420965|11980576|FG002|Overall Study|Adverse Event|0
7581258|NCT01417377|11980584|FG000|Overall Study|Lost to Follow-up|12
7581259|NCT01417377|11980584|FG000|Overall Study|Enrolled, but not treated|1
7581260|NCT01416272|11980588|FG000|Overall Study|Unacceptable distance visual acuity|2
7581261|NCT01416272|11980588|FG000|Overall Study|Lost to Follow-up|1
7581262|NCT01416272|11980588|FG000|Overall Study|Study related complaints|1
7581263|NCT01414166|11980594|FG000|Overall Study|Adverse Event|10
7581264|NCT01414166|11980595|FG001|Overall Study|Adverse Event|2
7581265|NCT01414166|11980594|FG000|Overall Study|Lost to Follow-up|4
7581266|NCT01414166|11980595|FG001|Overall Study|Lost to Follow-up|1
7581267|NCT01414166|11980594|FG000|Overall Study|Non-compliance with study drug|2
7581268|NCT01414166|11980595|FG001|Overall Study|Non-compliance with study drug|0
7581269|NCT01414166|11980594|FG000|Overall Study|Physician Decision|2
7581270|NCT01414166|11980595|FG001|Overall Study|Physician Decision|0
7581271|NCT01414166|11980594|FG000|Overall Study|Protocol Violation|2
7581272|NCT01414166|11980595|FG001|Overall Study|Protocol Violation|0
7581273|NCT01414166|11980594|FG000|Overall Study|Study terminated by Sponsor|68
7581274|NCT01414166|11980595|FG001|Overall Study|Study terminated by Sponsor|75
7581275|NCT01414166|11980594|FG000|Overall Study|Withdrawal by Subject|3
7581276|NCT01414166|11980595|FG001|Overall Study|Withdrawal by Subject|5
7581277|NCT01409031|11980622|FG000|Overall Study|transferred to other hosp|1
7581278|NCT01409031|11980623|FG001|Overall Study|transferred to other hosp|0
7581279|NCT01403194|11980646|FG000|Overall Study|Screen Failure|2
7581280|NCT01403194|11980646|FG000|Overall Study|Lost to Follow-up|8
7581281|NCT01397552|11980652|FG000|Overall Study|Adverse Event|1
7581282|NCT01397552|11980653|FG001|Overall Study|Adverse Event|0
7581283|NCT01397552|11980652|FG000|Overall Study|Withdrawal by Subject|2
7581284|NCT01397552|11980653|FG001|Overall Study|Withdrawal by Subject|1
7581285|NCT01392170|11980659|FG000|Overall Study|Withdrawal by Subject|1
7581286|NCT01392170|11980659|FG000|Overall Study|Ineligible|1
7581287|NCT01389817|11980665|FG000|Overall Study|Physician Decision|1
7581288|NCT01389817|11980666|FG001|Overall Study|Physician Decision|0
7581289|NCT01389817|11980665|FG000|Overall Study|Lost to Follow-up|1
7581290|NCT01389817|11980666|FG001|Overall Study|Lost to Follow-up|0
7581291|NCT01389817|11980665|FG000|Overall Study|Withdrawal by Subject|2
7581292|NCT01389817|11980666|FG001|Overall Study|Withdrawal by Subject|0
7581293|NCT01390181|11980676|FG000|Overall Study|Lost to Follow-up|1
7581294|NCT01390181|11980676|FG000|Overall Study|Study Terminated due to Low Accrual|3
7581295|NCT01372618|11980711|FG000|Overall Study|PI Died. Study Terminated|9
7581296|NCT01379274|11980719|FG000|Overall Study|funding withdrawn|1
7581297|NCT01369641|11980732|FG000|Overall Study|Withdrawal by Subject|1
7581298|NCT01359254|11980747|FG000|Overall Study|Death|1
7581299|NCT01359254|11980748|FG001|Overall Study|Death|0
7581300|NCT01352416|11980785|FG000|Overall Study|Physician Decision|1
7581301|NCT01352416|11980786|FG001|Overall Study|Physician Decision|2
7581302|NCT01352416|11980787|FG002|Overall Study|Physician Decision|2
7581303|NCT01352416|11980788|FG003|Overall Study|Physician Decision|1
7581304|NCT01349595|11980804|FG000|Overall Study|Lack of funding|2
7581305|NCT01349595|11980805|FG001|Overall Study|Lack of funding|2
7581306|NCT01347840|11980824|FG000|Overall Study|Withdrawal by Subject|1
7581307|NCT01335997|11980835|FG000|Period I and II|Adverse Event|63
7581308|NCT01335997|11980836|FG001|Period I and II|Adverse Event|43
7581309|NCT01335997|11980835|FG000|Period I and II|Noncompliance with Study Drug|1
7581310|NCT01335997|11980836|FG001|Period I and II|Noncompliance with Study Drug|1
7581311|NCT01335997|11980835|FG000|Period I and II|Lost to Follow-up|3
7581312|NCT01335997|11980836|FG001|Period I and II|Lost to Follow-up|5
7581313|NCT01335997|11980835|FG000|Period I and II|Withdrawal by Subject|9
7581314|NCT01335997|11980836|FG001|Period I and II|Withdrawal by Subject|4
7581315|NCT01335997|11980835|FG000|Period I and II|Study Terminated by Sponsor|406
7581316|NCT01335997|11980836|FG001|Period I and II|Study Terminated by Sponsor|415
7581317|NCT01335997|11980835|FG000|Period I and II|Protocol Violation|9
7581318|NCT01335997|11980836|FG001|Period I and II|Protocol Violation|10
7581319|NCT01335997|11980835|FG000|Period I and II|Physician Decision|2
7581320|NCT01335997|11980836|FG001|Period I and II|Physician Decision|1
7581321|NCT01335997|11980835|FG000|Period III|Adverse Event|0
7581322|NCT01335997|11980836|FG001|Period III|Adverse Event|2
7581323|NCT01335997|11980835|FG000|Period III|Study Terminated by Sponsor|77
7581324|NCT01335997|11980836|FG001|Period III|Study Terminated by Sponsor|76
7581325|NCT01335997|11980835|FG000|Period III|Protocol Violation|0
7581326|NCT01335997|11980836|FG001|Period III|Protocol Violation|1
7581327|NCT01335997|11980835|FG000|Period III|Lost to Follow-up|1
7581328|NCT01335997|11980836|FG001|Period III|Lost to Follow-up|0
7581329|NCT01341587|11980859|FG000|Overall Study|Lost to Follow-up|2
7581330|NCT01341587|11980860|FG001|Overall Study|Lost to Follow-up|0
7581331|NCT01341587|11980859|FG000|Overall Study|stopped using the meters|2
7581332|NCT01341587|11980860|FG001|Overall Study|stopped using the meters|10
7581333|NCT01332799|11980872|FG000|Overall Study|Insufficient funding|10
7581334|NCT01332799|11980873|FG001|Overall Study|Insufficient funding|10
7581335|NCT01329549|11980879|FG000|Overall Study|Withdrawal by Subject|1
7581336|NCT01329549|11980879|FG000|Overall Study|Adverse Event|1
7581337|NCT01326845|11980885|FG000|Overall Study|Administrative Problems|5
7581338|NCT01326845|11980886|FG001|Overall Study|Administrative Problems|2
7581339|NCT01326845|11980885|FG000|Overall Study|Adverse Event|1
7581340|NCT01326845|11980886|FG001|Overall Study|Adverse Event|0
7581341|NCT01326845|11980885|FG000|Overall Study|Misisng|1
7581342|NCT01326845|11980886|FG001|Overall Study|Misisng|3
7581343|NCT01329341|11980892|FG000|Overall Study|Withdrawal by Subject|44
7581344|NCT01320683|11980905|FG000|Overall Study|Positive antibody response|1
7581345|NCT01313273|11980911|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
7581346|NCT01313273|11980912|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
7581347|NCT01313273|11980911|FG000|Overall Study|Withdrawal by Subject|1
7581348|NCT01313273|11980912|FG001|Overall Study|Withdrawal by Subject|0
7581349|NCT01313273|11980911|FG000|Overall Study|Screening Chromogranin A-in normal range|0
7581350|NCT01313273|11980912|FG001|Overall Study|Screening Chromogranin A-in normal range|1
7581351|NCT01321008|11980918|FG000|Overall Study|Early Study Termination|1
7581352|NCT01310803|11980924|FG000|Overall Study|Subject terminated by Sponsor|1
7581353|NCT01310803|11980925|FG001|Overall Study|Subject terminated by Sponsor|0
7581354|NCT01313923|11980944|FG000|Overall Study|Physician Decision|3
7581355|NCT01321697|11980948|FG000|Overall Study|Study Terminated|7
7581356|NCT01312428|11980954|FG000|Overall Study|Study Termination|3
7581357|NCT01312428|11980955|FG001|Overall Study|Study Termination|4
7581358|NCT01290822|11981013|FG000|Overall Study|Withdrawal by Subject|1
7581359|NCT01290822|11981013|FG000|Overall Study|Physician Decision|10
7581360|NCT01290718|11981017|FG000|Overall Study|Early termination of the study|4
7581361|NCT01293123|11981023|FG000|Overall Study|Lost to Follow-up|0
7581362|NCT01293123|11981024|FG001|Overall Study|Lost to Follow-up|1
7581363|NCT01294046|11981030|FG000|Overall Study|Infection and surgical explant|1
7581364|NCT01294046|11981030|FG000|Overall Study|Eligibility criteria expanded|1
7581365|NCT01294046|11981030|FG000|Overall Study|Stimulation response inadqequate|1
7581366|NCT01281124|11981074|FG000|Overall Study|Death|1
7581367|NCT01282216|11981086|FG000|Overall Study|Graft failure|0
7581368|NCT01282216|11981087|FG001|Overall Study|Graft failure|0
7581369|NCT01282216|11981088|FG002|Overall Study|Graft failure|3
7581370|NCT01282216|11981089|FG003|Overall Study|Graft failure|2
7581371|NCT01282216|11981086|FG000|Overall Study|Physician Decision|0
7581372|NCT01282216|11981087|FG001|Overall Study|Physician Decision|0
7581373|NCT01282216|11981088|FG002|Overall Study|Physician Decision|11
7581374|NCT01282216|11981089|FG003|Overall Study|Physician Decision|0
7581375|NCT01282216|11981086|FG000|Overall Study|Relapse|0
7581376|NCT01282216|11981087|FG001|Overall Study|Relapse|0
7581377|NCT01282216|11981088|FG002|Overall Study|Relapse|17
7581378|NCT01282216|11981089|FG003|Overall Study|Relapse|6
7581379|NCT01282216|11981086|FG000|Overall Study|Death|0
7581380|NCT01282216|11981087|FG001|Overall Study|Death|0
7581381|NCT01282216|11981088|FG002|Overall Study|Death|2
7581382|NCT01282216|11981089|FG003|Overall Study|Death|0
7581383|NCT01284491|11981095|FG000|Overall Study|Study termination|13
7581384|NCT01274533|11981127|FG000|Overall Study|Withdrawal by Subject|1
7581385|NCT01274533|11981127|FG000|Overall Study|Non-compliance|1
7581386|NCT01274533|11981127|FG000|Overall Study|Disease progression|2
7581387|NCT01279616|11981131|FG000|Overall Study|donor could not be located|5
7581388|NCT01279616|11981131|FG000|Overall Study|no signs of sickle cell disease|2
7581389|NCT01276054|11981137|FG000|Overall Study|No one to oversee trial after P.I. left|2
7581390|NCT01276054|11981138|FG001|Overall Study|No one to oversee trial after P.I. left|2
7581391|NCT01264965|11981144|FG000|Overall Study|Withdrawal by Subject|10
7581392|NCT01266824|11981150|FG000|Overall Study|Study terminated prior to completion|2
7581393|NCT01266824|11981151|FG001|Overall Study|Study terminated prior to completion|3
7581394|NCT01264835|11981157|FG000|Overall Study|Lost to Follow-up|1
7581395|NCT01274429|11981161|FG000|Overall Study|Study closed do to lack of funding|5
7581396|NCT01273064|11981170|FG000|Overall Study|Adverse Event|5
7581397|NCT01273064|11981171|FG001|Overall Study|Adverse Event|1
7581398|NCT01273064|11981172|FG002|Overall Study|Adverse Event|3
7581399|NCT01273064|11981173|FG003|Overall Study|Adverse Event|2
7581400|NCT01273064|11981174|FG004|Overall Study|Adverse Event|1
7581401|NCT01273064|11981170|FG000|Overall Study|Withdrawal by Subject|4
7581402|NCT01273064|11981171|FG001|Overall Study|Withdrawal by Subject|2
7581403|NCT01273064|11981172|FG002|Overall Study|Withdrawal by Subject|2
7581404|NCT01273064|11981173|FG003|Overall Study|Withdrawal by Subject|2
7581405|NCT01273064|11981174|FG004|Overall Study|Withdrawal by Subject|0
7581406|NCT01273064|11981170|FG000|Overall Study|Study Termination|13
7581407|NCT01273064|11981171|FG001|Overall Study|Study Termination|27
7581408|NCT01273064|11981172|FG002|Overall Study|Study Termination|26
7581409|NCT01273064|11981173|FG003|Overall Study|Study Termination|16
7581410|NCT01273064|11981174|FG004|Overall Study|Study Termination|8
7581411|NCT01273064|11981170|FG000|Overall Study|Lost to Follow-up|1
7581412|NCT01273064|11981171|FG001|Overall Study|Lost to Follow-up|0
7581413|NCT01273064|11981172|FG002|Overall Study|Lost to Follow-up|0
7581414|NCT01273064|11981173|FG003|Overall Study|Lost to Follow-up|0
7581415|NCT01273064|11981174|FG004|Overall Study|Lost to Follow-up|0
7581416|NCT01273064|11981170|FG000|Overall Study|Physician Decision|0
7581417|NCT01273064|11981171|FG001|Overall Study|Physician Decision|0
7581418|NCT01273064|11981172|FG002|Overall Study|Physician Decision|0
7581419|NCT01273064|11981173|FG003|Overall Study|Physician Decision|0
7581420|NCT01273064|11981174|FG004|Overall Study|Physician Decision|1
7581421|NCT01274559|11981188|FG000|Overall Study|Adverse Event|57
7581422|NCT01274559|11981189|FG001|Overall Study|Adverse Event|13
7581423|NCT01274559|11981188|FG000|Overall Study|Death|1
7581424|NCT01274559|11981189|FG001|Overall Study|Death|1
7581425|NCT01274559|11981188|FG000|Overall Study|Lost to Follow-up|3
7581426|NCT01274559|11981189|FG001|Overall Study|Lost to Follow-up|3
7581427|NCT01274559|11981188|FG000|Overall Study|Non-compliance with Study Drug|2
7581428|NCT01274559|11981189|FG001|Overall Study|Non-compliance with Study Drug|4
7581429|NCT01274559|11981188|FG000|Overall Study|Physician Decision|2
7581430|NCT01274559|11981189|FG001|Overall Study|Physician Decision|1
7581431|NCT01274559|11981188|FG000|Overall Study|Protocol Violation|28
7581432|NCT01274559|11981189|FG001|Overall Study|Protocol Violation|23
7581433|NCT01274559|11981188|FG000|Overall Study|Study Terminated by Sponsor|79
7581434|NCT01274559|11981189|FG001|Overall Study|Study Terminated by Sponsor|87
7581435|NCT01274559|11981188|FG000|Overall Study|Withdrawal by Subject|25
7581436|NCT01274559|11981189|FG001|Overall Study|Withdrawal by Subject|13
7581437|NCT01267825|11981223|FG000|Overall Study|study terminated. no data collected.|1
7581438|NCT01267825|11981224|FG001|Overall Study|study terminated. no data collected.|0
7581439|NCT01259284|11981233|FG000|Overall Study|Study Termination|2
7581440|NCT01259284|11981234|FG001|Overall Study|Study Termination|0
7581441|NCT01259284|11981235|FG002|Overall Study|Study Termination|0
7624946|NCT04471935|12036186|FG000|Overall Study|Withdrawal by Subject|1
7624947|NCT04471935|12036186|FG000|Overall Study|Deemed ineligible to participate|1
7624948|NCT04498832|12036218|FG000|Overall Study|Adverse Event|1
7624949|NCT04498832|12036219|FG001|Overall Study|Adverse Event|3
7624950|NCT04498832|12036218|FG000|Overall Study|Withdrawal by Subject|0
7624951|NCT04498832|12036219|FG001|Overall Study|Withdrawal by Subject|1
7624952|NCT04109222|12036228|FG000|Overall Study|Adverse Event|1
7624953|NCT04109222|12036229|FG001|Overall Study|Adverse Event|0
7624954|NCT04109222|12036230|FG002|Overall Study|Adverse Event|0
7624955|NCT04046939|12036242|FG000|Primary Assessment Period|Adverse Event|1
7624956|NCT04046939|12036243|FG001|Primary Assessment Period|Adverse Event|0
7624957|NCT04046939|12036244|FG002|Primary Assessment Period|Adverse Event|0
7624958|NCT04046939|12036245|FG003|Primary Assessment Period|Adverse Event|0
7624959|NCT04046939|12036242|FG000|Primary Assessment Period|Withdrawal by Subject|1
7624960|NCT04046939|12036243|FG001|Primary Assessment Period|Withdrawal by Subject|0
7624961|NCT04046939|12036244|FG002|Primary Assessment Period|Withdrawal by Subject|1
7624962|NCT04046939|12036245|FG003|Primary Assessment Period|Withdrawal by Subject|0
7624963|NCT04046939|12036242|FG000|Primary Assessment Period|Physician Decision|0
7624964|NCT04046939|12036243|FG001|Primary Assessment Period|Physician Decision|0
7624965|NCT04046939|12036244|FG002|Primary Assessment Period|Physician Decision|1
7624966|NCT04046939|12036245|FG003|Primary Assessment Period|Physician Decision|0
7624967|NCT04046939|12036242|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
7624968|NCT04046939|12036243|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
7624969|NCT04046939|12036244|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
7624970|NCT04046939|12036245|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
7624971|NCT03912259|12036263|FG000|Overall Study|Adverse Event (AE)|2
7624972|NCT03912259|12036264|FG001|Overall Study|Adverse Event (AE)|4
7624973|NCT03912259|12036263|FG000|Overall Study|Lack of Efficacy|4
7624974|NCT03912259|12036264|FG001|Overall Study|Lack of Efficacy|1
7624975|NCT03912259|12036263|FG000|Overall Study|Withdrawal by Subject|11
7624976|NCT03912259|12036264|FG001|Overall Study|Withdrawal by Subject|1
7624977|NCT03890367|12036274|FG000|Overall Study|Withdrawal by parent/guardian|1
7624978|NCT03890367|12036275|FG001|Overall Study|Withdrawal by parent/guardian|3
7624979|NCT03890367|12036276|FG002|Overall Study|Withdrawal by parent/guardian|0
7581442|NCT01249157|11981243|FG000|Overall Study|Withdrawal by Subject|1
7581443|NCT01263028|11981247|FG000|Overall Study|Withdrawal by Subject|1
7581444|NCT01263028|11981247|FG000|Overall Study|Adverse Event|1
7581445|NCT01263028|11981247|FG000|Overall Study|Study terminated due to low enrollment.|4
7581446|NCT01259024|11981259|FG000|Overall Study|Physician Decision|1
7581447|NCT01251952|11981263|FG000|Overall Study|Adverse Event|1
7581448|NCT01251120|11981269|FG000|Overall Study|Lack of Efficacy|0
7581449|NCT01251120|11981270|FG001|Overall Study|Lack of Efficacy|1
7581450|NCT01248130|11981278|FG000|Overall Study|Protocol Violation|1
7581451|NCT01248130|11981279|FG001|Overall Study|Protocol Violation|0
7581452|NCT01248130|11981278|FG000|Overall Study|Ineligible|1
7581453|NCT01248130|11981279|FG001|Overall Study|Ineligible|0
7581454|NCT01243892|11981287|FG000|Overall Study|Did not meet eligibility criteria|2
7581455|NCT01243892|11981288|FG001|Overall Study|Did not meet eligibility criteria|0
7581456|NCT01246011|11981297|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
7581457|NCT01246011|11981298|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
7581458|NCT01246011|11981299|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
7581459|NCT01246011|11981297|FG000|Overall Study|Withdrawal by Subject|0
7270084|NCT00413660|11484165|FG005|Post Week 12|Withdrawal by Subject|0
7270085|NCT00413660|11484166|FG006|Post Week 12|Withdrawal by Subject|0
7270086|NCT00413660|11484167|FG007|Post Week 12|Withdrawal by Subject|0
7270087|NCT00413660|11484168|FG008|Post Week 12|Withdrawal by Subject|0
7270088|NCT00413660|11484169|FG009|Post Week 12|Withdrawal by Subject|0
7270089|NCT00413660|11484170|FG010|Post Week 12|Withdrawal by Subject|1
7270090|NCT00413660|11484160|FG000|Post Week 12|Other|1
7270091|NCT00413660|11484161|FG001|Post Week 12|Other|2
7270092|NCT00413660|11484162|FG002|Post Week 12|Other|3
7270093|NCT00413660|11484163|FG003|Post Week 12|Other|0
7270094|NCT00413660|11484164|FG004|Post Week 12|Other|1
7270095|NCT00413660|11484165|FG005|Post Week 12|Other|1
7270096|NCT00413660|11484166|FG006|Post Week 12|Other|1
7270097|NCT00413660|11484167|FG007|Post Week 12|Other|0
7270098|NCT00413660|11484168|FG008|Post Week 12|Other|0
7270099|NCT00413660|11484169|FG009|Post Week 12|Other|0
7270100|NCT00413660|11484170|FG010|Post Week 12|Other|0
7270101|NCT00413777|11484202|FG000|Fixed-dose Period|Lost to Follow-up|1
7270102|NCT00413777|11484203|FG001|Fixed-dose Period|Lost to Follow-up|1
7270103|NCT00413777|11484202|FG000|Fixed-dose Period|Adverse Event|2
7270104|NCT00413777|11484203|FG001|Fixed-dose Period|Adverse Event|1
7270105|NCT00413777|11484202|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
7270106|NCT00413777|11484203|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
7270107|NCT00413777|11484202|FG000|Fixed-dose Period|Withdrew Consent|0
7270108|NCT00413777|11484203|FG001|Fixed-dose Period|Withdrew Consent|1
7270109|NCT00413894|11484209|FG000|Overall Study|Withdrawal by Subject|10
7270110|NCT00413894|11484209|FG000|Overall Study|Administrative Reasons|1
7270111|NCT00413894|11484209|FG000|Overall Study|Hb <10 grams/deciliter|12
7270112|NCT00413894|11484209|FG000|Overall Study|Adverse Event|28
7270113|NCT00413894|11484209|FG000|Overall Study|Protocol Violation|11
7270114|NCT00413894|11484209|FG000|Overall Study|Other|18
7270115|NCT00413920|11484218|FG000|Overall Study|Adverse Event|9
7270116|NCT00413920|11484219|FG001|Overall Study|Adverse Event|11
7270117|NCT00413920|11484218|FG000|Overall Study|Lack of Efficacy|11
7270118|NCT00413920|11484219|FG001|Overall Study|Lack of Efficacy|9
7270119|NCT00413920|11484218|FG000|Overall Study|Death|3
7270120|NCT00413920|11484219|FG001|Overall Study|Death|5
7270121|NCT00413920|11484218|FG000|Overall Study|Graft Loss|5
7270122|NCT00413920|11484219|FG001|Overall Study|Graft Loss|3
7270123|NCT00413959|11484225|FG000|Overall Study|Pt had only one cycle.|1
7270124|NCT00414011|11484229|FG000|Overall Study|Physician Decision|3
7270125|NCT00414011|11484229|FG000|Overall Study|Withdrawal by Subject|2
7270126|NCT00414050|11484238|FG000|Overall Study|Adverse Event|1
7270127|NCT00414050|11484239|FG001|Overall Study|Adverse Event|1
7270128|NCT00414050|11484240|FG002|Overall Study|Adverse Event|1
7581460|NCT01246011|11981298|FG001|Overall Study|Withdrawal by Subject|0
7581461|NCT01246011|11981299|FG002|Overall Study|Withdrawal by Subject|1
7581462|NCT01242020|11981310|FG000|Overall Study|Withdrawal by Subject|2
7581463|NCT01242020|11981311|FG001|Overall Study|Withdrawal by Subject|0
7581464|NCT01242020|11981310|FG000|Overall Study|Failed screening|1
7581465|NCT01242020|11981311|FG001|Overall Study|Failed screening|0
7581466|NCT01244620|11981317|FG000|Overall Study|Study terminated|4
7581467|NCT01244620|11981318|FG001|Overall Study|Study terminated|4
7581468|NCT01244620|11981319|FG002|Overall Study|Study terminated|4
7581469|NCT01244620|11981320|FG003|Overall Study|Study terminated|4
7581470|NCT01241279|11981336|FG000|Overall Study|Lost to Follow-up|0
7581471|NCT01241279|11981337|FG001|Overall Study|Lost to Follow-up|1
7581472|NCT01230788|11981343|FG000|Overall Study|Prescribed exclusion drug|1
7581473|NCT01239680|11981349|FG000|Overall Study|Withdrawal by Subject|2
7581474|NCT01239680|11981350|FG001|Overall Study|Withdrawal by Subject|0
7581475|NCT01230307|11981381|FG000|Overall Study|LVAD Placement|0
7581476|NCT01230307|11981382|FG001|Overall Study|LVAD Placement|2
7581477|NCT01230489|11981388|FG000|Overall Study|Death|2
7581478|NCT01230489|11981388|FG000|Overall Study|Adverse Event|2
7581479|NCT01230489|11981388|FG000|Overall Study|Treatment modality changed|1
7581480|NCT01217060|11981444|FG000|Overall Study|Withdrawal by Subject|1
7581481|NCT01217047|11981452|FG000|Overall Study|Lost to Follow-up|0
7581482|NCT01217047|11981453|FG001|Overall Study|Lost to Follow-up|1
7581483|NCT01217047|11981454|FG002|Overall Study|Lost to Follow-up|0
7581484|NCT01206101|11981465|FG000|Overall Study|Adverse Event|1
7581485|NCT01206101|11981466|FG001|Overall Study|Adverse Event|0
7581486|NCT01206101|11981465|FG000|Overall Study|Physician Decision|0
7581487|NCT01206101|11981466|FG001|Overall Study|Physician Decision|1
7581488|NCT01206101|11981465|FG000|Overall Study|Unclassified|1
7581489|NCT01206101|11981466|FG001|Overall Study|Unclassified|0
7581490|NCT01209520|11981489|FG000|Overall Study|Withdrawal by Subject|3
7581491|NCT01207102|11981510|FG000|Overall Study|Withdrawal by Subject|5
7581492|NCT01207102|11981510|FG000|Overall Study|Adverse Event|2
7581493|NCT01207102|11981510|FG000|Overall Study|progression|2
7581494|NCT01207102|11981510|FG000|Overall Study|Withdrawal by Treating Physician|1
7581495|NCT01206439|11981528|FG000|Overall Study|subject did not meet inclusion criteria|1
7581496|NCT01198548|11981550|FG000|Overall Study|Disease Progression|9
7581497|NCT01198548|11981550|FG000|Overall Study|Administrative Decision|1
7581498|NCT01193556|11981573|FG000|Overall Study|Study termination|26
7581499|NCT01193556|11981574|FG001|Overall Study|Study termination|25
7581500|NCT01189435|11981580|FG000|Overall Study|Withdrawal by Subject|1
7581501|NCT01189435|11981580|FG000|Overall Study|Physician Decision|1
7581502|NCT01193530|11981586|FG000|Overall Study|Withdrawal by Subject|2
7581503|NCT01193530|11981587|FG001|Overall Study|Withdrawal by Subject|2
7581504|NCT01193530|11981586|FG000|Overall Study|Began Contraindicated Therapy|1
7581505|NCT01193530|11981587|FG001|Overall Study|Began Contraindicated Therapy|0
7581506|NCT01193530|11981586|FG000|Overall Study|Lost Light Box|0
7581507|NCT01193530|11981587|FG001|Overall Study|Lost Light Box|1
7581508|NCT01193530|11981586|FG000|Overall Study|Returned home - out of state|0
7581509|NCT01193530|11981587|FG001|Overall Study|Returned home - out of state|1
7581510|NCT01193530|11981586|FG000|Overall Study|Non-Compliance|0
7581511|NCT01193530|11981587|FG001|Overall Study|Non-Compliance|1
7581512|NCT01183221|11981621|FG000|3 Weeks Wash Out|Lost to Follow-up|1
7581513|NCT01183221|11981622|FG001|3 Weeks Wash Out|Lost to Follow-up|1
7581514|NCT01189227|11981630|FG000|Overall Study|Study terminated due to low accrual|6
7581515|NCT01189227|11981631|FG001|Overall Study|Study terminated due to low accrual|3
7581516|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2|Adverse Event|3
7581517|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2|Adverse Event|1
7581518|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2|Adverse Event|1
7581519|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2|Adverse Event|0
7581520|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
7581521|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
7581522|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
7581523|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
7581524|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2|Administrative problems|0
7581525|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2|Administrative problems|0
7581526|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2|Administrative problems|2
7581527|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2|Administrative problems|4
7581528|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2|Death|0
7581529|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2|Death|0
7581530|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2|Death|1
7581531|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2|Death|0
7581532|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7581533|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
7581534|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7581535|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
7581536|NCT01179737|11981641|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
7581537|NCT01179737|11981642|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
7581538|NCT01179737|11981643|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
7581539|NCT01179737|11981644|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
7581540|NCT01179737|11981641|FG000|Extension|The study was terminated|3
7581541|NCT01179737|11981642|FG001|Extension|The study was terminated|0
7581542|NCT01179737|11981643|FG002|Extension|The study was terminated|0
7581543|NCT01179737|11981644|FG003|Extension|The study was terminated|0
7581544|NCT01183468|11981657|FG000|Overall Study|Lost to Follow-up|2
7581545|NCT01183468|11981658|FG001|Overall Study|Lost to Follow-up|1
7581546|NCT01183468|11981659|FG002|Overall Study|Lost to Follow-up|0
7581547|NCT01183468|11981660|FG003|Overall Study|Lost to Follow-up|0
7581548|NCT01183468|11981657|FG000|Overall Study|Physician Decision|1
7581549|NCT01183468|11981658|FG001|Overall Study|Physician Decision|0
7581550|NCT01183468|11981659|FG002|Overall Study|Physician Decision|0
7581551|NCT01183468|11981660|FG003|Overall Study|Physician Decision|0
7581552|NCT01183468|11981657|FG000|Overall Study|Withdrawal by Subject|0
7581553|NCT01183468|11981658|FG001|Overall Study|Withdrawal by Subject|1
7581554|NCT01183468|11981659|FG002|Overall Study|Withdrawal by Subject|0
7581555|NCT01183468|11981660|FG003|Overall Study|Withdrawal by Subject|0
7581556|NCT01181921|11981668|FG000|Overall Study|Lost to Follow-up|1
7581557|NCT01188798|11981674|FG000|Overall Study|Death|0
7581558|NCT01188798|11981675|FG001|Overall Study|Death|1
7581559|NCT01188798|11981674|FG000|Overall Study|Required additional transplant|1
7581560|NCT01188798|11981675|FG001|Overall Study|Required additional transplant|1
7581561|NCT01188798|11981674|FG000|Overall Study|Protocol closure|1
7581562|NCT01188798|11981675|FG001|Overall Study|Protocol closure|1
7581563|NCT01174368|11981682|FG000|Overall Study|Withdrawal by Subject|1
7581564|NCT01183884|11981690|FG000|Overall Study|Progressive Disease|26
7581565|NCT01183884|11981690|FG000|Overall Study|Adverse Event|3
7581566|NCT01183884|11981690|FG000|Overall Study|Withdrawal by Subject|1
7581567|NCT01183884|11981690|FG000|Overall Study|Other Complicating Disease|3
7581568|NCT01183884|11981690|FG000|Overall Study|Not Treated|1
7581569|NCT01183884|11981690|FG000|Overall Study|Other|4
7581570|NCT01166178|11981700|FG000|Overall Study|Withdrawal by Subject|1
7581571|NCT01166178|11981701|FG001|Overall Study|Withdrawal by Subject|0
7581572|NCT01166178|11981700|FG000|Overall Study|Study was terminated|20
7581573|NCT01166178|11981701|FG001|Overall Study|Study was terminated|8
7581574|NCT01176513|11981707|FG000|Overall Study|Withdrew subjects prior to dosing|3
7581575|NCT01179399|11981715|FG000|Overall Study|Adverse Event|1
7581576|NCT01179399|11981715|FG000|Overall Study|Lack of Efficacy|30
7581577|NCT01179399|11981715|FG000|Overall Study|Withdrawal by Subject|1
7581578|NCT01171534|11981730|FG000|Overall Study|Lost to Follow-up|0
7581579|NCT01171534|11981731|FG001|Overall Study|Lost to Follow-up|2
7581580|NCT01171534|11981730|FG000|Overall Study|screen failure|0
7581581|NCT01171534|11981731|FG001|Overall Study|screen failure|1
7581582|NCT01162304|11981767|FG000|Overall Study|Beck scale to high|11
7581583|NCT01147393|11981819|FG000|Dose Level 1|Dose limiting Toxicity|2
7581584|NCT01147393|11981819|FG000|Dose Level -1|Dose Limited Toxicity|1
7581585|NCT01147536|11981832|FG000|Overall Study|Administrative study close|2
7581586|NCT01147536|11981832|FG000|Overall Study|Death|1
7581587|NCT01133288|11981845|FG000|Eligibility Assessment|met exclusion criteria|5
7581588|NCT01133288|11981845|FG000|Intervention Allocation|study terminated|2
7581589|NCT01142128|11981853|FG000|Overall Study|Physician Decision|1
7581590|NCT01142128|11981853|FG000|Overall Study|Lost to Follow-up|1
7581591|NCT01142128|11981853|FG000|Overall Study|Withdrawal by Subject|2
7581592|NCT01128114|11981872|FG000|Overall Study|Treatment Withdrawn|6
7581593|NCT01128114|11981872|FG000|Overall Study|Screening Failed|2
7581594|NCT01126879|11981878|FG000|Overall Study|Progressive Disease|3
7581595|NCT01126879|11981879|FG001|Overall Study|Progressive Disease|1
7581596|NCT01126879|11981878|FG000|Overall Study|Withdrawal by Subject|1
7581597|NCT01126879|11981879|FG001|Overall Study|Withdrawal by Subject|0
7581598|NCT01126879|11981878|FG000|Overall Study|Adverse Event|0
7581599|NCT01126879|11981879|FG001|Overall Study|Adverse Event|1
7581600|NCT01126879|11981878|FG000|Overall Study|Physician Decision|1
7581601|NCT01126879|11981879|FG001|Overall Study|Physician Decision|0
7581602|NCT01136811|11981885|FG000|Overall Study|Physician Decision|11
7581603|NCT01139125|11981898|FG000|Overall Study|Withdrawal by Subject|1
7581604|NCT01131455|11981922|FG000|Overall Study|Death of PI|6
7581605|NCT01131455|11981923|FG001|Overall Study|Death of PI|4
7581606|NCT01131455|11981924|FG002|Overall Study|Death of PI|0
7581607|NCT01123850|11981941|FG000|Overall Study|Slow enrollment|45
7581608|NCT01122381|11981974|FG000|Overall Study|study terminated early|0
7581609|NCT01122381|11981975|FG001|Overall Study|study terminated early|1
7581610|NCT01116232|11981981|FG000|Overall Study|Progressive diease|4
7624980|NCT03890367|12036274|FG000|Overall Study|Protocol deviation|2
7624981|NCT03890367|12036275|FG001|Overall Study|Protocol deviation|2
7624982|NCT03890367|12036276|FG002|Overall Study|Protocol deviation|1
7624983|NCT03890367|12036274|FG000|Overall Study|Lost to Follow-up|1
7624984|NCT03890367|12036275|FG001|Overall Study|Lost to Follow-up|1
7624985|NCT03890367|12036276|FG002|Overall Study|Lost to Follow-up|0
7581611|NCT01108523|11982009|FG000|Overall Study|Protocol Violation|4
7581612|NCT01106534|11982017|FG000|Overall Study|Withdrawal by Subject|18
7581613|NCT01106534|11982017|FG000|Overall Study|Lost to Follow-up|2
7581614|NCT01106534|11982017|FG000|Overall Study|Death|16
7581615|NCT01106534|11982017|FG000|Overall Study|Physician Decision|1
7581616|NCT01100658|11982026|FG000|Overall Study|Withdrawal by Subject|1
7581617|NCT01103180|11982032|FG000|Overall Study|Withdrawal by Subject|8
7581618|NCT01103180|11982033|FG001|Overall Study|Withdrawal by Subject|13
7581619|NCT01103180|11982032|FG000|Overall Study|Lost to Follow-up|13
7581620|NCT01103180|11982033|FG001|Overall Study|Lost to Follow-up|7
7581621|NCT01103180|11982032|FG000|Overall Study|Physician Decision|1
7581622|NCT01103180|11982033|FG001|Overall Study|Physician Decision|0
7581623|NCT01103180|11982032|FG000|Overall Study|Protocol Violation|0
7581624|NCT01103180|11982033|FG001|Overall Study|Protocol Violation|1
7581625|NCT01102140|11982050|FG000|Overall Study|Lost to Follow-up|1
7581626|NCT01102140|11982051|FG001|Overall Study|Lost to Follow-up|0
7581627|NCT01102140|11982050|FG000|Overall Study|Investigator terminated study|2
7581628|NCT01102140|11982051|FG001|Overall Study|Investigator terminated study|2
7581629|NCT01095250|11982063|FG000|Overall Study|administrative reasons|8
7581630|NCT01095250|11982064|FG001|Overall Study|administrative reasons|10
7581631|NCT01095250|11982065|FG002|Overall Study|administrative reasons|7
7581632|NCT01095250|11982066|FG003|Overall Study|administrative reasons|5
7581633|NCT01095250|11982063|FG000|Overall Study|Withdrawal by Subject|0
7581634|NCT01095250|11982064|FG001|Overall Study|Withdrawal by Subject|0
7581635|NCT01095250|11982065|FG002|Overall Study|Withdrawal by Subject|1
7581636|NCT01095250|11982066|FG003|Overall Study|Withdrawal by Subject|0
7581637|NCT01093846|11982083|FG000|Overall Study|Adverse Event|0
7581638|NCT01093846|11982084|FG001|Overall Study|Adverse Event|0
7581639|NCT01093846|11982085|FG002|Overall Study|Adverse Event|1
7581640|NCT01093846|11982083|FG000|Overall Study|Lack of Efficacy|0
7581641|NCT01093846|11982084|FG001|Overall Study|Lack of Efficacy|0
7581642|NCT01093846|11982085|FG002|Overall Study|Lack of Efficacy|4
7581643|NCT01093846|11982083|FG000|Overall Study|Condition no longer required study drug|1
7581644|NCT01093846|11982084|FG001|Overall Study|Condition no longer required study drug|1
7581645|NCT01093846|11982085|FG002|Overall Study|Condition no longer required study drug|1
7581646|NCT01093846|11982083|FG000|Overall Study|Administrative Problems|18
7581647|NCT01093846|11982084|FG001|Overall Study|Administrative Problems|17
7581648|NCT01093846|11982085|FG002|Overall Study|Administrative Problems|15
7581649|NCT01081886|11982098|FG000|Overall Study|Study termination|11
7581650|NCT01081886|11982099|FG001|Overall Study|Study termination|13
7581651|NCT01080768|11982120|FG000|Overall Study|Protocol Deviation|2
7581652|NCT01080768|11982121|FG001|Overall Study|Protocol Deviation|1
7581653|NCT01074502|11982131|FG000|Overall Study|Withdrawal by Subject|1
7581654|NCT01069861|11982144|FG000|Overall Study|Death|1
7581655|NCT01069861|11982144|FG000|Overall Study|Adverse Event|1
7581656|NCT01069861|11982144|FG000|Overall Study|Did not meet entrance criteria|1
7581657|NCT01069120|11982177|FG000|Overall Study|Study prematurely terminated|27
7581658|NCT01058642|11982196|FG000|Treatment Period 1|Adverse Event|0
7581659|NCT01058642|11982197|FG001|Treatment Period 1|Adverse Event|1
7581660|NCT01058642|11982198|FG002|Treatment Period 1|Adverse Event|1
7581661|NCT01058642|11982199|FG003|Treatment Period 1|Adverse Event|0
7581662|NCT01058642|11982196|FG000|Treatment Period 1|Physician Decision|0
7581663|NCT01058642|11982197|FG001|Treatment Period 1|Physician Decision|0
7581664|NCT01058642|11982198|FG002|Treatment Period 1|Physician Decision|1
7581665|NCT01058642|11982199|FG003|Treatment Period 1|Physician Decision|0
7581666|NCT01058642|11982196|FG000|Treatment Period 1|Withdrawal by Subject|1
7581667|NCT01058642|11982197|FG001|Treatment Period 1|Withdrawal by Subject|0
7581668|NCT01058642|11982198|FG002|Treatment Period 1|Withdrawal by Subject|0
7581669|NCT01058642|11982199|FG003|Treatment Period 1|Withdrawal by Subject|0
7581670|NCT01058642|11982196|FG000|Treatment Period 1|Lack of Efficacy|0
7581671|NCT01058642|11982197|FG001|Treatment Period 1|Lack of Efficacy|0
7581672|NCT01058642|11982198|FG002|Treatment Period 1|Lack of Efficacy|0
7581673|NCT01058642|11982199|FG003|Treatment Period 1|Lack of Efficacy|1
7581674|NCT01058642|11982196|FG000|Treatment Period 1|Protocol Violation|0
7581675|NCT01058642|11982197|FG001|Treatment Period 1|Protocol Violation|0
7581676|NCT01058642|11982198|FG002|Treatment Period 1|Protocol Violation|0
7581677|NCT01058642|11982199|FG003|Treatment Period 1|Protocol Violation|1
7581678|NCT01058642|11982196|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
7581679|NCT01058642|11982197|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
7581680|NCT01058642|11982198|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
7581681|NCT01058642|11982199|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
7581682|NCT01065818|11982207|FG000|Overall Study|Withdrawal by Subject|1
7581683|NCT01065818|11982207|FG000|Overall Study|Not a candidate for surgery|1
7581684|NCT01051921|11982211|FG000|Overall Study|Physician Decision|9
7581685|NCT01051921|11982211|FG000|Overall Study|Adverse Event|8
7581686|NCT01051921|11982211|FG000|Overall Study|Withdrawal by Subject|7
7581687|NCT01051921|11982211|FG000|Overall Study|Lost to Follow-up|4
7581688|NCT01051921|11982211|FG000|Overall Study|virological failure|1
7581689|NCT01051921|11982211|FG000|Overall Study|patient moved|1
7581690|NCT01058369|11982233|FG000|Overall Study|Adverse Event|1
7581691|NCT01058369|11982233|FG000|Overall Study|Early termination study|1
7581692|NCT01053221|11982243|FG000|Overall Study|The study was closed prematurely|5
7581693|NCT01053221|11982244|FG001|Overall Study|The study was closed prematurely|9
7581694|NCT01038752|11982252|FG000|Overall Study|Tumor Progression|2
7581695|NCT01038752|11982253|FG001|Overall Study|Tumor Progression|2
7581696|NCT01038752|11982252|FG000|Overall Study|Lost to Follow-up|3
7581697|NCT01038752|11982253|FG001|Overall Study|Lost to Follow-up|3
7581698|NCT01050218|11982259|FG000|Overall Study|Adverse Event|37
7581699|NCT01050218|11982259|FG000|Overall Study|Lack of Efficacy|8
7581700|NCT01050218|11982259|FG000|Overall Study|Protocol Violation|3
7581701|NCT01050218|11982259|FG000|Overall Study|Withdrawal by Subject|18
7581702|NCT01050218|11982259|FG000|Overall Study|Discontinued by sponsor|18
7581703|NCT01050218|11982259|FG000|Overall Study|Compliance|2
7581704|NCT01050218|11982259|FG000|Overall Study|Failed to return|7
7581705|NCT01050218|11982259|FG000|Overall Study|Serious Adverse Event|1
7581706|NCT01050218|11982259|FG000|Overall Study|Family emergency|1
7581707|NCT01045694|11982263|FG000|Overall Study|Withdrawal by Subject|2
7581708|NCT01031628|11982288|FG000|Overall Study|Study terminated early|0
7581709|NCT01031628|11982289|FG001|Overall Study|Study terminated early|1
7581710|NCT01031628|11982290|FG002|Overall Study|Study terminated early|3
7581711|NCT01031628|11982291|FG003|Overall Study|Study terminated early|0
7581712|NCT01030198|11982322|FG000|Overall Study|Could not measure efficacy accurately|0
7581713|NCT01030198|11982323|FG001|Overall Study|Could not measure efficacy accurately|7
7581714|NCT01028300|11982329|FG000|Overall Study|Study Terminated|4
7581715|NCT01022398|11982340|FG000|Overall Study|Study terminated|2
7581716|NCT01022398|11982341|FG001|Overall Study|Study terminated|2
7581717|NCT01019980|11982348|FG000|Overall Study|Drug not available.|2
7581718|NCT01019980|11982349|FG001|Overall Study|Drug not available.|0
7581719|NCT01017263|11982359|FG000|Overall Study|not eligible|12
7581720|NCT01018810|11982386|FG000|Overall Study|Withdrawal by Subject|0
7581721|NCT01018810|11982387|FG001|Overall Study|Withdrawal by Subject|1
7581722|NCT01018810|11982388|FG002|Overall Study|Withdrawal by Subject|0
7581723|NCT01018810|11982389|FG003|Overall Study|Withdrawal by Subject|0
7581724|NCT01018810|11982390|FG004|Overall Study|Withdrawal by Subject|0
7581725|NCT01018810|11982386|FG000|Overall Study|Sponsor Decision|2
7581726|NCT01018810|11982387|FG001|Overall Study|Sponsor Decision|0
7581727|NCT01018810|11982388|FG002|Overall Study|Sponsor Decision|1
7581728|NCT01018810|11982389|FG003|Overall Study|Sponsor Decision|1
7581729|NCT01018810|11982390|FG004|Overall Study|Sponsor Decision|1
7581730|NCT01014767|11982419|FG000|Overall Study|PI left institution, data unavailable|12
7581731|NCT01014767|11982420|FG001|Overall Study|PI left institution, data unavailable|1
7581732|NCT01014767|11982421|FG002|Overall Study|PI left institution, data unavailable|4
7581733|NCT01014767|11982422|FG003|Overall Study|PI left institution, data unavailable|1
7581734|NCT01013701|11982432|FG000|Overall Study|study prematurely terminated|7
7581735|NCT01012414|11982437|FG000|Overall Study|Withdrawal by Subject|2
7581736|NCT01012414|11982437|FG000|Overall Study|Lost to Follow-up|1
7581737|NCT01012414|11982437|FG000|Overall Study|Trial was stopped before completed|7
7581738|NCT01001390|11982456|FG000|Overall Study|Failure to wear AFO device|2
7581739|NCT01001390|11982457|FG001|Overall Study|Failure to wear AFO device|0
7581740|NCT01004510|11982475|FG000|Overall Study|Adverse Event|1
7581741|NCT01005914|11982479|FG000|Overall Study|Adverse Event|4
7581742|NCT01005914|11982479|FG000|Overall Study|Death|4
7581743|NCT01005914|11982479|FG000|Overall Study|Lack of Efficacy|1
7581744|NCT01005914|11982479|FG000|Overall Study|Withdrawal by Subject|1
7581745|NCT00996333|11982483|FG000|Overall Study|Screen failure|1
7581746|NCT00996333|11982483|FG000|Overall Study|Withdrawal by Subject|1
7581747|NCT00996333|11982483|FG000|Overall Study|Death|4
7581748|NCT00996333|11982483|FG000|Overall Study|Adverse Event|1
7581749|NCT00996333|11982483|FG000|Overall Study|Physician Decision|1
7581750|NCT00996333|11982483|FG000|Overall Study|Other|5
7581751|NCT00998738|11982487|FG000|Overall Study|Uknown|1
7581752|NCT00997386|11982495|FG000|Overall Study|Death|7
7581753|NCT00985738|11982501|FG000|Overall Study|Study closed prematurely|8
7581754|NCT00985738|11982502|FG001|Overall Study|Study closed prematurely|8
7581755|NCT00975611|11982595|FG000|Overall Study|Screen Fail|16
7581756|NCT00975611|11982595|FG000|Overall Study|Physician Decision|1
7581757|NCT00974922|11982620|FG000|Overall Study|study terminated|24
7581758|NCT00965146|11982635|FG000|Overall Study|Death|7
7581759|NCT00965146|11982635|FG000|Overall Study|Lost to Follow-up|22
7581760|NCT00965146|11982635|FG000|Overall Study|Withdrawal by Subject|17
7581761|NCT00965146|11982635|FG000|Overall Study|Unable to return|1
7581762|NCT00965146|11982635|FG000|Overall Study|Unwilling to return|11
7581763|NCT00965146|11982635|FG000|Overall Study|Intercurrent illness|1
7581764|NCT00965146|11982635|FG000|Overall Study|Revision / Removal of Study Implant|6
7581765|NCT00965146|11982635|FG000|Overall Study|Overall Study Termination|145
7581766|NCT00972023|11982639|FG000|Overall Study|Withdrawal by Subject|1
7581767|NCT00953329|11982658|FG000|Overall Study|Lack of Efficacy|1
7581768|NCT00958893|11982675|FG000|Overall Study|Study prematurely terminated|4
7581769|NCT00966654|11982679|FG000|Overall Study|Study was terminated,PI left institution|12
7581770|NCT00960154|11982687|FG000|Overall Study|Study termination|25
7581771|NCT00960154|11982688|FG001|Overall Study|Study termination|25
7624986|NCT03607422|12036294|FG000|Overall Study|Adverse Event|7
7624987|NCT03607422|12036295|FG001|Overall Study|Adverse Event|3
7624988|NCT03607422|12036296|FG002|Overall Study|Adverse Event|2
7624989|NCT03607422|12036297|FG003|Overall Study|Adverse Event|0
7624990|NCT03607422|12036298|FG004|Overall Study|Adverse Event|2
7624991|NCT03607422|12036299|FG005|Overall Study|Adverse Event|0
7624992|NCT03607422|12036294|FG000|Overall Study|Withdrawal by Subject|11
7624993|NCT03607422|12036295|FG001|Overall Study|Withdrawal by Subject|3
7624994|NCT03607422|12036296|FG002|Overall Study|Withdrawal by Subject|6
7624995|NCT03607422|12036297|FG003|Overall Study|Withdrawal by Subject|2
7624996|NCT03607422|12036298|FG004|Overall Study|Withdrawal by Subject|0
7624997|NCT03607422|12036299|FG005|Overall Study|Withdrawal by Subject|0
7270129|NCT00414050|11484241|FG003|Overall Study|Adverse Event|1
7270130|NCT00414050|11484238|FG000|Overall Study|Lost to Follow-up|2
7270131|NCT00414050|11484239|FG001|Overall Study|Lost to Follow-up|2
7270132|NCT00414050|11484240|FG002|Overall Study|Lost to Follow-up|1
7270133|NCT00414050|11484241|FG003|Overall Study|Lost to Follow-up|1
7270134|NCT00414050|11484238|FG000|Overall Study|Withdrawal by Subject|5
7270135|NCT00414050|11484239|FG001|Overall Study|Withdrawal by Subject|3
7624998|NCT03607422|12036294|FG000|Overall Study|Lost to Follow-up|0
7624999|NCT03607422|12036295|FG001|Overall Study|Lost to Follow-up|0
7625000|NCT03607422|12036296|FG002|Overall Study|Lost to Follow-up|1
7625001|NCT03607422|12036297|FG003|Overall Study|Lost to Follow-up|0
7625002|NCT03607422|12036298|FG004|Overall Study|Lost to Follow-up|0
7625003|NCT03607422|12036299|FG005|Overall Study|Lost to Follow-up|0
7625004|NCT03607422|12036294|FG000|Overall Study|Other|12
7625005|NCT03607422|12036295|FG001|Overall Study|Other|4
7625006|NCT03607422|12036296|FG002|Overall Study|Other|1
7625007|NCT03607422|12036297|FG003|Overall Study|Other|2
7625008|NCT03607422|12036298|FG004|Overall Study|Other|0
7625009|NCT03607422|12036299|FG005|Overall Study|Other|2
7625010|NCT03607422|12036294|FG000|Overall Study|Ongoing at Time of Analysis|8
7625011|NCT03607422|12036295|FG001|Overall Study|Ongoing at Time of Analysis|0
7625012|NCT03607422|12036296|FG002|Overall Study|Ongoing at Time of Analysis|2
7625013|NCT03607422|12036297|FG003|Overall Study|Ongoing at Time of Analysis|1
7625014|NCT03607422|12036298|FG004|Overall Study|Ongoing at Time of Analysis|1
7625015|NCT03607422|12036299|FG005|Overall Study|Ongoing at Time of Analysis|1
7625016|NCT03600805|12036317|FG000|Overall Study|Adverse Event|2
7625017|NCT03600805|12036318|FG001|Overall Study|Adverse Event|1
7625018|NCT03600805|12036319|FG002|Overall Study|Adverse Event|1
7625019|NCT03600805|12036320|FG003|Overall Study|Adverse Event|7
7625020|NCT03600805|12036317|FG000|Overall Study|Lack of Efficacy|2
7625021|NCT03600805|12036318|FG001|Overall Study|Lack of Efficacy|1
7625022|NCT03600805|12036319|FG002|Overall Study|Lack of Efficacy|0
7625023|NCT03600805|12036320|FG003|Overall Study|Lack of Efficacy|0
7625024|NCT03600805|12036317|FG000|Overall Study|Withdrawal by Subject|1
7625025|NCT03600805|12036318|FG001|Overall Study|Withdrawal by Subject|0
7625026|NCT03600805|12036319|FG002|Overall Study|Withdrawal by Subject|0
7625027|NCT03600805|12036320|FG003|Overall Study|Withdrawal by Subject|1
7625028|NCT03600805|12036317|FG000|Overall Study|Other unspecified|14
7625029|NCT03600805|12036318|FG001|Overall Study|Other unspecified|6
7625030|NCT03600805|12036319|FG002|Overall Study|Other unspecified|7
7625031|NCT03600805|12036320|FG003|Overall Study|Other unspecified|11
7625032|NCT03434119|12036343|FG000|Overall Study|Randomized but not treated|1
7625033|NCT03434119|12036344|FG001|Overall Study|Randomized but not treated|0
7625034|NCT03434119|12036343|FG000|Overall Study|Adverse Event|1
7625035|NCT03434119|12036344|FG001|Overall Study|Adverse Event|0
7625036|NCT03434119|12036343|FG000|Overall Study|Poor Compliance to Protocol|0
7625037|NCT03434119|12036344|FG001|Overall Study|Poor Compliance to Protocol|1
7625038|NCT03434119|12036343|FG000|Overall Study|Study Terminated by Sponsor|91
7625039|NCT03434119|12036344|FG001|Overall Study|Study Terminated by Sponsor|102
7270136|NCT00414050|11484240|FG002|Overall Study|Withdrawal by Subject|2
7625040|NCT03434119|12036343|FG000|Overall Study|Withdrawal by Subject|7
7625041|NCT03434119|12036344|FG001|Overall Study|Withdrawal by Subject|5
7625042|NCT03434119|12036343|FG000|Overall Study|Other than specified|7
7625043|NCT03434119|12036344|FG001|Overall Study|Other than specified|5
7625044|NCT03417245|12036352|FG000|Overall Study|Adverse Event|1
7625045|NCT03417245|12036353|FG001|Overall Study|Adverse Event|0
7625046|NCT03417245|12036352|FG000|Overall Study|Protocol Violation|1
7625047|NCT03417245|12036353|FG001|Overall Study|Protocol Violation|0
7625048|NCT03417245|12036352|FG000|Overall Study|Withdrawal by Subject|1
7625049|NCT03417245|12036353|FG001|Overall Study|Withdrawal by Subject|1
7625050|NCT03417102|12036361|FG000|Overall Study|Adverse Event|0
7625051|NCT03417102|12036362|FG001|Overall Study|Adverse Event|1
7270137|NCT00414050|11484241|FG003|Overall Study|Withdrawal by Subject|4
7581772|NCT00960752|11982697|FG000|Overall Study|Adverse Event|0
7581773|NCT00960752|11982698|FG001|Overall Study|Adverse Event|0
7581774|NCT00960752|11982699|FG002|Overall Study|Adverse Event|1
7581775|NCT00960752|11982697|FG000|Overall Study|Progression|0
7581776|NCT00960752|11982698|FG001|Overall Study|Progression|0
7581777|NCT00960752|11982699|FG002|Overall Study|Progression|1
7581778|NCT00958347|11982707|FG000|Overall Study|Death|43
7581779|NCT00958347|11982707|FG000|Overall Study|Withdrawal by Subject|23
7581780|NCT00958347|11982707|FG000|Overall Study|Lost to Follow-up|15
7581781|NCT00958347|11982707|FG000|Overall Study|revision/removal|10
7581782|NCT00958347|11982707|FG000|Overall Study|study termination|135
7581783|NCT00953615|11982720|FG000|Overall Study|Adverse Event|1
7581784|NCT00957034|11982732|FG000|Overall Study|Adverse Event|0
7581785|NCT00957034|11982733|FG001|Overall Study|Adverse Event|1
7581786|NCT00957034|11982734|FG002|Overall Study|Adverse Event|1
7581787|NCT00957034|11982732|FG000|Overall Study|Sponsor Terminated Study|6
7581788|NCT00957034|11982733|FG001|Overall Study|Sponsor Terminated Study|1
7581789|NCT00957034|11982734|FG002|Overall Study|Sponsor Terminated Study|5
7581790|NCT00957034|11982732|FG000|Overall Study|Withdrawal by Subject|0
7581791|NCT00957034|11982733|FG001|Overall Study|Withdrawal by Subject|2
7581792|NCT00957034|11982734|FG002|Overall Study|Withdrawal by Subject|0
7581793|NCT00949988|11982742|FG000|Overall Study|Withdrawal by Subject|3
7581794|NCT00948194|11982748|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
7581795|NCT00948194|11982749|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
7581796|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
7581797|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
7581798|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
7581799|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
7581800|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
7581801|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
7581802|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
7581803|NCT00946985|11982755|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
7581804|NCT00946985|11982755|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
7581805|NCT00950690|11982763|FG000|Overall Study|Death|4
7581806|NCT00950690|11982763|FG000|Overall Study|Adverse Event|15
7581807|NCT00950690|11982763|FG000|Overall Study|Lack of Efficacy|22
7581808|NCT00950690|11982763|FG000|Overall Study|Lost to Follow-up|40
7581809|NCT00950690|11982763|FG000|Overall Study|Other|163
7581810|NCT00944229|11982767|FG000|Overall Study|Withdrawal by Subject|11
7581811|NCT00944229|11982767|FG000|Overall Study|Physician Decision|14
7581812|NCT00941928|11982771|FG000|Overall Study|Withdrawal by Subject|1
7581813|NCT00941928|11982771|FG000|Overall Study|Disease Progression|1
7581814|NCT00947011|11982788|FG000|Overall Study|Study was terminated,PI left institution|12
7581815|NCT00943605|11982796|FG000|Overall Study|Study termination|30
7581816|NCT00943605|11982797|FG001|Overall Study|Study termination|30
7581817|NCT00942409|11982803|FG000|Overall Study|Lack of Efficacy|1
7581818|NCT00942409|11982803|FG000|Overall Study|study drug unavailable|2
7581819|NCT00936598|11982813|FG000|Overall Study|Withdrawal by Subject|1
7581820|NCT00936598|11982814|FG001|Overall Study|Withdrawal by Subject|0
7581821|NCT00936598|11982813|FG000|Overall Study|Ineligible after consent|1
7581822|NCT00936598|11982814|FG001|Overall Study|Ineligible after consent|0
7581823|NCT00934791|11982838|FG000|Overall Study|Withdrawal by Subject|1
7581824|NCT00934791|11982839|FG001|Overall Study|Withdrawal by Subject|0
7581825|NCT00925548|11982887|FG000|Overall Study|Discontinuation of trial by sponsor|10
7581826|NCT00925548|11982888|FG001|Overall Study|Discontinuation of trial by sponsor|5
7581827|NCT00926575|11982897|FG000|Overall Study|Adverse Event|1
7270138|NCT00414050|11484238|FG000|Overall Study|Subject discontinued for other reason|1
7270139|NCT00414050|11484239|FG001|Overall Study|Subject discontinued for other reason|2
7270140|NCT00414050|11484240|FG002|Overall Study|Subject discontinued for other reason|2
7270141|NCT00414050|11484241|FG003|Overall Study|Subject discontinued for other reason|1
7581828|NCT00926575|11982898|FG001|Overall Study|Adverse Event|1
7581829|NCT00926575|11982897|FG000|Overall Study|Death|4
7581830|NCT00926575|11982898|FG001|Overall Study|Death|4
7581831|NCT00926575|11982897|FG000|Overall Study|Lost to Follow-up|1
7581832|NCT00926575|11982898|FG001|Overall Study|Lost to Follow-up|1
7581833|NCT00926575|11982897|FG000|Overall Study|Physician Decision|1
7581834|NCT00926575|11982898|FG001|Overall Study|Physician Decision|2
7581835|NCT00926575|11982897|FG000|Overall Study|Protocol Violation|1
7581836|NCT00926575|11982898|FG001|Overall Study|Protocol Violation|0
7581837|NCT00926575|11982897|FG000|Overall Study|Withdrawal by Subject|8
7581838|NCT00926575|11982898|FG001|Overall Study|Withdrawal by Subject|9
7581839|NCT00918463|11982925|FG000|Overall Study|Death|1
7581840|NCT00918463|11982925|FG000|Overall Study|Lack of Efficacy|1
7581841|NCT00913692|11982929|FG000|Screening (4 Months)|Physician Decision|3
7581842|NCT00913692|11982929|FG000|Screening (4 Months)|Not eligible after screening phase.|6
7581843|NCT00913692|11982929|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
7581844|NCT00918645|11982936|FG000|Overall Study|Withdrawal by Subject|1
7581845|NCT00906035|11982969|FG000|Overall Study|Withdrawal by Subject|2
7581846|NCT00906035|11982970|FG001|Overall Study|Withdrawal by Subject|3
7581847|NCT00906035|11982971|FG002|Overall Study|Withdrawal by Subject|0
7581848|NCT00894790|11983002|FG000|Overall Study|Protocol Violation|0
7581849|NCT00894790|11983003|FG001|Overall Study|Protocol Violation|1
7581850|NCT00894790|11983002|FG000|Overall Study|Lost to Follow-up|0
7581851|NCT00894790|11983003|FG001|Overall Study|Lost to Follow-up|1
7581852|NCT00894790|11983002|FG000|Overall Study|Did not meet entrance criteria|1
7581853|NCT00894790|11983003|FG001|Overall Study|Did not meet entrance criteria|0
7581854|NCT00902668|11983009|FG000|Overall Study|Protocol stopped due to slow accrual.|3
7581855|NCT00881205|11983015|FG000|Overall Study|Adverse Event|8
7581856|NCT00881205|11983016|FG001|Overall Study|Adverse Event|3
7581857|NCT00881205|11983015|FG000|Overall Study|Withdrawal by Subject|1
7581858|NCT00881205|11983016|FG001|Overall Study|Withdrawal by Subject|2
7581859|NCT00881205|11983015|FG000|Overall Study|Lost to Follow-up|0
7581860|NCT00881205|11983016|FG001|Overall Study|Lost to Follow-up|1
7581861|NCT00881205|11983015|FG000|Overall Study|Administrative problems|1
7581862|NCT00881205|11983016|FG001|Overall Study|Administrative problems|1
7581863|NCT00881205|11983015|FG000|Overall Study|Condition no longer requires drug|1
7581864|NCT00881205|11983016|FG001|Overall Study|Condition no longer requires drug|0
7581865|NCT00903006|11983033|FG000|Overall Study|Withdrawal by Subject|2
7581866|NCT00903006|11983034|FG001|Overall Study|Withdrawal by Subject|0
7581867|NCT00903006|11983035|FG002|Overall Study|Withdrawal by Subject|0
7581868|NCT00903006|11983036|FG003|Overall Study|Withdrawal by Subject|0
7581869|NCT00903006|11983033|FG000|Overall Study|Progressive Disease|0
7581870|NCT00903006|11983034|FG001|Overall Study|Progressive Disease|3
7581871|NCT00903006|11983035|FG002|Overall Study|Progressive Disease|1
7581872|NCT00903006|11983036|FG003|Overall Study|Progressive Disease|0
7581873|NCT00887315|11983053|FG000|Overall Study|Study termination|7
7581874|NCT00887315|11983054|FG001|Overall Study|Study termination|4
7581875|NCT00891904|11983060|FG000|Overall Study|Death|1
7581876|NCT00891904|11983060|FG000|Overall Study|Adverse Event|1
7581877|NCT00881608|11983069|FG000|Overall Study|Study prematurely terminated|11
7581878|NCT00889421|11983081|FG000|Overall Study|Lack of Efficacy|3
7581879|NCT00882310|11983098|FG000|Overall Study|Screen Failure|10
7581880|NCT00882310|11983098|FG000|Overall Study|Never received treatment|1
7581881|NCT00882310|11983098|FG000|Overall Study|Death|6
7581882|NCT00882310|11983098|FG000|Overall Study|Progression of disease|4
7581883|NCT00882310|11983098|FG000|Overall Study|Adverse Event|1
7581884|NCT00880542|11983102|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
7581885|NCT00880542|11983102|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
7581886|NCT00880542|11983102|FG000|REP: Surgical Resection|progressive disease|1
7581887|NCT00874939|11983110|FG000|Overall Study|Study terminated|4
7581888|NCT00877071|11983137|FG000|Overall Study|disease progression|2
7581889|NCT00878969|11983144|FG000|Overall Study|Physician Decision|5
7581890|NCT00878969|11983145|FG001|Overall Study|Physician Decision|3
7581891|NCT00878969|11983146|FG002|Overall Study|Physician Decision|2
7581892|NCT00878969|11983144|FG000|Overall Study|Withdrawal by Subject|1
7581893|NCT00878969|11983145|FG001|Overall Study|Withdrawal by Subject|6
7581894|NCT00878969|11983146|FG002|Overall Study|Withdrawal by Subject|3
7581895|NCT00878969|11983144|FG000|Overall Study|kidney transplant|2
7581896|NCT00878969|11983145|FG001|Overall Study|kidney transplant|3
7581897|NCT00878969|11983146|FG002|Overall Study|kidney transplant|2
7581898|NCT00878969|11983144|FG000|Overall Study|Adverse Event|3
7581899|NCT00878969|11983145|FG001|Overall Study|Adverse Event|1
7581900|NCT00878969|11983146|FG002|Overall Study|Adverse Event|2
7581901|NCT00878969|11983144|FG000|Overall Study|Lost to Follow-up|2
7581902|NCT00878969|11983145|FG001|Overall Study|Lost to Follow-up|1
7581903|NCT00878969|11983146|FG002|Overall Study|Lost to Follow-up|0
7581904|NCT00878969|11983144|FG000|Overall Study|Protocol Violation|2
7581905|NCT00878969|11983145|FG001|Overall Study|Protocol Violation|0
7581906|NCT00878969|11983146|FG002|Overall Study|Protocol Violation|0
7581907|NCT00878969|11983144|FG000|Overall Study|Death|0
7581908|NCT00878969|11983145|FG001|Overall Study|Death|0
7581909|NCT00878969|11983146|FG002|Overall Study|Death|2
7581910|NCT00878969|11983144|FG000|Overall Study|Pregnancy|0
7581911|NCT00878969|11983145|FG001|Overall Study|Pregnancy|1
7581912|NCT00878969|11983146|FG002|Overall Study|Pregnancy|0
7581913|NCT00865514|11983154|FG000|Overall Study|Infusion cost exceeded funding|2
7581914|NCT00863512|11983171|FG000|Overall Study|Adverse Event|2
7581915|NCT00863512|11983172|FG001|Overall Study|Adverse Event|0
7581916|NCT00863512|11983171|FG000|Overall Study|Withdrawal by Subject|11
7581917|NCT00863512|11983172|FG001|Overall Study|Withdrawal by Subject|0
7581918|NCT00863512|11983171|FG000|Overall Study|Physician Decision|1
7581919|NCT00863512|11983172|FG001|Overall Study|Physician Decision|0
7581920|NCT00868998|11983178|FG000|Overall Study|Screen Failure|1
7581921|NCT00868998|11983178|FG000|Overall Study|Withdrawal by Subject|1
7581922|NCT00868998|11983178|FG000|Overall Study|Progression of disease|2
7581923|NCT00868998|11983178|FG000|Overall Study|Death|1
7581924|NCT00869258|11983182|FG000|Overall Study|Physician Decision|1
7581925|NCT00863330|11983186|FG000|Overall Study|study terminated early due to administra|6
7581926|NCT00853229|11983192|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7581927|NCT00853229|11983193|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
7581928|NCT00860249|11983204|FG000|Overall Study|trial was terminated prior to completion|21
7581929|NCT00860249|11983205|FG001|Overall Study|trial was terminated prior to completion|18
7581930|NCT00860249|11983206|FG002|Overall Study|trial was terminated prior to completion|21
7581931|NCT00860158|11983214|FG000|Overall Study|Study Terminated|1
7581932|NCT00853567|11983221|FG000|Overall Study|Study prematurely terminated|71
7581933|NCT00849524|11983229|FG000|Overall Study|Lack of Efficacy|3
7581934|NCT00851682|11983244|FG000|Overall Study|screen failure|5
7581935|NCT00851682|11983245|FG001|Overall Study|screen failure|0
7581936|NCT00851747|11983267|FG000|Overall Study|Physician Decision|6
7581937|NCT00851747|11983268|FG001|Overall Study|Physician Decision|6
7581938|NCT00851747|11983269|FG002|Overall Study|Physician Decision|6
7581939|NCT00852241|11983276|FG000|Overall Study|Physician Decision|18
7581940|NCT00851552|11983280|FG000|Overall Study|Death|2
7581941|NCT00851552|11983280|FG000|Overall Study|Adverse Event|1
7581942|NCT00851552|11983280|FG000|Overall Study|Disease Progression|4
7581943|NCT00845845|11983290|FG000|Overall Study|Lost to Follow-up|0
7581944|NCT00845845|11983291|FG001|Overall Study|Lost to Follow-up|4
7581945|NCT00851591|11983299|FG000|Overall Study|Withdrawal by Subject|2
7581946|NCT00851591|11983300|FG001|Overall Study|Withdrawal by Subject|0
7581947|NCT00835679|11983337|FG000|Overall Study|Withdrawal by Subject|1
7581948|NCT00835679|11983338|FG001|Overall Study|Withdrawal by Subject|0
7581949|NCT00835679|11983339|FG002|Overall Study|Withdrawal by Subject|0
7581950|NCT00835679|11983340|FG003|Overall Study|Withdrawal by Subject|0
7581951|NCT00841035|11983354|FG000|Phase 1 Overall Study|Physician Decision|13
7581952|NCT00840827|11983372|FG000|Overall Study|Adverse Event|1
7581953|NCT00840827|11983372|FG000|Overall Study|Lack of Efficacy|4
7581954|NCT00840827|11983372|FG000|Overall Study|Physician Decision|1
7581955|NCT00832624|11983406|FG000|Overall Study|Study Terminated|10
7581956|NCT00827567|11983449|FG000|Overall Study|Progression of Disease/Screen Failure|4
7625052|NCT03417102|12036361|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
7625053|NCT03417102|12036362|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
7625054|NCT03417102|12036361|FG000|Overall Study|Other|0
7625055|NCT03417102|12036362|FG001|Overall Study|Other|1
7625056|NCT03278626|12036368|FG000|Overall Study|Death|2
7625057|NCT03278626|12036368|FG000|Overall Study|Toxicity|1
7625058|NCT03278626|12036368|FG000|Overall Study|Disease Progression|2
7625059|NCT03211858|12036374|FG000|Overall Study|Adverse Event|8
7625060|NCT03211858|12036375|FG001|Overall Study|Adverse Event|6
7625061|NCT03211858|12036374|FG000|Overall Study|Lack of Efficacy|0
7625062|NCT03211858|12036375|FG001|Overall Study|Lack of Efficacy|4
7625063|NCT03211858|12036374|FG000|Overall Study|Poor compliance to protocol|6
7625064|NCT03211858|12036375|FG001|Overall Study|Poor compliance to protocol|2
7625065|NCT03211858|12036374|FG000|Overall Study|Non-serious Hypoglycemia|1
7625066|NCT03211858|12036375|FG001|Overall Study|Non-serious Hypoglycemia|0
7625067|NCT03211858|12036374|FG000|Overall Study|Other than specified above|22
7625068|NCT03211858|12036375|FG001|Overall Study|Other than specified above|21
7625069|NCT03077438|12036391|FG000|Overall Study|Protocol Violation|3
7625070|NCT03077438|12036392|FG001|Overall Study|Protocol Violation|5
7625071|NCT03077438|12036391|FG000|Overall Study|Withdrawal by Subject|3
7625072|NCT03077438|12036392|FG001|Overall Study|Withdrawal by Subject|6
7625073|NCT03077438|12036391|FG000|Overall Study|Lost to Follow-up|6
7625074|NCT03077438|12036392|FG001|Overall Study|Lost to Follow-up|3
7625075|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
7625076|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
7581957|NCT00815633|11983453|FG000|Overall Study|study terminated|1
7581958|NCT00814983|11983459|FG000|Overall Study|Screen failure|1
7581959|NCT00814983|11983460|FG001|Overall Study|Screen failure|0
7581960|NCT00814983|11983459|FG000|Overall Study|Withdrawal by Subject|1
7581961|NCT00814983|11983460|FG001|Overall Study|Withdrawal by Subject|0
7581962|NCT00814983|11983459|FG000|Overall Study|Graft failure|1
7581963|NCT00814983|11983460|FG001|Overall Study|Graft failure|0
7581964|NCT00819832|11983483|FG000|Overall Study|Sponsor Termination of Study|3
7581965|NCT00819832|11983484|FG001|Overall Study|Sponsor Termination of Study|0
7581966|NCT00819832|11983485|FG002|Overall Study|Sponsor Termination of Study|0
7581967|NCT00819832|11983486|FG003|Overall Study|Sponsor Termination of Study|0
7581968|NCT00819832|11983487|FG004|Overall Study|Sponsor Termination of Study|0
7581969|NCT00819832|11983488|FG005|Overall Study|Sponsor Termination of Study|0
7581970|NCT00814892|11983511|FG000|Overall Study|Disease Progression|1
7581971|NCT00814892|11983511|FG000|Overall Study|Study Termination|1
7581972|NCT00802659|11983528|FG000|Overall Study|Physician Decision|0
7581973|NCT00802659|11983529|FG001|Overall Study|Physician Decision|1
7581974|NCT00802659|11983530|FG002|Overall Study|Physician Decision|0
7581975|NCT00802659|11983531|FG003|Overall Study|Physician Decision|0
7581976|NCT00807365|11983541|FG000|Overall Study|Study Terminated|5
7581977|NCT00814333|11983547|FG000|Enrollment|Lost to Follow-up|1
7581978|NCT00814333|11983548|FG001|Enrollment|Lost to Follow-up|0
7581979|NCT00808080|11983554|FG000|Overall Study|Patients Became Ineligible for infusion|6
7581980|NCT00802893|11983559|FG000|Overall Study|study terminated|3
7581981|NCT00809341|11983565|FG000|Overall Study|Physician Decision|0
7581982|NCT00809341|11983566|FG001|Overall Study|Physician Decision|1
7581983|NCT00808899|11983594|FG000|Overall Study|Death|1
7581984|NCT00808899|11983594|FG000|Overall Study|Physician Decision|3
7581985|NCT00803179|11983605|FG000|Overall Study|Lost to Follow-up|3
7581986|NCT00790452|11983644|FG000|Overall Study|Drug supply issue|1
7581987|NCT00790452|11983645|FG001|Overall Study|Drug supply issue|0
7581988|NCT00787917|11983657|FG000|Blinded Treatment|Adverse Event|1
7581989|NCT00787917|11983658|FG001|Blinded Treatment|Adverse Event|0
7581990|NCT00787917|11983657|FG000|Blinded Treatment|Lack of Efficacy|1
7581991|NCT00787917|11983658|FG001|Blinded Treatment|Lack of Efficacy|0
7581992|NCT00787917|11983657|FG000|Blinded Treatment|Administrative problems|3
7581993|NCT00787917|11983658|FG001|Blinded Treatment|Administrative problems|2
7581994|NCT00787917|11983657|FG000|Open Label|Unsatisfactory therapeutic effect|1
7581995|NCT00787917|11983658|FG001|Open Label|Unsatisfactory therapeutic effect|0
7581996|NCT00787917|11983657|FG000|Open Label|Administrative problems|3
7581997|NCT00787917|11983658|FG001|Open Label|Administrative problems|0
7581998|NCT00798590|11983668|FG000|Overall Study|P.I, Left institution. Study terminated|11
7581999|NCT00798590|11983669|FG001|Overall Study|P.I, Left institution. Study terminated|8
7582000|NCT00796510|11983677|FG000|Overall Study|Death|1
7582001|NCT00796510|11983678|FG001|Overall Study|Death|0
7582002|NCT00796510|11983677|FG000|Overall Study|Study Terminated|2
7582003|NCT00796510|11983678|FG001|Overall Study|Study Terminated|0
7582004|NCT00796861|11983684|FG000|Overall Study|Withdrawal by Subject|2
7582005|NCT00796861|11983684|FG000|Overall Study|Death|2
7582006|NCT00791076|11983688|FG000|Overall Study|Study was terminated,PI left institution|8
7582007|NCT00796107|11983703|FG000|Overall Study|Lack of Efficacy|1
7582008|NCT00796107|11983703|FG000|Overall Study|Progressive Disease|5
7582009|NCT00785356|11983727|FG000|Overall Study|Study prematurely terminated|8
7582010|NCT00782483|11983735|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
7582011|NCT00784043|11983745|FG000|Overall Study|Withdrawal by Subject|8
7582012|NCT00784043|11983746|FG001|Overall Study|Withdrawal by Subject|5
7582013|NCT00784043|11983745|FG000|Overall Study|Protocol Terminated|23
7582014|NCT00784043|11983746|FG001|Overall Study|Protocol Terminated|1
7582015|NCT00774306|11983769|FG000|Overall Study|Adverse Event|3
7582016|NCT00774306|11983770|FG001|Overall Study|Adverse Event|0
7582017|NCT00774306|11983771|FG002|Overall Study|Adverse Event|0
7582018|NCT00774306|11983772|FG003|Overall Study|Adverse Event|0
7582019|NCT00774306|11983769|FG000|Overall Study|Protocol Violation|2
7582020|NCT00774306|11983770|FG001|Overall Study|Protocol Violation|0
7582021|NCT00774306|11983771|FG002|Overall Study|Protocol Violation|3
7582022|NCT00774306|11983772|FG003|Overall Study|Protocol Violation|0
7582023|NCT00774306|11983769|FG000|Overall Study|Withdrawal by Subject|6
7582024|NCT00774306|11983770|FG001|Overall Study|Withdrawal by Subject|1
7582025|NCT00774306|11983771|FG002|Overall Study|Withdrawal by Subject|1
7582026|NCT00774306|11983772|FG003|Overall Study|Withdrawal by Subject|0
7582027|NCT00774306|11983769|FG000|Overall Study|Lost to Follow-up|6
7582028|NCT00774306|11983770|FG001|Overall Study|Lost to Follow-up|0
7582029|NCT00774306|11983771|FG002|Overall Study|Lost to Follow-up|4
7582030|NCT00774306|11983772|FG003|Overall Study|Lost to Follow-up|5
7582031|NCT00774306|11983769|FG000|Overall Study|Death|1
7582032|NCT00774306|11983770|FG001|Overall Study|Death|1
7582033|NCT00774306|11983771|FG002|Overall Study|Death|0
7582034|NCT00774306|11983772|FG003|Overall Study|Death|0
7582035|NCT00779038|11983795|FG000|Overall Study|Study Prematurely Terminated|13
7582036|NCT00776100|11983810|FG000|Overall Study|Disease Progression|1
7582037|NCT00776100|11983811|FG001|Overall Study|Disease Progression|0
7582038|NCT00771316|11983819|FG000|Overall Study|Adverse Event|0
7582039|NCT00771316|11983820|FG001|Overall Study|Adverse Event|1
7582040|NCT00771316|11983819|FG000|Overall Study|Patient withdrew consent|1
7582041|NCT00771316|11983820|FG001|Overall Study|Patient withdrew consent|0
7582042|NCT00771316|11983819|FG000|Overall Study|Discontinued due to early termination|1
7582043|NCT00771316|11983820|FG001|Overall Study|Discontinued due to early termination|0
7582044|NCT00768040|11983841|FG000|Overall Study|Adverse Event|3
7582045|NCT00768040|11983842|FG001|Overall Study|Adverse Event|2
7582046|NCT00768040|11983841|FG000|Overall Study|Abnormal laboratory value|1
7582047|NCT00768040|11983842|FG001|Overall Study|Abnormal laboratory value|1
7582048|NCT00776555|11983850|FG000|Overall Study|Study terminated|3
7582049|NCT00776555|11983851|FG001|Overall Study|Study terminated|0
7582050|NCT00775190|11983859|FG000|Overall Study|Lost to Follow-up|2
7582051|NCT00775190|11983860|FG001|Overall Study|Lost to Follow-up|3
7582052|NCT00775190|11983859|FG000|Overall Study|Withdrawal by Subject|1
7582053|NCT00775190|11983860|FG001|Overall Study|Withdrawal by Subject|2
7582054|NCT00775190|11983859|FG000|Overall Study|Protocol Violation|1
7582055|NCT00775190|11983860|FG001|Overall Study|Protocol Violation|0
7582056|NCT00762723|11983873|FG000|Overall Study|Study Terminated slow enrollement|5
7582057|NCT00762723|11983874|FG001|Overall Study|Study Terminated slow enrollement|5
7582058|NCT00762723|11983875|FG002|Overall Study|Study Terminated slow enrollement|3
7582059|NCT00770965|11983887|FG000|Safety Set|Withdrawal by Subject|0
7582060|NCT00770965|11983888|FG001|Safety Set|Withdrawal by Subject|0
7582061|NCT00770965|11983889|FG002|Safety Set|Withdrawal by Subject|0
7582062|NCT00770965|11983890|FG003|Safety Set|Withdrawal by Subject|1
7582063|NCT00770965|11983887|FG000|Safety Set|Protocol deviation|0
7582064|NCT00770965|11983888|FG001|Safety Set|Protocol deviation|0
7582065|NCT00770965|11983889|FG002|Safety Set|Protocol deviation|1
7582066|NCT00770965|11983890|FG003|Safety Set|Protocol deviation|0
7582067|NCT00770965|11983887|FG000|Excluded Set|Administrative problems|14
7582068|NCT00770965|11983888|FG001|Excluded Set|Administrative problems|12
7582069|NCT00770965|11983889|FG002|Excluded Set|Administrative problems|12
7582070|NCT00770965|11983890|FG003|Excluded Set|Administrative problems|10
7582071|NCT00770965|11983887|FG000|Excluded Set|Withdrawal by Subject|1
7582072|NCT00770965|11983888|FG001|Excluded Set|Withdrawal by Subject|1
7582073|NCT00770965|11983889|FG002|Excluded Set|Withdrawal by Subject|2
7582074|NCT00770965|11983890|FG003|Excluded Set|Withdrawal by Subject|3
7582075|NCT00769002|11983904|FG000|Overall Study|Study was not completed, no data|9
7582076|NCT00769002|11983905|FG001|Overall Study|Study was not completed, no data|9
7582077|NCT00766636|11983912|FG000|Overall Study|Withdrawal by Subject|1
7582078|NCT00766636|11983913|FG001|Overall Study|Withdrawal by Subject|1
7582079|NCT00766636|11983912|FG000|Overall Study|Incomplete Treatment|0
7582080|NCT00766636|11983913|FG001|Overall Study|Incomplete Treatment|1
7582081|NCT00766636|11983912|FG000|Overall Study|Adverse Event|1
7582082|NCT00766636|11983913|FG001|Overall Study|Adverse Event|0
7582083|NCT00766636|11983912|FG000|Overall Study|Disease Progression|1
7582084|NCT00766636|11983913|FG001|Overall Study|Disease Progression|0
7582085|NCT00768248|11983921|FG000|Overall Study|Research coordinator didn't collect data|1
7582086|NCT00768248|11983922|FG001|Overall Study|Research coordinator didn't collect data|1
7582087|NCT00764699|11983932|FG000|Overall Study|PI left and study terminated|3
7582088|NCT00763009|11983940|FG000|Overall Study|Coronary Anatomy unsuitable|1
7582089|NCT00761176|11983947|FG000|Overall Study|Death|1
7582090|NCT00761176|11983948|FG001|Overall Study|Death|0
7582091|NCT00761176|11983947|FG000|Overall Study|Withdrawal by Subject|1
7582092|NCT00761176|11983948|FG001|Overall Study|Withdrawal by Subject|1
7582093|NCT00754793|11983973|FG000|Overall Study|voluntary withdrawn from study|0
7582094|NCT00754793|11983974|FG001|Overall Study|voluntary withdrawn from study|1
7582095|NCT00754052|11983982|FG000|Overall Study|Study terminated by Sponsor|5
7582096|NCT00754052|11983983|FG001|Overall Study|Study terminated by Sponsor|3
7582097|NCT00750204|11984005|FG000|Overall Study|study halted prematurely|1
7582098|NCT00750204|11984006|FG001|Overall Study|study halted prematurely|1
7582099|NCT00752986|11984028|FG000|Overall Study|Withdrawal by Subject|2
7582100|NCT00752986|11984029|FG001|Overall Study|Withdrawal by Subject|1
7582101|NCT00752986|11984030|FG002|Overall Study|Withdrawal by Subject|2
7582102|NCT00752986|11984028|FG000|Overall Study|Protocol Violation|3
7582103|NCT00752986|11984029|FG001|Overall Study|Protocol Violation|0
7582104|NCT00752986|11984030|FG002|Overall Study|Protocol Violation|0
7582105|NCT00754013|11984053|FG000|Overall Study|Lost to Follow-up|1
7582106|NCT00754013|11984054|FG001|Overall Study|Lost to Follow-up|1
7582107|NCT00754013|11984053|FG000|Overall Study|didn't return after study termed|3
7582108|NCT00754013|11984054|FG001|Overall Study|didn't return after study termed|4
7582109|NCT00735553|11984063|FG000|Overall Study|Study prematurely terminated|77
7582110|NCT00751933|11984071|FG000|Overall Study|Withdrawal by Subject|0
7582111|NCT00751933|11984072|FG001|Overall Study|Withdrawal by Subject|1
7582112|NCT00751933|11984073|FG002|Overall Study|Withdrawal by Subject|0
7582113|NCT00751933|11984074|FG003|Overall Study|Withdrawal by Subject|0
7582114|NCT00751933|11984071|FG000|Overall Study|Physician Decision|0
7582115|NCT00751933|11984072|FG001|Overall Study|Physician Decision|0
7582116|NCT00751933|11984073|FG002|Overall Study|Physician Decision|1
7582117|NCT00751933|11984074|FG003|Overall Study|Physician Decision|1
7582118|NCT00747461|11984091|FG000|Overall Study|study terminated by sponsor|5
7582119|NCT00736385|11984106|FG000|Overall Study|Withdrawal by Subject|2
7582120|NCT00736385|11984107|FG001|Overall Study|Withdrawal by Subject|2
7582121|NCT00736385|11984106|FG000|Overall Study|Adverse Event|0
7582122|NCT00736385|11984107|FG001|Overall Study|Adverse Event|1
7582123|NCT00739063|11984130|FG000|Overall Study|Screen failures|8
7582124|NCT00740597|11984134|FG000|Overall Study|insurance would not cover treatment|1
7582125|NCT00737282|11984153|FG000|Overall Study|Study prematurely terminated|175
7582126|NCT00739882|11984161|FG000|Double-blind Period|Adverse Event|1
7582127|NCT00739882|11984162|FG001|Double-blind Period|Adverse Event|2
7582128|NCT00739882|11984161|FG000|Double-blind Period|Protocol Violation|1
7582129|NCT00739882|11984162|FG001|Double-blind Period|Protocol Violation|0
7582130|NCT00739882|11984161|FG000|Double-blind Period|Lack of Efficacy|1
7582131|NCT00739882|11984162|FG001|Double-blind Period|Lack of Efficacy|1
7582132|NCT00739882|11984161|FG000|Double-blind Period|Other|16
7582133|NCT00739882|11984162|FG001|Double-blind Period|Other|8
7582134|NCT00739882|11984161|FG000|Open-label Period|Adverse Event|1
7582135|NCT00739882|11984162|FG001|Open-label Period|Adverse Event|0
7582136|NCT00739882|11984161|FG000|Open-label Period|Other|9
7582137|NCT00739882|11984162|FG001|Open-label Period|Other|5
7582138|NCT00735254|11984194|FG000|Overall Study|Protocol Violation|1
7582139|NCT00735254|11984195|FG001|Overall Study|Protocol Violation|1
7582140|NCT00735254|11984196|FG002|Overall Study|Protocol Violation|1
7582141|NCT00735254|11984197|FG003|Overall Study|Protocol Violation|0
7582142|NCT00729365|11984210|FG000|Overall Study|Physician Decision|33
7582143|NCT00729365|11984211|FG001|Overall Study|Physician Decision|6
7582144|NCT00729365|11984212|FG002|Overall Study|Physician Decision|7
7582145|NCT00724282|11984230|FG000|Overall Study|Withdrawal by Subject|3
7582146|NCT00724282|11984230|FG000|Overall Study|Physician Decision|1
7582147|NCT00730886|11984236|FG000|Overall Study|Lost to Follow-up|1
7582148|NCT00730886|11984237|FG001|Overall Study|Lost to Follow-up|0
7582149|NCT00730886|11984236|FG000|Overall Study|Physician Decision|1
7582150|NCT00730886|11984237|FG001|Overall Study|Physician Decision|0
7625077|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Adverse Event|2
7625078|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Adverse Event|5
7625079|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
7625080|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
7625081|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
7625082|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
7625083|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Randomized by error|0
7625084|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Randomized by error|5
7625085|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Randomized and not treated|0
7625086|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Randomized and not treated|3
7625087|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
7625088|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
7625089|NCT02948959|12036408|FG000|52 Weeks Treatment Period|Change of residence location|0
7625090|NCT02948959|12036409|FG001|52 Weeks Treatment Period|Change of residence location|1
7625091|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Adverse Event|0
7625092|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Adverse Event|2
7625093|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
7625094|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
7625095|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
7625096|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
7625097|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Randomized by error|0
7625098|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Randomized by error|3
7625099|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Change of residence location|0
7625100|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Change of residence location|2
7625101|NCT02948959|12036408|FG000|12 Weeks Follow-up Period|Study site closure|1
7625102|NCT02948959|12036409|FG001|12 Weeks Follow-up Period|Study site closure|0
7625103|NCT02878603|12036425|FG000|Overall Study|Lost to Follow-up|4
7625104|NCT02878603|12036426|FG001|Overall Study|Lost to Follow-up|1
7625105|NCT02878603|12036425|FG000|Overall Study|Withdrawal by Subject|1
7625106|NCT02878603|12036426|FG001|Overall Study|Withdrawal by Subject|1
7625107|NCT02878603|12036425|FG000|Overall Study|Death|1
7625108|NCT02878603|12036426|FG001|Overall Study|Death|0
7625109|NCT02878603|12036425|FG000|Overall Study|Physician Decision|0
7625110|NCT02878603|12036426|FG001|Overall Study|Physician Decision|3
7625111|NCT02864407|12036432|FG000|Overall Study|Protocol Violation|3
7625112|NCT02864407|12036432|FG000|Overall Study|Lost to Follow-up|115
7625113|NCT02864407|12036432|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
7625114|NCT02864407|12036432|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
7625115|NCT02864407|12036432|FG000|Overall Study|Consent prior to the contract date|1
7625116|NCT02846532|12036439|FG000|Overall Study|Lost to Follow-up|0
7625117|NCT02846532|12036440|FG001|Overall Study|Lost to Follow-up|1
7625118|NCT02846532|12036441|FG002|Overall Study|Lost to Follow-up|1
7625119|NCT02846532|12036439|FG000|Overall Study|Withdrawal by Subject|1
7625120|NCT02846532|12036440|FG001|Overall Study|Withdrawal by Subject|2
7625121|NCT02846532|12036441|FG002|Overall Study|Withdrawal by Subject|0
7625122|NCT02688933|12036451|FG000|Overall Study|Adverse Event|3
7625123|NCT02688933|12036452|FG001|Overall Study|Adverse Event|1
7625124|NCT02688933|12036451|FG000|Overall Study|Lack of Efficacy|2
7625125|NCT02688933|12036452|FG001|Overall Study|Lack of Efficacy|2
7625126|NCT02688933|12036451|FG000|Overall Study|Poor compliance to protocol|7
7625127|NCT02688933|12036452|FG001|Overall Study|Poor compliance to protocol|4
7582151|NCT00729560|11984265|FG000|Overall Study|Withdrawal by Subject|3
7582152|NCT00714948|11984286|FG000|Overall Study|Adverse Event|2
7582153|NCT00720343|11984290|FG000|Overall Study|Physician Decision|3
7582154|NCT00720343|11984290|FG000|Overall Study|No data|3
7582155|NCT00718640|11984305|FG000|Overall Study|Adverse Event|4
7582156|NCT00718640|11984305|FG000|Overall Study|Death|1
7582157|NCT00718640|11984305|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
7582158|NCT00720083|11984311|FG000|Overall Study|Ineligible|1
7582159|NCT00720083|11984312|FG001|Overall Study|Ineligible|2
7582160|NCT00717275|11984318|FG000|Overall Study|Premature study termination.|3
7582161|NCT00708734|11984322|FG000|Overall Study|scheduling conflict|2
7582162|NCT00708734|11984322|FG000|Overall Study|moved|1
7582163|NCT00708734|11984322|FG000|Overall Study|leg injury|1
7582164|NCT00708734|11984322|FG000|Overall Study|knee replacement|1
7582165|NCT00708734|11984322|FG000|Overall Study|vertigo|1
7582166|NCT00708734|11984322|FG000|Overall Study|leg fracture|1
7582167|NCT00711087|11984328|FG000|Overall Study|Lost to Follow-up|1
7582168|NCT00711087|11984329|FG001|Overall Study|Lost to Follow-up|0
7582169|NCT00706797|11984337|FG000|Overall Study|Lack of Efficacy|3
7582170|NCT00706797|11984338|FG001|Overall Study|Lack of Efficacy|0
7582171|NCT00706797|11984337|FG000|Overall Study|Adverse Event|0
7582172|NCT00706797|11984338|FG001|Overall Study|Adverse Event|3
7582173|NCT00706797|11984337|FG000|Overall Study|Withdrawal by Subject|8
7582174|NCT00706797|11984338|FG001|Overall Study|Withdrawal by Subject|1
7582175|NCT00706797|11984337|FG000|Overall Study|Death|1
7582176|NCT00706797|11984338|FG001|Overall Study|Death|0
7582177|NCT00706797|11984337|FG000|Overall Study|Discontinuation of study by sponsor|52
7582178|NCT00706797|11984338|FG001|Overall Study|Discontinuation of study by sponsor|63
7582179|NCT00706797|11984337|FG000|Overall Study|Protocol Violation|3
7582180|NCT00706797|11984338|FG001|Overall Study|Protocol Violation|2
7582181|NCT00706797|11984337|FG000|Overall Study|Lost to Follow-up|1
7582182|NCT00706797|11984338|FG001|Overall Study|Lost to Follow-up|2
7582183|NCT00706797|11984337|FG000|Overall Study|Other|1
7582184|NCT00706797|11984338|FG001|Overall Study|Other|0
7582185|NCT00713596|11984347|FG000|Overall Study|Study was terminated|2
7582186|NCT00713596|11984348|FG001|Overall Study|Study was terminated|3
7582187|NCT00713596|11984349|FG002|Overall Study|Study was terminated|2
7582188|NCT00703092|11984362|FG000|Overall Study|Withdrawal by Subject|2
7582189|NCT00713258|11984368|FG000|Overall Study|Adverse Event|2
7582190|NCT00713258|11984369|FG001|Overall Study|Adverse Event|4
7582191|NCT00713258|11984368|FG000|Overall Study|Non-Compliance|2
7582192|NCT00713258|11984369|FG001|Overall Study|Non-Compliance|1
7582193|NCT00713258|11984368|FG000|Overall Study|Other|1
7582194|NCT00713258|11984369|FG001|Overall Study|Other|1
7582195|NCT00707434|11984379|FG000|Overall Study|Adverse Event|1
7582196|NCT00707161|11984383|FG000|Overall Study|Physician Decision|6
7582197|NCT00708916|11984396|FG000|Overall Study|Subject Noncompliance|2
7582198|NCT00708916|11984396|FG000|Overall Study|Adverse Event|2
7582199|NCT00700778|11984401|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
7582200|NCT00699842|11984408|FG000|Overall Study|Death|0
7582201|NCT00699842|11984409|FG001|Overall Study|Death|1
7582202|NCT00699842|11984410|FG002|Overall Study|Death|0
7582203|NCT00702962|11984420|FG000|Overall Study|Progressive disease|0
7582204|NCT00702962|11984421|FG001|Overall Study|Progressive disease|1
7582205|NCT00702962|11984420|FG000|Overall Study|Hospitalized for other health disorder|1
7582206|NCT00702962|11984421|FG001|Overall Study|Hospitalized for other health disorder|0
7582207|NCT00703534|11984431|FG000|Overall Study|Adverse Event|14
7582208|NCT00703534|11984432|FG001|Overall Study|Adverse Event|3
7582209|NCT00703534|11984431|FG000|Overall Study|Withdrawal by Subject|8
7582210|NCT00703534|11984432|FG001|Overall Study|Withdrawal by Subject|7
7582211|NCT00703534|11984431|FG000|Overall Study|Incorrect Enrollment|6
7582212|NCT00703534|11984432|FG001|Overall Study|Incorrect Enrollment|6
7582213|NCT00703534|11984431|FG000|Overall Study|Lost to Follow-up|1
7582214|NCT00703534|11984432|FG001|Overall Study|Lost to Follow-up|4
7582215|NCT00703534|11984431|FG000|Overall Study|Severe Non Compliance|1
7582216|NCT00703534|11984432|FG001|Overall Study|Severe Non Compliance|5
7582217|NCT00698009|11984438|FG000|Overall Study|Withdrawal by Subject|1
7582218|NCT00702702|11984462|FG000|Overall Study|Study prematurely terminated|56
7582219|NCT00699413|11984481|FG000|Overall Study|Withdrawal by Subject|0
7582220|NCT00699413|11984482|FG001|Overall Study|Withdrawal by Subject|2
7582221|NCT00699413|11984481|FG000|Overall Study|Study terminated by sponsor|4
7582222|NCT00699413|11984482|FG001|Overall Study|Study terminated by sponsor|2
7582223|NCT00686972|11984492|FG000|Overall Study|P.I, Left institution. Study terminated|51
7582224|NCT00693017|11984498|FG000|Overall Study|Sponsor Decision|2
7582225|NCT00693017|11984499|FG001|Overall Study|Sponsor Decision|1
7582226|NCT00693017|11984498|FG000|Overall Study|Death|0
7582227|NCT00693017|11984499|FG001|Overall Study|Death|1
7582228|NCT00692003|11984538|FG000|Overall Study|Sponsor Decision|5
7582229|NCT00692003|11984539|FG001|Overall Study|Sponsor Decision|1
7582230|NCT00678288|11984547|FG000|Overall Study|Adverse Event|0
7582231|NCT00678288|11984548|FG001|Overall Study|Adverse Event|2
7582232|NCT00678288|11984547|FG000|Overall Study|Withdrawal by Subject|1
7582233|NCT00678288|11984548|FG001|Overall Study|Withdrawal by Subject|1
7582234|NCT00678288|11984547|FG000|Overall Study|Study terminated by the sponsor|2
7625128|NCT02688933|12036451|FG000|Overall Study|Hypoglycemia|2
7625129|NCT02688933|12036452|FG001|Overall Study|Hypoglycemia|0
7582235|NCT00678288|11984548|FG001|Overall Study|Study terminated by the sponsor|0
7582236|NCT00678288|11984547|FG000|Overall Study|Not compliant with study medication|0
7582237|NCT00678288|11984548|FG001|Overall Study|Not compliant with study medication|1
7582238|NCT00678288|11984547|FG000|Overall Study|Switch to commercial drug|0
7582239|NCT00678288|11984548|FG001|Overall Study|Switch to commercial drug|1
7582240|NCT00678288|11984547|FG000|Overall Study|Reason not reported|1
7582241|NCT00678288|11984548|FG001|Overall Study|Reason not reported|0
7582242|NCT00678288|11984547|FG000|Overall Study|Disease progression/recurrence/relapse|6
7582243|NCT00678288|11984548|FG001|Overall Study|Disease progression/recurrence/relapse|1
7582244|NCT00689052|11984560|FG000|Overall Study|Adverse Event|4
7582245|NCT00689052|11984561|FG001|Overall Study|Adverse Event|6
7582246|NCT00689052|11984560|FG000|Overall Study|Protocol Violation|1
7582247|NCT00689052|11984561|FG001|Overall Study|Protocol Violation|0
7582248|NCT00689052|11984560|FG000|Overall Study|Lost to Follow-up|2
7582249|NCT00689052|11984561|FG001|Overall Study|Lost to Follow-up|0
7582250|NCT00689052|11984560|FG000|Overall Study|Withdrawal by Subject|2
7582251|NCT00689052|11984561|FG001|Overall Study|Withdrawal by Subject|0
7582252|NCT00689052|11984560|FG000|Overall Study|Early termination of the trial|22
7582253|NCT00689052|11984561|FG001|Overall Study|Early termination of the trial|24
7582254|NCT00683917|11984581|FG000|Overall Study|Study prematurely terminated|10
7582255|NCT00686036|11984604|FG000|Overall Study|Adverse Event|3
7582256|NCT00686036|11984605|FG001|Overall Study|Adverse Event|0
7582257|NCT00686036|11984604|FG000|Overall Study|Withdrawal by Subject|3
7582258|NCT00686036|11984605|FG001|Overall Study|Withdrawal by Subject|1
7582259|NCT00686036|11984604|FG000|Overall Study|Study terminated by AstraZeneca|2
7582260|NCT00686036|11984605|FG001|Overall Study|Study terminated by AstraZeneca|1
7582261|NCT00686036|11984604|FG000|Overall Study|PSA ≥ 10ng/mL|1
7582262|NCT00686036|11984605|FG001|Overall Study|PSA ≥ 10ng/mL|0
7582263|NCT00686036|11984604|FG000|Overall Study|Other reasons not identified|0
7582264|NCT00686036|11984605|FG001|Overall Study|Other reasons not identified|4
7582265|NCT00683787|11984627|FG000|Overall Study|Progression|3
7582266|NCT00683787|11984628|FG001|Overall Study|Progression|3
7582267|NCT00683787|11984629|FG002|Overall Study|Progression|0
7582268|NCT00683787|11984627|FG000|Overall Study|Adverse Event|0
7582269|NCT00683787|11984628|FG001|Overall Study|Adverse Event|0
7582270|NCT00683787|11984629|FG002|Overall Study|Adverse Event|2
7582271|NCT00678041|11984644|FG000|Overall Study|Physician Decision|5
7582272|NCT00678041|11984645|FG001|Overall Study|Physician Decision|5
7582273|NCT00681629|11984663|FG000|Overall Study|Study termination|4
7582274|NCT00681629|11984664|FG001|Overall Study|Study termination|2
7582275|NCT00681629|11984663|FG000|Overall Study|Adverse Event|1
7582276|NCT00681629|11984664|FG001|Overall Study|Adverse Event|0
7582277|NCT00673361|11984724|FG000|Overall Study|Screen Failure|2
7582278|NCT00673179|11984741|FG000|Overall Study|Toxicity/Complications|3
7582279|NCT00673179|11984742|FG001|Overall Study|Toxicity/Complications|0
7582280|NCT00660348|11984761|FG000|Overall Study|Withdrawal by Subject|1
7582281|NCT00660348|11984762|FG001|Overall Study|Withdrawal by Subject|0
7582282|NCT00664066|11984768|FG000|Overall Study|Study terminated|3
7582283|NCT00667017|11984772|FG000|Overall Study|Withdrawal by Subject|1
7582284|NCT00665444|11984776|FG000|Overall Study|Physician Decision|1
7582285|NCT00665444|11984776|FG000|Overall Study|Study Terminated by Study Sponsor|1
7582286|NCT00660595|11984791|FG000|Overall Study|Lost to Follow-up|0
7582287|NCT00660595|11984792|FG001|Overall Study|Lost to Follow-up|1
7582288|NCT00660595|11984791|FG000|Overall Study|Did not consent to participate in study|12
7582289|NCT00660595|11984792|FG001|Overall Study|Did not consent to participate in study|8
7582290|NCT00660595|11984791|FG000|Overall Study|Participant left hospital|1
7582291|NCT00660595|11984792|FG001|Overall Study|Participant left hospital|0
7582292|NCT00660595|11984791|FG000|Overall Study|Non Specified reasons|5
7582293|NCT00660595|11984792|FG001|Overall Study|Non Specified reasons|0
7582294|NCT00646282|11984809|FG000|Overall Study|Protocol terminated|4
7582295|NCT00646282|11984810|FG001|Overall Study|Protocol terminated|4
7582296|NCT00657553|11984818|FG000|Overall Study|low accrual, no analysis run|5
7582297|NCT00657553|11984819|FG001|Overall Study|low accrual, no analysis run|5
7582298|NCT00648895|11984840|FG000|Overall Study|Lack of Efficacy|0
7582299|NCT00648895|11984841|FG001|Overall Study|Lack of Efficacy|1
7582300|NCT00647426|11984847|FG000|Overall Study|Withdrawal by Subject|2
7582301|NCT00645567|11984852|FG000|Overall Study|Adverse Event|1
7582302|NCT00637806|11984863|FG000|Double-blind Phase|Study Discontinued|2
7582303|NCT00637806|11984864|FG001|Double-blind Phase|Study Discontinued|0
7582304|NCT00637806|11984865|FG002|Double-blind Phase|Study Discontinued|1
7582305|NCT00637806|11984866|FG003|Double-blind Phase|Study Discontinued|0
7582306|NCT00637806|11984863|FG000|Extension Phase|Study Discontinued|0
7582307|NCT00637806|11984864|FG001|Extension Phase|Study Discontinued|0
7582308|NCT00637806|11984865|FG002|Extension Phase|Study Discontinued|0
7582309|NCT00637806|11984866|FG003|Extension Phase|Study Discontinued|1
7582310|NCT00629798|11984891|FG000|Overall Study|Not Treated|4
7582311|NCT00637728|11984901|FG000|Double-blind Phase|Adverse Event|1
7582312|NCT00637728|11984902|FG001|Double-blind Phase|Adverse Event|0
7582313|NCT00637728|11984903|FG002|Double-blind Phase|Adverse Event|0
7582314|NCT00637728|11984901|FG000|Double-blind Phase|Non-compliance|2
7582315|NCT00637728|11984902|FG001|Double-blind Phase|Non-compliance|0
7582316|NCT00637728|11984903|FG002|Double-blind Phase|Non-compliance|0
7582317|NCT00637728|11984901|FG000|Double-blind Phase|Study Discontinued|1
7582318|NCT00637728|11984902|FG001|Double-blind Phase|Study Discontinued|1
7582319|NCT00637728|11984903|FG002|Double-blind Phase|Study Discontinued|0
7582320|NCT00637416|11984938|FG000|Overall Study|Lost to Follow-up|1
7582321|NCT00637416|11984939|FG001|Overall Study|Lost to Follow-up|1
7582322|NCT00637416|11984938|FG000|Overall Study|Unable to take study drug|0
7582323|NCT00637416|11984939|FG001|Overall Study|Unable to take study drug|1
7582324|NCT00631137|11984989|FG000|Overall Study|Withdrawal by Subject|1
7582325|NCT00631137|11984990|FG001|Overall Study|Withdrawal by Subject|0
7582326|NCT00633061|11985007|FG000|Overall Study|Study closed|86
7582327|NCT00633061|11985008|FG001|Overall Study|Study closed|0
7582328|NCT00630292|11985020|FG000|Overall Study|Withdrawal by Subject|1
7582329|NCT00634010|11985026|FG000|Overall Study|Adverse Event|2
7582330|NCT00634010|11985027|FG001|Overall Study|Adverse Event|5
7582331|NCT00634010|11985026|FG000|Overall Study|Withdrawal by Subject|5
7582332|NCT00634010|11985027|FG001|Overall Study|Withdrawal by Subject|6
7582333|NCT00634010|11985026|FG000|Overall Study|Physician Decision|1
7582334|NCT00634010|11985027|FG001|Overall Study|Physician Decision|1
7582335|NCT00634010|11985026|FG000|Overall Study|Disease Progression|1
7582336|NCT00634010|11985027|FG001|Overall Study|Disease Progression|1
7582337|NCT00634010|11985026|FG000|Overall Study|Non-Compliant|1
7582338|NCT00634010|11985027|FG001|Overall Study|Non-Compliant|1
7625130|NCT02688933|12036451|FG000|Overall Study|Other than Specified|14
7625131|NCT02688933|12036452|FG001|Overall Study|Other than Specified|25
7625132|NCT02688933|12036451|FG000|Overall Study|Lost to Follow-up|1
7625133|NCT02688933|12036452|FG001|Overall Study|Lost to Follow-up|5
7625134|NCT02492165|12036471|FG000|Overall Study|Withdrawal by Subject|0
7625135|NCT02492165|12036472|FG001|Overall Study|Withdrawal by Subject|1
7625136|NCT02492165|12036473|FG002|Overall Study|Withdrawal by Subject|0
7625137|NCT02492165|12036474|FG003|Overall Study|Withdrawal by Subject|0
7625138|NCT02476006|12036484|FG000|Overall Study|Death|4
7625139|NCT02476006|12036484|FG000|Overall Study|Lack of treatment efficacy|2
7625140|NCT02476006|12036484|FG000|Overall Study|Pregnancy|1
7625141|NCT02476006|12036484|FG000|Overall Study|Participant did not wish to continue|39
7625142|NCT02476006|12036484|FG000|Overall Study|Adverse Event|41
7625143|NCT02476006|12036484|FG000|Overall Study|Poor compliance to study protocol|3
7625144|NCT02476006|12036484|FG000|Overall Study|Sponsor decision|6
7625145|NCT02476006|12036484|FG000|Overall Study|Lost to Follow-up|5
7625146|NCT02476006|12036484|FG000|Overall Study|Physician Decision|5
7625147|NCT02476006|12036484|FG000|Overall Study|Study ended treatment not available|4
7625148|NCT02476006|12036484|FG000|Overall Study|Switched to commercial drug|4
7625149|NCT02476006|12036484|FG000|Overall Study|Excluded from study|1
7625150|NCT02476006|12036484|FG000|Overall Study|Protocol Violation|1
7625151|NCT02476006|12036484|FG000|Overall Study|Enrolled but not treated|4
7625152|NCT02468414|12036490|FG000|Overall Study|Early Study Termination by Sponsor|1
7625153|NCT02468414|12036491|FG001|Overall Study|Early Study Termination by Sponsor|0
7625154|NCT02468414|12036490|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
7625155|NCT02468414|12036491|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
7625156|NCT02468414|12036490|FG000|Overall Study|Screen Failure|1
7625157|NCT02468414|12036491|FG001|Overall Study|Screen Failure|0
7625158|NCT02462876|12036497|FG000|Overall Study|Death|3
7625159|NCT02462876|12036497|FG000|Overall Study|Lost to Follow-up|7
7625160|NCT02462876|12036497|FG000|Overall Study|Surgical Bypass|9
7625161|NCT02462876|12036497|FG000|Overall Study|Amputation Above the Metatarsals|1
7625162|NCT02462876|12036497|FG000|Overall Study|36 months follow-up visit missed|1
7625163|NCT02462876|12036497|FG000|Overall Study|Patient did not come back since 4 months follow-up|1
7625164|NCT02462876|12036497|FG000|Overall Study|Patient did not come back to the vascular department|1
7625165|NCT02462876|12036497|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1
7625166|NCT02462876|12036497|FG000|Overall Study|Patient refused to come back|1
7625167|NCT02462876|12036497|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1
7625168|NCT02462876|12036497|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1
7625169|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
7625170|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
7625171|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
7625172|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
7625173|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
7625174|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
7625175|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
7625176|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
7625177|NCT02332590|12036503|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
7625178|NCT02332590|12036504|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
7625179|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
7625180|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
7625181|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
7625182|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
7625183|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
7625184|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
7625185|NCT02332590|12036503|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
7625186|NCT02332590|12036504|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
7625187|NCT02255656|12036512|FG000|Overall Study|Adverse Event|11
7625188|NCT02255656|12036512|FG000|Overall Study|Poor compliance to protocol|3
7625189|NCT02255656|12036512|FG000|Overall Study|Lost to Follow-up|30
7625190|NCT02255656|12036512|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
7625191|NCT02255656|12036512|FG000|Overall Study|Other|126
7625192|NCT02134028|12036531|FG000|Overall Study|Lack of Efficacy|1
7625193|NCT02134028|12036532|FG001|Overall Study|Lack of Efficacy|0
7625194|NCT02134028|12036533|FG002|Overall Study|Lack of Efficacy|3
7625195|NCT02134028|12036534|FG003|Overall Study|Lack of Efficacy|2
7625196|NCT02134028|12036535|FG004|Overall Study|Lack of Efficacy|1
7625197|NCT02134028|12036536|FG005|Overall Study|Lack of Efficacy|2
7625198|NCT02134028|12036537|FG006|Overall Study|Lack of Efficacy|1
7625199|NCT02134028|12036538|FG007|Overall Study|Lack of Efficacy|0
7625200|NCT02134028|12036531|FG000|Overall Study|Poor compliance to protocol|1
7625201|NCT02134028|12036532|FG001|Overall Study|Poor compliance to protocol|1
7625202|NCT02134028|12036533|FG002|Overall Study|Poor compliance to protocol|3
7625203|NCT02134028|12036534|FG003|Overall Study|Poor compliance to protocol|7
7582339|NCT00626561|11985077|FG000|Overall Study|Withdrawal by Subject|2
7582340|NCT00626561|11985077|FG000|Overall Study|Disease Progression|2
7582341|NCT00613730|11985081|FG000|Overall Study|Disease progression|2
7582342|NCT00613730|11985081|FG000|Overall Study|Administrative decision|1
7582343|NCT00625586|11985085|FG000|Overall Study|Adverse Event|1
7582344|NCT00625742|11985093|FG000|Overall Study|Disease Progression|2
7582345|NCT00625742|11985093|FG000|Overall Study|Withdrawal by Subject|1
7582346|NCT00625742|11985093|FG000|Overall Study|Adverse Event|4
7582347|NCT00625742|11985093|FG000|Overall Study|Lost to Follow-up|4
7582348|NCT00625742|11985093|FG000|Overall Study|Ineligible|1
7582349|NCT00619151|11985103|FG000|Overall Study|Study terminated prior to followup|1
7582350|NCT00619151|11985104|FG001|Overall Study|Study terminated prior to followup|0
7582351|NCT00622167|11985110|FG000|Overall Study|Did not meet angiographic criteria|20
7582352|NCT00616759|11985129|FG000|Overall Study|Physician Decision|2
7582353|NCT00616759|11985130|FG001|Overall Study|Physician Decision|0
7582354|NCT00616759|11985129|FG000|Overall Study|Withdrawal by Subject|1
7582355|NCT00616759|11985130|FG001|Overall Study|Withdrawal by Subject|2
7582356|NCT00616642|11985138|FG000|Overall Study|Withdrawal by Subject|0
7582357|NCT00616642|11985139|FG001|Overall Study|Withdrawal by Subject|1
7582358|NCT00619515|11985145|FG000|Overall Study|Study Termination by IRB|73
7582359|NCT00612677|11985153|FG000|Overall Study|study closed before treatment started|1
7582360|NCT00616603|11985160|FG000|Overall Study|Physician Decision|2
7582361|NCT00616603|11985161|FG001|Overall Study|Physician Decision|0
7582362|NCT00616603|11985162|FG002|Overall Study|Physician Decision|2
7582363|NCT00609765|11985203|FG000|Overall Study|Study ended prior to 12 months|1
7582364|NCT00595920|11985228|FG000|Overall Study|The OLTERMS study was discontinued by th|116
7582365|NCT00596947|11985234|FG000|Overall Study|study halted due to low enrollment|5
7582366|NCT00596947|11985235|FG001|Overall Study|study halted due to low enrollment|3
7582367|NCT00596947|11985234|FG000|Overall Study|Lost to Follow-up|1
7582368|NCT00596947|11985235|FG001|Overall Study|Lost to Follow-up|0
7582369|NCT00584012|11985241|FG000|Overall Study|Withdrawal by Subject|1
7582370|NCT00577772|11985277|FG000|Overall Study|Lost to Follow-up|0
7582371|NCT00577772|11985278|FG001|Overall Study|Lost to Follow-up|1
7582372|NCT00592007|11985284|FG000|Overall Study|Withdrawal by Subject|1
7582373|NCT00592007|11985284|FG000|Overall Study|patient ineligible (out of lab range)|1
7582374|NCT00595582|11985288|FG000|Overall Study|Pilot study that PI terminated|2
7582375|NCT00595582|11985288|FG000|Overall Study|Lost to Follow-up|1
7582376|NCT00595582|11985288|FG000|Overall Study|Adverse Event|2
7582377|NCT00595582|11985288|FG000|Overall Study|Physician Decision|5
7582378|NCT00588146|11985292|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
7582379|NCT00588146|11985293|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
7582380|NCT00590538|11985308|FG000|Overall Study|Study terminated before completed|2
7582381|NCT00583115|11985312|FG000|Overall Study|Death|1
7582382|NCT00582712|11985316|FG000|Overall Study|Adverse Event|1
7582383|NCT00582712|11985316|FG000|Overall Study|Lack of Efficacy|1
7582384|NCT00582712|11985316|FG000|Overall Study|Withdrawal by Subject|1
7582385|NCT00582712|11985316|FG000|Overall Study|Complicating disease requiring treatment|1
7582386|NCT00587795|11985347|FG000|Overall Study|Withdrawal by Subject|1
7582387|NCT00587795|11985348|FG001|Overall Study|Withdrawal by Subject|0
7582388|NCT00590135|11985354|FG000|Overall Study|Primary endpoint measure not obtainable|59
7582389|NCT00582036|11985361|FG000|Overall Study|Withdrawal by Subject|0
7582390|NCT00582036|11985362|FG001|Overall Study|Withdrawal by Subject|1
7582391|NCT00585585|11985368|FG000|Overall Study|Adverse Event|1
7582392|NCT00585221|11985372|FG000|Overall Study|Protocol Violation|8
7582393|NCT00581113|11985378|FG000|Overall Study|Withdrawal by Subject|0
7582394|NCT00581113|11985379|FG001|Overall Study|Withdrawal by Subject|1
7582395|NCT00579254|11985385|FG000|Overall Study|Lost to Follow-up|39
7582396|NCT00579254|11985385|FG000|Overall Study|Discontinued when study terminated|73
7582397|NCT00587223|11985389|FG000|Overall Study|Adverse Event|1
7582398|NCT00577395|11985420|FG000|Overall Study|Study was terminated early by Sponsor|7
7582399|NCT00577395|11985421|FG001|Overall Study|Study was terminated early by Sponsor|6
7582400|NCT00573391|11985429|FG000|Overall Study|study stopped|2
7582401|NCT00573391|11985430|FG001|Overall Study|study stopped|2
7582402|NCT00573391|11985429|FG000|Overall Study|Death|1
7582403|NCT00573391|11985430|FG001|Overall Study|Death|0
7582404|NCT00574080|11985474|FG000|Overall Study|Death|10
7582405|NCT00574080|11985475|FG001|Overall Study|Death|10
7582406|NCT00558558|11985481|FG000|Overall Study|Unable to swallow|1
7582407|NCT00558558|11985481|FG000|Overall Study|Withdrawal by Subject|1
7582408|NCT00558558|11985481|FG000|Overall Study|Lack of Efficacy|4
7582409|NCT00573937|11985491|FG000|Overall Study|Study Terminated|0
7582410|NCT00573937|11985492|FG001|Overall Study|Study Terminated|1
7582411|NCT00577317|11985500|FG000|Overall Study|Study Terminated|0
7582412|NCT00577317|11985501|FG001|Overall Study|Study Terminated|2
7582413|NCT00571922|11985509|FG000|Overall Study|Completion unknown|36
7582414|NCT00571922|11985510|FG001|Overall Study|Completion unknown|36
7582415|NCT00573157|11985522|FG000|Overall Study|Adverse Event|3
7582416|NCT00573157|11985523|FG001|Overall Study|Adverse Event|1
7582417|NCT00573157|11985522|FG000|Overall Study|Other|1
7582418|NCT00573157|11985523|FG001|Overall Study|Other|1
7582419|NCT00561912|11985542|FG000|Overall Study|ineligible|1
7582420|NCT00561795|11985548|FG000|Overall Study|Adverse Event|3
7582421|NCT00561795|11985549|FG001|Overall Study|Adverse Event|3
7582422|NCT00561795|11985550|FG002|Overall Study|Adverse Event|0
7582423|NCT00561795|11985551|FG003|Overall Study|Adverse Event|0
7582424|NCT00561795|11985548|FG000|Overall Study|Study Closed/Terminated|0
7582425|NCT00561795|11985549|FG001|Overall Study|Study Closed/Terminated|3
7582426|NCT00561795|11985550|FG002|Overall Study|Study Closed/Terminated|0
7582427|NCT00561795|11985551|FG003|Overall Study|Study Closed/Terminated|0
7582428|NCT00561795|11985548|FG000|Overall Study|Physician Decision|1
7582429|NCT00561795|11985549|FG001|Overall Study|Physician Decision|0
7582430|NCT00561795|11985550|FG002|Overall Study|Physician Decision|0
7582431|NCT00561795|11985551|FG003|Overall Study|Physician Decision|0
7582432|NCT00556075|11985587|FG000|Overall Study|Lost to Follow-up|3
7582433|NCT00556075|11985588|FG001|Overall Study|Lost to Follow-up|0
7582434|NCT00556075|11985589|FG002|Overall Study|Lost to Follow-up|3
7582435|NCT00556075|11985587|FG000|Overall Study|Withdrawal by Subject|3
7582436|NCT00556075|11985588|FG001|Overall Study|Withdrawal by Subject|3
7582437|NCT00556075|11985589|FG002|Overall Study|Withdrawal by Subject|0
7582438|NCT00556075|11985587|FG000|Overall Study|Protocol Violation|1
7582439|NCT00556075|11985588|FG001|Overall Study|Protocol Violation|1
7582440|NCT00556075|11985589|FG002|Overall Study|Protocol Violation|3
7582441|NCT00556075|11985587|FG000|Overall Study|Not eligible|1
7582442|NCT00556075|11985588|FG001|Overall Study|Not eligible|1
7582443|NCT00556075|11985589|FG002|Overall Study|Not eligible|2
7582444|NCT00556075|11985587|FG000|Overall Study|Adverse Event|1
7582445|NCT00556075|11985588|FG001|Overall Study|Adverse Event|2
7582446|NCT00556075|11985589|FG002|Overall Study|Adverse Event|0
7582447|NCT00556075|11985587|FG000|Overall Study|Personal issues|4
7582448|NCT00556075|11985588|FG001|Overall Study|Personal issues|1
7582449|NCT00556075|11985589|FG002|Overall Study|Personal issues|0
7582450|NCT00556075|11985587|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7582451|NCT00556075|11985588|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
7582452|NCT00556075|11985589|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
7582453|NCT00556166|11985601|FG000|Overall Study|Withdrawal by Subject|1
7582454|NCT00539838|11985625|FG000|Overall Study|Fail to return|2
7582455|NCT00539838|11985626|FG001|Overall Study|Fail to return|0
7582456|NCT00539838|11985627|FG002|Overall Study|Fail to return|0
7582457|NCT00539838|11985625|FG000|Overall Study|Withdrawal by Subject|0
7582458|NCT00539838|11985626|FG001|Overall Study|Withdrawal by Subject|4
7582459|NCT00539838|11985627|FG002|Overall Study|Withdrawal by Subject|0
7582460|NCT00539838|11985625|FG000|Overall Study|Death|0
7582461|NCT00539838|11985626|FG001|Overall Study|Death|2
7582462|NCT00539838|11985627|FG002|Overall Study|Death|0
7582463|NCT00539838|11985625|FG000|Overall Study|Did not cooperate|1
7582464|NCT00539838|11985626|FG001|Overall Study|Did not cooperate|0
7582465|NCT00539838|11985627|FG002|Overall Study|Did not cooperate|1
7582466|NCT00539838|11985625|FG000|Overall Study|Administrative|4
7582467|NCT00539838|11985626|FG001|Overall Study|Administrative|0
7582468|NCT00539838|11985627|FG002|Overall Study|Administrative|8
7582469|NCT00549328|11985637|FG000|Overall Study|Adverse Event|2
7582470|NCT00549328|11985637|FG000|Overall Study|Disease Progression|10
7582471|NCT00549328|11985637|FG000|Overall Study|Death|1
7582472|NCT00549328|11985637|FG000|Overall Study|Use of Prohibited Medication|1
7582473|NCT00548327|11985643|FG000|Overall Study|Adverse Event|0
7582474|NCT00548327|11985644|FG001|Overall Study|Adverse Event|1
7582475|NCT00547300|11985675|FG000|Overall Study|Study was Administratively Terminated|25
7582476|NCT00547300|11985676|FG001|Overall Study|Study was Administratively Terminated|24
7582477|NCT00547300|11985675|FG000|Overall Study|Did not Meet Entry Criteria|0
7582478|NCT00547300|11985676|FG001|Overall Study|Did not Meet Entry Criteria|2
7582479|NCT00535262|11985708|FG000|Overall Study|No funding|3
7582480|NCT00537199|11985725|FG000|Overall Study|Study Terminated|1
7582481|NCT00536978|11985735|FG000|Overall Study|Not eligible for Adback Infusion|22
7582482|NCT00524485|11985739|FG000|Overall Study|Withdrawal by Subject|5
7625204|NCT02134028|12036535|FG004|Overall Study|Poor compliance to protocol|1
7625205|NCT02134028|12036536|FG005|Overall Study|Poor compliance to protocol|1
7625206|NCT02134028|12036537|FG006|Overall Study|Poor compliance to protocol|0
7625207|NCT02134028|12036538|FG007|Overall Study|Poor compliance to protocol|0
7625208|NCT02134028|12036531|FG000|Overall Study|Other unspecified|4
7625209|NCT02134028|12036532|FG001|Overall Study|Other unspecified|22
7625210|NCT02134028|12036533|FG002|Overall Study|Other unspecified|33
7625211|NCT02134028|12036534|FG003|Overall Study|Other unspecified|64
7625212|NCT02134028|12036535|FG004|Overall Study|Other unspecified|8
7625213|NCT02134028|12036536|FG005|Overall Study|Other unspecified|6
7625214|NCT02134028|12036537|FG006|Overall Study|Other unspecified|2
7625215|NCT02134028|12036538|FG007|Overall Study|Other unspecified|1
7625216|NCT02134028|12036531|FG000|Overall Study|Adverse Event|3
7625217|NCT02134028|12036532|FG001|Overall Study|Adverse Event|19
7625218|NCT02134028|12036533|FG002|Overall Study|Adverse Event|13
7625219|NCT02134028|12036534|FG003|Overall Study|Adverse Event|32
7625220|NCT02134028|12036535|FG004|Overall Study|Adverse Event|4
7625221|NCT02134028|12036536|FG005|Overall Study|Adverse Event|5
7625222|NCT02134028|12036537|FG006|Overall Study|Adverse Event|1
7625223|NCT02134028|12036538|FG007|Overall Study|Adverse Event|2
7625224|NCT01900444|12036562|FG000|Overall Study|Protocol Violation|2
7625225|NCT01900444|12036562|FG000|Overall Study|Lost to Follow-up|1
7625226|NCT01887912|12036568|FG000|Overall Study|Serious adverse event|400
7582483|NCT00524134|11985761|FG000|Overall Study|Withdrawal by Subject|1
7582484|NCT00524134|11985761|FG000|Overall Study|Physician Decision|1
7582485|NCT00527748|11985765|FG000|Overall Study|Other|3
7582486|NCT00517699|11985769|FG000|Overall Study|Withdrawal by Subject|1
7582487|NCT00517699|11985769|FG000|Overall Study|Lack of Efficacy|1
7582488|NCT00517699|11985769|FG000|Overall Study|Administrative error|1
7582489|NCT00517699|11985769|FG000|Overall Study|Study terminated by Sponsor|2
7582490|NCT00528775|11985773|FG000|Overall Study|Other not specified|1
7582491|NCT00527982|11985809|FG000|Overall Study|Physician Decision|1
7582492|NCT00527982|11985810|FG001|Overall Study|Physician Decision|0
7582493|NCT00524459|11985816|FG000|Overall Study|Withdrawal by Subject|1
7582494|NCT00524459|11985816|FG000|Overall Study|Other|1
7582495|NCT00517361|11985820|FG000|Overall Study|Death|6
7582496|NCT00517361|11985820|FG000|Overall Study|The study was terminated|5
7582497|NCT00522457|11985832|FG000|Overall Study|Due to disease progression|16
7582498|NCT00522457|11985832|FG000|Overall Study|Adverse Event|2
7582499|NCT00526331|11985836|FG000|Overall Study|Sponsor Termination|55
7582500|NCT00522301|11985857|FG000|Overall Study|Withdrawal by Subject|1
7582501|NCT00522301|11985857|FG000|Overall Study|Adverse Event|5
7582502|NCT00517192|11985863|FG000|Overall Study|Adverse Event|1
7582503|NCT00517192|11985864|FG001|Overall Study|Adverse Event|1
7582504|NCT00517192|11985863|FG000|Overall Study|Lost to Follow-up|1
7582505|NCT00517192|11985864|FG001|Overall Study|Lost to Follow-up|1
7582506|NCT00517192|11985863|FG000|Overall Study|Withdrawal by Subject|1
7582507|NCT00517192|11985864|FG001|Overall Study|Withdrawal by Subject|0
7582508|NCT00517192|11985863|FG000|Overall Study|Early termination of the trial|16
7582509|NCT00517192|11985864|FG001|Overall Study|Early termination of the trial|18
7582510|NCT00503581|11985877|FG000|Overall Study|Study closed|3
7582511|NCT00503581|11985878|FG001|Overall Study|Study closed|4
7582512|NCT00503581|11985879|FG002|Overall Study|Study closed|2
7582513|NCT00509600|11985887|FG000|Overall Study|Adverse Event|1
7582514|NCT00515112|11985893|FG000|Overall Study|Death|0
7582515|NCT00515112|11985894|FG001|Overall Study|Death|1
7582516|NCT00515112|11985893|FG000|Overall Study|The study was terminated|3
7582517|NCT00515112|11985894|FG001|Overall Study|The study was terminated|2
7582518|NCT00508872|11985900|FG000|Overall Study|Lost to Follow-up|1
7582519|NCT00508872|11985900|FG000|Overall Study|Physician Decision|1
7582520|NCT00514813|11985908|FG000|Overall Study|Study terminated|14
7582521|NCT00514813|11985909|FG001|Overall Study|Study terminated|74
7582522|NCT00514813|11985910|FG002|Overall Study|Study terminated|40
7582523|NCT00514813|11985911|FG003|Overall Study|Study terminated|2
7582524|NCT00514813|11985908|FG000|Overall Study|Adverse Event|0
7582525|NCT00514813|11985909|FG001|Overall Study|Adverse Event|2
7582526|NCT00514813|11985910|FG002|Overall Study|Adverse Event|2
7582527|NCT00514813|11985911|FG003|Overall Study|Adverse Event|0
7582528|NCT00514813|11985908|FG000|Overall Study|Protocol Violation|1
7582529|NCT00514813|11985909|FG001|Overall Study|Protocol Violation|0
7582530|NCT00514813|11985910|FG002|Overall Study|Protocol Violation|0
7582531|NCT00514813|11985911|FG003|Overall Study|Protocol Violation|0
7582532|NCT00514813|11985908|FG000|Overall Study|Withdrawal by Subject|0
7582533|NCT00514813|11985909|FG001|Overall Study|Withdrawal by Subject|1
7582534|NCT00514813|11985910|FG002|Overall Study|Withdrawal by Subject|0
7582535|NCT00514813|11985911|FG003|Overall Study|Withdrawal by Subject|0
7582536|NCT00514813|11985908|FG000|Overall Study|Lack of Efficacy|0
7582537|NCT00514813|11985909|FG001|Overall Study|Lack of Efficacy|1
7582538|NCT00514813|11985910|FG002|Overall Study|Lack of Efficacy|0
7582539|NCT00514813|11985911|FG003|Overall Study|Lack of Efficacy|0
7582540|NCT00514813|11985908|FG000|Overall Study|Kidney transplant|0
7582541|NCT00514813|11985909|FG001|Overall Study|Kidney transplant|6
7582542|NCT00514813|11985910|FG002|Overall Study|Kidney transplant|2
7582543|NCT00514813|11985911|FG003|Overall Study|Kidney transplant|0
7582544|NCT00514813|11985908|FG000|Overall Study|Death|0
7582545|NCT00514813|11985909|FG001|Overall Study|Death|2
7582546|NCT00514813|11985910|FG002|Overall Study|Death|3
7582547|NCT00514813|11985911|FG003|Overall Study|Death|2
7582548|NCT00501228|11985944|FG000|Overall Study|Withdrawal by Subject|1
7582549|NCT00496782|11985950|FG000|Overall Study|Protocol Violation|1
7582550|NCT00496782|11985951|FG001|Overall Study|Protocol Violation|2
7582551|NCT00487578|11985963|FG000|Overall Study|Adverse Event|1
7582552|NCT00487578|11985964|FG001|Overall Study|Adverse Event|2
7582553|NCT00487578|11985963|FG000|Overall Study|Lack of Efficacy|0
7582554|NCT00487578|11985964|FG001|Overall Study|Lack of Efficacy|1
7582555|NCT00487578|11985963|FG000|Overall Study|Lost to Follow-up|0
7582556|NCT00487578|11985964|FG001|Overall Study|Lost to Follow-up|1
7582557|NCT00503009|11985973|FG000|Overall Study|Protocol Violation|1
7582558|NCT00503009|11985974|FG001|Overall Study|Protocol Violation|0
7582559|NCT00503009|11985975|FG002|Overall Study|Protocol Violation|1
7582560|NCT00503009|11985973|FG000|Overall Study|Withdrawal by Subject|0
7582561|NCT00503009|11985974|FG001|Overall Study|Withdrawal by Subject|1
7582562|NCT00503009|11985975|FG002|Overall Study|Withdrawal by Subject|1
7582563|NCT00503009|11985973|FG000|Overall Study|Physician Decision|0
7582564|NCT00503009|11985974|FG001|Overall Study|Physician Decision|1
7582565|NCT00503009|11985975|FG002|Overall Study|Physician Decision|1
7582566|NCT00499590|11985990|FG000|Overall Study|Study Terminated|112
7582567|NCT00499590|11985991|FG001|Overall Study|Study Terminated|112
7582568|NCT00499590|11985992|FG002|Overall Study|Study Terminated|112
7582569|NCT00499590|11985990|FG000|Overall Study|Not treated|1
7582570|NCT00499590|11985991|FG001|Overall Study|Not treated|0
7582571|NCT00499590|11985992|FG002|Overall Study|Not treated|1
7582572|NCT00503841|11986027|FG000|Overall Study|All screen failures|44
7582573|NCT00493025|11986033|FG000|Overall Study|Physician Decision|19
7582574|NCT00491400|11986040|FG000|Overall Study|Withdrawal by Subject|5
7582575|NCT00491400|11986041|FG001|Overall Study|Withdrawal by Subject|4
7582576|NCT00490776|11986049|FG000|Overall Study|Withdrawal by Subject|1
7582577|NCT00490776|11986049|FG000|Overall Study|Administrative Problems|1
7582578|NCT00490776|11986049|FG000|Overall Study|Death|1
7582579|NCT00490776|11986049|FG000|Overall Study|New Cancer Therapy|1
7582580|NCT00490776|11986049|FG000|Overall Study|Disease Progression|5
7582581|NCT00487162|11986055|FG000|Overall Study|Adverse Event|0
7582582|NCT00487162|11986056|FG001|Overall Study|Adverse Event|1
7582583|NCT00487162|11986055|FG000|Overall Study|Physician Decision|0
7582584|NCT00487162|11986056|FG001|Overall Study|Physician Decision|1
7582585|NCT00487162|11986055|FG000|Overall Study|Withdrawal by Subject|2
7582586|NCT00487162|11986056|FG001|Overall Study|Withdrawal by Subject|3
7582587|NCT00487981|11986062|FG000|Overall Study|Hypothyroidism diagnosis|1
7582588|NCT00491387|11986066|FG000|Overall Study|study terminated|20
7582589|NCT00483119|11986077|FG000|Overall Study|Adverse Event|0
7582590|NCT00483119|11986078|FG001|Overall Study|Adverse Event|1
7582591|NCT00483119|11986077|FG000|Overall Study|Physician Decision|1
7582592|NCT00483119|11986078|FG001|Overall Study|Physician Decision|0
7582593|NCT00470067|11986119|FG000|Overall Study|Death|1
7582594|NCT00470067|11986119|FG000|Overall Study|Disease Progression|6
7582595|NCT00475657|11986146|FG000|Overall Study|Death|1
7582596|NCT00475657|11986146|FG000|Overall Study|Sponsor's Decision|3
7582597|NCT00472082|11986150|FG000|Overall Study|Study prematurely terminated|5
7582598|NCT00467753|11986164|FG000|Overall Study|Lost to Follow-up|1
7582599|NCT00467753|11986165|FG001|Overall Study|Lost to Follow-up|2
7582600|NCT00467753|11986164|FG000|Overall Study|Adverse Event|2
7582601|NCT00467753|11986165|FG001|Overall Study|Adverse Event|0
7582602|NCT00456612|11986175|FG000|Overall Study|Withdrawal by Subject|3
7582603|NCT00469612|11986182|FG000|Overall Study|Study terminated before data collected|2
7582604|NCT00469612|11986183|FG001|Overall Study|Study terminated before data collected|0
7582605|NCT00461812|11986189|FG000|Overall Study|study terminated|10
7582606|NCT00461682|11986199|FG000|Overall Study|Protocol Violation|1
7582607|NCT00462904|11986205|FG000|Overall Study|Lost to Follow-up|1
7582608|NCT00450333|11986213|FG000|Overall Study|Study terminated|47
7582609|NCT00450333|11986214|FG001|Overall Study|Study terminated|54
7582610|NCT00450333|11986215|FG002|Overall Study|Study terminated|16
7582611|NCT00450333|11986216|FG003|Overall Study|Study terminated|21
7582612|NCT00450333|11986213|FG000|Overall Study|Adverse Event|1
7582613|NCT00450333|11986214|FG001|Overall Study|Adverse Event|7
7582614|NCT00450333|11986215|FG002|Overall Study|Adverse Event|2
7582615|NCT00450333|11986216|FG003|Overall Study|Adverse Event|2
7582616|NCT00450333|11986213|FG000|Overall Study|Protocol Violation|1
7582617|NCT00450333|11986214|FG001|Overall Study|Protocol Violation|0
7582618|NCT00450333|11986215|FG002|Overall Study|Protocol Violation|1
7582619|NCT00450333|11986216|FG003|Overall Study|Protocol Violation|0
7582620|NCT00450333|11986213|FG000|Overall Study|Withdrawal by Subject|1
7582621|NCT00450333|11986214|FG001|Overall Study|Withdrawal by Subject|0
7582622|NCT00450333|11986215|FG002|Overall Study|Withdrawal by Subject|3
7582623|NCT00450333|11986216|FG003|Overall Study|Withdrawal by Subject|0
7582624|NCT00450333|11986213|FG000|Overall Study|Kidney transplant|1
7582625|NCT00450333|11986214|FG001|Overall Study|Kidney transplant|0
7582626|NCT00450333|11986215|FG002|Overall Study|Kidney transplant|1
7582627|NCT00450333|11986216|FG003|Overall Study|Kidney transplant|3
7582628|NCT00450333|11986213|FG000|Overall Study|Death|3
7582629|NCT00450333|11986214|FG001|Overall Study|Death|2
7582630|NCT00450333|11986215|FG002|Overall Study|Death|2
7582631|NCT00450333|11986216|FG003|Overall Study|Death|2
7582632|NCT00455143|11986226|FG000|Overall Study|Physician Decision|1
7582633|NCT00455143|11986226|FG000|Overall Study|Withdrawal by Subject|1
7582634|NCT00455143|11986226|FG000|Overall Study|Staff was not avail to follow patient|2
7582635|NCT00455143|11986226|FG000|Overall Study|No longer met Inclusion Criteria|1
7582636|NCT00455143|11986226|FG000|Overall Study|Surgical time, staff not available|1
7582637|NCT00454571|11986242|FG000|Overall Study|Adverse Event|2
7582638|NCT00454571|11986243|FG001|Overall Study|Adverse Event|0
7582639|NCT00454571|11986242|FG000|Overall Study|Physician Decision|0
7582640|NCT00454571|11986243|FG001|Overall Study|Physician Decision|1
7582641|NCT00454571|11986242|FG000|Overall Study|Protocol Violation|1
7582642|NCT00454571|11986243|FG001|Overall Study|Protocol Violation|0
7582643|NCT00454571|11986242|FG000|Overall Study|Withdrawal by Subject|10
7582644|NCT00454571|11986243|FG001|Overall Study|Withdrawal by Subject|5
7582645|NCT00452361|11986251|FG000|Overall Study|Adverse Event|8
7582646|NCT00452361|11986252|FG001|Overall Study|Adverse Event|0
7582647|NCT00452361|11986251|FG000|Overall Study|Withdrawal by Subject|0
7582648|NCT00452361|11986252|FG001|Overall Study|Withdrawal by Subject|1
7582649|NCT00452361|11986251|FG000|Overall Study|Premature termination|13
7582650|NCT00452361|11986252|FG001|Overall Study|Premature termination|9
7582651|NCT00443040|11986261|FG000|Overall Study|Withdrawal by Subject|1
7582652|NCT00443040|11986262|FG001|Overall Study|Withdrawal by Subject|0
7582653|NCT00443040|11986263|FG002|Overall Study|Withdrawal by Subject|0
7582654|NCT00443040|11986261|FG000|Overall Study|Converted to an open laparotomy|3
7582655|NCT00443040|11986262|FG001|Overall Study|Converted to an open laparotomy|0
7582656|NCT00443040|11986263|FG002|Overall Study|Converted to an open laparotomy|1
7582657|NCT00447421|11986271|FG000|Overall Study|Lack of Efficacy|1
7582658|NCT00447421|11986271|FG000|Overall Study|Adverse Event|3
7582659|NCT00447421|11986271|FG000|Overall Study|Sponsor Decision|2
7582660|NCT00441272|11986277|FG000|Overall Study|Study terminated prior to enrollment|25
7582661|NCT00441272|11986278|FG001|Overall Study|Study terminated prior to enrollment|25
7582662|NCT00440271|11986290|FG000|Overall Study|Protocol Violation|1
7582663|NCT00440271|11986291|FG001|Overall Study|Protocol Violation|1
7582664|NCT00440271|11986290|FG000|Overall Study|Adverse Event|0
7582665|NCT00440271|11986291|FG001|Overall Study|Adverse Event|1
7582666|NCT00440271|11986290|FG000|Overall Study|Lost to Follow-up|1
7582667|NCT00440271|11986291|FG001|Overall Study|Lost to Follow-up|0
7582668|NCT00440271|11986290|FG000|Overall Study|Withdrawal by Subject|0
7582669|NCT00440271|11986291|FG001|Overall Study|Withdrawal by Subject|2
7582670|NCT00440271|11986290|FG000|Overall Study|Lack of Efficacy|0
7582671|NCT00440271|11986291|FG001|Overall Study|Lack of Efficacy|1
7582672|NCT00440271|11986290|FG000|Overall Study|Due to closure of trial|8
7582673|NCT00440271|11986291|FG001|Overall Study|Due to closure of trial|10
7582674|NCT00440271|11986290|FG000|Overall Study|Other|2
7582675|NCT00440271|11986291|FG001|Overall Study|Other|0
7582676|NCT00429026|11986301|FG000|Overall Study|Inevaluable for response.|40
7582677|NCT00439569|11986312|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
7582678|NCT00439569|11986312|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
7582679|NCT00439569|11986312|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7582680|NCT00422669|11986319|FG000|Overall Study|The study was terminated early.|98
7582681|NCT00422669|11986320|FG001|Overall Study|The study was terminated early.|100
7582682|NCT00422669|11986321|FG002|Overall Study|The study was terminated early.|7
7582683|NCT00434590|11986333|FG000|Overall Study|Administrative problems|5
7582684|NCT00434590|11986334|FG001|Overall Study|Administrative problems|5
7582685|NCT00424645|11986342|FG000|Overall Study|Death|1
7582686|NCT00424645|11986343|FG001|Overall Study|Death|0
7582687|NCT00430027|11986349|FG000|Overall Study|Study terminated|8
7582688|NCT00429858|11986353|FG000|Overall Study|Withdrawal by Subject|1
7582689|NCT00429858|11986353|FG000|Overall Study|Study Termination|1
7582690|NCT00425438|11986360|FG000|Overall Study|Termination by Sponsor|25
7582691|NCT00425438|11986361|FG001|Overall Study|Termination by Sponsor|27
7582692|NCT00422942|11986371|FG000|Overall Study|Study terminated by Sponsor|3
7582693|NCT00409344|11986377|FG000|Overall Study|no enrollment|0
7582694|NCT00409344|11986378|FG001|Overall Study|no enrollment|0
7582695|NCT00414453|11986384|FG000|Overall Study|Abnormal lab work|16
7582696|NCT00417248|11986394|FG000|Overall Study|Study Terminated|6
7582697|NCT00417248|11986394|FG000|Overall Study|Death|1
7582698|NCT00417248|11986394|FG000|Overall Study|Lack of Efficacy|1
7582699|NCT00418145|11986399|FG000|Overall Study|study terminated|6
7582700|NCT00409331|11986405|FG000|Overall Study|Physician Decision|1
7582701|NCT00391430|11986422|FG000|Overall Study|Withdrawal by Subject|3
7582702|NCT00391430|11986423|FG001|Overall Study|Withdrawal by Subject|0
7582703|NCT00391430|11986424|FG002|Overall Study|Withdrawal by Subject|12
7625227|NCT01887912|12036569|FG001|Overall Study|Serious adverse event|198
7625228|NCT01887912|12036568|FG000|Overall Study|Other Adverse Event|34
7625229|NCT01887912|12036569|FG001|Overall Study|Other Adverse Event|15
7625230|NCT01887912|12036568|FG000|Overall Study|Protocol Violation|67
7625231|NCT01887912|12036569|FG001|Overall Study|Protocol Violation|37
7625232|NCT01887912|12036568|FG000|Overall Study|Lost to Follow-up|163
7625233|NCT01887912|12036569|FG001|Overall Study|Lost to Follow-up|74
7625234|NCT01887912|12036568|FG000|Overall Study|Withdrawal by Subject|606
7625235|NCT01887912|12036569|FG001|Overall Study|Withdrawal by Subject|349
7625236|NCT01887912|12036568|FG000|Overall Study|Other|122
7625237|NCT01887912|12036569|FG001|Overall Study|Other|58
7582704|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
7582705|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7582706|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
7582707|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
7582708|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7582709|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
7582710|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
7582711|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7582712|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
7582713|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
7582714|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7582715|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
7582716|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
7582717|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7582718|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
7582719|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
7582720|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7582721|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
7582722|NCT00384293|11986457|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
7582723|NCT00384293|11986458|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7582724|NCT00384293|11986459|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
7582725|NCT00384293|11986457|FG000|Post-randomization Period|Adverse Event|0
7582726|NCT00384293|11986458|FG001|Post-randomization Period|Adverse Event|23
7582727|NCT00384293|11986459|FG002|Post-randomization Period|Adverse Event|7
7582728|NCT00384293|11986457|FG000|Post-randomization Period|Lost to Follow-up|0
7582729|NCT00384293|11986458|FG001|Post-randomization Period|Lost to Follow-up|2
7582730|NCT00384293|11986459|FG002|Post-randomization Period|Lost to Follow-up|1
7582731|NCT00384293|11986457|FG000|Post-randomization Period|Protocol Violation|0
7582732|NCT00384293|11986458|FG001|Post-randomization Period|Protocol Violation|1
7582733|NCT00384293|11986459|FG002|Post-randomization Period|Protocol Violation|0
7582734|NCT00384293|11986457|FG000|Post-randomization Period|Withdrawal by Subject|0
7582735|NCT00384293|11986458|FG001|Post-randomization Period|Withdrawal by Subject|8
7582736|NCT00384293|11986459|FG002|Post-randomization Period|Withdrawal by Subject|6
7582737|NCT00384293|11986457|FG000|Post-randomization Period|Trial Termination|0
7582738|NCT00384293|11986458|FG001|Post-randomization Period|Trial Termination|180
7582739|NCT00384293|11986459|FG002|Post-randomization Period|Trial Termination|204
7582740|NCT00384293|11986457|FG000|Post-randomization Period|Patient Randomized in Error|0
7582741|NCT00384293|11986458|FG001|Post-randomization Period|Patient Randomized in Error|0
7582742|NCT00384293|11986459|FG002|Post-randomization Period|Patient Randomized in Error|1
7582743|NCT00377455|11986480|FG000|Overall Study|Withdrawal by Subject|1
7582744|NCT00371462|11986486|FG000|Overall Study|Withdrawal by Subject|1
7582745|NCT00371462|11986487|FG001|Overall Study|Withdrawal by Subject|0
7582746|NCT00371462|11986486|FG000|Overall Study|Other|7
7582747|NCT00371462|11986487|FG001|Overall Study|Other|8
7582748|NCT00369265|11986495|FG000|Overall Study|Study terminated|4
7582749|NCT00369265|11986496|FG001|Overall Study|Study terminated|7
7582750|NCT00364689|11986509|FG000|Overall Study|Lost to Follow-up|1
7582751|NCT00352118|11986515|FG000|Overall Study|Physician Decision|4
7582752|NCT00356421|11986538|FG000|Overall Study|Lack of Efficacy|3
7582753|NCT00356421|11986539|FG001|Overall Study|Lack of Efficacy|0
7582754|NCT00356421|11986538|FG000|Overall Study|Withdrawal by Subject|9
7582755|NCT00356421|11986539|FG001|Overall Study|Withdrawal by Subject|2
7582756|NCT00356421|11986538|FG000|Overall Study|Related to study drug|15
7582757|NCT00356421|11986539|FG001|Overall Study|Related to study drug|12
7582758|NCT00356421|11986538|FG000|Overall Study|Not related to study drug|5
7582759|NCT00356421|11986539|FG001|Overall Study|Not related to study drug|3
7582760|NCT00350623|11986548|FG000|Overall Study|Lost to Follow-up|8
7582761|NCT00350623|11986549|FG001|Overall Study|Lost to Follow-up|3
7582762|NCT00350623|11986550|FG002|Overall Study|Lost to Follow-up|4
7582763|NCT00350623|11986548|FG000|Overall Study|Withdrawal by Subject|0
7582764|NCT00350623|11986549|FG001|Overall Study|Withdrawal by Subject|1
7582765|NCT00350623|11986550|FG002|Overall Study|Withdrawal by Subject|1
7582766|NCT00350623|11986548|FG000|Overall Study|patient traveling outside the country|0
7582767|NCT00350623|11986549|FG001|Overall Study|patient traveling outside the country|0
7582768|NCT00350623|11986550|FG002|Overall Study|patient traveling outside the country|1
7582769|NCT00350844|11986578|FG000|Overall Study|Lost to Follow-up|1
7582770|NCT00348556|11986582|FG000|Overall Study|Adverse Event|1
7582771|NCT00319839|11986586|FG000|Overall Study|Adverse Event|5
7582772|NCT00319839|11986586|FG000|Overall Study|Withdrawal by Subject|1
7582773|NCT00344019|11986593|FG000|Overall Study|did not meet final inclusion criteria|0
7582774|NCT00344019|11986594|FG001|Overall Study|did not meet final inclusion criteria|0
7582775|NCT00344019|11986595|FG002|Overall Study|did not meet final inclusion criteria|74
7582776|NCT00338455|11986608|FG000|Overall Study|Death|2
7582777|NCT00338455|11986609|FG001|Overall Study|Death|1
7582778|NCT00338455|11986608|FG000|Overall Study|Physician Decision|1
7582779|NCT00338455|11986609|FG001|Overall Study|Physician Decision|0
7582780|NCT00329108|11986617|FG000|Overall Study|Adverse Event|2
7582781|NCT00329108|11986618|FG001|Overall Study|Adverse Event|2
7582782|NCT00329108|11986617|FG000|Overall Study|Lack of Efficacy|3
7582783|NCT00329108|11986618|FG001|Overall Study|Lack of Efficacy|3
7582784|NCT00329108|11986617|FG000|Overall Study|Withdrawal by Subject|0
7582785|NCT00329108|11986618|FG001|Overall Study|Withdrawal by Subject|2
7582786|NCT00329108|11986617|FG000|Overall Study|symptomatic deterioration|1
7582787|NCT00329108|11986618|FG001|Overall Study|symptomatic deterioration|1
7582788|NCT00329108|11986617|FG000|Overall Study|Subject no longer willing to participate|2
7582789|NCT00329108|11986618|FG001|Overall Study|Subject no longer willing to participate|2
7582790|NCT00329108|11986617|FG000|Overall Study|study terminated by sponsor|1
7582791|NCT00329108|11986618|FG001|Overall Study|study terminated by sponsor|0
7582792|NCT00329108|11986617|FG000|Overall Study|withdrew patient after SAE resolved|1
7582793|NCT00329108|11986618|FG001|Overall Study|withdrew patient after SAE resolved|0
7582794|NCT00329108|11986617|FG000|Overall Study|Protocol Violation|0
7582795|NCT00329108|11986618|FG001|Overall Study|Protocol Violation|2
7582796|NCT00333229|11986639|FG000|Overall Study|Lack of Efficacy|0
7582797|NCT00333229|11986640|FG001|Overall Study|Lack of Efficacy|1
7582798|NCT00314327|11986686|FG000|Overall Study|Withdrawal by Subject|1
7582799|NCT00308113|11986694|FG000|Overall Study|Protocol closure|0
7582800|NCT00308113|11986695|FG001|Overall Study|Protocol closure|0
7582801|NCT00308113|11986696|FG002|Overall Study|Protocol closure|0
7582802|NCT00308113|11986697|FG003|Overall Study|Protocol closure|1
7582803|NCT00298740|11986717|FG000|Overall Study|Lack of Efficacy|6
7582804|NCT00298740|11986717|FG000|Overall Study|Withdrawal by Subject|3
7582805|NCT00301080|11986721|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
7582806|NCT00301080|11986722|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7582807|NCT00301080|11986723|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7582808|NCT00301080|11986724|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7582809|NCT00301080|11986725|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
7582810|NCT00290407|11986743|FG000|Overall Study|Physician Decision|2
7582811|NCT00295490|11986751|FG000|Overall Study|Protocol Violation|0
7582812|NCT00295490|11986752|FG001|Overall Study|Protocol Violation|0
7582813|NCT00295490|11986753|FG002|Overall Study|Protocol Violation|3
7582814|NCT00295490|11986754|FG003|Overall Study|Protocol Violation|3
7582815|NCT00295490|11986751|FG000|Overall Study|Withdrawal by Subject|0
7582816|NCT00295490|11986752|FG001|Overall Study|Withdrawal by Subject|2
7582817|NCT00295490|11986753|FG002|Overall Study|Withdrawal by Subject|0
7582818|NCT00295490|11986754|FG003|Overall Study|Withdrawal by Subject|1
7582819|NCT00295490|11986751|FG000|Overall Study|Lost to Follow-up|0
7582820|NCT00295490|11986752|FG001|Overall Study|Lost to Follow-up|0
7582821|NCT00295490|11986753|FG002|Overall Study|Lost to Follow-up|1
7582822|NCT00295490|11986754|FG003|Overall Study|Lost to Follow-up|0
7582823|NCT00295490|11986751|FG000|Overall Study|Adverse Event|1
7582824|NCT00295490|11986752|FG001|Overall Study|Adverse Event|0
7582825|NCT00295490|11986753|FG002|Overall Study|Adverse Event|0
7582826|NCT00295490|11986754|FG003|Overall Study|Adverse Event|0
7582827|NCT00295490|11986751|FG000|Overall Study|Other|0
7582828|NCT00295490|11986752|FG001|Overall Study|Other|2
7582829|NCT00295490|11986753|FG002|Overall Study|Other|0
7582830|NCT00295490|11986754|FG003|Overall Study|Other|1
7582831|NCT00268463|11986766|FG000|Overall Study|study terminated due to low accrual|10
7582832|NCT00268463|11986767|FG001|Overall Study|study terminated due to low accrual|12
7582833|NCT00276419|11986784|FG000|First Intervention|Adverse Event|1
7582834|NCT00276419|11986785|FG001|First Intervention|Adverse Event|0
7582835|NCT00276419|11986784|FG000|First Intervention|Withdrawal by Subject|0
7582836|NCT00276419|11986785|FG001|First Intervention|Withdrawal by Subject|2
7582837|NCT00271947|11986833|FG000|Overall Study|Lost to Follow-up|1
7582838|NCT00252174|11986853|FG000|Overall Study|Withdrawal by Subject|0
7582839|NCT00252174|11986854|FG001|Overall Study|Withdrawal by Subject|1
7582840|NCT00252174|11986855|FG002|Overall Study|Withdrawal by Subject|0
7582841|NCT00256295|11986863|FG000|Overall Study|Withdrawal by Subject|3
7582842|NCT00256295|11986863|FG000|Overall Study|Death|1
7582843|NCT00239720|11986877|FG000|Overall Study|Adverse Event|1
7582844|NCT00239720|11986878|FG001|Overall Study|Adverse Event|0
7582845|NCT00239720|11986877|FG000|Overall Study|Lost to Follow-up|0
7582846|NCT00239720|11986878|FG001|Overall Study|Lost to Follow-up|1
7582847|NCT00250718|11986884|FG000|Overall Study|Death|1
7582848|NCT00250718|11986884|FG000|Overall Study|Adverse Event|1
7582849|NCT00250718|11986884|FG000|Overall Study|Withdrawal by Subject|1
7582850|NCT00206375|11986932|FG000|Overall Study|Lost to Follow-up|1
7582851|NCT00206375|11986933|FG001|Overall Study|Lost to Follow-up|0
7582852|NCT00206375|11986934|FG002|Overall Study|Lost to Follow-up|0
7582853|NCT00206375|11986932|FG000|Overall Study|Withdrawal by Subject|2
7582854|NCT00206375|11986933|FG001|Overall Study|Withdrawal by Subject|1
7582855|NCT00206375|11986934|FG002|Overall Study|Withdrawal by Subject|3
7582856|NCT00206375|11986932|FG000|Overall Study|Study terminated due to lack of funds|0
7582857|NCT00206375|11986933|FG001|Overall Study|Study terminated due to lack of funds|1
7582858|NCT00206375|11986934|FG002|Overall Study|Study terminated due to lack of funds|1
7582859|NCT00229931|11986944|FG000|Overall Study|Death|1
7582860|NCT00229931|11986945|FG001|Overall Study|Death|0
7582861|NCT00229931|11986944|FG000|Overall Study|Lost to Follow-up|3
7582862|NCT00229931|11986945|FG001|Overall Study|Lost to Follow-up|2
7582863|NCT00209131|11986953|FG000|Overall Study|Lack of personnel due to turnovers.|15
7582864|NCT00209131|11986954|FG001|Overall Study|Lack of personnel due to turnovers.|11
7582865|NCT00209027|11986984|FG000|Overall Study|study terminated|10
7582866|NCT00209027|11986985|FG001|Overall Study|study terminated|0
7582867|NCT00182637|11986991|FG000|Overall Study|Adverse Event|2
7582868|NCT00182637|11986991|FG000|Overall Study|Disease Progression|1
7582869|NCT00176488|11986996|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
7582870|NCT00162773|11987033|FG000|Overall Study|P.I, Left institution. Study terminated|22
7582871|NCT00147238|11987063|FG000|Overall Study|Inevaluable|8
7582872|NCT00165503|11987067|FG000|Overall Study|Death|1
7582873|NCT00165503|11987067|FG000|Overall Study|Lost to Follow-up|12
7582874|NCT00165503|11987067|FG000|Overall Study|Unresectable|3
7582875|NCT00160563|11987074|FG000|Overall Study|Adverse Event|1
7582876|NCT00160563|11987075|FG001|Overall Study|Adverse Event|1
7582877|NCT00160563|11987076|FG002|Overall Study|Adverse Event|1
7582878|NCT00160563|11987074|FG000|Overall Study|Lost to Follow-up|1
7582879|NCT00160563|11987075|FG001|Overall Study|Lost to Follow-up|1
7582880|NCT00160563|11987076|FG002|Overall Study|Lost to Follow-up|2
7582881|NCT00160563|11987074|FG000|Overall Study|Protocol Violation|0
7582882|NCT00160563|11987075|FG001|Overall Study|Protocol Violation|0
7582883|NCT00160563|11987076|FG002|Overall Study|Protocol Violation|3
7582884|NCT00160563|11987074|FG000|Overall Study|Withdrawal by Subject|1
7582885|NCT00160563|11987075|FG001|Overall Study|Withdrawal by Subject|2
7582886|NCT00160563|11987076|FG002|Overall Study|Withdrawal by Subject|3
7582887|NCT00160563|11987074|FG000|Overall Study|Other (listed in the study report)|48
7582888|NCT00160563|11987075|FG001|Overall Study|Other (listed in the study report)|40
7582889|NCT00160563|11987076|FG002|Overall Study|Other (listed in the study report)|81
7582890|NCT00160563|11987074|FG000|Overall Study|Missing reason|0
7582891|NCT00160563|11987075|FG001|Overall Study|Missing reason|1
7582892|NCT00160563|11987076|FG002|Overall Study|Missing reason|0
7582893|NCT00142519|11987087|FG000|Overall Study|Not Treated|7
7582894|NCT00142519|11987088|FG001|Overall Study|Not Treated|9
7582895|NCT00142519|11987087|FG000|Overall Study|Protocol Violation|1
7582896|NCT00142519|11987088|FG001|Overall Study|Protocol Violation|0
7582897|NCT00142519|11987087|FG000|Overall Study|Withdrawal by Subject|10
7582898|NCT00142519|11987088|FG001|Overall Study|Withdrawal by Subject|7
7582899|NCT00138073|11987103|FG000|Overall Study|lack of resources|55
7582900|NCT00113386|11987109|FG000|Overall Study|Withdrawal by Subject|1
7582901|NCT00113386|11987110|FG001|Overall Study|Withdrawal by Subject|0
7582902|NCT00113386|11987109|FG000|Overall Study|Physician Decision|0
7582903|NCT00113386|11987110|FG001|Overall Study|Physician Decision|1
7582904|NCT00113386|11987109|FG000|Overall Study|Toxicity|3
7582905|NCT00113386|11987110|FG001|Overall Study|Toxicity|0
7582906|NCT00113386|11987109|FG000|Overall Study|Ineligible|1
7582907|NCT00113386|11987110|FG001|Overall Study|Ineligible|2
7582908|NCT00113386|11987109|FG000|Overall Study|Unknown - Lost to Follow-Up|2
7582909|NCT00113386|11987110|FG001|Overall Study|Unknown - Lost to Follow-Up|1
7582910|NCT00138151|11987116|FG000|Overall Study|Withdrawal by Subject|3
7582911|NCT00138151|11987116|FG000|Overall Study|Physician Decision|1
7582912|NCT00129974|11987120|FG000|Overall Study|Other|1
7582913|NCT00126659|11987127|FG000|Overall Study|Adverse Event|0
7582914|NCT00126659|11987128|FG001|Overall Study|Adverse Event|0
7582915|NCT00126659|11987129|FG002|Overall Study|Adverse Event|2
7582916|NCT00125268|11987146|FG000|Overall Study|Withdrawal by Subject|1
7582917|NCT00125268|11987147|FG001|Overall Study|Withdrawal by Subject|1
7582918|NCT00113399|11987155|FG000|Overall Study|Death|1
7582919|NCT00113399|11987156|FG001|Overall Study|Death|1
7582920|NCT00113399|11987155|FG000|Overall Study|Withdrawal by Subject|1
7582921|NCT00113399|11987156|FG001|Overall Study|Withdrawal by Subject|2
7582922|NCT00113399|11987155|FG000|Overall Study|Complete Response|0
7582923|NCT00113399|11987156|FG001|Overall Study|Complete Response|1
7582924|NCT00113399|11987155|FG000|Overall Study|Other|0
7582925|NCT00113399|11987156|FG001|Overall Study|Other|1
7582926|NCT00107614|11987166|FG000|Overall Study|Physician Decision|10
7582927|NCT00107614|11987166|FG000|Overall Study|Death|2
7582928|NCT00107315|11987170|FG000|Overall Study|Disease Progression|9
7582929|NCT00107315|11987170|FG000|Overall Study|Adverse Event|4
7582930|NCT00107315|11987170|FG000|Overall Study|Withdrawal by Subject|2
7582931|NCT00108433|11987176|FG000|Overall Study|Lack of Efficacy|1
7582932|NCT00108433|11987177|FG001|Overall Study|Lack of Efficacy|2
7582933|NCT00108433|11987176|FG000|Overall Study|Death|3
7582934|NCT00108433|11987177|FG001|Overall Study|Death|0
7582935|NCT00108433|11987176|FG000|Overall Study|Adverse Event|3
7582936|NCT00108433|11987177|FG001|Overall Study|Adverse Event|1
7582937|NCT00108433|11987176|FG000|Overall Study|Other|14
7582938|NCT00108433|11987177|FG001|Overall Study|Other|14
7582939|NCT00113919|11987183|FG000|Overall Study|Physician Decision|8
7582940|NCT00113919|11987183|FG000|Overall Study|Death|6
7582941|NCT00100828|11987196|FG000|Overall Study|Physician Decision|6
7582942|NCT00104728|11987200|FG000|Overall Study|screen failures|19
7582943|NCT00083915|11987219|FG000|Overall Study|Death|6
7582944|NCT00083915|11987220|FG001|Overall Study|Death|3
7582945|NCT00083915|11987219|FG000|Overall Study|Physician Decision|11
7582946|NCT00083915|11987220|FG001|Overall Study|Physician Decision|6
7582947|NCT00083915|11987219|FG000|Overall Study|Withdrawal by Subject|8
7582948|NCT00083915|11987220|FG001|Overall Study|Withdrawal by Subject|3
7582949|NCT00083915|11987219|FG000|Overall Study|disease progression|18
7582950|NCT00083915|11987220|FG001|Overall Study|disease progression|23
7582951|NCT00083915|11987219|FG000|Overall Study|Failure to collect|3
7582952|NCT00083915|11987220|FG001|Overall Study|Failure to collect|0
7582953|NCT00083915|11987219|FG000|Overall Study|No response|3
7582954|NCT00083915|11987220|FG001|Overall Study|No response|1
7582955|NCT00083915|11987219|FG000|Overall Study|Insurance issues|1
7582956|NCT00083915|11987220|FG001|Overall Study|Insurance issues|1
7582957|NCT00088829|11987239|FG000|Overall Study|PI left institution and study was close|22
7625238|NCT01437423|12036602|FG000|Overall Study|Lost to Follow-up|12
7625239|NCT01437423|12036602|FG000|Overall Study|Off label usage|3
7625240|NCT01410890|12036608|FG000|Overall Study|Withdrawal by Subject|0
7625241|NCT01410890|12036609|FG001|Overall Study|Withdrawal by Subject|1
7625242|NCT01190228|12036620|FG000|Overall Study|Protocol Violation|4
7625243|NCT01190228|12036621|FG001|Overall Study|Protocol Violation|0
7625244|NCT01190228|12036622|FG002|Overall Study|Protocol Violation|0
7625245|NCT01190228|12036620|FG000|Overall Study|Withdrawal by Subject|1
7625246|NCT01190228|12036621|FG001|Overall Study|Withdrawal by Subject|0
7625247|NCT01190228|12036622|FG002|Overall Study|Withdrawal by Subject|0
7625248|NCT01146652|12036634|FG000|Overall Study|Adverse Event|506
7625249|NCT01146652|12036635|FG001|Overall Study|Adverse Event|15
7625250|NCT01146652|12036634|FG000|Overall Study|Lack of Efficacy|91
7625251|NCT01146652|12036635|FG001|Overall Study|Lack of Efficacy|7
7625252|NCT01146652|12036634|FG000|Overall Study|Poor compliance to protocol|38
7625253|NCT01146652|12036635|FG001|Overall Study|Poor compliance to protocol|1
7625254|NCT01146652|12036634|FG000|Overall Study|Other unspecified reasons|314
7625255|NCT01146652|12036635|FG001|Overall Study|Other unspecified reasons|22
7625256|NCT01146652|12036634|FG000|Overall Study|Enrolled but not treated|2
7625257|NCT01146652|12036635|FG001|Overall Study|Enrolled but not treated|0
7625258|NCT01049035|12036655|FG000|Overall Study|Serious adverse event|0
7625259|NCT01049035|12036656|FG001|Overall Study|Serious adverse event|1
7625260|NCT01049035|12036657|FG002|Overall Study|Serious adverse event|1
7625261|NCT01049035|12036658|FG003|Overall Study|Serious adverse event|2
7625262|NCT01049035|12036659|FG004|Overall Study|Serious adverse event|0
7625263|NCT01049035|12036660|FG005|Overall Study|Serious adverse event|0
7625264|NCT01049035|12036661|FG006|Overall Study|Serious adverse event|0
7625265|NCT01049035|12036655|FG000|Overall Study|Other adverse event (AE)|0
7625266|NCT01049035|12036656|FG001|Overall Study|Other adverse event (AE)|0
7625267|NCT01049035|12036657|FG002|Overall Study|Other adverse event (AE)|0
7625268|NCT01049035|12036658|FG003|Overall Study|Other adverse event (AE)|1
7625269|NCT01049035|12036659|FG004|Overall Study|Other adverse event (AE)|0
7625270|NCT01049035|12036660|FG005|Overall Study|Other adverse event (AE)|0
7625271|NCT01049035|12036661|FG006|Overall Study|Other adverse event (AE)|0
7582958|NCT00085631|11987262|FG000|Overall Study|Missing Data|4
7582959|NCT00085631|11987263|FG001|Overall Study|Missing Data|11
7582960|NCT00085631|11987264|FG002|Overall Study|Missing Data|7
7582961|NCT00062751|11987276|FG000|Overall Study|Disease progression|24
7582962|NCT00062751|11987277|FG001|Overall Study|Disease progression|17
7582963|NCT00062751|11987278|FG002|Overall Study|Disease progression|24
7582964|NCT00062751|11987279|FG003|Overall Study|Disease progression|2
7582965|NCT00062751|11987280|FG004|Overall Study|Disease progression|2
7582966|NCT00062751|11987276|FG000|Overall Study|Adverse Event|4
7582967|NCT00062751|11987277|FG001|Overall Study|Adverse Event|7
7582968|NCT00062751|11987278|FG002|Overall Study|Adverse Event|2
7582969|NCT00062751|11987279|FG003|Overall Study|Adverse Event|2
7582970|NCT00062751|11987280|FG004|Overall Study|Adverse Event|2
7582971|NCT00062751|11987276|FG000|Overall Study|Other|2
7582972|NCT00062751|11987277|FG001|Overall Study|Other|3
7582973|NCT00062751|11987278|FG002|Overall Study|Other|1
7582974|NCT00062751|11987279|FG003|Overall Study|Other|0
7582975|NCT00062751|11987280|FG004|Overall Study|Other|1
7582976|NCT00062751|11987276|FG000|Overall Study|Withdrawal by Subject|1
7582977|NCT00062751|11987277|FG001|Overall Study|Withdrawal by Subject|2
7582978|NCT00062751|11987278|FG002|Overall Study|Withdrawal by Subject|2
7582979|NCT00062751|11987279|FG003|Overall Study|Withdrawal by Subject|1
7582980|NCT00062751|11987280|FG004|Overall Study|Withdrawal by Subject|0
7582981|NCT00062751|11987276|FG000|Overall Study|Symptomatic deterioration|1
7582982|NCT00062751|11987277|FG001|Overall Study|Symptomatic deterioration|1
7582983|NCT00062751|11987278|FG002|Overall Study|Symptomatic deterioration|0
7582984|NCT00062751|11987279|FG003|Overall Study|Symptomatic deterioration|0
7582985|NCT00062751|11987280|FG004|Overall Study|Symptomatic deterioration|1
7582986|NCT00062751|11987276|FG000|Overall Study|Death|1
7582987|NCT00062751|11987277|FG001|Overall Study|Death|0
7582988|NCT00062751|11987278|FG002|Overall Study|Death|1
7582989|NCT00062751|11987279|FG003|Overall Study|Death|0
7582990|NCT00062751|11987280|FG004|Overall Study|Death|0
7582991|NCT00066807|11987295|FG000|Overall Study|Study was terminated early|14
7582992|NCT00066807|11987296|FG001|Overall Study|Study was terminated early|15
7582993|NCT00038142|11987317|FG000|Overall Study|Ineligible|1
7582994|NCT00038142|11987318|FG001|Overall Study|Ineligible|0
7582995|NCT00038142|11987317|FG000|Overall Study|Progressive Disease|11
7582996|NCT00038142|11987318|FG001|Overall Study|Progressive Disease|7
7582997|NCT00038142|11987317|FG000|Overall Study|Death|1
7582998|NCT00038142|11987318|FG001|Overall Study|Death|0
7582999|NCT00038142|11987317|FG000|Overall Study|Adverse Event|1
7583000|NCT00038142|11987318|FG001|Overall Study|Adverse Event|0
7583001|NCT00038142|11987317|FG000|Overall Study|Unknown Reason|8
7583002|NCT00038142|11987318|FG001|Overall Study|Unknown Reason|0
7583003|NCT00006478|11987333|FG000|Overall Study|Vaccine could not be produced|1
7583004|NCT00006478|11987333|FG000|Overall Study|Physician Decision|6
7583005|NCT00006916|11987346|FG000|Overall Study|Device not inserted|4
7583006|NCT00006916|11987346|FG000|Overall Study|Complication of device insertion|1
7583007|NCT02009384|11987420|FG000|Overall Study|Death|2
7583008|NCT04558125|11987424|FG000|Overall Study|Death|1
7583009|NCT02401308|11987430|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
7583010|NCT02401308|11987431|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
7583011|NCT04381988|11987439|FG000|Overall Study|The study was terminated|4
7583012|NCT04381988|11987440|FG001|Overall Study|The study was terminated|0
7583013|NCT00479167|11987468|FG000|Overall Study|Withdrawal by Subject|1
7583014|NCT03998189|11987475|FG000|Overall Study|Lack of Efficacy|0
7583015|NCT03998189|11987476|FG001|Overall Study|Lack of Efficacy|1
7583016|NCT02934503|11987590|FG000|Overall Study|progression of disease|3
7583017|NCT02934503|11987590|FG000|Overall Study|Withdrawal by Subject|1
7583018|NCT02137252|11987596|FG000|Overall Study|trial terminated early|2
7583019|NCT02137252|11987597|FG001|Overall Study|trial terminated early|1
7583020|NCT01294670|11987612|FG000|Overall Study|Not treated|1
7583021|NCT01294670|11987613|FG001|Overall Study|Not treated|0
7583022|NCT01294670|11987614|FG002|Overall Study|Not treated|0
7583023|NCT01294670|11987615|FG003|Overall Study|Not treated|0
7583024|NCT01294670|11987616|FG004|Overall Study|Not treated|0
7583025|NCT03095287|11987628|FG000|Overall Study|Treatment Failure|1
7583026|NCT03095287|11987628|FG000|Overall Study|Adverse Event|1
7583027|NCT02930122|11987638|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
7583028|NCT02930122|11987639|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
7583029|NCT04144166|11987659|FG000|Overall Study|Discharged before study start|1
7583030|NCT04144166|11987659|FG000|Overall Study|Pregnancy|1
7583031|NCT04144166|11987659|FG000|Overall Study|Nail polish could not be removed from finger|1
7583032|NCT04090164|11987670|FG000|Overall Study|incomplete data on file|245
7583033|NCT04090164|11987671|FG001|Overall Study|incomplete data on file|0
7583034|NCT03997825|11987760|FG000|Overall Study|Death|3
7583035|NCT03997825|11987760|FG000|Overall Study|Lost to Follow-up|10
7583036|NCT03997825|11987760|FG000|Overall Study|Withdrawal by Subject|3
7583037|NCT03997825|11987760|FG000|Overall Study|Refused participation|1
7583038|NCT03764813|11987797|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7583039|NCT03764813|11987798|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7583040|NCT03764813|11987799|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
7583041|NCT03764813|11987800|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
7625272|NCT01049035|12036655|FG000|Overall Study|Non-compliance with the protocol|12
7625273|NCT01049035|12036656|FG001|Overall Study|Non-compliance with the protocol|6
7625274|NCT01049035|12036657|FG002|Overall Study|Non-compliance with the protocol|14
7625275|NCT01049035|12036658|FG003|Overall Study|Non-compliance with the protocol|5
7625276|NCT01049035|12036659|FG004|Overall Study|Non-compliance with the protocol|3
7625277|NCT01049035|12036660|FG005|Overall Study|Non-compliance with the protocol|4
7625278|NCT01049035|12036661|FG006|Overall Study|Non-compliance with the protocol|10
7625279|NCT01049035|12036655|FG000|Overall Study|Lost to Follow-up|5
7625280|NCT01049035|12036656|FG001|Overall Study|Lost to Follow-up|4
7625281|NCT01049035|12036657|FG002|Overall Study|Lost to Follow-up|4
7625282|NCT01049035|12036658|FG003|Overall Study|Lost to Follow-up|1
7625283|NCT01049035|12036659|FG004|Overall Study|Lost to Follow-up|0
7625284|NCT01049035|12036660|FG005|Overall Study|Lost to Follow-up|3
7625285|NCT01049035|12036661|FG006|Overall Study|Lost to Follow-up|3
7625286|NCT01049035|12036655|FG000|Overall Study|Voluntary withdrawal not due to an AE|16
7625287|NCT01049035|12036656|FG001|Overall Study|Voluntary withdrawal not due to an AE|10
7625288|NCT01049035|12036657|FG002|Overall Study|Voluntary withdrawal not due to an AE|8
7625289|NCT01049035|12036658|FG003|Overall Study|Voluntary withdrawal not due to an AE|2
7625290|NCT01049035|12036659|FG004|Overall Study|Voluntary withdrawal not due to an AE|1
7625291|NCT01049035|12036660|FG005|Overall Study|Voluntary withdrawal not due to an AE|5
7625292|NCT01049035|12036661|FG006|Overall Study|Voluntary withdrawal not due to an AE|2
7625295|NCT00726063|12036704|FG000|Overall Study|Adverse Event|9
7625296|NCT00726063|12036705|FG001|Overall Study|Adverse Event|7
7625297|NCT00713206|12036722|FG000|Overall Study|Lost to Follow-up|4
7625298|NCT00713206|12036723|FG001|Overall Study|Lost to Follow-up|4
7625299|NCT00713206|12036722|FG000|Overall Study|Death|1
7625300|NCT00713206|12036723|FG001|Overall Study|Death|0
7583042|NCT04584788|11987820|FG000|Overall Study|Physician Decision|8
7583043|NCT04584788|11987820|FG000|Overall Study|Withdrawal by Subject|1
7583044|NCT04584788|11987820|FG000|Overall Study|Adverse Event|3
7583045|NCT03783923|11987835|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3
7583046|NCT03783923|11987836|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2
7583047|NCT03783923|11987835|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1
7583048|NCT03783923|11987836|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0
7583049|NCT03783923|11987835|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0
7583050|NCT03783923|11987836|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2
7583051|NCT03783923|11987835|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
7583052|NCT03783923|11987836|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1
7583053|NCT03783923|11987835|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0
7583054|NCT03783923|11987836|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1
7583055|NCT03718429|11987844|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
7583056|NCT03718429|11987845|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
7583057|NCT03718429|11987846|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1
7583058|NCT03718429|11987847|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0
7583083|NCT03022461|11987911|FG000|Overall Study|Death|3
7583096|NCT02689349|11987931|FG000|Overall Study|Not implanted|4
7583097|NCT02689349|11987932|FG001|Overall Study|Not implanted|0
7583098|NCT02689349|11987931|FG000|Overall Study|Withdrawal by Subject|9
7583099|NCT02689349|11987932|FG001|Overall Study|Withdrawal by Subject|0
7583100|NCT02680574|11987943|FG000|Overall Study|Death|137
7583101|NCT02680574|11987944|FG001|Overall Study|Death|137
7583102|NCT02680574|11987943|FG000|Overall Study|Withdrawal by Subject|17
7583103|NCT02680574|11987944|FG001|Overall Study|Withdrawal by Subject|9
7583104|NCT02680574|11987943|FG000|Overall Study|Lost to Follow-up|4
7583105|NCT02680574|11987944|FG001|Overall Study|Lost to Follow-up|6
7583106|NCT02648347|11987952|FG000|Overall Study|Death|174
7583107|NCT02648347|11987953|FG001|Overall Study|Death|167
7583108|NCT02648347|11987952|FG000|Overall Study|Withdrawal by Subject|16
7583109|NCT02648347|11987953|FG001|Overall Study|Withdrawal by Subject|9
7583110|NCT02648347|11987952|FG000|Overall Study|Lost to Follow-up|18
7583111|NCT02648347|11987953|FG001|Overall Study|Lost to Follow-up|21
7583112|NCT02648347|11987952|FG000|Overall Study|Missing|1
7583113|NCT02648347|11987953|FG001|Overall Study|Missing|0
7583114|NCT02224755|11987974|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
7583115|NCT02224755|11987975|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
7583116|NCT02224755|11987974|FG000|Two Year Follow up Post-implant|Death|103
7583117|NCT02224755|11987975|FG001|Two Year Follow up Post-implant|Death|98
7583118|NCT02224755|11987974|FG000|Two Year Follow up Post-implant|Heart transplant|137
7583119|NCT02224755|11987975|FG001|Two Year Follow up Post-implant|Heart transplant|119
7583120|NCT02224755|11987974|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7583121|NCT02224755|11987975|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
7583122|NCT02224755|11987974|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
7583123|NCT02224755|11987975|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
7583124|NCT02090114|11987995|FG000|Overall Study|Withdrawal by Subject|3
7583125|NCT02090114|11987996|FG001|Overall Study|Withdrawal by Subject|6
7583126|NCT02090114|11987997|FG002|Overall Study|Withdrawal by Subject|2
7583127|NCT02090114|11987998|FG003|Overall Study|Withdrawal by Subject|1
7583128|NCT02090114|11987995|FG000|Overall Study|Physician Decision|5
7583129|NCT02090114|11987996|FG001|Overall Study|Physician Decision|0
7583130|NCT02090114|11987997|FG002|Overall Study|Physician Decision|1
7583131|NCT02090114|11987998|FG003|Overall Study|Physician Decision|1
7583132|NCT02090114|11987995|FG000|Overall Study|Adverse Event|1
7583133|NCT02090114|11987996|FG001|Overall Study|Adverse Event|2
7583134|NCT02090114|11987997|FG002|Overall Study|Adverse Event|2
7583135|NCT02090114|11987998|FG003|Overall Study|Adverse Event|0
7583136|NCT02090114|11987995|FG000|Overall Study|Progressive Disease|20
7583137|NCT02090114|11987996|FG001|Overall Study|Progressive Disease|21
7583138|NCT02090114|11987997|FG002|Overall Study|Progressive Disease|23
7583139|NCT02090114|11987998|FG003|Overall Study|Progressive Disease|6
7583140|NCT02090114|11987995|FG000|Overall Study|Death|1
7583141|NCT02090114|11987996|FG001|Overall Study|Death|0
7583142|NCT02090114|11987997|FG002|Overall Study|Death|1
7583143|NCT02090114|11987998|FG003|Overall Study|Death|0
7583144|NCT00121485|11988019|FG000|Overall Study|Not implanted|1
7583145|NCT00121485|11988020|FG001|Overall Study|Not implanted|5
7583146|NCT00121485|11988019|FG000|Overall Study|Crossover|0
7583147|NCT00121485|11988020|FG001|Overall Study|Crossover|2
7625301|NCT04422990|12036736|FG000|Overall Study|Withdrawal by Subject|0
7625302|NCT04422990|12036737|FG001|Overall Study|Withdrawal by Subject|1
7625303|NCT04422990|12036736|FG000|Overall Study|Travel|3
7625304|NCT04422990|12036737|FG001|Overall Study|Travel|0
7625305|NCT04358549|12036752|FG000|Overall Study|Adverse Event|0
7625306|NCT04358549|12036753|FG001|Overall Study|Adverse Event|1
7625307|NCT04358549|12036752|FG000|Overall Study|Death|1
7625308|NCT04358549|12036753|FG001|Overall Study|Death|0
7625309|NCT04358549|12036752|FG000|Overall Study|Lost to Follow-up|2
7625310|NCT04358549|12036753|FG001|Overall Study|Lost to Follow-up|1
7625311|NCT04358549|12036752|FG000|Overall Study|Withdrawal by Subject|6
7625312|NCT04358549|12036753|FG001|Overall Study|Withdrawal by Subject|6
7625313|NCT04358549|12036752|FG000|Overall Study|Start remdesivir|1
7625314|NCT04358549|12036753|FG001|Overall Study|Start remdesivir|0
7270142|NCT00414050|11484238|FG000|Overall Study|Subject Moved|0
7625315|NCT04532099|12036782|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1
7583148|NCT00078806|11988035|FG000|Part 1A|Adverse Event|2
7583149|NCT00078806|11988036|FG001|Part 1A|Adverse Event|0
7583150|NCT00078806|11988037|FG002|Part 1A|Adverse Event|0
7583151|NCT00078806|11988038|FG003|Part 1A|Adverse Event|0
7583152|NCT00078806|11988035|FG000|Part 1A|Lack of Efficacy|7
7583153|NCT00078806|11988036|FG001|Part 1A|Lack of Efficacy|0
7583154|NCT00078806|11988037|FG002|Part 1A|Lack of Efficacy|0
7583155|NCT00078806|11988038|FG003|Part 1A|Lack of Efficacy|0
7583156|NCT00078806|11988035|FG000|Part 1A|Other|1
7583157|NCT00078806|11988036|FG001|Part 1A|Other|0
7583158|NCT00078806|11988037|FG002|Part 1A|Other|0
7583159|NCT00078806|11988038|FG003|Part 1A|Other|0
7583160|NCT00078806|11988035|FG000|Part 1B|Adverse Event|1
7583161|NCT00078806|11988036|FG001|Part 1B|Adverse Event|0
7583162|NCT00078806|11988037|FG002|Part 1B|Adverse Event|0
7583163|NCT00078806|11988038|FG003|Part 1B|Adverse Event|0
7583164|NCT00078806|11988035|FG000|Part 1B|Lack of Efficacy|7
7583165|NCT00078806|11988036|FG001|Part 1B|Lack of Efficacy|0
7583166|NCT00078806|11988037|FG002|Part 1B|Lack of Efficacy|0
7583167|NCT00078806|11988038|FG003|Part 1B|Lack of Efficacy|0
7583168|NCT00078806|11988035|FG000|Part 2|Adverse Event|0
7583169|NCT00078806|11988036|FG001|Part 2|Adverse Event|1
7583170|NCT00078806|11988037|FG002|Part 2|Adverse Event|0
7583171|NCT00078806|11988038|FG003|Part 2|Adverse Event|0
7583172|NCT00162370|11988053|FG000|Efficacy Population|Lost to Follow-up|51
7583173|NCT00214500|11988069|FG000|Treatment Period|Adverse Event|1
7583174|NCT00214500|11988069|FG000|Extension Period|Withdrawal by Subject|2
7583175|NCT00283959|11988081|FG000|Extension Period|Low Compliance|1
7583176|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
7583177|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
7583178|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
7583179|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
7583180|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
7583181|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
7583182|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7583183|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
7583184|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
7583185|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
7583186|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
7583187|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
7583188|NCT00290758|11988087|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
7583189|NCT00290758|11988088|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
7583190|NCT00290758|11988087|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6
7583191|NCT00290758|11988088|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5
7583192|NCT00310388|11988098|FG000|Primary Reporting Phase|Adverse Event|101
7583193|NCT00310388|11988099|FG001|Primary Reporting Phase|Adverse Event|0
7583194|NCT00310388|11988098|FG000|Primary Reporting Phase|Lack of Efficacy|56
7583195|NCT00310388|11988099|FG001|Primary Reporting Phase|Lack of Efficacy|0
7583196|NCT00310388|11988098|FG000|Primary Reporting Phase|Withdrawal by Subject|97
7583197|NCT00310388|11988099|FG001|Primary Reporting Phase|Withdrawal by Subject|0
7583198|NCT00310388|11988098|FG000|Primary Reporting Phase|Protocol Violation|10
7583199|NCT00310388|11988099|FG001|Primary Reporting Phase|Protocol Violation|0
7583200|NCT00310388|11988098|FG000|Primary Reporting Phase|Pregnancy|3
7583201|NCT00310388|11988099|FG001|Primary Reporting Phase|Pregnancy|0
7583202|NCT00310388|11988098|FG000|Primary Reporting Phase|Change in participant medical condition|3
7583203|NCT00310388|11988099|FG001|Primary Reporting Phase|Change in participant medical condition|0
7583204|NCT00310388|11988098|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
7583205|NCT00310388|11988099|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
7583206|NCT00310388|11988098|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
7583207|NCT00310388|11988099|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
7583208|NCT00310388|11988098|FG000|Primary Reporting Phase|Physician Decision|2
7583209|NCT00310388|11988099|FG001|Primary Reporting Phase|Physician Decision|0
7583210|NCT00310388|11988098|FG000|Primary Reporting Phase|Request of the sponsor|19
7583211|NCT00310388|11988099|FG001|Primary Reporting Phase|Request of the sponsor|0
7583212|NCT00310388|11988098|FG000|Primary Reporting Phase|Failed to return|8
7583213|NCT00310388|11988099|FG001|Primary Reporting Phase|Failed to return|0
7583214|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant request unrelated to study|2
7583215|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant request unrelated to study|0
7583216|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant request|2
7583217|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant request|0
7583218|NCT00310388|11988098|FG000|Primary Reporting Phase|Ministry of Health decision|25
7583219|NCT00310388|11988099|FG001|Primary Reporting Phase|Ministry of Health decision|0
7583220|NCT00310388|11988098|FG000|Primary Reporting Phase|Discontinuation of study|1
7583221|NCT00310388|11988099|FG001|Primary Reporting Phase|Discontinuation of study|0
7583222|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1
7583223|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0
7583224|NCT00310388|11988098|FG000|Primary Reporting Phase|Termination of study at sponsor request|3
7583225|NCT00310388|11988099|FG001|Primary Reporting Phase|Termination of study at sponsor request|0
7583226|NCT00310388|11988098|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1
7583227|NCT00310388|11988099|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0
7583228|NCT00310388|11988098|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2
7583229|NCT00310388|11988099|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0
7583230|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant passed away|1
7583231|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant passed away|0
7583232|NCT00310388|11988098|FG000|Primary Reporting Phase|Participant retired the informed consent|1
7583233|NCT00310388|11988099|FG001|Primary Reporting Phase|Participant retired the informed consent|0
7583234|NCT00310388|11988098|FG000|Primary Reporting Phase|Missing|1
7583235|NCT00310388|11988099|FG001|Primary Reporting Phase|Missing|0
7583236|NCT00310388|11988098|FG000|Primary Reporting Phase|Other|1
7583237|NCT00310388|11988099|FG001|Primary Reporting Phase|Other|0
7583238|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
7583239|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
7583240|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Adverse Event|0
7583241|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Adverse Event|1
7583242|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
7583243|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
7583244|NCT00310388|11988098|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
7583245|NCT00310388|11988099|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
7625316|NCT04532099|12036783|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0
7625317|NCT04532099|12036784|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0
7625318|NCT04385199|12036798|FG000|Overall Study|Withdrawal by Subject|1
7625319|NCT04385199|12036799|FG001|Overall Study|Withdrawal by Subject|0
7583246|NCT04651114|11988104|FG000|Overall Study|Withdrawal by Subject|8
7583256|NCT03768089|11988162|FG000|Part A|Lost to Follow-up|0
7583257|NCT03768089|11988163|FG001|Part A|Lost to Follow-up|0
7583258|NCT03768089|11988164|FG002|Part A|Lost to Follow-up|0
7583259|NCT03768089|11988165|FG003|Part A|Lost to Follow-up|0
7583260|NCT03768089|11988166|FG004|Part A|Lost to Follow-up|1
7583261|NCT03768089|11988167|FG005|Part A|Lost to Follow-up|0
7583262|NCT03768089|11988168|FG006|Part A|Lost to Follow-up|0
7583263|NCT03768089|11988169|FG007|Part A|Lost to Follow-up|0
7583264|NCT03768089|11988170|FG008|Part A|Lost to Follow-up|0
7583265|NCT03768089|11988171|FG009|Part A|Lost to Follow-up|0
7583266|NCT03768089|11988172|FG010|Part A|Lost to Follow-up|0
7583267|NCT03768089|11988173|FG011|Part A|Lost to Follow-up|0
7583268|NCT03768089|11988174|FG012|Part A|Lost to Follow-up|0
7583269|NCT03768089|11988175|FG013|Part A|Lost to Follow-up|0
7583270|NCT03768089|11988176|FG014|Part A|Lost to Follow-up|0
7583271|NCT03768089|11988177|FG015|Part A|Lost to Follow-up|0
7583272|NCT03768089|11988178|FG016|Part A|Lost to Follow-up|0
7583273|NCT03768089|11988179|FG017|Part A|Lost to Follow-up|0
7583274|NCT03768089|11988162|FG000|Part C|Randomized, Never Dosed|0
7583275|NCT03768089|11988163|FG001|Part C|Randomized, Never Dosed|0
7583276|NCT03768089|11988164|FG002|Part C|Randomized, Never Dosed|0
7583277|NCT03768089|11988165|FG003|Part C|Randomized, Never Dosed|0
7583278|NCT03768089|11988166|FG004|Part C|Randomized, Never Dosed|0
7583279|NCT03768089|11988167|FG005|Part C|Randomized, Never Dosed|0
7583280|NCT03768089|11988168|FG006|Part C|Randomized, Never Dosed|0
7583281|NCT03768089|11988169|FG007|Part C|Randomized, Never Dosed|0
7583282|NCT03768089|11988170|FG008|Part C|Randomized, Never Dosed|0
7583283|NCT03768089|11988171|FG009|Part C|Randomized, Never Dosed|0
7583284|NCT03768089|11988172|FG010|Part C|Randomized, Never Dosed|0
7583285|NCT03768089|11988173|FG011|Part C|Randomized, Never Dosed|0
7583286|NCT03768089|11988174|FG012|Part C|Randomized, Never Dosed|0
7583287|NCT03768089|11988175|FG013|Part C|Randomized, Never Dosed|0
7583288|NCT03768089|11988176|FG014|Part C|Randomized, Never Dosed|1
7583289|NCT03768089|11988177|FG015|Part C|Randomized, Never Dosed|0
7583290|NCT03768089|11988178|FG016|Part C|Randomized, Never Dosed|0
7583291|NCT03768089|11988179|FG017|Part C|Randomized, Never Dosed|0
7583299|NCT03446573|11988255|FG000|Overall Study|Withdrawal by Subject|7
7583300|NCT03446573|11988256|FG001|Overall Study|Withdrawal by Subject|16
7583301|NCT03446573|11988255|FG000|Overall Study|Physician Decision|1
7583302|NCT03446573|11988256|FG001|Overall Study|Physician Decision|1
7583303|NCT03446573|11988255|FG000|Overall Study|Lost to Follow-up|3
7583304|NCT03446573|11988256|FG001|Overall Study|Lost to Follow-up|5
7583305|NCT03446573|11988255|FG000|Overall Study|Protocol Violation|3
7583306|NCT03446573|11988256|FG001|Overall Study|Protocol Violation|2
7583307|NCT03446573|11988255|FG000|Overall Study|Lack of Efficacy|0
7583308|NCT03446573|11988256|FG001|Overall Study|Lack of Efficacy|3
7583309|NCT03446573|11988255|FG000|Overall Study|Adverse Event|13
7583310|NCT03446573|11988256|FG001|Overall Study|Adverse Event|2
7583311|NCT03446573|11988255|FG000|Overall Study|Ongoing at the time of interim analysis|342
7583312|NCT03446573|11988256|FG001|Overall Study|Ongoing at the time of interim analysis|343
7583313|NCT03409666|11988267|FG000|Overall Study|Physician Decision|0
7583314|NCT03409666|11988268|FG001|Overall Study|Physician Decision|1
7583315|NCT03409666|11988267|FG000|Overall Study|Protocol Violation|0
7583316|NCT03409666|11988268|FG001|Overall Study|Protocol Violation|3
7583357|NCT03126019|11988341|FG000|Overall Study|Participants Still Ongoing in the Study|17
7583358|NCT03126019|11988342|FG001|Overall Study|Participants Still Ongoing in the Study|87
7583359|NCT03126019|11988341|FG000|Overall Study|Death|2
7583360|NCT03126019|11988342|FG001|Overall Study|Death|7
7583361|NCT03126019|11988341|FG000|Overall Study|Lost to Follow-up|2
7583362|NCT03126019|11988342|FG001|Overall Study|Lost to Follow-up|3
7583363|NCT03126019|11988341|FG000|Overall Study|Withdrawal by Participant|1
7583364|NCT03126019|11988342|FG001|Overall Study|Withdrawal by Participant|3
7583365|NCT03126019|11988341|FG000|Overall Study|Reason not Specified|1
7583366|NCT03126019|11988342|FG001|Overall Study|Reason not Specified|3
7583385|NCT03089606|11988362|FG000|Overall Study|Progression after Cycle 1|1
7583386|NCT02955602|11988388|FG000|Overall Study|Adverse Event|0
7583387|NCT02955602|11988389|FG001|Overall Study|Adverse Event|3
7583388|NCT02955602|11988390|FG002|Overall Study|Adverse Event|0
7583389|NCT02955602|11988388|FG000|Overall Study|Withdrawal of informed consent|1
7583390|NCT02955602|11988389|FG001|Overall Study|Withdrawal of informed consent|3
7583391|NCT02955602|11988390|FG002|Overall Study|Withdrawal of informed consent|2
7583392|NCT02955602|11988388|FG000|Overall Study|Lost to Follow-up|0
7583393|NCT02955602|11988389|FG001|Overall Study|Lost to Follow-up|0
7583394|NCT02955602|11988390|FG002|Overall Study|Lost to Follow-up|1
7583395|NCT02955602|11988388|FG000|Overall Study|Other|0
7583396|NCT02955602|11988389|FG001|Overall Study|Other|1
7583397|NCT02955602|11988390|FG002|Overall Study|Other|3
7583398|NCT02850016|11988405|FG000|Overall Study|Withdrawal by Subject|1
7583399|NCT02850016|11988406|FG001|Overall Study|Withdrawal by Subject|2
7583400|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1
7583401|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1
7583402|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1
7583403|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0
7583404|NCT02846545|11988414|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1
7583405|NCT02846545|11988415|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5
7583406|NCT02846545|11988414|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1
7583407|NCT02846545|11988415|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1
7583408|NCT02846545|11988414|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1
7583409|NCT02846545|11988415|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1
7583430|NCT02544750|11988495|FG000|Overall Study|Physician Decision|3
7583431|NCT02544750|11988496|FG001|Overall Study|Physician Decision|1
7583432|NCT02544750|11988495|FG000|Overall Study|Other reasons|69
7583433|NCT02544750|11988496|FG001|Overall Study|Other reasons|39
7583434|NCT02544750|11988495|FG000|Overall Study|Met withdrawal criteria|2
7583435|NCT02544750|11988496|FG001|Overall Study|Met withdrawal criteria|2
7583436|NCT02544750|11988495|FG000|Overall Study|Transition To Commercial Product|1
7583437|NCT02544750|11988496|FG001|Overall Study|Transition To Commercial Product|0
7583438|NCT02544750|11988495|FG000|Overall Study|Withdrawal by Parent/Guardian|8
7583439|NCT02544750|11988496|FG001|Overall Study|Withdrawal by Parent/Guardian|7
7583440|NCT02544750|11988495|FG000|Overall Study|Adverse Event|8
7583441|NCT02544750|11988496|FG001|Overall Study|Adverse Event|10
7583442|NCT02544750|11988495|FG000|Overall Study|Withdrawal by Subject|10
7583443|NCT02544750|11988496|FG001|Overall Study|Withdrawal by Subject|4
7583444|NCT02544750|11988495|FG000|Overall Study|Lost to Follow-up|1
7583445|NCT02544750|11988496|FG001|Overall Study|Lost to Follow-up|0
7583446|NCT02448771|11988502|FG000|Overall Study|Disease Progression|30
7583447|NCT02448771|11988502|FG000|Overall Study|Unacceptable Toxicity|1
7583448|NCT02448771|11988502|FG000|Overall Study|Physician Decision|3
7583449|NCT02448771|11988502|FG000|Overall Study|Started new therapy|2
7583450|NCT02337829|11988511|FG000|Overall Study|Death|0
7583451|NCT02337829|11988512|FG001|Overall Study|Death|1
7583452|NCT02337829|11988513|FG002|Overall Study|Death|0
7583453|NCT02337829|11988514|FG003|Overall Study|Death|0
7583454|NCT02337829|11988511|FG000|Overall Study|Study terminated by sponsor|12
7583455|NCT02337829|11988512|FG001|Overall Study|Study terminated by sponsor|10
7583456|NCT02337829|11988513|FG002|Overall Study|Study terminated by sponsor|5
7583457|NCT02337829|11988514|FG003|Overall Study|Study terminated by sponsor|6
7583458|NCT02337829|11988511|FG000|Overall Study|discontinued for other reasons|6
7583459|NCT02337829|11988512|FG001|Overall Study|discontinued for other reasons|3
7583460|NCT02337829|11988513|FG002|Overall Study|discontinued for other reasons|1
7583461|NCT02337829|11988514|FG003|Overall Study|discontinued for other reasons|4
7583462|NCT02062944|11988526|FG000|Overall Study|Lost to Follow-up|1
7583463|NCT02062944|11988526|FG000|Overall Study|New hemotological disorder identified|1
7583464|NCT02062944|11988526|FG000|Overall Study|Uncontrolled Hypertension|1
7583465|NCT02062944|11988526|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3
7583466|NCT02053792|11988533|FG000|Overall Study|Physician Decision|0
7583467|NCT02053792|11988534|FG001|Overall Study|Physician Decision|1
7583468|NCT02053792|11988533|FG000|Overall Study|Development of High titer FIX inhibitor|0
7583469|NCT02053792|11988534|FG001|Overall Study|Development of High titer FIX inhibitor|1
7583470|NCT02053792|11988533|FG000|Overall Study|Lack of Efficacy|1
7583471|NCT02053792|11988534|FG001|Overall Study|Lack of Efficacy|0
7583472|NCT02053792|11988533|FG000|Overall Study|Adverse Event|1
7583473|NCT02053792|11988534|FG001|Overall Study|Adverse Event|0
7583474|NCT02053792|11988533|FG000|Overall Study|Withdrawal by Subject|2
7583475|NCT02053792|11988534|FG001|Overall Study|Withdrawal by Subject|2
7583476|NCT02053792|11988533|FG000|Overall Study|The patient was not compliant to the study procedure|1
7583477|NCT02053792|11988534|FG001|Overall Study|The patient was not compliant to the study procedure|0
7583478|NCT02053792|11988533|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1
7583479|NCT02053792|11988534|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0
7583480|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583481|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
7583482|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583483|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
7583484|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
7583485|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
7583486|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7583487|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
7583488|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583489|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
7583490|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583491|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
7583492|NCT01972217|11988544|FG000|Part A: Open-label Safety Run-in Period|Death|0
7583493|NCT01972217|11988545|FG001|Part A: Open-label Safety Run-in Period|Death|1
7583494|NCT01972217|11988546|FG002|Part A: Open-label Safety Run-in Period|Death|0
7583495|NCT01972217|11988547|FG003|Part A: Open-label Safety Run-in Period|Death|0
7583496|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Death|0
7583497|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Death|0
7583498|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Death|43
7583499|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Death|44
7583500|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
7583501|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
7583502|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
7583503|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
7583504|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Screen failure|0
7583505|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Screen failure|0
7583506|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Screen failure|0
7583507|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Screen failure|1
7583508|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7583509|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
7583510|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
7583511|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
7583512|NCT01972217|11988544|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583513|NCT01972217|11988545|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583514|NCT01972217|11988546|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
7583515|NCT01972217|11988547|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
7583536|NCT01640301|11988594|FG000|Overall Study|Death|0
7583537|NCT01640301|11988595|FG001|Overall Study|Death|8
7583538|NCT00554515|11988608|FG000|Overall Study|Withdrawal by Subject|3
7583539|NCT00554515|11988608|FG000|Overall Study|Disease progression|52
7583540|NCT00554515|11988608|FG000|Overall Study|Physician Decision|18
7583541|NCT00554515|11988608|FG000|Overall Study|Withdrawal by Subject|11
7583542|NCT00554515|11988608|FG000|Overall Study|Adverse Event|9
7583543|NCT00554515|11988608|FG000|Overall Study|Death|2
7583544|NCT00554515|11988608|FG000|Overall Study|Achieved Stable Disease|7
7583545|NCT00554515|11988608|FG000|Overall Study|Other|1
7583546|NCT00554515|11988608|FG000|Overall Study|Misc|15
7583547|NCT00107198|11988633|FG000|Overall Study|Lack of Efficacy|28
7583548|NCT00107198|11988633|FG000|Overall Study|Lost to Follow-up|12
7583549|NCT00107198|11988633|FG000|Overall Study|Protocol Violation|1
7583550|NCT00107198|11988633|FG000|Overall Study|Withdrawal by Subject|6
7583551|NCT00107198|11988633|FG000|Overall Study|Ineligible|5
7625328|NCT04311177|12036817|FG000|Overall Study|Adverse Event|3
7625329|NCT04311177|12036818|FG001|Overall Study|Adverse Event|1
7625330|NCT04311177|12036817|FG000|Overall Study|Physician Decision|4
7625331|NCT04311177|12036818|FG001|Overall Study|Physician Decision|3
7625332|NCT04311177|12036817|FG000|Overall Study|Withdrawal by Subject|1
7625333|NCT04311177|12036818|FG001|Overall Study|Withdrawal by Subject|0
7625334|NCT04241133|12036826|FG000|Overall Study|COVID19 Precautions|14
7625335|NCT04241133|12036827|FG001|Overall Study|COVID19 Precautions|34
7625336|NCT04150068|12036857|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24
7625337|NCT04150068|12036858|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12
7625338|NCT04150068|12036859|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35
7625339|NCT04150068|12036857|FG000|Maintenance Period (Week 26 Analysis)|Death|0
7625340|NCT04150068|12036858|FG001|Maintenance Period (Week 26 Analysis)|Death|0
7625341|NCT04150068|12036859|FG002|Maintenance Period (Week 26 Analysis)|Death|1
7625342|NCT04133519|12036868|FG000|Overall Study|Withdrawal by Subject|5
7583552|NCT00345358|11988641|FG000|Primary Vaccination Phase|Other|0
7583553|NCT00345358|11988642|FG001|Primary Vaccination Phase|Other|1
7583554|NCT00345358|11988643|FG002|Primary Vaccination Phase|Other|1
7583555|NCT00345358|11988644|FG003|Primary Vaccination Phase|Other|0
7583556|NCT00345358|11988641|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3
7583557|NCT00345358|11988642|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1
7583558|NCT00345358|11988643|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1
7583559|NCT00345358|11988644|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0
7583560|NCT00345358|11988641|FG000|Primary Vaccination Phase|Withdrawal by Subject|1
7583561|NCT00345358|11988642|FG001|Primary Vaccination Phase|Withdrawal by Subject|2
7583562|NCT00345358|11988643|FG002|Primary Vaccination Phase|Withdrawal by Subject|4
7583563|NCT00345358|11988644|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
7583564|NCT00345358|11988641|FG000|Primary Vaccination Phase|Lost to Follow-up|1
7583565|NCT00345358|11988642|FG001|Primary Vaccination Phase|Lost to Follow-up|0
7583566|NCT00345358|11988643|FG002|Primary Vaccination Phase|Lost to Follow-up|2
7583567|NCT00345358|11988644|FG003|Primary Vaccination Phase|Lost to Follow-up|2
7583568|NCT00345358|11988641|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
7583569|NCT00345358|11988642|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7583570|NCT00345358|11988643|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
7583571|NCT00345358|11988644|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
7583572|NCT00345358|11988641|FG000|Booster Vaccination Phase|Lost to Follow-up|3
7583573|NCT00345358|11988642|FG001|Booster Vaccination Phase|Lost to Follow-up|0
7583574|NCT00345358|11988643|FG002|Booster Vaccination Phase|Lost to Follow-up|0
7583575|NCT00345358|11988644|FG003|Booster Vaccination Phase|Lost to Follow-up|0
7583576|NCT00372229|11988660|FG000|Study Phase|Graft loss|0
7583577|NCT00372229|11988661|FG001|Study Phase|Graft loss|3
7583578|NCT00372229|11988660|FG000|Study Phase|Protocol Violation|3
7583579|NCT00372229|11988661|FG001|Study Phase|Protocol Violation|4
7583580|NCT00372229|11988660|FG000|Study Phase|Consent withdrawn|16
7583581|NCT00372229|11988661|FG001|Study Phase|Consent withdrawn|14
7583582|NCT00372229|11988660|FG000|Study Phase|Refused treatment/did not cooperate|3
7583583|NCT00372229|11988661|FG001|Study Phase|Refused treatment/did not cooperate|1
7583584|NCT00372229|11988660|FG000|Study Phase|Death|3
7583585|NCT00372229|11988661|FG001|Study Phase|Death|2
7583586|NCT00372229|11988660|FG000|Study Phase|Reason not specified|3
7583587|NCT00372229|11988661|FG001|Study Phase|Reason not specified|2
7583588|NCT00372229|11988660|FG000|Study Phase|Lost to Follow-up|3
7583589|NCT00372229|11988661|FG001|Study Phase|Lost to Follow-up|3
7583590|NCT00372229|11988660|FG000|Follow-Up Phase|Graft loss|8
7583591|NCT00372229|11988661|FG001|Follow-Up Phase|Graft loss|7
7583592|NCT00372229|11988660|FG000|Follow-Up Phase|Consent withdrawn|13
7583593|NCT00372229|11988661|FG001|Follow-Up Phase|Consent withdrawn|19
7583594|NCT00372229|11988660|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0
7583595|NCT00372229|11988661|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1
7583596|NCT00372229|11988660|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1
7583597|NCT00372229|11988661|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0
7583598|NCT00372229|11988660|FG000|Follow-Up Phase|Death|9
7583599|NCT00372229|11988661|FG001|Follow-Up Phase|Death|12
7583600|NCT00372229|11988660|FG000|Follow-Up Phase|Administrative|1
7583601|NCT00372229|11988661|FG001|Follow-Up Phase|Administrative|0
7583602|NCT00372229|11988660|FG000|Follow-Up Phase|Reason not specified|2
7583603|NCT00372229|11988661|FG001|Follow-Up Phase|Reason not specified|3
7583604|NCT00372229|11988660|FG000|Follow-Up Phase|Lost to Follow-up|12
7583605|NCT00372229|11988661|FG001|Follow-Up Phase|Lost to Follow-up|10
7583612|NCT00413699|11988678|FG000|Initial Period|Death|25
7583613|NCT00413699|11988679|FG001|Initial Period|Death|30
7583614|NCT00413699|11988680|FG002|Initial Period|Death|0
7583615|NCT00413699|11988678|FG000|Initial Period|Lack of Efficacy|59
7583616|NCT00413699|11988679|FG001|Initial Period|Lack of Efficacy|115
7583617|NCT00413699|11988680|FG002|Initial Period|Lack of Efficacy|0
7583618|NCT00413699|11988678|FG000|Initial Period|Lost to Follow-up|31
7583619|NCT00413699|11988679|FG001|Initial Period|Lost to Follow-up|101
7583620|NCT00413699|11988680|FG002|Initial Period|Lost to Follow-up|0
7583621|NCT00413699|11988678|FG000|Initial Period|Protocol Violation|38
7583622|NCT00413699|11988679|FG001|Initial Period|Protocol Violation|89
7583623|NCT00413699|11988680|FG002|Initial Period|Protocol Violation|0
7583624|NCT00413699|11988678|FG000|Initial Period|Pregnancy|10
7583625|NCT00413699|11988679|FG001|Initial Period|Pregnancy|8
7583626|NCT00413699|11988680|FG002|Initial Period|Pregnancy|0
7583627|NCT00413699|11988678|FG000|Initial Period|Did not meet entrance criteria|2
7583628|NCT00413699|11988679|FG001|Initial Period|Did not meet entrance criteria|2
7583629|NCT00413699|11988680|FG002|Initial Period|Did not meet entrance criteria|0
7583630|NCT00413699|11988678|FG000|Initial Period|Medication error without adverse event|0
7583631|NCT00413699|11988679|FG001|Initial Period|Medication error without adverse event|1
7583632|NCT00413699|11988680|FG002|Initial Period|Medication error without adverse event|0
7583633|NCT00413699|11988678|FG000|Initial Period|Study terminated by Sponsor|0
7583634|NCT00413699|11988679|FG001|Initial Period|Study terminated by Sponsor|1
7583635|NCT00413699|11988680|FG002|Initial Period|Study terminated by Sponsor|0
7583636|NCT00413699|11988678|FG000|Initial Period|Other|67
7583637|NCT00413699|11988679|FG001|Initial Period|Other|211
7583638|NCT00413699|11988680|FG002|Initial Period|Other|0
7583639|NCT00413699|11988678|FG000|Initial Period|Adverse event related to study drug|178
7583640|NCT00413699|11988679|FG001|Initial Period|Adverse event related to study drug|527
7583641|NCT00413699|11988680|FG002|Initial Period|Adverse event related to study drug|0
7583642|NCT00413699|11988678|FG000|Initial Period|Adverse event not related to study drug|113
7583643|NCT00413699|11988679|FG001|Initial Period|Adverse event not related to study drug|248
7583644|NCT00413699|11988680|FG002|Initial Period|Adverse event not related to study drug|0
7583645|NCT00413699|11988678|FG000|Initial Period|Missing end of study page|0
7583646|NCT00413699|11988679|FG001|Initial Period|Missing end of study page|4
7583647|NCT00413699|11988680|FG002|Initial Period|Missing end of study page|0
7583648|NCT00413699|11988678|FG000|Initial Period|No longer willing to participate|116
7583649|NCT00413699|11988679|FG001|Initial Period|No longer willing to participate|368
7583650|NCT00413699|11988680|FG002|Initial Period|No longer willing to participate|0
7583651|NCT00413699|11988678|FG000|Extension Period|No Longer Willing to Participate|0
7583652|NCT00413699|11988679|FG001|Extension Period|No Longer Willing to Participate|0
7583653|NCT00413699|11988680|FG002|Extension Period|No Longer Willing to Participate|2
7583654|NCT00413699|11988678|FG000|Extension Period|Protocol Violation|0
7583655|NCT00413699|11988679|FG001|Extension Period|Protocol Violation|0
7583656|NCT00413699|11988680|FG002|Extension Period|Protocol Violation|1
7583657|NCT00413699|11988678|FG000|Extension Period|Adverse Event|0
7583658|NCT00413699|11988679|FG001|Extension Period|Adverse Event|0
7583659|NCT00413699|11988680|FG002|Extension Period|Adverse Event|2
7625343|NCT04133519|12036869|FG001|Overall Study|Withdrawal by Subject|4
7625344|NCT04133519|12036868|FG000|Overall Study|Protocol Violation|0
7625345|NCT04133519|12036869|FG001|Overall Study|Protocol Violation|1
7625346|NCT04133519|12036868|FG000|Overall Study|Never started treatment|1
7625347|NCT04133519|12036869|FG001|Overall Study|Never started treatment|1
7625348|NCT04098367|12036889|FG000|Overall Study|Adverse Event|0
7625349|NCT04098367|12036890|FG001|Overall Study|Adverse Event|0
7625350|NCT04098367|12036891|FG002|Overall Study|Adverse Event|1
7625351|NCT04098367|12036889|FG000|Overall Study|Lost to Follow-up|1
7625352|NCT04098367|12036890|FG001|Overall Study|Lost to Follow-up|5
7625353|NCT04098367|12036891|FG002|Overall Study|Lost to Follow-up|2
7625354|NCT04098367|12036889|FG000|Overall Study|Withdrawal by Subject|0
7625355|NCT04098367|12036890|FG001|Overall Study|Withdrawal by Subject|0
7625356|NCT04098367|12036891|FG002|Overall Study|Withdrawal by Subject|1
7625357|NCT04098367|12036889|FG000|Overall Study|Sick . Could not attend visit|1
7625358|NCT04098367|12036890|FG001|Overall Study|Sick . Could not attend visit|0
7625359|NCT04098367|12036891|FG002|Overall Study|Sick . Could not attend visit|0
7625360|NCT04091087|12036908|FG000|Overall Study|Not treated|1
7625361|NCT04091087|12036909|FG001|Overall Study|Not treated|0
7625362|NCT04091087|12036908|FG000|Overall Study|Adverse Event|4
7625363|NCT04091087|12036909|FG001|Overall Study|Adverse Event|4
7625364|NCT04091087|12036908|FG000|Overall Study|Protocol Violation|0
7625365|NCT04091087|12036909|FG001|Overall Study|Protocol Violation|1
7625366|NCT04091087|12036908|FG000|Overall Study|Withdrawal by Subject|5
7625367|NCT04091087|12036909|FG001|Overall Study|Withdrawal by Subject|2
7625368|NCT04009629|12036917|FG000|Overall Study|Withdrawal by Subject|2
7625369|NCT04009629|12036918|FG001|Overall Study|Withdrawal by Subject|0
7625370|NCT03937908|12036927|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0
7625371|NCT03937908|12036928|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1
7583660|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Adverse Event|2
7583661|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Adverse Event|0
7583662|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Adverse Event|0
7583663|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Adverse Event|0
7583664|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Adverse Event|0
7583665|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Adverse Event|0
7583666|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Protocol Violation|1
7583667|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Protocol Violation|0
7583668|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Protocol Violation|0
7583669|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Protocol Violation|0
7583670|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Protocol Violation|0
7583671|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Protocol Violation|0
7583672|NCT00436826|11988718|FG000|Double Blind Period (DBP)|Other|10
7583673|NCT00436826|11988719|FG001|Double Blind Period (DBP)|Other|11
7583674|NCT00436826|11988720|FG002|Double Blind Period (DBP)|Other|0
7583675|NCT00436826|11988721|FG003|Double Blind Period (DBP)|Other|0
7583676|NCT00436826|11988722|FG004|Double Blind Period (DBP)|Other|0
7583677|NCT00436826|11988723|FG005|Double Blind Period (DBP)|Other|0
7583678|NCT00436826|11988718|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583679|NCT00436826|11988719|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583680|NCT00436826|11988720|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583681|NCT00436826|11988721|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
7583682|NCT00436826|11988722|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583683|NCT00436826|11988723|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
7583684|NCT00436826|11988718|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583685|NCT00436826|11988719|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583686|NCT00436826|11988720|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46
7583687|NCT00436826|11988721|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25
7583688|NCT00436826|11988722|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583689|NCT00436826|11988723|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0
7583690|NCT00436826|11988718|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583691|NCT00436826|11988719|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583692|NCT00436826|11988720|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583693|NCT00436826|11988721|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
7583694|NCT00436826|11988722|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
7583695|NCT00436826|11988723|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
7625372|NCT03891264|12036934|FG000|Overall Study|Adverse Event|1
7625373|NCT03891264|12036934|FG000|Overall Study|Withdrawal by Subject|2
7625374|NCT03891264|12036934|FG000|Overall Study|Physician Decision|2
7625391|NCT03823287|12036967|FG000|Overall Study|Withdrawal by Subject|7
7625392|NCT03823287|12036968|FG001|Overall Study|Withdrawal by Subject|6
7625393|NCT03823287|12036967|FG000|Overall Study|Death|4
7625394|NCT03823287|12036968|FG001|Overall Study|Death|1
7625395|NCT03823287|12036967|FG000|Overall Study|Lost to Follow-up|2
7625396|NCT03823287|12036968|FG001|Overall Study|Lost to Follow-up|3
7625397|NCT03823287|12036967|FG000|Overall Study|Physician Decision|2
7625398|NCT03823287|12036968|FG001|Overall Study|Physician Decision|1
7625399|NCT03823287|12036967|FG000|Overall Study|Adverse Event|0
7625400|NCT03823287|12036968|FG001|Overall Study|Adverse Event|3
7625401|NCT03823287|12036967|FG000|Overall Study|Ongoing in the study at Primary Completion Date|319
7625402|NCT03823287|12036968|FG001|Overall Study|Ongoing in the study at Primary Completion Date|323
7625403|NCT03815175|12036974|FG000|Overall Study|Subject Lost to Follow-up|6
7625404|NCT03815175|12036974|FG000|Overall Study|Subject Withdrew Consent|48
7625405|NCT03815175|12036974|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
7625406|NCT03815175|12036974|FG000|Overall Study|Death|86
7625407|NCT03815175|12036974|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
7625408|NCT03815175|12036974|FG000|Overall Study|Subject Discontinued by Sponsor|2
7625409|NCT03815175|12036974|FG000|Overall Study|Other Status Change Reason|1
7625410|NCT03815175|12036974|FG000|Overall Study|Missed Visit|12
7625419|NCT03603639|12037046|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625420|NCT03603639|12037047|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625421|NCT03603639|12037048|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625422|NCT03603639|12037049|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1
7625423|NCT03603639|12037050|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625424|NCT03603639|12037051|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0
7625425|NCT03603639|12037046|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625426|NCT03603639|12037047|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625427|NCT03603639|12037048|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625428|NCT03603639|12037049|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0
7625429|NCT03603639|12037050|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625430|NCT03603639|12037051|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1
7625431|NCT03587636|12037063|FG000|Overall Study|Lost to Follow-up|2
7625432|NCT03587636|12037064|FG001|Overall Study|Lost to Follow-up|5
7583696|NCT00442546|11988742|FG000|Overall Study|Adverse Event|11
7583697|NCT00442546|11988743|FG001|Overall Study|Adverse Event|17
7583698|NCT00442546|11988744|FG002|Overall Study|Adverse Event|13
7583699|NCT00442546|11988742|FG000|Overall Study|Lost to Follow-up|1
7583700|NCT00442546|11988743|FG001|Overall Study|Lost to Follow-up|2
7583701|NCT00442546|11988744|FG002|Overall Study|Lost to Follow-up|1
7583702|NCT00442546|11988742|FG000|Overall Study|Other|4
7583703|NCT00442546|11988743|FG001|Overall Study|Other|9
7583704|NCT00442546|11988744|FG002|Overall Study|Other|6
7583705|NCT00442546|11988742|FG000|Overall Study|Withdrawal by Subject|5
7583706|NCT00442546|11988743|FG001|Overall Study|Withdrawal by Subject|5
7583707|NCT00442546|11988744|FG002|Overall Study|Withdrawal by Subject|7
7583708|NCT00442546|11988742|FG000|Overall Study|Randomized But Not Treated|5
7583709|NCT00442546|11988743|FG001|Overall Study|Randomized But Not Treated|4
7583710|NCT00442546|11988744|FG002|Overall Study|Randomized But Not Treated|6
7583711|NCT04715932|11988756|FG000|Overall Study|Lost to Follow-up|1
7583712|NCT04715932|11988757|FG001|Overall Study|Lost to Follow-up|0
7583713|NCT04666441|11988771|FG000|Overall Study|Lost to Follow-up|1
7583714|NCT04666441|11988772|FG001|Overall Study|Lost to Follow-up|4
7583715|NCT04666441|11988773|FG002|Overall Study|Lost to Follow-up|1
7583716|NCT04666441|11988774|FG003|Overall Study|Lost to Follow-up|3
7583717|NCT04666441|11988775|FG004|Overall Study|Lost to Follow-up|0
7583718|NCT04666441|11988776|FG005|Overall Study|Lost to Follow-up|2
7583719|NCT04666441|11988777|FG006|Overall Study|Lost to Follow-up|2
7583720|NCT04666441|11988778|FG007|Overall Study|Lost to Follow-up|2
7583721|NCT04666441|11988771|FG000|Overall Study|Subject Decision|1
7583722|NCT04666441|11988772|FG001|Overall Study|Subject Decision|1
7583723|NCT04666441|11988773|FG002|Overall Study|Subject Decision|3
7583724|NCT04666441|11988774|FG003|Overall Study|Subject Decision|1
7583725|NCT04666441|11988775|FG004|Overall Study|Subject Decision|0
7583726|NCT04666441|11988776|FG005|Overall Study|Subject Decision|1
7583727|NCT04666441|11988777|FG006|Overall Study|Subject Decision|3
7583728|NCT04666441|11988778|FG007|Overall Study|Subject Decision|2
7583729|NCT04259346|11988832|FG000|Overall Study|Lost to Follow-up|1
7583730|NCT04259346|11988833|FG001|Overall Study|Lost to Follow-up|3
7583731|NCT04259346|11988832|FG000|Overall Study|Protocol Violation|1
7583732|NCT04259346|11988833|FG001|Overall Study|Protocol Violation|0
7583733|NCT04259346|11988832|FG000|Overall Study|Withdrawal by Subject|1
7583734|NCT04259346|11988833|FG001|Overall Study|Withdrawal by Subject|0
7583735|NCT04259346|11988832|FG000|Overall Study|Adverse Event|1
7583736|NCT04259346|11988833|FG001|Overall Study|Adverse Event|1
7583737|NCT03959423|11988841|FG000|Overall Study|Withdrawal by Subject|2
7583738|NCT03959423|11988842|FG001|Overall Study|Withdrawal by Subject|3
7583739|NCT03959423|11988841|FG000|Overall Study|Physician Decision|0
7583740|NCT03959423|11988842|FG001|Overall Study|Physician Decision|1
7583741|NCT03959423|11988841|FG000|Overall Study|Lost to Follow-up|1
7583742|NCT03959423|11988842|FG001|Overall Study|Lost to Follow-up|0
7583743|NCT03959423|11988841|FG000|Overall Study|Withdrawal by Parent/Guardian|6
7583744|NCT03959423|11988842|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7583745|NCT03713320|11988850|FG000|Randomized Period|Adverse Event|1
7583746|NCT03713320|11988851|FG001|Randomized Period|Adverse Event|5
7583747|NCT03713320|11988852|FG002|Randomized Period|Adverse Event|0
7583748|NCT03713320|11988850|FG000|Randomized Period|Physician Decision|1
7583749|NCT03713320|11988851|FG001|Randomized Period|Physician Decision|1
7583750|NCT03713320|11988852|FG002|Randomized Period|Physician Decision|0
7583751|NCT03713320|11988850|FG000|Randomized Period|Withdrawal by Subject|4
7583752|NCT03713320|11988851|FG001|Randomized Period|Withdrawal by Subject|0
7583753|NCT03713320|11988852|FG002|Randomized Period|Withdrawal by Subject|0
7583754|NCT03713320|11988850|FG000|Randomized Period|Participant decision|3
7583755|NCT03713320|11988851|FG001|Randomized Period|Participant decision|1
7583756|NCT03713320|11988852|FG002|Randomized Period|Participant decision|0
7583757|NCT03713320|11988850|FG000|Randomized Period|Study terminated by sponsor|6
7583758|NCT03713320|11988851|FG001|Randomized Period|Study terminated by sponsor|3
7583759|NCT03713320|11988852|FG002|Randomized Period|Study terminated by sponsor|0
7583760|NCT03713320|11988850|FG000|Cobomarsen Crossover Period|Physician Decision|0
7583761|NCT03713320|11988851|FG001|Cobomarsen Crossover Period|Physician Decision|0
7583762|NCT03713320|11988852|FG002|Cobomarsen Crossover Period|Physician Decision|2
7583763|NCT03713320|11988850|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7583764|NCT03713320|11988851|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
7583765|NCT03713320|11988852|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5
7625433|NCT03573336|12037094|FG000|Overall Study|Study terminated|2
7625434|NCT03573336|12037095|FG001|Overall Study|Study terminated|4
7625435|NCT03573336|12037096|FG002|Overall Study|Study terminated|2
7625436|NCT03570697|12037106|FG000|Overall Study|Lost to Follow-up|0
7625437|NCT03570697|12037107|FG001|Overall Study|Lost to Follow-up|1
7625438|NCT03570697|12037106|FG000|Overall Study|Death|2
7625439|NCT03570697|12037107|FG001|Overall Study|Death|0
7625440|NCT03570697|12037106|FG000|Overall Study|Withdrawal by Subject|4
7625441|NCT03570697|12037107|FG001|Overall Study|Withdrawal by Subject|2
7625442|NCT03548051|12037115|FG000|Overall Study|Death|1
7625443|NCT03548051|12037116|FG001|Overall Study|Death|1
7625444|NCT03548051|12037115|FG000|Overall Study|Withdrawal by Subject|1
7625445|NCT03548051|12037116|FG001|Overall Study|Withdrawal by Subject|0
7625446|NCT03503318|12037142|FG000|Overall Study|Death|1
7625447|NCT03503318|12037143|FG001|Overall Study|Death|0
7625448|NCT03503318|12037144|FG002|Overall Study|Death|4
7625449|NCT03503318|12037142|FG000|Overall Study|Adverse Event|3
7625450|NCT03503318|12037143|FG001|Overall Study|Adverse Event|4
7625451|NCT03503318|12037144|FG002|Overall Study|Adverse Event|2
7625452|NCT03503318|12037142|FG000|Overall Study|Withdrawal by Subject|12
7625453|NCT03503318|12037143|FG001|Overall Study|Withdrawal by Subject|17
7625454|NCT03503318|12037144|FG002|Overall Study|Withdrawal by Subject|16
7625455|NCT03503318|12037142|FG000|Overall Study|Protocol Violation|5
7625456|NCT03503318|12037143|FG001|Overall Study|Protocol Violation|0
7625457|NCT03503318|12037144|FG002|Overall Study|Protocol Violation|3
7625458|NCT03503318|12037142|FG000|Overall Study|Lost to Follow-up|17
7625459|NCT03503318|12037143|FG001|Overall Study|Lost to Follow-up|15
7625460|NCT03503318|12037144|FG002|Overall Study|Lost to Follow-up|12
7625461|NCT03503318|12037142|FG000|Overall Study|Other than specified|1
7625462|NCT03503318|12037143|FG001|Overall Study|Other than specified|3
7625463|NCT03503318|12037144|FG002|Overall Study|Other than specified|3
7625464|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
7625465|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
7625466|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7625467|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
7625468|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
7625469|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
7625470|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
7625471|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
7625472|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7625473|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
7625474|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7625475|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
7625476|NCT03493854|12037154|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
7625477|NCT03493854|12037155|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
7625478|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
7583784|NCT03409731|11988868|FG000|Overall Study|Withdrawal by Subject|1
7583785|NCT03409731|11988868|FG000|Overall Study|Death|2
7583786|NCT03283566|11988874|FG000|Overall Study|Lost to Follow-up|1
7583787|NCT03283566|11988875|FG001|Overall Study|Lost to Follow-up|2
7583788|NCT03077412|11988884|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1
7583789|NCT03077412|11988885|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5
7583790|NCT03077412|11988886|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3
7583791|NCT03077412|11988884|FG000|Overall Study|Protocol-Specified Disease Worsening|1
7583792|NCT03077412|11988885|FG001|Overall Study|Protocol-Specified Disease Worsening|3
7583793|NCT03077412|11988886|FG002|Overall Study|Protocol-Specified Disease Worsening|3
7583794|NCT03077412|11988884|FG000|Overall Study|Adverse Event|1
7583795|NCT03077412|11988885|FG001|Overall Study|Adverse Event|2
7583796|NCT03077412|11988886|FG002|Overall Study|Adverse Event|2
7583797|NCT03077412|11988884|FG000|Overall Study|Investigator's Discretion|0
7583798|NCT03077412|11988885|FG001|Overall Study|Investigator's Discretion|1
7583799|NCT03077412|11988886|FG002|Overall Study|Investigator's Discretion|1
7583800|NCT03077412|11988884|FG000|Overall Study|Withdrew Consent|0
7583801|NCT03077412|11988885|FG001|Overall Study|Withdrew Consent|2
7583802|NCT03077412|11988886|FG002|Overall Study|Withdrew Consent|0
7583803|NCT02384850|11988931|FG000|Overall Study|Withdrawal by Subject|2
7583804|NCT02384850|11988932|FG001|Overall Study|Withdrawal by Subject|2
7583836|NCT00971867|11988991|FG000|Overall Study|Adverse Event|4
7583837|NCT00971867|11988991|FG000|Overall Study|Participant Withdrew Consent|1
7583838|NCT00971867|11988991|FG000|Overall Study|Disease Progression|6
7583839|NCT00853307|11988997|FG000|Overall Study|Adverse Event|1
7583840|NCT00853307|11988998|FG001|Overall Study|Adverse Event|2
7583841|NCT00853307|11988997|FG000|Overall Study|Withdrawal by Subject|1
7583842|NCT00853307|11988998|FG001|Overall Study|Withdrawal by Subject|2
7583843|NCT00853307|11988997|FG000|Overall Study|Reason Not Specified|0
7583844|NCT00853307|11988998|FG001|Overall Study|Reason Not Specified|1
7583845|NCT00545129|11989012|FG000|Overall Study|Lack of Efficacy|2
7583846|NCT00545129|11989013|FG001|Overall Study|Lack of Efficacy|5
7583847|NCT00545129|11989012|FG000|Overall Study|Death|2
7583848|NCT00545129|11989013|FG001|Overall Study|Death|1
7583849|NCT00545129|11989012|FG000|Overall Study|Adverse Event|1
7583850|NCT00545129|11989013|FG001|Overall Study|Adverse Event|1
7583851|NCT00545129|11989012|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
7583852|NCT00545129|11989013|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
7583853|NCT00545129|11989012|FG000|Overall Study|Other|3
7583854|NCT00545129|11989013|FG001|Overall Study|Other|3
7625479|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
7625480|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7625481|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
7625482|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
7625483|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
7625484|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
7625485|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
7625486|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
7625487|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
7625488|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
7625489|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
7625490|NCT03493854|12037154|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
7625491|NCT03493854|12037155|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
7625492|NCT03493854|12037154|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7625493|NCT03493854|12037155|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
7625494|NCT03493854|12037154|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
7625495|NCT03493854|12037155|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
7625496|NCT03493451|12037164|FG000|Overall Study|Death|11
7625497|NCT03493451|12037165|FG001|Overall Study|Death|26
7625498|NCT03493451|12037166|FG002|Overall Study|Death|3
7625499|NCT03493451|12037164|FG000|Overall Study|Lost to Follow-up|1
7625500|NCT03493451|12037165|FG001|Overall Study|Lost to Follow-up|4
7625501|NCT03493451|12037166|FG002|Overall Study|Lost to Follow-up|1
7625502|NCT03493451|12037164|FG000|Overall Study|Withdrawal by Subject|1
7625503|NCT03493451|12037165|FG001|Overall Study|Withdrawal by Subject|1
7625504|NCT03493451|12037166|FG002|Overall Study|Withdrawal by Subject|2
7625505|NCT03493451|12037164|FG000|Overall Study|Progressive Disease|1
7625506|NCT03493451|12037165|FG001|Overall Study|Progressive Disease|0
7625507|NCT03493451|12037166|FG002|Overall Study|Progressive Disease|0
7625508|NCT03493451|12037164|FG000|Overall Study|Transferred to long term extension study|8
7625509|NCT03493451|12037165|FG001|Overall Study|Transferred to long term extension study|13
7625510|NCT03493451|12037166|FG002|Overall Study|Transferred to long term extension study|5
7625511|NCT03476239|12037174|FG000|Overall Study|Withdrawal by Subject|10
7625512|NCT03476239|12037174|FG000|Overall Study|Death|80
7625513|NCT03476239|12037174|FG000|Overall Study|Lost to Follow-up|8
7625514|NCT03401749|12037190|FG000|Overall Study|Lost to Follow-up|20
7625515|NCT03401749|12037191|FG001|Overall Study|Lost to Follow-up|16
7625516|NCT03401749|12037192|FG002|Overall Study|Lost to Follow-up|26
7583855|NCT00548093|11989021|FG000|Overall Study|Death|33
7583856|NCT00548093|11989022|FG001|Overall Study|Death|13
7583857|NCT00548093|11989021|FG000|Overall Study|Lost to Follow-up|3
7583858|NCT00548093|11989022|FG001|Overall Study|Lost to Follow-up|1
7583859|NCT00548093|11989021|FG000|Overall Study|Objective progression or relapse|1
7583860|NCT00548093|11989022|FG001|Overall Study|Objective progression or relapse|1
7583861|NCT00548093|11989021|FG000|Overall Study|Other|11
7583862|NCT00548093|11989022|FG001|Overall Study|Other|1
7583863|NCT00548093|11989021|FG000|Overall Study|Withdrawal by Subject|1
7583864|NCT00548093|11989022|FG001|Overall Study|Withdrawal by Subject|0
7583865|NCT00548093|11989021|FG000|Overall Study|Completed post-treatment follow-up|1
7583866|NCT00548093|11989022|FG001|Overall Study|Completed post-treatment follow-up|0
7625517|NCT03337113|12037204|FG000|Overall Study|Adverse Event|1
7625518|NCT03337113|12037205|FG001|Overall Study|Adverse Event|1
7625519|NCT03337113|12037206|FG002|Overall Study|Adverse Event|0
7625520|NCT03337113|12037207|FG003|Overall Study|Adverse Event|1
7625521|NCT03337113|12037204|FG000|Overall Study|Physician Decision|0
7625522|NCT03337113|12037205|FG001|Overall Study|Physician Decision|2
7625523|NCT03337113|12037206|FG002|Overall Study|Physician Decision|0
7625524|NCT03337113|12037207|FG003|Overall Study|Physician Decision|1
7625525|NCT03337113|12037204|FG000|Overall Study|Withdrawal by Subject|0
7625526|NCT03337113|12037205|FG001|Overall Study|Withdrawal by Subject|0
7625527|NCT03337113|12037206|FG002|Overall Study|Withdrawal by Subject|1
7625528|NCT03337113|12037207|FG003|Overall Study|Withdrawal by Subject|0
7270143|NCT00414050|11484239|FG001|Overall Study|Subject Moved|0
7583867|NCT00554606|11989031|FG000|Overall Study|Adverse Event|3
7583868|NCT00554606|11989031|FG000|Overall Study|Abnormal laboratory values|1
7583869|NCT00554606|11989031|FG000|Overall Study|Unsatisfactory therapeutic effect|14
7583870|NCT00554606|11989031|FG000|Overall Study|Subject withdrew consent|2
7583871|NCT00554606|11989031|FG000|Overall Study|Lost to Follow-up|2
7583872|NCT00554606|11989031|FG000|Overall Study|Administrative problems|60
7583873|NCT00554606|11989031|FG000|Overall Study|Death|1
7583874|NCT00554606|11989031|FG000|Overall Study|Protocol deviation|2
7583879|NCT00566995|11989069|FG000|Overall Study|Toxicity|4
7583880|NCT00566995|11989069|FG000|Overall Study|Withdrew consent|3
7583881|NCT00586924|11989079|FG000|Overall Study|Adverse event/serious adverse event|0
7583882|NCT00586924|11989080|FG001|Overall Study|Adverse event/serious adverse event|0
7583883|NCT00586924|11989081|FG002|Overall Study|Adverse event/serious adverse event|0
7583884|NCT00586924|11989082|FG003|Overall Study|Adverse event/serious adverse event|1
7583885|NCT00586924|11989083|FG004|Overall Study|Adverse event/serious adverse event|0
7583886|NCT00586924|11989084|FG005|Overall Study|Adverse event/serious adverse event|2
7583887|NCT00586924|11989079|FG000|Overall Study|Initiation of alternative cancer therapy|0
7583888|NCT00586924|11989080|FG001|Overall Study|Initiation of alternative cancer therapy|0
7583889|NCT00586924|11989081|FG002|Overall Study|Initiation of alternative cancer therapy|0
7583890|NCT00586924|11989082|FG003|Overall Study|Initiation of alternative cancer therapy|0
7583891|NCT00586924|11989083|FG004|Overall Study|Initiation of alternative cancer therapy|0
7583892|NCT00586924|11989084|FG005|Overall Study|Initiation of alternative cancer therapy|1
7583893|NCT00586924|11989079|FG000|Overall Study|Disease progression|0
7583894|NCT00586924|11989080|FG001|Overall Study|Disease progression|0
7583895|NCT00586924|11989081|FG002|Overall Study|Disease progression|0
7583896|NCT00586924|11989082|FG003|Overall Study|Disease progression|1
7583897|NCT00586924|11989083|FG004|Overall Study|Disease progression|1
7583898|NCT00586924|11989084|FG005|Overall Study|Disease progression|0
7583899|NCT00586924|11989079|FG000|Overall Study|Development of neutralizing antibodies|2
7583900|NCT00586924|11989080|FG001|Overall Study|Development of neutralizing antibodies|2
7583901|NCT00586924|11989081|FG002|Overall Study|Development of neutralizing antibodies|2
7583902|NCT00586924|11989082|FG003|Overall Study|Development of neutralizing antibodies|0
7583903|NCT00586924|11989083|FG004|Overall Study|Development of neutralizing antibodies|0
7583904|NCT00586924|11989084|FG005|Overall Study|Development of neutralizing antibodies|22
7583905|NCT00586924|11989079|FG000|Overall Study|Complete response|0
7583906|NCT00586924|11989080|FG001|Overall Study|Complete response|1
7583907|NCT00586924|11989081|FG002|Overall Study|Complete response|0
7583908|NCT00586924|11989082|FG003|Overall Study|Complete response|0
7583909|NCT00586924|11989083|FG004|Overall Study|Complete response|2
7583910|NCT00586924|11989084|FG005|Overall Study|Complete response|2
7583911|NCT00586924|11989079|FG000|Overall Study|Other|1
7583912|NCT00586924|11989080|FG001|Overall Study|Other|0
7583913|NCT00586924|11989081|FG002|Overall Study|Other|1
7583914|NCT00586924|11989082|FG003|Overall Study|Other|1
7583915|NCT00586924|11989083|FG004|Overall Study|Other|1
7583916|NCT00586924|11989084|FG005|Overall Study|Other|6
7583875|NCT00555009|11989039|FG000|Overall Study|Withdrawal by Subject|0
7583876|NCT00555009|11989040|FG001|Overall Study|Withdrawal by Subject|1
7583877|NCT00555009|11989039|FG000|Overall Study|Terminated by Sponsor|2
7583878|NCT00555009|11989040|FG001|Overall Study|Terminated by Sponsor|5
7583917|NCT00588861|11989100|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95
7583918|NCT00588861|11989101|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86
7583919|NCT00588861|11989100|FG000|6 Months|Patients did not return for follow-up|98
7583920|NCT00588861|11989101|FG001|6 Months|Patients did not return for follow-up|73
7583921|NCT00588861|11989100|FG000|1 Year|Patients did not return for follow-up|89
7583922|NCT00588861|11989101|FG001|1 Year|Patients did not return for follow-up|82
7583923|NCT00588861|11989100|FG000|2 Years|Patients did not return for follow-up|92
7583924|NCT00588861|11989101|FG001|2 Years|Patients did not return for follow-up|87
7583925|NCT00588861|11989100|FG000|4 Years|Patients did not return for follow-up|91
7583926|NCT00588861|11989101|FG001|4 Years|Patients did not return for follow-up|103
7583927|NCT00588861|11989100|FG000|6 Years|Patients did not return for follow-up|104
7583928|NCT00588861|11989101|FG001|6 Years|Patients did not return for follow-up|109
7583929|NCT00588861|11989100|FG000|8 Years|Patients did not return for follow-up|105
7583930|NCT00588861|11989101|FG001|8 Years|Patients did not return for follow-up|114
7583931|NCT00588861|11989100|FG000|10 Years|Incomplete due to study termination|107
7583932|NCT00588861|11989101|FG001|10 Years|Incomplete due to study termination|114
7625584|NCT03233048|12037241|FG000|Overall Study|Withdrawal by Subject|1
7583998|NCT03288142|11989129|FG000|Overall Study|Lost to Follow-up|22
7583999|NCT03288142|11989130|FG001|Overall Study|Lost to Follow-up|15
7584000|NCT03112603|11989140|FG000|End of Randomization Period|Lost to Follow-up|1
7584001|NCT03112603|11989141|FG001|End of Randomization Period|Lost to Follow-up|0
7584002|NCT03112603|11989142|FG002|End of Randomization Period|Lost to Follow-up|0
7584003|NCT03112603|11989140|FG000|End of Randomization Period|Subject/Guardian Decision|4
7584004|NCT03112603|11989141|FG001|End of Randomization Period|Subject/Guardian Decision|11
7584005|NCT03112603|11989142|FG002|End of Randomization Period|Subject/Guardian Decision|0
7584006|NCT03112603|11989140|FG000|End of Randomization Period|Physician Decision|4
7584007|NCT03112603|11989141|FG001|End of Randomization Period|Physician Decision|14
7584008|NCT03112603|11989142|FG002|End of Randomization Period|Physician Decision|0
7584009|NCT03112603|11989140|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4
7584010|NCT03112603|11989141|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5
7584011|NCT03112603|11989142|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0
7584012|NCT03112603|11989140|FG000|End of Randomization Period|Death|8
7584013|NCT03112603|11989141|FG001|End of Randomization Period|Death|7
7584014|NCT03112603|11989142|FG002|End of Randomization Period|Death|0
7584015|NCT03112603|11989140|FG000|End of Randomization Period|Disease Relapse|9
7584016|NCT03112603|11989141|FG001|End of Randomization Period|Disease Relapse|7
7584017|NCT03112603|11989142|FG002|End of Randomization Period|Disease Relapse|0
7584018|NCT03112603|11989140|FG000|End of Randomization Period|Lack of Efficacy|24
7584019|NCT03112603|11989141|FG001|End of Randomization Period|Lack of Efficacy|70
7584020|NCT03112603|11989142|FG002|End of Randomization Period|Lack of Efficacy|0
7584021|NCT03112603|11989140|FG000|End of Randomization Period|Adverse Event|28
7584022|NCT03112603|11989141|FG001|End of Randomization Period|Adverse Event|8
7584023|NCT03112603|11989142|FG002|End of Randomization Period|Adverse Event|0
7584024|NCT03112603|11989140|FG000|End of Randomization Period|Ongoing Treatment|83
7584025|NCT03112603|11989141|FG001|End of Randomization Period|Ongoing Treatment|42
7584026|NCT03112603|11989142|FG002|End of Randomization Period|Ongoing Treatment|0
7584027|NCT03112603|11989140|FG000|End of Cross Over Period|Death|0
7584028|NCT03112603|11989141|FG001|End of Cross Over Period|Death|0
7584029|NCT03112603|11989142|FG002|End of Cross Over Period|Death|1
7584030|NCT03112603|11989140|FG000|End of Cross Over Period|Subject/Guardian Decision|0
7584031|NCT03112603|11989141|FG001|End of Cross Over Period|Subject/Guardian Decision|0
7584032|NCT03112603|11989142|FG002|End of Cross Over Period|Subject/Guardian Decision|3
7584033|NCT03112603|11989140|FG000|End of Cross Over Period|Physician Decision|0
7584034|NCT03112603|11989141|FG001|End of Cross Over Period|Physician Decision|0
7584035|NCT03112603|11989142|FG002|End of Cross Over Period|Physician Decision|3
7584036|NCT03112603|11989140|FG000|End of Cross Over Period|Lack of Efficacy|0
7584037|NCT03112603|11989141|FG001|End of Cross Over Period|Lack of Efficacy|0
7584038|NCT03112603|11989142|FG002|End of Cross Over Period|Lack of Efficacy|4
7584039|NCT03112603|11989140|FG000|End of Cross Over Period|Adverse Event|0
7584040|NCT03112603|11989141|FG001|End of Cross Over Period|Adverse Event|0
7584041|NCT03112603|11989142|FG002|End of Cross Over Period|Adverse Event|4
7584042|NCT03112603|11989140|FG000|End of Cross Over Period|Treatment Ongoing|0
7584043|NCT03112603|11989141|FG001|End of Cross Over Period|Treatment Ongoing|0
7584044|NCT03112603|11989142|FG002|End of Cross Over Period|Treatment Ongoing|46
7584059|NCT02767570|11989159|FG000|Overall Study|Lost to Follow-up|3
7584060|NCT02767570|11989160|FG001|Overall Study|Lost to Follow-up|0
7584061|NCT02767570|11989159|FG000|Overall Study|COVID shutdown|2
7584062|NCT02767570|11989160|FG001|Overall Study|COVID shutdown|5
7584063|NCT02767570|11989159|FG000|Overall Study|Increased pain|2
7584064|NCT02767570|11989160|FG001|Overall Study|Increased pain|0
7584065|NCT02767570|11989159|FG000|Overall Study|Withdrawal by Subject|1
7584066|NCT02767570|11989160|FG001|Overall Study|Withdrawal by Subject|3
7584067|NCT02767570|11989159|FG000|Overall Study|Unrelated medical issue|1
7584068|NCT02767570|11989160|FG001|Overall Study|Unrelated medical issue|1
7584069|NCT02767570|11989159|FG000|Overall Study|Received intra-articular injection|0
7584070|NCT02767570|11989160|FG001|Overall Study|Received intra-articular injection|1
7584071|NCT02702180|11989169|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
7584072|NCT02702180|11989170|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
7584073|NCT02702180|11989171|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7584074|NCT02702180|11989169|FG000|Double-blind Treatment Period|Adverse Event|0
7584075|NCT02702180|11989170|FG001|Double-blind Treatment Period|Adverse Event|0
7584076|NCT02702180|11989171|FG002|Double-blind Treatment Period|Adverse Event|1
7584077|NCT02702180|11989169|FG000|Double-blind Treatment Period|Lack of Efficacy|0
7584078|NCT02702180|11989170|FG001|Double-blind Treatment Period|Lack of Efficacy|0
7584079|NCT02702180|11989171|FG002|Double-blind Treatment Period|Lack of Efficacy|1
7584080|NCT02702180|11989169|FG000|Double-blind Treatment Period|Protocol Violation|0
7584081|NCT02702180|11989170|FG001|Double-blind Treatment Period|Protocol Violation|0
7584082|NCT02702180|11989171|FG002|Double-blind Treatment Period|Protocol Violation|2
7584083|NCT02702180|11989169|FG000|Open-label Treatment Period|Withdrawal by Subject|0
7584084|NCT02702180|11989170|FG001|Open-label Treatment Period|Withdrawal by Subject|1
7584085|NCT02702180|11989171|FG002|Open-label Treatment Period|Withdrawal by Subject|1
7584086|NCT02702180|11989169|FG000|Open-label Treatment Period|Withdrawn in error|0
7584087|NCT02702180|11989170|FG001|Open-label Treatment Period|Withdrawn in error|0
7584088|NCT02702180|11989171|FG002|Open-label Treatment Period|Withdrawn in error|1
7584089|NCT02545049|11989182|FG000|Overall Study|Withdrawal by Subject|1
7584090|NCT02545049|11989183|FG001|Overall Study|Withdrawal by Subject|7
7584091|NCT02545049|11989182|FG000|Overall Study|Lost to Follow-up|4
7584092|NCT02545049|11989183|FG001|Overall Study|Lost to Follow-up|6
7584093|NCT02545049|11989182|FG000|Overall Study|GCP violations|37
7584094|NCT02545049|11989183|FG001|Overall Study|GCP violations|48
7584095|NCT02448381|11989191|FG000|Overall Study|Adverse Event|2
7584096|NCT02448381|11989192|FG001|Overall Study|Adverse Event|0
7584097|NCT02448381|11989191|FG000|Overall Study|Lost to Follow-up|16
7584098|NCT02448381|11989192|FG001|Overall Study|Lost to Follow-up|9
7584099|NCT02448381|11989191|FG000|Overall Study|Physician Decision|1
7270144|NCT00414050|11484240|FG002|Overall Study|Subject Moved|0
7270145|NCT00414050|11484241|FG003|Overall Study|Subject Moved|1
7270146|NCT00414076|11484253|FG000|Overall Study|Progression|1
7270147|NCT00414076|11484254|FG001|Overall Study|Progression|2
7270148|NCT00414076|11484253|FG000|Overall Study|Withdrawal by Subject|1
7270149|NCT00414076|11484254|FG001|Overall Study|Withdrawal by Subject|3
7270150|NCT00414076|11484253|FG000|Overall Study|Adverse Event|1
7270151|NCT00414076|11484254|FG001|Overall Study|Adverse Event|0
7270152|NCT00414310|11484290|FG000|Overall Study|Not treated|1
7270153|NCT00414310|11484291|FG001|Overall Study|Not treated|0
7270154|NCT00414388|11484299|FG000|Overall Study|Adverse Event|1
7270155|NCT00414440|11484306|FG000|Core Period|Withdrawal by Subject|70
7270156|NCT00414440|11484307|FG001|Core Period|Withdrawal by Subject|32
7270157|NCT00414440|11484306|FG000|Extension Period|Lost to Follow-up|44
7270158|NCT00414440|11484307|FG001|Extension Period|Lost to Follow-up|52
7270159|NCT00414440|11484306|FG000|Extension Period|Did not consent to continue follow up|61
7270160|NCT00414440|11484307|FG001|Extension Period|Did not consent to continue follow up|54
7270161|NCT00414440|11484306|FG000|Extension Period|Other|1
7270162|NCT00414440|11484307|FG001|Extension Period|Other|1
7270163|NCT00414440|11484306|FG000|Extension Period|Administrative|16
7270164|NCT00414440|11484307|FG001|Extension Period|Administrative|16
7270165|NCT00414440|11484306|FG000|Extension Period|Death|1
7270166|NCT00414440|11484307|FG001|Extension Period|Death|2
7270167|NCT00414440|11484306|FG000|Extension Period|Withdrawal by Subject|9
7270168|NCT00414440|11484307|FG001|Extension Period|Withdrawal by Subject|7
7270169|NCT00414440|11484306|FG000|Extension Period|Not included in follow up period|18
7270170|NCT00414440|11484307|FG001|Extension Period|Not included in follow up period|8
7270171|NCT00414466|11484317|FG000|Overall Study|Adverse Event|0
7270172|NCT00414466|11484318|FG001|Overall Study|Adverse Event|0
7270173|NCT00414466|11484319|FG002|Overall Study|Adverse Event|1
7270174|NCT00414466|11484320|FG003|Overall Study|Adverse Event|1
7270175|NCT00414466|11484317|FG000|Overall Study|Lack of Efficacy|1
7270176|NCT00414466|11484318|FG001|Overall Study|Lack of Efficacy|0
7270177|NCT00414466|11484319|FG002|Overall Study|Lack of Efficacy|0
7270178|NCT00414466|11484320|FG003|Overall Study|Lack of Efficacy|0
7270179|NCT00414466|11484317|FG000|Overall Study|Withdrawn by Sponsor|1
7270180|NCT00414466|11484318|FG001|Overall Study|Withdrawn by Sponsor|0
7270181|NCT00414466|11484319|FG002|Overall Study|Withdrawn by Sponsor|0
7270182|NCT00414466|11484320|FG003|Overall Study|Withdrawn by Sponsor|0
7270183|NCT00414544|11484346|FG000|Overall Study|Lost to Follow-up|14
7270184|NCT00414596|11484352|FG000|Overall Study|Protocol Violation|2
7270185|NCT00414609|11484358|FG000|Core Study|Adverse Event|9
7270186|NCT00414609|11484359|FG001|Core Study|Adverse Event|11
7270187|NCT00414609|11484360|FG002|Core Study|Adverse Event|0
7270188|NCT00414609|11484358|FG000|Core Study|Abnormal laboratory values|0
7270189|NCT00414609|11484359|FG001|Core Study|Abnormal laboratory values|1
7270190|NCT00414609|11484360|FG002|Core Study|Abnormal laboratory values|0
7270191|NCT00414609|11484358|FG000|Core Study|Abnormal test procedure results|1
7270192|NCT00414609|11484359|FG001|Core Study|Abnormal test procedure results|1
7270193|NCT00414609|11484360|FG002|Core Study|Abnormal test procedure results|0
7270194|NCT00414609|11484358|FG000|Core Study|Protocol deviation|0
7270195|NCT00414609|11484359|FG001|Core Study|Protocol deviation|1
7270196|NCT00414609|11484360|FG002|Core Study|Protocol deviation|0
7270197|NCT00414609|11484358|FG000|Core Study|Patient withdrew consent|10
7270198|NCT00414609|11484359|FG001|Core Study|Patient withdrew consent|11
7270199|NCT00414609|11484360|FG002|Core Study|Patient withdrew consent|0
7270200|NCT00414609|11484358|FG000|Core Study|Lost to Follow-up|7
7270201|NCT00414609|11484359|FG001|Core Study|Lost to Follow-up|4
7270202|NCT00414609|11484360|FG002|Core Study|Lost to Follow-up|0
7270203|NCT00414609|11484358|FG000|Core Study|Administrative problems|0
7270204|NCT00414609|11484359|FG001|Core Study|Administrative problems|2
7270205|NCT00414609|11484360|FG002|Core Study|Administrative problems|0
7270206|NCT00414609|11484358|FG000|Core Study|Death|7
7270207|NCT00414609|11484359|FG001|Core Study|Death|14
7584100|NCT02448381|11989192|FG001|Overall Study|Physician Decision|1
7584101|NCT02448381|11989191|FG000|Overall Study|Pregnancy|1
7584102|NCT02448381|11989192|FG001|Overall Study|Pregnancy|0
7584103|NCT02448381|11989191|FG000|Overall Study|Withdrawal by Subject|13
7584104|NCT02448381|11989192|FG001|Overall Study|Withdrawal by Subject|9
7584105|NCT02448381|11989191|FG000|Overall Study|Noncompliance with Study Procedures|2
7584106|NCT02448381|11989192|FG001|Overall Study|Noncompliance with Study Procedures|0
7584123|NCT01849874|11989215|FG000|Overall Study|Death|34
7584124|NCT01849874|11989216|FG001|Overall Study|Death|16
7584125|NCT01849874|11989215|FG000|Overall Study|Withdrawal by Subject|4
7584126|NCT01849874|11989216|FG001|Overall Study|Withdrawal by Subject|8
7584127|NCT01849874|11989215|FG000|Overall Study|Lost to Follow-up|0
7584128|NCT01849874|11989216|FG001|Overall Study|Lost to Follow-up|1
7584129|NCT01849874|11989215|FG000|Overall Study|Randomized but Never Treated|1
7584130|NCT01849874|11989216|FG001|Overall Study|Randomized but Never Treated|8
7584131|NCT01849874|11989215|FG000|Overall Study|Ongoing|162
7584132|NCT01849874|11989216|FG001|Overall Study|Ongoing|69
7584133|NCT01724866|11989226|FG000|Overall Study|Adverse Event|0
7584134|NCT01724866|11989227|FG001|Overall Study|Adverse Event|0
7584135|NCT01724866|11989228|FG002|Overall Study|Adverse Event|1
7584136|NCT01724866|11989229|FG003|Overall Study|Adverse Event|1
7584137|NCT01724866|11989226|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584138|NCT01724866|11989227|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2
7584139|NCT01724866|11989228|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584140|NCT01724866|11989229|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
7584141|NCT01724866|11989226|FG000|Overall Study|Investigator's Discretion|0
7584142|NCT01724866|11989227|FG001|Overall Study|Investigator's Discretion|1
7584143|NCT01724866|11989228|FG002|Overall Study|Investigator's Discretion|1
7584144|NCT01724866|11989229|FG003|Overall Study|Investigator's Discretion|0
7584145|NCT01724866|11989226|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1
7584146|NCT01724866|11989227|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584147|NCT01724866|11989228|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584148|NCT01724866|11989229|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
7584149|NCT01724866|11989226|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7584150|NCT01724866|11989227|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2
7584151|NCT01724866|11989228|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1
7584152|NCT01724866|11989229|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
7584153|NCT01670877|11989243|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584154|NCT01670877|11989244|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1
7584155|NCT01670877|11989245|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584156|NCT01670877|11989246|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584157|NCT01670877|11989247|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584158|NCT01670877|11989248|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0
7584159|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584160|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584161|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1
7584162|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584163|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584164|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
7584165|NCT01670877|11989243|FG000|Part I and Part 2|Grade 2 vomiting|0
7584166|NCT01670877|11989244|FG001|Part I and Part 2|Grade 2 vomiting|0
7584167|NCT01670877|11989245|FG002|Part I and Part 2|Grade 2 vomiting|0
7584168|NCT01670877|11989246|FG003|Part I and Part 2|Grade 2 vomiting|1
7584169|NCT01670877|11989247|FG004|Part I and Part 2|Grade 2 vomiting|0
7584170|NCT01670877|11989248|FG005|Part I and Part 2|Grade 2 vomiting|0
7584171|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584172|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584173|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584174|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1
7584175|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584176|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0
7584177|NCT01670877|11989243|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584178|NCT01670877|11989244|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584179|NCT01670877|11989245|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584180|NCT01670877|11989246|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1
7584181|NCT01670877|11989247|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584182|NCT01670877|11989248|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
7584191|NCT00667628|11989273|FG000|Overall Study|Lost to Follow-up|1
7584192|NCT00667628|11989274|FG001|Overall Study|Lost to Follow-up|0
7584193|NCT00667628|11989273|FG000|Overall Study|Death|6
7584194|NCT00667628|11989274|FG001|Overall Study|Death|6
7584195|NCT00667628|11989273|FG000|Overall Study|Investigator Considers in Best Interest|1
7584196|NCT00667628|11989274|FG001|Overall Study|Investigator Considers in Best Interest|0
7584197|NCT00667628|11989273|FG000|Overall Study|Sponsor Terminated Study|17
7584198|NCT00667628|11989274|FG001|Overall Study|Sponsor Terminated Study|21
7625615|NCT02943993|12037291|FG000|Overall Study|Withdrawal by Subject|52
7625616|NCT02943993|12037291|FG000|Overall Study|Transfer to another institution|6
7625617|NCT02943993|12037291|FG000|Overall Study|Lost to Follow-up|135
7625618|NCT02943993|12037291|FG000|Overall Study|Death|98
7625619|NCT02943993|12037291|FG000|Overall Study|Other reason for premature termination|32
7625620|NCT02943993|12037291|FG000|Overall Study|Missing reason for termination|7
7625621|NCT02877134|12037313|FG000|Overall Study|Death|0
7625622|NCT02877134|12037314|FG001|Overall Study|Death|1
7625623|NCT02877134|12037315|FG002|Overall Study|Death|0
7625624|NCT02877134|12037316|FG003|Overall Study|Death|0
7625625|NCT02877134|12037317|FG004|Overall Study|Death|0
7625626|NCT02877134|12037318|FG005|Overall Study|Death|1
7625627|NCT02877134|12037319|FG006|Overall Study|Death|0
7625628|NCT02877134|12037313|FG000|Overall Study|Lost to Follow-up|0
7625629|NCT02877134|12037314|FG001|Overall Study|Lost to Follow-up|4
7625630|NCT02877134|12037315|FG002|Overall Study|Lost to Follow-up|0
7625631|NCT02877134|12037316|FG003|Overall Study|Lost to Follow-up|1
7625632|NCT02877134|12037317|FG004|Overall Study|Lost to Follow-up|0
7625633|NCT02877134|12037318|FG005|Overall Study|Lost to Follow-up|0
7625634|NCT02877134|12037319|FG006|Overall Study|Lost to Follow-up|0
7625635|NCT02877134|12037313|FG000|Overall Study|Withdrawal by Subject|13
7625636|NCT02877134|12037314|FG001|Overall Study|Withdrawal by Subject|19
7625637|NCT02877134|12037315|FG002|Overall Study|Withdrawal by Subject|4
7625638|NCT02877134|12037316|FG003|Overall Study|Withdrawal by Subject|6
7625639|NCT02877134|12037317|FG004|Overall Study|Withdrawal by Subject|3
7625640|NCT02877134|12037318|FG005|Overall Study|Withdrawal by Subject|5
7625641|NCT02877134|12037319|FG006|Overall Study|Withdrawal by Subject|0
7625642|NCT02877134|12037313|FG000|Overall Study|Other|1
7625643|NCT02877134|12037314|FG001|Overall Study|Other|1
7625644|NCT02877134|12037315|FG002|Overall Study|Other|2
7625645|NCT02877134|12037316|FG003|Overall Study|Other|6
7625646|NCT02877134|12037317|FG004|Overall Study|Other|3
7625647|NCT02877134|12037318|FG005|Overall Study|Other|1
7625648|NCT02877134|12037319|FG006|Overall Study|Other|1
7625649|NCT02762708|12037341|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7625650|NCT02762708|12037342|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2
7625651|NCT02762708|12037343|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7625652|NCT02762708|12037344|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0
7584199|NCT03581786|11989299|FG000|Overall Study|Death|17
7584200|NCT03581786|11989300|FG001|Overall Study|Death|12
7584201|NCT03581786|11989299|FG000|Overall Study|Withdrawal by Subject|2
7584202|NCT03581786|11989300|FG001|Overall Study|Withdrawal by Subject|4
7584203|NCT03581786|11989299|FG000|Overall Study|Lost to Follow-up|1
7584204|NCT03581786|11989300|FG001|Overall Study|Lost to Follow-up|0
7584205|NCT03581786|11989299|FG000|Overall Study|reason other than specified above|0
7584206|NCT03581786|11989300|FG001|Overall Study|reason other than specified above|1
7584207|NCT03581786|11989299|FG000|Overall Study|Ongoing in the study|123
7584208|NCT03581786|11989300|FG001|Overall Study|Ongoing in the study|129
7584209|NCT03486314|11989323|FG000|Part A|Adverse Event|1
7584210|NCT03486314|11989324|FG001|Part A|Adverse Event|0
7584211|NCT03486314|11989325|FG002|Part A|Adverse Event|0
7584212|NCT03486314|11989323|FG000|Part A|Symptomatic Deterioration|2
7584213|NCT03486314|11989324|FG001|Part A|Symptomatic Deterioration|0
7584214|NCT03486314|11989325|FG002|Part A|Symptomatic Deterioration|0
7584215|NCT02988713|11989333|FG000|Overall Study|Withdrawal by Subject|1
7584216|NCT02988713|11989333|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2
7584217|NCT02794883|11989340|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0
7584218|NCT02794883|11989341|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0
7584219|NCT02794883|11989342|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1
7584220|NCT02794883|11989340|FG000|Pre-Surgical Treatment|Progressive Disease|0
7584221|NCT02794883|11989341|FG001|Pre-Surgical Treatment|Progressive Disease|1
7584222|NCT02794883|11989342|FG002|Pre-Surgical Treatment|Progressive Disease|0
7584223|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1
7584224|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4
7584225|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0
7584226|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1
7584227|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7584228|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
7584229|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7584230|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6
7584231|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
7584232|NCT02794883|11989340|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0
7584233|NCT02794883|11989341|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7584234|NCT02794883|11989342|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
7584235|NCT02794883|11989340|FG000|Follow-up Period (up to 2 Years)|Death|12
7584236|NCT02794883|11989341|FG001|Follow-up Period (up to 2 Years)|Death|10
7584237|NCT02794883|11989342|FG002|Follow-up Period (up to 2 Years)|Death|10
7584238|NCT02677987|11989352|FG000|Overall Study|Withdrawal by Subject|3
7584239|NCT02677987|11989353|FG001|Overall Study|Withdrawal by Subject|0
7584240|NCT02677987|11989352|FG000|Overall Study|Lost to Follow-up|1
7584241|NCT02677987|11989353|FG001|Overall Study|Lost to Follow-up|0
7584260|NCT01928394|11989396|FG000|Treatment Period|Disease progression|17
7584261|NCT01928394|11989397|FG001|Treatment Period|Disease progression|2
7584262|NCT01928394|11989398|FG002|Treatment Period|Disease progression|12
7584263|NCT01928394|11989399|FG003|Treatment Period|Disease progression|48
7584264|NCT01928394|11989400|FG004|Treatment Period|Disease progression|3
7584265|NCT01928394|11989401|FG005|Treatment Period|Disease progression|25
7584266|NCT01928394|11989402|FG006|Treatment Period|Disease progression|38
7584267|NCT01928394|11989403|FG007|Treatment Period|Disease progression|16
7584268|NCT01928394|11989404|FG008|Treatment Period|Disease progression|3
7584269|NCT01928394|11989405|FG009|Treatment Period|Disease progression|11
7584270|NCT01928394|11989406|FG010|Treatment Period|Disease progression|22
7584271|NCT01928394|11989407|FG011|Treatment Period|Disease progression|73
7584272|NCT01928394|11989408|FG012|Treatment Period|Disease progression|38
7584273|NCT01928394|11989409|FG013|Treatment Period|Disease progression|118
7584274|NCT01928394|11989410|FG014|Treatment Period|Disease progression|59
7584275|NCT01928394|11989411|FG015|Treatment Period|Disease progression|1
7584276|NCT01928394|11989412|FG016|Treatment Period|Disease progression|43
7584277|NCT01928394|11989413|FG017|Treatment Period|Disease progression|56
7584278|NCT01928394|11989414|FG018|Treatment Period|Disease progression|50
7584279|NCT01928394|11989415|FG019|Treatment Period|Disease progression|71
7584280|NCT01928394|11989416|FG020|Treatment Period|Disease progression|30
7584281|NCT01928394|11989417|FG021|Treatment Period|Disease progression|31
7584282|NCT01928394|11989418|FG022|Treatment Period|Disease progression|31
7584283|NCT01928394|11989396|FG000|Treatment Period|Study drug toxicity|1
7584284|NCT01928394|11989397|FG001|Treatment Period|Study drug toxicity|1
7584285|NCT01928394|11989398|FG002|Treatment Period|Study drug toxicity|3
7584286|NCT01928394|11989399|FG003|Treatment Period|Study drug toxicity|3
7584287|NCT01928394|11989400|FG004|Treatment Period|Study drug toxicity|0
7584288|NCT01928394|11989401|FG005|Treatment Period|Study drug toxicity|9
7584289|NCT01928394|11989402|FG006|Treatment Period|Study drug toxicity|7
7584290|NCT01928394|11989403|FG007|Treatment Period|Study drug toxicity|1
7584291|NCT01928394|11989404|FG008|Treatment Period|Study drug toxicity|0
7584292|NCT01928394|11989405|FG009|Treatment Period|Study drug toxicity|5
7584293|NCT01928394|11989406|FG010|Treatment Period|Study drug toxicity|2
7584294|NCT01928394|11989407|FG011|Treatment Period|Study drug toxicity|3
7584295|NCT01928394|11989408|FG012|Treatment Period|Study drug toxicity|7
7584296|NCT01928394|11989409|FG013|Treatment Period|Study drug toxicity|5
7584297|NCT01928394|11989410|FG014|Treatment Period|Study drug toxicity|12
7584298|NCT01928394|11989411|FG015|Treatment Period|Study drug toxicity|0
7584299|NCT01928394|11989412|FG016|Treatment Period|Study drug toxicity|3
7584300|NCT01928394|11989413|FG017|Treatment Period|Study drug toxicity|3
7584301|NCT01928394|11989414|FG018|Treatment Period|Study drug toxicity|12
7584302|NCT01928394|11989415|FG019|Treatment Period|Study drug toxicity|15
7584303|NCT01928394|11989416|FG020|Treatment Period|Study drug toxicity|4
7584304|NCT01928394|11989417|FG021|Treatment Period|Study drug toxicity|7
7584305|NCT01928394|11989418|FG022|Treatment Period|Study drug toxicity|4
7584306|NCT01928394|11989396|FG000|Treatment Period|AE unrelated to study drug|0
7584307|NCT01928394|11989397|FG001|Treatment Period|AE unrelated to study drug|0
7584308|NCT01928394|11989398|FG002|Treatment Period|AE unrelated to study drug|2
7584309|NCT01928394|11989399|FG003|Treatment Period|AE unrelated to study drug|3
7584310|NCT01928394|11989400|FG004|Treatment Period|AE unrelated to study drug|0
7584311|NCT01928394|11989401|FG005|Treatment Period|AE unrelated to study drug|5
7584312|NCT01928394|11989402|FG006|Treatment Period|AE unrelated to study drug|1
7584313|NCT01928394|11989403|FG007|Treatment Period|AE unrelated to study drug|0
7584314|NCT01928394|11989404|FG008|Treatment Period|AE unrelated to study drug|0
7584315|NCT01928394|11989405|FG009|Treatment Period|AE unrelated to study drug|2
7584316|NCT01928394|11989406|FG010|Treatment Period|AE unrelated to study drug|0
7584317|NCT01928394|11989407|FG011|Treatment Period|AE unrelated to study drug|12
7584318|NCT01928394|11989408|FG012|Treatment Period|AE unrelated to study drug|6
7584319|NCT01928394|11989409|FG013|Treatment Period|AE unrelated to study drug|13
7584320|NCT01928394|11989410|FG014|Treatment Period|AE unrelated to study drug|6
7584321|NCT01928394|11989411|FG015|Treatment Period|AE unrelated to study drug|1
7584322|NCT01928394|11989412|FG016|Treatment Period|AE unrelated to study drug|1
7584323|NCT01928394|11989413|FG017|Treatment Period|AE unrelated to study drug|6
7584324|NCT01928394|11989414|FG018|Treatment Period|AE unrelated to study drug|3
7584325|NCT01928394|11989415|FG019|Treatment Period|AE unrelated to study drug|5
7584326|NCT01928394|11989416|FG020|Treatment Period|AE unrelated to study drug|1
7584327|NCT01928394|11989417|FG021|Treatment Period|AE unrelated to study drug|1
7584328|NCT01928394|11989418|FG022|Treatment Period|AE unrelated to study drug|0
7584329|NCT01928394|11989396|FG000|Treatment Period|Participant request to stop therapy|0
7584330|NCT01928394|11989397|FG001|Treatment Period|Participant request to stop therapy|0
7584331|NCT01928394|11989398|FG002|Treatment Period|Participant request to stop therapy|0
7584332|NCT01928394|11989399|FG003|Treatment Period|Participant request to stop therapy|0
7584333|NCT01928394|11989400|FG004|Treatment Period|Participant request to stop therapy|0
7584334|NCT01928394|11989401|FG005|Treatment Period|Participant request to stop therapy|3
7584335|NCT01928394|11989402|FG006|Treatment Period|Participant request to stop therapy|3
7584336|NCT01928394|11989403|FG007|Treatment Period|Participant request to stop therapy|0
7584337|NCT01928394|11989404|FG008|Treatment Period|Participant request to stop therapy|0
7584338|NCT01928394|11989405|FG009|Treatment Period|Participant request to stop therapy|0
7584339|NCT01928394|11989406|FG010|Treatment Period|Participant request to stop therapy|3
7584340|NCT01928394|11989407|FG011|Treatment Period|Participant request to stop therapy|2
7584341|NCT01928394|11989408|FG012|Treatment Period|Participant request to stop therapy|1
7584342|NCT01928394|11989409|FG013|Treatment Period|Participant request to stop therapy|2
7584343|NCT01928394|11989410|FG014|Treatment Period|Participant request to stop therapy|4
7584344|NCT01928394|11989411|FG015|Treatment Period|Participant request to stop therapy|0
7584345|NCT01928394|11989412|FG016|Treatment Period|Participant request to stop therapy|1
7584346|NCT01928394|11989413|FG017|Treatment Period|Participant request to stop therapy|3
7584347|NCT01928394|11989414|FG018|Treatment Period|Participant request to stop therapy|1
7584348|NCT01928394|11989415|FG019|Treatment Period|Participant request to stop therapy|1
7584349|NCT01928394|11989416|FG020|Treatment Period|Participant request to stop therapy|3
7584350|NCT01928394|11989417|FG021|Treatment Period|Participant request to stop therapy|1
7584351|NCT01928394|11989418|FG022|Treatment Period|Participant request to stop therapy|3
7584352|NCT01928394|11989396|FG000|Treatment Period|Participant withdrew consent|0
7584353|NCT01928394|11989397|FG001|Treatment Period|Participant withdrew consent|0
7584354|NCT01928394|11989398|FG002|Treatment Period|Participant withdrew consent|1
7584355|NCT01928394|11989399|FG003|Treatment Period|Participant withdrew consent|1
7584356|NCT01928394|11989400|FG004|Treatment Period|Participant withdrew consent|0
7584357|NCT01928394|11989401|FG005|Treatment Period|Participant withdrew consent|1
7584358|NCT01928394|11989402|FG006|Treatment Period|Participant withdrew consent|0
7584359|NCT01928394|11989403|FG007|Treatment Period|Participant withdrew consent|1
7584360|NCT01928394|11989404|FG008|Treatment Period|Participant withdrew consent|0
7584361|NCT01928394|11989405|FG009|Treatment Period|Participant withdrew consent|0
7584362|NCT01928394|11989406|FG010|Treatment Period|Participant withdrew consent|1
7584363|NCT01928394|11989407|FG011|Treatment Period|Participant withdrew consent|1
7584364|NCT01928394|11989408|FG012|Treatment Period|Participant withdrew consent|1
7584365|NCT01928394|11989409|FG013|Treatment Period|Participant withdrew consent|0
7584366|NCT01928394|11989410|FG014|Treatment Period|Participant withdrew consent|2
7584367|NCT01928394|11989411|FG015|Treatment Period|Participant withdrew consent|0
7584368|NCT01928394|11989412|FG016|Treatment Period|Participant withdrew consent|2
7584369|NCT01928394|11989413|FG017|Treatment Period|Participant withdrew consent|1
7584370|NCT01928394|11989414|FG018|Treatment Period|Participant withdrew consent|1
7584371|NCT01928394|11989415|FG019|Treatment Period|Participant withdrew consent|1
7584372|NCT01928394|11989416|FG020|Treatment Period|Participant withdrew consent|0
7584373|NCT01928394|11989417|FG021|Treatment Period|Participant withdrew consent|2
7584374|NCT01928394|11989418|FG022|Treatment Period|Participant withdrew consent|0
7584375|NCT01928394|11989396|FG000|Treatment Period|Poor/non-compliance|0
7584376|NCT01928394|11989397|FG001|Treatment Period|Poor/non-compliance|0
7584377|NCT01928394|11989398|FG002|Treatment Period|Poor/non-compliance|0
7584378|NCT01928394|11989399|FG003|Treatment Period|Poor/non-compliance|1
7584379|NCT01928394|11989400|FG004|Treatment Period|Poor/non-compliance|0
7584380|NCT01928394|11989401|FG005|Treatment Period|Poor/non-compliance|0
7584381|NCT01928394|11989402|FG006|Treatment Period|Poor/non-compliance|0
7584382|NCT01928394|11989403|FG007|Treatment Period|Poor/non-compliance|0
7584383|NCT01928394|11989404|FG008|Treatment Period|Poor/non-compliance|0
7584384|NCT01928394|11989405|FG009|Treatment Period|Poor/non-compliance|0
7584385|NCT01928394|11989406|FG010|Treatment Period|Poor/non-compliance|0
7584386|NCT01928394|11989407|FG011|Treatment Period|Poor/non-compliance|0
7584387|NCT01928394|11989408|FG012|Treatment Period|Poor/non-compliance|1
7584388|NCT01928394|11989409|FG013|Treatment Period|Poor/non-compliance|0
7584389|NCT01928394|11989410|FG014|Treatment Period|Poor/non-compliance|1
7584390|NCT01928394|11989411|FG015|Treatment Period|Poor/non-compliance|0
7584391|NCT01928394|11989412|FG016|Treatment Period|Poor/non-compliance|0
7584392|NCT01928394|11989413|FG017|Treatment Period|Poor/non-compliance|1
7584393|NCT01928394|11989414|FG018|Treatment Period|Poor/non-compliance|0
7584394|NCT01928394|11989415|FG019|Treatment Period|Poor/non-compliance|1
7584395|NCT01928394|11989416|FG020|Treatment Period|Poor/non-compliance|0
7584396|NCT01928394|11989417|FG021|Treatment Period|Poor/non-compliance|0
7584397|NCT01928394|11989418|FG022|Treatment Period|Poor/non-compliance|0
7584398|NCT01928394|11989396|FG000|Treatment Period|other reason|0
7584399|NCT01928394|11989397|FG001|Treatment Period|other reason|0
7584400|NCT01928394|11989398|FG002|Treatment Period|other reason|0
7584401|NCT01928394|11989399|FG003|Treatment Period|other reason|0
7584402|NCT01928394|11989400|FG004|Treatment Period|other reason|0
7584403|NCT01928394|11989401|FG005|Treatment Period|other reason|0
7584404|NCT01928394|11989402|FG006|Treatment Period|other reason|0
7584405|NCT01928394|11989403|FG007|Treatment Period|other reason|0
7584406|NCT01928394|11989404|FG008|Treatment Period|other reason|0
7584407|NCT01928394|11989405|FG009|Treatment Period|other reason|0
7584408|NCT01928394|11989406|FG010|Treatment Period|other reason|1
7584409|NCT01928394|11989407|FG011|Treatment Period|other reason|1
7584410|NCT01928394|11989408|FG012|Treatment Period|other reason|1
7584411|NCT01928394|11989409|FG013|Treatment Period|other reason|0
7584412|NCT01928394|11989410|FG014|Treatment Period|other reason|1
7584413|NCT01928394|11989411|FG015|Treatment Period|other reason|0
7584414|NCT01928394|11989412|FG016|Treatment Period|other reason|0
7584415|NCT01928394|11989413|FG017|Treatment Period|other reason|0
7584416|NCT01928394|11989414|FG018|Treatment Period|other reason|2
7584417|NCT01928394|11989415|FG019|Treatment Period|other reason|2
7584418|NCT01928394|11989416|FG020|Treatment Period|other reason|0
7584419|NCT01928394|11989417|FG021|Treatment Period|other reason|0
7584420|NCT01928394|11989418|FG022|Treatment Period|other reason|0
7584421|NCT01928394|11989396|FG000|Treatment Period|Maximum clinical benefit|0
7584422|NCT01928394|11989397|FG001|Treatment Period|Maximum clinical benefit|0
7584423|NCT01928394|11989398|FG002|Treatment Period|Maximum clinical benefit|0
7584424|NCT01928394|11989399|FG003|Treatment Period|Maximum clinical benefit|0
7584425|NCT01928394|11989400|FG004|Treatment Period|Maximum clinical benefit|0
7584426|NCT01928394|11989401|FG005|Treatment Period|Maximum clinical benefit|0
7584427|NCT01928394|11989402|FG006|Treatment Period|Maximum clinical benefit|0
7584428|NCT01928394|11989403|FG007|Treatment Period|Maximum clinical benefit|0
7584429|NCT01928394|11989404|FG008|Treatment Period|Maximum clinical benefit|0
7584430|NCT01928394|11989405|FG009|Treatment Period|Maximum clinical benefit|0
7584431|NCT01928394|11989406|FG010|Treatment Period|Maximum clinical benefit|1
7584432|NCT01928394|11989407|FG011|Treatment Period|Maximum clinical benefit|1
7584433|NCT01928394|11989408|FG012|Treatment Period|Maximum clinical benefit|0
7584434|NCT01928394|11989409|FG013|Treatment Period|Maximum clinical benefit|0
7584435|NCT01928394|11989410|FG014|Treatment Period|Maximum clinical benefit|1
7584436|NCT01928394|11989411|FG015|Treatment Period|Maximum clinical benefit|0
7584437|NCT01928394|11989412|FG016|Treatment Period|Maximum clinical benefit|0
7584438|NCT01928394|11989413|FG017|Treatment Period|Maximum clinical benefit|1
7584439|NCT01928394|11989414|FG018|Treatment Period|Maximum clinical benefit|1
7584440|NCT01928394|11989415|FG019|Treatment Period|Maximum clinical benefit|0
7584441|NCT01928394|11989416|FG020|Treatment Period|Maximum clinical benefit|2
7584442|NCT01928394|11989417|FG021|Treatment Period|Maximum clinical benefit|0
7584443|NCT01928394|11989418|FG022|Treatment Period|Maximum clinical benefit|0
7584444|NCT01928394|11989396|FG000|Treatment Period|Lost to Follow-up|0
7584445|NCT01928394|11989397|FG001|Treatment Period|Lost to Follow-up|0
7584446|NCT01928394|11989398|FG002|Treatment Period|Lost to Follow-up|0
7584447|NCT01928394|11989399|FG003|Treatment Period|Lost to Follow-up|0
7584448|NCT01928394|11989400|FG004|Treatment Period|Lost to Follow-up|0
7584449|NCT01928394|11989401|FG005|Treatment Period|Lost to Follow-up|0
7584450|NCT01928394|11989402|FG006|Treatment Period|Lost to Follow-up|0
7584451|NCT01928394|11989403|FG007|Treatment Period|Lost to Follow-up|0
7584452|NCT01928394|11989404|FG008|Treatment Period|Lost to Follow-up|0
7584453|NCT01928394|11989405|FG009|Treatment Period|Lost to Follow-up|0
7584454|NCT01928394|11989406|FG010|Treatment Period|Lost to Follow-up|0
7584455|NCT01928394|11989407|FG011|Treatment Period|Lost to Follow-up|0
7584456|NCT01928394|11989408|FG012|Treatment Period|Lost to Follow-up|0
7584457|NCT01928394|11989409|FG013|Treatment Period|Lost to Follow-up|0
7584458|NCT01928394|11989410|FG014|Treatment Period|Lost to Follow-up|0
7584459|NCT01928394|11989411|FG015|Treatment Period|Lost to Follow-up|0
7584460|NCT01928394|11989412|FG016|Treatment Period|Lost to Follow-up|0
7584461|NCT01928394|11989413|FG017|Treatment Period|Lost to Follow-up|0
7584462|NCT01928394|11989414|FG018|Treatment Period|Lost to Follow-up|0
7584463|NCT01928394|11989415|FG019|Treatment Period|Lost to Follow-up|0
7584464|NCT01928394|11989416|FG020|Treatment Period|Lost to Follow-up|0
7584465|NCT01928394|11989417|FG021|Treatment Period|Lost to Follow-up|0
7584466|NCT01928394|11989418|FG022|Treatment Period|Lost to Follow-up|1
7584467|NCT01928394|11989396|FG000|Treatment Period|Death|0
7584468|NCT01928394|11989397|FG001|Treatment Period|Death|0
7584469|NCT01928394|11989398|FG002|Treatment Period|Death|0
7584470|NCT01928394|11989399|FG003|Treatment Period|Death|0
7584471|NCT01928394|11989400|FG004|Treatment Period|Death|0
7584472|NCT01928394|11989401|FG005|Treatment Period|Death|0
7584473|NCT01928394|11989402|FG006|Treatment Period|Death|0
7584474|NCT01928394|11989403|FG007|Treatment Period|Death|0
7584475|NCT01928394|11989404|FG008|Treatment Period|Death|0
7584476|NCT01928394|11989405|FG009|Treatment Period|Death|0
7584477|NCT01928394|11989406|FG010|Treatment Period|Death|0
7584478|NCT01928394|11989407|FG011|Treatment Period|Death|0
7584479|NCT01928394|11989408|FG012|Treatment Period|Death|0
7584480|NCT01928394|11989409|FG013|Treatment Period|Death|1
7584481|NCT01928394|11989410|FG014|Treatment Period|Death|2
7584482|NCT01928394|11989411|FG015|Treatment Period|Death|0
7584483|NCT01928394|11989412|FG016|Treatment Period|Death|0
7584484|NCT01928394|11989413|FG017|Treatment Period|Death|0
7584485|NCT01928394|11989414|FG018|Treatment Period|Death|0
7584486|NCT01928394|11989415|FG019|Treatment Period|Death|0
7584487|NCT01928394|11989416|FG020|Treatment Period|Death|0
7584488|NCT01928394|11989417|FG021|Treatment Period|Death|0
7584489|NCT01928394|11989418|FG022|Treatment Period|Death|0
7584490|NCT01928394|11989396|FG000|Follow-up Period|Participant withdrew consent|3
7584491|NCT01928394|11989397|FG001|Follow-up Period|Participant withdrew consent|0
7584492|NCT01928394|11989398|FG002|Follow-up Period|Participant withdrew consent|1
7584493|NCT01928394|11989399|FG003|Follow-up Period|Participant withdrew consent|4
7584578|NCT01928394|11989415|FG019|Follow-up Period|Lost to Follow-up|0
7584494|NCT01928394|11989400|FG004|Follow-up Period|Participant withdrew consent|0
7584495|NCT01928394|11989401|FG005|Follow-up Period|Participant withdrew consent|2
7584496|NCT01928394|11989402|FG006|Follow-up Period|Participant withdrew consent|5
7584497|NCT01928394|11989403|FG007|Follow-up Period|Participant withdrew consent|1
7584498|NCT01928394|11989404|FG008|Follow-up Period|Participant withdrew consent|0
7584499|NCT01928394|11989405|FG009|Follow-up Period|Participant withdrew consent|0
7584500|NCT01928394|11989406|FG010|Follow-up Period|Participant withdrew consent|5
7584501|NCT01928394|11989407|FG011|Follow-up Period|Participant withdrew consent|8
7584502|NCT01928394|11989408|FG012|Follow-up Period|Participant withdrew consent|2
7584503|NCT01928394|11989409|FG013|Follow-up Period|Participant withdrew consent|12
7584504|NCT01928394|11989410|FG014|Follow-up Period|Participant withdrew consent|7
7584505|NCT01928394|11989411|FG015|Follow-up Period|Participant withdrew consent|0
7584506|NCT01928394|11989412|FG016|Follow-up Period|Participant withdrew consent|5
7584507|NCT01928394|11989413|FG017|Follow-up Period|Participant withdrew consent|3
7584508|NCT01928394|11989414|FG018|Follow-up Period|Participant withdrew consent|2
7584509|NCT01928394|11989415|FG019|Follow-up Period|Participant withdrew consent|7
7584510|NCT01928394|11989416|FG020|Follow-up Period|Participant withdrew consent|4
7584511|NCT01928394|11989417|FG021|Follow-up Period|Participant withdrew consent|6
7584512|NCT01928394|11989418|FG022|Follow-up Period|Participant withdrew consent|2
7584513|NCT01928394|11989396|FG000|Follow-up Period|Death|0
7584514|NCT01928394|11989397|FG001|Follow-up Period|Death|0
7584515|NCT01928394|11989398|FG002|Follow-up Period|Death|2
7584516|NCT01928394|11989399|FG003|Follow-up Period|Death|6
7584517|NCT01928394|11989400|FG004|Follow-up Period|Death|0
7584518|NCT01928394|11989401|FG005|Follow-up Period|Death|6
7584519|NCT01928394|11989402|FG006|Follow-up Period|Death|6
7584520|NCT01928394|11989403|FG007|Follow-up Period|Death|2
7584521|NCT01928394|11989404|FG008|Follow-up Period|Death|1
7584522|NCT01928394|11989405|FG009|Follow-up Period|Death|2
7584523|NCT01928394|11989406|FG010|Follow-up Period|Death|4
7584524|NCT01928394|11989407|FG011|Follow-up Period|Death|12
7584525|NCT01928394|11989408|FG012|Follow-up Period|Death|11
7584526|NCT01928394|11989409|FG013|Follow-up Period|Death|25
7584527|NCT01928394|11989410|FG014|Follow-up Period|Death|18
7584528|NCT01928394|11989411|FG015|Follow-up Period|Death|0
7584529|NCT01928394|11989412|FG016|Follow-up Period|Death|6
7584530|NCT01928394|11989413|FG017|Follow-up Period|Death|5
7584531|NCT01928394|11989414|FG018|Follow-up Period|Death|13
7584532|NCT01928394|11989415|FG019|Follow-up Period|Death|13
7584533|NCT01928394|11989416|FG020|Follow-up Period|Death|5
7584534|NCT01928394|11989417|FG021|Follow-up Period|Death|3
7584535|NCT01928394|11989418|FG022|Follow-up Period|Death|2
7270208|NCT00414609|11484360|FG002|Core Study|Death|0
7584536|NCT01928394|11989396|FG000|Follow-up Period|other reason|0
7584537|NCT01928394|11989397|FG001|Follow-up Period|other reason|0
7584538|NCT01928394|11989398|FG002|Follow-up Period|other reason|0
7584539|NCT01928394|11989399|FG003|Follow-up Period|other reason|0
7584540|NCT01928394|11989400|FG004|Follow-up Period|other reason|0
7584541|NCT01928394|11989401|FG005|Follow-up Period|other reason|0
7584542|NCT01928394|11989402|FG006|Follow-up Period|other reason|1
7584543|NCT01928394|11989403|FG007|Follow-up Period|other reason|3
7584544|NCT01928394|11989404|FG008|Follow-up Period|other reason|0
7584545|NCT01928394|11989405|FG009|Follow-up Period|other reason|0
7584546|NCT01928394|11989406|FG010|Follow-up Period|other reason|2
7584547|NCT01928394|11989407|FG011|Follow-up Period|other reason|1
7584548|NCT01928394|11989408|FG012|Follow-up Period|other reason|0
7584549|NCT01928394|11989409|FG013|Follow-up Period|other reason|1
7584550|NCT01928394|11989410|FG014|Follow-up Period|other reason|4
7584551|NCT01928394|11989411|FG015|Follow-up Period|other reason|0
7584552|NCT01928394|11989412|FG016|Follow-up Period|other reason|2
7584553|NCT01928394|11989413|FG017|Follow-up Period|other reason|0
7584554|NCT01928394|11989414|FG018|Follow-up Period|other reason|1
7584555|NCT01928394|11989415|FG019|Follow-up Period|other reason|1
7584556|NCT01928394|11989416|FG020|Follow-up Period|other reason|0
7584557|NCT01928394|11989417|FG021|Follow-up Period|other reason|0
7584558|NCT01928394|11989418|FG022|Follow-up Period|other reason|1
7584559|NCT01928394|11989396|FG000|Follow-up Period|Lost to Follow-up|0
7584560|NCT01928394|11989397|FG001|Follow-up Period|Lost to Follow-up|0
7584561|NCT01928394|11989398|FG002|Follow-up Period|Lost to Follow-up|0
7584562|NCT01928394|11989399|FG003|Follow-up Period|Lost to Follow-up|0
7584563|NCT01928394|11989400|FG004|Follow-up Period|Lost to Follow-up|0
7584564|NCT01928394|11989401|FG005|Follow-up Period|Lost to Follow-up|0
7584565|NCT01928394|11989402|FG006|Follow-up Period|Lost to Follow-up|0
7584566|NCT01928394|11989403|FG007|Follow-up Period|Lost to Follow-up|0
7584567|NCT01928394|11989404|FG008|Follow-up Period|Lost to Follow-up|0
7584568|NCT01928394|11989405|FG009|Follow-up Period|Lost to Follow-up|0
7584569|NCT01928394|11989406|FG010|Follow-up Period|Lost to Follow-up|0
7584570|NCT01928394|11989407|FG011|Follow-up Period|Lost to Follow-up|1
7584571|NCT01928394|11989408|FG012|Follow-up Period|Lost to Follow-up|1
7584572|NCT01928394|11989409|FG013|Follow-up Period|Lost to Follow-up|0
7584573|NCT01928394|11989410|FG014|Follow-up Period|Lost to Follow-up|1
7584574|NCT01928394|11989411|FG015|Follow-up Period|Lost to Follow-up|0
7584575|NCT01928394|11989412|FG016|Follow-up Period|Lost to Follow-up|1
7584576|NCT01928394|11989413|FG017|Follow-up Period|Lost to Follow-up|0
7584577|NCT01928394|11989414|FG018|Follow-up Period|Lost to Follow-up|0
7584579|NCT01928394|11989416|FG020|Follow-up Period|Lost to Follow-up|0
7584580|NCT01928394|11989417|FG021|Follow-up Period|Lost to Follow-up|0
7584581|NCT01928394|11989418|FG022|Follow-up Period|Lost to Follow-up|1
7584582|NCT01657500|11989468|FG000|Overall Study|set impropperly matched|3
7584583|NCT01657500|11989469|FG001|Overall Study|set impropperly matched|3
7584584|NCT01657500|11989468|FG000|Overall Study|Lost to Follow-up|2
7584585|NCT01657500|11989469|FG001|Overall Study|Lost to Follow-up|2
7584586|NCT04810221|11989475|FG000|Overall Study|Physician Decision|3
7584587|NCT04575038|11989481|FG000|Overall Study|Withdrawal by Subject|1
7584588|NCT04575038|11989482|FG001|Overall Study|Withdrawal by Subject|1
7584589|NCT04545567|11989490|FG000|Overall Study|tested positive for SARS-co-V2|1
7584590|NCT04545567|11989491|FG001|Overall Study|tested positive for SARS-co-V2|1
7584591|NCT04545567|11989490|FG000|Overall Study|Withdrawal by Subject|0
7584592|NCT04545567|11989491|FG001|Overall Study|Withdrawal by Subject|1
7584593|NCT04397757|11989503|FG000|Overall Study|Death|3
7584594|NCT04397757|11989504|FG001|Overall Study|Death|11
7584595|NCT04397757|11989503|FG000|Overall Study|Withdrawal by Subject|2
7584596|NCT04397757|11989504|FG001|Overall Study|Withdrawal by Subject|0
7584597|NCT04397757|11989503|FG000|Overall Study|Lost to Follow-up|4
7584598|NCT04397757|11989504|FG001|Overall Study|Lost to Follow-up|3
7584599|NCT04112303|11989541|FG000|Overall Study|Death|1
7584600|NCT03896477|11989548|FG000|Overall Study|Met Ineligibility Criteria During the Study|1
7584601|NCT03896477|11989549|FG001|Overall Study|Met Ineligibility Criteria During the Study|1
7584602|NCT03896477|11989550|FG002|Overall Study|Met Ineligibility Criteria During the Study|2
7584603|NCT03896477|11989548|FG000|Overall Study|Parent Requested Withdrawal|8
7584604|NCT03896477|11989549|FG001|Overall Study|Parent Requested Withdrawal|12
7584605|NCT03896477|11989550|FG002|Overall Study|Parent Requested Withdrawal|9
7584606|NCT03896477|11989548|FG000|Overall Study|Adverse Event|0
7584607|NCT03896477|11989549|FG001|Overall Study|Adverse Event|0
7584608|NCT03896477|11989550|FG002|Overall Study|Adverse Event|1
7584609|NCT03896477|11989548|FG000|Overall Study|Death|1
7584610|NCT03896477|11989549|FG001|Overall Study|Death|0
7584611|NCT03896477|11989550|FG002|Overall Study|Death|0
7584612|NCT03896477|11989548|FG000|Overall Study|Other|5
7584613|NCT03896477|11989549|FG001|Overall Study|Other|6
7584614|NCT03896477|11989550|FG002|Overall Study|Other|7
7584615|NCT03896477|11989548|FG000|Overall Study|Lost to Follow-up|2
7584616|NCT03896477|11989549|FG001|Overall Study|Lost to Follow-up|1
7584617|NCT03896477|11989550|FG002|Overall Study|Lost to Follow-up|1
7584618|NCT03760185|11989561|FG000|Overall Study|Lost to Follow-up|1
7584619|NCT03760185|11989562|FG001|Overall Study|Lost to Follow-up|1
7584620|NCT03732534|11989570|FG000|Overall Study|Study terminated by Sponsor|6
7584621|NCT03692910|11989574|FG000|Overall Study|Lost to Follow-up|4
7584622|NCT03692910|11989575|FG001|Overall Study|Lost to Follow-up|0
7584623|NCT03692910|11989576|FG002|Overall Study|Lost to Follow-up|0
7584624|NCT03692910|11989574|FG000|Overall Study|Withdrawal by Subject|2
7584625|NCT03692910|11989575|FG001|Overall Study|Withdrawal by Subject|0
7584626|NCT03692910|11989576|FG002|Overall Study|Withdrawal by Subject|0
7584627|NCT03673956|11989586|FG000|Overall Study|Lost to Follow-up|1
7584628|NCT03673956|11989587|FG001|Overall Study|Lost to Follow-up|0
7584629|NCT03673956|11989588|FG002|Overall Study|Lost to Follow-up|0
7584630|NCT03673956|11989589|FG003|Overall Study|Lost to Follow-up|0
7584631|NCT03673956|11989586|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1
7584632|NCT03673956|11989587|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7584633|NCT03673956|11989588|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7584634|NCT03673956|11989589|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0
7584640|NCT03205163|11989660|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
7584641|NCT03205163|11989661|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
7584642|NCT03178045|11989678|FG000|Overall Study|Withdrawal by Subject|5
7584643|NCT03178045|11989679|FG001|Overall Study|Withdrawal by Subject|7
7584644|NCT03178045|11989678|FG000|Overall Study|Surgery Cancelled/Relocated|34
7584645|NCT03178045|11989679|FG001|Overall Study|Surgery Cancelled/Relocated|30
7584646|NCT03178045|11989678|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
7584647|NCT03178045|11989679|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
7584648|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584649|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584650|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
7584651|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
7584652|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
7584653|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7584654|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
7584655|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7584656|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
7584657|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
7584658|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7584659|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
7584660|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7584661|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
7584662|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
7584663|NCT03145766|11989691|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
7584664|NCT03145766|11989692|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584665|NCT03145766|11989693|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584666|NCT03145766|11989694|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
7584667|NCT03145766|11989695|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
7584668|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
7584669|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584670|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584671|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
7584672|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
7584673|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7584674|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
7584675|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
7584676|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
7584677|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
7584678|NCT03145766|11989691|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584679|NCT03145766|11989692|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584680|NCT03145766|11989693|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
7584681|NCT03145766|11989694|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7584682|NCT03145766|11989695|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
7584683|NCT03106987|11989712|FG000|Overall Study|Death|37
7584684|NCT03106987|11989713|FG001|Overall Study|Death|22
7584685|NCT03106987|11989714|FG002|Overall Study|Death|12
7584686|NCT03106987|11989715|FG003|Overall Study|Death|8
7584687|NCT03106987|11989712|FG000|Overall Study|Lost to Follow-up|2
7584688|NCT03106987|11989713|FG001|Overall Study|Lost to Follow-up|0
7584689|NCT03106987|11989714|FG002|Overall Study|Lost to Follow-up|2
7584690|NCT03106987|11989715|FG003|Overall Study|Lost to Follow-up|2
7584691|NCT03106987|11989712|FG000|Overall Study|Withdrawal by Subject|5
7584692|NCT03106987|11989713|FG001|Overall Study|Withdrawal by Subject|1
7584693|NCT03106987|11989714|FG002|Overall Study|Withdrawal by Subject|4
7584694|NCT03106987|11989715|FG003|Overall Study|Withdrawal by Subject|1
7584695|NCT03103087|11989728|FG000|Overall Study|Did not receive any study drug|1
7584696|NCT03103087|11989729|FG001|Overall Study|Did not receive any study drug|0
7584697|NCT03103087|11989730|FG002|Overall Study|Did not receive any study drug|0
7584698|NCT03103087|11989728|FG000|Overall Study|Protocol Violation|1
7584699|NCT03103087|11989729|FG001|Overall Study|Protocol Violation|2
7584700|NCT03103087|11989730|FG002|Overall Study|Protocol Violation|1
7584701|NCT03103087|11989728|FG000|Overall Study|Lack of Efficacy|2
7584702|NCT03103087|11989729|FG001|Overall Study|Lack of Efficacy|1
7584703|NCT03103087|11989730|FG002|Overall Study|Lack of Efficacy|1
7584704|NCT03103087|11989728|FG000|Overall Study|Pregnancy|0
7584705|NCT03103087|11989729|FG001|Overall Study|Pregnancy|0
7584706|NCT03103087|11989730|FG002|Overall Study|Pregnancy|1
7584707|NCT03103087|11989728|FG000|Overall Study|Adverse Event|2
7584708|NCT03103087|11989729|FG001|Overall Study|Adverse Event|15
7584709|NCT03103087|11989730|FG002|Overall Study|Adverse Event|6
7584710|NCT03103087|11989728|FG000|Overall Study|Withdrawal by Subject|13
7584711|NCT03103087|11989729|FG001|Overall Study|Withdrawal by Subject|6
7584712|NCT03103087|11989730|FG002|Overall Study|Withdrawal by Subject|6
7584713|NCT03103087|11989728|FG000|Overall Study|Lost to Follow-up|4
7584714|NCT03103087|11989729|FG001|Overall Study|Lost to Follow-up|2
7584715|NCT03103087|11989730|FG002|Overall Study|Lost to Follow-up|7
7584716|NCT03103087|11989728|FG000|Overall Study|Other reason not reported|1
7584717|NCT03103087|11989729|FG001|Overall Study|Other reason not reported|3
7584718|NCT03103087|11989730|FG002|Overall Study|Other reason not reported|5
7584719|NCT03049735|11989743|FG000|Overall Study|Discontinued due to AE (not dosed)|0
7584720|NCT03049735|11989744|FG001|Overall Study|Discontinued due to AE (not dosed)|0
7584721|NCT03049735|11989745|FG002|Overall Study|Discontinued due to AE (not dosed)|1
7584722|NCT03049735|11989743|FG000|Overall Study|Other|5
7584723|NCT03049735|11989744|FG001|Overall Study|Other|3
7584724|NCT03049735|11989745|FG002|Overall Study|Other|1
7584725|NCT03049735|11989743|FG000|Overall Study|Lack of Efficacy|4
7584726|NCT03049735|11989744|FG001|Overall Study|Lack of Efficacy|0
7584727|NCT03049735|11989745|FG002|Overall Study|Lack of Efficacy|3
7584728|NCT03049735|11989743|FG000|Overall Study|Protocol deviation|1
7584729|NCT03049735|11989744|FG001|Overall Study|Protocol deviation|0
7584730|NCT03049735|11989745|FG002|Overall Study|Protocol deviation|0
7584731|NCT03049735|11989743|FG000|Overall Study|Pregnancy|0
7584732|NCT03049735|11989744|FG001|Overall Study|Pregnancy|0
7584733|NCT03049735|11989745|FG002|Overall Study|Pregnancy|1
7584734|NCT03049735|11989743|FG000|Overall Study|Adverse Event|7
7584735|NCT03049735|11989744|FG001|Overall Study|Adverse Event|18
7584736|NCT03049735|11989745|FG002|Overall Study|Adverse Event|5
7584737|NCT03049735|11989743|FG000|Overall Study|Withdrawal by Subject|10
7584738|NCT03049735|11989744|FG001|Overall Study|Withdrawal by Subject|3
7584739|NCT03049735|11989745|FG002|Overall Study|Withdrawal by Subject|7
7584740|NCT03049735|11989743|FG000|Overall Study|Lost to Follow-up|1
7584741|NCT03049735|11989744|FG001|Overall Study|Lost to Follow-up|5
7584742|NCT03049735|11989745|FG002|Overall Study|Lost to Follow-up|5
7584743|NCT03021551|11989753|FG000|Overall Study|Equipment Issues|2
7584744|NCT03021551|11989753|FG000|Overall Study|Protocol Violation|1
7584745|NCT02990338|11989759|FG000|Overall Study|Adverse Event|19
7584746|NCT02990338|11989760|FG001|Overall Study|Adverse Event|11
7584747|NCT02990338|11989759|FG000|Overall Study|Progressive disease|88
7584748|NCT02990338|11989760|FG001|Overall Study|Progressive disease|66
7584749|NCT02990338|11989759|FG000|Overall Study|Poor compliance to protocol|0
7584750|NCT02990338|11989760|FG001|Overall Study|Poor compliance to protocol|1
7584751|NCT02990338|11989759|FG000|Overall Study|Withdrawal by Subject|6
7584752|NCT02990338|11989760|FG001|Overall Study|Withdrawal by Subject|5
7584753|NCT02990338|11989759|FG000|Overall Study|Other|1
7584754|NCT02990338|11989760|FG001|Overall Study|Other|4
7584755|NCT02990338|11989759|FG000|Overall Study|Randomized but not treated|4
7584756|NCT02990338|11989760|FG001|Overall Study|Randomized but not treated|2
7584757|NCT02932332|11989780|FG000|Overall Study|Withdrawal by Subject|1
7584758|NCT02932332|11989781|FG001|Overall Study|Withdrawal by Subject|1
7584759|NCT02932332|11989782|FG002|Overall Study|Withdrawal by Subject|0
7584760|NCT02932332|11989783|FG003|Overall Study|Withdrawal by Subject|1
7584761|NCT02932332|11989780|FG000|Overall Study|Chest pain|0
7584762|NCT02932332|11989781|FG001|Overall Study|Chest pain|0
7584763|NCT02932332|11989782|FG002|Overall Study|Chest pain|0
7584764|NCT02932332|11989783|FG003|Overall Study|Chest pain|1
7584765|NCT02932332|11989780|FG000|Overall Study|Not Dyspneic cough|1
7584766|NCT02932332|11989781|FG001|Overall Study|Not Dyspneic cough|2
7584767|NCT02932332|11989782|FG002|Overall Study|Not Dyspneic cough|1
7584768|NCT02932332|11989783|FG003|Overall Study|Not Dyspneic cough|0
7625702|NCT02550873|12037421|FG000|Randomized Double Blind|Adverse Event|3
7625703|NCT02550873|12037422|FG001|Randomized Double Blind|Adverse Event|1
7625704|NCT02550873|12037423|FG002|Randomized Double Blind|Adverse Event|0
7625705|NCT02550873|12037421|FG000|Randomized Double Blind|Disease progression|1
7625706|NCT02550873|12037422|FG001|Randomized Double Blind|Disease progression|1
7625707|NCT02550873|12037423|FG002|Randomized Double Blind|Disease progression|0
7625708|NCT02550873|12037421|FG000|Open Label Extension|Study ongoing|0
7625709|NCT02550873|12037422|FG001|Open Label Extension|Study ongoing|0
7625710|NCT02550873|12037423|FG002|Open Label Extension|Study ongoing|111
7625711|NCT02542267|12037445|FG000|Overall Study|Withdrawal by Subject|10
7625712|NCT02542267|12037445|FG000|Overall Study|Physician Decision|6
7625713|NCT02542267|12037445|FG000|Overall Study|Lost to Follow-up|4
7625714|NCT02542267|12037445|FG000|Overall Study|Death|13
7625715|NCT02542267|12037445|FG000|Overall Study|Surgical Bypass of All Study Devices|13
7625716|NCT02542267|12037445|FG000|Overall Study|Other|9
7625717|NCT02462603|12037449|FG000|Overall Study|Investigator Decision|1
7625718|NCT02462603|12037449|FG000|Overall Study|Non-Compliance|1
7625719|NCT02462603|12037449|FG000|Overall Study|Withdrawal by Subject|2
7625720|NCT02420717|12037460|FG000|Overall Study|Did not receive all study medication|2
7625721|NCT02420717|12037461|FG001|Overall Study|Did not receive all study medication|0
7625722|NCT02420717|12037462|FG002|Overall Study|Did not receive all study medication|0
7625723|NCT02408068|12037470|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
7625724|NCT02408068|12037471|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
7625725|NCT02408068|12037472|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
7625726|NCT02408068|12037473|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
7625727|NCT02408068|12037474|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
7625728|NCT02408068|12037475|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
7584769|NCT02588248|11989826|FG000|Overall Study|Physician Decision|4
7584770|NCT02588248|11989827|FG001|Overall Study|Physician Decision|3
7584771|NCT02535065|11989838|FG000|Overall Study|Death|13
7584772|NCT02535065|11989838|FG000|Overall Study|Lost to Follow-up|1
7584773|NCT02535065|11989838|FG000|Overall Study|Withdrawal by Subject|6
7584774|NCT02451358|11989850|FG000|Overall Study|Withdrawal by Subject|1
7584775|NCT02451358|11989851|FG001|Overall Study|Withdrawal by Subject|1
7584776|NCT02451358|11989852|FG002|Overall Study|Withdrawal by Subject|0
7584777|NCT02451358|11989853|FG003|Overall Study|Withdrawal by Subject|0
7584778|NCT02451358|11989850|FG000|Overall Study|Protocol Violation|0
7584779|NCT02451358|11989851|FG001|Overall Study|Protocol Violation|1
7584780|NCT02451358|11989852|FG002|Overall Study|Protocol Violation|1
7584781|NCT02451358|11989853|FG003|Overall Study|Protocol Violation|0
7584782|NCT02178709|11989872|FG000|Overall Study|Adverse Event|5
7584783|NCT02178709|11989872|FG000|Overall Study|Death|2
7584784|NCT02178709|11989872|FG000|Overall Study|Withdrawal by Subject|2
7584785|NCT02178709|11989872|FG000|Overall Study|Physician Decision|2
7584786|NCT02178709|11989872|FG000|Overall Study|Disease Progression|5
7584787|NCT01980017|11989882|FG000|Overall Study|Lost to Follow-up|30
7584788|NCT01980017|11989883|FG001|Overall Study|Lost to Follow-up|21
7584789|NCT01980017|11989882|FG000|Overall Study|Death|0
7584790|NCT01980017|11989883|FG001|Overall Study|Death|1
7584791|NCT01890759|11989894|FG000|Overall Study|Protocol Violation|0
7584792|NCT01890759|11989895|FG001|Overall Study|Protocol Violation|2
7584793|NCT01890759|11989894|FG000|Overall Study|Lost to Follow-up|0
7584794|NCT01890759|11989895|FG001|Overall Study|Lost to Follow-up|2
7584795|NCT01890759|11989894|FG000|Overall Study|Withdrawal by Subject|2
7584796|NCT01890759|11989895|FG001|Overall Study|Withdrawal by Subject|8
7584797|NCT01721746|11989908|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0
7584798|NCT01721746|11989909|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13
7584799|NCT01721746|11989908|FG000|Pre-Treatment|Withdrawal by Subject|1
7584800|NCT01721746|11989909|FG001|Pre-Treatment|Withdrawal by Subject|16
7584801|NCT01721746|11989908|FG000|Pre-Treatment|Poor/Non-compliance|1
7584802|NCT01721746|11989909|FG001|Pre-Treatment|Poor/Non-compliance|0
7584803|NCT01721746|11989908|FG000|Pre-Treatment|Participant no longer met study criteria|2
7584804|NCT01721746|11989909|FG001|Pre-Treatment|Participant no longer met study criteria|2
7584805|NCT01721746|11989908|FG000|Treatment|Disease Progression|192
7584806|NCT01721746|11989909|FG001|Treatment|Disease Progression|74
7584807|NCT01721746|11989908|FG000|Treatment|Study Drug Toxicity|19
7584808|NCT01721746|11989909|FG001|Treatment|Study Drug Toxicity|11
7584809|NCT01721746|11989908|FG000|Treatment|Adverse Event unrelated to Study Drug|6
7584810|NCT01721746|11989909|FG001|Treatment|Adverse Event unrelated to Study Drug|3
7584811|NCT01721746|11989908|FG000|Treatment|Participant request to discontinue Study treatment|26
7584812|NCT01721746|11989909|FG001|Treatment|Participant request to discontinue Study treatment|7
7584813|NCT01721746|11989908|FG000|Treatment|Participant withdrew consent|4
7584814|NCT01721746|11989909|FG001|Treatment|Participant withdrew consent|2
7584815|NCT01721746|11989908|FG000|Treatment|Maximum Clinical Benefit|9
7584816|NCT01721746|11989909|FG001|Treatment|Maximum Clinical Benefit|3
7584817|NCT01721746|11989908|FG000|Treatment|Poor/Non-compliance|2
7584818|NCT01721746|11989909|FG001|Treatment|Poor/Non-compliance|0
7584819|NCT01721746|11989908|FG000|Treatment|Participant no longer met Study criteria|4
7584820|NCT01721746|11989909|FG001|Treatment|Participant no longer met Study criteria|0
7584821|NCT01721746|11989908|FG000|Treatment|Other reasons|6
7584822|NCT01721746|11989909|FG001|Treatment|Other reasons|2
7584823|NCT01587040|11989920|FG000|Overall Study|Protocol Violation|0
7584824|NCT01587040|11989921|FG001|Overall Study|Protocol Violation|0
7584825|NCT01587040|11989922|FG002|Overall Study|Protocol Violation|1
7584826|NCT01587040|11989923|FG003|Overall Study|Protocol Violation|0
7584827|NCT01587040|11989920|FG000|Overall Study|Adverse Event|0
7584828|NCT01587040|11989921|FG001|Overall Study|Adverse Event|1
7584829|NCT01587040|11989922|FG002|Overall Study|Adverse Event|10
7584830|NCT01587040|11989923|FG003|Overall Study|Adverse Event|0
7584831|NCT01587040|11989920|FG000|Overall Study|Disease progression|12
7584832|NCT01587040|11989921|FG001|Overall Study|Disease progression|1
7584833|NCT01587040|11989922|FG002|Overall Study|Disease progression|15
7584834|NCT01587040|11989923|FG003|Overall Study|Disease progression|3
7584835|NCT01587040|11989920|FG000|Overall Study|Other than specified|5
7584836|NCT01587040|11989921|FG001|Overall Study|Other than specified|1
7584837|NCT01587040|11989922|FG002|Overall Study|Other than specified|11
7584838|NCT01587040|11989923|FG003|Overall Study|Other than specified|1
7584839|NCT01254409|11989941|FG000|Overall Study|Adverse Event|0
7584840|NCT01254409|11989942|FG001|Overall Study|Adverse Event|1
7584841|NCT01254409|11989943|FG002|Overall Study|Adverse Event|0
7584842|NCT01254409|11989944|FG003|Overall Study|Adverse Event|0
7584843|NCT01253161|11989957|FG000|Overall Study|Adverse Event|1
7584844|NCT00728962|11989984|FG000|Implant Placement Surgery|Adverse Event|8
7584845|NCT00728962|11989984|FG000|Implant Placement Surgery|Lost to Follow-up|1
7584846|NCT00728962|11989984|FG000|Implant Placement Surgery|Protocol Violation|1
7584847|NCT00728962|11989984|FG000|Permanent Prosthesis Placement|Adverse Event|3
7584848|NCT00728962|11989984|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
7584849|NCT00728754|11989990|FG000|Permanent Prosthesis Placement|Adverse Event|1
7584850|NCT00728754|11989991|FG001|Permanent Prosthesis Placement|Adverse Event|1
7584851|NCT00728754|11989990|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
7584852|NCT00728754|11989991|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
7584853|NCT00728754|11989990|FG000|One Year Post Placement Follow-up|Adverse Event|1
7584854|NCT00728754|11989991|FG001|One Year Post Placement Follow-up|Adverse Event|0
7584855|NCT00723944|11989999|FG000|Permanent Prosthesis Placement|Adverse Event|1
7584856|NCT00723944|11990000|FG001|Permanent Prosthesis Placement|Adverse Event|7
7584857|NCT00723944|11989999|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
7584858|NCT00723944|11990000|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
7584859|NCT00723944|11989999|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
7584860|NCT00723944|11990000|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
7584861|NCT00467142|11990006|FG000|Overall Study|Withdrawal by Subject|1
7584862|NCT00467142|11990006|FG000|Overall Study|Adverse Event|1
7584863|NCT00467142|11990006|FG000|Overall Study|Protocol Violation|1
7625729|NCT02174861|12037486|FG000|Overall Study|Decision by sponsor|8
7625730|NCT02174861|12037486|FG000|Overall Study|Withdrawal by Subject|124
7625731|NCT02174861|12037486|FG000|Overall Study|Lost to Follow-up|26
7625732|NCT02052739|12037494|FG000|Overall Study|Withdrew due to Adverse Event|3
7625733|NCT02052739|12037495|FG001|Overall Study|Withdrew due to Adverse Event|0
7625734|NCT02052739|12037494|FG000|Overall Study|Participant Died|2
7625735|NCT02052739|12037495|FG001|Overall Study|Participant Died|1
7625736|NCT01944020|12037505|FG000|Overall Study|Withdrawal by Subject|5
7625737|NCT01944020|12037506|FG001|Overall Study|Withdrawal by Subject|0
7625738|NCT01689519|12037514|FG000|Intent to Treat|Death|157
7625739|NCT01689519|12037515|FG001|Intent to Treat|Death|167
7625740|NCT01689519|12037514|FG000|Intent to Treat|Lost to Follow-up|4
7625741|NCT01689519|12037515|FG001|Intent to Treat|Lost to Follow-up|8
7625742|NCT01689519|12037514|FG000|Intent to Treat|Other|2
7625743|NCT01689519|12037515|FG001|Intent to Treat|Other|4
7625744|NCT01689519|12037514|FG000|Intent to Treat|Physician Decision|4
7625745|NCT01689519|12037515|FG001|Intent to Treat|Physician Decision|1
7625746|NCT01689519|12037514|FG000|Intent to Treat|Study terminated by Spon6sor|59
7625747|NCT01689519|12037515|FG001|Intent to Treat|Study terminated by Spon6sor|48
7625748|NCT01689519|12037514|FG000|Intent to Treat|Withdrawal by Subject|21
7625749|NCT01689519|12037515|FG001|Intent to Treat|Withdrawal by Subject|20
7625750|NCT01689519|12037514|FG000|Safety Population|Death|158
7625751|NCT01689519|12037515|FG001|Safety Population|Death|165
7625752|NCT01689519|12037514|FG000|Safety Population|Lost to Follow-up|4
7625753|NCT01689519|12037515|FG001|Safety Population|Lost to Follow-up|8
7625754|NCT01689519|12037514|FG000|Safety Population|Other|2
7625755|NCT01689519|12037515|FG001|Safety Population|Other|4
7625756|NCT01689519|12037514|FG000|Safety Population|Physician Decision|4
7625757|NCT01689519|12037515|FG001|Safety Population|Physician Decision|1
7625758|NCT01689519|12037514|FG000|Safety Population|Study Terminated By Sponsor|60
7625759|NCT01689519|12037515|FG001|Safety Population|Study Terminated By Sponsor|47
7625760|NCT01689519|12037514|FG000|Safety Population|Withdrawal by Subject|20
7625761|NCT01689519|12037515|FG001|Safety Population|Withdrawal by Subject|20
7625762|NCT01622088|12037521|FG000|Overall Study|Adverse Event|20
7625763|NCT01622088|12037521|FG000|Overall Study|Lost to Follow-up|1
7625764|NCT01622088|12037521|FG000|Overall Study|Withdrawal by Subject|20
7625765|NCT01622088|12037521|FG000|Overall Study|Investigator Decision|1
7625766|NCT01622088|12037521|FG000|Overall Study|Death|53
7625767|NCT01622088|12037521|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521
7625768|NCT01486264|12037528|FG000|Overall Study|Death|1
7625769|NCT01486264|12037529|FG001|Overall Study|Death|1
7625770|NCT01486264|12037528|FG000|Overall Study|Adverse Event|3
7625771|NCT01486264|12037529|FG001|Overall Study|Adverse Event|3
7625772|NCT01486264|12037528|FG000|Overall Study|Lack of Efficacy|6
7625773|NCT01486264|12037529|FG001|Overall Study|Lack of Efficacy|10
7625774|NCT01486264|12037528|FG000|Overall Study|Withdrawal by Subject|7
7625775|NCT01486264|12037529|FG001|Overall Study|Withdrawal by Subject|18
7625776|NCT01486264|12037528|FG000|Overall Study|Physician Decision|1
7625777|NCT01486264|12037529|FG001|Overall Study|Physician Decision|1
7625778|NCT01486264|12037528|FG000|Overall Study|Protocol Violation|3
7625779|NCT01486264|12037529|FG001|Overall Study|Protocol Violation|0
7625780|NCT01486264|12037528|FG000|Overall Study|Lost to Follow-up|3
7625781|NCT01486264|12037529|FG001|Overall Study|Lost to Follow-up|2
7625782|NCT01486264|12037528|FG000|Overall Study|Other|5
7625783|NCT01486264|12037529|FG001|Overall Study|Other|11
7625784|NCT01486264|12037528|FG000|Overall Study|Not treated|0
7625785|NCT01486264|12037529|FG001|Overall Study|Not treated|1
7625786|NCT01419080|12037535|FG000|Overall Study|Withdrawal by Subject|75
7625787|NCT01419080|12037535|FG000|Overall Study|Death|30
7625788|NCT01419080|12037535|FG000|Overall Study|Lost to Follow-up|23
7625789|NCT01419080|12037535|FG000|Overall Study|Too Ill|3
7625790|NCT01317160|12037543|FG000|Overall Study|Incorrect inclusion|1
7625791|NCT01317160|12037544|FG001|Overall Study|Incorrect inclusion|1
7625792|NCT01317160|12037543|FG000|Overall Study|Lost to Follow-up|3
7625793|NCT01317160|12037544|FG001|Overall Study|Lost to Follow-up|3
7625794|NCT01317160|12037543|FG000|Overall Study|Withdrawal by Subject|0
7625795|NCT01317160|12037544|FG001|Overall Study|Withdrawal by Subject|2
7625796|NCT01094782|12037584|FG000|Overall Study|Withdrawal by Subject|5
7625797|NCT01094782|12037585|FG001|Overall Study|Withdrawal by Subject|5
7625798|NCT01094782|12037586|FG002|Overall Study|Withdrawal by Subject|1
7625799|NCT01094782|12037587|FG003|Overall Study|Withdrawal by Subject|5
7584864|NCT04557371|11990043|FG000|Overall Study|Covid-19-related|0
7584865|NCT04557371|11990044|FG001|Overall Study|Covid-19-related|1
7584866|NCT04557371|11990045|FG002|Overall Study|Covid-19-related|0
7584867|NCT04557371|11990043|FG000|Overall Study|Withdrawal by Subject|0
7584868|NCT04557371|11990044|FG001|Overall Study|Withdrawal by Subject|1
7584869|NCT04557371|11990045|FG002|Overall Study|Withdrawal by Subject|0
7584870|NCT04557371|11990043|FG000|Overall Study|Adverse Event|1
7584871|NCT04557371|11990044|FG001|Overall Study|Adverse Event|0
7584872|NCT04557371|11990045|FG002|Overall Study|Adverse Event|0
7584873|NCT04369742|11990066|FG000|Overall Study|Lost to Follow-Up (Day 14)|7
7584874|NCT04369742|11990067|FG001|Overall Study|Lost to Follow-Up (Day 14)|4
7584875|NCT04369742|11990066|FG000|Overall Study|Lost to Follow-Up (Day 30)|7
7584876|NCT04369742|11990067|FG001|Overall Study|Lost to Follow-Up (Day 30)|7
7584877|NCT03969589|11990097|FG000|Overall Study|Lost to Follow-up|3
7584878|NCT03969589|11990098|FG001|Overall Study|Lost to Follow-up|2
7584879|NCT03969589|11990097|FG000|Overall Study|Declined Follow-Up|0
7584880|NCT03969589|11990098|FG001|Overall Study|Declined Follow-Up|1
7584881|NCT03655691|11990141|FG000|Overall Study|Adverse Event|0
7584882|NCT03655691|11990142|FG001|Overall Study|Adverse Event|0
7584883|NCT03655691|11990143|FG002|Overall Study|Adverse Event|1
7584884|NCT03655691|11990141|FG000|Overall Study|Lost to Follow-up|1
7584885|NCT03655691|11990142|FG001|Overall Study|Lost to Follow-up|1
7584886|NCT03655691|11990143|FG002|Overall Study|Lost to Follow-up|2
7584887|NCT03655691|11990141|FG000|Overall Study|Protocol Violation|0
7584888|NCT03655691|11990142|FG001|Overall Study|Protocol Violation|1
7584889|NCT03655691|11990143|FG002|Overall Study|Protocol Violation|0
7584890|NCT03655691|11990141|FG000|Overall Study|Withdrawal by Subject|1
7270209|NCT00414609|11484358|FG000|Extension Study|Adverse Event|0
7270210|NCT00414609|11484359|FG001|Extension Study|Adverse Event|0
7270211|NCT00414609|11484360|FG002|Extension Study|Adverse Event|14
7270212|NCT00414609|11484358|FG000|Extension Study|Unsatisfactory therapeutic effect|0
7270213|NCT00414609|11484359|FG001|Extension Study|Unsatisfactory therapeutic effect|0
7270214|NCT00414609|11484360|FG002|Extension Study|Unsatisfactory therapeutic effect|2
7270215|NCT00414609|11484358|FG000|Extension Study|Withdrawal by Subject|0
7270216|NCT00414609|11484359|FG001|Extension Study|Withdrawal by Subject|0
7270217|NCT00414609|11484360|FG002|Extension Study|Withdrawal by Subject|13
7270218|NCT00414609|11484358|FG000|Extension Study|Lost to Follow-up|0
7270219|NCT00414609|11484359|FG001|Extension Study|Lost to Follow-up|0
7270220|NCT00414609|11484360|FG002|Extension Study|Lost to Follow-up|10
7270221|NCT00414609|11484358|FG000|Extension Study|Administrative problems|0
7270222|NCT00414609|11484359|FG001|Extension Study|Administrative problems|0
7270223|NCT00414609|11484360|FG002|Extension Study|Administrative problems|1
7270224|NCT00414609|11484358|FG000|Extension Study|Death|0
7270225|NCT00414609|11484359|FG001|Extension Study|Death|0
7270226|NCT00414609|11484360|FG002|Extension Study|Death|17
7270227|NCT00414661|11484382|FG000|Overall Study|Death|2
7270228|NCT00414661|11484383|FG001|Overall Study|Death|5
7270229|NCT00414661|11484384|FG002|Overall Study|Death|0
7584891|NCT03655691|11990142|FG001|Overall Study|Withdrawal by Subject|1
7584892|NCT03655691|11990143|FG002|Overall Study|Withdrawal by Subject|0
7584893|NCT03364686|11990155|FG000|Overall Study|Physician Decision|2
7584894|NCT03326856|11990173|FG000|Overall Study|Lost to Follow-up|1
7270230|NCT00414661|11484385|FG003|Overall Study|Death|0
7584895|NCT03326856|11990174|FG001|Overall Study|Lost to Follow-up|1
7584896|NCT03326856|11990175|FG002|Overall Study|Lost to Follow-up|0
7584897|NCT03326856|11990176|FG003|Overall Study|Lost to Follow-up|0
7584898|NCT03326856|11990177|FG004|Overall Study|Lost to Follow-up|0
7584905|NCT03240692|11990202|FG000|Overall Study|Physician Decision|1
7584906|NCT03240692|11990202|FG000|Overall Study|Withdrawal by Subject|1
7584907|NCT03227029|11990209|FG000|Overall Study|Child Wheezed (no treatment)|0
7584908|NCT03227029|11990210|FG001|Overall Study|Child Wheezed (no treatment)|1
7584909|NCT03227029|11990211|FG002|Overall Study|Child Wheezed (no treatment)|0
7584910|NCT03227029|11990209|FG000|Overall Study|No post RSV season visit due to COVID|3
7584911|NCT03227029|11990210|FG001|Overall Study|No post RSV season visit due to COVID|3
7584912|NCT03227029|11990211|FG002|Overall Study|No post RSV season visit due to COVID|2
7584913|NCT03227029|11990209|FG000|Overall Study|Not able to get to clinic|0
7584914|NCT03227029|11990210|FG001|Overall Study|Not able to get to clinic|0
7584915|NCT03227029|11990211|FG002|Overall Study|Not able to get to clinic|1
7584916|NCT03227029|11990209|FG000|Overall Study|Withdrawal by Subject|1
7584917|NCT03227029|11990210|FG001|Overall Study|Withdrawal by Subject|0
7584918|NCT03227029|11990211|FG002|Overall Study|Withdrawal by Subject|0
7584919|NCT03227029|11990209|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
7584920|NCT03227029|11990210|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
7584921|NCT03227029|11990211|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
7584922|NCT03182829|11990239|FG000|Overall Study|Protocol Violation|12
7584923|NCT03182829|11990240|FG001|Overall Study|Protocol Violation|12
7584924|NCT03182829|11990239|FG000|Overall Study|Other|4
7584925|NCT03182829|11990240|FG001|Overall Study|Other|3
7584926|NCT03181789|11990250|FG000|Overall Study|Withdrawal by Subject|0
7584927|NCT03181789|11990251|FG001|Overall Study|Withdrawal by Subject|1
7584928|NCT03181789|11990252|FG002|Overall Study|Withdrawal by Subject|1
7584929|NCT03181789|11990253|FG003|Overall Study|Withdrawal by Subject|0
7584930|NCT03181789|11990250|FG000|Overall Study|Lost to Follow-up|7
7584931|NCT03181789|11990251|FG001|Overall Study|Lost to Follow-up|1
7584932|NCT03181789|11990252|FG002|Overall Study|Lost to Follow-up|0
7584933|NCT03181789|11990253|FG003|Overall Study|Lost to Follow-up|0
7584934|NCT03181789|11990250|FG000|Overall Study|Participant unable to adhere to visit|0
7584935|NCT03181789|11990251|FG001|Overall Study|Participant unable to adhere to visit|1
7584936|NCT03181789|11990252|FG002|Overall Study|Participant unable to adhere to visit|0
7584937|NCT03181789|11990253|FG003|Overall Study|Participant unable to adhere to visit|0
7584938|NCT03164356|11990268|FG000|Overall Study|Lost to Follow-up|1
7584939|NCT03164356|11990269|FG001|Overall Study|Lost to Follow-up|1
7584940|NCT03164356|11990270|FG002|Overall Study|Lost to Follow-up|2
7584941|NCT03164356|11990271|FG003|Overall Study|Lost to Follow-up|1
7584942|NCT03164356|11990268|FG000|Overall Study|Physician Decision|0
7584943|NCT03164356|11990269|FG001|Overall Study|Physician Decision|0
7584944|NCT03164356|11990270|FG002|Overall Study|Physician Decision|3
7584945|NCT03164356|11990271|FG003|Overall Study|Physician Decision|0
7584946|NCT03164356|11990268|FG000|Overall Study|Protocol Violation|2
7584947|NCT03164356|11990269|FG001|Overall Study|Protocol Violation|1
7584948|NCT03164356|11990270|FG002|Overall Study|Protocol Violation|0
7584949|NCT03164356|11990271|FG003|Overall Study|Protocol Violation|0
7584950|NCT03164356|11990268|FG000|Overall Study|Withdrawal by Subject|1
7584951|NCT03164356|11990269|FG001|Overall Study|Withdrawal by Subject|0
7584952|NCT03164356|11990270|FG002|Overall Study|Withdrawal by Subject|0
7584953|NCT03164356|11990271|FG003|Overall Study|Withdrawal by Subject|0
7584954|NCT03164356|11990268|FG000|Overall Study|Study timeframe interrupted by COVID-19|1
7584955|NCT03164356|11990269|FG001|Overall Study|Study timeframe interrupted by COVID-19|0
7584956|NCT03164356|11990270|FG002|Overall Study|Study timeframe interrupted by COVID-19|0
7584957|NCT03164356|11990271|FG003|Overall Study|Study timeframe interrupted by COVID-19|1
7584958|NCT03164356|11990268|FG000|Overall Study|Subject Incarcerated|0
7584959|NCT03164356|11990269|FG001|Overall Study|Subject Incarcerated|1
7584960|NCT03164356|11990270|FG002|Overall Study|Subject Incarcerated|0
7584961|NCT03164356|11990271|FG003|Overall Study|Subject Incarcerated|0
7584962|NCT03164356|11990268|FG000|Overall Study|Prosthetist unable to participate|0
7584963|NCT03164356|11990269|FG001|Overall Study|Prosthetist unable to participate|2
7584964|NCT03164356|11990270|FG002|Overall Study|Prosthetist unable to participate|1
7584965|NCT03164356|11990271|FG003|Overall Study|Prosthetist unable to participate|0
7625800|NCT01094782|12037588|FG004|Overall Study|Withdrawal by Subject|5
7625801|NCT01094782|12037589|FG005|Overall Study|Withdrawal by Subject|0
7625802|NCT01094782|12037584|FG000|Overall Study|Lost to Follow-up|1
7625803|NCT01094782|12037585|FG001|Overall Study|Lost to Follow-up|0
7625804|NCT01094782|12037586|FG002|Overall Study|Lost to Follow-up|0
7625805|NCT01094782|12037587|FG003|Overall Study|Lost to Follow-up|2
7625806|NCT01094782|12037588|FG004|Overall Study|Lost to Follow-up|1
7625807|NCT01094782|12037589|FG005|Overall Study|Lost to Follow-up|4
7625808|NCT01094782|12037584|FG000|Overall Study|Positive Drug Screen|2
7625809|NCT01094782|12037585|FG001|Overall Study|Positive Drug Screen|2
7625810|NCT01094782|12037586|FG002|Overall Study|Positive Drug Screen|1
7625811|NCT01094782|12037587|FG003|Overall Study|Positive Drug Screen|1
7625812|NCT01094782|12037588|FG004|Overall Study|Positive Drug Screen|3
7584966|NCT02975700|11990291|FG000|Overall Study|Adverse Event|1
7584967|NCT02975700|11990291|FG000|Overall Study|Progressive disease|3
7584968|NCT02975700|11990291|FG000|Overall Study|Failed screening criteria|2
7584969|NCT02941549|11990298|FG000|Overall Study|Adverse Event|1
7584970|NCT02941549|11990299|FG001|Overall Study|Adverse Event|0
7584971|NCT02941549|11990300|FG002|Overall Study|Adverse Event|0
7584972|NCT02941549|11990298|FG000|Overall Study|Withdrawal by Subject|2
7584973|NCT02941549|11990299|FG001|Overall Study|Withdrawal by Subject|1
7584974|NCT02941549|11990300|FG002|Overall Study|Withdrawal by Subject|2
7584975|NCT02927938|11990324|FG000|Overall Study|Death|0
7584976|NCT02927938|11990325|FG001|Overall Study|Death|1
7584977|NCT02927938|11990326|FG002|Overall Study|Death|0
7584978|NCT02927938|11990327|FG003|Overall Study|Death|4
7584979|NCT02927938|11990324|FG000|Overall Study|Early Study Termination|1
7584980|NCT02927938|11990325|FG001|Overall Study|Early Study Termination|5
7584981|NCT02927938|11990326|FG002|Overall Study|Early Study Termination|4
7584982|NCT02927938|11990327|FG003|Overall Study|Early Study Termination|3
7584983|NCT02823574|11990367|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1
7584984|NCT02823574|11990368|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584985|NCT02823574|11990369|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584986|NCT02823574|11990370|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
7584987|NCT02823574|11990367|FG000|Pre-Treatment Period|Disease progression|0
7584988|NCT02823574|11990368|FG001|Pre-Treatment Period|Disease progression|0
7584989|NCT02823574|11990369|FG002|Pre-Treatment Period|Disease progression|1
7584990|NCT02823574|11990370|FG003|Pre-Treatment Period|Disease progression|0
7584991|NCT02823574|11990367|FG000|Treatment Period|Poor/Non Compliance|1
7584992|NCT02823574|11990368|FG001|Treatment Period|Poor/Non Compliance|0
7584993|NCT02823574|11990369|FG002|Treatment Period|Poor/Non Compliance|0
7584994|NCT02823574|11990370|FG003|Treatment Period|Poor/Non Compliance|1
7584995|NCT02823574|11990367|FG000|Treatment Period|Maximum Clinical Benefit|1
7584996|NCT02823574|11990368|FG001|Treatment Period|Maximum Clinical Benefit|0
7584997|NCT02823574|11990369|FG002|Treatment Period|Maximum Clinical Benefit|2
7584998|NCT02823574|11990370|FG003|Treatment Period|Maximum Clinical Benefit|0
7584999|NCT02823574|11990367|FG000|Treatment Period|Lost to Follow-up|1
7585000|NCT02823574|11990368|FG001|Treatment Period|Lost to Follow-up|0
7585001|NCT02823574|11990369|FG002|Treatment Period|Lost to Follow-up|0
7585002|NCT02823574|11990370|FG003|Treatment Period|Lost to Follow-up|0
7585003|NCT02823574|11990367|FG000|Treatment Period|Participant withdrew consent|2
7625813|NCT01094782|12037589|FG005|Overall Study|Positive Drug Screen|2
7625814|NCT01094782|12037584|FG000|Overall Study|Sensory Deficit at Site of QST|0
7625815|NCT01094782|12037585|FG001|Overall Study|Sensory Deficit at Site of QST|1
7625816|NCT01094782|12037586|FG002|Overall Study|Sensory Deficit at Site of QST|0
7625817|NCT01094782|12037587|FG003|Overall Study|Sensory Deficit at Site of QST|0
7625818|NCT01094782|12037588|FG004|Overall Study|Sensory Deficit at Site of QST|0
7625819|NCT01094782|12037589|FG005|Overall Study|Sensory Deficit at Site of QST|0
7625820|NCT01094782|12037584|FG000|Overall Study|Unable to Complete Questionnaires|0
7625821|NCT01094782|12037585|FG001|Overall Study|Unable to Complete Questionnaires|1
7625822|NCT01094782|12037586|FG002|Overall Study|Unable to Complete Questionnaires|0
7625823|NCT01094782|12037587|FG003|Overall Study|Unable to Complete Questionnaires|0
7585004|NCT02823574|11990368|FG001|Treatment Period|Participant withdrew consent|0
7585005|NCT02823574|11990369|FG002|Treatment Period|Participant withdrew consent|0
7585006|NCT02823574|11990370|FG003|Treatment Period|Participant withdrew consent|0
7585007|NCT02823574|11990367|FG000|Treatment Period|Participant request to discontinue|4
7585008|NCT02823574|11990368|FG001|Treatment Period|Participant request to discontinue|0
7585009|NCT02823574|11990369|FG002|Treatment Period|Participant request to discontinue|2
7585010|NCT02823574|11990370|FG003|Treatment Period|Participant request to discontinue|3
7585011|NCT02823574|11990367|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10
7585012|NCT02823574|11990368|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2
7585013|NCT02823574|11990369|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8
7585014|NCT02823574|11990370|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1
7585015|NCT02823574|11990367|FG000|Treatment Period|Study Drug Toxicity|7
7585016|NCT02823574|11990368|FG001|Treatment Period|Study Drug Toxicity|2
7585017|NCT02823574|11990369|FG002|Treatment Period|Study Drug Toxicity|13
7585018|NCT02823574|11990370|FG003|Treatment Period|Study Drug Toxicity|3
7585019|NCT02823574|11990367|FG000|Treatment Period|Disease Progression|112
7585020|NCT02823574|11990368|FG001|Treatment Period|Disease Progression|60
7585021|NCT02823574|11990369|FG002|Treatment Period|Disease Progression|80
7585022|NCT02823574|11990370|FG003|Treatment Period|Disease Progression|41
7585023|NCT02823574|11990367|FG000|Treatment Period|participant no longer meets study criteria|0
7585024|NCT02823574|11990368|FG001|Treatment Period|participant no longer meets study criteria|0
7585025|NCT02823574|11990369|FG002|Treatment Period|participant no longer meets study criteria|1
7585026|NCT02823574|11990370|FG003|Treatment Period|participant no longer meets study criteria|0
7585027|NCT02823574|11990367|FG000|Treatment Period|Death|0
7585028|NCT02823574|11990368|FG001|Treatment Period|Death|0
7585029|NCT02823574|11990369|FG002|Treatment Period|Death|2
7585030|NCT02823574|11990370|FG003|Treatment Period|Death|1
7585031|NCT02823574|11990367|FG000|Treatment Period|Other reasons|1
7585032|NCT02823574|11990368|FG001|Treatment Period|Other reasons|2
7585033|NCT02823574|11990369|FG002|Treatment Period|Other reasons|0
7585034|NCT02823574|11990370|FG003|Treatment Period|Other reasons|1
7585035|NCT02743819|11990392|FG000|Overall Study|Lack of Efficacy|5
7585036|NCT02743819|11990392|FG000|Overall Study|Death|2
7585037|NCT02743819|11990392|FG000|Overall Study|Adverse Event|1
7585038|NCT02729753|11990398|FG000|Overall Study|Device Malfunction. No units in stock.|0
7270231|NCT00414661|11484382|FG000|Overall Study|Lost to Follow-up|1
7270232|NCT00414661|11484383|FG001|Overall Study|Lost to Follow-up|4
7270233|NCT00414661|11484384|FG002|Overall Study|Lost to Follow-up|0
7270234|NCT00414661|11484385|FG003|Overall Study|Lost to Follow-up|1
7270235|NCT00414661|11484382|FG000|Overall Study|Withdrawal by Subject|5
7270236|NCT00414661|11484383|FG001|Overall Study|Withdrawal by Subject|2
7270237|NCT00414661|11484384|FG002|Overall Study|Withdrawal by Subject|2
7270238|NCT00414661|11484385|FG003|Overall Study|Withdrawal by Subject|2
7270239|NCT00414661|11484382|FG000|Overall Study|Other|6
7270240|NCT00414661|11484383|FG001|Overall Study|Other|3
7270241|NCT00414661|11484384|FG002|Overall Study|Other|0
7270242|NCT00414661|11484385|FG003|Overall Study|Other|0
7270243|NCT00414726|11484406|FG000|Overall Study|Withdrawal by Subject|0
7270244|NCT00414726|11484407|FG001|Overall Study|Withdrawal by Subject|1
7270245|NCT00414765|11484415|FG000|Overall Study|Adverse Event|5
7270246|NCT00414765|11484416|FG001|Overall Study|Adverse Event|9
7270247|NCT00414765|11484415|FG000|Overall Study|Withdrawal by Subject|1
7270248|NCT00414765|11484416|FG001|Overall Study|Withdrawal by Subject|1
7270249|NCT00414765|11484415|FG000|Overall Study|Disease Progression|0
7270250|NCT00414765|11484416|FG001|Overall Study|Disease Progression|1
7270251|NCT00414908|11484433|FG000|Overall Study|Protocol Violation|1
7270252|NCT00414908|11484434|FG001|Overall Study|Protocol Violation|1
7270253|NCT00414960|11484444|FG000|Overall Study|Adverse Event|4
7270254|NCT00414960|11484445|FG001|Overall Study|Adverse Event|0
7270255|NCT00414960|11484444|FG000|Overall Study|Withdrawal by Subject|3
7270256|NCT00414960|11484445|FG001|Overall Study|Withdrawal by Subject|0
7270257|NCT00414960|11484444|FG000|Overall Study|Physician Decision|0
7270258|NCT00414960|11484445|FG001|Overall Study|Physician Decision|1
7270259|NCT00414973|11484455|FG000|Overall Study|Withdrawal by Subject|14
7270260|NCT00414973|11484456|FG001|Overall Study|Withdrawal by Subject|4
7270261|NCT00414973|11484457|FG002|Overall Study|Withdrawal by Subject|1
7270262|NCT00414973|11484458|FG003|Overall Study|Withdrawal by Subject|0
7270263|NCT00414973|11484455|FG000|Overall Study|Adverse Event|10
7270264|NCT00414973|11484456|FG001|Overall Study|Adverse Event|0
7270265|NCT00414973|11484457|FG002|Overall Study|Adverse Event|1
7270266|NCT00414973|11484458|FG003|Overall Study|Adverse Event|0
7270267|NCT00414973|11484455|FG000|Overall Study|Protocol Violation|3
7270268|NCT00414973|11484456|FG001|Overall Study|Protocol Violation|4
7270269|NCT00414973|11484457|FG002|Overall Study|Protocol Violation|0
7270270|NCT00414973|11484458|FG003|Overall Study|Protocol Violation|0
7270271|NCT00414973|11484455|FG000|Overall Study|Lost to Follow-up|0
7585039|NCT02729753|11990399|FG001|Overall Study|Device Malfunction. No units in stock.|1
7585040|NCT02704130|11990410|FG000|Overall Study|Physician Decision|5
7585041|NCT02704130|11990411|FG001|Overall Study|Physician Decision|3
7585042|NCT02701192|11990417|FG000|Overall Study|Protocol Violation|2
7585043|NCT02701192|11990417|FG000|Overall Study|Lost to Follow-up|4
7585044|NCT02653482|11990451|FG000|Overall Study|Death|1
7585045|NCT02653482|11990452|FG001|Overall Study|Death|1
7585046|NCT02632409|11990460|FG000|Randomized|AE unrelated to study Drug|0
7585047|NCT02632409|11990461|FG001|Randomized|AE unrelated to study Drug|1
7585048|NCT02632409|11990460|FG000|Randomized|Participant withdrew consent|2
7585049|NCT02632409|11990461|FG001|Randomized|Participant withdrew consent|1
7585050|NCT02632409|11990460|FG000|Randomized|No Longer meets study criteria|5
7585051|NCT02632409|11990461|FG001|Randomized|No Longer meets study criteria|0
7585052|NCT02632409|11990460|FG000|Randomized|other reasons|1
7585053|NCT02632409|11990461|FG001|Randomized|other reasons|0
7585054|NCT02632409|11990460|FG000|Treatment Period|Ongoing Treatment|20
7585055|NCT02632409|11990461|FG001|Treatment Period|Ongoing Treatment|21
7585056|NCT02632409|11990460|FG000|Treatment Period|Disease Recurrence|147
7585057|NCT02632409|11990461|FG001|Treatment Period|Disease Recurrence|90
7585058|NCT02632409|11990460|FG000|Treatment Period|Study Drug Toxicity|8
7585059|NCT02632409|11990461|FG001|Treatment Period|Study Drug Toxicity|49
7585060|NCT02632409|11990460|FG000|Treatment Period|Death|1
7585061|NCT02632409|11990461|FG001|Treatment Period|Death|0
7585062|NCT02632409|11990460|FG000|Treatment Period|AE unrelated to study drug|15
7585063|NCT02632409|11990461|FG001|Treatment Period|AE unrelated to study drug|16
7585064|NCT02632409|11990460|FG000|Treatment Period|Request to discontinue treatment|4
7585065|NCT02632409|11990461|FG001|Treatment Period|Request to discontinue treatment|19
7585066|NCT02632409|11990460|FG000|Treatment Period|Participant withdrew consent|7
7585067|NCT02632409|11990461|FG001|Treatment Period|Participant withdrew consent|5
7585068|NCT02632409|11990460|FG000|Treatment Period|Lost to Follow-up|0
7585069|NCT02632409|11990461|FG001|Treatment Period|Lost to Follow-up|1
7585070|NCT02632409|11990460|FG000|Treatment Period|Maximum clinical benefit|1
7585071|NCT02632409|11990461|FG001|Treatment Period|Maximum clinical benefit|0
7585072|NCT02632409|11990460|FG000|Treatment Period|No longer meets study criteria|3
7585073|NCT02632409|11990461|FG001|Treatment Period|No longer meets study criteria|0
7585074|NCT02632409|11990460|FG000|Treatment Period|Administrative Reason by sponsor|0
7585075|NCT02632409|11990461|FG001|Treatment Period|Administrative Reason by sponsor|1
7585076|NCT02632409|11990460|FG000|Treatment Period|Other Reasons|10
7585077|NCT02632409|11990461|FG001|Treatment Period|Other Reasons|6
7585078|NCT02612194|11990470|FG000|Overall Study|Death|5
7585079|NCT02612194|11990471|FG001|Overall Study|Death|0
7585080|NCT02612194|11990472|FG002|Overall Study|Death|2
7585081|NCT02612194|11990470|FG000|Overall Study|Early Study Termination|1
7585082|NCT02612194|11990471|FG001|Overall Study|Early Study Termination|0
7585083|NCT02612194|11990472|FG002|Overall Study|Early Study Termination|0
7585084|NCT02586207|11990479|FG000|Overall Study|Physician Decision|1
7585085|NCT02586207|11990479|FG000|Overall Study|Withdrawal by Subject|1
7585086|NCT02542397|11990483|FG000|Overall Study|Death|2
7585087|NCT02542397|11990483|FG000|Overall Study|Physician Decision|6
7585088|NCT02542397|11990483|FG000|Overall Study|Withdrawal by Subject|6
7585089|NCT02542397|11990483|FG000|Overall Study|Lost to Follow-up|2
7585090|NCT02519777|11990491|FG000|Overall Study|Death|1
7585091|NCT02519777|11990492|FG001|Overall Study|Death|0
7585092|NCT02519777|11990493|FG002|Overall Study|Death|0
7585093|NCT02519777|11990491|FG000|Overall Study|Lost to Follow-up|0
7585094|NCT02519777|11990492|FG001|Overall Study|Lost to Follow-up|4
7585095|NCT02519777|11990493|FG002|Overall Study|Lost to Follow-up|2
7585096|NCT02519777|11990491|FG000|Overall Study|Withdrawal by Subject|3
7585097|NCT02519777|11990492|FG001|Overall Study|Withdrawal by Subject|1
7585098|NCT02519777|11990493|FG002|Overall Study|Withdrawal by Subject|0
7585099|NCT02519777|11990491|FG000|Overall Study|Severe Debilitation|1
7585100|NCT02519777|11990492|FG001|Overall Study|Severe Debilitation|1
7585101|NCT02519777|11990493|FG002|Overall Study|Severe Debilitation|1
7585102|NCT02519777|11990491|FG000|Overall Study|Not able to get to clinic|1
7585103|NCT02519777|11990492|FG001|Overall Study|Not able to get to clinic|2
7585104|NCT02519777|11990493|FG002|Overall Study|Not able to get to clinic|1
7585108|NCT02395666|11990507|FG000|Overall Study|Physician Decision|3
7585109|NCT02395666|11990508|FG001|Overall Study|Physician Decision|0
7585110|NCT02395666|11990507|FG000|Overall Study|Lost to Follow-up|1
7585111|NCT02395666|11990508|FG001|Overall Study|Lost to Follow-up|0
7585112|NCT02395666|11990507|FG000|Overall Study|Withdrawal by Subject|2
7585113|NCT02395666|11990508|FG001|Overall Study|Withdrawal by Subject|1
7585114|NCT02357810|11990518|FG000|Registered and Started Treatment|Withdrawal by Subject|1
7585115|NCT02357810|11990518|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
7585116|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Adverse Event|5
7585117|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Progressive Disease|39
7585118|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
7585119|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Protocol Violation|1
7585120|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Death|1
7585121|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Physician Decision|1
7585122|NCT02357810|11990518|FG000|Reached 12 Weeks Response|Other|1
7585123|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Adverse Event|5
7585124|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
7585125|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Progressive Disease|15
7585126|NCT02357810|11990518|FG000|12 Week Response and Further Treatment|Wound Complications|1
7585127|NCT02357810|11990518|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
7585128|NCT02357810|11990518|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
7585129|NCT02343549|11990522|FG000|Overall Study|Death|11
7585130|NCT02343549|11990522|FG000|Overall Study|Withdrawal by Subject|2
7625824|NCT01094782|12037588|FG004|Overall Study|Unable to Complete Questionnaires|0
7625825|NCT01094782|12037589|FG005|Overall Study|Unable to Complete Questionnaires|0
7625826|NCT01094782|12037584|FG000|Overall Study|Healthy Subject Had Pain|0
7625827|NCT01094782|12037585|FG001|Overall Study|Healthy Subject Had Pain|1
7625828|NCT01094782|12037586|FG002|Overall Study|Healthy Subject Had Pain|0
7625829|NCT01094782|12037587|FG003|Overall Study|Healthy Subject Had Pain|0
7625830|NCT01094782|12037588|FG004|Overall Study|Healthy Subject Had Pain|0
7625831|NCT01094782|12037589|FG005|Overall Study|Healthy Subject Had Pain|0
7625832|NCT01094782|12037584|FG000|Overall Study|Hypertension|0
7625833|NCT01094782|12037585|FG001|Overall Study|Hypertension|0
7625834|NCT01094782|12037586|FG002|Overall Study|Hypertension|1
7625835|NCT01094782|12037587|FG003|Overall Study|Hypertension|0
7625836|NCT01094782|12037588|FG004|Overall Study|Hypertension|0
7625837|NCT01094782|12037589|FG005|Overall Study|Hypertension|0
7625838|NCT01094782|12037584|FG000|Overall Study|Wrong Pain Condition|0
7625839|NCT01094782|12037585|FG001|Overall Study|Wrong Pain Condition|0
7625840|NCT01094782|12037586|FG002|Overall Study|Wrong Pain Condition|0
7625841|NCT01094782|12037587|FG003|Overall Study|Wrong Pain Condition|2
7625842|NCT01094782|12037588|FG004|Overall Study|Wrong Pain Condition|1
7625843|NCT01094782|12037589|FG005|Overall Study|Wrong Pain Condition|1
7625844|NCT01094782|12037584|FG000|Overall Study|Recent Interventional Injection|0
7625845|NCT01094782|12037585|FG001|Overall Study|Recent Interventional Injection|0
7625846|NCT01094782|12037586|FG002|Overall Study|Recent Interventional Injection|0
7625847|NCT01094782|12037587|FG003|Overall Study|Recent Interventional Injection|0
7625848|NCT01094782|12037588|FG004|Overall Study|Recent Interventional Injection|0
7625849|NCT01094782|12037589|FG005|Overall Study|Recent Interventional Injection|1
7625850|NCT01094782|12037584|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625851|NCT01094782|12037585|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625852|NCT01094782|12037586|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625853|NCT01094782|12037587|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625854|NCT01094782|12037588|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
7625855|NCT01094782|12037589|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
7625856|NCT01094782|12037584|FG000|Overall Study|Noncompliance With Study Schedule|0
7625857|NCT01094782|12037585|FG001|Overall Study|Noncompliance With Study Schedule|0
7625858|NCT01094782|12037586|FG002|Overall Study|Noncompliance With Study Schedule|0
7625859|NCT01094782|12037587|FG003|Overall Study|Noncompliance With Study Schedule|1
7625860|NCT01094782|12037588|FG004|Overall Study|Noncompliance With Study Schedule|0
7625861|NCT01094782|12037589|FG005|Overall Study|Noncompliance With Study Schedule|0
7625862|NCT00932737|12037625|FG000|Overall Study|Not treated in second episode|1
7625863|NCT00932737|12037626|FG001|Overall Study|Not treated in second episode|0
7625864|NCT00932737|12037625|FG000|Overall Study|Adverse Event|0
7625865|NCT00932737|12037626|FG001|Overall Study|Adverse Event|1
7625866|NCT00710710|12037652|FG000|Overall Study|Consent withdrawn|2
7625867|NCT00710710|12037653|FG001|Overall Study|Consent withdrawn|2
7625868|NCT00710710|12037652|FG000|Overall Study|Protocol Violation|0
7625869|NCT00710710|12037653|FG001|Overall Study|Protocol Violation|1
7625870|NCT00710710|12037652|FG000|Overall Study|Adverse Event|3
7625871|NCT00710710|12037653|FG001|Overall Study|Adverse Event|3
7625872|NCT00710710|12037652|FG000|Overall Study|Progressive disease|40
7625873|NCT00710710|12037653|FG001|Overall Study|Progressive disease|38
7625874|NCT00608023|12037662|FG000|Overall Study|Withdrawal by Subject|8
7625875|NCT00608023|12037663|FG001|Overall Study|Withdrawal by Subject|10
7625876|NCT00608023|12037664|FG002|Overall Study|Withdrawal by Subject|7
7625877|NCT00608023|12037662|FG000|Overall Study|Adverse Event|1
7625878|NCT00608023|12037663|FG001|Overall Study|Adverse Event|4
7625879|NCT00608023|12037664|FG002|Overall Study|Adverse Event|5
7625880|NCT00608023|12037662|FG000|Overall Study|Lost to Follow-up|2
7625881|NCT00608023|12037663|FG001|Overall Study|Lost to Follow-up|2
7625882|NCT00608023|12037664|FG002|Overall Study|Lost to Follow-up|1
7625883|NCT00608023|12037662|FG000|Overall Study|Protocol Violation|1
7625884|NCT00608023|12037663|FG001|Overall Study|Protocol Violation|3
7625885|NCT00608023|12037664|FG002|Overall Study|Protocol Violation|1
7625886|NCT00608023|12037662|FG000|Overall Study|Unknown reason|0
7625887|NCT00608023|12037663|FG001|Overall Study|Unknown reason|3
7625888|NCT00608023|12037664|FG002|Overall Study|Unknown reason|0
7625889|NCT00551616|12037677|FG000|Overall Study|Lost to Follow-up|48
7585134|NCT02315066|11990548|FG000|Overall Study|Lost to Follow-up|0
7585135|NCT02315066|11990549|FG001|Overall Study|Lost to Follow-up|1
7585136|NCT02315066|11990550|FG002|Overall Study|Lost to Follow-up|1
7585137|NCT02315066|11990551|FG003|Overall Study|Lost to Follow-up|0
7585138|NCT02315066|11990552|FG004|Overall Study|Lost to Follow-up|1
7585139|NCT02315066|11990553|FG005|Overall Study|Lost to Follow-up|0
7585140|NCT02315066|11990554|FG006|Overall Study|Lost to Follow-up|2
7585141|NCT02315066|11990555|FG007|Overall Study|Lost to Follow-up|1
7585142|NCT02315066|11990556|FG008|Overall Study|Lost to Follow-up|0
7585143|NCT02315066|11990557|FG009|Overall Study|Lost to Follow-up|0
7585144|NCT02315066|11990558|FG010|Overall Study|Lost to Follow-up|1
7585145|NCT02315066|11990559|FG011|Overall Study|Lost to Follow-up|2
7585146|NCT02315066|11990560|FG012|Overall Study|Lost to Follow-up|0
7585147|NCT02315066|11990561|FG013|Overall Study|Lost to Follow-up|4
7585148|NCT02315066|11990548|FG000|Overall Study|Death|2
7585149|NCT02315066|11990549|FG001|Overall Study|Death|7
7585150|NCT02315066|11990550|FG002|Overall Study|Death|6
7585151|NCT02315066|11990551|FG003|Overall Study|Death|11
7585152|NCT02315066|11990552|FG004|Overall Study|Death|10
7585153|NCT02315066|11990553|FG005|Overall Study|Death|3
7585154|NCT02315066|11990554|FG006|Overall Study|Death|9
7585155|NCT02315066|11990555|FG007|Overall Study|Death|9
7585156|NCT02315066|11990556|FG008|Overall Study|Death|10
7585157|NCT02315066|11990557|FG009|Overall Study|Death|8
7585158|NCT02315066|11990558|FG010|Overall Study|Death|10
7585159|NCT02315066|11990559|FG011|Overall Study|Death|7
7585160|NCT02315066|11990560|FG012|Overall Study|Death|8
7585161|NCT02315066|11990561|FG013|Overall Study|Death|21
7585162|NCT02315066|11990548|FG000|Overall Study|Other|0
7585163|NCT02315066|11990549|FG001|Overall Study|Other|0
7585164|NCT02315066|11990550|FG002|Overall Study|Other|0
7585165|NCT02315066|11990551|FG003|Overall Study|Other|0
7585166|NCT02315066|11990552|FG004|Overall Study|Other|0
7585167|NCT02315066|11990553|FG005|Overall Study|Other|0
7585168|NCT02315066|11990554|FG006|Overall Study|Other|0
7585169|NCT02315066|11990555|FG007|Overall Study|Other|1
7585170|NCT02315066|11990556|FG008|Overall Study|Other|1
7585171|NCT02315066|11990557|FG009|Overall Study|Other|2
7585172|NCT02315066|11990558|FG010|Overall Study|Other|0
7585173|NCT02315066|11990559|FG011|Overall Study|Other|0
7585174|NCT02315066|11990560|FG012|Overall Study|Other|0
7585175|NCT02315066|11990561|FG013|Overall Study|Other|0
7585176|NCT02315066|11990548|FG000|Overall Study|Subject refused further follow-up|0
7585177|NCT02315066|11990549|FG001|Overall Study|Subject refused further follow-up|2
7585178|NCT02315066|11990550|FG002|Overall Study|Subject refused further follow-up|2
7585179|NCT02315066|11990551|FG003|Overall Study|Subject refused further follow-up|0
7585180|NCT02315066|11990552|FG004|Overall Study|Subject refused further follow-up|0
7585181|NCT02315066|11990553|FG005|Overall Study|Subject refused further follow-up|0
7585182|NCT02315066|11990554|FG006|Overall Study|Subject refused further follow-up|2
7585183|NCT02315066|11990555|FG007|Overall Study|Subject refused further follow-up|3
7585184|NCT02315066|11990556|FG008|Overall Study|Subject refused further follow-up|0
7585185|NCT02315066|11990557|FG009|Overall Study|Subject refused further follow-up|1
7585186|NCT02315066|11990558|FG010|Overall Study|Subject refused further follow-up|1
7585187|NCT02315066|11990559|FG011|Overall Study|Subject refused further follow-up|2
7585188|NCT02315066|11990560|FG012|Overall Study|Subject refused further follow-up|2
7585189|NCT02315066|11990561|FG013|Overall Study|Subject refused further follow-up|4
7585190|NCT02315066|11990548|FG000|Overall Study|Study ongoing at date of cut-off|0
7585191|NCT02315066|11990549|FG001|Overall Study|Study ongoing at date of cut-off|0
7585192|NCT02315066|11990550|FG002|Overall Study|Study ongoing at date of cut-off|0
7585193|NCT02315066|11990551|FG003|Overall Study|Study ongoing at date of cut-off|0
7585194|NCT02315066|11990552|FG004|Overall Study|Study ongoing at date of cut-off|0
7585195|NCT02315066|11990553|FG005|Overall Study|Study ongoing at date of cut-off|0
7585196|NCT02315066|11990554|FG006|Overall Study|Study ongoing at date of cut-off|0
7585197|NCT02315066|11990555|FG007|Overall Study|Study ongoing at date of cut-off|0
7585198|NCT02315066|11990556|FG008|Overall Study|Study ongoing at date of cut-off|0
7585199|NCT02315066|11990557|FG009|Overall Study|Study ongoing at date of cut-off|0
7585200|NCT02315066|11990558|FG010|Overall Study|Study ongoing at date of cut-off|0
7585201|NCT02315066|11990559|FG011|Overall Study|Study ongoing at date of cut-off|0
7585202|NCT02315066|11990560|FG012|Overall Study|Study ongoing at date of cut-off|0
7585203|NCT02315066|11990561|FG013|Overall Study|Study ongoing at date of cut-off|1
7585204|NCT02256631|11990607|FG000|Overall Study|Lost to Follow-up|1
7585205|NCT02256631|11990608|FG001|Overall Study|Lost to Follow-up|1
7585206|NCT02256631|11990609|FG002|Overall Study|Lost to Follow-up|0
7585207|NCT02256631|11990610|FG003|Overall Study|Lost to Follow-up|2
7585208|NCT02256631|11990611|FG004|Overall Study|Lost to Follow-up|0
7585209|NCT02256631|11990612|FG005|Overall Study|Lost to Follow-up|1
7585210|NCT02256631|11990613|FG006|Overall Study|Lost to Follow-up|1
7585211|NCT02256631|11990607|FG000|Overall Study|Withdrawal by Subject|0
7585212|NCT02256631|11990608|FG001|Overall Study|Withdrawal by Subject|0
7585213|NCT02256631|11990609|FG002|Overall Study|Withdrawal by Subject|0
7585214|NCT02256631|11990610|FG003|Overall Study|Withdrawal by Subject|1
7585215|NCT02256631|11990611|FG004|Overall Study|Withdrawal by Subject|1
7585216|NCT02256631|11990612|FG005|Overall Study|Withdrawal by Subject|0
7585217|NCT02256631|11990613|FG006|Overall Study|Withdrawal by Subject|1
7585218|NCT02256631|11990607|FG000|Overall Study|Unable to get to clinic|0
7585219|NCT02256631|11990608|FG001|Overall Study|Unable to get to clinic|2
7585220|NCT02256631|11990609|FG002|Overall Study|Unable to get to clinic|0
7585221|NCT02256631|11990610|FG003|Overall Study|Unable to get to clinic|1
7585222|NCT02256631|11990611|FG004|Overall Study|Unable to get to clinic|0
7585223|NCT02256631|11990612|FG005|Overall Study|Unable to get to clinic|1
7585224|NCT02256631|11990613|FG006|Overall Study|Unable to get to clinic|2
7585233|NCT02080260|11990648|FG000|Overall Study|Death|18
7585234|NCT02080260|11990648|FG000|Overall Study|Withdrawal by Subject|1
7585235|NCT02051933|11990654|FG000|Overall Study|Physician Decision|0
7585236|NCT02051933|11990655|FG001|Overall Study|Physician Decision|1
7585243|NCT01774253|11990734|FG000|Overall Study|Lack of Efficacy|4
7585244|NCT01774253|11990734|FG000|Overall Study|Physician Decision|2
7585245|NCT01774253|11990734|FG000|Overall Study|Withdrawal by Subject|2
7585246|NCT01774253|11990734|FG000|Overall Study|Death|1
7585247|NCT01505608|11990744|FG000|Phase I|Lack of Efficacy|0
7585248|NCT01505608|11990745|FG001|Phase I|Lack of Efficacy|4
7585249|NCT01505608|11990744|FG000|Phase I|Adverse Event|0
7585250|NCT01505608|11990745|FG001|Phase I|Adverse Event|1
7585251|NCT01505608|11990744|FG000|Phase I|Withdrawal by Subject|0
7585252|NCT01505608|11990745|FG001|Phase I|Withdrawal by Subject|1
7585253|NCT01505608|11990744|FG000|Phase II|Lack of Efficacy|2
7585254|NCT01505608|11990745|FG001|Phase II|Lack of Efficacy|1
7585255|NCT01505608|11990744|FG000|Phase II|Protocol Violation|0
7585256|NCT01505608|11990745|FG001|Phase II|Protocol Violation|1
7585257|NCT01483820|11990754|FG000|Overall Study|Lack of Efficacy|6
7585258|NCT01483820|11990754|FG000|Overall Study|Adverse Event|1
7585259|NCT01483820|11990754|FG000|Overall Study|Death|1
7585260|NCT01355679|11990758|FG000|Overall Study|benign tumor types found at biopsy|2
7585261|NCT01166386|11990783|FG000|Overall Study|Withdrawal by Subject|3
7585262|NCT01166386|11990784|FG001|Overall Study|Withdrawal by Subject|5
7585263|NCT01114217|11990792|FG000|Overall Study|Adverse Event|5
7585264|NCT01114217|11990793|FG001|Overall Study|Adverse Event|3
7585265|NCT01114217|11990792|FG000|Overall Study|Lost to Follow-up|17
7585266|NCT01114217|11990793|FG001|Overall Study|Lost to Follow-up|33
7585267|NCT01114217|11990792|FG000|Overall Study|Withdrawal by Subject|21
7585268|NCT01114217|11990793|FG001|Overall Study|Withdrawal by Subject|28
7585269|NCT01114217|11990792|FG000|Overall Study|Other-Clerical Error|3
7585270|NCT01114217|11990793|FG001|Overall Study|Other-Clerical Error|0
7585271|NCT01114217|11990792|FG000|Overall Study|Other-Early termination|6
7585272|NCT01114217|11990793|FG001|Overall Study|Other-Early termination|10
7585273|NCT01114217|11990792|FG000|Overall Study|Other-Procedure|1
7585274|NCT01114217|11990793|FG001|Overall Study|Other-Procedure|1
7585275|NCT01114217|11990792|FG000|Overall Study|Other-Pregnancy|2
7585276|NCT01114217|11990793|FG001|Overall Study|Other-Pregnancy|4
7585277|NCT01114217|11990792|FG000|Overall Study|Other-Protocol Violation|1
7585278|NCT01114217|11990793|FG001|Overall Study|Other-Protocol Violation|3
7585279|NCT01114217|11990792|FG000|Overall Study|Other-Lack of Efficacy|1
7585280|NCT01114217|11990793|FG001|Overall Study|Other-Lack of Efficacy|0
7585281|NCT01114217|11990792|FG000|Overall Study|Other-Non Compliance|2
7585282|NCT01114217|11990793|FG001|Overall Study|Other-Non Compliance|0
7585283|NCT01114217|11990792|FG000|Overall Study|Other-Physician Decision|1
7585284|NCT01114217|11990793|FG001|Overall Study|Other-Physician Decision|1
7585285|NCT01114217|11990792|FG000|Overall Study|Other-Sponsor Decision|10
7585286|NCT01114217|11990793|FG001|Overall Study|Other-Sponsor Decision|12
7585287|NCT01114217|11990792|FG000|Overall Study|Other-Study Termination|0
7585288|NCT01114217|11990793|FG001|Overall Study|Other-Study Termination|1
7585289|NCT01114217|11990792|FG000|Overall Study|Other-Study Withdrawn|1
7585290|NCT01114217|11990793|FG001|Overall Study|Other-Study Withdrawn|1
7585291|NCT01114217|11990792|FG000|Overall Study|Other-Site Stopped Communicating|2
7585292|NCT01114217|11990793|FG001|Overall Study|Other-Site Stopped Communicating|0
7585293|NCT01114217|11990792|FG000|Overall Study|Other-Lost to Follow-up|1
7585294|NCT01114217|11990793|FG001|Overall Study|Other-Lost to Follow-up|0
7585295|NCT01114217|11990792|FG000|Overall Study|Other-Withdrawal by Subject|1
7585296|NCT01114217|11990793|FG001|Overall Study|Other-Withdrawal by Subject|1
7585297|NCT01114204|11990799|FG000|Overall Study|Adverse Event|3
7585298|NCT01114204|11990800|FG001|Overall Study|Adverse Event|2
7585299|NCT01114204|11990799|FG000|Overall Study|Lost to Follow-up|1
7585300|NCT01114204|11990800|FG001|Overall Study|Lost to Follow-up|0
7585301|NCT01114204|11990799|FG000|Overall Study|Withdrawal by Subject|10
7585302|NCT01114204|11990800|FG001|Overall Study|Withdrawal by Subject|6
7585303|NCT01114204|11990799|FG000|Overall Study|Death|1
7585304|NCT01114204|11990800|FG001|Overall Study|Death|0
7585305|NCT01114204|11990799|FG000|Overall Study|Other-Personal reasons|2
7585306|NCT01114204|11990800|FG001|Overall Study|Other-Personal reasons|0
7585307|NCT01114204|11990799|FG000|Overall Study|Other-Medical monitor request|1
7585308|NCT01114204|11990800|FG001|Overall Study|Other-Medical monitor request|0
7585309|NCT01114204|11990799|FG000|Overall Study|Other-Participant request|2
7585310|NCT01114204|11990800|FG001|Overall Study|Other-Participant request|0
7585311|NCT01114204|11990799|FG000|Overall Study|Other-Protocol Violation|1
7585312|NCT01114204|11990800|FG001|Overall Study|Other-Protocol Violation|0
7585313|NCT01114139|11990808|FG000|Overall Study|Adverse Event|3
7585314|NCT01114139|11990809|FG001|Overall Study|Adverse Event|2
7585315|NCT01114139|11990808|FG000|Overall Study|Lost to Follow-up|15
7585316|NCT01114139|11990809|FG001|Overall Study|Lost to Follow-up|3
7585317|NCT01114139|11990808|FG000|Overall Study|Withdrawal by Subject|17
7585318|NCT01114139|11990809|FG001|Overall Study|Withdrawal by Subject|6
7585319|NCT01114139|11990808|FG000|Overall Study|Other-Missed 1 visit|1
7585320|NCT01114139|11990809|FG001|Overall Study|Other-Missed 1 visit|0
7585321|NCT01114139|11990808|FG000|Overall Study|Other-Protocol Violation|1
7585322|NCT01114139|11990809|FG001|Overall Study|Other-Protocol Violation|0
7585323|NCT01114139|11990808|FG000|Overall Study|Other-Out of window for study drug dose|1
7585324|NCT01114139|11990809|FG001|Overall Study|Other-Out of window for study drug dose|0
7585325|NCT01114139|11990808|FG000|Overall Study|Other-Participant falsified records|0
7585326|NCT01114139|11990809|FG001|Overall Study|Other-Participant falsified records|1
7585327|NCT01114139|11990808|FG000|Overall Study|Other-Participant went on hospice|0
7585328|NCT01114139|11990809|FG001|Overall Study|Other-Participant went on hospice|1
7585329|NCT01114139|11990808|FG000|Overall Study|Other-Physician changed treatment|1
7585330|NCT01114139|11990809|FG001|Overall Study|Other-Physician changed treatment|0
7585331|NCT01114139|11990808|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
7585332|NCT01114139|11990809|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
7585333|NCT01059071|11990815|FG000|Overall Study|Lack of Efficacy|1
7585334|NCT01059071|11990816|FG001|Overall Study|Lack of Efficacy|4
7585335|NCT01059071|11990817|FG002|Overall Study|Lack of Efficacy|2
7585336|NCT01059071|11990818|FG003|Overall Study|Lack of Efficacy|3
7585337|NCT01059071|11990815|FG000|Overall Study|Withdrawal by Subject|1
7585338|NCT01059071|11990816|FG001|Overall Study|Withdrawal by Subject|0
7585339|NCT01059071|11990817|FG002|Overall Study|Withdrawal by Subject|0
7585340|NCT01059071|11990818|FG003|Overall Study|Withdrawal by Subject|2
7585341|NCT01059071|11990815|FG000|Overall Study|Physician Decision|0
7585342|NCT01059071|11990816|FG001|Overall Study|Physician Decision|0
7585343|NCT01059071|11990817|FG002|Overall Study|Physician Decision|0
7585344|NCT01059071|11990818|FG003|Overall Study|Physician Decision|1
7585345|NCT01027702|11990826|FG000|Overall Study|Received subsequent therapy|1
7585346|NCT01027702|11990827|FG001|Overall Study|Received subsequent therapy|2
7585347|NCT01027702|11990828|FG002|Overall Study|Received subsequent therapy|0
7585348|NCT01027702|11990829|FG003|Overall Study|Received subsequent therapy|4
7585349|NCT01027702|11990830|FG004|Overall Study|Received subsequent therapy|1
7585350|NCT01027702|11990831|FG005|Overall Study|Received subsequent therapy|0
7585351|NCT01027702|11990832|FG006|Overall Study|Received subsequent therapy|1
7585352|NCT01027702|11990826|FG000|Overall Study|Death|0
7585353|NCT01027702|11990827|FG001|Overall Study|Death|0
7585354|NCT01027702|11990828|FG002|Overall Study|Death|1
7585355|NCT01027702|11990829|FG003|Overall Study|Death|0
7585356|NCT01027702|11990830|FG004|Overall Study|Death|0
7585357|NCT01027702|11990831|FG005|Overall Study|Death|0
7585358|NCT01027702|11990832|FG006|Overall Study|Death|0
7585359|NCT00991887|11990845|FG000|Overall Study|Lost to Follow-up|2
7585360|NCT00991887|11990846|FG001|Overall Study|Lost to Follow-up|1
7585361|NCT00968864|11990852|FG000|Overall Study|Protocol exception/ not evaluable|1
7585362|NCT00934700|11990863|FG000|Overall Study|missing scan|5
7585363|NCT00934700|11990864|FG001|Overall Study|missing scan|9
7585364|NCT00934700|11990863|FG000|Overall Study|Death|8
7585365|NCT00934700|11990864|FG001|Overall Study|Death|3
7585366|NCT00867568|11990871|FG000|Overall Study|Lack of Efficacy|10
7585367|NCT00867568|11990871|FG000|Overall Study|Adverse Event|4
7585368|NCT00867568|11990871|FG000|Overall Study|Withdrawal by Subject|1
7585390|NCT00628446|11990908|FG000|Overall Study|Lost to Follow-up|3
7585391|NCT00628446|11990908|FG000|Overall Study|Withdrawal by Subject|1
7585392|NCT00628446|11990908|FG000|Overall Study|Protocol Violation|3
7585393|NCT00621751|11990915|FG000|Overall Study|Adverse Event|0
7585394|NCT00621751|11990916|FG001|Overall Study|Adverse Event|1
7585395|NCT00605215|11990925|FG000|Overall Study|Death|0
7585396|NCT00605215|11990926|FG001|Overall Study|Death|0
7585397|NCT00605215|11990927|FG002|Overall Study|Death|1
7585398|NCT00605215|11990925|FG000|Overall Study|Adverse Event|19
7585399|NCT00605215|11990926|FG001|Overall Study|Adverse Event|21
7585400|NCT00605215|11990927|FG002|Overall Study|Adverse Event|26
7585401|NCT00605215|11990925|FG000|Overall Study|Refusal to sign the re-consent form|8
7585402|NCT00605215|11990926|FG001|Overall Study|Refusal to sign the re-consent form|3
7585403|NCT00605215|11990927|FG002|Overall Study|Refusal to sign the re-consent form|3
7585404|NCT00605215|11990925|FG000|Overall Study|Withdrawal by Subject|39
7585405|NCT00605215|11990926|FG001|Overall Study|Withdrawal by Subject|37
7585406|NCT00605215|11990927|FG002|Overall Study|Withdrawal by Subject|27
7585407|NCT00605215|11990925|FG000|Overall Study|Request of Primary Care Physician or Investigator|6
7585408|NCT00605215|11990926|FG001|Overall Study|Request of Primary Care Physician or Investigator|4
7585409|NCT00605215|11990927|FG002|Overall Study|Request of Primary Care Physician or Investigator|4
7585410|NCT00605215|11990925|FG000|Overall Study|Protocol Violation|3
7585411|NCT00605215|11990926|FG001|Overall Study|Protocol Violation|4
7585412|NCT00605215|11990927|FG002|Overall Study|Protocol Violation|1
7585413|NCT00605215|11990925|FG000|Overall Study|Pregnancy|8
7585414|NCT00605215|11990926|FG001|Overall Study|Pregnancy|5
7585415|NCT00605215|11990927|FG002|Overall Study|Pregnancy|4
7585416|NCT00605215|11990925|FG000|Overall Study|Lost to Follow-up|8
7585417|NCT00605215|11990926|FG001|Overall Study|Lost to Follow-up|5
7585418|NCT00605215|11990927|FG002|Overall Study|Lost to Follow-up|2
7585419|NCT00605215|11990925|FG000|Overall Study|Other than specified|0
7585420|NCT00605215|11990926|FG001|Overall Study|Other than specified|2
7585421|NCT00605215|11990927|FG002|Overall Study|Other than specified|1
7585422|NCT00552513|11990941|FG000|Overall Study|Lost to Follow-up|5
7585423|NCT00552513|11990942|FG001|Overall Study|Lost to Follow-up|1
7585424|NCT00368836|11990952|FG000|Phase II|Screen Failure|1
7585425|NCT00368836|11990952|FG000|Phase II|Withdrawal by Subject|1
7585426|NCT00368836|11990952|FG000|Phase II|unable to collect blood and/or breath|17
7585427|NCT00368836|11990952|FG000|Phase II|Protocol Violation|2
7585428|NCT00290511|11990959|FG000|Overall Study|Adverse Event|1
7585429|NCT00290511|11990959|FG000|Overall Study|Death|1
7585430|NCT00290511|11990959|FG000|Overall Study|Physician Decision|1
7585431|NCT00290511|11990959|FG000|Overall Study|Withdrawal by Subject|1
7625890|NCT00551616|12037678|FG001|Overall Study|Lost to Follow-up|40
7625892|NCT00492050|12037688|FG000|Overall Study|Adverse Event|1
7625893|NCT00492050|12037688|FG000|Overall Study|Lack of Efficacy|1
7625894|NCT00492050|12037688|FG000|Overall Study|Withdrawal by Subject|3
7625895|NCT00492050|12037688|FG000|Overall Study|Unable to collect SCT|2
7625896|NCT00492050|12037688|FG000|Overall Study|Progressive Disease|2
7585432|NCT00641537|11990972|FG000|96-week Period|Adverse Event|0
7585433|NCT00641537|11990973|FG001|96-week Period|Adverse Event|1
7585434|NCT00641537|11990974|FG002|96-week Period|Adverse Event|3
7585435|NCT00641537|11990975|FG003|96-week Period|Adverse Event|0
7585436|NCT00641537|11990976|FG004|96-week Period|Adverse Event|2
7585437|NCT00641537|11990977|FG005|96-week Period|Adverse Event|0
7585438|NCT00641537|11990978|FG006|96-week Period|Adverse Event|0
7585439|NCT00641537|11990979|FG007|96-week Period|Adverse Event|0
7585440|NCT00641537|11990972|FG000|96-week Period|Lost to Follow-up|3
7585441|NCT00641537|11990973|FG001|96-week Period|Lost to Follow-up|1
7585442|NCT00641537|11990974|FG002|96-week Period|Lost to Follow-up|2
7585443|NCT00641537|11990975|FG003|96-week Period|Lost to Follow-up|2
7585444|NCT00641537|11990976|FG004|96-week Period|Lost to Follow-up|4
7585445|NCT00641537|11990977|FG005|96-week Period|Lost to Follow-up|0
7585446|NCT00641537|11990978|FG006|96-week Period|Lost to Follow-up|1
7585447|NCT00641537|11990979|FG007|96-week Period|Lost to Follow-up|0
7585448|NCT00641537|11990972|FG000|96-week Period|Protocol Violation|0
7585449|NCT00641537|11990973|FG001|96-week Period|Protocol Violation|1
7585450|NCT00641537|11990974|FG002|96-week Period|Protocol Violation|0
7585451|NCT00641537|11990975|FG003|96-week Period|Protocol Violation|1
7585452|NCT00641537|11990976|FG004|96-week Period|Protocol Violation|0
7585453|NCT00641537|11990977|FG005|96-week Period|Protocol Violation|1
7585454|NCT00641537|11990978|FG006|96-week Period|Protocol Violation|0
7585455|NCT00641537|11990979|FG007|96-week Period|Protocol Violation|0
7585456|NCT00641537|11990972|FG000|96-week Period|Death|2
7585457|NCT00641537|11990973|FG001|96-week Period|Death|0
7585458|NCT00641537|11990974|FG002|96-week Period|Death|1
7585459|NCT00641537|11990975|FG003|96-week Period|Death|0
7585460|NCT00641537|11990976|FG004|96-week Period|Death|0
7585461|NCT00641537|11990977|FG005|96-week Period|Death|0
7585462|NCT00641537|11990978|FG006|96-week Period|Death|0
7585463|NCT00641537|11990979|FG007|96-week Period|Death|0
7585464|NCT00641537|11990972|FG000|96-week Period|Other|4
7585465|NCT00641537|11990973|FG001|96-week Period|Other|7
7585466|NCT00641537|11990974|FG002|96-week Period|Other|14
7585467|NCT00641537|11990975|FG003|96-week Period|Other|9
7585468|NCT00641537|11990976|FG004|96-week Period|Other|11
7585469|NCT00641537|11990977|FG005|96-week Period|Other|6
7585470|NCT00641537|11990978|FG006|96-week Period|Other|4
7585471|NCT00641537|11990979|FG007|96-week Period|Other|6
7585472|NCT00641537|11990972|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585473|NCT00641537|11990973|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585474|NCT00641537|11990974|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585475|NCT00641537|11990975|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
7585476|NCT00641537|11990976|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
7585477|NCT00641537|11990977|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
7585478|NCT00641537|11990978|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585479|NCT00641537|11990979|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
7585480|NCT00641537|11990972|FG000|24-Week Supplemental Follow-up Period|Other|0
7585481|NCT00641537|11990973|FG001|24-Week Supplemental Follow-up Period|Other|2
7585482|NCT00641537|11990974|FG002|24-Week Supplemental Follow-up Period|Other|2
7585483|NCT00641537|11990975|FG003|24-Week Supplemental Follow-up Period|Other|1
7585484|NCT00641537|11990976|FG004|24-Week Supplemental Follow-up Period|Other|3
7585485|NCT00641537|11990977|FG005|24-Week Supplemental Follow-up Period|Other|0
7585486|NCT00641537|11990978|FG006|24-Week Supplemental Follow-up Period|Other|1
7585487|NCT00641537|11990979|FG007|24-Week Supplemental Follow-up Period|Other|1
7585488|NCT00655824|11990997|FG000|Overall Study|Adverse Event|3
7585489|NCT00655824|11990997|FG000|Overall Study|Early Termination of Study by Sponsor|74
7585490|NCT00655824|11990997|FG000|Overall Study|Protocol Violation|1
7585491|NCT00655824|11990997|FG000|Overall Study|Withdrawal by Subject|4
7585492|NCT00655824|11990997|FG000|Overall Study|Deterioration of Trial Disease|2
7585493|NCT00663052|11991003|FG000|Overall Study|Adverse Event|6
7585494|NCT00663052|11991004|FG001|Overall Study|Adverse Event|3
7585495|NCT00663052|11991003|FG000|Overall Study|Discontinuation of Study by Sponsor|2
7585496|NCT00663052|11991004|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7585497|NCT00663052|11991003|FG000|Overall Study|Protocol Violation|1
7585498|NCT00663052|11991004|FG001|Overall Study|Protocol Violation|0
7585499|NCT00663052|11991003|FG000|Overall Study|Withdrawal by Subject|2
7585500|NCT00663052|11991004|FG001|Overall Study|Withdrawal by Subject|5
7585501|NCT00663052|11991003|FG000|Overall Study|Unsatisfactory Response - Efficacy|1
7585502|NCT00663052|11991004|FG001|Overall Study|Unsatisfactory Response - Efficacy|1
7585503|NCT00663052|11991003|FG000|Overall Study|Other|0
7585504|NCT00663052|11991004|FG001|Overall Study|Other|1
7585505|NCT00686374|11991010|FG000|Overall Study|Lack of Efficacy|10
7585506|NCT00686374|11991010|FG000|Overall Study|Adverse Event|8
7585507|NCT00686374|11991010|FG000|Overall Study|Withdrew consent|5
7585508|NCT00686374|11991010|FG000|Overall Study|Lost to Follow-up|1
7585509|NCT00686374|11991010|FG000|Overall Study|Missing reason|33
7585510|NCT00686374|11991010|FG000|Overall Study|Other, not specified|4
7585511|NCT00698828|11991017|FG000|Overall Study|Adverse Event|3
7585512|NCT00698828|11991018|FG001|Overall Study|Adverse Event|4
7585513|NCT00698828|11991019|FG002|Overall Study|Adverse Event|4
7585514|NCT00698828|11991017|FG000|Overall Study|Death|0
7585515|NCT00698828|11991018|FG001|Overall Study|Death|0
7585516|NCT00698828|11991019|FG002|Overall Study|Death|1
7585517|NCT00698828|11991017|FG000|Overall Study|Exacerbation of COPD|1
7585518|NCT00698828|11991018|FG001|Overall Study|Exacerbation of COPD|3
7585519|NCT00698828|11991019|FG002|Overall Study|Exacerbation of COPD|0
7585520|NCT00698828|11991017|FG000|Overall Study|Exacerbation of COPD (Not treated)|1
7585521|NCT00698828|11991018|FG001|Overall Study|Exacerbation of COPD (Not treated)|0
7585522|NCT00698828|11991019|FG002|Overall Study|Exacerbation of COPD (Not treated)|0
7585523|NCT00698828|11991017|FG000|Overall Study|Investigator/Sponsor decision|1
7585524|NCT00698828|11991018|FG001|Overall Study|Investigator/Sponsor decision|0
7585525|NCT00698828|11991019|FG002|Overall Study|Investigator/Sponsor decision|2
7585526|NCT00698828|11991017|FG000|Overall Study|Lost to Follow-up|1
7585527|NCT00698828|11991018|FG001|Overall Study|Lost to Follow-up|1
7585528|NCT00698828|11991019|FG002|Overall Study|Lost to Follow-up|0
7585529|NCT00698828|11991017|FG000|Overall Study|Withdrew consent|0
7585530|NCT00698828|11991018|FG001|Overall Study|Withdrew consent|7
7585531|NCT00698828|11991019|FG002|Overall Study|Withdrew consent|4
7585532|NCT00698828|11991017|FG000|Overall Study|Withdrew consent (not treated)|2
7585533|NCT00698828|11991018|FG001|Overall Study|Withdrew consent (not treated)|0
7585534|NCT00698828|11991019|FG002|Overall Study|Withdrew consent (not treated)|0
7625905|NCT00061945|12037773|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
7625906|NCT00061945|12037774|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
7625907|NCT00061945|12037773|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
7625908|NCT00061945|12037774|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
7625909|NCT00061945|12037773|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7625910|NCT00061945|12037774|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
7625911|NCT00061945|12037773|FG000|Course IV: Alemtuzumab|Early exits|6
7625912|NCT00061945|12037774|FG001|Course IV: Alemtuzumab|Early exits|15
7625913|NCT04018612|12037786|FG000|Overall Study|Withdrawal by Subject|1
7625914|NCT04018612|12037787|FG001|Overall Study|Withdrawal by Subject|0
7625915|NCT04018612|12037788|FG002|Overall Study|Withdrawal by Subject|1
7625916|NCT03976648|12037798|FG000|Overall Study|Adverse Event|0
7625917|NCT03976648|12037799|FG001|Overall Study|Adverse Event|2
7625918|NCT03976648|12037798|FG000|Overall Study|Study terminated by sponsor|21
7625919|NCT03976648|12037799|FG001|Overall Study|Study terminated by sponsor|8
7270272|NCT00414973|11484456|FG001|Overall Study|Lost to Follow-up|2
7270273|NCT00414973|11484457|FG002|Overall Study|Lost to Follow-up|0
7270274|NCT00414973|11484458|FG003|Overall Study|Lost to Follow-up|0
7270275|NCT00414973|11484455|FG000|Overall Study|Sponsor Decision|1
7270276|NCT00414973|11484456|FG001|Overall Study|Sponsor Decision|0
7270277|NCT00414973|11484457|FG002|Overall Study|Sponsor Decision|0
7270278|NCT00414973|11484458|FG003|Overall Study|Sponsor Decision|0
7270279|NCT00414973|11484455|FG000|Overall Study|Death|0
7270280|NCT00414973|11484456|FG001|Overall Study|Death|0
7270281|NCT00414973|11484457|FG002|Overall Study|Death|1
7270282|NCT00414973|11484458|FG003|Overall Study|Death|0
7270283|NCT00415051|11484468|FG000|Overall Study|Protocol Violation|1
7270284|NCT00415168|11484472|FG000|Overall Study|Death|26
7270285|NCT00415168|11484472|FG000|Overall Study|Lost to Follow-up|3
7270286|NCT00415168|11484472|FG000|Overall Study|Physician Decision|13
7270287|NCT00415168|11484472|FG000|Overall Study|Sponsor Decision|4
7270288|NCT00415168|11484472|FG000|Overall Study|Withdrawal by Subject|6
7270289|NCT00415194|11484478|FG000|Overall Study|Adverse Event|37
7270290|NCT00415194|11484479|FG001|Overall Study|Adverse Event|32
7270291|NCT00415194|11484478|FG000|Overall Study|Entry Criteria Not Met|4
7270292|NCT00415194|11484479|FG001|Overall Study|Entry Criteria Not Met|8
7270293|NCT00415194|11484478|FG000|Overall Study|Lost to Follow-up|1
7270294|NCT00415194|11484479|FG001|Overall Study|Lost to Follow-up|0
7625920|NCT03619902|12037809|FG000|Overall Study|Termination of Study by Investigator|1
7625921|NCT03619902|12037809|FG000|Overall Study|Use of Excluded/Prohibited Medication|1
7270295|NCT00415194|11484478|FG000|Overall Study|Physician Decision|10
7270296|NCT00415194|11484479|FG001|Overall Study|Physician Decision|16
7270297|NCT00415194|11484478|FG000|Overall Study|Progressive Disease|180
7585535|NCT00712933|11991027|FG000|Overall Study|Adverse Event|69
7585536|NCT00712933|11991027|FG000|Overall Study|Lack of Efficacy|6
7585537|NCT00712933|11991027|FG000|Overall Study|Lost to Follow-up|22
7585538|NCT00712933|11991027|FG000|Overall Study|Non-compliance with study drug|13
7585539|NCT00712933|11991027|FG000|Overall Study|Other Pregnancy|37
7585540|NCT00712933|11991027|FG000|Overall Study|Sponsor decision|14
7585541|NCT00712933|11991027|FG000|Overall Study|Withdrew consent|4
7585542|NCT00712933|11991027|FG000|Overall Study|Hip replacement surgery|1
7585543|NCT00712933|11991027|FG000|Overall Study|Involved in Clinical research|3
7585544|NCT00712933|11991027|FG000|Overall Study|Participant hospitalized|1
7585545|NCT00712933|11991027|FG000|Overall Study|Participant travelled overseas|2
7585546|NCT00712933|11991027|FG000|Overall Study|Death of patient|1
7585547|NCT00712933|11991027|FG000|Overall Study|Other Physician decision|1
7585548|NCT00712933|11991027|FG000|Overall Study|Not committed to contraception|1
7585549|NCT00712933|11991027|FG000|Overall Study|Participant received medication|1
7585550|NCT00712933|11991027|FG000|Overall Study|Physician Decision|36
7585551|NCT00712933|11991027|FG000|Overall Study|Protocol Violation|4
7585552|NCT00712933|11991027|FG000|Overall Study|Withdrawal by Subject|151
7585553|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Adverse Event|20
7585554|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Adverse Event|10
7585555|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Adverse Event|5
7585556|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Adverse Event|0
7585557|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Adverse Event|0
7585558|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Adverse Event|0
7585559|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Adverse Event|0
7585560|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Adverse Event|0
7585561|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Adverse Event|0
7585562|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Adverse Event|0
7585563|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Adverse Event|0
7585564|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Adverse Event|0
7585565|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Lost to Follow-up|0
7585566|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Lost to Follow-up|0
7585567|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Lost to Follow-up|2
7585568|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Lost to Follow-up|0
7585569|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Lost to Follow-up|0
7585570|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Lost to Follow-up|0
7585571|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Lost to Follow-up|0
7585572|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Lost to Follow-up|0
7585573|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Lost to Follow-up|0
7585574|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Lost to Follow-up|0
7585575|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Lost to Follow-up|0
7585576|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Lost to Follow-up|0
7585577|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Randomized but not treated|1
7585578|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Randomized but not treated|0
7585579|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Randomized but not treated|0
7585580|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Randomized but not treated|0
7625922|NCT03517449|12037850|FG000|Overall Study|Death|184
7625923|NCT03517449|12037851|FG001|Overall Study|Death|236
7625924|NCT03517449|12037850|FG000|Overall Study|Lost to Follow-up|0
7625925|NCT03517449|12037851|FG001|Overall Study|Lost to Follow-up|2
7625926|NCT03517449|12037850|FG000|Overall Study|Withdrawal by Subject|7
7625927|NCT03517449|12037851|FG001|Overall Study|Withdrawal by Subject|26
7625928|NCT03517449|12037850|FG000|Overall Study|Participants Ongoing|220
7625929|NCT03517449|12037851|FG001|Overall Study|Participants Ongoing|152
7625930|NCT03470922|12037859|FG000|Overall Study|Death|107
7585581|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Randomized but not treated|0
7585582|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Randomized but not treated|0
7585583|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Randomized but not treated|0
7585584|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Randomized but not treated|0
7585585|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Randomized but not treated|0
7585586|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Randomized but not treated|0
7585587|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Randomized but not treated|0
7585588|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Randomized but not treated|0
7585589|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Converted to CDMS|30
7585590|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Converted to CDMS|27
7585591|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Converted to CDMS|71
7585592|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Converted to CDMS|0
7585593|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Converted to CDMS|0
7585594|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Converted to CDMS|0
7585595|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Converted to CDMS|0
7585596|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Converted to CDMS|0
7585597|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Converted to CDMS|0
7585598|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Converted to CDMS|0
7585599|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Converted to CDMS|0
7585600|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Converted to CDMS|0
7585601|NCT00725985|11991051|FG000|ITP- Treatment Disposition|Other|50
7585602|NCT00725985|11991052|FG001|ITP- Treatment Disposition|Other|38
7585603|NCT00725985|11991053|FG002|ITP- Treatment Disposition|Other|24
7585604|NCT00725985|11991054|FG003|ITP- Treatment Disposition|Other|0
7585605|NCT00725985|11991055|FG004|ITP- Treatment Disposition|Other|0
7585606|NCT00725985|11991056|FG005|ITP- Treatment Disposition|Other|0
7585607|NCT00725985|11991057|FG006|ITP- Treatment Disposition|Other|0
7585608|NCT00725985|11991058|FG007|ITP- Treatment Disposition|Other|0
7585609|NCT00725985|11991059|FG008|ITP- Treatment Disposition|Other|0
7585610|NCT00725985|11991060|FG009|ITP- Treatment Disposition|Other|0
7585611|NCT00725985|11991061|FG010|ITP- Treatment Disposition|Other|0
7585612|NCT00725985|11991062|FG011|ITP- Treatment Disposition|Other|0
7585613|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0
7585614|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0
7585615|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0
7585616|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2
7585617|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2
7585618|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5
7585619|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0
7585620|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0
7585621|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0
7585622|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0
7585623|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0
7585624|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0
7585625|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Death|0
7585626|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Death|0
7585627|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Death|0
7585628|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Death|0
7585629|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Death|1
7585630|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Death|0
7585631|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Death|0
7585632|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Death|0
7585633|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Death|0
7585634|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Death|0
7585635|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Death|0
7585636|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Death|0
7585637|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585638|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585639|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585640|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
7585641|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585642|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585643|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585644|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585645|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585646|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585647|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585648|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
7585649|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Disease progression|0
7585650|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Disease progression|0
7585651|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Disease progression|0
7585652|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Disease progression|0
7585653|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Disease progression|0
7585654|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Disease progression|4
7585655|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Disease progression|0
7585656|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Disease progression|0
7585657|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Disease progression|0
7585658|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Disease progression|0
7585659|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Disease progression|0
7585660|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Disease progression|0
7585661|NCT00725985|11991051|FG000|OLMP (Up to 96 Weeks)|Other|0
7585662|NCT00725985|11991052|FG001|OLMP (Up to 96 Weeks)|Other|0
7585663|NCT00725985|11991053|FG002|OLMP (Up to 96 Weeks)|Other|0
7585664|NCT00725985|11991054|FG003|OLMP (Up to 96 Weeks)|Other|15
7585665|NCT00725985|11991055|FG004|OLMP (Up to 96 Weeks)|Other|20
7585666|NCT00725985|11991056|FG005|OLMP (Up to 96 Weeks)|Other|44
7585667|NCT00725985|11991057|FG006|OLMP (Up to 96 Weeks)|Other|0
7585668|NCT00725985|11991058|FG007|OLMP (Up to 96 Weeks)|Other|0
7585669|NCT00725985|11991059|FG008|OLMP (Up to 96 Weeks)|Other|0
7585670|NCT00725985|11991060|FG009|OLMP (Up to 96 Weeks)|Other|0
7585671|NCT00725985|11991061|FG010|OLMP (Up to 96 Weeks)|Other|0
7585672|NCT00725985|11991062|FG011|OLMP (Up to 96 Weeks)|Other|0
7585673|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585674|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585675|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585676|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585677|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585678|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585679|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585680|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
7585681|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585682|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585683|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585684|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
7585685|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585686|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585687|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585688|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585689|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585690|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585691|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585692|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585693|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
7585694|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585695|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585696|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
7585697|NCT00725985|11991051|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585698|NCT00725985|11991052|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585699|NCT00725985|11991053|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585700|NCT00725985|11991054|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585701|NCT00725985|11991055|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585702|NCT00725985|11991056|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585703|NCT00725985|11991057|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
7585704|NCT00725985|11991058|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
7585705|NCT00725985|11991059|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
7585706|NCT00725985|11991060|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585707|NCT00725985|11991061|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585708|NCT00725985|11991062|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
7585709|NCT00725985|11991051|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0
7585710|NCT00725985|11991052|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0
7585711|NCT00725985|11991053|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0
7585712|NCT00725985|11991054|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0
7585713|NCT00725985|11991055|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0
7585714|NCT00725985|11991056|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0
7585715|NCT00725985|11991057|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0
7585716|NCT00725985|11991058|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0
7585717|NCT00725985|11991059|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0
7585718|NCT00725985|11991060|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34
7585719|NCT00725985|11991061|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36
7585720|NCT00725985|11991062|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14
7625931|NCT03470922|12037860|FG001|Overall Study|Death|118
7625932|NCT03470922|12037859|FG000|Overall Study|Lost to Follow-up|5
7625933|NCT03470922|12037860|FG001|Overall Study|Lost to Follow-up|5
7625934|NCT03470922|12037859|FG000|Overall Study|Participant Withdrew Consent|4
7625935|NCT03470922|12037860|FG001|Overall Study|Participant Withdrew Consent|9
7625936|NCT03470922|12037859|FG000|Overall Study|Other reasons|1
7625937|NCT03470922|12037860|FG001|Overall Study|Other reasons|0
7625938|NCT03470922|12037859|FG000|Overall Study|Not reported|1
7625939|NCT03470922|12037860|FG001|Overall Study|Not reported|0
7625940|NCT03308825|12037870|FG000|Overall Study|Lost to Follow-up|2
7625941|NCT03308825|12037871|FG001|Overall Study|Lost to Follow-up|2
7625942|NCT03308825|12037872|FG002|Overall Study|Lost to Follow-up|1
7625943|NCT03308825|12037873|FG003|Overall Study|Lost to Follow-up|0
7625944|NCT03308825|12037870|FG000|Overall Study|Protocol Violation|0
7625945|NCT03308825|12037871|FG001|Overall Study|Protocol Violation|2
7625946|NCT03308825|12037872|FG002|Overall Study|Protocol Violation|0
7625947|NCT03308825|12037873|FG003|Overall Study|Protocol Violation|0
7625948|NCT02915302|12037889|FG000|Overall Study|Adverse Event|3
7270298|NCT00415194|11484479|FG001|Overall Study|Progressive Disease|217
7585721|NCT04860258|11991095|FG000|Overall Study|Withdrawal by Subject|0
7585722|NCT04860258|11991096|FG001|Overall Study|Withdrawal by Subject|0
7585723|NCT04860258|11991097|FG002|Overall Study|Withdrawal by Subject|4
7585724|NCT04860258|11991098|FG003|Overall Study|Withdrawal by Subject|1
7585725|NCT04860258|11991099|FG004|Overall Study|Withdrawal by Subject|4
7585726|NCT04860258|11991100|FG005|Overall Study|Withdrawal by Subject|1
7585727|NCT04860258|11991101|FG006|Overall Study|Withdrawal by Subject|0
7585729|NCT03787303|11991134|FG000|Overall Study|Death|1
7585730|NCT03787303|11991134|FG000|Overall Study|Premature Termination of Study|1
7585731|NCT03673098|11991144|FG000|Overall Study|Lost to Follow-up|2
7585732|NCT03673098|11991145|FG001|Overall Study|Lost to Follow-up|3
7585733|NCT03673098|11991144|FG000|Overall Study|Withdrawal by Subject|6
7585734|NCT03673098|11991145|FG001|Overall Study|Withdrawal by Subject|1
7585735|NCT03673098|11991144|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2
7585736|NCT03673098|11991145|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0
7585737|NCT03520569|11991158|FG000|Overall Study|Withdrawal by Subject|1
7585738|NCT03499899|11991171|FG000|Overall Study|Adverse Event|2
7585739|NCT03499899|11991172|FG001|Overall Study|Adverse Event|3
7585740|NCT03499899|11991173|FG002|Overall Study|Adverse Event|3
7585741|NCT03499899|11991171|FG000|Overall Study|Death|0
7585742|NCT03499899|11991172|FG001|Overall Study|Death|0
7585743|NCT03499899|11991173|FG002|Overall Study|Death|1
7585744|NCT03499899|11991171|FG000|Overall Study|Physician Decision|3
7585745|NCT03499899|11991172|FG001|Overall Study|Physician Decision|6
7585746|NCT03499899|11991173|FG002|Overall Study|Physician Decision|6
7585747|NCT03499899|11991171|FG000|Overall Study|Progressive disease|15
7585748|NCT03499899|11991172|FG001|Overall Study|Progressive disease|23
7585749|NCT03499899|11991173|FG002|Overall Study|Progressive disease|23
7585750|NCT03499899|11991171|FG000|Overall Study|Patient decision|0
7585751|NCT03499899|11991172|FG001|Overall Study|Patient decision|1
7585752|NCT03499899|11991173|FG002|Overall Study|Patient decision|1
7585753|NCT03499899|11991171|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0
7585754|NCT03499899|11991172|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1
7585755|NCT03499899|11991173|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0
7585766|NCT03419741|11991192|FG000|Overall Study|Adverse Event|1
7585767|NCT03419741|11991193|FG001|Overall Study|Adverse Event|0
7585768|NCT03419741|11991192|FG000|Overall Study|Withdrawal by Subject|1
7585769|NCT03419741|11991193|FG001|Overall Study|Withdrawal by Subject|2
7585770|NCT02688530|11991221|FG000|Overall Study|Withdrawal by Subject|0
7585771|NCT02688530|11991222|FG001|Overall Study|Withdrawal by Subject|1
7585772|NCT02688530|11991223|FG002|Overall Study|Withdrawal by Subject|0
7585773|NCT02688530|11991224|FG003|Overall Study|Withdrawal by Subject|0
7585774|NCT02688530|11991221|FG000|Overall Study|Lost to Follow-up|0
7585775|NCT02688530|11991222|FG001|Overall Study|Lost to Follow-up|0
7585776|NCT02688530|11991223|FG002|Overall Study|Lost to Follow-up|2
7585777|NCT02688530|11991224|FG003|Overall Study|Lost to Follow-up|0
7585790|NCT02383966|11991250|FG000|Overall Study|Ongoing at clinical cut-off date|25
7585791|NCT02383966|11991251|FG001|Overall Study|Ongoing at clinical cut-off date|4
7585792|NCT02383966|11991250|FG000|Overall Study|Randomized, but not treated|1
7585793|NCT02383966|11991251|FG001|Overall Study|Randomized, but not treated|3
7585794|NCT02073565|11991259|FG000|Cohort A|Withdrawal by Subject|1
7585795|NCT02073565|11991260|FG001|Cohort A|Withdrawal by Subject|0
7585796|NCT02073565|11991259|FG000|Cohort B|Withdrawal by Subject|1
7585797|NCT02073565|11991260|FG001|Cohort B|Withdrawal by Subject|2
7585798|NCT02073565|11991259|FG000|Cohort C|Withdrawal by Subject|0
7585799|NCT02073565|11991260|FG001|Cohort C|Withdrawal by Subject|2
7585800|NCT02073565|11991259|FG000|Cohort C|Lost to Follow-up|0
7585801|NCT02073565|11991260|FG001|Cohort C|Lost to Follow-up|2
7585802|NCT02060487|11991269|FG000|Overall Study|Other|1
7585803|NCT02060487|11991270|FG001|Overall Study|Other|2
7585804|NCT02060487|11991271|FG002|Overall Study|Other|1
7585805|NCT02060487|11991269|FG000|Overall Study|Lack of Efficacy|0
7585806|NCT02060487|11991270|FG001|Overall Study|Lack of Efficacy|1
7585807|NCT02060487|11991271|FG002|Overall Study|Lack of Efficacy|0
7585808|NCT02060487|11991269|FG000|Overall Study|Withdrawal by Subject|3
7585809|NCT02060487|11991270|FG001|Overall Study|Withdrawal by Subject|10
7585810|NCT02060487|11991271|FG002|Overall Study|Withdrawal by Subject|4
7585811|NCT02060487|11991269|FG000|Overall Study|Study Terminated By Sponsor|87
7585812|NCT02060487|11991270|FG001|Overall Study|Study Terminated By Sponsor|89
7585813|NCT02060487|11991271|FG002|Overall Study|Study Terminated By Sponsor|100
7270299|NCT00415194|11484478|FG000|Overall Study|Protocol Violation|4
7270300|NCT00415194|11484479|FG001|Overall Study|Protocol Violation|2
7270301|NCT00415194|11484478|FG000|Overall Study|Withdrawal by Subject|28
7270302|NCT00415194|11484479|FG001|Overall Study|Withdrawal by Subject|21
7270303|NCT00415194|11484478|FG000|Overall Study|Death Due to Study Disease|26
7270304|NCT00415194|11484479|FG001|Overall Study|Death Due to Study Disease|29
7585814|NCT02060487|11991269|FG000|Overall Study|Randomized in error|1
7585815|NCT02060487|11991270|FG001|Overall Study|Randomized in error|0
7585816|NCT02060487|11991271|FG002|Overall Study|Randomized in error|0
7585817|NCT02060487|11991269|FG000|Overall Study|Protocol Violation|0
7585818|NCT02060487|11991270|FG001|Overall Study|Protocol Violation|1
7585819|NCT02060487|11991271|FG002|Overall Study|Protocol Violation|1
7585820|NCT02060487|11991269|FG000|Overall Study|Lost to Follow-up|3
7585821|NCT02060487|11991270|FG001|Overall Study|Lost to Follow-up|0
7585822|NCT02060487|11991271|FG002|Overall Study|Lost to Follow-up|2
7585823|NCT02060487|11991269|FG000|Overall Study|Death|34
7585824|NCT02060487|11991270|FG001|Overall Study|Death|25
7585825|NCT02060487|11991271|FG002|Overall Study|Death|19
7585826|NCT02060487|11991269|FG000|Overall Study|Adverse Event|0
7585827|NCT02060487|11991270|FG001|Overall Study|Adverse Event|0
7585828|NCT02060487|11991271|FG002|Overall Study|Adverse Event|1
7585829|NCT00331773|11991316|FG000|Overall Study|Withdrawal by Subject|6
7585830|NCT00331773|11991317|FG001|Overall Study|Withdrawal by Subject|4
7585831|NCT00331773|11991316|FG000|Overall Study|Protocol Violation|10
7585832|NCT00331773|11991317|FG001|Overall Study|Protocol Violation|3
7625949|NCT02915302|12037890|FG001|Overall Study|Adverse Event|0
7625950|NCT02915302|12037889|FG000|Overall Study|Protocol Violation|20
7625951|NCT02915302|12037890|FG001|Overall Study|Protocol Violation|27
7625952|NCT02915302|12037889|FG000|Overall Study|Lost to Follow-up|19
7625953|NCT02915302|12037890|FG001|Overall Study|Lost to Follow-up|22
7625954|NCT02915302|12037889|FG000|Overall Study|Withdrawal by Subject|22
7625955|NCT02915302|12037890|FG001|Overall Study|Withdrawal by Subject|29
7625956|NCT02915302|12037889|FG000|Overall Study|Other|1
7625957|NCT02915302|12037890|FG001|Overall Study|Other|0
7625958|NCT02744040|12037913|FG000|Overall Study|Withdrawal by Subject|3
7625959|NCT02744040|12037914|FG001|Overall Study|Withdrawal by Subject|2
7625960|NCT02744040|12037915|FG002|Overall Study|Withdrawal by Subject|2
7625961|NCT02744040|12037913|FG000|Overall Study|Physician Decision|0
7625962|NCT02744040|12037914|FG001|Overall Study|Physician Decision|8
7625963|NCT02744040|12037915|FG002|Overall Study|Physician Decision|13
7625964|NCT02744040|12037913|FG000|Overall Study|Lost to Follow-up|3
7625965|NCT02744040|12037914|FG001|Overall Study|Lost to Follow-up|1
7625966|NCT02744040|12037915|FG002|Overall Study|Lost to Follow-up|7
7625967|NCT02698826|12037923|FG000|Overall Study|Death|13
7625968|NCT02698826|12037923|FG000|Overall Study|Adverse Event|1
7625969|NCT02617589|12037931|FG000|All Randomized|Request to discontinue study treatment|1
7625970|NCT02617589|12037932|FG001|All Randomized|Request to discontinue study treatment|3
7625971|NCT02617589|12037931|FG000|All Randomized|Participant Withdrew Consent|1
7625972|NCT02617589|12037932|FG001|All Randomized|Participant Withdrew Consent|2
7270305|NCT00415194|11484478|FG000|Overall Study|Death Due to Study Drug Related AE|11
7270306|NCT00415194|11484479|FG001|Overall Study|Death Due to Study Drug Related AE|1
7270307|NCT00415194|11484478|FG000|Overall Study|Death Due to Procedural Related AE|0
7270308|NCT00415194|11484479|FG001|Overall Study|Death Due to Procedural Related AE|1
7270309|NCT00415194|11484478|FG000|Overall Study|Death Due to AE (Other Causes)|27
7625973|NCT02617589|12037931|FG000|Treatment Period|Other Reasons|2
7625974|NCT02617589|12037932|FG001|Treatment Period|Other Reasons|2
7625975|NCT02617589|12037931|FG000|Treatment Period|Not reported|1
7625976|NCT02617589|12037932|FG001|Treatment Period|Not reported|0
7625977|NCT02617589|12037931|FG000|Treatment Period|Poor/Non compliance|1
7625978|NCT02617589|12037932|FG001|Treatment Period|Poor/Non compliance|1
7625979|NCT02617589|12037931|FG000|Treatment Period|Maximum Clinical Benefit|0
7625980|NCT02617589|12037932|FG001|Treatment Period|Maximum Clinical Benefit|2
7625981|NCT02617589|12037931|FG000|Treatment Period|Participant Withdrew Consent|2
7625982|NCT02617589|12037932|FG001|Treatment Period|Participant Withdrew Consent|6
7625983|NCT02617589|12037931|FG000|Treatment Period|Participant Request to discontinue|12
7625984|NCT02617589|12037932|FG001|Treatment Period|Participant Request to discontinue|20
7585833|NCT04882995|11991365|FG000|Overall Study|Withdrawal by Subject|1
7585834|NCT04882995|11991366|FG001|Overall Study|Withdrawal by Subject|2
7585835|NCT04882995|11991365|FG000|Overall Study|Protocol Violation|4
7585836|NCT04882995|11991366|FG001|Overall Study|Protocol Violation|4
7585837|NCT04882995|11991365|FG000|Overall Study|Surgery postponed due to COVID|1
7585838|NCT04882995|11991366|FG001|Overall Study|Surgery postponed due to COVID|1
7585839|NCT04640168|11991383|FG000|Overall Study|Withdrawal by Subject|8
7585840|NCT04640168|11991384|FG001|Overall Study|Withdrawal by Subject|7
7585841|NCT04640168|11991383|FG000|Overall Study|Lost to Follow-up|1
7585842|NCT04640168|11991384|FG001|Overall Study|Lost to Follow-up|0
7585843|NCT04640168|11991383|FG000|Overall Study|Enrolled but not treated|12
7585844|NCT04640168|11991384|FG001|Overall Study|Enrolled but not treated|12
7585845|NCT04465630|11991390|FG000|Overall Study|Sponsor Decision to terminate the study|54
7585846|NCT04465630|11991390|FG000|Overall Study|Screen failure|8
7585847|NCT04465630|11991390|FG000|Overall Study|Baseline failure|16
7585848|NCT04459598|11991397|FG000|Overall Study|Adverse Event|1
7585849|NCT04459598|11991398|FG001|Overall Study|Adverse Event|1
7585905|NCT03584009|11991531|FG000|Overall Study|Death|25
7585906|NCT03584009|11991532|FG001|Overall Study|Death|18
7585907|NCT03584009|11991531|FG000|Overall Study|Lost to Follow-up|0
7585908|NCT03584009|11991532|FG001|Overall Study|Lost to Follow-up|1
7585909|NCT03584009|11991531|FG000|Overall Study|Physician Decision|1
7585910|NCT03584009|11991532|FG001|Overall Study|Physician Decision|1
7585911|NCT03584009|11991531|FG000|Overall Study|Study Terminated by Sponsor|22
7585912|NCT03584009|11991532|FG001|Overall Study|Study Terminated by Sponsor|30
7585913|NCT03584009|11991531|FG000|Overall Study|Withdrawal by Subject|3
7585914|NCT03584009|11991532|FG001|Overall Study|Withdrawal by Subject|2
7585915|NCT03583359|11991543|FG000|Overall Study|Withdrawal by Subject|15
7585916|NCT03583359|11991544|FG001|Overall Study|Withdrawal by Subject|6
7585917|NCT03583359|11991543|FG000|Overall Study|Lost to Follow-up|12
7585918|NCT03583359|11991544|FG001|Overall Study|Lost to Follow-up|3
7585919|NCT03583359|11991543|FG000|Overall Study|Adverse Event|0
7585920|NCT03583359|11991544|FG001|Overall Study|Adverse Event|1
7585921|NCT03583359|11991543|FG000|Overall Study|Protocol Violation|0
7585922|NCT03583359|11991544|FG001|Overall Study|Protocol Violation|1
7585923|NCT03583359|11991543|FG000|Overall Study|Other|2
7585924|NCT03583359|11991544|FG001|Overall Study|Other|1
7585878|NCT04387136|11991422|FG000|Overall Study|Protocol Deviation by SOC staff|1
7585879|NCT04387136|11991423|FG001|Overall Study|Protocol Deviation by SOC staff|2
7585880|NCT04351269|11991432|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70
7585881|NCT04351269|11991433|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32
7585882|NCT04351269|11991434|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29
7585883|NCT04351269|11991432|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0
7585884|NCT04351269|11991433|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1
7585885|NCT04351269|11991434|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0
7585886|NCT04351269|11991432|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7585887|NCT04351269|11991433|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1
7585888|NCT04351269|11991434|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0
7585889|NCT04351269|11991432|FG000|Overall Study|Subjects followed long-term at different health care system|0
7585890|NCT04351269|11991433|FG001|Overall Study|Subjects followed long-term at different health care system|4
7585891|NCT04351269|11991434|FG002|Overall Study|Subjects followed long-term at different health care system|0
7585892|NCT04351269|11991432|FG000|Overall Study|Lost to Follow-up|1
7585893|NCT04351269|11991433|FG001|Overall Study|Lost to Follow-up|3
7585894|NCT04351269|11991434|FG002|Overall Study|Lost to Follow-up|0
7585895|NCT04285229|11991451|FG000|Overall Study|Adverse Event|1
7585896|NCT04285229|11991452|FG001|Overall Study|Adverse Event|2
7585897|NCT04285229|11991451|FG000|Overall Study|Withdrawal by Subject|1
7585898|NCT04285229|11991452|FG001|Overall Study|Withdrawal by Subject|0
7585899|NCT04285229|11991451|FG000|Overall Study|Sponsor Decision|1
7585900|NCT04285229|11991452|FG001|Overall Study|Sponsor Decision|0
7585901|NCT03668808|11991502|FG000|First Intervention|Withdrawal by Subject|2
7585902|NCT03668808|11991503|FG001|First Intervention|Withdrawal by Subject|2
7585903|NCT03656874|11991522|FG000|Overall Study|Lost to Follow-up|3
7585904|NCT03656874|11991523|FG001|Overall Study|Lost to Follow-up|17
7585973|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10
7585974|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Adverse Event|7
7585975|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Protocol Violation|6
7585976|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5
7585977|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|other|3
7585978|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Death|2
7585979|NCT03557307|11991578|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2
7585980|NCT03557307|11991578|FG000|Maintenance Phase|Adverse Event|4
7585981|NCT03557307|11991578|FG000|Maintenance Phase|Death|3
7585982|NCT03557307|11991578|FG000|Maintenance Phase|Lost to Follow-up|2
7585983|NCT03557307|11991578|FG000|Maintenance Phase|Pregnancy|2
7585984|NCT03557307|11991578|FG000|Maintenance Phase|Protocol Violation|11
7585985|NCT03557307|11991578|FG000|Maintenance Phase|Withdrawal by Subject|2
7585986|NCT03557307|11991578|FG000|Maintenance Phase|other|3
7585987|NCT03379675|11991625|FG000|Overall Study|Lost to Follow-up|0
7585988|NCT03379675|11991626|FG001|Overall Study|Lost to Follow-up|1
7585989|NCT03379675|11991627|FG002|Overall Study|Lost to Follow-up|0
7585990|NCT03379675|11991625|FG000|Overall Study|Adverse Event|2
7585991|NCT03379675|11991626|FG001|Overall Study|Adverse Event|0
7585992|NCT03379675|11991627|FG002|Overall Study|Adverse Event|0
7585993|NCT03379675|11991625|FG000|Overall Study|Withdrawal by Subject|2
7585994|NCT03379675|11991626|FG001|Overall Study|Withdrawal by Subject|1
7585995|NCT03379675|11991627|FG002|Overall Study|Withdrawal by Subject|2
7585996|NCT03336619|11991648|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192
7585997|NCT03336619|11991649|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204
7585998|NCT03336619|11991648|FG000|Overall Study|Withdrawal by Subject|17
7585999|NCT03336619|11991649|FG001|Overall Study|Withdrawal by Subject|16
7586000|NCT03336619|11991648|FG000|Overall Study|Adverse Event|2
7586001|NCT03336619|11991649|FG001|Overall Study|Adverse Event|5
7586002|NCT03336619|11991648|FG000|Overall Study|Physician Decision|3
7586003|NCT03336619|11991649|FG001|Overall Study|Physician Decision|0
7586004|NCT03274687|11991660|FG000|Overall Study|Protocol Violation|1
7586005|NCT03274687|11991661|FG001|Overall Study|Protocol Violation|1
7586006|NCT03245450|11991674|FG000|Overall Study|Radiological disease progression|3
7586007|NCT03245450|11991675|FG001|Overall Study|Radiological disease progression|3
7586008|NCT03245450|11991676|FG002|Overall Study|Radiological disease progression|2
7586009|NCT03245450|11991677|FG003|Overall Study|Radiological disease progression|2
7586010|NCT03245450|11991678|FG004|Overall Study|Radiological disease progression|7
7586011|NCT03245450|11991679|FG005|Overall Study|Radiological disease progression|6
7586012|NCT03245450|11991680|FG006|Overall Study|Radiological disease progression|6
7586013|NCT03245450|11991674|FG000|Overall Study|Clinical disease progression|0
7586014|NCT03245450|11991675|FG001|Overall Study|Clinical disease progression|0
7586015|NCT03245450|11991676|FG002|Overall Study|Clinical disease progression|1
7586016|NCT03245450|11991677|FG003|Overall Study|Clinical disease progression|0
7586017|NCT03245450|11991678|FG004|Overall Study|Clinical disease progression|0
7586018|NCT03245450|11991679|FG005|Overall Study|Clinical disease progression|2
7586019|NCT03245450|11991680|FG006|Overall Study|Clinical disease progression|0
7586020|NCT03245450|11991674|FG000|Overall Study|Other|0
7586021|NCT03245450|11991675|FG001|Overall Study|Other|0
7586022|NCT03245450|11991676|FG002|Overall Study|Other|0
7586023|NCT03245450|11991677|FG003|Overall Study|Other|1
7586024|NCT03245450|11991678|FG004|Overall Study|Other|1
7586025|NCT03245450|11991679|FG005|Overall Study|Other|1
7586026|NCT03245450|11991680|FG006|Overall Study|Other|1
7586027|NCT03245450|11991674|FG000|Overall Study|Withdrawal by Subject|0
7586028|NCT03245450|11991675|FG001|Overall Study|Withdrawal by Subject|1
7586029|NCT03245450|11991676|FG002|Overall Study|Withdrawal by Subject|0
7586030|NCT03245450|11991677|FG003|Overall Study|Withdrawal by Subject|0
7586031|NCT03245450|11991678|FG004|Overall Study|Withdrawal by Subject|0
7586032|NCT03245450|11991679|FG005|Overall Study|Withdrawal by Subject|0
7586033|NCT03245450|11991680|FG006|Overall Study|Withdrawal by Subject|0
7586034|NCT03245450|11991674|FG000|Overall Study|Adverse Event|0
7586035|NCT03245450|11991675|FG001|Overall Study|Adverse Event|0
7586036|NCT03245450|11991676|FG002|Overall Study|Adverse Event|0
7270310|NCT00415194|11484479|FG001|Overall Study|Death Due to AE (Other Causes)|15
7270311|NCT00415363|11484487|FG000|Overall Study|Withdrawal by Subject|4
7270312|NCT00415363|11484488|FG001|Overall Study|Withdrawal by Subject|4
7270313|NCT00415363|11484487|FG000|Overall Study|Adverse Event|4
7270314|NCT00415363|11484488|FG001|Overall Study|Adverse Event|4
7586037|NCT03245450|11991677|FG003|Overall Study|Adverse Event|0
7270315|NCT00415363|11484487|FG000|Overall Study|Lost to Follow-up|2
7270316|NCT00415363|11484488|FG001|Overall Study|Lost to Follow-up|1
7586038|NCT03245450|11991678|FG004|Overall Study|Adverse Event|1
7586039|NCT03245450|11991679|FG005|Overall Study|Adverse Event|0
7586040|NCT03245450|11991680|FG006|Overall Study|Adverse Event|2
7586041|NCT03086369|11991707|FG000|Overall Study|Lost to Follow-up|1
7586042|NCT03086369|11991708|FG001|Overall Study|Lost to Follow-up|0
7586043|NCT03086369|11991709|FG002|Overall Study|Lost to Follow-up|0
7586044|NCT03086369|11991710|FG003|Overall Study|Lost to Follow-up|2
7586045|NCT03086369|11991711|FG004|Overall Study|Lost to Follow-up|1
7586046|NCT03086369|11991707|FG000|Overall Study|Physician Decision|0
7586047|NCT03086369|11991708|FG001|Overall Study|Physician Decision|0
7586048|NCT03086369|11991709|FG002|Overall Study|Physician Decision|0
7586049|NCT03086369|11991710|FG003|Overall Study|Physician Decision|1
7586050|NCT03086369|11991711|FG004|Overall Study|Physician Decision|2
7586051|NCT03086369|11991707|FG000|Overall Study|Withdrawal by Subject|0
7586052|NCT03086369|11991708|FG001|Overall Study|Withdrawal by Subject|0
7586053|NCT03086369|11991709|FG002|Overall Study|Withdrawal by Subject|0
7586054|NCT03086369|11991710|FG003|Overall Study|Withdrawal by Subject|5
7586055|NCT03086369|11991711|FG004|Overall Study|Withdrawal by Subject|3
7586056|NCT03086369|11991707|FG000|Overall Study|Progressive Disease|0
7586057|NCT03086369|11991708|FG001|Overall Study|Progressive Disease|0
7586058|NCT03086369|11991709|FG002|Overall Study|Progressive Disease|0
7586059|NCT03086369|11991710|FG003|Overall Study|Progressive Disease|1
7586060|NCT03086369|11991711|FG004|Overall Study|Progressive Disease|1
7586065|NCT02927847|11991735|FG000|Overall Study|Lost to Follow-up|1
7586066|NCT02927847|11991736|FG001|Overall Study|Lost to Follow-up|0
7586067|NCT02927847|11991735|FG000|Overall Study|Withdrawal by Subject|4
7586068|NCT02927847|11991736|FG001|Overall Study|Withdrawal by Subject|2
7586069|NCT02927847|11991735|FG000|Overall Study|PI withdrawn due to missed visits|1
7586070|NCT02927847|11991736|FG001|Overall Study|PI withdrawn due to missed visits|1
7586071|NCT02892149|11991753|FG000|Overall Study|Death|262
7586072|NCT02892149|11991754|FG001|Overall Study|Death|278
7586073|NCT02892149|11991753|FG000|Overall Study|Withdrawal by Subject|53
7586074|NCT02892149|11991754|FG001|Overall Study|Withdrawal by Subject|47
7586075|NCT02892149|11991753|FG000|Overall Study|Lost to Follow-up|37
7586076|NCT02892149|11991754|FG001|Overall Study|Lost to Follow-up|31
7270317|NCT00415363|11484487|FG000|Overall Study|Physician Decision|3
7270318|NCT00415363|11484488|FG001|Overall Study|Physician Decision|1
7270319|NCT00415363|11484487|FG000|Overall Study|Death|16
7270320|NCT00415363|11484488|FG001|Overall Study|Death|12
7270321|NCT00415363|11484487|FG000|Overall Study|Progressive disease|26
7270322|NCT00415363|11484488|FG001|Overall Study|Progressive disease|32
7270323|NCT00415519|11484515|FG000|Overall Study|Adverse Event|1
7270324|NCT00415519|11484516|FG001|Overall Study|Adverse Event|0
7270325|NCT00415519|11484515|FG000|Overall Study|Withdrawal by Subject|2
7270326|NCT00415519|11484516|FG001|Overall Study|Withdrawal by Subject|0
7270327|NCT00415519|11484515|FG000|Overall Study|Patient's convenience|1
7270328|NCT00415519|11484516|FG001|Overall Study|Patient's convenience|0
7586107|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
7586108|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
7586109|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
7586110|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
7586111|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
7586112|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
7586113|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
7586114|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
7586115|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586116|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586117|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586118|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586119|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586120|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
7586121|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
7586122|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586123|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586124|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586125|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586126|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586127|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
7586128|NCT02720523|11991790|FG000|Period 1: Placebo-controlled Period|Other|0
7586129|NCT02720523|11991791|FG001|Period 1: Placebo-controlled Period|Other|0
7586130|NCT02720523|11991792|FG002|Period 1: Placebo-controlled Period|Other|1
7586131|NCT02720523|11991793|FG003|Period 1: Placebo-controlled Period|Other|1
7586132|NCT02720523|11991794|FG004|Period 1: Placebo-controlled Period|Other|0
7586133|NCT02720523|11991795|FG005|Period 1: Placebo-controlled Period|Other|0
7586134|NCT02720523|11991796|FG006|Period 1: Placebo-controlled Period|Other|0
7586135|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Ongoing|0
7586136|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Ongoing|0
7586137|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Ongoing|0
7586138|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Ongoing|0
7586139|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Ongoing|57
7586140|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Ongoing|54
7586141|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Ongoing|45
7586142|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Adverse Event|0
7586143|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Adverse Event|0
7586144|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Adverse Event|0
7586145|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Adverse Event|0
7586146|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Adverse Event|4
7586147|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Adverse Event|7
7586148|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Adverse Event|11
7586149|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7270382|NCT00415636|11484554|FG000|Overall Study|Adverse Event|0
7586150|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7586151|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7270361|NCT00415597|11484531|FG000|Enrollment|Withdrawal by Subject|1
7270362|NCT00415597|11484531|FG000|Enrollment|Protocol Violation|1
7270363|NCT00415597|11484531|FG000|Treatment|Adverse Event|110
7586152|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
7586153|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
7586154|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7586155|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
7586156|NCT02720523|11991790|FG000|Period 2: Long-term Extension Period|Other|0
7586157|NCT02720523|11991791|FG001|Period 2: Long-term Extension Period|Other|0
7586158|NCT02720523|11991792|FG002|Period 2: Long-term Extension Period|Other|0
7586159|NCT02720523|11991793|FG003|Period 2: Long-term Extension Period|Other|0
7586160|NCT02720523|11991794|FG004|Period 2: Long-term Extension Period|Other|2
7586161|NCT02720523|11991795|FG005|Period 2: Long-term Extension Period|Other|0
7586162|NCT02720523|11991796|FG006|Period 2: Long-term Extension Period|Other|3
7586163|NCT02625324|11991809|FG000|30-Day Follow-up for Primary Endpoint|Death|1
7586164|NCT02625324|11991809|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7586165|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Death|5
7586166|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
7586167|NCT02625324|11991809|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
7586168|NCT02625324|11991809|FG000|12-Month Follow-up Secondary Endpoint|Death|4
7586169|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Death|2
7586170|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7586171|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7586172|NCT02625324|11991809|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7586173|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Death|2
7586174|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
7586175|NCT02625324|11991809|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error to be corrected by site|1
7625985|NCT02617589|12037931|FG000|Treatment Period|Adverse event unrelated to study drug|15
7625986|NCT02617589|12037932|FG001|Treatment Period|Adverse event unrelated to study drug|9
7625987|NCT02617589|12037931|FG000|Treatment Period|Death|1
7625988|NCT02617589|12037932|FG001|Treatment Period|Death|1
7625989|NCT02617589|12037931|FG000|Treatment Period|Study Drug Toxicity|26
7625990|NCT02617589|12037932|FG001|Treatment Period|Study Drug Toxicity|20
7625991|NCT02617589|12037931|FG000|Treatment Period|Disease Progression|214
7625992|NCT02617589|12037932|FG001|Treatment Period|Disease Progression|137
7625993|NCT02617589|12037931|FG000|Treatment Period|Completed Treatment|0
7625994|NCT02617589|12037932|FG001|Treatment Period|Completed Treatment|76
7625995|NCT02614859|12037940|FG000|Overall Study|Physician Decision|0
7625996|NCT02614859|12037941|FG001|Overall Study|Physician Decision|1
7270364|NCT00415597|11484531|FG000|Treatment|Lack of Efficacy|39
7270365|NCT00415597|11484531|FG000|Treatment|Protocol Violation|67
7270366|NCT00415597|11484531|FG000|Treatment|Physician Decision|3
7270367|NCT00415597|11484531|FG000|Treatment|Withdrawal by Subject|51
7270368|NCT00415597|11484531|FG000|Treatment|Lost to Follow-up|28
7270369|NCT00415597|11484531|FG000|Treatment|Drug Screen|2
7270370|NCT00415597|11484531|FG000|Treatment|Administrative|3
7270371|NCT00415597|11484531|FG000|Treatment|Sponsor Decision|1
7270372|NCT00415597|11484531|FG000|Treatment|Multiple Reasons|1
7270373|NCT00415610|11484538|FG000|Overall Study|Death|3
7270374|NCT00415610|11484539|FG001|Overall Study|Death|2
7270375|NCT00415610|11484540|FG002|Overall Study|Death|5
7270376|NCT00415636|11484554|FG000|Overall Study|Symptomatic deterioration|1
7270377|NCT00415636|11484555|FG001|Overall Study|Symptomatic deterioration|0
7270378|NCT00415636|11484556|FG002|Overall Study|Symptomatic deterioration|1
7270379|NCT00415636|11484557|FG003|Overall Study|Symptomatic deterioration|2
7270380|NCT00415636|11484558|FG004|Overall Study|Symptomatic deterioration|0
7270381|NCT00415636|11484559|FG005|Overall Study|Symptomatic deterioration|1
7586192|NCT02468778|11991853|FG000|Overall Study|Death|2
7586193|NCT02468778|11991854|FG001|Overall Study|Death|1
7586194|NCT02468778|11991855|FG002|Overall Study|Death|0
7586195|NCT02468778|11991853|FG000|Overall Study|Lost to Follow-up|1
7586196|NCT02468778|11991854|FG001|Overall Study|Lost to Follow-up|2
7586197|NCT02468778|11991855|FG002|Overall Study|Lost to Follow-up|2
7586198|NCT02468778|11991853|FG000|Overall Study|Withdrawal by Subject|0
7586199|NCT02468778|11991854|FG001|Overall Study|Withdrawal by Subject|1
7586200|NCT02468778|11991855|FG002|Overall Study|Withdrawal by Subject|1
7586201|NCT02435849|11991863|FG000|Overall Study|Enrolled but not infused|18
7586202|NCT02435849|11991863|FG000|Overall Study|Death|16
7270383|NCT00415636|11484555|FG001|Overall Study|Adverse Event|0
7270384|NCT00415636|11484556|FG002|Overall Study|Adverse Event|0
7270385|NCT00415636|11484557|FG003|Overall Study|Adverse Event|1
7586203|NCT02435849|11991863|FG000|Overall Study|Lack of Efficacy|9
7586204|NCT02435849|11991863|FG000|Overall Study|New therapy for study indication|7
7586205|NCT02435849|11991863|FG000|Overall Study|Subject/guardian decision|2
7586206|NCT02435849|11991863|FG000|Overall Study|Study follow-up ongoing|45
7270386|NCT00415636|11484558|FG004|Overall Study|Adverse Event|1
7270387|NCT00415636|11484559|FG005|Overall Study|Adverse Event|0
7586265|NCT02311478|11991926|FG000|Overall Study|Withdrawal by Subject|1
7586266|NCT02311478|11991926|FG000|Overall Study|Lost to Follow-up|5
7586267|NCT02311478|11991926|FG000|Overall Study|Failed IUD Insertion|1
7586268|NCT02292238|11991933|FG000|Overall Study|Protocol Violation|1
7586269|NCT02292238|11991934|FG001|Overall Study|Protocol Violation|2
7586270|NCT02292238|11991933|FG000|Overall Study|Withdrawal by Subject|2
7586271|NCT02292238|11991934|FG001|Overall Study|Withdrawal by Subject|1
7586272|NCT02292238|11991933|FG000|Overall Study|Lost to Follow-up|1
7586273|NCT02292238|11991934|FG001|Overall Study|Lost to Follow-up|0
7586274|NCT02292238|11991933|FG000|Overall Study|Physician Decision|0
7586275|NCT02292238|11991934|FG001|Overall Study|Physician Decision|1
7586276|NCT02277119|11991953|FG000|Overall Study|Lack of Efficacy|1
7586277|NCT02277119|11991954|FG001|Overall Study|Lack of Efficacy|1
7586278|NCT02277119|11991955|FG002|Overall Study|Lack of Efficacy|1
7586279|NCT02277119|11991953|FG000|Overall Study|Protocol Violation|2
7586280|NCT02277119|11991954|FG001|Overall Study|Protocol Violation|3
7586281|NCT02277119|11991955|FG002|Overall Study|Protocol Violation|7
7586285|NCT02255097|11991967|FG000|Overall Study|Death|151
7586286|NCT02255097|11991967|FG000|Overall Study|Lost to Follow-up|5
7586287|NCT02255097|11991967|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8
7586288|NCT02255097|11991967|FG000|Overall Study|Withdrawal by Subject|7
7586289|NCT02255097|11991967|FG000|Overall Study|Allocated but not treated|1
7586290|NCT02200614|11991978|FG000|Double Blind Treatment|Adverse Event|86
7586291|NCT02200614|11991979|FG001|Double Blind Treatment|Adverse Event|48
7586292|NCT02200614|11991978|FG000|Double Blind Treatment|Confirmed metastasis|120
7586293|NCT02200614|11991979|FG001|Double Blind Treatment|Confirmed metastasis|140
7586294|NCT02200614|11991978|FG000|Double Blind Treatment|Judgment of the investigator|59
7586295|NCT02200614|11991979|FG001|Double Blind Treatment|Judgment of the investigator|99
7586296|NCT02200614|11991978|FG000|Double Blind Treatment|Metastasis by local reading|1
7586297|NCT02200614|11991979|FG001|Double Blind Treatment|Metastasis by local reading|3
7586298|NCT02200614|11991978|FG000|Double Blind Treatment|Other reason|6
7586299|NCT02200614|11991979|FG001|Double Blind Treatment|Other reason|2
7586300|NCT02200614|11991978|FG000|Double Blind Treatment|Personal reason|77
7586301|NCT02200614|11991979|FG001|Double Blind Treatment|Personal reason|85
7586302|NCT02200614|11991978|FG000|Double Blind Treatment|Protocol deviation|14
7586303|NCT02200614|11991979|FG001|Double Blind Treatment|Protocol deviation|7
7586304|NCT02200614|11991978|FG000|Double Blind Treatment|Not treated|1
7586305|NCT02200614|11991979|FG001|Double Blind Treatment|Not treated|0
7586306|NCT02200614|11991978|FG000|Open Label|Adverse Event|41
7586307|NCT02200614|11991979|FG001|Open Label|Adverse Event|11
7586308|NCT02200614|11991978|FG000|Open Label|Confirmed metastasis|1
7586309|NCT02200614|11991979|FG001|Open Label|Confirmed metastasis|0
7586310|NCT02200614|11991978|FG000|Open Label|Judgment of the investigator|29
7586311|NCT02200614|11991979|FG001|Open Label|Judgment of the investigator|2
7586312|NCT02200614|11991978|FG000|Open Label|Metastasis by local reading|138
7586313|NCT02200614|11991979|FG001|Open Label|Metastasis by local reading|27
7586314|NCT02200614|11991978|FG000|Open Label|Other reason|22
7586315|NCT02200614|11991979|FG001|Open Label|Other reason|4
7586316|NCT02200614|11991978|FG000|Open Label|Personal reason|60
7586317|NCT02200614|11991979|FG001|Open Label|Personal reason|8
7586318|NCT02200614|11991978|FG000|Open Label|Protocol deviation|3
7586319|NCT02200614|11991979|FG001|Open Label|Protocol deviation|2
7586320|NCT02200614|11991978|FG000|Open Label|Missing|2
7586321|NCT02200614|11991979|FG001|Open Label|Missing|2
7586326|NCT02083081|11991993|FG000|Overall Study|Lost to Follow-up|31
7586327|NCT02083081|11991994|FG001|Overall Study|Lost to Follow-up|9
7586328|NCT02069899|11992003|FG000|Overall Study|Adverse Event|6
7586329|NCT02069899|11992004|FG001|Overall Study|Adverse Event|0
7586330|NCT02069899|11992005|FG002|Overall Study|Adverse Event|1
7586331|NCT02069899|11992003|FG000|Overall Study|Withdrawal by Participant|2
7586332|NCT02069899|11992004|FG001|Overall Study|Withdrawal by Participant|0
7586333|NCT02069899|11992005|FG002|Overall Study|Withdrawal by Participant|0
7586334|NCT02069899|11992003|FG000|Overall Study|Lost to Follow-up|1
7270388|NCT00415636|11484554|FG000|Overall Study|Withdrawal by Subject|0
7270389|NCT00415636|11484555|FG001|Overall Study|Withdrawal by Subject|0
7270390|NCT00415636|11484556|FG002|Overall Study|Withdrawal by Subject|0
7270391|NCT00415636|11484557|FG003|Overall Study|Withdrawal by Subject|0
7270392|NCT00415636|11484558|FG004|Overall Study|Withdrawal by Subject|1
7270393|NCT00415636|11484559|FG005|Overall Study|Withdrawal by Subject|0
7270394|NCT00415636|11484554|FG000|Overall Study|Disease progression|0
7270395|NCT00415636|11484555|FG001|Overall Study|Disease progression|0
7270396|NCT00415636|11484556|FG002|Overall Study|Disease progression|0
7270397|NCT00415636|11484557|FG003|Overall Study|Disease progression|3
7270398|NCT00415636|11484558|FG004|Overall Study|Disease progression|0
7270399|NCT00415636|11484559|FG005|Overall Study|Disease progression|1
7586335|NCT02069899|11992004|FG001|Overall Study|Lost to Follow-up|0
7586336|NCT02069899|11992005|FG002|Overall Study|Lost to Follow-up|1
7586337|NCT02069899|11992003|FG000|Overall Study|Other|4
7586338|NCT02069899|11992004|FG001|Overall Study|Other|0
7586339|NCT02069899|11992005|FG002|Overall Study|Other|0
7586340|NCT02069899|11992003|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7586341|NCT02069899|11992004|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1
7586342|NCT02069899|11992005|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0
7586395|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586343|NCT02069899|11992003|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7586344|NCT02069899|11992004|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0
7586345|NCT02069899|11992005|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1
7270400|NCT00415909|11484599|FG000|Overall Study|Withdrawal by Subject|2
7270401|NCT00415909|11484599|FG000|Overall Study|Death|1
7270402|NCT00416078|11484605|FG000|Overall Study|Death|3
7270403|NCT00416078|11484606|FG001|Overall Study|Death|4
7270404|NCT00416078|11484605|FG000|Overall Study|Withdrawal by Subject|3
7270405|NCT00416078|11484606|FG001|Overall Study|Withdrawal by Subject|2
7270406|NCT00416078|11484605|FG000|Overall Study|Physician Decision|1
7270407|NCT00416078|11484606|FG001|Overall Study|Physician Decision|0
7270408|NCT00416078|11484605|FG000|Overall Study|Lost to Follow-up|4
7270409|NCT00416078|11484606|FG001|Overall Study|Lost to Follow-up|2
7270410|NCT00416195|11484629|FG000|Overall Study|Adverse Event|1
7270411|NCT00416195|11484630|FG001|Overall Study|Adverse Event|2
7270412|NCT00416195|11484629|FG000|Overall Study|Protocol Violation|1
7270413|NCT00416195|11484630|FG001|Overall Study|Protocol Violation|1
7270414|NCT00416195|11484629|FG000|Overall Study|Other|0
7270415|NCT00416195|11484630|FG001|Overall Study|Other|1
7586351|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586352|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2
7586353|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7586354|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6
7586355|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4
7586356|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1
7586357|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586358|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586359|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586360|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0
7586361|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586362|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586363|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586364|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7586365|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1
7586366|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586367|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586368|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586369|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7586370|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0
7270416|NCT00416312|11484636|FG000|Overall Study|tumors not visible on imaging|2
7270417|NCT00416455|11484642|FG000|Overall Study|PET / CT not done|3
7270418|NCT00416455|11484643|FG001|Overall Study|PET / CT not done|5
7270419|NCT00416455|11484642|FG000|Overall Study|PET / CT poor quality|2
7270420|NCT00416455|11484643|FG001|Overall Study|PET / CT poor quality|1
7586371|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586372|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586373|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586374|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13
7586375|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18
7586376|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1
7586377|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586378|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586379|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586380|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0
7586381|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7586382|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586383|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586384|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3
7586385|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1
7586386|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586387|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586388|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586389|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586390|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0
7586391|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586392|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586393|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7586394|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1
7586396|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586397|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586398|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586399|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586400|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0
7586401|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586402|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586403|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586404|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586405|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1
7586406|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586407|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586408|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586409|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7270421|NCT00416455|11484642|FG000|Overall Study|Inadequate pathology|11
7270422|NCT00416455|11484643|FG001|Overall Study|Inadequate pathology|2
7270423|NCT00416520|11484671|FG000|Open-label Period|Adverse Event|28
7270424|NCT00416520|11484672|FG001|Open-label Period|Adverse Event|10
7270425|NCT00416520|11484673|FG002|Open-label Period|Adverse Event|0
7270426|NCT00416520|11484674|FG003|Open-label Period|Adverse Event|0
7270427|NCT00416520|11484671|FG000|Open-label Period|Death|2
7270428|NCT00416520|11484672|FG001|Open-label Period|Death|1
7270429|NCT00416520|11484673|FG002|Open-label Period|Death|0
7270430|NCT00416520|11484674|FG003|Open-label Period|Death|0
7270431|NCT00416520|11484671|FG000|Open-label Period|Lack of Efficacy|8
7270432|NCT00416520|11484672|FG001|Open-label Period|Lack of Efficacy|1
7270433|NCT00416520|11484673|FG002|Open-label Period|Lack of Efficacy|0
7270434|NCT00416520|11484674|FG003|Open-label Period|Lack of Efficacy|0
7270435|NCT00416520|11484671|FG000|Open-label Period|Protocol Violation|3
7270436|NCT00416520|11484672|FG001|Open-label Period|Protocol Violation|3
7586410|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0
7586411|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7270437|NCT00416520|11484673|FG002|Open-label Period|Protocol Violation|0
7270438|NCT00416520|11484674|FG003|Open-label Period|Protocol Violation|0
7270439|NCT00416520|11484671|FG000|Open-label Period|Withdrawal by Subject|16
7270440|NCT00416520|11484672|FG001|Open-label Period|Withdrawal by Subject|5
7270441|NCT00416520|11484673|FG002|Open-label Period|Withdrawal by Subject|0
7586412|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586413|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586414|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4
7586415|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1
7586416|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2
7586417|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586418|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586419|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586420|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0
7586421|NCT02018861|11992028|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586422|NCT02018861|11992029|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586423|NCT02018861|11992030|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586424|NCT02018861|11992031|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2
7586425|NCT02018861|11992032|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1
7586426|NCT02018861|11992033|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586427|NCT02018861|11992034|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586428|NCT02018861|11992035|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586429|NCT02018861|11992036|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586430|NCT02018861|11992037|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0
7586431|NCT02018861|11992028|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586432|NCT02018861|11992029|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586433|NCT02018861|11992030|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586434|NCT02018861|11992031|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586435|NCT02018861|11992032|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586436|NCT02018861|11992033|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586437|NCT02018861|11992034|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5
7586438|NCT02018861|11992035|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2
7586439|NCT02018861|11992036|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586440|NCT02018861|11992037|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0
7586441|NCT02018861|11992028|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586442|NCT02018861|11992029|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586443|NCT02018861|11992030|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586444|NCT02018861|11992031|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586445|NCT02018861|11992032|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586446|NCT02018861|11992033|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586447|NCT02018861|11992034|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3
7586448|NCT02018861|11992035|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1
7586449|NCT02018861|11992036|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586450|NCT02018861|11992037|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0
7586451|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586452|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586453|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586454|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586455|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586456|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586457|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586458|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586459|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1
7586460|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0
7586461|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586462|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586463|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586464|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586465|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586466|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586467|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586468|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586469|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1
7586470|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0
7586471|NCT02018861|11992028|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586472|NCT02018861|11992029|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586473|NCT02018861|11992030|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586474|NCT02018861|11992031|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586475|NCT02018861|11992032|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586476|NCT02018861|11992033|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586477|NCT02018861|11992034|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586478|NCT02018861|11992035|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7586479|NCT02018861|11992036|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1
7586480|NCT02018861|11992037|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0
7270442|NCT00416520|11484674|FG003|Open-label Period|Withdrawal by Subject|0
7270443|NCT00416520|11484671|FG000|Open-label Period|Other Reasons|3
7270444|NCT00416520|11484672|FG001|Open-label Period|Other Reasons|12
7270445|NCT00416520|11484673|FG002|Open-label Period|Other Reasons|0
7270446|NCT00416520|11484674|FG003|Open-label Period|Other Reasons|0
7270447|NCT00416520|11484671|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
7270448|NCT00416520|11484672|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
7270449|NCT00416520|11484673|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
7270450|NCT00416520|11484674|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
7270451|NCT00416520|11484671|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7270452|NCT00416520|11484672|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7270453|NCT00416520|11484673|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
7270454|NCT00416520|11484674|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
7270455|NCT00416520|11484671|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
7270456|NCT00416520|11484672|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
7270457|NCT00416520|11484673|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
7270458|NCT00416520|11484674|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
7270459|NCT00416598|11484697|FG000|Induction & Intensification|Adverse Event|38
7270460|NCT00416598|11484697|FG000|Induction & Intensification|Death|32
7270461|NCT00416598|11484697|FG000|Induction & Intensification|Withdrawal by Subject|46
7270462|NCT00416598|11484697|FG000|Induction & Intensification|Alternative Treatment|135
7270463|NCT00416598|11484697|FG000|Induction & Intensification|Physician discretion/other medical issue|45
7270464|NCT00416598|11484697|FG000|Induction & Intensification|Relapse/progression|29
7270465|NCT00416598|11484697|FG000|Induction & Intensification|Failed induction|87
7270466|NCT00416598|11484697|FG000|Decitabine Maintenance|Adverse Event|5
7270467|NCT00416598|11484697|FG000|Decitabine Maintenance|Withdrawal by Subject|18
7586493|NCT01721759|11992075|FG000|Treatment Period|Disease Progression|85
7586494|NCT01721759|11992075|FG000|Treatment Period|Study drug toxicity|14
7586495|NCT01721759|11992075|FG000|Treatment Period|Death|1
7586496|NCT01721759|11992075|FG000|Treatment Period|Adverse event unrelated to study drug|11
7586497|NCT01721759|11992075|FG000|Treatment Period|Participant request to withdraw|3
7586498|NCT01721759|11992075|FG000|Treatment Period|Other Reasons|3
7586499|NCT01721759|11992075|FG000|End of Study Period|Participant Withdrew Consent|5
7586500|NCT01721759|11992075|FG000|End of Study Period|Death|101
7586501|NCT01721759|11992075|FG000|End of Study Period|Lost to Follow-up|1
7586502|NCT01721759|11992075|FG000|End of Study Period|Other Reasons|10
7270468|NCT00416598|11484697|FG000|Decitabine Maintenance|Progression/relapse|38
7270469|NCT00416598|11484697|FG000|Decitabine Maintenance|Alternative treatment|2
7586551|NCT01544335|11992144|FG000|Overall Study|Lost to Follow-up|27
7586552|NCT01544335|11992144|FG000|Overall Study|Death|4
7586553|NCT01544335|11992144|FG000|Overall Study|Disease progression|3
7586554|NCT01544335|11992144|FG000|Overall Study|Baseline Measurements not Available|19
7586576|NCT01451515|11992177|FG000|Overall Study|Death|0
7586577|NCT01451515|11992178|FG001|Overall Study|Death|1
7586578|NCT01451515|11992179|FG002|Overall Study|Death|0
7586579|NCT01451515|11992177|FG000|Overall Study|Withdrawal by Subject|0
7586580|NCT01451515|11992178|FG001|Overall Study|Withdrawal by Subject|1
7586581|NCT01451515|11992179|FG002|Overall Study|Withdrawal by Subject|0
7586582|NCT01451515|11992177|FG000|Overall Study|Development of unacceptable toxicity during treatment|0
7586583|NCT01451515|11992178|FG001|Overall Study|Development of unacceptable toxicity during treatment|0
7586584|NCT01451515|11992179|FG002|Overall Study|Development of unacceptable toxicity during treatment|1
7586585|NCT01451515|11992177|FG000|Overall Study|Relapse (except CNS)|1
7586586|NCT01451515|11992178|FG001|Overall Study|Relapse (except CNS)|1
7586587|NCT01451515|11992179|FG002|Overall Study|Relapse (except CNS)|0
7586714|NCT01302834|11992273|FG000|Overall Study|Protocol Violation|17
7586715|NCT01302834|11992274|FG001|Overall Study|Protocol Violation|23
7586716|NCT01302834|11992273|FG000|Overall Study|HIV positive|1
7586717|NCT01302834|11992274|FG001|Overall Study|HIV positive|3
7586730|NCT01177540|11992313|FG000|Overall Study|Adverse Event|1
7388249|NCT01218126|11647006|FG000|Overall Study|Withdrawal by Subject|2
7586731|NCT01177540|11992314|FG001|Overall Study|Adverse Event|0
7586794|NCT00792259|11992372|FG000|Overall Study|Poor Quality Scans|1
7586795|NCT00792259|11992373|FG001|Overall Study|Poor Quality Scans|0
7586796|NCT00792259|11992374|FG002|Overall Study|Poor Quality Scans|0
7586797|NCT00662792|11992382|FG000|Period 1|Personal Reasons|0
7586798|NCT00662792|11992383|FG001|Period 1|Personal Reasons|0
7586799|NCT00662792|11992384|FG002|Period 1|Personal Reasons|1
7586800|NCT00662792|11992385|FG003|Period 1|Personal Reasons|0
7586801|NCT00662792|11992382|FG000|Period 1|Refused continuing medication|0
7586802|NCT00662792|11992383|FG001|Period 1|Refused continuing medication|1
7586803|NCT00662792|11992384|FG002|Period 1|Refused continuing medication|1
7586804|NCT00662792|11992385|FG003|Period 1|Refused continuing medication|0
7586805|NCT00662792|11992382|FG000|Period 1|Lost to Follow-up|1
7586806|NCT00662792|11992383|FG001|Period 1|Lost to Follow-up|0
7586807|NCT00662792|11992384|FG002|Period 1|Lost to Follow-up|0
7586808|NCT00662792|11992385|FG003|Period 1|Lost to Follow-up|0
7586809|NCT00662792|11992382|FG000|Period 1|Other adverse event (AE)|0
7586810|NCT00662792|11992383|FG001|Period 1|Other adverse event (AE)|2
7586811|NCT00662792|11992384|FG002|Period 1|Other adverse event (AE)|0
7586812|NCT00662792|11992385|FG003|Period 1|Other adverse event (AE)|0
7586813|NCT00662792|11992382|FG000|Period 1|Worsening of disease under study (AE)|1
7586814|NCT00662792|11992383|FG001|Period 1|Worsening of disease under study (AE)|3
7586815|NCT00662792|11992384|FG002|Period 1|Worsening of disease under study (AE)|2
7586816|NCT00662792|11992385|FG003|Period 1|Worsening of disease under study (AE)|0
7586817|NCT00662792|11992382|FG000|Period 1|Not treated|0
7586818|NCT00662792|11992383|FG001|Period 1|Not treated|1
7586819|NCT00662792|11992384|FG002|Period 1|Not treated|0
7388250|NCT01218126|11647007|FG001|Overall Study|Withdrawal by Subject|5
7586820|NCT00662792|11992385|FG003|Period 1|Not treated|0
7586821|NCT00662792|11992382|FG000|Period 2|Worsening of disease under study|1
7586822|NCT00662792|11992383|FG001|Period 2|Worsening of disease under study|0
7586823|NCT00662792|11992384|FG002|Period 2|Worsening of disease under study|0
7586824|NCT00662792|11992385|FG003|Period 2|Worsening of disease under study|3
7586825|NCT00662792|11992382|FG000|Period 3|Refused continuing medication|1
7586826|NCT00662792|11992383|FG001|Period 3|Refused continuing medication|0
7586827|NCT00662792|11992384|FG002|Period 3|Refused continuing medication|1
7586828|NCT00662792|11992385|FG003|Period 3|Refused continuing medication|0
7586829|NCT00662792|11992382|FG000|Period 3|Other adverse event (AE)|0
7586830|NCT00662792|11992383|FG001|Period 3|Other adverse event (AE)|0
7586831|NCT00662792|11992384|FG002|Period 3|Other adverse event (AE)|1
7586832|NCT00662792|11992385|FG003|Period 3|Other adverse event (AE)|1
7586833|NCT00662792|11992382|FG000|Period 4|Refused continuing medication|0
7586834|NCT00662792|11992383|FG001|Period 4|Refused continuing medication|1
7586835|NCT00662792|11992384|FG002|Period 4|Refused continuing medication|0
7586836|NCT00662792|11992385|FG003|Period 4|Refused continuing medication|0
7586837|NCT00662792|11992382|FG000|Period 4|Other adverse event (AE)|1
7586838|NCT00662792|11992383|FG001|Period 4|Other adverse event (AE)|0
7586839|NCT00662792|11992384|FG002|Period 4|Other adverse event (AE)|0
7586840|NCT00662792|11992385|FG003|Period 4|Other adverse event (AE)|0
7586841|NCT00662792|11992382|FG000|Period 4|Worsening of disease under study (AE)|0
7586842|NCT00662792|11992383|FG001|Period 4|Worsening of disease under study (AE)|0
7586843|NCT00662792|11992384|FG002|Period 4|Worsening of disease under study (AE)|0
7586844|NCT00662792|11992385|FG003|Period 4|Worsening of disease under study (AE)|1
7586846|NCT00567580|11992427|FG000|Overall Study|Protocol Violation|28
7586847|NCT00567580|11992428|FG001|Overall Study|Protocol Violation|24
7586848|NCT00567580|11992429|FG002|Overall Study|Protocol Violation|24
7586849|NCT00528021|11992444|FG000|Overall Study|Lack of Efficacy|17
7586850|NCT00528021|11992445|FG001|Overall Study|Lack of Efficacy|13
7586851|NCT00528021|11992446|FG002|Overall Study|Lack of Efficacy|7
7586852|NCT00528021|11992447|FG003|Overall Study|Lack of Efficacy|9
7626017|NCT02519348|12037973|FG000|Overall Study|Death|31
7626018|NCT02519348|12037974|FG001|Overall Study|Death|74
7626019|NCT02519348|12037975|FG002|Overall Study|Death|47
7626020|NCT02519348|12037976|FG003|Overall Study|Death|54
7626021|NCT02519348|12037977|FG004|Overall Study|Death|63
7626022|NCT02519348|12037978|FG005|Overall Study|Death|18
7626023|NCT02519348|12037979|FG006|Overall Study|Death|2
7626024|NCT02519348|12037980|FG007|Overall Study|Death|5
7626025|NCT02519348|12037981|FG008|Overall Study|Death|5
7626026|NCT02519348|12037973|FG000|Overall Study|Withdrawal by Subject|4
7626027|NCT02519348|12037974|FG001|Overall Study|Withdrawal by Subject|7
7626028|NCT02519348|12037975|FG002|Overall Study|Withdrawal by Subject|4
7626029|NCT02519348|12037976|FG003|Overall Study|Withdrawal by Subject|3
7626030|NCT02519348|12037977|FG004|Overall Study|Withdrawal by Subject|3
7626031|NCT02519348|12037978|FG005|Overall Study|Withdrawal by Subject|2
7626032|NCT02519348|12037979|FG006|Overall Study|Withdrawal by Subject|0
7626033|NCT02519348|12037980|FG007|Overall Study|Withdrawal by Subject|0
7626034|NCT02519348|12037981|FG008|Overall Study|Withdrawal by Subject|1
7626035|NCT02519348|12037973|FG000|Overall Study|Lost to Follow-up|0
7626036|NCT02519348|12037974|FG001|Overall Study|Lost to Follow-up|0
7626037|NCT02519348|12037975|FG002|Overall Study|Lost to Follow-up|1
7626038|NCT02519348|12037976|FG003|Overall Study|Lost to Follow-up|0
7626039|NCT02519348|12037977|FG004|Overall Study|Lost to Follow-up|2
7626040|NCT02519348|12037978|FG005|Overall Study|Lost to Follow-up|1
7626041|NCT02519348|12037979|FG006|Overall Study|Lost to Follow-up|1
7626042|NCT02519348|12037980|FG007|Overall Study|Lost to Follow-up|0
7626043|NCT02519348|12037981|FG008|Overall Study|Lost to Follow-up|0
7626044|NCT02519348|12037973|FG000|Overall Study|Other|0
7626045|NCT02519348|12037974|FG001|Overall Study|Other|3
7626046|NCT02519348|12037975|FG002|Overall Study|Other|0
7626047|NCT02519348|12037976|FG003|Overall Study|Other|0
7626048|NCT02519348|12037977|FG004|Overall Study|Other|1
7626049|NCT02519348|12037978|FG005|Overall Study|Other|0
7626050|NCT02519348|12037979|FG006|Overall Study|Other|0
7626051|NCT02519348|12037980|FG007|Overall Study|Other|0
7626052|NCT02519348|12037981|FG008|Overall Study|Other|0
7626053|NCT02519348|12037973|FG000|Overall Study|Ongoing at the time of data cut-off date|5
7626054|NCT02519348|12037974|FG001|Overall Study|Ongoing at the time of data cut-off date|20
7626055|NCT02519348|12037975|FG002|Overall Study|Ongoing at the time of data cut-off date|23
7626056|NCT02519348|12037976|FG003|Overall Study|Ongoing at the time of data cut-off date|12
7626057|NCT02519348|12037977|FG004|Overall Study|Ongoing at the time of data cut-off date|15
7626058|NCT02519348|12037978|FG005|Overall Study|Ongoing at the time of data cut-off date|26
7626059|NCT02519348|12037979|FG006|Overall Study|Ongoing at the time of data cut-off date|0
7626060|NCT02519348|12037980|FG007|Overall Study|Ongoing at the time of data cut-off date|0
7626061|NCT02519348|12037981|FG008|Overall Study|Ongoing at the time of data cut-off date|0
7586887|NCT00799266|11992533|FG000|Overall Study|Adverse Event|0
7586888|NCT00799266|11992534|FG001|Overall Study|Adverse Event|1
7586889|NCT00799266|11992533|FG000|Overall Study|Subject withdrew consent|3
7586890|NCT00799266|11992534|FG001|Overall Study|Subject withdrew consent|0
7586891|NCT00844480|11992546|FG000|Overall Study|Withdrawal by Subject|2
7586892|NCT00844480|11992547|FG001|Overall Study|Withdrawal by Subject|3
7586893|NCT00873366|11992557|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1
7586894|NCT00873366|11992557|FG000|Overall Study|Off tamoxifen due to side effects|2
7586895|NCT00873366|11992557|FG000|Overall Study|Refused to continue DM-BT testing|3
7586896|NCT00930722|11992593|FG000|Overall Study|Lost to Follow-up|16
7586897|NCT00930722|11992593|FG000|Overall Study|No longer willing to participate|9
7586898|NCT00930722|11992593|FG000|Overall Study|Study terminated by sponsor|2
7586899|NCT00940498|11992605|FG000|Overall Study|Death|2
7586900|NCT00940498|11992606|FG001|Overall Study|Death|0
7586901|NCT00940498|11992607|FG002|Overall Study|Death|0
7586902|NCT00940498|11992608|FG003|Overall Study|Death|1
7586903|NCT00940498|11992609|FG004|Overall Study|Death|5
7586904|NCT00940498|11992610|FG005|Overall Study|Death|0
7586905|NCT00940498|11992611|FG006|Overall Study|Death|1
7586906|NCT00940498|11992612|FG007|Overall Study|Death|0
7586907|NCT00940498|11992605|FG000|Overall Study|Lost to Follow-up|1
7586908|NCT00940498|11992606|FG001|Overall Study|Lost to Follow-up|1
7586909|NCT00940498|11992607|FG002|Overall Study|Lost to Follow-up|2
7586910|NCT00940498|11992608|FG003|Overall Study|Lost to Follow-up|0
7586911|NCT00940498|11992609|FG004|Overall Study|Lost to Follow-up|1
7586912|NCT00940498|11992610|FG005|Overall Study|Lost to Follow-up|0
7586913|NCT00940498|11992611|FG006|Overall Study|Lost to Follow-up|0
7586914|NCT00940498|11992612|FG007|Overall Study|Lost to Follow-up|1
7586915|NCT00940498|11992605|FG000|Overall Study|Disease Progression|0
7586916|NCT00940498|11992606|FG001|Overall Study|Disease Progression|0
7586917|NCT00940498|11992607|FG002|Overall Study|Disease Progression|1
7586918|NCT00940498|11992608|FG003|Overall Study|Disease Progression|1
7586919|NCT00940498|11992609|FG004|Overall Study|Disease Progression|0
7586920|NCT00940498|11992610|FG005|Overall Study|Disease Progression|1
7586921|NCT00940498|11992611|FG006|Overall Study|Disease Progression|0
7586922|NCT00940498|11992612|FG007|Overall Study|Disease Progression|0
7586923|NCT00940498|11992605|FG000|Overall Study|Physician Decision|0
7586924|NCT00940498|11992606|FG001|Overall Study|Physician Decision|0
7586925|NCT00940498|11992607|FG002|Overall Study|Physician Decision|0
7586926|NCT00940498|11992608|FG003|Overall Study|Physician Decision|0
7586927|NCT00940498|11992609|FG004|Overall Study|Physician Decision|2
7586928|NCT00940498|11992610|FG005|Overall Study|Physician Decision|0
7586929|NCT00940498|11992611|FG006|Overall Study|Physician Decision|0
7586930|NCT00940498|11992612|FG007|Overall Study|Physician Decision|0
7586931|NCT00940498|11992605|FG000|Overall Study|Not treated due to disease related pain|0
7586932|NCT00940498|11992606|FG001|Overall Study|Not treated due to disease related pain|0
7586933|NCT00940498|11992607|FG002|Overall Study|Not treated due to disease related pain|0
7587061|NCT02711137|11992762|FG000|Overall Study|Physician Decision|1
7586934|NCT00940498|11992608|FG003|Overall Study|Not treated due to disease related pain|0
7586935|NCT00940498|11992609|FG004|Overall Study|Not treated due to disease related pain|1
7586936|NCT00940498|11992610|FG005|Overall Study|Not treated due to disease related pain|0
7586937|NCT00940498|11992611|FG006|Overall Study|Not treated due to disease related pain|0
7586938|NCT00940498|11992612|FG007|Overall Study|Not treated due to disease related pain|0
7626062|NCT02429414|12038004|FG000|Overall Study|Physician Decision|0
7626063|NCT02429414|12038005|FG001|Overall Study|Physician Decision|1
7626064|NCT02258659|12038015|FG000|Overall Study|Withdrawal by Subject|1
7626065|NCT02111850|12038030|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626066|NCT02111850|12038031|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626067|NCT02111850|12038032|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626068|NCT02111850|12038033|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626069|NCT02111850|12038034|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1
7626070|NCT02111850|12038035|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626071|NCT02111850|12038036|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626072|NCT02111850|12038037|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626073|NCT02111850|12038038|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626074|NCT02111850|12038039|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626075|NCT02111850|12038040|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
7626076|NCT01483027|12038081|FG000|Overall Study|Administrative Reasons|2
7626077|NCT01483027|12038082|FG001|Overall Study|Administrative Reasons|1
7626078|NCT01483027|12038081|FG000|Overall Study|Withdrawal by Subject|21
7626079|NCT01483027|12038082|FG001|Overall Study|Withdrawal by Subject|32
7626080|NCT01483027|12038081|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22
7626081|NCT01483027|12038082|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24
7626082|NCT01483027|12038081|FG000|Overall Study|Lost to Follow-up|1
7626083|NCT01483027|12038082|FG001|Overall Study|Lost to Follow-up|1
7626084|NCT01483027|12038081|FG000|Overall Study|Adverse Event|0
7626085|NCT01483027|12038082|FG001|Overall Study|Adverse Event|1
7626086|NCT01483027|12038081|FG000|Overall Study|Withdrawal by Subject|0
7626087|NCT01483027|12038082|FG001|Overall Study|Withdrawal by Subject|1
7626088|NCT01379781|12038094|FG000|Overall Study|Lost to Follow-up|11
7626089|NCT01379781|12038095|FG001|Overall Study|Lost to Follow-up|8
7270470|NCT00416598|11484697|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
7586939|NCT04553913|11992645|FG000|Overall Study|patient's block resolved prior to PACU|1
7586940|NCT04553913|11992645|FG000|Overall Study|did not use the device properly|5
7586941|NCT04009824|11992660|FG000|Overall Study|COVID-19 pandemic restriction/closure|2
7586942|NCT04009824|11992661|FG001|Overall Study|COVID-19 pandemic restriction/closure|3
7586943|NCT04009824|11992662|FG002|Overall Study|COVID-19 pandemic restriction/closure|5
7586944|NCT04009824|11992663|FG003|Overall Study|COVID-19 pandemic restriction/closure|2
7586945|NCT04009824|11992664|FG004|Overall Study|COVID-19 pandemic restriction/closure|3
7586946|NCT03449758|11992686|FG000|Overall Study|Major protocol deviation|1
7586947|NCT03449758|11992686|FG000|Overall Study|Treatment inefficacy|5
7586948|NCT03449758|11992686|FG000|Overall Study|Adverse Event|9
7586949|NCT03449758|11992686|FG000|Overall Study|Consent withdrawal|1
7586950|NCT03449758|11992686|FG000|Overall Study|Other unspecified reason|3
7586951|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3
7586952|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586953|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586954|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0
7586955|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7586956|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
7586957|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7586958|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
7586959|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12
7586960|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9
7586961|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7586962|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
7586963|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Death|0
7586964|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Death|1
7586965|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Death|0
7586966|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Death|0
7586967|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586968|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1
7586969|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586970|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0
7586971|NCT03222973|11992693|FG000|Part 1 (Week 0 to Week 72)|Other|8
7586972|NCT03222973|11992694|FG001|Part 1 (Week 0 to Week 72)|Other|2
7586973|NCT03222973|11992695|FG002|Part 1 (Week 0 to Week 72)|Other|0
7586974|NCT03222973|11992696|FG003|Part 1 (Week 0 to Week 72)|Other|0
7586975|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0
7586976|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0
7586977|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2
7586978|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0
7587062|NCT02711137|11992763|FG001|Overall Study|Physician Decision|0
7586979|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7586980|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
7586981|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10
7586982|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11
7586983|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7586984|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0
7586985|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2
7586986|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1
7586987|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0
7586988|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0
7586989|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2
7586990|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1
7586991|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Other|0
7586992|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Other|0
7586993|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Other|84
7586994|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Other|100
7586995|NCT03222973|11992693|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586996|NCT03222973|11992694|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586997|NCT03222973|11992695|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1
7586998|NCT03222973|11992696|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
7586999|NCT03187262|11992706|FG000|Induction|Lack of Efficacy|2
7587000|NCT03187262|11992706|FG000|Induction|Progressive Disease|4
7587001|NCT03187262|11992706|FG000|Consolidation|Progressive Disease|5
7587002|NCT02987959|11992714|FG000|Overall Study|Grantor stopped supply of drugs|6
7587003|NCT02985541|11992718|FG000|Overall Study|Withdrawal by Subject|33
7587004|NCT02985541|11992718|FG000|Overall Study|Lost to Follow-up|26
7587005|NCT02985541|11992718|FG000|Overall Study|Adverse Event|27
7587006|NCT02985541|11992718|FG000|Overall Study|Physician Decision|2
7587007|NCT02985541|11992718|FG000|Overall Study|Pregnancy|2
7587008|NCT02985541|11992718|FG000|Overall Study|Wish for pregnancy|44
7587009|NCT02985541|11992718|FG000|Overall Study|Other reason|5
7587010|NCT02985541|11992718|FG000|Overall Study|Not valid for analysis|2
7587011|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Adverse Event|5
7587012|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Adverse Event|0
7587013|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
7587014|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
7587015|NCT02960893|11992724|FG000|Randomization Phase (8-week)|Reason Not Specified|0
7587016|NCT02960893|11992725|FG001|Randomization Phase (8-week)|Reason Not Specified|1
7587017|NCT02960893|11992724|FG000|Extension Phase (48-week)|Adverse Event|2
7587018|NCT02960893|11992725|FG001|Extension Phase (48-week)|Adverse Event|3
7587019|NCT02960893|11992724|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
7587020|NCT02960893|11992725|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
7587021|NCT02960893|11992724|FG000|Extension Phase (48-week)|Other Reason|2
7587022|NCT02960893|11992725|FG001|Extension Phase (48-week)|Other Reason|1
7587023|NCT02960893|11992724|FG000|Extension Phase (48-week)|Lost to Follow-up|1
7587024|NCT02960893|11992725|FG001|Extension Phase (48-week)|Lost to Follow-up|1
7587025|NCT02960893|11992724|FG000|Extension Phase (48-week)|Sponsors Decision|1
7587026|NCT02960893|11992725|FG001|Extension Phase (48-week)|Sponsors Decision|0
7587027|NCT02940522|11992740|FG000|Overall Study|Lost to Follow-up|1
7587028|NCT02940522|11992741|FG001|Overall Study|Lost to Follow-up|2
7587029|NCT02940522|11992740|FG000|Overall Study|Withdrawal by Subject|1
7587030|NCT02940522|11992741|FG001|Overall Study|Withdrawal by Subject|0
7587031|NCT02711137|11992762|FG000|Overall Study|Death|1
7587032|NCT02711137|11992763|FG001|Overall Study|Death|4
7587033|NCT02711137|11992764|FG002|Overall Study|Death|5
7587034|NCT02711137|11992765|FG003|Overall Study|Death|5
7587035|NCT02711137|11992766|FG004|Overall Study|Death|3
7587036|NCT02711137|11992767|FG005|Overall Study|Death|1
7587037|NCT02711137|11992768|FG006|Overall Study|Death|61
7587038|NCT02711137|11992769|FG007|Overall Study|Death|3
7587039|NCT02711137|11992770|FG008|Overall Study|Death|0
7587040|NCT02711137|11992771|FG009|Overall Study|Death|1
7587041|NCT02711137|11992772|FG010|Overall Study|Death|1
7587042|NCT02711137|11992773|FG011|Overall Study|Death|1
7587043|NCT02711137|11992774|FG012|Overall Study|Death|0
7587044|NCT02711137|11992775|FG013|Overall Study|Death|0
7587045|NCT02711137|11992776|FG014|Overall Study|Death|0
7587046|NCT02711137|11992762|FG000|Overall Study|Study Terminated by Sponsor|0
7587047|NCT02711137|11992763|FG001|Overall Study|Study Terminated by Sponsor|0
7587048|NCT02711137|11992764|FG002|Overall Study|Study Terminated by Sponsor|1
7587049|NCT02711137|11992765|FG003|Overall Study|Study Terminated by Sponsor|0
7587050|NCT02711137|11992766|FG004|Overall Study|Study Terminated by Sponsor|0
7587051|NCT02711137|11992767|FG005|Overall Study|Study Terminated by Sponsor|0
7587052|NCT02711137|11992768|FG006|Overall Study|Study Terminated by Sponsor|1
7587053|NCT02711137|11992769|FG007|Overall Study|Study Terminated by Sponsor|0
7587054|NCT02711137|11992770|FG008|Overall Study|Study Terminated by Sponsor|0
7587055|NCT02711137|11992771|FG009|Overall Study|Study Terminated by Sponsor|0
7587056|NCT02711137|11992772|FG010|Overall Study|Study Terminated by Sponsor|0
7587057|NCT02711137|11992773|FG011|Overall Study|Study Terminated by Sponsor|0
7587058|NCT02711137|11992774|FG012|Overall Study|Study Terminated by Sponsor|0
7587059|NCT02711137|11992775|FG013|Overall Study|Study Terminated by Sponsor|0
7587060|NCT02711137|11992776|FG014|Overall Study|Study Terminated by Sponsor|0
7587063|NCT02711137|11992764|FG002|Overall Study|Physician Decision|2
7587064|NCT02711137|11992765|FG003|Overall Study|Physician Decision|1
7587065|NCT02711137|11992766|FG004|Overall Study|Physician Decision|1
7587066|NCT02711137|11992767|FG005|Overall Study|Physician Decision|0
7587067|NCT02711137|11992768|FG006|Overall Study|Physician Decision|12
7587068|NCT02711137|11992769|FG007|Overall Study|Physician Decision|2
7587069|NCT02711137|11992770|FG008|Overall Study|Physician Decision|1
7587070|NCT02711137|11992771|FG009|Overall Study|Physician Decision|1
7587071|NCT02711137|11992772|FG010|Overall Study|Physician Decision|3
7587072|NCT02711137|11992773|FG011|Overall Study|Physician Decision|2
7587073|NCT02711137|11992774|FG012|Overall Study|Physician Decision|1
7587074|NCT02711137|11992775|FG013|Overall Study|Physician Decision|1
7587075|NCT02711137|11992776|FG014|Overall Study|Physician Decision|2
7587076|NCT02711137|11992762|FG000|Overall Study|Other|0
7587077|NCT02711137|11992763|FG001|Overall Study|Other|1
7587078|NCT02711137|11992764|FG002|Overall Study|Other|0
7587079|NCT02711137|11992765|FG003|Overall Study|Other|0
7587080|NCT02711137|11992766|FG004|Overall Study|Other|0
7587081|NCT02711137|11992767|FG005|Overall Study|Other|0
7587082|NCT02711137|11992768|FG006|Overall Study|Other|3
7587083|NCT02711137|11992769|FG007|Overall Study|Other|0
7587084|NCT02711137|11992770|FG008|Overall Study|Other|0
7587085|NCT02711137|11992771|FG009|Overall Study|Other|0
7587086|NCT02711137|11992772|FG010|Overall Study|Other|0
7587087|NCT02711137|11992773|FG011|Overall Study|Other|0
7587088|NCT02711137|11992774|FG012|Overall Study|Other|0
7587089|NCT02711137|11992775|FG013|Overall Study|Other|0
7587090|NCT02711137|11992776|FG014|Overall Study|Other|1
7587091|NCT02711137|11992762|FG000|Overall Study|Withdrawal by Subject|1
7587092|NCT02711137|11992763|FG001|Overall Study|Withdrawal by Subject|0
7587093|NCT02711137|11992764|FG002|Overall Study|Withdrawal by Subject|0
7587094|NCT02711137|11992765|FG003|Overall Study|Withdrawal by Subject|1
7587095|NCT02711137|11992766|FG004|Overall Study|Withdrawal by Subject|1
7587096|NCT02711137|11992767|FG005|Overall Study|Withdrawal by Subject|0
7587097|NCT02711137|11992768|FG006|Overall Study|Withdrawal by Subject|7
7587098|NCT02711137|11992769|FG007|Overall Study|Withdrawal by Subject|0
7587099|NCT02711137|11992770|FG008|Overall Study|Withdrawal by Subject|0
7587100|NCT02711137|11992771|FG009|Overall Study|Withdrawal by Subject|0
7587101|NCT02711137|11992772|FG010|Overall Study|Withdrawal by Subject|0
7587102|NCT02711137|11992773|FG011|Overall Study|Withdrawal by Subject|0
7587103|NCT02711137|11992774|FG012|Overall Study|Withdrawal by Subject|0
7587104|NCT02711137|11992775|FG013|Overall Study|Withdrawal by Subject|1
7587105|NCT02711137|11992776|FG014|Overall Study|Withdrawal by Subject|0
7587106|NCT02711137|11992762|FG000|Overall Study|Lost to Follow-up|1
7587107|NCT02711137|11992763|FG001|Overall Study|Lost to Follow-up|0
7587108|NCT02711137|11992764|FG002|Overall Study|Lost to Follow-up|0
7587109|NCT02711137|11992765|FG003|Overall Study|Lost to Follow-up|0
7587110|NCT02711137|11992766|FG004|Overall Study|Lost to Follow-up|0
7587111|NCT02711137|11992767|FG005|Overall Study|Lost to Follow-up|0
7587112|NCT02711137|11992768|FG006|Overall Study|Lost to Follow-up|2
7587113|NCT02711137|11992769|FG007|Overall Study|Lost to Follow-up|0
7587114|NCT02711137|11992770|FG008|Overall Study|Lost to Follow-up|0
7587115|NCT02711137|11992771|FG009|Overall Study|Lost to Follow-up|0
7587116|NCT02711137|11992772|FG010|Overall Study|Lost to Follow-up|0
7587117|NCT02711137|11992773|FG011|Overall Study|Lost to Follow-up|0
7587118|NCT02711137|11992774|FG012|Overall Study|Lost to Follow-up|0
7587119|NCT02711137|11992775|FG013|Overall Study|Lost to Follow-up|0
7587120|NCT02711137|11992776|FG014|Overall Study|Lost to Follow-up|0
7587219|NCT02343120|11992910|FG001|Part 2: Expansion|Lost to Follow-up|0
7270471|NCT00416624|11484705|FG000|Overall Study|Withdrawal by Subject|1
7587177|NCT02545868|11992874|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
7587178|NCT02545868|11992875|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
7587179|NCT02545868|11992876|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
7587180|NCT02470091|11992891|FG000|Overall Study|Withdrawal by Subject|1
7587181|NCT02470091|11992892|FG001|Overall Study|Withdrawal by Subject|0
7587182|NCT02470091|11992891|FG000|Overall Study|Ineligible|0
7587183|NCT02470091|11992892|FG001|Overall Study|Ineligible|2
7587184|NCT02440425|11992900|FG000|Overall Study|Death likely due to disease progression|1
7587185|NCT02440425|11992900|FG000|Overall Study|Withdrawal by Subject|2
7587186|NCT02440425|11992900|FG000|Overall Study|Adverse Event|1
7587187|NCT02440425|11992900|FG000|Overall Study|Adverse Event/Ineligible|1
7587188|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Sponsor decision|1
7587189|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Sponsor decision|2
7587190|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Sponsor decision|3
7587191|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Sponsor decision|2
7587192|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Sponsor decision|0
7587193|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Death|1
7587194|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Death|2
7587195|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Death|2
7587196|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Death|2
7587197|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Death|1
7587198|NCT02343120|11992909|FG000|Part 1: Dose Escalation|Lost to Follow-up|1
7587199|NCT02343120|11992910|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
7587200|NCT02343120|11992911|FG002|Part 1: Dose Escalation|Lost to Follow-up|0
7587201|NCT02343120|11992912|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
7587202|NCT02343120|11992913|FG004|Part 1: Dose Escalation|Lost to Follow-up|0
7587203|NCT02343120|11992909|FG000|Part 2: Expansion|Sponsor decision|0
7587204|NCT02343120|11992910|FG001|Part 2: Expansion|Sponsor decision|0
7587205|NCT02343120|11992911|FG002|Part 2: Expansion|Sponsor decision|0
7587206|NCT02343120|11992912|FG003|Part 2: Expansion|Sponsor decision|165
7587207|NCT02343120|11992913|FG004|Part 2: Expansion|Sponsor decision|67
7587208|NCT02343120|11992909|FG000|Part 2: Expansion|Death|0
7587209|NCT02343120|11992910|FG001|Part 2: Expansion|Death|0
7587210|NCT02343120|11992911|FG002|Part 2: Expansion|Death|0
7587211|NCT02343120|11992912|FG003|Part 2: Expansion|Death|74
7587212|NCT02343120|11992913|FG004|Part 2: Expansion|Death|17
7587213|NCT02343120|11992909|FG000|Part 2: Expansion|Withdrawal by Subject|0
7587214|NCT02343120|11992910|FG001|Part 2: Expansion|Withdrawal by Subject|0
7587215|NCT02343120|11992911|FG002|Part 2: Expansion|Withdrawal by Subject|0
7587216|NCT02343120|11992912|FG003|Part 2: Expansion|Withdrawal by Subject|28
7587217|NCT02343120|11992913|FG004|Part 2: Expansion|Withdrawal by Subject|2
7587218|NCT02343120|11992909|FG000|Part 2: Expansion|Lost to Follow-up|0
7587220|NCT02343120|11992911|FG002|Part 2: Expansion|Lost to Follow-up|0
7587221|NCT02343120|11992912|FG003|Part 2: Expansion|Lost to Follow-up|5
7587222|NCT02343120|11992913|FG004|Part 2: Expansion|Lost to Follow-up|2
7587223|NCT02343120|11992909|FG000|Part 2: Expansion|Other|0
7587224|NCT02343120|11992910|FG001|Part 2: Expansion|Other|0
7587225|NCT02343120|11992911|FG002|Part 2: Expansion|Other|0
7587226|NCT02343120|11992912|FG003|Part 2: Expansion|Other|1
7587227|NCT02343120|11992913|FG004|Part 2: Expansion|Other|5
7587228|NCT02343120|11992909|FG000|Part 2: Expansion|Adverse Event|0
7587229|NCT02343120|11992910|FG001|Part 2: Expansion|Adverse Event|0
7587230|NCT02343120|11992911|FG002|Part 2: Expansion|Adverse Event|0
7587231|NCT02343120|11992912|FG003|Part 2: Expansion|Adverse Event|1
7587232|NCT02343120|11992913|FG004|Part 2: Expansion|Adverse Event|1
7587312|NCT01659151|11992980|FG000|Overall Study|Inadequate TIL growth|1
7626090|NCT02513394|12038107|FG000|Overall Study|Withdrawal by Subject|11
7626091|NCT02513394|12038108|FG001|Overall Study|Withdrawal by Subject|23
7626092|NCT02513394|12038107|FG000|Overall Study|Ineligible|1
7626093|NCT02513394|12038108|FG001|Overall Study|Ineligible|0
7626094|NCT02445339|12038143|FG000|Overall Study|Physician Decision|1
7626095|NCT02445339|12038144|FG001|Overall Study|Physician Decision|0
7626096|NCT02445339|12038143|FG000|Overall Study|Lost to Follow-up|11
7626097|NCT02445339|12038144|FG001|Overall Study|Lost to Follow-up|15
7626098|NCT03298867|12038165|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
7626099|NCT03298867|12038166|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
7626100|NCT03298867|12038165|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
7626101|NCT03298867|12038166|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
7626102|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
7626103|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
7626104|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
7626105|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
7626106|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
7626107|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
7626108|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
7626109|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
7626110|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
7626111|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
7626112|NCT03298867|12038165|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
7626113|NCT03298867|12038166|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
7626114|NCT03298867|12038165|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
7626115|NCT03298867|12038166|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
7626116|NCT03220581|12038174|FG000|Overall Study|Withdrawal by Subject|0
7626117|NCT03220581|12038175|FG001|Overall Study|Withdrawal by Subject|1
7626118|NCT03220581|12038174|FG000|Overall Study|Lost to Follow-up|3
7626119|NCT03220581|12038175|FG001|Overall Study|Lost to Follow-up|6
7626140|NCT02768870|12038196|FG000|Overall Study|Not Implanted with Device|2
7626141|NCT02768870|12038196|FG000|Overall Study|Death|1
7626142|NCT02768870|12038196|FG000|Overall Study|Reoperation|4
7626143|NCT02768870|12038196|FG000|Overall Study|On Study|19
7626144|NCT02648698|12038202|FG000|Overall Study|Protocol Violation|1
7626145|NCT02648698|12038203|FG001|Overall Study|Protocol Violation|5
7626150|NCT02000882|12038213|FG000|Overall Study|Adverse Event|3
7626151|NCT02000882|12038213|FG000|Overall Study|Physician Decision|2
7626152|NCT02000882|12038213|FG000|Overall Study|Withdrawal by Subject|1
7626153|NCT01642004|12038232|FG000|Randomization|Adverse Event unrelated to study drug|1
7626154|NCT01642004|12038233|FG001|Randomization|Adverse Event unrelated to study drug|0
7626155|NCT01642004|12038232|FG000|Randomization|Withdrawal by Subject|1
7626156|NCT01642004|12038233|FG001|Randomization|Withdrawal by Subject|6
7626157|NCT01642004|12038232|FG000|Randomization|No longer meets study criteria|2
7626158|NCT01642004|12038233|FG001|Randomization|No longer meets study criteria|2
7626159|NCT01642004|12038232|FG000|Treatment|Disease progression|88
7626160|NCT01642004|12038233|FG001|Treatment|Disease progression|80
7626161|NCT01642004|12038232|FG000|Treatment|Study drug toxicity|5
7587313|NCT01539863|11992995|FG000|Overall Study|Lost to Follow-up|5
7587314|NCT01539863|11992996|FG001|Overall Study|Lost to Follow-up|4
7587315|NCT01439165|11993017|FG000|Overall Study|Protocol Violation|3
7587316|NCT01439165|11993018|FG001|Overall Study|Protocol Violation|0
7587317|NCT01439165|11993017|FG000|Overall Study|Lost to Follow-up|11
7587318|NCT01439165|11993018|FG001|Overall Study|Lost to Follow-up|1
7587319|NCT01439165|11993017|FG000|Overall Study|Withdrawal by Subject|7
7587320|NCT01439165|11993018|FG001|Overall Study|Withdrawal by Subject|1
7587321|NCT01264679|11993024|FG000|Overall Study|Participation in Another Clinical Trial|1
7587322|NCT01264679|11993024|FG000|Overall Study|Physician Decision|1
7587323|NCT01264679|11993024|FG000|Overall Study|Sponsor's Suspension of Dosing|2
7587324|NCT01264679|11993024|FG000|Overall Study|Withdrawal by Subject|1
7587325|NCT01155388|11993031|FG000|Overall Study|Adverse Event|1
7587326|NCT01155388|11993032|FG001|Overall Study|Adverse Event|0
7587327|NCT01137435|11993039|FG000|Overall Study|Lost to Follow-up|24
7587328|NCT01137435|11993039|FG000|Overall Study|Off label usage|4
7587329|NCT01064817|11993056|FG000|Study Completion|Physician Decision|1
7587330|NCT01064817|11993057|FG001|Study Completion|Physician Decision|0
7587331|NCT01064817|11993056|FG000|Study Completion|Withdrawal by Subject|1
7587332|NCT01064817|11993057|FG001|Study Completion|Withdrawal by Subject|0
7587333|NCT01026220|11993063|FG000|Induction|Death|1
7587334|NCT01026220|11993064|FG001|Induction|Death|0
7587335|NCT01026220|11993065|FG002|Induction|Death|0
7587336|NCT01026220|11993063|FG000|Induction|Lack of Efficacy|2
7587337|NCT01026220|11993064|FG001|Induction|Lack of Efficacy|0
7587338|NCT01026220|11993065|FG002|Induction|Lack of Efficacy|0
7587339|NCT01026220|11993063|FG000|Induction|Physician Decision|12
7587340|NCT01026220|11993064|FG001|Induction|Physician Decision|0
7587341|NCT01026220|11993065|FG002|Induction|Physician Decision|0
7587342|NCT01026220|11993063|FG000|Induction|Withdrawal by Subject|9
7587343|NCT01026220|11993064|FG001|Induction|Withdrawal by Subject|0
7587344|NCT01026220|11993065|FG002|Induction|Withdrawal by Subject|0
7587345|NCT01026220|11993063|FG000|Induction|Ineligible|1
7587346|NCT01026220|11993064|FG001|Induction|Ineligible|0
7587347|NCT01026220|11993065|FG002|Induction|Ineligible|0
7587348|NCT01026220|11993063|FG000|Consolidation Maintenance|Death|0
7587349|NCT01026220|11993064|FG001|Consolidation Maintenance|Death|1
7587350|NCT01026220|11993065|FG002|Consolidation Maintenance|Death|0
7587351|NCT01026220|11993063|FG000|Consolidation Maintenance|Lack of Efficacy|0
7587352|NCT01026220|11993064|FG001|Consolidation Maintenance|Lack of Efficacy|1
7587353|NCT01026220|11993065|FG002|Consolidation Maintenance|Lack of Efficacy|1
7587354|NCT01026220|11993063|FG000|Consolidation Maintenance|Physician Decision|0
7587355|NCT01026220|11993064|FG001|Consolidation Maintenance|Physician Decision|2
7587356|NCT01026220|11993065|FG002|Consolidation Maintenance|Physician Decision|7
7587357|NCT01026220|11993063|FG000|Consolidation Maintenance|Withdrawal by Subject|0
7587358|NCT01026220|11993064|FG001|Consolidation Maintenance|Withdrawal by Subject|2
7587359|NCT01026220|11993065|FG002|Consolidation Maintenance|Withdrawal by Subject|6
7587360|NCT00567567|11993087|FG000|Overall Study|Adverse Event|0
7587361|NCT00567567|11993088|FG001|Overall Study|Adverse Event|2
7587362|NCT00567567|11993089|FG002|Overall Study|Adverse Event|5
7587363|NCT00567567|11993087|FG000|Overall Study|Death|8
7587364|NCT00567567|11993088|FG001|Overall Study|Death|1
7587365|NCT00567567|11993089|FG002|Overall Study|Death|5
7587366|NCT00567567|11993087|FG000|Overall Study|Lack of Efficacy|16
7587367|NCT00567567|11993088|FG001|Overall Study|Lack of Efficacy|17
7587368|NCT00567567|11993089|FG002|Overall Study|Lack of Efficacy|48
7587369|NCT00567567|11993087|FG000|Overall Study|Lost to Follow-up|0
7587370|NCT00567567|11993088|FG001|Overall Study|Lost to Follow-up|0
7587371|NCT00567567|11993089|FG002|Overall Study|Lost to Follow-up|1
7587372|NCT00567567|11993087|FG000|Overall Study|Physician Decision|16
7587373|NCT00567567|11993088|FG001|Overall Study|Physician Decision|18
7587374|NCT00567567|11993089|FG002|Overall Study|Physician Decision|84
7587375|NCT00567567|11993087|FG000|Overall Study|Withdrawal by Subject|0
7587376|NCT00567567|11993088|FG001|Overall Study|Withdrawal by Subject|0
7587377|NCT00567567|11993089|FG002|Overall Study|Withdrawal by Subject|2
7587378|NCT00567567|11993087|FG000|Overall Study|Ineligible|4
7587379|NCT00567567|11993088|FG001|Overall Study|Ineligible|0
7587380|NCT00567567|11993089|FG002|Overall Study|Ineligible|9
7587381|NCT00567567|11993087|FG000|Overall Study|Refusal by patient/parent/guardian|9
7587382|NCT00567567|11993088|FG001|Overall Study|Refusal by patient/parent/guardian|16
7587383|NCT00567567|11993089|FG002|Overall Study|Refusal by patient/parent/guardian|122
7587384|NCT00567567|11993087|FG000|Overall Study|Enrolled another COG therapeutic study|99
7587385|NCT00567567|11993088|FG001|Overall Study|Enrolled another COG therapeutic study|80
7587386|NCT00567567|11993089|FG002|Overall Study|Enrolled another COG therapeutic study|0
7587387|NCT00567567|11993087|FG000|Overall Study|Unable adequate stem cell for transplant|0
7587388|NCT00567567|11993088|FG001|Overall Study|Unable adequate stem cell for transplant|0
7587389|NCT00567567|11993089|FG002|Overall Study|Unable adequate stem cell for transplant|2
7587390|NCT00450450|11993101|FG000|Overall Study|Death|1
7587391|NCT00450450|11993102|FG001|Overall Study|Death|3
7587392|NCT00450450|11993101|FG000|Overall Study|Relapse|2
7587393|NCT00450450|11993102|FG001|Overall Study|Relapse|0
7587394|NCT00450450|11993101|FG000|Overall Study|Missing Data|2
7587395|NCT00450450|11993102|FG001|Overall Study|Missing Data|0
7587396|NCT00346164|11993112|FG000|Overall Study|Adverse Event|0
7587397|NCT00346164|11993113|FG001|Overall Study|Adverse Event|0
7587398|NCT00346164|11993114|FG002|Overall Study|Adverse Event|0
7587399|NCT00346164|11993115|FG003|Overall Study|Adverse Event|1
7587400|NCT00346164|11993112|FG000|Overall Study|Lack of Efficacy|0
7587401|NCT00346164|11993113|FG001|Overall Study|Lack of Efficacy|1
7587402|NCT00346164|11993114|FG002|Overall Study|Lack of Efficacy|7
7587403|NCT00346164|11993115|FG003|Overall Study|Lack of Efficacy|25
7587404|NCT00346164|11993112|FG000|Overall Study|Physician Decision|0
7587405|NCT00346164|11993113|FG001|Overall Study|Physician Decision|1
7587406|NCT00346164|11993114|FG002|Overall Study|Physician Decision|2
7587407|NCT00346164|11993115|FG003|Overall Study|Physician Decision|27
7587408|NCT00346164|11993112|FG000|Overall Study|Protocol Violation|6
7587409|NCT00346164|11993113|FG001|Overall Study|Protocol Violation|2
7587410|NCT00346164|11993114|FG002|Overall Study|Protocol Violation|10
7587411|NCT00346164|11993115|FG003|Overall Study|Protocol Violation|4
7587412|NCT00346164|11993112|FG000|Overall Study|Withdrawal by Subject|0
7587413|NCT00346164|11993113|FG001|Overall Study|Withdrawal by Subject|0
7587414|NCT00346164|11993114|FG002|Overall Study|Withdrawal by Subject|2
7587415|NCT00346164|11993115|FG003|Overall Study|Withdrawal by Subject|0
7587416|NCT00346164|11993112|FG000|Overall Study|Ineligible|11
7587417|NCT00346164|11993113|FG001|Overall Study|Ineligible|2
7587418|NCT00346164|11993114|FG002|Overall Study|Ineligible|2
7587419|NCT00346164|11993115|FG003|Overall Study|Ineligible|23
7587420|NCT00346164|11993112|FG000|Overall Study|Refusal of further protocol therapy|0
7587421|NCT00346164|11993113|FG001|Overall Study|Refusal of further protocol therapy|1
7587422|NCT00346164|11993114|FG002|Overall Study|Refusal of further protocol therapy|3
7587423|NCT00346164|11993115|FG003|Overall Study|Refusal of further protocol therapy|15
7587424|NCT00346164|11993112|FG000|Overall Study|Inability to start week 16 tx on time|0
7587425|NCT00346164|11993113|FG001|Overall Study|Inability to start week 16 tx on time|0
7587426|NCT00346164|11993114|FG002|Overall Study|Inability to start week 16 tx on time|0
7587427|NCT00346164|11993115|FG003|Overall Study|Inability to start week 16 tx on time|11
7626162|NCT01642004|12038233|FG001|Treatment|Study drug toxicity|13
7626163|NCT01642004|12038232|FG000|Treatment|Death|1
7626164|NCT01642004|12038233|FG001|Treatment|Death|0
7626165|NCT01642004|12038232|FG000|Treatment|Adverse event unrelated to study drug|6
7626166|NCT01642004|12038233|FG001|Treatment|Adverse event unrelated to study drug|13
7626167|NCT01642004|12038232|FG000|Treatment|Withdrawal by Subject|5
7626168|NCT01642004|12038233|FG001|Treatment|Withdrawal by Subject|9
7626169|NCT01642004|12038232|FG000|Treatment|Maximum clinical benefit|2
7626170|NCT01642004|12038233|FG001|Treatment|Maximum clinical benefit|7
7626171|NCT01642004|12038232|FG000|Treatment|Poor/non-compliance|1
7626172|NCT01642004|12038233|FG001|Treatment|Poor/non-compliance|0
7626173|NCT01642004|12038232|FG000|Treatment|No longer meets study criteria|1
7626174|NCT01642004|12038233|FG001|Treatment|No longer meets study criteria|2
7626175|NCT01642004|12038232|FG000|Treatment|Other|1
7626176|NCT01642004|12038233|FG001|Treatment|Other|2
7626177|NCT01642004|12038232|FG000|Treatment|Missing from data|0
7626178|NCT01642004|12038233|FG001|Treatment|Missing from data|1
7626179|NCT01326104|12038241|FG000|Overall Study|progressed prior to vaccine|0
7626180|NCT01326104|12038242|FG001|Overall Study|progressed prior to vaccine|2
7626181|NCT01326104|12038241|FG000|Overall Study|unable to make vaccine|0
7626182|NCT01326104|12038242|FG001|Overall Study|unable to make vaccine|2
7626183|NCT01244815|12038252|FG000|Overall Study|Not Treated|0
7626184|NCT01244815|12038253|FG001|Overall Study|Not Treated|1
7626185|NCT01244815|12038254|FG002|Overall Study|Not Treated|0
7626186|NCT01244815|12038255|FG003|Overall Study|Not Treated|0
7626187|NCT01244815|12038252|FG000|Overall Study|Adverse Event|4
7626188|NCT01244815|12038253|FG001|Overall Study|Adverse Event|7
7626189|NCT01244815|12038254|FG002|Overall Study|Adverse Event|5
7626190|NCT01244815|12038255|FG003|Overall Study|Adverse Event|5
7626191|NCT01244815|12038252|FG000|Overall Study|Treatment Failure|0
7626192|NCT01244815|12038253|FG001|Overall Study|Treatment Failure|0
7626193|NCT01244815|12038254|FG002|Overall Study|Treatment Failure|0
7626194|NCT01244815|12038255|FG003|Overall Study|Treatment Failure|1
7626195|NCT01244815|12038252|FG000|Overall Study|Lost to Follow-up|3
7626196|NCT01244815|12038253|FG001|Overall Study|Lost to Follow-up|2
7626197|NCT01244815|12038254|FG002|Overall Study|Lost to Follow-up|3
7626198|NCT01244815|12038255|FG003|Overall Study|Lost to Follow-up|2
7626199|NCT01244815|12038252|FG000|Overall Study|Withdrawal by Subject|0
7626200|NCT01244815|12038253|FG001|Overall Study|Withdrawal by Subject|2
7626201|NCT01244815|12038254|FG002|Overall Study|Withdrawal by Subject|0
7626202|NCT01244815|12038255|FG003|Overall Study|Withdrawal by Subject|3
7626203|NCT01244815|12038252|FG000|Overall Study|Protocol Violation|7
7626204|NCT01244815|12038253|FG001|Overall Study|Protocol Violation|4
7626205|NCT01244815|12038254|FG002|Overall Study|Protocol Violation|3
7626206|NCT01244815|12038255|FG003|Overall Study|Protocol Violation|1
7626207|NCT01244815|12038252|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
7626208|NCT01244815|12038253|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7626209|NCT01244815|12038254|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
7587456|NCT04360187|11993176|FG000|Double-Blind Treatment|Adverse Event|9
7587457|NCT04360187|11993177|FG001|Double-Blind Treatment|Adverse Event|11
7587458|NCT04360187|11993176|FG000|Double-Blind Treatment|Lack of Efficacy|7
7587459|NCT04360187|11993177|FG001|Double-Blind Treatment|Lack of Efficacy|2
7587460|NCT04360187|11993176|FG000|Double-Blind Treatment|Physician Decision|1
7587461|NCT04360187|11993177|FG001|Double-Blind Treatment|Physician Decision|0
7587462|NCT04360187|11993176|FG000|Double-Blind Treatment|Withdrawal by Subject|4
7587463|NCT04360187|11993177|FG001|Double-Blind Treatment|Withdrawal by Subject|2
7587464|NCT04360187|11993176|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2
7587465|NCT04360187|11993177|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0
7587466|NCT04360187|11993176|FG000|Follow-Up|Lost to Follow-up|1
7587467|NCT04360187|11993177|FG001|Follow-Up|Lost to Follow-up|0
7587476|NCT03978091|11993201|FG000|Overall Study|Lost to Follow-up|0
7587477|NCT03978091|11993202|FG001|Overall Study|Lost to Follow-up|0
7587478|NCT03978091|11993203|FG002|Overall Study|Lost to Follow-up|1
7587479|NCT03978091|11993204|FG003|Overall Study|Lost to Follow-up|0
7587480|NCT03978091|11993205|FG004|Overall Study|Lost to Follow-up|0
7587481|NCT03978091|11993206|FG005|Overall Study|Lost to Follow-up|0
7587482|NCT03978091|11993201|FG000|Overall Study|Withdrawal by Subject|0
7587483|NCT03978091|11993202|FG001|Overall Study|Withdrawal by Subject|0
7587484|NCT03978091|11993203|FG002|Overall Study|Withdrawal by Subject|0
7587485|NCT03978091|11993204|FG003|Overall Study|Withdrawal by Subject|1
7587486|NCT03978091|11993205|FG004|Overall Study|Withdrawal by Subject|1
7587487|NCT03978091|11993206|FG005|Overall Study|Withdrawal by Subject|0
7587488|NCT03853291|11993230|FG000|Overall Study|Lost to Follow-up|1
7587489|NCT03853291|11993231|FG001|Overall Study|Lost to Follow-up|2
7587490|NCT03853291|11993232|FG002|Overall Study|Lost to Follow-up|0
7587491|NCT03853291|11993233|FG003|Overall Study|Lost to Follow-up|0
7587492|NCT03853291|11993234|FG004|Overall Study|Lost to Follow-up|0
7587493|NCT03853291|11993235|FG005|Overall Study|Lost to Follow-up|0
7587494|NCT03853291|11993230|FG000|Overall Study|Determined to be ineligible|1
7587495|NCT03853291|11993231|FG001|Overall Study|Determined to be ineligible|1
7587496|NCT03853291|11993232|FG002|Overall Study|Determined to be ineligible|0
7587497|NCT03853291|11993233|FG003|Overall Study|Determined to be ineligible|0
7587498|NCT03853291|11993234|FG004|Overall Study|Determined to be ineligible|0
7587499|NCT03853291|11993235|FG005|Overall Study|Determined to be ineligible|0
7587551|NCT03120949|11993336|FG000|Overall Study|randomized in error|1
7587552|NCT03120949|11993337|FG001|Overall Study|randomized in error|0
7587553|NCT03120949|11993336|FG000|Overall Study|Death|13
7587554|NCT03120949|11993337|FG001|Overall Study|Death|13
7587555|NCT03120949|11993336|FG000|Overall Study|Lost to Follow-up|23
7587556|NCT03120949|11993337|FG001|Overall Study|Lost to Follow-up|13
7587557|NCT03120949|11993336|FG000|Overall Study|Withdrawal by Subject|139
7587558|NCT03120949|11993337|FG001|Overall Study|Withdrawal by Subject|124
7587559|NCT03120949|11993336|FG000|Overall Study|Covid-19|43
7587560|NCT03120949|11993337|FG001|Overall Study|Covid-19|34
7587561|NCT03120949|11993336|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1
7587562|NCT03120949|11993337|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3
7587563|NCT03120949|11993336|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1
7587564|NCT03120949|11993337|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0
7587565|NCT03120949|11993336|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1
7587566|NCT03120949|11993337|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0
7587567|NCT03120949|11993336|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1
7587568|NCT03120949|11993337|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0
7587569|NCT03120949|11993336|FG000|Overall Study|Site was closed|2
7587570|NCT03120949|11993337|FG001|Overall Study|Site was closed|3
7587571|NCT03120949|11993336|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1
7587572|NCT03120949|11993337|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0
7587573|NCT03120949|11993336|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0
7587574|NCT03120949|11993337|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1
7587575|NCT03120949|11993336|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1
7587576|NCT03120949|11993337|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0
7587577|NCT03120949|11993336|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1
7587578|NCT03120949|11993337|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0
7587579|NCT03120949|11993336|FG000|Overall Study|Other: Adverse Event|0
7587580|NCT03120949|11993337|FG001|Overall Study|Other: Adverse Event|1
7587581|NCT03120949|11993336|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0
7587582|NCT03120949|11993337|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1
7587583|NCT03120949|11993336|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0
7587584|NCT03120949|11993337|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2
7587585|NCT03120949|11993336|FG000|Overall Study|Subject Refusal To Attend Visit|0
7587586|NCT03120949|11993337|FG001|Overall Study|Subject Refusal To Attend Visit|1
7587587|NCT03120949|11993336|FG000|Overall Study|Personal Reasons|0
7587588|NCT03120949|11993337|FG001|Overall Study|Personal Reasons|1
7587589|NCT03120949|11993336|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0
7587590|NCT03120949|11993337|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1
7587591|NCT03120949|11993336|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0
7587592|NCT03120949|11993337|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1
7587593|NCT03120949|11993336|FG000|Overall Study|Compliance With Medication|0
7587594|NCT03120949|11993337|FG001|Overall Study|Compliance With Medication|1
7587595|NCT03120949|11993336|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0
7587596|NCT03120949|11993337|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1
7587597|NCT03120949|11993336|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0
7587598|NCT03120949|11993337|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1
7587599|NCT03120949|11993336|FG000|Overall Study|Study Terminated By Principal Investigator|0
7587600|NCT03120949|11993337|FG001|Overall Study|Study Terminated By Principal Investigator|1
7587601|NCT03077698|11993358|FG000|Progestin Monotherapy|Stable Disease|8
7587602|NCT03077698|11993359|FG001|Progestin Monotherapy|Stable Disease|0
7587603|NCT03077698|11993358|FG000|Progestin Monotherapy|Adverse Event|1
7587604|NCT03077698|11993359|FG001|Progestin Monotherapy|Adverse Event|0
7587605|NCT03077698|11993358|FG000|Progestin Monotherapy|Death|1
7587606|NCT03077698|11993359|FG001|Progestin Monotherapy|Death|0
7587607|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0
7587608|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2
7587609|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6
7587610|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5
7587611|NCT03077698|11993358|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0
7587612|NCT03077698|11993359|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2
7587613|NCT03077698|11993358|FG000|Safety Follow Up|Withdrawal by Subject|2
7587614|NCT03077698|11993359|FG001|Safety Follow Up|Withdrawal by Subject|1
7587615|NCT03077698|11993358|FG000|Safety Follow Up|Transfer of care to hospice|1
7587616|NCT03077698|11993359|FG001|Safety Follow Up|Transfer of care to hospice|0
7587617|NCT02911935|11993366|FG000|Overall Study|Lost to Follow-up|5
7587618|NCT02911935|11993367|FG001|Overall Study|Lost to Follow-up|7
7587619|NCT02874742|11993376|FG000|Overall Study|Death|3
7587620|NCT02874742|11993377|FG001|Overall Study|Death|1
7587621|NCT02874742|11993378|FG002|Overall Study|Death|1
7587622|NCT02874742|11993376|FG000|Overall Study|Lost to Follow-up|2
7587623|NCT02874742|11993377|FG001|Overall Study|Lost to Follow-up|0
7587624|NCT02874742|11993378|FG002|Overall Study|Lost to Follow-up|0
7587625|NCT02874742|11993376|FG000|Overall Study|Withdrawal by Subject|8
7587626|NCT02874742|11993377|FG001|Overall Study|Withdrawal by Subject|4
7587627|NCT02874742|11993378|FG002|Overall Study|Withdrawal by Subject|0
7587628|NCT02874742|11993376|FG000|Overall Study|Other|3
7587629|NCT02874742|11993377|FG001|Overall Study|Other|1
7587630|NCT02874742|11993378|FG002|Overall Study|Other|0
7587631|NCT02874742|11993376|FG000|Overall Study|Ongoing|87
7587632|NCT02874742|11993377|FG001|Overall Study|Ongoing|98
7587633|NCT02874742|11993378|FG002|Overall Study|Ongoing|15
7587642|NCT02557672|11993414|FG000|Overall Study|Withdrawal by Subject|4
7587643|NCT02557672|11993415|FG001|Overall Study|Withdrawal by Subject|2
7587644|NCT02509312|11993423|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5
7587645|NCT02509312|11993424|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3
7587646|NCT02509312|11993423|FG000|Overall Study|Obstetrician refusal|0
7587647|NCT02509312|11993424|FG001|Overall Study|Obstetrician refusal|1
7587648|NCT02509312|11993423|FG000|Overall Study|Patient elected for TOLAC|1
7587649|NCT02509312|11993424|FG001|Overall Study|Patient elected for TOLAC|0
7587650|NCT02509312|11993423|FG000|Overall Study|Cesarean deemed stat|1
7587651|NCT02509312|11993424|FG001|Overall Study|Cesarean deemed stat|0
7587652|NCT02509312|11993423|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0
7587653|NCT02509312|11993424|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1
7626210|NCT01244815|12038255|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
7626211|NCT01142596|12038267|FG000|Overall Study|Withdrawal by Subject|9
7626212|NCT01142596|12038268|FG001|Overall Study|Withdrawal by Subject|35
7626213|NCT01142596|12038267|FG000|Overall Study|Adverse Event|8
7626214|NCT01142596|12038268|FG001|Overall Study|Adverse Event|35
7587654|NCT02360280|11993454|FG000|Overall Study|Withdrawal by Subject|2
7587655|NCT02360280|11993455|FG001|Overall Study|Withdrawal by Subject|0
7587656|NCT02360280|11993454|FG000|Overall Study|Adverse Event|0
7587657|NCT02360280|11993455|FG001|Overall Study|Adverse Event|1
7587658|NCT02360280|11993454|FG000|Overall Study|Lost to Follow-up|1
7587659|NCT02360280|11993455|FG001|Overall Study|Lost to Follow-up|0
7587660|NCT02163395|11993461|FG000|Overall Study|Withdrawal by Subject|1
7587661|NCT02163395|11993461|FG000|Overall Study|Lost to Follow-up|3
7587662|NCT02163395|11993461|FG000|Overall Study|Adverse Event|1
7587663|NCT02097134|11993465|FG000|Overall Study|Physician Decision|4
7587664|NCT02097134|11993465|FG000|Overall Study|Non-Protocol Therapy|1
7587665|NCT02097134|11993465|FG000|Overall Study|Progressive Disease|3
7587666|NCT02097134|11993465|FG000|Overall Study|Refusal of Further Protocol Therapy|1
7587667|NCT02096588|11993472|FG000|Overall Study|Lack of Efficacy|2
7587668|NCT02096588|11993473|FG001|Overall Study|Lack of Efficacy|0
7587669|NCT02096588|11993472|FG000|Overall Study|Withdrawal by Subject|0
7587670|NCT02096588|11993473|FG001|Overall Study|Withdrawal by Subject|1
7587671|NCT02053350|11993479|FG000|Overall Study|Withdrawal by Subject|1
7587672|NCT02053350|11993479|FG000|Overall Study|Adverse Event|4
7587687|NCT01965704|11993499|FG000|Overall Study|Withdrawal by Subject|2
7587688|NCT01965704|11993500|FG001|Overall Study|Withdrawal by Subject|2
7587689|NCT01965704|11993501|FG002|Overall Study|Withdrawal by Subject|1
7587690|NCT01965704|11993502|FG003|Overall Study|Withdrawal by Subject|1
7587691|NCT01965704|11993499|FG000|Overall Study|Delivered at home|1
7587692|NCT01965704|11993500|FG001|Overall Study|Delivered at home|1
7587693|NCT01965704|11993501|FG002|Overall Study|Delivered at home|0
7587694|NCT01965704|11993502|FG003|Overall Study|Delivered at home|0
7587695|NCT01965704|11993499|FG000|Overall Study|Experienced complications|0
7587696|NCT01965704|11993500|FG001|Overall Study|Experienced complications|0
7587697|NCT01965704|11993501|FG002|Overall Study|Experienced complications|2
7587698|NCT01965704|11993502|FG003|Overall Study|Experienced complications|2
7587699|NCT01965704|11993499|FG000|Overall Study|Adverse Event|0
7587700|NCT01965704|11993500|FG001|Overall Study|Adverse Event|0
7587701|NCT01965704|11993501|FG002|Overall Study|Adverse Event|1
7587702|NCT01965704|11993502|FG003|Overall Study|Adverse Event|1
7587703|NCT01965704|11993499|FG000|Overall Study|Did not meet inclusion criteria|0
7587704|NCT01965704|11993500|FG001|Overall Study|Did not meet inclusion criteria|0
7587705|NCT01965704|11993501|FG002|Overall Study|Did not meet inclusion criteria|1
7587706|NCT01965704|11993502|FG003|Overall Study|Did not meet inclusion criteria|1
7587725|NCT01661881|11993555|FG000|Overall Study|Disease Progression|1
7587726|NCT01621568|11993570|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1
7587727|NCT01621568|11993571|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0
7587728|NCT01621568|11993570|FG000|Week 5-6 No Treatment|Death|1
7587729|NCT01621568|11993571|FG001|Week 5-6 No Treatment|Death|0
7587730|NCT01070069|11993594|FG000|Overall Study|Death|1
7587731|NCT01070069|11993595|FG001|Overall Study|Death|0
7587732|NCT01070069|11993596|FG002|Overall Study|Death|2
7587733|NCT01070069|11993597|FG003|Overall Study|Death|0
7587734|NCT01070069|11993598|FG004|Overall Study|Death|1
7587735|NCT01070069|11993594|FG000|Overall Study|Withdrawal by Subject|1
7587736|NCT01070069|11993595|FG001|Overall Study|Withdrawal by Subject|1
7587737|NCT01070069|11993596|FG002|Overall Study|Withdrawal by Subject|4
7587738|NCT01070069|11993597|FG003|Overall Study|Withdrawal by Subject|0
7587739|NCT01070069|11993598|FG004|Overall Study|Withdrawal by Subject|0
7587740|NCT01070069|11993594|FG000|Overall Study|Lost to Follow-up|4
7587741|NCT01070069|11993595|FG001|Overall Study|Lost to Follow-up|1
7587742|NCT01070069|11993596|FG002|Overall Study|Lost to Follow-up|0
7587743|NCT01070069|11993597|FG003|Overall Study|Lost to Follow-up|0
7587744|NCT01070069|11993598|FG004|Overall Study|Lost to Follow-up|3
7587745|NCT00501046|11993637|FG000|Overall Study|Adverse Event|21
7587746|NCT00501046|11993638|FG001|Overall Study|Adverse Event|25
7587747|NCT00501046|11993637|FG000|Overall Study|Death|23
7587748|NCT00501046|11993638|FG001|Overall Study|Death|30
7587749|NCT00501046|11993637|FG000|Overall Study|Lost to Follow-up|14
7587750|NCT00501046|11993638|FG001|Overall Study|Lost to Follow-up|13
7587751|NCT00501046|11993637|FG000|Overall Study|Physician Decision|7
7587752|NCT00501046|11993638|FG001|Overall Study|Physician Decision|2
7587753|NCT00501046|11993637|FG000|Overall Study|Pregnancy|0
7587754|NCT00501046|11993638|FG001|Overall Study|Pregnancy|3
7587755|NCT00501046|11993637|FG000|Overall Study|Protocol Violation|2
7587756|NCT00501046|11993638|FG001|Overall Study|Protocol Violation|1
7587757|NCT00501046|11993637|FG000|Overall Study|Withdrawal by Subject|84
7587758|NCT00501046|11993638|FG001|Overall Study|Withdrawal by Subject|83
7587759|NCT00501046|11993637|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
7587760|NCT00501046|11993638|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
7587761|NCT00500682|11993646|FG000|Overall Study|Adverse Event|37
7587762|NCT00500682|11993647|FG001|Overall Study|Adverse Event|29
7587763|NCT00500682|11993646|FG000|Overall Study|Death|25
7587764|NCT00500682|11993647|FG001|Overall Study|Death|16
7587765|NCT00500682|11993646|FG000|Overall Study|Lost to Follow-up|11
7587766|NCT00500682|11993647|FG001|Overall Study|Lost to Follow-up|11
7587767|NCT00500682|11993646|FG000|Overall Study|Physician Decision|6
7587768|NCT00500682|11993647|FG001|Overall Study|Physician Decision|10
7587769|NCT00500682|11993646|FG000|Overall Study|Pregnancy|2
7587770|NCT00500682|11993647|FG001|Overall Study|Pregnancy|0
7587771|NCT00500682|11993646|FG000|Overall Study|Protocol Violation|1
7587772|NCT00500682|11993647|FG001|Overall Study|Protocol Violation|3
7587773|NCT00500682|11993646|FG000|Overall Study|Withdrawal by Subject|80
7587774|NCT00500682|11993647|FG001|Overall Study|Withdrawal by Subject|74
7587775|NCT00500682|11993646|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
7587776|NCT00500682|11993647|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
7587789|NCT00001277|11993667|FG000|Overall Study|Adverse Event|0
7587790|NCT00001277|11993668|FG001|Overall Study|Adverse Event|0
7587791|NCT00001277|11993669|FG002|Overall Study|Adverse Event|1
7587792|NCT00001277|11993667|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7587793|NCT00001277|11993668|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0
7587794|NCT00001277|11993669|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2
7626215|NCT01142596|12038267|FG000|Overall Study|Lack of Efficacy|5
7626216|NCT01142596|12038268|FG001|Overall Study|Lack of Efficacy|9
7626217|NCT01142596|12038267|FG000|Overall Study|Lost to Follow-up|2
7626218|NCT01142596|12038268|FG001|Overall Study|Lost to Follow-up|3
7626219|NCT01142596|12038267|FG000|Overall Study|Other reason (not specified)|5
7626220|NCT01142596|12038268|FG001|Overall Study|Other reason (not specified)|4
7626221|NCT01098110|12038277|FG000|Overall Study|Withdrawal by Subject|14
7626222|NCT01098110|12038278|FG001|Overall Study|Withdrawal by Subject|24
7626223|NCT01098110|12038279|FG002|Overall Study|Withdrawal by Subject|19
7626224|NCT01098110|12038277|FG000|Overall Study|Adverse Event|30
7626225|NCT01098110|12038278|FG001|Overall Study|Adverse Event|32
7626226|NCT01098110|12038279|FG002|Overall Study|Adverse Event|43
7626227|NCT01098110|12038277|FG000|Overall Study|Lack of Efficacy|13
7626228|NCT01098110|12038278|FG001|Overall Study|Lack of Efficacy|9
7626229|NCT01098110|12038279|FG002|Overall Study|Lack of Efficacy|27
7626230|NCT01098110|12038277|FG000|Overall Study|Other|4
7626231|NCT01098110|12038278|FG001|Overall Study|Other|7
7626232|NCT01098110|12038279|FG002|Overall Study|Other|5
7626233|NCT01098110|12038277|FG000|Overall Study|Untreated|1
7626234|NCT01098110|12038278|FG001|Overall Study|Untreated|1
7626235|NCT01098110|12038279|FG002|Overall Study|Untreated|0
7626236|NCT01006265|12038291|FG000|Overall Study|Lost to Follow-up|1
7626237|NCT01006265|12038292|FG001|Overall Study|Lost to Follow-up|0
7587795|NCT01009294|11993678|FG000|Overall Study|Study discontinued by Sponsor|6
7587796|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Death|1
7587797|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Death|0
7587798|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Death|0
7587799|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Death|0
7587800|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Death|0
7587801|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Death|0
7587802|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Death|0
7587803|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Death|0
7587804|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Death|0
7587805|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Death|0
7587806|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Death|0
7587807|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Death|0
7587808|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Death|0
7587809|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6
7587810|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0
7587811|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0
7587812|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0
7587813|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0
7587814|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0
7587815|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0
7587816|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0
7587817|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0
7587818|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0
7587819|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0
7587820|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0
7587821|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0
7587822|NCT01072175|11993703|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
7587823|NCT01072175|11993704|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587824|NCT01072175|11993705|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587825|NCT01072175|11993706|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587826|NCT01072175|11993707|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587827|NCT01072175|11993708|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587828|NCT01072175|11993709|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587829|NCT01072175|11993710|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587830|NCT01072175|11993711|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587831|NCT01072175|11993712|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587832|NCT01072175|11993713|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587833|NCT01072175|11993714|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587834|NCT01072175|11993715|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
7587835|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Death|0
7587836|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Death|4
7587837|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Death|18
7587838|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Death|21
7587839|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Death|68
7270472|NCT00416624|11484706|FG001|Overall Study|Withdrawal by Subject|6
7587840|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Death|0
7587841|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Death|0
7587842|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Death|0
7587843|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Death|0
7587844|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Death|0
7587845|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Death|0
7587846|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Death|0
7587847|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Death|0
7587848|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587849|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587850|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2
7587851|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587852|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4
7587853|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587854|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587855|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587856|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587857|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587858|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587859|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587860|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0
7587861|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587862|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7587863|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587864|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
7587865|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
7587866|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587867|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587868|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587869|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587870|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587871|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7270473|NCT00416624|11484707|FG002|Overall Study|Withdrawal by Subject|4
7270474|NCT00416624|11484708|FG003|Overall Study|Withdrawal by Subject|9
7270475|NCT00416624|11484705|FG000|Overall Study|Death|4
7270476|NCT00416624|11484706|FG001|Overall Study|Death|7
7270477|NCT00416624|11484707|FG002|Overall Study|Death|7
7270478|NCT00416624|11484708|FG003|Overall Study|Death|1
7587872|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7626238|NCT01006265|12038293|FG002|Overall Study|Lost to Follow-up|1
7626239|NCT01006265|12038294|FG003|Overall Study|Lost to Follow-up|0
7626240|NCT01006265|12038291|FG000|Overall Study|Withdrawal by Subject|4
7626241|NCT01006265|12038292|FG001|Overall Study|Withdrawal by Subject|7
7626242|NCT01006265|12038293|FG002|Overall Study|Withdrawal by Subject|5
7626243|NCT01006265|12038294|FG003|Overall Study|Withdrawal by Subject|5
7626244|NCT01006265|12038291|FG000|Overall Study|Administrative reason|1
7626245|NCT01006265|12038292|FG001|Overall Study|Administrative reason|2
7626246|NCT01006265|12038293|FG002|Overall Study|Administrative reason|3
7626247|NCT01006265|12038294|FG003|Overall Study|Administrative reason|0
7626248|NCT00534976|12038316|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
7626249|NCT00534976|12038317|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
7626250|NCT00534976|12038316|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
7626251|NCT00534976|12038317|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
7626252|NCT00534976|12038316|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
7626253|NCT00534976|12038317|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
7626254|NCT00337675|12038326|FG000|Overall Study|Adverse Event|10
7626255|NCT00337675|12038327|FG001|Overall Study|Adverse Event|9
7626256|NCT00337675|12038328|FG002|Overall Study|Adverse Event|19
7626257|NCT00337675|12038326|FG000|Overall Study|Lack of Efficacy|10
7626258|NCT00337675|12038327|FG001|Overall Study|Lack of Efficacy|7
7626259|NCT00337675|12038328|FG002|Overall Study|Lack of Efficacy|9
7626260|NCT00337675|12038326|FG000|Overall Study|Lost to Follow-up|22
7626261|NCT00337675|12038327|FG001|Overall Study|Lost to Follow-up|19
7626262|NCT00337675|12038328|FG002|Overall Study|Lost to Follow-up|17
7626263|NCT00337675|12038326|FG000|Overall Study|Physician Decision|9
7626264|NCT00337675|12038327|FG001|Overall Study|Physician Decision|17
7626265|NCT00337675|12038328|FG002|Overall Study|Physician Decision|14
7626266|NCT00337675|12038326|FG000|Overall Study|Protocol Violation|21
7626267|NCT00337675|12038327|FG001|Overall Study|Protocol Violation|24
7626268|NCT00337675|12038328|FG002|Overall Study|Protocol Violation|19
7626269|NCT00337675|12038326|FG000|Overall Study|Withdrawal by Subject|25
7626270|NCT00337675|12038327|FG001|Overall Study|Withdrawal by Subject|25
7626271|NCT00337675|12038328|FG002|Overall Study|Withdrawal by Subject|19
7626272|NCT00337675|12038326|FG000|Overall Study|Progressive Disease|0
7626273|NCT00337675|12038327|FG001|Overall Study|Progressive Disease|2
7626274|NCT00337675|12038328|FG002|Overall Study|Progressive Disease|0
7626275|NCT00337675|12038326|FG000|Overall Study|Trial Terminated|0
7626276|NCT00337675|12038327|FG001|Overall Study|Trial Terminated|0
7626277|NCT00337675|12038328|FG002|Overall Study|Trial Terminated|2
7626278|NCT00317772|12038340|FG000|Overall Study|Adverse Event|0
7626279|NCT00317772|12038341|FG001|Overall Study|Adverse Event|0
7626280|NCT00317772|12038342|FG002|Overall Study|Adverse Event|0
7626281|NCT00317772|12038343|FG003|Overall Study|Adverse Event|2
7626282|NCT00317772|12038340|FG000|Overall Study|Disease Progression|2
7626283|NCT00317772|12038341|FG001|Overall Study|Disease Progression|2
7626284|NCT00317772|12038342|FG002|Overall Study|Disease Progression|1
7587873|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
7587874|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587875|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587876|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
7587877|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
7587878|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
7587879|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587880|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587881|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587882|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587883|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587884|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587885|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587886|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
7587887|NCT01072175|11993703|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587888|NCT01072175|11993704|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
7587889|NCT01072175|11993705|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587890|NCT01072175|11993706|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
7587891|NCT01072175|11993707|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
7587892|NCT01072175|11993708|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587893|NCT01072175|11993709|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587894|NCT01072175|11993710|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587895|NCT01072175|11993711|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587896|NCT01072175|11993712|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587897|NCT01072175|11993713|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587898|NCT01072175|11993714|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587899|NCT01072175|11993715|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
7587900|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Death|0
7587901|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Death|0
7587902|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Death|0
7587903|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Death|0
7587904|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Death|0
7587905|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Death|44
7587906|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Death|34
7587907|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Death|39
7587908|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Death|0
7587909|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Death|0
7587910|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Death|0
7587911|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Death|0
7587912|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Death|0
7587913|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587914|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587915|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587916|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587917|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587918|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587919|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587920|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1
7587921|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587922|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587923|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587924|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587925|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0
7587926|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587927|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587928|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587929|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587930|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587931|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587932|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7587933|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
7587934|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587935|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587936|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587937|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587938|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
7587939|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587940|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587941|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587942|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587943|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587944|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
7587945|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
7587946|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
7587947|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587948|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587949|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587950|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587951|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
7587952|NCT01072175|11993703|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587953|NCT01072175|11993704|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587954|NCT01072175|11993705|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587955|NCT01072175|11993706|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587956|NCT01072175|11993707|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587957|NCT01072175|11993708|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
7587958|NCT01072175|11993709|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
7587959|NCT01072175|11993710|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587960|NCT01072175|11993711|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587961|NCT01072175|11993712|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587962|NCT01072175|11993713|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587963|NCT01072175|11993714|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587964|NCT01072175|11993715|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
7587965|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0
7587966|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0
7587967|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0
7587968|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0
7587969|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0
7587970|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0
7587971|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0
7587972|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0
7587973|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37
7587974|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0
7587975|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0
7587976|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0
7587977|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0
7587978|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587979|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587980|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587981|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587982|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587983|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587984|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587985|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587986|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
7587987|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587988|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587989|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587990|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
7587991|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587992|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587993|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587994|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587995|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587996|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587997|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587998|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7587999|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
7588000|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588001|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588002|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588003|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
7588004|NCT01072175|11993703|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588005|NCT01072175|11993704|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588006|NCT01072175|11993705|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588007|NCT01072175|11993706|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588008|NCT01072175|11993707|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588009|NCT01072175|11993708|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588010|NCT01072175|11993709|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588011|NCT01072175|11993710|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588012|NCT01072175|11993711|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
7588013|NCT01072175|11993712|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588014|NCT01072175|11993713|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588015|NCT01072175|11993714|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588016|NCT01072175|11993715|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
7588017|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Death|0
7588018|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Death|0
7588019|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Death|0
7588020|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Death|0
7588021|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Death|0
7588022|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Death|0
7588023|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Death|0
7588024|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Death|0
7588025|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Death|0
7588026|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Death|10
7588027|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Death|12
7588028|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Death|28
7588029|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Death|26
7588030|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Physician Decision|0
7588031|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Physician Decision|0
7588032|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Physician Decision|0
7588033|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Physician Decision|0
7588034|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Physician Decision|0
7588035|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Physician Decision|0
7588036|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Physician Decision|0
7588037|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Physician Decision|0
7588038|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Physician Decision|0
7588039|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Physician Decision|0
7588040|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Physician Decision|1
7588041|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Physician Decision|1
7588042|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Physician Decision|1
7588043|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0
7588044|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0
7588045|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0
7588046|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0
7588047|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0
7588048|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0
7588049|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0
7588050|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0
7588051|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0
7588052|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0
7588053|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1
7588054|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1
7588055|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3
7588056|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Study closed/terminated|0
7588057|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Study closed/terminated|0
7588058|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Study closed/terminated|0
7588059|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Study closed/terminated|0
7588060|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Study closed/terminated|0
7588061|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Study closed/terminated|0
7588062|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Study closed/terminated|0
7588063|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Study closed/terminated|0
7588064|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Study closed/terminated|0
7588065|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Study closed/terminated|2
7588066|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Study closed/terminated|1
7588067|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Study closed/terminated|10
7588131|NCT01174563|11993807|FG000|Overall Study|Sponsor's decision|1
7588068|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Study closed/terminated|9
7588069|NCT01072175|11993703|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588070|NCT01072175|11993704|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588071|NCT01072175|11993705|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588072|NCT01072175|11993706|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588073|NCT01072175|11993707|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588074|NCT01072175|11993708|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588075|NCT01072175|11993709|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588076|NCT01072175|11993710|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588077|NCT01072175|11993711|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588078|NCT01072175|11993712|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0
7588079|NCT01072175|11993713|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1
7588080|NCT01072175|11993714|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3
7588081|NCT01072175|11993715|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0
7626285|NCT00317772|12038343|FG003|Overall Study|Disease Progression|7
7626286|NCT00291486|12038359|FG000|Overall Study|Adverse Event|0
7626287|NCT00291486|12038360|FG001|Overall Study|Adverse Event|3
7626288|NCT00291486|12038361|FG002|Overall Study|Adverse Event|0
7626289|NCT00291486|12038362|FG003|Overall Study|Adverse Event|1
7626290|NCT00291486|12038363|FG004|Overall Study|Adverse Event|0
7626291|NCT00291486|12038359|FG000|Overall Study|Withdrawal by Subject|0
7626292|NCT00291486|12038360|FG001|Overall Study|Withdrawal by Subject|0
7626293|NCT00291486|12038361|FG002|Overall Study|Withdrawal by Subject|0
7626294|NCT00291486|12038362|FG003|Overall Study|Withdrawal by Subject|0
7270479|NCT00416624|11484705|FG000|Overall Study|Adverse Event|8
7270480|NCT00416624|11484706|FG001|Overall Study|Adverse Event|3
7270481|NCT00416624|11484707|FG002|Overall Study|Adverse Event|2
7270482|NCT00416624|11484708|FG003|Overall Study|Adverse Event|2
7270483|NCT00416624|11484705|FG000|Overall Study|Other|8
7270484|NCT00416624|11484706|FG001|Overall Study|Other|11
7270485|NCT00416624|11484707|FG002|Overall Study|Other|5
7270486|NCT00416624|11484708|FG003|Overall Study|Other|5
7270487|NCT00416624|11484705|FG000|Overall Study|Cancel|1
7270488|NCT00416624|11484706|FG001|Overall Study|Cancel|0
7270489|NCT00416624|11484707|FG002|Overall Study|Cancel|0
7270490|NCT00416624|11484708|FG003|Overall Study|Cancel|0
7270491|NCT00416715|11484718|FG000|Overall Study|Not evaluable for joint aches|7
7270492|NCT00416715|11484718|FG000|Overall Study|Vitamin D levels not evaluable|8
7270493|NCT00416884|11484729|FG000|Overall Study|Study terminated due to low accrual|1
7626295|NCT00291486|12038363|FG004|Overall Study|Withdrawal by Subject|1
7626296|NCT00291486|12038359|FG000|Overall Study|Disease progression|1
7626297|NCT00291486|12038360|FG001|Overall Study|Disease progression|0
7626298|NCT00291486|12038361|FG002|Overall Study|Disease progression|1
7626299|NCT00291486|12038362|FG003|Overall Study|Disease progression|0
7626300|NCT00291486|12038363|FG004|Overall Study|Disease progression|0
7626301|NCT00284856|12038387|FG000|Overall Study|Adverse Event|3
7626302|NCT00284856|12038388|FG001|Overall Study|Adverse Event|3
7626303|NCT00284856|12038389|FG002|Overall Study|Adverse Event|3
7626304|NCT00284856|12038387|FG000|Overall Study|Lack of Efficacy|2
7588082|NCT01087203|11993749|FG000|Overall Study|Lost to Follow-up|2
7588083|NCT01087203|11993750|FG001|Overall Study|Lost to Follow-up|0
7588084|NCT01087203|11993749|FG000|Overall Study|Withdrawal by Subject|2
7588085|NCT01087203|11993750|FG001|Overall Study|Withdrawal by Subject|6
7588086|NCT01087203|11993749|FG000|Overall Study|Lack of Efficacy|1
7588087|NCT01087203|11993750|FG001|Overall Study|Lack of Efficacy|2
7588088|NCT01087203|11993749|FG000|Overall Study|Study terminated by sponsor|27
7588089|NCT01087203|11993750|FG001|Overall Study|Study terminated by sponsor|27
7588090|NCT01108055|11993761|FG000|Overall Study|Ineligible|11
7588091|NCT01108055|11993761|FG000|Overall Study|Not evaluable- didn't complete treatment|4
7588094|NCT01136967|11993771|FG000|Overall Study|Adverse Event|9
7588095|NCT01136967|11993772|FG001|Overall Study|Adverse Event|12
7588096|NCT01136967|11993771|FG000|Overall Study|Participant Choice|8
7588097|NCT01136967|11993772|FG001|Overall Study|Participant Choice|3
7588098|NCT01136967|11993771|FG000|Overall Study|Lost to Follow-up|0
7588099|NCT01136967|11993772|FG001|Overall Study|Lost to Follow-up|1
7588100|NCT01136967|11993771|FG000|Overall Study|Withdrawal by Subject|1
7588101|NCT01136967|11993772|FG001|Overall Study|Withdrawal by Subject|2
7588102|NCT01136967|11993771|FG000|Overall Study|Clinical Progression|3
7588103|NCT01136967|11993772|FG001|Overall Study|Clinical Progression|5
7588104|NCT01136967|11993771|FG000|Overall Study|Radiation|1
7588105|NCT01136967|11993772|FG001|Overall Study|Radiation|0
7588106|NCT01136967|11993771|FG000|Overall Study|Non-compliance|1
7588107|NCT01136967|11993772|FG001|Overall Study|Non-compliance|0
7588108|NCT01136967|11993771|FG000|Overall Study|Investigator's Choice|1
7588109|NCT01136967|11993772|FG001|Overall Study|Investigator's Choice|1
7588110|NCT01136967|11993771|FG000|Overall Study|Increase in Lesion Size|0
7588111|NCT01136967|11993772|FG001|Overall Study|Increase in Lesion Size|2
7588112|NCT01136967|11993771|FG000|Overall Study|Diagnosis of Second Primary Cancer|0
7588113|NCT01136967|11993772|FG001|Overall Study|Diagnosis of Second Primary Cancer|1
7588126|NCT01174563|11993807|FG000|Overall Study|Progressive Disease|45
7588127|NCT01174563|11993807|FG000|Overall Study|Death|5
7588128|NCT01174563|11993807|FG000|Overall Study|Investigator's Discretion|5
7588129|NCT01174563|11993807|FG000|Overall Study|Participant Withdrew Consent|3
7588130|NCT01174563|11993807|FG000|Overall Study|Rash Adverse Event|1
7588132|NCT01235962|11993887|FG000|Overall Study|Withdrawal by Subject|20
7588133|NCT01235962|11993888|FG001|Overall Study|Withdrawal by Subject|19
7588134|NCT01235962|11993889|FG002|Overall Study|Withdrawal by Subject|62
7588135|NCT01235962|11993890|FG003|Overall Study|Withdrawal by Subject|49
7588136|NCT01235962|11993887|FG000|Overall Study|Lost to Follow-up|21
7588137|NCT01235962|11993888|FG001|Overall Study|Lost to Follow-up|16
7588138|NCT01235962|11993889|FG002|Overall Study|Lost to Follow-up|47
7588139|NCT01235962|11993890|FG003|Overall Study|Lost to Follow-up|32
7588140|NCT01235962|11993887|FG000|Overall Study|Physician Decision|5
7588141|NCT01235962|11993888|FG001|Overall Study|Physician Decision|0
7588142|NCT01235962|11993889|FG002|Overall Study|Physician Decision|9
7588143|NCT01235962|11993890|FG003|Overall Study|Physician Decision|5
7588144|NCT01239368|11993918|FG000|Overall Study|Principal investigator discretion|1
7588145|NCT01239368|11993919|FG001|Overall Study|Principal investigator discretion|0
7588146|NCT01239368|11993920|FG002|Overall Study|Principal investigator discretion|0
7588147|NCT01239368|11993921|FG003|Overall Study|Principal investigator discretion|0
7588148|NCT01239368|11993922|FG004|Overall Study|Principal investigator discretion|1
7588149|NCT01239368|11993923|FG005|Overall Study|Principal investigator discretion|2
7588150|NCT01239368|11993924|FG006|Overall Study|Principal investigator discretion|0
7588151|NCT01239368|11993925|FG007|Overall Study|Principal investigator discretion|0
7588152|NCT01239368|11993926|FG008|Overall Study|Principal investigator discretion|0
7588153|NCT01239368|11993927|FG009|Overall Study|Principal investigator discretion|1
7588154|NCT01239368|11993918|FG000|Overall Study|Disease progression on study|1
7588155|NCT01239368|11993919|FG001|Overall Study|Disease progression on study|1
7588156|NCT01239368|11993920|FG002|Overall Study|Disease progression on study|1
7588157|NCT01239368|11993921|FG003|Overall Study|Disease progression on study|1
7588158|NCT01239368|11993922|FG004|Overall Study|Disease progression on study|4
7588159|NCT01239368|11993923|FG005|Overall Study|Disease progression on study|2
7588160|NCT01239368|11993924|FG006|Overall Study|Disease progression on study|5
7588161|NCT01239368|11993925|FG007|Overall Study|Disease progression on study|0
7588162|NCT01239368|11993926|FG008|Overall Study|Disease progression on study|0
7588163|NCT01239368|11993927|FG009|Overall Study|Disease progression on study|2
7588164|NCT01239368|11993918|FG000|Overall Study|Refused further treatment|0
7588165|NCT01239368|11993919|FG001|Overall Study|Refused further treatment|0
7588166|NCT01239368|11993920|FG002|Overall Study|Refused further treatment|0
7588167|NCT01239368|11993921|FG003|Overall Study|Refused further treatment|0
7588168|NCT01239368|11993922|FG004|Overall Study|Refused further treatment|0
7588169|NCT01239368|11993923|FG005|Overall Study|Refused further treatment|0
7588170|NCT01239368|11993924|FG006|Overall Study|Refused further treatment|0
7588171|NCT01239368|11993925|FG007|Overall Study|Refused further treatment|0
7588172|NCT01239368|11993926|FG008|Overall Study|Refused further treatment|0
7588173|NCT01239368|11993927|FG009|Overall Study|Refused further treatment|1
7588174|NCT01239368|11993918|FG000|Overall Study|Death|0
7588175|NCT01239368|11993919|FG001|Overall Study|Death|0
7588176|NCT01239368|11993920|FG002|Overall Study|Death|0
7588177|NCT01239368|11993921|FG003|Overall Study|Death|0
7588092|NCT01111019|11993765|FG000|Overall Study|Withdrew Prematurely|2
7588093|NCT01111019|11993765|FG000|Overall Study|Other|1
7588114|NCT01137955|11993789|FG000|Overall Study|Withdrawal by Subject|5
7588115|NCT01137955|11993790|FG001|Overall Study|Withdrawal by Subject|4
7588178|NCT01239368|11993922|FG004|Overall Study|Death|0
7588179|NCT01239368|11993923|FG005|Overall Study|Death|0
7588180|NCT01239368|11993924|FG006|Overall Study|Death|1
7588181|NCT01239368|11993925|FG007|Overall Study|Death|0
7588182|NCT01239368|11993926|FG008|Overall Study|Death|0
7588183|NCT01239368|11993927|FG009|Overall Study|Death|0
7626305|NCT00284856|12038388|FG001|Overall Study|Lack of Efficacy|1
7626306|NCT00284856|12038389|FG002|Overall Study|Lack of Efficacy|8
7626307|NCT00284856|12038387|FG000|Overall Study|Lost to Follow-up|25
7626308|NCT00284856|12038388|FG001|Overall Study|Lost to Follow-up|21
7626309|NCT00284856|12038389|FG002|Overall Study|Lost to Follow-up|22
7626310|NCT00284856|12038387|FG000|Overall Study|Protocol Violation|5
7626311|NCT00284856|12038388|FG001|Overall Study|Protocol Violation|4
7626312|NCT00284856|12038389|FG002|Overall Study|Protocol Violation|5
7626313|NCT00284856|12038387|FG000|Overall Study|Withdrawal by Subject|12
7626314|NCT00284856|12038388|FG001|Overall Study|Withdrawal by Subject|16
7626315|NCT00284856|12038389|FG002|Overall Study|Withdrawal by Subject|18
7626316|NCT00284856|12038387|FG000|Overall Study|Other|4
7626317|NCT00284856|12038388|FG001|Overall Study|Other|5
7626318|NCT00284856|12038389|FG002|Overall Study|Other|4
7588116|NCT01140451|11993799|FG000|Overall Study|Withdrawal by Subject|26
7588117|NCT01140451|11993800|FG001|Overall Study|Withdrawal by Subject|33
7588118|NCT01140451|11993799|FG000|Overall Study|Adverse Event|2
7588119|NCT01140451|11993800|FG001|Overall Study|Adverse Event|6
7588120|NCT01140451|11993799|FG000|Overall Study|Physician Decision|5
7588121|NCT01140451|11993800|FG001|Overall Study|Physician Decision|3
7588122|NCT01140451|11993799|FG000|Overall Study|Lost to Follow-up|2
7588123|NCT01140451|11993800|FG001|Overall Study|Lost to Follow-up|0
7588124|NCT01140451|11993799|FG000|Overall Study|Participants Planning Pregnancy|3
7588125|NCT01140451|11993800|FG001|Overall Study|Participants Planning Pregnancy|0
7588184|NCT01247701|11993960|FG000|Overall Study|Death|2
7588185|NCT01247701|11993960|FG000|Overall Study|Relapsed|8
7588186|NCT01266031|11993967|FG000|Overall Study|Not treated|0
7588187|NCT01266031|11993968|FG001|Overall Study|Not treated|3
7588188|NCT01266031|11993969|FG002|Overall Study|Not treated|2
7588189|NCT01287741|11993990|FG000|Overall Study|Withdrawal by Subject|35
7588190|NCT01287741|11993991|FG001|Overall Study|Withdrawal by Subject|38
7588191|NCT01287741|11993990|FG000|Overall Study|Protocol Violation|2
7588192|NCT01287741|11993991|FG001|Overall Study|Protocol Violation|0
7588193|NCT01287741|11993990|FG000|Overall Study|Physician Decision|15
7588194|NCT01287741|11993991|FG001|Overall Study|Physician Decision|23
7588195|NCT01287741|11993990|FG000|Overall Study|Non-compliance|8
7588196|NCT01287741|11993991|FG001|Overall Study|Non-compliance|6
7588197|NCT01287741|11993990|FG000|Overall Study|Lost to Follow-up|10
7588198|NCT01287741|11993991|FG001|Overall Study|Lost to Follow-up|8
7588199|NCT01287741|11993990|FG000|Overall Study|Death|32
7588200|NCT01287741|11993991|FG001|Overall Study|Death|44
7588201|NCT01287741|11993990|FG000|Overall Study|Adverse Event|4
7588202|NCT01287741|11993991|FG001|Overall Study|Adverse Event|6
7588203|NCT01287741|11993990|FG000|Overall Study|Study terminated by Sponsor|307
7588204|NCT01287741|11993991|FG001|Overall Study|Study terminated by Sponsor|315
7588205|NCT01287741|11993990|FG000|Overall Study|Progressive disease|190
7588206|NCT01287741|11993991|FG001|Overall Study|Progressive disease|166
7588207|NCT01287741|11993990|FG000|Overall Study|Reason not specified|23
7588208|NCT01287741|11993991|FG001|Overall Study|Reason not specified|9
7588209|NCT01313689|11994008|FG000|24-Week Randomization 1|Adverse Event|10
7588210|NCT01313689|11994009|FG001|24-Week Randomization 1|Adverse Event|5
7588211|NCT01313689|11994010|FG002|24-Week Randomization 1|Adverse Event|0
7588212|NCT01313689|11994011|FG003|24-Week Randomization 1|Adverse Event|0
7588213|NCT01313689|11994012|FG004|24-Week Randomization 1|Adverse Event|0
7588214|NCT01313689|11994008|FG000|24-Week Randomization 1|Physician Decision|4
7588215|NCT01313689|11994009|FG001|24-Week Randomization 1|Physician Decision|5
7588216|NCT01313689|11994010|FG002|24-Week Randomization 1|Physician Decision|0
7588217|NCT01313689|11994011|FG003|24-Week Randomization 1|Physician Decision|0
7588218|NCT01313689|11994012|FG004|24-Week Randomization 1|Physician Decision|0
7588219|NCT01313689|11994008|FG000|24-Week Randomization 1|Withdrawal by Subject|5
7588220|NCT01313689|11994009|FG001|24-Week Randomization 1|Withdrawal by Subject|0
7588221|NCT01313689|11994010|FG002|24-Week Randomization 1|Withdrawal by Subject|0
7588222|NCT01313689|11994011|FG003|24-Week Randomization 1|Withdrawal by Subject|0
7588223|NCT01313689|11994012|FG004|24-Week Randomization 1|Withdrawal by Subject|0
7588224|NCT01313689|11994008|FG000|24-Week Randomization 2|Adverse Event|0
7588225|NCT01313689|11994009|FG001|24-Week Randomization 2|Adverse Event|0
7588226|NCT01313689|11994010|FG002|24-Week Randomization 2|Adverse Event|2
7588227|NCT01313689|11994011|FG003|24-Week Randomization 2|Adverse Event|0
7588228|NCT01313689|11994012|FG004|24-Week Randomization 2|Adverse Event|8
7588229|NCT01313689|11994008|FG000|24-Week Randomization 2|Withdrawal by Subject|0
7588230|NCT01313689|11994009|FG001|24-Week Randomization 2|Withdrawal by Subject|0
7588231|NCT01313689|11994010|FG002|24-Week Randomization 2|Withdrawal by Subject|1
7588232|NCT01313689|11994011|FG003|24-Week Randomization 2|Withdrawal by Subject|1
7588233|NCT01313689|11994012|FG004|24-Week Randomization 2|Withdrawal by Subject|3
7588234|NCT01313689|11994008|FG000|24-Week Randomization 2|Physician Decision|0
7588235|NCT01313689|11994009|FG001|24-Week Randomization 2|Physician Decision|0
7270494|NCT00416949|11484733|FG000|Overall Study|Patients refused to participate|5
7588236|NCT01313689|11994010|FG002|24-Week Randomization 2|Physician Decision|0
7588237|NCT01313689|11994011|FG003|24-Week Randomization 2|Physician Decision|0
7588238|NCT01313689|11994012|FG004|24-Week Randomization 2|Physician Decision|4
7588260|NCT01318993|11994044|FG000|Overall Study|Adverse Event|53
7588261|NCT01318993|11994044|FG000|Overall Study|Lack of Efficacy|121
7588262|NCT01318993|11994044|FG000|Overall Study|Protocol Violation|3
7588263|NCT01318993|11994044|FG000|Overall Study|Protocol based stopping criteria|6
7588264|NCT01318993|11994044|FG000|Overall Study|Study closed or terminated|174
7588265|NCT01318993|11994044|FG000|Overall Study|Lost to Follow-up|4
7588266|NCT01318993|11994044|FG000|Overall Study|Physician Decision|13
7588267|NCT01318993|11994044|FG000|Overall Study|Withdrawal by Subject|24
7588268|NCT04480710|11994066|FG000|Overall Study|Adverse Event|0
7588269|NCT04480710|11994067|FG001|Overall Study|Adverse Event|2
7588270|NCT04480710|11994068|FG002|Overall Study|Adverse Event|0
7588271|NCT04480710|11994069|FG003|Overall Study|Adverse Event|0
7588272|NCT04480710|11994066|FG000|Overall Study|Withdrawal by Subject|0
7588273|NCT04480710|11994067|FG001|Overall Study|Withdrawal by Subject|1
7588274|NCT04480710|11994068|FG002|Overall Study|Withdrawal by Subject|0
7588275|NCT04480710|11994069|FG003|Overall Study|Withdrawal by Subject|0
7588239|NCT01315353|11994034|FG000|Overall Study|Death|2
7588240|NCT01315353|11994035|FG001|Overall Study|Death|1
7588241|NCT01315353|11994036|FG002|Overall Study|Death|0
7588242|NCT01315353|11994034|FG000|Overall Study|Withdrawal by Subject|2
7588243|NCT01315353|11994035|FG001|Overall Study|Withdrawal by Subject|6
7588244|NCT01315353|11994036|FG002|Overall Study|Withdrawal by Subject|1
7588245|NCT01315353|11994034|FG000|Overall Study|Lost to Follow-up|13
7588246|NCT01315353|11994035|FG001|Overall Study|Lost to Follow-up|6
7588247|NCT01315353|11994036|FG002|Overall Study|Lost to Follow-up|6
7588248|NCT01315353|11994034|FG000|Overall Study|Unwilling to adhere to requirements|5
7588249|NCT01315353|11994035|FG001|Overall Study|Unwilling to adhere to requirements|5
7588250|NCT01315353|11994036|FG002|Overall Study|Unwilling to adhere to requirements|4
7588251|NCT01315353|11994034|FG000|Overall Study|Site closing|7
7588252|NCT01315353|11994035|FG001|Overall Study|Site closing|4
7588253|NCT01315353|11994036|FG002|Overall Study|Site closing|0
7588254|NCT01315353|11994034|FG000|Overall Study|Taken off study by site in error|0
7588255|NCT01315353|11994035|FG001|Overall Study|Taken off study by site in error|1
7588256|NCT01315353|11994036|FG002|Overall Study|Taken off study by site in error|0
7588257|NCT01315353|11994034|FG000|Overall Study|Inadvertent randomization/assignment|0
7588258|NCT01315353|11994035|FG001|Overall Study|Inadvertent randomization/assignment|0
7588259|NCT01315353|11994036|FG002|Overall Study|Inadvertent randomization/assignment|2
7588276|NCT04480710|11994066|FG000|Overall Study|Physician Decision|0
7588277|NCT04480710|11994067|FG001|Overall Study|Physician Decision|0
7588278|NCT04480710|11994068|FG002|Overall Study|Physician Decision|1
7588279|NCT04480710|11994069|FG003|Overall Study|Physician Decision|0
7588281|NCT04225676|11994089|FG000|Overall Study|Physician Decision|1
7588282|NCT04225676|11994089|FG000|Overall Study|Lack of Efficacy|1
7588283|NCT04225676|11994089|FG000|Overall Study|Study terminated by sponsor|3
7588284|NCT04045132|11994097|FG000|Overall Study|Lost to Follow-up|3
7588285|NCT04045132|11994098|FG001|Overall Study|Lost to Follow-up|6
7588286|NCT03891524|11994123|FG000|Overall Study|Death|0
7588287|NCT03891524|11994124|FG001|Overall Study|Death|0
7588288|NCT03891524|11994125|FG002|Overall Study|Death|0
7588289|NCT03891524|11994126|FG003|Overall Study|Death|0
7588290|NCT03891524|11994127|FG004|Overall Study|Death|0
7588291|NCT03891524|11994128|FG005|Overall Study|Death|0
7588292|NCT03891524|11994129|FG006|Overall Study|Death|0
7588293|NCT03891524|11994130|FG007|Overall Study|Death|1
7588294|NCT03891524|11994123|FG000|Overall Study|Withdrawal by Subject|0
7588295|NCT03891524|11994124|FG001|Overall Study|Withdrawal by Subject|1
7588296|NCT03891524|11994125|FG002|Overall Study|Withdrawal by Subject|2
7588297|NCT03891524|11994126|FG003|Overall Study|Withdrawal by Subject|1
7588298|NCT03891524|11994127|FG004|Overall Study|Withdrawal by Subject|2
7588299|NCT03891524|11994128|FG005|Overall Study|Withdrawal by Subject|2
7588300|NCT03891524|11994129|FG006|Overall Study|Withdrawal by Subject|2
7588301|NCT03891524|11994130|FG007|Overall Study|Withdrawal by Subject|1
7588302|NCT03796208|11994167|FG000|Overall Study|Withdrawal by Subject|3
7588303|NCT03796208|11994168|FG001|Overall Study|Withdrawal by Subject|0
7588304|NCT03796208|11994167|FG000|Overall Study|Loss of pregnancy|1
7588305|NCT03796208|11994168|FG001|Overall Study|Loss of pregnancy|1
7588306|NCT03796208|11994167|FG000|Overall Study|Changed prenatal clinics|0
7588307|NCT03796208|11994168|FG001|Overall Study|Changed prenatal clinics|5
7588308|NCT03796208|11994167|FG000|Overall Study|Lost to Follow-up|20
7588309|NCT03796208|11994168|FG001|Overall Study|Lost to Follow-up|16
7588310|NCT03611010|11994187|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1
7588311|NCT03611010|11994188|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0
7588312|NCT03611010|11994189|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0
7588313|NCT03611010|11994190|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0
7588314|NCT03476798|11994211|FG000|Overall Study|Death|1
7588315|NCT03476798|11994211|FG000|Overall Study|Withdrawal by Subject|2
7588316|NCT03476798|11994211|FG000|Overall Study|Protocol Violation|2
7588337|NCT03355664|11994239|FG000|Overall Study|Adverse Event|1
7588338|NCT03355664|11994240|FG001|Overall Study|Adverse Event|2
7588339|NCT03355664|11994239|FG000|Overall Study|Lost to Follow-up|11
7588340|NCT03355664|11994240|FG001|Overall Study|Lost to Follow-up|7
7588341|NCT03355664|11994239|FG000|Overall Study|Protocol Violation|1
7588342|NCT03355664|11994240|FG001|Overall Study|Protocol Violation|2
7588343|NCT03355664|11994239|FG000|Overall Study|Withdrawal by Subject|2
7588344|NCT03355664|11994240|FG001|Overall Study|Withdrawal by Subject|1
7588349|NCT03290131|11994254|FG000|Overall Study|Adverse Event|22
7588350|NCT03290131|11994255|FG001|Overall Study|Adverse Event|57
7588351|NCT03290131|11994256|FG002|Overall Study|Adverse Event|11
7588352|NCT03290131|11994254|FG000|Overall Study|Withdrawal by Subject|18
7588353|NCT03290131|11994255|FG001|Overall Study|Withdrawal by Subject|13
7588354|NCT03290131|11994256|FG002|Overall Study|Withdrawal by Subject|8
7588355|NCT03290131|11994254|FG000|Overall Study|MS Relapse|2
7588356|NCT03290131|11994255|FG001|Overall Study|MS Relapse|1
7588357|NCT03290131|11994256|FG002|Overall Study|MS Relapse|0
7588358|NCT03290131|11994254|FG000|Overall Study|Unknown reason|0
7588359|NCT03290131|11994255|FG001|Overall Study|Unknown reason|1
7588360|NCT03290131|11994256|FG002|Overall Study|Unknown reason|0
7588383|NCT03117049|11994312|FG000|Overall Study|Continued the follow-up period|109
7588384|NCT03117049|11994313|FG001|Overall Study|Continued the follow-up period|129
7588385|NCT03117049|11994312|FG000|Overall Study|Died|82
7588386|NCT03117049|11994313|FG001|Overall Study|Died|93
7588387|NCT03117049|11994312|FG000|Overall Study|Consent withdrawal|7
7588388|NCT03117049|11994313|FG001|Overall Study|Consent withdrawal|6
7588389|NCT03117049|11994312|FG000|Overall Study|Missing contact|3
7588390|NCT03117049|11994313|FG001|Overall Study|Missing contact|3
7588391|NCT02842086|11994321|FG000|Overall Study|Randomized but Never Treated|6
7588392|NCT02842086|11994322|FG001|Overall Study|Randomized but Never Treated|6
7588393|NCT02842086|11994321|FG000|Overall Study|Still in Double-Blind Phase|7
7588394|NCT02842086|11994322|FG001|Overall Study|Still in Double-Blind Phase|3
7588395|NCT02842086|11994321|FG000|Overall Study|Adverse Event|18
7588396|NCT02842086|11994322|FG001|Overall Study|Adverse Event|20
7588397|NCT02842086|11994321|FG000|Overall Study|Death|3
7588398|NCT02842086|11994322|FG001|Overall Study|Death|3
7588399|NCT02842086|11994321|FG000|Overall Study|Investigator's Discretion|9
7588400|NCT02842086|11994322|FG001|Overall Study|Investigator's Discretion|13
7588401|NCT02842086|11994321|FG000|Overall Study|Non-Compliance with Study Drug|9
7588402|NCT02842086|11994322|FG001|Overall Study|Non-Compliance with Study Drug|8
7588403|NCT02842086|11994321|FG000|Overall Study|Protocol Violation|8
7588404|NCT02842086|11994322|FG001|Overall Study|Protocol Violation|4
7588405|NCT02842086|11994321|FG000|Overall Study|Withdrew Consent|205
7588406|NCT02842086|11994322|FG001|Overall Study|Withdrew Consent|194
7588407|NCT02842086|11994321|FG000|Overall Study|Lost to Follow-up|274
7588408|NCT02842086|11994322|FG001|Overall Study|Lost to Follow-up|236
7588409|NCT02842086|11994321|FG000|Overall Study|HIV-1 Infection|5
7588410|NCT02842086|11994322|FG001|Overall Study|HIV-1 Infection|6
7588411|NCT02663622|11994332|FG000|Overall Study|Death|3
7588412|NCT02663622|11994333|FG001|Overall Study|Death|1
7588413|NCT02663622|11994334|FG002|Overall Study|Death|1
7588414|NCT02663622|11994335|FG003|Overall Study|Death|8
7588415|NCT02663622|11994332|FG000|Overall Study|Protocol Violation|0
7588416|NCT02663622|11994333|FG001|Overall Study|Protocol Violation|0
7588417|NCT02663622|11994334|FG002|Overall Study|Protocol Violation|0
7588418|NCT02663622|11994335|FG003|Overall Study|Protocol Violation|1
7588419|NCT02655016|11994348|FG000|Overall Study|Disease progression|6
7588420|NCT02655016|11994349|FG001|Overall Study|Disease progression|4
7588421|NCT02655016|11994348|FG000|Overall Study|Site closed|0
7588422|NCT02655016|11994349|FG001|Overall Study|Site closed|1
7588423|NCT02655016|11994348|FG000|Overall Study|Death|30
7588424|NCT02655016|11994349|FG001|Overall Study|Death|48
7588425|NCT02655016|11994348|FG000|Overall Study|Lost to Follow-up|1
7588426|NCT02655016|11994349|FG001|Overall Study|Lost to Follow-up|1
7588427|NCT02655016|11994348|FG000|Overall Study|Withdrawal by Subject|18
7588428|NCT02655016|11994349|FG001|Overall Study|Withdrawal by Subject|36
7588429|NCT02636439|11994358|FG000|Overall Study|Adverse Event|2
7588430|NCT02636439|11994359|FG001|Overall Study|Adverse Event|2
7588431|NCT02636439|11994358|FG000|Overall Study|Lost to Follow-up|1
7588432|NCT02636439|11994359|FG001|Overall Study|Lost to Follow-up|0
7588433|NCT02636439|11994358|FG000|Overall Study|Non-compliance|1
7588434|NCT02636439|11994359|FG001|Overall Study|Non-compliance|1
7588435|NCT02636439|11994358|FG000|Overall Study|Personal reasons|2
7588436|NCT02636439|11994359|FG001|Overall Study|Personal reasons|0
7588437|NCT02567825|11994367|FG000|Overall Study|No follow-up post-randomization|5
7588438|NCT02567825|11994368|FG001|Overall Study|No follow-up post-randomization|1
7588439|NCT02567825|11994367|FG000|Overall Study|Follow-up less than 23 months|16
7588440|NCT02567825|11994368|FG001|Overall Study|Follow-up less than 23 months|20
7588442|NCT02536755|11994383|FG000|Overall Study|Adverse Event|4
7588443|NCT02516241|11994393|FG000|Overall Study|Death|255
7588444|NCT02516241|11994394|FG001|Overall Study|Death|262
7588445|NCT02516241|11994395|FG002|Overall Study|Death|270
7588446|NCT02516241|11994393|FG000|Overall Study|Lost to Follow-up|1
7588447|NCT02516241|11994394|FG001|Overall Study|Lost to Follow-up|1
7588448|NCT02516241|11994395|FG002|Overall Study|Lost to Follow-up|3
7588449|NCT02516241|11994393|FG000|Overall Study|Withdrawal by Subject|2
7588450|NCT02516241|11994394|FG001|Overall Study|Withdrawal by Subject|7
7588451|NCT02516241|11994395|FG002|Overall Study|Withdrawal by Subject|12
7588452|NCT02516241|11994393|FG000|Overall Study|participants ongoing at data cut-off|84
7588453|NCT02516241|11994394|FG001|Overall Study|participants ongoing at data cut-off|76
7588454|NCT02516241|11994395|FG002|Overall Study|participants ongoing at data cut-off|59
7588455|NCT02442349|11994408|FG000|Overall Study|Death|14
7588456|NCT02442349|11994408|FG000|Overall Study|Withdrawal by Subject|8
7588457|NCT02442349|11994408|FG000|Overall Study|On-going Study at Data Cut-off|149
7588458|NCT02362035|11994412|FG000|Overall Study|Death|67
7588459|NCT02362035|11994412|FG000|Overall Study|Lost to Follow-up|3
7588460|NCT02362035|11994412|FG000|Overall Study|Adverse Event|1
7588461|NCT02362035|11994412|FG000|Overall Study|Physician Decision|1
7588462|NCT02362035|11994412|FG000|Overall Study|Subject started another cancer therapy|10
7588463|NCT02362035|11994412|FG000|Overall Study|Study terminated by sponsor|45
7588464|NCT02362035|11994412|FG000|Overall Study|Decision by subject not related to AE/SAE|2
7588465|NCT02362035|11994412|FG000|Overall Study|Decision by PI not related to AE/SAE|1
7588466|NCT02362035|11994412|FG000|Overall Study|Disease progression|11
7588467|NCT02362035|11994412|FG000|Overall Study|Withdrawal by Subject|20
7588468|NCT02328014|11994424|FG000|Overall Study|Adverse Event|1
7588469|NCT02328014|11994425|FG001|Overall Study|Adverse Event|0
7588470|NCT02328014|11994426|FG002|Overall Study|Adverse Event|0
7588471|NCT02328014|11994427|FG003|Overall Study|Adverse Event|1
7588472|NCT02328014|11994424|FG000|Overall Study|Death|0
7588473|NCT02328014|11994425|FG001|Overall Study|Death|0
7588474|NCT02328014|11994426|FG002|Overall Study|Death|0
7588475|NCT02328014|11994427|FG003|Overall Study|Death|4
7588476|NCT02328014|11994424|FG000|Overall Study|Physician Decision|0
7588477|NCT02328014|11994425|FG001|Overall Study|Physician Decision|0
7588478|NCT02328014|11994426|FG002|Overall Study|Physician Decision|0
7588479|NCT02328014|11994427|FG003|Overall Study|Physician Decision|1
7588480|NCT02328014|11994424|FG000|Overall Study|Disease Progression|1
7588481|NCT02328014|11994425|FG001|Overall Study|Disease Progression|0
7588482|NCT02328014|11994426|FG002|Overall Study|Disease Progression|1
7588483|NCT02328014|11994427|FG003|Overall Study|Disease Progression|3
7588484|NCT02328014|11994424|FG000|Overall Study|Study Terminated by Sponsor|4
7588485|NCT02328014|11994425|FG001|Overall Study|Study Terminated by Sponsor|1
7588486|NCT02328014|11994426|FG002|Overall Study|Study Terminated by Sponsor|1
7588487|NCT02328014|11994427|FG003|Overall Study|Study Terminated by Sponsor|0
7588488|NCT02328014|11994424|FG000|Overall Study|Subject Started Another Cancer Therapy|0
7588489|NCT02328014|11994425|FG001|Overall Study|Subject Started Another Cancer Therapy|5
7588490|NCT02328014|11994426|FG002|Overall Study|Subject Started Another Cancer Therapy|4
7588491|NCT02328014|11994427|FG003|Overall Study|Subject Started Another Cancer Therapy|12
7588492|NCT02328014|11994424|FG000|Overall Study|Withdrawal by Subject|0
7588493|NCT02328014|11994425|FG001|Overall Study|Withdrawal by Subject|0
7588494|NCT02328014|11994426|FG002|Overall Study|Withdrawal by Subject|0
7588495|NCT02328014|11994427|FG003|Overall Study|Withdrawal by Subject|1
7588505|NCT02207569|11994450|FG000|1-Month|Death|6
7588506|NCT02207569|11994450|FG000|1-Month|Withdrawal by Subject|2
7588507|NCT02207569|11994450|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
7588508|NCT02207569|11994450|FG000|6-Month|Death|8
7588509|NCT02207569|11994450|FG000|6-Month|Withdrawal by Subject|2
7588510|NCT02207569|11994450|FG000|12-Month|Death|14
7588511|NCT02207569|11994450|FG000|12-Month|Withdrawal by Subject|2
7588512|NCT02207569|11994450|FG000|24-Month|Death|23
7588513|NCT02207569|11994450|FG000|24-Month|Withdrawal by Subject|3
7588514|NCT02207569|11994450|FG000|36-Month|Death|23
7588515|NCT02207569|11994450|FG000|36-Month|Withdrawal by Subject|4
7588516|NCT02207569|11994450|FG000|48-Month|Death|25
7588517|NCT02207569|11994450|FG000|48-Month|Withdrawal by Subject|2
7588518|NCT02207569|11994450|FG000|48-Month|Lost to Follow-up|4
7588519|NCT02207569|11994450|FG000|60-Month|Death|1
7588520|NCT02207569|11994450|FG000|60-Month|Lost to Follow-up|1
7588521|NCT02207569|11994450|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1
7588522|NCT02207569|11994450|FG000|60-Month|Covid-19 pt not willing to be seen|1
7588523|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Adverse Event|0
7588524|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Adverse Event|6
7588525|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2
7588526|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1
7588527|NCT02201108|11994456|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2
7588528|NCT02201108|11994457|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0
7588529|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10
7588530|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14
7588531|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0
7588532|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1
7588533|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Other reason|4
7588534|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Other reason|7
7588535|NCT02201108|11994456|FG000|Open Label Period (up to Week 192)|Adverse Event|7
7588536|NCT02201108|11994457|FG001|Open Label Period (up to Week 192)|Adverse Event|5
7270495|NCT00417027|11484740|FG000|Overall Study|Protocol Violation|0
7270496|NCT00417027|11484741|FG001|Overall Study|Protocol Violation|5
7270497|NCT00417027|11484742|FG002|Overall Study|Protocol Violation|5
7270498|NCT00417079|11484752|FG000|Overall Study|Disease progression|267
7270499|NCT00417079|11484753|FG001|Overall Study|Disease progression|180
7270500|NCT00417079|11484752|FG000|Overall Study|Adverse Event|32
7270501|NCT00417079|11484753|FG001|Overall Study|Adverse Event|67
7270502|NCT00417079|11484752|FG000|Overall Study|Non-compliance to protocol|0
7270503|NCT00417079|11484753|FG001|Overall Study|Non-compliance to protocol|1
7270504|NCT00417079|11484752|FG000|Overall Study|Lost to Follow-up|2
7270505|NCT00417079|11484753|FG001|Overall Study|Lost to Follow-up|0
7270506|NCT00417079|11484752|FG000|Overall Study|Withdrawal by Subject|17
7270507|NCT00417079|11484753|FG001|Overall Study|Withdrawal by Subject|8
7270508|NCT00417079|11484752|FG000|Overall Study|Not treated|6
7270509|NCT00417079|11484753|FG001|Overall Study|Not treated|7
7270510|NCT00417079|11484752|FG000|Overall Study|Screened failure|2
7270511|NCT00417079|11484753|FG001|Overall Study|Screened failure|1
7270512|NCT00417079|11484752|FG000|Overall Study|Investigator's decision|1
7270513|NCT00417079|11484753|FG001|Overall Study|Investigator's decision|4
7270514|NCT00417079|11484752|FG000|Overall Study|Non-confirmed Disease progression|1
7270515|NCT00417079|11484753|FG001|Overall Study|Non-confirmed Disease progression|1
7270516|NCT00417079|11484752|FG000|Overall Study|Clinical deterioration|1
7270517|NCT00417079|11484753|FG001|Overall Study|Clinical deterioration|0
7270518|NCT00417079|11484752|FG000|Overall Study|Screening error|2
7270519|NCT00417079|11484753|FG001|Overall Study|Screening error|1
7270520|NCT00417079|11484752|FG000|Overall Study|Withdrawal by subject's family|0
7270521|NCT00417079|11484753|FG001|Overall Study|Withdrawal by subject's family|1
7270522|NCT00417079|11484752|FG000|Overall Study|Patient unable to come to the clinic|0
7270523|NCT00417079|11484753|FG001|Overall Study|Patient unable to come to the clinic|1
7588637|NCT01116648|11994597|FG000|Phase 1 Dose Level 3|Adverse Event|0
7588638|NCT01116648|11994598|FG001|Phase 1 Dose Level 3|Adverse Event|0
7588639|NCT01116648|11994599|FG002|Phase 1 Dose Level 3|Adverse Event|0
7588640|NCT01116648|11994600|FG003|Phase 1 Dose Level 3|Adverse Event|2
7588641|NCT01116648|11994601|FG004|Phase 1 Dose Level 3|Adverse Event|0
7588642|NCT01116648|11994602|FG005|Phase 1 Dose Level 3|Adverse Event|0
7588643|NCT01116648|11994603|FG006|Phase 1 Dose Level 3|Adverse Event|0
7588644|NCT01116648|11994604|FG007|Phase 1 Dose Level 3|Adverse Event|0
7588645|NCT01116648|11994605|FG008|Phase 1 Dose Level 3|Adverse Event|0
7588646|NCT01116648|11994606|FG009|Phase 1 Dose Level 3|Adverse Event|0
7588647|NCT01116648|11994607|FG010|Phase 1 Dose Level 3|Adverse Event|0
7588648|NCT01116648|11994608|FG011|Phase 1 Dose Level 3|Adverse Event|0
7588649|NCT01116648|11994609|FG012|Phase 1 Dose Level 3|Adverse Event|0
7588650|NCT01116648|11994610|FG013|Phase 1 Dose Level 3|Adverse Event|0
7588651|NCT01116648|11994611|FG014|Phase 1 Dose Level 3|Adverse Event|0
7588652|NCT01078662|11994641|FG000|Overall Study|Death|41
7588653|NCT01078662|11994642|FG001|Overall Study|Death|103
7588654|NCT01078662|11994643|FG002|Overall Study|Death|18
7588655|NCT01078662|11994644|FG003|Overall Study|Death|5
7588656|NCT01078662|11994645|FG004|Overall Study|Death|8
7588657|NCT01078662|11994641|FG000|Overall Study|Patients reached data cut-off|12
7588658|NCT01078662|11994642|FG001|Overall Study|Patients reached data cut-off|53
7588659|NCT01078662|11994643|FG002|Overall Study|Patients reached data cut-off|2
7588660|NCT01078662|11994644|FG003|Overall Study|Patients reached data cut-off|2
7588661|NCT01078662|11994645|FG004|Overall Study|Patients reached data cut-off|3
7588662|NCT01078662|11994641|FG000|Overall Study|Withdrawal by Subject|4
7588663|NCT01078662|11994642|FG001|Overall Study|Withdrawal by Subject|11
7588664|NCT01078662|11994643|FG002|Overall Study|Withdrawal by Subject|1
7588665|NCT01078662|11994644|FG003|Overall Study|Withdrawal by Subject|0
7588666|NCT01078662|11994645|FG004|Overall Study|Withdrawal by Subject|0
7588667|NCT01078662|11994641|FG000|Overall Study|Protocol Violation|0
7588668|NCT01078662|11994642|FG001|Overall Study|Protocol Violation|1
7588669|NCT01078662|11994643|FG002|Overall Study|Protocol Violation|0
7588670|NCT01078662|11994644|FG003|Overall Study|Protocol Violation|0
7588671|NCT01078662|11994645|FG004|Overall Study|Protocol Violation|0
7588672|NCT01078662|11994641|FG000|Overall Study|Lost to Follow-up|1
7588673|NCT01078662|11994642|FG001|Overall Study|Lost to Follow-up|0
7588674|NCT01078662|11994643|FG002|Overall Study|Lost to Follow-up|0
7588675|NCT01078662|11994644|FG003|Overall Study|Lost to Follow-up|0
7588676|NCT01078662|11994645|FG004|Overall Study|Lost to Follow-up|0
7588677|NCT00680901|11994656|FG000|Overall Study|Lost to Follow-up|8
7588678|NCT00680901|11994657|FG001|Overall Study|Lost to Follow-up|8
7588679|NCT00680901|11994656|FG000|Overall Study|Withdrawal by Subject|4
7588680|NCT00680901|11994657|FG001|Overall Study|Withdrawal by Subject|13
7588681|NCT00680901|11994656|FG000|Overall Study|Physician Decision|0
7588682|NCT00680901|11994657|FG001|Overall Study|Physician Decision|1
7588683|NCT00680901|11994656|FG000|Overall Study|Ongoing: On Study Treatment|16
7588684|NCT00680901|11994657|FG001|Overall Study|Ongoing: On Study Treatment|13
7588685|NCT00680901|11994656|FG000|Overall Study|Ongoing: In Follow Up|45
7588686|NCT00680901|11994657|FG001|Overall Study|Ongoing: In Follow Up|41
7626319|NCT00070707|12038399|FG000|Overall Study|Adverse Event|1
7626320|NCT00070707|12038400|FG001|Overall Study|Adverse Event|2
7626321|NCT00070707|12038399|FG000|Overall Study|Lack of Efficacy|4
7626322|NCT00070707|12038400|FG001|Overall Study|Lack of Efficacy|1
7626323|NCT00070707|12038399|FG000|Overall Study|Protocol Violation|8
7626324|NCT00070707|12038400|FG001|Overall Study|Protocol Violation|4
7626325|NCT00070707|12038399|FG000|Overall Study|Unrelated to Study Medication|1
7626326|NCT00070707|12038400|FG001|Overall Study|Unrelated to Study Medication|0
7588813|NCT01335685|11994691|FG000|Overall Study|Study Terminated by Sponsor|2
7588814|NCT01335685|11994692|FG001|Overall Study|Study Terminated by Sponsor|1
7588815|NCT01335685|11994693|FG002|Overall Study|Study Terminated by Sponsor|1
7588816|NCT01335685|11994694|FG003|Overall Study|Study Terminated by Sponsor|10
7588817|NCT01335685|11994695|FG004|Overall Study|Study Terminated by Sponsor|0
7588818|NCT01335685|11994696|FG005|Overall Study|Study Terminated by Sponsor|4
7588819|NCT01335685|11994697|FG006|Overall Study|Study Terminated by Sponsor|2
7588820|NCT01335685|11994698|FG007|Overall Study|Study Terminated by Sponsor|3
7588821|NCT01335685|11994691|FG000|Overall Study|Withdrawal by Subject|1
7588822|NCT01335685|11994692|FG001|Overall Study|Withdrawal by Subject|0
7588823|NCT01335685|11994693|FG002|Overall Study|Withdrawal by Subject|0
7588824|NCT01335685|11994694|FG003|Overall Study|Withdrawal by Subject|1
7588825|NCT01335685|11994695|FG004|Overall Study|Withdrawal by Subject|0
7588826|NCT01335685|11994696|FG005|Overall Study|Withdrawal by Subject|0
7588827|NCT01335685|11994697|FG006|Overall Study|Withdrawal by Subject|0
7588828|NCT01335685|11994698|FG007|Overall Study|Withdrawal by Subject|0
7588829|NCT01335685|11994691|FG000|Overall Study|Reason not Specified|0
7588830|NCT01335685|11994692|FG001|Overall Study|Reason not Specified|0
7588831|NCT01335685|11994693|FG002|Overall Study|Reason not Specified|1
7588832|NCT01335685|11994694|FG003|Overall Study|Reason not Specified|0
7588833|NCT01335685|11994695|FG004|Overall Study|Reason not Specified|0
7588834|NCT01335685|11994696|FG005|Overall Study|Reason not Specified|1
7588835|NCT01335685|11994697|FG006|Overall Study|Reason not Specified|0
7588836|NCT01335685|11994698|FG007|Overall Study|Reason not Specified|0
7588837|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
7588838|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
7588839|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
7588840|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
7588841|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
7588842|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
7588843|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
7588844|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
7588845|NCT01336621|11994721|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
7588846|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
7588847|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1
7588848|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
7588849|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1
7588850|NCT01336621|11994721|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
7588851|NCT04170296|11994741|FG000|Overall Study|Adverse Event|1
7588852|NCT04170296|11994742|FG001|Overall Study|Adverse Event|0
7588853|NCT04170296|11994741|FG000|Overall Study|Withdrawal by Subject|3
7588854|NCT04170296|11994742|FG001|Overall Study|Withdrawal by Subject|2
7588855|NCT04170296|11994741|FG000|Overall Study|Lost to Follow-up|4
7588856|NCT04170296|11994742|FG001|Overall Study|Lost to Follow-up|2
7588857|NCT04039217|11994754|FG000|Overall Study|Lost to Follow-up|1
7588858|NCT03078192|11994808|FG000|Overall Study|Withdrawal by Subject|2
7588859|NCT03078192|11994809|FG001|Overall Study|Withdrawal by Subject|1
7588860|NCT03078192|11994808|FG000|Overall Study|screen failure|0
7588861|NCT03078192|11994809|FG001|Overall Study|screen failure|3
7588862|NCT02903823|11994824|FG000|Overall Study|Physician Decision|5
7588863|NCT02903823|11994824|FG000|Overall Study|Could not advance catheter|1
7588864|NCT02903823|11994824|FG000|Overall Study|Catheter dislodgement|1
7588865|NCT01547117|11994846|FG000|Overall Study|Physician Decision|0
7588866|NCT01547117|11994847|FG001|Overall Study|Physician Decision|1
7588867|NCT01547117|11994848|FG002|Overall Study|Physician Decision|1
7588868|NCT01547117|11994849|FG003|Overall Study|Physician Decision|3
7588869|NCT01547117|11994846|FG000|Overall Study|Withdrawal by Subject|1
7588870|NCT01547117|11994847|FG001|Overall Study|Withdrawal by Subject|2
7588871|NCT01547117|11994848|FG002|Overall Study|Withdrawal by Subject|1
7588872|NCT01547117|11994849|FG003|Overall Study|Withdrawal by Subject|2
7588873|NCT01431508|11994875|FG000|Overall Study|Lack of Efficacy|1
7588874|NCT01431508|11994875|FG000|Overall Study|Unable to Follow Protocol Procedures|1
7588875|NCT00871351|11994882|FG000|Overall Study|Withdrawal by Subject|1
7588876|NCT00871351|11994883|FG001|Overall Study|Withdrawal by Subject|0
7588877|NCT00871351|11994884|FG002|Overall Study|Withdrawal by Subject|0
7588878|NCT00871351|11994882|FG000|Overall Study|Adverse Event|3
7588879|NCT00871351|11994883|FG001|Overall Study|Adverse Event|1
7588880|NCT00871351|11994884|FG002|Overall Study|Adverse Event|0
7588881|NCT00832455|11994892|FG000|Overall Study|Adverse Event|13
7588882|NCT00832455|11994892|FG000|Overall Study|Lost to Follow-up|26
7588883|NCT00832455|11994892|FG000|Overall Study|Protocol Violation|4
7588884|NCT00832455|11994892|FG000|Overall Study|Withdrawal by Subject|17
7588885|NCT00832455|11994892|FG000|Overall Study|Screening Failure|2
7588886|NCT00832455|11994892|FG000|Overall Study|Stopped Medication|4
7588887|NCT00832455|11994892|FG000|Overall Study|Parent misunderstood study|1
7588888|NCT00832455|11994892|FG000|Overall Study|Parent dissatisfied|1
7588889|NCT00832455|11994892|FG000|Overall Study|No improvement|3
7588890|NCT00832455|11994892|FG000|Overall Study|Patient moved|1
7588891|NCT00812006|11994908|FG000|Overall Study|Lost to Follow-up|0
7270524|NCT00417079|11484752|FG000|Overall Study|abnormal liver function tests|0
7270525|NCT00417079|11484753|FG001|Overall Study|abnormal liver function tests|1
7270526|NCT00417170|11484761|FG000|Overall Study|Adverse Event|1
7270527|NCT00417170|11484762|FG001|Overall Study|Adverse Event|1
7270528|NCT00417170|11484761|FG000|Overall Study|Withdrawal by Subject|1
7270529|NCT00417170|11484762|FG001|Overall Study|Withdrawal by Subject|1
7270530|NCT00417170|11484761|FG000|Overall Study|Lost to Follow-up|0
7270531|NCT00417170|11484762|FG001|Overall Study|Lost to Follow-up|1
7270532|NCT00417482|11484786|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
7270533|NCT00417482|11484787|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
7270534|NCT00417482|11484788|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
7270535|NCT00417482|11484786|FG000|Phase B 1st 16 Weeks|Adverse Event|2
7270536|NCT00417482|11484787|FG001|Phase B 1st 16 Weeks|Adverse Event|0
7270537|NCT00417482|11484788|FG002|Phase B 1st 16 Weeks|Adverse Event|1
7270538|NCT00417482|11484786|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7270539|NCT00417482|11484787|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
7270540|NCT00417482|11484788|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
7270541|NCT00417482|11484786|FG000|Phase B 1st 16 Weeks|Death|1
7270542|NCT00417482|11484787|FG001|Phase B 1st 16 Weeks|Death|0
7270543|NCT00417482|11484788|FG002|Phase B 1st 16 Weeks|Death|0
7270544|NCT00417482|11484786|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
7270545|NCT00417482|11484787|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
7270546|NCT00417482|11484788|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
7270547|NCT00417482|11484786|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
7270548|NCT00417482|11484787|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
7270549|NCT00417482|11484788|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
7270550|NCT00417482|11484786|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
7270551|NCT00417482|11484787|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7270552|NCT00417482|11484788|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
7270553|NCT00417482|11484786|FG000|Phase B 2nd 16 Weeks|Death|1
7270554|NCT00417482|11484787|FG001|Phase B 2nd 16 Weeks|Death|1
7270555|NCT00417482|11484788|FG002|Phase B 2nd 16 Weeks|Death|0
7270556|NCT00417612|11484804|FG000|Overall Study|Errant diagnosis|0
7270557|NCT00417612|11484805|FG001|Overall Study|Errant diagnosis|1
7270558|NCT00417612|11484804|FG000|Overall Study|Adverse Event|2
7270559|NCT00417612|11484805|FG001|Overall Study|Adverse Event|0
7270560|NCT00417612|11484804|FG000|Overall Study|Protocol Violation|0
7270561|NCT00417612|11484805|FG001|Overall Study|Protocol Violation|2
7588892|NCT00812006|11994909|FG001|Overall Study|Lost to Follow-up|0
7588893|NCT00812006|11994910|FG002|Overall Study|Lost to Follow-up|2
7588894|NCT00812006|11994908|FG000|Overall Study|Physician Decision|0
7588895|NCT00812006|11994909|FG001|Overall Study|Physician Decision|0
7588896|NCT00812006|11994910|FG002|Overall Study|Physician Decision|1
7270562|NCT00417612|11484804|FG000|Overall Study|Lost to Follow-up|1
7270563|NCT00417612|11484805|FG001|Overall Study|Lost to Follow-up|0
7270564|NCT00417885|11484824|FG000|Overall Study|Adverse Event|1
7270565|NCT00417885|11484824|FG000|Overall Study|Objective Progression or Relapse|3
7270566|NCT00417885|11484824|FG000|Overall Study|Transferred to Another Sunitinib Study|2
7270567|NCT00417963|11484828|FG000|Overall Study|Lost to Follow-up|3
7270568|NCT00417963|11484828|FG000|Overall Study|Withdrawal by Subject|18
7270569|NCT00417963|11484828|FG000|Overall Study|Death|17
7270570|NCT00417963|11484828|FG000|Overall Study|Study device could not be deployed|3
7270571|NCT00417976|11484837|FG000|Overall Study|Non compliance unrelated to toxicity|1
7270572|NCT00417976|11484837|FG000|Overall Study|Treatment -related toxicity|2
7270573|NCT00417989|11484844|FG000|Overall Study|Withdrawal by Subject|13
7270574|NCT00417989|11484845|FG001|Overall Study|Withdrawal by Subject|13
7270575|NCT00417989|11484844|FG000|Overall Study|Lost to Follow-up|1
7270576|NCT00417989|11484845|FG001|Overall Study|Lost to Follow-up|6
7270577|NCT00417989|11484844|FG000|Overall Study|Protocol Violation|1
7270578|NCT00417989|11484845|FG001|Overall Study|Protocol Violation|0
7270579|NCT00417989|11484844|FG000|Overall Study|Death|0
7270580|NCT00417989|11484845|FG001|Overall Study|Death|1
7270581|NCT00417989|11484844|FG000|Overall Study|Physician Decision|5
7270582|NCT00417989|11484845|FG001|Overall Study|Physician Decision|2
7270583|NCT00418184|11484885|FG000|Double-blind Phase|Withdrawal by Subject|22
7270584|NCT00418184|11484886|FG001|Double-blind Phase|Withdrawal by Subject|9
7270585|NCT00418184|11484885|FG000|Double-blind Phase|Adverse Event|2
7270586|NCT00418184|11484886|FG001|Double-blind Phase|Adverse Event|1
7270587|NCT00418184|11484885|FG000|Double-blind Phase|Poor compliance|3
7270588|NCT00418184|11484886|FG001|Double-blind Phase|Poor compliance|1
7270589|NCT00418314|11484902|FG000|Overall Study|Withdrawal by Subject|1
7270590|NCT00418314|11484903|FG001|Overall Study|Withdrawal by Subject|2
7270591|NCT00418379|11484912|FG000|Year 1|Adverse Event|9
7270592|NCT00418379|11484913|FG001|Year 1|Adverse Event|15
7270593|NCT00418379|11484914|FG002|Year 1|Adverse Event|3
7270594|NCT00418379|11484912|FG000|Year 1|Withdrawal by Subject|7
7270595|NCT00418379|11484913|FG001|Year 1|Withdrawal by Subject|8
7588897|NCT00812006|11994908|FG000|Overall Study|Withdrawal by Subject|2
7270596|NCT00418379|11484914|FG002|Year 1|Withdrawal by Subject|5
7588898|NCT00812006|11994909|FG001|Overall Study|Withdrawal by Subject|1
7588899|NCT00812006|11994910|FG002|Overall Study|Withdrawal by Subject|1
7588900|NCT00812006|11994908|FG000|Overall Study|Lack of Qualifying Event|4
7588901|NCT00812006|11994909|FG001|Overall Study|Lack of Qualifying Event|2
7588902|NCT00812006|11994910|FG002|Overall Study|Lack of Qualifying Event|2
7588903|NCT00687531|11994923|FG000|Overall Study|Did not meet protocol eligibility|104
7588904|NCT00687531|11994923|FG000|Overall Study|Adverse Event|5
7588905|NCT00687531|11994923|FG000|Overall Study|Lost to Follow-up|26
7588906|NCT00654628|11994927|FG000|6-week Active Treatment Period|Adverse Event|9
7588907|NCT00654628|11994927|FG000|6-week Active Treatment Period|Lost to Follow-up|10
7588908|NCT00654628|11994927|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
7588909|NCT00654628|11994927|FG000|6-week Active Treatment Period|Out of window period|1
7588910|NCT00654628|11994927|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
7588911|NCT00654628|11994927|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
7588912|NCT00536380|11994953|FG000|Overall Study|Adverse Event|0
7588913|NCT00536380|11994954|FG001|Overall Study|Adverse Event|2
7588914|NCT00536380|11994955|FG002|Overall Study|Adverse Event|2
7588915|NCT00536380|11994953|FG000|Overall Study|Lost to Follow-up|0
7588916|NCT00536380|11994954|FG001|Overall Study|Lost to Follow-up|0
7588917|NCT00536380|11994955|FG002|Overall Study|Lost to Follow-up|1
7588918|NCT00536380|11994953|FG000|Overall Study|Withdrawal unrelated to study drug|2
7588919|NCT00536380|11994954|FG001|Overall Study|Withdrawal unrelated to study drug|0
7588920|NCT00536380|11994955|FG002|Overall Study|Withdrawal unrelated to study drug|1
7588921|NCT00536380|11994953|FG000|Overall Study|Withdrawal related to study drug|7
7588922|NCT00536380|11994954|FG001|Overall Study|Withdrawal related to study drug|5
7588923|NCT00536380|11994955|FG002|Overall Study|Withdrawal related to study drug|2
7588924|NCT00536380|11994953|FG000|Overall Study|Noncompliance with protocol|3
7588925|NCT00536380|11994954|FG001|Overall Study|Noncompliance with protocol|2
7588926|NCT00536380|11994955|FG002|Overall Study|Noncompliance with protocol|2
7588927|NCT00536380|11994953|FG000|Overall Study|Did not meet protocol eligibility|0
7588928|NCT00536380|11994954|FG001|Overall Study|Did not meet protocol eligibility|0
7588929|NCT00536380|11994955|FG002|Overall Study|Did not meet protocol eligibility|1
7588930|NCT00536380|11994953|FG000|Overall Study|Administrative|0
7588931|NCT00536380|11994954|FG001|Overall Study|Administrative|0
7588932|NCT00536380|11994955|FG002|Overall Study|Administrative|1
7588933|NCT00521599|11994966|FG000|Overall Study|Adverse Event|5
7588934|NCT00521599|11994967|FG001|Overall Study|Adverse Event|7
7588935|NCT00521599|11994968|FG002|Overall Study|Adverse Event|6
7588936|NCT00521599|11994966|FG000|Overall Study|Treatment Failure|8
7588937|NCT00521599|11994967|FG001|Overall Study|Treatment Failure|9
7588938|NCT00521599|11994968|FG002|Overall Study|Treatment Failure|22
7588939|NCT00521599|11994966|FG000|Overall Study|Lost to Follow-up|2
7588940|NCT00521599|11994967|FG001|Overall Study|Lost to Follow-up|1
7588941|NCT00521599|11994968|FG002|Overall Study|Lost to Follow-up|2
7588942|NCT00521599|11994966|FG000|Overall Study|Withdrawal by Subject|3
7588943|NCT00521599|11994967|FG001|Overall Study|Withdrawal by Subject|5
7588944|NCT00521599|11994968|FG002|Overall Study|Withdrawal by Subject|1
7588945|NCT00521599|11994966|FG000|Overall Study|Withdrawal by subject treatment related|3
7588946|NCT00521599|11994967|FG001|Overall Study|Withdrawal by subject treatment related|1
7588947|NCT00521599|11994968|FG002|Overall Study|Withdrawal by subject treatment related|2
7588948|NCT00521599|11994966|FG000|Overall Study|Protocol Violation|2
7588949|NCT00521599|11994967|FG001|Overall Study|Protocol Violation|4
7588950|NCT00521599|11994968|FG002|Overall Study|Protocol Violation|2
7588951|NCT00521599|11994966|FG000|Overall Study|Did not meet protocol eligibility|2
7588952|NCT00521599|11994967|FG001|Overall Study|Did not meet protocol eligibility|2
7588953|NCT00521599|11994968|FG002|Overall Study|Did not meet protocol eligibility|1
7588954|NCT00496834|11994979|FG000|Overall Study|Withdrawal by Subject|4
7588955|NCT00496834|11994980|FG001|Overall Study|Withdrawal by Subject|6
7588956|NCT00496834|11994979|FG000|Overall Study|Contraindicated medication administered|0
7588957|NCT00496834|11994980|FG001|Overall Study|Contraindicated medication administered|1
7588958|NCT00496834|11994979|FG000|Overall Study|Inclusion/exclusion criteria not met|3
7588959|NCT00496834|11994980|FG001|Overall Study|Inclusion/exclusion criteria not met|2
7588960|NCT00496834|11994979|FG000|Overall Study|Adverse Event|5
7588961|NCT00496834|11994980|FG001|Overall Study|Adverse Event|3
7588962|NCT00496834|11994979|FG000|Overall Study|IP administration violation|2
7588963|NCT00496834|11994980|FG001|Overall Study|IP administration violation|0
7588964|NCT00496834|11994979|FG000|Overall Study|Lost to Follow-up|2
7588965|NCT00496834|11994980|FG001|Overall Study|Lost to Follow-up|0
7588966|NCT00496834|11994979|FG000|Overall Study|Blood Pressure control failure|2
7588967|NCT00496834|11994980|FG001|Overall Study|Blood Pressure control failure|1
7588968|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
7588969|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
7588970|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Death|0
7588971|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Death|1
7588972|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
7588973|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
7588974|NCT00442897|11994990|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
7588975|NCT00442897|11994991|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
7588976|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
7588977|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
7588978|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7588979|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
7588980|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
7588981|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
7588982|NCT00442897|11994990|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
7588983|NCT00442897|11994991|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
7588984|NCT00423579|11994999|FG000|Overall Study|Lost to Follow-up|3
7588985|NCT00423579|11995000|FG001|Overall Study|Lost to Follow-up|0
7588986|NCT00423579|11994999|FG000|Overall Study|Protocol Violation|1
7588987|NCT00423579|11995000|FG001|Overall Study|Protocol Violation|3
7588988|NCT00423579|11994999|FG000|Overall Study|Diagnosis of diabetes|0
7588989|NCT00423579|11995000|FG001|Overall Study|Diagnosis of diabetes|1
7588990|NCT00394355|11995010|FG000|Overall Study|Adverse Event|10
7588991|NCT00394355|11995011|FG001|Overall Study|Adverse Event|6
7588992|NCT00394355|11995012|FG002|Overall Study|Adverse Event|7
7588993|NCT00394355|11995013|FG003|Overall Study|Adverse Event|8
7588994|NCT00394355|11995010|FG000|Overall Study|Did not meet protocol eligibility|1
7588995|NCT00394355|11995011|FG001|Overall Study|Did not meet protocol eligibility|5
7588996|NCT00394355|11995012|FG002|Overall Study|Did not meet protocol eligibility|4
7588997|NCT00394355|11995013|FG003|Overall Study|Did not meet protocol eligibility|2
7588998|NCT00394355|11995010|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
7588999|NCT00394355|11995011|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
7589000|NCT00394355|11995012|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
7589001|NCT00394355|11995013|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
7589002|NCT00394355|11995010|FG000|Overall Study|Subject withdrawal - related to drug|1
7589003|NCT00394355|11995011|FG001|Overall Study|Subject withdrawal - related to drug|0
7589004|NCT00394355|11995012|FG002|Overall Study|Subject withdrawal - related to drug|0
7589005|NCT00394355|11995013|FG003|Overall Study|Subject withdrawal - related to drug|0
7589006|NCT00394355|11995010|FG000|Overall Study|Lost to Follow-up|7
7589007|NCT00394355|11995011|FG001|Overall Study|Lost to Follow-up|5
7589008|NCT00394355|11995012|FG002|Overall Study|Lost to Follow-up|4
7589009|NCT00394355|11995013|FG003|Overall Study|Lost to Follow-up|3
7589010|NCT00394355|11995010|FG000|Overall Study|Noncompliance with protocol|4
7589011|NCT00394355|11995011|FG001|Overall Study|Noncompliance with protocol|3
7589012|NCT00394355|11995012|FG002|Overall Study|Noncompliance with protocol|10
7589013|NCT00394355|11995013|FG003|Overall Study|Noncompliance with protocol|8
7589014|NCT00394355|11995010|FG000|Overall Study|Administrative|0
7589015|NCT00394355|11995011|FG001|Overall Study|Administrative|1
7589016|NCT00394355|11995012|FG002|Overall Study|Administrative|1
7589017|NCT00394355|11995013|FG003|Overall Study|Administrative|1
7589018|NCT00394355|11995010|FG000|Overall Study|Lack of Efficacy|0
7589019|NCT00394355|11995011|FG001|Overall Study|Lack of Efficacy|0
7589020|NCT00394355|11995012|FG002|Overall Study|Lack of Efficacy|2
7589021|NCT00394355|11995013|FG003|Overall Study|Lack of Efficacy|3
7589022|NCT00166504|11995034|FG000|Overall Study|Adverse Event|3
7589023|NCT00166504|11995035|FG001|Overall Study|Adverse Event|3
7589024|NCT00166504|11995034|FG000|Overall Study|Lost to Follow-up|1
7589025|NCT00166504|11995035|FG001|Overall Study|Lost to Follow-up|1
7589026|NCT00166504|11995034|FG000|Overall Study|Withdrawal by Subject|1
7589027|NCT00166504|11995035|FG001|Overall Study|Withdrawal by Subject|0
7626327|NCT04474197|12038430|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626328|NCT04474197|12038431|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1
7626329|NCT04474197|12038432|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626330|NCT04474197|12038433|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0
7626358|NCT03712345|12038511|FG000|Overall Study|Failure to meet randomization criteria|0
7626359|NCT03712345|12038512|FG001|Overall Study|Failure to meet randomization criteria|0
7626360|NCT03712345|12038513|FG002|Overall Study|Failure to meet randomization criteria|1
7626361|NCT03694275|12038523|FG000|Overall Study|Adverse Event|0
7626362|NCT03694275|12038524|FG001|Overall Study|Adverse Event|1
7626363|NCT03694275|12038523|FG000|Overall Study|Reason not Specified|0
7626364|NCT03694275|12038524|FG001|Overall Study|Reason not Specified|1
7626365|NCT03391232|12038533|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0
7626366|NCT03391232|12038534|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1
7626367|NCT03391232|12038533|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0
7626368|NCT03391232|12038534|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2
7626369|NCT03323736|12038545|FG000|Overall Study|Screen Failure|14
7626370|NCT03323736|12038546|FG001|Overall Study|Screen Failure|9
7626371|NCT03323736|12038547|FG002|Overall Study|Screen Failure|1
7626372|NCT03323736|12038545|FG000|Overall Study|Withdrawal Before Treatment|3
7626373|NCT03323736|12038546|FG001|Overall Study|Withdrawal Before Treatment|1
7626374|NCT03323736|12038547|FG002|Overall Study|Withdrawal Before Treatment|1
7626375|NCT03323736|12038545|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
7626376|NCT03323736|12038546|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
7626377|NCT03323736|12038547|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
7626378|NCT03073980|12038569|FG000|Overall Study|Lost to Follow-up|10
7626379|NCT03073980|12038570|FG001|Overall Study|Lost to Follow-up|2
7626380|NCT03073980|12038571|FG002|Overall Study|Lost to Follow-up|9
7626381|NCT03073980|12038569|FG000|Overall Study|No post-procedure data|0
7626382|NCT03073980|12038570|FG001|Overall Study|No post-procedure data|0
7626383|NCT03073980|12038571|FG002|Overall Study|No post-procedure data|2
7626384|NCT02544074|12038613|FG000|Overall Study|Withdrawal by Subject|0
7626385|NCT02544074|12038614|FG001|Overall Study|Withdrawal by Subject|1
7626386|NCT02544074|12038615|FG002|Overall Study|Withdrawal by Subject|0
7626387|NCT02544074|12038616|FG003|Overall Study|Withdrawal by Subject|0
7626388|NCT02544074|12038617|FG004|Overall Study|Withdrawal by Subject|0
7626389|NCT02544074|12038618|FG005|Overall Study|Withdrawal by Subject|0
7626390|NCT02544074|12038619|FG006|Overall Study|Withdrawal by Subject|0
7626391|NCT02544074|12038620|FG007|Overall Study|Withdrawal by Subject|0
7626392|NCT02544074|12038621|FG008|Overall Study|Withdrawal by Subject|0
7626393|NCT02544074|12038622|FG009|Overall Study|Withdrawal by Subject|0
7626394|NCT02544074|12038623|FG010|Overall Study|Withdrawal by Subject|0
7626395|NCT02544074|12038624|FG011|Overall Study|Withdrawal by Subject|0
7626396|NCT02544074|12038625|FG012|Overall Study|Withdrawal by Subject|0
7589028|NCT01345240|11995046|FG000|Overall Study|Adverse Event|3
7589029|NCT01345240|11995047|FG001|Overall Study|Adverse Event|5
7589030|NCT01345240|11995048|FG002|Overall Study|Adverse Event|4
7589031|NCT01345240|11995049|FG003|Overall Study|Adverse Event|2
7589032|NCT01345240|11995050|FG004|Overall Study|Adverse Event|1
7589033|NCT01345240|11995046|FG000|Overall Study|Lost to Follow-up|8
7589034|NCT01345240|11995047|FG001|Overall Study|Lost to Follow-up|9
7589035|NCT01345240|11995048|FG002|Overall Study|Lost to Follow-up|14
7589036|NCT01345240|11995049|FG003|Overall Study|Lost to Follow-up|7
7589037|NCT01345240|11995050|FG004|Overall Study|Lost to Follow-up|9
7626331|NCT04369950|12038450|FG000|Overall Study|Protocol Violation|2
7626332|NCT04369950|12038451|FG001|Overall Study|Protocol Violation|2
7626333|NCT04070326|12038459|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1
7626334|NCT04070326|12038460|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0
7626335|NCT04003610|12038471|FG000|Overall Study|Lost to Follow-up|0
7626336|NCT04003610|12038472|FG001|Overall Study|Lost to Follow-up|1
7626337|NCT04003610|12038473|FG002|Overall Study|Lost to Follow-up|0
7626338|NCT04003610|12038471|FG000|Overall Study|Death|0
7626339|NCT04003610|12038472|FG001|Overall Study|Death|0
7626340|NCT04003610|12038473|FG002|Overall Study|Death|3
7626341|NCT04003610|12038471|FG000|Overall Study|Study Terminated by Sponsor|0
7626342|NCT04003610|12038472|FG001|Overall Study|Study Terminated by Sponsor|0
7626343|NCT04003610|12038473|FG002|Overall Study|Study Terminated by Sponsor|3
7626344|NCT03920293|12038484|FG000|Overall Study|Withdrawal by Subject|2
7626345|NCT03920293|12038485|FG001|Overall Study|Withdrawal by Subject|1
7626346|NCT03920293|12038484|FG000|Overall Study|Physician Decision|1
7626347|NCT03920293|12038485|FG001|Overall Study|Physician Decision|2
7626348|NCT03920293|12038484|FG000|Overall Study|Adverse Event|0
7626349|NCT03920293|12038485|FG001|Overall Study|Adverse Event|2
7626350|NCT03920293|12038484|FG000|Overall Study|Sponsor Decision|0
7626351|NCT03920293|12038485|FG001|Overall Study|Sponsor Decision|1
7626352|NCT03920293|12038484|FG000|Overall Study|Death|2
7626353|NCT03920293|12038485|FG001|Overall Study|Death|0
7626354|NCT03920293|12038484|FG000|Overall Study|Protocol Violation|1
7626355|NCT03920293|12038485|FG001|Overall Study|Protocol Violation|0
7626356|NCT03920293|12038484|FG000|Overall Study|Noncompliance|1
7626357|NCT03920293|12038485|FG001|Overall Study|Noncompliance|0
7626397|NCT02544074|12038626|FG013|Overall Study|Withdrawal by Subject|0
7626398|NCT02544074|12038627|FG014|Overall Study|Withdrawal by Subject|0
7626399|NCT02544074|12038628|FG015|Overall Study|Withdrawal by Subject|0
7626400|NCT02544074|12038629|FG016|Overall Study|Withdrawal by Subject|0
7626401|NCT02544074|12038630|FG017|Overall Study|Withdrawal by Subject|0
7626402|NCT02544074|12038631|FG018|Overall Study|Withdrawal by Subject|0
7626403|NCT02544074|12038632|FG019|Overall Study|Withdrawal by Subject|0
7626404|NCT02544074|12038633|FG020|Overall Study|Withdrawal by Subject|0
7626405|NCT02544074|12038613|FG000|Overall Study|Tablet error|0
7626406|NCT02544074|12038614|FG001|Overall Study|Tablet error|0
7626407|NCT02544074|12038615|FG002|Overall Study|Tablet error|0
7626408|NCT02544074|12038616|FG003|Overall Study|Tablet error|0
7626409|NCT02544074|12038617|FG004|Overall Study|Tablet error|0
7626410|NCT02544074|12038618|FG005|Overall Study|Tablet error|1
7626411|NCT02544074|12038619|FG006|Overall Study|Tablet error|0
7626412|NCT02544074|12038620|FG007|Overall Study|Tablet error|0
7626413|NCT02544074|12038621|FG008|Overall Study|Tablet error|0
7626414|NCT02544074|12038622|FG009|Overall Study|Tablet error|1
7626415|NCT02544074|12038623|FG010|Overall Study|Tablet error|0
7626416|NCT02544074|12038624|FG011|Overall Study|Tablet error|0
7626417|NCT02544074|12038625|FG012|Overall Study|Tablet error|0
7626418|NCT02544074|12038626|FG013|Overall Study|Tablet error|0
7626419|NCT02544074|12038627|FG014|Overall Study|Tablet error|0
7626420|NCT02544074|12038628|FG015|Overall Study|Tablet error|0
7626421|NCT02544074|12038629|FG016|Overall Study|Tablet error|0
7626422|NCT02544074|12038630|FG017|Overall Study|Tablet error|0
7626423|NCT02544074|12038631|FG018|Overall Study|Tablet error|0
7626424|NCT02544074|12038632|FG019|Overall Study|Tablet error|0
7626425|NCT02544074|12038633|FG020|Overall Study|Tablet error|0
7626426|NCT02317627|12038670|FG000|Overall Study|Withdrawal by Subject|0
7626427|NCT02317627|12038671|FG001|Overall Study|Withdrawal by Subject|1
7626428|NCT02317627|12038672|FG002|Overall Study|Withdrawal by Subject|1
7626429|NCT02317627|12038670|FG000|Overall Study|Lost to Follow-up|2
7626430|NCT02317627|12038671|FG001|Overall Study|Lost to Follow-up|0
7626431|NCT02317627|12038672|FG002|Overall Study|Lost to Follow-up|0
7626432|NCT02317627|12038670|FG000|Overall Study|Stopped by Investigator|0
7626433|NCT02317627|12038671|FG001|Overall Study|Stopped by Investigator|1
7626434|NCT02317627|12038672|FG002|Overall Study|Stopped by Investigator|0
7626435|NCT02317627|12038670|FG000|Overall Study|Adverse Event|0
7626436|NCT02317627|12038671|FG001|Overall Study|Adverse Event|2
7626437|NCT02317627|12038672|FG002|Overall Study|Adverse Event|3
7626438|NCT02317627|12038670|FG000|Overall Study|Non-compliance with study drug|0
7626439|NCT02317627|12038671|FG001|Overall Study|Non-compliance with study drug|1
7626440|NCT02317627|12038672|FG002|Overall Study|Non-compliance with study drug|0
7626441|NCT01935128|12038686|FG000|Overall Study|Death|1
7626442|NCT01935128|12038686|FG000|Overall Study|Adverse Event|6
7626443|NCT01909934|12038690|FG000|Overall Study|Ongoing|23
7626444|NCT01909934|12038690|FG000|Overall Study|Withdrawal by Subject|3
7589038|NCT01371305|11995077|FG000|Overall Study|Adverse Event|0
7589039|NCT01371305|11995078|FG001|Overall Study|Adverse Event|0
7589040|NCT01371305|11995079|FG002|Overall Study|Adverse Event|0
7589041|NCT01371305|11995080|FG003|Overall Study|Adverse Event|2
7589042|NCT01371305|11995081|FG004|Overall Study|Adverse Event|1
7589043|NCT01371305|11995082|FG005|Overall Study|Adverse Event|0
7589044|NCT01371305|11995077|FG000|Overall Study|Study terminated by sponsor|0
7589045|NCT01371305|11995078|FG001|Overall Study|Study terminated by sponsor|0
7589046|NCT01371305|11995079|FG002|Overall Study|Study terminated by sponsor|0
7589047|NCT01371305|11995080|FG003|Overall Study|Study terminated by sponsor|0
7589048|NCT01371305|11995081|FG004|Overall Study|Study terminated by sponsor|3
7589049|NCT01371305|11995082|FG005|Overall Study|Study terminated by sponsor|1
7589050|NCT01371305|11995077|FG000|Overall Study|Subject request|0
7589051|NCT01371305|11995078|FG001|Overall Study|Subject request|0
7270597|NCT00418379|11484912|FG000|Year 1|Any other reason not above-mentioned|2
7270598|NCT00418379|11484913|FG001|Year 1|Any other reason not above-mentioned|5
7270599|NCT00418379|11484914|FG002|Year 1|Any other reason not above-mentioned|7
7270600|NCT00418379|11484912|FG000|Year 2|Adverse Event|5
7270601|NCT00418379|11484913|FG001|Year 2|Adverse Event|2
7270602|NCT00418379|11484914|FG002|Year 2|Adverse Event|1
7270603|NCT00418379|11484912|FG000|Year 2|Withdrawal by Subject|1
7270604|NCT00418379|11484913|FG001|Year 2|Withdrawal by Subject|1
7270605|NCT00418379|11484914|FG002|Year 2|Withdrawal by Subject|3
7270606|NCT00418379|11484912|FG000|Year 2|Any other reason not above-mentioned|2
7270607|NCT00418379|11484913|FG001|Year 2|Any other reason not above-mentioned|1
7270608|NCT00418379|11484914|FG002|Year 2|Any other reason not above-mentioned|6
7270609|NCT00418379|11484912|FG000|Year 3|Withdrawal by Subject|1
7270610|NCT00418379|11484913|FG001|Year 3|Withdrawal by Subject|1
7270611|NCT00418379|11484914|FG002|Year 3|Withdrawal by Subject|2
7270612|NCT00418379|11484912|FG000|Year 3|Any other reason not above-mentioned|2
7270613|NCT00418379|11484913|FG001|Year 3|Any other reason not above-mentioned|1
7270614|NCT00418379|11484914|FG002|Year 3|Any other reason not above-mentioned|1
7270615|NCT00418379|11484912|FG000|Year 4|Adverse Event|0
7270616|NCT00418379|11484913|FG001|Year 4|Adverse Event|1
7270617|NCT00418379|11484914|FG002|Year 4|Adverse Event|0
7270618|NCT00418379|11484912|FG000|Year 4|Withdrawal by Subject|2
7270619|NCT00418379|11484913|FG001|Year 4|Withdrawal by Subject|3
7270620|NCT00418379|11484914|FG002|Year 4|Withdrawal by Subject|2
7270621|NCT00418379|11484912|FG000|Year 4|Any other reason not above-mentioned|1
7270622|NCT00418379|11484913|FG001|Year 4|Any other reason not above-mentioned|1
7270623|NCT00418379|11484914|FG002|Year 4|Any other reason not above-mentioned|0
7270624|NCT00418379|11484912|FG000|Year 5|Adverse Event|0
7270625|NCT00418379|11484913|FG001|Year 5|Adverse Event|1
7270626|NCT00418379|11484914|FG002|Year 5|Adverse Event|0
7270627|NCT00418379|11484912|FG000|Year 5|Any other reason not above-mentioned|2
7270628|NCT00418379|11484913|FG001|Year 5|Any other reason not above-mentioned|4
7270629|NCT00418379|11484914|FG002|Year 5|Any other reason not above-mentioned|3
7270630|NCT00418522|11484933|FG000|Overall Study|Adverse Event|7
7270631|NCT00418522|11484934|FG001|Overall Study|Adverse Event|1
7270632|NCT00418522|11484933|FG000|Overall Study|Lack of Efficacy|1
7270633|NCT00418522|11484934|FG001|Overall Study|Lack of Efficacy|3
7270634|NCT00418522|11484933|FG000|Overall Study|Lost to Follow-up|10
7270635|NCT00418522|11484934|FG001|Overall Study|Lost to Follow-up|4
7270636|NCT00418522|11484933|FG000|Overall Study|Withdrawal by Subject|31
7270637|NCT00418522|11484934|FG001|Overall Study|Withdrawal by Subject|7
7270638|NCT00418522|11484933|FG000|Overall Study|Other|27
7270639|NCT00418522|11484934|FG001|Overall Study|Other|23
7270640|NCT00418522|11484933|FG000|Overall Study|Randomized but did not receive treatment|7
7270641|NCT00418522|11484934|FG001|Overall Study|Randomized but did not receive treatment|4
7270642|NCT00418561|11484943|FG000|Overall Study|Participant's (guardian's) decision|0
7270643|NCT00418561|11484944|FG001|Overall Study|Participant's (guardian's) decision|1
7270644|NCT00418561|11484945|FG002|Overall Study|Participant's (guardian's) decision|0
7270645|NCT00418665|11484965|FG000|Treatment Period|Ineligibility determined|1
7270646|NCT00418665|11484966|FG001|Treatment Period|Ineligibility determined|1
7270647|NCT00418665|11484967|FG002|Treatment Period|Ineligibility determined|0
7270648|NCT00418665|11484965|FG000|Treatment Period|Adverse Event|2
7270649|NCT00418665|11484966|FG001|Treatment Period|Adverse Event|2
7270650|NCT00418665|11484967|FG002|Treatment Period|Adverse Event|0
7270651|NCT00418665|11484965|FG000|Treatment Period|Withdrawal by Subject|0
7270652|NCT00418665|11484966|FG001|Treatment Period|Withdrawal by Subject|3
7270653|NCT00418665|11484967|FG002|Treatment Period|Withdrawal by Subject|1
7270654|NCT00418665|11484965|FG000|Treatment Period|Requirement for alternative therapy|1
7270655|NCT00418665|11484966|FG001|Treatment Period|Requirement for alternative therapy|0
7270656|NCT00418665|11484967|FG002|Treatment Period|Requirement for alternative therapy|0
7270657|NCT00418665|11484965|FG000|Treatment Period|Physician Decision|1
7270658|NCT00418665|11484966|FG001|Treatment Period|Physician Decision|0
7589052|NCT01371305|11995079|FG002|Overall Study|Subject request|0
7589053|NCT01371305|11995080|FG003|Overall Study|Subject request|0
7589054|NCT01371305|11995081|FG004|Overall Study|Subject request|0
7589055|NCT01371305|11995082|FG005|Overall Study|Subject request|1
7626445|NCT01909934|12038690|FG000|Overall Study|Lost to Follow-up|1
7626446|NCT01909934|12038690|FG000|Overall Study|Withdrawal of Informed Consent|1
7626447|NCT01909934|12038690|FG000|Overall Study|Death|22
7626448|NCT01841359|12038694|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2
7626449|NCT01841359|12038694|FG000|Overall Study|Concommitant medical issues|2
7626450|NCT01841359|12038694|FG000|Overall Study|Adverse Event|3
7626451|NCT01841359|12038694|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1
7626452|NCT01459666|12038703|FG000|Overall Study|PI left institution|5
7626453|NCT01459666|12038704|FG001|Overall Study|PI left institution|4
7626454|NCT01369199|12038710|FG000|Overall Study|Withdrawal by Subject|1
7626455|NCT01369199|12038710|FG000|Overall Study|Lost to Follow-up|2
7626456|NCT01368497|12038714|FG000|Overall Study|Lost to Follow-up|2
7270659|NCT00418665|11484967|FG002|Treatment Period|Physician Decision|3
7270660|NCT00418665|11484965|FG000|Treatment Extension|Adverse Event|1
7270661|NCT00418665|11484966|FG001|Treatment Extension|Adverse Event|0
7589056|NCT01376323|11995102|FG000|Overall Study|Adverse Event|1
7589057|NCT01376323|11995103|FG001|Overall Study|Adverse Event|0
7589058|NCT01376323|11995104|FG002|Overall Study|Adverse Event|0
7589059|NCT01376323|11995105|FG003|Overall Study|Adverse Event|2
7589060|NCT01376323|11995106|FG004|Overall Study|Adverse Event|0
7589061|NCT01376323|11995102|FG000|Overall Study|Lost to Follow-up|0
7589062|NCT01376323|11995103|FG001|Overall Study|Lost to Follow-up|0
7589063|NCT01376323|11995104|FG002|Overall Study|Lost to Follow-up|0
7589064|NCT01376323|11995105|FG003|Overall Study|Lost to Follow-up|2
7589065|NCT01376323|11995106|FG004|Overall Study|Lost to Follow-up|0
7589066|NCT01376323|11995102|FG000|Overall Study|Physician Decision|1
7589067|NCT01376323|11995103|FG001|Overall Study|Physician Decision|0
7589068|NCT01376323|11995104|FG002|Overall Study|Physician Decision|2
7589069|NCT01376323|11995105|FG003|Overall Study|Physician Decision|1
7589070|NCT01376323|11995106|FG004|Overall Study|Physician Decision|1
7589071|NCT01376323|11995102|FG000|Overall Study|Withdrawal by Subject|0
7589072|NCT01376323|11995103|FG001|Overall Study|Withdrawal by Subject|1
7589073|NCT01376323|11995104|FG002|Overall Study|Withdrawal by Subject|1
7589074|NCT01376323|11995105|FG003|Overall Study|Withdrawal by Subject|0
7589075|NCT01376323|11995106|FG004|Overall Study|Withdrawal by Subject|0
7589076|NCT01386658|11995130|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0
7589077|NCT01386658|11995131|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9
7589078|NCT01386658|11995130|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
7589079|NCT01386658|11995131|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
7589080|NCT01386684|11995141|FG000|Overall Study|Lost to Follow-up|51
7589081|NCT01386684|11995141|FG000|Overall Study|Other|51
7589082|NCT01386684|11995141|FG000|Overall Study|Death|47
7589083|NCT01386684|11995141|FG000|Overall Study|Withdrawal of Consent|44
7589084|NCT01386684|11995141|FG000|Overall Study|Alternative Therapy Required|37
7589085|NCT01386684|11995141|FG000|Overall Study|Disease Progression|28
7589086|NCT01386684|11995141|FG000|Overall Study|Adverse Event|20
7589087|NCT01386684|11995141|FG000|Overall Study|Noncompliance|8
7589088|NCT01386684|11995141|FG000|Overall Study|Protocol Violation|4
7589089|NCT01386684|11995141|FG000|Overall Study|Missing|3
7589090|NCT04980014|11995158|FG000|Overall Study|Participants who are Duplicated|1
7589091|NCT04980014|11995158|FG000|Overall Study|Follow-up Failure|13
7589092|NCT04980014|11995158|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2
7589093|NCT04980014|11995158|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2
7589094|NCT04980014|11995158|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57
7626469|NCT03560258|12038743|FG002|Overall Study|Lost to Follow-up|0
7589145|NCT03735849|11995234|FG000|Overall Study|Lost to Follow-up|1
7589146|NCT03735849|11995235|FG001|Overall Study|Lost to Follow-up|0
7589147|NCT03735849|11995236|FG002|Overall Study|Lost to Follow-up|0
7270662|NCT00418665|11484967|FG002|Treatment Extension|Adverse Event|0
7270663|NCT00418665|11484965|FG000|Treatment Extension|Withdrawal by Subject|1
7270664|NCT00418665|11484966|FG001|Treatment Extension|Withdrawal by Subject|0
7270665|NCT00418665|11484967|FG002|Treatment Extension|Withdrawal by Subject|0
7270666|NCT00418665|11484965|FG000|Treatment Extension|Requirement for alternative therapy|2
7270667|NCT00418665|11484966|FG001|Treatment Extension|Requirement for alternative therapy|2
7270668|NCT00418665|11484967|FG002|Treatment Extension|Requirement for alternative therapy|0
7270669|NCT00418665|11484965|FG000|Treatment Extension|Physician Decision|2
7270670|NCT00418665|11484966|FG001|Treatment Extension|Physician Decision|2
7270671|NCT00418665|11484967|FG002|Treatment Extension|Physician Decision|1
7270672|NCT00418665|11484965|FG000|Treatment Extension|Death|0
7270673|NCT00418665|11484966|FG001|Treatment Extension|Death|0
7270674|NCT00418665|11484967|FG002|Treatment Extension|Death|1
7270675|NCT00418691|11484978|FG000|Overall Study|Lost to Follow-up|1
7270676|NCT00418691|11484979|FG001|Overall Study|Lost to Follow-up|2
7270677|NCT00418691|11484980|FG002|Overall Study|Lost to Follow-up|3
7270678|NCT00418691|11484978|FG000|Overall Study|Started new medication voiding entry|0
7270679|NCT00418691|11484979|FG001|Overall Study|Started new medication voiding entry|0
7270680|NCT00418691|11484980|FG002|Overall Study|Started new medication voiding entry|1
7270681|NCT00418691|11484978|FG000|Overall Study|Progressive Disease|1
7270682|NCT00418691|11484979|FG001|Overall Study|Progressive Disease|0
7270683|NCT00418691|11484980|FG002|Overall Study|Progressive Disease|1
7270684|NCT00418717|11484988|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
7270685|NCT00418717|11484988|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
7270686|NCT00418886|11484994|FG000|Overall Study|discontinue treatment survival follow up|90
7270687|NCT00418886|11484995|FG001|Overall Study|discontinue treatment survival follow up|91
7270688|NCT00418886|11484994|FG000|Overall Study|Death|122
7270689|NCT00418886|11484995|FG001|Overall Study|Death|147
7270690|NCT00418886|11484994|FG000|Overall Study|Withdrawal by Subject|9
7270691|NCT00418886|11484995|FG001|Overall Study|Withdrawal by Subject|10
7270692|NCT00418886|11484994|FG000|Overall Study|Lost to Follow-up|4
7270693|NCT00418886|11484995|FG001|Overall Study|Lost to Follow-up|6
7270694|NCT00418886|11484994|FG000|Overall Study|withdrawn due to other reason|1
7270695|NCT00418886|11484995|FG001|Overall Study|withdrawn due to other reason|0
7270696|NCT00418886|11484994|FG000|Overall Study|randomised but no treatment received|0
7270697|NCT00418886|11484995|FG001|Overall Study|randomised but no treatment received|1
7270698|NCT00418938|11485003|FG000|Overall Study|Reimbursement|1
7270699|NCT00418938|11485004|FG001|Overall Study|Reimbursement|0
7270700|NCT00418938|11485003|FG000|Overall Study|Administrative decision|3
7270701|NCT00418938|11485004|FG001|Overall Study|Administrative decision|3
7270702|NCT00418938|11485003|FG000|Overall Study|Withdrawal by Subject|16
7270703|NCT00418938|11485004|FG001|Overall Study|Withdrawal by Subject|15
7270704|NCT00418938|11485003|FG000|Overall Study|Lost to Follow-up|1
7270705|NCT00418938|11485004|FG001|Overall Study|Lost to Follow-up|3
7270706|NCT00418938|11485003|FG000|Overall Study|Adverse Event|1
7270707|NCT00418938|11485004|FG001|Overall Study|Adverse Event|1
7270708|NCT00418938|11485003|FG000|Overall Study|On-going|1
7270709|NCT00418938|11485004|FG001|Overall Study|On-going|1
7270710|NCT00418938|11485003|FG000|Overall Study|Ineligibility Determined|1
7270711|NCT00418938|11485004|FG001|Overall Study|Ineligibility Determined|0
7270712|NCT00419003|11485047|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
7270713|NCT00419003|11485048|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
7270714|NCT00419003|11485047|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
7270715|NCT00419003|11485048|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
7270716|NCT00419094|11485059|FG000|Overall Study|Adverse Event|3
7270717|NCT00419094|11485060|FG001|Overall Study|Adverse Event|7
7270718|NCT00419094|11485059|FG000|Overall Study|Lack of Efficacy|1
7589148|NCT03735849|11995234|FG000|Overall Study|Participant unable to adhere to visit|1
7589149|NCT03735849|11995235|FG001|Overall Study|Participant unable to adhere to visit|0
7589150|NCT03735849|11995236|FG002|Overall Study|Participant unable to adhere to visit|0
7589151|NCT03735849|11995234|FG000|Overall Study|Not Randomized|0
7589152|NCT03735849|11995235|FG001|Overall Study|Not Randomized|0
7589153|NCT03735849|11995236|FG002|Overall Study|Not Randomized|4
7626457|NCT05096312|12038720|FG000|Overall Study|Lost to Follow-up|2
7626458|NCT05096312|12038721|FG001|Overall Study|Lost to Follow-up|4
7626459|NCT05096312|12038720|FG000|Overall Study|Adverse Event|1
7626460|NCT05096312|12038721|FG001|Overall Study|Adverse Event|0
7626467|NCT03560258|12038741|FG000|Overall Study|Lost to Follow-up|3
7626468|NCT03560258|12038742|FG001|Overall Study|Lost to Follow-up|0
7626470|NCT03560258|12038741|FG000|Overall Study|Protocol Violation|0
7626471|NCT03560258|12038742|FG001|Overall Study|Protocol Violation|1
7626472|NCT03560258|12038743|FG002|Overall Study|Protocol Violation|0
7626473|NCT03560258|12038741|FG000|Overall Study|Withdrawal by Subject|0
7626474|NCT03560258|12038742|FG001|Overall Study|Withdrawal by Subject|0
7626475|NCT03560258|12038743|FG002|Overall Study|Withdrawal by Subject|1
7626476|NCT03684304|12038753|FG000|Overall Study|Lost to Follow-up|19
7626477|NCT03684304|12038754|FG001|Overall Study|Lost to Follow-up|17
7626478|NCT04528641|12038775|FG000|Overall Study|Withdrawal by Subject|0
7626479|NCT04528641|12038776|FG001|Overall Study|Withdrawal by Subject|0
7626480|NCT04528641|12038777|FG002|Overall Study|Withdrawal by Subject|0
7626481|NCT04528641|12038778|FG003|Overall Study|Withdrawal by Subject|1
7626482|NCT04528641|12038779|FG004|Overall Study|Withdrawal by Subject|0
7626483|NCT04528641|12038780|FG005|Overall Study|Withdrawal by Subject|1
7626484|NCT04034238|12038816|FG000|Dose Escalation Phase|Withdrawal by Subject|1
7626485|NCT04034238|12038817|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7626486|NCT04034238|12038818|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7626487|NCT04034238|12038819|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7626488|NCT04034238|12038816|FG000|Dose Escalation Phase|Screen failures|0
7626489|NCT04034238|12038817|FG001|Dose Escalation Phase|Screen failures|0
7626490|NCT04034238|12038818|FG002|Dose Escalation Phase|Screen failures|0
7626491|NCT04034238|12038819|FG003|Dose Escalation Phase|Screen failures|2
7626492|NCT04034238|12038816|FG000|Dose Expansion Phase|Not treated due to study hold.|0
7626493|NCT04034238|12038817|FG001|Dose Expansion Phase|Not treated due to study hold.|0
7626494|NCT04034238|12038818|FG002|Dose Expansion Phase|Not treated due to study hold.|0
7626495|NCT04034238|12038819|FG003|Dose Expansion Phase|Not treated due to study hold.|1
7626496|NCT04034238|12038816|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626497|NCT04034238|12038817|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626498|NCT04034238|12038818|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1
7626499|NCT04034238|12038819|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
7626500|NCT03984305|12038832|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19
7626501|NCT03984305|12038833|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15
7626502|NCT03984305|12038832|FG000|Overall Study|Withdrawal by Subject|3
7626503|NCT03984305|12038833|FG001|Overall Study|Withdrawal by Subject|3
7626504|NCT03984305|12038832|FG000|Overall Study|Lost to Follow-up|1
7626505|NCT03984305|12038833|FG001|Overall Study|Lost to Follow-up|0
7626506|NCT03982368|12038842|FG000|Overall Study|Adverse Event|6
7626507|NCT03982368|12038843|FG001|Overall Study|Adverse Event|4
7626508|NCT03982368|12038844|FG002|Overall Study|Adverse Event|3
7626509|NCT03982368|12038842|FG000|Overall Study|Lost to Follow-up|2
7626510|NCT03982368|12038843|FG001|Overall Study|Lost to Follow-up|1
7626511|NCT03982368|12038844|FG002|Overall Study|Lost to Follow-up|0
7626512|NCT03982368|12038842|FG000|Overall Study|Withdrawal by Subject|1
7626513|NCT03982368|12038843|FG001|Overall Study|Withdrawal by Subject|2
7626514|NCT03982368|12038844|FG002|Overall Study|Withdrawal by Subject|0
7626515|NCT03982368|12038842|FG000|Overall Study|unknow|4
7626516|NCT03982368|12038843|FG001|Overall Study|unknow|0
7626517|NCT03982368|12038844|FG002|Overall Study|unknow|2
7626518|NCT03952143|12038857|FG000|Lead-In Period|Adverse Event|2
7626519|NCT03952143|12038858|FG001|Lead-In Period|Adverse Event|0
7626520|NCT03952143|12038859|FG002|Lead-In Period|Adverse Event|0
7626521|NCT03952143|12038857|FG000|Lead-In Period|Lack of Efficacy|2
7626522|NCT03952143|12038858|FG001|Lead-In Period|Lack of Efficacy|0
7626523|NCT03952143|12038859|FG002|Lead-In Period|Lack of Efficacy|0
7626524|NCT03952143|12038857|FG000|Lead-In Period|Physician Decision|5
7626525|NCT03952143|12038858|FG001|Lead-In Period|Physician Decision|0
7626526|NCT03952143|12038859|FG002|Lead-In Period|Physician Decision|0
7626527|NCT03952143|12038857|FG000|Lead-In Period|Protocol Violation|5
7626528|NCT03952143|12038858|FG001|Lead-In Period|Protocol Violation|0
7626529|NCT03952143|12038859|FG002|Lead-In Period|Protocol Violation|0
7626530|NCT03952143|12038857|FG000|Lead-In Period|Withdrawal by Subject|19
7626531|NCT03952143|12038858|FG001|Lead-In Period|Withdrawal by Subject|0
7589154|NCT03552393|11995252|FG000|Core Period|Kidney Transplant|1
7589155|NCT03552393|11995252|FG000|Core Period|Prohibited Medication|1
7589156|NCT03552393|11995252|FG000|Safety Extension Period|Kidney Transplant|4
7626532|NCT03952143|12038859|FG002|Lead-In Period|Withdrawal by Subject|0
7626533|NCT03952143|12038857|FG000|Treatment Period|Adverse Event|0
7626534|NCT03952143|12038858|FG001|Treatment Period|Adverse Event|0
7626535|NCT03952143|12038859|FG002|Treatment Period|Adverse Event|1
7626536|NCT03952143|12038857|FG000|Treatment Period|Lost to Follow-up|0
7626537|NCT03952143|12038858|FG001|Treatment Period|Lost to Follow-up|2
7626538|NCT03952143|12038859|FG002|Treatment Period|Lost to Follow-up|0
7626539|NCT03952143|12038857|FG000|Treatment Period|Physician Decision|0
7626540|NCT03952143|12038858|FG001|Treatment Period|Physician Decision|0
7626541|NCT03952143|12038859|FG002|Treatment Period|Physician Decision|2
7626542|NCT03952143|12038857|FG000|Treatment Period|Protocol Violation|0
7626543|NCT03952143|12038858|FG001|Treatment Period|Protocol Violation|0
7626544|NCT03952143|12038859|FG002|Treatment Period|Protocol Violation|1
7626545|NCT03952143|12038857|FG000|Treatment Period|Withdrawal by Subject|0
7626546|NCT03952143|12038858|FG001|Treatment Period|Withdrawal by Subject|5
7626547|NCT03952143|12038859|FG002|Treatment Period|Withdrawal by Subject|26
7626548|NCT03952143|12038857|FG000|Treatment Period|Due to COVID 19 restrictions|0
7589205|NCT03333382|11995281|FG000|Overall Study|Lost to Follow-up|1
7589206|NCT03333382|11995282|FG001|Overall Study|Lost to Follow-up|0
7589207|NCT03107611|11995321|FG000|Overall Study|Adverse Event|1
7589208|NCT03107611|11995322|FG001|Overall Study|Adverse Event|0
7589209|NCT03107611|11995323|FG002|Overall Study|Adverse Event|2
7589210|NCT03107611|11995321|FG000|Overall Study|Lost to Follow-up|3
7589211|NCT03107611|11995322|FG001|Overall Study|Lost to Follow-up|3
7589212|NCT03107611|11995323|FG002|Overall Study|Lost to Follow-up|3
7589213|NCT03107611|11995321|FG000|Overall Study|Protocol Violation|0
7589214|NCT03107611|11995322|FG001|Overall Study|Protocol Violation|0
7589215|NCT03107611|11995323|FG002|Overall Study|Protocol Violation|1
7589216|NCT03107611|11995321|FG000|Overall Study|Withdrawal by Subject|1
7589217|NCT03107611|11995322|FG001|Overall Study|Withdrawal by Subject|0
7589218|NCT03107611|11995323|FG002|Overall Study|Withdrawal by Subject|1
7589219|NCT03107611|11995321|FG000|Overall Study|Worsening signs/symptoms|2
7589220|NCT03107611|11995322|FG001|Overall Study|Worsening signs/symptoms|1
7589221|NCT03107611|11995323|FG002|Overall Study|Worsening signs/symptoms|2
7589222|NCT02720016|11995334|FG000|Overall Study|Separation of couple|6
7589223|NCT02720016|11995335|FG001|Overall Study|Separation of couple|8
7589224|NCT02720016|11995336|FG002|Overall Study|Separation of couple|2
7589225|NCT02720016|11995334|FG000|Overall Study|Withdrawal by Subject|6
7589226|NCT02720016|11995335|FG001|Overall Study|Withdrawal by Subject|6
7589227|NCT02720016|11995336|FG002|Overall Study|Withdrawal by Subject|4
7589228|NCT02720016|11995334|FG000|Overall Study|Scheduling issues|2
7589229|NCT02720016|11995335|FG001|Overall Study|Scheduling issues|4
7589230|NCT02720016|11995336|FG002|Overall Study|Scheduling issues|7
7589231|NCT02720016|11995334|FG000|Overall Study|Childcare|2
7589232|NCT02720016|11995335|FG001|Overall Study|Childcare|0
7589233|NCT02720016|11995336|FG002|Overall Study|Childcare|2
7589234|NCT02720016|11995334|FG000|Overall Study|Withdrawal by PI|2
7589235|NCT02720016|11995335|FG001|Overall Study|Withdrawal by PI|2
7589236|NCT02720016|11995336|FG002|Overall Study|Withdrawal by PI|0
7589237|NCT02720016|11995334|FG000|Overall Study|Moved away|2
7589238|NCT02720016|11995335|FG001|Overall Study|Moved away|0
7589239|NCT02720016|11995336|FG002|Overall Study|Moved away|0
7589240|NCT02720016|11995334|FG000|Overall Study|Not Primary Health Concern|0
7589241|NCT02720016|11995335|FG001|Overall Study|Not Primary Health Concern|0
7589242|NCT02720016|11995336|FG002|Overall Study|Not Primary Health Concern|2
7589243|NCT02720016|11995334|FG000|Overall Study|Transportation issues|0
7589244|NCT02720016|11995335|FG001|Overall Study|Transportation issues|0
7589245|NCT02720016|11995336|FG002|Overall Study|Transportation issues|1
7589246|NCT02720016|11995334|FG000|Overall Study|Other|0
7589247|NCT02720016|11995335|FG001|Overall Study|Other|0
7589248|NCT02720016|11995336|FG002|Overall Study|Other|2
7589249|NCT02607956|11995347|FG000|Double-Blinded Phase|Withdrew Consent|17
7589250|NCT02607956|11995348|FG001|Double-Blinded Phase|Withdrew Consent|19
7589251|NCT02607956|11995349|FG002|Double-Blinded Phase|Withdrew Consent|0
7589252|NCT02607956|11995350|FG003|Double-Blinded Phase|Withdrew Consent|0
7589253|NCT02607956|11995347|FG000|Double-Blinded Phase|Lost to Follow-up|19
7589254|NCT02607956|11995348|FG001|Double-Blinded Phase|Lost to Follow-up|16
7589255|NCT02607956|11995349|FG002|Double-Blinded Phase|Lost to Follow-up|0
7589256|NCT02607956|11995350|FG003|Double-Blinded Phase|Lost to Follow-up|0
7589257|NCT02607956|11995347|FG000|Double-Blinded Phase|Randomized but never treated|7
7589258|NCT02607956|11995348|FG001|Double-Blinded Phase|Randomized but never treated|5
7589259|NCT02607956|11995349|FG002|Double-Blinded Phase|Randomized but never treated|0
7589260|NCT02607956|11995350|FG003|Double-Blinded Phase|Randomized but never treated|0
7589261|NCT02607956|11995347|FG000|Double-Blinded Phase|Investigator's Discretion|7
7589262|NCT02607956|11995348|FG001|Double-Blinded Phase|Investigator's Discretion|2
7589263|NCT02607956|11995349|FG002|Double-Blinded Phase|Investigator's Discretion|0
7589264|NCT02607956|11995350|FG003|Double-Blinded Phase|Investigator's Discretion|0
7589265|NCT02607956|11995347|FG000|Double-Blinded Phase|Death|4
7589266|NCT02607956|11995348|FG001|Double-Blinded Phase|Death|4
7589267|NCT02607956|11995349|FG002|Double-Blinded Phase|Death|0
7589268|NCT02607956|11995350|FG003|Double-Blinded Phase|Death|0
7589269|NCT02607956|11995347|FG000|Double-Blinded Phase|Adverse Event|4
7589270|NCT02607956|11995348|FG001|Double-Blinded Phase|Adverse Event|3
7589271|NCT02607956|11995349|FG002|Double-Blinded Phase|Adverse Event|0
7589272|NCT02607956|11995350|FG003|Double-Blinded Phase|Adverse Event|0
7589273|NCT02607956|11995347|FG000|Double-Blinded Phase|Protocol Violation|3
7589274|NCT02607956|11995348|FG001|Double-Blinded Phase|Protocol Violation|1
7589275|NCT02607956|11995349|FG002|Double-Blinded Phase|Protocol Violation|0
7589276|NCT02607956|11995350|FG003|Double-Blinded Phase|Protocol Violation|0
7589277|NCT02607956|11995347|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589278|NCT02607956|11995348|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
7589279|NCT02607956|11995349|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589280|NCT02607956|11995350|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0
7589281|NCT02607956|11995347|FG000|Open-Label Extension Phase|Withdrew Consent|0
7589282|NCT02607956|11995348|FG001|Open-Label Extension Phase|Withdrew Consent|0
7589283|NCT02607956|11995349|FG002|Open-Label Extension Phase|Withdrew Consent|10
7589284|NCT02607956|11995350|FG003|Open-Label Extension Phase|Withdrew Consent|16
7589285|NCT02607956|11995347|FG000|Open-Label Extension Phase|Lost to Follow-up|0
7589371|NCT02564523|11995388|FG008|Overall Study|Lost to Follow-up|0
7589286|NCT02607956|11995348|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7589287|NCT02607956|11995349|FG002|Open-Label Extension Phase|Lost to Follow-up|14
7589288|NCT02607956|11995350|FG003|Open-Label Extension Phase|Lost to Follow-up|6
7589289|NCT02607956|11995347|FG000|Open-Label Extension Phase|Death|0
7589290|NCT02607956|11995348|FG001|Open-Label Extension Phase|Death|0
7589291|NCT02607956|11995349|FG002|Open-Label Extension Phase|Death|1
7589292|NCT02607956|11995350|FG003|Open-Label Extension Phase|Death|3
7589293|NCT02607956|11995347|FG000|Open-Label Extension Phase|Investigator's Discretion|0
7589294|NCT02607956|11995348|FG001|Open-Label Extension Phase|Investigator's Discretion|0
7589295|NCT02607956|11995349|FG002|Open-Label Extension Phase|Investigator's Discretion|2
7589296|NCT02607956|11995350|FG003|Open-Label Extension Phase|Investigator's Discretion|2
7589297|NCT02607956|11995347|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589298|NCT02607956|11995348|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589299|NCT02607956|11995349|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2
7589300|NCT02607956|11995350|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0
7589301|NCT02607956|11995347|FG000|Open-Label Extension Phase|Protocol Violation|0
7589302|NCT02607956|11995348|FG001|Open-Label Extension Phase|Protocol Violation|0
7589303|NCT02607956|11995349|FG002|Open-Label Extension Phase|Protocol Violation|0
7589304|NCT02607956|11995350|FG003|Open-Label Extension Phase|Protocol Violation|2
7589305|NCT02607956|11995347|FG000|Open-Label Extension Phase|Pregnancy|0
7589306|NCT02607956|11995348|FG001|Open-Label Extension Phase|Pregnancy|0
7589307|NCT02607956|11995349|FG002|Open-Label Extension Phase|Pregnancy|0
7589308|NCT02607956|11995350|FG003|Open-Label Extension Phase|Pregnancy|1
7589309|NCT02564523|11995380|FG000|Overall Study|Withdrawal by Subject|3
7589310|NCT02564523|11995381|FG001|Overall Study|Withdrawal by Subject|0
7589311|NCT02564523|11995382|FG002|Overall Study|Withdrawal by Subject|1
7589312|NCT02564523|11995383|FG003|Overall Study|Withdrawal by Subject|0
7589313|NCT02564523|11995384|FG004|Overall Study|Withdrawal by Subject|1
7589314|NCT02564523|11995385|FG005|Overall Study|Withdrawal by Subject|0
7589315|NCT02564523|11995386|FG006|Overall Study|Withdrawal by Subject|1
7589316|NCT02564523|11995387|FG007|Overall Study|Withdrawal by Subject|0
7589317|NCT02564523|11995388|FG008|Overall Study|Withdrawal by Subject|0
7589318|NCT02564523|11995389|FG009|Overall Study|Withdrawal by Subject|0
7589319|NCT02564523|11995390|FG010|Overall Study|Withdrawal by Subject|1
7589320|NCT02564523|11995391|FG011|Overall Study|Withdrawal by Subject|0
7589321|NCT02564523|11995392|FG012|Overall Study|Withdrawal by Subject|1
7589322|NCT02564523|11995393|FG013|Overall Study|Withdrawal by Subject|0
7589323|NCT02564523|11995394|FG014|Overall Study|Withdrawal by Subject|0
7589324|NCT02564523|11995395|FG015|Overall Study|Withdrawal by Subject|0
7589325|NCT02564523|11995396|FG016|Overall Study|Withdrawal by Subject|0
7589326|NCT02564523|11995397|FG017|Overall Study|Withdrawal by Subject|0
7589327|NCT02564523|11995380|FG000|Overall Study|Adverse Event|0
7589328|NCT02564523|11995381|FG001|Overall Study|Adverse Event|0
7589329|NCT02564523|11995382|FG002|Overall Study|Adverse Event|0
7589330|NCT02564523|11995383|FG003|Overall Study|Adverse Event|0
7589331|NCT02564523|11995384|FG004|Overall Study|Adverse Event|0
7589332|NCT02564523|11995385|FG005|Overall Study|Adverse Event|0
7589333|NCT02564523|11995386|FG006|Overall Study|Adverse Event|0
7589334|NCT02564523|11995387|FG007|Overall Study|Adverse Event|0
7589335|NCT02564523|11995388|FG008|Overall Study|Adverse Event|0
7589336|NCT02564523|11995389|FG009|Overall Study|Adverse Event|0
7589337|NCT02564523|11995390|FG010|Overall Study|Adverse Event|0
7589338|NCT02564523|11995391|FG011|Overall Study|Adverse Event|0
7589339|NCT02564523|11995392|FG012|Overall Study|Adverse Event|0
7589340|NCT02564523|11995393|FG013|Overall Study|Adverse Event|0
7589341|NCT02564523|11995394|FG014|Overall Study|Adverse Event|0
7589342|NCT02564523|11995395|FG015|Overall Study|Adverse Event|0
7589343|NCT02564523|11995396|FG016|Overall Study|Adverse Event|0
7589344|NCT02564523|11995397|FG017|Overall Study|Adverse Event|1
7589345|NCT02564523|11995380|FG000|Overall Study|Death|0
7589346|NCT02564523|11995381|FG001|Overall Study|Death|0
7589347|NCT02564523|11995382|FG002|Overall Study|Death|0
7589348|NCT02564523|11995383|FG003|Overall Study|Death|0
7589349|NCT02564523|11995384|FG004|Overall Study|Death|0
7589350|NCT02564523|11995385|FG005|Overall Study|Death|0
7589351|NCT02564523|11995386|FG006|Overall Study|Death|1
7589352|NCT02564523|11995387|FG007|Overall Study|Death|0
7589353|NCT02564523|11995388|FG008|Overall Study|Death|0
7589354|NCT02564523|11995389|FG009|Overall Study|Death|0
7589355|NCT02564523|11995390|FG010|Overall Study|Death|1
7589356|NCT02564523|11995391|FG011|Overall Study|Death|0
7589357|NCT02564523|11995392|FG012|Overall Study|Death|0
7589358|NCT02564523|11995393|FG013|Overall Study|Death|0
7589359|NCT02564523|11995394|FG014|Overall Study|Death|0
7589360|NCT02564523|11995395|FG015|Overall Study|Death|0
7589361|NCT02564523|11995396|FG016|Overall Study|Death|0
7589362|NCT02564523|11995397|FG017|Overall Study|Death|0
7589363|NCT02564523|11995380|FG000|Overall Study|Lost to Follow-up|2
7589364|NCT02564523|11995381|FG001|Overall Study|Lost to Follow-up|1
7589365|NCT02564523|11995382|FG002|Overall Study|Lost to Follow-up|4
7589366|NCT02564523|11995383|FG003|Overall Study|Lost to Follow-up|0
7589367|NCT02564523|11995384|FG004|Overall Study|Lost to Follow-up|1
7589368|NCT02564523|11995385|FG005|Overall Study|Lost to Follow-up|0
7589369|NCT02564523|11995386|FG006|Overall Study|Lost to Follow-up|1
7589370|NCT02564523|11995387|FG007|Overall Study|Lost to Follow-up|0
7589372|NCT02564523|11995389|FG009|Overall Study|Lost to Follow-up|0
7589373|NCT02564523|11995390|FG010|Overall Study|Lost to Follow-up|0
7589374|NCT02564523|11995391|FG011|Overall Study|Lost to Follow-up|1
7589375|NCT02564523|11995392|FG012|Overall Study|Lost to Follow-up|1
7589376|NCT02564523|11995393|FG013|Overall Study|Lost to Follow-up|0
7589377|NCT02564523|11995394|FG014|Overall Study|Lost to Follow-up|0
7589378|NCT02564523|11995395|FG015|Overall Study|Lost to Follow-up|0
7589379|NCT02564523|11995396|FG016|Overall Study|Lost to Follow-up|0
7589380|NCT02564523|11995397|FG017|Overall Study|Lost to Follow-up|0
7589381|NCT02564523|11995380|FG000|Overall Study|Physician Decision|0
7589382|NCT02564523|11995381|FG001|Overall Study|Physician Decision|0
7589383|NCT02564523|11995382|FG002|Overall Study|Physician Decision|0
7589384|NCT02564523|11995383|FG003|Overall Study|Physician Decision|0
7589385|NCT02564523|11995384|FG004|Overall Study|Physician Decision|1
7589386|NCT02564523|11995385|FG005|Overall Study|Physician Decision|0
7589387|NCT02564523|11995386|FG006|Overall Study|Physician Decision|0
7589388|NCT02564523|11995387|FG007|Overall Study|Physician Decision|0
7589389|NCT02564523|11995388|FG008|Overall Study|Physician Decision|0
7589390|NCT02564523|11995389|FG009|Overall Study|Physician Decision|0
7589391|NCT02564523|11995390|FG010|Overall Study|Physician Decision|1
7589392|NCT02564523|11995391|FG011|Overall Study|Physician Decision|0
7589393|NCT02564523|11995392|FG012|Overall Study|Physician Decision|0
7589394|NCT02564523|11995393|FG013|Overall Study|Physician Decision|0
7589395|NCT02564523|11995394|FG014|Overall Study|Physician Decision|0
7589396|NCT02564523|11995395|FG015|Overall Study|Physician Decision|0
7589397|NCT02564523|11995396|FG016|Overall Study|Physician Decision|0
7589398|NCT02564523|11995397|FG017|Overall Study|Physician Decision|0
7589399|NCT02564523|11995380|FG000|Overall Study|Protocol Violation|2
7589400|NCT02564523|11995381|FG001|Overall Study|Protocol Violation|2
7589401|NCT02564523|11995382|FG002|Overall Study|Protocol Violation|5
7589402|NCT02564523|11995383|FG003|Overall Study|Protocol Violation|0
7589403|NCT02564523|11995384|FG004|Overall Study|Protocol Violation|1
7589404|NCT02564523|11995385|FG005|Overall Study|Protocol Violation|0
7589405|NCT02564523|11995386|FG006|Overall Study|Protocol Violation|0
7589406|NCT02564523|11995387|FG007|Overall Study|Protocol Violation|0
7589407|NCT02564523|11995388|FG008|Overall Study|Protocol Violation|0
7589408|NCT02564523|11995389|FG009|Overall Study|Protocol Violation|0
7589409|NCT02564523|11995390|FG010|Overall Study|Protocol Violation|0
7589410|NCT02564523|11995391|FG011|Overall Study|Protocol Violation|0
7589411|NCT02564523|11995392|FG012|Overall Study|Protocol Violation|0
7589412|NCT02564523|11995393|FG013|Overall Study|Protocol Violation|0
7589413|NCT02564523|11995394|FG014|Overall Study|Protocol Violation|0
7589414|NCT02564523|11995395|FG015|Overall Study|Protocol Violation|0
7589415|NCT02564523|11995396|FG016|Overall Study|Protocol Violation|0
7589416|NCT02564523|11995397|FG017|Overall Study|Protocol Violation|0
7589417|NCT02564523|11995380|FG000|Overall Study|Other|3
7589418|NCT02564523|11995381|FG001|Overall Study|Other|0
7589419|NCT02564523|11995382|FG002|Overall Study|Other|0
7270719|NCT00419094|11485060|FG001|Overall Study|Lack of Efficacy|0
7589420|NCT02564523|11995383|FG003|Overall Study|Other|1
7589421|NCT02564523|11995384|FG004|Overall Study|Other|0
7589422|NCT02564523|11995385|FG005|Overall Study|Other|0
7589423|NCT02564523|11995386|FG006|Overall Study|Other|0
7589424|NCT02564523|11995387|FG007|Overall Study|Other|0
7589425|NCT02564523|11995388|FG008|Overall Study|Other|0
7589426|NCT02564523|11995389|FG009|Overall Study|Other|0
7270720|NCT00419094|11485059|FG000|Overall Study|Lost to Follow-up|0
7589427|NCT02564523|11995390|FG010|Overall Study|Other|0
7589428|NCT02564523|11995391|FG011|Overall Study|Other|0
7589429|NCT02564523|11995392|FG012|Overall Study|Other|0
7589430|NCT02564523|11995393|FG013|Overall Study|Other|0
7589431|NCT02564523|11995394|FG014|Overall Study|Other|0
7589432|NCT02564523|11995395|FG015|Overall Study|Other|0
7589433|NCT02564523|11995396|FG016|Overall Study|Other|0
7589434|NCT02564523|11995397|FG017|Overall Study|Other|0
7589440|NCT01798004|11995502|FG000|Overall Study|Death|2
7589441|NCT01798004|11995502|FG000|Overall Study|Lack of Efficacy|8
7589442|NCT01798004|11995502|FG000|Overall Study|Physician Decision|25
7589443|NCT01798004|11995502|FG000|Overall Study|Withdrawal by Subject|4
7589444|NCT01798004|11995502|FG000|Overall Study|Ineligible|4
7589445|NCT01798004|11995502|FG000|Overall Study|Patient/parent refusal|7
7589446|NCT01798004|11995502|FG000|Overall Study|Initiation of other non-protocol therapy|5
7589447|NCT01798004|11995502|FG000|Overall Study|Enrollment another COG therapeutic trial|32
7589448|NCT01447628|11995529|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589449|NCT01447628|11995530|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589450|NCT01447628|11995531|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
7589451|NCT01447628|11995532|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1
7589452|NCT01175356|11995552|FG000|Overall Study|Death|1
7589453|NCT01175356|11995552|FG000|Overall Study|Lack of Efficacy|12
7589454|NCT01175356|11995552|FG000|Overall Study|Lost to Follow-up|1
7589455|NCT01175356|11995552|FG000|Overall Study|Physician Decision|23
7589456|NCT01175356|11995552|FG000|Overall Study|Ineligible|1
7589457|NCT01175356|11995552|FG000|Overall Study|Treatment Slot Not Available|18
7589458|NCT01175356|11995552|FG000|Overall Study|Refusal by patient/parent/guardian|6
7589459|NCT01175356|11995552|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
7589460|NCT01175356|11995552|FG000|Overall Study|On other COG study w/tumor tx intent|7
7589461|NCT01175356|11995552|FG000|Overall Study|Inadequate stem cell for transplant|1
7589462|NCT01175356|11995552|FG000|Overall Study|Initiation other tx prior to completion|9
7589463|NCT00515853|11995558|FG000|Overall Study|Lost to Follow-up|9
7589464|NCT00515853|11995559|FG001|Overall Study|Lost to Follow-up|13
7589465|NCT00515853|11995558|FG000|Overall Study|Withdrawal by Subject|6
7589466|NCT00515853|11995559|FG001|Overall Study|Withdrawal by Subject|4
7589467|NCT00003458|11995565|FG000|Overall Study|Not evaluable|4
7626549|NCT03952143|12038858|FG001|Treatment Period|Due to COVID 19 restrictions|2
7626550|NCT03952143|12038859|FG002|Treatment Period|Due to COVID 19 restrictions|5
7626551|NCT03952143|12038857|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0
7626552|NCT03952143|12038858|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0
7626553|NCT03952143|12038859|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1
7626554|NCT03691428|12038876|FG000|Overall Study|Withdrawal by Subject|6
7626555|NCT03691428|12038877|FG001|Overall Study|Withdrawal by Subject|8
7626556|NCT03685708|12038886|FG000|Overall Study|Withdrawal by Subject|0
7626557|NCT03685708|12038887|FG001|Overall Study|Withdrawal by Subject|0
7626558|NCT03685708|12038888|FG002|Overall Study|Withdrawal by Subject|1
7626559|NCT03685708|12038886|FG000|Overall Study|Screen Fail|0
7626560|NCT03685708|12038887|FG001|Overall Study|Screen Fail|1
7626561|NCT03685708|12038888|FG002|Overall Study|Screen Fail|1
7626562|NCT03685708|12038886|FG000|Overall Study|COVID 19 Pandemic|1
7626563|NCT03685708|12038887|FG001|Overall Study|COVID 19 Pandemic|1
7626564|NCT03685708|12038888|FG002|Overall Study|COVID 19 Pandemic|6
7626565|NCT03685708|12038886|FG000|Overall Study|Disease Progression|0
7626566|NCT03685708|12038887|FG001|Overall Study|Disease Progression|0
7626567|NCT03685708|12038888|FG002|Overall Study|Disease Progression|1
7626568|NCT03669588|12038898|FG000|Overall Study|Adverse Event|1
7626569|NCT03669588|12038899|FG001|Overall Study|Adverse Event|0
7626570|NCT03669588|12038898|FG000|Overall Study|Physician Decision|0
7626571|NCT03669588|12038899|FG001|Overall Study|Physician Decision|1
7626572|NCT03669588|12038898|FG000|Overall Study|Protocol Violation|1
7626573|NCT03669588|12038899|FG001|Overall Study|Protocol Violation|0
7626574|NCT03669588|12038898|FG000|Overall Study|Sponsor Decision|1
7626575|NCT03669588|12038899|FG001|Overall Study|Sponsor Decision|1
7626576|NCT03669588|12038898|FG000|Overall Study|Withdrawal by Subject|1
7626577|NCT03669588|12038899|FG001|Overall Study|Withdrawal by Subject|4
7626578|NCT03669588|12038898|FG000|Overall Study|Rescue Therapy Needed|0
7626579|NCT03669588|12038899|FG001|Overall Study|Rescue Therapy Needed|1
7626580|NCT03531632|12038908|FG000|Overall Study|Adverse Event|0
7626581|NCT03531632|12038909|FG001|Overall Study|Adverse Event|0
7626582|NCT03531632|12038910|FG002|Overall Study|Adverse Event|1
7626583|NCT03531632|12038908|FG000|Overall Study|Death|4
7626584|NCT03531632|12038909|FG001|Overall Study|Death|0
7626585|NCT03531632|12038910|FG002|Overall Study|Death|14
7626586|NCT03531632|12038908|FG000|Overall Study|Study Terminated|1
7626587|NCT03531632|12038909|FG001|Overall Study|Study Terminated|3
7626588|NCT03531632|12038910|FG002|Overall Study|Study Terminated|11
7589468|NCT04613739|11995590|FG000|Overall Study|Lost to Follow-up|6
7589469|NCT04613739|11995591|FG001|Overall Study|Lost to Follow-up|9
7589470|NCT04613739|11995590|FG000|Overall Study|potentially duplicative/fraudulent|1
7589471|NCT04613739|11995591|FG001|Overall Study|potentially duplicative/fraudulent|3
7589472|NCT04573972|11995599|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
7589473|NCT04573972|11995600|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
7589474|NCT04407806|11995618|FG000|Overall Study|Withdrawal by Subject|1
7589475|NCT04407806|11995619|FG001|Overall Study|Withdrawal by Subject|2
7589487|NCT04186663|11995646|FG000|Overall Study|Lost to Follow-up|1
7589488|NCT04186663|11995646|FG000|Overall Study|Unable to complete blood draw|3
7589489|NCT04158219|11995650|FG000|Overall Study|Lost to Follow-up|1
7589490|NCT04056299|11995670|FG000|Overall Study|Sponsor discontinued study|3
7589491|NCT04056299|11995671|FG001|Overall Study|Sponsor discontinued study|3
7589492|NCT03954743|11995719|FG000|Overall Study|Adverse Event|1
7589493|NCT03954743|11995720|FG001|Overall Study|Adverse Event|0
7589494|NCT03954743|11995719|FG000|Overall Study|Lost to Follow-up|6
7589495|NCT03954743|11995720|FG001|Overall Study|Lost to Follow-up|4
7589496|NCT03954743|11995719|FG000|Overall Study|Protocol Violation|1
7589497|NCT03954743|11995720|FG001|Overall Study|Protocol Violation|0
7589498|NCT03954743|11995719|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
7589499|NCT03954743|11995720|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
7589500|NCT03954743|11995719|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
7589501|NCT03954743|11995720|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7589502|NCT03880565|11995728|FG000|Overall Study|Withdrawal by Subject|1
7589503|NCT03880565|11995729|FG001|Overall Study|Withdrawal by Subject|0
7589504|NCT03833661|11995735|FG000|Overall Study|Treatment ongoing|9
7589505|NCT03809663|11995743|FG000|Overall Study|Decision by sponsor|24
7589506|NCT03809663|11995744|FG001|Overall Study|Decision by sponsor|18
7589507|NCT03809663|11995745|FG002|Overall Study|Decision by sponsor|20
7589508|NCT03809663|11995746|FG003|Overall Study|Decision by sponsor|20
7589509|NCT03809663|11995747|FG004|Overall Study|Decision by sponsor|0
7589510|NCT03809663|11995748|FG005|Overall Study|Decision by sponsor|0
7589511|NCT03809663|11995743|FG000|Overall Study|Withdrawal by Subject|26
7589512|NCT03809663|11995744|FG001|Overall Study|Withdrawal by Subject|22
7589513|NCT03809663|11995745|FG002|Overall Study|Withdrawal by Subject|27
7589514|NCT03809663|11995746|FG003|Overall Study|Withdrawal by Subject|26
7589515|NCT03809663|11995747|FG004|Overall Study|Withdrawal by Subject|0
7589516|NCT03809663|11995748|FG005|Overall Study|Withdrawal by Subject|0
7589517|NCT03809663|11995743|FG000|Overall Study|Lost to Follow-up|1
7589518|NCT03809663|11995744|FG001|Overall Study|Lost to Follow-up|4
7589519|NCT03809663|11995745|FG002|Overall Study|Lost to Follow-up|1
7589520|NCT03809663|11995746|FG003|Overall Study|Lost to Follow-up|1
7589521|NCT03809663|11995747|FG004|Overall Study|Lost to Follow-up|0
7589522|NCT03809663|11995748|FG005|Overall Study|Lost to Follow-up|0
7589523|NCT03782792|11995775|FG000|Overall Study|Patient left the country|0
7589524|NCT03782792|11995776|FG001|Overall Study|Patient left the country|1
7589525|NCT03782792|11995775|FG000|Overall Study|Withdrawal by Subject|1
7589526|NCT03782792|11995776|FG001|Overall Study|Withdrawal by Subject|2
7589527|NCT03733119|11995795|FG000|Overall Study|Physician Decision|2
7589528|NCT03733119|11995796|FG001|Overall Study|Physician Decision|1
7589529|NCT03733119|11995795|FG000|Overall Study|ineligible to treat per protocol|0
7589530|NCT03733119|11995796|FG001|Overall Study|ineligible to treat per protocol|1
7589531|NCT03661996|11995807|FG000|Overall Study|Adverse Event|0
7589532|NCT03661996|11995808|FG001|Overall Study|Adverse Event|0
7589533|NCT03661996|11995809|FG002|Overall Study|Adverse Event|1
7589534|NCT03661996|11995810|FG003|Overall Study|Adverse Event|1
7589535|NCT03661996|11995811|FG004|Overall Study|Adverse Event|0
7589536|NCT03661996|11995807|FG000|Overall Study|Lost to Follow-up|5
7589537|NCT03661996|11995808|FG001|Overall Study|Lost to Follow-up|1
7589538|NCT03661996|11995809|FG002|Overall Study|Lost to Follow-up|2
7589539|NCT03661996|11995810|FG003|Overall Study|Lost to Follow-up|2
7589540|NCT03661996|11995811|FG004|Overall Study|Lost to Follow-up|6
7589541|NCT03661996|11995807|FG000|Overall Study|Physician Decision|1
7589542|NCT03661996|11995808|FG001|Overall Study|Physician Decision|1
7589543|NCT03661996|11995809|FG002|Overall Study|Physician Decision|1
7589544|NCT03661996|11995810|FG003|Overall Study|Physician Decision|2
7589545|NCT03661996|11995811|FG004|Overall Study|Physician Decision|0
7589546|NCT03661996|11995807|FG000|Overall Study|Protocol Violation|0
7589547|NCT03661996|11995808|FG001|Overall Study|Protocol Violation|0
7589548|NCT03661996|11995809|FG002|Overall Study|Protocol Violation|0
7589549|NCT03661996|11995810|FG003|Overall Study|Protocol Violation|0
7589550|NCT03661996|11995811|FG004|Overall Study|Protocol Violation|1
7589551|NCT03661996|11995807|FG000|Overall Study|Withdrawal by Subject|3
7589552|NCT03661996|11995808|FG001|Overall Study|Withdrawal by Subject|5
7589553|NCT03661996|11995809|FG002|Overall Study|Withdrawal by Subject|1
7589554|NCT03661996|11995810|FG003|Overall Study|Withdrawal by Subject|7
7589555|NCT03661996|11995811|FG004|Overall Study|Withdrawal by Subject|7
7589556|NCT03661996|11995807|FG000|Overall Study|Sponsors Decision|2
7589557|NCT03661996|11995808|FG001|Overall Study|Sponsors Decision|0
7589558|NCT03661996|11995809|FG002|Overall Study|Sponsors Decision|0
7589559|NCT03661996|11995810|FG003|Overall Study|Sponsors Decision|0
7589560|NCT03661996|11995811|FG004|Overall Study|Sponsors Decision|0
7589561|NCT03661996|11995807|FG000|Overall Study|Other|1
7589562|NCT03661996|11995808|FG001|Overall Study|Other|1
7589476|NCT04324021|11995628|FG000|Overall Study|Adverse Event|1
7589477|NCT04324021|11995629|FG001|Overall Study|Adverse Event|0
7589478|NCT04324021|11995630|FG002|Overall Study|Adverse Event|0
7589479|NCT04324021|11995628|FG000|Overall Study|Lack of Efficacy|0
7589480|NCT04324021|11995629|FG001|Overall Study|Lack of Efficacy|0
7589481|NCT04324021|11995630|FG002|Overall Study|Lack of Efficacy|1
7589482|NCT04324021|11995628|FG000|Overall Study|Death|1
7589483|NCT04324021|11995629|FG001|Overall Study|Death|1
7589484|NCT04324021|11995630|FG002|Overall Study|Death|0
7589485|NCT04209621|11995641|FG000|Overall Study|Death|1
7589486|NCT04209621|11995641|FG000|Overall Study|Study Terminated Early|2
7589563|NCT03661996|11995809|FG002|Overall Study|Other|1
7589564|NCT03661996|11995810|FG003|Overall Study|Other|1
7589565|NCT03661996|11995811|FG004|Overall Study|Other|0
7589566|NCT03633461|11995828|FG000|Overall Study|Lost to Follow-up|0
7589567|NCT03633461|11995829|FG001|Overall Study|Lost to Follow-up|1
7589568|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Adverse Event|9
7589569|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Adverse Event|11
7589570|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Death|0
7589571|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Death|4
7589572|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2
7589573|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3
7589574|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Pregnancy|0
7589575|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Pregnancy|1
7589576|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Protocol Violation|1
7589577|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Protocol Violation|0
7589578|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7589579|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11
7589580|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76
7589581|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120
7589582|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Other|4
7589583|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Other|3
7589584|NCT03517722|11995857|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0
7589585|NCT03517722|11995858|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2
7589586|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0
7589587|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1
7589588|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0
7589589|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1
7589590|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7589591|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
7589592|NCT03517722|11995857|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87
7589593|NCT03517722|11995858|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134
7589594|NCT03499314|11995867|FG000|Overall Study|Time Commitment|1
7589595|NCT03499314|11995868|FG001|Overall Study|Time Commitment|2
7589596|NCT03499314|11995867|FG000|Overall Study|Medical issue unrelated to research study|1
7589597|NCT03499314|11995868|FG001|Overall Study|Medical issue unrelated to research study|1
7626590|NCT03206073|12038941|FG000|Overall Study|Participant Noncompliance|0
7626591|NCT03206073|12038942|FG001|Overall Study|Participant Noncompliance|1
7626592|NCT03206073|12038943|FG002|Overall Study|Participant Noncompliance|0
7626593|NCT03206073|12038944|FG003|Overall Study|Participant Noncompliance|0
7626594|NCT03206073|12038941|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
7626595|NCT03206073|12038942|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
7626596|NCT03206073|12038943|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
7626597|NCT03206073|12038944|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
7626598|NCT03206073|12038941|FG000|Overall Study|Death|0
7626599|NCT03206073|12038942|FG001|Overall Study|Death|0
7626600|NCT03206073|12038943|FG002|Overall Study|Death|1
7626601|NCT03206073|12038944|FG003|Overall Study|Death|0
7626602|NCT03206073|12038941|FG000|Overall Study|Taken off active treatment|0
7626603|NCT03206073|12038942|FG001|Overall Study|Taken off active treatment|0
7626604|NCT03206073|12038943|FG002|Overall Study|Taken off active treatment|3
7626605|NCT03206073|12038944|FG003|Overall Study|Taken off active treatment|0
7626606|NCT03102034|12038969|FG000|Overall Study|Withdrawal by Subject|1
7626607|NCT03102034|12038970|FG001|Overall Study|Withdrawal by Subject|0
7626608|NCT02723864|12038987|FG000|Overall Study|Refused further treatment|1
7626609|NCT02723864|12038988|FG001|Overall Study|Refused further treatment|0
7626610|NCT02723864|12038989|FG002|Overall Study|Refused further treatment|0
7626611|NCT02723864|12038990|FG003|Overall Study|Refused further treatment|0
7626612|NCT02723864|12038991|FG004|Overall Study|Refused further treatment|1
7626613|NCT02723864|12038992|FG005|Overall Study|Refused further treatment|2
7626614|NCT02723864|12038993|FG006|Overall Study|Refused further treatment|0
7626615|NCT02723864|12038987|FG000|Overall Study|Exceed treatment hold time|0
7626616|NCT02723864|12038988|FG001|Overall Study|Exceed treatment hold time|1
7626617|NCT02723864|12038989|FG002|Overall Study|Exceed treatment hold time|0
7626618|NCT02723864|12038990|FG003|Overall Study|Exceed treatment hold time|0
7626619|NCT02723864|12038991|FG004|Overall Study|Exceed treatment hold time|0
7626620|NCT02723864|12038992|FG005|Overall Study|Exceed treatment hold time|0
7589598|NCT03439124|11995876|FG000|Overall Study|Adverse Event|2
7589599|NCT03439124|11995877|FG001|Overall Study|Adverse Event|0
7589600|NCT03439124|11995876|FG000|Overall Study|Lost to Follow-up|1
7589601|NCT03439124|11995877|FG001|Overall Study|Lost to Follow-up|0
7589602|NCT03439124|11995876|FG000|Overall Study|Other reasons|1
7589603|NCT03439124|11995877|FG001|Overall Study|Other reasons|0
7589604|NCT03369431|11995885|FG000|Overall Study|Lost to Follow-up|1
7589605|NCT03369431|11995886|FG001|Overall Study|Lost to Follow-up|3
7589606|NCT03369431|11995885|FG000|Overall Study|Withdrawal by Subject|2
7589607|NCT03369431|11995886|FG001|Overall Study|Withdrawal by Subject|3
7589608|NCT03369431|11995885|FG000|Overall Study|Protocol Violation|1
7589609|NCT03369431|11995886|FG001|Overall Study|Protocol Violation|1
7589622|NCT03336866|11995909|FG000|Overall Study|Lost to Follow-up|2
7589623|NCT03336866|11995910|FG001|Overall Study|Lost to Follow-up|0
7589624|NCT03336866|11995911|FG002|Overall Study|Lost to Follow-up|3
7589625|NCT03336866|11995909|FG000|Overall Study|Withdrawal by Subject|1
7589626|NCT03336866|11995910|FG001|Overall Study|Withdrawal by Subject|1
7589627|NCT03336866|11995911|FG002|Overall Study|Withdrawal by Subject|0
7589628|NCT03336866|11995909|FG000|Overall Study|Noncompliance with clinic house rules|0
7589629|NCT03336866|11995910|FG001|Overall Study|Noncompliance with clinic house rules|0
7589630|NCT03336866|11995911|FG002|Overall Study|Noncompliance with clinic house rules|1
7589631|NCT03332173|11995924|FG000|Overall Study|Death|7
7589632|NCT03332173|11995924|FG000|Overall Study|Withdrawal by Subject|6
7589633|NCT03332173|11995924|FG000|Overall Study|Lost to Follow-up|2
7589634|NCT03332173|11995924|FG000|Overall Study|Transferred to long-term extension study|29
7589635|NCT03322293|11995931|FG000|Overall Study|Lost to Follow-up|0
7589636|NCT03322293|11995932|FG001|Overall Study|Lost to Follow-up|0
7589637|NCT03322293|11995933|FG002|Overall Study|Lost to Follow-up|1
7589638|NCT03254394|11995955|FG000|Overall Study|Withdrawal by Subject|0
7589639|NCT03254394|11995956|FG001|Overall Study|Withdrawal by Subject|2
7589640|NCT03253809|11995962|FG000|Overall Study|Unable to obtain study related data|14
7589641|NCT03151408|11995982|FG000|Overall Study|Adverse Event|24
7589642|NCT03151408|11995983|FG001|Overall Study|Adverse Event|23
7589643|NCT03151408|11995982|FG000|Overall Study|Death|46
7589644|NCT03151408|11995983|FG001|Overall Study|Death|26
7589645|NCT03151408|11995982|FG000|Overall Study|Physician Decision|13
7589646|NCT03151408|11995983|FG001|Overall Study|Physician Decision|19
7589647|NCT03151408|11995982|FG000|Overall Study|Withdrawal by Subject|16
7589648|NCT03151408|11995983|FG001|Overall Study|Withdrawal by Subject|20
7589649|NCT03151408|11995982|FG000|Overall Study|Progressive disease|45
7589650|NCT03151408|11995983|FG001|Overall Study|Progressive disease|61
7589651|NCT03151408|11995982|FG000|Overall Study|non-compliance by patient|1
7589652|NCT03151408|11995983|FG001|Overall Study|non-compliance by patient|0
7589653|NCT03151408|11995982|FG000|Overall Study|other reasons|56
7589654|NCT03151408|11995983|FG001|Overall Study|other reasons|52
7589655|NCT03151408|11995982|FG000|Overall Study|randomized and not treated|2
7589656|NCT03151408|11995983|FG001|Overall Study|randomized and not treated|2
7589657|NCT03137173|11995991|FG000|Overall Study|Withdrawal by Subject|8
7589658|NCT03137173|11995992|FG001|Overall Study|Withdrawal by Subject|13
7589659|NCT03137173|11995991|FG000|Overall Study|Death|1
7589660|NCT03137173|11995992|FG001|Overall Study|Death|3
7589661|NCT03137173|11995991|FG000|Overall Study|Physician Decision|1
7589662|NCT03137173|11995992|FG001|Overall Study|Physician Decision|0
7589663|NCT03137173|11995991|FG000|Overall Study|Lost to Follow-up|13
7589664|NCT03137173|11995992|FG001|Overall Study|Lost to Follow-up|18
7589665|NCT03137173|11995991|FG000|Overall Study|Other reasons|3
7589666|NCT03137173|11995992|FG001|Overall Study|Other reasons|2
7589667|NCT03028740|11996031|FG000|Overall Study|Did not Receive Study Drug|4
7589668|NCT03028740|11996032|FG001|Overall Study|Did not Receive Study Drug|5
7589669|NCT03028740|11996031|FG000|Overall Study|Adverse Event|8
7589670|NCT03028740|11996032|FG001|Overall Study|Adverse Event|26
7589671|NCT03028740|11996031|FG000|Overall Study|Lack of Efficacy|0
7589672|NCT03028740|11996032|FG001|Overall Study|Lack of Efficacy|1
7589673|NCT03028740|11996031|FG000|Overall Study|Withdrawal by Subject|48
7589674|NCT03028740|11996032|FG001|Overall Study|Withdrawal by Subject|101
7589675|NCT03028740|11996031|FG000|Overall Study|Lost to Follow-up|30
7589676|NCT03028740|11996032|FG001|Overall Study|Lost to Follow-up|54
7589677|NCT03028740|11996031|FG000|Overall Study|Physician Decision|4
7589678|NCT03028740|11996032|FG001|Overall Study|Physician Decision|11
7589679|NCT03028740|11996031|FG000|Overall Study|Protocol Violation|4
7589680|NCT03028740|11996032|FG001|Overall Study|Protocol Violation|8
7589681|NCT03028740|11996031|FG000|Overall Study|Non-compliance with Study Drug|0
7589682|NCT03028740|11996032|FG001|Overall Study|Non-compliance with Study Drug|2
7589683|NCT03028740|11996031|FG000|Overall Study|Study Terminated by Sponsor|467
7589684|NCT03028740|11996032|FG001|Overall Study|Study Terminated by Sponsor|917
7589685|NCT03028740|11996031|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27
7589686|NCT03028740|11996032|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55
7589687|NCT03028740|11996031|FG000|Overall Study|Reason not Specified|1
7589688|NCT03028740|11996032|FG001|Overall Study|Reason not Specified|5
7589689|NCT02998476|11996084|FG000|Overall Study|Lost to Follow-up|1
7589690|NCT02998476|11996085|FG001|Overall Study|Lost to Follow-up|0
7589691|NCT02998476|11996084|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2
7589692|NCT02998476|11996085|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0
7589693|NCT02998476|11996084|FG000|Overall Study|Withdrawal by Subject|1
7589694|NCT02998476|11996085|FG001|Overall Study|Withdrawal by Subject|2
7589695|NCT02998476|11996084|FG000|Overall Study|Death|45
7589696|NCT02998476|11996085|FG001|Overall Study|Death|2
7589697|NCT02998476|11996084|FG000|Overall Study|Other|6
7589698|NCT02998476|11996085|FG001|Overall Study|Other|1
7589706|NCT02924064|11996107|FG000|Overall Study|Adverse Event|2
7589707|NCT02924064|11996108|FG001|Overall Study|Adverse Event|2
7589708|NCT02924064|11996107|FG000|Overall Study|Lost to Follow-up|0
7589709|NCT02924064|11996108|FG001|Overall Study|Lost to Follow-up|2
7589710|NCT02924064|11996107|FG000|Overall Study|Physician Decision|0
7589711|NCT02924064|11996108|FG001|Overall Study|Physician Decision|2
7589712|NCT02924064|11996107|FG000|Overall Study|Protocol Violation|1
7589713|NCT02924064|11996108|FG001|Overall Study|Protocol Violation|3
7589714|NCT02924064|11996107|FG000|Overall Study|Withdrawal by Subject|4
7589715|NCT02924064|11996108|FG001|Overall Study|Withdrawal by Subject|5
7589716|NCT02924064|11996107|FG000|Overall Study|Other|17
7589717|NCT02924064|11996108|FG001|Overall Study|Other|29
7589718|NCT02916706|11996116|FG000|Overall Study|Adverse Event|0
7589719|NCT02916706|11996117|FG001|Overall Study|Adverse Event|1
7589720|NCT02916706|11996116|FG000|Overall Study|Lost to Follow-up|0
7589721|NCT02916706|11996117|FG001|Overall Study|Lost to Follow-up|1
7589722|NCT02916706|11996116|FG000|Overall Study|Physician Decision|1
7589723|NCT02916706|11996117|FG001|Overall Study|Physician Decision|0
7589724|NCT02916706|11996116|FG000|Overall Study|Protocol Violation|3
7589725|NCT02916706|11996117|FG001|Overall Study|Protocol Violation|1
7589726|NCT02916706|11996116|FG000|Overall Study|Withdrawal by Subject|6
7589727|NCT02916706|11996117|FG001|Overall Study|Withdrawal by Subject|9
7589728|NCT02916706|11996116|FG000|Overall Study|Other|5
7589729|NCT02916706|11996117|FG001|Overall Study|Other|19
7589730|NCT02889900|11996123|FG000|Overall Study|Adverse Event|11
7589731|NCT02889900|11996123|FG000|Overall Study|Condition under investigation worsened|32
7589732|NCT02889900|11996123|FG000|Overall Study|Other|5
7589733|NCT02889900|11996123|FG000|Overall Study|Withdrawal by Subject|7
7589734|NCT02889900|11996123|FG000|Overall Study|Not treated|2
7589735|NCT02866695|11996127|FG000|Overall Study|Adverse Event|1
7589736|NCT02866695|11996127|FG000|Overall Study|Lost to Follow-up|1
7589737|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2
7589738|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1
7589739|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7589740|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
7589741|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1
7589742|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589743|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589744|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
7589745|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1
7589746|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589747|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589748|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
7589749|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0
7589750|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3
7589751|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0
7589752|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0
7589753|NCT02834793|11996133|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589754|NCT02834793|11996134|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1
7589755|NCT02834793|11996135|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589756|NCT02834793|11996136|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
7589757|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589758|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589759|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7
7589760|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
7589761|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589762|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589763|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4
7589764|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
7589765|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589766|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589767|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5
7589768|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0
7589769|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589770|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589771|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9
7589772|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
7589773|NCT02834793|11996133|FG000|Extension Phase A (up to 52 Weeks)|Other|0
7589774|NCT02834793|11996134|FG001|Extension Phase A (up to 52 Weeks)|Other|0
7589775|NCT02834793|11996135|FG002|Extension Phase A (up to 52 Weeks)|Other|1
7589776|NCT02834793|11996136|FG003|Extension Phase A (up to 52 Weeks)|Other|0
7589777|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589778|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589779|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
7589780|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1
7589781|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589782|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589783|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0
7589784|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1
7589785|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589786|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589787|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
7589788|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8
7589789|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Other|0
7589790|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Other|0
7589791|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Other|0
7589792|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Other|1
7589793|NCT02834793|11996133|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589794|NCT02834793|11996134|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589795|NCT02834793|11996135|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
7589796|NCT02834793|11996136|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1
7589797|NCT02810457|11996146|FG000|Overall Study|Randomised but no treatment received|2
7589798|NCT02810457|11996147|FG001|Overall Study|Randomised but no treatment received|1
7589799|NCT02810457|11996146|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
7589800|NCT02810457|11996147|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
7589801|NCT02810457|11996146|FG000|Overall Study|Adverse Event|37
7589802|NCT02810457|11996147|FG001|Overall Study|Adverse Event|43
7589803|NCT02810457|11996146|FG000|Overall Study|Patient decision|31
7589804|NCT02810457|11996147|FG001|Overall Study|Patient decision|35
7589805|NCT02810457|11996146|FG000|Overall Study|Patient lost to follow-up|2
7589806|NCT02810457|11996147|FG001|Overall Study|Patient lost to follow-up|2
7589807|NCT02810457|11996146|FG000|Overall Study|Death|39
7589808|NCT02810457|11996147|FG001|Overall Study|Death|28
7589809|NCT02810457|11996146|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
7589810|NCT02810457|11996147|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
7589811|NCT02810457|11996146|FG000|Overall Study|Clinical progression|15
7589812|NCT02810457|11996147|FG001|Overall Study|Clinical progression|16
7589813|NCT02810457|11996146|FG000|Overall Study|Investigator decision|3
7589814|NCT02810457|11996147|FG001|Overall Study|Investigator decision|2
7589815|NCT02810457|11996146|FG000|Overall Study|Patient ineligibility|3
7589816|NCT02810457|11996147|FG001|Overall Study|Patient ineligibility|0
7589817|NCT02810457|11996146|FG000|Overall Study|Miscalculated PD|1
7589818|NCT02810457|11996147|FG001|Overall Study|Miscalculated PD|0
7589819|NCT02810457|11996146|FG000|Overall Study|Physician Decision|0
7589820|NCT02810457|11996147|FG001|Overall Study|Physician Decision|1
7626621|NCT02723864|12038993|FG006|Overall Study|Exceed treatment hold time|0
7626622|NCT02723864|12038987|FG000|Overall Study|Clinical progression|0
7626623|NCT02723864|12038988|FG001|Overall Study|Clinical progression|0
7626624|NCT02723864|12038989|FG002|Overall Study|Clinical progression|1
7626625|NCT02723864|12038990|FG003|Overall Study|Clinical progression|0
7626626|NCT02723864|12038991|FG004|Overall Study|Clinical progression|0
7626627|NCT02723864|12038992|FG005|Overall Study|Clinical progression|3
7626628|NCT02723864|12038993|FG006|Overall Study|Clinical progression|1
7626629|NCT02723864|12038987|FG000|Overall Study|Physician Decision|0
7626630|NCT02723864|12038988|FG001|Overall Study|Physician Decision|0
7626631|NCT02723864|12038989|FG002|Overall Study|Physician Decision|0
7626632|NCT02723864|12038990|FG003|Overall Study|Physician Decision|0
7626633|NCT02723864|12038991|FG004|Overall Study|Physician Decision|0
7626634|NCT02723864|12038992|FG005|Overall Study|Physician Decision|0
7626635|NCT02723864|12038993|FG006|Overall Study|Physician Decision|1
7589821|NCT02745535|11996183|FG000|Overall Study|Death|1
7589822|NCT02745535|11996183|FG000|Overall Study|Adverse Event|3
7589823|NCT02745535|11996183|FG000|Overall Study|Lost to Follow-up|2
7589824|NCT02625090|11996221|FG000|Overall Study|Participant wants to be pregnant|2
7589825|NCT02625090|11996221|FG000|Overall Study|For the Promoter|1
7589826|NCT02625090|11996221|FG000|Overall Study|Sponsor's Decision|9
7589827|NCT02625090|11996221|FG000|Overall Study|Somnolence|1
7589828|NCT02625090|11996221|FG000|Overall Study|Study terminated by Sponsor|7
7589829|NCT02625090|11996221|FG000|Overall Study|Negative Benefit/Risk|1
7589830|NCT02625090|11996221|FG000|Overall Study|Protocol Deviation|2
7589831|NCT02625090|11996221|FG000|Overall Study|Lack of Efficacy|16
7589832|NCT02625090|11996221|FG000|Overall Study|Adverse Event|3
7589833|NCT02539225|11996228|FG000|Part A|Adverse Event|13
7589834|NCT02539225|11996229|FG001|Part A|Adverse Event|4
7589835|NCT02539225|11996228|FG000|Part A|Withdrawal by Subject|2
7589836|NCT02539225|11996229|FG001|Part A|Withdrawal by Subject|4
7589837|NCT02539225|11996228|FG000|Part A|Physician Decision|4
7589838|NCT02539225|11996229|FG001|Part A|Physician Decision|7
7589839|NCT02539225|11996228|FG000|Part A|Did Not Receive study Drug|1
7589840|NCT02539225|11996229|FG001|Part A|Did Not Receive study Drug|1
7589841|NCT02539225|11996228|FG000|Pre Treatment for Part B|Progressive disease|1
7589842|NCT02539225|11996229|FG001|Pre Treatment for Part B|Progressive disease|1
7589843|NCT02539225|11996228|FG000|Pre Treatment for Part B|Adverse Event|1
7589844|NCT02539225|11996229|FG001|Pre Treatment for Part B|Adverse Event|1
7589845|NCT02539225|11996228|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
7589846|NCT02539225|11996229|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
7589847|NCT02539225|11996228|FG000|Pre Treatment for Part B|Physician Decision|2
7589848|NCT02539225|11996229|FG001|Pre Treatment for Part B|Physician Decision|0
7589849|NCT02539225|11996228|FG000|Part B|Adverse Event|4
7589850|NCT02539225|11996229|FG001|Part B|Adverse Event|4
7589851|NCT02539225|11996228|FG000|Part B|Withdrawal by Subject|0
7589852|NCT02539225|11996229|FG001|Part B|Withdrawal by Subject|3
7589853|NCT02539225|11996228|FG000|Part B|Physician Decision|0
7589854|NCT02539225|11996229|FG001|Part B|Physician Decision|9
7589855|NCT02526017|11996257|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589856|NCT02526017|11996258|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589857|NCT02526017|11996259|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589858|NCT02526017|11996260|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589859|NCT02526017|11996261|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1
7589860|NCT02526017|11996262|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589861|NCT02526017|11996263|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589862|NCT02526017|11996264|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589863|NCT02526017|11996265|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
7589864|NCT02482233|11996327|FG000|Overall Study|Lost to Follow-up|1
7589865|NCT02482233|11996328|FG001|Overall Study|Lost to Follow-up|1
7589866|NCT02400736|11996345|FG000|Overall Study|Lost to Follow-up|6
7589867|NCT02400736|11996346|FG001|Overall Study|Lost to Follow-up|6
7589868|NCT02400736|11996345|FG000|Overall Study|Withdrawal by Subject|2
7589869|NCT02400736|11996346|FG001|Overall Study|Withdrawal by Subject|1
7589870|NCT02400736|11996345|FG000|Overall Study|Moved from the area|3
7589871|NCT02400736|11996346|FG001|Overall Study|Moved from the area|1
7589872|NCT02369653|11996358|FG000|Overall Study|Lost to Follow-up|0
7589873|NCT02369653|11996359|FG001|Overall Study|Lost to Follow-up|1
7589874|NCT02369653|11996358|FG000|Overall Study|Administrative reason by sponsor|0
7589875|NCT02369653|11996359|FG001|Overall Study|Administrative reason by sponsor|1
7589876|NCT02369653|11996358|FG000|Overall Study|Death|1
7589877|NCT02369653|11996359|FG001|Overall Study|Death|2
7589878|NCT02369653|11996358|FG000|Overall Study|Participant withdrew consent|13
7589879|NCT02369653|11996359|FG001|Overall Study|Participant withdrew consent|3
7270721|NCT00419094|11485060|FG001|Overall Study|Lost to Follow-up|2
7589887|NCT02326974|11996373|FG000|Overall Study|Withdrawal by Subject|2
7589888|NCT02326974|11996373|FG000|Overall Study|failed heterogenity evaluation|5
7589889|NCT02284568|11996384|FG000|Overall Study|Adverse Event|2
7589890|NCT02284568|11996385|FG001|Overall Study|Adverse Event|9
7589891|NCT02284568|11996386|FG002|Overall Study|Adverse Event|4
7589892|NCT02284568|11996384|FG000|Overall Study|Withdrawal by Subject|22
7589893|NCT02284568|11996385|FG001|Overall Study|Withdrawal by Subject|21
7589894|NCT02284568|11996386|FG002|Overall Study|Withdrawal by Subject|1
7589895|NCT02284568|11996384|FG000|Overall Study|Noncompliance with study drug admin|1
7589896|NCT02284568|11996385|FG001|Overall Study|Noncompliance with study drug admin|2
7589897|NCT02284568|11996386|FG002|Overall Study|Noncompliance with study drug admin|0
7589898|NCT02284568|11996384|FG000|Overall Study|Noncompliance|1
7589899|NCT02284568|11996385|FG001|Overall Study|Noncompliance|0
7589900|NCT02284568|11996386|FG002|Overall Study|Noncompliance|0
7589901|NCT02284568|11996384|FG000|Overall Study|Protocol Violation|0
7589902|NCT02284568|11996385|FG001|Overall Study|Protocol Violation|1
7589903|NCT02284568|11996386|FG002|Overall Study|Protocol Violation|0
7589904|NCT02284568|11996384|FG000|Overall Study|Sponsor requested patient stop treatment|0
7589905|NCT02284568|11996385|FG001|Overall Study|Sponsor requested patient stop treatment|0
7589906|NCT02284568|11996386|FG002|Overall Study|Sponsor requested patient stop treatment|90
7589907|NCT02284568|11996384|FG000|Overall Study|Lost to Follow-up|0
7589908|NCT02284568|11996385|FG001|Overall Study|Lost to Follow-up|3
7589909|NCT02284568|11996386|FG002|Overall Study|Lost to Follow-up|0
7589910|NCT02284568|11996384|FG000|Overall Study|Lack of Efficacy|4
7589911|NCT02284568|11996385|FG001|Overall Study|Lack of Efficacy|7
7589912|NCT02284568|11996386|FG002|Overall Study|Lack of Efficacy|0
7589913|NCT02284568|11996384|FG000|Overall Study|Other|1
7589914|NCT02284568|11996385|FG001|Overall Study|Other|2
7589915|NCT02284568|11996386|FG002|Overall Study|Other|0
7589916|NCT02284568|11996384|FG000|Overall Study|Withdrew before taking study drug|0
7589917|NCT02284568|11996385|FG001|Overall Study|Withdrew before taking study drug|1
7589918|NCT02284568|11996386|FG002|Overall Study|Withdrew before taking study drug|0
7626636|NCT02723864|12038987|FG000|Overall Study|Changes in patient condition|0
7626637|NCT02723864|12038988|FG001|Overall Study|Changes in patient condition|0
7626638|NCT02723864|12038989|FG002|Overall Study|Changes in patient condition|0
7626639|NCT02723864|12038990|FG003|Overall Study|Changes in patient condition|0
7626640|NCT02723864|12038991|FG004|Overall Study|Changes in patient condition|0
7626641|NCT02723864|12038992|FG005|Overall Study|Changes in patient condition|1
7626642|NCT02723864|12038993|FG006|Overall Study|Changes in patient condition|0
7626643|NCT02723864|12038987|FG000|Overall Study|Patient choice|0
7626644|NCT02723864|12038988|FG001|Overall Study|Patient choice|0
7626645|NCT02723864|12038989|FG002|Overall Study|Patient choice|0
7626646|NCT02723864|12038990|FG003|Overall Study|Patient choice|0
7626647|NCT02723864|12038991|FG004|Overall Study|Patient choice|0
7626648|NCT02723864|12038992|FG005|Overall Study|Patient choice|1
7626649|NCT02723864|12038993|FG006|Overall Study|Patient choice|0
7626650|NCT02723864|12038987|FG000|Overall Study|Adverse Event|0
7626651|NCT02723864|12038988|FG001|Overall Study|Adverse Event|0
7626652|NCT02723864|12038989|FG002|Overall Study|Adverse Event|0
7626653|NCT02723864|12038990|FG003|Overall Study|Adverse Event|0
7626654|NCT02723864|12038991|FG004|Overall Study|Adverse Event|0
7626655|NCT02723864|12038992|FG005|Overall Study|Adverse Event|1
7626656|NCT02723864|12038993|FG006|Overall Study|Adverse Event|0
7626657|NCT02723864|12038987|FG000|Overall Study|Started new treatment|0
7626658|NCT02723864|12038988|FG001|Overall Study|Started new treatment|0
7626659|NCT02723864|12038989|FG002|Overall Study|Started new treatment|0
7626660|NCT02723864|12038990|FG003|Overall Study|Started new treatment|0
7626661|NCT02723864|12038991|FG004|Overall Study|Started new treatment|0
7626662|NCT02723864|12038992|FG005|Overall Study|Started new treatment|1
7626663|NCT02723864|12038993|FG006|Overall Study|Started new treatment|0
7626664|NCT02723864|12038987|FG000|Overall Study|Switched to alternative treatment|0
7626665|NCT02723864|12038988|FG001|Overall Study|Switched to alternative treatment|0
7626666|NCT02723864|12038989|FG002|Overall Study|Switched to alternative treatment|0
7626667|NCT02723864|12038990|FG003|Overall Study|Switched to alternative treatment|0
7626668|NCT02723864|12038991|FG004|Overall Study|Switched to alternative treatment|0
7626669|NCT02723864|12038992|FG005|Overall Study|Switched to alternative treatment|1
7626670|NCT02723864|12038993|FG006|Overall Study|Switched to alternative treatment|0
7626671|NCT02723864|12038987|FG000|Overall Study|Late determination of ineligibility|0
7626672|NCT02723864|12038988|FG001|Overall Study|Late determination of ineligibility|0
7626673|NCT02723864|12038989|FG002|Overall Study|Late determination of ineligibility|0
7626674|NCT02723864|12038990|FG003|Overall Study|Late determination of ineligibility|0
7626675|NCT02723864|12038991|FG004|Overall Study|Late determination of ineligibility|0
7626676|NCT02723864|12038992|FG005|Overall Study|Late determination of ineligibility|1
7626677|NCT02723864|12038993|FG006|Overall Study|Late determination of ineligibility|0
7626678|NCT02691013|12039041|FG000|Overall Study|Withdrawal by Subject|3
7626679|NCT02691013|12039042|FG001|Overall Study|Withdrawal by Subject|0
7626680|NCT02597062|12039050|FG000|Overall Study|Ineligible|1
7626681|NCT02130882|12039056|FG000|Overall Study|Withdrawal by Subject|0
7626682|NCT02130882|12039057|FG001|Overall Study|Withdrawal by Subject|1
7626683|NCT01850563|12039065|FG000|Overall Study|Not eligible|3
7626684|NCT01850563|12039066|FG001|Overall Study|Not eligible|0
7626685|NCT01827111|12039073|FG000|Overall Study|Disease Progression|1
7626686|NCT01437111|12039077|FG000|Overall Study|Adverse Event|2
7626687|NCT01437111|12039077|FG000|Overall Study|Withdrawal by Subject|4
7626688|NCT01437111|12039077|FG000|Overall Study|Not reported|5
7626689|NCT01437111|12039077|FG000|Overall Study|Physician Decision|1
7626690|NCT01437111|12039077|FG000|Overall Study|Lost to Follow-up|5
7626691|NCT01437111|12039077|FG000|Overall Study|Protocol Violation|1
7626692|NCT01004263|12039114|FG000|Overall Study|Adverse Event|15
7626693|NCT01004263|12039114|FG000|Overall Study|Withdrawal by Subject|58
7626694|NCT01004263|12039114|FG000|Overall Study|Protocol Violation|10
7626695|NCT01004263|12039114|FG000|Overall Study|Lost to Follow-up|64
7626696|NCT01004263|12039114|FG000|Overall Study|Lack of Efficacy|13
7626697|NCT01004263|12039114|FG000|Overall Study|Pregnancy|2
7626698|NCT01004263|12039114|FG000|Overall Study|Physician Decision|15
7626699|NCT01004263|12039114|FG000|Overall Study|Lack of Qualifying Event|2
7626700|NCT01001234|12039123|FG000|Overall Study|Withdrawal by Subject|2
7626701|NCT01001234|12039124|FG001|Overall Study|Withdrawal by Subject|0
7589919|NCT02227238|11996400|FG000|Overall Study|Other: Reached stopping criteria|0
7589920|NCT02227238|11996401|FG001|Overall Study|Other: Reached stopping criteria|1
7589921|NCT02227238|11996400|FG000|Overall Study|Adverse Event|8
7589922|NCT02227238|11996401|FG001|Overall Study|Adverse Event|18
7589923|NCT02227238|11996400|FG000|Overall Study|Lack of Efficacy|10
7589924|NCT02227238|11996401|FG001|Overall Study|Lack of Efficacy|22
7589925|NCT02227238|11996400|FG000|Overall Study|Protocol Violation|7
7589926|NCT02227238|11996401|FG001|Overall Study|Protocol Violation|8
7589927|NCT02227238|11996400|FG000|Overall Study|Withdrawal by Subject|5
7589928|NCT02227238|11996401|FG001|Overall Study|Withdrawal by Subject|4
7589929|NCT02227238|11996400|FG000|Overall Study|Physician Decision|0
7589930|NCT02227238|11996401|FG001|Overall Study|Physician Decision|9
7589931|NCT02227238|11996400|FG000|Overall Study|Lost to Follow-up|7
7589932|NCT02227238|11996401|FG001|Overall Study|Lost to Follow-up|5
7589933|NCT02195986|11996410|FG000|Overall Study|Adverse Event|3
7589934|NCT02195986|11996411|FG001|Overall Study|Adverse Event|0
7589935|NCT02195986|11996412|FG002|Overall Study|Adverse Event|0
7589936|NCT02195986|11996410|FG000|Overall Study|Withdrawal by Subject|0
7589937|NCT02195986|11996411|FG001|Overall Study|Withdrawal by Subject|3
7589938|NCT02195986|11996412|FG002|Overall Study|Withdrawal by Subject|0
7589939|NCT02195986|11996410|FG000|Overall Study|Family Emergency|0
7589940|NCT02195986|11996411|FG001|Overall Study|Family Emergency|0
7589941|NCT02195986|11996412|FG002|Overall Study|Family Emergency|1
7589942|NCT02195986|11996410|FG000|Overall Study|Protocol Violation|0
7589943|NCT02195986|11996411|FG001|Overall Study|Protocol Violation|1
7589944|NCT02195986|11996412|FG002|Overall Study|Protocol Violation|1
7589945|NCT02195986|11996410|FG000|Overall Study|Non-compliance|0
7589946|NCT02195986|11996411|FG001|Overall Study|Non-compliance|1
7589947|NCT02195986|11996412|FG002|Overall Study|Non-compliance|0
7589948|NCT02086448|11996433|FG000|Overall Study|Withdrawal by Subject|1
7589949|NCT02086448|11996434|FG001|Overall Study|Withdrawal by Subject|0
7589950|NCT02086448|11996435|FG002|Overall Study|Withdrawal by Subject|0
7589951|NCT02086448|11996436|FG003|Overall Study|Withdrawal by Subject|2
7589952|NCT01982630|11996454|FG000|Overall Study|Adverse Event|2
7589953|NCT01982630|11996455|FG001|Overall Study|Adverse Event|0
7589954|NCT01982630|11996456|FG002|Overall Study|Adverse Event|1
7589955|NCT01982630|11996457|FG003|Overall Study|Adverse Event|0
7589956|NCT01982630|11996458|FG004|Overall Study|Adverse Event|1
7589957|NCT01982630|11996459|FG005|Overall Study|Adverse Event|2
7589958|NCT01982630|11996460|FG006|Overall Study|Adverse Event|1
7589959|NCT01982630|11996461|FG007|Overall Study|Adverse Event|0
7589960|NCT01982630|11996454|FG000|Overall Study|Physician Decision|1
7589961|NCT01982630|11996455|FG001|Overall Study|Physician Decision|0
7589962|NCT01982630|11996456|FG002|Overall Study|Physician Decision|2
7589963|NCT01982630|11996457|FG003|Overall Study|Physician Decision|1
7589964|NCT01982630|11996458|FG004|Overall Study|Physician Decision|2
7589965|NCT01982630|11996459|FG005|Overall Study|Physician Decision|0
7589966|NCT01982630|11996460|FG006|Overall Study|Physician Decision|0
7589967|NCT01982630|11996461|FG007|Overall Study|Physician Decision|0
7589968|NCT01982630|11996454|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0
7589969|NCT01982630|11996455|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0
7589970|NCT01982630|11996456|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2
7589971|NCT01982630|11996457|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0
7589972|NCT01982630|11996458|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0
7589973|NCT01982630|11996459|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0
7589974|NCT01982630|11996460|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0
7589975|NCT01982630|11996461|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0
7589976|NCT01982630|11996454|FG000|Overall Study|Withdrawal by Subject|0
7589977|NCT01982630|11996455|FG001|Overall Study|Withdrawal by Subject|0
7589978|NCT01982630|11996456|FG002|Overall Study|Withdrawal by Subject|0
7589979|NCT01982630|11996457|FG003|Overall Study|Withdrawal by Subject|0
7589980|NCT01982630|11996458|FG004|Overall Study|Withdrawal by Subject|0
7589981|NCT01982630|11996459|FG005|Overall Study|Withdrawal by Subject|1
7589982|NCT01982630|11996460|FG006|Overall Study|Withdrawal by Subject|0
7589983|NCT01982630|11996461|FG007|Overall Study|Withdrawal by Subject|0
7589984|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
7589985|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
7589986|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
7589987|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
7589988|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
7589989|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
7589990|NCT01982448|11996516|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
7589991|NCT01982448|11996517|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
7589992|NCT01752920|11996549|FG000|Overall Study|Adverse Event|1
7589993|NCT01752920|11996550|FG001|Overall Study|Adverse Event|0
7589994|NCT01752920|11996551|FG002|Overall Study|Adverse Event|5
7589995|NCT01752920|11996552|FG003|Overall Study|Adverse Event|10
7589996|NCT01752920|11996549|FG000|Overall Study|Clinical Disease Progression|6
7589997|NCT01752920|11996550|FG001|Overall Study|Clinical Disease Progression|4
7589998|NCT01752920|11996551|FG002|Overall Study|Clinical Disease Progression|1
7589999|NCT01752920|11996552|FG003|Overall Study|Clinical Disease Progression|13
7590000|NCT01752920|11996549|FG000|Overall Study|Physician Decision|1
7590001|NCT01752920|11996550|FG001|Overall Study|Physician Decision|0
7590002|NCT01752920|11996551|FG002|Overall Study|Physician Decision|0
7590003|NCT01752920|11996552|FG003|Overall Study|Physician Decision|3
7590004|NCT01752920|11996549|FG000|Overall Study|Radiographic Disease Progression|20
7590005|NCT01752920|11996550|FG001|Overall Study|Radiographic Disease Progression|7
7590006|NCT01752920|11996551|FG002|Overall Study|Radiographic Disease Progression|12
7590007|NCT01752920|11996552|FG003|Overall Study|Radiographic Disease Progression|29
7590008|NCT01752920|11996549|FG000|Overall Study|Study Terminated by Sponsor|0
7590009|NCT01752920|11996550|FG001|Overall Study|Study Terminated by Sponsor|0
7590010|NCT01752920|11996551|FG002|Overall Study|Study Terminated by Sponsor|0
7590011|NCT01752920|11996552|FG003|Overall Study|Study Terminated by Sponsor|1
7590012|NCT01752920|11996549|FG000|Overall Study|Withdrawal by Subject|0
7590013|NCT01752920|11996550|FG001|Overall Study|Withdrawal by Subject|1
7590014|NCT01752920|11996551|FG002|Overall Study|Withdrawal by Subject|0
7590015|NCT01752920|11996552|FG003|Overall Study|Withdrawal by Subject|1
7590016|NCT01752920|11996549|FG000|Overall Study|Lack of clinical benefit|1
7590017|NCT01752920|11996550|FG001|Overall Study|Lack of clinical benefit|1
7590018|NCT01752920|11996551|FG002|Overall Study|Lack of clinical benefit|1
7590019|NCT01752920|11996552|FG003|Overall Study|Lack of clinical benefit|1
7590022|NCT01740297|11996584|FG000|Overall Study|Withdrawal by Subject|4
7590023|NCT01740297|11996585|FG001|Overall Study|Withdrawal by Subject|16
7270722|NCT00419094|11485059|FG000|Overall Study|Protocol Violation|1
7270723|NCT00419094|11485060|FG001|Overall Study|Protocol Violation|14
7270724|NCT00419094|11485059|FG000|Overall Study|Withdrawal of consent|1
7270725|NCT00419094|11485060|FG001|Overall Study|Withdrawal of consent|5
7270726|NCT00419094|11485059|FG000|Overall Study|Other: Error determining exit criteria|1
7270727|NCT00419094|11485060|FG001|Overall Study|Other: Error determining exit criteria|0
7590024|NCT01740297|11996586|FG002|Overall Study|Withdrawal by Subject|17
7590025|NCT01740297|11996584|FG000|Overall Study|Death|8
7590026|NCT01740297|11996585|FG001|Overall Study|Death|46
7590027|NCT01740297|11996586|FG002|Overall Study|Death|40
7590028|NCT01740297|11996584|FG000|Overall Study|Lost to Follow-up|1
7590029|NCT01740297|11996585|FG001|Overall Study|Lost to Follow-up|2
7590030|NCT01740297|11996586|FG002|Overall Study|Lost to Follow-up|4
7590031|NCT01729754|11996600|FG000|Part 1|Adverse Event|2
7590032|NCT01729754|11996601|FG001|Part 1|Adverse Event|0
7590033|NCT01729754|11996602|FG002|Part 1|Adverse Event|0
7590034|NCT01729754|11996603|FG003|Part 1|Adverse Event|1
7590035|NCT01729754|11996604|FG004|Part 1|Adverse Event|0
7590036|NCT01729754|11996605|FG005|Part 1|Adverse Event|0
7590037|NCT01729754|11996606|FG006|Part 1|Adverse Event|2
7590038|NCT01729754|11996607|FG007|Part 1|Adverse Event|0
7590039|NCT01729754|11996608|FG008|Part 1|Adverse Event|0
7590040|NCT01729754|11996609|FG009|Part 1|Adverse Event|5
7590041|NCT01729754|11996600|FG000|Part 1|Lack of Efficacy|1
7590042|NCT01729754|11996601|FG001|Part 1|Lack of Efficacy|0
7590043|NCT01729754|11996602|FG002|Part 1|Lack of Efficacy|0
7590044|NCT01729754|11996603|FG003|Part 1|Lack of Efficacy|0
7590045|NCT01729754|11996604|FG004|Part 1|Lack of Efficacy|0
7590046|NCT01729754|11996605|FG005|Part 1|Lack of Efficacy|0
7590047|NCT01729754|11996606|FG006|Part 1|Lack of Efficacy|2
7590048|NCT01729754|11996607|FG007|Part 1|Lack of Efficacy|0
7590049|NCT01729754|11996608|FG008|Part 1|Lack of Efficacy|0
7590050|NCT01729754|11996609|FG009|Part 1|Lack of Efficacy|0
7590051|NCT01729754|11996600|FG000|Part 1|Lost to Follow-up|1
7590052|NCT01729754|11996601|FG001|Part 1|Lost to Follow-up|0
7590053|NCT01729754|11996602|FG002|Part 1|Lost to Follow-up|0
7590054|NCT01729754|11996603|FG003|Part 1|Lost to Follow-up|2
7590055|NCT01729754|11996604|FG004|Part 1|Lost to Follow-up|0
7590056|NCT01729754|11996605|FG005|Part 1|Lost to Follow-up|0
7590057|NCT01729754|11996606|FG006|Part 1|Lost to Follow-up|3
7590058|NCT01729754|11996607|FG007|Part 1|Lost to Follow-up|0
7590059|NCT01729754|11996608|FG008|Part 1|Lost to Follow-up|0
7590060|NCT01729754|11996609|FG009|Part 1|Lost to Follow-up|3
7590061|NCT01729754|11996600|FG000|Part 1|Non-compliance with Study Drug|1
7590062|NCT01729754|11996601|FG001|Part 1|Non-compliance with Study Drug|0
7590063|NCT01729754|11996602|FG002|Part 1|Non-compliance with Study Drug|0
7590064|NCT01729754|11996603|FG003|Part 1|Non-compliance with Study Drug|0
7590065|NCT01729754|11996604|FG004|Part 1|Non-compliance with Study Drug|0
7590066|NCT01729754|11996605|FG005|Part 1|Non-compliance with Study Drug|0
7590067|NCT01729754|11996606|FG006|Part 1|Non-compliance with Study Drug|0
7590068|NCT01729754|11996607|FG007|Part 1|Non-compliance with Study Drug|0
7590069|NCT01729754|11996608|FG008|Part 1|Non-compliance with Study Drug|0
7590070|NCT01729754|11996609|FG009|Part 1|Non-compliance with Study Drug|0
7590071|NCT01729754|11996600|FG000|Part 1|Physician Decision|0
7590072|NCT01729754|11996601|FG001|Part 1|Physician Decision|0
7590073|NCT01729754|11996602|FG002|Part 1|Physician Decision|0
7590074|NCT01729754|11996603|FG003|Part 1|Physician Decision|0
7590075|NCT01729754|11996604|FG004|Part 1|Physician Decision|0
7590076|NCT01729754|11996605|FG005|Part 1|Physician Decision|0
7590077|NCT01729754|11996606|FG006|Part 1|Physician Decision|0
7590078|NCT01729754|11996607|FG007|Part 1|Physician Decision|0
7590079|NCT01729754|11996608|FG008|Part 1|Physician Decision|0
7590080|NCT01729754|11996609|FG009|Part 1|Physician Decision|4
7590081|NCT01729754|11996600|FG000|Part 1|Pregnancy|0
7590082|NCT01729754|11996601|FG001|Part 1|Pregnancy|0
7590083|NCT01729754|11996602|FG002|Part 1|Pregnancy|0
7590084|NCT01729754|11996603|FG003|Part 1|Pregnancy|1
7590085|NCT01729754|11996604|FG004|Part 1|Pregnancy|0
7590086|NCT01729754|11996605|FG005|Part 1|Pregnancy|0
7590087|NCT01729754|11996606|FG006|Part 1|Pregnancy|0
7590088|NCT01729754|11996607|FG007|Part 1|Pregnancy|0
7590089|NCT01729754|11996608|FG008|Part 1|Pregnancy|0
7590090|NCT01729754|11996609|FG009|Part 1|Pregnancy|1
7590091|NCT01729754|11996600|FG000|Part 1|Progressive Disease|0
7590092|NCT01729754|11996601|FG001|Part 1|Progressive Disease|0
7590093|NCT01729754|11996602|FG002|Part 1|Progressive Disease|0
7590094|NCT01729754|11996603|FG003|Part 1|Progressive Disease|0
7590095|NCT01729754|11996604|FG004|Part 1|Progressive Disease|0
7590096|NCT01729754|11996605|FG005|Part 1|Progressive Disease|0
7590097|NCT01729754|11996606|FG006|Part 1|Progressive Disease|0
7590098|NCT01729754|11996607|FG007|Part 1|Progressive Disease|0
7590099|NCT01729754|11996608|FG008|Part 1|Progressive Disease|0
7590100|NCT01729754|11996609|FG009|Part 1|Progressive Disease|1
7590101|NCT01729754|11996600|FG000|Part 1|Protocol Violation|2
7590102|NCT01729754|11996601|FG001|Part 1|Protocol Violation|0
7590103|NCT01729754|11996602|FG002|Part 1|Protocol Violation|0
7590104|NCT01729754|11996603|FG003|Part 1|Protocol Violation|1
7590105|NCT01729754|11996604|FG004|Part 1|Protocol Violation|0
7590106|NCT01729754|11996605|FG005|Part 1|Protocol Violation|0
7590107|NCT01729754|11996606|FG006|Part 1|Protocol Violation|1
7590108|NCT01729754|11996607|FG007|Part 1|Protocol Violation|0
7590109|NCT01729754|11996608|FG008|Part 1|Protocol Violation|0
7590110|NCT01729754|11996609|FG009|Part 1|Protocol Violation|0
7590111|NCT01729754|11996600|FG000|Part 1|Withdrawal by Subject|5
7590112|NCT01729754|11996601|FG001|Part 1|Withdrawal by Subject|0
7590113|NCT01729754|11996602|FG002|Part 1|Withdrawal by Subject|0
7590114|NCT01729754|11996603|FG003|Part 1|Withdrawal by Subject|7
7590115|NCT01729754|11996604|FG004|Part 1|Withdrawal by Subject|0
7590116|NCT01729754|11996605|FG005|Part 1|Withdrawal by Subject|0
7590117|NCT01729754|11996606|FG006|Part 1|Withdrawal by Subject|5
7590118|NCT01729754|11996607|FG007|Part 1|Withdrawal by Subject|0
7590119|NCT01729754|11996608|FG008|Part 1|Withdrawal by Subject|0
7590120|NCT01729754|11996609|FG009|Part 1|Withdrawal by Subject|6
7590121|NCT01729754|11996600|FG000|Part 1|Other Protocol Specified Criteria|2
7590122|NCT01729754|11996601|FG001|Part 1|Other Protocol Specified Criteria|0
7590123|NCT01729754|11996602|FG002|Part 1|Other Protocol Specified Criteria|0
7590124|NCT01729754|11996603|FG003|Part 1|Other Protocol Specified Criteria|0
7590125|NCT01729754|11996604|FG004|Part 1|Other Protocol Specified Criteria|0
7590126|NCT01729754|11996605|FG005|Part 1|Other Protocol Specified Criteria|0
7590127|NCT01729754|11996606|FG006|Part 1|Other Protocol Specified Criteria|1
7590128|NCT01729754|11996607|FG007|Part 1|Other Protocol Specified Criteria|0
7590129|NCT01729754|11996608|FG008|Part 1|Other Protocol Specified Criteria|0
7590130|NCT01729754|11996609|FG009|Part 1|Other Protocol Specified Criteria|4
7590131|NCT01729754|11996600|FG000|Part 2|Adverse Event|2
7590132|NCT01729754|11996601|FG001|Part 2|Adverse Event|0
7590133|NCT01729754|11996602|FG002|Part 2|Adverse Event|0
7590134|NCT01729754|11996603|FG003|Part 2|Adverse Event|0
7590135|NCT01729754|11996604|FG004|Part 2|Adverse Event|0
7590136|NCT01729754|11996605|FG005|Part 2|Adverse Event|0
7590137|NCT01729754|11996606|FG006|Part 2|Adverse Event|0
7590138|NCT01729754|11996607|FG007|Part 2|Adverse Event|0
7590139|NCT01729754|11996608|FG008|Part 2|Adverse Event|1
7590140|NCT01729754|11996609|FG009|Part 2|Adverse Event|2
7590141|NCT01729754|11996600|FG000|Part 2|Lack of Efficacy|0
7590142|NCT01729754|11996601|FG001|Part 2|Lack of Efficacy|0
7590143|NCT01729754|11996602|FG002|Part 2|Lack of Efficacy|0
7590144|NCT01729754|11996603|FG003|Part 2|Lack of Efficacy|0
7590145|NCT01729754|11996604|FG004|Part 2|Lack of Efficacy|0
7590146|NCT01729754|11996605|FG005|Part 2|Lack of Efficacy|0
7590147|NCT01729754|11996606|FG006|Part 2|Lack of Efficacy|0
7590148|NCT01729754|11996607|FG007|Part 2|Lack of Efficacy|0
7590149|NCT01729754|11996608|FG008|Part 2|Lack of Efficacy|2
7590150|NCT01729754|11996609|FG009|Part 2|Lack of Efficacy|2
7590151|NCT01729754|11996600|FG000|Part 2|Lost to Follow-up|0
7590152|NCT01729754|11996601|FG001|Part 2|Lost to Follow-up|0
7590153|NCT01729754|11996602|FG002|Part 2|Lost to Follow-up|0
7590154|NCT01729754|11996603|FG003|Part 2|Lost to Follow-up|2
7590155|NCT01729754|11996604|FG004|Part 2|Lost to Follow-up|0
7590156|NCT01729754|11996605|FG005|Part 2|Lost to Follow-up|0
7590157|NCT01729754|11996606|FG006|Part 2|Lost to Follow-up|0
7590158|NCT01729754|11996607|FG007|Part 2|Lost to Follow-up|1
7590159|NCT01729754|11996608|FG008|Part 2|Lost to Follow-up|0
7270728|NCT00419094|11485059|FG000|Overall Study|Other: Patient non-compliant|0
7270729|NCT00419094|11485060|FG001|Overall Study|Other: Patient non-compliant|1
7270730|NCT00419094|11485059|FG000|Overall Study|Other: No contact for extended period|0
7388251|NCT01218126|11647008|FG002|Overall Study|Withdrawal by Subject|4
7590160|NCT01729754|11996609|FG009|Part 2|Lost to Follow-up|2
7590161|NCT01729754|11996600|FG000|Part 2|Non-Compliance with Study Drug|0
7590162|NCT01729754|11996601|FG001|Part 2|Non-Compliance with Study Drug|0
7590163|NCT01729754|11996602|FG002|Part 2|Non-Compliance with Study Drug|0
7590164|NCT01729754|11996603|FG003|Part 2|Non-Compliance with Study Drug|0
7590165|NCT01729754|11996604|FG004|Part 2|Non-Compliance with Study Drug|0
7590166|NCT01729754|11996605|FG005|Part 2|Non-Compliance with Study Drug|0
7590167|NCT01729754|11996606|FG006|Part 2|Non-Compliance with Study Drug|0
7590168|NCT01729754|11996607|FG007|Part 2|Non-Compliance with Study Drug|0
7590169|NCT01729754|11996608|FG008|Part 2|Non-Compliance with Study Drug|0
7590170|NCT01729754|11996609|FG009|Part 2|Non-Compliance with Study Drug|1
7590171|NCT01729754|11996600|FG000|Part 2|Pregnancy|0
7590172|NCT01729754|11996601|FG001|Part 2|Pregnancy|0
7590173|NCT01729754|11996602|FG002|Part 2|Pregnancy|0
7590174|NCT01729754|11996603|FG003|Part 2|Pregnancy|1
7590175|NCT01729754|11996604|FG004|Part 2|Pregnancy|0
7590176|NCT01729754|11996605|FG005|Part 2|Pregnancy|0
7590177|NCT01729754|11996606|FG006|Part 2|Pregnancy|0
7590178|NCT01729754|11996607|FG007|Part 2|Pregnancy|0
7590179|NCT01729754|11996608|FG008|Part 2|Pregnancy|0
7590180|NCT01729754|11996609|FG009|Part 2|Pregnancy|1
7590181|NCT01729754|11996600|FG000|Part 2|Withdrawal by Subject|3
7590182|NCT01729754|11996601|FG001|Part 2|Withdrawal by Subject|0
7590183|NCT01729754|11996602|FG002|Part 2|Withdrawal by Subject|0
7590184|NCT01729754|11996603|FG003|Part 2|Withdrawal by Subject|2
7590185|NCT01729754|11996604|FG004|Part 2|Withdrawal by Subject|0
7590186|NCT01729754|11996605|FG005|Part 2|Withdrawal by Subject|0
7590187|NCT01729754|11996606|FG006|Part 2|Withdrawal by Subject|0
7590188|NCT01729754|11996607|FG007|Part 2|Withdrawal by Subject|1
7590189|NCT01729754|11996608|FG008|Part 2|Withdrawal by Subject|1
7590190|NCT01729754|11996609|FG009|Part 2|Withdrawal by Subject|4
7590191|NCT01729754|11996600|FG000|Part 2|Other Protocol Specified Criteria|1
7590192|NCT01729754|11996601|FG001|Part 2|Other Protocol Specified Criteria|0
7590193|NCT01729754|11996602|FG002|Part 2|Other Protocol Specified Criteria|0
7590194|NCT01729754|11996603|FG003|Part 2|Other Protocol Specified Criteria|0
7590195|NCT01729754|11996604|FG004|Part 2|Other Protocol Specified Criteria|0
7590196|NCT01729754|11996605|FG005|Part 2|Other Protocol Specified Criteria|0
7590197|NCT01729754|11996606|FG006|Part 2|Other Protocol Specified Criteria|0
7590198|NCT01729754|11996607|FG007|Part 2|Other Protocol Specified Criteria|1
7590199|NCT01729754|11996608|FG008|Part 2|Other Protocol Specified Criteria|0
7590200|NCT01729754|11996609|FG009|Part 2|Other Protocol Specified Criteria|0
7590201|NCT01729754|11996600|FG000|Part 3|Adverse Event|0
7590202|NCT01729754|11996601|FG001|Part 3|Adverse Event|0
7590203|NCT01729754|11996602|FG002|Part 3|Adverse Event|1
7590204|NCT01729754|11996603|FG003|Part 3|Adverse Event|0
7590205|NCT01729754|11996604|FG004|Part 3|Adverse Event|0
7590206|NCT01729754|11996605|FG005|Part 3|Adverse Event|5
7590207|NCT01729754|11996606|FG006|Part 3|Adverse Event|0
7590208|NCT01729754|11996607|FG007|Part 3|Adverse Event|0
7590209|NCT01729754|11996608|FG008|Part 3|Adverse Event|0
7590210|NCT01729754|11996609|FG009|Part 3|Adverse Event|3
7590211|NCT01729754|11996600|FG000|Part 3|Death|0
7590212|NCT01729754|11996601|FG001|Part 3|Death|0
7590213|NCT01729754|11996602|FG002|Part 3|Death|0
7590214|NCT01729754|11996603|FG003|Part 3|Death|0
7590215|NCT01729754|11996604|FG004|Part 3|Death|0
7590216|NCT01729754|11996605|FG005|Part 3|Death|2
7590217|NCT01729754|11996606|FG006|Part 3|Death|0
7590218|NCT01729754|11996607|FG007|Part 3|Death|0
7590219|NCT01729754|11996608|FG008|Part 3|Death|0
7590220|NCT01729754|11996609|FG009|Part 3|Death|0
7590221|NCT01729754|11996600|FG000|Part 3|Lack of Efficacy|0
7590222|NCT01729754|11996601|FG001|Part 3|Lack of Efficacy|0
7590223|NCT01729754|11996602|FG002|Part 3|Lack of Efficacy|0
7590224|NCT01729754|11996603|FG003|Part 3|Lack of Efficacy|0
7590225|NCT01729754|11996604|FG004|Part 3|Lack of Efficacy|2
7590226|NCT01729754|11996605|FG005|Part 3|Lack of Efficacy|0
7590227|NCT01729754|11996606|FG006|Part 3|Lack of Efficacy|0
7590228|NCT01729754|11996607|FG007|Part 3|Lack of Efficacy|0
7590229|NCT01729754|11996608|FG008|Part 3|Lack of Efficacy|0
7590230|NCT01729754|11996609|FG009|Part 3|Lack of Efficacy|4
7270731|NCT00419094|11485060|FG001|Overall Study|Other: No contact for extended period|1
7270732|NCT00419120|11485066|FG000|Long Term Follow up Period|study ongoing|10
7388252|NCT01218126|11647009|FG003|Overall Study|Withdrawal by Subject|6
7469653|NCT01925612|11771505|FG004|Overall Study|Progressive Disease|0
7469654|NCT01925612|11771501|FG000|Overall Study|Adverse Event|3
7469655|NCT01925612|11771502|FG001|Overall Study|Adverse Event|3
7469656|NCT01925612|11771503|FG002|Overall Study|Adverse Event|0
7469657|NCT01925612|11771504|FG003|Overall Study|Adverse Event|1
7469658|NCT01925612|11771505|FG004|Overall Study|Adverse Event|2
7469659|NCT01925703|11771521|FG000|Overall Study|Physician Decision|1
7469660|NCT01925703|11771521|FG000|Overall Study|Lost to Follow-up|2
7469661|NCT01925703|11771521|FG000|Overall Study|Discharge prior to full iron repletion|1
7469662|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7469663|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7469664|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7469665|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
7469666|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
7469667|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
7469668|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7469669|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
7469670|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
7469671|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7469672|NCT01925768|11771527|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
7469673|NCT01925768|11771528|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
7469674|NCT01925768|11771527|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7469675|NCT01925768|11771528|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
7469676|NCT01925768|11771527|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
7469677|NCT01925768|11771528|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
7469678|NCT01925768|11771527|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
7469679|NCT01925768|11771528|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
7469680|NCT01925768|11771527|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
7469681|NCT01925768|11771528|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
7590231|NCT01729754|11996600|FG000|Part 3|Lost to Follow-up|0
7590232|NCT01729754|11996601|FG001|Part 3|Lost to Follow-up|1
7590233|NCT01729754|11996602|FG002|Part 3|Lost to Follow-up|2
7590234|NCT01729754|11996603|FG003|Part 3|Lost to Follow-up|0
7590235|NCT01729754|11996604|FG004|Part 3|Lost to Follow-up|0
7590236|NCT01729754|11996605|FG005|Part 3|Lost to Follow-up|3
7590237|NCT01729754|11996606|FG006|Part 3|Lost to Follow-up|0
7590238|NCT01729754|11996607|FG007|Part 3|Lost to Follow-up|0
7590239|NCT01729754|11996608|FG008|Part 3|Lost to Follow-up|1
7590240|NCT01729754|11996609|FG009|Part 3|Lost to Follow-up|0
7590241|NCT01729754|11996600|FG000|Part 3|Physician Decision|0
7590242|NCT01729754|11996601|FG001|Part 3|Physician Decision|0
7590243|NCT01729754|11996602|FG002|Part 3|Physician Decision|1
7590244|NCT01729754|11996603|FG003|Part 3|Physician Decision|0
7590245|NCT01729754|11996604|FG004|Part 3|Physician Decision|0
7590246|NCT01729754|11996605|FG005|Part 3|Physician Decision|0
7590247|NCT01729754|11996606|FG006|Part 3|Physician Decision|0
7590248|NCT01729754|11996607|FG007|Part 3|Physician Decision|0
7590249|NCT01729754|11996608|FG008|Part 3|Physician Decision|0
7590250|NCT01729754|11996609|FG009|Part 3|Physician Decision|0
7590251|NCT01729754|11996600|FG000|Part 3|Withdrawal by Subject|0
7590252|NCT01729754|11996601|FG001|Part 3|Withdrawal by Subject|4
7590253|NCT01729754|11996602|FG002|Part 3|Withdrawal by Subject|1
7590254|NCT01729754|11996603|FG003|Part 3|Withdrawal by Subject|0
7590255|NCT01729754|11996604|FG004|Part 3|Withdrawal by Subject|2
7590256|NCT01729754|11996605|FG005|Part 3|Withdrawal by Subject|1
7590257|NCT01729754|11996606|FG006|Part 3|Withdrawal by Subject|0
7590258|NCT01729754|11996607|FG007|Part 3|Withdrawal by Subject|2
7590259|NCT01729754|11996608|FG008|Part 3|Withdrawal by Subject|0
7590260|NCT01729754|11996609|FG009|Part 3|Withdrawal by Subject|0
7590261|NCT01729754|11996600|FG000|Part 3|Other Protocol Specified Criteria|0
7590262|NCT01729754|11996601|FG001|Part 3|Other Protocol Specified Criteria|0
7590263|NCT01729754|11996602|FG002|Part 3|Other Protocol Specified Criteria|0
7590264|NCT01729754|11996603|FG003|Part 3|Other Protocol Specified Criteria|0
7590265|NCT01729754|11996604|FG004|Part 3|Other Protocol Specified Criteria|0
7590266|NCT01729754|11996605|FG005|Part 3|Other Protocol Specified Criteria|2
7590267|NCT01729754|11996606|FG006|Part 3|Other Protocol Specified Criteria|0
7590268|NCT01729754|11996607|FG007|Part 3|Other Protocol Specified Criteria|1
7590269|NCT01729754|11996608|FG008|Part 3|Other Protocol Specified Criteria|0
7590270|NCT01729754|11996609|FG009|Part 3|Other Protocol Specified Criteria|0
7590299|NCT01564537|11996674|FG000|Overall Study|Withdrawal by Participant|4
7590300|NCT01564537|11996675|FG001|Overall Study|Withdrawal by Participant|4
7590301|NCT01564537|11996674|FG000|Overall Study|Lost to Follow-up|1
7590302|NCT01564537|11996675|FG001|Overall Study|Lost to Follow-up|0
7590303|NCT01564537|11996674|FG000|Overall Study|Other Miscellaneous Reasons|1
7590304|NCT01564537|11996675|FG001|Overall Study|Other Miscellaneous Reasons|2
7590305|NCT01515306|11996684|FG000|Overall Study|Adverse Event|3
7590306|NCT01515306|11996685|FG001|Overall Study|Adverse Event|2
7590307|NCT01515306|11996684|FG000|Overall Study|Progressive Disease|19
7590308|NCT01515306|11996685|FG001|Overall Study|Progressive Disease|9
7590309|NCT01515306|11996684|FG000|Overall Study|Withdrawal by Subject|1
7590310|NCT01515306|11996685|FG001|Overall Study|Withdrawal by Subject|2
7590311|NCT01515306|11996684|FG000|Overall Study|Physician Decision|1
7590312|NCT01515306|11996685|FG001|Overall Study|Physician Decision|1
7590313|NCT01423851|11996706|FG000|Whole Study|Disease progression|2
7590314|NCT01423851|11996707|FG001|Whole Study|Disease progression|1
7590315|NCT01423851|11996708|FG002|Whole Study|Disease progression|1
7590316|NCT01423851|11996709|FG003|Whole Study|Disease progression|4
7590317|NCT01423851|11996710|FG004|Whole Study|Disease progression|1
7590318|NCT01423851|11996711|FG005|Whole Study|Disease progression|3
7590319|NCT01423851|11996712|FG006|Whole Study|Disease progression|1
7590320|NCT01423851|11996713|FG007|Whole Study|Disease progression|4
7590321|NCT01423851|11996714|FG008|Whole Study|Disease progression|0
7590322|NCT01423851|11996715|FG009|Whole Study|Disease progression|2
7590323|NCT01423851|11996716|FG010|Whole Study|Disease progression|10
7590324|NCT01423851|11996706|FG000|Whole Study|Physician Decision|0
7590325|NCT01423851|11996707|FG001|Whole Study|Physician Decision|1
7590326|NCT01423851|11996708|FG002|Whole Study|Physician Decision|2
7590327|NCT01423851|11996709|FG003|Whole Study|Physician Decision|0
7590328|NCT01423851|11996710|FG004|Whole Study|Physician Decision|2
7590329|NCT01423851|11996711|FG005|Whole Study|Physician Decision|0
7590330|NCT01423851|11996712|FG006|Whole Study|Physician Decision|2
7270733|NCT00419159|11485072|FG000|Overall Study|Adverse Event|7
7270734|NCT00419159|11485073|FG001|Overall Study|Adverse Event|15
7270735|NCT00419159|11485072|FG000|Overall Study|Abnormal laboratory value(s)|0
7270736|NCT00419159|11485073|FG001|Overall Study|Abnormal laboratory value(s)|2
7270737|NCT00419159|11485072|FG000|Overall Study|Subject's no longer requires study drug|0
7270738|NCT00419159|11485073|FG001|Overall Study|Subject's no longer requires study drug|1
7270739|NCT00419159|11485072|FG000|Overall Study|Protocol Violation|1
7270740|NCT00419159|11485073|FG001|Overall Study|Protocol Violation|0
7270741|NCT00419159|11485072|FG000|Overall Study|Withdrawal by Subject|10
7270742|NCT00419159|11485073|FG001|Overall Study|Withdrawal by Subject|3
7270743|NCT00419159|11485072|FG000|Overall Study|Lost to Follow-up|0
7270744|NCT00419159|11485073|FG001|Overall Study|Lost to Follow-up|1
7270745|NCT00419159|11485072|FG000|Overall Study|Death|2
7270746|NCT00419159|11485073|FG001|Overall Study|Death|2
7270747|NCT00419159|11485072|FG000|Overall Study|Disease progression|79
7270748|NCT00419159|11485073|FG001|Overall Study|Disease progression|76
7270749|NCT00419263|11485090|FG000|Overall Study|Lost to Follow-up|2
7270750|NCT00419263|11485091|FG001|Overall Study|Lost to Follow-up|1
7270751|NCT00419263|11485092|FG002|Overall Study|Lost to Follow-up|1
7270752|NCT00419263|11485090|FG000|Overall Study|Randomized in Error, Not Treated|1
7270753|NCT00419263|11485091|FG001|Overall Study|Randomized in Error, Not Treated|1
7270754|NCT00419263|11485092|FG002|Overall Study|Randomized in Error, Not Treated|0
7270755|NCT00419263|11485090|FG000|Overall Study|Adverse Event|0
7270756|NCT00419263|11485091|FG001|Overall Study|Adverse Event|0
7270757|NCT00419263|11485092|FG002|Overall Study|Adverse Event|1
7270758|NCT00419263|11485090|FG000|Overall Study|Withdrawal by Subject|0
7270759|NCT00419263|11485091|FG001|Overall Study|Withdrawal by Subject|0
7270760|NCT00419263|11485092|FG002|Overall Study|Withdrawal by Subject|1
7270761|NCT00419341|11485110|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
7270762|NCT00419341|11485110|FG000|Wash in/Wash Out Period|Adverse Event|2
7270763|NCT00419341|11485110|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
7270764|NCT00419341|11485110|FG000|Efficacy Period|Withdrawal by Subject|6
7270765|NCT00419341|11485110|FG000|Efficacy Period|Protocol Violation|1
7270766|NCT00419341|11485110|FG000|Efficacy Period|Lost to Follow-up|1
7270767|NCT00419341|11485110|FG000|Efficacy Period|Non-compliance|1
7270768|NCT00419341|11485110|FG000|Efficacy Period|Termination of study site|1
7270769|NCT00419380|11485118|FG000|Overall Study|Lack of Efficacy|1
7270770|NCT00419380|11485119|FG001|Overall Study|Lack of Efficacy|7
7270771|NCT00419380|11485118|FG000|Overall Study|Physician Decision|0
7270772|NCT00419380|11485119|FG001|Overall Study|Physician Decision|1
7270773|NCT00419380|11485118|FG000|Overall Study|Lost to Follow-up|0
7270774|NCT00419380|11485119|FG001|Overall Study|Lost to Follow-up|1
7270775|NCT00419380|11485118|FG000|Overall Study|Withdrawal by Subject|0
7270776|NCT00419380|11485119|FG001|Overall Study|Withdrawal by Subject|1
7270777|NCT00419393|11485125|FG000|Overall Study|Adverse Event|5
7270778|NCT00419393|11485125|FG000|Overall Study|Protocol Violation|5
7270779|NCT00419393|11485125|FG000|Overall Study|Withdrawal by Subject|7
7270780|NCT00419393|11485125|FG000|Overall Study|Other: Sponsor request|3
7270781|NCT00419393|11485125|FG000|Overall Study|Other: Subject had temporal lobectomy|1
7270782|NCT00419393|11485125|FG000|Overall Study|Other: Site closure|1
7270783|NCT00419393|11485125|FG000|Overall Study|Other: Other health problems|1
7270784|NCT00419393|11485125|FG000|Overall Study|Other: Investigator decision|1
7590331|NCT01423851|11996713|FG007|Whole Study|Physician Decision|1
7270785|NCT00419562|11485144|FG000|Overall Study|Lost to Follow-up|12
7270786|NCT00419562|11485145|FG001|Overall Study|Lost to Follow-up|13
7270787|NCT00419562|11485144|FG000|Overall Study|Withdrawal by Subject|20
7270788|NCT00419562|11485145|FG001|Overall Study|Withdrawal by Subject|18
7270789|NCT00419562|11485144|FG000|Overall Study|Participant Institutionalized|1
7270790|NCT00419562|11485145|FG001|Overall Study|Participant Institutionalized|0
7270791|NCT00419744|11485158|FG000|Overall Study|Adverse Event|39
7270792|NCT00419744|11485159|FG001|Overall Study|Adverse Event|40
7590332|NCT01423851|11996714|FG008|Whole Study|Physician Decision|3
7590333|NCT01423851|11996715|FG009|Whole Study|Physician Decision|4
7590334|NCT01423851|11996716|FG010|Whole Study|Physician Decision|12
7590335|NCT01423851|11996706|FG000|Whole Study|Withdrawal by Subject|1
7590336|NCT01423851|11996707|FG001|Whole Study|Withdrawal by Subject|1
7590337|NCT01423851|11996708|FG002|Whole Study|Withdrawal by Subject|0
7590338|NCT01423851|11996709|FG003|Whole Study|Withdrawal by Subject|0
7590339|NCT01423851|11996710|FG004|Whole Study|Withdrawal by Subject|0
7590340|NCT01423851|11996711|FG005|Whole Study|Withdrawal by Subject|0
7590341|NCT01423851|11996712|FG006|Whole Study|Withdrawal by Subject|0
7590342|NCT01423851|11996713|FG007|Whole Study|Withdrawal by Subject|0
7590343|NCT01423851|11996714|FG008|Whole Study|Withdrawal by Subject|2
7590344|NCT01423851|11996715|FG009|Whole Study|Withdrawal by Subject|0
7590345|NCT01423851|11996716|FG010|Whole Study|Withdrawal by Subject|4
7590346|NCT01423851|11996706|FG000|Whole Study|Adverse Event|0
7590347|NCT01423851|11996707|FG001|Whole Study|Adverse Event|0
7590348|NCT01423851|11996708|FG002|Whole Study|Adverse Event|0
7590349|NCT01423851|11996709|FG003|Whole Study|Adverse Event|2
7590350|NCT01423851|11996710|FG004|Whole Study|Adverse Event|0
7590351|NCT01423851|11996711|FG005|Whole Study|Adverse Event|0
7590352|NCT01423851|11996712|FG006|Whole Study|Adverse Event|0
7590353|NCT01423851|11996713|FG007|Whole Study|Adverse Event|3
7590354|NCT01423851|11996714|FG008|Whole Study|Adverse Event|3
7590355|NCT01423851|11996715|FG009|Whole Study|Adverse Event|2
7590356|NCT01423851|11996716|FG010|Whole Study|Adverse Event|3
7590367|NCT01334606|11996772|FG000|Overall Study|Study Terminated due to slow enrolment|18
7590368|NCT01317875|11996788|FG000|Overall Study|Other|0
7590369|NCT01317875|11996789|FG001|Overall Study|Other|0
7590370|NCT01317875|11996790|FG002|Overall Study|Other|1
7590371|NCT01317875|11996791|FG003|Overall Study|Other|0
7590372|NCT01317875|11996792|FG004|Overall Study|Other|0
7590373|NCT01317875|11996793|FG005|Overall Study|Other|0
7590374|NCT01317875|11996794|FG006|Overall Study|Other|0
7590375|NCT01317875|11996795|FG007|Overall Study|Other|0
7590376|NCT01317875|11996796|FG008|Overall Study|Other|0
7590377|NCT01317875|11996797|FG009|Overall Study|Other|0
7590378|NCT01317875|11996788|FG000|Overall Study|Noncompliance with study drug|0
7590379|NCT01317875|11996789|FG001|Overall Study|Noncompliance with study drug|0
7590380|NCT01317875|11996790|FG002|Overall Study|Noncompliance with study drug|1
7590381|NCT01317875|11996791|FG003|Overall Study|Noncompliance with study drug|0
7590382|NCT01317875|11996792|FG004|Overall Study|Noncompliance with study drug|0
7590383|NCT01317875|11996793|FG005|Overall Study|Noncompliance with study drug|0
7590384|NCT01317875|11996794|FG006|Overall Study|Noncompliance with study drug|0
7590385|NCT01317875|11996795|FG007|Overall Study|Noncompliance with study drug|0
7590386|NCT01317875|11996796|FG008|Overall Study|Noncompliance with study drug|0
7590387|NCT01317875|11996797|FG009|Overall Study|Noncompliance with study drug|0
7590388|NCT01317875|11996788|FG000|Overall Study|Progressive Disease|1
7590389|NCT01317875|11996789|FG001|Overall Study|Progressive Disease|0
7590390|NCT01317875|11996790|FG002|Overall Study|Progressive Disease|2
7590391|NCT01317875|11996791|FG003|Overall Study|Progressive Disease|0
7590392|NCT01317875|11996792|FG004|Overall Study|Progressive Disease|1
7590393|NCT01317875|11996793|FG005|Overall Study|Progressive Disease|0
7590394|NCT01317875|11996794|FG006|Overall Study|Progressive Disease|0
7590395|NCT01317875|11996795|FG007|Overall Study|Progressive Disease|1
7590396|NCT01317875|11996796|FG008|Overall Study|Progressive Disease|0
7590397|NCT01317875|11996797|FG009|Overall Study|Progressive Disease|0
7590398|NCT01317875|11996788|FG000|Overall Study|Withdrawal by Subject|0
7590399|NCT01317875|11996789|FG001|Overall Study|Withdrawal by Subject|0
7590400|NCT01317875|11996790|FG002|Overall Study|Withdrawal by Subject|0
7590401|NCT01317875|11996791|FG003|Overall Study|Withdrawal by Subject|0
7590402|NCT01317875|11996792|FG004|Overall Study|Withdrawal by Subject|1
7590403|NCT01317875|11996793|FG005|Overall Study|Withdrawal by Subject|0
7590404|NCT01317875|11996794|FG006|Overall Study|Withdrawal by Subject|0
7590405|NCT01317875|11996795|FG007|Overall Study|Withdrawal by Subject|3
7590406|NCT01317875|11996796|FG008|Overall Study|Withdrawal by Subject|0
7590407|NCT01317875|11996797|FG009|Overall Study|Withdrawal by Subject|0
7590408|NCT01317875|11996788|FG000|Overall Study|Physician Decision|0
7590409|NCT01317875|11996789|FG001|Overall Study|Physician Decision|1
7590410|NCT01317875|11996790|FG002|Overall Study|Physician Decision|1
7590411|NCT01317875|11996791|FG003|Overall Study|Physician Decision|0
7590412|NCT01317875|11996792|FG004|Overall Study|Physician Decision|2
7590413|NCT01317875|11996793|FG005|Overall Study|Physician Decision|0
7590414|NCT01317875|11996794|FG006|Overall Study|Physician Decision|0
7590415|NCT01317875|11996795|FG007|Overall Study|Physician Decision|2
7590416|NCT01317875|11996796|FG008|Overall Study|Physician Decision|0
7590417|NCT01317875|11996797|FG009|Overall Study|Physician Decision|0
7590418|NCT01317875|11996788|FG000|Overall Study|Death|0
7590419|NCT01317875|11996789|FG001|Overall Study|Death|0
7590420|NCT01317875|11996790|FG002|Overall Study|Death|2
7590421|NCT01317875|11996791|FG003|Overall Study|Death|1
7590422|NCT01317875|11996792|FG004|Overall Study|Death|0
7590423|NCT01317875|11996793|FG005|Overall Study|Death|1
7590424|NCT01317875|11996794|FG006|Overall Study|Death|0
7590425|NCT01317875|11996795|FG007|Overall Study|Death|4
7590426|NCT01317875|11996796|FG008|Overall Study|Death|0
7590427|NCT01317875|11996797|FG009|Overall Study|Death|0
7590428|NCT01317875|11996788|FG000|Overall Study|Adverse Event|2
7590429|NCT01317875|11996789|FG001|Overall Study|Adverse Event|1
7590430|NCT01317875|11996790|FG002|Overall Study|Adverse Event|2
7590431|NCT01317875|11996791|FG003|Overall Study|Adverse Event|1
7590432|NCT01317875|11996792|FG004|Overall Study|Adverse Event|5
7590433|NCT01317875|11996793|FG005|Overall Study|Adverse Event|1
7590434|NCT01317875|11996794|FG006|Overall Study|Adverse Event|2
7590435|NCT01317875|11996795|FG007|Overall Study|Adverse Event|5
7590436|NCT01317875|11996796|FG008|Overall Study|Adverse Event|0
7590437|NCT01317875|11996797|FG009|Overall Study|Adverse Event|0
7590438|NCT01216683|11996862|FG000|Induction|Never started treatment|0
7590439|NCT01216683|11996863|FG001|Induction|Never started treatment|6
7590440|NCT01216683|11996864|FG002|Induction|Never started treatment|3
7590441|NCT01216683|11996862|FG000|Induction|Lack of Efficacy|4
7590442|NCT01216683|11996863|FG001|Induction|Lack of Efficacy|3
7590443|NCT01216683|11996864|FG002|Induction|Lack of Efficacy|7
7590444|NCT01216683|11996862|FG000|Induction|Adverse Event|0
7590445|NCT01216683|11996863|FG001|Induction|Adverse Event|5
7590446|NCT01216683|11996864|FG002|Induction|Adverse Event|5
7590447|NCT01216683|11996862|FG000|Induction|Death|0
7590448|NCT01216683|11996863|FG001|Induction|Death|0
7590449|NCT01216683|11996864|FG002|Induction|Death|2
7590450|NCT01216683|11996862|FG000|Induction|Withdrawal by Subject|0
7590451|NCT01216683|11996863|FG001|Induction|Withdrawal by Subject|4
7590452|NCT01216683|11996864|FG002|Induction|Withdrawal by Subject|2
7590453|NCT01216683|11996862|FG000|Induction|Other disease|0
7590454|NCT01216683|11996863|FG001|Induction|Other disease|1
7590455|NCT01216683|11996864|FG002|Induction|Other disease|2
7270793|NCT00419744|11485160|FG002|Overall Study|Adverse Event|50
7270794|NCT00419744|11485158|FG000|Overall Study|Withdrawal by Subject|45
7270795|NCT00419744|11485159|FG001|Overall Study|Withdrawal by Subject|49
7270796|NCT00419744|11485160|FG002|Overall Study|Withdrawal by Subject|52
7590456|NCT01216683|11996862|FG000|Continuation|Lack of Efficacy|3
7590457|NCT01216683|11996863|FG001|Continuation|Lack of Efficacy|2
7590458|NCT01216683|11996864|FG002|Continuation|Lack of Efficacy|7
7590459|NCT01216683|11996862|FG000|Continuation|Adverse Event|5
7270797|NCT00419744|11485158|FG000|Overall Study|Lost to Follow-up|8
7270798|NCT00419744|11485159|FG001|Overall Study|Lost to Follow-up|10
7270799|NCT00419744|11485160|FG002|Overall Study|Lost to Follow-up|6
7270800|NCT00419744|11485158|FG000|Overall Study|Protocol Violation|4
7270801|NCT00419744|11485159|FG001|Overall Study|Protocol Violation|7
7270802|NCT00419744|11485160|FG002|Overall Study|Protocol Violation|8
7270803|NCT00419744|11485158|FG000|Overall Study|Randomized in error|9
7270804|NCT00419744|11485159|FG001|Overall Study|Randomized in error|6
7270805|NCT00419744|11485160|FG002|Overall Study|Randomized in error|7
7270806|NCT00419744|11485158|FG000|Overall Study|Moving out of state|2
7270807|NCT00419744|11485159|FG001|Overall Study|Moving out of state|0
7270808|NCT00419744|11485160|FG002|Overall Study|Moving out of state|1
7270809|NCT00419744|11485158|FG000|Overall Study|Physician Decision|10
7270810|NCT00419744|11485159|FG001|Overall Study|Physician Decision|5
7270811|NCT00419744|11485160|FG002|Overall Study|Physician Decision|6
7270812|NCT00419744|11485158|FG000|Overall Study|Spirometry mouthpiece issues|0
7270813|NCT00419744|11485159|FG001|Overall Study|Spirometry mouthpiece issues|1
7270814|NCT00419744|11485160|FG002|Overall Study|Spirometry mouthpiece issues|2
7270815|NCT00419744|11485158|FG000|Overall Study|Incorrect medication kit dispensed|0
7270816|NCT00419744|11485159|FG001|Overall Study|Incorrect medication kit dispensed|0
7270817|NCT00419744|11485160|FG002|Overall Study|Incorrect medication kit dispensed|1
7270818|NCT00419757|11485170|FG000|Overall Study|Adverse Event|1
7270819|NCT00419757|11485171|FG001|Overall Study|Adverse Event|4
7270820|NCT00419757|11485170|FG000|Overall Study|Lost to Follow-up|1
7270821|NCT00419757|11485171|FG001|Overall Study|Lost to Follow-up|4
7270822|NCT00419757|11485170|FG000|Overall Study|Withdrawal by Subject|7
7270823|NCT00419757|11485171|FG001|Overall Study|Withdrawal by Subject|1
7270824|NCT00419757|11485170|FG000|Overall Study|Protocol Violation|2
7270825|NCT00419757|11485171|FG001|Overall Study|Protocol Violation|3
7270826|NCT00419757|11485170|FG000|Overall Study|Study specific discontinuation criteria|4
7270827|NCT00419757|11485171|FG001|Overall Study|Study specific discontinuation criteria|8
7270828|NCT00419757|11485170|FG000|Overall Study|Multiple reasons|3
7270829|NCT00419757|11485171|FG001|Overall Study|Multiple reasons|1
7270830|NCT00419770|11485181|FG000|Overall Study|Withdrawal by Subject|5
7270831|NCT00419770|11485182|FG001|Overall Study|Withdrawal by Subject|1
7270832|NCT00419926|11485190|FG000|Overall Study|Withdrawal by Subject|7
7270833|NCT00419926|11485191|FG001|Overall Study|Withdrawal by Subject|3
7270834|NCT00419926|11485190|FG000|Overall Study|Administrative Problem|4
7270835|NCT00419926|11485191|FG001|Overall Study|Administrative Problem|4
7270836|NCT00419926|11485190|FG000|Overall Study|Lost to Follow-up|1
7270837|NCT00419926|11485191|FG001|Overall Study|Lost to Follow-up|2
7270838|NCT00419926|11485190|FG000|Overall Study|Death|2
7270839|NCT00419926|11485191|FG001|Overall Study|Death|1
7590460|NCT01216683|11996863|FG001|Continuation|Adverse Event|3
7590461|NCT01216683|11996864|FG002|Continuation|Adverse Event|16
7590462|NCT01216683|11996862|FG000|Continuation|Death|1
7590463|NCT01216683|11996863|FG001|Continuation|Death|0
7590464|NCT01216683|11996864|FG002|Continuation|Death|2
7590465|NCT01216683|11996862|FG000|Continuation|Withdrawal by Subject|4
7590466|NCT01216683|11996863|FG001|Continuation|Withdrawal by Subject|5
7590467|NCT01216683|11996864|FG002|Continuation|Withdrawal by Subject|9
7590468|NCT01216683|11996862|FG000|Continuation|Other diseases|0
7590469|NCT01216683|11996863|FG001|Continuation|Other diseases|2
7590470|NCT01216683|11996864|FG002|Continuation|Other diseases|1
7590471|NCT01216683|11996862|FG000|Continuation|Physician Decision|1
7590472|NCT01216683|11996863|FG001|Continuation|Physician Decision|0
7590473|NCT01216683|11996864|FG002|Continuation|Physician Decision|1
7590474|NCT01216683|11996862|FG000|Continuation|Non-compliance|1
7590475|NCT01216683|11996863|FG001|Continuation|Non-compliance|0
7590476|NCT01216683|11996864|FG002|Continuation|Non-compliance|1
7590477|NCT01216683|11996862|FG000|Continuation|Insurance change|0
7590478|NCT01216683|11996863|FG001|Continuation|Insurance change|1
7590479|NCT01216683|11996864|FG002|Continuation|Insurance change|0
7590480|NCT01216683|11996862|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
7590481|NCT01216683|11996863|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
7590482|NCT01216683|11996864|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
7590483|NCT01216683|11996862|FG000|Continuation|Not reported|0
7590484|NCT01216683|11996863|FG001|Continuation|Not reported|0
7590485|NCT01216683|11996864|FG002|Continuation|Not reported|1
7590486|NCT01216683|11996862|FG000|Continuation|Never started treatment|0
7590487|NCT01216683|11996863|FG001|Continuation|Never started treatment|1
7590488|NCT01216683|11996864|FG002|Continuation|Never started treatment|5
7590489|NCT01085097|11996888|FG000|Overall Study|Adverse Event|0
7590490|NCT01085097|11996889|FG001|Overall Study|Adverse Event|0
7590491|NCT01085097|11996890|FG002|Overall Study|Adverse Event|2
7590492|NCT01085097|11996888|FG000|Overall Study|Treatment failure|2
7590493|NCT01085097|11996889|FG001|Overall Study|Treatment failure|0
7590494|NCT01085097|11996890|FG002|Overall Study|Treatment failure|0
7590495|NCT00920621|11996902|FG000|Overall Study|Lost to Follow-up|16
7590496|NCT00920621|11996903|FG001|Overall Study|Lost to Follow-up|17
7590497|NCT00920621|11996904|FG002|Overall Study|Lost to Follow-up|19
7590498|NCT00920621|11996905|FG003|Overall Study|Lost to Follow-up|21
7590499|NCT00920621|11996902|FG000|Overall Study|Fetal/neonatal deaths|16
7590500|NCT00920621|11996903|FG001|Overall Study|Fetal/neonatal deaths|14
7590501|NCT00920621|11996904|FG002|Overall Study|Fetal/neonatal deaths|16
7590502|NCT00920621|11996905|FG003|Overall Study|Fetal/neonatal deaths|14
7590503|NCT00920621|11996902|FG000|Overall Study|Blood sample not collected|22
7590504|NCT00920621|11996903|FG001|Overall Study|Blood sample not collected|14
7590505|NCT00920621|11996904|FG002|Overall Study|Blood sample not collected|0
7590506|NCT00920621|11996905|FG003|Overall Study|Blood sample not collected|0
7626702|NCT01001234|12039125|FG002|Overall Study|Withdrawal by Subject|3
7626703|NCT01001234|12039126|FG003|Overall Study|Withdrawal by Subject|0
7626704|NCT01001234|12039127|FG004|Overall Study|Withdrawal by Subject|0
7626705|NCT01001234|12039123|FG000|Overall Study|Protocol Violation|34
7626706|NCT01001234|12039124|FG001|Overall Study|Protocol Violation|3
7626707|NCT01001234|12039125|FG002|Overall Study|Protocol Violation|19
7626708|NCT01001234|12039126|FG003|Overall Study|Protocol Violation|18
7626709|NCT01001234|12039127|FG004|Overall Study|Protocol Violation|0
7626710|NCT01001234|12039123|FG000|Overall Study|Lost to Follow-up|0
7626711|NCT01001234|12039124|FG001|Overall Study|Lost to Follow-up|0
7626712|NCT01001234|12039125|FG002|Overall Study|Lost to Follow-up|1
7626713|NCT01001234|12039126|FG003|Overall Study|Lost to Follow-up|2
7626714|NCT01001234|12039127|FG004|Overall Study|Lost to Follow-up|0
7626715|NCT01001234|12039123|FG000|Overall Study|Physician Decision|1
7626716|NCT01001234|12039124|FG001|Overall Study|Physician Decision|0
7626717|NCT01001234|12039125|FG002|Overall Study|Physician Decision|0
7626718|NCT01001234|12039126|FG003|Overall Study|Physician Decision|0
7626719|NCT01001234|12039127|FG004|Overall Study|Physician Decision|0
7626720|NCT01001234|12039123|FG000|Overall Study|Not Treated: Adverse Event|1
7626721|NCT01001234|12039124|FG001|Overall Study|Not Treated: Adverse Event|0
7626722|NCT01001234|12039125|FG002|Overall Study|Not Treated: Adverse Event|0
7626723|NCT01001234|12039126|FG003|Overall Study|Not Treated: Adverse Event|0
7626724|NCT01001234|12039127|FG004|Overall Study|Not Treated: Adverse Event|0
7626725|NCT01001234|12039123|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
7626726|NCT01001234|12039124|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
7626727|NCT01001234|12039125|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
7626728|NCT01001234|12039126|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
7626729|NCT01001234|12039127|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
7626730|NCT01001234|12039123|FG000|Overall Study|Not Treated: Protocol Violation|3
7626731|NCT01001234|12039124|FG001|Overall Study|Not Treated: Protocol Violation|0
7626732|NCT01001234|12039125|FG002|Overall Study|Not Treated: Protocol Violation|0
7626733|NCT01001234|12039126|FG003|Overall Study|Not Treated: Protocol Violation|0
7626734|NCT01001234|12039127|FG004|Overall Study|Not Treated: Protocol Violation|0
7626735|NCT01001234|12039123|FG000|Overall Study|Not Treated: Lost to Follow-up|53
7626736|NCT01001234|12039124|FG001|Overall Study|Not Treated: Lost to Follow-up|4
7626737|NCT01001234|12039125|FG002|Overall Study|Not Treated: Lost to Follow-up|7
7626738|NCT01001234|12039126|FG003|Overall Study|Not Treated: Lost to Follow-up|5
7626739|NCT01001234|12039127|FG004|Overall Study|Not Treated: Lost to Follow-up|0
7626740|NCT01001234|12039123|FG000|Overall Study|Not Treated: Pregnancy|3
7626741|NCT01001234|12039124|FG001|Overall Study|Not Treated: Pregnancy|0
7626742|NCT01001234|12039125|FG002|Overall Study|Not Treated: Pregnancy|0
7626743|NCT01001234|12039126|FG003|Overall Study|Not Treated: Pregnancy|0
7626744|NCT01001234|12039127|FG004|Overall Study|Not Treated: Pregnancy|0
7590507|NCT00500071|11996930|FG000|Screening and Washout Phase|Protocol Violation|1
7590508|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
7590509|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
7590510|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
7590511|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
7590512|NCT00500071|11996930|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
7590513|NCT00500071|11996930|FG000|30-day Safety Follow-up|Lost to Follow-up|17
7590514|NCT00447122|11996938|FG000|Overall Study|worsening medical condition -came off|0
7590515|NCT00447122|11996939|FG001|Overall Study|worsening medical condition -came off|1
7590516|NCT00447122|11996940|FG002|Overall Study|worsening medical condition -came off|0
7590517|NCT00447122|11996941|FG003|Overall Study|worsening medical condition -came off|0
7590518|NCT00382252|11996951|FG000|Overall Study|Death|4
7590519|NCT00382252|11996951|FG000|Overall Study|Protocol Violation|8
7590520|NCT00382252|11996951|FG000|Overall Study|Not treated by RFA|1
7590539|NCT00309985|11996983|FG000|Overall Study|Disease progression|12
7590540|NCT00309985|11996984|FG001|Overall Study|Disease progression|0
7590541|NCT00309985|11996983|FG000|Overall Study|Adverse Event|30
7590542|NCT00309985|11996984|FG001|Overall Study|Adverse Event|0
7590543|NCT00309985|11996983|FG000|Overall Study|Death|2
7590544|NCT00309985|11996984|FG001|Overall Study|Death|0
7590545|NCT00309985|11996983|FG000|Overall Study|Withdrawal by Subject|5
7590546|NCT00309985|11996984|FG001|Overall Study|Withdrawal by Subject|1
7590547|NCT00309985|11996983|FG000|Overall Study|Physician Decision|3
7590548|NCT00309985|11996984|FG001|Overall Study|Physician Decision|0
7590549|NCT00309985|11996983|FG000|Overall Study|Never started treatment|7
7590550|NCT00309985|11996984|FG001|Overall Study|Never started treatment|0
7590551|NCT00309985|11996983|FG000|Overall Study|Complicating disease|1
7590552|NCT00309985|11996984|FG001|Overall Study|Complicating disease|0
7590553|NCT00309985|11996983|FG000|Overall Study|Non-compliance|1
7590554|NCT00309985|11996984|FG001|Overall Study|Non-compliance|0
7590555|NCT00309985|11996983|FG000|Overall Study|Chemotherapy discontinued only|1
7590556|NCT00309985|11996984|FG001|Overall Study|Chemotherapy discontinued only|0
7590557|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590558|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590559|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590560|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7590561|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
7270840|NCT00419952|11485199|FG000|Overall Study|Adverse Event|8
7270841|NCT00419952|11485200|FG001|Overall Study|Adverse Event|10
7270842|NCT00419952|11485199|FG000|Overall Study|Withdrawal by Subject|44
7270843|NCT00419952|11485200|FG001|Overall Study|Withdrawal by Subject|43
7270844|NCT00419952|11485199|FG000|Overall Study|Lost to Follow-up|43
7270845|NCT00419952|11485200|FG001|Overall Study|Lost to Follow-up|34
7270846|NCT00419952|11485199|FG000|Overall Study|Protocol Violation|32
7270847|NCT00419952|11485200|FG001|Overall Study|Protocol Violation|24
7590562|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2
7590563|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|headache|0
7590564|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|headache|0
7590565|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|headache|0
7590566|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|headache|0
7590567|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|headache|1
7590568|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|headache|0
7590569|NCT00290251|11996993|FG000|Treatment 1 (Months 2-4)|Out of body experience|0
7590570|NCT00290251|11996994|FG001|Treatment 1 (Months 2-4)|Out of body experience|0
7590571|NCT00290251|11996995|FG002|Treatment 1 (Months 2-4)|Out of body experience|0
7590572|NCT00290251|11996996|FG003|Treatment 1 (Months 2-4)|Out of body experience|1
7590573|NCT00290251|11996997|FG004|Treatment 1 (Months 2-4)|Out of body experience|0
7590574|NCT00290251|11996998|FG005|Treatment 1 (Months 2-4)|Out of body experience|0
7626745|NCT01001234|12039123|FG000|Overall Study|Not Treated: Physician Decision|37
7626746|NCT01001234|12039124|FG001|Overall Study|Not Treated: Physician Decision|4
7626747|NCT01001234|12039125|FG002|Overall Study|Not Treated: Physician Decision|0
7626748|NCT01001234|12039126|FG003|Overall Study|Not Treated: Physician Decision|0
7626749|NCT01001234|12039127|FG004|Overall Study|Not Treated: Physician Decision|0
7626750|NCT01001234|12039123|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
7626751|NCT01001234|12039124|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
7626752|NCT01001234|12039125|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
7626753|NCT01001234|12039126|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
7626754|NCT01001234|12039127|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
7626755|NCT00924170|12039135|FG000|Overall Study|Refused further treatment|0
7626756|NCT00924170|12039136|FG001|Overall Study|Refused further treatment|1
7626757|NCT00924170|12039135|FG000|Overall Study|Physician Decision|0
7626758|NCT00924170|12039136|FG001|Overall Study|Physician Decision|1
7626759|NCT00924170|12039135|FG000|Overall Study|Progressive disease|3
7626760|NCT00924170|12039136|FG001|Overall Study|Progressive disease|6
7626761|NCT00924170|12039135|FG000|Overall Study|Stopped due to neutralizing antibodies|3
7626762|NCT00924170|12039136|FG001|Overall Study|Stopped due to neutralizing antibodies|0
7626763|NCT00924170|12039135|FG000|Overall Study|Death|1
7626764|NCT00924170|12039136|FG001|Overall Study|Death|0
7626765|NCT00894556|12039151|FG000|Baseline Phase|Did not meet Randomization Criteria|0
7626766|NCT00894556|12039152|FG001|Baseline Phase|Did not meet Randomization Criteria|0
7626767|NCT00894556|12039153|FG002|Baseline Phase|Did not meet Randomization Criteria|0
7626768|NCT00894556|12039154|FG003|Baseline Phase|Did not meet Randomization Criteria|85
7626769|NCT00894556|12039151|FG000|Treatment Phase|Lost to Follow-up|2
7626770|NCT00894556|12039152|FG001|Treatment Phase|Lost to Follow-up|3
7626771|NCT00894556|12039153|FG002|Treatment Phase|Lost to Follow-up|1
7626772|NCT00894556|12039154|FG003|Treatment Phase|Lost to Follow-up|0
7626773|NCT00894556|12039151|FG000|Treatment Phase|Lack of Qualifying Event|2
7626774|NCT00894556|12039152|FG001|Treatment Phase|Lack of Qualifying Event|1
7626775|NCT00894556|12039153|FG002|Treatment Phase|Lack of Qualifying Event|0
7626776|NCT00894556|12039154|FG003|Treatment Phase|Lack of Qualifying Event|0
7626777|NCT00840177|12039164|FG000|Overall Study|Adverse Event|5
7626778|NCT00840177|12039165|FG001|Overall Study|Adverse Event|1
7626779|NCT00840177|12039166|FG002|Overall Study|Adverse Event|1
7626780|NCT00840177|12039164|FG000|Overall Study|Refusal unrelated to adverse events|1
7626781|NCT00840177|12039165|FG001|Overall Study|Refusal unrelated to adverse events|0
7626782|NCT00840177|12039166|FG002|Overall Study|Refusal unrelated to adverse events|1
7626783|NCT00840177|12039164|FG000|Overall Study|Progression/relapse|2
7626784|NCT00840177|12039165|FG001|Overall Study|Progression/relapse|0
7626785|NCT00840177|12039166|FG002|Overall Study|Progression/relapse|0
7626786|NCT00840177|12039164|FG000|Overall Study|Death|4
7626787|NCT00840177|12039165|FG001|Overall Study|Death|5
7626788|NCT00840177|12039166|FG002|Overall Study|Death|5
7626789|NCT00840177|12039164|FG000|Overall Study|not protocol specified|6
7626790|NCT00840177|12039165|FG001|Overall Study|not protocol specified|3
7626791|NCT00840177|12039166|FG002|Overall Study|not protocol specified|0
7626792|NCT00840177|12039164|FG000|Overall Study|Ineligible|0
7626793|NCT00840177|12039165|FG001|Overall Study|Ineligible|0
7626794|NCT00840177|12039166|FG002|Overall Study|Ineligible|3
7626795|NCT00840177|12039164|FG000|Overall Study|Did not start treatment|0
7626796|NCT00840177|12039165|FG001|Overall Study|Did not start treatment|0
7626797|NCT00840177|12039166|FG002|Overall Study|Did not start treatment|1
7590575|NCT01403948|11997034|FG000|Overall Study|Progressive disease|0
7590576|NCT01403948|11997035|FG001|Overall Study|Progressive disease|2
7590577|NCT01403948|11997036|FG002|Overall Study|Progressive disease|2
7590578|NCT01403948|11997037|FG003|Overall Study|Progressive disease|4
7590579|NCT01403948|11997038|FG004|Overall Study|Progressive disease|2
7590580|NCT01403948|11997039|FG005|Overall Study|Progressive disease|6
7590581|NCT01403948|11997040|FG006|Overall Study|Progressive disease|2
7590582|NCT01403948|11997041|FG007|Overall Study|Progressive disease|4
7590583|NCT01403948|11997042|FG008|Overall Study|Progressive disease|5
7590584|NCT01403948|11997043|FG009|Overall Study|Progressive disease|5
7590585|NCT01403948|11997034|FG000|Overall Study|Other Adverse Event (Other than DLT)|0
7590586|NCT01403948|11997035|FG001|Overall Study|Other Adverse Event (Other than DLT)|0
7590587|NCT01403948|11997036|FG002|Overall Study|Other Adverse Event (Other than DLT)|0
7590588|NCT01403948|11997037|FG003|Overall Study|Other Adverse Event (Other than DLT)|0
7590589|NCT01403948|11997038|FG004|Overall Study|Other Adverse Event (Other than DLT)|2
7590590|NCT01403948|11997039|FG005|Overall Study|Other Adverse Event (Other than DLT)|0
7590591|NCT01403948|11997040|FG006|Overall Study|Other Adverse Event (Other than DLT)|2
7590592|NCT01403948|11997041|FG007|Overall Study|Other Adverse Event (Other than DLT)|0
7590593|NCT01403948|11997042|FG008|Overall Study|Other Adverse Event (Other than DLT)|1
7590594|NCT01403948|11997043|FG009|Overall Study|Other Adverse Event (Other than DLT)|0
7590595|NCT01403948|11997034|FG000|Overall Study|Lost to Follow-up|0
7590596|NCT01403948|11997035|FG001|Overall Study|Lost to Follow-up|0
7590597|NCT01403948|11997036|FG002|Overall Study|Lost to Follow-up|0
7590598|NCT01403948|11997037|FG003|Overall Study|Lost to Follow-up|0
7590599|NCT01403948|11997038|FG004|Overall Study|Lost to Follow-up|0
7590600|NCT01403948|11997039|FG005|Overall Study|Lost to Follow-up|0
7590601|NCT01403948|11997040|FG006|Overall Study|Lost to Follow-up|0
7590602|NCT01403948|11997041|FG007|Overall Study|Lost to Follow-up|0
7590603|NCT01403948|11997042|FG008|Overall Study|Lost to Follow-up|0
7590604|NCT01403948|11997043|FG009|Overall Study|Lost to Follow-up|1
7590605|NCT01403948|11997034|FG000|Overall Study|Refused cont. medication|0
7590606|NCT01403948|11997035|FG001|Overall Study|Refused cont. medication|0
7590607|NCT01403948|11997036|FG002|Overall Study|Refused cont. medication|0
7590608|NCT01403948|11997037|FG003|Overall Study|Refused cont. medication|0
7590609|NCT01403948|11997038|FG004|Overall Study|Refused cont. medication|1
7590610|NCT01403948|11997039|FG005|Overall Study|Refused cont. medication|0
7590611|NCT01403948|11997040|FG006|Overall Study|Refused cont. medication|0
7590612|NCT01403948|11997041|FG007|Overall Study|Refused cont. medication|0
7590613|NCT01403948|11997042|FG008|Overall Study|Refused cont. medication|0
7590614|NCT01403948|11997043|FG009|Overall Study|Refused cont. medication|1
7590615|NCT01403948|11997034|FG000|Overall Study|other than above|1
7590616|NCT01403948|11997035|FG001|Overall Study|other than above|2
7590617|NCT01403948|11997036|FG002|Overall Study|other than above|1
7590618|NCT01403948|11997037|FG003|Overall Study|other than above|0
7590619|NCT01403948|11997038|FG004|Overall Study|other than above|1
7590620|NCT01403948|11997039|FG005|Overall Study|other than above|1
7590621|NCT01403948|11997040|FG006|Overall Study|other than above|2
7590622|NCT01403948|11997041|FG007|Overall Study|other than above|0
7590623|NCT01403948|11997042|FG008|Overall Study|other than above|0
7590624|NCT01403948|11997043|FG009|Overall Study|other than above|0
7626798|NCT00820950|12039179|FG000|Overall Study|Scheduling Conflict|0
7626799|NCT00820950|12039180|FG001|Overall Study|Scheduling Conflict|0
7626800|NCT00820950|12039181|FG002|Overall Study|Scheduling Conflict|0
7626801|NCT00820950|12039182|FG003|Overall Study|Scheduling Conflict|0
7626802|NCT00820950|12039183|FG004|Overall Study|Scheduling Conflict|0
7626803|NCT00820950|12039184|FG005|Overall Study|Scheduling Conflict|0
7626804|NCT00820950|12039185|FG006|Overall Study|Scheduling Conflict|1
7626805|NCT00820950|12039186|FG007|Overall Study|Scheduling Conflict|1
7626806|NCT00820950|12039187|FG008|Overall Study|Scheduling Conflict|0
7626807|NCT00820950|12039188|FG009|Overall Study|Scheduling Conflict|0
7626808|NCT00820950|12039179|FG000|Overall Study|Protocol Violation|1
7626809|NCT00820950|12039180|FG001|Overall Study|Protocol Violation|1
7626810|NCT00820950|12039181|FG002|Overall Study|Protocol Violation|0
7626811|NCT00820950|12039182|FG003|Overall Study|Protocol Violation|0
7626812|NCT00820950|12039183|FG004|Overall Study|Protocol Violation|0
7626813|NCT00820950|12039184|FG005|Overall Study|Protocol Violation|0
7626814|NCT00820950|12039185|FG006|Overall Study|Protocol Violation|0
7626815|NCT00820950|12039186|FG007|Overall Study|Protocol Violation|0
7626816|NCT00820950|12039187|FG008|Overall Study|Protocol Violation|0
7626817|NCT00820950|12039188|FG009|Overall Study|Protocol Violation|0
7626818|NCT00806416|12039230|FG000|Period 1 - Part I|Adverse Event|0
7626819|NCT00806416|12039231|FG001|Period 1 - Part I|Adverse Event|1
7626820|NCT00806416|12039232|FG002|Period 1 - Part I|Adverse Event|0
7626821|NCT00806416|12039233|FG003|Period 1 - Part I|Adverse Event|0
7626822|NCT00806416|12039230|FG000|Period 1 - Part I|Lost to Follow-up|0
7626823|NCT00806416|12039231|FG001|Period 1 - Part I|Lost to Follow-up|2
7626824|NCT00806416|12039232|FG002|Period 1 - Part I|Lost to Follow-up|0
7626825|NCT00806416|12039233|FG003|Period 1 - Part I|Lost to Follow-up|0
7626826|NCT00806416|12039230|FG000|Period 1 - Part I|Withdrawal by Subject|3
7626827|NCT00806416|12039231|FG001|Period 1 - Part I|Withdrawal by Subject|1
7626828|NCT00806416|12039232|FG002|Period 1 - Part I|Withdrawal by Subject|0
7626829|NCT00806416|12039233|FG003|Period 1 - Part I|Withdrawal by Subject|0
7626830|NCT00806416|12039230|FG000|Period 1 - Part II|Withdrawal by Subject|0
7626831|NCT00806416|12039231|FG001|Period 1 - Part II|Withdrawal by Subject|0
7626832|NCT00806416|12039232|FG002|Period 1 - Part II|Withdrawal by Subject|0
7626833|NCT00806416|12039233|FG003|Period 1 - Part II|Withdrawal by Subject|2
7590625|NCT01404312|11997071|FG000|Overall Study|Death|21
7590626|NCT01404312|11997072|FG001|Overall Study|Death|27
7590627|NCT01404312|11997071|FG000|Overall Study|Withdrawal by Subject|15
7590628|NCT01404312|11997072|FG001|Overall Study|Withdrawal by Subject|18
7590629|NCT01404312|11997071|FG000|Overall Study|Participant Unable to get to clinic|93
7590630|NCT01404312|11997072|FG001|Overall Study|Participant Unable to get to clinic|103
7590631|NCT01404312|11997071|FG000|Overall Study|Lost to Follow-up|115
7590632|NCT01404312|11997072|FG001|Overall Study|Lost to Follow-up|111
7590633|NCT01404312|11997071|FG000|Overall Study|Site closed|22
7590634|NCT01404312|11997072|FG001|Overall Study|Site closed|21
7590635|NCT01404312|11997071|FG000|Overall Study|Participant not willing to adhere to req|31
7590636|NCT01404312|11997072|FG001|Overall Study|Participant not willing to adhere to req|29
7590637|NCT01404312|11997071|FG000|Overall Study|Severe debilitation, unable to continue|1
7590638|NCT01404312|11997072|FG001|Overall Study|Severe debilitation, unable to continue|2
7626834|NCT00729651|12039243|FG000|Overall Study|Withdrawal by Subject|5
7626835|NCT00729651|12039244|FG001|Overall Study|Withdrawal by Subject|6
7626836|NCT00729651|12039243|FG000|Overall Study|Lost to Follow-up|5
7626837|NCT00729651|12039244|FG001|Overall Study|Lost to Follow-up|4
7626838|NCT00729651|12039243|FG000|Overall Study|Protocol Violation|0
7626839|NCT00729651|12039244|FG001|Overall Study|Protocol Violation|1
7626840|NCT00729651|12039243|FG000|Overall Study|Adverse Event|7
7626841|NCT00729651|12039244|FG001|Overall Study|Adverse Event|3
7626842|NCT00729651|12039243|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
7626843|NCT00729651|12039244|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
7626844|NCT00729651|12039243|FG000|Overall Study|Subject's private reason|2
7626845|NCT00729651|12039244|FG001|Overall Study|Subject's private reason|0
7626846|NCT00698815|12039253|FG000|Overall Study|Death|1
7626847|NCT00698815|12039254|FG001|Overall Study|Death|2
7626848|NCT00698815|12039255|FG002|Overall Study|Death|4
7626849|NCT00698815|12039253|FG000|Overall Study|Withdrawal by Subject|6
7626850|NCT00698815|12039254|FG001|Overall Study|Withdrawal by Subject|3
7626851|NCT00698815|12039255|FG002|Overall Study|Withdrawal by Subject|2
7626852|NCT00698815|12039253|FG000|Overall Study|MD discretion|2
7626853|NCT00698815|12039254|FG001|Overall Study|MD discretion|7
7626854|NCT00698815|12039255|FG002|Overall Study|MD discretion|2
7626855|NCT00698815|12039253|FG000|Overall Study|Did not receive protocol treatment|1
7626856|NCT00698815|12039254|FG001|Overall Study|Did not receive protocol treatment|2
7626857|NCT00698815|12039255|FG002|Overall Study|Did not receive protocol treatment|2
7626858|NCT00692913|12039278|FG000|Overall Study|Adverse Event|8
7626859|NCT00692913|12039279|FG001|Overall Study|Adverse Event|4
7626860|NCT00692913|12039278|FG000|Overall Study|Lost to Follow-up|3
7626861|NCT00692913|12039279|FG001|Overall Study|Lost to Follow-up|5
7626862|NCT00692913|12039278|FG000|Overall Study|Physician Decision|2
7626863|NCT00692913|12039279|FG001|Overall Study|Physician Decision|0
7626864|NCT00692913|12039278|FG000|Overall Study|Protocol Violation|1
7626865|NCT00692913|12039279|FG001|Overall Study|Protocol Violation|1
7626866|NCT00692913|12039278|FG000|Overall Study|Withdrawal by Subject|15
7626867|NCT00692913|12039279|FG001|Overall Study|Withdrawal by Subject|20
7626868|NCT00617708|12039325|FG000|Overall Study|Adverse Event|0
7626869|NCT00617708|12039326|FG001|Overall Study|Adverse Event|6
7590639|NCT01425008|11997098|FG000|Dose Escalation Phase|Progressive Disease|2
7590640|NCT01425008|11997099|FG001|Dose Escalation Phase|Progressive Disease|3
7590641|NCT01425008|11997100|FG002|Dose Escalation Phase|Progressive Disease|2
7590642|NCT01425008|11997101|FG003|Dose Escalation Phase|Progressive Disease|3
7590643|NCT01425008|11997102|FG004|Dose Escalation Phase|Progressive Disease|5
7590644|NCT01425008|11997103|FG005|Dose Escalation Phase|Progressive Disease|4
7590645|NCT01425008|11997104|FG006|Dose Escalation Phase|Progressive Disease|0
7590646|NCT01425008|11997105|FG007|Dose Escalation Phase|Progressive Disease|2
7590647|NCT01425008|11997106|FG008|Dose Escalation Phase|Progressive Disease|6
7590648|NCT01425008|11997107|FG009|Dose Escalation Phase|Progressive Disease|2
7590649|NCT01425008|11997108|FG010|Dose Escalation Phase|Progressive Disease|0
7590650|NCT01425008|11997109|FG011|Dose Escalation Phase|Progressive Disease|0
7590651|NCT01425008|11997110|FG012|Dose Escalation Phase|Progressive Disease|0
7590652|NCT01425008|11997111|FG013|Dose Escalation Phase|Progressive Disease|0
7590653|NCT01425008|11997112|FG014|Dose Escalation Phase|Progressive Disease|0
7590654|NCT01425008|11997113|FG015|Dose Escalation Phase|Progressive Disease|0
7590655|NCT01425008|11997114|FG016|Dose Escalation Phase|Progressive Disease|0
7590656|NCT01425008|11997115|FG017|Dose Escalation Phase|Progressive Disease|0
7590657|NCT01425008|11997116|FG018|Dose Escalation Phase|Progressive Disease|0
7590658|NCT01425008|11997098|FG000|Dose Escalation Phase|Adverse Event|2
7590659|NCT01425008|11997099|FG001|Dose Escalation Phase|Adverse Event|0
7590660|NCT01425008|11997100|FG002|Dose Escalation Phase|Adverse Event|0
7590661|NCT01425008|11997101|FG003|Dose Escalation Phase|Adverse Event|0
7590662|NCT01425008|11997102|FG004|Dose Escalation Phase|Adverse Event|0
7590663|NCT01425008|11997103|FG005|Dose Escalation Phase|Adverse Event|2
7590664|NCT01425008|11997104|FG006|Dose Escalation Phase|Adverse Event|0
7590665|NCT01425008|11997105|FG007|Dose Escalation Phase|Adverse Event|0
7590666|NCT01425008|11997106|FG008|Dose Escalation Phase|Adverse Event|2
7590667|NCT01425008|11997107|FG009|Dose Escalation Phase|Adverse Event|0
7590668|NCT01425008|11997108|FG010|Dose Escalation Phase|Adverse Event|0
7590669|NCT01425008|11997109|FG011|Dose Escalation Phase|Adverse Event|0
7590670|NCT01425008|11997110|FG012|Dose Escalation Phase|Adverse Event|0
7590671|NCT01425008|11997111|FG013|Dose Escalation Phase|Adverse Event|0
7590672|NCT01425008|11997112|FG014|Dose Escalation Phase|Adverse Event|0
7590673|NCT01425008|11997113|FG015|Dose Escalation Phase|Adverse Event|0
7590674|NCT01425008|11997114|FG016|Dose Escalation Phase|Adverse Event|0
7590675|NCT01425008|11997115|FG017|Dose Escalation Phase|Adverse Event|0
7590676|NCT01425008|11997116|FG018|Dose Escalation Phase|Adverse Event|0
7590677|NCT01425008|11997098|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590678|NCT01425008|11997099|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7270848|NCT00419952|11485199|FG000|Overall Study|Pregnancy|4
7270849|NCT00419952|11485200|FG001|Overall Study|Pregnancy|2
7270850|NCT00419952|11485199|FG000|Overall Study|Physician Decision|1
7270851|NCT00419952|11485200|FG001|Overall Study|Physician Decision|3
7270852|NCT00419952|11485199|FG000|Overall Study|Incorrectly enrolled|10
7590679|NCT01425008|11997100|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590680|NCT01425008|11997101|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590681|NCT01425008|11997102|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590682|NCT01425008|11997103|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590683|NCT01425008|11997104|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
7590684|NCT01425008|11997105|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590685|NCT01425008|11997106|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
7590686|NCT01425008|11997107|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590687|NCT01425008|11997108|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590688|NCT01425008|11997109|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590689|NCT01425008|11997110|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590690|NCT01425008|11997111|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590691|NCT01425008|11997112|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590692|NCT01425008|11997113|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590693|NCT01425008|11997114|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590694|NCT01425008|11997115|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590695|NCT01425008|11997116|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
7590696|NCT01425008|11997098|FG000|Dose Escalation Phase|Withdrawal by Subject|0
7590697|NCT01425008|11997099|FG001|Dose Escalation Phase|Withdrawal by Subject|0
7590698|NCT01425008|11997100|FG002|Dose Escalation Phase|Withdrawal by Subject|0
7590699|NCT01425008|11997101|FG003|Dose Escalation Phase|Withdrawal by Subject|0
7590700|NCT01425008|11997102|FG004|Dose Escalation Phase|Withdrawal by Subject|1
7590701|NCT01425008|11997103|FG005|Dose Escalation Phase|Withdrawal by Subject|1
7590702|NCT01425008|11997104|FG006|Dose Escalation Phase|Withdrawal by Subject|1
7590703|NCT01425008|11997105|FG007|Dose Escalation Phase|Withdrawal by Subject|0
7590704|NCT01425008|11997106|FG008|Dose Escalation Phase|Withdrawal by Subject|1
7590705|NCT01425008|11997107|FG009|Dose Escalation Phase|Withdrawal by Subject|0
7590706|NCT01425008|11997108|FG010|Dose Escalation Phase|Withdrawal by Subject|0
7590707|NCT01425008|11997109|FG011|Dose Escalation Phase|Withdrawal by Subject|0
7590708|NCT01425008|11997110|FG012|Dose Escalation Phase|Withdrawal by Subject|0
7590709|NCT01425008|11997111|FG013|Dose Escalation Phase|Withdrawal by Subject|0
7590710|NCT01425008|11997112|FG014|Dose Escalation Phase|Withdrawal by Subject|0
7590711|NCT01425008|11997113|FG015|Dose Escalation Phase|Withdrawal by Subject|0
7590712|NCT01425008|11997114|FG016|Dose Escalation Phase|Withdrawal by Subject|0
7590713|NCT01425008|11997115|FG017|Dose Escalation Phase|Withdrawal by Subject|0
7590714|NCT01425008|11997116|FG018|Dose Escalation Phase|Withdrawal by Subject|0
7590715|NCT01425008|11997098|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
7590716|NCT01425008|11997099|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
7590717|NCT01425008|11997100|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
7590718|NCT01425008|11997101|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
7590719|NCT01425008|11997102|FG004|Dose Escalation Phase|Symptomatic Deterioration|0
7590720|NCT01425008|11997103|FG005|Dose Escalation Phase|Symptomatic Deterioration|0
7590721|NCT01425008|11997104|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
7590722|NCT01425008|11997105|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
7590723|NCT01425008|11997106|FG008|Dose Escalation Phase|Symptomatic Deterioration|2
7590724|NCT01425008|11997107|FG009|Dose Escalation Phase|Symptomatic Deterioration|2
7590725|NCT01425008|11997108|FG010|Dose Escalation Phase|Symptomatic Deterioration|0
7590726|NCT01425008|11997109|FG011|Dose Escalation Phase|Symptomatic Deterioration|0
7590727|NCT01425008|11997110|FG012|Dose Escalation Phase|Symptomatic Deterioration|0
7590728|NCT01425008|11997111|FG013|Dose Escalation Phase|Symptomatic Deterioration|0
7590729|NCT01425008|11997112|FG014|Dose Escalation Phase|Symptomatic Deterioration|0
7590730|NCT01425008|11997113|FG015|Dose Escalation Phase|Symptomatic Deterioration|0
7590731|NCT01425008|11997114|FG016|Dose Escalation Phase|Symptomatic Deterioration|0
7590732|NCT01425008|11997115|FG017|Dose Escalation Phase|Symptomatic Deterioration|0
7590733|NCT01425008|11997116|FG018|Dose Escalation Phase|Symptomatic Deterioration|0
7590734|NCT01425008|11997098|FG000|Dose Escalation Phase|Other|0
7590735|NCT01425008|11997099|FG001|Dose Escalation Phase|Other|0
7590736|NCT01425008|11997100|FG002|Dose Escalation Phase|Other|0
7590737|NCT01425008|11997101|FG003|Dose Escalation Phase|Other|0
7590738|NCT01425008|11997102|FG004|Dose Escalation Phase|Other|0
7590739|NCT01425008|11997103|FG005|Dose Escalation Phase|Other|0
7590740|NCT01425008|11997104|FG006|Dose Escalation Phase|Other|0
7590741|NCT01425008|11997105|FG007|Dose Escalation Phase|Other|0
7590742|NCT01425008|11997106|FG008|Dose Escalation Phase|Other|1
7590743|NCT01425008|11997107|FG009|Dose Escalation Phase|Other|0
7590744|NCT01425008|11997108|FG010|Dose Escalation Phase|Other|0
7590745|NCT01425008|11997109|FG011|Dose Escalation Phase|Other|0
7590746|NCT01425008|11997110|FG012|Dose Escalation Phase|Other|0
7590747|NCT01425008|11997111|FG013|Dose Escalation Phase|Other|0
7590748|NCT01425008|11997112|FG014|Dose Escalation Phase|Other|0
7590749|NCT01425008|11997113|FG015|Dose Escalation Phase|Other|0
7590750|NCT01425008|11997114|FG016|Dose Escalation Phase|Other|0
7590751|NCT01425008|11997115|FG017|Dose Escalation Phase|Other|0
7590752|NCT01425008|11997116|FG018|Dose Escalation Phase|Other|0
7590753|NCT01425008|11997098|FG000|Dose Expansion Phase|Progressive Disease|0
7590754|NCT01425008|11997099|FG001|Dose Expansion Phase|Progressive Disease|0
7590755|NCT01425008|11997100|FG002|Dose Expansion Phase|Progressive Disease|0
7590756|NCT01425008|11997101|FG003|Dose Expansion Phase|Progressive Disease|0
7590757|NCT01425008|11997102|FG004|Dose Expansion Phase|Progressive Disease|0
7590758|NCT01425008|11997103|FG005|Dose Expansion Phase|Progressive Disease|0
7590759|NCT01425008|11997104|FG006|Dose Expansion Phase|Progressive Disease|0
7590760|NCT01425008|11997105|FG007|Dose Expansion Phase|Progressive Disease|0
7590761|NCT01425008|11997106|FG008|Dose Expansion Phase|Progressive Disease|0
7590762|NCT01425008|11997107|FG009|Dose Expansion Phase|Progressive Disease|0
7590763|NCT01425008|11997108|FG010|Dose Expansion Phase|Progressive Disease|10
7590764|NCT01425008|11997109|FG011|Dose Expansion Phase|Progressive Disease|4
7590765|NCT01425008|11997110|FG012|Dose Expansion Phase|Progressive Disease|12
7590766|NCT01425008|11997111|FG013|Dose Expansion Phase|Progressive Disease|1
7590767|NCT01425008|11997112|FG014|Dose Expansion Phase|Progressive Disease|5
7590768|NCT01425008|11997113|FG015|Dose Expansion Phase|Progressive Disease|8
7590769|NCT01425008|11997114|FG016|Dose Expansion Phase|Progressive Disease|9
7590770|NCT01425008|11997115|FG017|Dose Expansion Phase|Progressive Disease|2
7590771|NCT01425008|11997116|FG018|Dose Expansion Phase|Progressive Disease|10
7590772|NCT01425008|11997098|FG000|Dose Expansion Phase|Withdrawal by Subject|0
7590773|NCT01425008|11997099|FG001|Dose Expansion Phase|Withdrawal by Subject|0
7590774|NCT01425008|11997100|FG002|Dose Expansion Phase|Withdrawal by Subject|0
7590775|NCT01425008|11997101|FG003|Dose Expansion Phase|Withdrawal by Subject|0
7590776|NCT01425008|11997102|FG004|Dose Expansion Phase|Withdrawal by Subject|0
7590777|NCT01425008|11997103|FG005|Dose Expansion Phase|Withdrawal by Subject|0
7590778|NCT01425008|11997104|FG006|Dose Expansion Phase|Withdrawal by Subject|0
7590779|NCT01425008|11997105|FG007|Dose Expansion Phase|Withdrawal by Subject|0
7590780|NCT01425008|11997106|FG008|Dose Expansion Phase|Withdrawal by Subject|0
7590781|NCT01425008|11997107|FG009|Dose Expansion Phase|Withdrawal by Subject|0
7590782|NCT01425008|11997108|FG010|Dose Expansion Phase|Withdrawal by Subject|1
7590783|NCT01425008|11997109|FG011|Dose Expansion Phase|Withdrawal by Subject|0
7590784|NCT01425008|11997110|FG012|Dose Expansion Phase|Withdrawal by Subject|0
7590785|NCT01425008|11997111|FG013|Dose Expansion Phase|Withdrawal by Subject|0
7590786|NCT01425008|11997112|FG014|Dose Expansion Phase|Withdrawal by Subject|0
7590787|NCT01425008|11997113|FG015|Dose Expansion Phase|Withdrawal by Subject|1
7590788|NCT01425008|11997114|FG016|Dose Expansion Phase|Withdrawal by Subject|1
7590789|NCT01425008|11997115|FG017|Dose Expansion Phase|Withdrawal by Subject|0
7590790|NCT01425008|11997116|FG018|Dose Expansion Phase|Withdrawal by Subject|0
7590791|NCT01425008|11997098|FG000|Dose Expansion Phase|Other|0
7590792|NCT01425008|11997099|FG001|Dose Expansion Phase|Other|0
7590793|NCT01425008|11997100|FG002|Dose Expansion Phase|Other|0
7590794|NCT01425008|11997101|FG003|Dose Expansion Phase|Other|0
7590795|NCT01425008|11997102|FG004|Dose Expansion Phase|Other|0
7590796|NCT01425008|11997103|FG005|Dose Expansion Phase|Other|0
7590797|NCT01425008|11997104|FG006|Dose Expansion Phase|Other|0
7590798|NCT01425008|11997105|FG007|Dose Expansion Phase|Other|0
7590799|NCT01425008|11997106|FG008|Dose Expansion Phase|Other|0
7590800|NCT01425008|11997107|FG009|Dose Expansion Phase|Other|0
7590801|NCT01425008|11997108|FG010|Dose Expansion Phase|Other|0
7590802|NCT01425008|11997109|FG011|Dose Expansion Phase|Other|0
7590803|NCT01425008|11997110|FG012|Dose Expansion Phase|Other|1
7590804|NCT01425008|11997111|FG013|Dose Expansion Phase|Other|0
7590805|NCT01425008|11997112|FG014|Dose Expansion Phase|Other|0
7590806|NCT01425008|11997113|FG015|Dose Expansion Phase|Other|0
7590807|NCT01425008|11997114|FG016|Dose Expansion Phase|Other|2
7590808|NCT01425008|11997115|FG017|Dose Expansion Phase|Other|0
7590809|NCT01425008|11997116|FG018|Dose Expansion Phase|Other|4
7590810|NCT01425008|11997098|FG000|Dose Expansion Phase|Symptomatic Deterioration|0
7590811|NCT01425008|11997099|FG001|Dose Expansion Phase|Symptomatic Deterioration|0
7590812|NCT01425008|11997100|FG002|Dose Expansion Phase|Symptomatic Deterioration|0
7590813|NCT01425008|11997101|FG003|Dose Expansion Phase|Symptomatic Deterioration|0
7590814|NCT01425008|11997102|FG004|Dose Expansion Phase|Symptomatic Deterioration|0
7590815|NCT01425008|11997103|FG005|Dose Expansion Phase|Symptomatic Deterioration|0
7590816|NCT01425008|11997104|FG006|Dose Expansion Phase|Symptomatic Deterioration|0
7590817|NCT01425008|11997105|FG007|Dose Expansion Phase|Symptomatic Deterioration|0
7590818|NCT01425008|11997106|FG008|Dose Expansion Phase|Symptomatic Deterioration|0
7590819|NCT01425008|11997107|FG009|Dose Expansion Phase|Symptomatic Deterioration|0
7590893|NCT03861481|11997197|FG000|Overall Study|Relapse|1
7590820|NCT01425008|11997108|FG010|Dose Expansion Phase|Symptomatic Deterioration|2
7590821|NCT01425008|11997109|FG011|Dose Expansion Phase|Symptomatic Deterioration|1
7590822|NCT01425008|11997110|FG012|Dose Expansion Phase|Symptomatic Deterioration|0
7590823|NCT01425008|11997111|FG013|Dose Expansion Phase|Symptomatic Deterioration|0
7590824|NCT01425008|11997112|FG014|Dose Expansion Phase|Symptomatic Deterioration|0
7590825|NCT01425008|11997113|FG015|Dose Expansion Phase|Symptomatic Deterioration|1
7590826|NCT01425008|11997114|FG016|Dose Expansion Phase|Symptomatic Deterioration|2
7590827|NCT01425008|11997115|FG017|Dose Expansion Phase|Symptomatic Deterioration|0
7590828|NCT01425008|11997116|FG018|Dose Expansion Phase|Symptomatic Deterioration|1
7590829|NCT01425008|11997098|FG000|Dose Expansion Phase|Adverse Event|0
7590830|NCT01425008|11997099|FG001|Dose Expansion Phase|Adverse Event|0
7590831|NCT01425008|11997100|FG002|Dose Expansion Phase|Adverse Event|0
7590832|NCT01425008|11997101|FG003|Dose Expansion Phase|Adverse Event|0
7590833|NCT01425008|11997102|FG004|Dose Expansion Phase|Adverse Event|0
7590834|NCT01425008|11997103|FG005|Dose Expansion Phase|Adverse Event|0
7590835|NCT01425008|11997104|FG006|Dose Expansion Phase|Adverse Event|0
7590836|NCT01425008|11997105|FG007|Dose Expansion Phase|Adverse Event|0
7590837|NCT01425008|11997106|FG008|Dose Expansion Phase|Adverse Event|0
7590838|NCT01425008|11997107|FG009|Dose Expansion Phase|Adverse Event|0
7590839|NCT01425008|11997108|FG010|Dose Expansion Phase|Adverse Event|2
7590840|NCT01425008|11997109|FG011|Dose Expansion Phase|Adverse Event|3
7590841|NCT01425008|11997110|FG012|Dose Expansion Phase|Adverse Event|3
7590842|NCT01425008|11997111|FG013|Dose Expansion Phase|Adverse Event|0
7590843|NCT01425008|11997112|FG014|Dose Expansion Phase|Adverse Event|1
7590844|NCT01425008|11997113|FG015|Dose Expansion Phase|Adverse Event|1
7590845|NCT01425008|11997114|FG016|Dose Expansion Phase|Adverse Event|5
7590846|NCT01425008|11997115|FG017|Dose Expansion Phase|Adverse Event|0
7590847|NCT01425008|11997116|FG018|Dose Expansion Phase|Adverse Event|3
7590848|NCT01425008|11997098|FG000|Dose Expansion Phase|Lost to Follow-up|0
7590849|NCT01425008|11997099|FG001|Dose Expansion Phase|Lost to Follow-up|0
7590850|NCT01425008|11997100|FG002|Dose Expansion Phase|Lost to Follow-up|0
7590851|NCT01425008|11997101|FG003|Dose Expansion Phase|Lost to Follow-up|0
7590852|NCT01425008|11997102|FG004|Dose Expansion Phase|Lost to Follow-up|0
7590853|NCT01425008|11997103|FG005|Dose Expansion Phase|Lost to Follow-up|0
7590854|NCT01425008|11997104|FG006|Dose Expansion Phase|Lost to Follow-up|0
7590855|NCT01425008|11997105|FG007|Dose Expansion Phase|Lost to Follow-up|0
7590856|NCT01425008|11997106|FG008|Dose Expansion Phase|Lost to Follow-up|0
7590857|NCT01425008|11997107|FG009|Dose Expansion Phase|Lost to Follow-up|0
7590858|NCT01425008|11997108|FG010|Dose Expansion Phase|Lost to Follow-up|0
7590859|NCT01425008|11997109|FG011|Dose Expansion Phase|Lost to Follow-up|0
7590860|NCT01425008|11997110|FG012|Dose Expansion Phase|Lost to Follow-up|0
7590861|NCT01425008|11997111|FG013|Dose Expansion Phase|Lost to Follow-up|0
7590862|NCT01425008|11997112|FG014|Dose Expansion Phase|Lost to Follow-up|0
7590863|NCT01425008|11997113|FG015|Dose Expansion Phase|Lost to Follow-up|0
7590864|NCT01425008|11997114|FG016|Dose Expansion Phase|Lost to Follow-up|1
7590865|NCT01425008|11997115|FG017|Dose Expansion Phase|Lost to Follow-up|0
7590866|NCT01425008|11997116|FG018|Dose Expansion Phase|Lost to Follow-up|0
7590867|NCT01425008|11997098|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590868|NCT01425008|11997099|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590869|NCT01425008|11997100|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590870|NCT01425008|11997101|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590871|NCT01425008|11997102|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590872|NCT01425008|11997103|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590873|NCT01425008|11997104|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590874|NCT01425008|11997105|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590875|NCT01425008|11997106|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590876|NCT01425008|11997107|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7270853|NCT00419952|11485200|FG001|Overall Study|Incorrectly enrolled|3
7270854|NCT00419952|11485199|FG000|Overall Study|Intake of prohibited medication|2
7270855|NCT00419952|11485200|FG001|Overall Study|Intake of prohibited medication|2
7270856|NCT00419952|11485199|FG000|Overall Study|Occurence of 2 or more exacerbations|2
7270857|NCT00419952|11485200|FG001|Overall Study|Occurence of 2 or more exacerbations|0
7270858|NCT00419952|11485199|FG000|Overall Study|Diary or medication non-compliance|2
7270859|NCT00419952|11485200|FG001|Overall Study|Diary or medication non-compliance|4
7270860|NCT00419952|11485199|FG000|Overall Study|Abnormal ECG|1
7270861|NCT00419952|11485200|FG001|Overall Study|Abnormal ECG|0
7270862|NCT00420004|11485209|FG000|Overall Study|Adverse Event|4
7270863|NCT00420004|11485210|FG001|Overall Study|Adverse Event|1
7270864|NCT00420004|11485211|FG002|Overall Study|Adverse Event|1
7270865|NCT00420004|11485209|FG000|Overall Study|Lack of Efficacy|5
7270866|NCT00420004|11485210|FG001|Overall Study|Lack of Efficacy|4
7270867|NCT00420004|11485211|FG002|Overall Study|Lack of Efficacy|1
7590877|NCT01425008|11997108|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590878|NCT01425008|11997109|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590879|NCT01425008|11997110|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590880|NCT01425008|11997111|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590881|NCT01425008|11997112|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590882|NCT01425008|11997113|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590883|NCT01425008|11997114|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590884|NCT01425008|11997115|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
7590885|NCT01425008|11997116|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
7626870|NCT00617708|12039327|FG002|Overall Study|Adverse Event|9
7626871|NCT00617708|12039325|FG000|Overall Study|Withdrawal by Subject|1
7626872|NCT00617708|12039326|FG001|Overall Study|Withdrawal by Subject|1
7626873|NCT00617708|12039327|FG002|Overall Study|Withdrawal by Subject|7
7626874|NCT00617708|12039325|FG000|Overall Study|Death|0
7626875|NCT00617708|12039326|FG001|Overall Study|Death|6
7626876|NCT00617708|12039327|FG002|Overall Study|Death|5
7626877|NCT00617708|12039325|FG000|Overall Study|Progression/Relapse|7
7626878|NCT00617708|12039326|FG001|Overall Study|Progression/Relapse|40
7626879|NCT00617708|12039327|FG002|Overall Study|Progression/Relapse|36
7626880|NCT00617708|12039325|FG000|Overall Study|Not protocol specified|1
7626881|NCT00617708|12039326|FG001|Overall Study|Not protocol specified|4
7626882|NCT00617708|12039327|FG002|Overall Study|Not protocol specified|2
7626883|NCT00617708|12039325|FG000|Overall Study|Not eligible|1
7626884|NCT00617708|12039326|FG001|Overall Study|Not eligible|3
7626885|NCT00617708|12039327|FG002|Overall Study|Not eligible|5
7626886|NCT00516737|12039339|FG000|Overall Study|Lost to Follow-up|2
7626887|NCT00516737|12039340|FG001|Overall Study|Lost to Follow-up|0
7626888|NCT00516737|12039339|FG000|Overall Study|Physician Decision|0
7626889|NCT00516737|12039340|FG001|Overall Study|Physician Decision|1
7626890|NCT00516737|12039339|FG000|Overall Study|Withdrawal by Subject|0
7626891|NCT00516737|12039340|FG001|Overall Study|Withdrawal by Subject|1
7626892|NCT00516737|12039339|FG000|Overall Study|Lack of Qualifying Event|9
7626893|NCT00516737|12039340|FG001|Overall Study|Lack of Qualifying Event|6
7626894|NCT00358527|12039348|FG000|Overall Study|Adverse Event|4
7626895|NCT00358527|12039349|FG001|Overall Study|Adverse Event|0
7626896|NCT00358527|12039348|FG000|Overall Study|Withdrawal by Subject|1
7626897|NCT00358527|12039349|FG001|Overall Study|Withdrawal by Subject|1
7626898|NCT00358527|12039348|FG000|Overall Study|Non-compliance with protocol|6
7626899|NCT00358527|12039349|FG001|Overall Study|Non-compliance with protocol|1
7626900|NCT00358527|12039348|FG000|Overall Study|Administrative|2
7626901|NCT00358527|12039349|FG001|Overall Study|Administrative|1
7626902|NCT00326898|12039358|FG000|Overall Study|Disease progression|52
7626903|NCT00326898|12039359|FG001|Overall Study|Disease progression|54
7626904|NCT00326898|12039360|FG002|Overall Study|Disease progression|102
7626905|NCT00326898|12039358|FG000|Overall Study|Adverse Event|124
7626906|NCT00326898|12039359|FG001|Overall Study|Adverse Event|128
7626907|NCT00326898|12039360|FG002|Overall Study|Adverse Event|33
7626908|NCT00326898|12039358|FG000|Overall Study|Death|2
7626909|NCT00326898|12039359|FG001|Overall Study|Death|0
7626910|NCT00326898|12039360|FG002|Overall Study|Death|0
7626911|NCT00326898|12039358|FG000|Overall Study|Withdrawal by Subject|134
7626912|NCT00326898|12039359|FG001|Overall Study|Withdrawal by Subject|128
7626913|NCT00326898|12039360|FG002|Overall Study|Withdrawal by Subject|32
7626914|NCT00326898|12039358|FG000|Overall Study|Alternative therapy|1
7626915|NCT00326898|12039359|FG001|Overall Study|Alternative therapy|0
7626916|NCT00326898|12039360|FG002|Overall Study|Alternative therapy|0
7626917|NCT00326898|12039358|FG000|Overall Study|Other complicating disease|5
7626918|NCT00326898|12039359|FG001|Overall Study|Other complicating disease|5
7626919|NCT00326898|12039360|FG002|Overall Study|Other complicating disease|4
7626920|NCT00326898|12039358|FG000|Overall Study|Other/Missing/Unknown|33
7626921|NCT00326898|12039359|FG001|Overall Study|Other/Missing/Unknown|28
7626922|NCT00326898|12039360|FG002|Overall Study|Other/Missing/Unknown|32
7626923|NCT00156065|12039371|FG000|Overall Study|Enrolled But Never Received Treatment|1
7626924|NCT00156065|12039372|FG001|Overall Study|Enrolled But Never Received Treatment|1
7626925|NCT00156065|12039373|FG002|Overall Study|Enrolled But Never Received Treatment|0
7626926|NCT00156065|12039371|FG000|Overall Study|Adverse Event|8
7626927|NCT00156065|12039372|FG001|Overall Study|Adverse Event|11
7626928|NCT00156065|12039373|FG002|Overall Study|Adverse Event|4
7626929|NCT00156065|12039371|FG000|Overall Study|Lack of Efficacy|2
7626930|NCT00156065|12039372|FG001|Overall Study|Lack of Efficacy|9
7626931|NCT00156065|12039373|FG002|Overall Study|Lack of Efficacy|3
7626932|NCT00156065|12039371|FG000|Overall Study|Withdrawal by Subject|13
7626933|NCT00156065|12039372|FG001|Overall Study|Withdrawal by Subject|26
7626934|NCT00156065|12039373|FG002|Overall Study|Withdrawal by Subject|16
7626935|NCT00156065|12039371|FG000|Overall Study|Lost to Follow-up|5
7626936|NCT00156065|12039372|FG001|Overall Study|Lost to Follow-up|7
7626937|NCT00156065|12039373|FG002|Overall Study|Lost to Follow-up|1
7626938|NCT00156065|12039371|FG000|Overall Study|Other|2
7626939|NCT00156065|12039372|FG001|Overall Study|Other|9
7626940|NCT00156065|12039373|FG002|Overall Study|Other|3
7626941|NCT00150176|12039383|FG000|Overall Study|Adverse Event|16
7626942|NCT00150176|12039384|FG001|Overall Study|Adverse Event|53
7626943|NCT00150176|12039383|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
7590886|NCT04425902|11997169|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1
7590887|NCT04072146|11997182|FG000|Overall Study|Adverse Event|0
7590888|NCT04072146|11997183|FG001|Overall Study|Adverse Event|1
7590889|NCT03861481|11997197|FG000|Overall Study|COVID-19 pandemic circumstances|0
7590890|NCT03861481|11997198|FG001|Overall Study|COVID-19 pandemic circumstances|1
7590891|NCT03861481|11997197|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1
7590892|NCT03861481|11997198|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0
7590894|NCT03861481|11997198|FG001|Overall Study|Relapse|0
7590895|NCT03861481|11997197|FG000|Overall Study|Withdrawal by Subject|0
7590896|NCT03861481|11997198|FG001|Overall Study|Withdrawal by Subject|1
7590897|NCT03861481|11997197|FG000|Overall Study|Lack of Efficacy|4
7590898|NCT03861481|11997198|FG001|Overall Study|Lack of Efficacy|5
7590903|NCT03648476|11997214|FG000|Overall Study|Withdrawal by Subject|2
7590904|NCT03648476|11997215|FG001|Overall Study|Withdrawal by Subject|1
7590905|NCT03375203|11997227|FG000|Overall Study|Protocol Violation|0
7590906|NCT03375203|11997228|FG001|Overall Study|Protocol Violation|0
7590907|NCT03375203|11997229|FG002|Overall Study|Protocol Violation|1
7590908|NCT03375203|11997230|FG003|Overall Study|Protocol Violation|0
7590909|NCT03375203|11997231|FG004|Overall Study|Protocol Violation|0
7590910|NCT03375203|11997227|FG000|Overall Study|Adverse Event|2
7590911|NCT03375203|11997228|FG001|Overall Study|Adverse Event|3
7590912|NCT03375203|11997229|FG002|Overall Study|Adverse Event|0
7590913|NCT03375203|11997230|FG003|Overall Study|Adverse Event|2
7590914|NCT03375203|11997231|FG004|Overall Study|Adverse Event|2
7590915|NCT03375203|11997227|FG000|Overall Study|Withdrawal by Subject|3
7590916|NCT03375203|11997228|FG001|Overall Study|Withdrawal by Subject|0
7590917|NCT03375203|11997229|FG002|Overall Study|Withdrawal by Subject|1
7590918|NCT03375203|11997230|FG003|Overall Study|Withdrawal by Subject|0
7590919|NCT03375203|11997231|FG004|Overall Study|Withdrawal by Subject|2
7590920|NCT03375203|11997227|FG000|Overall Study|Non-compliance with study drug|1
7590921|NCT03375203|11997228|FG001|Overall Study|Non-compliance with study drug|0
7590922|NCT03375203|11997229|FG002|Overall Study|Non-compliance with study drug|0
7590923|NCT03375203|11997230|FG003|Overall Study|Non-compliance with study drug|0
7590924|NCT03375203|11997231|FG004|Overall Study|Non-compliance with study drug|0
7590925|NCT03375203|11997227|FG000|Overall Study|Randomized, not treated.|0
7590926|NCT03375203|11997228|FG001|Overall Study|Randomized, not treated.|1
7590927|NCT03375203|11997229|FG002|Overall Study|Randomized, not treated.|0
7590928|NCT03375203|11997230|FG003|Overall Study|Randomized, not treated.|0
7590929|NCT03375203|11997231|FG004|Overall Study|Randomized, not treated.|0
7590930|NCT02926833|11997248|FG000|Overall Study|Full Consent Withdrawal|0
7590931|NCT02926833|11997249|FG001|Overall Study|Full Consent Withdrawal|0
7590932|NCT02926833|11997250|FG002|Overall Study|Full Consent Withdrawal|0
7590933|NCT02926833|11997251|FG003|Overall Study|Full Consent Withdrawal|2
7590934|NCT02926833|11997248|FG000|Overall Study|Death|1
7590935|NCT02926833|11997249|FG001|Overall Study|Death|1
7590936|NCT02926833|11997250|FG002|Overall Study|Death|1
7590937|NCT02926833|11997251|FG003|Overall Study|Death|7
7590938|NCT02926833|11997248|FG000|Overall Study|Still on study|2
7590939|NCT02926833|11997249|FG001|Overall Study|Still on study|3
7590940|NCT02926833|11997250|FG002|Overall Study|Still on study|5
7590941|NCT02926833|11997251|FG003|Overall Study|Still on study|14
7590942|NCT02926833|11997248|FG000|Overall Study|Adverse Event|0
7590943|NCT02926833|11997249|FG001|Overall Study|Adverse Event|0
7590944|NCT02926833|11997250|FG002|Overall Study|Adverse Event|1
7590945|NCT02926833|11997251|FG003|Overall Study|Adverse Event|0
7590978|NCT02348216|11997282|FG000|Overall Study|Death|4
7590979|NCT02348216|11997283|FG001|Overall Study|Death|27
7590980|NCT02348216|11997284|FG002|Overall Study|Death|3
7590981|NCT02348216|11997285|FG003|Overall Study|Death|18
7590982|NCT02348216|11997286|FG004|Overall Study|Death|9
7590983|NCT02348216|11997287|FG005|Overall Study|Death|23
7590984|NCT02348216|11997288|FG006|Overall Study|Death|6
7590985|NCT02348216|11997282|FG000|Overall Study|Full consent withdrawal|0
7590986|NCT02348216|11997283|FG001|Overall Study|Full consent withdrawal|0
7590987|NCT02348216|11997284|FG002|Overall Study|Full consent withdrawal|0
7590988|NCT02348216|11997285|FG003|Overall Study|Full consent withdrawal|1
7590989|NCT02348216|11997286|FG004|Overall Study|Full consent withdrawal|0
7590990|NCT02348216|11997287|FG005|Overall Study|Full consent withdrawal|0
7590991|NCT02348216|11997288|FG006|Overall Study|Full consent withdrawal|1
7590992|NCT02348216|11997282|FG000|Overall Study|Lost to Follow-up|0
7590993|NCT02348216|11997283|FG001|Overall Study|Lost to Follow-up|0
7590994|NCT02348216|11997284|FG002|Overall Study|Lost to Follow-up|0
7590995|NCT02348216|11997285|FG003|Overall Study|Lost to Follow-up|0
7590996|NCT02348216|11997286|FG004|Overall Study|Lost to Follow-up|0
7590997|NCT02348216|11997287|FG005|Overall Study|Lost to Follow-up|0
7590998|NCT02348216|11997288|FG006|Overall Study|Lost to Follow-up|1
7590999|NCT02348216|11997282|FG000|Overall Study|Still on study|3
7591000|NCT02348216|11997283|FG001|Overall Study|Still on study|50
7591001|NCT02348216|11997284|FG002|Overall Study|Still on study|21
7591002|NCT02348216|11997285|FG003|Overall Study|Still on study|19
7591003|NCT02348216|11997286|FG004|Overall Study|Still on study|32
7591004|NCT02348216|11997287|FG005|Overall Study|Still on study|27
7591005|NCT02348216|11997288|FG006|Overall Study|Still on study|32
7591006|NCT02348216|11997282|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
7591007|NCT02348216|11997283|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7591008|NCT02348216|11997284|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
7591009|NCT02348216|11997285|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
7591010|NCT02348216|11997286|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
7591011|NCT02348216|11997287|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
7591012|NCT02348216|11997288|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
7626944|NCT00150176|12039384|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
7626945|NCT00150176|12039383|FG000|Overall Study|Withdrawal by Subject|19
7626946|NCT00150176|12039384|FG001|Overall Study|Withdrawal by Subject|12
7626947|NCT00150176|12039383|FG000|Overall Study|Lost to Follow-up|3
7626948|NCT00150176|12039384|FG001|Overall Study|Lost to Follow-up|3
7626949|NCT00150176|12039383|FG000|Overall Study|OTHER|11
7626950|NCT00150176|12039384|FG001|Overall Study|OTHER|13
7626951|NCT00145509|12039393|FG000|Overall Study|Adverse Event|10
7626952|NCT00145509|12039394|FG001|Overall Study|Adverse Event|3
7626953|NCT00145509|12039393|FG000|Overall Study|Lack of Efficacy|3
7626954|NCT00145509|12039394|FG001|Overall Study|Lack of Efficacy|1
7626955|NCT00145509|12039393|FG000|Overall Study|Lost to Follow-up|5
7626956|NCT00145509|12039394|FG001|Overall Study|Lost to Follow-up|9
7626957|NCT00145509|12039393|FG000|Overall Study|Withdrew Consent|2
7626958|NCT00145509|12039394|FG001|Overall Study|Withdrew Consent|7
7626959|NCT00145509|12039393|FG000|Overall Study|Reason not provided|2
7626960|NCT00145509|12039394|FG001|Overall Study|Reason not provided|1
7626961|NCT00145496|12039402|FG000|Overall Study|Adverse Event|42
7626962|NCT00145496|12039403|FG001|Overall Study|Adverse Event|30
7626963|NCT00145496|12039402|FG000|Overall Study|Lack of Efficacy|12
7626964|NCT00145496|12039403|FG001|Overall Study|Lack of Efficacy|7
7270868|NCT00420004|11485209|FG000|Overall Study|Lost to Follow-up|31
7270869|NCT00420004|11485210|FG001|Overall Study|Lost to Follow-up|12
7270870|NCT00420004|11485211|FG002|Overall Study|Lost to Follow-up|10
7270871|NCT00420004|11485209|FG000|Overall Study|Entry Criteria Not Met|0
7270872|NCT00420004|11485210|FG001|Overall Study|Entry Criteria Not Met|1
7270873|NCT00420004|11485211|FG002|Overall Study|Entry Criteria Not Met|0
7270874|NCT00420004|11485209|FG000|Overall Study|Physician Decision|14
7270875|NCT00420004|11485210|FG001|Overall Study|Physician Decision|4
7270876|NCT00420004|11485211|FG002|Overall Study|Physician Decision|2
7270877|NCT00420004|11485209|FG000|Overall Study|Protocol Violation|5
7270878|NCT00420004|11485210|FG001|Overall Study|Protocol Violation|4
7270879|NCT00420004|11485211|FG002|Overall Study|Protocol Violation|3
7270880|NCT00420004|11485209|FG000|Overall Study|Withdrawal by Subject|67
7270881|NCT00420004|11485210|FG001|Overall Study|Withdrawal by Subject|42
7270882|NCT00420004|11485211|FG002|Overall Study|Withdrawal by Subject|14
7270883|NCT00420004|11485209|FG000|Overall Study|Sponsor Decision|3
7270884|NCT00420004|11485210|FG001|Overall Study|Sponsor Decision|3
7270885|NCT00420004|11485211|FG002|Overall Study|Sponsor Decision|1
7270886|NCT00420056|11485232|FG000|Overall Study|Objective progression or relapse|17
7270887|NCT00420095|11485238|FG000|Overall Study|Adverse Event|1
7270888|NCT00420095|11485239|FG001|Overall Study|Adverse Event|0
7270889|NCT00420095|11485238|FG000|Overall Study|Protocol Violation|1
7270890|NCT00420095|11485239|FG001|Overall Study|Protocol Violation|1
7270891|NCT00420095|11485238|FG000|Overall Study|Lost to Follow-up|1
7270892|NCT00420095|11485239|FG001|Overall Study|Lost to Follow-up|0
7270893|NCT00420199|11485256|FG000|Overall Study|Participant no longer met study criteria|1
7270894|NCT00420199|11485257|FG001|Overall Study|Participant no longer met study criteria|0
7270895|NCT00420212|11485271|FG000|Overall Study|Adverse Event|22
7270896|NCT00420212|11485272|FG001|Overall Study|Adverse Event|40
7270897|NCT00420212|11485273|FG002|Overall Study|Adverse Event|36
7270898|NCT00420212|11485271|FG000|Overall Study|Lost to Follow-up|9
7270899|NCT00420212|11485272|FG001|Overall Study|Lost to Follow-up|11
7270900|NCT00420212|11485273|FG002|Overall Study|Lost to Follow-up|11
7270901|NCT00420212|11485271|FG000|Overall Study|Withdrawal by Subject|31
7270902|NCT00420212|11485272|FG001|Overall Study|Withdrawal by Subject|22
7270903|NCT00420212|11485273|FG002|Overall Study|Withdrawal by Subject|19
7270904|NCT00420212|11485271|FG000|Overall Study|Physician Decision|4
7270905|NCT00420212|11485272|FG001|Overall Study|Physician Decision|4
7270906|NCT00420212|11485273|FG002|Overall Study|Physician Decision|3
7270907|NCT00420212|11485271|FG000|Overall Study|Protocol Violation|4
7270908|NCT00420212|11485272|FG001|Overall Study|Protocol Violation|4
7270909|NCT00420212|11485273|FG002|Overall Study|Protocol Violation|8
7270910|NCT00420212|11485271|FG000|Overall Study|Death|0
7591197|NCT01231906|11997356|FG000|Overall Study|Lack of Efficacy|75
7591198|NCT01231906|11997357|FG001|Overall Study|Lack of Efficacy|68
7591199|NCT01231906|11997356|FG000|Overall Study|Lost to Follow-up|1
7591200|NCT01231906|11997357|FG001|Overall Study|Lost to Follow-up|0
7591201|NCT01231906|11997356|FG000|Overall Study|Physician Decision|34
7591202|NCT01231906|11997357|FG001|Overall Study|Physician Decision|24
7591203|NCT01231906|11997356|FG000|Overall Study|Withdrawal by Subject|0
7591204|NCT01231906|11997357|FG001|Overall Study|Withdrawal by Subject|4
7591205|NCT01231906|11997356|FG000|Overall Study|Ineligible|10
7591206|NCT01231906|11997357|FG001|Overall Study|Ineligible|3
7591207|NCT01231906|11997356|FG000|Overall Study|No treatment|1
7591208|NCT01231906|11997357|FG001|Overall Study|No treatment|2
7626965|NCT00145496|12039402|FG000|Overall Study|Withdrawal by Subject|32
7626966|NCT00145496|12039403|FG001|Overall Study|Withdrawal by Subject|26
7626967|NCT00145496|12039402|FG000|Overall Study|Lost to Follow-up|12
7626968|NCT00145496|12039403|FG001|Overall Study|Lost to Follow-up|5
7626969|NCT00145496|12039402|FG000|Overall Study|Other|25
7626970|NCT00145496|12039403|FG001|Overall Study|Other|13
7626971|NCT00145470|12039411|FG000|Overall Study|Adverse Event|19
7626972|NCT00145470|12039412|FG001|Overall Study|Adverse Event|25
7626973|NCT00145470|12039411|FG000|Overall Study|Lack of Efficacy|27
7626974|NCT00145470|12039412|FG001|Overall Study|Lack of Efficacy|13
7626975|NCT00145470|12039411|FG000|Overall Study|Withdrawal by Subject|36
7626976|NCT00145470|12039412|FG001|Overall Study|Withdrawal by Subject|34
7626977|NCT00145470|12039411|FG000|Overall Study|Lost to Follow-up|21
7626978|NCT00145470|12039412|FG001|Overall Study|Lost to Follow-up|17
7626979|NCT00145470|12039411|FG000|Overall Study|Reason Not Reported|9
7626980|NCT00145470|12039412|FG001|Overall Study|Reason Not Reported|9
7626981|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626982|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626983|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626984|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626985|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626986|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
7626987|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
7626988|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626989|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626990|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626991|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626992|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626993|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
7626994|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
7626995|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626996|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626997|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7626998|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
7626999|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627000|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627001|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
7627002|NCT00129402|12039420|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627003|NCT00129402|12039421|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627004|NCT00129402|12039422|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7627005|NCT00129402|12039423|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627006|NCT00129402|12039424|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
7627007|NCT00129402|12039425|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627008|NCT00129402|12039426|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
7627009|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627010|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627011|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
7627012|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627013|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627014|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627015|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
7627016|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627017|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627018|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
7627019|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627020|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627021|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
7627022|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
7627023|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627024|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627025|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
7591209|NCT01470326|11997363|FG000|Overall Study|Protocol Violation|32
7591210|NCT01470326|11997363|FG000|Overall Study|No Drug Administration Information|2
7591211|NCT01470326|11997363|FG000|Overall Study|No Visit After 1st Day of Treatment|119
7591212|NCT01480180|11997369|FG000|Main Phase|Withdrawal criteria|12
7591213|NCT01480180|11997370|FG001|Main Phase|Withdrawal criteria|1
7591214|NCT01480180|11997371|FG002|Main Phase|Withdrawal criteria|0
7591215|NCT01480180|11997372|FG003|Main Phase|Withdrawal criteria|0
7591216|NCT01480180|11997373|FG004|Main Phase|Withdrawal criteria|0
7591217|NCT01480180|11997374|FG005|Main Phase|Withdrawal criteria|0
7591218|NCT01480180|11997369|FG000|Main Phase|Lack of Efficacy|1
7591219|NCT01480180|11997370|FG001|Main Phase|Lack of Efficacy|0
7591220|NCT01480180|11997371|FG002|Main Phase|Lack of Efficacy|0
7591221|NCT01480180|11997372|FG003|Main Phase|Lack of Efficacy|0
7591222|NCT01480180|11997373|FG004|Main Phase|Lack of Efficacy|0
7591223|NCT01480180|11997374|FG005|Main Phase|Lack of Efficacy|0
7591224|NCT01480180|11997369|FG000|Main Phase|Non-compliance|3
7591225|NCT01480180|11997370|FG001|Main Phase|Non-compliance|0
7591226|NCT01480180|11997371|FG002|Main Phase|Non-compliance|0
7591227|NCT01480180|11997372|FG003|Main Phase|Non-compliance|0
7591228|NCT01480180|11997373|FG004|Main Phase|Non-compliance|0
7591229|NCT01480180|11997374|FG005|Main Phase|Non-compliance|0
7591230|NCT01480180|11997369|FG000|Main Phase|Unclassified|3
7591231|NCT01480180|11997370|FG001|Main Phase|Unclassified|0
7591232|NCT01480180|11997371|FG002|Main Phase|Unclassified|0
7591233|NCT01480180|11997372|FG003|Main Phase|Unclassified|0
7591234|NCT01480180|11997373|FG004|Main Phase|Unclassified|0
7591235|NCT01480180|11997374|FG005|Main Phase|Unclassified|0
7591236|NCT01480180|11997369|FG000|Extension Phase, Part 1|Withdrawal criteria|0
7591237|NCT01480180|11997370|FG001|Extension Phase, Part 1|Withdrawal criteria|0
7591238|NCT01480180|11997371|FG002|Extension Phase, Part 1|Withdrawal criteria|5
7591239|NCT01480180|11997372|FG003|Extension Phase, Part 1|Withdrawal criteria|0
7591240|NCT01480180|11997373|FG004|Extension Phase, Part 1|Withdrawal criteria|0
7591241|NCT01480180|11997374|FG005|Extension Phase, Part 1|Withdrawal criteria|0
7591242|NCT01480180|11997369|FG000|Extension Phase, Part 1|Unclassified|0
7591243|NCT01480180|11997370|FG001|Extension Phase, Part 1|Unclassified|0
7591244|NCT01480180|11997371|FG002|Extension Phase, Part 1|Unclassified|1
7591245|NCT01480180|11997372|FG003|Extension Phase, Part 1|Unclassified|0
7591246|NCT01480180|11997373|FG004|Extension Phase, Part 1|Unclassified|0
7591247|NCT01480180|11997374|FG005|Extension Phase, Part 1|Unclassified|0
7591248|NCT01480180|11997369|FG000|Extension Phase, Part 1|Adverse Event|0
7591249|NCT01480180|11997370|FG001|Extension Phase, Part 1|Adverse Event|0
7591250|NCT01480180|11997371|FG002|Extension Phase, Part 1|Adverse Event|4
7591251|NCT01480180|11997372|FG003|Extension Phase, Part 1|Adverse Event|1
7591252|NCT01480180|11997373|FG004|Extension Phase, Part 1|Adverse Event|0
7591253|NCT01480180|11997374|FG005|Extension Phase, Part 1|Adverse Event|0
7591254|NCT01480180|11997369|FG000|Extension Phase, Part 1|Change of treatment|0
7591255|NCT01480180|11997370|FG001|Extension Phase, Part 1|Change of treatment|0
7591256|NCT01480180|11997371|FG002|Extension Phase, Part 1|Change of treatment|0
7591257|NCT01480180|11997372|FG003|Extension Phase, Part 1|Change of treatment|9
7591258|NCT01480180|11997373|FG004|Extension Phase, Part 1|Change of treatment|0
7591259|NCT01480180|11997374|FG005|Extension Phase, Part 1|Change of treatment|0
7591260|NCT01480180|11997369|FG000|Extension Phase, Part 2|Withdrawal criteria|0
7591261|NCT01480180|11997370|FG001|Extension Phase, Part 2|Withdrawal criteria|0
7591262|NCT01480180|11997371|FG002|Extension Phase, Part 2|Withdrawal criteria|10
7591263|NCT01480180|11997372|FG003|Extension Phase, Part 2|Withdrawal criteria|6
7591264|NCT01480180|11997373|FG004|Extension Phase, Part 2|Withdrawal criteria|1
7591265|NCT01480180|11997374|FG005|Extension Phase, Part 2|Withdrawal criteria|0
7591266|NCT01480180|11997369|FG000|Extension Phase, Part 2|Lack of Efficacy|0
7591267|NCT01480180|11997370|FG001|Extension Phase, Part 2|Lack of Efficacy|0
7591268|NCT01480180|11997371|FG002|Extension Phase, Part 2|Lack of Efficacy|4
7591269|NCT01480180|11997372|FG003|Extension Phase, Part 2|Lack of Efficacy|0
7591270|NCT01480180|11997373|FG004|Extension Phase, Part 2|Lack of Efficacy|0
7591271|NCT01480180|11997374|FG005|Extension Phase, Part 2|Lack of Efficacy|0
7591272|NCT01480180|11997369|FG000|Extension Phase, Part 2|Unclassified|0
7591273|NCT01480180|11997370|FG001|Extension Phase, Part 2|Unclassified|0
7591274|NCT01480180|11997371|FG002|Extension Phase, Part 2|Unclassified|3
7591275|NCT01480180|11997372|FG003|Extension Phase, Part 2|Unclassified|1
7591276|NCT01480180|11997373|FG004|Extension Phase, Part 2|Unclassified|1
7591277|NCT01480180|11997374|FG005|Extension Phase, Part 2|Unclassified|0
7627026|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627027|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627028|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627029|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
7627030|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627031|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627032|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
7627033|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627034|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627035|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
7627036|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
7627037|NCT00129402|12039420|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627038|NCT00129402|12039421|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627039|NCT00129402|12039422|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7627040|NCT00129402|12039423|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627041|NCT00129402|12039424|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627042|NCT00129402|12039425|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
7627043|NCT00129402|12039426|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
7627044|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627045|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7591278|NCT01545050|11997410|FG000|Overall Study|Lack of Efficacy|0
7591279|NCT01545050|11997411|FG001|Overall Study|Lack of Efficacy|0
7591280|NCT01545050|11997412|FG002|Overall Study|Lack of Efficacy|0
7591281|NCT01545050|11997413|FG003|Overall Study|Lack of Efficacy|3
7591282|NCT01545050|11997414|FG004|Overall Study|Lack of Efficacy|2
7591283|NCT01545050|11997410|FG000|Overall Study|Adverse Event|1
7591284|NCT01545050|11997411|FG001|Overall Study|Adverse Event|1
7591285|NCT01545050|11997412|FG002|Overall Study|Adverse Event|2
7591286|NCT01545050|11997413|FG003|Overall Study|Adverse Event|2
7591287|NCT01545050|11997414|FG004|Overall Study|Adverse Event|0
7591288|NCT01545050|11997410|FG000|Overall Study|Discontinued study treatment|1
7591289|NCT01545050|11997411|FG001|Overall Study|Discontinued study treatment|0
7591290|NCT01545050|11997412|FG002|Overall Study|Discontinued study treatment|0
7591291|NCT01545050|11997413|FG003|Overall Study|Discontinued study treatment|0
7591292|NCT01545050|11997414|FG004|Overall Study|Discontinued study treatment|0
7591293|NCT01545050|11997410|FG000|Overall Study|Withdrawal by Subject|1
7591294|NCT01545050|11997411|FG001|Overall Study|Withdrawal by Subject|0
7591295|NCT01545050|11997412|FG002|Overall Study|Withdrawal by Subject|0
7591296|NCT01545050|11997413|FG003|Overall Study|Withdrawal by Subject|2
7591297|NCT01545050|11997414|FG004|Overall Study|Withdrawal by Subject|1
7591298|NCT01545050|11997410|FG000|Overall Study|Participant no longer meets study criteria|0
7591299|NCT01545050|11997411|FG001|Overall Study|Participant no longer meets study criteria|2
7591300|NCT01545050|11997412|FG002|Overall Study|Participant no longer meets study criteria|0
7591301|NCT01545050|11997413|FG003|Overall Study|Participant no longer meets study criteria|0
7591302|NCT01545050|11997414|FG004|Overall Study|Participant no longer meets study criteria|1
7591303|NCT01545050|11997410|FG000|Overall Study|Administrative reason by sponsor|4
7591304|NCT01545050|11997411|FG001|Overall Study|Administrative reason by sponsor|2
7591305|NCT01545050|11997412|FG002|Overall Study|Administrative reason by sponsor|3
7591306|NCT01545050|11997413|FG003|Overall Study|Administrative reason by sponsor|5
7591307|NCT01545050|11997414|FG004|Overall Study|Administrative reason by sponsor|5
7627046|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627047|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627048|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627049|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
7627050|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
7627051|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627052|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627053|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627054|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627055|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627056|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
7627057|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
7627058|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627059|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627060|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627061|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627062|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627063|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
7627064|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
7627065|NCT00129402|12039420|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627066|NCT00129402|12039421|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627067|NCT00129402|12039422|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627068|NCT00129402|12039423|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627069|NCT00129402|12039424|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627070|NCT00129402|12039425|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
7627071|NCT00129402|12039426|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
7627072|NCT00101439|12039436|FG000|Period 2|Withdrawal by Subject|0
7627073|NCT00101439|12039437|FG001|Period 2|Withdrawal by Subject|2
7627074|NCT00096200|12039446|FG000|Overall Study|Adverse Event|0
7627075|NCT00096200|12039447|FG001|Overall Study|Adverse Event|4
7627076|NCT00096200|12039448|FG002|Overall Study|Adverse Event|0
7627077|NCT00096200|12039446|FG000|Overall Study|Withdrawal by Subject|1
7627078|NCT00096200|12039447|FG001|Overall Study|Withdrawal by Subject|2
7627079|NCT00096200|12039448|FG002|Overall Study|Withdrawal by Subject|0
7627080|NCT00096200|12039446|FG000|Overall Study|Ineligible pathology|0
7627081|NCT00096200|12039447|FG001|Overall Study|Ineligible pathology|1
7627082|NCT00096200|12039448|FG002|Overall Study|Ineligible pathology|0
7270911|NCT00420212|11485272|FG001|Overall Study|Death|0
7270912|NCT00420212|11485273|FG002|Overall Study|Death|1
7270913|NCT00420212|11485271|FG000|Overall Study|Other-Unspecified|21
7270914|NCT00420212|11485272|FG001|Overall Study|Other-Unspecified|14
7270915|NCT00420212|11485273|FG002|Overall Study|Other-Unspecified|18
7270916|NCT00420238|11485286|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
7270917|NCT00420238|11485287|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
7270918|NCT00420238|11485286|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
7270919|NCT00420238|11485287|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
7270920|NCT00420238|11485286|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
7270921|NCT00420238|11485287|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
7270922|NCT00420238|11485286|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
7270923|NCT00420238|11485287|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
7270924|NCT00420238|11485286|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
7270925|NCT00420238|11485287|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
7270926|NCT00420238|11485286|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7270927|NCT00420238|11485287|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
7591308|NCT01555021|11997441|FG000|Overall Study|Lost to Follow-up|1
7591309|NCT01555021|11997442|FG001|Overall Study|Lost to Follow-up|2
7591310|NCT01561430|11997458|FG000|Overall Study|Adverse Event|0
7591311|NCT01561430|11997459|FG001|Overall Study|Adverse Event|0
7591312|NCT01561430|11997460|FG002|Overall Study|Adverse Event|3
7591313|NCT01561430|11997461|FG003|Overall Study|Adverse Event|1
7591314|NCT01561430|11997458|FG000|Overall Study|Withdrawal by Subject|0
7591315|NCT01561430|11997459|FG001|Overall Study|Withdrawal by Subject|0
7591316|NCT01561430|11997460|FG002|Overall Study|Withdrawal by Subject|1
7591317|NCT01561430|11997461|FG003|Overall Study|Withdrawal by Subject|0
7591318|NCT01561430|11997458|FG000|Overall Study|Physician Decision|0
7591319|NCT01561430|11997459|FG001|Overall Study|Physician Decision|1
7591320|NCT01561430|11997460|FG002|Overall Study|Physician Decision|0
7591321|NCT01561430|11997461|FG003|Overall Study|Physician Decision|0
7591322|NCT01561430|11997458|FG000|Overall Study|Sponsor Decision|1
7591323|NCT01561430|11997459|FG001|Overall Study|Sponsor Decision|14
7591324|NCT01561430|11997460|FG002|Overall Study|Sponsor Decision|13
7591325|NCT01561430|11997461|FG003|Overall Study|Sponsor Decision|12
7591326|NCT01595009|11997481|FG000|Core|Patients completed per protocol|85
7591327|NCT01595009|11997482|FG001|Core|Patients completed per protocol|44
7591328|NCT01595009|11997483|FG002|Core|Patients completed per protocol|0
7591329|NCT01595009|11997484|FG003|Core|Patients completed per protocol|0
7591330|NCT01595009|11997481|FG000|Core|Adverse Event|19
7591331|NCT01595009|11997482|FG001|Core|Adverse Event|23
7591332|NCT01595009|11997483|FG002|Core|Adverse Event|0
7591333|NCT01595009|11997484|FG003|Core|Adverse Event|0
7591334|NCT01595009|11997481|FG000|Core|Disease progression|14
7591335|NCT01595009|11997482|FG001|Core|Disease progression|26
7591336|NCT01595009|11997483|FG002|Core|Disease progression|0
7591337|NCT01595009|11997484|FG003|Core|Disease progression|0
7591338|NCT01595009|11997481|FG000|Core|Withdrawal by Subject|4
7591339|NCT01595009|11997482|FG001|Core|Withdrawal by Subject|17
7591340|NCT01595009|11997483|FG002|Core|Withdrawal by Subject|0
7591341|NCT01595009|11997484|FG003|Core|Withdrawal by Subject|0
7591342|NCT01595009|11997481|FG000|Core|Death|3
7591343|NCT01595009|11997482|FG001|Core|Death|6
7591344|NCT01595009|11997483|FG002|Core|Death|0
7591345|NCT01595009|11997484|FG003|Core|Death|0
7591346|NCT01595009|11997481|FG000|Core|Lost to Follow-up|1
7591347|NCT01595009|11997482|FG001|Core|Lost to Follow-up|2
7591348|NCT01595009|11997483|FG002|Core|Lost to Follow-up|0
7591349|NCT01595009|11997484|FG003|Core|Lost to Follow-up|0
7591350|NCT01595009|11997481|FG000|Core|Protocol deviation|0
7591351|NCT01595009|11997482|FG001|Core|Protocol deviation|1
7591352|NCT01595009|11997483|FG002|Core|Protocol deviation|0
7591353|NCT01595009|11997484|FG003|Core|Protocol deviation|0
7591354|NCT01595009|11997481|FG000|Core|Administrative problems|0
7591355|NCT01595009|11997482|FG001|Core|Administrative problems|1
7591356|NCT01595009|11997483|FG002|Core|Administrative problems|0
7591357|NCT01595009|11997484|FG003|Core|Administrative problems|0
7591358|NCT01595009|11997481|FG000|Extension|Administrative problems|0
7591359|NCT01595009|11997482|FG001|Extension|Administrative problems|0
7591360|NCT01595009|11997483|FG002|Extension|Administrative problems|0
7591361|NCT01595009|11997484|FG003|Extension|Administrative problems|1
7591362|NCT01595009|11997481|FG000|Extension|Patients completed per protocol|0
7591363|NCT01595009|11997482|FG001|Extension|Patients completed per protocol|0
7591364|NCT01595009|11997483|FG002|Extension|Patients completed per protocol|0
7591365|NCT01595009|11997484|FG003|Extension|Patients completed per protocol|2
7591366|NCT01595009|11997481|FG000|Extension|Disease progression|0
7591367|NCT01595009|11997482|FG001|Extension|Disease progression|0
7591368|NCT01595009|11997483|FG002|Extension|Disease progression|4
7591369|NCT01595009|11997484|FG003|Extension|Disease progression|7
7591370|NCT01595009|11997481|FG000|Extension|Adverse Event|0
7591371|NCT01595009|11997482|FG001|Extension|Adverse Event|0
7591372|NCT01595009|11997483|FG002|Extension|Adverse Event|0
7591373|NCT01595009|11997484|FG003|Extension|Adverse Event|1
7591374|NCT01620944|11997512|FG000|Overall Study|Early termination of Study|2
7591375|NCT01620944|11997513|FG001|Overall Study|Early termination of Study|1
7591376|NCT01627561|11997521|FG000|Overall Study|Lost to Follow-up|1
7591377|NCT01627561|11997522|FG001|Overall Study|Lost to Follow-up|0
7591378|NCT01627561|11997521|FG000|Overall Study|Withdrawal by Subject|0
7591379|NCT01627561|11997522|FG001|Overall Study|Withdrawal by Subject|1
7591380|NCT01627561|11997521|FG000|Overall Study|Migrated/moved from study area|0
7591381|NCT01627561|11997522|FG001|Overall Study|Migrated/moved from study area|2
7591382|NCT01652534|11997547|FG000|Overall Study|Lack of Efficacy|1
7591383|NCT01652534|11997548|FG001|Overall Study|Lack of Efficacy|0
7591384|NCT04799405|11997574|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2
7591385|NCT04529499|11997584|FG000|Overall Study|Withdrawal by Subject|9
7591386|NCT04529499|11997585|FG001|Overall Study|Withdrawal by Subject|11
7591387|NCT04529499|11997584|FG000|Overall Study|Physician Decision|1
7591388|NCT04529499|11997585|FG001|Overall Study|Physician Decision|2
7591389|NCT04529499|11997584|FG000|Overall Study|Adverse Event|4
7591390|NCT04529499|11997585|FG001|Overall Study|Adverse Event|4
7591391|NCT04529499|11997584|FG000|Overall Study|Death|14
7591392|NCT04529499|11997585|FG001|Overall Study|Death|11
7591393|NCT04529499|11997584|FG000|Overall Study|Lost to Follow-up|1
7591394|NCT04529499|11997585|FG001|Overall Study|Lost to Follow-up|1
7591395|NCT04529499|11997584|FG000|Overall Study|Others|7
7591396|NCT04529499|11997585|FG001|Overall Study|Others|11
7591397|NCT04501094|11997593|FG000|Overall Study|Death (unrelated to research)|1
7591398|NCT04501094|11997594|FG001|Overall Study|Death (unrelated to research)|0
7627083|NCT03257267|12039458|FG000|Overall Study|Adverse Event|9
7627084|NCT03257267|12039459|FG001|Overall Study|Adverse Event|7
7627085|NCT03257267|12039458|FG000|Overall Study|Death|92
7627086|NCT03257267|12039459|FG001|Overall Study|Death|95
7627087|NCT03257267|12039458|FG000|Overall Study|Lost to Follow-up|2
7627088|NCT03257267|12039459|FG001|Overall Study|Lost to Follow-up|2
7627089|NCT03257267|12039458|FG000|Overall Study|Non-compliance with Study Drug|0
7627090|NCT03257267|12039459|FG001|Overall Study|Non-compliance with Study Drug|1
7627091|NCT03257267|12039458|FG000|Overall Study|Participant Decision|34
7627092|NCT03257267|12039459|FG001|Overall Study|Participant Decision|42
7627093|NCT03257267|12039458|FG000|Overall Study|Physician Decision|1
7627094|NCT03257267|12039459|FG001|Overall Study|Physician Decision|3
7627095|NCT03257267|12039458|FG000|Overall Study|Disease Progression|98
7627096|NCT03257267|12039459|FG001|Overall Study|Disease Progression|117
7627097|NCT03257267|12039458|FG000|Overall Study|Withdrawal of Consent|8
7627098|NCT03257267|12039459|FG001|Overall Study|Withdrawal of Consent|26
7627099|NCT03257267|12039458|FG000|Overall Study|Study Ongoing|53
7627100|NCT03257267|12039459|FG001|Overall Study|Study Ongoing|11
7627101|NCT04223830|12039487|FG000|Overall Study|Lost to Follow-up|9
7627102|NCT04223830|12039487|FG000|Overall Study|Adverse Event|1
7627103|NCT04153188|12039503|FG000|Overall Study|Lost to Follow-up|1
7627104|NCT04153188|12039504|FG001|Overall Study|Lost to Follow-up|1
7627105|NCT04153188|12039503|FG000|Overall Study|Withdrawal by Subject|2
7627106|NCT04153188|12039504|FG001|Overall Study|Withdrawal by Subject|0
7627107|NCT04153188|12039503|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0
7627108|NCT04153188|12039504|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1
7627130|NCT04179786|12039540|FG000|Overall Study|Withdrawal by Subject|8
7627131|NCT04140292|12039546|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4
7627132|NCT04140292|12039547|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16
7627141|NCT03553836|12039591|FG000|Overall Study|Ongoing in Study|460
7627142|NCT03553836|12039592|FG001|Overall Study|Ongoing in Study|459
7627143|NCT03553836|12039591|FG000|Overall Study|Withdrawal by Subject|9
7627144|NCT03553836|12039592|FG001|Overall Study|Withdrawal by Subject|10
7627145|NCT03553836|12039591|FG000|Overall Study|Lost to Follow-up|1
7627146|NCT03553836|12039592|FG001|Overall Study|Lost to Follow-up|3
7627147|NCT03553836|12039591|FG000|Overall Study|Death|17
7627148|NCT03553836|12039592|FG001|Overall Study|Death|17
7627149|NCT02954237|12039614|FG000|Overall Study|Withdrawal by Subject|25
7627150|NCT02954237|12039614|FG000|Overall Study|Missed visit|16
7627151|NCT02954237|12039614|FG000|Overall Study|Death|2
7627152|NCT02714218|12039630|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
7627153|NCT02714218|12039631|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1
7627154|NCT02714218|12039632|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
7627155|NCT02714218|12039630|FG000|Pre-Treatment Period|Other reasons|0
7627156|NCT02714218|12039631|FG001|Pre-Treatment Period|Other reasons|1
7627157|NCT02714218|12039632|FG002|Pre-Treatment Period|Other reasons|0
7627158|NCT02714218|12039630|FG000|Treatment Period|Disease Progression|55
7627159|NCT02714218|12039631|FG001|Treatment Period|Disease Progression|52
7627160|NCT02714218|12039632|FG002|Treatment Period|Disease Progression|14
7627161|NCT02714218|12039630|FG000|Treatment Period|Study drug toxicity|46
7627162|NCT02714218|12039631|FG001|Treatment Period|Study drug toxicity|70
7627163|NCT02714218|12039632|FG002|Treatment Period|Study drug toxicity|6
7591399|NCT04414618|11997602|FG000|Overall Study|Death|3
7591400|NCT04414618|11997603|FG001|Overall Study|Death|3
7591401|NCT04414618|11997602|FG000|Overall Study|Withdrawal by Subject|2
7591402|NCT04414618|11997603|FG001|Overall Study|Withdrawal by Subject|1
7591403|NCT04414618|11997602|FG000|Overall Study|Lost to Follow-up|2
7591404|NCT04414618|11997603|FG001|Overall Study|Lost to Follow-up|3
7591405|NCT04414618|11997602|FG000|Overall Study|Physician Decision|1
7591406|NCT04414618|11997603|FG001|Overall Study|Physician Decision|0
7591407|NCT04412057|11997612|FG000|Overall Study|Death|3
7591408|NCT04412057|11997613|FG001|Overall Study|Death|7
7591409|NCT04412057|11997612|FG000|Overall Study|Discharged prior to receiving study treatment|1
7591410|NCT04412057|11997613|FG001|Overall Study|Discharged prior to receiving study treatment|0
7591411|NCT04402060|11997622|FG000|Overall Study|Death|1
7591412|NCT04402060|11997623|FG001|Overall Study|Death|12
7591413|NCT04402060|11997624|FG002|Overall Study|Death|7
7591414|NCT04402060|11997622|FG000|Overall Study|Adverse Event|0
7591415|NCT04402060|11997623|FG001|Overall Study|Adverse Event|0
7591416|NCT04402060|11997624|FG002|Overall Study|Adverse Event|1
7591417|NCT04402060|11997622|FG000|Overall Study|Withdrawal by Subject|0
7591418|NCT04402060|11997623|FG001|Overall Study|Withdrawal by Subject|1
7591419|NCT04402060|11997624|FG002|Overall Study|Withdrawal by Subject|2
7591420|NCT04402060|11997622|FG000|Overall Study|Sponsor Request|0
7591421|NCT04402060|11997623|FG001|Overall Study|Sponsor Request|2
7591422|NCT04402060|11997624|FG002|Overall Study|Sponsor Request|0
7591423|NCT04402060|11997622|FG000|Overall Study|Physician Decision|0
7591424|NCT04402060|11997623|FG001|Overall Study|Physician Decision|0
7591425|NCT04402060|11997624|FG002|Overall Study|Physician Decision|1
7591426|NCT04402060|11997622|FG000|Overall Study|Other|0
7591427|NCT04402060|11997623|FG001|Overall Study|Other|1
7591428|NCT04402060|11997624|FG002|Overall Study|Other|0
7591429|NCT04396626|11997637|FG000|Overall Study|Premature termination of study|975
7591430|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7
7591431|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8
7591432|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7591433|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0
7591434|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Protocol Violation|2
7591435|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Protocol Violation|3
7591436|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Protocol Violation|0
7591437|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Protocol Violation|0
7591438|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Physician Decision|2
7591439|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Physician Decision|5
7591440|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Physician Decision|0
7591441|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Physician Decision|0
7591442|NCT04376684|11997663|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4
7591443|NCT04376684|11997664|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8
7591444|NCT04376684|11997665|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0
7591445|NCT04376684|11997666|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0
7591446|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7591447|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0
7591448|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7591449|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1
7591450|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Physician Decision|0
7591451|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Physician Decision|0
7591452|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Physician Decision|1
7591453|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Physician Decision|1
7591454|NCT04376684|11997663|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0
7591455|NCT04376684|11997664|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0
7591456|NCT04376684|11997665|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3
7591457|NCT04376684|11997666|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2
7591458|NCT04353284|11997678|FG000|Overall Study|Adverse Event|1
7591459|NCT04353284|11997679|FG001|Overall Study|Adverse Event|1
7591460|NCT04353284|11997678|FG000|Overall Study|Lost to Follow-up|1
7591461|NCT04353284|11997679|FG001|Overall Study|Lost to Follow-up|0
7591462|NCT04294147|11997687|FG000|Overall Study|Protocol Violation|2
7591463|NCT04294147|11997688|FG001|Overall Study|Protocol Violation|0
7591464|NCT04231825|11997700|FG000|Overall Study|Protocol Violation|3
7591465|NCT04231825|11997701|FG001|Overall Study|Protocol Violation|3
7591466|NCT04231825|11997700|FG000|Overall Study|Lost to Follow-up|0
7591467|NCT04231825|11997701|FG001|Overall Study|Lost to Follow-up|1
7591468|NCT04196686|11997707|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0
7591469|NCT04196686|11997708|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3
7591470|NCT04178772|11997714|FG000|Overall Study|Unsatisfacotry VIsual Response|1
7591471|NCT04178772|11997714|FG000|Overall Study|study terminated early due to COVID-19|7
7591472|NCT04148651|11997718|FG000|Overall Study|Lost to Follow-up|2
7591473|NCT03893448|11997733|FG000|Overall Study|Withdrawal by Parent/Guardian|59
7591474|NCT03893448|11997734|FG001|Overall Study|Withdrawal by Parent/Guardian|85
7591475|NCT03893448|11997733|FG000|Overall Study|Physician Decision|8
7591476|NCT03893448|11997734|FG001|Overall Study|Physician Decision|14
7591477|NCT03893448|11997733|FG000|Overall Study|Lost to Follow-up|34
7591478|NCT03893448|11997734|FG001|Overall Study|Lost to Follow-up|27
7591479|NCT03893448|11997733|FG000|Overall Study|Death|1
7591480|NCT03893448|11997734|FG001|Overall Study|Death|0
7270928|NCT00420290|11485301|FG000|Overall Study|Adverse Event|3
7270929|NCT00420290|11485302|FG001|Overall Study|Adverse Event|1
7270930|NCT00420290|11485301|FG000|Overall Study|Withdrawal by Subject|0
7270931|NCT00420290|11485302|FG001|Overall Study|Withdrawal by Subject|2
7270932|NCT00420290|11485301|FG000|Overall Study|did not meet inclusion/exclusion|1
7270933|NCT00420290|11485302|FG001|Overall Study|did not meet inclusion/exclusion|1
7270934|NCT00420303|11485310|FG000|Overall Study|Serious Adverse Event|1
7270935|NCT00420303|11485311|FG001|Overall Study|Serious Adverse Event|0
7270936|NCT00420303|11485310|FG000|Overall Study|Lack of Efficacy|0
7270937|NCT00420303|11485311|FG001|Overall Study|Lack of Efficacy|3
7270938|NCT00420303|11485310|FG000|Overall Study|Physician Decision|0
7270939|NCT00420303|11485311|FG001|Overall Study|Physician Decision|1
7270940|NCT00420316|11485319|FG000|Overall Study|Withdrawal by Subject|0
7270941|NCT00420316|11485320|FG001|Overall Study|Withdrawal by Subject|1
7270942|NCT00420316|11485319|FG000|Overall Study|Lost to Follow-up|12
7270943|NCT00420316|11485320|FG001|Overall Study|Lost to Follow-up|8
7270944|NCT00420342|11485329|FG000|Overall Study|Lost to Follow-up|1
7270945|NCT00420342|11485330|FG001|Overall Study|Lost to Follow-up|0
7270946|NCT00420342|11485331|FG002|Overall Study|Lost to Follow-up|1
7270947|NCT00420342|11485329|FG000|Overall Study|Withdrawal by Subject|0
7270948|NCT00420342|11485330|FG001|Overall Study|Withdrawal by Subject|2
7270949|NCT00420342|11485331|FG002|Overall Study|Withdrawal by Subject|0
7270950|NCT00420381|11485339|FG000|Overall Study|Protocol Violation|1
7270951|NCT00420407|11485345|FG000|Overall Study|Lost to Follow-up|0
7270952|NCT00420407|11485346|FG001|Overall Study|Lost to Follow-up|3
7270953|NCT00420407|11485345|FG000|Overall Study|Physician Decision|2
7270954|NCT00420407|11485346|FG001|Overall Study|Physician Decision|1
7270955|NCT00420407|11485345|FG000|Overall Study|subject identified as detainee|1
7270956|NCT00420407|11485346|FG001|Overall Study|subject identified as detainee|0
7270957|NCT00420407|11485345|FG000|Overall Study|subject identified as Jehovah's witness|1
7270958|NCT00420407|11485346|FG001|Overall Study|subject identified as Jehovah's witness|0
7270959|NCT00420407|11485345|FG000|Overall Study|Withdrawal by Subject|0
7270960|NCT00420407|11485346|FG001|Overall Study|Withdrawal by Subject|2
7270961|NCT00420420|11485355|FG000|Overall Study|Adverse Event|5
7270962|NCT00420420|11485356|FG001|Overall Study|Adverse Event|3
7270963|NCT00420420|11485355|FG000|Overall Study|Protocol Violation|1
7270964|NCT00420420|11485356|FG001|Overall Study|Protocol Violation|1
7270965|NCT00420420|11485355|FG000|Overall Study|Withdrawal by Subject|1
7270966|NCT00420420|11485356|FG001|Overall Study|Withdrawal by Subject|0
7270967|NCT00420420|11485355|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
7270968|NCT00420420|11485356|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
7270969|NCT00420511|11485370|FG000|Overall Study|Adverse Event|1
7270970|NCT00420511|11485371|FG001|Overall Study|Adverse Event|1
7270971|NCT00420511|11485370|FG000|Overall Study|Lost to Follow-up|1
7270972|NCT00420511|11485371|FG001|Overall Study|Lost to Follow-up|0
7270973|NCT00420628|11485381|FG000|Overall Study|Withdrawn by parent or gaurdian|5
7270974|NCT00420628|11485382|FG001|Overall Study|Withdrawn by parent or gaurdian|2
7270975|NCT00420628|11485381|FG000|Overall Study|Lost to Follow-up|3
7270976|NCT00420628|11485382|FG001|Overall Study|Lost to Follow-up|2
7270977|NCT00420628|11485381|FG000|Overall Study|Adverse Event|1
7270978|NCT00420628|11485382|FG001|Overall Study|Adverse Event|0
7270979|NCT00420641|11485391|FG000|Overall Study|Adverse Event|3
7270980|NCT00420641|11485392|FG001|Overall Study|Adverse Event|25
7270981|NCT00420641|11485393|FG002|Overall Study|Adverse Event|10
7270982|NCT00420641|11485391|FG000|Overall Study|Lost to Follow-up|2
7270983|NCT00420641|11485392|FG001|Overall Study|Lost to Follow-up|4
7270984|NCT00420641|11485393|FG002|Overall Study|Lost to Follow-up|2
7270985|NCT00420641|11485391|FG000|Overall Study|Protocol Violation|8
7270986|NCT00420641|11485392|FG001|Overall Study|Protocol Violation|8
7270987|NCT00420641|11485393|FG002|Overall Study|Protocol Violation|7
7270988|NCT00420641|11485391|FG000|Overall Study|Withdrawal by Subject|15
7270989|NCT00420641|11485392|FG001|Overall Study|Withdrawal by Subject|21
7270990|NCT00420641|11485393|FG002|Overall Study|Withdrawal by Subject|14
7270991|NCT00420641|11485391|FG000|Overall Study|Lack of Efficacy|6
7591565|NCT03811574|11997845|FG000|Overall Study|Withdrawal by Subject|2
7591566|NCT03811574|11997846|FG001|Overall Study|Withdrawal by Subject|4
7591567|NCT03811574|11997847|FG002|Overall Study|Withdrawal by Subject|0
7627164|NCT02714218|12039630|FG000|Treatment Period|Adverse event unrelated to study drug|13
7627165|NCT02714218|12039631|FG001|Treatment Period|Adverse event unrelated to study drug|6
7627166|NCT02714218|12039632|FG002|Treatment Period|Adverse event unrelated to study drug|1
7627167|NCT02714218|12039630|FG000|Treatment Period|Request to discontinue treatment|1
7627168|NCT02714218|12039631|FG001|Treatment Period|Request to discontinue treatment|4
7627169|NCT02714218|12039632|FG002|Treatment Period|Request to discontinue treatment|1
7627170|NCT02714218|12039630|FG000|Treatment Period|Participant withdrew consent|2
7627171|NCT02714218|12039631|FG001|Treatment Period|Participant withdrew consent|2
7627172|NCT02714218|12039632|FG002|Treatment Period|Participant withdrew consent|0
7627173|NCT02714218|12039630|FG000|Treatment Period|Maximum clinical benefit|4
7627174|NCT02714218|12039631|FG001|Treatment Period|Maximum clinical benefit|2
7627175|NCT02714218|12039632|FG002|Treatment Period|Maximum clinical benefit|0
7627176|NCT02714218|12039630|FG000|Treatment Period|Administrative reason by sponsor|2
7627177|NCT02714218|12039631|FG001|Treatment Period|Administrative reason by sponsor|1
7627178|NCT02714218|12039632|FG002|Treatment Period|Administrative reason by sponsor|0
7627179|NCT02714218|12039630|FG000|Treatment Period|Other reasons|6
7627180|NCT02714218|12039631|FG001|Treatment Period|Other reasons|6
7627181|NCT02714218|12039632|FG002|Treatment Period|Other reasons|0
7627182|NCT02714218|12039630|FG000|Treatment Period|Completed treatment as per protocol|36
7627183|NCT02714218|12039631|FG001|Treatment Period|Completed treatment as per protocol|27
7627184|NCT02714218|12039632|FG002|Treatment Period|Completed treatment as per protocol|3
7627185|NCT02714218|12039630|FG000|Treatment Period|Not reported|9
7270992|NCT00420641|11485392|FG001|Overall Study|Lack of Efficacy|5
7270993|NCT00420641|11485393|FG002|Overall Study|Lack of Efficacy|4
7270994|NCT00420641|11485391|FG000|Overall Study|Non-compliance|7
7270995|NCT00420641|11485392|FG001|Overall Study|Non-compliance|5
7270996|NCT00420641|11485393|FG002|Overall Study|Non-compliance|4
7270997|NCT00420641|11485391|FG000|Overall Study|Other|4
7270998|NCT00420641|11485392|FG001|Overall Study|Other|4
7270999|NCT00420641|11485393|FG002|Overall Study|Other|3
7271000|NCT00420745|11485403|FG000|Overall Study|Adverse Event|2
7271001|NCT00420745|11485404|FG001|Overall Study|Adverse Event|2
7271002|NCT00420745|11485403|FG000|Overall Study|Lost to Follow-up|10
7271003|NCT00420745|11485404|FG001|Overall Study|Lost to Follow-up|2
7271004|NCT00420745|11485403|FG000|Overall Study|Protocol Violation|1
7271005|NCT00420745|11485404|FG001|Overall Study|Protocol Violation|0
7271006|NCT00420745|11485403|FG000|Overall Study|Physician Decision|1
7271007|NCT00420745|11485404|FG001|Overall Study|Physician Decision|1
7271008|NCT00420745|11485403|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
7271009|NCT00420745|11485404|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
7271010|NCT00420745|11485403|FG000|Overall Study|Age limit exceeded for Dose 2|1
7271011|NCT00420745|11485404|FG001|Overall Study|Age limit exceeded for Dose 2|0
7271012|NCT00420784|11485423|FG000|Overall Study|Adverse Event|11
7271013|NCT00420784|11485424|FG001|Overall Study|Adverse Event|29
7271014|NCT00420784|11485425|FG002|Overall Study|Adverse Event|10
7271015|NCT00420784|11485426|FG003|Overall Study|Adverse Event|5
7271016|NCT00420784|11485423|FG000|Overall Study|Withdrawal by Subject|0
7271017|NCT00420784|11485424|FG001|Overall Study|Withdrawal by Subject|1
7271018|NCT00420784|11485425|FG002|Overall Study|Withdrawal by Subject|0
7591568|NCT03727750|11997883|FG000|Overall Study|Death|45
7591569|NCT03727750|11997883|FG000|Overall Study|Withdrawal by Subject|2
7591570|NCT03727750|11997883|FG000|Overall Study|Lost to Follow-up|1
7591571|NCT03727750|11997883|FG000|Overall Study|Other|1
7591572|NCT03715829|11997893|FG000|Dose Ranging Period|Adverse Event|2
7591573|NCT03715829|11997894|FG001|Dose Ranging Period|Adverse Event|4
7591574|NCT03715829|11997895|FG002|Dose Ranging Period|Adverse Event|5
7591575|NCT03715829|11997896|FG003|Dose Ranging Period|Adverse Event|2
7591576|NCT03715829|11997897|FG004|Dose Ranging Period|Adverse Event|3
7591577|NCT03715829|11997898|FG005|Dose Ranging Period|Adverse Event|3
7591578|NCT03715829|11997899|FG006|Dose Ranging Period|Adverse Event|0
7591579|NCT03715829|11997900|FG007|Dose Ranging Period|Adverse Event|0
7591580|NCT03715829|11997901|FG008|Dose Ranging Period|Adverse Event|0
7591581|NCT03715829|11997902|FG009|Dose Ranging Period|Adverse Event|0
7591582|NCT03715829|11997903|FG010|Dose Ranging Period|Adverse Event|0
7591583|NCT03715829|11997893|FG000|Dose Ranging Period|Lack of Efficacy|0
7591584|NCT03715829|11997894|FG001|Dose Ranging Period|Lack of Efficacy|1
7591585|NCT03715829|11997895|FG002|Dose Ranging Period|Lack of Efficacy|0
7591586|NCT03715829|11997896|FG003|Dose Ranging Period|Lack of Efficacy|1
7591587|NCT03715829|11997897|FG004|Dose Ranging Period|Lack of Efficacy|0
7591588|NCT03715829|11997898|FG005|Dose Ranging Period|Lack of Efficacy|0
7591589|NCT03715829|11997899|FG006|Dose Ranging Period|Lack of Efficacy|0
7591590|NCT03715829|11997900|FG007|Dose Ranging Period|Lack of Efficacy|0
7591591|NCT03715829|11997901|FG008|Dose Ranging Period|Lack of Efficacy|0
7591592|NCT03715829|11997902|FG009|Dose Ranging Period|Lack of Efficacy|0
7591593|NCT03715829|11997903|FG010|Dose Ranging Period|Lack of Efficacy|0
7591594|NCT03715829|11997893|FG000|Dose Ranging Period|Lost to Follow-up|2
7591595|NCT03715829|11997894|FG001|Dose Ranging Period|Lost to Follow-up|0
7591596|NCT03715829|11997895|FG002|Dose Ranging Period|Lost to Follow-up|1
7591597|NCT03715829|11997896|FG003|Dose Ranging Period|Lost to Follow-up|1
7591598|NCT03715829|11997897|FG004|Dose Ranging Period|Lost to Follow-up|1
7591599|NCT03715829|11997898|FG005|Dose Ranging Period|Lost to Follow-up|2
7591600|NCT03715829|11997899|FG006|Dose Ranging Period|Lost to Follow-up|0
7591601|NCT03715829|11997900|FG007|Dose Ranging Period|Lost to Follow-up|0
7591602|NCT03715829|11997901|FG008|Dose Ranging Period|Lost to Follow-up|0
7591603|NCT03715829|11997902|FG009|Dose Ranging Period|Lost to Follow-up|0
7591604|NCT03715829|11997903|FG010|Dose Ranging Period|Lost to Follow-up|0
7591605|NCT03715829|11997893|FG000|Dose Ranging Period|Protocol Violation|0
7591606|NCT03715829|11997894|FG001|Dose Ranging Period|Protocol Violation|0
7591607|NCT03715829|11997895|FG002|Dose Ranging Period|Protocol Violation|0
7591608|NCT03715829|11997896|FG003|Dose Ranging Period|Protocol Violation|1
7591609|NCT03715829|11997897|FG004|Dose Ranging Period|Protocol Violation|0
7591610|NCT03715829|11997898|FG005|Dose Ranging Period|Protocol Violation|0
7591611|NCT03715829|11997899|FG006|Dose Ranging Period|Protocol Violation|0
7591612|NCT03715829|11997900|FG007|Dose Ranging Period|Protocol Violation|0
7591613|NCT03715829|11997901|FG008|Dose Ranging Period|Protocol Violation|0
7591614|NCT03715829|11997902|FG009|Dose Ranging Period|Protocol Violation|0
7591615|NCT03715829|11997903|FG010|Dose Ranging Period|Protocol Violation|0
7591616|NCT03715829|11997893|FG000|Dose Ranging Period|Withdrawal by Subject|8
7271019|NCT00420784|11485426|FG003|Overall Study|Withdrawal by Subject|0
7271020|NCT00420784|11485423|FG000|Overall Study|Lost to Follow-up|0
7271021|NCT00420784|11485424|FG001|Overall Study|Lost to Follow-up|0
7271022|NCT00420784|11485425|FG002|Overall Study|Lost to Follow-up|2
7271023|NCT00420784|11485426|FG003|Overall Study|Lost to Follow-up|1
7271024|NCT00420784|11485423|FG000|Overall Study|Virologic Stopping Rule|17
7271025|NCT00420784|11485424|FG001|Overall Study|Virologic Stopping Rule|26
7271026|NCT00420784|11485425|FG002|Overall Study|Virologic Stopping Rule|41
7271027|NCT00420784|11485426|FG003|Overall Study|Virologic Stopping Rule|67
7271028|NCT00420784|11485423|FG000|Overall Study|Other|1
7271029|NCT00420784|11485424|FG001|Overall Study|Other|2
7271030|NCT00420784|11485425|FG002|Overall Study|Other|0
7271031|NCT00420784|11485426|FG003|Overall Study|Other|5
7271032|NCT00420849|11485437|FG000|Overall Study|Lack of Efficacy|154
7271033|NCT00420849|11485437|FG000|Overall Study|Adverse Event|107
7271034|NCT00420849|11485437|FG000|Overall Study|Withdrawal by Subject|28
7271035|NCT00420849|11485437|FG000|Overall Study|Death|18
7271036|NCT00420849|11485437|FG000|Overall Study|Other|14
7271037|NCT00420849|11485437|FG000|Overall Study|Transplant|8
7271038|NCT00420849|11485437|FG000|Overall Study|Protocol Violation|1
7271039|NCT00420849|11485437|FG000|Overall Study|Lost to Follow-up|1
7271040|NCT00420927|11485451|FG000|Period 1|Adverse Event|19
7271041|NCT00420927|11485452|FG001|Period 1|Adverse Event|15
7271042|NCT00420927|11485453|FG002|Period 1|Adverse Event|0
7271043|NCT00420927|11485454|FG003|Period 1|Adverse Event|0
7271044|NCT00420927|11485455|FG004|Period 1|Adverse Event|0
7271045|NCT00420927|11485456|FG005|Period 1|Adverse Event|0
7271046|NCT00420927|11485457|FG006|Period 1|Adverse Event|0
7271047|NCT00420927|11485451|FG000|Period 1|Withdrawal by Subject|7
7271048|NCT00420927|11485452|FG001|Period 1|Withdrawal by Subject|12
7271049|NCT00420927|11485453|FG002|Period 1|Withdrawal by Subject|0
7271050|NCT00420927|11485454|FG003|Period 1|Withdrawal by Subject|0
7271051|NCT00420927|11485455|FG004|Period 1|Withdrawal by Subject|0
7271052|NCT00420927|11485456|FG005|Period 1|Withdrawal by Subject|0
7271053|NCT00420927|11485457|FG006|Period 1|Withdrawal by Subject|0
7271054|NCT00420927|11485451|FG000|Period 1|Lost to Follow-up|8
7271055|NCT00420927|11485452|FG001|Period 1|Lost to Follow-up|6
7271056|NCT00420927|11485453|FG002|Period 1|Lost to Follow-up|0
7271057|NCT00420927|11485454|FG003|Period 1|Lost to Follow-up|0
7271058|NCT00420927|11485455|FG004|Period 1|Lost to Follow-up|0
7271059|NCT00420927|11485456|FG005|Period 1|Lost to Follow-up|0
7271060|NCT00420927|11485457|FG006|Period 1|Lost to Follow-up|0
7271061|NCT00420927|11485451|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
7271062|NCT00420927|11485452|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
7271063|NCT00420927|11485453|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
7271064|NCT00420927|11485454|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
7271065|NCT00420927|11485455|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
7271066|NCT00420927|11485456|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
7271067|NCT00420927|11485457|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
7271068|NCT00420927|11485451|FG000|Period 1|Death|2
7271069|NCT00420927|11485452|FG001|Period 1|Death|0
7271070|NCT00420927|11485453|FG002|Period 1|Death|0
7271071|NCT00420927|11485454|FG003|Period 1|Death|0
7271072|NCT00420927|11485455|FG004|Period 1|Death|0
7271073|NCT00420927|11485456|FG005|Period 1|Death|0
7271074|NCT00420927|11485457|FG006|Period 1|Death|0
7271075|NCT00420927|11485451|FG000|Period 1|Subject moved/relocated|0
7271076|NCT00420927|11485452|FG001|Period 1|Subject moved/relocated|2
7271077|NCT00420927|11485453|FG002|Period 1|Subject moved/relocated|0
7271078|NCT00420927|11485454|FG003|Period 1|Subject moved/relocated|0
7271079|NCT00420927|11485455|FG004|Period 1|Subject moved/relocated|0
7271080|NCT00420927|11485456|FG005|Period 1|Subject moved/relocated|0
7271081|NCT00420927|11485457|FG006|Period 1|Subject moved/relocated|0
7271082|NCT00420927|11485451|FG000|Period 1|Noncompliant with study drug|1
7271083|NCT00420927|11485452|FG001|Period 1|Noncompliant with study drug|1
7271084|NCT00420927|11485453|FG002|Period 1|Noncompliant with study drug|0
7271085|NCT00420927|11485454|FG003|Period 1|Noncompliant with study drug|0
7271086|NCT00420927|11485455|FG004|Period 1|Noncompliant with study drug|0
7271087|NCT00420927|11485456|FG005|Period 1|Noncompliant with study drug|0
7271088|NCT00420927|11485457|FG006|Period 1|Noncompliant with study drug|0
7271089|NCT00420927|11485451|FG000|Period 1|Randomization error|1
7271090|NCT00420927|11485452|FG001|Period 1|Randomization error|0
7591617|NCT03715829|11997894|FG001|Dose Ranging Period|Withdrawal by Subject|4
7591618|NCT03715829|11997895|FG002|Dose Ranging Period|Withdrawal by Subject|3
7591619|NCT03715829|11997896|FG003|Dose Ranging Period|Withdrawal by Subject|9
7591620|NCT03715829|11997897|FG004|Dose Ranging Period|Withdrawal by Subject|2
7591621|NCT03715829|11997898|FG005|Dose Ranging Period|Withdrawal by Subject|3
7591622|NCT03715829|11997899|FG006|Dose Ranging Period|Withdrawal by Subject|0
7591623|NCT03715829|11997900|FG007|Dose Ranging Period|Withdrawal by Subject|0
7591624|NCT03715829|11997901|FG008|Dose Ranging Period|Withdrawal by Subject|0
7591625|NCT03715829|11997902|FG009|Dose Ranging Period|Withdrawal by Subject|0
7591626|NCT03715829|11997903|FG010|Dose Ranging Period|Withdrawal by Subject|0
7591627|NCT03715829|11997893|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591628|NCT03715829|11997894|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591629|NCT03715829|11997895|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1
7591630|NCT03715829|11997896|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591631|NCT03715829|11997897|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591632|NCT03715829|11997898|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591633|NCT03715829|11997899|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591634|NCT03715829|11997900|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591635|NCT03715829|11997901|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591636|NCT03715829|11997902|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591832|NCT03387150|11998110|FG005|Overall Study|Withdrawal by Subject|2
7591637|NCT03715829|11997903|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
7591638|NCT03715829|11997893|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591639|NCT03715829|11997894|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591640|NCT03715829|11997895|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7591641|NCT03715829|11997896|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591642|NCT03715829|11997897|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
7591643|NCT03715829|11997898|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591644|NCT03715829|11997899|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591645|NCT03715829|11997900|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591646|NCT03715829|11997901|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591647|NCT03715829|11997902|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591648|NCT03715829|11997903|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
7591649|NCT03715829|11997893|FG000|Dose Ranging Period|Other|0
7591650|NCT03715829|11997894|FG001|Dose Ranging Period|Other|0
7591651|NCT03715829|11997895|FG002|Dose Ranging Period|Other|2
7591652|NCT03715829|11997896|FG003|Dose Ranging Period|Other|0
7591653|NCT03715829|11997897|FG004|Dose Ranging Period|Other|0
7591654|NCT03715829|11997898|FG005|Dose Ranging Period|Other|3
7591655|NCT03715829|11997899|FG006|Dose Ranging Period|Other|0
7591656|NCT03715829|11997900|FG007|Dose Ranging Period|Other|0
7591657|NCT03715829|11997901|FG008|Dose Ranging Period|Other|0
7591658|NCT03715829|11997902|FG009|Dose Ranging Period|Other|0
7591659|NCT03715829|11997903|FG010|Dose Ranging Period|Other|0
7591660|NCT03715829|11997893|FG000|Extension Period|Adverse Event|0
7591661|NCT03715829|11997894|FG001|Extension Period|Adverse Event|0
7591662|NCT03715829|11997895|FG002|Extension Period|Adverse Event|0
7591663|NCT03715829|11997896|FG003|Extension Period|Adverse Event|0
7591664|NCT03715829|11997897|FG004|Extension Period|Adverse Event|0
7591665|NCT03715829|11997898|FG005|Extension Period|Adverse Event|0
7591666|NCT03715829|11997899|FG006|Extension Period|Adverse Event|3
7591667|NCT03715829|11997900|FG007|Extension Period|Adverse Event|1
7591668|NCT03715829|11997901|FG008|Extension Period|Adverse Event|6
7591669|NCT03715829|11997902|FG009|Extension Period|Adverse Event|0
7591670|NCT03715829|11997903|FG010|Extension Period|Adverse Event|0
7591671|NCT03715829|11997893|FG000|Extension Period|Lack of Efficacy|0
7591672|NCT03715829|11997894|FG001|Extension Period|Lack of Efficacy|0
7591673|NCT03715829|11997895|FG002|Extension Period|Lack of Efficacy|0
7591674|NCT03715829|11997896|FG003|Extension Period|Lack of Efficacy|0
7591675|NCT03715829|11997897|FG004|Extension Period|Lack of Efficacy|0
7591676|NCT03715829|11997898|FG005|Extension Period|Lack of Efficacy|0
7591677|NCT03715829|11997899|FG006|Extension Period|Lack of Efficacy|1
7591678|NCT03715829|11997900|FG007|Extension Period|Lack of Efficacy|9
7591679|NCT03715829|11997901|FG008|Extension Period|Lack of Efficacy|2
7591680|NCT03715829|11997902|FG009|Extension Period|Lack of Efficacy|0
7591681|NCT03715829|11997903|FG010|Extension Period|Lack of Efficacy|0
7591682|NCT03715829|11997893|FG000|Extension Period|Lost to Follow-up|0
7591683|NCT03715829|11997894|FG001|Extension Period|Lost to Follow-up|0
7271091|NCT00420927|11485453|FG002|Period 1|Randomization error|0
7271092|NCT00420927|11485454|FG003|Period 1|Randomization error|0
7591684|NCT03715829|11997895|FG002|Extension Period|Lost to Follow-up|0
7591685|NCT03715829|11997896|FG003|Extension Period|Lost to Follow-up|0
7591686|NCT03715829|11997897|FG004|Extension Period|Lost to Follow-up|0
7591687|NCT03715829|11997898|FG005|Extension Period|Lost to Follow-up|0
7591688|NCT03715829|11997899|FG006|Extension Period|Lost to Follow-up|0
7591689|NCT03715829|11997900|FG007|Extension Period|Lost to Follow-up|0
7591690|NCT03715829|11997901|FG008|Extension Period|Lost to Follow-up|2
7591691|NCT03715829|11997902|FG009|Extension Period|Lost to Follow-up|0
7591692|NCT03715829|11997903|FG010|Extension Period|Lost to Follow-up|0
7591693|NCT03715829|11997893|FG000|Extension Period|Protocol Violation|0
7591694|NCT03715829|11997894|FG001|Extension Period|Protocol Violation|0
7591695|NCT03715829|11997895|FG002|Extension Period|Protocol Violation|0
7591696|NCT03715829|11997896|FG003|Extension Period|Protocol Violation|0
7591697|NCT03715829|11997897|FG004|Extension Period|Protocol Violation|0
7591698|NCT03715829|11997898|FG005|Extension Period|Protocol Violation|0
7591699|NCT03715829|11997899|FG006|Extension Period|Protocol Violation|0
7591700|NCT03715829|11997900|FG007|Extension Period|Protocol Violation|0
7591701|NCT03715829|11997901|FG008|Extension Period|Protocol Violation|1
7591702|NCT03715829|11997902|FG009|Extension Period|Protocol Violation|0
7591703|NCT03715829|11997903|FG010|Extension Period|Protocol Violation|0
7591704|NCT03715829|11997893|FG000|Extension Period|Withdrawal by Subject|0
7591705|NCT03715829|11997894|FG001|Extension Period|Withdrawal by Subject|0
7591706|NCT03715829|11997895|FG002|Extension Period|Withdrawal by Subject|0
7591707|NCT03715829|11997896|FG003|Extension Period|Withdrawal by Subject|0
7591708|NCT03715829|11997897|FG004|Extension Period|Withdrawal by Subject|0
7591709|NCT03715829|11997898|FG005|Extension Period|Withdrawal by Subject|0
7591710|NCT03715829|11997899|FG006|Extension Period|Withdrawal by Subject|3
7591711|NCT03715829|11997900|FG007|Extension Period|Withdrawal by Subject|3
7591712|NCT03715829|11997901|FG008|Extension Period|Withdrawal by Subject|12
7591713|NCT03715829|11997902|FG009|Extension Period|Withdrawal by Subject|3
7591714|NCT03715829|11997903|FG010|Extension Period|Withdrawal by Subject|0
7591715|NCT03715829|11997893|FG000|Extension Period|Medication Error Without Associated Adverse Event|0
7591716|NCT03715829|11997894|FG001|Extension Period|Medication Error Without Associated Adverse Event|0
7591717|NCT03715829|11997895|FG002|Extension Period|Medication Error Without Associated Adverse Event|0
7591718|NCT03715829|11997896|FG003|Extension Period|Medication Error Without Associated Adverse Event|0
7591719|NCT03715829|11997897|FG004|Extension Period|Medication Error Without Associated Adverse Event|0
7591720|NCT03715829|11997898|FG005|Extension Period|Medication Error Without Associated Adverse Event|0
7591721|NCT03715829|11997899|FG006|Extension Period|Medication Error Without Associated Adverse Event|0
7591722|NCT03715829|11997900|FG007|Extension Period|Medication Error Without Associated Adverse Event|1
7591723|NCT03715829|11997901|FG008|Extension Period|Medication Error Without Associated Adverse Event|1
7591724|NCT03715829|11997902|FG009|Extension Period|Medication Error Without Associated Adverse Event|0
7591725|NCT03715829|11997903|FG010|Extension Period|Medication Error Without Associated Adverse Event|0
7591726|NCT03715829|11997893|FG000|Extension Period|No Longer Meets Eligibility Criteria|0
7591727|NCT03715829|11997894|FG001|Extension Period|No Longer Meets Eligibility Criteria|0
7591728|NCT03715829|11997895|FG002|Extension Period|No Longer Meets Eligibility Criteria|0
7591729|NCT03715829|11997896|FG003|Extension Period|No Longer Meets Eligibility Criteria|0
7591730|NCT03715829|11997897|FG004|Extension Period|No Longer Meets Eligibility Criteria|0
7591731|NCT03715829|11997898|FG005|Extension Period|No Longer Meets Eligibility Criteria|0
7591732|NCT03715829|11997899|FG006|Extension Period|No Longer Meets Eligibility Criteria|0
7591733|NCT03715829|11997900|FG007|Extension Period|No Longer Meets Eligibility Criteria|0
7591734|NCT03715829|11997901|FG008|Extension Period|No Longer Meets Eligibility Criteria|1
7591735|NCT03715829|11997902|FG009|Extension Period|No Longer Meets Eligibility Criteria|0
7591736|NCT03715829|11997903|FG010|Extension Period|No Longer Meets Eligibility Criteria|0
7591737|NCT03715829|11997893|FG000|Extension Period|Other|0
7591738|NCT03715829|11997894|FG001|Extension Period|Other|0
7591739|NCT03715829|11997895|FG002|Extension Period|Other|0
7591740|NCT03715829|11997896|FG003|Extension Period|Other|0
7591741|NCT03715829|11997897|FG004|Extension Period|Other|0
7591742|NCT03715829|11997898|FG005|Extension Period|Other|0
7591743|NCT03715829|11997899|FG006|Extension Period|Other|1
7591744|NCT03715829|11997900|FG007|Extension Period|Other|2
7591745|NCT03715829|11997901|FG008|Extension Period|Other|4
7591746|NCT03715829|11997902|FG009|Extension Period|Other|0
7591747|NCT03715829|11997903|FG010|Extension Period|Other|0
7591748|NCT03693430|11997931|FG000|Overall Study|Lost to Follow-up|3
7591749|NCT03693430|11997932|FG001|Overall Study|Lost to Follow-up|14
7591750|NCT03693430|11997931|FG000|Overall Study|Death|1
7591751|NCT03693430|11997932|FG001|Overall Study|Death|0
7591752|NCT03693430|11997931|FG000|Overall Study|Withdrawal by Subject|0
7591753|NCT03693430|11997932|FG001|Overall Study|Withdrawal by Subject|4
7591754|NCT03677934|11997940|FG000|Overall Study|Study is ongoing|240
7591755|NCT03677934|11997941|FG001|Overall Study|Study is ongoing|161
7591756|NCT03677934|11997940|FG000|Overall Study|Adverse Event|5
7591757|NCT03677934|11997941|FG001|Overall Study|Adverse Event|0
7591758|NCT03677934|11997940|FG000|Overall Study|Death|2
7591759|NCT03677934|11997941|FG001|Overall Study|Death|0
7591760|NCT03677934|11997940|FG000|Overall Study|Withdrawal by Subject|0
7591761|NCT03677934|11997941|FG001|Overall Study|Withdrawal by Subject|5
7591762|NCT03677934|11997940|FG000|Overall Study|Physician Decision|0
7591763|NCT03677934|11997941|FG001|Overall Study|Physician Decision|1
7591764|NCT03677934|11997940|FG000|Overall Study|Damaged implant (no associated AE reported)|1
7591765|NCT03677934|11997941|FG001|Overall Study|Damaged implant (no associated AE reported)|0
7627186|NCT02714218|12039631|FG001|Treatment Period|Not reported|6
7627187|NCT02714218|12039632|FG002|Treatment Period|Not reported|0
7627216|NCT02652949|12039649|FG000|30-Day Follow-up for Primary Endpoint|Death|1
7627217|NCT02652949|12039649|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
7627218|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Death|5
7627219|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
7627220|NCT02652949|12039649|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
7591766|NCT03575104|11997983|FG000|Overall Study|Adverse Event|4
7591767|NCT03575104|11997984|FG001|Overall Study|Adverse Event|3
7591768|NCT03575104|11997985|FG002|Overall Study|Adverse Event|4
7591769|NCT03575104|11997983|FG000|Overall Study|Withdrawal by Subject|13
7591770|NCT03575104|11997984|FG001|Overall Study|Withdrawal by Subject|16
7591771|NCT03575104|11997985|FG002|Overall Study|Withdrawal by Subject|11
7591772|NCT03575104|11997983|FG000|Overall Study|Other reasons|6
7591773|NCT03575104|11997984|FG001|Overall Study|Other reasons|8
7591774|NCT03575104|11997985|FG002|Overall Study|Other reasons|6
7591775|NCT03575104|11997983|FG000|Overall Study|Lost to Follow-up|1
7591776|NCT03575104|11997984|FG001|Overall Study|Lost to Follow-up|2
7591777|NCT03575104|11997985|FG002|Overall Study|Lost to Follow-up|1
7591778|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
7591779|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2
7591780|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5
7591781|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7591782|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
7591783|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
7591784|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7
7591785|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10
7591786|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9
7591787|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7591788|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
7591789|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6
7591790|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591791|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591792|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
7591793|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591794|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591795|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
7591796|NCT03569475|11997996|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7591797|NCT03569475|11997997|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
7591798|NCT03569475|11997998|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2
7591799|NCT03569475|11997996|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0
7591800|NCT03569475|11997997|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7591801|NCT03569475|11997998|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
7591802|NCT03569475|11997996|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0
7591803|NCT03569475|11997997|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7591804|NCT03569475|11997998|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
7591805|NCT03545191|11998052|FG000|Overall Study|Death|1
7591806|NCT03545191|11998053|FG001|Overall Study|Death|0
7591807|NCT03545191|11998054|FG002|Overall Study|Death|0
7591808|NCT03545191|11998052|FG000|Overall Study|Adverse Event|4
7591809|NCT03545191|11998053|FG001|Overall Study|Adverse Event|2
7591810|NCT03545191|11998054|FG002|Overall Study|Adverse Event|7
7591811|NCT03545191|11998052|FG000|Overall Study|Other reasons|3
7591812|NCT03545191|11998053|FG001|Overall Study|Other reasons|11
7591813|NCT03545191|11998054|FG002|Overall Study|Other reasons|8
7591814|NCT03545191|11998052|FG000|Overall Study|Withdrawal by Subject|13
7591815|NCT03545191|11998053|FG001|Overall Study|Withdrawal by Subject|10
7591816|NCT03545191|11998054|FG002|Overall Study|Withdrawal by Subject|12
7591817|NCT03545191|11998052|FG000|Overall Study|Lost to Follow-up|1
7591818|NCT03545191|11998053|FG001|Overall Study|Lost to Follow-up|2
7591819|NCT03545191|11998054|FG002|Overall Study|Lost to Follow-up|3
7591820|NCT03500549|11998064|FG000|RCP (Day 1 - Week 16)|Adverse Event|3
7591821|NCT03500549|11998065|FG001|RCP (Day 1 - Week 16)|Adverse Event|0
7591822|NCT03500549|11998064|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3
7591823|NCT03500549|11998065|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7
7591824|NCT03456700|11998076|FG000|Overall Study|Withdrawal by Subject|1
7591825|NCT03427411|11998091|FG000|Overall Study|Screen failure - platelets too low|0
7591826|NCT03427411|11998092|FG001|Overall Study|Screen failure - platelets too low|1
7591827|NCT03387150|11998105|FG000|Overall Study|Withdrawal by Subject|3
7591828|NCT03387150|11998106|FG001|Overall Study|Withdrawal by Subject|0
7591829|NCT03387150|11998107|FG002|Overall Study|Withdrawal by Subject|3
7591830|NCT03387150|11998108|FG003|Overall Study|Withdrawal by Subject|4
7591831|NCT03387150|11998109|FG004|Overall Study|Withdrawal by Subject|1
7591833|NCT03387150|11998111|FG006|Overall Study|Withdrawal by Subject|0
7591834|NCT03387150|11998105|FG000|Overall Study|Lost to Follow-up|3
7591835|NCT03387150|11998106|FG001|Overall Study|Lost to Follow-up|2
7591836|NCT03387150|11998107|FG002|Overall Study|Lost to Follow-up|2
7591837|NCT03387150|11998108|FG003|Overall Study|Lost to Follow-up|3
7591838|NCT03387150|11998109|FG004|Overall Study|Lost to Follow-up|3
7591839|NCT03387150|11998110|FG005|Overall Study|Lost to Follow-up|3
7591840|NCT03387150|11998111|FG006|Overall Study|Lost to Follow-up|0
7591841|NCT03387150|11998105|FG000|Overall Study|Participant unable to adhere to visit|0
7591842|NCT03387150|11998106|FG001|Overall Study|Participant unable to adhere to visit|1
7591843|NCT03387150|11998107|FG002|Overall Study|Participant unable to adhere to visit|0
7591844|NCT03387150|11998108|FG003|Overall Study|Participant unable to adhere to visit|0
7591845|NCT03387150|11998109|FG004|Overall Study|Participant unable to adhere to visit|2
7591846|NCT03387150|11998110|FG005|Overall Study|Participant unable to adhere to visit|2
7591847|NCT03387150|11998111|FG006|Overall Study|Participant unable to adhere to visit|0
7627221|NCT02652949|12039649|FG000|12-Month Follow-up Secondary Endpoint|Death|4
7627222|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Death|2
7627223|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
7627224|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
7627225|NCT02652949|12039649|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27
7627226|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Death|2
7627227|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1
7627228|NCT02652949|12039649|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error-to be corrected by site|1
7627229|NCT02649439|12039661|FG000|Overall Study|Switched to alternative treatment|6
7627230|NCT02649439|12039662|FG001|Overall Study|Switched to alternative treatment|4
7627231|NCT02649439|12039661|FG000|Overall Study|Patient decision|1
7627232|NCT02649439|12039662|FG001|Overall Study|Patient decision|0
7627233|NCT02649439|12039661|FG000|Overall Study|Patient going out of country|1
7627234|NCT02649439|12039662|FG001|Overall Study|Patient going out of country|0
7627235|NCT02649439|12039661|FG000|Overall Study|To start finasteride|1
7627236|NCT02649439|12039662|FG001|Overall Study|To start finasteride|0
7627237|NCT02649439|12039661|FG000|Overall Study|Physician Decision|1
7627238|NCT02649439|12039662|FG001|Overall Study|Physician Decision|0
7591938|NCT03366792|11998153|FG000|Overall Study|Withdrawal by Subject|7
7591939|NCT03366792|11998153|FG000|Overall Study|Lost to Follow-up|2
7591940|NCT03366792|11998153|FG000|Overall Study|Ineligible (could not reach perinium)|2
7591941|NCT03366792|11998153|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4
7591942|NCT03366337|11998161|FG000|Overall Study|Lost to Follow-up|1
7591943|NCT03366337|11998162|FG001|Overall Study|Lost to Follow-up|0
7591944|NCT03366337|11998163|FG002|Overall Study|Lost to Follow-up|1
7591945|NCT03366337|11998164|FG003|Overall Study|Lost to Follow-up|0
7591946|NCT03366337|11998161|FG000|Overall Study|Withdrawal by Subject|2
7591947|NCT03366337|11998162|FG001|Overall Study|Withdrawal by Subject|0
7591948|NCT03366337|11998163|FG002|Overall Study|Withdrawal by Subject|1
7591949|NCT03366337|11998164|FG003|Overall Study|Withdrawal by Subject|1
7591950|NCT03342053|11998176|FG000|Overall Study|Adverse Event|2
7591951|NCT03342053|11998177|FG001|Overall Study|Adverse Event|0
7591952|NCT03342053|11998176|FG000|Overall Study|Withdrawal by Subject|0
7591953|NCT03342053|11998177|FG001|Overall Study|Withdrawal by Subject|1
7591954|NCT03283241|11998185|FG000|Overall Study|Adverse Event|4
7591955|NCT03283241|11998186|FG001|Overall Study|Adverse Event|1
7591956|NCT03283241|11998185|FG000|Overall Study|Withdrawal by Subject|0
7591957|NCT03283241|11998186|FG001|Overall Study|Withdrawal by Subject|1
7591958|NCT03283241|11998185|FG000|Overall Study|Subject relocated to Finland|0
7591959|NCT03283241|11998186|FG001|Overall Study|Subject relocated to Finland|1
7591960|NCT03242772|11998194|FG000|Overall Study|Lost to Follow-up|2
7591961|NCT03242772|11998195|FG001|Overall Study|Lost to Follow-up|0
7591962|NCT03242772|11998194|FG000|Overall Study|Physician Decision|0
7591963|NCT03242772|11998195|FG001|Overall Study|Physician Decision|1
7591964|NCT03242772|11998194|FG000|Overall Study|Withdrawal by Subject|1
7591965|NCT03242772|11998195|FG001|Overall Study|Withdrawal by Subject|0
7591966|NCT03236311|11998203|FG000|Overall Study|Study terminated by sponsor|0
7591967|NCT03236311|11998204|FG001|Overall Study|Study terminated by sponsor|2
7591968|NCT03236311|11998203|FG000|Overall Study|Adverse Event|0
7591969|NCT03236311|11998204|FG001|Overall Study|Adverse Event|1
7591970|NCT03192046|11998212|FG000|Overall Study|Withdrawal by Subject|1
7591971|NCT03192046|11998213|FG001|Overall Study|Withdrawal by Subject|1
7591972|NCT03190369|11998221|FG000|Overall Study|Poor compliance to protocol|0
7591973|NCT03190369|11998222|FG001|Overall Study|Poor compliance to protocol|1
7591974|NCT03190369|11998221|FG000|Overall Study|Withdraw before treatment|1
7591975|NCT03190369|11998222|FG001|Overall Study|Withdraw before treatment|5
7591976|NCT03190369|11998221|FG000|Overall Study|Randomized but not treated|0
7591977|NCT03190369|11998222|FG001|Overall Study|Randomized but not treated|2
7627239|NCT02649439|12039661|FG000|Overall Study|Disease progression on study|12
7627240|NCT02649439|12039662|FG001|Overall Study|Disease progression on study|13
7627241|NCT02649439|12039661|FG000|Overall Study|Refused further treatment|1
7627242|NCT02649439|12039662|FG001|Overall Study|Refused further treatment|0
7627243|NCT02649439|12039661|FG000|Overall Study|Refused further follow up|2
7627244|NCT02649439|12039662|FG001|Overall Study|Refused further follow up|7
7627245|NCT02649439|12039661|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
7627246|NCT02649439|12039662|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
7627247|NCT02649439|12039661|FG000|Overall Study|No treatment, per protocol|1
7627248|NCT02649439|12039662|FG001|Overall Study|No treatment, per protocol|0
7627249|NCT02649439|12039661|FG000|Overall Study|PSA DT makes ineligible|0
7627250|NCT02649439|12039662|FG001|Overall Study|PSA DT makes ineligible|1
7627251|NCT02649439|12039661|FG000|Overall Study|Rising PSA No Mets|0
7627252|NCT02649439|12039662|FG001|Overall Study|Rising PSA No Mets|1
7627253|NCT02649439|12039661|FG000|Overall Study|Rising PSA|0
7627254|NCT02649439|12039662|FG001|Overall Study|Rising PSA|1
7627255|NCT02649439|12039661|FG000|Overall Study|Signed follow up protocol|0
7627256|NCT02649439|12039662|FG001|Overall Study|Signed follow up protocol|1
7591978|NCT04657198|11998231|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1
7591979|NCT04657198|11998232|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7591980|NCT04657198|11998233|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0
7591981|NCT04590586|11998247|FG000|Overall Study|Death|7
7591982|NCT04590586|11998248|FG001|Overall Study|Death|1
7591983|NCT04590586|11998249|FG002|Overall Study|Death|37
7591984|NCT04590586|11998250|FG003|Overall Study|Death|34
7591985|NCT04590586|11998251|FG004|Overall Study|Death|19
7591986|NCT04590586|11998252|FG005|Overall Study|Death|3
7591987|NCT04590586|11998247|FG000|Overall Study|Lost to Follow-up|3
7591988|NCT04590586|11998248|FG001|Overall Study|Lost to Follow-up|0
7591989|NCT04590586|11998249|FG002|Overall Study|Lost to Follow-up|11
7591990|NCT04590586|11998250|FG003|Overall Study|Lost to Follow-up|11
7591991|NCT04590586|11998251|FG004|Overall Study|Lost to Follow-up|6
7591992|NCT04590586|11998252|FG005|Overall Study|Lost to Follow-up|0
7591993|NCT04590586|11998247|FG000|Overall Study|Withdrawal by Subject|0
7591994|NCT04590586|11998248|FG001|Overall Study|Withdrawal by Subject|0
7591995|NCT04590586|11998249|FG002|Overall Study|Withdrawal by Subject|6
7591996|NCT04590586|11998250|FG003|Overall Study|Withdrawal by Subject|0
7591997|NCT04590586|11998251|FG004|Overall Study|Withdrawal by Subject|3
7591998|NCT04590586|11998252|FG005|Overall Study|Withdrawal by Subject|0
7591999|NCT04590586|11998247|FG000|Overall Study|Other|3
7592000|NCT04590586|11998248|FG001|Overall Study|Other|0
7592001|NCT04590586|11998249|FG002|Overall Study|Other|1
7592002|NCT04590586|11998250|FG003|Overall Study|Other|1
7592003|NCT04590586|11998251|FG004|Overall Study|Other|2
7592004|NCT04590586|11998252|FG005|Overall Study|Other|1
7592005|NCT04312009|11998278|FG000|Overall Study|Withdrawal by Subject|2
7592006|NCT04312009|11998279|FG001|Overall Study|Withdrawal by Subject|1
7592007|NCT04191382|11998288|FG000|Overall Study|Withdrawal by Subject|1
7592008|NCT04191382|11998289|FG001|Overall Study|Withdrawal by Subject|0
7592009|NCT04191382|11998290|FG002|Overall Study|Withdrawal by Subject|0
7592010|NCT03937466|11998307|FG000|Overall Study|not eligbile after the 2-week diary|9
7592011|NCT03937466|11998307|FG000|Overall Study|never returned their diary|6
7592012|NCT03937466|11998307|FG000|Overall Study|dropped out of study before getting Chilipad|5
7592013|NCT03937466|11998307|FG000|Overall Study|3 did not complete follow-up questionnaire.|3
7592014|NCT03850483|11998320|FG000|Treatment for Stage 1|Adverse Event|1
7592015|NCT03850483|11998321|FG001|Treatment for Stage 1|Adverse Event|1
7592016|NCT03850483|11998322|FG002|Treatment for Stage 1|Adverse Event|3
7592017|NCT03850483|11998323|FG003|Treatment for Stage 1|Adverse Event|0
7592018|NCT03850483|11998324|FG004|Treatment for Stage 1|Adverse Event|2
7592019|NCT03850483|11998325|FG005|Treatment for Stage 1|Adverse Event|0
7592020|NCT03850483|11998326|FG006|Treatment for Stage 1|Adverse Event|2
7592021|NCT03850483|11998327|FG007|Treatment for Stage 1|Adverse Event|2
7592022|NCT03850483|11998328|FG008|Treatment for Stage 1|Adverse Event|0
7592023|NCT03850483|11998329|FG009|Treatment for Stage 1|Adverse Event|0
7592024|NCT03850483|11998320|FG000|Treatment for Stage 1|Withdrawal by Subject|4
7592025|NCT03850483|11998321|FG001|Treatment for Stage 1|Withdrawal by Subject|4
7592026|NCT03850483|11998322|FG002|Treatment for Stage 1|Withdrawal by Subject|2
7592027|NCT03850483|11998323|FG003|Treatment for Stage 1|Withdrawal by Subject|2
7592028|NCT03850483|11998324|FG004|Treatment for Stage 1|Withdrawal by Subject|2
7592029|NCT03850483|11998325|FG005|Treatment for Stage 1|Withdrawal by Subject|1
7592030|NCT03850483|11998326|FG006|Treatment for Stage 1|Withdrawal by Subject|2
7592031|NCT03850483|11998327|FG007|Treatment for Stage 1|Withdrawal by Subject|3
7592032|NCT03850483|11998328|FG008|Treatment for Stage 1|Withdrawal by Subject|0
7592033|NCT03850483|11998329|FG009|Treatment for Stage 1|Withdrawal by Subject|0
7592034|NCT03850483|11998320|FG000|Treatment for Stage 1|Protocol Violation|1
7592035|NCT03850483|11998321|FG001|Treatment for Stage 1|Protocol Violation|0
7592036|NCT03850483|11998322|FG002|Treatment for Stage 1|Protocol Violation|0
7592037|NCT03850483|11998323|FG003|Treatment for Stage 1|Protocol Violation|0
7592038|NCT03850483|11998324|FG004|Treatment for Stage 1|Protocol Violation|0
7271093|NCT00420927|11485455|FG004|Period 1|Randomization error|0
7271094|NCT00420927|11485456|FG005|Period 1|Randomization error|0
7271095|NCT00420927|11485457|FG006|Period 1|Randomization error|0
7592039|NCT03850483|11998325|FG005|Treatment for Stage 1|Protocol Violation|0
7592040|NCT03850483|11998326|FG006|Treatment for Stage 1|Protocol Violation|1
7592041|NCT03850483|11998327|FG007|Treatment for Stage 1|Protocol Violation|0
7592042|NCT03850483|11998328|FG008|Treatment for Stage 1|Protocol Violation|0
7592043|NCT03850483|11998329|FG009|Treatment for Stage 1|Protocol Violation|0
7592044|NCT03850483|11998320|FG000|Treatment for Stage 1|Physician Decision|0
7592045|NCT03850483|11998321|FG001|Treatment for Stage 1|Physician Decision|0
7592046|NCT03850483|11998322|FG002|Treatment for Stage 1|Physician Decision|0
7592047|NCT03850483|11998323|FG003|Treatment for Stage 1|Physician Decision|0
7592048|NCT03850483|11998324|FG004|Treatment for Stage 1|Physician Decision|0
7592049|NCT03850483|11998325|FG005|Treatment for Stage 1|Physician Decision|1
7592050|NCT03850483|11998326|FG006|Treatment for Stage 1|Physician Decision|0
7592051|NCT03850483|11998327|FG007|Treatment for Stage 1|Physician Decision|0
7592052|NCT03850483|11998328|FG008|Treatment for Stage 1|Physician Decision|0
7592053|NCT03850483|11998329|FG009|Treatment for Stage 1|Physician Decision|0
7592054|NCT03850483|11998320|FG000|Treatment for Stage 1|Other|0
7592055|NCT03850483|11998321|FG001|Treatment for Stage 1|Other|0
7592056|NCT03850483|11998322|FG002|Treatment for Stage 1|Other|0
7592057|NCT03850483|11998323|FG003|Treatment for Stage 1|Other|0
7592058|NCT03850483|11998324|FG004|Treatment for Stage 1|Other|2
7592059|NCT03850483|11998325|FG005|Treatment for Stage 1|Other|1
7592060|NCT03850483|11998326|FG006|Treatment for Stage 1|Other|0
7592061|NCT03850483|11998327|FG007|Treatment for Stage 1|Other|0
7592062|NCT03850483|11998328|FG008|Treatment for Stage 1|Other|0
7592063|NCT03850483|11998329|FG009|Treatment for Stage 1|Other|0
7592064|NCT03850483|11998320|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592065|NCT03850483|11998321|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592066|NCT03850483|11998322|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1
7592067|NCT03850483|11998323|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592068|NCT03850483|11998324|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592069|NCT03850483|11998325|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592070|NCT03850483|11998326|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592071|NCT03850483|11998327|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592072|NCT03850483|11998328|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592073|NCT03850483|11998329|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0
7592074|NCT03850483|11998320|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592075|NCT03850483|11998321|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592076|NCT03850483|11998322|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592077|NCT03850483|11998323|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592078|NCT03850483|11998324|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592079|NCT03850483|11998325|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1
7592080|NCT03850483|11998326|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592081|NCT03850483|11998327|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592082|NCT03850483|11998328|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592083|NCT03850483|11998329|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0
7592084|NCT03850483|11998320|FG000|Treatment for Stage 1|Lost to Follow-up|0
7592085|NCT03850483|11998321|FG001|Treatment for Stage 1|Lost to Follow-up|1
7592086|NCT03850483|11998322|FG002|Treatment for Stage 1|Lost to Follow-up|1
7592087|NCT03850483|11998323|FG003|Treatment for Stage 1|Lost to Follow-up|1
7592088|NCT03850483|11998324|FG004|Treatment for Stage 1|Lost to Follow-up|0
7592089|NCT03850483|11998325|FG005|Treatment for Stage 1|Lost to Follow-up|1
7592090|NCT03850483|11998326|FG006|Treatment for Stage 1|Lost to Follow-up|2
7592091|NCT03850483|11998327|FG007|Treatment for Stage 1|Lost to Follow-up|0
7592092|NCT03850483|11998328|FG008|Treatment for Stage 1|Lost to Follow-up|0
7592093|NCT03850483|11998329|FG009|Treatment for Stage 1|Lost to Follow-up|0
7592094|NCT03850483|11998320|FG000|Treatment for Stage 1|Lack of Efficacy|1
7592095|NCT03850483|11998321|FG001|Treatment for Stage 1|Lack of Efficacy|2
7592096|NCT03850483|11998322|FG002|Treatment for Stage 1|Lack of Efficacy|2
7592097|NCT03850483|11998323|FG003|Treatment for Stage 1|Lack of Efficacy|3
7592098|NCT03850483|11998324|FG004|Treatment for Stage 1|Lack of Efficacy|2
7592099|NCT03850483|11998325|FG005|Treatment for Stage 1|Lack of Efficacy|4
7592100|NCT03850483|11998326|FG006|Treatment for Stage 1|Lack of Efficacy|3
7592101|NCT03850483|11998327|FG007|Treatment for Stage 1|Lack of Efficacy|1
7592102|NCT03850483|11998328|FG008|Treatment for Stage 1|Lack of Efficacy|0
7592103|NCT03850483|11998329|FG009|Treatment for Stage 1|Lack of Efficacy|0
7592104|NCT03850483|11998320|FG000|Treatment for Stage 1|Death|0
7592105|NCT03850483|11998321|FG001|Treatment for Stage 1|Death|0
7592106|NCT03850483|11998322|FG002|Treatment for Stage 1|Death|0
7592107|NCT03850483|11998323|FG003|Treatment for Stage 1|Death|0
7592108|NCT03850483|11998324|FG004|Treatment for Stage 1|Death|0
7592109|NCT03850483|11998325|FG005|Treatment for Stage 1|Death|1
7592110|NCT03850483|11998326|FG006|Treatment for Stage 1|Death|0
7592111|NCT03850483|11998327|FG007|Treatment for Stage 1|Death|0
7592112|NCT03850483|11998328|FG008|Treatment for Stage 1|Death|0
7592113|NCT03850483|11998329|FG009|Treatment for Stage 1|Death|0
7592114|NCT03850483|11998320|FG000|Treatment for Stage 1|Refused Further Treatment|1
7592115|NCT03850483|11998321|FG001|Treatment for Stage 1|Refused Further Treatment|0
7592116|NCT03850483|11998322|FG002|Treatment for Stage 1|Refused Further Treatment|2
7592117|NCT03850483|11998323|FG003|Treatment for Stage 1|Refused Further Treatment|0
7592118|NCT03850483|11998324|FG004|Treatment for Stage 1|Refused Further Treatment|1
7592119|NCT03850483|11998325|FG005|Treatment for Stage 1|Refused Further Treatment|0
7592120|NCT03850483|11998326|FG006|Treatment for Stage 1|Refused Further Treatment|1
7592121|NCT03850483|11998327|FG007|Treatment for Stage 1|Refused Further Treatment|0
7592122|NCT03850483|11998328|FG008|Treatment for Stage 1|Refused Further Treatment|0
7592123|NCT03850483|11998329|FG009|Treatment for Stage 1|Refused Further Treatment|0
7592124|NCT03850483|11998320|FG000|Treatment for Stage 1|Randomized but not Treated|0
7592125|NCT03850483|11998321|FG001|Treatment for Stage 1|Randomized but not Treated|0
7592126|NCT03850483|11998322|FG002|Treatment for Stage 1|Randomized but not Treated|0
7592127|NCT03850483|11998323|FG003|Treatment for Stage 1|Randomized but not Treated|0
7592128|NCT03850483|11998324|FG004|Treatment for Stage 1|Randomized but not Treated|0
7592129|NCT03850483|11998325|FG005|Treatment for Stage 1|Randomized but not Treated|1
7592130|NCT03850483|11998326|FG006|Treatment for Stage 1|Randomized but not Treated|0
7592131|NCT03850483|11998327|FG007|Treatment for Stage 1|Randomized but not Treated|0
7592132|NCT03850483|11998328|FG008|Treatment for Stage 1|Randomized but not Treated|0
7592133|NCT03850483|11998329|FG009|Treatment for Stage 1|Randomized but not Treated|0
7592134|NCT03850483|11998320|FG000|Follow-up for Stage 1|Withdrawal by Subject|0
7592135|NCT03850483|11998321|FG001|Follow-up for Stage 1|Withdrawal by Subject|0
7592136|NCT03850483|11998322|FG002|Follow-up for Stage 1|Withdrawal by Subject|0
7592137|NCT03850483|11998323|FG003|Follow-up for Stage 1|Withdrawal by Subject|0
7592138|NCT03850483|11998324|FG004|Follow-up for Stage 1|Withdrawal by Subject|0
7592139|NCT03850483|11998325|FG005|Follow-up for Stage 1|Withdrawal by Subject|0
7592140|NCT03850483|11998326|FG006|Follow-up for Stage 1|Withdrawal by Subject|1
7592141|NCT03850483|11998327|FG007|Follow-up for Stage 1|Withdrawal by Subject|2
7592142|NCT03850483|11998328|FG008|Follow-up for Stage 1|Withdrawal by Subject|0
7592143|NCT03850483|11998329|FG009|Follow-up for Stage 1|Withdrawal by Subject|0
7592144|NCT03850483|11998320|FG000|Follow-up for Stage 1|Physician Decision|0
7592145|NCT03850483|11998321|FG001|Follow-up for Stage 1|Physician Decision|0
7592146|NCT03850483|11998322|FG002|Follow-up for Stage 1|Physician Decision|0
7592147|NCT03850483|11998323|FG003|Follow-up for Stage 1|Physician Decision|0
7592148|NCT03850483|11998324|FG004|Follow-up for Stage 1|Physician Decision|1
7592149|NCT03850483|11998325|FG005|Follow-up for Stage 1|Physician Decision|0
7592150|NCT03850483|11998326|FG006|Follow-up for Stage 1|Physician Decision|1
7592151|NCT03850483|11998327|FG007|Follow-up for Stage 1|Physician Decision|0
7592152|NCT03850483|11998328|FG008|Follow-up for Stage 1|Physician Decision|0
7592153|NCT03850483|11998329|FG009|Follow-up for Stage 1|Physician Decision|0
7592154|NCT03850483|11998320|FG000|Follow-up for Stage 1|Lack of Efficacy|0
7592155|NCT03850483|11998321|FG001|Follow-up for Stage 1|Lack of Efficacy|0
7592156|NCT03850483|11998322|FG002|Follow-up for Stage 1|Lack of Efficacy|1
7592157|NCT03850483|11998323|FG003|Follow-up for Stage 1|Lack of Efficacy|0
7592158|NCT03850483|11998324|FG004|Follow-up for Stage 1|Lack of Efficacy|0
7592159|NCT03850483|11998325|FG005|Follow-up for Stage 1|Lack of Efficacy|0
7592160|NCT03850483|11998326|FG006|Follow-up for Stage 1|Lack of Efficacy|0
7592161|NCT03850483|11998327|FG007|Follow-up for Stage 1|Lack of Efficacy|1
7592162|NCT03850483|11998328|FG008|Follow-up for Stage 1|Lack of Efficacy|0
7592163|NCT03850483|11998329|FG009|Follow-up for Stage 1|Lack of Efficacy|0
7592164|NCT03850483|11998320|FG000|Follow-up for Stage 1|Adverse Event|0
7592165|NCT03850483|11998321|FG001|Follow-up for Stage 1|Adverse Event|0
7592166|NCT03850483|11998322|FG002|Follow-up for Stage 1|Adverse Event|1
7592167|NCT03850483|11998323|FG003|Follow-up for Stage 1|Adverse Event|0
7592168|NCT03850483|11998324|FG004|Follow-up for Stage 1|Adverse Event|0
7592169|NCT03850483|11998325|FG005|Follow-up for Stage 1|Adverse Event|1
7592170|NCT03850483|11998326|FG006|Follow-up for Stage 1|Adverse Event|0
7592171|NCT03850483|11998327|FG007|Follow-up for Stage 1|Adverse Event|0
7592172|NCT03850483|11998328|FG008|Follow-up for Stage 1|Adverse Event|0
7592173|NCT03850483|11998329|FG009|Follow-up for Stage 1|Adverse Event|0
7592174|NCT03850483|11998320|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0
7592175|NCT03850483|11998321|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1
7592176|NCT03850483|11998322|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0
7592177|NCT03850483|11998323|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0
7592178|NCT03850483|11998324|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2
7592179|NCT03850483|11998325|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2
7592180|NCT03850483|11998326|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0
7592181|NCT03850483|11998327|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0
7592182|NCT03850483|11998328|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0
7592183|NCT03850483|11998329|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0
7592184|NCT03850483|11998320|FG000|Follow-up for Stage 1|Other|0
7592185|NCT03850483|11998321|FG001|Follow-up for Stage 1|Other|2
7592186|NCT03850483|11998322|FG002|Follow-up for Stage 1|Other|0
7592187|NCT03850483|11998323|FG003|Follow-up for Stage 1|Other|2
7592188|NCT03850483|11998324|FG004|Follow-up for Stage 1|Other|0
7592189|NCT03850483|11998325|FG005|Follow-up for Stage 1|Other|1
7592190|NCT03850483|11998326|FG006|Follow-up for Stage 1|Other|0
7592191|NCT03850483|11998327|FG007|Follow-up for Stage 1|Other|0
7592192|NCT03850483|11998328|FG008|Follow-up for Stage 1|Other|0
7592193|NCT03850483|11998329|FG009|Follow-up for Stage 1|Other|0
7592194|NCT03850483|11998320|FG000|Treatment for Stage 2|Adverse Event|0
7592195|NCT03850483|11998321|FG001|Treatment for Stage 2|Adverse Event|0
7592196|NCT03850483|11998322|FG002|Treatment for Stage 2|Adverse Event|0
7592197|NCT03850483|11998323|FG003|Treatment for Stage 2|Adverse Event|0
7592198|NCT03850483|11998324|FG004|Treatment for Stage 2|Adverse Event|0
7592199|NCT03850483|11998325|FG005|Treatment for Stage 2|Adverse Event|0
7592200|NCT03850483|11998326|FG006|Treatment for Stage 2|Adverse Event|0
7592201|NCT03850483|11998327|FG007|Treatment for Stage 2|Adverse Event|0
7592202|NCT03850483|11998328|FG008|Treatment for Stage 2|Adverse Event|0
7592203|NCT03850483|11998329|FG009|Treatment for Stage 2|Adverse Event|1
7592204|NCT03850483|11998320|FG000|Treatment for Stage 2|Lack of Efficacy|0
7592205|NCT03850483|11998321|FG001|Treatment for Stage 2|Lack of Efficacy|0
7592206|NCT03850483|11998322|FG002|Treatment for Stage 2|Lack of Efficacy|0
7271096|NCT00420927|11485451|FG000|Period 1|Suspected tuberculosis/positive test|1
7271097|NCT00420927|11485452|FG001|Period 1|Suspected tuberculosis/positive test|1
7271098|NCT00420927|11485453|FG002|Period 1|Suspected tuberculosis/positive test|0
7271099|NCT00420927|11485454|FG003|Period 1|Suspected tuberculosis/positive test|0
7271100|NCT00420927|11485455|FG004|Period 1|Suspected tuberculosis/positive test|0
7271101|NCT00420927|11485456|FG005|Period 1|Suspected tuberculosis/positive test|0
7271102|NCT00420927|11485457|FG006|Period 1|Suspected tuberculosis/positive test|0
7271103|NCT00420927|11485451|FG000|Period 1|Study site closure|0
7271104|NCT00420927|11485452|FG001|Period 1|Study site closure|1
7271105|NCT00420927|11485453|FG002|Period 1|Study site closure|0
7271106|NCT00420927|11485454|FG003|Period 1|Study site closure|0
7271107|NCT00420927|11485455|FG004|Period 1|Study site closure|0
7271108|NCT00420927|11485456|FG005|Period 1|Study site closure|0
7271109|NCT00420927|11485457|FG006|Period 1|Study site closure|0
7271110|NCT00420927|11485451|FG000|Period 1|Subject received new diagnosis|0
7271111|NCT00420927|11485452|FG001|Period 1|Subject received new diagnosis|2
7271112|NCT00420927|11485453|FG002|Period 1|Subject received new diagnosis|0
7271113|NCT00420927|11485454|FG003|Period 1|Subject received new diagnosis|0
7271114|NCT00420927|11485455|FG004|Period 1|Subject received new diagnosis|0
7271115|NCT00420927|11485456|FG005|Period 1|Subject received new diagnosis|0
7271116|NCT00420927|11485457|FG006|Period 1|Subject received new diagnosis|0
7271117|NCT00420927|11485451|FG000|Period 1|Received wrong treatment/incorrect dose|0
7271118|NCT00420927|11485452|FG001|Period 1|Received wrong treatment/incorrect dose|1
7592207|NCT03850483|11998323|FG003|Treatment for Stage 2|Lack of Efficacy|0
7592208|NCT03850483|11998324|FG004|Treatment for Stage 2|Lack of Efficacy|0
7592209|NCT03850483|11998325|FG005|Treatment for Stage 2|Lack of Efficacy|0
7271119|NCT00420927|11485453|FG002|Period 1|Received wrong treatment/incorrect dose|0
7271120|NCT00420927|11485454|FG003|Period 1|Received wrong treatment/incorrect dose|0
7271121|NCT00420927|11485455|FG004|Period 1|Received wrong treatment/incorrect dose|0
7592210|NCT03850483|11998326|FG006|Treatment for Stage 2|Lack of Efficacy|0
7592211|NCT03850483|11998327|FG007|Treatment for Stage 2|Lack of Efficacy|0
7592212|NCT03850483|11998328|FG008|Treatment for Stage 2|Lack of Efficacy|1
7592213|NCT03850483|11998329|FG009|Treatment for Stage 2|Lack of Efficacy|0
7592214|NCT03850483|11998320|FG000|Treatment for Stage 2|Lost to Follow-up|0
7592215|NCT03850483|11998321|FG001|Treatment for Stage 2|Lost to Follow-up|0
7592216|NCT03850483|11998322|FG002|Treatment for Stage 2|Lost to Follow-up|0
7592217|NCT03850483|11998323|FG003|Treatment for Stage 2|Lost to Follow-up|0
7592218|NCT03850483|11998324|FG004|Treatment for Stage 2|Lost to Follow-up|0
7592219|NCT03850483|11998325|FG005|Treatment for Stage 2|Lost to Follow-up|0
7592220|NCT03850483|11998326|FG006|Treatment for Stage 2|Lost to Follow-up|0
7592221|NCT03850483|11998327|FG007|Treatment for Stage 2|Lost to Follow-up|0
7592222|NCT03850483|11998328|FG008|Treatment for Stage 2|Lost to Follow-up|0
7592223|NCT03850483|11998329|FG009|Treatment for Stage 2|Lost to Follow-up|3
7592224|NCT03850483|11998320|FG000|Treatment for Stage 2|Physician Decision|0
7592225|NCT03850483|11998321|FG001|Treatment for Stage 2|Physician Decision|0
7592226|NCT03850483|11998322|FG002|Treatment for Stage 2|Physician Decision|0
7592227|NCT03850483|11998323|FG003|Treatment for Stage 2|Physician Decision|0
7592228|NCT03850483|11998324|FG004|Treatment for Stage 2|Physician Decision|0
7592229|NCT03850483|11998325|FG005|Treatment for Stage 2|Physician Decision|0
7592230|NCT03850483|11998326|FG006|Treatment for Stage 2|Physician Decision|0
7592231|NCT03850483|11998327|FG007|Treatment for Stage 2|Physician Decision|0
7592232|NCT03850483|11998328|FG008|Treatment for Stage 2|Physician Decision|0
7592233|NCT03850483|11998329|FG009|Treatment for Stage 2|Physician Decision|1
7592234|NCT03850483|11998320|FG000|Treatment for Stage 2|Protocol Violation|0
7592235|NCT03850483|11998321|FG001|Treatment for Stage 2|Protocol Violation|0
7592236|NCT03850483|11998322|FG002|Treatment for Stage 2|Protocol Violation|0
7592237|NCT03850483|11998323|FG003|Treatment for Stage 2|Protocol Violation|0
7592238|NCT03850483|11998324|FG004|Treatment for Stage 2|Protocol Violation|0
7592239|NCT03850483|11998325|FG005|Treatment for Stage 2|Protocol Violation|0
7592240|NCT03850483|11998326|FG006|Treatment for Stage 2|Protocol Violation|0
7592241|NCT03850483|11998327|FG007|Treatment for Stage 2|Protocol Violation|0
7592242|NCT03850483|11998328|FG008|Treatment for Stage 2|Protocol Violation|1
7592243|NCT03850483|11998329|FG009|Treatment for Stage 2|Protocol Violation|0
7592244|NCT03850483|11998320|FG000|Treatment for Stage 2|Withdrawal by Subject|0
7592245|NCT03850483|11998321|FG001|Treatment for Stage 2|Withdrawal by Subject|0
7592246|NCT03850483|11998322|FG002|Treatment for Stage 2|Withdrawal by Subject|0
7592247|NCT03850483|11998323|FG003|Treatment for Stage 2|Withdrawal by Subject|0
7592248|NCT03850483|11998324|FG004|Treatment for Stage 2|Withdrawal by Subject|0
7592249|NCT03850483|11998325|FG005|Treatment for Stage 2|Withdrawal by Subject|0
7592250|NCT03850483|11998326|FG006|Treatment for Stage 2|Withdrawal by Subject|0
7592251|NCT03850483|11998327|FG007|Treatment for Stage 2|Withdrawal by Subject|0
7592252|NCT03850483|11998328|FG008|Treatment for Stage 2|Withdrawal by Subject|2
7592253|NCT03850483|11998329|FG009|Treatment for Stage 2|Withdrawal by Subject|5
7592254|NCT03850483|11998320|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592255|NCT03850483|11998321|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592256|NCT03850483|11998322|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592257|NCT03850483|11998323|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592258|NCT03850483|11998324|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592259|NCT03850483|11998325|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592260|NCT03850483|11998326|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592261|NCT03850483|11998327|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592262|NCT03850483|11998328|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0
7592263|NCT03850483|11998329|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1
7592264|NCT03850483|11998320|FG000|Treatment for Stage 2|Refused Further Treatment|0
7592265|NCT03850483|11998321|FG001|Treatment for Stage 2|Refused Further Treatment|0
7592266|NCT03850483|11998322|FG002|Treatment for Stage 2|Refused Further Treatment|0
7592267|NCT03850483|11998323|FG003|Treatment for Stage 2|Refused Further Treatment|0
7592268|NCT03850483|11998324|FG004|Treatment for Stage 2|Refused Further Treatment|0
7592269|NCT03850483|11998325|FG005|Treatment for Stage 2|Refused Further Treatment|0
7592270|NCT03850483|11998326|FG006|Treatment for Stage 2|Refused Further Treatment|0
7592271|NCT03850483|11998327|FG007|Treatment for Stage 2|Refused Further Treatment|0
7592272|NCT03850483|11998328|FG008|Treatment for Stage 2|Refused Further Treatment|1
7592273|NCT03850483|11998329|FG009|Treatment for Stage 2|Refused Further Treatment|0
7592274|NCT03850483|11998320|FG000|Follow-up For Stage 2|Lost to Follow-up|0
7592275|NCT03850483|11998321|FG001|Follow-up For Stage 2|Lost to Follow-up|0
7592276|NCT03850483|11998322|FG002|Follow-up For Stage 2|Lost to Follow-up|0
7592277|NCT03850483|11998323|FG003|Follow-up For Stage 2|Lost to Follow-up|0
7592278|NCT03850483|11998324|FG004|Follow-up For Stage 2|Lost to Follow-up|0
7592279|NCT03850483|11998325|FG005|Follow-up For Stage 2|Lost to Follow-up|0
7592280|NCT03850483|11998326|FG006|Follow-up For Stage 2|Lost to Follow-up|0
7592281|NCT03850483|11998327|FG007|Follow-up For Stage 2|Lost to Follow-up|0
7592282|NCT03850483|11998328|FG008|Follow-up For Stage 2|Lost to Follow-up|0
7592283|NCT03850483|11998329|FG009|Follow-up For Stage 2|Lost to Follow-up|1
7592284|NCT03850483|11998320|FG000|Follow-up For Stage 2|Other|0
7592285|NCT03850483|11998321|FG001|Follow-up For Stage 2|Other|0
7592286|NCT03850483|11998322|FG002|Follow-up For Stage 2|Other|0
7592287|NCT03850483|11998323|FG003|Follow-up For Stage 2|Other|0
7592288|NCT03850483|11998324|FG004|Follow-up For Stage 2|Other|0
7592289|NCT03850483|11998325|FG005|Follow-up For Stage 2|Other|0
7592290|NCT03850483|11998326|FG006|Follow-up For Stage 2|Other|0
7592291|NCT03850483|11998327|FG007|Follow-up For Stage 2|Other|0
7592292|NCT03850483|11998328|FG008|Follow-up For Stage 2|Other|0
7592293|NCT03850483|11998329|FG009|Follow-up For Stage 2|Other|1
7592300|NCT03804684|11998361|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3
7592301|NCT03804684|11998362|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18
7592308|NCT03473925|11998403|FG000|Overall Study|Death|48
7592309|NCT03473925|11998404|FG001|Overall Study|Death|44
7592310|NCT03473925|11998403|FG000|Overall Study|Sponsor Decision|2
7592311|NCT03473925|11998404|FG001|Overall Study|Sponsor Decision|7
7592312|NCT03473925|11998403|FG000|Overall Study|Withdrawal by Subject|1
7592313|NCT03473925|11998404|FG001|Overall Study|Withdrawal by Subject|3
7592314|NCT03473925|11998403|FG000|Overall Study|Not Treated|1
7592315|NCT03473925|11998404|FG001|Overall Study|Not Treated|1
7592320|NCT03230097|11998432|FG000|Overall Study|Adverse Event|2
7592321|NCT03230097|11998433|FG001|Overall Study|Adverse Event|1
7592322|NCT03230097|11998432|FG000|Overall Study|non-compliance|0
7592323|NCT03230097|11998433|FG001|Overall Study|non-compliance|1
7592324|NCT03230097|11998432|FG000|Overall Study|Lost to Follow-up|2
7592325|NCT03230097|11998433|FG001|Overall Study|Lost to Follow-up|4
7592326|NCT03230097|11998432|FG000|Overall Study|Withdrawal by Subject|7
7592327|NCT03230097|11998433|FG001|Overall Study|Withdrawal by Subject|3
7592328|NCT03230097|11998432|FG000|Overall Study|Trial termination|4
7592329|NCT03230097|11998433|FG001|Overall Study|Trial termination|5
7592330|NCT03230097|11998432|FG000|Overall Study|Covid-19 pandemic outbreak|0
7592331|NCT03230097|11998433|FG001|Overall Study|Covid-19 pandemic outbreak|1
7592332|NCT03230097|11998432|FG000|Overall Study|outcome event|0
7592333|NCT03230097|11998433|FG001|Overall Study|outcome event|1
7592334|NCT03029780|11998454|FG000|Overall Study|Disease Progression|20
7592335|NCT03029780|11998455|FG001|Overall Study|Disease Progression|22
7592336|NCT03029780|11998454|FG000|Overall Study|Study Drug Toxicity|15
7592337|NCT03029780|11998455|FG001|Overall Study|Study Drug Toxicity|11
7592338|NCT03029780|11998454|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2
7592339|NCT03029780|11998455|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7592340|NCT03029780|11998454|FG000|Overall Study|Participant request to discontinue study treatment|4
7592341|NCT03029780|11998455|FG001|Overall Study|Participant request to discontinue study treatment|1
7592342|NCT03029780|11998454|FG000|Overall Study|Maximum clinical benefit|1
7592343|NCT03029780|11998455|FG001|Overall Study|Maximum clinical benefit|0
7592344|NCT03029780|11998454|FG000|Overall Study|Participant no longer meets study criteria|0
7592345|NCT03029780|11998455|FG001|Overall Study|Participant no longer meets study criteria|1
7592346|NCT03029780|11998454|FG000|Overall Study|Other reasons|6
7592347|NCT03029780|11998455|FG001|Overall Study|Other reasons|6
7592348|NCT03029780|11998454|FG000|Overall Study|Not reported|1
7592349|NCT03029780|11998455|FG001|Overall Study|Not reported|1
7592350|NCT03029780|11998454|FG000|Overall Study|Death|2
7592351|NCT03029780|11998455|FG001|Overall Study|Death|6
7627281|NCT02447718|12039694|FG000|Overall Study|Lost to Follow-up|8
7627282|NCT02447718|12039695|FG001|Overall Study|Lost to Follow-up|0
7627283|NCT02447718|12039694|FG000|Overall Study|Withdrawal by Subject|3
7627284|NCT02447718|12039695|FG001|Overall Study|Withdrawal by Subject|0
7627285|NCT02447718|12039694|FG000|Overall Study|Screen Failure|1
7627286|NCT02447718|12039695|FG001|Overall Study|Screen Failure|0
7592375|NCT02803593|11998503|FG000|Overall Study|Lost to Follow-up|17
7592376|NCT02803593|11998504|FG001|Overall Study|Lost to Follow-up|35
7592377|NCT02663908|11998512|FG000|Overall Study|Withdrawal by Subject|8
7592378|NCT02663908|11998513|FG001|Overall Study|Withdrawal by Subject|5
7592379|NCT02663908|11998512|FG000|Overall Study|Lost to Follow-up|1
7592380|NCT02663908|11998513|FG001|Overall Study|Lost to Follow-up|5
7592381|NCT02663908|11998512|FG000|Overall Study|Adverse Event|13
7592382|NCT02663908|11998513|FG001|Overall Study|Adverse Event|11
7592383|NCT02663908|11998512|FG000|Overall Study|Protocol Violation|1
7592384|NCT02663908|11998513|FG001|Overall Study|Protocol Violation|2
7592385|NCT02663908|11998512|FG000|Overall Study|Lack of therapeutic response|2
7592386|NCT02663908|11998513|FG001|Overall Study|Lack of therapeutic response|0
7592387|NCT02663908|11998512|FG000|Overall Study|COVID-19|1
7592388|NCT02663908|11998513|FG001|Overall Study|COVID-19|0
7592389|NCT02663908|11998512|FG000|Overall Study|Site closed|1
7592390|NCT02663908|11998513|FG001|Overall Study|Site closed|0
7592391|NCT02663908|11998512|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1
7592392|NCT02663908|11998513|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0
7592393|NCT02663908|11998512|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1
7592394|NCT02663908|11998513|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0
7592395|NCT02663908|11998512|FG000|Overall Study|Intolerance to FIRMAGON therapy|1
7592396|NCT02663908|11998513|FG001|Overall Study|Intolerance to FIRMAGON therapy|0
7592397|NCT02663908|11998512|FG000|Overall Study|Death|1
7592398|NCT02663908|11998513|FG001|Overall Study|Death|0
7592399|NCT02663908|11998512|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1
7592400|NCT02663908|11998513|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0
7592401|NCT02663908|11998512|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0
7592402|NCT02663908|11998513|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1
7592403|NCT02650284|11998521|FG000|Overall Study|Lost to Follow-up|3
7592404|NCT02650284|11998522|FG001|Overall Study|Lost to Follow-up|3
7592405|NCT02650284|11998521|FG000|Overall Study|Consent incorrectly taken|0
7592406|NCT02650284|11998522|FG001|Overall Study|Consent incorrectly taken|1
7592412|NCT02500797|11998555|FG000|Overall Study|Cancel (rapid disease progression)|0
7592413|NCT02500797|11998556|FG001|Overall Study|Cancel (rapid disease progression)|0
7592414|NCT02500797|11998557|FG002|Overall Study|Cancel (rapid disease progression)|0
7592415|NCT02500797|11998558|FG003|Overall Study|Cancel (rapid disease progression)|0
7592416|NCT02500797|11998559|FG004|Overall Study|Cancel (rapid disease progression)|1
7592417|NCT02500797|11998560|FG005|Overall Study|Cancel (rapid disease progression)|1
7592418|NCT02500797|11998561|FG006|Overall Study|Cancel (rapid disease progression)|0
7592419|NCT02500797|11998562|FG007|Overall Study|Cancel (rapid disease progression)|0
7592420|NCT02500797|11998555|FG000|Overall Study|Withdrawal by Subject|1
7592421|NCT02500797|11998556|FG001|Overall Study|Withdrawal by Subject|0
7592422|NCT02500797|11998557|FG002|Overall Study|Withdrawal by Subject|0
7592423|NCT02500797|11998558|FG003|Overall Study|Withdrawal by Subject|0
7592424|NCT02500797|11998559|FG004|Overall Study|Withdrawal by Subject|0
7592425|NCT02500797|11998560|FG005|Overall Study|Withdrawal by Subject|0
7592426|NCT02500797|11998561|FG006|Overall Study|Withdrawal by Subject|0
7592427|NCT02500797|11998562|FG007|Overall Study|Withdrawal by Subject|0
7592444|NCT02426658|11998610|FG000|Overall Study|Withdrawal by Subject|1
7592445|NCT02426658|11998610|FG000|Overall Study|Patient expired before treatment|2
7592462|NCT02277106|11998631|FG000|Stage 2|Adverse Event|0
7592463|NCT02277106|11998632|FG001|Stage 2|Adverse Event|0
7592464|NCT02277106|11998633|FG002|Stage 2|Adverse Event|1
7592465|NCT02175030|11998646|FG000|Overall Study|Failed screen after consent|7
7592466|NCT02175030|11998647|FG001|Overall Study|Failed screen after consent|6
7592467|NCT02175030|11998646|FG000|Overall Study|Failed IUD Insertion|20
7592468|NCT02175030|11998647|FG001|Overall Study|Failed IUD Insertion|21
7592469|NCT02175030|11998646|FG000|Overall Study|Physician Decision|1
7271122|NCT00420927|11485456|FG005|Period 1|Received wrong treatment/incorrect dose|0
7271123|NCT00420927|11485457|FG006|Period 1|Received wrong treatment/incorrect dose|0
7271124|NCT00420927|11485451|FG000|Period 1|Failed to meet entry criteria|8
7271125|NCT00420927|11485452|FG001|Period 1|Failed to meet entry criteria|7
7271126|NCT00420927|11485453|FG002|Period 1|Failed to meet entry criteria|0
7271127|NCT00420927|11485454|FG003|Period 1|Failed to meet entry criteria|0
7271128|NCT00420927|11485455|FG004|Period 1|Failed to meet entry criteria|0
7271129|NCT00420927|11485456|FG005|Period 1|Failed to meet entry criteria|0
7271130|NCT00420927|11485457|FG006|Period 1|Failed to meet entry criteria|0
7271131|NCT00420927|11485451|FG000|Period 1|Took prohibited medication|1
7271132|NCT00420927|11485452|FG001|Period 1|Took prohibited medication|3
7271133|NCT00420927|11485453|FG002|Period 1|Took prohibited medication|0
7271134|NCT00420927|11485454|FG003|Period 1|Took prohibited medication|0
7271135|NCT00420927|11485455|FG004|Period 1|Took prohibited medication|0
7271136|NCT00420927|11485456|FG005|Period 1|Took prohibited medication|0
7271137|NCT00420927|11485457|FG006|Period 1|Took prohibited medication|0
7271138|NCT00420927|11485451|FG000|Period 2|Adverse Event|0
7271139|NCT00420927|11485452|FG001|Period 2|Adverse Event|0
7271140|NCT00420927|11485453|FG002|Period 2|Adverse Event|7
7271141|NCT00420927|11485454|FG003|Period 2|Adverse Event|3
7271142|NCT00420927|11485455|FG004|Period 2|Adverse Event|17
7271143|NCT00420927|11485456|FG005|Period 2|Adverse Event|6
7271144|NCT00420927|11485457|FG006|Period 2|Adverse Event|20
7271145|NCT00420927|11485451|FG000|Period 2|Withdrawal by Subject|0
7271146|NCT00420927|11485452|FG001|Period 2|Withdrawal by Subject|0
7271147|NCT00420927|11485453|FG002|Period 2|Withdrawal by Subject|1
7271148|NCT00420927|11485454|FG003|Period 2|Withdrawal by Subject|3
7271149|NCT00420927|11485455|FG004|Period 2|Withdrawal by Subject|11
7271150|NCT00420927|11485456|FG005|Period 2|Withdrawal by Subject|2
7271151|NCT00420927|11485457|FG006|Period 2|Withdrawal by Subject|12
7271152|NCT00420927|11485451|FG000|Period 2|Lost to Follow-up|0
7271153|NCT00420927|11485452|FG001|Period 2|Lost to Follow-up|0
7271154|NCT00420927|11485453|FG002|Period 2|Lost to Follow-up|2
7271155|NCT00420927|11485454|FG003|Period 2|Lost to Follow-up|2
7271156|NCT00420927|11485455|FG004|Period 2|Lost to Follow-up|6
7592470|NCT02175030|11998647|FG001|Overall Study|Physician Decision|1
7271157|NCT00420927|11485456|FG005|Period 2|Lost to Follow-up|3
7592471|NCT02175030|11998646|FG000|Overall Study|Lost to Follow-up|6
7592472|NCT02175030|11998647|FG001|Overall Study|Lost to Follow-up|6
7592473|NCT02175030|11998646|FG000|Overall Study|Withdrawal by Subject|1
7592474|NCT02175030|11998647|FG001|Overall Study|Withdrawal by Subject|4
7592476|NCT02017717|11998666|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0
7592477|NCT02017717|11998667|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0
7592478|NCT02017717|11998668|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0
7592479|NCT02017717|11998669|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1
7592480|NCT02017717|11998670|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0
7592481|NCT02017717|11998671|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0
7592482|NCT02017717|11998672|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0
7592483|NCT02017717|11998673|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0
7592484|NCT02017717|11998674|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0
7592485|NCT02017717|11998666|FG000|Before Treatment Period|Participant request to stop therapy|0
7592486|NCT02017717|11998667|FG001|Before Treatment Period|Participant request to stop therapy|0
7592487|NCT02017717|11998668|FG002|Before Treatment Period|Participant request to stop therapy|0
7592488|NCT02017717|11998669|FG003|Before Treatment Period|Participant request to stop therapy|0
7592489|NCT02017717|11998670|FG004|Before Treatment Period|Participant request to stop therapy|5
7592490|NCT02017717|11998671|FG005|Before Treatment Period|Participant request to stop therapy|0
7592491|NCT02017717|11998672|FG006|Before Treatment Period|Participant request to stop therapy|0
7592492|NCT02017717|11998673|FG007|Before Treatment Period|Participant request to stop therapy|0
7592493|NCT02017717|11998674|FG008|Before Treatment Period|Participant request to stop therapy|0
7592494|NCT02017717|11998666|FG000|Before Treatment Period|Participant withdrew consent|0
7592495|NCT02017717|11998667|FG001|Before Treatment Period|Participant withdrew consent|0
7592496|NCT02017717|11998668|FG002|Before Treatment Period|Participant withdrew consent|0
7592497|NCT02017717|11998669|FG003|Before Treatment Period|Participant withdrew consent|0
7592498|NCT02017717|11998670|FG004|Before Treatment Period|Participant withdrew consent|11
7592499|NCT02017717|11998671|FG005|Before Treatment Period|Participant withdrew consent|0
7592500|NCT02017717|11998672|FG006|Before Treatment Period|Participant withdrew consent|0
7592501|NCT02017717|11998673|FG007|Before Treatment Period|Participant withdrew consent|0
7592502|NCT02017717|11998674|FG008|Before Treatment Period|Participant withdrew consent|2
7592503|NCT02017717|11998666|FG000|Before Treatment Period|Lost to Follow-up|0
7592504|NCT02017717|11998667|FG001|Before Treatment Period|Lost to Follow-up|0
7592505|NCT02017717|11998668|FG002|Before Treatment Period|Lost to Follow-up|0
7592506|NCT02017717|11998669|FG003|Before Treatment Period|Lost to Follow-up|0
7592507|NCT02017717|11998670|FG004|Before Treatment Period|Lost to Follow-up|1
7592508|NCT02017717|11998671|FG005|Before Treatment Period|Lost to Follow-up|0
7592509|NCT02017717|11998672|FG006|Before Treatment Period|Lost to Follow-up|0
7592510|NCT02017717|11998673|FG007|Before Treatment Period|Lost to Follow-up|0
7592511|NCT02017717|11998674|FG008|Before Treatment Period|Lost to Follow-up|0
7592512|NCT02017717|11998666|FG000|Before Treatment Period|Participant no longer met criteria|0
7592513|NCT02017717|11998667|FG001|Before Treatment Period|Participant no longer met criteria|0
7592514|NCT02017717|11998668|FG002|Before Treatment Period|Participant no longer met criteria|0
7592515|NCT02017717|11998669|FG003|Before Treatment Period|Participant no longer met criteria|1
7592516|NCT02017717|11998670|FG004|Before Treatment Period|Participant no longer met criteria|2
7592517|NCT02017717|11998671|FG005|Before Treatment Period|Participant no longer met criteria|0
7592518|NCT02017717|11998672|FG006|Before Treatment Period|Participant no longer met criteria|0
7592519|NCT02017717|11998673|FG007|Before Treatment Period|Participant no longer met criteria|1
7592520|NCT02017717|11998674|FG008|Before Treatment Period|Participant no longer met criteria|0
7592521|NCT02017717|11998666|FG000|Before Treatment Period|other reason|0
7592522|NCT02017717|11998667|FG001|Before Treatment Period|other reason|0
7592523|NCT02017717|11998668|FG002|Before Treatment Period|other reason|0
7592524|NCT02017717|11998669|FG003|Before Treatment Period|other reason|0
7592525|NCT02017717|11998670|FG004|Before Treatment Period|other reason|1
7592526|NCT02017717|11998671|FG005|Before Treatment Period|other reason|0
7592527|NCT02017717|11998672|FG006|Before Treatment Period|other reason|0
7592528|NCT02017717|11998673|FG007|Before Treatment Period|other reason|0
7592529|NCT02017717|11998674|FG008|Before Treatment Period|other reason|0
7592530|NCT02017717|11998666|FG000|Treatment Period|Disease progression|7
7592531|NCT02017717|11998667|FG001|Treatment Period|Disease progression|9
7592532|NCT02017717|11998668|FG002|Treatment Period|Disease progression|12
7592533|NCT02017717|11998669|FG003|Treatment Period|Disease progression|165
7592534|NCT02017717|11998670|FG004|Treatment Period|Disease progression|134
7592535|NCT02017717|11998671|FG005|Treatment Period|Disease progression|20
7592536|NCT02017717|11998672|FG006|Treatment Period|Disease progression|26
7592537|NCT02017717|11998673|FG007|Treatment Period|Disease progression|17
7592538|NCT02017717|11998674|FG008|Treatment Period|Disease progression|22
7592539|NCT02017717|11998666|FG000|Treatment Period|Study drug toxicity|3
7592540|NCT02017717|11998667|FG001|Treatment Period|Study drug toxicity|0
7592541|NCT02017717|11998668|FG002|Treatment Period|Study drug toxicity|1
7592542|NCT02017717|11998669|FG003|Treatment Period|Study drug toxicity|7
7592543|NCT02017717|11998670|FG004|Treatment Period|Study drug toxicity|11
7592544|NCT02017717|11998671|FG005|Treatment Period|Study drug toxicity|4
7592545|NCT02017717|11998672|FG006|Treatment Period|Study drug toxicity|4
7592546|NCT02017717|11998673|FG007|Treatment Period|Study drug toxicity|5
7592547|NCT02017717|11998674|FG008|Treatment Period|Study drug toxicity|3
7592548|NCT02017717|11998666|FG000|Treatment Period|Death|0
7592549|NCT02017717|11998667|FG001|Treatment Period|Death|0
7592550|NCT02017717|11998668|FG002|Treatment Period|Death|1
7592551|NCT02017717|11998669|FG003|Treatment Period|Death|0
7592552|NCT02017717|11998670|FG004|Treatment Period|Death|0
7592553|NCT02017717|11998671|FG005|Treatment Period|Death|0
7592554|NCT02017717|11998672|FG006|Treatment Period|Death|0
7592555|NCT02017717|11998673|FG007|Treatment Period|Death|1
7592556|NCT02017717|11998674|FG008|Treatment Period|Death|0
7592557|NCT02017717|11998666|FG000|Treatment Period|Adverse event unrelated to study drug|0
7592558|NCT02017717|11998667|FG001|Treatment Period|Adverse event unrelated to study drug|0
7592559|NCT02017717|11998668|FG002|Treatment Period|Adverse event unrelated to study drug|2
7592560|NCT02017717|11998669|FG003|Treatment Period|Adverse event unrelated to study drug|4
7592561|NCT02017717|11998670|FG004|Treatment Period|Adverse event unrelated to study drug|5
7592562|NCT02017717|11998671|FG005|Treatment Period|Adverse event unrelated to study drug|0
7592563|NCT02017717|11998672|FG006|Treatment Period|Adverse event unrelated to study drug|0
7592564|NCT02017717|11998673|FG007|Treatment Period|Adverse event unrelated to study drug|0
7592565|NCT02017717|11998674|FG008|Treatment Period|Adverse event unrelated to study drug|1
7592566|NCT02017717|11998666|FG000|Treatment Period|Participant request to stop therapy|0
7592567|NCT02017717|11998667|FG001|Treatment Period|Participant request to stop therapy|0
7592568|NCT02017717|11998668|FG002|Treatment Period|Participant request to stop therapy|3
7592569|NCT02017717|11998669|FG003|Treatment Period|Participant request to stop therapy|4
7592570|NCT02017717|11998670|FG004|Treatment Period|Participant request to stop therapy|7
7592571|NCT02017717|11998671|FG005|Treatment Period|Participant request to stop therapy|5
7592572|NCT02017717|11998672|FG006|Treatment Period|Participant request to stop therapy|0
7592573|NCT02017717|11998673|FG007|Treatment Period|Participant request to stop therapy|2
7592574|NCT02017717|11998674|FG008|Treatment Period|Participant request to stop therapy|1
7592575|NCT02017717|11998666|FG000|Treatment Period|Participant withdrew consent|0
7592576|NCT02017717|11998667|FG001|Treatment Period|Participant withdrew consent|0
7592577|NCT02017717|11998668|FG002|Treatment Period|Participant withdrew consent|1
7592578|NCT02017717|11998669|FG003|Treatment Period|Participant withdrew consent|1
7592579|NCT02017717|11998670|FG004|Treatment Period|Participant withdrew consent|4
7592580|NCT02017717|11998671|FG005|Treatment Period|Participant withdrew consent|0
7592581|NCT02017717|11998672|FG006|Treatment Period|Participant withdrew consent|0
7592582|NCT02017717|11998673|FG007|Treatment Period|Participant withdrew consent|2
7592583|NCT02017717|11998674|FG008|Treatment Period|Participant withdrew consent|0
7592584|NCT02017717|11998666|FG000|Treatment Period|Participant no longer met criteria|0
7592585|NCT02017717|11998667|FG001|Treatment Period|Participant no longer met criteria|0
7592586|NCT02017717|11998668|FG002|Treatment Period|Participant no longer met criteria|0
7592587|NCT02017717|11998669|FG003|Treatment Period|Participant no longer met criteria|0
7592588|NCT02017717|11998670|FG004|Treatment Period|Participant no longer met criteria|1
7592589|NCT02017717|11998671|FG005|Treatment Period|Participant no longer met criteria|0
7592590|NCT02017717|11998672|FG006|Treatment Period|Participant no longer met criteria|0
7592591|NCT02017717|11998673|FG007|Treatment Period|Participant no longer met criteria|0
7592592|NCT02017717|11998674|FG008|Treatment Period|Participant no longer met criteria|0
7592593|NCT02017717|11998666|FG000|Treatment Period|other reasons|0
7592594|NCT02017717|11998667|FG001|Treatment Period|other reasons|0
7592595|NCT02017717|11998668|FG002|Treatment Period|other reasons|0
7592596|NCT02017717|11998669|FG003|Treatment Period|other reasons|0
7592597|NCT02017717|11998670|FG004|Treatment Period|other reasons|1
7592598|NCT02017717|11998671|FG005|Treatment Period|other reasons|0
7592599|NCT02017717|11998672|FG006|Treatment Period|other reasons|0
7592600|NCT02017717|11998673|FG007|Treatment Period|other reasons|1
7592601|NCT02017717|11998674|FG008|Treatment Period|other reasons|1
7592602|NCT02017717|11998666|FG000|Treatment Period|Maximum clinical benefit|0
7592603|NCT02017717|11998667|FG001|Treatment Period|Maximum clinical benefit|0
7592604|NCT02017717|11998668|FG002|Treatment Period|Maximum clinical benefit|0
7592605|NCT02017717|11998669|FG003|Treatment Period|Maximum clinical benefit|0
7592606|NCT02017717|11998670|FG004|Treatment Period|Maximum clinical benefit|1
7592607|NCT02017717|11998671|FG005|Treatment Period|Maximum clinical benefit|0
7592608|NCT02017717|11998672|FG006|Treatment Period|Maximum clinical benefit|0
7592609|NCT02017717|11998673|FG007|Treatment Period|Maximum clinical benefit|0
7592610|NCT02017717|11998674|FG008|Treatment Period|Maximum clinical benefit|0
7592644|NCT01746173|11998739|FG000|Overall Study|Disease Progression|2
7271158|NCT00420927|11485457|FG006|Period 2|Lost to Follow-up|9
7271159|NCT00420927|11485451|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
7271160|NCT00420927|11485452|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
7271161|NCT00420927|11485453|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
7271162|NCT00420927|11485454|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
7271163|NCT00420927|11485455|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
7271164|NCT00420927|11485456|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
7271165|NCT00420927|11485457|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
7271166|NCT00420927|11485451|FG000|Period 2|Received wrong treatment/incorrect dose|0
7271167|NCT00420927|11485452|FG001|Period 2|Received wrong treatment/incorrect dose|0
7271168|NCT00420927|11485453|FG002|Period 2|Received wrong treatment/incorrect dose|0
7271169|NCT00420927|11485454|FG003|Period 2|Received wrong treatment/incorrect dose|0
7271170|NCT00420927|11485455|FG004|Period 2|Received wrong treatment/incorrect dose|0
7271171|NCT00420927|11485456|FG005|Period 2|Received wrong treatment/incorrect dose|0
7271172|NCT00420927|11485457|FG006|Period 2|Received wrong treatment/incorrect dose|1
7271173|NCT00420927|11485451|FG000|Period 2|Subject unable to find transportation|0
7271174|NCT00420927|11485452|FG001|Period 2|Subject unable to find transportation|0
7271175|NCT00420927|11485453|FG002|Period 2|Subject unable to find transportation|0
7271176|NCT00420927|11485454|FG003|Period 2|Subject unable to find transportation|0
7271177|NCT00420927|11485455|FG004|Period 2|Subject unable to find transportation|0
7271178|NCT00420927|11485456|FG005|Period 2|Subject unable to find transportation|0
7271179|NCT00420927|11485457|FG006|Period 2|Subject unable to find transportation|1
7271180|NCT00420927|11485451|FG000|Period 2|Physician Decision|0
7271181|NCT00420927|11485452|FG001|Period 2|Physician Decision|0
7271182|NCT00420927|11485453|FG002|Period 2|Physician Decision|0
7271183|NCT00420927|11485454|FG003|Period 2|Physician Decision|0
7271184|NCT00420927|11485455|FG004|Period 2|Physician Decision|1
7271185|NCT00420927|11485456|FG005|Period 2|Physician Decision|1
7271186|NCT00420927|11485457|FG006|Period 2|Physician Decision|0
7271187|NCT00420927|11485451|FG000|Period 2|Sponsor decision|0
7271188|NCT00420927|11485452|FG001|Period 2|Sponsor decision|0
7271189|NCT00420927|11485453|FG002|Period 2|Sponsor decision|1
7271190|NCT00420927|11485454|FG003|Period 2|Sponsor decision|0
7271191|NCT00420927|11485455|FG004|Period 2|Sponsor decision|0
7271192|NCT00420927|11485456|FG005|Period 2|Sponsor decision|0
7271193|NCT00420927|11485457|FG006|Period 2|Sponsor decision|1
7271194|NCT00420927|11485451|FG000|Period 2|Randomization error|0
7271195|NCT00420927|11485452|FG001|Period 2|Randomization error|0
7271196|NCT00420927|11485453|FG002|Period 2|Randomization error|0
7271197|NCT00420927|11485454|FG003|Period 2|Randomization error|0
7271198|NCT00420927|11485455|FG004|Period 2|Randomization error|1
7271199|NCT00420927|11485456|FG005|Period 2|Randomization error|1
7271200|NCT00420927|11485457|FG006|Period 2|Randomization error|0
7271201|NCT00420927|11485451|FG000|Period 2|Noncompliant with study drug|0
7271202|NCT00420927|11485452|FG001|Period 2|Noncompliant with study drug|0
7271203|NCT00420927|11485453|FG002|Period 2|Noncompliant with study drug|0
7271204|NCT00420927|11485454|FG003|Period 2|Noncompliant with study drug|1
7271205|NCT00420927|11485455|FG004|Period 2|Noncompliant with study drug|0
7271206|NCT00420927|11485456|FG005|Period 2|Noncompliant with study drug|0
7271207|NCT00420927|11485457|FG006|Period 2|Noncompliant with study drug|2
7271208|NCT00420927|11485451|FG000|Period 2|Methotrexate intolerance|0
7271209|NCT00420927|11485452|FG001|Period 2|Methotrexate intolerance|0
7271210|NCT00420927|11485453|FG002|Period 2|Methotrexate intolerance|0
7271211|NCT00420927|11485454|FG003|Period 2|Methotrexate intolerance|0
7271212|NCT00420927|11485455|FG004|Period 2|Methotrexate intolerance|0
7271213|NCT00420927|11485456|FG005|Period 2|Methotrexate intolerance|0
7271214|NCT00420927|11485457|FG006|Period 2|Methotrexate intolerance|1
7271215|NCT00420927|11485451|FG000|Period 2|Took prohibited medication|0
7271216|NCT00420927|11485452|FG001|Period 2|Took prohibited medication|0
7271217|NCT00420927|11485453|FG002|Period 2|Took prohibited medication|0
7271218|NCT00420927|11485454|FG003|Period 2|Took prohibited medication|0
7271219|NCT00420927|11485455|FG004|Period 2|Took prohibited medication|1
7271220|NCT00420927|11485456|FG005|Period 2|Took prohibited medication|0
7271221|NCT00420927|11485457|FG006|Period 2|Took prohibited medication|0
7271222|NCT00421148|11485501|FG000|Overall Study|Lost to Follow-up|0
7271223|NCT00421148|11485502|FG001|Overall Study|Lost to Follow-up|0
7271224|NCT00421148|11485503|FG002|Overall Study|Lost to Follow-up|0
7592713|NCT01349959|11998795|FG000|Overall Study|Adverse Event|7
7271225|NCT00421148|11485504|FG003|Overall Study|Lost to Follow-up|0
7271226|NCT00421148|11485505|FG004|Overall Study|Lost to Follow-up|0
7271227|NCT00421148|11485506|FG005|Overall Study|Lost to Follow-up|0
7271228|NCT00421148|11485507|FG006|Overall Study|Lost to Follow-up|0
7271229|NCT00421148|11485508|FG007|Overall Study|Lost to Follow-up|0
7271230|NCT00421148|11485509|FG008|Overall Study|Lost to Follow-up|0
7271231|NCT00421148|11485510|FG009|Overall Study|Lost to Follow-up|0
7271232|NCT00421148|11485511|FG010|Overall Study|Lost to Follow-up|0
7271233|NCT00421148|11485512|FG011|Overall Study|Lost to Follow-up|0
7271234|NCT00421148|11485513|FG012|Overall Study|Lost to Follow-up|0
7271235|NCT00421148|11485514|FG013|Overall Study|Lost to Follow-up|0
7271236|NCT00421148|11485515|FG014|Overall Study|Lost to Follow-up|0
7271237|NCT00421148|11485516|FG015|Overall Study|Lost to Follow-up|0
7271238|NCT00421148|11485517|FG016|Overall Study|Lost to Follow-up|0
7271239|NCT00421148|11485518|FG017|Overall Study|Lost to Follow-up|1
7271240|NCT00421148|11485519|FG018|Overall Study|Lost to Follow-up|0
7271241|NCT00421148|11485520|FG019|Overall Study|Lost to Follow-up|0
7271242|NCT00421148|11485501|FG000|Overall Study|Withdrawal by Subject|0
7271243|NCT00421148|11485502|FG001|Overall Study|Withdrawal by Subject|0
7271244|NCT00421148|11485503|FG002|Overall Study|Withdrawal by Subject|0
7271245|NCT00421148|11485504|FG003|Overall Study|Withdrawal by Subject|0
7271246|NCT00421148|11485505|FG004|Overall Study|Withdrawal by Subject|0
7271247|NCT00421148|11485506|FG005|Overall Study|Withdrawal by Subject|0
7271248|NCT00421148|11485507|FG006|Overall Study|Withdrawal by Subject|0
7271249|NCT00421148|11485508|FG007|Overall Study|Withdrawal by Subject|0
7271250|NCT00421148|11485509|FG008|Overall Study|Withdrawal by Subject|0
7271251|NCT00421148|11485510|FG009|Overall Study|Withdrawal by Subject|0
7271252|NCT00421148|11485511|FG010|Overall Study|Withdrawal by Subject|0
7271253|NCT00421148|11485512|FG011|Overall Study|Withdrawal by Subject|0
7271254|NCT00421148|11485513|FG012|Overall Study|Withdrawal by Subject|0
7271255|NCT00421148|11485514|FG013|Overall Study|Withdrawal by Subject|0
7271256|NCT00421148|11485515|FG014|Overall Study|Withdrawal by Subject|0
7271257|NCT00421148|11485516|FG015|Overall Study|Withdrawal by Subject|0
7271258|NCT00421148|11485517|FG016|Overall Study|Withdrawal by Subject|0
7271259|NCT00421148|11485518|FG017|Overall Study|Withdrawal by Subject|1
7271260|NCT00421148|11485519|FG018|Overall Study|Withdrawal by Subject|0
7271261|NCT00421148|11485520|FG019|Overall Study|Withdrawal by Subject|0
7271262|NCT00421148|11485501|FG000|Overall Study|Protocol Violation|0
7271263|NCT00421148|11485502|FG001|Overall Study|Protocol Violation|0
7271264|NCT00421148|11485503|FG002|Overall Study|Protocol Violation|0
7271265|NCT00421148|11485504|FG003|Overall Study|Protocol Violation|0
7271266|NCT00421148|11485505|FG004|Overall Study|Protocol Violation|0
7271267|NCT00421148|11485506|FG005|Overall Study|Protocol Violation|1
7271268|NCT00421148|11485507|FG006|Overall Study|Protocol Violation|0
7271269|NCT00421148|11485508|FG007|Overall Study|Protocol Violation|0
7271270|NCT00421148|11485509|FG008|Overall Study|Protocol Violation|0
7271271|NCT00421148|11485510|FG009|Overall Study|Protocol Violation|0
7271272|NCT00421148|11485511|FG010|Overall Study|Protocol Violation|0
7271273|NCT00421148|11485512|FG011|Overall Study|Protocol Violation|0
7271274|NCT00421148|11485513|FG012|Overall Study|Protocol Violation|0
7271275|NCT00421148|11485514|FG013|Overall Study|Protocol Violation|0
7271276|NCT00421148|11485515|FG014|Overall Study|Protocol Violation|0
7271277|NCT00421148|11485516|FG015|Overall Study|Protocol Violation|0
7271278|NCT00421148|11485517|FG016|Overall Study|Protocol Violation|0
7271279|NCT00421148|11485518|FG017|Overall Study|Protocol Violation|0
7271280|NCT00421148|11485519|FG018|Overall Study|Protocol Violation|1
7271281|NCT00421148|11485520|FG019|Overall Study|Protocol Violation|0
7271282|NCT00421174|11485564|FG000|Overall Study|Withdrawal by Subject|0
7271283|NCT00421174|11485565|FG001|Overall Study|Withdrawal by Subject|1
7271284|NCT00421174|11485564|FG000|Overall Study|Ineligible due to infection|2
7271285|NCT00421174|11485565|FG001|Overall Study|Ineligible due to infection|0
7271286|NCT00421304|11485574|FG000|Overall Study|Lost to Follow-up|5
7271287|NCT00421304|11485575|FG001|Overall Study|Lost to Follow-up|2
7271288|NCT00421304|11485576|FG002|Overall Study|Lost to Follow-up|5
7271289|NCT00421304|11485574|FG000|Overall Study|Withdrawal by Subject|2
7271290|NCT00421304|11485575|FG001|Overall Study|Withdrawal by Subject|2
7271291|NCT00421304|11485576|FG002|Overall Study|Withdrawal by Subject|2
7271292|NCT00421304|11485574|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
7271293|NCT00421304|11485575|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
7271294|NCT00421304|11485576|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
7271295|NCT00421304|11485574|FG000|Overall Study|Did not attend Day 360 visit|0
7271296|NCT00421304|11485575|FG001|Overall Study|Did not attend Day 360 visit|0
7271297|NCT00421304|11485576|FG002|Overall Study|Did not attend Day 360 visit|1
7271298|NCT00421343|11485586|FG000|Overall Study|Death|1
7271299|NCT00421343|11485586|FG000|Overall Study|Withdrawal by Subject|2
7271300|NCT00421343|11485586|FG000|Overall Study|Lost to Follow-up|3
7271301|NCT00421408|11485592|FG000|Overall Study|Lost to Follow-up|30
7271302|NCT00421408|11485593|FG001|Overall Study|Lost to Follow-up|20
7271303|NCT00421408|11485592|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
7271304|NCT00421408|11485593|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
7271305|NCT00421707|11485610|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
7271306|NCT00421707|11485611|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
7271307|NCT00421707|11485610|FG000|Period 1: Treatment Period 1|Adverse Event|7
7271308|NCT00421707|11485611|FG001|Period 1: Treatment Period 1|Adverse Event|2
7271309|NCT00421707|11485610|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
7271310|NCT00421707|11485611|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
7271311|NCT00421707|11485610|FG000|Period 1: Treatment Period 1|Protocol Violation|1
7271312|NCT00421707|11485611|FG001|Period 1: Treatment Period 1|Protocol Violation|0
7271313|NCT00421707|11485610|FG000|Period 2: Washout|Adverse Event|1
7271314|NCT00421707|11485611|FG001|Period 2: Washout|Adverse Event|1
7592948|NCT00700882|11998960|FG000|Overall Study|Never received treatment|6
7592949|NCT00700882|11998960|FG000|Overall Study|Ineligible|2
7592950|NCT00700882|11998960|FG000|Overall Study|No KIT mutation|51
7592973|NCT00644228|11998979|FG000|Randomization & Eligibility|Ineligible|31
7592974|NCT00644228|11998980|FG001|Randomization & Eligibility|Ineligible|21
7592975|NCT00644228|11998979|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
7592976|NCT00644228|11998980|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
7592977|NCT00644228|11998979|FG000|Randomization & Eligibility|Invalid Consent|0
7592978|NCT00644228|11998980|FG001|Randomization & Eligibility|Invalid Consent|1
7592979|NCT00644228|11998979|FG000|Induction Therapy|Adverse Event|22
7592980|NCT00644228|11998980|FG001|Induction Therapy|Adverse Event|55
7592981|NCT00644228|11998979|FG000|Induction Therapy|Withdrawal by Subject|10
7592982|NCT00644228|11998980|FG001|Induction Therapy|Withdrawal by Subject|3
7592983|NCT00644228|11998979|FG000|Induction Therapy|Progression/Relapse|24
7592984|NCT00644228|11998980|FG001|Induction Therapy|Progression/Relapse|12
7592985|NCT00644228|11998979|FG000|Induction Therapy|Death|3
7592986|NCT00644228|11998980|FG001|Induction Therapy|Death|7
7592987|NCT00644228|11998979|FG000|Induction Therapy|Not Protocol-Specified|24
7592988|NCT00644228|11998980|FG001|Induction Therapy|Not Protocol-Specified|28
7592989|NCT00644228|11998979|FG000|Maintenance|Adverse Event|27
7592990|NCT00644228|11998980|FG001|Maintenance|Adverse Event|31
7592991|NCT00644228|11998979|FG000|Maintenance|Withdrawal by Subject|6
7592992|NCT00644228|11998980|FG001|Maintenance|Withdrawal by Subject|4
7592993|NCT00644228|11998979|FG000|Maintenance|Progression/Relapse|67
7592994|NCT00644228|11998980|FG001|Maintenance|Progression/Relapse|42
7592995|NCT00644228|11998979|FG000|Maintenance|Death|3
7592996|NCT00644228|11998980|FG001|Maintenance|Death|3
7592997|NCT00644228|11998979|FG000|Maintenance|Not Protocol-Specified|14
7592998|NCT00644228|11998980|FG001|Maintenance|Not Protocol-Specified|15
7592999|NCT00644228|11998979|FG000|Maintenance|On Treatment|26
7593000|NCT00644228|11998980|FG001|Maintenance|On Treatment|40
7593255|NCT00378482|11999024|FG000|Overall Study|Lost to Follow-up|1
7593256|NCT00378482|11999024|FG000|Overall Study|Lack of Efficacy|8
7593257|NCT00378482|11999024|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
7593258|NCT00378482|11999024|FG000|Overall Study|Withdrawal by Subject|4
7593259|NCT00378482|11999024|FG000|Overall Study|Adverse Event|9
7593260|NCT00316888|11999030|FG000|Overall Study|Adverse Event|4
7593261|NCT00316888|11999031|FG001|Overall Study|Adverse Event|5
7593262|NCT00316888|11999030|FG000|Overall Study|Withdrawal by Subject|2
7593263|NCT00316888|11999031|FG001|Overall Study|Withdrawal by Subject|2
7271315|NCT00421707|11485610|FG000|Period 2: Washout|Withdrawal by Subject|0
7271316|NCT00421707|11485611|FG001|Period 2: Washout|Withdrawal by Subject|1
7271317|NCT00421707|11485610|FG000|Period 2: Washout|Lost to Follow-up|0
7271318|NCT00421707|11485611|FG001|Period 2: Washout|Lost to Follow-up|1
7271319|NCT00421707|11485610|FG000|Period 2: Washout|Other: Pregnancy|0
7271320|NCT00421707|11485611|FG001|Period 2: Washout|Other: Pregnancy|1
7271321|NCT00421707|11485610|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
7271322|NCT00421707|11485611|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
7271323|NCT00421707|11485610|FG000|Period 3:Treatment Period 2|Protocol Violation|1
7271324|NCT00421707|11485611|FG001|Period 3:Treatment Period 2|Protocol Violation|0
7271325|NCT00421707|11485610|FG000|Period 3:Treatment Period 2|Adverse Event|0
7271326|NCT00421707|11485611|FG001|Period 3:Treatment Period 2|Adverse Event|2
7271327|NCT00421733|11485623|FG000|Overall Study|Adverse Event|4
7271328|NCT00421733|11485624|FG001|Overall Study|Adverse Event|9
7271329|NCT00421733|11485625|FG002|Overall Study|Adverse Event|2
7271330|NCT00421733|11485623|FG000|Overall Study|Lost to Follow-up|1
7271331|NCT00421733|11485624|FG001|Overall Study|Lost to Follow-up|2
7271332|NCT00421733|11485625|FG002|Overall Study|Lost to Follow-up|4
7271333|NCT00421733|11485623|FG000|Overall Study|Withdrawal by Subject|1
7271334|NCT00421733|11485624|FG001|Overall Study|Withdrawal by Subject|2
7271335|NCT00421733|11485625|FG002|Overall Study|Withdrawal by Subject|7
7271336|NCT00421733|11485623|FG000|Overall Study|Death|0
7271337|NCT00421733|11485624|FG001|Overall Study|Death|3
7271338|NCT00421733|11485625|FG002|Overall Study|Death|0
7271339|NCT00421733|11485623|FG000|Overall Study|Required dialysis|1
7271340|NCT00421733|11485624|FG001|Overall Study|Required dialysis|0
7271341|NCT00421733|11485625|FG002|Overall Study|Required dialysis|0
7271342|NCT00421733|11485623|FG000|Overall Study|Administrative|2
7271343|NCT00421733|11485624|FG001|Overall Study|Administrative|0
7271344|NCT00421733|11485625|FG002|Overall Study|Administrative|0
7271345|NCT00421733|11485623|FG000|Overall Study|Did not satisfy entry criteria|1
7271346|NCT00421733|11485624|FG001|Overall Study|Did not satisfy entry criteria|3
7271347|NCT00421733|11485625|FG002|Overall Study|Did not satisfy entry criteria|2
7271348|NCT00421733|11485623|FG000|Overall Study|Sponsor request|1
7271349|NCT00421733|11485624|FG001|Overall Study|Sponsor request|0
7271350|NCT00421733|11485625|FG002|Overall Study|Sponsor request|3
7271351|NCT00421733|11485623|FG000|Overall Study|Protocol deviation|4
7271352|NCT00421733|11485624|FG001|Overall Study|Protocol deviation|7
7271353|NCT00421733|11485625|FG002|Overall Study|Protocol deviation|2
7271354|NCT00421889|11485646|FG000|Overall Study|Adverse Event|1
7271355|NCT00421889|11485647|FG001|Overall Study|Adverse Event|0
7271356|NCT00421889|11485648|FG002|Overall Study|Adverse Event|1
7271357|NCT00421889|11485649|FG003|Overall Study|Adverse Event|1
7271358|NCT00421889|11485650|FG004|Overall Study|Adverse Event|1
7271359|NCT00421889|11485651|FG005|Overall Study|Adverse Event|4
7271360|NCT00421889|11485652|FG006|Overall Study|Adverse Event|1
7271361|NCT00421889|11485653|FG007|Overall Study|Adverse Event|0
7593264|NCT00316888|11999030|FG000|Overall Study|Not start protocol therapy|0
7593265|NCT00316888|11999031|FG001|Overall Study|Not start protocol therapy|1
7271362|NCT00421889|11485654|FG008|Overall Study|Adverse Event|2
7271363|NCT00421889|11485646|FG000|Overall Study|Withdrawal by Subject|1
7271364|NCT00421889|11485647|FG001|Overall Study|Withdrawal by Subject|3
7271365|NCT00421889|11485648|FG002|Overall Study|Withdrawal by Subject|0
7271366|NCT00421889|11485649|FG003|Overall Study|Withdrawal by Subject|0
7271367|NCT00421889|11485650|FG004|Overall Study|Withdrawal by Subject|2
7271368|NCT00421889|11485651|FG005|Overall Study|Withdrawal by Subject|0
7271369|NCT00421889|11485652|FG006|Overall Study|Withdrawal by Subject|0
7271370|NCT00421889|11485653|FG007|Overall Study|Withdrawal by Subject|0
7271371|NCT00421889|11485654|FG008|Overall Study|Withdrawal by Subject|0
7271372|NCT00421889|11485646|FG000|Overall Study|Death|0
7271373|NCT00421889|11485647|FG001|Overall Study|Death|0
7271374|NCT00421889|11485648|FG002|Overall Study|Death|0
7271375|NCT00421889|11485649|FG003|Overall Study|Death|0
7271376|NCT00421889|11485650|FG004|Overall Study|Death|1
7271377|NCT00421889|11485651|FG005|Overall Study|Death|1
7271378|NCT00421889|11485652|FG006|Overall Study|Death|0
7271379|NCT00421889|11485653|FG007|Overall Study|Death|0
7271380|NCT00421889|11485654|FG008|Overall Study|Death|0
7271381|NCT00421889|11485646|FG000|Overall Study|Progressive disease|3
7271382|NCT00421889|11485647|FG001|Overall Study|Progressive disease|2
7271383|NCT00421889|11485648|FG002|Overall Study|Progressive disease|2
7271384|NCT00421889|11485649|FG003|Overall Study|Progressive disease|3
7271385|NCT00421889|11485650|FG004|Overall Study|Progressive disease|2
7271386|NCT00421889|11485651|FG005|Overall Study|Progressive disease|21
7271387|NCT00421889|11485652|FG006|Overall Study|Progressive disease|3
7271388|NCT00421889|11485653|FG007|Overall Study|Progressive disease|1
7593298|NCT03178487|11999069|FG000|Overall Study|Adverse Event|1
7271389|NCT00421889|11485654|FG008|Overall Study|Progressive disease|5
7271390|NCT00421889|11485646|FG000|Overall Study|Patient/Investigator request|0
7271391|NCT00421889|11485647|FG001|Overall Study|Patient/Investigator request|0
7271392|NCT00421889|11485648|FG002|Overall Study|Patient/Investigator request|0
7593299|NCT03178487|11999070|FG001|Overall Study|Adverse Event|1
7593300|NCT03178487|11999069|FG000|Overall Study|Withdrawal by Subject|2
7593301|NCT03178487|11999070|FG001|Overall Study|Withdrawal by Subject|1
7593302|NCT03178487|11999069|FG000|Overall Study|Lost to Follow-up|1
7593303|NCT03178487|11999070|FG001|Overall Study|Lost to Follow-up|0
7593304|NCT03178487|11999069|FG000|Overall Study|Other|0
7593305|NCT03178487|11999070|FG001|Overall Study|Other|2
7627292|NCT01962948|12039713|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
7627293|NCT01962948|12039714|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3
7627294|NCT01962948|12039715|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6
7627295|NCT01962948|12039716|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0
7627296|NCT01938001|12039725|FG000|Overall Study|Withdrawal by Subject|25
7627297|NCT01938001|12039726|FG001|Overall Study|Withdrawal by Subject|17
7627298|NCT01938001|12039725|FG000|Overall Study|Non-compliant|1
7627299|NCT01938001|12039726|FG001|Overall Study|Non-compliant|0
7627300|NCT01938001|12039725|FG000|Overall Study|Participant Moved|0
7627301|NCT01938001|12039726|FG001|Overall Study|Participant Moved|1
7627302|NCT01938001|12039725|FG000|Overall Study|Lost to Follow-up|1
7627303|NCT01938001|12039726|FG001|Overall Study|Lost to Follow-up|3
7627304|NCT01938001|12039725|FG000|Overall Study|Death|16
7627305|NCT01938001|12039726|FG001|Overall Study|Death|26
7627306|NCT01529008|12039734|FG000|Bone Marrow Harvesting|Physician Decision|1
7627307|NCT01529008|12039735|FG001|Bone Marrow Harvesting|Physician Decision|1
7627308|NCT01529008|12039734|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0
7627309|NCT01529008|12039735|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2
7627310|NCT01529008|12039734|FG000|Treatment|Adverse Event|6
7627311|NCT01529008|12039735|FG001|Treatment|Adverse Event|0
7627312|NCT01529008|12039734|FG000|Treatment|Other|3
7627313|NCT01529008|12039735|FG001|Treatment|Other|1
7627314|NCT01529008|12039734|FG000|Efficacy Analysis|Protocol Violation|2
7627315|NCT01529008|12039735|FG001|Efficacy Analysis|Protocol Violation|0
7627316|NCT01529008|12039734|FG000|Efficacy Analysis|Physician Decision|0
7627317|NCT01529008|12039735|FG001|Efficacy Analysis|Physician Decision|1
7627318|NCT01529008|12039734|FG000|Efficacy Analysis|Withdrawal by Subject|0
7627319|NCT01529008|12039735|FG001|Efficacy Analysis|Withdrawal by Subject|2
7627320|NCT01484691|12039744|FG000|Overall Study|Withdrawal by Subject|1
7627321|NCT01484691|12039745|FG001|Overall Study|Withdrawal by Subject|1
7627322|NCT01484691|12039746|FG002|Overall Study|Withdrawal by Subject|1
7627323|NCT01484691|12039744|FG000|Overall Study|Physician Decision|0
7627324|NCT01484691|12039745|FG001|Overall Study|Physician Decision|2
7627325|NCT01484691|12039746|FG002|Overall Study|Physician Decision|1
7593306|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Protocol deviation|2
7593307|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Protocol deviation|1
7593308|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Protocol deviation|0
7593309|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Protocol deviation|0
7593310|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Pregnancy|0
7593311|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Pregnancy|1
7593312|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Pregnancy|0
7593313|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Pregnancy|0
7593314|NCT03096834|11999083|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1
7593315|NCT03096834|11999084|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1
7593316|NCT03096834|11999085|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0
7593317|NCT03096834|11999086|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0
7593318|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0
7593319|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0
7593320|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15
7593321|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15
7593322|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Adverse Event|0
7593323|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Adverse Event|0
7593324|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Adverse Event|5
7593325|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Adverse Event|6
7593326|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|New therapy for study indication|0
7593327|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|New therapy for study indication|0
7593328|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|New therapy for study indication|1
7593329|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|New therapy for study indication|1
7271393|NCT00421889|11485649|FG003|Overall Study|Patient/Investigator request|0
7593330|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Physician Decision|0
7593331|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Physician Decision|0
7593332|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Physician Decision|1
7271394|NCT00421889|11485650|FG004|Overall Study|Patient/Investigator request|0
7271395|NCT00421889|11485651|FG005|Overall Study|Patient/Investigator request|9
7271396|NCT00421889|11485652|FG006|Overall Study|Patient/Investigator request|0
7271397|NCT00421889|11485653|FG007|Overall Study|Patient/Investigator request|1
7271398|NCT00421889|11485654|FG008|Overall Study|Patient/Investigator request|3
7593333|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Physician Decision|0
7593334|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Pregnancy|0
7593335|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Pregnancy|0
7593336|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Pregnancy|1
7593337|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Pregnancy|0
7593338|NCT03096834|11999083|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0
7593339|NCT03096834|11999084|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0
7593340|NCT03096834|11999085|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9
7593341|NCT03096834|11999086|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17
7593342|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|New therapy for study indication|0
7593343|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|New therapy for study indication|0
7593344|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|New therapy for study indication|0
7593345|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|New therapy for study indication|1
7593346|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|Protocol deviation|0
7593347|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|Protocol deviation|0
7593348|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|Protocol deviation|0
7593349|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|Protocol deviation|1
7593350|NCT03096834|11999083|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0
7593351|NCT03096834|11999084|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0
7593352|NCT03096834|11999085|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1
7593353|NCT03096834|11999086|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0
7593354|NCT03089853|11999097|FG000|Overall Study|Lost to Follow-up|2
7593355|NCT03089853|11999098|FG001|Overall Study|Lost to Follow-up|1
7593356|NCT03070392|11999106|FG000|Overall Study|Not Treated|7
7593357|NCT03070392|11999107|FG001|Overall Study|Not Treated|0
7593358|NCT03070392|11999108|FG002|Overall Study|Not Treated|3
7593359|NCT03070392|11999109|FG003|Overall Study|Not Treated|12
7593360|NCT03070392|11999106|FG000|Overall Study|Death|3
7593361|NCT03070392|11999107|FG001|Overall Study|Death|0
7593362|NCT03070392|11999108|FG002|Overall Study|Death|0
7593363|NCT03070392|11999109|FG003|Overall Study|Death|1
7593364|NCT03070392|11999106|FG000|Overall Study|Withdrawal by Subject|7
7593365|NCT03070392|11999107|FG001|Overall Study|Withdrawal by Subject|0
7593366|NCT03070392|11999108|FG002|Overall Study|Withdrawal by Subject|0
7593367|NCT03070392|11999109|FG003|Overall Study|Withdrawal by Subject|3
7593368|NCT03070392|11999106|FG000|Overall Study|Physician Decision|1
7593369|NCT03070392|11999107|FG001|Overall Study|Physician Decision|0
7593370|NCT03070392|11999108|FG002|Overall Study|Physician Decision|0
7593371|NCT03070392|11999109|FG003|Overall Study|Physician Decision|2
7593372|NCT03070392|11999106|FG000|Overall Study|Progressive Disease|154
7593373|NCT03070392|11999107|FG001|Overall Study|Progressive Disease|6
7593374|NCT03070392|11999108|FG002|Overall Study|Progressive Disease|2
7593375|NCT03070392|11999109|FG003|Overall Study|Progressive Disease|70
7593376|NCT03070392|11999106|FG000|Overall Study|Adverse Event|6
7593377|NCT03070392|11999107|FG001|Overall Study|Adverse Event|1
7593378|NCT03070392|11999108|FG002|Overall Study|Adverse Event|1
7593379|NCT03070392|11999109|FG003|Overall Study|Adverse Event|3
7593380|NCT03070392|11999106|FG000|Overall Study|Alternate anticancer treatment|1
7593381|NCT03070392|11999107|FG001|Overall Study|Alternate anticancer treatment|0
7593382|NCT03070392|11999108|FG002|Overall Study|Alternate anticancer treatment|0
7593383|NCT03070392|11999109|FG003|Overall Study|Alternate anticancer treatment|1
7593384|NCT03070392|11999106|FG000|Overall Study|Ongoing|73
7593385|NCT03070392|11999107|FG001|Overall Study|Ongoing|0
7593386|NCT03070392|11999108|FG002|Overall Study|Ongoing|0
7593387|NCT03070392|11999109|FG003|Overall Study|Ongoing|11
7593388|NCT03048578|11999117|FG000|Overall Study|Withdrawal by Subject|5
7593389|NCT03048578|11999118|FG001|Overall Study|Withdrawal by Subject|6
7593390|NCT03048578|11999117|FG000|Overall Study|Lost to Follow-up|22
7593391|NCT03048578|11999118|FG001|Overall Study|Lost to Follow-up|10
7593392|NCT03048578|11999117|FG000|Overall Study|Adverse Event|1
7593393|NCT03048578|11999118|FG001|Overall Study|Adverse Event|2
7593394|NCT03048578|11999117|FG000|Overall Study|Terminated|3
7593395|NCT03048578|11999118|FG001|Overall Study|Terminated|2
7593396|NCT03015194|11999124|FG000|Overall Study|Death|10
7593397|NCT03015194|11999124|FG000|Overall Study|Withdrawal by Subject|2
7593398|NCT03012815|11999131|FG000|Overall Study|Lost to Follow-up|1
7593399|NCT03012815|11999132|FG001|Overall Study|Lost to Follow-up|0
7593400|NCT03012815|11999131|FG000|Overall Study|Physician Decision|3
7593401|NCT03012815|11999132|FG001|Overall Study|Physician Decision|2
7593402|NCT03012815|11999131|FG000|Overall Study|Adverse Event|1
7593403|NCT03012815|11999132|FG001|Overall Study|Adverse Event|0
7593404|NCT03001011|11999141|FG000|Overall Study|Adverse Event|9
7593405|NCT03001011|11999142|FG001|Overall Study|Adverse Event|3
7593406|NCT03001011|11999141|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
7593407|NCT03001011|11999142|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
7593408|NCT03001011|11999141|FG000|Overall Study|Other than specified above|3
7593409|NCT03001011|11999142|FG001|Overall Study|Other than specified above|8
7593410|NCT02999633|11999149|FG000|Overall Study|Adverse Event|2
7593411|NCT02999633|11999149|FG000|Overall Study|Progressive disease|12
7593412|NCT02993757|11999155|FG000|Overall Study|Non compliance with the protocol|155
7593413|NCT02993757|11999156|FG001|Overall Study|Non compliance with the protocol|170
7593414|NCT02993757|11999155|FG000|Overall Study|Lost to Follow-up|1
7593415|NCT02993757|11999156|FG001|Overall Study|Lost to Follow-up|0
7593416|NCT02993757|11999155|FG000|Overall Study|Voluntary withdraw not due adverse event|8
7593417|NCT02993757|11999156|FG001|Overall Study|Voluntary withdraw not due adverse event|8
7593418|NCT02992418|11999164|FG000|Overall Study|Withdrawal by Subject|11
7593419|NCT02992418|11999165|FG001|Overall Study|Withdrawal by Subject|12
7593420|NCT02992418|11999164|FG000|Overall Study|Non-compliance with the protocol|308
7593421|NCT02992418|11999165|FG001|Overall Study|Non-compliance with the protocol|308
7593422|NCT02992418|11999164|FG000|Overall Study|Lost to Follow-up|27
7593423|NCT02992418|11999165|FG001|Overall Study|Lost to Follow-up|22
7593424|NCT02979535|11999173|FG000|Overall Study|Non compliance with the protocol|78
7593425|NCT02979535|11999174|FG001|Overall Study|Non compliance with the protocol|82
7593426|NCT02979535|11999173|FG000|Overall Study|Consent withdrawn by participant|11
7593427|NCT02979535|11999174|FG001|Overall Study|Consent withdrawn by participant|18
7593428|NCT02979535|11999173|FG000|Overall Study|Lost to Follow-up|6
7593429|NCT02979535|11999174|FG001|Overall Study|Lost to Follow-up|1
7593430|NCT02978716|11999183|FG000|Overall Study|Death|25
7593431|NCT02978716|11999184|FG001|Overall Study|Death|13
7593432|NCT02978716|11999185|FG002|Overall Study|Death|20
7593433|NCT02978716|11999183|FG000|Overall Study|Lost to Follow-up|0
7593434|NCT02978716|11999184|FG001|Overall Study|Lost to Follow-up|0
7593435|NCT02978716|11999185|FG002|Overall Study|Lost to Follow-up|1
7593436|NCT02978716|11999183|FG000|Overall Study|Withdrawal by Subject|6
7593437|NCT02978716|11999184|FG001|Overall Study|Withdrawal by Subject|4
7593438|NCT02978716|11999185|FG002|Overall Study|Withdrawal by Subject|5
7593439|NCT02978716|11999183|FG000|Overall Study|Sponsor terminated|2
7593440|NCT02978716|11999184|FG001|Overall Study|Sponsor terminated|13
7593441|NCT02978716|11999185|FG002|Overall Study|Sponsor terminated|9
7593442|NCT02978716|11999183|FG000|Overall Study|Other|1
7593443|NCT02978716|11999184|FG001|Overall Study|Other|3
7593444|NCT02978716|11999185|FG002|Overall Study|Other|0
7593445|NCT02973321|11999200|FG000|Overall Study|Other than specified|0
7593446|NCT02973321|11999201|FG001|Overall Study|Other than specified|5
7593447|NCT02973321|11999202|FG002|Overall Study|Other than specified|3
7593448|NCT02973321|11999203|FG003|Overall Study|Other than specified|3
7593449|NCT02973321|11999204|FG004|Overall Study|Other than specified|1
7593450|NCT02973321|11999200|FG000|Overall Study|Lack of Efficacy|0
7593451|NCT02973321|11999201|FG001|Overall Study|Lack of Efficacy|0
7593452|NCT02973321|11999202|FG002|Overall Study|Lack of Efficacy|0
7593453|NCT02973321|11999203|FG003|Overall Study|Lack of Efficacy|0
7593454|NCT02973321|11999204|FG004|Overall Study|Lack of Efficacy|1
7593455|NCT02973321|11999200|FG000|Overall Study|Adverse Event|1
7593456|NCT02973321|11999201|FG001|Overall Study|Adverse Event|10
7593457|NCT02973321|11999202|FG002|Overall Study|Adverse Event|11
7593458|NCT02973321|11999203|FG003|Overall Study|Adverse Event|13
7593459|NCT02973321|11999204|FG004|Overall Study|Adverse Event|3
7593460|NCT02943785|11999219|FG000|Overall Study|Adverse Event|112
7593461|NCT02943785|11999220|FG001|Overall Study|Adverse Event|97
7593462|NCT02943785|11999219|FG000|Overall Study|Withdrawal by Subject|63
7593463|NCT02943785|11999220|FG001|Overall Study|Withdrawal by Subject|126
7593464|NCT02943785|11999219|FG000|Overall Study|Physician Decision|23
7593465|NCT02943785|11999220|FG001|Overall Study|Physician Decision|47
7593466|NCT02943785|11999219|FG000|Overall Study|Death|46
7593467|NCT02943785|11999220|FG001|Overall Study|Death|46
7593468|NCT02943785|11999219|FG000|Overall Study|Lost to Follow-up|1
7593469|NCT02943785|11999220|FG001|Overall Study|Lost to Follow-up|0
7593470|NCT02943785|11999219|FG000|Overall Study|Other|16
7593471|NCT02943785|11999220|FG001|Overall Study|Other|19
7593472|NCT02943785|11999219|FG000|Overall Study|Did not receive any study medication|21
7593473|NCT02943785|11999220|FG001|Overall Study|Did not receive any study medication|28
7593474|NCT02923674|11999229|FG000|Overall Study|Clinic Closed Due to COVID-19|14
7593475|NCT02923674|11999230|FG001|Overall Study|Clinic Closed Due to COVID-19|11
7593476|NCT02923674|11999231|FG002|Overall Study|Clinic Closed Due to COVID-19|14
7593477|NCT02923674|11999229|FG000|Overall Study|Lost to Follow-up|7
7593478|NCT02923674|11999230|FG001|Overall Study|Lost to Follow-up|12
7593479|NCT02923674|11999231|FG002|Overall Study|Lost to Follow-up|7
7593480|NCT02923674|11999229|FG000|Overall Study|Problem with intervention|2
7593481|NCT02923674|11999230|FG001|Overall Study|Problem with intervention|2
7593482|NCT02923674|11999231|FG002|Overall Study|Problem with intervention|1
7593483|NCT02923674|11999229|FG000|Overall Study|Adverse Event|3
7593484|NCT02923674|11999230|FG001|Overall Study|Adverse Event|1
7593485|NCT02923674|11999231|FG002|Overall Study|Adverse Event|1
7593486|NCT02923674|11999229|FG000|Overall Study|Withdrawal by Subject|2
7593487|NCT02923674|11999230|FG001|Overall Study|Withdrawal by Subject|2
7593488|NCT02923674|11999231|FG002|Overall Study|Withdrawal by Subject|2
7593489|NCT02921971|11999241|FG000|Overall Study|Adverse Event|1
7593490|NCT02921971|11999242|FG001|Overall Study|Adverse Event|2
7593491|NCT02921971|11999241|FG000|Overall Study|Lack of Efficacy|3
7593492|NCT02921971|11999242|FG001|Overall Study|Lack of Efficacy|1
7593493|NCT02921971|11999241|FG000|Overall Study|Other than specified above|2
7593494|NCT02921971|11999242|FG001|Overall Study|Other than specified above|1
7627326|NCT00400946|12039773|FG000|Overall Study|Ineligible|0
7627327|NCT00400946|12039774|FG001|Overall Study|Ineligible|0
7627328|NCT00400946|12039775|FG002|Overall Study|Ineligible|0
7627329|NCT00400946|12039776|FG003|Overall Study|Ineligible|5
7627330|NCT00400946|12039777|FG004|Overall Study|Ineligible|1
7627331|NCT00400946|12039773|FG000|Overall Study|Induction Failure|0
7627332|NCT00400946|12039774|FG001|Overall Study|Induction Failure|0
7627333|NCT00400946|12039775|FG002|Overall Study|Induction Failure|0
7627334|NCT00400946|12039776|FG003|Overall Study|Induction Failure|11
7627335|NCT00400946|12039777|FG004|Overall Study|Induction Failure|8
7627336|NCT00400946|12039773|FG000|Overall Study|Induction Death|0
7627337|NCT00400946|12039774|FG001|Overall Study|Induction Death|0
7627338|NCT00400946|12039775|FG002|Overall Study|Induction Death|0
7627339|NCT00400946|12039776|FG003|Overall Study|Induction Death|13
7627340|NCT00400946|12039777|FG004|Overall Study|Induction Death|3
7627341|NCT00400946|12039773|FG000|Overall Study|Lost to Follow-up|1
7627342|NCT00400946|12039774|FG001|Overall Study|Lost to Follow-up|1
7627343|NCT00400946|12039775|FG002|Overall Study|Lost to Follow-up|0
7627344|NCT00400946|12039776|FG003|Overall Study|Lost to Follow-up|0
7627345|NCT00400946|12039777|FG004|Overall Study|Lost to Follow-up|1
7627346|NCT00400946|12039773|FG000|Overall Study|Remission Death|1
7627347|NCT00400946|12039774|FG001|Overall Study|Remission Death|1
7627348|NCT00400946|12039775|FG002|Overall Study|Remission Death|0
7593495|NCT02886286|11999250|FG000|Overall Study|pump motor stall|0
7593496|NCT02886286|11999251|FG001|Overall Study|pump motor stall|1
7593497|NCT02865187|11999259|FG000|Overall Study|Lost to Follow-up|12
7593498|NCT02865187|11999260|FG001|Overall Study|Lost to Follow-up|7
7593499|NCT02865187|11999259|FG000|Overall Study|Adverse Event|1
7593500|NCT02865187|11999260|FG001|Overall Study|Adverse Event|0
7593515|NCT02824198|11999281|FG000|Overall Study|Non-compliance with the protocol|5
7593516|NCT02824198|11999282|FG001|Overall Study|Non-compliance with the protocol|1
7593517|NCT02824198|11999281|FG000|Overall Study|Lost to Follow-up|5
7593518|NCT02824198|11999282|FG001|Overall Study|Lost to Follow-up|2
7593519|NCT02824198|11999281|FG000|Overall Study|Withdrawal by Subject|5
7593520|NCT02824198|11999282|FG001|Overall Study|Withdrawal by Subject|0
7593521|NCT02821754|11999293|FG000|Overall Study|Procedure not required prior to amendment change|13
7593522|NCT02821754|11999294|FG001|Overall Study|Procedure not required prior to amendment change|11
7593523|NCT02821754|11999295|FG002|Overall Study|Procedure not required prior to amendment change|0
7593524|NCT02821754|11999293|FG000|Overall Study|Participant's Clinical status|2
7593525|NCT02821754|11999294|FG001|Overall Study|Participant's Clinical status|0
7593526|NCT02821754|11999295|FG002|Overall Study|Participant's Clinical status|0
7593527|NCT02821754|11999293|FG000|Overall Study|Participant removed for noncompliance|1
7593528|NCT02821754|11999294|FG001|Overall Study|Participant removed for noncompliance|0
7593529|NCT02821754|11999295|FG002|Overall Study|Participant removed for noncompliance|0
7593530|NCT02821754|11999293|FG000|Overall Study|Drug not available.|0
7593531|NCT02821754|11999294|FG001|Overall Study|Drug not available.|0
7593532|NCT02821754|11999295|FG002|Overall Study|Drug not available.|1
7593533|NCT02821754|11999293|FG000|Overall Study|Participant declined to participate (before treatment started.)|0
7593534|NCT02821754|11999294|FG001|Overall Study|Participant declined to participate (before treatment started.)|1
7593535|NCT02821754|11999295|FG002|Overall Study|Participant declined to participate (before treatment started.)|1
7593536|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Adverse Event|10
7593537|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Adverse Event|0
7593538|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
7593539|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
7593540|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
7593541|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
7593542|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
7593543|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
7593544|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Randomized but not treated|2
7593545|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Randomized but not treated|1
7593546|NCT02787551|11999303|FG000|Core Period: 26 Weeks|Other than specified|3
7593547|NCT02787551|11999304|FG001|Core Period: 26 Weeks|Other than specified|1
7593548|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
7593549|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
7593550|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
7593551|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
7593552|NCT02787551|11999303|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
7593553|NCT02787551|11999304|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
7593554|NCT02735044|11999324|FG000|Overall Study|Adverse Event|3
7593555|NCT02735044|11999325|FG001|Overall Study|Adverse Event|3
7593556|NCT02735044|11999324|FG000|Overall Study|Lack of Efficacy|1
7593557|NCT02735044|11999325|FG001|Overall Study|Lack of Efficacy|0
7593558|NCT02735044|11999324|FG000|Overall Study|Poor compliance to protocol|7
7593559|NCT02735044|11999325|FG001|Overall Study|Poor compliance to protocol|7
7593560|NCT02735044|11999324|FG000|Overall Study|Randomized and not treated|0
7593561|NCT02735044|11999325|FG001|Overall Study|Randomized and not treated|2
7593562|NCT02735044|11999324|FG000|Overall Study|Other, not specified above|5
7593563|NCT02735044|11999325|FG001|Overall Study|Other, not specified above|11
7593564|NCT02720744|11999333|FG000|Overall Study|Protocol Violation|0
7593565|NCT02720744|11999334|FG001|Overall Study|Protocol Violation|2
7593566|NCT02720744|11999333|FG000|Overall Study|Pregnancy|2
7593567|NCT02720744|11999334|FG001|Overall Study|Pregnancy|0
7593568|NCT02720744|11999333|FG000|Overall Study|Lack of Efficacy|2
7593569|NCT02720744|11999334|FG001|Overall Study|Lack of Efficacy|8
7593570|NCT02720744|11999333|FG000|Overall Study|Adverse Event|21
7593571|NCT02720744|11999334|FG001|Overall Study|Adverse Event|3
7593572|NCT02720744|11999333|FG000|Overall Study|Withdrawal by Subject|11
7593573|NCT02720744|11999334|FG001|Overall Study|Withdrawal by Subject|11
7593574|NCT02720744|11999333|FG000|Overall Study|Lost to follow up|2
7593575|NCT02720744|11999334|FG001|Overall Study|Lost to follow up|0
7593576|NCT02720744|11999333|FG000|Overall Study|Non Compliance with Investigational Product|0
7593577|NCT02720744|11999334|FG001|Overall Study|Non Compliance with Investigational Product|1
7593578|NCT02720744|11999333|FG000|Overall Study|Excluded Concomitant Medication|0
7593579|NCT02720744|11999334|FG001|Overall Study|Excluded Concomitant Medication|1
7593580|NCT02713867|11999342|FG000|Randomization|Other Reason|2
7593581|NCT02713867|11999343|FG001|Randomization|Other Reason|1
7593582|NCT02713867|11999342|FG000|Randomization|Participant Withdrew consent|0
7593583|NCT02713867|11999343|FG001|Randomization|Participant Withdrew consent|2
7593584|NCT02713867|11999342|FG000|Treatment Period|Not Reported|1
7593585|NCT02713867|11999343|FG001|Treatment Period|Not Reported|0
7593586|NCT02713867|11999342|FG000|Treatment Period|Other Reasons|12
7593587|NCT02713867|11999343|FG001|Treatment Period|Other Reasons|18
7593588|NCT02713867|11999342|FG000|Treatment Period|Administrative reason by sponsor|9
7593589|NCT02713867|11999343|FG001|Treatment Period|Administrative reason by sponsor|4
7593590|NCT02713867|11999342|FG000|Treatment Period|No longer meets study criteria|2
7593591|NCT02713867|11999343|FG001|Treatment Period|No longer meets study criteria|1
7593592|NCT02713867|11999342|FG000|Treatment Period|Poor/Non Compliance|1
7593593|NCT02713867|11999343|FG001|Treatment Period|Poor/Non Compliance|0
7593594|NCT02713867|11999342|FG000|Treatment Period|Maximum Clinical Benefit|3
7593595|NCT02713867|11999343|FG001|Treatment Period|Maximum Clinical Benefit|4
7593596|NCT02713867|11999342|FG000|Treatment Period|Withdrew consent|1
7593597|NCT02713867|11999343|FG001|Treatment Period|Withdrew consent|6
7593598|NCT02713867|11999342|FG000|Treatment Period|Requested to Discontinue|8
7593599|NCT02713867|11999343|FG001|Treatment Period|Requested to Discontinue|7
7593600|NCT02713867|11999342|FG000|Treatment Period|AE unrelated to Study Drug|8
7593601|NCT02713867|11999343|FG001|Treatment Period|AE unrelated to Study Drug|9
7593602|NCT02713867|11999342|FG000|Treatment Period|Death|7
7593603|NCT02713867|11999343|FG001|Treatment Period|Death|3
7593604|NCT02713867|11999342|FG000|Treatment Period|Study Drug Toxicity|16
7593605|NCT02713867|11999343|FG001|Treatment Period|Study Drug Toxicity|20
7593606|NCT02713867|11999342|FG000|Treatment Period|Disease Progression|79
7593607|NCT02713867|11999343|FG001|Treatment Period|Disease Progression|78
7593608|NCT02704403|11999351|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4
7593609|NCT02704403|11999352|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3
7593610|NCT02704403|11999351|FG000|Overall Study|Administrative reasons by sponsor|1251
7593611|NCT02704403|11999352|FG001|Overall Study|Administrative reasons by sponsor|616
7593612|NCT02704403|11999351|FG000|Overall Study|Death|4
7593613|NCT02704403|11999352|FG001|Overall Study|Death|3
7593614|NCT02704403|11999351|FG000|Overall Study|Endpoint event|52
7593615|NCT02704403|11999352|FG001|Overall Study|Endpoint event|24
7593616|NCT02704403|11999351|FG000|Overall Study|Lost to Follow-up|22
7593617|NCT02704403|11999352|FG001|Overall Study|Lost to Follow-up|11
7593618|NCT02704403|11999351|FG000|Overall Study|Protocol Violation|15
7593619|NCT02704403|11999352|FG001|Overall Study|Protocol Violation|15
7593620|NCT02704403|11999351|FG000|Overall Study|Adverse Event|2
7593621|NCT02704403|11999352|FG001|Overall Study|Adverse Event|0
7593622|NCT02704403|11999351|FG000|Overall Study|Withdrawal by Subject|85
7593623|NCT02704403|11999352|FG001|Overall Study|Withdrawal by Subject|45
7593624|NCT02704403|11999351|FG000|Overall Study|Investigator decision|1
7593625|NCT02704403|11999352|FG001|Overall Study|Investigator decision|1
7593626|NCT02704403|11999351|FG000|Overall Study|Follow-up not possible|1
7593627|NCT02704403|11999352|FG001|Overall Study|Follow-up not possible|2
7593628|NCT02694185|11999360|FG000|Overall Study|Withdrawal by Subject|45
7271399|NCT00421889|11485646|FG000|Overall Study|Lost to Follow-up|0
7271400|NCT00421889|11485647|FG001|Overall Study|Lost to Follow-up|0
7271401|NCT00421889|11485648|FG002|Overall Study|Lost to Follow-up|0
7271402|NCT00421889|11485649|FG003|Overall Study|Lost to Follow-up|0
7271403|NCT00421889|11485650|FG004|Overall Study|Lost to Follow-up|0
7271404|NCT00421889|11485651|FG005|Overall Study|Lost to Follow-up|0
7271405|NCT00421889|11485652|FG006|Overall Study|Lost to Follow-up|0
7271406|NCT00421889|11485653|FG007|Overall Study|Lost to Follow-up|0
7271407|NCT00421889|11485654|FG008|Overall Study|Lost to Follow-up|1
7271408|NCT00421928|11485681|FG000|Overall Study|Adverse Event|61
7271409|NCT00421928|11485682|FG001|Overall Study|Adverse Event|140
7271410|NCT00421928|11485683|FG002|Overall Study|Adverse Event|22
7271411|NCT00421928|11485681|FG000|Overall Study|Lost to Follow-up|5
7271412|NCT00421928|11485682|FG001|Overall Study|Lost to Follow-up|0
7271413|NCT00421928|11485683|FG002|Overall Study|Lost to Follow-up|3
7271414|NCT00421928|11485681|FG000|Overall Study|Withdrawal by Subject|50
7593629|NCT02694185|11999361|FG001|Overall Study|Withdrawal by Subject|0
7593630|NCT02692651|11999369|FG000|Study Treatment|Death|7
7593631|NCT02692651|11999370|FG001|Study Treatment|Death|3
7593632|NCT02692651|11999369|FG000|Study Treatment|comfort care|1
7593633|NCT02692651|11999370|FG001|Study Treatment|comfort care|1
7593634|NCT02692651|11999369|FG000|Study Treatment|Protocol violation per treating team preference|8
7593635|NCT02692651|11999370|FG001|Study Treatment|Protocol violation per treating team preference|6
7593636|NCT02692651|11999369|FG000|Post Study Treatment Follow-up|Death|4
7593637|NCT02692651|11999370|FG001|Post Study Treatment Follow-up|Death|4
7593638|NCT02674061|11999378|FG000|Overall Study|Death|229
7593639|NCT02674061|11999379|FG001|Overall Study|Death|77
7593640|NCT02674061|11999378|FG000|Overall Study|Lost to Follow-up|3
7593641|NCT02674061|11999379|FG001|Overall Study|Lost to Follow-up|3
7593642|NCT02674061|11999378|FG000|Overall Study|Withdrawal by Subject|9
7593643|NCT02674061|11999379|FG001|Overall Study|Withdrawal by Subject|1
7593644|NCT02674061|11999378|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44
7593645|NCT02674061|11999379|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10
7593646|NCT02656706|11999387|FG000|Overall Study|Insurance Denial|1
7593647|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
7593648|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593649|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593650|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593651|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593652|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593653|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593654|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593655|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
7593656|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593657|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
7593658|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
7593659|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593660|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593661|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593662|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593663|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593664|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
7593665|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
7593666|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
7593667|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
7593668|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593669|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593670|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593671|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593672|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593673|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
7593674|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7593675|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
7593676|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
7593677|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593678|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593679|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593680|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593681|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593682|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
7593683|NCT02628444|11999403|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7593684|NCT02628444|11999404|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
7593685|NCT02628444|11999405|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
7593686|NCT02628444|11999406|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593687|NCT02628444|11999407|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593688|NCT02628444|11999408|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593689|NCT02628444|11999409|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593690|NCT02628444|11999410|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593691|NCT02628444|11999411|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
7593692|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593693|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593694|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593695|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
7271415|NCT00421928|11485682|FG001|Overall Study|Withdrawal by Subject|48
7593696|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593697|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593698|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593699|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593700|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
7593701|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593702|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593703|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
7593704|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593705|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593706|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
7593707|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
7593708|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
7593709|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
7593710|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593711|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593712|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
7593713|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
7593794|NCT02587520|11999492|FG010|Overall Study|Withdrawal by Subject|0
7593714|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
7593715|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
7593716|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
7593717|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
7593718|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
7593719|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593720|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593721|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593722|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593723|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7593724|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593725|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
7593726|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
7593727|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
7593728|NCT02628444|11999403|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593729|NCT02628444|11999404|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593730|NCT02628444|11999405|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
7593731|NCT02628444|11999406|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593732|NCT02628444|11999407|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593733|NCT02628444|11999408|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7593734|NCT02628444|11999409|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
7593735|NCT02628444|11999410|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
7593736|NCT02628444|11999411|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
7593737|NCT02623725|11999447|FG000|Overall Study|Non compliance with protocol|9
7593738|NCT02623725|11999448|FG001|Overall Study|Non compliance with protocol|3
7593739|NCT02623725|11999447|FG000|Overall Study|Serious adverse event|0
7593740|NCT02623725|11999448|FG001|Overall Study|Serious adverse event|2
7593741|NCT02623725|11999447|FG000|Overall Study|Withdrawal by Subject|7
7593742|NCT02623725|11999448|FG001|Overall Study|Withdrawal by Subject|1
7593743|NCT02608684|11999456|FG000|Overall Study|Physician Decision|2
7593744|NCT02608684|11999456|FG000|Overall Study|Withdrawal by Subject|1
7593745|NCT02603887|11999460|FG000|Stage 1|Adverse Event|4
7593746|NCT02603887|11999460|FG000|Stage 1|Disease progression|1
7593747|NCT02603887|11999460|FG000|Stage 2|FDA guidance|1
7593748|NCT02587520|11999482|FG000|Overall Study|Protocol Violation|2
7593749|NCT02587520|11999483|FG001|Overall Study|Protocol Violation|0
7593750|NCT02587520|11999484|FG002|Overall Study|Protocol Violation|0
7593751|NCT02587520|11999485|FG003|Overall Study|Protocol Violation|2
7593752|NCT02587520|11999486|FG004|Overall Study|Protocol Violation|0
7593753|NCT02587520|11999487|FG005|Overall Study|Protocol Violation|1
7593754|NCT02587520|11999488|FG006|Overall Study|Protocol Violation|1
7593755|NCT02587520|11999489|FG007|Overall Study|Protocol Violation|1
7593756|NCT02587520|11999490|FG008|Overall Study|Protocol Violation|3
7593757|NCT02587520|11999491|FG009|Overall Study|Protocol Violation|3
7593758|NCT02587520|11999492|FG010|Overall Study|Protocol Violation|1
7593759|NCT02587520|11999493|FG011|Overall Study|Protocol Violation|2
7593760|NCT02587520|11999494|FG012|Overall Study|Protocol Violation|0
7593761|NCT02587520|11999495|FG013|Overall Study|Protocol Violation|0
7593762|NCT02587520|11999496|FG014|Overall Study|Protocol Violation|0
7593763|NCT02587520|11999497|FG015|Overall Study|Protocol Violation|0
7593764|NCT02587520|11999498|FG016|Overall Study|Protocol Violation|0
7593765|NCT02587520|11999499|FG017|Overall Study|Protocol Violation|0
7593766|NCT02587520|11999482|FG000|Overall Study|Adverse Event|0
7593767|NCT02587520|11999483|FG001|Overall Study|Adverse Event|0
7593768|NCT02587520|11999484|FG002|Overall Study|Adverse Event|0
7593769|NCT02587520|11999485|FG003|Overall Study|Adverse Event|0
7593770|NCT02587520|11999486|FG004|Overall Study|Adverse Event|0
7593771|NCT02587520|11999487|FG005|Overall Study|Adverse Event|0
7593772|NCT02587520|11999488|FG006|Overall Study|Adverse Event|0
7593773|NCT02587520|11999489|FG007|Overall Study|Adverse Event|0
7593774|NCT02587520|11999490|FG008|Overall Study|Adverse Event|0
7593775|NCT02587520|11999491|FG009|Overall Study|Adverse Event|0
7593776|NCT02587520|11999492|FG010|Overall Study|Adverse Event|0
7593777|NCT02587520|11999493|FG011|Overall Study|Adverse Event|1
7593778|NCT02587520|11999494|FG012|Overall Study|Adverse Event|0
7593779|NCT02587520|11999495|FG013|Overall Study|Adverse Event|0
7593780|NCT02587520|11999496|FG014|Overall Study|Adverse Event|0
7593781|NCT02587520|11999497|FG015|Overall Study|Adverse Event|0
7593782|NCT02587520|11999498|FG016|Overall Study|Adverse Event|0
7593783|NCT02587520|11999499|FG017|Overall Study|Adverse Event|0
7593784|NCT02587520|11999482|FG000|Overall Study|Withdrawal by Subject|0
7593785|NCT02587520|11999483|FG001|Overall Study|Withdrawal by Subject|0
7593786|NCT02587520|11999484|FG002|Overall Study|Withdrawal by Subject|1
7593787|NCT02587520|11999485|FG003|Overall Study|Withdrawal by Subject|1
7593788|NCT02587520|11999486|FG004|Overall Study|Withdrawal by Subject|0
7593789|NCT02587520|11999487|FG005|Overall Study|Withdrawal by Subject|1
7593790|NCT02587520|11999488|FG006|Overall Study|Withdrawal by Subject|1
7593791|NCT02587520|11999489|FG007|Overall Study|Withdrawal by Subject|0
7593792|NCT02587520|11999490|FG008|Overall Study|Withdrawal by Subject|0
7593793|NCT02587520|11999491|FG009|Overall Study|Withdrawal by Subject|0
7593795|NCT02587520|11999493|FG011|Overall Study|Withdrawal by Subject|0
7593796|NCT02587520|11999494|FG012|Overall Study|Withdrawal by Subject|0
7593797|NCT02587520|11999495|FG013|Overall Study|Withdrawal by Subject|1
7593798|NCT02587520|11999496|FG014|Overall Study|Withdrawal by Subject|0
7593799|NCT02587520|11999497|FG015|Overall Study|Withdrawal by Subject|0
7593800|NCT02587520|11999498|FG016|Overall Study|Withdrawal by Subject|0
7593801|NCT02587520|11999499|FG017|Overall Study|Withdrawal by Subject|0
7593802|NCT02587520|11999482|FG000|Overall Study|Lost to Follow-up|0
7593803|NCT02587520|11999483|FG001|Overall Study|Lost to Follow-up|2
7593804|NCT02587520|11999484|FG002|Overall Study|Lost to Follow-up|0
7593805|NCT02587520|11999485|FG003|Overall Study|Lost to Follow-up|2
7593806|NCT02587520|11999486|FG004|Overall Study|Lost to Follow-up|0
7593807|NCT02587520|11999487|FG005|Overall Study|Lost to Follow-up|1
7593808|NCT02587520|11999488|FG006|Overall Study|Lost to Follow-up|1
7593809|NCT02587520|11999489|FG007|Overall Study|Lost to Follow-up|1
7593810|NCT02587520|11999490|FG008|Overall Study|Lost to Follow-up|0
7593811|NCT02587520|11999491|FG009|Overall Study|Lost to Follow-up|2
7593812|NCT02587520|11999492|FG010|Overall Study|Lost to Follow-up|2
7593813|NCT02587520|11999493|FG011|Overall Study|Lost to Follow-up|1
7593814|NCT02587520|11999494|FG012|Overall Study|Lost to Follow-up|0
7593815|NCT02587520|11999495|FG013|Overall Study|Lost to Follow-up|0
7593816|NCT02587520|11999496|FG014|Overall Study|Lost to Follow-up|0
7593817|NCT02587520|11999497|FG015|Overall Study|Lost to Follow-up|0
7593818|NCT02587520|11999498|FG016|Overall Study|Lost to Follow-up|0
7593819|NCT02587520|11999499|FG017|Overall Study|Lost to Follow-up|0
7593820|NCT02584829|11999539|FG000|Overall Study|Physician Decision|1
7593821|NCT02584829|11999540|FG001|Overall Study|Physician Decision|0
7593822|NCT02584829|11999539|FG000|Overall Study|Withdrawal by Subject|0
7593823|NCT02584829|11999540|FG001|Overall Study|Withdrawal by Subject|1
7593824|NCT02584829|11999539|FG000|Overall Study|Progressive Disease|0
7593825|NCT02584829|11999540|FG001|Overall Study|Progressive Disease|3
7593826|NCT02570308|11999553|FG000|Overall Study|Death|1
7593827|NCT02570308|11999554|FG001|Overall Study|Death|5
7593828|NCT02570308|11999555|FG002|Overall Study|Death|4
7593829|NCT02570308|11999556|FG003|Overall Study|Death|4
7593830|NCT02570308|11999557|FG004|Overall Study|Death|69
7593831|NCT02570308|11999553|FG000|Overall Study|Lost to Follow-up|0
7593832|NCT02570308|11999554|FG001|Overall Study|Lost to Follow-up|0
7593833|NCT02570308|11999555|FG002|Overall Study|Lost to Follow-up|0
7593834|NCT02570308|11999556|FG003|Overall Study|Lost to Follow-up|0
7593835|NCT02570308|11999557|FG004|Overall Study|Lost to Follow-up|2
7593836|NCT02570308|11999553|FG000|Overall Study|Withdrawal by Subject|0
7593837|NCT02570308|11999554|FG001|Overall Study|Withdrawal by Subject|0
7593838|NCT02570308|11999555|FG002|Overall Study|Withdrawal by Subject|0
7593839|NCT02570308|11999556|FG003|Overall Study|Withdrawal by Subject|0
7593840|NCT02570308|11999557|FG004|Overall Study|Withdrawal by Subject|1
7593841|NCT02570308|11999553|FG000|Overall Study|Other|0
7593842|NCT02570308|11999554|FG001|Overall Study|Other|0
7593843|NCT02570308|11999555|FG002|Overall Study|Other|0
7593844|NCT02570308|11999556|FG003|Overall Study|Other|0
7593845|NCT02570308|11999557|FG004|Overall Study|Other|2
7593846|NCT02514083|11999575|FG000|Overall Study|Adverse Event|1
7627349|NCT00400946|12039776|FG003|Overall Study|Remission Death|0
7627350|NCT00400946|12039777|FG004|Overall Study|Remission Death|1
7627351|NCT00400946|12039773|FG000|Overall Study|Relapse|9
7627352|NCT00400946|12039774|FG001|Overall Study|Relapse|2
7627353|NCT00400946|12039775|FG002|Overall Study|Relapse|1
7627354|NCT00400946|12039776|FG003|Overall Study|Relapse|1
7627355|NCT00400946|12039777|FG004|Overall Study|Relapse|5
7627356|NCT00400946|12039773|FG000|Overall Study|Transplant in CR1|0
7627357|NCT00400946|12039774|FG001|Overall Study|Transplant in CR1|0
7627358|NCT00400946|12039775|FG002|Overall Study|Transplant in CR1|0
7627359|NCT00400946|12039776|FG003|Overall Study|Transplant in CR1|10
7627360|NCT00400946|12039777|FG004|Overall Study|Transplant in CR1|1
7627361|NCT00400946|12039773|FG000|Overall Study|Withdrawal by Subject|2
7627362|NCT00400946|12039774|FG001|Overall Study|Withdrawal by Subject|5
7627363|NCT00400946|12039775|FG002|Overall Study|Withdrawal by Subject|1
7627364|NCT00400946|12039776|FG003|Overall Study|Withdrawal by Subject|5
7627365|NCT00400946|12039777|FG004|Overall Study|Withdrawal by Subject|8
7627366|NCT00400946|12039773|FG000|Overall Study|Clinical|1
7627367|NCT00400946|12039774|FG001|Overall Study|Clinical|2
7627368|NCT00400946|12039775|FG002|Overall Study|Clinical|0
7627369|NCT00400946|12039776|FG003|Overall Study|Clinical|2
7627370|NCT00400946|12039777|FG004|Overall Study|Clinical|9
7627371|NCT00400946|12039773|FG000|Overall Study|Other|0
7627372|NCT00400946|12039774|FG001|Overall Study|Other|0
7627373|NCT00400946|12039775|FG002|Overall Study|Other|0
7627374|NCT00400946|12039776|FG003|Overall Study|Other|0
7627375|NCT00400946|12039777|FG004|Overall Study|Other|1
7627376|NCT00180414|12039797|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4
7627377|NCT00180414|12039798|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4
7627378|NCT03886220|12039835|FG000|Treatment Period|Discontinued study drug during the treatment period|5
7627379|NCT03886220|12039836|FG001|Treatment Period|Discontinued study drug during the treatment period|12
7627380|NCT03886220|12039835|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
7627381|NCT03886220|12039836|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
7271416|NCT00421928|11485683|FG002|Overall Study|Withdrawal by Subject|43
7627382|NCT03886220|12039835|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1
7627383|NCT03886220|12039836|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
7593847|NCT02497612|11999583|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
7593848|NCT02497612|11999584|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
7593849|NCT02497612|11999585|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
7593850|NCT02497612|11999586|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
7593851|NCT02497612|11999583|FG000|Overall Study|Participant's request|2
7593852|NCT02497612|11999584|FG001|Overall Study|Participant's request|3
7593853|NCT02497612|11999585|FG002|Overall Study|Participant's request|4
7593854|NCT02497612|11999586|FG003|Overall Study|Participant's request|1
7593855|NCT02497612|11999583|FG000|Overall Study|Investigator's judgement|1
7593856|NCT02497612|11999584|FG001|Overall Study|Investigator's judgement|0
7593857|NCT02497612|11999585|FG002|Overall Study|Investigator's judgement|0
7593858|NCT02497612|11999586|FG003|Overall Study|Investigator's judgement|2
7593859|NCT02497612|11999583|FG000|Overall Study|Adverse Event|3
7593860|NCT02497612|11999584|FG001|Overall Study|Adverse Event|1
7593861|NCT02497612|11999585|FG002|Overall Study|Adverse Event|4
7593862|NCT02497612|11999586|FG003|Overall Study|Adverse Event|1
7593863|NCT02497612|11999583|FG000|Overall Study|Lost to Follow-up|1
7593864|NCT02497612|11999584|FG001|Overall Study|Lost to Follow-up|1
7593865|NCT02497612|11999585|FG002|Overall Study|Lost to Follow-up|0
7593866|NCT02497612|11999586|FG003|Overall Study|Lost to Follow-up|1
7593867|NCT02497612|11999583|FG000|Overall Study|Other unspecified|1
7593868|NCT02497612|11999584|FG001|Overall Study|Other unspecified|1
7593869|NCT02497612|11999585|FG002|Overall Study|Other unspecified|2
7593870|NCT02497612|11999586|FG003|Overall Study|Other unspecified|0
7593871|NCT02497612|11999583|FG000|Overall Study|Not eligible|1
7593872|NCT02497612|11999584|FG001|Overall Study|Not eligible|0
7593873|NCT02497612|11999585|FG002|Overall Study|Not eligible|0
7593874|NCT02497612|11999586|FG003|Overall Study|Not eligible|1
7593875|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
7593876|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
7593877|NCT02460458|11999596|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
7593878|NCT02460458|11999596|FG000|First Prospective Phase|Lost to Follow-up|16
7593879|NCT02460458|11999596|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
7593880|NCT02457559|11999611|FG000|Overall Study|Progressive Disease|1
7593881|NCT02457559|11999612|FG001|Overall Study|Progressive Disease|2
7593882|NCT02457559|11999613|FG002|Overall Study|Progressive Disease|3
7593883|NCT02457559|11999614|FG003|Overall Study|Progressive Disease|0
7593884|NCT02457559|11999615|FG004|Overall Study|Progressive Disease|0
7593885|NCT02457559|11999616|FG005|Overall Study|Progressive Disease|2
7593886|NCT02457559|11999617|FG006|Overall Study|Progressive Disease|1
7593887|NCT02457559|11999618|FG007|Overall Study|Progressive Disease|0
7593888|NCT02457559|11999619|FG008|Overall Study|Progressive Disease|1
7593889|NCT02457559|11999620|FG009|Overall Study|Progressive Disease|1
7593890|NCT02457559|11999621|FG010|Overall Study|Progressive Disease|1
7593891|NCT02457559|11999611|FG000|Overall Study|Investigator's Discretion|0
7593892|NCT02457559|11999612|FG001|Overall Study|Investigator's Discretion|0
7593893|NCT02457559|11999613|FG002|Overall Study|Investigator's Discretion|2
7593894|NCT02457559|11999614|FG003|Overall Study|Investigator's Discretion|0
7593895|NCT02457559|11999615|FG004|Overall Study|Investigator's Discretion|1
7593896|NCT02457559|11999616|FG005|Overall Study|Investigator's Discretion|0
7593897|NCT02457559|11999617|FG006|Overall Study|Investigator's Discretion|1
7593898|NCT02457559|11999618|FG007|Overall Study|Investigator's Discretion|0
7593899|NCT02457559|11999619|FG008|Overall Study|Investigator's Discretion|1
7593900|NCT02457559|11999620|FG009|Overall Study|Investigator's Discretion|0
7593901|NCT02457559|11999621|FG010|Overall Study|Investigator's Discretion|1
7593902|NCT02457559|11999611|FG000|Overall Study|Adverse Event|0
7593903|NCT02457559|11999612|FG001|Overall Study|Adverse Event|1
7593904|NCT02457559|11999613|FG002|Overall Study|Adverse Event|2
7593905|NCT02457559|11999614|FG003|Overall Study|Adverse Event|0
7593906|NCT02457559|11999615|FG004|Overall Study|Adverse Event|0
7593907|NCT02457559|11999616|FG005|Overall Study|Adverse Event|0
7593908|NCT02457559|11999617|FG006|Overall Study|Adverse Event|0
7593909|NCT02457559|11999618|FG007|Overall Study|Adverse Event|0
7593910|NCT02457559|11999619|FG008|Overall Study|Adverse Event|0
7593911|NCT02457559|11999620|FG009|Overall Study|Adverse Event|0
7593912|NCT02457559|11999621|FG010|Overall Study|Adverse Event|0
7593913|NCT02457559|11999611|FG000|Overall Study|Reason not Specified|1
7593914|NCT02457559|11999612|FG001|Overall Study|Reason not Specified|0
7593915|NCT02457559|11999613|FG002|Overall Study|Reason not Specified|0
7593916|NCT02457559|11999614|FG003|Overall Study|Reason not Specified|0
7593917|NCT02457559|11999615|FG004|Overall Study|Reason not Specified|0
7593918|NCT02457559|11999616|FG005|Overall Study|Reason not Specified|0
7593919|NCT02457559|11999617|FG006|Overall Study|Reason not Specified|0
7593920|NCT02457559|11999618|FG007|Overall Study|Reason not Specified|0
7593921|NCT02457559|11999619|FG008|Overall Study|Reason not Specified|0
7593922|NCT02457559|11999620|FG009|Overall Study|Reason not Specified|2
7593923|NCT02457559|11999621|FG010|Overall Study|Reason not Specified|0
7593924|NCT02457559|11999611|FG000|Overall Study|Death|0
7593925|NCT02457559|11999612|FG001|Overall Study|Death|0
7593926|NCT02457559|11999613|FG002|Overall Study|Death|0
7593927|NCT02457559|11999614|FG003|Overall Study|Death|0
7593928|NCT02457559|11999615|FG004|Overall Study|Death|0
7593929|NCT02457559|11999616|FG005|Overall Study|Death|0
7593930|NCT02457559|11999617|FG006|Overall Study|Death|0
7593931|NCT02457559|11999618|FG007|Overall Study|Death|0
7593932|NCT02457559|11999619|FG008|Overall Study|Death|1
7593933|NCT02457559|11999620|FG009|Overall Study|Death|1
7593934|NCT02457559|11999621|FG010|Overall Study|Death|0
7593935|NCT02381652|11999671|FG000|Overall Study|Withdrawal by Subject|0
7593936|NCT02381652|11999672|FG001|Overall Study|Withdrawal by Subject|0
7593937|NCT02381652|11999673|FG002|Overall Study|Withdrawal by Subject|1
7593938|NCT02367794|11999682|FG000|Overall Study|Death|252
7593939|NCT02367794|11999683|FG001|Overall Study|Death|245
7593940|NCT02367794|11999684|FG002|Overall Study|Death|243
7593941|NCT02367794|11999682|FG000|Overall Study|Lost to Follow-up|1
7593942|NCT02367794|11999683|FG001|Overall Study|Lost to Follow-up|2
7593943|NCT02367794|11999684|FG002|Overall Study|Lost to Follow-up|2
7593944|NCT02367794|11999682|FG000|Overall Study|Physician Decision|0
7593945|NCT02367794|11999683|FG001|Overall Study|Physician Decision|5
7593946|NCT02367794|11999684|FG002|Overall Study|Physician Decision|3
7593947|NCT02367794|11999682|FG000|Overall Study|Protocol Violation|1
7593948|NCT02367794|11999683|FG001|Overall Study|Protocol Violation|0
7593949|NCT02367794|11999684|FG002|Overall Study|Protocol Violation|1
7593950|NCT02367794|11999682|FG000|Overall Study|Withdrawal by Subject|25
7593951|NCT02367794|11999683|FG001|Overall Study|Withdrawal by Subject|12
7593952|NCT02367794|11999684|FG002|Overall Study|Withdrawal by Subject|20
7593953|NCT02367794|11999682|FG000|Overall Study|Brain metastasis|1
7593954|NCT02367794|11999683|FG001|Overall Study|Brain metastasis|0
7593955|NCT02367794|11999684|FG002|Overall Study|Brain metastasis|0
7593956|NCT02367794|11999682|FG000|Overall Study|Randomized in error|0
7593957|NCT02367794|11999683|FG001|Overall Study|Randomized in error|0
7593958|NCT02367794|11999684|FG002|Overall Study|Randomized in error|1
7593959|NCT02367794|11999682|FG000|Overall Study|Patient unable to receive carboplatin|0
7593960|NCT02367794|11999683|FG001|Overall Study|Patient unable to receive carboplatin|0
7593961|NCT02367794|11999684|FG002|Overall Study|Patient unable to receive carboplatin|1
7593962|NCT02367794|11999682|FG000|Overall Study|Hypercalcemia prior to C1D1|0
7593963|NCT02367794|11999683|FG001|Overall Study|Hypercalcemia prior to C1D1|0
7593964|NCT02367794|11999684|FG002|Overall Study|Hypercalcemia prior to C1D1|1
7593965|NCT02367794|11999682|FG000|Overall Study|Adverse Event|0
7593966|NCT02367794|11999683|FG001|Overall Study|Adverse Event|0
7593967|NCT02367794|11999684|FG002|Overall Study|Adverse Event|2
7593968|NCT02367794|11999682|FG000|Overall Study|Study Terminated By Sponsor|0
7593969|NCT02367794|11999683|FG001|Overall Study|Study Terminated By Sponsor|1
7593970|NCT02367794|11999684|FG002|Overall Study|Study Terminated By Sponsor|1
7593971|NCT02367794|11999682|FG000|Overall Study|Moved to Roll-Over Study|0
7593972|NCT02367794|11999683|FG001|Overall Study|Moved to Roll-Over Study|15
7593973|NCT02367794|11999684|FG002|Overall Study|Moved to Roll-Over Study|13
7593974|NCT02367794|11999682|FG000|Overall Study|Sponsor Request|60
7593975|NCT02367794|11999683|FG001|Overall Study|Sponsor Request|57
7593976|NCT02367794|11999684|FG002|Overall Study|Sponsor Request|45
7593977|NCT02367794|11999682|FG000|Overall Study|Moved into PTAP Study|0
7593978|NCT02367794|11999683|FG001|Overall Study|Moved into PTAP Study|2
7593979|NCT02367794|11999684|FG002|Overall Study|Moved into PTAP Study|3
7593980|NCT02367794|11999682|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0
7593981|NCT02367794|11999683|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2
7593982|NCT02367794|11999684|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1
7593983|NCT02367794|11999682|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0
7593984|NCT02367794|11999683|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1
7593985|NCT02367794|11999684|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0
7593986|NCT02367794|11999682|FG000|Overall Study|Participant Enrolled in Extended Protocol|0
7593987|NCT02367794|11999683|FG001|Overall Study|Participant Enrolled in Extended Protocol|1
7593988|NCT02367794|11999684|FG002|Overall Study|Participant Enrolled in Extended Protocol|0
7593989|NCT02367794|11999682|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7593990|NCT02367794|11999683|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0
7593991|NCT02367794|11999684|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1
7593992|NCT02353832|11999717|FG000|Overall Study|Ineligible after enrollment|1
7593993|NCT02353832|11999717|FG000|Overall Study|Lost to Follow-up|1
7593994|NCT02353728|11999721|FG000|Overall Study|Subject non-compliance|1
7593995|NCT02345070|11999728|FG000|Overall Study|Adverse Event|12
7593996|NCT02345070|11999729|FG001|Overall Study|Adverse Event|8
7593997|NCT02345070|11999730|FG002|Overall Study|Adverse Event|16
7593998|NCT02345070|11999728|FG000|Overall Study|Poor compliance to protocol|2
7593999|NCT02345070|11999729|FG001|Overall Study|Poor compliance to protocol|0
7594000|NCT02345070|11999730|FG002|Overall Study|Poor compliance to protocol|0
7594001|NCT02345070|11999728|FG000|Overall Study|Other than specified above|6
7594002|NCT02345070|11999729|FG001|Overall Study|Other than specified above|3
7594003|NCT02345070|11999730|FG002|Overall Study|Other than specified above|7
7594004|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7594005|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
7594006|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1
7594007|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7594008|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2
7594009|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
7594010|NCT02325466|11999738|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1
7594011|NCT02325466|11999739|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0
7594012|NCT02325466|11999740|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2
7594013|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1
7594014|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7594015|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
7594016|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7594017|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
7594018|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0
7594019|NCT02325466|11999738|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1
7594020|NCT02325466|11999739|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7594021|NCT02325466|11999740|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
7594022|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1
7594023|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7594024|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0
7594025|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7594026|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1
7594027|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
7594028|NCT02325466|11999738|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7594029|NCT02325466|11999739|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1
7594030|NCT02325466|11999740|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
7594031|NCT02322710|11999751|FG000|Overall Study|No efficacy assessment post-baseline|0
7594032|NCT02322710|11999752|FG001|Overall Study|No efficacy assessment post-baseline|1
7594033|NCT02322710|11999751|FG000|Overall Study|Protocol Violation|20
7594034|NCT02322710|11999752|FG001|Overall Study|Protocol Violation|25
7594035|NCT02234310|11999800|FG000|Overall Study|Physician Decision|1
7594036|NCT02234310|11999800|FG000|Overall Study|Adverse Event|1
7594037|NCT02234310|11999800|FG000|Overall Study|Eligibility Criteria not fulfilled|2
7594038|NCT02234310|11999800|FG000|Overall Study|Withdrawal by Subject|2
7594039|NCT02158091|11999814|FG000|Overall Study|DLT|2
7594040|NCT02158091|11999815|FG001|Overall Study|DLT|1
7594041|NCT02158091|11999816|FG002|Overall Study|DLT|0
7594042|NCT02106195|11999853|FG000|Overall Study|Adverse Event|2
7594043|NCT02106195|11999853|FG000|Overall Study|Protocol Violation|1
7594044|NCT02104180|11999865|FG000|Overall Study|Protocol Violation|1
7594045|NCT02104180|11999866|FG001|Overall Study|Protocol Violation|0
7594046|NCT02040857|11999876|FG000|Overall Study|Adverse Event|14
7594047|NCT02040857|11999876|FG000|Overall Study|Physician Decision|5
7594048|NCT02040857|11999876|FG000|Overall Study|Withdrawal by Subject|31
7594049|NCT02040857|11999876|FG000|Overall Study|patient non-compliance|3
7594050|NCT02040857|11999876|FG000|Overall Study|Lost to Follow-up|2
7594051|NCT02040857|11999876|FG000|Overall Study|recurrence|4
7594052|NCT02040857|11999876|FG000|Overall Study|ineligible|1
7594053|NCT01943825|11999896|FG000|Overall Study|Lost to Follow-up|9
7594054|NCT01943825|11999897|FG001|Overall Study|Lost to Follow-up|3
7594055|NCT01943825|11999898|FG002|Overall Study|Lost to Follow-up|12
7594056|NCT01943825|11999899|FG003|Overall Study|Lost to Follow-up|8
7594057|NCT01943825|11999896|FG000|Overall Study|Withdrawal by Subject|1
7594058|NCT01943825|11999897|FG001|Overall Study|Withdrawal by Subject|0
7594059|NCT01943825|11999898|FG002|Overall Study|Withdrawal by Subject|3
7271417|NCT00421928|11485681|FG000|Overall Study|Lack of Efficacy|15
7271418|NCT00421928|11485682|FG001|Overall Study|Lack of Efficacy|7
7271419|NCT00421928|11485683|FG002|Overall Study|Lack of Efficacy|35
7271420|NCT00421928|11485681|FG000|Overall Study|Study drug non-compliant|6
7271421|NCT00421928|11485682|FG001|Overall Study|Study drug non-compliant|7
7271422|NCT00421928|11485683|FG002|Overall Study|Study drug non-compliant|4
7271423|NCT00421928|11485681|FG000|Overall Study|All other|26
7271424|NCT00421928|11485682|FG001|Overall Study|All other|21
7271425|NCT00421928|11485683|FG002|Overall Study|All other|27
7271426|NCT00421928|11485681|FG000|Overall Study|Death|0
7271427|NCT00421928|11485682|FG001|Overall Study|Death|1
7271428|NCT00421928|11485683|FG002|Overall Study|Death|0
7271429|NCT00421993|11485695|FG000|Overall Study|Withdrawal by Subject|22
7271430|NCT00421993|11485696|FG001|Overall Study|Withdrawal by Subject|23
7271431|NCT00421993|11485697|FG002|Overall Study|Withdrawal by Subject|23
7271432|NCT00421993|11485698|FG003|Overall Study|Withdrawal by Subject|24
7271433|NCT00421993|11485695|FG000|Overall Study|Lost to Follow-up|18
7271434|NCT00421993|11485696|FG001|Overall Study|Lost to Follow-up|19
7271435|NCT00421993|11485697|FG002|Overall Study|Lost to Follow-up|22
7271436|NCT00421993|11485698|FG003|Overall Study|Lost to Follow-up|20
7271437|NCT00421993|11485695|FG000|Overall Study|Adverse Event|11
7271438|NCT00421993|11485696|FG001|Overall Study|Adverse Event|1
7271439|NCT00421993|11485697|FG002|Overall Study|Adverse Event|6
7271440|NCT00421993|11485698|FG003|Overall Study|Adverse Event|4
7271441|NCT00421993|11485695|FG000|Overall Study|Protocol Violation|2
7271442|NCT00421993|11485696|FG001|Overall Study|Protocol Violation|2
7271443|NCT00421993|11485697|FG002|Overall Study|Protocol Violation|0
7271444|NCT00421993|11485698|FG003|Overall Study|Protocol Violation|1
7271445|NCT00421993|11485695|FG000|Overall Study|Lack of Efficacy|0
7271446|NCT00421993|11485696|FG001|Overall Study|Lack of Efficacy|3
7271447|NCT00421993|11485697|FG002|Overall Study|Lack of Efficacy|0
7271448|NCT00421993|11485698|FG003|Overall Study|Lack of Efficacy|5
7271449|NCT00421993|11485695|FG000|Overall Study|Pregnancy|0
7271450|NCT00421993|11485696|FG001|Overall Study|Pregnancy|1
7271451|NCT00421993|11485697|FG002|Overall Study|Pregnancy|1
7271452|NCT00421993|11485698|FG003|Overall Study|Pregnancy|2
7271453|NCT00421993|11485695|FG000|Overall Study|Subject transportation issues|0
7271454|NCT00421993|11485696|FG001|Overall Study|Subject transportation issues|0
7271455|NCT00421993|11485697|FG002|Overall Study|Subject transportation issues|0
7271456|NCT00421993|11485698|FG003|Overall Study|Subject transportation issues|1
7271457|NCT00422058|11485723|FG000|Double-Blind, Week 0-20|Adverse Event|3
7271458|NCT00422058|11485724|FG001|Double-Blind, Week 0-20|Adverse Event|4
7594060|NCT01943825|11999899|FG003|Overall Study|Withdrawal by Subject|2
7594061|NCT01943825|11999896|FG000|Overall Study|Other than specified above|0
7271459|NCT00422058|11485725|FG002|Double-Blind, Week 0-20|Adverse Event|5
7271460|NCT00422058|11485726|FG003|Double-Blind, Week 0-20|Adverse Event|9
7594062|NCT01943825|11999897|FG001|Overall Study|Other than specified above|1
7594063|NCT01943825|11999898|FG002|Overall Study|Other than specified above|0
7594064|NCT01943825|11999899|FG003|Overall Study|Other than specified above|1
7627384|NCT03627091|12039858|FG000|Overall Study|Adverse Event|0
7627385|NCT03627091|12039859|FG001|Overall Study|Adverse Event|0
7627386|NCT03627091|12039860|FG002|Overall Study|Adverse Event|2
7627387|NCT03627091|12039858|FG000|Overall Study|Withdrawal by Subject|2
7627388|NCT03627091|12039859|FG001|Overall Study|Withdrawal by Subject|0
7627389|NCT03627091|12039860|FG002|Overall Study|Withdrawal by Subject|2
7627390|NCT03627091|12039858|FG000|Overall Study|Physician Decision|2
7627391|NCT03627091|12039859|FG001|Overall Study|Physician Decision|0
7627392|NCT03627091|12039860|FG002|Overall Study|Physician Decision|0
7627393|NCT03627091|12039858|FG000|Overall Study|Site terminated by sponsor|0
7627394|NCT03627091|12039859|FG001|Overall Study|Site terminated by sponsor|1
7627395|NCT03627091|12039860|FG002|Overall Study|Site terminated by sponsor|0
7627396|NCT03627091|12039858|FG000|Overall Study|Disease relapse|7
7627397|NCT03627091|12039859|FG001|Overall Study|Disease relapse|5
7627398|NCT03627091|12039860|FG002|Overall Study|Disease relapse|1
7627399|NCT03627091|12039858|FG000|Overall Study|Other|1
7627400|NCT03627091|12039859|FG001|Overall Study|Other|0
7627401|NCT03627091|12039860|FG002|Overall Study|Other|0
7627402|NCT03568318|12039875|FG000|Overall Study|Adverse Event|3
7627403|NCT03568318|12039876|FG001|Overall Study|Adverse Event|1
7627404|NCT03568318|12039877|FG002|Overall Study|Adverse Event|1
7627405|NCT03568318|12039878|FG003|Overall Study|Adverse Event|0
7627406|NCT03568318|12039879|FG004|Overall Study|Adverse Event|1
7627407|NCT03568318|12039880|FG005|Overall Study|Adverse Event|0
7627408|NCT03568318|12039875|FG000|Overall Study|Withdrawal by Subject|6
7627409|NCT03568318|12039876|FG001|Overall Study|Withdrawal by Subject|5
7627410|NCT03568318|12039877|FG002|Overall Study|Withdrawal by Subject|2
7627411|NCT03568318|12039878|FG003|Overall Study|Withdrawal by Subject|1
7627412|NCT03568318|12039879|FG004|Overall Study|Withdrawal by Subject|0
7627413|NCT03568318|12039880|FG005|Overall Study|Withdrawal by Subject|0
7627414|NCT03568318|12039875|FG000|Overall Study|Lost to Follow-up|3
7627415|NCT03568318|12039876|FG001|Overall Study|Lost to Follow-up|2
7627416|NCT03568318|12039877|FG002|Overall Study|Lost to Follow-up|2
7627417|NCT03568318|12039878|FG003|Overall Study|Lost to Follow-up|2
7627418|NCT03568318|12039879|FG004|Overall Study|Lost to Follow-up|1
7627419|NCT03568318|12039880|FG005|Overall Study|Lost to Follow-up|0
7627420|NCT03568318|12039875|FG000|Overall Study|Other|3
7627421|NCT03568318|12039876|FG001|Overall Study|Other|1
7627422|NCT03568318|12039877|FG002|Overall Study|Other|3
7627423|NCT03568318|12039878|FG003|Overall Study|Other|0
7627424|NCT03568318|12039879|FG004|Overall Study|Other|0
7627425|NCT03568318|12039880|FG005|Overall Study|Other|0
7627426|NCT03568318|12039875|FG000|Overall Study|Ongoing at Time of Analysis|5
7627427|NCT03568318|12039876|FG001|Overall Study|Ongoing at Time of Analysis|3
7627428|NCT03568318|12039877|FG002|Overall Study|Ongoing at Time of Analysis|2
7627429|NCT03568318|12039878|FG003|Overall Study|Ongoing at Time of Analysis|1
7627430|NCT03568318|12039879|FG004|Overall Study|Ongoing at Time of Analysis|0
7627431|NCT03568318|12039880|FG005|Overall Study|Ongoing at Time of Analysis|0
7627432|NCT03498560|12039894|FG000|Overall Study|Found Ineligible|2
7627433|NCT03498560|12039894|FG000|Overall Study|Withdrawal by Subject|14
7627434|NCT03498560|12039894|FG000|Overall Study|Lost to Follow-up|4
7627435|NCT03498560|12039894|FG000|Overall Study|Death|1
7627436|NCT03441360|12039902|FG000|Overall Study|Radiological disease progression|5
7627437|NCT03441360|12039903|FG001|Overall Study|Radiological disease progression|6
7627438|NCT03441360|12039904|FG002|Overall Study|Radiological disease progression|4
7627439|NCT03441360|12039902|FG000|Overall Study|Clinical disease progression|2
7627440|NCT03441360|12039903|FG001|Overall Study|Clinical disease progression|2
7594107|NCT01853748|11999957|FG000|Allocation|Withdrawal by Subject|1
7594108|NCT01853748|11999958|FG001|Allocation|Withdrawal by Subject|13
7594109|NCT01853748|11999957|FG000|Allocation|not sufficient to receive intervention|0
7594110|NCT01853748|11999958|FG001|Allocation|not sufficient to receive intervention|1
7594111|NCT01853748|11999957|FG000|Follow-Up|Withdrawal by Subject|7
7594112|NCT01853748|11999958|FG001|Follow-Up|Withdrawal by Subject|6
7594113|NCT01853748|11999957|FG000|Follow-Up|Adverse Event|67
7594114|NCT01853748|11999958|FG001|Follow-Up|Adverse Event|7
7594115|NCT01853748|11999957|FG000|Follow-Up|not available for data collection|16
7594116|NCT01853748|11999958|FG001|Follow-Up|not available for data collection|4
7594117|NCT01817751|11999973|FG000|Overall Study|Physician Decision|1
7594118|NCT01722331|11999980|FG000|Part 1|Adverse Event|5
7594119|NCT01722331|11999981|FG001|Part 1|Adverse Event|0
7594120|NCT01722331|11999982|FG002|Part 1|Adverse Event|0
7594121|NCT01722331|11999983|FG003|Part 1|Adverse Event|0
7594122|NCT01722331|11999984|FG004|Part 1|Adverse Event|0
7594123|NCT01722331|11999985|FG005|Part 1|Adverse Event|0
7594124|NCT01722331|11999986|FG006|Part 1|Adverse Event|0
7594125|NCT01722331|11999980|FG000|Part 1|Lack of Efficacy|0
7594126|NCT01722331|11999981|FG001|Part 1|Lack of Efficacy|0
7594127|NCT01722331|11999982|FG002|Part 1|Lack of Efficacy|1
7594128|NCT01722331|11999983|FG003|Part 1|Lack of Efficacy|0
7594129|NCT01722331|11999984|FG004|Part 1|Lack of Efficacy|2
7594130|NCT01722331|11999985|FG005|Part 1|Lack of Efficacy|0
7594131|NCT01722331|11999986|FG006|Part 1|Lack of Efficacy|0
7594132|NCT01722331|11999980|FG000|Part 1|Lost to Follow-up|1
7594133|NCT01722331|11999981|FG001|Part 1|Lost to Follow-up|0
7594134|NCT01722331|11999982|FG002|Part 1|Lost to Follow-up|2
7594135|NCT01722331|11999983|FG003|Part 1|Lost to Follow-up|0
7594136|NCT01722331|11999984|FG004|Part 1|Lost to Follow-up|1
7594137|NCT01722331|11999985|FG005|Part 1|Lost to Follow-up|0
7594138|NCT01722331|11999986|FG006|Part 1|Lost to Follow-up|0
7594139|NCT01722331|11999980|FG000|Part 1|Physician Decision|0
7594140|NCT01722331|11999981|FG001|Part 1|Physician Decision|0
7594141|NCT01722331|11999982|FG002|Part 1|Physician Decision|3
7594142|NCT01722331|11999983|FG003|Part 1|Physician Decision|0
7594143|NCT01722331|11999984|FG004|Part 1|Physician Decision|1
7594144|NCT01722331|11999985|FG005|Part 1|Physician Decision|0
7594145|NCT01722331|11999986|FG006|Part 1|Physician Decision|0
7594146|NCT01722331|11999980|FG000|Part 1|Pregnancy|1
7594147|NCT01722331|11999981|FG001|Part 1|Pregnancy|0
7594148|NCT01722331|11999982|FG002|Part 1|Pregnancy|0
7594149|NCT01722331|11999983|FG003|Part 1|Pregnancy|0
7594150|NCT01722331|11999984|FG004|Part 1|Pregnancy|0
7594151|NCT01722331|11999985|FG005|Part 1|Pregnancy|0
7594152|NCT01722331|11999986|FG006|Part 1|Pregnancy|0
7594153|NCT01722331|11999980|FG000|Part 1|Progressive Disease|0
7594154|NCT01722331|11999981|FG001|Part 1|Progressive Disease|0
7594155|NCT01722331|11999982|FG002|Part 1|Progressive Disease|0
7594156|NCT01722331|11999983|FG003|Part 1|Progressive Disease|0
7594157|NCT01722331|11999984|FG004|Part 1|Progressive Disease|1
7594158|NCT01722331|11999985|FG005|Part 1|Progressive Disease|0
7594159|NCT01722331|11999986|FG006|Part 1|Progressive Disease|0
7594160|NCT01722331|11999980|FG000|Part 1|Protocol Violation|1
7594161|NCT01722331|11999981|FG001|Part 1|Protocol Violation|0
7594162|NCT01722331|11999982|FG002|Part 1|Protocol Violation|0
7594163|NCT01722331|11999983|FG003|Part 1|Protocol Violation|0
7594164|NCT01722331|11999984|FG004|Part 1|Protocol Violation|1
7594165|NCT01722331|11999985|FG005|Part 1|Protocol Violation|0
7594166|NCT01722331|11999986|FG006|Part 1|Protocol Violation|0
7594167|NCT01722331|11999980|FG000|Part 1|Withdrawal by Subject|2
7594168|NCT01722331|11999981|FG001|Part 1|Withdrawal by Subject|0
7594169|NCT01722331|11999982|FG002|Part 1|Withdrawal by Subject|3
7594170|NCT01722331|11999983|FG003|Part 1|Withdrawal by Subject|0
7594171|NCT01722331|11999984|FG004|Part 1|Withdrawal by Subject|3
7594172|NCT01722331|11999985|FG005|Part 1|Withdrawal by Subject|0
7594173|NCT01722331|11999986|FG006|Part 1|Withdrawal by Subject|0
7594174|NCT01722331|11999980|FG000|Part 2|Adverse Event|3
7594175|NCT01722331|11999981|FG001|Part 2|Adverse Event|0
7594176|NCT01722331|11999982|FG002|Part 2|Adverse Event|0
7594177|NCT01722331|11999983|FG003|Part 2|Adverse Event|0
7594178|NCT01722331|11999984|FG004|Part 2|Adverse Event|0
7594179|NCT01722331|11999985|FG005|Part 2|Adverse Event|1
7594180|NCT01722331|11999986|FG006|Part 2|Adverse Event|0
7594181|NCT01722331|11999980|FG000|Part 2|Lack of Efficacy|3
7594182|NCT01722331|11999981|FG001|Part 2|Lack of Efficacy|0
7594183|NCT01722331|11999982|FG002|Part 2|Lack of Efficacy|11
7594184|NCT01722331|11999983|FG003|Part 2|Lack of Efficacy|0
7594185|NCT01722331|11999984|FG004|Part 2|Lack of Efficacy|0
7594186|NCT01722331|11999985|FG005|Part 2|Lack of Efficacy|3
7594187|NCT01722331|11999986|FG006|Part 2|Lack of Efficacy|3
7594188|NCT01722331|11999980|FG000|Part 2|Lost to Follow-up|0
7594189|NCT01722331|11999981|FG001|Part 2|Lost to Follow-up|0
7594190|NCT01722331|11999982|FG002|Part 2|Lost to Follow-up|3
7594191|NCT01722331|11999983|FG003|Part 2|Lost to Follow-up|0
7594192|NCT01722331|11999984|FG004|Part 2|Lost to Follow-up|0
7594193|NCT01722331|11999985|FG005|Part 2|Lost to Follow-up|1
7594194|NCT01722331|11999986|FG006|Part 2|Lost to Follow-up|1
7594195|NCT01722331|11999980|FG000|Part 2|Non-Compliance with Study Drug|1
7594196|NCT01722331|11999981|FG001|Part 2|Non-Compliance with Study Drug|0
7594197|NCT01722331|11999982|FG002|Part 2|Non-Compliance with Study Drug|1
7594198|NCT01722331|11999983|FG003|Part 2|Non-Compliance with Study Drug|0
7594199|NCT01722331|11999984|FG004|Part 2|Non-Compliance with Study Drug|0
7594200|NCT01722331|11999985|FG005|Part 2|Non-Compliance with Study Drug|0
7594201|NCT01722331|11999986|FG006|Part 2|Non-Compliance with Study Drug|0
7594202|NCT01722331|11999980|FG000|Part 2|Physician Decision|0
7594203|NCT01722331|11999981|FG001|Part 2|Physician Decision|0
7594204|NCT01722331|11999982|FG002|Part 2|Physician Decision|2
7594205|NCT01722331|11999983|FG003|Part 2|Physician Decision|0
7594206|NCT01722331|11999984|FG004|Part 2|Physician Decision|0
7594207|NCT01722331|11999985|FG005|Part 2|Physician Decision|0
7594208|NCT01722331|11999986|FG006|Part 2|Physician Decision|0
7594209|NCT01722331|11999980|FG000|Part 2|Pregnancy|0
7594210|NCT01722331|11999981|FG001|Part 2|Pregnancy|0
7594211|NCT01722331|11999982|FG002|Part 2|Pregnancy|0
7594212|NCT01722331|11999983|FG003|Part 2|Pregnancy|0
7594213|NCT01722331|11999984|FG004|Part 2|Pregnancy|0
7594214|NCT01722331|11999985|FG005|Part 2|Pregnancy|1
7594215|NCT01722331|11999986|FG006|Part 2|Pregnancy|0
7594216|NCT01722331|11999980|FG000|Part 2|Progressive Disease|0
7594217|NCT01722331|11999981|FG001|Part 2|Progressive Disease|0
7594218|NCT01722331|11999982|FG002|Part 2|Progressive Disease|1
7594219|NCT01722331|11999983|FG003|Part 2|Progressive Disease|0
7594220|NCT01722331|11999984|FG004|Part 2|Progressive Disease|0
7594221|NCT01722331|11999985|FG005|Part 2|Progressive Disease|0
7594222|NCT01722331|11999986|FG006|Part 2|Progressive Disease|0
7594223|NCT01722331|11999980|FG000|Part 2|Protocol Violation|1
7594224|NCT01722331|11999981|FG001|Part 2|Protocol Violation|0
7594225|NCT01722331|11999982|FG002|Part 2|Protocol Violation|0
7594226|NCT01722331|11999983|FG003|Part 2|Protocol Violation|0
7594227|NCT01722331|11999984|FG004|Part 2|Protocol Violation|0
7594228|NCT01722331|11999985|FG005|Part 2|Protocol Violation|0
7594229|NCT01722331|11999986|FG006|Part 2|Protocol Violation|0
7594230|NCT01722331|11999980|FG000|Part 2|Withdrawal by Subject|5
7594231|NCT01722331|11999981|FG001|Part 2|Withdrawal by Subject|0
7594232|NCT01722331|11999982|FG002|Part 2|Withdrawal by Subject|3
7594233|NCT01722331|11999983|FG003|Part 2|Withdrawal by Subject|0
7594234|NCT01722331|11999984|FG004|Part 2|Withdrawal by Subject|0
7594235|NCT01722331|11999985|FG005|Part 2|Withdrawal by Subject|2
7594236|NCT01722331|11999986|FG006|Part 2|Withdrawal by Subject|2
7594237|NCT01722331|11999980|FG000|Part 2|Other Protocol Specified Criteria|6
7594238|NCT01722331|11999981|FG001|Part 2|Other Protocol Specified Criteria|0
7594239|NCT01722331|11999982|FG002|Part 2|Other Protocol Specified Criteria|10
7594240|NCT01722331|11999983|FG003|Part 2|Other Protocol Specified Criteria|0
7594241|NCT01722331|11999984|FG004|Part 2|Other Protocol Specified Criteria|0
7594242|NCT01722331|11999985|FG005|Part 2|Other Protocol Specified Criteria|2
7594243|NCT01722331|11999986|FG006|Part 2|Other Protocol Specified Criteria|1
7594244|NCT01722331|11999980|FG000|Part 3|Adverse Event|2
7594245|NCT01722331|11999981|FG001|Part 3|Adverse Event|2
7594246|NCT01722331|11999982|FG002|Part 3|Adverse Event|0
7594247|NCT01722331|11999983|FG003|Part 3|Adverse Event|1
7594248|NCT01722331|11999984|FG004|Part 3|Adverse Event|0
7594249|NCT01722331|11999985|FG005|Part 3|Adverse Event|0
7594250|NCT01722331|11999986|FG006|Part 3|Adverse Event|0
7594251|NCT01722331|11999980|FG000|Part 3|Death|1
7594252|NCT01722331|11999981|FG001|Part 3|Death|0
7594253|NCT01722331|11999982|FG002|Part 3|Death|0
7594254|NCT01722331|11999983|FG003|Part 3|Death|0
7594255|NCT01722331|11999984|FG004|Part 3|Death|0
7594256|NCT01722331|11999985|FG005|Part 3|Death|0
7594257|NCT01722331|11999986|FG006|Part 3|Death|0
7594258|NCT01722331|11999980|FG000|Part 3|Lack of Efficacy|1
7594259|NCT01722331|11999981|FG001|Part 3|Lack of Efficacy|0
7594260|NCT01722331|11999982|FG002|Part 3|Lack of Efficacy|0
7594261|NCT01722331|11999983|FG003|Part 3|Lack of Efficacy|0
7594262|NCT01722331|11999984|FG004|Part 3|Lack of Efficacy|0
7594263|NCT01722331|11999985|FG005|Part 3|Lack of Efficacy|0
7594264|NCT01722331|11999986|FG006|Part 3|Lack of Efficacy|0
7594265|NCT01722331|11999980|FG000|Part 3|Lost to Follow-up|3
7594266|NCT01722331|11999981|FG001|Part 3|Lost to Follow-up|4
7594267|NCT01722331|11999982|FG002|Part 3|Lost to Follow-up|0
7594268|NCT01722331|11999983|FG003|Part 3|Lost to Follow-up|0
7594269|NCT01722331|11999984|FG004|Part 3|Lost to Follow-up|0
7594270|NCT01722331|11999985|FG005|Part 3|Lost to Follow-up|1
7594271|NCT01722331|11999986|FG006|Part 3|Lost to Follow-up|0
7594272|NCT01722331|11999980|FG000|Part 3|Non-Compliance with Study Drug|0
7594273|NCT01722331|11999981|FG001|Part 3|Non-Compliance with Study Drug|1
7594274|NCT01722331|11999982|FG002|Part 3|Non-Compliance with Study Drug|0
7594275|NCT01722331|11999983|FG003|Part 3|Non-Compliance with Study Drug|0
7594276|NCT01722331|11999984|FG004|Part 3|Non-Compliance with Study Drug|0
7594277|NCT01722331|11999985|FG005|Part 3|Non-Compliance with Study Drug|0
7594278|NCT01722331|11999986|FG006|Part 3|Non-Compliance with Study Drug|0
7594279|NCT01722331|11999980|FG000|Part 3|Physician Decision|1
7594280|NCT01722331|11999981|FG001|Part 3|Physician Decision|1
7594281|NCT01722331|11999982|FG002|Part 3|Physician Decision|0
7594282|NCT01722331|11999983|FG003|Part 3|Physician Decision|0
7594283|NCT01722331|11999984|FG004|Part 3|Physician Decision|0
7594284|NCT01722331|11999985|FG005|Part 3|Physician Decision|0
7594285|NCT01722331|11999986|FG006|Part 3|Physician Decision|1
7594286|NCT01722331|11999980|FG000|Part 3|Protocol Violation|2
7594287|NCT01722331|11999981|FG001|Part 3|Protocol Violation|1
7594288|NCT01722331|11999982|FG002|Part 3|Protocol Violation|0
7594289|NCT01722331|11999983|FG003|Part 3|Protocol Violation|0
7594290|NCT01722331|11999984|FG004|Part 3|Protocol Violation|0
7594291|NCT01722331|11999985|FG005|Part 3|Protocol Violation|0
7594292|NCT01722331|11999986|FG006|Part 3|Protocol Violation|0
7594293|NCT01722331|11999980|FG000|Part 3|Withdrawal by Subject|4
7594294|NCT01722331|11999981|FG001|Part 3|Withdrawal by Subject|7
7594295|NCT01722331|11999982|FG002|Part 3|Withdrawal by Subject|0
7594296|NCT01722331|11999983|FG003|Part 3|Withdrawal by Subject|0
7594297|NCT01722331|11999984|FG004|Part 3|Withdrawal by Subject|0
7594298|NCT01722331|11999985|FG005|Part 3|Withdrawal by Subject|2
7594299|NCT01722331|11999986|FG006|Part 3|Withdrawal by Subject|1
7594300|NCT01722331|11999980|FG000|Part 3|Other Protocol Specified Criteria|1
7594301|NCT01722331|11999981|FG001|Part 3|Other Protocol Specified Criteria|1
7594302|NCT01722331|11999982|FG002|Part 3|Other Protocol Specified Criteria|0
7594303|NCT01722331|11999983|FG003|Part 3|Other Protocol Specified Criteria|0
7594304|NCT01722331|11999984|FG004|Part 3|Other Protocol Specified Criteria|0
7594305|NCT01722331|11999985|FG005|Part 3|Other Protocol Specified Criteria|0
7594306|NCT01722331|11999986|FG006|Part 3|Other Protocol Specified Criteria|0
7594307|NCT01716117|12000000|FG000|Overall Study|Death|5
7594308|NCT01716117|12000001|FG001|Overall Study|Death|2
7594309|NCT01716117|12000000|FG000|Overall Study|Withdrawal by Subject|2
7594310|NCT01716117|12000001|FG001|Overall Study|Withdrawal by Subject|0
7594311|NCT01698905|12000015|FG000|Overall Study|Adverse Event|4
7594312|NCT01698905|12000015|FG000|Overall Study|Physician Decision|2
7594313|NCT01698905|12000015|FG000|Overall Study|Pregnancy|1
7594314|NCT01698905|12000015|FG000|Overall Study|Protocol Violation|1
7594315|NCT01698905|12000015|FG000|Overall Study|Subject/guardian decision|2
7594316|NCT01698905|12000015|FG000|Overall Study|Death|1
7594317|NCT01630590|12000036|FG000|Overall Study|Adverse Event|9
7594318|NCT01630590|12000036|FG000|Overall Study|Lack of Efficacy|37
7594319|NCT01630590|12000036|FG000|Overall Study|Withdrawal by Subject|4
7594320|NCT01630590|12000036|FG000|Overall Study|2nd primary tumor|2
7594321|NCT01630590|12000036|FG000|Overall Study|Automobile accident|1
7594322|NCT01630590|12000036|FG000|Overall Study|Maximum benefit|4
7594323|NCT01619085|12000040|FG000|Overall Study|Adverse Event|231
7594324|NCT01619085|12000040|FG000|Overall Study|Protocol Violation|4
7271461|NCT00422058|11485727|FG004|Double-Blind, Week 0-20|Adverse Event|5
7594325|NCT01619085|12000040|FG000|Overall Study|Lost to Follow-up|3
7594326|NCT01619085|12000040|FG000|Overall Study|Withdrawal by Subject|45
7594327|NCT01619085|12000040|FG000|Overall Study|Other than specified|96
7594328|NCT01619085|12000040|FG000|Overall Study|Not treated|1
7594329|NCT01619085|12000040|FG000|Overall Study|Death|145
7594330|NCT01499095|12000053|FG000|Overall Study|Randomized But Not Treated|1
7594331|NCT01499095|12000054|FG001|Overall Study|Randomized But Not Treated|1
7594332|NCT01499095|12000053|FG000|Overall Study|Adverse Event|12
7594333|NCT01499095|12000054|FG001|Overall Study|Adverse Event|7
7594334|NCT01499095|12000053|FG000|Overall Study|Lack of Efficacy|2
7594335|NCT01499095|12000054|FG001|Overall Study|Lack of Efficacy|1
7594336|NCT01499095|12000053|FG000|Overall Study|Protocol Violation|6
7594337|NCT01499095|12000054|FG001|Overall Study|Protocol Violation|7
7594338|NCT01499095|12000053|FG000|Overall Study|Received Rescue Therapy|32
7594339|NCT01499095|12000054|FG001|Overall Study|Received Rescue Therapy|40
7594340|NCT01499095|12000053|FG000|Overall Study|Diverse Reasons|22
7594341|NCT01499095|12000054|FG001|Overall Study|Diverse Reasons|25
7594342|NCT01499095|12000053|FG000|Overall Study|Lost to Follow-up|6
7594343|NCT01499095|12000054|FG001|Overall Study|Lost to Follow-up|4
7594344|NCT01499095|12000053|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
7594345|NCT01499095|12000054|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
7271462|NCT00422058|11485728|FG005|Double-Blind, Week 0-20|Adverse Event|3
7594346|NCT01499095|12000053|FG000|Overall Study|Hypoglycemia|3
7594347|NCT01499095|12000054|FG001|Overall Study|Hypoglycemia|1
7594348|NCT01499095|12000053|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
7594349|NCT01499095|12000054|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
7594350|NCT01499095|12000053|FG000|Overall Study|Change in Injection Schedule|2
7594351|NCT01499095|12000054|FG001|Overall Study|Change in Injection Schedule|0
7594352|NCT01499095|12000053|FG000|Overall Study|Perceived Lack of Efficacy|1
7594353|NCT01499095|12000054|FG001|Overall Study|Perceived Lack of Efficacy|1
7594354|NCT01499082|12000065|FG000|Overall Study|Randomized but not Treated|0
7594355|NCT01499082|12000066|FG001|Overall Study|Randomized but not Treated|1
7594356|NCT01499082|12000065|FG000|Overall Study|Adverse Event|12
7594357|NCT01499082|12000066|FG001|Overall Study|Adverse Event|16
7594358|NCT01499082|12000065|FG000|Overall Study|Lack of Efficacy|1
7594359|NCT01499082|12000066|FG001|Overall Study|Lack of Efficacy|1
7594360|NCT01499082|12000065|FG000|Overall Study|Protocol Violation|6
7594361|NCT01499082|12000066|FG001|Overall Study|Protocol Violation|8
7594362|NCT01499082|12000065|FG000|Overall Study|Diverse Reasons|18
7594363|NCT01499082|12000066|FG001|Overall Study|Diverse Reasons|14
7594364|NCT01499082|12000065|FG000|Overall Study|Site Closure for Noncompliance|5
7594365|NCT01499082|12000066|FG001|Overall Study|Site Closure for Noncompliance|2
7594366|NCT01499082|12000065|FG000|Overall Study|Hypoglycemia|2
7594367|NCT01499082|12000066|FG001|Overall Study|Hypoglycemia|3
7594368|NCT01499082|12000065|FG000|Overall Study|Lost to Follow-up|1
7594369|NCT01499082|12000066|FG001|Overall Study|Lost to Follow-up|3
7594371|NCT01488890|12000082|FG000|Overall Study|Serious adverse event|2
7594372|NCT01488890|12000083|FG001|Overall Study|Serious adverse event|0
7594373|NCT01488890|12000084|FG002|Overall Study|Serious adverse event|0
7594374|NCT01488890|12000085|FG003|Overall Study|Serious adverse event|0
7594375|NCT01488890|12000082|FG000|Overall Study|Protocol Violation|3
7594376|NCT01488890|12000083|FG001|Overall Study|Protocol Violation|0
7594377|NCT01488890|12000084|FG002|Overall Study|Protocol Violation|4
7594378|NCT01488890|12000085|FG003|Overall Study|Protocol Violation|0
7594379|NCT01488890|12000082|FG000|Overall Study|Lost to Follow-up|13
7594380|NCT01488890|12000083|FG001|Overall Study|Lost to Follow-up|10
7594381|NCT01488890|12000084|FG002|Overall Study|Lost to Follow-up|20
7594382|NCT01488890|12000085|FG003|Overall Study|Lost to Follow-up|3
7594383|NCT01488890|12000082|FG000|Overall Study|Withdrawal by Subject|14
7594384|NCT01488890|12000083|FG001|Overall Study|Withdrawal by Subject|10
7594385|NCT01488890|12000084|FG002|Overall Study|Withdrawal by Subject|11
7594386|NCT01488890|12000085|FG003|Overall Study|Withdrawal by Subject|2
7594387|NCT01436396|12000101|FG000|Overall Study|Protocol Violation|7
7594388|NCT01436396|12000102|FG001|Overall Study|Protocol Violation|5
7594389|NCT01436396|12000101|FG000|Overall Study|Adverse Event|1
7594390|NCT01436396|12000102|FG001|Overall Study|Adverse Event|2
7594391|NCT01436396|12000101|FG000|Overall Study|Withdrawal by Subject|19
7594392|NCT01436396|12000102|FG001|Overall Study|Withdrawal by Subject|29
7594393|NCT01436396|12000101|FG000|Overall Study|Serious adverse event|2
7594394|NCT01436396|12000102|FG001|Overall Study|Serious adverse event|3
7594395|NCT01436396|12000101|FG000|Overall Study|Lost to Follow-up|3
7594396|NCT01436396|12000102|FG001|Overall Study|Lost to Follow-up|3
7594397|NCT01411241|12000110|FG000|Overall Study|Protocol Violation|0
7594398|NCT01411241|12000111|FG001|Overall Study|Protocol Violation|5
7594399|NCT01411241|12000110|FG000|Overall Study|Withdrawal by Subject|9
7594400|NCT01411241|12000111|FG001|Overall Study|Withdrawal by Subject|10
7594401|NCT01411241|12000110|FG000|Overall Study|Serious Adverse Event|0
7594402|NCT01411241|12000111|FG001|Overall Study|Serious Adverse Event|3
7594403|NCT01411241|12000110|FG000|Overall Study|Lost to Follow-up|2
7594404|NCT01411241|12000111|FG001|Overall Study|Lost to Follow-up|4
7594405|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
7594406|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
7594407|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
7594408|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
7594409|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
7594410|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
7594411|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
7594412|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
7594413|NCT01374516|12000119|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
7594414|NCT01374516|12000120|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
7594415|NCT01374516|12000119|FG000|Surveillance Expansion Period|Protocol Violation|386
7594416|NCT01374516|12000120|FG001|Surveillance Expansion Period|Protocol Violation|217
7594417|NCT01374516|12000119|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
7594418|NCT01374516|12000120|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
7594419|NCT01374516|12000119|FG000|Surveillance Expansion Period|Lost to Follow-up|73
7594420|NCT01374516|12000120|FG001|Surveillance Expansion Period|Lost to Follow-up|45
7594421|NCT01374516|12000119|FG000|Surveillance Expansion Period|Serious adverse event|20
7594422|NCT01374516|12000120|FG001|Surveillance Expansion Period|Serious adverse event|5
7594423|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
7594424|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
7594425|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
7594426|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
7594427|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
7594428|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
7594429|NCT01373281|12000135|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
7594430|NCT01373281|12000136|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
7594431|NCT01373281|12000135|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
7594432|NCT01373281|12000136|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
7594433|NCT01373281|12000135|FG000|Surveillance Expansion Period|Protocol Violation|9
7594434|NCT01373281|12000136|FG001|Surveillance Expansion Period|Protocol Violation|1
7594435|NCT01373281|12000135|FG000|Surveillance Expansion Period|Lost to Follow-up|10
7594436|NCT01373281|12000136|FG001|Surveillance Expansion Period|Lost to Follow-up|8
7594437|NCT01373281|12000135|FG000|Surveillance Expansion Period|Serious adverse event|3
7594438|NCT01373281|12000136|FG001|Surveillance Expansion Period|Serious adverse event|4
7594439|NCT01302847|12000157|FG000|Overall Study|Ongoing|0
7594440|NCT01302847|12000158|FG001|Overall Study|Ongoing|0
7594441|NCT01302847|12000159|FG002|Overall Study|Ongoing|0
7594442|NCT01302847|12000160|FG003|Overall Study|Ongoing|0
7594443|NCT01302847|12000161|FG004|Overall Study|Ongoing|0
7594444|NCT01302847|12000162|FG005|Overall Study|Ongoing|27
7594445|NCT01302847|12000163|FG006|Overall Study|Ongoing|22
7594446|NCT01302847|12000164|FG007|Overall Study|Ongoing|17
7594447|NCT01302847|12000157|FG000|Overall Study|Death|0
7594448|NCT01302847|12000158|FG001|Overall Study|Death|1
7594449|NCT01302847|12000159|FG002|Overall Study|Death|0
7594450|NCT01302847|12000160|FG003|Overall Study|Death|0
7594451|NCT01302847|12000161|FG004|Overall Study|Death|0
7594452|NCT01302847|12000162|FG005|Overall Study|Death|1
7594453|NCT01302847|12000163|FG006|Overall Study|Death|1
7594454|NCT01302847|12000164|FG007|Overall Study|Death|0
7594455|NCT01302847|12000157|FG000|Overall Study|Pregnancy|2
7594456|NCT01302847|12000158|FG001|Overall Study|Pregnancy|0
7594457|NCT01302847|12000159|FG002|Overall Study|Pregnancy|0
7594458|NCT01302847|12000160|FG003|Overall Study|Pregnancy|0
7594459|NCT01302847|12000161|FG004|Overall Study|Pregnancy|0
7594460|NCT01302847|12000162|FG005|Overall Study|Pregnancy|0
7594461|NCT01302847|12000163|FG006|Overall Study|Pregnancy|0
7594462|NCT01302847|12000164|FG007|Overall Study|Pregnancy|0
7594463|NCT01302847|12000157|FG000|Overall Study|Virologic failure|0
7594464|NCT01302847|12000158|FG001|Overall Study|Virologic failure|2
7594465|NCT01302847|12000159|FG002|Overall Study|Virologic failure|2
7594466|NCT01302847|12000160|FG003|Overall Study|Virologic failure|0
7594467|NCT01302847|12000161|FG004|Overall Study|Virologic failure|1
7594468|NCT01302847|12000162|FG005|Overall Study|Virologic failure|1
7594469|NCT01302847|12000163|FG006|Overall Study|Virologic failure|0
7594470|NCT01302847|12000164|FG007|Overall Study|Virologic failure|2
7594471|NCT01302847|12000157|FG000|Overall Study|Severe debilitation, unable to continue|0
7594472|NCT01302847|12000158|FG001|Overall Study|Severe debilitation, unable to continue|0
7594473|NCT01302847|12000159|FG002|Overall Study|Severe debilitation, unable to continue|0
7594474|NCT01302847|12000160|FG003|Overall Study|Severe debilitation, unable to continue|0
7594475|NCT01302847|12000161|FG004|Overall Study|Severe debilitation, unable to continue|0
7594476|NCT01302847|12000162|FG005|Overall Study|Severe debilitation, unable to continue|1
7594477|NCT01302847|12000163|FG006|Overall Study|Severe debilitation, unable to continue|1
7594478|NCT01302847|12000164|FG007|Overall Study|Severe debilitation, unable to continue|0
7594479|NCT01302847|12000157|FG000|Overall Study|Not able to get to clinic|1
7594480|NCT01302847|12000158|FG001|Overall Study|Not able to get to clinic|1
7594481|NCT01302847|12000159|FG002|Overall Study|Not able to get to clinic|0
7594482|NCT01302847|12000160|FG003|Overall Study|Not able to get to clinic|0
7594483|NCT01302847|12000161|FG004|Overall Study|Not able to get to clinic|0
7594484|NCT01302847|12000162|FG005|Overall Study|Not able to get to clinic|0
7594485|NCT01302847|12000163|FG006|Overall Study|Not able to get to clinic|0
7594486|NCT01302847|12000164|FG007|Overall Study|Not able to get to clinic|0
7594487|NCT01302847|12000157|FG000|Overall Study|Site closing|2
7594488|NCT01302847|12000158|FG001|Overall Study|Site closing|2
7594489|NCT01302847|12000159|FG002|Overall Study|Site closing|0
7594490|NCT01302847|12000160|FG003|Overall Study|Site closing|0
7594491|NCT01302847|12000161|FG004|Overall Study|Site closing|0
7594492|NCT01302847|12000162|FG005|Overall Study|Site closing|0
7594493|NCT01302847|12000163|FG006|Overall Study|Site closing|0
7594494|NCT01302847|12000164|FG007|Overall Study|Site closing|0
7594495|NCT01302847|12000157|FG000|Overall Study|Withdrawal by Subject|1
7271463|NCT00422058|11485723|FG000|Double-Blind, Week 0-20|Protocol Violation|3
7271464|NCT00422058|11485724|FG001|Double-Blind, Week 0-20|Protocol Violation|2
7271465|NCT00422058|11485725|FG002|Double-Blind, Week 0-20|Protocol Violation|2
7271466|NCT00422058|11485726|FG003|Double-Blind, Week 0-20|Protocol Violation|3
7271467|NCT00422058|11485727|FG004|Double-Blind, Week 0-20|Protocol Violation|2
7271468|NCT00422058|11485728|FG005|Double-Blind, Week 0-20|Protocol Violation|2
7271469|NCT00422058|11485723|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
7271470|NCT00422058|11485724|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
7271471|NCT00422058|11485725|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
7271472|NCT00422058|11485726|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
7271473|NCT00422058|11485727|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
7271474|NCT00422058|11485728|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
7271475|NCT00422058|11485723|FG000|Double-Blind, Week 0-20|Other|11
7271476|NCT00422058|11485724|FG001|Double-Blind, Week 0-20|Other|3
7271477|NCT00422058|11485725|FG002|Double-Blind, Week 0-20|Other|8
7271478|NCT00422058|11485726|FG003|Double-Blind, Week 0-20|Other|8
7271479|NCT00422058|11485727|FG004|Double-Blind, Week 0-20|Other|4
7271480|NCT00422058|11485728|FG005|Double-Blind, Week 0-20|Other|10
7271481|NCT00422058|11485723|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7271482|NCT00422058|11485724|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
7271483|NCT00422058|11485725|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
7271484|NCT00422058|11485726|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
7594496|NCT01302847|12000158|FG001|Overall Study|Withdrawal by Subject|0
7594497|NCT01302847|12000159|FG002|Overall Study|Withdrawal by Subject|0
7594498|NCT01302847|12000160|FG003|Overall Study|Withdrawal by Subject|0
7594499|NCT01302847|12000161|FG004|Overall Study|Withdrawal by Subject|1
7594500|NCT01302847|12000162|FG005|Overall Study|Withdrawal by Subject|0
7594501|NCT01302847|12000163|FG006|Overall Study|Withdrawal by Subject|0
7594502|NCT01302847|12000164|FG007|Overall Study|Withdrawal by Subject|1
7594503|NCT01302847|12000157|FG000|Overall Study|Not willing to adhere to requirements|5
7594504|NCT01302847|12000158|FG001|Overall Study|Not willing to adhere to requirements|0
7594505|NCT01302847|12000159|FG002|Overall Study|Not willing to adhere to requirements|0
7594506|NCT01302847|12000160|FG003|Overall Study|Not willing to adhere to requirements|1
7594507|NCT01302847|12000161|FG004|Overall Study|Not willing to adhere to requirements|0
7594508|NCT01302847|12000162|FG005|Overall Study|Not willing to adhere to requirements|0
7594509|NCT01302847|12000163|FG006|Overall Study|Not willing to adhere to requirements|0
7594510|NCT01302847|12000164|FG007|Overall Study|Not willing to adhere to requirements|2
7594511|NCT01302847|12000157|FG000|Overall Study|Site unable to contact participant|2
7594512|NCT01302847|12000158|FG001|Overall Study|Site unable to contact participant|1
7594513|NCT01302847|12000159|FG002|Overall Study|Site unable to contact participant|0
7594514|NCT01302847|12000160|FG003|Overall Study|Site unable to contact participant|0
7594515|NCT01302847|12000161|FG004|Overall Study|Site unable to contact participant|0
7594516|NCT01302847|12000162|FG005|Overall Study|Site unable to contact participant|0
7594517|NCT01302847|12000163|FG006|Overall Study|Site unable to contact participant|2
7594518|NCT01302847|12000164|FG007|Overall Study|Site unable to contact participant|0
7594519|NCT01287611|12000193|FG000|Overall Study|Lost to Follow-up|29
7594520|NCT01287611|12000194|FG001|Overall Study|Lost to Follow-up|16
7594521|NCT01287611|12000193|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
7594522|NCT01287611|12000194|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
7594523|NCT01254422|12000204|FG000|Overall Study|Protocol Violation|1
7594524|NCT01254422|12000205|FG001|Overall Study|Protocol Violation|0
7594525|NCT01254422|12000204|FG000|Overall Study|Adverse Event|1
7594526|NCT01254422|12000205|FG001|Overall Study|Adverse Event|0
7594527|NCT01254422|12000204|FG000|Overall Study|Serious adverse event|0
7594528|NCT01254422|12000205|FG001|Overall Study|Serious adverse event|1
7594529|NCT01254422|12000204|FG000|Overall Study|Lost to Follow-up|1
7594530|NCT01254422|12000205|FG001|Overall Study|Lost to Follow-up|0
7594531|NCT01187433|12000213|FG000|Overall Study|Protocol Violation|6
7594532|NCT01187433|12000214|FG001|Overall Study|Protocol Violation|2
7594533|NCT01187433|12000213|FG000|Overall Study|Withdrawal by Subject|5
7594534|NCT01187433|12000214|FG001|Overall Study|Withdrawal by Subject|2
7594535|NCT01150045|12000224|FG000|Overall Study|Protocol Violation|0
7594536|NCT01150045|12000225|FG001|Overall Study|Protocol Violation|1
7594537|NCT01150045|12000226|FG002|Overall Study|Protocol Violation|0
7594538|NCT01150045|12000227|FG003|Overall Study|Protocol Violation|1
7594539|NCT01098032|12000237|FG000|Overall Study|Withdrawal by Subject|1
7594540|NCT01098032|12000238|FG001|Overall Study|Withdrawal by Subject|1
7594541|NCT01034306|12000246|FG000|Overall Study|Adverse Event|1
7594542|NCT01034306|12000247|FG001|Overall Study|Adverse Event|0
7594543|NCT01034306|12000246|FG000|Overall Study|Lost to Follow-up|0
7594544|NCT01034306|12000247|FG001|Overall Study|Lost to Follow-up|1
7594545|NCT01034306|12000246|FG000|Overall Study|Withdrawal by Subject|2
7594546|NCT01034306|12000247|FG001|Overall Study|Withdrawal by Subject|2
7594547|NCT01034306|12000246|FG000|Overall Study|hospitalized and decided to stop|1
7594548|NCT01034306|12000247|FG001|Overall Study|hospitalized and decided to stop|0
7594549|NCT01034306|12000246|FG000|Overall Study|Noncomplience|1
7594550|NCT01034306|12000247|FG001|Overall Study|Noncomplience|0
7594555|NCT00993447|12000259|FG000|Overall Study|Withdrawal by Subject|23
7594556|NCT00993447|12000260|FG001|Overall Study|Withdrawal by Subject|8
7594557|NCT00993447|12000259|FG000|Overall Study|Protocol Violation|12
7594558|NCT00993447|12000260|FG001|Overall Study|Protocol Violation|8
7594559|NCT00993447|12000259|FG000|Overall Study|Lost to Follow-up|1
7594560|NCT00993447|12000260|FG001|Overall Study|Lost to Follow-up|3
7594561|NCT00993447|12000259|FG000|Overall Study|Adverse Event|1
7594562|NCT00993447|12000260|FG001|Overall Study|Adverse Event|0
7594563|NCT00945009|12000269|FG000|Overall Study|Lack of Efficacy|10
7594564|NCT00945009|12000270|FG001|Overall Study|Lack of Efficacy|0
7594565|NCT00945009|12000271|FG002|Overall Study|Lack of Efficacy|0
7594566|NCT00945009|12000269|FG000|Overall Study|Physician Decision|21
7594567|NCT00945009|12000270|FG001|Overall Study|Physician Decision|4
7594568|NCT00945009|12000271|FG002|Overall Study|Physician Decision|3
7594569|NCT00945009|12000269|FG000|Overall Study|Protocol Violation|6
7594570|NCT00945009|12000270|FG001|Overall Study|Protocol Violation|1
7594571|NCT00945009|12000271|FG002|Overall Study|Protocol Violation|0
7594572|NCT00945009|12000269|FG000|Overall Study|Withdrawal by Subject|1
7594573|NCT00945009|12000270|FG001|Overall Study|Withdrawal by Subject|0
7594574|NCT00945009|12000271|FG002|Overall Study|Withdrawal by Subject|0
7594575|NCT00945009|12000269|FG000|Overall Study|Ineligible|6
7594576|NCT00945009|12000270|FG001|Overall Study|Ineligible|1
7594577|NCT00945009|12000271|FG002|Overall Study|Ineligible|0
7594578|NCT00945009|12000269|FG000|Overall Study|Inevaluable|0
7594579|NCT00945009|12000270|FG001|Overall Study|Inevaluable|1
7594580|NCT00945009|12000271|FG002|Overall Study|Inevaluable|0
7594581|NCT00945009|12000269|FG000|Overall Study|Refusal of further protocol|1
7594582|NCT00945009|12000270|FG001|Overall Study|Refusal of further protocol|0
7594583|NCT00945009|12000271|FG002|Overall Study|Refusal of further protocol|0
7594584|NCT00942877|12000281|FG000|Overall Study|Refused further treatment|1
7594585|NCT00942877|12000282|FG001|Overall Study|Refused further treatment|1
7594586|NCT00942877|12000281|FG000|Overall Study|Patient was not treated|1
7594587|NCT00942877|12000282|FG001|Overall Study|Patient was not treated|0
7594588|NCT00942877|12000281|FG000|Overall Study|Adverse Event|1
7594589|NCT00942877|12000282|FG001|Overall Study|Adverse Event|0
7594590|NCT00942877|12000281|FG000|Overall Study|Progressive disease|42
7594591|NCT00942877|12000282|FG001|Overall Study|Progressive disease|3
7594592|NCT00880893|12000297|FG000|Overall Study|Protocol Violation|13
7594593|NCT00880893|12000298|FG001|Overall Study|Protocol Violation|1
7594594|NCT00880893|12000297|FG000|Overall Study|Withdrawal by Subject|15
7594595|NCT00880893|12000298|FG001|Overall Study|Withdrawal by Subject|11
7594596|NCT00880893|12000297|FG000|Overall Study|Lost to Follow-up|76
7594597|NCT00880893|12000298|FG001|Overall Study|Lost to Follow-up|33
7594598|NCT00880893|12000297|FG000|Overall Study|Serious adverse event|3
7594599|NCT00880893|12000298|FG001|Overall Study|Serious adverse event|0
7594600|NCT00866918|12000306|FG000|Overall Study|Death|1
7594601|NCT00866918|12000307|FG001|Overall Study|Death|5
7594602|NCT00866918|12000306|FG000|Overall Study|Lack of Efficacy|1
7594603|NCT00866918|12000307|FG001|Overall Study|Lack of Efficacy|1
7594604|NCT00866918|12000306|FG000|Overall Study|Physician Decision|10
7594605|NCT00866918|12000307|FG001|Overall Study|Physician Decision|2
7594606|NCT00866918|12000306|FG000|Overall Study|Ineligible|2
7594607|NCT00866918|12000307|FG001|Overall Study|Ineligible|4
7594608|NCT00866918|12000306|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
7594609|NCT00866918|12000307|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
7594610|NCT00866918|12000306|FG000|Overall Study|Secondary malignancy|1
7594611|NCT00866918|12000307|FG001|Overall Study|Secondary malignancy|0
7627441|NCT03441360|12039904|FG002|Overall Study|Clinical disease progression|0
7627442|NCT03441360|12039902|FG000|Overall Study|Adverse Event|1
7627443|NCT03441360|12039903|FG001|Overall Study|Adverse Event|0
7627444|NCT03441360|12039904|FG002|Overall Study|Adverse Event|1
7627445|NCT03368170|12039914|FG000|Overall Study|Adverse Event|2
7627446|NCT03368170|12039915|FG001|Overall Study|Adverse Event|1
7627447|NCT03336528|12039923|FG000|Overall Study|Protocol Violation|1
7627448|NCT03336528|12039924|FG001|Overall Study|Protocol Violation|1
7627449|NCT03336528|12039923|FG000|Overall Study|Discharged within 48 hours of study medication|8
7627450|NCT03336528|12039924|FG001|Overall Study|Discharged within 48 hours of study medication|6
7627451|NCT03336528|12039923|FG000|Overall Study|Did not receive study medication|1
7627452|NCT03336528|12039924|FG001|Overall Study|Did not receive study medication|2
7627453|NCT03334409|12039934|FG000|Overall Study|Did not meet inclusion criteria|1
7627454|NCT03334409|12039935|FG001|Overall Study|Did not meet inclusion criteria|0
7594612|NCT00587301|12000313|FG000|Overall Study|Screen Failure|9
7594613|NCT00587301|12000313|FG000|Overall Study|Lost to Follow-up|22
7594614|NCT00587301|12000313|FG000|Overall Study|Withdrawal by Subject|7
7594615|NCT00587301|12000313|FG000|Overall Study|Protocol Violation|7
7594616|NCT00579527|12000317|FG000|Overall Study|Death|4
7594617|NCT00576836|12000322|FG000|Overall Study|Death|0
7594618|NCT00576836|12000323|FG001|Overall Study|Death|1
7594619|NCT00576836|12000322|FG000|Overall Study|Physician Decision|0
7594620|NCT00576836|12000323|FG001|Overall Study|Physician Decision|1
7594621|NCT00576407|12000327|FG000|Overall Study|Death|7
7594622|NCT00576407|12000327|FG000|Overall Study|Physician Decision|1
7594719|NCT00547339|12000366|FG000|Overall Study|Physician Decision|0
7594720|NCT00547339|12000367|FG001|Overall Study|Physician Decision|0
7594721|NCT00547339|12000368|FG002|Overall Study|Physician Decision|1
7594722|NCT00547339|12000369|FG003|Overall Study|Physician Decision|0
7594723|NCT00531232|12000391|FG000|Overall Study|Investigator decision|0
7594724|NCT00531232|12000392|FG001|Overall Study|Investigator decision|0
7594725|NCT00531232|12000393|FG002|Overall Study|Investigator decision|4
7594726|NCT00531232|12000391|FG000|Overall Study|Participants refused further treatment|0
7594727|NCT00531232|12000392|FG001|Overall Study|Participants refused further treatment|1
7594728|NCT00531232|12000393|FG002|Overall Study|Participants refused further treatment|2
7594729|NCT00531232|12000391|FG000|Overall Study|Adverse events (AEs)|1
7594730|NCT00531232|12000392|FG001|Overall Study|Adverse events (AEs)|2
7594731|NCT00531232|12000393|FG002|Overall Study|Adverse events (AEs)|2
7594732|NCT00531232|12000391|FG000|Overall Study|Treatment failure|1
7594733|NCT00531232|12000392|FG001|Overall Study|Treatment failure|3
7594734|NCT00531232|12000393|FG002|Overall Study|Treatment failure|7
7594735|NCT00531232|12000391|FG000|Overall Study|Disease recurrence|0
7594736|NCT00531232|12000392|FG001|Overall Study|Disease recurrence|0
7594737|NCT00531232|12000393|FG002|Overall Study|Disease recurrence|1
7594738|NCT00531232|12000391|FG000|Overall Study|Deceased|2
7594739|NCT00531232|12000392|FG001|Overall Study|Deceased|2
7594740|NCT00531232|12000393|FG002|Overall Study|Deceased|2
7594741|NCT00531232|12000391|FG000|Overall Study|Withdrawal by Subject|0
7594742|NCT00531232|12000392|FG001|Overall Study|Withdrawal by Subject|1
7594743|NCT00531232|12000393|FG002|Overall Study|Withdrawal by Subject|2
7594744|NCT00531232|12000391|FG000|Overall Study|Other|0
7594745|NCT00531232|12000392|FG001|Overall Study|Other|0
7594746|NCT00531232|12000393|FG002|Overall Study|Other|5
7594747|NCT00379340|12000409|FG000|Overall Study|Death|0
7594748|NCT00379340|12000410|FG001|Overall Study|Death|0
7594749|NCT00379340|12000411|FG002|Overall Study|Death|0
7594750|NCT00379340|12000412|FG003|Overall Study|Death|2
7594751|NCT00379340|12000413|FG004|Overall Study|Death|0
7594752|NCT00379340|12000409|FG000|Overall Study|Lack of Efficacy|6
7594753|NCT00379340|12000410|FG001|Overall Study|Lack of Efficacy|1
7594754|NCT00379340|12000411|FG002|Overall Study|Lack of Efficacy|0
7594755|NCT00379340|12000412|FG003|Overall Study|Lack of Efficacy|4
7594756|NCT00379340|12000413|FG004|Overall Study|Lack of Efficacy|3
7594757|NCT00379340|12000409|FG000|Overall Study|Physician Decision|6
7594758|NCT00379340|12000410|FG001|Overall Study|Physician Decision|2
7594759|NCT00379340|12000411|FG002|Overall Study|Physician Decision|1
7594760|NCT00379340|12000412|FG003|Overall Study|Physician Decision|2
7594761|NCT00379340|12000413|FG004|Overall Study|Physician Decision|3
7594762|NCT00379340|12000409|FG000|Overall Study|Withdrawal by Subject|0
7594763|NCT00379340|12000410|FG001|Overall Study|Withdrawal by Subject|0
7594764|NCT00379340|12000411|FG002|Overall Study|Withdrawal by Subject|0
7594765|NCT00379340|12000412|FG003|Overall Study|Withdrawal by Subject|1
7594766|NCT00379340|12000413|FG004|Overall Study|Withdrawal by Subject|0
7594767|NCT00379340|12000409|FG000|Overall Study|Refusal of further protocol therapy|1
7594768|NCT00379340|12000410|FG001|Overall Study|Refusal of further protocol therapy|0
7594769|NCT00379340|12000411|FG002|Overall Study|Refusal of further protocol therapy|1
7594770|NCT00379340|12000412|FG003|Overall Study|Refusal of further protocol therapy|1
7594771|NCT00379340|12000413|FG004|Overall Study|Refusal of further protocol therapy|7
7594772|NCT00379340|12000409|FG000|Overall Study|On more than 1 tumor therapeutic study|0
7594773|NCT00379340|12000410|FG001|Overall Study|On more than 1 tumor therapeutic study|0
7594774|NCT00379340|12000411|FG002|Overall Study|On more than 1 tumor therapeutic study|0
7594775|NCT00379340|12000412|FG003|Overall Study|On more than 1 tumor therapeutic study|2
7594776|NCT00379340|12000413|FG004|Overall Study|On more than 1 tumor therapeutic study|0
7594777|NCT00379340|12000409|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
7594778|NCT00379340|12000410|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
7271485|NCT00422058|11485727|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
7271486|NCT00422058|11485728|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
7271487|NCT00422058|11485723|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
7271488|NCT00422058|11485724|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
7271489|NCT00422058|11485725|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
7271490|NCT00422058|11485726|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
7271491|NCT00422058|11485727|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
7271492|NCT00422058|11485728|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
7271493|NCT00422058|11485723|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
7271494|NCT00422058|11485724|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
7271495|NCT00422058|11485725|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
7271496|NCT00422058|11485726|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
7271497|NCT00422058|11485727|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
7271498|NCT00422058|11485728|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
7271499|NCT00422058|11485723|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
7271500|NCT00422058|11485724|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7271501|NCT00422058|11485725|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
7271502|NCT00422058|11485726|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
7271503|NCT00422058|11485727|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
7271504|NCT00422058|11485728|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
7271505|NCT00422058|11485723|FG000|Open-Label Extension, Week 20-104|Other|13
7271506|NCT00422058|11485724|FG001|Open-Label Extension, Week 20-104|Other|14
7271507|NCT00422058|11485725|FG002|Open-Label Extension, Week 20-104|Other|6
7271508|NCT00422058|11485726|FG003|Open-Label Extension, Week 20-104|Other|13
7271509|NCT00422058|11485727|FG004|Open-Label Extension, Week 20-104|Other|16
7271510|NCT00422058|11485728|FG005|Open-Label Extension, Week 20-104|Other|18
7271511|NCT00422084|11485744|FG000|Overall Study|Adverse Event|21
7271512|NCT00422084|11485745|FG001|Overall Study|Adverse Event|7
7594779|NCT00379340|12000411|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
7594780|NCT00379340|12000412|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
7594781|NCT00379340|12000413|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
7594782|NCT00304070|12000429|FG000|Overall Study|Death|0
7594783|NCT00304070|12000430|FG001|Overall Study|Death|0
7594784|NCT00304070|12000431|FG002|Overall Study|Death|3
7594785|NCT00304070|12000429|FG000|Overall Study|Lost to Follow-up|0
7594786|NCT00304070|12000430|FG001|Overall Study|Lost to Follow-up|0
7594787|NCT00304070|12000431|FG002|Overall Study|Lost to Follow-up|1
7594788|NCT00304070|12000429|FG000|Overall Study|Physician Decision|0
7594789|NCT00304070|12000430|FG001|Overall Study|Physician Decision|0
7594790|NCT00304070|12000431|FG002|Overall Study|Physician Decision|3
7594791|NCT00304070|12000429|FG000|Overall Study|Withdrawal by Subject|0
7271513|NCT00422084|11485744|FG000|Overall Study|Withdrawal by Subject|12
7271514|NCT00422084|11485745|FG001|Overall Study|Withdrawal by Subject|9
7271515|NCT00422084|11485744|FG000|Overall Study|Lost to Follow-up|14
7594792|NCT00304070|12000430|FG001|Overall Study|Withdrawal by Subject|0
7594793|NCT00304070|12000431|FG002|Overall Study|Withdrawal by Subject|1
7594794|NCT00304070|12000429|FG000|Overall Study|Progressive Disease|3
7594795|NCT00304070|12000430|FG001|Overall Study|Progressive Disease|7
7594796|NCT00304070|12000431|FG002|Overall Study|Progressive Disease|4
7627455|NCT03084536|12039953|FG000|Overall Study|Determined to be ineligible|0
7627456|NCT03084536|12039954|FG001|Overall Study|Determined to be ineligible|0
7627457|NCT03084536|12039955|FG002|Overall Study|Determined to be ineligible|16
7627458|NCT03084536|12039953|FG000|Overall Study|Withdrawal by Subject|0
7627459|NCT03084536|12039954|FG001|Overall Study|Withdrawal by Subject|0
7627460|NCT03084536|12039955|FG002|Overall Study|Withdrawal by Subject|4
7627461|NCT03084536|12039953|FG000|Overall Study|Physician Decision|0
7627462|NCT03084536|12039954|FG001|Overall Study|Physician Decision|0
7627463|NCT03084536|12039955|FG002|Overall Study|Physician Decision|3
7627464|NCT03084536|12039953|FG000|Overall Study|Death|0
7627465|NCT03084536|12039954|FG001|Overall Study|Death|0
7271516|NCT00422084|11485745|FG001|Overall Study|Lost to Follow-up|9
7271517|NCT00422084|11485744|FG000|Overall Study|Protocol Violation|4
7271518|NCT00422084|11485745|FG001|Overall Study|Protocol Violation|1
7271519|NCT00422084|11485744|FG000|Overall Study|Lack of Efficacy|40
7271520|NCT00422084|11485745|FG001|Overall Study|Lack of Efficacy|42
7271521|NCT00422084|11485744|FG000|Overall Study|P. vivax infection|3
7271522|NCT00422084|11485745|FG001|Overall Study|P. vivax infection|6
7271523|NCT00422084|11485744|FG000|Overall Study|Cyesis|1
7271524|NCT00422084|11485745|FG001|Overall Study|Cyesis|0
7271525|NCT00422084|11485744|FG000|Overall Study|Withdrawn from study accidentally|1
7271526|NCT00422084|11485745|FG001|Overall Study|Withdrawn from study accidentally|0
7271527|NCT00422084|11485744|FG000|Overall Study|Non-compliance|1
7271528|NCT00422084|11485745|FG001|Overall Study|Non-compliance|0
7271529|NCT00422084|11485744|FG000|Overall Study|Re-location|0
7271530|NCT00422084|11485745|FG001|Overall Study|Re-location|1
7271531|NCT00422084|11485744|FG000|Overall Study|Not defined|1
7271532|NCT00422084|11485745|FG001|Overall Study|Not defined|1
7271533|NCT00422097|11485757|FG000|Dose Level 2|Still on treatment|0
7271534|NCT00422097|11485758|FG001|Dose Level 2|Still on treatment|1
7271535|NCT00422097|11485759|FG002|Dose Level 2|Still on treatment|0
7271536|NCT00422097|11485760|FG003|Dose Level 2|Still on treatment|0
7271537|NCT00422097|11485761|FG004|Dose Level 2|Still on treatment|0
7271538|NCT00422097|11485762|FG005|Dose Level 2|Still on treatment|0
7627466|NCT03084536|12039955|FG002|Overall Study|Death|1
7627467|NCT03084536|12039953|FG000|Overall Study|Lost to Follow-up|0
7627468|NCT03084536|12039954|FG001|Overall Study|Lost to Follow-up|0
7627469|NCT03084536|12039955|FG002|Overall Study|Lost to Follow-up|1
7627470|NCT03084536|12039953|FG000|Overall Study|Protocol Violation|0
7627471|NCT03084536|12039954|FG001|Overall Study|Protocol Violation|0
7627472|NCT03084536|12039955|FG002|Overall Study|Protocol Violation|1
7627473|NCT03084536|12039953|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0
7627474|NCT03084536|12039954|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0
7627475|NCT03084536|12039955|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1
7627476|NCT02988661|12040007|FG000|Overall Study|Death|2
7627477|NCT02988661|12040008|FG001|Overall Study|Death|18
7627478|NCT02988661|12040007|FG000|Overall Study|Lost to Follow-up|0
7627479|NCT02988661|12040008|FG001|Overall Study|Lost to Follow-up|33
7627480|NCT02988661|12040007|FG000|Overall Study|Withdrawal by Subject|0
7627481|NCT02988661|12040008|FG001|Overall Study|Withdrawal by Subject|6
7627482|NCT02988661|12040007|FG000|Overall Study|Unable to complete the 18-month survey|1
7627483|NCT02988661|12040008|FG001|Overall Study|Unable to complete the 18-month survey|27
7627484|NCT02921776|12040020|FG000|Overall Study|patient deterioration, fatigue|2
7627485|NCT02921776|12040021|FG001|Overall Study|patient deterioration, fatigue|6
7627486|NCT02921776|12040022|FG002|Overall Study|patient deterioration, fatigue|0
7627487|NCT02921776|12040023|FG003|Overall Study|patient deterioration, fatigue|0
7627488|NCT02921776|12040024|FG004|Overall Study|patient deterioration, fatigue|0
7627489|NCT02921776|12040025|FG005|Overall Study|patient deterioration, fatigue|0
7271539|NCT00422097|11485763|FG006|Dose Level 2|Still on treatment|0
7627490|NCT02921776|12040026|FG006|Overall Study|patient deterioration, fatigue|0
7627491|NCT02921776|12040027|FG007|Overall Study|patient deterioration, fatigue|0
7627492|NCT02921776|12040020|FG000|Overall Study|Withdrawal by Subject|0
7627493|NCT02921776|12040021|FG001|Overall Study|Withdrawal by Subject|2
7271540|NCT00422097|11485764|FG007|Dose Level 2|Still on treatment|0
7271541|NCT00422162|11485790|FG000|Overall Study|Adverse Event|11
7271542|NCT00422162|11485791|FG001|Overall Study|Adverse Event|9
7594797|NCT01701583|12000455|FG000|Overall Study|Withdrawal by Subject|2
7594798|NCT01701583|12000456|FG001|Overall Study|Withdrawal by Subject|0
7594799|NCT01714817|12000465|FG000|Year 1 Period|Lack of Efficacy|11
7594800|NCT01714817|12000466|FG001|Year 1 Period|Lack of Efficacy|9
7594801|NCT01714817|12000465|FG000|Year 1 Period|Adverse Event|20
7594802|NCT01714817|12000466|FG001|Year 1 Period|Adverse Event|17
7594803|NCT01714817|12000465|FG000|Year 1 Period|Withdrawal by Subject|6
7594804|NCT01714817|12000466|FG001|Year 1 Period|Withdrawal by Subject|7
7594805|NCT01714817|12000465|FG000|Year 1 Period|Death|1
7594806|NCT01714817|12000466|FG001|Year 1 Period|Death|1
7594807|NCT01714817|12000465|FG000|Year 1 Period|Lost to Follow-up|0
7594808|NCT01714817|12000466|FG001|Year 1 Period|Lost to Follow-up|2
7594809|NCT01714817|12000465|FG000|Year 1 Period|Poor / non-compliance|0
7594810|NCT01714817|12000466|FG001|Year 1 Period|Poor / non-compliance|1
7594811|NCT01714817|12000465|FG000|Year 1 Period|Pregnancy|2
7594812|NCT01714817|12000466|FG001|Year 1 Period|Pregnancy|0
7594813|NCT01714817|12000465|FG000|Year 1 Period|Participant no longer meets criteria|6
7594814|NCT01714817|12000466|FG001|Year 1 Period|Participant no longer meets criteria|2
7594815|NCT01714817|12000465|FG000|Year 1 Period|Not treated- received ACE inhibition|1
7594816|NCT01714817|12000466|FG001|Year 1 Period|Not treated- received ACE inhibition|0
7594817|NCT01714817|12000465|FG000|Year 1 Period|Change in Concomitant Medication|0
7594818|NCT01714817|12000466|FG001|Year 1 Period|Change in Concomitant Medication|1
7594819|NCT01714817|12000465|FG000|Year 1 Period|Need of use of Prohibited Medications|1
7594820|NCT01714817|12000466|FG001|Year 1 Period|Need of use of Prohibited Medications|0
7594821|NCT01714817|12000465|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0
7594822|NCT01714817|12000466|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1
7594823|NCT01714817|12000465|FG000|Year 1 Period|Hypersensitivity to the medication|0
7594824|NCT01714817|12000466|FG001|Year 1 Period|Hypersensitivity to the medication|1
7594825|NCT01714817|12000465|FG000|Year 2 Period|Lack of Efficacy|4
7594826|NCT01714817|12000466|FG001|Year 2 Period|Lack of Efficacy|12
7594827|NCT01714817|12000465|FG000|Year 2 Period|Adverse Event|7
7594828|NCT01714817|12000466|FG001|Year 2 Period|Adverse Event|6
7594829|NCT01714817|12000465|FG000|Year 2 Period|Participant request to stop treatment|4
7594830|NCT01714817|12000466|FG001|Year 2 Period|Participant request to stop treatment|4
7594831|NCT01714817|12000465|FG000|Year 2 Period|Administrative reason by Sponsor|4
7594832|NCT01714817|12000466|FG001|Year 2 Period|Administrative reason by Sponsor|3
7594833|NCT01714817|12000465|FG000|Year 2 Period|Participant withdrew consent|1
7594834|NCT01714817|12000466|FG001|Year 2 Period|Participant withdrew consent|5
7594835|NCT01714817|12000465|FG000|Year 2 Period|Participant no longer meets criteria|1
7594836|NCT01714817|12000466|FG001|Year 2 Period|Participant no longer meets criteria|4
7594837|NCT01714817|12000465|FG000|Year 2 Period|Lost to Follow-up|2
7594838|NCT01714817|12000466|FG001|Year 2 Period|Lost to Follow-up|0
7594839|NCT01714817|12000465|FG000|Year 2 Period|Participant went to US stopped treatment|0
7594840|NCT01714817|12000466|FG001|Year 2 Period|Participant went to US stopped treatment|1
7594841|NCT01714817|12000465|FG000|Year 2 Period|Pregnancy|1
7594842|NCT01714817|12000466|FG001|Year 2 Period|Pregnancy|1
7594843|NCT01714817|12000465|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2
7594844|NCT01714817|12000466|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1
7594845|NCT01714817|12000465|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0
7594846|NCT01714817|12000466|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1
7594847|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
7594848|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
7594849|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Disease progression|1
7594850|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Disease progression|4
7594851|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Not effective|0
7594852|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Not effective|1
7594853|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7594854|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
7594855|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7594856|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1
7594857|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
7594858|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
7594859|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0
7594860|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1
7594861|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Pregnancy|1
7594862|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Pregnancy|0
7594863|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1
7594864|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0
7594865|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
7594866|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
7594867|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
7594868|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
7594869|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0
7594870|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1
7594871|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
7594872|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
7594873|NCT01714817|12000465|FG000|Long-Term Extension (LTE) Period|Study was terminated|0
7594874|NCT01714817|12000466|FG001|Long-Term Extension (LTE) Period|Study was terminated|1
7627494|NCT02921776|12040022|FG002|Overall Study|Withdrawal by Subject|0
7627495|NCT02921776|12040023|FG003|Overall Study|Withdrawal by Subject|1
7627496|NCT02921776|12040024|FG004|Overall Study|Withdrawal by Subject|1
7627497|NCT02921776|12040025|FG005|Overall Study|Withdrawal by Subject|0
7627498|NCT02921776|12040026|FG006|Overall Study|Withdrawal by Subject|8
7627499|NCT02921776|12040027|FG007|Overall Study|Withdrawal by Subject|1
7627500|NCT02921776|12040020|FG000|Overall Study|Death|0
7627501|NCT02921776|12040021|FG001|Overall Study|Death|0
7627502|NCT02921776|12040022|FG002|Overall Study|Death|0
7627503|NCT02921776|12040023|FG003|Overall Study|Death|2
7627504|NCT02921776|12040024|FG004|Overall Study|Death|0
7627505|NCT02921776|12040025|FG005|Overall Study|Death|0
7627506|NCT02921776|12040026|FG006|Overall Study|Death|0
7627507|NCT02921776|12040027|FG007|Overall Study|Death|0
7627508|NCT02921776|12040020|FG000|Overall Study|extubation or early discharge|0
7627509|NCT02921776|12040021|FG001|Overall Study|extubation or early discharge|0
7627510|NCT02921776|12040022|FG002|Overall Study|extubation or early discharge|0
7627511|NCT02921776|12040023|FG003|Overall Study|extubation or early discharge|5
7627512|NCT02921776|12040024|FG004|Overall Study|extubation or early discharge|5
7627513|NCT02921776|12040025|FG005|Overall Study|extubation or early discharge|0
7627514|NCT02921776|12040026|FG006|Overall Study|extubation or early discharge|0
7627515|NCT02921776|12040027|FG007|Overall Study|extubation or early discharge|0
7627516|NCT02921776|12040020|FG000|Overall Study|Lost to Follow-up|0
7594875|NCT01755689|12000479|FG000|Overall Study|Withdrawal by Subject|1
7594876|NCT01755689|12000480|FG001|Overall Study|Withdrawal by Subject|3
7594877|NCT01755689|12000481|FG002|Overall Study|Withdrawal by Subject|2
7594878|NCT01755689|12000482|FG003|Overall Study|Withdrawal by Subject|1
7594879|NCT01755689|12000483|FG004|Overall Study|Withdrawal by Subject|1
7594880|NCT01755689|12000479|FG000|Overall Study|Migrated/moved from study area|0
7594881|NCT01755689|12000480|FG001|Overall Study|Migrated/moved from study area|1
7594882|NCT01755689|12000481|FG002|Overall Study|Migrated/moved from study area|1
7594883|NCT01755689|12000482|FG003|Overall Study|Migrated/moved from study area|1
7594884|NCT01755689|12000483|FG004|Overall Study|Migrated/moved from study area|1
7594885|NCT01755689|12000479|FG000|Overall Study|Lost to Follow-up|1
7594886|NCT01755689|12000480|FG001|Overall Study|Lost to Follow-up|0
7594887|NCT01755689|12000481|FG002|Overall Study|Lost to Follow-up|1
7594888|NCT01755689|12000482|FG003|Overall Study|Lost to Follow-up|0
7594889|NCT01755689|12000483|FG004|Overall Study|Lost to Follow-up|2
7594890|NCT01755689|12000479|FG000|Overall Study|Pregnancy|1
7594891|NCT01755689|12000480|FG001|Overall Study|Pregnancy|1
7594892|NCT01755689|12000481|FG002|Overall Study|Pregnancy|2
7594893|NCT01755689|12000482|FG003|Overall Study|Pregnancy|4
7594894|NCT01755689|12000483|FG004|Overall Study|Pregnancy|2
7594895|NCT01762761|12000505|FG000|Overall Study|Adverse Event|15
7594896|NCT01762761|12000506|FG001|Overall Study|Adverse Event|17
7594897|NCT01762761|12000505|FG000|Overall Study|Lack of Efficacy|9
7594898|NCT01762761|12000506|FG001|Overall Study|Lack of Efficacy|25
7594899|NCT01762761|12000505|FG000|Overall Study|Protocol Violation|1
7594900|NCT01762761|12000506|FG001|Overall Study|Protocol Violation|1
7594901|NCT01762761|12000505|FG000|Overall Study|Study closed/terminated|0
7594902|NCT01762761|12000506|FG001|Overall Study|Study closed/terminated|2
7594903|NCT01762761|12000505|FG000|Overall Study|Lost to Follow-up|3
7594904|NCT01762761|12000506|FG001|Overall Study|Lost to Follow-up|6
7594905|NCT01762761|12000505|FG000|Overall Study|Physician Decision|4
7594906|NCT01762761|12000506|FG001|Overall Study|Physician Decision|6
7594907|NCT01762761|12000505|FG000|Overall Study|Withdrawal by Subject|7
7594908|NCT01762761|12000506|FG001|Overall Study|Withdrawal by Subject|8
7594913|NCT01774370|12000530|FG000|Overall Study|Never taken the PRADAXA during the study|4
7594914|NCT01774370|12000530|FG000|Overall Study|Administered prior to the contract date|4
7594915|NCT01774370|12000530|FG000|Overall Study|Subjects of contraindications|34
7594916|NCT01774370|12000530|FG000|Overall Study|Violated inclusion/exclusion criteria|53
7594917|NCT01774370|12000530|FG000|Overall Study|Follow-up failure|34
7594918|NCT01777295|12000536|FG000|Overall Study|Withdrawal by Subject|2
7594919|NCT01777295|12000537|FG001|Overall Study|Withdrawal by Subject|2
7594920|NCT01777295|12000536|FG000|Overall Study|Pregnancy|0
7594921|NCT01777295|12000537|FG001|Overall Study|Pregnancy|1
7594922|NCT01777295|12000536|FG000|Overall Study|Personal problem|1
7594923|NCT01777295|12000537|FG001|Overall Study|Personal problem|0
7594924|NCT01777295|12000536|FG000|Overall Study|Investigator call for AEs check|1
7594925|NCT01777295|12000537|FG001|Overall Study|Investigator call for AEs check|0
7594926|NCT01787552|12000557|FG000|Overall Study|Withdrawal by Subject|2
7594927|NCT01787552|12000558|FG001|Overall Study|Withdrawal by Subject|0
7594928|NCT01787552|12000559|FG002|Overall Study|Withdrawal by Subject|0
7594929|NCT01787552|12000560|FG003|Overall Study|Withdrawal by Subject|4
7594930|NCT01787552|12000557|FG000|Overall Study|Physician Decision|2
7594931|NCT01787552|12000558|FG001|Overall Study|Physician Decision|2
7594932|NCT01787552|12000559|FG002|Overall Study|Physician Decision|1
7594933|NCT01787552|12000560|FG003|Overall Study|Physician Decision|2
7594934|NCT01787552|12000557|FG000|Overall Study|Death|0
7594935|NCT01787552|12000558|FG001|Overall Study|Death|0
7594936|NCT01787552|12000559|FG002|Overall Study|Death|0
7594937|NCT01787552|12000560|FG003|Overall Study|Death|1
7594938|NCT01787552|12000557|FG000|Overall Study|Adverse Event|2
7594939|NCT01787552|12000558|FG001|Overall Study|Adverse Event|5
7594940|NCT01787552|12000559|FG002|Overall Study|Adverse Event|2
7594941|NCT01787552|12000560|FG003|Overall Study|Adverse Event|16
7594942|NCT01787552|12000557|FG000|Overall Study|Study terminated by Sponsor|0
7594943|NCT01787552|12000558|FG001|Overall Study|Study terminated by Sponsor|0
7594944|NCT01787552|12000559|FG002|Overall Study|Study terminated by Sponsor|1
7594945|NCT01787552|12000560|FG003|Overall Study|Study terminated by Sponsor|3
7594946|NCT01787552|12000557|FG000|Overall Study|Progressive Disease|2
7594947|NCT01787552|12000558|FG001|Overall Study|Progressive Disease|2
7594948|NCT01787552|12000559|FG002|Overall Study|Progressive Disease|1
7594949|NCT01787552|12000560|FG003|Overall Study|Progressive Disease|1
7594950|NCT01807117|12000575|FG000|Overall Study|Physician Decision|2
7594951|NCT01807117|12000575|FG000|Overall Study|Disease diagnosis not a study disease|1
7594962|NCT01814826|12000603|FG000|Overall Study|Other|3
7594963|NCT01814826|12000604|FG001|Overall Study|Other|5
7594964|NCT01814826|12000605|FG002|Overall Study|Other|0
7594965|NCT01814826|12000603|FG000|Overall Study|Death|29
7594966|NCT01814826|12000604|FG001|Overall Study|Death|24
7594967|NCT01814826|12000605|FG002|Overall Study|Death|3
7594968|NCT01829711|12000614|FG000|Overall Study|Lost to Follow-up|2
7594969|NCT01829711|12000614|FG000|Overall Study|Withdrawal by Subject|3
7594970|NCT01829711|12000614|FG000|Overall Study|Death|4
7594971|NCT01829711|12000614|FG000|Overall Study|Started new therapies|17
7594972|NCT01829711|12000614|FG000|Overall Study|Adverse Event|3
7594973|NCT01829711|12000614|FG000|Overall Study|Due to progression of disease|13
7594909|NCT01763788|12000517|FG000|Overall Study|Lost to Follow-up|0
7594910|NCT01763788|12000518|FG001|Overall Study|Lost to Follow-up|0
7594911|NCT01763788|12000519|FG002|Overall Study|Lost to Follow-up|1
7594912|NCT01763788|12000520|FG003|Overall Study|Lost to Follow-up|0
7594952|NCT01808261|12000583|FG000|Overall Study|Physician Decision|0
7594953|NCT01808261|12000584|FG001|Overall Study|Physician Decision|2
7594954|NCT01808261|12000583|FG000|Overall Study|Study Closed/Terminated|25
7594955|NCT01808261|12000584|FG001|Overall Study|Study Closed/Terminated|23
7594956|NCT01808261|12000583|FG000|Overall Study|Adverse event, non-fatal|2
7594957|NCT01808261|12000584|FG001|Overall Study|Adverse event, non-fatal|0
7594958|NCT01808261|12000583|FG000|Overall Study|Consent withdrawn by subject|6
7594959|NCT01808261|12000584|FG001|Overall Study|Consent withdrawn by subject|7
7594960|NCT01808261|12000583|FG000|Overall Study|Lost to Follow-up|3
7594961|NCT01808261|12000584|FG001|Overall Study|Lost to Follow-up|1
7594974|NCT01829711|12000614|FG000|Overall Study|Due to lack of response|1
7627517|NCT02921776|12040021|FG001|Overall Study|Lost to Follow-up|0
7627518|NCT02921776|12040022|FG002|Overall Study|Lost to Follow-up|0
7627519|NCT02921776|12040023|FG003|Overall Study|Lost to Follow-up|0
7627520|NCT02921776|12040024|FG004|Overall Study|Lost to Follow-up|0
7627521|NCT02921776|12040025|FG005|Overall Study|Lost to Follow-up|2
7627522|NCT02921776|12040026|FG006|Overall Study|Lost to Follow-up|3
7627523|NCT02921776|12040027|FG007|Overall Study|Lost to Follow-up|6
7627524|NCT02870348|12040051|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4
7627525|NCT02841280|12040057|FG000|Overall Study|Adverse Event|2
7627526|NCT02841280|12040058|FG001|Overall Study|Adverse Event|1
7627527|NCT02841280|12040057|FG000|Overall Study|Death|1
7627528|NCT02841280|12040058|FG001|Overall Study|Death|0
7627529|NCT02841280|12040057|FG000|Overall Study|Lost to Follow-up|2
7627530|NCT02841280|12040058|FG001|Overall Study|Lost to Follow-up|2
7627531|NCT02841280|12040057|FG000|Overall Study|Withdrawal by Subject|7
7627532|NCT02841280|12040058|FG001|Overall Study|Withdrawal by Subject|3
7627533|NCT02841280|12040057|FG000|Overall Study|Stop Point: BP above threshold|2
7627534|NCT02841280|12040058|FG001|Overall Study|Stop Point: BP above threshold|0
7627535|NCT02771275|12040081|FG000|Overall Study|Reoperation|2
7627536|NCT02771275|12040081|FG000|Overall Study|On Study|11
7627537|NCT02675426|12040088|FG000|Overall Study|Adverse Event|6
7627538|NCT02675426|12040089|FG001|Overall Study|Adverse Event|2
7627539|NCT02675426|12040090|FG002|Overall Study|Adverse Event|9
7627540|NCT02675426|12040088|FG000|Overall Study|Withdrawal by Subject|3
7627541|NCT02675426|12040089|FG001|Overall Study|Withdrawal by Subject|5
7627542|NCT02675426|12040090|FG002|Overall Study|Withdrawal by Subject|5
7627543|NCT02675426|12040088|FG000|Overall Study|Lost to Follow-up|1
7627544|NCT02675426|12040089|FG001|Overall Study|Lost to Follow-up|0
7627545|NCT02675426|12040090|FG002|Overall Study|Lost to Follow-up|2
7627546|NCT02675426|12040088|FG000|Overall Study|Other|3
7627547|NCT02675426|12040089|FG001|Overall Study|Other|1
7627548|NCT02675426|12040090|FG002|Overall Study|Other|2
7271543|NCT00422162|11485790|FG000|Overall Study|Lack of Efficacy|4
7271544|NCT00422162|11485791|FG001|Overall Study|Lack of Efficacy|10
7594975|NCT01846273|12000621|FG000|Overall Study|Adverse Event|9
7594976|NCT01846273|12000622|FG001|Overall Study|Adverse Event|7
7594977|NCT01846273|12000623|FG002|Overall Study|Adverse Event|0
7594978|NCT01846273|12000621|FG000|Overall Study|Subject withdrew consent|5
7594979|NCT01846273|12000622|FG001|Overall Study|Subject withdrew consent|8
7594980|NCT01846273|12000623|FG002|Overall Study|Subject withdrew consent|0
7594981|NCT01846273|12000621|FG000|Overall Study|Lost to Follow-up|2
7594982|NCT01846273|12000622|FG001|Overall Study|Lost to Follow-up|1
7594983|NCT01846273|12000623|FG002|Overall Study|Lost to Follow-up|0
7594984|NCT01846273|12000621|FG000|Overall Study|Administrative problems|1
7594985|NCT01846273|12000622|FG001|Overall Study|Administrative problems|0
7594986|NCT01846273|12000623|FG002|Overall Study|Administrative problems|0
7594987|NCT01846273|12000621|FG000|Overall Study|Death|2
7594988|NCT01846273|12000622|FG001|Overall Study|Death|1
7594989|NCT01846273|12000623|FG002|Overall Study|Death|0
7594990|NCT01846273|12000621|FG000|Overall Study|Disease Progression|0
7594991|NCT01846273|12000622|FG001|Overall Study|Disease Progression|4
7594992|NCT01846273|12000623|FG002|Overall Study|Disease Progression|0
7594993|NCT01846273|12000621|FG000|Overall Study|Protocol Deviation|2
7594994|NCT01846273|12000622|FG001|Overall Study|Protocol Deviation|3
7594995|NCT01846273|12000623|FG002|Overall Study|Protocol Deviation|0
7594996|NCT01846273|12000621|FG000|Overall Study|Physician Decision|1
7594997|NCT01846273|12000622|FG001|Overall Study|Physician Decision|2
7594998|NCT01846273|12000623|FG002|Overall Study|Physician Decision|0
7594999|NCT01875185|12000633|FG000|Overall Study|study was terminated|52
7595000|NCT01875185|12000634|FG001|Overall Study|study was terminated|48
7595001|NCT01891643|12000660|FG000|Overall Study|Adverse event unrelated to study drug|2
7595002|NCT01891643|12000661|FG001|Overall Study|Adverse event unrelated to study drug|5
7595003|NCT01891643|12000660|FG000|Overall Study|Disease Progression|4
7595004|NCT01891643|12000661|FG001|Overall Study|Disease Progression|3
7595005|NCT01891643|12000660|FG000|Overall Study|Study Drug Toxicity|3
7595006|NCT01891643|12000661|FG001|Overall Study|Study Drug Toxicity|0
7595007|NCT01891643|12000660|FG000|Overall Study|Maximum Clinical Benefit|0
7595008|NCT01891643|12000661|FG001|Overall Study|Maximum Clinical Benefit|1
7595009|NCT01891643|12000660|FG000|Overall Study|Poor/Non-compliance|0
7595010|NCT01891643|12000661|FG001|Overall Study|Poor/Non-compliance|1
7595011|NCT01891643|12000660|FG000|Overall Study|Participant request to discontinue|1
7595012|NCT01891643|12000661|FG001|Overall Study|Participant request to discontinue|0
7627607|NCT02498444|12040162|FG000|Overall Study|Withdrawal by Subject|3
7627608|NCT02498444|12040163|FG001|Overall Study|Withdrawal by Subject|0
7627609|NCT02498444|12040162|FG000|Overall Study|Physician Decision|1
7627610|NCT02498444|12040163|FG001|Overall Study|Physician Decision|0
7271545|NCT00422162|11485790|FG000|Overall Study|Withdrawal by Subject|7
7595019|NCT01901432|12000677|FG000|Overall Study|Adverse Event|0
7595020|NCT01901432|12000678|FG001|Overall Study|Adverse Event|1
7595021|NCT01901432|12000679|FG002|Overall Study|Adverse Event|1
7595022|NCT01901432|12000680|FG003|Overall Study|Adverse Event|0
7595023|NCT01901432|12000681|FG004|Overall Study|Adverse Event|1
7595024|NCT01901432|12000677|FG000|Overall Study|Withdrawal by Subject|0
7595025|NCT01901432|12000678|FG001|Overall Study|Withdrawal by Subject|0
7271546|NCT00422162|11485791|FG001|Overall Study|Withdrawal by Subject|6
7271547|NCT00422162|11485790|FG000|Overall Study|Lost to Follow-up|1
7271548|NCT00422162|11485791|FG001|Overall Study|Lost to Follow-up|2
7271549|NCT00422162|11485790|FG000|Overall Study|Non-Compliant with Protocol|1
7271550|NCT00422162|11485791|FG001|Overall Study|Non-Compliant with Protocol|1
7271551|NCT00422162|11485790|FG000|Overall Study|Other|0
7271552|NCT00422162|11485791|FG001|Overall Study|Other|1
7271553|NCT00422162|11485790|FG000|Overall Study|Didn't Receive Treatment|0
7271554|NCT00422162|11485791|FG001|Overall Study|Didn't Receive Treatment|1
7595026|NCT01901432|12000679|FG002|Overall Study|Withdrawal by Subject|1
7595027|NCT01901432|12000680|FG003|Overall Study|Withdrawal by Subject|0
7595028|NCT01901432|12000681|FG004|Overall Study|Withdrawal by Subject|5
7595029|NCT01901432|12000677|FG000|Overall Study|Physician Decision|0
7595030|NCT01901432|12000678|FG001|Overall Study|Physician Decision|0
7595031|NCT01901432|12000679|FG002|Overall Study|Physician Decision|0
7595032|NCT01901432|12000680|FG003|Overall Study|Physician Decision|0
7595033|NCT01901432|12000681|FG004|Overall Study|Physician Decision|2
7595034|NCT01901432|12000677|FG000|Overall Study|Patient decision to stop study drug|0
7595035|NCT01901432|12000678|FG001|Overall Study|Patient decision to stop study drug|0
7595036|NCT01901432|12000679|FG002|Overall Study|Patient decision to stop study drug|0
7595037|NCT01901432|12000680|FG003|Overall Study|Patient decision to stop study drug|0
7595038|NCT01901432|12000681|FG004|Overall Study|Patient decision to stop study drug|1
7627611|NCT02487108|12040173|FG000|Overall Study|Adverse Event|1
7627612|NCT02487108|12040174|FG001|Overall Study|Adverse Event|6
7627613|NCT02487108|12040175|FG002|Overall Study|Adverse Event|12
7627614|NCT02487108|12040176|FG003|Overall Study|Adverse Event|6
7627615|NCT02487108|12040173|FG000|Overall Study|Withdrawal by Subject|8
7627616|NCT02487108|12040174|FG001|Overall Study|Withdrawal by Subject|5
7627617|NCT02487108|12040175|FG002|Overall Study|Withdrawal by Subject|5
7627618|NCT02487108|12040176|FG003|Overall Study|Withdrawal by Subject|0
7627619|NCT02487108|12040173|FG000|Overall Study|Non-compliance to study medication|3
7627620|NCT02487108|12040174|FG001|Overall Study|Non-compliance to study medication|2
7627621|NCT02487108|12040175|FG002|Overall Study|Non-compliance to study medication|5
7627622|NCT02487108|12040176|FG003|Overall Study|Non-compliance to study medication|4
7627623|NCT02487108|12040173|FG000|Overall Study|Protocol Violation|1
7627624|NCT02487108|12040174|FG001|Overall Study|Protocol Violation|1
7627625|NCT02487108|12040175|FG002|Overall Study|Protocol Violation|2
7627626|NCT02487108|12040176|FG003|Overall Study|Protocol Violation|0
7627627|NCT02487108|12040173|FG000|Overall Study|Non-compliance to study procedures|0
7627628|NCT02487108|12040174|FG001|Overall Study|Non-compliance to study procedures|0
7627629|NCT02487108|12040175|FG002|Overall Study|Non-compliance to study procedures|0
7595039|NCT01904279|12000702|FG000|Overall Study|Lack of Efficacy|2
7595040|NCT01904279|12000703|FG001|Overall Study|Lack of Efficacy|3
7595041|NCT01904279|12000702|FG000|Overall Study|Withdrawal by Subject|1
7595042|NCT01904279|12000703|FG001|Overall Study|Withdrawal by Subject|0
7627630|NCT02487108|12040176|FG003|Overall Study|Non-compliance to study procedures|1
7627631|NCT02487108|12040173|FG000|Overall Study|Other than specified|3
7627632|NCT02487108|12040174|FG001|Overall Study|Other than specified|2
7627633|NCT02487108|12040175|FG002|Overall Study|Other than specified|2
7627634|NCT02487108|12040176|FG003|Overall Study|Other than specified|0
7627635|NCT02455557|12040186|FG000|Overall Study|Withdrawal by Subject|2
7627636|NCT02387996|12040199|FG000|Overall Study|Disease Progression|144
7627637|NCT02387996|12040199|FG000|Overall Study|Study Drug Toxicity|14
7627638|NCT02387996|12040199|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
7627639|NCT02387996|12040199|FG000|Overall Study|Subject Request to Discontinue Treatment|9
7627640|NCT02387996|12040199|FG000|Overall Study|Subject Withdrew Consent|1
7627641|NCT02387996|12040199|FG000|Overall Study|Lost to Follow-up|1
7627642|NCT02387996|12040199|FG000|Overall Study|Poor/Non-Compliance|1
7627643|NCT02351856|12040216|FG000|Overall Study|Adverse Event|2
7627644|NCT02351856|12040216|FG000|Overall Study|Physician Decision|5
7627645|NCT02351856|12040216|FG000|Overall Study|Study terminated by sponsor|1
7627646|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Adverse Event|0
7627647|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Adverse Event|0
7627648|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Adverse Event|1
7627649|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Adverse Event|1
7627650|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6
7627651|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6
7627652|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2
7627653|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7
7627654|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627655|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627656|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1
7627657|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0
7627658|NCT02349386|12040224|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627659|NCT02349386|12040225|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627660|NCT02349386|12040226|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1
7627661|NCT02349386|12040227|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
7627662|NCT02349386|12040224|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
7627663|NCT02349386|12040225|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
7627664|NCT02349386|12040226|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
7627665|NCT02349386|12040227|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
7627666|NCT02349386|12040224|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627667|NCT02349386|12040225|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627668|NCT02349386|12040226|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1
7627669|NCT02349386|12040227|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
7627670|NCT01904032|12040261|FG000|Overall Study|Adverse Event|3
7627671|NCT01904032|12040262|FG001|Overall Study|Adverse Event|1
7627672|NCT01904032|12040261|FG000|Overall Study|Lost to Follow-up|4
7627673|NCT01904032|12040262|FG001|Overall Study|Lost to Follow-up|2
7627674|NCT01632878|12040288|FG000|Screening|Physician Decision|268
7627675|NCT01632878|12040288|FG000|Treatment|Lost to Follow-up|41
7627676|NCT01632878|12040288|FG000|Treatment|Withdrawal by Subject|36
7627677|NCT01632878|12040288|FG000|Treatment|Physician Decision|34
7627678|NCT01632878|12040288|FG000|Treatment|missing information|4
7627679|NCT01632878|12040288|FG000|Treatment|no information on study completion|43
7627680|NCT01097005|12040296|FG000|Overall Study|Case Report Form not collected|18
7627681|NCT01097005|12040296|FG000|Overall Study|Subjects cannot visit the hospital|1
7627682|NCT01097005|12040296|FG000|Overall Study|Poor medication compliance|1
7627683|NCT01097005|12040296|FG000|Overall Study|No examination data available|244
7627684|NCT01097005|12040296|FG000|Overall Study|Deviation from exclusion criteria|37
7627685|NCT01097005|12040296|FG000|Overall Study|Adverse Event|14
7627686|NCT01097005|12040296|FG000|Overall Study|Discontinuance by complication|50
7627687|NCT00931255|12040308|FG000|Overall Study|Follow up biopsy not done|2
7627688|NCT00931255|12040309|FG001|Overall Study|Follow up biopsy not done|3
7595043|NCT01917318|12000712|FG000|First Treatment|Withdrawal by Subject|0
7595044|NCT01917318|12000713|FG001|First Treatment|Withdrawal by Subject|1
7595045|NCT01921218|12000721|FG000|Overall Study|Death|2
7595046|NCT01921218|12000722|FG001|Overall Study|Death|1
7595047|NCT01921218|12000721|FG000|Overall Study|Withdrawal by Subject|0
7595048|NCT01921218|12000722|FG001|Overall Study|Withdrawal by Subject|2
7595049|NCT01921218|12000721|FG000|Overall Study|Kidney transplant|1
7595050|NCT01921218|12000722|FG001|Overall Study|Kidney transplant|1
7595069|NCT01931098|12000763|FG000|Overall Study|Withdrawal by Subject|0
7595070|NCT01931098|12000764|FG001|Overall Study|Withdrawal by Subject|1
7595071|NCT01931098|12000763|FG000|Overall Study|Enrolled in different protocol|0
7595072|NCT01931098|12000764|FG001|Overall Study|Enrolled in different protocol|1
7595073|NCT01931098|12000763|FG000|Overall Study|Unable to begin trmt:active infection|0
7595074|NCT01931098|12000764|FG001|Overall Study|Unable to begin trmt:active infection|1
7595075|NCT01931098|12000763|FG000|Overall Study|Refused further treatment|0
7595076|NCT01931098|12000764|FG001|Overall Study|Refused further treatment|1
7595077|NCT01945021|12000772|FG000|Overall Study|Adverse Event|1
7595078|NCT01945021|12000772|FG000|Overall Study|Withdrawal of consent|12
7595079|NCT01945021|12000772|FG000|Overall Study|Lost to Follow-up|5
7595080|NCT01945021|12000772|FG000|Overall Study|Death|65
7595081|NCT03951077|12000822|FG000|Overall Study|Adverse Event|1
7595082|NCT03951077|12000823|FG001|Overall Study|Adverse Event|0
7595083|NCT03951077|12000824|FG002|Overall Study|Adverse Event|0
7595084|NCT03951077|12000825|FG003|Overall Study|Adverse Event|0
7595085|NCT03951077|12000826|FG004|Overall Study|Adverse Event|0
7595086|NCT03951077|12000827|FG005|Overall Study|Adverse Event|0
7595087|NCT03951077|12000822|FG000|Overall Study|Withdrawal by Subject|3
7595088|NCT03951077|12000823|FG001|Overall Study|Withdrawal by Subject|3
7595089|NCT03951077|12000824|FG002|Overall Study|Withdrawal by Subject|0
7595090|NCT03951077|12000825|FG003|Overall Study|Withdrawal by Subject|3
7595091|NCT03951077|12000826|FG004|Overall Study|Withdrawal by Subject|3
7595092|NCT03951077|12000827|FG005|Overall Study|Withdrawal by Subject|2
7595093|NCT03951077|12000822|FG000|Overall Study|Lost to Follow-up|1
7595094|NCT03951077|12000823|FG001|Overall Study|Lost to Follow-up|1
7595095|NCT03951077|12000824|FG002|Overall Study|Lost to Follow-up|2
7595096|NCT03951077|12000825|FG003|Overall Study|Lost to Follow-up|3
7595097|NCT03951077|12000826|FG004|Overall Study|Lost to Follow-up|2
7595098|NCT03951077|12000827|FG005|Overall Study|Lost to Follow-up|3
7595099|NCT03951077|12000822|FG000|Overall Study|Non-Compliance With Study Procedures|0
7595100|NCT03951077|12000823|FG001|Overall Study|Non-Compliance With Study Procedures|0
7595101|NCT03951077|12000824|FG002|Overall Study|Non-Compliance With Study Procedures|0
7595102|NCT03951077|12000825|FG003|Overall Study|Non-Compliance With Study Procedures|0
7595103|NCT03951077|12000826|FG004|Overall Study|Non-Compliance With Study Procedures|1
7595104|NCT03951077|12000827|FG005|Overall Study|Non-Compliance With Study Procedures|0
7595105|NCT03951077|12000822|FG000|Overall Study|Other, Not Specified|12
7595106|NCT03951077|12000823|FG001|Overall Study|Other, Not Specified|10
7595107|NCT03951077|12000824|FG002|Overall Study|Other, Not Specified|10
7595108|NCT03951077|12000825|FG003|Overall Study|Other, Not Specified|5
7595109|NCT03951077|12000826|FG004|Overall Study|Other, Not Specified|9
7595110|NCT03951077|12000827|FG005|Overall Study|Other, Not Specified|6
7595111|NCT03951077|12000822|FG000|Overall Study|Did Not Receive Any Study Drug|1
7595112|NCT03951077|12000823|FG001|Overall Study|Did Not Receive Any Study Drug|0
7595113|NCT03951077|12000824|FG002|Overall Study|Did Not Receive Any Study Drug|1
7595114|NCT03951077|12000825|FG003|Overall Study|Did Not Receive Any Study Drug|1
7595115|NCT03951077|12000826|FG004|Overall Study|Did Not Receive Any Study Drug|1
7595116|NCT03951077|12000827|FG005|Overall Study|Did Not Receive Any Study Drug|0
7595117|NCT03873246|12000844|FG000|Overall Study|Adverse Event|1
7595118|NCT03873246|12000845|FG001|Overall Study|Adverse Event|3
7595119|NCT03873246|12000846|FG002|Overall Study|Adverse Event|3
7595120|NCT03873246|12000844|FG000|Overall Study|Lost to Follow-up|4
7595121|NCT03873246|12000845|FG001|Overall Study|Lost to Follow-up|4
7595122|NCT03873246|12000846|FG002|Overall Study|Lost to Follow-up|5
7595123|NCT03873246|12000844|FG000|Overall Study|Protocol Violation|0
7595124|NCT03873246|12000845|FG001|Overall Study|Protocol Violation|1
7595051|NCT01923168|12000731|FG000|Overall Study|Protocol Violation|1
7595052|NCT01923168|12000732|FG001|Overall Study|Protocol Violation|1
7595053|NCT01923168|12000733|FG002|Overall Study|Protocol Violation|0
7595054|NCT01923168|12000731|FG000|Overall Study|Subject/guardian decision|14
7595055|NCT01923168|12000732|FG001|Overall Study|Subject/guardian decision|14
7595056|NCT01923168|12000733|FG002|Overall Study|Subject/guardian decision|4
7595057|NCT01923168|12000731|FG000|Overall Study|Adverse Event|12
7595058|NCT01923168|12000732|FG001|Overall Study|Adverse Event|12
7595059|NCT01923168|12000733|FG002|Overall Study|Adverse Event|0
7595060|NCT01923168|12000731|FG000|Overall Study|Physician Decision|6
7595061|NCT01923168|12000732|FG001|Overall Study|Physician Decision|9
7595062|NCT01923168|12000733|FG002|Overall Study|Physician Decision|5
7595063|NCT01923168|12000731|FG000|Overall Study|Progressive disease|4
7595064|NCT01923168|12000732|FG001|Overall Study|Progressive disease|3
7595065|NCT01923168|12000733|FG002|Overall Study|Progressive disease|7
7595066|NCT01923168|12000731|FG000|Overall Study|Death|0
7595067|NCT01923168|12000732|FG001|Overall Study|Death|0
7595068|NCT01923168|12000733|FG002|Overall Study|Death|1
7595125|NCT03873246|12000846|FG002|Overall Study|Protocol Violation|0
7595126|NCT03873246|12000844|FG000|Overall Study|Withdrawal by Subject|0
7595127|NCT03873246|12000845|FG001|Overall Study|Withdrawal by Subject|4
7595128|NCT03873246|12000846|FG002|Overall Study|Withdrawal by Subject|1
7595129|NCT03807349|12000855|FG000|Overall Study|Early Study Termination|9
7595130|NCT03769649|12000859|FG000|Overall Study|Lost to Follow-up|4
7595131|NCT03408444|12000924|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1
7595132|NCT03408444|12000925|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595133|NCT03408444|12000926|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595134|NCT03408444|12000927|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0
7595135|NCT03408444|12000924|FG000|Overall Study|Lens Discomfort|0
7595136|NCT03408444|12000925|FG001|Overall Study|Lens Discomfort|1
7595137|NCT03408444|12000926|FG002|Overall Study|Lens Discomfort|0
7595138|NCT03408444|12000927|FG003|Overall Study|Lens Discomfort|0
7595139|NCT03408444|12000924|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595140|NCT03408444|12000925|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595141|NCT03408444|12000926|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1
7595142|NCT03408444|12000927|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0
7595143|NCT03408444|12000924|FG000|Overall Study|Withdrawal by Subject|0
7595144|NCT03408444|12000925|FG001|Overall Study|Withdrawal by Subject|2
7595145|NCT03408444|12000926|FG002|Overall Study|Withdrawal by Subject|3
7595146|NCT03408444|12000927|FG003|Overall Study|Withdrawal by Subject|0
7595147|NCT03408444|12000924|FG000|Overall Study|Lost to Follow-up|0
7595148|NCT03408444|12000925|FG001|Overall Study|Lost to Follow-up|0
7595149|NCT03408444|12000926|FG002|Overall Study|Lost to Follow-up|1
7595150|NCT03408444|12000927|FG003|Overall Study|Lost to Follow-up|0
7595151|NCT03408444|12000924|FG000|Overall Study|Adverse Event|0
7595152|NCT03408444|12000925|FG001|Overall Study|Adverse Event|0
7595153|NCT03408444|12000926|FG002|Overall Study|Adverse Event|0
7595154|NCT03408444|12000927|FG003|Overall Study|Adverse Event|1
7595155|NCT03408444|12000924|FG000|Overall Study|Lens Handling Difficulties|0
7595156|NCT03408444|12000925|FG001|Overall Study|Lens Handling Difficulties|0
7595157|NCT03408444|12000926|FG002|Overall Study|Lens Handling Difficulties|1
7595158|NCT03408444|12000927|FG003|Overall Study|Lens Handling Difficulties|0
7595159|NCT03408444|12000924|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595160|NCT03408444|12000925|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595161|NCT03408444|12000926|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0
7595162|NCT03408444|12000927|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3
7627689|NCT04537078|12040355|FG000|Overall Study|Protocol Violation|3
7627690|NCT04537078|12040356|FG001|Overall Study|Protocol Violation|2
7627691|NCT04537078|12040355|FG000|Overall Study|Lost to Follow-up|1
7627692|NCT04537078|12040356|FG001|Overall Study|Lost to Follow-up|0
7627693|NCT04537078|12040355|FG000|Overall Study|Withdrawal by Subject|0
7627694|NCT04537078|12040356|FG001|Overall Study|Withdrawal by Subject|1
7627695|NCT04425252|12040371|FG000|Overall Study|Withdrawal by Subject|2
7627696|NCT04425252|12040372|FG001|Overall Study|Withdrawal by Subject|1
7627697|NCT04425252|12040371|FG000|Overall Study|Lost to Follow-up|1
7627698|NCT04425252|12040372|FG001|Overall Study|Lost to Follow-up|0
7627699|NCT04425252|12040371|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1
7627700|NCT04425252|12040372|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1
7627701|NCT03875313|12040401|FG000|Overall Study|Withdrawal by Subject|1
7627702|NCT03875313|12040402|FG001|Overall Study|Withdrawal by Subject|3
7627703|NCT03875313|12040403|FG002|Overall Study|Withdrawal by Subject|0
7627704|NCT03875313|12040404|FG003|Overall Study|Withdrawal by Subject|0
7627705|NCT03875313|12040405|FG004|Overall Study|Withdrawal by Subject|0
7627706|NCT03875313|12040401|FG000|Overall Study|Death|0
7627707|NCT03875313|12040402|FG001|Overall Study|Death|0
7627708|NCT03875313|12040403|FG002|Overall Study|Death|0
7627709|NCT03875313|12040404|FG003|Overall Study|Death|0
7271555|NCT00422227|11485814|FG000|Overall Study|Adverse Event|3
7271556|NCT00422227|11485815|FG001|Overall Study|Adverse Event|8
7271557|NCT00422227|11485814|FG000|Overall Study|Lost to Follow-up|1
7271558|NCT00422227|11485815|FG001|Overall Study|Lost to Follow-up|3
7271559|NCT00422227|11485814|FG000|Overall Study|Withdrawal by Subject|0
7271560|NCT00422227|11485815|FG001|Overall Study|Withdrawal by Subject|4
7271561|NCT00422292|11485836|FG000|Overall Study|Serious adverse events|1
7271562|NCT00422292|11485837|FG001|Overall Study|Serious adverse events|4
7271563|NCT00422292|11485838|FG002|Overall Study|Serious adverse events|0
7271564|NCT00422292|11485839|FG003|Overall Study|Serious adverse events|0
7271565|NCT00422292|11485836|FG000|Overall Study|Adverse Event|1
7271566|NCT00422292|11485837|FG001|Overall Study|Adverse Event|0
7271567|NCT00422292|11485838|FG002|Overall Study|Adverse Event|1
7271568|NCT00422292|11485839|FG003|Overall Study|Adverse Event|0
7271569|NCT00422292|11485836|FG000|Overall Study|Protocol Violation|4
7271570|NCT00422292|11485837|FG001|Overall Study|Protocol Violation|25
7271571|NCT00422292|11485838|FG002|Overall Study|Protocol Violation|8
7271572|NCT00422292|11485839|FG003|Overall Study|Protocol Violation|5
7271573|NCT00422292|11485836|FG000|Overall Study|Lost to Follow-up|6
7271574|NCT00422292|11485837|FG001|Overall Study|Lost to Follow-up|12
7271575|NCT00422292|11485838|FG002|Overall Study|Lost to Follow-up|6
7271576|NCT00422292|11485839|FG003|Overall Study|Lost to Follow-up|6
7271577|NCT00422292|11485836|FG000|Overall Study|Withdrawal by Subject|6
7271578|NCT00422292|11485837|FG001|Overall Study|Withdrawal by Subject|25
7271579|NCT00422292|11485838|FG002|Overall Study|Withdrawal by Subject|7
7271580|NCT00422292|11485839|FG003|Overall Study|Withdrawal by Subject|13
7271581|NCT00422383|11485854|FG000|Overall Study|Adverse Event|5
7271582|NCT00422383|11485855|FG001|Overall Study|Adverse Event|3
7271583|NCT00422383|11485856|FG002|Overall Study|Adverse Event|1
7271584|NCT00422383|11485857|FG003|Overall Study|Adverse Event|1
7271585|NCT00422383|11485858|FG004|Overall Study|Adverse Event|0
7271586|NCT00422383|11485854|FG000|Overall Study|Lack of Efficacy|4
7271587|NCT00422383|11485855|FG001|Overall Study|Lack of Efficacy|4
7271588|NCT00422383|11485856|FG002|Overall Study|Lack of Efficacy|2
7271589|NCT00422383|11485857|FG003|Overall Study|Lack of Efficacy|1
7271590|NCT00422383|11485858|FG004|Overall Study|Lack of Efficacy|1
7271591|NCT00422383|11485854|FG000|Overall Study|Lost to Follow-up|0
7271592|NCT00422383|11485855|FG001|Overall Study|Lost to Follow-up|1
7271593|NCT00422383|11485856|FG002|Overall Study|Lost to Follow-up|0
7271594|NCT00422383|11485857|FG003|Overall Study|Lost to Follow-up|0
7271595|NCT00422383|11485858|FG004|Overall Study|Lost to Follow-up|1
7271596|NCT00422383|11485854|FG000|Overall Study|Protocol Violation|1
7271597|NCT00422383|11485855|FG001|Overall Study|Protocol Violation|1
7271598|NCT00422383|11485856|FG002|Overall Study|Protocol Violation|1
7271599|NCT00422383|11485857|FG003|Overall Study|Protocol Violation|0
7271600|NCT00422383|11485858|FG004|Overall Study|Protocol Violation|0
7271601|NCT00422383|11485854|FG000|Overall Study|Withdrawal by Subject|5
7271602|NCT00422383|11485855|FG001|Overall Study|Withdrawal by Subject|5
7271603|NCT00422383|11485856|FG002|Overall Study|Withdrawal by Subject|0
7271604|NCT00422383|11485857|FG003|Overall Study|Withdrawal by Subject|0
7271605|NCT00422383|11485858|FG004|Overall Study|Withdrawal by Subject|1
7271606|NCT00422422|11485876|FG000|Overall Study|Lack of Efficacy|1
7271607|NCT00422422|11485876|FG000|Overall Study|Protocol Violation|1
7271608|NCT00422422|11485876|FG000|Overall Study|Withdrawal by Subject|2
7271609|NCT00422422|11485876|FG000|Overall Study|SAE, non-fatal|1
7271610|NCT00422422|11485876|FG000|Overall Study|AE, non-serious non-fatal|5
7271611|NCT00422461|11485890|FG000|Overall Study|Adverse Event|1
7271612|NCT00422461|11485891|FG001|Overall Study|Adverse Event|2
7271613|NCT00422461|11485892|FG002|Overall Study|Adverse Event|1
7271614|NCT00422461|11485893|FG003|Overall Study|Adverse Event|1
7271615|NCT00422461|11485890|FG000|Overall Study|Other|0
7271616|NCT00422461|11485891|FG001|Overall Study|Other|0
7271617|NCT00422461|11485892|FG002|Overall Study|Other|0
7271618|NCT00422461|11485893|FG003|Overall Study|Other|2
7271619|NCT00422461|11485890|FG000|Overall Study|Participants no longer willing to participate in study|1
7271620|NCT00422461|11485891|FG001|Overall Study|Participants no longer willing to participate in study|0
7271621|NCT00422461|11485892|FG002|Overall Study|Participants no longer willing to participate in study|0
7271622|NCT00422461|11485893|FG003|Overall Study|Participants no longer willing to participate in study|0
7271623|NCT00422461|11485890|FG000|Overall Study|Randomized but not treated|1
7271624|NCT00422461|11485891|FG001|Overall Study|Randomized but not treated|1
7271625|NCT00422461|11485892|FG002|Overall Study|Randomized but not treated|0
7271626|NCT00422461|11485893|FG003|Overall Study|Randomized but not treated|0
7271627|NCT00422513|11485905|FG000|Overall Study|Lack of Efficacy|4
7271628|NCT00422513|11485906|FG001|Overall Study|Lack of Efficacy|5
7271629|NCT00422513|11485905|FG000|Overall Study|Protocol Violation|23
7271630|NCT00422513|11485906|FG001|Overall Study|Protocol Violation|7
7271631|NCT00422513|11485905|FG000|Overall Study|Refused Treatment|4
7595166|NCT02862548|12000961|FG000|Randomized Phase (Up to Week 48)|Death|0
7595167|NCT02862548|12000962|FG001|Randomized Phase (Up to Week 48)|Death|1
7595168|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Death|2
7595169|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Death|0
7595170|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1
7595171|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0
7595172|NCT02862548|12000961|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0
7595173|NCT02862548|12000962|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1
7595174|NCT02335099|12000981|FG000|Treatment|Withdrawal by Subject|1
7595175|NCT02335099|12000982|FG001|Treatment|Withdrawal by Subject|3
7595176|NCT02335099|12000981|FG000|Treatment|Lost to Follow-up|2
7595177|NCT02335099|12000982|FG001|Treatment|Lost to Follow-up|0
7595178|NCT02335099|12000981|FG000|Treatment|Death|1
7595179|NCT02335099|12000982|FG001|Treatment|Death|0
7595180|NCT02335099|12000981|FG000|Treatment|Adverse Event|1
7595181|NCT02335099|12000982|FG001|Treatment|Adverse Event|2
7595182|NCT02335099|12000981|FG000|Follow-up|Death|0
7595183|NCT02335099|12000982|FG001|Follow-up|Death|1
7595184|NCT02330562|12000999|FG000|Overall Study|Adverse Event|0
7595185|NCT02330562|12001000|FG001|Overall Study|Adverse Event|0
7595186|NCT02330562|12001001|FG002|Overall Study|Adverse Event|3
7595187|NCT02330562|12001002|FG003|Overall Study|Adverse Event|0
7595188|NCT02330562|12001003|FG004|Overall Study|Adverse Event|3
7595189|NCT02330562|12001004|FG005|Overall Study|Adverse Event|1
7595190|NCT02330562|12001005|FG006|Overall Study|Adverse Event|0
7595191|NCT02330562|12001006|FG007|Overall Study|Adverse Event|0
7595192|NCT02330562|12001007|FG008|Overall Study|Adverse Event|0
7595193|NCT02330562|12001008|FG009|Overall Study|Adverse Event|1
7595194|NCT02330562|12001009|FG010|Overall Study|Adverse Event|1
7595195|NCT02330562|12000999|FG000|Overall Study|Participant decision|1
7595196|NCT02330562|12001000|FG001|Overall Study|Participant decision|0
7595197|NCT02330562|12001001|FG002|Overall Study|Participant decision|4
7595198|NCT02330562|12001002|FG003|Overall Study|Participant decision|1
7595199|NCT02330562|12001003|FG004|Overall Study|Participant decision|5
7595200|NCT02330562|12001004|FG005|Overall Study|Participant decision|2
7595201|NCT02330562|12001005|FG006|Overall Study|Participant decision|0
7595202|NCT02330562|12001006|FG007|Overall Study|Participant decision|0
7595203|NCT02330562|12001007|FG008|Overall Study|Participant decision|0
7595204|NCT02330562|12001008|FG009|Overall Study|Participant decision|3
7595205|NCT02330562|12001009|FG010|Overall Study|Participant decision|0
7595206|NCT02330562|12000999|FG000|Overall Study|Disease progression|5
7595207|NCT02330562|12001000|FG001|Overall Study|Disease progression|3
7595208|NCT02330562|12001001|FG002|Overall Study|Disease progression|20
7595209|NCT02330562|12001002|FG003|Overall Study|Disease progression|28
7595210|NCT02330562|12001003|FG004|Overall Study|Disease progression|23
7595211|NCT02330562|12001004|FG005|Overall Study|Disease progression|7
7595212|NCT02330562|12001005|FG006|Overall Study|Disease progression|1
7595213|NCT02330562|12001006|FG007|Overall Study|Disease progression|1
7595214|NCT02330562|12001007|FG008|Overall Study|Disease progression|1
7595215|NCT02330562|12001008|FG009|Overall Study|Disease progression|0
7595216|NCT02330562|12001009|FG010|Overall Study|Disease progression|5
7595217|NCT02330562|12000999|FG000|Overall Study|Other reasons|0
7595218|NCT02330562|12001000|FG001|Overall Study|Other reasons|0
7595219|NCT02330562|12001001|FG002|Overall Study|Other reasons|0
7595220|NCT02330562|12001002|FG003|Overall Study|Other reasons|1
7595221|NCT02330562|12001003|FG004|Overall Study|Other reasons|0
7595222|NCT02330562|12001004|FG005|Overall Study|Other reasons|0
7595223|NCT02330562|12001005|FG006|Overall Study|Other reasons|0
7595224|NCT02330562|12001006|FG007|Overall Study|Other reasons|0
7595225|NCT02330562|12001007|FG008|Overall Study|Other reasons|0
7595226|NCT02330562|12001008|FG009|Overall Study|Other reasons|0
7595227|NCT02330562|12001009|FG010|Overall Study|Other reasons|0
7595228|NCT02330562|12000999|FG000|Overall Study|Withdrawal by Subject|0
7595229|NCT02330562|12001000|FG001|Overall Study|Withdrawal by Subject|0
7595230|NCT02330562|12001001|FG002|Overall Study|Withdrawal by Subject|0
7595231|NCT02330562|12001002|FG003|Overall Study|Withdrawal by Subject|0
7595232|NCT02330562|12001003|FG004|Overall Study|Withdrawal by Subject|0
7595233|NCT02330562|12001004|FG005|Overall Study|Withdrawal by Subject|0
7595234|NCT02330562|12001005|FG006|Overall Study|Withdrawal by Subject|0
7595235|NCT02330562|12001006|FG007|Overall Study|Withdrawal by Subject|0
7595236|NCT02330562|12001007|FG008|Overall Study|Withdrawal by Subject|0
7595237|NCT02330562|12001008|FG009|Overall Study|Withdrawal by Subject|1
7595238|NCT02330562|12001009|FG010|Overall Study|Withdrawal by Subject|0
7595239|NCT02035137|12001066|FG000|Overall Study|Physician Decision|0
7595240|NCT02035137|12001067|FG001|Overall Study|Physician Decision|0
7595241|NCT02035137|12001068|FG002|Overall Study|Physician Decision|1
7595242|NCT02035137|12001066|FG000|Overall Study|Withdrawal by Subject|0
7595243|NCT02035137|12001067|FG001|Overall Study|Withdrawal by Subject|1
7595244|NCT02035137|12001068|FG002|Overall Study|Withdrawal by Subject|2
7595245|NCT02035137|12001066|FG000|Overall Study|Ineligible|0
7595246|NCT02035137|12001067|FG001|Overall Study|Ineligible|1
7595247|NCT02035137|12001068|FG002|Overall Study|Ineligible|2
7595248|NCT02035137|12001066|FG000|Overall Study|Disease progression prior to treatment start|2
7595249|NCT02035137|12001067|FG001|Overall Study|Disease progression prior to treatment start|0
7595250|NCT02035137|12001068|FG002|Overall Study|Disease progression prior to treatment start|0
7595251|NCT01589523|12001089|FG000|Overall Study|Withdrawal by Subject|1
7595252|NCT00777036|12001109|FG000|On Treatment|Reason Not Specified|4
7595253|NCT00777036|12001110|FG001|On Treatment|Reason Not Specified|7
7595254|NCT00777036|12001111|FG002|On Treatment|Reason Not Specified|12
7595255|NCT00777036|12001109|FG000|On Treatment|Failure to Meet Study Criteria|0
7595256|NCT00777036|12001110|FG001|On Treatment|Failure to Meet Study Criteria|1
7595257|NCT00777036|12001111|FG002|On Treatment|Failure to Meet Study Criteria|0
7595258|NCT00777036|12001109|FG000|On Treatment|Non-compliance with Study Drug|1
7595259|NCT00777036|12001110|FG001|On Treatment|Non-compliance with Study Drug|0
7595260|NCT00777036|12001111|FG002|On Treatment|Non-compliance with Study Drug|0
7595261|NCT00777036|12001109|FG000|On Treatment|Maximum Clinical Benefit|2
7595262|NCT00777036|12001110|FG001|On Treatment|Maximum Clinical Benefit|0
7595263|NCT00777036|12001111|FG002|On Treatment|Maximum Clinical Benefit|1
7595264|NCT00777036|12001109|FG000|On Treatment|Withdrawal by Subject|3
7595265|NCT00777036|12001110|FG001|On Treatment|Withdrawal by Subject|2
7595266|NCT00777036|12001111|FG002|On Treatment|Withdrawal by Subject|3
7595267|NCT00777036|12001109|FG000|On Treatment|Death|0
7595268|NCT00777036|12001110|FG001|On Treatment|Death|2
7595269|NCT00777036|12001111|FG002|On Treatment|Death|0
7595270|NCT00777036|12001109|FG000|On Treatment|Study Drug Toxicity|0
7595271|NCT00777036|12001110|FG001|On Treatment|Study Drug Toxicity|0
7595272|NCT00777036|12001111|FG002|On Treatment|Study Drug Toxicity|1
7595273|NCT00777036|12001109|FG000|On Treatment|Progressive Disease|5
7595274|NCT00777036|12001110|FG001|On Treatment|Progressive Disease|4
7595275|NCT00777036|12001111|FG002|On Treatment|Progressive Disease|6
7595276|NCT00777036|12001109|FG000|Follow-Up|Lost to Follow-up|1
7595277|NCT00777036|12001110|FG001|Follow-Up|Lost to Follow-up|0
7595278|NCT00777036|12001111|FG002|Follow-Up|Lost to Follow-up|0
7595279|NCT00777036|12001109|FG000|Follow-Up|Reason Not Specified|2
7595280|NCT00777036|12001110|FG001|Follow-Up|Reason Not Specified|0
7595281|NCT00777036|12001111|FG002|Follow-Up|Reason Not Specified|0
7595282|NCT00777036|12001109|FG000|Follow-Up|Withdrawal by Subject|1
7595283|NCT00777036|12001110|FG001|Follow-Up|Withdrawal by Subject|0
7595284|NCT00777036|12001111|FG002|Follow-Up|Withdrawal by Subject|4
7595285|NCT00777036|12001109|FG000|Follow-Up|Death|1
7595286|NCT00777036|12001110|FG001|Follow-Up|Death|8
7595287|NCT00777036|12001111|FG002|Follow-Up|Death|0
7627710|NCT03875313|12040405|FG004|Overall Study|Death|1
7627711|NCT03875313|12040401|FG000|Overall Study|Lost to Follow-up|0
7627712|NCT03875313|12040402|FG001|Overall Study|Lost to Follow-up|0
7627713|NCT03875313|12040403|FG002|Overall Study|Lost to Follow-up|0
7627714|NCT03875313|12040404|FG003|Overall Study|Lost to Follow-up|0
7627715|NCT03875313|12040405|FG004|Overall Study|Lost to Follow-up|1
7627716|NCT03875313|12040401|FG000|Overall Study|Study Termination by Sponsor|0
7627717|NCT03875313|12040402|FG001|Overall Study|Study Termination by Sponsor|1
7627718|NCT03875313|12040403|FG002|Overall Study|Study Termination by Sponsor|1
7627719|NCT03875313|12040404|FG003|Overall Study|Study Termination by Sponsor|0
7627720|NCT03875313|12040405|FG004|Overall Study|Study Termination by Sponsor|1
7627721|NCT03875313|12040401|FG000|Overall Study|New Anticancer Treatment|0
7627722|NCT03875313|12040402|FG001|Overall Study|New Anticancer Treatment|1
7627723|NCT03875313|12040403|FG002|Overall Study|New Anticancer Treatment|2
7627724|NCT03875313|12040404|FG003|Overall Study|New Anticancer Treatment|1
7627725|NCT03875313|12040405|FG004|Overall Study|New Anticancer Treatment|0
7627726|NCT03875313|12040401|FG000|Overall Study|Other, Not Specified|2
7627727|NCT03875313|12040402|FG001|Overall Study|Other, Not Specified|11
7627728|NCT03875313|12040403|FG002|Overall Study|Other, Not Specified|3
7627729|NCT03875313|12040404|FG003|Overall Study|Other, Not Specified|3
7627730|NCT03875313|12040405|FG004|Overall Study|Other, Not Specified|1
7627731|NCT03694353|12040417|FG000|Overall Study|Withdrawal by Subject|1
7627732|NCT03694353|12040417|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1
7627733|NCT03583554|12040421|FG000|Period 2|Did not receive treatment due to loss of contact|1
7627734|NCT03583554|12040422|FG001|Period 2|Did not receive treatment due to loss of contact|0
7627735|NCT03583554|12040423|FG002|Period 2|Did not receive treatment due to loss of contact|1
7595288|NCT03703102|12001172|FG000|Overall Study|Adverse Event|4
7595289|NCT03703102|12001173|FG001|Overall Study|Adverse Event|3
7595290|NCT03703102|12001174|FG002|Overall Study|Adverse Event|7
7595291|NCT03703102|12001175|FG003|Overall Study|Adverse Event|3
7595292|NCT03703102|12001176|FG004|Overall Study|Adverse Event|13
7595293|NCT03703102|12001172|FG000|Overall Study|Lack of Efficacy|4
7595294|NCT03703102|12001173|FG001|Overall Study|Lack of Efficacy|0
7595295|NCT03703102|12001174|FG002|Overall Study|Lack of Efficacy|1
7595296|NCT03703102|12001175|FG003|Overall Study|Lack of Efficacy|4
7595297|NCT03703102|12001176|FG004|Overall Study|Lack of Efficacy|1
7595298|NCT03703102|12001172|FG000|Overall Study|Lost to Follow-up|0
7595299|NCT03703102|12001173|FG001|Overall Study|Lost to Follow-up|0
7595300|NCT03703102|12001174|FG002|Overall Study|Lost to Follow-up|1
7595301|NCT03703102|12001175|FG003|Overall Study|Lost to Follow-up|2
7595302|NCT03703102|12001176|FG004|Overall Study|Lost to Follow-up|2
7595303|NCT03703102|12001172|FG000|Overall Study|Physician Decision|2
7595304|NCT03703102|12001173|FG001|Overall Study|Physician Decision|2
7595305|NCT03703102|12001174|FG002|Overall Study|Physician Decision|2
7595306|NCT03703102|12001175|FG003|Overall Study|Physician Decision|2
7595307|NCT03703102|12001176|FG004|Overall Study|Physician Decision|4
7595308|NCT03703102|12001172|FG000|Overall Study|Withdrawal by Subject|7
7595309|NCT03703102|12001173|FG001|Overall Study|Withdrawal by Subject|5
7595310|NCT03703102|12001174|FG002|Overall Study|Withdrawal by Subject|5
7595311|NCT03703102|12001175|FG003|Overall Study|Withdrawal by Subject|5
7595312|NCT03703102|12001176|FG004|Overall Study|Withdrawal by Subject|9
7595313|NCT03703102|12001172|FG000|Overall Study|Ineligibility|0
7595314|NCT03703102|12001173|FG001|Overall Study|Ineligibility|0
7595315|NCT03703102|12001174|FG002|Overall Study|Ineligibility|1
7595316|NCT03703102|12001175|FG003|Overall Study|Ineligibility|0
7595317|NCT03703102|12001176|FG004|Overall Study|Ineligibility|0
7595318|NCT03703102|12001172|FG000|Overall Study|Protocol Deviation|4
7595319|NCT03703102|12001173|FG001|Overall Study|Protocol Deviation|4
7595320|NCT03703102|12001174|FG002|Overall Study|Protocol Deviation|3
7595321|NCT03703102|12001175|FG003|Overall Study|Protocol Deviation|0
7595322|NCT03703102|12001176|FG004|Overall Study|Protocol Deviation|0
7595323|NCT03703102|12001172|FG000|Overall Study|Non-Compliance with Study Drug|1
7595324|NCT03703102|12001173|FG001|Overall Study|Non-Compliance with Study Drug|1
7595325|NCT03703102|12001174|FG002|Overall Study|Non-Compliance with Study Drug|2
7595326|NCT03703102|12001175|FG003|Overall Study|Non-Compliance with Study Drug|1
7595327|NCT03703102|12001176|FG004|Overall Study|Non-Compliance with Study Drug|4
7595373|NCT02514447|12001274|FG007|Overall Study|Sponsor Termination of Study|0
7595374|NCT02514447|12001275|FG008|Overall Study|Sponsor Termination of Study|0
7595375|NCT02514447|12001267|FG000|Overall Study|Study completion per Investigator|1
7595376|NCT02514447|12001268|FG001|Overall Study|Study completion per Investigator|0
7595377|NCT02514447|12001269|FG002|Overall Study|Study completion per Investigator|1
7595378|NCT02514447|12001270|FG003|Overall Study|Study completion per Investigator|2
7595379|NCT02514447|12001271|FG004|Overall Study|Study completion per Investigator|0
7595380|NCT02514447|12001272|FG005|Overall Study|Study completion per Investigator|0
7595381|NCT02514447|12001273|FG006|Overall Study|Study completion per Investigator|0
7595382|NCT02514447|12001274|FG007|Overall Study|Study completion per Investigator|0
7595383|NCT02514447|12001275|FG008|Overall Study|Study completion per Investigator|1
7627736|NCT03408873|12040440|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3
7627737|NCT03408873|12040440|FG000|Visit 2 Assessment|Lost to Follow-up|1
7627738|NCT03408873|12040440|FG000|Visit 3 Assessment|Withdrawal by Subject|1
7627739|NCT03408873|12040440|FG000|Visit 4 Assessment|Lost to Follow-up|2
7627740|NCT03408873|12040440|FG000|Visit 5 Assessment|Lost to Follow-up|1
7627741|NCT03408873|12040440|FG000|Visit 6 Assessment|Withdrawal by Subject|1
7627744|NCT03096288|12040453|FG000|Overall Study|Withdrawal by Subject|0
7627745|NCT03096288|12040454|FG001|Overall Study|Withdrawal by Subject|1
7627746|NCT03096288|12040455|FG002|Overall Study|Withdrawal by Subject|0
7271632|NCT00422513|11485906|FG001|Overall Study|Refused Treatment|2
7271633|NCT00422513|11485905|FG000|Overall Study|Withdrawal by Subject|2
7271634|NCT00422513|11485906|FG001|Overall Study|Withdrawal by Subject|1
7271635|NCT00422513|11485905|FG000|Overall Study|early termination of the study|67
7271636|NCT00422513|11485906|FG001|Overall Study|early termination of the study|80
7271637|NCT00422513|11485905|FG000|Overall Study|Adverse Event|4
7271638|NCT00422513|11485906|FG001|Overall Study|Adverse Event|4
7627747|NCT03096288|12040456|FG003|Overall Study|Withdrawal by Subject|1
7627748|NCT02919436|12040468|FG000|Overall Study|Did not undergo surgery|16
7627749|NCT02919436|12040469|FG001|Overall Study|Did not undergo surgery|20
7627750|NCT02919436|12040468|FG000|Overall Study|Enrolled before trial registration|44
7595328|NCT03395704|12001195|FG000|Overall Study|Adverse Event|2
7595329|NCT03395704|12001196|FG001|Overall Study|Adverse Event|1
7595330|NCT03395704|12001195|FG000|Overall Study|Withdrawal by Subject|2
7595331|NCT03395704|12001196|FG001|Overall Study|Withdrawal by Subject|1
7595332|NCT03395704|12001195|FG000|Overall Study|Physician Decision|0
7595333|NCT03395704|12001196|FG001|Overall Study|Physician Decision|1
7595334|NCT03335813|12001202|FG000|Overall Study|Withdrawal by Subject|1
7595335|NCT03246503|12001206|FG000|Overall Study|Lost to Follow-up|23
7595336|NCT03246503|12001206|FG000|Overall Study|Withdrawal by Subject|20
7595337|NCT03246503|12001206|FG000|Overall Study|Physician Decision|5
7595338|NCT03246503|12001206|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5
7595339|NCT02514447|12001267|FG000|Overall Study|Withdrawal by Subject|3
7595340|NCT02514447|12001268|FG001|Overall Study|Withdrawal by Subject|1
7595341|NCT02514447|12001269|FG002|Overall Study|Withdrawal by Subject|1
7595342|NCT02514447|12001270|FG003|Overall Study|Withdrawal by Subject|0
7595343|NCT02514447|12001271|FG004|Overall Study|Withdrawal by Subject|0
7595344|NCT02514447|12001272|FG005|Overall Study|Withdrawal by Subject|0
7595345|NCT02514447|12001273|FG006|Overall Study|Withdrawal by Subject|0
7595346|NCT02514447|12001274|FG007|Overall Study|Withdrawal by Subject|1
7595347|NCT02514447|12001275|FG008|Overall Study|Withdrawal by Subject|1
7595348|NCT02514447|12001267|FG000|Overall Study|Death|24
7595349|NCT02514447|12001268|FG001|Overall Study|Death|28
7595350|NCT02514447|12001269|FG002|Overall Study|Death|29
7595351|NCT02514447|12001270|FG003|Overall Study|Death|0
7595352|NCT02514447|12001271|FG004|Overall Study|Death|3
7595353|NCT02514447|12001272|FG005|Overall Study|Death|4
7595354|NCT02514447|12001273|FG006|Overall Study|Death|8
7595355|NCT02514447|12001274|FG007|Overall Study|Death|6
7595356|NCT02514447|12001275|FG008|Overall Study|Death|5
7595357|NCT02514447|12001267|FG000|Overall Study|Lost to Follow-up|1
7595358|NCT02514447|12001268|FG001|Overall Study|Lost to Follow-up|0
7595359|NCT02514447|12001269|FG002|Overall Study|Lost to Follow-up|0
7595360|NCT02514447|12001270|FG003|Overall Study|Lost to Follow-up|0
7595361|NCT02514447|12001271|FG004|Overall Study|Lost to Follow-up|0
7595362|NCT02514447|12001272|FG005|Overall Study|Lost to Follow-up|0
7595363|NCT02514447|12001273|FG006|Overall Study|Lost to Follow-up|0
7595364|NCT02514447|12001274|FG007|Overall Study|Lost to Follow-up|0
7595365|NCT02514447|12001275|FG008|Overall Study|Lost to Follow-up|1
7595366|NCT02514447|12001267|FG000|Overall Study|Sponsor Termination of Study|0
7595367|NCT02514447|12001268|FG001|Overall Study|Sponsor Termination of Study|1
7595368|NCT02514447|12001269|FG002|Overall Study|Sponsor Termination of Study|1
7595369|NCT02514447|12001270|FG003|Overall Study|Sponsor Termination of Study|0
7595370|NCT02514447|12001271|FG004|Overall Study|Sponsor Termination of Study|0
7595371|NCT02514447|12001272|FG005|Overall Study|Sponsor Termination of Study|0
7595372|NCT02514447|12001273|FG006|Overall Study|Sponsor Termination of Study|0
7595384|NCT01785563|12001319|FG000|Overall Study|Physician Decision|10
7595385|NCT01785563|12001319|FG000|Overall Study|Withdrawal by Subject|1
7595386|NCT01785563|12001319|FG000|Overall Study|Protocol Violation|2
7595387|NCT01434290|12001334|FG000|Overall Study|Protocol Violation|6
7595388|NCT01434290|12001335|FG001|Overall Study|Protocol Violation|3
7595389|NCT01434290|12001334|FG000|Overall Study|No protocol treatment|2
7595390|NCT01434290|12001335|FG001|Overall Study|No protocol treatment|4
7595391|NCT01062399|12001347|FG000|Overall Study|Protocol Violation|0
7595392|NCT01062399|12001348|FG001|Overall Study|Protocol Violation|1
7595393|NCT01062399|12001349|FG002|Overall Study|Protocol Violation|0
7595394|NCT01062399|12001350|FG003|Overall Study|Protocol Violation|6
7595395|NCT01062399|12001351|FG004|Overall Study|Protocol Violation|4
7595396|NCT00750269|12001368|FG000|Overall Study|Protocol Violation|0
7595397|NCT00750269|12001369|FG001|Overall Study|Protocol Violation|1
7595398|NCT00750269|12001370|FG002|Overall Study|Protocol Violation|1
7595399|NCT00750269|12001371|FG003|Overall Study|Protocol Violation|2
7595400|NCT00750269|12001372|FG004|Overall Study|Protocol Violation|4
7595401|NCT00750269|12001368|FG000|Overall Study|Withdrawal by Subject|0
7595402|NCT00750269|12001369|FG001|Overall Study|Withdrawal by Subject|0
7595403|NCT00750269|12001370|FG002|Overall Study|Withdrawal by Subject|2
7595404|NCT00750269|12001371|FG003|Overall Study|Withdrawal by Subject|2
7595405|NCT00750269|12001372|FG004|Overall Study|Withdrawal by Subject|2
7595406|NCT00750269|12001368|FG000|Overall Study|Physician Decision|0
7595407|NCT00750269|12001369|FG001|Overall Study|Physician Decision|0
7595408|NCT00750269|12001370|FG002|Overall Study|Physician Decision|0
7595409|NCT00750269|12001371|FG003|Overall Study|Physician Decision|0
7595410|NCT00750269|12001372|FG004|Overall Study|Physician Decision|2
7595411|NCT00750269|12001368|FG000|Overall Study|Patient too large for positioning|0
7595412|NCT00750269|12001369|FG001|Overall Study|Patient too large for positioning|0
7595413|NCT00750269|12001370|FG002|Overall Study|Patient too large for positioning|1
7595414|NCT00750269|12001371|FG003|Overall Study|Patient too large for positioning|0
7595415|NCT00750269|12001372|FG004|Overall Study|Patient too large for positioning|0
7595416|NCT00750269|12001368|FG000|Overall Study|Site error|0
7595417|NCT00750269|12001369|FG001|Overall Study|Site error|0
7595418|NCT00750269|12001370|FG002|Overall Study|Site error|0
7595419|NCT00750269|12001371|FG003|Overall Study|Site error|1
7595420|NCT00750269|12001372|FG004|Overall Study|Site error|0
7595421|NCT00750269|12001368|FG000|Overall Study|SBRT plan could not be drawn|0
7595422|NCT00750269|12001369|FG001|Overall Study|SBRT plan could not be drawn|0
7595423|NCT00750269|12001370|FG002|Overall Study|SBRT plan could not be drawn|0
7595424|NCT00750269|12001371|FG003|Overall Study|SBRT plan could not be drawn|0
7595425|NCT00750269|12001372|FG004|Overall Study|SBRT plan could not be drawn|1
7595426|NCT00750269|12001368|FG000|Overall Study|Fiducials could not be placed|0
7595427|NCT00750269|12001369|FG001|Overall Study|Fiducials could not be placed|0
7595428|NCT00750269|12001370|FG002|Overall Study|Fiducials could not be placed|0
7595429|NCT00750269|12001371|FG003|Overall Study|Fiducials could not be placed|0
7595430|NCT00750269|12001372|FG004|Overall Study|Fiducials could not be placed|1
7595431|NCT00712322|12001394|FG000|Overall Study|Protocol deviation|0
7595432|NCT00712322|12001395|FG001|Overall Study|Protocol deviation|1
7595433|NCT00712322|12001396|FG002|Overall Study|Protocol deviation|0
7595434|NCT00323856|12001404|FG000|Overall Study|Withdrawal by Subject|1
7595435|NCT00323856|12001404|FG000|Overall Study|Was uncooperative and noncompliant|1
7595436|NCT00323856|12001404|FG000|Overall Study|Reason not specified|1
7595437|NCT00323856|12001404|FG000|Overall Study|Missing|2
7595438|NCT00103038|12001408|FG000|Overall Study|Withdrawal by Subject|8
7595439|NCT00103038|12001408|FG000|Overall Study|Screen failure|3
7595440|NCT00103038|12001408|FG000|Overall Study|Death|1
7595441|NCT00103038|12001408|FG000|Overall Study|Physician Decision|1
7595442|NCT04524663|12001424|FG000|Overall Study|Withdrawal by Subject|0
7595443|NCT04524663|12001425|FG001|Overall Study|Withdrawal by Subject|2
7627751|NCT02919436|12040469|FG001|Overall Study|Enrolled before trial registration|33
7627752|NCT02028884|12040483|FG000|Double-blind Period|Adverse Event|5
7627753|NCT02028884|12040484|FG001|Double-blind Period|Adverse Event|3
7627754|NCT02028884|12040483|FG000|Double-blind Period|Eligibility Violation|1
7627755|NCT02028884|12040484|FG001|Double-blind Period|Eligibility Violation|0
7627756|NCT02028884|12040483|FG000|Double-blind Period|Non-Compliance With Study Drug|2
7627757|NCT02028884|12040484|FG001|Double-blind Period|Non-Compliance With Study Drug|0
7627758|NCT02028884|12040483|FG000|Double-blind Period|Withdrawal by Subject|2
7627759|NCT02028884|12040484|FG001|Double-blind Period|Withdrawal by Subject|0
7627760|NCT02028884|12040483|FG000|Double-blind Period|On-going in Study|8
7627761|NCT02028884|12040484|FG001|Double-blind Period|On-going in Study|20
7627762|NCT02028884|12040483|FG000|Open-label Extension Period|Adverse Event|2
7627763|NCT02028884|12040484|FG001|Open-label Extension Period|Adverse Event|1
7627764|NCT02028884|12040483|FG000|Open-label Extension Period|Lack of Efficacy|3
7595460|NCT03738423|12001481|FG000|Overall Study|Withdrawal by Subject|9
7595461|NCT03738423|12001482|FG001|Overall Study|Withdrawal by Subject|12
7595462|NCT03738423|12001483|FG002|Overall Study|Withdrawal by Subject|9
7595463|NCT03738423|12001484|FG003|Overall Study|Withdrawal by Subject|12
7595464|NCT03738423|12001485|FG004|Overall Study|Withdrawal by Subject|10
7595465|NCT03738423|12001481|FG000|Overall Study|Lack of Efficacy|3
7595466|NCT03738423|12001482|FG001|Overall Study|Lack of Efficacy|1
7595467|NCT03738423|12001483|FG002|Overall Study|Lack of Efficacy|1
7595468|NCT03738423|12001484|FG003|Overall Study|Lack of Efficacy|1
7595469|NCT03738423|12001485|FG004|Overall Study|Lack of Efficacy|2
7595470|NCT03738423|12001481|FG000|Overall Study|Lost to Follow-up|1
7595471|NCT03738423|12001482|FG001|Overall Study|Lost to Follow-up|0
7595472|NCT03738423|12001483|FG002|Overall Study|Lost to Follow-up|1
7595473|NCT03738423|12001484|FG003|Overall Study|Lost to Follow-up|1
7595474|NCT03738423|12001485|FG004|Overall Study|Lost to Follow-up|0
7595475|NCT03738423|12001481|FG000|Overall Study|Protocol Violation|1
7595476|NCT03738423|12001482|FG001|Overall Study|Protocol Violation|0
7595477|NCT03738423|12001483|FG002|Overall Study|Protocol Violation|0
7595478|NCT03738423|12001484|FG003|Overall Study|Protocol Violation|0
7595479|NCT03738423|12001485|FG004|Overall Study|Protocol Violation|1
7595480|NCT03738423|12001481|FG000|Overall Study|Physician Decision|0
7595481|NCT03738423|12001482|FG001|Overall Study|Physician Decision|0
7595482|NCT03738423|12001483|FG002|Overall Study|Physician Decision|1
7595483|NCT03738423|12001484|FG003|Overall Study|Physician Decision|0
7595484|NCT03738423|12001485|FG004|Overall Study|Physician Decision|1
7595485|NCT03738423|12001481|FG000|Overall Study|Death|0
7595486|NCT03738423|12001482|FG001|Overall Study|Death|0
7595487|NCT03738423|12001483|FG002|Overall Study|Death|0
7595488|NCT03738423|12001484|FG003|Overall Study|Death|0
7595489|NCT03738423|12001485|FG004|Overall Study|Death|1
7595490|NCT03738423|12001481|FG000|Overall Study|Randomized but never treated|0
7595491|NCT03738423|12001482|FG001|Overall Study|Randomized but never treated|0
7595492|NCT03738423|12001483|FG002|Overall Study|Randomized but never treated|1
7595493|NCT03738423|12001484|FG003|Overall Study|Randomized but never treated|1
7595494|NCT03738423|12001485|FG004|Overall Study|Randomized but never treated|0
7595495|NCT03600818|12001499|FG000|Overall Study|Adverse Event|4
7595496|NCT03600818|12001500|FG001|Overall Study|Adverse Event|7
7595497|NCT03600818|12001499|FG000|Overall Study|Lack of Efficacy|9
7595498|NCT03600818|12001500|FG001|Overall Study|Lack of Efficacy|4
7595499|NCT03600818|12001499|FG000|Overall Study|Withdrawal by Subject|4
7595500|NCT03600818|12001500|FG001|Overall Study|Withdrawal by Subject|3
7595501|NCT03600818|12001499|FG000|Overall Study|Other-unspecified|5
7595502|NCT03600818|12001500|FG001|Overall Study|Other-unspecified|3
7595503|NCT03600818|12001499|FG000|Overall Study|Randomized and not treated|0
7595504|NCT03600818|12001500|FG001|Overall Study|Randomized and not treated|1
7595505|NCT03578276|12001509|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2
7595506|NCT03578276|12001510|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2
7595507|NCT03035409|12001525|FG000|Overall Study|Adverse Event|5
7595508|NCT03035409|12001525|FG000|Overall Study|Death|2
7595509|NCT03035409|12001525|FG000|Overall Study|Withdrawal by Subject|2
7595510|NCT03035409|12001525|FG000|Overall Study|Non compliance|4
7595511|NCT03035409|12001525|FG000|Overall Study|Patient was jittery|1
7595512|NCT03035409|12001525|FG000|Overall Study|Did not like Questionnaire|1
7595513|NCT03035409|12001525|FG000|Overall Study|Aspartate Aminotransferase increased|1
7595514|NCT03035409|12001525|FG000|Overall Study|Did not like taking drugs|1
7595515|NCT02971761|12001529|FG000|Overall Study|GTx-024 drug supply was withdrawn|2
7627765|NCT02028884|12040484|FG001|Open-label Extension Period|Lack of Efficacy|0
7627766|NCT02028884|12040483|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
7627767|NCT02028884|12040484|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
7627768|NCT02028884|12040483|FG000|Open-label Extension Period|Withdrawal by Subject|0
7627769|NCT02028884|12040484|FG001|Open-label Extension Period|Withdrawal by Subject|2
7627770|NCT02028884|12040483|FG000|Open-label Extension Period|On-going in Study|19
7627771|NCT02028884|12040484|FG001|Open-label Extension Period|On-going in Study|14
7627772|NCT01983774|12040495|FG000|Overall Study|Lung Transplant|0
7627773|NCT01983774|12040496|FG001|Overall Study|Lung Transplant|1
7627774|NCT01983774|12040495|FG000|Overall Study|Lost to Follow-up|1
7627775|NCT01983774|12040496|FG001|Overall Study|Lost to Follow-up|0
7627776|NCT01974206|12040506|FG000|Overall Study|Did Not Take Study Drug|0
7627777|NCT01974206|12040507|FG001|Overall Study|Did Not Take Study Drug|1
7627778|NCT01974206|12040506|FG000|Overall Study|Physician Decision|1
7627779|NCT01974206|12040507|FG001|Overall Study|Physician Decision|0
7627780|NCT01974206|12040506|FG000|Overall Study|Withdrawal by Subject|3
7627781|NCT01974206|12040507|FG001|Overall Study|Withdrawal by Subject|0
7627782|NCT01974206|12040506|FG000|Overall Study|Lost to Follow-up|1
7627783|NCT01974206|12040507|FG001|Overall Study|Lost to Follow-up|0
7627784|NCT01974206|12040506|FG000|Overall Study|Death|1
7627785|NCT01974206|12040507|FG001|Overall Study|Death|0
7627786|NCT01970865|12040530|FG000|Overall Study|Death|3
7627787|NCT01970865|12040531|FG001|Overall Study|Death|1
7627788|NCT01970865|12040532|FG002|Overall Study|Death|3
7627789|NCT01970865|12040533|FG003|Overall Study|Death|4
7627790|NCT01970865|12040534|FG004|Overall Study|Death|6
7627791|NCT01970865|12040535|FG005|Overall Study|Death|3
7627792|NCT01970865|12040536|FG006|Overall Study|Death|1
7627793|NCT01970865|12040537|FG007|Overall Study|Death|3
7627794|NCT01970865|12040538|FG008|Overall Study|Death|2
7627795|NCT01970865|12040539|FG009|Overall Study|Death|1
7627796|NCT01970865|12040540|FG010|Overall Study|Death|1
7627797|NCT01970865|12040541|FG011|Overall Study|Death|4
7627798|NCT01970865|12040542|FG012|Overall Study|Death|14
7627799|NCT01970865|12040543|FG013|Overall Study|Death|19
7627800|NCT01970865|12040544|FG014|Overall Study|Death|15
7627801|NCT01970865|12040545|FG015|Overall Study|Death|10
7627802|NCT01970865|12040546|FG016|Overall Study|Death|1
7627803|NCT01970865|12040530|FG000|Overall Study|Lost to Follow-up|0
7627804|NCT01970865|12040531|FG001|Overall Study|Lost to Follow-up|0
7627805|NCT01970865|12040532|FG002|Overall Study|Lost to Follow-up|0
7627806|NCT01970865|12040533|FG003|Overall Study|Lost to Follow-up|1
7627807|NCT01970865|12040534|FG004|Overall Study|Lost to Follow-up|1
7627808|NCT01970865|12040535|FG005|Overall Study|Lost to Follow-up|0
7627809|NCT01970865|12040536|FG006|Overall Study|Lost to Follow-up|0
7627810|NCT01970865|12040537|FG007|Overall Study|Lost to Follow-up|0
7627811|NCT01970865|12040538|FG008|Overall Study|Lost to Follow-up|0
7627812|NCT01970865|12040539|FG009|Overall Study|Lost to Follow-up|0
7627813|NCT01970865|12040540|FG010|Overall Study|Lost to Follow-up|0
7627814|NCT01970865|12040541|FG011|Overall Study|Lost to Follow-up|0
7627815|NCT01970865|12040542|FG012|Overall Study|Lost to Follow-up|1
7627816|NCT01970865|12040543|FG013|Overall Study|Lost to Follow-up|0
7627817|NCT01970865|12040544|FG014|Overall Study|Lost to Follow-up|0
7627818|NCT01970865|12040545|FG015|Overall Study|Lost to Follow-up|0
7627819|NCT01970865|12040546|FG016|Overall Study|Lost to Follow-up|0
7595528|NCT01968213|12001570|FG000|Overall Study|Ongoing|90
7595529|NCT01968213|12001571|FG001|Overall Study|Ongoing|9
7595536|NCT01627574|12001595|FG000|Overall Study|Withdrawal by Subject|8
7595537|NCT01627574|12001596|FG001|Overall Study|Withdrawal by Subject|5
7595538|NCT01627574|12001595|FG000|Overall Study|Lost to Follow-up|13
7595539|NCT01627574|12001596|FG001|Overall Study|Lost to Follow-up|13
7595540|NCT01498458|12001602|FG000|Overall Study|Adverse Event|4
7595541|NCT01498458|12001602|FG000|Overall Study|Physician Decision|3
7595542|NCT01427712|12001611|FG000|Overall Study|Transfer to a different hospital|2
7595543|NCT01427712|12001611|FG000|Overall Study|Lost to Follow-up|1
7595544|NCT01427712|12001611|FG000|Overall Study|Aggravation of cystic fibrosis|3
7595545|NCT01427712|12001611|FG000|Overall Study|Failure to visit|1
7595546|NCT01369147|12001618|FG000|Overall Study|All collected data were unintentionally destroyed|0
7595547|NCT01369147|12001619|FG001|Overall Study|All collected data were unintentionally destroyed|1
7595548|NCT01369147|12001620|FG002|Overall Study|All collected data were unintentionally destroyed|0
7595549|NCT01097746|12001628|FG000|Overall Study|Adverse Event|4
7595550|NCT01097746|12001628|FG000|Overall Study|taken off study before any treatment given|1
7595551|NCT01079780|12001635|FG000|Overall Study|Disease progression|43
7595552|NCT01079780|12001636|FG001|Overall Study|Disease progression|7
7595553|NCT01079780|12001637|FG002|Overall Study|Disease progression|31
7595554|NCT01079780|12001635|FG000|Overall Study|Adverse Event|13
7595555|NCT01079780|12001636|FG001|Overall Study|Adverse Event|5
7595556|NCT01079780|12001637|FG002|Overall Study|Adverse Event|7
7595557|NCT01079780|12001635|FG000|Overall Study|Death|2
7595558|NCT01079780|12001636|FG001|Overall Study|Death|0
7595559|NCT01079780|12001637|FG002|Overall Study|Death|2
7595560|NCT01079780|12001635|FG000|Overall Study|Withdrawal by Subject|6
7595561|NCT01079780|12001636|FG001|Overall Study|Withdrawal by Subject|4
7595562|NCT01079780|12001637|FG002|Overall Study|Withdrawal by Subject|4
7595563|NCT01079780|12001635|FG000|Overall Study|Alternative therapy|2
7595564|NCT01079780|12001636|FG001|Overall Study|Alternative therapy|0
7595565|NCT01079780|12001637|FG002|Overall Study|Alternative therapy|2
7595566|NCT01079780|12001635|FG000|Overall Study|Physician Decision|1
7595567|NCT01079780|12001636|FG001|Overall Study|Physician Decision|0
7595568|NCT01079780|12001637|FG002|Overall Study|Physician Decision|1
7595569|NCT01079780|12001635|FG000|Overall Study|Error made in lesion measurement|1
7595570|NCT01079780|12001636|FG001|Overall Study|Error made in lesion measurement|0
7595571|NCT01079780|12001637|FG002|Overall Study|Error made in lesion measurement|0
7595572|NCT01079780|12001635|FG000|Overall Study|Patient had surgery|1
7595573|NCT01079780|12001636|FG001|Overall Study|Patient had surgery|0
7595574|NCT01079780|12001637|FG002|Overall Study|Patient had surgery|0
7595575|NCT01079780|12001635|FG000|Overall Study|Treatment cycle delay|0
7595576|NCT01079780|12001636|FG001|Overall Study|Treatment cycle delay|0
7595577|NCT01079780|12001637|FG002|Overall Study|Treatment cycle delay|1
7595578|NCT01079780|12001635|FG000|Overall Study|Never started treatment|1
7595579|NCT01079780|12001636|FG001|Overall Study|Never started treatment|0
7595580|NCT01079780|12001637|FG002|Overall Study|Never started treatment|2
7595581|NCT00075946|12001649|FG000|Overall Study|Path ineligible: undetermined histology|0
7595582|NCT00075946|12001650|FG001|Overall Study|Path ineligible: undetermined histology|0
7595583|NCT00075946|12001651|FG002|Overall Study|Path ineligible: undetermined histology|0
7595584|NCT00075946|12001652|FG003|Overall Study|Path ineligible: undetermined histology|0
7595585|NCT00075946|12001653|FG004|Overall Study|Path ineligible: undetermined histology|6
7595586|NCT00075946|12001649|FG000|Overall Study|Did not achieve response after induction|0
7595587|NCT00075946|12001650|FG001|Overall Study|Did not achieve response after induction|0
7595588|NCT00075946|12001651|FG002|Overall Study|Did not achieve response after induction|0
7595589|NCT00075946|12001652|FG003|Overall Study|Did not achieve response after induction|0
7595590|NCT00075946|12001653|FG004|Overall Study|Did not achieve response after induction|182
7595591|NCT00075946|12001649|FG000|Overall Study|Incorrectly randomized (no response)|5
7595592|NCT00075946|12001650|FG001|Overall Study|Incorrectly randomized (no response)|5
7595593|NCT00075946|12001651|FG002|Overall Study|Incorrectly randomized (no response)|5
7595594|NCT00075946|12001652|FG003|Overall Study|Incorrectly randomized (no response)|1
7595595|NCT00075946|12001653|FG004|Overall Study|Incorrectly randomized (no response)|0
7595596|NCT00075946|12001649|FG000|Overall Study|Still on treatment at time of analysis|52
7595597|NCT00075946|12001650|FG001|Overall Study|Still on treatment at time of analysis|19
7595598|NCT00075946|12001651|FG002|Overall Study|Still on treatment at time of analysis|3
7595599|NCT00075946|12001652|FG003|Overall Study|Still on treatment at time of analysis|9
7595600|NCT00075946|12001653|FG004|Overall Study|Still on treatment at time of analysis|0
7595601|NCT00075946|12001649|FG000|Overall Study|Adverse Event|2
7595602|NCT00075946|12001650|FG001|Overall Study|Adverse Event|10
7595603|NCT00075946|12001651|FG002|Overall Study|Adverse Event|0
7595604|NCT00075946|12001652|FG003|Overall Study|Adverse Event|2
7595605|NCT00075946|12001653|FG004|Overall Study|Adverse Event|0
7595606|NCT00075946|12001649|FG000|Overall Study|Death|0
7595607|NCT00075946|12001650|FG001|Overall Study|Death|1
7595608|NCT00075946|12001651|FG002|Overall Study|Death|0
7595609|NCT00075946|12001652|FG003|Overall Study|Death|0
7595610|NCT00075946|12001653|FG004|Overall Study|Death|0
7595611|NCT00075946|12001649|FG000|Overall Study|Withdrawal by Subject|23
7595612|NCT00075946|12001650|FG001|Overall Study|Withdrawal by Subject|58
7595613|NCT00075946|12001651|FG002|Overall Study|Withdrawal by Subject|4
7595614|NCT00075946|12001652|FG003|Overall Study|Withdrawal by Subject|9
7595615|NCT00075946|12001653|FG004|Overall Study|Withdrawal by Subject|0
7595616|NCT00075946|12001649|FG000|Overall Study|Alternative therapy|16
7595617|NCT00075946|12001650|FG001|Overall Study|Alternative therapy|2
7595618|NCT00075946|12001651|FG002|Overall Study|Alternative therapy|5
7595619|NCT00075946|12001652|FG003|Overall Study|Alternative therapy|0
7595620|NCT00075946|12001653|FG004|Overall Study|Alternative therapy|0
7595621|NCT00075946|12001649|FG000|Overall Study|Other complicating disease|7
7595622|NCT00075946|12001650|FG001|Overall Study|Other complicating disease|13
7595623|NCT00075946|12001651|FG002|Overall Study|Other complicating disease|1
7595624|NCT00075946|12001652|FG003|Overall Study|Other complicating disease|4
7595625|NCT00075946|12001653|FG004|Overall Study|Other complicating disease|0
7595626|NCT00075946|12001649|FG000|Overall Study|No response to retreatment|23
7595627|NCT00075946|12001650|FG001|Overall Study|No response to retreatment|0
7595628|NCT00075946|12001651|FG002|Overall Study|No response to retreatment|2
7595629|NCT00075946|12001652|FG003|Overall Study|No response to retreatment|0
7595630|NCT00075946|12001653|FG004|Overall Study|No response to retreatment|0
7595631|NCT00075946|12001649|FG000|Overall Study|Time to progression less than 6 months|15
7595632|NCT00075946|12001650|FG001|Overall Study|Time to progression less than 6 months|30
7595633|NCT00075946|12001651|FG002|Overall Study|Time to progression less than 6 months|8
7595634|NCT00075946|12001652|FG003|Overall Study|Time to progression less than 6 months|3
7595635|NCT00075946|12001653|FG004|Overall Study|Time to progression less than 6 months|0
7595636|NCT00075946|12001649|FG000|Overall Study|Other|5
7595637|NCT00075946|12001650|FG001|Overall Study|Other|13
7271639|NCT00422513|11485905|FG000|Overall Study|Death|3
7271640|NCT00422513|11485906|FG001|Overall Study|Death|7
7595638|NCT00075946|12001651|FG002|Overall Study|Other|0
7595639|NCT00075946|12001652|FG003|Overall Study|Other|2
7595640|NCT00075946|12001653|FG004|Overall Study|Other|0
7595641|NCT00003641|12001666|FG000|Overall Study|Withdrawal by Subject|0
7595642|NCT00003641|12001667|FG001|Overall Study|Withdrawal by Subject|100
7595643|NCT00003641|12001666|FG000|Overall Study|Adverse Event|0
7595644|NCT00003641|12001667|FG001|Overall Study|Adverse Event|38
7595645|NCT00003641|12001666|FG000|Overall Study|Disease progression|0
7595646|NCT00003641|12001667|FG001|Overall Study|Disease progression|2
7595647|NCT00003641|12001666|FG000|Overall Study|Unknown/missing|0
7595648|NCT00003641|12001667|FG001|Overall Study|Unknown/missing|22
7595649|NCT00003641|12001666|FG000|Overall Study|Should not receive interferon therapy|2
7595650|NCT00003641|12001667|FG001|Overall Study|Should not receive interferon therapy|0
7595651|NCT00003641|12001666|FG000|Overall Study|Never started interferon|567
7595652|NCT00003641|12001667|FG001|Overall Study|Never started interferon|12
7627820|NCT01970865|12040530|FG000|Overall Study|Withdrawal by Subject|0
7627821|NCT01970865|12040531|FG001|Overall Study|Withdrawal by Subject|0
7627822|NCT01970865|12040532|FG002|Overall Study|Withdrawal by Subject|0
7627823|NCT01970865|12040533|FG003|Overall Study|Withdrawal by Subject|1
7627824|NCT01970865|12040534|FG004|Overall Study|Withdrawal by Subject|2
7627825|NCT01970865|12040535|FG005|Overall Study|Withdrawal by Subject|0
7627826|NCT01970865|12040536|FG006|Overall Study|Withdrawal by Subject|0
7627827|NCT01970865|12040537|FG007|Overall Study|Withdrawal by Subject|0
7627828|NCT01970865|12040538|FG008|Overall Study|Withdrawal by Subject|0
7627829|NCT01970865|12040539|FG009|Overall Study|Withdrawal by Subject|0
7627830|NCT01970865|12040540|FG010|Overall Study|Withdrawal by Subject|0
7627831|NCT01970865|12040541|FG011|Overall Study|Withdrawal by Subject|1
7627832|NCT01970865|12040542|FG012|Overall Study|Withdrawal by Subject|2
7627833|NCT01970865|12040543|FG013|Overall Study|Withdrawal by Subject|5
7627834|NCT01970865|12040544|FG014|Overall Study|Withdrawal by Subject|2
7627835|NCT01970865|12040545|FG015|Overall Study|Withdrawal by Subject|7
7627836|NCT01970865|12040546|FG016|Overall Study|Withdrawal by Subject|0
7627837|NCT01970865|12040530|FG000|Overall Study|Other|0
7627838|NCT01970865|12040531|FG001|Overall Study|Other|0
7627839|NCT01970865|12040532|FG002|Overall Study|Other|0
7627840|NCT01970865|12040533|FG003|Overall Study|Other|1
7627841|NCT01970865|12040534|FG004|Overall Study|Other|0
7627842|NCT01970865|12040535|FG005|Overall Study|Other|0
7627843|NCT01970865|12040536|FG006|Overall Study|Other|0
7627844|NCT01970865|12040537|FG007|Overall Study|Other|0
7627845|NCT01970865|12040538|FG008|Overall Study|Other|0
7627846|NCT01970865|12040539|FG009|Overall Study|Other|0
7627847|NCT01970865|12040540|FG010|Overall Study|Other|0
7627848|NCT01970865|12040541|FG011|Overall Study|Other|0
7627849|NCT01970865|12040542|FG012|Overall Study|Other|0
7627850|NCT01970865|12040543|FG013|Overall Study|Other|1
7627851|NCT01970865|12040544|FG014|Overall Study|Other|0
7627852|NCT01970865|12040545|FG015|Overall Study|Other|1
7627853|NCT01970865|12040546|FG016|Overall Study|Other|0
7627854|NCT01970865|12040530|FG000|Overall Study|Study ongoing|0
7627855|NCT01970865|12040531|FG001|Overall Study|Study ongoing|2
7627856|NCT01970865|12040532|FG002|Overall Study|Study ongoing|0
7627857|NCT01970865|12040533|FG003|Overall Study|Study ongoing|6
7627858|NCT01970865|12040534|FG004|Overall Study|Study ongoing|8
7627859|NCT01970865|12040535|FG005|Overall Study|Study ongoing|0
7627860|NCT01970865|12040536|FG006|Overall Study|Study ongoing|2
7627861|NCT01970865|12040537|FG007|Overall Study|Study ongoing|0
7627862|NCT01970865|12040538|FG008|Overall Study|Study ongoing|1
7627863|NCT01970865|12040539|FG009|Overall Study|Study ongoing|3
7627864|NCT01970865|12040540|FG010|Overall Study|Study ongoing|29
7627865|NCT01970865|12040541|FG011|Overall Study|Study ongoing|22
7627866|NCT01970865|12040542|FG012|Overall Study|Study ongoing|43
7627867|NCT01970865|12040543|FG013|Overall Study|Study ongoing|41
7627868|NCT01970865|12040544|FG014|Overall Study|Study ongoing|29
7627869|NCT01970865|12040545|FG015|Overall Study|Study ongoing|29
7627870|NCT01970865|12040546|FG016|Overall Study|Study ongoing|2
7627871|NCT00589420|12040607|FG000|Overall Study|screen failure|1
7595653|NCT01956669|12001680|FG000|Overall Study|Disease Progression|12
7595654|NCT01956669|12001681|FG001|Overall Study|Disease Progression|7
7595655|NCT01956669|12001682|FG002|Overall Study|Disease Progression|7
7271641|NCT00422591|11485912|FG000|Overall Study|Physician Decision|4
7271642|NCT00422591|11485912|FG000|Overall Study|Withdrawal by Subject|2
7271643|NCT00422734|11485931|FG000|Overall Study|Physician Decision|1
7271644|NCT00422734|11485932|FG001|Overall Study|Physician Decision|1
7271645|NCT00422734|11485931|FG000|Overall Study|Protocol Violation|1
7595656|NCT01956669|12001683|FG003|Overall Study|Disease Progression|8
7595657|NCT01956669|12001684|FG004|Overall Study|Disease Progression|4
7595658|NCT01956669|12001685|FG005|Overall Study|Disease Progression|3
7595659|NCT01956669|12001686|FG006|Overall Study|Disease Progression|5
7595660|NCT01956669|12001680|FG000|Overall Study|Adverse Event|0
7595661|NCT01956669|12001681|FG001|Overall Study|Adverse Event|2
7595662|NCT01956669|12001682|FG002|Overall Study|Adverse Event|2
7595663|NCT01956669|12001683|FG003|Overall Study|Adverse Event|1
7595664|NCT01956669|12001684|FG004|Overall Study|Adverse Event|0
7595665|NCT01956669|12001685|FG005|Overall Study|Adverse Event|0
7595666|NCT01956669|12001686|FG006|Overall Study|Adverse Event|0
7595667|NCT01956669|12001680|FG000|Overall Study|Physician Decision|0
7595668|NCT01956669|12001681|FG001|Overall Study|Physician Decision|2
7595669|NCT01956669|12001682|FG002|Overall Study|Physician Decision|0
7595670|NCT01956669|12001683|FG003|Overall Study|Physician Decision|0
7595671|NCT01956669|12001684|FG004|Overall Study|Physician Decision|0
7595672|NCT01956669|12001685|FG005|Overall Study|Physician Decision|1
7595673|NCT01956669|12001686|FG006|Overall Study|Physician Decision|0
7595674|NCT01956669|12001680|FG000|Overall Study|Withdrawal by Subject|0
7595675|NCT01956669|12001681|FG001|Overall Study|Withdrawal by Subject|0
7595676|NCT01956669|12001682|FG002|Overall Study|Withdrawal by Subject|1
7595677|NCT01956669|12001683|FG003|Overall Study|Withdrawal by Subject|1
7595678|NCT01956669|12001684|FG004|Overall Study|Withdrawal by Subject|0
7595679|NCT01956669|12001685|FG005|Overall Study|Withdrawal by Subject|0
7595680|NCT01956669|12001686|FG006|Overall Study|Withdrawal by Subject|1
7595681|NCT01967823|12001711|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1
7595682|NCT01989676|12001721|FG000|Overall Study|Death|52
7595683|NCT01989676|12001722|FG001|Overall Study|Death|60
7595684|NCT01989676|12001721|FG000|Overall Study|Protocol Violation|2
7595685|NCT01989676|12001722|FG001|Overall Study|Protocol Violation|1
7595686|NCT01989676|12001721|FG000|Overall Study|Lost to Follow-up|8
7595687|NCT01989676|12001722|FG001|Overall Study|Lost to Follow-up|18
7595688|NCT01989676|12001721|FG000|Overall Study|No longer willing to participate in study|26
7595689|NCT01989676|12001722|FG001|Overall Study|No longer willing to participate in study|26
7595690|NCT01989676|12001721|FG000|Overall Study|Participants terminated from study by Sponsor|26
7595691|NCT01989676|12001722|FG001|Overall Study|Participants terminated from study by Sponsor|30
7595692|NCT01989676|12001721|FG000|Overall Study|Other|4
7595693|NCT01989676|12001722|FG001|Overall Study|Other|3
7595694|NCT01992653|12001737|FG000|Overall Study|Death|0
7595695|NCT01992653|12001738|FG001|Overall Study|Death|0
7595696|NCT01992653|12001739|FG002|Overall Study|Death|1
7595697|NCT01992653|12001740|FG003|Overall Study|Death|0
7595698|NCT01992653|12001741|FG004|Overall Study|Death|1
7595699|NCT01992653|12001742|FG005|Overall Study|Death|0
7595700|NCT01992653|12001743|FG006|Overall Study|Death|4
7595701|NCT01992653|12001744|FG007|Overall Study|Death|2
7595702|NCT01992653|12001737|FG000|Overall Study|Lost to Follow-up|0
7595703|NCT01992653|12001738|FG001|Overall Study|Lost to Follow-up|0
7595704|NCT01992653|12001739|FG002|Overall Study|Lost to Follow-up|0
7595705|NCT01992653|12001740|FG003|Overall Study|Lost to Follow-up|0
7595706|NCT01992653|12001741|FG004|Overall Study|Lost to Follow-up|0
7595707|NCT01992653|12001742|FG005|Overall Study|Lost to Follow-up|0
7595708|NCT01992653|12001743|FG006|Overall Study|Lost to Follow-up|0
7595709|NCT01992653|12001744|FG007|Overall Study|Lost to Follow-up|1
7595710|NCT01992653|12001737|FG000|Overall Study|Study Completed|0
7595711|NCT01992653|12001738|FG001|Overall Study|Study Completed|0
7595712|NCT01992653|12001739|FG002|Overall Study|Study Completed|0
7595713|NCT01992653|12001740|FG003|Overall Study|Study Completed|0
7595714|NCT01992653|12001741|FG004|Overall Study|Study Completed|0
7595715|NCT01992653|12001742|FG005|Overall Study|Study Completed|0
7595716|NCT01992653|12001743|FG006|Overall Study|Study Completed|0
7595717|NCT01992653|12001744|FG007|Overall Study|Study Completed|1
7595718|NCT01992653|12001737|FG000|Overall Study|Disease Progression|0
7595719|NCT01992653|12001738|FG001|Overall Study|Disease Progression|0
7595720|NCT01992653|12001739|FG002|Overall Study|Disease Progression|0
7595721|NCT01992653|12001740|FG003|Overall Study|Disease Progression|0
7595722|NCT01992653|12001741|FG004|Overall Study|Disease Progression|0
7595723|NCT01992653|12001742|FG005|Overall Study|Disease Progression|0
7595724|NCT01992653|12001743|FG006|Overall Study|Disease Progression|4
7595725|NCT01992653|12001744|FG007|Overall Study|Disease Progression|0
7627872|NCT04993339|12040617|FG000|Overall Study|Lost to Follow-up|0
7627873|NCT04993339|12040618|FG001|Overall Study|Lost to Follow-up|1
7627874|NCT04993339|12040617|FG000|Overall Study|no MRI scan|3
7627875|NCT04993339|12040618|FG001|Overall Study|no MRI scan|1
7627876|NCT04919161|12040660|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
7627877|NCT04919161|12040661|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
7627878|NCT04919161|12040660|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
7627879|NCT04919161|12040661|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
7627880|NCT04919161|12040660|FG000|Overall Study|Acute ankle sprain after session 1|0
7627881|NCT04919161|12040661|FG001|Overall Study|Acute ankle sprain after session 1|1
7627882|NCT04883541|12040752|FG000|Overall Study|Not attending regular yoga class|16
7627883|NCT04883541|12040753|FG001|Overall Study|Not attending regular yoga class|0
7627884|NCT04883541|12040752|FG000|Overall Study|Not attending the pregnancy school|0
7627885|NCT04883541|12040753|FG001|Overall Study|Not attending the pregnancy school|9
7627886|NCT04357782|12040769|FG000|Overall Study|Discharged from hospital|1
7627887|NCT04357782|12040770|FG001|Overall Study|Discharged from hospital|0
7627888|NCT04357782|12040769|FG000|Overall Study|Death|0
7627889|NCT04357782|12040770|FG001|Overall Study|Death|2
7627890|NCT03760068|12040797|FG000|Overall Study|Withdrawal by Subject|7
7627891|NCT03760068|12040798|FG001|Overall Study|Withdrawal by Subject|8
7627892|NCT03760068|12040797|FG000|Overall Study|Adverse Event|1
7627893|NCT03760068|12040798|FG001|Overall Study|Adverse Event|2
7627894|NCT03760068|12040797|FG000|Overall Study|Administrative Decision by Sponsor|0
7627895|NCT03760068|12040798|FG001|Overall Study|Administrative Decision by Sponsor|2
7627896|NCT03760068|12040797|FG000|Overall Study|Physician Decision|1
7627897|NCT03760068|12040798|FG001|Overall Study|Physician Decision|2
7627898|NCT03760068|12040797|FG000|Overall Study|Lost to Follow-up|4
7627899|NCT03760068|12040798|FG001|Overall Study|Lost to Follow-up|9
7627900|NCT03760068|12040797|FG000|Overall Study|Subject Moved Out of State|1
7627901|NCT03760068|12040798|FG001|Overall Study|Subject Moved Out of State|0
7627902|NCT03628781|12040816|FG000|Overall Study|Lost to Follow-up|16
7627903|NCT03628781|12040817|FG001|Overall Study|Lost to Follow-up|8
7627904|NCT03628781|12040816|FG000|Overall Study|Withdrawal by Subject|16
7627905|NCT03628781|12040817|FG001|Overall Study|Withdrawal by Subject|1
7627906|NCT03560206|12040825|FG000|Overall Study|Lost to Follow-up|19
7627907|NCT03560206|12040826|FG001|Overall Study|Lost to Follow-up|11
7627908|NCT03560206|12040825|FG000|Overall Study|Withdrawal by Subject|2
7627909|NCT03560206|12040826|FG001|Overall Study|Withdrawal by Subject|4
7627910|NCT03560206|12040825|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5
7627911|NCT03560206|12040826|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0
7627912|NCT03560206|12040825|FG000|Overall Study|Busy schedule|14
7627913|NCT03560206|12040826|FG001|Overall Study|Busy schedule|2
7627914|NCT03560206|12040825|FG000|Overall Study|patients' new health condition such as cancer|10
7627915|NCT03560206|12040826|FG001|Overall Study|patients' new health condition such as cancer|1
7627916|NCT03340766|12040835|FG000|Overall Study|Death|6
7627917|NCT03340766|12040836|FG001|Overall Study|Death|6
7627918|NCT03340766|12040837|FG002|Overall Study|Death|2
7627919|NCT03340766|12040835|FG000|Overall Study|Withdrawal by Subject|2
7627920|NCT03340766|12040836|FG001|Overall Study|Withdrawal by Subject|1
7627921|NCT03340766|12040837|FG002|Overall Study|Withdrawal by Subject|2
7627922|NCT03340766|12040835|FG000|Overall Study|Continuing Study|3
7627923|NCT03340766|12040836|FG001|Overall Study|Continuing Study|3
7627924|NCT03340766|12040837|FG002|Overall Study|Continuing Study|5
7627925|NCT02706847|12040858|FG000|Day 1 to Week 12|Adverse Event|2
7627926|NCT02706847|12040859|FG001|Day 1 to Week 12|Adverse Event|2
7627927|NCT02706847|12040860|FG002|Day 1 to Week 12|Adverse Event|1
7627928|NCT02706847|12040861|FG003|Day 1 to Week 12|Adverse Event|12
7627929|NCT02706847|12040858|FG000|Day 1 to Week 12|Withdrawal by Subject|2
7627930|NCT02706847|12040859|FG001|Day 1 to Week 12|Withdrawal by Subject|1
7627931|NCT02706847|12040860|FG002|Day 1 to Week 12|Withdrawal by Subject|4
7627932|NCT02706847|12040861|FG003|Day 1 to Week 12|Withdrawal by Subject|2
7627933|NCT02706847|12040858|FG000|Day 1 to Week 12|Lost to Follow-up|2
7627934|NCT02706847|12040859|FG001|Day 1 to Week 12|Lost to Follow-up|1
7627935|NCT02706847|12040860|FG002|Day 1 to Week 12|Lost to Follow-up|0
7627936|NCT02706847|12040861|FG003|Day 1 to Week 12|Lost to Follow-up|0
7627937|NCT02706847|12040858|FG000|Day 1 to Week 12|Other|4
7627938|NCT02706847|12040859|FG001|Day 1 to Week 12|Other|4
7627939|NCT02706847|12040860|FG002|Day 1 to Week 12|Other|2
7627940|NCT02706847|12040861|FG003|Day 1 to Week 12|Other|2
7627941|NCT02706847|12040858|FG000|Day 1 to Week 12|Randomized in Error|0
7627942|NCT02706847|12040859|FG001|Day 1 to Week 12|Randomized in Error|0
7627943|NCT02706847|12040860|FG002|Day 1 to Week 12|Randomized in Error|1
7595726|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
7595727|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
7595728|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
7595729|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
7595730|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
7595731|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
7595732|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
7595733|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
7595734|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
7595735|NCT02001974|12001765|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7595736|NCT02001974|12001766|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
7595737|NCT02001974|12001767|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
7595738|NCT02014558|12001788|FG000|Overall Study|Never Received Study Drug|0
7595739|NCT02014558|12001789|FG001|Overall Study|Never Received Study Drug|0
7595740|NCT02014558|12001790|FG002|Overall Study|Never Received Study Drug|0
7595741|NCT02014558|12001791|FG003|Overall Study|Never Received Study Drug|0
7595742|NCT02014558|12001792|FG004|Overall Study|Never Received Study Drug|1
7595743|NCT02014558|12001793|FG005|Overall Study|Never Received Study Drug|0
7595744|NCT02014558|12001794|FG006|Overall Study|Never Received Study Drug|1
7595745|NCT02014558|12001795|FG007|Overall Study|Never Received Study Drug|0
7595746|NCT02014558|12001796|FG008|Overall Study|Never Received Study Drug|2
7595747|NCT02014558|12001797|FG009|Overall Study|Never Received Study Drug|0
7595748|NCT02014558|12001798|FG010|Overall Study|Never Received Study Drug|2
7595749|NCT02014558|12001799|FG011|Overall Study|Never Received Study Drug|2
7595750|NCT02014558|12001800|FG012|Overall Study|Never Received Study Drug|0
7595751|NCT02014558|12001788|FG000|Overall Study|Adverse Event|0
7595752|NCT02014558|12001789|FG001|Overall Study|Adverse Event|0
7595753|NCT02014558|12001790|FG002|Overall Study|Adverse Event|0
7595754|NCT02014558|12001791|FG003|Overall Study|Adverse Event|0
7595755|NCT02014558|12001792|FG004|Overall Study|Adverse Event|1
7595756|NCT02014558|12001793|FG005|Overall Study|Adverse Event|0
7595757|NCT02014558|12001794|FG006|Overall Study|Adverse Event|0
7595758|NCT02014558|12001795|FG007|Overall Study|Adverse Event|0
7595759|NCT02014558|12001796|FG008|Overall Study|Adverse Event|2
7595760|NCT02014558|12001797|FG009|Overall Study|Adverse Event|2
7595761|NCT02014558|12001798|FG010|Overall Study|Adverse Event|5
7595762|NCT02014558|12001799|FG011|Overall Study|Adverse Event|21
7595763|NCT02014558|12001800|FG012|Overall Study|Adverse Event|3
7595764|NCT02014558|12001788|FG000|Overall Study|Death|1
7595765|NCT02014558|12001789|FG001|Overall Study|Death|0
7595766|NCT02014558|12001790|FG002|Overall Study|Death|0
7595767|NCT02014558|12001791|FG003|Overall Study|Death|0
7595768|NCT02014558|12001792|FG004|Overall Study|Death|0
7595769|NCT02014558|12001793|FG005|Overall Study|Death|0
7595770|NCT02014558|12001794|FG006|Overall Study|Death|1
7595771|NCT02014558|12001795|FG007|Overall Study|Death|1
7595772|NCT02014558|12001796|FG008|Overall Study|Death|2
7595773|NCT02014558|12001797|FG009|Overall Study|Death|5
7595774|NCT02014558|12001798|FG010|Overall Study|Death|5
7595775|NCT02014558|12001799|FG011|Overall Study|Death|19
7595776|NCT02014558|12001800|FG012|Overall Study|Death|2
7595777|NCT02014558|12001788|FG000|Overall Study|Lack of Efficacy|1
7595778|NCT02014558|12001789|FG001|Overall Study|Lack of Efficacy|2
7595779|NCT02014558|12001790|FG002|Overall Study|Lack of Efficacy|1
7595780|NCT02014558|12001791|FG003|Overall Study|Lack of Efficacy|1
7595781|NCT02014558|12001792|FG004|Overall Study|Lack of Efficacy|0
7595782|NCT02014558|12001793|FG005|Overall Study|Lack of Efficacy|0
7595783|NCT02014558|12001794|FG006|Overall Study|Lack of Efficacy|1
7595784|NCT02014558|12001795|FG007|Overall Study|Lack of Efficacy|3
7595785|NCT02014558|12001796|FG008|Overall Study|Lack of Efficacy|3
7595786|NCT02014558|12001797|FG009|Overall Study|Lack of Efficacy|3
7595787|NCT02014558|12001798|FG010|Overall Study|Lack of Efficacy|16
7595788|NCT02014558|12001799|FG011|Overall Study|Lack of Efficacy|8
7595789|NCT02014558|12001800|FG012|Overall Study|Lack of Efficacy|5
7595790|NCT02014558|12001788|FG000|Overall Study|Lost to Follow-up|0
7595791|NCT02014558|12001789|FG001|Overall Study|Lost to Follow-up|0
7595792|NCT02014558|12001790|FG002|Overall Study|Lost to Follow-up|0
7595793|NCT02014558|12001791|FG003|Overall Study|Lost to Follow-up|0
7595794|NCT02014558|12001792|FG004|Overall Study|Lost to Follow-up|0
7595795|NCT02014558|12001793|FG005|Overall Study|Lost to Follow-up|0
7595796|NCT02014558|12001794|FG006|Overall Study|Lost to Follow-up|0
7595797|NCT02014558|12001795|FG007|Overall Study|Lost to Follow-up|0
7595798|NCT02014558|12001796|FG008|Overall Study|Lost to Follow-up|0
7595799|NCT02014558|12001797|FG009|Overall Study|Lost to Follow-up|0
7595800|NCT02014558|12001798|FG010|Overall Study|Lost to Follow-up|1
7595801|NCT02014558|12001799|FG011|Overall Study|Lost to Follow-up|0
7595802|NCT02014558|12001800|FG012|Overall Study|Lost to Follow-up|0
7595803|NCT02014558|12001788|FG000|Overall Study|Progressive Disease|1
7595804|NCT02014558|12001789|FG001|Overall Study|Progressive Disease|0
7595805|NCT02014558|12001790|FG002|Overall Study|Progressive Disease|1
7595806|NCT02014558|12001791|FG003|Overall Study|Progressive Disease|1
7595807|NCT02014558|12001792|FG004|Overall Study|Progressive Disease|1
7595808|NCT02014558|12001793|FG005|Overall Study|Progressive Disease|2
7595809|NCT02014558|12001794|FG006|Overall Study|Progressive Disease|1
7595810|NCT02014558|12001795|FG007|Overall Study|Progressive Disease|6
7595811|NCT02014558|12001796|FG008|Overall Study|Progressive Disease|5
7595812|NCT02014558|12001797|FG009|Overall Study|Progressive Disease|6
7595813|NCT02014558|12001798|FG010|Overall Study|Progressive Disease|22
7595814|NCT02014558|12001799|FG011|Overall Study|Progressive Disease|31
7595815|NCT02014558|12001800|FG012|Overall Study|Progressive Disease|6
7595816|NCT02014558|12001788|FG000|Overall Study|Withdrawal by Subject|0
7595817|NCT02014558|12001789|FG001|Overall Study|Withdrawal by Subject|0
7595818|NCT02014558|12001790|FG002|Overall Study|Withdrawal by Subject|0
7595819|NCT02014558|12001791|FG003|Overall Study|Withdrawal by Subject|0
7595820|NCT02014558|12001792|FG004|Overall Study|Withdrawal by Subject|1
7595821|NCT02014558|12001793|FG005|Overall Study|Withdrawal by Subject|0
7595822|NCT02014558|12001794|FG006|Overall Study|Withdrawal by Subject|0
7595823|NCT02014558|12001795|FG007|Overall Study|Withdrawal by Subject|0
7595824|NCT02014558|12001796|FG008|Overall Study|Withdrawal by Subject|0
7595825|NCT02014558|12001797|FG009|Overall Study|Withdrawal by Subject|2
7595826|NCT02014558|12001798|FG010|Overall Study|Withdrawal by Subject|6
7595827|NCT02014558|12001799|FG011|Overall Study|Withdrawal by Subject|10
7595828|NCT02014558|12001800|FG012|Overall Study|Withdrawal by Subject|0
7595829|NCT02014558|12001788|FG000|Overall Study|Miscellaneous|2
7595830|NCT02014558|12001789|FG001|Overall Study|Miscellaneous|1
7595831|NCT02014558|12001790|FG002|Overall Study|Miscellaneous|1
7595832|NCT02014558|12001791|FG003|Overall Study|Miscellaneous|1
7595833|NCT02014558|12001792|FG004|Overall Study|Miscellaneous|0
7595834|NCT02014558|12001793|FG005|Overall Study|Miscellaneous|1
7595835|NCT02014558|12001794|FG006|Overall Study|Miscellaneous|0
7595836|NCT02014558|12001795|FG007|Overall Study|Miscellaneous|1
7595837|NCT02014558|12001796|FG008|Overall Study|Miscellaneous|1
7595838|NCT02014558|12001797|FG009|Overall Study|Miscellaneous|3
7595839|NCT02014558|12001798|FG010|Overall Study|Miscellaneous|12
7595840|NCT02014558|12001799|FG011|Overall Study|Miscellaneous|11
7595841|NCT02014558|12001800|FG012|Overall Study|Miscellaneous|1
7627944|NCT02706847|12040861|FG003|Day 1 to Week 12|Randomized in Error|0
7627945|NCT02706847|12040858|FG000|Week 12 to Week 24|Adverse Event|1
7627946|NCT02706847|12040859|FG001|Week 12 to Week 24|Adverse Event|2
7627947|NCT02706847|12040860|FG002|Week 12 to Week 24|Adverse Event|2
7627948|NCT02706847|12040861|FG003|Week 12 to Week 24|Adverse Event|5
7627949|NCT02706847|12040858|FG000|Week 12 to Week 24|Withdrawal by Subject|1
7627950|NCT02706847|12040859|FG001|Week 12 to Week 24|Withdrawal by Subject|0
7627951|NCT02706847|12040860|FG002|Week 12 to Week 24|Withdrawal by Subject|1
7627952|NCT02706847|12040861|FG003|Week 12 to Week 24|Withdrawal by Subject|4
7627953|NCT02706847|12040858|FG000|Week 12 to Week 24|Lost to Follow-up|0
7627954|NCT02706847|12040859|FG001|Week 12 to Week 24|Lost to Follow-up|0
7627955|NCT02706847|12040860|FG002|Week 12 to Week 24|Lost to Follow-up|0
7627956|NCT02706847|12040861|FG003|Week 12 to Week 24|Lost to Follow-up|1
7627957|NCT02706847|12040858|FG000|Week 12 to Week 24|Other|1
7627958|NCT02706847|12040859|FG001|Week 12 to Week 24|Other|0
7627959|NCT02706847|12040860|FG002|Week 12 to Week 24|Other|1
7627960|NCT02706847|12040861|FG003|Week 12 to Week 24|Other|4
7627961|NCT02564900|12040886|FG000|Dose Escalation|Progressive disease per RECIST|2
7627962|NCT02564900|12040887|FG001|Dose Escalation|Progressive disease per RECIST|3
7627963|NCT02564900|12040888|FG002|Dose Escalation|Progressive disease per RECIST|3
7627964|NCT02564900|12040889|FG003|Dose Escalation|Progressive disease per RECIST|3
7627965|NCT02564900|12040890|FG004|Dose Escalation|Progressive disease per RECIST|3
7627966|NCT02564900|12040891|FG005|Dose Escalation|Progressive disease per RECIST|1
7627967|NCT02564900|12040892|FG006|Dose Escalation|Progressive disease per RECIST|0
7627968|NCT02564900|12040893|FG007|Dose Escalation|Progressive disease per RECIST|0
7627969|NCT02564900|12040894|FG008|Dose Escalation|Progressive disease per RECIST|0
7627970|NCT02564900|12040895|FG009|Dose Escalation|Progressive disease per RECIST|0
7627971|NCT02564900|12040896|FG010|Dose Escalation|Progressive disease per RECIST|0
7627972|NCT02564900|12040897|FG011|Dose Escalation|Progressive disease per RECIST|0
7627973|NCT02564900|12040898|FG012|Dose Escalation|Progressive disease per RECIST|0
7627974|NCT02564900|12040899|FG013|Dose Escalation|Progressive disease per RECIST|0
7627975|NCT02564900|12040900|FG014|Dose Escalation|Progressive disease per RECIST|0
7627976|NCT02564900|12040886|FG000|Dose Escalation|Ongoing|1
7627977|NCT02564900|12040887|FG001|Dose Escalation|Ongoing|0
7627978|NCT02564900|12040888|FG002|Dose Escalation|Ongoing|0
7627979|NCT02564900|12040889|FG003|Dose Escalation|Ongoing|2
7627980|NCT02564900|12040890|FG004|Dose Escalation|Ongoing|2
7627981|NCT02564900|12040891|FG005|Dose Escalation|Ongoing|2
7627982|NCT02564900|12040892|FG006|Dose Escalation|Ongoing|0
7627983|NCT02564900|12040893|FG007|Dose Escalation|Ongoing|0
7627984|NCT02564900|12040894|FG008|Dose Escalation|Ongoing|0
7595842|NCT02024555|12001855|FG000|Overall Study|Lost to Follow-up|1
7595843|NCT02024555|12001856|FG001|Overall Study|Lost to Follow-up|1
7595844|NCT02024555|12001855|FG000|Overall Study|Withdrawal by Subject|5
7595845|NCT02024555|12001856|FG001|Overall Study|Withdrawal by Subject|1
7595846|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595847|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595848|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595849|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595850|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595851|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595852|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595853|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595854|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
7595855|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595856|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595857|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595858|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595859|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595860|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595861|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595862|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595863|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
7595864|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595865|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595866|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595867|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
7595868|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595869|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595870|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595871|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595872|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595873|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595874|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595875|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595876|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595877|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595878|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595879|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595880|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595881|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
7595882|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595883|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595884|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595885|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595886|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595887|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595888|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595889|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595890|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
7595891|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595892|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595893|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595894|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595895|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595896|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595897|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595898|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595899|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
7595900|NCT02034123|12001880|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595901|NCT02034123|12001881|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595902|NCT02034123|12001882|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595903|NCT02034123|12001883|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7595904|NCT02034123|12001884|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
7595905|NCT02034123|12001885|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595906|NCT02034123|12001886|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595907|NCT02034123|12001887|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595908|NCT02034123|12001888|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595909|NCT02034123|12001889|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595910|NCT02034123|12001890|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595911|NCT02034123|12001891|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595912|NCT02034123|12001892|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595913|NCT02034123|12001893|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595914|NCT02034123|12001894|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595915|NCT02034123|12001895|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595916|NCT02034123|12001896|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7595917|NCT02034123|12001897|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
7627985|NCT02564900|12040895|FG009|Dose Escalation|Ongoing|0
7627986|NCT02564900|12040896|FG010|Dose Escalation|Ongoing|0
7627987|NCT02564900|12040897|FG011|Dose Escalation|Ongoing|0
7627988|NCT02564900|12040898|FG012|Dose Escalation|Ongoing|0
7627989|NCT02564900|12040899|FG013|Dose Escalation|Ongoing|0
7627990|NCT02564900|12040900|FG014|Dose Escalation|Ongoing|0
7627991|NCT02564900|12040886|FG000|Dose Escalation|Adverse Event|0
7627992|NCT02564900|12040887|FG001|Dose Escalation|Adverse Event|0
7627993|NCT02564900|12040888|FG002|Dose Escalation|Adverse Event|0
7627994|NCT02564900|12040889|FG003|Dose Escalation|Adverse Event|1
7627995|NCT02564900|12040890|FG004|Dose Escalation|Adverse Event|1
7627996|NCT02564900|12040891|FG005|Dose Escalation|Adverse Event|3
7627997|NCT02564900|12040892|FG006|Dose Escalation|Adverse Event|0
7627998|NCT02564900|12040893|FG007|Dose Escalation|Adverse Event|0
7627999|NCT02564900|12040894|FG008|Dose Escalation|Adverse Event|0
7628000|NCT02564900|12040895|FG009|Dose Escalation|Adverse Event|0
7628001|NCT02564900|12040896|FG010|Dose Escalation|Adverse Event|0
7628002|NCT02564900|12040897|FG011|Dose Escalation|Adverse Event|0
7628003|NCT02564900|12040898|FG012|Dose Escalation|Adverse Event|0
7628004|NCT02564900|12040899|FG013|Dose Escalation|Adverse Event|0
7628005|NCT02564900|12040900|FG014|Dose Escalation|Adverse Event|0
7628006|NCT02564900|12040886|FG000|Dose Expansion|Progressive disease per RECIST|0
7628007|NCT02564900|12040887|FG001|Dose Expansion|Progressive disease per RECIST|0
7628008|NCT02564900|12040888|FG002|Dose Expansion|Progressive disease per RECIST|0
7628009|NCT02564900|12040889|FG003|Dose Expansion|Progressive disease per RECIST|0
7628010|NCT02564900|12040890|FG004|Dose Expansion|Progressive disease per RECIST|0
7628011|NCT02564900|12040891|FG005|Dose Expansion|Progressive disease per RECIST|0
7628012|NCT02564900|12040892|FG006|Dose Expansion|Progressive disease per RECIST|19
7628013|NCT02564900|12040893|FG007|Dose Expansion|Progressive disease per RECIST|17
7628014|NCT02564900|12040894|FG008|Dose Expansion|Progressive disease per RECIST|8
7628015|NCT02564900|12040895|FG009|Dose Expansion|Progressive disease per RECIST|16
7628016|NCT02564900|12040896|FG010|Dose Expansion|Progressive disease per RECIST|13
7628017|NCT02564900|12040897|FG011|Dose Expansion|Progressive disease per RECIST|19
7628018|NCT02564900|12040898|FG012|Dose Expansion|Progressive disease per RECIST|10
7628019|NCT02564900|12040899|FG013|Dose Expansion|Progressive disease per RECIST|13
7628020|NCT02564900|12040900|FG014|Dose Expansion|Progressive disease per RECIST|11
7628021|NCT02564900|12040886|FG000|Dose Expansion|Clinical progression|0
7628022|NCT02564900|12040887|FG001|Dose Expansion|Clinical progression|0
7628023|NCT02564900|12040888|FG002|Dose Expansion|Clinical progression|0
7628024|NCT02564900|12040889|FG003|Dose Expansion|Clinical progression|0
7628025|NCT02564900|12040890|FG004|Dose Expansion|Clinical progression|0
7628026|NCT02564900|12040891|FG005|Dose Expansion|Clinical progression|0
7628027|NCT02564900|12040892|FG006|Dose Expansion|Clinical progression|5
7628028|NCT02564900|12040893|FG007|Dose Expansion|Clinical progression|12
7628029|NCT02564900|12040894|FG008|Dose Expansion|Clinical progression|0
7628030|NCT02564900|12040895|FG009|Dose Expansion|Clinical progression|3
7628031|NCT02564900|12040896|FG010|Dose Expansion|Clinical progression|2
7628032|NCT02564900|12040897|FG011|Dose Expansion|Clinical progression|0
7628033|NCT02564900|12040898|FG012|Dose Expansion|Clinical progression|1
7628034|NCT02564900|12040899|FG013|Dose Expansion|Clinical progression|3
7628035|NCT02564900|12040900|FG014|Dose Expansion|Clinical progression|1
7628036|NCT02564900|12040886|FG000|Dose Expansion|Adverse Event|0
7628037|NCT02564900|12040887|FG001|Dose Expansion|Adverse Event|0
7628038|NCT02564900|12040888|FG002|Dose Expansion|Adverse Event|0
7628039|NCT02564900|12040889|FG003|Dose Expansion|Adverse Event|0
7628040|NCT02564900|12040890|FG004|Dose Expansion|Adverse Event|0
7628041|NCT02564900|12040891|FG005|Dose Expansion|Adverse Event|0
7628042|NCT02564900|12040892|FG006|Dose Expansion|Adverse Event|9
7628043|NCT02564900|12040893|FG007|Dose Expansion|Adverse Event|22
7628044|NCT02564900|12040894|FG008|Dose Expansion|Adverse Event|0
7628045|NCT02564900|12040895|FG009|Dose Expansion|Adverse Event|11
7628046|NCT02564900|12040896|FG010|Dose Expansion|Adverse Event|0
7628047|NCT02564900|12040897|FG011|Dose Expansion|Adverse Event|5
7628048|NCT02564900|12040898|FG012|Dose Expansion|Adverse Event|2
7628049|NCT02564900|12040899|FG013|Dose Expansion|Adverse Event|2
7628050|NCT02564900|12040900|FG014|Dose Expansion|Adverse Event|1
7628051|NCT02564900|12040886|FG000|Dose Expansion|Ongoing|0
7628052|NCT02564900|12040887|FG001|Dose Expansion|Ongoing|0
7628053|NCT02564900|12040888|FG002|Dose Expansion|Ongoing|0
7628054|NCT02564900|12040889|FG003|Dose Expansion|Ongoing|0
7628055|NCT02564900|12040890|FG004|Dose Expansion|Ongoing|0
7628056|NCT02564900|12040891|FG005|Dose Expansion|Ongoing|0
7628057|NCT02564900|12040892|FG006|Dose Expansion|Ongoing|9
7595918|NCT02040584|12001942|FG000|Overall Study|Adverse Event|13
7595919|NCT02040584|12001943|FG001|Overall Study|Adverse Event|6
7595920|NCT02040584|12001942|FG000|Overall Study|Protocol Violation|9
7595921|NCT02040584|12001943|FG001|Overall Study|Protocol Violation|11
7595922|NCT02040584|12001942|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7595923|NCT02040584|12001943|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7595924|NCT02040584|12001942|FG000|Overall Study|Death|6
7595925|NCT02040584|12001943|FG001|Overall Study|Death|3
7595926|NCT02040584|12001942|FG000|Overall Study|Transplant rejection/retransplant|0
7595927|NCT02040584|12001943|FG001|Overall Study|Transplant rejection/retransplant|1
7595928|NCT02040584|12001942|FG000|Overall Study|Immunosuppressant/prohibited med use|7
7595929|NCT02040584|12001943|FG001|Overall Study|Immunosuppressant/prohibited med use|10
7595930|NCT02045797|12001962|FG000|Overall Study|Adverse Event|3
7595931|NCT02045797|12001963|FG001|Overall Study|Adverse Event|1
7595932|NCT02045797|12001964|FG002|Overall Study|Adverse Event|0
7595933|NCT02045797|12001962|FG000|Overall Study|Lack of Efficacy|1
7595934|NCT02045797|12001963|FG001|Overall Study|Lack of Efficacy|0
7595935|NCT02045797|12001964|FG002|Overall Study|Lack of Efficacy|0
7595936|NCT02045797|12001962|FG000|Overall Study|Lost to Follow-up|2
7595937|NCT02045797|12001963|FG001|Overall Study|Lost to Follow-up|3
7595938|NCT02045797|12001964|FG002|Overall Study|Lost to Follow-up|1
7595939|NCT02045797|12001962|FG000|Overall Study|Physician Decision|0
7595940|NCT02045797|12001963|FG001|Overall Study|Physician Decision|1
7271646|NCT00422734|11485932|FG001|Overall Study|Protocol Violation|6
7271647|NCT00422734|11485931|FG000|Overall Study|Withdrawal by Subject|12
7271648|NCT00422734|11485932|FG001|Overall Study|Withdrawal by Subject|8
7271649|NCT00422734|11485931|FG000|Overall Study|Adverse Event|0
7271650|NCT00422734|11485932|FG001|Overall Study|Adverse Event|3
7271651|NCT00422734|11485931|FG000|Overall Study|Partner Decision|0
7271652|NCT00422734|11485932|FG001|Overall Study|Partner Decision|3
7271653|NCT00422799|11485938|FG000|Overall Study|Withdrawal by Subject|6
7271654|NCT00422799|11485938|FG000|Overall Study|Adverse Event|7
7271655|NCT00422903|11485961|FG000|Overall Study|Disease Progression|3
7271656|NCT00422903|11485962|FG001|Overall Study|Disease Progression|1
7271657|NCT00422903|11485961|FG000|Overall Study|Adverse Event|0
7271658|NCT00422903|11485962|FG001|Overall Study|Adverse Event|2
7271659|NCT00422903|11485961|FG000|Overall Study|Informed Consent Withdrawn|1
7271660|NCT00422903|11485962|FG001|Overall Study|Informed Consent Withdrawn|2
7271661|NCT00423046|11485970|FG000|Overall Study|Other|340
7271662|NCT00423046|11485971|FG001|Overall Study|Other|345
7271663|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
7271664|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
7271665|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
7271666|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
7271667|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
7271668|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
7271669|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
7271670|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
7271671|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7271672|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
7271673|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
7271674|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
7271675|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
7271676|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
7271677|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
7271678|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
7595941|NCT02045797|12001964|FG002|Overall Study|Physician Decision|0
7595942|NCT02045797|12001962|FG000|Overall Study|Withdrawal by Subject|1
7595943|NCT02045797|12001963|FG001|Overall Study|Withdrawal by Subject|2
7595944|NCT02045797|12001964|FG002|Overall Study|Withdrawal by Subject|0
7628058|NCT02564900|12040893|FG007|Dose Expansion|Ongoing|10
7628059|NCT02564900|12040894|FG008|Dose Expansion|Ongoing|11
7628060|NCT02564900|12040895|FG009|Dose Expansion|Ongoing|3
7628061|NCT02564900|12040896|FG010|Dose Expansion|Ongoing|0
7628062|NCT02564900|12040897|FG011|Dose Expansion|Ongoing|0
7628063|NCT02564900|12040898|FG012|Dose Expansion|Ongoing|4
7628064|NCT02564900|12040899|FG013|Dose Expansion|Ongoing|0
7628065|NCT02564900|12040900|FG014|Dose Expansion|Ongoing|6
7628066|NCT02564900|12040886|FG000|Dose Expansion|Death|0
7628067|NCT02564900|12040887|FG001|Dose Expansion|Death|0
7628068|NCT02564900|12040888|FG002|Dose Expansion|Death|0
7628069|NCT02564900|12040889|FG003|Dose Expansion|Death|0
7628070|NCT02564900|12040890|FG004|Dose Expansion|Death|0
7628071|NCT02564900|12040891|FG005|Dose Expansion|Death|0
7628072|NCT02564900|12040892|FG006|Dose Expansion|Death|1
7271679|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Death|1
7271680|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Death|1
7271681|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Death|0
7271682|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Death|0
7271683|NCT00423085|11485982|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
7271684|NCT00423085|11485983|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7271685|NCT00423085|11485984|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7271686|NCT00423085|11485985|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
7271687|NCT00423085|11485982|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
7271688|NCT00423085|11485983|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
7271689|NCT00423085|11485984|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
7271690|NCT00423085|11485985|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
7271691|NCT00423085|11485982|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7271692|NCT00423085|11485983|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7271693|NCT00423085|11485984|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
7271694|NCT00423085|11485985|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
7271695|NCT00423085|11485982|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7271696|NCT00423085|11485983|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7271697|NCT00423085|11485984|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
7271698|NCT00423085|11485985|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
7271699|NCT00423085|11485982|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
7271700|NCT00423085|11485983|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
7271701|NCT00423085|11485984|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
7271702|NCT00423085|11485985|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
7271703|NCT00423085|11485982|FG000|52-Week Open-Label Extension Phase|Death|0
7271704|NCT00423085|11485983|FG001|52-Week Open-Label Extension Phase|Death|0
7271705|NCT00423085|11485984|FG002|52-Week Open-Label Extension Phase|Death|0
7271706|NCT00423085|11485985|FG003|52-Week Open-Label Extension Phase|Death|2
7271707|NCT00423098|11485997|FG000|Overall Study|Adverse Event|1
7271708|NCT00423098|11485998|FG001|Overall Study|Adverse Event|2
7271709|NCT00423098|11485997|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7271710|NCT00423098|11485998|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7271711|NCT00423098|11485997|FG000|Overall Study|Administrative problems|0
7271712|NCT00423098|11485998|FG001|Overall Study|Administrative problems|1
7271713|NCT00423098|11485997|FG000|Overall Study|Death|2
7628073|NCT02564900|12040893|FG007|Dose Expansion|Death|0
7628074|NCT02564900|12040894|FG008|Dose Expansion|Death|0
7595945|NCT02049710|12001974|FG000|Overall Study|Lost to Follow-up|319
7595946|NCT02049710|12001975|FG001|Overall Study|Lost to Follow-up|324
7595947|NCT02055547|12001981|FG000|Overall Study|Protocol Violation|0
7595948|NCT02055547|12001982|FG001|Overall Study|Protocol Violation|0
7595949|NCT02055547|12001983|FG002|Overall Study|Protocol Violation|1
7595950|NCT02055547|12001984|FG003|Overall Study|Protocol Violation|0
7595951|NCT02055547|12001985|FG004|Overall Study|Protocol Violation|0
7595952|NCT02055547|12001986|FG005|Overall Study|Protocol Violation|0
7595953|NCT02055547|12001987|FG006|Overall Study|Protocol Violation|1
7595954|NCT02055547|12001988|FG007|Overall Study|Protocol Violation|0
7595955|NCT02055547|12001989|FG008|Overall Study|Protocol Violation|0
7595956|NCT02055547|12001990|FG009|Overall Study|Protocol Violation|0
7595957|NCT02055547|12001991|FG010|Overall Study|Protocol Violation|0
7595958|NCT02055547|12001992|FG011|Overall Study|Protocol Violation|0
7595959|NCT02055547|12001993|FG012|Overall Study|Protocol Violation|0
7595960|NCT02055547|12001994|FG013|Overall Study|Protocol Violation|0
7595961|NCT02055547|12001995|FG014|Overall Study|Protocol Violation|0
7595962|NCT02055547|12001996|FG015|Overall Study|Protocol Violation|0
7595963|NCT02055547|12001997|FG016|Overall Study|Protocol Violation|0
7595964|NCT02055547|12001998|FG017|Overall Study|Protocol Violation|0
7595965|NCT02055547|12001999|FG018|Overall Study|Protocol Violation|0
7595966|NCT02055547|12001981|FG000|Overall Study|Physician Decision|0
7595967|NCT02055547|12001982|FG001|Overall Study|Physician Decision|1
7595968|NCT02055547|12001983|FG002|Overall Study|Physician Decision|1
7595969|NCT02055547|12001984|FG003|Overall Study|Physician Decision|0
7595970|NCT02055547|12001985|FG004|Overall Study|Physician Decision|1
7595971|NCT02055547|12001986|FG005|Overall Study|Physician Decision|0
7595972|NCT02055547|12001987|FG006|Overall Study|Physician Decision|0
7595973|NCT02055547|12001988|FG007|Overall Study|Physician Decision|0
7595974|NCT02055547|12001989|FG008|Overall Study|Physician Decision|0
7595975|NCT02055547|12001990|FG009|Overall Study|Physician Decision|1
7595976|NCT02055547|12001991|FG010|Overall Study|Physician Decision|1
7595977|NCT02055547|12001992|FG011|Overall Study|Physician Decision|0
7595978|NCT02055547|12001993|FG012|Overall Study|Physician Decision|0
7595979|NCT02055547|12001994|FG013|Overall Study|Physician Decision|0
7595980|NCT02055547|12001995|FG014|Overall Study|Physician Decision|0
7595981|NCT02055547|12001996|FG015|Overall Study|Physician Decision|0
7595982|NCT02055547|12001997|FG016|Overall Study|Physician Decision|0
7595983|NCT02055547|12001998|FG017|Overall Study|Physician Decision|0
7595984|NCT02055547|12001999|FG018|Overall Study|Physician Decision|0
7595985|NCT02055547|12001981|FG000|Overall Study|Adverse Event|0
7595986|NCT02055547|12001982|FG001|Overall Study|Adverse Event|0
7595987|NCT02055547|12001983|FG002|Overall Study|Adverse Event|0
7595988|NCT02055547|12001984|FG003|Overall Study|Adverse Event|0
7595989|NCT02055547|12001985|FG004|Overall Study|Adverse Event|0
7595990|NCT02055547|12001986|FG005|Overall Study|Adverse Event|0
7595991|NCT02055547|12001987|FG006|Overall Study|Adverse Event|1
7595992|NCT02055547|12001988|FG007|Overall Study|Adverse Event|0
7595993|NCT02055547|12001989|FG008|Overall Study|Adverse Event|1
7595994|NCT02055547|12001990|FG009|Overall Study|Adverse Event|0
7595995|NCT02055547|12001991|FG010|Overall Study|Adverse Event|0
7595996|NCT02055547|12001992|FG011|Overall Study|Adverse Event|0
7595997|NCT02055547|12001993|FG012|Overall Study|Adverse Event|0
7595998|NCT02055547|12001994|FG013|Overall Study|Adverse Event|0
7595999|NCT02055547|12001995|FG014|Overall Study|Adverse Event|0
7596000|NCT02055547|12001996|FG015|Overall Study|Adverse Event|0
7596001|NCT02055547|12001997|FG016|Overall Study|Adverse Event|0
7596002|NCT02055547|12001998|FG017|Overall Study|Adverse Event|0
7596003|NCT02055547|12001999|FG018|Overall Study|Adverse Event|0
7596004|NCT02055547|12001981|FG000|Overall Study|Withdrawal by Subject|0
7596005|NCT02055547|12001982|FG001|Overall Study|Withdrawal by Subject|0
7596006|NCT02055547|12001983|FG002|Overall Study|Withdrawal by Subject|0
7596007|NCT02055547|12001984|FG003|Overall Study|Withdrawal by Subject|0
7596008|NCT02055547|12001985|FG004|Overall Study|Withdrawal by Subject|0
7596009|NCT02055547|12001986|FG005|Overall Study|Withdrawal by Subject|1
7596010|NCT02055547|12001987|FG006|Overall Study|Withdrawal by Subject|0
7596011|NCT02055547|12001988|FG007|Overall Study|Withdrawal by Subject|0
7596012|NCT02055547|12001989|FG008|Overall Study|Withdrawal by Subject|1
7596013|NCT02055547|12001990|FG009|Overall Study|Withdrawal by Subject|0
7596014|NCT02055547|12001991|FG010|Overall Study|Withdrawal by Subject|0
7596015|NCT02055547|12001992|FG011|Overall Study|Withdrawal by Subject|0
7596016|NCT02055547|12001993|FG012|Overall Study|Withdrawal by Subject|0
7596017|NCT02055547|12001994|FG013|Overall Study|Withdrawal by Subject|1
7596018|NCT02055547|12001995|FG014|Overall Study|Withdrawal by Subject|0
7596019|NCT02055547|12001996|FG015|Overall Study|Withdrawal by Subject|1
7596020|NCT02055547|12001997|FG016|Overall Study|Withdrawal by Subject|0
7596021|NCT02055547|12001998|FG017|Overall Study|Withdrawal by Subject|0
7596022|NCT02055547|12001999|FG018|Overall Study|Withdrawal by Subject|0
7596023|NCT02055547|12001981|FG000|Overall Study|Lost to Follow-up|0
7596024|NCT02055547|12001982|FG001|Overall Study|Lost to Follow-up|0
7596025|NCT02055547|12001983|FG002|Overall Study|Lost to Follow-up|1
7596026|NCT02055547|12001984|FG003|Overall Study|Lost to Follow-up|0
7596027|NCT02055547|12001985|FG004|Overall Study|Lost to Follow-up|0
7596028|NCT02055547|12001986|FG005|Overall Study|Lost to Follow-up|0
7596029|NCT02055547|12001987|FG006|Overall Study|Lost to Follow-up|0
7596030|NCT02055547|12001988|FG007|Overall Study|Lost to Follow-up|0
7596031|NCT02055547|12001989|FG008|Overall Study|Lost to Follow-up|0
7596032|NCT02055547|12001990|FG009|Overall Study|Lost to Follow-up|0
7596033|NCT02055547|12001991|FG010|Overall Study|Lost to Follow-up|0
7596034|NCT02055547|12001992|FG011|Overall Study|Lost to Follow-up|0
7596035|NCT02055547|12001993|FG012|Overall Study|Lost to Follow-up|0
7596036|NCT02055547|12001994|FG013|Overall Study|Lost to Follow-up|0
7596037|NCT02055547|12001995|FG014|Overall Study|Lost to Follow-up|0
7596038|NCT02055547|12001996|FG015|Overall Study|Lost to Follow-up|0
7596039|NCT02055547|12001997|FG016|Overall Study|Lost to Follow-up|0
7596040|NCT02055547|12001998|FG017|Overall Study|Lost to Follow-up|0
7596041|NCT02055547|12001999|FG018|Overall Study|Lost to Follow-up|0
7628075|NCT02564900|12040895|FG009|Dose Expansion|Death|0
7628076|NCT02564900|12040896|FG010|Dose Expansion|Death|1
7628077|NCT02564900|12040897|FG011|Dose Expansion|Death|0
7628078|NCT02564900|12040898|FG012|Dose Expansion|Death|1
7628079|NCT02564900|12040899|FG013|Dose Expansion|Death|1
7628080|NCT02564900|12040900|FG014|Dose Expansion|Death|0
7628081|NCT02564900|12040886|FG000|Dose Expansion|Withdrawal by Subject|0
7628082|NCT02564900|12040887|FG001|Dose Expansion|Withdrawal by Subject|0
7628083|NCT02564900|12040888|FG002|Dose Expansion|Withdrawal by Subject|0
7628084|NCT02564900|12040889|FG003|Dose Expansion|Withdrawal by Subject|0
7628085|NCT02564900|12040890|FG004|Dose Expansion|Withdrawal by Subject|0
7628086|NCT02564900|12040891|FG005|Dose Expansion|Withdrawal by Subject|0
7628087|NCT02564900|12040892|FG006|Dose Expansion|Withdrawal by Subject|4
7628088|NCT02564900|12040893|FG007|Dose Expansion|Withdrawal by Subject|0
7628089|NCT02564900|12040894|FG008|Dose Expansion|Withdrawal by Subject|0
7628090|NCT02564900|12040895|FG009|Dose Expansion|Withdrawal by Subject|0
7628091|NCT02564900|12040896|FG010|Dose Expansion|Withdrawal by Subject|1
7628092|NCT02564900|12040897|FG011|Dose Expansion|Withdrawal by Subject|0
7628093|NCT02564900|12040898|FG012|Dose Expansion|Withdrawal by Subject|0
7628094|NCT02564900|12040899|FG013|Dose Expansion|Withdrawal by Subject|1
7628095|NCT02564900|12040900|FG014|Dose Expansion|Withdrawal by Subject|1
7628096|NCT02564900|12040886|FG000|Dose Expansion|Other|0
7628097|NCT02564900|12040887|FG001|Dose Expansion|Other|0
7628098|NCT02564900|12040888|FG002|Dose Expansion|Other|0
7628099|NCT02564900|12040889|FG003|Dose Expansion|Other|0
7628100|NCT02564900|12040890|FG004|Dose Expansion|Other|0
7628101|NCT02564900|12040891|FG005|Dose Expansion|Other|0
7628102|NCT02564900|12040892|FG006|Dose Expansion|Other|1
7628103|NCT02564900|12040893|FG007|Dose Expansion|Other|0
7628104|NCT02564900|12040894|FG008|Dose Expansion|Other|1
7628105|NCT02564900|12040895|FG009|Dose Expansion|Other|0
7628106|NCT02564900|12040896|FG010|Dose Expansion|Other|0
7271714|NCT00423098|11485998|FG001|Overall Study|Death|0
7271715|NCT00423137|11486008|FG000|Overall Study|Lost to Follow-up|0
7271716|NCT00423137|11486009|FG001|Overall Study|Lost to Follow-up|0
7271717|NCT00423137|11486010|FG002|Overall Study|Lost to Follow-up|1
7628107|NCT02564900|12040897|FG011|Dose Expansion|Other|0
7628108|NCT02564900|12040898|FG012|Dose Expansion|Other|0
7628109|NCT02564900|12040899|FG013|Dose Expansion|Other|0
7628110|NCT02564900|12040900|FG014|Dose Expansion|Other|1
7628111|NCT02564900|12040886|FG000|Dose Expansion|Did not receive treatment|0
7628112|NCT02564900|12040887|FG001|Dose Expansion|Did not receive treatment|0
7628113|NCT02564900|12040888|FG002|Dose Expansion|Did not receive treatment|0
7628114|NCT02564900|12040889|FG003|Dose Expansion|Did not receive treatment|0
7596042|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0
7596043|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0
7596044|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0
7596045|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0
7596046|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0
7596047|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0
7596048|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0
7596049|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1
7596050|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0
7596051|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1
7596052|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0
7596053|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0
7596054|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596055|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596056|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596057|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596058|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596059|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596060|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596061|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
7271718|NCT00423137|11486011|FG003|Overall Study|Lost to Follow-up|0
7271719|NCT00423137|11486008|FG000|Overall Study|Protocol Violation|0
7271720|NCT00423137|11486009|FG001|Overall Study|Protocol Violation|0
7271721|NCT00423137|11486010|FG002|Overall Study|Protocol Violation|0
7271722|NCT00423137|11486011|FG003|Overall Study|Protocol Violation|1
7271723|NCT00423137|11486008|FG000|Overall Study|Adverse Event Study disease worse|1
7271724|NCT00423137|11486009|FG001|Overall Study|Adverse Event Study disease worse|0
7271725|NCT00423137|11486010|FG002|Overall Study|Adverse Event Study disease worse|3
7271726|NCT00423137|11486011|FG003|Overall Study|Adverse Event Study disease worse|1
7271727|NCT00423137|11486008|FG000|Overall Study|Adverse Event Other|0
7271728|NCT00423137|11486009|FG001|Overall Study|Adverse Event Other|0
7271729|NCT00423137|11486010|FG002|Overall Study|Adverse Event Other|2
7271730|NCT00423137|11486011|FG003|Overall Study|Adverse Event Other|0
7271731|NCT00423150|11486024|FG000|Overall Study|Adverse Event|11
7271732|NCT00423150|11486024|FG000|Overall Study|Progression of disease being studied|69
7271733|NCT00423150|11486024|FG000|Overall Study|Withdrawal by Subject|1
7271734|NCT00423150|11486024|FG000|Overall Study|Non-compliance with protocol|1
7271735|NCT00423150|11486024|FG000|Overall Study|Administrative|4
7271736|NCT00423189|11486031|FG000|Overall Study|Death|0
7271737|NCT00423189|11486032|FG001|Overall Study|Death|1
7271738|NCT00423189|11486033|FG002|Overall Study|Death|0
7271739|NCT00423267|11486048|FG000|Period A|Withdrawal by Subject|0
7271740|NCT00423267|11486049|FG001|Period A|Withdrawal by Subject|1
7271741|NCT00423267|11486048|FG000|Period A|Non-compliance with protocol|1
7271742|NCT00423267|11486049|FG001|Period A|Non-compliance with protocol|0
7271743|NCT00423267|11486048|FG000|Period A|Administrative|1
7271744|NCT00423267|11486049|FG001|Period A|Administrative|0
7271745|NCT00423293|11486057|FG000|Overall Study|Ineligible / No protocol treatment|11
7271746|NCT00423319|11486063|FG000|Overall Study|Death|2
7596062|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596063|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596064|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596065|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
7596066|NCT02064387|12002045|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596067|NCT02064387|12002046|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596068|NCT02064387|12002047|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596069|NCT02064387|12002048|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596070|NCT02064387|12002049|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596071|NCT02064387|12002050|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596072|NCT02064387|12002051|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596073|NCT02064387|12002052|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596074|NCT02064387|12002053|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
7596075|NCT02064387|12002054|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596076|NCT02064387|12002055|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596077|NCT02064387|12002056|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
7596078|NCT02064387|12002045|FG000|Part 2 Max 35 Months Followup Duration|Death|0
7596079|NCT02064387|12002046|FG001|Part 2 Max 35 Months Followup Duration|Death|0
7596080|NCT02064387|12002047|FG002|Part 2 Max 35 Months Followup Duration|Death|0
7596081|NCT02064387|12002048|FG003|Part 2 Max 35 Months Followup Duration|Death|0
7596082|NCT02064387|12002049|FG004|Part 2 Max 35 Months Followup Duration|Death|0
7596083|NCT02064387|12002050|FG005|Part 2 Max 35 Months Followup Duration|Death|0
7596084|NCT02064387|12002051|FG006|Part 2 Max 35 Months Followup Duration|Death|0
7596085|NCT02064387|12002052|FG007|Part 2 Max 35 Months Followup Duration|Death|0
7596086|NCT02064387|12002053|FG008|Part 2 Max 35 Months Followup Duration|Death|0
7596087|NCT02064387|12002054|FG009|Part 2 Max 35 Months Followup Duration|Death|0
7596088|NCT02064387|12002055|FG010|Part 2 Max 35 Months Followup Duration|Death|5
7596089|NCT02064387|12002056|FG011|Part 2 Max 35 Months Followup Duration|Death|3
7596090|NCT02064387|12002045|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596091|NCT02064387|12002046|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596092|NCT02064387|12002047|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596093|NCT02064387|12002048|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596094|NCT02064387|12002049|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596095|NCT02064387|12002050|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596096|NCT02064387|12002051|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596097|NCT02064387|12002052|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596098|NCT02064387|12002053|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596099|NCT02064387|12002054|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7596100|NCT02064387|12002055|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
7596101|NCT02064387|12002056|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
7628115|NCT02564900|12040890|FG004|Dose Expansion|Did not receive treatment|0
7628116|NCT02564900|12040891|FG005|Dose Expansion|Did not receive treatment|0
7628117|NCT02564900|12040892|FG006|Dose Expansion|Did not receive treatment|1
7628118|NCT02564900|12040893|FG007|Dose Expansion|Did not receive treatment|1
7628119|NCT02564900|12040894|FG008|Dose Expansion|Did not receive treatment|0
7628120|NCT02564900|12040895|FG009|Dose Expansion|Did not receive treatment|0
7628121|NCT02564900|12040896|FG010|Dose Expansion|Did not receive treatment|0
7628122|NCT02564900|12040897|FG011|Dose Expansion|Did not receive treatment|0
7628123|NCT02564900|12040898|FG012|Dose Expansion|Did not receive treatment|0
7628124|NCT02564900|12040899|FG013|Dose Expansion|Did not receive treatment|0
7628125|NCT02564900|12040900|FG014|Dose Expansion|Did not receive treatment|1
7628126|NCT02561299|12040943|FG000|Overall Study|Death|2
7628127|NCT02561299|12040944|FG001|Overall Study|Death|4
7628128|NCT02561299|12040943|FG000|Overall Study|Lost to Follow-up|1
7628129|NCT02561299|12040944|FG001|Overall Study|Lost to Follow-up|0
7628130|NCT02561299|12040943|FG000|Overall Study|Withdrawal by Subject|2
7628131|NCT02561299|12040944|FG001|Overall Study|Withdrawal by Subject|2
7628132|NCT02548143|12040952|FG000|Overall Study|Adverse Event|1
7628133|NCT02548143|12040953|FG001|Overall Study|Adverse Event|0
7628134|NCT02548143|12040952|FG000|Overall Study|Withdrawal by Subject|0
7628135|NCT02548143|12040953|FG001|Overall Study|Withdrawal by Subject|1
7628136|NCT02448680|12040961|FG000|Overall Study|Physician Decision|1
7628137|NCT02448680|12040962|FG001|Overall Study|Physician Decision|1
7628138|NCT02448680|12040961|FG000|Overall Study|Withdrawal by Subject|0
7628139|NCT02448680|12040962|FG001|Overall Study|Withdrawal by Subject|2
7628140|NCT02178358|12040995|FG000|Overall Study|Withdrawal by Subject|0
7628141|NCT02178358|12040996|FG001|Overall Study|Withdrawal by Subject|2
7628142|NCT02178358|12040997|FG002|Overall Study|Withdrawal by Subject|2
7628143|NCT02178358|12040995|FG000|Overall Study|Lost to Follow-up|1
7628144|NCT02178358|12040996|FG001|Overall Study|Lost to Follow-up|0
7628145|NCT02178358|12040997|FG002|Overall Study|Lost to Follow-up|0
7628146|NCT02073279|12041008|FG000|Double-blind Period|Adverse Event|1
7628147|NCT02073279|12041009|FG001|Double-blind Period|Adverse Event|1
7628148|NCT02073279|12041008|FG000|Double-blind Period|Protocol Deviation|0
7596102|NCT02076178|12002097|FG000|Oral Phase|Adverse Event|0
7596103|NCT02076178|12002098|FG001|Oral Phase|Adverse Event|7
7596104|NCT02076178|12002097|FG000|Oral Phase|Withdrawal by Subject|0
7596105|NCT02076178|12002098|FG001|Oral Phase|Withdrawal by Subject|4
7596106|NCT02076178|12002097|FG000|Oral Phase|Physician Decision|0
7596107|NCT02076178|12002098|FG001|Oral Phase|Physician Decision|1
7596108|NCT02076178|12002097|FG000|Injection Phase|Protocol defined stopping criteria|1
7596109|NCT02076178|12002098|FG001|Injection Phase|Protocol defined stopping criteria|0
7596110|NCT02076178|12002097|FG000|Injection Phase|Withdrawal by Subject|0
7596111|NCT02076178|12002098|FG001|Injection Phase|Withdrawal by Subject|3
7596112|NCT02076178|12002097|FG000|Injection Phase|Physician Decision|0
7596113|NCT02076178|12002098|FG001|Injection Phase|Physician Decision|3
7596114|NCT02076178|12002097|FG000|Injection Phase|Lost to Follow-up|0
7596115|NCT02076178|12002098|FG001|Injection Phase|Lost to Follow-up|1
7596116|NCT02079766|12002108|FG000|Overall Study|Physician Decision|1
7596117|NCT02079766|12002109|FG001|Overall Study|Physician Decision|0
7596118|NCT02079766|12002108|FG000|Overall Study|Withdrawal by Subject|1
7596119|NCT02079766|12002109|FG001|Overall Study|Withdrawal by Subject|0
7596168|NCT02087189|12002142|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
7596169|NCT02112916|12002167|FG000|Overall Study|Adverse Event|6
7596170|NCT02112916|12002168|FG001|Overall Study|Adverse Event|9
7596171|NCT02112916|12002169|FG002|Overall Study|Adverse Event|3
7596172|NCT02112916|12002170|FG003|Overall Study|Adverse Event|2
7596173|NCT02112916|12002167|FG000|Overall Study|Death|9
7596174|NCT02112916|12002168|FG001|Overall Study|Death|9
7596175|NCT02112916|12002169|FG002|Overall Study|Death|3
7596176|NCT02112916|12002170|FG003|Overall Study|Death|4
7596177|NCT02112916|12002167|FG000|Overall Study|Lost to Follow-up|1
7596178|NCT02112916|12002168|FG001|Overall Study|Lost to Follow-up|0
7596179|NCT02112916|12002169|FG002|Overall Study|Lost to Follow-up|0
7596180|NCT02112916|12002170|FG003|Overall Study|Lost to Follow-up|0
7596181|NCT02112916|12002167|FG000|Overall Study|Physician Decision|94
7596182|NCT02112916|12002168|FG001|Overall Study|Physician Decision|72
7596183|NCT02112916|12002169|FG002|Overall Study|Physician Decision|24
7596184|NCT02112916|12002170|FG003|Overall Study|Physician Decision|15
7596185|NCT02112916|12002167|FG000|Overall Study|Withdrawal by Subject|5
7596186|NCT02112916|12002168|FG001|Overall Study|Withdrawal by Subject|3
7596187|NCT02112916|12002169|FG002|Overall Study|Withdrawal by Subject|1
7596188|NCT02112916|12002170|FG003|Overall Study|Withdrawal by Subject|1
7596189|NCT02112916|12002167|FG000|Overall Study|Ineligible|4
7596190|NCT02112916|12002168|FG001|Overall Study|Ineligible|8
7596191|NCT02112916|12002169|FG002|Overall Study|Ineligible|3
7596192|NCT02112916|12002170|FG003|Overall Study|Ineligible|8
7596193|NCT02112916|12002167|FG000|Overall Study|Inevaluable|6
7596194|NCT02112916|12002168|FG001|Overall Study|Inevaluable|4
7596195|NCT02112916|12002169|FG002|Overall Study|Inevaluable|5
7596196|NCT02112916|12002170|FG003|Overall Study|Inevaluable|5
7596197|NCT02112916|12002167|FG000|Overall Study|Refusal of further protocol therapy|19
7596198|NCT02112916|12002168|FG001|Overall Study|Refusal of further protocol therapy|16
7596199|NCT02112916|12002169|FG002|Overall Study|Refusal of further protocol therapy|1
7596200|NCT02112916|12002170|FG003|Overall Study|Refusal of further protocol therapy|7
7596201|NCT02112916|12002167|FG000|Overall Study|Development of SMN|1
7596202|NCT02112916|12002168|FG001|Overall Study|Development of SMN|0
7596203|NCT02112916|12002169|FG002|Overall Study|Development of SMN|0
7596204|NCT02112916|12002170|FG003|Overall Study|Development of SMN|1
7596205|NCT02112916|12002167|FG000|Overall Study|Relapse/Progression|10
7596206|NCT02112916|12002168|FG001|Overall Study|Relapse/Progression|18
7596207|NCT02112916|12002169|FG002|Overall Study|Relapse/Progression|15
7596208|NCT02112916|12002170|FG003|Overall Study|Relapse/Progression|2
7596209|NCT02112916|12002167|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7596210|NCT02112916|12002168|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
7596211|NCT02112916|12002169|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7596212|NCT02112916|12002170|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
7596213|NCT02112916|12002167|FG000|Overall Study|Still on Therapy|44
7596214|NCT02112916|12002168|FG001|Overall Study|Still on Therapy|47
7596215|NCT02112916|12002169|FG002|Overall Study|Still on Therapy|3
7596216|NCT02112916|12002170|FG003|Overall Study|Still on Therapy|2
7596217|NCT02112916|12002167|FG000|Overall Study|Identified to have Ph+ T-ALL|0
7596218|NCT02112916|12002168|FG001|Overall Study|Identified to have Ph+ T-ALL|1
7596219|NCT02112916|12002169|FG002|Overall Study|Identified to have Ph+ T-ALL|0
7596220|NCT02112916|12002170|FG003|Overall Study|Identified to have Ph+ T-ALL|0
7596221|NCT02112916|12002167|FG000|Overall Study|Identified to have Ph+ T-Lly|0
7596222|NCT02112916|12002168|FG001|Overall Study|Identified to have Ph+ T-Lly|0
7596223|NCT02112916|12002169|FG002|Overall Study|Identified to have Ph+ T-Lly|1
7596224|NCT02112916|12002170|FG003|Overall Study|Identified to have Ph+ T-Lly|0
7596227|NCT02135029|12002201|FG000|Overall Study|Adverse Event|2
7596228|NCT02135029|12002202|FG001|Overall Study|Adverse Event|2
7596229|NCT02135029|12002203|FG002|Overall Study|Adverse Event|2
7596230|NCT02135029|12002201|FG000|Overall Study|Lost to Follow-up|0
7596231|NCT02135029|12002202|FG001|Overall Study|Lost to Follow-up|1
7596232|NCT02135029|12002203|FG002|Overall Study|Lost to Follow-up|0
7596233|NCT02135029|12002201|FG000|Overall Study|Withdrawal by Subject|2
7596120|NCT02081391|12002119|FG000|12-hour Treatment|Withdrawal by Subject|3
7596121|NCT02081391|12002120|FG001|12-hour Treatment|Withdrawal by Subject|2
7596122|NCT02081391|12002121|FG002|12-hour Treatment|Withdrawal by Subject|0
7596123|NCT02081391|12002122|FG003|12-hour Treatment|Withdrawal by Subject|0
7596124|NCT02081391|12002119|FG000|12-hour Treatment|Physician Decision|4
7596125|NCT02081391|12002120|FG001|12-hour Treatment|Physician Decision|1
7596126|NCT02081391|12002121|FG002|12-hour Treatment|Physician Decision|0
7596127|NCT02081391|12002122|FG003|12-hour Treatment|Physician Decision|0
7596128|NCT02081391|12002119|FG000|12-hour Treatment|Lack of Efficacy|3
7596129|NCT02081391|12002120|FG001|12-hour Treatment|Lack of Efficacy|0
7596130|NCT02081391|12002121|FG002|12-hour Treatment|Lack of Efficacy|0
7596131|NCT02081391|12002122|FG003|12-hour Treatment|Lack of Efficacy|0
7596132|NCT02081391|12002119|FG000|12-hour Treatment|Adverse Event|4
7596133|NCT02081391|12002120|FG001|12-hour Treatment|Adverse Event|2
7596134|NCT02081391|12002121|FG002|12-hour Treatment|Adverse Event|0
7596135|NCT02081391|12002122|FG003|12-hour Treatment|Adverse Event|0
7596136|NCT02081391|12002119|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2
7596137|NCT02081391|12002120|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0
7596138|NCT02081391|12002121|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1
7596139|NCT02081391|12002122|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0
7596140|NCT02081391|12002119|FG000|12-hour Treatment|Further reasons|2
7596141|NCT02081391|12002120|FG001|12-hour Treatment|Further reasons|1
7596142|NCT02081391|12002121|FG002|12-hour Treatment|Further reasons|0
7596143|NCT02081391|12002122|FG003|12-hour Treatment|Further reasons|0
7596144|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Physician Decision|10
7596145|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Physician Decision|5
7596146|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Physician Decision|0
7596147|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Physician Decision|0
7596148|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1
7596149|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3
7596150|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7596151|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0
7596152|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Adverse Event|1
7596153|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Adverse Event|0
7596154|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Adverse Event|0
7596155|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Adverse Event|0
7596156|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
7596157|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
7596158|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
7596159|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
7596160|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Technical Problems|1
7596161|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Technical Problems|1
7596162|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Technical Problems|0
7596163|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Technical Problems|0
7596164|NCT02081391|12002119|FG000|24-hour Treatment and Trial Completion|Further reasons|3
7596165|NCT02081391|12002120|FG001|24-hour Treatment and Trial Completion|Further reasons|4
7596166|NCT02081391|12002121|FG002|24-hour Treatment and Trial Completion|Further reasons|0
7596167|NCT02081391|12002122|FG003|24-hour Treatment and Trial Completion|Further reasons|0
7596225|NCT02114697|12002187|FG000|Overall Study|Study terminated|5
7596226|NCT02114697|12002188|FG001|Overall Study|Study terminated|4
7596234|NCT02135029|12002202|FG001|Overall Study|Withdrawal by Subject|0
7596235|NCT02135029|12002203|FG002|Overall Study|Withdrawal by Subject|1
7596236|NCT02135029|12002201|FG000|Overall Study|Other|0
7596237|NCT02135029|12002202|FG001|Overall Study|Other|1
7596238|NCT02135029|12002203|FG002|Overall Study|Other|0
7596239|NCT02135029|12002201|FG000|Overall Study|Death|0
7596240|NCT02135029|12002202|FG001|Overall Study|Death|1
7596241|NCT02135029|12002203|FG002|Overall Study|Death|0
7628149|NCT02073279|12041009|FG001|Double-blind Period|Protocol Deviation|1
7628150|NCT02073279|12041008|FG000|Double-blind Period|Withdrawal by Subject|2
7628151|NCT02073279|12041009|FG001|Double-blind Period|Withdrawal by Subject|2
7628152|NCT02073279|12041008|FG000|Double-blind Period|Reason Not Specified|1
7628153|NCT02073279|12041009|FG001|Double-blind Period|Reason Not Specified|2
7628154|NCT02073279|12041008|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
7628155|NCT02073279|12041009|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
7628156|NCT02073279|12041008|FG000|Double-blind Period|On-going in Study|11
7628157|NCT02073279|12041009|FG001|Double-blind Period|On-going in Study|40
7628158|NCT02073279|12041008|FG000|Open-label Extension Period|Lack of Efficacy|1
7628159|NCT02073279|12041009|FG001|Open-label Extension Period|Lack of Efficacy|0
7628160|NCT02073279|12041008|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
7628161|NCT02073279|12041009|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
7628162|NCT02073279|12041008|FG000|Open-label Extension Period|Withdrawal by Subject|1
7628163|NCT02073279|12041009|FG001|Open-label Extension Period|Withdrawal by Subject|1
7628164|NCT02073279|12041008|FG000|Open-label Extension Period|Reason Not Specified|1
7628165|NCT02073279|12041009|FG001|Open-label Extension Period|Reason Not Specified|1
7628166|NCT02073279|12041008|FG000|Open-label Extension Period|On-going in Study|14
7596242|NCT02137239|12002214|FG000|Overall Study|Discontinued Study Treatment|0
7596243|NCT02137239|12002215|FG001|Overall Study|Discontinued Study Treatment|3
7596244|NCT02137239|12002214|FG000|Overall Study|Withdrew Consent|1
7596245|NCT02137239|12002215|FG001|Overall Study|Withdrew Consent|1
7596246|NCT02137239|12002214|FG000|Overall Study|Adverse Event|2
7596247|NCT02137239|12002215|FG001|Overall Study|Adverse Event|2
7628167|NCT02073279|12041009|FG001|Open-label Extension Period|On-going in Study|13
7628168|NCT01544127|12041021|FG000|Overall Study|Lost to Follow-up|4
7628169|NCT01544127|12041022|FG001|Overall Study|Lost to Follow-up|2
7628170|NCT01544127|12041023|FG002|Overall Study|Lost to Follow-up|9
7628171|NCT01544127|12041021|FG000|Overall Study|Withdrawal by Subject|2
7628172|NCT01544127|12041022|FG001|Overall Study|Withdrawal by Subject|2
7628173|NCT01544127|12041023|FG002|Overall Study|Withdrawal by Subject|1
7628174|NCT01544127|12041021|FG000|Overall Study|Discharged out of catchment area|1
7628175|NCT01544127|12041022|FG001|Overall Study|Discharged out of catchment area|1
7628176|NCT01544127|12041023|FG002|Overall Study|Discharged out of catchment area|1
7628177|NCT01544127|12041021|FG000|Overall Study|Death|1
7628178|NCT01544127|12041022|FG001|Overall Study|Death|0
7628179|NCT01544127|12041023|FG002|Overall Study|Death|0
7628180|NCT01544127|12041021|FG000|Overall Study|Jail or Prison|1
7628181|NCT01544127|12041022|FG001|Overall Study|Jail or Prison|1
7628182|NCT01544127|12041023|FG002|Overall Study|Jail or Prison|2
7628183|NCT01544127|12041021|FG000|Overall Study|Became Psychotic|1
7628184|NCT01544127|12041022|FG001|Overall Study|Became Psychotic|0
7628185|NCT01544127|12041023|FG002|Overall Study|Became Psychotic|0
7628186|NCT01544127|12041021|FG000|Overall Study|Researcher withdrew|1
7628187|NCT01544127|12041022|FG001|Overall Study|Researcher withdrew|0
7628188|NCT01544127|12041023|FG002|Overall Study|Researcher withdrew|0
7628189|NCT01544127|12041021|FG000|Overall Study|Went active duty|0
7628190|NCT01544127|12041022|FG001|Overall Study|Went active duty|0
7628191|NCT01544127|12041023|FG002|Overall Study|Went active duty|1
7628192|NCT00442559|12041050|FG000|Overall Study|Lost to Follow-up|32
7628193|NCT00442559|12041051|FG001|Overall Study|Lost to Follow-up|34
7628194|NCT00442559|12041050|FG000|Overall Study|Protocol Violation|1
7628195|NCT00442559|12041051|FG001|Overall Study|Protocol Violation|1
7628196|NCT00442559|12041050|FG000|Overall Study|Withdrawal by Subject|1
7628197|NCT00442559|12041051|FG001|Overall Study|Withdrawal by Subject|0
7628198|NCT00117338|12041065|FG000|Overall Study|Adverse Event|0
7628199|NCT00117338|12041066|FG001|Overall Study|Adverse Event|1
7628200|NCT00117338|12041065|FG000|Overall Study|Protocol Violation|3
7628201|NCT00117338|12041066|FG001|Overall Study|Protocol Violation|2
7628202|NCT00117338|12041065|FG000|Overall Study|Withdrawal by Subject|1
7628203|NCT00117338|12041066|FG001|Overall Study|Withdrawal by Subject|0
7628204|NCT00117338|12041065|FG000|Overall Study|Did not meet Inclusion Criteria|1
7628205|NCT00117338|12041066|FG001|Overall Study|Did not meet Inclusion Criteria|0
7628206|NCT00117338|12041065|FG000|Overall Study|Lack of Efficacy|0
7628207|NCT00117338|12041066|FG001|Overall Study|Lack of Efficacy|1
7596248|NCT02148133|12002221|FG000|Overall Study|Investigator discretion|1
7596249|NCT02148133|12002221|FG000|Overall Study|Lack of Efficacy|1
7596250|NCT02148133|12002221|FG000|Overall Study|Protocol deviation|1
7596251|NCT02148133|12002221|FG000|Overall Study|Protocol-defined stopping criteria|2
7596252|NCT02165215|12002241|FG000|Induction Phase|Adverse Event|1
7596253|NCT02165215|12002242|FG001|Induction Phase|Adverse Event|0
7596254|NCT02165215|12002243|FG002|Induction Phase|Adverse Event|0
7596255|NCT02165215|12002241|FG000|Induction Phase|Withdrawal by Subject|10
7596256|NCT02165215|12002242|FG001|Induction Phase|Withdrawal by Subject|0
7596257|NCT02165215|12002243|FG002|Induction Phase|Withdrawal by Subject|0
7596258|NCT02165215|12002241|FG000|Induction Phase|Protocol Violation|1
7596259|NCT02165215|12002242|FG001|Induction Phase|Protocol Violation|0
7596260|NCT02165215|12002243|FG002|Induction Phase|Protocol Violation|0
7596261|NCT02165215|12002241|FG000|Induction Phase|Physician Decision|1
7596262|NCT02165215|12002242|FG001|Induction Phase|Physician Decision|0
7596263|NCT02165215|12002243|FG002|Induction Phase|Physician Decision|0
7596264|NCT02165215|12002241|FG000|Induction Phase|Lack of Efficacy|2
7596265|NCT02165215|12002242|FG001|Induction Phase|Lack of Efficacy|0
7596266|NCT02165215|12002243|FG002|Induction Phase|Lack of Efficacy|0
7596267|NCT02165215|12002241|FG000|Induction Phase|Non-Compliance|2
7596268|NCT02165215|12002242|FG001|Induction Phase|Non-Compliance|0
7596269|NCT02165215|12002243|FG002|Induction Phase|Non-Compliance|0
7596270|NCT02165215|12002241|FG000|Induction Phase|Lost to Follow-up|6
7596271|NCT02165215|12002242|FG001|Induction Phase|Lost to Follow-up|0
7596272|NCT02165215|12002243|FG002|Induction Phase|Lost to Follow-up|0
7596273|NCT02165215|12002241|FG000|Maintenance Phase|Withdrawal by Subject|0
7596274|NCT02165215|12002242|FG001|Maintenance Phase|Withdrawal by Subject|7
7596275|NCT02165215|12002243|FG002|Maintenance Phase|Withdrawal by Subject|3
7596276|NCT02165215|12002241|FG000|Maintenance Phase|Multiple reasons|0
7596277|NCT02165215|12002242|FG001|Maintenance Phase|Multiple reasons|2
7596278|NCT02165215|12002243|FG002|Maintenance Phase|Multiple reasons|1
7596279|NCT02165215|12002241|FG000|Maintenance Phase|Lost to Follow-up|0
7596280|NCT02165215|12002242|FG001|Maintenance Phase|Lost to Follow-up|2
7596281|NCT02165215|12002243|FG002|Maintenance Phase|Lost to Follow-up|0
7596282|NCT02165215|12002241|FG000|Maintenance Phase|Adverse Event|0
7596283|NCT02165215|12002242|FG001|Maintenance Phase|Adverse Event|1
7596284|NCT02165215|12002243|FG002|Maintenance Phase|Adverse Event|1
7596285|NCT02180217|12002257|FG000|Overall Study|Adverse Event|3
7596286|NCT02180217|12002258|FG001|Overall Study|Adverse Event|2
7596287|NCT02180217|12002259|FG002|Overall Study|Adverse Event|22
7596288|NCT02180217|12002257|FG000|Overall Study|Death|1
7596289|NCT02180217|12002258|FG001|Overall Study|Death|1
7596290|NCT02180217|12002259|FG002|Overall Study|Death|0
7596291|NCT02180217|12002257|FG000|Overall Study|Withdrawal by Subject|1
7596292|NCT02180217|12002258|FG001|Overall Study|Withdrawal by Subject|1
7596293|NCT02180217|12002259|FG002|Overall Study|Withdrawal by Subject|4
7596294|NCT02180217|12002257|FG000|Overall Study|Subject/Guardian decision|5
7596295|NCT02180217|12002258|FG001|Overall Study|Subject/Guardian decision|3
7596296|NCT02180217|12002259|FG002|Overall Study|Subject/Guardian decision|6
7596297|NCT02180217|12002257|FG000|Overall Study|Physician Decision|1
7596298|NCT02180217|12002258|FG001|Overall Study|Physician Decision|1
7596299|NCT02180217|12002259|FG002|Overall Study|Physician Decision|6
7596300|NCT02180217|12002257|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7596301|NCT02180217|12002258|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7596302|NCT02180217|12002259|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7596303|NCT02193867|12002283|FG000|Overall Study|Death|2
7596304|NCT02193867|12002283|FG000|Overall Study|Sponsor Study Termination|2
7596305|NCT02215096|12002290|FG000|Run-In Period (Up to Week 2)|Adverse Event|1
7596306|NCT02215096|12002291|FG001|Run-In Period (Up to Week 2)|Adverse Event|0
7596307|NCT02215096|12002292|FG002|Run-In Period (Up to Week 2)|Adverse Event|0
7596308|NCT02215096|12002293|FG003|Run-In Period (Up to Week 2)|Adverse Event|0
7596309|NCT02215096|12002294|FG004|Run-In Period (Up to Week 2)|Adverse Event|0
7596310|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596311|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596312|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596313|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
7596314|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
7596315|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596316|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596317|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596318|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
7596319|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
7596320|NCT02215096|12002290|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7596321|NCT02215096|12002291|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
7596322|NCT02215096|12002292|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7596323|NCT02215096|12002293|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
7596324|NCT02215096|12002294|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
7628208|NCT04851314|12041074|FG000|Overall Study|Unable to complete research set-up procedures|0
7628209|NCT04851314|12041075|FG001|Overall Study|Unable to complete research set-up procedures|2
7628210|NCT04851314|12041074|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
7628211|NCT04851314|12041075|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
7628212|NCT04823494|12041102|FG000|Overall Study|Programming software malfunction.|1
7628213|NCT04823494|12041103|FG001|Overall Study|Programming software malfunction.|0
7628214|NCT04823494|12041102|FG000|Overall Study|Withdrawal by Subject|1
7628215|NCT04823494|12041103|FG001|Overall Study|Withdrawal by Subject|0
7628216|NCT04823494|12041102|FG000|Overall Study|Devices lost|0
7628217|NCT04823494|12041103|FG001|Overall Study|Devices lost|1
7628221|NCT04799782|12041126|FG000|Washout|Physician Decision|2
7628222|NCT04799782|12041127|FG001|Washout|Physician Decision|0
7628223|NCT04799782|12041126|FG000|Washout|Withdrawal by Subject|0
7628224|NCT04799782|12041127|FG001|Washout|Withdrawal by Subject|2
7628225|NCT04799782|12041126|FG000|Washout|Lost to Follow-up|0
7628226|NCT04799782|12041127|FG001|Washout|Lost to Follow-up|1
7596325|NCT02218697|12002312|FG000|Overall Study|Adverse Event|0
7596326|NCT02218697|12002313|FG001|Overall Study|Adverse Event|2
7596327|NCT02218697|12002312|FG000|Overall Study|Unwilling to be vaccinated in left arm|0
7596328|NCT02218697|12002313|FG001|Overall Study|Unwilling to be vaccinated in left arm|1
7596329|NCT02218697|12002312|FG000|Overall Study|Withdrawal by Subject|2
7596330|NCT02218697|12002313|FG001|Overall Study|Withdrawal by Subject|3
7596331|NCT02221037|12002323|FG000|Overall Study|Physician Decision|0
7596332|NCT02221037|12002324|FG001|Overall Study|Physician Decision|0
7596333|NCT02221037|12002325|FG002|Overall Study|Physician Decision|1
7596334|NCT02221037|12002326|FG003|Overall Study|Physician Decision|0
7596335|NCT02224456|12002340|FG000|Overall Study|Lack of Efficacy|1
7596336|NCT02224456|12002340|FG000|Overall Study|Lost to Follow-up|15
7596337|NCT02224456|12002340|FG000|Overall Study|Withdrawal by Subject|9
7596338|NCT02224456|12002340|FG000|Overall Study|Physician Decision|3
7596339|NCT02224456|12002340|FG000|Overall Study|Death|2
7596340|NCT02224456|12002340|FG000|Overall Study|Pregnancy|4
7596341|NCT02224456|12002340|FG000|Overall Study|Protocol Violation|1
7596342|NCT02224456|12002340|FG000|Overall Study|Treatment Interruptions of ≥28 days|1
7596343|NCT02231762|12002344|FG000|Combination Phase|Adverse Event|10
7596344|NCT02231762|12002345|FG001|Combination Phase|Adverse Event|0
7596345|NCT02231762|12002346|FG002|Combination Phase|Adverse Event|0
7596346|NCT02231762|12002347|FG003|Combination Phase|Adverse Event|0
7596347|NCT02231762|12002344|FG000|Combination Phase|Withdrawal by Subject|2
7596348|NCT02231762|12002345|FG001|Combination Phase|Withdrawal by Subject|0
7596349|NCT02231762|12002346|FG002|Combination Phase|Withdrawal by Subject|0
7596350|NCT02231762|12002347|FG003|Combination Phase|Withdrawal by Subject|0
7596351|NCT02231762|12002344|FG000|Combination Phase|Disease Progression|6
7596352|NCT02231762|12002345|FG001|Combination Phase|Disease Progression|0
7596353|NCT02231762|12002346|FG002|Combination Phase|Disease Progression|0
7596354|NCT02231762|12002347|FG003|Combination Phase|Disease Progression|0
7596355|NCT02231762|12002344|FG000|Combination Phase|Did not meet inclusion criteria|1
7596356|NCT02231762|12002345|FG001|Combination Phase|Did not meet inclusion criteria|0
7596357|NCT02231762|12002346|FG002|Combination Phase|Did not meet inclusion criteria|0
7596358|NCT02231762|12002347|FG003|Combination Phase|Did not meet inclusion criteria|0
7596359|NCT02231762|12002344|FG000|Combination Phase|Protocol Violation|1
7596360|NCT02231762|12002345|FG001|Combination Phase|Protocol Violation|0
7596361|NCT02231762|12002346|FG002|Combination Phase|Protocol Violation|0
7596362|NCT02231762|12002347|FG003|Combination Phase|Protocol Violation|0
7596363|NCT02231762|12002344|FG000|Maintenance Phase|Disease progression|0
7596364|NCT02231762|12002345|FG001|Maintenance Phase|Disease progression|3
7596365|NCT02231762|12002346|FG002|Maintenance Phase|Disease progression|4
7596366|NCT02231762|12002347|FG003|Maintenance Phase|Disease progression|3
7596367|NCT02231762|12002344|FG000|Maintenance Phase|Adverse Event|0
7596368|NCT02231762|12002345|FG001|Maintenance Phase|Adverse Event|0
7596369|NCT02231762|12002346|FG002|Maintenance Phase|Adverse Event|1
7596370|NCT02231762|12002347|FG003|Maintenance Phase|Adverse Event|2
7596371|NCT02234843|12002371|FG000|Overall Study|Death|1
7596372|NCT02234843|12002372|FG001|Overall Study|Death|0
7596373|NCT02234843|12002373|FG002|Overall Study|Death|0
7596374|NCT02234843|12002374|FG003|Overall Study|Death|0
7596375|NCT02234843|12002375|FG004|Overall Study|Death|0
7596376|NCT02234843|12002376|FG005|Overall Study|Death|0
7596377|NCT02234843|12002377|FG006|Overall Study|Death|0
7596378|NCT02234843|12002378|FG007|Overall Study|Death|0
7596379|NCT02234843|12002379|FG008|Overall Study|Death|0
7596380|NCT02234843|12002380|FG009|Overall Study|Death|0
7596381|NCT02234843|12002371|FG000|Overall Study|Protocol Violation|1
7596382|NCT02234843|12002372|FG001|Overall Study|Protocol Violation|0
7596383|NCT02234843|12002373|FG002|Overall Study|Protocol Violation|1
7596384|NCT02234843|12002374|FG003|Overall Study|Protocol Violation|0
7596385|NCT02234843|12002375|FG004|Overall Study|Protocol Violation|0
7596386|NCT02234843|12002376|FG005|Overall Study|Protocol Violation|0
7596387|NCT02234843|12002377|FG006|Overall Study|Protocol Violation|0
7596388|NCT02234843|12002378|FG007|Overall Study|Protocol Violation|0
7596389|NCT02234843|12002379|FG008|Overall Study|Protocol Violation|0
7596390|NCT02234843|12002380|FG009|Overall Study|Protocol Violation|0
7596391|NCT02234843|12002371|FG000|Overall Study|Efficacy outcome reached|2
7596392|NCT02234843|12002372|FG001|Overall Study|Efficacy outcome reached|0
7596393|NCT02234843|12002373|FG002|Overall Study|Efficacy outcome reached|0
7596394|NCT02234843|12002374|FG003|Overall Study|Efficacy outcome reached|0
7596395|NCT02234843|12002375|FG004|Overall Study|Efficacy outcome reached|0
7596396|NCT02234843|12002376|FG005|Overall Study|Efficacy outcome reached|2
7596397|NCT02234843|12002377|FG006|Overall Study|Efficacy outcome reached|0
7596398|NCT02234843|12002378|FG007|Overall Study|Efficacy outcome reached|0
7596399|NCT02234843|12002379|FG008|Overall Study|Efficacy outcome reached|0
7596400|NCT02234843|12002380|FG009|Overall Study|Efficacy outcome reached|0
7596401|NCT02234843|12002371|FG000|Overall Study|Patient convenience|2
7596402|NCT02234843|12002372|FG001|Overall Study|Patient convenience|0
7596403|NCT02234843|12002373|FG002|Overall Study|Patient convenience|0
7596404|NCT02234843|12002374|FG003|Overall Study|Patient convenience|0
7596405|NCT02234843|12002375|FG004|Overall Study|Patient convenience|0
7596406|NCT02234843|12002376|FG005|Overall Study|Patient convenience|1
7596407|NCT02234843|12002377|FG006|Overall Study|Patient convenience|0
7596408|NCT02234843|12002378|FG007|Overall Study|Patient convenience|0
7596409|NCT02234843|12002379|FG008|Overall Study|Patient convenience|0
7596410|NCT02234843|12002380|FG009|Overall Study|Patient convenience|0
7596411|NCT02234843|12002371|FG000|Overall Study|Withdrawal by Subject|5
7596412|NCT02234843|12002372|FG001|Overall Study|Withdrawal by Subject|1
7596413|NCT02234843|12002373|FG002|Overall Study|Withdrawal by Subject|1
7596414|NCT02234843|12002374|FG003|Overall Study|Withdrawal by Subject|0
7596415|NCT02234843|12002375|FG004|Overall Study|Withdrawal by Subject|0
7596416|NCT02234843|12002376|FG005|Overall Study|Withdrawal by Subject|7
7596417|NCT02234843|12002377|FG006|Overall Study|Withdrawal by Subject|0
7596418|NCT02234843|12002378|FG007|Overall Study|Withdrawal by Subject|0
7596419|NCT02234843|12002379|FG008|Overall Study|Withdrawal by Subject|0
7596420|NCT02234843|12002380|FG009|Overall Study|Withdrawal by Subject|0
7596421|NCT02234843|12002371|FG000|Overall Study|Recovery|1
7596422|NCT02234843|12002372|FG001|Overall Study|Recovery|0
7596423|NCT02234843|12002373|FG002|Overall Study|Recovery|0
7596424|NCT02234843|12002374|FG003|Overall Study|Recovery|0
7596425|NCT02234843|12002375|FG004|Overall Study|Recovery|0
7596426|NCT02234843|12002376|FG005|Overall Study|Recovery|0
7596427|NCT02234843|12002377|FG006|Overall Study|Recovery|0
7596428|NCT02234843|12002378|FG007|Overall Study|Recovery|0
7596429|NCT02234843|12002379|FG008|Overall Study|Recovery|0
7596430|NCT02234843|12002380|FG009|Overall Study|Recovery|0
7596431|NCT02234843|12002371|FG000|Overall Study|Other|0
7596432|NCT02234843|12002372|FG001|Overall Study|Other|2
7596433|NCT02234843|12002373|FG002|Overall Study|Other|0
7596434|NCT02234843|12002374|FG003|Overall Study|Other|1
7596435|NCT02234843|12002375|FG004|Overall Study|Other|0
7596436|NCT02234843|12002376|FG005|Overall Study|Other|1
7596437|NCT02234843|12002377|FG006|Overall Study|Other|0
7596438|NCT02234843|12002378|FG007|Overall Study|Other|1
7596439|NCT02234843|12002379|FG008|Overall Study|Other|0
7596440|NCT02234843|12002380|FG009|Overall Study|Other|0
7596441|NCT02234843|12002371|FG000|Overall Study|Physician Decision|4
7596442|NCT02234843|12002372|FG001|Overall Study|Physician Decision|1
7596443|NCT02234843|12002373|FG002|Overall Study|Physician Decision|0
7596444|NCT02234843|12002374|FG003|Overall Study|Physician Decision|1
7596445|NCT02234843|12002375|FG004|Overall Study|Physician Decision|0
7596446|NCT02234843|12002376|FG005|Overall Study|Physician Decision|0
7596447|NCT02234843|12002377|FG006|Overall Study|Physician Decision|0
7596448|NCT02234843|12002378|FG007|Overall Study|Physician Decision|1
7596449|NCT02234843|12002379|FG008|Overall Study|Physician Decision|0
7596450|NCT02234843|12002380|FG009|Overall Study|Physician Decision|0
7596451|NCT02234843|12002371|FG000|Overall Study|Adverse Event|5
7596452|NCT02234843|12002372|FG001|Overall Study|Adverse Event|1
7271747|NCT00423319|11486064|FG001|Overall Study|Death|0
7271748|NCT00423319|11486063|FG000|Overall Study|Adverse Event|93
7271749|NCT00423319|11486064|FG001|Overall Study|Adverse Event|112
7271750|NCT00423319|11486063|FG000|Overall Study|Withdrawal by Subject|86
7271751|NCT00423319|11486064|FG001|Overall Study|Withdrawal by Subject|99
7271752|NCT00423319|11486063|FG000|Overall Study|Lost to Follow-up|4
7596453|NCT02234843|12002373|FG002|Overall Study|Adverse Event|1
7596454|NCT02234843|12002374|FG003|Overall Study|Adverse Event|3
7596455|NCT02234843|12002375|FG004|Overall Study|Adverse Event|2
7271753|NCT00423319|11486064|FG001|Overall Study|Lost to Follow-up|3
7271754|NCT00423319|11486063|FG000|Overall Study|Poor compliance or noncompliance|1
7271755|NCT00423319|11486064|FG001|Overall Study|Poor compliance or noncompliance|1
7271756|NCT00423319|11486063|FG000|Overall Study|No longer meets study criteria|15
7271757|NCT00423319|11486064|FG001|Overall Study|No longer meets study criteria|15
7271758|NCT00423319|11486063|FG000|Overall Study|Other|23
7271759|NCT00423319|11486064|FG001|Overall Study|Other|22
7271760|NCT00423332|11486073|FG000|Overall Study|Adverse Event|6
7271761|NCT00423332|11486074|FG001|Overall Study|Adverse Event|2
7271762|NCT00423332|11486073|FG000|Overall Study|Withdrawal by Subject|1
7271763|NCT00423332|11486074|FG001|Overall Study|Withdrawal by Subject|0
7271764|NCT00423332|11486073|FG000|Overall Study|Condition under investigation worsened|1
7271765|NCT00423332|11486074|FG001|Overall Study|Condition under investigation worsened|1
7271766|NCT00423332|11486073|FG000|Overall Study|Progressive at Week 6|0
7271767|NCT00423332|11486074|FG001|Overall Study|Progressive at Week 6|1
7271768|NCT00423332|11486073|FG000|Overall Study|Unblinded before 12 weeks|1
7271769|NCT00423332|11486074|FG001|Overall Study|Unblinded before 12 weeks|3
7271770|NCT00423449|11486099|FG000|Overall Study|Clinical Adverse Event|1
7271771|NCT00423449|11486100|FG001|Overall Study|Clinical Adverse Event|0
7271772|NCT00423449|11486101|FG002|Overall Study|Clinical Adverse Event|1
7271773|NCT00423449|11486102|FG003|Overall Study|Clinical Adverse Event|8
7271774|NCT00423449|11486103|FG004|Overall Study|Clinical Adverse Event|2
7271775|NCT00423449|11486099|FG000|Overall Study|Death|1
7271776|NCT00423449|11486100|FG001|Overall Study|Death|0
7271777|NCT00423449|11486101|FG002|Overall Study|Death|2
7271778|NCT00423449|11486102|FG003|Overall Study|Death|1
7271779|NCT00423449|11486103|FG004|Overall Study|Death|1
7271780|NCT00423449|11486099|FG000|Overall Study|Progressive Disease|1
7596456|NCT02234843|12002376|FG005|Overall Study|Adverse Event|1
7596457|NCT02234843|12002377|FG006|Overall Study|Adverse Event|0
7596458|NCT02234843|12002378|FG007|Overall Study|Adverse Event|0
7596459|NCT02234843|12002379|FG008|Overall Study|Adverse Event|1
7596460|NCT02234843|12002380|FG009|Overall Study|Adverse Event|0
7596461|NCT02234843|12002371|FG000|Overall Study|Non-compliance with study drug|1
7596462|NCT02234843|12002372|FG001|Overall Study|Non-compliance with study drug|0
7596463|NCT02234843|12002373|FG002|Overall Study|Non-compliance with study drug|0
7596464|NCT02234843|12002374|FG003|Overall Study|Non-compliance with study drug|0
7596465|NCT02234843|12002375|FG004|Overall Study|Non-compliance with study drug|0
7596466|NCT02234843|12002376|FG005|Overall Study|Non-compliance with study drug|1
7596467|NCT02234843|12002377|FG006|Overall Study|Non-compliance with study drug|1
7596468|NCT02234843|12002378|FG007|Overall Study|Non-compliance with study drug|0
7596469|NCT02234843|12002379|FG008|Overall Study|Non-compliance with study drug|0
7596470|NCT02234843|12002380|FG009|Overall Study|Non-compliance with study drug|0
7596471|NCT02234843|12002371|FG000|Overall Study|Lost to Follow-up|0
7596472|NCT02234843|12002372|FG001|Overall Study|Lost to Follow-up|1
7596473|NCT02234843|12002373|FG002|Overall Study|Lost to Follow-up|0
7596474|NCT02234843|12002374|FG003|Overall Study|Lost to Follow-up|0
7596475|NCT02234843|12002375|FG004|Overall Study|Lost to Follow-up|0
7596476|NCT02234843|12002376|FG005|Overall Study|Lost to Follow-up|0
7596477|NCT02234843|12002377|FG006|Overall Study|Lost to Follow-up|1
7596478|NCT02234843|12002378|FG007|Overall Study|Lost to Follow-up|0
7596479|NCT02234843|12002379|FG008|Overall Study|Lost to Follow-up|0
7596480|NCT02234843|12002380|FG009|Overall Study|Lost to Follow-up|0
7628218|NCT04821245|12041111|FG000|Overall Study|Withdrawal by Subject|3
7628219|NCT04821245|12041111|FG000|Overall Study|Physician Decision|1
7271781|NCT00423449|11486100|FG001|Overall Study|Progressive Disease|3
7271782|NCT00423449|11486101|FG002|Overall Study|Progressive Disease|8
7271783|NCT00423449|11486102|FG003|Overall Study|Progressive Disease|11
7271784|NCT00423449|11486103|FG004|Overall Study|Progressive Disease|4
7271785|NCT00423449|11486099|FG000|Overall Study|Laboratory Adverse Event|0
7271786|NCT00423449|11486100|FG001|Overall Study|Laboratory Adverse Event|1
7271787|NCT00423449|11486101|FG002|Overall Study|Laboratory Adverse Event|2
7271788|NCT00423449|11486102|FG003|Overall Study|Laboratory Adverse Event|0
7271789|NCT00423449|11486103|FG004|Overall Study|Laboratory Adverse Event|0
7271790|NCT00423449|11486099|FG000|Overall Study|Other|0
7271791|NCT00423449|11486100|FG001|Overall Study|Other|0
7271792|NCT00423449|11486101|FG002|Overall Study|Other|0
7271793|NCT00423449|11486102|FG003|Overall Study|Other|1
7271794|NCT00423449|11486103|FG004|Overall Study|Other|0
7271795|NCT00423449|11486099|FG000|Overall Study|Protocol Violation|0
7271796|NCT00423449|11486100|FG001|Overall Study|Protocol Violation|0
7271797|NCT00423449|11486101|FG002|Overall Study|Protocol Violation|2
7271798|NCT00423449|11486102|FG003|Overall Study|Protocol Violation|1
7271799|NCT00423449|11486103|FG004|Overall Study|Protocol Violation|0
7271800|NCT00423592|11486116|FG000|Overall Study|Adverse Event (through Week 12)|2
7271801|NCT00423592|11486116|FG000|Overall Study|Adverse Event (post Week 12)|5
7271802|NCT00423605|11486120|FG000|Overall Study|Adverse Event|129
7271803|NCT00423605|11486120|FG000|Overall Study|Withdrawal by Subject|36
7271804|NCT00423605|11486120|FG000|Overall Study|Lost to Follow-up|15
7271805|NCT00423605|11486120|FG000|Overall Study|Lack of Efficacy|38
7271806|NCT00423605|11486120|FG000|Overall Study|Sponsor Decision|3
7271807|NCT00423605|11486120|FG000|Overall Study|Physician Decision|8
7271808|NCT00423605|11486120|FG000|Overall Study|Protocol Violation|7
7271809|NCT00423605|11486120|FG000|Overall Study|Not one of the pre-specified options|5
7271810|NCT00423657|11486126|FG000|Overall Study|Withdrew consent|10
7271811|NCT00423657|11486127|FG001|Overall Study|Withdrew consent|8
7271812|NCT00423657|11486126|FG000|Overall Study|Non-compliance|0
7271813|NCT00423657|11486127|FG001|Overall Study|Non-compliance|1
7271814|NCT00423657|11486126|FG000|Overall Study|Other|15
7271815|NCT00423657|11486127|FG001|Overall Study|Other|16
7271816|NCT00423657|11486126|FG000|Overall Study|Request of sponsor/investigator|1
7628220|NCT04821245|12041111|FG000|Overall Study|Protocol Violation|5
7596481|NCT02243306|12002415|FG000|Overall Study|Adverse Event|0
7596482|NCT02243306|12002416|FG001|Overall Study|Adverse Event|1
7596483|NCT02243306|12002415|FG000|Overall Study|Other: Reached stopping criteria|0
7596484|NCT02243306|12002416|FG001|Overall Study|Other: Reached stopping criteria|1
7596485|NCT02243306|12002415|FG000|Overall Study|Physician Decision|0
7596486|NCT02243306|12002416|FG001|Overall Study|Physician Decision|1
7596493|NCT03926611|12002443|FG000|Overall Study|Adverse Event|0
7596494|NCT03926611|12002444|FG001|Overall Study|Adverse Event|0
7596495|NCT03926611|12002445|FG002|Overall Study|Adverse Event|0
7596496|NCT03926611|12002446|FG003|Overall Study|Adverse Event|3
7596497|NCT03926611|12002447|FG004|Overall Study|Adverse Event|1
7596498|NCT03926611|12002448|FG005|Overall Study|Adverse Event|3
7596499|NCT03926611|12002449|FG006|Overall Study|Adverse Event|0
7596500|NCT03926611|12002443|FG000|Overall Study|Lack of Efficacy|1
7596501|NCT03926611|12002444|FG001|Overall Study|Lack of Efficacy|2
7596502|NCT03926611|12002445|FG002|Overall Study|Lack of Efficacy|0
7596503|NCT03926611|12002446|FG003|Overall Study|Lack of Efficacy|0
7596504|NCT03926611|12002447|FG004|Overall Study|Lack of Efficacy|1
7596505|NCT03926611|12002448|FG005|Overall Study|Lack of Efficacy|0
7596506|NCT03926611|12002449|FG006|Overall Study|Lack of Efficacy|1
7596507|NCT03926611|12002443|FG000|Overall Study|Physician Decision|0
7596508|NCT03926611|12002444|FG001|Overall Study|Physician Decision|0
7596509|NCT03926611|12002445|FG002|Overall Study|Physician Decision|0
7596510|NCT03926611|12002446|FG003|Overall Study|Physician Decision|0
7596511|NCT03926611|12002447|FG004|Overall Study|Physician Decision|0
7596512|NCT03926611|12002448|FG005|Overall Study|Physician Decision|1
7596513|NCT03926611|12002449|FG006|Overall Study|Physician Decision|0
7596514|NCT03926611|12002443|FG000|Overall Study|Protocol Violation|1
7596515|NCT03926611|12002444|FG001|Overall Study|Protocol Violation|0
7596516|NCT03926611|12002445|FG002|Overall Study|Protocol Violation|0
7596517|NCT03926611|12002446|FG003|Overall Study|Protocol Violation|1
7596518|NCT03926611|12002447|FG004|Overall Study|Protocol Violation|1
7596519|NCT03926611|12002448|FG005|Overall Study|Protocol Violation|1
7596520|NCT03926611|12002449|FG006|Overall Study|Protocol Violation|1
7596521|NCT03926611|12002443|FG000|Overall Study|Technical problems|0
7596522|NCT03926611|12002444|FG001|Overall Study|Technical problems|0
7596523|NCT03926611|12002445|FG002|Overall Study|Technical problems|0
7596524|NCT03926611|12002446|FG003|Overall Study|Technical problems|0
7596525|NCT03926611|12002447|FG004|Overall Study|Technical problems|0
7596526|NCT03926611|12002448|FG005|Overall Study|Technical problems|1
7596527|NCT03926611|12002449|FG006|Overall Study|Technical problems|0
7596528|NCT03926611|12002443|FG000|Overall Study|Withdrawal by Subject|1
7596529|NCT03926611|12002444|FG001|Overall Study|Withdrawal by Subject|1
7596530|NCT03926611|12002445|FG002|Overall Study|Withdrawal by Subject|1
7596531|NCT03926611|12002446|FG003|Overall Study|Withdrawal by Subject|0
7596532|NCT03926611|12002447|FG004|Overall Study|Withdrawal by Subject|0
7596533|NCT03926611|12002448|FG005|Overall Study|Withdrawal by Subject|1
7596534|NCT03926611|12002449|FG006|Overall Study|Withdrawal by Subject|3
7596535|NCT03926611|12002443|FG000|Overall Study|Covid-19 pandemic|0
7596536|NCT03926611|12002444|FG001|Overall Study|Covid-19 pandemic|0
7596537|NCT03926611|12002445|FG002|Overall Study|Covid-19 pandemic|1
7596538|NCT03926611|12002446|FG003|Overall Study|Covid-19 pandemic|0
7596539|NCT03926611|12002447|FG004|Overall Study|Covid-19 pandemic|1
7596540|NCT03926611|12002448|FG005|Overall Study|Covid-19 pandemic|2
7596541|NCT03926611|12002449|FG006|Overall Study|Covid-19 pandemic|0
7596542|NCT03838484|12002473|FG000|Overall Study|Lost to Follow-up|0
7596543|NCT03838484|12002474|FG001|Overall Study|Lost to Follow-up|1
7596544|NCT03838484|12002475|FG002|Overall Study|Lost to Follow-up|0
7596545|NCT03838484|12002476|FG003|Overall Study|Lost to Follow-up|0
7596546|NCT03814720|12002497|FG000|Overall Study|Lost to Follow-up|0
7596547|NCT03814720|12002498|FG001|Overall Study|Lost to Follow-up|1
7596548|NCT03814720|12002499|FG002|Overall Study|Lost to Follow-up|0
7596549|NCT03814720|12002500|FG003|Overall Study|Lost to Follow-up|0
7596550|NCT03814720|12002501|FG004|Overall Study|Lost to Follow-up|0
7596551|NCT03635424|12002515|FG000|Overall Study|Adverse Event|1
7596552|NCT03635424|12002515|FG000|Overall Study|Death|1
7596553|NCT03635424|12002515|FG000|Overall Study|Device not implanted|1
7596554|NCT03529110|12002521|FG000|Overall Study|Progressive Disease|66
7596555|NCT03529110|12002522|FG001|Overall Study|Progressive Disease|158
7596556|NCT03529110|12002521|FG000|Overall Study|Clinical Progression|4
7596557|NCT03529110|12002522|FG001|Overall Study|Clinical Progression|12
7596558|NCT03529110|12002521|FG000|Overall Study|Adverse Event|35
7596559|NCT03529110|12002522|FG001|Overall Study|Adverse Event|17
7596560|NCT03529110|12002521|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13
7596561|NCT03529110|12002522|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11
7596562|NCT03529110|12002521|FG000|Overall Study|Lack of Efficacy|3
7596563|NCT03529110|12002522|FG001|Overall Study|Lack of Efficacy|3
7596564|NCT03529110|12002521|FG000|Overall Study|Physician Decision|2
7596565|NCT03529110|12002522|FG001|Overall Study|Physician Decision|8
7596566|NCT03529110|12002521|FG000|Overall Study|Miscellaneous|2
7596567|NCT03529110|12002522|FG001|Overall Study|Miscellaneous|5
7596568|NCT03517540|12002532|FG000|Overall Study|Protocol Violation|2
7596569|NCT03517540|12002533|FG001|Overall Study|Protocol Violation|0
7596570|NCT03517540|12002534|FG002|Overall Study|Protocol Violation|0
7596571|NCT03517540|12002535|FG003|Overall Study|Protocol Violation|1
7596572|NCT03517540|12002532|FG000|Overall Study|Adverse Event|9
7596573|NCT03517540|12002533|FG001|Overall Study|Adverse Event|3
7596574|NCT03517540|12002534|FG002|Overall Study|Adverse Event|8
7596575|NCT03517540|12002535|FG003|Overall Study|Adverse Event|1
7596576|NCT03517540|12002532|FG000|Overall Study|Withdrawal by Subject|3
7596577|NCT03517540|12002533|FG001|Overall Study|Withdrawal by Subject|4
7596578|NCT03517540|12002534|FG002|Overall Study|Withdrawal by Subject|1
7596579|NCT03517540|12002535|FG003|Overall Study|Withdrawal by Subject|3
7596580|NCT03437278|12002557|FG000|Overall Study|Adverse Event|0
7596581|NCT03437278|12002558|FG001|Overall Study|Adverse Event|0
7596582|NCT03437278|12002559|FG002|Overall Study|Adverse Event|1
7596583|NCT03437278|12002557|FG000|Overall Study|Progressive disease|1
7596584|NCT03437278|12002558|FG001|Overall Study|Progressive disease|0
7596585|NCT03437278|12002559|FG002|Overall Study|Progressive disease|0
7596586|NCT03437278|12002557|FG000|Overall Study|Physician Decision|1
7596587|NCT03437278|12002558|FG001|Overall Study|Physician Decision|0
7596588|NCT03437278|12002559|FG002|Overall Study|Physician Decision|1
7596589|NCT03350815|12002569|FG000|Period 1|Adverse Event|10
7596590|NCT03350815|12002570|FG001|Period 1|Adverse Event|0
7596591|NCT03350815|12002571|FG002|Period 1|Adverse Event|0
7596592|NCT03350815|12002572|FG003|Period 1|Adverse Event|0
7596593|NCT03350815|12002569|FG000|Period 1|Technical problems|1
7596594|NCT03350815|12002570|FG001|Period 1|Technical problems|0
7596595|NCT03350815|12002571|FG002|Period 1|Technical problems|0
7596596|NCT03350815|12002572|FG003|Period 1|Technical problems|0
7596597|NCT03350815|12002569|FG000|Period 1|Lost to Follow-up|3
7596598|NCT03350815|12002570|FG001|Period 1|Lost to Follow-up|0
7596599|NCT03350815|12002571|FG002|Period 1|Lost to Follow-up|0
7596600|NCT03350815|12002572|FG003|Period 1|Lost to Follow-up|0
7596601|NCT03350815|12002569|FG000|Period 1|Physician Decision|1
7596602|NCT03350815|12002570|FG001|Period 1|Physician Decision|0
7596603|NCT03350815|12002571|FG002|Period 1|Physician Decision|0
7596604|NCT03350815|12002572|FG003|Period 1|Physician Decision|0
7596605|NCT03350815|12002569|FG000|Period 1|Withdrawal by Subject|8
7596606|NCT03350815|12002570|FG001|Period 1|Withdrawal by Subject|0
7596607|NCT03350815|12002571|FG002|Period 1|Withdrawal by Subject|0
7596608|NCT03350815|12002572|FG003|Period 1|Withdrawal by Subject|0
7596609|NCT03350815|12002569|FG000|Period 1|Lack of Efficacy|15
7596610|NCT03350815|12002570|FG001|Period 1|Lack of Efficacy|0
7596611|NCT03350815|12002571|FG002|Period 1|Lack of Efficacy|0
7596612|NCT03350815|12002572|FG003|Period 1|Lack of Efficacy|0
7596613|NCT03350815|12002569|FG000|Period 1|Non-compliance with study treatment|2
7596614|NCT03350815|12002570|FG001|Period 1|Non-compliance with study treatment|0
7596615|NCT03350815|12002571|FG002|Period 1|Non-compliance with study treatment|0
7596616|NCT03350815|12002572|FG003|Period 1|Non-compliance with study treatment|0
7596617|NCT03350815|12002569|FG000|Period 1|Protocol Violation|3
7596618|NCT03350815|12002570|FG001|Period 1|Protocol Violation|0
7596619|NCT03350815|12002571|FG002|Period 1|Protocol Violation|0
7596620|NCT03350815|12002572|FG003|Period 1|Protocol Violation|0
7596621|NCT03350815|12002569|FG000|Period 2|Adverse Event|0
7596622|NCT03350815|12002570|FG001|Period 2|Adverse Event|3
7596623|NCT03350815|12002571|FG002|Period 2|Adverse Event|5
7596624|NCT03350815|12002572|FG003|Period 2|Adverse Event|0
7596625|NCT03350815|12002569|FG000|Period 2|Technical problem|0
7596626|NCT03350815|12002570|FG001|Period 2|Technical problem|1
7596627|NCT03350815|12002571|FG002|Period 2|Technical problem|0
7596628|NCT03350815|12002572|FG003|Period 2|Technical problem|0
7596629|NCT03350815|12002569|FG000|Period 2|Lost to Follow-up|0
7596630|NCT03350815|12002570|FG001|Period 2|Lost to Follow-up|3
7596631|NCT03350815|12002571|FG002|Period 2|Lost to Follow-up|3
7596632|NCT03350815|12002572|FG003|Period 2|Lost to Follow-up|0
7596633|NCT03350815|12002569|FG000|Period 2|Physician Decision|0
7596634|NCT03350815|12002570|FG001|Period 2|Physician Decision|0
7596635|NCT03350815|12002571|FG002|Period 2|Physician Decision|1
7596636|NCT03350815|12002572|FG003|Period 2|Physician Decision|0
7596637|NCT03350815|12002569|FG000|Period 2|Withdrawal by Subject|0
7596638|NCT03350815|12002570|FG001|Period 2|Withdrawal by Subject|3
7596639|NCT03350815|12002571|FG002|Period 2|Withdrawal by Subject|4
7596640|NCT03350815|12002572|FG003|Period 2|Withdrawal by Subject|0
7596641|NCT03350815|12002569|FG000|Period 2|Lack of Efficacy|0
7596642|NCT03350815|12002570|FG001|Period 2|Lack of Efficacy|6
7596643|NCT03350815|12002571|FG002|Period 2|Lack of Efficacy|2
7596644|NCT03350815|12002572|FG003|Period 2|Lack of Efficacy|0
7596645|NCT03350815|12002569|FG000|Period 2|Protocol Violation|0
7596646|NCT03350815|12002570|FG001|Period 2|Protocol Violation|0
7596647|NCT03350815|12002571|FG002|Period 2|Protocol Violation|1
7596648|NCT03350815|12002572|FG003|Period 2|Protocol Violation|0
7596649|NCT03350815|12002569|FG000|Period 2|New therapy for study indication|0
7596650|NCT03350815|12002570|FG001|Period 2|New therapy for study indication|0
7596651|NCT03350815|12002571|FG002|Period 2|New therapy for study indication|1
7596652|NCT03350815|12002572|FG003|Period 2|New therapy for study indication|0
7596653|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7596654|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1
7596655|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7596656|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1
7596657|NCT03249714|12002585|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1
7596658|NCT03249714|12002586|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0
7596659|NCT03249714|12002585|FG000|Open-label Treatment (Extension Part)|Adverse Event|2
7596660|NCT03249714|12002586|FG001|Open-label Treatment (Extension Part)|Adverse Event|0
7596661|NCT03170882|12002610|FG000|Overall Study|Ongoing|10
7596662|NCT03170882|12002611|FG001|Overall Study|Ongoing|14
7596663|NCT03170882|12002610|FG000|Overall Study|Death|15
7596664|NCT03170882|12002611|FG001|Overall Study|Death|29
7596665|NCT03170882|12002610|FG000|Overall Study|Lost to Follow-up|0
7596666|NCT03170882|12002611|FG001|Overall Study|Lost to Follow-up|1
7596667|NCT03170882|12002610|FG000|Overall Study|Withdrawal by Subject|4
7596668|NCT03170882|12002611|FG001|Overall Study|Withdrawal by Subject|6
7596669|NCT03170882|12002610|FG000|Overall Study|Reason not Specified|0
7596670|NCT03170882|12002611|FG001|Overall Study|Reason not Specified|1
7596671|NCT03074318|12002621|FG000|Overall Study|Adverse Event|0
7596672|NCT03074318|12002622|FG001|Overall Study|Adverse Event|1
7596673|NCT03074318|12002623|FG002|Overall Study|Adverse Event|1
7596674|NCT03074318|12002624|FG003|Overall Study|Adverse Event|1
7596675|NCT03074318|12002621|FG000|Overall Study|Death|1
7596676|NCT03074318|12002622|FG001|Overall Study|Death|0
7596677|NCT03074318|12002623|FG002|Overall Study|Death|0
7596678|NCT03074318|12002624|FG003|Overall Study|Death|0
7596679|NCT03074318|12002621|FG000|Overall Study|Withdrawal by Subject|1
7596680|NCT03074318|12002622|FG001|Overall Study|Withdrawal by Subject|2
7596681|NCT03074318|12002623|FG002|Overall Study|Withdrawal by Subject|2
7596682|NCT03074318|12002624|FG003|Overall Study|Withdrawal by Subject|4
7596683|NCT03074318|12002621|FG000|Overall Study|Trial Closure|2
7596684|NCT03074318|12002622|FG001|Overall Study|Trial Closure|2
7596685|NCT03074318|12002623|FG002|Overall Study|Trial Closure|3
7596686|NCT03074318|12002624|FG003|Overall Study|Trial Closure|11
7596687|NCT03010319|12002645|FG000|Overall Study|Adverse Event|15
7596688|NCT03010319|12002646|FG001|Overall Study|Adverse Event|9
7596689|NCT03010319|12002645|FG000|Overall Study|Withdrawal by Subject|1
7596690|NCT03010319|12002646|FG001|Overall Study|Withdrawal by Subject|6
7596691|NCT03010319|12002645|FG000|Overall Study|Physician Decision|2
7596692|NCT03010319|12002646|FG001|Overall Study|Physician Decision|4
7596693|NCT03010319|12002645|FG000|Overall Study|Sponsor requested withdrawal|2
7596694|NCT03010319|12002646|FG001|Overall Study|Sponsor requested withdrawal|2
7596695|NCT03010319|12002645|FG000|Overall Study|Death|1
7596696|NCT03010319|12002646|FG001|Overall Study|Death|0
7596697|NCT03010319|12002645|FG000|Overall Study|Lost to Follow-up|0
7596698|NCT03010319|12002646|FG001|Overall Study|Lost to Follow-up|1
7596699|NCT03010319|12002645|FG000|Overall Study|Other Reason|5
7596700|NCT03010319|12002646|FG001|Overall Study|Other Reason|7
7596701|NCT02915016|12002660|FG000|Overall Study|Lost to Follow-up|4
7596702|NCT02915016|12002661|FG001|Overall Study|Lost to Follow-up|2
7596703|NCT02915016|12002662|FG002|Overall Study|Lost to Follow-up|5
7596704|NCT02915016|12002663|FG003|Overall Study|Lost to Follow-up|3
7596705|NCT02915016|12002664|FG004|Overall Study|Lost to Follow-up|5
7596706|NCT02915016|12002665|FG005|Overall Study|Lost to Follow-up|2
7596707|NCT02915016|12002666|FG006|Overall Study|Lost to Follow-up|8
7596708|NCT02915016|12002667|FG007|Overall Study|Lost to Follow-up|2
7596709|NCT02915016|12002660|FG000|Overall Study|Physician Decision|0
7596710|NCT02915016|12002661|FG001|Overall Study|Physician Decision|0
7596711|NCT02915016|12002662|FG002|Overall Study|Physician Decision|1
7596712|NCT02915016|12002663|FG003|Overall Study|Physician Decision|0
7596713|NCT02915016|12002664|FG004|Overall Study|Physician Decision|0
7596714|NCT02915016|12002665|FG005|Overall Study|Physician Decision|1
7596715|NCT02915016|12002666|FG006|Overall Study|Physician Decision|2
7596716|NCT02915016|12002667|FG007|Overall Study|Physician Decision|0
7596717|NCT02915016|12002660|FG000|Overall Study|Withdrawal by Subject|2
7596718|NCT02915016|12002661|FG001|Overall Study|Withdrawal by Subject|0
7596719|NCT02915016|12002662|FG002|Overall Study|Withdrawal by Subject|1
7596720|NCT02915016|12002663|FG003|Overall Study|Withdrawal by Subject|0
7596721|NCT02915016|12002664|FG004|Overall Study|Withdrawal by Subject|1
7596722|NCT02915016|12002665|FG005|Overall Study|Withdrawal by Subject|3
7596723|NCT02915016|12002666|FG006|Overall Study|Withdrawal by Subject|1
7596724|NCT02915016|12002667|FG007|Overall Study|Withdrawal by Subject|1
7596725|NCT02915016|12002660|FG000|Overall Study|Elected not to continue|0
7596726|NCT02915016|12002661|FG001|Overall Study|Elected not to continue|0
7596727|NCT02915016|12002662|FG002|Overall Study|Elected not to continue|0
7596728|NCT02915016|12002663|FG003|Overall Study|Elected not to continue|1
7596729|NCT02915016|12002664|FG004|Overall Study|Elected not to continue|0
7596730|NCT02915016|12002665|FG005|Overall Study|Elected not to continue|0
7596731|NCT02915016|12002666|FG006|Overall Study|Elected not to continue|1
7596732|NCT02915016|12002667|FG007|Overall Study|Elected not to continue|0
7596733|NCT02915016|12002660|FG000|Overall Study|HIV infection|1
7596734|NCT02915016|12002661|FG001|Overall Study|HIV infection|1
7596735|NCT02915016|12002662|FG002|Overall Study|HIV infection|1
7596736|NCT02915016|12002663|FG003|Overall Study|HIV infection|0
7596737|NCT02915016|12002664|FG004|Overall Study|HIV infection|1
7596738|NCT02915016|12002665|FG005|Overall Study|HIV infection|0
7596739|NCT02915016|12002666|FG006|Overall Study|HIV infection|0
7596740|NCT02915016|12002667|FG007|Overall Study|HIV infection|0
7596741|NCT02915016|12002660|FG000|Overall Study|Participant unable to adhere|0
7596742|NCT02915016|12002661|FG001|Overall Study|Participant unable to adhere|0
7596743|NCT02915016|12002662|FG002|Overall Study|Participant unable to adhere|0
7596744|NCT02915016|12002663|FG003|Overall Study|Participant unable to adhere|0
7596745|NCT02915016|12002664|FG004|Overall Study|Participant unable to adhere|0
7596746|NCT02915016|12002665|FG005|Overall Study|Participant unable to adhere|0
7596747|NCT02915016|12002666|FG006|Overall Study|Participant unable to adhere|0
7596748|NCT02915016|12002667|FG007|Overall Study|Participant unable to adhere|1
7596749|NCT02871401|12002687|FG000|Overall Study|Adverse Event|1
7596750|NCT02871401|12002688|FG001|Overall Study|Adverse Event|0
7596751|NCT02701283|12002706|FG000|Overall Study|Death|25
7596752|NCT02701283|12002707|FG001|Overall Study|Death|29
7596753|NCT02701283|12002708|FG002|Overall Study|Death|19
7596754|NCT02701283|12002706|FG000|Overall Study|Lost to Follow-up|3
7596755|NCT02701283|12002707|FG001|Overall Study|Lost to Follow-up|8
7596756|NCT02701283|12002708|FG002|Overall Study|Lost to Follow-up|1
7596757|NCT02701283|12002706|FG000|Overall Study|Withdrawal by Subject|12
7596758|NCT02701283|12002707|FG001|Overall Study|Withdrawal by Subject|41
7596759|NCT02701283|12002708|FG002|Overall Study|Withdrawal by Subject|1
7596760|NCT02701283|12002706|FG000|Overall Study|Missed 2-year visit|22
7596761|NCT02701283|12002707|FG001|Overall Study|Missed 2-year visit|27
7596762|NCT02701283|12002708|FG002|Overall Study|Missed 2-year visit|0
7596763|NCT02701283|12002706|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
7596764|NCT02701283|12002707|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
7596765|NCT02701283|12002708|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
7596766|NCT02696031|12002722|FG000|Up to Week 24|Adverse Event|2
7596767|NCT02696031|12002723|FG001|Up to Week 24|Adverse Event|4
7596768|NCT02696031|12002724|FG002|Up to Week 24|Adverse Event|2
7596769|NCT02696031|12002725|FG003|Up to Week 24|Adverse Event|0
7596770|NCT02696031|12002726|FG004|Up to Week 24|Adverse Event|0
7596771|NCT02696031|12002727|FG005|Up to Week 24|Adverse Event|0
7596772|NCT02696031|12002722|FG000|Up to Week 24|Lack of Efficacy|2
7596773|NCT02696031|12002723|FG001|Up to Week 24|Lack of Efficacy|1
7596774|NCT02696031|12002724|FG002|Up to Week 24|Lack of Efficacy|2
7596775|NCT02696031|12002725|FG003|Up to Week 24|Lack of Efficacy|0
7596776|NCT02696031|12002726|FG004|Up to Week 24|Lack of Efficacy|0
7596777|NCT02696031|12002727|FG005|Up to Week 24|Lack of Efficacy|0
7596778|NCT02696031|12002722|FG000|Up to Week 24|Lost to Follow-up|0
7596779|NCT02696031|12002723|FG001|Up to Week 24|Lost to Follow-up|1
7596780|NCT02696031|12002724|FG002|Up to Week 24|Lost to Follow-up|1
7596781|NCT02696031|12002725|FG003|Up to Week 24|Lost to Follow-up|0
7596782|NCT02696031|12002726|FG004|Up to Week 24|Lost to Follow-up|0
7596783|NCT02696031|12002727|FG005|Up to Week 24|Lost to Follow-up|0
7596784|NCT02696031|12002722|FG000|Up to Week 24|Physician Decision|1
7596785|NCT02696031|12002723|FG001|Up to Week 24|Physician Decision|0
7596786|NCT02696031|12002724|FG002|Up to Week 24|Physician Decision|1
7596787|NCT02696031|12002725|FG003|Up to Week 24|Physician Decision|0
7596788|NCT02696031|12002726|FG004|Up to Week 24|Physician Decision|0
7596789|NCT02696031|12002727|FG005|Up to Week 24|Physician Decision|0
7596790|NCT02696031|12002722|FG000|Up to Week 24|Protocol Violation|1
7596791|NCT02696031|12002723|FG001|Up to Week 24|Protocol Violation|0
7596792|NCT02696031|12002724|FG002|Up to Week 24|Protocol Violation|0
7596793|NCT02696031|12002725|FG003|Up to Week 24|Protocol Violation|0
7596794|NCT02696031|12002726|FG004|Up to Week 24|Protocol Violation|0
7596795|NCT02696031|12002727|FG005|Up to Week 24|Protocol Violation|0
7596796|NCT02696031|12002722|FG000|Up to Week 24|Withdrawal by Subject|4
7596797|NCT02696031|12002723|FG001|Up to Week 24|Withdrawal by Subject|1
7596798|NCT02696031|12002724|FG002|Up to Week 24|Withdrawal by Subject|5
7596799|NCT02696031|12002725|FG003|Up to Week 24|Withdrawal by Subject|0
7596800|NCT02696031|12002726|FG004|Up to Week 24|Withdrawal by Subject|0
7596801|NCT02696031|12002727|FG005|Up to Week 24|Withdrawal by Subject|0
7596802|NCT02696031|12002722|FG000|Up to Week 52|Adverse Event|4
7596803|NCT02696031|12002723|FG001|Up to Week 52|Adverse Event|5
7596804|NCT02696031|12002724|FG002|Up to Week 52|Adverse Event|3
7596805|NCT02696031|12002725|FG003|Up to Week 52|Adverse Event|0
7596806|NCT02696031|12002726|FG004|Up to Week 52|Adverse Event|0
7596807|NCT02696031|12002727|FG005|Up to Week 52|Adverse Event|0
7596808|NCT02696031|12002722|FG000|Up to Week 52|Lack of Efficacy|10
7596809|NCT02696031|12002723|FG001|Up to Week 52|Lack of Efficacy|7
7596810|NCT02696031|12002724|FG002|Up to Week 52|Lack of Efficacy|11
7596811|NCT02696031|12002725|FG003|Up to Week 52|Lack of Efficacy|0
7596812|NCT02696031|12002726|FG004|Up to Week 52|Lack of Efficacy|0
7596813|NCT02696031|12002727|FG005|Up to Week 52|Lack of Efficacy|0
7596814|NCT02696031|12002722|FG000|Up to Week 52|Lost to Follow-up|1
7596815|NCT02696031|12002723|FG001|Up to Week 52|Lost to Follow-up|1
7596816|NCT02696031|12002724|FG002|Up to Week 52|Lost to Follow-up|1
7596817|NCT02696031|12002725|FG003|Up to Week 52|Lost to Follow-up|0
7596818|NCT02696031|12002726|FG004|Up to Week 52|Lost to Follow-up|0
7596819|NCT02696031|12002727|FG005|Up to Week 52|Lost to Follow-up|0
7596820|NCT02696031|12002722|FG000|Up to Week 52|Physician Decision|1
7596821|NCT02696031|12002723|FG001|Up to Week 52|Physician Decision|1
7596822|NCT02696031|12002724|FG002|Up to Week 52|Physician Decision|2
7596823|NCT02696031|12002725|FG003|Up to Week 52|Physician Decision|0
7596824|NCT02696031|12002726|FG004|Up to Week 52|Physician Decision|0
7596825|NCT02696031|12002727|FG005|Up to Week 52|Physician Decision|0
7596826|NCT02696031|12002722|FG000|Up to Week 52|Pregnancy|0
7596827|NCT02696031|12002723|FG001|Up to Week 52|Pregnancy|2
7596828|NCT02696031|12002724|FG002|Up to Week 52|Pregnancy|0
7596829|NCT02696031|12002725|FG003|Up to Week 52|Pregnancy|0
7596830|NCT02696031|12002726|FG004|Up to Week 52|Pregnancy|0
7596831|NCT02696031|12002727|FG005|Up to Week 52|Pregnancy|0
7596832|NCT02696031|12002722|FG000|Up to Week 52|Protocol Violation|1
7596833|NCT02696031|12002723|FG001|Up to Week 52|Protocol Violation|0
7596834|NCT02696031|12002724|FG002|Up to Week 52|Protocol Violation|0
7596835|NCT02696031|12002725|FG003|Up to Week 52|Protocol Violation|0
7271817|NCT00423657|11486127|FG001|Overall Study|Request of sponsor/investigator|0
7271818|NCT00423670|11486140|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
7271819|NCT00423670|11486141|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
7271820|NCT00423670|11486142|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
7271821|NCT00423670|11486143|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
7271822|NCT00423670|11486144|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
7271823|NCT00423670|11486145|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
7271824|NCT00423670|11486146|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
7271825|NCT00423670|11486147|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
7271826|NCT00423670|11486140|FG000|Treatment Period|Adverse Event|8
7271827|NCT00423670|11486141|FG001|Treatment Period|Adverse Event|12
7271828|NCT00423670|11486142|FG002|Treatment Period|Adverse Event|15
7271829|NCT00423670|11486143|FG003|Treatment Period|Adverse Event|20
7271830|NCT00423670|11486144|FG004|Treatment Period|Adverse Event|9
7271831|NCT00423670|11486145|FG005|Treatment Period|Adverse Event|4
7271832|NCT00423670|11486146|FG006|Treatment Period|Adverse Event|7
7271833|NCT00423670|11486147|FG007|Treatment Period|Adverse Event|2
7271834|NCT00423670|11486140|FG000|Treatment Period|Protocol-defined clinical event|0
7271835|NCT00423670|11486141|FG001|Treatment Period|Protocol-defined clinical event|7
7271836|NCT00423670|11486142|FG002|Treatment Period|Protocol-defined clinical event|4
7271837|NCT00423670|11486143|FG003|Treatment Period|Protocol-defined clinical event|12
7271838|NCT00423670|11486144|FG004|Treatment Period|Protocol-defined clinical event|5
7271839|NCT00423670|11486145|FG005|Treatment Period|Protocol-defined clinical event|4
7271840|NCT00423670|11486146|FG006|Treatment Period|Protocol-defined clinical event|16
7271841|NCT00423670|11486147|FG007|Treatment Period|Protocol-defined clinical event|15
7271842|NCT00423670|11486140|FG000|Treatment Period|Lost to Follow-up|2
7271843|NCT00423670|11486141|FG001|Treatment Period|Lost to Follow-up|1
7271844|NCT00423670|11486142|FG002|Treatment Period|Lost to Follow-up|3
7271845|NCT00423670|11486143|FG003|Treatment Period|Lost to Follow-up|1
7271846|NCT00423670|11486144|FG004|Treatment Period|Lost to Follow-up|6
7271847|NCT00423670|11486145|FG005|Treatment Period|Lost to Follow-up|0
7271848|NCT00423670|11486146|FG006|Treatment Period|Lost to Follow-up|3
7271849|NCT00423670|11486147|FG007|Treatment Period|Lost to Follow-up|1
7271850|NCT00423670|11486140|FG000|Treatment Period|Subject withdrew (not treatment related)|3
7271851|NCT00423670|11486141|FG001|Treatment Period|Subject withdrew (not treatment related)|9
7271852|NCT00423670|11486142|FG002|Treatment Period|Subject withdrew (not treatment related)|4
7271853|NCT00423670|11486143|FG003|Treatment Period|Subject withdrew (not treatment related)|4
7271854|NCT00423670|11486144|FG004|Treatment Period|Subject withdrew (not treatment related)|5
7271855|NCT00423670|11486145|FG005|Treatment Period|Subject withdrew (not treatment related)|0
7271856|NCT00423670|11486146|FG006|Treatment Period|Subject withdrew (not treatment related)|3
7271857|NCT00423670|11486147|FG007|Treatment Period|Subject withdrew (not treatment related)|0
7271858|NCT00423670|11486140|FG000|Treatment Period|Investigator decision|0
7596836|NCT02696031|12002726|FG004|Up to Week 52|Protocol Violation|0
7596837|NCT02696031|12002727|FG005|Up to Week 52|Protocol Violation|0
7596838|NCT02696031|12002722|FG000|Up to Week 52|Withdrawal by Subject|12
7596839|NCT02696031|12002723|FG001|Up to Week 52|Withdrawal by Subject|3
7596840|NCT02696031|12002724|FG002|Up to Week 52|Withdrawal by Subject|9
7596841|NCT02696031|12002725|FG003|Up to Week 52|Withdrawal by Subject|0
7596842|NCT02696031|12002726|FG004|Up to Week 52|Withdrawal by Subject|0
7596843|NCT02696031|12002727|FG005|Up to Week 52|Withdrawal by Subject|0
7596844|NCT02696031|12002722|FG000|Up to Week 104|Pregnancy|0
7596845|NCT02696031|12002723|FG001|Up to Week 104|Pregnancy|2
7596846|NCT02696031|12002724|FG002|Up to Week 104|Pregnancy|1
7596847|NCT02696031|12002725|FG003|Up to Week 104|Pregnancy|0
7596848|NCT02696031|12002726|FG004|Up to Week 104|Pregnancy|0
7596849|NCT02696031|12002727|FG005|Up to Week 104|Pregnancy|0
7596850|NCT02696031|12002722|FG000|Up to Week 104|Withdrawal by Subject|15
7596851|NCT02696031|12002723|FG001|Up to Week 104|Withdrawal by Subject|10
7596852|NCT02696031|12002724|FG002|Up to Week 104|Withdrawal by Subject|16
7596853|NCT02696031|12002725|FG003|Up to Week 104|Withdrawal by Subject|0
7596854|NCT02696031|12002726|FG004|Up to Week 104|Withdrawal by Subject|0
7596855|NCT02696031|12002727|FG005|Up to Week 104|Withdrawal by Subject|0
7596856|NCT02696031|12002722|FG000|Up to Week 104|Protocol Violation|1
7596857|NCT02696031|12002723|FG001|Up to Week 104|Protocol Violation|0
7596858|NCT02696031|12002724|FG002|Up to Week 104|Protocol Violation|0
7596859|NCT02696031|12002725|FG003|Up to Week 104|Protocol Violation|0
7596860|NCT02696031|12002726|FG004|Up to Week 104|Protocol Violation|0
7596861|NCT02696031|12002727|FG005|Up to Week 104|Protocol Violation|0
7596862|NCT02696031|12002722|FG000|Up to Week 104|Physician Decision|1
7596863|NCT02696031|12002723|FG001|Up to Week 104|Physician Decision|2
7596864|NCT02696031|12002724|FG002|Up to Week 104|Physician Decision|3
7596865|NCT02696031|12002725|FG003|Up to Week 104|Physician Decision|0
7596866|NCT02696031|12002726|FG004|Up to Week 104|Physician Decision|0
7596867|NCT02696031|12002727|FG005|Up to Week 104|Physician Decision|0
7596868|NCT02696031|12002722|FG000|Up to Week 104|Lost to Follow-up|2
7596869|NCT02696031|12002723|FG001|Up to Week 104|Lost to Follow-up|3
7596870|NCT02696031|12002724|FG002|Up to Week 104|Lost to Follow-up|1
7596871|NCT02696031|12002725|FG003|Up to Week 104|Lost to Follow-up|0
7596872|NCT02696031|12002726|FG004|Up to Week 104|Lost to Follow-up|0
7596873|NCT02696031|12002727|FG005|Up to Week 104|Lost to Follow-up|0
7596874|NCT02696031|12002722|FG000|Up to Week 104|Lack of Efficacy|13
7596875|NCT02696031|12002723|FG001|Up to Week 104|Lack of Efficacy|12
7596876|NCT02696031|12002724|FG002|Up to Week 104|Lack of Efficacy|11
7596877|NCT02696031|12002725|FG003|Up to Week 104|Lack of Efficacy|0
7596878|NCT02696031|12002726|FG004|Up to Week 104|Lack of Efficacy|0
7596879|NCT02696031|12002727|FG005|Up to Week 104|Lack of Efficacy|0
7596880|NCT02696031|12002722|FG000|Up to Week 104|Adverse Event|7
7596881|NCT02696031|12002723|FG001|Up to Week 104|Adverse Event|11
7596882|NCT02696031|12002724|FG002|Up to Week 104|Adverse Event|5
7596883|NCT02696031|12002725|FG003|Up to Week 104|Adverse Event|0
7596884|NCT02696031|12002726|FG004|Up to Week 104|Adverse Event|0
7596885|NCT02696031|12002727|FG005|Up to Week 104|Adverse Event|0
7596886|NCT02696031|12002722|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596887|NCT02696031|12002723|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1
7596888|NCT02696031|12002724|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596889|NCT02696031|12002725|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596890|NCT02696031|12002726|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596891|NCT02696031|12002727|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
7596892|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596893|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596894|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
7596895|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6
7596896|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8
7596897|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2
7596898|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596899|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596900|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596901|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1
7596902|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1
7596903|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0
7596904|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596905|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596906|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596907|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1
7596908|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596909|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
7596910|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596911|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596912|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596913|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596914|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1
7596915|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
7596916|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596917|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596918|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
7596919|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7596920|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
7596921|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3
7596922|NCT02696031|12002722|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596923|NCT02696031|12002723|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596924|NCT02696031|12002724|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0
7596925|NCT02696031|12002725|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1
7596926|NCT02696031|12002726|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4
7596927|NCT02696031|12002727|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1
7596928|NCT02689453|12002739|FG000|Overall Study|Progressive disease|0
7596929|NCT02689453|12002740|FG001|Overall Study|Progressive disease|1
7596930|NCT02689453|12002741|FG002|Overall Study|Progressive disease|1
7596931|NCT02476851|12002753|FG000|Overall Study|Protocol Violation|1
7596932|NCT02476851|12002754|FG001|Overall Study|Protocol Violation|1
7596933|NCT02208024|12002779|FG000|Overall Study|Withdrawal by Subject|1
7596934|NCT01866111|12002787|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14
7596935|NCT01866111|12002788|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13
7596936|NCT01866111|12002789|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20
7596937|NCT01866111|12002790|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30
7596938|NCT01866111|12002787|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65
7596939|NCT01866111|12002788|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67
7596940|NCT01866111|12002789|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63
7596941|NCT01866111|12002790|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52
7596942|NCT01767129|12002800|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
7596943|NCT01767129|12002801|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
7596949|NCT01586910|12002832|FG000|Overall Study|Death|4
7596950|NCT01586910|12002833|FG001|Overall Study|Death|4
7596951|NCT01586910|12002832|FG000|Overall Study|Withdrawal by Subject|6
7596952|NCT01586910|12002833|FG001|Overall Study|Withdrawal by Subject|43
7596953|NCT01586910|12002832|FG000|Overall Study|Physician withdrew Subject|5
7596954|NCT01586910|12002833|FG001|Overall Study|Physician withdrew Subject|24
7271859|NCT00423670|11486141|FG001|Treatment Period|Investigator decision|0
7271860|NCT00423670|11486142|FG002|Treatment Period|Investigator decision|0
7271861|NCT00423670|11486143|FG003|Treatment Period|Investigator decision|0
7271862|NCT00423670|11486144|FG004|Treatment Period|Investigator decision|0
7271863|NCT00423670|11486145|FG005|Treatment Period|Investigator decision|0
7271864|NCT00423670|11486146|FG006|Treatment Period|Investigator decision|0
7271865|NCT00423670|11486147|FG007|Treatment Period|Investigator decision|1
7271866|NCT00423670|11486140|FG000|Treatment Period|Non-compliance with protocol|3
7271867|NCT00423670|11486141|FG001|Treatment Period|Non-compliance with protocol|1
7271868|NCT00423670|11486142|FG002|Treatment Period|Non-compliance with protocol|1
7271869|NCT00423670|11486143|FG003|Treatment Period|Non-compliance with protocol|3
7271870|NCT00423670|11486144|FG004|Treatment Period|Non-compliance with protocol|2
7271871|NCT00423670|11486145|FG005|Treatment Period|Non-compliance with protocol|0
7271872|NCT00423670|11486146|FG006|Treatment Period|Non-compliance with protocol|2
7271873|NCT00423670|11486147|FG007|Treatment Period|Non-compliance with protocol|2
7271874|NCT00423670|11486140|FG000|Follow-up Period|Lost to Follow-up|0
7271875|NCT00423670|11486141|FG001|Follow-up Period|Lost to Follow-up|12
7271876|NCT00423670|11486142|FG002|Follow-up Period|Lost to Follow-up|8
7271877|NCT00423670|11486143|FG003|Follow-up Period|Lost to Follow-up|3
7271878|NCT00423670|11486144|FG004|Follow-up Period|Lost to Follow-up|1
7271879|NCT00423670|11486145|FG005|Follow-up Period|Lost to Follow-up|0
7596998|NCT00504582|12002900|FG000|Overall Study|Lost to Follow-up|1
7596999|NCT00504582|12002901|FG001|Overall Study|Lost to Follow-up|0
7597000|NCT00504582|12002902|FG002|Overall Study|Lost to Follow-up|0
7597001|NCT02257918|12002923|FG000|Overall Study|Lost to Follow-up|4
7597002|NCT02257918|12002924|FG001|Overall Study|Lost to Follow-up|1
7597003|NCT02257918|12002925|FG002|Overall Study|Lost to Follow-up|0
7597004|NCT02257918|12002923|FG000|Overall Study|Withdrawal by Subject|0
7597005|NCT02257918|12002924|FG001|Overall Study|Withdrawal by Subject|0
7597006|NCT02257918|12002925|FG002|Overall Study|Withdrawal by Subject|1
7597007|NCT02257918|12002923|FG000|Overall Study|Pregnancy|0
7597008|NCT02257918|12002924|FG001|Overall Study|Pregnancy|0
7597009|NCT02257918|12002925|FG002|Overall Study|Pregnancy|1
7597010|NCT02258542|12002937|FG000|Overall Study|eg. not made to the visit|7
7597011|NCT02258542|12002938|FG001|Overall Study|eg. not made to the visit|4
7597012|NCT02258542|12002939|FG002|Overall Study|eg. not made to the visit|0
7597013|NCT02258542|12002940|FG003|Overall Study|eg. not made to the visit|1
7597014|NCT02258542|12002937|FG000|Overall Study|study specific discount. criteria|1
7597015|NCT02258542|12002938|FG001|Overall Study|study specific discount. criteria|1
7597016|NCT02258542|12002939|FG002|Overall Study|study specific discount. criteria|0
7597017|NCT02258542|12002940|FG003|Overall Study|study specific discount. criteria|0
7597018|NCT02258542|12002937|FG000|Overall Study|Withdrawal by Subject|20
7597019|NCT02258542|12002938|FG001|Overall Study|Withdrawal by Subject|20
7597020|NCT02258542|12002939|FG002|Overall Study|Withdrawal by Subject|7
7597021|NCT02258542|12002940|FG003|Overall Study|Withdrawal by Subject|1
7597022|NCT02258542|12002937|FG000|Overall Study|Lost to Follow-up|5
7597023|NCT02258542|12002938|FG001|Overall Study|Lost to Follow-up|12
7597024|NCT02258542|12002939|FG002|Overall Study|Lost to Follow-up|1
7597025|NCT02258542|12002940|FG003|Overall Study|Lost to Follow-up|2
7271880|NCT00423670|11486146|FG006|Follow-up Period|Lost to Follow-up|5
7271881|NCT00423670|11486147|FG007|Follow-up Period|Lost to Follow-up|0
7271882|NCT00423670|11486140|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
7271883|NCT00423670|11486141|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
7271884|NCT00423670|11486142|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
7271885|NCT00423670|11486143|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
7271886|NCT00423670|11486144|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
7271887|NCT00423670|11486145|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
7271888|NCT00423670|11486146|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
7271889|NCT00423670|11486147|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
7271890|NCT00423670|11486140|FG000|Follow-up Period|Non-compliance with protocol|2
7271891|NCT00423670|11486141|FG001|Follow-up Period|Non-compliance with protocol|0
7271892|NCT00423670|11486142|FG002|Follow-up Period|Non-compliance with protocol|1
7271893|NCT00423670|11486143|FG003|Follow-up Period|Non-compliance with protocol|1
7271894|NCT00423670|11486144|FG004|Follow-up Period|Non-compliance with protocol|0
7271895|NCT00423670|11486145|FG005|Follow-up Period|Non-compliance with protocol|0
7271896|NCT00423670|11486146|FG006|Follow-up Period|Non-compliance with protocol|3
7271897|NCT00423670|11486147|FG007|Follow-up Period|Non-compliance with protocol|2
7271898|NCT00423722|11486181|FG000|Overall Study|Death|4
7271899|NCT00423722|11486182|FG001|Overall Study|Death|4
7271900|NCT00423722|11486181|FG000|Overall Study|Declined to participate|2
7271901|NCT00423722|11486182|FG001|Overall Study|Declined to participate|3
7271902|NCT00423722|11486181|FG000|Overall Study|Unable to complete questionnaires|4
7271903|NCT00423722|11486182|FG001|Overall Study|Unable to complete questionnaires|4
7271904|NCT00423722|11486181|FG000|Overall Study|Withdrawal by Subject|4
7271905|NCT00423722|11486182|FG001|Overall Study|Withdrawal by Subject|2
7271906|NCT00423735|11486197|FG000|Overall Study|Ineligible / No protocol treatment|8
7271907|NCT00423735|11486198|FG001|Overall Study|Ineligible / No protocol treatment|6
7271908|NCT00423735|11486199|FG002|Overall Study|Ineligible / No protocol treatment|0
7271909|NCT00423800|11486211|FG000|Overall Study|Protocol Violation|0
7271910|NCT00423800|11486212|FG001|Overall Study|Protocol Violation|1
7271911|NCT00423813|11486222|FG000|Overall Study|Adverse Event|11
7271912|NCT00423813|11486223|FG001|Overall Study|Adverse Event|30
7271913|NCT00423813|11486224|FG002|Overall Study|Adverse Event|40
7271914|NCT00423813|11486222|FG000|Overall Study|Withdrawal by Subject|6
7271915|NCT00423813|11486223|FG001|Overall Study|Withdrawal by Subject|8
7271916|NCT00423813|11486224|FG002|Overall Study|Withdrawal by Subject|5
7271917|NCT00423813|11486222|FG000|Overall Study|Lost to Follow-up|5
7271918|NCT00423813|11486223|FG001|Overall Study|Lost to Follow-up|4
7271919|NCT00423813|11486224|FG002|Overall Study|Lost to Follow-up|4
7271920|NCT00423813|11486222|FG000|Overall Study|Lack of Efficacy|23
7271921|NCT00423813|11486223|FG001|Overall Study|Lack of Efficacy|18
7271922|NCT00423813|11486224|FG002|Overall Study|Lack of Efficacy|19
7271923|NCT00423813|11486222|FG000|Overall Study|Physician Decision|2
7271924|NCT00423813|11486223|FG001|Overall Study|Physician Decision|0
7597026|NCT02258542|12002937|FG000|Overall Study|Death|5
7597027|NCT02258542|12002938|FG001|Overall Study|Death|4
7597028|NCT02258542|12002939|FG002|Overall Study|Death|0
7271925|NCT00423813|11486224|FG002|Overall Study|Physician Decision|0
7271926|NCT00423813|11486222|FG000|Overall Study|Sponsor Decision|0
7271927|NCT00423813|11486223|FG001|Overall Study|Sponsor Decision|1
7597029|NCT02258542|12002940|FG003|Overall Study|Death|1
7597030|NCT02258542|12002937|FG000|Overall Study|Adverse Event|3
7597031|NCT02258542|12002938|FG001|Overall Study|Adverse Event|4
7597032|NCT02258542|12002939|FG002|Overall Study|Adverse Event|0
7597033|NCT02258542|12002940|FG003|Overall Study|Adverse Event|0
7597034|NCT02258542|12002937|FG000|Overall Study|Protocol Violation|1
7597035|NCT02258542|12002938|FG001|Overall Study|Protocol Violation|2
7597036|NCT02258542|12002939|FG002|Overall Study|Protocol Violation|0
7597037|NCT02258542|12002940|FG003|Overall Study|Protocol Violation|0
7597038|NCT02258542|12002937|FG000|Overall Study|Eligibility criteria not fulfilled|0
7597039|NCT02258542|12002938|FG001|Overall Study|Eligibility criteria not fulfilled|2
7597040|NCT02258542|12002939|FG002|Overall Study|Eligibility criteria not fulfilled|0
7597041|NCT02258542|12002940|FG003|Overall Study|Eligibility criteria not fulfilled|0
7271928|NCT00423813|11486224|FG002|Overall Study|Sponsor Decision|0
7597042|NCT02290431|12002968|FG000|Overall Study|Adverse Event|20
7597043|NCT02290431|12002968|FG000|Overall Study|Progressive disease|4
7597044|NCT02290431|12002968|FG000|Overall Study|Study terminated by Sponsor|1
7597045|NCT02290431|12002968|FG000|Overall Study|Physician Decision|2
7597046|NCT02314923|12002982|FG000|Overall Study|Death|0
7597047|NCT02314923|12002983|FG001|Overall Study|Death|0
7597048|NCT02314923|12002984|FG002|Overall Study|Death|0
7597049|NCT02314923|12002985|FG003|Overall Study|Death|1
7597050|NCT02314923|12002986|FG004|Overall Study|Death|0
7597051|NCT02314923|12002987|FG005|Overall Study|Death|0
7597052|NCT02314923|12002988|FG006|Overall Study|Death|0
7597053|NCT02314923|12002989|FG007|Overall Study|Death|0
7597054|NCT02314923|12002990|FG008|Overall Study|Death|0
7597055|NCT02314923|12002991|FG009|Overall Study|Death|0
7597056|NCT02314923|12002982|FG000|Overall Study|Lost to Follow-up|2
7597057|NCT02314923|12002983|FG001|Overall Study|Lost to Follow-up|3
7597058|NCT02314923|12002984|FG002|Overall Study|Lost to Follow-up|1
7597059|NCT02314923|12002985|FG003|Overall Study|Lost to Follow-up|0
7597060|NCT02314923|12002986|FG004|Overall Study|Lost to Follow-up|0
7597061|NCT02314923|12002987|FG005|Overall Study|Lost to Follow-up|0
7597062|NCT02314923|12002988|FG006|Overall Study|Lost to Follow-up|3
7597063|NCT02314923|12002989|FG007|Overall Study|Lost to Follow-up|4
7597064|NCT02314923|12002990|FG008|Overall Study|Lost to Follow-up|2
7597065|NCT02314923|12002991|FG009|Overall Study|Lost to Follow-up|0
7597066|NCT02314923|12002982|FG000|Overall Study|Withdrawal by Subject|0
7597067|NCT02314923|12002983|FG001|Overall Study|Withdrawal by Subject|0
7597068|NCT02314923|12002984|FG002|Overall Study|Withdrawal by Subject|1
7597069|NCT02314923|12002985|FG003|Overall Study|Withdrawal by Subject|0
7597070|NCT02314923|12002986|FG004|Overall Study|Withdrawal by Subject|1
7597071|NCT02314923|12002987|FG005|Overall Study|Withdrawal by Subject|0
7597072|NCT02314923|12002988|FG006|Overall Study|Withdrawal by Subject|1
7597073|NCT02314923|12002989|FG007|Overall Study|Withdrawal by Subject|0
7597074|NCT02314923|12002990|FG008|Overall Study|Withdrawal by Subject|0
7597075|NCT02314923|12002991|FG009|Overall Study|Withdrawal by Subject|0
7597076|NCT02314923|12002982|FG000|Overall Study|Physician Decision|0
7597077|NCT02314923|12002983|FG001|Overall Study|Physician Decision|1
7597078|NCT02314923|12002984|FG002|Overall Study|Physician Decision|0
7597079|NCT02314923|12002985|FG003|Overall Study|Physician Decision|0
7597080|NCT02314923|12002986|FG004|Overall Study|Physician Decision|0
7597081|NCT02314923|12002987|FG005|Overall Study|Physician Decision|0
7597082|NCT02314923|12002988|FG006|Overall Study|Physician Decision|0
7597083|NCT02314923|12002989|FG007|Overall Study|Physician Decision|0
7597084|NCT02314923|12002990|FG008|Overall Study|Physician Decision|0
7597085|NCT02314923|12002991|FG009|Overall Study|Physician Decision|0
7597086|NCT02314923|12002982|FG000|Overall Study|Participant unavailable|0
7597087|NCT02314923|12002983|FG001|Overall Study|Participant unavailable|0
7597088|NCT02314923|12002984|FG002|Overall Study|Participant unavailable|0
7597089|NCT02314923|12002985|FG003|Overall Study|Participant unavailable|0
7597090|NCT02314923|12002986|FG004|Overall Study|Participant unavailable|0
7597091|NCT02314923|12002987|FG005|Overall Study|Participant unavailable|1
7597092|NCT02314923|12002988|FG006|Overall Study|Participant unavailable|0
7597093|NCT02314923|12002989|FG007|Overall Study|Participant unavailable|0
7597094|NCT02314923|12002990|FG008|Overall Study|Participant unavailable|0
7597095|NCT02314923|12002991|FG009|Overall Study|Participant unavailable|0
7597096|NCT02314923|12002982|FG000|Overall Study|Screen failure|0
7597097|NCT02314923|12002983|FG001|Overall Study|Screen failure|0
7597098|NCT02314923|12002984|FG002|Overall Study|Screen failure|0
7597099|NCT02314923|12002985|FG003|Overall Study|Screen failure|0
7597100|NCT02314923|12002986|FG004|Overall Study|Screen failure|0
7597101|NCT02314923|12002987|FG005|Overall Study|Screen failure|0
7597102|NCT02314923|12002988|FG006|Overall Study|Screen failure|1
7597103|NCT02314923|12002989|FG007|Overall Study|Screen failure|0
7597104|NCT02314923|12002990|FG008|Overall Study|Screen failure|0
7597105|NCT02314923|12002991|FG009|Overall Study|Screen failure|0
7597106|NCT02314923|12002982|FG000|Overall Study|Participant relocation|1
7597107|NCT02314923|12002983|FG001|Overall Study|Participant relocation|0
7597108|NCT02314923|12002984|FG002|Overall Study|Participant relocation|0
7597109|NCT02314923|12002985|FG003|Overall Study|Participant relocation|0
7597110|NCT02314923|12002986|FG004|Overall Study|Participant relocation|0
7597111|NCT02314923|12002987|FG005|Overall Study|Participant relocation|0
7597112|NCT02314923|12002988|FG006|Overall Study|Participant relocation|0
7597113|NCT02314923|12002989|FG007|Overall Study|Participant relocation|1
7597114|NCT02314923|12002990|FG008|Overall Study|Participant relocation|0
7597115|NCT02314923|12002991|FG009|Overall Study|Participant relocation|0
7597116|NCT04524507|12003032|FG000|Overall Study|Lost to Follow-up|2
7597117|NCT04524507|12003033|FG001|Overall Study|Lost to Follow-up|4
7597118|NCT04524507|12003032|FG000|Overall Study|Withdrawal by Subject|2
7597119|NCT04524507|12003033|FG001|Overall Study|Withdrawal by Subject|9
7597120|NCT04524507|12003032|FG000|Overall Study|Death|2
7597121|NCT04524507|12003033|FG001|Overall Study|Death|10
7597122|NCT04382924|12003042|FG000|Overall Study|Death|2
7597123|NCT04382924|12003043|FG001|Overall Study|Death|5
7597124|NCT04382924|12003044|FG002|Overall Study|Death|4
7597125|NCT04382924|12003042|FG000|Overall Study|Protocol Violation|0
7597126|NCT04382924|12003043|FG001|Overall Study|Protocol Violation|1
7597127|NCT04382924|12003044|FG002|Overall Study|Protocol Violation|1
7597128|NCT04382924|12003042|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
7597129|NCT04382924|12003043|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
7597130|NCT04382924|12003044|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
7597131|NCT04382924|12003042|FG000|Overall Study|Withdrawal by Subject|6
7597132|NCT04382924|12003043|FG001|Overall Study|Withdrawal by Subject|3
7597133|NCT04382924|12003044|FG002|Overall Study|Withdrawal by Subject|6
7271929|NCT00423813|11486222|FG000|Overall Study|Protocol Violation|9
7597134|NCT03842436|12003075|FG000|Overall Study|Lost to Follow-up|1
7597135|NCT03462030|12003096|FG000|Overall Study|Withdrawal by Subject|1
7597136|NCT03462030|12003097|FG001|Overall Study|Withdrawal by Subject|1
7597137|NCT03446768|12003105|FG000|Overall Study|Withdrawal by Subject|0
7597138|NCT03446768|12003106|FG001|Overall Study|Withdrawal by Subject|1
7597139|NCT03253393|12003151|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
7597140|NCT03253393|12003152|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
7597141|NCT03253393|12003153|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
7597142|NCT03188822|12003167|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
7597143|NCT03188822|12003167|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
7597144|NCT03128671|12003173|FG000|Allocation|ICU discharge prior to intervention initiation|4
7597145|NCT03128671|12003174|FG001|Allocation|ICU discharge prior to intervention initiation|0
7597146|NCT03128671|12003173|FG000|Allocation|Death|1
7597147|NCT03128671|12003174|FG001|Allocation|Death|0
7597148|NCT03128671|12003173|FG000|Allocation|Withdrawal by Subject|4
7597149|NCT03128671|12003174|FG001|Allocation|Withdrawal by Subject|0
7597150|NCT03128671|12003173|FG000|Intervention|Withdrawal by Subject|11
7597151|NCT03128671|12003174|FG001|Intervention|Withdrawal by Subject|10
7597152|NCT03128671|12003173|FG000|Intervention|Palliative/hospice care initiated|9
7597153|NCT03128671|12003174|FG001|Intervention|Palliative/hospice care initiated|10
7597154|NCT03128671|12003173|FG000|Intervention|Death|13
7597155|NCT03128671|12003174|FG001|Intervention|Death|11
7597156|NCT03128671|12003173|FG000|Intervention|Interrupted by hurricane|1
7597157|NCT03128671|12003174|FG001|Intervention|Interrupted by hurricane|0
7597158|NCT03128671|12003173|FG000|Intervention|Physician Decision|2
7597159|NCT03128671|12003174|FG001|Intervention|Physician Decision|3
7597160|NCT03111732|12003180|FG000|Overall Study|Enrolled in different study|1
7597161|NCT03111732|12003180|FG000|Overall Study|Progressive disease|3
7597162|NCT03111732|12003180|FG000|Overall Study|Withdrawal by Subject|1
7597163|NCT03065244|12003191|FG000|Overall Study|Lost to Follow-up|1
7597164|NCT03065244|12003192|FG001|Overall Study|Lost to Follow-up|1
7597165|NCT03065244|12003191|FG000|Overall Study|Diagnosed with a different disease|1
7597166|NCT03065244|12003192|FG001|Overall Study|Diagnosed with a different disease|1
7597167|NCT03065244|12003191|FG000|Overall Study|Protocol Violation|0
7597168|NCT03065244|12003192|FG001|Overall Study|Protocol Violation|1
7597169|NCT03065244|12003191|FG000|Overall Study|Withdrawal by Subject|1
7597170|NCT03065244|12003192|FG001|Overall Study|Withdrawal by Subject|1
7597171|NCT02879305|12003200|FG000|Overall Study|Investigator Site Closed|55
7597172|NCT02879305|12003201|FG001|Overall Study|Investigator Site Closed|57
7597173|NCT02879305|12003200|FG000|Overall Study|Withdrawal by Subject|44
7597174|NCT02879305|12003201|FG001|Overall Study|Withdrawal by Subject|42
7597175|NCT02879305|12003200|FG000|Overall Study|Lost to Follow-up|17
7597176|NCT02879305|12003201|FG001|Overall Study|Lost to Follow-up|12
7597177|NCT02879305|12003200|FG000|Overall Study|Other|1
7597178|NCT02879305|12003201|FG001|Overall Study|Other|0
7597179|NCT02787850|12003218|FG000|Overall Study|Withdrawal by Subject|0
7597180|NCT02787850|12003219|FG001|Overall Study|Withdrawal by Subject|1
7597181|NCT02676284|12003238|FG000|Overall Study|Withdrawal by Subject|1
7597182|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
7597183|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597184|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597185|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597186|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597187|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597188|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
7597189|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
7597190|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597191|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597192|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597193|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597194|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
7597195|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
7597196|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
7597197|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597198|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597199|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597200|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597201|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
7597202|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
7597203|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
7597204|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
7597205|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
7597206|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
7597207|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
7597208|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
7597209|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
7597210|NCT02431702|12003242|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
7271930|NCT00423813|11486223|FG001|Overall Study|Protocol Violation|4
7271931|NCT00423813|11486224|FG002|Overall Study|Protocol Violation|4
7271932|NCT00423813|11486222|FG000|Overall Study|Pregnancy|0
7271933|NCT00423813|11486223|FG001|Overall Study|Pregnancy|0
7271934|NCT00423813|11486224|FG002|Overall Study|Pregnancy|1
7271935|NCT00423813|11486222|FG000|Overall Study|Subject started night shift work|1
7271936|NCT00423813|11486223|FG001|Overall Study|Subject started night shift work|0
7271937|NCT00423813|11486224|FG002|Overall Study|Subject started night shift work|0
7271938|NCT00423813|11486222|FG000|Overall Study|Will start exclusionary medications|0
7271939|NCT00423813|11486223|FG001|Overall Study|Will start exclusionary medications|1
7271940|NCT00423813|11486224|FG002|Overall Study|Will start exclusionary medications|0
7271941|NCT00423813|11486222|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
7271942|NCT00423813|11486223|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
7271943|NCT00423813|11486224|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
7271944|NCT00423852|11486232|FG000|Overall Study|Removed pior to the high-dose portion|3
7271945|NCT00423891|11486248|FG000|Enrolled|Withdrawal by Subject|0
7271946|NCT00423891|11486249|FG001|Enrolled|Withdrawal by Subject|0
7271947|NCT00423891|11486250|FG002|Enrolled|Withdrawal by Subject|1
7271948|NCT00423891|11486248|FG000|Enrolled|Lost to Follow-up|0
7271949|NCT00423891|11486249|FG001|Enrolled|Lost to Follow-up|0
7271950|NCT00423891|11486250|FG002|Enrolled|Lost to Follow-up|1
7271951|NCT00423891|11486248|FG000|Enrolled|No longer met criteria|11
7271952|NCT00423891|11486249|FG001|Enrolled|No longer met criteria|2
7271953|NCT00423891|11486250|FG002|Enrolled|No longer met criteria|1
7271954|NCT00423891|11486248|FG000|Treatment|Withdrawal by Subject|1
7271955|NCT00423891|11486249|FG001|Treatment|Withdrawal by Subject|0
7271956|NCT00423891|11486250|FG002|Treatment|Withdrawal by Subject|0
7271957|NCT00423891|11486248|FG000|Treatment|Lost to Follow-up|1
7271958|NCT00423891|11486249|FG001|Treatment|Lost to Follow-up|0
7271959|NCT00423891|11486250|FG002|Treatment|Lost to Follow-up|0
7271960|NCT00423891|11486248|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
7271961|NCT00423891|11486249|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
7271962|NCT00423891|11486250|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
7271963|NCT00423891|11486248|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
7271964|NCT00423891|11486249|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
7271965|NCT00423891|11486250|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
7271966|NCT00423917|11486260|FG000|Overall Study|Cancel|2
7271967|NCT00423917|11486260|FG000|Overall Study|Ineligible|1
7271968|NCT00423930|11486264|FG000|Overall Study|Withdrawal by Subject|2
7271969|NCT00423943|11486270|FG000|Overall Study|Withdrawal by Subject|3
7271970|NCT00423943|11486271|FG001|Overall Study|Withdrawal by Subject|1
7271971|NCT00424021|11486281|FG000|NCT00046319 Study Period|Adverse Event|1
7271972|NCT00424021|11486282|FG001|NCT00046319 Study Period|Adverse Event|0
7271973|NCT00424021|11486283|FG002|NCT00046319 Study Period|Adverse Event|1
7271974|NCT00424021|11486284|FG003|NCT00046319 Study Period|Adverse Event|1
7271975|NCT00424021|11486281|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
7271976|NCT00424021|11486282|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
7271977|NCT00424021|11486283|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
7271978|NCT00424021|11486284|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
7271979|NCT00424021|11486281|FG000|NCT00046319 Study Period|Sponsor discretion|0
7271980|NCT00424021|11486282|FG001|NCT00046319 Study Period|Sponsor discretion|1
7271981|NCT00424021|11486283|FG002|NCT00046319 Study Period|Sponsor discretion|0
7271982|NCT00424021|11486284|FG003|NCT00046319 Study Period|Sponsor discretion|0
7271983|NCT00424021|11486281|FG000|NCT00046319 Study Period|Lost to Follow-up|0
7271984|NCT00424021|11486282|FG001|NCT00046319 Study Period|Lost to Follow-up|1
7271985|NCT00424021|11486283|FG002|NCT00046319 Study Period|Lost to Follow-up|0
7271986|NCT00424021|11486284|FG003|NCT00046319 Study Period|Lost to Follow-up|0
7271987|NCT00424021|11486281|FG000|AMB-220-E Study Period|Adverse Event|1
7271988|NCT00424021|11486282|FG001|AMB-220-E Study Period|Adverse Event|1
7271989|NCT00424021|11486283|FG002|AMB-220-E Study Period|Adverse Event|3
7271990|NCT00424021|11486284|FG003|AMB-220-E Study Period|Adverse Event|7
7271991|NCT00424021|11486281|FG000|AMB-220-E Study Period|Death|0
7271992|NCT00424021|11486282|FG001|AMB-220-E Study Period|Death|0
7597211|NCT02431702|12003243|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597212|NCT02431702|12003244|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597213|NCT02431702|12003245|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597214|NCT02431702|12003246|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597215|NCT02431702|12003247|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597216|NCT02431702|12003248|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
7597217|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597218|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
7597219|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
7597220|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597221|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597222|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597223|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
7597224|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597225|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
7597226|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
7597227|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597228|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597229|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597230|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
7597231|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597232|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
7597233|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
7597234|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7271993|NCT00424021|11486283|FG002|AMB-220-E Study Period|Death|1
7597235|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597236|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597237|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
7597238|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597239|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
7597240|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597241|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597242|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597243|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597244|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
7597245|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Other|0
7597246|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Other|2
7597247|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Other|2
7597248|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Other|0
7597249|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Other|0
7597250|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Other|0
7597251|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Other|0
7597252|NCT02431702|12003242|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597253|NCT02431702|12003243|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597254|NCT02431702|12003244|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
7597255|NCT02431702|12003245|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597256|NCT02431702|12003246|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597257|NCT02431702|12003247|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597258|NCT02431702|12003248|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
7597259|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597260|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597261|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597262|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
7597263|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
7597264|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597265|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
7597266|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597267|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597268|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597269|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
7597270|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597271|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
7597272|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
7597273|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597274|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597275|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597276|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
7597277|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7597278|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
7597279|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
7597280|NCT02431702|12003242|FG000|Part 3: 9 Month of Additional Treatment|Other|0
7597281|NCT02431702|12003243|FG001|Part 3: 9 Month of Additional Treatment|Other|0
7597282|NCT02431702|12003244|FG002|Part 3: 9 Month of Additional Treatment|Other|0
7597283|NCT02431702|12003245|FG003|Part 3: 9 Month of Additional Treatment|Other|1
7597284|NCT02431702|12003246|FG004|Part 3: 9 Month of Additional Treatment|Other|1
7597285|NCT02431702|12003247|FG005|Part 3: 9 Month of Additional Treatment|Other|6
7597286|NCT02431702|12003248|FG006|Part 3: 9 Month of Additional Treatment|Other|0
7597287|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
7597288|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
7597289|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7597290|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
7597291|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
7597292|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
7597293|NCT02200770|12003285|FG000|Randomized-controlled Period (RCP)|Other|1
7597294|NCT02200770|12003286|FG001|Randomized-controlled Period (RCP)|Other|2
7597295|NCT02200770|12003285|FG000|Open-label Period (OLP)|Adverse Event|1
7597296|NCT02200770|12003286|FG001|Open-label Period (OLP)|Adverse Event|2
7597297|NCT02200770|12003285|FG000|Open-label Period (OLP)|Death|1
7597298|NCT02200770|12003286|FG001|Open-label Period (OLP)|Death|2
7597299|NCT02200770|12003285|FG000|Open-label Period (OLP)|Lost to Follow-up|0
7597300|NCT02200770|12003286|FG001|Open-label Period (OLP)|Lost to Follow-up|1
7597301|NCT02200770|12003285|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
7597302|NCT02200770|12003286|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
7597303|NCT02200770|12003285|FG000|Open-label Period (OLP)|Other|6
7597304|NCT02200770|12003286|FG001|Open-label Period (OLP)|Other|15
7597305|NCT02136069|12003296|FG000|Overall Study|UC flare-up|1
7597306|NCT02136069|12003297|FG001|Overall Study|UC flare-up|0
7597307|NCT02136069|12003296|FG000|Overall Study|Adverse Event|6
7597308|NCT02136069|12003297|FG001|Overall Study|Adverse Event|8
7597309|NCT02136069|12003296|FG000|Overall Study|Death|0
7597310|NCT02136069|12003297|FG001|Overall Study|Death|1
7597311|NCT02136069|12003296|FG000|Overall Study|Lack of Efficacy|10
7597312|NCT02136069|12003297|FG001|Overall Study|Lack of Efficacy|4
7597313|NCT02136069|12003296|FG000|Overall Study|Lost to Follow-up|1
7597314|NCT02136069|12003297|FG001|Overall Study|Lost to Follow-up|0
7597315|NCT02136069|12003296|FG000|Overall Study|Non-Compliance|1
7597316|NCT02136069|12003297|FG001|Overall Study|Non-Compliance|0
7597317|NCT02136069|12003296|FG000|Overall Study|Physician Decision|5
7597318|NCT02136069|12003297|FG001|Overall Study|Physician Decision|4
7597319|NCT02136069|12003296|FG000|Overall Study|Withdrawal by Subject|10
7597320|NCT02136069|12003297|FG001|Overall Study|Withdrawal by Subject|11
7597321|NCT02086552|12003303|FG000|Overall Study|Withdrawal by Subject|1
7597322|NCT01209767|12003312|FG000|Overall Study|Withdrawal by Subject|1
7597323|NCT01209767|12003312|FG000|Overall Study|Lost to Follow-up|3
7597324|NCT01186848|12003320|FG000|Overall Study|Lost to Follow-up|4
7597325|NCT01186848|12003320|FG000|Overall Study|Withdrawal by Subject|2
7597326|NCT01186848|12003320|FG000|Overall Study|Adverse Event|2
7597327|NCT01024608|12003337|FG000|Overall Study|Adverse Event|1
7597328|NCT01024608|12003338|FG001|Overall Study|Adverse Event|0
7597329|NCT01024608|12003337|FG000|Overall Study|Withdrawal by Subject|1
7597330|NCT01024608|12003338|FG001|Overall Study|Withdrawal by Subject|0
7597331|NCT01024608|12003337|FG000|Overall Study|Lost to Follow-up|0
7597332|NCT01024608|12003338|FG001|Overall Study|Lost to Follow-up|1
7597333|NCT01024608|12003337|FG000|Overall Study|Protocol Violation|0
7597334|NCT01024608|12003338|FG001|Overall Study|Protocol Violation|3
7597335|NCT01024608|12003337|FG000|Overall Study|Never received study treatment|2
7597336|NCT01024608|12003338|FG001|Overall Study|Never received study treatment|0
7597337|NCT00988247|12003346|FG000|Overall Study|Adverse Event|17
7597338|NCT00988247|12003347|FG001|Overall Study|Adverse Event|3
7597339|NCT00988247|12003346|FG000|Overall Study|Withdrawal by Subject|44
7597340|NCT00988247|12003347|FG001|Overall Study|Withdrawal by Subject|13
7597341|NCT00988247|12003346|FG000|Overall Study|Pregnancy|1
7597342|NCT00988247|12003347|FG001|Overall Study|Pregnancy|2
7597343|NCT00988247|12003346|FG000|Overall Study|Lost to Follow-up|11
7597344|NCT00988247|12003347|FG001|Overall Study|Lost to Follow-up|2
7597345|NCT00988247|12003346|FG000|Overall Study|Protocol Violation|4
7597346|NCT00988247|12003347|FG001|Overall Study|Protocol Violation|5
7597347|NCT00988247|12003346|FG000|Overall Study|Sponsor requested withdrawal|3
7597348|NCT00988247|12003347|FG001|Overall Study|Sponsor requested withdrawal|1
7597349|NCT00988247|12003346|FG000|Overall Study|Other|3
7597350|NCT00988247|12003347|FG001|Overall Study|Other|0
7597351|NCT00730639|12003379|FG000|Overall Study|Adverse Event|3
7597352|NCT00730639|12003380|FG001|Overall Study|Adverse Event|0
7597353|NCT00730639|12003381|FG002|Overall Study|Adverse Event|9
7597354|NCT00730639|12003382|FG003|Overall Study|Adverse Event|8
7597355|NCT00730639|12003383|FG004|Overall Study|Adverse Event|23
7597356|NCT00730639|12003379|FG000|Overall Study|Complete Response|0
7597357|NCT00730639|12003380|FG001|Overall Study|Complete Response|0
7597358|NCT00730639|12003381|FG002|Overall Study|Complete Response|2
7597359|NCT00730639|12003382|FG003|Overall Study|Complete Response|2
7597360|NCT00730639|12003383|FG004|Overall Study|Complete Response|1
7597361|NCT00730639|12003379|FG000|Overall Study|Completed Maximum Cycles|0
7597362|NCT00730639|12003380|FG001|Overall Study|Completed Maximum Cycles|0
7597363|NCT00730639|12003381|FG002|Overall Study|Completed Maximum Cycles|11
7271994|NCT00424021|11486284|FG003|AMB-220-E Study Period|Death|1
7597364|NCT00730639|12003382|FG003|Overall Study|Completed Maximum Cycles|3
7597365|NCT00730639|12003383|FG004|Overall Study|Completed Maximum Cycles|6
7597366|NCT00730639|12003379|FG000|Overall Study|Death|0
7597367|NCT00730639|12003380|FG001|Overall Study|Death|0
7597368|NCT00730639|12003381|FG002|Overall Study|Death|0
7597369|NCT00730639|12003382|FG003|Overall Study|Death|0
7597370|NCT00730639|12003383|FG004|Overall Study|Death|2
7597371|NCT00730639|12003379|FG000|Overall Study|Disease Progression|12
7597372|NCT00730639|12003380|FG001|Overall Study|Disease Progression|13
7597373|NCT00730639|12003381|FG002|Overall Study|Disease Progression|48
7597374|NCT00730639|12003382|FG003|Overall Study|Disease Progression|32
7597375|NCT00730639|12003383|FG004|Overall Study|Disease Progression|88
7597376|NCT00730639|12003379|FG000|Overall Study|non-specified|0
7597377|NCT00730639|12003380|FG001|Overall Study|non-specified|0
7271995|NCT00424021|11486281|FG000|AMB-220-E Study Period|Lost to Follow-up|0
7271996|NCT00424021|11486282|FG001|AMB-220-E Study Period|Lost to Follow-up|1
7271997|NCT00424021|11486283|FG002|AMB-220-E Study Period|Lost to Follow-up|1
7271998|NCT00424021|11486284|FG003|AMB-220-E Study Period|Lost to Follow-up|1
7271999|NCT00424021|11486281|FG000|AMB-220-E Study Period|Physician Decision|0
7272000|NCT00424021|11486282|FG001|AMB-220-E Study Period|Physician Decision|0
7272001|NCT00424021|11486283|FG002|AMB-220-E Study Period|Physician Decision|0
7272002|NCT00424021|11486284|FG003|AMB-220-E Study Period|Physician Decision|1
7469682|NCT01925768|11771527|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
7469683|NCT01925768|11771528|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
7469684|NCT01925950|11771549|FG000|Part 2|Withdrawal by Subject|1
7469685|NCT01925950|11771550|FG001|Part 2|Withdrawal by Subject|0
7469686|NCT01925989|11771558|FG000|Period 1|Sponsor Decision|1
7469687|NCT01925989|11771559|FG001|Period 1|Sponsor Decision|1
7469688|NCT01925989|11771560|FG002|Period 1|Sponsor Decision|0
7469689|NCT01925989|11771558|FG000|Period 1|Withdrawal by Subject|0
7469690|NCT01925989|11771559|FG001|Period 1|Withdrawal by Subject|1
7469691|NCT01925989|11771560|FG002|Period 1|Withdrawal by Subject|0
7469692|NCT01926015|11771574|FG000|Overall Study|Withdrawal by parent/guardian|0
7469693|NCT01926015|11771575|FG001|Overall Study|Withdrawal by parent/guardian|1
7597378|NCT00730639|12003381|FG002|Overall Study|non-specified|4
7597379|NCT00730639|12003382|FG003|Overall Study|non-specified|2
7597380|NCT00730639|12003383|FG004|Overall Study|non-specified|3
7597381|NCT00730639|12003379|FG000|Overall Study|Protocol Violation|0
7597382|NCT00730639|12003380|FG001|Overall Study|Protocol Violation|0
7597383|NCT00730639|12003381|FG002|Overall Study|Protocol Violation|1
7597384|NCT00730639|12003382|FG003|Overall Study|Protocol Violation|0
7597385|NCT00730639|12003383|FG004|Overall Study|Protocol Violation|0
7597386|NCT00730639|12003379|FG000|Overall Study|Withdrawal by Subject|0
7597387|NCT00730639|12003380|FG001|Overall Study|Withdrawal by Subject|0
7597388|NCT00730639|12003381|FG002|Overall Study|Withdrawal by Subject|6
7597389|NCT00730639|12003382|FG003|Overall Study|Withdrawal by Subject|3
7597390|NCT00730639|12003383|FG004|Overall Study|Withdrawal by Subject|4
7597391|NCT00730639|12003379|FG000|Overall Study|Treatment on-going|2
7597392|NCT00730639|12003380|FG001|Overall Study|Treatment on-going|5
7597393|NCT00730639|12003381|FG002|Overall Study|Treatment on-going|5
7597394|NCT00730639|12003382|FG003|Overall Study|Treatment on-going|4
7597395|NCT00730639|12003383|FG004|Overall Study|Treatment on-going|4
7597396|NCT04834362|12003412|FG000|Overall Study|Death|1
7597397|NCT04834362|12003413|FG001|Overall Study|Death|2
7597398|NCT04611789|12003439|FG000|Overall Study|Lost to Follow-up|1
7597399|NCT04611789|12003440|FG001|Overall Study|Lost to Follow-up|0
7597400|NCT04611789|12003441|FG002|Overall Study|Lost to Follow-up|0
7597401|NCT04254809|12003504|FG000|Overall Study|Lost to Follow-up|5
7597402|NCT04254809|12003505|FG001|Overall Study|Lost to Follow-up|10
7597403|NCT04230122|12003513|FG000|Overall Study|Lost to Follow-up|1
7597404|NCT04230122|12003514|FG001|Overall Study|Lost to Follow-up|0
7597405|NCT04033068|12003543|FG000|Overall Study|Withdrawal by Subject|0
7597406|NCT04033068|12003544|FG001|Overall Study|Withdrawal by Subject|0
7597407|NCT04033068|12003545|FG002|Overall Study|Withdrawal by Subject|1
7597408|NCT04033068|12003546|FG003|Overall Study|Withdrawal by Subject|0
7597409|NCT04033068|12003543|FG000|Overall Study|Lost to Follow-up|0
7597410|NCT04033068|12003544|FG001|Overall Study|Lost to Follow-up|1
7597411|NCT04033068|12003545|FG002|Overall Study|Lost to Follow-up|0
7597412|NCT04033068|12003546|FG003|Overall Study|Lost to Follow-up|0
7597413|NCT04033068|12003543|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597414|NCT04033068|12003544|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597415|NCT04033068|12003545|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
7597416|NCT04033068|12003546|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
7272003|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
7597417|NCT03561597|12003556|FG000|Overall Study|Lost to Follow-up|20
7597418|NCT03350984|12003562|FG000|Overall Study|Death|1
7272004|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
7272005|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
7272006|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
7272007|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
7272008|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
7272009|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
7272010|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
7597419|NCT03350984|12003563|FG001|Overall Study|Death|0
7597420|NCT03350984|12003562|FG000|Overall Study|Lost to Follow-up|5
7597421|NCT03350984|12003563|FG001|Overall Study|Lost to Follow-up|6
7597422|NCT03350984|12003562|FG000|Overall Study|Protocol Violation|1
7597423|NCT03350984|12003563|FG001|Overall Study|Protocol Violation|2
7597424|NCT03350984|12003562|FG000|Overall Study|Physician Decision|1
7597425|NCT03350984|12003563|FG001|Overall Study|Physician Decision|0
7597426|NCT03277261|12003571|FG000|Overall Study|Adverse Event|17
7597427|NCT03277261|12003572|FG001|Overall Study|Adverse Event|1
7597428|NCT03277261|12003571|FG000|Overall Study|Participant Withdrawal of Consent|6
7597429|NCT03277261|12003572|FG001|Overall Study|Participant Withdrawal of Consent|15
7597430|NCT03277261|12003571|FG000|Overall Study|Investigator / Sponsor Decision|4
7597431|NCT03277261|12003572|FG001|Overall Study|Investigator / Sponsor Decision|2
7597432|NCT03277261|12003571|FG000|Overall Study|Pregnancy|2
7597433|NCT03277261|12003572|FG001|Overall Study|Pregnancy|0
7597434|NCT03277261|12003571|FG000|Overall Study|Lost to Follow-up|2
7597435|NCT03277261|12003572|FG001|Overall Study|Lost to Follow-up|2
7597436|NCT03277261|12003571|FG000|Overall Study|Lack of Efficacy|2
7597437|NCT03277261|12003572|FG001|Overall Study|Lack of Efficacy|2
7597438|NCT03277261|12003571|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7597439|NCT03277261|12003572|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
7597440|NCT03277248|12003581|FG000|Overall Study|Adverse Event|3
7597441|NCT03277248|12003582|FG001|Overall Study|Adverse Event|1
7597442|NCT03277248|12003581|FG000|Overall Study|Subject Withdrawal of Consent|6
7597443|NCT03277248|12003582|FG001|Overall Study|Subject Withdrawal of Consent|23
7597444|NCT03277248|12003581|FG000|Overall Study|Investigator/Sponsor Decision|2
7597445|NCT03277248|12003582|FG001|Overall Study|Investigator/Sponsor Decision|2
7597446|NCT03277248|12003581|FG000|Overall Study|Pregnancy|4
7597447|NCT03277248|12003582|FG001|Overall Study|Pregnancy|1
7597448|NCT03277248|12003581|FG000|Overall Study|Lost to Follow-up|0
7597449|NCT03277248|12003582|FG001|Overall Study|Lost to Follow-up|2
7597450|NCT03277248|12003581|FG000|Overall Study|Lack of Efficacy|0
7597451|NCT03277248|12003582|FG001|Overall Study|Lack of Efficacy|2
7597452|NCT03277248|12003581|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7597453|NCT03277248|12003582|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
7597454|NCT03179462|12003591|FG000|Overall Study|screening failure|1
7597455|NCT03179462|12003592|FG001|Overall Study|screening failure|2
7597456|NCT03179462|12003593|FG002|Overall Study|screening failure|0
7597457|NCT03099707|12003603|FG000|Overall Study|Withdrawal by Subject|0
7597458|NCT03099707|12003604|FG001|Overall Study|Withdrawal by Subject|3
7597459|NCT03099707|12003603|FG000|Overall Study|Lost to Follow-up|0
7597460|NCT03099707|12003604|FG001|Overall Study|Lost to Follow-up|1
7597461|NCT03064763|12003610|FG000|Overall Study|Ongoing in study|10
7597462|NCT03064763|12003610|FG000|Overall Study|Death|8
7597463|NCT02906033|12003635|FG000|Baseline|Protocol Violation|37
7597464|NCT02906033|12003636|FG001|Baseline|Protocol Violation|33
7597465|NCT02906033|12003635|FG000|Follow-up|Lost to Follow-up|46
7597466|NCT02906033|12003636|FG001|Follow-up|Lost to Follow-up|62
7597467|NCT02837783|12003644|FG000|Overall Study|Adverse Event|1
7597468|NCT02837783|12003645|FG001|Overall Study|Adverse Event|0
7597469|NCT02837783|12003644|FG000|Overall Study|Other, Not Specified|1
7597470|NCT02837783|12003645|FG001|Overall Study|Other, Not Specified|2
7597471|NCT02786537|12003657|FG000|As Randomized|Adverse Event|0
7597472|NCT02786537|12003658|FG001|As Randomized|Adverse Event|11
7597473|NCT02786537|12003659|FG002|As Randomized|Adverse Event|0
7597474|NCT02786537|12003660|FG003|As Randomized|Adverse Event|4
7597475|NCT02786537|12003661|FG004|As Randomized|Adverse Event|6
7597476|NCT02786537|12003662|FG005|As Randomized|Adverse Event|2
7597477|NCT02786537|12003657|FG000|As Randomized|Lack of Efficacy|0
7597478|NCT02786537|12003658|FG001|As Randomized|Lack of Efficacy|0
7597479|NCT02786537|12003659|FG002|As Randomized|Lack of Efficacy|0
7597480|NCT02786537|12003660|FG003|As Randomized|Lack of Efficacy|1
7597481|NCT02786537|12003661|FG004|As Randomized|Lack of Efficacy|0
7597482|NCT02786537|12003662|FG005|As Randomized|Lack of Efficacy|0
7597483|NCT02786537|12003657|FG000|As Randomized|Withdrawal by Subject|1
7597484|NCT02786537|12003658|FG001|As Randomized|Withdrawal by Subject|2
7597485|NCT02786537|12003659|FG002|As Randomized|Withdrawal by Subject|0
7597486|NCT02786537|12003660|FG003|As Randomized|Withdrawal by Subject|1
7597487|NCT02786537|12003661|FG004|As Randomized|Withdrawal by Subject|1
7597488|NCT02786537|12003662|FG005|As Randomized|Withdrawal by Subject|0
7597489|NCT02786537|12003657|FG000|As Randomized|Death|0
7597490|NCT02786537|12003658|FG001|As Randomized|Death|2
7597491|NCT02786537|12003659|FG002|As Randomized|Death|0
7597492|NCT02786537|12003660|FG003|As Randomized|Death|3
7597493|NCT02786537|12003661|FG004|As Randomized|Death|1
7597494|NCT02786537|12003662|FG005|As Randomized|Death|0
7597495|NCT02786537|12003657|FG000|As Randomized|Non-compliance with study drug|1
7597496|NCT02786537|12003658|FG001|As Randomized|Non-compliance with study drug|11
7597497|NCT02786537|12003659|FG002|As Randomized|Non-compliance with study drug|0
7597498|NCT02786537|12003660|FG003|As Randomized|Non-compliance with study drug|1
7597499|NCT02786537|12003661|FG004|As Randomized|Non-compliance with study drug|0
7597500|NCT02786537|12003662|FG005|As Randomized|Non-compliance with study drug|1
7597501|NCT02786537|12003657|FG000|As Randomized|Lost to treatment follow-up|4
7597502|NCT02786537|12003658|FG001|As Randomized|Lost to treatment follow-up|32
7597503|NCT02786537|12003659|FG002|As Randomized|Lost to treatment follow-up|0
7597504|NCT02786537|12003660|FG003|As Randomized|Lost to treatment follow-up|24
7597505|NCT02786537|12003661|FG004|As Randomized|Lost to treatment follow-up|4
7597506|NCT02786537|12003662|FG005|As Randomized|Lost to treatment follow-up|4
7597507|NCT02786537|12003657|FG000|As Randomized|Incarceration|0
7597508|NCT02786537|12003658|FG001|As Randomized|Incarceration|1
7597509|NCT02786537|12003659|FG002|As Randomized|Incarceration|0
7597510|NCT02786537|12003660|FG003|As Randomized|Incarceration|0
7597511|NCT02786537|12003661|FG004|As Randomized|Incarceration|0
7597512|NCT02786537|12003662|FG005|As Randomized|Incarceration|0
7597513|NCT02786537|12003657|FG000|As Randomized|Opiate Dependency Relapse|0
7597514|NCT02786537|12003658|FG001|As Randomized|Opiate Dependency Relapse|1
7597515|NCT02786537|12003659|FG002|As Randomized|Opiate Dependency Relapse|0
7597516|NCT02786537|12003660|FG003|As Randomized|Opiate Dependency Relapse|0
7597517|NCT02786537|12003661|FG004|As Randomized|Opiate Dependency Relapse|0
7597518|NCT02786537|12003662|FG005|As Randomized|Opiate Dependency Relapse|0
7597519|NCT02786537|12003657|FG000|As Randomized|HCV drugs stolen from pt|0
7597520|NCT02786537|12003658|FG001|As Randomized|HCV drugs stolen from pt|1
7597521|NCT02786537|12003659|FG002|As Randomized|HCV drugs stolen from pt|0
7597522|NCT02786537|12003660|FG003|As Randomized|HCV drugs stolen from pt|0
7597523|NCT02786537|12003661|FG004|As Randomized|HCV drugs stolen from pt|0
7597524|NCT02786537|12003662|FG005|As Randomized|HCV drugs stolen from pt|0
7597525|NCT02786537|12003657|FG000|As Randomized|Advised to stop after lapse in dosing|0
7597526|NCT02786537|12003658|FG001|As Randomized|Advised to stop after lapse in dosing|1
7597527|NCT02786537|12003659|FG002|As Randomized|Advised to stop after lapse in dosing|0
7597528|NCT02786537|12003660|FG003|As Randomized|Advised to stop after lapse in dosing|0
7597529|NCT02786537|12003661|FG004|As Randomized|Advised to stop after lapse in dosing|0
7597530|NCT02786537|12003662|FG005|As Randomized|Advised to stop after lapse in dosing|0
7597531|NCT02786537|12003657|FG000|As Randomized|Subject lost insurance|0
7597532|NCT02786537|12003658|FG001|As Randomized|Subject lost insurance|0
7597533|NCT02786537|12003659|FG002|As Randomized|Subject lost insurance|0
7597534|NCT02786537|12003660|FG003|As Randomized|Subject lost insurance|1
7597535|NCT02786537|12003661|FG004|As Randomized|Subject lost insurance|0
7597536|NCT02786537|12003662|FG005|As Randomized|Subject lost insurance|0
7597537|NCT02786537|12003657|FG000|As Treated|Adverse Event|0
7597538|NCT02786537|12003658|FG001|As Treated|Adverse Event|11
7597539|NCT02786537|12003659|FG002|As Treated|Adverse Event|0
7597540|NCT02786537|12003660|FG003|As Treated|Adverse Event|4
7597541|NCT02786537|12003661|FG004|As Treated|Adverse Event|6
7272011|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
7272012|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
7469694|NCT01926015|11771574|FG000|Overall Study|Randomized not treated|2
7597542|NCT02786537|12003662|FG005|As Treated|Adverse Event|2
7597543|NCT02786537|12003657|FG000|As Treated|Death|0
7597544|NCT02786537|12003658|FG001|As Treated|Death|2
7597545|NCT02786537|12003659|FG002|As Treated|Death|0
7597546|NCT02786537|12003660|FG003|As Treated|Death|3
7597547|NCT02786537|12003661|FG004|As Treated|Death|1
7597548|NCT02786537|12003662|FG005|As Treated|Death|0
7597549|NCT02786537|12003657|FG000|As Treated|Lack of Efficacy|0
7597550|NCT02786537|12003658|FG001|As Treated|Lack of Efficacy|0
7597551|NCT02786537|12003659|FG002|As Treated|Lack of Efficacy|0
7597552|NCT02786537|12003660|FG003|As Treated|Lack of Efficacy|1
7597553|NCT02786537|12003661|FG004|As Treated|Lack of Efficacy|0
7597554|NCT02786537|12003662|FG005|As Treated|Lack of Efficacy|0
7597555|NCT02786537|12003657|FG000|As Treated|Lost to Follow-up|4
7597556|NCT02786537|12003658|FG001|As Treated|Lost to Follow-up|32
7597557|NCT02786537|12003659|FG002|As Treated|Lost to Follow-up|0
7597558|NCT02786537|12003660|FG003|As Treated|Lost to Follow-up|25
7597559|NCT02786537|12003661|FG004|As Treated|Lost to Follow-up|4
7597560|NCT02786537|12003662|FG005|As Treated|Lost to Follow-up|4
7597561|NCT02786537|12003657|FG000|As Treated|Non-compliance with study drug|1
7597562|NCT02786537|12003658|FG001|As Treated|Non-compliance with study drug|11
7597563|NCT02786537|12003659|FG002|As Treated|Non-compliance with study drug|0
7597564|NCT02786537|12003660|FG003|As Treated|Non-compliance with study drug|1
7597565|NCT02786537|12003661|FG004|As Treated|Non-compliance with study drug|0
7597566|NCT02786537|12003662|FG005|As Treated|Non-compliance with study drug|1
7597567|NCT02786537|12003657|FG000|As Treated|Lost insurance|0
7597568|NCT02786537|12003658|FG001|As Treated|Lost insurance|0
7597569|NCT02786537|12003659|FG002|As Treated|Lost insurance|0
7597570|NCT02786537|12003660|FG003|As Treated|Lost insurance|1
7597571|NCT02786537|12003661|FG004|As Treated|Lost insurance|0
7597572|NCT02786537|12003662|FG005|As Treated|Lost insurance|0
7597573|NCT02786537|12003657|FG000|As Treated|Withdrawal by Subject|1
7597574|NCT02786537|12003658|FG001|As Treated|Withdrawal by Subject|2
7597575|NCT02786537|12003659|FG002|As Treated|Withdrawal by Subject|0
7597576|NCT02786537|12003660|FG003|As Treated|Withdrawal by Subject|0
7597577|NCT02786537|12003661|FG004|As Treated|Withdrawal by Subject|1
7597578|NCT02786537|12003662|FG005|As Treated|Withdrawal by Subject|0
7597579|NCT02786537|12003657|FG000|As Treated|Incarceration|0
7597580|NCT02786537|12003658|FG001|As Treated|Incarceration|1
7597581|NCT02786537|12003659|FG002|As Treated|Incarceration|0
7597582|NCT02786537|12003660|FG003|As Treated|Incarceration|0
7597583|NCT02786537|12003661|FG004|As Treated|Incarceration|0
7597584|NCT02786537|12003662|FG005|As Treated|Incarceration|0
7597585|NCT02786537|12003657|FG000|As Treated|Opiate dependency relapse|0
7597586|NCT02786537|12003658|FG001|As Treated|Opiate dependency relapse|1
7597587|NCT02786537|12003659|FG002|As Treated|Opiate dependency relapse|0
7597588|NCT02786537|12003660|FG003|As Treated|Opiate dependency relapse|0
7597589|NCT02786537|12003661|FG004|As Treated|Opiate dependency relapse|0
7597590|NCT02786537|12003662|FG005|As Treated|Opiate dependency relapse|0
7597591|NCT02786537|12003657|FG000|As Treated|Drugs stolen from patient|0
7597592|NCT02786537|12003658|FG001|As Treated|Drugs stolen from patient|1
7597593|NCT02786537|12003659|FG002|As Treated|Drugs stolen from patient|0
7597594|NCT02786537|12003660|FG003|As Treated|Drugs stolen from patient|0
7597595|NCT02786537|12003661|FG004|As Treated|Drugs stolen from patient|0
7597596|NCT02786537|12003662|FG005|As Treated|Drugs stolen from patient|0
7597597|NCT02786537|12003657|FG000|As Treated|Advised to stop tx after loss of meds|0
7597598|NCT02786537|12003658|FG001|As Treated|Advised to stop tx after loss of meds|1
7597599|NCT02786537|12003659|FG002|As Treated|Advised to stop tx after loss of meds|0
7597600|NCT02786537|12003660|FG003|As Treated|Advised to stop tx after loss of meds|0
7597601|NCT02786537|12003661|FG004|As Treated|Advised to stop tx after loss of meds|0
7597602|NCT02786537|12003662|FG005|As Treated|Advised to stop tx after loss of meds|0
7597603|NCT02740231|12003772|FG000|Overall Study|Withdrawal by Subject|1
7597604|NCT02740231|12003773|FG001|Overall Study|Withdrawal by Subject|1
7597605|NCT02740231|12003774|FG002|Overall Study|Withdrawal by Subject|1
7597606|NCT02740231|12003775|FG003|Overall Study|Withdrawal by Subject|0
7597607|NCT02740231|12003772|FG000|Overall Study|Lack of Efficacy|0
7597608|NCT02740231|12003773|FG001|Overall Study|Lack of Efficacy|1
7597609|NCT02740231|12003774|FG002|Overall Study|Lack of Efficacy|0
7597610|NCT02740231|12003775|FG003|Overall Study|Lack of Efficacy|4
7597611|NCT02740231|12003772|FG000|Overall Study|Lost to Follow-up|1
7597612|NCT02740231|12003773|FG001|Overall Study|Lost to Follow-up|3
7597613|NCT02740231|12003774|FG002|Overall Study|Lost to Follow-up|0
7597614|NCT02740231|12003775|FG003|Overall Study|Lost to Follow-up|3
7597615|NCT02740231|12003772|FG000|Overall Study|Adverse Event|0
7597616|NCT02740231|12003773|FG001|Overall Study|Adverse Event|1
7597617|NCT02740231|12003774|FG002|Overall Study|Adverse Event|0
7597618|NCT02740231|12003775|FG003|Overall Study|Adverse Event|1
7597619|NCT02710084|12003787|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
7597620|NCT02710084|12003788|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
7597621|NCT02660034|12003809|FG000|Overall Study|Progressive Disease (Radiographic)|3
7597622|NCT02660034|12003810|FG001|Overall Study|Progressive Disease (Radiographic)|1
7597623|NCT02660034|12003811|FG002|Overall Study|Progressive Disease (Radiographic)|0
7597624|NCT02660034|12003812|FG003|Overall Study|Progressive Disease (Radiographic)|1
7597625|NCT02660034|12003813|FG004|Overall Study|Progressive Disease (Radiographic)|0
7597626|NCT02660034|12003814|FG005|Overall Study|Progressive Disease (Radiographic)|0
7597627|NCT02660034|12003815|FG006|Overall Study|Progressive Disease (Radiographic)|0
7597628|NCT02660034|12003816|FG007|Overall Study|Progressive Disease (Radiographic)|0
7597629|NCT02660034|12003817|FG008|Overall Study|Progressive Disease (Radiographic)|0
7597630|NCT02660034|12003818|FG009|Overall Study|Progressive Disease (Radiographic)|0
7597631|NCT02660034|12003819|FG010|Overall Study|Progressive Disease (Radiographic)|0
7597632|NCT02660034|12003820|FG011|Overall Study|Progressive Disease (Radiographic)|0
7597633|NCT02660034|12003821|FG012|Overall Study|Progressive Disease (Radiographic)|0
7597634|NCT02660034|12003822|FG013|Overall Study|Progressive Disease (Radiographic)|0
7597635|NCT02660034|12003809|FG000|Overall Study|Progressive Disease (Clinical)|7
7597636|NCT02660034|12003810|FG001|Overall Study|Progressive Disease (Clinical)|8
7597637|NCT02660034|12003811|FG002|Overall Study|Progressive Disease (Clinical)|3
7597638|NCT02660034|12003812|FG003|Overall Study|Progressive Disease (Clinical)|9
7597639|NCT02660034|12003813|FG004|Overall Study|Progressive Disease (Clinical)|3
7597640|NCT02660034|12003814|FG005|Overall Study|Progressive Disease (Clinical)|0
7597641|NCT02660034|12003815|FG006|Overall Study|Progressive Disease (Clinical)|0
7597642|NCT02660034|12003816|FG007|Overall Study|Progressive Disease (Clinical)|0
7597643|NCT02660034|12003817|FG008|Overall Study|Progressive Disease (Clinical)|0
7597644|NCT02660034|12003818|FG009|Overall Study|Progressive Disease (Clinical)|0
7597645|NCT02660034|12003819|FG010|Overall Study|Progressive Disease (Clinical)|0
7597646|NCT02660034|12003820|FG011|Overall Study|Progressive Disease (Clinical)|0
7597647|NCT02660034|12003821|FG012|Overall Study|Progressive Disease (Clinical)|0
7597648|NCT02660034|12003822|FG013|Overall Study|Progressive Disease (Clinical)|0
7597649|NCT02660034|12003809|FG000|Overall Study|Lost to Follow-up|0
7597650|NCT02660034|12003810|FG001|Overall Study|Lost to Follow-up|0
7597651|NCT02660034|12003811|FG002|Overall Study|Lost to Follow-up|1
7597652|NCT02660034|12003812|FG003|Overall Study|Lost to Follow-up|1
7597653|NCT02660034|12003813|FG004|Overall Study|Lost to Follow-up|0
7597654|NCT02660034|12003814|FG005|Overall Study|Lost to Follow-up|0
7597655|NCT02660034|12003815|FG006|Overall Study|Lost to Follow-up|0
7597656|NCT02660034|12003816|FG007|Overall Study|Lost to Follow-up|0
7597657|NCT02660034|12003817|FG008|Overall Study|Lost to Follow-up|0
7597658|NCT02660034|12003818|FG009|Overall Study|Lost to Follow-up|1
7597659|NCT02660034|12003819|FG010|Overall Study|Lost to Follow-up|1
7597660|NCT02660034|12003820|FG011|Overall Study|Lost to Follow-up|1
7597661|NCT02660034|12003821|FG012|Overall Study|Lost to Follow-up|0
7597662|NCT02660034|12003822|FG013|Overall Study|Lost to Follow-up|0
7597663|NCT02660034|12003809|FG000|Overall Study|Participant moved into special access scheme|1
7597664|NCT02660034|12003810|FG001|Overall Study|Participant moved into special access scheme|2
7597665|NCT02660034|12003811|FG002|Overall Study|Participant moved into special access scheme|0
7597666|NCT02660034|12003812|FG003|Overall Study|Participant moved into special access scheme|0
7597667|NCT02660034|12003813|FG004|Overall Study|Participant moved into special access scheme|0
7597668|NCT02660034|12003814|FG005|Overall Study|Participant moved into special access scheme|0
7597669|NCT02660034|12003815|FG006|Overall Study|Participant moved into special access scheme|0
7597670|NCT02660034|12003816|FG007|Overall Study|Participant moved into special access scheme|0
7597671|NCT02660034|12003817|FG008|Overall Study|Participant moved into special access scheme|0
7597672|NCT02660034|12003818|FG009|Overall Study|Participant moved into special access scheme|0
7597673|NCT02660034|12003819|FG010|Overall Study|Participant moved into special access scheme|0
7597674|NCT02660034|12003820|FG011|Overall Study|Participant moved into special access scheme|0
7597675|NCT02660034|12003821|FG012|Overall Study|Participant moved into special access scheme|0
7597676|NCT02660034|12003822|FG013|Overall Study|Participant moved into special access scheme|0
7597677|NCT02660034|12003809|FG000|Overall Study|Adverse Event|1
7597678|NCT02660034|12003810|FG001|Overall Study|Adverse Event|0
7597679|NCT02660034|12003811|FG002|Overall Study|Adverse Event|0
7597680|NCT02660034|12003812|FG003|Overall Study|Adverse Event|0
7597681|NCT02660034|12003813|FG004|Overall Study|Adverse Event|0
7597682|NCT02660034|12003814|FG005|Overall Study|Adverse Event|0
7597683|NCT02660034|12003815|FG006|Overall Study|Adverse Event|0
7597684|NCT02660034|12003816|FG007|Overall Study|Adverse Event|0
7597685|NCT02660034|12003817|FG008|Overall Study|Adverse Event|0
7597686|NCT02660034|12003818|FG009|Overall Study|Adverse Event|0
7597687|NCT02660034|12003819|FG010|Overall Study|Adverse Event|0
7597688|NCT02660034|12003820|FG011|Overall Study|Adverse Event|0
7597689|NCT02660034|12003821|FG012|Overall Study|Adverse Event|0
7597690|NCT02660034|12003822|FG013|Overall Study|Adverse Event|0
7597691|NCT02660034|12003809|FG000|Overall Study|Sponsor Decision|0
7597692|NCT02660034|12003810|FG001|Overall Study|Sponsor Decision|1
7597693|NCT02660034|12003811|FG002|Overall Study|Sponsor Decision|2
7597694|NCT02660034|12003812|FG003|Overall Study|Sponsor Decision|2
7597695|NCT02660034|12003813|FG004|Overall Study|Sponsor Decision|3
7597696|NCT02660034|12003814|FG005|Overall Study|Sponsor Decision|0
7597697|NCT02660034|12003815|FG006|Overall Study|Sponsor Decision|0
7597698|NCT02660034|12003816|FG007|Overall Study|Sponsor Decision|0
7597699|NCT02660034|12003817|FG008|Overall Study|Sponsor Decision|0
7597700|NCT02660034|12003818|FG009|Overall Study|Sponsor Decision|0
7597701|NCT02660034|12003819|FG010|Overall Study|Sponsor Decision|0
7597702|NCT02660034|12003820|FG011|Overall Study|Sponsor Decision|0
7597703|NCT02660034|12003821|FG012|Overall Study|Sponsor Decision|0
7597704|NCT02660034|12003822|FG013|Overall Study|Sponsor Decision|1
7597705|NCT02660034|12003809|FG000|Overall Study|Withdrawal by Subject|0
7597706|NCT02660034|12003810|FG001|Overall Study|Withdrawal by Subject|0
7597707|NCT02660034|12003811|FG002|Overall Study|Withdrawal by Subject|0
7597708|NCT02660034|12003812|FG003|Overall Study|Withdrawal by Subject|0
7597709|NCT02660034|12003813|FG004|Overall Study|Withdrawal by Subject|0
7597710|NCT02660034|12003814|FG005|Overall Study|Withdrawal by Subject|0
7597711|NCT02660034|12003815|FG006|Overall Study|Withdrawal by Subject|1
7597712|NCT02660034|12003816|FG007|Overall Study|Withdrawal by Subject|1
7597713|NCT02660034|12003817|FG008|Overall Study|Withdrawal by Subject|1
7597714|NCT02660034|12003818|FG009|Overall Study|Withdrawal by Subject|0
7597715|NCT02660034|12003819|FG010|Overall Study|Withdrawal by Subject|0
7597716|NCT02660034|12003820|FG011|Overall Study|Withdrawal by Subject|1
7597717|NCT02660034|12003821|FG012|Overall Study|Withdrawal by Subject|2
7597718|NCT02660034|12003822|FG013|Overall Study|Withdrawal by Subject|0
7597719|NCT02660034|12003809|FG000|Overall Study|Death|0
7597720|NCT02660034|12003810|FG001|Overall Study|Death|0
7597721|NCT02660034|12003811|FG002|Overall Study|Death|0
7597722|NCT02660034|12003812|FG003|Overall Study|Death|0
7597723|NCT02660034|12003813|FG004|Overall Study|Death|0
7597724|NCT02660034|12003814|FG005|Overall Study|Death|13
7597725|NCT02660034|12003815|FG006|Overall Study|Death|14
7597726|NCT02660034|12003816|FG007|Overall Study|Death|10
7597727|NCT02660034|12003817|FG008|Overall Study|Death|9
7597728|NCT02660034|12003818|FG009|Overall Study|Death|21
7597729|NCT02660034|12003819|FG010|Overall Study|Death|17
7597730|NCT02660034|12003820|FG011|Overall Study|Death|15
7597731|NCT02660034|12003821|FG012|Overall Study|Death|18
7597732|NCT02660034|12003822|FG013|Overall Study|Death|7
7597733|NCT02660034|12003809|FG000|Overall Study|Physician Decision|0
7597734|NCT02660034|12003810|FG001|Overall Study|Physician Decision|0
7597735|NCT02660034|12003811|FG002|Overall Study|Physician Decision|0
7597736|NCT02660034|12003812|FG003|Overall Study|Physician Decision|0
7597737|NCT02660034|12003813|FG004|Overall Study|Physician Decision|0
7597738|NCT02660034|12003814|FG005|Overall Study|Physician Decision|0
7597739|NCT02660034|12003815|FG006|Overall Study|Physician Decision|0
7597740|NCT02660034|12003816|FG007|Overall Study|Physician Decision|0
7597741|NCT02660034|12003817|FG008|Overall Study|Physician Decision|0
7597742|NCT02660034|12003818|FG009|Overall Study|Physician Decision|0
7597743|NCT02660034|12003819|FG010|Overall Study|Physician Decision|0
7597744|NCT02660034|12003820|FG011|Overall Study|Physician Decision|0
7597745|NCT02660034|12003821|FG012|Overall Study|Physician Decision|0
7597746|NCT02660034|12003822|FG013|Overall Study|Physician Decision|1
7597747|NCT02660034|12003809|FG000|Overall Study|Participants transferred to LTE|0
7597748|NCT02660034|12003810|FG001|Overall Study|Participants transferred to LTE|0
7597749|NCT02660034|12003811|FG002|Overall Study|Participants transferred to LTE|0
7597750|NCT02660034|12003812|FG003|Overall Study|Participants transferred to LTE|0
7597751|NCT02660034|12003813|FG004|Overall Study|Participants transferred to LTE|0
7597752|NCT02660034|12003814|FG005|Overall Study|Participants transferred to LTE|10
7597753|NCT02660034|12003815|FG006|Overall Study|Participants transferred to LTE|8
7597754|NCT02660034|12003816|FG007|Overall Study|Participants transferred to LTE|8
7597755|NCT02660034|12003817|FG008|Overall Study|Participants transferred to LTE|10
7597756|NCT02660034|12003818|FG009|Overall Study|Participants transferred to LTE|1
7597757|NCT02660034|12003819|FG010|Overall Study|Participants transferred to LTE|2
7597758|NCT02660034|12003820|FG011|Overall Study|Participants transferred to LTE|4
7597759|NCT02660034|12003821|FG012|Overall Study|Participants transferred to LTE|1
7597760|NCT02660034|12003822|FG013|Overall Study|Participants transferred to LTE|1
7597761|NCT02640625|12003856|FG000|Overall Study|Adverse Event|1
7597762|NCT02561962|12003870|FG000|Overall Study|Ongoing in study|1
7597763|NCT02561962|12003871|FG001|Overall Study|Ongoing in study|0
7597764|NCT02561962|12003872|FG002|Overall Study|Ongoing in study|0
7597765|NCT02561962|12003873|FG003|Overall Study|Ongoing in study|1
7597766|NCT02561962|12003874|FG004|Overall Study|Ongoing in study|0
7597767|NCT02561962|12003875|FG005|Overall Study|Ongoing in study|1
7597768|NCT02561962|12003876|FG006|Overall Study|Ongoing in study|0
7597769|NCT02561962|12003877|FG007|Overall Study|Ongoing in study|4
7597770|NCT02561962|12003878|FG008|Overall Study|Ongoing in study|1
7597771|NCT02561962|12003870|FG000|Overall Study|Withdrawal by Subject|1
7597772|NCT02561962|12003871|FG001|Overall Study|Withdrawal by Subject|0
7597773|NCT02561962|12003872|FG002|Overall Study|Withdrawal by Subject|0
7597774|NCT02561962|12003873|FG003|Overall Study|Withdrawal by Subject|0
7597775|NCT02561962|12003874|FG004|Overall Study|Withdrawal by Subject|1
7597776|NCT02561962|12003875|FG005|Overall Study|Withdrawal by Subject|1
7597777|NCT02561962|12003876|FG006|Overall Study|Withdrawal by Subject|2
7597778|NCT02561962|12003877|FG007|Overall Study|Withdrawal by Subject|1
7597779|NCT02561962|12003878|FG008|Overall Study|Withdrawal by Subject|0
7597780|NCT02561962|12003870|FG000|Overall Study|Decision by sponsor|0
7597781|NCT02561962|12003871|FG001|Overall Study|Decision by sponsor|0
7597782|NCT02561962|12003872|FG002|Overall Study|Decision by sponsor|0
7597783|NCT02561962|12003873|FG003|Overall Study|Decision by sponsor|0
7597784|NCT02561962|12003874|FG004|Overall Study|Decision by sponsor|1
7597785|NCT02561962|12003875|FG005|Overall Study|Decision by sponsor|1
7597786|NCT02561962|12003876|FG006|Overall Study|Decision by sponsor|0
7597787|NCT02561962|12003877|FG007|Overall Study|Decision by sponsor|3
7597788|NCT02561962|12003878|FG008|Overall Study|Decision by sponsor|0
7597789|NCT02561962|12003870|FG000|Overall Study|Lost to Follow-up|0
7597790|NCT02561962|12003871|FG001|Overall Study|Lost to Follow-up|0
7597791|NCT02561962|12003872|FG002|Overall Study|Lost to Follow-up|0
7597792|NCT02561962|12003873|FG003|Overall Study|Lost to Follow-up|0
7597793|NCT02561962|12003874|FG004|Overall Study|Lost to Follow-up|0
7272013|NCT00424047|11486303|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
7272014|NCT00424047|11486304|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
7272015|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Adverse Event|22
7272016|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Adverse Event|12
7272017|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Progression of disease|92
7272018|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Progression of disease|128
7272019|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
7272020|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
7597838|NCT01373151|12003958|FG003|Period 1|Withdrawal by Subject|1
7272021|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
7272022|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
7272023|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Death|11
7272024|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Death|11
7272025|NCT00424047|11486303|FG000|On Study at Time of Unblinding|Other|5
7272026|NCT00424047|11486304|FG001|On Study at Time of Unblinding|Other|4
7272027|NCT00424047|11486303|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
7272028|NCT00424047|11486304|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
7272029|NCT00424047|11486303|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
7272030|NCT00424047|11486304|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
7272031|NCT00424047|11486303|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
7272032|NCT00424047|11486304|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
7272033|NCT00424047|11486303|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
7272034|NCT00424047|11486304|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
7272035|NCT00424047|11486303|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
7272036|NCT00424047|11486304|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
7272037|NCT00424177|11486315|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
7272038|NCT00424177|11486315|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
7272039|NCT00424177|11486315|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
7272040|NCT00424177|11486315|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
7272041|NCT00424177|11486315|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
7272042|NCT00424177|11486315|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
7272043|NCT00424177|11486315|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7272044|NCT00424177|11486315|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
7272045|NCT00424177|11486315|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
7272046|NCT00424177|11486315|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
7272047|NCT00424190|11486329|FG000|Overall Study|Withdrew consent|3
7272048|NCT00424190|11486330|FG001|Overall Study|Withdrew consent|4
7272049|NCT00424190|11486329|FG000|Overall Study|Death|3
7272050|NCT00424190|11486330|FG001|Overall Study|Death|0
7272051|NCT00424190|11486329|FG000|Overall Study|Noncompliance|1
7272052|NCT00424190|11486330|FG001|Overall Study|Noncompliance|2
7272053|NCT00424190|11486329|FG000|Overall Study|Request of sponsor or investigator|0
7272054|NCT00424190|11486330|FG001|Overall Study|Request of sponsor or investigator|2
7597794|NCT02561962|12003875|FG005|Overall Study|Lost to Follow-up|1
7597795|NCT02561962|12003876|FG006|Overall Study|Lost to Follow-up|0
7597796|NCT02561962|12003877|FG007|Overall Study|Lost to Follow-up|0
7597797|NCT02561962|12003878|FG008|Overall Study|Lost to Follow-up|0
7597798|NCT02500589|12003900|FG000|Overall Study|Withdrawal by Subject|11
7597799|NCT02500589|12003901|FG001|Overall Study|Withdrawal by Subject|14
7597800|NCT02500589|12003900|FG000|Overall Study|Lost to Follow-up|10
7597801|NCT02500589|12003901|FG001|Overall Study|Lost to Follow-up|12
7597802|NCT02500589|12003900|FG000|Overall Study|Excluded post rand: cognitive impairment|0
7597803|NCT02500589|12003901|FG001|Overall Study|Excluded post rand: cognitive impairment|1
7272055|NCT00424190|11486329|FG000|Overall Study|Diagnosis of osteomyelitis|0
7272056|NCT00424190|11486330|FG001|Overall Study|Diagnosis of osteomyelitis|1
7272057|NCT00424190|11486329|FG000|Overall Study|Other|15
7272058|NCT00424190|11486330|FG001|Overall Study|Other|21
7272059|NCT00424255|11486338|FG000|Overall Study|Death|115
7597804|NCT02500589|12003900|FG000|Overall Study|Death|7
7597805|NCT02500589|12003901|FG001|Overall Study|Death|5
7597806|NCT02474329|12003911|FG000|Overall Study|Withdraw or did not contribute data.|13
7597807|NCT01388491|12003941|FG000|Overall Study|Adverse Event|10
7597808|NCT01388491|12003942|FG001|Overall Study|Adverse Event|9
7597809|NCT01388491|12003941|FG000|Overall Study|Sponsor Request|9
7597810|NCT01388491|12003942|FG001|Overall Study|Sponsor Request|7
7597811|NCT01388491|12003941|FG000|Overall Study|Withdrawal by Subject|6
7597812|NCT01388491|12003942|FG001|Overall Study|Withdrawal by Subject|10
7597813|NCT01388491|12003941|FG000|Overall Study|Lost to Follow-up|4
7597814|NCT01388491|12003942|FG001|Overall Study|Lost to Follow-up|3
7597815|NCT01388491|12003941|FG000|Overall Study|Protocol Violation|2
7597816|NCT01388491|12003942|FG001|Overall Study|Protocol Violation|0
7597817|NCT01388491|12003941|FG000|Overall Study|Noncompliance|2
7597818|NCT01388491|12003942|FG001|Overall Study|Noncompliance|0
7597819|NCT01388491|12003941|FG000|Overall Study|Pregnancy|1
7597820|NCT01388491|12003942|FG001|Overall Study|Pregnancy|0
7597821|NCT01373151|12003955|FG000|Period 1|Lack of Efficacy|3
7597822|NCT01373151|12003956|FG001|Period 1|Lack of Efficacy|0
7597823|NCT01373151|12003957|FG002|Period 1|Lack of Efficacy|0
7597824|NCT01373151|12003958|FG003|Period 1|Lack of Efficacy|0
7597825|NCT01373151|12003959|FG004|Period 1|Lack of Efficacy|1
7597826|NCT01373151|12003960|FG005|Period 1|Lack of Efficacy|0
7597827|NCT01373151|12003961|FG006|Period 1|Lack of Efficacy|0
7597828|NCT01373151|12003955|FG000|Period 1|Adverse Event|0
7597829|NCT01373151|12003956|FG001|Period 1|Adverse Event|0
7597830|NCT01373151|12003957|FG002|Period 1|Adverse Event|1
7597831|NCT01373151|12003958|FG003|Period 1|Adverse Event|0
7597832|NCT01373151|12003959|FG004|Period 1|Adverse Event|4
7597833|NCT01373151|12003960|FG005|Period 1|Adverse Event|3
7597834|NCT01373151|12003961|FG006|Period 1|Adverse Event|0
7597835|NCT01373151|12003955|FG000|Period 1|Withdrawal by Subject|2
7597836|NCT01373151|12003956|FG001|Period 1|Withdrawal by Subject|0
7597837|NCT01373151|12003957|FG002|Period 1|Withdrawal by Subject|3
7597839|NCT01373151|12003959|FG004|Period 1|Withdrawal by Subject|0
7597840|NCT01373151|12003960|FG005|Period 1|Withdrawal by Subject|1
7597841|NCT01373151|12003961|FG006|Period 1|Withdrawal by Subject|0
7597842|NCT01373151|12003955|FG000|Period 2|Lack of Efficacy|9
7597843|NCT01373151|12003956|FG001|Period 2|Lack of Efficacy|0
7597844|NCT01373151|12003957|FG002|Period 2|Lack of Efficacy|0
7597845|NCT01373151|12003958|FG003|Period 2|Lack of Efficacy|1
7597846|NCT01373151|12003959|FG004|Period 2|Lack of Efficacy|2
7597847|NCT01373151|12003960|FG005|Period 2|Lack of Efficacy|0
7597848|NCT01373151|12003961|FG006|Period 2|Lack of Efficacy|3
7597849|NCT01373151|12003955|FG000|Period 2|Adverse Event|0
7597850|NCT01373151|12003956|FG001|Period 2|Adverse Event|0
7597851|NCT01373151|12003957|FG002|Period 2|Adverse Event|3
7597852|NCT01373151|12003958|FG003|Period 2|Adverse Event|3
7597853|NCT01373151|12003959|FG004|Period 2|Adverse Event|0
7597854|NCT01373151|12003960|FG005|Period 2|Adverse Event|0
7597855|NCT01373151|12003961|FG006|Period 2|Adverse Event|1
7597856|NCT01373151|12003955|FG000|Period 2|subject request to discontinue|0
7597857|NCT01373151|12003956|FG001|Period 2|subject request to discontinue|1
7597858|NCT01373151|12003957|FG002|Period 2|subject request to discontinue|0
7597859|NCT01373151|12003958|FG003|Period 2|subject request to discontinue|0
7597860|NCT01373151|12003959|FG004|Period 2|subject request to discontinue|0
7597861|NCT01373151|12003960|FG005|Period 2|subject request to discontinue|0
7597862|NCT01373151|12003961|FG006|Period 2|subject request to discontinue|0
7597863|NCT01373151|12003955|FG000|Period 2|Withdrawal by Subject|0
7597864|NCT01373151|12003956|FG001|Period 2|Withdrawal by Subject|0
7597865|NCT01373151|12003957|FG002|Period 2|Withdrawal by Subject|0
7597866|NCT01373151|12003958|FG003|Period 2|Withdrawal by Subject|1
7597867|NCT01373151|12003959|FG004|Period 2|Withdrawal by Subject|0
7597868|NCT01373151|12003960|FG005|Period 2|Withdrawal by Subject|0
7597869|NCT01373151|12003961|FG006|Period 2|Withdrawal by Subject|0
7597870|NCT01373151|12003955|FG000|Period 2|Other|0
7597871|NCT01373151|12003956|FG001|Period 2|Other|0
7597872|NCT01373151|12003957|FG002|Period 2|Other|1
7597873|NCT01373151|12003958|FG003|Period 2|Other|0
7597874|NCT01373151|12003959|FG004|Period 2|Other|0
7597875|NCT01373151|12003960|FG005|Period 2|Other|0
7597876|NCT01373151|12003961|FG006|Period 2|Other|1
7597877|NCT01281644|12003990|FG000|Overall Study|Lost to Follow-up|3
7597878|NCT01281644|12003990|FG000|Overall Study|Withdrawal by Subject|2
7597879|NCT00960297|12004002|FG000|Overall Study|Physician Decision|1
7597880|NCT00960297|12004002|FG000|Overall Study|Venous port infection|1
7597881|NCT00960297|12004002|FG000|Overall Study|Disease progression|1
7597882|NCT00910650|12004006|FG000|Overall Study|Death|2
7597883|NCT00703326|12004016|FG000|Overall Study|Lost to Follow-up|47
7597884|NCT00703326|12004017|FG001|Overall Study|Lost to Follow-up|18
7597885|NCT00703326|12004016|FG000|Overall Study|Withdrawal by Subject|54
7597886|NCT00703326|12004017|FG001|Overall Study|Withdrawal by Subject|20
7597887|NCT00703326|12004016|FG000|Overall Study|Adverse Event|1
7597888|NCT00703326|12004017|FG001|Overall Study|Adverse Event|0
7597889|NCT00602667|12004027|FG000|Overall Study|Still on Therapy|0
7597890|NCT00602667|12004028|FG001|Overall Study|Still on Therapy|2
7597891|NCT00602667|12004029|FG002|Overall Study|Still on Therapy|2
7597892|NCT00602667|12004027|FG000|Overall Study|Death|0
7272060|NCT00424255|11486339|FG001|Overall Study|Death|111
7272061|NCT00424255|11486338|FG000|Overall Study|Lost to Follow-up|26
7272062|NCT00424255|11486339|FG001|Overall Study|Lost to Follow-up|20
7272063|NCT00424255|11486338|FG000|Overall Study|Protocol Violation|0
7272064|NCT00424255|11486339|FG001|Overall Study|Protocol Violation|1
7272065|NCT00424255|11486338|FG000|Overall Study|Withdrawal by Subject|34
7272066|NCT00424255|11486339|FG001|Overall Study|Withdrawal by Subject|38
7272067|NCT00424255|11486338|FG000|Overall Study|Physician Decision|3
7272068|NCT00424255|11486339|FG001|Overall Study|Physician Decision|7
7272069|NCT00424255|11486338|FG000|Overall Study|Cognitive Disturbance|1
7272070|NCT00424255|11486339|FG001|Overall Study|Cognitive Disturbance|0
7272071|NCT00424255|11486338|FG000|Overall Study|Non-compliance by Participants|1
7597893|NCT00602667|12004028|FG001|Overall Study|Death|1
7597894|NCT00602667|12004029|FG002|Overall Study|Death|1
7597895|NCT00602667|12004027|FG000|Overall Study|Family request|3
7597896|NCT00602667|12004028|FG001|Overall Study|Family request|25
7597897|NCT00602667|12004029|FG002|Overall Study|Family request|6
7597898|NCT00602667|12004027|FG000|Overall Study|Excessive toxicity|1
7597899|NCT00602667|12004028|FG001|Overall Study|Excessive toxicity|1
7597900|NCT00602667|12004029|FG002|Overall Study|Excessive toxicity|0
7597901|NCT00602667|12004027|FG000|Overall Study|Second malignancy|0
7597902|NCT00602667|12004028|FG001|Overall Study|Second malignancy|1
7597903|NCT00602667|12004029|FG002|Overall Study|Second malignancy|0
7597904|NCT00602667|12004027|FG000|Overall Study|Physician Decision|2
7597905|NCT00602667|12004028|FG001|Overall Study|Physician Decision|3
7597906|NCT00602667|12004029|FG002|Overall Study|Physician Decision|8
7597907|NCT00602667|12004027|FG000|Overall Study|Progressive disease|13
7597908|NCT00602667|12004028|FG001|Overall Study|Progressive disease|48
7597909|NCT00602667|12004029|FG002|Overall Study|Progressive disease|45
7597910|NCT00602667|12004027|FG000|Overall Study|Progressive disease prior to therapy|0
7597911|NCT00602667|12004028|FG001|Overall Study|Progressive disease prior to therapy|0
7597912|NCT00602667|12004029|FG002|Overall Study|Progressive disease prior to therapy|1
7597913|NCT00472186|12004070|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
7597914|NCT00472186|12004071|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
7597915|NCT03996876|12004081|FG000|Overall Study|Incomplete Data|2
7597916|NCT03996876|12004082|FG001|Overall Study|Incomplete Data|4
7597917|NCT03589976|12004091|FG000|Overall Study|Death|5
7597918|NCT03589976|12004092|FG001|Overall Study|Death|1
7597919|NCT03589976|12004091|FG000|Overall Study|Adverse Event|5
7597920|NCT03589976|12004092|FG001|Overall Study|Adverse Event|1
7597921|NCT03589976|12004091|FG000|Overall Study|Withdrawal by Subject|4
7597922|NCT03589976|12004092|FG001|Overall Study|Withdrawal by Subject|1
7597923|NCT03589976|12004091|FG000|Overall Study|Lost to Follow-up|1
7597924|NCT03589976|12004092|FG001|Overall Study|Lost to Follow-up|0
7597925|NCT03589976|12004091|FG000|Overall Study|Other|4
7597926|NCT03589976|12004092|FG001|Overall Study|Other|3
7597927|NCT03135262|12004139|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
7597928|NCT03135262|12004140|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597929|NCT03135262|12004141|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597930|NCT03135262|12004142|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597931|NCT03135262|12004143|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
7597932|NCT03135262|12004139|FG000|Overall Study|Progression of disease|0
7597933|NCT03135262|12004140|FG001|Overall Study|Progression of disease|0
7597934|NCT03135262|12004141|FG002|Overall Study|Progression of disease|0
7597935|NCT03135262|12004142|FG003|Overall Study|Progression of disease|1
7597936|NCT03135262|12004143|FG004|Overall Study|Progression of disease|0
7597937|NCT03135262|12004139|FG000|Overall Study|Death|6
7597938|NCT03135262|12004140|FG001|Overall Study|Death|2
7597939|NCT03135262|12004141|FG002|Overall Study|Death|2
7597940|NCT03135262|12004142|FG003|Overall Study|Death|2
7597941|NCT03135262|12004143|FG004|Overall Study|Death|0
7597942|NCT03135262|12004139|FG000|Overall Study|Withdrawal by Subject|0
7597943|NCT03135262|12004140|FG001|Overall Study|Withdrawal by Subject|0
7597944|NCT03135262|12004141|FG002|Overall Study|Withdrawal by Subject|1
7597945|NCT03135262|12004142|FG003|Overall Study|Withdrawal by Subject|0
7597946|NCT03135262|12004143|FG004|Overall Study|Withdrawal by Subject|1
7597947|NCT03135262|12004139|FG000|Overall Study|Study terminated by sponsor|2
7597948|NCT03135262|12004140|FG001|Overall Study|Study terminated by sponsor|4
7597949|NCT03135262|12004141|FG002|Overall Study|Study terminated by sponsor|4
7597950|NCT03135262|12004142|FG003|Overall Study|Study terminated by sponsor|3
7597951|NCT03135262|12004143|FG004|Overall Study|Study terminated by sponsor|0
7597952|NCT03104075|12004175|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
7597953|NCT03104075|12004176|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
7597954|NCT03038087|12004183|FG000|Overall Study|lost data|1
7597955|NCT02662985|12004223|FG000|Treatment Period 1|Adverse Event|0
7597956|NCT02662985|12004224|FG001|Treatment Period 1|Adverse Event|2
7597957|NCT02662985|12004223|FG000|Treatment Period 1|Protocol Violation|0
7597958|NCT02662985|12004224|FG001|Treatment Period 1|Protocol Violation|1
7597959|NCT02662985|12004223|FG000|Treatment Period 1|Physician Decision|1
7597960|NCT02662985|12004224|FG001|Treatment Period 1|Physician Decision|0
7597961|NCT02662985|12004223|FG000|Treatment Period 1|Withdrawal by Subject|0
7597962|NCT02662985|12004224|FG001|Treatment Period 1|Withdrawal by Subject|1
7597963|NCT02662985|12004223|FG000|Treatment Period 2|Lack of Efficacy|0
7597964|NCT02662985|12004224|FG001|Treatment Period 2|Lack of Efficacy|1
7597965|NCT02662985|12004223|FG000|Treatment Period 2|Lost to Follow-up|1
7597966|NCT02662985|12004224|FG001|Treatment Period 2|Lost to Follow-up|0
7597967|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7597968|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
7597969|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
7597970|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
7597971|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
7597972|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
7597973|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
7597974|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
7597975|NCT02662985|12004223|FG000|Treatment Period 3 (Extension Period)|Death|0
7597976|NCT02662985|12004224|FG001|Treatment Period 3 (Extension Period)|Death|1
7597977|NCT02606461|12004234|FG000|Overall Study|Withdrawal by Subject|3
7597978|NCT02606461|12004235|FG001|Overall Study|Withdrawal by Subject|2
7597979|NCT02606461|12004236|FG002|Overall Study|Withdrawal by Subject|14
7597980|NCT02606461|12004237|FG003|Overall Study|Withdrawal by Subject|11
7597981|NCT02606461|12004234|FG000|Overall Study|Death|16
7597982|NCT02606461|12004235|FG001|Overall Study|Death|25
7597983|NCT02606461|12004236|FG002|Overall Study|Death|105
7597984|NCT02606461|12004237|FG003|Overall Study|Death|58
7597985|NCT02606461|12004234|FG000|Overall Study|Lost to Follow-up|2
7597986|NCT02606461|12004235|FG001|Overall Study|Lost to Follow-up|2
7597987|NCT02606461|12004236|FG002|Overall Study|Lost to Follow-up|4
7597988|NCT02606461|12004237|FG003|Overall Study|Lost to Follow-up|1
7597989|NCT02606461|12004234|FG000|Overall Study|Physician Decision|0
7597990|NCT02606461|12004235|FG001|Overall Study|Physician Decision|0
7597991|NCT02606461|12004236|FG002|Overall Study|Physician Decision|1
7597992|NCT02606461|12004237|FG003|Overall Study|Physician Decision|1
7597993|NCT02606461|12004234|FG000|Overall Study|Disease Progression|1
7597994|NCT02606461|12004235|FG001|Overall Study|Disease Progression|0
7597995|NCT02606461|12004236|FG002|Overall Study|Disease Progression|0
7597996|NCT02606461|12004237|FG003|Overall Study|Disease Progression|0
7597997|NCT02606461|12004234|FG000|Overall Study|No treatment|0
7597998|NCT02606461|12004235|FG001|Overall Study|No treatment|0
7597999|NCT02606461|12004236|FG002|Overall Study|No treatment|1
7598000|NCT02606461|12004237|FG003|Overall Study|No treatment|0
7598001|NCT02606461|12004234|FG000|Overall Study|Ongoing|5
7598002|NCT02606461|12004235|FG001|Overall Study|Ongoing|1
7598003|NCT02606461|12004236|FG002|Overall Study|Ongoing|63
7598004|NCT02606461|12004237|FG003|Overall Study|Ongoing|26
7598005|NCT02536339|12004250|FG000|Overall Study|Death|20
7598006|NCT02536339|12004250|FG000|Overall Study|Withdrawal by Subject|3
7598007|NCT02536339|12004250|FG000|Overall Study|Lost to Follow-up|2
7598008|NCT02536339|12004250|FG000|Overall Study|Treatment discontinued|2
7598009|NCT02536339|12004250|FG000|Overall Study|Physician Decision|1
7598010|NCT02323295|12004256|FG000|Overall Study|Adverse Event|0
7598011|NCT02323295|12004257|FG001|Overall Study|Adverse Event|1
7598012|NCT02323295|12004256|FG000|Overall Study|Withdrawal by Subject|0
7598013|NCT02323295|12004257|FG001|Overall Study|Withdrawal by Subject|1
7598014|NCT02323295|12004256|FG000|Overall Study|Patient did not have surgery as planned.|0
7598015|NCT02323295|12004257|FG001|Overall Study|Patient did not have surgery as planned.|1
7598016|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
7598017|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
7598018|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
7598019|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
7598020|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
7598021|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
7598022|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
7598023|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
7598024|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
7598025|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
7598026|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Death|0
7598027|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Death|0
7598028|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Death|0
7598029|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Death|0
7598030|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Death|0
7598031|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Death|0
7598032|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Death|0
7598033|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Death|0
7598034|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Death|1
7598035|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Death|0
7598036|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
7598037|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598038|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
7598039|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598040|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598041|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598042|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598043|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598044|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
7598045|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
7598046|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598047|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598048|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598049|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598050|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
7598051|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598052|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598053|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
7598054|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
7598055|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
7598056|NCT02036970|12004287|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598057|NCT02036970|12004288|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598058|NCT02036970|12004289|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598059|NCT02036970|12004290|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
7598060|NCT02036970|12004291|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598061|NCT02036970|12004292|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598062|NCT02036970|12004293|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598063|NCT02036970|12004294|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598064|NCT02036970|12004295|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598065|NCT02036970|12004296|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
7598066|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Adverse Event|0
7598067|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Adverse Event|2
7598068|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Adverse Event|1
7598069|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Adverse Event|1
7598070|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Adverse Event|1
7598071|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Adverse Event|0
7598072|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Adverse Event|1
7598073|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Adverse Event|0
7598074|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Adverse Event|6
7598075|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Adverse Event|3
7598076|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
7598077|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
7598078|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
7598079|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
7598080|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
7598081|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
7598082|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
7598083|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
7598084|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
7598085|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
7598086|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598087|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7598088|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
7598089|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598090|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598091|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598092|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598093|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598094|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
7598095|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
7598096|NCT02036970|12004287|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
7598097|NCT02036970|12004288|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
7598098|NCT02036970|12004289|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
7598099|NCT02036970|12004290|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
7598100|NCT02036970|12004291|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
7598101|NCT02036970|12004292|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
7598102|NCT02036970|12004293|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
7598103|NCT02036970|12004294|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
7598104|NCT02036970|12004295|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
7598105|NCT02036970|12004296|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
7598106|NCT01941719|12004330|FG000|Overall Study|Lost to Follow-up|20
7598107|NCT01941719|12004331|FG001|Overall Study|Lost to Follow-up|19
7598108|NCT00943618|12004357|FG000|Overall Study|Lost to Follow-up|38
7598109|NCT00943618|12004358|FG001|Overall Study|Lost to Follow-up|48
7598110|NCT00943618|12004359|FG002|Overall Study|Lost to Follow-up|20
7598111|NCT00943618|12004357|FG000|Overall Study|Discontinued Medication|17
7598112|NCT00943618|12004358|FG001|Overall Study|Discontinued Medication|29
7598113|NCT00943618|12004359|FG002|Overall Study|Discontinued Medication|11
7598114|NCT03938272|12004369|FG000|Overall Study|Withdrawal by Subject|1
7598115|NCT03938272|12004370|FG001|Overall Study|Withdrawal by Subject|0
7598116|NCT03938272|12004369|FG000|Overall Study|Physician Decision|0
7598117|NCT03938272|12004370|FG001|Overall Study|Physician Decision|2
7598118|NCT03938272|12004369|FG000|Overall Study|Study termination by sponsor|10
7598119|NCT03938272|12004370|FG001|Overall Study|Study termination by sponsor|8
7598120|NCT03641339|12004382|FG000|Overall Study|Physician Decision|1
7598121|NCT03641339|12004383|FG001|Overall Study|Physician Decision|0
7598122|NCT03641339|12004384|FG002|Overall Study|Physician Decision|0
7598123|NCT03641339|12004385|FG003|Overall Study|Physician Decision|0
7598124|NCT03641339|12004386|FG004|Overall Study|Physician Decision|0
7598125|NCT03641339|12004387|FG005|Overall Study|Physician Decision|0
7598126|NCT03641339|12004382|FG000|Overall Study|Withdrawal by Subject|0
7598127|NCT03641339|12004383|FG001|Overall Study|Withdrawal by Subject|2
7598128|NCT03641339|12004384|FG002|Overall Study|Withdrawal by Subject|0
7598129|NCT03641339|12004385|FG003|Overall Study|Withdrawal by Subject|2
7598130|NCT03641339|12004386|FG004|Overall Study|Withdrawal by Subject|0
7598131|NCT03641339|12004387|FG005|Overall Study|Withdrawal by Subject|1
7598132|NCT03625466|12004403|FG000|Overall Study|Adverse Event|0
7598133|NCT03625466|12004404|FG001|Overall Study|Adverse Event|1
7598134|NCT03625466|12004403|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
7598135|NCT03625466|12004404|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
7598136|NCT03317795|12004412|FG000|Overall Study|IUD Expulsion|1
7598137|NCT03317795|12004413|FG001|Overall Study|IUD Expulsion|0
7598138|NCT03317795|12004412|FG000|Overall Study|Lost to Follow-up|1
7598139|NCT03317795|12004413|FG001|Overall Study|Lost to Follow-up|3
7598140|NCT03317795|12004412|FG000|Overall Study|Treatment change|0
7598141|NCT03317795|12004413|FG001|Overall Study|Treatment change|3
7598142|NCT03317795|12004412|FG000|Overall Study|Intolerance of medication|0
7598143|NCT03317795|12004413|FG001|Overall Study|Intolerance of medication|1
7598144|NCT03287245|12004423|FG000|Overall Study|Study terminated by sponsor|3
7598145|NCT03287245|12004424|FG001|Overall Study|Study terminated by sponsor|0
7272072|NCT00424255|11486339|FG001|Overall Study|Non-compliance by Participants|0
7272073|NCT00424255|11486338|FG000|Overall Study|Fatigue|1
7272074|NCT00424255|11486339|FG001|Overall Study|Fatigue|0
7272075|NCT00424255|11486338|FG000|Overall Study|Disease Progression|0
7272076|NCT00424255|11486339|FG001|Overall Study|Disease Progression|2
7598146|NCT03287245|12004425|FG002|Overall Study|Study terminated by sponsor|3
7598147|NCT03287245|12004426|FG003|Overall Study|Study terminated by sponsor|1
7598148|NCT03287245|12004423|FG000|Overall Study|Adverse Event|1
7598149|NCT03287245|12004424|FG001|Overall Study|Adverse Event|0
7598150|NCT03287245|12004425|FG002|Overall Study|Adverse Event|0
7598151|NCT03287245|12004426|FG003|Overall Study|Adverse Event|0
7598152|NCT03287245|12004423|FG000|Overall Study|Withdrawal by Subject|8
7598153|NCT03287245|12004424|FG001|Overall Study|Withdrawal by Subject|3
7598154|NCT03287245|12004425|FG002|Overall Study|Withdrawal by Subject|3
7598155|NCT03287245|12004426|FG003|Overall Study|Withdrawal by Subject|0
7598156|NCT03287245|12004423|FG000|Overall Study|Physician Decision|3
7598157|NCT03287245|12004424|FG001|Overall Study|Physician Decision|2
7598158|NCT03287245|12004425|FG002|Overall Study|Physician Decision|0
7598159|NCT03287245|12004426|FG003|Overall Study|Physician Decision|0
7598160|NCT03092219|12004467|FG000|Overall Study|Protocol Violation|7
7598161|NCT03092219|12004468|FG001|Overall Study|Protocol Violation|4
7598162|NCT03033069|12004481|FG000|Overall Study|Adverse Event|6
7598163|NCT03033069|12004482|FG001|Overall Study|Adverse Event|7
7598164|NCT03033069|12004483|FG002|Overall Study|Adverse Event|4
7598165|NCT03033069|12004484|FG003|Overall Study|Adverse Event|6
7598166|NCT03033069|12004481|FG000|Overall Study|Lack of Efficacy|0
7598167|NCT03033069|12004482|FG001|Overall Study|Lack of Efficacy|0
7598168|NCT03033069|12004483|FG002|Overall Study|Lack of Efficacy|1
7598169|NCT03033069|12004484|FG003|Overall Study|Lack of Efficacy|0
7598170|NCT03033069|12004481|FG000|Overall Study|Lost to Follow-up|6
7272077|NCT00424255|11486338|FG000|Overall Study|Sponsor Terminated Study|161
7598171|NCT03033069|12004482|FG001|Overall Study|Lost to Follow-up|5
7598172|NCT03033069|12004483|FG002|Overall Study|Lost to Follow-up|5
7598173|NCT03033069|12004484|FG003|Overall Study|Lost to Follow-up|6
7598174|NCT03033069|12004481|FG000|Overall Study|Non-Compliance With Study Drug|1
7598175|NCT03033069|12004482|FG001|Overall Study|Non-Compliance With Study Drug|1
7272078|NCT00424255|11486339|FG001|Overall Study|Sponsor Terminated Study|167
7272079|NCT00424294|11486356|FG000|Overall Study|Adverse Event|4
7272080|NCT00424294|11486357|FG001|Overall Study|Adverse Event|10
7272081|NCT00424294|11486356|FG000|Overall Study|Lack of Efficacy|2
7272082|NCT00424294|11486357|FG001|Overall Study|Lack of Efficacy|1
7272083|NCT00424294|11486356|FG000|Overall Study|Withdrawal by Subject|1
7272084|NCT00424294|11486357|FG001|Overall Study|Withdrawal by Subject|2
7272085|NCT00424294|11486356|FG000|Overall Study|Other|0
7272086|NCT00424294|11486357|FG001|Overall Study|Other|2
7272087|NCT00424294|11486356|FG000|Overall Study|Randomized but not Treated|1
7272088|NCT00424294|11486357|FG001|Overall Study|Randomized but not Treated|0
7272089|NCT00424346|11486367|FG000|Core Study|Adverse Event|5
7272090|NCT00424346|11486368|FG001|Core Study|Adverse Event|3
7272091|NCT00424346|11486369|FG002|Core Study|Adverse Event|1
7272092|NCT00424346|11486370|FG003|Core Study|Adverse Event|1
7598176|NCT03033069|12004483|FG002|Overall Study|Non-Compliance With Study Drug|1
7598177|NCT03033069|12004484|FG003|Overall Study|Non-Compliance With Study Drug|0
7598178|NCT03033069|12004481|FG000|Overall Study|Protocol Deviation|0
7598179|NCT03033069|12004482|FG001|Overall Study|Protocol Deviation|1
7598180|NCT03033069|12004483|FG002|Overall Study|Protocol Deviation|0
7598181|NCT03033069|12004484|FG003|Overall Study|Protocol Deviation|0
7598182|NCT03033069|12004481|FG000|Overall Study|Withdrawal by Subject|10
7598183|NCT03033069|12004482|FG001|Overall Study|Withdrawal by Subject|10
7598184|NCT03033069|12004483|FG002|Overall Study|Withdrawal by Subject|11
7598185|NCT03033069|12004484|FG003|Overall Study|Withdrawal by Subject|6
7598186|NCT03033069|12004481|FG000|Overall Study|Withdrawal By Caregiver|1
7598187|NCT03033069|12004482|FG001|Overall Study|Withdrawal By Caregiver|0
7598188|NCT03033069|12004483|FG002|Overall Study|Withdrawal By Caregiver|0
7598189|NCT03033069|12004484|FG003|Overall Study|Withdrawal By Caregiver|0
7598190|NCT03033069|12004481|FG000|Overall Study|Reason not Specified|0
7598191|NCT03033069|12004482|FG001|Overall Study|Reason not Specified|1
7598192|NCT03033069|12004483|FG002|Overall Study|Reason not Specified|0
7598193|NCT03033069|12004484|FG003|Overall Study|Reason not Specified|1
7598194|NCT02609503|12004509|FG000|Overall Study|Adverse Event|1
7598195|NCT02609503|12004509|FG000|Overall Study|Death|1
7598196|NCT02609503|12004509|FG000|Overall Study|Withdrawal by Subject|1
7598197|NCT02609503|12004509|FG000|Overall Study|Disease progression|1
7598198|NCT02587598|12004527|FG000|Overall Study|Death|4
7598199|NCT02587598|12004528|FG001|Overall Study|Death|8
7598200|NCT02587598|12004529|FG002|Overall Study|Death|4
7598201|NCT02587598|12004530|FG003|Overall Study|Death|16
7598202|NCT02587598|12004531|FG004|Overall Study|Death|9
7598203|NCT02587598|12004532|FG005|Overall Study|Death|4
7598204|NCT02587598|12004533|FG006|Overall Study|Death|6
7598205|NCT02587598|12004534|FG007|Overall Study|Death|7
7598206|NCT02587598|12004535|FG008|Overall Study|Death|9
7598207|NCT02587598|12004536|FG009|Overall Study|Death|1
7598208|NCT02587598|12004537|FG010|Overall Study|Death|3
7598209|NCT02587598|12004527|FG000|Overall Study|Study Terminated by the Sponsor|0
7598210|NCT02587598|12004528|FG001|Overall Study|Study Terminated by the Sponsor|1
7598211|NCT02587598|12004529|FG002|Overall Study|Study Terminated by the Sponsor|0
7598212|NCT02587598|12004530|FG003|Overall Study|Study Terminated by the Sponsor|3
7598213|NCT02587598|12004531|FG004|Overall Study|Study Terminated by the Sponsor|0
7598214|NCT02587598|12004532|FG005|Overall Study|Study Terminated by the Sponsor|1
7598215|NCT02587598|12004533|FG006|Overall Study|Study Terminated by the Sponsor|0
7598216|NCT02587598|12004534|FG007|Overall Study|Study Terminated by the Sponsor|0
7598217|NCT02587598|12004535|FG008|Overall Study|Study Terminated by the Sponsor|0
7598218|NCT02587598|12004536|FG009|Overall Study|Study Terminated by the Sponsor|1
7598219|NCT02587598|12004537|FG010|Overall Study|Study Terminated by the Sponsor|6
7272093|NCT00424346|11486367|FG000|Core Study|Abnormal Laboratory Values|0
7598220|NCT02587598|12004527|FG000|Overall Study|Reason for study withdrawal not specified|0
7598221|NCT02587598|12004528|FG001|Overall Study|Reason for study withdrawal not specified|1
7598222|NCT02587598|12004529|FG002|Overall Study|Reason for study withdrawal not specified|0
7598223|NCT02587598|12004530|FG003|Overall Study|Reason for study withdrawal not specified|0
7598224|NCT02587598|12004531|FG004|Overall Study|Reason for study withdrawal not specified|0
7598225|NCT02587598|12004532|FG005|Overall Study|Reason for study withdrawal not specified|0
7598226|NCT02587598|12004533|FG006|Overall Study|Reason for study withdrawal not specified|0
7598227|NCT02587598|12004534|FG007|Overall Study|Reason for study withdrawal not specified|0
7598228|NCT02587598|12004535|FG008|Overall Study|Reason for study withdrawal not specified|0
7598229|NCT02587598|12004536|FG009|Overall Study|Reason for study withdrawal not specified|0
7598230|NCT02587598|12004537|FG010|Overall Study|Reason for study withdrawal not specified|0
7598231|NCT02587598|12004527|FG000|Overall Study|Withdrawal by Subject|0
7598232|NCT02587598|12004528|FG001|Overall Study|Withdrawal by Subject|1
7598233|NCT02587598|12004529|FG002|Overall Study|Withdrawal by Subject|0
7598234|NCT02587598|12004530|FG003|Overall Study|Withdrawal by Subject|2
7598235|NCT02587598|12004531|FG004|Overall Study|Withdrawal by Subject|3
7598236|NCT02587598|12004532|FG005|Overall Study|Withdrawal by Subject|1
7598237|NCT02587598|12004533|FG006|Overall Study|Withdrawal by Subject|0
7598238|NCT02587598|12004534|FG007|Overall Study|Withdrawal by Subject|0
7598239|NCT02587598|12004535|FG008|Overall Study|Withdrawal by Subject|0
7598240|NCT02587598|12004536|FG009|Overall Study|Withdrawal by Subject|1
7598241|NCT02587598|12004537|FG010|Overall Study|Withdrawal by Subject|2
7598242|NCT02587598|12004527|FG000|Overall Study|Physician Decision|0
7598243|NCT02587598|12004528|FG001|Overall Study|Physician Decision|0
7598244|NCT02587598|12004529|FG002|Overall Study|Physician Decision|0
7598245|NCT02587598|12004530|FG003|Overall Study|Physician Decision|0
7598246|NCT02587598|12004531|FG004|Overall Study|Physician Decision|0
7598247|NCT02587598|12004532|FG005|Overall Study|Physician Decision|0
7598248|NCT02587598|12004533|FG006|Overall Study|Physician Decision|0
7598249|NCT02587598|12004534|FG007|Overall Study|Physician Decision|0
7598250|NCT02587598|12004535|FG008|Overall Study|Physician Decision|0
7598251|NCT02587598|12004536|FG009|Overall Study|Physician Decision|0
7598252|NCT02587598|12004537|FG010|Overall Study|Physician Decision|3
7598253|NCT02485574|12004573|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
7598275|NCT01460160|12004607|FG000|Treatment Phase|Lack of Efficacy|3
7598276|NCT01460160|12004607|FG000|Treatment Phase|Study Drug Toxicity|2
7598277|NCT01460160|12004607|FG000|Treatment Phase|Adverse Event|8
7598278|NCT01460160|12004607|FG000|Treatment Phase|Withdrawal by Subject|4
7598279|NCT01460160|12004607|FG000|Treatment Phase|Death|2
7598280|NCT01460160|12004607|FG000|Treatment Phase|Other reasons|9
7598281|NCT01460160|12004607|FG000|Follow-up Phase|Withdrawal by Subject|4
7272094|NCT00424346|11486368|FG001|Core Study|Abnormal Laboratory Values|1
7272095|NCT00424346|11486369|FG002|Core Study|Abnormal Laboratory Values|0
7272096|NCT00424346|11486370|FG003|Core Study|Abnormal Laboratory Values|0
7272097|NCT00424346|11486367|FG000|Core Study|Lack of Efficacy|1
7272098|NCT00424346|11486368|FG001|Core Study|Lack of Efficacy|3
7272099|NCT00424346|11486369|FG002|Core Study|Lack of Efficacy|0
7272100|NCT00424346|11486370|FG003|Core Study|Lack of Efficacy|4
7272101|NCT00424346|11486367|FG000|Core Study|Withdrawal by Subject|1
7272102|NCT00424346|11486368|FG001|Core Study|Withdrawal by Subject|0
7272103|NCT00424346|11486369|FG002|Core Study|Withdrawal by Subject|0
7272104|NCT00424346|11486370|FG003|Core Study|Withdrawal by Subject|2
7272105|NCT00424346|11486367|FG000|Core Study|Lost to Follow-up|1
7272106|NCT00424346|11486368|FG001|Core Study|Lost to Follow-up|1
7272107|NCT00424346|11486369|FG002|Core Study|Lost to Follow-up|0
7272108|NCT00424346|11486370|FG003|Core Study|Lost to Follow-up|0
7272109|NCT00424346|11486367|FG000|Core Study|Administrative Problems|1
7272110|NCT00424346|11486368|FG001|Core Study|Administrative Problems|0
7272111|NCT00424346|11486369|FG002|Core Study|Administrative Problems|1
7272112|NCT00424346|11486370|FG003|Core Study|Administrative Problems|0
7272113|NCT00424346|11486367|FG000|Core Study|Protocol Violation|0
7272114|NCT00424346|11486368|FG001|Core Study|Protocol Violation|0
7272115|NCT00424346|11486369|FG002|Core Study|Protocol Violation|2
7272116|NCT00424346|11486370|FG003|Core Study|Protocol Violation|0
7272117|NCT00424346|11486367|FG000|Extension Phase|Adverse Event|0
7272118|NCT00424346|11486368|FG001|Extension Phase|Adverse Event|9
7272119|NCT00424346|11486369|FG002|Extension Phase|Adverse Event|5
7272120|NCT00424346|11486370|FG003|Extension Phase|Adverse Event|4
7272121|NCT00424346|11486367|FG000|Extension Phase|Lack of Efficacy|0
7272122|NCT00424346|11486368|FG001|Extension Phase|Lack of Efficacy|16
7272123|NCT00424346|11486369|FG002|Extension Phase|Lack of Efficacy|14
7272124|NCT00424346|11486370|FG003|Extension Phase|Lack of Efficacy|11
7272125|NCT00424346|11486367|FG000|Extension Phase|Withdrawal by Subject|0
7272126|NCT00424346|11486368|FG001|Extension Phase|Withdrawal by Subject|5
7272127|NCT00424346|11486369|FG002|Extension Phase|Withdrawal by Subject|3
7272128|NCT00424346|11486370|FG003|Extension Phase|Withdrawal by Subject|4
7272129|NCT00424346|11486367|FG000|Extension Phase|Lost to Follow-up|0
7272130|NCT00424346|11486368|FG001|Extension Phase|Lost to Follow-up|2
7272131|NCT00424346|11486369|FG002|Extension Phase|Lost to Follow-up|0
7272132|NCT00424346|11486370|FG003|Extension Phase|Lost to Follow-up|0
7272133|NCT00424346|11486367|FG000|Extension Phase|Administrative Problems|0
7272134|NCT00424346|11486368|FG001|Extension Phase|Administrative Problems|69
7272135|NCT00424346|11486369|FG002|Extension Phase|Administrative Problems|32
7272136|NCT00424346|11486370|FG003|Extension Phase|Administrative Problems|35
7272137|NCT00424346|11486367|FG000|Extension Phase|Death|0
7272138|NCT00424346|11486368|FG001|Extension Phase|Death|0
7272139|NCT00424346|11486369|FG002|Extension Phase|Death|0
7272140|NCT00424346|11486370|FG003|Extension Phase|Death|1
7272141|NCT00424346|11486367|FG000|Extension Phase|Protocol Violation|0
7272142|NCT00424346|11486368|FG001|Extension Phase|Protocol Violation|1
7272143|NCT00424346|11486369|FG002|Extension Phase|Protocol Violation|1
7272144|NCT00424346|11486370|FG003|Extension Phase|Protocol Violation|0
7272145|NCT00424372|11486383|FG000|Overall Study|Death|1
7272146|NCT00424372|11486383|FG000|Overall Study|Adverse Event|18
7272147|NCT00424372|11486383|FG000|Overall Study|Lack of Efficacy|6
7272148|NCT00424372|11486383|FG000|Overall Study|Withdrawal by Subject|4
7272149|NCT00424372|11486383|FG000|Overall Study|Protocol Violation|1
7272150|NCT00424372|11486383|FG000|Overall Study|Health deterioration|1
7272151|NCT00424385|11486387|FG000|Cohort 0|Withdrawal by Subject|5
7272152|NCT00424385|11486387|FG000|Cohort 0|Physician Decision|1
7272153|NCT00424385|11486387|FG000|Cohort 1|Withdrawal by Subject|1
7272154|NCT00424398|11486396|FG000|Overall Study|Withdrawal by Subject|2
7272155|NCT00424398|11486397|FG001|Overall Study|Withdrawal by Subject|1
7272156|NCT00424398|11486398|FG002|Overall Study|Withdrawal by Subject|0
7272157|NCT00424398|11486396|FG000|Overall Study|Subject met exclusion criteria|1
7272158|NCT00424398|11486397|FG001|Overall Study|Subject met exclusion criteria|0
7272159|NCT00424398|11486398|FG002|Overall Study|Subject met exclusion criteria|0
7272160|NCT00424463|11486409|FG000|Overall Study|Adverse Event|2
7598282|NCT01460160|12004607|FG000|Follow-up Phase|Death|14
7598283|NCT01460160|12004607|FG000|Follow-up Phase|Lost to Follow-up|7
7598284|NCT01460160|12004607|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
7598285|NCT01460160|12004607|FG000|Follow-up Phase|Other and not reported reasons|5
7598286|NCT01170702|12004615|FG000|Overall Study|Exclusion criteria met after consent|1
7598287|NCT01170702|12004616|FG001|Overall Study|Exclusion criteria met after consent|2
7598288|NCT01170702|12004617|FG002|Overall Study|Exclusion criteria met after consent|0
7598289|NCT01170702|12004618|FG003|Overall Study|Exclusion criteria met after consent|2
7598290|NCT01018563|12004628|FG000|Overall Study|Termination of the study by Sponsor|2
7598291|NCT01018563|12004629|FG001|Overall Study|Termination of the study by Sponsor|1
7598292|NCT00805961|12004639|FG000|Modality Therapy|Withdrawal by Subject|1
7598293|NCT00805961|12004639|FG000|Modality Therapy|Adverse Event|1
7598294|NCT00805961|12004639|FG000|Modality Therapy|Disease Progression|2
7598295|NCT00805961|12004639|FG000|Treatment-Free Interval|Adverse Event|3
7598296|NCT00805961|12004639|FG000|Treatment-Free Interval|Intercurrent Illness|2
7598297|NCT00805961|12004639|FG000|Treatment-Free Interval|Physician Decision|1
7598298|NCT00805961|12004639|FG000|Treatment-Free Interval|Lack of Efficacy|1
7598299|NCT00805961|12004639|FG000|Maintenance Treatment|Lack of Efficacy|13
7598300|NCT00805961|12004639|FG000|Maintenance Treatment|Intercurrent Illness|7
7598301|NCT00805961|12004639|FG000|Maintenance Treatment|Adverse Event|6
7598302|NCT00805961|12004639|FG000|Maintenance Treatment|Withdrawal by Subject|5
7598303|NCT00805961|12004639|FG000|Maintenance Treatment|Symptomatic Deterioration|2
7598304|NCT00805961|12004639|FG000|Maintenance Treatment|Withdrawn Consent|1
7598305|NCT03921424|12004660|FG000|Overall Study|Lost to Follow-up|0
7598306|NCT03921424|12004661|FG001|Overall Study|Lost to Follow-up|1
7598307|NCT03921424|12004660|FG000|Overall Study|Withdrawal By Parent/Guardian|0
7598308|NCT03921424|12004661|FG001|Overall Study|Withdrawal By Parent/Guardian|2
7598309|NCT03598777|12004674|FG000|Overall Study|Study Terminated by Sponsor|3
7598310|NCT03598777|12004675|FG001|Overall Study|Study Terminated by Sponsor|0
7598311|NCT03598777|12004676|FG002|Overall Study|Study Terminated by Sponsor|0
7598312|NCT03598777|12004677|FG003|Overall Study|Study Terminated by Sponsor|0
7598313|NCT03598777|12004678|FG004|Overall Study|Study Terminated by Sponsor|15
7272161|NCT00424463|11486410|FG001|Overall Study|Adverse Event|3
7272162|NCT00424463|11486411|FG002|Overall Study|Adverse Event|2
7272163|NCT00424463|11486409|FG000|Overall Study|Physician Decision|0
7272164|NCT00424463|11486410|FG001|Overall Study|Physician Decision|2
7272165|NCT00424463|11486411|FG002|Overall Study|Physician Decision|2
7272166|NCT00424463|11486409|FG000|Overall Study|Withdrawal by Subject|4
7272167|NCT00424463|11486410|FG001|Overall Study|Withdrawal by Subject|2
7598314|NCT03598777|12004674|FG000|Overall Study|Withdrawal by Subject|1
7598315|NCT03598777|12004675|FG001|Overall Study|Withdrawal by Subject|1
7598316|NCT03598777|12004676|FG002|Overall Study|Withdrawal by Subject|0
7598317|NCT03598777|12004677|FG003|Overall Study|Withdrawal by Subject|0
7598318|NCT03598777|12004678|FG004|Overall Study|Withdrawal by Subject|0
7598319|NCT03598777|12004674|FG000|Overall Study|Adverse Event|1
7598320|NCT03598777|12004675|FG001|Overall Study|Adverse Event|0
7598321|NCT03598777|12004676|FG002|Overall Study|Adverse Event|0
7598322|NCT03598777|12004677|FG003|Overall Study|Adverse Event|0
7598323|NCT03598777|12004678|FG004|Overall Study|Adverse Event|0
7598324|NCT03598777|12004674|FG000|Overall Study|Lost to Follow-up|1
7598325|NCT03598777|12004675|FG001|Overall Study|Lost to Follow-up|0
7598326|NCT03598777|12004676|FG002|Overall Study|Lost to Follow-up|0
7598327|NCT03598777|12004677|FG003|Overall Study|Lost to Follow-up|0
7598328|NCT03598777|12004678|FG004|Overall Study|Lost to Follow-up|0
7598329|NCT03406078|12004695|FG000|Overall Study|Death|1
7598330|NCT03406078|12004696|FG001|Overall Study|Death|0
7598331|NCT03406078|12004695|FG000|Overall Study|Lost to Follow-up|0
7598332|NCT03406078|12004696|FG001|Overall Study|Lost to Follow-up|1
7598333|NCT03406078|12004695|FG000|Overall Study|Withdrawal by Subject|5
7598334|NCT03406078|12004696|FG001|Overall Study|Withdrawal by Subject|2
7598335|NCT03345342|12004718|FG000|Open-Label Phase|Adverse Event|30
7598336|NCT03345342|12004719|FG001|Open-Label Phase|Adverse Event|0
7598337|NCT03345342|12004720|FG002|Open-Label Phase|Adverse Event|0
7598338|NCT03345342|12004721|FG003|Open-Label Phase|Adverse Event|0
7598339|NCT03345342|12004722|FG004|Open-Label Phase|Adverse Event|0
7598340|NCT03345342|12004718|FG000|Open-Label Phase|Death|1
7598341|NCT03345342|12004719|FG001|Open-Label Phase|Death|0
7598342|NCT03345342|12004720|FG002|Open-Label Phase|Death|0
7598343|NCT03345342|12004721|FG003|Open-Label Phase|Death|0
7598344|NCT03345342|12004722|FG004|Open-Label Phase|Death|0
7598345|NCT03345342|12004718|FG000|Open-Label Phase|Initiated Prohibited Medication|2
7598346|NCT03345342|12004719|FG001|Open-Label Phase|Initiated Prohibited Medication|0
7598347|NCT03345342|12004720|FG002|Open-Label Phase|Initiated Prohibited Medication|0
7598348|NCT03345342|12004721|FG003|Open-Label Phase|Initiated Prohibited Medication|0
7598349|NCT03345342|12004722|FG004|Open-Label Phase|Initiated Prohibited Medication|0
7598350|NCT03345342|12004718|FG000|Open-Label Phase|Lack of Efficacy|6
7598351|NCT03345342|12004719|FG001|Open-Label Phase|Lack of Efficacy|0
7598352|NCT03345342|12004720|FG002|Open-Label Phase|Lack of Efficacy|0
7598353|NCT03345342|12004721|FG003|Open-Label Phase|Lack of Efficacy|0
7598354|NCT03345342|12004722|FG004|Open-Label Phase|Lack of Efficacy|0
7598355|NCT03345342|12004718|FG000|Open-Label Phase|Lost to Follow-up|9
7598356|NCT03345342|12004719|FG001|Open-Label Phase|Lost to Follow-up|0
7598357|NCT03345342|12004720|FG002|Open-Label Phase|Lost to Follow-up|0
7598358|NCT03345342|12004721|FG003|Open-Label Phase|Lost to Follow-up|0
7598359|NCT03345342|12004722|FG004|Open-Label Phase|Lost to Follow-up|0
7598360|NCT03345342|12004718|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
7598361|NCT03345342|12004719|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
7598362|NCT03345342|12004720|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
7598363|NCT03345342|12004721|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
7598364|NCT03345342|12004722|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
7598365|NCT03345342|12004718|FG000|Open-Label Phase|Physician Decision|4
7598366|NCT03345342|12004719|FG001|Open-Label Phase|Physician Decision|0
7598367|NCT03345342|12004720|FG002|Open-Label Phase|Physician Decision|0
7598368|NCT03345342|12004721|FG003|Open-Label Phase|Physician Decision|0
7598369|NCT03345342|12004722|FG004|Open-Label Phase|Physician Decision|0
7598370|NCT03345342|12004718|FG000|Open-Label Phase|Protocol Violation|8
7598371|NCT03345342|12004719|FG001|Open-Label Phase|Protocol Violation|0
7598372|NCT03345342|12004720|FG002|Open-Label Phase|Protocol Violation|0
7598373|NCT03345342|12004721|FG003|Open-Label Phase|Protocol Violation|0
7598374|NCT03345342|12004722|FG004|Open-Label Phase|Protocol Violation|0
7598375|NCT03345342|12004718|FG000|Open-Label Phase|Withdrawal by Subject|57
7598376|NCT03345342|12004719|FG001|Open-Label Phase|Withdrawal by Subject|0
7598377|NCT03345342|12004720|FG002|Open-Label Phase|Withdrawal by Subject|0
7598378|NCT03345342|12004721|FG003|Open-Label Phase|Withdrawal by Subject|0
7598379|NCT03345342|12004722|FG004|Open-Label Phase|Withdrawal by Subject|0
7598380|NCT03345342|12004718|FG000|Open-Label Phase|Other|15
7598381|NCT03345342|12004719|FG001|Open-Label Phase|Other|0
7598382|NCT03345342|12004720|FG002|Open-Label Phase|Other|0
7598383|NCT03345342|12004721|FG003|Open-Label Phase|Other|0
7598384|NCT03345342|12004722|FG004|Open-Label Phase|Other|0
7598385|NCT03345342|12004718|FG000|Double-Blind Phase|Adverse Event|0
7598386|NCT03345342|12004719|FG001|Double-Blind Phase|Adverse Event|1
7598387|NCT03345342|12004720|FG002|Double-Blind Phase|Adverse Event|6
7598388|NCT03345342|12004721|FG003|Double-Blind Phase|Adverse Event|0
7598389|NCT03345342|12004722|FG004|Double-Blind Phase|Adverse Event|0
7598390|NCT03345342|12004718|FG000|Double-Blind Phase|Death|0
7598391|NCT03345342|12004719|FG001|Double-Blind Phase|Death|2
7598392|NCT03345342|12004720|FG002|Double-Blind Phase|Death|1
7272168|NCT00424463|11486411|FG002|Overall Study|Withdrawal by Subject|5
7598393|NCT03345342|12004721|FG003|Double-Blind Phase|Death|0
7598394|NCT03345342|12004722|FG004|Double-Blind Phase|Death|0
7598395|NCT03345342|12004718|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
7598396|NCT03345342|12004719|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
7598397|NCT03345342|12004720|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
7598398|NCT03345342|12004721|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
7598399|NCT03345342|12004722|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
7598400|NCT03345342|12004718|FG000|Double-Blind Phase|Lost to Follow-up|0
7598401|NCT03345342|12004719|FG001|Double-Blind Phase|Lost to Follow-up|1
7598402|NCT03345342|12004720|FG002|Double-Blind Phase|Lost to Follow-up|7
7598403|NCT03345342|12004721|FG003|Double-Blind Phase|Lost to Follow-up|0
7598404|NCT03345342|12004722|FG004|Double-Blind Phase|Lost to Follow-up|0
7598405|NCT03345342|12004718|FG000|Double-Blind Phase|Physician Decision|0
7598406|NCT03345342|12004719|FG001|Double-Blind Phase|Physician Decision|1
7598407|NCT03345342|12004720|FG002|Double-Blind Phase|Physician Decision|4
7598408|NCT03345342|12004721|FG003|Double-Blind Phase|Physician Decision|0
7598409|NCT03345342|12004722|FG004|Double-Blind Phase|Physician Decision|0
7598410|NCT03345342|12004718|FG000|Double-Blind Phase|Protocol Violation|0
7598411|NCT03345342|12004719|FG001|Double-Blind Phase|Protocol Violation|0
7598412|NCT03345342|12004720|FG002|Double-Blind Phase|Protocol Violation|1
7598413|NCT03345342|12004721|FG003|Double-Blind Phase|Protocol Violation|0
7598414|NCT03345342|12004722|FG004|Double-Blind Phase|Protocol Violation|0
7598415|NCT03345342|12004718|FG000|Double-Blind Phase|Withdrawal by Subject|0
7598416|NCT03345342|12004719|FG001|Double-Blind Phase|Withdrawal by Subject|16
7598417|NCT03345342|12004720|FG002|Double-Blind Phase|Withdrawal by Subject|38
7598418|NCT03345342|12004721|FG003|Double-Blind Phase|Withdrawal by Subject|0
7598419|NCT03345342|12004722|FG004|Double-Blind Phase|Withdrawal by Subject|0
7598420|NCT03345342|12004718|FG000|Double-Blind Phase|Other|0
7598421|NCT03345342|12004719|FG001|Double-Blind Phase|Other|1
7598422|NCT03345342|12004720|FG002|Double-Blind Phase|Other|3
7598423|NCT03345342|12004721|FG003|Double-Blind Phase|Other|0
7598424|NCT03345342|12004722|FG004|Double-Blind Phase|Other|0
7598425|NCT03345342|12004718|FG000|Follow-Up Phase|Adverse Event|0
7598426|NCT03345342|12004719|FG001|Follow-Up Phase|Adverse Event|0
7598427|NCT03345342|12004720|FG002|Follow-Up Phase|Adverse Event|0
7598428|NCT03345342|12004721|FG003|Follow-Up Phase|Adverse Event|0
7272169|NCT00424463|11486409|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
7272170|NCT00424463|11486410|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
7272171|NCT00424463|11486411|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
7272172|NCT00424463|11486409|FG000|Overall Study|Patient's convenience|0
7272173|NCT00424463|11486410|FG001|Overall Study|Patient's convenience|0
7272174|NCT00424463|11486411|FG002|Overall Study|Patient's convenience|1
7272175|NCT00424476|11486422|FG000|Overall Study|Withdrawal by Subject|7
7272176|NCT00424476|11486423|FG001|Overall Study|Withdrawal by Subject|6
7272177|NCT00424476|11486424|FG002|Overall Study|Withdrawal by Subject|3
7272178|NCT00424476|11486422|FG000|Overall Study|Adverse Event|19
7272179|NCT00424476|11486423|FG001|Overall Study|Adverse Event|16
7272180|NCT00424476|11486424|FG002|Overall Study|Adverse Event|15
7272181|NCT00424476|11486422|FG000|Overall Study|Lack of Efficacy|16
7272182|NCT00424476|11486423|FG001|Overall Study|Lack of Efficacy|12
7272183|NCT00424476|11486424|FG002|Overall Study|Lack of Efficacy|12
7272184|NCT00424476|11486422|FG000|Overall Study|Lack of Compliance|1
7272185|NCT00424476|11486423|FG001|Overall Study|Lack of Compliance|1
7272186|NCT00424476|11486424|FG002|Overall Study|Lack of Compliance|1
7272187|NCT00424476|11486422|FG000|Overall Study|Lost to Follow-up|4
7272188|NCT00424476|11486423|FG001|Overall Study|Lost to Follow-up|6
7272189|NCT00424476|11486424|FG002|Overall Study|Lost to Follow-up|3
7272190|NCT00424476|11486422|FG000|Overall Study|Protocol Violation|7
7272191|NCT00424476|11486423|FG001|Overall Study|Protocol Violation|2
7272192|NCT00424476|11486424|FG002|Overall Study|Protocol Violation|3
7272193|NCT00424476|11486422|FG000|Overall Study|Physician Decision|3
7272194|NCT00424476|11486423|FG001|Overall Study|Physician Decision|2
7272195|NCT00424476|11486424|FG002|Overall Study|Physician Decision|3
7272196|NCT00424476|11486422|FG000|Overall Study|Other|4
7272197|NCT00424476|11486423|FG001|Overall Study|Other|3
7272198|NCT00424476|11486424|FG002|Overall Study|Other|9
7272199|NCT00424489|11486432|FG000|Overall Study|Death|3
7272200|NCT00424515|11486442|FG000|Overall Study|Progressive Disease|10
7272201|NCT00424515|11486443|FG001|Overall Study|Progressive Disease|11
7272202|NCT00424515|11486442|FG000|Overall Study|Adverse Event|0
7272203|NCT00424515|11486443|FG001|Overall Study|Adverse Event|1
7272204|NCT00424515|11486442|FG000|Overall Study|Intercurrent Illness|0
7272205|NCT00424515|11486443|FG001|Overall Study|Intercurrent Illness|1
7598429|NCT03345342|12004722|FG004|Follow-Up Phase|Adverse Event|4
7598430|NCT03345342|12004718|FG000|Follow-Up Phase|Lost to Follow-up|0
7598431|NCT03345342|12004719|FG001|Follow-Up Phase|Lost to Follow-up|0
7598432|NCT03345342|12004720|FG002|Follow-Up Phase|Lost to Follow-up|0
7598433|NCT03345342|12004721|FG003|Follow-Up Phase|Lost to Follow-up|0
7598434|NCT03345342|12004722|FG004|Follow-Up Phase|Lost to Follow-up|6
7598435|NCT03345342|12004718|FG000|Follow-Up Phase|Physician Decision|0
7598436|NCT03345342|12004719|FG001|Follow-Up Phase|Physician Decision|0
7598437|NCT03345342|12004720|FG002|Follow-Up Phase|Physician Decision|0
7598438|NCT03345342|12004721|FG003|Follow-Up Phase|Physician Decision|0
7598439|NCT03345342|12004722|FG004|Follow-Up Phase|Physician Decision|5
7598440|NCT03345342|12004718|FG000|Follow-Up Phase|Withdrawal by Subject|0
7598441|NCT03345342|12004719|FG001|Follow-Up Phase|Withdrawal by Subject|0
7598442|NCT03345342|12004720|FG002|Follow-Up Phase|Withdrawal by Subject|0
7598443|NCT03345342|12004721|FG003|Follow-Up Phase|Withdrawal by Subject|5
7598444|NCT03345342|12004722|FG004|Follow-Up Phase|Withdrawal by Subject|15
7598445|NCT03345342|12004718|FG000|Follow-Up Phase|Other|0
7598446|NCT03345342|12004719|FG001|Follow-Up Phase|Other|0
7598447|NCT03345342|12004720|FG002|Follow-Up Phase|Other|0
7598448|NCT03345342|12004721|FG003|Follow-Up Phase|Other|3
7598449|NCT03345342|12004722|FG004|Follow-Up Phase|Other|1
7598450|NCT02880241|12004755|FG000|Overall Study|Lack of Efficacy|1
7598451|NCT02880241|12004756|FG001|Overall Study|Lack of Efficacy|0
7598452|NCT02880241|12004757|FG002|Overall Study|Lack of Efficacy|0
7598453|NCT02880241|12004758|FG003|Overall Study|Lack of Efficacy|0
7598454|NCT02880241|12004759|FG004|Overall Study|Lack of Efficacy|0
7598455|NCT02880241|12004760|FG005|Overall Study|Lack of Efficacy|0
7598456|NCT02832687|12004778|FG000|Overall Study|Adverse Event|0
7598457|NCT02832687|12004779|FG001|Overall Study|Adverse Event|2
7598458|NCT02499900|12004791|FG000|Core Study Period|Other|1
7598459|NCT02499900|12004792|FG001|Core Study Period|Other|4
7598460|NCT02499900|12004791|FG000|Core Study Period|Lost to Follow-up|1
7598461|NCT02499900|12004792|FG001|Core Study Period|Lost to Follow-up|2
7598462|NCT02499900|12004791|FG000|Core Study Period|Per sponsor request|0
7598463|NCT02499900|12004792|FG001|Core Study Period|Per sponsor request|1
7598464|NCT02499900|12004791|FG000|Core Study Period|Pregnancy|1
7598465|NCT02499900|12004792|FG001|Core Study Period|Pregnancy|0
7598466|NCT02499900|12004791|FG000|Core Study Period|Protocol Violation|3
7598467|NCT02499900|12004792|FG001|Core Study Period|Protocol Violation|0
7598468|NCT02499900|12004791|FG000|Core Study Period|Withdrawal by Subject|11
7598469|NCT02499900|12004792|FG001|Core Study Period|Withdrawal by Subject|10
7598470|NCT02499900|12004791|FG000|Core Study Period|Adverse Event|18
7598471|NCT02499900|12004792|FG001|Core Study Period|Adverse Event|14
7598472|NCT02499900|12004791|FG000|Core Study Period|Death|0
7598473|NCT02499900|12004792|FG001|Core Study Period|Death|1
7598474|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Physician Decision|1
7598475|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Physician Decision|0
7598476|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
7598477|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
7598478|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
7598479|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
7598480|NCT02499900|12004791|FG000|Completed Core, Continued Into Extension|Personal motivation|1
7598481|NCT02499900|12004792|FG001|Completed Core, Continued Into Extension|Personal motivation|0
7598482|NCT02499900|12004791|FG000|Extension Study Period|Adverse Event|2
7598483|NCT02499900|12004792|FG001|Extension Study Period|Adverse Event|4
7598484|NCT02499900|12004791|FG000|Extension Study Period|Withdrawal by Subject|5
7598485|NCT02499900|12004792|FG001|Extension Study Period|Withdrawal by Subject|2
7598486|NCT02499900|12004791|FG000|Extension Study Period|Physician Decision|2
7598487|NCT02499900|12004792|FG001|Extension Study Period|Physician Decision|5
7272206|NCT00424515|11486442|FG000|Overall Study|Withdrawal by Subject|1
7272207|NCT00424515|11486443|FG001|Overall Study|Withdrawal by Subject|0
7272208|NCT00424528|11486452|FG000|Overall Study|Adverse Event|2
7272209|NCT00424528|11486453|FG001|Overall Study|Adverse Event|1
7272210|NCT00424528|11486454|FG002|Overall Study|Adverse Event|2
7272211|NCT00424528|11486452|FG000|Overall Study|Protocol Violation|1
7272212|NCT00424528|11486453|FG001|Overall Study|Protocol Violation|1
7272213|NCT00424528|11486454|FG002|Overall Study|Protocol Violation|0
7272214|NCT00424528|11486452|FG000|Overall Study|Lost to Follow-up|0
7272215|NCT00424528|11486453|FG001|Overall Study|Lost to Follow-up|1
7272216|NCT00424528|11486454|FG002|Overall Study|Lost to Follow-up|0
7272217|NCT00424528|11486452|FG000|Overall Study|noncompliance with study requirements|2
7272218|NCT00424528|11486453|FG001|Overall Study|noncompliance with study requirements|1
7272219|NCT00424528|11486454|FG002|Overall Study|noncompliance with study requirements|2
7272220|NCT00424593|11486473|FG000|Acute Double-Blind Period|Adverse Event|16
7272221|NCT00424593|11486474|FG001|Acute Double-Blind Period|Adverse Event|7
7272222|NCT00424593|11486473|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
7272223|NCT00424593|11486474|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
7272224|NCT00424593|11486473|FG000|Acute Double-Blind Period|Protocol Violation|2
7272225|NCT00424593|11486474|FG001|Acute Double-Blind Period|Protocol Violation|2
7272226|NCT00424593|11486473|FG000|Acute Double-Blind Period|Physician Decision|1
7272227|NCT00424593|11486474|FG001|Acute Double-Blind Period|Physician Decision|2
7272228|NCT00424593|11486473|FG000|Acute Double-Blind Period|Lost to Follow-up|1
7272229|NCT00424593|11486474|FG001|Acute Double-Blind Period|Lost to Follow-up|1
7272230|NCT00424593|11486473|FG000|Acute Double-Blind Period|Lack of Efficacy|0
7272231|NCT00424593|11486474|FG001|Acute Double-Blind Period|Lack of Efficacy|1
7272232|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
7272233|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
7272234|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Adverse Event|18
7272235|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Adverse Event|0
7272236|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
7272237|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
7272238|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Protocol Violation|9
7272239|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Protocol Violation|0
7272240|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
7272241|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
7272242|NCT00424593|11486473|FG000|Dose-Blind Extension Period|Physician Decision|3
7272243|NCT00424593|11486474|FG001|Dose-Blind Extension Period|Physician Decision|0
7272244|NCT00424632|11486495|FG000|Overall Study|Death|0
7272245|NCT00424632|11486496|FG001|Overall Study|Death|0
7272246|NCT00424632|11486497|FG002|Overall Study|Death|0
7272247|NCT00424632|11486498|FG003|Overall Study|Death|0
7272248|NCT00424632|11486499|FG004|Overall Study|Death|0
7272249|NCT00424632|11486500|FG005|Overall Study|Death|2
7272250|NCT00424632|11486501|FG006|Overall Study|Death|0
7272251|NCT00424632|11486502|FG007|Overall Study|Death|0
7272252|NCT00424632|11486503|FG008|Overall Study|Death|0
7272253|NCT00424632|11486504|FG009|Overall Study|Death|0
7272254|NCT00424632|11486495|FG000|Overall Study|Adverse Event|0
7272255|NCT00424632|11486496|FG001|Overall Study|Adverse Event|0
7272256|NCT00424632|11486497|FG002|Overall Study|Adverse Event|0
7598488|NCT02499900|12004791|FG000|Extension Study Period|Pregnancy|1
7598489|NCT02499900|12004792|FG001|Extension Study Period|Pregnancy|2
7598490|NCT02499900|12004791|FG000|Extension Study Period|Lost to Follow-up|2
7598491|NCT02499900|12004792|FG001|Extension Study Period|Lost to Follow-up|5
7598492|NCT02499900|12004791|FG000|Extension Study Period|Other|0
7598493|NCT02499900|12004792|FG001|Extension Study Period|Other|2
7598494|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
7598495|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
7598496|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
7598497|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
7598498|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
7598499|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
7598500|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
7598501|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
7598502|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
7598503|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
7598504|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
7598505|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
7598506|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
7598507|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
7598508|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
7598509|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
7598510|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7598511|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
7598512|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
7598513|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
7598514|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
7598515|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
7598516|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
7598517|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
7598518|NCT02269917|12004819|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
7598519|NCT02269917|12004820|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
7598520|NCT02269917|12004821|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
7598521|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
7598522|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
7598523|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
7598524|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7598525|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7598526|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
7598527|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7598528|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7598529|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
7598530|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7598531|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7598532|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
7598533|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7598534|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
7598535|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
7598536|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7598537|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7598538|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
7598539|NCT02269917|12004819|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
7598540|NCT02269917|12004820|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
7598541|NCT02269917|12004821|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
7598542|NCT02225366|12004832|FG000|Overall Study|Lack of Efficacy|1
7598543|NCT02225366|12004833|FG001|Overall Study|Lack of Efficacy|0
7598544|NCT01530997|12004839|FG000|Overall Study|Physician Decision|1
7598545|NCT01530997|12004839|FG000|Overall Study|Withdrawal by Subject|1
7598546|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Death|0
7598547|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Death|1
7598548|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
7598549|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
7598550|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
7598551|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
7598552|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
7598553|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
7598554|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
7598555|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
7598556|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
7598557|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
7598558|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
7272257|NCT00424632|11486498|FG003|Overall Study|Adverse Event|0
7598559|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
7598560|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
7598561|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
7598562|NCT01067521|12004865|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
7598563|NCT01067521|12004866|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
7598564|NCT01067521|12004865|FG000|Open-Label Period|Death|3
7598565|NCT01067521|12004866|FG001|Open-Label Period|Death|1
7598566|NCT01067521|12004865|FG000|Open-Label Period|Adverse Event|30
7598567|NCT01067521|12004866|FG001|Open-Label Period|Adverse Event|28
7598568|NCT01067521|12004865|FG000|Open-Label Period|Withdrawal by Subject|160
7598569|NCT01067521|12004866|FG001|Open-Label Period|Withdrawal by Subject|88
7598570|NCT01067521|12004865|FG000|Open-Label Period|Physician Decision|13
7598571|NCT01067521|12004866|FG001|Open-Label Period|Physician Decision|11
7598572|NCT01067521|12004865|FG000|Open-Label Period|Non-compliance with study drug|5
7598573|NCT01067521|12004866|FG001|Open-Label Period|Non-compliance with study drug|0
7598574|NCT01067521|12004865|FG000|Open-Label Period|Protocol Violation|3
7598575|NCT01067521|12004866|FG001|Open-Label Period|Protocol Violation|0
7598576|NCT01067521|12004865|FG000|Open-Label Period|Pregnancy|14
7598577|NCT01067521|12004866|FG001|Open-Label Period|Pregnancy|8
7598578|NCT01067521|12004865|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
7598579|NCT01067521|12004866|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
7598580|NCT01067521|12004865|FG000|Open-Label Period|Lost to Follow-up|21
7598581|NCT01067521|12004866|FG001|Open-Label Period|Lost to Follow-up|20
7598582|NCT01047319|12004880|FG000|Overall Study|Teva requested participant withdrawal|3
7598583|NCT01047319|12004881|FG001|Overall Study|Teva requested participant withdrawal|0
7598584|NCT01047319|12004882|FG002|Overall Study|Teva requested participant withdrawal|1
7598585|NCT01047319|12004880|FG000|Overall Study|Protocol Violation|3
7598586|NCT01047319|12004881|FG001|Overall Study|Protocol Violation|2
7598587|NCT01047319|12004882|FG002|Overall Study|Protocol Violation|4
7598588|NCT01047319|12004880|FG000|Overall Study|Lack of Efficacy|4
7598589|NCT01047319|12004881|FG001|Overall Study|Lack of Efficacy|3
7598590|NCT01047319|12004882|FG002|Overall Study|Lack of Efficacy|3
7598591|NCT01047319|12004880|FG000|Overall Study|Death|5
7598592|NCT01047319|12004881|FG001|Overall Study|Death|1
7598593|NCT01047319|12004882|FG002|Overall Study|Death|5
7598594|NCT01047319|12004880|FG000|Overall Study|Pregnancy|13
7598595|NCT01047319|12004881|FG001|Overall Study|Pregnancy|8
7598596|NCT01047319|12004882|FG002|Overall Study|Pregnancy|8
7598597|NCT01047319|12004880|FG000|Overall Study|Physician Decision|12
7598598|NCT01047319|12004881|FG001|Overall Study|Physician Decision|9
7598599|NCT01047319|12004882|FG002|Overall Study|Physician Decision|10
7598600|NCT01047319|12004880|FG000|Overall Study|Lost to Follow-up|14
7598601|NCT01047319|12004881|FG001|Overall Study|Lost to Follow-up|10
7598602|NCT01047319|12004882|FG002|Overall Study|Lost to Follow-up|10
7598603|NCT01047319|12004880|FG000|Overall Study|Adverse Event|16
7598604|NCT01047319|12004881|FG001|Overall Study|Adverse Event|27
7598605|NCT01047319|12004882|FG002|Overall Study|Adverse Event|21
7598606|NCT01047319|12004880|FG000|Overall Study|Withdrawal by Subject|77
7598607|NCT01047319|12004881|FG001|Overall Study|Withdrawal by Subject|75
7598608|NCT01047319|12004882|FG002|Overall Study|Withdrawal by Subject|87
7598609|NCT01047319|12004880|FG000|Overall Study|Study terminated by Sponsor|198
7598610|NCT01047319|12004881|FG001|Overall Study|Study terminated by Sponsor|215
7598611|NCT01047319|12004882|FG002|Overall Study|Study terminated by Sponsor|203
7598612|NCT00988052|12004892|FG000|Overall Study|Missing|1
7598613|NCT00988052|12004893|FG001|Overall Study|Missing|0
7598614|NCT00988052|12004892|FG000|Overall Study|Teva requested subject withdrawal|3
7598615|NCT00988052|12004893|FG001|Overall Study|Teva requested subject withdrawal|1
7598616|NCT00988052|12004892|FG000|Overall Study|Death|1
7598617|NCT00988052|12004893|FG001|Overall Study|Death|3
7598618|NCT00988052|12004892|FG000|Overall Study|Protocol Violation|6
7598619|NCT00988052|12004893|FG001|Overall Study|Protocol Violation|5
7598620|NCT00988052|12004892|FG000|Overall Study|Pregnancy|6
7598621|NCT00988052|12004893|FG001|Overall Study|Pregnancy|6
7598622|NCT00988052|12004892|FG000|Overall Study|Lack of Efficacy|8
7598623|NCT00988052|12004893|FG001|Overall Study|Lack of Efficacy|7
7598624|NCT00988052|12004892|FG000|Overall Study|Lost to Follow-up|6
7598625|NCT00988052|12004893|FG001|Overall Study|Lost to Follow-up|11
7598626|NCT00988052|12004892|FG000|Overall Study|Physician Decision|27
7598627|NCT00988052|12004893|FG001|Overall Study|Physician Decision|28
7598628|NCT00988052|12004892|FG000|Overall Study|Adverse Event|35
7598629|NCT00988052|12004893|FG001|Overall Study|Adverse Event|28
7598630|NCT00988052|12004892|FG000|Overall Study|Withdrawal by Subject|90
7598631|NCT00988052|12004893|FG001|Overall Study|Withdrawal by Subject|91
7598632|NCT00988052|12004892|FG000|Overall Study|Study terminated by sponsor|240
7598633|NCT00988052|12004893|FG001|Overall Study|Study terminated by sponsor|236
7598634|NCT02021773|12004902|FG000|Overall Study|Adverse Event|1
7598635|NCT02021773|12004903|FG001|Overall Study|Adverse Event|4
7598636|NCT02021773|12004904|FG002|Overall Study|Adverse Event|3
7598637|NCT02021773|12004902|FG000|Overall Study|Lack of Efficacy|2
7598638|NCT02021773|12004903|FG001|Overall Study|Lack of Efficacy|2
7598639|NCT02021773|12004904|FG002|Overall Study|Lack of Efficacy|2
7598640|NCT02021773|12004902|FG000|Overall Study|Protocol Violation|2
7598641|NCT02021773|12004903|FG001|Overall Study|Protocol Violation|3
7598642|NCT02021773|12004904|FG002|Overall Study|Protocol Violation|1
7598643|NCT02021773|12004902|FG000|Overall Study|Withdrawal by Subject|3
7598644|NCT02021773|12004903|FG001|Overall Study|Withdrawal by Subject|4
7598645|NCT02021773|12004904|FG002|Overall Study|Withdrawal by Subject|5
7598646|NCT02021773|12004902|FG000|Overall Study|Lost to Follow-up|1
7598647|NCT02021773|12004903|FG001|Overall Study|Lost to Follow-up|3
7598648|NCT02021773|12004904|FG002|Overall Study|Lost to Follow-up|0
7598649|NCT02021773|12004902|FG000|Overall Study|Reason not specified|3
7598650|NCT02021773|12004903|FG001|Overall Study|Reason not specified|0
7598651|NCT02021773|12004904|FG002|Overall Study|Reason not specified|0
7598652|NCT04553406|12004928|FG000|Overall Study|Study Discontinuation|0
7598653|NCT04553406|12004929|FG001|Overall Study|Study Discontinuation|1
7598654|NCT03792750|12004935|FG000|Overall Study|Death|3
7598655|NCT03739138|12004956|FG000|Overall Study|Death|0
7598656|NCT03739138|12004957|FG001|Overall Study|Death|7
7598657|NCT03739138|12004958|FG002|Overall Study|Death|4
7598658|NCT03739138|12004959|FG003|Overall Study|Death|13
7598659|NCT03739138|12004960|FG004|Overall Study|Death|0
7598660|NCT03739138|12004956|FG000|Overall Study|Lost to Follow-up|0
7598661|NCT03739138|12004957|FG001|Overall Study|Lost to Follow-up|0
7598662|NCT03739138|12004958|FG002|Overall Study|Lost to Follow-up|1
7598663|NCT03739138|12004959|FG003|Overall Study|Lost to Follow-up|0
7598664|NCT03739138|12004960|FG004|Overall Study|Lost to Follow-up|0
7598665|NCT03739138|12004956|FG000|Overall Study|Study Terminated By Sponsor|0
7598666|NCT03739138|12004957|FG001|Overall Study|Study Terminated By Sponsor|0
7598667|NCT03739138|12004958|FG002|Overall Study|Study Terminated By Sponsor|0
7598668|NCT03739138|12004959|FG003|Overall Study|Study Terminated By Sponsor|4
7598669|NCT03739138|12004960|FG004|Overall Study|Study Terminated By Sponsor|0
7598670|NCT03739138|12004956|FG000|Overall Study|Withdrawal by Subject|0
7598671|NCT03739138|12004957|FG001|Overall Study|Withdrawal by Subject|0
7598672|NCT03739138|12004958|FG002|Overall Study|Withdrawal by Subject|0
7598673|NCT03739138|12004959|FG003|Overall Study|Withdrawal by Subject|1
7598674|NCT03739138|12004960|FG004|Overall Study|Withdrawal by Subject|0
7598711|NCT03468309|12004980|FG000|Overall Study|Lost to Follow-up|4
7598712|NCT03468309|12004980|FG000|Overall Study|Withdrawal by Subject|2
7598713|NCT03347123|12004986|FG000|Overall Study|Death|1
7598714|NCT03347123|12004987|FG001|Overall Study|Death|2
7598715|NCT03347123|12004988|FG002|Overall Study|Death|0
7598716|NCT03347123|12004989|FG003|Overall Study|Death|0
7598717|NCT03347123|12004990|FG004|Overall Study|Death|0
7598718|NCT03347123|12004991|FG005|Overall Study|Death|0
7598719|NCT03347123|12004992|FG006|Overall Study|Death|0
7598720|NCT03347123|12004986|FG000|Overall Study|Withdrawal by Subject|1
7598721|NCT03347123|12004987|FG001|Overall Study|Withdrawal by Subject|0
7598722|NCT03347123|12004988|FG002|Overall Study|Withdrawal by Subject|0
7598723|NCT03347123|12004989|FG003|Overall Study|Withdrawal by Subject|0
7598724|NCT03347123|12004990|FG004|Overall Study|Withdrawal by Subject|0
7598725|NCT03347123|12004991|FG005|Overall Study|Withdrawal by Subject|0
7598726|NCT03347123|12004992|FG006|Overall Study|Withdrawal by Subject|0
7598727|NCT03347123|12004986|FG000|Overall Study|Reason not Specified|3
7272258|NCT00424632|11486499|FG004|Overall Study|Adverse Event|0
7598728|NCT03347123|12004987|FG001|Overall Study|Reason not Specified|4
7598729|NCT03347123|12004988|FG002|Overall Study|Reason not Specified|0
7598730|NCT03347123|12004989|FG003|Overall Study|Reason not Specified|0
7598731|NCT03347123|12004990|FG004|Overall Study|Reason not Specified|0
7598732|NCT03347123|12004991|FG005|Overall Study|Reason not Specified|0
7598733|NCT03347123|12004992|FG006|Overall Study|Reason not Specified|0
7598734|NCT03318523|12005007|FG000|PC Period: Up to Year 1|Adverse Event|1
7598735|NCT03318523|12005008|FG001|PC Period: Up to Year 1|Adverse Event|0
7598736|NCT03318523|12005009|FG002|PC Period: Up to Year 1|Adverse Event|2
7598737|NCT03318523|12005010|FG003|PC Period: Up to Year 1|Adverse Event|0
7598738|NCT03318523|12005011|FG004|PC Period: Up to Year 1|Adverse Event|0
7598739|NCT03318523|12005012|FG005|PC Period: Up to Year 1|Adverse Event|0
7598740|NCT03318523|12005013|FG006|PC Period: Up to Year 1|Adverse Event|0
7598741|NCT03318523|12005014|FG007|PC Period: Up to Year 1|Adverse Event|0
7598742|NCT03318523|12005015|FG008|PC Period: Up to Year 1|Adverse Event|0
7598743|NCT03318523|12005016|FG009|PC Period: Up to Year 1|Adverse Event|0
7598744|NCT03318523|12005007|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
7598745|NCT03318523|12005008|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
7598746|NCT03318523|12005009|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
7598747|NCT03318523|12005010|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
7598748|NCT03318523|12005011|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
7598749|NCT03318523|12005012|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
7598750|NCT03318523|12005013|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
7598751|NCT03318523|12005014|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
7598752|NCT03318523|12005015|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
7598753|NCT03318523|12005016|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
7598754|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598755|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598756|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598757|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598758|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7598759|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598760|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598761|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
7598762|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
7598763|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
7598764|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598765|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598766|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598767|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598768|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7598769|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598770|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
7598771|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
7598772|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
7598773|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
7598774|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598775|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598776|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598777|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598778|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598779|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
7598780|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598781|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598782|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598783|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
7598784|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598785|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598786|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598787|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598788|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598789|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598790|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598791|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598792|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
7598793|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
7598794|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598795|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598796|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598797|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
7598798|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
7598799|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
7598800|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
7598942|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Other|0
7598801|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
7598802|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
7598803|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
7598804|NCT03318523|12005007|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598805|NCT03318523|12005008|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598806|NCT03318523|12005009|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598807|NCT03318523|12005010|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598808|NCT03318523|12005011|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
7598809|NCT03318523|12005012|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598810|NCT03318523|12005013|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598811|NCT03318523|12005014|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
7598812|NCT03318523|12005015|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
7598813|NCT03318523|12005016|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
7598814|NCT02906020|12005050|FG000|Part 1: Dose Escalation Period|Adverse Event|0
7598815|NCT02906020|12005051|FG001|Part 1: Dose Escalation Period|Adverse Event|1
7598816|NCT02906020|12005052|FG002|Part 1: Dose Escalation Period|Adverse Event|0
7598817|NCT02906020|12005053|FG003|Part 1: Dose Escalation Period|Adverse Event|1
7598818|NCT02906020|12005054|FG004|Part 1: Dose Escalation Period|Adverse Event|0
7598819|NCT02906020|12005055|FG005|Part 1: Dose Escalation Period|Adverse Event|0
7598820|NCT02906020|12005056|FG006|Part 1: Dose Escalation Period|Adverse Event|0
7598821|NCT02906020|12005057|FG007|Part 1: Dose Escalation Period|Adverse Event|0
7598822|NCT02906020|12005058|FG008|Part 1: Dose Escalation Period|Adverse Event|0
7598823|NCT02906020|12005059|FG009|Part 1: Dose Escalation Period|Adverse Event|0
7598824|NCT02906020|12005060|FG010|Part 1: Dose Escalation Period|Adverse Event|0
7598825|NCT02906020|12005061|FG011|Part 1: Dose Escalation Period|Adverse Event|0
7598826|NCT02906020|12005062|FG012|Part 1: Dose Escalation Period|Adverse Event|0
7598827|NCT02906020|12005063|FG013|Part 1: Dose Escalation Period|Adverse Event|0
7598828|NCT02906020|12005064|FG014|Part 1: Dose Escalation Period|Adverse Event|0
7598829|NCT02906020|12005065|FG015|Part 1: Dose Escalation Period|Adverse Event|0
7598830|NCT02906020|12005050|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0
7598831|NCT02906020|12005051|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0
7598832|NCT02906020|12005052|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0
7598833|NCT02906020|12005053|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0
7598834|NCT02906020|12005054|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0
7598835|NCT02906020|12005055|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0
7598836|NCT02906020|12005056|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0
7598837|NCT02906020|12005057|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0
7598838|NCT02906020|12005058|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6
7598839|NCT02906020|12005059|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15
7598840|NCT02906020|12005060|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0
7598841|NCT02906020|12005061|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0
7598842|NCT02906020|12005062|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0
7598843|NCT02906020|12005063|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0
7598844|NCT02906020|12005064|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0
7598845|NCT02906020|12005065|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0
7598846|NCT02906020|12005050|FG000|Part 2: Double-blind Treatment Period|Other|0
7598847|NCT02906020|12005051|FG001|Part 2: Double-blind Treatment Period|Other|0
7598848|NCT02906020|12005052|FG002|Part 2: Double-blind Treatment Period|Other|0
7598849|NCT02906020|12005053|FG003|Part 2: Double-blind Treatment Period|Other|0
7598850|NCT02906020|12005054|FG004|Part 2: Double-blind Treatment Period|Other|0
7598851|NCT02906020|12005055|FG005|Part 2: Double-blind Treatment Period|Other|0
7598852|NCT02906020|12005056|FG006|Part 2: Double-blind Treatment Period|Other|0
7598853|NCT02906020|12005057|FG007|Part 2: Double-blind Treatment Period|Other|0
7598854|NCT02906020|12005058|FG008|Part 2: Double-blind Treatment Period|Other|6
7598855|NCT02906020|12005059|FG009|Part 2: Double-blind Treatment Period|Other|10
7598856|NCT02906020|12005060|FG010|Part 2: Double-blind Treatment Period|Other|0
7598857|NCT02906020|12005061|FG011|Part 2: Double-blind Treatment Period|Other|0
7598858|NCT02906020|12005062|FG012|Part 2: Double-blind Treatment Period|Other|0
7598859|NCT02906020|12005063|FG013|Part 2: Double-blind Treatment Period|Other|0
7598860|NCT02906020|12005064|FG014|Part 2: Double-blind Treatment Period|Other|0
7598861|NCT02906020|12005065|FG015|Part 2: Double-blind Treatment Period|Other|0
7598862|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0
7598863|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0
7598864|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0
7598865|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0
7598866|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0
7598867|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0
7598868|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0
7598869|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0
7598870|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0
7598871|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0
7598872|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0
7598873|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0
7598874|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10
7598875|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4
7598876|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0
7598877|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0
7598878|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598879|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598880|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598881|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598882|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598883|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598884|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598885|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598886|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598887|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598888|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598889|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598890|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7
7598891|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4
7598892|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0
7598893|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1
7598894|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598895|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598896|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598897|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598898|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598899|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598900|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598901|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598902|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598903|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598904|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598905|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598906|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7598907|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
7598908|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598909|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
7598910|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598911|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598912|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598913|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598914|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598915|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598916|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598917|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598918|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598919|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598920|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598921|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598922|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1
7598923|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4
7598924|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598925|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
7598926|NCT02906020|12005050|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598927|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598928|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598929|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598930|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598931|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598932|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598933|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598934|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598935|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598936|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598937|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
7598938|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67
7598939|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64
7598940|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7
7598941|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8
7598943|NCT02906020|12005051|FG001|Part 2: Long-term Follow-up Period|Other|0
7598944|NCT02906020|12005052|FG002|Part 2: Long-term Follow-up Period|Other|0
7598945|NCT02906020|12005053|FG003|Part 2: Long-term Follow-up Period|Other|0
7598946|NCT02906020|12005054|FG004|Part 2: Long-term Follow-up Period|Other|0
7598947|NCT02906020|12005055|FG005|Part 2: Long-term Follow-up Period|Other|0
7598948|NCT02906020|12005056|FG006|Part 2: Long-term Follow-up Period|Other|0
7598949|NCT02906020|12005057|FG007|Part 2: Long-term Follow-up Period|Other|0
7598950|NCT02906020|12005058|FG008|Part 2: Long-term Follow-up Period|Other|0
7598951|NCT02906020|12005059|FG009|Part 2: Long-term Follow-up Period|Other|0
7598952|NCT02906020|12005060|FG010|Part 2: Long-term Follow-up Period|Other|0
7598953|NCT02906020|12005061|FG011|Part 2: Long-term Follow-up Period|Other|0
7598954|NCT02906020|12005062|FG012|Part 2: Long-term Follow-up Period|Other|13
7598955|NCT02906020|12005063|FG013|Part 2: Long-term Follow-up Period|Other|8
7598956|NCT02906020|12005064|FG014|Part 2: Long-term Follow-up Period|Other|3
7598957|NCT02906020|12005065|FG015|Part 2: Long-term Follow-up Period|Other|2
7272259|NCT00424632|11486500|FG005|Overall Study|Adverse Event|0
7272260|NCT00424632|11486501|FG006|Overall Study|Adverse Event|0
7272261|NCT00424632|11486502|FG007|Overall Study|Adverse Event|0
7272262|NCT00424632|11486503|FG008|Overall Study|Adverse Event|3
7272263|NCT00424632|11486504|FG009|Overall Study|Adverse Event|2
7272264|NCT00424632|11486495|FG000|Overall Study|Global deterioration of health status|0
7272265|NCT00424632|11486496|FG001|Overall Study|Global deterioration of health status|0
7469695|NCT01926015|11771575|FG001|Overall Study|Randomized not treated|0
7272266|NCT00424632|11486497|FG002|Overall Study|Global deterioration of health status|0
7272267|NCT00424632|11486498|FG003|Overall Study|Global deterioration of health status|1
7272268|NCT00424632|11486499|FG004|Overall Study|Global deterioration of health status|1
7272269|NCT00424632|11486500|FG005|Overall Study|Global deterioration of health status|0
7272270|NCT00424632|11486501|FG006|Overall Study|Global deterioration of health status|0
7272271|NCT00424632|11486502|FG007|Overall Study|Global deterioration of health status|0
7272272|NCT00424632|11486503|FG008|Overall Study|Global deterioration of health status|0
7272273|NCT00424632|11486504|FG009|Overall Study|Global deterioration of health status|0
7272274|NCT00424632|11486495|FG000|Overall Study|Objective progression or relapse|1
7272275|NCT00424632|11486496|FG001|Overall Study|Objective progression or relapse|1
7272276|NCT00424632|11486497|FG002|Overall Study|Objective progression or relapse|1
7272277|NCT00424632|11486498|FG003|Overall Study|Objective progression or relapse|2
7272278|NCT00424632|11486499|FG004|Overall Study|Objective progression or relapse|2
7272279|NCT00424632|11486500|FG005|Overall Study|Objective progression or relapse|13
7272280|NCT00424632|11486501|FG006|Overall Study|Objective progression or relapse|7
7599358|NCT02549092|12005145|FG000|Treatment Period|Adverse Event|2
7599359|NCT02549092|12005146|FG001|Treatment Period|Adverse Event|2
7599360|NCT02549092|12005145|FG000|Treatment Period|Withdrawal by Subject|1
7599361|NCT02549092|12005146|FG001|Treatment Period|Withdrawal by Subject|3
7599362|NCT02549092|12005145|FG000|Treatment Period|Lack of Efficacy|0
7599363|NCT02549092|12005146|FG001|Treatment Period|Lack of Efficacy|2
7599364|NCT02549092|12005145|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
7599365|NCT02549092|12005146|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
7599366|NCT02549092|12005145|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7599367|NCT02549092|12005146|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
7599368|NCT02323126|12005167|FG000|Overall Study|Patient / guardian decision|0
7599369|NCT02323126|12005168|FG001|Overall Study|Patient / guardian decision|1
7599370|NCT02323126|12005169|FG002|Overall Study|Patient / guardian decision|2
7599371|NCT02323126|12005167|FG000|Overall Study|Progressive disease|14
7599372|NCT02323126|12005168|FG001|Overall Study|Progressive disease|8
7599373|NCT02323126|12005169|FG002|Overall Study|Progressive disease|14
7599374|NCT02323126|12005167|FG000|Overall Study|Physician Decision|0
7599375|NCT02323126|12005168|FG001|Overall Study|Physician Decision|1
7599376|NCT02323126|12005169|FG002|Overall Study|Physician Decision|3
7599377|NCT02323126|12005167|FG000|Overall Study|Death|1
7599378|NCT02323126|12005168|FG001|Overall Study|Death|1
7599379|NCT02323126|12005169|FG002|Overall Study|Death|4
7599380|NCT02323126|12005167|FG000|Overall Study|Adverse Event|3
7599381|NCT02323126|12005168|FG001|Overall Study|Adverse Event|5
7599382|NCT02323126|12005169|FG002|Overall Study|Adverse Event|7
7599391|NCT01126749|12005194|FG000|Phase 1b|Other|0
7599392|NCT01126749|12005195|FG001|Phase 1b|Other|1
7599393|NCT01126749|12005196|FG002|Phase 1b|Other|0
7599394|NCT01126749|12005197|FG003|Phase 1b|Other|0
7599395|NCT01126749|12005194|FG000|Phase 1b|Withdrawal by Subject|0
7599396|NCT01126749|12005195|FG001|Phase 1b|Withdrawal by Subject|1
7599397|NCT01126749|12005196|FG002|Phase 1b|Withdrawal by Subject|0
7599398|NCT01126749|12005197|FG003|Phase 1b|Withdrawal by Subject|0
7599399|NCT01126749|12005194|FG000|Phase 1b|Death|3
7599400|NCT01126749|12005195|FG001|Phase 1b|Death|4
7599401|NCT01126749|12005196|FG002|Phase 1b|Death|0
7599402|NCT01126749|12005197|FG003|Phase 1b|Death|0
7599403|NCT01126749|12005194|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7599404|NCT01126749|12005195|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
7599405|NCT01126749|12005196|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4
7599406|NCT01126749|12005197|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7
7599407|NCT01126749|12005194|FG000|Phase 2|Study Termination by Sponsor|0
7599408|NCT01126749|12005195|FG001|Phase 2|Study Termination by Sponsor|0
7599409|NCT01126749|12005196|FG002|Phase 2|Study Termination by Sponsor|12
7599410|NCT01126749|12005197|FG003|Phase 2|Study Termination by Sponsor|6
7599411|NCT01126749|12005194|FG000|Phase 2|Other|0
7599412|NCT01126749|12005195|FG001|Phase 2|Other|0
7599413|NCT01126749|12005196|FG002|Phase 2|Other|4
7599414|NCT01126749|12005197|FG003|Phase 2|Other|2
7599415|NCT01126749|12005194|FG000|Phase 2|Withdrawal by Subject|0
7599416|NCT01126749|12005195|FG001|Phase 2|Withdrawal by Subject|0
7599417|NCT01126749|12005196|FG002|Phase 2|Withdrawal by Subject|0
7599418|NCT01126749|12005197|FG003|Phase 2|Withdrawal by Subject|2
7599419|NCT01126749|12005194|FG000|Phase 2|Lost to Follow-up|0
7599420|NCT01126749|12005195|FG001|Phase 2|Lost to Follow-up|0
7599421|NCT01126749|12005196|FG002|Phase 2|Lost to Follow-up|0
7599422|NCT01126749|12005197|FG003|Phase 2|Lost to Follow-up|1
7599423|NCT01126749|12005194|FG000|Phase 2|Death|0
7599424|NCT01126749|12005195|FG001|Phase 2|Death|0
7599425|NCT01126749|12005196|FG002|Phase 2|Death|22
7469696|NCT01926028|11771584|FG000|Overall Study|Lost to Follow-up|7
7599426|NCT01126749|12005197|FG003|Phase 2|Death|22
7599427|NCT01126749|12005194|FG000|Phase 2|Adverse Event|0
7599428|NCT01126749|12005195|FG001|Phase 2|Adverse Event|0
7599429|NCT01126749|12005196|FG002|Phase 2|Adverse Event|0
7599430|NCT01126749|12005197|FG003|Phase 2|Adverse Event|1
7599431|NCT01059448|12005220|FG000|Overall Study|Adverse Event|1
7599432|NCT01059448|12005221|FG001|Overall Study|Adverse Event|3
7599433|NCT01059448|12005222|FG002|Overall Study|Adverse Event|0
7599434|NCT01059448|12005223|FG003|Overall Study|Adverse Event|1
7599435|NCT01059448|12005220|FG000|Overall Study|Withdrawal by Subject|2
7599436|NCT01059448|12005221|FG001|Overall Study|Withdrawal by Subject|0
7599437|NCT01059448|12005222|FG002|Overall Study|Withdrawal by Subject|2
7599438|NCT01059448|12005223|FG003|Overall Study|Withdrawal by Subject|4
7599439|NCT01059448|12005220|FG000|Overall Study|Disease Progression|2
7599440|NCT01059448|12005221|FG001|Overall Study|Disease Progression|1
7599441|NCT01059448|12005222|FG002|Overall Study|Disease Progression|4
7599442|NCT01059448|12005223|FG003|Overall Study|Disease Progression|2
7599443|NCT01059448|12005220|FG000|Overall Study|Administrative Decision|43
7599444|NCT01059448|12005221|FG001|Overall Study|Administrative Decision|49
7599445|NCT01059448|12005222|FG002|Overall Study|Administrative Decision|45
7599446|NCT01059448|12005223|FG003|Overall Study|Administrative Decision|46
7599447|NCT01059448|12005220|FG000|Overall Study|Lost to Follow-up|0
7599448|NCT01059448|12005221|FG001|Overall Study|Lost to Follow-up|0
7599449|NCT01059448|12005222|FG002|Overall Study|Lost to Follow-up|2
7599450|NCT01059448|12005223|FG003|Overall Study|Lost to Follow-up|0
7599451|NCT01059448|12005220|FG000|Overall Study|Death|0
7599452|NCT01059448|12005221|FG001|Overall Study|Death|1
7599453|NCT01059448|12005222|FG002|Overall Study|Death|0
7599454|NCT01059448|12005223|FG003|Overall Study|Death|0
7599455|NCT01059448|12005220|FG000|Overall Study|Other|1
7599456|NCT01059448|12005221|FG001|Overall Study|Other|1
7599457|NCT01059448|12005222|FG002|Overall Study|Other|0
7599458|NCT01059448|12005223|FG003|Overall Study|Other|1
7599459|NCT00821587|12005235|FG000|Overall Study|Physician Decision|0
7599460|NCT00821587|12005236|FG001|Overall Study|Physician Decision|1
7599461|NCT00585195|12005263|FG000|Overall Study|Adverse Event|0
7599462|NCT00585195|12005264|FG001|Overall Study|Adverse Event|0
7599463|NCT00585195|12005265|FG002|Overall Study|Adverse Event|0
7599464|NCT00585195|12005266|FG003|Overall Study|Adverse Event|0
7599465|NCT00585195|12005267|FG004|Overall Study|Adverse Event|2
7599466|NCT00585195|12005268|FG005|Overall Study|Adverse Event|1
7599467|NCT00585195|12005269|FG006|Overall Study|Adverse Event|0
7599468|NCT00585195|12005270|FG007|Overall Study|Adverse Event|1
7599469|NCT00585195|12005271|FG008|Overall Study|Adverse Event|0
7599470|NCT00585195|12005272|FG009|Overall Study|Adverse Event|0
7599471|NCT00585195|12005273|FG010|Overall Study|Adverse Event|3
7599472|NCT00585195|12005274|FG011|Overall Study|Adverse Event|0
7599473|NCT00585195|12005275|FG012|Overall Study|Adverse Event|8
7599474|NCT00585195|12005276|FG013|Overall Study|Adverse Event|6
7599475|NCT00585195|12005277|FG014|Overall Study|Adverse Event|4
7599476|NCT00585195|12005278|FG015|Overall Study|Adverse Event|1
7599477|NCT00585195|12005279|FG016|Overall Study|Adverse Event|14
7599478|NCT00585195|12005280|FG017|Overall Study|Adverse Event|9
7599479|NCT00585195|12005281|FG018|Overall Study|Adverse Event|2
7599480|NCT00585195|12005282|FG019|Overall Study|Adverse Event|3
7599481|NCT00585195|12005283|FG020|Overall Study|Adverse Event|1
7599482|NCT00585195|12005263|FG000|Overall Study|Progressive Disease|2
7599483|NCT00585195|12005264|FG001|Overall Study|Progressive Disease|2
7599484|NCT00585195|12005265|FG002|Overall Study|Progressive Disease|5
7599485|NCT00585195|12005266|FG003|Overall Study|Progressive Disease|4
7599486|NCT00585195|12005267|FG004|Overall Study|Progressive Disease|6
7599487|NCT00585195|12005268|FG005|Overall Study|Progressive Disease|4
7599488|NCT00585195|12005269|FG006|Overall Study|Progressive Disease|6
7599489|NCT00585195|12005270|FG007|Overall Study|Progressive Disease|3
7599490|NCT00585195|12005271|FG008|Overall Study|Progressive Disease|0
7599491|NCT00585195|12005272|FG009|Overall Study|Progressive Disease|5
7599492|NCT00585195|12005273|FG010|Overall Study|Progressive Disease|2
7599493|NCT00585195|12005274|FG011|Overall Study|Progressive Disease|25
7599494|NCT00585195|12005275|FG012|Overall Study|Progressive Disease|29
7599495|NCT00585195|12005276|FG013|Overall Study|Progressive Disease|26
7599496|NCT00585195|12005277|FG014|Overall Study|Progressive Disease|21
7599497|NCT00585195|12005278|FG015|Overall Study|Progressive Disease|12
7599498|NCT00585195|12005279|FG016|Overall Study|Progressive Disease|94
7599499|NCT00585195|12005280|FG017|Overall Study|Progressive Disease|42
7599500|NCT00585195|12005281|FG018|Overall Study|Progressive Disease|4
7599501|NCT00585195|12005282|FG019|Overall Study|Progressive Disease|9
7599502|NCT00585195|12005283|FG020|Overall Study|Progressive Disease|8
7599503|NCT00585195|12005263|FG000|Overall Study|Withdrawal by Subject|1
7599504|NCT00585195|12005264|FG001|Overall Study|Withdrawal by Subject|1
7599505|NCT00585195|12005265|FG002|Overall Study|Withdrawal by Subject|2
7599506|NCT00585195|12005266|FG003|Overall Study|Withdrawal by Subject|2
7599507|NCT00585195|12005267|FG004|Overall Study|Withdrawal by Subject|0
7599508|NCT00585195|12005268|FG005|Overall Study|Withdrawal by Subject|0
7599509|NCT00585195|12005269|FG006|Overall Study|Withdrawal by Subject|0
7599510|NCT00585195|12005270|FG007|Overall Study|Withdrawal by Subject|1
7599511|NCT00585195|12005271|FG008|Overall Study|Withdrawal by Subject|0
7599512|NCT00585195|12005272|FG009|Overall Study|Withdrawal by Subject|0
7599513|NCT00585195|12005273|FG010|Overall Study|Withdrawal by Subject|3
7599514|NCT00585195|12005274|FG011|Overall Study|Withdrawal by Subject|8
7599515|NCT00585195|12005275|FG012|Overall Study|Withdrawal by Subject|15
7599516|NCT00585195|12005276|FG013|Overall Study|Withdrawal by Subject|0
7599517|NCT00585195|12005277|FG014|Overall Study|Withdrawal by Subject|3
7599518|NCT00585195|12005278|FG015|Overall Study|Withdrawal by Subject|0
7599519|NCT00585195|12005279|FG016|Overall Study|Withdrawal by Subject|7
7599520|NCT00585195|12005280|FG017|Overall Study|Withdrawal by Subject|1
7599521|NCT00585195|12005281|FG018|Overall Study|Withdrawal by Subject|2
7599522|NCT00585195|12005282|FG019|Overall Study|Withdrawal by Subject|2
7599523|NCT00585195|12005283|FG020|Overall Study|Withdrawal by Subject|0
7599524|NCT00585195|12005263|FG000|Overall Study|Other|0
7599525|NCT00585195|12005264|FG001|Overall Study|Other|1
7599526|NCT00585195|12005265|FG002|Overall Study|Other|1
7599527|NCT00585195|12005266|FG003|Overall Study|Other|1
7599528|NCT00585195|12005267|FG004|Overall Study|Other|0
7599529|NCT00585195|12005268|FG005|Overall Study|Other|1
7599530|NCT00585195|12005269|FG006|Overall Study|Other|0
7599531|NCT00585195|12005270|FG007|Overall Study|Other|0
7599532|NCT00585195|12005271|FG008|Overall Study|Other|2
7599533|NCT00585195|12005272|FG009|Overall Study|Other|1
7599534|NCT00585195|12005273|FG010|Overall Study|Other|0
7599535|NCT00585195|12005274|FG011|Overall Study|Other|19
7599536|NCT00585195|12005275|FG012|Overall Study|Other|23
7599537|NCT00585195|12005276|FG013|Overall Study|Other|7
7599538|NCT00585195|12005277|FG014|Overall Study|Other|11
7599539|NCT00585195|12005278|FG015|Overall Study|Other|3
7599540|NCT00585195|12005279|FG016|Overall Study|Other|28
7599541|NCT00585195|12005280|FG017|Overall Study|Other|12
7599542|NCT00585195|12005281|FG018|Overall Study|Other|10
7599543|NCT00585195|12005282|FG019|Overall Study|Other|4
7599544|NCT00585195|12005283|FG020|Overall Study|Other|2
7599545|NCT00585195|12005263|FG000|Overall Study|Randomized not treated|0
7599546|NCT00585195|12005264|FG001|Overall Study|Randomized not treated|0
7599547|NCT00585195|12005265|FG002|Overall Study|Randomized not treated|1
7599548|NCT00585195|12005266|FG003|Overall Study|Randomized not treated|0
7599549|NCT00585195|12005267|FG004|Overall Study|Randomized not treated|1
7599550|NCT00585195|12005268|FG005|Overall Study|Randomized not treated|0
7599551|NCT00585195|12005269|FG006|Overall Study|Randomized not treated|1
7599552|NCT00585195|12005270|FG007|Overall Study|Randomized not treated|0
7599553|NCT00585195|12005271|FG008|Overall Study|Randomized not treated|0
7599554|NCT00585195|12005272|FG009|Overall Study|Randomized not treated|0
7599555|NCT00585195|12005273|FG010|Overall Study|Randomized not treated|2
7599556|NCT00585195|12005274|FG011|Overall Study|Randomized not treated|0
7599557|NCT00585195|12005275|FG012|Overall Study|Randomized not treated|0
7599558|NCT00585195|12005276|FG013|Overall Study|Randomized not treated|0
7599559|NCT00585195|12005277|FG014|Overall Study|Randomized not treated|0
7599560|NCT00585195|12005278|FG015|Overall Study|Randomized not treated|1
7599561|NCT00585195|12005279|FG016|Overall Study|Randomized not treated|0
7599562|NCT00585195|12005280|FG017|Overall Study|Randomized not treated|1
7599563|NCT00585195|12005281|FG018|Overall Study|Randomized not treated|3
7599564|NCT00585195|12005282|FG019|Overall Study|Randomized not treated|0
7599565|NCT00585195|12005283|FG020|Overall Study|Randomized not treated|2
7599566|NCT00585195|12005263|FG000|Overall Study|Death|0
7599567|NCT00585195|12005264|FG001|Overall Study|Death|0
7599568|NCT00585195|12005265|FG002|Overall Study|Death|0
7599569|NCT00585195|12005266|FG003|Overall Study|Death|0
7599570|NCT00585195|12005267|FG004|Overall Study|Death|0
7599571|NCT00585195|12005268|FG005|Overall Study|Death|0
7599572|NCT00585195|12005269|FG006|Overall Study|Death|0
7599573|NCT00585195|12005270|FG007|Overall Study|Death|0
7599574|NCT00585195|12005271|FG008|Overall Study|Death|1
7599575|NCT00585195|12005272|FG009|Overall Study|Death|0
7599576|NCT00585195|12005273|FG010|Overall Study|Death|1
7599577|NCT00585195|12005274|FG011|Overall Study|Death|1
7599578|NCT00585195|12005275|FG012|Overall Study|Death|7
7599579|NCT00585195|12005276|FG013|Overall Study|Death|2
7599580|NCT00585195|12005277|FG014|Overall Study|Death|8
7599581|NCT00585195|12005278|FG015|Overall Study|Death|2
7599582|NCT00585195|12005279|FG016|Overall Study|Death|11
7599583|NCT00585195|12005280|FG017|Overall Study|Death|0
7599584|NCT00585195|12005281|FG018|Overall Study|Death|0
7599585|NCT00585195|12005282|FG019|Overall Study|Death|0
7599586|NCT00585195|12005283|FG020|Overall Study|Death|1
7599587|NCT00585195|12005263|FG000|Overall Study|Lost to Follow-up|0
7599588|NCT00585195|12005264|FG001|Overall Study|Lost to Follow-up|0
7599589|NCT00585195|12005265|FG002|Overall Study|Lost to Follow-up|0
7599590|NCT00585195|12005266|FG003|Overall Study|Lost to Follow-up|0
7599591|NCT00585195|12005267|FG004|Overall Study|Lost to Follow-up|0
7599592|NCT00585195|12005268|FG005|Overall Study|Lost to Follow-up|0
7599593|NCT00585195|12005269|FG006|Overall Study|Lost to Follow-up|0
7599594|NCT00585195|12005270|FG007|Overall Study|Lost to Follow-up|0
7599595|NCT00585195|12005271|FG008|Overall Study|Lost to Follow-up|0
7599596|NCT00585195|12005272|FG009|Overall Study|Lost to Follow-up|0
7599597|NCT00585195|12005273|FG010|Overall Study|Lost to Follow-up|0
7599598|NCT00585195|12005274|FG011|Overall Study|Lost to Follow-up|0
7599599|NCT00585195|12005275|FG012|Overall Study|Lost to Follow-up|1
7272281|NCT00424632|11486502|FG007|Overall Study|Objective progression or relapse|3
7272282|NCT00424632|11486503|FG008|Overall Study|Objective progression or relapse|12
7272283|NCT00424632|11486504|FG009|Overall Study|Objective progression or relapse|4
7272284|NCT00424632|11486495|FG000|Overall Study|Other|0
7272285|NCT00424632|11486496|FG001|Overall Study|Other|0
7272286|NCT00424632|11486497|FG002|Overall Study|Other|0
7272287|NCT00424632|11486498|FG003|Overall Study|Other|1
7272288|NCT00424632|11486499|FG004|Overall Study|Other|0
7272289|NCT00424632|11486500|FG005|Overall Study|Other|0
7272290|NCT00424632|11486501|FG006|Overall Study|Other|0
7272291|NCT00424632|11486502|FG007|Overall Study|Other|0
7272292|NCT00424632|11486503|FG008|Overall Study|Other|1
7272293|NCT00424632|11486504|FG009|Overall Study|Other|0
7272294|NCT00424749|11486535|FG000|Overall Study|Withdrawal by Subject|1
7272295|NCT00424762|11486541|FG000|Overall Study|Withdrawal by Subject|18
7272296|NCT00424762|11486542|FG001|Overall Study|Withdrawal by Subject|19
7272297|NCT00424762|11486541|FG000|Overall Study|Lost to Follow-up|2
7272298|NCT00424762|11486542|FG001|Overall Study|Lost to Follow-up|3
7272299|NCT00424775|11486548|FG000|Overall Study|Adverse Event|2
7272300|NCT00424775|11486549|FG001|Overall Study|Adverse Event|0
7272301|NCT00424775|11486548|FG000|Overall Study|Lack of Efficacy|1
7272302|NCT00424775|11486549|FG001|Overall Study|Lack of Efficacy|0
7272303|NCT00424827|11486553|FG000|Overall Study|Adverse Event|1
7272304|NCT00425061|11486573|FG000|Overall Study|Adverse Event|1
7272305|NCT00425061|11486574|FG001|Overall Study|Adverse Event|0
7272306|NCT00425061|11486575|FG002|Overall Study|Adverse Event|0
7272307|NCT00425061|11486576|FG003|Overall Study|Adverse Event|2
7272308|NCT00425061|11486577|FG004|Overall Study|Adverse Event|2
7272309|NCT00425061|11486578|FG005|Overall Study|Adverse Event|0
7272310|NCT00425061|11486579|FG006|Overall Study|Adverse Event|0
7272311|NCT00425061|11486573|FG000|Overall Study|Lost to Follow-up|0
7272312|NCT00425061|11486574|FG001|Overall Study|Lost to Follow-up|1
7272313|NCT00425061|11486575|FG002|Overall Study|Lost to Follow-up|0
7272314|NCT00425061|11486576|FG003|Overall Study|Lost to Follow-up|0
7272315|NCT00425061|11486577|FG004|Overall Study|Lost to Follow-up|0
7272316|NCT00425061|11486578|FG005|Overall Study|Lost to Follow-up|0
7272317|NCT00425061|11486579|FG006|Overall Study|Lost to Follow-up|0
7272318|NCT00425061|11486573|FG000|Overall Study|Protocol Violation|1
7272319|NCT00425061|11486574|FG001|Overall Study|Protocol Violation|0
7272320|NCT00425061|11486575|FG002|Overall Study|Protocol Violation|0
7272321|NCT00425061|11486576|FG003|Overall Study|Protocol Violation|0
7272322|NCT00425061|11486577|FG004|Overall Study|Protocol Violation|0
7272323|NCT00425061|11486578|FG005|Overall Study|Protocol Violation|0
7272324|NCT00425061|11486579|FG006|Overall Study|Protocol Violation|0
7272325|NCT00425061|11486573|FG000|Overall Study|Withdrawal by Subject|0
7272326|NCT00425061|11486574|FG001|Overall Study|Withdrawal by Subject|1
7272327|NCT00425061|11486575|FG002|Overall Study|Withdrawal by Subject|0
7272328|NCT00425061|11486576|FG003|Overall Study|Withdrawal by Subject|0
7272329|NCT00425061|11486577|FG004|Overall Study|Withdrawal by Subject|1
7272330|NCT00425061|11486578|FG005|Overall Study|Withdrawal by Subject|0
7272331|NCT00425061|11486579|FG006|Overall Study|Withdrawal by Subject|3
7272332|NCT00425061|11486573|FG000|Overall Study|Sponsor's request|0
7272333|NCT00425061|11486574|FG001|Overall Study|Sponsor's request|0
7272334|NCT00425061|11486575|FG002|Overall Study|Sponsor's request|0
7599600|NCT00585195|12005276|FG013|Overall Study|Lost to Follow-up|0
7599601|NCT00585195|12005277|FG014|Overall Study|Lost to Follow-up|0
7599602|NCT00585195|12005278|FG015|Overall Study|Lost to Follow-up|0
7599603|NCT00585195|12005279|FG016|Overall Study|Lost to Follow-up|0
7599604|NCT00585195|12005280|FG017|Overall Study|Lost to Follow-up|2
7599605|NCT00585195|12005281|FG018|Overall Study|Lost to Follow-up|0
7599606|NCT00585195|12005282|FG019|Overall Study|Lost to Follow-up|0
7599607|NCT00585195|12005283|FG020|Overall Study|Lost to Follow-up|0
7599608|NCT00585195|12005263|FG000|Overall Study|Ongoing|0
7599609|NCT00585195|12005264|FG001|Overall Study|Ongoing|0
7599610|NCT00585195|12005265|FG002|Overall Study|Ongoing|0
7599611|NCT00585195|12005266|FG003|Overall Study|Ongoing|0
7599612|NCT00585195|12005267|FG004|Overall Study|Ongoing|0
7599613|NCT00585195|12005268|FG005|Overall Study|Ongoing|0
7599614|NCT00585195|12005269|FG006|Overall Study|Ongoing|0
7599615|NCT00585195|12005270|FG007|Overall Study|Ongoing|0
7599616|NCT00585195|12005271|FG008|Overall Study|Ongoing|0
7599617|NCT00585195|12005272|FG009|Overall Study|Ongoing|0
7599618|NCT00585195|12005273|FG010|Overall Study|Ongoing|0
7599619|NCT00585195|12005274|FG011|Overall Study|Ongoing|0
7599620|NCT00585195|12005275|FG012|Overall Study|Ongoing|2
7272335|NCT00425061|11486576|FG003|Overall Study|Sponsor's request|0
7272336|NCT00425061|11486577|FG004|Overall Study|Sponsor's request|19
7272337|NCT00425061|11486578|FG005|Overall Study|Sponsor's request|4
7272338|NCT00425061|11486579|FG006|Overall Study|Sponsor's request|15
7272339|NCT00425061|11486573|FG000|Overall Study|Physician Decision|0
7272340|NCT00425061|11486574|FG001|Overall Study|Physician Decision|0
7272341|NCT00425061|11486575|FG002|Overall Study|Physician Decision|0
7272342|NCT00425061|11486576|FG003|Overall Study|Physician Decision|0
7272343|NCT00425061|11486577|FG004|Overall Study|Physician Decision|1
7272344|NCT00425061|11486578|FG005|Overall Study|Physician Decision|0
7272345|NCT00425061|11486579|FG006|Overall Study|Physician Decision|0
7272346|NCT00425061|11486573|FG000|Overall Study|Other|0
7272347|NCT00425061|11486574|FG001|Overall Study|Other|0
7272348|NCT00425061|11486575|FG002|Overall Study|Other|0
7272349|NCT00425061|11486576|FG003|Overall Study|Other|0
7272350|NCT00425061|11486577|FG004|Overall Study|Other|3
7272351|NCT00425061|11486578|FG005|Overall Study|Other|0
7272352|NCT00425061|11486579|FG006|Overall Study|Other|1
7272353|NCT00425113|11486599|FG000|Overall Study|uncontrolled diabetes mellitus|1
7272354|NCT00425113|11486600|FG001|Overall Study|uncontrolled diabetes mellitus|0
7272355|NCT00425113|11486599|FG000|Overall Study|diagnosis of abdominal TB|0
7272356|NCT00425113|11486600|FG001|Overall Study|diagnosis of abdominal TB|1
7272357|NCT00425113|11486599|FG000|Overall Study|missing study drug more than 14 days|0
7272358|NCT00425113|11486600|FG001|Overall Study|missing study drug more than 14 days|1
7272359|NCT00425113|11486599|FG000|Overall Study|Withdrawal by Subject|1
7272360|NCT00425113|11486600|FG001|Overall Study|Withdrawal by Subject|0
7272361|NCT00425269|11486609|FG000|Overall Study|Pregnancy|5
7272362|NCT00425269|11486610|FG001|Overall Study|Pregnancy|7
7272363|NCT00425269|11486609|FG000|Overall Study|Lost to Follow-up|9
7272364|NCT00425269|11486610|FG001|Overall Study|Lost to Follow-up|9
7272365|NCT00425269|11486609|FG000|Overall Study|moved or medical reason|5
7272366|NCT00425269|11486610|FG001|Overall Study|moved or medical reason|4
7272367|NCT00425308|11486618|FG000|Overall Study|Adverse Event|2
7272368|NCT00425308|11486619|FG001|Overall Study|Adverse Event|1
7272369|NCT00425308|11486618|FG000|Overall Study|Withdrawal by Subject|1
7272370|NCT00425308|11486619|FG001|Overall Study|Withdrawal by Subject|0
7272371|NCT00425308|11486618|FG000|Overall Study|Death|1
7272372|NCT00425308|11486619|FG001|Overall Study|Death|0
7272373|NCT00425373|11486634|FG000|Overall Study|Adverse Event|2
7272374|NCT00425373|11486635|FG001|Overall Study|Adverse Event|2
7272375|NCT00425373|11486636|FG002|Overall Study|Adverse Event|0
7272376|NCT00425373|11486637|FG003|Overall Study|Adverse Event|1
7272377|NCT00425373|11486638|FG004|Overall Study|Adverse Event|4
7272378|NCT00425373|11486639|FG005|Overall Study|Adverse Event|6
7272379|NCT00425373|11486640|FG006|Overall Study|Adverse Event|2
7272380|NCT00425373|11486641|FG007|Overall Study|Adverse Event|3
7272381|NCT00425373|11486642|FG008|Overall Study|Adverse Event|8
7272382|NCT00425373|11486634|FG000|Overall Study|Lost to Follow-up|0
7272383|NCT00425373|11486635|FG001|Overall Study|Lost to Follow-up|1
7272384|NCT00425373|11486636|FG002|Overall Study|Lost to Follow-up|0
7272385|NCT00425373|11486637|FG003|Overall Study|Lost to Follow-up|0
7272386|NCT00425373|11486638|FG004|Overall Study|Lost to Follow-up|1
7272387|NCT00425373|11486639|FG005|Overall Study|Lost to Follow-up|0
7272388|NCT00425373|11486640|FG006|Overall Study|Lost to Follow-up|0
7272389|NCT00425373|11486641|FG007|Overall Study|Lost to Follow-up|0
7272390|NCT00425373|11486642|FG008|Overall Study|Lost to Follow-up|0
7272391|NCT00425373|11486634|FG000|Overall Study|Protocol Violation|1
7272392|NCT00425373|11486635|FG001|Overall Study|Protocol Violation|0
7599621|NCT00585195|12005276|FG013|Overall Study|Ongoing|0
7272393|NCT00425373|11486636|FG002|Overall Study|Protocol Violation|1
7272394|NCT00425373|11486637|FG003|Overall Study|Protocol Violation|0
7272395|NCT00425373|11486638|FG004|Overall Study|Protocol Violation|0
7272396|NCT00425373|11486639|FG005|Overall Study|Protocol Violation|0
7272397|NCT00425373|11486640|FG006|Overall Study|Protocol Violation|0
7272398|NCT00425373|11486641|FG007|Overall Study|Protocol Violation|5
7599622|NCT00585195|12005277|FG014|Overall Study|Ongoing|0
7272399|NCT00425373|11486642|FG008|Overall Study|Protocol Violation|3
7272400|NCT00425373|11486634|FG000|Overall Study|Withdrawal by Subject|2
7272401|NCT00425373|11486635|FG001|Overall Study|Withdrawal by Subject|0
7272402|NCT00425373|11486636|FG002|Overall Study|Withdrawal by Subject|2
7599623|NCT00585195|12005278|FG015|Overall Study|Ongoing|0
7599624|NCT00585195|12005279|FG016|Overall Study|Ongoing|0
7599625|NCT00585195|12005280|FG017|Overall Study|Ongoing|0
7599626|NCT00585195|12005281|FG018|Overall Study|Ongoing|0
7599627|NCT00585195|12005282|FG019|Overall Study|Ongoing|0
7599628|NCT00585195|12005283|FG020|Overall Study|Ongoing|0
7599629|NCT00585195|12005263|FG000|Overall Study|Withdrawn Due to Pregnancy|0
7599630|NCT00585195|12005264|FG001|Overall Study|Withdrawn Due to Pregnancy|0
7599631|NCT00585195|12005265|FG002|Overall Study|Withdrawn Due to Pregnancy|0
7599632|NCT00585195|12005266|FG003|Overall Study|Withdrawn Due to Pregnancy|0
7599633|NCT00585195|12005267|FG004|Overall Study|Withdrawn Due to Pregnancy|0
7599634|NCT00585195|12005268|FG005|Overall Study|Withdrawn Due to Pregnancy|0
7599635|NCT00585195|12005269|FG006|Overall Study|Withdrawn Due to Pregnancy|0
7599636|NCT00585195|12005270|FG007|Overall Study|Withdrawn Due to Pregnancy|0
7599637|NCT00585195|12005271|FG008|Overall Study|Withdrawn Due to Pregnancy|0
7599638|NCT00585195|12005272|FG009|Overall Study|Withdrawn Due to Pregnancy|0
7599639|NCT00585195|12005273|FG010|Overall Study|Withdrawn Due to Pregnancy|0
7599640|NCT00585195|12005274|FG011|Overall Study|Withdrawn Due to Pregnancy|0
7599641|NCT00585195|12005275|FG012|Overall Study|Withdrawn Due to Pregnancy|0
7599642|NCT00585195|12005276|FG013|Overall Study|Withdrawn Due to Pregnancy|0
7599643|NCT00585195|12005277|FG014|Overall Study|Withdrawn Due to Pregnancy|1
7599644|NCT00585195|12005278|FG015|Overall Study|Withdrawn Due to Pregnancy|0
7599645|NCT00585195|12005279|FG016|Overall Study|Withdrawn Due to Pregnancy|0
7599646|NCT00585195|12005280|FG017|Overall Study|Withdrawn Due to Pregnancy|0
7599647|NCT00585195|12005281|FG018|Overall Study|Withdrawn Due to Pregnancy|0
7599648|NCT00585195|12005282|FG019|Overall Study|Withdrawn Due to Pregnancy|0
7599649|NCT00585195|12005283|FG020|Overall Study|Withdrawn Due to Pregnancy|0
7599650|NCT04446429|12005368|FG000|Overall Study|Lost to Follow-up|6
7599651|NCT04446429|12005369|FG001|Overall Study|Lost to Follow-up|0
7599652|NCT04194528|12005392|FG000|Overall Study|Adverse Event|1
7272403|NCT00425373|11486637|FG003|Overall Study|Withdrawal by Subject|1
7599653|NCT03116685|12005424|FG000|Overall Study|Physician Decision|0
7599654|NCT03116685|12005425|FG001|Overall Study|Physician Decision|1
7599655|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Adverse Event|1
7599656|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Adverse Event|1
7599657|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Adverse Event|0
7599658|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Adverse Event|0
7599659|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Adverse Event|1
7599660|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
7599661|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
7599662|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599663|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599664|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
7599665|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Reason not specified|0
7599666|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Reason not specified|0
7599667|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Reason not specified|0
7599668|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Reason not specified|1
7599669|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Reason not specified|0
7599670|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7599671|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
7599672|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
7599673|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7599674|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
7599675|NCT03099304|12005436|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
7599676|NCT03099304|12005437|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
7599677|NCT03099304|12005438|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
7599678|NCT03099304|12005439|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
7599679|NCT03099304|12005440|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
7599680|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
7599681|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
7599682|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
7599683|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
7272404|NCT00425373|11486638|FG004|Overall Study|Withdrawal by Subject|4
7272405|NCT00425373|11486639|FG005|Overall Study|Withdrawal by Subject|0
7272406|NCT00425373|11486640|FG006|Overall Study|Withdrawal by Subject|2
7272407|NCT00425373|11486641|FG007|Overall Study|Withdrawal by Subject|2
7272408|NCT00425373|11486642|FG008|Overall Study|Withdrawal by Subject|2
7272409|NCT00425373|11486634|FG000|Overall Study|Lack of Efficacy|0
7272410|NCT00425373|11486635|FG001|Overall Study|Lack of Efficacy|0
7272411|NCT00425373|11486636|FG002|Overall Study|Lack of Efficacy|0
7272412|NCT00425373|11486637|FG003|Overall Study|Lack of Efficacy|0
7272413|NCT00425373|11486638|FG004|Overall Study|Lack of Efficacy|1
7272414|NCT00425373|11486639|FG005|Overall Study|Lack of Efficacy|3
7272415|NCT00425373|11486640|FG006|Overall Study|Lack of Efficacy|3
7272416|NCT00425373|11486641|FG007|Overall Study|Lack of Efficacy|0
7272417|NCT00425373|11486642|FG008|Overall Study|Lack of Efficacy|5
7272418|NCT00425503|11486670|FG000|Overall Study|Adverse Event|2
7272419|NCT00425503|11486670|FG000|Overall Study|Protocol Violation|1
7272420|NCT00425555|11486676|FG000|Overall Study|Withdrawal by Subject|11
7272421|NCT00425555|11486677|FG001|Overall Study|Withdrawal by Subject|8
7272422|NCT00425555|11486676|FG000|Overall Study|Lost to Follow-up|0
7272423|NCT00425555|11486677|FG001|Overall Study|Lost to Follow-up|1
7272424|NCT00425555|11486676|FG000|Overall Study|Administrative problems|3
7272425|NCT00425555|11486677|FG001|Overall Study|Administrative problems|0
7272426|NCT00425555|11486676|FG000|Overall Study|Death|1
7272427|NCT00425555|11486677|FG001|Overall Study|Death|2
7272428|NCT00425555|11486676|FG000|Overall Study|New cancer therapy|2
7272429|NCT00425555|11486677|FG001|Overall Study|New cancer therapy|1
7272430|NCT00425555|11486676|FG000|Overall Study|Disease progression|36
7272431|NCT00425555|11486677|FG001|Overall Study|Disease progression|33
7272432|NCT00425555|11486676|FG000|Overall Study|Adverse Event|25
7272433|NCT00425555|11486677|FG001|Overall Study|Adverse Event|15
7272434|NCT00425555|11486676|FG000|Overall Study|Protocol Violation|1
7272435|NCT00425555|11486677|FG001|Overall Study|Protocol Violation|0
7272436|NCT00425607|11486686|FG000|Overall Study|Death|1
7272437|NCT00425607|11486686|FG000|Overall Study|Withdrawal by Subject|1
7272438|NCT00425698|11486696|FG000|Overall Study|Adverse Event|3
7272439|NCT00425698|11486697|FG001|Overall Study|Adverse Event|1
7272440|NCT00425698|11486696|FG000|Overall Study|Withdrawal by Subject|0
7272441|NCT00425698|11486697|FG001|Overall Study|Withdrawal by Subject|1
7272442|NCT00425750|11486703|FG000|Overall Study|Death|1
7272443|NCT00425750|11486703|FG000|Overall Study|Withdrawal by Subject|3
7272444|NCT00425750|11486703|FG000|Overall Study|Adverse Event|3
7599684|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
7599685|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
7599686|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599687|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599688|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
7599689|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
7599690|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Adverse Event|0
7599691|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Adverse Event|0
7599692|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Adverse Event|0
7599693|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Adverse Event|1
7599694|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Adverse Event|1
7599695|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599696|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599697|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
7599698|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
7599699|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
7599700|NCT03099304|12005436|FG000|DB Period Weeks 24 to 52|Reason not specified|0
7599701|NCT03099304|12005437|FG001|DB Period Weeks 24 to 52|Reason not specified|0
7599702|NCT03099304|12005438|FG002|DB Period Weeks 24 to 52|Reason not specified|0
7599703|NCT03099304|12005439|FG003|DB Period Weeks 24 to 52|Reason not specified|1
7599704|NCT03099304|12005440|FG004|DB Period Weeks 24 to 52|Reason not specified|0
7599705|NCT02682901|12005486|FG000|Overall Study|Adverse Event|10
7599706|NCT02682901|12005487|FG001|Overall Study|Adverse Event|3
7599707|NCT02682901|12005486|FG000|Overall Study|Lack of Efficacy|0
7599708|NCT02682901|12005487|FG001|Overall Study|Lack of Efficacy|1
7599709|NCT02555657|12005495|FG000|Overall Study|Death|274
7599710|NCT02555657|12005496|FG001|Overall Study|Death|262
7599711|NCT02555657|12005495|FG000|Overall Study|Physician Decision|0
7599712|NCT02555657|12005496|FG001|Overall Study|Physician Decision|1
7599713|NCT02555657|12005495|FG000|Overall Study|Sponsor Decision|27
7599714|NCT02555657|12005496|FG001|Overall Study|Sponsor Decision|15
7599715|NCT02555657|12005495|FG000|Overall Study|Withdrawal by Subject|11
7599716|NCT02555657|12005496|FG001|Overall Study|Withdrawal by Subject|32
7599717|NCT02190721|12005506|FG000|Overall Study|Patient was out of the city|0
7599718|NCT02190721|12005507|FG001|Overall Study|Patient was out of the city|1
7599719|NCT02190721|12005508|FG002|Overall Study|Patient was out of the city|0
7599720|NCT00739401|12005541|FG000|Overall Study|patients were not due for the 2 year follow-up|34
7599721|NCT00739401|12005541|FG000|Overall Study|Death|3
7599722|NCT00739401|12005541|FG000|Overall Study|Withdrawal by Subject|4
7599723|NCT00651742|12005545|FG000|Overall Study|Objective Disease Progression|22
7599724|NCT00651742|12005545|FG000|Overall Study|Toxicity|3
7599725|NCT00651742|12005545|FG000|Overall Study|Investigator Judgment|1
7599726|NCT00651742|12005545|FG000|Overall Study|Withdrawal of Consent|1
7599727|NCT00651742|12005545|FG000|Overall Study|Enrolled but not treated|1
7599728|NCT04930263|12005564|FG000|Overall Study|Withdrawal by Subject|3
7599729|NCT04930263|12005565|FG001|Overall Study|Withdrawal by Subject|5
7599730|NCT04321252|12005580|FG000|Overall Study|Withdrawal by Subject|0
7599731|NCT04321252|12005581|FG001|Overall Study|Withdrawal by Subject|0
7599732|NCT04321252|12005582|FG002|Overall Study|Withdrawal by Subject|0
7599733|NCT04321252|12005583|FG003|Overall Study|Withdrawal by Subject|0
7599734|NCT04321252|12005584|FG004|Overall Study|Withdrawal by Subject|0
7599735|NCT04321252|12005585|FG005|Overall Study|Withdrawal by Subject|1
7599736|NCT04321252|12005586|FG006|Overall Study|Withdrawal by Subject|0
7599737|NCT04321252|12005587|FG007|Overall Study|Withdrawal by Subject|0
7599738|NCT04321252|12005588|FG008|Overall Study|Withdrawal by Subject|0
7599739|NCT04176445|12005618|FG000|Overall Study|Adverse Event|0
7599740|NCT04176445|12005619|FG001|Overall Study|Adverse Event|1
7599741|NCT04176445|12005618|FG000|Overall Study|change plans weaning after first intervention|0
7599742|NCT04176445|12005619|FG001|Overall Study|change plans weaning after first intervention|1
7599743|NCT04126213|12005631|FG000|Overall Study|Lost to Follow-up|9
7599744|NCT04126213|12005632|FG001|Overall Study|Lost to Follow-up|1
7599745|NCT04126213|12005633|FG002|Overall Study|Lost to Follow-up|5
7599746|NCT04126213|12005634|FG003|Overall Study|Lost to Follow-up|10
7599747|NCT04126213|12005635|FG004|Overall Study|Lost to Follow-up|4
7599748|NCT04126213|12005636|FG005|Overall Study|Lost to Follow-up|7
7599749|NCT04126213|12005631|FG000|Overall Study|Withdrawal by Subject|3
7599750|NCT04126213|12005632|FG001|Overall Study|Withdrawal by Subject|2
7599751|NCT04126213|12005633|FG002|Overall Study|Withdrawal by Subject|1
7599752|NCT04126213|12005634|FG003|Overall Study|Withdrawal by Subject|1
7599753|NCT04126213|12005635|FG004|Overall Study|Withdrawal by Subject|1
7599754|NCT04126213|12005636|FG005|Overall Study|Withdrawal by Subject|1
7599755|NCT04126213|12005631|FG000|Overall Study|Other|0
7599756|NCT04126213|12005632|FG001|Overall Study|Other|0
7599757|NCT04126213|12005633|FG002|Overall Study|Other|2
7599758|NCT04126213|12005634|FG003|Overall Study|Other|2
7599759|NCT04126213|12005635|FG004|Overall Study|Other|0
7599760|NCT04126213|12005636|FG005|Overall Study|Other|1
7599761|NCT04126213|12005631|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7599762|NCT04126213|12005632|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7599763|NCT04126213|12005633|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7599764|NCT04126213|12005634|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7599765|NCT04126213|12005635|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7599766|NCT04126213|12005636|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
7599767|NCT03672188|12005672|FG000|Overall Study|Withdrawal by Subject|0
7599768|NCT03672188|12005673|FG001|Overall Study|Withdrawal by Subject|0
7599769|NCT03672188|12005674|FG002|Overall Study|Withdrawal by Subject|0
7599770|NCT03672188|12005675|FG003|Overall Study|Withdrawal by Subject|3
7599771|NCT03672188|12005676|FG004|Overall Study|Withdrawal by Subject|0
7599772|NCT03672188|12005677|FG005|Overall Study|Withdrawal by Subject|0
7599773|NCT03672188|12005678|FG006|Overall Study|Withdrawal by Subject|0
7599774|NCT03672188|12005679|FG007|Overall Study|Withdrawal by Subject|0
7599775|NCT03672188|12005680|FG008|Overall Study|Withdrawal by Subject|0
7599776|NCT03672188|12005681|FG009|Overall Study|Withdrawal by Subject|0
7599777|NCT03672188|12005682|FG010|Overall Study|Withdrawal by Subject|0
7272445|NCT00425750|11486703|FG000|Overall Study|Progression of disease|18
7272446|NCT00425854|11486713|FG000|Overall Study|Progressive Disease|19
7599778|NCT03672188|12005683|FG011|Overall Study|Withdrawal by Subject|0
7599779|NCT03672188|12005684|FG012|Overall Study|Withdrawal by Subject|0
7599780|NCT03672188|12005685|FG013|Overall Study|Withdrawal by Subject|0
7599781|NCT03672188|12005686|FG014|Overall Study|Withdrawal by Subject|0
7599782|NCT03672188|12005672|FG000|Overall Study|Death|0
7599783|NCT03672188|12005673|FG001|Overall Study|Death|0
7599784|NCT03672188|12005674|FG002|Overall Study|Death|0
7599785|NCT03672188|12005675|FG003|Overall Study|Death|0
7599786|NCT03672188|12005676|FG004|Overall Study|Death|0
7272447|NCT00425854|11486714|FG001|Overall Study|Progressive Disease|12
7272448|NCT00425854|11486713|FG000|Overall Study|Dose reduction toxicity AE|8
7599787|NCT03672188|12005677|FG005|Overall Study|Death|0
7599788|NCT03672188|12005678|FG006|Overall Study|Death|0
7599789|NCT03672188|12005679|FG007|Overall Study|Death|0
7599790|NCT03672188|12005680|FG008|Overall Study|Death|0
7599791|NCT03672188|12005681|FG009|Overall Study|Death|0
7599792|NCT03672188|12005682|FG010|Overall Study|Death|0
7599793|NCT03672188|12005683|FG011|Overall Study|Death|0
7599794|NCT03672188|12005684|FG012|Overall Study|Death|1
7599795|NCT03672188|12005685|FG013|Overall Study|Death|0
7599796|NCT03672188|12005686|FG014|Overall Study|Death|0
7599797|NCT03672188|12005672|FG000|Overall Study|Lost to Follow-up|0
7599798|NCT03672188|12005673|FG001|Overall Study|Lost to Follow-up|0
7599799|NCT03672188|12005674|FG002|Overall Study|Lost to Follow-up|1
7599800|NCT03672188|12005675|FG003|Overall Study|Lost to Follow-up|0
7599801|NCT03672188|12005676|FG004|Overall Study|Lost to Follow-up|0
7599802|NCT03672188|12005677|FG005|Overall Study|Lost to Follow-up|0
7599803|NCT03672188|12005678|FG006|Overall Study|Lost to Follow-up|0
7599804|NCT03672188|12005679|FG007|Overall Study|Lost to Follow-up|0
7599805|NCT03672188|12005680|FG008|Overall Study|Lost to Follow-up|0
7599806|NCT03672188|12005681|FG009|Overall Study|Lost to Follow-up|0
7599807|NCT03672188|12005682|FG010|Overall Study|Lost to Follow-up|0
7599808|NCT03672188|12005683|FG011|Overall Study|Lost to Follow-up|0
7599809|NCT03672188|12005684|FG012|Overall Study|Lost to Follow-up|0
7599810|NCT03672188|12005685|FG013|Overall Study|Lost to Follow-up|0
7599811|NCT03672188|12005686|FG014|Overall Study|Lost to Follow-up|0
7599812|NCT03230916|12005767|FG000|Overall Study|Withdrawal by Subject|0
7599813|NCT03230916|12005768|FG001|Overall Study|Withdrawal by Subject|0
7599814|NCT03230916|12005769|FG002|Overall Study|Withdrawal by Subject|0
7599815|NCT03230916|12005770|FG003|Overall Study|Withdrawal by Subject|0
7599816|NCT03230916|12005771|FG004|Overall Study|Withdrawal by Subject|0
7599817|NCT03230916|12005772|FG005|Overall Study|Withdrawal by Subject|1
7599818|NCT03230916|12005773|FG006|Overall Study|Withdrawal by Subject|0
7599819|NCT03230916|12005774|FG007|Overall Study|Withdrawal by Subject|0
7599820|NCT03230916|12005775|FG008|Overall Study|Withdrawal by Subject|0
7599821|NCT03230916|12005776|FG009|Overall Study|Withdrawal by Subject|0
7599822|NCT03230916|12005777|FG010|Overall Study|Withdrawal by Subject|0
7599823|NCT03195894|12005820|FG000|Overall Study|"An example is Started other treatment."|4
7599824|NCT03195894|12005821|FG001|Overall Study|"An example is Started other treatment."|5
7599825|NCT03195894|12005820|FG000|Overall Study|Withdrawal by Subject|15
7599826|NCT03195894|12005821|FG001|Overall Study|Withdrawal by Subject|4
7599827|NCT03195894|12005820|FG000|Overall Study|Lost to Follow-up|14
7599828|NCT03195894|12005821|FG001|Overall Study|Lost to Follow-up|19
7599829|NCT03032705|12005832|FG000|Overall Study|Lost to Follow-up|16
7599830|NCT03032705|12005833|FG001|Overall Study|Lost to Follow-up|17
7599831|NCT03032705|12005832|FG000|Overall Study|did not quality|6
7599832|NCT03032705|12005833|FG001|Overall Study|did not quality|6
7272449|NCT00425854|11486714|FG001|Overall Study|Dose reduction toxicity AE|7
7599833|NCT02573259|12005846|FG000|Overall Study|Death|1
7599834|NCT02573259|12005847|FG001|Overall Study|Death|6
7599835|NCT02573259|12005848|FG002|Overall Study|Death|5
7599836|NCT02573259|12005849|FG003|Overall Study|Death|6
7599837|NCT02573259|12005850|FG004|Overall Study|Death|9
7599838|NCT02573259|12005851|FG005|Overall Study|Death|32
7599839|NCT02573259|12005852|FG006|Overall Study|Death|21
7599840|NCT02573259|12005846|FG000|Overall Study|Lost to Follow-up|0
7599841|NCT02573259|12005847|FG001|Overall Study|Lost to Follow-up|0
7599842|NCT02573259|12005848|FG002|Overall Study|Lost to Follow-up|0
7599843|NCT02573259|12005849|FG003|Overall Study|Lost to Follow-up|0
7599844|NCT02573259|12005850|FG004|Overall Study|Lost to Follow-up|0
7599845|NCT02573259|12005851|FG005|Overall Study|Lost to Follow-up|2
7599846|NCT02573259|12005852|FG006|Overall Study|Lost to Follow-up|1
7599847|NCT02573259|12005846|FG000|Overall Study|Participant refused further follow-up|0
7599848|NCT02573259|12005847|FG001|Overall Study|Participant refused further follow-up|2
7599849|NCT02573259|12005848|FG002|Overall Study|Participant refused further follow-up|1
7599850|NCT02573259|12005849|FG003|Overall Study|Participant refused further follow-up|0
7599851|NCT02573259|12005850|FG004|Overall Study|Participant refused further follow-up|3
7599852|NCT02573259|12005851|FG005|Overall Study|Participant refused further follow-up|20
7599853|NCT02573259|12005852|FG006|Overall Study|Participant refused further follow-up|7
7599854|NCT02573259|12005846|FG000|Overall Study|Other|0
7599855|NCT02573259|12005847|FG001|Overall Study|Other|0
7599856|NCT02573259|12005848|FG002|Overall Study|Other|0
7599857|NCT02573259|12005849|FG003|Overall Study|Other|0
7599858|NCT02573259|12005850|FG004|Overall Study|Other|1
7599859|NCT02573259|12005851|FG005|Overall Study|Other|4
7599860|NCT02573259|12005852|FG006|Overall Study|Other|5
7599861|NCT02318329|12005894|FG000|Overall Study|Progressive Disease|2
7599862|NCT02318329|12005895|FG001|Overall Study|Progressive Disease|3
7599863|NCT02318329|12005896|FG002|Overall Study|Progressive Disease|2
7599864|NCT02318329|12005897|FG003|Overall Study|Progressive Disease|3
7599865|NCT02318329|12005898|FG004|Overall Study|Progressive Disease|3
7599866|NCT02318329|12005899|FG005|Overall Study|Progressive Disease|3
7599867|NCT02318329|12005900|FG006|Overall Study|Progressive Disease|1
7599868|NCT02318329|12005901|FG007|Overall Study|Progressive Disease|1
7599869|NCT02318329|12005902|FG008|Overall Study|Progressive Disease|5
7599870|NCT02318329|12005903|FG009|Overall Study|Progressive Disease|39
7599871|NCT02318329|12005894|FG000|Overall Study|Death|0
7599872|NCT02318329|12005895|FG001|Overall Study|Death|0
7599873|NCT02318329|12005896|FG002|Overall Study|Death|0
7599874|NCT02318329|12005897|FG003|Overall Study|Death|0
7599875|NCT02318329|12005898|FG004|Overall Study|Death|0
7599876|NCT02318329|12005899|FG005|Overall Study|Death|0
7599877|NCT02318329|12005900|FG006|Overall Study|Death|0
7599878|NCT02318329|12005901|FG007|Overall Study|Death|0
7599879|NCT02318329|12005902|FG008|Overall Study|Death|0
7599880|NCT02318329|12005903|FG009|Overall Study|Death|5
7599881|NCT02318329|12005894|FG000|Overall Study|Lost to Follow-up|0
7599882|NCT02318329|12005895|FG001|Overall Study|Lost to Follow-up|0
7599883|NCT02318329|12005896|FG002|Overall Study|Lost to Follow-up|0
7599884|NCT02318329|12005897|FG003|Overall Study|Lost to Follow-up|0
7599885|NCT02318329|12005898|FG004|Overall Study|Lost to Follow-up|0
7599886|NCT02318329|12005899|FG005|Overall Study|Lost to Follow-up|0
7599887|NCT02318329|12005900|FG006|Overall Study|Lost to Follow-up|0
7599888|NCT02318329|12005901|FG007|Overall Study|Lost to Follow-up|0
7599889|NCT02318329|12005902|FG008|Overall Study|Lost to Follow-up|0
7599890|NCT02318329|12005903|FG009|Overall Study|Lost to Follow-up|1
7599891|NCT02318329|12005894|FG000|Overall Study|Withdrawal by Subject|0
7599892|NCT02318329|12005895|FG001|Overall Study|Withdrawal by Subject|0
7599893|NCT02318329|12005896|FG002|Overall Study|Withdrawal by Subject|0
7599894|NCT02318329|12005897|FG003|Overall Study|Withdrawal by Subject|0
7599895|NCT02318329|12005898|FG004|Overall Study|Withdrawal by Subject|0
7599896|NCT02318329|12005899|FG005|Overall Study|Withdrawal by Subject|0
7599897|NCT02318329|12005900|FG006|Overall Study|Withdrawal by Subject|0
7599898|NCT02318329|12005901|FG007|Overall Study|Withdrawal by Subject|0
7599899|NCT02318329|12005902|FG008|Overall Study|Withdrawal by Subject|0
7599900|NCT02318329|12005903|FG009|Overall Study|Withdrawal by Subject|6
7599901|NCT02318329|12005894|FG000|Overall Study|Other|1
7599902|NCT02318329|12005895|FG001|Overall Study|Other|1
7599903|NCT02318329|12005896|FG002|Overall Study|Other|1
7599904|NCT02318329|12005897|FG003|Overall Study|Other|0
7599905|NCT02318329|12005898|FG004|Overall Study|Other|0
7599906|NCT02318329|12005899|FG005|Overall Study|Other|0
7599907|NCT02318329|12005900|FG006|Overall Study|Other|0
7599908|NCT02318329|12005901|FG007|Overall Study|Other|0
7599909|NCT02318329|12005902|FG008|Overall Study|Other|1
7599910|NCT02318329|12005903|FG009|Overall Study|Other|1
7599911|NCT01602666|12005946|FG000|Induction Chemotherapy|Death|2
7599912|NCT01602666|12005947|FG001|Induction Chemotherapy|Death|1
7599913|NCT01602666|12005946|FG000|Induction Chemotherapy|Lack of Efficacy|16
7599914|NCT01602666|12005947|FG001|Induction Chemotherapy|Lack of Efficacy|7
7599915|NCT01602666|12005946|FG000|Induction Chemotherapy|Physician Decision|12
7599916|NCT01602666|12005947|FG001|Induction Chemotherapy|Physician Decision|5
7599917|NCT01602666|12005946|FG000|Induction Chemotherapy|Withdrawal by Subject|0
7599918|NCT01602666|12005947|FG001|Induction Chemotherapy|Withdrawal by Subject|2
7599919|NCT01602666|12005946|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
7599920|NCT01602666|12005947|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
7599921|NCT01602666|12005946|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
7599922|NCT01602666|12005947|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
7599923|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
7599924|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
7599925|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
7599926|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
7599927|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
7599928|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
7599929|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
7599930|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
7599931|NCT01602666|12005946|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
7599932|NCT01602666|12005947|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
7599933|NCT01375959|12005957|FG000|First Intervention (6 Weeks)|Adverse Event|2
7599934|NCT01375959|12005958|FG001|First Intervention (6 Weeks)|Adverse Event|3
7599935|NCT01375959|12005957|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
7599936|NCT01375959|12005958|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
7599937|NCT01375959|12005957|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7599938|NCT01375959|12005958|FG001|Second Intervention (6 Weeks)|Adverse Event|2
7599939|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Death|3
7599940|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Death|0
7599941|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Death|0
7599942|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Death|0
7599943|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Death|0
7599944|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Physician Decision|6
7599945|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Physician Decision|5
7599946|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Physician Decision|4
7599947|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Physician Decision|0
7599948|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Physician Decision|0
7599949|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Adverse Event|0
7599950|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Adverse Event|5
7599951|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Adverse Event|3
7599952|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Adverse Event|0
7599953|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Adverse Event|0
7599954|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Other|0
7599955|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Other|0
7599956|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Other|1
7599957|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Other|0
7599958|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Other|0
7599959|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
7599960|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7599961|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
7599962|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7599963|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
7599964|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
7599965|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
7599966|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
7599967|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7599968|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
7599969|NCT01224106|12005969|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
7599970|NCT01224106|12005970|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
7599971|NCT01224106|12005971|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7599972|NCT01224106|12005972|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7599973|NCT01224106|12005973|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
7599974|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Death|0
7599975|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Death|0
7599976|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Death|0
7599977|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Death|1
7599978|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Death|3
7599979|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
7599980|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7599981|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
7599982|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
7599983|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
7599984|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
7599985|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
7599986|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
7599987|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
7599988|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
7599989|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7272450|NCT00425854|11486713|FG000|Overall Study|Other Adverse Event|2
7272451|NCT00425854|11486714|FG001|Overall Study|Other Adverse Event|2
7272452|NCT00425945|11486723|FG000|Overall Study|Concern about Supplement|2
7272453|NCT00425945|11486724|FG001|Overall Study|Concern about Supplement|0
7272454|NCT00425945|11486723|FG000|Overall Study|Inconvenience|0
7272455|NCT00425945|11486724|FG001|Overall Study|Inconvenience|2
7272456|NCT00425945|11486723|FG000|Overall Study|Lost to Follow-up|0
7272457|NCT00425945|11486724|FG001|Overall Study|Lost to Follow-up|2
7272458|NCT00425945|11486723|FG000|Overall Study|Began hypertension medication|1
7272459|NCT00425945|11486724|FG001|Overall Study|Began hypertension medication|0
7272460|NCT00425945|11486723|FG000|Overall Study|Began cancer treatments|1
7272461|NCT00425945|11486724|FG001|Overall Study|Began cancer treatments|0
7272462|NCT00425945|11486723|FG000|Overall Study|Moved from area|0
7272463|NCT00425945|11486724|FG001|Overall Study|Moved from area|1
7272464|NCT00426127|11486732|FG000|Overall Study|Adverse Event|1
7272465|NCT00426127|11486732|FG000|Overall Study|Removed due to disease progression|1
7272466|NCT00426231|11486747|FG000|Overall Study|Withdrawal by Subject|9
7272467|NCT00426231|11486748|FG001|Overall Study|Withdrawal by Subject|12
7272468|NCT00426270|11486754|FG000|Overall Study|Incorrectly Enrolled in the Study|1
7272469|NCT00426270|11486754|FG000|Overall Study|Adverse Event|5
7272470|NCT00426361|11486774|FG000|Overall Study|Lost to Follow-up|3
7272471|NCT00426361|11486775|FG001|Overall Study|Lost to Follow-up|2
7272472|NCT00426361|11486776|FG002|Overall Study|Lost to Follow-up|5
7272473|NCT00426361|11486774|FG000|Overall Study|Withdrawal by Subject|1
7272474|NCT00426361|11486775|FG001|Overall Study|Withdrawal by Subject|3
7272475|NCT00426361|11486776|FG002|Overall Study|Withdrawal by Subject|0
7272476|NCT00426556|11486805|FG000|Phase I - Core Phase|Disease Progression|0
7272477|NCT00426556|11486806|FG001|Phase I - Core Phase|Disease Progression|6
7272478|NCT00426556|11486807|FG002|Phase I - Core Phase|Disease Progression|2
7272479|NCT00426556|11486808|FG003|Phase I - Core Phase|Disease Progression|0
7272480|NCT00426556|11486805|FG000|Phase I - Core Phase|Adverse Event|1
7272481|NCT00426556|11486806|FG001|Phase I - Core Phase|Adverse Event|3
7272482|NCT00426556|11486807|FG002|Phase I - Core Phase|Adverse Event|1
7272483|NCT00426556|11486808|FG003|Phase I - Core Phase|Adverse Event|0
7272484|NCT00426556|11486805|FG000|Phase I - Core Phase|Death|0
7272485|NCT00426556|11486806|FG001|Phase I - Core Phase|Death|1
7272486|NCT00426556|11486807|FG002|Phase I - Core Phase|Death|0
7272487|NCT00426556|11486808|FG003|Phase I - Core Phase|Death|0
7272488|NCT00426556|11486805|FG000|Phase I - Extension Phase|Adverse Event|0
7272489|NCT00426556|11486806|FG001|Phase I - Extension Phase|Adverse Event|1
7272490|NCT00426556|11486807|FG002|Phase I - Extension Phase|Adverse Event|1
7272491|NCT00426556|11486808|FG003|Phase I - Extension Phase|Adverse Event|0
7272492|NCT00426556|11486805|FG000|Phase I - Extension Phase|Disease Progression|5
7272493|NCT00426556|11486806|FG001|Phase I - Extension Phase|Disease Progression|5
7272494|NCT00426556|11486807|FG002|Phase I - Extension Phase|Disease Progression|6
7272495|NCT00426556|11486808|FG003|Phase I - Extension Phase|Disease Progression|0
7272496|NCT00426556|11486805|FG000|Phase II - Core Phase|Withdrawal by Subject|0
7272497|NCT00426556|11486806|FG001|Phase II - Core Phase|Withdrawal by Subject|0
7272498|NCT00426556|11486807|FG002|Phase II - Core Phase|Withdrawal by Subject|0
7272499|NCT00426556|11486808|FG003|Phase II - Core Phase|Withdrawal by Subject|3
7272500|NCT00426556|11486805|FG000|Phase II - Core Phase|Disease Progression|0
7272501|NCT00426556|11486806|FG001|Phase II - Core Phase|Disease Progression|0
7272502|NCT00426556|11486807|FG002|Phase II - Core Phase|Disease Progression|0
7599990|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7599991|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
7599992|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
7599993|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
7599994|NCT01224106|12005969|FG000|Open-Label Extension (OLE) Phase|Other|0
7599995|NCT01224106|12005970|FG001|Open-Label Extension (OLE) Phase|Other|0
7599996|NCT01224106|12005971|FG002|Open-Label Extension (OLE) Phase|Other|0
7599997|NCT01224106|12005972|FG003|Open-Label Extension (OLE) Phase|Other|5
7599998|NCT01224106|12005973|FG004|Open-Label Extension (OLE) Phase|Other|3
7599999|NCT00354835|12006002|FG000|Overall Study|Death|1
7600000|NCT00354835|12006003|FG001|Overall Study|Death|1
7600001|NCT00354835|12006002|FG000|Overall Study|Physician Decision|8
7600002|NCT00354835|12006003|FG001|Overall Study|Physician Decision|13
7600003|NCT00354835|12006002|FG000|Overall Study|Withdrawal by Subject|2
7600004|NCT00354835|12006003|FG001|Overall Study|Withdrawal by Subject|1
7600005|NCT00354835|12006002|FG000|Overall Study|Ineligible|17
7600006|NCT00354835|12006003|FG001|Overall Study|Ineligible|16
7600007|NCT00354835|12006002|FG000|Overall Study|Disease progression or relapse|15
7600008|NCT00354835|12006003|FG001|Overall Study|Disease progression or relapse|22
7600009|NCT00354835|12006002|FG000|Overall Study|Adverse Event|6
7600010|NCT00354835|12006003|FG001|Overall Study|Adverse Event|0
7600011|NCT00354835|12006002|FG000|Overall Study|Refusal of further therapy|3
7600012|NCT00354835|12006003|FG001|Overall Study|Refusal of further therapy|8
7600013|NCT04531241|12006024|FG000|Period 1|Withdrawal by Subject|2
7600014|NCT04531241|12006025|FG001|Period 1|Withdrawal by Subject|0
7600015|NCT04531241|12006024|FG000|Period 1|Dispesed incorrect lens power|1
7600016|NCT04531241|12006025|FG001|Period 1|Dispesed incorrect lens power|0
7600017|NCT04531241|12006024|FG000|Period 1|Protocol Violation|1
7600018|NCT04531241|12006025|FG001|Period 1|Protocol Violation|0
7600019|NCT04531241|12006024|FG000|Period 1|No longer eligible|0
7600020|NCT04531241|12006025|FG001|Period 1|No longer eligible|1
7600021|NCT04531241|12006024|FG000|Period 1|Lens Discomfort|0
7600022|NCT04531241|12006025|FG001|Period 1|Lens Discomfort|1
7600023|NCT04531241|12006024|FG000|Period 2|Covid-19 Related|1
7600024|NCT04531241|12006025|FG001|Period 2|Covid-19 Related|1
7600025|NCT04185220|12006070|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
7600026|NCT04185220|12006071|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
7600027|NCT04185220|12006070|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
7600028|NCT04185220|12006071|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
7600029|NCT03600714|12006088|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
7600030|NCT03470441|12006109|FG000|Overall Study|Death|0
7600031|NCT03470441|12006110|FG001|Overall Study|Death|1
7600032|NCT03470441|12006111|FG002|Overall Study|Death|1
7600033|NCT03470441|12006112|FG003|Overall Study|Death|0
7600034|NCT03470441|12006109|FG000|Overall Study|Adverse Event|0
7600035|NCT03470441|12006110|FG001|Overall Study|Adverse Event|0
7600036|NCT03470441|12006111|FG002|Overall Study|Adverse Event|0
7600037|NCT03470441|12006112|FG003|Overall Study|Adverse Event|1
7600038|NCT03470441|12006109|FG000|Overall Study|Withdrawal by Subject|1
7600039|NCT03470441|12006110|FG001|Overall Study|Withdrawal by Subject|4
7600040|NCT03470441|12006111|FG002|Overall Study|Withdrawal by Subject|1
7600041|NCT03470441|12006112|FG003|Overall Study|Withdrawal by Subject|3
7600042|NCT03452397|12006126|FG000|Overall Study|Adverse Event|1
7272503|NCT00426556|11486808|FG003|Phase II - Core Phase|Disease Progression|16
7272504|NCT00426556|11486805|FG000|Phase II - Core Phase|Adverse Event|0
7272505|NCT00426556|11486806|FG001|Phase II - Core Phase|Adverse Event|0
7272506|NCT00426556|11486807|FG002|Phase II - Core Phase|Adverse Event|0
7272507|NCT00426556|11486808|FG003|Phase II - Core Phase|Adverse Event|8
7272508|NCT00426556|11486805|FG000|Phase II - Extension Phase|Disease Progression|0
7272509|NCT00426556|11486806|FG001|Phase II - Extension Phase|Disease Progression|0
7272510|NCT00426556|11486807|FG002|Phase II - Extension Phase|Disease Progression|0
7272511|NCT00426556|11486808|FG003|Phase II - Extension Phase|Disease Progression|21
7272512|NCT00426556|11486805|FG000|Phase II - Extension Phase|Adverse Event|0
7272513|NCT00426556|11486806|FG001|Phase II - Extension Phase|Adverse Event|0
7272514|NCT00426556|11486807|FG002|Phase II - Extension Phase|Adverse Event|0
7272515|NCT00426556|11486808|FG003|Phase II - Extension Phase|Adverse Event|2
7600043|NCT03452397|12006127|FG001|Overall Study|Adverse Event|0
7600044|NCT03452397|12006128|FG002|Overall Study|Adverse Event|0
7600045|NCT03452397|12006129|FG003|Overall Study|Adverse Event|0
7600046|NCT03452397|12006126|FG000|Overall Study|Administrative reason|0
7600047|NCT03452397|12006127|FG001|Overall Study|Administrative reason|0
7600048|NCT03452397|12006128|FG002|Overall Study|Administrative reason|1
7600049|NCT03452397|12006129|FG003|Overall Study|Administrative reason|1
7600050|NCT03452397|12006126|FG000|Overall Study|Withdrawal by Subject|0
7600051|NCT03452397|12006127|FG001|Overall Study|Withdrawal by Subject|0
7600052|NCT03452397|12006128|FG002|Overall Study|Withdrawal by Subject|1
7600053|NCT03452397|12006129|FG003|Overall Study|Withdrawal by Subject|0
7600054|NCT03448939|12006143|FG000|Overall Study|Adverse Event|5
7600055|NCT03448939|12006144|FG001|Overall Study|Adverse Event|1
7600056|NCT03448939|12006143|FG000|Overall Study|Lost to Follow-up|6
7600057|NCT03448939|12006144|FG001|Overall Study|Lost to Follow-up|6
7600058|NCT03448939|12006143|FG000|Overall Study|Pregnancy|1
7600059|NCT03448939|12006144|FG001|Overall Study|Pregnancy|1
7600060|NCT03448939|12006143|FG000|Overall Study|Withdrawal by Subject|9
7600061|NCT03448939|12006144|FG001|Overall Study|Withdrawal by Subject|3
7600062|NCT03283371|12006161|FG000|Placebo-controlled|Adverse Event|1
7600063|NCT03283371|12006162|FG001|Placebo-controlled|Adverse Event|1
7600064|NCT03283371|12006163|FG002|Placebo-controlled|Adverse Event|0
7600065|NCT03283371|12006164|FG003|Placebo-controlled|Adverse Event|0
7600066|NCT03283371|12006161|FG000|Placebo-controlled|Lack of Efficacy|1
7600067|NCT03283371|12006162|FG001|Placebo-controlled|Lack of Efficacy|0
7600068|NCT03283371|12006163|FG002|Placebo-controlled|Lack of Efficacy|0
7600069|NCT03283371|12006164|FG003|Placebo-controlled|Lack of Efficacy|0
7600070|NCT03283371|12006161|FG000|Placebo-controlled|Withdrawal by Subject|1
7600071|NCT03283371|12006162|FG001|Placebo-controlled|Withdrawal by Subject|1
7600072|NCT03283371|12006163|FG002|Placebo-controlled|Withdrawal by Subject|0
7600073|NCT03283371|12006164|FG003|Placebo-controlled|Withdrawal by Subject|0
7600074|NCT03283371|12006161|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
7600075|NCT03283371|12006162|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
7600076|NCT03283371|12006163|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
7600077|NCT03283371|12006164|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
7272516|NCT00426660|11486818|FG000|Overall Study|Death|14
7600078|NCT03283371|12006161|FG000|Open-label Phase|Adverse Event|0
7600079|NCT03283371|12006162|FG001|Open-label Phase|Adverse Event|0
7600080|NCT03283371|12006163|FG002|Open-label Phase|Adverse Event|2
7600081|NCT03283371|12006164|FG003|Open-label Phase|Adverse Event|0
7600082|NCT03283371|12006161|FG000|Open-label Phase|Withdrawal by Subject|0
7600083|NCT03283371|12006162|FG001|Open-label Phase|Withdrawal by Subject|0
7600084|NCT03283371|12006163|FG002|Open-label Phase|Withdrawal by Subject|1
7600085|NCT03283371|12006164|FG003|Open-label Phase|Withdrawal by Subject|0
7600086|NCT03283371|12006161|FG000|Open-label Phase|Other|0
7600087|NCT03283371|12006162|FG001|Open-label Phase|Other|0
7272517|NCT00426660|11486818|FG000|Overall Study|Adverse Event|23
7272518|NCT00426660|11486818|FG000|Overall Study|Insufficient Clinical Response|22
7272519|NCT00426660|11486818|FG000|Overall Study|Lost to Follow-up|15
7272520|NCT00426660|11486818|FG000|Overall Study|Other|23
7272521|NCT00426660|11486818|FG000|Overall Study|Withdrawal by Subject|18
7272522|NCT00426660|11486818|FG000|Overall Study|Protocol Violation|1
7272523|NCT00426660|11486818|FG000|Overall Study|Enrolled Not Treated|15
7272524|NCT00426751|11486824|FG000|Overall Study|Adverse Event|8
7272525|NCT00426751|11486825|FG001|Overall Study|Adverse Event|1
7272526|NCT00426751|11486824|FG000|Overall Study|Lost to Follow-up|7
7272527|NCT00426751|11486825|FG001|Overall Study|Lost to Follow-up|6
7272528|NCT00426751|11486824|FG000|Overall Study|Consent Withdrawn|0
7272529|NCT00426751|11486825|FG001|Overall Study|Consent Withdrawn|1
7272530|NCT00426751|11486824|FG000|Overall Study|Other Reasons|7
7272531|NCT00426751|11486825|FG001|Overall Study|Other Reasons|12
7272532|NCT00426764|11486831|FG000|Overall Study|Protocol Violation|1
7272533|NCT00426764|11486831|FG000|Overall Study|Withdrawal by Subject|4
7272534|NCT00426764|11486831|FG000|Overall Study|Physician Decision|6
7272535|NCT00426764|11486831|FG000|Overall Study|Compassionate Use|1
7272536|NCT00426764|11486831|FG000|Overall Study|Progressive Disease|83
7272537|NCT00426764|11486831|FG000|Overall Study|Adverse Event|24
7272538|NCT00426764|11486831|FG000|Overall Study|Other|1
7272539|NCT00426764|11486831|FG000|Overall Study|Death|1
7272540|NCT00426764|11486831|FG000|Overall Study|Other Reasons (Miscellaneous)|10
7272541|NCT00426842|11486841|FG000|Overall Study|Lost to Follow-up|1
7272542|NCT00427011|11486851|FG000|Overall Study|Adverse Event|10
7272543|NCT00427011|11486851|FG000|Overall Study|Withdrawal by Subject|1
7272544|NCT00427011|11486851|FG000|Overall Study|Lack of Efficacy|2
7272545|NCT00427011|11486851|FG000|Overall Study|Other|12
7272546|NCT00427349|11486880|FG000|Overall Study|Lack of Efficacy|23
7272547|NCT00427349|11486880|FG000|Overall Study|Adverse Event|14
7600088|NCT03283371|12006163|FG002|Open-label Phase|Other|1
7600089|NCT03283371|12006164|FG003|Open-label Phase|Other|1
7600090|NCT03257254|12006174|FG000|Overall Study|Withdrawal by Subject|7
7600091|NCT03257254|12006174|FG000|Overall Study|Lost to Follow-up|9
7600092|NCT03257254|12006174|FG000|Overall Study|Study discontinued by sponsor|5
7600093|NCT03084718|12006183|FG000|Overall Study|Withdrawal by Subject|4
7600094|NCT03084718|12006184|FG001|Overall Study|Withdrawal by Subject|3
7600095|NCT03084718|12006185|FG002|Overall Study|Withdrawal by Subject|4
7600096|NCT03084718|12006186|FG003|Overall Study|Withdrawal by Subject|0
7600097|NCT03084718|12006187|FG004|Overall Study|Withdrawal by Subject|0
7600098|NCT03084718|12006183|FG000|Overall Study|Physician Decision|1
7600099|NCT03084718|12006184|FG001|Overall Study|Physician Decision|0
7600100|NCT03084718|12006185|FG002|Overall Study|Physician Decision|0
7600101|NCT03084718|12006186|FG003|Overall Study|Physician Decision|0
7600102|NCT03084718|12006187|FG004|Overall Study|Physician Decision|0
7600103|NCT03084718|12006183|FG000|Overall Study|Adverse Event|3
7600104|NCT03084718|12006184|FG001|Overall Study|Adverse Event|5
7600105|NCT03084718|12006185|FG002|Overall Study|Adverse Event|5
7600106|NCT03084718|12006186|FG003|Overall Study|Adverse Event|8
7600107|NCT03084718|12006187|FG004|Overall Study|Adverse Event|2
7600108|NCT03084718|12006183|FG000|Overall Study|Lack of Efficacy|2
7600109|NCT03084718|12006184|FG001|Overall Study|Lack of Efficacy|0
7600110|NCT03084718|12006185|FG002|Overall Study|Lack of Efficacy|1
7600111|NCT03084718|12006186|FG003|Overall Study|Lack of Efficacy|4
7600112|NCT03084718|12006187|FG004|Overall Study|Lack of Efficacy|0
7600113|NCT03084718|12006183|FG000|Overall Study|Lost to Follow-up|0
7600114|NCT03084718|12006184|FG001|Overall Study|Lost to Follow-up|1
7600115|NCT03084718|12006185|FG002|Overall Study|Lost to Follow-up|0
7600116|NCT03084718|12006186|FG003|Overall Study|Lost to Follow-up|0
7600117|NCT03084718|12006187|FG004|Overall Study|Lost to Follow-up|2
7600118|NCT03084718|12006183|FG000|Overall Study|Protocol Violation|0
7600119|NCT03084718|12006184|FG001|Overall Study|Protocol Violation|0
7600120|NCT03084718|12006185|FG002|Overall Study|Protocol Violation|1
7600121|NCT03084718|12006186|FG003|Overall Study|Protocol Violation|0
7600122|NCT03084718|12006187|FG004|Overall Study|Protocol Violation|0
7600123|NCT03084718|12006183|FG000|Overall Study|Death|0
7600124|NCT03084718|12006184|FG001|Overall Study|Death|1
7600125|NCT03084718|12006185|FG002|Overall Study|Death|0
7600126|NCT03084718|12006186|FG003|Overall Study|Death|0
7600127|NCT03084718|12006187|FG004|Overall Study|Death|0
7600128|NCT03084718|12006183|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7600129|NCT03084718|12006184|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7600130|NCT03084718|12006185|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
7600131|NCT03084718|12006186|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
7600132|NCT03084718|12006187|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
7600133|NCT03069417|12006204|FG000|Overall Study|Lost to Follow-up|2
7600134|NCT03069417|12006205|FG001|Overall Study|Lost to Follow-up|0
7600135|NCT03069417|12006204|FG000|Overall Study|Reason Unknown|4
7600136|NCT03069417|12006205|FG001|Overall Study|Reason Unknown|7
7600137|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600138|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600139|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600140|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600141|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600142|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
7600143|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600144|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600145|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600146|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
7600147|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Death|2
7600148|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Death|1
7600149|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Death|3
7600150|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Death|1
7600151|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Death|2
7600152|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Death|3
7600153|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Death|3
7600154|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Death|0
7600155|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Death|0
7600156|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Death|0
7600157|NCT02936323|12006234|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600158|NCT02936323|12006235|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600159|NCT02936323|12006236|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600160|NCT02936323|12006237|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600161|NCT02936323|12006238|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600162|NCT02936323|12006239|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
7600163|NCT02936323|12006240|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600164|NCT02936323|12006241|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600165|NCT02936323|12006242|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600166|NCT02936323|12006243|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
7600167|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600168|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600169|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600170|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600171|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600172|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600173|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
7600174|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
7600175|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
7600176|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
7600177|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Physician Decision|0
7600178|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Physician Decision|0
7600179|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Physician Decision|0
7600180|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Physician Decision|0
7600181|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Physician Decision|0
7600182|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Physician Decision|0
7600183|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Physician Decision|0
7600184|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Physician Decision|0
7600185|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Physician Decision|0
7600186|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Physician Decision|1
7600187|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
7600188|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
7600189|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
7600190|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
7600191|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
7600192|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
7600193|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
7600194|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
7600195|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
7600196|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
7600197|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600198|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600199|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600200|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600201|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600202|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600203|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600204|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600205|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
7600206|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
7600207|NCT02936323|12006234|FG000|Phase 2a Dose Expansion|Death|0
7600208|NCT02936323|12006235|FG001|Phase 2a Dose Expansion|Death|0
7600209|NCT02936323|12006236|FG002|Phase 2a Dose Expansion|Death|0
7600210|NCT02936323|12006237|FG003|Phase 2a Dose Expansion|Death|0
7600211|NCT02936323|12006238|FG004|Phase 2a Dose Expansion|Death|0
7600212|NCT02936323|12006239|FG005|Phase 2a Dose Expansion|Death|0
7600213|NCT02936323|12006240|FG006|Phase 2a Dose Expansion|Death|0
7600214|NCT02936323|12006241|FG007|Phase 2a Dose Expansion|Death|4
7600215|NCT02936323|12006242|FG008|Phase 2a Dose Expansion|Death|8
7600216|NCT02936323|12006243|FG009|Phase 2a Dose Expansion|Death|10
7600231|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
7600232|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
7600233|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7600234|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
7600235|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7600236|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7600237|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600238|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
7600239|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
7600240|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
7600241|NCT02429791|12006295|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
7600242|NCT02429791|12006296|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7600243|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
7600244|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
7600245|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7600246|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
7600247|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
7600248|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7600249|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
7600250|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
7600251|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600252|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600253|NCT02429791|12006295|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
7600254|NCT02429791|12006296|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
7600255|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
7600256|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
7600257|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
7600258|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
7600259|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
7600260|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
7600261|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600262|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
7600263|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
7600264|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
7600265|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7600266|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
7600267|NCT02422797|12006311|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
7600268|NCT02422797|12006312|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
7600269|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
7600270|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
7600271|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
7600272|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
7600273|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
7600274|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
7600275|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7600276|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
7600277|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
7600278|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
7600279|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
7600280|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
7600281|NCT02422797|12006311|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
7600282|NCT02422797|12006312|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
7600283|NCT02132611|12006341|FG000|Overall Study|Death|2
7600284|NCT01147822|12006347|FG000|Overall Study|Death|66
7600285|NCT01147822|12006348|FG001|Overall Study|Death|59
7600286|NCT01147822|12006347|FG000|Overall Study|Protocol Violation|0
7600287|NCT01147822|12006348|FG001|Overall Study|Protocol Violation|1
7600288|NCT01147822|12006347|FG000|Overall Study|Lost to Follow-up|3
7600289|NCT01147822|12006348|FG001|Overall Study|Lost to Follow-up|2
7600290|NCT01147822|12006347|FG000|Overall Study|Physician Decision|0
7600291|NCT01147822|12006348|FG001|Overall Study|Physician Decision|2
7600292|NCT01147822|12006347|FG000|Overall Study|Withdrawal by Subject|8
7600293|NCT01147822|12006348|FG001|Overall Study|Withdrawal by Subject|13
7600294|NCT01147822|12006347|FG000|Overall Study|Not Completed/Ongoing|111
7600295|NCT01147822|12006348|FG001|Overall Study|Not Completed/Ongoing|102
7272548|NCT00427349|11486880|FG000|Overall Study|Death|1
7272549|NCT00427349|11486880|FG000|Overall Study|Withdrawal by Subject|3
7272550|NCT00427349|11486880|FG000|Overall Study|Alternative therapy|1
7272551|NCT00427349|11486880|FG000|Overall Study|Other|2
7272552|NCT00427349|11486880|FG000|Overall Study|Ineligible|1
7272553|NCT00427349|11486880|FG000|Overall Study|Never started therapy|1
7272554|NCT00427635|11486890|FG000|Treatment Phase|Withdrawal by Subject|1
7272555|NCT00427635|11486891|FG001|Treatment Phase|Withdrawal by Subject|0
7272556|NCT00427635|11486890|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
7272557|NCT00427635|11486891|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
7272558|NCT00427648|11486899|FG000|Overall Study|Protocol Violation|1
7272559|NCT00427648|11486900|FG001|Overall Study|Protocol Violation|2
7272560|NCT00427648|11486899|FG000|Overall Study|Adverse Event|0
7272561|NCT00427648|11486900|FG001|Overall Study|Adverse Event|1
7272562|NCT00427700|11486915|FG000|Overall Study|Lost to Follow-up|2
7272563|NCT00427700|11486916|FG001|Overall Study|Lost to Follow-up|5
7272564|NCT00427700|11486915|FG000|Overall Study|no induction of menses|1
7272565|NCT00427700|11486916|FG001|Overall Study|no induction of menses|4
7272566|NCT00427700|11486915|FG000|Overall Study|Pregnancy|0
7272567|NCT00427700|11486916|FG001|Overall Study|Pregnancy|2
7272568|NCT00427778|11486927|FG000|First Intervention (4 Weeks)|no longer interested|1
7272569|NCT00427778|11486928|FG001|First Intervention (4 Weeks)|no longer interested|0
7272570|NCT00427778|11486927|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
7272571|NCT00427778|11486928|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
7272572|NCT00427778|11486927|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
7272573|NCT00427778|11486928|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
7272574|NCT00427778|11486927|FG000|First Intervention (4 Weeks)|anxious about using ring|1
7272575|NCT00427778|11486928|FG001|First Intervention (4 Weeks)|anxious about using ring|0
7272576|NCT00427895|11486969|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272577|NCT00427895|11486970|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272578|NCT00427895|11486971|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272579|NCT00427895|11486972|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
7272580|NCT00427895|11486973|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272581|NCT00427895|11486974|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7600296|NCT04476251|12006369|FG000|Overall Study|Not treated|1
7600297|NCT03915860|12006377|FG000|Overall Study|Adverse Event|3
7600298|NCT03915860|12006377|FG000|Overall Study|Withdrawal by Subject|6
7600299|NCT03915860|12006377|FG000|Overall Study|Lost to Follow-up|2
7600300|NCT03915860|12006377|FG000|Overall Study|Other than specified|3
7600301|NCT03795233|12006396|FG000|Overall Study|Withdrawal by Subject|2
7600302|NCT03795233|12006397|FG001|Overall Study|Withdrawal by Subject|1
7600303|NCT03795233|12006396|FG000|Overall Study|Lost to Follow-up|1
7600304|NCT03795233|12006397|FG001|Overall Study|Lost to Follow-up|0
7600305|NCT03795233|12006396|FG000|Overall Study|Death|1
7600306|NCT03795233|12006397|FG001|Overall Study|Death|0
7600307|NCT03786380|12006408|FG000|Overall Study|Adverse Event|1
7600308|NCT03786380|12006409|FG001|Overall Study|Adverse Event|0
7600309|NCT03786380|12006410|FG002|Overall Study|Adverse Event|0
7600310|NCT03786380|12006411|FG003|Overall Study|Adverse Event|3
7600311|NCT03786380|12006412|FG004|Overall Study|Adverse Event|1
7600312|NCT03786380|12006408|FG000|Overall Study|Lack of Efficacy|0
7600313|NCT03786380|12006409|FG001|Overall Study|Lack of Efficacy|0
7600314|NCT03786380|12006410|FG002|Overall Study|Lack of Efficacy|0
7600315|NCT03786380|12006411|FG003|Overall Study|Lack of Efficacy|0
7600316|NCT03786380|12006412|FG004|Overall Study|Lack of Efficacy|1
7600317|NCT03786380|12006408|FG000|Overall Study|Withdrawal by Subject|1
7600318|NCT03786380|12006409|FG001|Overall Study|Withdrawal by Subject|2
7600319|NCT03786380|12006410|FG002|Overall Study|Withdrawal by Subject|2
7600320|NCT03786380|12006411|FG003|Overall Study|Withdrawal by Subject|1
7600321|NCT03786380|12006412|FG004|Overall Study|Withdrawal by Subject|2
7600322|NCT03786380|12006408|FG000|Overall Study|Lost to Follow-up|3
7600323|NCT03786380|12006409|FG001|Overall Study|Lost to Follow-up|0
7600324|NCT03786380|12006410|FG002|Overall Study|Lost to Follow-up|1
7600325|NCT03786380|12006411|FG003|Overall Study|Lost to Follow-up|2
7600326|NCT03786380|12006412|FG004|Overall Study|Lost to Follow-up|0
7600327|NCT03786380|12006408|FG000|Overall Study|Physician Decision|0
7600328|NCT03786380|12006409|FG001|Overall Study|Physician Decision|0
7600329|NCT03786380|12006410|FG002|Overall Study|Physician Decision|1
7600330|NCT03786380|12006411|FG003|Overall Study|Physician Decision|0
7600331|NCT03786380|12006412|FG004|Overall Study|Physician Decision|0
7600332|NCT03786380|12006408|FG000|Overall Study|Study Terminated by the Sponsor|30
7600333|NCT03786380|12006409|FG001|Overall Study|Study Terminated by the Sponsor|20
7600334|NCT03786380|12006410|FG002|Overall Study|Study Terminated by the Sponsor|50
7600335|NCT03786380|12006411|FG003|Overall Study|Study Terminated by the Sponsor|57
7600336|NCT03786380|12006412|FG004|Overall Study|Study Terminated by the Sponsor|23
7600337|NCT03786380|12006408|FG000|Overall Study|Reason Not Specified|0
7600338|NCT03786380|12006409|FG001|Overall Study|Reason Not Specified|0
7600339|NCT03786380|12006410|FG002|Overall Study|Reason Not Specified|0
7600340|NCT03786380|12006411|FG003|Overall Study|Reason Not Specified|0
7600341|NCT03786380|12006412|FG004|Overall Study|Reason Not Specified|1
7600342|NCT03645863|12006436|FG000|Overall Study|Withdrawal by Subject|1
7600343|NCT03645863|12006437|FG001|Overall Study|Withdrawal by Subject|0
7600344|NCT03645863|12006438|FG002|Overall Study|Withdrawal by Subject|0
7600345|NCT03564145|12006446|FG000|Overall Study|Adverse Event|4
7600346|NCT03564145|12006446|FG000|Overall Study|Lost to Follow-up|21
7600347|NCT03564145|12006446|FG000|Overall Study|Protocol Violation|2
7600348|NCT03564145|12006446|FG000|Overall Study|Withdrawal by Subject|48
7600349|NCT03564145|12006446|FG000|Overall Study|Study Terminated by Sponsor|146
7600350|NCT03564145|12006446|FG000|Overall Study|Physician Decision|1
7600351|NCT03564145|12006446|FG000|Overall Study|Other Than Specified|1
7600352|NCT03564145|12006446|FG000|Overall Study|Pregnancy|1
7600353|NCT03564119|12006452|FG000|Overall Study|Adverse Event|4
7600354|NCT03564119|12006453|FG001|Overall Study|Adverse Event|0
7600355|NCT03564119|12006452|FG000|Overall Study|Lost to Follow-up|1
7600356|NCT03564119|12006453|FG001|Overall Study|Lost to Follow-up|4
7600357|NCT03564119|12006452|FG000|Overall Study|Protocol Violation|1
7600358|NCT03564119|12006453|FG001|Overall Study|Protocol Violation|0
7600359|NCT03564119|12006452|FG000|Overall Study|Withdrawal by Subject|9
7600360|NCT03564119|12006453|FG001|Overall Study|Withdrawal by Subject|4
7600361|NCT03564119|12006452|FG000|Overall Study|Other Than Specified|0
7600362|NCT03564119|12006453|FG001|Overall Study|Other Than Specified|1
7600363|NCT03181529|12006508|FG000|Overall Study|Withdrawal by Subject|1
7600364|NCT03181529|12006509|FG001|Overall Study|Withdrawal by Subject|1
7600365|NCT03181529|12006508|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
7600366|NCT03181529|12006509|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
7600374|NCT02779556|12006521|FG000|Baseline|Partial baseline interview completed|1
7600375|NCT02779556|12006522|FG001|Baseline|Partial baseline interview completed|0
7600376|NCT02779556|12006521|FG000|3 Months|Lost to Follow-up|40
7600377|NCT02779556|12006522|FG001|3 Months|Lost to Follow-up|29
7600378|NCT02779556|12006521|FG000|3 Months|Missed 3 month clinic visit|27
7600379|NCT02779556|12006522|FG001|3 Months|Missed 3 month clinic visit|19
7600380|NCT02779556|12006521|FG000|6 Month|Lost to Follow-up|33
7600381|NCT02779556|12006522|FG001|6 Month|Lost to Follow-up|39
7600382|NCT02779556|12006521|FG000|6 Month HbA1c|No value collected during window|69
7600383|NCT02779556|12006522|FG001|6 Month HbA1c|No value collected during window|50
7272582|NCT00427895|11486975|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272583|NCT00427895|11486976|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
7272584|NCT00427895|11486969|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272585|NCT00427895|11486970|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272586|NCT00427895|11486971|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272587|NCT00427895|11486972|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272588|NCT00427895|11486973|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272589|NCT00427895|11486974|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
7272590|NCT00427895|11486975|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
7600384|NCT02779556|12006521|FG000|12 Month HbA1c|No value collected during window|138
7600385|NCT02779556|12006522|FG001|12 Month HbA1c|No value collected during window|102
7600386|NCT02675751|12006537|FG000|Overall Study|Lost to Follow-up|16
7600387|NCT02621424|12006552|FG000|Overall Study|Withdrawal by Subject|1
7600388|NCT02621424|12006553|FG001|Overall Study|Withdrawal by Subject|2
7272591|NCT00427895|11486976|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
7272592|NCT00427895|11486969|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
7272593|NCT00427895|11486970|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
7272594|NCT00427895|11486971|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
7272595|NCT00427895|11486972|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
7600389|NCT02595372|12006559|FG000|Overall Study|Adverse Event|6
7600390|NCT02595372|12006559|FG000|Overall Study|Physician Decision|2
7600391|NCT02595372|12006559|FG000|Overall Study|Disease Progression|1
7600392|NCT02334722|12006565|FG000|Overall Study|Lost to Follow-up|4
7600393|NCT02334722|12006566|FG001|Overall Study|Lost to Follow-up|0
7600394|NCT02334722|12006565|FG000|Overall Study|6 week questionnaire not completed|2
7600395|NCT02334722|12006566|FG001|Overall Study|6 week questionnaire not completed|0
7600396|NCT02334722|12006565|FG000|Overall Study|Unable to obtain medication|1
7600397|NCT02334722|12006566|FG001|Overall Study|Unable to obtain medication|1
7600398|NCT02334722|12006565|FG000|Overall Study|Withdrawal by Subject|0
7600399|NCT02334722|12006566|FG001|Overall Study|Withdrawal by Subject|3
7600400|NCT02334722|12006565|FG000|Overall Study|Adverse Event|0
7600401|NCT02334722|12006566|FG001|Overall Study|Adverse Event|2
7600402|NCT02334722|12006565|FG000|Overall Study|Physician Decision|0
7600403|NCT02334722|12006566|FG001|Overall Study|Physician Decision|1
7600404|NCT01966731|12006576|FG000|Overall Study|Death|2
7600405|NCT01966731|12006576|FG000|Overall Study|Lost to Follow-up|1
7600406|NCT01966731|12006576|FG000|Overall Study|Physician Decision|2
7600407|NCT01966731|12006576|FG000|Overall Study|Follow up is not complete|600
7600408|NCT01966731|12006576|FG000|Overall Study|Screening Failure|29
7600409|NCT01966731|12006576|FG000|Overall Study|Found to be ineligible|1
7600424|NCT01675479|12006610|FG000|Overall Study|Lost to Follow-up|11
7600425|NCT00812708|12006614|FG000|Overall Study|Device could not be implanted|2
7600426|NCT00812708|12006614|FG000|Overall Study|Lack of medical insurance|1
7600427|NCT00812708|12006614|FG000|Overall Study|Switched to another study|1
7600428|NCT00812708|12006614|FG000|Overall Study|Surgery cancelled due to uveitis|1
7600429|NCT00812708|12006614|FG000|Overall Study|Signed consent but later withdrew|3
7600430|NCT00741988|12006621|FG000|Overall Study|Adverse Event|2
7600431|NCT00741988|12006622|FG001|Overall Study|Adverse Event|4
7600432|NCT00741988|12006621|FG000|Overall Study|Lack of Efficacy|2
7600433|NCT00741988|12006622|FG001|Overall Study|Lack of Efficacy|0
7600434|NCT00515671|12006639|FG000|Overall Study|Lost to Follow-up|13
7600435|NCT00515671|12006640|FG001|Overall Study|Lost to Follow-up|10
7600436|NCT00515671|12006639|FG000|Overall Study|Withdrawal by Subject|3
7600437|NCT00515671|12006640|FG001|Overall Study|Withdrawal by Subject|5
7600438|NCT00515671|12006639|FG000|Overall Study|incarcerated|1
7600439|NCT00515671|12006640|FG001|Overall Study|incarcerated|2
7600440|NCT00455403|12006648|FG000|Overall Study|Lost to Follow-up|2
7272596|NCT00427895|11486973|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
7272597|NCT00427895|11486974|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
7272598|NCT00427895|11486975|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
7272599|NCT00427895|11486976|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
7272600|NCT00427895|11486969|FG000|Vax 2/Year 3 to 4|Failed to Return|0
7272601|NCT00427895|11486970|FG001|Vax 2/Year 3 to 4|Failed to Return|0
7272602|NCT00427895|11486971|FG002|Vax 2/Year 3 to 4|Failed to Return|0
7272603|NCT00427895|11486972|FG003|Vax 2/Year 3 to 4|Failed to Return|0
7272604|NCT00427895|11486973|FG004|Vax 2/Year 3 to 4|Failed to Return|1
7272605|NCT00427895|11486974|FG005|Vax 2/Year 3 to 4|Failed to Return|0
7272606|NCT00427895|11486975|FG006|Vax 2/Year 3 to 4|Failed to Return|0
7272607|NCT00427895|11486976|FG007|Vax 2/Year 3 to 4|Failed to Return|0
7272608|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7272609|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
7272610|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
7272611|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
7272612|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7272613|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7272614|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7272615|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
7272616|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
7272617|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7600441|NCT00455403|12006649|FG001|Overall Study|Lost to Follow-up|1
7600442|NCT00455403|12006648|FG000|Overall Study|Withdrawal by Subject|1
7600443|NCT00455403|12006649|FG001|Overall Study|Withdrawal by Subject|3
7600444|NCT00455403|12006648|FG000|Overall Study|Protocol Violation|0
7600445|NCT00455403|12006649|FG001|Overall Study|Protocol Violation|2
7600448|NCT04128319|12006673|FG000|Overall Study|Death|3
7600449|NCT03761810|12006679|FG000|Overall Study|Adverse Event|12
7600450|NCT03761810|12006680|FG001|Overall Study|Adverse Event|0
7600451|NCT03761810|12006679|FG000|Overall Study|Lost to Follow-up|15
7600452|NCT03761810|12006680|FG001|Overall Study|Lost to Follow-up|7
7600453|NCT03761810|12006679|FG000|Overall Study|Pregnancy|1
7600454|NCT03761810|12006680|FG001|Overall Study|Pregnancy|0
7600455|NCT03761810|12006679|FG000|Overall Study|Withdrawal by Subject|14
7600456|NCT03761810|12006680|FG001|Overall Study|Withdrawal by Subject|5
7600457|NCT03761810|12006679|FG000|Overall Study|Physician Decision|1
7600458|NCT03761810|12006680|FG001|Overall Study|Physician Decision|0
7600459|NCT03761810|12006679|FG000|Overall Study|Withdrawal by Parent/Guardian|4
7600460|NCT03761810|12006680|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7600461|NCT03761810|12006679|FG000|Overall Study|Other Than Specified|1
7600462|NCT03761810|12006680|FG001|Overall Study|Other Than Specified|0
7600463|NCT03761784|12006688|FG000|Overall Study|Adverse Event|4
7600464|NCT03761784|12006689|FG001|Overall Study|Adverse Event|0
7600465|NCT03761784|12006688|FG000|Overall Study|Lost to Follow-up|10
7600466|NCT03761784|12006689|FG001|Overall Study|Lost to Follow-up|7
7600467|NCT03761784|12006688|FG000|Overall Study|Pregnancy|1
7600468|NCT03761784|12006689|FG001|Overall Study|Pregnancy|0
7600469|NCT03761784|12006688|FG000|Overall Study|Protocol Violation|2
7600470|NCT03761784|12006689|FG001|Overall Study|Protocol Violation|0
7600471|NCT03761784|12006688|FG000|Overall Study|Withdrawal by Parent or Guardian|4
7600472|NCT03761784|12006689|FG001|Overall Study|Withdrawal by Parent or Guardian|1
7600473|NCT03761784|12006688|FG000|Overall Study|Withdrawal by Subject|9
7600474|NCT03761784|12006689|FG001|Overall Study|Withdrawal by Subject|4
7600475|NCT03761784|12006688|FG000|Overall Study|Physician Decision|1
7600476|NCT03761784|12006689|FG001|Overall Study|Physician Decision|0
7600477|NCT03761784|12006688|FG000|Overall Study|Other Than Specified|1
7600478|NCT03761784|12006689|FG001|Overall Study|Other Than Specified|0
7600479|NCT03361865|12006697|FG000|Overall Study|Death|17
7600480|NCT03361865|12006698|FG001|Overall Study|Death|18
7600481|NCT03361865|12006697|FG000|Overall Study|Physician Decision|1
7600482|NCT03361865|12006698|FG001|Overall Study|Physician Decision|9
7600483|NCT03361865|12006697|FG000|Overall Study|Withdrawal by Subject|1
7600484|NCT03361865|12006698|FG001|Overall Study|Withdrawal by Subject|0
7600485|NCT02929056|12006724|FG000|Overall Study|Lost to Follow-up|0
7600486|NCT02929056|12006725|FG001|Overall Study|Lost to Follow-up|1
7600487|NCT02896855|12006733|FG000|Overall Study|Death|50
7600488|NCT02896855|12006734|FG001|Overall Study|Death|40
7600489|NCT02896855|12006733|FG000|Overall Study|Lost to Follow-up|15
7600490|NCT02896855|12006734|FG001|Overall Study|Lost to Follow-up|9
7600491|NCT02896855|12006733|FG000|Overall Study|Withdrawal by Subject|7
7600492|NCT02896855|12006734|FG001|Overall Study|Withdrawal by Subject|4
7600493|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Adverse Event|1
7600494|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Adverse Event|1
7600495|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Adverse Event|1
7600496|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Adverse Event|0
7600497|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Adverse Event|0
7600498|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Adverse Event|0
7600499|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Adverse Event|0
7600500|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Adverse Event|0
7600501|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600502|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600503|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600504|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
7600505|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600506|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600507|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600508|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
7600509|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
7600510|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
7600511|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
7600512|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
7600513|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
7600514|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
7600515|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
7600516|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
7600517|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600518|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600519|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
7600520|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600521|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600522|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600523|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600524|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
7600525|NCT02871778|12006747|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
7600526|NCT02871778|12006748|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
7600527|NCT02871778|12006749|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
7600528|NCT02871778|12006750|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
7600529|NCT02871778|12006751|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
7600530|NCT02871778|12006752|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
7600531|NCT02871778|12006753|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
7600532|NCT02871778|12006754|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
7600533|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Adverse Event|2
7600534|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Adverse Event|2
7600535|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Adverse Event|0
7600536|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Adverse Event|0
7600537|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Adverse Event|0
7600538|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Adverse Event|0
7600539|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Adverse Event|0
7600540|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Adverse Event|0
7600541|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
7600542|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
7600543|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
7600544|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
7600545|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
7272699|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Death|0
7600546|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
7600547|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
7600548|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
7600549|NCT02871778|12006747|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7600550|NCT02871778|12006748|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600551|NCT02871778|12006749|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
7600552|NCT02871778|12006750|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600553|NCT02871778|12006751|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600554|NCT02871778|12006752|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600555|NCT02871778|12006753|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600556|NCT02871778|12006754|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
7600557|NCT02871778|12006747|FG000|Part B: Treatment Period 3|Adverse Event|0
7600558|NCT02871778|12006748|FG001|Part B: Treatment Period 3|Adverse Event|0
7600559|NCT02871778|12006749|FG002|Part B: Treatment Period 3|Adverse Event|0
7600560|NCT02871778|12006750|FG003|Part B: Treatment Period 3|Adverse Event|0
7600561|NCT02871778|12006751|FG004|Part B: Treatment Period 3|Adverse Event|1
7600562|NCT02871778|12006752|FG005|Part B: Treatment Period 3|Adverse Event|1
7600563|NCT02871778|12006753|FG006|Part B: Treatment Period 3|Adverse Event|1
7600564|NCT02871778|12006754|FG007|Part B: Treatment Period 3|Adverse Event|0
7600565|NCT02756208|12006787|FG000|Overall Study|Withdrawal by Subject|1
7600566|NCT02756208|12006788|FG001|Overall Study|Withdrawal by Subject|0
7600567|NCT02756208|12006789|FG002|Overall Study|Withdrawal by Subject|1
7600568|NCT02756208|12006790|FG003|Overall Study|Withdrawal by Subject|3
7600569|NCT02756208|12006787|FG000|Overall Study|Lost to Follow-up|3
7600570|NCT02756208|12006788|FG001|Overall Study|Lost to Follow-up|1
7600571|NCT02756208|12006789|FG002|Overall Study|Lost to Follow-up|1
7600572|NCT02756208|12006790|FG003|Overall Study|Lost to Follow-up|1
7600573|NCT02756208|12006787|FG000|Overall Study|Physician Decision|1
7600574|NCT02756208|12006788|FG001|Overall Study|Physician Decision|0
7600575|NCT02756208|12006789|FG002|Overall Study|Physician Decision|0
7600576|NCT02756208|12006790|FG003|Overall Study|Physician Decision|0
7600577|NCT02756208|12006787|FG000|Overall Study|Protocol Violation|0
7600578|NCT02756208|12006788|FG001|Overall Study|Protocol Violation|1
7600579|NCT02756208|12006789|FG002|Overall Study|Protocol Violation|0
7600580|NCT02756208|12006790|FG003|Overall Study|Protocol Violation|0
7600581|NCT02149121|12006807|FG000|Main Study Period|Lack of Efficacy|2
7600582|NCT02149121|12006808|FG001|Main Study Period|Lack of Efficacy|2
7600583|NCT02149121|12006809|FG002|Main Study Period|Lack of Efficacy|1
7600584|NCT02149121|12006810|FG003|Main Study Period|Lack of Efficacy|0
7600585|NCT02149121|12006811|FG004|Main Study Period|Lack of Efficacy|0
7272618|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
7272619|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
7272620|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7272621|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7272622|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7600586|NCT02149121|12006812|FG005|Main Study Period|Lack of Efficacy|0
7600587|NCT02149121|12006813|FG006|Main Study Period|Lack of Efficacy|0
7600588|NCT02149121|12006807|FG000|Main Study Period|Withdrawal by Subject|9
7600589|NCT02149121|12006808|FG001|Main Study Period|Withdrawal by Subject|5
7600590|NCT02149121|12006809|FG002|Main Study Period|Withdrawal by Subject|1
7600591|NCT02149121|12006810|FG003|Main Study Period|Withdrawal by Subject|0
7600592|NCT02149121|12006811|FG004|Main Study Period|Withdrawal by Subject|0
7600593|NCT02149121|12006812|FG005|Main Study Period|Withdrawal by Subject|0
7600594|NCT02149121|12006813|FG006|Main Study Period|Withdrawal by Subject|0
7600595|NCT02149121|12006807|FG000|Main Study Period|Adverse Event|2
7600596|NCT02149121|12006808|FG001|Main Study Period|Adverse Event|5
7600597|NCT02149121|12006809|FG002|Main Study Period|Adverse Event|1
7600598|NCT02149121|12006810|FG003|Main Study Period|Adverse Event|0
7600599|NCT02149121|12006811|FG004|Main Study Period|Adverse Event|0
7600600|NCT02149121|12006812|FG005|Main Study Period|Adverse Event|0
7600601|NCT02149121|12006813|FG006|Main Study Period|Adverse Event|0
7600602|NCT02149121|12006807|FG000|Main Study Period|Protocol Violation|2
7600603|NCT02149121|12006808|FG001|Main Study Period|Protocol Violation|0
7600604|NCT02149121|12006809|FG002|Main Study Period|Protocol Violation|0
7600605|NCT02149121|12006810|FG003|Main Study Period|Protocol Violation|0
7600606|NCT02149121|12006811|FG004|Main Study Period|Protocol Violation|0
7600607|NCT02149121|12006812|FG005|Main Study Period|Protocol Violation|0
7600608|NCT02149121|12006813|FG006|Main Study Period|Protocol Violation|0
7600609|NCT02149121|12006807|FG000|Main Study Period|Lost to Follow-up|2
7600610|NCT02149121|12006808|FG001|Main Study Period|Lost to Follow-up|1
7600611|NCT02149121|12006809|FG002|Main Study Period|Lost to Follow-up|0
7600612|NCT02149121|12006810|FG003|Main Study Period|Lost to Follow-up|0
7600613|NCT02149121|12006811|FG004|Main Study Period|Lost to Follow-up|0
7272623|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
7272624|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7272625|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
7272626|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272627|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272628|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272629|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272630|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272631|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
7272632|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7272633|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
7272634|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
7272635|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
7272636|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7272637|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7272638|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7272639|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
7272640|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272641|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272642|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272643|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
7272644|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272645|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272646|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272647|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
7272648|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7272649|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
7272650|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
7272651|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
7272652|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7272653|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7272654|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7272655|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
7272656|NCT00427895|11486969|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
7272657|NCT00427895|11486970|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
7272658|NCT00427895|11486971|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
7272659|NCT00427895|11486972|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
7600614|NCT02149121|12006812|FG005|Main Study Period|Lost to Follow-up|0
7600615|NCT02149121|12006813|FG006|Main Study Period|Lost to Follow-up|0
7600616|NCT02149121|12006807|FG000|Main Study Period|Death|1
7600617|NCT02149121|12006808|FG001|Main Study Period|Death|0
7600618|NCT02149121|12006809|FG002|Main Study Period|Death|0
7600619|NCT02149121|12006810|FG003|Main Study Period|Death|0
7272660|NCT00427895|11486973|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
7272661|NCT00427895|11486974|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
7272662|NCT00427895|11486975|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
7272663|NCT00427895|11486976|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
7272664|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7272665|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
7272666|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
7272667|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
7272668|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7272669|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7272670|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7272671|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
7272672|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
7272673|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
7272674|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
7272675|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
7272676|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
7272677|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
7272678|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
7272679|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
7272680|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
7272681|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
7272682|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
7272683|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
7272684|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7272685|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7272686|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7272687|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
7272688|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
7272689|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
7272690|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
7272691|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
7272692|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
7272693|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
7272694|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
7272695|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
7272696|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Death|1
7600620|NCT02149121|12006811|FG004|Main Study Period|Death|0
7272697|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Death|0
7272698|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Death|0
7272700|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Death|0
7272701|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Death|0
7272702|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Death|0
7272703|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Death|0
7272704|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
7272705|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
7272706|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
7272707|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
7600621|NCT02149121|12006812|FG005|Main Study Period|Death|0
7600622|NCT02149121|12006813|FG006|Main Study Period|Death|0
7600623|NCT02149121|12006807|FG000|Main Study Period|Physician Decision|1
7600624|NCT02149121|12006808|FG001|Main Study Period|Physician Decision|0
7600625|NCT02149121|12006809|FG002|Main Study Period|Physician Decision|0
7600626|NCT02149121|12006810|FG003|Main Study Period|Physician Decision|0
7600627|NCT02149121|12006811|FG004|Main Study Period|Physician Decision|0
7600628|NCT02149121|12006812|FG005|Main Study Period|Physician Decision|0
7600629|NCT02149121|12006813|FG006|Main Study Period|Physician Decision|0
7600630|NCT02149121|12006807|FG000|Main Study Period|Developed any malignancy|0
7600631|NCT02149121|12006808|FG001|Main Study Period|Developed any malignancy|1
7600632|NCT02149121|12006809|FG002|Main Study Period|Developed any malignancy|1
7600633|NCT02149121|12006810|FG003|Main Study Period|Developed any malignancy|0
7600634|NCT02149121|12006811|FG004|Main Study Period|Developed any malignancy|0
7600635|NCT02149121|12006812|FG005|Main Study Period|Developed any malignancy|0
7600636|NCT02149121|12006813|FG006|Main Study Period|Developed any malignancy|0
7600637|NCT02149121|12006807|FG000|Main Study Period|Unmet predefined eligibility criteria|2
7600638|NCT02149121|12006808|FG001|Main Study Period|Unmet predefined eligibility criteria|2
7600639|NCT02149121|12006809|FG002|Main Study Period|Unmet predefined eligibility criteria|0
7600640|NCT02149121|12006810|FG003|Main Study Period|Unmet predefined eligibility criteria|0
7600641|NCT02149121|12006811|FG004|Main Study Period|Unmet predefined eligibility criteria|0
7600642|NCT02149121|12006812|FG005|Main Study Period|Unmet predefined eligibility criteria|0
7600643|NCT02149121|12006813|FG006|Main Study Period|Unmet predefined eligibility criteria|0
7600644|NCT02149121|12006807|FG000|Main Study Period|Disease progression|0
7600645|NCT02149121|12006808|FG001|Main Study Period|Disease progression|1
7600646|NCT02149121|12006809|FG002|Main Study Period|Disease progression|0
7600647|NCT02149121|12006810|FG003|Main Study Period|Disease progression|0
7600648|NCT02149121|12006811|FG004|Main Study Period|Disease progression|0
7600649|NCT02149121|12006812|FG005|Main Study Period|Disease progression|0
7600650|NCT02149121|12006813|FG006|Main Study Period|Disease progression|0
7600651|NCT02149121|12006807|FG000|Extension Study Period|Withdrawal by Subject|0
7600652|NCT02149121|12006808|FG001|Extension Study Period|Withdrawal by Subject|0
7600653|NCT02149121|12006809|FG002|Extension Study Period|Withdrawal by Subject|0
7600654|NCT02149121|12006810|FG003|Extension Study Period|Withdrawal by Subject|1
7600655|NCT02149121|12006811|FG004|Extension Study Period|Withdrawal by Subject|0
7600656|NCT02149121|12006812|FG005|Extension Study Period|Withdrawal by Subject|2
7600657|NCT02149121|12006813|FG006|Extension Study Period|Withdrawal by Subject|0
7600658|NCT01889186|12006836|FG000|Overall Study|Adverse event- not related to progression|18
7600659|NCT01889186|12006837|FG001|Overall Study|Adverse event- not related to progression|5
7600660|NCT01889186|12006836|FG000|Overall Study|Adverse event- related to progression|7
7600661|NCT01889186|12006837|FG001|Overall Study|Adverse event- related to progression|2
7600662|NCT01889186|12006836|FG000|Overall Study|COVID-19 logistical restrictions|1
7600663|NCT01889186|12006837|FG001|Overall Study|COVID-19 logistical restrictions|0
7600664|NCT01889186|12006836|FG000|Overall Study|Investigator request|1
7600665|NCT01889186|12006837|FG001|Overall Study|Investigator request|1
7600666|NCT01889186|12006836|FG000|Overall Study|Progressive disease- Richter's|12
7600667|NCT01889186|12006837|FG001|Overall Study|Progressive disease- Richter's|7
7600668|NCT01889186|12006836|FG000|Overall Study|Progressive disease per protocol|46
7600669|NCT01889186|12006837|FG001|Overall Study|Progressive disease per protocol|17
7600670|NCT01889186|12006836|FG000|Overall Study|Stem cell transplant|2
7600671|NCT01889186|12006837|FG001|Overall Study|Stem cell transplant|1
7600672|NCT01889186|12006836|FG000|Overall Study|Withdrew consent|2
7600673|NCT01889186|12006837|FG001|Overall Study|Withdrew consent|3
7600674|NCT01889186|12006836|FG000|Overall Study|Other, not specified|18
7600675|NCT01889186|12006837|FG001|Overall Study|Other, not specified|15
7600676|NCT01850004|12006845|FG000|Overall Study|Subject Moved|1
7600677|NCT01850004|12006845|FG000|Overall Study|Poor/Non-compliance|1
7600678|NCT01850004|12006845|FG000|Overall Study|Subject Withdrew Consent|4
7600679|NCT01850004|12006845|FG000|Overall Study|Subject Request to Discontinue Treatment|1
7600680|NCT01850004|12006845|FG000|Overall Study|AE Unrelated to Study Drug|1
7600681|NCT01510184|12006852|FG000|Overall Study|Sponsor discretion|28
7600682|NCT01510184|12006853|FG001|Overall Study|Sponsor discretion|28
7600683|NCT01510184|12006852|FG000|Overall Study|Death|1
7600684|NCT01510184|12006853|FG001|Overall Study|Death|2
7600685|NCT01510184|12006852|FG000|Overall Study|Withdrawal by Subject|1
7600686|NCT01510184|12006853|FG001|Overall Study|Withdrawal by Subject|4
7600687|NCT01510184|12006852|FG000|Overall Study|Other|0
7600688|NCT01510184|12006853|FG001|Overall Study|Other|1
7600689|NCT01471444|12006861|FG000|Overall Study|Physician Decision|3
7600690|NCT01471444|12006862|FG001|Overall Study|Physician Decision|2
7600691|NCT01471444|12006861|FG000|Overall Study|Withdrawal by Subject|0
7600692|NCT01471444|12006862|FG001|Overall Study|Withdrawal by Subject|1
7600693|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600694|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600695|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600696|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600697|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600698|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600699|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600700|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
7600701|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
7600702|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
7600703|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600704|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600705|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600706|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600707|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
7600708|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600709|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600710|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600711|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600712|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600713|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600714|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600715|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
7600716|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600717|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600718|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600719|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600720|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600721|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7600722|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
7600723|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
7600724|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600725|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600726|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600727|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600728|NCT03745651|12006913|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
7600729|NCT03745651|12006914|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7600730|NCT03745651|12006915|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
7600731|NCT03745651|12006916|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600732|NCT03745651|12006917|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600733|NCT03745651|12006918|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600734|NCT03745651|12006919|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
7600735|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600736|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600737|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600738|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600739|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600740|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
7600741|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600742|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600743|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600744|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600745|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7600746|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600747|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7600748|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
7600749|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600750|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600751|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600752|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
7600753|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
7600754|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7600755|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
7600756|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600757|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600758|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600759|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7600760|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600761|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
7600762|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
7600763|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600764|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600765|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600766|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7600767|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600768|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
7600769|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
7600770|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600771|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600772|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600773|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600774|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600775|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7600776|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600777|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600778|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600779|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600780|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
7600781|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
7600782|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
7600783|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
7600784|NCT03745651|12006913|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600785|NCT03745651|12006914|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600786|NCT03745651|12006915|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600787|NCT03745651|12006916|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600788|NCT03745651|12006917|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600789|NCT03745651|12006918|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
7600790|NCT03745651|12006919|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
7600791|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
7600792|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
7600793|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
7600794|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600795|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600796|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600797|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
7600798|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
7600799|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600800|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600801|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600802|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600803|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600804|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
7600805|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
7600806|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
7600807|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
7600808|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600809|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600810|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600811|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
7600812|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600813|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
7600814|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600815|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600816|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600817|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600818|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
7600819|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
7600820|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600821|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600822|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600823|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600824|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600825|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
7600826|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600827|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
7600828|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600829|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600830|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600831|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600832|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
7600833|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
7600834|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
7600835|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
7600836|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600837|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600838|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600839|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
7600840|NCT03745638|12006938|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
7600841|NCT03745638|12006939|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
7600842|NCT03745638|12006940|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600843|NCT03745638|12006941|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600844|NCT03745638|12006942|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600845|NCT03745638|12006943|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600846|NCT03745638|12006944|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
7600847|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600848|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600849|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600850|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600851|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
7600852|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
7272708|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
7272709|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
7272710|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
7272711|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
7272712|NCT00427895|11486969|FG000|Vax 1/Year 1 Follow-up|Other|0
7272713|NCT00427895|11486970|FG001|Vax 1/Year 1 Follow-up|Other|0
7272714|NCT00427895|11486971|FG002|Vax 1/Year 1 Follow-up|Other|0
7600853|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
7600854|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600855|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600856|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600857|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
7600858|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
7600859|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7600860|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
7600861|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600862|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600863|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
7600864|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
7600865|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
7600866|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
7600867|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
7600868|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600869|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600870|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600871|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600872|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
7600873|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
7600874|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
7600875|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600876|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600877|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7272715|NCT00427895|11486972|FG003|Vax 1/Year 1 Follow-up|Other|2
7272716|NCT00427895|11486973|FG004|Vax 1/Year 1 Follow-up|Other|0
7600878|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600879|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600880|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
7600881|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
7600882|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600883|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600884|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
7600885|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
7600886|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
7600887|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
7600888|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
7600889|NCT03745638|12006938|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600890|NCT03745638|12006939|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600891|NCT03745638|12006940|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600892|NCT03745638|12006941|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600893|NCT03745638|12006942|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
7600894|NCT03745638|12006943|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
7600895|NCT03745638|12006944|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
7600896|NCT03715764|12006963|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
7600897|NCT03715764|12006964|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
7600898|NCT03715764|12006963|FG000|3 Month Follow-up|Lost to Follow-up|2
7600899|NCT03715764|12006964|FG001|3 Month Follow-up|Lost to Follow-up|2
7600900|NCT03715764|12006963|FG000|3 Month Follow-up|Withdrawal by Subject|1
7600901|NCT03715764|12006964|FG001|3 Month Follow-up|Withdrawal by Subject|1
7600902|NCT03715764|12006963|FG000|6 Month Follow-up|Lost to Follow-up|3
7600903|NCT03715764|12006964|FG001|6 Month Follow-up|Lost to Follow-up|0
7600904|NCT03715764|12006963|FG000|12 Month Follow-up|Lost to Follow-up|2
7600905|NCT03715764|12006964|FG001|12 Month Follow-up|Lost to Follow-up|3
7600906|NCT03715764|12006963|FG000|12 Month Follow-up|Pregnancy|0
7600907|NCT03715764|12006964|FG001|12 Month Follow-up|Pregnancy|1
7600908|NCT03715764|12006963|FG000|12 Month Follow-up|Surgery|2
7600909|NCT03715764|12006964|FG001|12 Month Follow-up|Surgery|0
7600910|NCT03715764|12006963|FG000|12 Month Follow-up|Wrong address|1
7600911|NCT03715764|12006964|FG001|12 Month Follow-up|Wrong address|0
7600912|NCT03715764|12006963|FG000|12 Month Follow-up|No symptoms|1
7600913|NCT03715764|12006964|FG001|12 Month Follow-up|No symptoms|0
7600914|NCT03715764|12006963|FG000|12 Month Follow-up|Changed primary care centre|0
7600915|NCT03715764|12006964|FG001|12 Month Follow-up|Changed primary care centre|1
7600916|NCT03654729|12006977|FG000|Overall Study|Death|9
7600917|NCT03654729|12006978|FG001|Overall Study|Death|9
7600918|NCT03654729|12006979|FG002|Overall Study|Death|16
7600919|NCT03654729|12006977|FG000|Overall Study|Withdrawal by Subject|8
7600920|NCT03654729|12006978|FG001|Overall Study|Withdrawal by Subject|6
7600921|NCT03654729|12006979|FG002|Overall Study|Withdrawal by Subject|4
7600922|NCT03654729|12006977|FG000|Overall Study|Study terminated by Sponsor|3
7600923|NCT03654729|12006978|FG001|Overall Study|Study terminated by Sponsor|5
7600924|NCT03654729|12006979|FG002|Overall Study|Study terminated by Sponsor|4
7600925|NCT03654729|12006977|FG000|Overall Study|Not reported|2
7600926|NCT03654729|12006978|FG001|Overall Study|Not reported|4
7600927|NCT03654729|12006979|FG002|Overall Study|Not reported|5
7600928|NCT03654729|12006977|FG000|Overall Study|Progressive disease|3
7600929|NCT03654729|12006978|FG001|Overall Study|Progressive disease|0
7600930|NCT03654729|12006979|FG002|Overall Study|Progressive disease|0
7600931|NCT03654729|12006977|FG000|Overall Study|Lost to Follow-up|2
7600932|NCT03654729|12006978|FG001|Overall Study|Lost to Follow-up|0
7600933|NCT03654729|12006979|FG002|Overall Study|Lost to Follow-up|0
7600934|NCT03654729|12006977|FG000|Overall Study|Physician Decision|2
7600935|NCT03654729|12006978|FG001|Overall Study|Physician Decision|0
7600936|NCT03654729|12006979|FG002|Overall Study|Physician Decision|0
7600937|NCT03654729|12006977|FG000|Overall Study|Protocol Violation|1
7600938|NCT03654729|12006978|FG001|Overall Study|Protocol Violation|1
7600939|NCT03654729|12006979|FG002|Overall Study|Protocol Violation|0
7600940|NCT03654729|12006977|FG000|Overall Study|Non-compliance with study drug|0
7600941|NCT03654729|12006978|FG001|Overall Study|Non-compliance with study drug|1
7600942|NCT03654729|12006979|FG002|Overall Study|Non-compliance with study drug|0
7600943|NCT03654729|12006977|FG000|Overall Study|Site terminated by Sponsor|1
7600944|NCT03654729|12006978|FG001|Overall Study|Site terminated by Sponsor|0
7600945|NCT03654729|12006979|FG002|Overall Study|Site terminated by Sponsor|0
7600946|NCT02976038|12007031|FG000|Overall Study|Physician Decision|22
7600947|NCT02976038|12007031|FG000|Overall Study|Withdrawal by Subject|3
7600948|NCT02976038|12007031|FG000|Overall Study|Lost to Follow-up|2
7600949|NCT02976038|12007031|FG000|Overall Study|Adverse Event|1
7600950|NCT02631070|12007047|FG000|Overall Study|Withdrawal by Subject|35
7600951|NCT02631070|12007048|FG001|Overall Study|Withdrawal by Subject|13
7600952|NCT02631070|12007047|FG000|Overall Study|Death|45
7600953|NCT02631070|12007048|FG001|Overall Study|Death|24
7600954|NCT02631070|12007047|FG000|Overall Study|Lost to Follow-up|5
7600955|NCT02631070|12007048|FG001|Overall Study|Lost to Follow-up|1
7600956|NCT02631070|12007047|FG000|Overall Study|Transition to rollover protocol|52
7600957|NCT02631070|12007048|FG001|Overall Study|Transition to rollover protocol|21
7600958|NCT02631070|12007047|FG000|Overall Study|Other reasons|12
7600959|NCT02631070|12007048|FG001|Overall Study|Other reasons|5
7600960|NCT02281955|12007054|FG000|Overall Study|Death|1
7600961|NCT02202434|12007062|FG000|Overall Study|Death|70
7600962|NCT02202434|12007063|FG001|Overall Study|Death|39
7600963|NCT02202434|12007064|FG002|Overall Study|Death|13
7600964|NCT02202434|12007065|FG003|Overall Study|Death|27
7600965|NCT02202434|12007062|FG000|Overall Study|Lost to Follow-up|1
7600966|NCT02202434|12007063|FG001|Overall Study|Lost to Follow-up|1
7600967|NCT02202434|12007064|FG002|Overall Study|Lost to Follow-up|1
7600968|NCT02202434|12007065|FG003|Overall Study|Lost to Follow-up|0
7600969|NCT02202434|12007062|FG000|Overall Study|Physician Decision|2
7600970|NCT02202434|12007063|FG001|Overall Study|Physician Decision|3
7600971|NCT02202434|12007064|FG002|Overall Study|Physician Decision|0
7600972|NCT02202434|12007065|FG003|Overall Study|Physician Decision|0
7600973|NCT02202434|12007062|FG000|Overall Study|Withdrawal by Subject|13
7600974|NCT02202434|12007063|FG001|Overall Study|Withdrawal by Subject|14
7600975|NCT02202434|12007064|FG002|Overall Study|Withdrawal by Subject|1
7600976|NCT02202434|12007065|FG003|Overall Study|Withdrawal by Subject|4
7600977|NCT02202434|12007062|FG000|Overall Study|Completed Study|1
7600978|NCT02202434|12007063|FG001|Overall Study|Completed Study|0
7600979|NCT02202434|12007064|FG002|Overall Study|Completed Study|0
7600980|NCT02202434|12007065|FG003|Overall Study|Completed Study|0
7600981|NCT02202434|12007062|FG000|Overall Study|Visit Missed|21
7600982|NCT02202434|12007063|FG001|Overall Study|Visit Missed|12
7600983|NCT02202434|12007064|FG002|Overall Study|Visit Missed|0
7600984|NCT02202434|12007065|FG003|Overall Study|Visit Missed|5
7600985|NCT02202434|12007062|FG000|Overall Study|Other|1
7600986|NCT02202434|12007063|FG001|Overall Study|Other|0
7600987|NCT02202434|12007064|FG002|Overall Study|Other|0
7600988|NCT02202434|12007065|FG003|Overall Study|Other|1
7600989|NCT01230242|12007079|FG000|Overall Study|Physician Decision|2
7600990|NCT01230242|12007079|FG000|Overall Study|Withdrawal by Subject|1
7600991|NCT00983437|12007083|FG000|Overall Study|Adverse Event|9
7600992|NCT00983437|12007083|FG000|Overall Study|Lack of Efficacy|1
7600993|NCT00983437|12007083|FG000|Overall Study|Withdrawal by Subject|8
7600994|NCT00983437|12007083|FG000|Overall Study|Noncompliance to Study Procedures|1
7600995|NCT00983437|12007083|FG000|Overall Study|Lost to Follow-up|2
7600996|NCT00983437|12007083|FG000|Overall Study|Other Reason|26
7600997|NCT00965757|12007089|FG000|Double-blind Phase|Progression of concomitant disease|1
7600998|NCT00965757|12007090|FG001|Double-blind Phase|Progression of concomitant disease|2
7600999|NCT00965757|12007091|FG002|Double-blind Phase|Progression of concomitant disease|0
7601000|NCT00965757|12007092|FG003|Double-blind Phase|Progression of concomitant disease|0
7601001|NCT00965757|12007089|FG000|Double-blind Phase|Adverse drug reaction|2
7601002|NCT00965757|12007090|FG001|Double-blind Phase|Adverse drug reaction|1
7601003|NCT00965757|12007091|FG002|Double-blind Phase|Adverse drug reaction|0
7601004|NCT00965757|12007092|FG003|Double-blind Phase|Adverse drug reaction|0
7601005|NCT00965757|12007089|FG000|Double-blind Phase|Abnormal Laboratory Value|2
7601006|NCT00965757|12007090|FG001|Double-blind Phase|Abnormal Laboratory Value|0
7601007|NCT00965757|12007091|FG002|Double-blind Phase|Abnormal Laboratory Value|0
7601008|NCT00965757|12007092|FG003|Double-blind Phase|Abnormal Laboratory Value|0
7601009|NCT00965757|12007089|FG000|Double-blind Phase|Lack of Efficacy|7
7601010|NCT00965757|12007090|FG001|Double-blind Phase|Lack of Efficacy|11
7601011|NCT00965757|12007091|FG002|Double-blind Phase|Lack of Efficacy|0
7601012|NCT00965757|12007092|FG003|Double-blind Phase|Lack of Efficacy|0
7601013|NCT00965757|12007089|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
7601014|NCT00965757|12007090|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7272717|NCT00427895|11486974|FG005|Vax 1/Year 1 Follow-up|Other|0
7272718|NCT00427895|11486975|FG006|Vax 1/Year 1 Follow-up|Other|0
7272719|NCT00427895|11486976|FG007|Vax 1/Year 1 Follow-up|Other|0
7272720|NCT00427895|11486969|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
7272721|NCT00427895|11486970|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
7272722|NCT00427895|11486971|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
7272723|NCT00427895|11486972|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
7272724|NCT00427895|11486973|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7272725|NCT00427895|11486974|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7272726|NCT00427895|11486975|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7272727|NCT00427895|11486976|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
7272728|NCT00427908|11487019|FG000|Primary Phase|Lost to Follow-up|4
7272729|NCT00427908|11487020|FG001|Primary Phase|Lost to Follow-up|0
7272730|NCT00427908|11487021|FG002|Primary Phase|Lost to Follow-up|2
7272731|NCT00427908|11487022|FG003|Primary Phase|Lost to Follow-up|0
7272732|NCT00427908|11487019|FG000|Primary Phase|Withdrawal by Subject|1
7272733|NCT00427908|11487020|FG001|Primary Phase|Withdrawal by Subject|2
7272734|NCT00427908|11487021|FG002|Primary Phase|Withdrawal by Subject|1
7272735|NCT00427908|11487022|FG003|Primary Phase|Withdrawal by Subject|0
7272736|NCT00427908|11487019|FG000|Primary Phase|Adverse Event|0
7272737|NCT00427908|11487020|FG001|Primary Phase|Adverse Event|1
7272738|NCT00427908|11487021|FG002|Primary Phase|Adverse Event|0
7272739|NCT00427908|11487022|FG003|Primary Phase|Adverse Event|0
7272740|NCT00427921|11487057|FG000|Overall Study|Adverse Event|26
7272741|NCT00427921|11487057|FG000|Overall Study|Withdrawal by Subject|4
7272742|NCT00427921|11487057|FG000|Overall Study|Lost to Follow-up|2
7272743|NCT00427921|11487057|FG000|Overall Study|Other reason not specified|10
7272744|NCT00427921|11487057|FG000|Overall Study|Adverse Event + Hospitalization|1
7272745|NCT00427921|11487057|FG000|Overall Study|Adverse Event + Withdrew Consent|1
7272746|NCT00427921|11487057|FG000|Overall Study|Adverse Event + No Response|1
7601015|NCT00965757|12007091|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7601016|NCT00965757|12007092|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
7601017|NCT00965757|12007089|FG000|Double-blind Phase|Lost to Follow-up|0
7272747|NCT00427921|11487057|FG000|Overall Study|Adverse Event + Worsening of CD|1
7272748|NCT00427921|11487057|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
7272749|NCT00427921|11487057|FG000|Overall Study|Adverse Event + Lost Response|1
7272750|NCT00427921|11487057|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
7601018|NCT00965757|12007090|FG001|Double-blind Phase|Lost to Follow-up|1
7601019|NCT00965757|12007091|FG002|Double-blind Phase|Lost to Follow-up|0
7601020|NCT00965757|12007092|FG003|Double-blind Phase|Lost to Follow-up|0
7601021|NCT00965757|12007089|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
7601022|NCT00965757|12007090|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
7601023|NCT00965757|12007091|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
7601024|NCT00965757|12007092|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
7601025|NCT00965757|12007089|FG000|Double-blind Phase|Other|1
7601026|NCT00965757|12007090|FG001|Double-blind Phase|Other|0
7601027|NCT00965757|12007091|FG002|Double-blind Phase|Other|0
7601028|NCT00965757|12007092|FG003|Double-blind Phase|Other|0
7601029|NCT00965757|12007089|FG000|Extension Phase|Progression of concomitant disease|0
7601030|NCT00965757|12007090|FG001|Extension Phase|Progression of concomitant disease|0
7601031|NCT00965757|12007091|FG002|Extension Phase|Progression of concomitant disease|4
7601032|NCT00965757|12007092|FG003|Extension Phase|Progression of concomitant disease|2
7601033|NCT00965757|12007089|FG000|Extension Phase|Adverse drug reaction|0
7601034|NCT00965757|12007090|FG001|Extension Phase|Adverse drug reaction|0
7601035|NCT00965757|12007091|FG002|Extension Phase|Adverse drug reaction|6
7601036|NCT00965757|12007092|FG003|Extension Phase|Adverse drug reaction|3
7601037|NCT00965757|12007089|FG000|Extension Phase|Abnormal Laboratory Value|0
7601038|NCT00965757|12007090|FG001|Extension Phase|Abnormal Laboratory Value|0
7601039|NCT00965757|12007091|FG002|Extension Phase|Abnormal Laboratory Value|6
7601040|NCT00965757|12007092|FG003|Extension Phase|Abnormal Laboratory Value|1
7601041|NCT00965757|12007089|FG000|Extension Phase|Lack of Efficacy|0
7601042|NCT00965757|12007090|FG001|Extension Phase|Lack of Efficacy|0
7601043|NCT00965757|12007091|FG002|Extension Phase|Lack of Efficacy|8
7601044|NCT00965757|12007092|FG003|Extension Phase|Lack of Efficacy|12
7601045|NCT00965757|12007089|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
7601046|NCT00965757|12007090|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
7601047|NCT00965757|12007091|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
7601048|NCT00965757|12007092|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
7601049|NCT00965757|12007089|FG000|Extension Phase|Lost to Follow-up|0
7601050|NCT00965757|12007090|FG001|Extension Phase|Lost to Follow-up|0
7601051|NCT00965757|12007091|FG002|Extension Phase|Lost to Follow-up|0
7601052|NCT00965757|12007092|FG003|Extension Phase|Lost to Follow-up|1
7272751|NCT00427921|11487057|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
7272752|NCT00427934|11487065|FG000|Overall Study|Adverse Event|1
7272753|NCT00427934|11487066|FG001|Overall Study|Adverse Event|0
7272754|NCT00427934|11487067|FG002|Overall Study|Adverse Event|5
7272755|NCT00427934|11487068|FG003|Overall Study|Adverse Event|4
7272756|NCT00427934|11487065|FG000|Overall Study|Lack of Efficacy|0
7272757|NCT00427934|11487066|FG001|Overall Study|Lack of Efficacy|0
7272758|NCT00427934|11487067|FG002|Overall Study|Lack of Efficacy|5
7272759|NCT00427934|11487068|FG003|Overall Study|Lack of Efficacy|2
7272760|NCT00427934|11487065|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
7272761|NCT00427934|11487066|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
7272762|NCT00427934|11487067|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
7272763|NCT00427934|11487068|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
7272764|NCT00427934|11487065|FG000|Overall Study|Other|0
7272765|NCT00427934|11487066|FG001|Overall Study|Other|0
7272766|NCT00427934|11487067|FG002|Overall Study|Other|11
7272767|NCT00427934|11487068|FG003|Overall Study|Other|5
7601053|NCT00965757|12007089|FG000|Extension Phase|Ineligible after Taking Study Drug|0
7601054|NCT00965757|12007090|FG001|Extension Phase|Ineligible after Taking Study Drug|0
7601055|NCT00965757|12007091|FG002|Extension Phase|Ineligible after Taking Study Drug|3
7601056|NCT00965757|12007092|FG003|Extension Phase|Ineligible after Taking Study Drug|3
7601057|NCT00965757|12007089|FG000|Extension Phase|Protocol Violation|0
7601058|NCT00965757|12007090|FG001|Extension Phase|Protocol Violation|0
7601059|NCT00965757|12007091|FG002|Extension Phase|Protocol Violation|0
7601060|NCT00965757|12007092|FG003|Extension Phase|Protocol Violation|1
7601061|NCT00965757|12007089|FG000|Extension Phase|Other|0
7601062|NCT00965757|12007090|FG001|Extension Phase|Other|0
7601063|NCT00965757|12007091|FG002|Extension Phase|Other|2
7272768|NCT00427934|11487065|FG000|Overall Study|Withdrawal by Subject|0
7272769|NCT00427934|11487066|FG001|Overall Study|Withdrawal by Subject|0
7272770|NCT00427934|11487067|FG002|Overall Study|Withdrawal by Subject|1
7272771|NCT00427934|11487068|FG003|Overall Study|Withdrawal by Subject|3
7272772|NCT00427960|11487082|FG000|Overall Study|Adverse Event|2
7272773|NCT00427960|11487083|FG001|Overall Study|Adverse Event|0
7272774|NCT00427960|11487082|FG000|Overall Study|Withdrawal by Subject|0
7601064|NCT00965757|12007092|FG003|Extension Phase|Other|1
7601065|NCT00928447|12007100|FG000|Overall Study|Withdrawal by Subject|1
7601066|NCT00928447|12007100|FG000|Overall Study|Investigator's decision|1
7601067|NCT00893789|12007108|FG000|Overall Study|Withdrawal by Subject|3
7601068|NCT00893789|12007109|FG001|Overall Study|Withdrawal by Subject|1
7601069|NCT00893789|12007110|FG002|Overall Study|Withdrawal by Subject|3
7601070|NCT00893789|12007111|FG003|Overall Study|Withdrawal by Subject|1
7601071|NCT00893789|12007108|FG000|Overall Study|Noncompliance With Study Drug|1
7601072|NCT00893789|12007109|FG001|Overall Study|Noncompliance With Study Drug|0
7601073|NCT00893789|12007110|FG002|Overall Study|Noncompliance With Study Drug|1
7601074|NCT00893789|12007111|FG003|Overall Study|Noncompliance With Study Drug|2
7601075|NCT00893789|12007108|FG000|Overall Study|Noncompliance With Study Procedures|1
7601076|NCT00893789|12007109|FG001|Overall Study|Noncompliance With Study Procedures|0
7601077|NCT00893789|12007110|FG002|Overall Study|Noncompliance With Study Procedures|0
7601078|NCT00893789|12007111|FG003|Overall Study|Noncompliance With Study Procedures|0
7601079|NCT00893789|12007108|FG000|Overall Study|Taking Excluded Concomitant Medication|1
7601080|NCT00893789|12007109|FG001|Overall Study|Taking Excluded Concomitant Medication|0
7601081|NCT00893789|12007110|FG002|Overall Study|Taking Excluded Concomitant Medication|1
7601082|NCT00893789|12007111|FG003|Overall Study|Taking Excluded Concomitant Medication|0
7601083|NCT00893789|12007108|FG000|Overall Study|Adverse Event|0
7601084|NCT00893789|12007109|FG001|Overall Study|Adverse Event|2
7272775|NCT00427960|11487083|FG001|Overall Study|Withdrawal by Subject|3
7272776|NCT00427960|11487082|FG000|Overall Study|Other|0
7272777|NCT00427960|11487083|FG001|Overall Study|Other|1
7272778|NCT00427999|11487093|FG000|Overall Study|Adverse Event|6
7272779|NCT00427999|11487093|FG000|Overall Study|Abnormal laboratory values|1
7272780|NCT00427999|11487093|FG000|Overall Study|Unsatisfactory therapeutic effect|13
7272781|NCT00427999|11487093|FG000|Overall Study|Protocol Violation|2
7272782|NCT00427999|11487093|FG000|Overall Study|Withdrawal by Subject|9
7272783|NCT00427999|11487093|FG000|Overall Study|Death|1
7272784|NCT00428090|11487106|FG000|Overall Study|Adverse Event|10
7272785|NCT00428090|11487107|FG001|Overall Study|Adverse Event|8
7272786|NCT00428090|11487108|FG002|Overall Study|Adverse Event|10
7272787|NCT00428090|11487109|FG003|Overall Study|Adverse Event|11
7272788|NCT00428090|11487106|FG000|Overall Study|Lost to Follow-up|3
7272789|NCT00428090|11487107|FG001|Overall Study|Lost to Follow-up|6
7272790|NCT00428090|11487108|FG002|Overall Study|Lost to Follow-up|1
7601085|NCT00893789|12007110|FG002|Overall Study|Adverse Event|1
7601086|NCT00893789|12007111|FG003|Overall Study|Adverse Event|5
7272791|NCT00428090|11487109|FG003|Overall Study|Lost to Follow-up|4
7272792|NCT00428090|11487106|FG000|Overall Study|Protocol Violation|3
7272793|NCT00428090|11487107|FG001|Overall Study|Protocol Violation|1
7601087|NCT00893789|12007108|FG000|Overall Study|Protocol Violation|0
7601088|NCT00893789|12007109|FG001|Overall Study|Protocol Violation|1
7601089|NCT00893789|12007110|FG002|Overall Study|Protocol Violation|1
7601090|NCT00893789|12007111|FG003|Overall Study|Protocol Violation|4
7601091|NCT00893789|12007108|FG000|Overall Study|Lost to Follow-up|0
7601092|NCT00893789|12007109|FG001|Overall Study|Lost to Follow-up|0
7601093|NCT00893789|12007110|FG002|Overall Study|Lost to Follow-up|0
7601094|NCT00893789|12007111|FG003|Overall Study|Lost to Follow-up|1
7272794|NCT00428090|11487108|FG002|Overall Study|Protocol Violation|3
7272795|NCT00428090|11487109|FG003|Overall Study|Protocol Violation|3
7272796|NCT00428090|11487106|FG000|Overall Study|Withdrawal by Subject|10
7601095|NCT03901144|12007129|FG000|Overall Study|Lost to Follow-up|1
7601096|NCT03901144|12007130|FG001|Overall Study|Lost to Follow-up|1
7601097|NCT03901144|12007131|FG002|Overall Study|Lost to Follow-up|1
7601098|NCT03901144|12007132|FG003|Overall Study|Lost to Follow-up|1
7601165|NCT03877926|12007485|FG000|Overall Study|Adverse Event|1
7601166|NCT03877926|12007486|FG001|Overall Study|Adverse Event|0
7601167|NCT03877926|12007487|FG002|Overall Study|Adverse Event|0
7601168|NCT03877926|12007488|FG003|Overall Study|Adverse Event|0
7601169|NCT03877926|12007485|FG000|Overall Study|Death|2
7601170|NCT03877926|12007486|FG001|Overall Study|Death|2
7601171|NCT03877926|12007487|FG002|Overall Study|Death|2
7601172|NCT03877926|12007488|FG003|Overall Study|Death|0
7601173|NCT03877926|12007485|FG000|Overall Study|Lost to Follow-up|41
7601174|NCT03877926|12007486|FG001|Overall Study|Lost to Follow-up|52
7601175|NCT03877926|12007487|FG002|Overall Study|Lost to Follow-up|45
7601176|NCT03877926|12007488|FG003|Overall Study|Lost to Follow-up|17
7601177|NCT03877926|12007485|FG000|Overall Study|Physician Decision|2
7601178|NCT03877926|12007486|FG001|Overall Study|Physician Decision|0
7601179|NCT03877926|12007487|FG002|Overall Study|Physician Decision|2
7601180|NCT03877926|12007488|FG003|Overall Study|Physician Decision|0
7601181|NCT03877926|12007485|FG000|Overall Study|Withdrawal by Subject|18
7601182|NCT03877926|12007486|FG001|Overall Study|Withdrawal by Subject|21
7272797|NCT00428090|11487107|FG001|Overall Study|Withdrawal by Subject|12
7272798|NCT00428090|11487108|FG002|Overall Study|Withdrawal by Subject|15
7272799|NCT00428090|11487109|FG003|Overall Study|Withdrawal by Subject|5
7272800|NCT00428090|11487106|FG000|Overall Study|Sponsor terminated study|0
7272801|NCT00428090|11487107|FG001|Overall Study|Sponsor terminated study|1
7272802|NCT00428090|11487108|FG002|Overall Study|Sponsor terminated study|0
7272803|NCT00428090|11487109|FG003|Overall Study|Sponsor terminated study|0
7272804|NCT00428090|11487106|FG000|Overall Study|Non-compliance|4
7272805|NCT00428090|11487107|FG001|Overall Study|Non-compliance|0
7272806|NCT00428090|11487108|FG002|Overall Study|Non-compliance|1
7272807|NCT00428090|11487109|FG003|Overall Study|Non-compliance|3
7601183|NCT03877926|12007487|FG002|Overall Study|Withdrawal by Subject|12
7601184|NCT03877926|12007488|FG003|Overall Study|Withdrawal by Subject|4
7601185|NCT03877926|12007485|FG000|Overall Study|Other - Various|4
7601186|NCT03877926|12007486|FG001|Overall Study|Other - Various|1
7601187|NCT03877926|12007487|FG002|Overall Study|Other - Various|1
7601188|NCT03877926|12007488|FG003|Overall Study|Other - Various|0
7601189|NCT03877926|12007485|FG000|Overall Study|Not Treated|3
7601190|NCT03877926|12007486|FG001|Overall Study|Not Treated|1
7601191|NCT03877926|12007487|FG002|Overall Study|Not Treated|1
7601192|NCT03877926|12007488|FG003|Overall Study|Not Treated|0
7601193|NCT03862807|12007511|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
7601194|NCT03857867|12007515|FG000|Overall Study|Physician Decision|1
7601195|NCT03691571|12007522|FG000|Overall Study|Withdrawal by Subject|9
7601196|NCT03691571|12007523|FG001|Overall Study|Withdrawal by Subject|2
7601197|NCT03436199|12007533|FG000|Overall Study|Adverse Event|15
7601198|NCT03436199|12007534|FG001|Overall Study|Adverse Event|40
7601199|NCT03436199|12007535|FG002|Overall Study|Adverse Event|7
7601099|NCT03461211|12007157|FG000|Overall Study|Adverse Event|1
7601100|NCT03461211|12007158|FG001|Overall Study|Adverse Event|1
7601101|NCT03461211|12007157|FG000|Overall Study|Lack of Efficacy|0
7601102|NCT03461211|12007158|FG001|Overall Study|Lack of Efficacy|1
7601103|NCT03276780|12007168|FG000|Overall Study|Withdrawal by Subject|5
7601104|NCT03276780|12007169|FG001|Overall Study|Withdrawal by Subject|3
7601105|NCT03276780|12007168|FG000|Overall Study|Lost to Follow-up|3
7601106|NCT03276780|12007169|FG001|Overall Study|Lost to Follow-up|5
7601107|NCT03276780|12007168|FG000|Overall Study|Moved out of state|1
7601108|NCT03276780|12007169|FG001|Overall Study|Moved out of state|1
7601109|NCT03276780|12007168|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
7601110|NCT03276780|12007169|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
7601111|NCT03276780|12007168|FG000|Overall Study|No show to appointments after baseline through Week 5|8
7601112|NCT03276780|12007169|FG001|Overall Study|No show to appointments after baseline through Week 5|1
7601113|NCT03050814|12007193|FG000|Overall Study|Screen failures|0
7601114|NCT03050814|12007194|FG001|Overall Study|Screen failures|0
7601115|NCT03050814|12007195|FG002|Overall Study|Screen failures|4
7601116|NCT02797262|12007203|FG000|Overall Study|Withdrawal by Subject|5
7601117|NCT02797262|12007204|FG001|Overall Study|Withdrawal by Subject|1
7601118|NCT02797262|12007203|FG000|Overall Study|Lost to Follow-up|10
7601119|NCT02797262|12007204|FG001|Overall Study|Lost to Follow-up|7
7601120|NCT02797262|12007203|FG000|Overall Study|Death|1
7601121|NCT02797262|12007204|FG001|Overall Study|Death|2
7601122|NCT02797262|12007203|FG000|Overall Study|Adverse Event|1
7601123|NCT02797262|12007204|FG001|Overall Study|Adverse Event|0
7601124|NCT02797262|12007203|FG000|Overall Study|COVID-19|2
7601125|NCT02797262|12007204|FG001|Overall Study|COVID-19|1
7601126|NCT02797262|12007203|FG000|Overall Study|Out-of-country|1
7601127|NCT02797262|12007204|FG001|Overall Study|Out-of-country|0
7601128|NCT02409368|12007222|FG000|Overall Study|Adverse event unrelated to study drug|16
7601129|NCT02409368|12007223|FG001|Overall Study|Adverse event unrelated to study drug|42
7601130|NCT02409368|12007224|FG002|Overall Study|Adverse event unrelated to study drug|10
7601131|NCT02409368|12007222|FG000|Overall Study|Death|5
7601132|NCT02409368|12007223|FG001|Overall Study|Death|17
7601133|NCT02409368|12007224|FG002|Overall Study|Death|5
7601134|NCT02409368|12007222|FG000|Overall Study|Disease Progression|101
7601135|NCT02409368|12007223|FG001|Overall Study|Disease Progression|346
7601136|NCT02409368|12007224|FG002|Overall Study|Disease Progression|63
7601137|NCT02409368|12007222|FG000|Overall Study|Lost to Follow-up|1
7601138|NCT02409368|12007223|FG001|Overall Study|Lost to Follow-up|5
7601139|NCT02409368|12007224|FG002|Overall Study|Lost to Follow-up|0
7601140|NCT02409368|12007222|FG000|Overall Study|maximum clinical benefit|3
7601141|NCT02409368|12007223|FG001|Overall Study|maximum clinical benefit|8
7601142|NCT02409368|12007224|FG002|Overall Study|maximum clinical benefit|1
7601143|NCT02409368|12007222|FG000|Overall Study|poor/non compliant|0
7601144|NCT02409368|12007223|FG001|Overall Study|poor/non compliant|2
7601145|NCT02409368|12007224|FG002|Overall Study|poor/non compliant|2
7601146|NCT02409368|12007222|FG000|Overall Study|study drug toxicity|12
7601147|NCT02409368|12007223|FG001|Overall Study|study drug toxicity|35
7601148|NCT02409368|12007224|FG002|Overall Study|study drug toxicity|6
7601149|NCT02409368|12007222|FG000|Overall Study|no longer meets study criteria|3
7601150|NCT02409368|12007223|FG001|Overall Study|no longer meets study criteria|9
7601151|NCT02409368|12007224|FG002|Overall Study|no longer meets study criteria|3
7601152|NCT02409368|12007222|FG000|Overall Study|Participant request to discontinue|3
7601153|NCT02409368|12007223|FG001|Overall Study|Participant request to discontinue|3
7601154|NCT02409368|12007224|FG002|Overall Study|Participant request to discontinue|3
7601155|NCT02409368|12007222|FG000|Overall Study|Participant withdrew consent|2
7601156|NCT02409368|12007223|FG001|Overall Study|Participant withdrew consent|4
7601157|NCT02409368|12007224|FG002|Overall Study|Participant withdrew consent|3
7601158|NCT02409368|12007222|FG000|Overall Study|Other Reasons|2
7601159|NCT02409368|12007223|FG001|Overall Study|Other Reasons|17
7601160|NCT02409368|12007224|FG002|Overall Study|Other Reasons|3
7601161|NCT02409368|12007222|FG000|Overall Study|Not Reported|0
7601162|NCT02409368|12007223|FG001|Overall Study|Not Reported|1
7601163|NCT02409368|12007224|FG002|Overall Study|Not Reported|0
7601164|NCT01285102|12007400|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
7601200|NCT03436199|12007533|FG000|Overall Study|Withdrawal by Subject|4
7601201|NCT03436199|12007534|FG001|Overall Study|Withdrawal by Subject|10
7601202|NCT03436199|12007535|FG002|Overall Study|Withdrawal by Subject|3
7601203|NCT03436199|12007533|FG000|Overall Study|Lost to Follow-up|1
7601204|NCT03436199|12007534|FG001|Overall Study|Lost to Follow-up|0
7601205|NCT03436199|12007535|FG002|Overall Study|Lost to Follow-up|2
7601206|NCT03436199|12007533|FG000|Overall Study|Protocol Violation|1
7601207|NCT03436199|12007534|FG001|Overall Study|Protocol Violation|1
7601208|NCT03436199|12007535|FG002|Overall Study|Protocol Violation|0
7601209|NCT03436199|12007533|FG000|Overall Study|Physician Decision|0
7601210|NCT03436199|12007534|FG001|Overall Study|Physician Decision|1
7601211|NCT03436199|12007535|FG002|Overall Study|Physician Decision|0
7601212|NCT03436199|12007533|FG000|Overall Study|Could not return to clinic|1
7601213|NCT03436199|12007534|FG001|Overall Study|Could not return to clinic|0
7601214|NCT03436199|12007535|FG002|Overall Study|Could not return to clinic|0
7601215|NCT03436199|12007533|FG000|Overall Study|Withdrawn per physician|0
7601216|NCT03436199|12007534|FG001|Overall Study|Withdrawn per physician|1
7601217|NCT03436199|12007535|FG002|Overall Study|Withdrawn per physician|0
7272808|NCT00428090|11487106|FG000|Overall Study|Par. did not returned to visit|1
7272809|NCT00428090|11487107|FG001|Overall Study|Par. did not returned to visit|0
7272810|NCT00428090|11487108|FG002|Overall Study|Par. did not returned to visit|0
7272811|NCT00428090|11487109|FG003|Overall Study|Par. did not returned to visit|1
7272812|NCT00428090|11487106|FG000|Overall Study|Follow-Up visit not possible|1
7272813|NCT00428090|11487107|FG001|Overall Study|Follow-Up visit not possible|0
7272814|NCT00428090|11487108|FG002|Overall Study|Follow-Up visit not possible|0
7272815|NCT00428090|11487109|FG003|Overall Study|Follow-Up visit not possible|0
7272816|NCT00428090|11487106|FG000|Overall Study|Prohibited medication used for SAE|1
7272817|NCT00428090|11487107|FG001|Overall Study|Prohibited medication used for SAE|0
7272818|NCT00428090|11487108|FG002|Overall Study|Prohibited medication used for SAE|0
7272819|NCT00428090|11487109|FG003|Overall Study|Prohibited medication used for SAE|0
7272820|NCT00428090|11487106|FG000|Overall Study|Death of par.|1
7272821|NCT00428090|11487107|FG001|Overall Study|Death of par.|0
7272822|NCT00428090|11487108|FG002|Overall Study|Death of par.|1
7272823|NCT00428090|11487109|FG003|Overall Study|Death of par.|0
7272824|NCT00428090|11487106|FG000|Overall Study|Visit 7 exceed the visit window|0
7272825|NCT00428090|11487107|FG001|Overall Study|Visit 7 exceed the visit window|1
7272826|NCT00428090|11487108|FG002|Overall Study|Visit 7 exceed the visit window|0
7272827|NCT00428090|11487109|FG003|Overall Study|Visit 7 exceed the visit window|0
7272828|NCT00428090|11487106|FG000|Overall Study|Medical monitor terminated par.|0
7272829|NCT00428090|11487107|FG001|Overall Study|Medical monitor terminated par.|1
7601226|NCT03217136|12007563|FG000|Overall Study|Lost to Follow-up|2
7601227|NCT03217136|12007564|FG001|Overall Study|Lost to Follow-up|1
7601228|NCT03217136|12007563|FG000|Overall Study|Site Randomized Participant in Error|0
7601229|NCT03217136|12007564|FG001|Overall Study|Site Randomized Participant in Error|1
7601230|NCT03217136|12007563|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
7601231|NCT03217136|12007564|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
7601232|NCT03217136|12007563|FG000|Overall Study|Dispensing Error|1
7601233|NCT03217136|12007564|FG001|Overall Study|Dispensing Error|0
7601234|NCT03217136|12007563|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7601235|NCT03217136|12007564|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7601236|NCT03181542|12007572|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
7601237|NCT03181542|12007573|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
7601238|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5
7601239|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2
7272830|NCT00428090|11487108|FG002|Overall Study|Medical monitor terminated par.|0
7272831|NCT00428090|11487109|FG003|Overall Study|Medical monitor terminated par.|0
7272832|NCT00428090|11487106|FG000|Overall Study|Mental status of par. was|0
7272833|NCT00428090|11487107|FG001|Overall Study|Mental status of par. was|1
7272834|NCT00428090|11487108|FG002|Overall Study|Mental status of par. was|0
7272835|NCT00428090|11487109|FG003|Overall Study|Mental status of par. was|0
7272836|NCT00428090|11487106|FG000|Overall Study|Worsening of AD|0
7272837|NCT00428090|11487107|FG001|Overall Study|Worsening of AD|0
7272838|NCT00428090|11487108|FG002|Overall Study|Worsening of AD|1
7272839|NCT00428090|11487109|FG003|Overall Study|Worsening of AD|0
7272840|NCT00428090|11487106|FG000|Overall Study|Excluded for concerning QTc value|0
7272841|NCT00428090|11487107|FG001|Overall Study|Excluded for concerning QTc value|0
7272842|NCT00428090|11487108|FG002|Overall Study|Excluded for concerning QTc value|1
7272843|NCT00428090|11487109|FG003|Overall Study|Excluded for concerning QTc value|0
7272844|NCT00428090|11487106|FG000|Overall Study|Insufficient AD documentation|0
7272845|NCT00428090|11487107|FG001|Overall Study|Insufficient AD documentation|0
7272846|NCT00428090|11487108|FG002|Overall Study|Insufficient AD documentation|1
7272847|NCT00428090|11487109|FG003|Overall Study|Insufficient AD documentation|0
7272848|NCT00428090|11487106|FG000|Overall Study|High MMSE scores|0
7272849|NCT00428090|11487107|FG001|Overall Study|High MMSE scores|0
7272850|NCT00428090|11487108|FG002|Overall Study|High MMSE scores|1
7272851|NCT00428090|11487109|FG003|Overall Study|High MMSE scores|0
7272852|NCT00428090|11487106|FG000|Overall Study|Deterioration of cognitive status|0
7272853|NCT00428090|11487107|FG001|Overall Study|Deterioration of cognitive status|0
7272854|NCT00428090|11487108|FG002|Overall Study|Deterioration of cognitive status|1
7272855|NCT00428090|11487109|FG003|Overall Study|Deterioration of cognitive status|0
7272856|NCT00428090|11487106|FG000|Overall Study|Serious adverse event|0
7272857|NCT00428090|11487107|FG001|Overall Study|Serious adverse event|0
7272858|NCT00428090|11487108|FG002|Overall Study|Serious adverse event|1
7272859|NCT00428090|11487109|FG003|Overall Study|Serious adverse event|0
7272860|NCT00428090|11487106|FG000|Overall Study|Excluded for heart insufficiency|0
7272861|NCT00428090|11487107|FG001|Overall Study|Excluded for heart insufficiency|0
7272862|NCT00428090|11487108|FG002|Overall Study|Excluded for heart insufficiency|1
7272863|NCT00428090|11487109|FG003|Overall Study|Excluded for heart insufficiency|0
7272864|NCT00428090|11487106|FG000|Overall Study|Raised Creatinine Value|0
7272865|NCT00428090|11487107|FG001|Overall Study|Raised Creatinine Value|0
7272866|NCT00428090|11487108|FG002|Overall Study|Raised Creatinine Value|0
7272867|NCT00428090|11487109|FG003|Overall Study|Raised Creatinine Value|1
7601240|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3
7601241|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8
7601242|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15
7601243|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24
7601244|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
7601245|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601246|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0
7601247|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601248|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3
7601249|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1
7601250|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601251|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601252|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601253|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1
7601254|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601255|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0
7601256|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Other|1
7601257|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Other|2
7601258|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Other|0
7601259|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Other|2
7601260|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Other|1
7601261|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Other|0
7601262|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7601263|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2
7601264|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601265|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601266|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0
7601267|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1
7601268|NCT03985293|12007628|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7601269|NCT03985293|12007629|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4
7601270|NCT03985293|12007630|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2
7601271|NCT03985293|12007631|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0
7601272|NCT03985293|12007632|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1
7601273|NCT03985293|12007633|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7
7601274|NCT03985293|12007628|FG000|FOLLOW-UP|Lost to Follow-up|0
7601275|NCT03985293|12007629|FG001|FOLLOW-UP|Lost to Follow-up|0
7601276|NCT03985293|12007630|FG002|FOLLOW-UP|Lost to Follow-up|1
7601277|NCT03985293|12007631|FG003|FOLLOW-UP|Lost to Follow-up|0
7601278|NCT03985293|12007632|FG004|FOLLOW-UP|Lost to Follow-up|0
7601279|NCT03985293|12007633|FG005|FOLLOW-UP|Lost to Follow-up|0
7272868|NCT00428116|11487129|FG000|Overall Study|Death|1
7272869|NCT00428116|11487130|FG001|Overall Study|Death|0
7272870|NCT00428116|11487129|FG000|Overall Study|Withdrawal by Subject|1
7272871|NCT00428116|11487130|FG001|Overall Study|Withdrawal by Subject|0
7272872|NCT00428116|11487129|FG000|Overall Study|Lost to Follow-up|1
7272873|NCT00428116|11487130|FG001|Overall Study|Lost to Follow-up|0
7272874|NCT00428220|11487137|FG000|Overall Study|Participant died|8
7272875|NCT00428220|11487137|FG000|Overall Study|Global deterioration of health status|7
7272876|NCT00428220|11487137|FG000|Overall Study|Lost to Follow-up|4
7272877|NCT00428220|11487137|FG000|Overall Study|Objective progression or relapse|123
7272878|NCT00428220|11487137|FG000|Overall Study|Participant refused continued treatment|7
7272879|NCT00428220|11487137|FG000|Overall Study|Adverse Event|51
7272880|NCT00428220|11487137|FG000|Overall Study|Other|23
7272881|NCT00428246|11487155|FG000|Overall Study|Withdrawal by Subject|0
7272882|NCT00428246|11487156|FG001|Overall Study|Withdrawal by Subject|0
7272883|NCT00428246|11487157|FG002|Overall Study|Withdrawal by Subject|1
7272884|NCT00428246|11487155|FG000|Overall Study|Adverse Event|1
7272885|NCT00428246|11487156|FG001|Overall Study|Adverse Event|0
7272886|NCT00428246|11487157|FG002|Overall Study|Adverse Event|0
7272887|NCT00428389|11487178|FG000|Core Phase|Adverse Event|6
7272888|NCT00428389|11487179|FG001|Core Phase|Adverse Event|4
7272889|NCT00428389|11487178|FG000|Core Phase|Lack of Efficacy|2
7272890|NCT00428389|11487179|FG001|Core Phase|Lack of Efficacy|0
7272891|NCT00428389|11487178|FG000|Core Phase|Abnormal test procedure result(s)|0
7272892|NCT00428389|11487179|FG001|Core Phase|Abnormal test procedure result(s)|1
7272893|NCT00428389|11487178|FG000|Core Phase|Withdrawal by Subject|3
7272894|NCT00428389|11487179|FG001|Core Phase|Withdrawal by Subject|4
7272895|NCT00428389|11487178|FG000|Core Phase|Protocol deviation|0
7272896|NCT00428389|11487179|FG001|Core Phase|Protocol deviation|2
7272897|NCT00428389|11487178|FG000|Extension Phase|Adverse Event|17
7272898|NCT00428389|11487179|FG001|Extension Phase|Adverse Event|11
7272899|NCT00428389|11487178|FG000|Extension Phase|Lack of Efficacy|4
7272900|NCT00428389|11487179|FG001|Extension Phase|Lack of Efficacy|3
7272901|NCT00428389|11487178|FG000|Extension Phase|Withdrawal by Subject|6
7272902|NCT00428389|11487179|FG001|Extension Phase|Withdrawal by Subject|6
7272903|NCT00428389|11487178|FG000|Extension Phase|Lost to Follow-up|0
7601280|NCT03846427|12007647|FG000|Overall Study|Death|7
7601281|NCT03846427|12007647|FG000|Overall Study|Withdrawal by Subject|2
7601282|NCT03846427|12007647|FG000|Overall Study|Remaining in study|59
7601285|NCT03776357|12007660|FG000|Overall Study|Lost to Follow-up|3
7272904|NCT00428389|11487179|FG001|Extension Phase|Lost to Follow-up|3
7272905|NCT00428389|11487178|FG000|Extension Phase|Death|1
7272906|NCT00428389|11487179|FG001|Extension Phase|Death|0
7272907|NCT00428389|11487178|FG000|Extension Phase|Protocol Violation|3
7272908|NCT00428389|11487179|FG001|Extension Phase|Protocol Violation|2
7272909|NCT00428389|11487178|FG000|Extension Phase|Administrative problems|1
7272910|NCT00428389|11487179|FG001|Extension Phase|Administrative problems|1
7272911|NCT00428441|11487185|FG000|Overall Study|Lost to Follow-up|1
7272912|NCT00428597|11487204|FG000|Overall Study|Randomized but not treated|3
7272913|NCT00428597|11487205|FG001|Overall Study|Randomized but not treated|3
7272914|NCT00428597|11487204|FG000|Overall Study|Objective Progression or Relapse|19
7272915|NCT00428597|11487205|FG001|Overall Study|Objective Progression or Relapse|47
7272916|NCT00428597|11487204|FG000|Overall Study|Study Terminated by Sponsor|41
7272917|NCT00428597|11487205|FG001|Overall Study|Study Terminated by Sponsor|16
7272918|NCT00428597|11487204|FG000|Overall Study|Adverse Event|15
7272919|NCT00428597|11487205|FG001|Overall Study|Adverse Event|7
7272920|NCT00428597|11487204|FG000|Overall Study|Global Deterioration of Health Status|1
7272921|NCT00428597|11487205|FG001|Overall Study|Global Deterioration of Health Status|5
7272922|NCT00428597|11487204|FG000|Overall Study|Protocol Violation|2
7272923|NCT00428597|11487205|FG001|Overall Study|Protocol Violation|1
7272924|NCT00428597|11487204|FG000|Overall Study|Withdrawal by Subject|2
7272925|NCT00428597|11487205|FG001|Overall Study|Withdrawal by Subject|1
7272926|NCT00428597|11487204|FG000|Overall Study|Other|1
7272927|NCT00428597|11487205|FG001|Overall Study|Other|1
7272928|NCT00428597|11487204|FG000|Overall Study|Lost to Follow-up|0
7272929|NCT00428597|11487205|FG001|Overall Study|Lost to Follow-up|1
7272930|NCT00428597|11487204|FG000|Overall Study|Pregnancy|1
7272931|NCT00428597|11487205|FG001|Overall Study|Pregnancy|0
7272932|NCT00428597|11487204|FG000|Overall Study|Death|1
7272933|NCT00428597|11487205|FG001|Overall Study|Death|3
7272934|NCT00428610|11487214|FG000|Overall Study|Death Due to Adverse Event|3
7272935|NCT00428610|11487215|FG001|Overall Study|Death Due to Adverse Event|0
7272936|NCT00428610|11487216|FG002|Overall Study|Death Due to Adverse Event|5
7272937|NCT00428610|11487214|FG000|Overall Study|Death Due to Progressive Disease|0
7272938|NCT00428610|11487215|FG001|Overall Study|Death Due to Progressive Disease|0
7272939|NCT00428610|11487216|FG002|Overall Study|Death Due to Progressive Disease|2
7601286|NCT03656068|12007664|FG000|Overall Study|Withdrawal by Subject|4
7601287|NCT03656068|12007664|FG000|Overall Study|Adverse Event|1
7601288|NCT03400956|12007680|FG000|Treatment Period 1|Adverse Event|0
7601289|NCT03400956|12007681|FG001|Treatment Period 1|Adverse Event|1
7601290|NCT03400956|12007682|FG002|Treatment Period 1|Adverse Event|0
7601291|NCT03400956|12007680|FG000|Treatment Period 1|Lost to Follow-up|0
7601292|NCT03400956|12007681|FG001|Treatment Period 1|Lost to Follow-up|0
7601293|NCT03400956|12007682|FG002|Treatment Period 1|Lost to Follow-up|1
7601294|NCT03400956|12007680|FG000|Treatment Period 1|Protocol Violation|0
7601295|NCT03400956|12007681|FG001|Treatment Period 1|Protocol Violation|2
7601296|NCT03400956|12007682|FG002|Treatment Period 1|Protocol Violation|0
7601297|NCT03400956|12007680|FG000|Treatment Period 1|Study terminated by sponsor|3
7601298|NCT03400956|12007681|FG001|Treatment Period 1|Study terminated by sponsor|1
7601299|NCT03400956|12007682|FG002|Treatment Period 1|Study terminated by sponsor|1
7601300|NCT03400956|12007680|FG000|Treatment Period 1|Withdrawal by Subject|0
7601301|NCT03400956|12007681|FG001|Treatment Period 1|Withdrawal by Subject|2
7601302|NCT03400956|12007682|FG002|Treatment Period 1|Withdrawal by Subject|4
7601303|NCT03400956|12007680|FG000|Treatment Period 1|Other|1
7601304|NCT03400956|12007681|FG001|Treatment Period 1|Other|2
7601305|NCT03400956|12007682|FG002|Treatment Period 1|Other|3
7601306|NCT03400956|12007680|FG000|Post-treatment Period 1|Adverse Event|0
7601307|NCT03400956|12007681|FG001|Post-treatment Period 1|Adverse Event|0
7601308|NCT03400956|12007682|FG002|Post-treatment Period 1|Adverse Event|1
7601309|NCT03400956|12007680|FG000|Post-treatment Period 1|Physician Decision|2
7601310|NCT03400956|12007681|FG001|Post-treatment Period 1|Physician Decision|3
7601311|NCT03400956|12007682|FG002|Post-treatment Period 1|Physician Decision|0
7601312|NCT03400956|12007680|FG000|Post-treatment Period 1|Study terminated by sponsor|11
7601313|NCT03400956|12007681|FG001|Post-treatment Period 1|Study terminated by sponsor|10
7601314|NCT03400956|12007682|FG002|Post-treatment Period 1|Study terminated by sponsor|11
7601315|NCT03400956|12007680|FG000|Post-treatment Period 1|Withdrawal by Subject|5
7601316|NCT03400956|12007681|FG001|Post-treatment Period 1|Withdrawal by Subject|0
7601317|NCT03400956|12007682|FG002|Post-treatment Period 1|Withdrawal by Subject|0
7601318|NCT03400956|12007680|FG000|Post-treatment Period 1|Other|4
7272940|NCT00428610|11487214|FG000|Overall Study|Adverse Event|2
7272941|NCT00428610|11487215|FG001|Overall Study|Adverse Event|3
7272942|NCT00428610|11487216|FG002|Overall Study|Adverse Event|2
7272943|NCT00428610|11487214|FG000|Overall Study|Investigator Decision|2
7272944|NCT00428610|11487215|FG001|Overall Study|Investigator Decision|1
7272945|NCT00428610|11487216|FG002|Overall Study|Investigator Decision|1
7272946|NCT00428610|11487214|FG000|Overall Study|Progressive Disease|42
7272947|NCT00428610|11487215|FG001|Overall Study|Progressive Disease|14
7272948|NCT00428610|11487216|FG002|Overall Study|Progressive Disease|22
7272949|NCT00428610|11487214|FG000|Overall Study|Withdrawal by Subject|4
7272950|NCT00428610|11487215|FG001|Overall Study|Withdrawal by Subject|0
7272951|NCT00428610|11487216|FG002|Overall Study|Withdrawal by Subject|0
7272952|NCT00428714|11487226|FG000|Overall Study|Progressive Disease|28
7272953|NCT00428714|11487227|FG001|Overall Study|Progressive Disease|36
7272954|NCT00428714|11487226|FG000|Overall Study|Withdrawal by Subject|0
7272955|NCT00428714|11487227|FG001|Overall Study|Withdrawal by Subject|3
7272956|NCT00428714|11487226|FG000|Overall Study|Adverse Event|0
7272957|NCT00428714|11487227|FG001|Overall Study|Adverse Event|2
7272958|NCT00428714|11487226|FG000|Overall Study|Physician Decision|1
7272959|NCT00428714|11487227|FG001|Overall Study|Physician Decision|1
7272960|NCT00428714|11487226|FG000|Overall Study|Death due to Progressive Disease (PD)|1
7272961|NCT00428714|11487227|FG001|Overall Study|Death due to Progressive Disease (PD)|0
7272962|NCT00428714|11487226|FG000|Overall Study|Death due to other then PD|1
7272963|NCT00428714|11487227|FG001|Overall Study|Death due to other then PD|0
7272964|NCT00428792|11487236|FG000|Overall Study|Lack of Efficacy|1
7272965|NCT00428792|11487237|FG001|Overall Study|Lack of Efficacy|3
7272966|NCT00428792|11487236|FG000|Overall Study|Lost to Follow-up|0
7272967|NCT00428792|11487237|FG001|Overall Study|Lost to Follow-up|1
7272968|NCT00428844|11487246|FG000|Completed Study Drug Treatment|Adverse Event|2
7272969|NCT00428844|11487247|FG001|Completed Study Drug Treatment|Adverse Event|4
7272970|NCT00428844|11487248|FG002|Completed Study Drug Treatment|Adverse Event|4
7272971|NCT00428844|11487246|FG000|Completed Study Drug Treatment|Protocol Violation|0
7272972|NCT00428844|11487247|FG001|Completed Study Drug Treatment|Protocol Violation|1
7272973|NCT00428844|11487248|FG002|Completed Study Drug Treatment|Protocol Violation|1
7272974|NCT00428844|11487246|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
7272975|NCT00428844|11487247|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
7272976|NCT00428844|11487248|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
7272977|NCT00428844|11487246|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
7272978|NCT00428844|11487247|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
7272979|NCT00428844|11487248|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
7272980|NCT00428844|11487246|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
7272981|NCT00428844|11487247|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
7272982|NCT00428844|11487248|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
7601319|NCT03400956|12007681|FG001|Post-treatment Period 1|Other|3
7601320|NCT03400956|12007682|FG002|Post-treatment Period 1|Other|4
7601321|NCT03400956|12007680|FG000|Treatment Period 2|Adverse Event|2
7601322|NCT03400956|12007681|FG001|Treatment Period 2|Adverse Event|1
7601323|NCT03400956|12007682|FG002|Treatment Period 2|Adverse Event|1
7601324|NCT03400956|12007680|FG000|Treatment Period 2|Lost to Follow-up|1
7601325|NCT03400956|12007681|FG001|Treatment Period 2|Lost to Follow-up|1
7601326|NCT03400956|12007682|FG002|Treatment Period 2|Lost to Follow-up|0
7601327|NCT03400956|12007680|FG000|Treatment Period 2|Withdrawal by Subject|0
7601328|NCT03400956|12007681|FG001|Treatment Period 2|Withdrawal by Subject|0
7601329|NCT03400956|12007682|FG002|Treatment Period 2|Withdrawal by Subject|3
7601330|NCT03400956|12007680|FG000|Treatment Period 2|Other|1
7601331|NCT03400956|12007681|FG001|Treatment Period 2|Other|1
7601332|NCT03400956|12007682|FG002|Treatment Period 2|Other|0
7601333|NCT03400956|12007680|FG000|Follow-up Period|Withdrawal by Subject|0
7601334|NCT03400956|12007681|FG001|Follow-up Period|Withdrawal by Subject|0
7601335|NCT03400956|12007682|FG002|Follow-up Period|Withdrawal by Subject|1
7601336|NCT03400956|12007680|FG000|Follow-up Period|Other|0
7601337|NCT03400956|12007681|FG001|Follow-up Period|Other|0
7601338|NCT03400956|12007682|FG002|Follow-up Period|Other|1
7601339|NCT03126539|12007695|FG000|Overall Study|Lost to Follow-up|1
7601340|NCT03126539|12007696|FG001|Overall Study|Lost to Follow-up|1
7601341|NCT03126539|12007697|FG002|Overall Study|Lost to Follow-up|1
7601342|NCT03126539|12007698|FG003|Overall Study|Lost to Follow-up|0
7601343|NCT03126539|12007699|FG004|Overall Study|Lost to Follow-up|0
7272983|NCT00428844|11487246|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7272984|NCT00428844|11487247|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
7272985|NCT00428844|11487248|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
7272986|NCT00428844|11487246|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
7272987|NCT00428844|11487247|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7272988|NCT00428844|11487248|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
7272989|NCT00428844|11487246|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
7272990|NCT00428844|11487247|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7272991|NCT00428844|11487248|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
7272992|NCT00428844|11487246|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7272993|NCT00428844|11487247|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
7272994|NCT00428844|11487248|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
7272995|NCT00428948|11487262|FG000|Overall Study|Lost to Follow-up|15
7272996|NCT00428948|11487263|FG001|Overall Study|Lost to Follow-up|8
7272997|NCT00428948|11487262|FG000|Overall Study|Adverse Event|148
7272998|NCT00428948|11487263|FG001|Overall Study|Adverse Event|24
7272999|NCT00428948|11487262|FG000|Overall Study|Subject Met Withdrawal Criteria|4
7273000|NCT00428948|11487263|FG001|Overall Study|Subject Met Withdrawal Criteria|0
7273001|NCT00428948|11487262|FG000|Overall Study|Investigator Withdrew Subject|3
7273002|NCT00428948|11487263|FG001|Overall Study|Investigator Withdrew Subject|4
7273003|NCT00428948|11487262|FG000|Overall Study|Subject Withdrew Consent|50
7273004|NCT00428948|11487263|FG001|Overall Study|Subject Withdrew Consent|30
7273005|NCT00428948|11487262|FG000|Overall Study|Protocol Deviation|1
7273006|NCT00428948|11487263|FG001|Overall Study|Protocol Deviation|1
7273007|NCT00429104|11487287|FG000|Overall Study|Protocol Violation|1
7601364|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7601365|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1
7601366|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3
7601367|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5
7601368|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4
7601369|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9
7601370|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6
7601371|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601372|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601373|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601374|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601375|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0
7601376|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601377|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7273008|NCT00429169|11487297|FG000|Overall Study|Lost to Follow-up|0
7273009|NCT00429169|11487298|FG001|Overall Study|Lost to Follow-up|1
7601378|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601379|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601380|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1
7601381|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3
7601382|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2
7601383|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601384|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601385|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601386|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601387|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0
7601388|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601389|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601390|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601391|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601392|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601393|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7601394|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1
7601395|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601396|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601397|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601398|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601399|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0
7601400|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601401|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601402|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601403|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601404|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601405|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601406|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1
7273028|NCT00429299|11487328|FG002|Overall Study|Adverse Event|1
7601407|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601408|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601409|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601410|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601411|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0
7601412|NCT02819635|12007750|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2
7601413|NCT02819635|12007751|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7601414|NCT02819635|12007752|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1
7601415|NCT02819635|12007753|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7601416|NCT02819635|12007754|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5
7601417|NCT02819635|12007755|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7
7601418|NCT02819635|12007756|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3
7601419|NCT02819635|12007757|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601420|NCT02819635|12007758|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601421|NCT02819635|12007759|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601422|NCT02819635|12007760|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601423|NCT02819635|12007761|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0
7601424|NCT02819635|12007750|FG000|Substudy 2, Part 2|Adverse Event|0
7601425|NCT02819635|12007751|FG001|Substudy 2, Part 2|Adverse Event|0
7601426|NCT02819635|12007752|FG002|Substudy 2, Part 2|Adverse Event|0
7601427|NCT02819635|12007753|FG003|Substudy 2, Part 2|Adverse Event|0
7601428|NCT02819635|12007754|FG004|Substudy 2, Part 2|Adverse Event|0
7601429|NCT02819635|12007755|FG005|Substudy 2, Part 2|Adverse Event|4
7601430|NCT02819635|12007756|FG006|Substudy 2, Part 2|Adverse Event|0
7601431|NCT02819635|12007757|FG007|Substudy 2, Part 2|Adverse Event|0
7601432|NCT02819635|12007758|FG008|Substudy 2, Part 2|Adverse Event|0
7601433|NCT02819635|12007759|FG009|Substudy 2, Part 2|Adverse Event|0
7601434|NCT02819635|12007760|FG010|Substudy 2, Part 2|Adverse Event|0
7601435|NCT02819635|12007761|FG011|Substudy 2, Part 2|Adverse Event|0
7601436|NCT02819635|12007750|FG000|Substudy 2, Part 2|Withdrew consent|0
7601437|NCT02819635|12007751|FG001|Substudy 2, Part 2|Withdrew consent|0
7601438|NCT02819635|12007752|FG002|Substudy 2, Part 2|Withdrew consent|0
7601439|NCT02819635|12007753|FG003|Substudy 2, Part 2|Withdrew consent|0
7601440|NCT02819635|12007754|FG004|Substudy 2, Part 2|Withdrew consent|0
7601441|NCT02819635|12007755|FG005|Substudy 2, Part 2|Withdrew consent|3
7601442|NCT02819635|12007756|FG006|Substudy 2, Part 2|Withdrew consent|1
7601443|NCT02819635|12007757|FG007|Substudy 2, Part 2|Withdrew consent|0
7601444|NCT02819635|12007758|FG008|Substudy 2, Part 2|Withdrew consent|0
7601445|NCT02819635|12007759|FG009|Substudy 2, Part 2|Withdrew consent|0
7601446|NCT02819635|12007760|FG010|Substudy 2, Part 2|Withdrew consent|0
7601447|NCT02819635|12007761|FG011|Substudy 2, Part 2|Withdrew consent|0
7601448|NCT02819635|12007750|FG000|Substudy 2, Part 2|Lost to Follow-up|0
7601449|NCT02819635|12007751|FG001|Substudy 2, Part 2|Lost to Follow-up|0
7601450|NCT02819635|12007752|FG002|Substudy 2, Part 2|Lost to Follow-up|0
7601451|NCT02819635|12007753|FG003|Substudy 2, Part 2|Lost to Follow-up|0
7601452|NCT02819635|12007754|FG004|Substudy 2, Part 2|Lost to Follow-up|0
7601453|NCT02819635|12007755|FG005|Substudy 2, Part 2|Lost to Follow-up|0
7601454|NCT02819635|12007756|FG006|Substudy 2, Part 2|Lost to Follow-up|1
7273010|NCT00429169|11487297|FG000|Overall Study|Ineligibility discovered after entry|2
7273011|NCT00429169|11487298|FG001|Overall Study|Ineligibility discovered after entry|1
7273012|NCT00429182|11487306|FG000|Overall Study|Not evaluable, Disease Progression|2
7273013|NCT00429182|11487306|FG000|Overall Study|Not eligible|5
7273014|NCT00429273|11487313|FG000|Overall Study|Lost to Follow-up|1
7273015|NCT00429273|11487314|FG001|Overall Study|Lost to Follow-up|2
7273016|NCT00429273|11487315|FG002|Overall Study|Lost to Follow-up|2
7273017|NCT00429273|11487313|FG000|Overall Study|Physician Decision|6
7273018|NCT00429273|11487314|FG001|Overall Study|Physician Decision|5
7273019|NCT00429273|11487315|FG002|Overall Study|Physician Decision|5
7273020|NCT00429273|11487313|FG000|Overall Study|Adverse Event|1
7273021|NCT00429273|11487314|FG001|Overall Study|Adverse Event|1
7273022|NCT00429273|11487315|FG002|Overall Study|Adverse Event|2
7601455|NCT02819635|12007757|FG007|Substudy 2, Part 2|Lost to Follow-up|0
7601456|NCT02819635|12007758|FG008|Substudy 2, Part 2|Lost to Follow-up|0
7601457|NCT02819635|12007759|FG009|Substudy 2, Part 2|Lost to Follow-up|0
7601458|NCT02819635|12007760|FG010|Substudy 2, Part 2|Lost to Follow-up|0
7601459|NCT02819635|12007761|FG011|Substudy 2, Part 2|Lost to Follow-up|0
7601460|NCT02819635|12007750|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601461|NCT02819635|12007751|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601462|NCT02819635|12007752|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601463|NCT02819635|12007753|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601464|NCT02819635|12007754|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601465|NCT02819635|12007755|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601466|NCT02819635|12007756|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2
7273023|NCT00429299|11487326|FG000|Overall Study|Disease Progression|1
7273024|NCT00429299|11487327|FG001|Overall Study|Disease Progression|1
7273025|NCT00429299|11487328|FG002|Overall Study|Disease Progression|0
7273026|NCT00429299|11487326|FG000|Overall Study|Adverse Event|2
7273027|NCT00429299|11487327|FG001|Overall Study|Adverse Event|5
7601467|NCT02819635|12007757|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601468|NCT02819635|12007758|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601469|NCT02819635|12007759|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601470|NCT02819635|12007760|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601471|NCT02819635|12007761|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0
7601472|NCT02819635|12007750|FG000|Substudy 2, Part 2|Other, not specified|0
7601473|NCT02819635|12007751|FG001|Substudy 2, Part 2|Other, not specified|0
7601474|NCT02819635|12007752|FG002|Substudy 2, Part 2|Other, not specified|0
7601475|NCT02819635|12007753|FG003|Substudy 2, Part 2|Other, not specified|0
7601476|NCT02819635|12007754|FG004|Substudy 2, Part 2|Other, not specified|0
7601477|NCT02819635|12007755|FG005|Substudy 2, Part 2|Other, not specified|4
7601478|NCT02819635|12007756|FG006|Substudy 2, Part 2|Other, not specified|8
7601479|NCT02819635|12007757|FG007|Substudy 2, Part 2|Other, not specified|0
7601480|NCT02819635|12007758|FG008|Substudy 2, Part 2|Other, not specified|0
7601481|NCT02819635|12007759|FG009|Substudy 2, Part 2|Other, not specified|0
7601482|NCT02819635|12007760|FG010|Substudy 2, Part 2|Other, not specified|0
7601483|NCT02819635|12007761|FG011|Substudy 2, Part 2|Other, not specified|0
7601484|NCT02819635|12007750|FG000|Substudy 3|Adverse Event|0
7601485|NCT02819635|12007751|FG001|Substudy 3|Adverse Event|0
7601486|NCT02819635|12007752|FG002|Substudy 3|Adverse Event|0
7601487|NCT02819635|12007753|FG003|Substudy 3|Adverse Event|0
7601488|NCT02819635|12007754|FG004|Substudy 3|Adverse Event|0
7601489|NCT02819635|12007755|FG005|Substudy 3|Adverse Event|0
7601490|NCT02819635|12007756|FG006|Substudy 3|Adverse Event|0
7601491|NCT02819635|12007757|FG007|Substudy 3|Adverse Event|0
7601492|NCT02819635|12007758|FG008|Substudy 3|Adverse Event|32
7601493|NCT02819635|12007759|FG009|Substudy 3|Adverse Event|3
7601494|NCT02819635|12007760|FG010|Substudy 3|Adverse Event|12
7601495|NCT02819635|12007761|FG011|Substudy 3|Adverse Event|18
7601496|NCT02819635|12007750|FG000|Substudy 3|Withdrew consent|0
7601497|NCT02819635|12007751|FG001|Substudy 3|Withdrew consent|0
7601498|NCT02819635|12007752|FG002|Substudy 3|Withdrew consent|0
7601499|NCT02819635|12007753|FG003|Substudy 3|Withdrew consent|0
7601500|NCT02819635|12007754|FG004|Substudy 3|Withdrew consent|0
7601501|NCT02819635|12007755|FG005|Substudy 3|Withdrew consent|0
7601502|NCT02819635|12007756|FG006|Substudy 3|Withdrew consent|0
7601503|NCT02819635|12007757|FG007|Substudy 3|Withdrew consent|0
7601504|NCT02819635|12007758|FG008|Substudy 3|Withdrew consent|11
7601505|NCT02819635|12007759|FG009|Substudy 3|Withdrew consent|1
7601506|NCT02819635|12007760|FG010|Substudy 3|Withdrew consent|4
7601507|NCT02819635|12007761|FG011|Substudy 3|Withdrew consent|9
7601508|NCT02819635|12007750|FG000|Substudy 3|Lost to Follow-up|0
7601509|NCT02819635|12007751|FG001|Substudy 3|Lost to Follow-up|0
7601510|NCT02819635|12007752|FG002|Substudy 3|Lost to Follow-up|0
7601511|NCT02819635|12007753|FG003|Substudy 3|Lost to Follow-up|0
7601512|NCT02819635|12007754|FG004|Substudy 3|Lost to Follow-up|0
7601513|NCT02819635|12007755|FG005|Substudy 3|Lost to Follow-up|0
7601514|NCT02819635|12007756|FG006|Substudy 3|Lost to Follow-up|0
7601515|NCT02819635|12007757|FG007|Substudy 3|Lost to Follow-up|0
7601516|NCT02819635|12007758|FG008|Substudy 3|Lost to Follow-up|1
7601517|NCT02819635|12007759|FG009|Substudy 3|Lost to Follow-up|0
7601518|NCT02819635|12007760|FG010|Substudy 3|Lost to Follow-up|1
7601519|NCT02819635|12007761|FG011|Substudy 3|Lost to Follow-up|1
7601520|NCT02819635|12007750|FG000|Substudy 3|COVID-19 Logistical Restrictions|0
7273029|NCT00429299|11487326|FG000|Overall Study|Protocol Violation|1
7273030|NCT00429299|11487327|FG001|Overall Study|Protocol Violation|0
7601521|NCT02819635|12007751|FG001|Substudy 3|COVID-19 Logistical Restrictions|0
7601522|NCT02819635|12007752|FG002|Substudy 3|COVID-19 Logistical Restrictions|0
7601523|NCT02819635|12007753|FG003|Substudy 3|COVID-19 Logistical Restrictions|0
7601524|NCT02819635|12007754|FG004|Substudy 3|COVID-19 Logistical Restrictions|0
7601525|NCT02819635|12007755|FG005|Substudy 3|COVID-19 Logistical Restrictions|0
7601526|NCT02819635|12007756|FG006|Substudy 3|COVID-19 Logistical Restrictions|0
7601527|NCT02819635|12007757|FG007|Substudy 3|COVID-19 Logistical Restrictions|0
7601528|NCT02819635|12007758|FG008|Substudy 3|COVID-19 Logistical Restrictions|0
7601529|NCT02819635|12007759|FG009|Substudy 3|COVID-19 Logistical Restrictions|0
7601530|NCT02819635|12007760|FG010|Substudy 3|COVID-19 Logistical Restrictions|0
7601531|NCT02819635|12007761|FG011|Substudy 3|COVID-19 Logistical Restrictions|1
7601532|NCT02819635|12007750|FG000|Substudy 3|Other, not specified|0
7601533|NCT02819635|12007751|FG001|Substudy 3|Other, not specified|0
7601534|NCT02819635|12007752|FG002|Substudy 3|Other, not specified|0
7601535|NCT02819635|12007753|FG003|Substudy 3|Other, not specified|0
7601536|NCT02819635|12007754|FG004|Substudy 3|Other, not specified|0
7601537|NCT02819635|12007755|FG005|Substudy 3|Other, not specified|0
7601538|NCT02819635|12007756|FG006|Substudy 3|Other, not specified|0
7601539|NCT02819635|12007757|FG007|Substudy 3|Other, not specified|0
7601540|NCT02819635|12007758|FG008|Substudy 3|Other, not specified|202
7601541|NCT02819635|12007759|FG009|Substudy 3|Other, not specified|5
7601542|NCT02819635|12007760|FG010|Substudy 3|Other, not specified|89
7601543|NCT02819635|12007761|FG011|Substudy 3|Other, not specified|39
7601544|NCT02756013|12007789|FG000|Overall Study|Adverse Event|1
7601545|NCT02756013|12007789|FG000|Overall Study|Hypersensitivity|1
7273031|NCT00429299|11487328|FG002|Overall Study|Protocol Violation|0
7273032|NCT00429299|11487326|FG000|Overall Study|Withdrawal by Subject|0
7273033|NCT00429299|11487327|FG001|Overall Study|Withdrawal by Subject|1
7273034|NCT00429299|11487328|FG002|Overall Study|Withdrawal by Subject|3
7273035|NCT00429364|11487338|FG000|Overall Study|Withdrawal by Subject|11
7273036|NCT00429364|11487339|FG001|Overall Study|Withdrawal by Subject|5
7273037|NCT00429364|11487338|FG000|Overall Study|Physician Decision|4
7273038|NCT00429364|11487339|FG001|Overall Study|Physician Decision|2
7273039|NCT00429364|11487338|FG000|Overall Study|Lost to Follow-up|7
7273040|NCT00429364|11487339|FG001|Overall Study|Lost to Follow-up|6
7273041|NCT00429364|11487338|FG000|Overall Study|Death|0
7601564|NCT02419807|12007842|FG000|Overall Study|Withdrawal by Subject|4
7601565|NCT02419807|12007842|FG000|Overall Study|Physician Decision|1
7601566|NCT02419807|12007842|FG000|Overall Study|Protocol Violation|5
7601581|NCT02242942|12007858|FG000|Overall Study|Death|17
7601582|NCT02242942|12007859|FG001|Overall Study|Death|20
7601583|NCT02242942|12007860|FG002|Overall Study|Death|2
7601584|NCT02242942|12007858|FG000|Overall Study|Physician Decision|1
7601585|NCT02242942|12007859|FG001|Overall Study|Physician Decision|0
7601586|NCT02242942|12007860|FG002|Overall Study|Physician Decision|0
7601587|NCT02242942|12007858|FG000|Overall Study|Withdrawal by Subject|8
7601588|NCT02242942|12007859|FG001|Overall Study|Withdrawal by Subject|10
7601589|NCT02242942|12007860|FG002|Overall Study|Withdrawal by Subject|0
7601590|NCT02242942|12007858|FG000|Overall Study|On-going in Study|190
7601591|NCT02242942|12007859|FG001|Overall Study|On-going in Study|186
7601592|NCT02242942|12007860|FG002|Overall Study|On-going in Study|11
7601593|NCT02231749|12007872|FG000|Overall Study|Disease progression|229
7601594|NCT02231749|12007873|FG001|Overall Study|Disease progression|297
7601595|NCT02231749|12007872|FG000|Overall Study|Study Drug Toxicity|134
7601596|NCT02231749|12007873|FG001|Overall Study|Study Drug Toxicity|63
7601597|NCT02231749|12007872|FG000|Overall Study|Death|1
7601598|NCT02231749|12007873|FG001|Overall Study|Death|1
7273042|NCT00429364|11487339|FG001|Overall Study|Death|1
7273043|NCT00429364|11487338|FG000|Overall Study|Underwent aortic root surgery|10
7273044|NCT00429364|11487339|FG001|Overall Study|Underwent aortic root surgery|18
7273045|NCT00429364|11487338|FG000|Overall Study|Pregnancy|0
7273046|NCT00429364|11487339|FG001|Overall Study|Pregnancy|1
7469697|NCT01926028|11771585|FG001|Overall Study|Lost to Follow-up|6
7469698|NCT01926028|11771586|FG002|Overall Study|Lost to Follow-up|0
7469699|NCT01926028|11771584|FG000|Overall Study|Physician Decision|1
7469700|NCT01926028|11771585|FG001|Overall Study|Physician Decision|5
7469701|NCT01926028|11771586|FG002|Overall Study|Physician Decision|0
7469702|NCT01926028|11771584|FG000|Overall Study|Withdrawal by Subject|9
7601599|NCT02231749|12007872|FG000|Overall Study|AE unrelated to Study drug|32
7601600|NCT02231749|12007873|FG001|Overall Study|AE unrelated to Study drug|31
7469703|NCT01926028|11771585|FG001|Overall Study|Withdrawal by Subject|9
7601601|NCT02231749|12007872|FG000|Overall Study|Participant's request to discontinue|10
7601602|NCT02231749|12007873|FG001|Overall Study|Participant's request to discontinue|21
7601603|NCT02231749|12007872|FG000|Overall Study|Participant withdrew Consent|8
7601604|NCT02231749|12007873|FG001|Overall Study|Participant withdrew Consent|15
7601605|NCT02231749|12007872|FG000|Overall Study|Lost to Follow-up|1
7601606|NCT02231749|12007873|FG001|Overall Study|Lost to Follow-up|2
7601607|NCT02231749|12007872|FG000|Overall Study|Maximum Clinical Benefit|5
7601608|NCT02231749|12007873|FG001|Overall Study|Maximum Clinical Benefit|8
7601609|NCT02231749|12007872|FG000|Overall Study|Poor/Non-Compliance|0
7601610|NCT02231749|12007873|FG001|Overall Study|Poor/Non-Compliance|3
7601611|NCT02231749|12007872|FG000|Overall Study|Pregnancy|1
7601612|NCT02231749|12007873|FG001|Overall Study|Pregnancy|0
7601613|NCT02231749|12007872|FG000|Overall Study|other|0
7601614|NCT02231749|12007873|FG001|Overall Study|other|8
7601615|NCT02231749|12007872|FG000|Overall Study|No longer meets Study Criteria|1
7601616|NCT02231749|12007873|FG001|Overall Study|No longer meets Study Criteria|0
7601617|NCT02227199|12007882|FG000|Overall Study|Physician Decision|0
7601618|NCT02227199|12007883|FG001|Overall Study|Physician Decision|0
7601619|NCT02227199|12007884|FG002|Overall Study|Physician Decision|1
7601620|NCT02227199|12007882|FG000|Overall Study|Adverse Event|0
7601621|NCT02227199|12007883|FG001|Overall Study|Adverse Event|0
7601622|NCT02227199|12007884|FG002|Overall Study|Adverse Event|3
7601623|NCT02181413|12007898|FG000|Overall Study|Adverse Event|7
7601624|NCT02181413|12007899|FG001|Overall Study|Adverse Event|24
7601625|NCT02181413|12007898|FG000|Overall Study|Progressive Disease|121
7601626|NCT02181413|12007899|FG001|Overall Study|Progressive Disease|143
7601627|NCT02181413|12007898|FG000|Overall Study|Withdrawal by Subject|5
7601628|NCT02181413|12007899|FG001|Overall Study|Withdrawal by Subject|8
7601629|NCT02181413|12007898|FG000|Overall Study|Reason Not Specified|19
7601630|NCT02181413|12007899|FG001|Overall Study|Reason Not Specified|20
7601631|NCT02181413|12007898|FG000|Overall Study|Ongoing Study Treatment|0
7601632|NCT02181413|12007899|FG001|Overall Study|Ongoing Study Treatment|1
7601633|NCT02181413|12007898|FG000|Overall Study|Lost to Follow-up|0
7601634|NCT02181413|12007899|FG001|Overall Study|Lost to Follow-up|1
7601635|NCT02095678|12007907|FG000|Overall Study|Withdrawal by Subject|0
7601636|NCT02095678|12007908|FG001|Overall Study|Withdrawal by Subject|1
7601637|NCT02095678|12007907|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
7601638|NCT02095678|12007908|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
7601639|NCT02095678|12007907|FG000|Overall Study|lesion impacted by previous treatment|1
7601640|NCT02095678|12007908|FG001|Overall Study|lesion impacted by previous treatment|1
7601641|NCT02095678|12007907|FG000|Overall Study|No Confirmed Diagnosis|0
7601642|NCT02095678|12007908|FG001|Overall Study|No Confirmed Diagnosis|3
7601643|NCT02095678|12007907|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
7601644|NCT02095678|12007908|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
7601645|NCT02095678|12007907|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
7601646|NCT02095678|12007908|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
7601659|NCT01955109|12007937|FG000|Overall Study|Adverse Event|2
7601660|NCT01955109|12007938|FG001|Overall Study|Adverse Event|0
7601661|NCT01955109|12007937|FG000|Overall Study|Participant unwilling to continue|35
7601662|NCT01955109|12007938|FG001|Overall Study|Participant unwilling to continue|7
7601663|NCT01955109|12007937|FG000|Overall Study|Physician Decision|2
7601664|NCT01955109|12007938|FG001|Overall Study|Physician Decision|0
7601665|NCT01955109|12007937|FG000|Overall Study|Lost to Follow-up|3
7601666|NCT01955109|12007938|FG001|Overall Study|Lost to Follow-up|1
7601667|NCT01955109|12007937|FG000|Overall Study|Non-compliance|3
7601668|NCT01955109|12007938|FG001|Overall Study|Non-compliance|1
7273047|NCT00429416|11487354|FG000|Overall Study|Death|1
7273048|NCT00429494|11487358|FG000|Overall Study|Withdrawal by Subject|9
7273049|NCT00429494|11487358|FG000|Overall Study|Death|6
7273050|NCT00429572|11487366|FG000|Overall Study|Disease progression|1
7273051|NCT00429585|11487372|FG000|Overall Study|Death|1
7273052|NCT00429585|11487373|FG001|Overall Study|Death|0
7273053|NCT00429585|11487372|FG000|Overall Study|Lost to Follow-up|27
7273054|NCT00429585|11487373|FG001|Overall Study|Lost to Follow-up|20
7273055|NCT00429585|11487372|FG000|Overall Study|Physician Decision|2
7273056|NCT00429585|11487373|FG001|Overall Study|Physician Decision|0
7273057|NCT00429663|11487381|FG000|Overall Study|Lost to Follow-up|24
7273058|NCT00429663|11487382|FG001|Overall Study|Lost to Follow-up|31
7273059|NCT00429663|11487381|FG000|Overall Study|Physician Decision|6
7273060|NCT00429663|11487382|FG001|Overall Study|Physician Decision|3
7273061|NCT00429663|11487381|FG000|Overall Study|Withdrawal by Subject|2
7273062|NCT00429663|11487382|FG001|Overall Study|Withdrawal by Subject|5
7273063|NCT00429663|11487381|FG000|Overall Study|Death|4
7273064|NCT00429663|11487382|FG001|Overall Study|Death|0
7273065|NCT00429793|11487397|FG000|Overall Study|Improper pre-protocol treatment|3
7273066|NCT00429793|11487397|FG000|Overall Study|Required test not done|1
7273067|NCT00429793|11487397|FG000|Overall Study|Never treated|1
7273068|NCT00429793|11487397|FG000|Overall Study|Non-measurable|1
7273069|NCT00430248|11487424|FG000|Overall Study|Adverse Event|49
7273070|NCT00430248|11487425|FG001|Overall Study|Adverse Event|61
7273071|NCT00430248|11487426|FG002|Overall Study|Adverse Event|64
7273072|NCT00430248|11487424|FG000|Overall Study|Protocol Violation|10
7273073|NCT00430248|11487425|FG001|Overall Study|Protocol Violation|2
7273074|NCT00430248|11487426|FG002|Overall Study|Protocol Violation|4
7273075|NCT00430248|11487424|FG000|Overall Study|Personal Reasons|12
7273076|NCT00430248|11487425|FG001|Overall Study|Personal Reasons|24
7273077|NCT00430248|11487426|FG002|Overall Study|Personal Reasons|9
7273078|NCT00430248|11487424|FG000|Overall Study|Lost to Follow-up|28
7273079|NCT00430248|11487425|FG001|Overall Study|Lost to Follow-up|33
7273080|NCT00430248|11487426|FG002|Overall Study|Lost to Follow-up|28
7273081|NCT00430248|11487424|FG000|Overall Study|Therapeutic Failure|1
7273082|NCT00430248|11487425|FG001|Overall Study|Therapeutic Failure|1
7273083|NCT00430248|11487426|FG002|Overall Study|Therapeutic Failure|1
7601753|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7601754|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
7601755|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
7601756|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
7601757|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7601758|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
7601759|NCT01854775|12007987|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7601760|NCT01854775|12007988|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
7601761|NCT01854775|12007989|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
7601762|NCT01854775|12007987|FG000|Extension Phase|Pregnancy|3
7601763|NCT01854775|12007988|FG001|Extension Phase|Pregnancy|0
7601764|NCT01854775|12007989|FG002|Extension Phase|Pregnancy|0
7601765|NCT01854775|12007987|FG000|Extension Phase|Investigator's Discretion|1
7601766|NCT01854775|12007988|FG001|Extension Phase|Investigator's Discretion|0
7601767|NCT01854775|12007989|FG002|Extension Phase|Investigator's Discretion|0
7601768|NCT01854775|12007987|FG000|Extension Phase|Non-Compliance with Study Drug|1
7601769|NCT01854775|12007988|FG001|Extension Phase|Non-Compliance with Study Drug|0
7601770|NCT01854775|12007989|FG002|Extension Phase|Non-Compliance with Study Drug|0
7601771|NCT01854775|12007987|FG000|Extension Phase|Lost to Follow-up|2
7601772|NCT01854775|12007988|FG001|Extension Phase|Lost to Follow-up|0
7601773|NCT01854775|12007989|FG002|Extension Phase|Lost to Follow-up|0
7601774|NCT01854775|12007987|FG000|Extension Phase|Still on Study|32
7273084|NCT00430248|11487424|FG000|Overall Study|Withdrawal by Subject|14
7273085|NCT00430248|11487425|FG001|Overall Study|Withdrawal by Subject|20
7273086|NCT00430248|11487426|FG002|Overall Study|Withdrawal by Subject|16
7273087|NCT00430248|11487424|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7469704|NCT01926028|11771586|FG002|Overall Study|Withdrawal by Subject|2
7601775|NCT01854775|12007988|FG001|Extension Phase|Still on Study|47
7601776|NCT01854775|12007989|FG002|Extension Phase|Still on Study|18
7601777|NCT01839331|12008015|FG000|Overall Study|Early Termination|3
7601778|NCT01839331|12008016|FG001|Overall Study|Early Termination|0
7601779|NCT01839331|12008017|FG002|Overall Study|Early Termination|1
7601780|NCT01839331|12008018|FG003|Overall Study|Early Termination|2
7601781|NCT01839331|12008015|FG000|Overall Study|Protocol Violation|1
7601782|NCT01839331|12008016|FG001|Overall Study|Protocol Violation|6
7601783|NCT01839331|12008017|FG002|Overall Study|Protocol Violation|4
7601784|NCT01839331|12008018|FG003|Overall Study|Protocol Violation|3
7601787|NCT01235234|12008057|FG000|Overall Study|Adverse Event|2
7601788|NCT01235234|12008058|FG001|Overall Study|Adverse Event|2
7601789|NCT01235234|12008059|FG002|Overall Study|Adverse Event|1
7273088|NCT00430248|11487425|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
7273089|NCT00430248|11487426|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
7273090|NCT00430248|11487424|FG000|Overall Study|Gout Flare|3
7273091|NCT00430248|11487425|FG001|Overall Study|Gout Flare|7
7273092|NCT00430248|11487426|FG002|Overall Study|Gout Flare|2
7273093|NCT00430248|11487424|FG000|Overall Study|Reason Not Specified|8
7273094|NCT00430248|11487425|FG001|Overall Study|Reason Not Specified|8
7273095|NCT00430248|11487426|FG002|Overall Study|Reason Not Specified|11
7273096|NCT00430300|11487438|FG000|Overall Study|Adverse Event|0
7273097|NCT00430300|11487439|FG001|Overall Study|Adverse Event|2
7273098|NCT00430300|11487440|FG002|Overall Study|Adverse Event|1
7273099|NCT00430300|11487441|FG003|Overall Study|Adverse Event|1
7273100|NCT00430300|11487438|FG000|Overall Study|Withdrawal by Subject|1
7273101|NCT00430300|11487439|FG001|Overall Study|Withdrawal by Subject|0
7273102|NCT00430300|11487440|FG002|Overall Study|Withdrawal by Subject|5
7273103|NCT00430300|11487441|FG003|Overall Study|Withdrawal by Subject|0
7273104|NCT00430300|11487438|FG000|Overall Study|Laboratory abnormality|1
7601790|NCT01160211|12008070|FG000|Overall Study|ongoing|90
7601791|NCT01160211|12008071|FG001|Overall Study|ongoing|75
7601792|NCT01160211|12008072|FG002|Overall Study|ongoing|79
7601793|NCT01160211|12008070|FG000|Overall Study|Withdrawal by Subject|3
7601794|NCT01160211|12008071|FG001|Overall Study|Withdrawal by Subject|5
7601795|NCT01160211|12008072|FG002|Overall Study|Withdrawal by Subject|3
7601796|NCT01160211|12008070|FG000|Overall Study|Physician Decision|2
7601797|NCT01160211|12008071|FG001|Overall Study|Physician Decision|0
7601798|NCT01160211|12008072|FG002|Overall Study|Physician Decision|0
7601799|NCT01160211|12008070|FG000|Overall Study|Lost to Follow-up|4
7601800|NCT01160211|12008071|FG001|Overall Study|Lost to Follow-up|7
7601801|NCT01160211|12008072|FG002|Overall Study|Lost to Follow-up|5
7601802|NCT01093573|12008084|FG000|Overall Study|Physician Decision|0
7601803|NCT01093573|12008085|FG001|Overall Study|Physician Decision|0
7601804|NCT01093573|12008086|FG002|Overall Study|Physician Decision|1
7601805|NCT01093573|12008084|FG000|Overall Study|Insurance Denied|0
7601806|NCT01093573|12008085|FG001|Overall Study|Insurance Denied|0
7601807|NCT01093573|12008086|FG002|Overall Study|Insurance Denied|1
7601808|NCT00828854|12008097|FG000|Overall Study|Disease Progression|17
7601809|NCT00828854|12008097|FG000|Overall Study|Adverse Event|9
7601810|NCT00828854|12008097|FG000|Overall Study|Reason not Specified|1
7601811|NCT00753545|12008103|FG000|Overall Study|Death|98
7601812|NCT00753545|12008104|FG001|Overall Study|Death|112
7601813|NCT00753545|12008103|FG000|Overall Study|Lost to Follow-up|2
7601814|NCT00753545|12008104|FG001|Overall Study|Lost to Follow-up|3
7601815|NCT00753545|12008103|FG000|Overall Study|Protocol Violation|1
7601816|NCT00753545|12008104|FG001|Overall Study|Protocol Violation|0
7601817|NCT00753545|12008103|FG000|Overall Study|Voluntary Discontinuation of Patient|7
7601818|NCT00753545|12008104|FG001|Overall Study|Voluntary Discontinuation of Patient|3
7601819|NCT00494234|12008112|FG000|Overall Study|Lack of Efficacy|12
7601820|NCT00494234|12008113|FG001|Overall Study|Lack of Efficacy|9
7601821|NCT00494234|12008112|FG000|Overall Study|Withdrawal by Subject|1
7601822|NCT00494234|12008113|FG001|Overall Study|Withdrawal by Subject|0
7601823|NCT00494234|12008112|FG000|Overall Study|Death|2
7601824|NCT00494234|12008113|FG001|Overall Study|Death|1
7601825|NCT04600076|12008145|FG000|Overall Study|Lost to Follow-up|3
7601826|NCT04375397|12008151|FG000|Overall Study|Death|1
7601827|NCT04375397|12008152|FG001|Overall Study|Death|1
7601828|NCT04375397|12008151|FG000|Overall Study|Withdrew consent|2
7601829|NCT04375397|12008152|FG001|Overall Study|Withdrew consent|0
7601830|NCT04375397|12008151|FG000|Overall Study|Lost to Follow-up|6
7601831|NCT04375397|12008152|FG001|Overall Study|Lost to Follow-up|4
7601832|NCT04375397|12008151|FG000|Overall Study|Other, not specified|0
7601833|NCT04375397|12008152|FG001|Overall Study|Other, not specified|1
7601834|NCT04075734|12008177|FG000|Overall Study|Lost to Follow-up|1
7601835|NCT04075734|12008178|FG001|Overall Study|Lost to Follow-up|1
7601836|NCT04075734|12008179|FG002|Overall Study|Lost to Follow-up|0
7601837|NCT04075734|12008177|FG000|Overall Study|Withdrawal by Subject|3
7601838|NCT04075734|12008178|FG001|Overall Study|Withdrawal by Subject|0
7601839|NCT04075734|12008179|FG002|Overall Study|Withdrawal by Subject|0
7601840|NCT03915470|12008207|FG000|Overall Study|Death|3
7601841|NCT03915470|12008208|FG001|Overall Study|Death|1
7601842|NCT03915470|12008207|FG000|Overall Study|Adverse Event|1
7601843|NCT03915470|12008208|FG001|Overall Study|Adverse Event|0
7601844|NCT03915470|12008207|FG000|Overall Study|Physician Decision|1
7601845|NCT03915470|12008208|FG001|Overall Study|Physician Decision|0
7601846|NCT03915470|12008207|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
7601847|NCT03915470|12008208|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1
7601848|NCT03881553|12008221|FG000|Overall Study|Discharged prior to participation|1
7601849|NCT03881553|12008222|FG001|Overall Study|Discharged prior to participation|1
7601850|NCT03881553|12008223|FG002|Overall Study|Discharged prior to participation|0
7601851|NCT03881553|12008221|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
7601852|NCT03881553|12008222|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0
7601853|NCT03881553|12008223|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1
7273105|NCT00430300|11487439|FG001|Overall Study|Laboratory abnormality|0
7601854|NCT03718000|12008312|FG000|Overall Study|Relocation|2
7601855|NCT03718000|12008313|FG001|Overall Study|Relocation|4
7601856|NCT03718000|12008312|FG000|Overall Study|Pregnancy|0
7601857|NCT03718000|12008313|FG001|Overall Study|Pregnancy|1
7601870|NCT03654651|12008358|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
7601871|NCT03654651|12008359|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
7601872|NCT03633396|12008368|FG000|Overall Study|Withdrawal by Subject|4
7601873|NCT03633396|12008369|FG001|Overall Study|Withdrawal by Subject|4
7601874|NCT03633396|12008368|FG000|Overall Study|Adverse Event|1
7601875|NCT03633396|12008369|FG001|Overall Study|Adverse Event|1
7601876|NCT03633396|12008368|FG000|Overall Study|Lack of Efficacy|1
7601877|NCT03633396|12008369|FG001|Overall Study|Lack of Efficacy|0
7601878|NCT03633396|12008368|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0
7601879|NCT03633396|12008369|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1
7601880|NCT03612856|12008378|FG000|Pre-dose Period|Physician Decision|0
7601881|NCT03612856|12008379|FG001|Pre-dose Period|Physician Decision|1
7601882|NCT03612856|12008380|FG002|Pre-dose Period|Physician Decision|1
7601883|NCT03612856|12008378|FG000|Pre-dose Period|Withdrawal by Subject|0
7601884|NCT03612856|12008379|FG001|Pre-dose Period|Withdrawal by Subject|1
7601885|NCT03612856|12008380|FG002|Pre-dose Period|Withdrawal by Subject|0
7601886|NCT03607994|12008390|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7601887|NCT03607994|12008391|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
7601899|NCT03505671|12008425|FG000|Overall Study|Withdrawal by Subject|2
7601900|NCT03505671|12008426|FG001|Overall Study|Withdrawal by Subject|1
7601901|NCT03505671|12008425|FG000|Overall Study|Lost to Follow-up|1
7601902|NCT03505671|12008426|FG001|Overall Study|Lost to Follow-up|0
7601903|NCT03469999|12008432|FG000|Overall Study|Lost to Follow-up|2
7601904|NCT03463993|12008439|FG000|Overall Study|Lost to Follow-up|7
7601905|NCT03463993|12008440|FG001|Overall Study|Lost to Follow-up|8
7601906|NCT03463993|12008439|FG000|Overall Study|Withdrawal by Subject|2
7601907|NCT03463993|12008440|FG001|Overall Study|Withdrawal by Subject|0
7601908|NCT03463993|12008439|FG000|Overall Study|Protocol Violation|4
7601909|NCT03463993|12008440|FG001|Overall Study|Protocol Violation|1
7601910|NCT03463993|12008439|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9
7601911|NCT03463993|12008440|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11
7601912|NCT03463993|12008439|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7
7601913|NCT03463993|12008440|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6
7601914|NCT03390101|12008449|FG000|Weeks 0-12|Withdrawal by Subject|0
7601915|NCT03390101|12008450|FG001|Weeks 0-12|Withdrawal by Subject|1
7601916|NCT03390101|12008451|FG002|Weeks 0-12|Withdrawal by Subject|1
7601917|NCT03390101|12008449|FG000|Weeks 0-12|Lost to Follow-up|0
7601918|NCT03390101|12008450|FG001|Weeks 0-12|Lost to Follow-up|1
7601919|NCT03390101|12008451|FG002|Weeks 0-12|Lost to Follow-up|0
7601920|NCT03390101|12008449|FG000|Weeks 12-54|Withdrawal by Subject|0
7601921|NCT03390101|12008450|FG001|Weeks 12-54|Withdrawal by Subject|3
7601922|NCT03390101|12008451|FG002|Weeks 12-54|Withdrawal by Subject|1
7601923|NCT03390101|12008449|FG000|Weeks 12-54|Pregnancy|1
7601924|NCT03390101|12008450|FG001|Weeks 12-54|Pregnancy|0
7601925|NCT03390101|12008451|FG002|Weeks 12-54|Pregnancy|0
7601926|NCT03390101|12008449|FG000|Weeks 12-54|Adverse Event|2
7601927|NCT03390101|12008450|FG001|Weeks 12-54|Adverse Event|1
7601928|NCT03390101|12008451|FG002|Weeks 12-54|Adverse Event|1
7601929|NCT03213158|12008459|FG000|Overall Study|Withdrawal by Subject|1
7601930|NCT03213158|12008459|FG000|Overall Study|Physician Decision|2
7601931|NCT03179605|12008463|FG000|Overall Study|Withdrawal by Subject|1
7601932|NCT03150862|12008484|FG000|Overall Study|Death|2
7601933|NCT03150862|12008485|FG001|Overall Study|Death|7
7601934|NCT03150862|12008486|FG002|Overall Study|Death|8
7601935|NCT03150862|12008487|FG003|Overall Study|Death|27
7601936|NCT03150862|12008488|FG004|Overall Study|Death|4
7601937|NCT03150862|12008489|FG005|Overall Study|Death|8
7601938|NCT03150862|12008490|FG006|Overall Study|Death|6
7601939|NCT03150862|12008491|FG007|Overall Study|Death|21
7601940|NCT03150862|12008484|FG000|Overall Study|Withdrawal by Subject|1
7273106|NCT00430300|11487440|FG002|Overall Study|Laboratory abnormality|0
7273107|NCT00430300|11487441|FG003|Overall Study|Laboratory abnormality|0
7601941|NCT03150862|12008485|FG001|Overall Study|Withdrawal by Subject|1
7601942|NCT03150862|12008486|FG002|Overall Study|Withdrawal by Subject|0
7601943|NCT03150862|12008487|FG003|Overall Study|Withdrawal by Subject|3
7601944|NCT03150862|12008488|FG004|Overall Study|Withdrawal by Subject|1
7601945|NCT03150862|12008489|FG005|Overall Study|Withdrawal by Subject|1
7601946|NCT03150862|12008490|FG006|Overall Study|Withdrawal by Subject|1
7601947|NCT03150862|12008491|FG007|Overall Study|Withdrawal by Subject|3
7601948|NCT03150862|12008484|FG000|Overall Study|Lost to Follow-up|0
7601949|NCT03150862|12008485|FG001|Overall Study|Lost to Follow-up|0
7601950|NCT03150862|12008486|FG002|Overall Study|Lost to Follow-up|1
7601951|NCT03150862|12008487|FG003|Overall Study|Lost to Follow-up|0
7601952|NCT03150862|12008488|FG004|Overall Study|Lost to Follow-up|0
7601953|NCT03150862|12008489|FG005|Overall Study|Lost to Follow-up|0
7601954|NCT03150862|12008490|FG006|Overall Study|Lost to Follow-up|0
7601955|NCT03150862|12008491|FG007|Overall Study|Lost to Follow-up|2
7601956|NCT03150862|12008484|FG000|Overall Study|Sponsor's decision|0
7601957|NCT03150862|12008485|FG001|Overall Study|Sponsor's decision|0
7601958|NCT03150862|12008486|FG002|Overall Study|Sponsor's decision|0
7601959|NCT03150862|12008487|FG003|Overall Study|Sponsor's decision|10
7601960|NCT03150862|12008488|FG004|Overall Study|Sponsor's decision|3
7601961|NCT03150862|12008489|FG005|Overall Study|Sponsor's decision|0
7601962|NCT03150862|12008490|FG006|Overall Study|Sponsor's decision|1
7601963|NCT03150862|12008491|FG007|Overall Study|Sponsor's decision|1
7273108|NCT00430300|11487438|FG000|Overall Study|Other|0
7273109|NCT00430300|11487439|FG001|Overall Study|Other|0
7273110|NCT00430300|11487440|FG002|Overall Study|Other|0
7273111|NCT00430300|11487441|FG003|Overall Study|Other|1
7273112|NCT00430352|11487451|FG000|Overall Study|Disease progression|58
7273113|NCT00430352|11487451|FG000|Overall Study|Withdrawal by Subject|11
7273114|NCT00430352|11487451|FG000|Overall Study|Adverse Event|16
7273115|NCT00430352|11487451|FG000|Overall Study|Death|5
7273116|NCT00430352|11487451|FG000|Overall Study|Other|48
7273117|NCT00430482|11487457|FG000|Completed Treatment|Insufficient Treatment|7
7273118|NCT00430482|11487458|FG001|Completed Treatment|Insufficient Treatment|11
7273119|NCT00430495|11487468|FG000|Overall Study|Adverse Event|2
7273120|NCT00430495|11487469|FG001|Overall Study|Adverse Event|3
7273121|NCT00430495|11487470|FG002|Overall Study|Adverse Event|2
7273122|NCT00430495|11487471|FG003|Overall Study|Adverse Event|0
7273123|NCT00430495|11487468|FG000|Overall Study|Death|0
7273124|NCT00430495|11487469|FG001|Overall Study|Death|0
7273125|NCT00430495|11487470|FG002|Overall Study|Death|1
7273126|NCT00430495|11487471|FG003|Overall Study|Death|0
7273127|NCT00430495|11487468|FG000|Overall Study|Lost to Follow-up|0
7273128|NCT00430495|11487469|FG001|Overall Study|Lost to Follow-up|1
7273129|NCT00430495|11487470|FG002|Overall Study|Lost to Follow-up|4
7273130|NCT00430495|11487471|FG003|Overall Study|Lost to Follow-up|0
7273131|NCT00430495|11487468|FG000|Overall Study|Protocol Violation|1
7273132|NCT00430495|11487469|FG001|Overall Study|Protocol Violation|0
7273133|NCT00430495|11487470|FG002|Overall Study|Protocol Violation|1
7273134|NCT00430495|11487471|FG003|Overall Study|Protocol Violation|0
7273135|NCT00430495|11487468|FG000|Overall Study|Disease Progression|1
7273136|NCT00430495|11487469|FG001|Overall Study|Disease Progression|1
7273137|NCT00430495|11487470|FG002|Overall Study|Disease Progression|0
7273138|NCT00430495|11487471|FG003|Overall Study|Disease Progression|0
7273139|NCT00430495|11487468|FG000|Overall Study|Other|8
7273140|NCT00430495|11487469|FG001|Overall Study|Other|2
7273141|NCT00430495|11487470|FG002|Overall Study|Other|5
7273142|NCT00430495|11487471|FG003|Overall Study|Other|4
7273143|NCT00430495|11487468|FG000|Overall Study|Randomized but not Treated|2
7273144|NCT00430495|11487469|FG001|Overall Study|Randomized but not Treated|0
7273145|NCT00430495|11487470|FG002|Overall Study|Randomized but not Treated|0
7273146|NCT00430495|11487471|FG003|Overall Study|Randomized but not Treated|0
7273147|NCT00430521|11487489|FG000|Overall Study|Adverse Event|0
7273148|NCT00430521|11487490|FG001|Overall Study|Adverse Event|0
7273149|NCT00430521|11487491|FG002|Overall Study|Adverse Event|0
7273150|NCT00430521|11487492|FG003|Overall Study|Adverse Event|0
7273151|NCT00430521|11487493|FG004|Overall Study|Adverse Event|0
7273152|NCT00430521|11487494|FG005|Overall Study|Adverse Event|2
7273153|NCT00430521|11487495|FG006|Overall Study|Adverse Event|1
7273154|NCT00430521|11487496|FG007|Overall Study|Adverse Event|0
7273155|NCT00430521|11487489|FG000|Overall Study|Lost to Follow-up|7
7273156|NCT00430521|11487490|FG001|Overall Study|Lost to Follow-up|8
7273157|NCT00430521|11487491|FG002|Overall Study|Lost to Follow-up|3
7273158|NCT00430521|11487492|FG003|Overall Study|Lost to Follow-up|5
7273159|NCT00430521|11487493|FG004|Overall Study|Lost to Follow-up|5
7273160|NCT00430521|11487494|FG005|Overall Study|Lost to Follow-up|2
7273161|NCT00430521|11487495|FG006|Overall Study|Lost to Follow-up|8
7273162|NCT00430521|11487496|FG007|Overall Study|Lost to Follow-up|10
7273163|NCT00430521|11487489|FG000|Overall Study|Pregnancy|0
7273164|NCT00430521|11487490|FG001|Overall Study|Pregnancy|0
7273165|NCT00430521|11487491|FG002|Overall Study|Pregnancy|0
7273166|NCT00430521|11487492|FG003|Overall Study|Pregnancy|0
7601964|NCT03150862|12008484|FG000|Overall Study|Change in Methylation status|0
7601965|NCT03150862|12008485|FG001|Overall Study|Change in Methylation status|0
7273167|NCT00430521|11487493|FG004|Overall Study|Pregnancy|0
7273168|NCT00430521|11487494|FG005|Overall Study|Pregnancy|0
7273169|NCT00430521|11487495|FG006|Overall Study|Pregnancy|1
7273170|NCT00430521|11487496|FG007|Overall Study|Pregnancy|0
7273171|NCT00430521|11487489|FG000|Overall Study|Vaccine Expired|0
7273172|NCT00430521|11487490|FG001|Overall Study|Vaccine Expired|0
7273173|NCT00430521|11487491|FG002|Overall Study|Vaccine Expired|0
7273174|NCT00430521|11487492|FG003|Overall Study|Vaccine Expired|0
7273175|NCT00430521|11487493|FG004|Overall Study|Vaccine Expired|0
7601966|NCT03150862|12008486|FG002|Overall Study|Change in Methylation status|0
7601967|NCT03150862|12008487|FG003|Overall Study|Change in Methylation status|0
7601968|NCT03150862|12008488|FG004|Overall Study|Change in Methylation status|1
7601969|NCT03150862|12008489|FG005|Overall Study|Change in Methylation status|0
7601970|NCT03150862|12008490|FG006|Overall Study|Change in Methylation status|0
7601971|NCT03150862|12008491|FG007|Overall Study|Change in Methylation status|0
7601972|NCT03150862|12008484|FG000|Overall Study|Roll over in to Long Term Extension|0
7601973|NCT03150862|12008485|FG001|Overall Study|Roll over in to Long Term Extension|0
7601974|NCT03150862|12008486|FG002|Overall Study|Roll over in to Long Term Extension|0
7601975|NCT03150862|12008487|FG003|Overall Study|Roll over in to Long Term Extension|0
7601976|NCT03150862|12008488|FG004|Overall Study|Roll over in to Long Term Extension|0
7601977|NCT03150862|12008489|FG005|Overall Study|Roll over in to Long Term Extension|0
7601978|NCT03150862|12008490|FG006|Overall Study|Roll over in to Long Term Extension|0
7601979|NCT03150862|12008491|FG007|Overall Study|Roll over in to Long Term Extension|1
7601980|NCT03150862|12008484|FG000|Overall Study|Progressive Disease|0
7601981|NCT03150862|12008485|FG001|Overall Study|Progressive Disease|0
7601982|NCT03150862|12008486|FG002|Overall Study|Progressive Disease|0
7601983|NCT03150862|12008487|FG003|Overall Study|Progressive Disease|0
7601984|NCT03150862|12008488|FG004|Overall Study|Progressive Disease|0
7601985|NCT03150862|12008489|FG005|Overall Study|Progressive Disease|0
7601986|NCT03150862|12008490|FG006|Overall Study|Progressive Disease|0
7601987|NCT03150862|12008491|FG007|Overall Study|Progressive Disease|2
7601988|NCT03074695|12008520|FG000|Overall Study|Delivered with caesarean before request for analgesia|1
7601989|NCT03074695|12008521|FG001|Overall Study|Delivered with caesarean before request for analgesia|1
7601990|NCT03074695|12008520|FG000|Overall Study|Research staff not available|1
7601991|NCT03074695|12008521|FG001|Overall Study|Research staff not available|2
7601992|NCT03074695|12008520|FG000|Overall Study|Did not receive neuraxial block|2
7601993|NCT03074695|12008521|FG001|Overall Study|Did not receive neuraxial block|2
7601994|NCT03052608|12008529|FG000|Treatment Phase|Adverse Event|10
7601995|NCT03052608|12008530|FG001|Treatment Phase|Adverse Event|12
7273176|NCT00430521|11487494|FG005|Overall Study|Vaccine Expired|1
7273177|NCT00430521|11487495|FG006|Overall Study|Vaccine Expired|0
7273178|NCT00430521|11487496|FG007|Overall Study|Vaccine Expired|0
7273179|NCT00430521|11487489|FG000|Overall Study|Protocol Violation|1
7273180|NCT00430521|11487490|FG001|Overall Study|Protocol Violation|0
7273181|NCT00430521|11487491|FG002|Overall Study|Protocol Violation|0
7273182|NCT00430521|11487492|FG003|Overall Study|Protocol Violation|0
7273183|NCT00430521|11487493|FG004|Overall Study|Protocol Violation|0
7273184|NCT00430521|11487494|FG005|Overall Study|Protocol Violation|0
7273185|NCT00430521|11487495|FG006|Overall Study|Protocol Violation|0
7273186|NCT00430521|11487496|FG007|Overall Study|Protocol Violation|0
7273187|NCT00430521|11487489|FG000|Overall Study|Withdrawal by Subject|3
7273188|NCT00430521|11487490|FG001|Overall Study|Withdrawal by Subject|1
7273189|NCT00430521|11487491|FG002|Overall Study|Withdrawal by Subject|0
7273190|NCT00430521|11487492|FG003|Overall Study|Withdrawal by Subject|3
7273191|NCT00430521|11487493|FG004|Overall Study|Withdrawal by Subject|0
7273192|NCT00430521|11487494|FG005|Overall Study|Withdrawal by Subject|0
7273193|NCT00430521|11487495|FG006|Overall Study|Withdrawal by Subject|0
7273194|NCT00430521|11487496|FG007|Overall Study|Withdrawal by Subject|2
7273195|NCT00430573|11487527|FG000|Overall Study|Withdrawal by Subject|5
7273196|NCT00430638|11487544|FG000|Overall Study|Adverse Event|15
7273197|NCT00430638|11487545|FG001|Overall Study|Adverse Event|15
7273198|NCT00430638|11487544|FG000|Overall Study|Uncontrolled blood pressure|48
7273199|NCT00430638|11487545|FG001|Overall Study|Uncontrolled blood pressure|13
7273200|NCT00430638|11487544|FG000|Overall Study|Lost to Follow-up|1
7601996|NCT03052608|12008529|FG000|Treatment Phase|Death|6
7601997|NCT03052608|12008530|FG001|Treatment Phase|Death|4
7601998|NCT03052608|12008529|FG000|Treatment Phase|Withdrawal by Subject|4
7601999|NCT03052608|12008530|FG001|Treatment Phase|Withdrawal by Subject|12
7273201|NCT00430638|11487545|FG001|Overall Study|Lost to Follow-up|7
7273202|NCT00430638|11487544|FG000|Overall Study|Protocol Violation|6
7273203|NCT00430638|11487545|FG001|Overall Study|Protocol Violation|4
7602000|NCT03052608|12008529|FG000|Treatment Phase|Global Deterioration of Health Status|0
7602001|NCT03052608|12008530|FG001|Treatment Phase|Global Deterioration of Health Status|3
7602002|NCT03052608|12008529|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
7602003|NCT03052608|12008530|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
7602004|NCT03052608|12008529|FG000|Treatment Phase|Subject didn't receive study treatment.|0
7602005|NCT03052608|12008530|FG001|Treatment Phase|Subject didn't receive study treatment.|1
7602006|NCT03052608|12008529|FG000|Treatment Phase|Ongoing|103
7602007|NCT03052608|12008530|FG001|Treatment Phase|Ongoing|31
7602008|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Death|23
7602009|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Death|28
7602010|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
7602011|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
7602012|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
7602013|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
7602014|NCT03052608|12008529|FG000|Long-Term Follow-up Phase|Ongoing|122
7602015|NCT03052608|12008530|FG001|Long-Term Follow-up Phase|Ongoing|99
7602030|NCT02922725|12008551|FG000|Overall Study|Withdrawal by Subject|1
7602031|NCT02922725|12008552|FG001|Overall Study|Withdrawal by Subject|0
7602032|NCT02922725|12008553|FG002|Overall Study|Withdrawal by Subject|0
7602033|NCT02886572|12008560|FG000|Overall Study|Death|8
7602034|NCT02805257|12008566|FG000|Overall Study|Lost to Follow-up|7
7602035|NCT02805257|12008567|FG001|Overall Study|Lost to Follow-up|6
7602036|NCT02805257|12008566|FG000|Overall Study|Death|0
7602037|NCT02805257|12008567|FG001|Overall Study|Death|1
7602038|NCT02696564|12008606|FG000|Overall Study|Death|1
7602039|NCT02696564|12008607|FG001|Overall Study|Death|2
7602040|NCT02696564|12008606|FG000|Overall Study|Withdrawal by Subject|3
7602041|NCT02696564|12008607|FG001|Overall Study|Withdrawal by Subject|2
7602042|NCT02696564|12008606|FG000|Overall Study|Lost to Follow-up|3
7602043|NCT02696564|12008607|FG001|Overall Study|Lost to Follow-up|3
7602044|NCT02696564|12008606|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3
7602045|NCT02696564|12008607|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1
7602046|NCT02696564|12008606|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
7602047|NCT02696564|12008607|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2
7602048|NCT02696564|12008606|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
7602049|NCT02696564|12008607|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1
7602050|NCT02696564|12008606|FG000|Overall Study|Participant diagnosed with lung cancer|1
7602051|NCT02696564|12008607|FG001|Overall Study|Participant diagnosed with lung cancer|0
7602052|NCT02696564|12008606|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0
7602053|NCT02696564|12008607|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2
7602066|NCT02640950|12008626|FG000|Overall Study|Adverse Event|1
7602067|NCT02640950|12008626|FG000|Overall Study|Withdrawal by Subject|1
7602068|NCT02639065|12008630|FG000|Study Treatment|Disease Progression|11
7602069|NCT02639065|12008630|FG000|Study Treatment|Adverse Event|8
7602070|NCT02639065|12008630|FG000|Study Treatment|Withdrawal by Subject|1
7602071|NCT02639065|12008630|FG000|Follow up|Withdrawal by Subject|1
7602072|NCT02639065|12008630|FG000|Follow up|Symptomatic Deterioration|2
7602073|NCT02639065|12008630|FG000|Follow up|Death|2
7602074|NCT02639065|12008630|FG000|Follow up|Study Terminated|1
7602075|NCT02639065|12008630|FG000|Follow up|Disease Progression|3
7602076|NCT02564263|12008636|FG000|Overall Study|Adverse Event|31
7602077|NCT02564263|12008637|FG001|Overall Study|Adverse Event|29
7602078|NCT02564263|12008636|FG000|Overall Study|Death|236
7273204|NCT00430638|11487544|FG000|Overall Study|Withdrawal by Subject|4
7273205|NCT00430638|11487545|FG001|Overall Study|Withdrawal by Subject|6
7273206|NCT00430638|11487544|FG000|Overall Study|Non-compliant|2
7273207|NCT00430638|11487545|FG001|Overall Study|Non-compliant|1
7273208|NCT00430638|11487544|FG000|Overall Study|Other|2
7273209|NCT00430638|11487545|FG001|Overall Study|Other|2
7273210|NCT00430677|11487558|FG000|Short-term Period|Death|1
7273211|NCT00430677|11487559|FG001|Short-term Period|Death|1
7273212|NCT00430677|11487560|FG002|Short-term Period|Death|5
7273213|NCT00430677|11487558|FG000|Short-term Period|Adverse Event|15
7273214|NCT00430677|11487559|FG001|Short-term Period|Adverse Event|13
7273215|NCT00430677|11487560|FG002|Short-term Period|Adverse Event|9
7273216|NCT00430677|11487558|FG000|Short-term Period|Lack of Efficacy|5
7273217|NCT00430677|11487559|FG001|Short-term Period|Lack of Efficacy|6
7273218|NCT00430677|11487560|FG002|Short-term Period|Lack of Efficacy|4
7273219|NCT00430677|11487558|FG000|Short-term Period|Withdrawal by Subject|1
7602079|NCT02564263|12008637|FG001|Overall Study|Death|242
7602080|NCT02564263|12008636|FG000|Overall Study|Withdrawal by Subject|5
7602081|NCT02564263|12008637|FG001|Overall Study|Withdrawal by Subject|18
7602082|NCT02564263|12008636|FG000|Overall Study|Ongoing in Study|42
7273220|NCT00430677|11487559|FG001|Short-term Period|Withdrawal by Subject|1
7273221|NCT00430677|11487560|FG002|Short-term Period|Withdrawal by Subject|2
7273222|NCT00430677|11487558|FG000|Short-term Period|Participant no longer met study criteria|1
7273223|NCT00430677|11487559|FG001|Short-term Period|Participant no longer met study criteria|1
7602083|NCT02564263|12008637|FG001|Overall Study|Ongoing in Study|25
7602098|NCT02372136|12008654|FG000|Overall Study|Death|3
7602099|NCT02372136|12008655|FG001|Overall Study|Death|1
7602100|NCT02367456|12008666|FG000|Overall Study|Death|8
7602101|NCT02367456|12008667|FG001|Overall Study|Death|21
7602102|NCT02367456|12008668|FG002|Overall Study|Death|14
7602103|NCT02367456|12008666|FG000|Overall Study|Lost to Follow-up|1
7602104|NCT02367456|12008667|FG001|Overall Study|Lost to Follow-up|3
7602105|NCT02367456|12008668|FG002|Overall Study|Lost to Follow-up|1
7602106|NCT02367456|12008666|FG000|Overall Study|Ongoing|0
7602107|NCT02367456|12008667|FG001|Overall Study|Ongoing|6
7602108|NCT02367456|12008668|FG002|Overall Study|Ongoing|15
7602109|NCT02367456|12008666|FG000|Overall Study|Other reason|3
7602110|NCT02367456|12008667|FG001|Overall Study|Other reason|0
7602111|NCT02367456|12008668|FG002|Overall Study|Other reason|0
7602116|NCT02022033|12008685|FG000|Overall Study|Physician Decision|1
7273224|NCT00430677|11487560|FG002|Short-term Period|Participant no longer met study criteria|2
7273225|NCT00430677|11487558|FG000|Short-term Period|Poor compliance/ noncompliance|0
7273226|NCT00430677|11487559|FG001|Short-term Period|Poor compliance/ noncompliance|1
7273227|NCT00430677|11487560|FG002|Short-term Period|Poor compliance/ noncompliance|0
7273228|NCT00430677|11487558|FG000|Short-term Period|Pregnancy|0
7273229|NCT00430677|11487559|FG001|Short-term Period|Pregnancy|2
7273230|NCT00430677|11487560|FG002|Short-term Period|Pregnancy|0
7273231|NCT00430677|11487558|FG000|Long-term Extension Period|Death|1
7273232|NCT00430677|11487559|FG001|Long-term Extension Period|Death|0
7273233|NCT00430677|11487560|FG002|Long-term Extension Period|Death|0
7273234|NCT00430677|11487558|FG000|Long-term Extension Period|Adverse Event|3
7273235|NCT00430677|11487559|FG001|Long-term Extension Period|Adverse Event|2
7273236|NCT00430677|11487560|FG002|Long-term Extension Period|Adverse Event|5
7273237|NCT00430677|11487558|FG000|Long-term Extension Period|Lack of Efficacy|5
7273238|NCT00430677|11487559|FG001|Long-term Extension Period|Lack of Efficacy|3
7273239|NCT00430677|11487560|FG002|Long-term Extension Period|Lack of Efficacy|8
7273240|NCT00430677|11487558|FG000|Long-term Extension Period|Lost to Follow-up|1
7273241|NCT00430677|11487559|FG001|Long-term Extension Period|Lost to Follow-up|1
7273242|NCT00430677|11487560|FG002|Long-term Extension Period|Lost to Follow-up|1
7273243|NCT00430677|11487558|FG000|Long-term Extension Period|Withdrawal by Subject|5
7273244|NCT00430677|11487559|FG001|Long-term Extension Period|Withdrawal by Subject|1
7273245|NCT00430677|11487560|FG002|Long-term Extension Period|Withdrawal by Subject|2
7273246|NCT00430677|11487558|FG000|Long-term Extension Period|Pregnancy|1
7273247|NCT00430677|11487559|FG001|Long-term Extension Period|Pregnancy|1
7273248|NCT00430677|11487560|FG002|Long-term Extension Period|Pregnancy|0
7273249|NCT00430677|11487558|FG000|Long-term Extension Period|Administrative reason by sponsor|41
7273250|NCT00430677|11487559|FG001|Long-term Extension Period|Administrative reason by sponsor|49
7273251|NCT00430677|11487560|FG002|Long-term Extension Period|Administrative reason by sponsor|46
7273252|NCT00430677|11487558|FG000|Long-term Extension Period|Other|2
7273253|NCT00430677|11487559|FG001|Long-term Extension Period|Other|1
7273254|NCT00430677|11487560|FG002|Long-term Extension Period|Other|1
7273255|NCT00430677|11487558|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
7273256|NCT00430677|11487559|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
7273257|NCT00430677|11487560|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
7602133|NCT01434602|12008703|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602134|NCT01434602|12008704|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
7602135|NCT01434602|12008705|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602136|NCT01434602|12008706|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602137|NCT01434602|12008707|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
7602138|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602139|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602140|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602141|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
7602142|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
7602143|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7273258|NCT00430716|11487589|FG000|Double Blind Phase|Death|1
7273259|NCT00430716|11487590|FG001|Double Blind Phase|Death|0
7273260|NCT00430716|11487591|FG002|Double Blind Phase|Death|0
7273261|NCT00430716|11487589|FG000|Double Blind Phase|No longer willing to participate|2
7273262|NCT00430716|11487590|FG001|Double Blind Phase|No longer willing to participate|1
7273263|NCT00430716|11487591|FG002|Double Blind Phase|No longer willing to participate|1
7273264|NCT00430716|11487589|FG000|Double Blind Phase|Other|0
7273265|NCT00430716|11487590|FG001|Double Blind Phase|Other|2
7273266|NCT00430716|11487591|FG002|Double Blind Phase|Other|0
7273267|NCT00430716|11487589|FG000|Double Blind Phase|Study terminated by sponsor|1
7273268|NCT00430716|11487590|FG001|Double Blind Phase|Study terminated by sponsor|1
7273269|NCT00430716|11487591|FG002|Double Blind Phase|Study terminated by sponsor|2
7273270|NCT00430716|11487589|FG000|Double Blind Phase|Adverse Event|1
7273271|NCT00430716|11487590|FG001|Double Blind Phase|Adverse Event|1
7273272|NCT00430716|11487591|FG002|Double Blind Phase|Adverse Event|3
7273273|NCT00430716|11487589|FG000|Double Blind Phase|Not treated|1
7273274|NCT00430716|11487590|FG001|Double Blind Phase|Not treated|0
7273275|NCT00430716|11487591|FG002|Double Blind Phase|Not treated|0
7273276|NCT00430716|11487589|FG000|Open Label Phase|Lost to Follow-up|1
7273277|NCT00430716|11487590|FG001|Open Label Phase|Lost to Follow-up|0
7273278|NCT00430716|11487591|FG002|Open Label Phase|Lost to Follow-up|1
7273279|NCT00430716|11487589|FG000|Open Label Phase|No longer willing to participate|0
7273280|NCT00430716|11487590|FG001|Open Label Phase|No longer willing to participate|1
7273281|NCT00430716|11487591|FG002|Open Label Phase|No longer willing to participate|1
7273282|NCT00430716|11487589|FG000|Open Label Phase|Other|3
7273283|NCT00430716|11487590|FG001|Open Label Phase|Other|1
7273284|NCT00430716|11487591|FG002|Open Label Phase|Other|1
7273285|NCT00430716|11487589|FG000|Open Label Phase|Protocol Violation|1
7273286|NCT00430716|11487590|FG001|Open Label Phase|Protocol Violation|0
7273287|NCT00430716|11487591|FG002|Open Label Phase|Protocol Violation|0
7273288|NCT00430716|11487589|FG000|Open Label Phase|Study terminated by sponsor|4
7273289|NCT00430716|11487590|FG001|Open Label Phase|Study terminated by sponsor|5
7273290|NCT00430716|11487591|FG002|Open Label Phase|Study terminated by sponsor|4
7273291|NCT00430755|11487599|FG000|Overall Study|Withdrawal by Subject|53
7273292|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
7273293|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
7273294|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
7273295|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7273296|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
7273297|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
7273298|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
7273299|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
7273300|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
7273301|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
7273302|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
7273303|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
7273304|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
7273305|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7273306|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
7273307|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
7602144|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602145|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602146|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
7602147|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
7602148|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602149|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602150|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602151|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
7602152|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
7602153|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602154|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602155|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602156|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
7602157|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
7602158|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602159|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602160|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602161|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
7602162|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
7602163|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602164|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602165|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602166|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
7602167|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
7602168|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602169|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602170|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
7602171|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
7602172|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
7602173|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602174|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602175|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602176|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
7602177|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
7602178|NCT01434602|12008703|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602179|NCT01434602|12008704|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602180|NCT01434602|12008705|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602181|NCT01434602|12008706|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
7602182|NCT01434602|12008707|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
7602183|NCT01358877|12008731|FG000|Overall Study|Death|80
7602184|NCT01358877|12008732|FG001|Overall Study|Death|89
7602185|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
7602186|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
7602187|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
7602188|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
7602189|NCT01358877|12008731|FG000|Overall Study|Ongoing follow-up for overall survival|7
7602190|NCT01358877|12008732|FG001|Overall Study|Ongoing follow-up for overall survival|5
7602191|NCT01358877|12008731|FG000|Overall Study|Other|142
7602192|NCT01358877|12008732|FG001|Overall Study|Other|129
7602193|NCT01239797|12008740|FG000|Randomized Participants|Participant no longer meets study criteria|1
7602194|NCT01239797|12008741|FG001|Randomized Participants|Participant no longer meets study criteria|1
7602195|NCT01239797|12008740|FG000|Randomized Participants|Participant withdrew consent|1
7602196|NCT01239797|12008741|FG001|Randomized Participants|Participant withdrew consent|7
7602197|NCT01239797|12008740|FG000|Randomized Participants|Adverse event unrelated to study drug|0
7602198|NCT01239797|12008741|FG001|Randomized Participants|Adverse event unrelated to study drug|1
7602199|NCT01239797|12008740|FG000|Treated Participants|Disease progression|185
7602200|NCT01239797|12008741|FG001|Treated Participants|Disease progression|185
7602201|NCT01239797|12008740|FG000|Treated Participants|Study drug toxicity|39
7602202|NCT01239797|12008741|FG001|Treated Participants|Study drug toxicity|45
7602203|NCT01239797|12008740|FG000|Treated Participants|Adverse event unrelated to study drug|31
7602204|NCT01239797|12008741|FG001|Treated Participants|Adverse event unrelated to study drug|37
7602205|NCT01239797|12008740|FG000|Treated Participants|Participants request to discontinue study treatment|28
7602206|NCT01239797|12008741|FG001|Treated Participants|Participants request to discontinue study treatment|18
7602207|NCT01239797|12008740|FG000|Treated Participants|Administrative reason by sponsor|13
7602208|NCT01239797|12008741|FG001|Treated Participants|Administrative reason by sponsor|4
7602209|NCT01239797|12008740|FG000|Treated Participants|Other reasons|14
7602210|NCT01239797|12008741|FG001|Treated Participants|Other reasons|14
7602211|NCT01239797|12008740|FG000|Treated Participants|Participant withdrew consent|6
7602212|NCT01239797|12008741|FG001|Treated Participants|Participant withdrew consent|11
7602213|NCT01239797|12008740|FG000|Treated Participants|Death|1
7602214|NCT01239797|12008741|FG001|Treated Participants|Death|1
7602215|NCT01239797|12008740|FG000|Treated Participants|Participant no longer meets study criteria|1
7602216|NCT01239797|12008741|FG001|Treated Participants|Participant no longer meets study criteria|1
7602217|NCT01239797|12008740|FG000|Treated Participants|Poor/non-compliance|0
7602218|NCT01239797|12008741|FG001|Treated Participants|Poor/non-compliance|1
7602219|NCT01236521|12008749|FG000|Overall Study|Withdrawal by Subject|12
7602220|NCT01236521|12008750|FG001|Overall Study|Withdrawal by Subject|17
7602221|NCT01236521|12008749|FG000|Overall Study|Death|2
7602222|NCT01236521|12008750|FG001|Overall Study|Death|1
7602223|NCT01236521|12008749|FG000|Overall Study|Lost to Follow-up|9
7602224|NCT01236521|12008750|FG001|Overall Study|Lost to Follow-up|7
7602225|NCT01103349|12008759|FG000|Overall Study|Adverse Event|8
7602226|NCT01103349|12008760|FG001|Overall Study|Adverse Event|5
7602227|NCT01103349|12008761|FG002|Overall Study|Adverse Event|3
7602228|NCT01103349|12008759|FG000|Overall Study|Consent withdrawn|1
7602229|NCT01103349|12008760|FG001|Overall Study|Consent withdrawn|0
7602230|NCT01103349|12008761|FG002|Overall Study|Consent withdrawn|0
7602231|NCT01103349|12008759|FG000|Overall Study|Incorrectly included in the trial|1
7602232|NCT01103349|12008760|FG001|Overall Study|Incorrectly included in the trial|0
7602233|NCT01103349|12008761|FG002|Overall Study|Incorrectly included in the trial|0
7602234|NCT01103349|12008759|FG000|Overall Study|Withdrawal by Subject|1
7602235|NCT01103349|12008760|FG001|Overall Study|Withdrawal by Subject|1
7602236|NCT01103349|12008761|FG002|Overall Study|Withdrawal by Subject|0
7602237|NCT01103349|12008759|FG000|Overall Study|did not want to take trial medication|0
7602238|NCT01103349|12008760|FG001|Overall Study|did not want to take trial medication|1
7602239|NCT01103349|12008761|FG002|Overall Study|did not want to take trial medication|0
7602240|NCT01103349|12008759|FG000|Overall Study|forgot to take medication|0
7602241|NCT01103349|12008760|FG001|Overall Study|forgot to take medication|0
7602242|NCT01103349|12008761|FG002|Overall Study|forgot to take medication|1
7602243|NCT01092143|12008774|FG000|Overall Study|Adverse Event|10
7602244|NCT01092143|12008775|FG001|Overall Study|Adverse Event|5
7602245|NCT01092143|12008776|FG002|Overall Study|Adverse Event|1
7602246|NCT01092143|12008777|FG003|Overall Study|Adverse Event|4
7602247|NCT01092143|12008778|FG004|Overall Study|Adverse Event|3
7602248|NCT01092143|12008774|FG000|Overall Study|Lost to Follow-up|1
7602249|NCT01092143|12008775|FG001|Overall Study|Lost to Follow-up|0
7602250|NCT01092143|12008776|FG002|Overall Study|Lost to Follow-up|1
7602251|NCT01092143|12008777|FG003|Overall Study|Lost to Follow-up|0
7602252|NCT01092143|12008778|FG004|Overall Study|Lost to Follow-up|0
7602253|NCT01092143|12008774|FG000|Overall Study|Consent withdrawn|2
7602254|NCT01092143|12008775|FG001|Overall Study|Consent withdrawn|1
7602255|NCT01092143|12008776|FG002|Overall Study|Consent withdrawn|0
7602256|NCT01092143|12008777|FG003|Overall Study|Consent withdrawn|1
7602257|NCT01092143|12008778|FG004|Overall Study|Consent withdrawn|3
7602258|NCT01092143|12008774|FG000|Overall Study|Not treated|0
7602259|NCT01092143|12008775|FG001|Overall Study|Not treated|0
7602260|NCT01092143|12008776|FG002|Overall Study|Not treated|1
7602261|NCT01092143|12008777|FG003|Overall Study|Not treated|0
7602262|NCT01092143|12008778|FG004|Overall Study|Not treated|0
7602263|NCT01092143|12008774|FG000|Overall Study|did not reversibility criteria|0
7602264|NCT01092143|12008775|FG001|Overall Study|did not reversibility criteria|0
7602265|NCT01092143|12008776|FG002|Overall Study|did not reversibility criteria|1
7602266|NCT01092143|12008777|FG003|Overall Study|did not reversibility criteria|0
7602267|NCT01092143|12008778|FG004|Overall Study|did not reversibility criteria|0
7602268|NCT01092143|12008774|FG000|Overall Study|Increased Albuterol use for >2 days|0
7602269|NCT01092143|12008775|FG001|Overall Study|Increased Albuterol use for >2 days|1
7602270|NCT01092143|12008776|FG002|Overall Study|Increased Albuterol use for >2 days|0
7602271|NCT01092143|12008777|FG003|Overall Study|Increased Albuterol use for >2 days|0
7602272|NCT01092143|12008778|FG004|Overall Study|Increased Albuterol use for >2 days|0
7602273|NCT01092143|12008774|FG000|Overall Study|Ineligible patient|1
7602274|NCT01092143|12008775|FG001|Overall Study|Ineligible patient|0
7602275|NCT01092143|12008776|FG002|Overall Study|Ineligible patient|0
7602276|NCT01092143|12008777|FG003|Overall Study|Ineligible patient|0
7602277|NCT01092143|12008778|FG004|Overall Study|Ineligible patient|0
7602278|NCT01092143|12008774|FG000|Overall Study|Drop in FEV1 at visit 9|1
7602279|NCT01092143|12008775|FG001|Overall Study|Drop in FEV1 at visit 9|0
7602280|NCT01092143|12008776|FG002|Overall Study|Drop in FEV1 at visit 9|0
7602281|NCT01092143|12008777|FG003|Overall Study|Drop in FEV1 at visit 9|0
7602282|NCT01092143|12008778|FG004|Overall Study|Drop in FEV1 at visit 9|0
7602283|NCT01092143|12008774|FG000|Overall Study|Patient travel|0
7602284|NCT01092143|12008775|FG001|Overall Study|Patient travel|0
7602285|NCT01092143|12008776|FG002|Overall Study|Patient travel|0
7602286|NCT01092143|12008777|FG003|Overall Study|Patient travel|0
7602287|NCT01092143|12008778|FG004|Overall Study|Patient travel|1
7602288|NCT01092143|12008774|FG000|Overall Study|Non compliance with study medication|0
7602289|NCT01092143|12008775|FG001|Overall Study|Non compliance with study medication|0
7602290|NCT01092143|12008776|FG002|Overall Study|Non compliance with study medication|0
7602291|NCT01092143|12008777|FG003|Overall Study|Non compliance with study medication|0
7602292|NCT01092143|12008778|FG004|Overall Study|Non compliance with study medication|1
7602293|NCT01092143|12008774|FG000|Overall Study|Randomized by mistake|0
7602294|NCT01092143|12008775|FG001|Overall Study|Randomized by mistake|0
7602295|NCT01092143|12008776|FG002|Overall Study|Randomized by mistake|0
7602296|NCT01092143|12008777|FG003|Overall Study|Randomized by mistake|1
7602297|NCT01092143|12008778|FG004|Overall Study|Randomized by mistake|0
7602298|NCT01092143|12008774|FG000|Overall Study|Pregnancy|0
7602299|NCT01092143|12008775|FG001|Overall Study|Pregnancy|0
7602300|NCT01092143|12008776|FG002|Overall Study|Pregnancy|0
7602301|NCT01092143|12008777|FG003|Overall Study|Pregnancy|1
7602302|NCT01092143|12008778|FG004|Overall Study|Pregnancy|0
7602303|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
7602304|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
7602305|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
7602306|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
7602307|NCT00640133|12008802|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
7602308|NCT00640133|12008803|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
7602309|NCT00593567|12008813|FG000|Overall Study|Adverse Event|2
7602310|NCT00593567|12008814|FG001|Overall Study|Adverse Event|0
7602311|NCT00593567|12008813|FG000|Overall Study|Physician Decision|2
7602312|NCT00593567|12008814|FG001|Overall Study|Physician Decision|0
7602313|NCT00593567|12008813|FG000|Overall Study|Protocol Violation|13
7602314|NCT00593567|12008814|FG001|Overall Study|Protocol Violation|7
7602315|NCT00593567|12008813|FG000|Overall Study|Lack of Efficacy|2
7602316|NCT00593567|12008814|FG001|Overall Study|Lack of Efficacy|1
7602317|NCT00593567|12008813|FG000|Overall Study|Withdrawal by Subject|1
7602318|NCT00593567|12008814|FG001|Overall Study|Withdrawal by Subject|2
7602339|NCT02983617|12008831|FG000|Overall Study|Adverse Event|0
7602340|NCT02983617|12008832|FG001|Overall Study|Adverse Event|7
7602341|NCT02983617|12008831|FG000|Overall Study|Death|0
7602342|NCT02983617|12008832|FG001|Overall Study|Death|1
7602343|NCT02983617|12008831|FG000|Overall Study|Investigator's Discretion|0
7602344|NCT02983617|12008832|FG001|Overall Study|Investigator's Discretion|1
7602345|NCT02649946|12008866|FG000|Overall Study|Withdrawal by Subject|1
7602346|NCT02649946|12008867|FG001|Overall Study|Withdrawal by Subject|1
7602347|NCT02649946|12008866|FG000|Overall Study|Death|7
7602348|NCT02649946|12008867|FG001|Overall Study|Death|9
7602349|NCT02649946|12008866|FG000|Overall Study|Physician Decision|1
7602350|NCT02649946|12008867|FG001|Overall Study|Physician Decision|0
7602351|NCT02649946|12008866|FG000|Overall Study|Lost to Follow-up|2
7602352|NCT02649946|12008867|FG001|Overall Study|Lost to Follow-up|1
7602353|NCT02649946|12008866|FG000|Overall Study|Erroneously enrolled|1
7602354|NCT02649946|12008867|FG001|Overall Study|Erroneously enrolled|0
7602355|NCT02649946|12008866|FG000|Overall Study|Missed 6-month follow-up visit|0
7602356|NCT02649946|12008867|FG001|Overall Study|Missed 6-month follow-up visit|4
7602399|NCT02345850|12008892|FG000|Overall Study|Not transplanted|10
7602400|NCT02345850|12008893|FG001|Overall Study|Not transplanted|5
7602401|NCT02345850|12008894|FG002|Overall Study|Not transplanted|4
7602402|NCT02345850|12008892|FG000|Overall Study|Lost to Follow-up|2
7602403|NCT02345850|12008893|FG001|Overall Study|Lost to Follow-up|3
7602404|NCT02345850|12008894|FG002|Overall Study|Lost to Follow-up|2
7602405|NCT02345850|12008892|FG000|Overall Study|Withdrawal by Subject|1
7602406|NCT02345850|12008893|FG001|Overall Study|Withdrawal by Subject|0
7602407|NCT02345850|12008894|FG002|Overall Study|Withdrawal by Subject|0
7602408|NCT02343302|12008904|FG000|Overall Study|Physician Decision|1
7602409|NCT02343302|12008905|FG001|Overall Study|Physician Decision|1
7602410|NCT01464164|12008947|FG000|Overall Study|Screen failure|0
7602411|NCT01464164|12008948|FG001|Overall Study|Screen failure|1
7602412|NCT01464164|12008949|FG002|Overall Study|Screen failure|2
7602413|NCT01464164|12008950|FG003|Overall Study|Screen failure|0
7602414|NCT01464164|12008951|FG004|Overall Study|Screen failure|0
7602415|NCT01464164|12008952|FG005|Overall Study|Screen failure|0
7602416|NCT01464164|12008953|FG006|Overall Study|Screen failure|0
7602417|NCT01464164|12008947|FG000|Overall Study|Physician Decision|0
7602418|NCT01464164|12008948|FG001|Overall Study|Physician Decision|0
7602419|NCT01464164|12008949|FG002|Overall Study|Physician Decision|0
7602420|NCT01464164|12008950|FG003|Overall Study|Physician Decision|0
7602421|NCT01464164|12008951|FG004|Overall Study|Physician Decision|0
7602422|NCT01464164|12008952|FG005|Overall Study|Physician Decision|0
7602423|NCT01464164|12008953|FG006|Overall Study|Physician Decision|2
7602424|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
7602425|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602426|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7273308|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
7273309|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
7273310|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Death|0
7602427|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602428|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
7602429|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
7602430|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
7602431|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
7602432|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
7273311|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Death|1
7602433|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
7602434|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
7602435|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602436|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602437|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602438|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
7602439|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
7602440|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602441|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602442|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602443|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
7602444|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
7602445|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602446|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602447|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602448|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
7602449|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
7602450|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602451|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602452|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602453|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
7602454|NCT01111565|12008983|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
7602455|NCT01111565|12008984|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602456|NCT01111565|12008985|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602457|NCT01111565|12008986|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602458|NCT01111565|12008987|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
7602459|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602460|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602461|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602462|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
7602463|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
7602464|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602465|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602466|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
7602467|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602468|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
7602469|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
7602470|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
7602471|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7602472|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
7602473|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
7602474|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602475|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602476|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602477|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
7602478|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
7602479|NCT01111565|12008983|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602480|NCT01111565|12008984|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602481|NCT01111565|12008985|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602482|NCT01111565|12008986|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
7602483|NCT01111565|12008987|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
7273312|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Death|0
7273313|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
7273314|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7273315|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
7273316|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
7273317|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
7273318|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
7273319|NCT00430781|11487625|FG000|Interim Analysis; 11 February 2008|Ongoing|23
7273320|NCT00430781|11487626|FG001|Interim Analysis; 11 February 2008|Ongoing|20
7273321|NCT00430781|11487627|FG002|Interim Analysis; 11 February 2008|Ongoing|25
7273322|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
7273323|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
7273324|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
7273325|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
7273326|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
7273327|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
7273328|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
7273329|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
7273330|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
7273331|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Physician Decision|0
7273332|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Physician Decision|6
7273333|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Physician Decision|6
7273334|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Other|0
7602484|NCT01092117|12008997|FG000|Index Procedure to 1 Month|Death|1
7602485|NCT01092117|12008997|FG000|1 Month|Death|1
7602486|NCT01092117|12008997|FG000|1 Month|Withdrawal by Subject|1
7602487|NCT01092117|12008997|FG000|1 Month|Lost to Follow-up|1
7602488|NCT01092117|12008997|FG000|6 Months|Death|2
7602489|NCT01092117|12008997|FG000|6 Months|Withdrawal by Subject|3
7602490|NCT01092117|12008997|FG000|12 Month|Death|11
7602491|NCT01092117|12008997|FG000|12 Month|Withdrawal by Subject|2
7602492|NCT01092117|12008997|FG000|12 Month|Lost to Follow-up|1
7602493|NCT01092117|12008997|FG000|Year 2|Death|5
7602494|NCT01092117|12008997|FG000|Year 2|Withdrawal by Subject|4
7602495|NCT01092117|12008997|FG000|Year 2|Lost to Follow-up|1
7602496|NCT01092117|12008997|FG000|Year 3|Death|7
7273335|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Other|1
7273336|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Other|0
7273337|NCT00430781|11487625|FG000|Final Analysis; 31 July 2008|Ongoing|0
7602497|NCT01092117|12008997|FG000|Year 3|Withdrawal by Subject|9
7602498|NCT01092117|12008997|FG000|Year 3|Lost to Follow-up|3
7602499|NCT01092117|12008997|FG000|Year 4|Death|8
7602500|NCT01092117|12008997|FG000|Year 4|Withdrawal by Subject|4
7602501|NCT01092117|12008997|FG000|Year 4|Lost to Follow-up|4
7602502|NCT00950989|12009005|FG000|Overall Study|Death|0
7602503|NCT00950989|12009006|FG001|Overall Study|Death|0
7602504|NCT00950989|12009007|FG002|Overall Study|Death|1
7602505|NCT00950989|12009008|FG003|Overall Study|Death|0
7602506|NCT00950989|12009005|FG000|Overall Study|Administrative Decision|0
7602507|NCT00950989|12009006|FG001|Overall Study|Administrative Decision|1
7602508|NCT00950989|12009007|FG002|Overall Study|Administrative Decision|0
7602509|NCT00950989|12009008|FG003|Overall Study|Administrative Decision|0
7602510|NCT00950989|12009005|FG000|Overall Study|Disease Progression|0
7602511|NCT00950989|12009006|FG001|Overall Study|Disease Progression|0
7602512|NCT00950989|12009007|FG002|Overall Study|Disease Progression|1
7602513|NCT00950989|12009008|FG003|Overall Study|Disease Progression|0
7602514|NCT00950989|12009005|FG000|Overall Study|Withdrawal by Subject|2
7602515|NCT00950989|12009006|FG001|Overall Study|Withdrawal by Subject|1
7602516|NCT00950989|12009007|FG002|Overall Study|Withdrawal by Subject|0
7602517|NCT00950989|12009008|FG003|Overall Study|Withdrawal by Subject|0
7602518|NCT00950989|12009005|FG000|Overall Study|Adverse Event|2
7602519|NCT00950989|12009006|FG001|Overall Study|Adverse Event|1
7602520|NCT00950989|12009007|FG002|Overall Study|Adverse Event|1
7602521|NCT00950989|12009008|FG003|Overall Study|Adverse Event|0
7273338|NCT00430781|11487626|FG001|Final Analysis; 31 July 2008|Ongoing|29
7273339|NCT00430781|11487627|FG002|Final Analysis; 31 July 2008|Ongoing|32
7273340|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
7273341|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7273342|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
7273343|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7273344|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
7273345|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
7273346|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7273347|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
7273348|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
7273349|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7273350|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
7273351|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
7273352|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
7273353|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7273354|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
7273355|NCT00430781|11487625|FG000|End-of-Study Analysis; 28 July 2011|Other|4
7273356|NCT00430781|11487626|FG001|End-of-Study Analysis; 28 July 2011|Other|1
7273357|NCT00430781|11487627|FG002|End-of-Study Analysis; 28 July 2011|Other|0
7273358|NCT00430937|11487640|FG000|Overall Study|Adverse Event|3
7273359|NCT00430937|11487641|FG001|Overall Study|Adverse Event|8
7273360|NCT00430937|11487640|FG000|Overall Study|Death|0
7273361|NCT00430937|11487641|FG001|Overall Study|Death|1
7602522|NCT00489307|12009023|FG000|Overall Study|Death|1
7602523|NCT00489307|12009024|FG001|Overall Study|Death|1
7602524|NCT00489307|12009023|FG000|Overall Study|Lost to Follow-up|2
7602525|NCT00489307|12009024|FG001|Overall Study|Lost to Follow-up|2
7602526|NCT00489307|12009023|FG000|Overall Study|Physician Decision|1
7602527|NCT00489307|12009024|FG001|Overall Study|Physician Decision|0
7602528|NCT00489307|12009023|FG000|Overall Study|Withdrawal by Subject|2
7602529|NCT00489307|12009024|FG001|Overall Study|Withdrawal by Subject|4
7602530|NCT00489307|12009023|FG000|Overall Study|Hospitalization unrelated to treatment|10
7602531|NCT00489307|12009024|FG001|Overall Study|Hospitalization unrelated to treatment|7
7602532|NCT00489307|12009023|FG000|Overall Study|Surgery after assignment|1
7602533|NCT00489307|12009024|FG001|Overall Study|Surgery after assignment|0
7602534|NCT00489307|12009023|FG000|Overall Study|Did not fill up the forms|2
7602535|NCT00489307|12009024|FG001|Overall Study|Did not fill up the forms|1
7602536|NCT00489307|12009023|FG000|Overall Study|Patient or family refusal|5
7602537|NCT00489307|12009024|FG001|Overall Study|Patient or family refusal|9
7602538|NCT00072410|12009032|FG000|Overall Study|Progressive disease|0
7602539|NCT00072410|12009033|FG001|Overall Study|Progressive disease|3
7273362|NCT00430937|11487640|FG000|Overall Study|Lost to Follow-up|6
7273363|NCT00430937|11487641|FG001|Overall Study|Lost to Follow-up|6
7273364|NCT00430937|11487640|FG000|Overall Study|Withdrawal by Subject|5
7273365|NCT00430937|11487641|FG001|Overall Study|Withdrawal by Subject|2
7273366|NCT00430937|11487640|FG000|Overall Study|Protocol Violation|3
7273367|NCT00430937|11487641|FG001|Overall Study|Protocol Violation|2
7273368|NCT00430937|11487640|FG000|Overall Study|Lack of Efficacy|6
7273369|NCT00430937|11487641|FG001|Overall Study|Lack of Efficacy|5
7273370|NCT00430937|11487640|FG000|Overall Study|Inappropriate enrollment|2
7273371|NCT00430937|11487641|FG001|Overall Study|Inappropriate enrollment|1
7273372|NCT00430937|11487640|FG000|Overall Study|Administrative reasons|1
7273373|NCT00430937|11487641|FG001|Overall Study|Administrative reasons|0
7273374|NCT00430937|11487640|FG000|Overall Study|Protocol discontinuation criteria met|1
7273375|NCT00430937|11487641|FG001|Overall Study|Protocol discontinuation criteria met|2
7273376|NCT00430937|11487640|FG000|Overall Study|Unable to classify|0
7273377|NCT00430937|11487641|FG001|Overall Study|Unable to classify|1
7273378|NCT00430989|11487649|FG000|Overall Study|Lost to Follow-up|2
7273379|NCT00430989|11487650|FG001|Overall Study|Lost to Follow-up|3
7273380|NCT00430989|11487649|FG000|Overall Study|Withdrawal by Subject|15
7273381|NCT00430989|11487650|FG001|Overall Study|Withdrawal by Subject|14
7273382|NCT00430989|11487649|FG000|Overall Study|Protocol Violation|30
7273383|NCT00430989|11487650|FG001|Overall Study|Protocol Violation|37
7273384|NCT00430989|11487649|FG000|Overall Study|Not eligible|13
7273385|NCT00430989|11487650|FG001|Overall Study|Not eligible|6
7273386|NCT00431067|11487667|FG000|Overall Study|Other Adverse Event|9
7273387|NCT00431067|11487667|FG000|Overall Study|Progressive disease|30
7273388|NCT00431067|11487667|FG000|Overall Study|Non-compliance,lost to follow-up|2
7273389|NCT00431444|11487688|FG000|Overall Study|Protocol Violation|1
7273390|NCT00431444|11487689|FG001|Overall Study|Protocol Violation|4
7273391|NCT00431444|11487688|FG000|Overall Study|Adverse Event|2
7273392|NCT00431444|11487689|FG001|Overall Study|Adverse Event|1
7273393|NCT00431444|11487688|FG000|Overall Study|Withdrawal by Subject|1
7273394|NCT00431444|11487689|FG001|Overall Study|Withdrawal by Subject|1
7602540|NCT04498247|12009080|FG000|Overall Study|Lost to Follow-up|0
7602541|NCT04498247|12009081|FG001|Overall Study|Lost to Follow-up|0
7602542|NCT04498247|12009082|FG002|Overall Study|Lost to Follow-up|0
7602543|NCT04498247|12009083|FG003|Overall Study|Lost to Follow-up|1
7602544|NCT04498247|12009084|FG004|Overall Study|Lost to Follow-up|0
7602545|NCT04498247|12009085|FG005|Overall Study|Lost to Follow-up|0
7602546|NCT04498247|12009086|FG006|Overall Study|Lost to Follow-up|0
7602547|NCT04498247|12009087|FG007|Overall Study|Lost to Follow-up|0
7602548|NCT04498247|12009080|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
7602549|NCT04498247|12009081|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
7602550|NCT04498247|12009082|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
7602551|NCT04498247|12009083|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
7602552|NCT04498247|12009084|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
7602553|NCT04498247|12009085|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
7602554|NCT04498247|12009086|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
7602555|NCT04498247|12009087|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
7602556|NCT04498247|12009080|FG000|Overall Study|Withdrawal by Subject|0
7602557|NCT04498247|12009081|FG001|Overall Study|Withdrawal by Subject|8
7602558|NCT04498247|12009082|FG002|Overall Study|Withdrawal by Subject|0
7602559|NCT04498247|12009083|FG003|Overall Study|Withdrawal by Subject|7
7602560|NCT04498247|12009084|FG004|Overall Study|Withdrawal by Subject|0
7602561|NCT04498247|12009085|FG005|Overall Study|Withdrawal by Subject|0
7602562|NCT04498247|12009086|FG006|Overall Study|Withdrawal by Subject|1
7602563|NCT04498247|12009087|FG007|Overall Study|Withdrawal by Subject|0
7602564|NCT04498247|12009080|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
7602565|NCT04498247|12009081|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
7602566|NCT04498247|12009082|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
7602567|NCT04498247|12009083|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
7602568|NCT04498247|12009084|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
7273395|NCT00431444|11487688|FG000|Overall Study|Lost to Follow-up|1
7273396|NCT00431444|11487689|FG001|Overall Study|Lost to Follow-up|0
7273397|NCT00431444|11487688|FG000|Overall Study|Administrative Problems|0
7273398|NCT00431444|11487689|FG001|Overall Study|Administrative Problems|1
7602569|NCT04498247|12009085|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
7273399|NCT00431496|11487695|FG000|Overall Study|Adverse Event|3
7602570|NCT04498247|12009086|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
7602571|NCT04498247|12009087|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
7602572|NCT04472650|12009104|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
7602573|NCT04472650|12009105|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
7602574|NCT04151290|12009122|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
7602575|NCT04038385|12009128|FG000|Overall Study|Completed baseline assessment only|7
7602576|NCT04038385|12009129|FG001|Overall Study|Completed baseline assessment only|4
7602577|NCT04038385|12009128|FG000|Overall Study|Moved out of area|4
7602578|NCT04038385|12009129|FG001|Overall Study|Moved out of area|2
7602579|NCT04038385|12009128|FG000|Overall Study|Discontinued study involvement|6
7602580|NCT04038385|12009129|FG001|Overall Study|Discontinued study involvement|1
7273400|NCT00431496|11487695|FG000|Overall Study|Lost to Follow-up|1
7273401|NCT00431496|11487695|FG000|Overall Study|Withdrawal by Subject|2
7273402|NCT00431496|11487695|FG000|Overall Study|Protocol-specified criteria|5
7273403|NCT00431834|11487708|FG000|Overall Study|Withdrawal by Subject|7
7273404|NCT00431834|11487708|FG000|Overall Study|Death|3
7273405|NCT00431834|11487708|FG000|Overall Study|Missed Endpoint Visit|2
7273406|NCT00431834|11487708|FG000|Overall Study|Lost to Follow-up|1
7273407|NCT00431847|11487719|FG000|Overall Study|completion of less than two study visits|6
7273408|NCT00431847|11487720|FG001|Overall Study|completion of less than two study visits|3
7273409|NCT00431847|11487721|FG002|Overall Study|completion of less than two study visits|4
7273410|NCT00431847|11487722|FG003|Overall Study|completion of less than two study visits|14
7273411|NCT00431847|11487723|FG004|Overall Study|completion of less than two study visits|0
7273412|NCT00431847|11487719|FG000|Overall Study|Protocol Violation|0
7273413|NCT00431847|11487720|FG001|Overall Study|Protocol Violation|0
7273414|NCT00431847|11487721|FG002|Overall Study|Protocol Violation|0
7273415|NCT00431847|11487722|FG003|Overall Study|Protocol Violation|0
7273416|NCT00431847|11487723|FG004|Overall Study|Protocol Violation|1
7273417|NCT00431951|11487737|FG000|Overall Study|Inability to follow study procedures|1
7273418|NCT00431951|11487738|FG001|Overall Study|Inability to follow study procedures|0
7273419|NCT00431951|11487739|FG002|Overall Study|Inability to follow study procedures|1
7273420|NCT00431951|11487740|FG003|Overall Study|Inability to follow study procedures|2
7273421|NCT00431951|11487737|FG000|Overall Study|Lost to Follow-up|0
7273422|NCT00431951|11487738|FG001|Overall Study|Lost to Follow-up|1
7273423|NCT00431951|11487739|FG002|Overall Study|Lost to Follow-up|0
7273424|NCT00431951|11487740|FG003|Overall Study|Lost to Follow-up|0
7273425|NCT00431951|11487737|FG000|Overall Study|Withdrawal by Subject|0
7273426|NCT00431951|11487738|FG001|Overall Study|Withdrawal by Subject|1
7273427|NCT00431951|11487739|FG002|Overall Study|Withdrawal by Subject|0
7273428|NCT00431951|11487740|FG003|Overall Study|Withdrawal by Subject|0
7602581|NCT03923738|12009135|FG000|Period 1|Adverse Event|1
7602582|NCT03923738|12009135|FG000|Period 1|Withdrawal by Subject|1
7602583|NCT03887117|12009145|FG000|Overall Study|Discontinued prematurely|0
7602584|NCT03887117|12009146|FG001|Overall Study|Discontinued prematurely|1
7602585|NCT03887117|12009147|FG002|Overall Study|Discontinued prematurely|1
7602586|NCT03887117|12009148|FG003|Overall Study|Discontinued prematurely|2
7602587|NCT03858634|12009169|FG000|Overall Study|Withdrawal by Subject|1
7602588|NCT03858634|12009170|FG001|Overall Study|Withdrawal by Subject|0
7602589|NCT03858634|12009169|FG000|Overall Study|Adverse Event|1
7602590|NCT03858634|12009170|FG001|Overall Study|Adverse Event|0
7602591|NCT03858634|12009169|FG000|Overall Study|Lost to Follow-up|0
7602592|NCT03858634|12009170|FG001|Overall Study|Lost to Follow-up|1
7602593|NCT03858634|12009169|FG000|Overall Study|Other, Not Specified|1
7602594|NCT03858634|12009170|FG001|Overall Study|Other, Not Specified|1
7602595|NCT03819114|12009188|FG000|Overall Study|Protocol Violation|0
7602596|NCT03819114|12009189|FG001|Overall Study|Protocol Violation|1
7602597|NCT03819114|12009190|FG002|Overall Study|Protocol Violation|1
7602598|NCT03819114|12009191|FG003|Overall Study|Protocol Violation|0
7602599|NCT03819114|12009188|FG000|Overall Study|Lost to Follow-up|0
7602600|NCT03819114|12009189|FG001|Overall Study|Lost to Follow-up|0
7602601|NCT03819114|12009190|FG002|Overall Study|Lost to Follow-up|1
7602602|NCT03819114|12009191|FG003|Overall Study|Lost to Follow-up|0
7602603|NCT03804268|12009205|FG000|Overall Study|Adverse Event|2
7602604|NCT03804268|12009206|FG001|Overall Study|Adverse Event|2
7602605|NCT03804268|12009205|FG000|Overall Study|Withdrawal by Subject|2
7602606|NCT03804268|12009206|FG001|Overall Study|Withdrawal by Subject|0
7602607|NCT03804268|12009205|FG000|Overall Study|Lost to Follow-up|1
7602608|NCT03804268|12009206|FG001|Overall Study|Lost to Follow-up|0
7602609|NCT03804268|12009205|FG000|Overall Study|Physician Decision|2
7602610|NCT03804268|12009206|FG001|Overall Study|Physician Decision|0
7602611|NCT04435808|12009215|FG000|Overall Study|Study stopped by DSMB|0
7602612|NCT04435808|12009216|FG001|Overall Study|Study stopped by DSMB|1
7602613|NCT04409262|12009224|FG000|Overall Study|Adverse Event|0
7602614|NCT04409262|12009225|FG001|Overall Study|Adverse Event|2
7602615|NCT04409262|12009224|FG000|Overall Study|Death|55
7602616|NCT04409262|12009225|FG001|Overall Study|Death|97
7602617|NCT04409262|12009224|FG000|Overall Study|Lost to Follow-up|12
7602618|NCT04409262|12009225|FG001|Overall Study|Lost to Follow-up|23
7602619|NCT04409262|12009224|FG000|Overall Study|Lack of Staff|0
7602620|NCT04409262|12009225|FG001|Overall Study|Lack of Staff|1
7602621|NCT04409262|12009224|FG000|Overall Study|Protocol Violation|3
7602622|NCT04409262|12009225|FG001|Overall Study|Protocol Violation|1
7602623|NCT04409262|12009224|FG000|Overall Study|Withdrawal by Subject|5
7602624|NCT04409262|12009225|FG001|Overall Study|Withdrawal by Subject|10
7602625|NCT04305912|12009234|FG000|First Intervention|COVID-19 Suspension|2
7602626|NCT04305912|12009235|FG001|First Intervention|COVID-19 Suspension|0
7602627|NCT04305912|12009234|FG000|First Intervention|Withdrawal by Subject|0
7602628|NCT04305912|12009235|FG001|First Intervention|Withdrawal by Subject|1
7602629|NCT04305912|12009234|FG000|Second Intervention|Adverse Event|0
7602630|NCT04305912|12009235|FG001|Second Intervention|Adverse Event|1
7602631|NCT03987919|12009254|FG000|Overall Study|Adverse Event|1
7602632|NCT03987919|12009255|FG001|Overall Study|Adverse Event|4
7602633|NCT03987919|12009256|FG002|Overall Study|Adverse Event|1
7602634|NCT03987919|12009257|FG003|Overall Study|Adverse Event|3
7602635|NCT03987919|12009254|FG000|Overall Study|Death|4
7602636|NCT03987919|12009255|FG001|Overall Study|Death|4
7602637|NCT03987919|12009256|FG002|Overall Study|Death|4
7602638|NCT03987919|12009257|FG003|Overall Study|Death|1
7602639|NCT03987919|12009254|FG000|Overall Study|Lost to Follow-up|5
7602640|NCT03987919|12009255|FG001|Overall Study|Lost to Follow-up|6
7602641|NCT03987919|12009256|FG002|Overall Study|Lost to Follow-up|8
7273429|NCT00431951|11487737|FG000|Overall Study|Adverse Event|0
7273430|NCT00431951|11487738|FG001|Overall Study|Adverse Event|0
7273431|NCT00431951|11487739|FG002|Overall Study|Adverse Event|1
7273432|NCT00431951|11487740|FG003|Overall Study|Adverse Event|0
7602642|NCT03987919|12009257|FG003|Overall Study|Lost to Follow-up|12
7602643|NCT03987919|12009254|FG000|Overall Study|Physician Decision|0
7602644|NCT03987919|12009255|FG001|Overall Study|Physician Decision|2
7602645|NCT03987919|12009256|FG002|Overall Study|Physician Decision|0
7602646|NCT03987919|12009257|FG003|Overall Study|Physician Decision|4
7602647|NCT03987919|12009254|FG000|Overall Study|Pregnancy|1
7602648|NCT03987919|12009255|FG001|Overall Study|Pregnancy|0
7602649|NCT03987919|12009256|FG002|Overall Study|Pregnancy|1
7602650|NCT03987919|12009257|FG003|Overall Study|Pregnancy|1
7602651|NCT03987919|12009254|FG000|Overall Study|Protocol Violation|0
7602652|NCT03987919|12009255|FG001|Overall Study|Protocol Violation|1
7602653|NCT03987919|12009256|FG002|Overall Study|Protocol Violation|0
7602654|NCT03987919|12009257|FG003|Overall Study|Protocol Violation|0
7602655|NCT03987919|12009254|FG000|Overall Study|Site terminated by Sponsor|0
7602656|NCT03987919|12009255|FG001|Overall Study|Site terminated by Sponsor|0
7602657|NCT03987919|12009256|FG002|Overall Study|Site terminated by Sponsor|0
7602658|NCT03987919|12009257|FG003|Overall Study|Site terminated by Sponsor|1
7602659|NCT03987919|12009254|FG000|Overall Study|Withdrawal by Subject|7
7602660|NCT03987919|12009255|FG001|Overall Study|Withdrawal by Subject|7
7602661|NCT03987919|12009256|FG002|Overall Study|Withdrawal by Subject|8
7602662|NCT03987919|12009257|FG003|Overall Study|Withdrawal by Subject|4
7602663|NCT03987919|12009254|FG000|Overall Study|Other - as reported by the investigator|1
7602664|NCT03987919|12009255|FG001|Overall Study|Other - as reported by the investigator|3
7602665|NCT03987919|12009256|FG002|Overall Study|Other - as reported by the investigator|2
7602666|NCT03987919|12009257|FG003|Overall Study|Other - as reported by the investigator|0
7602667|NCT03861039|12009286|FG000|Overall Study|Adverse Event|2
7602668|NCT03861039|12009287|FG001|Overall Study|Adverse Event|5
7602669|NCT03861039|12009288|FG002|Overall Study|Adverse Event|11
7602670|NCT03861039|12009286|FG000|Overall Study|Withdrawal by Subject|1
7602671|NCT03861039|12009287|FG001|Overall Study|Withdrawal by Subject|3
7602672|NCT03861039|12009288|FG002|Overall Study|Withdrawal by Subject|4
7602673|NCT03759587|12009298|FG000|Overall Study|Ongoing|19
7273433|NCT00431964|11487756|FG000|Overall Study|Adverse Event|1
7602674|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Adverse Event|3
7602675|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Adverse Event|2
7602676|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Adverse Event|0
7602677|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Adverse Event|3
7602678|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Screen Failure|0
7602679|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Screen Failure|1
7602680|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Screen Failure|0
7602681|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Screen Failure|0
7602682|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Death|6
7602683|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Death|2
7602684|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Death|2
7602685|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Death|9
7602686|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4
7602687|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2
7602688|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2
7602689|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11
7602690|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Physician Decision|1
7602691|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Physician Decision|1
7602692|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Physician Decision|0
7602693|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Physician Decision|3
7602694|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Protocol Violation|0
7602695|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
7602696|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Protocol Violation|0
7602697|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Protocol Violation|1
7602698|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5
7602699|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0
7602700|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5
7602701|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23
7602702|NCT03730662|12009306|FG000|Treatment Period (52 Weeks)|Personal Reason|2
7602703|NCT03730662|12009307|FG001|Treatment Period (52 Weeks)|Personal Reason|2
7602704|NCT03730662|12009308|FG002|Treatment Period (52 Weeks)|Personal Reason|0
7602705|NCT03730662|12009309|FG003|Treatment Period (52 Weeks)|Personal Reason|2
7602706|NCT03730662|12009306|FG000|Variable Treatment Period|Adverse Event|1
7602707|NCT03730662|12009307|FG001|Variable Treatment Period|Adverse Event|2
7602708|NCT03730662|12009308|FG002|Variable Treatment Period|Adverse Event|0
7602709|NCT03730662|12009309|FG003|Variable Treatment Period|Adverse Event|7
7602710|NCT03730662|12009306|FG000|Variable Treatment Period|Death|9
7602711|NCT03730662|12009307|FG001|Variable Treatment Period|Death|0
7602712|NCT03730662|12009308|FG002|Variable Treatment Period|Death|6
7602713|NCT03730662|12009309|FG003|Variable Treatment Period|Death|26
7602714|NCT03730662|12009306|FG000|Variable Treatment Period|Lost to Follow-up|2
7602715|NCT03730662|12009307|FG001|Variable Treatment Period|Lost to Follow-up|1
7602716|NCT03730662|12009308|FG002|Variable Treatment Period|Lost to Follow-up|4
7602717|NCT03730662|12009309|FG003|Variable Treatment Period|Lost to Follow-up|11
7602718|NCT03730662|12009306|FG000|Variable Treatment Period|Personal Reason|0
7602719|NCT03730662|12009307|FG001|Variable Treatment Period|Personal Reason|2
7602720|NCT03730662|12009308|FG002|Variable Treatment Period|Personal Reason|1
7602721|NCT03730662|12009309|FG003|Variable Treatment Period|Personal Reason|6
7602722|NCT03730662|12009306|FG000|Variable Treatment Period|Physician Decision|0
7602723|NCT03730662|12009307|FG001|Variable Treatment Period|Physician Decision|0
7602724|NCT03730662|12009308|FG002|Variable Treatment Period|Physician Decision|0
7602725|NCT03730662|12009309|FG003|Variable Treatment Period|Physician Decision|3
7602726|NCT03730662|12009306|FG000|Variable Treatment Period|Protocol Violation|0
7602727|NCT03730662|12009307|FG001|Variable Treatment Period|Protocol Violation|1
7602728|NCT03730662|12009308|FG002|Variable Treatment Period|Protocol Violation|1
7602729|NCT03730662|12009309|FG003|Variable Treatment Period|Protocol Violation|1
7602730|NCT03730662|12009306|FG000|Variable Treatment Period|Withdrawal by Subject|2
7602731|NCT03730662|12009307|FG001|Variable Treatment Period|Withdrawal by Subject|1
7602732|NCT03730662|12009308|FG002|Variable Treatment Period|Withdrawal by Subject|4
7602733|NCT03730662|12009309|FG003|Variable Treatment Period|Withdrawal by Subject|17
7602734|NCT03538444|12009325|FG000|Overall Study|opioid withdrawal|1
7602735|NCT03538444|12009326|FG001|Overall Study|opioid withdrawal|0
7602756|NCT03252925|12009362|FG000|Overall Study|Withdrawal by Subject|1
7602757|NCT03252925|12009363|FG001|Overall Study|Withdrawal by Subject|0
7602758|NCT03252925|12009362|FG000|Overall Study|Protocol Violation|6
7602759|NCT03252925|12009363|FG001|Overall Study|Protocol Violation|0
7602760|NCT03252925|12009362|FG000|Overall Study|Adverse Event|1
7602761|NCT03252925|12009363|FG001|Overall Study|Adverse Event|0
7602762|NCT03252925|12009362|FG000|Overall Study|Lost to Follow-up|6
7602763|NCT03252925|12009363|FG001|Overall Study|Lost to Follow-up|6
7602764|NCT03185832|12009373|FG000|Overall Study|Death|9
7602765|NCT03185832|12009374|FG001|Overall Study|Death|14
7602766|NCT03185832|12009375|FG002|Overall Study|Death|9
7602767|NCT03185832|12009376|FG003|Overall Study|Death|7
7602768|NCT03185832|12009373|FG000|Overall Study|Withdrawn - vital status available|0
7602769|NCT03185832|12009374|FG001|Overall Study|Withdrawn - vital status available|1
7602770|NCT03185832|12009375|FG002|Overall Study|Withdrawn - vital status available|1
7602771|NCT03185832|12009376|FG003|Overall Study|Withdrawn - vital status available|4
7602772|NCT02959918|12009407|FG000|Overall Study|Adverse Event|1
7602773|NCT02959918|12009408|FG001|Overall Study|Adverse Event|1
7602774|NCT02959918|12009409|FG002|Overall Study|Adverse Event|2
7602775|NCT02959918|12009410|FG003|Overall Study|Adverse Event|0
7602776|NCT02959918|12009411|FG004|Overall Study|Adverse Event|0
7602777|NCT02959918|12009412|FG005|Overall Study|Adverse Event|2
7602778|NCT02959918|12009413|FG006|Overall Study|Adverse Event|2
7602779|NCT02959918|12009414|FG007|Overall Study|Adverse Event|1
7602780|NCT02959918|12009415|FG008|Overall Study|Adverse Event|2
7602781|NCT02959918|12009416|FG009|Overall Study|Adverse Event|1
7602782|NCT02959918|12009417|FG010|Overall Study|Adverse Event|1
7602783|NCT02959918|12009418|FG011|Overall Study|Adverse Event|3
7602784|NCT02959918|12009419|FG012|Overall Study|Adverse Event|2
7602785|NCT02959918|12009420|FG013|Overall Study|Adverse Event|4
7602786|NCT02959918|12009407|FG000|Overall Study|Lost to Follow-up|0
7602787|NCT02959918|12009408|FG001|Overall Study|Lost to Follow-up|0
7602788|NCT02959918|12009409|FG002|Overall Study|Lost to Follow-up|0
7602789|NCT02959918|12009410|FG003|Overall Study|Lost to Follow-up|0
7602790|NCT02959918|12009411|FG004|Overall Study|Lost to Follow-up|0
7602791|NCT02959918|12009412|FG005|Overall Study|Lost to Follow-up|0
7602792|NCT02959918|12009413|FG006|Overall Study|Lost to Follow-up|0
7602793|NCT02959918|12009414|FG007|Overall Study|Lost to Follow-up|0
7602794|NCT02959918|12009415|FG008|Overall Study|Lost to Follow-up|0
7602795|NCT02959918|12009416|FG009|Overall Study|Lost to Follow-up|1
7602796|NCT02959918|12009417|FG010|Overall Study|Lost to Follow-up|0
7602797|NCT02959918|12009418|FG011|Overall Study|Lost to Follow-up|0
7602798|NCT02959918|12009419|FG012|Overall Study|Lost to Follow-up|1
7602799|NCT02959918|12009420|FG013|Overall Study|Lost to Follow-up|0
7602800|NCT02959918|12009407|FG000|Overall Study|Withdrawal by Subject|0
7602801|NCT02959918|12009408|FG001|Overall Study|Withdrawal by Subject|0
7602802|NCT02959918|12009409|FG002|Overall Study|Withdrawal by Subject|1
7602803|NCT02959918|12009410|FG003|Overall Study|Withdrawal by Subject|2
7602804|NCT02959918|12009411|FG004|Overall Study|Withdrawal by Subject|0
7602805|NCT02959918|12009412|FG005|Overall Study|Withdrawal by Subject|0
7602806|NCT02959918|12009413|FG006|Overall Study|Withdrawal by Subject|1
7602807|NCT02959918|12009414|FG007|Overall Study|Withdrawal by Subject|0
7602808|NCT02959918|12009415|FG008|Overall Study|Withdrawal by Subject|1
7602809|NCT02959918|12009416|FG009|Overall Study|Withdrawal by Subject|1
7602810|NCT02959918|12009417|FG010|Overall Study|Withdrawal by Subject|2
7602811|NCT02959918|12009418|FG011|Overall Study|Withdrawal by Subject|3
7602812|NCT02959918|12009419|FG012|Overall Study|Withdrawal by Subject|1
7602813|NCT02959918|12009420|FG013|Overall Study|Withdrawal by Subject|1
7602814|NCT02959918|12009407|FG000|Overall Study|Protocol Violation|0
7602815|NCT02959918|12009408|FG001|Overall Study|Protocol Violation|0
7602816|NCT02959918|12009409|FG002|Overall Study|Protocol Violation|1
7602817|NCT02959918|12009410|FG003|Overall Study|Protocol Violation|0
7602818|NCT02959918|12009411|FG004|Overall Study|Protocol Violation|0
7602819|NCT02959918|12009412|FG005|Overall Study|Protocol Violation|1
7602820|NCT02959918|12009413|FG006|Overall Study|Protocol Violation|0
7602821|NCT02959918|12009414|FG007|Overall Study|Protocol Violation|0
7602822|NCT02959918|12009415|FG008|Overall Study|Protocol Violation|2
7602823|NCT02959918|12009416|FG009|Overall Study|Protocol Violation|1
7602824|NCT02959918|12009417|FG010|Overall Study|Protocol Violation|0
7602825|NCT02959918|12009418|FG011|Overall Study|Protocol Violation|1
7602826|NCT02959918|12009419|FG012|Overall Study|Protocol Violation|1
7602827|NCT02959918|12009420|FG013|Overall Study|Protocol Violation|0
7602828|NCT02959918|12009407|FG000|Overall Study|Stopping Rule Met|1
7602829|NCT02959918|12009408|FG001|Overall Study|Stopping Rule Met|0
7602830|NCT02959918|12009409|FG002|Overall Study|Stopping Rule Met|3
7602831|NCT02959918|12009410|FG003|Overall Study|Stopping Rule Met|4
7602832|NCT02959918|12009411|FG004|Overall Study|Stopping Rule Met|5
7602833|NCT02959918|12009412|FG005|Overall Study|Stopping Rule Met|3
7273434|NCT00431964|11487757|FG001|Overall Study|Adverse Event|0
7273435|NCT00431964|11487756|FG000|Overall Study|Lost to Follow-up|1
7273436|NCT00431964|11487757|FG001|Overall Study|Lost to Follow-up|2
7273437|NCT00431964|11487756|FG000|Overall Study|Physician Decision|2
7273438|NCT00431964|11487757|FG001|Overall Study|Physician Decision|2
7273439|NCT00431964|11487756|FG000|Overall Study|Withdrawal by Subject|2
7273440|NCT00431964|11487757|FG001|Overall Study|Withdrawal by Subject|1
7273441|NCT00431964|11487756|FG000|Overall Study|Parental Consent Withdrawn|0
7273442|NCT00431964|11487757|FG001|Overall Study|Parental Consent Withdrawn|2
7273443|NCT00431964|11487756|FG000|Overall Study|Due to Unstable Health|0
7273444|NCT00431964|11487757|FG001|Overall Study|Due to Unstable Health|1
7273445|NCT00432042|11487766|FG000|Overall Study|Protocol Violation|2
7273446|NCT00432042|11487767|FG001|Overall Study|Protocol Violation|0
7273447|NCT00432042|11487768|FG002|Overall Study|Protocol Violation|0
7273448|NCT00432042|11487766|FG000|Overall Study|Withdrawal by Subject|0
7273449|NCT00432042|11487767|FG001|Overall Study|Withdrawal by Subject|0
7273450|NCT00432042|11487768|FG002|Overall Study|Withdrawal by Subject|2
7273451|NCT00432042|11487766|FG000|Overall Study|Lost to Follow-up|5
7273452|NCT00432042|11487767|FG001|Overall Study|Lost to Follow-up|1
7273453|NCT00432042|11487768|FG002|Overall Study|Lost to Follow-up|0
7273454|NCT00432159|11487781|FG000|Overall Study|Death|0
7273455|NCT00432159|11487782|FG001|Overall Study|Death|1
7273456|NCT00432159|11487783|FG002|Overall Study|Death|0
7273457|NCT00432159|11487784|FG003|Overall Study|Death|0
7273458|NCT00432159|11487785|FG004|Overall Study|Death|0
7273459|NCT00432159|11487781|FG000|Overall Study|Failure|9
7273460|NCT00432159|11487782|FG001|Overall Study|Failure|5
7273461|NCT00432159|11487783|FG002|Overall Study|Failure|3
7273462|NCT00432159|11487784|FG003|Overall Study|Failure|2
7273463|NCT00432159|11487785|FG004|Overall Study|Failure|3
7602834|NCT02959918|12009413|FG006|Overall Study|Stopping Rule Met|2
7602835|NCT02959918|12009414|FG007|Overall Study|Stopping Rule Met|4
7602836|NCT02959918|12009415|FG008|Overall Study|Stopping Rule Met|1
7602837|NCT02959918|12009416|FG009|Overall Study|Stopping Rule Met|1
7602838|NCT02959918|12009417|FG010|Overall Study|Stopping Rule Met|3
7602839|NCT02959918|12009418|FG011|Overall Study|Stopping Rule Met|5
7602840|NCT02959918|12009419|FG012|Overall Study|Stopping Rule Met|2
7602841|NCT02959918|12009420|FG013|Overall Study|Stopping Rule Met|1
7602842|NCT02959918|12009407|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
7602843|NCT02959918|12009408|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2
7602844|NCT02959918|12009409|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
7602845|NCT02959918|12009410|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3
7602846|NCT02959918|12009411|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602847|NCT02959918|12009412|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602848|NCT02959918|12009413|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7273464|NCT00432159|11487781|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
7273465|NCT00432159|11487782|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
7273466|NCT00432159|11487783|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
7273467|NCT00432159|11487784|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
7273468|NCT00432159|11487785|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
7273469|NCT00432172|11487801|FG000|Overall Study|Physician Decision|0
7273470|NCT00432172|11487802|FG001|Overall Study|Physician Decision|0
7273471|NCT00432172|11487803|FG002|Overall Study|Physician Decision|2
7602849|NCT02959918|12009414|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7273472|NCT00432172|11487804|FG003|Overall Study|Physician Decision|0
7273473|NCT00432172|11487801|FG000|Overall Study|Adverse Event|4
7602850|NCT02959918|12009415|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602851|NCT02959918|12009416|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602852|NCT02959918|12009417|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602853|NCT02959918|12009418|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602854|NCT02959918|12009419|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602855|NCT02959918|12009420|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
7602856|NCT02959918|12009407|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602857|NCT02959918|12009408|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602858|NCT02959918|12009409|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602859|NCT02959918|12009410|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602860|NCT02959918|12009411|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602861|NCT02959918|12009412|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602862|NCT02959918|12009413|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602863|NCT02959918|12009414|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1
7602864|NCT02959918|12009415|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602865|NCT02959918|12009416|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602866|NCT02959918|12009417|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602867|NCT02959918|12009418|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602868|NCT02959918|12009419|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602869|NCT02959918|12009420|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0
7602870|NCT02959918|12009407|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0
7602871|NCT02959918|12009408|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0
7602872|NCT02959918|12009409|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0
7602873|NCT02959918|12009410|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0
7602874|NCT02959918|12009411|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0
7602875|NCT02959918|12009412|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0
7602876|NCT02959918|12009413|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0
7602877|NCT02959918|12009414|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0
7602878|NCT02959918|12009415|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1
7602879|NCT02959918|12009416|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0
7602880|NCT02959918|12009417|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0
7602881|NCT02959918|12009418|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0
7602882|NCT02959918|12009419|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0
7602883|NCT02959918|12009420|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0
7602884|NCT02959918|12009407|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602885|NCT02959918|12009408|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602886|NCT02959918|12009409|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602887|NCT02959918|12009410|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602888|NCT02959918|12009411|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602889|NCT02959918|12009412|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602890|NCT02959918|12009413|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602891|NCT02959918|12009414|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602892|NCT02959918|12009415|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602893|NCT02959918|12009416|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1
7602894|NCT02959918|12009417|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602895|NCT02959918|12009418|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602896|NCT02959918|12009419|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602897|NCT02959918|12009420|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
7602898|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Adverse Event|2
7602899|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Adverse Event|4
7273474|NCT00432172|11487802|FG001|Overall Study|Adverse Event|2
7273475|NCT00432172|11487803|FG002|Overall Study|Adverse Event|4
7273476|NCT00432172|11487804|FG003|Overall Study|Adverse Event|3
7273477|NCT00432172|11487801|FG000|Overall Study|Disease progression|0
7273478|NCT00432172|11487802|FG001|Overall Study|Disease progression|2
7273479|NCT00432172|11487803|FG002|Overall Study|Disease progression|5
7602900|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|disease progression|58
7602901|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|disease progression|47
7602902|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Death|3
7602903|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Death|6
7602904|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Physician Decision|3
7602905|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Physician Decision|1
7602906|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
7602907|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
7602908|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
7602909|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
7602910|NCT02472964|12009455|FG000|Part 1 (up to Week 24)|Other|2
7602911|NCT02472964|12009456|FG001|Part 1 (up to Week 24)|Other|1
7602912|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
7602913|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
7602914|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
7602915|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
7602916|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Death|0
7602917|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Death|1
7602918|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
7602919|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
7602920|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
7602921|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
7602922|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
7602923|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
7602924|NCT02472964|12009455|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
7602925|NCT02472964|12009456|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
7602926|NCT02178722|12009467|FG000|Overall Study|Withdrawal by Subject|0
7602927|NCT02178722|12009468|FG001|Overall Study|Withdrawal by Subject|0
7602928|NCT02178722|12009469|FG002|Overall Study|Withdrawal by Subject|0
7602929|NCT02178722|12009470|FG003|Overall Study|Withdrawal by Subject|2
7602930|NCT02178722|12009471|FG004|Overall Study|Withdrawal by Subject|33
7602931|NCT02178722|12009467|FG000|Overall Study|Death|2
7602932|NCT02178722|12009468|FG001|Overall Study|Death|13
7602933|NCT02178722|12009469|FG002|Overall Study|Death|12
7602934|NCT02178722|12009470|FG003|Overall Study|Death|12
7602935|NCT02178722|12009471|FG004|Overall Study|Death|205
7602936|NCT02178722|12009467|FG000|Overall Study|Lost to Follow-up|0
7602937|NCT02178722|12009468|FG001|Overall Study|Lost to Follow-up|0
7602938|NCT02178722|12009469|FG002|Overall Study|Lost to Follow-up|0
7602939|NCT02178722|12009470|FG003|Overall Study|Lost to Follow-up|2
7602940|NCT02178722|12009471|FG004|Overall Study|Lost to Follow-up|11
7602941|NCT02178722|12009467|FG000|Overall Study|Study terminated by Sponsor|2
7602942|NCT02178722|12009468|FG001|Overall Study|Study terminated by Sponsor|7
7602943|NCT02178722|12009469|FG002|Overall Study|Study terminated by Sponsor|6
7602944|NCT02178722|12009470|FG003|Overall Study|Study terminated by Sponsor|4
7602945|NCT02178722|12009471|FG004|Overall Study|Study terminated by Sponsor|128
7602946|NCT02178722|12009467|FG000|Overall Study|Physician Decision|0
7602947|NCT02178722|12009468|FG001|Overall Study|Physician Decision|0
7602948|NCT02178722|12009469|FG002|Overall Study|Physician Decision|0
7602949|NCT02178722|12009470|FG003|Overall Study|Physician Decision|0
7602950|NCT02178722|12009471|FG004|Overall Study|Physician Decision|3
7602951|NCT02178722|12009467|FG000|Overall Study|Other|0
7602952|NCT02178722|12009468|FG001|Overall Study|Other|0
7602953|NCT02178722|12009469|FG002|Overall Study|Other|0
7602954|NCT02178722|12009470|FG003|Overall Study|Other|0
7602955|NCT02178722|12009471|FG004|Overall Study|Other|2
7602956|NCT01258803|12009486|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602957|NCT01258803|12009487|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602958|NCT01258803|12009488|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602959|NCT01258803|12009489|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602960|NCT01258803|12009490|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
7602961|NCT01258803|12009491|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
7602962|NCT01258803|12009486|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602963|NCT01258803|12009487|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
7602964|NCT01258803|12009488|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602965|NCT01258803|12009489|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602966|NCT01258803|12009490|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602967|NCT01258803|12009491|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
7602968|NCT01258803|12009486|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602969|NCT01258803|12009487|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602970|NCT01258803|12009488|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
7602971|NCT01258803|12009489|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602972|NCT01258803|12009490|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602973|NCT01258803|12009491|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
7602974|NCT00862251|12009512|FG000|Overall Study|Adverse Event|8
7602975|NCT00862251|12009513|FG001|Overall Study|Adverse Event|3
7602976|NCT00862251|12009514|FG002|Overall Study|Adverse Event|1
7602977|NCT00862251|12009512|FG000|Overall Study|Lost to Follow-up|0
7602978|NCT00862251|12009513|FG001|Overall Study|Lost to Follow-up|0
7602979|NCT00862251|12009514|FG002|Overall Study|Lost to Follow-up|1
7602980|NCT00862251|12009512|FG000|Overall Study|Protocol Violation|2
7602981|NCT00862251|12009513|FG001|Overall Study|Protocol Violation|0
7602982|NCT00862251|12009514|FG002|Overall Study|Protocol Violation|1
7602983|NCT00862251|12009512|FG000|Overall Study|Withdrawal by Subject|9
7602984|NCT00862251|12009513|FG001|Overall Study|Withdrawal by Subject|2
7602985|NCT00862251|12009514|FG002|Overall Study|Withdrawal by Subject|6
7602986|NCT00783263|12009529|FG000|Overall Study|Adverse Event|3
7602987|NCT00783263|12009530|FG001|Overall Study|Adverse Event|0
7602988|NCT00783263|12009531|FG002|Overall Study|Adverse Event|2
7602989|NCT00783263|12009532|FG003|Overall Study|Adverse Event|1
7602990|NCT00783263|12009529|FG000|Overall Study|Lost to Follow-up|1
7602991|NCT00783263|12009530|FG001|Overall Study|Lost to Follow-up|1
7602992|NCT00783263|12009531|FG002|Overall Study|Lost to Follow-up|0
7602993|NCT00783263|12009532|FG003|Overall Study|Lost to Follow-up|0
7602994|NCT00783263|12009529|FG000|Overall Study|Withdrawal by Subject|0
7273480|NCT00432172|11487804|FG003|Overall Study|Disease progression|1
7273481|NCT00432172|11487801|FG000|Overall Study|Withdrawal by Subject|0
7273482|NCT00432172|11487802|FG001|Overall Study|Withdrawal by Subject|1
7273483|NCT00432172|11487803|FG002|Overall Study|Withdrawal by Subject|0
7273484|NCT00432172|11487804|FG003|Overall Study|Withdrawal by Subject|2
7273485|NCT00432172|11487801|FG000|Overall Study|No treatment received|2
7273486|NCT00432172|11487802|FG001|Overall Study|No treatment received|2
7273487|NCT00432172|11487803|FG002|Overall Study|No treatment received|0
7273488|NCT00432172|11487804|FG003|Overall Study|No treatment received|1
7273489|NCT00432237|11487820|FG000|Overall Study|Adverse Event|0
7273490|NCT00432237|11487821|FG001|Overall Study|Adverse Event|0
7273491|NCT00432237|11487822|FG002|Overall Study|Adverse Event|0
7273492|NCT00432237|11487823|FG003|Overall Study|Adverse Event|1
7273493|NCT00432237|11487820|FG000|Overall Study|Lack of Efficacy|0
7273494|NCT00432237|11487821|FG001|Overall Study|Lack of Efficacy|0
7273495|NCT00432237|11487822|FG002|Overall Study|Lack of Efficacy|0
7273496|NCT00432237|11487823|FG003|Overall Study|Lack of Efficacy|1
7273497|NCT00432237|11487820|FG000|Overall Study|Lost to Follow-up|10
7273498|NCT00432237|11487821|FG001|Overall Study|Lost to Follow-up|10
7273499|NCT00432237|11487822|FG002|Overall Study|Lost to Follow-up|18
7273500|NCT00432237|11487823|FG003|Overall Study|Lost to Follow-up|18
7273501|NCT00432237|11487820|FG000|Overall Study|Physician Decision|1
7273502|NCT00432237|11487821|FG001|Overall Study|Physician Decision|3
7273503|NCT00432237|11487822|FG002|Overall Study|Physician Decision|2
7273504|NCT00432237|11487823|FG003|Overall Study|Physician Decision|1
7273505|NCT00432237|11487820|FG000|Overall Study|Pregnancy|0
7273506|NCT00432237|11487821|FG001|Overall Study|Pregnancy|1
7273507|NCT00432237|11487822|FG002|Overall Study|Pregnancy|0
7273508|NCT00432237|11487823|FG003|Overall Study|Pregnancy|0
7273509|NCT00432237|11487820|FG000|Overall Study|Protocol Violation|13
7273510|NCT00432237|11487821|FG001|Overall Study|Protocol Violation|10
7273511|NCT00432237|11487822|FG002|Overall Study|Protocol Violation|11
7273512|NCT00432237|11487823|FG003|Overall Study|Protocol Violation|8
7273513|NCT00432237|11487820|FG000|Overall Study|Withdrawal by Subject|5
7273514|NCT00432237|11487821|FG001|Overall Study|Withdrawal by Subject|6
7273515|NCT00432237|11487822|FG002|Overall Study|Withdrawal by Subject|9
7273516|NCT00432237|11487823|FG003|Overall Study|Withdrawal by Subject|11
7273517|NCT00432237|11487820|FG000|Overall Study|Lack of Qualifying Event|38
7273518|NCT00432237|11487821|FG001|Overall Study|Lack of Qualifying Event|71
7273519|NCT00432237|11487822|FG002|Overall Study|Lack of Qualifying Event|69
7273520|NCT00432237|11487823|FG003|Overall Study|Lack of Qualifying Event|84
7273521|NCT00432276|11487835|FG000|Overall Study|Hyperglycemic Rescue|44
7273522|NCT00432276|11487836|FG001|Overall Study|Hyperglycemic Rescue|87
7273523|NCT00432276|11487835|FG000|Overall Study|Adverse Event|13
7273524|NCT00432276|11487836|FG001|Overall Study|Adverse Event|16
7273525|NCT00432276|11487835|FG000|Overall Study|Protocol Violation|25
7273526|NCT00432276|11487836|FG001|Overall Study|Protocol Violation|20
7273527|NCT00432276|11487835|FG000|Overall Study|Lost to Follow-up|6
7273528|NCT00432276|11487836|FG001|Overall Study|Lost to Follow-up|2
7273529|NCT00432276|11487835|FG000|Overall Study|Withdrawal by Subject|25
7273530|NCT00432276|11487836|FG001|Overall Study|Withdrawal by Subject|20
7273531|NCT00432276|11487835|FG000|Overall Study|Physician Decision|6
7273532|NCT00432276|11487836|FG001|Overall Study|Physician Decision|8
7273533|NCT00432276|11487835|FG000|Overall Study|Other|2
7602995|NCT00783263|12009530|FG001|Overall Study|Withdrawal by Subject|1
7602996|NCT00783263|12009531|FG002|Overall Study|Withdrawal by Subject|1
7602997|NCT00783263|12009532|FG003|Overall Study|Withdrawal by Subject|2
7602998|NCT00782184|12009557|FG000|Overall Study|Adverse Event|1
7602999|NCT00782184|12009558|FG001|Overall Study|Adverse Event|2
7603000|NCT00782184|12009557|FG000|Overall Study|Protocol Violation|0
7273534|NCT00432276|11487836|FG001|Overall Study|Other|3
7273535|NCT00432380|11487854|FG000|Overall Study|Migrated/moved from study area|3
7273536|NCT00432380|11487855|FG001|Overall Study|Migrated/moved from study area|4
7273537|NCT00432380|11487856|FG002|Overall Study|Migrated/moved from study area|1
7273538|NCT00432380|11487854|FG000|Overall Study|Adverse Event|1
7273539|NCT00432380|11487855|FG001|Overall Study|Adverse Event|0
7273540|NCT00432380|11487856|FG002|Overall Study|Adverse Event|0
7273541|NCT00432562|11487876|FG000|Overall Study|Death|3
7273542|NCT00432562|11487877|FG001|Overall Study|Death|0
7273543|NCT00432666|11487894|FG000|Main Period|Adverse Event|1
7273544|NCT00432666|11487895|FG001|Main Period|Adverse Event|1
7273545|NCT00432666|11487894|FG000|Main Period|Consent Withdrawn|1
7273546|NCT00432666|11487895|FG001|Main Period|Consent Withdrawn|0
7273547|NCT00432666|11487894|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
7273548|NCT00432666|11487895|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
7273549|NCT00432666|11487894|FG000|Open-Label Extension Period|Lack of Efficacy|6
7273550|NCT00432666|11487895|FG001|Open-Label Extension Period|Lack of Efficacy|0
7273551|NCT00432666|11487894|FG000|Open-Label Extension Period|Adverse Event|5
7273552|NCT00432666|11487895|FG001|Open-Label Extension Period|Adverse Event|0
7273553|NCT00432666|11487894|FG000|Open-Label Extension Period|Consent withdrawn|10
7273554|NCT00432666|11487895|FG001|Open-Label Extension Period|Consent withdrawn|0
7273555|NCT00432666|11487894|FG000|Open-Label Extension Period|Physician Decision|3
7273556|NCT00432666|11487895|FG001|Open-Label Extension Period|Physician Decision|0
7273557|NCT00432679|11487903|FG000|Overall Study|Adverse Event|2
7273558|NCT00432679|11487904|FG001|Overall Study|Adverse Event|1
7273559|NCT00432679|11487903|FG000|Overall Study|Withdrawal by Subject|3
7273560|NCT00432679|11487904|FG001|Overall Study|Withdrawal by Subject|2
7273561|NCT00432744|11487912|FG000|Months 0-6|Withdrawal by Subject|4
7273562|NCT00432744|11487913|FG001|Months 0-6|Withdrawal by Subject|4
7273563|NCT00432744|11487912|FG000|Months 0-6|Too disabled to score|1
7273564|NCT00432744|11487913|FG001|Months 0-6|Too disabled to score|0
7273565|NCT00432744|11487912|FG000|Months 7 - 12|Withdrawal by Subject|1
7273566|NCT00432744|11487913|FG001|Months 7 - 12|Withdrawal by Subject|0
7273567|NCT00432744|11487912|FG000|Months 7 - 12|Too disabled to score|0
7273568|NCT00432744|11487913|FG001|Months 7 - 12|Too disabled to score|1
7273569|NCT00432809|11487922|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
7273570|NCT00432809|11487923|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
7273571|NCT00432809|11487924|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
7273572|NCT00432809|11487922|FG000|1 Year Follow-up|Withdrawal by Subject|7
7273573|NCT00432809|11487923|FG001|1 Year Follow-up|Withdrawal by Subject|0
7273574|NCT00432809|11487924|FG002|1 Year Follow-up|Withdrawal by Subject|1
7273575|NCT00432835|11487934|FG000|Overall Study|Adverse event: lead dislodgement.|6
7273576|NCT00432835|11487935|FG001|Overall Study|Adverse event: lead dislodgement.|7
7273595|NCT00432991|11487952|FG000|Overall Study|Protocol Violation|7
7273596|NCT00432991|11487953|FG001|Overall Study|Protocol Violation|12
7273597|NCT00433004|11487961|FG000|Overall Study|Lost to Follow-up|5
7603001|NCT00782184|12009558|FG001|Overall Study|Protocol Violation|1
7603002|NCT00782184|12009557|FG000|Overall Study|Withdrawal by Subject|3
7603003|NCT00782184|12009558|FG001|Overall Study|Withdrawal by Subject|2
7603004|NCT00635882|12009571|FG000|Overall Study|Protocol Violation|1
7603005|NCT00635882|12009572|FG001|Overall Study|Protocol Violation|0
7603006|NCT00635882|12009573|FG002|Overall Study|Protocol Violation|0
7603007|NCT00635882|12009574|FG003|Overall Study|Protocol Violation|0
7603008|NCT00635882|12009575|FG004|Overall Study|Protocol Violation|0
7603009|NCT00635882|12009576|FG005|Overall Study|Protocol Violation|0
7273598|NCT00433004|11487962|FG001|Overall Study|Lost to Follow-up|7
7273599|NCT00433017|11487970|FG000|Overall Study|Adverse Event|5
7273600|NCT00433017|11487971|FG001|Overall Study|Adverse Event|3
7273601|NCT00433017|11487970|FG000|Overall Study|Withdrawal by Subject|4
7273602|NCT00433017|11487971|FG001|Overall Study|Withdrawal by Subject|5
7273603|NCT00433017|11487970|FG000|Overall Study|Lost to Follow-up|3
7273604|NCT00433017|11487971|FG001|Overall Study|Lost to Follow-up|4
7273605|NCT00433017|11487970|FG000|Overall Study|Administrative problems|80
7273606|NCT00433017|11487971|FG001|Overall Study|Administrative problems|86
7273607|NCT00433017|11487970|FG000|Overall Study|Protocol Violation|1
7273608|NCT00433017|11487971|FG001|Overall Study|Protocol Violation|0
7273609|NCT00433017|11487970|FG000|Overall Study|Death|2
7273610|NCT00433017|11487971|FG001|Overall Study|Death|2
7273611|NCT00433017|11487970|FG000|Overall Study|Subject no longer requires study drug|1
7273612|NCT00433017|11487971|FG001|Overall Study|Subject no longer requires study drug|1
7273613|NCT00433147|11487981|FG000|Overall Study|Adverse Event|0
7273614|NCT00433147|11487982|FG001|Overall Study|Adverse Event|1
7273615|NCT00433147|11487983|FG002|Overall Study|Adverse Event|0
7603010|NCT00535405|12009604|FG000|Overall Study|Adverse Event|6
7603011|NCT00535405|12009605|FG001|Overall Study|Adverse Event|8
7603012|NCT00535405|12009606|FG002|Overall Study|Adverse Event|3
7603013|NCT00535405|12009607|FG003|Overall Study|Adverse Event|8
7603014|NCT00535405|12009608|FG004|Overall Study|Adverse Event|6
7603015|NCT00535405|12009604|FG000|Overall Study|Lost to Follow-up|1
7603016|NCT00535405|12009605|FG001|Overall Study|Lost to Follow-up|3
7603017|NCT00535405|12009606|FG002|Overall Study|Lost to Follow-up|3
7603018|NCT00535405|12009607|FG003|Overall Study|Lost to Follow-up|2
7603019|NCT00535405|12009608|FG004|Overall Study|Lost to Follow-up|1
7603020|NCT00535405|12009604|FG000|Overall Study|Physician Decision|3
7603021|NCT00535405|12009605|FG001|Overall Study|Physician Decision|2
7603022|NCT00535405|12009606|FG002|Overall Study|Physician Decision|0
7603023|NCT00535405|12009607|FG003|Overall Study|Physician Decision|1
7603024|NCT00535405|12009608|FG004|Overall Study|Physician Decision|1
7603025|NCT00535405|12009604|FG000|Overall Study|Protocol Violation|2
7603026|NCT00535405|12009605|FG001|Overall Study|Protocol Violation|2
7603027|NCT00535405|12009606|FG002|Overall Study|Protocol Violation|2
7603028|NCT00535405|12009607|FG003|Overall Study|Protocol Violation|1
7603029|NCT00535405|12009608|FG004|Overall Study|Protocol Violation|0
7603030|NCT00535405|12009604|FG000|Overall Study|Withdrawal by Subject|5
7603031|NCT00535405|12009605|FG001|Overall Study|Withdrawal by Subject|11
7603032|NCT00535405|12009606|FG002|Overall Study|Withdrawal by Subject|10
7603033|NCT00535405|12009607|FG003|Overall Study|Withdrawal by Subject|10
7603034|NCT00535405|12009608|FG004|Overall Study|Withdrawal by Subject|8
7603035|NCT00496730|12009622|FG000|Overall Study|Lost to Follow-up|4
7603036|NCT00496730|12009623|FG001|Overall Study|Lost to Follow-up|3
7603037|NCT00496730|12009622|FG000|Overall Study|Withdrawal by Subject|2
7603038|NCT00496730|12009623|FG001|Overall Study|Withdrawal by Subject|2
7603039|NCT00462748|12009632|FG000|Overall Study|Adverse Event|7
7603040|NCT00462748|12009633|FG001|Overall Study|Adverse Event|5
7603041|NCT00462748|12009634|FG002|Overall Study|Adverse Event|9
7603042|NCT00462748|12009632|FG000|Overall Study|Protocol Violation|0
7603043|NCT00462748|12009633|FG001|Overall Study|Protocol Violation|2
7603044|NCT00462748|12009634|FG002|Overall Study|Protocol Violation|1
7603045|NCT00462748|12009632|FG000|Overall Study|Withdrew consent|3
7603046|NCT00462748|12009633|FG001|Overall Study|Withdrew consent|3
7603047|NCT00462748|12009634|FG002|Overall Study|Withdrew consent|0
7603048|NCT00462748|12009632|FG000|Overall Study|Lost to Follow-up|1
7603049|NCT00462748|12009633|FG001|Overall Study|Lost to Follow-up|1
7603050|NCT00462748|12009634|FG002|Overall Study|Lost to Follow-up|1
7603051|NCT00462748|12009632|FG000|Overall Study|Discontinued after 41 days Rx|1
7603052|NCT00462748|12009633|FG001|Overall Study|Discontinued after 41 days Rx|0
7603053|NCT00462748|12009634|FG002|Overall Study|Discontinued after 41 days Rx|0
7603054|NCT00418834|12009644|FG000|Overall Study|Adverse Event|16
7603055|NCT00418834|12009645|FG001|Overall Study|Adverse Event|9
7603056|NCT00418834|12009644|FG000|Overall Study|Lost to Follow-up|0
7603057|NCT00418834|12009645|FG001|Overall Study|Lost to Follow-up|1
7603058|NCT00418834|12009644|FG000|Overall Study|Protocol Violation|4
7603059|NCT00418834|12009645|FG001|Overall Study|Protocol Violation|3
7603060|NCT00418834|12009644|FG000|Overall Study|Withdrawal by Subject|3
7603061|NCT00418834|12009645|FG001|Overall Study|Withdrawal by Subject|7
7603062|NCT00409773|12009656|FG000|Overall Study|Adverse Event|3
7603063|NCT00409773|12009657|FG001|Overall Study|Adverse Event|4
7603064|NCT00409773|12009658|FG002|Overall Study|Adverse Event|4
7603065|NCT00409773|12009659|FG003|Overall Study|Adverse Event|2
7603066|NCT00409773|12009660|FG004|Overall Study|Adverse Event|6
7603067|NCT00409773|12009656|FG000|Overall Study|Lost to Follow-up|6
7603068|NCT00409773|12009657|FG001|Overall Study|Lost to Follow-up|1
7603069|NCT00409773|12009658|FG002|Overall Study|Lost to Follow-up|2
7603070|NCT00409773|12009659|FG003|Overall Study|Lost to Follow-up|3
7603071|NCT00409773|12009660|FG004|Overall Study|Lost to Follow-up|1
7603072|NCT00409773|12009656|FG000|Overall Study|Physician Decision|0
7603073|NCT00409773|12009657|FG001|Overall Study|Physician Decision|0
7603074|NCT00409773|12009658|FG002|Overall Study|Physician Decision|0
7603075|NCT00409773|12009659|FG003|Overall Study|Physician Decision|2
7603076|NCT00409773|12009660|FG004|Overall Study|Physician Decision|0
7603077|NCT00409773|12009656|FG000|Overall Study|Protocol Violation|0
7603078|NCT00409773|12009657|FG001|Overall Study|Protocol Violation|2
7603079|NCT00409773|12009658|FG002|Overall Study|Protocol Violation|3
7603080|NCT00409773|12009659|FG003|Overall Study|Protocol Violation|3
7603081|NCT00409773|12009660|FG004|Overall Study|Protocol Violation|1
7603082|NCT00409773|12009656|FG000|Overall Study|Withdrawal by Subject|0
7603083|NCT00409773|12009657|FG001|Overall Study|Withdrawal by Subject|0
7603084|NCT00409773|12009658|FG002|Overall Study|Withdrawal by Subject|0
7603085|NCT00409773|12009659|FG003|Overall Study|Withdrawal by Subject|2
7603086|NCT00409773|12009660|FG004|Overall Study|Withdrawal by Subject|1
7603087|NCT00409773|12009656|FG000|Overall Study|Lack of Eligibility|0
7603088|NCT00409773|12009657|FG001|Overall Study|Lack of Eligibility|0
7603089|NCT00409773|12009658|FG002|Overall Study|Lack of Eligibility|0
7603090|NCT00409773|12009659|FG003|Overall Study|Lack of Eligibility|0
7603091|NCT00409773|12009660|FG004|Overall Study|Lack of Eligibility|1
7603092|NCT00276484|12009674|FG000|Overall Study|Adverse Event|4
7603093|NCT00276484|12009675|FG001|Overall Study|Adverse Event|7
7603094|NCT00276484|12009674|FG000|Overall Study|Lost to Follow-up|1
7603095|NCT00276484|12009675|FG001|Overall Study|Lost to Follow-up|1
7603096|NCT00276484|12009674|FG000|Overall Study|Protocol Violation|0
7603097|NCT00276484|12009675|FG001|Overall Study|Protocol Violation|1
7603098|NCT00276484|12009674|FG000|Overall Study|Withdrawal by Subject|4
7603099|NCT00276484|12009675|FG001|Overall Study|Withdrawal by Subject|3
7603100|NCT00276484|12009674|FG000|Overall Study|Could not take time off work|0
7603101|NCT00276484|12009675|FG001|Overall Study|Could not take time off work|1
7603102|NCT00276458|12009683|FG000|Overall Study|Adverse Event|0
7603103|NCT00276458|12009684|FG001|Overall Study|Adverse Event|2
7603104|NCT00276458|12009683|FG000|Overall Study|Lost to Follow-up|2
7603105|NCT00276458|12009684|FG001|Overall Study|Lost to Follow-up|2
7603106|NCT00276458|12009683|FG000|Overall Study|Protocol Violation|4
7603107|NCT00276458|12009684|FG001|Overall Study|Protocol Violation|3
7603108|NCT00271817|12009693|FG000|Part 1|Adverse Event|68
7603109|NCT00271817|12009694|FG001|Part 1|Adverse Event|25
7603110|NCT00271817|12009695|FG002|Part 1|Adverse Event|156
7603111|NCT00271817|12009693|FG000|Part 1|Lost to Follow-up|6
7603112|NCT00271817|12009694|FG001|Part 1|Lost to Follow-up|8
7603113|NCT00271817|12009695|FG002|Part 1|Lost to Follow-up|24
7273616|NCT00433147|11487984|FG003|Overall Study|Adverse Event|0
7273617|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
7273618|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
7273619|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Death|0
7273620|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Death|0
7273621|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7273622|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
7273623|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
7273624|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
7273625|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
7273626|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
7273627|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
7273628|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
7273629|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
7273630|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
7273631|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7273632|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
7273633|NCT00433160|11487996|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
7273634|NCT00433160|11487997|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
7273635|NCT00433160|11487996|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
7273636|NCT00433160|11487997|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
7273637|NCT00433160|11487996|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
7273638|NCT00433160|11487997|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
7273639|NCT00433160|11487996|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
7603114|NCT00271817|12009693|FG000|Part 1|Protocol Violation|5
7603115|NCT00271817|12009694|FG001|Part 1|Protocol Violation|4
7603116|NCT00271817|12009695|FG002|Part 1|Protocol Violation|7
7603117|NCT00271817|12009693|FG000|Part 1|Patient Moved|3
7603118|NCT00271817|12009694|FG001|Part 1|Patient Moved|1
7603119|NCT00271817|12009695|FG002|Part 1|Patient Moved|5
7603120|NCT00271817|12009693|FG000|Part 1|Withdrawal by Subject|23
7603121|NCT00271817|12009694|FG001|Part 1|Withdrawal by Subject|17
7273640|NCT00433160|11487997|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
7273641|NCT00433160|11487996|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
7273642|NCT00433160|11487997|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
7273643|NCT00433160|11487996|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
7273644|NCT00433160|11487997|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
7273645|NCT00433160|11487996|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
7273646|NCT00433160|11487997|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
7273647|NCT00433160|11487996|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
7273648|NCT00433160|11487997|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
7273649|NCT00433199|11488009|FG000|Double-Blind Period|Adverse Event|0
7273650|NCT00433199|11488010|FG001|Double-Blind Period|Adverse Event|25
7273651|NCT00433199|11488009|FG000|Double-Blind Period|Lack of Efficacy|0
7273652|NCT00433199|11488010|FG001|Double-Blind Period|Lack of Efficacy|2
7273653|NCT00433199|11488009|FG000|Double-Blind Period|Lost to Follow-up|2
7603122|NCT00271817|12009695|FG002|Part 1|Withdrawal by Subject|45
7603123|NCT00271817|12009693|FG000|Part 1|LDL < 50 mg/dL|1
7603124|NCT00271817|12009694|FG001|Part 1|LDL < 50 mg/dL|4
7603125|NCT00271817|12009695|FG002|Part 1|LDL < 50 mg/dL|48
7603126|NCT00271817|12009693|FG000|Part 2|Adverse Event|0
7603127|NCT00271817|12009694|FG001|Part 2|Adverse Event|17
7603128|NCT00271817|12009695|FG002|Part 2|Adverse Event|33
7603129|NCT00271817|12009693|FG000|Part 2|Lack of Efficacy|0
7603130|NCT00271817|12009694|FG001|Part 2|Lack of Efficacy|1
7603131|NCT00271817|12009695|FG002|Part 2|Lack of Efficacy|6
7603132|NCT00271817|12009693|FG000|Part 2|Lost to Follow-up|0
7603133|NCT00271817|12009694|FG001|Part 2|Lost to Follow-up|6
7603134|NCT00271817|12009695|FG002|Part 2|Lost to Follow-up|18
7603135|NCT00271817|12009693|FG000|Part 2|Protocol Violation|0
7603136|NCT00271817|12009694|FG001|Part 2|Protocol Violation|3
7603137|NCT00271817|12009695|FG002|Part 2|Protocol Violation|5
7603138|NCT00271817|12009693|FG000|Part 2|Patient Moved|0
7603139|NCT00271817|12009694|FG001|Part 2|Patient Moved|0
7603140|NCT00271817|12009695|FG002|Part 2|Patient Moved|5
7603141|NCT00271817|12009693|FG000|Part 2|Withdrawal by Subject|0
7603142|NCT00271817|12009694|FG001|Part 2|Withdrawal by Subject|2
7603143|NCT00271817|12009695|FG002|Part 2|Withdrawal by Subject|13
7603144|NCT00271817|12009693|FG000|Part 2|LDL < 50 mg/dL|0
7603145|NCT00271817|12009694|FG001|Part 2|LDL < 50 mg/dL|3
7603146|NCT00271817|12009695|FG002|Part 2|LDL < 50 mg/dL|4
7603147|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Adverse Event|1
7603148|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Adverse Event|6
7603149|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Adverse Event|0
7603150|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Adverse Event|0
7603151|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Adverse Event|0
7603152|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
7603153|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
7603154|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603155|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603156|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
7603157|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
7603158|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
7603159|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603160|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603161|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
7603162|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
7273654|NCT00433199|11488010|FG001|Double-Blind Period|Lost to Follow-up|5
7273655|NCT00433199|11488009|FG000|Double-Blind Period|Withdrawal by Subject|8
7273656|NCT00433199|11488010|FG001|Double-Blind Period|Withdrawal by Subject|19
7273657|NCT00433199|11488009|FG000|Double-Blind Period|Protocol Violation|1
7273658|NCT00433199|11488010|FG001|Double-Blind Period|Protocol Violation|10
7273659|NCT00433199|11488009|FG000|Double-Blind Period|Administrative|1
7273660|NCT00433199|11488010|FG001|Double-Blind Period|Administrative|5
7273661|NCT00433199|11488009|FG000|Open-Label Period|Adverse Event|0
7273662|NCT00433199|11488010|FG001|Open-Label Period|Adverse Event|19
7273663|NCT00433199|11488009|FG000|Open-Label Period|Lack of Efficacy|0
7273664|NCT00433199|11488010|FG001|Open-Label Period|Lack of Efficacy|2
7273665|NCT00433199|11488009|FG000|Open-Label Period|Lost to Follow-up|0
7273666|NCT00433199|11488010|FG001|Open-Label Period|Lost to Follow-up|3
7273667|NCT00433199|11488009|FG000|Open-Label Period|Withdrawal by Subject|0
7273668|NCT00433199|11488010|FG001|Open-Label Period|Withdrawal by Subject|7
7273669|NCT00433199|11488009|FG000|Open-Label Period|Protocol Violation|0
7273670|NCT00433199|11488010|FG001|Open-Label Period|Protocol Violation|2
7273671|NCT00433199|11488009|FG000|Open-Label Period|Administrative|0
7273672|NCT00433199|11488010|FG001|Open-Label Period|Administrative|1
7273673|NCT00433290|11488023|FG000|Overall Study|Adverse Event|24
7273674|NCT00433290|11488024|FG001|Overall Study|Adverse Event|7
7273675|NCT00433290|11488023|FG000|Overall Study|Lack of Efficacy|1
7273676|NCT00433290|11488024|FG001|Overall Study|Lack of Efficacy|5
7273677|NCT00433290|11488023|FG000|Overall Study|Withdrawal by Subject|4
7273678|NCT00433290|11488024|FG001|Overall Study|Withdrawal by Subject|2
7273679|NCT00433290|11488023|FG000|Overall Study|Protocol Violation|3
7273680|NCT00433290|11488024|FG001|Overall Study|Protocol Violation|2
7273681|NCT00433290|11488023|FG000|Overall Study|Physician Decision|2
7603163|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
7603164|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
7603165|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
7603166|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
7603167|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Death|2
7603168|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Death|2
7603169|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Death|0
7603170|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Death|0
7603171|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Death|0
7603172|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Physician Decision|3
7603173|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Physician Decision|4
7603174|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Physician Decision|0
7603175|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Physician Decision|0
7603176|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Physician Decision|0
7603177|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
7603178|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
7603179|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
7603180|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
7603181|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
7603182|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
7603183|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
7603184|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603185|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603186|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
7603187|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
7603188|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7273682|NCT00433290|11488024|FG001|Overall Study|Physician Decision|0
7273683|NCT00433290|11488023|FG000|Overall Study|Entry Criteria Not Met|0
7273684|NCT00433290|11488024|FG001|Overall Study|Entry Criteria Not Met|1
7273685|NCT00433290|11488023|FG000|Overall Study|Lost to Follow-up|1
7273686|NCT00433290|11488024|FG001|Overall Study|Lost to Follow-up|0
7273687|NCT00433329|11488030|FG000|Overall Study|Adverse Event|9
7273688|NCT00433329|11488030|FG000|Overall Study|Death|4
7273689|NCT00433329|11488030|FG000|Overall Study|Withdrew consent|3
7273690|NCT00433329|11488030|FG000|Overall Study|Discontinued sildenafil|2
7273691|NCT00433329|11488030|FG000|Overall Study|Moved out of state|1
7273692|NCT00433329|11488030|FG000|Overall Study|Lost to Follow-up|1
7273693|NCT00433329|11488030|FG000|Overall Study|Physician Decision|1
7273694|NCT00433381|11488036|FG000|Overall Study|Ineligible / no protocol treatment|3
7273695|NCT00433381|11488037|FG001|Overall Study|Ineligible / no protocol treatment|3
7273696|NCT00433446|11488051|FG000|Overall Study|Adverse Event|4
7273697|NCT00433446|11488051|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7273698|NCT00433446|11488051|FG000|Overall Study|Progression|44
7273699|NCT00433446|11488051|FG000|Overall Study|Other - Not Protocol specified|3
7273700|NCT00433446|11488051|FG000|Overall Study|Ineligible|9
7273701|NCT00433537|11488055|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7273702|NCT00433537|11488056|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
7273703|NCT00433537|11488057|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
7273704|NCT00433537|11488055|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7273705|NCT00433537|11488056|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
7273706|NCT00433537|11488057|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
7273707|NCT00433537|11488055|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
7273708|NCT00433537|11488056|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
7273709|NCT00433537|11488057|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
7273710|NCT00433537|11488055|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7273711|NCT00433537|11488056|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
7273712|NCT00433537|11488057|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
7273713|NCT00433537|11488055|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
7273714|NCT00433537|11488056|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7273715|NCT00433537|11488057|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
7273716|NCT00433537|11488055|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
7273717|NCT00433537|11488056|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7273718|NCT00433537|11488057|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
7273719|NCT00433537|11488055|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
7273720|NCT00433537|11488056|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7273721|NCT00433537|11488057|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
7273722|NCT00433537|11488055|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
7273723|NCT00433537|11488056|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7603189|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603190|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603191|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
7603192|NCT03420781|12009727|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
7603193|NCT03420781|12009728|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
7603194|NCT03420781|12009729|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
7603195|NCT03420781|12009730|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
7603196|NCT03420781|12009731|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
7603197|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7603198|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7603199|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7603200|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
7603201|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
7273724|NCT00433537|11488057|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
7273725|NCT00433537|11488055|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
7273726|NCT00433537|11488056|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
7273727|NCT00433537|11488057|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
7273728|NCT00433654|11488079|FG000|Overall Study|Death|4
7273729|NCT00433654|11488080|FG001|Overall Study|Death|0
7273730|NCT00433654|11488079|FG000|Overall Study|Missed visit|6
7273731|NCT00433654|11488080|FG001|Overall Study|Missed visit|3
7273732|NCT00433654|11488079|FG000|Overall Study|Subject not yet due for visit|4
7273733|NCT00433654|11488080|FG001|Overall Study|Subject not yet due for visit|0
7273734|NCT00433654|11488079|FG000|Overall Study|Withdrawal by Subject|1
7273735|NCT00433654|11488080|FG001|Overall Study|Withdrawal by Subject|2
7273736|NCT00433771|11488097|FG000|Overall Study|screen fail|14
7273737|NCT00433771|11488097|FG000|Overall Study|Treated and later found to be ineligible|2
7273738|NCT00433771|11488097|FG000|Overall Study|Death|2
7273739|NCT00433771|11488097|FG000|Overall Study|Failure to deploy stent|1
7273740|NCT00433836|11488103|FG000|Overall Study|Adverse Event|7
7273741|NCT00433836|11488104|FG001|Overall Study|Adverse Event|0
7273742|NCT00433836|11488103|FG000|Overall Study|Lost to Follow-up|3
7273743|NCT00433836|11488104|FG001|Overall Study|Lost to Follow-up|0
7273744|NCT00433836|11488103|FG000|Overall Study|Withdrawal by Subject|2
7273745|NCT00433836|11488104|FG001|Overall Study|Withdrawal by Subject|1
7273746|NCT00433836|11488103|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7273747|NCT00433836|11488104|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7273748|NCT00433836|11488103|FG000|Overall Study|Protocol Violation|0
7273749|NCT00433836|11488104|FG001|Overall Study|Protocol Violation|2
7273750|NCT00433836|11488103|FG000|Overall Study|Condition no longer requires study drug|0
7273751|NCT00433836|11488104|FG001|Overall Study|Condition no longer requires study drug|1
7273752|NCT00433836|11488103|FG000|Overall Study|Abnormal laboratory values|0
7273753|NCT00433836|11488104|FG001|Overall Study|Abnormal laboratory values|1
7273754|NCT00433914|11488112|FG000|Overall Study|Withdrawal by Subject|0
7273755|NCT00433914|11488113|FG001|Overall Study|Withdrawal by Subject|2
7273756|NCT00433914|11488112|FG000|Overall Study|Lost to Follow-up|0
7273757|NCT00433914|11488113|FG001|Overall Study|Lost to Follow-up|1
7273758|NCT00433966|11488121|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
7273759|NCT00433966|11488122|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
7273760|NCT00433966|11488123|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7273761|NCT00433966|11488124|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
7273762|NCT00433966|11488121|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
7273763|NCT00433966|11488122|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
7273764|NCT00433966|11488123|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7273765|NCT00433966|11488124|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
7273766|NCT00433966|11488121|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
7273767|NCT00433966|11488122|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
7603202|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603203|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603204|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603205|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
7603206|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
7603207|NCT03420781|12009727|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
7603208|NCT03420781|12009728|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
7603209|NCT03420781|12009729|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
7603210|NCT03420781|12009730|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
7603211|NCT03420781|12009731|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
7603212|NCT03316586|12009747|FG000|Overall Study|Adverse Event|2
7603213|NCT03316586|12009747|FG000|Overall Study|Physician Decision|3
7603214|NCT03316586|12009747|FG000|Overall Study|Lack of Efficacy|10
7603215|NCT03316586|12009747|FG000|Overall Study|still on treatment|1
7603216|NCT03316586|12009747|FG000|Overall Study|Patient needed radiation therapy|1
7603217|NCT03316586|12009747|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
7273768|NCT00433966|11488123|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7273769|NCT00433966|11488124|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
7273770|NCT00433966|11488121|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
7273771|NCT00433966|11488122|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
7273772|NCT00433966|11488123|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
7273773|NCT00433966|11488124|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
7273774|NCT00433966|11488121|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
7273775|NCT00433966|11488122|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
7273776|NCT00433966|11488123|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
7273777|NCT00433966|11488124|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
7273778|NCT00434057|11488157|FG000|Overall Study|Withdrawal by Subject|1
7273779|NCT00434109|11488161|FG000|Overall Study|Physician Decision|9
7273780|NCT00434109|11488161|FG000|Overall Study|Adverse Event|5
7273781|NCT00434109|11488161|FG000|Overall Study|Protocol Violation|1
7273782|NCT00434109|11488161|FG000|Overall Study|had embolism, did not receive sunitinib|3
7273783|NCT00434122|11488167|FG000|Overall Study|Non-compliance with protocol|0
7273784|NCT00434122|11488168|FG001|Overall Study|Non-compliance with protocol|1
7273785|NCT00434122|11488167|FG000|Overall Study|loss of subject contact|1
7273786|NCT00434122|11488168|FG001|Overall Study|loss of subject contact|1
7273787|NCT00434122|11488167|FG000|Overall Study|Personal reasons|1
7273788|NCT00434122|11488168|FG001|Overall Study|Personal reasons|1
7273789|NCT00434122|11488167|FG000|Overall Study|Large follicle size|2
7273790|NCT00434122|11488168|FG001|Overall Study|Large follicle size|2
7273791|NCT00434122|11488167|FG000|Overall Study|Low follicular response.|1
7273792|NCT00434122|11488168|FG001|Overall Study|Low follicular response.|2
7273793|NCT00434122|11488167|FG000|Overall Study|Travelling of subject.|1
7273794|NCT00434122|11488168|FG001|Overall Study|Travelling of subject.|0
7273795|NCT00434148|11488178|FG000|Overall Study|Adverse Event|18
7273796|NCT00434148|11488179|FG001|Overall Study|Adverse Event|18
7273797|NCT00434148|11488178|FG000|Overall Study|Lack of Efficacy|25
7273798|NCT00434148|11488179|FG001|Overall Study|Lack of Efficacy|28
7273799|NCT00434148|11488178|FG000|Overall Study|Withdrawal by Subject|15
7273800|NCT00434148|11488179|FG001|Overall Study|Withdrawal by Subject|15
7273801|NCT00434148|11488178|FG000|Overall Study|Protocol Violation|4
7273802|NCT00434148|11488179|FG001|Overall Study|Protocol Violation|0
7273803|NCT00434148|11488178|FG000|Overall Study|Administrative problems|6
7273804|NCT00434148|11488179|FG001|Overall Study|Administrative problems|10
7273805|NCT00434148|11488178|FG000|Overall Study|Lost to Follow-up|0
7603218|NCT03269695|12009766|FG000|Overall Study|Adverse Event|2
7603219|NCT03269695|12009767|FG001|Overall Study|Adverse Event|1
7603220|NCT03269695|12009766|FG000|Overall Study|Lack of Efficacy|0
7603221|NCT03269695|12009767|FG001|Overall Study|Lack of Efficacy|1
7603222|NCT03269695|12009766|FG000|Overall Study|Withdrawal by Subject|0
7603223|NCT03269695|12009767|FG001|Overall Study|Withdrawal by Subject|1
7603224|NCT03268811|12009776|FG000|Overall Study|Adverse Event|0
7603225|NCT03268811|12009777|FG001|Overall Study|Adverse Event|1
7603226|NCT03227757|12009784|FG000|Overall Study|Death|7
7603227|NCT03227757|12009784|FG000|Overall Study|Withdrawal|5
7603228|NCT03227757|12009784|FG000|Overall Study|Missed visits|4
7603229|NCT03142334|12009794|FG000|Overall Study|Death|18
7603230|NCT03142334|12009795|FG001|Overall Study|Death|33
7603231|NCT03142334|12009794|FG000|Overall Study|Withdrawal by Subject|15
7603232|NCT03142334|12009795|FG001|Overall Study|Withdrawal by Subject|11
7603233|NCT03142334|12009794|FG000|Overall Study|Ongoing on trial follow up|463
7603234|NCT03142334|12009795|FG001|Overall Study|Ongoing on trial follow up|454
7603235|NCT02857426|12009875|FG000|Overall Study|Disease progression|34
7603236|NCT02857426|12009876|FG001|Overall Study|Disease progression|13
7603237|NCT02857426|12009875|FG000|Overall Study|Study drug toxicity|4
7603238|NCT02857426|12009876|FG001|Overall Study|Study drug toxicity|1
7603239|NCT02857426|12009875|FG000|Overall Study|Death|1
7603240|NCT02857426|12009876|FG001|Overall Study|Death|0
7603241|NCT02857426|12009875|FG000|Overall Study|Adverse event unrelated to study drug|6
7603242|NCT02857426|12009876|FG001|Overall Study|Adverse event unrelated to study drug|2
7603243|NCT02857426|12009875|FG000|Overall Study|Participant withdrew consent|1
7603244|NCT02857426|12009876|FG001|Overall Study|Participant withdrew consent|1
7603245|NCT02857426|12009875|FG000|Overall Study|Maximum clinical benefit|1
7603246|NCT02857426|12009876|FG001|Overall Study|Maximum clinical benefit|0
7603247|NCT02857426|12009875|FG000|Overall Study|Completed treatment|0
7603248|NCT02857426|12009876|FG001|Overall Study|Completed treatment|2
7603249|NCT02855125|12009884|FG000|Overall Study|Withdrawal by Subject|2
7603250|NCT02855125|12009885|FG001|Overall Study|Withdrawal by Subject|2
7603251|NCT02855125|12009884|FG000|Overall Study|Clinical Disease Progression|5
7603252|NCT02855125|12009885|FG001|Overall Study|Clinical Disease Progression|4
7603253|NCT02855125|12009884|FG000|Overall Study|Radiologic Disease Progression|36
7603254|NCT02855125|12009885|FG001|Overall Study|Radiologic Disease Progression|39
7603255|NCT02855125|12009884|FG000|Overall Study|Adverse Event|11
7603256|NCT02855125|12009885|FG001|Overall Study|Adverse Event|7
7603257|NCT02855125|12009884|FG000|Overall Study|Physician Decision|1
7603258|NCT02855125|12009885|FG001|Overall Study|Physician Decision|0
7603259|NCT02855125|12009884|FG000|Overall Study|On Treatment|9
7603260|NCT02855125|12009885|FG001|Overall Study|On Treatment|11
7603261|NCT02855125|12009884|FG000|Overall Study|Randomized but not treated|0
7603262|NCT02855125|12009885|FG001|Overall Study|Randomized but not treated|1
7603265|NCT02527798|12009931|FG000|Overall Study|Physician Decision|1
7603266|NCT02527798|12009932|FG001|Overall Study|Physician Decision|0
7603267|NCT02527798|12009933|FG002|Overall Study|Physician Decision|1
7603268|NCT02527798|12009934|FG003|Overall Study|Physician Decision|1
7603269|NCT02527798|12009935|FG004|Overall Study|Physician Decision|0
7603270|NCT02527798|12009936|FG005|Overall Study|Physician Decision|0
7603271|NCT02527798|12009931|FG000|Overall Study|Death|0
7603272|NCT02527798|12009932|FG001|Overall Study|Death|0
7603273|NCT02527798|12009933|FG002|Overall Study|Death|1
7603274|NCT02527798|12009934|FG003|Overall Study|Death|0
7603275|NCT02527798|12009935|FG004|Overall Study|Death|0
7603276|NCT02527798|12009936|FG005|Overall Study|Death|0
7603277|NCT02527798|12009931|FG000|Overall Study|Withdrawal by Subject|0
7603278|NCT02527798|12009932|FG001|Overall Study|Withdrawal by Subject|1
7603279|NCT02527798|12009933|FG002|Overall Study|Withdrawal by Subject|2
7603280|NCT02527798|12009934|FG003|Overall Study|Withdrawal by Subject|0
7603281|NCT02527798|12009935|FG004|Overall Study|Withdrawal by Subject|0
7603282|NCT02527798|12009936|FG005|Overall Study|Withdrawal by Subject|0
7603283|NCT02527798|12009931|FG000|Overall Study|Reason undisclosed|1
7603284|NCT02527798|12009932|FG001|Overall Study|Reason undisclosed|0
7603285|NCT02527798|12009933|FG002|Overall Study|Reason undisclosed|1
7603286|NCT02527798|12009934|FG003|Overall Study|Reason undisclosed|0
7603287|NCT02527798|12009935|FG004|Overall Study|Reason undisclosed|0
7603288|NCT02527798|12009936|FG005|Overall Study|Reason undisclosed|0
7603289|NCT02527798|12009931|FG000|Overall Study|Did not receive intervention|1
7603290|NCT02527798|12009932|FG001|Overall Study|Did not receive intervention|1
7603291|NCT02527798|12009933|FG002|Overall Study|Did not receive intervention|0
7603292|NCT02527798|12009934|FG003|Overall Study|Did not receive intervention|0
7603293|NCT02527798|12009935|FG004|Overall Study|Did not receive intervention|0
7603294|NCT02527798|12009936|FG005|Overall Study|Did not receive intervention|0
7603295|NCT02279745|12009987|FG000|Overall Study|Adverse Event|7
7603296|NCT02279745|12009987|FG000|Overall Study|Death|6
7603297|NCT02279745|12009987|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
7603298|NCT02279745|12009987|FG000|Overall Study|Withdrawal by Subject|2
7603299|NCT02279745|12009987|FG000|Overall Study|Pregnancy|1
7603300|NCT02279745|12009987|FG000|Overall Study|Study Non-compliance|1
7603301|NCT02279745|12009987|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
7603302|NCT02030938|12010010|FG000|Overall Study|Lost to Follow-up|4
7603303|NCT02030938|12010010|FG000|Overall Study|Withdrawal by Subject|1
7603304|NCT02006147|12010022|FG000|Overall Study|Protocol Violation|1
7603305|NCT02006147|12010023|FG001|Overall Study|Protocol Violation|1
7603306|NCT02006147|12010024|FG002|Overall Study|Protocol Violation|0
7603307|NCT02006147|12010025|FG003|Overall Study|Protocol Violation|0
7603308|NCT02006147|12010022|FG000|Overall Study|Withdrawal by Subject|0
7603309|NCT02006147|12010023|FG001|Overall Study|Withdrawal by Subject|1
7603310|NCT02006147|12010024|FG002|Overall Study|Withdrawal by Subject|0
7603311|NCT02006147|12010025|FG003|Overall Study|Withdrawal by Subject|0
7603312|NCT02006147|12010022|FG000|Overall Study|Withdrawal by Sponsor|1
7603313|NCT02006147|12010023|FG001|Overall Study|Withdrawal by Sponsor|0
7603314|NCT02006147|12010024|FG002|Overall Study|Withdrawal by Sponsor|0
7603315|NCT02006147|12010025|FG003|Overall Study|Withdrawal by Sponsor|0
7603316|NCT01925794|12010031|FG000|180 Days|Death|2
7603317|NCT01925794|12010031|FG000|180 Days|Withdrawal by Subject|2
7603318|NCT01925794|12010031|FG000|270 Days|Death|2
7603319|NCT01925794|12010031|FG000|270 Days|Protocol Violation|3
7603320|NCT01849250|12010054|FG000|Overall Study|Withdrawal by Subject|1
7603321|NCT01849250|12010055|FG001|Overall Study|Withdrawal by Subject|0
7603322|NCT01849250|12010054|FG000|Overall Study|Not Evaluable|5
7603323|NCT01849250|12010055|FG001|Overall Study|Not Evaluable|3
7603324|NCT01849250|12010054|FG000|Overall Study|Screen Failure|1
7603325|NCT01849250|12010055|FG001|Overall Study|Screen Failure|0
7603326|NCT01441115|12010066|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
7603327|NCT01199302|12010077|FG000|Overall Study|Adverse Event|1
7603328|NCT01199302|12010078|FG001|Overall Study|Adverse Event|1
7603329|NCT01199302|12010079|FG002|Overall Study|Adverse Event|2
7603330|NCT01199302|12010080|FG003|Overall Study|Adverse Event|0
7603331|NCT01199302|12010077|FG000|Overall Study|Withdrawal by Subject|2
7603332|NCT01199302|12010078|FG001|Overall Study|Withdrawal by Subject|2
7603333|NCT01199302|12010079|FG002|Overall Study|Withdrawal by Subject|3
7603334|NCT01199302|12010080|FG003|Overall Study|Withdrawal by Subject|0
7603335|NCT01199302|12010077|FG000|Overall Study|Disease Progression|3
7603336|NCT01199302|12010078|FG001|Overall Study|Disease Progression|4
7603337|NCT01199302|12010079|FG002|Overall Study|Disease Progression|4
7603338|NCT01199302|12010080|FG003|Overall Study|Disease Progression|2
7603339|NCT01199302|12010077|FG000|Overall Study|Study Termination|13
7603340|NCT01199302|12010078|FG001|Overall Study|Study Termination|8
7603341|NCT01199302|12010079|FG002|Overall Study|Study Termination|11
7603342|NCT01199302|12010080|FG003|Overall Study|Study Termination|9
7603343|NCT01199302|12010077|FG000|Overall Study|Lost to Follow-up|0
7603344|NCT01199302|12010078|FG001|Overall Study|Lost to Follow-up|1
7603345|NCT01199302|12010079|FG002|Overall Study|Lost to Follow-up|0
7603346|NCT01199302|12010080|FG003|Overall Study|Lost to Follow-up|0
7603347|NCT01199302|12010077|FG000|Overall Study|Other|1
7603348|NCT01199302|12010078|FG001|Overall Study|Other|0
7603349|NCT01199302|12010079|FG002|Overall Study|Other|0
7603350|NCT01199302|12010080|FG003|Overall Study|Other|0
7603351|NCT01123707|12010091|FG000|Overall Study|Lost to Follow-up|3
7273806|NCT00434148|11488179|FG001|Overall Study|Lost to Follow-up|1
7273807|NCT00434148|11488178|FG000|Overall Study|Condition no longer requires study drug|1
7273808|NCT00434148|11488179|FG001|Overall Study|Condition no longer requires study drug|0
7273809|NCT00434148|11488178|FG000|Overall Study|Abnormal test procedure result|0
7273810|NCT00434148|11488179|FG001|Overall Study|Abnormal test procedure result|1
7273811|NCT00434161|11488188|FG000|Overall Study|Adverse Event|5
7273812|NCT00434161|11488189|FG001|Overall Study|Adverse Event|1
7273813|NCT00434161|11488190|FG002|Overall Study|Adverse Event|4
7273814|NCT00434161|11488188|FG000|Overall Study|Lost to Follow-up|0
7273815|NCT00434161|11488189|FG001|Overall Study|Lost to Follow-up|1
7273816|NCT00434161|11488190|FG002|Overall Study|Lost to Follow-up|0
7273817|NCT00434161|11488188|FG000|Overall Study|Death|1
7273818|NCT00434161|11488189|FG001|Overall Study|Death|0
7273819|NCT00434161|11488190|FG002|Overall Study|Death|1
7273820|NCT00434161|11488188|FG000|Overall Study|Non-Compliance|1
7273821|NCT00434161|11488189|FG001|Overall Study|Non-Compliance|1
7273822|NCT00434161|11488190|FG002|Overall Study|Non-Compliance|0
7273823|NCT00434161|11488188|FG000|Overall Study|Withdrawal by Subject|2
7273824|NCT00434161|11488189|FG001|Overall Study|Withdrawal by Subject|0
7273825|NCT00434161|11488190|FG002|Overall Study|Withdrawal by Subject|3
7273826|NCT00434161|11488188|FG000|Overall Study|Logistical error study assessments|1
7273827|NCT00434161|11488189|FG001|Overall Study|Logistical error study assessments|0
7273828|NCT00434161|11488190|FG002|Overall Study|Logistical error study assessments|3
7273829|NCT00434213|11488205|FG000|Overall Study|Adverse Event|12
7273830|NCT00434213|11488205|FG000|Overall Study|Lack of Efficacy|9
7273831|NCT00434213|11488205|FG000|Overall Study|Lost to Follow-up|14
7273832|NCT00434213|11488205|FG000|Overall Study|Withdrawal by Subject|7
7273833|NCT00434213|11488205|FG000|Overall Study|Protocol Violation|3
7273834|NCT00434213|11488205|FG000|Overall Study|Unable to comply with study visit window|2
7273835|NCT00434213|11488205|FG000|Overall Study|Application site reaction|1
7273836|NCT00434213|11488205|FG000|Overall Study|Non-compliant to study schedule|1
7273837|NCT00434252|11488211|FG000|Overall Study|Lack of Efficacy|50
7273838|NCT00434252|11488212|FG001|Overall Study|Lack of Efficacy|100
7273839|NCT00434252|11488211|FG000|Overall Study|Adverse Event|6
7273840|NCT00434252|11488212|FG001|Overall Study|Adverse Event|13
7273841|NCT00434252|11488211|FG000|Overall Study|Death|1
7273842|NCT00434252|11488212|FG001|Overall Study|Death|2
7273843|NCT00434252|11488211|FG000|Overall Study|Lost to Follow-up|0
7273844|NCT00434252|11488212|FG001|Overall Study|Lost to Follow-up|1
7273845|NCT00434252|11488211|FG000|Overall Study|Physician Decision|4
7273846|NCT00434252|11488212|FG001|Overall Study|Physician Decision|8
7273847|NCT00434252|11488211|FG000|Overall Study|Withdrawal by Subject|3
7273848|NCT00434252|11488212|FG001|Overall Study|Withdrawal by Subject|7
7273849|NCT00434304|11488227|FG000|Overall Study|Adverse Event|14
7273850|NCT00434304|11488227|FG000|Overall Study|Lack of Efficacy|2
7273851|NCT00434304|11488227|FG000|Overall Study|Withdrawal by Subject|4
7273852|NCT00434330|11488238|FG000|Overall Study|Adverse Event|0
7273853|NCT00434330|11488239|FG001|Overall Study|Adverse Event|0
7273854|NCT00434330|11488240|FG002|Overall Study|Adverse Event|1
7273855|NCT00434330|11488241|FG003|Overall Study|Adverse Event|0
7273856|NCT00434330|11488242|FG004|Overall Study|Adverse Event|0
7273857|NCT00434330|11488243|FG005|Overall Study|Adverse Event|0
7273858|NCT00434330|11488238|FG000|Overall Study|Death|1
7273859|NCT00434330|11488239|FG001|Overall Study|Death|0
7273860|NCT00434330|11488240|FG002|Overall Study|Death|0
7273861|NCT00434330|11488241|FG003|Overall Study|Death|0
7273862|NCT00434330|11488242|FG004|Overall Study|Death|1
7273863|NCT00434330|11488243|FG005|Overall Study|Death|1
7273864|NCT00434330|11488238|FG000|Overall Study|Withdrawal by Subject|0
7603352|NCT01123707|12010092|FG001|Overall Study|Lost to Follow-up|1
7603353|NCT01123707|12010093|FG002|Overall Study|Lost to Follow-up|3
7603354|NCT01123707|12010094|FG003|Overall Study|Lost to Follow-up|2
7603355|NCT01123707|12010091|FG000|Overall Study|Adverse Event|5
7603356|NCT01123707|12010092|FG001|Overall Study|Adverse Event|7
7603357|NCT01123707|12010093|FG002|Overall Study|Adverse Event|5
7603358|NCT01123707|12010094|FG003|Overall Study|Adverse Event|3
7603359|NCT01123707|12010091|FG000|Overall Study|Sponsor Discontinued Study|30
7603360|NCT01123707|12010092|FG001|Overall Study|Sponsor Discontinued Study|24
7603361|NCT01123707|12010093|FG002|Overall Study|Sponsor Discontinued Study|25
7603362|NCT01123707|12010094|FG003|Overall Study|Sponsor Discontinued Study|40
7603363|NCT01123707|12010091|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7603364|NCT01123707|12010092|FG001|Overall Study|Participant Met Withdrawal Criteria|1
7603365|NCT01123707|12010093|FG002|Overall Study|Participant Met Withdrawal Criteria|0
7603366|NCT01123707|12010094|FG003|Overall Study|Participant Met Withdrawal Criteria|1
7603367|NCT01123707|12010091|FG000|Overall Study|Investigator Withdrew Participant|0
7603368|NCT01123707|12010092|FG001|Overall Study|Investigator Withdrew Participant|1
7603369|NCT01123707|12010093|FG002|Overall Study|Investigator Withdrew Participant|1
7603370|NCT01123707|12010094|FG003|Overall Study|Investigator Withdrew Participant|1
7603371|NCT01123707|12010091|FG000|Overall Study|Subject Withdrew Consent|4
7603372|NCT01123707|12010092|FG001|Overall Study|Subject Withdrew Consent|5
7603373|NCT01123707|12010093|FG002|Overall Study|Subject Withdrew Consent|1
7603374|NCT01123707|12010094|FG003|Overall Study|Subject Withdrew Consent|2
7603375|NCT01123707|12010091|FG000|Overall Study|Lack of Efficacy|1
7603376|NCT01123707|12010092|FG001|Overall Study|Lack of Efficacy|2
7603377|NCT01123707|12010093|FG002|Overall Study|Lack of Efficacy|1
7603378|NCT01123707|12010094|FG003|Overall Study|Lack of Efficacy|0
7603379|NCT01123707|12010091|FG000|Overall Study|Subject Met Exclusion Criteria|0
7603380|NCT01123707|12010092|FG001|Overall Study|Subject Met Exclusion Criteria|0
7603381|NCT01123707|12010093|FG002|Overall Study|Subject Met Exclusion Criteria|2
7603382|NCT01123707|12010094|FG003|Overall Study|Subject Met Exclusion Criteria|1
7603383|NCT00462943|12010111|FG000|Overall Study|Failure to achieve a response|5
7603384|NCT00462943|12010112|FG001|Overall Study|Failure to achieve a response|5
7603385|NCT00462943|12010113|FG002|Overall Study|Failure to achieve a response|1
7603386|NCT00462943|12010111|FG000|Overall Study|Adverse Event|6
7603387|NCT00462943|12010112|FG001|Overall Study|Adverse Event|4
7603388|NCT00462943|12010113|FG002|Overall Study|Adverse Event|1
7603389|NCT00462943|12010111|FG000|Overall Study|Protocol Violation|1
7603390|NCT00462943|12010112|FG001|Overall Study|Protocol Violation|0
7603391|NCT00462943|12010113|FG002|Overall Study|Protocol Violation|0
7603392|NCT00462943|12010111|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
7603393|NCT00462943|12010112|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
7603394|NCT00462943|12010113|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
7603395|NCT00462943|12010111|FG000|Overall Study|Disease Progression|15
7603396|NCT00462943|12010112|FG001|Overall Study|Disease Progression|15
7603397|NCT00462943|12010113|FG002|Overall Study|Disease Progression|9
7603398|NCT00462943|12010111|FG000|Overall Study|Death|5
7603399|NCT00462943|12010112|FG001|Overall Study|Death|2
7603400|NCT00462943|12010113|FG002|Overall Study|Death|7
7603401|NCT00462943|12010111|FG000|Overall Study|Stem Cell Transplant|1
7603402|NCT00462943|12010112|FG001|Overall Study|Stem Cell Transplant|1
7603403|NCT00462943|12010113|FG002|Overall Study|Stem Cell Transplant|0
7603404|NCT00462943|12010111|FG000|Overall Study|Bone Marrow Transplant|1
7603405|NCT00462943|12010112|FG001|Overall Study|Bone Marrow Transplant|0
7603406|NCT00462943|12010113|FG002|Overall Study|Bone Marrow Transplant|0
7603407|NCT00462943|12010111|FG000|Overall Study|Required Lymphocyte Infusion|1
7603408|NCT00462943|12010112|FG001|Overall Study|Required Lymphocyte Infusion|0
7603409|NCT00462943|12010113|FG002|Overall Study|Required Lymphocyte Infusion|0
7603410|NCT00462943|12010111|FG000|Overall Study|Transplant - not specified|1
7603411|NCT00462943|12010112|FG001|Overall Study|Transplant - not specified|0
7603412|NCT00462943|12010113|FG002|Overall Study|Transplant - not specified|1
7603413|NCT00462943|12010111|FG000|Overall Study|Physician Decision|1
7603414|NCT00462943|12010112|FG001|Overall Study|Physician Decision|0
7603415|NCT00462943|12010113|FG002|Overall Study|Physician Decision|0
7603416|NCT00462943|12010111|FG000|Overall Study|Withdrawal by Subject|0
7603417|NCT00462943|12010112|FG001|Overall Study|Withdrawal by Subject|1
7603418|NCT00462943|12010113|FG002|Overall Study|Withdrawal by Subject|0
7603419|NCT00248287|12010123|FG000|Overall Study|Adverse Event|11
7273865|NCT00434330|11488239|FG001|Overall Study|Withdrawal by Subject|0
7603420|NCT00248287|12010124|FG001|Overall Study|Adverse Event|10
7603421|NCT00248287|12010123|FG000|Overall Study|Death|1
7603422|NCT00248287|12010124|FG001|Overall Study|Death|0
7603423|NCT00248287|12010123|FG000|Overall Study|Lost to Follow-up|0
7603424|NCT00248287|12010124|FG001|Overall Study|Lost to Follow-up|1
7603425|NCT00248287|12010123|FG000|Overall Study|Investigator Request|4
7603426|NCT00248287|12010124|FG001|Overall Study|Investigator Request|3
7603427|NCT00248287|12010123|FG000|Overall Study|Patient Request|5
7603428|NCT00248287|12010124|FG001|Overall Study|Patient Request|3
7603429|NCT00248287|12010123|FG000|Overall Study|Other|3
7603430|NCT00248287|12010124|FG001|Overall Study|Other|2
7603431|NCT00105560|12010134|FG000|Overall Study|Lost to Follow-up|1
7603432|NCT04569786|12010168|FG000|Overall Study|Lost to Follow-up|1
7603433|NCT04569786|12010169|FG001|Overall Study|Lost to Follow-up|0
7603434|NCT04569786|12010170|FG002|Overall Study|Lost to Follow-up|4
7603435|NCT04569786|12010171|FG003|Overall Study|Lost to Follow-up|1
7603436|NCT04569786|12010172|FG004|Overall Study|Lost to Follow-up|0
7603437|NCT04569786|12010168|FG000|Overall Study|Withdrawal by Subject|0
7603438|NCT04569786|12010169|FG001|Overall Study|Withdrawal by Subject|0
7603439|NCT04569786|12010170|FG002|Overall Study|Withdrawal by Subject|0
7603440|NCT04569786|12010171|FG003|Overall Study|Withdrawal by Subject|5
7603441|NCT04569786|12010172|FG004|Overall Study|Withdrawal by Subject|1
7603442|NCT04569786|12010168|FG000|Overall Study|Physician Decision|0
7603443|NCT04569786|12010169|FG001|Overall Study|Physician Decision|0
7603444|NCT04569786|12010170|FG002|Overall Study|Physician Decision|0
7603445|NCT04569786|12010171|FG003|Overall Study|Physician Decision|1
7603446|NCT04569786|12010172|FG004|Overall Study|Physician Decision|0
7603447|NCT04129944|12010193|FG000|Overall Study|Death|0
7603448|NCT04129944|12010194|FG001|Overall Study|Death|0
7603449|NCT04129944|12010195|FG002|Overall Study|Death|0
7603450|NCT04129944|12010196|FG003|Overall Study|Death|1
7603451|NCT04129944|12010193|FG000|Overall Study|Lost to Follow-up|1
7603452|NCT04129944|12010194|FG001|Overall Study|Lost to Follow-up|0
7603453|NCT04129944|12010195|FG002|Overall Study|Lost to Follow-up|0
7603454|NCT04129944|12010196|FG003|Overall Study|Lost to Follow-up|0
7603455|NCT04129944|12010193|FG000|Overall Study|Withdrawal by Subject|1
7603456|NCT04129944|12010194|FG001|Overall Study|Withdrawal by Subject|0
7603457|NCT04129944|12010195|FG002|Overall Study|Withdrawal by Subject|1
7603458|NCT04129944|12010196|FG003|Overall Study|Withdrawal by Subject|2
7603459|NCT03857542|12010217|FG000|Overall Study|Adverse Event|1
7603460|NCT03857542|12010218|FG001|Overall Study|Adverse Event|3
7603461|NCT03857542|12010217|FG000|Overall Study|Withdrawal by Subject|2
7603462|NCT03857542|12010218|FG001|Overall Study|Withdrawal by Subject|1
7603463|NCT03857542|12010217|FG000|Overall Study|Lost to Follow-up|2
7603464|NCT03857542|12010218|FG001|Overall Study|Lost to Follow-up|1
7603465|NCT03857542|12010217|FG000|Overall Study|Reason not Specified|1
7603466|NCT03857542|12010218|FG001|Overall Study|Reason not Specified|0
7603485|NCT03656744|12010252|FG000|Overall Study|Adverse Event|1
7603486|NCT03656744|12010253|FG001|Overall Study|Adverse Event|4
7603487|NCT03656744|12010254|FG002|Overall Study|Adverse Event|1
7603488|NCT03656744|12010252|FG000|Overall Study|Protocol Violation|1
7603489|NCT03656744|12010253|FG001|Overall Study|Protocol Violation|0
7603490|NCT03656744|12010254|FG002|Overall Study|Protocol Violation|0
7603491|NCT03656744|12010252|FG000|Overall Study|Lost to Follow-up|2
7603492|NCT03656744|12010253|FG001|Overall Study|Lost to Follow-up|2
7603493|NCT03656744|12010254|FG002|Overall Study|Lost to Follow-up|0
7603494|NCT03656744|12010252|FG000|Overall Study|Withdrawal by Subject|0
7603495|NCT03656744|12010253|FG001|Overall Study|Withdrawal by Subject|1
7603496|NCT03656744|12010254|FG002|Overall Study|Withdrawal by Subject|0
7603497|NCT03656744|12010252|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
7603498|NCT03656744|12010253|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
7603499|NCT03656744|12010254|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
7603500|NCT03510598|12010262|FG000|Overall Study|Withdrawal by Subject|1
7603501|NCT03487796|12010270|FG000|Overall Study|Lost to Follow-up|18
7603502|NCT03487796|12010271|FG001|Overall Study|Lost to Follow-up|6
7603503|NCT03446612|12010285|FG000|Overall Study|Protocol defined stopping criteria|0
7603504|NCT03446612|12010286|FG001|Overall Study|Protocol defined stopping criteria|1
7603505|NCT03370120|12010307|FG000|Overall Study|Adverse event, non-fatal|24
7603506|NCT03370120|12010307|FG000|Overall Study|Withdrawal by Subject|6
7603507|NCT03370120|12010307|FG000|Overall Study|Lost to Follow-up|1
7603508|NCT03370120|12010307|FG000|Overall Study|Lack of Efficacy|37
7603509|NCT03370120|12010307|FG000|Overall Study|Per sponsor's instructions|1
7603510|NCT03370120|12010307|FG000|Overall Study|Study was terminated by parent company UCB|2
7603511|NCT03370120|12010307|FG000|Overall Study|The study was ended by the promoter|3
7273866|NCT00434330|11488240|FG002|Overall Study|Withdrawal by Subject|1
7273867|NCT00434330|11488241|FG003|Overall Study|Withdrawal by Subject|1
7273868|NCT00434330|11488242|FG004|Overall Study|Withdrawal by Subject|0
7273869|NCT00434330|11488243|FG005|Overall Study|Withdrawal by Subject|0
7273870|NCT00434330|11488238|FG000|Overall Study|Renal transplant|0
7273871|NCT00434330|11488239|FG001|Overall Study|Renal transplant|0
7273872|NCT00434330|11488240|FG002|Overall Study|Renal transplant|0
7273873|NCT00434330|11488241|FG003|Overall Study|Renal transplant|1
7273874|NCT00434330|11488242|FG004|Overall Study|Renal transplant|0
7273875|NCT00434330|11488243|FG005|Overall Study|Renal transplant|0
7273876|NCT00434330|11488238|FG000|Overall Study|Subject Not Compliant With Study|0
7273877|NCT00434330|11488239|FG001|Overall Study|Subject Not Compliant With Study|0
7273878|NCT00434330|11488240|FG002|Overall Study|Subject Not Compliant With Study|1
7273879|NCT00434330|11488241|FG003|Overall Study|Subject Not Compliant With Study|0
7273880|NCT00434330|11488242|FG004|Overall Study|Subject Not Compliant With Study|0
7273881|NCT00434330|11488243|FG005|Overall Study|Subject Not Compliant With Study|0
7273882|NCT00434421|11488266|FG000|Overall Study|Withdrawal by Subject|1
7273883|NCT00434421|11488266|FG000|Overall Study|Non-compliance with study treatment|1
7273884|NCT00434512|11488289|FG000|Overall Study|Migrated/moved from study area|0
7273885|NCT00434512|11488290|FG001|Overall Study|Migrated/moved from study area|0
7273886|NCT00434512|11488291|FG002|Overall Study|Migrated/moved from study area|0
7273887|NCT00434512|11488292|FG003|Overall Study|Migrated/moved from study area|1
7273888|NCT00434512|11488293|FG004|Overall Study|Migrated/moved from study area|1
7273889|NCT00434512|11488294|FG005|Overall Study|Migrated/moved from study area|1
7273890|NCT00434512|11488289|FG000|Overall Study|Other|0
7273891|NCT00434512|11488290|FG001|Overall Study|Other|1
7273892|NCT00434512|11488291|FG002|Overall Study|Other|0
7273893|NCT00434512|11488292|FG003|Overall Study|Other|0
7273894|NCT00434512|11488293|FG004|Overall Study|Other|0
7273895|NCT00434512|11488294|FG005|Overall Study|Other|0
7273896|NCT00434577|11488317|FG000|Months 0-3|Serious Adverse Event|0
7273897|NCT00434577|11488318|FG001|Months 0-3|Serious Adverse Event|0
7273898|NCT00434577|11488319|FG002|Months 0-3|Serious Adverse Event|1
7273899|NCT00434577|11488320|FG003|Months 0-3|Serious Adverse Event|0
7273900|NCT00434577|11488321|FG004|Months 0-3|Serious Adverse Event|0
7273901|NCT00434577|11488317|FG000|Months 0-3|Adverse Event|0
7603512|NCT03370120|12010307|FG000|Overall Study|Discontinuation of drug development|3
7603513|NCT03370120|12010307|FG000|Overall Study|End of project|2
7603514|NCT03370120|12010307|FG000|Overall Study|Premature study closure|2
7603515|NCT03370120|12010307|FG000|Overall Study|Premature program termination|1
7603516|NCT03370120|12010307|FG000|Overall Study|Premature study termination|7
7603517|NCT03370120|12010307|FG000|Overall Study|Trial terminated by sponsor|2
7603518|NCT03370120|12010307|FG000|Overall Study|Trial discontinued by sponsor|2
7603519|NCT03370120|12010307|FG000|Overall Study|Study ended|15
7603520|NCT03370120|12010307|FG000|Overall Study|Clinical trial has been cancelled|1
7603521|NCT03370120|12010307|FG000|Overall Study|End of study per sponsor decision|2
7603522|NCT03370120|12010307|FG000|Overall Study|Promoter's decision|2
7603523|NCT03370120|12010307|FG000|Overall Study|The trial has been suspended|3
7603524|NCT03370120|12010307|FG000|Overall Study|Sponsor stopped PSL development based on data|3
7603525|NCT03370120|12010307|FG000|Overall Study|Early termination by order of sponsor|2
7603526|NCT03370120|12010307|FG000|Overall Study|Discontinuation of the study|5
7603527|NCT03370120|12010307|FG000|Overall Study|End of clinical trial discontinuation|1
7603528|NCT03370120|12010307|FG000|Overall Study|Because the clinical trial ended halfway|4
7603529|NCT03370120|12010307|FG000|Overall Study|Development discontinued|5
7603530|NCT03370120|12010307|FG000|Overall Study|Padsenovil program closed|3
7603531|NCT03370120|12010307|FG000|Overall Study|End of project|2
7603532|NCT03370120|12010307|FG000|Overall Study|Termination of project|1
7603533|NCT03370120|12010307|FG000|Overall Study|The study was interrupted by sponsor|4
7603534|NCT03370120|12010307|FG000|Overall Study|The protocol was interrupted by sponsor|1
7603535|NCT03370120|12010307|FG000|Overall Study|End of sponsor decision|1
7603536|NCT03370120|12010307|FG000|Overall Study|The study was terminated prematurely by study lead|1
7603537|NCT03370120|12010307|FG000|Overall Study|Early termination of studies|5
7603538|NCT03370120|12010307|FG000|Overall Study|This study is ended early|1
7603539|NCT03370120|12010307|FG000|Overall Study|End of padsevonil program|2
7603540|NCT03370120|12010307|FG000|Overall Study|Decision of sponsor|6
7603541|NCT03370120|12010307|FG000|Overall Study|Asked by the sponsor|3
7603542|NCT03370120|12010307|FG000|Overall Study|Sponsor decision to stop the protocol|1
7603543|NCT03370120|12010307|FG000|Overall Study|PI decision poor compliance from participant|1
7603544|NCT03370120|12010307|FG000|Overall Study|Promoter ended the study|3
7603545|NCT03370120|12010307|FG000|Overall Study|Premature study close by sponsor's decision|4
7603546|NCT03370120|12010307|FG000|Overall Study|Study terminated by sponsor|33
7603547|NCT03370120|12010307|FG000|Overall Study|Sponsor prematurely terminated this study|2
7603548|NCT03370120|12010307|FG000|Overall Study|Sponsor decision to terminate study|63
7603549|NCT03370120|12010307|FG000|Overall Study|Program closure|3
7603550|NCT03370120|12010307|FG000|Overall Study|Study ended prematurely|1
7603551|NCT03370120|12010307|FG000|Overall Study|Study stopped by sponsor|2
7603552|NCT03370120|12010307|FG000|Overall Study|Program termination|55
7603553|NCT03370120|12010307|FG000|Overall Study|Sponsor decision|62
7603554|NCT03370120|12010307|FG000|Overall Study|Sponsor study closure|10
7603555|NCT03143829|12010330|FG000|Overall Study|Withdrawal by Subject|2
7603556|NCT03143829|12010331|FG001|Overall Study|Withdrawal by Subject|5
7603557|NCT03143829|12010330|FG000|Overall Study|Lost to Follow-up|0
7603558|NCT03143829|12010331|FG001|Overall Study|Lost to Follow-up|2
7603559|NCT03143829|12010330|FG000|Overall Study|Death|1
7603560|NCT03143829|12010331|FG001|Overall Study|Death|1
7603561|NCT03143829|12010330|FG000|Overall Study|changed treatment, no longer eligible|2
7603562|NCT03143829|12010331|FG001|Overall Study|changed treatment, no longer eligible|2
7603563|NCT02963610|12010346|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
7603564|NCT02766335|12010353|FG000|Initial Registration|Adverse Event|6
7603565|NCT02766335|12010354|FG001|Initial Registration|Adverse Event|3
7603566|NCT02766335|12010355|FG002|Initial Registration|Adverse Event|0
7603567|NCT02766335|12010353|FG000|Initial Registration|Refusal unrelated to adverse event|1
7603568|NCT02766335|12010354|FG001|Initial Registration|Refusal unrelated to adverse event|0
7603569|NCT02766335|12010355|FG002|Initial Registration|Refusal unrelated to adverse event|0
7603570|NCT02766335|12010353|FG000|Initial Registration|Progression/relapse|49
7603571|NCT02766335|12010354|FG001|Initial Registration|Progression/relapse|15
7603572|NCT02766335|12010355|FG002|Initial Registration|Progression/relapse|0
7603573|NCT02766335|12010353|FG000|Initial Registration|Death|1
7603574|NCT02766335|12010354|FG001|Initial Registration|Death|3
7603575|NCT02766335|12010355|FG002|Initial Registration|Death|0
7603576|NCT02766335|12010353|FG000|Initial Registration|not protocol specified|1
7603577|NCT02766335|12010354|FG001|Initial Registration|not protocol specified|9
7603578|NCT02766335|12010355|FG002|Initial Registration|not protocol specified|0
7603579|NCT02766335|12010353|FG000|Re-registration of Arm I to MEDI4738|Death|0
7603580|NCT02766335|12010354|FG001|Re-registration of Arm I to MEDI4738|Death|0
7603581|NCT02766335|12010355|FG002|Re-registration of Arm I to MEDI4738|Death|1
7603582|NCT02766335|12010353|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
7603583|NCT02766335|12010354|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
7603584|NCT02766335|12010355|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
7603585|NCT02606136|12010361|FG000|Overall Study|Participant/Legal Guardian Decision|5
7603586|NCT02606136|12010361|FG000|Overall Study|Withdrawal by Subject|1
7603587|NCT02228382|12010370|FG000|Overall Study|Death|5
7603588|NCT02228382|12010371|FG001|Overall Study|Death|7
7603589|NCT02228382|12010372|FG002|Overall Study|Death|5
7603590|NCT02228382|12010373|FG003|Overall Study|Death|0
7603591|NCT02228382|12010374|FG004|Overall Study|Death|2
7603592|NCT02228382|12010370|FG000|Overall Study|Participant refused further follow-up|0
7603593|NCT02228382|12010371|FG001|Overall Study|Participant refused further follow-up|0
7603594|NCT02228382|12010372|FG002|Overall Study|Participant refused further follow-up|1
7603595|NCT02228382|12010373|FG003|Overall Study|Participant refused further follow-up|0
7603596|NCT02228382|12010374|FG004|Overall Study|Participant refused further follow-up|0
7603597|NCT02228382|12010370|FG000|Overall Study|Study terminated by sponsor|3
7603598|NCT02228382|12010371|FG001|Overall Study|Study terminated by sponsor|5
7603599|NCT02228382|12010372|FG002|Overall Study|Study terminated by sponsor|7
7603600|NCT02228382|12010373|FG003|Overall Study|Study terminated by sponsor|0
7603601|NCT02228382|12010374|FG004|Overall Study|Study terminated by sponsor|0
7603602|NCT02228382|12010370|FG000|Overall Study|Lost to Follow-up|0
7603603|NCT02228382|12010371|FG001|Overall Study|Lost to Follow-up|0
7603604|NCT02228382|12010372|FG002|Overall Study|Lost to Follow-up|3
7603605|NCT02228382|12010373|FG003|Overall Study|Lost to Follow-up|1
7603606|NCT02228382|12010374|FG004|Overall Study|Lost to Follow-up|0
7603607|NCT02228382|12010370|FG000|Overall Study|Withdrawal by Subject|0
7603608|NCT02228382|12010371|FG001|Overall Study|Withdrawal by Subject|3
7603609|NCT02228382|12010372|FG002|Overall Study|Withdrawal by Subject|2
7603610|NCT02228382|12010373|FG003|Overall Study|Withdrawal by Subject|1
7603611|NCT02228382|12010374|FG004|Overall Study|Withdrawal by Subject|0
7603612|NCT02228382|12010370|FG000|Overall Study|Other|2
7603613|NCT02228382|12010371|FG001|Overall Study|Other|3
7603614|NCT02228382|12010372|FG002|Overall Study|Other|3
7603615|NCT02228382|12010373|FG003|Overall Study|Other|0
7273902|NCT00434577|11488318|FG001|Months 0-3|Adverse Event|1
7273903|NCT00434577|11488319|FG002|Months 0-3|Adverse Event|1
7273904|NCT00434577|11488320|FG003|Months 0-3|Adverse Event|0
7273905|NCT00434577|11488321|FG004|Months 0-3|Adverse Event|0
7273906|NCT00434577|11488317|FG000|Months 0-3|Lost to Follow-up|0
7273907|NCT00434577|11488318|FG001|Months 0-3|Lost to Follow-up|0
7273908|NCT00434577|11488319|FG002|Months 0-3|Lost to Follow-up|0
7273909|NCT00434577|11488320|FG003|Months 0-3|Lost to Follow-up|0
7273910|NCT00434577|11488321|FG004|Months 0-3|Lost to Follow-up|2
7273911|NCT00434577|11488317|FG000|Months 0-3|Protocol Violation|1
7273912|NCT00434577|11488318|FG001|Months 0-3|Protocol Violation|0
7273913|NCT00434577|11488319|FG002|Months 0-3|Protocol Violation|1
7273914|NCT00434577|11488320|FG003|Months 0-3|Protocol Violation|0
7273915|NCT00434577|11488321|FG004|Months 0-3|Protocol Violation|0
7273916|NCT00434577|11488317|FG000|Months 0-3|Withdrawal by Subject|2
7273917|NCT00434577|11488318|FG001|Months 0-3|Withdrawal by Subject|1
7273918|NCT00434577|11488319|FG002|Months 0-3|Withdrawal by Subject|1
7273919|NCT00434577|11488320|FG003|Months 0-3|Withdrawal by Subject|1
7273920|NCT00434577|11488321|FG004|Months 0-3|Withdrawal by Subject|1
7273921|NCT00434642|11488335|FG000|Blinded Treatment Phase|Adverse Event|12
7273922|NCT00434642|11488336|FG001|Blinded Treatment Phase|Adverse Event|58
7273923|NCT00434642|11488335|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
7273924|NCT00434642|11488336|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
7273925|NCT00434642|11488335|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
7273926|NCT00434642|11488336|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
7273927|NCT00434642|11488335|FG000|Blinded Treatment Phase|Physician Decision|19
7273928|NCT00434642|11488336|FG001|Blinded Treatment Phase|Physician Decision|27
7273929|NCT00434642|11488335|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
7273930|NCT00434642|11488336|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
7273931|NCT00434642|11488335|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
7273932|NCT00434642|11488336|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
7273933|NCT00434642|11488335|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
7273934|NCT00434642|11488336|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
7273935|NCT00434642|11488335|FG000|Open-label Treatment Phase|Adverse Event|0
7273936|NCT00434642|11488336|FG001|Open-label Treatment Phase|Adverse Event|5
7273937|NCT00434642|11488335|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
7603616|NCT02228382|12010374|FG004|Overall Study|Other|0
7603617|NCT02001623|12010424|FG000|Overall Study|Disease Progression|2
7603618|NCT02001623|12010425|FG001|Overall Study|Disease Progression|2
7603619|NCT02001623|12010426|FG002|Overall Study|Disease Progression|3
7603620|NCT02001623|12010427|FG003|Overall Study|Disease Progression|2
7603621|NCT02001623|12010428|FG004|Overall Study|Disease Progression|3
7273938|NCT00434642|11488336|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
7603622|NCT02001623|12010429|FG005|Overall Study|Disease Progression|2
7603623|NCT02001623|12010430|FG006|Overall Study|Disease Progression|3
7603624|NCT02001623|12010431|FG007|Overall Study|Disease Progression|3
7603625|NCT02001623|12010432|FG008|Overall Study|Disease Progression|7
7603626|NCT02001623|12010433|FG009|Overall Study|Disease Progression|40
7603627|NCT02001623|12010434|FG010|Overall Study|Disease Progression|5
7603628|NCT02001623|12010435|FG011|Overall Study|Disease Progression|9
7603629|NCT02001623|12010436|FG012|Overall Study|Disease Progression|9
7603630|NCT02001623|12010437|FG013|Overall Study|Disease Progression|20
7603631|NCT02001623|12010438|FG014|Overall Study|Disease Progression|9
7603632|NCT02001623|12010424|FG000|Overall Study|Physician Decision|0
7603633|NCT02001623|12010425|FG001|Overall Study|Physician Decision|0
7603634|NCT02001623|12010426|FG002|Overall Study|Physician Decision|0
7603635|NCT02001623|12010427|FG003|Overall Study|Physician Decision|0
7603636|NCT02001623|12010428|FG004|Overall Study|Physician Decision|0
7603637|NCT02001623|12010429|FG005|Overall Study|Physician Decision|0
7603638|NCT02001623|12010430|FG006|Overall Study|Physician Decision|0
7603639|NCT02001623|12010431|FG007|Overall Study|Physician Decision|0
7603640|NCT02001623|12010432|FG008|Overall Study|Physician Decision|3
7603641|NCT02001623|12010433|FG009|Overall Study|Physician Decision|2
7603642|NCT02001623|12010434|FG010|Overall Study|Physician Decision|3
7603643|NCT02001623|12010435|FG011|Overall Study|Physician Decision|3
7603644|NCT02001623|12010436|FG012|Overall Study|Physician Decision|1
7603645|NCT02001623|12010437|FG013|Overall Study|Physician Decision|2
7603646|NCT02001623|12010438|FG014|Overall Study|Physician Decision|1
7603647|NCT02001623|12010424|FG000|Overall Study|Death|0
7603648|NCT02001623|12010425|FG001|Overall Study|Death|1
7603649|NCT02001623|12010426|FG002|Overall Study|Death|0
7603650|NCT02001623|12010427|FG003|Overall Study|Death|0
7603651|NCT02001623|12010428|FG004|Overall Study|Death|0
7603652|NCT02001623|12010429|FG005|Overall Study|Death|0
7603653|NCT02001623|12010430|FG006|Overall Study|Death|0
7603654|NCT02001623|12010431|FG007|Overall Study|Death|0
7603655|NCT02001623|12010432|FG008|Overall Study|Death|0
7603656|NCT02001623|12010433|FG009|Overall Study|Death|0
7603657|NCT02001623|12010434|FG010|Overall Study|Death|0
7603658|NCT02001623|12010435|FG011|Overall Study|Death|0
7603659|NCT02001623|12010436|FG012|Overall Study|Death|0
7603660|NCT02001623|12010437|FG013|Overall Study|Death|0
7603661|NCT02001623|12010438|FG014|Overall Study|Death|0
7603662|NCT02001623|12010424|FG000|Overall Study|Adverse Event|0
7603663|NCT02001623|12010425|FG001|Overall Study|Adverse Event|0
7603664|NCT02001623|12010426|FG002|Overall Study|Adverse Event|0
7603665|NCT02001623|12010427|FG003|Overall Study|Adverse Event|0
7603666|NCT02001623|12010428|FG004|Overall Study|Adverse Event|0
7603667|NCT02001623|12010429|FG005|Overall Study|Adverse Event|1
7603668|NCT02001623|12010430|FG006|Overall Study|Adverse Event|0
7603669|NCT02001623|12010431|FG007|Overall Study|Adverse Event|3
7603670|NCT02001623|12010432|FG008|Overall Study|Adverse Event|4
7603671|NCT02001623|12010433|FG009|Overall Study|Adverse Event|6
7603672|NCT02001623|12010434|FG010|Overall Study|Adverse Event|4
7603673|NCT02001623|12010435|FG011|Overall Study|Adverse Event|0
7603674|NCT02001623|12010436|FG012|Overall Study|Adverse Event|3
7603675|NCT02001623|12010437|FG013|Overall Study|Adverse Event|5
7603676|NCT02001623|12010438|FG014|Overall Study|Adverse Event|6
7603677|NCT02001623|12010424|FG000|Overall Study|Other - Miscellaneous|0
7603678|NCT02001623|12010425|FG001|Overall Study|Other - Miscellaneous|0
7603679|NCT02001623|12010426|FG002|Overall Study|Other - Miscellaneous|0
7603680|NCT02001623|12010427|FG003|Overall Study|Other - Miscellaneous|0
7603681|NCT02001623|12010428|FG004|Overall Study|Other - Miscellaneous|0
7603682|NCT02001623|12010429|FG005|Overall Study|Other - Miscellaneous|0
7603683|NCT02001623|12010430|FG006|Overall Study|Other - Miscellaneous|0
7603684|NCT02001623|12010431|FG007|Overall Study|Other - Miscellaneous|0
7603685|NCT02001623|12010432|FG008|Overall Study|Other - Miscellaneous|0
7603686|NCT02001623|12010433|FG009|Overall Study|Other - Miscellaneous|1
7603687|NCT02001623|12010434|FG010|Overall Study|Other - Miscellaneous|0
7603688|NCT02001623|12010435|FG011|Overall Study|Other - Miscellaneous|0
7603689|NCT02001623|12010436|FG012|Overall Study|Other - Miscellaneous|0
7603690|NCT02001623|12010437|FG013|Overall Study|Other - Miscellaneous|1
7603691|NCT02001623|12010438|FG014|Overall Study|Other - Miscellaneous|0
7603692|NCT02001623|12010424|FG000|Overall Study|Withdrawal by Subject|1
7603693|NCT02001623|12010425|FG001|Overall Study|Withdrawal by Subject|0
7603694|NCT02001623|12010426|FG002|Overall Study|Withdrawal by Subject|0
7603695|NCT02001623|12010427|FG003|Overall Study|Withdrawal by Subject|0
7603696|NCT02001623|12010428|FG004|Overall Study|Withdrawal by Subject|0
7603697|NCT02001623|12010429|FG005|Overall Study|Withdrawal by Subject|0
7603698|NCT02001623|12010430|FG006|Overall Study|Withdrawal by Subject|0
7603699|NCT02001623|12010431|FG007|Overall Study|Withdrawal by Subject|0
7603700|NCT02001623|12010432|FG008|Overall Study|Withdrawal by Subject|1
7603701|NCT02001623|12010433|FG009|Overall Study|Withdrawal by Subject|3
7603702|NCT02001623|12010434|FG010|Overall Study|Withdrawal by Subject|2
7603703|NCT02001623|12010435|FG011|Overall Study|Withdrawal by Subject|2
7603704|NCT02001623|12010436|FG012|Overall Study|Withdrawal by Subject|1
7603705|NCT02001623|12010437|FG013|Overall Study|Withdrawal by Subject|5
7603706|NCT02001623|12010438|FG014|Overall Study|Withdrawal by Subject|2
7603707|NCT02001623|12010424|FG000|Overall Study|Lost to Follow-up|0
7603708|NCT02001623|12010425|FG001|Overall Study|Lost to Follow-up|0
7603709|NCT02001623|12010426|FG002|Overall Study|Lost to Follow-up|0
7603710|NCT02001623|12010427|FG003|Overall Study|Lost to Follow-up|0
7603711|NCT02001623|12010428|FG004|Overall Study|Lost to Follow-up|0
7603712|NCT02001623|12010429|FG005|Overall Study|Lost to Follow-up|0
7603713|NCT02001623|12010430|FG006|Overall Study|Lost to Follow-up|0
7603714|NCT02001623|12010431|FG007|Overall Study|Lost to Follow-up|0
7603715|NCT02001623|12010432|FG008|Overall Study|Lost to Follow-up|0
7603716|NCT02001623|12010433|FG009|Overall Study|Lost to Follow-up|1
7603717|NCT02001623|12010434|FG010|Overall Study|Lost to Follow-up|0
7603718|NCT02001623|12010435|FG011|Overall Study|Lost to Follow-up|0
7603719|NCT02001623|12010436|FG012|Overall Study|Lost to Follow-up|0
7603720|NCT02001623|12010437|FG013|Overall Study|Lost to Follow-up|0
7603721|NCT02001623|12010438|FG014|Overall Study|Lost to Follow-up|0
7603722|NCT02001623|12010424|FG000|Overall Study|Start of New Anti-cancer Treatment|0
7603723|NCT02001623|12010425|FG001|Overall Study|Start of New Anti-cancer Treatment|0
7603859|NCT03215706|12010659|FG001|Randomization|other reasons|2
7603724|NCT02001623|12010426|FG002|Overall Study|Start of New Anti-cancer Treatment|0
7603725|NCT02001623|12010427|FG003|Overall Study|Start of New Anti-cancer Treatment|0
7603726|NCT02001623|12010428|FG004|Overall Study|Start of New Anti-cancer Treatment|0
7603727|NCT02001623|12010429|FG005|Overall Study|Start of New Anti-cancer Treatment|0
7603728|NCT02001623|12010430|FG006|Overall Study|Start of New Anti-cancer Treatment|0
7603729|NCT02001623|12010431|FG007|Overall Study|Start of New Anti-cancer Treatment|0
7603730|NCT02001623|12010432|FG008|Overall Study|Start of New Anti-cancer Treatment|0
7603731|NCT02001623|12010433|FG009|Overall Study|Start of New Anti-cancer Treatment|0
7603732|NCT02001623|12010434|FG010|Overall Study|Start of New Anti-cancer Treatment|0
7603733|NCT02001623|12010435|FG011|Overall Study|Start of New Anti-cancer Treatment|1
7603734|NCT02001623|12010436|FG012|Overall Study|Start of New Anti-cancer Treatment|0
7603735|NCT02001623|12010437|FG013|Overall Study|Start of New Anti-cancer Treatment|1
7603736|NCT02001623|12010438|FG014|Overall Study|Start of New Anti-cancer Treatment|0
7603737|NCT02001623|12010424|FG000|Overall Study|Dose Delay Due to Toxicity|0
7603738|NCT02001623|12010425|FG001|Overall Study|Dose Delay Due to Toxicity|0
7603739|NCT02001623|12010426|FG002|Overall Study|Dose Delay Due to Toxicity|0
7603740|NCT02001623|12010427|FG003|Overall Study|Dose Delay Due to Toxicity|0
7603741|NCT02001623|12010428|FG004|Overall Study|Dose Delay Due to Toxicity|0
7603742|NCT02001623|12010429|FG005|Overall Study|Dose Delay Due to Toxicity|0
7603743|NCT02001623|12010430|FG006|Overall Study|Dose Delay Due to Toxicity|0
7603744|NCT02001623|12010431|FG007|Overall Study|Dose Delay Due to Toxicity|0
7603745|NCT02001623|12010432|FG008|Overall Study|Dose Delay Due to Toxicity|0
7603746|NCT02001623|12010433|FG009|Overall Study|Dose Delay Due to Toxicity|0
7603747|NCT02001623|12010434|FG010|Overall Study|Dose Delay Due to Toxicity|0
7603748|NCT02001623|12010435|FG011|Overall Study|Dose Delay Due to Toxicity|0
7603749|NCT02001623|12010436|FG012|Overall Study|Dose Delay Due to Toxicity|0
7603750|NCT02001623|12010437|FG013|Overall Study|Dose Delay Due to Toxicity|1
7603751|NCT02001623|12010438|FG014|Overall Study|Dose Delay Due to Toxicity|0
7603752|NCT01900002|12010487|FG000|Overall Study|Withdrawal by Subject|2
7603753|NCT01900002|12010487|FG000|Overall Study|ineligible for Y-90|4
7603754|NCT01595061|12010491|FG000|Overall Study|Never Treated|3
7603755|NCT01595061|12010491|FG000|Overall Study|Inadequate Pathology|1
7273939|NCT00434759|11488344|FG000|Overall Study|Lack of Efficacy|5
7273940|NCT00434759|11488345|FG001|Overall Study|Lack of Efficacy|4
7273941|NCT00434759|11488344|FG000|Overall Study|Withdrawal by Subject|17
7273942|NCT00434759|11488345|FG001|Overall Study|Withdrawal by Subject|1
7273943|NCT00434759|11488344|FG000|Overall Study|family affairs|2
7273944|NCT00434759|11488345|FG001|Overall Study|family affairs|0
7273945|NCT00434876|11488355|FG000|Overall Study|Lost to Follow-up|1
7273946|NCT00434876|11488356|FG001|Overall Study|Lost to Follow-up|1
7273947|NCT00434954|11488364|FG000|Overall Study|Adverse Event|17
7273948|NCT00434954|11488365|FG001|Overall Study|Adverse Event|2
7273949|NCT00434954|11488364|FG000|Overall Study|Entry criteria not met|14
7273950|NCT00434954|11488365|FG001|Overall Study|Entry criteria not met|16
7273951|NCT00434954|11488364|FG000|Overall Study|Lost to Follow-up|0
7273952|NCT00434954|11488365|FG001|Overall Study|Lost to Follow-up|1
7273953|NCT00434954|11488364|FG000|Overall Study|Physician Decision|6
7273954|NCT00434954|11488365|FG001|Overall Study|Physician Decision|3
7273955|NCT00434954|11488364|FG000|Overall Study|Protocol Violation|36
7273956|NCT00434954|11488365|FG001|Overall Study|Protocol Violation|27
7273957|NCT00434954|11488364|FG000|Overall Study|Sponsor decision|1
7273958|NCT00434954|11488365|FG001|Overall Study|Sponsor decision|0
7273959|NCT00434954|11488364|FG000|Overall Study|Subject decision|8
7273960|NCT00434954|11488365|FG001|Overall Study|Subject decision|22
7273961|NCT00434967|11488375|FG000|Overall Study|Adverse Event|2
7273962|NCT00434967|11488376|FG001|Overall Study|Adverse Event|4
7273963|NCT00434967|11488377|FG002|Overall Study|Adverse Event|3
7273964|NCT00434967|11488378|FG003|Overall Study|Adverse Event|3
7273965|NCT00434967|11488375|FG000|Overall Study|Lost to Follow-up|0
7273966|NCT00434967|11488376|FG001|Overall Study|Lost to Follow-up|0
7273967|NCT00434967|11488377|FG002|Overall Study|Lost to Follow-up|1
7273968|NCT00434967|11488378|FG003|Overall Study|Lost to Follow-up|0
7273969|NCT00434967|11488375|FG000|Overall Study|Withdrawal by Subject|2
7603756|NCT04502212|12010495|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
7603757|NCT04502212|12010495|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1
7603758|NCT04794803|12010511|FG000|Overall Study|Death|1
7603759|NCT04794803|12010512|FG001|Overall Study|Death|3
7603760|NCT04794803|12010511|FG000|Overall Study|Lost to Follow-up|2
7603761|NCT04794803|12010512|FG001|Overall Study|Lost to Follow-up|2
7603762|NCT04794803|12010511|FG000|Overall Study|Withdrawal by Subject|1
7603763|NCT04794803|12010512|FG001|Overall Study|Withdrawal by Subject|0
7603764|NCT04794803|12010511|FG000|Overall Study|Physician Decision|1
7603765|NCT04794803|12010512|FG001|Overall Study|Physician Decision|1
7603766|NCT04794803|12010511|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4
7603767|NCT04794803|12010512|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1
7603768|NCT04794803|12010511|FG000|Overall Study|Refused to continue the treatment|1
7603769|NCT04794803|12010512|FG001|Overall Study|Refused to continue the treatment|0
7603770|NCT04794803|12010511|FG000|Overall Study|Patient admitted to ICU|0
7603771|NCT04794803|12010512|FG001|Overall Study|Patient admitted to ICU|1
7603772|NCT04706403|12010523|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
7603773|NCT04706403|12010524|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
7603774|NCT04706403|12010525|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
7603775|NCT04706403|12010526|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
7603776|NCT04706403|12010527|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
7603777|NCT04440449|12010541|FG000|Overall Study|Lost to Follow-up|2
7603778|NCT04440449|12010542|FG001|Overall Study|Lost to Follow-up|0
7603779|NCT04369469|12010551|FG000|Overall Study|Lost to Follow-up|2
7603780|NCT04369469|12010552|FG001|Overall Study|Lost to Follow-up|4
7603781|NCT04369469|12010551|FG000|Overall Study|Physician Decision|2
7603782|NCT04369469|12010552|FG001|Overall Study|Physician Decision|1
7603783|NCT04369469|12010551|FG000|Overall Study|Withdrawal by Subject|2
7603784|NCT04369469|12010552|FG001|Overall Study|Withdrawal by Subject|3
7603785|NCT04369469|12010551|FG000|Overall Study|Adverse Event|1
7603786|NCT04369469|12010552|FG001|Overall Study|Adverse Event|0
7603787|NCT04369469|12010551|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2
7603788|NCT04369469|12010552|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0
7603789|NCT04369469|12010551|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1
7603790|NCT04369469|12010552|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0
7603791|NCT04369469|12010551|FG000|Overall Study|Unable to Provide Consent|0
7603792|NCT04369469|12010552|FG001|Overall Study|Unable to Provide Consent|1
7603809|NCT03772574|12010582|FG000|Overall Study|Protocol Violation|2
7603810|NCT03772574|12010583|FG001|Overall Study|Protocol Violation|0
7603811|NCT03772574|12010584|FG002|Overall Study|Protocol Violation|0
7603812|NCT03772574|12010582|FG000|Overall Study|Discomfort|0
7603813|NCT03772574|12010583|FG001|Overall Study|Discomfort|5
7603814|NCT03772574|12010584|FG002|Overall Study|Discomfort|4
7603815|NCT03594955|12010592|FG000|Overall Study|Adverse Event|1
7603816|NCT03594955|12010592|FG000|Overall Study|Progressive disease|5
7603817|NCT03594955|12010592|FG000|Overall Study|Sponsor's decision|1
7603818|NCT03548220|12010600|FG000|Overall Study|Lost to Follow-up|1
7603819|NCT03548220|12010601|FG001|Overall Study|Lost to Follow-up|0
7603820|NCT03548220|12010602|FG002|Overall Study|Lost to Follow-up|0
7603821|NCT03548220|12010603|FG003|Overall Study|Lost to Follow-up|0
7273970|NCT00434967|11488376|FG001|Overall Study|Withdrawal by Subject|2
7603822|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1
7603823|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0
7603824|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2
7603825|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1
7603826|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3
7603827|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14
7603828|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7
7603829|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2
7603830|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1
7603831|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0
7603832|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
7603833|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2
7603834|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0
7603835|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1
7603836|NCT03434041|12010629|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2
7603837|NCT03434041|12010630|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0
7603838|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4
7603839|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3
7603840|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2
7603841|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0
7603842|NCT03434041|12010629|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1
7603843|NCT03434041|12010630|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0
7603844|NCT03420222|12010640|FG000|Overall Study|Withdrawal by Subject|5
7603845|NCT03420222|12010641|FG001|Overall Study|Withdrawal by Subject|0
7603846|NCT03420222|12010640|FG000|Overall Study|Physician Decision|0
7603847|NCT03420222|12010641|FG001|Overall Study|Physician Decision|1
7603848|NCT03409796|12010649|FG000|Overall Study|Adverse Event|2
7603849|NCT03409796|12010650|FG001|Overall Study|Adverse Event|0
7603850|NCT03409796|12010649|FG000|Overall Study|Other|0
7603851|NCT03409796|12010650|FG001|Overall Study|Other|1
7273971|NCT00434967|11488377|FG002|Overall Study|Withdrawal by Subject|4
7273972|NCT00434967|11488378|FG003|Overall Study|Withdrawal by Subject|6
7273973|NCT00434967|11488375|FG000|Overall Study|Randomized in error|0
7273974|NCT00434967|11488376|FG001|Overall Study|Randomized in error|0
7603852|NCT03215706|12010658|FG000|Randomization|Adverse Event unrelated to study drug|1
7603853|NCT03215706|12010659|FG001|Randomization|Adverse Event unrelated to study drug|0
7603854|NCT03215706|12010658|FG000|Randomization|participant withdrew consent|1
7603855|NCT03215706|12010659|FG001|Randomization|participant withdrew consent|3
7603856|NCT03215706|12010658|FG000|Randomization|no longer meets study criteria|1
7603857|NCT03215706|12010659|FG001|Randomization|no longer meets study criteria|4
7603858|NCT03215706|12010658|FG000|Randomization|other reasons|0
7603860|NCT03215706|12010658|FG000|Treatment Period|Disease Progression|150
7603861|NCT03215706|12010659|FG001|Treatment Period|Disease Progression|142
7603862|NCT03215706|12010658|FG000|Treatment Period|Study Drug Toxicity|53
7603863|NCT03215706|12010659|FG001|Treatment Period|Study Drug Toxicity|21
7603864|NCT03215706|12010658|FG000|Treatment Period|Death|2
7603865|NCT03215706|12010659|FG001|Treatment Period|Death|1
7603866|NCT03215706|12010658|FG000|Treatment Period|Adverse event unrelated to study drug|24
7603867|NCT03215706|12010659|FG001|Treatment Period|Adverse event unrelated to study drug|23
7603868|NCT03215706|12010658|FG000|Treatment Period|Request to D/C treatment|1
7603869|NCT03215706|12010659|FG001|Treatment Period|Request to D/C treatment|6
7603870|NCT03215706|12010658|FG000|Treatment Period|Participant withdrew consent|3
7603871|NCT03215706|12010659|FG001|Treatment Period|Participant withdrew consent|4
7603872|NCT03215706|12010658|FG000|Treatment Period|Lost to Follow-up|0
7603873|NCT03215706|12010659|FG001|Treatment Period|Lost to Follow-up|1
7603874|NCT03215706|12010658|FG000|Treatment Period|Other Reasons|4
7603875|NCT03215706|12010659|FG001|Treatment Period|Other Reasons|5
7603876|NCT03215706|12010658|FG000|Treatment Period|Ongoing in the treatment period|105
7603877|NCT03215706|12010659|FG001|Treatment Period|Ongoing in the treatment period|43
7273975|NCT00434967|11488377|FG002|Overall Study|Randomized in error|0
7273976|NCT00434967|11488378|FG003|Overall Study|Randomized in error|1
7273977|NCT00434967|11488375|FG000|Overall Study|Protocol Violation|0
7603898|NCT03093350|12010700|FG000|Overall Study|Death|1
7603899|NCT03093350|12010700|FG000|Overall Study|Signed consent, never began treartment|1
7603900|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Screen failures|7
7603901|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Screen failures|2
7603902|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8
7603903|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2
7603904|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Death|7
7603905|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Death|5
7603906|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1
7603907|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0
7603908|NCT02999854|12010713|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1
7603909|NCT02999854|12010714|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0
7603910|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Death|1
7603911|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Death|1
7603912|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
7603913|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1
7603914|NCT02999854|12010713|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
7603915|NCT02999854|12010714|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1
7603916|NCT02960763|12010725|FG000|Step 1|Withdrawal by Subject|10
7603917|NCT02960763|12010726|FG001|Step 1|Withdrawal by Subject|8
7603918|NCT02960763|12010727|FG002|Step 1|Withdrawal by Subject|13
7603919|NCT02960763|12010728|FG003|Step 1|Withdrawal by Subject|0
7603920|NCT02960763|12010729|FG004|Step 1|Withdrawal by Subject|0
7603921|NCT02960763|12010725|FG000|Step 1|Lost to Follow-up|7
7603922|NCT02960763|12010726|FG001|Step 1|Lost to Follow-up|9
7603923|NCT02960763|12010727|FG002|Step 1|Lost to Follow-up|13
7603924|NCT02960763|12010728|FG003|Step 1|Lost to Follow-up|0
7603925|NCT02960763|12010729|FG004|Step 1|Lost to Follow-up|0
7603926|NCT02960763|12010725|FG000|Step 1|Death|1
7603927|NCT02960763|12010726|FG001|Step 1|Death|1
7603928|NCT02960763|12010727|FG002|Step 1|Death|1
7603929|NCT02960763|12010728|FG003|Step 1|Death|0
7603930|NCT02960763|12010729|FG004|Step 1|Death|0
7603931|NCT02960763|12010725|FG000|Step 1|Investigator discretion|1
7603932|NCT02960763|12010726|FG001|Step 1|Investigator discretion|0
7603933|NCT02960763|12010727|FG002|Step 1|Investigator discretion|1
7603934|NCT02960763|12010728|FG003|Step 1|Investigator discretion|0
7603935|NCT02960763|12010729|FG004|Step 1|Investigator discretion|0
7603936|NCT02960763|12010725|FG000|Step 2|Withdrawal by Subject|0
7603937|NCT02960763|12010726|FG001|Step 2|Withdrawal by Subject|0
7603938|NCT02960763|12010727|FG002|Step 2|Withdrawal by Subject|0
7603939|NCT02960763|12010728|FG003|Step 2|Withdrawal by Subject|7
7603940|NCT02960763|12010729|FG004|Step 2|Withdrawal by Subject|3
7603941|NCT02960763|12010725|FG000|Step 2|Lost to Follow-up|0
7603942|NCT02960763|12010726|FG001|Step 2|Lost to Follow-up|0
7603943|NCT02960763|12010727|FG002|Step 2|Lost to Follow-up|0
7603944|NCT02960763|12010728|FG003|Step 2|Lost to Follow-up|4
7603945|NCT02960763|12010729|FG004|Step 2|Lost to Follow-up|1
7603946|NCT02960763|12010725|FG000|Step 2|Investigator discretion|0
7603947|NCT02960763|12010726|FG001|Step 2|Investigator discretion|0
7603948|NCT02960763|12010727|FG002|Step 2|Investigator discretion|0
7603949|NCT02960763|12010728|FG003|Step 2|Investigator discretion|0
7603950|NCT02960763|12010729|FG004|Step 2|Investigator discretion|1
7603951|NCT02839343|12010743|FG000|Overall Study|Withdrawal by Subject|3
7603952|NCT02839343|12010744|FG001|Overall Study|Withdrawal by Subject|1
7603953|NCT02839343|12010743|FG000|Overall Study|Disease Progression Prior to Treatment|1
7603954|NCT02839343|12010744|FG001|Overall Study|Disease Progression Prior to Treatment|0
7603955|NCT02839343|12010743|FG000|Overall Study|Adverse Event|1
7603956|NCT02839343|12010744|FG001|Overall Study|Adverse Event|0
7603957|NCT02819479|12010750|FG000|Overall Study|Adverse Event|2
7603958|NCT02601313|12010758|FG000|Overall Study|Death|2
7603959|NCT02601313|12010759|FG001|Overall Study|Death|16
7603960|NCT02601313|12010760|FG002|Overall Study|Death|4
7603961|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
7603962|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
7603963|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
7603964|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
7603965|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
7603966|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
7603967|NCT02601313|12010758|FG000|Overall Study|Still on study|0
7603968|NCT02601313|12010759|FG001|Overall Study|Still on study|52
7603969|NCT02601313|12010760|FG002|Overall Study|Still on study|10
7603970|NCT02601313|12010758|FG000|Overall Study|Enrolled, did not initiate AC|4
7603971|NCT02601313|12010759|FG001|Overall Study|Enrolled, did not initiate AC|0
7603972|NCT02601313|12010760|FG002|Overall Study|Enrolled, did not initiate AC|0
7603977|NCT02438722|12010790|FG000|Overall Study|Adverse Event|12
7603978|NCT02438722|12010791|FG001|Overall Study|Adverse Event|9
7603979|NCT02438722|12010790|FG000|Overall Study|Refusal unrelated to AE|2
7603980|NCT02438722|12010791|FG001|Overall Study|Refusal unrelated to AE|5
7603981|NCT02438722|12010790|FG000|Overall Study|Disease progression/relapse|46
7603982|NCT02438722|12010791|FG001|Overall Study|Disease progression/relapse|51
7603983|NCT02438722|12010790|FG000|Overall Study|Death|0
7603984|NCT02438722|12010791|FG001|Overall Study|Death|3
7603985|NCT02438722|12010790|FG000|Overall Study|Physician Decision|2
7603986|NCT02438722|12010791|FG001|Overall Study|Physician Decision|2
7603987|NCT02438722|12010790|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
7603988|NCT02438722|12010791|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
7603989|NCT02438722|12010790|FG000|Overall Study|Withdrawal by Subject|0
7603990|NCT02438722|12010791|FG001|Overall Study|Withdrawal by Subject|1
7603991|NCT02438722|12010790|FG000|Overall Study|On protocol treatment|15
7603992|NCT02438722|12010791|FG001|Overall Study|On protocol treatment|14
7603993|NCT02438722|12010790|FG000|Overall Study|Did not receive protocol treatment|5
7603994|NCT02438722|12010791|FG001|Overall Study|Did not receive protocol treatment|0
7604051|NCT02004691|12010838|FG000|PAP: Up to 52 Weeks|Poor compliance|1
7604052|NCT02004691|12010839|FG001|PAP: Up to 52 Weeks|Poor compliance|0
7604053|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1
7604054|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0
7604055|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0
7604056|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1
7604057|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Other|0
7604058|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Other|1
7604059|NCT02004691|12010838|FG000|ETP: Ongoing From Week 52|Ongoing|16
7604060|NCT02004691|12010839|FG001|ETP: Ongoing From Week 52|Ongoing|16
7273978|NCT00434967|11488376|FG001|Overall Study|Protocol Violation|1
7604091|NCT01668719|12010871|FG000|Phase I|On treatment|1
7604092|NCT01668719|12010872|FG001|Phase I|On treatment|0
7604093|NCT01668719|12010873|FG002|Phase I|On treatment|0
7604094|NCT01668719|12010871|FG000|Phase I|Adverse Event|2
7604095|NCT01668719|12010872|FG001|Phase I|Adverse Event|0
7604096|NCT01668719|12010873|FG002|Phase I|Adverse Event|0
7604097|NCT01668719|12010871|FG000|Phase I|Progression/relapse|1
7604098|NCT01668719|12010872|FG001|Phase I|Progression/relapse|0
7604099|NCT01668719|12010873|FG002|Phase I|Progression/relapse|0
7604100|NCT01668719|12010871|FG000|Phase I|not protocol specified|2
7604101|NCT01668719|12010872|FG001|Phase I|not protocol specified|0
7604102|NCT01668719|12010873|FG002|Phase I|not protocol specified|0
7604103|NCT01668719|12010871|FG000|Phase II|On treatment|0
7604104|NCT01668719|12010872|FG001|Phase II|On treatment|4
7604105|NCT01668719|12010873|FG002|Phase II|On treatment|3
7604106|NCT01668719|12010871|FG000|Phase II|Adverse Event|0
7604107|NCT01668719|12010872|FG001|Phase II|Adverse Event|18
7604108|NCT01668719|12010873|FG002|Phase II|Adverse Event|18
7604109|NCT01668719|12010871|FG000|Phase II|Refusal unrelated to adverse event|0
7604110|NCT01668719|12010872|FG001|Phase II|Refusal unrelated to adverse event|4
7604111|NCT01668719|12010873|FG002|Phase II|Refusal unrelated to adverse event|1
7604112|NCT01668719|12010871|FG000|Phase II|Progression/relapse|0
7604113|NCT01668719|12010872|FG001|Phase II|Progression/relapse|13
7604114|NCT01668719|12010873|FG002|Phase II|Progression/relapse|17
7604115|NCT01668719|12010871|FG000|Phase II|Death|0
7604116|NCT01668719|12010872|FG001|Phase II|Death|0
7604117|NCT01668719|12010873|FG002|Phase II|Death|2
7604118|NCT01668719|12010871|FG000|Phase II|not protocol specified|0
7604119|NCT01668719|12010872|FG001|Phase II|not protocol specified|13
7604120|NCT01668719|12010873|FG002|Phase II|not protocol specified|7
7273979|NCT00434967|11488377|FG002|Overall Study|Protocol Violation|0
7273980|NCT00434967|11488378|FG003|Overall Study|Protocol Violation|1
7273981|NCT00434967|11488375|FG000|Overall Study|Physician Decision|1
7273982|NCT00434967|11488376|FG001|Overall Study|Physician Decision|1
7273983|NCT00434967|11488377|FG002|Overall Study|Physician Decision|1
7273984|NCT00434967|11488378|FG003|Overall Study|Physician Decision|0
7273985|NCT00434967|11488375|FG000|Overall Study|Patient Disposition Challenges|2
7273986|NCT00434967|11488376|FG001|Overall Study|Patient Disposition Challenges|0
7273987|NCT00434967|11488377|FG002|Overall Study|Patient Disposition Challenges|0
7273988|NCT00434967|11488378|FG003|Overall Study|Patient Disposition Challenges|3
7273989|NCT00435019|11488399|FG000|Overall Study|Adverse Event|1
7273990|NCT00435019|11488400|FG001|Overall Study|Adverse Event|0
7273991|NCT00435019|11488399|FG000|Overall Study|Lack of Efficacy|1
7273992|NCT00435019|11488400|FG001|Overall Study|Lack of Efficacy|2
7273993|NCT00435019|11488399|FG000|Overall Study|Protocol Violation|3
7604177|NCT01515748|12010914|FG000|Overall Study|Withdrawal by Subject|32
7604178|NCT01515748|12010915|FG001|Overall Study|Withdrawal by Subject|41
7604179|NCT01515748|12010914|FG000|Overall Study|Lost to Follow-up|2
7604180|NCT01515748|12010915|FG001|Overall Study|Lost to Follow-up|4
7604181|NCT01515748|12010914|FG000|Overall Study|Ongoing|86
7604182|NCT01515748|12010915|FG001|Overall Study|Ongoing|90
7604183|NCT01261247|12010922|FG000|Overall Study|Ineligible|2
7604184|NCT00790933|12010954|FG000|Overall Study|Adverse Event|94
7604185|NCT00790933|12010955|FG001|Overall Study|Adverse Event|119
7604186|NCT00790933|12010956|FG002|Overall Study|Adverse Event|65
7604187|NCT00790933|12010957|FG003|Overall Study|Adverse Event|5
7604188|NCT00790933|12010958|FG004|Overall Study|Adverse Event|69
7604189|NCT00790933|12010954|FG000|Overall Study|Protocol Violation(s)|8
7604190|NCT00790933|12010955|FG001|Overall Study|Protocol Violation(s)|18
7604191|NCT00790933|12010956|FG002|Overall Study|Protocol Violation(s)|7
7604192|NCT00790933|12010957|FG003|Overall Study|Protocol Violation(s)|0
7604193|NCT00790933|12010958|FG004|Overall Study|Protocol Violation(s)|12
7604194|NCT00790933|12010954|FG000|Overall Study|Lack of Efficacy|192
7604195|NCT00790933|12010955|FG001|Overall Study|Lack of Efficacy|176
7604196|NCT00790933|12010956|FG002|Overall Study|Lack of Efficacy|130
7604197|NCT00790933|12010957|FG003|Overall Study|Lack of Efficacy|1
7604198|NCT00790933|12010958|FG004|Overall Study|Lack of Efficacy|121
7604199|NCT00790933|12010954|FG000|Overall Study|Study Terminated by Sponsor|0
7604200|NCT00790933|12010955|FG001|Overall Study|Study Terminated by Sponsor|0
7604201|NCT00790933|12010956|FG002|Overall Study|Study Terminated by Sponsor|1
7604202|NCT00790933|12010957|FG003|Overall Study|Study Terminated by Sponsor|0
7604203|NCT00790933|12010958|FG004|Overall Study|Study Terminated by Sponsor|0
7604204|NCT00790933|12010954|FG000|Overall Study|Withdrawal by Subject|123
7604205|NCT00790933|12010955|FG001|Overall Study|Withdrawal by Subject|120
7604206|NCT00790933|12010956|FG002|Overall Study|Withdrawal by Subject|52
7604207|NCT00790933|12010957|FG003|Overall Study|Withdrawal by Subject|6
7604208|NCT00790933|12010958|FG004|Overall Study|Withdrawal by Subject|50
7604209|NCT00790933|12010954|FG000|Overall Study|Lost to Follow-up|13
7604210|NCT00790933|12010955|FG001|Overall Study|Lost to Follow-up|31
7604211|NCT00790933|12010956|FG002|Overall Study|Lost to Follow-up|10
7604212|NCT00790933|12010957|FG003|Overall Study|Lost to Follow-up|1
7604213|NCT00790933|12010958|FG004|Overall Study|Lost to Follow-up|15
7604214|NCT00790933|12010954|FG000|Overall Study|Reason Not Specified|8
7604215|NCT00790933|12010955|FG001|Overall Study|Reason Not Specified|16
7604216|NCT00790933|12010956|FG002|Overall Study|Reason Not Specified|4
7604217|NCT00790933|12010957|FG003|Overall Study|Reason Not Specified|1
7604218|NCT00790933|12010958|FG004|Overall Study|Reason Not Specified|9
7604219|NCT04388527|12011020|FG000|Overall Study|Death|14
7604220|NCT04388527|12011020|FG000|Overall Study|Withdrawal by Subject|2
7604221|NCT04388527|12011020|FG000|Overall Study|Lost to Follow-up|1
7604222|NCT04280081|12011028|FG000|Overall Study|Adverse Event|4
7604223|NCT04280081|12011028|FG000|Overall Study|Death|2
7604224|NCT04280081|12011028|FG000|Overall Study|Progressive Disease|6
7604225|NCT04126083|12011050|FG000|Overall Study|Withdrawal by Subject|1
7604226|NCT03444038|12011173|FG000|Overall Study|Adverse Event|12
7604227|NCT03444038|12011173|FG000|Overall Study|Withdrawal by Subject|7
7604228|NCT03444038|12011173|FG000|Overall Study|Lost to Follow-up|1
7604229|NCT03444038|12011173|FG000|Overall Study|Physician Decision|2
7604230|NCT03444038|12011173|FG000|Overall Study|Lack of Efficacy|7
7604231|NCT03265665|12011183|FG000|24-week Data Collection|Withdrawal by Subject|2
7604232|NCT03265665|12011184|FG001|24-week Data Collection|Withdrawal by Subject|2
7604233|NCT03265665|12011183|FG000|24-week Data Collection|Lost to Follow-up|4
7604234|NCT03265665|12011184|FG001|24-week Data Collection|Lost to Follow-up|5
7604235|NCT03265665|12011183|FG000|36-week Data Collection|Lost to Follow-up|6
7604236|NCT03265665|12011184|FG001|36-week Data Collection|Lost to Follow-up|8
7604237|NCT02725593|12011198|FG000|Blinded Treatment Period|Withdrawal by Subject|4
7604238|NCT02725593|12011199|FG001|Blinded Treatment Period|Withdrawal by Subject|3
7604239|NCT02725593|12011198|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
7604240|NCT02725593|12011199|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
7604241|NCT02725593|12011198|FG000|Blinded Treatment Period|Lost to Follow-up|1
7604242|NCT02725593|12011199|FG001|Blinded Treatment Period|Lost to Follow-up|1
7604243|NCT02725593|12011198|FG000|Long Term Extension|Withdrawal by Subject|1
7604244|NCT02725593|12011199|FG001|Long Term Extension|Withdrawal by Subject|3
7604245|NCT02716675|12011208|FG000|Overall Study|Death|2
7604246|NCT02716675|12011209|FG001|Overall Study|Death|3
7604247|NCT02716675|12011210|FG002|Overall Study|Death|0
7604248|NCT02716675|12011208|FG000|Overall Study|Physician Decision|2
7604249|NCT02716675|12011209|FG001|Overall Study|Physician Decision|1
7604250|NCT02716675|12011210|FG002|Overall Study|Physician Decision|1
7604251|NCT02716675|12011208|FG000|Overall Study|Lost to Follow-up|100
7604252|NCT02716675|12011209|FG001|Overall Study|Lost to Follow-up|87
7604253|NCT02716675|12011210|FG002|Overall Study|Lost to Follow-up|99
7604254|NCT02716675|12011208|FG000|Overall Study|Withdrawal by Subject|22
7604255|NCT02716675|12011209|FG001|Overall Study|Withdrawal by Subject|25
7604256|NCT02716675|12011210|FG002|Overall Study|Withdrawal by Subject|20
7604257|NCT02716675|12011208|FG000|Overall Study|Protocol Violation|0
7604258|NCT02716675|12011209|FG001|Overall Study|Protocol Violation|3
7604259|NCT02716675|12011210|FG002|Overall Study|Protocol Violation|1
7604260|NCT02716675|12011208|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36
7604261|NCT02716675|12011209|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31
7604262|NCT02716675|12011210|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42
7604263|NCT02716675|12011208|FG000|Overall Study|Other|38
7604264|NCT02716675|12011209|FG001|Overall Study|Other|47
7604265|NCT02716675|12011210|FG002|Overall Study|Other|48
7604266|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0
7604267|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1
7604268|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1
7604269|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0
7604270|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0
7604271|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1
7604272|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0
7604273|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1
7273994|NCT00435019|11488400|FG001|Overall Study|Protocol Violation|1
7273995|NCT00435019|11488399|FG000|Overall Study|Personal reasons for withdrawal|8
7273996|NCT00435019|11488400|FG001|Overall Study|Personal reasons for withdrawal|7
7273997|NCT00435045|11488408|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7273998|NCT00435045|11488409|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
7273999|NCT00435045|11488408|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7274000|NCT00435045|11488409|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
7274001|NCT00435045|11488408|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
7274002|NCT00435045|11488409|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
7274003|NCT00435045|11488408|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
7274004|NCT00435045|11488409|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
7274005|NCT00435045|11488408|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
7604274|NCT02636946|12011225|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0
7604275|NCT02636946|12011226|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2
7604276|NCT02636946|12011225|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2
7604277|NCT02636946|12011226|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1
7604278|NCT02631941|12011242|FG000|Overall Study|Physician Decision|0
7604279|NCT02631941|12011243|FG001|Overall Study|Physician Decision|1
7604280|NCT02631941|12011244|FG002|Overall Study|Physician Decision|0
7604281|NCT02631941|12011245|FG003|Overall Study|Physician Decision|0
7604282|NCT02631941|12011246|FG004|Overall Study|Physician Decision|0
7604283|NCT02631941|12011247|FG005|Overall Study|Physician Decision|0
7604284|NCT02631941|12011248|FG006|Overall Study|Physician Decision|0
7604285|NCT02631941|12011249|FG007|Overall Study|Physician Decision|0
7604286|NCT02631941|12011250|FG008|Overall Study|Physician Decision|0
7604287|NCT02631941|12011251|FG009|Overall Study|Physician Decision|0
7604288|NCT02631941|12011242|FG000|Overall Study|Adverse Event|0
7604289|NCT02631941|12011243|FG001|Overall Study|Adverse Event|1
7604290|NCT02631941|12011244|FG002|Overall Study|Adverse Event|0
7604291|NCT02631941|12011245|FG003|Overall Study|Adverse Event|0
7604292|NCT02631941|12011246|FG004|Overall Study|Adverse Event|0
7604293|NCT02631941|12011247|FG005|Overall Study|Adverse Event|0
7604294|NCT02631941|12011248|FG006|Overall Study|Adverse Event|0
7604295|NCT02631941|12011249|FG007|Overall Study|Adverse Event|0
7604296|NCT02631941|12011250|FG008|Overall Study|Adverse Event|0
7604297|NCT02631941|12011251|FG009|Overall Study|Adverse Event|0
7604298|NCT02631941|12011242|FG000|Overall Study|Withdrawal by Subject|0
7604299|NCT02631941|12011243|FG001|Overall Study|Withdrawal by Subject|0
7604300|NCT02631941|12011244|FG002|Overall Study|Withdrawal by Subject|0
7604301|NCT02631941|12011245|FG003|Overall Study|Withdrawal by Subject|0
7604302|NCT02631941|12011246|FG004|Overall Study|Withdrawal by Subject|1
7604303|NCT02631941|12011247|FG005|Overall Study|Withdrawal by Subject|0
7604304|NCT02631941|12011248|FG006|Overall Study|Withdrawal by Subject|0
7604305|NCT02631941|12011249|FG007|Overall Study|Withdrawal by Subject|1
7604306|NCT02631941|12011250|FG008|Overall Study|Withdrawal by Subject|0
7604307|NCT02631941|12011251|FG009|Overall Study|Withdrawal by Subject|0
7604308|NCT02631941|12011242|FG000|Overall Study|Lost to Follow-up|0
7604309|NCT02631941|12011243|FG001|Overall Study|Lost to Follow-up|0
7604310|NCT02631941|12011244|FG002|Overall Study|Lost to Follow-up|0
7604311|NCT02631941|12011245|FG003|Overall Study|Lost to Follow-up|0
7604312|NCT02631941|12011246|FG004|Overall Study|Lost to Follow-up|0
7604313|NCT02631941|12011247|FG005|Overall Study|Lost to Follow-up|0
7604314|NCT02631941|12011248|FG006|Overall Study|Lost to Follow-up|0
7604315|NCT02631941|12011249|FG007|Overall Study|Lost to Follow-up|0
7604316|NCT02631941|12011250|FG008|Overall Study|Lost to Follow-up|1
7604317|NCT02631941|12011251|FG009|Overall Study|Lost to Follow-up|0
7604318|NCT02568215|12011264|FG000|Overall Study|Death|1
7604319|NCT02568215|12011265|FG001|Overall Study|Death|2
7604320|NCT02568215|12011266|FG002|Overall Study|Death|0
7604321|NCT02568215|12011264|FG000|Overall Study|Physician Decision|2
7604322|NCT02568215|12011265|FG001|Overall Study|Physician Decision|2
7604323|NCT02568215|12011266|FG002|Overall Study|Physician Decision|2
7604324|NCT02568215|12011264|FG000|Overall Study|Lost to Follow-up|29
7604325|NCT02568215|12011265|FG001|Overall Study|Lost to Follow-up|32
7604326|NCT02568215|12011266|FG002|Overall Study|Lost to Follow-up|41
7604327|NCT02568215|12011264|FG000|Overall Study|Withdrawal by Subject|21
7604328|NCT02568215|12011265|FG001|Overall Study|Withdrawal by Subject|19
7604329|NCT02568215|12011266|FG002|Overall Study|Withdrawal by Subject|22
7604330|NCT02568215|12011264|FG000|Overall Study|Protocol Violation|1
7604331|NCT02568215|12011265|FG001|Overall Study|Protocol Violation|1
7604332|NCT02568215|12011266|FG002|Overall Study|Protocol Violation|0
7274006|NCT00435045|11488409|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
7274007|NCT00435045|11488408|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
7274008|NCT00435045|11488409|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
7274009|NCT00435045|11488408|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7274010|NCT00435045|11488409|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
7274011|NCT00435045|11488408|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
7274012|NCT00435045|11488409|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
7274013|NCT00435045|11488408|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
7274014|NCT00435045|11488409|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
7274015|NCT00435045|11488408|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
7274016|NCT00435045|11488409|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
7274017|NCT00435045|11488408|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
7274018|NCT00435045|11488409|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
7274019|NCT00435162|11488418|FG000|Period 2 (2 Weeks)|Adverse Event|0
7274020|NCT00435162|11488419|FG001|Period 2 (2 Weeks)|Adverse Event|1
7274021|NCT00435162|11488420|FG002|Period 2 (2 Weeks)|Adverse Event|0
7274022|NCT00435162|11488421|FG003|Period 2 (2 Weeks)|Adverse Event|0
7274023|NCT00435162|11488422|FG004|Period 2 (2 Weeks)|Adverse Event|0
7274024|NCT00435162|11488423|FG005|Period 2 (2 Weeks)|Adverse Event|0
7274025|NCT00435188|11488438|FG000|Overall Study|Death|1
7274026|NCT00435188|11488439|FG001|Overall Study|Death|6
7274027|NCT00435188|11488438|FG000|Overall Study|Withdrawal by Subject|16
7274028|NCT00435188|11488439|FG001|Overall Study|Withdrawal by Subject|11
7274029|NCT00435188|11488438|FG000|Overall Study|Lost to Follow-up|5
7274030|NCT00435188|11488439|FG001|Overall Study|Lost to Follow-up|6
7274031|NCT00435370|11488449|FG000|Overall Study|Adverse Event|8
7274032|NCT00435370|11488450|FG001|Overall Study|Adverse Event|8
7274033|NCT00435370|11488449|FG000|Overall Study|Withdrawal by Subject|10
7274034|NCT00435370|11488450|FG001|Overall Study|Withdrawal by Subject|10
7274035|NCT00435370|11488449|FG000|Overall Study|Antipsychotic medication changed|4
7274036|NCT00435370|11488450|FG001|Overall Study|Antipsychotic medication changed|2
7274037|NCT00435409|11488458|FG000|Overall Study|Protocol Violation|1
7274038|NCT00435409|11488459|FG001|Overall Study|Protocol Violation|2
7274039|NCT00435409|11488460|FG002|Overall Study|Protocol Violation|0
7274040|NCT00435409|11488458|FG000|Overall Study|Lost to Follow-up|1
7274041|NCT00435409|11488459|FG001|Overall Study|Lost to Follow-up|2
7274042|NCT00435409|11488460|FG002|Overall Study|Lost to Follow-up|0
7274043|NCT00435409|11488458|FG000|Overall Study|Death|8
7274044|NCT00435409|11488459|FG001|Overall Study|Death|6
7274045|NCT00435409|11488460|FG002|Overall Study|Death|6
7274046|NCT00435409|11488458|FG000|Overall Study|Objective progression or relapse|158
7274047|NCT00435409|11488459|FG001|Overall Study|Objective progression or relapse|93
7274048|NCT00435409|11488460|FG002|Overall Study|Objective progression or relapse|58
7274049|NCT00435409|11488458|FG000|Overall Study|Global deterioration of health status|0
7274050|NCT00435409|11488459|FG001|Overall Study|Global deterioration of health status|0
7274051|NCT00435409|11488460|FG002|Overall Study|Global deterioration of health status|4
7274052|NCT00435409|11488458|FG000|Overall Study|Withdrawal by Subject|8
7274053|NCT00435409|11488459|FG001|Overall Study|Withdrawal by Subject|7
7604333|NCT02568215|12011264|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25
7604334|NCT02568215|12011265|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23
7604335|NCT02568215|12011266|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21
7604336|NCT02568215|12011264|FG000|Overall Study|Other|0
7604337|NCT02568215|12011265|FG001|Overall Study|Other|1
7604338|NCT02568215|12011266|FG002|Overall Study|Other|4
7604339|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5
7604340|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8
7604341|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Death|1
7604342|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Death|6
7604343|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0
7604344|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1
7604345|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44
7604346|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82
7604347|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2
7604348|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8
7604349|NCT02528643|12011294|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3
7274054|NCT00435409|11488460|FG002|Overall Study|Withdrawal by Subject|1
7274055|NCT00435409|11488458|FG000|Overall Study|Other|45
7274056|NCT00435409|11488459|FG001|Overall Study|Other|30
7274057|NCT00435409|11488460|FG002|Overall Study|Other|1
7274058|NCT00435409|11488458|FG000|Overall Study|Adverse Event|0
7274059|NCT00435409|11488459|FG001|Overall Study|Adverse Event|0
7274060|NCT00435409|11488460|FG002|Overall Study|Adverse Event|8
7274061|NCT00435409|11488458|FG000|Overall Study|Sponsor decision|0
7274062|NCT00435409|11488459|FG001|Overall Study|Sponsor decision|3
7274063|NCT00435409|11488460|FG002|Overall Study|Sponsor decision|0
7469705|NCT01926028|11771584|FG000|Overall Study|Non compliance or other reasons|4
7469706|NCT01926028|11771585|FG001|Overall Study|Non compliance or other reasons|2
7469707|NCT01926028|11771586|FG002|Overall Study|Non compliance or other reasons|0
7469708|NCT01926119|11771595|FG000|Overall Study|Withdrawal by Subject|1
7469709|NCT01926444|11771603|FG000|Overall Study|Colonoscopy not performed|0
7469710|NCT01926444|11771604|FG001|Overall Study|Colonoscopy not performed|0
7469711|NCT01926444|11771605|FG002|Overall Study|Colonoscopy not performed|4
7469712|NCT01926444|11771606|FG003|Overall Study|Colonoscopy not performed|2
7469713|NCT01926509|11771633|FG000|Overall Study|vital sign met discontinuation criteria|1
7469714|NCT01926509|11771634|FG001|Overall Study|vital sign met discontinuation criteria|0
7604350|NCT02528643|12011295|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5
7604351|NCT02528643|12011294|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0
7604352|NCT02528643|12011295|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1
7604353|NCT02237508|12011339|FG000|Overall Study|Withdrawal by Subject|0
7604354|NCT02237508|12011340|FG001|Overall Study|Withdrawal by Subject|2
7604355|NCT02237508|12011341|FG002|Overall Study|Withdrawal by Subject|0
7604356|NCT02237508|12011342|FG003|Overall Study|Withdrawal by Subject|1
7604357|NCT02237508|12011343|FG004|Overall Study|Withdrawal by Subject|0
7604358|NCT02237508|12011344|FG005|Overall Study|Withdrawal by Subject|1
7604359|NCT02237508|12011345|FG006|Overall Study|Withdrawal by Subject|1
7604360|NCT02237508|12011346|FG007|Overall Study|Withdrawal by Subject|0
7604361|NCT02237508|12011347|FG008|Overall Study|Withdrawal by Subject|1
7604362|NCT02237508|12011348|FG009|Overall Study|Withdrawal by Subject|0
7274064|NCT00435461|11488469|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
7274065|NCT00435461|11488470|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7274066|NCT00435461|11488471|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
7274067|NCT00435461|11488469|FG000|Overall Study|Protocol Violation|6
7274068|NCT00435461|11488470|FG001|Overall Study|Protocol Violation|9
7274069|NCT00435461|11488471|FG002|Overall Study|Protocol Violation|10
7274070|NCT00435461|11488469|FG000|Overall Study|Participant randomized(inadequate score)|1
7274071|NCT00435461|11488470|FG001|Overall Study|Participant randomized(inadequate score)|0
7274072|NCT00435461|11488471|FG002|Overall Study|Participant randomized(inadequate score)|0
7274073|NCT00435461|11488469|FG000|Overall Study|Compliance less than 80 percent|1
7274074|NCT00435461|11488470|FG001|Overall Study|Compliance less than 80 percent|0
7274075|NCT00435461|11488471|FG002|Overall Study|Compliance less than 80 percent|0
7274076|NCT00435461|11488469|FG000|Overall Study|In error, two study medications switched|1
7274077|NCT00435461|11488470|FG001|Overall Study|In error, two study medications switched|0
7274078|NCT00435461|11488471|FG002|Overall Study|In error, two study medications switched|0
7274079|NCT00435461|11488469|FG000|Overall Study|Lack of Efficacy|2
7274080|NCT00435461|11488470|FG001|Overall Study|Lack of Efficacy|1
7274081|NCT00435461|11488471|FG002|Overall Study|Lack of Efficacy|0
7274082|NCT00435461|11488469|FG000|Overall Study|Withdrawal by Subject|1
7274083|NCT00435461|11488470|FG001|Overall Study|Withdrawal by Subject|0
7274084|NCT00435461|11488471|FG002|Overall Study|Withdrawal by Subject|2
7274085|NCT00435461|11488469|FG000|Overall Study|Randomized in error|1
7274086|NCT00435461|11488470|FG001|Overall Study|Randomized in error|0
7274087|NCT00435461|11488471|FG002|Overall Study|Randomized in error|0
7274088|NCT00435461|11488469|FG000|Overall Study|Participant could not tolerate symptoms|0
7274089|NCT00435461|11488470|FG001|Overall Study|Participant could not tolerate symptoms|0
7274090|NCT00435461|11488471|FG002|Overall Study|Participant could not tolerate symptoms|1
7274091|NCT00435461|11488469|FG000|Overall Study|Participant could not swallow capsule|0
7274092|NCT00435461|11488470|FG001|Overall Study|Participant could not swallow capsule|0
7274093|NCT00435461|11488471|FG002|Overall Study|Participant could not swallow capsule|1
7274094|NCT00435461|11488469|FG000|Overall Study|Pregnancy|2
7274095|NCT00435461|11488470|FG001|Overall Study|Pregnancy|0
7274096|NCT00435461|11488471|FG002|Overall Study|Pregnancy|0
7274097|NCT00435461|11488469|FG000|Overall Study|Participant moved eDiary,studymedication|1
7274098|NCT00435461|11488470|FG001|Overall Study|Participant moved eDiary,studymedication|0
7274099|NCT00435461|11488471|FG002|Overall Study|Participant moved eDiary,studymedication|0
7274100|NCT00435461|11488469|FG000|Overall Study|Participant ended study one day early|1
7274101|NCT00435461|11488470|FG001|Overall Study|Participant ended study one day early|0
7274102|NCT00435461|11488471|FG002|Overall Study|Participant ended study one day early|0
7604363|NCT02237508|12011339|FG000|Overall Study|Physician Decision|0
7274103|NCT00435461|11488469|FG000|Overall Study|Noncompliance with study requirements|1
7274104|NCT00435461|11488470|FG001|Overall Study|Noncompliance with study requirements|1
7274105|NCT00435461|11488471|FG002|Overall Study|Noncompliance with study requirements|1
7274106|NCT00435461|11488469|FG000|Overall Study|Adverse Event|1
7274107|NCT00435461|11488470|FG001|Overall Study|Adverse Event|2
7274108|NCT00435461|11488471|FG002|Overall Study|Adverse Event|6
7274109|NCT00435461|11488469|FG000|Overall Study|Non-Compliance of diary|2
7274110|NCT00435461|11488470|FG001|Overall Study|Non-Compliance of diary|0
7274111|NCT00435461|11488471|FG002|Overall Study|Non-Compliance of diary|1
7274112|NCT00435461|11488469|FG000|Overall Study|Lost to Follow-up|1
7274113|NCT00435461|11488470|FG001|Overall Study|Lost to Follow-up|1
7274114|NCT00435461|11488471|FG002|Overall Study|Lost to Follow-up|2
7274115|NCT00435487|11488481|FG000|Overall Study|Death|3
7274116|NCT00435487|11488482|FG001|Overall Study|Death|4
7604364|NCT02237508|12011340|FG001|Overall Study|Physician Decision|1
7604365|NCT02237508|12011341|FG002|Overall Study|Physician Decision|0
7604366|NCT02237508|12011342|FG003|Overall Study|Physician Decision|0
7604367|NCT02237508|12011343|FG004|Overall Study|Physician Decision|0
7604368|NCT02237508|12011344|FG005|Overall Study|Physician Decision|0
7604369|NCT02237508|12011345|FG006|Overall Study|Physician Decision|0
7604370|NCT02237508|12011346|FG007|Overall Study|Physician Decision|0
7604371|NCT02237508|12011347|FG008|Overall Study|Physician Decision|0
7604372|NCT02237508|12011348|FG009|Overall Study|Physician Decision|0
7604373|NCT02237508|12011339|FG000|Overall Study|Protocol Violation|0
7604374|NCT02237508|12011340|FG001|Overall Study|Protocol Violation|0
7604375|NCT02237508|12011341|FG002|Overall Study|Protocol Violation|1
7604376|NCT02237508|12011342|FG003|Overall Study|Protocol Violation|0
7604377|NCT02237508|12011343|FG004|Overall Study|Protocol Violation|0
7604378|NCT02237508|12011344|FG005|Overall Study|Protocol Violation|0
7604379|NCT02237508|12011345|FG006|Overall Study|Protocol Violation|0
7604380|NCT02237508|12011346|FG007|Overall Study|Protocol Violation|0
7604381|NCT02237508|12011347|FG008|Overall Study|Protocol Violation|0
7604382|NCT02237508|12011348|FG009|Overall Study|Protocol Violation|0
7604383|NCT01706705|12011366|FG000|Overall Study|Death|1
7604384|NCT01706705|12011366|FG000|Overall Study|Lack of Efficacy|13
7604385|NCT01706705|12011366|FG000|Overall Study|Non-clinical|6
7604386|NCT01609842|12011375|FG000|Concurrent Intervention Control|pharmacy data not available|2
7604387|NCT01609842|12011376|FG001|Concurrent Intervention Control|pharmacy data not available|0
7604388|NCT00003479|12011408|FG000|Overall Study|Not evaluable|3
7604389|NCT04160195|12011414|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1
7604390|NCT04160195|12011415|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0
7604417|NCT04152447|12011438|FG000|Overall Study|Lost to Follow-up|1
7274117|NCT00435487|11488481|FG000|Overall Study|Adverse Event|0
7274118|NCT00435487|11488482|FG001|Overall Study|Adverse Event|3
7274119|NCT00435487|11488481|FG000|Overall Study|Lost to Follow-up|2
7274120|NCT00435487|11488482|FG001|Overall Study|Lost to Follow-up|2
7274121|NCT00435487|11488481|FG000|Overall Study|Other|5
7274122|NCT00435487|11488482|FG001|Overall Study|Other|2
7274123|NCT00435487|11488481|FG000|Overall Study|Withdrawal by Subject|2
7274124|NCT00435487|11488482|FG001|Overall Study|Withdrawal by Subject|1
7274125|NCT00435487|11488481|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
7274126|NCT00435487|11488482|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
7274127|NCT00435487|11488481|FG000|Overall Study|Received Drug in Other Treatment Group|0
7274128|NCT00435487|11488482|FG001|Overall Study|Received Drug in Other Treatment Group|1
7274129|NCT00435825|11488541|FG000|Overall Study|Abnormality of Laboratory Test|0
7274130|NCT00435825|11488542|FG001|Overall Study|Abnormality of Laboratory Test|1
7274131|NCT00435825|11488543|FG002|Overall Study|Abnormality of Laboratory Test|0
7274132|NCT00435825|11488544|FG003|Overall Study|Abnormality of Laboratory Test|0
7274133|NCT00435825|11488541|FG000|Overall Study|Insufficient Therapeutic Response|3
7274134|NCT00435825|11488542|FG001|Overall Study|Insufficient Therapeutic Response|1
7274135|NCT00435825|11488543|FG002|Overall Study|Insufficient Therapeutic Response|0
7274136|NCT00435825|11488544|FG003|Overall Study|Insufficient Therapeutic Response|3
7274137|NCT00435825|11488541|FG000|Overall Study|Other Protocol Violation|1
7274138|NCT00435825|11488542|FG001|Overall Study|Other Protocol Violation|0
7274139|NCT00435825|11488543|FG002|Overall Study|Other Protocol Violation|0
7274140|NCT00435825|11488544|FG003|Overall Study|Other Protocol Violation|0
7274141|NCT00435825|11488541|FG000|Overall Study|Refused treatment|2
7274142|NCT00435825|11488542|FG001|Overall Study|Refused treatment|0
7274143|NCT00435825|11488543|FG002|Overall Study|Refused treatment|0
7274144|NCT00435825|11488544|FG003|Overall Study|Refused treatment|5
7274145|NCT00435825|11488541|FG000|Overall Study|Failure to return|5
7274146|NCT00435825|11488542|FG001|Overall Study|Failure to return|0
7274147|NCT00435825|11488543|FG002|Overall Study|Failure to return|4
7274148|NCT00435825|11488544|FG003|Overall Study|Failure to return|0
7274149|NCT00435825|11488541|FG000|Overall Study|Did not receive study drug|1
7274150|NCT00435825|11488542|FG001|Overall Study|Did not receive study drug|0
7274151|NCT00435825|11488543|FG002|Overall Study|Did not receive study drug|2
7274152|NCT00435825|11488544|FG003|Overall Study|Did not receive study drug|0
7274153|NCT00435825|11488541|FG000|Overall Study|Did not enter follow-up|0
7274154|NCT00435825|11488542|FG001|Overall Study|Did not enter follow-up|4
7274155|NCT00435825|11488543|FG002|Overall Study|Did not enter follow-up|1
7274156|NCT00435825|11488544|FG003|Overall Study|Did not enter follow-up|3
7274157|NCT00435825|11488541|FG000|Overall Study|Did not complete full follow-up period|6
7274158|NCT00435825|11488542|FG001|Overall Study|Did not complete full follow-up period|6
7274159|NCT00435825|11488543|FG002|Overall Study|Did not complete full follow-up period|4
7274160|NCT00435825|11488544|FG003|Overall Study|Did not complete full follow-up period|5
7274161|NCT00435942|11488565|FG000|Overall Study|Death|17
7274162|NCT00435942|11488566|FG001|Overall Study|Death|10
7274163|NCT00435942|11488565|FG000|Overall Study|Withdrawal by Subject|2
7274164|NCT00435942|11488566|FG001|Overall Study|Withdrawal by Subject|0
7274165|NCT00435942|11488565|FG000|Overall Study|Lost to Follow-up|0
7274166|NCT00435942|11488566|FG001|Overall Study|Lost to Follow-up|16
7274167|NCT00435942|11488565|FG000|Overall Study|Conversion to Open Repair|1
7274168|NCT00435942|11488566|FG001|Overall Study|Conversion to Open Repair|0
7274169|NCT00435942|11488565|FG000|Overall Study|Technical Failure|3
7274170|NCT00435942|11488566|FG001|Overall Study|Technical Failure|0
7274171|NCT00435942|11488565|FG000|Overall Study|Other|0
7274172|NCT00435942|11488566|FG001|Overall Study|Other|1
7274173|NCT00435994|11488575|FG000|Overall Study|Lost to Follow-up|7
7274174|NCT00435994|11488576|FG001|Overall Study|Lost to Follow-up|0
7274175|NCT00435994|11488577|FG002|Overall Study|Lost to Follow-up|0
7274176|NCT00436007|11488589|FG000|Overall Study|Withdrawal by Subject|5
7274177|NCT00436007|11488590|FG001|Overall Study|Withdrawal by Subject|3
7274178|NCT00436007|11488591|FG002|Overall Study|Withdrawal by Subject|4
7274179|NCT00436007|11488589|FG000|Overall Study|Lost to Follow-up|14
7274180|NCT00436007|11488590|FG001|Overall Study|Lost to Follow-up|10
7604418|NCT04152447|12011439|FG001|Overall Study|Lost to Follow-up|0
7604419|NCT04152447|12011438|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1
7604420|NCT04152447|12011439|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1
7604421|NCT04152447|12011438|FG000|Overall Study|Withdrawal by Subject|0
7604422|NCT04152447|12011439|FG001|Overall Study|Withdrawal by Subject|1
7604423|NCT04152447|12011438|FG000|Overall Study|Found ineligible after enrolling|1
7604424|NCT04152447|12011439|FG001|Overall Study|Found ineligible after enrolling|1
7604425|NCT04152447|12011438|FG000|Overall Study|Did not receive VR headset in time.|0
7604426|NCT04152447|12011439|FG001|Overall Study|Did not receive VR headset in time.|2
7604391|NCT04159701|12011425|FG000|Period 1: Treatment Period|Pregnancy|1
7604392|NCT04159701|12011426|FG001|Period 1: Treatment Period|Pregnancy|0
7604393|NCT04159701|12011425|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4
7604394|NCT04159701|12011426|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1
7604395|NCT04159701|12011425|FG000|Period 1: Treatment Period|Withdrawal by Subject|3
7604396|NCT04159701|12011426|FG001|Period 1: Treatment Period|Withdrawal by Subject|0
7604397|NCT04159701|12011425|FG000|Washout Period|site terminated by sponsor|0
7604398|NCT04159701|12011426|FG001|Washout Period|site terminated by sponsor|1
7604399|NCT04159701|12011425|FG000|Washout Period|study terminated by sponsor|10
7604400|NCT04159701|12011426|FG001|Washout Period|study terminated by sponsor|3
7604401|NCT04159701|12011425|FG000|Washout Period|Withdrawal by Subject|1
7604402|NCT04159701|12011426|FG001|Washout Period|Withdrawal by Subject|0
7604403|NCT04159701|12011425|FG000|Washout Period|Inadvertent Enrollment|1
7604404|NCT04159701|12011426|FG001|Washout Period|Inadvertent Enrollment|0
7604405|NCT04159701|12011425|FG000|Washout Period|Miscellaneous|1
7604406|NCT04159701|12011426|FG001|Washout Period|Miscellaneous|0
7604407|NCT04159701|12011425|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0
7604408|NCT04159701|12011426|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2
7604409|NCT04159701|12011425|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0
7604410|NCT04159701|12011426|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1
7604411|NCT04159701|12011425|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6
7604412|NCT04159701|12011426|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3
7604413|NCT04159701|12011425|FG000|Post-treatment Follow-up|Withdrawal by Subject|3
7604414|NCT04159701|12011426|FG001|Post-treatment Follow-up|Withdrawal by Subject|0
7604415|NCT04159701|12011425|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1
7604416|NCT04159701|12011426|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0
7604427|NCT04150107|12011447|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2
7604428|NCT04150107|12011448|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0
7604429|NCT04150107|12011447|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0
7604430|NCT04150107|12011448|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1
7604431|NCT04006847|12011456|FG000|Overall Study|Product issue|1
7604432|NCT03922711|12011463|FG000|Overall Study|Adverse Event|3
7604433|NCT03922711|12011464|FG001|Overall Study|Adverse Event|2
7604434|NCT03922711|12011465|FG002|Overall Study|Adverse Event|2
7604435|NCT03922711|12011463|FG000|Overall Study|Protocol Violation|1
7604436|NCT03922711|12011464|FG001|Overall Study|Protocol Violation|0
7604437|NCT03922711|12011465|FG002|Overall Study|Protocol Violation|0
7604438|NCT03922711|12011463|FG000|Overall Study|Withdrawal by Subject|0
7604439|NCT03922711|12011464|FG001|Overall Study|Withdrawal by Subject|3
7604440|NCT03922711|12011465|FG002|Overall Study|Withdrawal by Subject|1
7604441|NCT03922711|12011463|FG000|Overall Study|Not further specified|0
7604442|NCT03922711|12011464|FG001|Overall Study|Not further specified|0
7604443|NCT03922711|12011465|FG002|Overall Study|Not further specified|1
7604444|NCT04460183|12011474|FG000|Overall Study|Lost to Follow-up|3
7604445|NCT04460183|12011475|FG001|Overall Study|Lost to Follow-up|1
7604446|NCT04460183|12011474|FG000|Overall Study|Withdrawal by Subject|1
7604447|NCT04460183|12011475|FG001|Overall Study|Withdrawal by Subject|0
7274181|NCT00436007|11488591|FG002|Overall Study|Lost to Follow-up|13
7604462|NCT03829332|12011503|FG000|Overall Study|Death|145
7604463|NCT03829332|12011504|FG001|Overall Study|Death|135
7604464|NCT03829332|12011503|FG000|Overall Study|Withdrawal by Subject|10
7604465|NCT03829332|12011504|FG001|Overall Study|Withdrawal by Subject|4
7604466|NCT03829332|12011503|FG000|Overall Study|Ongoing in Study|154
7604467|NCT03829332|12011504|FG001|Overall Study|Ongoing in Study|175
7274182|NCT00436007|11488589|FG000|Overall Study|Physician Decision|0
7274183|NCT00436007|11488590|FG001|Overall Study|Physician Decision|0
7274184|NCT00436007|11488591|FG002|Overall Study|Physician Decision|2
7274185|NCT00436007|11488589|FG000|Overall Study|Death|0
7274186|NCT00436007|11488590|FG001|Overall Study|Death|1
7274187|NCT00436007|11488591|FG002|Overall Study|Death|3
7274188|NCT00436007|11488589|FG000|Overall Study|Other|0
7274189|NCT00436007|11488590|FG001|Overall Study|Other|0
7274190|NCT00436007|11488591|FG002|Overall Study|Other|1
7274191|NCT00436163|11488617|FG000|Overall Study|Lost to Follow-up|2
7274192|NCT00436163|11488617|FG000|Overall Study|Adverse Event|1
7274193|NCT00436215|11488622|FG000|Overall Study|Refused further treatment|3
7274194|NCT00436215|11488622|FG000|Overall Study|Small bowel obstruction|1
7274195|NCT00436280|11488626|FG000|Period 1: Induction|Adverse Event|8
7274196|NCT00436280|11488626|FG000|Period 1: Induction|Progressive Disease|12
7274197|NCT00436280|11488626|FG000|Period 1: Induction|Stable Disease|6
7274198|NCT00436280|11488626|FG000|Period 1: Induction|Withdrawal by Subject|1
7274199|NCT00436280|11488626|FG000|Period 1: Induction|Death|1
7274200|NCT00436280|11488626|FG000|Period 2: Consolidation|Adverse Event|1
7274201|NCT00436280|11488626|FG000|Period 2: Consolidation|Progressive Disease|10
7274202|NCT00436280|11488626|FG000|Period 2: Consolidation|Stable Disease|1
7274203|NCT00436280|11488626|FG000|Period 2: Consolidation|Physician Decision|2
7274204|NCT00436280|11488626|FG000|Period 2: Consolidation|Withdrawal by Subject|2
7274205|NCT00436280|11488626|FG000|Period 2: Consolidation|Death|1
7274206|NCT00436280|11488626|FG000|Period 3: Maintenance|Adverse Event|6
7274207|NCT00436280|11488626|FG000|Period 3: Maintenance|Progressive Disease|12
7274208|NCT00436332|11488630|FG000|Overall Study|Adverse Event|9
7274209|NCT00436332|11488630|FG000|Overall Study|Withdrawal by Subject|2
7274210|NCT00436332|11488630|FG000|Overall Study|Progression|59
7274211|NCT00436332|11488630|FG000|Overall Study|Death|2
7274212|NCT00436332|11488630|FG000|Overall Study|Not Protocol Specified|6
7274213|NCT00436332|11488630|FG000|Overall Study|Ineligible|2
7274214|NCT00436332|11488630|FG000|Overall Study|Never Received Treatment|3
7274215|NCT00436345|11488636|FG000|Overall Study|ICU resident beyond follow-up period|3
7274216|NCT00436345|11488637|FG001|Overall Study|ICU resident beyond follow-up period|0
7274217|NCT00436436|11488644|FG000|Overall Study|Progression|4
7274218|NCT00436436|11488644|FG000|Overall Study|Adverse Event|2
7274219|NCT00436436|11488644|FG000|Overall Study|Death|6
7274220|NCT00436501|11488667|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
7274221|NCT00436501|11488668|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
7274222|NCT00436501|11488667|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
7274223|NCT00436501|11488668|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
7274224|NCT00436553|11488678|FG000|Overall Study|Adverse Event|4
7274225|NCT00436553|11488679|FG001|Overall Study|Adverse Event|3
7274226|NCT00436553|11488680|FG002|Overall Study|Adverse Event|4
7274227|NCT00436553|11488678|FG000|Overall Study|Death|3
7274228|NCT00436553|11488679|FG001|Overall Study|Death|1
7274229|NCT00436553|11488680|FG002|Overall Study|Death|3
7274230|NCT00436553|11488678|FG000|Overall Study|Lost to Follow-up|0
7274231|NCT00436553|11488679|FG001|Overall Study|Lost to Follow-up|2
7274232|NCT00436553|11488680|FG002|Overall Study|Lost to Follow-up|0
7274233|NCT00436553|11488678|FG000|Overall Study|Protocol Violation|1
7274234|NCT00436553|11488679|FG001|Overall Study|Protocol Violation|0
7274235|NCT00436553|11488680|FG002|Overall Study|Protocol Violation|0
7274236|NCT00436553|11488678|FG000|Overall Study|Withdrawal by Subject|5
7274237|NCT00436553|11488679|FG001|Overall Study|Withdrawal by Subject|6
7274238|NCT00436553|11488680|FG002|Overall Study|Withdrawal by Subject|3
7274241|NCT00436605|11488692|FG000|Overall Study|Protocol Violation|3
7274242|NCT00436618|11488699|FG000|Overall Study|Withdrawal by Subject|5
7274243|NCT00436618|11488700|FG001|Overall Study|Withdrawal by Subject|8
7274244|NCT00436618|11488701|FG002|Overall Study|Withdrawal by Subject|11
7274245|NCT00436618|11488699|FG000|Overall Study|Adverse Event|8
7274246|NCT00436618|11488700|FG001|Overall Study|Adverse Event|8
7274247|NCT00436618|11488701|FG002|Overall Study|Adverse Event|9
7274248|NCT00436618|11488699|FG000|Overall Study|Alternate Treatment|3
7274249|NCT00436618|11488700|FG001|Overall Study|Alternate Treatment|4
7274250|NCT00436618|11488701|FG002|Overall Study|Alternate Treatment|12
7604572|NCT03543046|12011562|FG000|Overall Study|Adverse Event|1
7604573|NCT03543046|12011563|FG001|Overall Study|Adverse Event|1
7604574|NCT03543046|12011562|FG000|Overall Study|Physician Decision|1
7604575|NCT03543046|12011563|FG001|Overall Study|Physician Decision|1
7604576|NCT03543046|12011562|FG000|Overall Study|Protocol Violation|1
7604577|NCT03543046|12011563|FG001|Overall Study|Protocol Violation|0
7604587|NCT03063203|12011613|FG000|Overall Study|Chose alternative therapy|3
7604588|NCT03063203|12011613|FG000|Overall Study|Death|2
7604589|NCT03063203|12011613|FG000|Overall Study|Disease progression|4
7604590|NCT03063203|12011613|FG000|Overall Study|Physician Decision|5
7274251|NCT00436618|11488699|FG000|Overall Study|Other Medical Problems|3
7604607|NCT02623205|12011657|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4
7274252|NCT00436618|11488700|FG001|Overall Study|Other Medical Problems|1
7274253|NCT00436618|11488701|FG002|Overall Study|Other Medical Problems|7
7274254|NCT00436618|11488699|FG000|Overall Study|Death|4
7274255|NCT00436618|11488700|FG001|Overall Study|Death|2
7274256|NCT00436618|11488701|FG002|Overall Study|Death|3
7274257|NCT00436618|11488699|FG000|Overall Study|New Primary or Other Reasons|6
7274258|NCT00436618|11488700|FG001|Overall Study|New Primary or Other Reasons|2
7274259|NCT00436618|11488701|FG002|Overall Study|New Primary or Other Reasons|12
7274260|NCT00436618|11488699|FG000|Overall Study|Still on treatment|1
7274261|NCT00436618|11488700|FG001|Overall Study|Still on treatment|2
7274262|NCT00436618|11488701|FG002|Overall Study|Still on treatment|7
7274263|NCT00436644|11488709|FG000|Overall Study|Adverse Event|2
7604608|NCT02623205|12011658|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3
7274264|NCT00436644|11488709|FG000|Overall Study|Death|1
7274265|NCT00436748|11488715|FG000|Overall Study|Ineligibility Determined|1
7274266|NCT00436748|11488716|FG001|Overall Study|Ineligibility Determined|1
7274267|NCT00436748|11488715|FG000|Overall Study|Adverse Event|0
7274268|NCT00436748|11488716|FG001|Overall Study|Adverse Event|2
7274269|NCT00436748|11488715|FG000|Overall Study|Consent Withdrawn|1
7274270|NCT00436748|11488716|FG001|Overall Study|Consent Withdrawn|4
7274271|NCT00436748|11488715|FG000|Overall Study|Administrative Decision|1
7274272|NCT00436748|11488716|FG001|Overall Study|Administrative Decision|0
7274273|NCT00436748|11488715|FG000|Overall Study|Lost to Follow-up|0
7274274|NCT00436748|11488716|FG001|Overall Study|Lost to Follow-up|1
7274275|NCT00436748|11488715|FG000|Overall Study|Protocol-specified Criteria|5
7274276|NCT00436748|11488716|FG001|Overall Study|Protocol-specified Criteria|4
7274277|NCT00436748|11488715|FG000|Overall Study|Other|3
7274278|NCT00436748|11488716|FG001|Overall Study|Other|0
7274279|NCT00436852|11488724|FG000|Overall Study|Death|23
7274280|NCT00436852|11488725|FG001|Overall Study|Death|34
7274281|NCT00436852|11488724|FG000|Overall Study|Lack of Efficacy|9
7274282|NCT00436852|11488725|FG001|Overall Study|Lack of Efficacy|7
7274283|NCT00436852|11488724|FG000|Overall Study|Withdrawal by Subject|2
7274284|NCT00436852|11488725|FG001|Overall Study|Withdrawal by Subject|4
7274285|NCT00436852|11488724|FG000|Overall Study|Ineligible|1
7274286|NCT00436852|11488725|FG001|Overall Study|Ineligible|0
7274287|NCT00436917|11488738|FG000|Overall Study|Withdrawal by Subject|13
7274288|NCT00436917|11488738|FG000|Overall Study|Adverse Event|2
7274289|NCT00436917|11488738|FG000|Overall Study|Physician Decision|1
7274290|NCT00436917|11488738|FG000|Overall Study|Death|1
7274291|NCT00436917|11488738|FG000|Overall Study|Lost to Follow-up|1
7274292|NCT00436917|11488738|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
7274293|NCT00436917|11488738|FG000|Overall Study|Increased creatinine|1
7274294|NCT00436917|11488738|FG000|Overall Study|Personal conflicts of patient|1
7274295|NCT00436956|11488742|FG000|Overall Study|Not evaluable|1
7274296|NCT00436956|11488743|FG001|Overall Study|Not evaluable|0
7274297|NCT00436982|11488761|FG000|Overall Study|Withdrawal by Subject|3
7604647|NCT01560637|12011698|FG000|Overall Study|Adverse Event|63
7604648|NCT01560637|12011698|FG000|Overall Study|Death|69
7604649|NCT01560637|12011698|FG000|Overall Study|Lost to Follow-up|8
7604650|NCT01560637|12011698|FG000|Overall Study|Protocol Violation|8
7604651|NCT01560637|12011698|FG000|Overall Study|Withdrawal by Subject|24
7604652|NCT01560637|12011698|FG000|Overall Study|Progressive Disease|20
7604653|NCT01560637|12011698|FG000|Overall Study|Other Reason Not Specified|6
7604654|NCT00999804|12011704|FG000|Overall Study|Lack of Efficacy|9
7604655|NCT00999804|12011705|FG001|Overall Study|Lack of Efficacy|2
7604656|NCT00999804|12011704|FG000|Overall Study|Adverse Event|4
7604657|NCT00999804|12011705|FG001|Overall Study|Adverse Event|3
7604658|NCT00999804|12011704|FG000|Overall Study|Withdrawal by Subject|4
7604659|NCT00999804|12011705|FG001|Overall Study|Withdrawal by Subject|0
7604660|NCT00999804|12011704|FG000|Overall Study|Death|1
7604661|NCT00999804|12011705|FG001|Overall Study|Death|0
7604662|NCT00999804|12011704|FG000|Overall Study|Ineligible|3
7604663|NCT00999804|12011705|FG001|Overall Study|Ineligible|0
7604664|NCT00458003|12011713|FG000|Overall Study|Non protocol spinal anesthesia|1
7604665|NCT00458003|12011714|FG001|Overall Study|Non protocol spinal anesthesia|1
7274298|NCT00436982|11488762|FG001|Overall Study|Withdrawal by Subject|1
7274299|NCT00436982|11488761|FG000|Overall Study|Did not receive allocated intervention|0
7274300|NCT00436982|11488762|FG001|Overall Study|Did not receive allocated intervention|1
7274301|NCT00436982|11488761|FG000|Overall Study|no RSA data|1
7274302|NCT00436982|11488762|FG001|Overall Study|no RSA data|2
7274303|NCT00437034|11488772|FG000|Overall Study|Adverse Event|1
7274304|NCT00437034|11488772|FG000|Overall Study|Disease progression during treatment|5
7274305|NCT00437073|11488778|FG000|Overall Study|Sponsor Terminated Study|1
7274306|NCT00437073|11488779|FG001|Overall Study|Sponsor Terminated Study|0
7274307|NCT00437073|11488778|FG000|Overall Study|Physician Decision|0
7274308|NCT00437073|11488779|FG001|Overall Study|Physician Decision|1
7274309|NCT00437125|11488785|FG000|Overall Study|Adverse Event|12
7274310|NCT00437125|11488785|FG000|Overall Study|Death|1
7274311|NCT00437125|11488785|FG000|Overall Study|Clinical Relapse|1
7274312|NCT00437125|11488785|FG000|Overall Study|Lack of Efficacy|1
7274313|NCT00437125|11488785|FG000|Overall Study|Lost to Follow-up|1
7274314|NCT00437125|11488785|FG000|Overall Study|Withdrawal by Subject|13
7274315|NCT00437125|11488785|FG000|Overall Study|Withdrawal by Caregiver|2
7604666|NCT03794544|12011756|FG000|Overall Study|Withdrawal by Subject|1
7604667|NCT03794544|12011757|FG001|Overall Study|Withdrawal by Subject|1
7604668|NCT03794544|12011758|FG002|Overall Study|Withdrawal by Subject|0
7604669|NCT03794544|12011759|FG003|Overall Study|Withdrawal by Subject|0
7604670|NCT03794544|12011756|FG000|Overall Study|Death|0
7604671|NCT03794544|12011757|FG001|Overall Study|Death|0
7604672|NCT03794544|12011758|FG002|Overall Study|Death|0
7604673|NCT03794544|12011759|FG003|Overall Study|Death|1
7604674|NCT03794544|12011756|FG000|Overall Study|Lost to Follow-up|0
7604675|NCT03794544|12011757|FG001|Overall Study|Lost to Follow-up|1
7604676|NCT03794544|12011758|FG002|Overall Study|Lost to Follow-up|1
7604677|NCT03794544|12011759|FG003|Overall Study|Lost to Follow-up|0
7604678|NCT03794544|12011756|FG000|Overall Study|Other|0
7604679|NCT03794544|12011757|FG001|Overall Study|Other|1
7604680|NCT03794544|12011758|FG002|Overall Study|Other|0
7274316|NCT00437125|11488785|FG000|Overall Study|Physician Decision|1
7274317|NCT00437203|11488799|FG000|Overall Study|Death|0
7274318|NCT00437203|11488800|FG001|Overall Study|Death|0
7274319|NCT00437203|11488801|FG002|Overall Study|Death|1
7274320|NCT00437203|11488802|FG003|Overall Study|Death|0
7274321|NCT00437203|11488803|FG004|Overall Study|Death|0
7274322|NCT00437203|11488804|FG005|Overall Study|Death|0
7274323|NCT00437203|11488805|FG006|Overall Study|Death|0
7274324|NCT00437203|11488806|FG007|Overall Study|Death|1
7274325|NCT00437203|11488807|FG008|Overall Study|Death|0
7274326|NCT00437203|11488808|FG009|Overall Study|Death|1
7274327|NCT00437203|11488799|FG000|Overall Study|Adverse Event|1
7274328|NCT00437203|11488800|FG001|Overall Study|Adverse Event|1
7274329|NCT00437203|11488801|FG002|Overall Study|Adverse Event|0
7274330|NCT00437203|11488802|FG003|Overall Study|Adverse Event|0
7274331|NCT00437203|11488803|FG004|Overall Study|Adverse Event|0
7274332|NCT00437203|11488804|FG005|Overall Study|Adverse Event|0
7274333|NCT00437203|11488805|FG006|Overall Study|Adverse Event|0
7274334|NCT00437203|11488806|FG007|Overall Study|Adverse Event|1
7274335|NCT00437203|11488807|FG008|Overall Study|Adverse Event|0
7274336|NCT00437203|11488808|FG009|Overall Study|Adverse Event|1
7274337|NCT00437203|11488799|FG000|Overall Study|Study terminated by sponsor|0
7274338|NCT00437203|11488800|FG001|Overall Study|Study terminated by sponsor|0
7274339|NCT00437203|11488801|FG002|Overall Study|Study terminated by sponsor|0
7274340|NCT00437203|11488802|FG003|Overall Study|Study terminated by sponsor|0
7274341|NCT00437203|11488803|FG004|Overall Study|Study terminated by sponsor|0
7274342|NCT00437203|11488804|FG005|Overall Study|Study terminated by sponsor|0
7274343|NCT00437203|11488805|FG006|Overall Study|Study terminated by sponsor|0
7274344|NCT00437203|11488806|FG007|Overall Study|Study terminated by sponsor|0
7274345|NCT00437203|11488807|FG008|Overall Study|Study terminated by sponsor|1
7274346|NCT00437203|11488808|FG009|Overall Study|Study terminated by sponsor|0
7274347|NCT00437203|11488799|FG000|Overall Study|Objective progression or relapse|5
7274348|NCT00437203|11488800|FG001|Overall Study|Objective progression or relapse|6
7274349|NCT00437203|11488801|FG002|Overall Study|Objective progression or relapse|2
7274350|NCT00437203|11488802|FG003|Overall Study|Objective progression or relapse|3
7274351|NCT00437203|11488803|FG004|Overall Study|Objective progression or relapse|3
7274352|NCT00437203|11488804|FG005|Overall Study|Objective progression or relapse|3
7274353|NCT00437203|11488805|FG006|Overall Study|Objective progression or relapse|6
7274354|NCT00437203|11488806|FG007|Overall Study|Objective progression or relapse|1
7274355|NCT00437203|11488807|FG008|Overall Study|Objective progression or relapse|2
7274356|NCT00437203|11488808|FG009|Overall Study|Objective progression or relapse|2
7274357|NCT00437203|11488799|FG000|Overall Study|Other|0
7274358|NCT00437203|11488800|FG001|Overall Study|Other|1
7274359|NCT00437203|11488801|FG002|Overall Study|Other|0
7274360|NCT00437203|11488802|FG003|Overall Study|Other|0
7274361|NCT00437203|11488803|FG004|Overall Study|Other|0
7274362|NCT00437203|11488804|FG005|Overall Study|Other|0
7274363|NCT00437203|11488805|FG006|Overall Study|Other|1
7274364|NCT00437203|11488806|FG007|Overall Study|Other|0
7274365|NCT00437203|11488807|FG008|Overall Study|Other|0
7274366|NCT00437203|11488808|FG009|Overall Study|Other|0
7274367|NCT00437268|11488841|FG000|Overall Study|Adverse Event|1
7274368|NCT00437268|11488842|FG001|Overall Study|Adverse Event|1
7274369|NCT00437268|11488841|FG000|Overall Study|Withdrawal by Subject|2
7274370|NCT00437268|11488842|FG001|Overall Study|Withdrawal by Subject|2
7274371|NCT00437268|11488841|FG000|Overall Study|Progressive disease|9
7274372|NCT00437268|11488842|FG001|Overall Study|Progressive disease|9
7604681|NCT03794544|12011759|FG003|Overall Study|Other|0
7604682|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Adverse Event|3
7604683|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Adverse Event|0
7604684|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Adverse Event|2
7604685|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Adverse Event|4
7604686|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Adverse Event|2
7604687|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Adverse Event|0
7604688|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Adverse Event|1
7604689|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1
7604690|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0
7604691|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1
7274373|NCT00437268|11488841|FG000|Overall Study|Physician Decision|1
7274374|NCT00437268|11488842|FG001|Overall Study|Physician Decision|0
7274375|NCT00437268|11488841|FG000|Overall Study|Death|0
7274376|NCT00437268|11488842|FG001|Overall Study|Death|1
7274377|NCT00437281|11488870|FG000|Overall Study|Adverse Event|0
7274378|NCT00437281|11488871|FG001|Overall Study|Adverse Event|0
7274379|NCT00437281|11488872|FG002|Overall Study|Adverse Event|0
7274380|NCT00437281|11488873|FG003|Overall Study|Adverse Event|1
7274381|NCT00437281|11488874|FG004|Overall Study|Adverse Event|0
7274382|NCT00437281|11488875|FG005|Overall Study|Adverse Event|1
7274383|NCT00437281|11488876|FG006|Overall Study|Adverse Event|0
7274384|NCT00437281|11488877|FG007|Overall Study|Adverse Event|0
7274385|NCT00437281|11488878|FG008|Overall Study|Adverse Event|0
7274386|NCT00437281|11488879|FG009|Overall Study|Adverse Event|1
7274387|NCT00437281|11488880|FG010|Overall Study|Adverse Event|0
7604692|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2
7604693|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1
7604694|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0
7274388|NCT00437281|11488881|FG011|Overall Study|Adverse Event|0
7274389|NCT00437281|11488882|FG012|Overall Study|Adverse Event|0
7274390|NCT00437281|11488883|FG013|Overall Study|Adverse Event|1
7274391|NCT00437281|11488884|FG014|Overall Study|Adverse Event|1
7274392|NCT00437281|11488885|FG015|Overall Study|Adverse Event|0
7274393|NCT00437281|11488886|FG016|Overall Study|Adverse Event|0
7274394|NCT00437281|11488887|FG017|Overall Study|Adverse Event|0
7274395|NCT00437281|11488888|FG018|Overall Study|Adverse Event|1
7274396|NCT00437281|11488889|FG019|Overall Study|Adverse Event|0
7274397|NCT00437281|11488870|FG000|Overall Study|Lost to Follow-up|0
7274398|NCT00437281|11488871|FG001|Overall Study|Lost to Follow-up|0
7274399|NCT00437281|11488872|FG002|Overall Study|Lost to Follow-up|0
7274400|NCT00437281|11488873|FG003|Overall Study|Lost to Follow-up|0
7274401|NCT00437281|11488874|FG004|Overall Study|Lost to Follow-up|0
7274402|NCT00437281|11488875|FG005|Overall Study|Lost to Follow-up|0
7274403|NCT00437281|11488876|FG006|Overall Study|Lost to Follow-up|0
7274404|NCT00437281|11488877|FG007|Overall Study|Lost to Follow-up|0
7274405|NCT00437281|11488878|FG008|Overall Study|Lost to Follow-up|0
7274406|NCT00437281|11488879|FG009|Overall Study|Lost to Follow-up|0
7274407|NCT00437281|11488880|FG010|Overall Study|Lost to Follow-up|0
7274408|NCT00437281|11488881|FG011|Overall Study|Lost to Follow-up|0
7274409|NCT00437281|11488882|FG012|Overall Study|Lost to Follow-up|0
7274410|NCT00437281|11488883|FG013|Overall Study|Lost to Follow-up|0
7274411|NCT00437281|11488884|FG014|Overall Study|Lost to Follow-up|0
7274412|NCT00437281|11488885|FG015|Overall Study|Lost to Follow-up|0
7274413|NCT00437281|11488886|FG016|Overall Study|Lost to Follow-up|0
7274414|NCT00437281|11488887|FG017|Overall Study|Lost to Follow-up|0
7274415|NCT00437281|11488888|FG018|Overall Study|Lost to Follow-up|0
7274416|NCT00437281|11488889|FG019|Overall Study|Lost to Follow-up|1
7274417|NCT00437294|11488963|FG000|Overall Study|Adverse Event|5
7274418|NCT00437294|11488964|FG001|Overall Study|Adverse Event|4
7274419|NCT00437294|11488963|FG000|Overall Study|Death|5
7274420|NCT00437294|11488964|FG001|Overall Study|Death|2
7274421|NCT00437294|11488963|FG000|Overall Study|Physician Decision|0
7274422|NCT00437294|11488964|FG001|Overall Study|Physician Decision|3
7274423|NCT00437294|11488963|FG000|Overall Study|Withdrawal by Subject|5
7274424|NCT00437294|11488964|FG001|Overall Study|Withdrawal by Subject|0
7274425|NCT00437294|11488963|FG000|Overall Study|Progressive Disease|19
7274426|NCT00437294|11488964|FG001|Overall Study|Progressive Disease|23
7274427|NCT00437294|11488963|FG000|Overall Study|Sponsor Decision|8
7274428|NCT00437294|11488964|FG001|Overall Study|Sponsor Decision|9
7274429|NCT00437294|11488963|FG000|Overall Study|Protocol Violation|0
7274430|NCT00437294|11488964|FG001|Overall Study|Protocol Violation|1
7274431|NCT00437294|11488963|FG000|Overall Study|Entry criteria not met|1
7274432|NCT00437294|11488964|FG001|Overall Study|Entry criteria not met|1
7274433|NCT00437489|11488978|FG000|Overall Study|Study terminated by sponsor|23
7274434|NCT00437489|11488979|FG001|Overall Study|Study terminated by sponsor|21
7274435|NCT00437489|11488978|FG000|Overall Study|Lost to Follow-up|0
7274436|NCT00437489|11488979|FG001|Overall Study|Lost to Follow-up|1
7274437|NCT00437645|11488987|FG000|Overall Study|Adverse Event|15
7274438|NCT00437645|11488988|FG001|Overall Study|Adverse Event|84
7274439|NCT00437645|11488987|FG000|Overall Study|Withdrawal by Subject|10
7274440|NCT00437645|11488988|FG001|Overall Study|Withdrawal by Subject|22
7274441|NCT00437645|11488987|FG000|Overall Study|Protocol Violation|3
7274442|NCT00437645|11488988|FG001|Overall Study|Protocol Violation|3
7274443|NCT00437645|11488987|FG000|Overall Study|Lost to Follow-up|2
7604695|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0
7604696|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Physician Decision|0
7604697|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Physician Decision|1
7604698|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Physician Decision|2
7604699|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Physician Decision|5
7604700|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Physician Decision|0
7604701|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Physician Decision|0
7604702|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Physician Decision|1
7604703|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Pregnancy|1
7604704|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Pregnancy|0
7274444|NCT00437645|11488988|FG001|Overall Study|Lost to Follow-up|3
7274445|NCT00437645|11488987|FG000|Overall Study|Administrative problems|2
7274446|NCT00437645|11488988|FG001|Overall Study|Administrative problems|1
7274447|NCT00437645|11488987|FG000|Overall Study|Lack of Efficacy|2
7604705|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Pregnancy|0
7604706|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Pregnancy|0
7604707|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Pregnancy|1
7604708|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Pregnancy|0
7604709|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Pregnancy|1
7604710|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Protocol Violation|1
7604711|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Protocol Violation|1
7274448|NCT00437645|11488988|FG001|Overall Study|Lack of Efficacy|1
7274449|NCT00437645|11488987|FG000|Overall Study|Condition no longer requires study drug|1
7274450|NCT00437645|11488988|FG001|Overall Study|Condition no longer requires study drug|1
7274451|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Adverse Event|4
7274452|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Adverse Event|7
7274453|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Adverse Event|14
7274454|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Non-compliance|1
7274455|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Non-compliance|1
7274456|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Non-compliance|4
7274457|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
7274458|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7274459|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
7274460|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
7274461|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
7274462|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
7274463|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
7274464|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
7274465|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
7274466|NCT00437658|11488997|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
7274467|NCT00437658|11488998|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7274468|NCT00437658|11488999|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7274469|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
7274470|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
7274471|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
7274472|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
7274473|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
7274474|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
7274475|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
7274476|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
7274477|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
7274478|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
7274479|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7274480|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
7274481|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
7274482|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
7274483|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
7274484|NCT00437658|11488997|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
7274485|NCT00437658|11488998|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
7274486|NCT00437658|11488999|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
7274487|NCT00437983|11489009|FG000|Overall Study|Adverse Event|6
7274488|NCT00437983|11489010|FG001|Overall Study|Adverse Event|6
7274489|NCT00437983|11489009|FG000|Overall Study|Protocol Violation|2
7274490|NCT00437983|11489010|FG001|Overall Study|Protocol Violation|1
7274491|NCT00437983|11489009|FG000|Overall Study|Withdrawal by Subject|5
7274492|NCT00437983|11489010|FG001|Overall Study|Withdrawal by Subject|6
7274493|NCT00438256|11489039|FG000|Overall Study|Ineligible for Resection|2
7274494|NCT00438256|11489040|FG001|Overall Study|Ineligible for Resection|1
7274495|NCT00438256|11489041|FG002|Overall Study|Ineligible for Resection|1
7274496|NCT00438256|11489042|FG003|Overall Study|Ineligible for Resection|7
7274497|NCT00438256|11489039|FG000|Overall Study|Excluded final Diagnosis|0
7274498|NCT00438256|11489040|FG001|Overall Study|Excluded final Diagnosis|0
7274499|NCT00438256|11489041|FG002|Overall Study|Excluded final Diagnosis|0
7604712|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Protocol Violation|0
7604713|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Protocol Violation|0
7604714|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Protocol Violation|0
7604715|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Protocol Violation|0
7604716|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Protocol Violation|0
7604717|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604718|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604719|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604720|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4
7604721|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7604722|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1
7604723|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2
7604724|NCT03732807|12011776|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604725|NCT03732807|12011777|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604726|NCT03732807|12011778|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604727|NCT03732807|12011779|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0
7274562|NCT00438672|11489150|FG001|Overall Study|Lost to Follow-up|9
7604728|NCT03732807|12011780|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604729|NCT03732807|12011781|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1
7604730|NCT03732807|12011782|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0
7604731|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604732|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604733|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604734|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1
7604735|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604736|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0
7604737|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2
7604738|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2
7604739|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
7604740|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
7604741|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
7604742|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
7604743|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
7604744|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
7274500|NCT00438256|11489042|FG003|Overall Study|Excluded final Diagnosis|2
7274501|NCT00438360|11489057|FG000|Overall Study|Adverse Event|6
7274502|NCT00438360|11489058|FG001|Overall Study|Adverse Event|1
7274503|NCT00438360|11489057|FG000|Overall Study|Lack of Efficacy|42
7274504|NCT00438360|11489058|FG001|Overall Study|Lack of Efficacy|27
7274505|NCT00438360|11489057|FG000|Overall Study|Other|24
7274506|NCT00438360|11489058|FG001|Overall Study|Other|15
7274507|NCT00438399|11489067|FG000|Overall Study|Lost to Follow-up|2
7274508|NCT00438399|11489068|FG001|Overall Study|Lost to Follow-up|2
7274509|NCT00438399|11489069|FG002|Overall Study|Lost to Follow-up|1
7274510|NCT00438399|11489070|FG003|Overall Study|Lost to Follow-up|1
7274511|NCT00438399|11489071|FG004|Overall Study|Lost to Follow-up|1
7274512|NCT00438399|11489072|FG005|Overall Study|Lost to Follow-up|1
7274513|NCT00438399|11489067|FG000|Overall Study|Adverse Event|0
7274514|NCT00438399|11489068|FG001|Overall Study|Adverse Event|0
7274515|NCT00438399|11489069|FG002|Overall Study|Adverse Event|1
7274516|NCT00438399|11489070|FG003|Overall Study|Adverse Event|1
7274517|NCT00438399|11489071|FG004|Overall Study|Adverse Event|0
7274518|NCT00438399|11489072|FG005|Overall Study|Adverse Event|1
7274519|NCT00438399|11489067|FG000|Overall Study|Withdrawal by Subject|5
7274520|NCT00438399|11489068|FG001|Overall Study|Withdrawal by Subject|6
7274521|NCT00438399|11489069|FG002|Overall Study|Withdrawal by Subject|3
7274522|NCT00438399|11489070|FG003|Overall Study|Withdrawal by Subject|2
7274523|NCT00438399|11489071|FG004|Overall Study|Withdrawal by Subject|2
7274524|NCT00438399|11489072|FG005|Overall Study|Withdrawal by Subject|2
7274525|NCT00438399|11489067|FG000|Overall Study|Protocol Violation|0
7274526|NCT00438399|11489068|FG001|Overall Study|Protocol Violation|0
7604745|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604746|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604747|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
7604748|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
7604749|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
7604750|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
7604751|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
7604752|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604753|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1
7604754|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604755|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604756|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604757|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604758|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
7604759|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7274527|NCT00438399|11489069|FG002|Overall Study|Protocol Violation|1
7274528|NCT00438399|11489070|FG003|Overall Study|Protocol Violation|0
7274529|NCT00438399|11489071|FG004|Overall Study|Protocol Violation|0
7274530|NCT00438399|11489072|FG005|Overall Study|Protocol Violation|1
7274531|NCT00438399|11489067|FG000|Overall Study|Subje stopped study|0
7274532|NCT00438399|11489068|FG001|Overall Study|Subje stopped study|0
7274533|NCT00438399|11489069|FG002|Overall Study|Subje stopped study|1
7274534|NCT00438399|11489070|FG003|Overall Study|Subje stopped study|0
7604760|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604761|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604762|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604763|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1
7604764|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604765|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0
7604766|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3
7604767|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2
7604768|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604769|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604770|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0
7604771|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604772|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
7604773|NCT03732807|12011776|FG000|Treatment Extension (Week 25 up to 48)|Other|1
7604774|NCT03732807|12011777|FG001|Treatment Extension (Week 25 up to 48)|Other|4
7604775|NCT03732807|12011778|FG002|Treatment Extension (Week 25 up to 48)|Other|0
7604776|NCT03732807|12011779|FG003|Treatment Extension (Week 25 up to 48)|Other|2
7604777|NCT03732807|12011780|FG004|Treatment Extension (Week 25 up to 48)|Other|0
7604778|NCT03732807|12011781|FG005|Treatment Extension (Week 25 up to 48)|Other|0
7604779|NCT03732807|12011782|FG006|Treatment Extension (Week 25 up to 48)|Other|0
7274535|NCT00438399|11489071|FG004|Overall Study|Subje stopped study|0
7274536|NCT00438399|11489072|FG005|Overall Study|Subje stopped study|0
7274537|NCT00438399|11489067|FG000|Overall Study|Pregnancy|0
7274538|NCT00438399|11489068|FG001|Overall Study|Pregnancy|0
7274539|NCT00438399|11489069|FG002|Overall Study|Pregnancy|0
7274540|NCT00438399|11489070|FG003|Overall Study|Pregnancy|0
7274541|NCT00438399|11489071|FG004|Overall Study|Pregnancy|0
7274542|NCT00438399|11489072|FG005|Overall Study|Pregnancy|1
7274543|NCT00438399|11489067|FG000|Overall Study|Patien stopped study at visit 4 by error|1
7274544|NCT00438399|11489068|FG001|Overall Study|Patien stopped study at visit 4 by error|0
7274545|NCT00438399|11489069|FG002|Overall Study|Patien stopped study at visit 4 by error|0
7274546|NCT00438399|11489070|FG003|Overall Study|Patien stopped study at visit 4 by error|0
7274547|NCT00438399|11489071|FG004|Overall Study|Patien stopped study at visit 4 by error|0
7274548|NCT00438399|11489072|FG005|Overall Study|Patien stopped study at visit 4 by error|0
7274549|NCT00438464|11489096|FG000|Overall Study|Terminated Early|14
7274550|NCT00438464|11489097|FG001|Overall Study|Terminated Early|5
7274551|NCT00438464|11489096|FG000|Overall Study|Incomplete data submission|0
7274552|NCT00438464|11489097|FG001|Overall Study|Incomplete data submission|2
7274553|NCT00438633|11489130|FG000|Overall Study|Withdrawal by Subject|1
7274554|NCT00438633|11489131|FG001|Overall Study|Withdrawal by Subject|0
7274555|NCT00438633|11489130|FG000|Overall Study|Lost to Follow-up|15
7604780|NCT03731364|12011804|FG000|Overall Study|Adverse Event|0
7604781|NCT03731364|12011805|FG001|Overall Study|Adverse Event|0
7604782|NCT03731364|12011806|FG002|Overall Study|Adverse Event|1
7604783|NCT03731364|12011807|FG003|Overall Study|Adverse Event|2
7604784|NCT03731364|12011808|FG004|Overall Study|Adverse Event|1
7604785|NCT04598152|12011860|FG000|Overall Study|Lost to Follow-up|0
7604786|NCT04598152|12011861|FG001|Overall Study|Lost to Follow-up|1
7604787|NCT04570670|12011895|FG000|Overall Study|Withdrawal by Subject|1
7604788|NCT04570670|12011896|FG001|Overall Study|Withdrawal by Subject|0
7604789|NCT04546581|12011912|FG000|Overall Study|Adverse Event|9
7604790|NCT04546581|12011913|FG001|Overall Study|Adverse Event|3
7604791|NCT04546581|12011912|FG000|Overall Study|Physician Decision|0
7604792|NCT04546581|12011913|FG001|Overall Study|Physician Decision|1
7604793|NCT04546581|12011912|FG000|Overall Study|Protocol Violation|1
7604794|NCT04546581|12011913|FG001|Overall Study|Protocol Violation|2
7604795|NCT04546581|12011912|FG000|Overall Study|Withdrawal by Subject|3
7604796|NCT04546581|12011913|FG001|Overall Study|Withdrawal by Subject|7
7604797|NCT04021290|12011925|FG000|Overall Study|Adverse Event|4
7604798|NCT04021290|12011926|FG001|Overall Study|Adverse Event|3
7604799|NCT04021290|12011925|FG000|Overall Study|Lack of Efficacy|0
7604800|NCT04021290|12011926|FG001|Overall Study|Lack of Efficacy|3
7604801|NCT04021290|12011925|FG000|Overall Study|Lost to Follow-up|2
7604802|NCT04021290|12011926|FG001|Overall Study|Lost to Follow-up|1
7604803|NCT04021290|12011925|FG000|Overall Study|Death|1
7604804|NCT04021290|12011926|FG001|Overall Study|Death|0
7604805|NCT04021290|12011925|FG000|Overall Study|Physician Decision|1
7604806|NCT04021290|12011926|FG001|Overall Study|Physician Decision|2
7604807|NCT04021290|12011925|FG000|Overall Study|Withdrawal by Subject|1
7604808|NCT04021290|12011926|FG001|Overall Study|Withdrawal by Subject|5
7604809|NCT04021290|12011925|FG000|Overall Study|Ongoing|89
7604810|NCT04021290|12011926|FG001|Overall Study|Ongoing|0
7604811|NCT04021290|12011925|FG000|Overall Study|Protocol Deviation|5
7604812|NCT04021290|12011926|FG001|Overall Study|Protocol Deviation|4
7604813|NCT03915626|12011932|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1
7604814|NCT03698279|12011948|FG000|Overall Study|Withdrawal by parent/guardian|1
7604815|NCT03698279|12011949|FG001|Overall Study|Withdrawal by parent/guardian|1
7604816|NCT03698279|12011950|FG002|Overall Study|Withdrawal by parent/guardian|1
7604817|NCT03698279|12011951|FG003|Overall Study|Withdrawal by parent/guardian|1
7604818|NCT03698279|12011952|FG004|Overall Study|Withdrawal by parent/guardian|0
7604819|NCT03698279|12011953|FG005|Overall Study|Withdrawal by parent/guardian|0
7604820|NCT03698279|12011948|FG000|Overall Study|Protocol deviation|1
7604821|NCT03698279|12011949|FG001|Overall Study|Protocol deviation|0
7604822|NCT03698279|12011950|FG002|Overall Study|Protocol deviation|1
7604823|NCT03698279|12011951|FG003|Overall Study|Protocol deviation|0
7274556|NCT00438633|11489131|FG001|Overall Study|Lost to Follow-up|17
7274557|NCT00438659|11489139|FG000|Overall Study|Discontinued Mometasone/Placebo|1
7274558|NCT00438659|11489140|FG001|Overall Study|Discontinued Mometasone/Placebo|2
7274559|NCT00438659|11489139|FG000|Overall Study|Cancel|5
7274560|NCT00438659|11489140|FG001|Overall Study|Cancel|2
7274561|NCT00438672|11489149|FG000|Overall Study|Lost to Follow-up|7
7274563|NCT00438815|11489180|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
7274564|NCT00438815|11489180|FG000|Overall Study|3-month follow-up no longer required|12
7274565|NCT00438815|11489180|FG000|Overall Study|Noncompliance with protocol requirements|9
7274566|NCT00438815|11489180|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
7274567|NCT00438815|11489180|FG000|Overall Study|Lost to Follow-up|6
7274568|NCT00438815|11489180|FG000|Overall Study|Withdrawal by Subject|6
7274569|NCT00438815|11489180|FG000|Overall Study|Death|1
7604824|NCT03698279|12011952|FG004|Overall Study|Protocol deviation|0
7604825|NCT03698279|12011953|FG005|Overall Study|Protocol deviation|0
7604826|NCT03698279|12011948|FG000|Overall Study|Withdrawal by Subject|0
7604827|NCT03698279|12011949|FG001|Overall Study|Withdrawal by Subject|0
7604828|NCT03698279|12011950|FG002|Overall Study|Withdrawal by Subject|1
7274570|NCT00439140|11489222|FG000|Treatment Cycle 1|Lost to Follow-up|1
7274571|NCT00439140|11489223|FG001|Treatment Cycle 1|Lost to Follow-up|1
7274572|NCT00439140|11489224|FG002|Treatment Cycle 1|Lost to Follow-up|1
7604829|NCT03698279|12011951|FG003|Overall Study|Withdrawal by Subject|0
7604830|NCT03698279|12011952|FG004|Overall Study|Withdrawal by Subject|0
7604831|NCT03698279|12011953|FG005|Overall Study|Withdrawal by Subject|0
7604832|NCT03698279|12011948|FG000|Overall Study|Lost to Follow-up|3
7604833|NCT03698279|12011949|FG001|Overall Study|Lost to Follow-up|1
7604834|NCT03698279|12011950|FG002|Overall Study|Lost to Follow-up|4
7604835|NCT03698279|12011951|FG003|Overall Study|Lost to Follow-up|5
7604836|NCT03698279|12011952|FG004|Overall Study|Lost to Follow-up|0
7604837|NCT03698279|12011953|FG005|Overall Study|Lost to Follow-up|0
7604838|NCT03478930|12011983|FG000|Overall Study|Adverse Event|0
7604839|NCT03478930|12011984|FG001|Overall Study|Adverse Event|1
7604840|NCT03478930|12011983|FG000|Overall Study|Lack of Efficacy|3
7604841|NCT03478930|12011984|FG001|Overall Study|Lack of Efficacy|3
7604842|NCT03478930|12011983|FG000|Overall Study|Withdrawal by Subject|6
7604843|NCT03478930|12011984|FG001|Overall Study|Withdrawal by Subject|5
7604844|NCT03434353|12011995|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10
7604845|NCT03434353|12011996|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3
7604846|NCT03434353|12011997|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11
7604847|NCT03434353|12011998|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3
7604848|NCT03434353|12011999|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17
7604849|NCT03434353|12011995|FG000|Overall Study|Withdrew consent|1
7604850|NCT03434353|12011996|FG001|Overall Study|Withdrew consent|0
7604851|NCT03434353|12011997|FG002|Overall Study|Withdrew consent|3
7604852|NCT03434353|12011998|FG003|Overall Study|Withdrew consent|0
7604853|NCT03434353|12011999|FG004|Overall Study|Withdrew consent|0
7604854|NCT03434353|12011995|FG000|Overall Study|Adverse Event|1
7604855|NCT03434353|12011996|FG001|Overall Study|Adverse Event|0
7604856|NCT03434353|12011997|FG002|Overall Study|Adverse Event|0
7604857|NCT03434353|12011998|FG003|Overall Study|Adverse Event|0
7604858|NCT03434353|12011999|FG004|Overall Study|Adverse Event|1
7604859|NCT03434353|12011995|FG000|Overall Study|Lost to Follow-up|2
7604860|NCT03434353|12011996|FG001|Overall Study|Lost to Follow-up|0
7274573|NCT00439140|11489222|FG000|Treatment Cycle 1|Personal reasons|0
7274574|NCT00439140|11489223|FG001|Treatment Cycle 1|Personal reasons|2
7274575|NCT00439140|11489224|FG002|Treatment Cycle 1|Personal reasons|0
7274576|NCT00439140|11489222|FG000|Treatment Cycle 1|Withdrawal by Subject|0
7274577|NCT00439140|11489223|FG001|Treatment Cycle 1|Withdrawal by Subject|1
7274578|NCT00439140|11489224|FG002|Treatment Cycle 1|Withdrawal by Subject|0
7274579|NCT00439140|11489222|FG000|Treatment Cycle 2|Withdrawal by Subject|1
7274580|NCT00439140|11489223|FG001|Treatment Cycle 2|Withdrawal by Subject|0
7274581|NCT00439140|11489224|FG002|Treatment Cycle 2|Withdrawal by Subject|0
7274582|NCT00439140|11489222|FG000|Treatment Cycle 2|Lost to Follow-up|1
7274583|NCT00439140|11489223|FG001|Treatment Cycle 2|Lost to Follow-up|1
7274584|NCT00439140|11489224|FG002|Treatment Cycle 2|Lost to Follow-up|0
7274585|NCT00439179|11489236|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7274586|NCT00439179|11489237|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
7274587|NCT00439179|11489238|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7274588|NCT00439179|11489239|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
7274589|NCT00439218|11489252|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
7274590|NCT00439231|11489256|FG000|Overall Study|Lack of Efficacy|28
7274591|NCT00439244|11489263|FG000|Overall Study|Adverse Event|5
7274592|NCT00439244|11489264|FG001|Overall Study|Adverse Event|2
7274593|NCT00439244|11489265|FG002|Overall Study|Adverse Event|3
7274594|NCT00439244|11489263|FG000|Overall Study|Withdrawal by Subject|3
7274595|NCT00439244|11489264|FG001|Overall Study|Withdrawal by Subject|1
7274596|NCT00439244|11489265|FG002|Overall Study|Withdrawal by Subject|2
7274597|NCT00439244|11489263|FG000|Overall Study|Lost to Follow-up|2
7274598|NCT00439244|11489264|FG001|Overall Study|Lost to Follow-up|1
7274599|NCT00439244|11489265|FG002|Overall Study|Lost to Follow-up|2
7274600|NCT00439244|11489263|FG000|Overall Study|Death|0
7274601|NCT00439244|11489264|FG001|Overall Study|Death|1
7274602|NCT00439244|11489265|FG002|Overall Study|Death|0
7274603|NCT00439244|11489263|FG000|Overall Study|Protocol Violation|0
7274604|NCT00439244|11489264|FG001|Overall Study|Protocol Violation|1
7274605|NCT00439244|11489265|FG002|Overall Study|Protocol Violation|0
7274606|NCT00439244|11489263|FG000|Overall Study|Administrative problems|1
7274607|NCT00439244|11489264|FG001|Overall Study|Administrative problems|0
7274608|NCT00439244|11489265|FG002|Overall Study|Administrative problems|0
7274609|NCT00439270|11489278|FG000|Phase 1 (18.1 Months)|Disease progression|3
7274610|NCT00439270|11489279|FG001|Phase 1 (18.1 Months)|Disease progression|2
7274611|NCT00439270|11489280|FG002|Phase 1 (18.1 Months)|Disease progression|3
7274612|NCT00439270|11489281|FG003|Phase 1 (18.1 Months)|Disease progression|0
7274613|NCT00439270|11489282|FG004|Phase 1 (18.1 Months)|Disease progression|3
7274614|NCT00439270|11489278|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
7274615|NCT00439270|11489279|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
7274616|NCT00439270|11489280|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
7274617|NCT00439270|11489281|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
7274618|NCT00439270|11489282|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
7274619|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Disease progression|0
7604861|NCT03434353|12011997|FG002|Overall Study|Lost to Follow-up|0
7604862|NCT03434353|12011998|FG003|Overall Study|Lost to Follow-up|0
7604863|NCT03434353|12011999|FG004|Overall Study|Lost to Follow-up|0
7604864|NCT03415022|12012013|FG000|Overall Study|Withdrawal by Subject|1
7604865|NCT03415022|12012014|FG001|Overall Study|Withdrawal by Subject|2
7274620|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Disease progression|0
7274621|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Disease progression|0
7274622|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Disease progression|18
7274623|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Disease progression|0
7604866|NCT03415022|12012013|FG000|Overall Study|COVID-19 Suspension|2
7604867|NCT03415022|12012014|FG001|Overall Study|COVID-19 Suspension|3
7604868|NCT03415022|12012013|FG000|Overall Study|Lost to Follow-up|2
7604869|NCT03415022|12012014|FG001|Overall Study|Lost to Follow-up|0
7604870|NCT03283670|12012020|FG000|Placebo Gas|Withdrawal by Subject|2
7604871|NCT03283670|12012020|FG000|25% Nitrous Oxide|Withdrawal by Subject|4
7604872|NCT03283670|12012020|FG000|50% Nitrous Oxide|Withdrawal by Subject|1
7604873|NCT03219567|12012051|FG000|Overall Study|Withdrawal by Subject|0
7604874|NCT03219567|12012052|FG001|Overall Study|Withdrawal by Subject|1
7604875|NCT03153111|12012070|FG000|Overall Study|Death|2
7604876|NCT03153111|12012071|FG001|Overall Study|Death|5
7604877|NCT03153111|12012070|FG000|Overall Study|Lost to Follow-up|1
7604878|NCT03153111|12012071|FG001|Overall Study|Lost to Follow-up|0
7604879|NCT03153111|12012070|FG000|Overall Study|Physician Decision|5
7604880|NCT03153111|12012071|FG001|Overall Study|Physician Decision|1
7604881|NCT03153111|12012070|FG000|Overall Study|Withdrawal by Subject|3
7604882|NCT03153111|12012071|FG001|Overall Study|Withdrawal by Subject|3
7604883|NCT03073733|12012080|FG000|Overall Study|Lost to Follow-up|1
7604884|NCT03073733|12012081|FG001|Overall Study|Lost to Follow-up|0
7604885|NCT03073733|12012082|FG002|Overall Study|Lost to Follow-up|0
7604886|NCT03073733|12012080|FG000|Overall Study|Physician Decision|0
7604887|NCT03073733|12012081|FG001|Overall Study|Physician Decision|1
7604888|NCT03073733|12012082|FG002|Overall Study|Physician Decision|0
7604889|NCT03073733|12012080|FG000|Overall Study|Withdrawal by Subject|0
7604890|NCT03073733|12012081|FG001|Overall Study|Withdrawal by Subject|0
7604891|NCT03073733|12012082|FG002|Overall Study|Withdrawal by Subject|1
7604895|NCT02702414|12012120|FG000|Overall Study|Death|77
7604896|NCT02702414|12012121|FG001|Overall Study|Death|34
7604897|NCT02702414|12012120|FG000|Overall Study|Lost to Follow-up|0
7604898|NCT02702414|12012121|FG001|Overall Study|Lost to Follow-up|1
7604899|NCT02702414|12012120|FG000|Overall Study|Withdrawal by Subject|0
7604900|NCT02702414|12012121|FG001|Overall Study|Withdrawal by Subject|1
7604901|NCT02702414|12012120|FG000|Overall Study|Participants Ongoing in Study|27
7604902|NCT02702414|12012121|FG001|Overall Study|Participants Ongoing in Study|15
7604903|NCT02702414|12012120|FG000|Overall Study|Not Treated|1
7604904|NCT02702414|12012121|FG001|Overall Study|Not Treated|0
7604905|NCT02425904|12012150|FG000|Overall Study|Lost to Follow-up|1
7604906|NCT02425904|12012151|FG001|Overall Study|Lost to Follow-up|0
7604907|NCT02425904|12012150|FG000|Overall Study|Withdrawal by Subject|2
7604908|NCT02425904|12012151|FG001|Overall Study|Withdrawal by Subject|0
7604909|NCT02425904|12012150|FG000|Overall Study|Death|0
7604910|NCT02425904|12012151|FG001|Overall Study|Death|3
7604911|NCT02420795|12012161|FG000|Overall Study|Withdrawal by Subject|1
7604912|NCT02420795|12012162|FG001|Overall Study|Withdrawal by Subject|0
7604913|NCT02420795|12012163|FG002|Overall Study|Withdrawal by Subject|0
7604914|NCT02420795|12012161|FG000|Overall Study|Adverse Event|1
7604915|NCT02420795|12012162|FG001|Overall Study|Adverse Event|0
7604916|NCT02420795|12012163|FG002|Overall Study|Adverse Event|0
7604917|NCT02420795|12012161|FG000|Overall Study|Progressive disease|2
7604918|NCT02420795|12012162|FG001|Overall Study|Progressive disease|2
7604919|NCT02420795|12012163|FG002|Overall Study|Progressive disease|4
7604920|NCT02420795|12012161|FG000|Overall Study|Death|0
7604921|NCT02420795|12012162|FG001|Overall Study|Death|0
7604922|NCT02420795|12012163|FG002|Overall Study|Death|1
7604923|NCT02240485|12012175|FG000|3 Months Post-admission|Lost to Follow-up|1
7604924|NCT02240485|12012176|FG001|3 Months Post-admission|Lost to Follow-up|5
7604925|NCT02240485|12012175|FG000|3 Months Post-admission|Withdrawal by Subject|2
7604926|NCT02240485|12012176|FG001|3 Months Post-admission|Withdrawal by Subject|1
7604927|NCT02240485|12012175|FG000|9 Months Post-admission|Lost to Follow-up|3
7604928|NCT02240485|12012176|FG001|9 Months Post-admission|Lost to Follow-up|1
7604929|NCT02240485|12012175|FG000|9 Months Post-admission|Withdrawal by Subject|0
7604930|NCT02240485|12012176|FG001|9 Months Post-admission|Withdrawal by Subject|3
7604931|NCT02240485|12012175|FG000|18 Months Post-admission|Lost to Follow-up|1
7604932|NCT02240485|12012176|FG001|18 Months Post-admission|Lost to Follow-up|1
7604933|NCT02240485|12012175|FG000|18 Months Post-admission|Withdrawal by Subject|2
7604934|NCT02240485|12012176|FG001|18 Months Post-admission|Withdrawal by Subject|4
7604935|NCT02227147|12012188|FG000|Controlled Treatment Period|Adverse Event|4
7604936|NCT02227147|12012189|FG001|Controlled Treatment Period|Adverse Event|3
7604937|NCT02227147|12012188|FG000|Controlled Treatment Period|Other|2
7604938|NCT02227147|12012189|FG001|Controlled Treatment Period|Other|0
7604939|NCT02227147|12012188|FG000|Follow-up Period|Other|3
7604940|NCT02227147|12012189|FG001|Follow-up Period|Other|5
7604941|NCT02199691|12012203|FG000|Overall Study|Protocol Violation|3
7604942|NCT02199691|12012204|FG001|Overall Study|Protocol Violation|3
7604943|NCT02199691|12012205|FG002|Overall Study|Protocol Violation|6
7604944|NCT02199691|12012206|FG003|Overall Study|Protocol Violation|7
7604945|NCT02199691|12012203|FG000|Overall Study|Withdrawal by Subject|5
7604946|NCT02199691|12012204|FG001|Overall Study|Withdrawal by Subject|3
7274624|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7604947|NCT02199691|12012205|FG002|Overall Study|Withdrawal by Subject|12
7604948|NCT02199691|12012206|FG003|Overall Study|Withdrawal by Subject|13
7604949|NCT02199691|12012203|FG000|Overall Study|Lost to Follow-up|2
7604950|NCT02199691|12012204|FG001|Overall Study|Lost to Follow-up|1
7604951|NCT02199691|12012205|FG002|Overall Study|Lost to Follow-up|9
7604952|NCT02199691|12012206|FG003|Overall Study|Lost to Follow-up|10
7274625|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7274626|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7274627|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
7274628|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
7274629|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
7274630|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
7274631|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
7274632|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
7274633|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
7274634|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7274635|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7274636|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7274637|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
7274638|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
7274639|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
7274640|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
7274641|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
7274642|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
7274643|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
7274644|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7274645|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7274646|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7274647|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
7274648|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
7274649|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7274650|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7274651|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7274652|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
7274653|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
7274654|NCT00439270|11489278|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7274655|NCT00439270|11489279|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7274656|NCT00439270|11489280|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7274657|NCT00439270|11489281|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
7274658|NCT00439270|11489282|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
7274659|NCT00439309|11489312|FG000|Follow-Up|Death|1
7274660|NCT00439309|11489313|FG001|Follow-Up|Death|0
7274661|NCT00439309|11489312|FG000|Follow-Up|Lost to Follow-up|2
7274662|NCT00439309|11489313|FG001|Follow-Up|Lost to Follow-up|0
7274663|NCT00439309|11489312|FG000|Follow-Up|Withdrawal by Subject|0
7274664|NCT00439309|11489313|FG001|Follow-Up|Withdrawal by Subject|1
7274665|NCT00439309|11489312|FG000|Follow-Up|Late response by subject|0
7274666|NCT00439309|11489313|FG001|Follow-Up|Late response by subject|1
7274667|NCT00439517|11489357|FG000|Overall Study|Subject on treatment|1
7274668|NCT00439517|11489358|FG001|Overall Study|Subject on treatment|0
7274669|NCT00439517|11489357|FG000|Overall Study|Subject in survival follow-up|1
7274670|NCT00439517|11489358|FG001|Overall Study|Subject in survival follow-up|0
7274671|NCT00439556|11489367|FG000|Overall Study|Patient was taken off study for non-comp|0
7274672|NCT00439556|11489368|FG001|Overall Study|Patient was taken off study for non-comp|1
7604953|NCT01751984|12012243|FG000|Overall Study|Adverse Event|5
7604954|NCT01751984|12012244|FG001|Overall Study|Adverse Event|3
7604955|NCT01751984|12012243|FG000|Overall Study|Withdrawal by Subject|0
7604956|NCT01751984|12012244|FG001|Overall Study|Withdrawal by Subject|1
7604957|NCT01751984|12012243|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
7604958|NCT01751984|12012244|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
7604959|NCT01732627|12012252|FG000|Overall Study|Withdrawal by Subject|1
7604960|NCT01732627|12012253|FG001|Overall Study|Withdrawal by Subject|0
7604961|NCT01702571|12012261|FG000|Overall Study|Death|1067
7604962|NCT01702571|12012262|FG001|Overall Study|Death|76
7604963|NCT01702571|12012261|FG000|Overall Study|Lost to Follow-up|144
7604964|NCT01702571|12012262|FG001|Overall Study|Lost to Follow-up|10
7604965|NCT01702571|12012261|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
7604966|NCT01702571|12012262|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
7604967|NCT01702571|12012261|FG000|Overall Study|Investigator Decision|5
7604968|NCT01702571|12012262|FG001|Overall Study|Investigator Decision|0
7604969|NCT01702571|12012261|FG000|Overall Study|Not Classifiable|1
7604970|NCT01702571|12012262|FG001|Overall Study|Not Classifiable|0
7604971|NCT01702571|12012261|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
7604972|NCT01702571|12012262|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
7604973|NCT01702571|12012261|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
7604974|NCT01702571|12012262|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
7604975|NCT01702571|12012261|FG000|Overall Study|Progressive Disease|3
7604976|NCT01702571|12012262|FG001|Overall Study|Progressive Disease|0
7604977|NCT01702571|12012261|FG000|Overall Study|Protocol Violation|2
7604978|NCT01702571|12012262|FG001|Overall Study|Protocol Violation|0
7604979|NCT01702571|12012261|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
7604980|NCT01702571|12012262|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
7604981|NCT01702571|12012261|FG000|Overall Study|Termination By Sponsor|4
7604982|NCT01702571|12012262|FG001|Overall Study|Termination By Sponsor|0
7604983|NCT01702571|12012261|FG000|Overall Study|Withdrawal by Subject|177
7604984|NCT01702571|12012262|FG001|Overall Study|Withdrawal by Subject|29
7604985|NCT01578239|12012270|FG000|Treatment Period|Progressive Disease|19
7604986|NCT01578239|12012271|FG001|Treatment Period|Progressive Disease|64
7604987|NCT01578239|12012270|FG000|Treatment Period|Physician Decision|17
7604988|NCT01578239|12012271|FG001|Treatment Period|Physician Decision|17
7604989|NCT01578239|12012270|FG000|Treatment Period|Adverse Event|13
7604990|NCT01578239|12012271|FG001|Treatment Period|Adverse Event|10
7604991|NCT01578239|12012270|FG000|Treatment Period|Non-compliance|2
7604992|NCT01578239|12012271|FG001|Treatment Period|Non-compliance|0
7604993|NCT01578239|12012270|FG000|Treatment Period|Withdrawal by Subject|10
7604994|NCT01578239|12012271|FG001|Treatment Period|Withdrawal by Subject|9
7604995|NCT01578239|12012270|FG000|Treatment Period|Other|6
7604996|NCT01578239|12012271|FG001|Treatment Period|Other|1
7604997|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Death|69
7604998|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Death|64
7604999|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Consent withdrawal|4
7605000|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Consent withdrawal|10
7605001|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
7605002|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
7605003|NCT01578239|12012270|FG000|Long-term Follow-Up Period|Other|2
7605004|NCT01578239|12012271|FG001|Long-term Follow-Up Period|Other|2
7605005|NCT01458340|12012280|FG000|Overall Study|Adverse Event|5
7605006|NCT01458340|12012281|FG001|Overall Study|Adverse Event|4
7605007|NCT01458340|12012282|FG002|Overall Study|Adverse Event|2
7605008|NCT01458340|12012280|FG000|Overall Study|Lost to Follow-up|3
7605009|NCT01458340|12012281|FG001|Overall Study|Lost to Follow-up|3
7605010|NCT01458340|12012282|FG002|Overall Study|Lost to Follow-up|10
7605011|NCT01458340|12012280|FG000|Overall Study|Miscellaneous|0
7605012|NCT01458340|12012281|FG001|Overall Study|Miscellaneous|1
7605013|NCT01458340|12012282|FG002|Overall Study|Miscellaneous|0
7605014|NCT01458340|12012280|FG000|Overall Study|Physician Decision|1
7605015|NCT01458340|12012281|FG001|Overall Study|Physician Decision|1
7605016|NCT01458340|12012282|FG002|Overall Study|Physician Decision|2
7605017|NCT01458340|12012280|FG000|Overall Study|Protocol Violation|6
7605018|NCT01458340|12012281|FG001|Overall Study|Protocol Violation|6
7605019|NCT01458340|12012282|FG002|Overall Study|Protocol Violation|5
7605020|NCT01458340|12012280|FG000|Overall Study|Withdrawal by Subject|12
7605021|NCT01458340|12012281|FG001|Overall Study|Withdrawal by Subject|6
7605022|NCT01458340|12012282|FG002|Overall Study|Withdrawal by Subject|4
7605023|NCT01336634|12012330|FG000|Overall Study|Study closed/terminated|5
7605024|NCT01336634|12012331|FG001|Overall Study|Study closed/terminated|6
7605025|NCT01336634|12012332|FG002|Overall Study|Study closed/terminated|6
7605026|NCT01336634|12012330|FG000|Overall Study|Lost to Follow-up|2
7605027|NCT01336634|12012331|FG001|Overall Study|Lost to Follow-up|1
7605028|NCT01336634|12012332|FG002|Overall Study|Lost to Follow-up|1
7605029|NCT01336634|12012330|FG000|Overall Study|Physician Decision|1
7605030|NCT01336634|12012331|FG001|Overall Study|Physician Decision|1
7605031|NCT01336634|12012332|FG002|Overall Study|Physician Decision|0
7605032|NCT01336634|12012330|FG000|Overall Study|Withdrawal by Subject|6
7605033|NCT01336634|12012331|FG001|Overall Study|Withdrawal by Subject|0
7605034|NCT01336634|12012332|FG002|Overall Study|Withdrawal by Subject|2
7605035|NCT01155375|12012345|FG000|Overall Study|Adverse Event|1
7605036|NCT01155375|12012346|FG001|Overall Study|Adverse Event|0
7605037|NCT00628095|12012359|FG000|Overall Study|Adverse Event|5
7605038|NCT00628095|12012360|FG001|Overall Study|Adverse Event|3
7605039|NCT00628095|12012359|FG000|Overall Study|Lack of Efficacy|0
7605040|NCT00628095|12012360|FG001|Overall Study|Lack of Efficacy|3
7605041|NCT00628095|12012359|FG000|Overall Study|Withdrawal by Subject|2
7605042|NCT00628095|12012360|FG001|Overall Study|Withdrawal by Subject|0
7605043|NCT00628095|12012359|FG000|Overall Study|Other|0
7605044|NCT00628095|12012360|FG001|Overall Study|Other|1
7605045|NCT03945825|12012392|FG000|Overall Study|Enrolled but treatment not administered|0
7605046|NCT03945825|12012393|FG001|Overall Study|Enrolled but treatment not administered|0
7605047|NCT03945825|12012394|FG002|Overall Study|Enrolled but treatment not administered|0
7605048|NCT03945825|12012395|FG003|Overall Study|Enrolled but treatment not administered|0
7605049|NCT03945825|12012396|FG004|Overall Study|Enrolled but treatment not administered|1
7605050|NCT03945825|12012397|FG005|Overall Study|Enrolled but treatment not administered|0
7605051|NCT03945825|12012392|FG000|Overall Study|Lost to Follow-up|1
7605052|NCT03945825|12012393|FG001|Overall Study|Lost to Follow-up|5
7605053|NCT03945825|12012394|FG002|Overall Study|Lost to Follow-up|0
7605054|NCT03945825|12012395|FG003|Overall Study|Lost to Follow-up|1
7605055|NCT03945825|12012396|FG004|Overall Study|Lost to Follow-up|2
7605056|NCT03945825|12012397|FG005|Overall Study|Lost to Follow-up|2
7605057|NCT03945825|12012392|FG000|Overall Study|Withdrawal by Subject|1
7605058|NCT03945825|12012393|FG001|Overall Study|Withdrawal by Subject|0
7605059|NCT03945825|12012394|FG002|Overall Study|Withdrawal by Subject|1
7605060|NCT03945825|12012395|FG003|Overall Study|Withdrawal by Subject|1
7605061|NCT03945825|12012396|FG004|Overall Study|Withdrawal by Subject|0
7605062|NCT03945825|12012397|FG005|Overall Study|Withdrawal by Subject|1
7605063|NCT03562767|12012444|FG000|Overall Study|Physician Decision|2
7605064|NCT03562767|12012445|FG001|Overall Study|Physician Decision|0
7605065|NCT03562767|12012446|FG002|Overall Study|Physician Decision|0
7605066|NCT03562767|12012444|FG000|Overall Study|Logistic Reason|1
7605067|NCT03562767|12012445|FG001|Overall Study|Logistic Reason|3
7605068|NCT03562767|12012446|FG002|Overall Study|Logistic Reason|0
7605069|NCT03559699|12012458|FG000|Overall Study|Withdrawal by Subject|6
7605070|NCT03559699|12012458|FG000|Overall Study|Lost to Follow-up|1
7605071|NCT03305016|12012475|FG000|Overall Study|Withdrawal by Subject|2
7605072|NCT03291067|12012492|FG000|Overall Study|Adverse Event|0
7605073|NCT03291067|12012493|FG001|Overall Study|Adverse Event|2
7274673|NCT00439556|11489369|FG002|Overall Study|Patient was taken off study for non-comp|0
7274674|NCT00439647|11489384|FG000|Overall Study|Withdrawal by Subject|25
7274675|NCT00439647|11489385|FG001|Overall Study|Withdrawal by Subject|22
7274676|NCT00439647|11489384|FG000|Overall Study|Death|15
7274677|NCT00439647|11489385|FG001|Overall Study|Death|18
7274678|NCT00439647|11489384|FG000|Overall Study|Adverse Event|11
7274679|NCT00439647|11489385|FG001|Overall Study|Adverse Event|11
7274680|NCT00439647|11489384|FG000|Overall Study|Lost to Follow-up|4
7274681|NCT00439647|11489385|FG001|Overall Study|Lost to Follow-up|12
7274682|NCT00439647|11489384|FG000|Overall Study|Protocol Violation|3
7274683|NCT00439647|11489385|FG001|Overall Study|Protocol Violation|4
7274684|NCT00439647|11489384|FG000|Overall Study|Lack of Efficacy|0
7274685|NCT00439647|11489385|FG001|Overall Study|Lack of Efficacy|4
7274686|NCT00439725|11489397|FG000|Treatment Period|Withdrawal by Subject|22
7274687|NCT00439725|11489398|FG001|Treatment Period|Withdrawal by Subject|19
7274688|NCT00439725|11489397|FG000|Treatment Period|Study terminated by sponsor|156
7274689|NCT00439725|11489398|FG001|Treatment Period|Study terminated by sponsor|148
7274690|NCT00439725|11489397|FG000|Treatment Period|Site closed by investigator|1
7274691|NCT00439725|11489398|FG001|Treatment Period|Site closed by investigator|2
7274692|NCT00439725|11489397|FG000|Treatment Period|Adverse Event|39
7274693|NCT00439725|11489398|FG001|Treatment Period|Adverse Event|18
7274694|NCT00439725|11489397|FG000|Treatment Period|Physician Decision|1
7274695|NCT00439725|11489398|FG001|Treatment Period|Physician Decision|1
7274696|NCT00439725|11489397|FG000|Treatment Period|Protocol Violation|2
7274697|NCT00439725|11489398|FG001|Treatment Period|Protocol Violation|1
7274698|NCT00439725|11489397|FG000|Treatment Period|Clinical endpoint reached|6
7274699|NCT00439725|11489398|FG001|Treatment Period|Clinical endpoint reached|50
7274700|NCT00439725|11489397|FG000|Treatment Period|Technical problems|1
7274701|NCT00439725|11489398|FG001|Treatment Period|Technical problems|0
7274702|NCT00439725|11489397|FG000|Treatment Period|Lost to Follow-up|1
7274703|NCT00439725|11489398|FG001|Treatment Period|Lost to Follow-up|1
7274704|NCT00439725|11489397|FG000|Treatment Period|Participant convenience|1
7274705|NCT00439725|11489398|FG001|Treatment Period|Participant convenience|0
7274706|NCT00439725|11489397|FG000|Treatment Period|Protocol driven decision point|1
7274707|NCT00439725|11489398|FG001|Treatment Period|Protocol driven decision point|1
7274708|NCT00439725|11489397|FG000|Treatment Period|Death|1
7274709|NCT00439725|11489398|FG001|Treatment Period|Death|1
7274710|NCT00439725|11489397|FG000|Treatment Period|Participant did not receive treatment|4
7274711|NCT00439725|11489398|FG001|Treatment Period|Participant did not receive treatment|4
7274712|NCT00439725|11489397|FG000|Observational Period|Withdrawal by Subject|2
7274713|NCT00439725|11489398|FG001|Observational Period|Withdrawal by Subject|2
7274714|NCT00439725|11489397|FG000|Observational Period|Lost to Follow-up|0
7274715|NCT00439725|11489398|FG001|Observational Period|Lost to Follow-up|1
7274716|NCT00439725|11489397|FG000|Observational Period|Death|0
7274717|NCT00439725|11489398|FG001|Observational Period|Death|2
7274718|NCT00439725|11489397|FG000|Observational Period|Study termination by sponsor|1
7605074|NCT03291067|12012494|FG002|Overall Study|Adverse Event|17
7605075|NCT03291067|12012495|FG003|Overall Study|Adverse Event|3
7605076|NCT03291067|12012492|FG000|Overall Study|Lost to Follow-up|2
7605077|NCT03291067|12012493|FG001|Overall Study|Lost to Follow-up|1
7605078|NCT03291067|12012494|FG002|Overall Study|Lost to Follow-up|0
7605079|NCT03291067|12012495|FG003|Overall Study|Lost to Follow-up|1
7605080|NCT03291067|12012492|FG000|Overall Study|Physician Decision|0
7605081|NCT03291067|12012493|FG001|Overall Study|Physician Decision|0
7605082|NCT03291067|12012494|FG002|Overall Study|Physician Decision|1
7605083|NCT03291067|12012495|FG003|Overall Study|Physician Decision|0
7605084|NCT03291067|12012492|FG000|Overall Study|Protocol Violation|5
7274719|NCT00439725|11489398|FG001|Observational Period|Study termination by sponsor|1
7274720|NCT00439725|11489397|FG000|Observational Period|Clinical endpoint reached|3
7274721|NCT00439725|11489398|FG001|Observational Period|Clinical endpoint reached|1
7274722|NCT00439725|11489397|FG000|Observational Period|Technical problems|1
7274723|NCT00439725|11489398|FG001|Observational Period|Technical problems|0
7274724|NCT00439725|11489397|FG000|Observational Period|Participant convenience|1
7274725|NCT00439725|11489398|FG001|Observational Period|Participant convenience|0
7274726|NCT00439777|11489406|FG000|Treatment Period|Death|29
7274727|NCT00439777|11489407|FG001|Treatment Period|Death|21
7274728|NCT00439777|11489406|FG000|Treatment Period|Study terminated by sponsor|125
7274729|NCT00439777|11489407|FG001|Treatment Period|Study terminated by sponsor|132
7274730|NCT00439777|11489406|FG000|Treatment Period|Site closed by investigator|0
7274731|NCT00439777|11489407|FG001|Treatment Period|Site closed by investigator|1
7274732|NCT00439777|11489406|FG000|Treatment Period|Did not take study treatment|7
7274733|NCT00439777|11489407|FG001|Treatment Period|Did not take study treatment|8
7274734|NCT00439777|11489406|FG000|Treatment Period|Adverse Event|111
7274735|NCT00439777|11489407|FG001|Treatment Period|Adverse Event|92
7274736|NCT00439777|11489406|FG000|Treatment Period|Protocol Violation|23
7274737|NCT00439777|11489407|FG001|Treatment Period|Protocol Violation|30
7274738|NCT00439777|11489406|FG000|Treatment Period|Withdrawal by Subject|66
7274739|NCT00439777|11489407|FG001|Treatment Period|Withdrawal by Subject|118
7274740|NCT00439777|11489406|FG000|Treatment Period|Lack of Efficacy|1
7274741|NCT00439777|11489407|FG001|Treatment Period|Lack of Efficacy|4
7274742|NCT00439777|11489406|FG000|Treatment Period|Lost to Follow-up|8
7274743|NCT00439777|11489407|FG001|Treatment Period|Lost to Follow-up|10
7274744|NCT00439777|11489406|FG000|Treatment Period|Protocol driven decision point|1
7274745|NCT00439777|11489407|FG001|Treatment Period|Protocol driven decision point|3
7274746|NCT00439777|11489406|FG000|Treatment Period|Physician Decision|7
7274747|NCT00439777|11489407|FG001|Treatment Period|Physician Decision|18
7274748|NCT00439777|11489406|FG000|Treatment Period|Clinical endpoint reached|26
7274749|NCT00439777|11489407|FG001|Treatment Period|Clinical endpoint reached|13
7274750|NCT00439777|11489406|FG000|Treatment Period|Technical problems|3
7274751|NCT00439777|11489407|FG001|Treatment Period|Technical problems|1
7274752|NCT00439777|11489406|FG000|Treatment Period|Participant convenience|12
7274753|NCT00439777|11489407|FG001|Treatment Period|Participant convenience|8
7274754|NCT00439777|11489406|FG000|Observational Period|Protocol Violation|0
7274755|NCT00439777|11489407|FG001|Observational Period|Protocol Violation|2
7274756|NCT00439777|11489406|FG000|Observational Period|Withdrawal by Subject|9
7274757|NCT00439777|11489407|FG001|Observational Period|Withdrawal by Subject|5
7274758|NCT00439777|11489406|FG000|Observational Period|Lost to Follow-up|1
7274759|NCT00439777|11489407|FG001|Observational Period|Lost to Follow-up|11
7274760|NCT00439777|11489406|FG000|Observational Period|Death|27
7274761|NCT00439777|11489407|FG001|Observational Period|Death|20
7274762|NCT00439777|11489406|FG000|Observational Period|Study terminated by sponsor|3
7274763|NCT00439777|11489407|FG001|Observational Period|Study terminated by sponsor|1
7274764|NCT00439777|11489406|FG000|Observational Period|Protocol driven decision point|0
7274765|NCT00439777|11489407|FG001|Observational Period|Protocol driven decision point|1
7274766|NCT00439777|11489406|FG000|Observational Period|Lack of Efficacy|1
7274767|NCT00439777|11489407|FG001|Observational Period|Lack of Efficacy|0
7274768|NCT00439777|11489406|FG000|Observational Period|Technical problems|0
7605085|NCT03291067|12012493|FG001|Overall Study|Protocol Violation|3
7605086|NCT03291067|12012494|FG002|Overall Study|Protocol Violation|4
7605087|NCT03291067|12012495|FG003|Overall Study|Protocol Violation|2
7605088|NCT03291067|12012492|FG000|Overall Study|Withdrawal by Subject|3
7605089|NCT03291067|12012493|FG001|Overall Study|Withdrawal by Subject|4
7274769|NCT00439777|11489407|FG001|Observational Period|Technical problems|1
7274770|NCT00440011|11489419|FG000|Overall Study|Adverse Event|2
7274771|NCT00440011|11489420|FG001|Overall Study|Adverse Event|0
7274772|NCT00440011|11489419|FG000|Overall Study|Lost to Follow-up|0
7274773|NCT00440011|11489420|FG001|Overall Study|Lost to Follow-up|2
7274774|NCT00440011|11489419|FG000|Overall Study|Protocol Violation|1
7274775|NCT00440011|11489420|FG001|Overall Study|Protocol Violation|1
7274776|NCT00440011|11489419|FG000|Overall Study|Withdrawal by Subject|1
7274777|NCT00440011|11489420|FG001|Overall Study|Withdrawal by Subject|0
7274778|NCT00440037|11489426|FG000|Overall Study|Withdrawal by Subject|6
7274779|NCT00440037|11489426|FG000|Overall Study|Administrative decision|3
7274780|NCT00440115|11489442|FG000|Overall Study|Death|7
7274781|NCT00440115|11489443|FG001|Overall Study|Death|9
7274782|NCT00440115|11489444|FG002|Overall Study|Death|5
7274783|NCT00440115|11489442|FG000|Overall Study|Incarceration|0
7274784|NCT00440115|11489443|FG001|Overall Study|Incarceration|2
7274785|NCT00440115|11489444|FG002|Overall Study|Incarceration|1
7274786|NCT00440193|11489463|FG000|Treatment Period|Adverse Event|74
7274787|NCT00440193|11489464|FG001|Treatment Period|Adverse Event|67
7274788|NCT00440193|11489463|FG000|Treatment Period|Death|19
7274789|NCT00440193|11489464|FG001|Treatment Period|Death|22
7274790|NCT00440193|11489463|FG000|Treatment Period|Lack of Efficacy|0
7274791|NCT00440193|11489464|FG001|Treatment Period|Lack of Efficacy|1
7274792|NCT00440193|11489463|FG000|Treatment Period|Lost to Follow-up|12
7274793|NCT00440193|11489464|FG001|Treatment Period|Lost to Follow-up|18
7274794|NCT00440193|11489463|FG000|Treatment Period|Physician Decision|3
7605090|NCT03291067|12012494|FG002|Overall Study|Withdrawal by Subject|7
7605091|NCT03291067|12012495|FG003|Overall Study|Withdrawal by Subject|5
7605092|NCT03291067|12012492|FG000|Overall Study|Other|0
7605093|NCT03291067|12012493|FG001|Overall Study|Other|4
7605094|NCT03291067|12012494|FG002|Overall Study|Other|4
7605095|NCT03291067|12012495|FG003|Overall Study|Other|6
7605096|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Death|8
7605097|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Death|8
7605098|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Death|0
7605099|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Death|0
7605100|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
7605101|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605102|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605103|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
7605104|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605105|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
7605106|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605107|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
7605108|NCT03271047|12012509|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
7605109|NCT03271047|12012510|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
7605110|NCT03271047|12012511|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
7605111|NCT03271047|12012512|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
7605112|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Other|0
7605113|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Other|0
7605114|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Other|0
7605115|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Other|1
7605116|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Death|0
7274795|NCT00440193|11489464|FG001|Treatment Period|Physician Decision|6
7274796|NCT00440193|11489463|FG000|Treatment Period|Protocol Violation|16
7274797|NCT00440193|11489464|FG001|Treatment Period|Protocol Violation|19
7274798|NCT00440193|11489463|FG000|Treatment Period|Withdrawal by Subject|36
7274799|NCT00440193|11489464|FG001|Treatment Period|Withdrawal by Subject|77
7274800|NCT00440193|11489463|FG000|Treatment Period|Clinical endpoint reached|28
7274801|NCT00440193|11489464|FG001|Treatment Period|Clinical endpoint reached|25
7605117|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Death|0
7605118|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Death|20
7605119|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Death|21
7605120|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
7605121|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
7605122|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
7605123|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
7605124|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
7605125|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
7605126|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
7605127|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
7605128|NCT03271047|12012509|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605129|NCT03271047|12012510|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605130|NCT03271047|12012511|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
7605131|NCT03271047|12012512|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
7605132|NCT03257436|12012524|FG000|Overall Study|Withdrawal by Subject|76
7605133|NCT03257436|12012524|FG000|Overall Study|Death|19
7605134|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
7605135|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
7605136|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
7605137|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
7605138|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7605139|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
7274802|NCT00440193|11489463|FG000|Treatment Period|Study terminated by sponsor|102
7274803|NCT00440193|11489464|FG001|Treatment Period|Study terminated by sponsor|94
7274804|NCT00440193|11489463|FG000|Treatment Period|Protocol driven decision point|2
7274805|NCT00440193|11489464|FG001|Treatment Period|Protocol driven decision point|2
7274806|NCT00440193|11489463|FG000|Treatment Period|Switch to commercial drug|0
7274807|NCT00440193|11489464|FG001|Treatment Period|Switch to commercial drug|2
7274808|NCT00440193|11489463|FG000|Treatment Period|Technical problems|1
7274809|NCT00440193|11489464|FG001|Treatment Period|Technical problems|1
7274810|NCT00440193|11489463|FG000|Treatment Period|Participant convenience|5
7274811|NCT00440193|11489464|FG001|Treatment Period|Participant convenience|2
7274812|NCT00440193|11489463|FG000|Treatment Period|Participant did not receive treatment|7
7274813|NCT00440193|11489464|FG001|Treatment Period|Participant did not receive treatment|13
7274814|NCT00440193|11489463|FG000|Treatment Period|Site closed by investigator|0
7274815|NCT00440193|11489464|FG001|Treatment Period|Site closed by investigator|2
7274816|NCT00440193|11489463|FG000|Observational Period|Adverse Event|2
7274817|NCT00440193|11489464|FG001|Observational Period|Adverse Event|2
7274818|NCT00440193|11489463|FG000|Observational Period|Death|15
7274819|NCT00440193|11489464|FG001|Observational Period|Death|20
7274820|NCT00440193|11489463|FG000|Observational Period|Lost to Follow-up|12
7274821|NCT00440193|11489464|FG001|Observational Period|Lost to Follow-up|8
7274822|NCT00440193|11489463|FG000|Observational Period|Protocol Violation|1
7274823|NCT00440193|11489464|FG001|Observational Period|Protocol Violation|0
7274824|NCT00440193|11489463|FG000|Observational Period|Withdrawal by Subject|11
7274825|NCT00440193|11489464|FG001|Observational Period|Withdrawal by Subject|8
7274826|NCT00440193|11489463|FG000|Observational Period|Physician Decision|1
7274827|NCT00440193|11489464|FG001|Observational Period|Physician Decision|0
7274828|NCT00440193|11489463|FG000|Observational Period|Clinical endpoint reached|1
7274829|NCT00440193|11489464|FG001|Observational Period|Clinical endpoint reached|0
7274830|NCT00440193|11489463|FG000|Observational Period|Participant convenience|2
7605140|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7605141|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
7605142|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
7605143|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7605144|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
7605145|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
7605146|NCT03158285|12012541|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
7605147|NCT03158285|12012542|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
7605148|NCT03158285|12012543|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
7605149|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
7605150|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
7605151|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
7605152|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
7605153|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
7605154|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
7605155|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7605156|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
7605157|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
7605158|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
7605159|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
7605160|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
7605161|NCT03158285|12012541|FG000|Active Treatment Period: Week 24 - 52|Other|1
7605162|NCT03158285|12012542|FG001|Active Treatment Period: Week 24 - 52|Other|1
7605163|NCT03158285|12012543|FG002|Active Treatment Period: Week 24 - 52|Other|0
7605164|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
7605165|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
7274831|NCT00440193|11489464|FG001|Observational Period|Participant convenience|0
7274832|NCT00440232|11489472|FG000|Overall Study|Lost to Follow-up|1
7605166|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
7605167|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
7605168|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
7605169|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
7605170|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
7605171|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
7274833|NCT00440232|11489473|FG001|Overall Study|Lost to Follow-up|1
7274834|NCT00440232|11489472|FG000|Overall Study|Unable to treat within allowed time|0
7274835|NCT00440232|11489473|FG001|Overall Study|Unable to treat within allowed time|1
7274836|NCT00440232|11489472|FG000|Overall Study|Onset of headache within 4 hours of fast|2
7274837|NCT00440232|11489473|FG001|Overall Study|Onset of headache within 4 hours of fast|2
7274838|NCT00440297|11489481|FG000|Overall Study|Adverse Event|8
7274839|NCT00440297|11489482|FG001|Overall Study|Adverse Event|5
7274840|NCT00440297|11489481|FG000|Overall Study|Lost to Follow-up|1
7274841|NCT00440297|11489482|FG001|Overall Study|Lost to Follow-up|0
7274842|NCT00440297|11489481|FG000|Overall Study|Physician Decision|1
7274843|NCT00440297|11489482|FG001|Overall Study|Physician Decision|0
7274844|NCT00440297|11489481|FG000|Overall Study|Protocol Violation|11
7274845|NCT00440297|11489482|FG001|Overall Study|Protocol Violation|7
7274846|NCT00440297|11489481|FG000|Overall Study|Withdrawal by Subject|1
7274847|NCT00440297|11489482|FG001|Overall Study|Withdrawal by Subject|6
7274848|NCT00440297|11489481|FG000|Overall Study|Randomized by mistake|1
7274849|NCT00440297|11489482|FG001|Overall Study|Randomized by mistake|0
7274850|NCT00440310|11489490|FG000|Overall Study|Lost to Follow-up|4
7274851|NCT00440310|11489491|FG001|Overall Study|Lost to Follow-up|5
7274852|NCT00440310|11489490|FG000|Overall Study|Protocol Violation|0
7274853|NCT00440310|11489491|FG001|Overall Study|Protocol Violation|1
7274854|NCT00440310|11489490|FG000|Overall Study|Withdrawal by Subject|15
7274855|NCT00440310|11489491|FG001|Overall Study|Withdrawal by Subject|14
7274856|NCT00440310|11489490|FG000|Overall Study|No Reply at EOS|7
7274857|NCT00440310|11489491|FG001|Overall Study|No Reply at EOS|7
7274858|NCT00440310|11489490|FG000|Overall Study|Other|1
7274859|NCT00440310|11489491|FG001|Overall Study|Other|0
7274860|NCT00440310|11489490|FG000|Overall Study|Status Unknown|1
7274861|NCT00440310|11489491|FG001|Overall Study|Status Unknown|3
7274862|NCT00440401|11489499|FG000|Overall Study|Adverse Event|2
7274863|NCT00440401|11489500|FG001|Overall Study|Adverse Event|1
7274864|NCT00440401|11489499|FG000|Overall Study|Other|2
7274865|NCT00440401|11489500|FG001|Overall Study|Other|5
7274866|NCT00440466|11489509|FG000|Overall Study|Death|3
7605172|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
7605173|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
7274867|NCT00440466|11489510|FG001|Overall Study|Death|2
7274868|NCT00440466|11489511|FG002|Overall Study|Death|9
7274869|NCT00440466|11489509|FG000|Overall Study|Adverse Event|3
7274870|NCT00440466|11489510|FG001|Overall Study|Adverse Event|4
7274871|NCT00440466|11489511|FG002|Overall Study|Adverse Event|11
7274872|NCT00440466|11489509|FG000|Overall Study|Lost to Follow-up|1
7274873|NCT00440466|11489510|FG001|Overall Study|Lost to Follow-up|0
7274874|NCT00440466|11489511|FG002|Overall Study|Lost to Follow-up|2
7274875|NCT00440466|11489509|FG000|Overall Study|Physician Decision|2
7274876|NCT00440466|11489510|FG001|Overall Study|Physician Decision|0
7605174|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
7605175|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
7605176|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Death|1
7605177|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Death|0
7605178|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Death|0
7605179|NCT03158285|12012541|FG000|Active Treatment Period: Week 52-100|Other|4
7605180|NCT03158285|12012542|FG001|Active Treatment Period: Week 52-100|Other|1
7605181|NCT03158285|12012543|FG002|Active Treatment Period: Week 52-100|Other|0
7605182|NCT04723173|12012556|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1
7605183|NCT03683823|12012600|FG000|Post-treatment Assessment|Withdrawal by Subject|1
7605184|NCT03683823|12012601|FG001|Post-treatment Assessment|Withdrawal by Subject|1
7605185|NCT03683823|12012600|FG000|Post-treatment Assessment|Lost to Follow-up|0
7605186|NCT03683823|12012601|FG001|Post-treatment Assessment|Lost to Follow-up|1
7605187|NCT03683823|12012600|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1
7605188|NCT03683823|12012601|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1
7605189|NCT03515551|12012627|FG000|Overall Study|Death|4
7605190|NCT03515551|12012628|FG001|Overall Study|Death|1
7605191|NCT03515551|12012629|FG002|Overall Study|Death|2
7605192|NCT03515551|12012630|FG003|Overall Study|Death|2
7605193|NCT03515551|12012631|FG004|Overall Study|Death|2
7605194|NCT03515551|12012632|FG005|Overall Study|Death|4
7605195|NCT03515551|12012633|FG006|Overall Study|Death|1
7605196|NCT03515551|12012627|FG000|Overall Study|Lost to Follow-up|0
7605197|NCT03515551|12012628|FG001|Overall Study|Lost to Follow-up|0
7605198|NCT03515551|12012629|FG002|Overall Study|Lost to Follow-up|1
7605199|NCT03515551|12012630|FG003|Overall Study|Lost to Follow-up|0
7605200|NCT03515551|12012631|FG004|Overall Study|Lost to Follow-up|0
7605201|NCT03515551|12012632|FG005|Overall Study|Lost to Follow-up|0
7605202|NCT03515551|12012633|FG006|Overall Study|Lost to Follow-up|0
7605203|NCT03515551|12012627|FG000|Overall Study|Withdrawal by Subject|0
7605204|NCT03515551|12012628|FG001|Overall Study|Withdrawal by Subject|1
7605205|NCT03515551|12012629|FG002|Overall Study|Withdrawal by Subject|0
7605206|NCT03515551|12012630|FG003|Overall Study|Withdrawal by Subject|0
7605207|NCT03515551|12012631|FG004|Overall Study|Withdrawal by Subject|0
7605208|NCT03515551|12012632|FG005|Overall Study|Withdrawal by Subject|0
7605209|NCT03515551|12012633|FG006|Overall Study|Withdrawal by Subject|1
7605210|NCT03515551|12012627|FG000|Overall Study|Study ended by sponsor|0
7605211|NCT03515551|12012628|FG001|Overall Study|Study ended by sponsor|0
7605212|NCT03515551|12012629|FG002|Overall Study|Study ended by sponsor|2
7605213|NCT03515551|12012630|FG003|Overall Study|Study ended by sponsor|1
7605214|NCT03515551|12012631|FG004|Overall Study|Study ended by sponsor|3
7605215|NCT03515551|12012632|FG005|Overall Study|Study ended by sponsor|0
7605216|NCT03515551|12012633|FG006|Overall Study|Study ended by sponsor|3
7605217|NCT03515551|12012627|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605218|NCT03515551|12012628|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1
7605219|NCT03515551|12012629|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605220|NCT03515551|12012630|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605221|NCT03515551|12012631|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605222|NCT03515551|12012632|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605223|NCT03515551|12012633|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
7605224|NCT03385265|12012658|FG000|Overall Study|Withdrawal by Subject|5
7605225|NCT03385265|12012659|FG001|Overall Study|Withdrawal by Subject|2
7605226|NCT03385265|12012660|FG002|Overall Study|Withdrawal by Subject|5
7605227|NCT03385265|12012661|FG003|Overall Study|Withdrawal by Subject|2
7605228|NCT02919306|12012714|FG000|Overall Study|Withdrawal by Subject|1
7605229|NCT02919306|12012715|FG001|Overall Study|Withdrawal by Subject|0
7605230|NCT02919306|12012714|FG000|Overall Study|Protocol Violation|1
7605231|NCT02919306|12012715|FG001|Overall Study|Protocol Violation|0
7605232|NCT02763189|12012723|FG000|Overall Study|Device failure|0
7605233|NCT02763189|12012724|FG001|Overall Study|Device failure|2
7605234|NCT02659514|12012741|FG000|Overall Study|Adverse Event|3
7605235|NCT02659514|12012742|FG001|Overall Study|Adverse Event|12
7605236|NCT02659514|12012741|FG000|Overall Study|Disease Progression|23
7605237|NCT02659514|12012742|FG001|Overall Study|Disease Progression|13
7605238|NCT02659514|12012741|FG000|Overall Study|Withdrawal by Subject|0
7605239|NCT02659514|12012742|FG001|Overall Study|Withdrawal by Subject|4
7605240|NCT02659514|12012741|FG000|Overall Study|Lost to Follow-up|0
7605241|NCT02659514|12012742|FG001|Overall Study|Lost to Follow-up|1
7605242|NCT02659514|12012741|FG000|Overall Study|Death|6
7605243|NCT02659514|12012742|FG001|Overall Study|Death|1
7605244|NCT02659514|12012741|FG000|Overall Study|Reason Unspecified|0
7605245|NCT02659514|12012742|FG001|Overall Study|Reason Unspecified|3
7605254|NCT01673867|12012790|FG000|Randomization|AE unrelated to study drug|1
7605255|NCT01673867|12012791|FG001|Randomization|AE unrelated to study drug|0
7605256|NCT01673867|12012790|FG000|Randomization|Requested treatment discontinuation|0
7605257|NCT01673867|12012791|FG001|Randomization|Requested treatment discontinuation|4
7605258|NCT01673867|12012790|FG000|Randomization|Withdrawal by Subject|0
7605259|NCT01673867|12012791|FG001|Randomization|Withdrawal by Subject|12
7605260|NCT01673867|12012790|FG000|Randomization|Lost to Follow-up|0
7605261|NCT01673867|12012791|FG001|Randomization|Lost to Follow-up|1
7605262|NCT01673867|12012790|FG000|Randomization|No longer meets criteria|4
7605263|NCT01673867|12012791|FG001|Randomization|No longer meets criteria|5
7605264|NCT01673867|12012790|FG000|Treatment|Disease Progression|194
7605265|NCT01673867|12012791|FG001|Treatment|Disease Progression|179
7605266|NCT01673867|12012790|FG000|Treatment|Study Drug Toxicity|17
7605267|NCT01673867|12012791|FG001|Treatment|Study Drug Toxicity|42
7605268|NCT01673867|12012790|FG000|Treatment|Death|1
7605269|NCT01673867|12012791|FG001|Treatment|Death|1
7605270|NCT01673867|12012790|FG000|Treatment|AE unrelated to study drug|19
7605271|NCT01673867|12012791|FG001|Treatment|AE unrelated to study drug|11
7605272|NCT01673867|12012790|FG000|Treatment|Requested treatment discontinuation|5
7605273|NCT01673867|12012791|FG001|Treatment|Requested treatment discontinuation|16
7605274|NCT01673867|12012790|FG000|Treatment|Withdrawal by Subject|4
7605275|NCT01673867|12012791|FG001|Treatment|Withdrawal by Subject|6
7605276|NCT01673867|12012790|FG000|Treatment|Maximum clinical benefit|0
7605277|NCT01673867|12012791|FG001|Treatment|Maximum clinical benefit|10
7605278|NCT01673867|12012790|FG000|Treatment|No longer meets criteria|2
7605279|NCT01673867|12012791|FG001|Treatment|No longer meets criteria|0
7605280|NCT01673867|12012790|FG000|Treatment|Required steroid therapy|1
7605281|NCT01673867|12012791|FG001|Treatment|Required steroid therapy|0
7605282|NCT01673867|12012790|FG000|Treatment|Health status not improved|1
7605283|NCT01673867|12012791|FG001|Treatment|Health status not improved|0
7605284|NCT01673867|12012790|FG000|Treatment|Required prolonged hospitalization|0
7605285|NCT01673867|12012791|FG001|Treatment|Required prolonged hospitalization|1
7605286|NCT01673867|12012790|FG000|Treatment|Symptomatic deterioration|0
7605287|NCT01673867|12012791|FG001|Treatment|Symptomatic deterioration|1
7274877|NCT00440466|11489511|FG002|Overall Study|Physician Decision|1
7605288|NCT01673867|12012790|FG000|Treatment|Physician Decision|0
7605289|NCT01673867|12012791|FG001|Treatment|Physician Decision|1
7605290|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
7605291|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
7605292|NCT00335777|12012801|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
7605293|NCT00335777|12012801|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
7274878|NCT00440466|11489509|FG000|Overall Study|Protocol Violation|2
7274879|NCT00440466|11489510|FG001|Overall Study|Protocol Violation|0
7274880|NCT00440466|11489511|FG002|Overall Study|Protocol Violation|4
7274881|NCT00440466|11489509|FG000|Overall Study|Withdrawal by Subject|2
7274882|NCT00440466|11489510|FG001|Overall Study|Withdrawal by Subject|5
7274883|NCT00440466|11489511|FG002|Overall Study|Withdrawal by Subject|9
7274884|NCT00440466|11489509|FG000|Overall Study|Began Dialysis|0
7274885|NCT00440466|11489510|FG001|Overall Study|Began Dialysis|0
7274886|NCT00440466|11489511|FG002|Overall Study|Began Dialysis|1
7274887|NCT00440466|11489509|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
7274888|NCT00440466|11489510|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7274889|NCT00440466|11489511|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
7274890|NCT00440518|11489535|FG000|Randomized /Titration Period|Lack of Efficacy|1
7274891|NCT00440518|11489536|FG001|Randomized /Titration Period|Lack of Efficacy|0
7274892|NCT00440518|11489537|FG002|Randomized /Titration Period|Lack of Efficacy|1
7274893|NCT00440518|11489535|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
7274894|NCT00440518|11489536|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
7274895|NCT00440518|11489537|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
7274896|NCT00440518|11489535|FG000|Randomized /Titration Period|Protocol Deviation|1
7274897|NCT00440518|11489536|FG001|Randomized /Titration Period|Protocol Deviation|0
7274898|NCT00440518|11489537|FG002|Randomized /Titration Period|Protocol Deviation|0
7605294|NCT00335777|12012801|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12
7605295|NCT00159588|12012809|FG000|5 Month Follow-up|Withdrawal by Subject|2
7605296|NCT00159588|12012810|FG001|5 Month Follow-up|Withdrawal by Subject|4
7605297|NCT00159588|12012811|FG002|5 Month Follow-up|Withdrawal by Subject|2
7605298|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
7605299|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605300|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
7605301|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605302|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605303|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605304|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
7605305|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605306|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
7605307|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605308|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605309|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605310|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605311|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
7605312|NCT03051217|12012825|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605313|NCT03051217|12012826|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605314|NCT03051217|12012827|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
7605315|NCT03051217|12012828|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605316|NCT03051217|12012829|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605317|NCT03051217|12012830|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605318|NCT03051217|12012831|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
7605319|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605320|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605321|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
7605322|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605323|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
7605324|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605325|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
7605326|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605327|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605328|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605329|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
7605330|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605331|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605332|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
7605333|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605334|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605335|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605336|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
7605337|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605338|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605339|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
7605340|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605341|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605342|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605343|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605344|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
7605345|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605346|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
7605347|NCT03051217|12012825|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605348|NCT03051217|12012826|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605349|NCT03051217|12012827|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605350|NCT03051217|12012828|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605351|NCT03051217|12012829|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605352|NCT03051217|12012830|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
7605353|NCT03051217|12012831|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
7605360|NCT02889809|12012884|FG000|Overall Study|Withdrawal by Subject|30
7605361|NCT02889809|12012885|FG001|Overall Study|Withdrawal by Subject|21
7605362|NCT02889809|12012884|FG000|Overall Study|Lost to Follow-up|1
7605363|NCT02889809|12012885|FG001|Overall Study|Lost to Follow-up|1
7605364|NCT02889809|12012884|FG000|Overall Study|Site Closed|12
7605365|NCT02889809|12012885|FG001|Overall Study|Site Closed|11
7274899|NCT00440518|11489535|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
7274900|NCT00440518|11489536|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
7274901|NCT00440518|11489537|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
7274902|NCT00440518|11489535|FG000|Randomized /Titration Period|Other|1
7274903|NCT00440518|11489536|FG001|Randomized /Titration Period|Other|0
7274904|NCT00440518|11489537|FG002|Randomized /Titration Period|Other|0
7274905|NCT00440518|11489535|FG000|Randomized /Titration Period|Lost to Follow-up|2
7274906|NCT00440518|11489536|FG001|Randomized /Titration Period|Lost to Follow-up|2
7274907|NCT00440518|11489537|FG002|Randomized /Titration Period|Lost to Follow-up|1
7274908|NCT00440518|11489535|FG000|Randomized /Titration Period|Adverse Event|2
7274909|NCT00440518|11489536|FG001|Randomized /Titration Period|Adverse Event|3
7274910|NCT00440518|11489537|FG002|Randomized /Titration Period|Adverse Event|0
7274911|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
7274912|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
7274913|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
7274914|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
7274915|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7274916|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
7274917|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
7274918|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
7274919|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
7274920|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
7274921|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
7274922|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
7274923|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Other|0
7274924|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Other|0
7274925|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Other|2
7274926|NCT00440518|11489535|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
7274927|NCT00440518|11489536|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
7274928|NCT00440518|11489537|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
7274929|NCT00440557|11489548|FG000|Overall Study|Withdrawal by Subject|10
7605366|NCT02849587|12012894|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
7605367|NCT02849587|12012895|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
7605368|NCT02849587|12012896|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
7605369|NCT02849587|12012894|FG000|Overall Study|Withdrawal by Subject|0
7605370|NCT02849587|12012895|FG001|Overall Study|Withdrawal by Subject|1
7605371|NCT02849587|12012896|FG002|Overall Study|Withdrawal by Subject|0
7605373|NCT02781727|12012943|FG000|Pre-dosing Period|Withdrawal by Subject|1
7605374|NCT02781727|12012944|FG001|Pre-dosing Period|Withdrawal by Subject|0
7605375|NCT02781727|12012943|FG000|Treatment Period|Withdrawal by Subject|1
7605376|NCT02781727|12012944|FG001|Treatment Period|Withdrawal by Subject|0
7605377|NCT02781727|12012943|FG000|Treatment Period|Lost to Follow-up|0
7605378|NCT02781727|12012944|FG001|Treatment Period|Lost to Follow-up|1
7605379|NCT02778204|12012954|FG000|Overall Study|Adverse Event|1
7605380|NCT02778204|12012955|FG001|Overall Study|Adverse Event|0
7605381|NCT02778204|12012956|FG002|Overall Study|Adverse Event|0
7605382|NCT02778204|12012957|FG003|Overall Study|Adverse Event|0
7605383|NCT02778204|12012954|FG000|Overall Study|Withdrawal by Subject|0
7605384|NCT02778204|12012955|FG001|Overall Study|Withdrawal by Subject|0
7605385|NCT02778204|12012956|FG002|Overall Study|Withdrawal by Subject|1
7605386|NCT02778204|12012957|FG003|Overall Study|Withdrawal by Subject|2
7605387|NCT02778204|12012954|FG000|Overall Study|Lost to Follow-up|1
7605388|NCT02778204|12012955|FG001|Overall Study|Lost to Follow-up|0
7605389|NCT02778204|12012956|FG002|Overall Study|Lost to Follow-up|2
7605390|NCT02778204|12012957|FG003|Overall Study|Lost to Follow-up|1
7605391|NCT02778204|12012954|FG000|Overall Study|Protocol Violation|0
7605392|NCT02778204|12012955|FG001|Overall Study|Protocol Violation|0
7605393|NCT02778204|12012956|FG002|Overall Study|Protocol Violation|1
7605394|NCT02778204|12012957|FG003|Overall Study|Protocol Violation|0
7605395|NCT02778204|12012954|FG000|Overall Study|Eligibility Violation|0
7605396|NCT02778204|12012955|FG001|Overall Study|Eligibility Violation|0
7605397|NCT02778204|12012956|FG002|Overall Study|Eligibility Violation|0
7605398|NCT02778204|12012957|FG003|Overall Study|Eligibility Violation|1
7605399|NCT02496611|12012980|FG000|Overall Study|Lost to Follow-up|2
7605400|NCT02496611|12012981|FG001|Overall Study|Lost to Follow-up|1
7605401|NCT02496611|12012980|FG000|Overall Study|Withdrawal by Subject|5
7605402|NCT02496611|12012981|FG001|Overall Study|Withdrawal by Subject|2
7605403|NCT02177695|12012999|FG000|ITT Analysis|Ineligible|5
7605404|NCT02177695|12013000|FG001|ITT Analysis|Ineligible|5
7605405|NCT02177695|12012999|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
7605406|NCT02177695|12013000|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
7605407|NCT02177695|12012999|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
7605408|NCT02177695|12013000|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
7605409|NCT02177695|12012999|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
7605410|NCT02177695|12013000|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
7605411|NCT02105636|12013030|FG000|Overall Study|Disease Progression|162
7605412|NCT02105636|12013031|FG001|Overall Study|Disease Progression|83
7605413|NCT02105636|12013030|FG000|Overall Study|Study Drug Toxicity|9
7605414|NCT02105636|12013031|FG001|Overall Study|Study Drug Toxicity|11
7605415|NCT02105636|12013030|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
7605416|NCT02105636|12013031|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7605506|NCT01150890|12013077|FG000|Overall Study|Withdrawal by Subject|0
7605417|NCT02105636|12013030|FG000|Overall Study|Subject Request to Discontinue Treatment|4
7605418|NCT02105636|12013031|FG001|Overall Study|Subject Request to Discontinue Treatment|6
7605419|NCT02105636|12013030|FG000|Overall Study|Subject Withdrew Consent|4
7605420|NCT02105636|12013031|FG001|Overall Study|Subject Withdrew Consent|1
7605421|NCT02105636|12013030|FG000|Overall Study|Maximum Clinical Benefit|1
7605422|NCT02105636|12013031|FG001|Overall Study|Maximum Clinical Benefit|1
7605423|NCT02105636|12013030|FG000|Overall Study|Poor/Non-compliance|0
7605424|NCT02105636|12013031|FG001|Overall Study|Poor/Non-compliance|1
7605425|NCT02105636|12013030|FG000|Overall Study|Reason Not Specified|0
7605426|NCT02105636|12013031|FG001|Overall Study|Reason Not Specified|2
7605427|NCT02105636|12013030|FG000|Overall Study|Not Reported|3
7605428|NCT02105636|12013031|FG001|Overall Study|Not Reported|0
7605429|NCT02038946|12013038|FG000|Overall Study|Death|5
7605430|NCT02038946|12013038|FG000|Overall Study|Withdrawal by Subject|3
7605431|NCT02038946|12013038|FG000|Overall Study|Lost to Follow-up|2
7605432|NCT02038946|12013038|FG000|Overall Study|Other reasons|2
7605433|NCT01988571|12013044|FG000|Overall Study|Death|3
7605434|NCT01988571|12013045|FG001|Overall Study|Death|1
7605435|NCT01988571|12013044|FG000|Overall Study|Physician Decision|2
7605436|NCT01988571|12013045|FG001|Overall Study|Physician Decision|1
7605437|NCT01988571|12013044|FG000|Overall Study|Lost to Follow-up|3
7605438|NCT01988571|12013045|FG001|Overall Study|Lost to Follow-up|0
7605439|NCT01988571|12013044|FG000|Overall Study|Withdrawal by Subject|31
7605440|NCT01988571|12013045|FG001|Overall Study|Withdrawal by Subject|33
7605441|NCT01332266|12013056|FG000|Phase 1b|Death|3
7605442|NCT01332266|12013057|FG001|Phase 1b|Death|3
7605443|NCT01332266|12013058|FG002|Phase 1b|Death|2
7605444|NCT01332266|12013059|FG003|Phase 1b|Death|0
7605445|NCT01332266|12013060|FG004|Phase 1b|Death|0
7605446|NCT01332266|12013056|FG000|Phase 1b|Lost to Follow-up|0
7605447|NCT01332266|12013057|FG001|Phase 1b|Lost to Follow-up|1
7605448|NCT01332266|12013058|FG002|Phase 1b|Lost to Follow-up|0
7605449|NCT01332266|12013059|FG003|Phase 1b|Lost to Follow-up|0
7605450|NCT01332266|12013060|FG004|Phase 1b|Lost to Follow-up|0
7605451|NCT01332266|12013056|FG000|Phase 1b|Withdrawal by Subject|1
7605452|NCT01332266|12013057|FG001|Phase 1b|Withdrawal by Subject|1
7605453|NCT01332266|12013058|FG002|Phase 1b|Withdrawal by Subject|1
7605454|NCT01332266|12013059|FG003|Phase 1b|Withdrawal by Subject|0
7605455|NCT01332266|12013060|FG004|Phase 1b|Withdrawal by Subject|0
7605456|NCT01332266|12013056|FG000|Phase 2|Death|0
7605457|NCT01332266|12013057|FG001|Phase 2|Death|0
7605458|NCT01332266|12013058|FG002|Phase 2|Death|0
7605459|NCT01332266|12013059|FG003|Phase 2|Death|33
7605460|NCT01332266|12013060|FG004|Phase 2|Death|36
7605461|NCT01332266|12013056|FG000|Phase 2|Lost to Follow-up|0
7605462|NCT01332266|12013057|FG001|Phase 2|Lost to Follow-up|0
7605463|NCT01332266|12013058|FG002|Phase 2|Lost to Follow-up|0
7605464|NCT01332266|12013059|FG003|Phase 2|Lost to Follow-up|2
7605465|NCT01332266|12013060|FG004|Phase 2|Lost to Follow-up|0
7605466|NCT01332266|12013056|FG000|Phase 2|Physician Decision|0
7605467|NCT01332266|12013057|FG001|Phase 2|Physician Decision|0
7605468|NCT01332266|12013058|FG002|Phase 2|Physician Decision|0
7605469|NCT01332266|12013059|FG003|Phase 2|Physician Decision|3
7605470|NCT01332266|12013060|FG004|Phase 2|Physician Decision|1
7605471|NCT01332266|12013056|FG000|Phase 2|Symptomatic deterioration|0
7605472|NCT01332266|12013057|FG001|Phase 2|Symptomatic deterioration|0
7605473|NCT01332266|12013058|FG002|Phase 2|Symptomatic deterioration|0
7605474|NCT01332266|12013059|FG003|Phase 2|Symptomatic deterioration|0
7605475|NCT01332266|12013060|FG004|Phase 2|Symptomatic deterioration|1
7605476|NCT01332266|12013056|FG000|Phase 2|Progression Disease|0
7605477|NCT01332266|12013057|FG001|Phase 2|Progression Disease|0
7605478|NCT01332266|12013058|FG002|Phase 2|Progression Disease|0
7605479|NCT01332266|12013059|FG003|Phase 2|Progression Disease|2
7605480|NCT01332266|12013060|FG004|Phase 2|Progression Disease|1
7605481|NCT01332266|12013056|FG000|Phase 2|Withdrawal by Subject|0
7605482|NCT01332266|12013057|FG001|Phase 2|Withdrawal by Subject|0
7605483|NCT01332266|12013058|FG002|Phase 2|Withdrawal by Subject|0
7605484|NCT01332266|12013059|FG003|Phase 2|Withdrawal by Subject|2
7605485|NCT01332266|12013060|FG004|Phase 2|Withdrawal by Subject|2
7605486|NCT01150890|12013077|FG000|Overall Study|Other|0
7605487|NCT01150890|12013078|FG001|Overall Study|Other|1
7605488|NCT01150890|12013079|FG002|Overall Study|Other|0
7605489|NCT01150890|12013080|FG003|Overall Study|Other|2
7605490|NCT01150890|12013077|FG000|Overall Study|Pregnancy|0
7605491|NCT01150890|12013078|FG001|Overall Study|Pregnancy|0
7605492|NCT01150890|12013079|FG002|Overall Study|Pregnancy|0
7605493|NCT01150890|12013080|FG003|Overall Study|Pregnancy|1
7605494|NCT01150890|12013077|FG000|Overall Study|Administrative Decision|4
7605495|NCT01150890|12013078|FG001|Overall Study|Administrative Decision|4
7605496|NCT01150890|12013079|FG002|Overall Study|Administrative Decision|5
7605497|NCT01150890|12013080|FG003|Overall Study|Administrative Decision|6
7605498|NCT01150890|12013077|FG000|Overall Study|Ineligibility determined|0
7605499|NCT01150890|12013078|FG001|Overall Study|Ineligibility determined|1
7605500|NCT01150890|12013079|FG002|Overall Study|Ineligibility determined|0
7605501|NCT01150890|12013080|FG003|Overall Study|Ineligibility determined|0
7605502|NCT01150890|12013077|FG000|Overall Study|Adverse Event|0
7605503|NCT01150890|12013078|FG001|Overall Study|Adverse Event|0
7605504|NCT01150890|12013079|FG002|Overall Study|Adverse Event|2
7605505|NCT01150890|12013080|FG003|Overall Study|Adverse Event|0
7605507|NCT01150890|12013078|FG001|Overall Study|Withdrawal by Subject|0
7605508|NCT01150890|12013079|FG002|Overall Study|Withdrawal by Subject|2
7605509|NCT01150890|12013080|FG003|Overall Study|Withdrawal by Subject|1
7605510|NCT01150890|12013077|FG000|Overall Study|Disease progression|0
7605511|NCT01150890|12013078|FG001|Overall Study|Disease progression|7
7605512|NCT01150890|12013079|FG002|Overall Study|Disease progression|3
7605513|NCT01150890|12013080|FG003|Overall Study|Disease progression|7
7605514|NCT01140867|12013093|FG000|Overall Study|Adverse Event|22
7605515|NCT01140867|12013093|FG000|Overall Study|Lack of Efficacy|3
7605516|NCT01140867|12013093|FG000|Overall Study|Lost to Follow-up|2
7605517|NCT01140867|12013093|FG000|Overall Study|Withdrawal by Subject|1
7605518|NCT01140867|12013093|FG000|Overall Study|Protocol Violation|1
7605519|NCT01140867|12013093|FG000|Overall Study|Uncooperative patient|2
7605520|NCT01140867|12013093|FG000|Overall Study|Medication Noncompliance|2
7605521|NCT01137773|12013099|FG000|Overall Study|Death|3
7605522|NCT01137773|12013100|FG001|Overall Study|Death|3
7605523|NCT01137773|12013099|FG000|Overall Study|Lost to Follow-up|6
7605524|NCT01137773|12013100|FG001|Overall Study|Lost to Follow-up|0
7605525|NCT01127256|12013110|FG000|Overall Study|Adverse Event|13
7605526|NCT01127256|12013111|FG001|Overall Study|Adverse Event|13
7605527|NCT01127256|12013110|FG000|Overall Study|Lack of Efficacy|4
7605528|NCT01127256|12013111|FG001|Overall Study|Lack of Efficacy|0
7605529|NCT01127256|12013110|FG000|Overall Study|Lost to Follow-up|16
7605530|NCT01127256|12013111|FG001|Overall Study|Lost to Follow-up|17
7605531|NCT01127256|12013110|FG000|Overall Study|Withdrawal by Subject|5
7605532|NCT01127256|12013111|FG001|Overall Study|Withdrawal by Subject|9
7605533|NCT01127256|12013110|FG000|Overall Study|Protocol Violation|1
7605534|NCT01127256|12013111|FG001|Overall Study|Protocol Violation|0
7605535|NCT01004861|12013130|FG000|Overall Study|Disease progression|3
7605536|NCT01004861|12013131|FG001|Overall Study|Disease progression|4
7605537|NCT01004861|12013132|FG002|Overall Study|Disease progression|5
7605538|NCT01004861|12013133|FG003|Overall Study|Disease progression|4
7605539|NCT01004861|12013134|FG004|Overall Study|Disease progression|4
7605540|NCT01004861|12013135|FG005|Overall Study|Disease progression|4
7605541|NCT01004861|12013136|FG006|Overall Study|Disease progression|5
7605542|NCT01004861|12013137|FG007|Overall Study|Disease progression|1
7605543|NCT01004861|12013138|FG008|Overall Study|Disease progression|4
7605544|NCT01004861|12013139|FG009|Overall Study|Disease progression|7
7605545|NCT01004861|12013140|FG010|Overall Study|Disease progression|6
7605546|NCT01004861|12013141|FG011|Overall Study|Disease progression|3
7605547|NCT01004861|12013142|FG012|Overall Study|Disease progression|8
7605548|NCT01004861|12013130|FG000|Overall Study|Physician Decision|0
7605549|NCT01004861|12013131|FG001|Overall Study|Physician Decision|2
7605550|NCT01004861|12013132|FG002|Overall Study|Physician Decision|1
7605551|NCT01004861|12013133|FG003|Overall Study|Physician Decision|1
7605552|NCT01004861|12013134|FG004|Overall Study|Physician Decision|1
7605553|NCT01004861|12013135|FG005|Overall Study|Physician Decision|0
7605554|NCT01004861|12013136|FG006|Overall Study|Physician Decision|0
7605555|NCT01004861|12013137|FG007|Overall Study|Physician Decision|1
7605556|NCT01004861|12013138|FG008|Overall Study|Physician Decision|0
7605557|NCT01004861|12013139|FG009|Overall Study|Physician Decision|0
7605558|NCT01004861|12013140|FG010|Overall Study|Physician Decision|0
7605559|NCT01004861|12013141|FG011|Overall Study|Physician Decision|0
7605560|NCT01004861|12013142|FG012|Overall Study|Physician Decision|3
7605561|NCT01004861|12013130|FG000|Overall Study|Adverse Event|0
7605562|NCT01004861|12013131|FG001|Overall Study|Adverse Event|0
7605563|NCT01004861|12013132|FG002|Overall Study|Adverse Event|0
7605564|NCT01004861|12013133|FG003|Overall Study|Adverse Event|1
7605565|NCT01004861|12013134|FG004|Overall Study|Adverse Event|0
7605566|NCT01004861|12013135|FG005|Overall Study|Adverse Event|2
7605567|NCT01004861|12013136|FG006|Overall Study|Adverse Event|1
7605568|NCT01004861|12013137|FG007|Overall Study|Adverse Event|1
7605569|NCT01004861|12013138|FG008|Overall Study|Adverse Event|13
7605570|NCT01004861|12013139|FG009|Overall Study|Adverse Event|1
7605571|NCT01004861|12013140|FG010|Overall Study|Adverse Event|1
7605572|NCT01004861|12013141|FG011|Overall Study|Adverse Event|0
7605573|NCT01004861|12013142|FG012|Overall Study|Adverse Event|2
7605574|NCT01004861|12013130|FG000|Overall Study|Protocol Violation|0
7605575|NCT01004861|12013131|FG001|Overall Study|Protocol Violation|0
7605576|NCT01004861|12013132|FG002|Overall Study|Protocol Violation|0
7605577|NCT01004861|12013133|FG003|Overall Study|Protocol Violation|0
7605578|NCT01004861|12013134|FG004|Overall Study|Protocol Violation|1
7605579|NCT01004861|12013135|FG005|Overall Study|Protocol Violation|0
7605580|NCT01004861|12013136|FG006|Overall Study|Protocol Violation|0
7605581|NCT01004861|12013137|FG007|Overall Study|Protocol Violation|0
7605582|NCT01004861|12013138|FG008|Overall Study|Protocol Violation|0
7605583|NCT01004861|12013139|FG009|Overall Study|Protocol Violation|0
7605584|NCT01004861|12013140|FG010|Overall Study|Protocol Violation|0
7605585|NCT01004861|12013141|FG011|Overall Study|Protocol Violation|0
7605586|NCT01004861|12013142|FG012|Overall Study|Protocol Violation|0
7605587|NCT01004861|12013130|FG000|Overall Study|Lost to Follow-up|0
7605588|NCT01004861|12013131|FG001|Overall Study|Lost to Follow-up|0
7605589|NCT01004861|12013132|FG002|Overall Study|Lost to Follow-up|0
7605590|NCT01004861|12013133|FG003|Overall Study|Lost to Follow-up|0
7605591|NCT01004861|12013134|FG004|Overall Study|Lost to Follow-up|0
7605592|NCT01004861|12013135|FG005|Overall Study|Lost to Follow-up|0
7605593|NCT01004861|12013136|FG006|Overall Study|Lost to Follow-up|0
7605594|NCT01004861|12013137|FG007|Overall Study|Lost to Follow-up|1
7605595|NCT01004861|12013138|FG008|Overall Study|Lost to Follow-up|3
7605596|NCT01004861|12013139|FG009|Overall Study|Lost to Follow-up|0
7605597|NCT01004861|12013140|FG010|Overall Study|Lost to Follow-up|0
7605598|NCT01004861|12013141|FG011|Overall Study|Lost to Follow-up|1
7605599|NCT01004861|12013142|FG012|Overall Study|Lost to Follow-up|0
7605600|NCT01004861|12013130|FG000|Overall Study|Non-compliance|0
7605601|NCT01004861|12013131|FG001|Overall Study|Non-compliance|0
7605602|NCT01004861|12013132|FG002|Overall Study|Non-compliance|0
7605603|NCT01004861|12013133|FG003|Overall Study|Non-compliance|0
7605604|NCT01004861|12013134|FG004|Overall Study|Non-compliance|0
7605605|NCT01004861|12013135|FG005|Overall Study|Non-compliance|0
7605606|NCT01004861|12013136|FG006|Overall Study|Non-compliance|0
7605607|NCT01004861|12013137|FG007|Overall Study|Non-compliance|0
7605608|NCT01004861|12013138|FG008|Overall Study|Non-compliance|5
7605609|NCT01004861|12013139|FG009|Overall Study|Non-compliance|0
7605610|NCT01004861|12013140|FG010|Overall Study|Non-compliance|0
7605611|NCT01004861|12013141|FG011|Overall Study|Non-compliance|0
7605612|NCT01004861|12013142|FG012|Overall Study|Non-compliance|1
7605613|NCT01004861|12013130|FG000|Overall Study|Other|0
7605614|NCT01004861|12013131|FG001|Overall Study|Other|0
7605615|NCT01004861|12013132|FG002|Overall Study|Other|0
7605616|NCT01004861|12013133|FG003|Overall Study|Other|0
7605617|NCT01004861|12013134|FG004|Overall Study|Other|0
7605618|NCT01004861|12013135|FG005|Overall Study|Other|0
7605619|NCT01004861|12013136|FG006|Overall Study|Other|0
7605620|NCT01004861|12013137|FG007|Overall Study|Other|0
7605621|NCT01004861|12013138|FG008|Overall Study|Other|0
7605622|NCT01004861|12013139|FG009|Overall Study|Other|2
7605623|NCT01004861|12013140|FG010|Overall Study|Other|1
7605624|NCT01004861|12013141|FG011|Overall Study|Other|2
7605625|NCT01004861|12013142|FG012|Overall Study|Other|3
7605626|NCT01004861|12013130|FG000|Overall Study|Patient decision|0
7274930|NCT00440557|11489549|FG001|Overall Study|Withdrawal by Subject|5
7274931|NCT00440557|11489550|FG002|Overall Study|Withdrawal by Subject|11
7274932|NCT00440557|11489548|FG000|Overall Study|Lost to Follow-up|1
7274933|NCT00440557|11489549|FG001|Overall Study|Lost to Follow-up|2
7274934|NCT00440557|11489550|FG002|Overall Study|Lost to Follow-up|6
7274935|NCT00440557|11489548|FG000|Overall Study|Adverse Event|3
7274936|NCT00440557|11489549|FG001|Overall Study|Adverse Event|3
7274937|NCT00440557|11489550|FG002|Overall Study|Adverse Event|5
7274938|NCT00440557|11489548|FG000|Overall Study|Death|2
7274939|NCT00440557|11489549|FG001|Overall Study|Death|6
7274940|NCT00440557|11489550|FG002|Overall Study|Death|3
7274941|NCT00440557|11489548|FG000|Overall Study|Began Dialysis|4
7274942|NCT00440557|11489549|FG001|Overall Study|Began Dialysis|1
7274943|NCT00440557|11489550|FG002|Overall Study|Began Dialysis|4
7274944|NCT00440557|11489548|FG000|Overall Study|Principal Investigator decision|0
7274945|NCT00440557|11489549|FG001|Overall Study|Principal Investigator decision|3
7274946|NCT00440557|11489550|FG002|Overall Study|Principal Investigator decision|1
7274947|NCT00440557|11489548|FG000|Overall Study|Patient moved|1
7274948|NCT00440557|11489549|FG001|Overall Study|Patient moved|2
7274949|NCT00440557|11489550|FG002|Overall Study|Patient moved|1
7274950|NCT00440557|11489548|FG000|Overall Study|Principal Investigator's office closed|3
7274951|NCT00440557|11489549|FG001|Overall Study|Principal Investigator's office closed|6
7274952|NCT00440557|11489550|FG002|Overall Study|Principal Investigator's office closed|4
7274953|NCT00440557|11489548|FG000|Overall Study|Patient transferred to nursing home|0
7274954|NCT00440557|11489549|FG001|Overall Study|Patient transferred to nursing home|1
7274955|NCT00440557|11489550|FG002|Overall Study|Patient transferred to nursing home|0
7274956|NCT00440557|11489548|FG000|Overall Study|Patient had surgery|1
7274957|NCT00440557|11489549|FG001|Overall Study|Patient had surgery|0
7274958|NCT00440557|11489550|FG002|Overall Study|Patient had surgery|0
7274959|NCT00440700|11489572|FG000|Overall Study|Withdrawal by Subject|8
7274960|NCT00440700|11489573|FG001|Overall Study|Withdrawal by Subject|8
7274961|NCT00440700|11489574|FG002|Overall Study|Withdrawal by Subject|4
7274962|NCT00440726|11489585|FG000|Phase 1|Dose-Limiting Toxicity|0
7274963|NCT00440726|11489586|FG001|Phase 1|Dose-Limiting Toxicity|1
7274964|NCT00440726|11489587|FG002|Phase 1|Dose-Limiting Toxicity|0
7274965|NCT00440726|11489585|FG000|Phase 1|Physician Decision|1
7274966|NCT00440726|11489586|FG001|Phase 1|Physician Decision|0
7605627|NCT01004861|12013131|FG001|Overall Study|Patient decision|0
7605628|NCT01004861|12013132|FG002|Overall Study|Patient decision|0
7605629|NCT01004861|12013133|FG003|Overall Study|Patient decision|0
7605630|NCT01004861|12013134|FG004|Overall Study|Patient decision|1
7605631|NCT01004861|12013135|FG005|Overall Study|Patient decision|0
7605632|NCT01004861|12013136|FG006|Overall Study|Patient decision|1
7605633|NCT01004861|12013137|FG007|Overall Study|Patient decision|0
7605634|NCT01004861|12013138|FG008|Overall Study|Patient decision|7
7605635|NCT01004861|12013139|FG009|Overall Study|Patient decision|1
7605636|NCT01004861|12013140|FG010|Overall Study|Patient decision|1
7605637|NCT01004861|12013141|FG011|Overall Study|Patient decision|2
7605638|NCT01004861|12013142|FG012|Overall Study|Patient decision|3
7605639|NCT01004861|12013130|FG000|Overall Study|Transitioned to Phase 4 study|0
7605640|NCT01004861|12013131|FG001|Overall Study|Transitioned to Phase 4 study|0
7605641|NCT01004861|12013132|FG002|Overall Study|Transitioned to Phase 4 study|0
7274967|NCT00440726|11489587|FG002|Phase 1|Physician Decision|0
7274968|NCT00440726|11489585|FG000|Phase 2|Death|0
7605642|NCT01004861|12013133|FG003|Overall Study|Transitioned to Phase 4 study|0
7605643|NCT01004861|12013134|FG004|Overall Study|Transitioned to Phase 4 study|0
7605644|NCT01004861|12013135|FG005|Overall Study|Transitioned to Phase 4 study|0
7605645|NCT01004861|12013136|FG006|Overall Study|Transitioned to Phase 4 study|0
7605646|NCT01004861|12013137|FG007|Overall Study|Transitioned to Phase 4 study|0
7605647|NCT01004861|12013138|FG008|Overall Study|Transitioned to Phase 4 study|2
7605648|NCT01004861|12013139|FG009|Overall Study|Transitioned to Phase 4 study|0
7605649|NCT01004861|12013140|FG010|Overall Study|Transitioned to Phase 4 study|0
7605650|NCT01004861|12013141|FG011|Overall Study|Transitioned to Phase 4 study|0
7605651|NCT01004861|12013142|FG012|Overall Study|Transitioned to Phase 4 study|0
7605652|NCT01004861|12013130|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605653|NCT01004861|12013131|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605654|NCT01004861|12013132|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605655|NCT01004861|12013133|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605656|NCT01004861|12013134|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605657|NCT01004861|12013135|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605658|NCT01004861|12013136|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605659|NCT01004861|12013137|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605660|NCT01004861|12013138|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
7605661|NCT01004861|12013139|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605662|NCT01004861|12013140|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605663|NCT01004861|12013141|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605664|NCT01004861|12013142|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
7605665|NCT01004861|12013130|FG000|Overall Study|Patient withdrew|0
7605666|NCT01004861|12013131|FG001|Overall Study|Patient withdrew|0
7605667|NCT01004861|12013132|FG002|Overall Study|Patient withdrew|0
7605668|NCT01004861|12013133|FG003|Overall Study|Patient withdrew|0
7605669|NCT01004861|12013134|FG004|Overall Study|Patient withdrew|0
7605670|NCT01004861|12013135|FG005|Overall Study|Patient withdrew|0
7605671|NCT01004861|12013136|FG006|Overall Study|Patient withdrew|0
7605672|NCT01004861|12013137|FG007|Overall Study|Patient withdrew|0
7605673|NCT01004861|12013138|FG008|Overall Study|Patient withdrew|1
7605674|NCT01004861|12013139|FG009|Overall Study|Patient withdrew|0
7605675|NCT01004861|12013140|FG010|Overall Study|Patient withdrew|0
7605676|NCT01004861|12013141|FG011|Overall Study|Patient withdrew|0
7605677|NCT01004861|12013142|FG012|Overall Study|Patient withdrew|0
7605678|NCT01004861|12013130|FG000|Overall Study|Surgical resection|0
7605679|NCT01004861|12013131|FG001|Overall Study|Surgical resection|0
7605680|NCT01004861|12013132|FG002|Overall Study|Surgical resection|0
7605681|NCT01004861|12013133|FG003|Overall Study|Surgical resection|0
7605682|NCT01004861|12013134|FG004|Overall Study|Surgical resection|0
7605683|NCT01004861|12013135|FG005|Overall Study|Surgical resection|0
7605684|NCT01004861|12013136|FG006|Overall Study|Surgical resection|0
7605685|NCT01004861|12013137|FG007|Overall Study|Surgical resection|0
7605686|NCT01004861|12013138|FG008|Overall Study|Surgical resection|1
7605687|NCT01004861|12013139|FG009|Overall Study|Surgical resection|0
7605688|NCT01004861|12013140|FG010|Overall Study|Surgical resection|0
7605689|NCT01004861|12013141|FG011|Overall Study|Surgical resection|0
7605690|NCT01004861|12013142|FG012|Overall Study|Surgical resection|0
7605691|NCT01004861|12013130|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605692|NCT01004861|12013131|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605693|NCT01004861|12013132|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605694|NCT01004861|12013133|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605695|NCT01004861|12013134|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605696|NCT01004861|12013135|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605697|NCT01004861|12013136|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605698|NCT01004861|12013137|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605699|NCT01004861|12013138|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
7605700|NCT01004861|12013139|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605701|NCT01004861|12013140|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605702|NCT01004861|12013141|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605703|NCT01004861|12013142|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
7605704|NCT01004861|12013130|FG000|Overall Study|Study termination by Sponsor|0
7605705|NCT01004861|12013131|FG001|Overall Study|Study termination by Sponsor|0
7605706|NCT01004861|12013132|FG002|Overall Study|Study termination by Sponsor|0
7605707|NCT01004861|12013133|FG003|Overall Study|Study termination by Sponsor|0
7605708|NCT01004861|12013134|FG004|Overall Study|Study termination by Sponsor|0
7605709|NCT01004861|12013135|FG005|Overall Study|Study termination by Sponsor|0
7605710|NCT01004861|12013136|FG006|Overall Study|Study termination by Sponsor|0
7605711|NCT01004861|12013137|FG007|Overall Study|Study termination by Sponsor|0
7605712|NCT01004861|12013138|FG008|Overall Study|Study termination by Sponsor|1
7605713|NCT01004861|12013139|FG009|Overall Study|Study termination by Sponsor|0
7605714|NCT01004861|12013140|FG010|Overall Study|Study termination by Sponsor|0
7605715|NCT01004861|12013141|FG011|Overall Study|Study termination by Sponsor|0
7605716|NCT01004861|12013142|FG012|Overall Study|Study termination by Sponsor|0
7605717|NCT00912223|12013174|FG000|Overall Study|Withdrawal by Subject|1
7605718|NCT00912223|12013174|FG000|Overall Study|Not transplanted|1
7605719|NCT00912223|12013174|FG000|Overall Study|Transformed disease|1
7605720|NCT00381381|12013178|FG000|Overall Study|Adverse Event|3
7605721|NCT00381381|12013178|FG000|Overall Study|Lost to Follow-up|52
7605722|NCT00381381|12013178|FG000|Overall Study|Withdrawal by Subject|9
7605723|NCT03712124|12013198|FG000|Overall Study|Protocol Violation|1
7605724|NCT03712124|12013199|FG001|Overall Study|Protocol Violation|0
7605725|NCT03535740|12013211|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
7605726|NCT03535740|12013211|FG000|Overall Study|Death|34
7605727|NCT03535740|12013211|FG000|Overall Study|Lost to Follow-up|1
7605728|NCT03535740|12013211|FG000|Overall Study|Withdrawal by Subject|13
7605729|NCT02896257|12013248|FG000|Providers|Without eligible patients|21
7605730|NCT02896257|12013249|FG001|Providers|Without eligible patients|28
7605731|NCT02896257|12013248|FG000|Patients|PFT entry criteria not met|43
7605732|NCT02896257|12013249|FG001|Patients|PFT entry criteria not met|50
7605733|NCT02896257|12013248|FG000|Patients|No capacity to review|8
7605734|NCT02896257|12013249|FG001|Patients|No capacity to review|11
7605735|NCT02896257|12013248|FG000|Patients|Appointment rescheduled/cancelled|5
7605736|NCT02896257|12013249|FG001|Patients|Appointment rescheduled/cancelled|7
7605737|NCT02896257|12013248|FG000|Patients|PCP not assigned a clinic|4
7605738|NCT02896257|12013249|FG001|Patients|PCP not assigned a clinic|0
7605739|NCT02896257|12013248|FG000|Patients|No history of COPD|0
7605740|NCT02896257|12013249|FG001|Patients|No history of COPD|1
7605741|NCT02896257|12013248|FG000|Patients|Deceased between review and index date|0
7605742|NCT02896257|12013249|FG001|Patients|Deceased between review and index date|1
7605743|NCT02896257|12013248|FG000|Patients|No ICS Rx upon review|1
7605744|NCT02896257|12013249|FG001|Patients|No ICS Rx upon review|1
7605745|NCT02896257|12013248|FG000|Patients|Protocol Violation|2
7605746|NCT02896257|12013249|FG001|Patients|Protocol Violation|1
7605747|NCT02896257|12013248|FG000|Patients|Hospice care|0
7605748|NCT02896257|12013249|FG001|Patients|Hospice care|1
7605749|NCT02736617|12013265|FG000|Treatment|Adverse Event|1
7605750|NCT02736617|12013265|FG000|Treatment|Lack of Efficacy|1
7605751|NCT02736617|12013265|FG000|Treatment|Withdrawal by Subject|1
7605752|NCT02736617|12013265|FG000|Maintenance|Lack of Efficacy|4
7274969|NCT00440726|11489586|FG001|Phase 2|Death|0
7274970|NCT00440726|11489587|FG002|Phase 2|Death|1
7274971|NCT00440726|11489585|FG000|Phase 2|Adverse Event|0
7274972|NCT00440726|11489586|FG001|Phase 2|Adverse Event|0
7274973|NCT00440726|11489587|FG002|Phase 2|Adverse Event|1
7274974|NCT00440947|11489619|FG000|36-Week Induction Phase|Adverse Event|16
7274975|NCT00440947|11489620|FG001|36-Week Induction Phase|Adverse Event|0
7274976|NCT00440947|11489621|FG002|36-Week Induction Phase|Adverse Event|0
7274977|NCT00440947|11489622|FG003|36-Week Induction Phase|Adverse Event|0
7274978|NCT00440947|11489623|FG004|36-Week Induction Phase|Adverse Event|0
7274979|NCT00440947|11489619|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
7274980|NCT00440947|11489620|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
7274981|NCT00440947|11489621|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
7274982|NCT00440947|11489622|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
7274983|NCT00440947|11489623|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
7274984|NCT00440947|11489619|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
7274985|NCT00440947|11489620|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7274986|NCT00440947|11489621|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7605753|NCT02736617|12013265|FG000|Maintenance|Physician Decision|1
7605754|NCT02579265|12013276|FG000|Overall Study|Weaned off earlier than 28 days|44
7605755|NCT02579265|12013277|FG001|Overall Study|Weaned off earlier than 28 days|43
7605756|NCT02579265|12013276|FG000|Overall Study|Adverse Event|2
7605757|NCT02579265|12013277|FG001|Overall Study|Adverse Event|0
7605758|NCT02579265|12013276|FG000|Overall Study|Any other reason not specified|0
7605759|NCT02579265|12013277|FG001|Overall Study|Any other reason not specified|2
7605760|NCT02579265|12013276|FG000|Overall Study|Withdrawal by Subject|2
7605761|NCT02579265|12013277|FG001|Overall Study|Withdrawal by Subject|0
7605762|NCT02579265|12013276|FG000|Overall Study|Physician Decision|1
7605763|NCT02579265|12013277|FG001|Overall Study|Physician Decision|0
7605764|NCT02579265|12013276|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
7605765|NCT02579265|12013277|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
7605766|NCT02013167|12013285|FG000|Overall Study|Withdrawal by Subject|15
7605767|NCT02013167|12013286|FG001|Overall Study|Withdrawal by Subject|14
7274987|NCT00440947|11489622|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7274988|NCT00440947|11489623|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
7274989|NCT00440947|11489619|FG000|36-Week Induction Phase|Non-compliance|10
7274990|NCT00440947|11489620|FG001|36-Week Induction Phase|Non-compliance|0
7274991|NCT00440947|11489621|FG002|36-Week Induction Phase|Non-compliance|0
7274992|NCT00440947|11489622|FG003|36-Week Induction Phase|Non-compliance|0
7274993|NCT00440947|11489623|FG004|36-Week Induction Phase|Non-compliance|0
7274994|NCT00440947|11489619|FG000|36-Week Induction Phase|Lost to Follow-up|16
7274995|NCT00440947|11489620|FG001|36-Week Induction Phase|Lost to Follow-up|0
7274996|NCT00440947|11489621|FG002|36-Week Induction Phase|Lost to Follow-up|0
7274997|NCT00440947|11489622|FG003|36-Week Induction Phase|Lost to Follow-up|0
7274998|NCT00440947|11489623|FG004|36-Week Induction Phase|Lost to Follow-up|0
7605768|NCT02013167|12013285|FG000|Overall Study|Sponsor Decision|1
7605769|NCT02013167|12013286|FG001|Overall Study|Sponsor Decision|3
7605770|NCT02013167|12013285|FG000|Overall Study|Lost to Follow-up|0
7605771|NCT02013167|12013286|FG001|Overall Study|Lost to Follow-up|1
7605772|NCT02013167|12013285|FG000|Overall Study|Death|85
7605773|NCT02013167|12013286|FG001|Overall Study|Death|160
7605774|NCT02004522|12013295|FG000|Overall Study|Adverse Event|55
7605775|NCT02004522|12013296|FG001|Overall Study|Adverse Event|6
7605776|NCT02004522|12013295|FG000|Overall Study|Withdrawal by Subject|13
7605777|NCT02004522|12013296|FG001|Overall Study|Withdrawal by Subject|7
7605778|NCT02004522|12013295|FG000|Overall Study|Death|12
7605779|NCT02004522|12013296|FG001|Overall Study|Death|3
7605780|NCT02004522|12013295|FG000|Overall Study|Physician Decision|3
7605781|NCT02004522|12013296|FG001|Overall Study|Physician Decision|4
7605782|NCT02004522|12013295|FG000|Overall Study|Protocol Violation|1
7605783|NCT02004522|12013296|FG001|Overall Study|Protocol Violation|0
7605784|NCT02004522|12013295|FG000|Overall Study|Other is reason listed by PI.|4
7605785|NCT02004522|12013296|FG001|Overall Study|Other is reason listed by PI.|1
7605786|NCT02004522|12013295|FG000|Overall Study|Never Dosed|2
7605787|NCT02004522|12013296|FG001|Overall Study|Never Dosed|4
7274999|NCT00440947|11489619|FG000|36-Week Induction Phase|Withdrawal by Subject|7
7275000|NCT00440947|11489620|FG001|36-Week Induction Phase|Withdrawal by Subject|0
7275001|NCT00440947|11489621|FG002|36-Week Induction Phase|Withdrawal by Subject|0
7275002|NCT00440947|11489622|FG003|36-Week Induction Phase|Withdrawal by Subject|0
7275003|NCT00440947|11489623|FG004|36-Week Induction Phase|Withdrawal by Subject|0
7275004|NCT00440947|11489619|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
7275005|NCT00440947|11489620|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7275006|NCT00440947|11489621|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7275007|NCT00440947|11489622|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7275008|NCT00440947|11489623|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
7275009|NCT00440947|11489619|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
7275010|NCT00440947|11489620|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
7275011|NCT00440947|11489621|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
7275012|NCT00440947|11489622|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
7275013|NCT00440947|11489623|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
7275014|NCT00440947|11489619|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
7605788|NCT02004522|12013295|FG000|Overall Study|Disease Progression|35
7605789|NCT02004522|12013296|FG001|Overall Study|Disease Progression|31
7605790|NCT02004522|12013295|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
7605791|NCT02004522|12013296|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
7605793|NCT01981850|12013313|FG000|Main Phase Stage 1|Death|2
7605794|NCT01981850|12013314|FG001|Main Phase Stage 1|Death|0
7605795|NCT01981850|12013315|FG002|Main Phase Stage 1|Death|0
7605796|NCT01981850|12013316|FG003|Main Phase Stage 1|Death|0
7605797|NCT01981850|12013317|FG004|Main Phase Stage 1|Death|0
7605798|NCT01981850|12013318|FG005|Main Phase Stage 1|Death|0
7605799|NCT01981850|12013319|FG006|Main Phase Stage 1|Death|0
7605800|NCT01981850|12013320|FG007|Main Phase Stage 1|Death|0
7605801|NCT01981850|12013321|FG008|Main Phase Stage 1|Death|0
7605802|NCT01981850|12013322|FG009|Main Phase Stage 1|Death|0
7605803|NCT01981850|12013313|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
7605804|NCT01981850|12013314|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
7605805|NCT01981850|12013315|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
7605806|NCT01981850|12013316|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
7605807|NCT01981850|12013317|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
7605808|NCT01981850|12013318|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
7605809|NCT01981850|12013319|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
7605810|NCT01981850|12013320|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
7605811|NCT01981850|12013321|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
7605812|NCT01981850|12013322|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
7605813|NCT01981850|12013313|FG000|Main Phase Stage 1|Lack of Efficacy|0
7605814|NCT01981850|12013314|FG001|Main Phase Stage 1|Lack of Efficacy|2
7605815|NCT01981850|12013315|FG002|Main Phase Stage 1|Lack of Efficacy|0
7605816|NCT01981850|12013316|FG003|Main Phase Stage 1|Lack of Efficacy|0
7275015|NCT00440947|11489620|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7275016|NCT00440947|11489621|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7275017|NCT00440947|11489622|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7275018|NCT00440947|11489623|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
7275019|NCT00440947|11489619|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
7275020|NCT00440947|11489620|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7275021|NCT00440947|11489621|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7275022|NCT00440947|11489622|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7275023|NCT00440947|11489623|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
7275024|NCT00440947|11489619|FG000|36-Week Induction Phase|Incarceration|3
7275025|NCT00440947|11489620|FG001|36-Week Induction Phase|Incarceration|0
7275026|NCT00440947|11489621|FG002|36-Week Induction Phase|Incarceration|0
7275027|NCT00440947|11489622|FG003|36-Week Induction Phase|Incarceration|0
7275028|NCT00440947|11489623|FG004|36-Week Induction Phase|Incarceration|0
7275029|NCT00440947|11489619|FG000|36-Week Induction Phase|Pregnancy|1
7275030|NCT00440947|11489620|FG001|36-Week Induction Phase|Pregnancy|0
7275031|NCT00440947|11489621|FG002|36-Week Induction Phase|Pregnancy|0
7275032|NCT00440947|11489622|FG003|36-Week Induction Phase|Pregnancy|0
7275033|NCT00440947|11489623|FG004|36-Week Induction Phase|Pregnancy|0
7275034|NCT00440947|11489619|FG000|48-Week Randomization Phase|Adverse Event|0
7275035|NCT00440947|11489620|FG001|48-Week Randomization Phase|Adverse Event|2
7275036|NCT00440947|11489621|FG002|48-Week Randomization Phase|Adverse Event|5
7275037|NCT00440947|11489622|FG003|48-Week Randomization Phase|Adverse Event|0
7275038|NCT00440947|11489623|FG004|48-Week Randomization Phase|Adverse Event|0
7275039|NCT00440947|11489619|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7275040|NCT00440947|11489620|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7275041|NCT00440947|11489621|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
7275042|NCT00440947|11489622|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7275043|NCT00440947|11489623|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
7275044|NCT00440947|11489619|FG000|48-Week Randomization Phase|Non-compliance|0
7275045|NCT00440947|11489620|FG001|48-Week Randomization Phase|Non-compliance|3
7275046|NCT00440947|11489621|FG002|48-Week Randomization Phase|Non-compliance|4
7275047|NCT00440947|11489622|FG003|48-Week Randomization Phase|Non-compliance|0
7275048|NCT00440947|11489623|FG004|48-Week Randomization Phase|Non-compliance|0
7275049|NCT00440947|11489619|FG000|48-Week Randomization Phase|Lost to Follow-up|0
7275050|NCT00440947|11489620|FG001|48-Week Randomization Phase|Lost to Follow-up|2
7275051|NCT00440947|11489621|FG002|48-Week Randomization Phase|Lost to Follow-up|8
7275052|NCT00440947|11489622|FG003|48-Week Randomization Phase|Lost to Follow-up|0
7605817|NCT01981850|12013317|FG004|Main Phase Stage 1|Lack of Efficacy|0
7605818|NCT01981850|12013318|FG005|Main Phase Stage 1|Lack of Efficacy|0
7605819|NCT01981850|12013319|FG006|Main Phase Stage 1|Lack of Efficacy|0
7605820|NCT01981850|12013320|FG007|Main Phase Stage 1|Lack of Efficacy|0
7605821|NCT01981850|12013321|FG008|Main Phase Stage 1|Lack of Efficacy|0
7605822|NCT01981850|12013322|FG009|Main Phase Stage 1|Lack of Efficacy|0
7605823|NCT01981850|12013313|FG000|Main Phase Stage 1|Various reasons|0
7605824|NCT01981850|12013314|FG001|Main Phase Stage 1|Various reasons|0
7605825|NCT01981850|12013315|FG002|Main Phase Stage 1|Various reasons|2
7605826|NCT01981850|12013316|FG003|Main Phase Stage 1|Various reasons|0
7605827|NCT01981850|12013317|FG004|Main Phase Stage 1|Various reasons|0
7605828|NCT01981850|12013318|FG005|Main Phase Stage 1|Various reasons|0
7605829|NCT01981850|12013319|FG006|Main Phase Stage 1|Various reasons|0
7605830|NCT01981850|12013320|FG007|Main Phase Stage 1|Various reasons|0
7605831|NCT01981850|12013321|FG008|Main Phase Stage 1|Various reasons|0
7605832|NCT01981850|12013322|FG009|Main Phase Stage 1|Various reasons|0
7605833|NCT01981850|12013313|FG000|Main Phase Stage 2|Adverse Event|0
7605834|NCT01981850|12013314|FG001|Main Phase Stage 2|Adverse Event|0
7605835|NCT01981850|12013315|FG002|Main Phase Stage 2|Adverse Event|0
7605836|NCT01981850|12013316|FG003|Main Phase Stage 2|Adverse Event|0
7605837|NCT01981850|12013317|FG004|Main Phase Stage 2|Adverse Event|6
7605838|NCT01981850|12013318|FG005|Main Phase Stage 2|Adverse Event|5
7605839|NCT01981850|12013319|FG006|Main Phase Stage 2|Adverse Event|7
7605840|NCT01981850|12013320|FG007|Main Phase Stage 2|Adverse Event|0
7605841|NCT01981850|12013321|FG008|Main Phase Stage 2|Adverse Event|0
7605842|NCT01981850|12013322|FG009|Main Phase Stage 2|Adverse Event|0
7605843|NCT01981850|12013313|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
7605844|NCT01981850|12013314|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
7605845|NCT01981850|12013315|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
7605846|NCT01981850|12013316|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
7605847|NCT01981850|12013317|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
7605848|NCT01981850|12013318|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
7605849|NCT01981850|12013319|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
7605850|NCT01981850|12013320|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
7605851|NCT01981850|12013321|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
7605852|NCT01981850|12013322|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
7605853|NCT01981850|12013313|FG000|Main Phase Stage 2|Lack of Efficacy|0
7605854|NCT01981850|12013314|FG001|Main Phase Stage 2|Lack of Efficacy|0
7605855|NCT01981850|12013315|FG002|Main Phase Stage 2|Lack of Efficacy|0
7275053|NCT00440947|11489623|FG004|48-Week Randomization Phase|Lost to Follow-up|0
7275054|NCT00440947|11489619|FG000|48-Week Randomization Phase|Protocol Violation|0
7275055|NCT00440947|11489620|FG001|48-Week Randomization Phase|Protocol Violation|0
7275056|NCT00440947|11489621|FG002|48-Week Randomization Phase|Protocol Violation|1
7275057|NCT00440947|11489622|FG003|48-Week Randomization Phase|Protocol Violation|0
7275058|NCT00440947|11489623|FG004|48-Week Randomization Phase|Protocol Violation|0
7275059|NCT00440947|11489619|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
7605856|NCT01981850|12013316|FG003|Main Phase Stage 2|Lack of Efficacy|0
7605857|NCT01981850|12013317|FG004|Main Phase Stage 2|Lack of Efficacy|1
7605858|NCT01981850|12013318|FG005|Main Phase Stage 2|Lack of Efficacy|2
7605859|NCT01981850|12013319|FG006|Main Phase Stage 2|Lack of Efficacy|0
7605860|NCT01981850|12013320|FG007|Main Phase Stage 2|Lack of Efficacy|0
7605861|NCT01981850|12013321|FG008|Main Phase Stage 2|Lack of Efficacy|0
7605862|NCT01981850|12013322|FG009|Main Phase Stage 2|Lack of Efficacy|0
7605863|NCT01981850|12013313|FG000|Main Phase Stage 2|Various reasons|0
7605864|NCT01981850|12013314|FG001|Main Phase Stage 2|Various reasons|0
7605865|NCT01981850|12013315|FG002|Main Phase Stage 2|Various reasons|0
7275060|NCT00440947|11489620|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
7275061|NCT00440947|11489621|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
7275062|NCT00440947|11489622|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
7275063|NCT00440947|11489623|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
7275064|NCT00440947|11489619|FG000|48-Week Randomization Phase|Pregnancy|0
7275065|NCT00440947|11489620|FG001|48-Week Randomization Phase|Pregnancy|0
7275066|NCT00440947|11489621|FG002|48-Week Randomization Phase|Pregnancy|1
7275067|NCT00440947|11489622|FG003|48-Week Randomization Phase|Pregnancy|0
7275068|NCT00440947|11489623|FG004|48-Week Randomization Phase|Pregnancy|0
7275069|NCT00440947|11489619|FG000|48-Week Randomization Phase|Incarceration|0
7275070|NCT00440947|11489620|FG001|48-Week Randomization Phase|Incarceration|3
7275071|NCT00440947|11489621|FG002|48-Week Randomization Phase|Incarceration|0
7275072|NCT00440947|11489622|FG003|48-Week Randomization Phase|Incarceration|0
7275073|NCT00440947|11489623|FG004|48-Week Randomization Phase|Incarceration|0
7275074|NCT00440947|11489619|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
7275075|NCT00440947|11489620|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
7275076|NCT00440947|11489621|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
7275077|NCT00440947|11489622|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
7275078|NCT00440947|11489623|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
7275079|NCT00440947|11489619|FG000|48-Week Randomization Phase|Physician Decision|0
7275080|NCT00440947|11489620|FG001|48-Week Randomization Phase|Physician Decision|2
7275081|NCT00440947|11489621|FG002|48-Week Randomization Phase|Physician Decision|0
7275082|NCT00440947|11489622|FG003|48-Week Randomization Phase|Physician Decision|0
7275083|NCT00440947|11489623|FG004|48-Week Randomization Phase|Physician Decision|0
7275084|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Adverse Event|0
7275085|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Adverse Event|0
7275086|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Adverse Event|0
7275087|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Adverse Event|1
7275088|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Adverse Event|3
7275089|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7275090|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7275091|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
7275092|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7275093|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
7605866|NCT01981850|12013316|FG003|Main Phase Stage 2|Various reasons|0
7605867|NCT01981850|12013317|FG004|Main Phase Stage 2|Various reasons|2
7605868|NCT01981850|12013318|FG005|Main Phase Stage 2|Various reasons|0
7605869|NCT01981850|12013319|FG006|Main Phase Stage 2|Various reasons|1
7605870|NCT01981850|12013320|FG007|Main Phase Stage 2|Various reasons|0
7605871|NCT01981850|12013321|FG008|Main Phase Stage 2|Various reasons|0
7605872|NCT01981850|12013322|FG009|Main Phase Stage 2|Various reasons|0
7605873|NCT01981850|12013313|FG000|Main Phase Stage 2|Progressive Disease|0
7605874|NCT01981850|12013314|FG001|Main Phase Stage 2|Progressive Disease|0
7605875|NCT01981850|12013315|FG002|Main Phase Stage 2|Progressive Disease|0
7605876|NCT01981850|12013316|FG003|Main Phase Stage 2|Progressive Disease|0
7605877|NCT01981850|12013317|FG004|Main Phase Stage 2|Progressive Disease|0
7605878|NCT01981850|12013318|FG005|Main Phase Stage 2|Progressive Disease|6
7605879|NCT01981850|12013319|FG006|Main Phase Stage 2|Progressive Disease|6
7605880|NCT01981850|12013320|FG007|Main Phase Stage 2|Progressive Disease|0
7605881|NCT01981850|12013321|FG008|Main Phase Stage 2|Progressive Disease|0
7605882|NCT01981850|12013322|FG009|Main Phase Stage 2|Progressive Disease|0
7605883|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Adverse Event|0
7605884|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Adverse Event|0
7605885|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Adverse Event|0
7605886|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Adverse Event|0
7605887|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Adverse Event|0
7605888|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Adverse Event|0
7605889|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Adverse Event|0
7605890|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Adverse Event|2
7605891|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Adverse Event|1
7605892|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Adverse Event|8
7605893|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
7605894|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
7605895|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
7275094|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7275095|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7275096|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
7275097|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
7275098|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
7275099|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Non-compliance|0
7275100|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Non-compliance|0
7275101|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Non-compliance|0
7275102|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Non-compliance|1
7275103|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Non-compliance|1
7275104|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
7275105|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
7275106|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
7275107|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
7275108|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
7275109|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
7275110|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
7275111|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
7275112|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
7275113|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
7275114|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7275115|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7275116|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
7275117|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
7275118|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
7275119|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Pregnancy|0
7275120|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Pregnancy|0
7275121|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Pregnancy|0
7275122|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Pregnancy|3
7275123|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Pregnancy|0
7275124|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Participant Moved|0
7275125|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Participant Moved|0
7275126|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Participant Moved|0
7275127|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Participant Moved|1
7275128|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Participant Moved|1
7275129|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
7275130|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
7275131|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
7275132|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
7275133|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
7275134|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7275135|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7275136|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
7275137|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7605896|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
7605897|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
7605898|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
7605899|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
7605900|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
7605901|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
7605902|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
7605903|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Various reasons|0
7605904|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Various reasons|0
7605905|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Various reasons|0
7605906|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Various reasons|0
7605907|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Various reasons|0
7605908|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Various reasons|0
7605909|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Various reasons|0
7605910|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Various reasons|3
7605911|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Various reasons|1
7605912|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Various reasons|3
7605913|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Progressive Disease|0
7605914|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Progressive Disease|0
7275138|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
7275139|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Other|0
7275140|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Other|0
7605915|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Progressive Disease|0
7605916|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Progressive Disease|0
7605917|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Progressive Disease|0
7605918|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Progressive Disease|0
7605919|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Progressive Disease|0
7605920|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Progressive Disease|3
7605921|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Progressive Disease|2
7605922|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Progressive Disease|9
7605923|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605924|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605925|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605926|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605927|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605928|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7275141|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Other|0
7605929|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605930|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605931|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
7605932|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
7605933|NCT01981850|12013313|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
7605934|NCT01981850|12013314|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
7605935|NCT01981850|12013315|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
7605936|NCT01981850|12013316|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
7605937|NCT01981850|12013317|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
7605938|NCT01981850|12013318|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
7605939|NCT01981850|12013319|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
7605940|NCT01981850|12013320|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
7605941|NCT01981850|12013321|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
7605942|NCT01981850|12013322|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
7605943|NCT01804816|12013354|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
7605944|NCT01804816|12013354|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
7605945|NCT01519960|12013388|FG000|Overall Study|Ongoing in Follow-Up|101
7605946|NCT01519960|12013389|FG001|Overall Study|Ongoing in Follow-Up|11
7605947|NCT01519960|12013390|FG002|Overall Study|Ongoing in Follow-Up|10
7605948|NCT01519960|12013388|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
7605949|NCT01519960|12013389|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
7605950|NCT01519960|12013390|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
7605951|NCT01519960|12013388|FG000|Overall Study|Adverse Event|0
7605952|NCT01519960|12013389|FG001|Overall Study|Adverse Event|1
7605953|NCT01519960|12013390|FG002|Overall Study|Adverse Event|0
7605954|NCT01519960|12013388|FG000|Overall Study|Withdrawal by Subject|0
7605955|NCT01519960|12013389|FG001|Overall Study|Withdrawal by Subject|4
7605956|NCT01519960|12013390|FG002|Overall Study|Withdrawal by Subject|0
7605957|NCT01519960|12013388|FG000|Overall Study|Lost to Follow-up|0
7605958|NCT01519960|12013389|FG001|Overall Study|Lost to Follow-up|1
7605959|NCT01519960|12013390|FG002|Overall Study|Lost to Follow-up|0
7605960|NCT00688376|12013403|FG000|Double-Blind Phase|Adverse Event|4
7605961|NCT00688376|12013404|FG001|Double-Blind Phase|Adverse Event|4
7605962|NCT00688376|12013403|FG000|Double-Blind Phase|Protocol Violation|1
7605963|NCT00688376|12013404|FG001|Double-Blind Phase|Protocol Violation|2
7605964|NCT00688376|12013403|FG000|Double-Blind Phase|Withdrawal by Subject|1
7605965|NCT00688376|12013404|FG001|Double-Blind Phase|Withdrawal by Subject|0
7605966|NCT00688376|12013403|FG000|Double-Blind Phase|Not treated|0
7605967|NCT00688376|12013404|FG001|Double-Blind Phase|Not treated|1
7605968|NCT00688376|12013403|FG000|Blinded Extension Phase|Adverse Event|3
7605969|NCT00688376|12013404|FG001|Blinded Extension Phase|Adverse Event|4
7605970|NCT00688376|12013403|FG000|Blinded Extension Phase|Withdrawal by Subject|0
7605971|NCT00688376|12013404|FG001|Blinded Extension Phase|Withdrawal by Subject|1
7605972|NCT00688376|12013403|FG000|Blinded Extension Phase|Physician Decision|1
7605973|NCT00688376|12013404|FG001|Blinded Extension Phase|Physician Decision|0
7605974|NCT00688376|12013403|FG000|Blinded Extension Phase|Other|1
7605975|NCT00688376|12013404|FG001|Blinded Extension Phase|Other|0
7275142|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Other|1
7275143|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Other|0
7275144|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Physician Decision|0
7275145|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Physician Decision|0
7275146|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Physician Decision|0
7275147|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Physician Decision|0
7275148|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Physician Decision|1
7275149|NCT00440947|11489619|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7275150|NCT00440947|11489620|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7275151|NCT00440947|11489621|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7275152|NCT00440947|11489622|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
7275153|NCT00440947|11489623|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
7469715|NCT01926509|11771635|FG002|Overall Study|vital sign met discontinuation criteria|0
7469716|NCT01926509|11771636|FG003|Overall Study|vital sign met discontinuation criteria|0
7469717|NCT01926626|11771646|FG000|Overall Study|Withdrawal by Subject|15
7469718|NCT01926626|11771646|FG000|Overall Study|Lost to Follow-up|7
7469719|NCT01926782|11771656|FG000|Overall Study|Participant moved|2
7469720|NCT01926782|11771657|FG001|Overall Study|Participant moved|0
7469721|NCT01926782|11771658|FG002|Overall Study|Participant moved|1
7469722|NCT01926782|11771659|FG003|Overall Study|Participant moved|1
7469723|NCT01926782|11771660|FG004|Overall Study|Participant moved|0
7469724|NCT01926782|11771661|FG005|Overall Study|Participant moved|3
7469725|NCT01926782|11771656|FG000|Overall Study|Physician Decision|0
7469726|NCT01926782|11771657|FG001|Overall Study|Physician Decision|2
7469727|NCT01926782|11771658|FG002|Overall Study|Physician Decision|1
7469728|NCT01926782|11771659|FG003|Overall Study|Physician Decision|1
7469729|NCT01926782|11771660|FG004|Overall Study|Physician Decision|0
7605976|NCT00121108|12013431|FG000|Overall Study|Lost to Follow-up|10
7605977|NCT00121108|12013432|FG001|Overall Study|Lost to Follow-up|22
7605978|NCT00121108|12013431|FG000|Overall Study|Withdrawal by Subject|106
7605979|NCT00121108|12013432|FG001|Overall Study|Withdrawal by Subject|195
7605980|NCT00121108|12013431|FG000|Overall Study|Death|5
7605981|NCT00121108|12013432|FG001|Overall Study|Death|8
7605982|NCT00003102|12013442|FG000|Overall Study|Physician Decision|1
7605983|NCT00003102|12013443|FG001|Overall Study|Physician Decision|1
7605984|NCT00003102|12013444|FG002|Overall Study|Physician Decision|0
7605985|NCT00003102|12013442|FG000|Overall Study|Progressive Disease|0
7605986|NCT00003102|12013443|FG001|Overall Study|Progressive Disease|1
7469730|NCT01926782|11771661|FG005|Overall Study|Physician Decision|0
7469731|NCT01926782|11771656|FG000|Overall Study|Other than specified|2
7469732|NCT01926782|11771657|FG001|Overall Study|Other than specified|3
7469733|NCT01926782|11771658|FG002|Overall Study|Other than specified|5
7605987|NCT00003102|12013444|FG002|Overall Study|Progressive Disease|0
7605988|NCT00003102|12013442|FG000|Overall Study|Adverse Event|0
7605989|NCT00003102|12013443|FG001|Overall Study|Adverse Event|1
7605990|NCT00003102|12013444|FG002|Overall Study|Adverse Event|1
7605991|NCT00003102|12013442|FG000|Overall Study|Death|0
7605992|NCT00003102|12013443|FG001|Overall Study|Death|0
7605993|NCT00003102|12013444|FG002|Overall Study|Death|1
7605994|NCT04633837|12013454|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
7605995|NCT04633837|12013455|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
7605996|NCT04057937|12013463|FG000|Placebo-controlled Phase|Adverse Event|3
7605997|NCT04057937|12013464|FG001|Placebo-controlled Phase|Adverse Event|0
7605998|NCT04057937|12013463|FG000|Active-treatment Phase|Withdrawal by Subject|1
7605999|NCT04057937|12013464|FG001|Active-treatment Phase|Withdrawal by Subject|0
7606000|NCT04057937|12013463|FG000|Active-treatment Phase|Pregnancy|0
7606001|NCT04057937|12013464|FG001|Active-treatment Phase|Pregnancy|1
7606002|NCT04057937|12013463|FG000|Active-treatment Phase|Physician Decision|0
7606003|NCT04057937|12013464|FG001|Active-treatment Phase|Physician Decision|1
7606004|NCT03032510|12013477|FG000|Overall Study|Adverse Event|5
7606005|NCT03032510|12013478|FG001|Overall Study|Adverse Event|2
7606006|NCT03032510|12013477|FG000|Overall Study|Lost to Follow-up|8
7606007|NCT03032510|12013478|FG001|Overall Study|Lost to Follow-up|7
7606008|NCT03032510|12013477|FG000|Overall Study|Withdrawal by Subject|8
7606009|NCT03032510|12013478|FG001|Overall Study|Withdrawal by Subject|7
7606010|NCT03032510|12013477|FG000|Overall Study|Subject noncompliance|4
7606011|NCT03032510|12013478|FG001|Overall Study|Subject noncompliance|2
7606012|NCT03032510|12013477|FG000|Overall Study|Physician Decision|2
7606013|NCT03032510|12013478|FG001|Overall Study|Physician Decision|0
7606014|NCT02946047|12013509|FG000|Overall Study|Adverse Event|1
7606015|NCT02946047|12013510|FG001|Overall Study|Adverse Event|0
7606016|NCT02946047|12013511|FG002|Overall Study|Adverse Event|0
7606017|NCT02946047|12013512|FG003|Overall Study|Adverse Event|0
7606018|NCT02784704|12013530|FG000|Overall Study|Adverse Event|4
7606019|NCT02784704|12013531|FG001|Overall Study|Adverse Event|2
7606020|NCT02784704|12013530|FG000|Overall Study|Lost to Follow-up|6
7606021|NCT02784704|12013531|FG001|Overall Study|Lost to Follow-up|4
7606022|NCT02784704|12013530|FG000|Overall Study|Withdrawal by Subject|1
7606023|NCT02784704|12013531|FG001|Overall Study|Withdrawal by Subject|3
7606024|NCT02784704|12013530|FG000|Overall Study|Subject Non Compliance|2
7606025|NCT02784704|12013531|FG001|Overall Study|Subject Non Compliance|0
7606026|NCT04831515|12013539|FG000|First Intervention|Adverse Event|0
7606027|NCT04831515|12013540|FG001|First Intervention|Adverse Event|1
7606028|NCT04634409|12013573|FG000|Overall Study|Death|0
7606029|NCT04634409|12013574|FG001|Overall Study|Death|0
7606030|NCT04634409|12013575|FG002|Overall Study|Death|0
7606031|NCT04634409|12013576|FG003|Overall Study|Death|0
7606032|NCT04634409|12013577|FG004|Overall Study|Death|0
7606033|NCT04634409|12013578|FG005|Overall Study|Death|0
7606034|NCT04634409|12013579|FG006|Overall Study|Death|0
7606035|NCT04634409|12013580|FG007|Overall Study|Death|0
7606036|NCT04634409|12013581|FG008|Overall Study|Death|0
7606037|NCT04634409|12013582|FG009|Overall Study|Death|0
7606038|NCT04634409|12013583|FG010|Overall Study|Death|1
7606039|NCT04634409|12013584|FG011|Overall Study|Death|0
7606040|NCT04634409|12013585|FG012|Overall Study|Death|1
7606041|NCT04634409|12013586|FG013|Overall Study|Death|0
7606042|NCT04634409|12013587|FG014|Overall Study|Death|0
7606043|NCT04634409|12013588|FG015|Overall Study|Death|0
7606044|NCT04634409|12013589|FG016|Overall Study|Death|0
7606045|NCT04634409|12013590|FG017|Overall Study|Death|0
7606046|NCT04634409|12013591|FG018|Overall Study|Death|0
7606047|NCT04634409|12013592|FG019|Overall Study|Death|0
7606048|NCT04634409|12013593|FG020|Overall Study|Death|0
7606049|NCT04634409|12013594|FG021|Overall Study|Death|0
7606050|NCT04634409|12013595|FG022|Overall Study|Death|0
7606051|NCT04634409|12013596|FG023|Overall Study|Death|0
7606052|NCT04634409|12013597|FG024|Overall Study|Death|0
7606053|NCT04634409|12013598|FG025|Overall Study|Death|0
7606054|NCT04634409|12013599|FG026|Overall Study|Death|0
7606055|NCT04634409|12013573|FG000|Overall Study|Adverse Event|0
7606056|NCT04634409|12013574|FG001|Overall Study|Adverse Event|0
7606057|NCT04634409|12013575|FG002|Overall Study|Adverse Event|1
7606058|NCT04634409|12013576|FG003|Overall Study|Adverse Event|0
7606059|NCT04634409|12013577|FG004|Overall Study|Adverse Event|0
7606060|NCT04634409|12013578|FG005|Overall Study|Adverse Event|1
7606061|NCT04634409|12013579|FG006|Overall Study|Adverse Event|0
7606062|NCT04634409|12013580|FG007|Overall Study|Adverse Event|0
7606063|NCT04634409|12013581|FG008|Overall Study|Adverse Event|0
7606064|NCT04634409|12013582|FG009|Overall Study|Adverse Event|0
7606065|NCT04634409|12013583|FG010|Overall Study|Adverse Event|0
7606066|NCT04634409|12013584|FG011|Overall Study|Adverse Event|0
7606067|NCT04634409|12013585|FG012|Overall Study|Adverse Event|0
7606068|NCT04634409|12013586|FG013|Overall Study|Adverse Event|0
7606069|NCT04634409|12013587|FG014|Overall Study|Adverse Event|0
7606070|NCT04634409|12013588|FG015|Overall Study|Adverse Event|0
7606071|NCT04634409|12013589|FG016|Overall Study|Adverse Event|0
7606072|NCT04634409|12013590|FG017|Overall Study|Adverse Event|0
7606073|NCT04634409|12013591|FG018|Overall Study|Adverse Event|0
7606074|NCT04634409|12013592|FG019|Overall Study|Adverse Event|0
7606075|NCT04634409|12013593|FG020|Overall Study|Adverse Event|0
7606076|NCT04634409|12013594|FG021|Overall Study|Adverse Event|0
7606077|NCT04634409|12013595|FG022|Overall Study|Adverse Event|0
7606078|NCT04634409|12013596|FG023|Overall Study|Adverse Event|0
7606079|NCT04634409|12013597|FG024|Overall Study|Adverse Event|0
7606080|NCT04634409|12013598|FG025|Overall Study|Adverse Event|0
7606081|NCT04634409|12013599|FG026|Overall Study|Adverse Event|0
7606082|NCT04634409|12013573|FG000|Overall Study|Lost to Follow-up|3
7606083|NCT04634409|12013574|FG001|Overall Study|Lost to Follow-up|1
7606084|NCT04634409|12013575|FG002|Overall Study|Lost to Follow-up|1
7606085|NCT04634409|12013576|FG003|Overall Study|Lost to Follow-up|3
7606086|NCT04634409|12013577|FG004|Overall Study|Lost to Follow-up|1
7275154|NCT00440999|11489637|FG000|Overall Study|Adverse Event|0
7275155|NCT00440999|11489638|FG001|Overall Study|Adverse Event|2
7275156|NCT00440999|11489637|FG000|Overall Study|Lack of Efficacy|6
7275157|NCT00440999|11489638|FG001|Overall Study|Lack of Efficacy|7
7275158|NCT00440999|11489637|FG000|Overall Study|Lost to Follow-up|19
7275159|NCT00440999|11489638|FG001|Overall Study|Lost to Follow-up|12
7275160|NCT00440999|11489637|FG000|Overall Study|Protocol Violation|1
7275161|NCT00440999|11489638|FG001|Overall Study|Protocol Violation|0
7275162|NCT00440999|11489637|FG000|Overall Study|Withdrawal by Subject|2
7275163|NCT00440999|11489638|FG001|Overall Study|Withdrawal by Subject|5
7275164|NCT00440999|11489637|FG000|Overall Study|Subjets missed the visit|1
7275165|NCT00440999|11489638|FG001|Overall Study|Subjets missed the visit|0
7275166|NCT00440999|11489637|FG000|Overall Study|Mixed infection at entry|1
7275167|NCT00440999|11489638|FG001|Overall Study|Mixed infection at entry|0
7275168|NCT00440999|11489637|FG000|Overall Study|P. falciparum malaria|5
7275169|NCT00440999|11489638|FG001|Overall Study|P. falciparum malaria|14
7275170|NCT00440999|11489637|FG000|Overall Study|Subj left hosp without inform staff|0
7275171|NCT00440999|11489638|FG001|Overall Study|Subj left hosp without inform staff|1
7275172|NCT00441012|11489648|FG000|Overall Study|Adverse Event|0
7275173|NCT00441012|11489649|FG001|Overall Study|Adverse Event|1
7275174|NCT00441012|11489648|FG000|Overall Study|Lost to Follow-up|3
7275175|NCT00441012|11489649|FG001|Overall Study|Lost to Follow-up|3
7275176|NCT00441012|11489648|FG000|Overall Study|Protocol Violation|10
7275177|NCT00441012|11489649|FG001|Overall Study|Protocol Violation|9
7275178|NCT00441012|11489648|FG000|Overall Study|Withdrawal by Subject|4
7275179|NCT00441012|11489649|FG001|Overall Study|Withdrawal by Subject|0
7275180|NCT00441012|11489648|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
7275181|NCT00441012|11489649|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
7275182|NCT00441064|11489657|FG000|Overall Study|Adverse Event|1
7275183|NCT00441064|11489658|FG001|Overall Study|Adverse Event|0
7275184|NCT00441064|11489657|FG000|Overall Study|Abnormal laboratory values|0
7275185|NCT00441064|11489658|FG001|Overall Study|Abnormal laboratory values|2
7275186|NCT00441064|11489657|FG000|Overall Study|Abnormal test procedure results|0
7275187|NCT00441064|11489658|FG001|Overall Study|Abnormal test procedure results|1
7275188|NCT00441064|11489657|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7275189|NCT00441064|11489658|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7275190|NCT00441064|11489657|FG000|Overall Study|Protocol Deviation|3
7275191|NCT00441064|11489658|FG001|Overall Study|Protocol Deviation|2
7275192|NCT00441064|11489657|FG000|Overall Study|Patient withdrew consent|5
7275193|NCT00441064|11489658|FG001|Overall Study|Patient withdrew consent|2
7275194|NCT00441090|11489669|FG000|Overall Study|Adverse Event|0
7275195|NCT00441090|11489670|FG001|Overall Study|Adverse Event|1
7275196|NCT00441090|11489671|FG002|Overall Study|Adverse Event|1
7275197|NCT00441090|11489672|FG003|Overall Study|Adverse Event|0
7275198|NCT00441090|11489673|FG004|Overall Study|Adverse Event|0
7275199|NCT00441090|11489669|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
7275200|NCT00441090|11489670|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
7275201|NCT00441090|11489671|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
7275202|NCT00441090|11489672|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
7275203|NCT00441090|11489673|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
7275204|NCT00441090|11489669|FG000|Overall Study|Withdrawal by Subject|1
7275205|NCT00441090|11489670|FG001|Overall Study|Withdrawal by Subject|0
7275206|NCT00441090|11489671|FG002|Overall Study|Withdrawal by Subject|1
7275207|NCT00441090|11489672|FG003|Overall Study|Withdrawal by Subject|0
7275208|NCT00441090|11489673|FG004|Overall Study|Withdrawal by Subject|0
7275209|NCT00441090|11489669|FG000|Overall Study|Lack of Efficacy|1
7275210|NCT00441090|11489670|FG001|Overall Study|Lack of Efficacy|0
7275211|NCT00441090|11489671|FG002|Overall Study|Lack of Efficacy|0
7275212|NCT00441090|11489672|FG003|Overall Study|Lack of Efficacy|0
7606087|NCT04634409|12013578|FG005|Overall Study|Lost to Follow-up|1
7606088|NCT04634409|12013579|FG006|Overall Study|Lost to Follow-up|1
7606089|NCT04634409|12013580|FG007|Overall Study|Lost to Follow-up|3
7606090|NCT04634409|12013581|FG008|Overall Study|Lost to Follow-up|3
7606091|NCT04634409|12013582|FG009|Overall Study|Lost to Follow-up|11
7606092|NCT04634409|12013583|FG010|Overall Study|Lost to Follow-up|8
7606093|NCT04634409|12013584|FG011|Overall Study|Lost to Follow-up|15
7606094|NCT04634409|12013585|FG012|Overall Study|Lost to Follow-up|3
7606095|NCT04634409|12013586|FG013|Overall Study|Lost to Follow-up|2
7275213|NCT00441090|11489673|FG004|Overall Study|Lack of Efficacy|0
7275214|NCT00441103|11489687|FG000|Overall Study|Adverse Event|2
7606096|NCT04634409|12013587|FG014|Overall Study|Lost to Follow-up|7
7606097|NCT04634409|12013588|FG015|Overall Study|Lost to Follow-up|0
7606098|NCT04634409|12013589|FG016|Overall Study|Lost to Follow-up|0
7606099|NCT04634409|12013590|FG017|Overall Study|Lost to Follow-up|0
7606100|NCT04634409|12013591|FG018|Overall Study|Lost to Follow-up|0
7606101|NCT04634409|12013592|FG019|Overall Study|Lost to Follow-up|0
7606102|NCT04634409|12013593|FG020|Overall Study|Lost to Follow-up|0
7606103|NCT04634409|12013594|FG021|Overall Study|Lost to Follow-up|0
7606104|NCT04634409|12013595|FG022|Overall Study|Lost to Follow-up|0
7606105|NCT04634409|12013596|FG023|Overall Study|Lost to Follow-up|0
7606106|NCT04634409|12013597|FG024|Overall Study|Lost to Follow-up|0
7606107|NCT04634409|12013598|FG025|Overall Study|Lost to Follow-up|0
7606108|NCT04634409|12013599|FG026|Overall Study|Lost to Follow-up|0
7606109|NCT04634409|12013573|FG000|Overall Study|Withdrawal by Subject|3
7606110|NCT04634409|12013574|FG001|Overall Study|Withdrawal by Subject|1
7606111|NCT04634409|12013575|FG002|Overall Study|Withdrawal by Subject|6
7606112|NCT04634409|12013576|FG003|Overall Study|Withdrawal by Subject|4
7606113|NCT04634409|12013577|FG004|Overall Study|Withdrawal by Subject|2
7606114|NCT04634409|12013578|FG005|Overall Study|Withdrawal by Subject|0
7606115|NCT04634409|12013579|FG006|Overall Study|Withdrawal by Subject|0
7606116|NCT04634409|12013580|FG007|Overall Study|Withdrawal by Subject|2
7606117|NCT04634409|12013581|FG008|Overall Study|Withdrawal by Subject|3
7606118|NCT04634409|12013582|FG009|Overall Study|Withdrawal by Subject|2
7606119|NCT04634409|12013583|FG010|Overall Study|Withdrawal by Subject|3
7606120|NCT04634409|12013584|FG011|Overall Study|Withdrawal by Subject|2
7606121|NCT04634409|12013585|FG012|Overall Study|Withdrawal by Subject|2
7606122|NCT04634409|12013586|FG013|Overall Study|Withdrawal by Subject|1
7275215|NCT00441103|11489688|FG001|Overall Study|Adverse Event|1
7275216|NCT00441103|11489687|FG000|Overall Study|Death|1
7275217|NCT00441103|11489688|FG001|Overall Study|Death|0
7275218|NCT00441103|11489687|FG000|Overall Study|Disease Progression|2
7275219|NCT00441103|11489688|FG001|Overall Study|Disease Progression|0
7275220|NCT00441103|11489687|FG000|Overall Study|Lost to Follow-up|1
7275221|NCT00441103|11489688|FG001|Overall Study|Lost to Follow-up|0
7275222|NCT00441103|11489687|FG000|Overall Study|Protocol Violation|1
7275223|NCT00441103|11489688|FG001|Overall Study|Protocol Violation|0
7275224|NCT00441103|11489687|FG000|Overall Study|Participant unable to use Rebiject II|1
7275225|NCT00441103|11489688|FG001|Overall Study|Participant unable to use Rebiject II|0
7275226|NCT00441103|11489687|FG000|Overall Study|Participant refused MRI|1
7606123|NCT04634409|12013587|FG014|Overall Study|Withdrawal by Subject|5
7606124|NCT04634409|12013588|FG015|Overall Study|Withdrawal by Subject|0
7606125|NCT04634409|12013589|FG016|Overall Study|Withdrawal by Subject|0
7606126|NCT04634409|12013590|FG017|Overall Study|Withdrawal by Subject|1
7606127|NCT04634409|12013591|FG018|Overall Study|Withdrawal by Subject|0
7606128|NCT04634409|12013592|FG019|Overall Study|Withdrawal by Subject|0
7606129|NCT04634409|12013593|FG020|Overall Study|Withdrawal by Subject|0
7606130|NCT04634409|12013594|FG021|Overall Study|Withdrawal by Subject|0
7606131|NCT04634409|12013595|FG022|Overall Study|Withdrawal by Subject|0
7606132|NCT04634409|12013596|FG023|Overall Study|Withdrawal by Subject|1
7606133|NCT04634409|12013597|FG024|Overall Study|Withdrawal by Subject|0
7606134|NCT04634409|12013598|FG025|Overall Study|Withdrawal by Subject|0
7606135|NCT04634409|12013599|FG026|Overall Study|Withdrawal by Subject|0
7275227|NCT00441103|11489688|FG001|Overall Study|Participant refused MRI|0
7275228|NCT00441103|11489687|FG000|Overall Study|Inclusion criteria absent|1
7275229|NCT00441103|11489688|FG001|Overall Study|Inclusion criteria absent|0
7275230|NCT00441103|11489687|FG000|Overall Study|Non-compliant|0
7606136|NCT04634409|12013573|FG000|Overall Study|Other - As reported by Investigator|1
7606137|NCT04634409|12013574|FG001|Overall Study|Other - As reported by Investigator|0
7606138|NCT04634409|12013575|FG002|Overall Study|Other - As reported by Investigator|0
7275231|NCT00441103|11489688|FG001|Overall Study|Non-compliant|1
7275232|NCT00441103|11489687|FG000|Overall Study|Participant decided to withdraw|1
7606139|NCT04634409|12013576|FG003|Overall Study|Other - As reported by Investigator|0
7606140|NCT04634409|12013577|FG004|Overall Study|Other - As reported by Investigator|0
7606141|NCT04634409|12013578|FG005|Overall Study|Other - As reported by Investigator|0
7606142|NCT04634409|12013579|FG006|Overall Study|Other - As reported by Investigator|0
7606143|NCT04634409|12013580|FG007|Overall Study|Other - As reported by Investigator|6
7606144|NCT04634409|12013581|FG008|Overall Study|Other - As reported by Investigator|4
7606145|NCT04634409|12013582|FG009|Overall Study|Other - As reported by Investigator|0
7606146|NCT04634409|12013583|FG010|Overall Study|Other - As reported by Investigator|1
7606147|NCT04634409|12013584|FG011|Overall Study|Other - As reported by Investigator|2
7606148|NCT04634409|12013585|FG012|Overall Study|Other - As reported by Investigator|2
7606149|NCT04634409|12013586|FG013|Overall Study|Other - As reported by Investigator|1
7606211|NCT03284424|12013765|FG001|Overall Study|Lost to Follow-up|0
7606150|NCT04634409|12013587|FG014|Overall Study|Other - As reported by Investigator|0
7606151|NCT04634409|12013588|FG015|Overall Study|Other - As reported by Investigator|0
7606152|NCT04634409|12013589|FG016|Overall Study|Other - As reported by Investigator|0
7606153|NCT04634409|12013590|FG017|Overall Study|Other - As reported by Investigator|0
7275233|NCT00441103|11489688|FG001|Overall Study|Participant decided to withdraw|0
7275234|NCT00441103|11489687|FG000|Overall Study|Participant's reason|0
7275235|NCT00441103|11489688|FG001|Overall Study|Participant's reason|1
7275236|NCT00441103|11489687|FG000|Overall Study|Participant decided to stop|0
7275237|NCT00441103|11489688|FG001|Overall Study|Participant decided to stop|1
7275238|NCT00441116|11489697|FG000|Overall Study|Adverse Event|1
7275239|NCT00441116|11489698|FG001|Overall Study|Adverse Event|1
7275240|NCT00441116|11489697|FG000|Overall Study|Withdrawal by Subject|1
7275241|NCT00441116|11489698|FG001|Overall Study|Withdrawal by Subject|0
7275242|NCT00441116|11489697|FG000|Overall Study|Did not meet Eligibility Criteria|1
7275243|NCT00441116|11489698|FG001|Overall Study|Did not meet Eligibility Criteria|1
7275244|NCT00441129|11489706|FG000|Overall Study|Withdrawal by Subject|6
7275245|NCT00441129|11489707|FG001|Overall Study|Withdrawal by Subject|14
7275246|NCT00441142|11489717|FG000|Overall Study|Adverse Event|2
7275247|NCT00441142|11489718|FG001|Overall Study|Adverse Event|3
7275248|NCT00441142|11489719|FG002|Overall Study|Adverse Event|3
7275249|NCT00441142|11489720|FG003|Overall Study|Adverse Event|22
7275250|NCT00441142|11489717|FG000|Overall Study|Lack of Efficacy|3
7275251|NCT00441142|11489718|FG001|Overall Study|Lack of Efficacy|3
7275252|NCT00441142|11489719|FG002|Overall Study|Lack of Efficacy|17
7275253|NCT00441142|11489720|FG003|Overall Study|Lack of Efficacy|32
7275254|NCT00441142|11489717|FG000|Overall Study|Withdrawal by Subject|0
7275255|NCT00441142|11489718|FG001|Overall Study|Withdrawal by Subject|0
7606154|NCT04634409|12013591|FG018|Overall Study|Other - As reported by Investigator|0
7606155|NCT04634409|12013592|FG019|Overall Study|Other - As reported by Investigator|0
7606156|NCT04634409|12013593|FG020|Overall Study|Other - As reported by Investigator|0
7606157|NCT04634409|12013594|FG021|Overall Study|Other - As reported by Investigator|0
7606158|NCT04634409|12013595|FG022|Overall Study|Other - As reported by Investigator|0
7606159|NCT04634409|12013596|FG023|Overall Study|Other - As reported by Investigator|0
7606160|NCT04634409|12013597|FG024|Overall Study|Other - As reported by Investigator|0
7606161|NCT04634409|12013598|FG025|Overall Study|Other - As reported by Investigator|0
7606162|NCT04634409|12013599|FG026|Overall Study|Other - As reported by Investigator|0
7606163|NCT03502681|12013704|FG000|Overall Study|Adverse Event|1
7606164|NCT03502681|12013705|FG001|Overall Study|Adverse Event|1
7606165|NCT03502681|12013704|FG000|Overall Study|Disease Progression|2
7606166|NCT03502681|12013705|FG001|Overall Study|Disease Progression|1
7606167|NCT03405662|12013712|FG000|Overall Study|COVID-19 restriction|1
7606168|NCT03405662|12013713|FG001|Overall Study|COVID-19 restriction|0
7606169|NCT03405662|12013712|FG000|Overall Study|unblinding|0
7606170|NCT03405662|12013713|FG001|Overall Study|unblinding|1
7606171|NCT03405662|12013712|FG000|Overall Study|placement in memory care facility|0
7606172|NCT03405662|12013713|FG001|Overall Study|placement in memory care facility|2
7606173|NCT03334435|12013728|FG000|Overall Study|Ongoing as of Week 52|70
7606174|NCT03334435|12013729|FG001|Overall Study|Ongoing as of Week 52|32
7606175|NCT03334435|12013730|FG002|Overall Study|Ongoing as of Week 52|379
7606176|NCT03334435|12013731|FG003|Overall Study|Ongoing as of Week 52|519
7606177|NCT03334435|12013732|FG004|Overall Study|Ongoing as of Week 52|146
7606178|NCT03334435|12013728|FG000|Overall Study|Lack of Efficacy|3
7606179|NCT03334435|12013729|FG001|Overall Study|Lack of Efficacy|5
7606180|NCT03334435|12013730|FG002|Overall Study|Lack of Efficacy|76
7606181|NCT03334435|12013731|FG003|Overall Study|Lack of Efficacy|140
7606182|NCT03334435|12013732|FG004|Overall Study|Lack of Efficacy|61
7606183|NCT03334435|12013728|FG000|Overall Study|Adverse Event|2
7606184|NCT03334435|12013729|FG001|Overall Study|Adverse Event|1
7606185|NCT03334435|12013730|FG002|Overall Study|Adverse Event|9
7606186|NCT03334435|12013731|FG003|Overall Study|Adverse Event|23
7606187|NCT03334435|12013732|FG004|Overall Study|Adverse Event|13
7606188|NCT03334435|12013728|FG000|Overall Study|Withdrawal by Subject|11
7606189|NCT03334435|12013729|FG001|Overall Study|Withdrawal by Subject|4
7606190|NCT03334435|12013730|FG002|Overall Study|Withdrawal by Subject|38
7606191|NCT03334435|12013731|FG003|Overall Study|Withdrawal by Subject|42
7606192|NCT03334435|12013732|FG004|Overall Study|Withdrawal by Subject|20
7606193|NCT03334435|12013728|FG000|Overall Study|Lost to Follow-up|3
7606194|NCT03334435|12013729|FG001|Overall Study|Lost to Follow-up|0
7606195|NCT03334435|12013730|FG002|Overall Study|Lost to Follow-up|2
7606196|NCT03334435|12013731|FG003|Overall Study|Lost to Follow-up|1
7606197|NCT03334435|12013732|FG004|Overall Study|Lost to Follow-up|1
7606198|NCT03334435|12013728|FG000|Overall Study|Death|0
7606199|NCT03334435|12013729|FG001|Overall Study|Death|0
7606200|NCT03334435|12013730|FG002|Overall Study|Death|0
7606201|NCT03334435|12013731|FG003|Overall Study|Death|1
7606202|NCT03334435|12013732|FG004|Overall Study|Death|0
7606203|NCT03334435|12013728|FG000|Overall Study|Other|0
7606204|NCT03334435|12013729|FG001|Overall Study|Other|1
7606205|NCT03334435|12013730|FG002|Overall Study|Other|3
7606206|NCT03334435|12013731|FG003|Overall Study|Other|2
7606207|NCT03334435|12013732|FG004|Overall Study|Other|1
7606208|NCT03284424|12013764|FG000|Overall Study|Death|56
7606209|NCT03284424|12013765|FG001|Overall Study|Death|13
7606210|NCT03284424|12013764|FG000|Overall Study|Lost to Follow-up|1
7606212|NCT03284424|12013764|FG000|Overall Study|Physician Decision|1
7606213|NCT03284424|12013765|FG001|Overall Study|Physician Decision|0
7606214|NCT03284424|12013764|FG000|Overall Study|Withdrawal by Subject|3
7606215|NCT03284424|12013765|FG001|Overall Study|Withdrawal by Subject|2
7606216|NCT03284424|12013764|FG000|Overall Study|Ongoing in study|44
7606217|NCT03284424|12013765|FG001|Overall Study|Ongoing in study|39
7606266|NCT02963766|12013795|FG000|Double-Blind Period|Adverse Event|1
7275256|NCT00441142|11489719|FG002|Overall Study|Withdrawal by Subject|2
7275257|NCT00441142|11489720|FG003|Overall Study|Withdrawal by Subject|10
7275258|NCT00441142|11489717|FG000|Overall Study|Patient still receiving active study tx|1
7275259|NCT00441142|11489718|FG001|Overall Study|Patient still receiving active study tx|0
7275260|NCT00441142|11489719|FG002|Overall Study|Patient still receiving active study tx|0
7275261|NCT00441142|11489720|FG003|Overall Study|Patient still receiving active study tx|2
7275262|NCT00441142|11489717|FG000|Overall Study|Physician Decision|0
7275263|NCT00441142|11489718|FG001|Overall Study|Physician Decision|1
7275264|NCT00441142|11489719|FG002|Overall Study|Physician Decision|0
7275265|NCT00441142|11489720|FG003|Overall Study|Physician Decision|1
7275266|NCT00441142|11489717|FG000|Overall Study|Death|0
7275267|NCT00441142|11489718|FG001|Overall Study|Death|0
7275268|NCT00441142|11489719|FG002|Overall Study|Death|0
7275269|NCT00441142|11489720|FG003|Overall Study|Death|1
7275270|NCT00441168|11489734|FG000|Treatment Period|Death|3
7275271|NCT00441168|11489735|FG001|Treatment Period|Death|0
7275272|NCT00441168|11489734|FG000|Treatment Period|Adverse Event|1
7275273|NCT00441168|11489735|FG001|Treatment Period|Adverse Event|2
7275274|NCT00441168|11489734|FG000|Treatment Period|Progressive Disease|0
7275275|NCT00441168|11489735|FG001|Treatment Period|Progressive Disease|2
7275276|NCT00441168|11489734|FG000|Treatment Period|Protocol Violation|0
7275277|NCT00441168|11489735|FG001|Treatment Period|Protocol Violation|1
7275278|NCT00441168|11489734|FG000|Treatment Period|Lost to Follow-up|0
7275279|NCT00441168|11489735|FG001|Treatment Period|Lost to Follow-up|1
7275280|NCT00441168|11489734|FG000|Treatment Period|Withdrawal by Subject|3
7275281|NCT00441168|11489735|FG001|Treatment Period|Withdrawal by Subject|0
7275282|NCT00441168|11489734|FG000|Treatment Period|qualified for stem-cell transplantation|3
7275283|NCT00441168|11489735|FG001|Treatment Period|qualified for stem-cell transplantation|0
7275284|NCT00441168|11489734|FG000|Treatment Period|refractory disease|1
7606267|NCT02963766|12013796|FG001|Double-Blind Period|Adverse Event|0
7606268|NCT02963766|12013797|FG002|Double-Blind Period|Adverse Event|1
7606269|NCT02963766|12013795|FG000|Double-Blind Period|Physician Decision|1
7606270|NCT02963766|12013796|FG001|Double-Blind Period|Physician Decision|0
7606271|NCT02963766|12013797|FG002|Double-Blind Period|Physician Decision|0
7275285|NCT00441168|11489735|FG001|Treatment Period|refractory disease|0
7275286|NCT00441168|11489734|FG000|Follow-up Period|Death|3
7275287|NCT00441168|11489735|FG001|Follow-up Period|Death|0
7275288|NCT00441168|11489734|FG000|Follow-up Period|Lost to Follow-up|5
7275289|NCT00441168|11489735|FG001|Follow-up Period|Lost to Follow-up|6
7275290|NCT00441168|11489734|FG000|Follow-up Period|Withdrawal by Subject|3
7275291|NCT00441168|11489735|FG001|Follow-up Period|Withdrawal by Subject|0
7606272|NCT02963766|12013795|FG000|Double-Blind Period|Withdrawal by Subject|1
7606273|NCT02963766|12013796|FG001|Double-Blind Period|Withdrawal by Subject|1
7606274|NCT02963766|12013797|FG002|Double-Blind Period|Withdrawal by Subject|0
7275292|NCT00441168|11489734|FG000|Follow-up Period|Other|1
7606275|NCT02963766|12013795|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0
7606276|NCT02963766|12013796|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0
7606277|NCT02963766|12013797|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1
7606278|NCT02963766|12013795|FG000|Double-Blind Period|Protocol Violation|1
7606279|NCT02963766|12013796|FG001|Double-Blind Period|Protocol Violation|0
7606280|NCT02963766|12013797|FG002|Double-Blind Period|Protocol Violation|0
7606281|NCT02963766|12013795|FG000|Double-Blind Period|Lost to Follow-up|0
7606282|NCT02963766|12013796|FG001|Double-Blind Period|Lost to Follow-up|1
7606283|NCT02963766|12013797|FG002|Double-Blind Period|Lost to Follow-up|0
7606284|NCT02963766|12013795|FG000|Open Label Extension (OLE)|Physician Decision|1
7606285|NCT02963766|12013796|FG001|Open Label Extension (OLE)|Physician Decision|2
7606286|NCT02963766|12013797|FG002|Open Label Extension (OLE)|Physician Decision|2
7606287|NCT02963766|12013795|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1
7606288|NCT02963766|12013796|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1
7606289|NCT02963766|12013797|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0
7606290|NCT02795182|12013819|FG000|Overall Study|Death|5
7606291|NCT02795182|12013820|FG001|Overall Study|Death|4
7275293|NCT00441168|11489735|FG001|Follow-up Period|Other|3
7275294|NCT00441337|11489775|FG000|Overall Study|Disease Progression|6
7275295|NCT00441337|11489776|FG001|Overall Study|Disease Progression|6
7275296|NCT00441337|11489777|FG002|Overall Study|Disease Progression|4
7275297|NCT00441337|11489778|FG003|Overall Study|Disease Progression|18
7275298|NCT00441337|11489775|FG000|Overall Study|Lost to Follow-up|0
7275299|NCT00441337|11489776|FG001|Overall Study|Lost to Follow-up|0
7275300|NCT00441337|11489777|FG002|Overall Study|Lost to Follow-up|0
7275301|NCT00441337|11489778|FG003|Overall Study|Lost to Follow-up|1
7275302|NCT00441337|11489775|FG000|Overall Study|Sponsor Decision|0
7275303|NCT00441337|11489776|FG001|Overall Study|Sponsor Decision|0
7275304|NCT00441337|11489777|FG002|Overall Study|Sponsor Decision|1
7275305|NCT00441337|11489778|FG003|Overall Study|Sponsor Decision|2
7275306|NCT00441337|11489775|FG000|Overall Study|Did not meet inclusion criteria|0
7275307|NCT00441337|11489776|FG001|Overall Study|Did not meet inclusion criteria|0
7275308|NCT00441337|11489777|FG002|Overall Study|Did not meet inclusion criteria|1
7275309|NCT00441337|11489778|FG003|Overall Study|Did not meet inclusion criteria|0
7275310|NCT00441363|11489819|FG000|Overall Study|Adverse Event|4
7275311|NCT00441363|11489820|FG001|Overall Study|Adverse Event|2
7275312|NCT00441363|11489819|FG000|Overall Study|Withdrawal by Subject|3
7275313|NCT00441363|11489820|FG001|Overall Study|Withdrawal by Subject|4
7275314|NCT00441363|11489819|FG000|Overall Study|Physician Decision|6
7275315|NCT00441363|11489820|FG001|Overall Study|Physician Decision|7
7275316|NCT00441363|11489819|FG000|Overall Study|Lost to Follow-up|2
7275317|NCT00441363|11489820|FG001|Overall Study|Lost to Follow-up|2
7275318|NCT00441363|11489819|FG000|Overall Study|Other|2
7275319|NCT00441363|11489820|FG001|Overall Study|Other|0
7275320|NCT00441441|11489828|FG000|Overall Study|Adverse Event|2
7275321|NCT00441441|11489829|FG001|Overall Study|Adverse Event|1
7275322|NCT00441441|11489828|FG000|Overall Study|Protocol Violation|4
7275323|NCT00441441|11489829|FG001|Overall Study|Protocol Violation|6
7275324|NCT00441441|11489828|FG000|Overall Study|Exacerbation of asthma|1
7275325|NCT00441441|11489829|FG001|Overall Study|Exacerbation of asthma|2
7606292|NCT02795182|12013821|FG002|Overall Study|Death|4
7606293|NCT02795182|12013822|FG003|Overall Study|Death|18
7606294|NCT02795182|12013819|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606295|NCT02795182|12013820|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606296|NCT02795182|12013821|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0
7606297|NCT02795182|12013822|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1
7606298|NCT02795182|12013819|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606299|NCT02795182|12013820|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606300|NCT02795182|12013821|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0
7606301|NCT02795182|12013822|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2
7606302|NCT02795182|12013819|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3
7606303|NCT02795182|12013820|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2
7606304|NCT02795182|12013821|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0
7606305|NCT02795182|12013822|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8
7606306|NCT02795182|12013819|FG000|Overall Study|Withdrawal by Subject|4
7606307|NCT02795182|12013820|FG001|Overall Study|Withdrawal by Subject|0
7606308|NCT02795182|12013821|FG002|Overall Study|Withdrawal by Subject|0
7275326|NCT00441441|11489828|FG000|Overall Study|Withdrawal by Subject|1
7275327|NCT00441441|11489829|FG001|Overall Study|Withdrawal by Subject|2
7275328|NCT00441441|11489828|FG000|Overall Study|Other|3
7275329|NCT00441441|11489829|FG001|Overall Study|Other|3
7606309|NCT02795182|12013822|FG003|Overall Study|Withdrawal by Subject|3
7606310|NCT02795182|12013819|FG000|Overall Study|Lost to Follow-up|0
7606311|NCT02795182|12013820|FG001|Overall Study|Lost to Follow-up|0
7606312|NCT02795182|12013821|FG002|Overall Study|Lost to Follow-up|1
7275330|NCT00441467|11489849|FG000|Overall Study|Adverse Event|6
7275331|NCT00441467|11489849|FG000|Overall Study|Withdrawal by Subject|3
7275332|NCT00441467|11489849|FG000|Overall Study|Progressive disease|9
7606313|NCT02795182|12013822|FG003|Overall Study|Lost to Follow-up|1
7606314|NCT02795182|12013819|FG000|Overall Study|Roll Over to Long Term Extension|3
7606315|NCT02795182|12013820|FG001|Overall Study|Roll Over to Long Term Extension|3
7606316|NCT02795182|12013821|FG002|Overall Study|Roll Over to Long Term Extension|2
7606317|NCT02795182|12013822|FG003|Overall Study|Roll Over to Long Term Extension|5
7606318|NCT02795182|12013819|FG000|Overall Study|Progressive Disease|0
7606319|NCT02795182|12013820|FG001|Overall Study|Progressive Disease|1
7606320|NCT02795182|12013821|FG002|Overall Study|Progressive Disease|0
7606321|NCT02795182|12013822|FG003|Overall Study|Progressive Disease|4
7606322|NCT02795182|12013819|FG000|Overall Study|Physician Decision|0
7606323|NCT02795182|12013820|FG001|Overall Study|Physician Decision|0
7606324|NCT02795182|12013821|FG002|Overall Study|Physician Decision|0
7606325|NCT02795182|12013822|FG003|Overall Study|Physician Decision|1
7606326|NCT02674464|12013857|FG000|Overall Study|Death|10
7606327|NCT02674464|12013858|FG001|Overall Study|Death|21
7606328|NCT02674464|12013857|FG000|Overall Study|Withdrawal by Subject|24
7606329|NCT02674464|12013858|FG001|Overall Study|Withdrawal by Subject|44
7606330|NCT02674464|12013857|FG000|Overall Study|Lost to Follow-up|97
7606331|NCT02674464|12013858|FG001|Overall Study|Lost to Follow-up|92
7606332|NCT02674464|12013857|FG000|Overall Study|Outside survey window|6
7606333|NCT02674464|12013858|FG001|Overall Study|Outside survey window|3
7606334|NCT02318784|12013864|FG000|Overall Study|Adverse Event|13
7275333|NCT00441480|11489855|FG000|Overall Study|Protocol Violation|1
7275334|NCT00441480|11489856|FG001|Overall Study|Protocol Violation|1
7275335|NCT00441480|11489855|FG000|Overall Study|Withdrawal by Subject|2
7275336|NCT00441480|11489856|FG001|Overall Study|Withdrawal by Subject|3
7275337|NCT00441545|11489862|FG000|First Intervention|Adverse Event|6
7275338|NCT00441545|11489863|FG001|First Intervention|Adverse Event|5
7275339|NCT00441545|11489862|FG000|First Intervention|Protocol Violation|2
7275340|NCT00441545|11489863|FG001|First Intervention|Protocol Violation|2
7275341|NCT00441545|11489862|FG000|First Intervention|Withdrawal by Subject|3
7275342|NCT00441545|11489863|FG001|First Intervention|Withdrawal by Subject|3
7275343|NCT00441545|11489862|FG000|First Intervention|Kidney transplant|1
7275344|NCT00441545|11489863|FG001|First Intervention|Kidney transplant|1
7275345|NCT00441545|11489862|FG000|First Intervention|Lack of Efficacy|2
7275346|NCT00441545|11489863|FG001|First Intervention|Lack of Efficacy|0
7606335|NCT02318784|12013864|FG000|Overall Study|Death|2
7606336|NCT02318784|12013864|FG000|Overall Study|Progressive Disease|37
7606337|NCT02318784|12013864|FG000|Overall Study|Withdrawal by Subject|10
7606338|NCT02317991|12013868|FG000|Overall Study|Adverse Event|12
7606339|NCT02317991|12013868|FG000|Overall Study|Death|4
7606340|NCT02317991|12013868|FG000|Overall Study|Withdrawal by Subject|8
7606341|NCT02317991|12013868|FG000|Overall Study|Progressive Disease|41
7275347|NCT00441545|11489862|FG000|First Intervention|Subject exceeded safety criteria|0
7606372|NCT02260193|12013907|FG000|Overall Study|Lack of Efficacy|0
7606373|NCT02260193|12013908|FG001|Overall Study|Lack of Efficacy|1
7606374|NCT02260193|12013909|FG002|Overall Study|Lack of Efficacy|6
7606375|NCT02260193|12013907|FG000|Overall Study|Adverse Event|3
7606376|NCT02260193|12013908|FG001|Overall Study|Adverse Event|4
7606377|NCT02260193|12013909|FG002|Overall Study|Adverse Event|1
7606378|NCT02260193|12013907|FG000|Overall Study|Protocol Violation|0
7606379|NCT02260193|12013908|FG001|Overall Study|Protocol Violation|4
7606380|NCT02260193|12013909|FG002|Overall Study|Protocol Violation|0
7606381|NCT02260193|12013907|FG000|Overall Study|Withdrawal by Subject|3
7606382|NCT02260193|12013908|FG001|Overall Study|Withdrawal by Subject|0
7606383|NCT02260193|12013909|FG002|Overall Study|Withdrawal by Subject|2
7606384|NCT02260193|12013907|FG000|Overall Study|Kidney Transplantation|0
7606385|NCT02260193|12013908|FG001|Overall Study|Kidney Transplantation|0
7606386|NCT02260193|12013909|FG002|Overall Study|Kidney Transplantation|1
7275348|NCT00441545|11489863|FG001|First Intervention|Subject exceeded safety criteria|1
7275349|NCT00441545|11489862|FG000|First Intervention|Subject met an exclusionary criteria|1
7275350|NCT00441545|11489863|FG001|First Intervention|Subject met an exclusionary criteria|0
7275351|NCT00441545|11489862|FG000|First Intervention|Extended hospitalization|1
7275352|NCT00441545|11489863|FG001|First Intervention|Extended hospitalization|0
7275353|NCT00441545|11489862|FG000|First Intervention|Site error|1
7275354|NCT00441545|11489863|FG001|First Intervention|Site error|0
7275355|NCT00441545|11489862|FG000|First Intervention|Sponsor's request|1
7275356|NCT00441545|11489863|FG001|First Intervention|Sponsor's request|0
7275357|NCT00441545|11489862|FG000|Second Intervention|Adverse Event|5
7275358|NCT00441545|11489863|FG001|Second Intervention|Adverse Event|2
7275359|NCT00441545|11489862|FG000|Second Intervention|Protocol Violation|4
7275360|NCT00441545|11489863|FG001|Second Intervention|Protocol Violation|1
7275361|NCT00441545|11489862|FG000|Second Intervention|Withdrawal by Subject|1
7275362|NCT00441545|11489863|FG001|Second Intervention|Withdrawal by Subject|1
7275363|NCT00441545|11489862|FG000|Second Intervention|Kidney Transplant|1
7275364|NCT00441545|11489863|FG001|Second Intervention|Kidney Transplant|1
7275365|NCT00441545|11489862|FG000|Second Intervention|Lack of Efficacy|0
7275366|NCT00441545|11489863|FG001|Second Intervention|Lack of Efficacy|1
7275367|NCT00441545|11489862|FG000|Second Intervention|Subject exceeded safety criteria|1
7275368|NCT00441545|11489863|FG001|Second Intervention|Subject exceeded safety criteria|0
7275369|NCT00441545|11489862|FG000|Second Intervention|Subject moved|0
7275370|NCT00441545|11489863|FG001|Second Intervention|Subject moved|1
7275371|NCT00441584|11489873|FG000|Overall Study|Lack of Efficacy|79
7275372|NCT00441584|11489873|FG000|Overall Study|Withdrawal by Subject|8
7275373|NCT00441584|11489873|FG000|Overall Study|Adverse Event|6
7275374|NCT00441584|11489873|FG000|Overall Study|Protocol Violation|5
7275375|NCT00441584|11489873|FG000|Overall Study|Lost to Follow-up|4
7275376|NCT00441584|11489873|FG000|Overall Study|Failure to meet eligibility criteria|3
7275377|NCT00441701|11489887|FG000|Overall Study|Adverse Event|3
7275378|NCT00441701|11489888|FG001|Overall Study|Adverse Event|2
7275379|NCT00441701|11489889|FG002|Overall Study|Adverse Event|1
7275380|NCT00441701|11489890|FG003|Overall Study|Adverse Event|0
7275381|NCT00441701|11489891|FG004|Overall Study|Adverse Event|2
7275382|NCT00441701|11489892|FG005|Overall Study|Adverse Event|2
7275383|NCT00441701|11489893|FG006|Overall Study|Adverse Event|0
7606478|NCT01832402|12014012|FG000|Overall Study|Lost to Follow-up|2
7606479|NCT01832402|12014013|FG001|Overall Study|Lost to Follow-up|0
7606480|NCT01832402|12014012|FG000|Overall Study|Withdrawal by Subject|3
7606481|NCT01832402|12014013|FG001|Overall Study|Withdrawal by Subject|3
7606482|NCT01832402|12014012|FG000|Overall Study|Declining Performance status|2
7606483|NCT01832402|12014013|FG001|Overall Study|Declining Performance status|1
7606484|NCT01468922|12014032|FG000|Overall Study|Screening failure|0
7606485|NCT01468922|12014033|FG001|Overall Study|Screening failure|0
7606486|NCT01468922|12014034|FG002|Overall Study|Screening failure|0
7606487|NCT01468922|12014035|FG003|Overall Study|Screening failure|0
7606488|NCT01468922|12014036|FG004|Overall Study|Screening failure|0
7606489|NCT01468922|12014037|FG005|Overall Study|Screening failure|0
7606490|NCT01468922|12014038|FG006|Overall Study|Screening failure|0
7606491|NCT01468922|12014039|FG007|Overall Study|Screening failure|0
7606492|NCT01468922|12014040|FG008|Overall Study|Screening failure|1
7606493|NCT01468922|12014032|FG000|Overall Study|Per patient choice|1
7606494|NCT01468922|12014033|FG001|Overall Study|Per patient choice|0
7606495|NCT01468922|12014034|FG002|Overall Study|Per patient choice|0
7606496|NCT01468922|12014035|FG003|Overall Study|Per patient choice|0
7606497|NCT01468922|12014036|FG004|Overall Study|Per patient choice|0
7606498|NCT01468922|12014037|FG005|Overall Study|Per patient choice|0
7606499|NCT01468922|12014038|FG006|Overall Study|Per patient choice|0
7606500|NCT01468922|12014039|FG007|Overall Study|Per patient choice|0
7606501|NCT01468922|12014040|FG008|Overall Study|Per patient choice|0
7606502|NCT01468922|12014032|FG000|Overall Study|Switched to alternative treatment|1
7606503|NCT01468922|12014033|FG001|Overall Study|Switched to alternative treatment|0
7606504|NCT01468922|12014034|FG002|Overall Study|Switched to alternative treatment|0
7606505|NCT01468922|12014035|FG003|Overall Study|Switched to alternative treatment|0
7606506|NCT01468922|12014036|FG004|Overall Study|Switched to alternative treatment|1
7606507|NCT01468922|12014037|FG005|Overall Study|Switched to alternative treatment|0
7606508|NCT01468922|12014038|FG006|Overall Study|Switched to alternative treatment|0
7606509|NCT01468922|12014039|FG007|Overall Study|Switched to alternative treatment|0
7606510|NCT01468922|12014040|FG008|Overall Study|Switched to alternative treatment|0
7606511|NCT01468922|12014032|FG000|Overall Study|Enrolled on new protocol|0
7606512|NCT01468922|12014033|FG001|Overall Study|Enrolled on new protocol|0
7606513|NCT01468922|12014034|FG002|Overall Study|Enrolled on new protocol|0
7275384|NCT00441701|11489894|FG007|Overall Study|Adverse Event|0
7275385|NCT00441701|11489895|FG008|Overall Study|Adverse Event|0
7275386|NCT00441701|11489896|FG009|Overall Study|Adverse Event|0
7275387|NCT00441701|11489887|FG000|Overall Study|Lack of Efficacy|2
7275388|NCT00441701|11489888|FG001|Overall Study|Lack of Efficacy|0
7275389|NCT00441701|11489889|FG002|Overall Study|Lack of Efficacy|2
7275390|NCT00441701|11489890|FG003|Overall Study|Lack of Efficacy|2
7275391|NCT00441701|11489891|FG004|Overall Study|Lack of Efficacy|0
7275392|NCT00441701|11489892|FG005|Overall Study|Lack of Efficacy|1
7275393|NCT00441701|11489893|FG006|Overall Study|Lack of Efficacy|0
7275394|NCT00441701|11489894|FG007|Overall Study|Lack of Efficacy|0
7275395|NCT00441701|11489895|FG008|Overall Study|Lack of Efficacy|0
7275396|NCT00441701|11489896|FG009|Overall Study|Lack of Efficacy|0
7275397|NCT00441701|11489887|FG000|Overall Study|Withdrawal by Subject|0
7275398|NCT00441701|11489888|FG001|Overall Study|Withdrawal by Subject|2
7606514|NCT01468922|12014035|FG003|Overall Study|Enrolled on new protocol|0
7606515|NCT01468922|12014036|FG004|Overall Study|Enrolled on new protocol|1
7606516|NCT01468922|12014037|FG005|Overall Study|Enrolled on new protocol|0
7606517|NCT01468922|12014038|FG006|Overall Study|Enrolled on new protocol|0
7606518|NCT01468922|12014039|FG007|Overall Study|Enrolled on new protocol|0
7606519|NCT01468922|12014040|FG008|Overall Study|Enrolled on new protocol|0
7606520|NCT01468922|12014032|FG000|Overall Study|Adverse Event|0
7606521|NCT01468922|12014033|FG001|Overall Study|Adverse Event|0
7606522|NCT01468922|12014034|FG002|Overall Study|Adverse Event|0
7606523|NCT01468922|12014035|FG003|Overall Study|Adverse Event|0
7606524|NCT01468922|12014036|FG004|Overall Study|Adverse Event|0
7606525|NCT01468922|12014037|FG005|Overall Study|Adverse Event|0
7606526|NCT01468922|12014038|FG006|Overall Study|Adverse Event|0
7275399|NCT00441701|11489889|FG002|Overall Study|Withdrawal by Subject|1
7275400|NCT00441701|11489890|FG003|Overall Study|Withdrawal by Subject|1
7275401|NCT00441701|11489891|FG004|Overall Study|Withdrawal by Subject|0
7275402|NCT00441701|11489892|FG005|Overall Study|Withdrawal by Subject|0
7275403|NCT00441701|11489893|FG006|Overall Study|Withdrawal by Subject|0
7275404|NCT00441701|11489894|FG007|Overall Study|Withdrawal by Subject|0
7275405|NCT00441701|11489895|FG008|Overall Study|Withdrawal by Subject|0
7275406|NCT00441701|11489896|FG009|Overall Study|Withdrawal by Subject|0
7275407|NCT00441727|11489917|FG000|Overall Study|Protocol Violation|19
7275408|NCT00441727|11489918|FG001|Overall Study|Protocol Violation|28
7275409|NCT00441727|11489919|FG002|Overall Study|Protocol Violation|32
7275410|NCT00441727|11489917|FG000|Overall Study|Adverse Event|26
7275411|NCT00441727|11489918|FG001|Overall Study|Adverse Event|33
7275412|NCT00441727|11489919|FG002|Overall Study|Adverse Event|28
7275413|NCT00441727|11489917|FG000|Overall Study|Lack of Efficacy|7
7606527|NCT01468922|12014039|FG007|Overall Study|Adverse Event|1
7275414|NCT00441727|11489918|FG001|Overall Study|Lack of Efficacy|8
7275415|NCT00441727|11489919|FG002|Overall Study|Lack of Efficacy|48
7275416|NCT00441727|11489917|FG000|Overall Study|Withdrawal by Subject|40
7275417|NCT00441727|11489918|FG001|Overall Study|Withdrawal by Subject|34
7275418|NCT00441727|11489919|FG002|Overall Study|Withdrawal by Subject|47
7275419|NCT00441727|11489917|FG000|Overall Study|Lost to Follow-up|5
7606528|NCT01468922|12014040|FG008|Overall Study|Adverse Event|0
7606529|NCT01468922|12014032|FG000|Overall Study|Infection of blood|0
7606530|NCT01468922|12014033|FG001|Overall Study|Infection of blood|0
7606531|NCT01468922|12014034|FG002|Overall Study|Infection of blood|0
7606532|NCT01468922|12014035|FG003|Overall Study|Infection of blood|0
7606533|NCT01468922|12014036|FG004|Overall Study|Infection of blood|0
7606534|NCT01468922|12014037|FG005|Overall Study|Infection of blood|0
7606535|NCT01468922|12014038|FG006|Overall Study|Infection of blood|0
7606536|NCT01468922|12014039|FG007|Overall Study|Infection of blood|1
7606537|NCT01468922|12014040|FG008|Overall Study|Infection of blood|0
7606538|NCT01468922|12014032|FG000|Overall Study|Patient choice - surgery|0
7606539|NCT01468922|12014033|FG001|Overall Study|Patient choice - surgery|0
7606540|NCT01468922|12014034|FG002|Overall Study|Patient choice - surgery|0
7606541|NCT01468922|12014035|FG003|Overall Study|Patient choice - surgery|0
7606542|NCT01468922|12014036|FG004|Overall Study|Patient choice - surgery|0
7606543|NCT01468922|12014037|FG005|Overall Study|Patient choice - surgery|0
7606544|NCT01468922|12014038|FG006|Overall Study|Patient choice - surgery|0
7606545|NCT01468922|12014039|FG007|Overall Study|Patient choice - surgery|1
7606546|NCT01468922|12014040|FG008|Overall Study|Patient choice - surgery|0
7606547|NCT01468922|12014032|FG000|Overall Study|Refused further treatment|0
7606548|NCT01468922|12014033|FG001|Overall Study|Refused further treatment|0
7606549|NCT01468922|12014034|FG002|Overall Study|Refused further treatment|0
7606550|NCT01468922|12014035|FG003|Overall Study|Refused further treatment|0
7606551|NCT01468922|12014036|FG004|Overall Study|Refused further treatment|0
7606552|NCT01468922|12014037|FG005|Overall Study|Refused further treatment|0
7606553|NCT01468922|12014038|FG006|Overall Study|Refused further treatment|0
7606554|NCT01468922|12014039|FG007|Overall Study|Refused further treatment|1
7606555|NCT01468922|12014040|FG008|Overall Study|Refused further treatment|0
7606556|NCT01381094|12014063|FG000|Overall Study|Adverse Event|1
7606557|NCT01381094|12014064|FG001|Overall Study|Adverse Event|2
7275420|NCT00441727|11489918|FG001|Overall Study|Lost to Follow-up|6
7275421|NCT00441727|11489919|FG002|Overall Study|Lost to Follow-up|5
7275422|NCT00441727|11489917|FG000|Overall Study|Safety Reasons|3
7275423|NCT00441727|11489918|FG001|Overall Study|Safety Reasons|1
7275424|NCT00441727|11489919|FG002|Overall Study|Safety Reasons|3
7275425|NCT00441727|11489917|FG000|Overall Study|Various reason specified|6
7275426|NCT00441727|11489918|FG001|Overall Study|Various reason specified|8
7275427|NCT00441727|11489919|FG002|Overall Study|Various reason specified|5
7275428|NCT00441792|11489951|FG000|Overall Study|Lost to Follow-up|0
7275429|NCT00441792|11489952|FG001|Overall Study|Lost to Follow-up|2
7275430|NCT00441974|11489979|FG000|Overall Study|Adverse Event|6
7275431|NCT00441974|11489979|FG000|Overall Study|Consent Withdrawn|35
7275432|NCT00441974|11489979|FG000|Overall Study|Lost to Follow-up|80
7275433|NCT00441974|11489979|FG000|Overall Study|Protocol Violation|7
7275434|NCT00442286|11490024|FG000|Overall Study|Death|2
7275435|NCT00442286|11490025|FG001|Overall Study|Death|2
7275436|NCT00442286|11490024|FG000|Overall Study|Lost to Follow-up|1
7275437|NCT00442286|11490025|FG001|Overall Study|Lost to Follow-up|0
7275438|NCT00442286|11490024|FG000|Overall Study|Withdrawal by Subject|2
7275439|NCT00442286|11490025|FG001|Overall Study|Withdrawal by Subject|0
7275440|NCT00442286|11490024|FG000|Overall Study|System explanted|1
7606558|NCT01381094|12014065|FG002|Overall Study|Adverse Event|0
7606559|NCT01381094|12014066|FG003|Overall Study|Adverse Event|1
7606560|NCT01381094|12014067|FG004|Overall Study|Adverse Event|0
7606561|NCT01381094|12014063|FG000|Overall Study|Lost to Follow-up|0
7606562|NCT01381094|12014064|FG001|Overall Study|Lost to Follow-up|0
7275441|NCT00442286|11490025|FG001|Overall Study|System explanted|0
7275442|NCT00442286|11490024|FG000|Overall Study|Patient Injury|1
7275443|NCT00442286|11490025|FG001|Overall Study|Patient Injury|0
7275444|NCT00442416|11490039|FG000|Overall Study|Adverse Event|4
7606563|NCT01381094|12014065|FG002|Overall Study|Lost to Follow-up|0
7606564|NCT01381094|12014066|FG003|Overall Study|Lost to Follow-up|0
7606565|NCT01381094|12014067|FG004|Overall Study|Lost to Follow-up|1
7606566|NCT01381094|12014063|FG000|Overall Study|Withdrawal of informed consent|0
7606567|NCT01381094|12014064|FG001|Overall Study|Withdrawal of informed consent|1
7606568|NCT01381094|12014065|FG002|Overall Study|Withdrawal of informed consent|0
7606569|NCT01381094|12014066|FG003|Overall Study|Withdrawal of informed consent|0
7606570|NCT01381094|12014067|FG004|Overall Study|Withdrawal of informed consent|0
7606571|NCT01381094|12014063|FG000|Overall Study|Participant given Aranesp injection|1
7606572|NCT01381094|12014064|FG001|Overall Study|Participant given Aranesp injection|0
7606573|NCT01381094|12014065|FG002|Overall Study|Participant given Aranesp injection|0
7606574|NCT01381094|12014066|FG003|Overall Study|Participant given Aranesp injection|0
7606575|NCT01381094|12014067|FG004|Overall Study|Participant given Aranesp injection|0
7606577|NCT01081951|12014089|FG000|Overall Study|Death|54
7606578|NCT01081951|12014090|FG001|Overall Study|Death|47
7606579|NCT01081951|12014089|FG000|Overall Study|Withdrawal by Subject|2
7606580|NCT01081951|12014090|FG001|Overall Study|Withdrawal by Subject|6
7606581|NCT01081951|12014089|FG000|Overall Study|Allocated treatment but did not take it|0
7606582|NCT01081951|12014090|FG001|Overall Study|Allocated treatment but did not take it|1
7606583|NCT01081951|12014089|FG000|Overall Study|Lost to Follow-up|0
7606584|NCT01081951|12014090|FG001|Overall Study|Lost to Follow-up|1
7275445|NCT00442416|11490040|FG001|Overall Study|Adverse Event|1
7275446|NCT00442416|11490039|FG000|Overall Study|Death|1
7275447|NCT00442416|11490040|FG001|Overall Study|Death|0
7275448|NCT00442416|11490039|FG000|Overall Study|Lack of Efficacy|2
7275449|NCT00442416|11490040|FG001|Overall Study|Lack of Efficacy|0
7275450|NCT00442416|11490039|FG000|Overall Study|Protocol Violation|2
7275451|NCT00442416|11490040|FG001|Overall Study|Protocol Violation|3
7275452|NCT00442416|11490039|FG000|Overall Study|Withdrew consent|1
7606639|NCT00788671|12014119|FG000|Overall Study|Death|2
7606640|NCT00788671|12014119|FG000|Overall Study|Unable to biopsy|1
7606641|NCT00788671|12014119|FG000|Overall Study|Withdrawal by Subject|4
7606642|NCT00788671|12014119|FG000|Overall Study|IUD expulsed|1
7606643|NCT00788671|12014119|FG000|Overall Study|Lost to follow up|2
7275453|NCT00442416|11490040|FG001|Overall Study|Withdrew consent|2
7275454|NCT00442416|11490039|FG000|Overall Study|Administrative/Other|27
7275455|NCT00442416|11490040|FG001|Overall Study|Administrative/Other|33
7275456|NCT00442468|11490046|FG000|Overall Study|Adverse Event|4
7275457|NCT00442468|11490046|FG000|Overall Study|Withdrawal by Subject|91
7275458|NCT00442468|11490046|FG000|Overall Study|Did not complete all study procedures|88
7275459|NCT00442572|11490056|FG000|Overall Study|Relapse|8
7275460|NCT00442572|11490057|FG001|Overall Study|Relapse|1
7275461|NCT00442572|11490056|FG000|Overall Study|Lost to Follow-up|0
7275462|NCT00442572|11490057|FG001|Overall Study|Lost to Follow-up|1
7275463|NCT00442572|11490056|FG000|Overall Study|Withdrawal by Subject|0
7275464|NCT00442572|11490057|FG001|Overall Study|Withdrawal by Subject|1
7275465|NCT00442598|11490067|FG000|Overall Study|Adverse Event|1
7275466|NCT00442598|11490068|FG001|Overall Study|Adverse Event|0
7275467|NCT00442598|11490069|FG002|Overall Study|Adverse Event|0
7606644|NCT03881059|12014139|FG000|Treatment Period - Part A|Adverse Event|1
7606645|NCT03881059|12014140|FG001|Treatment Period - Part A|Adverse Event|3
7606646|NCT03881059|12014141|FG002|Treatment Period - Part A|Adverse Event|4
7606647|NCT03881059|12014139|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0
7606648|NCT03881059|12014140|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1
7606649|NCT03881059|12014141|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1
7606650|NCT03881059|12014139|FG000|Treatment Period - Part A|Withdrawal by Subject|5
7606651|NCT03881059|12014140|FG001|Treatment Period - Part A|Withdrawal by Subject|2
7606652|NCT03881059|12014141|FG002|Treatment Period - Part A|Withdrawal by Subject|3
7606653|NCT03881059|12014139|FG000|Treatment Period - Part A|Other reasons|2
7606654|NCT03881059|12014140|FG001|Treatment Period - Part A|Other reasons|1
7606655|NCT03881059|12014141|FG002|Treatment Period - Part A|Other reasons|0
7606656|NCT03881059|12014139|FG000|Treatment Period - Part B|Adverse Event|0
7606657|NCT03881059|12014140|FG001|Treatment Period - Part B|Adverse Event|0
7606658|NCT03881059|12014141|FG002|Treatment Period - Part B|Adverse Event|3
7606659|NCT03881059|12014139|FG000|Treatment Period - Part B|Death|0
7606660|NCT03881059|12014140|FG001|Treatment Period - Part B|Death|1
7606661|NCT03881059|12014141|FG002|Treatment Period - Part B|Death|1
7606662|NCT03881059|12014139|FG000|Treatment Period - Part B|Lack of Efficacy|1
7606663|NCT03881059|12014140|FG001|Treatment Period - Part B|Lack of Efficacy|1
7606664|NCT03881059|12014141|FG002|Treatment Period - Part B|Lack of Efficacy|0
7606665|NCT03881059|12014139|FG000|Treatment Period - Part B|Lost to Follow-up|1
7606666|NCT03881059|12014140|FG001|Treatment Period - Part B|Lost to Follow-up|1
7606667|NCT03881059|12014141|FG002|Treatment Period - Part B|Lost to Follow-up|0
7606668|NCT03881059|12014139|FG000|Treatment Period - Part B|Site terminated by sponsor|1
7606669|NCT03881059|12014140|FG001|Treatment Period - Part B|Site terminated by sponsor|0
7606670|NCT03881059|12014141|FG002|Treatment Period - Part B|Site terminated by sponsor|3
7606671|NCT03881059|12014139|FG000|Treatment Period - Part B|Withdrawal by Subject|1
7606672|NCT03881059|12014140|FG001|Treatment Period - Part B|Withdrawal by Subject|0
7606673|NCT03881059|12014141|FG002|Treatment Period - Part B|Withdrawal by Subject|1
7606674|NCT03881059|12014139|FG000|Treatment Period - Part B|Other reasons|4
7606675|NCT03881059|12014140|FG001|Treatment Period - Part B|Other reasons|3
7606676|NCT03881059|12014141|FG002|Treatment Period - Part B|Other reasons|3
7606677|NCT03450629|12014160|FG000|Overall Study|Adverse Event|15
7606678|NCT03450629|12014161|FG001|Overall Study|Adverse Event|14
7606679|NCT03450629|12014160|FG000|Overall Study|Physician Decision|2
7606680|NCT03450629|12014161|FG001|Overall Study|Physician Decision|2
7606681|NCT03450629|12014160|FG000|Overall Study|Lack of Efficacy|2
7606682|NCT03450629|12014161|FG001|Overall Study|Lack of Efficacy|0
7606683|NCT03450629|12014160|FG000|Overall Study|Lost to Follow-up|4
7606684|NCT03450629|12014161|FG001|Overall Study|Lost to Follow-up|2
7606685|NCT03450629|12014160|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7606686|NCT03450629|12014161|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
7606687|NCT03450629|12014160|FG000|Overall Study|Non-Compliance With Study Drug|2
7606688|NCT03450629|12014161|FG001|Overall Study|Non-Compliance With Study Drug|1
7606689|NCT03450629|12014160|FG000|Overall Study|Protocol Violation|11
7606690|NCT03450629|12014161|FG001|Overall Study|Protocol Violation|8
7606691|NCT03450629|12014160|FG000|Overall Study|Withdrawal by Subject|12
7606692|NCT03450629|12014161|FG001|Overall Study|Withdrawal by Subject|6
7606693|NCT03367403|12014170|FG000|Overall Study|Adverse Event|20
7606694|NCT03367403|12014171|FG001|Overall Study|Adverse Event|6
7606695|NCT03367403|12014172|FG002|Overall Study|Adverse Event|2
7606696|NCT03367403|12014170|FG000|Overall Study|Withdrawal by Subject|12
7606697|NCT03367403|12014171|FG001|Overall Study|Withdrawal by Subject|12
7606698|NCT03367403|12014172|FG002|Overall Study|Withdrawal by Subject|1
7606699|NCT03367403|12014170|FG000|Overall Study|Death|1
7606700|NCT03367403|12014171|FG001|Overall Study|Death|2
7606701|NCT03367403|12014172|FG002|Overall Study|Death|0
7606702|NCT03367403|12014170|FG000|Overall Study|Physician Decision|0
7606703|NCT03367403|12014171|FG001|Overall Study|Physician Decision|1
7606704|NCT03367403|12014172|FG002|Overall Study|Physician Decision|0
7606705|NCT03367403|12014170|FG000|Overall Study|Protocol Violation|1
7606706|NCT03367403|12014171|FG001|Overall Study|Protocol Violation|1
7606707|NCT03367403|12014172|FG002|Overall Study|Protocol Violation|0
7606708|NCT03367403|12014170|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0
7606709|NCT03367403|12014171|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2
7606710|NCT03367403|12014172|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0
7606711|NCT03367403|12014170|FG000|Overall Study|COVID-19|3
7606712|NCT03367403|12014171|FG001|Overall Study|COVID-19|7
7606713|NCT03367403|12014172|FG002|Overall Study|COVID-19|0
7606714|NCT03367403|12014170|FG000|Overall Study|Abuse of Alcohol Intake|0
7606715|NCT03367403|12014171|FG001|Overall Study|Abuse of Alcohol Intake|1
7606716|NCT03367403|12014172|FG002|Overall Study|Abuse of Alcohol Intake|0
7606717|NCT03367403|12014170|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
7606718|NCT03367403|12014171|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1
7606719|NCT03367403|12014172|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
7606720|NCT03286426|12014180|FG000|Overall Study|Physician Decision|3
7606721|NCT02809677|12014197|FG000|Overall Study|Withdrawal by Subject|8
7275468|NCT00442598|11490067|FG000|Overall Study|Tumor progression|3
7275469|NCT00442598|11490068|FG001|Overall Study|Tumor progression|4
7275470|NCT00442598|11490069|FG002|Overall Study|Tumor progression|0
7275471|NCT00442598|11490067|FG000|Overall Study|Clinical deterioration|1
7275472|NCT00442598|11490068|FG001|Overall Study|Clinical deterioration|2
7275473|NCT00442598|11490069|FG002|Overall Study|Clinical deterioration|0
7275474|NCT00442598|11490067|FG000|Overall Study|CA125 progression|0
7275475|NCT00442598|11490068|FG001|Overall Study|CA125 progression|1
7275476|NCT00442598|11490069|FG002|Overall Study|CA125 progression|0
7275477|NCT00442598|11490067|FG000|Overall Study|Reduced creatinine clearance|1
7275478|NCT00442598|11490068|FG001|Overall Study|Reduced creatinine clearance|0
7275479|NCT00442598|11490069|FG002|Overall Study|Reduced creatinine clearance|0
7275480|NCT00442598|11490067|FG000|Overall Study|Death|0
7275481|NCT00442598|11490068|FG001|Overall Study|Death|1
7275482|NCT00442598|11490069|FG002|Overall Study|Death|0
7275483|NCT00442702|11490100|FG000|Titration Period|Adverse Event|2
7275484|NCT00442702|11490101|FG001|Titration Period|Adverse Event|0
7275485|NCT00442702|11490100|FG000|Titration Period|Death|3
7606722|NCT02554253|12014208|FG000|Overall Study|ineligible after enrollment|1
7606723|NCT02554253|12014209|FG001|Overall Study|ineligible after enrollment|0
7606724|NCT02554253|12014208|FG000|Overall Study|converted to transcatheter procedure|0
7606725|NCT02554253|12014209|FG001|Overall Study|converted to transcatheter procedure|1
7606726|NCT02554253|12014208|FG000|Overall Study|received both drugs|0
7606727|NCT02554253|12014209|FG001|Overall Study|received both drugs|1
7606728|NCT01307046|12014228|FG000|Overall Study|Adverse Event|3
7606729|NCT01307046|12014229|FG001|Overall Study|Adverse Event|3
7606730|NCT01307046|12014228|FG000|Overall Study|Lack of Efficacy|0
7606731|NCT01307046|12014229|FG001|Overall Study|Lack of Efficacy|2
7606732|NCT01307046|12014228|FG000|Overall Study|Physician Decision|2
7606733|NCT01307046|12014229|FG001|Overall Study|Physician Decision|0
7606734|NCT01307046|12014228|FG000|Overall Study|Withdrawal by Subject|1
7606735|NCT01307046|12014229|FG001|Overall Study|Withdrawal by Subject|1
7606736|NCT01307046|12014228|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
7606737|NCT01307046|12014229|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
7606738|NCT01307046|12014228|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
7606739|NCT01307046|12014229|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
7275486|NCT00442702|11490101|FG001|Titration Period|Death|2
7275487|NCT00442702|11490100|FG000|Titration Period|Insufficient Therapeutic Response|1
7275488|NCT00442702|11490101|FG001|Titration Period|Insufficient Therapeutic Response|0
7275489|NCT00442702|11490100|FG000|Titration Period|Refused Treatment|4
7275490|NCT00442702|11490101|FG001|Titration Period|Refused Treatment|1
7275491|NCT00442702|11490100|FG000|Titration Period|Failure to return|1
7275492|NCT00442702|11490101|FG001|Titration Period|Failure to return|0
7275493|NCT00442702|11490100|FG000|Titration Period|Hospitalized in another hospital|1
7275494|NCT00442702|11490101|FG001|Titration Period|Hospitalized in another hospital|0
7275495|NCT00442702|11490100|FG000|Evaluation Period|Adverse Event|1
7275496|NCT00442702|11490101|FG001|Evaluation Period|Adverse Event|0
7275497|NCT00442702|11490100|FG000|Evaluation Period|Death|1
7275498|NCT00442702|11490101|FG001|Evaluation Period|Death|1
7275499|NCT00442702|11490100|FG000|Evaluation Period|Insufficient Therapeutic Response|1
7275500|NCT00442702|11490101|FG001|Evaluation Period|Insufficient Therapeutic Response|0
7275501|NCT00442702|11490100|FG000|Evaluation Period|Refused treatment|1
7275502|NCT00442702|11490101|FG001|Evaluation Period|Refused treatment|1
7275503|NCT00442702|11490100|FG000|Evaluation Period|Renal transplant|0
7275504|NCT00442702|11490101|FG001|Evaluation Period|Renal transplant|1
7275505|NCT00442702|11490100|FG000|Evaluation Period|Failure to return|1
7275506|NCT00442702|11490101|FG001|Evaluation Period|Failure to return|0
7275507|NCT00442702|11490100|FG000|Evaluation Period|Site closure|0
7275508|NCT00442702|11490101|FG001|Evaluation Period|Site closure|1
7275509|NCT00442936|11490117|FG000|Overall Study|Protocol Violation|1
7275510|NCT00442936|11490118|FG001|Overall Study|Protocol Violation|0
7275511|NCT00442936|11490119|FG002|Overall Study|Protocol Violation|1
7275512|NCT00442936|11490120|FG003|Overall Study|Protocol Violation|1
7275513|NCT00442962|11490130|FG000|Overall Study|Pregnancy|1
7275514|NCT00442962|11490130|FG000|Overall Study|Lost to Follow-up|7
7275515|NCT00443053|11490136|FG000|Overall Study|Adverse Event|2
7275516|NCT00443053|11490137|FG001|Overall Study|Adverse Event|1
7275517|NCT00443053|11490136|FG000|Overall Study|Withdrawal by Subject|9
7275518|NCT00443053|11490137|FG001|Overall Study|Withdrawal by Subject|18
7275519|NCT00443053|11490136|FG000|Overall Study|Lost to Follow-up|4
7275520|NCT00443053|11490137|FG001|Overall Study|Lost to Follow-up|5
7275521|NCT00443053|11490136|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
7275522|NCT00443053|11490137|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
7275523|NCT00443053|11490136|FG000|Overall Study|Noncompliance|2
7275524|NCT00443053|11490137|FG001|Overall Study|Noncompliance|1
7275525|NCT00443053|11490136|FG000|Overall Study|Other|3
7275526|NCT00443053|11490137|FG001|Overall Study|Other|4
7275527|NCT00443053|11490136|FG000|Overall Study|Physician Decision|0
7275528|NCT00443053|11490137|FG001|Overall Study|Physician Decision|4
7275529|NCT00443079|11490145|FG000|Overall Study|Lost to Follow-up|0
7275530|NCT00443079|11490146|FG001|Overall Study|Lost to Follow-up|1
7275531|NCT00443118|11490157|FG000|Overall Study|unknown primary outcome|3
7606740|NCT01307033|12014237|FG000|8-week Double-blind Period|Adverse Event|2
7606741|NCT01307033|12014238|FG001|8-week Double-blind Period|Adverse Event|0
7606742|NCT01307033|12014239|FG002|8-week Double-blind Period|Adverse Event|0
7606743|NCT01307033|12014240|FG003|8-week Double-blind Period|Adverse Event|0
7606744|NCT01307033|12014237|FG000|8-week Double-blind Period|Withdrawal by Subject|4
7606745|NCT01307033|12014238|FG001|8-week Double-blind Period|Withdrawal by Subject|1
7606746|NCT01307033|12014239|FG002|8-week Double-blind Period|Withdrawal by Subject|0
7606747|NCT01307033|12014240|FG003|8-week Double-blind Period|Withdrawal by Subject|0
7606748|NCT01307033|12014237|FG000|8-week Double-blind Period|Lack of Efficacy|1
7606749|NCT01307033|12014238|FG001|8-week Double-blind Period|Lack of Efficacy|0
7606750|NCT01307033|12014239|FG002|8-week Double-blind Period|Lack of Efficacy|0
7606751|NCT01307033|12014240|FG003|8-week Double-blind Period|Lack of Efficacy|0
7606752|NCT01307033|12014237|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606753|NCT01307033|12014238|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
7606754|NCT01307033|12014239|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606755|NCT01307033|12014240|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
7606756|NCT01307033|12014237|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
7606757|NCT01307033|12014238|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
7275532|NCT00443118|11490158|FG001|Overall Study|unknown primary outcome|1
7606758|NCT01307033|12014239|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7606759|NCT01307033|12014240|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
7606760|NCT01307033|12014237|FG000|44-week Open-label Extension|Adverse Event|0
7606761|NCT01307033|12014238|FG001|44-week Open-label Extension|Adverse Event|0
7606762|NCT01307033|12014239|FG002|44-week Open-label Extension|Adverse Event|2
7606763|NCT01307033|12014240|FG003|44-week Open-label Extension|Adverse Event|1
7606764|NCT01307033|12014237|FG000|44-week Open-label Extension|Withdrawal by Subject|0
7606765|NCT01307033|12014238|FG001|44-week Open-label Extension|Withdrawal by Subject|0
7606766|NCT01307033|12014239|FG002|44-week Open-label Extension|Withdrawal by Subject|2
7606767|NCT01307033|12014240|FG003|44-week Open-label Extension|Withdrawal by Subject|1
7606768|NCT01307033|12014237|FG000|44-week Open-label Extension|Physician Decision|0
7606769|NCT01307033|12014238|FG001|44-week Open-label Extension|Physician Decision|0
7606770|NCT01307033|12014239|FG002|44-week Open-label Extension|Physician Decision|1
7606771|NCT01307033|12014240|FG003|44-week Open-label Extension|Physician Decision|0
7606772|NCT01307033|12014237|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606773|NCT01307033|12014238|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606774|NCT01307033|12014239|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
7606775|NCT01307033|12014240|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
7606776|NCT01307033|12014237|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7606777|NCT01307033|12014238|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
7606778|NCT01307033|12014239|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
7606779|NCT01307033|12014240|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
7606780|NCT01307033|12014237|FG000|44-week Open-label Extension|Death|0
7606781|NCT01307033|12014238|FG001|44-week Open-label Extension|Death|0
7606782|NCT01307033|12014239|FG002|44-week Open-label Extension|Death|0
7606783|NCT01307033|12014240|FG003|44-week Open-label Extension|Death|1
7606784|NCT00739674|12014254|FG000|Overall Study|Screening failures|19
7606785|NCT00739674|12014255|FG001|Overall Study|Screening failures|17
7606786|NCT00739674|12014254|FG000|Overall Study|Site 212 removal|19
7606787|NCT00739674|12014255|FG001|Overall Study|Site 212 removal|13
7606788|NCT00739674|12014254|FG000|Overall Study|No follow-up data|33
7606789|NCT00739674|12014255|FG001|Overall Study|No follow-up data|18
7606790|NCT00739674|12014254|FG000|Overall Study|Dietician consultation >30 days|1
7606791|NCT00739674|12014255|FG001|Overall Study|Dietician consultation >30 days|9
7606792|NCT00739674|12014254|FG000|Overall Study|Adverse Event|22
7606793|NCT00739674|12014255|FG001|Overall Study|Adverse Event|13
7606794|NCT00739674|12014254|FG000|Overall Study|Death|1
7606795|NCT00739674|12014255|FG001|Overall Study|Death|0
7606796|NCT00739674|12014254|FG000|Overall Study|Lack of Efficacy|1
7606797|NCT00739674|12014255|FG001|Overall Study|Lack of Efficacy|0
7606798|NCT00739674|12014254|FG000|Overall Study|Lost to Follow-up|52
7606799|NCT00739674|12014255|FG001|Overall Study|Lost to Follow-up|30
7606800|NCT00739674|12014254|FG000|Overall Study|Protocol Violation|5
7606801|NCT00739674|12014255|FG001|Overall Study|Protocol Violation|5
7606802|NCT00739674|12014254|FG000|Overall Study|Withdrawal by Subject|9
7606803|NCT00739674|12014255|FG001|Overall Study|Withdrawal by Subject|9
7606804|NCT00739674|12014254|FG000|Overall Study|Reason missing|2
7606805|NCT00739674|12014255|FG001|Overall Study|Reason missing|0
7606806|NCT00739674|12014254|FG000|Overall Study|Clinic closed|6
7606807|NCT00739674|12014255|FG001|Overall Study|Clinic closed|4
7606808|NCT00739674|12014254|FG000|Overall Study|Patient moved|3
7606809|NCT00739674|12014255|FG001|Overall Study|Patient moved|2
7606810|NCT00739674|12014254|FG000|Overall Study|Non compliant|4
7606811|NCT00739674|12014255|FG001|Overall Study|Non compliant|0
7606812|NCT00739674|12014254|FG000|Overall Study|Unable to attend visit|3
7606813|NCT00739674|12014255|FG001|Overall Study|Unable to attend visit|1
7606814|NCT00739674|12014254|FG000|Overall Study|Home monitoring off meds|1
7606815|NCT00739674|12014255|FG001|Overall Study|Home monitoring off meds|0
7606816|NCT00739674|12014254|FG000|Overall Study|Erectile dysfunction|0
7606817|NCT00739674|12014255|FG001|Overall Study|Erectile dysfunction|1
7606818|NCT00546754|12014263|FG000|Overall Study|Serious Adverse Event|1
7606819|NCT00546754|12014264|FG001|Overall Study|Serious Adverse Event|1
7606820|NCT00546754|12014263|FG000|Overall Study|Adverse Event|11
7606821|NCT00546754|12014264|FG001|Overall Study|Adverse Event|16
7606822|NCT00546754|12014263|FG000|Overall Study|Lack of Efficacy|1
7606823|NCT00546754|12014264|FG001|Overall Study|Lack of Efficacy|1
7606824|NCT00546754|12014263|FG000|Overall Study|Lost to Follow-up|9
7606825|NCT00546754|12014264|FG001|Overall Study|Lost to Follow-up|15
7606826|NCT00546754|12014263|FG000|Overall Study|Protocol Violation|3
7606827|NCT00546754|12014264|FG001|Overall Study|Protocol Violation|0
7606828|NCT00546754|12014263|FG000|Overall Study|Withdrawal by Subject|6
7606829|NCT00546754|12014264|FG001|Overall Study|Withdrawal by Subject|7
7606830|NCT00546754|12014263|FG000|Overall Study|Dyspnea|1
7606831|NCT00546754|12014264|FG001|Overall Study|Dyspnea|0
7606832|NCT00546754|12014263|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
7275533|NCT00443118|11490159|FG002|Overall Study|unknown primary outcome|0
7606833|NCT00546754|12014264|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
7606834|NCT00546754|12014263|FG000|Overall Study|Hip Replacement|1
7606835|NCT00546754|12014264|FG001|Overall Study|Hip Replacement|0
7606836|NCT00546754|12014263|FG000|Overall Study|Suicide|1
7606837|NCT00546754|12014264|FG001|Overall Study|Suicide|0
7606838|NCT00546754|12014263|FG000|Overall Study|Missing Cooperation|1
7606839|NCT00546754|12014264|FG001|Overall Study|Missing Cooperation|0
7606840|NCT00546754|12014263|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
7606841|NCT00546754|12014264|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
7606842|NCT00546754|12014263|FG000|Overall Study|Patient's Decision|0
7606843|NCT00546754|12014264|FG001|Overall Study|Patient's Decision|1
7606844|NCT00546754|12014263|FG000|Overall Study|Missing|14
7606845|NCT00546754|12014264|FG001|Overall Study|Missing|7
7606846|NCT00479713|12014272|FG000|Overall Study|Adverse Event|8
7275534|NCT00443118|11490157|FG000|Overall Study|Withdrawal by Subject|1
7275535|NCT00443118|11490158|FG001|Overall Study|Withdrawal by Subject|0
7275536|NCT00443118|11490159|FG002|Overall Study|Withdrawal by Subject|0
7275537|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
7275538|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
7275539|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
7275540|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
7275541|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
7275542|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
7275543|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7275544|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
7275545|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
7275546|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
7275547|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
7275548|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
7275549|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
7275550|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
7606847|NCT00479713|12014273|FG001|Overall Study|Adverse Event|6
7606848|NCT00479713|12014272|FG000|Overall Study|Death|1
7606849|NCT00479713|12014273|FG001|Overall Study|Death|0
7606850|NCT00479713|12014272|FG000|Overall Study|Lost to Follow-up|0
7606851|NCT00479713|12014273|FG001|Overall Study|Lost to Follow-up|1
7606852|NCT00479713|12014272|FG000|Overall Study|Protocol Violation|0
7606853|NCT00479713|12014273|FG001|Overall Study|Protocol Violation|1
7606854|NCT00479713|12014272|FG000|Overall Study|Withdrawal by Subject|4
7606855|NCT00479713|12014273|FG001|Overall Study|Withdrawal by Subject|1
7606856|NCT00406783|12014281|FG000|Overall Study|Adverse Event|4
7606857|NCT00406783|12014282|FG001|Overall Study|Adverse Event|4
7606858|NCT00406783|12014281|FG000|Overall Study|Treatment Failure|2
7606859|NCT00406783|12014282|FG001|Overall Study|Treatment Failure|3
7606860|NCT00406783|12014281|FG000|Overall Study|Lost to Follow-up|3
7606861|NCT00406783|12014282|FG001|Overall Study|Lost to Follow-up|0
7606862|NCT00406783|12014281|FG000|Overall Study|Withdrawal by Subject|1
7606863|NCT00406783|12014282|FG001|Overall Study|Withdrawal by Subject|4
7606864|NCT00406783|12014281|FG000|Overall Study|Protocol Violation|4
7606865|NCT00406783|12014282|FG001|Overall Study|Protocol Violation|4
7606866|NCT00405964|12014290|FG000|Overall Study|Treatment Failure|17
7606867|NCT00405964|12014291|FG001|Overall Study|Treatment Failure|45
7606868|NCT00405964|12014290|FG000|Overall Study|Adverse Event|7
7606869|NCT00405964|12014291|FG001|Overall Study|Adverse Event|16
7606870|NCT00405964|12014290|FG000|Overall Study|Lost to Follow-up|5
7606871|NCT00405964|12014291|FG001|Overall Study|Lost to Follow-up|5
7606872|NCT00405964|12014290|FG000|Overall Study|Withdrawal by Subject|19
7606873|NCT00405964|12014291|FG001|Overall Study|Withdrawal by Subject|23
7606874|NCT00405964|12014290|FG000|Overall Study|Protocol Violation|11
7606875|NCT00405964|12014291|FG001|Overall Study|Protocol Violation|6
7606876|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
7606877|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
7606878|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
7606879|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
7606880|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
7606881|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
7606882|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606883|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606884|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
7606885|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7606886|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7606887|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
7606888|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7606889|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7606890|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
7606891|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
7606892|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7606893|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
7606894|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7606895|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
7606896|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
7606897|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7606898|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
7606899|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
7606900|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
7606901|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
7606902|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7606903|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7606904|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7606905|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
7606906|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7606907|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7606908|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
7606909|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
7606910|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
7606911|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Administrative|1
7606912|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Administrative|3
7606913|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Administrative|3
7606914|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Administrative|3
7606915|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Administrative|3
7606916|NCT00383721|12014302|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
7606917|NCT00383721|12014303|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
7606918|NCT00383721|12014304|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
7606919|NCT00383721|12014305|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
7606920|NCT00383721|12014306|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
7606921|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Adverse Event|6
7606922|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Adverse Event|7
7606923|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Adverse Event|10
7606924|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Adverse Event|1
7606925|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Adverse Event|0
7606926|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
7606927|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
7606928|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
7606929|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
7606930|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
7606931|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
7606932|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
7606933|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
7606934|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
7606935|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
7606936|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7606937|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
7606938|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7606939|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
7606940|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7606941|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606942|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606943|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606944|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
7606945|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
7606946|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
7606947|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7606948|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7606949|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7606950|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7606951|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606952|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7606953|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606954|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7606955|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7606956|NCT00383721|12014302|FG000|26-Week Treatment Safety Extension|Administrative|1
7606957|NCT00383721|12014303|FG001|26-Week Treatment Safety Extension|Administrative|2
7606958|NCT00383721|12014304|FG002|26-Week Treatment Safety Extension|Administrative|3
7606959|NCT00383721|12014305|FG003|26-Week Treatment Safety Extension|Administrative|1
7606960|NCT00383721|12014306|FG004|26-Week Treatment Safety Extension|Administrative|0
7606961|NCT00383552|12014322|FG000|Overall Study|Adverse Event|7
7606962|NCT00383552|12014323|FG001|Overall Study|Adverse Event|6
7606963|NCT00383552|12014324|FG002|Overall Study|Adverse Event|9
7606964|NCT00383552|12014325|FG003|Overall Study|Adverse Event|6
7606965|NCT00383552|12014322|FG000|Overall Study|Lack of Efficacy|4
7606966|NCT00383552|12014323|FG001|Overall Study|Lack of Efficacy|13
7606967|NCT00383552|12014324|FG002|Overall Study|Lack of Efficacy|29
7606968|NCT00383552|12014325|FG003|Overall Study|Lack of Efficacy|42
7606969|NCT00383552|12014322|FG000|Overall Study|Lost to Follow-up|0
7606970|NCT00383552|12014323|FG001|Overall Study|Lost to Follow-up|1
7606971|NCT00383552|12014324|FG002|Overall Study|Lost to Follow-up|5
7606972|NCT00383552|12014325|FG003|Overall Study|Lost to Follow-up|1
7606973|NCT00383552|12014322|FG000|Overall Study|Did not wish to continue (unrelated)|4
7606974|NCT00383552|12014323|FG001|Overall Study|Did not wish to continue (unrelated)|9
7606975|NCT00383552|12014324|FG002|Overall Study|Did not wish to continue (unrelated)|5
7606976|NCT00383552|12014325|FG003|Overall Study|Did not wish to continue (unrelated)|6
7606977|NCT00383552|12014322|FG000|Overall Study|Did not wish to continue (related)|1
7606978|NCT00383552|12014323|FG001|Overall Study|Did not wish to continue (related)|0
7606979|NCT00383552|12014324|FG002|Overall Study|Did not wish to continue (related)|2
7606980|NCT00383552|12014325|FG003|Overall Study|Did not wish to continue (related)|3
7606981|NCT00383552|12014322|FG000|Overall Study|Noncompliance with the protocol|11
7606982|NCT00383552|12014323|FG001|Overall Study|Noncompliance with the protocol|6
7606983|NCT00383552|12014324|FG002|Overall Study|Noncompliance with the protocol|8
7606984|NCT00383552|12014325|FG003|Overall Study|Noncompliance with the protocol|10
7606985|NCT00383552|12014322|FG000|Overall Study|Did not meet protocol eligibility|8
7606986|NCT00383552|12014323|FG001|Overall Study|Did not meet protocol eligibility|6
7606987|NCT00383552|12014324|FG002|Overall Study|Did not meet protocol eligibility|2
7606988|NCT00383552|12014325|FG003|Overall Study|Did not meet protocol eligibility|3
7606989|NCT00383552|12014322|FG000|Overall Study|Administrative|1
7606990|NCT00383552|12014323|FG001|Overall Study|Administrative|0
7606991|NCT00383552|12014324|FG002|Overall Study|Administrative|1
7606992|NCT00383552|12014325|FG003|Overall Study|Administrative|1
7606993|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
7606994|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
7606995|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
7606996|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
7606997|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
7606998|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7606999|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
7607000|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
7607001|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
7607002|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
7607003|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7607004|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
7607005|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
7607006|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7607007|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
7607008|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
7607009|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
7607010|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
7607011|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
7607012|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
7607013|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
7607014|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7607015|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7607016|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
7607017|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
7607018|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
7607019|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7607020|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
7607021|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
7607022|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
7275551|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
7275552|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
7275553|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
7275554|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
7275555|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Missing|2
7275556|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Missing|1
7275557|NCT00443209|11490187|FG000|Months 1 to 12 Treatment Period|Not Treated|71
7275558|NCT00443209|11490188|FG001|Months 1 to 12 Treatment Period|Not Treated|43
7275559|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
7275560|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
7275561|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
7275562|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
7275563|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
7275564|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
7275565|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7275566|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
7275567|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
7275568|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
7275569|NCT00443209|11490187|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
7275570|NCT00443209|11490188|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
7607023|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
7607024|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
7607025|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
7607026|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607027|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
7607028|NCT00383435|12014345|FG000|26-Week Double-Blind Treatment Period|Administrative|5
7607029|NCT00383435|12014346|FG001|26-Week Double-Blind Treatment Period|Administrative|3
7607030|NCT00383435|12014347|FG002|26-Week Double-Blind Treatment Period|Administrative|1
7607031|NCT00383435|12014348|FG003|26-Week Double-Blind Treatment Period|Administrative|1
7607032|NCT00383435|12014349|FG004|26-Week Double-Blind Treatment Period|Administrative|1
7607033|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Adverse Event|4
7607034|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Adverse Event|2
7607035|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Adverse Event|5
7607036|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Adverse Event|5
7607037|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Adverse Event|1
7607038|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607039|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607040|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607041|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
7607042|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
7607043|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
7607044|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
7607045|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
7607046|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
7607047|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
7607048|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7607049|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
7607050|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7607051|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
7607052|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
7607053|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
7607054|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
7607055|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
7607056|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
7607057|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
7607058|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
7607059|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607060|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607061|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
7607062|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
7607063|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7607064|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607065|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607066|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
7607067|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
7607068|NCT00383435|12014345|FG000|26-Week Treatment Safety Extension|Administrative|1
7607069|NCT00383435|12014346|FG001|26-Week Treatment Safety Extension|Administrative|1
7275571|NCT00443261|11490194|FG000|Overall Study|Death|1
7275572|NCT00443430|11490204|FG000|Overall Study|Lack of Efficacy|3
7275573|NCT00443430|11490205|FG001|Overall Study|Lack of Efficacy|3
7275574|NCT00443430|11490204|FG000|Overall Study|Adverse Event|1
7275575|NCT00443430|11490205|FG001|Overall Study|Adverse Event|1
7275576|NCT00443456|11490211|FG000|Overall Study|Adverse Event|16
7275577|NCT00443456|11490211|FG000|Overall Study|Move|1
7275578|NCT00443456|11490211|FG000|Overall Study|Withdrawal by Subject|1
7275579|NCT00443534|11490219|FG000|Overall Study|Lack of Efficacy|67
7275580|NCT00443534|11490219|FG000|Overall Study|Adverse Event|16
7275581|NCT00443534|11490219|FG000|Overall Study|Death|9
7275582|NCT00443534|11490219|FG000|Overall Study|Withdrawal by Subject|8
7275583|NCT00443534|11490219|FG000|Overall Study|Study Terminated by Sponsor|12
7275584|NCT00443534|11490219|FG000|Overall Study|Other|10
7275585|NCT00443534|11490219|FG000|Overall Study|Enrolled, Not Treated|1
7275586|NCT00443560|11490242|FG000|Overall Study|No intrathecal dose|58
7275587|NCT00443560|11490243|FG001|Overall Study|No intrathecal dose|26
7275588|NCT00443560|11490242|FG000|Overall Study|Multiple pregnancies or fetal demise|2
7275589|NCT00443560|11490243|FG001|Overall Study|Multiple pregnancies or fetal demise|4
7275596|NCT00443651|11490260|FG000|Overall Study|Death|1
7275597|NCT00443651|11490261|FG001|Overall Study|Death|5
7275598|NCT00443651|11490260|FG000|Overall Study|Adverse Event|5
7275599|NCT00443651|11490261|FG001|Overall Study|Adverse Event|6
7275600|NCT00443651|11490260|FG000|Overall Study|Lost to Follow-up|18
7275601|NCT00443651|11490261|FG001|Overall Study|Lost to Follow-up|12
7275602|NCT00443651|11490260|FG000|Overall Study|Patient's/Guardian's Decision|58
7275603|NCT00443651|11490261|FG001|Overall Study|Patient's/Guardian's Decision|30
7275604|NCT00443651|11490260|FG000|Overall Study|Physician Decision|13
7275605|NCT00443651|11490261|FG001|Overall Study|Physician Decision|4
7275606|NCT00443651|11490260|FG000|Overall Study|Pregnancy|0
7607070|NCT00383435|12014347|FG002|26-Week Treatment Safety Extension|Administrative|0
7607071|NCT00383435|12014348|FG003|26-Week Treatment Safety Extension|Administrative|1
7607072|NCT00383435|12014349|FG004|26-Week Treatment Safety Extension|Administrative|0
7607073|NCT00381485|12014364|FG000|Open-Label Run-In Period|Adverse Event|9
7607074|NCT00381485|12014365|FG001|Open-Label Run-In Period|Adverse Event|0
7607075|NCT00381485|12014366|FG002|Open-Label Run-In Period|Adverse Event|0
7607076|NCT00381485|12014367|FG003|Open-Label Run-In Period|Adverse Event|0
7607077|NCT00381485|12014364|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
7607078|NCT00381485|12014365|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607079|NCT00381485|12014366|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607080|NCT00381485|12014367|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
7607081|NCT00381485|12014364|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
7607082|NCT00381485|12014365|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607083|NCT00381485|12014366|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607084|NCT00381485|12014367|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
7607085|NCT00381485|12014364|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
7607086|NCT00381485|12014365|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607087|NCT00381485|12014366|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607088|NCT00381485|12014367|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
7607089|NCT00381485|12014364|FG000|Open-Label Run-In Period|Lost to Follow-up|3
7607090|NCT00381485|12014365|FG001|Open-Label Run-In Period|Lost to Follow-up|0
7607091|NCT00381485|12014366|FG002|Open-Label Run-In Period|Lost to Follow-up|0
7607092|NCT00381485|12014367|FG003|Open-Label Run-In Period|Lost to Follow-up|0
7607093|NCT00381485|12014364|FG000|Open-Label Run-In Period|Treatment failure|1
7607094|NCT00381485|12014365|FG001|Open-Label Run-In Period|Treatment failure|0
7607095|NCT00381485|12014366|FG002|Open-Label Run-In Period|Treatment failure|0
7607096|NCT00381485|12014367|FG003|Open-Label Run-In Period|Treatment failure|0
7607097|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Adverse Event|0
7607098|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Adverse Event|2
7607099|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Adverse Event|2
7607100|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Adverse Event|5
7607101|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7607102|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
7607103|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
7607104|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
7607105|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
7607106|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
7607107|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
7607108|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
7607109|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
7607110|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
7607111|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
7607112|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
7607113|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
7607114|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607115|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
7607116|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
7607117|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
7607118|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
7607119|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
7607120|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
7607121|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7607122|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7607123|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
7275607|NCT00443651|11490261|FG001|Overall Study|Pregnancy|1
7607124|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
7607125|NCT00381485|12014364|FG000|Double-Blind Treatment Period|Administrative|0
7607126|NCT00381485|12014365|FG001|Double-Blind Treatment Period|Administrative|1
7607127|NCT00381485|12014366|FG002|Double-Blind Treatment Period|Administrative|0
7607128|NCT00381485|12014367|FG003|Double-Blind Treatment Period|Administrative|1
7607129|NCT00379288|12014380|FG000|Overall Study|Adverse Event|5
7607130|NCT00379288|12014381|FG001|Overall Study|Adverse Event|6
7607131|NCT00379288|12014382|FG002|Overall Study|Adverse Event|2
7607132|NCT00379288|12014383|FG003|Overall Study|Adverse Event|0
7607133|NCT00379288|12014380|FG000|Overall Study|Treatment Failure|0
7607134|NCT00379288|12014381|FG001|Overall Study|Treatment Failure|1
7607135|NCT00379288|12014382|FG002|Overall Study|Treatment Failure|0
7607136|NCT00379288|12014383|FG003|Overall Study|Treatment Failure|1
7607137|NCT00379288|12014380|FG000|Overall Study|Lost to Follow-up|3
7607138|NCT00379288|12014381|FG001|Overall Study|Lost to Follow-up|3
7607139|NCT00379288|12014382|FG002|Overall Study|Lost to Follow-up|2
7607140|NCT00379288|12014383|FG003|Overall Study|Lost to Follow-up|0
7607141|NCT00379288|12014380|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
7607142|NCT00379288|12014381|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
7607143|NCT00379288|12014382|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
7607144|NCT00379288|12014383|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
7607145|NCT00379288|12014380|FG000|Overall Study|Subject withdrew-related to study drug|1
7607146|NCT00379288|12014381|FG001|Overall Study|Subject withdrew-related to study drug|0
7607147|NCT00379288|12014382|FG002|Overall Study|Subject withdrew-related to study drug|0
7607148|NCT00379288|12014383|FG003|Overall Study|Subject withdrew-related to study drug|1
7607149|NCT00379288|12014380|FG000|Overall Study|Noncompliance with protocol|8
7607150|NCT00379288|12014381|FG001|Overall Study|Noncompliance with protocol|6
7607151|NCT00379288|12014382|FG002|Overall Study|Noncompliance with protocol|2
7275608|NCT00443703|11490269|FG000|Overall Study|Never Treated|3
7275609|NCT00443703|11490270|FG001|Overall Study|Never Treated|1
7275610|NCT00443703|11490269|FG000|Overall Study|Adverse Event|7
7275611|NCT00443703|11490270|FG001|Overall Study|Adverse Event|3
7607152|NCT00379288|12014383|FG003|Overall Study|Noncompliance with protocol|1
7607153|NCT00379288|12014380|FG000|Overall Study|Did not meet protocol eligibility|0
7607154|NCT00379288|12014381|FG001|Overall Study|Did not meet protocol eligibility|1
7607155|NCT00379288|12014382|FG002|Overall Study|Did not meet protocol eligibility|0
7607156|NCT00379288|12014383|FG003|Overall Study|Did not meet protocol eligibility|2
7607157|NCT00379288|12014380|FG000|Overall Study|Administrative|2
7607158|NCT00379288|12014381|FG001|Overall Study|Administrative|2
7607159|NCT00379288|12014382|FG002|Overall Study|Administrative|0
7607160|NCT00379288|12014383|FG003|Overall Study|Administrative|1
7607161|NCT00378378|12014396|FG000|Overall Study|Withdrawal by Subject|0
7607162|NCT00378378|12014397|FG001|Overall Study|Withdrawal by Subject|1
7607163|NCT00378378|12014398|FG002|Overall Study|Withdrawal by Subject|0
7607164|NCT00378378|12014396|FG000|Overall Study|Treatment Failure|0
7607165|NCT00378378|12014397|FG001|Overall Study|Treatment Failure|0
7607166|NCT00378378|12014398|FG002|Overall Study|Treatment Failure|1
7607167|NCT00378378|12014396|FG000|Overall Study|Non-compliance with protocol|0
7607168|NCT00378378|12014397|FG001|Overall Study|Non-compliance with protocol|0
7607169|NCT00378378|12014398|FG002|Overall Study|Non-compliance with protocol|1
7607170|NCT00089895|12014408|FG000|Overall Study|Consent Withdrawn|11
7607171|NCT00089895|12014409|FG001|Overall Study|Consent Withdrawn|14
7607172|NCT00089895|12014408|FG000|Overall Study|Technical reason|7
7607173|NCT00089895|12014409|FG001|Overall Study|Technical reason|2
7607174|NCT00089895|12014408|FG000|Overall Study|Surgery|0
7607175|NCT00089895|12014409|FG001|Overall Study|Surgery|1
7607176|NCT00089895|12014408|FG000|Overall Study|Bleeding|0
7607177|NCT00089895|12014409|FG001|Overall Study|Bleeding|2
7607178|NCT00089895|12014408|FG000|Overall Study|Physician Decision|3
7607179|NCT00089895|12014409|FG001|Overall Study|Physician Decision|7
7607180|NCT00089895|12014408|FG000|Overall Study|Exclusion criteria met|6
7275612|NCT00443703|11490269|FG000|Overall Study|Lack of Efficacy|3
7275613|NCT00443703|11490270|FG001|Overall Study|Lack of Efficacy|1
7275614|NCT00443703|11490269|FG000|Overall Study|Lost to Follow-up|0
7275615|NCT00443703|11490270|FG001|Overall Study|Lost to Follow-up|4
7275616|NCT00443703|11490269|FG000|Overall Study|Physician Decision|4
7275617|NCT00443703|11490270|FG001|Overall Study|Physician Decision|2
7275618|NCT00443703|11490269|FG000|Overall Study|Protocol Violation|1
7275619|NCT00443703|11490270|FG001|Overall Study|Protocol Violation|1
7275620|NCT00443703|11490269|FG000|Overall Study|Withdrawal by Subject|9
7275621|NCT00443703|11490270|FG001|Overall Study|Withdrawal by Subject|6
7275622|NCT00443703|11490269|FG000|Overall Study|Progressive Disease|1
7275623|NCT00443703|11490270|FG001|Overall Study|Progressive Disease|0
7275624|NCT00443729|11490278|FG000|Overall Study|Never Treated|0
7275625|NCT00443729|11490279|FG001|Overall Study|Never Treated|1
7275626|NCT00443729|11490278|FG000|Overall Study|Lack of Efficacy|4
7275627|NCT00443729|11490279|FG001|Overall Study|Lack of Efficacy|2
7275628|NCT00443729|11490278|FG000|Overall Study|Lost to Follow-up|0
7275629|NCT00443729|11490279|FG001|Overall Study|Lost to Follow-up|1
7275630|NCT00443729|11490278|FG000|Overall Study|Physician Decision|2
7275631|NCT00443729|11490279|FG001|Overall Study|Physician Decision|1
7275632|NCT00443729|11490278|FG000|Overall Study|Protocol Violation|1
7275633|NCT00443729|11490279|FG001|Overall Study|Protocol Violation|1
7275634|NCT00443729|11490278|FG000|Overall Study|Withdrawal by Subject|3
7275635|NCT00443729|11490279|FG001|Overall Study|Withdrawal by Subject|1
7275636|NCT00443755|11490287|FG000|Overall Study|Withdrawal by Subject|2
7275637|NCT00443755|11490288|FG001|Overall Study|Withdrawal by Subject|1
7607181|NCT00089895|12014409|FG001|Overall Study|Exclusion criteria met|6
7275638|NCT00443781|11490294|FG000|Overall Study|Lost to Follow-up|10
7275639|NCT00443781|11490294|FG000|Overall Study|Physician Decision|2
7275640|NCT00443781|11490294|FG000|Overall Study|Protocol Violation|1
7275641|NCT00443781|11490294|FG000|Overall Study|Withdrawal by Subject|6
7275642|NCT00443781|11490294|FG000|Overall Study|Unable to comply with study follow up|2
7607182|NCT00089895|12014408|FG000|Overall Study|Not otherwise specified|4
7607183|NCT00089895|12014409|FG001|Overall Study|Not otherwise specified|8
7607184|NCT00089895|12014408|FG000|Overall Study|Missing|4
7607185|NCT00089895|12014409|FG001|Overall Study|Missing|2
7607186|NCT02577354|12014417|FG000|Overall Study|Lack of Efficacy|4
7607187|NCT02577354|12014418|FG001|Overall Study|Lack of Efficacy|4
7607188|NCT02577354|12014417|FG000|Overall Study|Lost to Follow-up|3
7607189|NCT02577354|12014418|FG001|Overall Study|Lost to Follow-up|1
7607190|NCT02577354|12014417|FG000|Overall Study|Missed Visit|4
7607191|NCT02577354|12014418|FG001|Overall Study|Missed Visit|3
7607192|NCT02577354|12014417|FG000|Overall Study|Adverse Event|4
7607193|NCT02577354|12014418|FG001|Overall Study|Adverse Event|5
7607194|NCT02471807|12014434|FG000|Overall Study|Death|14
7607195|NCT02471807|12014434|FG000|Overall Study|Withdrawal by Subject|1
7607196|NCT02471807|12014434|FG000|Overall Study|Explant|5
7607197|NCT02471807|12014434|FG000|Overall Study|Visits not yet due|2
7607198|NCT02471807|12014434|FG000|Overall Study|Missed Visit|1
7607202|NCT01453946|12014460|FG000|Overall Study|Did not receive drug for the taper phase|1
7607203|NCT01453946|12014460|FG000|Overall Study|Protocol Violation|2
7607204|NCT01453946|12014460|FG000|Overall Study|Lack of Efficacy|3
7607205|NCT01453946|12014460|FG000|Overall Study|Adverse Event|3
7607206|NCT01444092|12014464|FG000|Overall Study|Adverse Event|8
7607207|NCT01444092|12014464|FG000|Overall Study|Protocol Violation|1
7607208|NCT01444092|12014464|FG000|Overall Study|Withdrawal by Subject|1
7607209|NCT01444092|12014464|FG000|Overall Study|Other Eligibility criteria|7
7607210|NCT01265784|12014471|FG000|Overall Study|Lost to Follow-up|5
7607211|NCT01265784|12014472|FG001|Overall Study|Lost to Follow-up|3
7607212|NCT01265784|12014473|FG002|Overall Study|Lost to Follow-up|2
7607213|NCT01265784|12014471|FG000|Overall Study|Withdrawal by Subject|0
7607214|NCT01265784|12014472|FG001|Overall Study|Withdrawal by Subject|5
7607215|NCT01265784|12014473|FG002|Overall Study|Withdrawal by Subject|0
7607216|NCT01265784|12014471|FG000|Overall Study|Physician Decision|1
7607217|NCT01265784|12014472|FG001|Overall Study|Physician Decision|0
7607218|NCT01265784|12014473|FG002|Overall Study|Physician Decision|1
7607219|NCT01265784|12014471|FG000|Overall Study|Adverse Event|1
7607220|NCT01265784|12014472|FG001|Overall Study|Adverse Event|0
7607221|NCT01265784|12014473|FG002|Overall Study|Adverse Event|0
7607222|NCT01265784|12014471|FG000|Overall Study|Death|3
7607223|NCT01265784|12014472|FG001|Overall Study|Death|0
7607224|NCT01265784|12014473|FG002|Overall Study|Death|0
7607225|NCT01265784|12014471|FG000|Overall Study|Protocol Violation|2
7607226|NCT01265784|12014472|FG001|Overall Study|Protocol Violation|0
7607227|NCT01265784|12014473|FG002|Overall Study|Protocol Violation|0
7607228|NCT01265784|12014471|FG000|Overall Study|Incorrectly Randomized|0
7607229|NCT01265784|12014472|FG001|Overall Study|Incorrectly Randomized|0
7607230|NCT01265784|12014473|FG002|Overall Study|Incorrectly Randomized|1
7607231|NCT00577577|12014483|FG000|Overall Study|Adverse Event|3
7607232|NCT00577577|12014484|FG001|Overall Study|Adverse Event|2
7607233|NCT00577577|12014483|FG000|Overall Study|Lost to Follow-up|1
7607234|NCT00577577|12014484|FG001|Overall Study|Lost to Follow-up|0
7607235|NCT00577577|12014483|FG000|Overall Study|Protocol Violation|0
7607236|NCT00577577|12014484|FG001|Overall Study|Protocol Violation|3
7607237|NCT00577577|12014483|FG000|Overall Study|Transportation|1
7607238|NCT00577577|12014484|FG001|Overall Study|Transportation|0
7607239|NCT00392327|12014498|FG000|Overall Study|Death|1
7607240|NCT00392327|12014499|FG001|Overall Study|Death|0
7607241|NCT00392327|12014500|FG002|Overall Study|Death|1
7607242|NCT00392327|12014501|FG003|Overall Study|Death|0
7607243|NCT00392327|12014502|FG004|Overall Study|Death|0
7607244|NCT00392327|12014503|FG005|Overall Study|Death|0
7607245|NCT00392327|12014504|FG006|Overall Study|Death|0
7607246|NCT00392327|12014505|FG007|Overall Study|Death|0
7607247|NCT00392327|12014498|FG000|Overall Study|Lack of Efficacy|8
7607248|NCT00392327|12014499|FG001|Overall Study|Lack of Efficacy|8
7607249|NCT00392327|12014500|FG002|Overall Study|Lack of Efficacy|9
7607250|NCT00392327|12014501|FG003|Overall Study|Lack of Efficacy|6
7607251|NCT00392327|12014502|FG004|Overall Study|Lack of Efficacy|3
7607252|NCT00392327|12014503|FG005|Overall Study|Lack of Efficacy|3
7607253|NCT00392327|12014504|FG006|Overall Study|Lack of Efficacy|3
7607254|NCT00392327|12014505|FG007|Overall Study|Lack of Efficacy|3
7607255|NCT00392327|12014498|FG000|Overall Study|Physician Decision|3
7607256|NCT00392327|12014499|FG001|Overall Study|Physician Decision|5
7607257|NCT00392327|12014500|FG002|Overall Study|Physician Decision|2
7607258|NCT00392327|12014501|FG003|Overall Study|Physician Decision|2
7607259|NCT00392327|12014502|FG004|Overall Study|Physician Decision|0
7607260|NCT00392327|12014503|FG005|Overall Study|Physician Decision|1
7607261|NCT00392327|12014504|FG006|Overall Study|Physician Decision|5
7607262|NCT00392327|12014505|FG007|Overall Study|Physician Decision|3
7607263|NCT00392327|12014498|FG000|Overall Study|Protocol Violation|0
7607264|NCT00392327|12014499|FG001|Overall Study|Protocol Violation|0
7607265|NCT00392327|12014500|FG002|Overall Study|Protocol Violation|1
7607266|NCT00392327|12014501|FG003|Overall Study|Protocol Violation|0
7607267|NCT00392327|12014502|FG004|Overall Study|Protocol Violation|0
7607268|NCT00392327|12014503|FG005|Overall Study|Protocol Violation|0
7607269|NCT00392327|12014504|FG006|Overall Study|Protocol Violation|0
7607270|NCT00392327|12014505|FG007|Overall Study|Protocol Violation|0
7607271|NCT00392327|12014498|FG000|Overall Study|Withdrawal by Subject|3
7607272|NCT00392327|12014499|FG001|Overall Study|Withdrawal by Subject|2
7607273|NCT00392327|12014500|FG002|Overall Study|Withdrawal by Subject|4
7607274|NCT00392327|12014501|FG003|Overall Study|Withdrawal by Subject|6
7607275|NCT00392327|12014502|FG004|Overall Study|Withdrawal by Subject|0
7607276|NCT00392327|12014503|FG005|Overall Study|Withdrawal by Subject|1
7607277|NCT00392327|12014504|FG006|Overall Study|Withdrawal by Subject|1
7607278|NCT00392327|12014505|FG007|Overall Study|Withdrawal by Subject|5
7607279|NCT00392327|12014498|FG000|Overall Study|Ineligible|0
7607280|NCT00392327|12014499|FG001|Overall Study|Ineligible|4
7607281|NCT00392327|12014500|FG002|Overall Study|Ineligible|3
7607282|NCT00392327|12014501|FG003|Overall Study|Ineligible|2
7607283|NCT00392327|12014502|FG004|Overall Study|Ineligible|0
7607284|NCT00392327|12014503|FG005|Overall Study|Ineligible|0
7607285|NCT00392327|12014504|FG006|Overall Study|Ineligible|0
7607286|NCT00392327|12014505|FG007|Overall Study|Ineligible|0
7607287|NCT00085202|12014525|FG000|Overall Study|Still on therapy|2
7607288|NCT00085202|12014526|FG001|Overall Study|Still on therapy|0
7607289|NCT00085202|12014525|FG000|Overall Study|Bone involvement confirmed by bone scan|0
7607290|NCT00085202|12014526|FG001|Overall Study|Bone involvement confirmed by bone scan|1
7275643|NCT00443781|11490294|FG000|Overall Study|Investigator terminated participation|1
7275644|NCT00443781|11490294|FG000|Overall Study|Insurance not covered|2
7275645|NCT00443781|11490294|FG000|Overall Study|PD/FAD not done|1
7275646|NCT00443820|11490302|FG000|Overall Study|Adverse Event|1
7275647|NCT00443820|11490303|FG001|Overall Study|Adverse Event|1
7275648|NCT00443820|11490304|FG002|Overall Study|Adverse Event|0
7275649|NCT00443820|11490305|FG003|Overall Study|Adverse Event|0
7275650|NCT00443820|11490302|FG000|Overall Study|Lack of Efficacy|3
7275651|NCT00443820|11490303|FG001|Overall Study|Lack of Efficacy|2
7275652|NCT00443820|11490304|FG002|Overall Study|Lack of Efficacy|1
7275653|NCT00443820|11490305|FG003|Overall Study|Lack of Efficacy|1
7275654|NCT00443820|11490302|FG000|Overall Study|Protocol Violation|2
7275655|NCT00443820|11490303|FG001|Overall Study|Protocol Violation|1
7275656|NCT00443820|11490304|FG002|Overall Study|Protocol Violation|2
7275657|NCT00443820|11490305|FG003|Overall Study|Protocol Violation|1
7275658|NCT00443820|11490302|FG000|Overall Study|Withdrawal by Subject|6
7275659|NCT00443820|11490303|FG001|Overall Study|Withdrawal by Subject|7
7275660|NCT00443820|11490304|FG002|Overall Study|Withdrawal by Subject|8
7275661|NCT00443820|11490305|FG003|Overall Study|Withdrawal by Subject|9
7275662|NCT00443820|11490302|FG000|Overall Study|Lost to Follow-up|9
7275663|NCT00443820|11490303|FG001|Overall Study|Lost to Follow-up|8
7275664|NCT00443820|11490304|FG002|Overall Study|Lost to Follow-up|6
7275665|NCT00443820|11490305|FG003|Overall Study|Lost to Follow-up|5
7275666|NCT00443820|11490302|FG000|Overall Study|Administrative problems|0
7275667|NCT00443820|11490303|FG001|Overall Study|Administrative problems|0
7275668|NCT00443820|11490304|FG002|Overall Study|Administrative problems|0
7275669|NCT00443820|11490305|FG003|Overall Study|Administrative problems|1
7275670|NCT00443820|11490302|FG000|Overall Study|Death|0
7275671|NCT00443820|11490303|FG001|Overall Study|Death|0
7275672|NCT00443820|11490304|FG002|Overall Study|Death|1
7607291|NCT00085202|12014525|FG000|Overall Study|Excessive toxicity|6
7607292|NCT00085202|12014526|FG001|Overall Study|Excessive toxicity|5
7275673|NCT00443820|11490305|FG003|Overall Study|Death|0
7275674|NCT00443846|11490317|FG000|Overall Study|Withdrawn due to intercurrent disease|1
7275675|NCT00443846|11490318|FG001|Overall Study|Withdrawn due to intercurrent disease|0
7275676|NCT00443846|11490317|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
7275677|NCT00443846|11490318|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
7275678|NCT00443846|11490317|FG000|Overall Study|Adverse Event|0
7275679|NCT00443846|11490318|FG001|Overall Study|Adverse Event|1
7275680|NCT00443846|11490317|FG000|Overall Study|Personal reason|8
7275681|NCT00443846|11490318|FG001|Overall Study|Personal reason|3
7275682|NCT00443846|11490317|FG000|Overall Study|Lost to Follow-up|1
7275683|NCT00443846|11490318|FG001|Overall Study|Lost to Follow-up|2
7607293|NCT00085202|12014525|FG000|Overall Study|Non-specified|3
7275684|NCT00443872|11490324|FG000|Overall Study|Protocol Violation|7
7275685|NCT00443872|11490324|FG000|Overall Study|Lost to Follow-up|2
7607294|NCT00085202|12014526|FG001|Overall Study|Non-specified|5
7607295|NCT00085202|12014525|FG000|Overall Study|Withdrawal by Subject|2
7607296|NCT00085202|12014526|FG001|Overall Study|Withdrawal by Subject|1
7607297|NCT00085202|12014525|FG000|Overall Study|Physician Decision|4
7607298|NCT00085202|12014526|FG001|Overall Study|Physician Decision|1
7607299|NCT00085202|12014525|FG000|Overall Study|Progressive disease|1
7607300|NCT00085202|12014526|FG001|Overall Study|Progressive disease|11
7275686|NCT00443872|11490324|FG000|Overall Study|Adverse Event|8
7275687|NCT00443898|11490341|FG000|Overall Study|Adverse Event|0
7275688|NCT00443898|11490342|FG001|Overall Study|Adverse Event|0
7275689|NCT00443898|11490343|FG002|Overall Study|Adverse Event|1
7607301|NCT04386616|12014627|FG000|Overall Study|Death|22
7607302|NCT04386616|12014628|FG001|Overall Study|Death|22
7607303|NCT04386616|12014629|FG002|Overall Study|Death|21
7607304|NCT04386616|12014627|FG000|Overall Study|Lost to Follow-up|5
7607305|NCT04386616|12014628|FG001|Overall Study|Lost to Follow-up|8
7607306|NCT04386616|12014629|FG002|Overall Study|Lost to Follow-up|6
7607307|NCT04386616|12014627|FG000|Overall Study|Withdrawal by Subject|2
7607308|NCT04386616|12014628|FG001|Overall Study|Withdrawal by Subject|4
7275690|NCT00443898|11490344|FG003|Overall Study|Adverse Event|1
7275691|NCT00443898|11490341|FG000|Overall Study|Lack of Efficacy|2
7275692|NCT00443898|11490342|FG001|Overall Study|Lack of Efficacy|3
7275693|NCT00443898|11490343|FG002|Overall Study|Lack of Efficacy|3
7275694|NCT00443898|11490344|FG003|Overall Study|Lack of Efficacy|1
7275695|NCT00443898|11490341|FG000|Overall Study|Protocol Violation|1
7275696|NCT00443898|11490342|FG001|Overall Study|Protocol Violation|1
7275697|NCT00443898|11490343|FG002|Overall Study|Protocol Violation|1
7275698|NCT00443898|11490344|FG003|Overall Study|Protocol Violation|0
7275699|NCT00443898|11490341|FG000|Overall Study|Withdrawal by Subject|11
7275700|NCT00443898|11490342|FG001|Overall Study|Withdrawal by Subject|10
7275701|NCT00443898|11490343|FG002|Overall Study|Withdrawal by Subject|10
7275702|NCT00443898|11490344|FG003|Overall Study|Withdrawal by Subject|6
7275703|NCT00443898|11490341|FG000|Overall Study|Lost to Follow-up|10
7275704|NCT00443898|11490342|FG001|Overall Study|Lost to Follow-up|10
7275705|NCT00443898|11490343|FG002|Overall Study|Lost to Follow-up|14
7275706|NCT00443898|11490344|FG003|Overall Study|Lost to Follow-up|10
7275707|NCT00443898|11490341|FG000|Overall Study|Death|0
7275708|NCT00443898|11490342|FG001|Overall Study|Death|1
7275709|NCT00443898|11490343|FG002|Overall Study|Death|0
7275710|NCT00443898|11490344|FG003|Overall Study|Death|0
7275711|NCT00444067|11490380|FG000|Overall Study|Lost to Follow-up|0
7275712|NCT00444067|11490381|FG001|Overall Study|Lost to Follow-up|1
7275713|NCT00444106|11490402|FG000|Overall Study|Lost to Follow-up|2
7275714|NCT00444106|11490403|FG001|Overall Study|Lost to Follow-up|1
7275715|NCT00444106|11490404|FG002|Overall Study|Lost to Follow-up|0
7275716|NCT00444106|11490402|FG000|Overall Study|Abnormal Test Procedure Results|0
7275717|NCT00444106|11490403|FG001|Overall Study|Abnormal Test Procedure Results|0
7275718|NCT00444106|11490404|FG002|Overall Study|Abnormal Test Procedure Results|1
7275719|NCT00444145|11490415|FG000|Overall Study|Withdrawal by Subject|2
7275720|NCT00444145|11490415|FG000|Overall Study|Lost to Follow-up|1
7275721|NCT00444145|11490415|FG000|Overall Study|non-compliant|11
7275722|NCT00444145|11490415|FG000|Overall Study|Screen Failures|5
7275723|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
7275724|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
7275725|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
7275726|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
7275727|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
7275728|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
7275729|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
7275730|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
7275731|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
7275732|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
7275733|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Adverse Event|0
7275734|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Adverse Event|0
7275735|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Adverse Event|3
7275736|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Adverse Event|2
7275737|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Adverse Event|13
7275738|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
7275739|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
7275740|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
7275741|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
7275742|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
7275743|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Patient's wish|0
7275744|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Patient's wish|0
7275745|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Patient's wish|19
7275746|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Patient's wish|9
7275747|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Patient's wish|20
7275748|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Protocol Violation|0
7275749|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Protocol Violation|0
7607309|NCT04386616|12014629|FG002|Overall Study|Withdrawal by Subject|1
7607310|NCT04386616|12014627|FG000|Overall Study|Adverse Event|1
7607311|NCT04386616|12014628|FG001|Overall Study|Adverse Event|1
7607312|NCT04386616|12014629|FG002|Overall Study|Adverse Event|0
7607313|NCT04296942|12014662|FG000|Overall Study|Study closure by sponsor|1
7607314|NCT04296942|12014663|FG001|Overall Study|Study closure by sponsor|0
7607315|NCT04296942|12014664|FG002|Overall Study|Study closure by sponsor|0
7607316|NCT04278872|12014676|FG000|Overall Study|Adverse Event|1
7607317|NCT04278872|12014677|FG001|Overall Study|Adverse Event|0
7607318|NCT04278872|12014676|FG000|Overall Study|Protocol Violation|0
7607319|NCT04278872|12014677|FG001|Overall Study|Protocol Violation|1
7607320|NCT04278872|12014676|FG000|Overall Study|Study Termination|2
7607321|NCT04278872|12014677|FG001|Overall Study|Study Termination|0
7607322|NCT04213807|12014686|FG000|Overall Study|Physician Decision|0
7607323|NCT04213807|12014687|FG001|Overall Study|Physician Decision|0
7607324|NCT04213807|12014688|FG002|Overall Study|Physician Decision|1
7607325|NCT03721107|12014765|FG000|Overall Study|Adverse Event|1
7607326|NCT03721107|12014766|FG001|Overall Study|Adverse Event|1
7607327|NCT03721107|12014767|FG002|Overall Study|Adverse Event|6
7607328|NCT03721107|12014768|FG003|Overall Study|Adverse Event|5
7275750|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Protocol Violation|103
7275751|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Protocol Violation|88
7275752|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Protocol Violation|87
7275753|NCT00444275|11490422|FG000|Maintenance Treatment Phase|Ineffectiveness|0
7275754|NCT00444275|11490423|FG001|Maintenance Treatment Phase|Ineffectiveness|0
7275755|NCT00444275|11490424|FG002|Maintenance Treatment Phase|Ineffectiveness|5
7275756|NCT00444275|11490425|FG003|Maintenance Treatment Phase|Ineffectiveness|3
7275757|NCT00444275|11490426|FG004|Maintenance Treatment Phase|Ineffectiveness|14
7275758|NCT00444457|11490445|FG000|Infant Series|Other|0
7275759|NCT00444457|11490446|FG001|Infant Series|Other|1
7275760|NCT00444457|11490447|FG002|Infant Series|Other|0
7275761|NCT00444457|11490448|FG003|Infant Series|Other|0
7275762|NCT00444457|11490445|FG000|Infant Series|Parent or legal guardian request|18
7275763|NCT00444457|11490446|FG001|Infant Series|Parent or legal guardian request|29
7275764|NCT00444457|11490447|FG002|Infant Series|Parent or legal guardian request|34
7469734|NCT01926782|11771659|FG003|Overall Study|Other than specified|12
7607329|NCT03721107|12014765|FG000|Overall Study|Lost to Follow-up|2
7607330|NCT03721107|12014766|FG001|Overall Study|Lost to Follow-up|0
7607331|NCT03721107|12014767|FG002|Overall Study|Lost to Follow-up|3
7607332|NCT03721107|12014768|FG003|Overall Study|Lost to Follow-up|0
7607333|NCT03721107|12014765|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607334|NCT03721107|12014766|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607335|NCT03721107|12014767|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
7607336|NCT03721107|12014768|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
7607337|NCT03721107|12014765|FG000|Overall Study|Physician Decision|0
7607338|NCT03721107|12014766|FG001|Overall Study|Physician Decision|1
7607339|NCT03721107|12014767|FG002|Overall Study|Physician Decision|0
7607340|NCT03721107|12014768|FG003|Overall Study|Physician Decision|0
7607341|NCT03721107|12014765|FG000|Overall Study|Pregnancy|0
7607342|NCT03721107|12014766|FG001|Overall Study|Pregnancy|0
7607343|NCT03721107|12014767|FG002|Overall Study|Pregnancy|1
7607344|NCT03721107|12014768|FG003|Overall Study|Pregnancy|0
7607345|NCT03721107|12014765|FG000|Overall Study|Withdrawal by Subject|1
7607346|NCT03721107|12014766|FG001|Overall Study|Withdrawal by Subject|1
7607347|NCT03721107|12014767|FG002|Overall Study|Withdrawal by Subject|5
7607348|NCT03721107|12014768|FG003|Overall Study|Withdrawal by Subject|5
7607349|NCT03721107|12014765|FG000|Overall Study|Other|1
7607350|NCT03721107|12014766|FG001|Overall Study|Other|0
7607351|NCT03721107|12014767|FG002|Overall Study|Other|0
7607352|NCT03721107|12014768|FG003|Overall Study|Other|1
7607403|NCT03294109|12014915|FG000|Overall Study|Withdrawal by Subject|6
7607404|NCT03294109|12014916|FG001|Overall Study|Withdrawal by Subject|5
7607405|NCT03268005|12014925|FG000|Overall Study|Death|2
7607406|NCT03268005|12014926|FG001|Overall Study|Death|1
7607407|NCT03268005|12014925|FG000|Overall Study|Lost to Follow-up|2
7607408|NCT03268005|12014926|FG001|Overall Study|Lost to Follow-up|2
7607409|NCT03268005|12014925|FG000|Overall Study|Withdrawal by Subject|11
7607410|NCT03268005|12014926|FG001|Overall Study|Withdrawal by Subject|11
7607411|NCT03225170|12014935|FG000|Overall Study|Lost to Follow-up|4
7607412|NCT03225170|12014936|FG001|Overall Study|Lost to Follow-up|4
7607413|NCT03225170|12014937|FG002|Overall Study|Lost to Follow-up|0
7607414|NCT03225170|12014935|FG000|Overall Study|Did not complete intervention/control writing exercise|0
7607415|NCT03225170|12014936|FG001|Overall Study|Did not complete intervention/control writing exercise|1
7607416|NCT03225170|12014937|FG002|Overall Study|Did not complete intervention/control writing exercise|0
7607417|NCT03219034|12014961|FG000|Overall Study|Lost to Follow-up|9
7607418|NCT03219034|12014962|FG001|Overall Study|Lost to Follow-up|13
7607419|NCT03219034|12014961|FG000|Overall Study|Additional dental work needed|1
7607420|NCT03219034|12014962|FG001|Overall Study|Additional dental work needed|0
7607421|NCT03219034|12014961|FG000|Overall Study|UPPP Surgery|1
7607422|NCT03219034|12014962|FG001|Overall Study|UPPP Surgery|0
7607423|NCT03219034|12014961|FG000|Overall Study|Dental sensitivity|0
7607424|NCT03219034|12014962|FG001|Overall Study|Dental sensitivity|1
7607425|NCT03219034|12014961|FG000|Overall Study|Death in family|0
7607426|NCT03219034|12014962|FG001|Overall Study|Death in family|1
7607496|NCT02785952|12015055|FG001|Overall Study|Adverse Event|19
7607427|NCT03168438|12014972|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
7607428|NCT03168438|12014973|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
7607429|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
7607430|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
7607431|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
7607432|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
7607433|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
7607434|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
7607435|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
7607436|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7607437|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Adverse Event|3
7607353|NCT03644849|12014808|FG000|Overall Study|Lost to Follow-up|1
7607354|NCT03644849|12014809|FG001|Overall Study|Lost to Follow-up|3
7607355|NCT03604159|12014817|FG000|Overall Study|Lost to Follow-up|6
7607356|NCT03604159|12014818|FG001|Overall Study|Lost to Follow-up|7
7607357|NCT03602885|12014826|FG000|Overall Study|Lost to Follow-up|3
7607358|NCT03602885|12014827|FG001|Overall Study|Lost to Follow-up|0
7607359|NCT03539601|12014837|FG000|Overall Study|Withdraw by parent/guardian|1
7607360|NCT03539601|12014838|FG001|Overall Study|Withdraw by parent/guardian|0
7607361|NCT03539601|12014839|FG002|Overall Study|Withdraw by parent/guardian|1
7607362|NCT03539601|12014840|FG003|Overall Study|Withdraw by parent/guardian|0
7607363|NCT03539601|12014837|FG000|Overall Study|Adverse Event|0
7607364|NCT03539601|12014838|FG001|Overall Study|Adverse Event|2
7607365|NCT03539601|12014839|FG002|Overall Study|Adverse Event|0
7607366|NCT03539601|12014840|FG003|Overall Study|Adverse Event|0
7607367|NCT03539601|12014837|FG000|Overall Study|Lost to Follow-up|2
7607368|NCT03539601|12014838|FG001|Overall Study|Lost to Follow-up|4
7607369|NCT03539601|12014839|FG002|Overall Study|Lost to Follow-up|5
7607370|NCT03539601|12014840|FG003|Overall Study|Lost to Follow-up|0
7607371|NCT03539601|12014837|FG000|Overall Study|Withdrawal by Subject|2
7607372|NCT03539601|12014838|FG001|Overall Study|Withdrawal by Subject|0
7607373|NCT03539601|12014839|FG002|Overall Study|Withdrawal by Subject|0
7607374|NCT03539601|12014840|FG003|Overall Study|Withdrawal by Subject|1
7607375|NCT03539601|12014837|FG000|Overall Study|Randomized but not treated|1
7607376|NCT03539601|12014838|FG001|Overall Study|Randomized but not treated|1
7607377|NCT03539601|12014839|FG002|Overall Study|Randomized but not treated|0
7607378|NCT03539601|12014840|FG003|Overall Study|Randomized but not treated|0
7607379|NCT03539458|12014858|FG000|Overall Study|Death|1
7607380|NCT03532451|12014864|FG000|Overall Study|Withdrawal by Subject|0
7607381|NCT03532451|12014865|FG001|Overall Study|Withdrawal by Subject|1
7607382|NCT03532451|12014864|FG000|Overall Study|Progression prior to the surgery|1
7607383|NCT03532451|12014865|FG001|Overall Study|Progression prior to the surgery|0
7607384|NCT03439657|12014891|FG000|Overall Study|Adverse Event|2
7607385|NCT03439657|12014892|FG001|Overall Study|Adverse Event|3
7607386|NCT03439657|12014891|FG000|Overall Study|Lost to Follow-up|1
7607387|NCT03439657|12014892|FG001|Overall Study|Lost to Follow-up|0
7607388|NCT03439657|12014891|FG000|Overall Study|Protocol Violation|1
7607389|NCT03439657|12014892|FG001|Overall Study|Protocol Violation|1
7607390|NCT03439657|12014891|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
7607391|NCT03439657|12014892|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
7607392|NCT03377790|12014902|FG000|Overall Study|Withdrawal by Subject|1
7607393|NCT03377790|12014903|FG001|Overall Study|Withdrawal by Subject|0
7607394|NCT03377790|12014902|FG000|Overall Study|Adverse Event|1
7607395|NCT03377790|12014903|FG001|Overall Study|Adverse Event|0
7607396|NCT03377790|12014902|FG000|Overall Study|Lost to Follow-up|0
7607397|NCT03377790|12014903|FG001|Overall Study|Lost to Follow-up|2
7607398|NCT03377790|12014902|FG000|Overall Study|Randomized but not treated|1
7607399|NCT03377790|12014903|FG001|Overall Study|Randomized but not treated|0
7607400|NCT03377790|12014902|FG000|Overall Study|Withdrawn by Parent/Guardian|7
7607401|NCT03377790|12014903|FG001|Overall Study|Withdrawn by Parent/Guardian|4
7607402|NCT03353675|12014909|FG000|Overall Study|Adverse Event|4
7607438|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Adverse Event|3
7607439|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Adverse Event|0
7607440|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Adverse Event|0
7607441|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
7607442|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
7607443|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
7607444|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
7607445|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Death|2
7607446|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Death|1
7607447|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Death|0
7607448|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Death|0
7607449|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
7607450|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
7607451|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
7607452|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
7607453|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Protocol Violation|0
7607454|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7607455|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7607456|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7607457|NCT03110380|12014982|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
7607458|NCT03110380|12014983|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
7607459|NCT03110380|12014984|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
7607460|NCT03110380|12014985|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
7607461|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
7607462|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
7607463|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
7607464|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
7607465|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
7607466|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
7607467|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
7607468|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
7607469|NCT03110380|12014982|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607470|NCT03110380|12014983|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607471|NCT03110380|12014984|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
7607472|NCT03110380|12014985|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
7607473|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7607474|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
7607475|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
7607476|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
7607477|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Death|3
7607478|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Death|3
7607479|NCT03078478|12015001|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
7607480|NCT03078478|12015002|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
7607481|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
7607482|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
7607483|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
7607484|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
7607485|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Death|4
7607486|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Death|6
7607487|NCT03078478|12015001|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
7607488|NCT03078478|12015002|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
7607489|NCT02993263|12015017|FG000|Overall Study|Equipment Software failed and results were lost.|323
7607490|NCT02985684|12015021|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
7607491|NCT02985684|12015021|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
7607492|NCT02985684|12015021|FG000|6-Month Closure Success Evaluation|Device Removal|3
7275765|NCT00444457|11490448|FG003|Infant Series|Parent or legal guardian request|14
7275766|NCT00444457|11490445|FG000|Infant Series|Lost to Follow-up|10
7275767|NCT00444457|11490446|FG001|Infant Series|Lost to Follow-up|11
7275768|NCT00444457|11490447|FG002|Infant Series|Lost to Follow-up|7
7275769|NCT00444457|11490448|FG003|Infant Series|Lost to Follow-up|6
7275770|NCT00444457|11490445|FG000|Infant Series|Protocol Violation|16
7275771|NCT00444457|11490446|FG001|Infant Series|Protocol Violation|8
7275772|NCT00444457|11490447|FG002|Infant Series|Protocol Violation|6
7275773|NCT00444457|11490448|FG003|Infant Series|Protocol Violation|3
7275774|NCT00444457|11490445|FG000|Infant Series|Failed to return|5
7275775|NCT00444457|11490446|FG001|Infant Series|Failed to return|4
7275776|NCT00444457|11490447|FG002|Infant Series|Failed to return|4
7275777|NCT00444457|11490448|FG003|Infant Series|Failed to return|2
7275778|NCT00444457|11490445|FG000|Infant Series|Investigator request|4
7275779|NCT00444457|11490446|FG001|Infant Series|Investigator request|3
7275780|NCT00444457|11490447|FG002|Infant Series|Investigator request|3
7275781|NCT00444457|11490448|FG003|Infant Series|Investigator request|2
7275782|NCT00444457|11490445|FG000|Infant Series|Other|0
7275783|NCT00444457|11490446|FG001|Infant Series|Other|2
7275784|NCT00444457|11490447|FG002|Infant Series|Other|4
7275785|NCT00444457|11490448|FG003|Infant Series|Other|0
7275786|NCT00444457|11490445|FG000|Infant Series|Adverse Event|1
7275787|NCT00444457|11490446|FG001|Infant Series|Adverse Event|2
7275788|NCT00444457|11490447|FG002|Infant Series|Adverse Event|2
7275789|NCT00444457|11490448|FG003|Infant Series|Adverse Event|0
7275790|NCT00444457|11490445|FG000|Infant Series|Death|0
7275791|NCT00444457|11490446|FG001|Infant Series|Death|1
7275792|NCT00444457|11490447|FG002|Infant Series|Death|1
7275793|NCT00444457|11490448|FG003|Infant Series|Death|1
7275794|NCT00444457|11490445|FG000|After Infant Series|Other|0
7275795|NCT00444457|11490446|FG001|After Infant Series|Other|1
7275796|NCT00444457|11490447|FG002|After Infant Series|Other|1
7275797|NCT00444457|11490448|FG003|After Infant Series|Other|1
7275798|NCT00444457|11490445|FG000|After Infant Series|Parent or legal guardian request|4
7275799|NCT00444457|11490446|FG001|After Infant Series|Parent or legal guardian request|11
7275800|NCT00444457|11490447|FG002|After Infant Series|Parent or legal guardian request|6
7275801|NCT00444457|11490448|FG003|After Infant Series|Parent or legal guardian request|3
7275802|NCT00444457|11490445|FG000|After Infant Series|Failed to return|7
7275803|NCT00444457|11490446|FG001|After Infant Series|Failed to return|6
7607493|NCT02873195|12015036|FG000|Overall Study|Ineligible|5
7607494|NCT02873195|12015037|FG001|Overall Study|Ineligible|0
7607495|NCT02785952|12015054|FG000|Overall Study|Adverse Event|31
7607497|NCT02785952|12015054|FG000|Overall Study|Refusal unrelated to adverse events|10
7607498|NCT02785952|12015055|FG001|Overall Study|Refusal unrelated to adverse events|5
7607499|NCT02785952|12015054|FG000|Overall Study|Disease progression/relapse|61
7607500|NCT02785952|12015055|FG001|Overall Study|Disease progression/relapse|89
7607501|NCT02785952|12015054|FG000|Overall Study|Death|11
7607502|NCT02785952|12015055|FG001|Overall Study|Death|7
7607503|NCT02785952|12015054|FG000|Overall Study|Other- not protocol specified|6
7607504|NCT02785952|12015055|FG001|Overall Study|Other- not protocol specified|4
7607505|NCT02785952|12015054|FG000|Overall Study|On protocol treatment|6
7607506|NCT02785952|12015055|FG001|Overall Study|On protocol treatment|3
7607507|NCT02748616|12015067|FG000|Overall Study|Lost to Follow-up|1
7607508|NCT02748616|12015067|FG000|Overall Study|Withdrawal by Subject|2
7607509|NCT02748616|12015067|FG000|Overall Study|Physician Decision|2
7607510|NCT02748616|12015067|FG000|Overall Study|Did Not Complete Ursodial Course|2
7607592|NCT01978938|12015292|FG001|Overall Study|Previously scheduled procedure|1
7607511|NCT02719522|12015071|FG000|Overall Study|Implant Failure|4
7607512|NCT02719522|12015071|FG000|Overall Study|Death|2
7607513|NCT02719522|12015071|FG000|Overall Study|Lost to Follow-up|5
7607514|NCT02585232|12015092|FG000|Overall Study|Lost to Follow-up|8
7607515|NCT02585232|12015093|FG001|Overall Study|Lost to Follow-up|8
7607516|NCT02585232|12015092|FG000|Overall Study|Withdrawal by Subject|4
7607517|NCT02585232|12015093|FG001|Overall Study|Withdrawal by Subject|8
7607523|NCT02545283|12015144|FG000|Overall Study|Lost to Follow-up|2
7607524|NCT02545283|12015145|FG001|Overall Study|Lost to Follow-up|4
7607525|NCT02545283|12015144|FG000|Overall Study|Withdrawal by Subject|5
7607526|NCT02545283|12015145|FG001|Overall Study|Withdrawal by Subject|9
7607527|NCT02545283|12015144|FG000|Overall Study|Death|109
7607528|NCT02545283|12015145|FG001|Overall Study|Death|211
7607529|NCT02545283|12015144|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
7607530|NCT02545283|12015145|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
7607531|NCT02545283|12015144|FG000|Overall Study|Study Terminated By Sponsor|33
7607532|NCT02545283|12015145|FG001|Overall Study|Study Terminated By Sponsor|71
7607533|NCT02524171|12015155|FG000|6-month Follow-up|Lost to Follow-up|53
7607534|NCT02524171|12015156|FG001|6-month Follow-up|Lost to Follow-up|45
7607535|NCT02524171|12015155|FG000|12-month Follow-up Interview|Lost to Follow-up|45
7607536|NCT02524171|12015156|FG001|12-month Follow-up Interview|Lost to Follow-up|41
7607552|NCT02306122|12015211|FG000|Initial Physician Randomization|Physician Decision|0
7607553|NCT02306122|12015212|FG001|Initial Physician Randomization|Physician Decision|0
7607554|NCT02306122|12015213|FG002|Initial Physician Randomization|Physician Decision|0
7607555|NCT02306122|12015214|FG003|Initial Physician Randomization|Physician Decision|0
7607556|NCT02306122|12015215|FG004|Initial Physician Randomization|Physician Decision|0
7607557|NCT02306122|12015216|FG005|Initial Physician Randomization|Physician Decision|0
7607558|NCT02306122|12015217|FG006|Initial Physician Randomization|Physician Decision|0
7607559|NCT02306122|12015218|FG007|Initial Physician Randomization|Physician Decision|0
7607560|NCT02306122|12015219|FG008|Initial Physician Randomization|Physician Decision|1
7607561|NCT02306122|12015220|FG009|Initial Physician Randomization|Physician Decision|0
7607562|NCT02306122|12015221|FG010|Initial Physician Randomization|Physician Decision|0
7607563|NCT02147184|12015259|FG000|Overall Study|Lost to Follow-up|28
7607564|NCT02147184|12015260|FG001|Overall Study|Lost to Follow-up|15
7607565|NCT02147184|12015259|FG000|Overall Study|Study Burden|11
7607566|NCT02147184|12015260|FG001|Overall Study|Study Burden|7
7607567|NCT02147184|12015259|FG000|Overall Study|Pregnancy|6
7607568|NCT02147184|12015260|FG001|Overall Study|Pregnancy|0
7607569|NCT02147184|12015259|FG000|Overall Study|Moved out of state|3
7607570|NCT02147184|12015260|FG001|Overall Study|Moved out of state|3
7607571|NCT02147184|12015259|FG000|Overall Study|Physician Decision|0
7607572|NCT02147184|12015260|FG001|Overall Study|Physician Decision|2
7607573|NCT02147184|12015259|FG000|Overall Study|Other|1
7607574|NCT02147184|12015260|FG001|Overall Study|Other|0
7607575|NCT02000219|12015285|FG000|14-Week Study Period|Physician Decision|1
7607576|NCT02000219|12015285|FG000|14-Week Study Period|Adverse Event|1
7607577|NCT02000219|12015285|FG000|14-Week Study Period|Underwent transplantation|1
7607578|NCT02000219|12015285|FG000|Continuation Period|Withdrawal by Subject|1
7607579|NCT02000219|12015285|FG000|Continuation Period|Had liver transplant|2
7607580|NCT02000219|12015285|FG000|Continuation Period|Non-compliance with study drug|2
7607581|NCT01978938|12015291|FG000|Overall Study|Lost to Follow-up|12
7607582|NCT01978938|12015292|FG001|Overall Study|Lost to Follow-up|6
7607583|NCT01978938|12015291|FG000|Overall Study|Withdrawal by Subject|8
7607584|NCT01978938|12015292|FG001|Overall Study|Withdrawal by Subject|4
7607585|NCT01978938|12015291|FG000|Overall Study|Adverse Event, non-fatal|2
7607586|NCT01978938|12015292|FG001|Overall Study|Adverse Event, non-fatal|1
7607587|NCT01978938|12015291|FG000|Overall Study|Participant noncompliance|1
7607588|NCT01978938|12015292|FG001|Overall Study|Participant noncompliance|1
7607589|NCT01978938|12015291|FG000|Overall Study|Did not meet inclusion criteria|0
7607590|NCT01978938|12015292|FG001|Overall Study|Did not meet inclusion criteria|1
7607591|NCT01978938|12015291|FG000|Overall Study|Previously scheduled procedure|0
7607593|NCT01854385|12015298|FG000|Pre-Treatment|Withdrawal by Subject|4
7607594|NCT01854385|12015298|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
7607595|NCT01854385|12015298|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
7607596|NCT01854385|12015298|FG000|Pre-Treatment|Unable to come for study visits|1
7607597|NCT01854385|12015298|FG000|Treatment|Lost to Follow-up|1
7607598|NCT01844856|12015304|FG000|Overall Study|Lost to Follow-up|15
7607599|NCT01844856|12015305|FG001|Overall Study|Lost to Follow-up|3
7607600|NCT01844856|12015304|FG000|Overall Study|Adverse Event|3
7607601|NCT01844856|12015305|FG001|Overall Study|Adverse Event|6
7607602|NCT01844856|12015304|FG000|Overall Study|Withdrawal by Subject|3
7607603|NCT01844856|12015305|FG001|Overall Study|Withdrawal by Subject|2
7607604|NCT01844856|12015304|FG000|Overall Study|Noncompliance|2
7607605|NCT01844856|12015305|FG001|Overall Study|Noncompliance|3
7607606|NCT01844856|12015304|FG000|Overall Study|Enterococcus Resistant|0
7607607|NCT01844856|12015305|FG001|Overall Study|Enterococcus Resistant|1
7607608|NCT01844856|12015304|FG000|Overall Study|Inadvertently Not Scheduled|1
7607609|NCT01844856|12015305|FG001|Overall Study|Inadvertently Not Scheduled|0
7607610|NCT01844856|12015304|FG000|Overall Study|Randomized but was a Screen Failure|0
7607611|NCT01844856|12015305|FG001|Overall Study|Randomized but was a Screen Failure|1
7607612|NCT01712789|12015344|FG000|Overall Study|Lack of Efficacy|2
7607613|NCT01712789|12015344|FG000|Overall Study|Lost to Follow-up|1
7607614|NCT01712789|12015344|FG000|Overall Study|Progressive Disease|504
7607615|NCT01712789|12015344|FG000|Overall Study|Death|57
7607616|NCT01712789|12015344|FG000|Overall Study|Adverse Event|52
7607617|NCT01712789|12015344|FG000|Overall Study|Miscellaneous|31
7607618|NCT01712789|12015344|FG000|Overall Study|Withdrawal by Subject|21
7607619|NCT01712789|12015344|FG000|Overall Study|Transition to Commercial Treatment|8
7607620|NCT01712789|12015344|FG000|Overall Study|Participants Did Not Receive Study Drug|6
7275804|NCT00444457|11490447|FG002|After Infant Series|Failed to return|5
7607633|NCT01542736|12015366|FG000|Overall Study|Death|1
7607634|NCT01535807|12015372|FG000|Overall Study|Withdrawal by Subject|1
7607635|NCT01535807|12015373|FG001|Overall Study|Withdrawal by Subject|1
7607636|NCT01535807|12015372|FG000|Overall Study|Data collection error|1
7607637|NCT01535807|12015373|FG001|Overall Study|Data collection error|1
7607638|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607639|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607640|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607641|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607642|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607643|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607644|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607645|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607646|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607647|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607648|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7275805|NCT00444457|11490448|FG003|After Infant Series|Failed to return|1
7275806|NCT00444457|11490445|FG000|After Infant Series|Lost to Follow-up|5
7607649|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607650|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
7607651|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607652|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
7607653|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607654|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607655|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7275807|NCT00444457|11490446|FG001|After Infant Series|Lost to Follow-up|5
7275808|NCT00444457|11490447|FG002|After Infant Series|Lost to Follow-up|5
7275809|NCT00444457|11490448|FG003|After Infant Series|Lost to Follow-up|2
7275810|NCT00444457|11490445|FG000|After Infant Series|Protocol Violation|2
7275811|NCT00444457|11490446|FG001|After Infant Series|Protocol Violation|4
7275812|NCT00444457|11490447|FG002|After Infant Series|Protocol Violation|2
7275813|NCT00444457|11490448|FG003|After Infant Series|Protocol Violation|2
7275814|NCT00444457|11490445|FG000|After Infant Series|Adverse Event|2
7275815|NCT00444457|11490446|FG001|After Infant Series|Adverse Event|2
7275816|NCT00444457|11490447|FG002|After Infant Series|Adverse Event|0
7275817|NCT00444457|11490448|FG003|After Infant Series|Adverse Event|0
7275818|NCT00444457|11490445|FG000|After Infant Series|Investigator request|0
7275819|NCT00444457|11490446|FG001|After Infant Series|Investigator request|0
7275820|NCT00444457|11490447|FG002|After Infant Series|Investigator request|0
7275821|NCT00444457|11490448|FG003|After Infant Series|Investigator request|1
7275822|NCT00444457|11490445|FG000|After Infant Series|Other|0
7275823|NCT00444457|11490446|FG001|After Infant Series|Other|1
7275824|NCT00444457|11490447|FG002|After Infant Series|Other|0
7275825|NCT00444457|11490448|FG003|After Infant Series|Other|0
7275826|NCT00444457|11490445|FG000|Toddler Dose|Lost to Follow-up|4
7275827|NCT00444457|11490446|FG001|Toddler Dose|Lost to Follow-up|1
7275828|NCT00444457|11490447|FG002|Toddler Dose|Lost to Follow-up|1
7275829|NCT00444457|11490448|FG003|Toddler Dose|Lost to Follow-up|3
7275830|NCT00444457|11490445|FG000|Toddler Dose|Failed to return|2
7275831|NCT00444457|11490446|FG001|Toddler Dose|Failed to return|2
7275832|NCT00444457|11490447|FG002|Toddler Dose|Failed to return|1
7275833|NCT00444457|11490448|FG003|Toddler Dose|Failed to return|3
7275834|NCT00444457|11490445|FG000|Toddler Dose|Parent or legal guardian request|0
7275835|NCT00444457|11490446|FG001|Toddler Dose|Parent or legal guardian request|3
7275836|NCT00444457|11490447|FG002|Toddler Dose|Parent or legal guardian request|2
7275837|NCT00444457|11490448|FG003|Toddler Dose|Parent or legal guardian request|1
7275838|NCT00444457|11490445|FG000|Toddler Dose|Protocol Violation|1
7275839|NCT00444457|11490446|FG001|Toddler Dose|Protocol Violation|0
7275840|NCT00444457|11490447|FG002|Toddler Dose|Protocol Violation|0
7275841|NCT00444457|11490448|FG003|Toddler Dose|Protocol Violation|1
7275842|NCT00444535|11490469|FG000|Overall Study|Withdrawal by Subject|5
7275843|NCT00444535|11490469|FG000|Overall Study|Physician Decision|5
7275844|NCT00444535|11490469|FG000|Overall Study|progressive disease|1
7275845|NCT00444535|11490469|FG000|Overall Study|Adverse Event|2
7275846|NCT00444587|11490475|FG000|Overall Study|Death|2
7275847|NCT00444587|11490476|FG001|Overall Study|Death|1
7275848|NCT00444587|11490475|FG000|Overall Study|Progression of the disease|73
7275849|NCT00444587|11490476|FG001|Overall Study|Progression of the disease|8
7275850|NCT00444587|11490475|FG000|Overall Study|Refused treatment/did not cooperate|4
7275851|NCT00444587|11490476|FG001|Overall Study|Refused treatment/did not cooperate|1
7275852|NCT00444587|11490475|FG000|Overall Study|Investigator decision|3
7275853|NCT00444587|11490476|FG001|Overall Study|Investigator decision|0
7275854|NCT00444587|11490475|FG000|Overall Study|Protocol Violation|1
7275855|NCT00444587|11490476|FG001|Overall Study|Protocol Violation|0
7275856|NCT00444587|11490475|FG000|Overall Study|Missing|0
7275857|NCT00444587|11490476|FG001|Overall Study|Missing|5
7275858|NCT00444600|11490488|FG000|Overall Study|Death|7
7607656|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607657|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
7607658|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607659|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
7607660|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
7607661|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607662|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607663|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607664|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607665|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
7607666|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
7607667|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
7607668|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Death|0
7607669|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Death|0
7607670|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Death|0
7607671|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Death|0
7607672|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Death|1
7607673|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Death|1
7607674|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Death|1
7607675|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Death|0
7607676|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Death|0
7607677|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Death|0
7607678|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Death|0
7607679|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Death|0
7607680|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Death|1
7607681|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Death|0
7607682|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Death|0
7607683|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607684|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607685|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607686|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607687|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607688|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607689|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607690|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607691|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607692|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607693|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
7607694|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607695|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607696|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607697|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
7607698|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607699|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607700|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607701|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607702|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607703|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607704|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607705|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607706|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607707|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607708|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607709|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607710|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607711|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
7607712|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
7607713|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607714|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607715|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607716|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
7607717|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607718|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607719|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607720|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607721|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607722|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607723|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
7607724|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607725|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607726|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607727|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
7607728|NCT01147666|12015394|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607729|NCT01147666|12015395|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607730|NCT01147666|12015396|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607731|NCT01147666|12015397|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607732|NCT01147666|12015398|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607733|NCT01147666|12015399|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607734|NCT01147666|12015400|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607735|NCT01147666|12015401|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607736|NCT01147666|12015402|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607737|NCT01147666|12015403|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607738|NCT01147666|12015404|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607739|NCT01147666|12015405|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607740|NCT01147666|12015406|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607741|NCT01147666|12015407|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
7607742|NCT01147666|12015408|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
7607743|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Death|0
7607744|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Death|0
7607745|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Death|0
7607746|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Death|0
7607747|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Death|1
7607748|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Death|1
7607749|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Death|1
7607750|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Death|0
7607751|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Death|0
7607752|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Death|0
7607753|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Death|0
7607754|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Death|0
7275859|NCT00444600|11490489|FG001|Overall Study|Death|5
7275860|NCT00444600|11490490|FG002|Overall Study|Death|3
7275861|NCT00444600|11490491|FG003|Overall Study|Death|2
7275862|NCT00444600|11490488|FG000|Overall Study|Dropped|11
7275863|NCT00444600|11490489|FG001|Overall Study|Dropped|11
7275864|NCT00444600|11490490|FG002|Overall Study|Dropped|7
7275865|NCT00444600|11490491|FG003|Overall Study|Dropped|7
7275866|NCT00444600|11490488|FG000|Overall Study|Missed visit|1
7275867|NCT00444600|11490489|FG001|Overall Study|Missed visit|0
7275868|NCT00444600|11490490|FG002|Overall Study|Missed visit|0
7275869|NCT00444600|11490491|FG003|Overall Study|Missed visit|1
7275870|NCT00444626|11490507|FG000|Initial Treatment Period|Withdrawal by Subject|2
7275871|NCT00444626|11490507|FG000|Initial Treatment Period|Adverse Event|1
7275872|NCT00444626|11490507|FG000|Initial Treatment Period|Lost to Follow-up|9
7275873|NCT00444678|11490520|FG000|Overall Study|Toxicity|11
7275874|NCT00444678|11490520|FG000|Overall Study|Disease Progression|12
7275875|NCT00444678|11490520|FG000|Overall Study|Death|3
7275876|NCT00444678|11490520|FG000|Overall Study|Physician Decision|3
7275877|NCT00444678|11490520|FG000|Overall Study|Withdrawal by Subject|2
7275878|NCT00444795|11490524|FG000|Overall Study|Not Treated|1
7275879|NCT00444795|11490524|FG000|Overall Study|Treated Prior to the Contract Date|2
7275880|NCT00444912|11490539|FG000|Overall Study|Death|1
7275881|NCT00444912|11490540|FG001|Overall Study|Death|2
7275882|NCT00444912|11490539|FG000|Overall Study|Lost to Follow-up|1
7275883|NCT00444912|11490540|FG001|Overall Study|Lost to Follow-up|0
7275884|NCT00444912|11490539|FG000|Overall Study|Participant Failed Mobilization|1
7275885|NCT00444912|11490540|FG001|Overall Study|Participant Failed Mobilization|0
7275886|NCT00444925|11490549|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
7275887|NCT00444925|11490550|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
7469735|NCT01926782|11771660|FG004|Overall Study|Other than specified|4
7607755|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Death|1
7607756|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Death|0
7607757|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Death|0
7607758|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607759|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607760|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607761|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607762|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
7607763|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607764|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607765|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607766|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607767|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607768|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607769|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607770|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
7607771|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
7607772|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
7607773|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607774|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607775|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607776|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
7607777|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607778|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607779|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607780|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607781|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607782|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607783|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607784|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607785|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607786|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607787|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
7607788|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607789|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607790|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607791|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607792|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607793|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607794|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607795|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607796|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7275888|NCT00444925|11490551|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
7275889|NCT00444925|11490549|FG000|Double-blind Treatment Period|Death|2
7275890|NCT00444925|11490550|FG001|Double-blind Treatment Period|Death|0
7275891|NCT00444925|11490551|FG002|Double-blind Treatment Period|Death|0
7275892|NCT00444925|11490549|FG000|Double-blind Treatment Period|Adverse Event|6
7275893|NCT00444925|11490550|FG001|Double-blind Treatment Period|Adverse Event|28
7275894|NCT00444925|11490551|FG002|Double-blind Treatment Period|Adverse Event|44
7275895|NCT00444925|11490549|FG000|Double-blind Treatment Period|Lack of Efficacy|5
7275896|NCT00444925|11490550|FG001|Double-blind Treatment Period|Lack of Efficacy|5
7275897|NCT00444925|11490551|FG002|Double-blind Treatment Period|Lack of Efficacy|13
7275898|NCT00444925|11490549|FG000|Double-blind Treatment Period|Lost to Follow-up|4
7275899|NCT00444925|11490550|FG001|Double-blind Treatment Period|Lost to Follow-up|8
7275900|NCT00444925|11490551|FG002|Double-blind Treatment Period|Lost to Follow-up|5
7607797|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607798|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607799|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607800|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607801|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
7607802|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
7607803|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607804|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607805|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607806|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
7607807|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607808|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607809|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607810|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607811|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607812|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607813|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
7607814|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607815|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607816|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607817|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
7607818|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607819|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607820|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607821|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607822|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607823|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607824|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607825|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607826|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607827|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607828|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607829|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607830|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
7607831|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607832|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
7607833|NCT01147666|12015394|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607834|NCT01147666|12015395|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607835|NCT01147666|12015396|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607836|NCT01147666|12015397|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607837|NCT01147666|12015398|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607838|NCT01147666|12015399|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607839|NCT01147666|12015400|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607840|NCT01147666|12015401|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607841|NCT01147666|12015402|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607842|NCT01147666|12015403|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607843|NCT01147666|12015404|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607844|NCT01147666|12015405|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607845|NCT01147666|12015406|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
7607846|NCT01147666|12015407|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
7607847|NCT01147666|12015408|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
7607848|NCT00982111|12015472|FG000|Overall Study|Adverse Event|1
7607849|NCT00982111|12015473|FG001|Overall Study|Adverse Event|1
7607850|NCT00982111|12015472|FG000|Overall Study|Progressive Disease|46
7607851|NCT00982111|12015473|FG001|Overall Study|Progressive Disease|39
7607852|NCT00982111|12015472|FG000|Overall Study|Lost to Follow-up|9
7607853|NCT00982111|12015473|FG001|Overall Study|Lost to Follow-up|6
7275901|NCT00444925|11490549|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
7275902|NCT00444925|11490550|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
7275903|NCT00444925|11490551|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
7275904|NCT00444925|11490549|FG000|Double-blind Treatment Period|Other|7
7275905|NCT00444925|11490550|FG001|Double-blind Treatment Period|Other|7
7275906|NCT00444925|11490551|FG002|Double-blind Treatment Period|Other|12
7275907|NCT00444951|11490562|FG000|Overall Study|Lost to Follow-up|1
7275908|NCT00444951|11490563|FG001|Overall Study|Lost to Follow-up|1
7275909|NCT00444951|11490564|FG002|Overall Study|Lost to Follow-up|0
7275910|NCT00444951|11490562|FG000|Overall Study|Withdrawal by Subject|4
7275911|NCT00444951|11490563|FG001|Overall Study|Withdrawal by Subject|5
7275912|NCT00444951|11490564|FG002|Overall Study|Withdrawal by Subject|3
7275913|NCT00445003|11490579|FG000|Overall Study|Death|1
7275914|NCT00445003|11490580|FG001|Overall Study|Death|2
7275915|NCT00445003|11490581|FG002|Overall Study|Death|1
7275916|NCT00445003|11490579|FG000|Overall Study|Missed Visit|3
7275917|NCT00445003|11490580|FG001|Overall Study|Missed Visit|5
7275918|NCT00445003|11490581|FG002|Overall Study|Missed Visit|1
7275919|NCT00445003|11490579|FG000|Overall Study|Dropped|1
7275920|NCT00445003|11490580|FG001|Overall Study|Dropped|3
7275921|NCT00445003|11490581|FG002|Overall Study|Dropped|2
7275922|NCT00445068|11490589|FG000|Overall Study|Disease progression|26
7275923|NCT00445068|11490589|FG000|Overall Study|Adverse Event|5
7275924|NCT00445068|11490589|FG000|Overall Study|Abnormal laboratory value|2
7275925|NCT00445068|11490589|FG000|Overall Study|Withdrawal by Subject|2
7275926|NCT00445068|11490589|FG000|Overall Study|Death|1
7275927|NCT00445146|11490593|FG000|Overall Study|Withdrew Consent|29
7275928|NCT00445146|11490593|FG000|Overall Study|Lack of Efficacy|28
7275929|NCT00445146|11490593|FG000|Overall Study|Investigator's Discretion|22
7275930|NCT00445146|11490593|FG000|Overall Study|Adverse Event|13
7275931|NCT00445146|11490593|FG000|Overall Study|Lost to Follow-up|13
7275932|NCT00445146|11490593|FG000|Overall Study|Death|9
7275933|NCT00445146|11490593|FG000|Overall Study|Protocol Violation|4
7275934|NCT00445146|11490593|FG000|Overall Study|Pregnancy|1
7275935|NCT00445224|11490608|FG000|Specific Exercises|Withdrawal by Subject|3
7275936|NCT00445224|11490609|FG001|Specific Exercises|Withdrawal by Subject|3
7275937|NCT00445224|11490608|FG000|Specific Exercises|Withdrawal by Subject|1
7275938|NCT00445224|11490609|FG001|Specific Exercises|Withdrawal by Subject|0
7275939|NCT00445328|11490665|FG000|Overall Study|Death|0
7275940|NCT00445328|11490666|FG001|Overall Study|Death|1
7275941|NCT00445328|11490665|FG000|Overall Study|Adverse Event|0
7275942|NCT00445328|11490666|FG001|Overall Study|Adverse Event|3
7275943|NCT00445328|11490665|FG000|Overall Study|Other|0
7275944|NCT00445328|11490666|FG001|Overall Study|Other|2
7275945|NCT00445328|11490665|FG000|Overall Study|Withdrawal by Subject|2
7275946|NCT00445328|11490666|FG001|Overall Study|Withdrawal by Subject|0
7275947|NCT00445328|11490665|FG000|Overall Study|Protocol Violation|1
7275948|NCT00445328|11490666|FG001|Overall Study|Protocol Violation|0
7275949|NCT00445341|11490672|FG000|Overall Study|refused further treatment|1
7275950|NCT00445341|11490672|FG000|Overall Study|taken off treatment too early|1
7275951|NCT00445432|11490679|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
7275952|NCT00445432|11490680|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
7275953|NCT00445432|11490681|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
7275954|NCT00445432|11490682|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
7275955|NCT00445432|11490679|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7607854|NCT00982111|12015472|FG000|Overall Study|New Anti-Cancer Therapy|5
7607855|NCT00982111|12015473|FG001|Overall Study|New Anti-Cancer Therapy|5
7607856|NCT00982111|12015472|FG000|Overall Study|Medical Decision|1
7607857|NCT00982111|12015473|FG001|Overall Study|Medical Decision|0
7607858|NCT00982111|12015472|FG000|Overall Study|Withdrawal by Subject|17
7607859|NCT00982111|12015473|FG001|Overall Study|Withdrawal by Subject|19
7607860|NCT00982111|12015472|FG000|Overall Study|Global Study End|0
7607861|NCT00982111|12015473|FG001|Overall Study|Global Study End|1
7607862|NCT00982111|12015472|FG000|Overall Study|Sponsor's Decision|0
7607863|NCT00982111|12015473|FG001|Overall Study|Sponsor's Decision|1
7607864|NCT00116142|12015487|FG000|Overall Study|Adverse Event|8
7607865|NCT00116142|12015488|FG001|Overall Study|Adverse Event|7
7607866|NCT00116142|12015487|FG000|Overall Study|Protocol Violation|2
7607867|NCT00116142|12015488|FG001|Overall Study|Protocol Violation|1
7607868|NCT00116142|12015487|FG000|Overall Study|Withdrawal by Subject|5
7607869|NCT00116142|12015488|FG001|Overall Study|Withdrawal by Subject|5
7607870|NCT00116142|12015487|FG000|Overall Study|Physician Decision|3
7607871|NCT00116142|12015488|FG001|Overall Study|Physician Decision|1
7607872|NCT00116142|12015487|FG000|Overall Study|Delayed Radiation Therapy|1
7607873|NCT00116142|12015488|FG001|Overall Study|Delayed Radiation Therapy|0
7607874|NCT00116142|12015487|FG000|Overall Study|Patient could not tolerate docetaxel|0
7607875|NCT00116142|12015488|FG001|Overall Study|Patient could not tolerate docetaxel|2
7607876|NCT00116142|12015487|FG000|Overall Study|Patient stopped due to depression|0
7607877|NCT00116142|12015488|FG001|Overall Study|Patient stopped due to depression|1
7607878|NCT00116142|12015487|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
7607879|NCT00116142|12015488|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
7607880|NCT00116142|12015487|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
7607881|NCT00116142|12015488|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
7607882|NCT00116142|12015487|FG000|Overall Study|Patient didn't start due to low platelet counts|0
7607883|NCT00116142|12015488|FG001|Overall Study|Patient didn't start due to low platelet counts|1
7607884|NCT00070018|12015497|FG000|Overall Study|Adverse Event|2
7607885|NCT00070018|12015497|FG000|Overall Study|Lack of Efficacy|1
7607886|NCT00070018|12015497|FG000|Overall Study|Withdrawal by Subject|1
7607887|NCT04447287|12015510|FG000|Period 1: Run-in Period|Adverse Event|3
7607888|NCT04447287|12015511|FG001|Period 1: Run-in Period|Adverse Event|0
7607889|NCT04447287|12015512|FG002|Period 1: Run-in Period|Adverse Event|0
7607890|NCT04447287|12015510|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
7607891|NCT04447287|12015511|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
7607892|NCT04447287|12015512|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
7607893|NCT04447287|12015510|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
7607894|NCT04447287|12015511|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
7607895|NCT04447287|12015512|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
7607896|NCT04039503|12015568|FG000|Overall Study|Adverse Event|3
7275956|NCT00445432|11490680|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7275957|NCT00445432|11490681|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
7275958|NCT00445432|11490682|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
7275959|NCT00445432|11490679|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
7275960|NCT00445432|11490680|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
7275961|NCT00445432|11490681|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7275962|NCT00445432|11490682|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
7275963|NCT00445432|11490679|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
7275964|NCT00445432|11490680|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
7275965|NCT00445432|11490681|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
7275966|NCT00445432|11490682|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
7275967|NCT00445432|11490679|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
7275968|NCT00445432|11490680|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
7275969|NCT00445432|11490681|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
7275970|NCT00445432|11490682|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
7275971|NCT00445432|11490679|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7275972|NCT00445432|11490680|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7275973|NCT00445432|11490681|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
7275974|NCT00445432|11490682|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
7275975|NCT00445432|11490679|FG000|148 Weeks of Adalimumab Treatment|Other|0
7275976|NCT00445432|11490680|FG001|148 Weeks of Adalimumab Treatment|Other|0
7275977|NCT00445432|11490681|FG002|148 Weeks of Adalimumab Treatment|Other|0
7275978|NCT00445432|11490682|FG003|148 Weeks of Adalimumab Treatment|Other|9
7275979|NCT00445458|11490697|FG000|Overall Study|Disease Progression|3
7275980|NCT00445458|11490698|FG001|Overall Study|Disease Progression|4
7275981|NCT00445458|11490699|FG002|Overall Study|Disease Progression|54
7275982|NCT00445458|11490700|FG003|Overall Study|Disease Progression|27
7275983|NCT00445458|11490697|FG000|Overall Study|Withdrawal by Subject|0
7275984|NCT00445458|11490698|FG001|Overall Study|Withdrawal by Subject|0
7275985|NCT00445458|11490699|FG002|Overall Study|Withdrawal by Subject|7
7607897|NCT04039503|12015569|FG001|Overall Study|Adverse Event|0
7607898|NCT04039503|12015570|FG002|Overall Study|Adverse Event|2
7607899|NCT04039503|12015571|FG003|Overall Study|Adverse Event|0
7607900|NCT04039503|12015568|FG000|Overall Study|Lost to Follow-up|0
7607901|NCT04039503|12015569|FG001|Overall Study|Lost to Follow-up|0
7607902|NCT04039503|12015570|FG002|Overall Study|Lost to Follow-up|1
7607903|NCT04039503|12015571|FG003|Overall Study|Lost to Follow-up|0
7607904|NCT04039503|12015568|FG000|Overall Study|Protocol Violation|0
7607905|NCT04039503|12015569|FG001|Overall Study|Protocol Violation|1
7607906|NCT04039503|12015570|FG002|Overall Study|Protocol Violation|2
7607907|NCT04039503|12015571|FG003|Overall Study|Protocol Violation|1
7607908|NCT04039503|12015568|FG000|Overall Study|Withdrawal by Subject|4
7607909|NCT04039503|12015569|FG001|Overall Study|Withdrawal by Subject|3
7607910|NCT04039503|12015570|FG002|Overall Study|Withdrawal by Subject|5
7607911|NCT04039503|12015571|FG003|Overall Study|Withdrawal by Subject|2
7607912|NCT03695172|12015589|FG000|Overall Study|Withdrawal by Subject|1
7607913|NCT03695172|12015590|FG001|Overall Study|Withdrawal by Subject|1
7607914|NCT03695172|12015591|FG002|Overall Study|Withdrawal by Subject|0
7275986|NCT00445458|11490700|FG003|Overall Study|Withdrawal by Subject|0
7607921|NCT03357952|12015645|FG000|Overall Study|Withdrawal by Subject|0
7607922|NCT03357952|12015646|FG001|Overall Study|Withdrawal by Subject|1
7607923|NCT03357952|12015645|FG000|Overall Study|Sponsor Decision|9
7607924|NCT03357952|12015646|FG001|Overall Study|Sponsor Decision|0
7607925|NCT03170869|12015661|FG000|Overall Study|Protocol Violation|5
7607926|NCT03170869|12015661|FG000|Overall Study|Early study termination|3
7607927|NCT03066622|12015668|FG000|Overall Study|Lost to Follow-up|24
7607928|NCT03066622|12015669|FG001|Overall Study|Lost to Follow-up|25
7607929|NCT03066622|12015668|FG000|Overall Study|Withdrawal by Subject|2
7607930|NCT03066622|12015669|FG001|Overall Study|Withdrawal by Subject|1
7607931|NCT03052920|12015675|FG000|Overall Study|Withdrawal by Subject|1
7607942|NCT02722434|12015703|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
7607943|NCT02722434|12015704|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
7607944|NCT02722434|12015703|FG000|Overall Study|Withdrawal After Beginning Treatment|0
7607945|NCT02722434|12015704|FG001|Overall Study|Withdrawal After Beginning Treatment|3
7607953|NCT01248247|12015767|FG000|Overall Study|Adverse Event|2
7607954|NCT01248247|12015768|FG001|Overall Study|Adverse Event|4
7607955|NCT01248247|12015769|FG002|Overall Study|Adverse Event|4
7607956|NCT01248247|12015770|FG003|Overall Study|Adverse Event|2
7275987|NCT00445458|11490697|FG000|Overall Study|Adverse Event|0
7607957|NCT01248247|12015767|FG000|Overall Study|Death|0
7607958|NCT01248247|12015768|FG001|Overall Study|Death|1
7607959|NCT01248247|12015769|FG002|Overall Study|Death|4
7607960|NCT01248247|12015770|FG003|Overall Study|Death|7
7607961|NCT01248247|12015767|FG000|Overall Study|Lost to Follow-up|0
7607962|NCT01248247|12015768|FG001|Overall Study|Lost to Follow-up|1
7607963|NCT01248247|12015769|FG002|Overall Study|Lost to Follow-up|1
7607964|NCT01248247|12015770|FG003|Overall Study|Lost to Follow-up|0
7607965|NCT01248247|12015767|FG000|Overall Study|Alternative treatment|0
7607966|NCT01248247|12015768|FG001|Overall Study|Alternative treatment|1
7607967|NCT01248247|12015769|FG002|Overall Study|Alternative treatment|0
7607968|NCT01248247|12015770|FG003|Overall Study|Alternative treatment|0
7607969|NCT01248247|12015767|FG000|Overall Study|Other|2
7607970|NCT01248247|12015768|FG001|Overall Study|Other|8
7607971|NCT01248247|12015769|FG002|Overall Study|Other|8
7607972|NCT01248247|12015770|FG003|Overall Study|Other|5
7607973|NCT01248247|12015767|FG000|Overall Study|Progression|18
7607974|NCT01248247|12015768|FG001|Overall Study|Progression|27
7607975|NCT01248247|12015769|FG002|Overall Study|Progression|56
7607976|NCT01248247|12015770|FG003|Overall Study|Progression|44
7607977|NCT01248247|12015767|FG000|Overall Study|Refuse further treatment|0
7607978|NCT01248247|12015768|FG001|Overall Study|Refuse further treatment|0
7607979|NCT01248247|12015769|FG002|Overall Study|Refuse further treatment|1
7607980|NCT01248247|12015770|FG003|Overall Study|Refuse further treatment|2
7607981|NCT01248247|12015767|FG000|Overall Study|Complicating disease|0
7607982|NCT01248247|12015768|FG001|Overall Study|Complicating disease|0
7607983|NCT01248247|12015769|FG002|Overall Study|Complicating disease|1
7607984|NCT01248247|12015770|FG003|Overall Study|Complicating disease|1
7607985|NCT01164228|12015782|FG000|Overall Study|Progression|24
7607986|NCT01164228|12015783|FG001|Overall Study|Progression|25
7607987|NCT01164228|12015782|FG000|Overall Study|Adverse Event|13
7607988|NCT01164228|12015783|FG001|Overall Study|Adverse Event|7
7607989|NCT01164228|12015782|FG000|Overall Study|Death|1
7607990|NCT01164228|12015783|FG001|Overall Study|Death|1
7607991|NCT01164228|12015782|FG000|Overall Study|Withdrawal by Subject|2
7607992|NCT01164228|12015783|FG001|Overall Study|Withdrawal by Subject|0
7607993|NCT01164228|12015782|FG000|Overall Study|Physician Decision|1
7607994|NCT01164228|12015783|FG001|Overall Study|Physician Decision|2
7607995|NCT01164228|12015782|FG000|Overall Study|Symptomatic deterioration|1
7607996|NCT01164228|12015783|FG001|Overall Study|Symptomatic deterioration|0
7607997|NCT01164228|12015782|FG000|Overall Study|Never started treatment|1
7607998|NCT01164228|12015783|FG001|Overall Study|Never started treatment|3
7607999|NCT01164228|12015782|FG000|Overall Study|Ineligible|1
7608000|NCT01164228|12015783|FG001|Overall Study|Ineligible|0
7608001|NCT00591318|12015850|FG000|Overall Study|Lack of Efficacy|2
7608002|NCT00591318|12015851|FG001|Overall Study|Lack of Efficacy|0
7608003|NCT00591318|12015850|FG000|Overall Study|Adverse Event|2
7608004|NCT00591318|12015851|FG001|Overall Study|Adverse Event|0
7608005|NCT04534517|12015872|FG000|Overall Study|Adverse Event|1
7608006|NCT04534517|12015872|FG000|Overall Study|Withdrawal by Subject|1
7608007|NCT04534517|12015872|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
7608008|NCT04534517|12015872|FG000|Overall Study|COVID-19 Related|1
7608009|NCT04494646|12015878|FG000|Overall Study|Adverse Event|0
7608010|NCT04494646|12015879|FG001|Overall Study|Adverse Event|1
7608011|NCT04494646|12015878|FG000|Overall Study|Withdrawal by Subject|0
7608012|NCT04494646|12015879|FG001|Overall Study|Withdrawal by Subject|1
7275988|NCT00445458|11490698|FG001|Overall Study|Adverse Event|0
7275989|NCT00445458|11490699|FG002|Overall Study|Adverse Event|3
7275990|NCT00445458|11490700|FG003|Overall Study|Adverse Event|0
7275991|NCT00445458|11490697|FG000|Overall Study|Death|0
7275992|NCT00445458|11490698|FG001|Overall Study|Death|1
7275993|NCT00445458|11490699|FG002|Overall Study|Death|2
7275994|NCT00445458|11490700|FG003|Overall Study|Death|0
7275995|NCT00445458|11490697|FG000|Overall Study|Physician Decision|0
7275996|NCT00445458|11490698|FG001|Overall Study|Physician Decision|0
7275997|NCT00445458|11490699|FG002|Overall Study|Physician Decision|1
7275998|NCT00445458|11490700|FG003|Overall Study|Physician Decision|1
7275999|NCT00445458|11490697|FG000|Overall Study|Surgery|0
7276000|NCT00445458|11490698|FG001|Overall Study|Surgery|0
7608013|NCT04258020|12015887|FG000|Overall Study|Withdrawal by Subject|1
7608014|NCT04258020|12015888|FG001|Overall Study|Withdrawal by Subject|0
7608015|NCT04234464|12015896|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
7608016|NCT04234464|12015897|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
7608017|NCT03852316|12015903|FG000|Overall Study|Protocol Violation|1
7608018|NCT03852316|12015903|FG000|Overall Study|Withdrawal by Subject|2
7608019|NCT03852316|12015903|FG000|Overall Study|Enrolled but Device not Utilized|1
7608020|NCT03789318|12015912|FG000|Overall Study|Adverse Event|0
7608021|NCT03789318|12015913|FG001|Overall Study|Adverse Event|0
7608022|NCT03789318|12015914|FG002|Overall Study|Adverse Event|1
7608023|NCT03789318|12015915|FG003|Overall Study|Adverse Event|1
7608024|NCT03789318|12015916|FG004|Overall Study|Adverse Event|0
7276001|NCT00445458|11490699|FG002|Overall Study|Surgery|1
7276002|NCT00445458|11490700|FG003|Overall Study|Surgery|0
7276003|NCT00445549|11490722|FG000|Overall Study|progressive disease|12
7276004|NCT00445601|11490733|FG000|Overall Study|Withdrawal by Subject|11
7276005|NCT00445601|11490734|FG001|Overall Study|Withdrawal by Subject|11
7276006|NCT00445601|11490733|FG000|Overall Study|TURBT Complication|12
7276007|NCT00445601|11490734|FG001|Overall Study|TURBT Complication|8
7276008|NCT00445601|11490733|FG000|Overall Study|Incorrect Disease Status|6
7276009|NCT00445601|11490734|FG001|Overall Study|Incorrect Disease Status|6
7276010|NCT00445601|11490733|FG000|Overall Study|Drug Delivery Issue|2
7276011|NCT00445601|11490734|FG001|Overall Study|Drug Delivery Issue|2
7276012|NCT00445601|11490733|FG000|Overall Study|Adverse Event|2
7276013|NCT00445601|11490734|FG001|Overall Study|Adverse Event|0
7276014|NCT00445601|11490733|FG000|Overall Study|Death prior to TURBT|0
7276015|NCT00445601|11490734|FG001|Overall Study|Death prior to TURBT|1
7276016|NCT00445679|11490748|FG000|Overall Study|Adverse Event|22
7276017|NCT00445679|11490749|FG001|Overall Study|Adverse Event|12
7276018|NCT00445679|11490750|FG002|Overall Study|Adverse Event|30
7276019|NCT00445679|11490751|FG003|Overall Study|Adverse Event|19
7276020|NCT00445679|11490748|FG000|Overall Study|Failed to return|1
7276021|NCT00445679|11490749|FG001|Overall Study|Failed to return|3
7276022|NCT00445679|11490750|FG002|Overall Study|Failed to return|2
7276023|NCT00445679|11490751|FG003|Overall Study|Failed to return|2
7276024|NCT00445679|11490748|FG000|Overall Study|Physician Decision|0
7608025|NCT03789318|12015912|FG000|Overall Study|Lost to Follow-up|0
7608026|NCT03789318|12015913|FG001|Overall Study|Lost to Follow-up|0
7608027|NCT03789318|12015914|FG002|Overall Study|Lost to Follow-up|1
7608028|NCT03789318|12015915|FG003|Overall Study|Lost to Follow-up|0
7608029|NCT03789318|12015916|FG004|Overall Study|Lost to Follow-up|0
7608030|NCT03789318|12015912|FG000|Overall Study|Withdrawal by Subject|0
7608031|NCT03789318|12015913|FG001|Overall Study|Withdrawal by Subject|0
7608032|NCT03789318|12015914|FG002|Overall Study|Withdrawal by Subject|1
7608033|NCT03789318|12015915|FG003|Overall Study|Withdrawal by Subject|0
7608034|NCT03789318|12015916|FG004|Overall Study|Withdrawal by Subject|0
7608057|NCT03103321|12015971|FG000|Overall Study|Protocol Violation|1
7608058|NCT03103321|12015972|FG001|Overall Study|Protocol Violation|1
7608059|NCT03103321|12015973|FG002|Overall Study|Protocol Violation|1
7608060|NCT03103321|12015974|FG003|Overall Study|Protocol Violation|0
7608061|NCT03079869|12015986|FG000|Overall Study|Adverse Event|6
7608062|NCT03079869|12015987|FG001|Overall Study|Adverse Event|8
7608063|NCT03079869|12015986|FG000|Overall Study|Withdrawal by Subject|4
7608064|NCT03079869|12015987|FG001|Overall Study|Withdrawal by Subject|1
7608065|NCT03079869|12015986|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
7608066|NCT03079869|12015987|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
7608067|NCT03033875|12015996|FG000|Overall Study|Withdrawal by Subject|5
7608068|NCT03033875|12015997|FG001|Overall Study|Withdrawal by Subject|9
7608069|NCT03033875|12015998|FG002|Overall Study|Withdrawal by Subject|4
7608070|NCT03033875|12015996|FG000|Overall Study|Other|14
7608071|NCT03033875|12015997|FG001|Overall Study|Other|15
7608072|NCT03033875|12015998|FG002|Overall Study|Other|8
7608073|NCT02887248|12016010|FG000|Overall Study|Withdrawal by Subject|1
7608074|NCT02887248|12016010|FG000|Overall Study|Adverse Event|1
7608075|NCT02887248|12016010|FG000|Overall Study|Progressive Disease|1
7608076|NCT02849990|12016014|FG000|Overall Study|Adverse Event|1
7276025|NCT00445679|11490749|FG001|Overall Study|Physician Decision|0
7276026|NCT00445679|11490750|FG002|Overall Study|Physician Decision|1
7276027|NCT00445679|11490751|FG003|Overall Study|Physician Decision|0
7276028|NCT00445679|11490748|FG000|Overall Study|Lost to Follow-up|10
7276029|NCT00445679|11490749|FG001|Overall Study|Lost to Follow-up|6
7276030|NCT00445679|11490750|FG002|Overall Study|Lost to Follow-up|6
7276031|NCT00445679|11490751|FG003|Overall Study|Lost to Follow-up|5
7276032|NCT00445679|11490748|FG000|Overall Study|Compliance|3
7276033|NCT00445679|11490749|FG001|Overall Study|Compliance|2
7276034|NCT00445679|11490750|FG002|Overall Study|Compliance|1
7276035|NCT00445679|11490751|FG003|Overall Study|Compliance|2
7276036|NCT00445679|11490748|FG000|Overall Study|Withdrawal of Informed Consent|0
7276037|NCT00445679|11490749|FG001|Overall Study|Withdrawal of Informed Consent|0
7276038|NCT00445679|11490750|FG002|Overall Study|Withdrawal of Informed Consent|1
7276039|NCT00445679|11490751|FG003|Overall Study|Withdrawal of Informed Consent|0
7608077|NCT02849990|12016014|FG000|Overall Study|Withdrawal by Subject|1
7608078|NCT02467270|12016047|FG000|Overall Study|Participants Never Treated|0
7608079|NCT02467270|12016048|FG001|Overall Study|Participants Never Treated|1
7608080|NCT02467270|12016049|FG002|Overall Study|Participants Never Treated|0
7608081|NCT02467270|12016047|FG000|Overall Study|Ongoing|50
7608082|NCT02467270|12016048|FG001|Overall Study|Ongoing|41
7608083|NCT02467270|12016049|FG002|Overall Study|Ongoing|43
7608084|NCT02467270|12016047|FG000|Overall Study|Adverse Event|16
7608085|NCT02467270|12016048|FG001|Overall Study|Adverse Event|15
7608086|NCT02467270|12016049|FG002|Overall Study|Adverse Event|14
7608087|NCT02467270|12016047|FG000|Overall Study|Progressive Disease|7
7608088|NCT02467270|12016048|FG001|Overall Study|Progressive Disease|7
7608089|NCT02467270|12016049|FG002|Overall Study|Progressive Disease|4
7608090|NCT02467270|12016047|FG000|Overall Study|Death|2
7608091|NCT02467270|12016048|FG001|Overall Study|Death|0
7608092|NCT02467270|12016049|FG002|Overall Study|Death|2
7608093|NCT02467270|12016047|FG000|Overall Study|Lack of Efficacy|12
7608094|NCT02467270|12016048|FG001|Overall Study|Lack of Efficacy|18
7608095|NCT02467270|12016049|FG002|Overall Study|Lack of Efficacy|23
7608096|NCT02467270|12016047|FG000|Overall Study|Non-compliance With Study Drug|0
7608097|NCT02467270|12016048|FG001|Overall Study|Non-compliance With Study Drug|2
7608098|NCT02467270|12016049|FG002|Overall Study|Non-compliance With Study Drug|1
7608099|NCT02467270|12016047|FG000|Overall Study|Lost to Follow-up|2
7608100|NCT02467270|12016048|FG001|Overall Study|Lost to Follow-up|1
7608101|NCT02467270|12016049|FG002|Overall Study|Lost to Follow-up|0
7608102|NCT02467270|12016047|FG000|Overall Study|Pregnancy|0
7608103|NCT02467270|12016048|FG001|Overall Study|Pregnancy|1
7608104|NCT02467270|12016049|FG002|Overall Study|Pregnancy|0
7608105|NCT02467270|12016047|FG000|Overall Study|Physician Decision|0
7608106|NCT02467270|12016048|FG001|Overall Study|Physician Decision|4
7608107|NCT02467270|12016049|FG002|Overall Study|Physician Decision|1
7608108|NCT02467270|12016047|FG000|Overall Study|Withdrawal by Subject|4
7608109|NCT02467270|12016048|FG001|Overall Study|Withdrawal by Subject|3
7608110|NCT02467270|12016049|FG002|Overall Study|Withdrawal by Subject|5
7608111|NCT02467270|12016047|FG000|Overall Study|Reason not Specified|1
7608112|NCT02467270|12016048|FG001|Overall Study|Reason not Specified|2
7608113|NCT02467270|12016049|FG002|Overall Study|Reason not Specified|1
7608114|NCT02452554|12016063|FG000|Overall Study|Death|2
7608115|NCT02452554|12016064|FG001|Overall Study|Death|1
7608116|NCT02452554|12016065|FG002|Overall Study|Death|0
7608117|NCT02452554|12016066|FG003|Overall Study|Death|0
7608118|NCT02452554|12016067|FG004|Overall Study|Death|0
7608119|NCT02452554|12016068|FG005|Overall Study|Death|0
7608120|NCT02452554|12016063|FG000|Overall Study|Lack of Efficacy|13
7608121|NCT02452554|12016064|FG001|Overall Study|Lack of Efficacy|14
7608122|NCT02452554|12016065|FG002|Overall Study|Lack of Efficacy|9
7276040|NCT00445679|11490748|FG000|Overall Study|Protocol Violation|2
7276041|NCT00445679|11490749|FG001|Overall Study|Protocol Violation|3
7276042|NCT00445679|11490750|FG002|Overall Study|Protocol Violation|3
7276043|NCT00445679|11490751|FG003|Overall Study|Protocol Violation|1
7276044|NCT00445679|11490748|FG000|Overall Study|Withdrawal by Subject|8
7276045|NCT00445679|11490749|FG001|Overall Study|Withdrawal by Subject|14
7276046|NCT00445679|11490750|FG002|Overall Study|Withdrawal by Subject|20
7276047|NCT00445679|11490751|FG003|Overall Study|Withdrawal by Subject|18
7276048|NCT00445679|11490748|FG000|Overall Study|Lack of Efficacy|2
7276049|NCT00445679|11490749|FG001|Overall Study|Lack of Efficacy|6
7276050|NCT00445679|11490750|FG002|Overall Study|Lack of Efficacy|2
7276051|NCT00445679|11490751|FG003|Overall Study|Lack of Efficacy|0
7276052|NCT00445692|11490761|FG000|Overall Study|Adverse Event|11
7276053|NCT00445692|11490761|FG000|Overall Study|Lack of Efficacy|5
7469736|NCT01926782|11771661|FG005|Overall Study|Other than specified|11
7469737|NCT01926782|11771656|FG000|Overall Study|Adverse Event|13
7469738|NCT01926782|11771657|FG001|Overall Study|Adverse Event|4
7469739|NCT01926782|11771658|FG002|Overall Study|Adverse Event|17
7469740|NCT01926782|11771659|FG003|Overall Study|Adverse Event|4
7608123|NCT02452554|12016066|FG003|Overall Study|Lack of Efficacy|1
7608124|NCT02452554|12016067|FG004|Overall Study|Lack of Efficacy|5
7608125|NCT02452554|12016068|FG005|Overall Study|Lack of Efficacy|8
7608126|NCT02452554|12016063|FG000|Overall Study|Physician Decision|0
7608127|NCT02452554|12016064|FG001|Overall Study|Physician Decision|1
7608128|NCT02452554|12016065|FG002|Overall Study|Physician Decision|0
7608129|NCT02452554|12016066|FG003|Overall Study|Physician Decision|0
7608130|NCT02452554|12016067|FG004|Overall Study|Physician Decision|0
7608131|NCT02452554|12016068|FG005|Overall Study|Physician Decision|0
7608132|NCT02452554|12016063|FG000|Overall Study|Withdrawal by Subject|1
7608133|NCT02452554|12016064|FG001|Overall Study|Withdrawal by Subject|0
7608134|NCT02452554|12016065|FG002|Overall Study|Withdrawal by Subject|2
7608135|NCT02452554|12016066|FG003|Overall Study|Withdrawal by Subject|0
7608136|NCT02452554|12016067|FG004|Overall Study|Withdrawal by Subject|0
7608137|NCT02452554|12016068|FG005|Overall Study|Withdrawal by Subject|1
7608138|NCT02452554|12016063|FG000|Overall Study|Ineligible|0
7608139|NCT02452554|12016064|FG001|Overall Study|Ineligible|1
7608140|NCT02452554|12016065|FG002|Overall Study|Ineligible|0
7608141|NCT02452554|12016066|FG003|Overall Study|Ineligible|0
7608142|NCT02452554|12016067|FG004|Overall Study|Ineligible|0
7608143|NCT02452554|12016068|FG005|Overall Study|Ineligible|0
7608144|NCT02452554|12016063|FG000|Overall Study|Never Received Treatment|1
7608145|NCT02452554|12016064|FG001|Overall Study|Never Received Treatment|0
7608146|NCT02452554|12016065|FG002|Overall Study|Never Received Treatment|0
7608147|NCT02452554|12016066|FG003|Overall Study|Never Received Treatment|0
7608148|NCT02452554|12016067|FG004|Overall Study|Never Received Treatment|0
7608149|NCT02452554|12016068|FG005|Overall Study|Never Received Treatment|0
7608150|NCT02318277|12016091|FG000|Overall Study|Physician Decision|0
7608151|NCT02318277|12016092|FG001|Overall Study|Physician Decision|0
7608152|NCT02318277|12016093|FG002|Overall Study|Physician Decision|0
7608153|NCT02318277|12016094|FG003|Overall Study|Physician Decision|0
7608154|NCT02318277|12016095|FG004|Overall Study|Physician Decision|0
7608155|NCT02318277|12016096|FG005|Overall Study|Physician Decision|0
7608156|NCT02318277|12016097|FG006|Overall Study|Physician Decision|0
7608157|NCT02318277|12016098|FG007|Overall Study|Physician Decision|1
7608158|NCT02318277|12016091|FG000|Overall Study|Other|0
7608159|NCT02318277|12016092|FG001|Overall Study|Other|0
7608160|NCT02318277|12016093|FG002|Overall Study|Other|0
7608161|NCT02318277|12016094|FG003|Overall Study|Other|0
7608162|NCT02318277|12016095|FG004|Overall Study|Other|0
7608163|NCT02318277|12016096|FG005|Overall Study|Other|0
7608164|NCT02318277|12016097|FG006|Overall Study|Other|1
7608165|NCT02318277|12016098|FG007|Overall Study|Other|0
7608166|NCT02318277|12016091|FG000|Overall Study|Withdrawal by Subject|0
7608167|NCT02318277|12016092|FG001|Overall Study|Withdrawal by Subject|0
7608168|NCT02318277|12016093|FG002|Overall Study|Withdrawal by Subject|1
7608169|NCT02318277|12016094|FG003|Overall Study|Withdrawal by Subject|0
7608170|NCT02318277|12016095|FG004|Overall Study|Withdrawal by Subject|1
7608171|NCT02318277|12016096|FG005|Overall Study|Withdrawal by Subject|1
7608172|NCT02318277|12016097|FG006|Overall Study|Withdrawal by Subject|6
7608173|NCT02318277|12016098|FG007|Overall Study|Withdrawal by Subject|14
7608174|NCT02318277|12016091|FG000|Overall Study|Participant trial terminated by sponsor|0
7608175|NCT02318277|12016092|FG001|Overall Study|Participant trial terminated by sponsor|0
7608176|NCT02318277|12016093|FG002|Overall Study|Participant trial terminated by sponsor|1
7608177|NCT02318277|12016094|FG003|Overall Study|Participant trial terminated by sponsor|0
7608178|NCT02318277|12016095|FG004|Overall Study|Participant trial terminated by sponsor|1
7608179|NCT02318277|12016096|FG005|Overall Study|Participant trial terminated by sponsor|2
7608180|NCT02318277|12016097|FG006|Overall Study|Participant trial terminated by sponsor|5
7608181|NCT02318277|12016098|FG007|Overall Study|Participant trial terminated by sponsor|16
7608182|NCT02318277|12016091|FG000|Overall Study|Lost to Follow-up|1
7608183|NCT02318277|12016092|FG001|Overall Study|Lost to Follow-up|0
7608184|NCT02318277|12016093|FG002|Overall Study|Lost to Follow-up|1
7608185|NCT02318277|12016094|FG003|Overall Study|Lost to Follow-up|0
7608186|NCT02318277|12016095|FG004|Overall Study|Lost to Follow-up|0
7608187|NCT02318277|12016096|FG005|Overall Study|Lost to Follow-up|0
7608188|NCT02318277|12016097|FG006|Overall Study|Lost to Follow-up|3
7608189|NCT02318277|12016098|FG007|Overall Study|Lost to Follow-up|4
7608190|NCT02318277|12016091|FG000|Overall Study|Death|5
7608191|NCT02318277|12016092|FG001|Overall Study|Death|3
7608192|NCT02318277|12016093|FG002|Overall Study|Death|1
7608193|NCT02318277|12016094|FG003|Overall Study|Death|4
7608194|NCT02318277|12016095|FG004|Overall Study|Death|6
7608195|NCT02318277|12016096|FG005|Overall Study|Death|5
7608196|NCT02318277|12016097|FG006|Overall Study|Death|34
7608197|NCT02318277|12016098|FG007|Overall Study|Death|58
7608198|NCT02318277|12016091|FG000|Overall Study|Transitioned to Hospice|0
7608199|NCT02318277|12016092|FG001|Overall Study|Transitioned to Hospice|0
7608200|NCT02318277|12016093|FG002|Overall Study|Transitioned to Hospice|0
7608201|NCT02318277|12016094|FG003|Overall Study|Transitioned to Hospice|0
7608202|NCT02318277|12016095|FG004|Overall Study|Transitioned to Hospice|0
7608203|NCT02318277|12016096|FG005|Overall Study|Transitioned to Hospice|1
7608204|NCT02318277|12016097|FG006|Overall Study|Transitioned to Hospice|0
7608205|NCT02318277|12016098|FG007|Overall Study|Transitioned to Hospice|0
7608206|NCT02143063|12016154|FG000|Overall Study|Lost to Follow-up|16
7608207|NCT02143063|12016155|FG001|Overall Study|Lost to Follow-up|28
7608208|NCT02143063|12016156|FG002|Overall Study|Lost to Follow-up|29
7608209|NCT02143063|12016154|FG000|Overall Study|Withdrawal by Subject|0
7608210|NCT02143063|12016155|FG001|Overall Study|Withdrawal by Subject|1
7608211|NCT02143063|12016156|FG002|Overall Study|Withdrawal by Subject|0
7608212|NCT02143063|12016154|FG000|Overall Study|Death|0
7608213|NCT02143063|12016155|FG001|Overall Study|Death|1
7608214|NCT02143063|12016156|FG002|Overall Study|Death|1
7608215|NCT02017964|12016164|FG000|Overall Study|Patient deemed ineligible|1
7608216|NCT01968785|12016170|FG000|Overall Study|Withdrawal by Subject|1
7608217|NCT01968785|12016171|FG001|Overall Study|Withdrawal by Subject|0
7276054|NCT00445770|11490791|FG000|Overall Study|Adverse Event|9
7276055|NCT00445770|11490792|FG001|Overall Study|Adverse Event|15
7276056|NCT00445770|11490793|FG002|Overall Study|Adverse Event|19
7276057|NCT00445770|11490791|FG000|Overall Study|Lack of Efficacy|38
7276058|NCT00445770|11490792|FG001|Overall Study|Lack of Efficacy|13
7276059|NCT00445770|11490793|FG002|Overall Study|Lack of Efficacy|6
7276060|NCT00445770|11490791|FG000|Overall Study|Lost to Follow-up|0
7276061|NCT00445770|11490792|FG001|Overall Study|Lost to Follow-up|2
7276062|NCT00445770|11490793|FG002|Overall Study|Lost to Follow-up|0
7276063|NCT00445770|11490791|FG000|Overall Study|Other|6
7276064|NCT00445770|11490792|FG001|Overall Study|Other|5
7276065|NCT00445770|11490793|FG002|Overall Study|Other|6
7276066|NCT00445848|11490803|FG000|Overall Study|Adverse Event|14
7276067|NCT00445848|11490803|FG000|Overall Study|Withdrawal by Subject|4
7276068|NCT00445848|11490803|FG000|Overall Study|Progression|62
7276069|NCT00445848|11490803|FG000|Overall Study|Other-Not protocol specified|5
7276070|NCT00445939|11490829|FG000|Period A - Week 0 - Week 4|Adverse Event|1
7276071|NCT00445939|11490830|FG001|Period A - Week 0 - Week 4|Adverse Event|2
7276072|NCT00445939|11490831|FG002|Period A - Week 0 - Week 4|Adverse Event|0
7276073|NCT00445939|11490832|FG003|Period A - Week 0 - Week 4|Adverse Event|0
7276074|NCT00445939|11490829|FG000|Period B - Week 4 - Week 8|Adverse Event|2
7276075|NCT00445939|11490830|FG001|Period B - Week 4 - Week 8|Adverse Event|0
7276076|NCT00445939|11490831|FG002|Period B - Week 4 - Week 8|Adverse Event|0
7276077|NCT00445939|11490832|FG003|Period B - Week 4 - Week 8|Adverse Event|1
7276078|NCT00445978|11490852|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
7276079|NCT00445978|11490852|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
7276080|NCT00445978|11490852|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
7276081|NCT00445978|11490852|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
7276082|NCT00445978|11490852|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
7276083|NCT00445978|11490852|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
7276084|NCT00445978|11490852|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
7276085|NCT00445978|11490852|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
7276086|NCT00445978|11490852|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
7276087|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
7276088|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
7276089|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
7276090|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
7276091|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
7276092|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
7608218|NCT01956110|12016179|FG000|Overall Study|Protocol Violation|25
7608219|NCT01956110|12016180|FG001|Overall Study|Protocol Violation|11
7608220|NCT01956110|12016179|FG000|Overall Study|Adverse Event|9
7608221|NCT01956110|12016180|FG001|Overall Study|Adverse Event|10
7608222|NCT01956110|12016179|FG000|Overall Study|Personal reasons|1
7608223|NCT01956110|12016180|FG001|Overall Study|Personal reasons|1
7608224|NCT01648023|12016189|FG000|Overall Study|Screen Fail Post Randomization|1
7608225|NCT01648023|12016190|FG001|Overall Study|Screen Fail Post Randomization|2
7608226|NCT01083433|12016213|FG000|Overall Study|Lost to Follow-up|2
7608227|NCT01083433|12016214|FG001|Overall Study|Lost to Follow-up|1
7608228|NCT01083433|12016215|FG002|Overall Study|Lost to Follow-up|1
7608229|NCT01083433|12016213|FG000|Overall Study|Withdrawal by Subject|0
7276093|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
7276094|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
7276095|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
7276096|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
7276097|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
7276098|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
7276099|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
7276100|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
7276101|NCT00446030|11490865|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
7276102|NCT00446030|11490866|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
7276103|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
7276104|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
7276105|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
7276106|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
7276107|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
7276108|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
7276109|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Death|2
7276110|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Death|2
7276111|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
7276112|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
7276113|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
7276114|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
7276115|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
7276116|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
7276117|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
7276118|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
7276119|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
7608230|NCT01083433|12016214|FG001|Overall Study|Withdrawal by Subject|5
7608231|NCT01083433|12016215|FG002|Overall Study|Withdrawal by Subject|3
7608232|NCT01083433|12016213|FG000|Overall Study|Pregnancy|0
7608233|NCT01083433|12016214|FG001|Overall Study|Pregnancy|0
7608234|NCT01083433|12016215|FG002|Overall Study|Pregnancy|1
7608235|NCT00787176|12016231|FG000|Overall Study|Low quality fetal heart rate tracing|7
7608236|NCT00787176|12016232|FG001|Overall Study|Low quality fetal heart rate tracing|3
7608237|NCT00787176|12016233|FG002|Overall Study|Low quality fetal heart rate tracing|6
7608238|NCT00787176|12016234|FG003|Overall Study|Low quality fetal heart rate tracing|5
7608239|NCT00352534|12016247|FG000|Initial Staging|Ineligible|8
7608240|NCT00352534|12016248|FG001|Initial Staging|Ineligible|9
7608241|NCT00352534|12016249|FG002|Initial Staging|Ineligible|0
7608242|NCT00352534|12016250|FG003|Initial Staging|Ineligible|0
7608243|NCT00352534|12016251|FG004|Initial Staging|Ineligible|0
7608244|NCT00352534|12016252|FG005|Initial Staging|Ineligible|0
7608245|NCT00352534|12016253|FG006|Initial Staging|Ineligible|0
7608246|NCT00352534|12016247|FG000|Final Risk Group Assignment|Lack of Efficacy|0
7608247|NCT00352534|12016248|FG001|Final Risk Group Assignment|Lack of Efficacy|0
7608248|NCT00352534|12016249|FG002|Final Risk Group Assignment|Lack of Efficacy|0
7608249|NCT00352534|12016250|FG003|Final Risk Group Assignment|Lack of Efficacy|2
7608250|NCT00352534|12016251|FG004|Final Risk Group Assignment|Lack of Efficacy|1
7608251|NCT00352534|12016252|FG005|Final Risk Group Assignment|Lack of Efficacy|19
7608252|NCT00352534|12016253|FG006|Final Risk Group Assignment|Lack of Efficacy|0
7608253|NCT00352534|12016247|FG000|Final Risk Group Assignment|Physician Decision|0
7608254|NCT00352534|12016248|FG001|Final Risk Group Assignment|Physician Decision|0
7608255|NCT00352534|12016249|FG002|Final Risk Group Assignment|Physician Decision|0
7608256|NCT00352534|12016250|FG003|Final Risk Group Assignment|Physician Decision|0
7608257|NCT00352534|12016251|FG004|Final Risk Group Assignment|Physician Decision|0
7608258|NCT00352534|12016252|FG005|Final Risk Group Assignment|Physician Decision|8
7608259|NCT00352534|12016253|FG006|Final Risk Group Assignment|Physician Decision|0
7608260|NCT00352534|12016247|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
7608261|NCT00352534|12016248|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
7608262|NCT00352534|12016249|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
7608263|NCT00352534|12016250|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
7608264|NCT00352534|12016251|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
7608265|NCT00352534|12016252|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
7608266|NCT00352534|12016253|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
7608267|NCT00352534|12016247|FG000|Final Risk Group Assignment|Ineligible|0
7608268|NCT00352534|12016248|FG001|Final Risk Group Assignment|Ineligible|0
7608269|NCT00352534|12016249|FG002|Final Risk Group Assignment|Ineligible|3
7608270|NCT00352534|12016250|FG003|Final Risk Group Assignment|Ineligible|1
7608271|NCT00352534|12016251|FG004|Final Risk Group Assignment|Ineligible|0
7608272|NCT00352534|12016252|FG005|Final Risk Group Assignment|Ineligible|13
7608273|NCT00352534|12016253|FG006|Final Risk Group Assignment|Ineligible|0
7608274|NCT00352534|12016247|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
7608275|NCT00352534|12016248|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
7608276|NCT00352534|12016249|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
7608277|NCT00352534|12016250|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
7608278|NCT00352534|12016251|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
7608279|NCT00352534|12016252|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
7608280|NCT00352534|12016253|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
7608281|NCT00352534|12016247|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7276120|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
7276121|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
7276122|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
7608282|NCT00352534|12016248|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608283|NCT00352534|12016249|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7276123|NCT00446030|11490865|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
7276124|NCT00446030|11490866|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
7276125|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
7276126|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
7276127|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
7276128|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
7276129|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
7276130|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Adverse Event|0
7276131|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Adverse Event|1
7276132|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Adverse Event|1
7276133|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Adverse Event|0
7276134|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Adverse Event|0
7276135|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
7276136|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
7276137|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
7276138|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
7276139|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
7276140|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Physician Decision|1
7276141|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Physician Decision|0
7276142|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Physician Decision|0
7608284|NCT00352534|12016250|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608285|NCT00352534|12016251|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608286|NCT00352534|12016252|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
7608287|NCT00352534|12016253|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
7608288|NCT00352534|12016247|FG000|Final Risk Group Assignment|Death|0
7608289|NCT00352534|12016248|FG001|Final Risk Group Assignment|Death|0
7608290|NCT00352534|12016249|FG002|Final Risk Group Assignment|Death|0
7608291|NCT00352534|12016250|FG003|Final Risk Group Assignment|Death|0
7608292|NCT00352534|12016251|FG004|Final Risk Group Assignment|Death|0
7608293|NCT00352534|12016252|FG005|Final Risk Group Assignment|Death|2
7608294|NCT00352534|12016253|FG006|Final Risk Group Assignment|Death|0
7608295|NCT00033293|12016265|FG000|Overall Study|Death|0
7608296|NCT00033293|12016266|FG001|Overall Study|Death|1
7608297|NCT00033293|12016265|FG000|Overall Study|Lack of Efficacy|5
7608298|NCT00033293|12016266|FG001|Overall Study|Lack of Efficacy|8
7608299|NCT00033293|12016265|FG000|Overall Study|Lost to Follow-up|0
7608300|NCT00033293|12016266|FG001|Overall Study|Lost to Follow-up|1
7608301|NCT00033293|12016265|FG000|Overall Study|Physician Decision|3
7608302|NCT00033293|12016266|FG001|Overall Study|Physician Decision|1
7608303|NCT00033293|12016265|FG000|Overall Study|Withdrawal by Subject|1
7608304|NCT00033293|12016266|FG001|Overall Study|Withdrawal by Subject|0
7608305|NCT00033293|12016265|FG000|Overall Study|Could not be weaned from steroid therapy|1
7608306|NCT00033293|12016266|FG001|Overall Study|Could not be weaned from steroid therapy|1
7608307|NCT00033293|12016265|FG000|Overall Study|Treatment refused|0
7608308|NCT00033293|12016266|FG001|Overall Study|Treatment refused|6
7276143|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Physician Decision|0
7276144|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Physician Decision|0
7276145|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
7276146|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
7276147|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
7276148|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
7276149|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
7276150|NCT00446095|11490877|FG000|Phase II (8 Weeks)|Ongoing|0
7276151|NCT00446095|11490878|FG001|Phase II (8 Weeks)|Ongoing|0
7276152|NCT00446095|11490879|FG002|Phase II (8 Weeks)|Ongoing|1
7276153|NCT00446095|11490880|FG003|Phase II (8 Weeks)|Ongoing|0
7276154|NCT00446095|11490881|FG004|Phase II (8 Weeks)|Ongoing|0
7276155|NCT00446095|11490877|FG000|Phase I (28 Days)|Adverse Event|0
7276156|NCT00446095|11490878|FG001|Phase I (28 Days)|Adverse Event|0
7276157|NCT00446095|11490879|FG002|Phase I (28 Days)|Adverse Event|0
7276158|NCT00446095|11490880|FG003|Phase I (28 Days)|Adverse Event|1
7276159|NCT00446095|11490881|FG004|Phase I (28 Days)|Adverse Event|0
7276160|NCT00446095|11490877|FG000|Phase I (28 Days)|Lack of Efficacy|0
7276161|NCT00446095|11490878|FG001|Phase I (28 Days)|Lack of Efficacy|0
7276162|NCT00446095|11490879|FG002|Phase I (28 Days)|Lack of Efficacy|0
7276163|NCT00446095|11490880|FG003|Phase I (28 Days)|Lack of Efficacy|0
7276164|NCT00446095|11490881|FG004|Phase I (28 Days)|Lack of Efficacy|3
7276165|NCT00446134|11490896|FG000|Overall Study|Adverse Event|7
7276166|NCT00446134|11490897|FG001|Overall Study|Adverse Event|17
7276167|NCT00446134|11490898|FG002|Overall Study|Adverse Event|13
7276168|NCT00446134|11490899|FG003|Overall Study|Adverse Event|18
7276169|NCT00446134|11490896|FG000|Overall Study|Lack of Efficacy|19
7276170|NCT00446134|11490897|FG001|Overall Study|Lack of Efficacy|19
7276171|NCT00446134|11490898|FG002|Overall Study|Lack of Efficacy|24
7276172|NCT00446134|11490899|FG003|Overall Study|Lack of Efficacy|19
7276173|NCT00446134|11490896|FG000|Overall Study|Protocol Violation|0
7276174|NCT00446134|11490897|FG001|Overall Study|Protocol Violation|2
7276175|NCT00446134|11490898|FG002|Overall Study|Protocol Violation|1
7276176|NCT00446134|11490899|FG003|Overall Study|Protocol Violation|0
7276177|NCT00446134|11490896|FG000|Overall Study|Lost to Follow-up|1
7276178|NCT00446134|11490897|FG001|Overall Study|Lost to Follow-up|3
7276179|NCT00446134|11490898|FG002|Overall Study|Lost to Follow-up|1
7276180|NCT00446134|11490899|FG003|Overall Study|Lost to Follow-up|1
7276181|NCT00446134|11490896|FG000|Overall Study|Withdrawal by Subject|3
7276182|NCT00446134|11490897|FG001|Overall Study|Withdrawal by Subject|3
7276183|NCT00446134|11490898|FG002|Overall Study|Withdrawal by Subject|1
7276184|NCT00446134|11490899|FG003|Overall Study|Withdrawal by Subject|3
7276185|NCT00446134|11490896|FG000|Overall Study|Physician Decision|0
7276186|NCT00446134|11490897|FG001|Overall Study|Physician Decision|0
7276187|NCT00446134|11490898|FG002|Overall Study|Physician Decision|0
7276188|NCT00446134|11490899|FG003|Overall Study|Physician Decision|2
7276189|NCT00446134|11490896|FG000|Overall Study|Adverse Event-Diarrhea|1
7276190|NCT00446134|11490897|FG001|Overall Study|Adverse Event-Diarrhea|1
7276191|NCT00446134|11490898|FG002|Overall Study|Adverse Event-Diarrhea|2
7276192|NCT00446134|11490899|FG003|Overall Study|Adverse Event-Diarrhea|0
7276193|NCT00446134|11490896|FG000|Overall Study|Reason Not Completed|3
7276194|NCT00446134|11490897|FG001|Overall Study|Reason Not Completed|0
7276195|NCT00446134|11490898|FG002|Overall Study|Reason Not Completed|1
7276196|NCT00446134|11490899|FG003|Overall Study|Reason Not Completed|2
7276197|NCT00446199|11490922|FG000|Overall Study|Adverse Event|7
7276198|NCT00446199|11490923|FG001|Overall Study|Adverse Event|4
7276199|NCT00446199|11490924|FG002|Overall Study|Adverse Event|6
7276200|NCT00446199|11490925|FG003|Overall Study|Adverse Event|4
7276201|NCT00446199|11490922|FG000|Overall Study|Lost to Follow-up|4
7276202|NCT00446199|11490923|FG001|Overall Study|Lost to Follow-up|5
7276203|NCT00446199|11490924|FG002|Overall Study|Lost to Follow-up|2
7276204|NCT00446199|11490925|FG003|Overall Study|Lost to Follow-up|6
7276205|NCT00446199|11490922|FG000|Overall Study|Protocol Violation|1
7276206|NCT00446199|11490923|FG001|Overall Study|Protocol Violation|2
7276207|NCT00446199|11490924|FG002|Overall Study|Protocol Violation|1
7276208|NCT00446199|11490925|FG003|Overall Study|Protocol Violation|3
7276209|NCT00446199|11490922|FG000|Overall Study|Withdrawal by Subject|2
7276210|NCT00446199|11490923|FG001|Overall Study|Withdrawal by Subject|5
7276211|NCT00446199|11490924|FG002|Overall Study|Withdrawal by Subject|9
7608309|NCT04497415|12016276|FG000|Overall Study|Lost to Follow-up|43
7608310|NCT04497415|12016277|FG001|Overall Study|Lost to Follow-up|27
7608311|NCT04594759|12016318|FG000|Overall Study|Lost to Follow-up|3
7608312|NCT04463069|12016324|FG000|Overall Study|Withdrawal by Subject|2
7608313|NCT04463069|12016325|FG001|Overall Study|Withdrawal by Subject|10
7608314|NCT04463069|12016324|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
7608315|NCT04463069|12016325|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
7608316|NCT04250337|12016333|FG000|Overall Study|Adverse Event|0
7608317|NCT04250337|12016334|FG001|Overall Study|Adverse Event|3
7608318|NCT04250337|12016333|FG000|Overall Study|Lack of Efficacy|1
7608319|NCT04250337|12016334|FG001|Overall Study|Lack of Efficacy|3
7608320|NCT04250337|12016333|FG000|Overall Study|Physician Decision|1
7608321|NCT04250337|12016334|FG001|Overall Study|Physician Decision|0
7608322|NCT04250337|12016333|FG000|Overall Study|Protocol Deviation|2
7608323|NCT04250337|12016334|FG001|Overall Study|Protocol Deviation|2
7608324|NCT04250337|12016333|FG000|Overall Study|Withdrawal by Subject|4
7608325|NCT04250337|12016334|FG001|Overall Study|Withdrawal by Subject|3
7608326|NCT04126733|12016341|FG000|Treatment Period|Other Reason|1
7608327|NCT04126733|12016341|FG000|Treatment Period|Death|1
7608328|NCT04126733|12016341|FG000|Treatment Period|Physician Decision|3
7608329|NCT04126733|12016341|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
7608330|NCT04126733|12016341|FG000|Treatment Period|Adverse Event|7
7608331|NCT04126733|12016341|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
7608332|NCT04126733|12016341|FG000|Treatment Period|Ongoing with Study Treatment|7
7608333|NCT04126733|12016341|FG000|Active Follow-up Period|Death|13
7608334|NCT04126733|12016341|FG000|Active Follow-up Period|Other Reason|1
7608335|NCT04126733|12016341|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
7608336|NCT04126733|12016341|FG000|Active Follow-up Period|Withdrawal by Subject|2
7608337|NCT04126733|12016341|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
7608338|NCT04126733|12016341|FG000|Long-term Follow-up Period|Death|5
7276212|NCT00446199|11490925|FG003|Overall Study|Withdrawal by Subject|10
7608361|NCT03575572|12016371|FG000|Overall Study|Withdrawal by Subject|2
7608362|NCT03575572|12016371|FG000|Overall Study|Physician Decision|2
7608363|NCT03521687|12016384|FG000|Overall Study|Adverse Event|4
7608364|NCT03521687|12016384|FG000|Overall Study|Physician Decision|1
7608380|NCT02966301|12016428|FG000|Overall Study|Death|2
7608381|NCT02966301|12016428|FG000|Overall Study|Withdrawal by Subject|1
7276213|NCT00446199|11490922|FG000|Overall Study|Site termination|2
7608382|NCT02832167|12016441|FG000|Treatment Period 1|Disease progression|90
7608383|NCT02832167|12016441|FG000|Treatment Period 1|Adverse event unrelated to study drug|12
7608384|NCT02832167|12016441|FG000|Treatment Period 1|Death|2
7608385|NCT02832167|12016441|FG000|Treatment Period 1|Study Drug Toxicity|6
7608413|NCT02659020|12016460|FG004|Overall Study|Lost to Follow-up|1
7608386|NCT02832167|12016441|FG000|Treatment Period 1|Participant request to discontinue|9
7608387|NCT02832167|12016441|FG000|Treatment Period 1|No longer meet study criteria|1
7608388|NCT02832167|12016441|FG000|Treatment Period 1|Participant withdrew consent|3
7608389|NCT02832167|12016441|FG000|Treatment Period 1|Other reasons|6
7608390|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Other reasons|1
7276214|NCT00446199|11490923|FG001|Overall Study|Site termination|0
7276215|NCT00446199|11490924|FG002|Overall Study|Site termination|0
7276216|NCT00446199|11490925|FG003|Overall Study|Site termination|1
7276217|NCT00446199|11490922|FG000|Overall Study|Randomization in Error|2
7276218|NCT00446199|11490923|FG001|Overall Study|Randomization in Error|0
7276219|NCT00446199|11490924|FG002|Overall Study|Randomization in Error|1
7276220|NCT00446199|11490925|FG003|Overall Study|Randomization in Error|1
7276221|NCT00446199|11490922|FG000|Overall Study|Lack of Efficacy|1
7276222|NCT00446199|11490923|FG001|Overall Study|Lack of Efficacy|0
7276223|NCT00446199|11490924|FG002|Overall Study|Lack of Efficacy|0
7276224|NCT00446199|11490925|FG003|Overall Study|Lack of Efficacy|1
7276225|NCT00446199|11490922|FG000|Overall Study|Non-compliant with study drug|1
7276226|NCT00446199|11490923|FG001|Overall Study|Non-compliant with study drug|0
7276227|NCT00446199|11490924|FG002|Overall Study|Non-compliant with study drug|5
7276228|NCT00446199|11490925|FG003|Overall Study|Non-compliant with study drug|0
7276229|NCT00446199|11490922|FG000|Overall Study|Non-compliant with visit schedule|1
7276230|NCT00446199|11490923|FG001|Overall Study|Non-compliant with visit schedule|1
7276231|NCT00446199|11490924|FG002|Overall Study|Non-compliant with visit schedule|1
7276232|NCT00446199|11490925|FG003|Overall Study|Non-compliant with visit schedule|2
7276233|NCT00446199|11490922|FG000|Overall Study|Hormone fear|0
7276234|NCT00446199|11490923|FG001|Overall Study|Hormone fear|0
7276235|NCT00446199|11490924|FG002|Overall Study|Hormone fear|0
7276236|NCT00446199|11490925|FG003|Overall Study|Hormone fear|1
7276237|NCT00446199|11490922|FG000|Overall Study|Lost interest in study participation|0
7276238|NCT00446199|11490923|FG001|Overall Study|Lost interest in study participation|1
7276239|NCT00446199|11490924|FG002|Overall Study|Lost interest in study participation|0
7276240|NCT00446199|11490925|FG003|Overall Study|Lost interest in study participation|0
7276241|NCT00446199|11490922|FG000|Overall Study|In-/Exclusion criterion violated|2
7276242|NCT00446199|11490923|FG001|Overall Study|In-/Exclusion criterion violated|1
7276243|NCT00446199|11490924|FG002|Overall Study|In-/Exclusion criterion violated|2
7276244|NCT00446199|11490925|FG003|Overall Study|In-/Exclusion criterion violated|1
7276245|NCT00446199|11490922|FG000|Overall Study|Move|0
7276246|NCT00446199|11490923|FG001|Overall Study|Move|1
7276247|NCT00446199|11490924|FG002|Overall Study|Move|0
7276248|NCT00446199|11490925|FG003|Overall Study|Move|0
7276249|NCT00446251|11490935|FG000|Overall Study|On-study Transplants|2
7276250|NCT00446251|11490935|FG000|Overall Study|Rituximab Infusion Reaction|2
7276251|NCT00446251|11490935|FG000|Overall Study|Lost to Follow-up|1
7276252|NCT00446446|11490947|FG000|Overall Study|Death|10
7276253|NCT00446446|11490947|FG000|Overall Study|Withdrawal by Subject|6
7276254|NCT00446446|11490947|FG000|Overall Study|Other|4
7276255|NCT00446446|11490947|FG000|Overall Study|Disease Progession|2
7276256|NCT00446446|11490947|FG000|Overall Study|Adverse Event|1
7276257|NCT00446446|11490947|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
7276258|NCT00446459|11490951|FG000|8 Months|Protocol Violation|12
7276259|NCT00446459|11490951|FG000|12 Months|Protocol Violation|4
7276260|NCT00446459|11490951|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
7276261|NCT00446511|11490959|FG000|Overall Study|Adverse Event|7
7276262|NCT00446511|11490960|FG001|Overall Study|Adverse Event|2
7276263|NCT00446511|11490961|FG002|Overall Study|Adverse Event|3
7276264|NCT00446511|11490962|FG003|Overall Study|Adverse Event|1
7276265|NCT00446511|11490959|FG000|Overall Study|Protocol Violation|0
7276266|NCT00446511|11490960|FG001|Overall Study|Protocol Violation|0
7276267|NCT00446511|11490961|FG002|Overall Study|Protocol Violation|0
7276268|NCT00446511|11490962|FG003|Overall Study|Protocol Violation|1
7608391|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
7608392|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Death|2
7608393|NCT02832167|12016441|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
7608394|NCT02832167|12016441|FG000|Treatment Period 2|Disease progression|69
7608395|NCT02832167|12016441|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
7608396|NCT02832167|12016441|FG000|Treatment Period 2|Maximum clinical benefit|1
7608397|NCT02832167|12016441|FG000|Treatment Period 2|Study Drug Toxicity|5
7608398|NCT02832167|12016441|FG000|Treatment Period 2|Participant request to discontinue|2
7608399|NCT02832167|12016441|FG000|Treatment Period 2|Participant withdrew consent|3
7608400|NCT02832167|12016441|FG000|Treatment Period 2|Other reasons|3
7608401|NCT02699554|12016445|FG000|Overall Study|Lost to Follow-up|9
7608402|NCT02659020|12016456|FG000|Overall Study|Adverse Event|0
7608403|NCT02659020|12016457|FG001|Overall Study|Adverse Event|0
7608404|NCT02659020|12016458|FG002|Overall Study|Adverse Event|0
7608405|NCT02659020|12016459|FG003|Overall Study|Adverse Event|2
7608406|NCT02659020|12016460|FG004|Overall Study|Adverse Event|0
7608407|NCT02659020|12016461|FG005|Overall Study|Adverse Event|0
7608408|NCT02659020|12016462|FG006|Overall Study|Adverse Event|2
7608409|NCT02659020|12016456|FG000|Overall Study|Lost to Follow-up|1
7608410|NCT02659020|12016457|FG001|Overall Study|Lost to Follow-up|2
7608411|NCT02659020|12016458|FG002|Overall Study|Lost to Follow-up|1
7608412|NCT02659020|12016459|FG003|Overall Study|Lost to Follow-up|6
7608414|NCT02659020|12016461|FG005|Overall Study|Lost to Follow-up|5
7608415|NCT02659020|12016462|FG006|Overall Study|Lost to Follow-up|0
7608416|NCT02659020|12016456|FG000|Overall Study|Physician Decision|0
7608417|NCT02659020|12016457|FG001|Overall Study|Physician Decision|0
7608418|NCT02659020|12016458|FG002|Overall Study|Physician Decision|0
7276269|NCT00446511|11490959|FG000|Overall Study|Withdrawal by Subject|0
7276270|NCT00446511|11490960|FG001|Overall Study|Withdrawal by Subject|0
7276271|NCT00446511|11490961|FG002|Overall Study|Withdrawal by Subject|0
7276272|NCT00446511|11490962|FG003|Overall Study|Withdrawal by Subject|3
7276273|NCT00446511|11490959|FG000|Overall Study|Administrative Problems|3
7276274|NCT00446511|11490960|FG001|Overall Study|Administrative Problems|0
7276275|NCT00446511|11490961|FG002|Overall Study|Administrative Problems|4
7276276|NCT00446511|11490962|FG003|Overall Study|Administrative Problems|1
7276277|NCT00446550|11490976|FG000|Overall Study|Adverse Event|1
7276278|NCT00446550|11490977|FG001|Overall Study|Adverse Event|0
7276279|NCT00446563|11490986|FG000|Overall Study|Adverse Event|4
7276280|NCT00446563|11490987|FG001|Overall Study|Adverse Event|3
7276281|NCT00446563|11490986|FG000|Overall Study|Abnormal laboratory value(s)|0
7276282|NCT00446563|11490987|FG001|Overall Study|Abnormal laboratory value(s)|1
7276283|NCT00446563|11490986|FG000|Overall Study|Abnormal test procedure result(s)|1
7276284|NCT00446563|11490987|FG001|Overall Study|Abnormal test procedure result(s)|0
7276285|NCT00446563|11490986|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7608419|NCT02659020|12016459|FG003|Overall Study|Physician Decision|1
7608420|NCT02659020|12016460|FG004|Overall Study|Physician Decision|1
7608421|NCT02659020|12016461|FG005|Overall Study|Physician Decision|0
7608422|NCT02659020|12016462|FG006|Overall Study|Physician Decision|1
7608423|NCT02659020|12016456|FG000|Overall Study|Withdrawal by Subject|2
7608424|NCT02659020|12016457|FG001|Overall Study|Withdrawal by Subject|1
7608425|NCT02659020|12016458|FG002|Overall Study|Withdrawal by Subject|0
7276286|NCT00446563|11490987|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7276287|NCT00446563|11490986|FG000|Overall Study|Withdrawal by Subject|2
7276288|NCT00446563|11490987|FG001|Overall Study|Withdrawal by Subject|1
7276289|NCT00446563|11490986|FG000|Overall Study|Administrative problems|0
7276290|NCT00446563|11490987|FG001|Overall Study|Administrative problems|1
7276291|NCT00446641|11490995|FG000|Overall Study|Withdrawal by Subject|8
7276292|NCT00446641|11490996|FG001|Overall Study|Withdrawal by Subject|3
7276293|NCT00446641|11490995|FG000|Overall Study|poor compliance|8
7276294|NCT00446641|11490996|FG001|Overall Study|poor compliance|6
7276295|NCT00446641|11490995|FG000|Overall Study|Lost to Follow-up|1
7276296|NCT00446641|11490996|FG001|Overall Study|Lost to Follow-up|1
7276297|NCT00446654|11491004|FG000|Overall Study|Withdrawal by Subject|1
7276298|NCT00446654|11491005|FG001|Overall Study|Withdrawal by Subject|0
7276299|NCT00446654|11491004|FG000|Overall Study|Adverse Event|1
7276300|NCT00446654|11491005|FG001|Overall Study|Adverse Event|0
7276301|NCT00446797|11491013|FG000|Overall Study|Lack of Efficacy|0
7276302|NCT00446797|11491014|FG001|Overall Study|Lack of Efficacy|2
7276303|NCT00446797|11491013|FG000|Overall Study|Lost to Follow-up|5
7276304|NCT00446797|11491014|FG001|Overall Study|Lost to Follow-up|3
7608426|NCT02659020|12016459|FG003|Overall Study|Withdrawal by Subject|3
7608427|NCT02659020|12016460|FG004|Overall Study|Withdrawal by Subject|3
7608428|NCT02659020|12016461|FG005|Overall Study|Withdrawal by Subject|6
7608429|NCT02659020|12016462|FG006|Overall Study|Withdrawal by Subject|3
7608430|NCT02659020|12016456|FG000|Overall Study|Progressive Disease|0
7608431|NCT02659020|12016457|FG001|Overall Study|Progressive Disease|0
7608432|NCT02659020|12016458|FG002|Overall Study|Progressive Disease|0
7608433|NCT02659020|12016459|FG003|Overall Study|Progressive Disease|4
7608434|NCT02659020|12016460|FG004|Overall Study|Progressive Disease|1
7608435|NCT02659020|12016461|FG005|Overall Study|Progressive Disease|0
7608436|NCT02659020|12016462|FG006|Overall Study|Progressive Disease|2
7608437|NCT02626949|12016487|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15
7608438|NCT02626949|12016488|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11
7608439|NCT02626949|12016487|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1
7608440|NCT02626949|12016488|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3
7608441|NCT02626949|12016487|FG000|Enrolled|Lost to Follow-up|7
7608442|NCT02626949|12016488|FG001|Enrolled|Lost to Follow-up|6
7608443|NCT02626949|12016487|FG000|Enrolled|Withdrawal by Subject|3
7276305|NCT00446797|11491013|FG000|Overall Study|Withdrawal by Subject|2
7276306|NCT00446797|11491014|FG001|Overall Study|Withdrawal by Subject|2
7276307|NCT00446797|11491013|FG000|Overall Study|Protocol Violation|1
7276308|NCT00446797|11491014|FG001|Overall Study|Protocol Violation|3
7276309|NCT00446797|11491013|FG000|Overall Study|subject entered at another site|0
7276310|NCT00446797|11491014|FG001|Overall Study|subject entered at another site|1
7608444|NCT02626949|12016488|FG001|Enrolled|Withdrawal by Subject|2
7608445|NCT02565914|12016503|FG000|Overall Study|Adverse Event|17
7608446|NCT02565914|12016503|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
7608447|NCT02565914|12016503|FG000|Overall Study|Lost to Follow-up|12
7608448|NCT02565914|12016503|FG000|Overall Study|Death (not treatment emergent)|1
7608449|NCT02565914|12016503|FG000|Overall Study|Other noncompliance|6
7608450|NCT02565914|12016503|FG000|Overall Study|Physician Decision|6
7608451|NCT02565914|12016503|FG000|Overall Study|Parent study termination by sponsor|1
7608452|NCT02565914|12016503|FG000|Overall Study|Commercial drug available|5
7608453|NCT02565914|12016503|FG000|Overall Study|Other|18
7608454|NCT02565914|12016503|FG000|Overall Study|Enrolled, but did not receive study drug|2
7608455|NCT02385045|12016515|FG000|Overall Study|Endoscopy could not be completed|4
7276311|NCT00446797|11491013|FG000|Overall Study|did not meet entrance criteria|0
7276312|NCT00446797|11491014|FG001|Overall Study|did not meet entrance criteria|1
7276313|NCT00446849|11491020|FG000|Acute Phase|Lack of Efficacy|64
7276314|NCT00446849|11491020|FG000|Acute Phase|Protocol Violation|10
7276315|NCT00446849|11491020|FG000|Acute Phase|Consent withdrawn|4
7276316|NCT00446849|11491020|FG000|Acute Phase|Lost to Follow-up|2
7276317|NCT00446849|11491020|FG000|Acute Phase|Physician Decision|1
7276318|NCT00446849|11491020|FG000|Acute Phase|noncompliance|1
7276319|NCT00446849|11491020|FG000|Maintenance Phase|Lack of Efficacy|40
7276320|NCT00446849|11491020|FG000|Maintenance Phase|Protocol Violation|7
7276321|NCT00446849|11491020|FG000|Maintenance Phase|Adverse Event|6
7276322|NCT00446849|11491020|FG000|Maintenance Phase|Consent withdrawn|5
7276323|NCT00446849|11491020|FG000|Maintenance Phase|Lost to Follow-up|3
7276324|NCT00446849|11491020|FG000|Maintenance Phase|Pregnancy|1
7276325|NCT00446849|11491020|FG000|Maintenance Phase|noncompliance|2
7276326|NCT00446849|11491020|FG000|Maintenance Phase|prohibited medication use|2
7276327|NCT00446849|11491020|FG000|Maintenance Phase|antibiotic use|1
7276328|NCT00446849|11491020|FG000|Maintenance Phase|study closure|1
7276329|NCT00446849|11491020|FG000|Maintenance Phase|hydrocodone use|1
7276330|NCT00446849|11491020|FG000|Maintenance Phase|concomitant medication use|1
7276331|NCT00446966|11491027|FG000|Overall Study|Lost to Follow-up|10
7276332|NCT00446966|11491028|FG001|Overall Study|Lost to Follow-up|7
7276333|NCT00446992|11491034|FG000|Overall Study|Adverse Event|11
7276334|NCT00446992|11491034|FG000|Overall Study|Lost to Follow-up|5
7276335|NCT00447005|11491038|FG000|Overall Study|Adverse Event|1
7276336|NCT00447005|11491038|FG000|Overall Study|Lack of Efficacy|11
7276337|NCT00447057|11491046|FG000|Overall Study|Adverse Event|4
7276338|NCT00447057|11491047|FG001|Overall Study|Adverse Event|10
7608456|NCT01845649|12016530|FG000|Overall Study|Adverse Event|7
7608457|NCT01845649|12016531|FG001|Overall Study|Adverse Event|10
7276339|NCT00447057|11491048|FG002|Overall Study|Adverse Event|0
7276340|NCT00447057|11491049|FG003|Overall Study|Adverse Event|3
7276341|NCT00447057|11491046|FG000|Overall Study|Death due to study disease|6
7276342|NCT00447057|11491047|FG001|Overall Study|Death due to study disease|4
7276343|NCT00447057|11491048|FG002|Overall Study|Death due to study disease|1
7276344|NCT00447057|11491049|FG003|Overall Study|Death due to study disease|1
7276345|NCT00447057|11491046|FG000|Overall Study|Lost to Follow-up|0
7276346|NCT00447057|11491047|FG001|Overall Study|Lost to Follow-up|1
7276347|NCT00447057|11491048|FG002|Overall Study|Lost to Follow-up|0
7276348|NCT00447057|11491049|FG003|Overall Study|Lost to Follow-up|0
7608458|NCT01845649|12016530|FG000|Overall Study|Lack of Efficacy|1
7608459|NCT01845649|12016531|FG001|Overall Study|Lack of Efficacy|1
7608460|NCT01845649|12016530|FG000|Overall Study|Lost to Follow-up|2
7608461|NCT01845649|12016531|FG001|Overall Study|Lost to Follow-up|2
7608462|NCT01845649|12016530|FG000|Overall Study|Withdrew Consent|12
7608463|NCT01845649|12016531|FG001|Overall Study|Withdrew Consent|4
7608464|NCT01845649|12016530|FG000|Overall Study|Protocol Deviation|7
7608465|NCT01845649|12016531|FG001|Overall Study|Protocol Deviation|4
7608466|NCT01845649|12016530|FG000|Overall Study|Reason not Specified|2
7608467|NCT01845649|12016531|FG001|Overall Study|Reason not Specified|1
7276349|NCT00447057|11491046|FG000|Overall Study|Entry criteria not met|1
7276350|NCT00447057|11491047|FG001|Overall Study|Entry criteria not met|1
7276351|NCT00447057|11491048|FG002|Overall Study|Entry criteria not met|0
7276352|NCT00447057|11491049|FG003|Overall Study|Entry criteria not met|0
7276353|NCT00447057|11491046|FG000|Overall Study|Protocol Violation|0
7276354|NCT00447057|11491047|FG001|Overall Study|Protocol Violation|1
7276355|NCT00447057|11491048|FG002|Overall Study|Protocol Violation|0
7276356|NCT00447057|11491049|FG003|Overall Study|Protocol Violation|0
7276357|NCT00447057|11491046|FG000|Overall Study|Withdrawal by Subject|4
7276358|NCT00447057|11491047|FG001|Overall Study|Withdrawal by Subject|5
7276359|NCT00447057|11491048|FG002|Overall Study|Withdrawal by Subject|1
7608474|NCT01816139|12016548|FG000|Overall Study|Adverse Event|6
7608475|NCT01816139|12016549|FG001|Overall Study|Adverse Event|8
7276360|NCT00447057|11491049|FG003|Overall Study|Withdrawal by Subject|1
7276361|NCT00447057|11491046|FG000|Overall Study|Physician Decision|9
7276362|NCT00447057|11491047|FG001|Overall Study|Physician Decision|6
7608476|NCT01816139|12016548|FG000|Overall Study|Lack of Efficacy|1
7608477|NCT01816139|12016549|FG001|Overall Study|Lack of Efficacy|2
7608478|NCT01816139|12016548|FG000|Overall Study|Lost to Follow-up|5
7608479|NCT01816139|12016549|FG001|Overall Study|Lost to Follow-up|3
7608480|NCT01816139|12016548|FG000|Overall Study|Withdrew Consent|6
7608481|NCT01816139|12016549|FG001|Overall Study|Withdrew Consent|4
7608482|NCT01816139|12016548|FG000|Overall Study|Protocol Violation|6
7608483|NCT01816139|12016549|FG001|Overall Study|Protocol Violation|3
7608484|NCT01816139|12016548|FG000|Overall Study|Reason not Specified|4
7608485|NCT01816139|12016549|FG001|Overall Study|Reason not Specified|2
7608486|NCT01455597|12016555|FG000|Overall Study|Adverse Event|7
7608487|NCT01455597|12016556|FG001|Overall Study|Adverse Event|0
7608488|NCT01455597|12016557|FG002|Overall Study|Adverse Event|5
7608489|NCT01455597|12016558|FG003|Overall Study|Adverse Event|1
7608490|NCT01455597|12016555|FG000|Overall Study|Lack of Efficacy|0
7608491|NCT01455597|12016556|FG001|Overall Study|Lack of Efficacy|1
7608492|NCT01455597|12016557|FG002|Overall Study|Lack of Efficacy|2
7608493|NCT01455597|12016558|FG003|Overall Study|Lack of Efficacy|0
7608494|NCT01455597|12016555|FG000|Overall Study|Lost to Follow-up|3
7276363|NCT00447057|11491048|FG002|Overall Study|Physician Decision|3
7276364|NCT00447057|11491049|FG003|Overall Study|Physician Decision|1
7276365|NCT00447057|11491046|FG000|Overall Study|Sponsor decision|1
7276366|NCT00447057|11491047|FG001|Overall Study|Sponsor decision|1
7276367|NCT00447057|11491048|FG002|Overall Study|Sponsor decision|0
7276368|NCT00447057|11491049|FG003|Overall Study|Sponsor decision|0
7276369|NCT00447057|11491046|FG000|Overall Study|Progressive disease|58
7276370|NCT00447057|11491047|FG001|Overall Study|Progressive disease|43
7276371|NCT00447057|11491048|FG002|Overall Study|Progressive disease|13
7608495|NCT01455597|12016556|FG001|Overall Study|Lost to Follow-up|0
7608496|NCT01455597|12016557|FG002|Overall Study|Lost to Follow-up|2
7608497|NCT01455597|12016558|FG003|Overall Study|Lost to Follow-up|1
7608498|NCT01455597|12016555|FG000|Overall Study|Withdrew Consent|6
7608499|NCT01455597|12016556|FG001|Overall Study|Withdrew Consent|5
7608500|NCT01455597|12016557|FG002|Overall Study|Withdrew Consent|8
7608501|NCT01455597|12016558|FG003|Overall Study|Withdrew Consent|5
7608502|NCT01455597|12016555|FG000|Overall Study|Reason not Specified|1
7608503|NCT01455597|12016556|FG001|Overall Study|Reason not Specified|2
7608504|NCT01455597|12016557|FG002|Overall Study|Reason not Specified|3
7608505|NCT01455597|12016558|FG003|Overall Study|Reason not Specified|3
7608506|NCT01400776|12016574|FG000|Overall Study|Adverse Event|7
7608507|NCT01400776|12016575|FG001|Overall Study|Adverse Event|2
7608508|NCT01400776|12016576|FG002|Overall Study|Adverse Event|9
7608509|NCT01400776|12016577|FG003|Overall Study|Adverse Event|2
7608510|NCT01400776|12016574|FG000|Overall Study|Lost to Follow-up|1
7608511|NCT01400776|12016575|FG001|Overall Study|Lost to Follow-up|0
7608512|NCT01400776|12016576|FG002|Overall Study|Lost to Follow-up|4
7608513|NCT01400776|12016577|FG003|Overall Study|Lost to Follow-up|1
7608514|NCT01400776|12016574|FG000|Overall Study|Withdrew Consent|4
7608515|NCT01400776|12016575|FG001|Overall Study|Withdrew Consent|2
7608516|NCT01400776|12016576|FG002|Overall Study|Withdrew Consent|6
7608517|NCT01400776|12016577|FG003|Overall Study|Withdrew Consent|1
7608518|NCT01400776|12016574|FG000|Overall Study|Protocol Deviation|6
7276372|NCT00447057|11491049|FG003|Overall Study|Progressive disease|18
7276373|NCT00447057|11491046|FG000|Overall Study|Death due to adverse event|0
7276374|NCT00447057|11491047|FG001|Overall Study|Death due to adverse event|0
7276375|NCT00447057|11491048|FG002|Overall Study|Death due to adverse event|1
7276376|NCT00447057|11491049|FG003|Overall Study|Death due to adverse event|2
7276377|NCT00447057|11491046|FG000|Overall Study|Death, study drug related|0
7276378|NCT00447057|11491047|FG001|Overall Study|Death, study drug related|1
7276379|NCT00447057|11491048|FG002|Overall Study|Death, study drug related|0
7276380|NCT00447057|11491049|FG003|Overall Study|Death, study drug related|0
7276381|NCT00447226|11491070|FG000|12-Week Open-label Phase|Adverse Event|0
7276382|NCT00447226|11491071|FG001|12-Week Open-label Phase|Adverse Event|3
7276383|NCT00447226|11491070|FG000|12-Week Open-label Phase|Protocol Violation|0
7276384|NCT00447226|11491071|FG001|12-Week Open-label Phase|Protocol Violation|1
7276385|NCT00447226|11491070|FG000|12-Week Open-label Phase|Disease Progression|0
7276386|NCT00447226|11491071|FG001|12-Week Open-label Phase|Disease Progression|20
7276387|NCT00447226|11491070|FG000|12-Week Open-label Phase|Physician Decision|0
7276388|NCT00447226|11491071|FG001|12-Week Open-label Phase|Physician Decision|1
7608519|NCT01400776|12016575|FG001|Overall Study|Protocol Deviation|1
7276389|NCT00447226|11491070|FG000|Double-blind Phase|Disease Progression|4
7276390|NCT00447226|11491071|FG001|Double-blind Phase|Disease Progression|3
7608520|NCT01400776|12016576|FG002|Overall Study|Protocol Deviation|5
7608521|NCT01400776|12016577|FG003|Overall Study|Protocol Deviation|2
7608522|NCT01400776|12016574|FG000|Overall Study|Reason not Specified|3
7608523|NCT01400776|12016575|FG001|Overall Study|Reason not Specified|0
7608524|NCT01400776|12016576|FG002|Overall Study|Reason not Specified|4
7608525|NCT01400776|12016577|FG003|Overall Study|Reason not Specified|3
7608526|NCT00511134|12016589|FG000|Overall Study|Withdrawal by Subject|0
7608527|NCT00511134|12016590|FG001|Overall Study|Withdrawal by Subject|2
7276391|NCT00447265|11491086|FG000|Overall Study|Physician Decision|1
7276392|NCT00447265|11491087|FG001|Overall Study|Physician Decision|0
7276393|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Adverse Event|7
7276394|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Adverse Event|3
7276395|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
7276396|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
7276397|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
7276398|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
7276399|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
7276400|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
7276401|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Physician Decision|4
7276402|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Physician Decision|1
7276403|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
7276404|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
7276405|NCT00447278|11491093|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
7276406|NCT00447278|11491094|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
7276407|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
7608558|NCT03725293|12016642|FG000|Overall Study|Physician Decision|9
7608559|NCT03725293|12016643|FG001|Overall Study|Physician Decision|6
7608560|NCT03725293|12016642|FG000|Overall Study|alternative vascular access needs|1
7608561|NCT03725293|12016643|FG001|Overall Study|alternative vascular access needs|2
7608562|NCT03725293|12016642|FG000|Overall Study|venous anatomy screen failures|2
7608563|NCT03725293|12016643|FG001|Overall Study|venous anatomy screen failures|1
7608564|NCT03702231|12016652|FG000|Overall Study|Withdrawal by Subject|1
7608565|NCT03702231|12016653|FG001|Overall Study|Withdrawal by Subject|0
7608566|NCT03702231|12016654|FG002|Overall Study|Withdrawal by Subject|0
7608567|NCT03702231|12016652|FG000|Overall Study|Protocol Violation|0
7608568|NCT03702231|12016653|FG001|Overall Study|Protocol Violation|0
7608569|NCT03702231|12016654|FG002|Overall Study|Protocol Violation|1
7608570|NCT03702231|12016652|FG000|Overall Study|COVID Pandemic|3
7608571|NCT03702231|12016653|FG001|Overall Study|COVID Pandemic|4
7608572|NCT03702231|12016654|FG002|Overall Study|COVID Pandemic|1
7608573|NCT03556358|12016685|FG000|Overall Study|Subjects Randomized that did not Treat|3
7608574|NCT03556358|12016686|FG001|Overall Study|Subjects Randomized that did not Treat|0
7608575|NCT03556358|12016685|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
7608576|NCT03556358|12016686|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
7608577|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
7608578|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
7608579|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
7608580|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
7608581|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
7608582|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
7608583|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
7608584|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
7608585|NCT03556358|12016685|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
7608586|NCT03556358|12016686|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
7608587|NCT03290781|12016699|FG000|Overall Study|Adverse Event|5
7608588|NCT03290781|12016700|FG001|Overall Study|Adverse Event|7
7608589|NCT03290781|12016701|FG002|Overall Study|Adverse Event|4
7608590|NCT03290781|12016702|FG003|Overall Study|Adverse Event|1
7608591|NCT03290781|12016703|FG004|Overall Study|Adverse Event|0
7608592|NCT03290781|12016704|FG005|Overall Study|Adverse Event|0
7608593|NCT03290781|12016705|FG006|Overall Study|Adverse Event|0
7608594|NCT03290781|12016699|FG000|Overall Study|Death|0
7608595|NCT03290781|12016700|FG001|Overall Study|Death|0
7608596|NCT03290781|12016701|FG002|Overall Study|Death|1
7276408|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
7276409|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7276410|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
7276411|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
7276412|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
7276413|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
7608597|NCT03290781|12016702|FG003|Overall Study|Death|0
7608598|NCT03290781|12016703|FG004|Overall Study|Death|1
7608599|NCT03290781|12016704|FG005|Overall Study|Death|0
7608600|NCT03290781|12016705|FG006|Overall Study|Death|0
7608601|NCT03290781|12016699|FG000|Overall Study|Withdrawal by Subject|6
7608602|NCT03290781|12016700|FG001|Overall Study|Withdrawal by Subject|5
7276414|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
7608603|NCT03290781|12016701|FG002|Overall Study|Withdrawal by Subject|9
7608604|NCT03290781|12016702|FG003|Overall Study|Withdrawal by Subject|10
7608605|NCT03290781|12016703|FG004|Overall Study|Withdrawal by Subject|1
7608606|NCT03290781|12016704|FG005|Overall Study|Withdrawal by Subject|2
7608607|NCT03290781|12016705|FG006|Overall Study|Withdrawal by Subject|0
7608608|NCT03290781|12016699|FG000|Overall Study|Physician Decision|0
7608609|NCT03290781|12016700|FG001|Overall Study|Physician Decision|1
7608610|NCT03290781|12016701|FG002|Overall Study|Physician Decision|0
7608611|NCT03290781|12016702|FG003|Overall Study|Physician Decision|0
7608612|NCT03290781|12016703|FG004|Overall Study|Physician Decision|0
7608613|NCT03290781|12016704|FG005|Overall Study|Physician Decision|0
7608614|NCT03290781|12016705|FG006|Overall Study|Physician Decision|0
7608615|NCT03290781|12016699|FG000|Overall Study|Site Terminated by Sponsor|1
7608616|NCT03290781|12016700|FG001|Overall Study|Site Terminated by Sponsor|0
7608617|NCT03290781|12016701|FG002|Overall Study|Site Terminated by Sponsor|2
7608618|NCT03290781|12016702|FG003|Overall Study|Site Terminated by Sponsor|1
7608619|NCT03290781|12016703|FG004|Overall Study|Site Terminated by Sponsor|0
7608620|NCT03290781|12016704|FG005|Overall Study|Site Terminated by Sponsor|0
7608621|NCT03290781|12016705|FG006|Overall Study|Site Terminated by Sponsor|0
7608622|NCT03290781|12016699|FG000|Overall Study|Lost to Follow-up|0
7608623|NCT03290781|12016700|FG001|Overall Study|Lost to Follow-up|0
7608624|NCT03290781|12016701|FG002|Overall Study|Lost to Follow-up|0
7608625|NCT03290781|12016702|FG003|Overall Study|Lost to Follow-up|1
7608626|NCT03290781|12016703|FG004|Overall Study|Lost to Follow-up|0
7608627|NCT03290781|12016704|FG005|Overall Study|Lost to Follow-up|0
7608628|NCT03290781|12016705|FG006|Overall Study|Lost to Follow-up|0
7608629|NCT03290781|12016699|FG000|Overall Study|Protocol Deviation|2
7608630|NCT03290781|12016700|FG001|Overall Study|Protocol Deviation|0
7608631|NCT03290781|12016701|FG002|Overall Study|Protocol Deviation|0
7608632|NCT03290781|12016702|FG003|Overall Study|Protocol Deviation|1
7608633|NCT03290781|12016703|FG004|Overall Study|Protocol Deviation|0
7608634|NCT03290781|12016704|FG005|Overall Study|Protocol Deviation|0
7608635|NCT03290781|12016705|FG006|Overall Study|Protocol Deviation|0
7608636|NCT03290781|12016699|FG000|Overall Study|Disease Relapse|32
7608637|NCT03290781|12016700|FG001|Overall Study|Disease Relapse|5
7608638|NCT03290781|12016701|FG002|Overall Study|Disease Relapse|38
7608639|NCT03290781|12016702|FG003|Overall Study|Disease Relapse|7
7608640|NCT03290781|12016703|FG004|Overall Study|Disease Relapse|3
7608641|NCT03290781|12016704|FG005|Overall Study|Disease Relapse|1
7608642|NCT03290781|12016705|FG006|Overall Study|Disease Relapse|4
7608643|NCT03290781|12016699|FG000|Overall Study|Other|3
7608644|NCT03290781|12016700|FG001|Overall Study|Other|0
7608645|NCT03290781|12016701|FG002|Overall Study|Other|2
7608646|NCT03290781|12016702|FG003|Overall Study|Other|2
7608647|NCT03290781|12016703|FG004|Overall Study|Other|0
7608648|NCT03290781|12016704|FG005|Overall Study|Other|0
7608649|NCT03290781|12016705|FG006|Overall Study|Other|0
7608650|NCT03228680|12016764|FG000|Overall Study|Adverse Event|13
7608651|NCT03228680|12016765|FG001|Overall Study|Adverse Event|18
7608652|NCT03228680|12016764|FG000|Overall Study|Randomization failure|0
7608653|NCT03228680|12016765|FG001|Overall Study|Randomization failure|1
7608654|NCT03228680|12016764|FG000|Overall Study|Withdrawal by Subject|1
7608655|NCT03228680|12016765|FG001|Overall Study|Withdrawal by Subject|0
7608656|NCT03228680|12016764|FG000|Overall Study|Other|9
7608657|NCT03228680|12016765|FG001|Overall Study|Other|16
7608658|NCT02679781|12016805|FG000|Overall Study|Lost to Follow-up|1
7608659|NCT02679781|12016806|FG001|Overall Study|Lost to Follow-up|2
7608660|NCT02679781|12016805|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
7608661|NCT02679781|12016806|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
7608662|NCT02624869|12016815|FG000|Overall Study|Lost to Follow-up|0
7608663|NCT02624869|12016816|FG001|Overall Study|Lost to Follow-up|0
7608664|NCT02624869|12016817|FG002|Overall Study|Lost to Follow-up|1
7608665|NCT02624869|12016815|FG000|Overall Study|Withdrawal by Subject|1
7608666|NCT02624869|12016816|FG001|Overall Study|Withdrawal by Subject|3
7608667|NCT02624869|12016817|FG002|Overall Study|Withdrawal by Subject|1
7608668|NCT02435433|12016856|FG000|Overall Study|On Treatment|11
7608669|NCT02435433|12016857|FG001|Overall Study|On Treatment|0
7608670|NCT02435433|12016858|FG002|Overall Study|On Treatment|0
7608671|NCT02435433|12016859|FG003|Overall Study|On Treatment|0
7608672|NCT02435433|12016860|FG004|Overall Study|On Treatment|0
7608673|NCT02435433|12016856|FG000|Overall Study|Withdrawal by Subject|2
7608674|NCT02435433|12016857|FG001|Overall Study|Withdrawal by Subject|3
7608675|NCT02435433|12016858|FG002|Overall Study|Withdrawal by Subject|0
7608676|NCT02435433|12016859|FG003|Overall Study|Withdrawal by Subject|0
7608677|NCT02435433|12016860|FG004|Overall Study|Withdrawal by Subject|0
7608678|NCT02435433|12016856|FG000|Overall Study|Lost to Follow-up|2
7608679|NCT02435433|12016857|FG001|Overall Study|Lost to Follow-up|2
7608680|NCT02435433|12016858|FG002|Overall Study|Lost to Follow-up|0
7608681|NCT02435433|12016859|FG003|Overall Study|Lost to Follow-up|0
7608682|NCT02435433|12016860|FG004|Overall Study|Lost to Follow-up|0
7276415|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
7276416|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
7276417|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
7276418|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
7276419|NCT00447278|11491093|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
7276420|NCT00447278|11491094|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
7276421|NCT00447382|11491108|FG000|Overall Study|Adverse Event|1
7276422|NCT00447382|11491109|FG001|Overall Study|Adverse Event|1
7276423|NCT00447382|11491108|FG000|Overall Study|Lack of Efficacy|1
7276424|NCT00447382|11491109|FG001|Overall Study|Lack of Efficacy|0
7276425|NCT00447382|11491108|FG000|Overall Study|Protocol Violation|2
7276426|NCT00447382|11491109|FG001|Overall Study|Protocol Violation|0
7276427|NCT00447382|11491108|FG000|Overall Study|Unclassified|2
7276428|NCT00447382|11491109|FG001|Overall Study|Unclassified|5
7276429|NCT00447499|11491115|FG000|Overall Study|Adverse Event|1
7276430|NCT00447499|11491115|FG000|Overall Study|Patient Decision|4
7276431|NCT00447499|11491115|FG000|Overall Study|Sponsor Decision|1
7276432|NCT00447499|11491115|FG000|Overall Study|Physician Decision|1
7276433|NCT00447590|11491121|FG000|Overall Study|Withdrawal by Subject|26
7276434|NCT00447590|11491121|FG000|Overall Study|Lost to Follow-up|24
7276435|NCT00447590|11491121|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
7276436|NCT00447694|11491125|FG000|Overall Study|Adverse Event|2
7276437|NCT00447694|11491125|FG000|Overall Study|Abnormal laboratory value|1
7276438|NCT00447694|11491125|FG000|Overall Study|Abnormal test procedure result|1
7276439|NCT00447694|11491125|FG000|Overall Study|Withdrawal by Subject|2
7276440|NCT00447772|11491129|FG000|Overall Study|Lack of Efficacy|3
7608689|NCT02368886|12016892|FG000|Overall Study|Cancel|1
7608690|NCT02368886|12016893|FG001|Overall Study|Cancel|1
7608691|NCT02368886|12016894|FG002|Overall Study|Cancel|1
7608692|NCT02368886|12016895|FG003|Overall Study|Cancel|3
7608693|NCT02368886|12016892|FG000|Overall Study|Ineligible|0
7608694|NCT02368886|12016893|FG001|Overall Study|Ineligible|0
7608695|NCT02368886|12016894|FG002|Overall Study|Ineligible|0
7608696|NCT02368886|12016895|FG003|Overall Study|Ineligible|1
7608697|NCT02354703|12016907|FG000|Overall Study|Withdrawal by Subject|1
7608698|NCT02354703|12016908|FG001|Overall Study|Withdrawal by Subject|1
7608699|NCT02354703|12016909|FG002|Overall Study|Withdrawal by Subject|1
7608700|NCT02354703|12016910|FG003|Overall Study|Withdrawal by Subject|1
7608701|NCT02354703|12016907|FG000|Overall Study|Lost to Follow-up|2
7608702|NCT02354703|12016908|FG001|Overall Study|Lost to Follow-up|7
7608703|NCT02354703|12016909|FG002|Overall Study|Lost to Follow-up|9
7608704|NCT02354703|12016910|FG003|Overall Study|Lost to Follow-up|2
7608705|NCT02354703|12016907|FG000|Overall Study|Adverse Event|0
7608706|NCT02354703|12016908|FG001|Overall Study|Adverse Event|0
7608707|NCT02354703|12016909|FG002|Overall Study|Adverse Event|1
7608708|NCT02354703|12016910|FG003|Overall Study|Adverse Event|0
7608709|NCT01981551|12016922|FG000|Overall Study|Refused further treatment|8
7608710|NCT01981551|12016922|FG000|Overall Study|Adverse Event|1
7276441|NCT00447772|11491129|FG000|Overall Study|Insufficient compliance|6
7608711|NCT00468130|12016932|FG000|Overall Study|Adverse Event|2
7608712|NCT00468130|12016933|FG001|Overall Study|Adverse Event|1
7608713|NCT00468130|12016932|FG000|Overall Study|Withdrawal by Subject|0
7608714|NCT00468130|12016933|FG001|Overall Study|Withdrawal by Subject|1
7608715|NCT00384111|12016941|FG000|Overall Study|Disease Progression|3
7608716|NCT00384111|12016941|FG000|Overall Study|Adverse Event|1
7608717|NCT00384111|12016941|FG000|Overall Study|Investigator Decision|3
7608718|NCT00384111|12016941|FG000|Overall Study|Study Terminated by the Sponsor|19
7276442|NCT00447772|11491129|FG000|Overall Study|Discontinuation of drug therapy|1
7276443|NCT00447772|11491129|FG000|Overall Study|Lost to Follow-up|9
7276444|NCT00447772|11491129|FG000|Overall Study|Withdrawal by Subject|1
7276445|NCT00447772|11491129|FG000|Overall Study|Unable to attend all study visits|2
7276446|NCT00447772|11491129|FG000|Overall Study|Adverse Event|1
7276447|NCT00447772|11491129|FG000|Overall Study|Patient relocated|1
7276448|NCT00447772|11491129|FG000|Overall Study|Incomplete documentation at visit 1|1
7276449|NCT00447772|11491129|FG000|Overall Study|Chemotherapy for lung cancer|1
7276450|NCT00447772|11491129|FG000|Overall Study|Premature re-injection required|1
7276451|NCT00447876|11491138|FG000|Overall Study|Withdrawal by Subject|1
7276452|NCT00447876|11491139|FG001|Overall Study|Withdrawal by Subject|4
7276453|NCT00447876|11491138|FG000|Overall Study|Lost to Follow-up|1
7608719|NCT04854642|12016945|FG000|Overall Study|Adverse Event|1
7608720|NCT04854642|12016946|FG001|Overall Study|Adverse Event|2
7608721|NCT04854642|12016945|FG000|Overall Study|Withdrawal by Subject|0
7608722|NCT04854642|12016946|FG001|Overall Study|Withdrawal by Subject|1
7608723|NCT04388787|12016967|FG000|Blinded Period|Patient could not follow instructions|1
7608724|NCT04388787|12016967|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
7608725|NCT04377620|12016991|FG000|Overall Study|Death|42
7608726|NCT04377620|12016992|FG001|Overall Study|Death|48
7608727|NCT04377620|12016993|FG002|Overall Study|Death|36
7608728|NCT04377620|12016991|FG000|Overall Study|Withdrawal by Subject|0
7608729|NCT04377620|12016992|FG001|Overall Study|Withdrawal by Subject|2
7608730|NCT04377620|12016993|FG002|Overall Study|Withdrawal by Subject|0
7608731|NCT04310566|12017024|FG000|Period 1|Study Termination due to COVID-19|15
7608732|NCT04310566|12017025|FG001|Period 1|Study Termination due to COVID-19|17
7608733|NCT04310566|12017024|FG000|Period 1|Protocol Violation|0
7608734|NCT04310566|12017025|FG001|Period 1|Protocol Violation|1
7608735|NCT04310566|12017024|FG000|Period 1|Subject no longer meets eligbility criteria|0
7608736|NCT04310566|12017025|FG001|Period 1|Subject no longer meets eligbility criteria|1
7608737|NCT04310566|12017024|FG000|Period 1|Lost to Follow-up|1
7608738|NCT04310566|12017025|FG001|Period 1|Lost to Follow-up|0
7608739|NCT04310566|12017024|FG000|Period 1|Withdrawal by Subject|0
7608740|NCT04310566|12017025|FG001|Period 1|Withdrawal by Subject|1
7608741|NCT04310566|12017024|FG000|Period 2|Study Termination|7
7608742|NCT04310566|12017025|FG001|Period 2|Study Termination|5
7608743|NCT04206020|12017033|FG000|Overall Study|Adverse Event|1
7608744|NCT04206020|12017034|FG001|Overall Study|Adverse Event|4
7608745|NCT04206020|12017033|FG000|Overall Study|Protocol Violation|2
7608746|NCT04206020|12017034|FG001|Overall Study|Protocol Violation|0
7608747|NCT04206020|12017033|FG000|Overall Study|Withdrawal by Subject|2
7608748|NCT04206020|12017034|FG001|Overall Study|Withdrawal by Subject|0
7608749|NCT04206020|12017033|FG000|Overall Study|Lost to Follow-up|2
7608750|NCT04206020|12017034|FG001|Overall Study|Lost to Follow-up|0
7608751|NCT04206020|12017033|FG000|Overall Study|Pregnancy|0
7608752|NCT04206020|12017034|FG001|Overall Study|Pregnancy|1
7608753|NCT04206020|12017033|FG000|Overall Study|Unable to attend visits|1
7608754|NCT04206020|12017034|FG001|Overall Study|Unable to attend visits|2
7608755|NCT04097301|12017040|FG000|Overall Study|Death|1
7608756|NCT04097301|12017040|FG000|Overall Study|Withdrawal by Subject|1
7608757|NCT04097301|12017040|FG000|Overall Study|Screening Failure|5
7608758|NCT03953079|12017053|FG000|Core Study|Withdrawal by Subject|1
7608759|NCT03953079|12017054|FG001|Core Study|Withdrawal by Subject|2
7608760|NCT03953079|12017055|FG002|Core Study|Withdrawal by Subject|1
7608761|NCT03953079|12017053|FG000|Core Study|COVID-19|0
7608762|NCT03953079|12017054|FG001|Core Study|COVID-19|1
7608763|NCT03953079|12017055|FG002|Core Study|COVID-19|0
7608764|NCT03953079|12017053|FG000|Core Study|Difficulties leaving the house|0
7608765|NCT03953079|12017054|FG001|Core Study|Difficulties leaving the house|1
7608766|NCT03953079|12017055|FG002|Core Study|Difficulties leaving the house|0
7608767|NCT03953079|12017053|FG000|Extension Study|Withdrawal by Subject|1
7608768|NCT03953079|12017054|FG001|Extension Study|Withdrawal by Subject|0
7608769|NCT03953079|12017055|FG002|Extension Study|Withdrawal by Subject|0
7608770|NCT03953079|12017053|FG000|Extension Study|Received Rescue Treatment|5
7608771|NCT03953079|12017054|FG001|Extension Study|Received Rescue Treatment|6
7608772|NCT03953079|12017055|FG002|Extension Study|Received Rescue Treatment|5
7608773|NCT03922750|12017067|FG000|Overall Study|Unclassified|0
7608774|NCT03922750|12017068|FG001|Overall Study|Unclassified|0
7608775|NCT03922750|12017069|FG002|Overall Study|Unclassified|1
7608776|NCT03922750|12017067|FG000|Overall Study|Adverse Event|0
7608777|NCT03922750|12017068|FG001|Overall Study|Adverse Event|1
7608778|NCT03922750|12017069|FG002|Overall Study|Adverse Event|0
7608779|NCT03910673|12017082|FG000|Overall Study|Adverse Event|0
7608780|NCT03910673|12017083|FG001|Overall Study|Adverse Event|0
7608781|NCT03910673|12017084|FG002|Overall Study|Adverse Event|0
7608782|NCT03910673|12017085|FG003|Overall Study|Adverse Event|2
7608783|NCT03910673|12017086|FG004|Overall Study|Adverse Event|0
7608784|NCT03885999|12017090|FG000|Overall Study|Adverse Event|1
7608785|NCT03882970|12017098|FG000|Overall Study|Adverse Event|5
7608786|NCT03882970|12017099|FG001|Overall Study|Adverse Event|7
7608787|NCT03882970|12017100|FG002|Overall Study|Adverse Event|3
7608788|NCT03882970|12017101|FG003|Overall Study|Adverse Event|1
7608789|NCT03882970|12017098|FG000|Overall Study|Death|1
7608790|NCT03882970|12017099|FG001|Overall Study|Death|2
7608791|NCT03882970|12017100|FG002|Overall Study|Death|1
7608792|NCT03882970|12017101|FG003|Overall Study|Death|1
7608793|NCT03882970|12017098|FG000|Overall Study|Lost to Follow-up|8
7608794|NCT03882970|12017099|FG001|Overall Study|Lost to Follow-up|9
7608795|NCT03882970|12017100|FG002|Overall Study|Lost to Follow-up|5
7608796|NCT03882970|12017101|FG003|Overall Study|Lost to Follow-up|5
7608797|NCT03882970|12017098|FG000|Overall Study|Physician Decision|0
7608798|NCT03882970|12017099|FG001|Overall Study|Physician Decision|2
7608799|NCT03882970|12017100|FG002|Overall Study|Physician Decision|2
7608800|NCT03882970|12017101|FG003|Overall Study|Physician Decision|2
7608801|NCT03882970|12017098|FG000|Overall Study|Protocol Violation|2
7608802|NCT03882970|12017099|FG001|Overall Study|Protocol Violation|0
7608803|NCT03882970|12017100|FG002|Overall Study|Protocol Violation|0
7608804|NCT03882970|12017101|FG003|Overall Study|Protocol Violation|0
7608805|NCT03882970|12017098|FG000|Overall Study|Withdrawal by Subject|8
7608806|NCT03882970|12017099|FG001|Overall Study|Withdrawal by Subject|17
7608807|NCT03882970|12017100|FG002|Overall Study|Withdrawal by Subject|7
7608808|NCT03882970|12017101|FG003|Overall Study|Withdrawal by Subject|22
7608809|NCT03882970|12017098|FG000|Overall Study|Personal Reason|2
7608810|NCT03882970|12017099|FG001|Overall Study|Personal Reason|3
7608811|NCT03882970|12017100|FG002|Overall Study|Personal Reason|1
7608812|NCT03882970|12017101|FG003|Overall Study|Personal Reason|3
7608813|NCT03867734|12017125|FG000|Overall Study|Lost to Follow-up|2
7608814|NCT03781778|12017135|FG000|Overall Study|Withdrawal by Subject|2
7608815|NCT03781778|12017136|FG001|Overall Study|Withdrawal by Subject|2
7276454|NCT00447876|11491139|FG001|Overall Study|Lost to Follow-up|0
7276455|NCT00447876|11491138|FG000|Overall Study|Deterioration of symptomology|1
7276456|NCT00447876|11491139|FG001|Overall Study|Deterioration of symptomology|0
7276457|NCT00447902|11491147|FG000|Overall Study|Adverse Event|0
7276458|NCT00447902|11491148|FG001|Overall Study|Adverse Event|3
7276459|NCT00447902|11491147|FG000|Overall Study|Protocol Violation|1
7276460|NCT00447902|11491148|FG001|Overall Study|Protocol Violation|0
7276461|NCT00447902|11491147|FG000|Overall Study|Withdrawal by Subject|0
7276462|NCT00447902|11491148|FG001|Overall Study|Withdrawal by Subject|1
7276463|NCT00447902|11491147|FG000|Overall Study|included patients who discontinued|1
7276464|NCT00447902|11491148|FG001|Overall Study|included patients who discontinued|1
7276465|NCT00447902|11491147|FG000|Overall Study|Lack of Efficacy|2
7276466|NCT00447902|11491148|FG001|Overall Study|Lack of Efficacy|1
7276467|NCT00448019|11491154|FG000|Overall Study|Withdrawal by Subject|3
7276468|NCT00448019|11491154|FG000|Overall Study|Disease progression|1
7276469|NCT00448019|11491154|FG000|Overall Study|Death|2
7276470|NCT00448019|11491154|FG000|Overall Study|Insurance Issues|1
7276471|NCT00448123|11491160|FG000|Overall Study|Lost to Follow-up|9
7276472|NCT00448123|11491161|FG001|Overall Study|Lost to Follow-up|6
7276473|NCT00448123|11491160|FG000|Overall Study|Physician Decision|6
7276474|NCT00448123|11491161|FG001|Overall Study|Physician Decision|6
7276475|NCT00448136|11491172|FG000|Overall Study|Death|3
7276476|NCT00448136|11491173|FG001|Overall Study|Death|8
7276477|NCT00448136|11491172|FG000|Overall Study|Investigator's decision (progression)|1
7276478|NCT00448136|11491173|FG001|Overall Study|Investigator's decision (progression)|0
7276479|NCT00448279|11491203|FG000|Overall Study|Lost to Follow-up|2
7276480|NCT00448279|11491204|FG001|Overall Study|Lost to Follow-up|2
7276481|NCT00448279|11491203|FG000|Overall Study|Adverse Event|1
7276482|NCT00448279|11491204|FG001|Overall Study|Adverse Event|1
7276483|NCT00448279|11491203|FG000|Overall Study|Disease progression|16
7276484|NCT00448279|11491204|FG001|Overall Study|Disease progression|18
7276485|NCT00448279|11491203|FG000|Overall Study|Withdrawal by Subject|4
7276486|NCT00448279|11491204|FG001|Overall Study|Withdrawal by Subject|3
7276487|NCT00448279|11491203|FG000|Overall Study|Other|6
7276488|NCT00448279|11491204|FG001|Overall Study|Other|4
7276489|NCT00448279|11491203|FG000|Overall Study|Protocol Violation|0
7276490|NCT00448279|11491204|FG001|Overall Study|Protocol Violation|1
7276491|NCT00448344|11491212|FG000|Overall Study|Lost to Follow-up|20
7608816|NCT03730480|12017155|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
7608817|NCT03713034|12017168|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
7608818|NCT03713034|12017169|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
7608819|NCT03654404|12017177|FG000|Overall Study|Death|1
7608820|NCT03654404|12017177|FG000|Overall Study|Lost to Follow-up|2
7608821|NCT03654404|12017177|FG000|Overall Study|Withdrawal by Subject|5
7608822|NCT03567057|12017184|FG000|Overall Study|Adverse Event|56
7608823|NCT03567057|12017185|FG001|Overall Study|Adverse Event|53
7608824|NCT03567057|12017186|FG002|Overall Study|Adverse Event|28
7608825|NCT03567057|12017184|FG000|Overall Study|Withdrawal by Subject|22
7276492|NCT00448344|11491213|FG001|Overall Study|Lost to Follow-up|22
7276493|NCT00448344|11491212|FG000|Overall Study|Withdrawal by Subject|6
7276494|NCT00448344|11491213|FG001|Overall Study|Withdrawal by Subject|8
7276495|NCT00448344|11491212|FG000|Overall Study|Death|3
7276496|NCT00448344|11491213|FG001|Overall Study|Death|4
7276497|NCT00448344|11491212|FG000|Overall Study|Physician Decision|1
7276498|NCT00448344|11491213|FG001|Overall Study|Physician Decision|2
7276499|NCT00448435|11491235|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
7276500|NCT00448435|11491236|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
7276501|NCT00448448|11491247|FG000|Overall Study|Withdrawal by Subject|13
7276502|NCT00448448|11491248|FG001|Overall Study|Withdrawal by Subject|2
7276503|NCT00448448|11491247|FG000|Overall Study|On protocol when study ended|83
7276504|NCT00448448|11491248|FG001|Overall Study|On protocol when study ended|36
7276505|NCT00448448|11491247|FG000|Overall Study|Lost to Follow-up|2
7276506|NCT00448448|11491248|FG001|Overall Study|Lost to Follow-up|1
7276507|NCT00448448|11491247|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
7276508|NCT00448448|11491248|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
7276509|NCT00448448|11491247|FG000|Overall Study|Signed consent lost|0
7276510|NCT00448448|11491248|FG001|Overall Study|Signed consent lost|1
7276511|NCT00448539|11491256|FG000|Overall Study|Medication non-compliance|4
7276512|NCT00448539|11491257|FG001|Overall Study|Medication non-compliance|1
7276513|NCT00448539|11491256|FG000|Overall Study|Protocol Violation|1
7276514|NCT00448539|11491257|FG001|Overall Study|Protocol Violation|0
7276515|NCT00448539|11491256|FG000|Overall Study|Request of the investigator or sponsor|67
7276516|NCT00448539|11491257|FG001|Overall Study|Request of the investigator or sponsor|54
7276517|NCT00448539|11491256|FG000|Overall Study|Withdrawal by Subject|20
7276518|NCT00448539|11491257|FG001|Overall Study|Withdrawal by Subject|24
7276519|NCT00448539|11491256|FG000|Overall Study|Diary non-compliance|1
7608826|NCT03567057|12017185|FG001|Overall Study|Withdrawal by Subject|24
7608827|NCT03567057|12017186|FG002|Overall Study|Withdrawal by Subject|13
7608828|NCT03567057|12017184|FG000|Overall Study|Lost to Follow-up|3
7608829|NCT03567057|12017185|FG001|Overall Study|Lost to Follow-up|5
7276520|NCT00448539|11491257|FG001|Overall Study|Diary non-compliance|0
7276521|NCT00448539|11491256|FG000|Overall Study|Adverse Event|9
7276522|NCT00448539|11491257|FG001|Overall Study|Adverse Event|26
7276523|NCT00448539|11491256|FG000|Overall Study|Lack of Efficacy|27
7276524|NCT00448539|11491257|FG001|Overall Study|Lack of Efficacy|40
7276525|NCT00448539|11491256|FG000|Overall Study|Miscellaneous|2
7276526|NCT00448539|11491257|FG001|Overall Study|Miscellaneous|1
7276527|NCT00448539|11491256|FG000|Overall Study|Change of meds|2
7608830|NCT03567057|12017186|FG002|Overall Study|Lost to Follow-up|2
7608831|NCT03567057|12017184|FG000|Overall Study|COVID-19 pandemic|4
7608832|NCT03567057|12017185|FG001|Overall Study|COVID-19 pandemic|3
7608833|NCT03567057|12017186|FG002|Overall Study|COVID-19 pandemic|0
7608834|NCT03567057|12017184|FG000|Overall Study|Non-compliance with study drug|4
7608835|NCT03567057|12017185|FG001|Overall Study|Non-compliance with study drug|2
7608836|NCT03567057|12017186|FG002|Overall Study|Non-compliance with study drug|0
7608837|NCT03567057|12017184|FG000|Overall Study|Lack of Efficacy|3
7608838|NCT03567057|12017185|FG001|Overall Study|Lack of Efficacy|0
7608839|NCT03567057|12017186|FG002|Overall Study|Lack of Efficacy|1
7608840|NCT03567057|12017184|FG000|Overall Study|Death|1
7608841|NCT03567057|12017185|FG001|Overall Study|Death|0
7608842|NCT03567057|12017186|FG002|Overall Study|Death|0
7608843|NCT03567057|12017184|FG000|Overall Study|Physician Decision|1
7608844|NCT03567057|12017185|FG001|Overall Study|Physician Decision|0
7608845|NCT03567057|12017186|FG002|Overall Study|Physician Decision|0
7608846|NCT03567057|12017184|FG000|Overall Study|Unstable medical condition|1
7608847|NCT03567057|12017185|FG001|Overall Study|Unstable medical condition|0
7608848|NCT03567057|12017186|FG002|Overall Study|Unstable medical condition|0
7608849|NCT03567057|12017184|FG000|Overall Study|Medical history event|0
7608850|NCT03567057|12017185|FG001|Overall Study|Medical history event|0
7608851|NCT03567057|12017186|FG002|Overall Study|Medical history event|1
7608852|NCT03567057|12017184|FG000|Overall Study|Other|0
7608853|NCT03567057|12017185|FG001|Overall Study|Other|0
7608854|NCT03567057|12017186|FG002|Overall Study|Other|1
7608855|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Other|9
7608856|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Other|0
7608857|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
7608858|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
7608859|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
7608860|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
7608861|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
7608862|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
7608863|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
7608864|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
7608865|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
7608866|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
7608867|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
7608868|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
7608869|NCT03548987|12017196|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
7608870|NCT03548987|12017197|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
7608871|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|other|12
7608872|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|other|23
7608873|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
7608874|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
7608875|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7608876|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
7608877|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
7608878|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
7608879|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
7608880|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
7608881|NCT03548987|12017196|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
7608882|NCT03548987|12017197|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
7608883|NCT03548064|12017212|FG000|Overall Study|Withdrawal by Subject|0
7608884|NCT03548064|12017213|FG001|Overall Study|Withdrawal by Subject|0
7608885|NCT03548064|12017214|FG002|Overall Study|Withdrawal by Subject|0
7608886|NCT03548064|12017215|FG003|Overall Study|Withdrawal by Subject|1
7608887|NCT03548064|12017216|FG004|Overall Study|Withdrawal by Subject|0
7608888|NCT03548064|12017217|FG005|Overall Study|Withdrawal by Subject|0
7608889|NCT03548064|12017218|FG006|Overall Study|Withdrawal by Subject|0
7608890|NCT03548064|12017219|FG007|Overall Study|Withdrawal by Subject|0
7608891|NCT03548064|12017212|FG000|Overall Study|Lost to Follow-up|0
7276528|NCT00448539|11491257|FG001|Overall Study|Change of meds|3
7276529|NCT00448539|11491256|FG000|Overall Study|Lost to Follow-up|1
7276530|NCT00448539|11491257|FG001|Overall Study|Lost to Follow-up|3
7276531|NCT00448591|11491263|FG000|Overall Study|Withdrawal by Subject|178
7276532|NCT00448591|11491263|FG000|Overall Study|Progressive Disease|1382
7608892|NCT03548064|12017213|FG001|Overall Study|Lost to Follow-up|0
7608893|NCT03548064|12017214|FG002|Overall Study|Lost to Follow-up|0
7608894|NCT03548064|12017215|FG003|Overall Study|Lost to Follow-up|0
7608895|NCT03548064|12017216|FG004|Overall Study|Lost to Follow-up|2
7608896|NCT03548064|12017217|FG005|Overall Study|Lost to Follow-up|0
7608897|NCT03548064|12017218|FG006|Overall Study|Lost to Follow-up|0
7608898|NCT03548064|12017219|FG007|Overall Study|Lost to Follow-up|0
7608899|NCT03548064|12017212|FG000|Overall Study|Covid-19 Pandemic|0
7608900|NCT03548064|12017213|FG001|Overall Study|Covid-19 Pandemic|0
7608901|NCT03548064|12017214|FG002|Overall Study|Covid-19 Pandemic|0
7608902|NCT03548064|12017215|FG003|Overall Study|Covid-19 Pandemic|0
7608903|NCT03548064|12017216|FG004|Overall Study|Covid-19 Pandemic|10
7608904|NCT03548064|12017217|FG005|Overall Study|Covid-19 Pandemic|3
7608905|NCT03548064|12017218|FG006|Overall Study|Covid-19 Pandemic|0
7608906|NCT03548064|12017219|FG007|Overall Study|Covid-19 Pandemic|0
7608907|NCT03446456|12017245|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
7608908|NCT03446456|12017246|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
7276533|NCT00448591|11491263|FG000|Overall Study|Adverse Event|382
7276534|NCT00448591|11491263|FG000|Overall Study|Protocol Violation|41
7276535|NCT00448591|11491263|FG000|Overall Study|Lost to Follow-up|19
7276536|NCT00448591|11491263|FG000|Overall Study|Treatment Regimen Completed|70
7276537|NCT00448591|11491263|FG000|Overall Study|Other|154
7276538|NCT00448591|11491263|FG000|Overall Study|Termination of Study|70
7276539|NCT00448669|11491271|FG000|Overall Study|Lost to Follow-up|52
7276540|NCT00448669|11491272|FG001|Overall Study|Lost to Follow-up|63
7276541|NCT00448669|11491271|FG000|Overall Study|Withdrawal by Subject|90
7276542|NCT00448669|11491272|FG001|Overall Study|Withdrawal by Subject|74
7608909|NCT03446456|12017245|FG000|Overall Study|Lost to Follow-up|1
7608910|NCT03446456|12017246|FG001|Overall Study|Lost to Follow-up|3
7608911|NCT03446456|12017245|FG000|Overall Study|Participant failed the toxicology test|1
7608912|NCT03446456|12017246|FG001|Overall Study|Participant failed the toxicology test|0
7608913|NCT03446456|12017245|FG000|Overall Study|Break down of the experimental equipment|1
7608914|NCT03446456|12017246|FG001|Overall Study|Break down of the experimental equipment|0
7608915|NCT03382834|12017254|FG000|Overall Study|Lost to Follow-up|1
7608916|NCT03382834|12017255|FG001|Overall Study|Lost to Follow-up|0
7608917|NCT03382834|12017254|FG000|Overall Study|Withdrawal by Subject|0
7608918|NCT03382834|12017255|FG001|Overall Study|Withdrawal by Subject|1
7608919|NCT03371823|12017263|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
7608920|NCT03371823|12017264|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
7608921|NCT03353350|12017274|FG000|30-week Core Treatment Period|Protocol Violation|1
7608922|NCT03353350|12017275|FG001|30-week Core Treatment Period|Protocol Violation|1
7608923|NCT03353350|12017276|FG002|30-week Core Treatment Period|Protocol Violation|1
7608924|NCT03353350|12017277|FG003|30-week Core Treatment Period|Protocol Violation|0
7608925|NCT03353350|12017274|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608926|NCT03353350|12017275|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608927|NCT03353350|12017276|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
7608928|NCT03353350|12017277|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
7608929|NCT03353350|12017274|FG000|30-week Core Treatment Period|Adverse Event|0
7608930|NCT03353350|12017275|FG001|30-week Core Treatment Period|Adverse Event|4
7608931|NCT03353350|12017276|FG002|30-week Core Treatment Period|Adverse Event|2
7608932|NCT03353350|12017277|FG003|30-week Core Treatment Period|Adverse Event|3
7608933|NCT03353350|12017274|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
7608934|NCT03353350|12017275|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
7608935|NCT03353350|12017276|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
7608936|NCT03353350|12017277|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
7608937|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Protocol Violation|2
7608938|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Protocol Violation|0
7608939|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Protocol Violation|0
7608940|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Protocol Violation|0
7608941|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
7608942|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
7608943|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
7276543|NCT00448669|11491271|FG000|Overall Study|Relocated|49
7276544|NCT00448669|11491272|FG001|Overall Study|Relocated|36
7608944|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
7608945|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Adverse Event|1
7608946|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Adverse Event|0
7608947|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Adverse Event|0
7608948|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Adverse Event|1
7608949|NCT03353350|12017274|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
7608950|NCT03353350|12017275|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
7608951|NCT03353350|12017276|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
7608952|NCT03353350|12017277|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
7608953|NCT03350503|12017287|FG000|Overall Study|Adverse Event|1
7608954|NCT03350503|12017287|FG000|Overall Study|Hospital Transfer or Removal|2
7608955|NCT03350503|12017287|FG000|Overall Study|Subject Wishes|2
7608959|NCT03282565|12017307|FG000|Overall Study|COVID-19 Research Shutdown|0
7608960|NCT03282565|12017308|FG001|Overall Study|COVID-19 Research Shutdown|2
7608961|NCT03282565|12017309|FG002|Overall Study|COVID-19 Research Shutdown|2
7608962|NCT03276936|12017319|FG000|Overall Study|Adverse Event|4
7608963|NCT03276936|12017320|FG001|Overall Study|Adverse Event|2
7608964|NCT03276936|12017319|FG000|Overall Study|Lost to Follow-up|16
7608965|NCT03276936|12017320|FG001|Overall Study|Lost to Follow-up|13
7608966|NCT03276936|12017319|FG000|Overall Study|Withdrawal by Subject|30
7608967|NCT03276936|12017320|FG001|Overall Study|Withdrawal by Subject|20
7608968|NCT03276936|12017319|FG000|Overall Study|Not mentioned|6
7608969|NCT03276936|12017320|FG001|Overall Study|Not mentioned|3
7608970|NCT03271021|12017328|FG000|Overall Study|Adverse Event|3
7608971|NCT03271021|12017329|FG001|Overall Study|Adverse Event|2
7608972|NCT03271021|12017328|FG000|Overall Study|Withdrawal by Subject|36
7608973|NCT03271021|12017329|FG001|Overall Study|Withdrawal by Subject|53
7608974|NCT03271021|12017328|FG000|Overall Study|Lost to Follow-up|34
7608975|NCT03271021|12017329|FG001|Overall Study|Lost to Follow-up|39
7608976|NCT03271021|12017328|FG000|Overall Study|Protocol Violation|6
7608977|NCT03271021|12017329|FG001|Overall Study|Protocol Violation|4
7608978|NCT03271021|12017328|FG000|Overall Study|Abnormal Lab Results|1
7608979|NCT03271021|12017329|FG001|Overall Study|Abnormal Lab Results|0
7608980|NCT03271021|12017328|FG000|Overall Study|Miscellaneous|9
7608981|NCT03271021|12017329|FG001|Overall Study|Miscellaneous|8
7608982|NCT03255083|12017339|FG000|Overall Study|Clinical progression|1
7608983|NCT03255083|12017340|FG001|Overall Study|Clinical progression|0
7608984|NCT03255083|12017341|FG002|Overall Study|Clinical progression|0
7608985|NCT03255083|12017342|FG003|Overall Study|Clinical progression|0
7608986|NCT03255083|12017339|FG000|Overall Study|Adverse Event|0
7608987|NCT03255083|12017340|FG001|Overall Study|Adverse Event|1
7608988|NCT03255083|12017341|FG002|Overall Study|Adverse Event|0
7608989|NCT03255083|12017342|FG003|Overall Study|Adverse Event|0
7608990|NCT03255083|12017339|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
7608991|NCT03255083|12017340|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
7608992|NCT03255083|12017341|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
7608993|NCT03255083|12017342|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
7608994|NCT03255083|12017339|FG000|Overall Study|Withdrawal by Subject|1
7608995|NCT03255083|12017340|FG001|Overall Study|Withdrawal by Subject|1
7608996|NCT03255083|12017341|FG002|Overall Study|Withdrawal by Subject|1
7608997|NCT03255083|12017342|FG003|Overall Study|Withdrawal by Subject|0
7608998|NCT03227471|12017367|FG000|Overall Study|Withdrawal by Subject|0
7608999|NCT03227471|12017368|FG001|Overall Study|Withdrawal by Subject|0
7609000|NCT03227471|12017369|FG002|Overall Study|Withdrawal by Subject|0
7609001|NCT03227471|12017370|FG003|Overall Study|Withdrawal by Subject|0
7609002|NCT03227471|12017371|FG004|Overall Study|Withdrawal by Subject|1
7609003|NCT03227471|12017372|FG005|Overall Study|Withdrawal by Subject|0
7609004|NCT03227471|12017373|FG006|Overall Study|Withdrawal by Subject|0
7609005|NCT03227471|12017374|FG007|Overall Study|Withdrawal by Subject|0
7609006|NCT03227471|12017375|FG008|Overall Study|Withdrawal by Subject|0
7609007|NCT03227471|12017376|FG009|Overall Study|Withdrawal by Subject|0
7609008|NCT03227471|12017377|FG010|Overall Study|Withdrawal by Subject|0
7609009|NCT03227471|12017378|FG011|Overall Study|Withdrawal by Subject|0
7609010|NCT03227471|12017379|FG012|Overall Study|Withdrawal by Subject|1
7609011|NCT03227471|12017380|FG013|Overall Study|Withdrawal by Subject|0
7609012|NCT03227471|12017381|FG014|Overall Study|Withdrawal by Subject|0
7609013|NCT03227471|12017367|FG000|Overall Study|Randomized, Never Dosed|0
7609014|NCT03227471|12017368|FG001|Overall Study|Randomized, Never Dosed|0
7609015|NCT03227471|12017369|FG002|Overall Study|Randomized, Never Dosed|0
7609016|NCT03227471|12017370|FG003|Overall Study|Randomized, Never Dosed|0
7609017|NCT03227471|12017371|FG004|Overall Study|Randomized, Never Dosed|0
7609018|NCT03227471|12017372|FG005|Overall Study|Randomized, Never Dosed|0
7609019|NCT03227471|12017373|FG006|Overall Study|Randomized, Never Dosed|0
7609020|NCT03227471|12017374|FG007|Overall Study|Randomized, Never Dosed|0
7609021|NCT03227471|12017375|FG008|Overall Study|Randomized, Never Dosed|0
7609022|NCT03227471|12017376|FG009|Overall Study|Randomized, Never Dosed|0
7609023|NCT03227471|12017377|FG010|Overall Study|Randomized, Never Dosed|0
7609024|NCT03227471|12017378|FG011|Overall Study|Randomized, Never Dosed|0
7609025|NCT03227471|12017379|FG012|Overall Study|Randomized, Never Dosed|0
7609026|NCT03227471|12017380|FG013|Overall Study|Randomized, Never Dosed|0
7609027|NCT03227471|12017381|FG014|Overall Study|Randomized, Never Dosed|1
7609042|NCT03194321|12017453|FG000|Overall Study|Withdrawal by Subject|1
7609043|NCT03194321|12017453|FG000|Overall Study|Lost to Follow-up|1
7609044|NCT03194321|12017453|FG000|Overall Study|Travel for Follow-up|1
7609045|NCT03085095|12017459|FG000|Overall Study|Adverse Event|23
7276545|NCT00448669|11491271|FG000|Overall Study|Were withdrawn by investigator|10
7276546|NCT00448669|11491272|FG001|Overall Study|Were withdrawn by investigator|6
7276547|NCT00448669|11491271|FG000|Overall Study|Death|2
7276548|NCT00448669|11491272|FG001|Overall Study|Death|4
7276549|NCT00448669|11491271|FG000|Overall Study|Had other reasons|5
7276550|NCT00448669|11491272|FG001|Overall Study|Had other reasons|6
7276551|NCT00448669|11491271|FG000|Overall Study|HIV-infected at enrollment|1
7276552|NCT00448669|11491272|FG001|Overall Study|HIV-infected at enrollment|2
7276553|NCT00448669|11491271|FG000|Overall Study|Never started drug|9
7276554|NCT00448669|11491272|FG001|Overall Study|Never started drug|7
7276555|NCT00448708|11491282|FG000|Overall Study|Death|21
7276556|NCT00448708|11491283|FG001|Overall Study|Death|17
7276557|NCT00448708|11491282|FG000|Overall Study|Withdrawal by Subject|8
7276558|NCT00448708|11491283|FG001|Overall Study|Withdrawal by Subject|4
7276559|NCT00448708|11491282|FG000|Overall Study|Lost to Follow-up|6
7276560|NCT00448708|11491283|FG001|Overall Study|Lost to Follow-up|8
7276561|NCT00448708|11491282|FG000|Overall Study|not listed|0
7276562|NCT00448708|11491283|FG001|Overall Study|not listed|2
7276563|NCT00448747|11491291|FG000|Overall Study|collapsed veins|1
7276564|NCT00448747|11491292|FG001|Overall Study|collapsed veins|0
7276565|NCT00448760|11491308|FG000|Overall Study|Death|3
7276566|NCT00448812|11491314|FG000|Year 2|Missed visit but remained in study|4
7609046|NCT03085095|12017460|FG001|Overall Study|Adverse Event|8
7276567|NCT00448812|11491315|FG001|Year 2|Missed visit but remained in study|1
7609047|NCT03085095|12017459|FG000|Overall Study|Protocol Violation|0
7609048|NCT03085095|12017460|FG001|Overall Study|Protocol Violation|1
7609049|NCT03085095|12017459|FG000|Overall Study|Lost to Follow-up|2
7609050|NCT03085095|12017460|FG001|Overall Study|Lost to Follow-up|1
7276568|NCT00448812|11491314|FG000|Year 3|Withdrawal by Subject|1
7276569|NCT00448812|11491315|FG001|Year 3|Withdrawal by Subject|3
7276570|NCT00448812|11491314|FG000|Year 3|Lost to Follow-up|1
7609051|NCT03085095|12017459|FG000|Overall Study|Withdrawal by Subject|17
7609052|NCT03085095|12017460|FG001|Overall Study|Withdrawal by Subject|6
7609053|NCT03085095|12017459|FG000|Overall Study|Physician Decision|9
7609054|NCT03085095|12017460|FG001|Overall Study|Physician Decision|3
7609055|NCT03085095|12017459|FG000|Overall Study|Testosterone Suppression Level Not Met|7
7609056|NCT03085095|12017460|FG001|Overall Study|Testosterone Suppression Level Not Met|13
7609057|NCT03085095|12017459|FG000|Overall Study|Did not Receive Study Drug|2
7609058|NCT03085095|12017460|FG001|Overall Study|Did not Receive Study Drug|2
7276571|NCT00448812|11491315|FG001|Year 3|Lost to Follow-up|0
7276572|NCT00448812|11491314|FG000|Year 3|Missed visit but remained in study|2
7276573|NCT00448812|11491315|FG001|Year 3|Missed visit but remained in study|0
7276574|NCT00448812|11491314|FG000|Year 5|Missed visit but remained in study|1
7276575|NCT00448812|11491315|FG001|Year 5|Missed visit but remained in study|0
7276576|NCT00448864|11491336|FG000|Overall Study|Death|1
7276577|NCT00448864|11491337|FG001|Overall Study|Death|0
7276578|NCT00448864|11491338|FG002|Overall Study|Death|0
7276579|NCT00448864|11491336|FG000|Overall Study|Lost to Follow-up|3
7276580|NCT00448864|11491337|FG001|Overall Study|Lost to Follow-up|1
7276581|NCT00448864|11491338|FG002|Overall Study|Lost to Follow-up|0
7276582|NCT00448864|11491336|FG000|Overall Study|Physician Decision|1
7276583|NCT00448864|11491337|FG001|Overall Study|Physician Decision|0
7276584|NCT00448864|11491338|FG002|Overall Study|Physician Decision|1
7276585|NCT00448864|11491336|FG000|Overall Study|Withdrawal by Subject|0
7276586|NCT00448864|11491337|FG001|Overall Study|Withdrawal by Subject|2
7276587|NCT00448864|11491338|FG002|Overall Study|Withdrawal by Subject|0
7276588|NCT00448864|11491336|FG000|Overall Study|Protocol Violation|0
7276589|NCT00448864|11491337|FG001|Overall Study|Protocol Violation|2
7276590|NCT00448864|11491338|FG002|Overall Study|Protocol Violation|0
7276591|NCT00448916|11491352|FG000|Overall Study|Adverse Event|2
7276592|NCT00448916|11491353|FG001|Overall Study|Adverse Event|2
7276593|NCT00448916|11491354|FG002|Overall Study|Adverse Event|3
7276594|NCT00448916|11491355|FG003|Overall Study|Adverse Event|2
7276595|NCT00448916|11491352|FG000|Overall Study|Lack of Efficacy|1
7276596|NCT00448916|11491353|FG001|Overall Study|Lack of Efficacy|0
7276597|NCT00448916|11491354|FG002|Overall Study|Lack of Efficacy|2
7276598|NCT00448916|11491355|FG003|Overall Study|Lack of Efficacy|1
7276599|NCT00448916|11491352|FG000|Overall Study|Withdrawal by Subject|3
7276600|NCT00448916|11491353|FG001|Overall Study|Withdrawal by Subject|3
7276601|NCT00448916|11491354|FG002|Overall Study|Withdrawal by Subject|1
7276602|NCT00448916|11491355|FG003|Overall Study|Withdrawal by Subject|1
7276603|NCT00448916|11491352|FG000|Overall Study|Other|1
7276604|NCT00448916|11491353|FG001|Overall Study|Other|0
7276605|NCT00448916|11491354|FG002|Overall Study|Other|0
7276606|NCT00448916|11491355|FG003|Overall Study|Other|0
7276607|NCT00448916|11491352|FG000|Overall Study|Lost to Follow-up|0
7276608|NCT00448916|11491353|FG001|Overall Study|Lost to Follow-up|1
7276609|NCT00448916|11491354|FG002|Overall Study|Lost to Follow-up|0
7276610|NCT00448916|11491355|FG003|Overall Study|Lost to Follow-up|1
7276611|NCT00448916|11491352|FG000|Overall Study|Protocol Violation|0
7276612|NCT00448916|11491353|FG001|Overall Study|Protocol Violation|0
7276613|NCT00448916|11491354|FG002|Overall Study|Protocol Violation|0
7276614|NCT00448916|11491355|FG003|Overall Study|Protocol Violation|1
7609059|NCT03085095|12017459|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
7609060|NCT03085095|12017460|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
7276615|NCT00449033|11491380|FG000|Treatment Period|Adverse Event|117
7276616|NCT00449033|11491381|FG001|Treatment Period|Adverse Event|83
7276617|NCT00449033|11491380|FG000|Treatment Period|Death|21
7276618|NCT00449033|11491381|FG001|Treatment Period|Death|12
7276619|NCT00449033|11491380|FG000|Treatment Period|Lost to Follow-up|0
7276620|NCT00449033|11491381|FG001|Treatment Period|Lost to Follow-up|2
7276621|NCT00449033|11491380|FG000|Treatment Period|Physician Decision|4
7276622|NCT00449033|11491381|FG001|Treatment Period|Physician Decision|5
7276623|NCT00449033|11491380|FG000|Treatment Period|Protocol Violation|8
7609061|NCT03048422|12017472|FG000|Overall Study|Death|1
7609062|NCT03048422|12017473|FG001|Overall Study|Death|0
7609063|NCT03048422|12017474|FG002|Overall Study|Death|0
7609064|NCT03048422|12017472|FG000|Overall Study|Lost to Follow-up|5
7609065|NCT03048422|12017473|FG001|Overall Study|Lost to Follow-up|0
7609066|NCT03048422|12017474|FG002|Overall Study|Lost to Follow-up|1
7609067|NCT03048422|12017472|FG000|Overall Study|Withdrawal by Subject|5
7609068|NCT03048422|12017473|FG001|Overall Study|Withdrawal by Subject|7
7609069|NCT03048422|12017474|FG002|Overall Study|Withdrawal by Subject|4
7609070|NCT03048422|12017472|FG000|Overall Study|Moved|3
7609071|NCT03048422|12017473|FG001|Overall Study|Moved|2
7609072|NCT03048422|12017474|FG002|Overall Study|Moved|2
7609073|NCT03048422|12017472|FG000|Overall Study|Noncompliant with Study Requirements|2
7609074|NCT03048422|12017473|FG001|Overall Study|Noncompliant with Study Requirements|1
7276624|NCT00449033|11491381|FG001|Treatment Period|Protocol Violation|7
7276625|NCT00449033|11491380|FG000|Treatment Period|Disease Progression|231
7276626|NCT00449033|11491381|FG001|Treatment Period|Disease Progression|288
7276627|NCT00449033|11491380|FG000|Treatment Period|Consent Withdrawn|36
7276628|NCT00449033|11491381|FG001|Treatment Period|Consent Withdrawn|20
7276629|NCT00449033|11491380|FG000|Treatment Period|Amended Protocol Criteria|22
7276630|NCT00449033|11491381|FG001|Treatment Period|Amended Protocol Criteria|18
7276631|NCT00449033|11491380|FG000|Treatment Period|Non-compliance|7
7276632|NCT00449033|11491381|FG001|Treatment Period|Non-compliance|8
7276633|NCT00449033|11491380|FG000|Treatment Period|Second Malignancy|0
7276634|NCT00449033|11491381|FG001|Treatment Period|Second Malignancy|1
7276635|NCT00449033|11491380|FG000|Treatment Period|Reason Missing|0
7276636|NCT00449033|11491381|FG001|Treatment Period|Reason Missing|4
7276637|NCT00449033|11491380|FG000|Treatment Period|Treatment Ongoing|6
7276638|NCT00449033|11491381|FG001|Treatment Period|Treatment Ongoing|4
7276639|NCT00449033|11491380|FG000|Follow-up Period|Death|299
7276640|NCT00449033|11491381|FG001|Follow-up Period|Death|311
7276641|NCT00449033|11491380|FG000|Follow-up Period|Lost to Follow-up|6
7276642|NCT00449033|11491381|FG001|Follow-up Period|Lost to Follow-up|10
7276643|NCT00449033|11491380|FG000|Follow-up Period|Reason Missing|120
7276644|NCT00449033|11491381|FG001|Follow-up Period|Reason Missing|113
7276645|NCT00449072|11491393|FG000|Overall Study|Adverse Event|3
7276646|NCT00449072|11491394|FG001|Overall Study|Adverse Event|1
7276647|NCT00449072|11491393|FG000|Overall Study|Protocol Violation|14
7276648|NCT00449072|11491394|FG001|Overall Study|Protocol Violation|12
7276649|NCT00449072|11491393|FG000|Overall Study|Lost to Follow-up|5
7276650|NCT00449072|11491394|FG001|Overall Study|Lost to Follow-up|7
7276651|NCT00449072|11491393|FG000|Overall Study|Withdrawal by Subject|11
7276652|NCT00449072|11491394|FG001|Overall Study|Withdrawal by Subject|8
7276653|NCT00449072|11491393|FG000|Overall Study|Lack of Efficacy|1
7276654|NCT00449072|11491394|FG001|Overall Study|Lack of Efficacy|1
7276655|NCT00449072|11491393|FG000|Overall Study|Physician Decision|1
7276656|NCT00449072|11491394|FG001|Overall Study|Physician Decision|0
7276657|NCT00449072|11491393|FG000|Overall Study|Not treated|0
7276658|NCT00449072|11491394|FG001|Overall Study|Not treated|1
7276659|NCT00449072|11491393|FG000|Overall Study|Excluded medication|0
7276660|NCT00449072|11491394|FG001|Overall Study|Excluded medication|2
7276661|NCT00449072|11491393|FG000|Overall Study|Non-compliance|2
7276662|NCT00449072|11491394|FG001|Overall Study|Non-compliance|5
7276663|NCT00449072|11491393|FG000|Overall Study|Sponsor decision|1
7276664|NCT00449072|11491394|FG001|Overall Study|Sponsor decision|3
7276665|NCT00449072|11491393|FG000|Overall Study|Relocation|3
7276666|NCT00449072|11491394|FG001|Overall Study|Relocation|2
7276667|NCT00449150|11491403|FG000|Overall Study|Adverse Event|11
7276668|NCT00449150|11491404|FG001|Overall Study|Adverse Event|18
7609075|NCT03048422|12017474|FG002|Overall Study|Noncompliant with Study Requirements|2
7609076|NCT03048422|12017472|FG000|Overall Study|Not Able to Get to Clinic|1
7609077|NCT03048422|12017473|FG001|Overall Study|Not Able to Get to Clinic|0
7609078|NCT03048422|12017474|FG002|Overall Study|Not Able to Get to Clinic|0
7276669|NCT00449150|11491405|FG002|Overall Study|Adverse Event|9
7276670|NCT00449150|11491403|FG000|Overall Study|Lack of Efficacy|1
7276671|NCT00449150|11491404|FG001|Overall Study|Lack of Efficacy|2
7276672|NCT00449150|11491405|FG002|Overall Study|Lack of Efficacy|2
7276673|NCT00449150|11491403|FG000|Overall Study|Other|16
7276674|NCT00449150|11491404|FG001|Overall Study|Other|13
7276675|NCT00449150|11491405|FG002|Overall Study|Other|14
7276676|NCT00449150|11491403|FG000|Overall Study|Withdrawal by Subject|17
7276677|NCT00449150|11491404|FG001|Overall Study|Withdrawal by Subject|18
7276678|NCT00449150|11491405|FG002|Overall Study|Withdrawal by Subject|21
7276679|NCT00449150|11491403|FG000|Overall Study|Protocol Violation|1
7276680|NCT00449150|11491404|FG001|Overall Study|Protocol Violation|2
7276681|NCT00449150|11491405|FG002|Overall Study|Protocol Violation|1
7609079|NCT03032068|12017492|FG000|Overall Study|Adverse Event|1
7609080|NCT02835690|12017512|FG000|Overall Study|Death|4
7609081|NCT02835690|12017513|FG001|Overall Study|Death|6
7609082|NCT02835690|12017514|FG002|Overall Study|Death|6
7609083|NCT02835690|12017512|FG000|Overall Study|Ongoing in Study (Follow-up)|10
7609084|NCT02835690|12017513|FG001|Overall Study|Ongoing in Study (Follow-up)|7
7609085|NCT02835690|12017514|FG002|Overall Study|Ongoing in Study (Follow-up)|9
7609086|NCT02835690|12017512|FG000|Overall Study|Not Treated|0
7609087|NCT02835690|12017513|FG001|Overall Study|Not Treated|2
7609088|NCT02835690|12017514|FG002|Overall Study|Not Treated|0
7609089|NCT02828982|12017522|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
7609090|NCT02828982|12017523|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
7609091|NCT02815280|12017537|FG000|Double-Blind Phase|Adverse Event|1
7609092|NCT02815280|12017538|FG001|Double-Blind Phase|Adverse Event|1
7609093|NCT02815280|12017537|FG000|Double-Blind Phase|Lost to Follow-up|10
7609094|NCT02815280|12017538|FG001|Double-Blind Phase|Lost to Follow-up|9
7609095|NCT02815280|12017537|FG000|Double-Blind Phase|Withdrawal by Subject|20
7609096|NCT02815280|12017538|FG001|Double-Blind Phase|Withdrawal by Subject|11
7609097|NCT02815280|12017537|FG000|Double-Blind Phase|Protocol Violation|2
7609098|NCT02815280|12017538|FG001|Double-Blind Phase|Protocol Violation|2
7609099|NCT02815280|12017537|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
7609100|NCT02815280|12017538|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
7609101|NCT02815280|12017537|FG000|Open-Label Phase|Adverse Event|2
7609102|NCT02815280|12017538|FG001|Open-Label Phase|Adverse Event|3
7609103|NCT02815280|12017537|FG000|Open-Label Phase|Lost to Follow-up|18
7609104|NCT02815280|12017538|FG001|Open-Label Phase|Lost to Follow-up|9
7609105|NCT02815280|12017537|FG000|Open-Label Phase|Withdrawal by Subject|33
7609106|NCT02815280|12017538|FG001|Open-Label Phase|Withdrawal by Subject|18
7276682|NCT00449163|11491416|FG000|Overall Study|Physician Decision|3
7276683|NCT00449176|11491423|FG000|Overall Study|Withdrawal by Subject|39
7276684|NCT00449176|11491424|FG001|Overall Study|Withdrawal by Subject|43
7276685|NCT00449176|11491425|FG002|Overall Study|Withdrawal by Subject|59
7276686|NCT00449176|11491423|FG000|Overall Study|Lost to Follow-up|13
7276687|NCT00449176|11491424|FG001|Overall Study|Lost to Follow-up|8
7276688|NCT00449176|11491425|FG002|Overall Study|Lost to Follow-up|12
7276689|NCT00449176|11491423|FG000|Overall Study|Adverse Event|51
7276690|NCT00449176|11491424|FG001|Overall Study|Adverse Event|107
7276691|NCT00449176|11491425|FG002|Overall Study|Adverse Event|15
7276692|NCT00449176|11491423|FG000|Overall Study|Lack of Efficacy|13
7276693|NCT00449176|11491424|FG001|Overall Study|Lack of Efficacy|7
7276694|NCT00449176|11491425|FG002|Overall Study|Lack of Efficacy|50
7276695|NCT00449176|11491423|FG000|Overall Study|Study drug non-compliant|14
7276696|NCT00449176|11491424|FG001|Overall Study|Study drug non-compliant|11
7276697|NCT00449176|11491425|FG002|Overall Study|Study drug non-compliant|11
7276698|NCT00449176|11491423|FG000|Overall Study|all other|22
7276699|NCT00449176|11491424|FG001|Overall Study|all other|19
7276700|NCT00449176|11491425|FG002|Overall Study|all other|20
7276701|NCT00449540|11491435|FG000|Pretreatment Phase|No migraine experienced|66
7276702|NCT00449540|11491436|FG001|Pretreatment Phase|No migraine experienced|0
7276703|NCT00449540|11491437|FG002|Pretreatment Phase|No migraine experienced|0
7276704|NCT00449540|11491435|FG000|Treatment Phase|did not experience or treat migraine|0
7276705|NCT00449540|11491436|FG001|Treatment Phase|did not experience or treat migraine|20
7276706|NCT00449540|11491437|FG002|Treatment Phase|did not experience or treat migraine|17
7276707|NCT00449644|11491449|FG000|Overall Study|Adverse Event|0
7276708|NCT00449644|11491450|FG001|Overall Study|Adverse Event|0
7276709|NCT00449644|11491451|FG002|Overall Study|Adverse Event|3
7276710|NCT00449644|11491452|FG003|Overall Study|Adverse Event|5
7276711|NCT00449644|11491449|FG000|Overall Study|Death|1
7276712|NCT00449644|11491450|FG001|Overall Study|Death|0
7276713|NCT00449644|11491451|FG002|Overall Study|Death|6
7276714|NCT00449644|11491452|FG003|Overall Study|Death|1
7276715|NCT00449644|11491449|FG000|Overall Study|Lost to Follow-up|1
7276716|NCT00449644|11491450|FG001|Overall Study|Lost to Follow-up|1
7276717|NCT00449644|11491451|FG002|Overall Study|Lost to Follow-up|5
7276718|NCT00449644|11491452|FG003|Overall Study|Lost to Follow-up|3
7276719|NCT00449644|11491449|FG000|Overall Study|Pregnancy|0
7276720|NCT00449644|11491450|FG001|Overall Study|Pregnancy|0
7276721|NCT00449644|11491451|FG002|Overall Study|Pregnancy|3
7276722|NCT00449644|11491452|FG003|Overall Study|Pregnancy|2
7276723|NCT00449644|11491449|FG000|Overall Study|Protocol Violation|4
7276724|NCT00449644|11491450|FG001|Overall Study|Protocol Violation|4
7276725|NCT00449644|11491451|FG002|Overall Study|Protocol Violation|3
7276726|NCT00449644|11491452|FG003|Overall Study|Protocol Violation|7
7276727|NCT00449644|11491449|FG000|Overall Study|Withdrawal by Subject|3
7276728|NCT00449644|11491450|FG001|Overall Study|Withdrawal by Subject|4
7276729|NCT00449644|11491451|FG002|Overall Study|Withdrawal by Subject|6
7276730|NCT00449644|11491452|FG003|Overall Study|Withdrawal by Subject|7
7276731|NCT00449644|11491449|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7276732|NCT00449644|11491450|FG001|Overall Study|Inclusion/exclusion criteria not met|0
7276733|NCT00449644|11491451|FG002|Overall Study|Inclusion/exclusion criteria not met|2
7609107|NCT02815280|12017537|FG000|Open-Label Phase|Protocol Violation|3
7609108|NCT02815280|12017538|FG001|Open-Label Phase|Protocol Violation|0
7609109|NCT02815280|12017537|FG000|Open-Label Phase|Administrative|26
7609110|NCT02815280|12017538|FG001|Open-Label Phase|Administrative|12
7609111|NCT02815280|12017537|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
7609112|NCT02815280|12017538|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
7609113|NCT02815267|12017550|FG000|Double-Blind Phase|Adverse Event|0
7609114|NCT02815267|12017551|FG001|Double-Blind Phase|Adverse Event|3
7609115|NCT02815267|12017550|FG000|Double-Blind Phase|Lost to Follow-up|17
7609116|NCT02815267|12017551|FG001|Double-Blind Phase|Lost to Follow-up|9
7609117|NCT02815267|12017550|FG000|Double-Blind Phase|Withdrawal by Subject|11
7609118|NCT02815267|12017551|FG001|Double-Blind Phase|Withdrawal by Subject|10
7609119|NCT02815267|12017550|FG000|Double-Blind Phase|Protocol Violation|3
7609120|NCT02815267|12017551|FG001|Double-Blind Phase|Protocol Violation|2
7609121|NCT02815267|12017550|FG000|Double-Blind Phase|Site withdrawal|1
7609122|NCT02815267|12017551|FG001|Double-Blind Phase|Site withdrawal|6
7609123|NCT02815267|12017550|FG000|Double-Blind Phase|Received a disallowed medication|1
7276734|NCT00449644|11491452|FG003|Overall Study|Inclusion/exclusion criteria not met|6
7276735|NCT00449644|11491449|FG000|Overall Study|Other|1
7276736|NCT00449644|11491450|FG001|Overall Study|Other|4
7276737|NCT00449644|11491451|FG002|Overall Study|Other|1
7276738|NCT00449644|11491452|FG003|Overall Study|Other|0
7276739|NCT00449644|11491449|FG000|Overall Study|Rolled-over to treatment with TMC207|0
7609124|NCT02815267|12017551|FG001|Double-Blind Phase|Received a disallowed medication|1
7609125|NCT02815267|12017550|FG000|Open-Label Phase|Adverse Event|1
7609126|NCT02815267|12017551|FG001|Open-Label Phase|Adverse Event|1
7609127|NCT02815267|12017550|FG000|Open-Label Phase|Lost to Follow-up|23
7609128|NCT02815267|12017551|FG001|Open-Label Phase|Lost to Follow-up|9
7609129|NCT02815267|12017550|FG000|Open-Label Phase|Withdrawal by Subject|24
7609130|NCT02815267|12017551|FG001|Open-Label Phase|Withdrawal by Subject|13
7609131|NCT02815267|12017550|FG000|Open-Label Phase|Protocol Violation|0
7609132|NCT02815267|12017551|FG001|Open-Label Phase|Protocol Violation|1
7609133|NCT02815267|12017550|FG000|Open-Label Phase|Administrative|21
7609134|NCT02815267|12017551|FG001|Open-Label Phase|Administrative|12
7609135|NCT02815267|12017550|FG000|Open-Label Phase|Other|2
7276740|NCT00449644|11491450|FG001|Overall Study|Rolled-over to treatment with TMC207|0
7276741|NCT00449644|11491451|FG002|Overall Study|Rolled-over to treatment with TMC207|0
7276742|NCT00449644|11491452|FG003|Overall Study|Rolled-over to treatment with TMC207|1
7276743|NCT00449670|11491467|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
7276744|NCT00449670|11491468|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
7276745|NCT00449670|11491467|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
7276746|NCT00449670|11491468|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
7276747|NCT00449670|11491467|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
7276748|NCT00449670|11491468|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
7276749|NCT00449670|11491467|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
7276750|NCT00449670|11491468|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
7276751|NCT00449670|11491467|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
7276752|NCT00449670|11491468|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
7276753|NCT00449670|11491467|FG000|Booster Phase (Study no.109873)|Other|0
7276754|NCT00449670|11491468|FG001|Booster Phase (Study no.109873)|Other|2
7276755|NCT00449696|11491483|FG000|Overall Study|Other Treatment Required|6
7276756|NCT00449696|11491484|FG001|Overall Study|Other Treatment Required|1
7276757|NCT00449696|11491483|FG000|Overall Study|Withdrawal by Subject|5
7276758|NCT00449696|11491484|FG001|Overall Study|Withdrawal by Subject|5
7276759|NCT00449696|11491483|FG000|Overall Study|Lost to Follow-up|2
7609136|NCT02815267|12017551|FG001|Open-Label Phase|Other|5
7609137|NCT02802228|12017563|FG000|Overall Study|Withdrawal by Subject|2
7609138|NCT02802228|12017564|FG001|Overall Study|Withdrawal by Subject|0
7276760|NCT00449696|11491484|FG001|Overall Study|Lost to Follow-up|3
7276761|NCT00449696|11491483|FG000|Overall Study|Others|7
7276762|NCT00449696|11491484|FG001|Overall Study|Others|0
7276763|NCT00449761|11491494|FG000|Overall Study|Disease progression|12
7609139|NCT02802228|12017563|FG000|Overall Study|Lost to Follow-up|1
7609140|NCT02802228|12017564|FG001|Overall Study|Lost to Follow-up|0
7609141|NCT02802228|12017563|FG000|Overall Study|Adverse Event|1
7609142|NCT02802228|12017564|FG001|Overall Study|Adverse Event|0
7609143|NCT02802228|12017563|FG000|Overall Study|Physician Decision|1
7609144|NCT02802228|12017564|FG001|Overall Study|Physician Decision|0
7609145|NCT02674516|12017595|FG000|Overall Study|Lost to Follow-up|3
7609146|NCT02674516|12017596|FG001|Overall Study|Lost to Follow-up|0
7609147|NCT02674516|12017595|FG000|Overall Study|Protocol Violation|0
7609148|NCT02674516|12017596|FG001|Overall Study|Protocol Violation|4
7609149|NCT02674516|12017595|FG000|Overall Study|Knowledge of study hypothesis|1
7609150|NCT02674516|12017596|FG001|Overall Study|Knowledge of study hypothesis|0
7609151|NCT02505425|12017615|FG000|Overall Study|Lost to Follow-up|41
7609152|NCT02505425|12017616|FG001|Overall Study|Lost to Follow-up|61
7609153|NCT02505425|12017617|FG002|Overall Study|Lost to Follow-up|31
7609154|NCT02505425|12017618|FG003|Overall Study|Lost to Follow-up|19
7276764|NCT00449761|11491494|FG000|Overall Study|Death|5
7276765|NCT00449761|11491494|FG000|Overall Study|New cancer therapy|1
7276766|NCT00449787|11491501|FG000|Overall Study|Lost to Follow-up|10
7276767|NCT00449787|11491502|FG001|Overall Study|Lost to Follow-up|8
7609155|NCT02505425|12017615|FG000|Overall Study|Withdrawal by Subject|39
7609156|NCT02505425|12017616|FG001|Overall Study|Withdrawal by Subject|9
7609157|NCT02505425|12017617|FG002|Overall Study|Withdrawal by Subject|19
7609158|NCT02505425|12017618|FG003|Overall Study|Withdrawal by Subject|7
7609159|NCT02505425|12017615|FG000|Overall Study|Death|8
7609160|NCT02505425|12017616|FG001|Overall Study|Death|12
7609161|NCT02505425|12017617|FG002|Overall Study|Death|0
7609162|NCT02505425|12017618|FG003|Overall Study|Death|0
7609163|NCT02487979|12017628|FG000|Overall Study|Physician Decision|2
7609164|NCT02487979|12017628|FG000|Overall Study|Withdrawal by Subject|2
7609165|NCT02487979|12017628|FG000|Overall Study|Progressive Disease|17
7609166|NCT02463448|12017632|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
7609167|NCT02463448|12017632|FG000|6 Months Through 12 Months|Lost to Follow-up|1
7276768|NCT00449787|11491501|FG000|Overall Study|Did not require medication|95
7276769|NCT00449787|11491502|FG001|Overall Study|Did not require medication|92
7276770|NCT00449865|11491512|FG000|Overall Study|Withdrawal by Subject|110
7276771|NCT00449865|11491513|FG001|Overall Study|Withdrawal by Subject|110
7276772|NCT00449865|11491512|FG000|Overall Study|Lost to Follow-up|36
7276773|NCT00449865|11491513|FG001|Overall Study|Lost to Follow-up|37
7276774|NCT00449865|11491512|FG000|Overall Study|Physician Decision|13
7609168|NCT02463448|12017632|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
7609169|NCT02463448|12017632|FG000|12 Months Through End of Study|Lost to Follow-up|1
7609170|NCT02276547|12017645|FG000|Overall Study|Death|2
7609171|NCT02276547|12017645|FG000|Overall Study|Explant|2
7609172|NCT02263885|12017649|FG000|Overall Study|Withdrawal by Subject|7
7609173|NCT02263885|12017649|FG000|Overall Study|Alternative Treatment|3
7276775|NCT00449865|11491513|FG001|Overall Study|Physician Decision|12
7609179|NCT01995175|12017658|FG000|Overall Study|Withdrawal by Subject|35
7609180|NCT01995175|12017658|FG000|Overall Study|Lost to Follow-up|102
7609181|NCT01995175|12017658|FG000|Overall Study|Other|67
7609182|NCT01995175|12017658|FG000|Overall Study|Migrated / moved from the study area|49
7609183|NCT01804270|12017672|FG000|Overall Study|Withdrawal by Subject|1
7609184|NCT01804270|12017673|FG001|Overall Study|Withdrawal by Subject|1
7609185|NCT01338636|12017679|FG000|Overall Study|Withdrawn due to lack of improvement|8
7609186|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
7609187|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609188|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609189|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
7609190|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
7609191|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609192|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609193|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
7609194|NCT01208974|12017683|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
7609195|NCT01208974|12017684|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609196|NCT01208974|12017685|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609197|NCT01208974|12017686|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
7609198|NCT00938912|12017693|FG000|Overall Study|Withdrawal by Subject|28
7609199|NCT00938912|12017693|FG000|Overall Study|Lost to Follow-up|4
7609200|NCT00938912|12017693|FG000|Overall Study|Lack of Efficacy|43
7609201|NCT00938912|12017693|FG000|Overall Study|Adverse event, non-fatal|24
7609202|NCT00938912|12017693|FG000|Overall Study|Adverse event, fatal|1
7609203|NCT00938912|12017693|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
7609204|NCT00938912|12017693|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
7609205|NCT00938912|12017693|FG000|Overall Study|Participant needed prohibit medication|1
7609206|NCT00938912|12017693|FG000|Overall Study|Participant was scheduled for lobal resection|1
7609207|NCT00938912|12017693|FG000|Overall Study|Did not meet Eligibility criteria|1
7609208|NCT00938912|12017693|FG000|Overall Study|Participant relocated not related to AE|1
7609209|NCT00938912|12017693|FG000|Overall Study|Participant moved to another city|1
7609210|NCT00938912|12017693|FG000|Overall Study|Participant experienced break through seizures|1
7609211|NCT00938912|12017693|FG000|Overall Study|No longer wished to participate in the study|1
7609212|NCT00938912|12017693|FG000|Overall Study|Protocol Deviation|2
7609237|NCT00579826|12017744|FG000|Overall Study|Withdrawal by Subject|5
7609238|NCT00579826|12017745|FG001|Overall Study|Withdrawal by Subject|3
7609239|NCT00322218|12017753|FG000|Overall Study|Death|3
7609240|NCT00322218|12017754|FG001|Overall Study|Death|6
7609241|NCT00186888|12017763|FG000|Overall Study|Toxicity|0
7609242|NCT00186888|12017764|FG001|Overall Study|Toxicity|1
7609243|NCT00186888|12017765|FG002|Overall Study|Toxicity|0
7609244|NCT00186888|12017763|FG000|Overall Study|Relapse or progression of disease|4
7609245|NCT00186888|12017764|FG001|Overall Study|Relapse or progression of disease|2
7609246|NCT00186888|12017765|FG002|Overall Study|Relapse or progression of disease|0
7609247|NCT04066491|12017811|FG000|Overall Study|Treatment ongoing|2
7609248|NCT04066491|12017812|FG001|Overall Study|Treatment ongoing|72
7609249|NCT04066491|12017813|FG002|Overall Study|Treatment ongoing|66
7609250|NCT04066491|12017811|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2
7609251|NCT04066491|12017812|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39
7609252|NCT04066491|12017813|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41
7609253|NCT04066491|12017811|FG000|Overall Study|Randomized, not treated|0
7609254|NCT04066491|12017812|FG001|Overall Study|Randomized, not treated|0
7609255|NCT04066491|12017813|FG002|Overall Study|Randomized, not treated|2
7609256|NCT03259425|12017822|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
7609257|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Adverse Event|2
7609258|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Adverse Event|6
7609259|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Adverse Event|0
7609260|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Adverse Event|0
7609261|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Adverse Event|0
7609262|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Adverse Event|0
7609263|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Adverse Event|0
7609264|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Adverse Event|0
7609265|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Adverse Event|0
7609266|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Adverse Event|0
7609267|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Adverse Event|0
7609268|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Adverse Event|0
7609269|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Adverse Event|0
7609270|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Adverse Event|0
7609271|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Adverse Event|0
7609272|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Adverse Event|0
7609273|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Adverse Event|0
7609274|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Adverse Event|0
7609275|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Adverse Event|0
7609276|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Adverse Event|0
7609277|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Adverse Event|0
7609278|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Adverse Event|0
7609279|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Adverse Event|0
7609280|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Adverse Event|0
7609281|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Adverse Event|0
7276776|NCT00449865|11491512|FG000|Overall Study|Death|31
7276777|NCT00449865|11491513|FG001|Overall Study|Death|40
7276778|NCT00449865|11491512|FG000|Overall Study|Protocol Violation|8
7276779|NCT00449865|11491513|FG001|Overall Study|Protocol Violation|7
7276780|NCT00449865|11491512|FG000|Overall Study|Study was stopped|324
7276781|NCT00449865|11491513|FG001|Overall Study|Study was stopped|328
7276782|NCT00449930|11491521|FG000|Overall Study|Adverse Event|9
7276783|NCT00449930|11491522|FG001|Overall Study|Adverse Event|19
7276784|NCT00449930|11491521|FG000|Overall Study|Trial Terminated ( Site Closed)|1
7276785|NCT00449930|11491522|FG001|Overall Study|Trial Terminated ( Site Closed)|0
7276786|NCT00449930|11491521|FG000|Overall Study|Lack of Efficacy|10
7276787|NCT00449930|11491522|FG001|Overall Study|Lack of Efficacy|1
7276788|NCT00449930|11491521|FG000|Overall Study|Lost to Follow-up|9
7276789|NCT00449930|11491522|FG001|Overall Study|Lost to Follow-up|14
7276790|NCT00449930|11491521|FG000|Overall Study|Physician Decision|1
7276791|NCT00449930|11491522|FG001|Overall Study|Physician Decision|2
7276792|NCT00449930|11491521|FG000|Overall Study|Protocol Violation|14
7276793|NCT00449930|11491522|FG001|Overall Study|Protocol Violation|15
7276794|NCT00449930|11491521|FG000|Overall Study|Withdrawal by Subject|16
7276795|NCT00449930|11491522|FG001|Overall Study|Withdrawal by Subject|23
7276796|NCT00449930|11491521|FG000|Overall Study|Glycemic discontinuation criteria|1
7276797|NCT00449930|11491522|FG001|Overall Study|Glycemic discontinuation criteria|1
7276798|NCT00449956|11491531|FG000|Overall Study|Adverse Event|7
7276799|NCT00449956|11491532|FG001|Overall Study|Adverse Event|1
7276800|NCT00449956|11491533|FG002|Overall Study|Adverse Event|6
7276801|NCT00449956|11491531|FG000|Overall Study|Lack of Efficacy|0
7276802|NCT00449956|11491532|FG001|Overall Study|Lack of Efficacy|0
7276803|NCT00449956|11491533|FG002|Overall Study|Lack of Efficacy|1
7276804|NCT00449956|11491531|FG000|Overall Study|Protocol Violation|1
7276805|NCT00449956|11491532|FG001|Overall Study|Protocol Violation|1
7276806|NCT00449956|11491533|FG002|Overall Study|Protocol Violation|1
7276807|NCT00449956|11491531|FG000|Overall Study|Withdrawal by Subject|0
7276808|NCT00449956|11491532|FG001|Overall Study|Withdrawal by Subject|1
7276809|NCT00449956|11491533|FG002|Overall Study|Withdrawal by Subject|0
7276810|NCT00449956|11491531|FG000|Overall Study|Physician Decision|2
7276811|NCT00449956|11491532|FG001|Overall Study|Physician Decision|1
7276812|NCT00449956|11491533|FG002|Overall Study|Physician Decision|1
7276813|NCT00450112|11491556|FG000|Overall Study|Other Treatment Required|5
7276814|NCT00450112|11491557|FG001|Overall Study|Other Treatment Required|1
7276815|NCT00450112|11491556|FG000|Overall Study|Withdrawal by Subject|4
7276816|NCT00450112|11491557|FG001|Overall Study|Withdrawal by Subject|1
7276817|NCT00450112|11491556|FG000|Overall Study|Lost to Follow-up|2
7276818|NCT00450112|11491557|FG001|Overall Study|Lost to Follow-up|1
7276819|NCT00450112|11491556|FG000|Overall Study|Others|2
7276820|NCT00450112|11491557|FG001|Overall Study|Others|3
7276821|NCT00450177|11491565|FG000|Overall Study|Adverse Event|7
7276822|NCT00450177|11491566|FG001|Overall Study|Adverse Event|4
7276823|NCT00450177|11491565|FG000|Overall Study|Withdrawal by Subject|1
7276824|NCT00450177|11491566|FG001|Overall Study|Withdrawal by Subject|6
7276825|NCT00450177|11491565|FG000|Overall Study|Withdrawal by Primary Team|1
7609282|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Adverse Event|0
7609283|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
7276826|NCT00450177|11491566|FG001|Overall Study|Withdrawal by Primary Team|1
7276827|NCT00450190|11491572|FG000|Overall Study|Withdrawal by Subject|2
7276828|NCT00450216|11491578|FG000|Overall Study|Adverse Event|38
7276829|NCT00450216|11491579|FG001|Overall Study|Adverse Event|23
7276830|NCT00450216|11491578|FG000|Overall Study|Withdrawal by Subject|48
7276831|NCT00450216|11491579|FG001|Overall Study|Withdrawal by Subject|26
7609284|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
7609285|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
7609286|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
7609287|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
7609288|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
7609289|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
7609290|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
7609291|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
7609292|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
7609293|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
7609294|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0
7609295|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0
7609296|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0
7609297|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0
7609298|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0
7609299|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0
7609300|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0
7609301|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0
7609302|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0
7609303|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0
7609304|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0
7609305|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0
7609306|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0
7609307|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0
7609308|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0
7609309|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
7609310|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
7609311|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609312|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609313|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609314|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609315|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609316|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609317|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609318|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609319|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609320|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609321|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609322|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609323|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609324|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609325|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609326|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609327|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609328|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609329|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609330|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609331|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0
7276895|NCT00450658|11491679|FG000|Overall Study|Adverse Event|24
7609332|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609333|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609334|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0
7609335|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
7609336|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
7609337|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
7609338|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
7609339|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
7609340|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
7609341|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
7609342|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
7609343|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
7609344|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
7609345|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
7609346|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0
7609347|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0
7609348|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0
7609349|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0
7609350|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0
7609351|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0
7609352|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0
7609353|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0
7609354|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0
7609355|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0
7609356|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0
7609357|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0
7609358|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0
7609359|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0
7609360|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0
7609361|NCT03129100|12017831|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
7609362|NCT03129100|12017832|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
7609363|NCT03129100|12017833|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
7609364|NCT03129100|12017834|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
7609365|NCT03129100|12017835|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
7276832|NCT00450216|11491578|FG000|Overall Study|Lost to Follow-up|16
7276833|NCT00450216|11491579|FG001|Overall Study|Lost to Follow-up|9
7276834|NCT00450216|11491578|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
7609366|NCT03129100|12017836|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
7609367|NCT03129100|12017837|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
7609368|NCT03129100|12017838|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
7609369|NCT03129100|12017839|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
7609370|NCT03129100|12017840|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
7609371|NCT03129100|12017841|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
7609372|NCT03129100|12017842|FG011|Lead-In Period (Period 1)|Surgery Programmed|0
7609373|NCT03129100|12017843|FG012|Lead-In Period (Period 1)|Surgery Programmed|0
7609374|NCT03129100|12017844|FG013|Lead-In Period (Period 1)|Surgery Programmed|0
7609375|NCT03129100|12017845|FG014|Lead-In Period (Period 1)|Surgery Programmed|0
7609376|NCT03129100|12017846|FG015|Lead-In Period (Period 1)|Surgery Programmed|0
7609377|NCT03129100|12017847|FG016|Lead-In Period (Period 1)|Surgery Programmed|0
7609378|NCT03129100|12017848|FG017|Lead-In Period (Period 1)|Surgery Programmed|0
7276835|NCT00450216|11491579|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
7276836|NCT00450216|11491578|FG000|Overall Study|misc|21
7276837|NCT00450216|11491579|FG001|Overall Study|misc|20
7276838|NCT00450255|11491596|FG000|Overall Study|Prior RFA ablation of liver|1
7276839|NCT00450372|11491606|FG000|Overall Study|Physician Decision|1
7276840|NCT00450385|11491613|FG000|Overall Study|Death|3
7276841|NCT00450385|11491613|FG000|Overall Study|Protocol Violation|1
7276842|NCT00450385|11491613|FG000|Overall Study|Withdrawal by Subject|2
7276843|NCT00450385|11491613|FG000|Overall Study|Lack of Efficacy|2
7276844|NCT00450385|11491613|FG000|Overall Study|Adverse Event|1
7276845|NCT00450385|11491613|FG000|Overall Study|Physician Decision|1
7276846|NCT00450385|11491613|FG000|Overall Study|Other|3
7276847|NCT00450437|11491629|FG000|Overall Study|Withdrawal by Subject|10
7276848|NCT00450437|11491630|FG001|Overall Study|Withdrawal by Subject|2
7276849|NCT00450437|11491631|FG002|Overall Study|Withdrawal by Subject|0
7276850|NCT00450437|11491632|FG003|Overall Study|Withdrawal by Subject|1
7276851|NCT00450437|11491629|FG000|Overall Study|Lost to Follow-up|31
7276852|NCT00450437|11491630|FG001|Overall Study|Lost to Follow-up|12
7276853|NCT00450437|11491631|FG002|Overall Study|Lost to Follow-up|19
7609379|NCT03129100|12017849|FG018|Lead-In Period (Period 1)|Surgery Programmed|0
7609380|NCT03129100|12017850|FG019|Lead-In Period (Period 1)|Surgery Programmed|0
7609381|NCT03129100|12017851|FG020|Lead-In Period (Period 1)|Surgery Programmed|0
7609382|NCT03129100|12017852|FG021|Lead-In Period (Period 1)|Surgery Programmed|0
7609383|NCT03129100|12017853|FG022|Lead-In Period (Period 1)|Surgery Programmed|0
7609384|NCT03129100|12017854|FG023|Lead-In Period (Period 1)|Surgery Programmed|0
7609385|NCT03129100|12017855|FG024|Lead-In Period (Period 1)|Surgery Programmed|0
7609386|NCT03129100|12017856|FG025|Lead-In Period (Period 1)|Surgery Programmed|0
7609387|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
7609388|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
7609389|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
7609390|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
7609391|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
7609392|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
7609393|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
7609394|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
7609395|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
7609396|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
7609397|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
7609398|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0
7609399|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0
7609400|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0
7609401|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0
7609402|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0
7609403|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0
7609404|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0
7276854|NCT00450437|11491632|FG003|Overall Study|Lost to Follow-up|9
7276855|NCT00450437|11491629|FG000|Overall Study|Protocol Violation|0
7276856|NCT00450437|11491630|FG001|Overall Study|Protocol Violation|1
7276857|NCT00450437|11491631|FG002|Overall Study|Protocol Violation|0
7276858|NCT00450437|11491632|FG003|Overall Study|Protocol Violation|1
7276859|NCT00450437|11491629|FG000|Overall Study|Inappropriate enrollment|4
7276860|NCT00450437|11491630|FG001|Overall Study|Inappropriate enrollment|1
7276861|NCT00450437|11491631|FG002|Overall Study|Inappropriate enrollment|3
7276862|NCT00450437|11491632|FG003|Overall Study|Inappropriate enrollment|0
7276863|NCT00450437|11491629|FG000|Overall Study|Administrative reason|0
7276864|NCT00450437|11491630|FG001|Overall Study|Administrative reason|0
7276865|NCT00450437|11491631|FG002|Overall Study|Administrative reason|1
7276866|NCT00450437|11491632|FG003|Overall Study|Administrative reason|0
7276867|NCT00450437|11491629|FG000|Overall Study|Unable to Classify|1
7276868|NCT00450437|11491630|FG001|Overall Study|Unable to Classify|0
7276869|NCT00450437|11491631|FG002|Overall Study|Unable to Classify|1
7276870|NCT00450437|11491632|FG003|Overall Study|Unable to Classify|0
7276871|NCT00450580|11491660|FG000|Overall Study|Adverse Event|5
7276872|NCT00450580|11491661|FG001|Overall Study|Adverse Event|7
7276873|NCT00450580|11491660|FG000|Overall Study|Lost to Follow-up|4
7276874|NCT00450580|11491661|FG001|Overall Study|Lost to Follow-up|5
7276875|NCT00450580|11491660|FG000|Overall Study|Withdrawal by Subject|2
7276876|NCT00450580|11491661|FG001|Overall Study|Withdrawal by Subject|2
7276877|NCT00450580|11491660|FG000|Overall Study|Protocol Violation|1
7276878|NCT00450580|11491661|FG001|Overall Study|Protocol Violation|1
7276879|NCT00450580|11491660|FG000|Overall Study|Protocol-defined virologic failure|1
7276880|NCT00450580|11491661|FG001|Overall Study|Protocol-defined virologic failure|0
7276881|NCT00450580|11491660|FG000|Overall Study|Could not comply with scheduled visits|1
7276882|NCT00450580|11491661|FG001|Overall Study|Could not comply with scheduled visits|0
7276883|NCT00450580|11491660|FG000|Overall Study|Patient went to Brazil|1
7276884|NCT00450580|11491661|FG001|Overall Study|Patient went to Brazil|0
7276885|NCT00450580|11491660|FG000|Overall Study|Patient could not swallow Norvir|1
7276886|NCT00450580|11491661|FG001|Overall Study|Patient could not swallow Norvir|0
7276887|NCT00450580|11491660|FG000|Overall Study|Withdrawal due to pregnancy|0
7276888|NCT00450580|11491661|FG001|Overall Study|Withdrawal due to pregnancy|1
7276889|NCT00450619|11491669|FG000|Overall Study|refused treatment after randomization|2
7276890|NCT00450619|11491670|FG001|Overall Study|refused treatment after randomization|0
7276891|NCT00450619|11491669|FG000|Overall Study|did not progress; refused further trmt|1
7276892|NCT00450619|11491670|FG001|Overall Study|did not progress; refused further trmt|1
7276893|NCT00450619|11491669|FG000|Overall Study|Adverse Event|1
7609405|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0
7609406|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0
7609407|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0
7609408|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0
7609409|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0
7609410|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0
7609411|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0
7609412|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0
7609413|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Death|0
7609414|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Death|0
7609415|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Death|1
7609416|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Death|0
7609417|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Death|0
7609418|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Death|0
7609419|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Death|0
7609420|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Death|0
7609421|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Death|0
7609422|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Death|0
7609423|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Death|0
7609424|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Death|0
7609425|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Death|0
7609426|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Death|0
7609427|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Death|0
7609428|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Death|0
7609429|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Death|0
7609430|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Death|0
7609431|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Death|0
7609432|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Death|0
7609433|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Death|0
7609434|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Death|0
7609435|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Death|0
7609436|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Death|0
7609437|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Death|0
7609438|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Death|0
7609439|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609440|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609441|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
7609442|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
7609443|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7609444|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
7609445|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
7609446|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609447|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609448|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609449|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609450|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609451|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609452|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609453|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609454|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609455|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609456|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609457|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609458|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609459|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609460|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609461|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609462|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609463|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609464|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
7609465|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
7609466|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
7609467|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
7609468|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
7609469|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
7609470|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
7609471|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
7609472|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
7609473|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
7609474|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
7609475|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
7609476|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0
7609477|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0
7609478|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0
7609479|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0
7609480|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0
7609481|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0
7609482|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0
7609483|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0
7609484|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0
7609485|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0
7609486|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0
7609487|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0
7609488|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0
7609489|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0
7609490|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0
7276894|NCT00450619|11491670|FG001|Overall Study|Adverse Event|0
7276896|NCT00450658|11491680|FG001|Overall Study|Adverse Event|15
7276897|NCT00450658|11491679|FG000|Overall Study|Withdrawal by Subject|43
7276898|NCT00450658|11491680|FG001|Overall Study|Withdrawal by Subject|26
7276899|NCT00450658|11491679|FG000|Overall Study|Lost to Follow-up|22
7276900|NCT00450658|11491680|FG001|Overall Study|Lost to Follow-up|5
7276901|NCT00450658|11491679|FG000|Overall Study|UGI ulcer|33
7276902|NCT00450658|11491680|FG001|Overall Study|UGI ulcer|34
7276903|NCT00450658|11491679|FG000|Overall Study|misc|21
7276904|NCT00450658|11491680|FG001|Overall Study|misc|10
7276905|NCT00450723|11491686|FG000|Overall Study|Physician Decision|5
7276906|NCT00450749|11491694|FG000|Overall Study|Withdrawal by Subject|0
7276907|NCT00450749|11491695|FG001|Overall Study|Withdrawal by Subject|0
7276908|NCT00450749|11491696|FG002|Overall Study|Withdrawal by Subject|2
7276909|NCT00450749|11491694|FG000|Overall Study|Noncompliant|0
7276910|NCT00450749|11491695|FG001|Overall Study|Noncompliant|1
7276911|NCT00450749|11491696|FG002|Overall Study|Noncompliant|0
7276912|NCT00450801|11491704|FG000|Overall Study|Death|1
7276913|NCT00450814|11491723|FG000|Overall Study|Failed to complete the initial therapy|0
7276914|NCT00450814|11491724|FG001|Overall Study|Failed to complete the initial therapy|0
7276915|NCT00450814|11491725|FG002|Overall Study|Failed to complete the initial therapy|0
7276916|NCT00450814|11491726|FG003|Overall Study|Failed to complete the initial therapy|1
7276917|NCT00450814|11491727|FG004|Overall Study|Failed to complete the initial therapy|1
7276918|NCT00450814|11491728|FG005|Overall Study|Failed to complete the initial therapy|1
7609491|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609492|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609493|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
7609494|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609495|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609496|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609497|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609498|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609499|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609500|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609501|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609502|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609503|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609504|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609505|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609506|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609507|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609508|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609509|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609510|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609511|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609512|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609513|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609514|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609515|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609516|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
7609517|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609518|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609519|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
7609520|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609521|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609522|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609523|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609524|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609525|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7276919|NCT00450814|11491729|FG006|Overall Study|Failed to complete the initial therapy|0
7276920|NCT00450814|11491730|FG007|Overall Study|Failed to complete the initial therapy|0
7276921|NCT00450814|11491731|FG008|Overall Study|Failed to complete the initial therapy|0
7276922|NCT00450814|11491732|FG009|Overall Study|Failed to complete the initial therapy|0
7276923|NCT00450814|11491733|FG010|Overall Study|Failed to complete the initial therapy|0
7276924|NCT00450814|11491723|FG000|Overall Study|Patient withdrawal prior to treatment|0
7609526|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609527|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609528|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609529|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609530|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609531|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609532|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609533|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609534|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609535|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609536|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609537|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609538|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609539|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609540|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609541|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609542|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
7609543|NCT03129100|12017831|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609544|NCT03129100|12017832|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609545|NCT03129100|12017833|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609546|NCT03129100|12017834|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609547|NCT03129100|12017835|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
7609548|NCT03129100|12017836|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
7609549|NCT03129100|12017837|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
7609550|NCT03129100|12017838|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609551|NCT03129100|12017839|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609552|NCT03129100|12017840|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609553|NCT03129100|12017841|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609554|NCT03129100|12017842|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609555|NCT03129100|12017843|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609556|NCT03129100|12017844|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609557|NCT03129100|12017845|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609558|NCT03129100|12017846|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609559|NCT03129100|12017847|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609560|NCT03129100|12017848|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609561|NCT03129100|12017849|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609562|NCT03129100|12017850|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609563|NCT03129100|12017851|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609564|NCT03129100|12017852|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609565|NCT03129100|12017853|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609566|NCT03129100|12017854|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609567|NCT03129100|12017855|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609568|NCT03129100|12017856|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0
7609569|NCT03129100|12017831|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609570|NCT03129100|12017832|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609571|NCT03129100|12017833|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609572|NCT03129100|12017834|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609573|NCT03129100|12017835|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609574|NCT03129100|12017836|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609575|NCT03129100|12017837|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609576|NCT03129100|12017838|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609577|NCT03129100|12017839|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609578|NCT03129100|12017840|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
7609579|NCT03129100|12017841|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7276925|NCT00450814|11491724|FG001|Overall Study|Patient withdrawal prior to treatment|0
7609580|NCT03129100|12017842|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609581|NCT03129100|12017843|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609582|NCT03129100|12017844|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609583|NCT03129100|12017845|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609584|NCT03129100|12017846|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609585|NCT03129100|12017847|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609586|NCT03129100|12017848|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609587|NCT03129100|12017849|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609588|NCT03129100|12017850|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609589|NCT03129100|12017851|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609590|NCT03129100|12017852|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609591|NCT03129100|12017853|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609592|NCT03129100|12017854|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609593|NCT03129100|12017855|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609594|NCT03129100|12017856|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
7609595|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609596|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609597|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609598|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609599|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609600|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609601|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609602|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609603|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609604|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609605|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609606|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6
7609607|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609608|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609609|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609610|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609611|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609612|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609613|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609614|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609615|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609616|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609617|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609618|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609619|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609620|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0
7609621|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609622|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609623|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609624|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609625|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609626|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609627|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609628|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609629|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609630|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609631|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609632|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12
7609633|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7
7609634|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4
7609635|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2
7609636|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609637|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609638|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609639|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609640|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609641|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609642|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609643|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609644|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609645|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609646|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0
7609647|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609648|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609649|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609650|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609651|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609652|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609653|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609654|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609655|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609656|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609657|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609658|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609659|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609660|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609661|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1
7609662|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609663|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609664|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609665|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609666|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609667|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609668|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609669|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609670|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609671|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609672|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0
7609673|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609674|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609675|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609676|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609677|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609678|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7276926|NCT00450814|11491725|FG002|Overall Study|Patient withdrawal prior to treatment|0
7276927|NCT00450814|11491726|FG003|Overall Study|Patient withdrawal prior to treatment|0
7276928|NCT00450814|11491727|FG004|Overall Study|Patient withdrawal prior to treatment|0
7276929|NCT00450814|11491728|FG005|Overall Study|Patient withdrawal prior to treatment|0
7276930|NCT00450814|11491729|FG006|Overall Study|Patient withdrawal prior to treatment|0
7276931|NCT00450814|11491730|FG007|Overall Study|Patient withdrawal prior to treatment|0
7276932|NCT00450814|11491731|FG008|Overall Study|Patient withdrawal prior to treatment|0
7276933|NCT00450814|11491732|FG009|Overall Study|Patient withdrawal prior to treatment|1
7276934|NCT00450814|11491733|FG010|Overall Study|Patient withdrawal prior to treatment|0
7276935|NCT00450866|11491758|FG000|Overall Study|Adverse Event|0
7276936|NCT00450866|11491759|FG001|Overall Study|Adverse Event|1
7276937|NCT00450866|11491758|FG000|Overall Study|Withdrawal by Subject|5
7276938|NCT00450866|11491759|FG001|Overall Study|Withdrawal by Subject|2
7276939|NCT00450866|11491758|FG000|Overall Study|Death|1
7276940|NCT00450866|11491759|FG001|Overall Study|Death|0
7276941|NCT00450866|11491758|FG000|Overall Study|Physician Decision|1
7276942|NCT00450866|11491759|FG001|Overall Study|Physician Decision|0
7276943|NCT00451035|11491769|FG000|Overall Study|Disease progression|11
7276944|NCT00451035|11491769|FG000|Overall Study|Death|3
7276945|NCT00451035|11491769|FG000|Overall Study|New anti-neoplastic therapy|3
7276946|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7276947|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
7276948|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
7276949|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
7276950|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
7276951|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
7276952|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
7276953|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
7276954|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
7276955|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
7276956|NCT00451178|11491780|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
7469741|NCT01926782|11771660|FG004|Overall Study|Adverse Event|3
7609679|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609680|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609681|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609682|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609683|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609684|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609685|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609686|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609687|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609688|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1
7609689|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609690|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609691|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609692|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609693|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609694|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609695|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609696|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609697|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609698|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0
7609699|NCT03129100|12017831|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609700|NCT03129100|12017832|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609701|NCT03129100|12017833|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609702|NCT03129100|12017834|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609703|NCT03129100|12017835|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609704|NCT03129100|12017836|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609836|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Death|0
7609705|NCT03129100|12017837|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609706|NCT03129100|12017838|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609707|NCT03129100|12017839|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609708|NCT03129100|12017840|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609709|NCT03129100|12017841|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609710|NCT03129100|12017842|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609711|NCT03129100|12017843|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24
7609712|NCT03129100|12017844|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609713|NCT03129100|12017845|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2
7609714|NCT03129100|12017846|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8
7609715|NCT03129100|12017847|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609716|NCT03129100|12017848|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609717|NCT03129100|12017849|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609718|NCT03129100|12017850|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609719|NCT03129100|12017851|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609720|NCT03129100|12017852|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609721|NCT03129100|12017853|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609722|NCT03129100|12017854|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609723|NCT03129100|12017855|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609724|NCT03129100|12017856|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0
7609725|NCT03129100|12017831|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609726|NCT03129100|12017832|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609727|NCT03129100|12017833|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609728|NCT03129100|12017834|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609729|NCT03129100|12017835|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609730|NCT03129100|12017836|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609731|NCT03129100|12017837|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609732|NCT03129100|12017838|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609733|NCT03129100|12017839|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609734|NCT03129100|12017840|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609735|NCT03129100|12017841|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609736|NCT03129100|12017842|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609737|NCT03129100|12017843|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609738|NCT03129100|12017844|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609739|NCT03129100|12017845|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609740|NCT03129100|12017846|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609741|NCT03129100|12017847|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609742|NCT03129100|12017848|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2
7609743|NCT03129100|12017849|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609744|NCT03129100|12017850|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3
7609745|NCT03129100|12017851|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609746|NCT03129100|12017852|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609747|NCT03129100|12017853|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609748|NCT03129100|12017854|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609749|NCT03129100|12017855|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609750|NCT03129100|12017856|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0
7609751|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609752|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609753|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609754|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609755|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609756|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609757|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609758|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609759|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609760|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609761|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609762|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609763|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609764|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609765|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609766|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609767|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609768|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609769|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609770|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609771|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2
7609772|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609773|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609774|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609775|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609776|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0
7609777|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Physician Decision|0
7609778|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Physician Decision|0
7609779|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Physician Decision|0
7609780|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Physician Decision|0
7609781|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Physician Decision|0
7609782|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Physician Decision|0
7609783|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Physician Decision|0
7609784|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Physician Decision|0
7609785|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Physician Decision|0
7609786|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Physician Decision|0
7609787|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Physician Decision|0
7609788|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Physician Decision|0
7609789|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Physician Decision|0
7609790|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Physician Decision|0
7609791|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Physician Decision|0
7609792|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Physician Decision|0
7276957|NCT00451178|11491781|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
7276958|NCT00451178|11491780|FG000|Prior to Maintenance Therapy|Physician Decision|2
7276959|NCT00451178|11491781|FG001|Prior to Maintenance Therapy|Physician Decision|0
7276960|NCT00451178|11491780|FG000|Prior to Maintenance Therapy|PD|2
7276961|NCT00451178|11491781|FG001|Prior to Maintenance Therapy|PD|0
7276962|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
7609793|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Physician Decision|0
7609794|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Physician Decision|0
7609795|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Physician Decision|0
7609796|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Physician Decision|0
7609797|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Physician Decision|1
7469742|NCT01926782|11771661|FG005|Overall Study|Adverse Event|14
7609798|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Physician Decision|0
7609799|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Physician Decision|0
7609800|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Physician Decision|0
7609801|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Physician Decision|0
7609802|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Physician Decision|0
7609803|NCT03129100|12017831|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609804|NCT03129100|12017832|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609805|NCT03129100|12017833|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609806|NCT03129100|12017834|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609807|NCT03129100|12017835|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609808|NCT03129100|12017836|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609809|NCT03129100|12017837|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609810|NCT03129100|12017838|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609811|NCT03129100|12017839|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609812|NCT03129100|12017840|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609813|NCT03129100|12017841|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609814|NCT03129100|12017842|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609815|NCT03129100|12017843|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609816|NCT03129100|12017844|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609817|NCT03129100|12017845|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609818|NCT03129100|12017846|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609819|NCT03129100|12017847|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609820|NCT03129100|12017848|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609821|NCT03129100|12017849|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609822|NCT03129100|12017850|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609823|NCT03129100|12017851|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1
7609824|NCT03129100|12017852|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0
7276963|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
7276964|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
7276965|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
7276966|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
7276967|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
7276968|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|Death|1
7276969|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|Death|0
7276970|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|PD|10
7276971|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|PD|0
7276972|NCT00451178|11491780|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
7276973|NCT00451178|11491781|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
7469743|NCT01926782|11771656|FG000|Overall Study|Poor compliance to protocol|5
7609825|NCT03129100|12017853|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609826|NCT03129100|12017854|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609827|NCT03129100|12017855|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609828|NCT03129100|12017856|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0
7609829|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Death|0
7609830|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Death|0
7609831|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Death|0
7609832|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Death|0
7609833|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Death|0
7609834|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Death|0
7609835|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Death|0
7609837|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Death|0
7609838|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Death|0
7609839|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Death|0
7609840|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Death|0
7609841|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Death|0
7609842|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Death|0
7609843|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Death|0
7609844|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Death|0
7609845|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Death|0
7609846|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Death|0
7609847|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Death|0
7609848|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Death|0
7609849|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Death|0
7609850|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Death|0
7609851|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Death|0
7609852|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Death|0
7609853|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Death|1
7609854|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Death|0
7609855|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609856|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609857|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609858|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609859|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609860|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609861|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609862|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609863|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609864|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609865|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609866|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609867|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609868|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609869|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609870|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609871|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609872|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609873|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609874|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609875|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609876|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609877|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609878|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0
7609879|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
7609880|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2
7609881|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609882|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609883|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609884|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609885|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609886|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609887|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609888|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609889|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609890|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609891|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609892|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609893|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609894|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609895|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609896|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609897|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609898|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609899|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609900|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609901|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609902|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609903|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0
7609904|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3
7609905|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20
7609906|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37
7609907|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609908|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609982|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Other|0
7609909|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609910|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609911|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609912|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609913|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609914|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609915|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609916|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609917|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609918|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609919|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609920|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609921|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609922|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609923|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609924|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609925|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609926|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609927|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609928|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609929|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609930|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609931|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2
7609932|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0
7609933|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609934|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609935|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609936|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609937|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609938|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609939|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609940|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609941|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609942|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609943|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609944|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609945|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609946|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609947|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609948|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609949|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609950|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609951|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609952|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609953|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609954|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609955|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609956|NCT03129100|12017854|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609957|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0
7609958|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1
7609959|NCT03129100|12017831|FG000|Period 4 (Post Treatment Follow-up)|Other|0
7609960|NCT03129100|12017832|FG001|Period 4 (Post Treatment Follow-up)|Other|0
7609961|NCT03129100|12017833|FG002|Period 4 (Post Treatment Follow-up)|Other|0
7609962|NCT03129100|12017834|FG003|Period 4 (Post Treatment Follow-up)|Other|0
7609963|NCT03129100|12017835|FG004|Period 4 (Post Treatment Follow-up)|Other|0
7609964|NCT03129100|12017836|FG005|Period 4 (Post Treatment Follow-up)|Other|0
7609965|NCT03129100|12017837|FG006|Period 4 (Post Treatment Follow-up)|Other|0
7609966|NCT03129100|12017838|FG007|Period 4 (Post Treatment Follow-up)|Other|0
7609967|NCT03129100|12017839|FG008|Period 4 (Post Treatment Follow-up)|Other|0
7609968|NCT03129100|12017840|FG009|Period 4 (Post Treatment Follow-up)|Other|0
7609969|NCT03129100|12017841|FG010|Period 4 (Post Treatment Follow-up)|Other|0
7609970|NCT03129100|12017842|FG011|Period 4 (Post Treatment Follow-up)|Other|0
7609971|NCT03129100|12017843|FG012|Period 4 (Post Treatment Follow-up)|Other|0
7609972|NCT03129100|12017844|FG013|Period 4 (Post Treatment Follow-up)|Other|0
7609973|NCT03129100|12017845|FG014|Period 4 (Post Treatment Follow-up)|Other|0
7609974|NCT03129100|12017846|FG015|Period 4 (Post Treatment Follow-up)|Other|0
7609975|NCT03129100|12017847|FG016|Period 4 (Post Treatment Follow-up)|Other|0
7609976|NCT03129100|12017848|FG017|Period 4 (Post Treatment Follow-up)|Other|0
7609977|NCT03129100|12017849|FG018|Period 4 (Post Treatment Follow-up)|Other|0
7609978|NCT03129100|12017850|FG019|Period 4 (Post Treatment Follow-up)|Other|0
7609979|NCT03129100|12017851|FG020|Period 4 (Post Treatment Follow-up)|Other|0
7609980|NCT03129100|12017852|FG021|Period 4 (Post Treatment Follow-up)|Other|0
7609981|NCT03129100|12017853|FG022|Period 4 (Post Treatment Follow-up)|Other|0
7609983|NCT03129100|12017855|FG024|Period 4 (Post Treatment Follow-up)|Other|0
7609984|NCT03129100|12017856|FG025|Period 4 (Post Treatment Follow-up)|Other|2
7609985|NCT02831257|12017893|FG000|Overall Study|Lack of Efficacy|3
7609986|NCT02831257|12017893|FG000|Overall Study|Adverse Event|2
7609987|NCT02831257|12017893|FG000|Overall Study|Physician Decision|1
7609988|NCT02831257|12017893|FG000|Overall Study|Withdrawal by Subject|6
7276974|NCT00451178|11491780|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
7276975|NCT00451178|11491781|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
7469744|NCT01926782|11771657|FG001|Overall Study|Poor compliance to protocol|3
7469745|NCT01926782|11771658|FG002|Overall Study|Poor compliance to protocol|8
7469746|NCT01926782|11771659|FG003|Overall Study|Poor compliance to protocol|0
7469747|NCT01926782|11771660|FG004|Overall Study|Poor compliance to protocol|1
7469748|NCT01926782|11771661|FG005|Overall Study|Poor compliance to protocol|6
7469749|NCT01926782|11771656|FG000|Overall Study|Randomized and not treated|0
7469750|NCT01926782|11771657|FG001|Overall Study|Randomized and not treated|0
7469751|NCT01926782|11771658|FG002|Overall Study|Randomized and not treated|0
7469752|NCT01926782|11771659|FG003|Overall Study|Randomized and not treated|1
7469753|NCT01926782|11771660|FG004|Overall Study|Randomized and not treated|0
7469754|NCT01926782|11771661|FG005|Overall Study|Randomized and not treated|0
7469755|NCT01926782|11771656|FG000|Overall Study|Withdrawal by Subject|6
7469756|NCT01926782|11771657|FG001|Overall Study|Withdrawal by Subject|1
7469757|NCT01926782|11771658|FG002|Overall Study|Withdrawal by Subject|8
7469758|NCT01926782|11771659|FG003|Overall Study|Withdrawal by Subject|1
7469759|NCT01926782|11771660|FG004|Overall Study|Withdrawal by Subject|0
7469760|NCT01926782|11771661|FG005|Overall Study|Withdrawal by Subject|5
7469761|NCT01926782|11771656|FG000|Overall Study|Related to study drug administration|0
7469762|NCT01926782|11771657|FG001|Overall Study|Related to study drug administration|0
7469763|NCT01926782|11771658|FG002|Overall Study|Related to study drug administration|0
7469764|NCT01926782|11771659|FG003|Overall Study|Related to study drug administration|0
7469765|NCT01926782|11771660|FG004|Overall Study|Related to study drug administration|0
7469766|NCT01926782|11771661|FG005|Overall Study|Related to study drug administration|2
7469767|NCT01926886|11771676|FG000|Overall Study|Administrative/other|1
7469768|NCT01926886|11771677|FG001|Overall Study|Administrative/other|0
7469769|NCT01926886|11771676|FG000|Overall Study|Adverse event/intercurrent illness|4
7469770|NCT01926886|11771677|FG001|Overall Study|Adverse event/intercurrent illness|0
7469771|NCT01926886|11771676|FG000|Overall Study|Disease progression/recurrence|4
7469772|NCT01926886|11771677|FG001|Overall Study|Disease progression/recurrence|0
7469773|NCT01926886|11771676|FG000|Overall Study|Withdrawal by Subject|15
7469774|NCT01926886|11771677|FG001|Overall Study|Withdrawal by Subject|0
7469775|NCT01926886|11771676|FG000|Overall Study|Failure to return|3
7469776|NCT01926886|11771677|FG001|Overall Study|Failure to return|0
7469777|NCT01926886|11771676|FG000|Overall Study|Recurrence of disease|1
7469778|NCT01926886|11771677|FG001|Overall Study|Recurrence of disease|0
7469779|NCT01926886|11771676|FG000|Overall Study|Progression of disease|2
7469780|NCT01926886|11771677|FG001|Overall Study|Progression of disease|0
7469781|NCT01926886|11771676|FG000|Overall Study|Death|1
7469782|NCT01926886|11771677|FG001|Overall Study|Death|0
7469783|NCT01926886|11771676|FG000|Overall Study|Did not cooperate|1
7469784|NCT01926886|11771677|FG001|Overall Study|Did not cooperate|0
7469785|NCT01927055|11771695|FG000|Open-label|Adverse Event|6
7469786|NCT01927055|11771696|FG001|Open-label|Adverse Event|0
7469787|NCT01927055|11771697|FG002|Open-label|Adverse Event|0
7469788|NCT01927055|11771695|FG000|Open-label|Withdrawal by Subject|1
7610023|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610024|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2
7610025|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1
7610026|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610027|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610028|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610029|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0
7610030|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3
7610031|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610032|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1
7610033|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610034|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610035|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610036|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0
7610037|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
7610038|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7610039|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
7610040|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610041|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610042|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610043|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
7610044|NCT02406027|12017931|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7610045|NCT02406027|12017932|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610046|NCT02406027|12017933|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
7610047|NCT02406027|12017934|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610048|NCT02406027|12017935|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610049|NCT02406027|12017936|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610050|NCT02406027|12017937|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
7610051|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Adverse Event|0
7610052|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Adverse Event|0
7610053|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Adverse Event|0
7610054|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Adverse Event|2
7610055|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Adverse Event|2
7610056|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Adverse Event|0
7610057|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Adverse Event|0
7610058|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Physician Decision|0
7610059|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Physician Decision|0
7610060|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Physician Decision|0
7610061|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Physician Decision|0
7610062|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Physician Decision|0
7610063|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Physician Decision|1
7610064|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Physician Decision|1
7610065|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610066|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610067|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610068|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2
7610069|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4
7610070|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0
7610071|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2
7610072|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610073|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610074|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
7610075|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
7610076|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
7610077|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
7610078|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
7610079|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610080|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610081|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610082|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610083|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610084|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
7610085|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
7610086|NCT02406027|12017931|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610087|NCT02406027|12017932|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610088|NCT02406027|12017933|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610089|NCT02406027|12017934|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610090|NCT02406027|12017935|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
7610091|NCT02406027|12017936|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610092|NCT02406027|12017937|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
7610093|NCT02374814|12017959|FG000|Overall Study|Lost to Follow-up|1
7610094|NCT02374814|12017960|FG001|Overall Study|Lost to Follow-up|1
7610095|NCT02374814|12017961|FG002|Overall Study|Lost to Follow-up|0
7610096|NCT02374814|12017962|FG003|Overall Study|Lost to Follow-up|1
7610097|NCT02374814|12017963|FG004|Overall Study|Lost to Follow-up|0
7610098|NCT02374814|12017964|FG005|Overall Study|Lost to Follow-up|0
7610099|NCT02374814|12017959|FG000|Overall Study|Withdrawal by Subject|0
7610100|NCT02374814|12017960|FG001|Overall Study|Withdrawal by Subject|0
7610101|NCT02374814|12017961|FG002|Overall Study|Withdrawal by Subject|1
7610102|NCT02374814|12017962|FG003|Overall Study|Withdrawal by Subject|1
7610103|NCT02374814|12017963|FG004|Overall Study|Withdrawal by Subject|0
7610104|NCT02374814|12017964|FG005|Overall Study|Withdrawal by Subject|0
7610105|NCT02142738|12017988|FG000|Overall Study|Adverse Event|13
7610106|NCT02142738|12017989|FG001|Overall Study|Adverse Event|9
7610107|NCT02142738|12017988|FG000|Overall Study|Death|92
7610108|NCT02142738|12017989|FG001|Overall Study|Death|112
7610109|NCT02142738|12017988|FG000|Overall Study|Lost to Follow-up|0
7610110|NCT02142738|12017989|FG001|Overall Study|Lost to Follow-up|3
7610111|NCT02142738|12017988|FG000|Overall Study|Withdrawal by Subject|6
7610112|NCT02142738|12017989|FG001|Overall Study|Withdrawal by Subject|7
7610113|NCT02142738|12017988|FG000|Overall Study|Follow up ended by sponsor|43
7610114|NCT02142738|12017989|FG001|Overall Study|Follow up ended by sponsor|20
7610125|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Adverse Event|0
7610126|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Adverse Event|0
7610127|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Adverse Event|1
7610128|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Adverse Event|0
7610129|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Adverse Event|0
7610130|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Adverse Event|0
7610131|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Adverse Event|0
7610132|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Adverse Event|0
7610133|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Adverse Event|0
7610134|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Adverse Event|0
7610135|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Adverse Event|0
7610136|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Adverse Event|0
7610137|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0
7610138|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0
7610139|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1
7610140|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0
7610141|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0
7610142|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0
7610143|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0
7610144|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0
7610145|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0
7610146|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0
7610147|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0
7610148|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0
7610149|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Progressive Disease|0
7610150|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Progressive Disease|1
7610151|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Progressive Disease|2
7610152|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Progressive Disease|0
7610153|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Progressive Disease|1
7610154|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Progressive Disease|1
7610155|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Progressive Disease|1
7610156|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Progressive Disease|0
7610157|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Progressive Disease|0
7610158|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Progressive Disease|0
7610159|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Progressive Disease|0
7610160|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Progressive Disease|0
7610161|NCT01667133|12018030|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610162|NCT01667133|12018031|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610163|NCT01667133|12018032|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610164|NCT01667133|12018033|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1
7610165|NCT01667133|12018034|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610166|NCT01667133|12018035|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610167|NCT01667133|12018036|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610168|NCT01667133|12018037|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610169|NCT01667133|12018038|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610170|NCT01667133|12018039|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610171|NCT01667133|12018040|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610172|NCT01667133|12018041|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0
7610173|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Adverse Event|0
7610174|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Adverse Event|0
7610175|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Adverse Event|0
7610176|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Adverse Event|0
7610177|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Adverse Event|0
7610178|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Adverse Event|0
7610179|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Adverse Event|0
7610180|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Adverse Event|2
7610181|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Adverse Event|1
7610182|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Adverse Event|1
7610183|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Adverse Event|0
7610184|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Adverse Event|0
7610185|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0
7610186|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0
7610187|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0
7610188|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0
7276976|NCT00451191|11491793|FG000|Overall Study|withdrawal or received alternate tx|15
7276977|NCT00451191|11491794|FG001|Overall Study|withdrawal or received alternate tx|11
7276978|NCT00451204|11491802|FG000|Overall Study|Adverse Event|4
7276979|NCT00451204|11491803|FG001|Overall Study|Adverse Event|6
7276980|NCT00451204|11491802|FG000|Overall Study|Lack of Efficacy|4
7276981|NCT00451204|11491803|FG001|Overall Study|Lack of Efficacy|4
7276982|NCT00451204|11491802|FG000|Overall Study|Lost to Follow-up|4
7276983|NCT00451204|11491803|FG001|Overall Study|Lost to Follow-up|4
7276984|NCT00451204|11491802|FG000|Overall Study|Protocol Violation|1
7276985|NCT00451204|11491803|FG001|Overall Study|Protocol Violation|0
7276986|NCT00451204|11491802|FG000|Overall Study|Patient refusal|8
7276987|NCT00451204|11491803|FG001|Overall Study|Patient refusal|4
7276988|NCT00451204|11491802|FG000|Overall Study|Other|1
7276989|NCT00451204|11491803|FG001|Overall Study|Other|2
7276990|NCT00451217|11491816|FG000|Overall Study|Lost to Follow-up|0
7276991|NCT00451217|11491817|FG001|Overall Study|Lost to Follow-up|1
7276992|NCT00451217|11491818|FG002|Overall Study|Lost to Follow-up|1
7276993|NCT00451217|11491819|FG003|Overall Study|Lost to Follow-up|1
7276994|NCT00451217|11491816|FG000|Overall Study|Withdrawal by Subject|1
7276995|NCT00451217|11491817|FG001|Overall Study|Withdrawal by Subject|0
7276996|NCT00451217|11491818|FG002|Overall Study|Withdrawal by Subject|0
7276997|NCT00451217|11491819|FG003|Overall Study|Withdrawal by Subject|0
7276998|NCT00451217|11491816|FG000|Overall Study|Not Treated|1
7276999|NCT00451217|11491817|FG001|Overall Study|Not Treated|1
7610189|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0
7610190|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0
7610191|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0
7610192|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0
7610193|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0
7610194|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2
7277000|NCT00451217|11491818|FG002|Overall Study|Not Treated|3
7277001|NCT00451217|11491819|FG003|Overall Study|Not Treated|4
7277002|NCT00451282|11491831|FG000|Overall Study|Lost to Follow-up|6
7277003|NCT00451282|11491832|FG001|Overall Study|Lost to Follow-up|5
7277004|NCT00451321|11491846|FG000|Overall Study|Lost to Follow-up|3
7277005|NCT00451321|11491847|FG001|Overall Study|Lost to Follow-up|3
7277006|NCT00451321|11491848|FG002|Overall Study|Lost to Follow-up|1
7277007|NCT00451321|11491849|FG003|Overall Study|Lost to Follow-up|3
7610195|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0
7610196|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0
7610197|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Progressive Disease|0
7610198|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Progressive Disease|0
7610199|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Progressive Disease|0
7610200|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Progressive Disease|0
7610201|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Progressive Disease|0
7610202|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Progressive Disease|0
7610203|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Progressive Disease|0
7610204|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Progressive Disease|0
7610205|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Progressive Disease|0
7610206|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Progressive Disease|0
7610207|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Progressive Disease|3
7610208|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Progressive Disease|5
7610209|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610210|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610211|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610212|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610213|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610214|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610215|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610216|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610217|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610218|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2
7610219|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610220|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0
7610221|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Death|0
7610222|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Death|0
7610223|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Death|0
7610224|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Death|0
7610225|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Death|0
7610226|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Death|0
7610227|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Death|0
7610228|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Death|0
7610229|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Death|0
7610230|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Death|1
7610231|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Death|0
7610232|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Death|0
7610233|NCT01667133|12018030|FG000|Phase 2: Dose-expansion|Other|0
7610234|NCT01667133|12018031|FG001|Phase 2: Dose-expansion|Other|0
7610235|NCT01667133|12018032|FG002|Phase 2: Dose-expansion|Other|0
7610236|NCT01667133|12018033|FG003|Phase 2: Dose-expansion|Other|0
7610237|NCT01667133|12018034|FG004|Phase 2: Dose-expansion|Other|0
7610238|NCT01667133|12018035|FG005|Phase 2: Dose-expansion|Other|0
7610239|NCT01667133|12018036|FG006|Phase 2: Dose-expansion|Other|0
7610240|NCT01667133|12018037|FG007|Phase 2: Dose-expansion|Other|0
7610241|NCT01667133|12018038|FG008|Phase 2: Dose-expansion|Other|0
7610242|NCT01667133|12018039|FG009|Phase 2: Dose-expansion|Other|0
7610243|NCT01667133|12018040|FG010|Phase 2: Dose-expansion|Other|0
7610244|NCT01667133|12018041|FG011|Phase 2: Dose-expansion|Other|1
7610245|NCT01585103|12018102|FG000|Overall Study|Unable to swallow Cytosponge|6
7610246|NCT01427725|12018106|FG000|Overall Study|Lost to Follow-up|17
7610247|NCT01427725|12018106|FG000|Overall Study|Protocol Violation|1
7610248|NCT01427725|12018106|FG000|Overall Study|Drug not administered|1
7610249|NCT01427725|12018106|FG000|Overall Study|Failure to visit|7
7610250|NCT01427725|12018106|FG000|Overall Study|Adverse Event|46
7277008|NCT00451321|11491850|FG004|Overall Study|Lost to Follow-up|0
7277009|NCT00451321|11491851|FG005|Overall Study|Lost to Follow-up|1
7277010|NCT00451321|11491852|FG006|Overall Study|Lost to Follow-up|0
7610251|NCT01427725|12018106|FG000|Overall Study|Failure to visit after administration|40
7610252|NCT01427725|12018106|FG000|Overall Study|Patient's rejection|27
7610253|NCT01427725|12018106|FG000|Overall Study|Transfer to a different hospital|17
7610254|NCT01427725|12018106|FG000|Overall Study|Lack of Efficacy|8
7610255|NCT01427725|12018106|FG000|Overall Study|Death|7
7610256|NCT01427725|12018106|FG000|Overall Study|Symptom improvement|6
7610257|NCT01427725|12018106|FG000|Overall Study|AE and Patient's rejection|5
7610258|NCT01427725|12018106|FG000|Overall Study|Physician Decision|5
7610259|NCT01427725|12018106|FG000|Overall Study|Exacerbation of underlying disease|5
7610260|NCT01427725|12018106|FG000|Overall Study|Oral feeding difficulty|5
7610261|NCT01427725|12018106|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1
7610262|NCT01427725|12018106|FG000|Overall Study|Forgetting prescription|1
7610263|NCT01427725|12018106|FG000|Overall Study|Other|2
7277011|NCT00451321|11491853|FG007|Overall Study|Lost to Follow-up|0
7610264|NCT04608344|12018117|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
7610265|NCT04608344|12018118|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
7610266|NCT04608344|12018117|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
7610267|NCT04608344|12018118|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
7610268|NCT04350372|12018137|FG000|Overall Study|Death|1
7277012|NCT00451321|11491846|FG000|Overall Study|Withdrawal by Subject|3
7277013|NCT00451321|11491847|FG001|Overall Study|Withdrawal by Subject|1
7277014|NCT00451321|11491848|FG002|Overall Study|Withdrawal by Subject|0
7277015|NCT00451321|11491849|FG003|Overall Study|Withdrawal by Subject|4
7277016|NCT00451321|11491850|FG004|Overall Study|Withdrawal by Subject|0
7277017|NCT00451321|11491851|FG005|Overall Study|Withdrawal by Subject|0
7277018|NCT00451321|11491852|FG006|Overall Study|Withdrawal by Subject|0
7277019|NCT00451321|11491853|FG007|Overall Study|Withdrawal by Subject|0
7277020|NCT00451321|11491846|FG000|Overall Study|Study closed/terminated|1
7277021|NCT00451321|11491847|FG001|Overall Study|Study closed/terminated|1
7277022|NCT00451321|11491848|FG002|Overall Study|Study closed/terminated|17
7277023|NCT00451321|11491849|FG003|Overall Study|Study closed/terminated|5
7277024|NCT00451321|11491850|FG004|Overall Study|Study closed/terminated|7
7277025|NCT00451321|11491851|FG005|Overall Study|Study closed/terminated|7
7277026|NCT00451321|11491852|FG006|Overall Study|Study closed/terminated|5
7277027|NCT00451321|11491853|FG007|Overall Study|Study closed/terminated|3
7277028|NCT00451321|11491846|FG000|Overall Study|Sponsor decision to amend protocol|0
7277029|NCT00451321|11491847|FG001|Overall Study|Sponsor decision to amend protocol|0
7277030|NCT00451321|11491848|FG002|Overall Study|Sponsor decision to amend protocol|0
7277031|NCT00451321|11491849|FG003|Overall Study|Sponsor decision to amend protocol|0
7277032|NCT00451321|11491850|FG004|Overall Study|Sponsor decision to amend protocol|0
7277033|NCT00451321|11491851|FG005|Overall Study|Sponsor decision to amend protocol|1
7277034|NCT00451321|11491852|FG006|Overall Study|Sponsor decision to amend protocol|1
7277035|NCT00451321|11491853|FG007|Overall Study|Sponsor decision to amend protocol|3
7277036|NCT00451451|11491875|FG000|Overall Study|Adverse Event|11
7277037|NCT00451451|11491876|FG001|Overall Study|Adverse Event|21
7277038|NCT00451451|11491877|FG002|Overall Study|Adverse Event|26
7610277|NCT04234984|12018188|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2
7610278|NCT04234984|12018188|FG000|Follow-up at the Second Time Point|Death|1
7610279|NCT04234984|12018188|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1
7610280|NCT04227197|12018196|FG000|Randomization|Protocol Violation|1
7610281|NCT04227197|12018197|FG001|Randomization|Protocol Violation|0
7610282|NCT04227197|12018196|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1
7610283|NCT04227197|12018197|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0
7610284|NCT04227197|12018196|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2
7610285|NCT04227197|12018197|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0
7610286|NCT04227197|12018196|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7
7610287|NCT04227197|12018197|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5
7610288|NCT04227197|12018196|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5
7610289|NCT04227197|12018197|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0
7277039|NCT00451451|11491878|FG003|Overall Study|Adverse Event|10
7277040|NCT00451451|11491875|FG000|Overall Study|Lost to Follow-up|11
7277041|NCT00451451|11491876|FG001|Overall Study|Lost to Follow-up|9
7277042|NCT00451451|11491877|FG002|Overall Study|Lost to Follow-up|8
7277043|NCT00451451|11491878|FG003|Overall Study|Lost to Follow-up|11
7610290|NCT04227197|12018196|FG000|2-week Follow-up Survey for PCP's|Not responsive|20
7610291|NCT04227197|12018197|FG001|2-week Follow-up Survey for PCP's|Not responsive|25
7610292|NCT04227197|12018196|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11
7610293|NCT04227197|12018197|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3
7610294|NCT04105725|12018208|FG000|Primary Intervention|Lost to Follow-up|0
7610295|NCT04105725|12018209|FG001|Primary Intervention|Lost to Follow-up|2
7610296|NCT04105725|12018208|FG000|Primary Intervention|Withdrawal by Subject|0
7610297|NCT04105725|12018209|FG001|Primary Intervention|Withdrawal by Subject|1
7610298|NCT04066023|12018218|FG000|Overall Study|Adverse Event|0
7610299|NCT04066023|12018219|FG001|Overall Study|Adverse Event|0
7610300|NCT04066023|12018220|FG002|Overall Study|Adverse Event|1
7610301|NCT04066023|12018218|FG000|Overall Study|Sponsor decision|3
7610302|NCT04066023|12018219|FG001|Overall Study|Sponsor decision|6
7610303|NCT04066023|12018220|FG002|Overall Study|Sponsor decision|2
7610304|NCT04066023|12018218|FG000|Overall Study|Physician Decision|0
7610305|NCT04066023|12018219|FG001|Overall Study|Physician Decision|0
7610306|NCT04066023|12018220|FG002|Overall Study|Physician Decision|1
7610307|NCT04066023|12018218|FG000|Overall Study|Lost to Follow-up|0
7610308|NCT04066023|12018219|FG001|Overall Study|Lost to Follow-up|1
7610309|NCT04066023|12018220|FG002|Overall Study|Lost to Follow-up|1
7610310|NCT04066023|12018218|FG000|Overall Study|Noncompliance|0
7610311|NCT04066023|12018219|FG001|Overall Study|Noncompliance|1
7610312|NCT04066023|12018220|FG002|Overall Study|Noncompliance|1
7610313|NCT03882957|12018241|FG000|Overall Study|Did not complete all three arms|1
7277044|NCT00451451|11491875|FG000|Overall Study|Consent Withdrawn|14
7277045|NCT00451451|11491876|FG001|Overall Study|Consent Withdrawn|9
7277046|NCT00451451|11491877|FG002|Overall Study|Consent Withdrawn|17
7277047|NCT00451451|11491878|FG003|Overall Study|Consent Withdrawn|17
7277048|NCT00451451|11491875|FG000|Overall Study|Investigator Decision|6
7277049|NCT00451451|11491876|FG001|Overall Study|Investigator Decision|2
7277050|NCT00451451|11491877|FG002|Overall Study|Investigator Decision|1
7277051|NCT00451451|11491878|FG003|Overall Study|Investigator Decision|2
7277052|NCT00451451|11491875|FG000|Overall Study|Subject Non-Compliance|8
7277053|NCT00451451|11491876|FG001|Overall Study|Subject Non-Compliance|4
7277054|NCT00451451|11491877|FG002|Overall Study|Subject Non-Compliance|3
7277055|NCT00451451|11491878|FG003|Overall Study|Subject Non-Compliance|3
7277056|NCT00451451|11491875|FG000|Overall Study|Death|1
7277057|NCT00451451|11491876|FG001|Overall Study|Death|0
7277058|NCT00451451|11491877|FG002|Overall Study|Death|0
7610314|NCT03387852|12018289|FG000|Overall Study|Adverse event (AE)|3
7610315|NCT03387852|12018290|FG001|Overall Study|Adverse event (AE)|0
7610316|NCT03387852|12018291|FG002|Overall Study|Adverse event (AE)|2
7610317|NCT03387852|12018292|FG003|Overall Study|Adverse event (AE)|0
7610318|NCT03387852|12018289|FG000|Overall Study|Loss of asthma control (LOAC)|28
7610319|NCT03387852|12018290|FG001|Overall Study|Loss of asthma control (LOAC)|16
7610320|NCT03387852|12018291|FG002|Overall Study|Loss of asthma control (LOAC)|20
7610321|NCT03387852|12018292|FG003|Overall Study|Loss of asthma control (LOAC)|14
7610322|NCT03387852|12018289|FG000|Overall Study|Withdrawal by participant|1
7610323|NCT03387852|12018290|FG001|Overall Study|Withdrawal by participant|1
7610324|NCT03387852|12018291|FG002|Overall Study|Withdrawal by participant|3
7610325|NCT03387852|12018292|FG003|Overall Study|Withdrawal by participant|2
7610326|NCT03387852|12018289|FG000|Overall Study|Other- Unspecified|1
7610327|NCT03387852|12018290|FG001|Overall Study|Other- Unspecified|1
7610328|NCT03387852|12018291|FG002|Overall Study|Other- Unspecified|2
7610329|NCT03387852|12018292|FG003|Overall Study|Other- Unspecified|1
7610330|NCT03387852|12018289|FG000|Overall Study|Poor compliance to protocol|0
7610331|NCT03387852|12018290|FG001|Overall Study|Poor compliance to protocol|0
7610332|NCT03387852|12018291|FG002|Overall Study|Poor compliance to protocol|0
7610333|NCT03387852|12018292|FG003|Overall Study|Poor compliance to protocol|1
7610334|NCT03387852|12018289|FG000|Overall Study|Randomized and not treated|0
7610335|NCT03387852|12018290|FG001|Overall Study|Randomized and not treated|0
7610336|NCT03387852|12018291|FG002|Overall Study|Randomized and not treated|0
7610337|NCT03387852|12018292|FG003|Overall Study|Randomized and not treated|1
7610338|NCT03364673|12018309|FG000|Overall Study|Withdrawal by Subject|2
7610339|NCT03364673|12018309|FG000|Overall Study|Injury unrelated to study|3
7610340|NCT03343704|12018315|FG000|Overall Study|Refused to complete follow up|0
7610341|NCT03343704|12018316|FG001|Overall Study|Refused to complete follow up|1
7610342|NCT03343704|12018315|FG000|Overall Study|Death|0
7610343|NCT03343704|12018316|FG001|Overall Study|Death|1
7610344|NCT03343704|12018315|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
7610345|NCT03343704|12018316|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
7610346|NCT03265145|12018326|FG000|Overall Study|Protocol Violation|2
7610347|NCT03265145|12018327|FG001|Overall Study|Protocol Violation|0
7610348|NCT03265145|12018326|FG000|Overall Study|Adverse Event|1
7610349|NCT03265145|12018327|FG001|Overall Study|Adverse Event|0
7610350|NCT03265145|12018326|FG000|Overall Study|Withdrawal by Subject|23
7610351|NCT03265145|12018327|FG001|Overall Study|Withdrawal by Subject|19
7610352|NCT03265145|12018326|FG000|Overall Study|Death|12
7610353|NCT03265145|12018327|FG001|Overall Study|Death|12
7610354|NCT03265145|12018326|FG000|Overall Study|Lost to Follow-up|13
7610355|NCT03265145|12018327|FG001|Overall Study|Lost to Follow-up|9
7610356|NCT03265145|12018326|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
7610357|NCT03265145|12018327|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
7610358|NCT03265145|12018326|FG000|Overall Study|Switched back to previous medication|1
7610359|NCT03265145|12018327|FG001|Overall Study|Switched back to previous medication|0
7610360|NCT03265145|12018326|FG000|Overall Study|Did not want to take medication|1
7610361|NCT03265145|12018327|FG001|Overall Study|Did not want to take medication|0
7610362|NCT03265145|12018326|FG000|Overall Study|Subject could not afford medication|0
7610363|NCT03265145|12018327|FG001|Overall Study|Subject could not afford medication|1
7610364|NCT03265145|12018326|FG000|Overall Study|Site closed|2
7610365|NCT03265145|12018327|FG001|Overall Study|Site closed|3
7610366|NCT03265145|12018326|FG000|Overall Study|Incorrectly randomized|16
7610367|NCT03265145|12018327|FG001|Overall Study|Incorrectly randomized|6
7610368|NCT03265145|12018326|FG000|Overall Study|Entered into Electronic Data Capture in error|0
7610369|NCT03265145|12018327|FG001|Overall Study|Entered into Electronic Data Capture in error|1
7610370|NCT03265145|12018326|FG000|Overall Study|Physician Decision|0
7610371|NCT03265145|12018327|FG001|Overall Study|Physician Decision|3
7610372|NCT03265145|12018326|FG000|Overall Study|Subject transferred to another facility|0
7610373|NCT03265145|12018327|FG001|Overall Study|Subject transferred to another facility|1
7610374|NCT03219164|12018336|FG000|Overall Study|Study Terminated by Sponsor|16
7610375|NCT03219164|12018337|FG001|Overall Study|Study Terminated by Sponsor|12
7610376|NCT03219164|12018336|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5
7610377|NCT03219164|12018337|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4
7610378|NCT03219164|12018336|FG000|Overall Study|Lost to Follow-up|1
7610379|NCT03219164|12018337|FG001|Overall Study|Lost to Follow-up|1
7610380|NCT03219164|12018336|FG000|Overall Study|Adverse Event|1
7610381|NCT03219164|12018337|FG001|Overall Study|Adverse Event|0
7610382|NCT03219164|12018336|FG000|Overall Study|Non-Compliance with Study Drug|1
7610383|NCT03219164|12018337|FG001|Overall Study|Non-Compliance with Study Drug|0
7277059|NCT00451451|11491878|FG003|Overall Study|Death|1
7277060|NCT00451451|11491875|FG000|Overall Study|Other Reasons for Not Completing Study|34
7277061|NCT00451451|11491876|FG001|Overall Study|Other Reasons for Not Completing Study|30
7277062|NCT00451451|11491877|FG002|Overall Study|Other Reasons for Not Completing Study|17
7277063|NCT00451451|11491878|FG003|Overall Study|Other Reasons for Not Completing Study|14
7277064|NCT00451555|11491893|FG000|Overall Study|Protocol Violation|2
7277065|NCT00451555|11491894|FG001|Overall Study|Protocol Violation|2
7277066|NCT00451555|11491893|FG000|Overall Study|Adverse Event|3
7277067|NCT00451555|11491894|FG001|Overall Study|Adverse Event|1
7277068|NCT00451555|11491893|FG000|Overall Study|Withdrawal by Subject|6
7277069|NCT00451555|11491894|FG001|Overall Study|Withdrawal by Subject|0
7277070|NCT00451555|11491893|FG000|Overall Study|Physician Decision|2
7277071|NCT00451555|11491894|FG001|Overall Study|Physician Decision|1
7277072|NCT00451906|11491920|FG000|Overall Study|Adverse Event|515
7277073|NCT00451906|11491920|FG000|Overall Study|Lost to Follow-up|31
7277074|NCT00451906|11491920|FG000|Overall Study|Withdrawal by Subject|111
7277075|NCT00451906|11491920|FG000|Overall Study|Protocol Violation|21
7277076|NCT00451906|11491920|FG000|Overall Study|Progressive disease|1328
7277077|NCT00451906|11491920|FG000|Overall Study|Termination of the study|108
7277078|NCT00451906|11491920|FG000|Overall Study|Other Reasons|121
7277079|NCT00451906|11491920|FG000|Overall Study|Did not complete final visit|4
7277080|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Adverse Event|21
7277081|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Adverse Event|34
7277082|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Adverse Event|14
7277083|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Adverse Event|17
7277084|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Adverse Event|0
7277085|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
7277086|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
7277087|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
7277088|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
7277089|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
7277090|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Protocol Violation|1
7277091|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Protocol Violation|3
7277092|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Protocol Violation|2
7277093|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Protocol Violation|0
7277094|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Protocol Violation|0
7277095|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Physician Decision|2
7277096|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Physician Decision|4
7277097|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Physician Decision|4
7277098|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Physician Decision|4
7277099|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Physician Decision|0
7277100|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
7277101|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
7277102|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
7277103|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
7277104|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
7277105|NCT00451958|11491928|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
7277106|NCT00451958|11491929|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
7277107|NCT00451958|11491930|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
7277108|NCT00451958|11491931|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
7277109|NCT00451958|11491932|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
7277110|NCT00452114|11491948|FG000|Overall Study|Physician Decision|3
7277111|NCT00452114|11491949|FG001|Overall Study|Physician Decision|3
7277112|NCT00452348|11491973|FG000|Overall Study|Adverse Event|6
7277113|NCT00452348|11491974|FG001|Overall Study|Adverse Event|9
7277114|NCT00452348|11491973|FG000|Overall Study|Lack of Efficacy|10
7610384|NCT03219164|12018336|FG000|Overall Study|Protocol Violation|0
7610385|NCT03219164|12018337|FG001|Overall Study|Protocol Violation|1
7610386|NCT03219164|12018336|FG000|Overall Study|Withdrew Assent|1
7610387|NCT03219164|12018337|FG001|Overall Study|Withdrew Assent|0
7610388|NCT03143153|12018346|FG000|Pre-Treatment|Participant request to discontinue study treatment|0
7610389|NCT03143153|12018347|FG001|Pre-Treatment|Participant request to discontinue study treatment|0
7610390|NCT03143153|12018348|FG002|Pre-Treatment|Participant request to discontinue study treatment|2
7610391|NCT03143153|12018346|FG000|Pre-Treatment|Participant withdrew consent|0
7610392|NCT03143153|12018347|FG001|Pre-Treatment|Participant withdrew consent|1
7610393|NCT03143153|12018348|FG002|Pre-Treatment|Participant withdrew consent|12
7610394|NCT03143153|12018346|FG000|Pre-Treatment|Participant no longer meets study criteria|0
7610395|NCT03143153|12018347|FG001|Pre-Treatment|Participant no longer meets study criteria|4
7610396|NCT03143153|12018348|FG002|Pre-Treatment|Participant no longer meets study criteria|2
7610397|NCT03143153|12018346|FG000|Pre-Treatment|Other Reasons|1
7610398|NCT03143153|12018347|FG001|Pre-Treatment|Other Reasons|2
7610399|NCT03143153|12018348|FG002|Pre-Treatment|Other Reasons|1
7610400|NCT03143153|12018346|FG000|Pre-Treatment|Disease Progression|1
7610401|NCT03143153|12018347|FG001|Pre-Treatment|Disease Progression|1
7610402|NCT03143153|12018348|FG002|Pre-Treatment|Disease Progression|2
7610403|NCT03143153|12018346|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7610404|NCT03143153|12018347|FG001|Pre-Treatment|Adverse event unrelated to study drug|3
7610405|NCT03143153|12018348|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
7610406|NCT03143153|12018346|FG000|Treatment|Disease progression|174
7610407|NCT03143153|12018347|FG001|Treatment|Disease progression|184
7610408|NCT03143153|12018348|FG002|Treatment|Disease progression|193
7610409|NCT03143153|12018346|FG000|Treatment|Study drug toxicity|59
7610410|NCT03143153|12018347|FG001|Treatment|Study drug toxicity|33
7610411|NCT03143153|12018348|FG002|Treatment|Study drug toxicity|40
7610412|NCT03143153|12018346|FG000|Treatment|Death|5
7610413|NCT03143153|12018347|FG001|Treatment|Death|3
7610414|NCT03143153|12018348|FG002|Treatment|Death|4
7610415|NCT03143153|12018346|FG000|Treatment|Adverse event unrelated to study drug|19
7610416|NCT03143153|12018347|FG001|Treatment|Adverse event unrelated to study drug|28
7610417|NCT03143153|12018348|FG002|Treatment|Adverse event unrelated to study drug|12
7610418|NCT03143153|12018346|FG000|Treatment|Participant request to discontinue study treatment|13
7610419|NCT03143153|12018347|FG001|Treatment|Participant request to discontinue study treatment|15
7610420|NCT03143153|12018348|FG002|Treatment|Participant request to discontinue study treatment|20
7610421|NCT03143153|12018346|FG000|Treatment|Participant withdrew consent|3
7610422|NCT03143153|12018347|FG001|Treatment|Participant withdrew consent|4
7610423|NCT03143153|12018348|FG002|Treatment|Participant withdrew consent|12
7610424|NCT03143153|12018346|FG000|Treatment|Pregnancy|1
7610425|NCT03143153|12018347|FG001|Treatment|Pregnancy|0
7277115|NCT00452348|11491974|FG001|Overall Study|Lack of Efficacy|9
7277116|NCT00452348|11491973|FG000|Overall Study|Lost to Follow-up|14
7277117|NCT00452348|11491974|FG001|Overall Study|Lost to Follow-up|8
7277118|NCT00452348|11491973|FG000|Overall Study|Protocol Violation|22
7277119|NCT00452348|11491974|FG001|Overall Study|Protocol Violation|28
7277120|NCT00452348|11491973|FG000|Overall Study|Withdrawal by Subject|18
7277121|NCT00452348|11491974|FG001|Overall Study|Withdrawal by Subject|21
7277122|NCT00452348|11491973|FG000|Overall Study|Other|9
7277123|NCT00452348|11491974|FG001|Overall Study|Other|9
7277124|NCT00452400|11491995|FG000|Overall Study|Adverse Event|1
7277125|NCT00452400|11491996|FG001|Overall Study|Adverse Event|1
7277126|NCT00452400|11491997|FG002|Overall Study|Adverse Event|5
7277127|NCT00452400|11491998|FG003|Overall Study|Adverse Event|0
7277128|NCT00452400|11491999|FG004|Overall Study|Adverse Event|2
7277129|NCT00452400|11491995|FG000|Overall Study|Protocol Violation|0
7277130|NCT00452400|11491996|FG001|Overall Study|Protocol Violation|0
7277131|NCT00452400|11491997|FG002|Overall Study|Protocol Violation|1
7277132|NCT00452400|11491998|FG003|Overall Study|Protocol Violation|0
7277133|NCT00452400|11491999|FG004|Overall Study|Protocol Violation|0
7277134|NCT00452400|11491995|FG000|Overall Study|Lost to Follow-up|1
7277135|NCT00452400|11491996|FG001|Overall Study|Lost to Follow-up|0
7277136|NCT00452400|11491997|FG002|Overall Study|Lost to Follow-up|0
7610426|NCT03143153|12018348|FG002|Treatment|Pregnancy|0
7610427|NCT03143153|12018346|FG000|Treatment|Maximum clinical benefit|1
7610428|NCT03143153|12018347|FG001|Treatment|Maximum clinical benefit|3
7610429|NCT03143153|12018348|FG002|Treatment|Maximum clinical benefit|4
7610430|NCT03143153|12018346|FG000|Treatment|Completed treatment as per Protocol|13
7610431|NCT03143153|12018347|FG001|Treatment|Completed treatment as per Protocol|8
7610432|NCT03143153|12018348|FG002|Treatment|Completed treatment as per Protocol|0
7610433|NCT03143153|12018346|FG000|Treatment|Other reasons|12
7610434|NCT03143153|12018347|FG001|Treatment|Other reasons|7
7610435|NCT03143153|12018348|FG002|Treatment|Other reasons|15
7610436|NCT03143153|12018346|FG000|Treatment|Not reported|1
7610437|NCT03143153|12018347|FG001|Treatment|Not reported|0
7610438|NCT03143153|12018348|FG002|Treatment|Not reported|0
7610439|NCT02921789|12018396|FG000|Overall Study|Adverse Event|0
7610440|NCT02921789|12018397|FG001|Overall Study|Adverse Event|1
7277137|NCT00452400|11491998|FG003|Overall Study|Lost to Follow-up|0
7277138|NCT00452400|11491999|FG004|Overall Study|Lost to Follow-up|0
7277139|NCT00452400|11491995|FG000|Overall Study|Withdrawal by Subject|1
7277140|NCT00452400|11491996|FG001|Overall Study|Withdrawal by Subject|0
7277141|NCT00452400|11491997|FG002|Overall Study|Withdrawal by Subject|1
7277142|NCT00452400|11491998|FG003|Overall Study|Withdrawal by Subject|0
7277143|NCT00452400|11491999|FG004|Overall Study|Withdrawal by Subject|0
7277144|NCT00452400|11491995|FG000|Overall Study|Lack of Efficacy|2
7277145|NCT00452400|11491996|FG001|Overall Study|Lack of Efficacy|0
7277146|NCT00452400|11491997|FG002|Overall Study|Lack of Efficacy|0
7277147|NCT00452400|11491998|FG003|Overall Study|Lack of Efficacy|0
7277148|NCT00452400|11491999|FG004|Overall Study|Lack of Efficacy|0
7277149|NCT00452400|11491995|FG000|Overall Study|Other reasons not listed above|0
7277150|NCT00452400|11491996|FG001|Overall Study|Other reasons not listed above|0
7277151|NCT00452400|11491997|FG002|Overall Study|Other reasons not listed above|0
7277152|NCT00452400|11491998|FG003|Overall Study|Other reasons not listed above|1
7277153|NCT00452400|11491999|FG004|Overall Study|Other reasons not listed above|1
7277154|NCT00452413|11492014|FG000|Overall Study|Progressive Disease|4
7277155|NCT00452413|11492015|FG001|Overall Study|Progressive Disease|11
7277156|NCT00452413|11492016|FG002|Overall Study|Progressive Disease|30
7277157|NCT00452413|11492014|FG000|Overall Study|Withdrawal by Subject|0
7277158|NCT00452413|11492015|FG001|Overall Study|Withdrawal by Subject|1
7277159|NCT00452413|11492016|FG002|Overall Study|Withdrawal by Subject|4
7277160|NCT00452413|11492014|FG000|Overall Study|Adverse Event|0
7277161|NCT00452413|11492015|FG001|Overall Study|Adverse Event|0
7277162|NCT00452413|11492016|FG002|Overall Study|Adverse Event|5
7277163|NCT00452413|11492014|FG000|Overall Study|Physician Decision|0
7277164|NCT00452413|11492015|FG001|Overall Study|Physician Decision|0
7610441|NCT02921789|12018396|FG000|Overall Study|Lost to Follow-up|1
7610442|NCT02921789|12018397|FG001|Overall Study|Lost to Follow-up|0
7610443|NCT02921789|12018396|FG000|Overall Study|Protocol Deviation|2
7610444|NCT02921789|12018397|FG001|Overall Study|Protocol Deviation|0
7610445|NCT02921789|12018396|FG000|Overall Study|Withdrawal by Subject|2
7610446|NCT02921789|12018397|FG001|Overall Study|Withdrawal by Subject|1
7610447|NCT02921789|12018396|FG000|Overall Study|Miscellaneous|3
7610448|NCT02921789|12018397|FG001|Overall Study|Miscellaneous|2
7610449|NCT02898077|12018405|FG000|Overall Study|Enrolled/randomized, but never treated|1
7610450|NCT02898077|12018406|FG001|Overall Study|Enrolled/randomized, but never treated|1
7610451|NCT02898077|12018405|FG000|Overall Study|Lost to Follow-up|4
7610452|NCT02898077|12018406|FG001|Overall Study|Lost to Follow-up|3
7610453|NCT02898077|12018405|FG000|Overall Study|Physician Decision|0
7610454|NCT02898077|12018406|FG001|Overall Study|Physician Decision|2
7610455|NCT02898077|12018405|FG000|Overall Study|Sponsor Decision|32
7610456|NCT02898077|12018406|FG001|Overall Study|Sponsor Decision|13
7610457|NCT02898077|12018405|FG000|Overall Study|Withdrawal by Subject|6
7610458|NCT02898077|12018406|FG001|Overall Study|Withdrawal by Subject|3
7610459|NCT02898077|12018405|FG000|Overall Study|Discontinued from treatment but refused follow-up|2
7610460|NCT02898077|12018406|FG001|Overall Study|Discontinued from treatment but refused follow-up|1
7610461|NCT02898077|12018405|FG000|Overall Study|Ended extension period|3
7610462|NCT02898077|12018406|FG001|Overall Study|Ended extension period|0
7610463|NCT02702271|12018414|FG000|Overall Study|Death|36
7610464|NCT02702271|12018415|FG001|Overall Study|Death|7
7610465|NCT02702271|12018414|FG000|Overall Study|Lost to Follow-up|12
7610466|NCT02702271|12018415|FG001|Overall Study|Lost to Follow-up|0
7610467|NCT02702271|12018414|FG000|Overall Study|Withdrawal by Subject|8
7610468|NCT02702271|12018415|FG001|Overall Study|Withdrawal by Subject|1
7610469|NCT02702271|12018414|FG000|Overall Study|Physician Decision|2
7610470|NCT02702271|12018415|FG001|Overall Study|Physician Decision|0
7610471|NCT02702271|12018414|FG000|Overall Study|Unsuccessful Implant Attempt|5
7610472|NCT02702271|12018415|FG001|Overall Study|Unsuccessful Implant Attempt|1
7610473|NCT02471339|12018439|FG000|Overall Study|Did not provide follow-up data|2
7610474|NCT02471339|12018440|FG001|Overall Study|Did not provide follow-up data|0
7610475|NCT02470585|12018449|FG000|Overall Study|Death|82
7610476|NCT02470585|12018450|FG001|Overall Study|Death|87
7610477|NCT02470585|12018451|FG002|Overall Study|Death|86
7610478|NCT02470585|12018449|FG000|Overall Study|Withdrawal by Subject|19
7610479|NCT02470585|12018450|FG001|Overall Study|Withdrawal by Subject|21
7610480|NCT02470585|12018451|FG002|Overall Study|Withdrawal by Subject|29
7610481|NCT02470585|12018449|FG000|Overall Study|Lost to Follow-up|2
7610482|NCT02470585|12018450|FG001|Overall Study|Lost to Follow-up|5
7610483|NCT02470585|12018451|FG002|Overall Study|Lost to Follow-up|4
7610484|NCT02470585|12018449|FG000|Overall Study|Other|4
7610485|NCT02470585|12018450|FG001|Overall Study|Other|4
7610486|NCT02470585|12018451|FG002|Overall Study|Other|6
7277165|NCT00452413|11492016|FG002|Overall Study|Physician Decision|4
7277166|NCT00452413|11492014|FG000|Overall Study|Death due to study disease|0
7277167|NCT00452413|11492015|FG001|Overall Study|Death due to study disease|0
7277168|NCT00452413|11492016|FG002|Overall Study|Death due to study disease|2
7277169|NCT00452413|11492014|FG000|Overall Study|Death due to adverse event (AE)|0
7610487|NCT02163694|12018482|FG000|Overall Study|Adverse event- related to progression|3
7610488|NCT02163694|12018483|FG001|Overall Study|Adverse event- related to progression|8
7610489|NCT02163694|12018482|FG000|Overall Study|Adverse event- not related to progression|7
7610490|NCT02163694|12018483|FG001|Overall Study|Adverse event- not related to progression|17
7610491|NCT02163694|12018482|FG000|Overall Study|Withdrew consent|8
7610492|NCT02163694|12018483|FG001|Overall Study|Withdrew consent|21
7610493|NCT02163694|12018482|FG000|Overall Study|Lost to Follow-up|1
7610494|NCT02163694|12018483|FG001|Overall Study|Lost to Follow-up|2
7610495|NCT02163694|12018482|FG000|Overall Study|Progressive disease per protocol|122
7610496|NCT02163694|12018483|FG001|Overall Study|Progressive disease per protocol|197
7610497|NCT02163694|12018482|FG000|Overall Study|Other, not specified|13
7610498|NCT02163694|12018483|FG001|Overall Study|Other, not specified|22
7610499|NCT01966471|12018491|FG000|Overall Study|Death|44
7610500|NCT01966471|12018492|FG001|Overall Study|Death|56
7610501|NCT01966471|12018491|FG000|Overall Study|Lost to Follow-up|46
7610502|NCT01966471|12018492|FG001|Overall Study|Lost to Follow-up|39
7610503|NCT01966471|12018491|FG000|Overall Study|Various reasons|4
7610504|NCT01966471|12018492|FG001|Overall Study|Various reasons|4
7610505|NCT01966471|12018491|FG000|Overall Study|Physician Decision|7
7610506|NCT01966471|12018492|FG001|Overall Study|Physician Decision|5
7610507|NCT01966471|12018491|FG000|Overall Study|Study Terminated By Sponsor|758
7610508|NCT01966471|12018492|FG001|Overall Study|Study Terminated By Sponsor|773
7610509|NCT01966471|12018491|FG000|Overall Study|Withdrawal by Subject|59
7610510|NCT01966471|12018492|FG001|Overall Study|Withdrawal by Subject|51
7610511|NCT01465334|12018522|FG000|Overall Study|Disease Progression|1
7610512|NCT01465334|12018523|FG001|Overall Study|Disease Progression|0
7610513|NCT01465334|12018522|FG000|Overall Study|Adverse Event|1
7610514|NCT01465334|12018523|FG001|Overall Study|Adverse Event|0
7610515|NCT01465334|12018522|FG000|Overall Study|Richter's transformation|0
7610516|NCT01465334|12018523|FG001|Overall Study|Richter's transformation|3
7610517|NCT01465334|12018522|FG000|Overall Study|Refractory Disease|0
7610518|NCT01465334|12018523|FG001|Overall Study|Refractory Disease|3
7610519|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7610520|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
7610521|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
7610522|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610523|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610524|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610525|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610526|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610527|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
7610528|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
7610529|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
7610530|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
7610531|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610532|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610533|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610534|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610535|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610536|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
7610537|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
7610538|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
7610539|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
7610540|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610541|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610542|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610543|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610544|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610545|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
7610546|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610547|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610548|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
7610549|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610550|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610551|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610552|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610553|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610554|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
7610555|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
7610556|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
7610557|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
7610558|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610559|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610560|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610561|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610562|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610563|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
7610564|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
7610565|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610566|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610567|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610568|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610569|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610570|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610571|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610572|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
7610573|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
7610574|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
7610575|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610576|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610577|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610578|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610579|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610580|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610581|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
7610582|NCT01307423|12018532|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610583|NCT01307423|12018533|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7610584|NCT01307423|12018534|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
7610585|NCT01307423|12018535|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610586|NCT01307423|12018536|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610587|NCT01307423|12018537|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610588|NCT01307423|12018538|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610589|NCT01307423|12018539|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610590|NCT01307423|12018540|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
7610591|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610592|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
7610593|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610594|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610595|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
7610596|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610597|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610598|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610599|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
7610600|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610601|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7610602|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
7610603|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
7610604|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
7610605|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610606|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610607|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610608|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
7610609|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610610|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610611|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610612|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610613|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610614|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
7610615|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610616|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610617|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
7610618|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610619|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
7610620|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
7610621|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610622|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610623|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7610624|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
7610625|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610626|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
7610627|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610628|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610629|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610630|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
7610631|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610632|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610633|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610634|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610635|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
7610636|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Other|0
7610637|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Other|0
7610638|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Other|0
7610639|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Other|1
7610640|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Other|0
7610641|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Other|0
7610642|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Other|0
7610643|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Other|0
7610644|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Other|0
7610645|NCT01307423|12018532|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610646|NCT01307423|12018533|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610647|NCT01307423|12018534|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610648|NCT01307423|12018535|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610649|NCT01307423|12018536|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610650|NCT01307423|12018537|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
7610651|NCT01307423|12018538|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610652|NCT01307423|12018539|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610653|NCT01307423|12018540|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
7610654|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
7610655|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
7610656|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
7610657|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
7610658|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
7610659|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
7610660|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
7610661|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
7610662|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
7610663|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610664|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
7610665|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
7610666|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610667|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610668|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610669|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
7610670|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
7610671|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
7610672|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610673|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610674|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
7610675|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610676|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610677|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610678|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610679|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610680|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
7610681|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610682|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
7610683|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
7610684|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610685|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610686|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610687|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
7610688|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
7610689|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
7610690|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610691|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610692|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610693|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610694|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610695|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610696|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
7610697|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610698|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
7610699|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
7610700|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
7610701|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
7610702|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
7610703|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
7610704|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
7610705|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
7610706|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
7610707|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
7610708|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610709|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7610710|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
7610711|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610712|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610713|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610714|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
7610715|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
7610716|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
7610717|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610718|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7610719|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
7610720|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610721|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610722|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610723|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610724|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610725|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
7610726|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610727|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7610728|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
7610729|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610730|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610731|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610732|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
7610733|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
7610734|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
7610735|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7277170|NCT00452413|11492015|FG001|Overall Study|Death due to adverse event (AE)|0
7277171|NCT00452413|11492016|FG002|Overall Study|Death due to adverse event (AE)|1
7277172|NCT00452413|11492014|FG000|Overall Study|On treatment|0
7277173|NCT00452413|11492015|FG001|Overall Study|On treatment|0
7277174|NCT00452413|11492016|FG002|Overall Study|On treatment|3
7277175|NCT00452439|11492036|FG000|Overall Study|Lost to Follow-up|1
7277176|NCT00452439|11492037|FG001|Overall Study|Lost to Follow-up|1
7277177|NCT00452439|11492036|FG000|Overall Study|Refused Treatment|4
7277178|NCT00452439|11492037|FG001|Overall Study|Refused Treatment|3
7277179|NCT00452439|11492036|FG000|Overall Study|Death|3
7277180|NCT00452439|11492037|FG001|Overall Study|Death|1
7277181|NCT00452439|11492036|FG000|Overall Study|Bone Marrow Transplant|0
7277182|NCT00452439|11492037|FG001|Overall Study|Bone Marrow Transplant|1
7277183|NCT00452439|11492036|FG000|Overall Study|Too Ill to Continue|0
7277184|NCT00452439|11492037|FG001|Overall Study|Too Ill to Continue|1
7277185|NCT00452439|11492036|FG000|Overall Study|Failed to achieve complete response|2
7277186|NCT00452439|11492037|FG001|Overall Study|Failed to achieve complete response|0
7277187|NCT00452439|11492036|FG000|Overall Study|Relapse|3
7277188|NCT00452439|11492037|FG001|Overall Study|Relapse|0
7277189|NCT00452439|11492036|FG000|Overall Study|Fracture|1
7277190|NCT00452439|11492037|FG001|Overall Study|Fracture|0
7277191|NCT00452452|11492046|FG000|Overall Study|Protocol Violation|0
7277192|NCT00452452|11492047|FG001|Overall Study|Protocol Violation|0
7277193|NCT00452452|11492048|FG002|Overall Study|Protocol Violation|1
7277194|NCT00452452|11492046|FG000|Overall Study|Withdrawal by Subject|1
7277195|NCT00452452|11492047|FG001|Overall Study|Withdrawal by Subject|0
7610736|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
7610737|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
7610738|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610739|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610740|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610741|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
7610742|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7610743|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
7610744|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610745|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
7610746|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610747|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610748|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610749|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610750|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610751|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
7610752|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
7610753|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
7610754|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
7610755|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
7610756|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
7610757|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
7610758|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
7610759|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
7610760|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
7277196|NCT00452452|11492048|FG002|Overall Study|Withdrawal by Subject|0
7277197|NCT00452452|11492046|FG000|Overall Study|Lost to Follow-up|1
7277198|NCT00452452|11492047|FG001|Overall Study|Lost to Follow-up|0
7277199|NCT00452452|11492048|FG002|Overall Study|Lost to Follow-up|0
7277200|NCT00452530|11492064|FG000|Overall Study|Death|1
7277201|NCT00452530|11492065|FG001|Overall Study|Death|0
7277202|NCT00452530|11492064|FG000|Overall Study|Adverse Event|40
7610761|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
7277203|NCT00452530|11492065|FG001|Overall Study|Adverse Event|44
7277204|NCT00452530|11492064|FG000|Overall Study|Withdrawal by Subject|68
7277205|NCT00452530|11492065|FG001|Overall Study|Withdrawal by Subject|57
7277206|NCT00452530|11492064|FG000|Overall Study|Lost to Follow-up|1
7277207|NCT00452530|11492065|FG001|Overall Study|Lost to Follow-up|0
7277208|NCT00452530|11492064|FG000|Overall Study|Poor compliance/noncompliance|1
7610762|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610763|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7610764|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610765|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610766|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610767|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610768|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610769|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
7610770|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
7610771|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610772|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
7610773|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7610774|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610775|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610776|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610777|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
7610778|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
7610779|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
7610780|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610781|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610782|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
7610783|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610784|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610785|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610786|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610787|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610788|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
7610789|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
7277209|NCT00452530|11492065|FG001|Overall Study|Poor compliance/noncompliance|2
7277210|NCT00452530|11492064|FG000|Overall Study|No longer met study criteria|18
7277211|NCT00452530|11492065|FG001|Overall Study|No longer met study criteria|22
7277212|NCT00452530|11492064|FG000|Overall Study|Other|7
7277213|NCT00452530|11492065|FG001|Overall Study|Other|11
7277214|NCT00452673|11492088|FG000|Dose Escalation Period|Disease Progression|6
7277215|NCT00452673|11492089|FG001|Dose Escalation Period|Disease Progression|6
7277216|NCT00452673|11492090|FG002|Dose Escalation Period|Disease Progression|2
7277217|NCT00452673|11492091|FG003|Dose Escalation Period|Disease Progression|6
7277218|NCT00452673|11492092|FG004|Dose Escalation Period|Disease Progression|0
7277219|NCT00452673|11492088|FG000|Dose Escalation Period|study drug toxicity|1
7277220|NCT00452673|11492089|FG001|Dose Escalation Period|study drug toxicity|3
7277221|NCT00452673|11492090|FG002|Dose Escalation Period|study drug toxicity|3
7277222|NCT00452673|11492091|FG003|Dose Escalation Period|study drug toxicity|1
7277223|NCT00452673|11492092|FG004|Dose Escalation Period|study drug toxicity|0
7277224|NCT00452673|11492088|FG000|Dose Escalation Period|Other|0
7277225|NCT00452673|11492089|FG001|Dose Escalation Period|Other|0
7277226|NCT00452673|11492090|FG002|Dose Escalation Period|Other|1
7277227|NCT00452673|11492091|FG003|Dose Escalation Period|Other|0
7277228|NCT00452673|11492092|FG004|Dose Escalation Period|Other|0
7277229|NCT00452673|11492088|FG000|Dose Escalation Period|Adverse Event|0
7277230|NCT00452673|11492089|FG001|Dose Escalation Period|Adverse Event|0
7277231|NCT00452673|11492090|FG002|Dose Escalation Period|Adverse Event|0
7610790|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610791|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610792|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610793|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610794|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610795|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610796|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
7610797|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
7610798|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
7610799|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
7610800|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
7610801|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
7610802|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
7610803|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
7610804|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
7610805|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
7610806|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
7610807|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610808|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
7277232|NCT00452673|11492091|FG003|Dose Escalation Period|Adverse Event|1
7610809|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
7610810|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610811|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610812|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610813|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610814|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610815|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
7610816|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610817|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
7610818|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
7610819|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610820|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610821|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610822|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610823|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
7610824|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
7610825|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610826|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
7610827|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610828|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610829|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610830|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610831|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610832|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610833|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
7610834|NCT01307423|12018532|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610835|NCT01307423|12018533|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610836|NCT01307423|12018534|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
7610837|NCT01307423|12018535|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610838|NCT01307423|12018536|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610839|NCT01307423|12018537|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610840|NCT01307423|12018538|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
7610841|NCT01307423|12018539|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
7610842|NCT01307423|12018540|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
7610843|NCT00655876|12018601|FG000|Overall Study|Protocol Violation|9
7610844|NCT00655876|12018602|FG001|Overall Study|Protocol Violation|7
7610845|NCT00265941|12018627|FG000|Overall Study|Protocol Violation|22
7610846|NCT00265941|12018628|FG001|Overall Study|Protocol Violation|25
7610847|NCT00265941|12018627|FG000|Overall Study|Lost to Follow-up|1
7610848|NCT00265941|12018628|FG001|Overall Study|Lost to Follow-up|1
7610849|NCT00114140|12018642|FG000|Overall Study|Protocol Violation|7
7610850|NCT00047008|12018655|FG000|Overall Study|Withdrawn consent|2
7277233|NCT00452673|11492092|FG004|Dose Escalation Period|Adverse Event|0
7610851|NCT00047008|12018656|FG001|Overall Study|Withdrawn consent|3
7610852|NCT00047008|12018655|FG000|Overall Study|Ineligible|9
7610853|NCT00047008|12018656|FG001|Overall Study|Ineligible|8
7277234|NCT00452673|11492088|FG000|Dose Escalation Period|Withdrawal by Subject|0
7277235|NCT00452673|11492089|FG001|Dose Escalation Period|Withdrawal by Subject|0
7277236|NCT00452673|11492090|FG002|Dose Escalation Period|Withdrawal by Subject|0
7277237|NCT00452673|11492091|FG003|Dose Escalation Period|Withdrawal by Subject|1
7277238|NCT00452673|11492092|FG004|Dose Escalation Period|Withdrawal by Subject|0
7277239|NCT00452673|11492088|FG000|Dose Expansion Period|Disease Progression|0
7277240|NCT00452673|11492089|FG001|Dose Expansion Period|Disease Progression|0
7277241|NCT00452673|11492090|FG002|Dose Expansion Period|Disease Progression|0
7277242|NCT00452673|11492091|FG003|Dose Expansion Period|Disease Progression|0
7277243|NCT00452673|11492092|FG004|Dose Expansion Period|Disease Progression|19
7277244|NCT00452673|11492088|FG000|Dose Expansion Period|Other|0
7610854|NCT04392583|12018666|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1
7277245|NCT00452673|11492089|FG001|Dose Expansion Period|Other|0
7277246|NCT00452673|11492090|FG002|Dose Expansion Period|Other|0
7277247|NCT00452673|11492091|FG003|Dose Expansion Period|Other|0
7277248|NCT00452673|11492092|FG004|Dose Expansion Period|Other|2
7277249|NCT00452699|11492105|FG000|Overall Study|Adverse Event|10
7277250|NCT00452699|11492106|FG001|Overall Study|Adverse Event|3
7277251|NCT00452699|11492105|FG000|Overall Study|Lack of Efficacy|6
7277252|NCT00452699|11492106|FG001|Overall Study|Lack of Efficacy|4
7277253|NCT00452699|11492105|FG000|Overall Study|Lost to Follow-up|6
7277254|NCT00452699|11492106|FG001|Overall Study|Lost to Follow-up|9
7277255|NCT00452699|11492105|FG000|Overall Study|Protocol Violation|21
7277256|NCT00452699|11492106|FG001|Overall Study|Protocol Violation|25
7277257|NCT00452699|11492105|FG000|Overall Study|Withdrawal by Subject|26
7277258|NCT00452699|11492106|FG001|Overall Study|Withdrawal by Subject|25
7277259|NCT00452699|11492105|FG000|Overall Study|Other|12
7277260|NCT00452699|11492106|FG001|Overall Study|Other|7
7277261|NCT00452790|11492114|FG000|Infant Series|Clinical hold - consent withdrawn|118
7277262|NCT00452790|11492115|FG001|Infant Series|Clinical hold - consent withdrawn|123
7277263|NCT00452790|11492114|FG000|Infant Series|Parent/legal guardian request|8
7277264|NCT00452790|11492115|FG001|Infant Series|Parent/legal guardian request|6
7277265|NCT00452790|11492114|FG000|Infant Series|Failed to return|4
7277266|NCT00452790|11492115|FG001|Infant Series|Failed to return|1
7277267|NCT00452790|11492114|FG000|Infant Series|Protocol Violation|1
7277268|NCT00452790|11492115|FG001|Infant Series|Protocol Violation|3
7277269|NCT00452790|11492114|FG000|Infant Series|Lost to Follow-up|2
7277270|NCT00452790|11492115|FG001|Infant Series|Lost to Follow-up|2
7277271|NCT00452790|11492114|FG000|Infant Series|Adverse Event|1
7277272|NCT00452790|11492115|FG001|Infant Series|Adverse Event|2
7277273|NCT00452790|11492114|FG000|Infant Series|Other reasons|1
7277274|NCT00452790|11492115|FG001|Infant Series|Other reasons|2
7277275|NCT00452790|11492114|FG000|Infant Series|Investigator request|0
7277276|NCT00452790|11492115|FG001|Infant Series|Investigator request|1
7277277|NCT00452790|11492114|FG000|Infant Series|Death|0
7277278|NCT00452790|11492115|FG001|Infant Series|Death|1
7277279|NCT00452790|11492114|FG000|After Infant Series|Investigator request|10
7277280|NCT00452790|11492115|FG001|After Infant Series|Investigator request|10
7277281|NCT00452790|11492114|FG000|After Infant Series|Adverse Event|4
7277282|NCT00452790|11492115|FG001|After Infant Series|Adverse Event|1
7277283|NCT00452790|11492114|FG000|After Infant Series|Parent/legal guardian request|1
7277284|NCT00452790|11492115|FG001|After Infant Series|Parent/legal guardian request|3
7277285|NCT00452790|11492114|FG000|After Infant Series|Lost to Follow-up|4
7277286|NCT00452790|11492115|FG001|After Infant Series|Lost to Follow-up|0
7277287|NCT00452790|11492114|FG000|After Infant Series|Failed to return|1
7277288|NCT00452790|11492115|FG001|After Infant Series|Failed to return|0
7277289|NCT00452790|11492114|FG000|After Infant Series|Other reasons|1
7610855|NCT04326439|12018676|FG000|Overall Study|Withdrawal by Subject|1
7610856|NCT04326439|12018677|FG001|Overall Study|Withdrawal by Subject|0
7610857|NCT04326439|12018676|FG000|Overall Study|Proceeded to HSCT after Induction 2|0
7610858|NCT04326439|12018677|FG001|Overall Study|Proceeded to HSCT after Induction 2|2
7610859|NCT04326439|12018676|FG000|Overall Study|Relapse after Induction 2|0
7610860|NCT04326439|12018677|FG001|Overall Study|Relapse after Induction 2|1
7610861|NCT04326439|12018676|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1
7610862|NCT04326439|12018677|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0
7610863|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Adverse Event|1
7610864|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Adverse Event|1
7610865|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Adverse Event|2
7610866|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Adverse Event|0
7610867|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Adverse Event|0
7610868|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7610869|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1
7610870|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2
7610871|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0
7610872|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0
7610873|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1
7610874|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5
7610875|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0
7610876|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0
7610877|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0
7610878|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11
7610879|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
7610880|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6
7610881|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
7610882|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0
7610883|NCT04003142|12018706|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2
7610884|NCT04003142|12018707|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1
7277290|NCT00452790|11492115|FG001|After Infant Series|Other reasons|0
7610885|NCT04003142|12018708|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2
7610886|NCT04003142|12018709|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0
7610887|NCT04003142|12018710|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0
7610888|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Adverse Event|0
7610889|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Adverse Event|4
7610890|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Adverse Event|4
7610891|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Adverse Event|2
7610892|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Adverse Event|3
7610893|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Death|0
7610894|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Death|0
7610895|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Death|0
7610896|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Death|0
7610897|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Death|1
7610898|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0
7610899|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2
7610900|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1
7610901|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2
7610902|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1
7610903|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Protocol Deviation|0
7610904|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Protocol Deviation|0
7610905|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Protocol Deviation|2
7610906|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Protocol Deviation|0
7610907|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Protocol Deviation|0
7610908|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0
7610909|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17
7610910|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14
7610911|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9
7610912|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5
7610913|NCT04003142|12018706|FG000|Extension Period (40 Weeks)|Miscellaneous|0
7610914|NCT04003142|12018707|FG001|Extension Period (40 Weeks)|Miscellaneous|4
7610915|NCT04003142|12018708|FG002|Extension Period (40 Weeks)|Miscellaneous|1
7610916|NCT04003142|12018709|FG003|Extension Period (40 Weeks)|Miscellaneous|0
7610917|NCT04003142|12018710|FG004|Extension Period (40 Weeks)|Miscellaneous|2
7277291|NCT00452790|11492114|FG000|Toddler Dose|Failed to return|0
7610918|NCT03402841|12018745|FG000|Overall Study|Withdrawal by Subject|4
7610919|NCT03402841|12018745|FG000|Overall Study|Lost to Follow-up|3
7610920|NCT03402841|12018745|FG000|Overall Study|Death|85
7610921|NCT03383666|12018749|FG000|Overall Study|Withdrawal by Subject|2
7610922|NCT03383666|12018749|FG000|Overall Study|Lost to Follow-up|2
7610939|NCT03219333|12018771|FG000|Overall Study|Withdrawal by Subject|8
7610940|NCT03219333|12018772|FG001|Overall Study|Withdrawal by Subject|3
7610941|NCT03219333|12018771|FG000|Overall Study|Lost to Follow-up|1
7610942|NCT03219333|12018772|FG001|Overall Study|Lost to Follow-up|0
7610943|NCT03219333|12018771|FG000|Overall Study|Death|94
7610944|NCT03219333|12018772|FG001|Overall Study|Death|44
7610945|NCT03219333|12018771|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
7610946|NCT03219333|12018772|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
7611015|NCT02881957|12018833|FG000|Overall Study|Comfort care|0
7611016|NCT02881957|12018834|FG001|Overall Study|Comfort care|1
7611017|NCT02881957|12018833|FG000|Overall Study|Concurrent trial enrollment|0
7611018|NCT02881957|12018834|FG001|Overall Study|Concurrent trial enrollment|1
7611019|NCT02881957|12018833|FG000|Overall Study|Discharged within 48 hours|0
7611020|NCT02881957|12018834|FG001|Overall Study|Discharged within 48 hours|1
7611021|NCT02881957|12018833|FG000|Overall Study|Withdrawal by Subject|2
7611022|NCT02881957|12018834|FG001|Overall Study|Withdrawal by Subject|1
7611023|NCT02881957|12018833|FG000|Overall Study|Protocol Violation|1
7611024|NCT02881957|12018834|FG001|Overall Study|Protocol Violation|0
7277292|NCT00452790|11492115|FG001|Toddler Dose|Failed to return|1
7277293|NCT00452790|11492114|FG000|Toddler Dose|Parent/legal guardian request|0
7277294|NCT00452790|11492115|FG001|Toddler Dose|Parent/legal guardian request|1
7277295|NCT00453102|11492129|FG000|Overall Study|Withdrawal by Subject|2
7277296|NCT00453154|11492136|FG000|Double BIind Maintenance|Adverse Event|0
7277297|NCT00453154|11492137|FG001|Double BIind Maintenance|Adverse Event|0
7277298|NCT00453154|11492138|FG002|Double BIind Maintenance|Adverse Event|3
7277299|NCT00453154|11492139|FG003|Double BIind Maintenance|Adverse Event|12
7277300|NCT00453154|11492136|FG000|Double BIind Maintenance|Death|0
7277301|NCT00453154|11492137|FG001|Double BIind Maintenance|Death|0
7277302|NCT00453154|11492138|FG002|Double BIind Maintenance|Death|2
7277303|NCT00453154|11492139|FG003|Double BIind Maintenance|Death|1
7277304|NCT00453154|11492136|FG000|Double BIind Maintenance|Withdrawal by Subject|0
7277305|NCT00453154|11492137|FG001|Double BIind Maintenance|Withdrawal by Subject|0
7277306|NCT00453154|11492138|FG002|Double BIind Maintenance|Withdrawal by Subject|4
7277307|NCT00453154|11492139|FG003|Double BIind Maintenance|Withdrawal by Subject|4
7611025|NCT02761694|12018856|FG000|Overall Study|Lack of Efficacy|0
7611026|NCT02761694|12018857|FG001|Overall Study|Lack of Efficacy|0
7611027|NCT02761694|12018858|FG002|Overall Study|Lack of Efficacy|0
7611028|NCT02761694|12018859|FG003|Overall Study|Lack of Efficacy|0
7611029|NCT02761694|12018860|FG004|Overall Study|Lack of Efficacy|0
7611030|NCT02761694|12018861|FG005|Overall Study|Lack of Efficacy|0
7611031|NCT02761694|12018862|FG006|Overall Study|Lack of Efficacy|6
7611032|NCT02761694|12018863|FG007|Overall Study|Lack of Efficacy|0
7611033|NCT02761694|12018864|FG008|Overall Study|Lack of Efficacy|0
7277308|NCT00453154|11492136|FG000|Double BIind Maintenance|Progression|0
7277309|NCT00453154|11492137|FG001|Double BIind Maintenance|Progression|0
7277310|NCT00453154|11492138|FG002|Double BIind Maintenance|Progression|29
7277311|NCT00453154|11492139|FG003|Double BIind Maintenance|Progression|26
7611034|NCT02761694|12018865|FG009|Overall Study|Lack of Efficacy|1
7611035|NCT02761694|12018866|FG010|Overall Study|Lack of Efficacy|1
7611036|NCT02761694|12018867|FG011|Overall Study|Lack of Efficacy|4
7611037|NCT02761694|12018856|FG000|Overall Study|Death|0
7611038|NCT02761694|12018857|FG001|Overall Study|Death|0
7611039|NCT02761694|12018858|FG002|Overall Study|Death|0
7611040|NCT02761694|12018859|FG003|Overall Study|Death|0
7611041|NCT02761694|12018860|FG004|Overall Study|Death|0
7611042|NCT02761694|12018861|FG005|Overall Study|Death|0
7611043|NCT02761694|12018862|FG006|Overall Study|Death|2
7611044|NCT02761694|12018863|FG007|Overall Study|Death|0
7611045|NCT02761694|12018864|FG008|Overall Study|Death|2
7611046|NCT02761694|12018865|FG009|Overall Study|Death|2
7611047|NCT02761694|12018866|FG010|Overall Study|Death|1
7611048|NCT02761694|12018867|FG011|Overall Study|Death|0
7611049|NCT02761694|12018856|FG000|Overall Study|Physician Decision|0
7277312|NCT00453154|11492136|FG000|Double BIind Maintenance|Medical Issues|0
7277313|NCT00453154|11492137|FG001|Double BIind Maintenance|Medical Issues|0
7277314|NCT00453154|11492138|FG002|Double BIind Maintenance|Medical Issues|3
7277315|NCT00453154|11492139|FG003|Double BIind Maintenance|Medical Issues|1
7277316|NCT00453154|11492136|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
7277317|NCT00453154|11492137|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
7277318|NCT00453154|11492138|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
7277319|NCT00453154|11492139|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
7277320|NCT00453180|11492150|FG000|Overall Study|Lost to Follow-up|2
7277321|NCT00453180|11492151|FG001|Overall Study|Lost to Follow-up|1
7277322|NCT00453180|11492150|FG000|Overall Study|Adverse Event|1
7277323|NCT00453180|11492151|FG001|Overall Study|Adverse Event|2
7277324|NCT00453206|11492161|FG000|Overall Study|Death|1
7277325|NCT00453310|11492165|FG000|Overall Study|Progression of Disease|10
7277326|NCT00453349|11492175|FG000|Randomized|Adverse Event|12
7277327|NCT00453349|11492176|FG001|Randomized|Adverse Event|11
7277328|NCT00453349|11492175|FG000|Randomized|Lack of Efficacy|2
7277329|NCT00453349|11492176|FG001|Randomized|Lack of Efficacy|1
7277330|NCT00453349|11492175|FG000|Randomized|Lost to Follow-up|7
7277331|NCT00453349|11492176|FG001|Randomized|Lost to Follow-up|5
7277332|NCT00453349|11492175|FG000|Randomized|Protocol Violation|1
7277333|NCT00453349|11492176|FG001|Randomized|Protocol Violation|1
7277334|NCT00453349|11492175|FG000|Randomized|Withdrawal by Subject|3
7277335|NCT00453349|11492176|FG001|Randomized|Withdrawal by Subject|5
7277336|NCT00453349|11492175|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
7277337|NCT00453349|11492176|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
7277338|NCT00453349|11492175|FG000|Completed Study|Adverse Event|12
7277339|NCT00453349|11492176|FG001|Completed Study|Adverse Event|11
7277340|NCT00453349|11492175|FG000|Completed Study|Lack of Efficacy|2
7277341|NCT00453349|11492176|FG001|Completed Study|Lack of Efficacy|1
7277342|NCT00453349|11492175|FG000|Completed Study|Lost to Follow-up|7
7277343|NCT00453349|11492176|FG001|Completed Study|Lost to Follow-up|5
7277344|NCT00453349|11492175|FG000|Completed Study|Protocol Violation|1
7277345|NCT00453349|11492176|FG001|Completed Study|Protocol Violation|1
7277346|NCT00453349|11492175|FG000|Completed Study|Withdrawal by Subject|3
7277347|NCT00453349|11492176|FG001|Completed Study|Withdrawal by Subject|5
7277348|NCT00453349|11492175|FG000|Completed Study|Lost to follow up after study treatment|2
7611050|NCT02761694|12018857|FG001|Overall Study|Physician Decision|0
7611051|NCT02761694|12018858|FG002|Overall Study|Physician Decision|0
7611052|NCT02761694|12018859|FG003|Overall Study|Physician Decision|0
7611053|NCT02761694|12018860|FG004|Overall Study|Physician Decision|0
7611054|NCT02761694|12018861|FG005|Overall Study|Physician Decision|0
7611055|NCT02761694|12018862|FG006|Overall Study|Physician Decision|1
7611056|NCT02761694|12018863|FG007|Overall Study|Physician Decision|0
7611057|NCT02761694|12018864|FG008|Overall Study|Physician Decision|0
7611058|NCT02761694|12018865|FG009|Overall Study|Physician Decision|0
7611059|NCT02761694|12018866|FG010|Overall Study|Physician Decision|0
7611060|NCT02761694|12018867|FG011|Overall Study|Physician Decision|0
7611061|NCT02761694|12018856|FG000|Overall Study|Withdrawal by Subject|0
7611062|NCT02761694|12018857|FG001|Overall Study|Withdrawal by Subject|0
7611063|NCT02761694|12018858|FG002|Overall Study|Withdrawal by Subject|0
7611064|NCT02761694|12018859|FG003|Overall Study|Withdrawal by Subject|1
7611065|NCT02761694|12018860|FG004|Overall Study|Withdrawal by Subject|0
7611066|NCT02761694|12018861|FG005|Overall Study|Withdrawal by Subject|0
7611067|NCT02761694|12018862|FG006|Overall Study|Withdrawal by Subject|4
7611068|NCT02761694|12018863|FG007|Overall Study|Withdrawal by Subject|0
7611069|NCT02761694|12018864|FG008|Overall Study|Withdrawal by Subject|2
7611070|NCT02761694|12018865|FG009|Overall Study|Withdrawal by Subject|1
7611071|NCT02761694|12018866|FG010|Overall Study|Withdrawal by Subject|0
7611072|NCT02761694|12018867|FG011|Overall Study|Withdrawal by Subject|0
7611073|NCT02761694|12018856|FG000|Overall Study|Lost to Follow-up|0
7611074|NCT02761694|12018857|FG001|Overall Study|Lost to Follow-up|0
7611075|NCT02761694|12018858|FG002|Overall Study|Lost to Follow-up|0
7611076|NCT02761694|12018859|FG003|Overall Study|Lost to Follow-up|0
7611077|NCT02761694|12018860|FG004|Overall Study|Lost to Follow-up|0
7611078|NCT02761694|12018861|FG005|Overall Study|Lost to Follow-up|0
7611079|NCT02761694|12018862|FG006|Overall Study|Lost to Follow-up|1
7611080|NCT02761694|12018863|FG007|Overall Study|Lost to Follow-up|0
7611081|NCT02761694|12018864|FG008|Overall Study|Lost to Follow-up|0
7611082|NCT02761694|12018865|FG009|Overall Study|Lost to Follow-up|0
7611083|NCT02761694|12018866|FG010|Overall Study|Lost to Follow-up|0
7611084|NCT02761694|12018867|FG011|Overall Study|Lost to Follow-up|1
7611085|NCT02761694|12018856|FG000|Overall Study|Adverse Event|0
7611086|NCT02761694|12018857|FG001|Overall Study|Adverse Event|0
7611087|NCT02761694|12018858|FG002|Overall Study|Adverse Event|0
7611088|NCT02761694|12018859|FG003|Overall Study|Adverse Event|0
7277349|NCT00453349|11492176|FG001|Completed Study|Lost to follow up after study treatment|11
7277350|NCT00453362|11492182|FG000|Overall Study|Adverse Event|5
7277351|NCT00453362|11492182|FG000|Overall Study|Death|7
7277352|NCT00453362|11492182|FG000|Overall Study|Physician Decision|2
7277353|NCT00453362|11492182|FG000|Overall Study|Withdrawal by Subject|3
7277354|NCT00453362|11492182|FG000|Overall Study|Progression of disease|56
7277355|NCT00453362|11492182|FG000|Overall Study|Screening Failure|14
7277356|NCT00453921|11492238|FG000|Overall Study|Withdrawal by Subject|1
7277357|NCT00453921|11492239|FG001|Overall Study|Withdrawal by Subject|1
7277358|NCT00453921|11492240|FG002|Overall Study|Withdrawal by Subject|1
7277359|NCT00453921|11492241|FG003|Overall Study|Withdrawal by Subject|1
7277360|NCT00453921|11492238|FG000|Overall Study|Lost to Follow-up|0
7277361|NCT00453921|11492239|FG001|Overall Study|Lost to Follow-up|0
7277362|NCT00453921|11492240|FG002|Overall Study|Lost to Follow-up|1
7277363|NCT00453921|11492241|FG003|Overall Study|Lost to Follow-up|0
7277364|NCT00453973|11492257|FG000|Overall Study|Adverse Event|4
7277365|NCT00453973|11492258|FG001|Overall Study|Adverse Event|9
7277366|NCT00453973|11492257|FG000|Overall Study|Withdrawal by Subject|7
7277367|NCT00453973|11492258|FG001|Overall Study|Withdrawal by Subject|6
7277368|NCT00453973|11492257|FG000|Overall Study|PI Decision|0
7277369|NCT00453973|11492258|FG001|Overall Study|PI Decision|2
7277370|NCT00453973|11492257|FG000|Overall Study|Relocation|1
7277371|NCT00453973|11492258|FG001|Overall Study|Relocation|0
7277372|NCT00453973|11492257|FG000|Overall Study|Renal transplant|1
7277373|NCT00453973|11492258|FG001|Overall Study|Renal transplant|1
7277374|NCT00453973|11492257|FG000|Overall Study|Site closed by sponsor|3
7277375|NCT00453973|11492258|FG001|Overall Study|Site closed by sponsor|0
7277376|NCT00453973|11492257|FG000|Overall Study|Sponsor Decision to Terminate Study|35
7277377|NCT00453973|11492258|FG001|Overall Study|Sponsor Decision to Terminate Study|30
7277378|NCT00453986|11492269|FG000|Overall Study|Lost to Follow-up|6
7277379|NCT00453986|11492270|FG001|Overall Study|Lost to Follow-up|5
7277380|NCT00453986|11492271|FG002|Overall Study|Lost to Follow-up|6
7277381|NCT00453986|11492272|FG003|Overall Study|Lost to Follow-up|2
7277382|NCT00453986|11492273|FG004|Overall Study|Lost to Follow-up|0
7277383|NCT00453999|11492292|FG000|Overall Study|Adverse Event|1
7277384|NCT00453999|11492293|FG001|Overall Study|Adverse Event|2
7277385|NCT00453999|11492294|FG002|Overall Study|Adverse Event|1
7277386|NCT00453999|11492292|FG000|Overall Study|Lost to Follow-up|0
7277387|NCT00453999|11492293|FG001|Overall Study|Lost to Follow-up|1
7611089|NCT02761694|12018860|FG004|Overall Study|Adverse Event|0
7611090|NCT02761694|12018861|FG005|Overall Study|Adverse Event|0
7611091|NCT02761694|12018862|FG006|Overall Study|Adverse Event|1
7277388|NCT00453999|11492294|FG002|Overall Study|Lost to Follow-up|1
7277389|NCT00453999|11492292|FG000|Overall Study|Withdrawal by Subject|2
7277390|NCT00453999|11492293|FG001|Overall Study|Withdrawal by Subject|1
7277391|NCT00453999|11492294|FG002|Overall Study|Withdrawal by Subject|1
7277392|NCT00453999|11492292|FG000|Overall Study|Subject Request|2
7277393|NCT00453999|11492293|FG001|Overall Study|Subject Request|1
7611092|NCT02761694|12018863|FG007|Overall Study|Adverse Event|0
7611093|NCT02761694|12018864|FG008|Overall Study|Adverse Event|1
7611094|NCT02761694|12018865|FG009|Overall Study|Adverse Event|0
7611095|NCT02761694|12018866|FG010|Overall Study|Adverse Event|0
7611096|NCT02761694|12018867|FG011|Overall Study|Adverse Event|1
7611097|NCT02761694|12018856|FG000|Overall Study|Other|4
7611098|NCT02761694|12018857|FG001|Overall Study|Other|4
7611099|NCT02761694|12018858|FG002|Overall Study|Other|1
7611100|NCT02761694|12018859|FG003|Overall Study|Other|2
7611101|NCT02761694|12018860|FG004|Overall Study|Other|3
7611102|NCT02761694|12018861|FG005|Overall Study|Other|3
7611103|NCT02761694|12018862|FG006|Overall Study|Other|18
7611104|NCT02761694|12018863|FG007|Overall Study|Other|8
7277394|NCT00453999|11492294|FG002|Overall Study|Subject Request|0
7611105|NCT02761694|12018864|FG008|Overall Study|Other|0
7611106|NCT02761694|12018865|FG009|Overall Study|Other|1
7611107|NCT02761694|12018866|FG010|Overall Study|Other|1
7611108|NCT02761694|12018867|FG011|Overall Study|Other|0
7611109|NCT02611960|12018896|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
7611110|NCT02611960|12018897|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
7611111|NCT02611960|12018896|FG000|Overall Study|Death|87
7611112|NCT02611960|12018897|FG001|Overall Study|Death|85
7611113|NCT02611960|12018896|FG000|Overall Study|Withdrawal by Subject|0
7611114|NCT02611960|12018897|FG001|Overall Study|Withdrawal by Subject|1
7611115|NCT02611960|12018896|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
7611116|NCT02611960|12018897|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
7611117|NCT02611960|12018896|FG000|Overall Study|Participants Ongoing|22
7611118|NCT02611960|12018897|FG001|Overall Study|Participants Ongoing|18
7611119|NCT02574455|12018906|FG000|Overall Study|Death|197
7611120|NCT02574455|12018907|FG001|Overall Study|Death|210
7611121|NCT02574455|12018906|FG000|Overall Study|Withdrawal of Consent|11
7611122|NCT02574455|12018907|FG001|Overall Study|Withdrawal of Consent|28
7611123|NCT02574455|12018906|FG000|Overall Study|Lost to Follow-up|4
7611124|NCT02574455|12018907|FG001|Overall Study|Lost to Follow-up|4
7611125|NCT02574455|12018906|FG000|Overall Study|Sponsor's Decision|55
7611126|NCT02574455|12018907|FG001|Overall Study|Sponsor's Decision|20
7611127|NCT02493660|12018915|FG000|Overall Study|Physician Decision|0
7611128|NCT02493660|12018916|FG001|Overall Study|Physician Decision|1
7611129|NCT02493660|12018915|FG000|Overall Study|Adverse Event|4
7611130|NCT02493660|12018916|FG001|Overall Study|Adverse Event|2
7611131|NCT02493660|12018915|FG000|Overall Study|Withdrawal by Subject|2
7611132|NCT02493660|12018916|FG001|Overall Study|Withdrawal by Subject|3
7611133|NCT02493660|12018915|FG000|Overall Study|Subject unable to return for follow-up visits|2
7611134|NCT02493660|12018916|FG001|Overall Study|Subject unable to return for follow-up visits|0
7611135|NCT02493660|12018915|FG000|Overall Study|Protocol Violation|0
7611136|NCT02493660|12018916|FG001|Overall Study|Protocol Violation|1
7611137|NCT02493660|12018915|FG000|Overall Study|Death|0
7611138|NCT02493660|12018916|FG001|Overall Study|Death|1
7611139|NCT02493660|12018915|FG000|Overall Study|Lost to Follow-up|2
7611140|NCT02493660|12018916|FG001|Overall Study|Lost to Follow-up|4
7611141|NCT02232087|12018924|FG000|Overall Study|Withdrawal by Subject|2
7611142|NCT02232087|12018925|FG001|Overall Study|Withdrawal by Subject|0
7611143|NCT02232087|12018926|FG002|Overall Study|Withdrawal by Subject|0
7611144|NCT02232087|12018927|FG003|Overall Study|Withdrawal by Subject|0
7611145|NCT02232087|12018928|FG004|Overall Study|Withdrawal by Subject|0
7611146|NCT02232087|12018929|FG005|Overall Study|Withdrawal by Subject|1
7611147|NCT02232087|12018924|FG000|Overall Study|poor inhalation technique|0
7611148|NCT02232087|12018925|FG001|Overall Study|poor inhalation technique|1
7611149|NCT02232087|12018926|FG002|Overall Study|poor inhalation technique|0
7611150|NCT02232087|12018927|FG003|Overall Study|poor inhalation technique|0
7611151|NCT02232087|12018928|FG004|Overall Study|poor inhalation technique|0
7611152|NCT02232087|12018929|FG005|Overall Study|poor inhalation technique|2
7611153|NCT02232087|12018924|FG000|Overall Study|protocol stop criteria|0
7611154|NCT02232087|12018925|FG001|Overall Study|protocol stop criteria|1
7611155|NCT02232087|12018926|FG002|Overall Study|protocol stop criteria|0
7611156|NCT02232087|12018927|FG003|Overall Study|protocol stop criteria|1
7611157|NCT02232087|12018928|FG004|Overall Study|protocol stop criteria|0
7611158|NCT02232087|12018929|FG005|Overall Study|protocol stop criteria|0
7611159|NCT02232087|12018924|FG000|Overall Study|Adverse Event|0
7611160|NCT02232087|12018925|FG001|Overall Study|Adverse Event|0
7611161|NCT02232087|12018926|FG002|Overall Study|Adverse Event|0
7611162|NCT02232087|12018927|FG003|Overall Study|Adverse Event|0
7611163|NCT02232087|12018928|FG004|Overall Study|Adverse Event|1
7611164|NCT02232087|12018929|FG005|Overall Study|Adverse Event|0
7611165|NCT01952847|12018956|FG000|Overall Study|Ineligible|1
7611166|NCT01952847|12018957|FG001|Overall Study|Ineligible|0
7611167|NCT01952847|12018958|FG002|Overall Study|Ineligible|0
7611168|NCT01952847|12018959|FG003|Overall Study|Ineligible|0
7611169|NCT01952847|12018956|FG000|Overall Study|Lack of Insurance Coverage|0
7611170|NCT01952847|12018957|FG001|Overall Study|Lack of Insurance Coverage|1
7611171|NCT01952847|12018958|FG002|Overall Study|Lack of Insurance Coverage|0
7611172|NCT01952847|12018959|FG003|Overall Study|Lack of Insurance Coverage|0
7611173|NCT01952847|12018956|FG000|Overall Study|Withdrawal by Subject|1
7611174|NCT01952847|12018957|FG001|Overall Study|Withdrawal by Subject|1
7611175|NCT01952847|12018958|FG002|Overall Study|Withdrawal by Subject|0
7611176|NCT01952847|12018959|FG003|Overall Study|Withdrawal by Subject|1
7611177|NCT01889238|12018971|FG000|Overall Study|Treatment ongoing|9
7277395|NCT00454051|11492305|FG000|Overall Study|Adverse Event|1
7277396|NCT00454051|11492306|FG001|Overall Study|Adverse Event|2
7277397|NCT00454051|11492305|FG000|Overall Study|Withdrawal by Subject|1
7277398|NCT00454051|11492306|FG001|Overall Study|Withdrawal by Subject|0
7277399|NCT00454051|11492305|FG000|Overall Study|Protocol Violation|1
7277400|NCT00454051|11492306|FG001|Overall Study|Protocol Violation|1
7277401|NCT00454116|11492315|FG000|Overall Study|Adverse Event|5
7277402|NCT00454116|11492316|FG001|Overall Study|Adverse Event|11
7277403|NCT00454116|11492317|FG002|Overall Study|Adverse Event|9
7277404|NCT00454116|11492315|FG000|Overall Study|Condition under investigation worsened|17
7277405|NCT00454116|11492316|FG001|Overall Study|Condition under investigation worsened|13
7277406|NCT00454116|11492317|FG002|Overall Study|Condition under investigation worsened|18
7277407|NCT00454116|11492315|FG000|Overall Study|Withdrawal by Subject|3
7277408|NCT00454116|11492316|FG001|Overall Study|Withdrawal by Subject|3
7277409|NCT00454116|11492317|FG002|Overall Study|Withdrawal by Subject|1
7277410|NCT00454116|11492315|FG000|Overall Study|Other|2
7277411|NCT00454116|11492316|FG001|Overall Study|Other|2
7277412|NCT00454116|11492317|FG002|Overall Study|Other|0
7277413|NCT00454142|11492325|FG000|Overall Study|Withdrawal by Subject|1
7277414|NCT00454181|11492333|FG000|Overall Study|Adverse Event|1
7277415|NCT00454181|11492334|FG001|Overall Study|Adverse Event|1
7277416|NCT00454181|11492333|FG000|Overall Study|Lost to Follow-up|11
7277417|NCT00454181|11492334|FG001|Overall Study|Lost to Follow-up|1
7277418|NCT00454181|11492333|FG000|Overall Study|Protocol Violation|1
7277419|NCT00454181|11492334|FG001|Overall Study|Protocol Violation|1
7277420|NCT00454181|11492333|FG000|Overall Study|Withdrawal by Subject|2
7277421|NCT00454181|11492334|FG001|Overall Study|Withdrawal by Subject|0
7277422|NCT00454194|11492342|FG000|Overall Study|Adverse Event|7
7277423|NCT00454194|11492343|FG001|Overall Study|Adverse Event|2
7277424|NCT00454194|11492342|FG000|Overall Study|Withdrawal by Subject|12
7277425|NCT00454194|11492343|FG001|Overall Study|Withdrawal by Subject|8
7277426|NCT00454194|11492342|FG000|Overall Study|Other Medical Problems|1
7277427|NCT00454194|11492343|FG001|Overall Study|Other Medical Problems|2
7277428|NCT00454194|11492342|FG000|Overall Study|Other Unspecified Reason|2
7277429|NCT00454194|11492343|FG001|Overall Study|Other Unspecified Reason|2
7277430|NCT00454207|11492351|FG000|Overall Study|Adverse Event|3
7277431|NCT00454207|11492352|FG001|Overall Study|Adverse Event|1
7277432|NCT00454207|11492351|FG000|Overall Study|Lack of Efficacy|1
7277433|NCT00454207|11492352|FG001|Overall Study|Lack of Efficacy|0
7277434|NCT00454207|11492351|FG000|Overall Study|Protocol Violation|0
7277435|NCT00454207|11492352|FG001|Overall Study|Protocol Violation|1
7277436|NCT00454246|11492373|FG000|Overall Study|Adverse Event|2
7277437|NCT00454246|11492374|FG001|Overall Study|Adverse Event|2
7277438|NCT00454246|11492375|FG002|Overall Study|Adverse Event|0
7277439|NCT00454246|11492373|FG000|Overall Study|Violation of selection criteria at entry|6
7277440|NCT00454246|11492374|FG001|Overall Study|Violation of selection criteria at entry|0
7277441|NCT00454246|11492375|FG002|Overall Study|Violation of selection criteria at entry|0
7277442|NCT00454246|11492373|FG000|Overall Study|Protocol Violation|1
7277443|NCT00454246|11492374|FG001|Overall Study|Protocol Violation|0
7277444|NCT00454246|11492375|FG002|Overall Study|Protocol Violation|0
7277445|NCT00454246|11492373|FG000|Overall Study|Refused Treatment|1
7277446|NCT00454246|11492374|FG001|Overall Study|Refused Treatment|1
7277447|NCT00454246|11492375|FG002|Overall Study|Refused Treatment|0
7277448|NCT00454246|11492373|FG000|Overall Study|Failure to return|1
7611198|NCT01672892|12018986|FG000|Overall Study|Protocol Violation|7
7611199|NCT01672892|12018987|FG001|Overall Study|Protocol Violation|3
7611200|NCT01560585|12018996|FG000|Overall Study|Physician Decision|3
7611201|NCT00979212|12019003|FG000|Overall Study|Protocol Violation|1
7611202|NCT00979212|12019004|FG001|Overall Study|Protocol Violation|8
7611203|NCT00979212|12019003|FG000|Overall Study|No protocol therapy received|1
7611204|NCT00979212|12019004|FG001|Overall Study|No protocol therapy received|0
7611205|NCT00777491|12019012|FG000|Overall Study|Protocol Violation|0
7611206|NCT00777491|12019013|FG001|Overall Study|Protocol Violation|2
7611207|NCT00777491|12019012|FG000|Overall Study|Did not receive any protocol treatment|2
7611208|NCT00777491|12019013|FG001|Overall Study|Did not receive any protocol treatment|0
7611209|NCT00759655|12019019|FG000|Overall Study|Termination of the study by sponsor|1
7611210|NCT00145795|12019025|FG000|Overall Study|Adverse Event|1
7611211|NCT00145795|12019026|FG001|Overall Study|Adverse Event|0
7611212|NCT00005044|12019034|FG000|Overall Study|Protocol Violation|37
7611213|NCT00005044|12019035|FG001|Overall Study|Protocol Violation|46
7611214|NCT00005044|12019034|FG000|Overall Study|Withdrawal by Subject|1
7611215|NCT00005044|12019035|FG001|Overall Study|Withdrawal by Subject|5
7611216|NCT00005044|12019034|FG000|Overall Study|No protocol treatment|0
7611217|NCT00005044|12019035|FG001|Overall Study|No protocol treatment|1
7611218|NCT00002874|12019043|FG000|Overall Study|Withdrawal by Subject|1
7611219|NCT00002874|12019044|FG001|Overall Study|Withdrawal by Subject|1
7611220|NCT00002874|12019043|FG000|Overall Study|Protocol Violation|44
7611221|NCT00002874|12019044|FG001|Overall Study|Protocol Violation|34
7611222|NCT04391894|12019055|FG000|Overall Study|Adverse Event|1
7611223|NCT04391894|12019056|FG001|Overall Study|Adverse Event|1
7611224|NCT04391894|12019057|FG002|Overall Study|Adverse Event|1
7611225|NCT04391894|12019058|FG003|Overall Study|Adverse Event|1
7611226|NCT04391894|12019059|FG004|Overall Study|Adverse Event|1
7611227|NCT04391894|12019055|FG000|Overall Study|Lost to Follow-up|1
7611228|NCT04391894|12019056|FG001|Overall Study|Lost to Follow-up|0
7611229|NCT04391894|12019057|FG002|Overall Study|Lost to Follow-up|0
7611230|NCT04391894|12019058|FG003|Overall Study|Lost to Follow-up|0
7611231|NCT04391894|12019059|FG004|Overall Study|Lost to Follow-up|0
7611232|NCT04391894|12019055|FG000|Overall Study|Protocol Violation|0
7611233|NCT04391894|12019056|FG001|Overall Study|Protocol Violation|0
7611234|NCT04391894|12019057|FG002|Overall Study|Protocol Violation|0
7611235|NCT04391894|12019058|FG003|Overall Study|Protocol Violation|1
7611236|NCT04391894|12019059|FG004|Overall Study|Protocol Violation|0
7611237|NCT04391894|12019055|FG000|Overall Study|Withdrawal by Subject|2
7611238|NCT04391894|12019056|FG001|Overall Study|Withdrawal by Subject|0
7611239|NCT04391894|12019057|FG002|Overall Study|Withdrawal by Subject|3
7611240|NCT04391894|12019058|FG003|Overall Study|Withdrawal by Subject|0
7611241|NCT04391894|12019059|FG004|Overall Study|Withdrawal by Subject|1
7611242|NCT04391894|12019055|FG000|Overall Study|Unsatisfactory Therapeutic effect|0
7611243|NCT04391894|12019056|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
7611244|NCT04391894|12019057|FG002|Overall Study|Unsatisfactory Therapeutic effect|0
7611245|NCT04391894|12019058|FG003|Overall Study|Unsatisfactory Therapeutic effect|0
7611246|NCT04391894|12019059|FG004|Overall Study|Unsatisfactory Therapeutic effect|1
7611247|NCT03428100|12019102|FG000|Overall Study|Adverse Event|1
7611248|NCT03428100|12019103|FG001|Overall Study|Adverse Event|0
7611249|NCT03428100|12019104|FG002|Overall Study|Adverse Event|3
7611250|NCT03428100|12019105|FG003|Overall Study|Adverse Event|1
7611251|NCT03428100|12019102|FG000|Overall Study|Lack of Efficacy|16
7611252|NCT03428100|12019103|FG001|Overall Study|Lack of Efficacy|10
7611253|NCT03428100|12019104|FG002|Overall Study|Lack of Efficacy|7
7611254|NCT03428100|12019105|FG003|Overall Study|Lack of Efficacy|6
7611255|NCT03428100|12019102|FG000|Overall Study|Protocol Deviation|0
7611256|NCT03428100|12019103|FG001|Overall Study|Protocol Deviation|2
7611257|NCT03428100|12019104|FG002|Overall Study|Protocol Deviation|2
7611258|NCT03428100|12019105|FG003|Overall Study|Protocol Deviation|0
7611259|NCT03428100|12019102|FG000|Overall Study|Withdrawal by Subject|4
7611260|NCT03428100|12019103|FG001|Overall Study|Withdrawal by Subject|0
7611261|NCT03428100|12019104|FG002|Overall Study|Withdrawal by Subject|0
7611262|NCT03428100|12019105|FG003|Overall Study|Withdrawal by Subject|0
7611263|NCT03428100|12019102|FG000|Overall Study|Physician Decision|0
7611264|NCT03428100|12019103|FG001|Overall Study|Physician Decision|1
7611265|NCT03428100|12019104|FG002|Overall Study|Physician Decision|0
7611266|NCT03428100|12019105|FG003|Overall Study|Physician Decision|0
7611267|NCT03341936|12019125|FG000|Overall Study|Ineligible|1
7611268|NCT03341936|12019125|FG000|Overall Study|Disease Progression|2
7611269|NCT03341936|12019125|FG000|Overall Study|Withdrew Consent|4
7611270|NCT03341936|12019125|FG000|Overall Study|Non-Compliance|1
7611271|NCT03341936|12019125|FG000|Overall Study|Physician Decision|1
7611272|NCT03341936|12019125|FG000|Overall Study|Withdrawal by Subject|1
7611273|NCT03341936|12019125|FG000|Overall Study|Other|1
7611274|NCT03144687|12019135|FG000|Overall Study|Death|0
7611275|NCT03144687|12019136|FG001|Overall Study|Death|2
7611276|NCT03144687|12019135|FG000|Overall Study|Lost to Follow-up|0
7611277|NCT03144687|12019136|FG001|Overall Study|Lost to Follow-up|1
7611278|NCT03144687|12019135|FG000|Overall Study|Physician Decision|0
7611279|NCT03144687|12019136|FG001|Overall Study|Physician Decision|1
7611280|NCT03144687|12019135|FG000|Overall Study|Withdrawal by Subject|1
7611281|NCT03144687|12019136|FG001|Overall Study|Withdrawal by Subject|3
7611282|NCT03144687|12019135|FG000|Overall Study|Not Reported|2
7611283|NCT03144687|12019136|FG001|Overall Study|Not Reported|0
7611286|NCT02880371|12019158|FG000|Phase 1b|Lost to Follow-up|1
7611287|NCT02880371|12019159|FG001|Phase 1b|Lost to Follow-up|0
7611288|NCT02880371|12019160|FG002|Phase 1b|Lost to Follow-up|0
7611289|NCT02880371|12019161|FG003|Phase 1b|Lost to Follow-up|0
7611290|NCT02880371|12019162|FG004|Phase 1b|Lost to Follow-up|0
7611291|NCT02880371|12019163|FG005|Phase 1b|Lost to Follow-up|0
7611292|NCT02880371|12019164|FG006|Phase 1b|Lost to Follow-up|0
7611293|NCT02880371|12019165|FG007|Phase 1b|Lost to Follow-up|0
7611294|NCT02880371|12019158|FG000|Phase 1b|Participants terminated by Sponsor|1
7611295|NCT02880371|12019159|FG001|Phase 1b|Participants terminated by Sponsor|0
7611296|NCT02880371|12019160|FG002|Phase 1b|Participants terminated by Sponsor|0
7611297|NCT02880371|12019161|FG003|Phase 1b|Participants terminated by Sponsor|0
7611298|NCT02880371|12019162|FG004|Phase 1b|Participants terminated by Sponsor|0
7277449|NCT00454246|11492374|FG001|Overall Study|Failure to return|0
7611299|NCT02880371|12019163|FG005|Phase 1b|Participants terminated by Sponsor|0
7611300|NCT02880371|12019164|FG006|Phase 1b|Participants terminated by Sponsor|0
7611301|NCT02880371|12019165|FG007|Phase 1b|Participants terminated by Sponsor|0
7611302|NCT02880371|12019158|FG000|Phase 1b|Withdrawal by Subject|0
7611303|NCT02880371|12019159|FG001|Phase 1b|Withdrawal by Subject|0
7611304|NCT02880371|12019160|FG002|Phase 1b|Withdrawal by Subject|1
7611305|NCT02880371|12019161|FG003|Phase 1b|Withdrawal by Subject|0
7611306|NCT02880371|12019162|FG004|Phase 1b|Withdrawal by Subject|0
7611307|NCT02880371|12019163|FG005|Phase 1b|Withdrawal by Subject|0
7611308|NCT02880371|12019164|FG006|Phase 1b|Withdrawal by Subject|0
7611309|NCT02880371|12019165|FG007|Phase 1b|Withdrawal by Subject|0
7611310|NCT02880371|12019158|FG000|Phase 1b|Death|4
7611311|NCT02880371|12019159|FG001|Phase 1b|Death|6
7611312|NCT02880371|12019160|FG002|Phase 1b|Death|5
7611313|NCT02880371|12019161|FG003|Phase 1b|Death|1
7611314|NCT02880371|12019162|FG004|Phase 1b|Death|0
7611315|NCT02880371|12019163|FG005|Phase 1b|Death|0
7611316|NCT02880371|12019164|FG006|Phase 1b|Death|0
7611317|NCT02880371|12019165|FG007|Phase 1b|Death|0
7611318|NCT02880371|12019158|FG000|Phase 1b|Enrolled but not Treated|0
7611319|NCT02880371|12019159|FG001|Phase 1b|Enrolled but not Treated|1
7611320|NCT02880371|12019160|FG002|Phase 1b|Enrolled but not Treated|0
7611321|NCT02880371|12019161|FG003|Phase 1b|Enrolled but not Treated|0
7611322|NCT02880371|12019162|FG004|Phase 1b|Enrolled but not Treated|0
7611323|NCT02880371|12019163|FG005|Phase 1b|Enrolled but not Treated|0
7611324|NCT02880371|12019164|FG006|Phase 1b|Enrolled but not Treated|0
7611325|NCT02880371|12019165|FG007|Phase 1b|Enrolled but not Treated|0
7611326|NCT02880371|12019158|FG000|Phase 2|Enrolled but not Treated|0
7611327|NCT02880371|12019159|FG001|Phase 2|Enrolled but not Treated|0
7611328|NCT02880371|12019160|FG002|Phase 2|Enrolled but not Treated|0
7611329|NCT02880371|12019161|FG003|Phase 2|Enrolled but not Treated|0
7611330|NCT02880371|12019162|FG004|Phase 2|Enrolled but not Treated|0
7611331|NCT02880371|12019163|FG005|Phase 2|Enrolled but not Treated|1
7611332|NCT02880371|12019164|FG006|Phase 2|Enrolled but not Treated|1
7611333|NCT02880371|12019165|FG007|Phase 2|Enrolled but not Treated|0
7611334|NCT02880371|12019158|FG000|Phase 2|Other|0
7611335|NCT02880371|12019159|FG001|Phase 2|Other|0
7611336|NCT02880371|12019160|FG002|Phase 2|Other|0
7611337|NCT02880371|12019161|FG003|Phase 2|Other|0
7611338|NCT02880371|12019162|FG004|Phase 2|Other|0
7611339|NCT02880371|12019163|FG005|Phase 2|Other|1
7611340|NCT02880371|12019164|FG006|Phase 2|Other|2
7611341|NCT02880371|12019165|FG007|Phase 2|Other|1
7611342|NCT02880371|12019158|FG000|Phase 2|Participants terminated by Sponsor|0
7611343|NCT02880371|12019159|FG001|Phase 2|Participants terminated by Sponsor|0
7611344|NCT02880371|12019160|FG002|Phase 2|Participants terminated by Sponsor|0
7611345|NCT02880371|12019161|FG003|Phase 2|Participants terminated by Sponsor|0
7611346|NCT02880371|12019162|FG004|Phase 2|Participants terminated by Sponsor|1
7611347|NCT02880371|12019163|FG005|Phase 2|Participants terminated by Sponsor|6
7611348|NCT02880371|12019164|FG006|Phase 2|Participants terminated by Sponsor|1
7611349|NCT02880371|12019165|FG007|Phase 2|Participants terminated by Sponsor|5
7611350|NCT02880371|12019158|FG000|Phase 2|Death|0
7611351|NCT02880371|12019159|FG001|Phase 2|Death|0
7611352|NCT02880371|12019160|FG002|Phase 2|Death|0
7611353|NCT02880371|12019161|FG003|Phase 2|Death|0
7611354|NCT02880371|12019162|FG004|Phase 2|Death|1
7611355|NCT02880371|12019163|FG005|Phase 2|Death|10
7611356|NCT02880371|12019164|FG006|Phase 2|Death|20
7611357|NCT02880371|12019165|FG007|Phase 2|Death|5
7611358|NCT02880371|12019158|FG000|Phase 2|Lost to Follow-up|0
7611359|NCT02880371|12019159|FG001|Phase 2|Lost to Follow-up|0
7611360|NCT02880371|12019160|FG002|Phase 2|Lost to Follow-up|0
7611361|NCT02880371|12019161|FG003|Phase 2|Lost to Follow-up|0
7611362|NCT02880371|12019162|FG004|Phase 2|Lost to Follow-up|0
7611363|NCT02880371|12019163|FG005|Phase 2|Lost to Follow-up|0
7611364|NCT02880371|12019164|FG006|Phase 2|Lost to Follow-up|3
7611365|NCT02880371|12019165|FG007|Phase 2|Lost to Follow-up|0
7611366|NCT02880371|12019158|FG000|Phase 2|Withdrawal by Subject|0
7611367|NCT02880371|12019159|FG001|Phase 2|Withdrawal by Subject|0
7611368|NCT02880371|12019160|FG002|Phase 2|Withdrawal by Subject|0
7611369|NCT02880371|12019161|FG003|Phase 2|Withdrawal by Subject|0
7611370|NCT02880371|12019162|FG004|Phase 2|Withdrawal by Subject|0
7611371|NCT02880371|12019163|FG005|Phase 2|Withdrawal by Subject|1
7611372|NCT02880371|12019164|FG006|Phase 2|Withdrawal by Subject|1
7611373|NCT02880371|12019165|FG007|Phase 2|Withdrawal by Subject|0
7611374|NCT02880371|12019158|FG000|Phase 2|End of Study page not completed by error|0
7611375|NCT02880371|12019159|FG001|Phase 2|End of Study page not completed by error|0
7611376|NCT02880371|12019160|FG002|Phase 2|End of Study page not completed by error|0
7611377|NCT02880371|12019161|FG003|Phase 2|End of Study page not completed by error|0
7611378|NCT02880371|12019162|FG004|Phase 2|End of Study page not completed by error|0
7611379|NCT02880371|12019163|FG005|Phase 2|End of Study page not completed by error|1
7611380|NCT02880371|12019164|FG006|Phase 2|End of Study page not completed by error|0
7611381|NCT02880371|12019165|FG007|Phase 2|End of Study page not completed by error|0
7611394|NCT02434354|12019194|FG000|Overall Study|screen fail|3
7611395|NCT02419417|12019209|FG000|Overall Study|Disease progression|5
7611396|NCT02419417|12019210|FG001|Overall Study|Disease progression|4
7611397|NCT02419417|12019211|FG002|Overall Study|Disease progression|13
7611398|NCT02419417|12019212|FG003|Overall Study|Disease progression|10
7611399|NCT02419417|12019213|FG004|Overall Study|Disease progression|10
7611400|NCT02419417|12019214|FG005|Overall Study|Disease progression|3
7611401|NCT02419417|12019215|FG006|Overall Study|Disease progression|4
7611402|NCT02419417|12019216|FG007|Overall Study|Disease progression|5
7611403|NCT02419417|12019217|FG008|Overall Study|Disease progression|13
7611404|NCT02419417|12019218|FG009|Overall Study|Disease progression|9
7611405|NCT02419417|12019219|FG010|Overall Study|Disease progression|0
7611406|NCT02419417|12019209|FG000|Overall Study|Study drug toxicity|0
7611407|NCT02419417|12019210|FG001|Overall Study|Study drug toxicity|0
7611408|NCT02419417|12019211|FG002|Overall Study|Study drug toxicity|0
7611409|NCT02419417|12019212|FG003|Overall Study|Study drug toxicity|0
7611410|NCT02419417|12019213|FG004|Overall Study|Study drug toxicity|1
7611411|NCT02419417|12019214|FG005|Overall Study|Study drug toxicity|0
7611412|NCT02419417|12019215|FG006|Overall Study|Study drug toxicity|0
7611413|NCT02419417|12019216|FG007|Overall Study|Study drug toxicity|0
7611414|NCT02419417|12019217|FG008|Overall Study|Study drug toxicity|0
7611415|NCT02419417|12019218|FG009|Overall Study|Study drug toxicity|0
7611416|NCT02419417|12019219|FG010|Overall Study|Study drug toxicity|0
7611417|NCT02419417|12019209|FG000|Overall Study|Adverse event unrelated to study drug|0
7611418|NCT02419417|12019210|FG001|Overall Study|Adverse event unrelated to study drug|0
7611419|NCT02419417|12019211|FG002|Overall Study|Adverse event unrelated to study drug|0
7611420|NCT02419417|12019212|FG003|Overall Study|Adverse event unrelated to study drug|0
7611421|NCT02419417|12019213|FG004|Overall Study|Adverse event unrelated to study drug|2
7611422|NCT02419417|12019214|FG005|Overall Study|Adverse event unrelated to study drug|1
7611423|NCT02419417|12019215|FG006|Overall Study|Adverse event unrelated to study drug|0
7611424|NCT02419417|12019216|FG007|Overall Study|Adverse event unrelated to study drug|1
7611425|NCT02419417|12019217|FG008|Overall Study|Adverse event unrelated to study drug|0
7611426|NCT02419417|12019218|FG009|Overall Study|Adverse event unrelated to study drug|0
7611427|NCT02419417|12019219|FG010|Overall Study|Adverse event unrelated to study drug|0
7611428|NCT02419417|12019209|FG000|Overall Study|Participant request to discontinue|0
7611429|NCT02419417|12019210|FG001|Overall Study|Participant request to discontinue|0
7611430|NCT02419417|12019211|FG002|Overall Study|Participant request to discontinue|0
7611431|NCT02419417|12019212|FG003|Overall Study|Participant request to discontinue|0
7611432|NCT02419417|12019213|FG004|Overall Study|Participant request to discontinue|0
7611433|NCT02419417|12019214|FG005|Overall Study|Participant request to discontinue|0
7611434|NCT02419417|12019215|FG006|Overall Study|Participant request to discontinue|0
7611435|NCT02419417|12019216|FG007|Overall Study|Participant request to discontinue|0
7611436|NCT02419417|12019217|FG008|Overall Study|Participant request to discontinue|0
7611437|NCT02419417|12019218|FG009|Overall Study|Participant request to discontinue|1
7611438|NCT02419417|12019219|FG010|Overall Study|Participant request to discontinue|0
7611439|NCT02419417|12019209|FG000|Overall Study|Withdrawal by Subject|0
7611440|NCT02419417|12019210|FG001|Overall Study|Withdrawal by Subject|0
7611441|NCT02419417|12019211|FG002|Overall Study|Withdrawal by Subject|0
7611442|NCT02419417|12019212|FG003|Overall Study|Withdrawal by Subject|0
7611443|NCT02419417|12019213|FG004|Overall Study|Withdrawal by Subject|0
7611444|NCT02419417|12019214|FG005|Overall Study|Withdrawal by Subject|0
7611445|NCT02419417|12019215|FG006|Overall Study|Withdrawal by Subject|0
7611446|NCT02419417|12019216|FG007|Overall Study|Withdrawal by Subject|0
7277450|NCT00454246|11492375|FG002|Overall Study|Failure to return|0
7611447|NCT02419417|12019217|FG008|Overall Study|Withdrawal by Subject|0
7611448|NCT02419417|12019218|FG009|Overall Study|Withdrawal by Subject|0
7611449|NCT02419417|12019219|FG010|Overall Study|Withdrawal by Subject|1
7611450|NCT02395120|12019253|FG000|Overall Study|Missed follow-up dental exam|57
7611451|NCT02395120|12019254|FG001|Overall Study|Missed follow-up dental exam|62
7611452|NCT02395120|12019255|FG002|Overall Study|Missed follow-up dental exam|6
7611453|NCT02395120|12019256|FG003|Overall Study|Missed follow-up dental exam|6
7611454|NCT02395120|12019257|FG004|Overall Study|Missed follow-up dental exam|51
7277451|NCT00454246|11492373|FG000|Overall Study|Early termination of study|62
7611469|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Death|3
7611470|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Death|3
7611471|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Death|0
7611472|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Death|0
7611473|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Adverse Event|2
7611474|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Adverse Event|8
7611475|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Adverse Event|0
7611476|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Adverse Event|0
7611477|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42
7611478|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29
7611479|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0
7611480|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0
7611481|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Physician Decision|2
7611482|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Physician Decision|4
7611483|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Physician Decision|0
7611484|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Physician Decision|0
7611485|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1
7611486|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2
7611487|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0
7611488|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0
7611489|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Protocol Violation|0
7611490|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Protocol Violation|1
7611491|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Protocol Violation|0
7611492|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Protocol Violation|0
7611493|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Non-Compliance|2
7611494|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Non-Compliance|4
7611495|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Non-Compliance|0
7611496|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Non-Compliance|0
7611497|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Other|6
7611498|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Other|3
7611499|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Other|0
7611500|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Other|0
7611501|NCT02051608|12019292|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3
7611502|NCT02051608|12019293|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2
7277452|NCT00454246|11492374|FG001|Overall Study|Early termination of study|26
7277453|NCT00454246|11492375|FG002|Overall Study|Early termination of study|9
7611503|NCT02051608|12019294|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
7611504|NCT02051608|12019295|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0
7611505|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Adverse Event|0
7611506|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Adverse Event|0
7611507|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Adverse Event|6
7611508|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Adverse Event|8
7611509|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Death|0
7611510|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Death|0
7611511|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Death|7
7611512|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Death|4
7611513|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Lost to Follow-up|0
7611514|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Lost to Follow-up|0
7611515|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Lost to Follow-up|0
7611516|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Lost to Follow-up|1
7611517|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Non-Compliance|0
7611518|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Non-Compliance|0
7611519|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Non-Compliance|1
7611520|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Non-Compliance|1
7611521|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
7611522|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
7611523|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39
7611524|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32
7611525|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7611526|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7277454|NCT00454363|11492394|FG000|Overall Study|Adverse Event|1
7277455|NCT00454363|11492395|FG001|Overall Study|Adverse Event|2
7277456|NCT00454363|11492394|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
7277457|NCT00454363|11492395|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
7277458|NCT00454584|11492420|FG000|Controlled Period|Adverse Event|5
7277459|NCT00454584|11492421|FG001|Controlled Period|Adverse Event|2
7277460|NCT00454584|11492422|FG002|Controlled Period|Adverse Event|1
7277461|NCT00454584|11492423|FG003|Controlled Period|Adverse Event|0
7277462|NCT00454584|11492424|FG004|Controlled Period|Adverse Event|0
7277463|NCT00454584|11492425|FG005|Controlled Period|Adverse Event|0
7277464|NCT00454584|11492420|FG000|Controlled Period|Lost to Follow-up|1
7611527|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0
7611528|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1
7611529|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Physician Decision|0
7611530|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Physician Decision|0
7611531|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Physician Decision|8
7611532|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Physician Decision|5
7611533|NCT02051608|12019292|FG000|Part 2: Open-label Extension|Other|0
7611534|NCT02051608|12019293|FG001|Part 2: Open-label Extension|Other|0
7611535|NCT02051608|12019294|FG002|Part 2: Open-label Extension|Other|9
7611536|NCT02051608|12019295|FG003|Part 2: Open-label Extension|Other|9
7277465|NCT00454584|11492421|FG001|Controlled Period|Lost to Follow-up|2
7277466|NCT00454584|11492422|FG002|Controlled Period|Lost to Follow-up|2
7611567|NCT00726596|12019376|FG000|Overall Study|Adverse Event|2
7611568|NCT00726596|12019377|FG001|Overall Study|Adverse Event|1
7611569|NCT00726596|12019376|FG000|Overall Study|Withdrawal by Subject|3
7611570|NCT00726596|12019377|FG001|Overall Study|Withdrawal by Subject|3
7611571|NCT00489827|12019385|FG000|Overall Study|Intraoperative exclusion criteria|1
7611572|NCT00489827|12019386|FG001|Overall Study|Intraoperative exclusion criteria|1
7611573|NCT00489827|12019385|FG000|Overall Study|Intraoperative exclusion criteria|1
7611574|NCT00489827|12019386|FG001|Overall Study|Intraoperative exclusion criteria|1
7611576|NCT04311463|12019442|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
7611577|NCT04311463|12019443|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
7611578|NCT04311463|12019442|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
7611579|NCT04311463|12019443|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
7611580|NCT04311463|12019442|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
7611581|NCT04311463|12019443|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
7611582|NCT03930186|12019459|FG000|Weeks 0 to 16|Adverse Event|6
7611583|NCT03930186|12019459|FG000|Weeks 0 to 16|Withdrawal by Subject|6
7611584|NCT03930186|12019459|FG000|Weeks 16 to 32|Adverse Event|1
7611585|NCT03930186|12019459|FG000|Weeks 16 to 32|Withdrawal by Subject|3
7611586|NCT03740100|12019463|FG000|Overall Study|Adverse Event|1
7611587|NCT03740100|12019463|FG000|Overall Study|Death|1
7611588|NCT03597295|12019467|FG000|Overall Study|Death|37
7611589|NCT03597295|12019467|FG000|Overall Study|Lost to Follow-up|3
7611590|NCT03597295|12019467|FG000|Overall Study|Participants ongoing in the study|54
7611591|NCT04808609|12019495|FG000|Overall Study|Lost to Follow-up|0
7611592|NCT04808609|12019496|FG001|Overall Study|Lost to Follow-up|2
7611593|NCT04808609|12019495|FG000|Overall Study|Administrative Withdrawal|0
7277467|NCT00454584|11492423|FG003|Controlled Period|Lost to Follow-up|0
7277468|NCT00454584|11492424|FG004|Controlled Period|Lost to Follow-up|0
7277469|NCT00454584|11492425|FG005|Controlled Period|Lost to Follow-up|0
7277470|NCT00454584|11492420|FG000|Controlled Period|Other|5
7611594|NCT04808609|12019496|FG001|Overall Study|Administrative Withdrawal|1
7611595|NCT04577781|12019504|FG000|Overall Study|Adverse Event|2
7611596|NCT04577781|12019505|FG001|Overall Study|Adverse Event|2
7611597|NCT04577781|12019504|FG000|Overall Study|Physician Decision|1
7611598|NCT04577781|12019505|FG001|Overall Study|Physician Decision|0
7611599|NCT04524598|12019516|FG000|Phase I - Feasibility|Lost to Follow-up|2
7611600|NCT04524598|12019517|FG001|Phase I - Feasibility|Lost to Follow-up|4
7611601|NCT04524598|12019518|FG002|Phase I - Feasibility|Lost to Follow-up|0
7611602|NCT04524598|12019519|FG003|Phase I - Feasibility|Lost to Follow-up|0
7611603|NCT04524598|12019520|FG004|Phase I - Feasibility|Lost to Follow-up|0
7611604|NCT04524598|12019516|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
7611605|NCT04524598|12019517|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
7611606|NCT04524598|12019518|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7611607|NCT04524598|12019519|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7277511|NCT00454636|11492444|FG001|Overall Study|Disease Progression|12
7611608|NCT04524598|12019520|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
7611609|NCT04524598|12019516|FG000|Phase II - Outcomes|Lost to Follow-up|0
7611610|NCT04524598|12019517|FG001|Phase II - Outcomes|Lost to Follow-up|0
7611611|NCT04524598|12019518|FG002|Phase II - Outcomes|Lost to Follow-up|16
7611612|NCT04524598|12019519|FG003|Phase II - Outcomes|Lost to Follow-up|8
7611613|NCT04524598|12019520|FG004|Phase II - Outcomes|Lost to Follow-up|0
7611614|NCT04524598|12019516|FG000|Phase II - Outcomes|Withdrawal by Subject|0
7611615|NCT04524598|12019517|FG001|Phase II - Outcomes|Withdrawal by Subject|0
7611616|NCT04524598|12019518|FG002|Phase II - Outcomes|Withdrawal by Subject|2
7611617|NCT04524598|12019519|FG003|Phase II - Outcomes|Withdrawal by Subject|0
7611618|NCT04524598|12019520|FG004|Phase II - Outcomes|Withdrawal by Subject|0
7611619|NCT04524598|12019516|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7611620|NCT04524598|12019517|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7611621|NCT04524598|12019518|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
7277471|NCT00454584|11492421|FG001|Controlled Period|Other|4
7277472|NCT00454584|11492422|FG002|Controlled Period|Other|2
7277473|NCT00454584|11492423|FG003|Controlled Period|Other|0
7277474|NCT00454584|11492424|FG004|Controlled Period|Other|0
7277475|NCT00454584|11492425|FG005|Controlled Period|Other|0
7277476|NCT00454584|11492420|FG000|After Controlled Period|Adverse Event|0
7277477|NCT00454584|11492421|FG001|After Controlled Period|Adverse Event|0
7277478|NCT00454584|11492422|FG002|After Controlled Period|Adverse Event|0
7611622|NCT04524598|12019519|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
7611623|NCT04524598|12019520|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
7277479|NCT00454584|11492423|FG003|After Controlled Period|Adverse Event|9
7277480|NCT00454584|11492424|FG004|After Controlled Period|Adverse Event|3
7277481|NCT00454584|11492425|FG005|After Controlled Period|Adverse Event|9
7277482|NCT00454584|11492420|FG000|After Controlled Period|Lack of Efficacy|0
7277483|NCT00454584|11492421|FG001|After Controlled Period|Lack of Efficacy|0
7277484|NCT00454584|11492422|FG002|After Controlled Period|Lack of Efficacy|0
7277485|NCT00454584|11492423|FG003|After Controlled Period|Lack of Efficacy|1
7277486|NCT00454584|11492424|FG004|After Controlled Period|Lack of Efficacy|0
7277487|NCT00454584|11492425|FG005|After Controlled Period|Lack of Efficacy|0
7277488|NCT00454584|11492420|FG000|After Controlled Period|Lost to Follow-up|0
7277489|NCT00454584|11492421|FG001|After Controlled Period|Lost to Follow-up|0
7277490|NCT00454584|11492422|FG002|After Controlled Period|Lost to Follow-up|0
7611624|NCT04524598|12019516|FG000|Phase II - Control Extension|Lost to Follow-up|0
7277491|NCT00454584|11492423|FG003|After Controlled Period|Lost to Follow-up|2
7611625|NCT04524598|12019517|FG001|Phase II - Control Extension|Lost to Follow-up|0
7611626|NCT04524598|12019518|FG002|Phase II - Control Extension|Lost to Follow-up|0
7611627|NCT04524598|12019519|FG003|Phase II - Control Extension|Lost to Follow-up|0
7611628|NCT04524598|12019520|FG004|Phase II - Control Extension|Lost to Follow-up|6
7611629|NCT04524598|12019516|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611630|NCT04524598|12019517|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611631|NCT04524598|12019518|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611632|NCT04524598|12019519|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
7611633|NCT04524598|12019520|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
7611634|NCT04518462|12019537|FG000|Overall Study|Withdrawal by Subject|0
7611635|NCT04518462|12019538|FG001|Overall Study|Withdrawal by Subject|0
7611636|NCT04518462|12019539|FG002|Overall Study|Withdrawal by Subject|1
7611637|NCT04518462|12019537|FG000|Overall Study|Physician Decision|1
7611638|NCT04518462|12019538|FG001|Overall Study|Physician Decision|1
7611639|NCT04518462|12019539|FG002|Overall Study|Physician Decision|0
7611640|NCT04432298|12019549|FG000|Overall Study|Other than specified|1
7611641|NCT04432298|12019550|FG001|Overall Study|Other than specified|0
7611642|NCT04432298|12019549|FG000|Overall Study|Lost to Follow-up|0
7611643|NCT04432298|12019550|FG001|Overall Study|Lost to Follow-up|1
7611644|NCT04432298|12019549|FG000|Overall Study|Death|3
7611645|NCT04432298|12019550|FG001|Overall Study|Death|2
7611646|NCT04432298|12019549|FG000|Overall Study|Withdrawal by Subject|2
7277492|NCT00454584|11492424|FG004|After Controlled Period|Lost to Follow-up|4
7277493|NCT00454584|11492425|FG005|After Controlled Period|Lost to Follow-up|6
7277494|NCT00454584|11492420|FG000|After Controlled Period|Other|0
7277495|NCT00454584|11492421|FG001|After Controlled Period|Other|0
7277496|NCT00454584|11492422|FG002|After Controlled Period|Other|0
7277497|NCT00454584|11492423|FG003|After Controlled Period|Other|1
7277498|NCT00454584|11492424|FG004|After Controlled Period|Other|0
7277499|NCT00454584|11492425|FG005|After Controlled Period|Other|0
7277500|NCT00454584|11492420|FG000|After Controlled Period|Other|0
7277501|NCT00454584|11492421|FG001|After Controlled Period|Other|0
7277502|NCT00454584|11492422|FG002|After Controlled Period|Other|0
7277503|NCT00454584|11492423|FG003|After Controlled Period|Other|13
7277504|NCT00454584|11492424|FG004|After Controlled Period|Other|5
7277505|NCT00454584|11492425|FG005|After Controlled Period|Other|17
7277506|NCT00454636|11492443|FG000|Overall Study|Adverse Event|10
7277507|NCT00454636|11492444|FG001|Overall Study|Adverse Event|6
7277508|NCT00454636|11492445|FG002|Overall Study|Adverse Event|9
7277509|NCT00454636|11492446|FG003|Overall Study|Adverse Event|15
7277510|NCT00454636|11492443|FG000|Overall Study|Disease Progression|11
7277512|NCT00454636|11492445|FG002|Overall Study|Disease Progression|4
7277513|NCT00454636|11492446|FG003|Overall Study|Disease Progression|11
7277514|NCT00454636|11492443|FG000|Overall Study|Protocol Violation|3
7277515|NCT00454636|11492444|FG001|Overall Study|Protocol Violation|2
7277516|NCT00454636|11492445|FG002|Overall Study|Protocol Violation|3
7277517|NCT00454636|11492446|FG003|Overall Study|Protocol Violation|3
7277518|NCT00454636|11492443|FG000|Overall Study|Death|6
7277519|NCT00454636|11492444|FG001|Overall Study|Death|1
7277520|NCT00454636|11492445|FG002|Overall Study|Death|1
7277521|NCT00454636|11492446|FG003|Overall Study|Death|1
7277522|NCT00454636|11492443|FG000|Overall Study|Patient refusal|1
7277523|NCT00454636|11492444|FG001|Overall Study|Patient refusal|1
7277524|NCT00454636|11492445|FG002|Overall Study|Patient refusal|3
7277525|NCT00454636|11492446|FG003|Overall Study|Patient refusal|2
7277526|NCT00454636|11492443|FG000|Overall Study|Lost to Follow-up|0
7277527|NCT00454636|11492444|FG001|Overall Study|Lost to Follow-up|1
7277528|NCT00454636|11492445|FG002|Overall Study|Lost to Follow-up|0
7277529|NCT00454636|11492446|FG003|Overall Study|Lost to Follow-up|0
7277530|NCT00454649|11492466|FG000|Overall Study|Lack of Efficacy|2
7277531|NCT00454649|11492467|FG001|Overall Study|Lack of Efficacy|2
7277532|NCT00454649|11492468|FG002|Overall Study|Lack of Efficacy|10
7277533|NCT00454649|11492469|FG003|Overall Study|Lack of Efficacy|3
7277534|NCT00454649|11492470|FG004|Overall Study|Lack of Efficacy|0
7277535|NCT00454649|11492471|FG005|Overall Study|Lack of Efficacy|4
7277536|NCT00454649|11492472|FG006|Overall Study|Lack of Efficacy|5
7277537|NCT00454649|11492473|FG007|Overall Study|Lack of Efficacy|13
7277538|NCT00454649|11492474|FG008|Overall Study|Lack of Efficacy|10
7277539|NCT00454649|11492475|FG009|Overall Study|Lack of Efficacy|2
7611647|NCT04432298|12019550|FG001|Overall Study|Withdrawal by Subject|0
7611648|NCT04428034|12019556|FG000|Enrollment to Intervention Completion|Protocol Violation|9
7611649|NCT04428034|12019556|FG000|Enrollment to Intervention Completion|Suspected Fraudulent Case|1
7611650|NCT03853694|12019576|FG000|Overall Study|Protocol Violation|3
7611651|NCT03853694|12019577|FG001|Overall Study|Protocol Violation|5
7611652|NCT03853694|12019578|FG002|Overall Study|Protocol Violation|3
7611653|NCT03853694|12019576|FG000|Overall Study|Delivered early|0
7611654|NCT03853694|12019577|FG001|Overall Study|Delivered early|1
7611655|NCT03853694|12019578|FG002|Overall Study|Delivered early|0
7611656|NCT03853694|12019576|FG000|Overall Study|not suitable to proceed|0
7611657|NCT03853694|12019577|FG001|Overall Study|not suitable to proceed|1
7611658|NCT03853694|12019578|FG002|Overall Study|not suitable to proceed|0
7611659|NCT03853694|12019576|FG000|Overall Study|difficult surgery|0
7611660|NCT03853694|12019577|FG001|Overall Study|difficult surgery|0
7611661|NCT03853694|12019578|FG002|Overall Study|difficult surgery|1
7611662|NCT03853694|12019576|FG000|Overall Study|Lost to Follow-up|0
7611663|NCT03853694|12019577|FG001|Overall Study|Lost to Follow-up|1
7611664|NCT03853694|12019578|FG002|Overall Study|Lost to Follow-up|0
7611665|NCT03853694|12019576|FG000|Overall Study|Withdrawal by Subject|0
7611666|NCT03853694|12019577|FG001|Overall Study|Withdrawal by Subject|1
7611667|NCT03853694|12019578|FG002|Overall Study|Withdrawal by Subject|0
7611668|NCT03785340|12019588|FG000|Overall Study|Lost to Follow-up|2
7611669|NCT03785340|12019589|FG001|Overall Study|Lost to Follow-up|0
7611670|NCT03785340|12019588|FG000|Overall Study|Adverse Event|1
7611671|NCT03785340|12019589|FG001|Overall Study|Adverse Event|0
7611682|NCT03173560|12019670|FG000|Overall Study|Ongoing on Treatment|38
7611683|NCT03173560|12019671|FG001|Overall Study|Ongoing on Treatment|50
7611684|NCT03173560|12019670|FG000|Overall Study|Ongoing Survival Follow-up|56
7611685|NCT03173560|12019671|FG001|Overall Study|Ongoing Survival Follow-up|57
7611686|NCT03173560|12019670|FG000|Overall Study|Lost to Follow-up|1
7611687|NCT03173560|12019671|FG001|Overall Study|Lost to Follow-up|4
7611688|NCT03173560|12019670|FG000|Overall Study|Withdrawal by Subject|10
7611689|NCT03173560|12019671|FG001|Overall Study|Withdrawal by Subject|5
7611690|NCT03173560|12019670|FG000|Overall Study|Other|0
7611691|NCT03173560|12019671|FG001|Overall Study|Other|1
7611692|NCT02865850|12019693|FG000|Overall Study|Death|15
7611693|NCT02865850|12019694|FG001|Overall Study|Death|19
7611694|NCT02865850|12019693|FG000|Overall Study|Withdrawal by Subject|3
7611695|NCT02865850|12019694|FG001|Overall Study|Withdrawal by Subject|2
7611696|NCT02865850|12019693|FG000|Overall Study|Lost to Follow-up|3
7611697|NCT02865850|12019694|FG001|Overall Study|Lost to Follow-up|2
7611698|NCT02763579|12019702|FG000|Overall Study|Death|101
7611699|NCT02763579|12019703|FG001|Overall Study|Death|132
7611700|NCT02763579|12019702|FG000|Overall Study|Lost to Follow-up|3
7611701|NCT02763579|12019703|FG001|Overall Study|Lost to Follow-up|1
7611702|NCT02763579|12019702|FG000|Overall Study|Withdrawal by Subject|18
7611703|NCT02763579|12019703|FG001|Overall Study|Withdrawal by Subject|9
7611704|NCT02763579|12019702|FG000|Overall Study|Physician Decision|2
7611705|NCT02763579|12019703|FG001|Overall Study|Physician Decision|0
7611706|NCT02763579|12019702|FG000|Overall Study|On-going in study|77
7611707|NCT02763579|12019703|FG001|Overall Study|On-going in study|60
7611708|NCT02746471|12019709|FG000|Overall Study|Death|43
7611709|NCT02746471|12019709|FG000|Overall Study|Exited before 36 months|1119
7277540|NCT00454649|11492466|FG000|Overall Study|Adverse Event|0
7277541|NCT00454649|11492467|FG001|Overall Study|Adverse Event|1
7277542|NCT00454649|11492468|FG002|Overall Study|Adverse Event|3
7277543|NCT00454649|11492469|FG003|Overall Study|Adverse Event|0
7277544|NCT00454649|11492470|FG004|Overall Study|Adverse Event|1
7277545|NCT00454649|11492471|FG005|Overall Study|Adverse Event|2
7277546|NCT00454649|11492472|FG006|Overall Study|Adverse Event|3
7277547|NCT00454649|11492473|FG007|Overall Study|Adverse Event|4
7277548|NCT00454649|11492474|FG008|Overall Study|Adverse Event|6
7277549|NCT00454649|11492475|FG009|Overall Study|Adverse Event|2
7277550|NCT00454649|11492466|FG000|Overall Study|Lost to Follow-up|0
7277551|NCT00454649|11492467|FG001|Overall Study|Lost to Follow-up|0
7277552|NCT00454649|11492468|FG002|Overall Study|Lost to Follow-up|1
7277553|NCT00454649|11492469|FG003|Overall Study|Lost to Follow-up|0
7277554|NCT00454649|11492470|FG004|Overall Study|Lost to Follow-up|0
7277555|NCT00454649|11492471|FG005|Overall Study|Lost to Follow-up|0
7277556|NCT00454649|11492472|FG006|Overall Study|Lost to Follow-up|1
7277557|NCT00454649|11492473|FG007|Overall Study|Lost to Follow-up|0
7277558|NCT00454649|11492474|FG008|Overall Study|Lost to Follow-up|0
7277559|NCT00454649|11492475|FG009|Overall Study|Lost to Follow-up|0
7277560|NCT00454649|11492466|FG000|Overall Study|Other|1
7277561|NCT00454649|11492467|FG001|Overall Study|Other|1
7277562|NCT00454649|11492468|FG002|Overall Study|Other|5
7277563|NCT00454649|11492469|FG003|Overall Study|Other|3
7611748|NCT02706873|12019727|FG000|Overall Study|Adverse Event|13
7611749|NCT02706873|12019728|FG001|Overall Study|Adverse Event|3
7611750|NCT02706873|12019729|FG002|Overall Study|Adverse Event|13
7277564|NCT00454649|11492470|FG004|Overall Study|Other|0
7277565|NCT00454649|11492471|FG005|Overall Study|Other|0
7277566|NCT00454649|11492472|FG006|Overall Study|Other|0
7277567|NCT00454649|11492473|FG007|Overall Study|Other|0
7611751|NCT02706873|12019730|FG003|Overall Study|Adverse Event|12
7611752|NCT02706873|12019727|FG000|Overall Study|Withdrawal by Subject|15
7611753|NCT02706873|12019728|FG001|Overall Study|Withdrawal by Subject|0
7611754|NCT02706873|12019729|FG002|Overall Study|Withdrawal by Subject|8
7611755|NCT02706873|12019730|FG003|Overall Study|Withdrawal by Subject|11
7611756|NCT02706873|12019727|FG000|Overall Study|Lost to Follow-up|3
7611757|NCT02706873|12019728|FG001|Overall Study|Lost to Follow-up|0
7611758|NCT02706873|12019729|FG002|Overall Study|Lost to Follow-up|4
7611759|NCT02706873|12019730|FG003|Overall Study|Lost to Follow-up|2
7611760|NCT02706873|12019727|FG000|Overall Study|Lack of Efficacy|10
7611761|NCT02706873|12019728|FG001|Overall Study|Lack of Efficacy|0
7611762|NCT02706873|12019729|FG002|Overall Study|Lack of Efficacy|0
7611763|NCT02706873|12019730|FG003|Overall Study|Lack of Efficacy|3
7611764|NCT02706873|12019727|FG000|Overall Study|Other|5
7611765|NCT02706873|12019728|FG001|Overall Study|Other|1
7611766|NCT02706873|12019729|FG002|Overall Study|Other|2
7611767|NCT02706873|12019730|FG003|Overall Study|Other|3
7611768|NCT02706873|12019727|FG000|Overall Study|Not Dosed|1
7611769|NCT02706873|12019728|FG001|Overall Study|Not Dosed|0
7611770|NCT02706873|12019729|FG002|Overall Study|Not Dosed|0
7611771|NCT02706873|12019730|FG003|Overall Study|Not Dosed|1
7611772|NCT02706873|12019727|FG000|Overall Study|Ongoing|0
7611773|NCT02706873|12019728|FG001|Overall Study|Ongoing|0
7611774|NCT02706873|12019729|FG002|Overall Study|Ongoing|0
7611775|NCT02706873|12019730|FG003|Overall Study|Ongoing|1
7611776|NCT02591953|12019744|FG000|Overall Study|Lost to Follow-up|6
7611777|NCT02591953|12019745|FG001|Overall Study|Lost to Follow-up|6
7611778|NCT02509494|12019759|FG000|Overall Study|Lost to Follow-up|8
7611779|NCT02509494|12019760|FG001|Overall Study|Lost to Follow-up|47
7611780|NCT02509494|12019761|FG002|Overall Study|Lost to Follow-up|19
7611781|NCT02509494|12019762|FG003|Overall Study|Lost to Follow-up|6
7611782|NCT02509494|12019763|FG004|Overall Study|Lost to Follow-up|3
7611783|NCT02509494|12019764|FG005|Overall Study|Lost to Follow-up|3
7611784|NCT02509494|12019765|FG006|Overall Study|Lost to Follow-up|1
7611785|NCT02509494|12019766|FG007|Overall Study|Lost to Follow-up|3
7611786|NCT02509494|12019767|FG008|Overall Study|Lost to Follow-up|1
7611787|NCT02509494|12019759|FG000|Overall Study|Physician Decision|2
7611788|NCT02509494|12019760|FG001|Overall Study|Physician Decision|1
7611789|NCT02509494|12019761|FG002|Overall Study|Physician Decision|0
7611790|NCT02509494|12019762|FG003|Overall Study|Physician Decision|0
7611791|NCT02509494|12019763|FG004|Overall Study|Physician Decision|0
7611792|NCT02509494|12019764|FG005|Overall Study|Physician Decision|0
7611793|NCT02509494|12019765|FG006|Overall Study|Physician Decision|0
7611794|NCT02509494|12019766|FG007|Overall Study|Physician Decision|0
7611795|NCT02509494|12019767|FG008|Overall Study|Physician Decision|0
7611796|NCT02509494|12019759|FG000|Overall Study|Withdrawal by Subject|4
7611797|NCT02509494|12019760|FG001|Overall Study|Withdrawal by Subject|17
7611798|NCT02509494|12019761|FG002|Overall Study|Withdrawal by Subject|7
7611799|NCT02509494|12019762|FG003|Overall Study|Withdrawal by Subject|5
7611800|NCT02509494|12019763|FG004|Overall Study|Withdrawal by Subject|0
7611801|NCT02509494|12019764|FG005|Overall Study|Withdrawal by Subject|6
7611802|NCT02509494|12019765|FG006|Overall Study|Withdrawal by Subject|1
7611803|NCT02509494|12019766|FG007|Overall Study|Withdrawal by Subject|2
7611804|NCT02509494|12019767|FG008|Overall Study|Withdrawal by Subject|1
7611805|NCT02509494|12019759|FG000|Overall Study|Death|0
7611806|NCT02509494|12019760|FG001|Overall Study|Death|1
7611807|NCT02509494|12019761|FG002|Overall Study|Death|0
7611808|NCT02509494|12019762|FG003|Overall Study|Death|0
7611809|NCT02509494|12019763|FG004|Overall Study|Death|1
7611810|NCT02509494|12019764|FG005|Overall Study|Death|0
7611811|NCT02509494|12019765|FG006|Overall Study|Death|0
7611812|NCT02509494|12019766|FG007|Overall Study|Death|1
7611813|NCT02509494|12019767|FG008|Overall Study|Death|0
7611814|NCT02509494|12019759|FG000|Overall Study|Other|0
7611815|NCT02509494|12019760|FG001|Overall Study|Other|4
7611816|NCT02509494|12019761|FG002|Overall Study|Other|5
7611817|NCT02509494|12019762|FG003|Overall Study|Other|0
7611818|NCT02509494|12019763|FG004|Overall Study|Other|0
7611819|NCT02509494|12019764|FG005|Overall Study|Other|0
7611820|NCT02509494|12019765|FG006|Overall Study|Other|0
7611821|NCT02509494|12019766|FG007|Overall Study|Other|0
7611822|NCT02509494|12019767|FG008|Overall Study|Other|0
7611823|NCT02509494|12019759|FG000|Overall Study|Non-Compliance With Study Drug|1
7611824|NCT02509494|12019760|FG001|Overall Study|Non-Compliance With Study Drug|11
7611825|NCT02509494|12019761|FG002|Overall Study|Non-Compliance With Study Drug|7
7611826|NCT02509494|12019762|FG003|Overall Study|Non-Compliance With Study Drug|0
7611827|NCT02509494|12019763|FG004|Overall Study|Non-Compliance With Study Drug|1
7611828|NCT02509494|12019764|FG005|Overall Study|Non-Compliance With Study Drug|2
7611829|NCT02509494|12019765|FG006|Overall Study|Non-Compliance With Study Drug|1
7611830|NCT02509494|12019766|FG007|Overall Study|Non-Compliance With Study Drug|1
7611831|NCT02509494|12019767|FG008|Overall Study|Non-Compliance With Study Drug|0
7611832|NCT02151981|12019812|FG000|Overall Study|Death|184
7611833|NCT02151981|12019813|FG001|Overall Study|Death|88
7611834|NCT02151981|12019812|FG000|Overall Study|Lost to Follow-up|7
7611835|NCT02151981|12019813|FG001|Overall Study|Lost to Follow-up|1
7611836|NCT02151981|12019812|FG000|Overall Study|Withdrawal by Subject|27
7611837|NCT02151981|12019813|FG001|Overall Study|Withdrawal by Subject|21
7611838|NCT02151981|12019812|FG000|Overall Study|Ongoing Study at Data Cut-off|60
7611839|NCT02151981|12019813|FG001|Overall Study|Ongoing Study at Data Cut-off|27
7611840|NCT02151981|12019812|FG000|Overall Study|Eligibility criteria not fulfilled|0
7611841|NCT02151981|12019813|FG001|Overall Study|Eligibility criteria not fulfilled|1
7611842|NCT02151981|12019812|FG000|Overall Study|Patient had no clinical benefit|1
7611843|NCT02151981|12019813|FG001|Overall Study|Patient had no clinical benefit|0
7611844|NCT02151981|12019812|FG000|Overall Study|Unwilling to continue to follow up visit|0
7611845|NCT02151981|12019813|FG001|Overall Study|Unwilling to continue to follow up visit|1
7611846|NCT02151981|12019812|FG000|Overall Study|Study terminated|0
7611847|NCT02151981|12019813|FG001|Overall Study|Study terminated|1
7611848|NCT02087423|12019822|FG000|Overall Study|Withdrawal by Subject|20
7611849|NCT02087423|12019823|FG001|Overall Study|Withdrawal by Subject|20
7611850|NCT02087423|12019824|FG002|Overall Study|Withdrawal by Subject|3
7611851|NCT02087423|12019822|FG000|Overall Study|Death|68
7611852|NCT02087423|12019823|FG001|Overall Study|Death|207
7611853|NCT02087423|12019824|FG002|Overall Study|Death|40
7611854|NCT02087423|12019822|FG000|Overall Study|Lost to Follow-up|0
7611855|NCT02087423|12019823|FG001|Overall Study|Lost to Follow-up|2
7611856|NCT02087423|12019824|FG002|Overall Study|Lost to Follow-up|0
7611857|NCT02087423|12019822|FG000|Overall Study|Terminated from study at final DCO|23
7611858|NCT02087423|12019823|FG001|Overall Study|Terminated from study at final DCO|36
7611859|NCT02087423|12019824|FG002|Overall Study|Terminated from study at final DCO|25
7611874|NCT01874353|12019845|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
7611875|NCT01874353|12019846|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611876|NCT01874353|12019847|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611877|NCT01874353|12019848|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
7611878|NCT01874353|12019845|FG000|Overall Study|Lost to Follow-up|2
7611879|NCT01874353|12019846|FG001|Overall Study|Lost to Follow-up|2
7611880|NCT01874353|12019847|FG002|Overall Study|Lost to Follow-up|2
7277568|NCT00454649|11492474|FG008|Overall Study|Other|3
7611881|NCT01874353|12019848|FG003|Overall Study|Lost to Follow-up|0
7611882|NCT01874353|12019845|FG000|Overall Study|Death|110
7611883|NCT01874353|12019846|FG001|Overall Study|Death|60
7611884|NCT01874353|12019847|FG002|Overall Study|Death|13
7611885|NCT01874353|12019848|FG003|Overall Study|Death|7
7611886|NCT01874353|12019845|FG000|Overall Study|Withdrawal by Subject|13
7611887|NCT01874353|12019846|FG001|Overall Study|Withdrawal by Subject|11
7611888|NCT01874353|12019847|FG002|Overall Study|Withdrawal by Subject|0
7611889|NCT01874353|12019848|FG003|Overall Study|Withdrawal by Subject|0
7277569|NCT00454649|11492475|FG009|Overall Study|Other|1
7277570|NCT00454649|11492466|FG000|Overall Study|Withdrawal by Subject|0
7277571|NCT00454649|11492467|FG001|Overall Study|Withdrawal by Subject|0
7277572|NCT00454649|11492468|FG002|Overall Study|Withdrawal by Subject|0
7277573|NCT00454649|11492469|FG003|Overall Study|Withdrawal by Subject|0
7277574|NCT00454649|11492470|FG004|Overall Study|Withdrawal by Subject|0
7277575|NCT00454649|11492471|FG005|Overall Study|Withdrawal by Subject|1
7277576|NCT00454649|11492472|FG006|Overall Study|Withdrawal by Subject|0
7277577|NCT00454649|11492473|FG007|Overall Study|Withdrawal by Subject|2
7277578|NCT00454649|11492474|FG008|Overall Study|Withdrawal by Subject|1
7277579|NCT00454649|11492475|FG009|Overall Study|Withdrawal by Subject|0
7277580|NCT00454779|11492518|FG000|First-line Treatment Phase|Lack of Efficacy|0
7277581|NCT00454779|11492519|FG001|First-line Treatment Phase|Lack of Efficacy|2
7277582|NCT00454779|11492518|FG000|First-line Treatment Phase|Withdrawal by Subject|2
7277583|NCT00454779|11492519|FG001|First-line Treatment Phase|Withdrawal by Subject|4
7277584|NCT00454779|11492518|FG000|First-line Treatment Phase|Lost to Follow-up|1
7277585|NCT00454779|11492519|FG001|First-line Treatment Phase|Lost to Follow-up|0
7277586|NCT00454779|11492518|FG000|First-line Treatment Phase|Protocol Violation|0
7277587|NCT00454779|11492519|FG001|First-line Treatment Phase|Protocol Violation|1
7277588|NCT00454779|11492518|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
7277589|NCT00454779|11492519|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
7277590|NCT00454779|11492518|FG000|First-line Treatment Phase|Ongoing|1
7277591|NCT00454779|11492519|FG001|First-line Treatment Phase|Ongoing|0
7277592|NCT00454779|11492518|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
7277593|NCT00454779|11492519|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
7277594|NCT00454779|11492518|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
7277595|NCT00454779|11492519|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
7277596|NCT00454779|11492518|FG000|Second-line Treatment Phase|Ongoing|0
7277597|NCT00454779|11492519|FG001|Second-line Treatment Phase|Ongoing|1
7277598|NCT00454805|11492527|FG000|Overall Study|Withdrawal by Subject|9
7277599|NCT00454805|11492528|FG001|Overall Study|Withdrawal by Subject|2
7277600|NCT00454805|11492527|FG000|Overall Study|Death|0
7277601|NCT00454805|11492528|FG001|Overall Study|Death|2
7277602|NCT00454805|11492527|FG000|Overall Study|Disease progression|16
7277603|NCT00454805|11492528|FG001|Overall Study|Disease progression|19
7277604|NCT00454805|11492527|FG000|Overall Study|In order to begin radiotherapy|1
7277605|NCT00454805|11492528|FG001|Overall Study|In order to begin radiotherapy|0
7277606|NCT00454818|11492542|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
7277607|NCT00454818|11492543|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
7469789|NCT01927055|11771696|FG001|Open-label|Withdrawal by Subject|0
7469790|NCT01927055|11771697|FG002|Open-label|Withdrawal by Subject|0
7469791|NCT01927055|11771695|FG000|Open-label|Study Stopped|4
7277608|NCT00454818|11492544|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
7277609|NCT00454818|11492545|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
7277610|NCT00454818|11492546|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
7277611|NCT00454818|11492542|FG000|Phase I: Open-label Dose-escalation|Death|0
7277612|NCT00454818|11492543|FG001|Phase I: Open-label Dose-escalation|Death|1
7277613|NCT00454818|11492544|FG002|Phase I: Open-label Dose-escalation|Death|0
7277614|NCT00454818|11492545|FG003|Phase I: Open-label Dose-escalation|Death|0
7277615|NCT00454818|11492546|FG004|Phase I: Open-label Dose-escalation|Death|0
7277616|NCT00454818|11492542|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7277617|NCT00454818|11492543|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7277618|NCT00454818|11492544|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7277619|NCT00454818|11492545|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
7277620|NCT00454818|11492546|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
7277621|NCT00454818|11492542|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7277622|NCT00454818|11492543|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7469792|NCT01927055|11771696|FG001|Open-label|Study Stopped|0
7611923|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
7611924|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
7611925|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
7611926|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
7611927|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
7611928|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
7611929|NCT02849626|12019932|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
7611930|NCT02849626|12019933|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
7611931|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
7611932|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
7611933|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
7611934|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
7611935|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
7611936|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
7611937|NCT02849626|12019932|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
7611938|NCT02849626|12019933|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
7611939|NCT02654132|12019951|FG000|Overall Study|Disease Progression|26
7611940|NCT02654132|12019952|FG001|Overall Study|Disease Progression|31
7611941|NCT02654132|12019951|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
7611942|NCT02654132|12019952|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
7611943|NCT02654132|12019951|FG000|Overall Study|Switched to another tx|0
7611944|NCT02654132|12019952|FG001|Overall Study|Switched to another tx|1
7611945|NCT02654132|12019951|FG000|Overall Study|Study Drug Toxicity|1
7611946|NCT02654132|12019952|FG001|Overall Study|Study Drug Toxicity|2
7611947|NCT02654132|12019951|FG000|Overall Study|Maximum Clinical Benefit|0
7611948|NCT02654132|12019952|FG001|Overall Study|Maximum Clinical Benefit|2
7611949|NCT02654132|12019951|FG000|Overall Study|Subj Request to Discontinue Treatment|1
7611950|NCT02654132|12019952|FG001|Overall Study|Subj Request to Discontinue Treatment|0
7611951|NCT02654132|12019951|FG000|Overall Study|Not Reported|0
7611952|NCT02654132|12019952|FG001|Overall Study|Not Reported|1
7611953|NCT02654132|12019951|FG000|Overall Study|Subject Withdrew Consent|2
7611954|NCT02654132|12019952|FG001|Overall Study|Subject Withdrew Consent|1
7611955|NCT02654132|12019951|FG000|Overall Study|Inadequate response to therapy|1
7611956|NCT02654132|12019952|FG001|Overall Study|Inadequate response to therapy|0
7611957|NCT02654132|12019951|FG000|Overall Study|Clinical Progression (not protocol)|0
7611958|NCT02654132|12019952|FG001|Overall Study|Clinical Progression (not protocol)|1
7611959|NCT02654132|12019951|FG000|Overall Study|Never treated|0
7611960|NCT02654132|12019952|FG001|Overall Study|Never treated|2
7611977|NCT02600923|12019968|FG000|Overall Study|Death|10
7611978|NCT02600923|12019968|FG000|Overall Study|Adverse Event|3
7611979|NCT02600923|12019968|FG000|Overall Study|Global deterioration of health status|2
7611980|NCT02600923|12019968|FG000|Overall Study|Insufficient clinical response|6
7611981|NCT02600923|12019968|FG000|Overall Study|Lost to Follow-up|1
7611982|NCT02600923|12019968|FG000|Overall Study|Withdrawal by Subject|5
7611983|NCT02600923|12019968|FG000|Overall Study|Objective progression or relapse|50
7611984|NCT02600923|12019968|FG000|Overall Study|Study terminated by Sponsor|53
7611985|NCT02600923|12019968|FG000|Overall Study|Not treated|1
7611986|NCT02412735|12019993|FG000|Overall Study|Adverse Event|0
7611987|NCT02412735|12019994|FG001|Overall Study|Adverse Event|1
7611988|NCT02412735|12019995|FG002|Overall Study|Adverse Event|2
7611989|NCT02412735|12019993|FG000|Overall Study|Withdrawal by Subject|23
7611990|NCT02412735|12019994|FG001|Overall Study|Withdrawal by Subject|27
7611991|NCT02412735|12019995|FG002|Overall Study|Withdrawal by Subject|22
7611992|NCT02412735|12019993|FG000|Overall Study|Investigator Decision|3
7611993|NCT02412735|12019994|FG001|Overall Study|Investigator Decision|3
7611994|NCT02412735|12019995|FG002|Overall Study|Investigator Decision|2
7611995|NCT02412735|12019993|FG000|Overall Study|Lost to Follow-up|17
7611996|NCT02412735|12019994|FG001|Overall Study|Lost to Follow-up|11
7611997|NCT02412735|12019995|FG002|Overall Study|Lost to Follow-up|18
7611998|NCT02412735|12019993|FG000|Overall Study|Reason not Specified|3
7611999|NCT02412735|12019994|FG001|Overall Study|Reason not Specified|2
7612000|NCT02412735|12019995|FG002|Overall Study|Reason not Specified|2
7612001|NCT02371889|12020005|FG000|Overall Study|Adverse medication effect|11
7612002|NCT02371889|12020006|FG001|Overall Study|Adverse medication effect|2
7612003|NCT02371889|12020005|FG000|Overall Study|Lost to Follow-up|6
7612004|NCT02371889|12020006|FG001|Overall Study|Lost to Follow-up|5
7612005|NCT02371889|12020005|FG000|Overall Study|Personal time constraints|2
7612006|NCT02371889|12020006|FG001|Overall Study|Personal time constraints|4
7612007|NCT02371889|12020005|FG000|Overall Study|Lack of Efficacy|0
7612008|NCT02371889|12020006|FG001|Overall Study|Lack of Efficacy|2
7612009|NCT02371889|12020005|FG000|Overall Study|Relapse|0
7612010|NCT02371889|12020006|FG001|Overall Study|Relapse|1
7612011|NCT02100722|12020027|FG000|Overall Study|Withdrawal pre-procedure|4
7612012|NCT02100722|12020028|FG001|Overall Study|Withdrawal pre-procedure|9
7612013|NCT02100722|12020027|FG000|Overall Study|Withdrawal post-procedure|0
7612014|NCT02100722|12020028|FG001|Overall Study|Withdrawal post-procedure|3
7612015|NCT02100722|12020027|FG000|Overall Study|Lost to Follow-up|2
7612016|NCT02100722|12020028|FG001|Overall Study|Lost to Follow-up|2
7612017|NCT02100722|12020027|FG000|Overall Study|Continuing on study|751
7612018|NCT02100722|12020028|FG001|Overall Study|Continuing on study|729
7612019|NCT02046096|12020037|FG000|Overall Study|Death|28
7612020|NCT02046096|12020038|FG001|Overall Study|Death|45
7612021|NCT02046096|12020037|FG000|Overall Study|Lost to Follow-up|9
7612022|NCT02046096|12020038|FG001|Overall Study|Lost to Follow-up|20
7612023|NCT02046096|12020037|FG000|Overall Study|Withdrawal by Subject|5
7612024|NCT02046096|12020038|FG001|Overall Study|Withdrawal by Subject|17
7612025|NCT02046096|12020037|FG000|Overall Study|Other endpoint|2
7612026|NCT02046096|12020038|FG001|Overall Study|Other endpoint|19
7612027|NCT01945775|12020048|FG000|Overall Study|Death|214
7612028|NCT01945775|12020049|FG001|Overall Study|Death|98
7612029|NCT01945775|12020048|FG000|Overall Study|Lost to Follow-up|12
7612030|NCT01945775|12020049|FG001|Overall Study|Lost to Follow-up|7
7612031|NCT01945775|12020048|FG000|Overall Study|Withdrawal by Subject|11
7612032|NCT01945775|12020049|FG001|Overall Study|Withdrawal by Subject|21
7612033|NCT01945775|12020048|FG000|Overall Study|Other|50
7612034|NCT01945775|12020049|FG001|Overall Study|Other|18
7612035|NCT01781637|12020057|FG000|Overall Study|Adverse Event|1
7612036|NCT01781637|12020058|FG001|Overall Study|Adverse Event|0
7612037|NCT01781637|12020057|FG000|Overall Study|Lack of Efficacy|2
7612038|NCT01781637|12020058|FG001|Overall Study|Lack of Efficacy|6
7612039|NCT01781637|12020057|FG000|Overall Study|Withdrawal by Subject|1
7612040|NCT01781637|12020058|FG001|Overall Study|Withdrawal by Subject|0
7612041|NCT01670539|12020064|FG000|Overall Study|Death|3
7612042|NCT01670539|12020065|FG001|Overall Study|Death|5
7612043|NCT01670539|12020064|FG000|Overall Study|Withdrawal by Subject|3
7612044|NCT01670539|12020065|FG001|Overall Study|Withdrawal by Subject|0
7612045|NCT00407602|12020072|FG000|Overall Study|Death - unrelated to device|1
7612046|NCT00407602|12020072|FG000|Overall Study|Device explanted|5
7612047|NCT00407602|12020072|FG000|Overall Study|Withdrawal by Subject|1
7612048|NCT04567186|12020092|FG000|Period 1|COVID-19 related|1
7612049|NCT04567186|12020093|FG001|Period 1|COVID-19 related|0
7277623|NCT00454818|11492544|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7277624|NCT00454818|11492545|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
7277625|NCT00454818|11492546|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
7277626|NCT00454818|11492542|FG000|Phase 2: Randomized Double-blind|Death|0
7277627|NCT00454818|11492543|FG001|Phase 2: Randomized Double-blind|Death|1
7277628|NCT00454818|11492544|FG002|Phase 2: Randomized Double-blind|Death|0
7277629|NCT00454818|11492545|FG003|Phase 2: Randomized Double-blind|Death|0
7277630|NCT00454818|11492546|FG004|Phase 2: Randomized Double-blind|Death|1
7277631|NCT00454818|11492542|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
7277632|NCT00454818|11492543|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
7277633|NCT00454818|11492544|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
7277634|NCT00454818|11492545|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
7277635|NCT00454818|11492546|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
7277636|NCT00454818|11492542|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7277637|NCT00454818|11492543|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7277638|NCT00454818|11492544|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
7277639|NCT00454818|11492545|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
7277640|NCT00454818|11492546|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
7277641|NCT00454857|11492563|FG000|Overall Study|Withdrawal by Subject|15
7277642|NCT00454857|11492563|FG000|Overall Study|Lost to Follow-up|16
7277643|NCT00454857|11492563|FG000|Overall Study|Noncompliance|6
7277644|NCT00454857|11492563|FG000|Overall Study|Death|5
7277645|NCT00454857|11492563|FG000|Overall Study|Other|11
7277646|NCT00454857|11492563|FG000|Overall Study|Reason unknown|1
7612050|NCT04567186|12020092|FG000|Period 1|Protocol Violation|0
7612051|NCT04567186|12020093|FG001|Period 1|Protocol Violation|1
7612052|NCT04567186|12020092|FG000|Period 1|Adverse Event|0
7612053|NCT04567186|12020093|FG001|Period 1|Adverse Event|2
7612054|NCT04567186|12020092|FG000|Period 2|COVID-19 Related|0
7612055|NCT04567186|12020093|FG001|Period 2|COVID-19 Related|1
7612056|NCT04567186|12020092|FG000|Period 2|Protocol Violation|0
7612057|NCT04567186|12020093|FG001|Period 2|Protocol Violation|1
7612058|NCT04567186|12020092|FG000|Period 2|Lost to Follow-up|0
7612059|NCT04567186|12020093|FG001|Period 2|Lost to Follow-up|1
7612060|NCT04567186|12020092|FG000|Period 3|Subject no longer meets eligibilty criteria|1
7277647|NCT00454909|11492570|FG000|Overall Study|Withdrawal by Subject|1
7277648|NCT00454909|11492571|FG001|Overall Study|Withdrawal by Subject|0
7277649|NCT00454909|11492572|FG002|Overall Study|Withdrawal by Subject|0
7277650|NCT00454909|11492570|FG000|Overall Study|Migrated/moved from study area|0
7277651|NCT00454909|11492571|FG001|Overall Study|Migrated/moved from study area|0
7277652|NCT00454909|11492572|FG002|Overall Study|Migrated/moved from study area|1
7277653|NCT00454909|11492570|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
7277654|NCT00454909|11492571|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
7277655|NCT00454909|11492572|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
7277656|NCT00454909|11492570|FG000|Overall Study|Others|1
7612061|NCT04567186|12020093|FG001|Period 3|Subject no longer meets eligibilty criteria|0
7612062|NCT04065074|12020099|FG000|Overall Study|Adverse Event|1
7612063|NCT04065074|12020099|FG000|Overall Study|Protocol Non-Compliance after injection|1
7612064|NCT03980730|12020105|FG000|Overall Study|Study Terminated by Sponsor|0
7612065|NCT03980730|12020106|FG001|Overall Study|Study Terminated by Sponsor|3
7612066|NCT03980730|12020105|FG000|Overall Study|Adverse Event|2
7612067|NCT03980730|12020106|FG001|Overall Study|Adverse Event|0
7612068|NCT03980730|12020105|FG000|Overall Study|Sponsor Request|0
7612069|NCT03980730|12020106|FG001|Overall Study|Sponsor Request|1
7612070|NCT03793010|12020114|FG000|Overall Study|Withdrawal by Subject|5
7612071|NCT03793010|12020115|FG001|Overall Study|Withdrawal by Subject|7
7612072|NCT03793010|12020114|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
7612073|NCT03793010|12020115|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
7612074|NCT03793010|12020114|FG000|Overall Study|Lost to Follow-up|1
7612075|NCT03793010|12020115|FG001|Overall Study|Lost to Follow-up|2
7612076|NCT03793010|12020114|FG000|Overall Study|Patient couldn't sit still for injection|1
7612077|NCT03793010|12020115|FG001|Overall Study|Patient couldn't sit still for injection|0
7612078|NCT03793010|12020114|FG000|Overall Study|Withdrew to pursue other treatment|1
7612079|NCT03793010|12020115|FG001|Overall Study|Withdrew to pursue other treatment|0
7612080|NCT03793010|12020114|FG000|Overall Study|Did not meet eligibility criteria|1
7612081|NCT03793010|12020115|FG001|Overall Study|Did not meet eligibility criteria|0
7612082|NCT03644017|12020121|FG000|Overall Study|Access Abandonment|5
7612083|NCT03644017|12020121|FG000|Overall Study|Kidney Transplant|2
7612084|NCT03592186|12020127|FG000|Overall Study|Withdrawal by Subject|1
7612085|NCT03592186|12020128|FG001|Overall Study|Withdrawal by Subject|0
7612086|NCT03592186|12020127|FG000|Overall Study|Lost to Follow-up|16
7612087|NCT03592186|12020128|FG001|Overall Study|Lost to Follow-up|11
7612088|NCT03529942|12020134|FG000|Overall Study|Withdrawal by Subject|13
7612089|NCT03529942|12020134|FG000|Overall Study|Physician Decision|1
7612090|NCT03529942|12020134|FG000|Overall Study|Lost to Follow-up|7
7612091|NCT03529942|12020134|FG000|Overall Study|Needle inserted but no drug administered|1
7612092|NCT03529942|12020134|FG000|Overall Study|Personal reasons|1
7612093|NCT03349775|12020143|FG000|Overall Study|Side Effects|1
7612094|NCT03349775|12020144|FG001|Overall Study|Side Effects|2
7612095|NCT03349775|12020143|FG000|Overall Study|Withdrawal by Subject|1
7612096|NCT03349775|12020144|FG001|Overall Study|Withdrawal by Subject|1
7612097|NCT03349775|12020143|FG000|Overall Study|No primary outcome measurements|0
7612098|NCT03349775|12020144|FG001|Overall Study|No primary outcome measurements|1
7612099|NCT03256344|12020161|FG000|Overall Study|Ongoing on study|3
7612100|NCT03256344|12020162|FG001|Overall Study|Ongoing on study|3
7612101|NCT03256344|12020161|FG000|Overall Study|Death|5
7612102|NCT03256344|12020162|FG001|Overall Study|Death|19
7612103|NCT03256344|12020161|FG000|Overall Study|Withdrawal by Subject|3
7612104|NCT03256344|12020162|FG001|Overall Study|Withdrawal by Subject|3
7612105|NCT03207815|12020170|FG000|Overall Study|Protocol Violation|3
7612106|NCT03207815|12020171|FG001|Overall Study|Protocol Violation|1
7612107|NCT03207815|12020170|FG000|Overall Study|Adverse Event|1
7612108|NCT03207815|12020171|FG001|Overall Study|Adverse Event|2
7612109|NCT03207815|12020170|FG000|Overall Study|Lost to Follow-up|1
7612110|NCT03207815|12020171|FG001|Overall Study|Lost to Follow-up|2
7612111|NCT03207815|12020170|FG000|Overall Study|Investigator's Discretion|1
7612112|NCT03207815|12020171|FG001|Overall Study|Investigator's Discretion|1
7612113|NCT03207815|12020170|FG000|Overall Study|Lack of Efficacy|0
7612114|NCT03207815|12020171|FG001|Overall Study|Lack of Efficacy|1
7612115|NCT03207815|12020170|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
7612116|NCT03207815|12020171|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
7612117|NCT03207815|12020170|FG000|Overall Study|Withdrew Consent|1
7612118|NCT03207815|12020171|FG001|Overall Study|Withdrew Consent|0
7612119|NCT02968563|12020197|FG000|Overall Study|Adverse Event|0
7612120|NCT02968563|12020198|FG001|Overall Study|Adverse Event|6
7612121|NCT02968563|12020197|FG000|Overall Study|Death|1
7612122|NCT02968563|12020198|FG001|Overall Study|Death|1
7612123|NCT02968563|12020197|FG000|Overall Study|Lost to Follow-up|0
7612124|NCT02968563|12020198|FG001|Overall Study|Lost to Follow-up|1
7612125|NCT02915783|12020204|FG000|Overall Study|Ongoing: Receiving Treatment|6
7612126|NCT02915783|12020204|FG000|Overall Study|Ongoing: In Survival Follow Up|8
7612127|NCT02913482|12020211|FG000|Overall Study|Death|0
7612128|NCT02913482|12020212|FG001|Overall Study|Death|2
7612129|NCT02913482|12020213|FG002|Overall Study|Death|2
7612130|NCT02913482|12020211|FG000|Overall Study|Progressive Disease|1
7612131|NCT02913482|12020212|FG001|Overall Study|Progressive Disease|1
7612132|NCT02913482|12020213|FG002|Overall Study|Progressive Disease|1
7612133|NCT02787044|12020225|FG000|Overall Study|Lost to Follow-up|15
7612134|NCT02787044|12020226|FG001|Overall Study|Lost to Follow-up|19
7612135|NCT02698163|12020238|FG000|Overall Study|Lost to Follow-up|0
7612136|NCT02698163|12020239|FG001|Overall Study|Lost to Follow-up|1
7612137|NCT01816165|12020266|FG000|Overall Study|Adverse Event|1
7612138|NCT01816165|12020267|FG001|Overall Study|Adverse Event|0
7612139|NCT01816165|12020268|FG002|Overall Study|Adverse Event|0
7612140|NCT01816165|12020269|FG003|Overall Study|Adverse Event|0
7612141|NCT01813929|12020291|FG000|Overall Study|Withdrawal by Subject|0
7612142|NCT01813929|12020292|FG001|Overall Study|Withdrawal by Subject|1
7612143|NCT00882050|12020313|FG000|Overall Study|Physician Decision|1
7612144|NCT00882050|12020314|FG001|Overall Study|Physician Decision|0
7612145|NCT00882050|12020315|FG002|Overall Study|Physician Decision|0
7612146|NCT00070564|12020329|FG000|Overall Study|Progression|2
7612147|NCT00070564|12020330|FG001|Overall Study|Progression|4
7612148|NCT00070564|12020331|FG002|Overall Study|Progression|7
7612149|NCT00070564|12020332|FG003|Overall Study|Progression|7
7612150|NCT00070564|12020333|FG004|Overall Study|Progression|1
7612151|NCT00070564|12020334|FG005|Overall Study|Progression|0
7612152|NCT00070564|12020329|FG000|Overall Study|Delinquent|1
7612153|NCT00070564|12020330|FG001|Overall Study|Delinquent|4
7612154|NCT00070564|12020331|FG002|Overall Study|Delinquent|2
7612155|NCT00070564|12020332|FG003|Overall Study|Delinquent|0
7612156|NCT00070564|12020333|FG004|Overall Study|Delinquent|0
7612157|NCT00070564|12020334|FG005|Overall Study|Delinquent|0
7612158|NCT00070564|12020329|FG000|Overall Study|Adverse Event|150
7612159|NCT00070564|12020330|FG001|Overall Study|Adverse Event|142
7612160|NCT00070564|12020331|FG002|Overall Study|Adverse Event|120
7612161|NCT00070564|12020332|FG003|Overall Study|Adverse Event|108
7612162|NCT00070564|12020333|FG004|Overall Study|Adverse Event|63
7612163|NCT00070564|12020334|FG005|Overall Study|Adverse Event|36
7612164|NCT00070564|12020329|FG000|Overall Study|Death|4
7612165|NCT00070564|12020330|FG001|Overall Study|Death|1
7612166|NCT00070564|12020331|FG002|Overall Study|Death|5
7612167|NCT00070564|12020332|FG003|Overall Study|Death|3
7612168|NCT00070564|12020333|FG004|Overall Study|Death|0
7612169|NCT00070564|12020334|FG005|Overall Study|Death|1
7612170|NCT00070564|12020329|FG000|Overall Study|Other, not protocol specified|17
7612171|NCT00070564|12020330|FG001|Overall Study|Other, not protocol specified|15
7612172|NCT00070564|12020331|FG002|Overall Study|Other, not protocol specified|14
7612173|NCT00070564|12020332|FG003|Overall Study|Other, not protocol specified|19
7612174|NCT00070564|12020333|FG004|Overall Study|Other, not protocol specified|6
7612175|NCT00070564|12020334|FG005|Overall Study|Other, not protocol specified|7
7612176|NCT00070564|12020329|FG000|Overall Study|Withdrawal by Subject|26
7612177|NCT00070564|12020330|FG001|Overall Study|Withdrawal by Subject|37
7612178|NCT00070564|12020331|FG002|Overall Study|Withdrawal by Subject|23
7612179|NCT00070564|12020332|FG003|Overall Study|Withdrawal by Subject|30
7612180|NCT00070564|12020333|FG004|Overall Study|Withdrawal by Subject|8
7612181|NCT00070564|12020334|FG005|Overall Study|Withdrawal by Subject|8
7612182|NCT00070564|12020329|FG000|Overall Study|Not reported|0
7612183|NCT00070564|12020330|FG001|Overall Study|Not reported|0
7612184|NCT00070564|12020331|FG002|Overall Study|Not reported|0
7612185|NCT00070564|12020332|FG003|Overall Study|Not reported|0
7612186|NCT00070564|12020333|FG004|Overall Study|Not reported|1
7612187|NCT00070564|12020334|FG005|Overall Study|Not reported|0
7612188|NCT04425720|12020365|FG000|Overall Study|Withdrawal by Subject|0
7612189|NCT04425720|12020366|FG001|Overall Study|Withdrawal by Subject|20
7612190|NCT04409509|12020375|FG000|Overall Study|Failure to meet randomization requirement|1
7612191|NCT04409509|12020376|FG001|Overall Study|Failure to meet randomization requirement|0
7612192|NCT04409509|12020375|FG000|Overall Study|Adverse Event|0
7612193|NCT04409509|12020376|FG001|Overall Study|Adverse Event|1
7612194|NCT04409509|12020375|FG000|Overall Study|Death|11
7277657|NCT00454909|11492571|FG001|Overall Study|Others|0
7277658|NCT00454909|11492572|FG002|Overall Study|Others|0
7277659|NCT00454987|11492584|FG000|Booster Period (NCT00258700)|Adverse Event|1
7277660|NCT00454987|11492585|FG001|Booster Period (NCT00258700)|Adverse Event|0
7612195|NCT04409509|12020376|FG001|Overall Study|Death|10
7612196|NCT04409509|12020375|FG000|Overall Study|Non-compliance with study drug|0
7612197|NCT04409509|12020376|FG001|Overall Study|Non-compliance with study drug|1
7612198|NCT04409509|12020375|FG000|Overall Study|Lost to Follow-up|0
7612199|NCT04409509|12020376|FG001|Overall Study|Lost to Follow-up|3
7612200|NCT04409509|12020375|FG000|Overall Study|Withdrawal by Subject|0
7612201|NCT04409509|12020376|FG001|Overall Study|Withdrawal by Subject|3
7612202|NCT04409509|12020375|FG000|Overall Study|Randomized by mistake|0
7612203|NCT04409509|12020376|FG001|Overall Study|Randomized by mistake|1
7612204|NCT04409509|12020375|FG000|Overall Study|Other|1
7612205|NCT04409509|12020376|FG001|Overall Study|Other|1
7612206|NCT04380519|12020386|FG000|Overall Study|Withdrawal by Subject|4
7612207|NCT04380519|12020387|FG001|Overall Study|Withdrawal by Subject|0
7612208|NCT04380519|12020388|FG002|Overall Study|Withdrawal by Subject|1
7612209|NCT04380519|12020386|FG000|Overall Study|Death|14
7612210|NCT04380519|12020387|FG001|Overall Study|Death|9
7612211|NCT04380519|12020388|FG002|Overall Study|Death|6
7612212|NCT04380519|12020386|FG000|Overall Study|Adverse Event|0
7612213|NCT04380519|12020387|FG001|Overall Study|Adverse Event|1
7612214|NCT04380519|12020388|FG002|Overall Study|Adverse Event|0
7612215|NCT04380519|12020386|FG000|Overall Study|relatives' decision|0
7612216|NCT04380519|12020387|FG001|Overall Study|relatives' decision|1
7612217|NCT04380519|12020388|FG002|Overall Study|relatives' decision|0
7612218|NCT04362813|12020398|FG000|Overall Study|Death|12
7612219|NCT04362813|12020399|FG001|Overall Study|Death|16
7612220|NCT04362813|12020398|FG000|Overall Study|Withdrawal by Subject|3
7612221|NCT04362813|12020399|FG001|Overall Study|Withdrawal by Subject|1
7612222|NCT04362813|12020398|FG000|Overall Study|Protocol Violation|0
7612223|NCT04362813|12020399|FG001|Overall Study|Protocol Violation|3
7612224|NCT04362813|12020398|FG000|Overall Study|Lost to Follow-up|1
7612225|NCT04362813|12020399|FG001|Overall Study|Lost to Follow-up|1
7612226|NCT04362813|12020398|FG000|Overall Study|Enrolled but did not receive treatment|2
7612227|NCT04362813|12020399|FG001|Overall Study|Enrolled but did not receive treatment|4
7612228|NCT03922321|12020457|FG000|Overall Study|Participant Moved|1
7612229|NCT03922321|12020457|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
7612230|NCT03911713|12020466|FG000|Overall Study|Lost to Follow-up|0
7612231|NCT03911713|12020467|FG001|Overall Study|Lost to Follow-up|2
7612232|NCT03911713|12020468|FG002|Overall Study|Lost to Follow-up|0
7612233|NCT03911713|12020469|FG003|Overall Study|Lost to Follow-up|0
7612234|NCT03911713|12020470|FG004|Overall Study|Lost to Follow-up|0
7612235|NCT03911713|12020466|FG000|Overall Study|Other|0
7612236|NCT03911713|12020467|FG001|Overall Study|Other|0
7612237|NCT03911713|12020468|FG002|Overall Study|Other|0
7612238|NCT03911713|12020469|FG003|Overall Study|Other|1
7612239|NCT03911713|12020470|FG004|Overall Study|Other|0
7612240|NCT03911713|12020466|FG000|Overall Study|Randomized, Never Dosed|1
7612241|NCT03911713|12020467|FG001|Overall Study|Randomized, Never Dosed|0
7612242|NCT03911713|12020468|FG002|Overall Study|Randomized, Never Dosed|0
7612243|NCT03911713|12020469|FG003|Overall Study|Randomized, Never Dosed|1
7612244|NCT03911713|12020470|FG004|Overall Study|Randomized, Never Dosed|0
7612245|NCT03852459|12020495|FG000|Overall Study|Adverse Event|2
7612246|NCT03852459|12020496|FG001|Overall Study|Adverse Event|2
7612247|NCT03852459|12020495|FG000|Overall Study|Withdrawal by Subject|1
7612248|NCT03852459|12020496|FG001|Overall Study|Withdrawal by Subject|1
7612249|NCT03740919|12020505|FG000|Lead-in Period|Lost to Follow-up|1
7612250|NCT03740919|12020506|FG001|Lead-in Period|Lost to Follow-up|0
7612251|NCT03740919|12020507|FG002|Lead-in Period|Lost to Follow-up|0
7612252|NCT03740919|12020508|FG003|Lead-in Period|Lost to Follow-up|0
7612253|NCT03740919|12020505|FG000|Lead-in Period|Physician Decision|2
7612254|NCT03740919|12020506|FG001|Lead-in Period|Physician Decision|0
7612255|NCT03740919|12020507|FG002|Lead-in Period|Physician Decision|0
7612256|NCT03740919|12020508|FG003|Lead-in Period|Physician Decision|0
7612257|NCT03740919|12020505|FG000|Lead-in Period|Protocol Violation|1
7612258|NCT03740919|12020506|FG001|Lead-in Period|Protocol Violation|0
7612259|NCT03740919|12020507|FG002|Lead-in Period|Protocol Violation|0
7612260|NCT03740919|12020508|FG003|Lead-in Period|Protocol Violation|0
7612261|NCT03740919|12020505|FG000|Lead-in Period|Withdrawal by Subject|10
7612262|NCT03740919|12020506|FG001|Lead-in Period|Withdrawal by Subject|0
7612263|NCT03740919|12020507|FG002|Lead-in Period|Withdrawal by Subject|0
7612264|NCT03740919|12020508|FG003|Lead-in Period|Withdrawal by Subject|0
7612265|NCT03740919|12020505|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
7612266|NCT03740919|12020506|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612267|NCT03740919|12020507|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612268|NCT03740919|12020508|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
7612269|NCT03740919|12020505|FG000|Lead-in Period|Study Task Too Burdensome|1
7612270|NCT03740919|12020506|FG001|Lead-in Period|Study Task Too Burdensome|0
7612271|NCT03740919|12020507|FG002|Lead-in Period|Study Task Too Burdensome|0
7612272|NCT03740919|12020508|FG003|Lead-in Period|Study Task Too Burdensome|0
7277661|NCT00454987|11492586|FG002|Booster Period (NCT00258700)|Adverse Event|0
7277662|NCT00454987|11492584|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
7277663|NCT00454987|11492585|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
7277664|NCT00454987|11492586|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
7277665|NCT00454987|11492584|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
7277666|NCT00454987|11492585|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
7277667|NCT00454987|11492586|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
7277668|NCT00455013|11492598|FG000|Short Term Period|Adverse Event|2
7277669|NCT00455013|11492599|FG001|Short Term Period|Adverse Event|5
7277670|NCT00455013|11492600|FG002|Short Term Period|Adverse Event|0
7277671|NCT00455013|11492598|FG000|Short Term Period|Withdrawal by Subject|0
7277672|NCT00455013|11492599|FG001|Short Term Period|Withdrawal by Subject|0
7277673|NCT00455013|11492600|FG002|Short Term Period|Withdrawal by Subject|1
7612273|NCT03740919|12020505|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
7612274|NCT03740919|12020506|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612275|NCT03740919|12020507|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612276|NCT03740919|12020508|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
7612277|NCT03740919|12020505|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
7612278|NCT03740919|12020506|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612279|NCT03740919|12020507|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612280|NCT03740919|12020508|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
7612281|NCT03740919|12020505|FG000|Treatment Period|Adverse Event|0
7612282|NCT03740919|12020506|FG001|Treatment Period|Adverse Event|0
7612283|NCT03740919|12020507|FG002|Treatment Period|Adverse Event|2
7612284|NCT03740919|12020508|FG003|Treatment Period|Adverse Event|0
7612285|NCT03740919|12020505|FG000|Treatment Period|Protocol Violation|0
7612286|NCT03740919|12020506|FG001|Treatment Period|Protocol Violation|1
7612287|NCT03740919|12020507|FG002|Treatment Period|Protocol Violation|0
7612288|NCT03740919|12020508|FG003|Treatment Period|Protocol Violation|0
7612289|NCT03740919|12020505|FG000|Treatment Period|Withdrawal by Subject|0
7612290|NCT03740919|12020506|FG001|Treatment Period|Withdrawal by Subject|7
7612291|NCT03740919|12020507|FG002|Treatment Period|Withdrawal by Subject|6
7612292|NCT03740919|12020508|FG003|Treatment Period|Withdrawal by Subject|2
7612293|NCT03740919|12020505|FG000|Treatment Period|Terminated by Sponsor|0
7612294|NCT03740919|12020506|FG001|Treatment Period|Terminated by Sponsor|1
7612295|NCT03740919|12020507|FG002|Treatment Period|Terminated by Sponsor|0
7612296|NCT03740919|12020508|FG003|Treatment Period|Terminated by Sponsor|0
7612297|NCT03740919|12020505|FG000|Treatment Period|Issue with Insulin Pump|0
7612298|NCT03740919|12020506|FG001|Treatment Period|Issue with Insulin Pump|1
7612299|NCT03740919|12020507|FG002|Treatment Period|Issue with Insulin Pump|0
7612300|NCT03740919|12020508|FG003|Treatment Period|Issue with Insulin Pump|0
7612301|NCT03740919|12020505|FG000|Treatment Period|Due to COVID-19 Pandemic|0
7612302|NCT03740919|12020506|FG001|Treatment Period|Due to COVID-19 Pandemic|0
7612303|NCT03740919|12020507|FG002|Treatment Period|Due to COVID-19 Pandemic|3
7277674|NCT00455013|11492598|FG000|Short Term Period|Lack of Efficacy|4
7277675|NCT00455013|11492599|FG001|Short Term Period|Lack of Efficacy|0
7612304|NCT03740919|12020508|FG003|Treatment Period|Due to COVID-19 Pandemic|1
7612305|NCT03740919|12020505|FG000|Treatment Period|Failure of Inclusion Criteria|0
7612306|NCT03740919|12020506|FG001|Treatment Period|Failure of Inclusion Criteria|0
7612307|NCT03740919|12020507|FG002|Treatment Period|Failure of Inclusion Criteria|1
7612308|NCT03740919|12020508|FG003|Treatment Period|Failure of Inclusion Criteria|0
7612309|NCT03740919|12020505|FG000|Treatment Period|Not Completing Diary|0
7612310|NCT03740919|12020506|FG001|Treatment Period|Not Completing Diary|0
7612311|NCT03740919|12020507|FG002|Treatment Period|Not Completing Diary|1
7612312|NCT03740919|12020508|FG003|Treatment Period|Not Completing Diary|0
7612313|NCT03740919|12020505|FG000|Treatment Period|Insulin Painful to Participant|0
7612314|NCT03740919|12020506|FG001|Treatment Period|Insulin Painful to Participant|0
7612315|NCT03740919|12020507|FG002|Treatment Period|Insulin Painful to Participant|1
7612316|NCT03740919|12020508|FG003|Treatment Period|Insulin Painful to Participant|0
7612317|NCT03647488|12020542|FG000|Overall Study|Progressive disease|10
7612318|NCT03647488|12020543|FG001|Overall Study|Progressive disease|0
7612319|NCT03647488|12020544|FG002|Overall Study|Progressive disease|0
7612320|NCT03647488|12020542|FG000|Overall Study|Adverse Event|5
7612321|NCT03647488|12020543|FG001|Overall Study|Adverse Event|0
7612322|NCT03647488|12020544|FG002|Overall Study|Adverse Event|0
7612323|NCT03647488|12020542|FG000|Overall Study|Clinical progression|2
7612324|NCT03647488|12020543|FG001|Overall Study|Clinical progression|0
7612325|NCT03647488|12020544|FG002|Overall Study|Clinical progression|0
7612326|NCT03647488|12020542|FG000|Overall Study|Participant refused to take investigational product|1
7612327|NCT03647488|12020543|FG001|Overall Study|Participant refused to take investigational product|0
7612328|NCT03647488|12020544|FG002|Overall Study|Participant refused to take investigational product|0
7612329|NCT03614923|12020553|FG000|Overall Study|Withdrawal by Subject|2
7612330|NCT03614923|12020554|FG001|Overall Study|Withdrawal by Subject|1
7612331|NCT03614923|12020555|FG002|Overall Study|Withdrawal by Subject|1
7612332|NCT03614923|12020553|FG000|Overall Study|Adverse Event|0
7612333|NCT03614923|12020554|FG001|Overall Study|Adverse Event|2
7612334|NCT03614923|12020555|FG002|Overall Study|Adverse Event|1
7612335|NCT03614923|12020553|FG000|Overall Study|Lost to Follow-up|1
7612336|NCT03614923|12020554|FG001|Overall Study|Lost to Follow-up|0
7612337|NCT03614923|12020555|FG002|Overall Study|Lost to Follow-up|1
7612338|NCT03614923|12020553|FG000|Overall Study|Lack of Efficacy|2
7612339|NCT03614923|12020554|FG001|Overall Study|Lack of Efficacy|0
7612340|NCT03614923|12020555|FG002|Overall Study|Lack of Efficacy|1
7612341|NCT03614923|12020553|FG000|Overall Study|Non-compliance|0
7612342|NCT03614923|12020554|FG001|Overall Study|Non-compliance|1
7612343|NCT03614923|12020555|FG002|Overall Study|Non-compliance|0
7612344|NCT03614923|12020553|FG000|Overall Study|Other|0
7612345|NCT03614923|12020554|FG001|Overall Study|Other|1
7612346|NCT03614923|12020555|FG002|Overall Study|Other|1
7612347|NCT03502187|12020566|FG000|Overall Study|Withdrawal by Subject|4
7612348|NCT03502187|12020567|FG001|Overall Study|Withdrawal by Subject|3
7612349|NCT03502187|12020568|FG002|Overall Study|Withdrawal by Subject|3
7612350|NCT03502187|12020566|FG000|Overall Study|Lost to Follow-up|5
7612351|NCT03502187|12020567|FG001|Overall Study|Lost to Follow-up|4
7612352|NCT03502187|12020568|FG002|Overall Study|Lost to Follow-up|5
7612353|NCT03447262|12020576|FG000|Overall Study|Adverse Event|7
7612354|NCT03447262|12020576|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
7612355|NCT03447262|12020576|FG000|Overall Study|Commercial Drug is Available for Participant|9
7612356|NCT03447262|12020576|FG000|Overall Study|Death|2
7612357|NCT03447262|12020576|FG000|Overall Study|Study Termination by Sponsor|455
7612358|NCT03447262|12020576|FG000|Overall Study|Other|4
7612359|NCT03432819|12020585|FG000|Overall Study|Lost to Follow-up|2
7612360|NCT03432819|12020586|FG001|Overall Study|Lost to Follow-up|2
7612361|NCT03432819|12020585|FG000|Overall Study|Withdrawal by Subject|5
7277676|NCT00455013|11492600|FG002|Short Term Period|Lack of Efficacy|0
7612362|NCT03432819|12020586|FG001|Overall Study|Withdrawal by Subject|3
7612363|NCT03323749|12020594|FG000|Double-blind Period|Lost to Follow-up|4
7612364|NCT03323749|12020595|FG001|Double-blind Period|Lost to Follow-up|5
7612365|NCT03323749|12020594|FG000|Double-blind Period|Adverse Event|3
7612366|NCT03323749|12020595|FG001|Double-blind Period|Adverse Event|1
7612367|NCT03323749|12020594|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
7612368|NCT03323749|12020595|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
7612369|NCT03323749|12020594|FG000|Open-Label Period|Adverse Event|3
7612370|NCT03323749|12020595|FG001|Open-Label Period|Adverse Event|10
7612371|NCT03323749|12020594|FG000|Open-Label Period|Withdrawal by Subject|7
7612372|NCT03323749|12020595|FG001|Open-Label Period|Withdrawal by Subject|5
7612373|NCT03322566|12020608|FG000|Overall Study|Death|34
7612374|NCT03322566|12020609|FG001|Overall Study|Death|35
7612375|NCT03322566|12020610|FG002|Overall Study|Death|23
7612376|NCT03322566|12020608|FG000|Overall Study|Physician Decision|6
7612377|NCT03322566|12020609|FG001|Overall Study|Physician Decision|7
7612378|NCT03322566|12020610|FG002|Overall Study|Physician Decision|2
7612379|NCT03322566|12020608|FG000|Overall Study|Withdrawal by Subject|4
7612380|NCT03322566|12020609|FG001|Overall Study|Withdrawal by Subject|3
7277677|NCT00455013|11492598|FG000|Short Term Period|Other|0
7277678|NCT00455013|11492599|FG001|Short Term Period|Other|0
7277679|NCT00455013|11492600|FG002|Short Term Period|Other|1
7277680|NCT00455013|11492598|FG000|Long Term Extension (LTE)|Adverse Event|0
7277681|NCT00455013|11492599|FG001|Long Term Extension (LTE)|Adverse Event|1
7277682|NCT00455013|11492600|FG002|Long Term Extension (LTE)|Adverse Event|1
7277683|NCT00455013|11492598|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
7277684|NCT00455013|11492599|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
7277685|NCT00455013|11492600|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
7277686|NCT00455013|11492598|FG000|Long Term Extension (LTE)|Death|1
7277687|NCT00455013|11492599|FG001|Long Term Extension (LTE)|Death|1
7277688|NCT00455013|11492600|FG002|Long Term Extension (LTE)|Death|0
7277689|NCT00455013|11492598|FG000|Long Term Extension (LTE)|No longer met criteria|0
7277690|NCT00455013|11492599|FG001|Long Term Extension (LTE)|No longer met criteria|0
7277691|NCT00455013|11492600|FG002|Long Term Extension (LTE)|No longer met criteria|1
7277692|NCT00455013|11492598|FG000|Long Term Extension (LTE)|Subject Request or refused|0
7277693|NCT00455013|11492599|FG001|Long Term Extension (LTE)|Subject Request or refused|0
7277694|NCT00455013|11492600|FG002|Long Term Extension (LTE)|Subject Request or refused|3
7277695|NCT00455013|11492598|FG000|Long Term Extension (LTE)|Poor non-compliance|0
7277696|NCT00455013|11492599|FG001|Long Term Extension (LTE)|Poor non-compliance|1
7277697|NCT00455013|11492600|FG002|Long Term Extension (LTE)|Poor non-compliance|0
7277698|NCT00455013|11492598|FG000|Long Term Extension (LTE)|non-specified|0
7277699|NCT00455013|11492599|FG001|Long Term Extension (LTE)|non-specified|0
7277700|NCT00455013|11492600|FG002|Long Term Extension (LTE)|non-specified|1
7277701|NCT00455195|11492610|FG000|Double-blind Study AGLU02704|Adverse Event|2
7277702|NCT00455195|11492611|FG001|Double-blind Study AGLU02704|Adverse Event|1
7277703|NCT00455195|11492610|FG000|Double-blind Study AGLU02704|Death|1
7277704|NCT00455195|11492611|FG001|Double-blind Study AGLU02704|Death|0
7277705|NCT00455195|11492610|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
7277706|NCT00455195|11492611|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
7277707|NCT00455195|11492610|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
7277708|NCT00455195|11492611|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
7277709|NCT00455312|11492619|FG000|Overall Study|Death|0
7277710|NCT00455312|11492620|FG001|Overall Study|Death|1
7277711|NCT00455429|11492630|FG000|Overall Study|Study Terminated by Sponsor|0
7277712|NCT00455429|11492631|FG001|Overall Study|Study Terminated by Sponsor|0
7277713|NCT00455429|11492632|FG002|Overall Study|Study Terminated by Sponsor|0
7277714|NCT00455429|11492633|FG003|Overall Study|Study Terminated by Sponsor|3
7277715|NCT00455429|11492630|FG000|Overall Study|Lost to Follow-up|1
7277716|NCT00455429|11492631|FG001|Overall Study|Lost to Follow-up|0
7277717|NCT00455429|11492632|FG002|Overall Study|Lost to Follow-up|0
7277718|NCT00455429|11492633|FG003|Overall Study|Lost to Follow-up|3
7277719|NCT00455429|11492630|FG000|Overall Study|Withdrawal by Subject|0
7612381|NCT03322566|12020610|FG002|Overall Study|Withdrawal by Subject|6
7612382|NCT03322566|12020608|FG000|Overall Study|Lost to Follow-up|0
7612383|NCT03322566|12020609|FG001|Overall Study|Lost to Follow-up|0
7612384|NCT03322566|12020610|FG002|Overall Study|Lost to Follow-up|1
7612385|NCT03322566|12020608|FG000|Overall Study|Study terminated by sponsor|1
7612386|NCT03322566|12020609|FG001|Overall Study|Study terminated by sponsor|0
7612387|NCT03322566|12020610|FG002|Overall Study|Study terminated by sponsor|1
7612388|NCT03322540|12020620|FG000|Overall Study|Death|21
7612389|NCT03322540|12020621|FG001|Overall Study|Death|28
7612390|NCT03322540|12020620|FG000|Overall Study|Lost to Follow-up|0
7612391|NCT03322540|12020621|FG001|Overall Study|Lost to Follow-up|1
7612392|NCT03322540|12020620|FG000|Overall Study|Physician Decision|7
7612393|NCT03322540|12020621|FG001|Overall Study|Physician Decision|6
7612394|NCT03322540|12020620|FG000|Overall Study|Withdrawal by Subject|3
7612395|NCT03322540|12020621|FG001|Overall Study|Withdrawal by Subject|1
7277720|NCT00455429|11492631|FG001|Overall Study|Withdrawal by Subject|1
7277721|NCT00455429|11492632|FG002|Overall Study|Withdrawal by Subject|1
7277722|NCT00455429|11492633|FG003|Overall Study|Withdrawal by Subject|0
7277723|NCT00455429|11492630|FG000|Overall Study|Lack of Efficacy|0
7277724|NCT00455429|11492631|FG001|Overall Study|Lack of Efficacy|1
7277725|NCT00455429|11492632|FG002|Overall Study|Lack of Efficacy|0
7277726|NCT00455429|11492633|FG003|Overall Study|Lack of Efficacy|1
7277727|NCT00455429|11492630|FG000|Overall Study|Adverse Event|0
7277728|NCT00455429|11492631|FG001|Overall Study|Adverse Event|1
7277729|NCT00455429|11492632|FG002|Overall Study|Adverse Event|0
7277730|NCT00455429|11492633|FG003|Overall Study|Adverse Event|3
7277731|NCT00455429|11492630|FG000|Overall Study|Randomly assigned but not treated|0
7277732|NCT00455429|11492631|FG001|Overall Study|Randomly assigned but not treated|0
7277733|NCT00455429|11492632|FG002|Overall Study|Randomly assigned but not treated|0
7277734|NCT00455429|11492633|FG003|Overall Study|Randomly assigned but not treated|2
7277735|NCT00455429|11492630|FG000|Overall Study|Personal Reason|1
7277736|NCT00455429|11492631|FG001|Overall Study|Personal Reason|0
7277737|NCT00455429|11492632|FG002|Overall Study|Personal Reason|0
7277738|NCT00455429|11492633|FG003|Overall Study|Personal Reason|0
7277739|NCT00455429|11492630|FG000|Overall Study|Non-compliance|0
7277740|NCT00455429|11492631|FG001|Overall Study|Non-compliance|0
7277741|NCT00455429|11492632|FG002|Overall Study|Non-compliance|0
7277742|NCT00455429|11492633|FG003|Overall Study|Non-compliance|1
7277743|NCT00455429|11492630|FG000|Overall Study|Other|0
7277744|NCT00455429|11492631|FG001|Overall Study|Other|2
7277745|NCT00455429|11492632|FG002|Overall Study|Other|0
7277746|NCT00455429|11492633|FG003|Overall Study|Other|1
7277747|NCT00455455|11492646|FG000|Washout|Withdrawal by Subject|0
7277748|NCT00455455|11492647|FG001|Washout|Withdrawal by Subject|1
7277749|NCT00455455|11492646|FG000|Washout|Withdrawal by Subject|1
7277750|NCT00455455|11492647|FG001|Washout|Withdrawal by Subject|0
7277751|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
7277752|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
7277753|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
7277754|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
7277755|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
7277756|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
7277757|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
7277758|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
7277759|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
7277760|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
7612396|NCT03322540|12020620|FG000|Overall Study|Study terminated by sponsor|0
7612397|NCT03322540|12020621|FG001|Overall Study|Study terminated by sponsor|1
7612398|NCT03189719|12020640|FG000|Overall Study|Death|260
7612399|NCT03189719|12020641|FG001|Overall Study|Death|308
7612400|NCT03189719|12020640|FG000|Overall Study|Withdrawal by Subject|5
7612401|NCT03189719|12020641|FG001|Overall Study|Withdrawal by Subject|3
7612402|NCT03189719|12020640|FG000|Overall Study|Ongoing in Study|108
7277761|NCT00455520|11492658|FG000|Open Label Tapentadol Extended Release|All other|33
7277762|NCT00455520|11492659|FG001|Open Label Tapentadol Extended Release|All other|0
7277763|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
7277764|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
7277765|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
7277766|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
7277767|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
7277768|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
7277769|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7277770|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
7277771|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
7277772|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
7277773|NCT00455520|11492658|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
7277774|NCT00455520|11492659|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
7277775|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
7277776|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7277777|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
7277778|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Disease Progression|5
7277779|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Disease Progression|0
7277780|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Disease Progression|0
7277781|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
7277782|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
7277783|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
7277784|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Not Reported|1
7277785|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Not Reported|0
7277786|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Not Reported|0
7277787|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
7277788|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
7277789|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
7277790|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
7277791|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7277792|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
7277793|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
7277794|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7277795|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
7277796|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
7612403|NCT03189719|12020641|FG001|Overall Study|Ongoing in Study|65
7612404|NCT03155997|12020649|FG000|Overall Study|Withdrawal by Subject|119
7612405|NCT03155997|12020650|FG001|Overall Study|Withdrawal by Subject|134
7612406|NCT03155997|12020649|FG000|Overall Study|Lost to Follow-up|12
7612407|NCT03155997|12020650|FG001|Overall Study|Lost to Follow-up|13
7612408|NCT03155997|12020649|FG000|Overall Study|Missing disposition data|0
7612409|NCT03155997|12020650|FG001|Overall Study|Missing disposition data|1
7612410|NCT03155997|12020649|FG000|Overall Study|On study treatment|2027
7612411|NCT03155997|12020650|FG001|Overall Study|On study treatment|2074
7612412|NCT03104400|12020660|FG000|Overall Study|Adverse Event|5
7612413|NCT03104400|12020661|FG001|Overall Study|Adverse Event|7
7612414|NCT03104400|12020662|FG002|Overall Study|Adverse Event|11
7612415|NCT03104400|12020663|FG003|Overall Study|Adverse Event|9
7612416|NCT03104400|12020664|FG004|Overall Study|Adverse Event|21
7612417|NCT03104400|12020660|FG000|Overall Study|Withdrawal by Subject|17
7612418|NCT03104400|12020661|FG001|Overall Study|Withdrawal by Subject|19
7612419|NCT03104400|12020662|FG002|Overall Study|Withdrawal by Subject|29
7612420|NCT03104400|12020663|FG003|Overall Study|Withdrawal by Subject|25
7612421|NCT03104400|12020664|FG004|Overall Study|Withdrawal by Subject|24
7612422|NCT03104400|12020660|FG000|Overall Study|Lost to Follow-up|4
7612423|NCT03104400|12020661|FG001|Overall Study|Lost to Follow-up|1
7612424|NCT03104400|12020662|FG002|Overall Study|Lost to Follow-up|4
7612425|NCT03104400|12020663|FG003|Overall Study|Lost to Follow-up|8
7612426|NCT03104400|12020664|FG004|Overall Study|Lost to Follow-up|7
7612427|NCT03104400|12020660|FG000|Overall Study|Lack of Efficacy|6
7612428|NCT03104400|12020661|FG001|Overall Study|Lack of Efficacy|3
7612429|NCT03104400|12020662|FG002|Overall Study|Lack of Efficacy|8
7612430|NCT03104400|12020663|FG003|Overall Study|Lack of Efficacy|2
7612431|NCT03104400|12020664|FG004|Overall Study|Lack of Efficacy|1
7612432|NCT03104400|12020660|FG000|Overall Study|COVID Logistical Restrictions|0
7612433|NCT03104400|12020661|FG001|Overall Study|COVID Logistical Restrictions|0
7612434|NCT03104400|12020662|FG002|Overall Study|COVID Logistical Restrictions|0
7612435|NCT03104400|12020663|FG003|Overall Study|COVID Logistical Restrictions|1
7612436|NCT03104400|12020664|FG004|Overall Study|COVID Logistical Restrictions|0
7612437|NCT03104400|12020660|FG000|Overall Study|Other|2
7612438|NCT03104400|12020661|FG001|Overall Study|Other|3
7612439|NCT03104400|12020662|FG002|Overall Study|Other|7
7612440|NCT03104400|12020663|FG003|Overall Study|Other|6
7612441|NCT03104400|12020664|FG004|Overall Study|Other|4
7612442|NCT03104400|12020660|FG000|Overall Study|Other|0
7612443|NCT03104400|12020661|FG001|Overall Study|Other|1
7612444|NCT03104400|12020662|FG002|Overall Study|Other|0
7612445|NCT03104400|12020663|FG003|Overall Study|Other|0
7612446|NCT03104400|12020664|FG004|Overall Study|Other|0
7612447|NCT03104374|12020681|FG000|Overall Study|Adverse Event|7
7612448|NCT03104374|12020682|FG001|Overall Study|Adverse Event|6
7612449|NCT03104374|12020683|FG002|Overall Study|Adverse Event|12
7612450|NCT03104374|12020684|FG003|Overall Study|Adverse Event|15
7612451|NCT03104374|12020681|FG000|Overall Study|Withdrawal by Subject|18
7612452|NCT03104374|12020682|FG001|Overall Study|Withdrawal by Subject|10
7612453|NCT03104374|12020683|FG002|Overall Study|Withdrawal by Subject|10
7612454|NCT03104374|12020684|FG003|Overall Study|Withdrawal by Subject|17
7612455|NCT03104374|12020681|FG000|Overall Study|Lost to Follow-up|4
7612456|NCT03104374|12020682|FG001|Overall Study|Lost to Follow-up|4
7612457|NCT03104374|12020683|FG002|Overall Study|Lost to Follow-up|6
7612458|NCT03104374|12020684|FG003|Overall Study|Lost to Follow-up|8
7612459|NCT03104374|12020681|FG000|Overall Study|Lack of Efficacy|6
7612460|NCT03104374|12020682|FG001|Overall Study|Lack of Efficacy|7
7612461|NCT03104374|12020683|FG002|Overall Study|Lack of Efficacy|12
7612462|NCT03104374|12020684|FG003|Overall Study|Lack of Efficacy|6
7612463|NCT03104374|12020681|FG000|Overall Study|Other|2
7612464|NCT03104374|12020682|FG001|Overall Study|Other|2
7612465|NCT03104374|12020683|FG002|Overall Study|Other|4
7612466|NCT03104374|12020684|FG003|Overall Study|Other|7
7612467|NCT03072043|12020697|FG000|Overall Study|Death|0
7612468|NCT03072043|12020698|FG001|Overall Study|Death|0
7612469|NCT03072043|12020699|FG002|Overall Study|Death|3
7612470|NCT03072043|12020697|FG000|Overall Study|Adverse Event|0
7612471|NCT03072043|12020698|FG001|Overall Study|Adverse Event|0
7612472|NCT03072043|12020699|FG002|Overall Study|Adverse Event|2
7612473|NCT03072043|12020697|FG000|Overall Study|Withdrawal by Subject|0
7612474|NCT03072043|12020698|FG001|Overall Study|Withdrawal by Subject|0
7612475|NCT03072043|12020699|FG002|Overall Study|Withdrawal by Subject|4
7612476|NCT02905032|12020727|FG000|Overall Study|Withdrawal by Subject|2
7612477|NCT02905032|12020728|FG001|Overall Study|Withdrawal by Subject|0
7612478|NCT02905032|12020729|FG002|Overall Study|Withdrawal by Subject|0
7612479|NCT02905032|12020727|FG000|Overall Study|Protocol Violation|6
7612480|NCT02905032|12020728|FG001|Overall Study|Protocol Violation|12
7612481|NCT02905032|12020729|FG002|Overall Study|Protocol Violation|0
7612482|NCT02837029|12020739|FG000|Screening|Failed to meet screening requirements.|7
7612483|NCT02837029|12020740|FG001|Screening|Failed to meet screening requirements.|3
7612484|NCT02837029|12020741|FG002|Screening|Failed to meet screening requirements.|0
7612485|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
7612486|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7612487|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
7612488|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7612489|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
7612490|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
7612491|NCT02837029|12020739|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7612492|NCT02837029|12020740|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
7612493|NCT02837029|12020741|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
7612494|NCT02837029|12020739|FG000|Cycle 2 and Beyond|Adverse Event|1
7612495|NCT02837029|12020740|FG001|Cycle 2 and Beyond|Adverse Event|0
7612496|NCT02837029|12020741|FG002|Cycle 2 and Beyond|Adverse Event|0
7612497|NCT02837029|12020739|FG000|2 Year Follow-up|Death|6
7612498|NCT02837029|12020740|FG001|2 Year Follow-up|Death|7
7612499|NCT02837029|12020741|FG002|2 Year Follow-up|Death|0
7612500|NCT02737475|12020796|FG000|Overall Study|Other reasons|0
7612501|NCT02737475|12020797|FG001|Overall Study|Other reasons|0
7612502|NCT02737475|12020798|FG002|Overall Study|Other reasons|0
7612503|NCT02737475|12020799|FG003|Overall Study|Other reasons|0
7612504|NCT02737475|12020800|FG004|Overall Study|Other reasons|1
7612505|NCT02737475|12020801|FG005|Overall Study|Other reasons|1
7612506|NCT02737475|12020802|FG006|Overall Study|Other reasons|0
7612507|NCT02737475|12020803|FG007|Overall Study|Other reasons|0
7612508|NCT02737475|12020804|FG008|Overall Study|Other reasons|1
7612509|NCT02737475|12020805|FG009|Overall Study|Other reasons|0
7612510|NCT02737475|12020806|FG010|Overall Study|Other reasons|1
7612511|NCT02737475|12020807|FG011|Overall Study|Other reasons|0
7612512|NCT02737475|12020808|FG012|Overall Study|Other reasons|0
7612513|NCT02737475|12020809|FG013|Overall Study|Other reasons|0
7612514|NCT02737475|12020810|FG014|Overall Study|Other reasons|0
7612515|NCT02737475|12020811|FG015|Overall Study|Other reasons|0
7612516|NCT02737475|12020812|FG016|Overall Study|Other reasons|0
7612517|NCT02737475|12020813|FG017|Overall Study|Other reasons|0
7612518|NCT02737475|12020814|FG018|Overall Study|Other reasons|0
7612519|NCT02737475|12020815|FG019|Overall Study|Other reasons|0
7612520|NCT02737475|12020816|FG020|Overall Study|Other reasons|0
7612521|NCT02737475|12020817|FG021|Overall Study|Other reasons|1
7612522|NCT02737475|12020818|FG022|Overall Study|Other reasons|0
7612523|NCT02737475|12020819|FG023|Overall Study|Other reasons|1
7612524|NCT02737475|12020820|FG024|Overall Study|Other reasons|1
7612525|NCT02737475|12020821|FG025|Overall Study|Other reasons|1
7612526|NCT02737475|12020822|FG026|Overall Study|Other reasons|0
7612527|NCT02737475|12020796|FG000|Overall Study|Death|1
7612528|NCT02737475|12020797|FG001|Overall Study|Death|0
7612529|NCT02737475|12020798|FG002|Overall Study|Death|0
7612530|NCT02737475|12020799|FG003|Overall Study|Death|1
7612531|NCT02737475|12020800|FG004|Overall Study|Death|0
7612532|NCT02737475|12020801|FG005|Overall Study|Death|0
7612533|NCT02737475|12020802|FG006|Overall Study|Death|0
7612534|NCT02737475|12020803|FG007|Overall Study|Death|2
7612535|NCT02737475|12020804|FG008|Overall Study|Death|0
7612536|NCT02737475|12020805|FG009|Overall Study|Death|0
7612537|NCT02737475|12020806|FG010|Overall Study|Death|0
7612538|NCT02737475|12020807|FG011|Overall Study|Death|4
7612539|NCT02737475|12020808|FG012|Overall Study|Death|2
7612540|NCT02737475|12020809|FG013|Overall Study|Death|2
7612541|NCT02737475|12020810|FG014|Overall Study|Death|0
7612542|NCT02737475|12020811|FG015|Overall Study|Death|2
7612543|NCT02737475|12020812|FG016|Overall Study|Death|2
7612544|NCT02737475|12020813|FG017|Overall Study|Death|2
7612545|NCT02737475|12020814|FG018|Overall Study|Death|1
7612546|NCT02737475|12020815|FG019|Overall Study|Death|0
7612547|NCT02737475|12020816|FG020|Overall Study|Death|0
7612548|NCT02737475|12020817|FG021|Overall Study|Death|0
7612549|NCT02737475|12020818|FG022|Overall Study|Death|0
7612550|NCT02737475|12020819|FG023|Overall Study|Death|0
7612551|NCT02737475|12020820|FG024|Overall Study|Death|0
7612552|NCT02737475|12020821|FG025|Overall Study|Death|0
7612553|NCT02737475|12020822|FG026|Overall Study|Death|0
7612554|NCT02737475|12020796|FG000|Overall Study|Participant withdrew consent|0
7612555|NCT02737475|12020797|FG001|Overall Study|Participant withdrew consent|0
7612556|NCT02737475|12020798|FG002|Overall Study|Participant withdrew consent|0
7612557|NCT02737475|12020799|FG003|Overall Study|Participant withdrew consent|0
7612558|NCT02737475|12020800|FG004|Overall Study|Participant withdrew consent|0
7612559|NCT02737475|12020801|FG005|Overall Study|Participant withdrew consent|2
7612560|NCT02737475|12020802|FG006|Overall Study|Participant withdrew consent|0
7612561|NCT02737475|12020803|FG007|Overall Study|Participant withdrew consent|0
7612562|NCT02737475|12020804|FG008|Overall Study|Participant withdrew consent|0
7612563|NCT02737475|12020805|FG009|Overall Study|Participant withdrew consent|0
7612564|NCT02737475|12020806|FG010|Overall Study|Participant withdrew consent|0
7612565|NCT02737475|12020807|FG011|Overall Study|Participant withdrew consent|0
7612566|NCT02737475|12020808|FG012|Overall Study|Participant withdrew consent|0
7612567|NCT02737475|12020809|FG013|Overall Study|Participant withdrew consent|0
7612568|NCT02737475|12020810|FG014|Overall Study|Participant withdrew consent|1
7612569|NCT02737475|12020811|FG015|Overall Study|Participant withdrew consent|0
7612570|NCT02737475|12020812|FG016|Overall Study|Participant withdrew consent|0
7612571|NCT02737475|12020813|FG017|Overall Study|Participant withdrew consent|2
7612572|NCT02737475|12020814|FG018|Overall Study|Participant withdrew consent|1
7612573|NCT02737475|12020815|FG019|Overall Study|Participant withdrew consent|0
7612574|NCT02737475|12020816|FG020|Overall Study|Participant withdrew consent|2
7612575|NCT02737475|12020817|FG021|Overall Study|Participant withdrew consent|0
7612576|NCT02737475|12020818|FG022|Overall Study|Participant withdrew consent|0
7612577|NCT02737475|12020819|FG023|Overall Study|Participant withdrew consent|0
7612578|NCT02737475|12020820|FG024|Overall Study|Participant withdrew consent|0
7612579|NCT02737475|12020821|FG025|Overall Study|Participant withdrew consent|0
7612580|NCT02737475|12020822|FG026|Overall Study|Participant withdrew consent|0
7612581|NCT02737475|12020796|FG000|Overall Study|Lost to Follow-up|0
7612582|NCT02737475|12020797|FG001|Overall Study|Lost to Follow-up|0
7612583|NCT02737475|12020798|FG002|Overall Study|Lost to Follow-up|0
7612584|NCT02737475|12020799|FG003|Overall Study|Lost to Follow-up|0
7612585|NCT02737475|12020800|FG004|Overall Study|Lost to Follow-up|0
7612586|NCT02737475|12020801|FG005|Overall Study|Lost to Follow-up|0
7612587|NCT02737475|12020802|FG006|Overall Study|Lost to Follow-up|0
7612588|NCT02737475|12020803|FG007|Overall Study|Lost to Follow-up|0
7612589|NCT02737475|12020804|FG008|Overall Study|Lost to Follow-up|0
7612590|NCT02737475|12020805|FG009|Overall Study|Lost to Follow-up|0
7612591|NCT02737475|12020806|FG010|Overall Study|Lost to Follow-up|0
7612592|NCT02737475|12020807|FG011|Overall Study|Lost to Follow-up|0
7612593|NCT02737475|12020808|FG012|Overall Study|Lost to Follow-up|0
7612594|NCT02737475|12020809|FG013|Overall Study|Lost to Follow-up|0
7612595|NCT02737475|12020810|FG014|Overall Study|Lost to Follow-up|0
7612596|NCT02737475|12020811|FG015|Overall Study|Lost to Follow-up|1
7612597|NCT02737475|12020812|FG016|Overall Study|Lost to Follow-up|0
7612598|NCT02737475|12020813|FG017|Overall Study|Lost to Follow-up|0
7612599|NCT02737475|12020814|FG018|Overall Study|Lost to Follow-up|0
7612600|NCT02737475|12020815|FG019|Overall Study|Lost to Follow-up|0
7612601|NCT02737475|12020816|FG020|Overall Study|Lost to Follow-up|0
7612602|NCT02737475|12020817|FG021|Overall Study|Lost to Follow-up|0
7612603|NCT02737475|12020818|FG022|Overall Study|Lost to Follow-up|0
7612604|NCT02737475|12020819|FG023|Overall Study|Lost to Follow-up|0
7612605|NCT02737475|12020820|FG024|Overall Study|Lost to Follow-up|0
7612606|NCT02737475|12020821|FG025|Overall Study|Lost to Follow-up|0
7612607|NCT02737475|12020822|FG026|Overall Study|Lost to Follow-up|0
7612608|NCT02737475|12020796|FG000|Overall Study|Disease Progression|0
7612609|NCT02737475|12020797|FG001|Overall Study|Disease Progression|0
7612610|NCT02737475|12020798|FG002|Overall Study|Disease Progression|0
7612611|NCT02737475|12020799|FG003|Overall Study|Disease Progression|0
7612612|NCT02737475|12020800|FG004|Overall Study|Disease Progression|0
7612613|NCT02737475|12020801|FG005|Overall Study|Disease Progression|0
7612614|NCT02737475|12020802|FG006|Overall Study|Disease Progression|0
7612615|NCT02737475|12020803|FG007|Overall Study|Disease Progression|0
7612616|NCT02737475|12020804|FG008|Overall Study|Disease Progression|0
7612617|NCT02737475|12020805|FG009|Overall Study|Disease Progression|0
7612618|NCT02737475|12020806|FG010|Overall Study|Disease Progression|0
7612619|NCT02737475|12020807|FG011|Overall Study|Disease Progression|0
7612620|NCT02737475|12020808|FG012|Overall Study|Disease Progression|0
7612621|NCT02737475|12020809|FG013|Overall Study|Disease Progression|0
7612622|NCT02737475|12020810|FG014|Overall Study|Disease Progression|0
7612623|NCT02737475|12020811|FG015|Overall Study|Disease Progression|0
7612624|NCT02737475|12020812|FG016|Overall Study|Disease Progression|0
7612625|NCT02737475|12020813|FG017|Overall Study|Disease Progression|0
7612626|NCT02737475|12020814|FG018|Overall Study|Disease Progression|0
7612627|NCT02737475|12020815|FG019|Overall Study|Disease Progression|0
7612628|NCT02737475|12020816|FG020|Overall Study|Disease Progression|0
7612629|NCT02737475|12020817|FG021|Overall Study|Disease Progression|0
7612630|NCT02737475|12020818|FG022|Overall Study|Disease Progression|0
7277797|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7277798|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
7277799|NCT00455533|11492667|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
7277800|NCT00455533|11492668|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7612631|NCT02737475|12020819|FG023|Overall Study|Disease Progression|0
7612632|NCT02737475|12020820|FG024|Overall Study|Disease Progression|0
7612633|NCT02737475|12020821|FG025|Overall Study|Disease Progression|0
7612634|NCT02737475|12020822|FG026|Overall Study|Disease Progression|1
7612635|NCT02642965|12020914|FG000|Overall Study|Lack of Efficacy|4
7612636|NCT02642965|12020914|FG000|Overall Study|Physician Decision|9
7612637|NCT02604433|12020920|FG000|Overall Study|Withdrawal by Subject|37
7612638|NCT02604433|12020921|FG001|Overall Study|Withdrawal by Subject|16
7612639|NCT02604433|12020920|FG000|Overall Study|Adverse Event|4
7612640|NCT02604433|12020921|FG001|Overall Study|Adverse Event|0
7612641|NCT02604433|12020920|FG000|Overall Study|Other reasons|3
7612642|NCT02604433|12020921|FG001|Overall Study|Other reasons|5
7612643|NCT02604433|12020920|FG000|Overall Study|Death|4
7612644|NCT02604433|12020921|FG001|Overall Study|Death|1
7612645|NCT02604433|12020920|FG000|Overall Study|Transition to Rollover Protocol|169
7612646|NCT02604433|12020921|FG001|Overall Study|Transition to Rollover Protocol|82
7612647|NCT02604433|12020920|FG000|Overall Study|Physician Decision|1
7612648|NCT02604433|12020921|FG001|Overall Study|Physician Decision|1
7612649|NCT02604433|12020920|FG000|Overall Study|Lack of Efficacy|0
7612650|NCT02604433|12020921|FG001|Overall Study|Lack of Efficacy|1
7612651|NCT02420821|12020946|FG000|Overall Study|Lost to Follow-up|2
7612652|NCT02420821|12020947|FG001|Overall Study|Lost to Follow-up|0
7612653|NCT02420821|12020946|FG000|Overall Study|Non-compliance|1
7612654|NCT02420821|12020947|FG001|Overall Study|Non-compliance|2
7612655|NCT02420821|12020946|FG000|Overall Study|Physician Decision|5
7612656|NCT02420821|12020947|FG001|Overall Study|Physician Decision|2
7612657|NCT02420821|12020946|FG000|Overall Study|Withdrawal by Subject|31
7612658|NCT02420821|12020947|FG001|Overall Study|Withdrawal by Subject|17
7612659|NCT02420821|12020946|FG000|Overall Study|Death|129
7612660|NCT02420821|12020947|FG001|Overall Study|Death|116
7612669|NCT02410343|12020965|FG000|Core Period (24 Weeks)|Adverse Event|1
7612670|NCT02410343|12020966|FG001|Core Period (24 Weeks)|Adverse Event|0
7612671|NCT02410343|12020965|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
7612672|NCT02410343|12020966|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
7612673|NCT02410343|12020965|FG000|Extension Period (12 Months)|Adverse Event|1
7612674|NCT02410343|12020966|FG001|Extension Period (12 Months)|Adverse Event|0
7612675|NCT02410343|12020965|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
7612676|NCT02410343|12020966|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
7277801|NCT00455533|11492669|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
7277802|NCT00455533|11492667|FG000|Period Two: Randomized Period|Death|0
7277803|NCT00455533|11492668|FG001|Period Two: Randomized Period|Death|0
7277804|NCT00455533|11492669|FG002|Period Two: Randomized Period|Death|3
7277805|NCT00455533|11492667|FG000|Period Two: Randomized Period|Disease Progression|0
7277806|NCT00455533|11492668|FG001|Period Two: Randomized Period|Disease Progression|1
7277807|NCT00455533|11492669|FG002|Period Two: Randomized Period|Disease Progression|1
7277808|NCT00455533|11492667|FG000|Period Two: Randomized Period|Lost to Follow-up|0
7277809|NCT00455533|11492668|FG001|Period Two: Randomized Period|Lost to Follow-up|0
7277810|NCT00455533|11492669|FG002|Period Two: Randomized Period|Lost to Follow-up|1
7277811|NCT00455533|11492667|FG000|Period Two: Randomized Period|Other - need reasons|0
7612677|NCT02339740|12020979|FG000|Overall Study|Death|1
7612678|NCT02339740|12020980|FG001|Overall Study|Death|0
7612679|NCT02339740|12020979|FG000|Overall Study|Physician Decision|0
7612680|NCT02339740|12020980|FG001|Overall Study|Physician Decision|2
7612681|NCT02339740|12020979|FG000|Overall Study|Withdrawal by Subject|5
7612682|NCT02339740|12020980|FG001|Overall Study|Withdrawal by Subject|1
7612683|NCT02339740|12020979|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
7612684|NCT02339740|12020980|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
7612685|NCT02045303|12021003|FG000|Overall Study|Protocol Violation|2
7612686|NCT02045303|12021004|FG001|Overall Study|Protocol Violation|1
7612687|NCT02045303|12021005|FG002|Overall Study|Protocol Violation|0
7612688|NCT02045303|12021003|FG000|Overall Study|Withdrawal by Subject|0
7612689|NCT02045303|12021004|FG001|Overall Study|Withdrawal by Subject|2
7612690|NCT02045303|12021005|FG002|Overall Study|Withdrawal by Subject|0
7612691|NCT02025556|12021017|FG000|Overall Study|Adverse Event|0
7612692|NCT02025556|12021018|FG001|Overall Study|Adverse Event|4
7612693|NCT02025556|12021019|FG002|Overall Study|Adverse Event|2
7277812|NCT00455533|11492668|FG001|Period Two: Randomized Period|Other - need reasons|1
7277813|NCT00455533|11492669|FG002|Period Two: Randomized Period|Other - need reasons|0
7612694|NCT02025556|12021017|FG000|Overall Study|Lack of Efficacy|2
7612695|NCT02025556|12021018|FG001|Overall Study|Lack of Efficacy|1
7612696|NCT02025556|12021019|FG002|Overall Study|Lack of Efficacy|0
7612697|NCT02025556|12021017|FG000|Overall Study|Protocol Violation|2
7612698|NCT02025556|12021018|FG001|Overall Study|Protocol Violation|1
7612699|NCT02025556|12021019|FG002|Overall Study|Protocol Violation|0
7612700|NCT02025556|12021017|FG000|Overall Study|Withdrawal by Subject|0
7612701|NCT02025556|12021018|FG001|Overall Study|Withdrawal by Subject|3
7612702|NCT02025556|12021019|FG002|Overall Study|Withdrawal by Subject|6
7612703|NCT02025556|12021017|FG000|Overall Study|Lost to Follow-up|2
7612704|NCT02025556|12021018|FG001|Overall Study|Lost to Follow-up|4
7612705|NCT02025556|12021019|FG002|Overall Study|Lost to Follow-up|0
7612706|NCT02025556|12021017|FG000|Overall Study|Reason not reported|0
7612707|NCT02025556|12021018|FG001|Overall Study|Reason not reported|0
7612708|NCT02025556|12021019|FG002|Overall Study|Reason not reported|1
7612709|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Adverse Event|1
7612710|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Adverse Event|5
7612711|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Adverse Event|2
7612712|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Adverse Event|2
7612713|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Adverse Event|4
7612714|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
7612715|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
7612716|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
7612717|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
7612718|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
7612719|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
7612720|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
7612721|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
7612722|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
7612723|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
7612724|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
7612725|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
7612726|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
7612727|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
7612728|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
7612729|NCT01986933|12021032|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612730|NCT01986933|12021033|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612731|NCT01986933|12021034|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612732|NCT01986933|12021035|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
7612733|NCT01986933|12021036|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
7612734|NCT01986933|12021032|FG000|Active-to-active (Part B)|Adverse Event|0
7612735|NCT01986933|12021033|FG001|Active-to-active (Part B)|Adverse Event|2
7612736|NCT01986933|12021034|FG002|Active-to-active (Part B)|Adverse Event|0
7612737|NCT01986933|12021035|FG003|Active-to-active (Part B)|Adverse Event|1
7612738|NCT01986933|12021036|FG004|Active-to-active (Part B)|Adverse Event|3
7612739|NCT01986933|12021032|FG000|Active-to-active (Part B)|Lack of Efficacy|0
7612740|NCT01986933|12021033|FG001|Active-to-active (Part B)|Lack of Efficacy|3
7277814|NCT00455533|11492667|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
7277815|NCT00455533|11492668|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
7277816|NCT00455533|11492669|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
7277817|NCT00455533|11492667|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
7277818|NCT00455533|11492668|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
7277819|NCT00455533|11492669|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
7277820|NCT00455741|11492732|FG000|Overall Study|Physician Decision|0
7277821|NCT00455741|11492733|FG001|Overall Study|Physician Decision|1
7277822|NCT00455858|11492749|FG000|Overall Study|Lost to Follow-up|2
7277823|NCT00455858|11492749|FG000|Overall Study|Protocol Violation|1
7277824|NCT00455858|11492749|FG000|Overall Study|Lack of Efficacy|1
7277825|NCT00455858|11492749|FG000|Overall Study|Well controlled FPG without insulin|1
7277826|NCT00455858|11492749|FG000|Overall Study|Withdrawal|1
7277827|NCT00455923|11492755|FG000|Overall Study|Pregnancy|0
7277828|NCT00455923|11492756|FG001|Overall Study|Pregnancy|2
7277829|NCT00455923|11492755|FG000|Overall Study|Other|3
7277830|NCT00455923|11492756|FG001|Overall Study|Other|1
7277831|NCT00456092|11492789|FG000|Extension Phase|Grade 2 or Greater AE|2
7277832|NCT00456092|11492790|FG001|Extension Phase|Grade 2 or Greater AE|2
7277833|NCT00456092|11492791|FG002|Extension Phase|Grade 2 or Greater AE|0
7277834|NCT00456092|11492792|FG003|Extension Phase|Grade 2 or Greater AE|0
7277835|NCT00456092|11492793|FG004|Extension Phase|Grade 2 or Greater AE|2
7277836|NCT00456092|11492789|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
7277837|NCT00456092|11492790|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
7277838|NCT00456092|11492791|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
7277839|NCT00456092|11492792|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
7277840|NCT00456092|11492793|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
7277841|NCT00456092|11492789|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
7277842|NCT00456092|11492790|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
7277843|NCT00456092|11492791|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
7277844|NCT00456092|11492792|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
7277845|NCT00456092|11492793|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
7277846|NCT00456092|11492789|FG000|Extension Phase|Withdrew Consent|2
7277847|NCT00456092|11492790|FG001|Extension Phase|Withdrew Consent|0
7277848|NCT00456092|11492791|FG002|Extension Phase|Withdrew Consent|0
7277849|NCT00456092|11492792|FG003|Extension Phase|Withdrew Consent|0
7612741|NCT01986933|12021034|FG002|Active-to-active (Part B)|Lack of Efficacy|2
7612742|NCT01986933|12021035|FG003|Active-to-active (Part B)|Lack of Efficacy|0
7277850|NCT00456092|11492793|FG004|Extension Phase|Withdrew Consent|0
7277851|NCT00456092|11492789|FG000|Extension Phase|Lost to Follow-up|1
7277852|NCT00456092|11492790|FG001|Extension Phase|Lost to Follow-up|1
7277853|NCT00456092|11492791|FG002|Extension Phase|Lost to Follow-up|0
7277854|NCT00456092|11492792|FG003|Extension Phase|Lost to Follow-up|0
7277855|NCT00456092|11492793|FG004|Extension Phase|Lost to Follow-up|1
7277856|NCT00456092|11492789|FG000|Extension Phase|Other|2
7277857|NCT00456092|11492790|FG001|Extension Phase|Other|0
7277858|NCT00456092|11492791|FG002|Extension Phase|Other|0
7277859|NCT00456092|11492792|FG003|Extension Phase|Other|1
7277860|NCT00456092|11492793|FG004|Extension Phase|Other|1
7277861|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
7277862|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
7277863|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
7277864|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7277865|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
7277866|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
7277867|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
7277868|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7277869|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7277870|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
7277871|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
7277872|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7277873|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7277874|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7277875|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
7277876|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7277877|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
7277878|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
7277879|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7277880|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
7277881|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7277882|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7277883|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
7277884|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7277885|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
7469793|NCT01927055|11771697|FG002|Open-label|Study Stopped|0
7612743|NCT01986933|12021036|FG004|Active-to-active (Part B)|Lack of Efficacy|4
7612744|NCT01986933|12021032|FG000|Active-to-active (Part B)|Pregnancy|0
7612745|NCT01986933|12021033|FG001|Active-to-active (Part B)|Pregnancy|0
7612746|NCT01986933|12021034|FG002|Active-to-active (Part B)|Pregnancy|0
7612747|NCT01986933|12021035|FG003|Active-to-active (Part B)|Pregnancy|0
7612748|NCT01986933|12021036|FG004|Active-to-active (Part B)|Pregnancy|1
7612749|NCT01986933|12021032|FG000|Active-to-active (Part B)|Physician Decision|0
7612750|NCT01986933|12021033|FG001|Active-to-active (Part B)|Physician Decision|0
7612751|NCT01986933|12021034|FG002|Active-to-active (Part B)|Physician Decision|1
7612752|NCT01986933|12021035|FG003|Active-to-active (Part B)|Physician Decision|1
7612753|NCT01986933|12021036|FG004|Active-to-active (Part B)|Physician Decision|0
7612754|NCT01986933|12021032|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
7612755|NCT01986933|12021033|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
7612756|NCT01986933|12021034|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
7612757|NCT01986933|12021035|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
7612758|NCT01986933|12021036|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
7612759|NCT01986933|12021032|FG000|Active-to-active (Part B)|Lost to Follow-up|0
7612760|NCT01986933|12021033|FG001|Active-to-active (Part B)|Lost to Follow-up|0
7612761|NCT01986933|12021034|FG002|Active-to-active (Part B)|Lost to Follow-up|0
7612762|NCT01986933|12021035|FG003|Active-to-active (Part B)|Lost to Follow-up|0
7612763|NCT01986933|12021036|FG004|Active-to-active (Part B)|Lost to Follow-up|1
7277919|NCT00456521|11492838|FG000|Overall Study|Withdrawal by Subject|43
7612764|NCT01986933|12021032|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
7612765|NCT01986933|12021033|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
7612766|NCT01986933|12021034|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
7612767|NCT01986933|12021035|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
7612768|NCT01986933|12021036|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
7612769|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Adverse Event|0
7612770|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Adverse Event|1
7612771|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Adverse Event|0
7612772|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Adverse Event|1
7612773|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Adverse Event|0
7612774|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
7612775|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
7612776|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
7612777|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
7612778|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
7612779|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Protocol Violation|0
7277886|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7277887|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
7277888|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
7277889|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7277890|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
7277891|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
7612780|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Protocol Violation|0
7612781|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Protocol Violation|1
7612782|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Protocol Violation|0
7277892|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
7612783|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Protocol Violation|0
7612784|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
7612785|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
7612786|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
7612787|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
7612788|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
7612789|NCT01986933|12021032|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
7612790|NCT01986933|12021033|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
7612791|NCT01986933|12021034|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
7612792|NCT01986933|12021035|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
7612793|NCT01986933|12021036|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
7612794|NCT01563107|12021082|FG000|Overall Study|Physician Decision|0
7612795|NCT01563107|12021083|FG001|Overall Study|Physician Decision|1
7612796|NCT01563107|12021084|FG002|Overall Study|Physician Decision|1
7612797|NCT01563107|12021085|FG003|Overall Study|Physician Decision|3
7612798|NCT01563107|12021082|FG000|Overall Study|Withdrawal by Subject|1
7612799|NCT01563107|12021083|FG001|Overall Study|Withdrawal by Subject|2
7612800|NCT01563107|12021084|FG002|Overall Study|Withdrawal by Subject|1
7612801|NCT01563107|12021085|FG003|Overall Study|Withdrawal by Subject|2
7277893|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
7277894|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
7277895|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
7277896|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7277897|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7277898|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
7277899|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7277900|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
7277901|NCT00456092|11492789|FG000|Treatment Phase (12 Weeks)|Other|1
7277902|NCT00456092|11492790|FG001|Treatment Phase (12 Weeks)|Other|0
7277903|NCT00456092|11492791|FG002|Treatment Phase (12 Weeks)|Other|1
7277904|NCT00456092|11492792|FG003|Treatment Phase (12 Weeks)|Other|0
7277905|NCT00456092|11492793|FG004|Treatment Phase (12 Weeks)|Other|0
7277906|NCT00456300|11492807|FG000|Overall Study|Adverse Event|1
7277907|NCT00456300|11492808|FG001|Overall Study|Adverse Event|0
7277908|NCT00456365|11492818|FG000|Overall Study|Lost to Follow-up|1
7277909|NCT00456365|11492819|FG001|Overall Study|Lost to Follow-up|3
7277910|NCT00456365|11492818|FG000|Overall Study|Withdrawal by Subject|4
7277911|NCT00456365|11492819|FG001|Overall Study|Withdrawal by Subject|7
7277912|NCT00456365|11492818|FG000|Overall Study|Pregnancy|1
7277913|NCT00456365|11492819|FG001|Overall Study|Pregnancy|1
7277914|NCT00456365|11492818|FG000|Overall Study|oncologic diagnosis|1
7277915|NCT00456365|11492819|FG001|Overall Study|oncologic diagnosis|1
7277916|NCT00456495|11492827|FG000|Overall Study|Physician Decision|2
7277917|NCT00456521|11492838|FG000|Overall Study|Adverse Event|150
7277918|NCT00456521|11492839|FG001|Overall Study|Adverse Event|25
7277920|NCT00456521|11492839|FG001|Overall Study|Withdrawal by Subject|24
7277921|NCT00456521|11492838|FG000|Overall Study|Lost to Follow-up|22
7277922|NCT00456521|11492839|FG001|Overall Study|Lost to Follow-up|17
7277923|NCT00456521|11492838|FG000|Overall Study|Lack of Efficacy|3
7277924|NCT00456521|11492839|FG001|Overall Study|Lack of Efficacy|6
7277925|NCT00456521|11492838|FG000|Overall Study|Protocol Violation|4
7277926|NCT00456521|11492839|FG001|Overall Study|Protocol Violation|0
7277927|NCT00456521|11492838|FG000|Overall Study|Pregnancy|1
7277928|NCT00456521|11492839|FG001|Overall Study|Pregnancy|1
7277929|NCT00456521|11492838|FG000|Overall Study|Drug non-compliance, moved, other|26
7277930|NCT00456521|11492839|FG001|Overall Study|Drug non-compliance, moved, other|11
7277931|NCT00456599|11492855|FG000|Overall Study|Non-compliance|1
7277932|NCT00456599|11492855|FG000|Overall Study|Withdrawal by Subject|2
7277933|NCT00456755|11492865|FG000|Overall Study|Lost to Follow-up|2
7277934|NCT00456755|11492866|FG001|Overall Study|Lost to Follow-up|1
7277935|NCT00456846|11492883|FG000|Overall Study|Adverse Event|2
7612812|NCT01042522|12021166|FG000|Overall Study|Adverse Event|1
7612813|NCT01042522|12021167|FG001|Overall Study|Adverse Event|2
7612814|NCT01042522|12021166|FG000|Overall Study|Disease Progression|5
7612815|NCT01042522|12021167|FG001|Overall Study|Disease Progression|0
7612816|NCT01042522|12021166|FG000|Overall Study|Death|1
7612817|NCT01042522|12021167|FG001|Overall Study|Death|0
7612818|NCT01042522|12021166|FG000|Overall Study|Patient Refused|0
7612819|NCT01042522|12021167|FG001|Overall Study|Patient Refused|3
7612820|NCT01042522|12021166|FG000|Overall Study|Withdrawal by Subject|1
7612821|NCT01042522|12021167|FG001|Overall Study|Withdrawal by Subject|1
7612822|NCT00710970|12021206|FG000|Overall Study|Never took drug|3
7612823|NCT00685919|12021214|FG000|Overall Study|Withdrawal by Subject|0
7612824|NCT00685919|12021215|FG001|Overall Study|Withdrawal by Subject|0
7612825|NCT00685919|12021216|FG002|Overall Study|Withdrawal by Subject|1
7612826|NCT00685919|12021217|FG003|Overall Study|Withdrawal by Subject|0
7612827|NCT00685919|12021214|FG000|Overall Study|Physician Decision|1
7612828|NCT00685919|12021215|FG001|Overall Study|Physician Decision|0
7612829|NCT00685919|12021216|FG002|Overall Study|Physician Decision|0
7612830|NCT00685919|12021217|FG003|Overall Study|Physician Decision|0
7612831|NCT00344487|12021227|FG000|Overall Study|immunologic failure|1
7612832|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Death|120
7612833|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Death|46
7612834|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Death|0
7612835|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
7612836|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
7612837|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
7612838|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
7612839|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
7612840|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
7612841|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7612842|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
7612843|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
7612844|NCT00281658|12021235|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7612845|NCT00281658|12021236|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
7612846|NCT00281658|12021237|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
7612847|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Death|0
7612848|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Death|0
7277936|NCT00456846|11492884|FG001|Overall Study|Adverse Event|15
7612849|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Death|97
7612850|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7612851|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
7612852|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
7612853|NCT00281658|12021235|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7612854|NCT00281658|12021236|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
7612855|NCT00281658|12021237|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
7612856|NCT04034355|12021268|FG000|Overall Study|Study terminated by Sponsor|10
7612857|NCT04034355|12021269|FG001|Overall Study|Study terminated by Sponsor|17
7612858|NCT04034355|12021268|FG000|Overall Study|Withdrawal by Subject|12
7612859|NCT04034355|12021269|FG001|Overall Study|Withdrawal by Subject|11
7612860|NCT04034355|12021268|FG000|Overall Study|Site terminated by Sponsor|4
7612861|NCT04034355|12021269|FG001|Overall Study|Site terminated by Sponsor|5
7612862|NCT04034355|12021268|FG000|Overall Study|Adverse Event|2
7612863|NCT04034355|12021269|FG001|Overall Study|Adverse Event|0
7612864|NCT04034355|12021268|FG000|Overall Study|Death|1
7612865|NCT04034355|12021269|FG001|Overall Study|Death|1
7612866|NCT04034355|12021268|FG000|Overall Study|Not reported|2
7612867|NCT04034355|12021269|FG001|Overall Study|Not reported|0
7612868|NCT04034355|12021268|FG000|Overall Study|Lost to Follow-up|1
7612869|NCT04034355|12021269|FG001|Overall Study|Lost to Follow-up|0
7612870|NCT04034355|12021268|FG000|Overall Study|Physician Decision|1
7612871|NCT04034355|12021269|FG001|Overall Study|Physician Decision|0
7612872|NCT04034355|12021268|FG000|Overall Study|Protocol Violation|0
7612873|NCT04034355|12021269|FG001|Overall Study|Protocol Violation|1
7612874|NCT04034355|12021268|FG000|Overall Study|Progressive disease|1
7612875|NCT04034355|12021269|FG001|Overall Study|Progressive disease|0
7612876|NCT03721276|12021281|FG000|Overall Study|Lost to Follow-up|5
7612877|NCT03721276|12021282|FG001|Overall Study|Lost to Follow-up|3
7612878|NCT03721276|12021281|FG000|Overall Study|Adverse Event|0
7612879|NCT03721276|12021282|FG001|Overall Study|Adverse Event|1
7612880|NCT03637491|12021305|FG000|Overall Study|Death|9
7612881|NCT03637491|12021306|FG001|Overall Study|Death|9
7612882|NCT03637491|12021307|FG002|Overall Study|Death|5
7612883|NCT03637491|12021308|FG003|Overall Study|Death|3
7612884|NCT03637491|12021305|FG000|Overall Study|Lost to Follow-up|0
7612885|NCT03637491|12021306|FG001|Overall Study|Lost to Follow-up|1
7612886|NCT03637491|12021307|FG002|Overall Study|Lost to Follow-up|0
7612887|NCT03637491|12021308|FG003|Overall Study|Lost to Follow-up|1
7612888|NCT03637491|12021305|FG000|Overall Study|Study Terminated By Sponsor|0
7612889|NCT03637491|12021306|FG001|Overall Study|Study Terminated By Sponsor|2
7612890|NCT03637491|12021307|FG002|Overall Study|Study Terminated By Sponsor|1
7612891|NCT03637491|12021308|FG003|Overall Study|Study Terminated By Sponsor|0
7612892|NCT03637491|12021305|FG000|Overall Study|Withdrawal by Subject|1
7612893|NCT03637491|12021306|FG001|Overall Study|Withdrawal by Subject|0
7612894|NCT03637491|12021307|FG002|Overall Study|Withdrawal by Subject|1
7612895|NCT03637491|12021308|FG003|Overall Study|Withdrawal by Subject|2
7612896|NCT03334539|12021399|FG000|Overall Study|Adverse Event|3
7612897|NCT03334539|12021400|FG001|Overall Study|Adverse Event|5
7612898|NCT03334539|12021401|FG002|Overall Study|Adverse Event|0
7612899|NCT03334539|12021399|FG000|Overall Study|Withdrawal by Subject|0
7612900|NCT03334539|12021400|FG001|Overall Study|Withdrawal by Subject|1
7612901|NCT03334539|12021401|FG002|Overall Study|Withdrawal by Subject|1
7612902|NCT03334539|12021399|FG000|Overall Study|Administrative Reasons|1
7612903|NCT03334539|12021400|FG001|Overall Study|Administrative Reasons|0
7612904|NCT03334539|12021401|FG002|Overall Study|Administrative Reasons|0
7612905|NCT03334539|12021399|FG000|Overall Study|Hypertension Not Controlled|0
7612906|NCT03334539|12021400|FG001|Overall Study|Hypertension Not Controlled|1
7612907|NCT03334539|12021401|FG002|Overall Study|Hypertension Not Controlled|0
7612908|NCT03269344|12021423|FG000|Overall Study|Protocol Violation|4
7612909|NCT03269344|12021424|FG001|Overall Study|Protocol Violation|3
7612910|NCT03076775|12021438|FG000|Overall Study|Lost to Follow-up|1
7612911|NCT03076775|12021439|FG001|Overall Study|Lost to Follow-up|0
7277937|NCT00456846|11492883|FG000|Overall Study|Physician Decision|11
7277938|NCT00456846|11492884|FG001|Overall Study|Physician Decision|6
7277939|NCT00456846|11492883|FG000|Overall Study|Protocol Deviation|2
7612912|NCT02660827|12021479|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
7612913|NCT02660827|12021479|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
7612914|NCT02660827|12021479|FG000|From Study to End of Continued Access|Adverse Event|3
7612915|NCT02660827|12021479|FG000|From Study to End of Continued Access|didn't participate continued access period|5
7612916|NCT02660827|12021479|FG000|Period 1: Study Period|Withdrawal by Subject|1
7612917|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
7612918|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
7612919|NCT02660827|12021479|FG000|Period 2: Continued Access Period|Adverse Event|3
7612920|NCT02425644|12021497|FG000|Overall Study|Lost to Follow-up|2
7612921|NCT02425644|12021498|FG001|Overall Study|Lost to Follow-up|3
7612922|NCT02425644|12021497|FG000|Overall Study|Withdrawal by Subject|41
7612923|NCT02425644|12021498|FG001|Overall Study|Withdrawal by Subject|36
7612924|NCT02425644|12021497|FG000|Overall Study|Lack of Efficacy|3
7612925|NCT02425644|12021498|FG001|Overall Study|Lack of Efficacy|10
7612926|NCT02425644|12021497|FG000|Overall Study|Adverse Event|13
7612927|NCT02425644|12021498|FG001|Overall Study|Adverse Event|3
7612928|NCT02425644|12021497|FG000|Overall Study|Death|0
7612929|NCT02425644|12021498|FG001|Overall Study|Death|2
7612930|NCT02425644|12021497|FG000|Overall Study|Other|18
7612931|NCT02425644|12021498|FG001|Overall Study|Other|17
7612932|NCT02270957|12021511|FG000|Overall Study|Lack of Efficacy|2
7612933|NCT02270957|12021512|FG001|Overall Study|Lack of Efficacy|4
7612934|NCT02270957|12021511|FG000|Overall Study|Adverse Event|2
7612935|NCT02270957|12021512|FG001|Overall Study|Adverse Event|0
7612936|NCT02054104|12021521|FG000|Overall Study|Did not want to continue due to college classes|1
7612937|NCT02054104|12021522|FG001|Overall Study|Did not want to continue due to college classes|0
7612938|NCT02054104|12021521|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
7612939|NCT02054104|12021522|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
7612940|NCT02054104|12021521|FG000|Overall Study|No evidence of immunologic response|2
7612941|NCT02054104|12021522|FG001|Overall Study|No evidence of immunologic response|2
7612942|NCT02054104|12021521|FG000|Overall Study|Disease Progression On Study|4
7612943|NCT02054104|12021522|FG001|Overall Study|Disease Progression On Study|5
7612944|NCT02054104|12021521|FG000|Overall Study|Diagnosis of lymphoma|0
7612945|NCT02054104|12021522|FG001|Overall Study|Diagnosis of lymphoma|1
7612946|NCT02054104|12021521|FG000|Overall Study|Inconclusive response|0
7612947|NCT02054104|12021522|FG001|Overall Study|Inconclusive response|1
7612948|NCT01899144|12021528|FG000|Treatment Period 2|Other|1
7277940|NCT00456846|11492884|FG001|Overall Study|Protocol Deviation|0
7277941|NCT00456846|11492883|FG000|Overall Study|Participant Discretion|1
7277942|NCT00456846|11492884|FG001|Overall Study|Participant Discretion|5
7277943|NCT00456846|11492883|FG000|Overall Study|Other|0
7277944|NCT00456846|11492884|FG001|Overall Study|Other|2
7277945|NCT00457002|11492898|FG000|Overall Study|Death|40
7277946|NCT00457002|11492899|FG001|Overall Study|Death|47
7277947|NCT00457002|11492898|FG000|Overall Study|Adverse Event|284
7277948|NCT00457002|11492899|FG001|Overall Study|Adverse Event|260
7277949|NCT00457002|11492898|FG000|Overall Study|Withdrawal by Subject|299
7277950|NCT00457002|11492899|FG001|Overall Study|Withdrawal by Subject|271
7277951|NCT00457002|11492898|FG000|Overall Study|Lost to Follow-up|72
7277952|NCT00457002|11492899|FG001|Overall Study|Lost to Follow-up|71
7277953|NCT00457002|11492898|FG000|Overall Study|Poor/Non-compliance|46
7277954|NCT00457002|11492899|FG001|Overall Study|Poor/Non-compliance|33
7277955|NCT00457002|11492898|FG000|Overall Study|No longer met criteria|41
7277956|NCT00457002|11492899|FG001|Overall Study|No longer met criteria|37
7277957|NCT00457002|11492898|FG000|Overall Study|Administrative reason by Sponsor|1
7277958|NCT00457002|11492899|FG001|Overall Study|Administrative reason by Sponsor|0
7277959|NCT00457002|11492898|FG000|Overall Study|non-specified|29
7612949|NCT01899144|12021528|FG000|Treatment Period 3|Other|2
7612950|NCT01899144|12021528|FG000|Treatment Period 5|Other|1
7612951|NCT01757665|12021542|FG000|Overall Study|Still on Study - Visit Completed|240
7612952|NCT01757665|12021543|FG001|Overall Study|Still on Study - Visit Completed|30
7612953|NCT01757665|12021542|FG000|Overall Study|Still on Study - Visit Pending|398
7612954|NCT01757665|12021543|FG001|Overall Study|Still on Study - Visit Pending|40
7612955|NCT01757665|12021542|FG000|Overall Study|Still on Study - Missed Visit|14
7612956|NCT01757665|12021543|FG001|Overall Study|Still on Study - Missed Visit|1
7612957|NCT01757665|12021542|FG000|Overall Study|Death|25
7612958|NCT01757665|12021543|FG001|Overall Study|Death|8
7612959|NCT01757665|12021542|FG000|Overall Study|Explant|1
7612960|NCT01757665|12021543|FG001|Overall Study|Explant|2
7612961|NCT01757665|12021542|FG000|Overall Study|Withdrawal by Subject|10
7612962|NCT01757665|12021543|FG001|Overall Study|Withdrawal by Subject|0
7612963|NCT01757665|12021542|FG000|Overall Study|Lost to Follow-up|1
7612964|NCT01757665|12021543|FG001|Overall Study|Lost to Follow-up|1
7612965|NCT01757665|12021542|FG000|Overall Study|Not Implanted with Device|5
7612966|NCT01757665|12021543|FG001|Overall Study|Not Implanted with Device|1
7277960|NCT00457002|11492899|FG001|Overall Study|non-specified|38
7277961|NCT00457002|11492898|FG000|Overall Study|treated for 1 day; missing status/reason|1
7277962|NCT00457002|11492899|FG001|Overall Study|treated for 1 day; missing status/reason|0
7277963|NCT00457015|11492907|FG000|Overall Study|Left study site against medical advice|0
7277964|NCT00457015|11492908|FG001|Overall Study|Left study site against medical advice|1
7277965|NCT00457249|11492925|FG000|Overall Study|Lost to Follow-up|3
7277966|NCT00457249|11492926|FG001|Overall Study|Lost to Follow-up|0
7277967|NCT00457249|11492925|FG000|Overall Study|Protocol Violation|4
7277968|NCT00457249|11492926|FG001|Overall Study|Protocol Violation|1
7277969|NCT00457249|11492925|FG000|Overall Study|Withdrawal by Subject|3
7277970|NCT00457249|11492926|FG001|Overall Study|Withdrawal by Subject|1
7277971|NCT00457249|11492925|FG000|Overall Study|Serious Adverse Events|2
7277972|NCT00457249|11492926|FG001|Overall Study|Serious Adverse Events|0
7277973|NCT00457301|11492936|FG000|Overall Study|Withdrawal by Subject|3
7277974|NCT00457301|11492937|FG001|Overall Study|Withdrawal by Subject|3
7277975|NCT00457301|11492936|FG000|Overall Study|Censored out of the study|15
7277976|NCT00457301|11492937|FG001|Overall Study|Censored out of the study|14
7277977|NCT00457301|11492936|FG000|Overall Study|Death|5
7277978|NCT00457301|11492937|FG001|Overall Study|Death|7
7277979|NCT00457392|11492954|FG000|Overall Study|Objective Progression or Relapse|229
7277980|NCT00457392|11492955|FG001|Overall Study|Objective Progression or Relapse|296
7277981|NCT00457392|11492954|FG000|Overall Study|Death|106
7277982|NCT00457392|11492955|FG001|Overall Study|Death|106
7277983|NCT00457392|11492954|FG000|Overall Study|Adverse Event|84
7277984|NCT00457392|11492955|FG001|Overall Study|Adverse Event|41
7277985|NCT00457392|11492954|FG000|Overall Study|Global Deterioration of Health Status|22
7277986|NCT00457392|11492955|FG001|Overall Study|Global Deterioration of Health Status|8
7277987|NCT00457392|11492954|FG000|Overall Study|Withdrawal by Subject|14
7277988|NCT00457392|11492955|FG001|Overall Study|Withdrawal by Subject|8
7277989|NCT00457392|11492954|FG000|Overall Study|Lost to Follow-up|6
7613015|NCT00603954|12021612|FG000|Overall Study|Protocol Violation|1
7613016|NCT00603954|12021613|FG001|Overall Study|Protocol Violation|2
7277990|NCT00457392|11492955|FG001|Overall Study|Lost to Follow-up|7
7613017|NCT04532294|12021627|FG000|Overall Study|Withdrawal by Subject|0
7613018|NCT04532294|12021628|FG001|Overall Study|Withdrawal by Subject|0
7613019|NCT04532294|12021629|FG002|Overall Study|Withdrawal by Subject|1
7613020|NCT04532294|12021627|FG000|Overall Study|Participants Not Dosed|0
7613021|NCT04532294|12021628|FG001|Overall Study|Participants Not Dosed|0
7613022|NCT04532294|12021629|FG002|Overall Study|Participants Not Dosed|2
7613023|NCT04250077|12021642|FG000|Overall Study|Withdrawal by Subject|0
7613024|NCT04250077|12021643|FG001|Overall Study|Withdrawal by Subject|1
7277991|NCT00457392|11492954|FG000|Overall Study|Protocol Violation|4
7277992|NCT00457392|11492955|FG001|Overall Study|Protocol Violation|3
7277993|NCT00457392|11492954|FG000|Overall Study|Other|7
7277994|NCT00457392|11492955|FG001|Overall Study|Other|4
7277995|NCT00457392|11492954|FG000|Overall Study|Study Terminated by Sponsor|1
7277996|NCT00457392|11492955|FG001|Overall Study|Study Terminated by Sponsor|4
7277997|NCT00457392|11492954|FG000|Overall Study|Randomized, Not Treated|7
7277998|NCT00457392|11492955|FG001|Overall Study|Randomized, Not Treated|3
7277999|NCT00457418|11492961|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
7278000|NCT00457418|11492961|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
7278001|NCT00457418|11492961|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
7278002|NCT00457418|11492961|FG000|Post PK Maintenance|Adverse Event|10
7278003|NCT00457418|11492961|FG000|Post PK Maintenance|Progression of Disease|6
7278004|NCT00457418|11492961|FG000|Post PK Maintenance|Withdrawal by Subject|11
7278005|NCT00457418|11492961|FG000|Post PK Maintenance|Lost to Follow-up|1
7278006|NCT00457626|11492965|FG000|Overall Study|Adverse Event|3
7278007|NCT00457626|11492965|FG000|Overall Study|Administrative Problems|2
7278008|NCT00457626|11492965|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
7469794|NCT01927055|11771695|FG000|Open-label|Supine Hypertension|4
7469795|NCT01927055|11771696|FG001|Open-label|Supine Hypertension|0
7469796|NCT01927055|11771697|FG002|Open-label|Supine Hypertension|0
7469797|NCT01927055|11771695|FG000|Open-label|Difficulty attending study visits|1
7469798|NCT01927055|11771696|FG001|Open-label|Difficulty attending study visits|0
7469799|NCT01927055|11771697|FG002|Open-label|Difficulty attending study visits|0
7469800|NCT01927055|11771695|FG000|Double-Blind|Adverse Event|0
7469801|NCT01927055|11771696|FG001|Double-Blind|Adverse Event|1
7469802|NCT01927055|11771697|FG002|Double-Blind|Adverse Event|1
7469803|NCT01927055|11771695|FG000|Double-Blind|Protocol Violation|0
7469804|NCT01927055|11771696|FG001|Double-Blind|Protocol Violation|0
7613025|NCT04250077|12021644|FG002|Overall Study|Withdrawal by Subject|0
7613026|NCT04250077|12021642|FG000|Overall Study|Lost to Follow-up|2
7613027|NCT04250077|12021643|FG001|Overall Study|Lost to Follow-up|3
7613028|NCT04250077|12021644|FG002|Overall Study|Lost to Follow-up|0
7613029|NCT03505710|12021698|FG000|Overall Study|Progressive Disease|22
7613030|NCT03505710|12021699|FG001|Overall Study|Progressive Disease|9
7613031|NCT03505710|12021700|FG002|Overall Study|Progressive Disease|34
7613032|NCT03505710|12021698|FG000|Overall Study|Clinical Progression|6
7613033|NCT03505710|12021699|FG001|Overall Study|Clinical Progression|6
7613034|NCT03505710|12021700|FG002|Overall Study|Clinical Progression|3
7613035|NCT03505710|12021698|FG000|Overall Study|Adverse Event|12
7278009|NCT00457639|11492969|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
7278010|NCT00457639|11492970|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
7278011|NCT00457639|11492969|FG000|Intervention 1 (6 Months)|unrelated illness|0
7278012|NCT00457639|11492970|FG001|Intervention 1 (6 Months)|unrelated illness|2
7278013|NCT00457639|11492969|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
7278014|NCT00457639|11492970|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
7278015|NCT00457665|11492978|FG000|12 Months|Drug allergy|1
7278016|NCT00457665|11492979|FG001|12 Months|Drug allergy|1
7278017|NCT00457665|11492978|FG000|12 Months|High HIV viral load|5
7278018|NCT00457665|11492979|FG001|12 Months|High HIV viral load|1
7278019|NCT00457665|11492978|FG000|12 Months|Lipodystrophy|2
7278020|NCT00457665|11492979|FG001|12 Months|Lipodystrophy|0
7278021|NCT00457665|11492978|FG000|12 Months|Withdrawal by Subject|0
7278022|NCT00457665|11492979|FG001|12 Months|Withdrawal by Subject|2
7278023|NCT00457665|11492978|FG000|12 Months|Abnormal Liver function tests|0
7278024|NCT00457665|11492979|FG001|12 Months|Abnormal Liver function tests|5
7278025|NCT00457665|11492978|FG000|24 Months|Withdrawal by Subject|3
7278026|NCT00457665|11492979|FG001|24 Months|Withdrawal by Subject|2
7278027|NCT00457665|11492978|FG000|24 Months|Lipodystrophy|1
7278028|NCT00457665|11492979|FG001|24 Months|Lipodystrophy|1
7278029|NCT00457665|11492978|FG000|24 Months|Abnormal liver function tests|1
7278030|NCT00457665|11492979|FG001|24 Months|Abnormal liver function tests|5
7278031|NCT00457691|11492987|FG000|Overall Study|Adverse Event|4
7278032|NCT00457691|11492988|FG001|Overall Study|Adverse Event|1
7278033|NCT00457691|11492987|FG000|Overall Study|Death|163
7278034|NCT00457691|11492988|FG001|Overall Study|Death|148
7278035|NCT00457691|11492987|FG000|Overall Study|Protocol Violation|1
7278036|NCT00457691|11492988|FG001|Overall Study|Protocol Violation|3
7613036|NCT03505710|12021699|FG001|Overall Study|Adverse Event|5
7613037|NCT03505710|12021700|FG002|Overall Study|Adverse Event|27
7613038|NCT03505710|12021698|FG000|Overall Study|Withdrawal by Subject|1
7613039|NCT03505710|12021699|FG001|Overall Study|Withdrawal by Subject|3
7613040|NCT03505710|12021700|FG002|Overall Study|Withdrawal by Subject|3
7613041|NCT03505710|12021698|FG000|Overall Study|Physician Decision|1
7613042|NCT03505710|12021699|FG001|Overall Study|Physician Decision|0
7613043|NCT03505710|12021700|FG002|Overall Study|Physician Decision|2
7613044|NCT03505710|12021698|FG000|Overall Study|Death|4
7613045|NCT03505710|12021699|FG001|Overall Study|Death|3
7613046|NCT03505710|12021700|FG002|Overall Study|Death|6
7613047|NCT03505710|12021698|FG000|Overall Study|Other Reasons|1
7278037|NCT00457691|11492987|FG000|Overall Study|Lost to Follow-up|23
7278038|NCT00457691|11492988|FG001|Overall Study|Lost to Follow-up|14
7278039|NCT00457691|11492987|FG000|Overall Study|Study terminated by Sponsor|1
7278040|NCT00457691|11492988|FG001|Overall Study|Study terminated by Sponsor|1
7278041|NCT00457691|11492987|FG000|Overall Study|Subject refused (reason other than AE)|14
7278042|NCT00457691|11492988|FG001|Overall Study|Subject refused (reason other than AE)|19
7278043|NCT00457691|11492987|FG000|Overall Study|Disease progression, study terminated|180
7278044|NCT00457691|11492988|FG001|Overall Study|Disease progression, study terminated|196
7278045|NCT00457743|11493010|FG000|Overall Study|Adverse Event|0
7278046|NCT00457743|11493011|FG001|Overall Study|Adverse Event|4
7278047|NCT00457743|11493012|FG002|Overall Study|Adverse Event|0
7278048|NCT00457743|11493010|FG000|Overall Study|Lack of Efficacy|3
7278049|NCT00457743|11493011|FG001|Overall Study|Lack of Efficacy|23
7278050|NCT00457743|11493012|FG002|Overall Study|Lack of Efficacy|3
7278051|NCT00457821|11493033|FG000|Part 2|Withdrawal by Subject|0
7278052|NCT00457821|11493034|FG001|Part 2|Withdrawal by Subject|0
7278053|NCT00457821|11493035|FG002|Part 2|Withdrawal by Subject|0
7278054|NCT00457821|11493036|FG003|Part 2|Withdrawal by Subject|0
7278055|NCT00457821|11493037|FG004|Part 2|Withdrawal by Subject|0
7278056|NCT00457821|11493038|FG005|Part 2|Withdrawal by Subject|0
7613048|NCT03505710|12021699|FG001|Overall Study|Other Reasons|1
7613049|NCT03505710|12021700|FG002|Overall Study|Other Reasons|1
7613050|NCT03296553|12021710|FG000|Overall Study|Withdrawal by Subject|1
7613051|NCT03296553|12021711|FG001|Overall Study|Withdrawal by Subject|1
7613052|NCT03296553|12021710|FG000|Overall Study|Death|1
7613053|NCT03296553|12021711|FG001|Overall Study|Death|0
7613054|NCT03049449|12021725|FG000|Overall Study|Did not receive treatment.|0
7613055|NCT03049449|12021726|FG001|Overall Study|Did not receive treatment.|0
7613056|NCT03049449|12021727|FG002|Overall Study|Did not receive treatment.|0
7613057|NCT03049449|12021728|FG003|Overall Study|Did not receive treatment.|0
7613058|NCT03049449|12021729|FG004|Overall Study|Did not receive treatment.|0
7613059|NCT03049449|12021730|FG005|Overall Study|Did not receive treatment.|0
7613060|NCT03049449|12021731|FG006|Overall Study|Did not receive treatment.|0
7613061|NCT03049449|12021732|FG007|Overall Study|Did not receive treatment.|0
7613062|NCT03049449|12021733|FG008|Overall Study|Did not receive treatment.|1
7613063|NCT03049449|12021734|FG009|Overall Study|Did not receive treatment.|0
7613064|NCT03049449|12021725|FG000|Overall Study|Enrolled and removed from study with no treatment|0
7613065|NCT03049449|12021726|FG001|Overall Study|Enrolled and removed from study with no treatment|0
7613066|NCT03049449|12021727|FG002|Overall Study|Enrolled and removed from study with no treatment|1
7613067|NCT03049449|12021728|FG003|Overall Study|Enrolled and removed from study with no treatment|1
7613068|NCT03049449|12021729|FG004|Overall Study|Enrolled and removed from study with no treatment|0
7613069|NCT03049449|12021730|FG005|Overall Study|Enrolled and removed from study with no treatment|0
7613070|NCT03049449|12021731|FG006|Overall Study|Enrolled and removed from study with no treatment|0
7613071|NCT03049449|12021732|FG007|Overall Study|Enrolled and removed from study with no treatment|0
7613072|NCT03049449|12021733|FG008|Overall Study|Enrolled and removed from study with no treatment|0
7613073|NCT03049449|12021734|FG009|Overall Study|Enrolled and removed from study with no treatment|0
7613074|NCT03049449|12021725|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613075|NCT03049449|12021726|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613076|NCT03049449|12021727|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613077|NCT03049449|12021728|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613078|NCT03049449|12021729|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613079|NCT03049449|12021730|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613080|NCT03049449|12021731|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613081|NCT03049449|12021732|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
7613082|NCT03049449|12021733|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0
7613083|NCT03049449|12021734|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1
7613084|NCT03000569|12021754|FG000|Overall Study|Withdrawal by Subject|1
7613085|NCT03000569|12021755|FG001|Overall Study|Withdrawal by Subject|0
7278057|NCT00457821|11493039|FG006|Part 2|Withdrawal by Subject|0
7278058|NCT00457821|11493040|FG007|Part 2|Withdrawal by Subject|1
7278059|NCT00458211|11493066|FG000|Overall Study|Lack of Efficacy|12
7278060|NCT00458211|11493066|FG000|Overall Study|Withdrawal by Subject|2
7278061|NCT00458211|11493066|FG000|Overall Study|Protocol Violation|2
7278062|NCT00458302|11493090|FG000|Overall Study|Adverse Event|4
7278063|NCT00458302|11493091|FG001|Overall Study|Adverse Event|14
7278064|NCT00458302|11493090|FG000|Overall Study|Pregnancy|2
7278065|NCT00458302|11493091|FG001|Overall Study|Pregnancy|1
7278066|NCT00458302|11493090|FG000|Overall Study|Protocol Violation|0
7278067|NCT00458302|11493091|FG001|Overall Study|Protocol Violation|2
7278068|NCT00458302|11493090|FG000|Overall Study|Withdrawal by Subject|6
7278069|NCT00458302|11493091|FG001|Overall Study|Withdrawal by Subject|4
7278070|NCT00458302|11493090|FG000|Overall Study|Inc/Exc Criteria Not Met|1
7278071|NCT00458302|11493091|FG001|Overall Study|Inc/Exc Criteria Not Met|1
7278072|NCT00458302|11493090|FG000|Overall Study|Study Termination By Sponsor|1
7278073|NCT00458302|11493091|FG001|Overall Study|Study Termination By Sponsor|0
7278074|NCT00458302|11493090|FG000|Overall Study|Lost to Follow-up|2
7278075|NCT00458302|11493091|FG001|Overall Study|Lost to Follow-up|0
7278076|NCT00458302|11493090|FG000|Overall Study|Other|4
7278077|NCT00458302|11493091|FG001|Overall Study|Other|2
7278078|NCT00458341|11493100|FG000|Cycle 1|Adverse Event|1
7278079|NCT00458341|11493101|FG001|Cycle 1|Adverse Event|0
7613086|NCT03000530|12021772|FG000|Overall Study|Adverse Event|0
7613087|NCT03000530|12021773|FG001|Overall Study|Adverse Event|0
7613088|NCT03000530|12021774|FG002|Overall Study|Adverse Event|2
7613089|NCT03000530|12021772|FG000|Overall Study|Lost to Follow-up|0
7613090|NCT03000530|12021773|FG001|Overall Study|Lost to Follow-up|3
7613091|NCT03000530|12021774|FG002|Overall Study|Lost to Follow-up|1
7613092|NCT03000530|12021772|FG000|Overall Study|Withdrawal by Subject|0
7613093|NCT03000530|12021773|FG001|Overall Study|Withdrawal by Subject|2
7613094|NCT03000530|12021774|FG002|Overall Study|Withdrawal by Subject|1
7613095|NCT02978781|12021788|FG000|Part A|Adverse Event|1
7613096|NCT02978781|12021789|FG001|Part A|Adverse Event|1
7613097|NCT02978781|12021790|FG002|Part A|Adverse Event|0
7613098|NCT02978781|12021791|FG003|Part A|Adverse Event|0
7613099|NCT02978781|12021792|FG004|Part A|Adverse Event|0
7613100|NCT02978781|12021788|FG000|Part A|Withdrawal by Subject|0
7613101|NCT02978781|12021789|FG001|Part A|Withdrawal by Subject|1
7613102|NCT02978781|12021790|FG002|Part A|Withdrawal by Subject|0
7613103|NCT02978781|12021791|FG003|Part A|Withdrawal by Subject|0
7613104|NCT02978781|12021792|FG004|Part A|Withdrawal by Subject|0
7613105|NCT02978781|12021788|FG000|Part B|Withdrawal by Subject|0
7613106|NCT02978781|12021789|FG001|Part B|Withdrawal by Subject|0
7613107|NCT02978781|12021790|FG002|Part B|Withdrawal by Subject|0
7613108|NCT02978781|12021791|FG003|Part B|Withdrawal by Subject|1
7613109|NCT02978781|12021792|FG004|Part B|Withdrawal by Subject|0
7613110|NCT02978781|12021788|FG000|Part C|Adverse Event|0
7613111|NCT02978781|12021789|FG001|Part C|Adverse Event|0
7613112|NCT02978781|12021790|FG002|Part C|Adverse Event|0
7613113|NCT02978781|12021791|FG003|Part C|Adverse Event|0
7613114|NCT02978781|12021792|FG004|Part C|Adverse Event|2
7613115|NCT02978781|12021788|FG000|Part C|Withdrawal by Subject|0
7613116|NCT02978781|12021789|FG001|Part C|Withdrawal by Subject|0
7613117|NCT02978781|12021790|FG002|Part C|Withdrawal by Subject|0
7613118|NCT02978781|12021791|FG003|Part C|Withdrawal by Subject|0
7613119|NCT02978781|12021792|FG004|Part C|Withdrawal by Subject|1
7613120|NCT02978781|12021788|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
7613121|NCT02978781|12021789|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
7613122|NCT02978781|12021790|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
7613123|NCT02978781|12021791|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
7613124|NCT02978781|12021792|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
7613125|NCT02964507|12021826|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
7613126|NCT02964507|12021827|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
7613127|NCT02964507|12021828|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
7613128|NCT02964507|12021829|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
7613129|NCT02964507|12021830|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
7613130|NCT02964507|12021831|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
7613131|NCT02964507|12021832|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
7613132|NCT02964507|12021833|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
7613133|NCT02964507|12021826|FG000|Overall Study|Ongoing at the time of analysis|1
7613134|NCT02964507|12021827|FG001|Overall Study|Ongoing at the time of analysis|0
7613135|NCT02964507|12021828|FG002|Overall Study|Ongoing at the time of analysis|2
7613136|NCT02964507|12021829|FG003|Overall Study|Ongoing at the time of analysis|0
7613137|NCT02964507|12021830|FG004|Overall Study|Ongoing at the time of analysis|0
7613138|NCT02964507|12021831|FG005|Overall Study|Ongoing at the time of analysis|0
7613139|NCT02964507|12021832|FG006|Overall Study|Ongoing at the time of analysis|0
7613140|NCT02964507|12021833|FG007|Overall Study|Ongoing at the time of analysis|0
7613141|NCT02964507|12021826|FG000|Overall Study|Study terminated by Sponsor|9
7613142|NCT02964507|12021827|FG001|Overall Study|Study terminated by Sponsor|1
7613143|NCT02964507|12021828|FG002|Overall Study|Study terminated by Sponsor|9
7613144|NCT02964507|12021829|FG003|Overall Study|Study terminated by Sponsor|3
7613145|NCT02964507|12021830|FG004|Overall Study|Study terminated by Sponsor|3
7613146|NCT02964507|12021831|FG005|Overall Study|Study terminated by Sponsor|2
7613147|NCT02964507|12021832|FG006|Overall Study|Study terminated by Sponsor|0
7613148|NCT02964507|12021833|FG007|Overall Study|Study terminated by Sponsor|0
7613149|NCT02964507|12021826|FG000|Overall Study|Other|3
7613150|NCT02964507|12021827|FG001|Overall Study|Other|0
7613151|NCT02964507|12021828|FG002|Overall Study|Other|0
7613152|NCT02964507|12021829|FG003|Overall Study|Other|0
7613153|NCT02964507|12021830|FG004|Overall Study|Other|1
7613154|NCT02964507|12021831|FG005|Overall Study|Other|0
7613155|NCT02964507|12021832|FG006|Overall Study|Other|0
7613156|NCT02964507|12021833|FG007|Overall Study|Other|0
7613157|NCT02964507|12021826|FG000|Overall Study|Death|11
7613158|NCT02964507|12021827|FG001|Overall Study|Death|9
7613159|NCT02964507|12021828|FG002|Overall Study|Death|12
7613160|NCT02964507|12021829|FG003|Overall Study|Death|2
7613161|NCT02964507|12021830|FG004|Overall Study|Death|10
7613162|NCT02964507|12021831|FG005|Overall Study|Death|5
7613163|NCT02964507|12021832|FG006|Overall Study|Death|0
7613164|NCT02964507|12021833|FG007|Overall Study|Death|0
7613165|NCT02964507|12021826|FG000|Overall Study|Withdrawal by Subject|1
7613166|NCT02964507|12021827|FG001|Overall Study|Withdrawal by Subject|0
7613167|NCT02964507|12021828|FG002|Overall Study|Withdrawal by Subject|1
7613168|NCT02964507|12021829|FG003|Overall Study|Withdrawal by Subject|1
7613169|NCT02964507|12021830|FG004|Overall Study|Withdrawal by Subject|0
7613170|NCT02964507|12021831|FG005|Overall Study|Withdrawal by Subject|1
7613171|NCT02964507|12021832|FG006|Overall Study|Withdrawal by Subject|0
7613172|NCT02964507|12021833|FG007|Overall Study|Withdrawal by Subject|0
7613173|NCT02964507|12021826|FG000|Overall Study|Physician Decision|1
7613174|NCT02964507|12021827|FG001|Overall Study|Physician Decision|0
7278080|NCT00458393|11493109|FG000|Overall Study|Withdrawal by Subject|67
7613175|NCT02964507|12021828|FG002|Overall Study|Physician Decision|1
7613176|NCT02964507|12021829|FG003|Overall Study|Physician Decision|0
7613177|NCT02964507|12021830|FG004|Overall Study|Physician Decision|1
7613178|NCT02964507|12021831|FG005|Overall Study|Physician Decision|0
7613179|NCT02964507|12021832|FG006|Overall Study|Physician Decision|0
7613180|NCT02964507|12021833|FG007|Overall Study|Physician Decision|0
7613181|NCT02942277|12021863|FG000|Year 1|Withdrawal by Subject|0
7613182|NCT02942277|12021864|FG001|Year 1|Withdrawal by Subject|0
7613183|NCT02942277|12021865|FG002|Year 1|Withdrawal by Subject|0
7613184|NCT02942277|12021866|FG003|Year 1|Withdrawal by Subject|0
7613185|NCT02942277|12021867|FG004|Year 1|Withdrawal by Subject|1
7613186|NCT02942277|12021868|FG005|Year 1|Withdrawal by Subject|3
7613187|NCT02942277|12021869|FG006|Year 1|Withdrawal by Subject|0
7613188|NCT02942277|12021870|FG007|Year 1|Withdrawal by Subject|1
7613189|NCT02942277|12021871|FG008|Year 1|Withdrawal by Subject|0
7613190|NCT02942277|12021872|FG009|Year 1|Withdrawal by Subject|0
7613191|NCT02942277|12021873|FG010|Year 1|Withdrawal by Subject|3
7613192|NCT02942277|12021863|FG000|Year 1|Travel|0
7613193|NCT02942277|12021864|FG001|Year 1|Travel|1
7613194|NCT02942277|12021865|FG002|Year 1|Travel|0
7613195|NCT02942277|12021866|FG003|Year 1|Travel|0
7613196|NCT02942277|12021867|FG004|Year 1|Travel|4
7613197|NCT02942277|12021868|FG005|Year 1|Travel|5
7613198|NCT02942277|12021869|FG006|Year 1|Travel|0
7613199|NCT02942277|12021870|FG007|Year 1|Travel|0
7613200|NCT02942277|12021871|FG008|Year 1|Travel|0
7613201|NCT02942277|12021872|FG009|Year 1|Travel|0
7613202|NCT02942277|12021873|FG010|Year 1|Travel|8
7278081|NCT00458393|11493110|FG001|Overall Study|Withdrawal by Subject|80
7278082|NCT00458393|11493109|FG000|Overall Study|Physician Decision|31
7278083|NCT00458393|11493110|FG001|Overall Study|Physician Decision|22
7278084|NCT00458393|11493109|FG000|Overall Study|Relocated|77
7278085|NCT00458393|11493110|FG001|Overall Study|Relocated|81
7278086|NCT00458393|11493109|FG000|Overall Study|Lost to Follow-up|115
7278087|NCT00458393|11493110|FG001|Overall Study|Lost to Follow-up|92
7278088|NCT00458393|11493109|FG000|Overall Study|Sites marked other on the form.|19
7278089|NCT00458393|11493110|FG001|Overall Study|Sites marked other on the form.|20
7278090|NCT00458484|11493141|FG000|Overall Study|Not eligible b/c prior radiation history|0
7278091|NCT00458484|11493142|FG001|Overall Study|Not eligible b/c prior radiation history|0
7278092|NCT00458484|11493143|FG002|Overall Study|Not eligible b/c prior radiation history|0
7278093|NCT00458484|11493144|FG003|Overall Study|Not eligible b/c prior radiation history|0
7278094|NCT00458484|11493145|FG004|Overall Study|Not eligible b/c prior radiation history|0
7278095|NCT00458484|11493146|FG005|Overall Study|Not eligible b/c prior radiation history|1
7278096|NCT00458484|11493147|FG006|Overall Study|Not eligible b/c prior radiation history|0
7278097|NCT00458705|11493172|FG000|Overall Study|Adverse Event|4
7278098|NCT00458705|11493172|FG000|Overall Study|Not Treated|1
7278099|NCT00458783|11493178|FG000|Overall Study|Protocol Violation|1228
7278100|NCT00458783|11493179|FG001|Overall Study|Protocol Violation|1220
7278101|NCT00459043|11493202|FG000|Overall Study|Withdrawal by Subject|1
7278102|NCT00459043|11493203|FG001|Overall Study|Withdrawal by Subject|0
7278103|NCT00459056|11493211|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
7278104|NCT00459056|11493212|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
7278105|NCT00459108|11493218|FG000|Overall Study|Withdrawal by Subject|5
7278106|NCT00459108|11493218|FG000|Overall Study|Adverse Event|3
7278107|NCT00459108|11493218|FG000|Overall Study|Death|2
7278108|NCT00459108|11493218|FG000|Overall Study|Progression|1
7278109|NCT00459134|11493225|FG000|Overall Study|Physician Decision|1
7278110|NCT00459134|11493226|FG001|Overall Study|Physician Decision|1
7278111|NCT00459134|11493225|FG000|Overall Study|Withdrawal by Subject|8
7278112|NCT00459134|11493226|FG001|Overall Study|Withdrawal by Subject|7
7278113|NCT00459134|11493225|FG000|Overall Study|Lost to Follow-up|6
7278114|NCT00459134|11493226|FG001|Overall Study|Lost to Follow-up|7
7278115|NCT00459134|11493225|FG000|Overall Study|Surgery|1
7278116|NCT00459134|11493226|FG001|Overall Study|Surgery|2
7278117|NCT00459134|11493225|FG000|Overall Study|Toxicity|4
7278118|NCT00459134|11493226|FG001|Overall Study|Toxicity|5
7278119|NCT00459134|11493225|FG000|Overall Study|Progression|1
7278120|NCT00459134|11493226|FG001|Overall Study|Progression|0
7278121|NCT00459134|11493225|FG000|Overall Study|Multiple Reasons|2
7278122|NCT00459134|11493226|FG001|Overall Study|Multiple Reasons|3
7278123|NCT00459186|11493232|FG000|Single Agent RAD001|Withdrawal by Subject|1
7278124|NCT00459186|11493232|FG000|PET Imaging and Assessment|Adverse Event|3
7278125|NCT00459290|11493236|FG000|Overall Study|Adverse Event|3
7278126|NCT00459290|11493236|FG000|Overall Study|Ineligible|2
7278127|NCT00459316|11493259|FG000|Steps 1 & 2|Other eligibility failure|1
7278128|NCT00459316|11493260|FG001|Steps 1 & 2|Other eligibility failure|1
7278129|NCT00459316|11493261|FG002|Steps 1 & 2|Other eligibility failure|0
7278130|NCT00459316|11493259|FG000|Steps 1 & 2|Death|1
7278131|NCT00459316|11493260|FG001|Steps 1 & 2|Death|1
7278132|NCT00459316|11493261|FG002|Steps 1 & 2|Death|0
7278133|NCT00459316|11493259|FG000|Steps 1 & 2|Not able to get to clinic|7
7278134|NCT00459316|11493260|FG001|Steps 1 & 2|Not able to get to clinic|4
7278135|NCT00459316|11493261|FG002|Steps 1 & 2|Not able to get to clinic|0
7278136|NCT00459316|11493259|FG000|Steps 1 & 2|Withdrawal by Subject|6
7278137|NCT00459316|11493260|FG001|Steps 1 & 2|Withdrawal by Subject|1
7613203|NCT02942277|12021863|FG000|Year 1|Joined Army|0
7613204|NCT02942277|12021864|FG001|Year 1|Joined Army|1
7278138|NCT00459316|11493261|FG002|Steps 1 & 2|Withdrawal by Subject|0
7278139|NCT00459316|11493259|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
7278140|NCT00459316|11493260|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
7278141|NCT00459316|11493261|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
7278142|NCT00459316|11493259|FG000|Steps 1 & 2|Lost to Follow-up|5
7613205|NCT02942277|12021865|FG002|Year 1|Joined Army|0
7278143|NCT00459316|11493260|FG001|Steps 1 & 2|Lost to Follow-up|0
7278144|NCT00459316|11493261|FG002|Steps 1 & 2|Lost to Follow-up|2
7613206|NCT02942277|12021866|FG003|Year 1|Joined Army|0
7613207|NCT02942277|12021867|FG004|Year 1|Joined Army|0
7613208|NCT02942277|12021868|FG005|Year 1|Joined Army|0
7613209|NCT02942277|12021869|FG006|Year 1|Joined Army|0
7613210|NCT02942277|12021870|FG007|Year 1|Joined Army|0
7613211|NCT02942277|12021871|FG008|Year 1|Joined Army|0
7613212|NCT02942277|12021872|FG009|Year 1|Joined Army|0
7613213|NCT02942277|12021873|FG010|Year 1|Joined Army|0
7613214|NCT02942277|12021863|FG000|Year 1|Subject met withdrawal criteria|0
7613215|NCT02942277|12021864|FG001|Year 1|Subject met withdrawal criteria|0
7613216|NCT02942277|12021865|FG002|Year 1|Subject met withdrawal criteria|0
7613217|NCT02942277|12021866|FG003|Year 1|Subject met withdrawal criteria|1
7613218|NCT02942277|12021867|FG004|Year 1|Subject met withdrawal criteria|0
7613219|NCT02942277|12021868|FG005|Year 1|Subject met withdrawal criteria|0
7613220|NCT02942277|12021869|FG006|Year 1|Subject met withdrawal criteria|0
7613221|NCT02942277|12021870|FG007|Year 1|Subject met withdrawal criteria|0
7613222|NCT02942277|12021871|FG008|Year 1|Subject met withdrawal criteria|0
7613223|NCT02942277|12021872|FG009|Year 1|Subject met withdrawal criteria|0
7613224|NCT02942277|12021873|FG010|Year 1|Subject met withdrawal criteria|0
7613225|NCT02942277|12021863|FG000|Year 1|Lost to Follow-up|0
7613226|NCT02942277|12021864|FG001|Year 1|Lost to Follow-up|0
7613227|NCT02942277|12021865|FG002|Year 1|Lost to Follow-up|0
7613228|NCT02942277|12021866|FG003|Year 1|Lost to Follow-up|0
7613229|NCT02942277|12021867|FG004|Year 1|Lost to Follow-up|1
7613230|NCT02942277|12021868|FG005|Year 1|Lost to Follow-up|0
7613231|NCT02942277|12021869|FG006|Year 1|Lost to Follow-up|0
7613232|NCT02942277|12021870|FG007|Year 1|Lost to Follow-up|0
7613233|NCT02942277|12021871|FG008|Year 1|Lost to Follow-up|0
7613234|NCT02942277|12021872|FG009|Year 1|Lost to Follow-up|0
7613235|NCT02942277|12021873|FG010|Year 1|Lost to Follow-up|2
7613236|NCT02942277|12021863|FG000|Year 1|Protocol Violation|0
7613237|NCT02942277|12021864|FG001|Year 1|Protocol Violation|0
7613238|NCT02942277|12021865|FG002|Year 1|Protocol Violation|0
7613239|NCT02942277|12021866|FG003|Year 1|Protocol Violation|0
7278145|NCT00459316|11493259|FG000|Step 3|Withdrawal by Subject|3
7278146|NCT00459316|11493260|FG001|Step 3|Withdrawal by Subject|0
7278147|NCT00459316|11493261|FG002|Step 3|Withdrawal by Subject|1
7278148|NCT00459342|11493284|FG000|Overall Study|Not eligible|1
7278149|NCT00459355|11493290|FG000|Overall Study|Subject no longer met inc criteria|20
7278150|NCT00459355|11493291|FG001|Overall Study|Subject no longer met inc criteria|18
7278151|NCT00459537|11493316|FG000|Overall Study|Adverse Event|1
7278152|NCT00459537|11493317|FG001|Overall Study|Adverse Event|6
7613240|NCT02942277|12021867|FG004|Year 1|Protocol Violation|1
7613241|NCT02942277|12021868|FG005|Year 1|Protocol Violation|1
7613242|NCT02942277|12021869|FG006|Year 1|Protocol Violation|0
7613243|NCT02942277|12021870|FG007|Year 1|Protocol Violation|0
7613244|NCT02942277|12021871|FG008|Year 1|Protocol Violation|0
7613245|NCT02942277|12021872|FG009|Year 1|Protocol Violation|0
7613246|NCT02942277|12021873|FG010|Year 1|Protocol Violation|2
7613247|NCT02942277|12021863|FG000|Year 1|Pregnancy|0
7613248|NCT02942277|12021864|FG001|Year 1|Pregnancy|0
7613249|NCT02942277|12021865|FG002|Year 1|Pregnancy|0
7613250|NCT02942277|12021866|FG003|Year 1|Pregnancy|0
7613251|NCT02942277|12021867|FG004|Year 1|Pregnancy|0
7613252|NCT02942277|12021868|FG005|Year 1|Pregnancy|1
7613253|NCT02942277|12021869|FG006|Year 1|Pregnancy|0
7613254|NCT02942277|12021870|FG007|Year 1|Pregnancy|0
7613255|NCT02942277|12021871|FG008|Year 1|Pregnancy|0
7613256|NCT02942277|12021872|FG009|Year 1|Pregnancy|0
7613257|NCT02942277|12021873|FG010|Year 1|Pregnancy|0
7613258|NCT02942277|12021863|FG000|Year 2|Lost to Follow-up|0
7613259|NCT02942277|12021864|FG001|Year 2|Lost to Follow-up|0
7613260|NCT02942277|12021865|FG002|Year 2|Lost to Follow-up|0
7613261|NCT02942277|12021866|FG003|Year 2|Lost to Follow-up|0
7613262|NCT02942277|12021867|FG004|Year 2|Lost to Follow-up|2
7613263|NCT02942277|12021868|FG005|Year 2|Lost to Follow-up|1
7613264|NCT02942277|12021869|FG006|Year 2|Lost to Follow-up|0
7613265|NCT02942277|12021870|FG007|Year 2|Lost to Follow-up|0
7613266|NCT02942277|12021871|FG008|Year 2|Lost to Follow-up|0
7613267|NCT02942277|12021872|FG009|Year 2|Lost to Follow-up|0
7613268|NCT02942277|12021873|FG010|Year 2|Lost to Follow-up|0
7613269|NCT02942277|12021863|FG000|Year 2|Did not rescreen|0
7613270|NCT02942277|12021864|FG001|Year 2|Did not rescreen|0
7613271|NCT02942277|12021865|FG002|Year 2|Did not rescreen|1
7613272|NCT02942277|12021866|FG003|Year 2|Did not rescreen|1
7613273|NCT02942277|12021867|FG004|Year 2|Did not rescreen|9
7613274|NCT02942277|12021868|FG005|Year 2|Did not rescreen|6
7613275|NCT02942277|12021869|FG006|Year 2|Did not rescreen|0
7613276|NCT02942277|12021870|FG007|Year 2|Did not rescreen|1
7613277|NCT02942277|12021871|FG008|Year 2|Did not rescreen|0
7613278|NCT02942277|12021872|FG009|Year 2|Did not rescreen|0
7613279|NCT02942277|12021873|FG010|Year 2|Did not rescreen|21
7613280|NCT02942277|12021863|FG000|Year 2|Met withdrawal criteria|0
7613281|NCT02942277|12021864|FG001|Year 2|Met withdrawal criteria|0
7613282|NCT02942277|12021865|FG002|Year 2|Met withdrawal criteria|0
7613283|NCT02942277|12021866|FG003|Year 2|Met withdrawal criteria|0
7613284|NCT02942277|12021867|FG004|Year 2|Met withdrawal criteria|1
7613285|NCT02942277|12021868|FG005|Year 2|Met withdrawal criteria|2
7613286|NCT02942277|12021869|FG006|Year 2|Met withdrawal criteria|0
7613287|NCT02942277|12021870|FG007|Year 2|Met withdrawal criteria|0
7613288|NCT02942277|12021871|FG008|Year 2|Met withdrawal criteria|0
7613289|NCT02942277|12021872|FG009|Year 2|Met withdrawal criteria|0
7613290|NCT02942277|12021873|FG010|Year 2|Met withdrawal criteria|1
7613291|NCT02942277|12021863|FG000|Year 2|Travel|0
7613292|NCT02942277|12021864|FG001|Year 2|Travel|1
7613293|NCT02942277|12021865|FG002|Year 2|Travel|0
7613294|NCT02942277|12021866|FG003|Year 2|Travel|0
7613295|NCT02942277|12021867|FG004|Year 2|Travel|0
7613296|NCT02942277|12021868|FG005|Year 2|Travel|1
7613297|NCT02942277|12021869|FG006|Year 2|Travel|0
7613298|NCT02942277|12021870|FG007|Year 2|Travel|0
7613299|NCT02942277|12021871|FG008|Year 2|Travel|0
7613300|NCT02942277|12021872|FG009|Year 2|Travel|1
7613301|NCT02942277|12021873|FG010|Year 2|Travel|3
7613302|NCT02942277|12021863|FG000|Year 2|Non-compliant|0
7613303|NCT02942277|12021864|FG001|Year 2|Non-compliant|0
7613304|NCT02942277|12021865|FG002|Year 2|Non-compliant|0
7613305|NCT02942277|12021866|FG003|Year 2|Non-compliant|0
7613306|NCT02942277|12021867|FG004|Year 2|Non-compliant|1
7613307|NCT02942277|12021868|FG005|Year 2|Non-compliant|1
7613308|NCT02942277|12021869|FG006|Year 2|Non-compliant|0
7613309|NCT02942277|12021870|FG007|Year 2|Non-compliant|0
7613310|NCT02942277|12021871|FG008|Year 2|Non-compliant|0
7613311|NCT02942277|12021872|FG009|Year 2|Non-compliant|0
7613312|NCT02942277|12021873|FG010|Year 2|Non-compliant|0
7613313|NCT02942277|12021863|FG000|Year 2|Withdrawal by Subject|0
7613314|NCT02942277|12021864|FG001|Year 2|Withdrawal by Subject|0
7613315|NCT02942277|12021865|FG002|Year 2|Withdrawal by Subject|0
7613316|NCT02942277|12021866|FG003|Year 2|Withdrawal by Subject|0
7613317|NCT02942277|12021867|FG004|Year 2|Withdrawal by Subject|0
7613318|NCT02942277|12021868|FG005|Year 2|Withdrawal by Subject|0
7613319|NCT02942277|12021869|FG006|Year 2|Withdrawal by Subject|1
7613320|NCT02942277|12021870|FG007|Year 2|Withdrawal by Subject|0
7613321|NCT02942277|12021871|FG008|Year 2|Withdrawal by Subject|0
7613322|NCT02942277|12021872|FG009|Year 2|Withdrawal by Subject|0
7613323|NCT02942277|12021873|FG010|Year 2|Withdrawal by Subject|0
7613324|NCT02942017|12021902|FG000|Overall Study|Adverse Event|0
7613325|NCT02942017|12021903|FG001|Overall Study|Adverse Event|1
7613326|NCT02942017|12021902|FG000|Overall Study|Withdrawal by Subject|0
7613327|NCT02942017|12021903|FG001|Overall Study|Withdrawal by Subject|1
7613328|NCT02942017|12021902|FG000|Overall Study|Lost to Follow-up|1
7613329|NCT02942017|12021903|FG001|Overall Study|Lost to Follow-up|1
7613330|NCT02942017|12021902|FG000|Overall Study|Randomized but not dosed|1
7613331|NCT02942017|12021903|FG001|Overall Study|Randomized but not dosed|3
7613332|NCT02942004|12021912|FG000|Overall Study|Withdrawal by Subject|0
7613333|NCT02942004|12021913|FG001|Overall Study|Withdrawal by Subject|2
7613334|NCT02942004|12021914|FG002|Overall Study|Withdrawal by Subject|3
7613335|NCT02942004|12021912|FG000|Overall Study|Lost to Follow-up|1
7613336|NCT02942004|12021913|FG001|Overall Study|Lost to Follow-up|1
7613337|NCT02942004|12021914|FG002|Overall Study|Lost to Follow-up|2
7613338|NCT02942004|12021912|FG000|Overall Study|Randomized but not dosed|3
7613339|NCT02942004|12021913|FG001|Overall Study|Randomized but not dosed|9
7613340|NCT02942004|12021914|FG002|Overall Study|Randomized but not dosed|4
7613341|NCT02861014|12021922|FG000|Primary Analysis|Adverse Event|7
7613342|NCT02861014|12021922|FG000|Primary Analysis|Death|1
7613343|NCT02861014|12021922|FG000|Primary Analysis|Lack of Efficacy|3
7613344|NCT02861014|12021922|FG000|Primary Analysis|Physician Decision|2
7613345|NCT02861014|12021922|FG000|Primary Analysis|Pregnancy|4
7613346|NCT02861014|12021922|FG000|Primary Analysis|Protocol Violation|2
7613347|NCT02861014|12021922|FG000|Primary Analysis|Study Terminated By Sponsor|3
7613348|NCT02861014|12021922|FG000|Primary Analysis|Withdrawal by Subject|14
7613349|NCT02861014|12021922|FG000|Primary Analysis|Commercial ocrelizumab|3
7613350|NCT02861014|12021922|FG000|Safety Follow-up|Adverse Event|1
7613351|NCT02861014|12021922|FG000|Safety Follow-up|Pregnancy|1
7613352|NCT02861014|12021922|FG000|Safety Follow-up|Withdrawal by Subject|9
7613353|NCT02861014|12021922|FG000|Safety Follow-up|Study terminated by sponsor|1
7613354|NCT02861014|12021922|FG000|Safety Follow-up|Physician Decision|1
7613355|NCT02861014|12021922|FG000|Safety Follow-up|Roll-over to a long term extension study|1
7613356|NCT02861014|12021922|FG000|Safety Follow-up|Commercial ocrelizumab|36
7613373|NCT02726880|12021946|FG000|Overall Study|Withdrawal by Subject|2
7613374|NCT02726880|12021947|FG001|Overall Study|Withdrawal by Subject|0
7613375|NCT02726880|12021946|FG000|Overall Study|Lost to Follow-up|1
7613376|NCT02726880|12021947|FG001|Overall Study|Lost to Follow-up|3
7613377|NCT02592551|12021969|FG000|Overall Study|Not evaluable|1
7613378|NCT02592551|12021970|FG001|Overall Study|Not evaluable|3
7613379|NCT02592551|12021971|FG002|Overall Study|Not evaluable|0
7613380|NCT02583048|12021983|FG000|Overall Study|Withdrawal by Subject|0
7613381|NCT02583048|12021984|FG001|Overall Study|Withdrawal by Subject|1
7613382|NCT02583048|12021985|FG002|Overall Study|Withdrawal by Subject|0
7613383|NCT02583048|12021983|FG000|Overall Study|Failed to meet eligibility criterion|0
7613384|NCT02583048|12021984|FG001|Overall Study|Failed to meet eligibility criterion|0
7613385|NCT02583048|12021985|FG002|Overall Study|Failed to meet eligibility criterion|1
7278153|NCT00459537|11493316|FG000|Overall Study|Lack of Efficacy|10
7278154|NCT00459537|11493317|FG001|Overall Study|Lack of Efficacy|11
7278155|NCT00459537|11493316|FG000|Overall Study|Withdrawal by Subject|20
7278156|NCT00459537|11493317|FG001|Overall Study|Withdrawal by Subject|26
7278157|NCT00459537|11493316|FG000|Overall Study|Lost to Follow-up|27
7278158|NCT00459537|11493317|FG001|Overall Study|Lost to Follow-up|30
7613414|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Adverse Event|3
7613415|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Adverse Event|3
7613416|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Adverse Event|2
7613417|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Adverse Event|1
7613418|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
7613419|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
7613420|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
7613421|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
7613422|NCT02539160|12022007|FG000|Phase 1 Pre-crossover|Protocol Violation|0
7613423|NCT02539160|12022008|FG001|Phase 1 Pre-crossover|Protocol Violation|0
7613424|NCT02539160|12022009|FG002|Phase 1 Pre-crossover|Protocol Violation|0
7613425|NCT02539160|12022010|FG003|Phase 1 Pre-crossover|Protocol Violation|2
7613426|NCT02507973|12022020|FG000|Overall Study|Adverse Event|1
7613427|NCT02477618|12022028|FG000|Overall Study|Completed Visits but Discontinued Drug|2
7613428|NCT02477618|12022029|FG001|Overall Study|Completed Visits but Discontinued Drug|1
7613429|NCT02477618|12022028|FG000|Overall Study|Died in Double-Blind Treatment Period|11
7278159|NCT00459537|11493316|FG000|Overall Study|Administrative problems|3
7278160|NCT00459537|11493317|FG001|Overall Study|Administrative problems|0
7278161|NCT00459537|11493316|FG000|Overall Study|Protocol Violation|4
7278162|NCT00459537|11493317|FG001|Overall Study|Protocol Violation|3
7278163|NCT00459537|11493316|FG000|Overall Study|Missing|1
7278164|NCT00459537|11493317|FG001|Overall Study|Missing|0
7278165|NCT00459667|11493326|FG000|Overall Study|Adverse Event|9
7278166|NCT00459667|11493327|FG001|Overall Study|Adverse Event|12
7278167|NCT00459667|11493328|FG002|Overall Study|Adverse Event|8
7278168|NCT00459667|11493326|FG000|Overall Study|Lost to Follow-up|5
7278169|NCT00459667|11493327|FG001|Overall Study|Lost to Follow-up|9
7278170|NCT00459667|11493328|FG002|Overall Study|Lost to Follow-up|3
7278171|NCT00459667|11493326|FG000|Overall Study|Pregnancy|1
7278172|NCT00459667|11493327|FG001|Overall Study|Pregnancy|1
7278173|NCT00459667|11493328|FG002|Overall Study|Pregnancy|1
7613430|NCT02477618|12022029|FG001|Overall Study|Died in Double-Blind Treatment Period|11
7613431|NCT02477618|12022028|FG000|Overall Study|Adverse Event|1
7613432|NCT02477618|12022029|FG001|Overall Study|Adverse Event|1
7613433|NCT02477618|12022028|FG000|Overall Study|Transferred Away from Study Site|1
7613434|NCT02477618|12022029|FG001|Overall Study|Transferred Away from Study Site|0
7613435|NCT02477618|12022028|FG000|Overall Study|Left Study Site for Rehabilitation|0
7613436|NCT02477618|12022029|FG001|Overall Study|Left Study Site for Rehabilitation|1
7613437|NCT02003924|12022061|FG000|Double-blind Phase|Lost to Follow-up|2
7613438|NCT02003924|12022062|FG001|Double-blind Phase|Lost to Follow-up|1
7613439|NCT02003924|12022063|FG002|Double-blind Phase|Lost to Follow-up|0
7613440|NCT02003924|12022061|FG000|Double-blind Phase|Protocol Violation|1
7613441|NCT02003924|12022062|FG001|Double-blind Phase|Protocol Violation|2
7613442|NCT02003924|12022063|FG002|Double-blind Phase|Protocol Violation|0
7613443|NCT02003924|12022061|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
7613444|NCT02003924|12022062|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
7613445|NCT02003924|12022063|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
7613446|NCT02003924|12022061|FG000|Double-blind Phase|Disease Progression|229
7613447|NCT02003924|12022062|FG001|Double-blind Phase|Disease Progression|247
7613448|NCT02003924|12022063|FG002|Double-blind Phase|Disease Progression|0
7613449|NCT02003924|12022061|FG000|Double-blind Phase|Adverse Event|120
7613450|NCT02003924|12022062|FG001|Double-blind Phase|Adverse Event|31
7613451|NCT02003924|12022063|FG002|Double-blind Phase|Adverse Event|0
7613452|NCT02003924|12022061|FG000|Double-blind Phase|Randomized But not Treated|3
7613453|NCT02003924|12022062|FG001|Double-blind Phase|Randomized But not Treated|3
7613454|NCT02003924|12022063|FG002|Double-blind Phase|Randomized But not Treated|0
7613455|NCT02003924|12022061|FG000|Double-blind Phase|Other|29
7613456|NCT02003924|12022062|FG001|Double-blind Phase|Other|50
7613457|NCT02003924|12022063|FG002|Double-blind Phase|Other|0
7613458|NCT02003924|12022061|FG000|Open-label Phase|Lost to Follow-up|0
7613459|NCT02003924|12022062|FG001|Open-label Phase|Lost to Follow-up|0
7613460|NCT02003924|12022063|FG002|Open-label Phase|Lost to Follow-up|1
7613461|NCT02003924|12022061|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
7613462|NCT02003924|12022062|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
7613463|NCT02003924|12022063|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
7613464|NCT02003924|12022061|FG000|Open-label Phase|Disease Progression|59
7613465|NCT02003924|12022062|FG001|Open-label Phase|Disease Progression|0
7613466|NCT02003924|12022063|FG002|Open-label Phase|Disease Progression|5
7613467|NCT02003924|12022061|FG000|Open-label Phase|Adverse Event|25
7613468|NCT02003924|12022062|FG001|Open-label Phase|Adverse Event|0
7613469|NCT02003924|12022063|FG002|Open-label Phase|Adverse Event|10
7613470|NCT02003924|12022061|FG000|Open-label Phase|Other|7
7613471|NCT02003924|12022062|FG001|Open-label Phase|Other|0
7613472|NCT02003924|12022063|FG002|Open-label Phase|Other|0
7613473|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Death|288
7613474|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Death|174
7613475|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Death|4
7613476|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
7613477|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
7613478|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
7613479|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
7613480|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
7613481|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
7613482|NCT02003924|12022061|FG000|Long-term Follow-up Phase|Other|5
7613483|NCT02003924|12022062|FG001|Long-term Follow-up Phase|Other|2
7613484|NCT02003924|12022063|FG002|Long-term Follow-up Phase|Other|1
7613485|NCT01971970|12022072|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
7613486|NCT01971970|12022073|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
7613487|NCT01971970|12022072|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
7613488|NCT01971970|12022073|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
7613489|NCT01971970|12022072|FG000|Week 14 Until Week 22|Lost to Follow-up|0
7613490|NCT01971970|12022073|FG001|Week 14 Until Week 22|Lost to Follow-up|1
7613491|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
7613492|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
7278174|NCT00459667|11493326|FG000|Overall Study|Protocol Violation|1
7278175|NCT00459667|11493327|FG001|Overall Study|Protocol Violation|0
7278176|NCT00459667|11493328|FG002|Overall Study|Protocol Violation|0
7278177|NCT00459667|11493326|FG000|Overall Study|Withdrawal by Subject|3
7278178|NCT00459667|11493327|FG001|Overall Study|Withdrawal by Subject|5
7278179|NCT00459667|11493328|FG002|Overall Study|Withdrawal by Subject|5
7278180|NCT00459667|11493326|FG000|Overall Study|Other disease modifying treatment|1
7278181|NCT00459667|11493327|FG001|Overall Study|Other disease modifying treatment|2
7278182|NCT00459667|11493328|FG002|Overall Study|Other disease modifying treatment|1
7278183|NCT00459667|11493326|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
7278184|NCT00459667|11493327|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
7278185|NCT00459667|11493328|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
7278186|NCT00459667|11493326|FG000|Overall Study|No treatment administered|6
7278187|NCT00459667|11493327|FG001|Overall Study|No treatment administered|3
7278188|NCT00459667|11493328|FG002|Overall Study|No treatment administered|1
7278189|NCT00459706|11493338|FG000|Overall Study|Adverse Event|19
7278190|NCT00459706|11493339|FG001|Overall Study|Adverse Event|13
7278191|NCT00459706|11493338|FG000|Overall Study|Withdrawal by Subject|1
7278192|NCT00459706|11493339|FG001|Overall Study|Withdrawal by Subject|6
7278193|NCT00459706|11493338|FG000|Overall Study|Physician Decision|2
7278194|NCT00459706|11493339|FG001|Overall Study|Physician Decision|0
7278195|NCT00459706|11493338|FG000|Overall Study|Discontinuation of Study by Sponsor|1
7278196|NCT00459706|11493339|FG001|Overall Study|Discontinuation of Study by Sponsor|0
7278197|NCT00459706|11493338|FG000|Overall Study|Protocol Violation|2
7278198|NCT00459706|11493339|FG001|Overall Study|Protocol Violation|1
7278199|NCT00459706|11493338|FG000|Overall Study|Failed to Return|1
7278200|NCT00459706|11493339|FG001|Overall Study|Failed to Return|0
7278201|NCT00459706|11493338|FG000|Overall Study|Other|0
7278202|NCT00459706|11493339|FG001|Overall Study|Other|1
7278203|NCT00459875|11493362|FG000|Overall Study|Ineligible participant|1
7278204|NCT00459875|11493362|FG000|Overall Study|Adverse Event|2
7278205|NCT00459953|11493368|FG000|Overall Study|not analyzed-household member in study|1
7278206|NCT00459953|11493369|FG001|Overall Study|not analyzed-household member in study|1
7278207|NCT00459979|11493375|FG000|Overall Study|Withdrawal by Subject|1
7278208|NCT00459979|11493375|FG000|Overall Study|Protocol Violation|1
7278209|NCT00460031|11493379|FG000|Overall Study|Adverse Event|5
7278210|NCT00460031|11493379|FG000|Overall Study|Withdrawal by Subject|5
7613493|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
7613494|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
7613495|NCT01971970|12022072|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
7613496|NCT01971970|12022073|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
7613497|NCT01971970|12022072|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
7613498|NCT01971970|12022073|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
7613499|NCT01969409|12022086|FG000|Overall Study|Death|2
7613500|NCT01969409|12022087|FG001|Overall Study|Death|2
7613501|NCT01969409|12022086|FG000|Overall Study|Transplant|1
7613502|NCT01969409|12022087|FG001|Overall Study|Transplant|1
7613503|NCT01969409|12022086|FG000|Overall Study|Withdrawal by Subject|0
7613504|NCT01969409|12022087|FG001|Overall Study|Withdrawal by Subject|1
7613505|NCT01459497|12022095|FG000|Overall Study|Inability to meet trial constraints.|1
7613506|NCT01459497|12022096|FG001|Overall Study|Inability to meet trial constraints.|0
7613507|NCT01459497|12022095|FG000|Overall Study|Physician Decision|1
7613508|NCT01459497|12022096|FG001|Overall Study|Physician Decision|1
7613509|NCT01459497|12022095|FG000|Overall Study|Hospitalization.|0
7613510|NCT01459497|12022096|FG001|Overall Study|Hospitalization.|3
7613511|NCT01459497|12022095|FG000|Overall Study|Disease progression.|0
7613512|NCT01459497|12022096|FG001|Overall Study|Disease progression.|1
7613513|NCT01307787|12022104|FG000|Overall Study|Withdrawal by Subject|2
7613514|NCT01307787|12022105|FG001|Overall Study|Withdrawal by Subject|0
7613515|NCT01250912|12022116|FG000|Overall Study|Lost to Follow-up|1
7613516|NCT01141712|12022132|FG000|Overall Study|Disease progression|3
7613517|NCT00659646|12022149|FG000|Overall Study|Protocol Violation|12
7613518|NCT00659646|12022150|FG001|Overall Study|Protocol Violation|8
7613519|NCT00659646|12022149|FG000|Overall Study|Adverse Event|1
7613520|NCT00659646|12022150|FG001|Overall Study|Adverse Event|0
7613521|NCT00659646|12022149|FG000|Overall Study|Lost to Follow-up|1
7613522|NCT00659646|12022150|FG001|Overall Study|Lost to Follow-up|0
7613523|NCT00659646|12022149|FG000|Overall Study|protocol noncompliance after randomized|1
7613524|NCT00659646|12022150|FG001|Overall Study|protocol noncompliance after randomized|0
7613525|NCT00477412|12022162|FG000|Overall Study|Death|0
7613526|NCT00477412|12022163|FG001|Overall Study|Death|0
7613527|NCT00477412|12022164|FG002|Overall Study|Death|0
7613528|NCT00477412|12022165|FG003|Overall Study|Death|4
7613529|NCT00477412|12022162|FG000|Overall Study|Lost to Follow-up|0
7613530|NCT00477412|12022163|FG001|Overall Study|Lost to Follow-up|0
7613531|NCT00477412|12022164|FG002|Overall Study|Lost to Follow-up|0
7613532|NCT00477412|12022165|FG003|Overall Study|Lost to Follow-up|1
7613533|NCT00477412|12022162|FG000|Overall Study|Withdrawal by Subject|0
7613534|NCT00477412|12022163|FG001|Overall Study|Withdrawal by Subject|0
7613535|NCT00477412|12022164|FG002|Overall Study|Withdrawal by Subject|0
7613536|NCT00477412|12022165|FG003|Overall Study|Withdrawal by Subject|2
7613537|NCT00477412|12022162|FG000|Overall Study|Second Malignancy|0
7613538|NCT00477412|12022163|FG001|Overall Study|Second Malignancy|0
7613539|NCT00477412|12022164|FG002|Overall Study|Second Malignancy|0
7613540|NCT00477412|12022165|FG003|Overall Study|Second Malignancy|1
7613541|NCT00477412|12022162|FG000|Overall Study|Adverse Event|1
7613542|NCT00477412|12022163|FG001|Overall Study|Adverse Event|0
7613543|NCT00477412|12022164|FG002|Overall Study|Adverse Event|1
7613544|NCT00477412|12022165|FG003|Overall Study|Adverse Event|0
7613545|NCT00369317|12022173|FG000|Overall Study|Adverse Event|3
7613546|NCT00369317|12022173|FG000|Overall Study|Death|1
7613547|NCT00369317|12022173|FG000|Overall Study|Lack of Efficacy|5
7613548|NCT00369317|12022173|FG000|Overall Study|Physician Decision|2
7613549|NCT00369317|12022173|FG000|Overall Study|Withdrawal by Subject|8
7613550|NCT00369317|12022173|FG000|Overall Study|Ineligible|1
7613551|NCT00261807|12022178|FG000|Overall Study|Lost to Follow-up|2
7613552|NCT00261807|12022178|FG000|Overall Study|Adverse Event|2
7613553|NCT00261807|12022178|FG000|Overall Study|Death|1
7613554|NCT00261807|12022178|FG000|Overall Study|Protocol Violation|2
7613555|NCT04620798|12022201|FG000|Overall Study|Lost to Follow-up|126
7613556|NCT04620798|12022202|FG001|Overall Study|Lost to Follow-up|138
7613557|NCT04256629|12022227|FG000|Overall Study|Adverse Event|0
7613558|NCT04256629|12022228|FG001|Overall Study|Adverse Event|0
7613559|NCT04256629|12022229|FG002|Overall Study|Adverse Event|0
7613560|NCT04256629|12022230|FG003|Overall Study|Adverse Event|0
7613561|NCT04256629|12022231|FG004|Overall Study|Adverse Event|0
7613562|NCT04256629|12022232|FG005|Overall Study|Adverse Event|1
7613563|NCT04256629|12022227|FG000|Overall Study|Protocol Violation|0
7613564|NCT04256629|12022228|FG001|Overall Study|Protocol Violation|1
7613565|NCT04256629|12022229|FG002|Overall Study|Protocol Violation|0
7613566|NCT04256629|12022230|FG003|Overall Study|Protocol Violation|0
7613567|NCT04256629|12022231|FG004|Overall Study|Protocol Violation|0
7613568|NCT04256629|12022232|FG005|Overall Study|Protocol Violation|0
7613576|NCT03284853|12022250|FG000|Overall Study|Adverse Event|40
7613577|NCT03284853|12022251|FG001|Overall Study|Adverse Event|4
7613578|NCT03284853|12022250|FG000|Overall Study|Withdrawal by Subject|5
7613579|NCT03284853|12022251|FG001|Overall Study|Withdrawal by Subject|1
7613580|NCT03284853|12022250|FG000|Overall Study|Lost to Follow-up|1
7613581|NCT03284853|12022251|FG001|Overall Study|Lost to Follow-up|0
7278211|NCT00460031|11493379|FG000|Overall Study|Death|1
7613582|NCT03284853|12022250|FG000|Overall Study|Lack of Efficacy|1
7613583|NCT03284853|12022251|FG001|Overall Study|Lack of Efficacy|0
7613584|NCT03284853|12022250|FG000|Overall Study|Disallowed Concurrent Medication|1
7613585|NCT03284853|12022251|FG001|Overall Study|Disallowed Concurrent Medication|1
7613586|NCT03284853|12022250|FG000|Overall Study|Protocol Violation|3
7613587|NCT03284853|12022251|FG001|Overall Study|Protocol Violation|3
7613588|NCT03284853|12022250|FG000|Overall Study|Death|0
7613589|NCT03284853|12022251|FG001|Overall Study|Death|1
7613590|NCT03284853|12022250|FG000|Overall Study|Other - Reason not reported in CSR|4
7613591|NCT03284853|12022251|FG001|Overall Study|Other - Reason not reported in CSR|3
7613592|NCT02774889|12022274|FG000|Overall Study|Lost to Follow-up|2
7613593|NCT02774889|12022275|FG001|Overall Study|Lost to Follow-up|1
7613594|NCT02297438|12022295|FG000|Overall Study|Death|79
7613595|NCT02297438|12022296|FG001|Overall Study|Death|86
7613596|NCT02297438|12022295|FG000|Overall Study|Lost to Follow-up|9
7613597|NCT02297438|12022296|FG001|Overall Study|Lost to Follow-up|7
7613598|NCT02297438|12022295|FG000|Overall Study|Withdrawal by Subject|7
7613599|NCT02297438|12022296|FG001|Overall Study|Withdrawal by Subject|0
7613600|NCT02297438|12022295|FG000|Overall Study|Other|9
7613601|NCT02297438|12022296|FG001|Overall Study|Other|5
7613602|NCT02297438|12022295|FG000|Overall Study|Ongoing|65
7613603|NCT02297438|12022296|FG001|Overall Study|Ongoing|73
7613604|NCT02297412|12022304|FG000|Overall Study|Canceled|1
7613605|NCT02297412|12022305|FG001|Overall Study|Canceled|1
7613606|NCT02250326|12022323|FG000|Treatment Period|Death|1
7613607|NCT02250326|12022324|FG001|Treatment Period|Death|12
7613608|NCT02250326|12022325|FG002|Treatment Period|Death|2
7613609|NCT02250326|12022323|FG000|Treatment Period|Adverse Event|8
7613610|NCT02250326|12022324|FG001|Treatment Period|Adverse Event|4
7613611|NCT02250326|12022325|FG002|Treatment Period|Adverse Event|8
7613612|NCT02250326|12022323|FG000|Treatment Period|Progressive Disease|42
7613613|NCT02250326|12022324|FG001|Treatment Period|Progressive Disease|36
7613614|NCT02250326|12022325|FG002|Treatment Period|Progressive Disease|45
7613615|NCT02250326|12022323|FG000|Treatment Period|Symptomatic Deterioration|9
7613616|NCT02250326|12022324|FG001|Treatment Period|Symptomatic Deterioration|4
7613617|NCT02250326|12022325|FG002|Treatment Period|Symptomatic Deterioration|10
7613618|NCT02250326|12022323|FG000|Treatment Period|Withdrawal by Subject|11
7613619|NCT02250326|12022324|FG001|Treatment Period|Withdrawal by Subject|5
7613620|NCT02250326|12022325|FG002|Treatment Period|Withdrawal by Subject|4
7613621|NCT02250326|12022323|FG000|Treatment Period|Miscellaneous|8
7613622|NCT02250326|12022324|FG001|Treatment Period|Miscellaneous|2
7613623|NCT02250326|12022325|FG002|Treatment Period|Miscellaneous|7
7613624|NCT02250326|12022323|FG000|Treatment Period|Randomized or assigned; not treated|2
7613625|NCT02250326|12022324|FG001|Treatment Period|Randomized or assigned; not treated|1
7613626|NCT02250326|12022325|FG002|Treatment Period|Randomized or assigned; not treated|1
7613627|NCT02250326|12022323|FG000|Follow-Up Period|Death|46
7613628|NCT02250326|12022324|FG001|Follow-Up Period|Death|26
7613629|NCT02250326|12022325|FG002|Follow-Up Period|Death|32
7613630|NCT02250326|12022323|FG000|Follow-Up Period|Unknown or Missing|2
7613631|NCT02250326|12022324|FG001|Follow-Up Period|Unknown or Missing|3
7613632|NCT02250326|12022325|FG002|Follow-Up Period|Unknown or Missing|3
7613633|NCT02250326|12022323|FG000|Follow-Up Period|Lost to Follow-up|1
7278212|NCT00460109|11493383|FG000|Overall Study|Death|1
7613634|NCT02250326|12022324|FG001|Follow-Up Period|Lost to Follow-up|1
7613635|NCT02250326|12022325|FG002|Follow-Up Period|Lost to Follow-up|3
7613636|NCT01503515|12022347|FG000|Overall Study|Adverse Event|4
7613637|NCT01503515|12022348|FG001|Overall Study|Adverse Event|5
7613638|NCT01503515|12022347|FG000|Overall Study|Death|0
7613639|NCT01503515|12022348|FG001|Overall Study|Death|1
7613640|NCT01503515|12022347|FG000|Overall Study|Physician Decision|14
7613641|NCT01503515|12022348|FG001|Overall Study|Physician Decision|23
7613642|NCT01503515|12022347|FG000|Overall Study|Withdrawal by Subject|0
7613643|NCT01503515|12022348|FG001|Overall Study|Withdrawal by Subject|1
7613644|NCT01503515|12022347|FG000|Overall Study|Institutional dx of proven/probable IFI|2
7613645|NCT01503515|12022348|FG001|Overall Study|Institutional dx of proven/probable IFI|4
7613646|NCT01503515|12022347|FG000|Overall Study|Ineligible|1
7613647|NCT01503515|12022348|FG001|Overall Study|Ineligible|1
7613648|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
7613649|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
7613650|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
7613651|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
7613652|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
7613653|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
7613654|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
7613655|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
7613656|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
7613657|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
7613658|NCT00245960|12022381|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
7613659|NCT00245960|12022382|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
7613660|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
7613661|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
7613662|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
7278213|NCT00460239|11493387|FG000|Overall Study|Physician Decision|0
7278214|NCT00460239|11493388|FG001|Overall Study|Physician Decision|1
7613663|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
7613664|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
7613665|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
7613666|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
7613667|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
7613668|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
7613669|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
7613670|NCT00245960|12022381|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
7613671|NCT00245960|12022382|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
7278215|NCT00460239|11493389|FG002|Overall Study|Physician Decision|0
7278216|NCT00460239|11493390|FG003|Overall Study|Physician Decision|0
7278217|NCT00460239|11493391|FG004|Overall Study|Physician Decision|0
7278218|NCT00460239|11493392|FG005|Overall Study|Physician Decision|2
7278219|NCT00460239|11493393|FG006|Overall Study|Physician Decision|0
7278220|NCT00460239|11493394|FG007|Overall Study|Physician Decision|0
7278221|NCT00460239|11493395|FG008|Overall Study|Physician Decision|0
7278222|NCT00460239|11493387|FG000|Overall Study|Withdrawal by Subject|0
7278223|NCT00460239|11493388|FG001|Overall Study|Withdrawal by Subject|0
7278224|NCT00460239|11493389|FG002|Overall Study|Withdrawal by Subject|0
7278225|NCT00460239|11493390|FG003|Overall Study|Withdrawal by Subject|0
7278226|NCT00460239|11493391|FG004|Overall Study|Withdrawal by Subject|0
7278227|NCT00460239|11493392|FG005|Overall Study|Withdrawal by Subject|1
7278228|NCT00460239|11493393|FG006|Overall Study|Withdrawal by Subject|0
7278229|NCT00460239|11493394|FG007|Overall Study|Withdrawal by Subject|0
7278230|NCT00460239|11493395|FG008|Overall Study|Withdrawal by Subject|0
7278231|NCT00460265|11493410|FG000|Overall Study|Lost to Follow-up|14
7613672|NCT04015336|12022469|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
7613681|NCT03913091|12022560|FG000|Overall Study|Lost to Follow-up|18
7613682|NCT03913091|12022561|FG001|Overall Study|Lost to Follow-up|11
7613683|NCT03913091|12022560|FG000|Overall Study|Required additional meds/surgery|1
7613684|NCT03913091|12022561|FG001|Overall Study|Required additional meds/surgery|2
7613685|NCT03913091|12022560|FG000|Overall Study|Chronic pain/history of substance abuse|1
7613686|NCT03913091|12022561|FG001|Overall Study|Chronic pain/history of substance abuse|1
7613687|NCT03802565|12022572|FG000|Overall Study|Adverse Event|0
7613688|NCT03802565|12022573|FG001|Overall Study|Adverse Event|1
7613689|NCT03802565|12022574|FG002|Overall Study|Adverse Event|2
7613690|NCT03802565|12022575|FG003|Overall Study|Adverse Event|1
7613691|NCT03802565|12022576|FG004|Overall Study|Adverse Event|1
7613692|NCT03802565|12022572|FG000|Overall Study|Withdrawal by Subject|2
7613693|NCT03802565|12022573|FG001|Overall Study|Withdrawal by Subject|2
7613694|NCT03802565|12022574|FG002|Overall Study|Withdrawal by Subject|2
7613695|NCT03802565|12022575|FG003|Overall Study|Withdrawal by Subject|0
7613696|NCT03802565|12022576|FG004|Overall Study|Withdrawal by Subject|1
7613697|NCT03802565|12022572|FG000|Overall Study|Protocol Violation|2
7613698|NCT03802565|12022573|FG001|Overall Study|Protocol Violation|1
7613699|NCT03802565|12022574|FG002|Overall Study|Protocol Violation|4
7613700|NCT03802565|12022575|FG003|Overall Study|Protocol Violation|5
7613701|NCT03802565|12022576|FG004|Overall Study|Protocol Violation|1
7613702|NCT03802565|12022572|FG000|Overall Study|Lost to Follow-up|0
7613703|NCT03802565|12022573|FG001|Overall Study|Lost to Follow-up|0
7613704|NCT03802565|12022574|FG002|Overall Study|Lost to Follow-up|1
7613705|NCT03802565|12022575|FG003|Overall Study|Lost to Follow-up|0
7613706|NCT03802565|12022576|FG004|Overall Study|Lost to Follow-up|0
7613707|NCT03802565|12022572|FG000|Overall Study|Subjects Related to Each Other|1
7613708|NCT03802565|12022573|FG001|Overall Study|Subjects Related to Each Other|0
7613709|NCT03802565|12022574|FG002|Overall Study|Subjects Related to Each Other|0
7613710|NCT03802565|12022575|FG003|Overall Study|Subjects Related to Each Other|2
7613711|NCT03802565|12022576|FG004|Overall Study|Subjects Related to Each Other|1
7613712|NCT03802565|12022572|FG000|Overall Study|Elevated Enzymes|0
7613713|NCT03802565|12022573|FG001|Overall Study|Elevated Enzymes|0
7613714|NCT03802565|12022574|FG002|Overall Study|Elevated Enzymes|0
7613715|NCT03802565|12022575|FG003|Overall Study|Elevated Enzymes|0
7613716|NCT03802565|12022576|FG004|Overall Study|Elevated Enzymes|2
7613717|NCT03769194|12022592|FG000|Overall Study|Withdrawal by Subject|0
7613718|NCT03769194|12022593|FG001|Overall Study|Withdrawal by Subject|7
7613719|NCT03769194|12022594|FG002|Overall Study|Withdrawal by Subject|4
7613720|NCT03769194|12022595|FG003|Overall Study|Withdrawal by Subject|1
7613721|NCT03769194|12022592|FG000|Overall Study|moved from study area|0
7613722|NCT03769194|12022593|FG001|Overall Study|moved from study area|2
7613723|NCT03769194|12022594|FG002|Overall Study|moved from study area|1
7613724|NCT03769194|12022595|FG003|Overall Study|moved from study area|1
7613725|NCT03769194|12022592|FG000|Overall Study|Lost to Follow-up|3
7613726|NCT03769194|12022593|FG001|Overall Study|Lost to Follow-up|6
7613727|NCT03769194|12022594|FG002|Overall Study|Lost to Follow-up|3
7613728|NCT03769194|12022595|FG003|Overall Study|Lost to Follow-up|6
7613729|NCT03769194|12022592|FG000|Overall Study|other|1
7613730|NCT03769194|12022593|FG001|Overall Study|other|3
7613731|NCT03769194|12022594|FG002|Overall Study|other|0
7613732|NCT03769194|12022595|FG003|Overall Study|other|1
7613733|NCT03738332|12022605|FG000|Overall Study|Withdrawal by Subject|1
7613734|NCT03416179|12022618|FG000|Overall Study|Death|67
7613735|NCT03416179|12022619|FG001|Overall Study|Death|60
7613736|NCT03416179|12022620|FG002|Overall Study|Death|96
7613737|NCT03416179|12022621|FG003|Overall Study|Death|88
7278232|NCT00460265|11493411|FG001|Overall Study|Lost to Follow-up|15
7278233|NCT00460265|11493410|FG000|Overall Study|Physician Decision|1
7613738|NCT03416179|12022618|FG000|Overall Study|Withdrawal by Subject|13
7613739|NCT03416179|12022619|FG001|Overall Study|Withdrawal by Subject|19
7613740|NCT03416179|12022620|FG002|Overall Study|Withdrawal by Subject|5
7613741|NCT03416179|12022621|FG003|Overall Study|Withdrawal by Subject|6
7613742|NCT03416179|12022618|FG000|Overall Study|Ongoing|121
7613743|NCT03416179|12022619|FG001|Overall Study|Ongoing|123
7613744|NCT03416179|12022620|FG002|Overall Study|Ongoing|62
7278234|NCT00460265|11493411|FG001|Overall Study|Physician Decision|2
7613745|NCT03416179|12022621|FG003|Overall Study|Ongoing|66
7613746|NCT03416179|12022618|FG000|Overall Study|Lost to Follow-up|0
7613747|NCT03416179|12022619|FG001|Overall Study|Lost to Follow-up|0
7278235|NCT00460265|11493410|FG000|Overall Study|Withdrawal by Subject|10
7278236|NCT00460265|11493411|FG001|Overall Study|Withdrawal by Subject|25
7278237|NCT00460265|11493410|FG000|Overall Study|Ongoing|60
7278238|NCT00460265|11493411|FG001|Overall Study|Ongoing|47
7278239|NCT00460408|11493421|FG000|Overall Study|Adverse Event|1
7278240|NCT00460408|11493422|FG001|Overall Study|Adverse Event|0
7278241|NCT00460408|11493423|FG002|Overall Study|Adverse Event|0
7278242|NCT00460408|11493424|FG003|Overall Study|Adverse Event|0
7278243|NCT00460408|11493421|FG000|Overall Study|Death|7
7278244|NCT00460408|11493422|FG001|Overall Study|Death|0
7278245|NCT00460408|11493423|FG002|Overall Study|Death|0
7278246|NCT00460408|11493424|FG003|Overall Study|Death|0
7278247|NCT00460408|11493421|FG000|Overall Study|Lost to Follow-up|11
7278248|NCT00460408|11493422|FG001|Overall Study|Lost to Follow-up|0
7278249|NCT00460408|11493423|FG002|Overall Study|Lost to Follow-up|1
7278250|NCT00460408|11493424|FG003|Overall Study|Lost to Follow-up|0
7278251|NCT00460408|11493421|FG000|Overall Study|Withdrawal by Subject|31
7278252|NCT00460408|11493422|FG001|Overall Study|Withdrawal by Subject|0
7278253|NCT00460408|11493423|FG002|Overall Study|Withdrawal by Subject|0
7278254|NCT00460408|11493424|FG003|Overall Study|Withdrawal by Subject|0
7278255|NCT00460408|11493421|FG000|Overall Study|Insufficient clinical response|5
7278256|NCT00460408|11493422|FG001|Overall Study|Insufficient clinical response|1
7278257|NCT00460408|11493423|FG002|Overall Study|Insufficient clinical response|5
7278258|NCT00460408|11493424|FG003|Overall Study|Insufficient clinical response|0
7613748|NCT03416179|12022620|FG002|Overall Study|Lost to Follow-up|0
7613749|NCT03416179|12022621|FG003|Overall Study|Lost to Follow-up|2
7613750|NCT03416179|12022618|FG000|Overall Study|Other|0
7613751|NCT03416179|12022619|FG001|Overall Study|Other|1
7613752|NCT03416179|12022620|FG002|Overall Study|Other|0
7613753|NCT03416179|12022621|FG003|Overall Study|Other|0
7613754|NCT03353922|12022631|FG000|Overall Study|Withdrawal by Subject|1
7613755|NCT03353922|12022632|FG001|Overall Study|Withdrawal by Subject|0
7613756|NCT03353922|12022633|FG002|Overall Study|Withdrawal by Subject|1
7613757|NCT03353922|12022634|FG003|Overall Study|Withdrawal by Subject|1
7613758|NCT03353922|12022635|FG004|Overall Study|Withdrawal by Subject|0
7613759|NCT03353922|12022636|FG005|Overall Study|Withdrawal by Subject|0
7613760|NCT03353922|12022631|FG000|Overall Study|Adverse Event|0
7613761|NCT03353922|12022632|FG001|Overall Study|Adverse Event|1
7613762|NCT03353922|12022633|FG002|Overall Study|Adverse Event|0
7613763|NCT03353922|12022634|FG003|Overall Study|Adverse Event|0
7613764|NCT03353922|12022635|FG004|Overall Study|Adverse Event|0
7278259|NCT00460408|11493421|FG000|Overall Study|Other|12
7278260|NCT00460408|11493422|FG001|Overall Study|Other|2
7278261|NCT00460408|11493423|FG002|Overall Study|Other|0
7613765|NCT03353922|12022636|FG005|Overall Study|Adverse Event|0
7278262|NCT00460408|11493424|FG003|Overall Study|Other|0
7278263|NCT00460434|11493448|FG000|Overall Study|Lost to Follow-up|3
7278264|NCT00460434|11493449|FG001|Overall Study|Lost to Follow-up|7
7278265|NCT00460564|11493472|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
7278266|NCT00460564|11493473|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
7278267|NCT00460564|11493474|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278268|NCT00460564|11493475|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278269|NCT00460564|11493476|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278270|NCT00460564|11493477|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278271|NCT00460564|11493478|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278272|NCT00460564|11493479|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278273|NCT00460564|11493472|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
7278274|NCT00460564|11493473|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278275|NCT00460564|11493474|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278276|NCT00460564|11493475|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278277|NCT00460564|11493476|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278278|NCT00460564|11493477|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278279|NCT00460564|11493478|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278280|NCT00460564|11493479|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278281|NCT00460564|11493472|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
7278282|NCT00460564|11493473|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
7278283|NCT00460564|11493474|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
7278284|NCT00460564|11493475|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
7278285|NCT00460564|11493476|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
7278286|NCT00460564|11493477|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
7278287|NCT00460564|11493478|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
7278288|NCT00460564|11493479|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
7278289|NCT00460564|11493472|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278290|NCT00460564|11493473|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278291|NCT00460564|11493474|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278292|NCT00460564|11493475|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278293|NCT00460564|11493476|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
7613766|NCT03173456|12022671|FG000|Baseline|Medication dispensing system malfunction'|0
7613767|NCT03173456|12022672|FG001|Baseline|Medication dispensing system malfunction'|1
7613768|NCT03173456|12022673|FG002|Baseline|Medication dispensing system malfunction'|0
7613769|NCT03173456|12022674|FG003|Baseline|Medication dispensing system malfunction'|0
7613770|NCT03173456|12022675|FG004|Baseline|Medication dispensing system malfunction'|2
7613771|NCT03173456|12022671|FG000|2 Hour Follow-up|Withdrawal by Subject|0
7613772|NCT03173456|12022672|FG001|2 Hour Follow-up|Withdrawal by Subject|1
7613773|NCT03173456|12022673|FG002|2 Hour Follow-up|Withdrawal by Subject|1
7613774|NCT03173456|12022674|FG003|2 Hour Follow-up|Withdrawal by Subject|1
7613775|NCT03173456|12022675|FG004|2 Hour Follow-up|Withdrawal by Subject|2
7613825|NCT02820753|12022752|FG000|2 Month|Withdrawal by Subject|3
7613826|NCT02820753|12022753|FG001|2 Month|Withdrawal by Subject|3
7613827|NCT02820753|12022752|FG000|2 Month|Lost to Follow-up|24
7613828|NCT02820753|12022753|FG001|2 Month|Lost to Follow-up|26
7613829|NCT02820753|12022752|FG000|2 Month|Stopped per NIH Hold|51
7613830|NCT02820753|12022753|FG001|2 Month|Stopped per NIH Hold|13
7613831|NCT02820753|12022752|FG000|6 Month|Withdrawal by Subject|2
7613832|NCT02820753|12022753|FG001|6 Month|Withdrawal by Subject|2
7613833|NCT02820753|12022752|FG000|6 Month|Lost to Follow-up|20
7613834|NCT02820753|12022753|FG001|6 Month|Lost to Follow-up|27
7613835|NCT02820753|12022752|FG000|6 Month|Stopped per NIH Hold|81
7613836|NCT02820753|12022753|FG001|6 Month|Stopped per NIH Hold|81
7613837|NCT02820753|12022752|FG000|6 Month|Death|0
7613838|NCT02820753|12022753|FG001|6 Month|Death|1
7613839|NCT02733042|12022778|FG000|Treatment Period|Adverse Event|1
7613840|NCT02733042|12022779|FG001|Treatment Period|Adverse Event|0
7613841|NCT02733042|12022780|FG002|Treatment Period|Adverse Event|1
7613842|NCT02733042|12022781|FG003|Treatment Period|Adverse Event|1
7613843|NCT02733042|12022782|FG004|Treatment Period|Adverse Event|0
7613844|NCT02733042|12022783|FG005|Treatment Period|Adverse Event|0
7613845|NCT02733042|12022784|FG006|Treatment Period|Adverse Event|0
7613846|NCT02733042|12022785|FG007|Treatment Period|Adverse Event|0
7613847|NCT02733042|12022786|FG008|Treatment Period|Adverse Event|0
7613848|NCT02733042|12022787|FG009|Treatment Period|Adverse Event|0
7613849|NCT02733042|12022788|FG010|Treatment Period|Adverse Event|2
7613850|NCT02733042|12022789|FG011|Treatment Period|Adverse Event|2
7613851|NCT02733042|12022790|FG012|Treatment Period|Adverse Event|0
7278294|NCT00460564|11493477|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
7278295|NCT00460564|11493478|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278296|NCT00460564|11493479|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278297|NCT00460564|11493472|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278298|NCT00460564|11493473|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278299|NCT00460564|11493474|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278300|NCT00460564|11493475|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278301|NCT00460564|11493476|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
7278302|NCT00460564|11493477|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278303|NCT00460564|11493478|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7278304|NCT00460564|11493479|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
7613852|NCT02733042|12022791|FG013|Treatment Period|Adverse Event|2
7613853|NCT02733042|12022792|FG014|Treatment Period|Adverse Event|0
7613854|NCT02733042|12022793|FG015|Treatment Period|Adverse Event|0
7613855|NCT02733042|12022794|FG016|Treatment Period|Adverse Event|0
7613856|NCT02733042|12022795|FG017|Treatment Period|Adverse Event|1
7613857|NCT02733042|12022796|FG018|Treatment Period|Adverse Event|0
7613858|NCT02733042|12022778|FG000|Treatment Period|Progressive Disease|2
7613859|NCT02733042|12022779|FG001|Treatment Period|Progressive Disease|1
7613860|NCT02733042|12022780|FG002|Treatment Period|Progressive Disease|3
7613861|NCT02733042|12022781|FG003|Treatment Period|Progressive Disease|1
7613862|NCT02733042|12022782|FG004|Treatment Period|Progressive Disease|1
7613863|NCT02733042|12022783|FG005|Treatment Period|Progressive Disease|3
7613864|NCT02733042|12022784|FG006|Treatment Period|Progressive Disease|0
7613865|NCT02733042|12022785|FG007|Treatment Period|Progressive Disease|3
7613866|NCT02733042|12022786|FG008|Treatment Period|Progressive Disease|3
7613867|NCT02733042|12022787|FG009|Treatment Period|Progressive Disease|0
7613868|NCT02733042|12022788|FG010|Treatment Period|Progressive Disease|2
7613869|NCT02733042|12022789|FG011|Treatment Period|Progressive Disease|2
7613870|NCT02733042|12022790|FG012|Treatment Period|Progressive Disease|8
7613871|NCT02733042|12022791|FG013|Treatment Period|Progressive Disease|1
7613872|NCT02733042|12022792|FG014|Treatment Period|Progressive Disease|4
7613873|NCT02733042|12022793|FG015|Treatment Period|Progressive Disease|7
7613874|NCT02733042|12022794|FG016|Treatment Period|Progressive Disease|2
7613875|NCT02733042|12022795|FG017|Treatment Period|Progressive Disease|3
7613876|NCT02733042|12022796|FG018|Treatment Period|Progressive Disease|4
7613877|NCT02733042|12022778|FG000|Treatment Period|Withdrawal by Subject|0
7613878|NCT02733042|12022779|FG001|Treatment Period|Withdrawal by Subject|1
7613879|NCT02733042|12022780|FG002|Treatment Period|Withdrawal by Subject|2
7613880|NCT02733042|12022781|FG003|Treatment Period|Withdrawal by Subject|1
7613881|NCT02733042|12022782|FG004|Treatment Period|Withdrawal by Subject|0
7278305|NCT00460577|11493501|FG000|Overall Study|Protocol Violation|2
7613882|NCT02733042|12022783|FG005|Treatment Period|Withdrawal by Subject|0
7613883|NCT02733042|12022784|FG006|Treatment Period|Withdrawal by Subject|0
7613884|NCT02733042|12022785|FG007|Treatment Period|Withdrawal by Subject|0
7613885|NCT02733042|12022786|FG008|Treatment Period|Withdrawal by Subject|1
7613886|NCT02733042|12022787|FG009|Treatment Period|Withdrawal by Subject|1
7613887|NCT02733042|12022788|FG010|Treatment Period|Withdrawal by Subject|0
7613888|NCT02733042|12022789|FG011|Treatment Period|Withdrawal by Subject|2
7613889|NCT02733042|12022790|FG012|Treatment Period|Withdrawal by Subject|1
7613890|NCT02733042|12022791|FG013|Treatment Period|Withdrawal by Subject|1
7613891|NCT02733042|12022792|FG014|Treatment Period|Withdrawal by Subject|0
7613892|NCT02733042|12022793|FG015|Treatment Period|Withdrawal by Subject|0
7613893|NCT02733042|12022794|FG016|Treatment Period|Withdrawal by Subject|0
7613894|NCT02733042|12022795|FG017|Treatment Period|Withdrawal by Subject|0
7613895|NCT02733042|12022796|FG018|Treatment Period|Withdrawal by Subject|0
7613896|NCT02733042|12022778|FG000|Treatment Period|Other|0
7613897|NCT02733042|12022779|FG001|Treatment Period|Other|0
7613898|NCT02733042|12022780|FG002|Treatment Period|Other|1
7613899|NCT02733042|12022781|FG003|Treatment Period|Other|0
7613900|NCT02733042|12022782|FG004|Treatment Period|Other|0
7613901|NCT02733042|12022783|FG005|Treatment Period|Other|0
7613902|NCT02733042|12022784|FG006|Treatment Period|Other|0
7613903|NCT02733042|12022785|FG007|Treatment Period|Other|0
7613904|NCT02733042|12022786|FG008|Treatment Period|Other|0
7613905|NCT02733042|12022787|FG009|Treatment Period|Other|1
7613906|NCT02733042|12022788|FG010|Treatment Period|Other|1
7613907|NCT02733042|12022789|FG011|Treatment Period|Other|0
7613908|NCT02733042|12022790|FG012|Treatment Period|Other|0
7613909|NCT02733042|12022791|FG013|Treatment Period|Other|0
7613910|NCT02733042|12022792|FG014|Treatment Period|Other|0
7613911|NCT02733042|12022793|FG015|Treatment Period|Other|1
7278306|NCT00460577|11493502|FG001|Overall Study|Protocol Violation|6
7278307|NCT00460603|11493520|FG000|Phase 1|Death|1
7278308|NCT00460603|11493521|FG001|Phase 1|Death|0
7278309|NCT00460603|11493522|FG002|Phase 1|Death|0
7278310|NCT00460603|11493523|FG003|Phase 1|Death|2
7278311|NCT00460603|11493524|FG004|Phase 1|Death|0
7278312|NCT00460603|11493525|FG005|Phase 1|Death|0
7278313|NCT00460603|11493526|FG006|Phase 1|Death|0
7278314|NCT00460603|11493527|FG007|Phase 1|Death|0
7278315|NCT00460603|11493528|FG008|Phase 1|Death|1
7278316|NCT00460603|11493529|FG009|Phase 1|Death|0
7278317|NCT00460603|11493530|FG010|Phase 1|Death|0
7278318|NCT00460603|11493531|FG011|Phase 1|Death|0
7278319|NCT00460603|11493520|FG000|Phase 1|Adverse Event|3
7278320|NCT00460603|11493521|FG001|Phase 1|Adverse Event|1
7278321|NCT00460603|11493522|FG002|Phase 1|Adverse Event|1
7278322|NCT00460603|11493523|FG003|Phase 1|Adverse Event|2
7278323|NCT00460603|11493524|FG004|Phase 1|Adverse Event|0
7278324|NCT00460603|11493525|FG005|Phase 1|Adverse Event|0
7278325|NCT00460603|11493526|FG006|Phase 1|Adverse Event|3
7278326|NCT00460603|11493527|FG007|Phase 1|Adverse Event|0
7278327|NCT00460603|11493528|FG008|Phase 1|Adverse Event|4
7278328|NCT00460603|11493529|FG009|Phase 1|Adverse Event|0
7278329|NCT00460603|11493530|FG010|Phase 1|Adverse Event|0
7278330|NCT00460603|11493531|FG011|Phase 1|Adverse Event|0
7278331|NCT00460603|11493520|FG000|Phase 1|Lack of Efficacy|1
7278332|NCT00460603|11493521|FG001|Phase 1|Lack of Efficacy|0
7278333|NCT00460603|11493522|FG002|Phase 1|Lack of Efficacy|1
7278334|NCT00460603|11493523|FG003|Phase 1|Lack of Efficacy|2
7278335|NCT00460603|11493524|FG004|Phase 1|Lack of Efficacy|2
7278336|NCT00460603|11493525|FG005|Phase 1|Lack of Efficacy|2
7278337|NCT00460603|11493526|FG006|Phase 1|Lack of Efficacy|2
7278338|NCT00460603|11493527|FG007|Phase 1|Lack of Efficacy|2
7278339|NCT00460603|11493528|FG008|Phase 1|Lack of Efficacy|11
7278340|NCT00460603|11493529|FG009|Phase 1|Lack of Efficacy|0
7278341|NCT00460603|11493530|FG010|Phase 1|Lack of Efficacy|0
7278342|NCT00460603|11493531|FG011|Phase 1|Lack of Efficacy|0
7278343|NCT00460603|11493520|FG000|Phase 1|Withdrawal by Subject|1
7278344|NCT00460603|11493521|FG001|Phase 1|Withdrawal by Subject|2
7278345|NCT00460603|11493522|FG002|Phase 1|Withdrawal by Subject|1
7278346|NCT00460603|11493523|FG003|Phase 1|Withdrawal by Subject|1
7278347|NCT00460603|11493524|FG004|Phase 1|Withdrawal by Subject|3
7278348|NCT00460603|11493525|FG005|Phase 1|Withdrawal by Subject|0
7278349|NCT00460603|11493526|FG006|Phase 1|Withdrawal by Subject|1
7278350|NCT00460603|11493527|FG007|Phase 1|Withdrawal by Subject|0
7278351|NCT00460603|11493528|FG008|Phase 1|Withdrawal by Subject|2
7278352|NCT00460603|11493529|FG009|Phase 1|Withdrawal by Subject|0
7278353|NCT00460603|11493530|FG010|Phase 1|Withdrawal by Subject|0
7278354|NCT00460603|11493531|FG011|Phase 1|Withdrawal by Subject|0
7278355|NCT00460603|11493520|FG000|Phase 1|Other|0
7278356|NCT00460603|11493521|FG001|Phase 1|Other|3
7278357|NCT00460603|11493522|FG002|Phase 1|Other|1
7278358|NCT00460603|11493523|FG003|Phase 1|Other|1
7278359|NCT00460603|11493524|FG004|Phase 1|Other|1
7278360|NCT00460603|11493525|FG005|Phase 1|Other|2
7278361|NCT00460603|11493526|FG006|Phase 1|Other|0
7613912|NCT02733042|12022794|FG016|Treatment Period|Other|0
7613913|NCT02733042|12022795|FG017|Treatment Period|Other|1
7278362|NCT00460603|11493527|FG007|Phase 1|Other|1
7278363|NCT00460603|11493528|FG008|Phase 1|Other|0
7278364|NCT00460603|11493529|FG009|Phase 1|Other|0
7278365|NCT00460603|11493530|FG010|Phase 1|Other|0
7278366|NCT00460603|11493531|FG011|Phase 1|Other|0
7613914|NCT02733042|12022796|FG018|Treatment Period|Other|0
7613915|NCT02733042|12022778|FG000|Treatment Period|Ongoing on Assigned Treatment|0
7613916|NCT02733042|12022779|FG001|Treatment Period|Ongoing on Assigned Treatment|0
7613917|NCT02733042|12022780|FG002|Treatment Period|Ongoing on Assigned Treatment|0
7613918|NCT02733042|12022781|FG003|Treatment Period|Ongoing on Assigned Treatment|0
7278367|NCT00460603|11493520|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278368|NCT00460603|11493521|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7613919|NCT02733042|12022782|FG004|Treatment Period|Ongoing on Assigned Treatment|3
7613920|NCT02733042|12022783|FG005|Treatment Period|Ongoing on Assigned Treatment|0
7613921|NCT02733042|12022784|FG006|Treatment Period|Ongoing on Assigned Treatment|0
7613922|NCT02733042|12022785|FG007|Treatment Period|Ongoing on Assigned Treatment|0
7613923|NCT02733042|12022786|FG008|Treatment Period|Ongoing on Assigned Treatment|0
7613924|NCT02733042|12022787|FG009|Treatment Period|Ongoing on Assigned Treatment|8
7613925|NCT02733042|12022788|FG010|Treatment Period|Ongoing on Assigned Treatment|4
7613926|NCT02733042|12022789|FG011|Treatment Period|Ongoing on Assigned Treatment|0
7613927|NCT02733042|12022790|FG012|Treatment Period|Ongoing on Assigned Treatment|0
7613928|NCT02733042|12022791|FG013|Treatment Period|Ongoing on Assigned Treatment|0
7613929|NCT02733042|12022792|FG014|Treatment Period|Ongoing on Assigned Treatment|0
7613930|NCT02733042|12022793|FG015|Treatment Period|Ongoing on Assigned Treatment|0
7613931|NCT02733042|12022794|FG016|Treatment Period|Ongoing on Assigned Treatment|0
7613932|NCT02733042|12022795|FG017|Treatment Period|Ongoing on Assigned Treatment|0
7613933|NCT02733042|12022796|FG018|Treatment Period|Ongoing on Assigned Treatment|1
7613934|NCT02733042|12022778|FG000|Treatment Period|Death|0
7613935|NCT02733042|12022779|FG001|Treatment Period|Death|0
7613936|NCT02733042|12022780|FG002|Treatment Period|Death|0
7613937|NCT02733042|12022781|FG003|Treatment Period|Death|0
7613938|NCT02733042|12022782|FG004|Treatment Period|Death|0
7613939|NCT02733042|12022783|FG005|Treatment Period|Death|0
7613940|NCT02733042|12022784|FG006|Treatment Period|Death|1
7613941|NCT02733042|12022785|FG007|Treatment Period|Death|0
7613942|NCT02733042|12022786|FG008|Treatment Period|Death|1
7613943|NCT02733042|12022787|FG009|Treatment Period|Death|0
7613944|NCT02733042|12022788|FG010|Treatment Period|Death|1
7613945|NCT02733042|12022789|FG011|Treatment Period|Death|0
7613946|NCT02733042|12022790|FG012|Treatment Period|Death|0
7613947|NCT02733042|12022791|FG013|Treatment Period|Death|0
7613948|NCT02733042|12022792|FG014|Treatment Period|Death|1
7613949|NCT02733042|12022793|FG015|Treatment Period|Death|2
7613950|NCT02733042|12022794|FG016|Treatment Period|Death|0
7613951|NCT02733042|12022795|FG017|Treatment Period|Death|0
7613952|NCT02733042|12022796|FG018|Treatment Period|Death|0
7613953|NCT02733042|12022778|FG000|Follow-up Period|Ongoing on Follow-up|2
7613954|NCT02733042|12022779|FG001|Follow-up Period|Ongoing on Follow-up|2
7613955|NCT02733042|12022780|FG002|Follow-up Period|Ongoing on Follow-up|4
7613956|NCT02733042|12022781|FG003|Follow-up Period|Ongoing on Follow-up|2
7613957|NCT02733042|12022782|FG004|Follow-up Period|Ongoing on Follow-up|0
7613958|NCT02733042|12022783|FG005|Follow-up Period|Ongoing on Follow-up|0
7613959|NCT02733042|12022784|FG006|Follow-up Period|Ongoing on Follow-up|0
7613960|NCT02733042|12022785|FG007|Follow-up Period|Ongoing on Follow-up|1
7613961|NCT02733042|12022786|FG008|Follow-up Period|Ongoing on Follow-up|0
7613962|NCT02733042|12022787|FG009|Follow-up Period|Ongoing on Follow-up|2
7278369|NCT00460603|11493522|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278370|NCT00460603|11493523|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278371|NCT00460603|11493524|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278372|NCT00460603|11493525|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278373|NCT00460603|11493526|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278374|NCT00460603|11493527|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278375|NCT00460603|11493528|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278376|NCT00460603|11493529|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
7278377|NCT00460603|11493530|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278378|NCT00460603|11493531|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
7278379|NCT00460603|11493520|FG000|Phase 2|Adverse Event|0
7278380|NCT00460603|11493521|FG001|Phase 2|Adverse Event|0
7278381|NCT00460603|11493522|FG002|Phase 2|Adverse Event|0
7278382|NCT00460603|11493523|FG003|Phase 2|Adverse Event|0
7278383|NCT00460603|11493524|FG004|Phase 2|Adverse Event|0
7278384|NCT00460603|11493525|FG005|Phase 2|Adverse Event|0
7278385|NCT00460603|11493526|FG006|Phase 2|Adverse Event|0
7278386|NCT00460603|11493527|FG007|Phase 2|Adverse Event|0
7278387|NCT00460603|11493528|FG008|Phase 2|Adverse Event|0
7278388|NCT00460603|11493529|FG009|Phase 2|Adverse Event|12
7278389|NCT00460603|11493530|FG010|Phase 2|Adverse Event|9
7278390|NCT00460603|11493531|FG011|Phase 2|Adverse Event|10
7278391|NCT00460603|11493520|FG000|Phase 2|Death|0
7278392|NCT00460603|11493521|FG001|Phase 2|Death|0
7278393|NCT00460603|11493522|FG002|Phase 2|Death|0
7278394|NCT00460603|11493523|FG003|Phase 2|Death|0
7278395|NCT00460603|11493524|FG004|Phase 2|Death|0
7278396|NCT00460603|11493525|FG005|Phase 2|Death|0
7613963|NCT02733042|12022788|FG010|Follow-up Period|Ongoing on Follow-up|4
7613964|NCT02733042|12022789|FG011|Follow-up Period|Ongoing on Follow-up|9
7278397|NCT00460603|11493526|FG006|Phase 2|Death|0
7613965|NCT02733042|12022790|FG012|Follow-up Period|Ongoing on Follow-up|1
7613966|NCT02733042|12022791|FG013|Follow-up Period|Ongoing on Follow-up|3
7613967|NCT02733042|12022792|FG014|Follow-up Period|Ongoing on Follow-up|0
7613968|NCT02733042|12022793|FG015|Follow-up Period|Ongoing on Follow-up|0
7613969|NCT02733042|12022794|FG016|Follow-up Period|Ongoing on Follow-up|0
7613970|NCT02733042|12022795|FG017|Follow-up Period|Ongoing on Follow-up|1
7613971|NCT02733042|12022796|FG018|Follow-up Period|Ongoing on Follow-up|0
7278398|NCT00460603|11493527|FG007|Phase 2|Death|0
7278399|NCT00460603|11493528|FG008|Phase 2|Death|0
7278400|NCT00460603|11493529|FG009|Phase 2|Death|4
7278401|NCT00460603|11493530|FG010|Phase 2|Death|2
7613972|NCT02733042|12022778|FG000|Follow-up Period|Death|1
7613973|NCT02733042|12022779|FG001|Follow-up Period|Death|1
7613974|NCT02733042|12022780|FG002|Follow-up Period|Death|2
7613975|NCT02733042|12022781|FG003|Follow-up Period|Death|0
7613976|NCT02733042|12022782|FG004|Follow-up Period|Death|1
7613977|NCT02733042|12022783|FG005|Follow-up Period|Death|2
7613978|NCT02733042|12022784|FG006|Follow-up Period|Death|0
7613979|NCT02733042|12022785|FG007|Follow-up Period|Death|3
7613980|NCT02733042|12022786|FG008|Follow-up Period|Death|3
7613981|NCT02733042|12022787|FG009|Follow-up Period|Death|0
7613982|NCT02733042|12022788|FG010|Follow-up Period|Death|0
7613983|NCT02733042|12022789|FG011|Follow-up Period|Death|0
7613984|NCT02733042|12022790|FG012|Follow-up Period|Death|8
7613985|NCT02733042|12022791|FG013|Follow-up Period|Death|1
7613986|NCT02733042|12022792|FG014|Follow-up Period|Death|1
7613987|NCT02733042|12022793|FG015|Follow-up Period|Death|4
7613988|NCT02733042|12022794|FG016|Follow-up Period|Death|0
7613989|NCT02733042|12022795|FG017|Follow-up Period|Death|1
7613990|NCT02733042|12022796|FG018|Follow-up Period|Death|2
7613991|NCT02733042|12022778|FG000|Follow-up Period|Other|0
7613992|NCT02733042|12022779|FG001|Follow-up Period|Other|0
7613993|NCT02733042|12022780|FG002|Follow-up Period|Other|0
7613994|NCT02733042|12022781|FG003|Follow-up Period|Other|1
7613995|NCT02733042|12022782|FG004|Follow-up Period|Other|0
7613996|NCT02733042|12022783|FG005|Follow-up Period|Other|0
7613997|NCT02733042|12022784|FG006|Follow-up Period|Other|0
7613998|NCT02733042|12022785|FG007|Follow-up Period|Other|0
7613999|NCT02733042|12022786|FG008|Follow-up Period|Other|0
7614000|NCT02733042|12022787|FG009|Follow-up Period|Other|0
7614001|NCT02733042|12022788|FG010|Follow-up Period|Other|0
7614002|NCT02733042|12022789|FG011|Follow-up Period|Other|0
7614003|NCT02733042|12022790|FG012|Follow-up Period|Other|0
7614004|NCT02733042|12022791|FG013|Follow-up Period|Other|0
7614005|NCT02733042|12022792|FG014|Follow-up Period|Other|0
7614006|NCT02733042|12022793|FG015|Follow-up Period|Other|0
7614007|NCT02733042|12022794|FG016|Follow-up Period|Other|0
7614008|NCT02733042|12022795|FG017|Follow-up Period|Other|0
7614009|NCT02733042|12022796|FG018|Follow-up Period|Other|0
7614010|NCT02733042|12022778|FG000|Follow-up Period|Withdrawal by Subject|0
7614011|NCT02733042|12022779|FG001|Follow-up Period|Withdrawal by Subject|0
7614012|NCT02733042|12022780|FG002|Follow-up Period|Withdrawal by Subject|0
7614013|NCT02733042|12022781|FG003|Follow-up Period|Withdrawal by Subject|0
7614014|NCT02733042|12022782|FG004|Follow-up Period|Withdrawal by Subject|0
7614015|NCT02733042|12022783|FG005|Follow-up Period|Withdrawal by Subject|0
7614016|NCT02733042|12022784|FG006|Follow-up Period|Withdrawal by Subject|0
7614017|NCT02733042|12022785|FG007|Follow-up Period|Withdrawal by Subject|0
7614018|NCT02733042|12022786|FG008|Follow-up Period|Withdrawal by Subject|1
7614019|NCT02733042|12022787|FG009|Follow-up Period|Withdrawal by Subject|0
7614020|NCT02733042|12022788|FG010|Follow-up Period|Withdrawal by Subject|1
7614021|NCT02733042|12022789|FG011|Follow-up Period|Withdrawal by Subject|0
7614022|NCT02733042|12022790|FG012|Follow-up Period|Withdrawal by Subject|0
7614023|NCT02733042|12022791|FG013|Follow-up Period|Withdrawal by Subject|0
7614024|NCT02733042|12022792|FG014|Follow-up Period|Withdrawal by Subject|0
7614025|NCT02733042|12022793|FG015|Follow-up Period|Withdrawal by Subject|1
7614026|NCT02733042|12022794|FG016|Follow-up Period|Withdrawal by Subject|0
7614027|NCT02733042|12022795|FG017|Follow-up Period|Withdrawal by Subject|0
7614028|NCT02733042|12022796|FG018|Follow-up Period|Withdrawal by Subject|0
7614029|NCT02574286|12022857|FG000|Overall Study|Adverse Event|3
7614030|NCT02574286|12022857|FG000|Overall Study|Withdrawal by Subject|2
7614031|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Adverse Event|0
7614032|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Adverse Event|1
7614033|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Adverse Event|1
7614034|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Adverse Event|0
7614035|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Adverse Event|0
7614036|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Adverse Event|0
7614037|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Adverse Event|0
7614038|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Adverse Event|0
7614039|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Adverse Event|0
7614040|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Adverse Event|0
7614041|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Adverse Event|0
7614042|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614043|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614044|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614045|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
7614046|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614047|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614048|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614049|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614050|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614051|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614052|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
7614053|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
7614054|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
7614055|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
7614056|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
7614057|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
7614058|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
7614059|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
7614060|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
7614061|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
7614062|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
7614063|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
7614064|NCT02471144|12022865|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7614065|NCT02471144|12022866|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
7614066|NCT02471144|12022867|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614067|NCT02471144|12022868|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614068|NCT02471144|12022869|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614069|NCT02471144|12022870|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614070|NCT02471144|12022871|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614071|NCT02471144|12022872|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614072|NCT02471144|12022873|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614073|NCT02471144|12022874|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614074|NCT02471144|12022875|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
7614075|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614076|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614077|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614078|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614079|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614080|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614081|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614082|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614083|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
7614084|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614085|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
7614086|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614087|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614088|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614089|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614090|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614091|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
7614092|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614093|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614094|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
7614095|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614096|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
7614097|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614098|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614099|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614100|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614101|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614102|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614103|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614104|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614105|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
7614106|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614107|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
7614108|NCT02471144|12022865|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614109|NCT02471144|12022866|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614110|NCT02471144|12022867|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7278402|NCT00460603|11493531|FG011|Phase 2|Death|2
7278403|NCT00460603|11493520|FG000|Phase 2|Protocol Violation|0
7278404|NCT00460603|11493521|FG001|Phase 2|Protocol Violation|0
7614111|NCT02471144|12022868|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614112|NCT02471144|12022869|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614113|NCT02471144|12022870|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614114|NCT02471144|12022871|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614115|NCT02471144|12022872|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
7614116|NCT02471144|12022873|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
7614117|NCT02471144|12022874|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614118|NCT02471144|12022875|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
7614119|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614120|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614121|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614122|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614123|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614124|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614125|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614126|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614127|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
7614128|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
7614129|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
7614130|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614131|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614132|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614133|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614134|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614135|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614136|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614137|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614138|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614139|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
7614140|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
7614141|NCT02471144|12022865|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614142|NCT02471144|12022866|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614143|NCT02471144|12022867|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614144|NCT02471144|12022868|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7278405|NCT00460603|11493522|FG002|Phase 2|Protocol Violation|0
7278406|NCT00460603|11493523|FG003|Phase 2|Protocol Violation|0
7278407|NCT00460603|11493524|FG004|Phase 2|Protocol Violation|0
7278408|NCT00460603|11493525|FG005|Phase 2|Protocol Violation|0
7278409|NCT00460603|11493526|FG006|Phase 2|Protocol Violation|0
7278410|NCT00460603|11493527|FG007|Phase 2|Protocol Violation|0
7278411|NCT00460603|11493528|FG008|Phase 2|Protocol Violation|0
7278412|NCT00460603|11493529|FG009|Phase 2|Protocol Violation|1
7278413|NCT00460603|11493530|FG010|Phase 2|Protocol Violation|1
7278414|NCT00460603|11493531|FG011|Phase 2|Protocol Violation|0
7278415|NCT00460603|11493520|FG000|Phase 2|Lost to Follow-up|0
7278416|NCT00460603|11493521|FG001|Phase 2|Lost to Follow-up|0
7278417|NCT00460603|11493522|FG002|Phase 2|Lost to Follow-up|0
7278418|NCT00460603|11493523|FG003|Phase 2|Lost to Follow-up|0
7278419|NCT00460603|11493524|FG004|Phase 2|Lost to Follow-up|0
7278420|NCT00460603|11493525|FG005|Phase 2|Lost to Follow-up|0
7278421|NCT00460603|11493526|FG006|Phase 2|Lost to Follow-up|0
7278422|NCT00460603|11493527|FG007|Phase 2|Lost to Follow-up|0
7278423|NCT00460603|11493528|FG008|Phase 2|Lost to Follow-up|0
7278424|NCT00460603|11493529|FG009|Phase 2|Lost to Follow-up|1
7278425|NCT00460603|11493530|FG010|Phase 2|Lost to Follow-up|0
7278426|NCT00460603|11493531|FG011|Phase 2|Lost to Follow-up|0
7278427|NCT00460603|11493520|FG000|Phase 2|Other|0
7278428|NCT00460603|11493521|FG001|Phase 2|Other|0
7278429|NCT00460603|11493522|FG002|Phase 2|Other|0
7278430|NCT00460603|11493523|FG003|Phase 2|Other|0
7278431|NCT00460603|11493524|FG004|Phase 2|Other|0
7278432|NCT00460603|11493525|FG005|Phase 2|Other|0
7278433|NCT00460603|11493526|FG006|Phase 2|Other|0
7278434|NCT00460603|11493527|FG007|Phase 2|Other|0
7278435|NCT00460603|11493528|FG008|Phase 2|Other|0
7278436|NCT00460603|11493529|FG009|Phase 2|Other|6
7278437|NCT00460603|11493530|FG010|Phase 2|Other|16
7278438|NCT00460603|11493531|FG011|Phase 2|Other|7
7278439|NCT00460603|11493520|FG000|Phase 2|Objective Progression or Relapse|0
7278440|NCT00460603|11493521|FG001|Phase 2|Objective Progression or Relapse|0
7278441|NCT00460603|11493522|FG002|Phase 2|Objective Progression or Relapse|0
7278442|NCT00460603|11493523|FG003|Phase 2|Objective Progression or Relapse|0
7278443|NCT00460603|11493524|FG004|Phase 2|Objective Progression or Relapse|0
7278444|NCT00460603|11493525|FG005|Phase 2|Objective Progression or Relapse|0
7278445|NCT00460603|11493526|FG006|Phase 2|Objective Progression or Relapse|0
7278446|NCT00460603|11493527|FG007|Phase 2|Objective Progression or Relapse|0
7278447|NCT00460603|11493528|FG008|Phase 2|Objective Progression or Relapse|0
7278448|NCT00460603|11493529|FG009|Phase 2|Objective Progression or Relapse|9
7278449|NCT00460603|11493530|FG010|Phase 2|Objective Progression or Relapse|10
7278450|NCT00460603|11493531|FG011|Phase 2|Objective Progression or Relapse|17
7278451|NCT00460603|11493520|FG000|Phase 2|Global Deterioration of Health Status|0
7278452|NCT00460603|11493521|FG001|Phase 2|Global Deterioration of Health Status|0
7278453|NCT00460603|11493522|FG002|Phase 2|Global Deterioration of Health Status|0
7278454|NCT00460603|11493523|FG003|Phase 2|Global Deterioration of Health Status|0
7278455|NCT00460603|11493524|FG004|Phase 2|Global Deterioration of Health Status|0
7278456|NCT00460603|11493525|FG005|Phase 2|Global Deterioration of Health Status|0
7278457|NCT00460603|11493526|FG006|Phase 2|Global Deterioration of Health Status|0
7614145|NCT02471144|12022869|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614146|NCT02471144|12022870|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614147|NCT02471144|12022871|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614148|NCT02471144|12022872|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614149|NCT02471144|12022873|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7278458|NCT00460603|11493527|FG007|Phase 2|Global Deterioration of Health Status|0
7614150|NCT02471144|12022874|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
7614151|NCT02471144|12022875|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
7614152|NCT02440464|12022893|FG000|Overall Study|Withdrawal by Subject|3
7614153|NCT02440464|12022894|FG001|Overall Study|Withdrawal by Subject|2
7614154|NCT02366728|12022911|FG000|Overall Study|Death|0
7614155|NCT02366728|12022912|FG001|Overall Study|Death|0
7614156|NCT02366728|12022913|FG002|Overall Study|Death|1
7614157|NCT02366728|12022911|FG000|Overall Study|Adverse Event|1
7614158|NCT02366728|12022912|FG001|Overall Study|Adverse Event|0
7614159|NCT02366728|12022913|FG002|Overall Study|Adverse Event|0
7614160|NCT02366728|12022911|FG000|Overall Study|Screen Failure|2
7614161|NCT02366728|12022912|FG001|Overall Study|Screen Failure|1
7614162|NCT02366728|12022913|FG002|Overall Study|Screen Failure|0
7614163|NCT02366728|12022911|FG000|Overall Study|Only yielded 2 vaccines|1
7614164|NCT02366728|12022912|FG001|Overall Study|Only yielded 2 vaccines|0
7614165|NCT02366728|12022913|FG002|Overall Study|Only yielded 2 vaccines|0
7614166|NCT02236572|12022921|FG000|Overall Study|Withdrawal by Subject|1
7614167|NCT02236572|12022921|FG000|Overall Study|Protocol Violation|1
7614168|NCT02236572|12022921|FG000|Overall Study|Lost to Follow-up|1
7614169|NCT02083354|12022925|FG000|Overall Study|Withdrawal by Subject|9
7614170|NCT02083354|12022925|FG000|Overall Study|Lost to Follow-up|1
7614171|NCT02083354|12022925|FG000|Overall Study|Adverse Event|3
7614172|NCT02083354|12022925|FG000|Overall Study|Disease progression|46
7614173|NCT02083354|12022925|FG000|Overall Study|Study closed/terminated|5
7614174|NCT01446016|12022959|FG000|Overall Study|Lost to Follow-up|3
7614175|NCT01446016|12022959|FG000|Overall Study|Withdrawal by Subject|1
7614176|NCT01446016|12022959|FG000|Overall Study|Toxicity|3
7614177|NCT01411332|12022978|FG000|Overall Study|Lost to Follow-up|1
7614178|NCT01411332|12022979|FG001|Overall Study|Lost to Follow-up|0
7614179|NCT01411332|12022978|FG000|Overall Study|Protocol Violation|1
7614180|NCT01411332|12022979|FG001|Overall Study|Protocol Violation|1
7614181|NCT01411332|12022978|FG000|Overall Study|Withdrawal by Subject|0
7614182|NCT01411332|12022979|FG001|Overall Study|Withdrawal by Subject|1
7614183|NCT01399918|12022985|FG000|Overall Study|Not eligible and not enrolled in the study|2
7614184|NCT01147653|12022995|FG000|Year 2|Withdrawal by Subject|2
7614185|NCT01147653|12022996|FG001|Year 2|Withdrawal by Subject|3
7614186|NCT01078454|12023016|FG000|Overall Study|Adverse Event|1
7614187|NCT01078454|12023017|FG001|Overall Study|Adverse Event|1
7614188|NCT01078454|12023016|FG000|Overall Study|Death|0
7614189|NCT01078454|12023017|FG001|Overall Study|Death|1
7614190|NCT00687596|12023025|FG000|Overall Study|Adverse Event (AE)|10
7614191|NCT00687596|12023026|FG001|Overall Study|Adverse Event (AE)|3
7614192|NCT00687596|12023025|FG000|Overall Study|Radiological Disease Progression|6
7614193|NCT00687596|12023026|FG001|Overall Study|Radiological Disease Progression|2
7614194|NCT00687596|12023025|FG000|Overall Study|Clinical Disease Progression|1
7614195|NCT00687596|12023026|FG001|Overall Study|Clinical Disease Progression|3
7614196|NCT00687596|12023025|FG000|Overall Study|Investigator Discretion|3
7614197|NCT00687596|12023026|FG001|Overall Study|Investigator Discretion|1
7278459|NCT00460603|11493528|FG008|Phase 2|Global Deterioration of Health Status|0
7278460|NCT00460603|11493529|FG009|Phase 2|Global Deterioration of Health Status|0
7278461|NCT00460603|11493530|FG010|Phase 2|Global Deterioration of Health Status|1
7278462|NCT00460603|11493531|FG011|Phase 2|Global Deterioration of Health Status|0
7278463|NCT00460603|11493520|FG000|Phase 2|Withdrawal by Subject|0
7278464|NCT00460603|11493521|FG001|Phase 2|Withdrawal by Subject|0
7278465|NCT00460603|11493522|FG002|Phase 2|Withdrawal by Subject|0
7278466|NCT00460603|11493523|FG003|Phase 2|Withdrawal by Subject|0
7278467|NCT00460603|11493524|FG004|Phase 2|Withdrawal by Subject|0
7278468|NCT00460603|11493525|FG005|Phase 2|Withdrawal by Subject|0
7278469|NCT00460603|11493526|FG006|Phase 2|Withdrawal by Subject|0
7278470|NCT00460603|11493527|FG007|Phase 2|Withdrawal by Subject|0
7278471|NCT00460603|11493528|FG008|Phase 2|Withdrawal by Subject|0
7278472|NCT00460603|11493529|FG009|Phase 2|Withdrawal by Subject|5
7278473|NCT00460603|11493530|FG010|Phase 2|Withdrawal by Subject|4
7278474|NCT00460603|11493531|FG011|Phase 2|Withdrawal by Subject|5
7278475|NCT00460603|11493520|FG000|Phase 2|Randomized, but not treated|0
7614198|NCT00687596|12023025|FG000|Overall Study|Sponsor Terminated Study|6
7614199|NCT00687596|12023026|FG001|Overall Study|Sponsor Terminated Study|17
7614200|NCT00458536|12023032|FG000|Overall Study|Disease progression prior to treatment|7
7614201|NCT00458536|12023032|FG000|Overall Study|Unable to make vaccine|3
7614202|NCT00458536|12023032|FG000|Overall Study|No measurable disease after surgery|2
7614203|NCT00458536|12023032|FG000|Overall Study|Did not have renal cell carcinoma|2
7614204|NCT00458536|12023032|FG000|Overall Study|Patient did not have surgery|1
7614205|NCT00458536|12023032|FG000|Overall Study|Ineligible due to toxicity|1
7614206|NCT00458536|12023032|FG000|Overall Study|Withdrawal by Subject|1
7614207|NCT00458536|12023032|FG000|Overall Study|Progressive disease during treatment|2
7614208|NCT00112840|12023039|FG000|Overall Study|Physician Decision|1
7614209|NCT00112840|12023040|FG001|Overall Study|Physician Decision|0
7614210|NCT00112840|12023041|FG002|Overall Study|Physician Decision|0
7614211|NCT00112840|12023039|FG000|Overall Study|Withdrawal by Subject|1
7614212|NCT00112840|12023040|FG001|Overall Study|Withdrawal by Subject|0
7614213|NCT00112840|12023041|FG002|Overall Study|Withdrawal by Subject|1
7278476|NCT00460603|11493521|FG001|Phase 2|Randomized, but not treated|0
7278477|NCT00460603|11493522|FG002|Phase 2|Randomized, but not treated|0
7278478|NCT00460603|11493523|FG003|Phase 2|Randomized, but not treated|0
7614214|NCT00112840|12023039|FG000|Overall Study|Protocol Violation|0
7614215|NCT00112840|12023040|FG001|Overall Study|Protocol Violation|0
7614216|NCT00112840|12023041|FG002|Overall Study|Protocol Violation|5
7614217|NCT04207749|12023070|FG000|Overall Study|Lost to Follow-up|0
7614218|NCT04207749|12023071|FG001|Overall Study|Lost to Follow-up|2
7614219|NCT04207749|12023070|FG000|Overall Study|Protocol Violation|0
7614220|NCT04207749|12023071|FG001|Overall Study|Protocol Violation|1
7614221|NCT04207749|12023070|FG000|Overall Study|Withdrawal by Subject|3
7614222|NCT04207749|12023071|FG001|Overall Study|Withdrawal by Subject|0
7614223|NCT04207749|12023070|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1
7614224|NCT04207749|12023071|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4
7614225|NCT04167345|12023085|FG000|Overall Study|Other|1
7614226|NCT04167345|12023086|FG001|Overall Study|Other|1
7614227|NCT04167345|12023087|FG002|Overall Study|Other|0
7614228|NCT04167345|12023088|FG003|Overall Study|Other|0
7614229|NCT04167345|12023089|FG004|Overall Study|Other|0
7614230|NCT04042077|12023107|FG000|Overall Study|Adverse Event|0
7614231|NCT04042077|12023108|FG001|Overall Study|Adverse Event|1
7614232|NCT04042077|12023107|FG000|Overall Study|Death|2
7614233|NCT04042077|12023108|FG001|Overall Study|Death|1
7614234|NCT04042077|12023107|FG000|Overall Study|Physician Decision|2
7614235|NCT04042077|12023108|FG001|Overall Study|Physician Decision|0
7614236|NCT04042077|12023107|FG000|Overall Study|Withdrawal by Subject|3
7614237|NCT04042077|12023108|FG001|Overall Study|Withdrawal by Subject|2
7614238|NCT04042077|12023107|FG000|Overall Study|Lack of Efficacy|0
7614239|NCT04042077|12023108|FG001|Overall Study|Lack of Efficacy|1
7614240|NCT04001803|12023120|FG000|Overall Study|Ongoing at the time of analysis|103
7614241|NCT04001803|12023120|FG000|Overall Study|Adverse Event|2
7614242|NCT04001803|12023120|FG000|Overall Study|Protocol Violation|2
7614243|NCT04001803|12023120|FG000|Overall Study|Lost to Follow-up|2
7614244|NCT04001803|12023120|FG000|Overall Study|Physician Decision|1
7614245|NCT04001803|12023120|FG000|Overall Study|Withdrawal by Subject|4
7614246|NCT03925324|12023136|FG000|Overall Study|Death|1
7614247|NCT03925324|12023137|FG001|Overall Study|Death|1
7614254|NCT03740009|12023156|FG000|Overall Study|Physician Decision|9
7614255|NCT03740009|12023156|FG000|Overall Study|Lost to Follow-up|1
7614256|NCT03738397|12023162|FG000|Overall Study|Adverse Event|3
7614257|NCT03738397|12023163|FG001|Overall Study|Adverse Event|7
7614258|NCT03738397|12023162|FG000|Overall Study|Withdrawal by Subject|8
7614259|NCT03738397|12023163|FG001|Overall Study|Withdrawal by Subject|11
7614260|NCT03738397|12023162|FG000|Overall Study|Lost to Follow-up|8
7614261|NCT03738397|12023163|FG001|Overall Study|Lost to Follow-up|5
7614262|NCT03738397|12023162|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7614263|NCT03738397|12023163|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7614264|NCT03738397|12023162|FG000|Overall Study|Other|4
7614265|NCT03738397|12023163|FG001|Overall Study|Other|6
7614266|NCT03666624|12023171|FG000|Overall Study|participant grieving over recent death of parent|1
7614267|NCT03666624|12023172|FG001|Overall Study|participant grieving over recent death of parent|0
7614268|NCT03649217|12023178|FG000|Overall Study|subject had severe ataxia not initially found|1
7278479|NCT00460603|11493524|FG004|Phase 2|Randomized, but not treated|0
7278480|NCT00460603|11493525|FG005|Phase 2|Randomized, but not treated|0
7278481|NCT00460603|11493526|FG006|Phase 2|Randomized, but not treated|0
7278482|NCT00460603|11493527|FG007|Phase 2|Randomized, but not treated|0
7278483|NCT00460603|11493528|FG008|Phase 2|Randomized, but not treated|0
7278484|NCT00460603|11493529|FG009|Phase 2|Randomized, but not treated|3
7278485|NCT00460603|11493530|FG010|Phase 2|Randomized, but not treated|0
7278486|NCT00460603|11493531|FG011|Phase 2|Randomized, but not treated|0
7278487|NCT00460655|11493559|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
7278488|NCT00460655|11493560|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
7614269|NCT03649217|12023178|FG000|Overall Study|subject had cognitive issues not initially found|1
7278489|NCT00460655|11493561|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
7614270|NCT03569293|12023188|FG000|Overall Study|Adverse Event|4
7614271|NCT03569293|12023189|FG001|Overall Study|Adverse Event|1
7614272|NCT03569293|12023190|FG002|Overall Study|Adverse Event|5
7614273|NCT03569293|12023191|FG003|Overall Study|Adverse Event|1
7614274|NCT03569293|12023192|FG004|Overall Study|Adverse Event|0
7614275|NCT03569293|12023193|FG005|Overall Study|Adverse Event|0
7614276|NCT03569293|12023188|FG000|Overall Study|Withdrawal by Subject|16
7614277|NCT03569293|12023189|FG001|Overall Study|Withdrawal by Subject|2
7614278|NCT03569293|12023190|FG002|Overall Study|Withdrawal by Subject|4
7614279|NCT03569293|12023191|FG003|Overall Study|Withdrawal by Subject|1
7614280|NCT03569293|12023192|FG004|Overall Study|Withdrawal by Subject|0
7614281|NCT03569293|12023193|FG005|Overall Study|Withdrawal by Subject|0
7614282|NCT03569293|12023188|FG000|Overall Study|Lost to Follow-up|1
7614283|NCT03569293|12023189|FG001|Overall Study|Lost to Follow-up|3
7614284|NCT03569293|12023190|FG002|Overall Study|Lost to Follow-up|1
7614285|NCT03569293|12023191|FG003|Overall Study|Lost to Follow-up|1
7614286|NCT03569293|12023192|FG004|Overall Study|Lost to Follow-up|0
7614287|NCT03569293|12023193|FG005|Overall Study|Lost to Follow-up|0
7614288|NCT03569293|12023188|FG000|Overall Study|Other|8
7614289|NCT03569293|12023189|FG001|Overall Study|Other|2
7614290|NCT03569293|12023190|FG002|Overall Study|Other|1
7614291|NCT03569293|12023191|FG003|Overall Study|Other|1
7614292|NCT03569293|12023192|FG004|Overall Study|Other|0
7614293|NCT03569293|12023193|FG005|Overall Study|Other|0
7614294|NCT03569293|12023188|FG000|Overall Study|Ongoing at Time of Analysis|8
7614295|NCT03569293|12023189|FG001|Overall Study|Ongoing at Time of Analysis|1
7614296|NCT03569293|12023190|FG002|Overall Study|Ongoing at Time of Analysis|3
7614297|NCT03569293|12023191|FG003|Overall Study|Ongoing at Time of Analysis|0
7614298|NCT03569293|12023192|FG004|Overall Study|Ongoing at Time of Analysis|0
7614299|NCT03569293|12023193|FG005|Overall Study|Ongoing at Time of Analysis|0
7278490|NCT00460655|11493562|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
7278491|NCT00460655|11493559|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
7278492|NCT00460655|11493560|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278493|NCT00460655|11493561|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278494|NCT00460655|11493562|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
7278495|NCT00460655|11493559|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7278496|NCT00460655|11493560|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
7278497|NCT00460655|11493561|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7278498|NCT00460655|11493562|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
7278499|NCT00460655|11493559|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
7278500|NCT00460655|11493560|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
7278501|NCT00460655|11493561|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
7278502|NCT00460655|11493562|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
7278503|NCT00460655|11493559|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278504|NCT00460655|11493560|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
7278505|NCT00460655|11493561|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
7614300|NCT03318003|12023278|FG000|Overall Study|Withdrawal by Subject|1
7614301|NCT03318003|12023279|FG001|Overall Study|Withdrawal by Subject|1
7614302|NCT03318003|12023278|FG000|Overall Study|fetal loss|0
7614303|NCT03318003|12023279|FG001|Overall Study|fetal loss|1
7614304|NCT03132753|12023305|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
7614305|NCT03132753|12023306|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
7614306|NCT03132753|12023305|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
7614307|NCT03132753|12023306|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
7614308|NCT03067077|12023321|FG000|Overall Study|Did not receive surgery|4
7614309|NCT03067077|12023322|FG001|Overall Study|Did not receive surgery|5
7614310|NCT03067077|12023321|FG000|Overall Study|Lost to Follow-up|3
7614311|NCT03067077|12023322|FG001|Overall Study|Lost to Follow-up|2
7614312|NCT03059446|12023328|FG000|Overall Study|Adverse Event|11
7614313|NCT03059446|12023328|FG000|Overall Study|Withdrawal of Consent|16
7614314|NCT03059446|12023328|FG000|Overall Study|Lost to Follow-up|3
7614315|NCT03059446|12023328|FG000|Overall Study|Protocol Violation|1
7614316|NCT03059446|12023328|FG000|Overall Study|Study Terminated by Sponsor|131
7614317|NCT03059446|12023328|FG000|Overall Study|Reason not Specified|5
7614318|NCT03011034|12023338|FG000|Overall Study|Adverse Event|1
7614319|NCT03011034|12023339|FG001|Overall Study|Adverse Event|0
7614326|NCT02601014|12023391|FG000|Overall Study|Adverse Event|3
7614327|NCT02601014|12023392|FG001|Overall Study|Adverse Event|3
7614328|NCT02601014|12023391|FG000|Overall Study|Death|3
7614329|NCT02601014|12023392|FG001|Overall Study|Death|1
7614330|NCT02601014|12023391|FG000|Overall Study|Disease progression|4
7614331|NCT02601014|12023392|FG001|Overall Study|Disease progression|8
7278506|NCT00460655|11493562|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
7278507|NCT00460655|11493559|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7278508|NCT00460655|11493560|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7278509|NCT00460655|11493561|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
7278510|NCT00460655|11493562|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
7278511|NCT00460746|11493572|FG000|Overall Study|Adverse Event|1
7278512|NCT00460746|11493572|FG000|Overall Study|Lost to Follow-up|1
7278513|NCT00460798|11493576|FG000|Overall Study|Death|59
7278514|NCT00460798|11493576|FG000|Overall Study|Adverse Event|27
7278515|NCT00460798|11493576|FG000|Overall Study|Lost to Follow-up|19
7278516|NCT00460798|11493576|FG000|Overall Study|Progressive Disease|99
7278517|NCT00460798|11493576|FG000|Overall Study|Other|27
7278518|NCT00460798|11493576|FG000|Overall Study|Ongoing at Date of Cut-Off|82
7278519|NCT00460798|11493576|FG000|Overall Study|Missing/Incomplete Dosing Information|27
7278520|NCT00460811|11493585|FG000|Overall Study|Adverse Event|4
7278521|NCT00460811|11493586|FG001|Overall Study|Adverse Event|6
7278522|NCT00460811|11493587|FG002|Overall Study|Adverse Event|3
7278523|NCT00460811|11493588|FG003|Overall Study|Adverse Event|10
7278524|NCT00460811|11493589|FG004|Overall Study|Adverse Event|2
7278525|NCT00460811|11493585|FG000|Overall Study|Noncompliance|1
7278526|NCT00460811|11493586|FG001|Overall Study|Noncompliance|0
7278527|NCT00460811|11493587|FG002|Overall Study|Noncompliance|0
7278528|NCT00460811|11493588|FG003|Overall Study|Noncompliance|2
7278529|NCT00460811|11493589|FG004|Overall Study|Noncompliance|1
7278530|NCT00460811|11493585|FG000|Overall Study|Withdrawal by Subject|7
7278531|NCT00460811|11493586|FG001|Overall Study|Withdrawal by Subject|7
7278532|NCT00460811|11493587|FG002|Overall Study|Withdrawal by Subject|6
7278533|NCT00460811|11493588|FG003|Overall Study|Withdrawal by Subject|3
7278534|NCT00460811|11493589|FG004|Overall Study|Withdrawal by Subject|11
7278535|NCT00460811|11493585|FG000|Overall Study|Physician Decision|1
7278536|NCT00460811|11493586|FG001|Overall Study|Physician Decision|0
7278537|NCT00460811|11493587|FG002|Overall Study|Physician Decision|0
7614368|NCT02538666|12023410|FG000|Overall Study|Disease progression|1
7614369|NCT02538666|12023411|FG001|Overall Study|Disease progression|0
7614370|NCT02538666|12023412|FG002|Overall Study|Disease progression|0
7614371|NCT02538666|12023410|FG000|Overall Study|no longer meets study criteria|1
7614372|NCT02538666|12023411|FG001|Overall Study|no longer meets study criteria|0
7614373|NCT02538666|12023412|FG002|Overall Study|no longer meets study criteria|0
7614374|NCT02538666|12023410|FG000|Overall Study|Withdrew Consent|0
7614375|NCT02538666|12023411|FG001|Overall Study|Withdrew Consent|1
7614376|NCT02538666|12023412|FG002|Overall Study|Withdrew Consent|1
7614377|NCT02527200|12023425|FG000|Overall Study|Withdrawal by Subject|3
7614378|NCT02527200|12023426|FG001|Overall Study|Withdrawal by Subject|2
7614379|NCT02527200|12023427|FG002|Overall Study|Withdrawal by Subject|1
7614380|NCT02527200|12023428|FG003|Overall Study|Withdrawal by Subject|0
7614381|NCT02527200|12023425|FG000|Overall Study|Unclassified|0
7614382|NCT02527200|12023426|FG001|Overall Study|Unclassified|1
7614383|NCT02527200|12023427|FG002|Overall Study|Unclassified|0
7614384|NCT02527200|12023428|FG003|Overall Study|Unclassified|0
7614385|NCT02527200|12023425|FG000|Overall Study|Lost to Follow-up|0
7614386|NCT02527200|12023426|FG001|Overall Study|Lost to Follow-up|0
7614387|NCT02527200|12023427|FG002|Overall Study|Lost to Follow-up|1
7614388|NCT02527200|12023428|FG003|Overall Study|Lost to Follow-up|0
7614389|NCT02511106|12023444|FG000|Overall Study|Lost to Follow-up|1
7614390|NCT02511106|12023445|FG001|Overall Study|Lost to Follow-up|2
7614391|NCT02511106|12023444|FG000|Overall Study|Withdrawal by Subject|19
7614392|NCT02511106|12023445|FG001|Overall Study|Withdrawal by Subject|14
7614393|NCT02511106|12023444|FG000|Overall Study|Ongoing study at data cut-off|309
7614394|NCT02511106|12023445|FG001|Overall Study|Ongoing study at data cut-off|307
7614395|NCT02511106|12023444|FG000|Overall Study|Without specified reason|1
7614396|NCT02511106|12023445|FG001|Overall Study|Without specified reason|0
7614397|NCT02511106|12023444|FG000|Overall Study|Missing|1
7614398|NCT02511106|12023445|FG001|Overall Study|Missing|0
7614399|NCT02224573|12023487|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0
7614400|NCT02224573|12023488|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1
7614401|NCT02224573|12023487|FG000|Treatment Phase|Started on Other IMP|1
7614402|NCT02224573|12023488|FG001|Treatment Phase|Started on Other IMP|0
7614403|NCT02224573|12023487|FG000|Treatment Phase|Participant Discontinued IMP|0
7614404|NCT02224573|12023488|FG001|Treatment Phase|Participant Discontinued IMP|1
7614405|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficacy|15
7614406|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficacy|8
7614407|NCT02224573|12023487|FG000|Treatment Phase|Began Commercial Product|1
7614408|NCT02224573|12023488|FG001|Treatment Phase|Began Commercial Product|0
7614409|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
7614410|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
7614411|NCT02224573|12023487|FG000|Treatment Phase|Met Withdrawal Criteria|5
7614412|NCT02224573|12023488|FG001|Treatment Phase|Met Withdrawal Criteria|7
7614413|NCT02224573|12023487|FG000|Treatment Phase|Participant Did Not Return for Visits|0
7614414|NCT02224573|12023488|FG001|Treatment Phase|Participant Did Not Return for Visits|1
7614415|NCT02224573|12023487|FG000|Treatment Phase|Continued Compassionate Use|1
7614416|NCT02224573|12023488|FG001|Treatment Phase|Continued Compassionate Use|0
7614417|NCT02224573|12023487|FG000|Treatment Phase|Lack of Efficiency|2
7614418|NCT02224573|12023488|FG001|Treatment Phase|Lack of Efficiency|1
7614419|NCT02224573|12023487|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0
7614420|NCT02224573|12023488|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1
7614421|NCT02224573|12023487|FG000|Treatment Phase|Participant Moved|2
7614422|NCT02224573|12023488|FG001|Treatment Phase|Participant Moved|0
7614423|NCT02224573|12023487|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62
7614424|NCT02224573|12023488|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48
7614425|NCT02224573|12023487|FG000|Treatment Phase|Refused Medication|1
7614426|NCT02224573|12023488|FG001|Treatment Phase|Refused Medication|1
7614427|NCT02224573|12023487|FG000|Treatment Phase|Adverse Event|26
7614428|NCT02224573|12023488|FG001|Treatment Phase|Adverse Event|38
7614429|NCT02224573|12023487|FG000|Treatment Phase|Placed in Group Home|0
7278538|NCT00460811|11493588|FG003|Overall Study|Physician Decision|0
7278539|NCT00460811|11493589|FG004|Overall Study|Physician Decision|0
7278540|NCT00460811|11493585|FG000|Overall Study|Lost to Follow-up|3
7278541|NCT00460811|11493586|FG001|Overall Study|Lost to Follow-up|2
7278542|NCT00460811|11493587|FG002|Overall Study|Lost to Follow-up|5
7278543|NCT00460811|11493588|FG003|Overall Study|Lost to Follow-up|3
7278544|NCT00460811|11493589|FG004|Overall Study|Lost to Follow-up|6
7278545|NCT00461123|11493631|FG000|Overall Study|Adverse Event|1
7278546|NCT00461123|11493632|FG001|Overall Study|Adverse Event|0
7278547|NCT00461123|11493631|FG000|Overall Study|Lost to Follow-up|1
7278548|NCT00461123|11493632|FG001|Overall Study|Lost to Follow-up|1
7278549|NCT00461123|11493631|FG000|Overall Study|Protocol Violation|3
7278550|NCT00461123|11493632|FG001|Overall Study|Protocol Violation|2
7278551|NCT00461123|11493631|FG000|Overall Study|Withdrawal by Subject|1
7278552|NCT00461123|11493632|FG001|Overall Study|Withdrawal by Subject|3
7278553|NCT00461175|11493640|FG000|Overall Study|Protocol Violation|522
7278554|NCT00461175|11493641|FG001|Overall Study|Protocol Violation|365
7278555|NCT00461253|11493649|FG000|Overall Study|Death|985
7278556|NCT00461253|11493650|FG001|Overall Study|Death|0
7278557|NCT00461253|11493649|FG000|Overall Study|Protocol Violation|613
7278558|NCT00461253|11493650|FG001|Overall Study|Protocol Violation|236
7278559|NCT00461253|11493649|FG000|Overall Study|no response|2609
7278560|NCT00461253|11493650|FG001|Overall Study|no response|11789
7278561|NCT00461253|11493649|FG000|Overall Study|administrative|773
7278562|NCT00461253|11493650|FG001|Overall Study|administrative|7773
7278563|NCT00461305|11493671|FG000|Treatment|Adverse Event|26
7278564|NCT00461305|11493672|FG001|Treatment|Adverse Event|3
7278565|NCT00461305|11493671|FG000|Treatment|Lost to Follow-up|4
7278566|NCT00461305|11493672|FG001|Treatment|Lost to Follow-up|2
7278567|NCT00461305|11493671|FG000|Treatment|Protocol Violation|13
7278568|NCT00461305|11493672|FG001|Treatment|Protocol Violation|2
7278569|NCT00461305|11493671|FG000|Treatment|Withdrawal by Subject|48
7614430|NCT02224573|12023488|FG001|Treatment Phase|Placed in Group Home|1
7614431|NCT02224573|12023487|FG000|Treatment Phase|Pursued Other Trials|1
7278570|NCT00461305|11493672|FG001|Treatment|Withdrawal by Subject|2
7278571|NCT00461305|11493671|FG000|Treatment|Never dispensed|5
7614432|NCT02224573|12023488|FG001|Treatment Phase|Pursued Other Trials|0
7614433|NCT02224573|12023487|FG000|Treatment Phase|Withdrawn by the Investigator|23
7614434|NCT02224573|12023488|FG001|Treatment Phase|Withdrawn by the Investigator|11
7614435|NCT02224573|12023487|FG000|Treatment Phase|Lost to Follow-up|2
7614436|NCT02224573|12023488|FG001|Treatment Phase|Lost to Follow-up|1
7614437|NCT02224573|12023487|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1
7614438|NCT02224573|12023488|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0
7614439|NCT02224573|12023487|FG000|Taper Phase|Hospitalization/Dose Reduction|1
7614440|NCT02224573|12023488|FG001|Taper Phase|Hospitalization/Dose Reduction|0
7614441|NCT02224573|12023487|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0
7614442|NCT02224573|12023488|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3
7614443|NCT02224573|12023487|FG000|Taper Phase|Adverse Event|1
7614444|NCT02224573|12023488|FG001|Taper Phase|Adverse Event|1
7614445|NCT01991067|12023497|FG000|Overall Study|Lost to Follow-up|6
7614446|NCT01991067|12023498|FG001|Overall Study|Lost to Follow-up|5
7614447|NCT01774721|12023519|FG000|Overall Study|Death|76
7614448|NCT01774721|12023520|FG001|Overall Study|Death|91
7614449|NCT01774721|12023519|FG000|Overall Study|Withdrawal by Subject|14
7614450|NCT01774721|12023520|FG001|Overall Study|Withdrawal by Subject|10
7614451|NCT01774721|12023519|FG000|Overall Study|Lost to Follow-up|1
7614452|NCT01774721|12023520|FG001|Overall Study|Lost to Follow-up|1
7614453|NCT01774721|12023519|FG000|Overall Study|Did not meet eligibility criteria|0
7614454|NCT01774721|12023520|FG001|Overall Study|Did not meet eligibility criteria|3
7614455|NCT01774721|12023519|FG000|Overall Study|Ongoing in study|136
7614456|NCT01774721|12023520|FG001|Overall Study|Ongoing in study|120
7614457|NCT01709331|12023537|FG000|Overall Study|Adverse Event|1
7614458|NCT01656434|12023543|FG000|Overall Study|Adverse Event|199
7278572|NCT00461305|11493672|FG001|Treatment|Never dispensed|0
7278573|NCT00461305|11493671|FG000|Treatment|Study drug not taken|1
7614459|NCT01656434|12023544|FG001|Overall Study|Adverse Event|63
7614460|NCT01656434|12023543|FG000|Overall Study|Enrollment terminated at trial site|2
7614461|NCT01656434|12023544|FG001|Overall Study|Enrollment terminated at trial site|0
7614462|NCT01656434|12023543|FG000|Overall Study|Lost to Follow-up|309
7614463|NCT01656434|12023544|FG001|Overall Study|Lost to Follow-up|76
7614464|NCT01656434|12023543|FG000|Overall Study|Site discontinued study participation|24
7614465|NCT01656434|12023544|FG001|Overall Study|Site discontinued study participation|9
7614466|NCT01656434|12023543|FG000|Overall Study|Screen failure|2
7614467|NCT01656434|12023544|FG001|Overall Study|Screen failure|0
7614468|NCT01656434|12023543|FG000|Overall Study|Protocol Violation|7
7614469|NCT01656434|12023544|FG001|Overall Study|Protocol Violation|0
7614470|NCT01656434|12023543|FG000|Overall Study|Pregnancy wish|18
7614471|NCT01656434|12023544|FG001|Overall Study|Pregnancy wish|6
7614472|NCT01656434|12023543|FG000|Overall Study|Pregnancy|45
7614473|NCT01656434|12023544|FG001|Overall Study|Pregnancy|10
7614474|NCT01656434|12023543|FG000|Overall Study|Physician Decision|7
7614475|NCT01656434|12023544|FG001|Overall Study|Physician Decision|2
7614476|NCT01656434|12023543|FG000|Overall Study|Non-compliance with study drug|48
7614477|NCT01656434|12023544|FG001|Overall Study|Non-compliance with study drug|9
7614478|NCT01656434|12023543|FG000|Overall Study|Study terminated by sponsor|1501
7614479|NCT01656434|12023544|FG001|Overall Study|Study terminated by sponsor|348
7614480|NCT01656434|12023543|FG000|Overall Study|Participant discontinued; drug related|13
7614481|NCT01656434|12023544|FG001|Overall Study|Participant discontinued; drug related|4
7614482|NCT01656434|12023543|FG000|Overall Study|Part. discontinued; unrelated to drug|55
7614483|NCT01656434|12023544|FG001|Overall Study|Part. discontinued; unrelated to drug|10
7614484|NCT01656434|12023543|FG000|Overall Study|Non-compliance with protocol|39
7614485|NCT01656434|12023544|FG001|Overall Study|Non-compliance with protocol|15
7614486|NCT01656434|12023543|FG000|Overall Study|Participant moved|40
7614487|NCT01656434|12023544|FG001|Overall Study|Participant moved|12
7614488|NCT01656434|12023543|FG000|Overall Study|Participant withdrew consent|28
7614489|NCT01656434|12023544|FG001|Overall Study|Participant withdrew consent|9
7614490|NCT01656434|12023543|FG000|Overall Study|Withdrawal by Subject|64
7614491|NCT01656434|12023544|FG001|Overall Study|Withdrawal by Subject|7
7614492|NCT01496118|12023573|FG000|Overall Study|Disease progression|3
7614493|NCT01496118|12023574|FG001|Overall Study|Disease progression|2
7614494|NCT01496118|12023575|FG002|Overall Study|Disease progression|3
7614495|NCT01496118|12023576|FG003|Overall Study|Disease progression|1
7614496|NCT01496118|12023577|FG004|Overall Study|Disease progression|2
7614497|NCT01496118|12023578|FG005|Overall Study|Disease progression|2
7614498|NCT01496118|12023579|FG006|Overall Study|Disease progression|14
7614499|NCT01496118|12023580|FG007|Overall Study|Disease progression|10
7614500|NCT01496118|12023573|FG000|Overall Study|Physician Decision|0
7614501|NCT01496118|12023574|FG001|Overall Study|Physician Decision|0
7614502|NCT01496118|12023575|FG002|Overall Study|Physician Decision|0
7614503|NCT01496118|12023576|FG003|Overall Study|Physician Decision|0
7614504|NCT01496118|12023577|FG004|Overall Study|Physician Decision|1
7614505|NCT01496118|12023578|FG005|Overall Study|Physician Decision|0
7614506|NCT01496118|12023579|FG006|Overall Study|Physician Decision|3
7614507|NCT01496118|12023580|FG007|Overall Study|Physician Decision|6
7614508|NCT01496118|12023573|FG000|Overall Study|Adverse Event|1
7614509|NCT01496118|12023574|FG001|Overall Study|Adverse Event|1
7614510|NCT01496118|12023575|FG002|Overall Study|Adverse Event|0
7614511|NCT01496118|12023576|FG003|Overall Study|Adverse Event|0
7614512|NCT01496118|12023577|FG004|Overall Study|Adverse Event|0
7614513|NCT01496118|12023578|FG005|Overall Study|Adverse Event|0
7614514|NCT01496118|12023579|FG006|Overall Study|Adverse Event|6
7614515|NCT01496118|12023580|FG007|Overall Study|Adverse Event|10
7614516|NCT01496118|12023573|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614517|NCT01496118|12023574|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614518|NCT01496118|12023575|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614519|NCT01496118|12023576|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614520|NCT01496118|12023577|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614521|NCT01496118|12023578|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614522|NCT01496118|12023579|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1
7614523|NCT01496118|12023580|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0
7614524|NCT01496118|12023573|FG000|Overall Study|Death|0
7614525|NCT01496118|12023574|FG001|Overall Study|Death|0
7614526|NCT01496118|12023575|FG002|Overall Study|Death|0
7614527|NCT01496118|12023576|FG003|Overall Study|Death|0
7614528|NCT01496118|12023577|FG004|Overall Study|Death|0
7614529|NCT01496118|12023578|FG005|Overall Study|Death|0
7614530|NCT01496118|12023579|FG006|Overall Study|Death|1
7614531|NCT01496118|12023580|FG007|Overall Study|Death|1
7614532|NCT01496118|12023573|FG000|Overall Study|Withdrawal by Subject|0
7614533|NCT01496118|12023574|FG001|Overall Study|Withdrawal by Subject|0
7614534|NCT01496118|12023575|FG002|Overall Study|Withdrawal by Subject|0
7614535|NCT01496118|12023576|FG003|Overall Study|Withdrawal by Subject|2
7614536|NCT01496118|12023577|FG004|Overall Study|Withdrawal by Subject|0
7614537|NCT01496118|12023578|FG005|Overall Study|Withdrawal by Subject|1
7614538|NCT01496118|12023579|FG006|Overall Study|Withdrawal by Subject|6
7614539|NCT01496118|12023580|FG007|Overall Study|Withdrawal by Subject|3
7614540|NCT01350934|12023600|FG000|Base Study|Adverse Event|6
7614541|NCT01350934|12023601|FG001|Base Study|Adverse Event|0
7614542|NCT01350934|12023600|FG000|Base Study|Lost to Follow-up|1
7614543|NCT01350934|12023601|FG001|Base Study|Lost to Follow-up|0
7614544|NCT01350934|12023600|FG000|Base Study|Protocol Violation|1
7614545|NCT01350934|12023601|FG001|Base Study|Protocol Violation|1
7614546|NCT01350934|12023600|FG000|Base Study|Withdrawal by Subject|1
7614547|NCT01350934|12023601|FG001|Base Study|Withdrawal by Subject|2
7614548|NCT01350934|12023600|FG000|Base Study|Non-Compliance With Study Drug|2
7614549|NCT01350934|12023601|FG001|Base Study|Non-Compliance With Study Drug|0
7614550|NCT01350934|12023600|FG000|Extension Study|Adverse Event|2
7614551|NCT01350934|12023601|FG001|Extension Study|Adverse Event|1
7614552|NCT01350934|12023600|FG000|Extension Study|Lost to Follow-up|2
7614553|NCT01350934|12023601|FG001|Extension Study|Lost to Follow-up|0
7614554|NCT01350934|12023600|FG000|Extension Study|Protocol Violation|1
7614555|NCT01350934|12023601|FG001|Extension Study|Protocol Violation|1
7278574|NCT00461305|11493672|FG001|Treatment|Study drug not taken|0
7278575|NCT00461305|11493671|FG000|Treatment|Partially missing diary|2
7278576|NCT00461305|11493672|FG001|Treatment|Partially missing diary|0
7278577|NCT00461305|11493671|FG000|Treatment|Other (missing drug etc)|2
7278578|NCT00461305|11493672|FG001|Treatment|Other (missing drug etc)|0
7278579|NCT00461305|11493671|FG000|Continued Treatment|Adverse Event|26
7614556|NCT01350934|12023600|FG000|Extension Study|Lack of Efficacy|0
7614557|NCT01350934|12023601|FG001|Extension Study|Lack of Efficacy|1
7614558|NCT01350934|12023600|FG000|Extension Study|Withdrawal by Subject|0
7614559|NCT01350934|12023601|FG001|Extension Study|Withdrawal by Subject|1
7614560|NCT01286207|12023610|FG000|Overall Study|Adverse Event|27
7614561|NCT01286207|12023611|FG001|Overall Study|Adverse Event|41
7614562|NCT01286207|12023612|FG002|Overall Study|Adverse Event|8
7614563|NCT01286207|12023610|FG000|Overall Study|Lost to Follow-up|49
7614564|NCT01286207|12023611|FG001|Overall Study|Lost to Follow-up|43
7614565|NCT01286207|12023612|FG002|Overall Study|Lost to Follow-up|20
7614566|NCT01286207|12023610|FG000|Overall Study|Withdrawal by Subject|93
7614567|NCT01286207|12023611|FG001|Overall Study|Withdrawal by Subject|79
7614568|NCT01286207|12023612|FG002|Overall Study|Withdrawal by Subject|41
7614569|NCT01286207|12023610|FG000|Overall Study|Lack of Response|92
7614570|NCT01286207|12023611|FG001|Overall Study|Lack of Response|38
7614571|NCT01286207|12023612|FG002|Overall Study|Lack of Response|8
7614572|NCT01286207|12023610|FG000|Overall Study|Other|37
7614573|NCT01286207|12023611|FG001|Overall Study|Other|47
7614574|NCT01286207|12023612|FG002|Overall Study|Other|13
7614576|NCT01227187|12023628|FG000|Overall Study|Physician Decision|0
7614577|NCT01227187|12023629|FG001|Overall Study|Physician Decision|0
7614578|NCT01227187|12023630|FG002|Overall Study|Physician Decision|0
7278580|NCT00461305|11493672|FG001|Continued Treatment|Adverse Event|0
7278581|NCT00461305|11493671|FG000|Continued Treatment|Lost to Follow-up|4
7278582|NCT00461305|11493672|FG001|Continued Treatment|Lost to Follow-up|0
7278583|NCT00461305|11493671|FG000|Continued Treatment|Protocol Violation|13
7278584|NCT00461305|11493672|FG001|Continued Treatment|Protocol Violation|0
7278585|NCT00461305|11493671|FG000|Continued Treatment|Withdrawal by Subject|48
7278586|NCT00461305|11493672|FG001|Continued Treatment|Withdrawal by Subject|0
7278587|NCT00461305|11493671|FG000|Continued Treatment|Partially missing diary|2
7278588|NCT00461305|11493672|FG001|Continued Treatment|Partially missing diary|0
7278589|NCT00461305|11493671|FG000|Continued Treatment|Other (missing drug etc)|2
7278590|NCT00461305|11493672|FG001|Continued Treatment|Other (missing drug etc)|0
7278591|NCT00461500|11493689|FG000|Overall Study|Adverse Event|1
7278592|NCT00461500|11493690|FG001|Overall Study|Adverse Event|0
7278593|NCT00461500|11493689|FG000|Overall Study|Lack of Efficacy|0
7278594|NCT00461500|11493690|FG001|Overall Study|Lack of Efficacy|1
7278595|NCT00461500|11493689|FG000|Overall Study|Expired Drug Treatment|1
7278596|NCT00461500|11493690|FG001|Overall Study|Expired Drug Treatment|1
7278597|NCT00461500|11493689|FG000|Overall Study|Study Stopped|1
7278598|NCT00461500|11493690|FG001|Overall Study|Study Stopped|2
7614579|NCT01227187|12023631|FG003|Overall Study|Physician Decision|1
7614580|NCT01144416|12023658|FG000|Intervention Period|Adverse Event|5
7614581|NCT01144416|12023659|FG001|Intervention Period|Adverse Event|6
7614582|NCT01144416|12023658|FG000|Intervention Period|Insufficient ovarian response|11
7278599|NCT00461500|11493689|FG000|Overall Study|Drug Treatment Misuse|1
7278600|NCT00461500|11493690|FG001|Overall Study|Drug Treatment Misuse|0
7278601|NCT00461500|11493689|FG000|Overall Study|No Longer Willing to Take Part in Study|1
7614583|NCT01144416|12023659|FG001|Intervention Period|Insufficient ovarian response|17
7614584|NCT01144416|12023658|FG000|Intervention Period|Risk of OHSS|0
7614585|NCT01144416|12023659|FG001|Intervention Period|Risk of OHSS|1
7614586|NCT01144416|12023658|FG000|Intervention Period|Too high ovarian response|4
7614587|NCT01144416|12023659|FG001|Intervention Period|Too high ovarian response|2
7614588|NCT01144416|12023658|FG000|Intervention Period|No/too few/bad oocytes|7
7614589|NCT01144416|12023659|FG001|Intervention Period|No/too few/bad oocytes|5
7614590|NCT01144416|12023658|FG000|Intervention Period|No or abnormal fertilization|25
7614591|NCT01144416|12023659|FG001|Intervention Period|No or abnormal fertilization|10
7614592|NCT01144416|12023658|FG000|Intervention Period|No/too few/bad quality embryos|3
7614593|NCT01144416|12023659|FG001|Intervention Period|No/too few/bad quality embryos|3
7614594|NCT01144416|12023658|FG000|Intervention Period|Other|7
7614595|NCT01144416|12023659|FG001|Intervention Period|Other|5
7614596|NCT01140048|12023669|FG000|Overall Study|Physician Decision|1
7614597|NCT01140048|12023669|FG000|Overall Study|Withdrawal by Subject|13
7614598|NCT01140048|12023669|FG000|Overall Study|Lost to Follow-up|31
7614599|NCT01065779|12023684|FG000|Overall Study|Duplicate Investigation|1
7614600|NCT01065779|12023684|FG000|Overall Study|Investigation Before Contract Date|37
7614601|NCT01065779|12023684|FG000|Overall Study|Non-enrollment Period Administration|10
7614602|NCT01065779|12023684|FG000|Overall Study|Not Administered With Study Drug|17
7614603|NCT01065779|12023684|FG000|Overall Study|Failed to Follow-up|10
7614604|NCT01065779|12023684|FG000|Overall Study|Inclusion Criteria Violation|7
7278602|NCT00461500|11493690|FG001|Overall Study|No Longer Willing to Take Part in Study|0
7614605|NCT00974571|12023691|FG000|Overall Study|Adverse Event|31
7614606|NCT00974571|12023692|FG001|Overall Study|Adverse Event|4
7614607|NCT00974571|12023693|FG002|Overall Study|Adverse Event|27
7614608|NCT00974571|12023691|FG000|Overall Study|Lack of Efficacy|3
7614609|NCT00974571|12023692|FG001|Overall Study|Lack of Efficacy|2
7614610|NCT00974571|12023693|FG002|Overall Study|Lack of Efficacy|9
7614611|NCT00974571|12023691|FG000|Overall Study|Lost to Follow-up|2
7614612|NCT00974571|12023692|FG001|Overall Study|Lost to Follow-up|1
7614613|NCT00974571|12023693|FG002|Overall Study|Lost to Follow-up|2
7614614|NCT00974571|12023691|FG000|Overall Study|Protocol Violation|13
7614615|NCT00974571|12023692|FG001|Overall Study|Protocol Violation|4
7614616|NCT00974571|12023693|FG002|Overall Study|Protocol Violation|18
7278603|NCT00461500|11493689|FG000|Overall Study|Lost to Follow-up|2
7278604|NCT00461500|11493690|FG001|Overall Study|Lost to Follow-up|2
7278605|NCT00461552|11493711|FG000|Overall Study|Drug Dispensing error|0
7278606|NCT00461552|11493712|FG001|Overall Study|Drug Dispensing error|2
7278607|NCT00461630|11493729|FG000|Overall Study|Death|798
7278608|NCT00461630|11493730|FG001|Overall Study|Death|732
7278609|NCT00461630|11493729|FG000|Overall Study|Lost to Follow-up|108
7278610|NCT00461630|11493730|FG001|Overall Study|Lost to Follow-up|95
7278611|NCT00461708|11493738|FG000|Overall Study|Adverse Event|17
7278612|NCT00461708|11493739|FG001|Overall Study|Adverse Event|7
7278613|NCT00461708|11493738|FG000|Overall Study|Lack of Efficacy|68
7278614|NCT00461708|11493739|FG001|Overall Study|Lack of Efficacy|20
7278615|NCT00461708|11493738|FG000|Overall Study|Physician Decision|10
7278616|NCT00461708|11493739|FG001|Overall Study|Physician Decision|4
7278617|NCT00461708|11493738|FG000|Overall Study|Withdrawal by Subject|8
7278618|NCT00461708|11493739|FG001|Overall Study|Withdrawal by Subject|2
7278619|NCT00461708|11493738|FG000|Overall Study|Other|4
7278620|NCT00461708|11493739|FG001|Overall Study|Other|4
7278621|NCT00461708|11493738|FG000|Overall Study|Death|8
7278622|NCT00461708|11493739|FG001|Overall Study|Death|1
7278623|NCT00461786|11493771|FG000|Overall Study|Entry Criteria Not Met|2
7278624|NCT00461786|11493771|FG000|Overall Study|Inevaluable (Never Treated)|1
7278625|NCT00461981|11493781|FG000|Overall Study|Lost to Follow-up|9
7278626|NCT00461981|11493782|FG001|Overall Study|Lost to Follow-up|6
7278627|NCT00461981|11493781|FG000|Overall Study|Withdrawal by Subject|2
7278628|NCT00461981|11493782|FG001|Overall Study|Withdrawal by Subject|3
7278629|NCT00462306|11493847|FG000|Overall Study|insufficient data|0
7278630|NCT00462306|11493848|FG001|Overall Study|insufficient data|13
7278631|NCT00462345|11493867|FG000|Overall Study|Withdrawal by Subject|2
7278632|NCT00462345|11493867|FG000|Overall Study|Did not complete second course|1
7278633|NCT00462384|11493871|FG000|Overall Study|Adverse Event|2
7278634|NCT00462384|11493871|FG000|Overall Study|Death|2
7278635|NCT00462384|11493871|FG000|Overall Study|Withdrawal by Subject|1
7278636|NCT00462384|11493871|FG000|Overall Study|Other|4
7278637|NCT00462462|11493891|FG000|Overall Study|Physician Decision|0
7278638|NCT00462462|11493892|FG001|Overall Study|Physician Decision|1
7278639|NCT00462488|11493902|FG000|Overall Study|Protocol Violation|1
7278640|NCT00462488|11493903|FG001|Overall Study|Protocol Violation|0
7278641|NCT00462488|11493902|FG000|Overall Study|Lack of Efficacy|19
7278642|NCT00462488|11493903|FG001|Overall Study|Lack of Efficacy|17
7278643|NCT00462501|11493909|FG000|Overall Study|Not treated|3
7614617|NCT00974571|12023691|FG000|Overall Study|Withdrawal by Subject|14
7614618|NCT00974571|12023692|FG001|Overall Study|Withdrawal by Subject|5
7614619|NCT00974571|12023693|FG002|Overall Study|Withdrawal by Subject|16
7614620|NCT00974571|12023691|FG000|Overall Study|Patient Moved|1
7614621|NCT00974571|12023692|FG001|Overall Study|Patient Moved|0
7614622|NCT00974571|12023693|FG002|Overall Study|Patient Moved|1
7614623|NCT00974571|12023691|FG000|Overall Study|Other|4
7614624|NCT00974571|12023692|FG001|Overall Study|Other|0
7614625|NCT00974571|12023693|FG002|Overall Study|Other|10
7614626|NCT00972738|12023704|FG000|Overall Study|Adverse Event|7
7614627|NCT00972738|12023705|FG001|Overall Study|Adverse Event|1
7614628|NCT00972738|12023706|FG002|Overall Study|Adverse Event|8
7614629|NCT00972738|12023704|FG000|Overall Study|Protocol Violation|2
7614630|NCT00972738|12023705|FG001|Overall Study|Protocol Violation|1
7614631|NCT00972738|12023706|FG002|Overall Study|Protocol Violation|3
7614632|NCT00972738|12023704|FG000|Overall Study|Lost to Follow-up|1
7614633|NCT00972738|12023705|FG001|Overall Study|Lost to Follow-up|0
7614634|NCT00972738|12023706|FG002|Overall Study|Lost to Follow-up|1
7614635|NCT00972738|12023704|FG000|Overall Study|Lack of Efficacy|5
7614636|NCT00972738|12023705|FG001|Overall Study|Lack of Efficacy|1
7614637|NCT00972738|12023706|FG002|Overall Study|Lack of Efficacy|11
7614638|NCT00972738|12023704|FG000|Overall Study|Withdrawal by Subject|5
7614639|NCT00972738|12023705|FG001|Overall Study|Withdrawal by Subject|1
7614640|NCT00972738|12023706|FG002|Overall Study|Withdrawal by Subject|4
7614641|NCT00972738|12023704|FG000|Overall Study|Moved|0
7614642|NCT00972738|12023705|FG001|Overall Study|Moved|0
7614643|NCT00972738|12023706|FG002|Overall Study|Moved|1
7614644|NCT00972738|12023704|FG000|Overall Study|Other|1
7614645|NCT00972738|12023705|FG001|Overall Study|Other|2
7614646|NCT00972738|12023706|FG002|Overall Study|Other|1
7614647|NCT00968201|12023716|FG000|Base Study - (Period II)|Adverse Event|8
7614648|NCT00968201|12023717|FG001|Base Study - (Period II)|Adverse Event|0
7614649|NCT00968201|12023718|FG002|Base Study - (Period II)|Adverse Event|16
7614650|NCT00968201|12023716|FG000|Base Study - (Period II)|Lack of Efficacy|0
7614651|NCT00968201|12023717|FG001|Base Study - (Period II)|Lack of Efficacy|0
7614652|NCT00968201|12023718|FG002|Base Study - (Period II)|Lack of Efficacy|1
7614653|NCT00968201|12023716|FG000|Base Study - (Period II)|Lost to Follow-up|2
7614654|NCT00968201|12023717|FG001|Base Study - (Period II)|Lost to Follow-up|0
7614655|NCT00968201|12023718|FG002|Base Study - (Period II)|Lost to Follow-up|7
7614656|NCT00968201|12023716|FG000|Base Study - (Period II)|Protocol Violation|12
7614657|NCT00968201|12023717|FG001|Base Study - (Period II)|Protocol Violation|0
7614658|NCT00968201|12023718|FG002|Base Study - (Period II)|Protocol Violation|12
7614659|NCT00968201|12023716|FG000|Base Study - (Period II)|Withdrawal by Subject|4
7614660|NCT00968201|12023717|FG001|Base Study - (Period II)|Withdrawal by Subject|0
7614661|NCT00968201|12023718|FG002|Base Study - (Period II)|Withdrawal by Subject|8
7614662|NCT00968201|12023716|FG000|Base Study - (Period II)|Site Error|0
7614663|NCT00968201|12023717|FG001|Base Study - (Period II)|Site Error|0
7614664|NCT00968201|12023718|FG002|Base Study - (Period II)|Site Error|1
7614665|NCT00968201|12023716|FG000|Extension Study - (Period III)|Adverse Event|0
7614666|NCT00968201|12023717|FG001|Extension Study - (Period III)|Adverse Event|5
7614667|NCT00968201|12023718|FG002|Extension Study - (Period III)|Adverse Event|22
7614668|NCT00968201|12023716|FG000|Extension Study - (Period III)|Lost to Follow-up|0
7614669|NCT00968201|12023717|FG001|Extension Study - (Period III)|Lost to Follow-up|7
7614670|NCT00968201|12023718|FG002|Extension Study - (Period III)|Lost to Follow-up|13
7614671|NCT00968201|12023716|FG000|Extension Study - (Period III)|Protocol Violation|0
7614672|NCT00968201|12023717|FG001|Extension Study - (Period III)|Protocol Violation|17
7614673|NCT00968201|12023718|FG002|Extension Study - (Period III)|Protocol Violation|14
7614674|NCT00968201|12023716|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
7614675|NCT00968201|12023717|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
7614676|NCT00968201|12023718|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
7614677|NCT00968201|12023716|FG000|Extension Study - (Period III)|Patient Relocated|0
7614678|NCT00968201|12023717|FG001|Extension Study - (Period III)|Patient Relocated|1
7614679|NCT00968201|12023718|FG002|Extension Study - (Period III)|Patient Relocated|1
7614680|NCT00968201|12023716|FG000|Extension Study - (Period III)|Noncompliance|0
7614681|NCT00968201|12023717|FG001|Extension Study - (Period III)|Noncompliance|0
7614682|NCT00968201|12023718|FG002|Extension Study - (Period III)|Noncompliance|3
7278644|NCT00462501|11493909|FG000|Overall Study|Adverse Event|2
7278645|NCT00462670|11493928|FG000|Overall Study|Adverse Event|3
7278646|NCT00462670|11493929|FG001|Overall Study|Adverse Event|5
7278647|NCT00462670|11493928|FG000|Overall Study|Lack of Efficacy|1
7278648|NCT00462670|11493929|FG001|Overall Study|Lack of Efficacy|0
7614683|NCT00968201|12023716|FG000|Extension Study - (Period III)|Other|0
7614684|NCT00968201|12023717|FG001|Extension Study - (Period III)|Other|0
7614685|NCT00968201|12023718|FG002|Extension Study - (Period III)|Other|2
7614686|NCT00968201|12023716|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
7614687|NCT00968201|12023717|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
7614688|NCT00968201|12023718|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
7614689|NCT00968149|12023729|FG000|Overall Study|Adverse Event|5
7278649|NCT00462670|11493928|FG000|Overall Study|Protocol Violation|1
7278650|NCT00462670|11493929|FG001|Overall Study|Protocol Violation|0
7614690|NCT00968149|12023730|FG001|Overall Study|Adverse Event|1
7614691|NCT00968149|12023729|FG000|Overall Study|Lack of Efficacy|0
7614692|NCT00968149|12023730|FG001|Overall Study|Lack of Efficacy|4
7614693|NCT00968149|12023729|FG000|Overall Study|Lost to Follow-up|0
7614694|NCT00968149|12023730|FG001|Overall Study|Lost to Follow-up|1
7614695|NCT00968149|12023729|FG000|Overall Study|Protocol Violation|4
7614696|NCT00968149|12023730|FG001|Overall Study|Protocol Violation|0
7614697|NCT00968149|12023729|FG000|Overall Study|Withdrawal by Subject|2
7614698|NCT00968149|12023730|FG001|Overall Study|Withdrawal by Subject|0
7614699|NCT00963469|12023739|FG000|Overall Study|Adverse Event|15
7614700|NCT00963469|12023740|FG001|Overall Study|Adverse Event|11
7614701|NCT00963469|12023741|FG002|Overall Study|Adverse Event|1
7614702|NCT00963469|12023739|FG000|Overall Study|Lack of Efficacy|10
7614703|NCT00963469|12023740|FG001|Overall Study|Lack of Efficacy|7
7614704|NCT00963469|12023741|FG002|Overall Study|Lack of Efficacy|2
7614705|NCT00963469|12023739|FG000|Overall Study|Lost to Follow-up|1
7614706|NCT00963469|12023740|FG001|Overall Study|Lost to Follow-up|1
7614707|NCT00963469|12023741|FG002|Overall Study|Lost to Follow-up|0
7614708|NCT00963469|12023739|FG000|Overall Study|Protocol Violation|5
7614709|NCT00963469|12023740|FG001|Overall Study|Protocol Violation|5
7614710|NCT00963469|12023741|FG002|Overall Study|Protocol Violation|3
7614711|NCT00963469|12023739|FG000|Overall Study|Withdrawal by Subject|4
7614712|NCT00963469|12023740|FG001|Overall Study|Withdrawal by Subject|1
7614713|NCT00963469|12023741|FG002|Overall Study|Withdrawal by Subject|1
7614714|NCT00963469|12023739|FG000|Overall Study|Pre-randomization Adverse Event|1
7614715|NCT00963469|12023740|FG001|Overall Study|Pre-randomization Adverse Event|2
7614716|NCT00963469|12023741|FG002|Overall Study|Pre-randomization Adverse Event|0
7614717|NCT00963469|12023739|FG000|Overall Study|Moved|1
7614718|NCT00963469|12023740|FG001|Overall Study|Moved|0
7614719|NCT00963469|12023741|FG002|Overall Study|Moved|0
7614720|NCT00963469|12023739|FG000|Overall Study|Site closed (local pollen Season ended)|4
7614721|NCT00963469|12023740|FG001|Overall Study|Site closed (local pollen Season ended)|1
7614722|NCT00963469|12023741|FG002|Overall Study|Site closed (local pollen Season ended)|3
7614723|NCT00960141|12023752|FG000|Overall Study|Adverse Event|4
7614724|NCT00960141|12023753|FG001|Overall Study|Adverse Event|8
7614725|NCT00960141|12023754|FG002|Overall Study|Adverse Event|2
7614726|NCT00960141|12023752|FG000|Overall Study|Lack of Efficacy|3
7614727|NCT00960141|12023753|FG001|Overall Study|Lack of Efficacy|4
7614728|NCT00960141|12023754|FG002|Overall Study|Lack of Efficacy|2
7614729|NCT00960141|12023752|FG000|Overall Study|Lost to Follow-up|1
7614730|NCT00960141|12023753|FG001|Overall Study|Lost to Follow-up|0
7614731|NCT00960141|12023754|FG002|Overall Study|Lost to Follow-up|0
7614732|NCT00960141|12023752|FG000|Overall Study|Protocol Violation|1
7614733|NCT00960141|12023753|FG001|Overall Study|Protocol Violation|3
7614734|NCT00960141|12023754|FG002|Overall Study|Protocol Violation|2
7614735|NCT00960141|12023752|FG000|Overall Study|Withdrawal by Subject|1
7614736|NCT00960141|12023753|FG001|Overall Study|Withdrawal by Subject|2
7614737|NCT00960141|12023754|FG002|Overall Study|Withdrawal by Subject|1
7614738|NCT00943683|12023764|FG000|Overall Study|Adverse Event|3
7614739|NCT00943683|12023765|FG001|Overall Study|Adverse Event|3
7614740|NCT00943683|12023764|FG000|Overall Study|Lost to Follow-up|1
7614741|NCT00943683|12023765|FG001|Overall Study|Lost to Follow-up|1
7614742|NCT00943683|12023764|FG000|Overall Study|Protocol Violation|1
7614743|NCT00943683|12023765|FG001|Overall Study|Protocol Violation|2
7614744|NCT00943683|12023764|FG000|Overall Study|Withdrawal by Subject|1
7614745|NCT00943683|12023765|FG001|Overall Study|Withdrawal by Subject|0
7614746|NCT00943683|12023764|FG000|Overall Study|Patient Moved|1
7278651|NCT00462670|11493928|FG000|Overall Study|Resolution of signs and symptoms|0
7278652|NCT00462670|11493929|FG001|Overall Study|Resolution of signs and symptoms|2
7278653|NCT00462709|11493935|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
7278654|NCT00462709|11493935|FG000|Overall Study|Lost to Follow-up|10
7278655|NCT00462709|11493935|FG000|Overall Study|Withdrawal by Subject|8
7278656|NCT00462709|11493935|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
7278657|NCT00462709|11493935|FG000|Overall Study|Death|2
7278658|NCT00462709|11493935|FG000|Overall Study|Logistical reasons|2
7278659|NCT00462709|11493935|FG000|Overall Study|Physician Decision|1
7278660|NCT00462709|11493935|FG000|Overall Study|Withdrew to start treatment with Cetor|1
7278661|NCT00462761|11493957|FG000|Overall Study|Adverse Event|6
7278662|NCT00462761|11493957|FG000|Overall Study|Withdrawal by Subject|9
7278663|NCT00462761|11493957|FG000|Overall Study|Physician Decision|5
7278664|NCT00462761|11493957|FG000|Overall Study|Disease progression|43
7278665|NCT00462761|11493957|FG000|Overall Study|Death|12
7278666|NCT00462761|11493957|FG000|Overall Study|Other|1
7278667|NCT00462826|11493989|FG000|Overall Study|Ineligible - second primary|1
7278668|NCT00462826|11493989|FG000|Overall Study|Ineligible - wrong cell type|1
7278669|NCT00462826|11493989|FG000|Overall Study|Ineligible - wrong primary|2
7278670|NCT00462826|11493989|FG000|Overall Study|Never treated|1
7469805|NCT01927055|11771697|FG002|Double-Blind|Protocol Violation|1
7469806|NCT01927055|11771695|FG000|Double-Blind|Withdrawal by Subject|0
7469807|NCT01927055|11771696|FG001|Double-Blind|Withdrawal by Subject|2
7469808|NCT01927055|11771697|FG002|Double-Blind|Withdrawal by Subject|3
7614747|NCT00943683|12023765|FG001|Overall Study|Patient Moved|0
7614748|NCT00943397|12023773|FG000|Overall Study|Adverse Event|0
7614749|NCT00943397|12023774|FG001|Overall Study|Adverse Event|6
7614750|NCT00943397|12023773|FG000|Overall Study|Lost to Follow-up|0
7614751|NCT00943397|12023774|FG001|Overall Study|Lost to Follow-up|4
7614752|NCT00943397|12023773|FG000|Overall Study|Protocol Violation|2
7614753|NCT00943397|12023774|FG001|Overall Study|Protocol Violation|5
7614754|NCT00943397|12023773|FG000|Overall Study|Withdrawal by Subject|1
7614755|NCT00943397|12023774|FG001|Overall Study|Withdrawal by Subject|1
7614756|NCT00943397|12023773|FG000|Overall Study|Site terminated and other|12
7614757|NCT00943397|12023774|FG001|Overall Study|Site terminated and other|56
7614758|NCT00911547|12023784|FG000|Overall Study|Adverse Event|8
7614759|NCT00911547|12023785|FG001|Overall Study|Adverse Event|27
7614760|NCT00911547|12023786|FG002|Overall Study|Adverse Event|11
7614761|NCT00911547|12023787|FG003|Overall Study|Adverse Event|6
7614762|NCT00911547|12023784|FG000|Overall Study|Lost to Follow-up|0
7614763|NCT00911547|12023785|FG001|Overall Study|Lost to Follow-up|0
7614764|NCT00911547|12023786|FG002|Overall Study|Lost to Follow-up|2
7614765|NCT00911547|12023787|FG003|Overall Study|Lost to Follow-up|1
7614766|NCT00911547|12023784|FG000|Overall Study|Protocol Violation|0
7614767|NCT00911547|12023785|FG001|Overall Study|Protocol Violation|5
7614768|NCT00911547|12023786|FG002|Overall Study|Protocol Violation|5
7614769|NCT00911547|12023787|FG003|Overall Study|Protocol Violation|1
7614770|NCT00911547|12023784|FG000|Overall Study|Withdrawal by Subject|3
7614771|NCT00911547|12023785|FG001|Overall Study|Withdrawal by Subject|10
7614772|NCT00911547|12023786|FG002|Overall Study|Withdrawal by Subject|4
7614773|NCT00911547|12023787|FG003|Overall Study|Withdrawal by Subject|8
7614774|NCT00899379|12023802|FG000|Overall Study|Adverse Event|2
7614775|NCT00899379|12023803|FG001|Overall Study|Adverse Event|2
7614776|NCT00899379|12023804|FG002|Overall Study|Adverse Event|1
7614777|NCT00899379|12023805|FG003|Overall Study|Adverse Event|1
7614778|NCT00899379|12023806|FG004|Overall Study|Adverse Event|2
7614779|NCT00899379|12023802|FG000|Overall Study|Lack of Efficacy|0
7614780|NCT00899379|12023803|FG001|Overall Study|Lack of Efficacy|4
7614781|NCT00899379|12023804|FG002|Overall Study|Lack of Efficacy|3
7614782|NCT00899379|12023805|FG003|Overall Study|Lack of Efficacy|0
7614783|NCT00899379|12023806|FG004|Overall Study|Lack of Efficacy|1
7614784|NCT00899379|12023802|FG000|Overall Study|Lost to Follow-up|9
7614785|NCT00899379|12023803|FG001|Overall Study|Lost to Follow-up|3
7614786|NCT00899379|12023804|FG002|Overall Study|Lost to Follow-up|0
7614787|NCT00899379|12023805|FG003|Overall Study|Lost to Follow-up|6
7614788|NCT00899379|12023806|FG004|Overall Study|Lost to Follow-up|2
7614789|NCT00899379|12023802|FG000|Overall Study|Protocol Violation|0
7614790|NCT00899379|12023803|FG001|Overall Study|Protocol Violation|0
7614791|NCT00899379|12023804|FG002|Overall Study|Protocol Violation|1
7614792|NCT00899379|12023805|FG003|Overall Study|Protocol Violation|1
7614793|NCT00899379|12023806|FG004|Overall Study|Protocol Violation|0
7614794|NCT00899379|12023802|FG000|Overall Study|Withdrawal by Subject|2
7614795|NCT00899379|12023803|FG001|Overall Study|Withdrawal by Subject|4
7614796|NCT00899379|12023804|FG002|Overall Study|Withdrawal by Subject|2
7614797|NCT00899379|12023805|FG003|Overall Study|Withdrawal by Subject|3
7614798|NCT00899379|12023806|FG004|Overall Study|Withdrawal by Subject|6
7614799|NCT00899379|12023802|FG000|Overall Study|Pregnancy|0
7614800|NCT00899379|12023803|FG001|Overall Study|Pregnancy|0
7614801|NCT00899379|12023804|FG002|Overall Study|Pregnancy|1
7614802|NCT00899379|12023805|FG003|Overall Study|Pregnancy|0
7614803|NCT00899379|12023806|FG004|Overall Study|Pregnancy|1
7614804|NCT00899379|12023802|FG000|Overall Study|Patient Uncooperative|0
7614805|NCT00899379|12023803|FG001|Overall Study|Patient Uncooperative|1
7614806|NCT00899379|12023804|FG002|Overall Study|Patient Uncooperative|0
7614807|NCT00899379|12023805|FG003|Overall Study|Patient Uncooperative|1
7614808|NCT00899379|12023806|FG004|Overall Study|Patient Uncooperative|2
7614809|NCT00899379|12023802|FG000|Overall Study|Abnormal Baseline ECG|0
7614810|NCT00899379|12023803|FG001|Overall Study|Abnormal Baseline ECG|0
7614811|NCT00899379|12023804|FG002|Overall Study|Abnormal Baseline ECG|0
7614812|NCT00899379|12023805|FG003|Overall Study|Abnormal Baseline ECG|1
7278671|NCT00462865|11494008|FG000|Overall Study|Adverse Event|1
7614813|NCT00899379|12023806|FG004|Overall Study|Abnormal Baseline ECG|0
7614814|NCT00899379|12023802|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614815|NCT00899379|12023803|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
7614816|NCT00899379|12023804|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
7614817|NCT00899379|12023805|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
7614818|NCT00899379|12023806|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
7614819|NCT00899379|12023802|FG000|Overall Study|Not Completed/Entered Extn|5
7614820|NCT00899379|12023803|FG001|Overall Study|Not Completed/Entered Extn|1
7614821|NCT00899379|12023804|FG002|Overall Study|Not Completed/Entered Extn|6
7614822|NCT00899379|12023805|FG003|Overall Study|Not Completed/Entered Extn|4
7614823|NCT00899379|12023806|FG004|Overall Study|Not Completed/Entered Extn|3
7614824|NCT00899379|12023802|FG000|Overall Study|Study Terminated|3
7614825|NCT00899379|12023803|FG001|Overall Study|Study Terminated|0
7614826|NCT00899379|12023804|FG002|Overall Study|Study Terminated|3
7614827|NCT00899379|12023805|FG003|Overall Study|Study Terminated|3
7614828|NCT00899379|12023806|FG004|Overall Study|Study Terminated|1
7614829|NCT00899379|12023802|FG000|Overall Study|Lost to Follow-up|3
7614830|NCT00899379|12023803|FG001|Overall Study|Lost to Follow-up|1
7614831|NCT00899379|12023804|FG002|Overall Study|Lost to Follow-up|0
7614832|NCT00899379|12023805|FG003|Overall Study|Lost to Follow-up|2
7614833|NCT00899379|12023806|FG004|Overall Study|Lost to Follow-up|5
7614834|NCT00899379|12023802|FG000|Overall Study|Withdrawal by Subject|4
7614835|NCT00899379|12023803|FG001|Overall Study|Withdrawal by Subject|7
7614836|NCT00899379|12023804|FG002|Overall Study|Withdrawal by Subject|4
7614837|NCT00899379|12023805|FG003|Overall Study|Withdrawal by Subject|7
7614838|NCT00899379|12023806|FG004|Overall Study|Withdrawal by Subject|2
7614839|NCT00899379|12023802|FG000|Overall Study|Pregnancy|1
7614840|NCT00899379|12023803|FG001|Overall Study|Pregnancy|0
7614841|NCT00899379|12023804|FG002|Overall Study|Pregnancy|0
7614842|NCT00899379|12023805|FG003|Overall Study|Pregnancy|0
7614843|NCT00899379|12023806|FG004|Overall Study|Pregnancy|0
7614844|NCT00899379|12023802|FG000|Overall Study|Patient Uncooperative|0
7614845|NCT00899379|12023803|FG001|Overall Study|Patient Uncooperative|0
7614846|NCT00899379|12023804|FG002|Overall Study|Patient Uncooperative|0
7614847|NCT00899379|12023805|FG003|Overall Study|Patient Uncooperative|1
7614848|NCT00899379|12023806|FG004|Overall Study|Patient Uncooperative|0
7614849|NCT00899379|12023802|FG000|Overall Study|Abnormal Prestudy Labs|0
7614850|NCT00899379|12023803|FG001|Overall Study|Abnormal Prestudy Labs|0
7614851|NCT00899379|12023804|FG002|Overall Study|Abnormal Prestudy Labs|0
7614852|NCT00899379|12023805|FG003|Overall Study|Abnormal Prestudy Labs|0
7614853|NCT00899379|12023806|FG004|Overall Study|Abnormal Prestudy Labs|2
7614854|NCT00899379|12023802|FG000|Overall Study|Abnormal Baseline ECG|0
7614855|NCT00899379|12023803|FG001|Overall Study|Abnormal Baseline ECG|0
7614856|NCT00899379|12023804|FG002|Overall Study|Abnormal Baseline ECG|1
7614857|NCT00899379|12023805|FG003|Overall Study|Abnormal Baseline ECG|1
7614858|NCT00899379|12023806|FG004|Overall Study|Abnormal Baseline ECG|0
7614859|NCT00899379|12023802|FG000|Overall Study|No Attack Pretreatment|3
7614860|NCT00899379|12023803|FG001|Overall Study|No Attack Pretreatment|5
7614861|NCT00899379|12023804|FG002|Overall Study|No Attack Pretreatment|5
7614862|NCT00899379|12023805|FG003|Overall Study|No Attack Pretreatment|6
7614863|NCT00899379|12023806|FG004|Overall Study|No Attack Pretreatment|4
7614864|NCT00899379|12023802|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614865|NCT00899379|12023803|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
7614866|NCT00899379|12023804|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
7614867|NCT00899379|12023805|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
7614868|NCT00899379|12023806|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
7614869|NCT00899379|12023802|FG000|Overall Study|Inc/Exc Criteria Not Met|0
7614870|NCT00899379|12023803|FG001|Overall Study|Inc/Exc Criteria Not Met|0
7614871|NCT00899379|12023804|FG002|Overall Study|Inc/Exc Criteria Not Met|1
7614872|NCT00899379|12023805|FG003|Overall Study|Inc/Exc Criteria Not Met|0
7614873|NCT00899379|12023806|FG004|Overall Study|Inc/Exc Criteria Not Met|0
7614874|NCT00898677|12023816|FG000|Overall Study|Adverse Event|0
7614875|NCT00898677|12023817|FG001|Overall Study|Adverse Event|0
7614876|NCT00898677|12023818|FG002|Overall Study|Adverse Event|1
7614877|NCT00898677|12023819|FG003|Overall Study|Adverse Event|0
7614878|NCT00898677|12023816|FG000|Overall Study|Lost to Follow-up|0
7614879|NCT00898677|12023817|FG001|Overall Study|Lost to Follow-up|0
7614880|NCT00898677|12023818|FG002|Overall Study|Lost to Follow-up|2
7614881|NCT00898677|12023819|FG003|Overall Study|Lost to Follow-up|0
7614882|NCT00898677|12023816|FG000|Overall Study|Protocol Violation|1
7614883|NCT00898677|12023817|FG001|Overall Study|Protocol Violation|1
7614884|NCT00898677|12023818|FG002|Overall Study|Protocol Violation|2
7614885|NCT00898677|12023819|FG003|Overall Study|Protocol Violation|0
7614886|NCT00898677|12023816|FG000|Overall Study|Withdrawal by Subject|0
7614887|NCT00898677|12023817|FG001|Overall Study|Withdrawal by Subject|0
7614888|NCT00898677|12023818|FG002|Overall Study|Withdrawal by Subject|0
7614889|NCT00898677|12023819|FG003|Overall Study|Withdrawal by Subject|1
7614890|NCT00898677|12023816|FG000|Overall Study|Not Treated: Adverse Event|0
7614891|NCT00898677|12023817|FG001|Overall Study|Not Treated: Adverse Event|2
7614892|NCT00898677|12023818|FG002|Overall Study|Not Treated: Adverse Event|1
7614893|NCT00898677|12023819|FG003|Overall Study|Not Treated: Adverse Event|0
7614894|NCT00898677|12023816|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
7614895|NCT00898677|12023817|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
7614896|NCT00898677|12023818|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
7614897|NCT00898677|12023819|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
7614898|NCT00898677|12023816|FG000|Overall Study|Not Treated: Pregnancy|0
7614899|NCT00898677|12023817|FG001|Overall Study|Not Treated: Pregnancy|0
7614900|NCT00898677|12023818|FG002|Overall Study|Not Treated: Pregnancy|1
7614901|NCT00898677|12023819|FG003|Overall Study|Not Treated: Pregnancy|0
7614902|NCT00898677|12023816|FG000|Overall Study|Not Treated: Protocol Violation|2
7614903|NCT00898677|12023817|FG001|Overall Study|Not Treated: Protocol Violation|0
7614904|NCT00898677|12023818|FG002|Overall Study|Not Treated: Protocol Violation|2
7614905|NCT00898677|12023819|FG003|Overall Study|Not Treated: Protocol Violation|0
7614906|NCT00898677|12023816|FG000|Overall Study|Not Treated: Withdraw by Subject|2
7614907|NCT00898677|12023817|FG001|Overall Study|Not Treated: Withdraw by Subject|16
7614908|NCT00898677|12023818|FG002|Overall Study|Not Treated: Withdraw by Subject|11
7614909|NCT00898677|12023819|FG003|Overall Study|Not Treated: Withdraw by Subject|3
7614910|NCT00898677|12023816|FG000|Overall Study|Not Treated: Patient uncooperative|2
7614911|NCT00898677|12023817|FG001|Overall Study|Not Treated: Patient uncooperative|3
7614912|NCT00898677|12023818|FG002|Overall Study|Not Treated: Patient uncooperative|1
7614913|NCT00898677|12023819|FG003|Overall Study|Not Treated: Patient uncooperative|0
7614914|NCT00898677|12023816|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614915|NCT00898677|12023817|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614916|NCT00898677|12023818|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
7614917|NCT00898677|12023819|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
7614918|NCT00898677|12023816|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
7614919|NCT00898677|12023817|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614920|NCT00898677|12023818|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614921|NCT00898677|12023819|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
7614922|NCT00898677|12023816|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7614923|NCT00898677|12023817|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
7278672|NCT00462982|11494029|FG000|Overall Study|Adverse Event|1
7278673|NCT00462982|11494029|FG000|Overall Study|Patient Not Treated|2
7278674|NCT00463047|11494033|FG000|Titration Period 1|Adverse Event|10
7278675|NCT00463047|11494034|FG001|Titration Period 1|Adverse Event|8
7278676|NCT00463047|11494033|FG000|Titration Period 1|Lack of Efficacy|10
7278677|NCT00463047|11494034|FG001|Titration Period 1|Lack of Efficacy|4
7278678|NCT00463047|11494033|FG000|Titration Period 1|Lost to Follow-up|2
7278679|NCT00463047|11494034|FG001|Titration Period 1|Lost to Follow-up|0
7614924|NCT00898677|12023818|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
7614925|NCT00898677|12023819|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
7614926|NCT00898677|12023816|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
7614927|NCT00898677|12023817|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
7614928|NCT00898677|12023818|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
7614929|NCT00898677|12023819|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
7614930|NCT00898677|12023816|FG000|Overall Study|Not Treated: Other (Not Specified)|0
7614931|NCT00898677|12023817|FG001|Overall Study|Not Treated: Other (Not Specified)|0
7614932|NCT00898677|12023818|FG002|Overall Study|Not Treated: Other (Not Specified)|2
7614933|NCT00898677|12023819|FG003|Overall Study|Not Treated: Other (Not Specified)|0
7614934|NCT00897949|12023832|FG000|Overall Study|Adverse Event|1
7614935|NCT00897949|12023833|FG001|Overall Study|Adverse Event|1
7614936|NCT00897949|12023834|FG002|Overall Study|Adverse Event|0
7614937|NCT00897949|12023832|FG000|Overall Study|Lost to Follow-up|0
7614938|NCT00897949|12023833|FG001|Overall Study|Lost to Follow-up|2
7614939|NCT00897949|12023834|FG002|Overall Study|Lost to Follow-up|1
7614940|NCT00897949|12023832|FG000|Overall Study|Protocol Violation|6
7614941|NCT00897949|12023833|FG001|Overall Study|Protocol Violation|3
7614942|NCT00897949|12023834|FG002|Overall Study|Protocol Violation|1
7614943|NCT00897949|12023832|FG000|Overall Study|Withdrawal by Subject|1
7614944|NCT00897949|12023833|FG001|Overall Study|Withdrawal by Subject|2
7614945|NCT00897949|12023834|FG002|Overall Study|Withdrawal by Subject|0
7614946|NCT00897949|12023832|FG000|Overall Study|Patient Uncoorperative|0
7614947|NCT00897949|12023833|FG001|Overall Study|Patient Uncoorperative|2
7614948|NCT00897949|12023834|FG002|Overall Study|Patient Uncoorperative|1
7614949|NCT00897949|12023832|FG000|Overall Study|Lost to Follow-up|30
7614950|NCT00897949|12023833|FG001|Overall Study|Lost to Follow-up|23
7614951|NCT00897949|12023834|FG002|Overall Study|Lost to Follow-up|17
7614952|NCT00897949|12023832|FG000|Overall Study|Withdrawal by Subject|24
7614953|NCT00897949|12023833|FG001|Overall Study|Withdrawal by Subject|31
7614954|NCT00897949|12023834|FG002|Overall Study|Withdrawal by Subject|17
7614955|NCT00897949|12023832|FG000|Overall Study|Abnormal Prestudy Labs|2
7614956|NCT00897949|12023833|FG001|Overall Study|Abnormal Prestudy Labs|3
7614957|NCT00897949|12023834|FG002|Overall Study|Abnormal Prestudy Labs|4
7614958|NCT00897949|12023832|FG000|Overall Study|Abnormal Baseline ECG|2
7614959|NCT00897949|12023833|FG001|Overall Study|Abnormal Baseline ECG|2
7614960|NCT00897949|12023834|FG002|Overall Study|Abnormal Baseline ECG|4
7614961|NCT00897949|12023832|FG000|Overall Study|Need for Concom. Med.|0
7614962|NCT00897949|12023833|FG001|Overall Study|Need for Concom. Med.|1
7614963|NCT00897949|12023834|FG002|Overall Study|Need for Concom. Med.|1
7614964|NCT00897949|12023832|FG000|Overall Study|Lack of Migraine Attack|29
7614965|NCT00897949|12023833|FG001|Overall Study|Lack of Migraine Attack|30
7614966|NCT00897949|12023834|FG002|Overall Study|Lack of Migraine Attack|19
7614967|NCT00897949|12023832|FG000|Overall Study|Did not take study drug|9
7614968|NCT00897949|12023833|FG001|Overall Study|Did not take study drug|3
7614969|NCT00897949|12023834|FG002|Overall Study|Did not take study drug|4
7614970|NCT00897104|12023851|FG000|Overall Study|Lost to Follow-up|12
7614971|NCT00897104|12023852|FG001|Overall Study|Lost to Follow-up|17
7614972|NCT00897104|12023853|FG002|Overall Study|Lost to Follow-up|2
7614973|NCT00897104|12023851|FG000|Overall Study|Pregnancy|0
7614974|NCT00897104|12023852|FG001|Overall Study|Pregnancy|1
7614975|NCT00897104|12023853|FG002|Overall Study|Pregnancy|0
7614976|NCT00897104|12023851|FG000|Overall Study|Protocol Violation|0
7614977|NCT00897104|12023852|FG001|Overall Study|Protocol Violation|1
7614978|NCT00897104|12023853|FG002|Overall Study|Protocol Violation|0
7614979|NCT00897104|12023851|FG000|Overall Study|Withdrawal by Subject|23
7614980|NCT00897104|12023852|FG001|Overall Study|Withdrawal by Subject|27
7614981|NCT00897104|12023853|FG002|Overall Study|Withdrawal by Subject|3
7614982|NCT00897104|12023851|FG000|Overall Study|Abnormal Prestudy Labs|2
7614983|NCT00897104|12023852|FG001|Overall Study|Abnormal Prestudy Labs|0
7614984|NCT00897104|12023853|FG002|Overall Study|Abnormal Prestudy Labs|0
7614985|NCT00897104|12023851|FG000|Overall Study|Abnormal Baseline ECG|2
7614986|NCT00897104|12023852|FG001|Overall Study|Abnormal Baseline ECG|2
7614987|NCT00897104|12023853|FG002|Overall Study|Abnormal Baseline ECG|0
7614988|NCT00897104|12023851|FG000|Overall Study|Need for Concom. Med.|0
7614989|NCT00897104|12023852|FG001|Overall Study|Need for Concom. Med.|1
7614990|NCT00897104|12023853|FG002|Overall Study|Need for Concom. Med.|1
7614991|NCT00897104|12023851|FG000|Overall Study|Lack of Migraine Attack|20
7614992|NCT00897104|12023852|FG001|Overall Study|Lack of Migraine Attack|22
7614993|NCT00897104|12023853|FG002|Overall Study|Lack of Migraine Attack|1
7614994|NCT00897104|12023851|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
7614995|NCT00897104|12023852|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
7614996|NCT00897104|12023853|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
7614997|NCT00897104|12023851|FG000|Overall Study|Other|3
7614998|NCT00897104|12023852|FG001|Overall Study|Other|0
7614999|NCT00897104|12023853|FG002|Overall Study|Other|0
7615000|NCT00897104|12023851|FG000|Overall Study|Protocol Violation|1
7615001|NCT00897104|12023852|FG001|Overall Study|Protocol Violation|0
7615002|NCT00897104|12023853|FG002|Overall Study|Protocol Violation|0
7615003|NCT00897104|12023851|FG000|Overall Study|Withdrawal by Subject|0
7615004|NCT00897104|12023852|FG001|Overall Study|Withdrawal by Subject|0
7615005|NCT00897104|12023853|FG002|Overall Study|Withdrawal by Subject|1
7615006|NCT00803790|12023863|FG000|Period 1|Adverse Event|0
7615007|NCT00803790|12023864|FG001|Period 1|Adverse Event|1
7615008|NCT00803790|12023865|FG002|Period 1|Adverse Event|0
7615009|NCT00803790|12023866|FG003|Period 1|Adverse Event|0
7615010|NCT00803790|12023863|FG000|Period 1|Lost to Follow-up|1
7615011|NCT00803790|12023864|FG001|Period 1|Lost to Follow-up|2
7615012|NCT00803790|12023865|FG002|Period 1|Lost to Follow-up|0
7615013|NCT00803790|12023866|FG003|Period 1|Lost to Follow-up|0
7615014|NCT00803790|12023863|FG000|Period 1|Withdrawal by Subject|8
7615015|NCT00803790|12023864|FG001|Period 1|Withdrawal by Subject|6
7615016|NCT00803790|12023865|FG002|Period 1|Withdrawal by Subject|0
7615017|NCT00803790|12023866|FG003|Period 1|Withdrawal by Subject|0
7615018|NCT00803790|12023863|FG000|Period 1|positive drug screen or personal reasons|0
7615019|NCT00803790|12023864|FG001|Period 1|positive drug screen or personal reasons|3
7615020|NCT00803790|12023865|FG002|Period 1|positive drug screen or personal reasons|0
7615021|NCT00803790|12023866|FG003|Period 1|positive drug screen or personal reasons|4
7615022|NCT00803790|12023863|FG000|Period 1|Protocol Violation|0
7615023|NCT00803790|12023864|FG001|Period 1|Protocol Violation|0
7615024|NCT00803790|12023865|FG002|Period 1|Protocol Violation|1
7615025|NCT00803790|12023866|FG003|Period 1|Protocol Violation|0
7615026|NCT00803790|12023863|FG000|Period 2|Adverse Event|0
7615027|NCT00803790|12023864|FG001|Period 2|Adverse Event|0
7278680|NCT00463047|11494033|FG000|Titration Period 1|Non-compliance with study medication|3
7278681|NCT00463047|11494034|FG001|Titration Period 1|Non-compliance with study medication|5
7278682|NCT00463047|11494033|FG000|Titration Period 1|Protocol Violation|5
7278683|NCT00463047|11494034|FG001|Titration Period 1|Protocol Violation|5
7278684|NCT00463047|11494033|FG000|Titration Period 1|Withdrawal by Subject|3
7278685|NCT00463047|11494034|FG001|Titration Period 1|Withdrawal by Subject|5
7278686|NCT00463047|11494033|FG000|Titration Period 1|Non-compliance procedures|4
7278687|NCT00463047|11494034|FG001|Titration Period 1|Non-compliance procedures|10
7278688|NCT00463047|11494033|FG000|Titration Period 1|Other|0
7278689|NCT00463047|11494034|FG001|Titration Period 1|Other|2
7278690|NCT00463047|11494033|FG000|Titration Period 2|Adverse Event|9
7278691|NCT00463047|11494034|FG001|Titration Period 2|Adverse Event|9
7278692|NCT00463047|11494033|FG000|Titration Period 2|Lack of Efficacy|6
7278693|NCT00463047|11494034|FG001|Titration Period 2|Lack of Efficacy|4
7278694|NCT00463047|11494033|FG000|Titration Period 2|Withdrawal by Subject|1
7278695|NCT00463047|11494034|FG001|Titration Period 2|Withdrawal by Subject|0
7278696|NCT00463047|11494033|FG000|Titration Period 2|Protocol Violation|2
7278697|NCT00463047|11494034|FG001|Titration Period 2|Protocol Violation|3
7278698|NCT00463047|11494033|FG000|Titration Period 2|Lost to Follow-up|1
7278699|NCT00463047|11494034|FG001|Titration Period 2|Lost to Follow-up|2
7278700|NCT00463047|11494033|FG000|Titration Period 2|Non-compliance study medication|4
7278701|NCT00463047|11494034|FG001|Titration Period 2|Non-compliance study medication|2
7278702|NCT00463047|11494033|FG000|Titration Period 2|Non-compliance procedures|4
7278703|NCT00463047|11494034|FG001|Titration Period 2|Non-compliance procedures|1
7615028|NCT00803790|12023865|FG002|Period 2|Adverse Event|1
7615029|NCT00803790|12023866|FG003|Period 2|Adverse Event|1
7615030|NCT00803790|12023863|FG000|Period 2|Withdrawal by Subject|1
7615031|NCT00803790|12023864|FG001|Period 2|Withdrawal by Subject|0
7615032|NCT00803790|12023865|FG002|Period 2|Withdrawal by Subject|0
7615033|NCT00803790|12023866|FG003|Period 2|Withdrawal by Subject|0
7615034|NCT00803790|12023863|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
7615035|NCT00803790|12023864|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
7615036|NCT00803790|12023865|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
7615037|NCT00803790|12023866|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
7615038|NCT00725491|12023879|FG000|Overall Study|Adverse Event|3
7615039|NCT00725491|12023880|FG001|Overall Study|Adverse Event|2
7615040|NCT00725491|12023879|FG000|Overall Study|Pregnancy|0
7615041|NCT00725491|12023880|FG001|Overall Study|Pregnancy|3
7615042|NCT00725491|12023879|FG000|Overall Study|Risk for hyperstimulation|2
7615043|NCT00725491|12023880|FG001|Overall Study|Risk for hyperstimulation|9
7278704|NCT00463047|11494033|FG000|Titration Period 2|Other|3
7278705|NCT00463047|11494034|FG001|Titration Period 2|Other|2
7278706|NCT00463047|11494033|FG000|Double-Blind Treatment Period 1|Adverse Event|0
7615044|NCT00725491|12023879|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
7615045|NCT00725491|12023880|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
7615046|NCT00725491|12023879|FG000|Overall Study|Fertilization failure|0
7615047|NCT00725491|12023880|FG001|Overall Study|Fertilization failure|1
7615048|NCT00725491|12023879|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
7615049|NCT00725491|12023880|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
7615050|NCT00703014|12023888|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
7615051|NCT00703014|12023889|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
7615052|NCT00703014|12023890|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7615053|NCT00703014|12023891|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
7615054|NCT00703014|12023888|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7615055|NCT00703014|12023889|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
7615056|NCT00703014|12023890|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
7615057|NCT00703014|12023891|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
7615058|NCT00702845|12023903|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
7615059|NCT00702845|12023904|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
7615060|NCT00702845|12023903|FG000|Overall Study|Too high ovarian response|5
7615061|NCT00702845|12023904|FG001|Overall Study|Too high ovarian response|1
7615062|NCT00702845|12023903|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
7615063|NCT00702845|12023904|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
7615064|NCT00702845|12023903|FG000|Overall Study|Insufficient ovarian response|1
7615065|NCT00702845|12023904|FG001|Overall Study|Insufficient ovarian response|0
7615066|NCT00702845|12023903|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
7615067|NCT00702845|12023904|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
7615068|NCT00702845|12023903|FG000|Overall Study|No or abnormal fertilization|4
7615069|NCT00702845|12023904|FG001|Overall Study|No or abnormal fertilization|2
7615070|NCT00702845|12023903|FG000|Overall Study|Patient's decision|2
7615071|NCT00702845|12023904|FG001|Overall Study|Patient's decision|1
7615072|NCT00702845|12023903|FG000|Overall Study|Not randomized|0
7615073|NCT00702845|12023904|FG001|Overall Study|Not randomized|1
7615074|NCT00702520|12023939|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615075|NCT00702520|12023940|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
7615076|NCT00702520|12023941|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615077|NCT00702520|12023942|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
7615078|NCT00702520|12023939|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
7615079|NCT00702520|12023940|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
7615080|NCT00702520|12023941|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7615081|NCT00702520|12023942|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
7615082|NCT00702520|12023939|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
7615083|NCT00702520|12023940|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
7615084|NCT00702520|12023941|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7615085|NCT00702520|12023942|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
7615086|NCT00697255|12023981|FG000|Stage 1a|Insufficient ovarian response|1
7615087|NCT00697255|12023982|FG001|Stage 1a|Insufficient ovarian response|0
7615088|NCT00697255|12023981|FG000|Stage 1a|Multifollicular growth|1
7615089|NCT00697255|12023982|FG001|Stage 1a|Multifollicular growth|0
7615090|NCT00697255|12023981|FG000|Stage 1a|Not growing of dominant follicle|1
7615091|NCT00697255|12023982|FG001|Stage 1a|Not growing of dominant follicle|0
7615092|NCT00697255|12023981|FG000|Stage 1b|Not growing of dominant follicle|0
7615093|NCT00697255|12023982|FG001|Stage 1b|Not growing of dominant follicle|1
7615094|NCT00697255|12023981|FG000|Stage 1b|Insufficient ovarian response|0
7615095|NCT00697255|12023982|FG001|Stage 1b|Insufficient ovarian response|1
7615096|NCT00696878|12023988|FG000|Overall Study|Adverse Event|8
7615097|NCT00696878|12023988|FG000|Overall Study|Withdrawal by Subject|87
7615098|NCT00696878|12023988|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
7615099|NCT00696878|12023988|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
7615100|NCT00696878|12023988|FG000|Overall Study|Trial stopped|32
7615101|NCT00696878|12023988|FG000|Overall Study|Other reason (not specified)|55
7615102|NCT00696800|12023994|FG000|Overall Study|Adverse Event|16
7615103|NCT00696800|12023995|FG001|Overall Study|Adverse Event|3
7615104|NCT00696800|12023994|FG000|Overall Study|Insufficient compliance with medication|2
7615105|NCT00696800|12023995|FG001|Overall Study|Insufficient compliance with medication|1
7615106|NCT00696800|12023994|FG000|Overall Study|Insufficient ovarian response on Day 8|4
7615107|NCT00696800|12023995|FG001|Overall Study|Insufficient ovarian response on Day 8|1
7615108|NCT00696800|12023994|FG000|Overall Study|Insufficient ovarian response|4
7615109|NCT00696800|12023995|FG001|Overall Study|Insufficient ovarian response|1
7615110|NCT00696800|12023994|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
7615111|NCT00696800|12023995|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
7615112|NCT00696800|12023994|FG000|Overall Study|Too high ovarian response|6
7615113|NCT00696800|12023995|FG001|Overall Study|Too high ovarian response|1
7615114|NCT00696800|12023994|FG000|Overall Study|No/too few/bad quality oocytes|4
7615115|NCT00696800|12023995|FG001|Overall Study|No/too few/bad quality oocytes|3
7615116|NCT00696800|12023994|FG000|Overall Study|No/abnormal fertilization|11
7615117|NCT00696800|12023995|FG001|Overall Study|No/abnormal fertilization|13
7615118|NCT00696800|12023994|FG000|Overall Study|No/too few/bad quality embryos|24
7615119|NCT00696800|12023995|FG001|Overall Study|No/too few/bad quality embryos|18
7615120|NCT00696800|12023994|FG000|Overall Study|Other Reasons|5
7615121|NCT00696800|12023995|FG001|Overall Study|Other Reasons|3
7615122|NCT00696800|12023994|FG000|Overall Study|Not treated|1
7615123|NCT00696800|12023995|FG001|Overall Study|Not treated|2
7615124|NCT00616967|12024003|FG000|Overall Study|Withdrawal by Subject|0
7615125|NCT00616967|12024004|FG001|Overall Study|Withdrawal by Subject|0
7615126|NCT00616967|12024005|FG002|Overall Study|Withdrawal by Subject|1
7615127|NCT00461032|12024025|FG000|Overall Study|Adverse Event|5
7615128|NCT00461032|12024026|FG001|Overall Study|Adverse Event|6
7615129|NCT00461032|12024025|FG000|Overall Study|Lack of Efficacy|5
7615130|NCT00461032|12024026|FG001|Overall Study|Lack of Efficacy|1
7615131|NCT00461032|12024025|FG000|Overall Study|Lost to Follow-up|7
7615132|NCT00461032|12024026|FG001|Overall Study|Lost to Follow-up|12
7615133|NCT00461032|12024025|FG000|Overall Study|Protocol Violation|4
7615134|NCT00461032|12024026|FG001|Overall Study|Protocol Violation|4
7615135|NCT00461032|12024025|FG000|Overall Study|Withdrawal by Subject|7
7615136|NCT00461032|12024026|FG001|Overall Study|Withdrawal by Subject|15
7615137|NCT00461032|12024025|FG000|Overall Study|Patient Moved or Relocated|2
7615138|NCT00461032|12024026|FG001|Overall Study|Patient Moved or Relocated|1
7615139|NCT00461032|12024025|FG000|Overall Study|Other|7
7615140|NCT00461032|12024026|FG001|Overall Study|Other|5
7615141|NCT00289874|12024047|FG000|Overall Study|Adverse Event|1
7615142|NCT00289874|12024048|FG001|Overall Study|Adverse Event|5
7615143|NCT00289874|12024047|FG000|Overall Study|Lost to Follow-up|1
7615144|NCT00289874|12024048|FG001|Overall Study|Lost to Follow-up|1
7615145|NCT00289874|12024047|FG000|Overall Study|Protocol Violation|3
7615146|NCT00289874|12024048|FG001|Overall Study|Protocol Violation|2
7615147|NCT00289874|12024047|FG000|Overall Study|Did not meet eligibility|1
7615148|NCT00289874|12024048|FG001|Overall Study|Did not meet eligibility|0
7615149|NCT00250458|12024056|FG000|Overall Study|Lost to Follow-up|4
7615150|NCT00250458|12024057|FG001|Overall Study|Lost to Follow-up|2
7615151|NCT00250458|12024056|FG000|Overall Study|Protocol Violation|0
7615152|NCT00250458|12024057|FG001|Overall Study|Protocol Violation|1
7615153|NCT00250458|12024056|FG000|Overall Study|Withdrawal by Subject|4
7615154|NCT00250458|12024057|FG001|Overall Study|Withdrawal by Subject|2
7615155|NCT00250458|12024056|FG000|Overall Study|Lack of Migraine Attack|20
7615156|NCT00250458|12024057|FG001|Overall Study|Lack of Migraine Attack|9
7615157|NCT00250458|12024056|FG000|Overall Study|Qualifying migraine but did not treat|3
7615158|NCT00250458|12024057|FG001|Overall Study|Qualifying migraine but did not treat|3
7615159|NCT00250458|12024056|FG000|Overall Study|Other|1
7615160|NCT00250458|12024057|FG001|Overall Study|Other|0
7615161|NCT00245570|12024063|FG000|Washout Between Periods III and IV|Adverse Event|0
7615162|NCT00245570|12024064|FG001|Washout Between Periods III and IV|Adverse Event|1
7615163|NCT00245570|12024065|FG002|Washout Between Periods III and IV|Adverse Event|0
7615164|NCT00245570|12024066|FG003|Washout Between Periods III and IV|Adverse Event|0
7278707|NCT00463047|11494034|FG001|Double-Blind Treatment Period 1|Adverse Event|2
7278708|NCT00463047|11494033|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
7615165|NCT00245570|12024067|FG004|Washout Between Periods III and IV|Adverse Event|0
7615166|NCT00245570|12024068|FG005|Washout Between Periods III and IV|Adverse Event|0
7615167|NCT00092131|12024092|FG000|Treatment Period I|Adverse Event|1
7615168|NCT00092131|12024093|FG001|Treatment Period I|Adverse Event|0
7615169|NCT00092131|12024092|FG000|Treatment Period II|Adverse Event|0
7615170|NCT00092131|12024093|FG001|Treatment Period II|Adverse Event|1
7615171|NCT00092118|12024101|FG000|Overall Study|Adverse Event|35
7615172|NCT00092118|12024102|FG001|Overall Study|Adverse Event|32
7615173|NCT00092118|12024101|FG000|Overall Study|Lack of Efficacy|12
7278709|NCT00463047|11494034|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
7278710|NCT00463047|11494033|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
7278711|NCT00463047|11494034|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
7278712|NCT00463047|11494033|FG000|Double-Blind Treatment Period 1|Other|1
7278713|NCT00463047|11494034|FG001|Double-Blind Treatment Period 1|Other|0
7278714|NCT00463047|11494033|FG000|Double-Blind Treatment Period 2|Adverse Event|0
7278715|NCT00463047|11494034|FG001|Double-Blind Treatment Period 2|Adverse Event|1
7278716|NCT00463047|11494033|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7278717|NCT00463047|11494034|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7278718|NCT00463047|11494033|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
7278719|NCT00463047|11494034|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
7278720|NCT00463060|11494043|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
7278721|NCT00463060|11494043|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
7278722|NCT00463151|11494056|FG000|Overall Study|Adverse Event|0
7278723|NCT00463151|11494057|FG001|Overall Study|Adverse Event|0
7278724|NCT00463151|11494058|FG002|Overall Study|Adverse Event|1
7278725|NCT00463151|11494059|FG003|Overall Study|Adverse Event|0
7278726|NCT00463151|11494056|FG000|Overall Study|Lack of Efficacy|2
7278727|NCT00463151|11494057|FG001|Overall Study|Lack of Efficacy|5
7278728|NCT00463151|11494058|FG002|Overall Study|Lack of Efficacy|2
7278729|NCT00463151|11494059|FG003|Overall Study|Lack of Efficacy|5
7278730|NCT00463151|11494056|FG000|Overall Study|Protocol Violation|0
7278731|NCT00463151|11494057|FG001|Overall Study|Protocol Violation|0
7278732|NCT00463151|11494058|FG002|Overall Study|Protocol Violation|0
7278733|NCT00463151|11494059|FG003|Overall Study|Protocol Violation|1
7278734|NCT00463151|11494056|FG000|Overall Study|Withdrawal by Subject|0
7278735|NCT00463151|11494057|FG001|Overall Study|Withdrawal by Subject|0
7278736|NCT00463151|11494058|FG002|Overall Study|Withdrawal by Subject|0
7278737|NCT00463151|11494059|FG003|Overall Study|Withdrawal by Subject|1
7278738|NCT00463229|11494071|FG000|Overall Study|Lost to Follow-up|5
7278739|NCT00463229|11494072|FG001|Overall Study|Lost to Follow-up|7
7278740|NCT00463229|11494071|FG000|Overall Study|Death|4
7278741|NCT00463229|11494072|FG001|Overall Study|Death|3
7278742|NCT00463346|11494081|FG000|Overall Study|Withdrawal by Subject|3
7278743|NCT00463346|11494082|FG001|Overall Study|Withdrawal by Subject|3
7278744|NCT00463385|11494094|FG000|Overall Study|Other|4
7278745|NCT00463385|11494095|FG001|Overall Study|Other|3
7278746|NCT00463385|11494096|FG002|Overall Study|Other|6
7278747|NCT00463385|11494097|FG003|Overall Study|Other|4
7278748|NCT00463385|11494094|FG000|Overall Study|Adverse Event|5
7278749|NCT00463385|11494095|FG001|Overall Study|Adverse Event|8
7278750|NCT00463385|11494096|FG002|Overall Study|Adverse Event|4
7278751|NCT00463385|11494097|FG003|Overall Study|Adverse Event|2
7278752|NCT00463385|11494094|FG000|Overall Study|Lack of Efficacy|6
7278753|NCT00463385|11494095|FG001|Overall Study|Lack of Efficacy|6
7278754|NCT00463385|11494096|FG002|Overall Study|Lack of Efficacy|7
7278755|NCT00463385|11494097|FG003|Overall Study|Lack of Efficacy|9
7278756|NCT00463385|11494094|FG000|Overall Study|Withdrawal by Subject|3
7278757|NCT00463385|11494095|FG001|Overall Study|Withdrawal by Subject|3
7278758|NCT00463385|11494096|FG002|Overall Study|Withdrawal by Subject|3
7278759|NCT00463385|11494097|FG003|Overall Study|Withdrawal by Subject|4
7278760|NCT00463385|11494094|FG000|Overall Study|Lost to Follow-up|0
7278761|NCT00463385|11494095|FG001|Overall Study|Lost to Follow-up|0
7278762|NCT00463385|11494096|FG002|Overall Study|Lost to Follow-up|0
7278763|NCT00463385|11494097|FG003|Overall Study|Lost to Follow-up|1
7278764|NCT00463385|11494094|FG000|Overall Study|Death|2
7278765|NCT00463385|11494095|FG001|Overall Study|Death|1
7278766|NCT00463385|11494096|FG002|Overall Study|Death|2
7278767|NCT00463385|11494097|FG003|Overall Study|Death|0
7278768|NCT00463385|11494094|FG000|Overall Study|Missing|2
7278769|NCT00463385|11494095|FG001|Overall Study|Missing|0
7278770|NCT00463385|11494096|FG002|Overall Study|Missing|0
7278771|NCT00463385|11494097|FG003|Overall Study|Missing|2
7278772|NCT00463385|11494094|FG000|Overall Study|1 participant received commercial drug|0
7278773|NCT00463385|11494095|FG001|Overall Study|1 participant received commercial drug|1
7615174|NCT00092118|12024102|FG001|Overall Study|Lack of Efficacy|14
7615175|NCT00092118|12024101|FG000|Overall Study|Lost to Follow-up|4
7615176|NCT00092118|12024102|FG001|Overall Study|Lost to Follow-up|3
7615177|NCT00092118|12024101|FG000|Overall Study|Protocol Violation|23
7615178|NCT00092118|12024102|FG001|Overall Study|Protocol Violation|25
7615179|NCT00092118|12024101|FG000|Overall Study|Withdrawal by Subject|4
7615180|NCT00092118|12024102|FG001|Overall Study|Withdrawal by Subject|10
7615181|NCT00092118|12024101|FG000|Overall Study|Other|6
7615182|NCT00092118|12024102|FG001|Overall Study|Other|5
7615183|NCT00090142|12024108|FG000|Treatment Period I|Lost to Follow-up|1
7615184|NCT00090142|12024109|FG001|Treatment Period I|Lost to Follow-up|2
7615185|NCT00090142|12024108|FG000|Treatment Period I|Protocol Violation|2
7615186|NCT00090142|12024109|FG001|Treatment Period I|Protocol Violation|0
7615187|NCT00090142|12024108|FG000|Treatment Period I|Withdrawal by Subject|2
7615188|NCT00090142|12024109|FG001|Treatment Period I|Withdrawal by Subject|0
7278774|NCT00463385|11494096|FG002|Overall Study|1 participant received commercial drug|0
7278775|NCT00463385|11494097|FG003|Overall Study|1 participant received commercial drug|0
7278776|NCT00463476|11494134|FG000|Overall Study|Withdrawal by Subject|1
7278777|NCT00463476|11494135|FG001|Overall Study|Withdrawal by Subject|2
7615189|NCT00090142|12024108|FG000|Treatment Period I|Other|0
7278778|NCT00463476|11494134|FG000|Overall Study|Lost to Follow-up|1
7278779|NCT00463476|11494135|FG001|Overall Study|Lost to Follow-up|1
7278780|NCT00463567|11494148|FG000|Overall Study|Adverse Event|29
7278781|NCT00463567|11494149|FG001|Overall Study|Adverse Event|26
7278782|NCT00463567|11494150|FG002|Overall Study|Adverse Event|17
7278783|NCT00463567|11494151|FG003|Overall Study|Adverse Event|46
7278784|NCT00463567|11494152|FG004|Overall Study|Adverse Event|10
7278785|NCT00463567|11494153|FG005|Overall Study|Adverse Event|10
7278786|NCT00463567|11494154|FG006|Overall Study|Adverse Event|4
7278787|NCT00463567|11494148|FG000|Overall Study|Withdrawal by Subject|29
7278788|NCT00463567|11494149|FG001|Overall Study|Withdrawal by Subject|22
7278789|NCT00463567|11494150|FG002|Overall Study|Withdrawal by Subject|20
7278790|NCT00463567|11494151|FG003|Overall Study|Withdrawal by Subject|37
7278791|NCT00463567|11494152|FG004|Overall Study|Withdrawal by Subject|6
7278792|NCT00463567|11494153|FG005|Overall Study|Withdrawal by Subject|5
7278793|NCT00463567|11494154|FG006|Overall Study|Withdrawal by Subject|1
7278794|NCT00463567|11494148|FG000|Overall Study|Protocol Deviation|13
7278795|NCT00463567|11494149|FG001|Overall Study|Protocol Deviation|9
7278796|NCT00463567|11494150|FG002|Overall Study|Protocol Deviation|14
7278797|NCT00463567|11494151|FG003|Overall Study|Protocol Deviation|11
7278798|NCT00463567|11494152|FG004|Overall Study|Protocol Deviation|1
7278799|NCT00463567|11494153|FG005|Overall Study|Protocol Deviation|1
7278800|NCT00463567|11494154|FG006|Overall Study|Protocol Deviation|2
7278801|NCT00463567|11494148|FG000|Overall Study|Lost to Follow-up|12
7278802|NCT00463567|11494149|FG001|Overall Study|Lost to Follow-up|6
7278803|NCT00463567|11494150|FG002|Overall Study|Lost to Follow-up|13
7278804|NCT00463567|11494151|FG003|Overall Study|Lost to Follow-up|8
7278805|NCT00463567|11494152|FG004|Overall Study|Lost to Follow-up|1
7278806|NCT00463567|11494153|FG005|Overall Study|Lost to Follow-up|1
7278807|NCT00463567|11494154|FG006|Overall Study|Lost to Follow-up|1
7278808|NCT00463567|11494148|FG000|Overall Study|Administrative problems|5
7278809|NCT00463567|11494149|FG001|Overall Study|Administrative problems|3
7278810|NCT00463567|11494150|FG002|Overall Study|Administrative problems|6
7278811|NCT00463567|11494151|FG003|Overall Study|Administrative problems|9
7278812|NCT00463567|11494152|FG004|Overall Study|Administrative problems|3
7278813|NCT00463567|11494153|FG005|Overall Study|Administrative problems|2
7278814|NCT00463567|11494154|FG006|Overall Study|Administrative problems|2
7278815|NCT00463567|11494148|FG000|Overall Study|Lack of Efficacy|4
7278816|NCT00463567|11494149|FG001|Overall Study|Lack of Efficacy|9
7278817|NCT00463567|11494150|FG002|Overall Study|Lack of Efficacy|9
7278818|NCT00463567|11494151|FG003|Overall Study|Lack of Efficacy|17
7278819|NCT00463567|11494152|FG004|Overall Study|Lack of Efficacy|1
7278820|NCT00463567|11494153|FG005|Overall Study|Lack of Efficacy|0
7278821|NCT00463567|11494154|FG006|Overall Study|Lack of Efficacy|1
7278822|NCT00463567|11494148|FG000|Overall Study|Abnormal lab value(s)|1
7615190|NCT00090142|12024109|FG001|Treatment Period I|Other|1
7615191|NCT00090142|12024108|FG000|Treatment Period II|Other|1
7615192|NCT00090142|12024109|FG001|Treatment Period II|Other|0
7278823|NCT00463567|11494149|FG001|Overall Study|Abnormal lab value(s)|1
7278824|NCT00463567|11494150|FG002|Overall Study|Abnormal lab value(s)|2
7278825|NCT00463567|11494151|FG003|Overall Study|Abnormal lab value(s)|1
7278826|NCT00463567|11494152|FG004|Overall Study|Abnormal lab value(s)|1
7615193|NCT04771013|12024121|FG000|Overall Study|Withdrawal by Subject|2
7615194|NCT04771013|12024122|FG001|Overall Study|Withdrawal by Subject|0
7615195|NCT04771013|12024121|FG000|Overall Study|Death|0
7615196|NCT04771013|12024122|FG001|Overall Study|Death|5
7615197|NCT04771013|12024121|FG000|Overall Study|Referred to another hospital before day 20|0
7615198|NCT04771013|12024122|FG001|Overall Study|Referred to another hospital before day 20|1
7615199|NCT04497987|12024130|FG000|Overall Study|Adverse Event|1
7615200|NCT04497987|12024131|FG001|Overall Study|Adverse Event|0
7615201|NCT04497987|12024130|FG000|Overall Study|Death|21
7615202|NCT04497987|12024131|FG001|Overall Study|Death|13
7615203|NCT04497987|12024130|FG000|Overall Study|Lost to Follow-up|19
7615204|NCT04497987|12024131|FG001|Overall Study|Lost to Follow-up|17
7615205|NCT04497987|12024130|FG000|Overall Study|Other - as reported by the investigator|22
7278827|NCT00463567|11494153|FG005|Overall Study|Abnormal lab value(s)|0
7615206|NCT04497987|12024131|FG001|Overall Study|Other - as reported by the investigator|16
7615207|NCT04497987|12024130|FG000|Overall Study|Physician Decision|1
7615208|NCT04497987|12024131|FG001|Overall Study|Physician Decision|0
7615209|NCT04497987|12024130|FG000|Overall Study|Withdrawal by Subject|35
7615210|NCT04497987|12024131|FG001|Overall Study|Withdrawal by Subject|21
7615211|NCT03512210|12024187|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3
7615212|NCT03512210|12024187|FG000|Step 1: MINMON Intervention|Protocol Violation|1
7615213|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Death|2
7615214|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Lost to Follow-up|30
7615215|NCT03512210|12024187|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2
7615216|NCT03180307|12024228|FG000|Overall Study|Lost to Follow-up|2
7615217|NCT03180307|12024229|FG001|Overall Study|Lost to Follow-up|0
7615218|NCT03180307|12024228|FG000|Overall Study|Death|1
7615219|NCT03180307|12024229|FG001|Overall Study|Death|0
7615220|NCT03180307|12024228|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3
7615221|NCT03180307|12024229|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0
7615222|NCT02668822|12024248|FG000|Overall Study|Protocol Violation|2
7615223|NCT02668822|12024249|FG001|Overall Study|Protocol Violation|0
7278828|NCT00463567|11494154|FG006|Overall Study|Abnormal lab value(s)|0
7615224|NCT02668822|12024248|FG000|Overall Study|Study Terminated by Sponsor|7
7615225|NCT02668822|12024249|FG001|Overall Study|Study Terminated by Sponsor|9
7615226|NCT02668783|12024257|FG000|Overall Study|Pregnancy|0
7615227|NCT02668783|12024258|FG001|Overall Study|Pregnancy|1
7615228|NCT02668783|12024257|FG000|Overall Study|Protocol Violation|2
7615229|NCT02668783|12024258|FG001|Overall Study|Protocol Violation|1
7615230|NCT02668783|12024257|FG000|Overall Study|Study terminated by sponsor|9
7615231|NCT02668783|12024258|FG001|Overall Study|Study terminated by sponsor|10
7615232|NCT02668783|12024257|FG000|Overall Study|Subject moved|1
7615233|NCT02668783|12024258|FG001|Overall Study|Subject moved|0
7615234|NCT02668783|12024257|FG000|Overall Study|Withdrawal by Subject|1
7278829|NCT00463567|11494148|FG000|Overall Study|Abnormal test procedure result(s)|1
7278830|NCT00463567|11494149|FG001|Overall Study|Abnormal test procedure result(s)|1
7278831|NCT00463567|11494150|FG002|Overall Study|Abnormal test procedure result(s)|6
7278832|NCT00463567|11494151|FG003|Overall Study|Abnormal test procedure result(s)|2
7278833|NCT00463567|11494152|FG004|Overall Study|Abnormal test procedure result(s)|0
7278834|NCT00463567|11494153|FG005|Overall Study|Abnormal test procedure result(s)|2
7278835|NCT00463567|11494154|FG006|Overall Study|Abnormal test procedure result(s)|0
7278836|NCT00463567|11494148|FG000|Overall Study|Death|1
7278837|NCT00463567|11494149|FG001|Overall Study|Death|0
7278838|NCT00463567|11494150|FG002|Overall Study|Death|2
7278839|NCT00463567|11494151|FG003|Overall Study|Death|0
7278840|NCT00463567|11494152|FG004|Overall Study|Death|0
7278841|NCT00463567|11494153|FG005|Overall Study|Death|0
7278842|NCT00463567|11494154|FG006|Overall Study|Death|0
7278843|NCT00463580|11494178|FG000|Overall Study|Lost to Follow-up|1
7278844|NCT00463580|11494179|FG001|Overall Study|Lost to Follow-up|0
7278845|NCT00463580|11494178|FG000|Overall Study|Schedule conflict|2
7278846|NCT00463580|11494179|FG001|Overall Study|Schedule conflict|0
7278847|NCT00463580|11494178|FG000|Overall Study|Medical/psychiatric complications|0
7278848|NCT00463580|11494179|FG001|Overall Study|Medical/psychiatric complications|2
7278849|NCT00463606|11494194|FG000|Overall Study|Adverse Event|21
7278850|NCT00463606|11494195|FG001|Overall Study|Adverse Event|18
7278851|NCT00463606|11494196|FG002|Overall Study|Adverse Event|11
7278852|NCT00463606|11494194|FG000|Overall Study|Withdrawal by Subject|11
7278853|NCT00463606|11494195|FG001|Overall Study|Withdrawal by Subject|11
7278854|NCT00463606|11494196|FG002|Overall Study|Withdrawal by Subject|5
7278855|NCT00463606|11494194|FG000|Overall Study|Lost to Follow-up|2
7278856|NCT00463606|11494195|FG001|Overall Study|Lost to Follow-up|2
7278857|NCT00463606|11494196|FG002|Overall Study|Lost to Follow-up|3
7278858|NCT00463606|11494194|FG000|Overall Study|Subject noncompliance|1
7278859|NCT00463606|11494195|FG001|Overall Study|Subject noncompliance|1
7278860|NCT00463606|11494196|FG002|Overall Study|Subject noncompliance|0
7278861|NCT00463606|11494194|FG000|Overall Study|Subject moved out of town|1
7278862|NCT00463606|11494195|FG001|Overall Study|Subject moved out of town|0
7278863|NCT00463606|11494196|FG002|Overall Study|Subject moved out of town|0
7278864|NCT00463606|11494194|FG000|Overall Study|Physician Decision|0
7278865|NCT00463606|11494195|FG001|Overall Study|Physician Decision|1
7278866|NCT00463606|11494196|FG002|Overall Study|Physician Decision|0
7278867|NCT00463606|11494194|FG000|Overall Study|Sponsor request|0
7278868|NCT00463606|11494195|FG001|Overall Study|Sponsor request|1
7615235|NCT02668783|12024258|FG001|Overall Study|Withdrawal by Subject|0
7615236|NCT02616146|12024266|FG000|Overall Study|Adverse Event|64
7615237|NCT02616146|12024267|FG001|Overall Study|Adverse Event|24
7615238|NCT02616146|12024266|FG000|Overall Study|Lost to Follow-up|23
7615239|NCT02616146|12024267|FG001|Overall Study|Lost to Follow-up|13
7615240|NCT02616146|12024266|FG000|Overall Study|Non-compliance with study protocol|2
7615241|NCT02616146|12024267|FG001|Overall Study|Non-compliance with study protocol|0
7615242|NCT02616146|12024266|FG000|Overall Study|Non-compliance with study drug|4
7278869|NCT00463606|11494196|FG002|Overall Study|Sponsor request|0
7615243|NCT02616146|12024267|FG001|Overall Study|Non-compliance with study drug|2
7615244|NCT02616146|12024266|FG000|Overall Study|Pregnancy|2
7615245|NCT02616146|12024267|FG001|Overall Study|Pregnancy|2
7615246|NCT02616146|12024266|FG000|Overall Study|Pregnancy wish|3
7615247|NCT02616146|12024267|FG001|Overall Study|Pregnancy wish|0
7615248|NCT02616146|12024266|FG000|Overall Study|Protocol Violation|6
7615249|NCT02616146|12024267|FG001|Overall Study|Protocol Violation|3
7615250|NCT02616146|12024266|FG000|Overall Study|Study terminated by sponsor|1372
7615251|NCT02616146|12024267|FG001|Overall Study|Study terminated by sponsor|432
7615252|NCT02616146|12024266|FG000|Overall Study|Participant moved|4
7615253|NCT02616146|12024267|FG001|Overall Study|Participant moved|3
7615254|NCT02616146|12024266|FG000|Overall Study|Withdrawal by Subject|30
7615255|NCT02616146|12024267|FG001|Overall Study|Withdrawal by Subject|24
7615256|NCT02616146|12024266|FG000|Overall Study|Physician Decision|2
7615257|NCT02616146|12024267|FG001|Overall Study|Physician Decision|1
7615258|NCT02524288|12024286|FG000|Overall Study|Adverse Event|115
7615259|NCT02524288|12024286|FG000|Overall Study|Lost to Follow-up|216
7615260|NCT02524288|12024286|FG000|Overall Study|Non-Compliance With Protocol|32
7615261|NCT02524288|12024286|FG000|Overall Study|Non-Compliance With Study Drug|14
7615262|NCT02524288|12024286|FG000|Overall Study|Pregnancy Wish|6
7615263|NCT02524288|12024286|FG000|Overall Study|Protocol Violation|6
7615264|NCT02524288|12024286|FG000|Overall Study|Screen Failure|2
7615265|NCT02524288|12024286|FG000|Overall Study|Site Discontinued Study Participation|1
7615266|NCT02524288|12024286|FG000|Overall Study|Study Terminated By Sponsor|1417
7615267|NCT02524288|12024286|FG000|Overall Study|Subject Moved|32
7615268|NCT02524288|12024286|FG000|Overall Study|Withdrawal by Subject|76
7615269|NCT02524288|12024286|FG000|Overall Study|Pregnancy|22
7615270|NCT02524288|12024286|FG000|Overall Study|Physician Decision|2
7615271|NCT02489942|12024290|FG000|Overall Study|Request by patient|602
7615272|NCT02489942|12024290|FG000|Overall Study|Improvement/remission|157
7615273|NCT02489942|12024290|FG000|Overall Study|No change/Progressive disease|263
7615274|NCT02489942|12024290|FG000|Overall Study|Adverse Event|522
7615275|NCT02489942|12024290|FG000|Overall Study|Other personal reasons|1218
7615276|NCT02489942|12024290|FG000|Overall Study|Lost to Follow-up|456
7615277|NCT02489942|12024290|FG000|Overall Study|Not continuously investigated|7
7615278|NCT02489942|12024290|FG000|Overall Study|Patient started jardiance treatment out of registration period|1
7615279|NCT02489942|12024290|FG000|Overall Study|Multiple registration|1
7615280|NCT02489942|12024290|FG000|Overall Study|No patient visit after entry|100
7615281|NCT02489942|12024290|FG000|Overall Study|No treatment with Jardiance|2
7615282|NCT02489942|12024290|FG000|Overall Study|Patient received Jardiance before registration|1
7615283|NCT02489942|12024290|FG000|Overall Study|No CRF collected|86
7278870|NCT00463606|11494194|FG000|Overall Study|Exclusion criteria violation|2
7278871|NCT00463606|11494195|FG001|Overall Study|Exclusion criteria violation|0
7278872|NCT00463606|11494196|FG002|Overall Study|Exclusion criteria violation|0
7278873|NCT00463606|11494194|FG000|Overall Study|Coordinator error|1
7278874|NCT00463606|11494195|FG001|Overall Study|Coordinator error|0
7278875|NCT00463606|11494196|FG002|Overall Study|Coordinator error|0
7278876|NCT00463606|11494194|FG000|Overall Study|Patient randomized in error|1
7278877|NCT00463606|11494195|FG001|Overall Study|Patient randomized in error|0
7278878|NCT00463606|11494196|FG002|Overall Study|Patient randomized in error|0
7278879|NCT00463606|11494194|FG000|Overall Study|Participation in another ABT-335 trial|1
7278880|NCT00463606|11494195|FG001|Overall Study|Participation in another ABT-335 trial|0
7278881|NCT00463606|11494196|FG002|Overall Study|Participation in another ABT-335 trial|0
7278882|NCT00463606|11494194|FG000|Overall Study|Protocol Violation|0
7278883|NCT00463606|11494195|FG001|Overall Study|Protocol Violation|0
7278884|NCT00463606|11494196|FG002|Overall Study|Protocol Violation|1
7278885|NCT00463684|11494204|FG000|Overall Study|Withdrawal by Subject|1
7278886|NCT00463684|11494204|FG000|Overall Study|Lost to Follow-up|3
7278887|NCT00463788|11494210|FG000|Overall Study|Progressive Disease|86
7278888|NCT00463788|11494211|FG001|Overall Study|Progressive Disease|42
7278889|NCT00463788|11494210|FG000|Overall Study|Adverse Event|6
7278890|NCT00463788|11494211|FG001|Overall Study|Adverse Event|2
7278891|NCT00463788|11494210|FG000|Overall Study|Withdrawal by Subject|6
7278892|NCT00463788|11494211|FG001|Overall Study|Withdrawal by Subject|2
7615284|NCT02409342|12024296|FG000|Overall Study|Death|181
7615285|NCT02409342|12024297|FG001|Overall Study|Death|174
7615286|NCT02409342|12024296|FG000|Overall Study|Withdrawal by Subject|24
7615287|NCT02409342|12024297|FG001|Overall Study|Withdrawal by Subject|16
7615288|NCT02409342|12024296|FG000|Overall Study|On-going in study|79
7615289|NCT02409342|12024297|FG001|Overall Study|On-going in study|92
7615290|NCT02409342|12024296|FG000|Overall Study|Lost to Follow-up|3
7615291|NCT02409342|12024297|FG001|Overall Study|Lost to Follow-up|3
7615292|NCT02275546|12024314|FG000|Treatment Period 2|Withdrawal by Subject|2
7278893|NCT00463788|11494210|FG000|Overall Study|Death|4
7278894|NCT00463788|11494211|FG001|Overall Study|Death|3
7278895|NCT00463788|11494210|FG000|Overall Study|Symptomatic Deterioration|2
7278896|NCT00463788|11494211|FG001|Overall Study|Symptomatic Deterioration|3
7278897|NCT00463788|11494210|FG000|Overall Study|Lost to Follow-up|1
7278898|NCT00463788|11494211|FG001|Overall Study|Lost to Follow-up|0
7615293|NCT02275546|12024315|FG001|Treatment Period 2|Withdrawal by Subject|1
7615294|NCT02275546|12024314|FG000|Treatment Period 2|Protocol Violation|0
7615295|NCT02275546|12024315|FG001|Treatment Period 2|Protocol Violation|1
7615296|NCT02077166|12024328|FG000|Overall Study|Death|6
7615297|NCT02077166|12024329|FG001|Overall Study|Death|7
7615298|NCT02077166|12024330|FG002|Overall Study|Death|5
7615299|NCT02077166|12024331|FG003|Overall Study|Death|6
7615300|NCT02077166|12024332|FG004|Overall Study|Death|4
7615301|NCT02077166|12024333|FG005|Overall Study|Death|32
7615302|NCT02077166|12024334|FG006|Overall Study|Death|22
7615303|NCT02077166|12024328|FG000|Overall Study|Study Closure by Sponsor|3
7615304|NCT02077166|12024329|FG001|Overall Study|Study Closure by Sponsor|0
7615305|NCT02077166|12024330|FG002|Overall Study|Study Closure by Sponsor|2
7615306|NCT02077166|12024331|FG003|Overall Study|Study Closure by Sponsor|2
7615307|NCT02077166|12024332|FG004|Overall Study|Study Closure by Sponsor|2
7615308|NCT02077166|12024333|FG005|Overall Study|Study Closure by Sponsor|12
7615309|NCT02077166|12024334|FG006|Overall Study|Study Closure by Sponsor|4
7615310|NCT02077166|12024328|FG000|Overall Study|Lost to Follow-up|0
7615311|NCT02077166|12024329|FG001|Overall Study|Lost to Follow-up|0
7615312|NCT02077166|12024330|FG002|Overall Study|Lost to Follow-up|0
7615313|NCT02077166|12024331|FG003|Overall Study|Lost to Follow-up|0
7615314|NCT02077166|12024332|FG004|Overall Study|Lost to Follow-up|0
7615315|NCT02077166|12024333|FG005|Overall Study|Lost to Follow-up|1
7615316|NCT02077166|12024334|FG006|Overall Study|Lost to Follow-up|0
7615317|NCT02077166|12024328|FG000|Overall Study|Withdrawal by Subject|3
7615318|NCT02077166|12024329|FG001|Overall Study|Withdrawal by Subject|0
7615319|NCT02077166|12024330|FG002|Overall Study|Withdrawal by Subject|1
7615320|NCT02077166|12024331|FG003|Overall Study|Withdrawal by Subject|1
7615321|NCT02077166|12024332|FG004|Overall Study|Withdrawal by Subject|1
7615322|NCT02077166|12024333|FG005|Overall Study|Withdrawal by Subject|3
7615323|NCT02077166|12024334|FG006|Overall Study|Withdrawal by Subject|0
7615324|NCT02077166|12024328|FG000|Overall Study|Other, Not Specified|0
7278899|NCT00463788|11494210|FG000|Overall Study|Protocol Violation|0
7278900|NCT00463788|11494211|FG001|Overall Study|Protocol Violation|1
7278901|NCT00463788|11494210|FG000|Overall Study|Other|3
7278902|NCT00463788|11494211|FG001|Overall Study|Other|0
7278903|NCT00463788|11494210|FG000|Overall Study|Randomized but not treated|1
7278904|NCT00463788|11494211|FG001|Overall Study|Randomized but not treated|1
7278905|NCT00463801|11494218|FG000|Overall Study|Protocol Violation|1
7278906|NCT00463801|11494218|FG000|Overall Study|Lack of Efficacy|2
7278907|NCT00463801|11494218|FG000|Overall Study|Adverse Event|4
7278908|NCT00463801|11494218|FG000|Overall Study|Lost to Follow-up|5
7278909|NCT00463801|11494218|FG000|Overall Study|No longer require therapy|1
7278910|NCT00463840|11494222|FG000|Overall Study|Disease progression|7
7278911|NCT00463840|11494222|FG000|Overall Study|Withdrawal by Subject|2
7278912|NCT00463840|11494222|FG000|Overall Study|Adverse Event|3
7278913|NCT00463866|11494228|FG000|Overall Study|Adverse Event|70
7278914|NCT00463866|11494229|FG001|Overall Study|Adverse Event|93
7278915|NCT00463866|11494228|FG000|Overall Study|Withdrawal by Subject|81
7278916|NCT00463866|11494229|FG001|Overall Study|Withdrawal by Subject|79
7278917|NCT00463866|11494228|FG000|Overall Study|Lost to Follow-up|46
7278918|NCT00463866|11494229|FG001|Overall Study|Lost to Follow-up|55
7278919|NCT00463866|11494228|FG000|Overall Study|Incorrect Enrolment|64
7278920|NCT00463866|11494229|FG001|Overall Study|Incorrect Enrolment|66
7615325|NCT02077166|12024329|FG001|Overall Study|Other, Not Specified|0
7615326|NCT02077166|12024330|FG002|Overall Study|Other, Not Specified|1
7615327|NCT02077166|12024331|FG003|Overall Study|Other, Not Specified|0
7615328|NCT02077166|12024332|FG004|Overall Study|Other, Not Specified|1
7278921|NCT00463866|11494228|FG000|Overall Study|Severe Non-Compliance to Protocol|25
7278922|NCT00463866|11494229|FG001|Overall Study|Severe Non-Compliance to Protocol|21
7278923|NCT00463866|11494228|FG000|Overall Study|Safety Reason|1
7615329|NCT02077166|12024333|FG005|Overall Study|Other, Not Specified|7
7615330|NCT02077166|12024334|FG006|Overall Study|Other, Not Specified|8
7615331|NCT01891344|12024359|FG000|Overall Study|Ongoing|6
7615332|NCT01891344|12024360|FG001|Overall Study|Ongoing|2
7615333|NCT01891344|12024361|FG002|Overall Study|Ongoing|0
7615334|NCT01891344|12024362|FG003|Overall Study|Ongoing|1
7615335|NCT01891344|12024363|FG004|Overall Study|Ongoing|4
7615336|NCT01891344|12024364|FG005|Overall Study|Ongoing|1
7615337|NCT01891344|12024365|FG006|Overall Study|Ongoing|0
7615338|NCT01891344|12024366|FG007|Overall Study|Ongoing|0
7615339|NCT01847274|12024388|FG000|Overall Study|Adverse Event|17
7615340|NCT01847274|12024389|FG001|Overall Study|Adverse Event|1
7615341|NCT01847274|12024390|FG002|Overall Study|Adverse Event|33
7615342|NCT01847274|12024391|FG003|Overall Study|Adverse Event|2
7615343|NCT01847274|12024388|FG000|Overall Study|Withdrawal by Subject|8
7615344|NCT01847274|12024389|FG001|Overall Study|Withdrawal by Subject|8
7615345|NCT01847274|12024390|FG002|Overall Study|Withdrawal by Subject|11
7615346|NCT01847274|12024391|FG003|Overall Study|Withdrawal by Subject|1
7615347|NCT01847274|12024388|FG000|Overall Study|Disease Progression|63
7615348|NCT01847274|12024389|FG001|Overall Study|Disease Progression|49
7615349|NCT01847274|12024390|FG002|Overall Study|Disease Progression|129
7615350|NCT01847274|12024391|FG003|Overall Study|Disease Progression|98
7615351|NCT01847274|12024388|FG000|Overall Study|Treatment Associated Risk|0
7615352|NCT01847274|12024389|FG001|Overall Study|Treatment Associated Risk|2
7615353|NCT01847274|12024390|FG002|Overall Study|Treatment Associated Risk|2
7615354|NCT01847274|12024391|FG003|Overall Study|Treatment Associated Risk|0
7615355|NCT01847274|12024388|FG000|Overall Study|Other Reasons|3
7615356|NCT01847274|12024389|FG001|Overall Study|Other Reasons|1
7615357|NCT01847274|12024390|FG002|Overall Study|Other Reasons|11
7615358|NCT01847274|12024391|FG003|Overall Study|Other Reasons|3
7615359|NCT01847274|12024388|FG000|Overall Study|Non Compliance|0
7615360|NCT01847274|12024389|FG001|Overall Study|Non Compliance|0
7615361|NCT01847274|12024390|FG002|Overall Study|Non Compliance|2
7615362|NCT01847274|12024391|FG003|Overall Study|Non Compliance|0
7615363|NCT01670656|12024406|FG000|Overall Study|Non-compliance with study drug|0
7615364|NCT01670656|12024407|FG001|Overall Study|Non-compliance with study drug|0
7615365|NCT01670656|12024408|FG002|Overall Study|Non-compliance with study drug|3
7615366|NCT01670656|12024409|FG003|Overall Study|Non-compliance with study drug|0
7615367|NCT01670656|12024410|FG004|Overall Study|Non-compliance with study drug|1
7615368|NCT01670656|12024406|FG000|Overall Study|Pregnancy|0
7615369|NCT01670656|12024407|FG001|Overall Study|Pregnancy|0
7615370|NCT01670656|12024408|FG002|Overall Study|Pregnancy|0
7615371|NCT01670656|12024409|FG003|Overall Study|Pregnancy|0
7615372|NCT01670656|12024410|FG004|Overall Study|Pregnancy|1
7615373|NCT01670656|12024406|FG000|Overall Study|Withdrawal by Subject|1
7615374|NCT01670656|12024407|FG001|Overall Study|Withdrawal by Subject|1
7615375|NCT01670656|12024408|FG002|Overall Study|Withdrawal by Subject|0
7615376|NCT01670656|12024409|FG003|Overall Study|Withdrawal by Subject|0
7615377|NCT01670656|12024410|FG004|Overall Study|Withdrawal by Subject|0
7615378|NCT01670656|12024406|FG000|Overall Study|Non-compliance with protocol|0
7615379|NCT01670656|12024407|FG001|Overall Study|Non-compliance with protocol|3
7615380|NCT01670656|12024408|FG002|Overall Study|Non-compliance with protocol|1
7615381|NCT01670656|12024409|FG003|Overall Study|Non-compliance with protocol|1
7615382|NCT01670656|12024410|FG004|Overall Study|Non-compliance with protocol|2
7615383|NCT01670656|12024406|FG000|Overall Study|Adverse Event|2
7615384|NCT01670656|12024407|FG001|Overall Study|Adverse Event|2
7615385|NCT01670656|12024408|FG002|Overall Study|Adverse Event|2
7615386|NCT01670656|12024409|FG003|Overall Study|Adverse Event|3
7615387|NCT01670656|12024410|FG004|Overall Study|Adverse Event|3
7615388|NCT01670656|12024406|FG000|Overall Study|Subject withdrew consent|0
7615389|NCT01670656|12024407|FG001|Overall Study|Subject withdrew consent|1
7615390|NCT01670656|12024408|FG002|Overall Study|Subject withdrew consent|2
7615391|NCT01670656|12024409|FG003|Overall Study|Subject withdrew consent|1
7615392|NCT01670656|12024410|FG004|Overall Study|Subject withdrew consent|1
7615393|NCT01670656|12024406|FG000|Overall Study|Lost to Follow-up|0
7615394|NCT01670656|12024407|FG001|Overall Study|Lost to Follow-up|0
7615395|NCT01670656|12024408|FG002|Overall Study|Lost to Follow-up|0
7615396|NCT01670656|12024409|FG003|Overall Study|Lost to Follow-up|0
7615397|NCT01670656|12024410|FG004|Overall Study|Lost to Follow-up|3
7615398|NCT01670656|12024406|FG000|Overall Study|Subject moved|0
7615399|NCT01670656|12024407|FG001|Overall Study|Subject moved|0
7615400|NCT01670656|12024408|FG002|Overall Study|Subject moved|0
7615401|NCT01670656|12024409|FG003|Overall Study|Subject moved|1
7615402|NCT01670656|12024410|FG004|Overall Study|Subject moved|0
7615403|NCT01501955|12024424|FG000|Overall Study|Withdrawal by Subject|1
7615404|NCT01501955|12024425|FG001|Overall Study|Withdrawal by Subject|0
7615405|NCT01501955|12024424|FG000|Overall Study|Adverse Event|1
7615406|NCT01501955|12024425|FG001|Overall Study|Adverse Event|3
7278924|NCT00463866|11494229|FG001|Overall Study|Safety Reason|3
7278925|NCT00463866|11494228|FG000|Overall Study|Mis-Randomization of subject|0
7278926|NCT00463866|11494229|FG001|Overall Study|Mis-Randomization of subject|1
7278927|NCT00463866|11494228|FG000|Overall Study|Other|22
7278928|NCT00463866|11494229|FG001|Overall Study|Other|22
7278929|NCT00464087|11494238|FG000|Overall Study|No PCI per inclusion criteria|0
7278930|NCT00464087|11494239|FG001|Overall Study|No PCI per inclusion criteria|0
7278931|NCT00464087|11494240|FG002|Overall Study|No PCI per inclusion criteria|29
7615439|NCT01277211|12024442|FG000|Overall Study|Adverse Event|60
7615440|NCT01277211|12024443|FG001|Overall Study|Adverse Event|22
7615441|NCT01277211|12024442|FG000|Overall Study|Pregnancy|9
7615442|NCT01277211|12024443|FG001|Overall Study|Pregnancy|4
7615443|NCT01277211|12024442|FG000|Overall Study|Lost to Follow-up|14
7615444|NCT01277211|12024443|FG001|Overall Study|Lost to Follow-up|9
7615445|NCT01277211|12024442|FG000|Overall Study|Did not wish to continue|17
7615446|NCT01277211|12024443|FG001|Overall Study|Did not wish to continue|0
7615447|NCT01277211|12024442|FG000|Overall Study|Withdrew Consent|9
7615448|NCT01277211|12024443|FG001|Overall Study|Withdrew Consent|9
7615449|NCT01277211|12024442|FG000|Overall Study|Non-compliance with protocol|13
7615450|NCT01277211|12024443|FG001|Overall Study|Non-compliance with protocol|4
7615451|NCT01277211|12024442|FG000|Overall Study|Did not meet protocol eligibility|1
7615452|NCT01277211|12024443|FG001|Overall Study|Did not meet protocol eligibility|0
7615453|NCT01277211|12024442|FG000|Overall Study|Administrative|3
7615454|NCT01277211|12024443|FG001|Overall Study|Administrative|0
7615455|NCT01277211|12024442|FG000|Overall Study|Pregnancy wish|0
7615456|NCT01277211|12024443|FG001|Overall Study|Pregnancy wish|2
7278964|NCT00464308|11494281|FG000|Overall Study|Adverse Event|22
7278965|NCT00464308|11494282|FG001|Overall Study|Adverse Event|27
7278966|NCT00464308|11494283|FG002|Overall Study|Adverse Event|16
7278967|NCT00464308|11494281|FG000|Overall Study|Lost to Follow-up|29
7278968|NCT00464308|11494282|FG001|Overall Study|Lost to Follow-up|19
7278969|NCT00464308|11494283|FG002|Overall Study|Lost to Follow-up|20
7278970|NCT00464308|11494281|FG000|Overall Study|Patient discontinued and other reasons|17
7278971|NCT00464308|11494282|FG001|Overall Study|Patient discontinued and other reasons|17
7278972|NCT00464308|11494283|FG002|Overall Study|Patient discontinued and other reasons|23
7278973|NCT00464308|11494281|FG000|Overall Study|Physician Decision|1
7615457|NCT01277211|12024442|FG000|Overall Study|Discontinued prior to treatment|24
7615458|NCT01277211|12024443|FG001|Overall Study|Discontinued prior to treatment|13
7615459|NCT01244828|12024453|FG000|Overall Study|Adverse Event|37
7615460|NCT01244828|12024453|FG000|Overall Study|Withdrawal by Subject|31
7615461|NCT01244828|12024453|FG000|Overall Study|Lack of Efficacy|7
7615462|NCT01244828|12024453|FG000|Overall Study|Lost to Follow-up|2
7615463|NCT01244828|12024453|FG000|Overall Study|Other reason (not specified)|1
7615469|NCT01181778|12024461|FG000|Overall Study|Physician Decision|48
7615470|NCT01047540|12024472|FG000|Overall Study|Protocol Violation|1
7615471|NCT01047540|12024473|FG001|Overall Study|Protocol Violation|0
7615472|NCT01047540|12024474|FG002|Overall Study|Protocol Violation|0
7615473|NCT01047540|12024475|FG003|Overall Study|Protocol Violation|0
7615474|NCT01047540|12024476|FG004|Overall Study|Protocol Violation|0
7615475|NCT01047540|12024472|FG000|Overall Study|Lost to Follow-up|1
7615476|NCT01047540|12024473|FG001|Overall Study|Lost to Follow-up|0
7615477|NCT01047540|12024474|FG002|Overall Study|Lost to Follow-up|0
7615478|NCT01047540|12024475|FG003|Overall Study|Lost to Follow-up|0
7615479|NCT01047540|12024476|FG004|Overall Study|Lost to Follow-up|0
7615480|NCT01047540|12024472|FG000|Overall Study|Withdrawal by Subject|1
7615481|NCT01047540|12024473|FG001|Overall Study|Withdrawal by Subject|0
7615482|NCT01047540|12024474|FG002|Overall Study|Withdrawal by Subject|3
7615483|NCT01047540|12024475|FG003|Overall Study|Withdrawal by Subject|0
7615484|NCT01047540|12024476|FG004|Overall Study|Withdrawal by Subject|1
7615485|NCT01047540|12024472|FG000|Overall Study|Pregnancy|1
7615486|NCT01047540|12024473|FG001|Overall Study|Pregnancy|0
7615487|NCT01047540|12024474|FG002|Overall Study|Pregnancy|0
7615488|NCT01047540|12024475|FG003|Overall Study|Pregnancy|0
7615489|NCT01047540|12024476|FG004|Overall Study|Pregnancy|0
7615490|NCT01047540|12024472|FG000|Overall Study|Adverse Event|1
7615491|NCT01047540|12024473|FG001|Overall Study|Adverse Event|0
7278974|NCT00464308|11494282|FG001|Overall Study|Physician Decision|0
7278975|NCT00464308|11494283|FG002|Overall Study|Physician Decision|0
7278976|NCT00464334|11494302|FG000|Overall Study|Adverse Event|0
7278977|NCT00464334|11494303|FG001|Overall Study|Adverse Event|0
7278978|NCT00464334|11494304|FG002|Overall Study|Adverse Event|0
7615492|NCT01047540|12024474|FG002|Overall Study|Adverse Event|0
7615493|NCT01047540|12024475|FG003|Overall Study|Adverse Event|0
7615494|NCT01047540|12024476|FG004|Overall Study|Adverse Event|0
7615495|NCT00778999|12024521|FG000|Overall Study|Discontinuation: no embryo transfer|14
7615496|NCT00778999|12024522|FG001|Overall Study|Discontinuation: no embryo transfer|14
7615497|NCT00778999|12024521|FG000|Overall Study|Did not receive recFSH|14
7615498|NCT00778999|12024522|FG001|Overall Study|Did not receive recFSH|20
7615499|NCT00620464|12024530|FG000|Overall Study|Adverse Event|15
7615500|NCT00620464|12024531|FG001|Overall Study|Adverse Event|17
7615501|NCT00620464|12024530|FG000|Overall Study|Lost to Follow-up|1
7615502|NCT00620464|12024531|FG001|Overall Study|Lost to Follow-up|1
7615503|NCT00620464|12024530|FG000|Overall Study|Planning Pregnancy|1
7615504|NCT00620464|12024531|FG001|Overall Study|Planning Pregnancy|4
7615505|NCT00620464|12024530|FG000|Overall Study|Personal|2
7615506|NCT00620464|12024531|FG001|Overall Study|Personal|2
7615507|NCT00620464|12024530|FG000|Overall Study|Used prohibited medication|1
7615508|NCT00620464|12024531|FG001|Overall Study|Used prohibited medication|0
7615509|NCT00620035|12024537|FG000|Overall Study|Adverse Event|106
7615510|NCT00620035|12024537|FG000|Overall Study|Withdrawal of Informed Consent|1
7615511|NCT00620035|12024537|FG000|Overall Study|Other Reason|38
7615512|NCT00210249|12024541|FG000|Overall Study|Lost to Follow-up|5
7615513|NCT00210249|12024541|FG000|Overall Study|Protocol Violation|11
7278979|NCT00464334|11494305|FG003|Overall Study|Adverse Event|1
7278980|NCT00464334|11494306|FG004|Overall Study|Adverse Event|1
7278981|NCT00464334|11494307|FG005|Overall Study|Adverse Event|1
7278982|NCT00464334|11494308|FG006|Overall Study|Adverse Event|0
7278983|NCT00464334|11494309|FG007|Overall Study|Adverse Event|0
7278984|NCT00464334|11494310|FG008|Overall Study|Adverse Event|2
7278985|NCT00464334|11494311|FG009|Overall Study|Adverse Event|1
7278986|NCT00464334|11494312|FG010|Overall Study|Adverse Event|2
7278987|NCT00464334|11494302|FG000|Overall Study|Lack of Efficacy|0
7615524|NCT03626168|12024573|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
7615525|NCT03626168|12024574|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
7615526|NCT03626168|12024573|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0
7615527|NCT03626168|12024574|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1
7615528|NCT03626168|12024573|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7615529|NCT03626168|12024574|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2
7615536|NCT04579393|12024604|FG000|Overall Study|Withdrawal by Subject|2
7615537|NCT04579393|12024605|FG001|Overall Study|Withdrawal by Subject|2
7615538|NCT04579393|12024604|FG000|Overall Study|Death|1
7615539|NCT04579393|12024605|FG001|Overall Study|Death|3
7615540|NCT04325906|12024623|FG000|Overall Study|Withdrawal by Subject|2
7615541|NCT04325906|12024624|FG001|Overall Study|Withdrawal by Subject|0
7615542|NCT04203667|12024634|FG000|Overall Study|Withdrawal by Subject|1
7615543|NCT04203667|12024634|FG000|Overall Study|Lost to Follow-up|1
7615544|NCT04203667|12024634|FG000|Overall Study|Death|1
7615545|NCT04203667|12024634|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1
7615546|NCT03679884|12024648|FG000|Overall Study|Other|12
7615547|NCT03679884|12024649|FG001|Overall Study|Other|12
7615548|NCT03679884|12024650|FG002|Overall Study|Other|12
7615549|NCT03679884|12024651|FG003|Overall Study|Other|7
7615550|NCT03679884|12024652|FG004|Overall Study|Other|8
7615551|NCT03679884|12024648|FG000|Overall Study|Lack of Efficacy|15
7278988|NCT00464334|11494303|FG001|Overall Study|Lack of Efficacy|1
7278989|NCT00464334|11494304|FG002|Overall Study|Lack of Efficacy|0
7278990|NCT00464334|11494305|FG003|Overall Study|Lack of Efficacy|0
7278991|NCT00464334|11494306|FG004|Overall Study|Lack of Efficacy|0
7278992|NCT00464334|11494307|FG005|Overall Study|Lack of Efficacy|0
7278993|NCT00464334|11494308|FG006|Overall Study|Lack of Efficacy|0
7278994|NCT00464334|11494309|FG007|Overall Study|Lack of Efficacy|0
7278995|NCT00464334|11494310|FG008|Overall Study|Lack of Efficacy|0
7278996|NCT00464334|11494311|FG009|Overall Study|Lack of Efficacy|0
7615552|NCT03679884|12024649|FG001|Overall Study|Lack of Efficacy|29
7615553|NCT03679884|12024650|FG002|Overall Study|Lack of Efficacy|13
7615554|NCT03679884|12024651|FG003|Overall Study|Lack of Efficacy|29
7615555|NCT03679884|12024652|FG004|Overall Study|Lack of Efficacy|10
7615556|NCT03679884|12024648|FG000|Overall Study|Death|1
7615557|NCT03679884|12024649|FG001|Overall Study|Death|0
7615558|NCT03679884|12024650|FG002|Overall Study|Death|0
7615559|NCT03679884|12024651|FG003|Overall Study|Death|0
7615560|NCT03679884|12024652|FG004|Overall Study|Death|0
7615561|NCT03679884|12024648|FG000|Overall Study|Adverse Event|2
7615562|NCT03679884|12024649|FG001|Overall Study|Adverse Event|10
7615563|NCT03679884|12024650|FG002|Overall Study|Adverse Event|9
7615564|NCT03679884|12024651|FG003|Overall Study|Adverse Event|6
7615565|NCT03679884|12024652|FG004|Overall Study|Adverse Event|6
7615566|NCT03679884|12024648|FG000|Overall Study|Withdrawal by Subject|12
7615567|NCT03679884|12024649|FG001|Overall Study|Withdrawal by Subject|23
7615568|NCT03679884|12024650|FG002|Overall Study|Withdrawal by Subject|8
7615569|NCT03679884|12024651|FG003|Overall Study|Withdrawal by Subject|8
7615570|NCT03679884|12024652|FG004|Overall Study|Withdrawal by Subject|9
7615571|NCT03679884|12024648|FG000|Overall Study|Lost to Follow-up|1
7615572|NCT03679884|12024649|FG001|Overall Study|Lost to Follow-up|4
7615573|NCT03679884|12024650|FG002|Overall Study|Lost to Follow-up|2
7615574|NCT03679884|12024651|FG003|Overall Study|Lost to Follow-up|0
7615575|NCT03679884|12024652|FG004|Overall Study|Lost to Follow-up|3
7615576|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
7615577|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
7615578|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
7615579|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
7615580|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
7615581|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
7615582|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
7615583|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
7615584|NCT03653026|12024666|FG000|Part 1: Placebo-controlled Period|Other|0
7615585|NCT03653026|12024667|FG001|Part 1: Placebo-controlled Period|Other|3
7615586|NCT03653026|12024668|FG002|Part 1: Placebo-controlled Period|Other|0
7615587|NCT03653026|12024669|FG003|Part 1: Placebo-controlled Period|Other|0
7615588|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Adverse Event|0
7615589|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Adverse Event|0
7615590|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Adverse Event|1
7615591|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Adverse Event|1
7615592|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
7615593|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
7615594|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
7615595|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
7615596|NCT03653026|12024666|FG000|Part 2: Open-label Extension|Other|0
7615597|NCT03653026|12024667|FG001|Part 2: Open-label Extension|Other|0
7615598|NCT03653026|12024668|FG002|Part 2: Open-label Extension|Other|1
7615599|NCT03653026|12024669|FG003|Part 2: Open-label Extension|Other|2
7615600|NCT03553498|12024683|FG000|Overall Study|Missing primary outcome|1
7615601|NCT03553498|12024684|FG001|Overall Study|Missing primary outcome|2
7615602|NCT03530293|12024692|FG000|Pre-randomization|Adverse Event|12
7615603|NCT03530293|12024693|FG001|Pre-randomization|Adverse Event|0
7615604|NCT03530293|12024694|FG002|Pre-randomization|Adverse Event|0
7615605|NCT03530293|12024692|FG000|Pre-randomization|Protocol Violation|2
7615606|NCT03530293|12024693|FG001|Pre-randomization|Protocol Violation|0
7615607|NCT03530293|12024694|FG002|Pre-randomization|Protocol Violation|0
7615608|NCT03530293|12024692|FG000|Pre-randomization|Study Terminated by Sponsor|5
7615609|NCT03530293|12024693|FG001|Pre-randomization|Study Terminated by Sponsor|0
7615610|NCT03530293|12024694|FG002|Pre-randomization|Study Terminated by Sponsor|0
7615611|NCT03530293|12024692|FG000|Pre-randomization|Withdrawal by Subject|5
7615612|NCT03530293|12024693|FG001|Pre-randomization|Withdrawal by Subject|0
7615613|NCT03530293|12024694|FG002|Pre-randomization|Withdrawal by Subject|0
7615614|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0
7615615|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2
7615616|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4
7615617|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
7615618|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0
7615619|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1
7615620|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0
7615621|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3
7615622|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2
7615623|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
7615624|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2
7615625|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0
7615626|NCT03530293|12024692|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0
7615627|NCT03530293|12024693|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
7615628|NCT03530293|12024694|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10
7615629|NCT03505749|12024703|FG000|Overall Study|Lost to Follow-up|7
7615630|NCT03505749|12024704|FG001|Overall Study|Lost to Follow-up|11
7615631|NCT03505749|12024703|FG000|Overall Study|Withdrawal by Subject|6
7615632|NCT03505749|12024704|FG001|Overall Study|Withdrawal by Subject|0
7615633|NCT03505749|12024703|FG000|Overall Study|Discharged from treatment|3
7615634|NCT03505749|12024704|FG001|Overall Study|Discharged from treatment|6
7615636|NCT03249376|12024728|FG000|Overall Study|Adverse Event|11
7615637|NCT03249376|12024729|FG001|Overall Study|Adverse Event|5
7615638|NCT03249376|12024728|FG000|Overall Study|Lack of Efficacy|2
7615639|NCT03249376|12024729|FG001|Overall Study|Lack of Efficacy|4
7615640|NCT03249376|12024728|FG000|Overall Study|Protocol Violation|3
7615641|NCT03249376|12024729|FG001|Overall Study|Protocol Violation|2
7615642|NCT03249376|12024728|FG000|Overall Study|Physician Decision|0
7615643|NCT03249376|12024729|FG001|Overall Study|Physician Decision|2
7615644|NCT03249376|12024728|FG000|Overall Study|Withdrawal by Subject|3
7615645|NCT03249376|12024729|FG001|Overall Study|Withdrawal by Subject|9
7615646|NCT03249376|12024728|FG000|Overall Study|LTFU|2
7615647|NCT03249376|12024729|FG001|Overall Study|LTFU|1
7278997|NCT00464334|11494312|FG010|Overall Study|Lack of Efficacy|0
7278998|NCT00464334|11494302|FG000|Overall Study|Lost to Follow-up|0
7278999|NCT00464334|11494303|FG001|Overall Study|Lost to Follow-up|0
7279000|NCT00464334|11494304|FG002|Overall Study|Lost to Follow-up|1
7279001|NCT00464334|11494305|FG003|Overall Study|Lost to Follow-up|0
7279002|NCT00464334|11494306|FG004|Overall Study|Lost to Follow-up|1
7279003|NCT00464334|11494307|FG005|Overall Study|Lost to Follow-up|0
7279004|NCT00464334|11494308|FG006|Overall Study|Lost to Follow-up|1
7279005|NCT00464334|11494309|FG007|Overall Study|Lost to Follow-up|0
7279006|NCT00464334|11494310|FG008|Overall Study|Lost to Follow-up|0
7279007|NCT00464334|11494311|FG009|Overall Study|Lost to Follow-up|0
7279008|NCT00464334|11494312|FG010|Overall Study|Lost to Follow-up|2
7615648|NCT03137381|12024739|FG000|Overall Study|Adverse Event|3
7615649|NCT03137381|12024740|FG001|Overall Study|Adverse Event|0
7615650|NCT03137381|12024741|FG002|Overall Study|Adverse Event|2
7615651|NCT03137381|12024742|FG003|Overall Study|Adverse Event|0
7615652|NCT03137381|12024739|FG000|Overall Study|Lost to Follow-up|2
7615653|NCT03137381|12024740|FG001|Overall Study|Lost to Follow-up|1
7615654|NCT03137381|12024741|FG002|Overall Study|Lost to Follow-up|1
7279009|NCT00464334|11494302|FG000|Overall Study|Progressive Disease|0
7279010|NCT00464334|11494303|FG001|Overall Study|Progressive Disease|0
7279011|NCT00464334|11494304|FG002|Overall Study|Progressive Disease|0
7279012|NCT00464334|11494305|FG003|Overall Study|Progressive Disease|0
7279013|NCT00464334|11494306|FG004|Overall Study|Progressive Disease|0
7279014|NCT00464334|11494307|FG005|Overall Study|Progressive Disease|1
7279015|NCT00464334|11494308|FG006|Overall Study|Progressive Disease|0
7279016|NCT00464334|11494309|FG007|Overall Study|Progressive Disease|0
7279017|NCT00464334|11494310|FG008|Overall Study|Progressive Disease|1
7279018|NCT00464334|11494311|FG009|Overall Study|Progressive Disease|0
7279019|NCT00464334|11494312|FG010|Overall Study|Progressive Disease|0
7279020|NCT00464334|11494302|FG000|Overall Study|Study Terminated by Sponsor|0
7279021|NCT00464334|11494303|FG001|Overall Study|Study Terminated by Sponsor|0
7279022|NCT00464334|11494304|FG002|Overall Study|Study Terminated by Sponsor|0
7279023|NCT00464334|11494305|FG003|Overall Study|Study Terminated by Sponsor|1
7279024|NCT00464334|11494306|FG004|Overall Study|Study Terminated by Sponsor|0
7279025|NCT00464334|11494307|FG005|Overall Study|Study Terminated by Sponsor|0
7279026|NCT00464334|11494308|FG006|Overall Study|Study Terminated by Sponsor|0
7279027|NCT00464334|11494309|FG007|Overall Study|Study Terminated by Sponsor|0
7279028|NCT00464334|11494310|FG008|Overall Study|Study Terminated by Sponsor|0
7279029|NCT00464334|11494311|FG009|Overall Study|Study Terminated by Sponsor|0
7279030|NCT00464334|11494312|FG010|Overall Study|Study Terminated by Sponsor|0
7279031|NCT00464334|11494302|FG000|Overall Study|Withdrawal by Subject|1
7279032|NCT00464334|11494303|FG001|Overall Study|Withdrawal by Subject|7
7279033|NCT00464334|11494304|FG002|Overall Study|Withdrawal by Subject|4
7279034|NCT00464334|11494305|FG003|Overall Study|Withdrawal by Subject|2
7279035|NCT00464334|11494306|FG004|Overall Study|Withdrawal by Subject|2
7279036|NCT00464334|11494307|FG005|Overall Study|Withdrawal by Subject|2
7279037|NCT00464334|11494308|FG006|Overall Study|Withdrawal by Subject|2
7279038|NCT00464334|11494309|FG007|Overall Study|Withdrawal by Subject|1
7279039|NCT00464334|11494310|FG008|Overall Study|Withdrawal by Subject|3
7615655|NCT03137381|12024742|FG003|Overall Study|Lost to Follow-up|0
7615656|NCT03137381|12024739|FG000|Overall Study|Protocol deviation|1
7615657|NCT03137381|12024740|FG001|Overall Study|Protocol deviation|1
7615658|NCT03137381|12024741|FG002|Overall Study|Protocol deviation|0
7615659|NCT03137381|12024742|FG003|Overall Study|Protocol deviation|1
7615660|NCT03137381|12024739|FG000|Overall Study|Withdrawal by Investigator|0
7615661|NCT03137381|12024740|FG001|Overall Study|Withdrawal by Investigator|1
7615662|NCT03137381|12024741|FG002|Overall Study|Withdrawal by Investigator|1
7615663|NCT03137381|12024742|FG003|Overall Study|Withdrawal by Investigator|0
7615664|NCT03137381|12024739|FG000|Overall Study|Withdrawal by Subject|3
7615665|NCT03137381|12024740|FG001|Overall Study|Withdrawal by Subject|4
7615666|NCT03137381|12024741|FG002|Overall Study|Withdrawal by Subject|3
7615667|NCT03137381|12024742|FG003|Overall Study|Withdrawal by Subject|0
7615668|NCT03137381|12024739|FG000|Overall Study|Pregnancy|0
7615669|NCT03137381|12024740|FG001|Overall Study|Pregnancy|0
7615670|NCT03137381|12024741|FG002|Overall Study|Pregnancy|1
7615671|NCT03137381|12024742|FG003|Overall Study|Pregnancy|0
7615672|NCT03118570|12024757|FG000|Overall Study|Adverse Event|2
7615673|NCT03118570|12024758|FG001|Overall Study|Adverse Event|0
7615674|NCT03118570|12024759|FG002|Overall Study|Adverse Event|0
7615675|NCT03118570|12024760|FG003|Overall Study|Adverse Event|0
7615676|NCT03118570|12024761|FG004|Overall Study|Adverse Event|3
7615677|NCT03118570|12024757|FG000|Overall Study|Withdrawal by Subject|0
7615678|NCT03118570|12024758|FG001|Overall Study|Withdrawal by Subject|1
7615679|NCT03118570|12024759|FG002|Overall Study|Withdrawal by Subject|4
7615680|NCT03118570|12024760|FG003|Overall Study|Withdrawal by Subject|0
7615681|NCT03118570|12024761|FG004|Overall Study|Withdrawal by Subject|1
7615682|NCT03118570|12024757|FG000|Overall Study|Lost to Follow-up|2
7615683|NCT03118570|12024758|FG001|Overall Study|Lost to Follow-up|3
7615684|NCT03118570|12024759|FG002|Overall Study|Lost to Follow-up|1
7615685|NCT03118570|12024760|FG003|Overall Study|Lost to Follow-up|0
7615686|NCT03118570|12024761|FG004|Overall Study|Lost to Follow-up|1
7615687|NCT03118570|12024757|FG000|Overall Study|Other, Not Specified|1
7615688|NCT03118570|12024758|FG001|Overall Study|Other, Not Specified|3
7615689|NCT03118570|12024759|FG002|Overall Study|Other, Not Specified|0
7279040|NCT00464334|11494311|FG009|Overall Study|Withdrawal by Subject|0
7615690|NCT03118570|12024760|FG003|Overall Study|Other, Not Specified|0
7615691|NCT03118570|12024761|FG004|Overall Study|Other, Not Specified|0
7615692|NCT03094416|12024774|FG000|Run-in|Screening failure|8
7615693|NCT03094416|12024774|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8
7615694|NCT03094416|12024774|FG000|Run-in|Withdrawal by Subject|3
7615695|NCT03094416|12024774|FG000|Treatment Period|Withdrawal by Subject|2
7615696|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25
7615697|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19
7615698|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0
7615699|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0
7615700|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Withdrew consent|14
7615701|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Withdrew consent|18
7615702|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Withdrew consent|0
7615703|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Withdrew consent|0
7615704|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6
7615705|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3
7615706|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0
7615707|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0
7615708|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3
7615709|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5
7615710|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0
7615711|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0
7615712|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Protocol Violation|2
7615713|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Protocol Violation|3
7615714|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Protocol Violation|0
7615715|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Protocol Violation|0
7615716|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Adverse Event|0
7615717|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Adverse Event|4
7615718|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Adverse Event|0
7615719|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Adverse Event|0
7615720|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Death|2
7615721|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Death|1
7615722|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Death|0
7615723|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Death|0
7615724|NCT02607930|12024808|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2
7615725|NCT02607930|12024809|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0
7615800|NCT00909610|12025017|FG001|Period: First Intervention|Adverse Event|1
7615726|NCT02607930|12024810|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0
7615727|NCT02607930|12024811|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0
7615728|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
7615729|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
7615730|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15
7615731|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10
7615732|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
7615733|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
7615734|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10
7615735|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13
7615736|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
7615737|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
7615738|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2
7615739|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5
7615740|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0
7615741|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0
7615742|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4
7615743|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2
7615744|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
7615745|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
7615746|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
7615747|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
7615748|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
7615749|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
7615750|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
7615751|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
7615752|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Death|0
7615753|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Death|0
7615754|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Death|0
7615755|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Death|1
7615756|NCT02607930|12024808|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7615757|NCT02607930|12024809|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7615758|NCT02607930|12024810|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1
7615759|NCT02607930|12024811|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
7279041|NCT00464334|11494312|FG010|Overall Study|Withdrawal by Subject|0
7279042|NCT00464490|11494367|FG000|Overall Study|Physician Decision|11
7279043|NCT00464490|11494368|FG001|Overall Study|Physician Decision|11
7279044|NCT00464542|11494374|FG000|Pre-treatment|Withdrawal by Subject|2
7615781|NCT02476201|12024852|FG000|Overall Study|Unable to program MPP|9
7615782|NCT02476201|12024852|FG000|Overall Study|Study echo not performed|5
7615783|NCT02476201|12024852|FG000|Overall Study|Adverse Event|4
7615784|NCT02476201|12024852|FG000|Overall Study|Death|2
7615785|NCT02476201|12024852|FG000|Overall Study|Lost to Follow-up|2
7615786|NCT02476201|12024852|FG000|Overall Study|MPP programmed to OFF|2
7615787|NCT02476201|12024852|FG000|Overall Study|Withdrawal by Subject|1
7615788|NCT02476201|12024852|FG000|Overall Study|Unsuccessful implant|1
7615789|NCT01399658|12024857|FG000|Overall Study|Ineligible|1
7615790|NCT01399658|12024857|FG000|Overall Study|Machine Technical Issue|3
7615791|NCT01399658|12024857|FG000|Overall Study|Standard of Care better than protocol therapy|1
7615792|NCT01399658|12024857|FG000|Overall Study|No reason given|1
7615793|NCT00919893|12024962|FG000|Overall Study|Protocol Violation|19
7615794|NCT00919893|12024963|FG001|Overall Study|Protocol Violation|9
7615795|NCT00909753|12025002|FG000|Period: Washout of 28 Days|Protocol Violation|2
7615796|NCT00909753|12025003|FG001|Period: Washout of 28 Days|Protocol Violation|3
7615797|NCT00909753|12025002|FG000|Period: Second Intervention|Protocol Violation|1
7615798|NCT00909753|12025003|FG001|Period: Second Intervention|Protocol Violation|0
7615799|NCT00909610|12025016|FG000|Period: First Intervention|Adverse Event|0
7615801|NCT00909610|12025016|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3
7615802|NCT00909610|12025017|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6
7615803|NCT00909610|12025016|FG000|Period: Second Intervention|Adverse Event|1
7615804|NCT00909610|12025017|FG001|Period: Second Intervention|Adverse Event|0
7615805|NCT00905606|12025045|FG000|Period 1|Adverse Event|0
7615806|NCT00905606|12025046|FG001|Period 1|Adverse Event|1
7615807|NCT00905606|12025045|FG000|Washout|Withdrawal by Subject|1
7615808|NCT00905606|12025046|FG001|Washout|Withdrawal by Subject|0
7615809|NCT00905567|12025052|FG000|Washout|Withdrawal by Subject|0
7615810|NCT00905567|12025053|FG001|Washout|Withdrawal by Subject|1
7615811|NCT00905346|12025059|FG000|Period 1|Withdrawal by Subject|1
7615812|NCT00905346|12025060|FG001|Period 1|Withdrawal by Subject|0
7615813|NCT00905164|12025066|FG000|Period 1|Protocol Violation|0
7615814|NCT00905164|12025067|FG001|Period 1|Protocol Violation|1
7615815|NCT00890591|12025078|FG000|Overall Study|Lack of Efficacy|20
7615816|NCT00890409|12025086|FG000|Overall Study|Lost to Follow-up|20
7615817|NCT00890409|12025087|FG001|Overall Study|Lost to Follow-up|21
7279045|NCT00464568|11494378|FG000|Overall Study|Adverse Event|2
7279046|NCT00464620|11494395|FG000|Overall Study|Physician Decision|1
7279047|NCT00464620|11494396|FG001|Overall Study|Physician Decision|0
7279048|NCT00464620|11494397|FG002|Overall Study|Physician Decision|0
7279049|NCT00464620|11494395|FG000|Overall Study|Withdrawal by Subject|1
7279050|NCT00464620|11494396|FG001|Overall Study|Withdrawal by Subject|0
7279051|NCT00464620|11494397|FG002|Overall Study|Withdrawal by Subject|3
7279052|NCT00464620|11494395|FG000|Overall Study|Ineligible sarcoma subtype|0
7279053|NCT00464620|11494396|FG001|Overall Study|Ineligible sarcoma subtype|2
7279054|NCT00464620|11494397|FG002|Overall Study|Ineligible sarcoma subtype|2
7279055|NCT00464620|11494395|FG000|Overall Study|Use of prohibited concomitant medication|0
7279056|NCT00464620|11494396|FG001|Overall Study|Use of prohibited concomitant medication|0
7279057|NCT00464620|11494397|FG002|Overall Study|Use of prohibited concomitant medication|2
7279058|NCT00464672|11494422|FG000|Overall Study|withdrawal of consent|0
7279059|NCT00464672|11494423|FG001|Overall Study|withdrawal of consent|0
7279060|NCT00464672|11494424|FG002|Overall Study|withdrawal of consent|0
7279061|NCT00464672|11494425|FG003|Overall Study|withdrawal of consent|1
7615818|NCT00888355|12025095|FG000|Overall Study|Adverse Event|10
7615819|NCT00888355|12025096|FG001|Overall Study|Adverse Event|0
7615820|NCT00888355|12025097|FG002|Overall Study|Adverse Event|3
7615821|NCT00888355|12025098|FG003|Overall Study|Adverse Event|3
7615822|NCT00888355|12025095|FG000|Overall Study|Lack of Efficacy|9
7615823|NCT00888355|12025096|FG001|Overall Study|Lack of Efficacy|2
7615824|NCT00888355|12025097|FG002|Overall Study|Lack of Efficacy|5
7615825|NCT00888355|12025098|FG003|Overall Study|Lack of Efficacy|2
7615826|NCT00888355|12025095|FG000|Overall Study|Lost to Follow-up|0
7615827|NCT00888355|12025096|FG001|Overall Study|Lost to Follow-up|2
7615828|NCT00888355|12025097|FG002|Overall Study|Lost to Follow-up|2
7615829|NCT00888355|12025098|FG003|Overall Study|Lost to Follow-up|0
7615830|NCT00888355|12025095|FG000|Overall Study|Protocol Violation|3
7615831|NCT00888355|12025096|FG001|Overall Study|Protocol Violation|2
7615832|NCT00888355|12025097|FG002|Overall Study|Protocol Violation|1
7615833|NCT00888355|12025098|FG003|Overall Study|Protocol Violation|2
7615834|NCT00888355|12025095|FG000|Overall Study|Withdrawal by Subject|0
7615835|NCT00888355|12025096|FG001|Overall Study|Withdrawal by Subject|3
7615836|NCT00888355|12025097|FG002|Overall Study|Withdrawal by Subject|1
7615837|NCT00888355|12025098|FG003|Overall Study|Withdrawal by Subject|3
7615838|NCT00887250|12025107|FG000|Overall Study|Adverse Event|3
7615839|NCT00887250|12025108|FG001|Overall Study|Adverse Event|0
7615840|NCT00887250|12025109|FG002|Overall Study|Adverse Event|7
7615841|NCT00887250|12025107|FG000|Overall Study|Lack of Efficacy|9
7615842|NCT00887250|12025108|FG001|Overall Study|Lack of Efficacy|6
7615843|NCT00887250|12025109|FG002|Overall Study|Lack of Efficacy|1
7615844|NCT00887250|12025107|FG000|Overall Study|Lost to Follow-up|2
7615845|NCT00887250|12025108|FG001|Overall Study|Lost to Follow-up|3
7615846|NCT00887250|12025109|FG002|Overall Study|Lost to Follow-up|1
7615847|NCT00887250|12025107|FG000|Overall Study|Protocol Violation|2
7615848|NCT00887250|12025108|FG001|Overall Study|Protocol Violation|2
7615849|NCT00887250|12025109|FG002|Overall Study|Protocol Violation|1
7615850|NCT00887250|12025107|FG000|Overall Study|Withdrawal by Subject|2
7615851|NCT00887250|12025108|FG001|Overall Study|Withdrawal by Subject|1
7279062|NCT00464672|11494426|FG004|Overall Study|withdrawal of consent|9
7279063|NCT00464672|11494427|FG005|Overall Study|withdrawal of consent|4
7279064|NCT00464672|11494422|FG000|Overall Study|Lost to Follow-up|25
7279065|NCT00464672|11494423|FG001|Overall Study|Lost to Follow-up|10
7279066|NCT00464672|11494424|FG002|Overall Study|Lost to Follow-up|0
7279067|NCT00464672|11494425|FG003|Overall Study|Lost to Follow-up|0
7279068|NCT00464672|11494426|FG004|Overall Study|Lost to Follow-up|1
7279069|NCT00464672|11494427|FG005|Overall Study|Lost to Follow-up|0
7279070|NCT00464737|11494477|FG000|Overall Study|Adverse Event|12
7279071|NCT00464737|11494478|FG001|Overall Study|Adverse Event|17
7279072|NCT00464737|11494479|FG002|Overall Study|Adverse Event|33
7279073|NCT00464737|11494477|FG000|Overall Study|Lack of Efficacy|7
7279074|NCT00464737|11494478|FG001|Overall Study|Lack of Efficacy|7
7279075|NCT00464737|11494479|FG002|Overall Study|Lack of Efficacy|4
7279076|NCT00464737|11494477|FG000|Overall Study|Withdrawal by Subject|5
7279077|NCT00464737|11494478|FG001|Overall Study|Withdrawal by Subject|3
7279078|NCT00464737|11494479|FG002|Overall Study|Withdrawal by Subject|5
7279079|NCT00464737|11494477|FG000|Overall Study|Protocol Violation|1
7279080|NCT00464737|11494478|FG001|Overall Study|Protocol Violation|1
7279081|NCT00464737|11494479|FG002|Overall Study|Protocol Violation|5
7279082|NCT00464737|11494477|FG000|Overall Study|Non-compliance|0
7279083|NCT00464737|11494478|FG001|Overall Study|Non-compliance|1
7279084|NCT00464737|11494479|FG002|Overall Study|Non-compliance|1
7279085|NCT00464737|11494477|FG000|Overall Study|Lost to Follow-up|5
7279086|NCT00464737|11494478|FG001|Overall Study|Lost to Follow-up|2
7279087|NCT00464737|11494479|FG002|Overall Study|Lost to Follow-up|5
7279088|NCT00464737|11494477|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
7279089|NCT00464737|11494478|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
7615852|NCT00887250|12025109|FG002|Overall Study|Withdrawal by Subject|2
7615853|NCT00887250|12025107|FG000|Overall Study|Patient uncooperative|0
7615854|NCT00887250|12025108|FG001|Overall Study|Patient uncooperative|0
7615855|NCT00887250|12025109|FG002|Overall Study|Patient uncooperative|1
7615856|NCT00886600|12025118|FG000|Double-blind Monotherapy|Adverse Event|1
7615857|NCT00886600|12025119|FG001|Double-blind Monotherapy|Adverse Event|1
7615858|NCT00886600|12025120|FG002|Double-blind Monotherapy|Adverse Event|1
7615859|NCT00886600|12025121|FG003|Double-blind Monotherapy|Adverse Event|1
7615860|NCT00886600|12025118|FG000|Double-blind Monotherapy|Protocol Violation|0
7615861|NCT00886600|12025119|FG001|Double-blind Monotherapy|Protocol Violation|0
7615862|NCT00886600|12025120|FG002|Double-blind Monotherapy|Protocol Violation|0
7615863|NCT00886600|12025121|FG003|Double-blind Monotherapy|Protocol Violation|1
7615864|NCT00886600|12025118|FG000|Double-blind Monotherapy|Withdrawal by Subject|1
7615865|NCT00886600|12025119|FG001|Double-blind Monotherapy|Withdrawal by Subject|0
7615866|NCT00886600|12025120|FG002|Double-blind Monotherapy|Withdrawal by Subject|0
7615867|NCT00886600|12025121|FG003|Double-blind Monotherapy|Withdrawal by Subject|0
7615868|NCT00886600|12025118|FG000|Combination Therapy Period|Adverse Event|0
7615869|NCT00886600|12025119|FG001|Combination Therapy Period|Adverse Event|0
7615870|NCT00886600|12025120|FG002|Combination Therapy Period|Adverse Event|1
7615871|NCT00886600|12025121|FG003|Combination Therapy Period|Adverse Event|0
7615872|NCT00886600|12025118|FG000|Combination Therapy Period|Protocol Violation|0
7615873|NCT00886600|12025119|FG001|Combination Therapy Period|Protocol Violation|0
7615874|NCT00886600|12025120|FG002|Combination Therapy Period|Protocol Violation|1
7615875|NCT00886600|12025121|FG003|Combination Therapy Period|Protocol Violation|0
7615876|NCT00882440|12025134|FG000|Overall Study|Adverse Event|2
7615877|NCT00882440|12025135|FG001|Overall Study|Adverse Event|2
7615878|NCT00882440|12025136|FG002|Overall Study|Adverse Event|2
7279090|NCT00464737|11494479|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
7279091|NCT00464737|11494477|FG000|Overall Study|Other: Subject left town; family illness|1
7279092|NCT00464737|11494478|FG001|Overall Study|Other: Subject left town; family illness|0
7279093|NCT00464737|11494479|FG002|Overall Study|Other: Subject left town; family illness|0
7279094|NCT00464737|11494477|FG000|Overall Study|Other: Study demands too great|0
7279095|NCT00464737|11494478|FG001|Overall Study|Other: Study demands too great|1
7279096|NCT00464737|11494479|FG002|Overall Study|Other: Study demands too great|0
7279097|NCT00464737|11494477|FG000|Overall Study|Other: Personal family reasons|0
7279098|NCT00464737|11494478|FG001|Overall Study|Other: Personal family reasons|0
7279099|NCT00464737|11494479|FG002|Overall Study|Other: Personal family reasons|1
7279100|NCT00464737|11494477|FG000|Overall Study|Other: Subject's disability per sponsor|0
7279101|NCT00464737|11494478|FG001|Overall Study|Other: Subject's disability per sponsor|0
7279102|NCT00464737|11494479|FG002|Overall Study|Other: Subject's disability per sponsor|1
7279103|NCT00464815|11494489|FG000|Overall Study|Withdrawal by Subject|6
7279104|NCT00464815|11494490|FG001|Overall Study|Withdrawal by Subject|3
7279105|NCT00464945|11494498|FG000|Infant Series|Withdrawal by parent/guardian request|2
7279106|NCT00464945|11494499|FG001|Infant Series|Withdrawal by parent/guardian request|1
7279107|NCT00464945|11494498|FG000|Infant Series|Protocol Violation|1
7279108|NCT00464945|11494499|FG001|Infant Series|Protocol Violation|0
7279109|NCT00464945|11494498|FG000|Infant Series|Lost to Follow-up|1
7279110|NCT00464945|11494499|FG001|Infant Series|Lost to Follow-up|0
7279111|NCT00464945|11494498|FG000|After Infant Series|Withdrawal by Subject|0
7279112|NCT00464945|11494499|FG001|After Infant Series|Withdrawal by Subject|2
7279113|NCT00464945|11494498|FG000|Toddler Dose|Lost to Follow-up|0
7279114|NCT00464945|11494499|FG001|Toddler Dose|Lost to Follow-up|1
7279115|NCT00465101|11494530|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
7279116|NCT00465101|11494530|FG000|Overall Study|Change in health precluded follow up|4
7279117|NCT00465101|11494530|FG000|Overall Study|Did not meet study criteria|4
7279118|NCT00465101|11494530|FG000|Overall Study|Lost to Follow-up|5
7279119|NCT00465101|11494530|FG000|Overall Study|Other|6
7279120|NCT00465101|11494530|FG000|Overall Study|Pt. Insurance not accepted at center|2
7279121|NCT00465101|11494530|FG000|Overall Study|Patient postponed procedure|1
7279122|NCT00465101|11494530|FG000|Overall Study|Site closed due to IRB expiration|1
7279123|NCT00465101|11494530|FG000|Overall Study|Unable to obtain IRB approval|1
7279124|NCT00465101|11494530|FG000|Overall Study|Death|3
7279125|NCT00465101|11494530|FG000|Overall Study|Withdrawal by Subject|25
7279126|NCT00465101|11494530|FG000|Overall Study|Physician Decision|1
7279127|NCT00465101|11494530|FG000|Overall Study|Withdrew consent prior to procedure|3
7279128|NCT00465179|11494556|FG000|Overall Study|Adverse Event|4
7279129|NCT00465179|11494556|FG000|Overall Study|Withdrawal by Subject|2
7279130|NCT00465179|11494556|FG000|Overall Study|Progression of Disease|47
7279131|NCT00465270|11494562|FG000|Overall Study|Death|7
7615879|NCT00882440|12025137|FG003|Overall Study|Adverse Event|1
7615880|NCT00882440|12025138|FG004|Overall Study|Adverse Event|1
7615881|NCT00882440|12025139|FG005|Overall Study|Adverse Event|4
7615882|NCT00882440|12025140|FG006|Overall Study|Adverse Event|2
7615883|NCT00882440|12025134|FG000|Overall Study|Lack of Efficacy|3
7615884|NCT00882440|12025135|FG001|Overall Study|Lack of Efficacy|5
7615885|NCT00882440|12025136|FG002|Overall Study|Lack of Efficacy|2
7615886|NCT00882440|12025137|FG003|Overall Study|Lack of Efficacy|0
7615887|NCT00882440|12025138|FG004|Overall Study|Lack of Efficacy|0
7615888|NCT00882440|12025139|FG005|Overall Study|Lack of Efficacy|3
7615889|NCT00882440|12025140|FG006|Overall Study|Lack of Efficacy|0
7615890|NCT00882440|12025134|FG000|Overall Study|Lost to Follow-up|2
7615891|NCT00882440|12025135|FG001|Overall Study|Lost to Follow-up|0
7615892|NCT00882440|12025136|FG002|Overall Study|Lost to Follow-up|1
7615893|NCT00882440|12025137|FG003|Overall Study|Lost to Follow-up|1
7615894|NCT00882440|12025138|FG004|Overall Study|Lost to Follow-up|1
7615895|NCT00882440|12025139|FG005|Overall Study|Lost to Follow-up|0
7615896|NCT00882440|12025140|FG006|Overall Study|Lost to Follow-up|1
7615897|NCT00882440|12025134|FG000|Overall Study|Protocol Violation|0
7615898|NCT00882440|12025135|FG001|Overall Study|Protocol Violation|0
7615899|NCT00882440|12025136|FG002|Overall Study|Protocol Violation|1
7615900|NCT00882440|12025137|FG003|Overall Study|Protocol Violation|1
7615901|NCT00882440|12025138|FG004|Overall Study|Protocol Violation|1
7615902|NCT00882440|12025139|FG005|Overall Study|Protocol Violation|0
7615903|NCT00882440|12025140|FG006|Overall Study|Protocol Violation|0
7615904|NCT00882440|12025134|FG000|Overall Study|Withdrawal by Subject|2
7615905|NCT00882440|12025135|FG001|Overall Study|Withdrawal by Subject|1
7615906|NCT00882440|12025136|FG002|Overall Study|Withdrawal by Subject|1
7615907|NCT00882440|12025137|FG003|Overall Study|Withdrawal by Subject|0
7615908|NCT00882440|12025138|FG004|Overall Study|Withdrawal by Subject|6
7615909|NCT00882440|12025139|FG005|Overall Study|Withdrawal by Subject|0
7615910|NCT00882440|12025140|FG006|Overall Study|Withdrawal by Subject|1
7615911|NCT00882440|12025134|FG000|Overall Study|Patient Uncooperative|2
7615912|NCT00882440|12025135|FG001|Overall Study|Patient Uncooperative|0
7615913|NCT00882440|12025136|FG002|Overall Study|Patient Uncooperative|0
7615914|NCT00882440|12025137|FG003|Overall Study|Patient Uncooperative|0
7615915|NCT00882440|12025138|FG004|Overall Study|Patient Uncooperative|1
7615916|NCT00882440|12025139|FG005|Overall Study|Patient Uncooperative|0
7615917|NCT00882440|12025140|FG006|Overall Study|Patient Uncooperative|0
7615918|NCT00870688|12025156|FG000|Overall Study|Lost to Follow-up|2
7615919|NCT00870688|12025156|FG000|Overall Study|Death, Unrelated|1
7615920|NCT00870688|12025156|FG000|Overall Study|Granules in the Stools|1
7615921|NCT00869128|12025159|FG000|Overall Study|lack of Compliance|6
7615922|NCT00869128|12025160|FG001|Overall Study|lack of Compliance|6
7615927|NCT00859521|12025191|FG000|Washout|Withdrawal by Subject|0
7615928|NCT00859521|12025192|FG001|Washout|Withdrawal by Subject|1
7615929|NCT00859430|12025198|FG000|First Intervention|Withdrawal by Subject|0
7615930|NCT00859430|12025199|FG001|First Intervention|Withdrawal by Subject|1
7615931|NCT00858702|12025205|FG000|Overall Study|Lack of Efficacy|1
7615932|NCT00858702|12025206|FG001|Overall Study|Lack of Efficacy|0
7615933|NCT00858702|12025205|FG000|Overall Study|Protocol Violation|1
7615934|NCT00858702|12025206|FG001|Overall Study|Protocol Violation|1
7615935|NCT00858702|12025205|FG000|Overall Study|Other|2
7615936|NCT00858702|12025206|FG001|Overall Study|Other|1
7615937|NCT00858702|12025205|FG000|Overall Study|Withdrawal by Subject|1
7615938|NCT00858702|12025206|FG001|Overall Study|Withdrawal by Subject|0
7615939|NCT00857285|12025214|FG000|Overall Study|Adverse Event|4
7615940|NCT00857285|12025215|FG001|Overall Study|Adverse Event|2
7615941|NCT00857285|12025214|FG000|Overall Study|Lack of Efficacy|0
7615942|NCT00857285|12025215|FG001|Overall Study|Lack of Efficacy|2
7615943|NCT00857285|12025214|FG000|Overall Study|Protocol Violation|3
7615944|NCT00857285|12025215|FG001|Overall Study|Protocol Violation|1
7615945|NCT00857285|12025214|FG000|Overall Study|Withdrawal by Subject|4
7615946|NCT00857285|12025215|FG001|Overall Study|Withdrawal by Subject|0
7615947|NCT00857285|12025214|FG000|Overall Study|Randomization criteria not met|1
7615948|NCT00857285|12025215|FG001|Overall Study|Randomization criteria not met|1
7615949|NCT00850174|12025231|FG000|Washout: One Week|Withdrawal by Subject|0
7615950|NCT00850174|12025232|FG001|Washout: One Week|Withdrawal by Subject|2
7615951|NCT00850174|12025231|FG000|Second Intervention|Withdrawal by Subject|1
7615952|NCT00850174|12025232|FG001|Second Intervention|Withdrawal by Subject|0
7615953|NCT00849797|12025245|FG000|First Intervention|bad veins|1
7615954|NCT00849797|12025246|FG001|First Intervention|bad veins|0
7615955|NCT00849797|12025245|FG000|First Intervention|Adverse Event|0
7615956|NCT00849797|12025246|FG001|First Intervention|Adverse Event|1
7615957|NCT00849797|12025245|FG000|Washout: One Week|Withdrawal by Subject|0
7615958|NCT00849797|12025246|FG001|Washout: One Week|Withdrawal by Subject|2
7615959|NCT00847405|12025260|FG000|First Intervention|Adverse Event|0
7615960|NCT00847405|12025261|FG001|First Intervention|Adverse Event|1
7615961|NCT00847405|12025260|FG000|Washout of 7 Days|Withdrawal by Subject|1
7615962|NCT00847405|12025261|FG001|Washout of 7 Days|Withdrawal by Subject|0
7615963|NCT00841815|12025274|FG000|Washout|Withdrawal by Subject|0
7615964|NCT00841815|12025275|FG001|Washout|Withdrawal by Subject|1
7615965|NCT00841698|12025282|FG000|First Intervention|Withdrawal by Subject|1
7615966|NCT00841698|12025283|FG001|First Intervention|Withdrawal by Subject|0
7615967|NCT00841659|12025289|FG000|Washout: 2 Weeks|Protocol Violation|1
7615968|NCT00841659|12025290|FG001|Washout: 2 Weeks|Protocol Violation|0
7615969|NCT00841542|12025296|FG000|Period 1|Adverse Event|1
7615970|NCT00841542|12025297|FG001|Period 1|Adverse Event|0
7615971|NCT00840879|12025303|FG000|Second Intervention|Withdrawal by Subject|1
7615972|NCT00840879|12025304|FG001|Second Intervention|Withdrawal by Subject|0
7615973|NCT00840632|12025324|FG000|First Intervention|Withdrawal by Subject|0
7615974|NCT00840632|12025325|FG001|First Intervention|Withdrawal by Subject|1
7615975|NCT00840632|12025324|FG000|Washout|Withdrawal by Subject|1
7615976|NCT00840632|12025325|FG001|Washout|Withdrawal by Subject|1
7615977|NCT00840411|12025338|FG000|First Intervention|Adverse Event|1
7615978|NCT00840411|12025339|FG001|First Intervention|Adverse Event|0
7615979|NCT00840411|12025338|FG000|Washout|Withdrawal by Subject|1
7615980|NCT00840411|12025339|FG001|Washout|Withdrawal by Subject|0
7279132|NCT00465270|11494563|FG001|Overall Study|Death|11
7615981|NCT00840216|12025352|FG000|Washout: 7 Days|Withdrawal by Subject|1
7615982|NCT00840216|12025353|FG001|Washout: 7 Days|Withdrawal by Subject|0
7615983|NCT00840203|12025359|FG000|First Intervention|Protocol Violation|1
7615984|NCT00840203|12025360|FG001|First Intervention|Protocol Violation|1
7615985|NCT00840203|12025359|FG000|Washout|Protocol Violation|1
7615986|NCT00840203|12025360|FG001|Washout|Protocol Violation|0
7615987|NCT00840073|12025373|FG000|Second Intervention|Missed 72 hour blood draw|1
7615988|NCT00840073|12025374|FG001|Second Intervention|Missed 72 hour blood draw|1
7615989|NCT00838630|12025387|FG000|First Intervention|Adverse Event|1
7615990|NCT00838630|12025388|FG001|First Intervention|Adverse Event|0
7615991|NCT00838630|12025387|FG000|Washout: 7 Days|Protocol Violation|1
7615992|NCT00838630|12025388|FG001|Washout: 7 Days|Protocol Violation|0
7615993|NCT00838279|12025394|FG000|Washout|Protocol Violation|1
7615994|NCT00838279|12025395|FG001|Washout|Protocol Violation|0
7615995|NCT00838279|12025394|FG000|Washout|Withdrawal by Subject|0
7615996|NCT00838279|12025395|FG001|Washout|Withdrawal by Subject|1
7615997|NCT00836901|12025408|FG000|First Intervention|Withdrawal by Subject|1
7615998|NCT00836901|12025409|FG001|First Intervention|Withdrawal by Subject|0
7615999|NCT00836706|12025415|FG000|Washout: 7 Days|Withdrawal by Subject|0
7616000|NCT00836706|12025416|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616001|NCT00836472|12025422|FG000|Washout|Adverse Event|1
7616002|NCT00836472|12025423|FG001|Washout|Adverse Event|2
7616003|NCT00836472|12025422|FG000|Washout|Withdrawal by Subject|1
7616004|NCT00836472|12025423|FG001|Washout|Withdrawal by Subject|1
7616005|NCT00836056|12025429|FG000|First Intervention|Adverse Event|1
7616006|NCT00836056|12025430|FG001|First Intervention|Adverse Event|0
7616007|NCT00835991|12025443|FG000|First Intervention|Adverse Event|0
7616008|NCT00835991|12025444|FG001|First Intervention|Adverse Event|1
7616009|NCT00835991|12025443|FG000|Washout|Protocol Violation|0
7616010|NCT00835991|12025444|FG001|Washout|Protocol Violation|2
7616011|NCT00835991|12025443|FG000|Washout|Withdrawal by Subject|3
7616012|NCT00835991|12025444|FG001|Washout|Withdrawal by Subject|1
7616013|NCT00835796|12025450|FG000|First Intervention|Withdrawal by Subject|0
7616014|NCT00835796|12025451|FG001|First Intervention|Withdrawal by Subject|1
7616015|NCT00835705|12025457|FG000|First Intervention|Difficulty with vein|1
7279133|NCT00465270|11494562|FG000|Overall Study|Withdrawal by Subject|34
7279134|NCT00465270|11494563|FG001|Overall Study|Withdrawal by Subject|78
7279135|NCT00465270|11494562|FG000|Overall Study|Lost to Follow-up|60
7279136|NCT00465270|11494563|FG001|Overall Study|Lost to Follow-up|67
7279137|NCT00465270|11494562|FG000|Overall Study|Investigator request|3
7279138|NCT00465270|11494563|FG001|Overall Study|Investigator request|4
7279139|NCT00465361|11494569|FG000|Baseline Assessment|Personal Issues/Scheduling|4
7279140|NCT00465569|11494584|FG000|Overall Study|persistent eczema during dose escalation|1
7279141|NCT00465569|11494585|FG001|Overall Study|persistent eczema during dose escalation|0
7279142|NCT00465647|11494610|FG000|Overall Study|Administrative|2
7279143|NCT00465647|11494611|FG001|Overall Study|Administrative|2
7279144|NCT00465647|11494612|FG002|Overall Study|Administrative|3
7279145|NCT00465647|11494613|FG003|Overall Study|Administrative|2
7279146|NCT00465647|11494610|FG000|Overall Study|Adverse Event|2
7279147|NCT00465647|11494611|FG001|Overall Study|Adverse Event|0
7279148|NCT00465647|11494612|FG002|Overall Study|Adverse Event|3
7279149|NCT00465647|11494613|FG003|Overall Study|Adverse Event|2
7279150|NCT00465647|11494610|FG000|Overall Study|Withdrawal by Subject|1
7279151|NCT00465647|11494611|FG001|Overall Study|Withdrawal by Subject|2
7279152|NCT00465647|11494612|FG002|Overall Study|Withdrawal by Subject|2
7279153|NCT00465647|11494613|FG003|Overall Study|Withdrawal by Subject|7
7279154|NCT00465647|11494610|FG000|Overall Study|"The other reasons included loss of IV"|8
7279155|NCT00465647|11494611|FG001|Overall Study|"The other reasons included loss of IV"|4
7279156|NCT00465647|11494612|FG002|Overall Study|"The other reasons included loss of IV"|3
7279157|NCT00465647|11494613|FG003|Overall Study|"The other reasons included loss of IV"|2
7279158|NCT00465738|11494635|FG000|Overall Study|Lost to Follow-up|2
7279159|NCT00465738|11494636|FG001|Overall Study|Lost to Follow-up|0
7279160|NCT00465738|11494635|FG000|Overall Study|Adverse Event|0
7279161|NCT00465738|11494636|FG001|Overall Study|Adverse Event|1
7279162|NCT00465738|11494635|FG000|Overall Study|Withdrawal by Subject|2
7279163|NCT00465738|11494636|FG001|Overall Study|Withdrawal by Subject|0
7279164|NCT00465738|11494635|FG000|Overall Study|Other|2
7279165|NCT00465738|11494636|FG001|Overall Study|Other|5
7279166|NCT00465816|11494645|FG000|Overall Study|Lost to Follow-up|0
7279167|NCT00465816|11494646|FG001|Overall Study|Lost to Follow-up|0
7279168|NCT00465816|11494647|FG002|Overall Study|Lost to Follow-up|2
7279169|NCT00465894|11494658|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
7279170|NCT00465894|11494659|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
7279171|NCT00465894|11494658|FG000|Treatment For 12 Weeks|Family Issues|1
7279172|NCT00465894|11494659|FG001|Treatment For 12 Weeks|Family Issues|1
7279173|NCT00465894|11494658|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
7279174|NCT00465894|11494659|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
7279175|NCT00465972|11494683|FG000|Overall Study|Withdrawal by Subject|2
7279176|NCT00465972|11494684|FG001|Overall Study|Withdrawal by Subject|1
7279177|NCT00465985|11494692|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
7279178|NCT00465985|11494693|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7279179|NCT00465985|11494692|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
7279180|NCT00465985|11494693|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
7279181|NCT00465985|11494692|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
7279182|NCT00465985|11494693|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
7279183|NCT00465985|11494692|FG000|Part III - Open-label Treatment Period|Adverse Event|1
7279184|NCT00465985|11494693|FG001|Part III - Open-label Treatment Period|Adverse Event|0
7279185|NCT00466167|11494710|FG000|Overall Study|Adverse Event|8
7279186|NCT00466167|11494711|FG001|Overall Study|Adverse Event|8
7279187|NCT00466167|11494712|FG002|Overall Study|Adverse Event|7
7279188|NCT00466167|11494710|FG000|Overall Study|Lack of Efficacy|2
7279189|NCT00466167|11494711|FG001|Overall Study|Lack of Efficacy|0
7279190|NCT00466167|11494712|FG002|Overall Study|Lack of Efficacy|3
7279191|NCT00466167|11494710|FG000|Overall Study|Protocol Violation|1
7279192|NCT00466167|11494711|FG001|Overall Study|Protocol Violation|1
7279193|NCT00466167|11494712|FG002|Overall Study|Protocol Violation|2
7279194|NCT00466167|11494710|FG000|Overall Study|Lost to Follow-up|3
7279195|NCT00466167|11494711|FG001|Overall Study|Lost to Follow-up|2
7279196|NCT00466167|11494712|FG002|Overall Study|Lost to Follow-up|2
7616016|NCT00835705|12025458|FG001|First Intervention|Difficulty with vein|0
7616017|NCT00835705|12025457|FG000|Second Intervention|Difficulty with vein|1
7616018|NCT00835705|12025458|FG001|Second Intervention|Difficulty with vein|0
7616019|NCT00835692|12025464|FG000|First Intervention|Withdrawal by Subject|1
7616020|NCT00835692|12025465|FG001|First Intervention|Withdrawal by Subject|0
7616021|NCT00835666|12025471|FG000|Washout|Protocol Violation|1
7616022|NCT00835666|12025472|FG001|Washout|Protocol Violation|0
7616023|NCT00835666|12025471|FG000|Washout|Withdrawal by Subject|1
7616024|NCT00835666|12025472|FG001|Washout|Withdrawal by Subject|0
7616025|NCT00835640|12025478|FG000|Second Intervention|Protocol Violation|1
7616026|NCT00835640|12025479|FG001|Second Intervention|Protocol Violation|0
7616027|NCT00835575|12025499|FG000|Washout of 14 Days|Withdrawal by Subject|1
7616028|NCT00835575|12025500|FG001|Washout of 14 Days|Withdrawal by Subject|0
7616029|NCT00835549|12025506|FG000|Washout of 7 Days|Withdrawal by Subject|2
7616030|NCT00835549|12025507|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616031|NCT00835536|12025513|FG000|Washout of 5 Weeks|Withdrawal by Subject|1
7616032|NCT00835536|12025514|FG001|Washout of 5 Weeks|Withdrawal by Subject|0
7616033|NCT00835406|12025534|FG000|Period: First Intervention|Adverse Event|0
7616034|NCT00835406|12025535|FG001|Period: First Intervention|Adverse Event|1
7616035|NCT00835406|12025534|FG000|Period: First Intervention|Withdrawal by Subject|2
7616036|NCT00835406|12025535|FG001|Period: First Intervention|Withdrawal by Subject|0
7616037|NCT00835406|12025534|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0
7616038|NCT00835406|12025535|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2
7616039|NCT00835367|12025541|FG000|Washout|Adverse Event|2
7616040|NCT00835367|12025542|FG001|Washout|Adverse Event|0
7616041|NCT00835367|12025541|FG000|Washout|Withdrawal by Subject|1
7616042|NCT00835367|12025542|FG001|Washout|Withdrawal by Subject|0
7616043|NCT00835367|12025541|FG000|Second Intervention|Adverse Event|1
7616044|NCT00835367|12025542|FG001|Second Intervention|Adverse Event|1
7616045|NCT00835354|12025548|FG000|First Intervention|Adverse Event|0
7616046|NCT00835354|12025549|FG001|First Intervention|Adverse Event|1
7616047|NCT00835263|12025562|FG000|Second Intervention|Adverse Event|1
7616048|NCT00835263|12025563|FG001|Second Intervention|Adverse Event|0
7616049|NCT00835211|12025569|FG000|First Intervention|Withdrawal by Subject|0
7616050|NCT00835211|12025570|FG001|First Intervention|Withdrawal by Subject|1
7616051|NCT00835211|12025569|FG000|Washout: 7 Days|Adverse Event|2
7616052|NCT00835211|12025570|FG001|Washout: 7 Days|Adverse Event|1
7616053|NCT00835211|12025569|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616054|NCT00835211|12025570|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616055|NCT00835172|12025576|FG000|Washout|Protocol Violation|0
7616056|NCT00835172|12025577|FG001|Washout|Protocol Violation|1
7616057|NCT00835081|12025590|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616058|NCT00835081|12025591|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616059|NCT00835042|12025597|FG000|First Intervention|Withdrawal by Subject|3
7616060|NCT00835042|12025598|FG001|First Intervention|Withdrawal by Subject|0
7616061|NCT00835042|12025597|FG000|First Intervention|Adverse Event|1
7616062|NCT00835042|12025598|FG001|First Intervention|Adverse Event|2
7616063|NCT00835042|12025597|FG000|Washout of 21 Days|Withdrawal by Subject|0
7616064|NCT00835042|12025598|FG001|Washout of 21 Days|Withdrawal by Subject|2
7616065|NCT00834873|12025625|FG000|First Intervention|Adverse Event|0
7616066|NCT00834873|12025626|FG001|First Intervention|Adverse Event|1
7616067|NCT00834795|12025632|FG000|Washout: 7 Days|Withdrawal by Subject|0
7616068|NCT00834795|12025633|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616069|NCT00834795|12025632|FG000|Second Intervention|Adverse Event|1
7616070|NCT00834795|12025633|FG001|Second Intervention|Adverse Event|0
7616071|NCT00834756|12025639|FG000|First Intervention|Adverse Event|1
7616072|NCT00834756|12025640|FG001|First Intervention|Adverse Event|0
7616073|NCT00834756|12025639|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616074|NCT00834756|12025640|FG001|Washout: 21 Days|Withdrawal by Subject|0
7616075|NCT00834743|12025646|FG000|Second Intervention|Withdrawal by Subject|1
7616076|NCT00834743|12025647|FG001|Second Intervention|Withdrawal by Subject|0
7616077|NCT00834717|12025653|FG000|First Intervention|Adverse Event|1
7616078|NCT00834717|12025654|FG001|First Intervention|Adverse Event|0
7616079|NCT00834717|12025653|FG000|First Intervention|Withdrawal by Subject|0
7616080|NCT00834717|12025654|FG001|First Intervention|Withdrawal by Subject|1
7616081|NCT00834639|12025660|FG000|Second Intervention|Physician Decision|0
7616082|NCT00834639|12025661|FG001|Second Intervention|Physician Decision|2
7616083|NCT00834613|12025667|FG000|First Intervention|Protocol Violation|1
7616084|NCT00834613|12025668|FG001|First Intervention|Protocol Violation|0
7616085|NCT00834587|12025674|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616086|NCT00834587|12025675|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616087|NCT00834522|12025702|FG000|Washout|Adverse Event|1
7616088|NCT00834522|12025703|FG001|Washout|Adverse Event|0
7616089|NCT00834522|12025702|FG000|Washout|Withdrawal by Subject|2
7616090|NCT00834522|12025703|FG001|Washout|Withdrawal by Subject|1
7616091|NCT00834444|12025709|FG000|First Intervention|Adverse Event|1
7279197|NCT00466167|11494710|FG000|Overall Study|Withdrawal by Subject|4
7279198|NCT00466167|11494711|FG001|Overall Study|Withdrawal by Subject|1
7279199|NCT00466167|11494712|FG002|Overall Study|Withdrawal by Subject|6
7279200|NCT00466167|11494710|FG000|Overall Study|patient did not meet inclusion criteria|1
7279201|NCT00466167|11494711|FG001|Overall Study|patient did not meet inclusion criteria|0
7279202|NCT00466167|11494712|FG002|Overall Study|patient did not meet inclusion criteria|1
7279203|NCT00466167|11494710|FG000|Overall Study|Not treated|1
7279204|NCT00466167|11494711|FG001|Overall Study|Not treated|0
7279205|NCT00466167|11494712|FG002|Overall Study|Not treated|0
7279206|NCT00466193|11494722|FG000|Overall Study|Adverse Event|0
7279207|NCT00466193|11494723|FG001|Overall Study|Adverse Event|1
7279208|NCT00466193|11494722|FG000|Overall Study|Lost to Follow-up|2
7279209|NCT00466193|11494723|FG001|Overall Study|Lost to Follow-up|4
7279210|NCT00466193|11494722|FG000|Overall Study|Physician Decision|1
7279211|NCT00466193|11494723|FG001|Overall Study|Physician Decision|0
7279212|NCT00466193|11494722|FG000|Overall Study|Protocol Violation|1
7279213|NCT00466193|11494723|FG001|Overall Study|Protocol Violation|1
7279214|NCT00466193|11494722|FG000|Overall Study|Withdrawal by Subject|7
7279215|NCT00466193|11494723|FG001|Overall Study|Withdrawal by Subject|2
7279216|NCT00466193|11494722|FG000|Overall Study|Patient refused Visit 4 procedures|1
7279217|NCT00466193|11494723|FG001|Overall Study|Patient refused Visit 4 procedures|0
7279218|NCT00466440|11494761|FG000|Overall Study|Adverse Event|0
7279219|NCT00466440|11494762|FG001|Overall Study|Adverse Event|3
7279220|NCT00466440|11494763|FG002|Overall Study|Adverse Event|1
7279221|NCT00466440|11494761|FG000|Overall Study|Death|1
7279222|NCT00466440|11494762|FG001|Overall Study|Death|1
7279223|NCT00466440|11494763|FG002|Overall Study|Death|0
7279224|NCT00466440|11494761|FG000|Overall Study|Progressive disease|13
7279225|NCT00466440|11494762|FG001|Overall Study|Progressive disease|5
7279226|NCT00466440|11494763|FG002|Overall Study|Progressive disease|4
7279227|NCT00466440|11494761|FG000|Overall Study|Lost to Follow-up|0
7279228|NCT00466440|11494762|FG001|Overall Study|Lost to Follow-up|1
7279229|NCT00466440|11494763|FG002|Overall Study|Lost to Follow-up|0
7279230|NCT00466440|11494761|FG000|Overall Study|Physician Decision|0
7279231|NCT00466440|11494762|FG001|Overall Study|Physician Decision|1
7616092|NCT00834444|12025710|FG001|First Intervention|Adverse Event|0
7616093|NCT00834444|12025709|FG000|First Intervention|Intolerance to Venopuncture|0
7616094|NCT00834444|12025710|FG001|First Intervention|Intolerance to Venopuncture|1
7616095|NCT00834444|12025709|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616096|NCT00834444|12025710|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616097|NCT00834444|12025709|FG000|Second Intervention|Adverse Event|1
7616098|NCT00834444|12025710|FG001|Second Intervention|Adverse Event|0
7616099|NCT00834431|12025716|FG000|First Intervention|Adverse Event|0
7616100|NCT00834431|12025717|FG001|First Intervention|Adverse Event|1
7616101|NCT00834431|12025716|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616102|NCT00834431|12025717|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616103|NCT00834418|12025723|FG000|Overall Study|Adverse Event|0
7616104|NCT00834418|12025724|FG001|Overall Study|Adverse Event|2
7616105|NCT00834340|12025737|FG000|Washout|Adverse Event|1
7616106|NCT00834340|12025738|FG001|Washout|Adverse Event|0
7616107|NCT00834340|12025737|FG000|Washout|Withdrawal by Subject|1
7616108|NCT00834340|12025738|FG001|Washout|Withdrawal by Subject|0
7616109|NCT00834249|12025751|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616110|NCT00834249|12025752|FG001|Washout: 7 Days|Withdrawal by Subject|1
7616111|NCT00834249|12025751|FG000|Second Intervention|Adverse Event|1
7616112|NCT00834249|12025752|FG001|Second Intervention|Adverse Event|0
7616113|NCT00834067|12025772|FG000|Washout of 21 Days|Protocol Violation|0
7616114|NCT00834067|12025773|FG001|Washout of 21 Days|Protocol Violation|1
7616115|NCT00833937|12025779|FG000|Washout|Withdrawal by Subject|1
7616116|NCT00833937|12025780|FG001|Washout|Withdrawal by Subject|0
7616117|NCT00830336|12025807|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616118|NCT00830336|12025808|FG001|Washout: 21 Days|Withdrawal by Subject|0
7616119|NCT00830258|12025814|FG000|First Intervention|Adverse Event|1
7616120|NCT00830258|12025815|FG001|First Intervention|Adverse Event|0
7616121|NCT00830258|12025814|FG000|Washout: 7 Days|Protocol Violation|1
7616122|NCT00830258|12025815|FG001|Washout: 7 Days|Protocol Violation|0
7616123|NCT00830219|12025821|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616124|NCT00830219|12025822|FG001|Washout of 7 Days|Withdrawal by Subject|1
7616125|NCT00830206|12025828|FG000|Washout: 21 Days|Withdrawal by Subject|1
7616126|NCT00830206|12025829|FG001|Washout: 21 Days|Withdrawal by Subject|1
7616127|NCT00830024|12025835|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616128|NCT00830024|12025836|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616129|NCT00829998|12025842|FG000|Washout|Adverse Event|0
7616130|NCT00829998|12025843|FG001|Washout|Adverse Event|1
7616131|NCT00829868|12025849|FG000|Washout|Physician Decision|1
7616132|NCT00829868|12025850|FG001|Washout|Physician Decision|0
7616133|NCT00829790|12025856|FG000|Washout of 14 Days|Withdrawal by Subject|0
7616134|NCT00829790|12025857|FG001|Washout of 14 Days|Withdrawal by Subject|1
7616135|NCT00829764|12025863|FG000|First Intervention|Adverse Event|1
7616136|NCT00829764|12025864|FG001|First Intervention|Adverse Event|0
7616137|NCT00829764|12025863|FG000|First Intervention|Withdrawal by Subject|1
7616138|NCT00829764|12025864|FG001|First Intervention|Withdrawal by Subject|1
7616139|NCT00829712|12025870|FG000|Washout of 7 Days|Withdrawal by Subject|0
7616140|NCT00829712|12025871|FG001|Washout of 7 Days|Withdrawal by Subject|1
7279232|NCT00466440|11494763|FG002|Overall Study|Physician Decision|2
7279233|NCT00466440|11494761|FG000|Overall Study|Protocol entry criteria not met|0
7279234|NCT00466440|11494762|FG001|Overall Study|Protocol entry criteria not met|0
7279235|NCT00466440|11494763|FG002|Overall Study|Protocol entry criteria not met|4
7279236|NCT00466440|11494761|FG000|Overall Study|Withdrawal by Subject|0
7279237|NCT00466440|11494762|FG001|Overall Study|Withdrawal by Subject|1
7279238|NCT00466440|11494763|FG002|Overall Study|Withdrawal by Subject|0
7279239|NCT00466440|11494761|FG000|Overall Study|Sponsor decision|0
7279240|NCT00466440|11494762|FG001|Overall Study|Sponsor decision|0
7279241|NCT00466440|11494763|FG002|Overall Study|Sponsor decision|1
7279242|NCT00466505|11494780|FG000|Overall Study|disease progression|13
7279243|NCT00466505|11494780|FG000|Overall Study|Adverse Event|4
7279244|NCT00466687|11494793|FG000|Overall Study|Adverse Event|1
7279245|NCT00466687|11494793|FG000|Overall Study|Other complicating illness|3
7279246|NCT00466687|11494793|FG000|Overall Study|Withdrawal by Subject|1
7279247|NCT00466687|11494793|FG000|Overall Study|Disease progression|29
7279248|NCT00466726|11494799|FG000|Overall Study|Not evaluable for response|14
7279249|NCT00466921|11494830|FG000|First 3 Cycles of Treatment|Adverse Event|2
7279250|NCT00466921|11494830|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
7279251|NCT00466921|11494830|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
7279252|NCT00466921|11494830|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
7279253|NCT00466921|11494830|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
7616141|NCT00829673|12025884|FG000|Washout of 7 Days|Withdrawal by Subject|1
7279254|NCT00466921|11494830|FG000|Follow up for a Minimum of 1 Year|Death|6
7279255|NCT00466947|11494836|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
7279256|NCT00466947|11494837|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
7616142|NCT00829673|12025885|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616143|NCT00829530|12025891|FG000|First Intervention|Adverse Event|0
7616144|NCT00829530|12025892|FG001|First Intervention|Adverse Event|1
7616145|NCT00829530|12025891|FG000|First Intervention|Intolerance to Venopuncture|0
7616146|NCT00829530|12025892|FG001|First Intervention|Intolerance to Venopuncture|1
7616147|NCT00829530|12025891|FG000|Second Intervention|Intolerance to Venopuncture|1
7616148|NCT00829530|12025892|FG001|Second Intervention|Intolerance to Venopuncture|0
7616149|NCT00829504|12025898|FG000|First Intervention|Adverse Event|1
7616150|NCT00829504|12025899|FG001|First Intervention|Adverse Event|0
7616151|NCT00829504|12025898|FG000|Washout of 7 Days|Withdrawal by Subject|1
7616152|NCT00829504|12025899|FG001|Washout of 7 Days|Withdrawal by Subject|0
7616153|NCT00829504|12025898|FG000|Second Intervention|Physician Decision|1
7616154|NCT00829504|12025899|FG001|Second Intervention|Physician Decision|0
7616155|NCT00829452|12025905|FG000|First Intervention|Withdrawal by Subject|0
7616156|NCT00829452|12025906|FG001|First Intervention|Withdrawal by Subject|1
7616157|NCT00829452|12025905|FG000|Washout of 42 Days|Withdrawal by Subject|0
7616158|NCT00829452|12025906|FG001|Washout of 42 Days|Withdrawal by Subject|1
7616159|NCT00829452|12025905|FG000|Second Intervention|Physician Decision|0
7616160|NCT00829452|12025906|FG001|Second Intervention|Physician Decision|1
7616161|NCT00829426|12025912|FG000|Washout: 7 Days|Withdrawal by Subject|1
7616162|NCT00829426|12025913|FG001|Washout: 7 Days|Withdrawal by Subject|0
7616163|NCT00829309|12025919|FG000|Washout: 7 Days|Protocol Violation|1
7616164|NCT00829309|12025920|FG001|Washout: 7 Days|Protocol Violation|0
7616165|NCT00828321|12025926|FG000|Washout of 42 Days|Withdrawal by Subject|2
7616166|NCT00828321|12025927|FG001|Washout of 42 Days|Withdrawal by Subject|0
7616167|NCT00828321|12025926|FG000|Second Intervention|Protocol Violation|0
7616168|NCT00828321|12025927|FG001|Second Intervention|Protocol Violation|1
7616169|NCT00806403|12025933|FG000|Overall Study|Death|4
7616170|NCT00806403|12025934|FG001|Overall Study|Death|3
7616171|NCT00796523|12025974|FG000|Overall Study|Lost to Follow-up|9
7616172|NCT00796523|12025975|FG001|Overall Study|Lost to Follow-up|7
7616173|NCT00794924|12025981|FG000|Overall Study|Lost to Follow-up|6
7616174|NCT00794924|12025982|FG001|Overall Study|Lost to Follow-up|8
7616175|NCT00794924|12025981|FG000|Overall Study|Withdrawal by Subject|48
7616176|NCT00794924|12025982|FG001|Overall Study|Withdrawal by Subject|60
7616177|NCT00794924|12025981|FG000|Overall Study|Adverse Event|6
7616178|NCT00794924|12025982|FG001|Overall Study|Adverse Event|2
7616179|NCT00794677|12025988|FG000|First Intervention|Withdrawal by Subject|2
7616180|NCT00794677|12025989|FG001|First Intervention|Withdrawal by Subject|0
7616181|NCT00792116|12025995|FG000|Overall Study|Lost to Follow-up|0
7616182|NCT00792116|12025996|FG001|Overall Study|Lost to Follow-up|1
7616183|NCT00792116|12025995|FG000|Overall Study|Discontnued intervention|1
7616184|NCT00792116|12025996|FG001|Overall Study|Discontnued intervention|0
7279257|NCT00466947|11494836|FG000|Study End Analysis Period|Adverse Event|35
7616185|NCT00756574|12026016|FG000|Overall Study|Withdrawal by Subject|9
7616186|NCT00756574|12026017|FG001|Overall Study|Withdrawal by Subject|7
7616187|NCT00756574|12026016|FG000|Overall Study|Lost to Follow-up|4
7616188|NCT00756574|12026017|FG001|Overall Study|Lost to Follow-up|4
7616189|NCT00740480|12026024|FG000|Overall Study|Adverse Event|1
7616190|NCT00740480|12026024|FG000|Overall Study|Physician Decision|1
7616191|NCT00724698|12026027|FG000|Overall Study|Adverse Event|9
7616192|NCT00724698|12026027|FG000|Overall Study|Failure of Therapy|4
7616193|NCT00724698|12026027|FG000|Overall Study|Poor Compliance|16
7616194|NCT00724698|12026027|FG000|Overall Study|Lost to Follow-up|36
7616195|NCT00724698|12026027|FG000|Overall Study|No Info|25
7279258|NCT00466947|11494837|FG001|Study End Analysis Period|Adverse Event|43
7279259|NCT00466947|11494836|FG000|Study End Analysis Period|Lost to Follow-up|1137
7279260|NCT00466947|11494837|FG001|Study End Analysis Period|Lost to Follow-up|1167
7279261|NCT00466947|11494836|FG000|Study End Analysis Period|Physician Decision|29
7279262|NCT00466947|11494837|FG001|Study End Analysis Period|Physician Decision|29
7279263|NCT00466947|11494836|FG000|Study End Analysis Period|Protocol Violation|9
7279264|NCT00466947|11494837|FG001|Study End Analysis Period|Protocol Violation|17
7279265|NCT00466947|11494836|FG000|Study End Analysis Period|Withdrawal by Subject|1264
7279266|NCT00466947|11494837|FG001|Study End Analysis Period|Withdrawal by Subject|1267
7279267|NCT00466947|11494836|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
7279268|NCT00466947|11494837|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
7279269|NCT00466947|11494836|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
7279270|NCT00466947|11494837|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
7279271|NCT00466947|11494836|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
7279272|NCT00466947|11494837|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
7279273|NCT00467051|11494858|FG000|Overall Study|Adverse Event|2
7279274|NCT00467259|11494869|FG000|Overall Study|Adverse Event|24
7279275|NCT00467259|11494870|FG001|Overall Study|Adverse Event|90
7616196|NCT00711555|12026030|FG000|Overall Study|Adverse Event|3
7616197|NCT00676494|12026033|FG000|Overall Study|Missed Visit|8
7616198|NCT00676494|12026033|FG000|Overall Study|Withdrawal by Subject|6
7616199|NCT00659061|12026041|FG000|Overall Study|Migration due to political unrest|21
7616200|NCT00659061|12026042|FG001|Overall Study|Migration due to political unrest|15
7616201|NCT00581477|12026053|FG000|Overall Study|Physician Decision|2
7616208|NCT00495131|12026117|FG000|Overall Study|Adverse Event|6
7616209|NCT00495131|12026118|FG001|Overall Study|Adverse Event|2
7616210|NCT00495131|12026117|FG000|Overall Study|Lack of Efficacy|0
7616211|NCT00495131|12026118|FG001|Overall Study|Lack of Efficacy|2
7616212|NCT00495131|12026117|FG000|Overall Study|Lost to Follow-up|0
7279276|NCT00467259|11494869|FG000|Overall Study|Protocol Violation|1
7279277|NCT00467259|11494870|FG001|Overall Study|Protocol Violation|7
7279278|NCT00467259|11494869|FG000|Overall Study|Withdrawal by Subject|34
7279279|NCT00467259|11494870|FG001|Overall Study|Withdrawal by Subject|108
7279280|NCT00467259|11494869|FG000|Overall Study|Physician Decision|0
7279281|NCT00467259|11494870|FG001|Overall Study|Physician Decision|2
7279282|NCT00467259|11494869|FG000|Overall Study|Lost to Follow-up|14
7279283|NCT00467259|11494870|FG001|Overall Study|Lost to Follow-up|34
7279284|NCT00467259|11494869|FG000|Overall Study|Site Closed|2
7279285|NCT00467259|11494870|FG001|Overall Study|Site Closed|1
7279286|NCT00467272|11494876|FG000|Overall Study|Pneumonia|2
7279287|NCT00467272|11494876|FG000|Overall Study|Thrombophlebitis|1
7279288|NCT00467285|11494882|FG000|Overall Study|Lost to Follow-up|4
7279289|NCT00467285|11494883|FG001|Overall Study|Lost to Follow-up|4
7279290|NCT00467363|11494911|FG000|Overall Study|Lost to Follow-up|80
7279291|NCT00467363|11494912|FG001|Overall Study|Lost to Follow-up|70
7279292|NCT00467519|11494927|FG000|Overall Study|Protocol Violation|8
7279293|NCT00467519|11494928|FG001|Overall Study|Protocol Violation|4
7279294|NCT00467519|11494927|FG000|Overall Study|Lost to Follow-up|2
7279295|NCT00467519|11494928|FG001|Overall Study|Lost to Follow-up|9
7279296|NCT00467519|11494927|FG000|Overall Study|Withdrawal by Subject|4
7279297|NCT00467519|11494928|FG001|Overall Study|Withdrawal by Subject|10
7279298|NCT00467558|11494936|FG000|Overall Study|Lost to Follow-up|2
7279299|NCT00467558|11494937|FG001|Overall Study|Lost to Follow-up|0
7279300|NCT00467584|11494946|FG000|Overall Study|Withdrawal by Subject|4
7279301|NCT00467584|11494947|FG001|Overall Study|Withdrawal by Subject|5
7279302|NCT00467584|11494948|FG002|Overall Study|Withdrawal by Subject|1
7279303|NCT00467597|11494960|FG000|Overall Study|Withdrawal by Subject|2
7279304|NCT00467597|11494961|FG001|Overall Study|Withdrawal by Subject|0
7279305|NCT00467610|11494971|FG000|Overall Study|Withdrawal by Subject|1
7279306|NCT00467649|11494977|FG000|Phase 1 (Randomized Population)|Adverse Event|2
7616281|NCT00430508|12026188|FG003|Overall Study|Adverse Event|3
7279307|NCT00467649|11494978|FG001|Phase 1 (Randomized Population)|Adverse Event|0
7279308|NCT00467649|11494979|FG002|Phase 1 (Randomized Population)|Adverse Event|0
7279309|NCT00467649|11494980|FG003|Phase 1 (Randomized Population)|Adverse Event|0
7279310|NCT00467649|11494981|FG004|Phase 1 (Randomized Population)|Adverse Event|0
7279311|NCT00467649|11494982|FG005|Phase 1 (Randomized Population)|Adverse Event|0
7279312|NCT00467649|11494977|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
7279313|NCT00467649|11494978|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
7279314|NCT00467649|11494979|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
7616213|NCT00495131|12026118|FG001|Overall Study|Lost to Follow-up|2
7616202|NCT00554190|12026074|FG000|Overall Study|Termination forms not completed|10
7616203|NCT00529152|12026094|FG000|Overall Study|Adverse Event|2
7616204|NCT00529152|12026094|FG000|Overall Study|Withdrawal by Subject|2
7616205|NCT00529152|12026094|FG000|Overall Study|Lost to Follow-up|1
7616206|NCT00526227|12026097|FG000|Overall Study|Device not implanted|1
7616207|NCT00526227|12026097|FG000|Overall Study|Death|1
7616214|NCT00495131|12026117|FG000|Overall Study|Withdrawal by Subject|1
7616215|NCT00495131|12026118|FG001|Overall Study|Withdrawal by Subject|0
7616216|NCT00484419|12026132|FG000|Overall Study|Adverse Event|3
7616217|NCT00484419|12026133|FG001|Overall Study|Adverse Event|0
7616218|NCT00484419|12026134|FG002|Overall Study|Adverse Event|0
7616219|NCT00484419|12026132|FG000|Overall Study|Lost to Follow-up|1
7616220|NCT00484419|12026133|FG001|Overall Study|Lost to Follow-up|0
7616221|NCT00484419|12026134|FG002|Overall Study|Lost to Follow-up|2
7616222|NCT00484419|12026132|FG000|Overall Study|Withdrawal by Subject|3
7616223|NCT00484419|12026133|FG001|Overall Study|Withdrawal by Subject|1
7616224|NCT00484419|12026134|FG002|Overall Study|Withdrawal by Subject|1
7616225|NCT00484419|12026132|FG000|Overall Study|subject met discontinuation criteria|2
7616226|NCT00484419|12026133|FG001|Overall Study|subject met discontinuation criteria|2
7616227|NCT00484419|12026134|FG002|Overall Study|subject met discontinuation criteria|4
7616228|NCT00484419|12026132|FG000|Overall Study|required restricted medication|1
7616229|NCT00484419|12026133|FG001|Overall Study|required restricted medication|0
7616230|NCT00484419|12026134|FG002|Overall Study|required restricted medication|1
7616231|NCT00484419|12026132|FG000|Overall Study|Physician Decision|1
7616232|NCT00484419|12026133|FG001|Overall Study|Physician Decision|1
7616233|NCT00484419|12026134|FG002|Overall Study|Physician Decision|1
7616234|NCT00484419|12026132|FG000|Overall Study|subject unable to receive medication|1
7616235|NCT00484419|12026133|FG001|Overall Study|subject unable to receive medication|0
7616236|NCT00484419|12026134|FG002|Overall Study|subject unable to receive medication|0
7616237|NCT00484419|12026132|FG000|Overall Study|subject relocated|0
7616238|NCT00484419|12026133|FG001|Overall Study|subject relocated|1
7616239|NCT00484419|12026134|FG002|Overall Study|subject relocated|0
7616240|NCT00484419|12026132|FG000|Overall Study|sponsor decision, randomized in error|0
7616241|NCT00484419|12026133|FG001|Overall Study|sponsor decision, randomized in error|0
7616242|NCT00484419|12026134|FG002|Overall Study|sponsor decision, randomized in error|2
7616243|NCT00474188|12026146|FG000|Overall Study|Withdrawal by Subject|1
7616244|NCT00474188|12026146|FG000|Overall Study|Study discontinued by sponsor|5
7616245|NCT00440531|12026152|FG000|Overall Study|Adverse Event|1
7616246|NCT00440531|12026153|FG001|Overall Study|Adverse Event|0
7616247|NCT00440531|12026154|FG002|Overall Study|Adverse Event|2
7616248|NCT00440531|12026152|FG000|Overall Study|Withdrawal by Subject|2
7616249|NCT00440531|12026153|FG001|Overall Study|Withdrawal by Subject|0
7616250|NCT00440531|12026154|FG002|Overall Study|Withdrawal by Subject|0
7616251|NCT00440531|12026152|FG000|Overall Study|Protocol Violation|1
7616252|NCT00440531|12026153|FG001|Overall Study|Protocol Violation|2
7616253|NCT00440531|12026154|FG002|Overall Study|Protocol Violation|0
7616254|NCT00440531|12026152|FG000|Overall Study|Lost to Follow-up|4
7616255|NCT00440531|12026153|FG001|Overall Study|Lost to Follow-up|3
7616256|NCT00440531|12026154|FG002|Overall Study|Lost to Follow-up|5
7616257|NCT00440531|12026152|FG000|Overall Study|see pre-assignment details|2
7616258|NCT00440531|12026153|FG001|Overall Study|see pre-assignment details|0
7616259|NCT00440531|12026154|FG002|Overall Study|see pre-assignment details|0
7616260|NCT00439738|12026162|FG000|Overall Study|Withdrawal by Subject|16
7616261|NCT00439738|12026163|FG001|Overall Study|Withdrawal by Subject|13
7616262|NCT00439738|12026162|FG000|Overall Study|Adverse Event|6
7616263|NCT00439738|12026163|FG001|Overall Study|Adverse Event|4
7616264|NCT00439738|12026162|FG000|Overall Study|Lost to Follow-up|5
7616265|NCT00439738|12026163|FG001|Overall Study|Lost to Follow-up|6
7616266|NCT00439738|12026162|FG000|Overall Study|Protocol Violation|6
7616267|NCT00439738|12026163|FG001|Overall Study|Protocol Violation|3
7616268|NCT00439738|12026162|FG000|Overall Study|Lack of Efficacy|2
7616269|NCT00439738|12026163|FG001|Overall Study|Lack of Efficacy|2
7616270|NCT00439738|12026162|FG000|Overall Study|Abnormal Lab Values|1
7616271|NCT00439738|12026163|FG001|Overall Study|Abnormal Lab Values|0
7616272|NCT00430950|12026176|FG000|Overall Study|Adverse Event|7
7616273|NCT00430950|12026177|FG001|Overall Study|Adverse Event|6
7616274|NCT00430950|12026176|FG000|Overall Study|Withdrawal by Subject|1
7616275|NCT00430950|12026177|FG001|Overall Study|Withdrawal by Subject|0
7616276|NCT00430950|12026176|FG000|Overall Study|concomitant medication,etc.|5
7616277|NCT00430950|12026177|FG001|Overall Study|concomitant medication,etc.|7
7616278|NCT00430508|12026185|FG000|Overall Study|Adverse Event|2
7616279|NCT00430508|12026186|FG001|Overall Study|Adverse Event|3
7616280|NCT00430508|12026187|FG002|Overall Study|Adverse Event|5
7616282|NCT00430508|12026185|FG000|Overall Study|Withdrawal by Subject|0
7616283|NCT00430508|12026186|FG001|Overall Study|Withdrawal by Subject|1
7616284|NCT00430508|12026187|FG002|Overall Study|Withdrawal by Subject|1
7616285|NCT00430508|12026188|FG003|Overall Study|Withdrawal by Subject|1
7616286|NCT00430508|12026185|FG000|Overall Study|responder at visit 4|0
7616287|NCT00430508|12026186|FG001|Overall Study|responder at visit 4|0
7616288|NCT00430508|12026187|FG002|Overall Study|responder at visit 4|2
7616289|NCT00430508|12026188|FG003|Overall Study|responder at visit 4|0
7616290|NCT00430508|12026185|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
7616291|NCT00430508|12026186|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7616292|NCT00430508|12026187|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
7616293|NCT00430508|12026188|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
7616294|NCT00430508|12026185|FG000|Overall Study|Other|1
7616295|NCT00430508|12026186|FG001|Overall Study|Other|1
7616296|NCT00430508|12026187|FG002|Overall Study|Other|3
7616297|NCT00430508|12026188|FG003|Overall Study|Other|0
7616298|NCT00430092|12026197|FG000|Overall Study|Adverse Event|0
7616299|NCT00430092|12026198|FG001|Overall Study|Adverse Event|0
7616300|NCT00430092|12026199|FG002|Overall Study|Adverse Event|1
7616301|NCT00430092|12026197|FG000|Overall Study|Lack of Efficacy|5
7616302|NCT00430092|12026198|FG001|Overall Study|Lack of Efficacy|2
7616303|NCT00430092|12026199|FG002|Overall Study|Lack of Efficacy|54
7616304|NCT00430092|12026197|FG000|Overall Study|Lost to Follow-up|1
7616305|NCT00430092|12026198|FG001|Overall Study|Lost to Follow-up|0
7616306|NCT00430092|12026199|FG002|Overall Study|Lost to Follow-up|0
7616307|NCT00430092|12026197|FG000|Overall Study|Protocol Violation|0
7616308|NCT00430092|12026198|FG001|Overall Study|Protocol Violation|1
7616309|NCT00430092|12026199|FG002|Overall Study|Protocol Violation|1
7616310|NCT00430092|12026197|FG000|Overall Study|Withdrawal by Subject|0
7616311|NCT00430092|12026198|FG001|Overall Study|Withdrawal by Subject|1
7616312|NCT00430092|12026199|FG002|Overall Study|Withdrawal by Subject|1
7616313|NCT00429923|12026207|FG000|Overall Study|Adverse Event|0
7279315|NCT00467649|11494980|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
7279316|NCT00467649|11494981|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
7279317|NCT00467649|11494982|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
7279318|NCT00467649|11494977|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
7279319|NCT00467649|11494978|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
7279320|NCT00467649|11494979|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
7279321|NCT00467649|11494980|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
7279322|NCT00467649|11494981|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
7279323|NCT00467649|11494982|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
7279324|NCT00467649|11494977|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
7279325|NCT00467649|11494978|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
7279326|NCT00467649|11494979|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7279327|NCT00467649|11494980|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7279328|NCT00467649|11494981|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7279329|NCT00467649|11494982|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
7279330|NCT00467649|11494977|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7279331|NCT00467649|11494978|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7279332|NCT00467649|11494979|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7279333|NCT00467649|11494980|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
7279334|NCT00467649|11494981|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7279335|NCT00467649|11494982|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
7279336|NCT00467649|11494977|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7279337|NCT00467649|11494978|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7279338|NCT00467649|11494979|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7279339|NCT00467649|11494980|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
7279340|NCT00467649|11494981|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7279341|NCT00467649|11494982|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
7279342|NCT00467649|11494977|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7279343|NCT00467649|11494978|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7616314|NCT00429923|12026208|FG001|Overall Study|Adverse Event|2
7616315|NCT00429923|12026209|FG002|Overall Study|Adverse Event|3
7616316|NCT00429923|12026207|FG000|Overall Study|Lack of Efficacy|4
7616317|NCT00429923|12026208|FG001|Overall Study|Lack of Efficacy|1
7616318|NCT00429923|12026209|FG002|Overall Study|Lack of Efficacy|33
7616319|NCT00429923|12026207|FG000|Overall Study|Lost to Follow-up|0
7279344|NCT00467649|11494979|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7279345|NCT00467649|11494980|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7279346|NCT00467649|11494981|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
7616320|NCT00429923|12026208|FG001|Overall Study|Lost to Follow-up|0
7616321|NCT00429923|12026209|FG002|Overall Study|Lost to Follow-up|2
7616322|NCT00429923|12026207|FG000|Overall Study|Withdrew Consent|1
7616323|NCT00429923|12026208|FG001|Overall Study|Withdrew Consent|0
7616324|NCT00429923|12026209|FG002|Overall Study|Withdrew Consent|1
7616325|NCT00429923|12026207|FG000|Overall Study|Early Termination|0
7616326|NCT00429923|12026208|FG001|Overall Study|Early Termination|1
7616327|NCT00429923|12026209|FG002|Overall Study|Early Termination|0
7616328|NCT00425100|12026214|FG000|Overall Study|Adverse Event|36
7616329|NCT00425100|12026214|FG000|Overall Study|Lack of Efficacy|4
7616330|NCT00425100|12026214|FG000|Overall Study|Lost to Follow-up|2
7616331|NCT00425100|12026214|FG000|Overall Study|Protocol Violation|4
7616332|NCT00425100|12026214|FG000|Overall Study|Withdrawal by Subject|7
7616333|NCT00415623|12026221|FG000|Overall Study|Adverse Event|3
7616334|NCT00415623|12026222|FG001|Overall Study|Adverse Event|4
7616335|NCT00415623|12026221|FG000|Overall Study|Death|1
7616336|NCT00415623|12026222|FG001|Overall Study|Death|0
7616337|NCT00415623|12026221|FG000|Overall Study|Withdrawal by Subject|1
7616338|NCT00415623|12026222|FG001|Overall Study|Withdrawal by Subject|1
7616339|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1
7616340|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
7616341|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1
7616342|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
7616343|NCT00412932|12026229|FG000|Olmesartan (Olm) 20 mg|Other|1
7616344|NCT00412932|12026229|FG000|Olmesartan 40 mg|Adverse Event|4
7616345|NCT00412932|12026229|FG000|Olmesartan 40 mg|Lack of Efficacy|3
7616346|NCT00412932|12026229|FG000|Olmesartan 40 mg|Withdrawal by Subject|1
7616347|NCT00412932|12026229|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
7616348|NCT00412932|12026229|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
7616349|NCT00412932|12026229|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
7616350|NCT00412932|12026229|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
7279347|NCT00467649|11494982|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
7279348|NCT00467740|11495005|FG000|Overall Study|Adverse Event|0
7279349|NCT00467740|11495006|FG001|Overall Study|Adverse Event|0
7279350|NCT00467740|11495007|FG002|Overall Study|Adverse Event|1
7279351|NCT00467740|11495008|FG003|Overall Study|Adverse Event|0
7279352|NCT00467740|11495009|FG004|Overall Study|Adverse Event|0
7279353|NCT00467740|11495005|FG000|Overall Study|Protocol Violation|0
7279354|NCT00467740|11495006|FG001|Overall Study|Protocol Violation|0
7279355|NCT00467740|11495007|FG002|Overall Study|Protocol Violation|1
7616351|NCT00397254|12026232|FG000|Overall Study|Lost to Follow-up|2
7616352|NCT00397254|12026233|FG001|Overall Study|Lost to Follow-up|2
7279356|NCT00467740|11495008|FG003|Overall Study|Protocol Violation|0
7279357|NCT00467740|11495009|FG004|Overall Study|Protocol Violation|0
7279358|NCT00467740|11495005|FG000|Overall Study|Lost to Follow-up|0
7279359|NCT00467740|11495006|FG001|Overall Study|Lost to Follow-up|1
7279360|NCT00467740|11495007|FG002|Overall Study|Lost to Follow-up|0
7279361|NCT00467740|11495008|FG003|Overall Study|Lost to Follow-up|0
7279362|NCT00467740|11495009|FG004|Overall Study|Lost to Follow-up|0
7279363|NCT00467740|11495005|FG000|Overall Study|Withdrawal by Subject|1
7279364|NCT00467740|11495006|FG001|Overall Study|Withdrawal by Subject|1
7279365|NCT00467740|11495007|FG002|Overall Study|Withdrawal by Subject|0
7279366|NCT00467740|11495008|FG003|Overall Study|Withdrawal by Subject|1
7279367|NCT00467740|11495009|FG004|Overall Study|Withdrawal by Subject|0
7279368|NCT00467740|11495005|FG000|Overall Study|Lack of Efficacy|0
7279369|NCT00467740|11495006|FG001|Overall Study|Lack of Efficacy|1
7279370|NCT00467740|11495007|FG002|Overall Study|Lack of Efficacy|0
7279371|NCT00467740|11495008|FG003|Overall Study|Lack of Efficacy|0
7279372|NCT00467740|11495009|FG004|Overall Study|Lack of Efficacy|0
7279373|NCT00467779|11495036|FG000|Stage 1|Adverse Event|1
7279374|NCT00467779|11495037|FG001|Stage 1|Adverse Event|0
7279375|NCT00467779|11495038|FG002|Stage 1|Adverse Event|0
7279376|NCT00467779|11495039|FG003|Stage 1|Adverse Event|0
7279377|NCT00467779|11495040|FG004|Stage 1|Adverse Event|0
7279378|NCT00467779|11495041|FG005|Stage 1|Adverse Event|1
7279379|NCT00467779|11495042|FG006|Stage 1|Adverse Event|2
7279380|NCT00467779|11495043|FG007|Stage 1|Adverse Event|1
7279381|NCT00467779|11495044|FG008|Stage 1|Adverse Event|0
7279382|NCT00467779|11495045|FG009|Stage 1|Adverse Event|0
7279383|NCT00467779|11495046|FG010|Stage 1|Adverse Event|0
7279384|NCT00467779|11495047|FG011|Stage 1|Adverse Event|0
7279385|NCT00467779|11495048|FG012|Stage 1|Adverse Event|0
7279386|NCT00467779|11495049|FG013|Stage 1|Adverse Event|0
7279387|NCT00467779|11495050|FG014|Stage 1|Adverse Event|0
7279388|NCT00467779|11495036|FG000|Stage 1|Disease Progression|2
7279389|NCT00467779|11495037|FG001|Stage 1|Disease Progression|2
7279390|NCT00467779|11495038|FG002|Stage 1|Disease Progression|2
7616353|NCT00338104|12026261|FG000|Overall Study|Protocol Violation|2
7616354|NCT00338104|12026262|FG001|Overall Study|Protocol Violation|1
7616355|NCT00338104|12026263|FG002|Overall Study|Protocol Violation|3
7616356|NCT00326183|12026273|FG000|Overall Study|Lost to Follow-up|104
7616357|NCT00326183|12026274|FG001|Overall Study|Lost to Follow-up|56
7616358|NCT00326183|12026273|FG000|Overall Study|Protocol Violation|6
7616359|NCT00326183|12026274|FG001|Overall Study|Protocol Violation|3
7616360|NCT00326183|12026273|FG000|Overall Study|Withdrawal by Subject|35
7616361|NCT00326183|12026274|FG001|Overall Study|Withdrawal by Subject|7
7616362|NCT00326183|12026273|FG000|Overall Study|Subject Moved|7
7616363|NCT00326183|12026274|FG001|Overall Study|Subject Moved|4
7616364|NCT00326183|12026273|FG000|Overall Study|Other|47
7616365|NCT00326183|12026274|FG001|Overall Study|Other|13
7616366|NCT00326183|12026273|FG000|Overall Study|Adverse Event|1
7616367|NCT00326183|12026274|FG001|Overall Study|Adverse Event|0
7616368|NCT00318656|12026287|FG000|Overall Study|Took Avandamet instead of Glim/Met|0
7616369|NCT00318656|12026288|FG001|Overall Study|Took Avandamet instead of Glim/Met|1
7616370|NCT00318656|12026287|FG000|Overall Study|Did not receive any treatment|0
7616371|NCT00318656|12026288|FG001|Overall Study|Did not receive any treatment|1
7616372|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Adverse Event|1
7616373|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Adverse Event|0
7616374|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Lack of Efficacy|0
7616375|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Lack of Efficacy|1
7616376|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Lost to Follow-up|3
7616377|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Lost to Follow-up|3
7616378|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5
7616379|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5
7616380|NCT00301262|12026294|FG000|Double Blind Phase (DB)|Other|1
7616381|NCT00301262|12026295|FG001|Double Blind Phase (DB)|Other|4
7616382|NCT00301262|12026294|FG000|Open Label Phase (OL)|Adverse Event|1
7616383|NCT00301262|12026295|FG001|Open Label Phase (OL)|Adverse Event|0
7616384|NCT00301262|12026294|FG000|Open Label Phase (OL)|Lost to Follow-up|1
7616385|NCT00301262|12026295|FG001|Open Label Phase (OL)|Lost to Follow-up|2
7616386|NCT00301262|12026294|FG000|Open Label Phase (OL)|Other|2
7616387|NCT00301262|12026295|FG001|Open Label Phase (OL)|Other|0
7616388|NCT00283868|12026322|FG000|Overall Study|Lost to Follow-up|7
7616389|NCT00283868|12026323|FG001|Overall Study|Lost to Follow-up|8
7616390|NCT00282867|12026330|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7616391|NCT00282867|12026331|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
7616392|NCT00282867|12026332|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
7616393|NCT00275340|12026339|FG000|Overall Study|Lost to Follow-up|2
7616394|NCT00275340|12026340|FG001|Overall Study|Lost to Follow-up|4
7616395|NCT00271544|12026344|FG000|Overall Study|Subjects did not receive a 4196 lead|7
7616396|NCT00271544|12026344|FG000|Overall Study|Model 4196 lead not attempted|9
7616397|NCT00271544|12026344|FG000|Overall Study|Implant not attempted|4
7616398|NCT00235326|12026381|FG000|Overall Study|Lost to Follow-up|746
7616399|NCT00235326|12026382|FG001|Overall Study|Lost to Follow-up|1400
7616400|NCT00232141|12026388|FG000|Overall Study|Adverse Event|9
7616401|NCT00232141|12026389|FG001|Overall Study|Adverse Event|4
7616402|NCT00232141|12026388|FG000|Overall Study|Lack of Efficacy|0
7616403|NCT00232141|12026389|FG001|Overall Study|Lack of Efficacy|3
7616404|NCT00232141|12026388|FG000|Overall Study|Lost to Follow-up|9
7616405|NCT00232141|12026389|FG001|Overall Study|Lost to Follow-up|6
7616406|NCT00232141|12026388|FG000|Overall Study|Other|8
7616407|NCT00232141|12026389|FG001|Overall Study|Other|10
7616408|NCT00232141|12026388|FG000|Overall Study|Withdrawal by Subject|5
7616409|NCT00232141|12026389|FG001|Overall Study|Withdrawal by Subject|3
7616410|NCT00224003|12026400|FG000|Overall Study|Adverse Event|1
7616411|NCT00224003|12026400|FG000|Overall Study|Protocol Violation|2
7616412|NCT00224003|12026400|FG000|Overall Study|Withdrawal by Subject|1
7616413|NCT00224003|12026400|FG000|Overall Study|unk|3
7616414|NCT00162942|12026405|FG000|Overall Study|Adverse Event|10
7616415|NCT00162942|12026406|FG001|Overall Study|Adverse Event|6
7616416|NCT00162942|12026405|FG000|Overall Study|Death|1
7616417|NCT00162942|12026406|FG001|Overall Study|Death|0
7616418|NCT00162942|12026405|FG000|Overall Study|Withdrawal by Subject|3
7616419|NCT00162942|12026406|FG001|Overall Study|Withdrawal by Subject|6
7616420|NCT00162942|12026405|FG000|Overall Study|Physician Decision|1
7616421|NCT00162942|12026406|FG001|Overall Study|Physician Decision|0
7616422|NCT00162942|12026405|FG000|Overall Study|Enter Open-Label Study|76
7616423|NCT00162942|12026406|FG001|Overall Study|Enter Open-Label Study|35
7616424|NCT00162942|12026405|FG000|Overall Study|Alternate Therapy|6
7616425|NCT00162942|12026406|FG001|Overall Study|Alternate Therapy|2
7616426|NCT00162942|12026405|FG000|Overall Study|Lack of Efficacy|1
7616427|NCT00162942|12026406|FG001|Overall Study|Lack of Efficacy|0
7616428|NCT00162942|12026405|FG000|Overall Study|Flare During Active Treatment|7
7616429|NCT00162942|12026406|FG001|Overall Study|Flare During Active Treatment|3
7616430|NCT00162942|12026405|FG000|Overall Study|2 or more consecutive treatments missed|1
7616431|NCT00162942|12026406|FG001|Overall Study|2 or more consecutive treatments missed|0
7616432|NCT00126776|12026426|FG000|Overall Study|follow up complete on all patients|0
7616433|NCT00126776|12026427|FG001|Overall Study|follow up complete on all patients|0
7616434|NCT00120042|12026434|FG000|Overall Study|all completed protocl|0
7616435|NCT00120042|12026435|FG001|Overall Study|all completed protocl|0
7616436|NCT00120042|12026436|FG002|Overall Study|all completed protocl|0
7616437|NCT00106626|12026445|FG000|Overall Study|Adverse Event|5
7616438|NCT00106626|12026446|FG001|Overall Study|Adverse Event|4
7616439|NCT00106626|12026447|FG002|Overall Study|Adverse Event|3
7616440|NCT00106626|12026448|FG003|Overall Study|Adverse Event|3
7616441|NCT00106626|12026445|FG000|Overall Study|Progressive Disease|4
7616442|NCT00106626|12026446|FG001|Overall Study|Progressive Disease|1
7616443|NCT00106626|12026447|FG002|Overall Study|Progressive Disease|9
7616444|NCT00106626|12026448|FG003|Overall Study|Progressive Disease|10
7616445|NCT00106626|12026445|FG000|Overall Study|Received radiation on new therapy|1
7616446|NCT00106626|12026446|FG001|Overall Study|Received radiation on new therapy|0
7616447|NCT00106626|12026447|FG002|Overall Study|Received radiation on new therapy|0
7616448|NCT00106626|12026448|FG003|Overall Study|Received radiation on new therapy|0
7616449|NCT00106626|12026445|FG000|Overall Study|> 14 day delay in therapy start|0
7616450|NCT00106626|12026446|FG001|Overall Study|> 14 day delay in therapy start|1
7616451|NCT00106626|12026447|FG002|Overall Study|> 14 day delay in therapy start|0
7616452|NCT00106626|12026448|FG003|Overall Study|> 14 day delay in therapy start|0
7616453|NCT00089141|12026465|FG000|Overall Study|Termination of trial|18
7616454|NCT00089141|12026466|FG001|Overall Study|Termination of trial|24
7279391|NCT00467779|11495039|FG003|Stage 1|Disease Progression|3
7279392|NCT00467779|11495040|FG004|Stage 1|Disease Progression|2
7279393|NCT00467779|11495041|FG005|Stage 1|Disease Progression|2
7616455|NCT00083759|12026472|FG000|Overall Study|Adverse Event|5
7616456|NCT00083759|12026473|FG001|Overall Study|Adverse Event|3
7616457|NCT00083759|12026472|FG000|Overall Study|Lost to Follow-up|1
7616458|NCT00083759|12026473|FG001|Overall Study|Lost to Follow-up|0
7616459|NCT00083759|12026472|FG000|Overall Study|Death|1
7616460|NCT00083759|12026473|FG001|Overall Study|Death|1
7616461|NCT00083759|12026472|FG000|Overall Study|Inadequate Therapeutic Response|32
7616462|NCT00083759|12026473|FG001|Overall Study|Inadequate Therapeutic Response|35
7616463|NCT00083759|12026472|FG000|Overall Study|Subject Withdrew Consent|2
7616464|NCT00083759|12026473|FG001|Overall Study|Subject Withdrew Consent|2
7616465|NCT00083759|12026472|FG000|Overall Study|Non-Compliance|1
7616466|NCT00083759|12026473|FG001|Overall Study|Non-Compliance|0
7616467|NCT00083759|12026472|FG000|Overall Study|Sponsor's Discretion|28
7616468|NCT00083759|12026473|FG001|Overall Study|Sponsor's Discretion|29
7616469|NCT00083759|12026472|FG000|Overall Study|Other|14
7616470|NCT00083759|12026473|FG001|Overall Study|Other|13
7616471|NCT03513068|12026479|FG000|Overall Study|Death|1
7616472|NCT03513068|12026480|FG001|Overall Study|Death|0
7616473|NCT03513068|12026479|FG000|Overall Study|Withdrawal by Subject|4
7616474|NCT03513068|12026480|FG001|Overall Study|Withdrawal by Subject|6
7616475|NCT03507127|12026488|FG000|Overall Study|Withdrawal by Subject|1
7616476|NCT03507127|12026489|FG001|Overall Study|Withdrawal by Subject|0
7616477|NCT03507127|12026488|FG000|Overall Study|Unable to meet smoking abstinence criterion|1
7616478|NCT03507127|12026489|FG001|Overall Study|Unable to meet smoking abstinence criterion|1
7616479|NCT03502811|12026495|FG000|Overall Study|Death|157
7616480|NCT03502811|12026495|FG000|Overall Study|Withdrawal by Subject|105
7616481|NCT03502811|12026495|FG000|Overall Study|Lost to Follow-up|26
7616482|NCT03502811|12026495|FG000|Overall Study|No Visits (Missed)|31
7616491|NCT03530995|12026529|FG000|Part 1 Period 3|Withdrawal by Subject|2
7616492|NCT03530995|12026530|FG001|Part 1 Period 3|Withdrawal by Subject|0
7616493|NCT03530995|12026529|FG000|Part 1 Period 3|Protocol Violation|1
7616494|NCT03530995|12026530|FG001|Part 1 Period 3|Protocol Violation|0
7616495|NCT03530995|12026529|FG000|Part 1 Period 4|Physician Decision|1
7616496|NCT03530995|12026530|FG001|Part 1 Period 4|Physician Decision|0
7616497|NCT03530995|12026529|FG000|Part 1 Period 4|Withdrawal by Subject|1
7616498|NCT03530995|12026530|FG001|Part 1 Period 4|Withdrawal by Subject|0
7279394|NCT00467779|11495042|FG006|Stage 1|Disease Progression|4
7616499|NCT03204812|12026560|FG000|Overall Study|Adverse Event|3
7616510|NCT03072459|12026571|FG000|Overall Study|Device revised/removed|1
7616511|NCT03072459|12026571|FG000|Overall Study|Subject not able to return|1
7616512|NCT03029234|12026575|FG000|Overall Study|Sponsor Decision|1
7616513|NCT03029234|12026575|FG000|Overall Study|Withdrawal by Subject|5
7616514|NCT03029234|12026575|FG000|Overall Study|Death|91
7616515|NCT03029234|12026575|FG000|Overall Study|Lost to Follow-up|2
7616516|NCT03019406|12026583|FG000|ETP: Ongoing From Week 26|Ongoing|6
7616517|NCT03019406|12026584|FG001|ETP: Ongoing From Week 26|Ongoing|5
7616518|NCT03019406|12026585|FG002|ETP: Ongoing From Week 26|Ongoing|5
7616519|NCT03019406|12026586|FG003|ETP: Ongoing From Week 26|Ongoing|3
7616520|NCT02874144|12026601|FG000|Overall Study|Lost to Follow-up|3
7616521|NCT02874144|12026602|FG001|Overall Study|Lost to Follow-up|5
7616522|NCT02611830|12026612|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
7616523|NCT02611830|12026613|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616524|NCT02611830|12026614|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616525|NCT02611830|12026615|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
7616526|NCT02611830|12026612|FG000|OL Induction Phase|Significant Protocol Deviation|4
7616527|NCT02611830|12026613|FG001|OL Induction Phase|Significant Protocol Deviation|0
7616528|NCT02611830|12026614|FG002|OL Induction Phase|Significant Protocol Deviation|0
7616529|NCT02611830|12026615|FG003|OL Induction Phase|Significant Protocol Deviation|0
7616530|NCT02611830|12026612|FG000|OL Induction Phase|Voluntary Withdrawal|5
7616531|NCT02611830|12026613|FG001|OL Induction Phase|Voluntary Withdrawal|0
7616532|NCT02611830|12026614|FG002|OL Induction Phase|Voluntary Withdrawal|0
7616533|NCT02611830|12026615|FG003|OL Induction Phase|Voluntary Withdrawal|0
7616534|NCT02611830|12026612|FG000|OL Induction Phase|Lack of Efficacy|9
7616535|NCT02611830|12026613|FG001|OL Induction Phase|Lack of Efficacy|0
7616536|NCT02611830|12026614|FG002|OL Induction Phase|Lack of Efficacy|0
7616537|NCT02611830|12026615|FG003|OL Induction Phase|Lack of Efficacy|0
7616538|NCT02611830|12026612|FG000|OL Induction Phase|Reason not specified|3
7616539|NCT02611830|12026613|FG001|OL Induction Phase|Reason not specified|0
7616540|NCT02611830|12026614|FG002|OL Induction Phase|Reason not specified|0
7616541|NCT02611830|12026615|FG003|OL Induction Phase|Reason not specified|0
7616542|NCT02611830|12026612|FG000|Maintenance Phase|Lack of Efficacy|0
7616543|NCT02611830|12026613|FG001|Maintenance Phase|Lack of Efficacy|29
7616544|NCT02611830|12026614|FG002|Maintenance Phase|Lack of Efficacy|18
7616545|NCT02611830|12026615|FG003|Maintenance Phase|Lack of Efficacy|6
7616546|NCT02611830|12026612|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
7616547|NCT02611830|12026613|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
7616548|NCT02611830|12026614|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
7616549|NCT02611830|12026615|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
7616550|NCT02611830|12026612|FG000|Maintenance Phase|Significant Protocol Deviation|0
7616551|NCT02611830|12026613|FG001|Maintenance Phase|Significant Protocol Deviation|0
7616552|NCT02611830|12026614|FG002|Maintenance Phase|Significant Protocol Deviation|1
7616553|NCT02611830|12026615|FG003|Maintenance Phase|Significant Protocol Deviation|1
7616554|NCT02611830|12026612|FG000|Maintenance Phase|Lost to Follow-up|0
7616555|NCT02611830|12026613|FG001|Maintenance Phase|Lost to Follow-up|0
7616556|NCT02611830|12026614|FG002|Maintenance Phase|Lost to Follow-up|0
7616557|NCT02611830|12026615|FG003|Maintenance Phase|Lost to Follow-up|1
7616558|NCT02611830|12026612|FG000|Maintenance Phase|Voluntary Withdrawal|0
7616559|NCT02611830|12026613|FG001|Maintenance Phase|Voluntary Withdrawal|1
7616560|NCT02611830|12026614|FG002|Maintenance Phase|Voluntary Withdrawal|2
7616561|NCT02611830|12026615|FG003|Maintenance Phase|Voluntary Withdrawal|5
7616562|NCT02611830|12026612|FG000|Maintenance Phase|Pregnancy|0
7616563|NCT02611830|12026613|FG001|Maintenance Phase|Pregnancy|0
7616564|NCT02611830|12026614|FG002|Maintenance Phase|Pregnancy|1
7616565|NCT02611830|12026615|FG003|Maintenance Phase|Pregnancy|0
7616566|NCT02611830|12026612|FG000|Maintenance Phase|Reason not specified|0
7616567|NCT02611830|12026613|FG001|Maintenance Phase|Reason not specified|1
7616568|NCT02611830|12026614|FG002|Maintenance Phase|Reason not specified|4
7616569|NCT02611830|12026615|FG003|Maintenance Phase|Reason not specified|0
7616570|NCT02611817|12026627|FG000|Open-label Induction Phase|Reason not Specified|9
7616571|NCT02611817|12026628|FG001|Open-label Induction Phase|Reason not Specified|0
7616572|NCT02611817|12026629|FG002|Open-label Induction Phase|Reason not Specified|0
7616573|NCT02611817|12026627|FG000|Open-label Induction Phase|Lack of Efficacy|8
7616574|NCT02611817|12026628|FG001|Open-label Induction Phase|Lack of Efficacy|0
7616575|NCT02611817|12026629|FG002|Open-label Induction Phase|Lack of Efficacy|0
7616576|NCT02611817|12026627|FG000|Open-label Induction Phase|Pregnancy|1
7616577|NCT02611817|12026628|FG001|Open-label Induction Phase|Pregnancy|0
7616578|NCT02611817|12026629|FG002|Open-label Induction Phase|Pregnancy|0
7616579|NCT02611817|12026627|FG000|Open-label Induction Phase|Withdrawal by Subject|9
7616580|NCT02611817|12026628|FG001|Open-label Induction Phase|Withdrawal by Subject|0
7616581|NCT02611817|12026629|FG002|Open-label Induction Phase|Withdrawal by Subject|0
7616582|NCT02611817|12026627|FG000|Open-label Induction Phase|Lost to Follow-up|2
7616583|NCT02611817|12026628|FG001|Open-label Induction Phase|Lost to Follow-up|0
7616584|NCT02611817|12026629|FG002|Open-label Induction Phase|Lost to Follow-up|0
7616585|NCT02611817|12026627|FG000|Open-label Induction Phase|Protocol Violation|5
7616586|NCT02611817|12026628|FG001|Open-label Induction Phase|Protocol Violation|0
7616587|NCT02611817|12026629|FG002|Open-label Induction Phase|Protocol Violation|0
7616588|NCT02611817|12026627|FG000|Open-label Induction Phase|Adverse Event|16
7616589|NCT02611817|12026628|FG001|Open-label Induction Phase|Adverse Event|0
7616590|NCT02611817|12026629|FG002|Open-label Induction Phase|Adverse Event|0
7616591|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Adverse Event|0
7616592|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Adverse Event|12
7616593|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Adverse Event|11
7616594|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
7616595|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
7616596|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
7616597|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Reason not Specified|0
7616598|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Reason not Specified|1
7616599|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Reason not Specified|2
7616600|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
7616601|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
7616602|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
7616603|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Pregnancy|0
7616604|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Pregnancy|0
7616605|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Pregnancy|1
7616606|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
7616607|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
7616608|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
7616609|NCT02611817|12026627|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
7616610|NCT02611817|12026628|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
7616611|NCT02611817|12026629|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
7616612|NCT02557139|12026639|FG000|Overall Study|Significant liver elevation|1
7616613|NCT02557139|12026640|FG001|Overall Study|Significant liver elevation|0
7616614|NCT02557139|12026641|FG002|Overall Study|Significant liver elevation|1
7616615|NCT02557139|12026639|FG000|Overall Study|Withdrawal by Subject|1
7616616|NCT02557139|12026640|FG001|Overall Study|Withdrawal by Subject|0
7616617|NCT02557139|12026641|FG002|Overall Study|Withdrawal by Subject|0
7616618|NCT02557139|12026639|FG000|Overall Study|Illness of prohibited medication|0
7616619|NCT02557139|12026640|FG001|Overall Study|Illness of prohibited medication|0
7616620|NCT02557139|12026641|FG002|Overall Study|Illness of prohibited medication|1
7616621|NCT02211131|12026660|FG000|Overall Study|Death|20
7616622|NCT02211131|12026661|FG001|Overall Study|Death|11
7616623|NCT02211131|12026660|FG000|Overall Study|Lost to Follow-up|1
7616624|NCT02211131|12026661|FG001|Overall Study|Lost to Follow-up|0
7616625|NCT02211131|12026660|FG000|Overall Study|Decision by Sponsor|1
7616626|NCT02211131|12026661|FG001|Overall Study|Decision by Sponsor|1
7616627|NCT02211131|12026660|FG000|Overall Study|Withdrawal by Subject|3
7616628|NCT02211131|12026661|FG001|Overall Study|Withdrawal by Subject|4
7616629|NCT02211131|12026660|FG000|Overall Study|Continuing on Study|49
7616630|NCT02211131|12026661|FG001|Overall Study|Continuing on Study|60
7616631|NCT02186847|12026676|FG000|Overall Study|Protocol Violation|3
7616632|NCT02186847|12026677|FG001|Overall Study|Protocol Violation|0
7616633|NCT02101034|12026688|FG000|Overall Study|Enrolled but did not start treatment|0
7616634|NCT02101034|12026689|FG001|Overall Study|Enrolled but did not start treatment|0
7616635|NCT02101034|12026690|FG002|Overall Study|Enrolled but did not start treatment|1
7616636|NCT02101034|12026691|FG003|Overall Study|Enrolled but did not start treatment|0
7616637|NCT02101034|12026692|FG004|Overall Study|Enrolled but did not start treatment|0
7279395|NCT00467779|11495043|FG007|Stage 1|Disease Progression|5
7279396|NCT00467779|11495044|FG008|Stage 1|Disease Progression|0
7279397|NCT00467779|11495045|FG009|Stage 1|Disease Progression|0
7279398|NCT00467779|11495046|FG010|Stage 1|Disease Progression|0
7279399|NCT00467779|11495047|FG011|Stage 1|Disease Progression|0
7279400|NCT00467779|11495048|FG012|Stage 1|Disease Progression|0
7279401|NCT00467779|11495049|FG013|Stage 1|Disease Progression|0
7279402|NCT00467779|11495050|FG014|Stage 1|Disease Progression|0
7279403|NCT00467779|11495036|FG000|Stage 1|Unspecified Reason|1
7279404|NCT00467779|11495037|FG001|Stage 1|Unspecified Reason|0
7279405|NCT00467779|11495038|FG002|Stage 1|Unspecified Reason|1
7279406|NCT00467779|11495039|FG003|Stage 1|Unspecified Reason|0
7279407|NCT00467779|11495040|FG004|Stage 1|Unspecified Reason|1
7279408|NCT00467779|11495041|FG005|Stage 1|Unspecified Reason|2
7279409|NCT00467779|11495042|FG006|Stage 1|Unspecified Reason|0
7279410|NCT00467779|11495043|FG007|Stage 1|Unspecified Reason|0
7279411|NCT00467779|11495044|FG008|Stage 1|Unspecified Reason|0
7279412|NCT00467779|11495045|FG009|Stage 1|Unspecified Reason|0
7279413|NCT00467779|11495046|FG010|Stage 1|Unspecified Reason|0
7279414|NCT00467779|11495047|FG011|Stage 1|Unspecified Reason|0
7279415|NCT00467779|11495048|FG012|Stage 1|Unspecified Reason|0
7279416|NCT00467779|11495049|FG013|Stage 1|Unspecified Reason|0
7279417|NCT00467779|11495050|FG014|Stage 1|Unspecified Reason|0
7279418|NCT00467779|11495036|FG000|Stage 1|Physician Decision|0
7279419|NCT00467779|11495037|FG001|Stage 1|Physician Decision|1
7279420|NCT00467779|11495038|FG002|Stage 1|Physician Decision|0
7616660|NCT01865617|12026732|FG000|Overall Study|Death|27
7616661|NCT01865617|12026733|FG001|Overall Study|Death|3
7616662|NCT01865617|12026734|FG002|Overall Study|Death|1
7616663|NCT01865617|12026735|FG003|Overall Study|Death|1
7616664|NCT01865617|12026736|FG004|Overall Study|Death|5
7616665|NCT01865617|12026737|FG005|Overall Study|Death|1
7616666|NCT01865617|12026738|FG006|Overall Study|Death|11
7616667|NCT01865617|12026739|FG007|Overall Study|Death|1
7616668|NCT01865617|12026740|FG008|Overall Study|Death|11
7616669|NCT01865617|12026741|FG009|Overall Study|Death|3
7616670|NCT01865617|12026742|FG010|Overall Study|Death|32
7616671|NCT01865617|12026743|FG011|Overall Study|Death|6
7616672|NCT01865617|12026744|FG012|Overall Study|Death|13
7616673|NCT01865617|12026732|FG000|Overall Study|Lost to Follow-up|2
7616674|NCT01865617|12026733|FG001|Overall Study|Lost to Follow-up|0
7616675|NCT01865617|12026734|FG002|Overall Study|Lost to Follow-up|0
7616676|NCT01865617|12026735|FG003|Overall Study|Lost to Follow-up|0
7616677|NCT01865617|12026736|FG004|Overall Study|Lost to Follow-up|0
7616678|NCT01865617|12026737|FG005|Overall Study|Lost to Follow-up|0
7616679|NCT01865617|12026738|FG006|Overall Study|Lost to Follow-up|0
7279421|NCT00467779|11495039|FG003|Stage 1|Physician Decision|0
7279422|NCT00467779|11495040|FG004|Stage 1|Physician Decision|0
7616680|NCT01865617|12026739|FG007|Overall Study|Lost to Follow-up|0
7616681|NCT01865617|12026740|FG008|Overall Study|Lost to Follow-up|0
7616682|NCT01865617|12026741|FG009|Overall Study|Lost to Follow-up|0
7616683|NCT01865617|12026742|FG010|Overall Study|Lost to Follow-up|0
7616684|NCT01865617|12026743|FG011|Overall Study|Lost to Follow-up|0
7616685|NCT01865617|12026744|FG012|Overall Study|Lost to Follow-up|0
7616686|NCT01865617|12026732|FG000|Overall Study|Withdrawal by Subject|1
7616687|NCT01865617|12026733|FG001|Overall Study|Withdrawal by Subject|0
7616688|NCT01865617|12026734|FG002|Overall Study|Withdrawal by Subject|0
7616689|NCT01865617|12026735|FG003|Overall Study|Withdrawal by Subject|0
7616690|NCT01865617|12026736|FG004|Overall Study|Withdrawal by Subject|0
7616691|NCT01865617|12026737|FG005|Overall Study|Withdrawal by Subject|0
7616692|NCT01865617|12026738|FG006|Overall Study|Withdrawal by Subject|0
7616693|NCT01865617|12026739|FG007|Overall Study|Withdrawal by Subject|0
7616694|NCT01865617|12026740|FG008|Overall Study|Withdrawal by Subject|0
7616695|NCT01865617|12026741|FG009|Overall Study|Withdrawal by Subject|0
7616696|NCT01865617|12026742|FG010|Overall Study|Withdrawal by Subject|0
7616697|NCT01865617|12026743|FG011|Overall Study|Withdrawal by Subject|0
7616698|NCT01865617|12026744|FG012|Overall Study|Withdrawal by Subject|0
7616699|NCT01865617|12026732|FG000|Overall Study|Patient proceeded to new therapy|0
7616700|NCT01865617|12026733|FG001|Overall Study|Patient proceeded to new therapy|0
7616701|NCT01865617|12026734|FG002|Overall Study|Patient proceeded to new therapy|0
7616702|NCT01865617|12026735|FG003|Overall Study|Patient proceeded to new therapy|0
7616703|NCT01865617|12026736|FG004|Overall Study|Patient proceeded to new therapy|2
7616704|NCT01865617|12026737|FG005|Overall Study|Patient proceeded to new therapy|0
7616705|NCT01865617|12026738|FG006|Overall Study|Patient proceeded to new therapy|0
7616706|NCT01865617|12026739|FG007|Overall Study|Patient proceeded to new therapy|0
7616707|NCT01865617|12026740|FG008|Overall Study|Patient proceeded to new therapy|0
7616708|NCT01865617|12026741|FG009|Overall Study|Patient proceeded to new therapy|0
7616709|NCT01865617|12026742|FG010|Overall Study|Patient proceeded to new therapy|0
7616710|NCT01865617|12026743|FG011|Overall Study|Patient proceeded to new therapy|0
7616711|NCT01865617|12026744|FG012|Overall Study|Patient proceeded to new therapy|0
7616712|NCT01865617|12026732|FG000|Overall Study|Other|0
7616713|NCT01865617|12026733|FG001|Overall Study|Other|0
7616714|NCT01865617|12026734|FG002|Overall Study|Other|0
7616715|NCT01865617|12026735|FG003|Overall Study|Other|0
7616716|NCT01865617|12026736|FG004|Overall Study|Other|0
7616717|NCT01865617|12026737|FG005|Overall Study|Other|0
7616718|NCT01865617|12026738|FG006|Overall Study|Other|1
7616719|NCT01865617|12026739|FG007|Overall Study|Other|0
7616720|NCT01865617|12026740|FG008|Overall Study|Other|0
7616721|NCT01865617|12026741|FG009|Overall Study|Other|0
7616722|NCT01865617|12026742|FG010|Overall Study|Other|0
7616723|NCT01865617|12026743|FG011|Overall Study|Other|0
7616724|NCT01865617|12026744|FG012|Overall Study|Other|0
7616725|NCT01828112|12026777|FG000|Overall Study|Adverse Event|6
7616726|NCT01828112|12026778|FG001|Overall Study|Adverse Event|8
7279423|NCT00467779|11495041|FG005|Stage 1|Physician Decision|0
7616727|NCT01828112|12026777|FG000|Overall Study|Death|9
7616728|NCT01828112|12026778|FG001|Overall Study|Death|5
7616729|NCT01828112|12026777|FG000|Overall Study|Physician Decision|5
7616730|NCT01828112|12026778|FG001|Overall Study|Physician Decision|5
7616731|NCT01828112|12026777|FG000|Overall Study|Progressive disease|56
7616732|NCT01828112|12026778|FG001|Overall Study|Progressive disease|82
7616733|NCT01828112|12026777|FG000|Overall Study|Subject/guardian decision|6
7616734|NCT01828112|12026778|FG001|Overall Study|Subject/guardian decision|8
7616735|NCT01670500|12026812|FG000|Overall Study|Withdrawal by Subject|1
7616736|NCT01670500|12026813|FG001|Overall Study|Withdrawal by Subject|0
7279424|NCT00467779|11495042|FG006|Stage 1|Physician Decision|0
7279425|NCT00467779|11495043|FG007|Stage 1|Physician Decision|0
7279426|NCT00467779|11495044|FG008|Stage 1|Physician Decision|0
7279427|NCT00467779|11495045|FG009|Stage 1|Physician Decision|0
7279428|NCT00467779|11495046|FG010|Stage 1|Physician Decision|0
7279429|NCT00467779|11495047|FG011|Stage 1|Physician Decision|0
7279430|NCT00467779|11495048|FG012|Stage 1|Physician Decision|0
7279431|NCT00467779|11495049|FG013|Stage 1|Physician Decision|0
7279432|NCT00467779|11495050|FG014|Stage 1|Physician Decision|0
7279433|NCT00467779|11495036|FG000|Stage 1|Withdrawal by Subject|0
7279434|NCT00467779|11495037|FG001|Stage 1|Withdrawal by Subject|0
7279435|NCT00467779|11495038|FG002|Stage 1|Withdrawal by Subject|0
7279436|NCT00467779|11495039|FG003|Stage 1|Withdrawal by Subject|0
7279437|NCT00467779|11495040|FG004|Stage 1|Withdrawal by Subject|0
7279438|NCT00467779|11495041|FG005|Stage 1|Withdrawal by Subject|0
7279439|NCT00467779|11495042|FG006|Stage 1|Withdrawal by Subject|1
7279440|NCT00467779|11495043|FG007|Stage 1|Withdrawal by Subject|1
7279441|NCT00467779|11495044|FG008|Stage 1|Withdrawal by Subject|0
7279442|NCT00467779|11495045|FG009|Stage 1|Withdrawal by Subject|0
7279443|NCT00467779|11495046|FG010|Stage 1|Withdrawal by Subject|0
7279444|NCT00467779|11495047|FG011|Stage 1|Withdrawal by Subject|0
7279445|NCT00467779|11495048|FG012|Stage 1|Withdrawal by Subject|0
7279446|NCT00467779|11495049|FG013|Stage 1|Withdrawal by Subject|0
7279447|NCT00467779|11495050|FG014|Stage 1|Withdrawal by Subject|0
7279448|NCT00467779|11495036|FG000|Stage 1A|Adverse Event|0
7279449|NCT00467779|11495037|FG001|Stage 1A|Adverse Event|0
7279450|NCT00467779|11495038|FG002|Stage 1A|Adverse Event|0
7279451|NCT00467779|11495039|FG003|Stage 1A|Adverse Event|0
7279452|NCT00467779|11495040|FG004|Stage 1A|Adverse Event|0
7279453|NCT00467779|11495041|FG005|Stage 1A|Adverse Event|0
7279454|NCT00467779|11495042|FG006|Stage 1A|Adverse Event|0
7279455|NCT00467779|11495043|FG007|Stage 1A|Adverse Event|0
7279456|NCT00467779|11495044|FG008|Stage 1A|Adverse Event|0
7279457|NCT00467779|11495045|FG009|Stage 1A|Adverse Event|0
7279458|NCT00467779|11495046|FG010|Stage 1A|Adverse Event|0
7279459|NCT00467779|11495047|FG011|Stage 1A|Adverse Event|0
7279460|NCT00467779|11495048|FG012|Stage 1A|Adverse Event|1
7279461|NCT00467779|11495049|FG013|Stage 1A|Adverse Event|0
7279462|NCT00467779|11495050|FG014|Stage 1A|Adverse Event|0
7279463|NCT00467779|11495036|FG000|Stage 1A|Death|0
7279464|NCT00467779|11495037|FG001|Stage 1A|Death|0
7279465|NCT00467779|11495038|FG002|Stage 1A|Death|0
7279466|NCT00467779|11495039|FG003|Stage 1A|Death|0
7279467|NCT00467779|11495040|FG004|Stage 1A|Death|0
7279468|NCT00467779|11495041|FG005|Stage 1A|Death|0
7279469|NCT00467779|11495042|FG006|Stage 1A|Death|0
7279470|NCT00467779|11495043|FG007|Stage 1A|Death|0
7279471|NCT00467779|11495044|FG008|Stage 1A|Death|0
7279472|NCT00467779|11495045|FG009|Stage 1A|Death|0
7279473|NCT00467779|11495046|FG010|Stage 1A|Death|0
7279474|NCT00467779|11495047|FG011|Stage 1A|Death|1
7279475|NCT00467779|11495048|FG012|Stage 1A|Death|1
7279476|NCT00467779|11495049|FG013|Stage 1A|Death|0
7279477|NCT00467779|11495050|FG014|Stage 1A|Death|0
7279478|NCT00467779|11495036|FG000|Stage 1A|Disease Progression|0
7279479|NCT00467779|11495037|FG001|Stage 1A|Disease Progression|0
7279480|NCT00467779|11495038|FG002|Stage 1A|Disease Progression|0
7279481|NCT00467779|11495039|FG003|Stage 1A|Disease Progression|0
7279482|NCT00467779|11495040|FG004|Stage 1A|Disease Progression|0
7279483|NCT00467779|11495041|FG005|Stage 1A|Disease Progression|0
7279484|NCT00467779|11495042|FG006|Stage 1A|Disease Progression|0
7616787|NCT04604184|12026835|FG000|Overall Study|Adverse Event|5
7616788|NCT04604184|12026836|FG001|Overall Study|Adverse Event|5
7616789|NCT04604184|12026835|FG000|Overall Study|Death|2
7616790|NCT04604184|12026836|FG001|Overall Study|Death|1
7616791|NCT04604184|12026835|FG000|Overall Study|Withdrawal by Subject|1
7616792|NCT04604184|12026836|FG001|Overall Study|Withdrawal by Subject|3
7616793|NCT04604184|12026835|FG000|Overall Study|Not treated|2
7616794|NCT04604184|12026836|FG001|Overall Study|Not treated|2
7616795|NCT04604184|12026835|FG000|Overall Study|Due to sponsor decision|9
7616796|NCT04604184|12026836|FG001|Overall Study|Due to sponsor decision|7
7616797|NCT04604184|12026835|FG000|Overall Study|Physician Decision|0
7616798|NCT04604184|12026836|FG001|Overall Study|Physician Decision|1
7616799|NCT04604184|12026835|FG000|Overall Study|Transfer to healthcare|1
7616800|NCT04604184|12026836|FG001|Overall Study|Transfer to healthcare|0
7616805|NCT03688555|12026865|FG000|Treatment Period|Adverse Event|0
7616806|NCT03688555|12026866|FG001|Treatment Period|Adverse Event|0
7616807|NCT03688555|12026867|FG002|Treatment Period|Adverse Event|1
7616808|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39
7616809|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616810|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616811|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0
7616812|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14
7616813|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7616814|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7279485|NCT00467779|11495043|FG007|Stage 1A|Disease Progression|0
7279486|NCT00467779|11495044|FG008|Stage 1A|Disease Progression|0
7279487|NCT00467779|11495045|FG009|Stage 1A|Disease Progression|2
7279488|NCT00467779|11495046|FG010|Stage 1A|Disease Progression|2
7616801|NCT04368429|12026844|FG000|Overall Study|Adverse Event|1
7616802|NCT04368429|12026845|FG001|Overall Study|Adverse Event|0
7616803|NCT03865316|12026859|FG000|Overall Study|Procedure Cancelled|4
7616804|NCT03865316|12026859|FG000|Overall Study|Equipment failure|4
7616815|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
7616816|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85
7616817|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616818|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616819|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
7616820|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51
7616821|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616822|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616823|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
7616824|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Death|1
7616825|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Death|0
7616826|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Death|0
7616827|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Death|0
7616828|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5
7616829|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616830|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616831|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
7616832|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23
7616833|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616834|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616835|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
7616836|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90
7616837|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616838|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616839|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
7616840|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13
7616841|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7279489|NCT00467779|11495047|FG011|Stage 1A|Disease Progression|5
7279490|NCT00467779|11495048|FG012|Stage 1A|Disease Progression|2
7279491|NCT00467779|11495049|FG013|Stage 1A|Disease Progression|0
7279492|NCT00467779|11495050|FG014|Stage 1A|Disease Progression|0
7279493|NCT00467779|11495036|FG000|Stage 1A|Physician Decision|0
7279494|NCT00467779|11495037|FG001|Stage 1A|Physician Decision|0
7279495|NCT00467779|11495038|FG002|Stage 1A|Physician Decision|0
7279496|NCT00467779|11495039|FG003|Stage 1A|Physician Decision|0
7279497|NCT00467779|11495040|FG004|Stage 1A|Physician Decision|0
7279498|NCT00467779|11495041|FG005|Stage 1A|Physician Decision|0
7279499|NCT00467779|11495042|FG006|Stage 1A|Physician Decision|0
7279500|NCT00467779|11495043|FG007|Stage 1A|Physician Decision|0
7279501|NCT00467779|11495044|FG008|Stage 1A|Physician Decision|0
7279502|NCT00467779|11495045|FG009|Stage 1A|Physician Decision|1
7279503|NCT00467779|11495046|FG010|Stage 1A|Physician Decision|0
7279504|NCT00467779|11495047|FG011|Stage 1A|Physician Decision|0
7279505|NCT00467779|11495048|FG012|Stage 1A|Physician Decision|0
7279506|NCT00467779|11495049|FG013|Stage 1A|Physician Decision|0
7279507|NCT00467779|11495050|FG014|Stage 1A|Physician Decision|0
7279508|NCT00467779|11495036|FG000|Stage 1A|Withdrawal by Subject|0
7279509|NCT00467779|11495037|FG001|Stage 1A|Withdrawal by Subject|0
7279510|NCT00467779|11495038|FG002|Stage 1A|Withdrawal by Subject|0
7279511|NCT00467779|11495039|FG003|Stage 1A|Withdrawal by Subject|0
7279512|NCT00467779|11495040|FG004|Stage 1A|Withdrawal by Subject|0
7279513|NCT00467779|11495041|FG005|Stage 1A|Withdrawal by Subject|0
7279514|NCT00467779|11495042|FG006|Stage 1A|Withdrawal by Subject|0
7279515|NCT00467779|11495043|FG007|Stage 1A|Withdrawal by Subject|0
7279516|NCT00467779|11495044|FG008|Stage 1A|Withdrawal by Subject|0
7279517|NCT00467779|11495045|FG009|Stage 1A|Withdrawal by Subject|0
7279518|NCT00467779|11495046|FG010|Stage 1A|Withdrawal by Subject|1
7279519|NCT00467779|11495047|FG011|Stage 1A|Withdrawal by Subject|1
7279520|NCT00467779|11495048|FG012|Stage 1A|Withdrawal by Subject|1
7279521|NCT00467779|11495049|FG013|Stage 1A|Withdrawal by Subject|0
7279522|NCT00467779|11495050|FG014|Stage 1A|Withdrawal by Subject|0
7279523|NCT00467779|11495036|FG000|Stage 1A|Unspecified Reason|0
7279524|NCT00467779|11495037|FG001|Stage 1A|Unspecified Reason|0
7279525|NCT00467779|11495038|FG002|Stage 1A|Unspecified Reason|0
7616842|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7616843|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
7616844|NCT03593213|12026877|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104
7616845|NCT03593213|12026878|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616846|NCT03593213|12026879|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616847|NCT03593213|12026880|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
7616848|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0
7616849|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15
7616850|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9
7616851|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8
7616852|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
7616853|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2
7616854|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
7616855|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4
7616856|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0
7616857|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4
7616858|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2
7616859|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3
7616860|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0
7616861|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5
7616862|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4
7616863|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1
7616864|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616865|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616866|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
7616867|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1
7616868|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0
7616869|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3
7616870|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2
7616871|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5
7616872|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
7616873|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1
7616874|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2
7616875|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
7616876|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0
7616877|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9
7616878|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11
7616879|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13
7616880|NCT03593213|12026877|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
7616881|NCT03593213|12026878|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1
7616882|NCT03593213|12026879|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3
7616883|NCT03593213|12026880|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
7616884|NCT03248531|12026929|FG000|Overall Study|Adverse Event|0
7616885|NCT03248531|12026930|FG001|Overall Study|Adverse Event|0
7616886|NCT03248531|12026931|FG002|Overall Study|Adverse Event|1
7616887|NCT03248531|12026929|FG000|Overall Study|Lost to Follow-up|1
7616888|NCT03248531|12026930|FG001|Overall Study|Lost to Follow-up|0
7616889|NCT03248531|12026931|FG002|Overall Study|Lost to Follow-up|5
7616890|NCT03248531|12026929|FG000|Overall Study|Withdrawal by Subject|3
7616891|NCT03248531|12026930|FG001|Overall Study|Withdrawal by Subject|3
7616892|NCT03248531|12026931|FG002|Overall Study|Withdrawal by Subject|2
7616893|NCT03248531|12026929|FG000|Overall Study|Sponsor Request|0
7616894|NCT03248531|12026930|FG001|Overall Study|Sponsor Request|2
7616895|NCT03248531|12026931|FG002|Overall Study|Sponsor Request|0
7616896|NCT03205605|12026946|FG000|Overall Study|Withdrawal by Subject|1
7616897|NCT02484456|12026962|FG000|Washout Period|Withdrawal by Subject|0
7616898|NCT02484456|12026963|FG001|Washout Period|Withdrawal by Subject|1
7616899|NCT02484456|12026962|FG000|Second Treatment Period: Week 1|Adverse Event|1
7616900|NCT02484456|12026963|FG001|Second Treatment Period: Week 1|Adverse Event|0
7616901|NCT02484456|12026962|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0
7616902|NCT02484456|12026963|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1
7616903|NCT02484456|12026962|FG000|Second Treatment Period: Week 2|Adverse Event|0
7616904|NCT02484456|12026963|FG001|Second Treatment Period: Week 2|Adverse Event|1
7616905|NCT02481830|12026972|FG000|Overall Study|No longer meets Study Criteria|1
7616906|NCT02481830|12026973|FG001|Overall Study|No longer meets Study Criteria|4
7616907|NCT02481830|12026972|FG000|Overall Study|Withdrawal by Subject|0
7616908|NCT02481830|12026973|FG001|Overall Study|Withdrawal by Subject|14
7616909|NCT02481830|12026972|FG000|Overall Study|Disease Progression|1
7279526|NCT00467779|11495039|FG003|Stage 1A|Unspecified Reason|0
7616910|NCT02481830|12026973|FG001|Overall Study|Disease Progression|1
7616911|NCT02481830|12026972|FG000|Overall Study|Participant not eligible for trial|0
7616912|NCT02481830|12026973|FG001|Overall Study|Participant not eligible for trial|1
7279527|NCT00467779|11495040|FG004|Stage 1A|Unspecified Reason|0
7616913|NCT02234323|12026979|FG000|All Enrolled|Not Treated: Completed study in database|2
7616914|NCT02234323|12026979|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
7616915|NCT02234323|12026979|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
7279528|NCT00467779|11495041|FG005|Stage 1A|Unspecified Reason|0
7279529|NCT00467779|11495042|FG006|Stage 1A|Unspecified Reason|0
7279530|NCT00467779|11495043|FG007|Stage 1A|Unspecified Reason|0
7279531|NCT00467779|11495044|FG008|Stage 1A|Unspecified Reason|0
7279532|NCT00467779|11495045|FG009|Stage 1A|Unspecified Reason|0
7279533|NCT00467779|11495046|FG010|Stage 1A|Unspecified Reason|0
7279534|NCT00467779|11495047|FG011|Stage 1A|Unspecified Reason|1
7279535|NCT00467779|11495048|FG012|Stage 1A|Unspecified Reason|1
7279536|NCT00467779|11495049|FG013|Stage 1A|Unspecified Reason|0
7279537|NCT00467779|11495050|FG014|Stage 1A|Unspecified Reason|0
7279538|NCT00467779|11495036|FG000|Stage 2|Adverse Event|0
7279539|NCT00467779|11495037|FG001|Stage 2|Adverse Event|0
7279540|NCT00467779|11495038|FG002|Stage 2|Adverse Event|0
7279541|NCT00467779|11495039|FG003|Stage 2|Adverse Event|0
7616916|NCT02234323|12026979|FG000|All Treated|Death|1
7616917|NCT02234323|12026979|FG000|All Treated|Physician Decision|5
7616918|NCT02234323|12026979|FG000|All Treated|Lack of Efficacy|3
7616919|NCT02234323|12026979|FG000|All Treated|Exceeded lab value limit|2
7616920|NCT02234323|12026979|FG000|All Treated|Other|7
7616921|NCT02220855|12026985|FG000|Overall Study|Adverse Event|8
7616922|NCT02220855|12026985|FG000|Overall Study|Disease Progression|5
7616923|NCT02220855|12026985|FG000|Overall Study|Withdrawal by Subject|1
7616924|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1
7616925|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616926|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616927|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616928|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616929|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616930|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
7616931|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2
7616932|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616933|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616934|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616935|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616936|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616937|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
7616938|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616939|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5
7616940|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616941|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616942|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616943|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616944|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
7616945|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616946|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616947|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1
7616948|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616949|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616950|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616951|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
7616952|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616953|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616954|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6
7616955|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616956|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616957|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7279542|NCT00467779|11495040|FG004|Stage 2|Adverse Event|0
7279543|NCT00467779|11495041|FG005|Stage 2|Adverse Event|0
7279544|NCT00467779|11495042|FG006|Stage 2|Adverse Event|0
7279545|NCT00467779|11495043|FG007|Stage 2|Adverse Event|0
7279546|NCT00467779|11495044|FG008|Stage 2|Adverse Event|1
7279547|NCT00467779|11495045|FG009|Stage 2|Adverse Event|0
7279548|NCT00467779|11495046|FG010|Stage 2|Adverse Event|0
7279549|NCT00467779|11495047|FG011|Stage 2|Adverse Event|0
7279550|NCT00467779|11495048|FG012|Stage 2|Adverse Event|0
7279551|NCT00467779|11495049|FG013|Stage 2|Adverse Event|0
7279552|NCT00467779|11495050|FG014|Stage 2|Adverse Event|0
7279553|NCT00467779|11495036|FG000|Stage 2|Death|0
7279554|NCT00467779|11495037|FG001|Stage 2|Death|0
7279555|NCT00467779|11495038|FG002|Stage 2|Death|0
7279556|NCT00467779|11495039|FG003|Stage 2|Death|0
7279557|NCT00467779|11495040|FG004|Stage 2|Death|0
7279558|NCT00467779|11495041|FG005|Stage 2|Death|0
7279559|NCT00467779|11495042|FG006|Stage 2|Death|0
7279560|NCT00467779|11495043|FG007|Stage 2|Death|0
7279561|NCT00467779|11495044|FG008|Stage 2|Death|1
7279562|NCT00467779|11495045|FG009|Stage 2|Death|0
7279563|NCT00467779|11495046|FG010|Stage 2|Death|0
7279564|NCT00467779|11495047|FG011|Stage 2|Death|0
7279565|NCT00467779|11495048|FG012|Stage 2|Death|0
7279566|NCT00467779|11495049|FG013|Stage 2|Death|0
7279567|NCT00467779|11495050|FG014|Stage 2|Death|0
7279568|NCT00467779|11495036|FG000|Stage 2|Disease Progression|0
7279569|NCT00467779|11495037|FG001|Stage 2|Disease Progression|0
7279570|NCT00467779|11495038|FG002|Stage 2|Disease Progression|0
7279571|NCT00467779|11495039|FG003|Stage 2|Disease Progression|0
7279572|NCT00467779|11495040|FG004|Stage 2|Disease Progression|0
7279573|NCT00467779|11495041|FG005|Stage 2|Disease Progression|0
7279574|NCT00467779|11495042|FG006|Stage 2|Disease Progression|0
7279575|NCT00467779|11495043|FG007|Stage 2|Disease Progression|0
7279576|NCT00467779|11495044|FG008|Stage 2|Disease Progression|16
7279577|NCT00467779|11495045|FG009|Stage 2|Disease Progression|0
7279578|NCT00467779|11495046|FG010|Stage 2|Disease Progression|0
7279579|NCT00467779|11495047|FG011|Stage 2|Disease Progression|0
7279580|NCT00467779|11495048|FG012|Stage 2|Disease Progression|0
7279581|NCT00467779|11495049|FG013|Stage 2|Disease Progression|0
7279582|NCT00467779|11495050|FG014|Stage 2|Disease Progression|0
7279583|NCT00467779|11495036|FG000|Stage 2|Unspecified Reason|0
7279584|NCT00467779|11495037|FG001|Stage 2|Unspecified Reason|0
7279585|NCT00467779|11495038|FG002|Stage 2|Unspecified Reason|0
7279586|NCT00467779|11495039|FG003|Stage 2|Unspecified Reason|0
7279587|NCT00467779|11495040|FG004|Stage 2|Unspecified Reason|0
7279588|NCT00467779|11495041|FG005|Stage 2|Unspecified Reason|0
7279589|NCT00467779|11495042|FG006|Stage 2|Unspecified Reason|0
7279590|NCT00467779|11495043|FG007|Stage 2|Unspecified Reason|0
7279591|NCT00467779|11495044|FG008|Stage 2|Unspecified Reason|3
7279592|NCT00467779|11495045|FG009|Stage 2|Unspecified Reason|0
7279593|NCT00467779|11495046|FG010|Stage 2|Unspecified Reason|0
7616958|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
7616959|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616960|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616961|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1
7616962|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616963|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616964|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616965|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
7616966|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616967|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616968|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616969|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2
7616970|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616971|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616972|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
7616973|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616974|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616975|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616976|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2
7616977|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616978|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616979|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
7616980|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616981|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7279594|NCT00467779|11495047|FG011|Stage 2|Unspecified Reason|0
7279595|NCT00467779|11495048|FG012|Stage 2|Unspecified Reason|0
7279596|NCT00467779|11495049|FG013|Stage 2|Unspecified Reason|0
7279597|NCT00467779|11495050|FG014|Stage 2|Unspecified Reason|0
7279598|NCT00467779|11495036|FG000|Stage 2A|Adverse Event|0
7279599|NCT00467779|11495037|FG001|Stage 2A|Adverse Event|0
7279600|NCT00467779|11495038|FG002|Stage 2A|Adverse Event|0
7279601|NCT00467779|11495039|FG003|Stage 2A|Adverse Event|0
7279602|NCT00467779|11495040|FG004|Stage 2A|Adverse Event|0
7279603|NCT00467779|11495041|FG005|Stage 2A|Adverse Event|0
7616982|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616983|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616984|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4
7616985|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616986|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
7616987|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616988|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616989|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616990|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616991|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5
7616992|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616993|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
7616994|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616995|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616996|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616997|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7616998|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1
7616999|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7617000|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
7279604|NCT00467779|11495042|FG006|Stage 2A|Adverse Event|0
7279605|NCT00467779|11495043|FG007|Stage 2A|Adverse Event|0
7279606|NCT00467779|11495044|FG008|Stage 2A|Adverse Event|0
7279607|NCT00467779|11495045|FG009|Stage 2A|Adverse Event|0
7279608|NCT00467779|11495046|FG010|Stage 2A|Adverse Event|0
7279609|NCT00467779|11495047|FG011|Stage 2A|Adverse Event|0
7279610|NCT00467779|11495048|FG012|Stage 2A|Adverse Event|0
7279611|NCT00467779|11495049|FG013|Stage 2A|Adverse Event|2
7279612|NCT00467779|11495050|FG014|Stage 2A|Adverse Event|0
7279613|NCT00467779|11495036|FG000|Stage 2A|Death|0
7279614|NCT00467779|11495037|FG001|Stage 2A|Death|0
7279615|NCT00467779|11495038|FG002|Stage 2A|Death|0
7279616|NCT00467779|11495039|FG003|Stage 2A|Death|0
7279617|NCT00467779|11495040|FG004|Stage 2A|Death|0
7279618|NCT00467779|11495041|FG005|Stage 2A|Death|0
7279619|NCT00467779|11495042|FG006|Stage 2A|Death|0
7279620|NCT00467779|11495043|FG007|Stage 2A|Death|0
7279621|NCT00467779|11495044|FG008|Stage 2A|Death|0
7279622|NCT00467779|11495045|FG009|Stage 2A|Death|0
7279623|NCT00467779|11495046|FG010|Stage 2A|Death|0
7279624|NCT00467779|11495047|FG011|Stage 2A|Death|0
7279625|NCT00467779|11495048|FG012|Stage 2A|Death|0
7279626|NCT00467779|11495049|FG013|Stage 2A|Death|1
7279627|NCT00467779|11495050|FG014|Stage 2A|Death|0
7279628|NCT00467779|11495036|FG000|Stage 2A|Disease Progression|0
7279629|NCT00467779|11495037|FG001|Stage 2A|Disease Progression|0
7279630|NCT00467779|11495038|FG002|Stage 2A|Disease Progression|0
7279631|NCT00467779|11495039|FG003|Stage 2A|Disease Progression|0
7617001|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617002|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617003|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617004|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617005|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1
7617006|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617007|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
7617008|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617009|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617010|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617011|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617012|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617013|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5
7617014|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
7617015|NCT01791595|12026996|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617016|NCT01791595|12026997|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617017|NCT01791595|12026998|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617018|NCT01791595|12026999|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617019|NCT01791595|12027000|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617020|NCT01791595|12027001|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3
7617021|NCT01791595|12027002|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
7617022|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617023|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617024|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617025|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617026|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617027|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
7617028|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1
7617029|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617030|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617031|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617032|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617033|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617034|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
7617035|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6
7617036|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617037|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617038|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617039|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617040|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617041|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
7617042|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2
7617043|NCT01791595|12026996|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617044|NCT01791595|12026997|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617045|NCT01791595|12026998|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617046|NCT01791595|12026999|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617047|NCT01791595|12027000|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617048|NCT01791595|12027001|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
7617049|NCT01791595|12027002|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1
7617050|NCT01192776|12027026|FG000|Overall Study|Death|8
7617051|NCT01192776|12027027|FG001|Overall Study|Death|15
7617052|NCT01192776|12027028|FG002|Overall Study|Death|18
7617053|NCT01192776|12027029|FG003|Overall Study|Death|15
7617054|NCT01192776|12027026|FG000|Overall Study|Lost to Follow-up|3
7617055|NCT01192776|12027027|FG001|Overall Study|Lost to Follow-up|6
7617056|NCT01192776|12027028|FG002|Overall Study|Lost to Follow-up|3
7617057|NCT01192776|12027029|FG003|Overall Study|Lost to Follow-up|5
7279632|NCT00467779|11495040|FG004|Stage 2A|Disease Progression|0
7279633|NCT00467779|11495041|FG005|Stage 2A|Disease Progression|0
7279634|NCT00467779|11495042|FG006|Stage 2A|Disease Progression|0
7279635|NCT00467779|11495043|FG007|Stage 2A|Disease Progression|0
7279636|NCT00467779|11495044|FG008|Stage 2A|Disease Progression|0
7279637|NCT00467779|11495045|FG009|Stage 2A|Disease Progression|0
7279638|NCT00467779|11495046|FG010|Stage 2A|Disease Progression|0
7279639|NCT00467779|11495047|FG011|Stage 2A|Disease Progression|0
7279640|NCT00467779|11495048|FG012|Stage 2A|Disease Progression|0
7279641|NCT00467779|11495049|FG013|Stage 2A|Disease Progression|10
7279642|NCT00467779|11495050|FG014|Stage 2A|Disease Progression|0
7279643|NCT00467779|11495036|FG000|Stage 2A|Unspecified Reason|0
7279644|NCT00467779|11495037|FG001|Stage 2A|Unspecified Reason|0
7279645|NCT00467779|11495038|FG002|Stage 2A|Unspecified Reason|0
7279646|NCT00467779|11495039|FG003|Stage 2A|Unspecified Reason|0
7279647|NCT00467779|11495040|FG004|Stage 2A|Unspecified Reason|0
7279648|NCT00467779|11495041|FG005|Stage 2A|Unspecified Reason|0
7279649|NCT00467779|11495042|FG006|Stage 2A|Unspecified Reason|0
7279650|NCT00467779|11495043|FG007|Stage 2A|Unspecified Reason|0
7279651|NCT00467779|11495044|FG008|Stage 2A|Unspecified Reason|0
7279652|NCT00467779|11495045|FG009|Stage 2A|Unspecified Reason|0
7279653|NCT00467779|11495046|FG010|Stage 2A|Unspecified Reason|0
7279654|NCT00467779|11495047|FG011|Stage 2A|Unspecified Reason|0
7279655|NCT00467779|11495048|FG012|Stage 2A|Unspecified Reason|0
7279656|NCT00467779|11495049|FG013|Stage 2A|Unspecified Reason|7
7279657|NCT00467779|11495050|FG014|Stage 2A|Unspecified Reason|0
7279658|NCT00467779|11495036|FG000|Stage 2A|Withdrawal by Subject|0
7279659|NCT00467779|11495037|FG001|Stage 2A|Withdrawal by Subject|0
7279660|NCT00467779|11495038|FG002|Stage 2A|Withdrawal by Subject|0
7279661|NCT00467779|11495039|FG003|Stage 2A|Withdrawal by Subject|0
7279662|NCT00467779|11495040|FG004|Stage 2A|Withdrawal by Subject|0
7279663|NCT00467779|11495041|FG005|Stage 2A|Withdrawal by Subject|0
7279664|NCT00467779|11495042|FG006|Stage 2A|Withdrawal by Subject|0
7279665|NCT00467779|11495043|FG007|Stage 2A|Withdrawal by Subject|0
7279666|NCT00467779|11495044|FG008|Stage 2A|Withdrawal by Subject|0
7279667|NCT00467779|11495045|FG009|Stage 2A|Withdrawal by Subject|0
7279668|NCT00467779|11495046|FG010|Stage 2A|Withdrawal by Subject|0
7279669|NCT00467779|11495047|FG011|Stage 2A|Withdrawal by Subject|0
7279670|NCT00467779|11495048|FG012|Stage 2A|Withdrawal by Subject|0
7279671|NCT00467779|11495049|FG013|Stage 2A|Withdrawal by Subject|1
7279672|NCT00467779|11495050|FG014|Stage 2A|Withdrawal by Subject|0
7279673|NCT00467779|11495036|FG000|Stage 3|Adverse Event|0
7279674|NCT00467779|11495037|FG001|Stage 3|Adverse Event|0
7279675|NCT00467779|11495038|FG002|Stage 3|Adverse Event|0
7279676|NCT00467779|11495039|FG003|Stage 3|Adverse Event|0
7279677|NCT00467779|11495040|FG004|Stage 3|Adverse Event|0
7279678|NCT00467779|11495041|FG005|Stage 3|Adverse Event|0
7279679|NCT00467779|11495042|FG006|Stage 3|Adverse Event|0
7617080|NCT03392883|12027075|FG000|Overall Study|Lost to Follow-up|122
7617081|NCT03392883|12027076|FG001|Overall Study|Lost to Follow-up|13
7617082|NCT03392883|12027077|FG002|Overall Study|Lost to Follow-up|9
7617083|NCT03392883|12027075|FG000|Overall Study|Death|4
7617084|NCT03392883|12027076|FG001|Overall Study|Death|0
7617085|NCT03392883|12027077|FG002|Overall Study|Death|0
7617086|NCT03392883|12027075|FG000|Overall Study|Lack of Efficacy|29
7617087|NCT03392883|12027076|FG001|Overall Study|Lack of Efficacy|0
7617088|NCT03392883|12027077|FG002|Overall Study|Lack of Efficacy|0
7617089|NCT03392883|12027075|FG000|Overall Study|Withdrawal by Subject|180
7617090|NCT03392883|12027076|FG001|Overall Study|Withdrawal by Subject|0
7617091|NCT03392883|12027077|FG002|Overall Study|Withdrawal by Subject|0
7617092|NCT03392883|12027075|FG000|Overall Study|Adverse Event|1
7617093|NCT03392883|12027076|FG001|Overall Study|Adverse Event|0
7617094|NCT03392883|12027077|FG002|Overall Study|Adverse Event|0
7617095|NCT03376789|12027085|FG000|Overall Study|Withdrawal by Subject|3
7617096|NCT03376789|12027086|FG001|Overall Study|Withdrawal by Subject|5
7617097|NCT03376789|12027085|FG000|Overall Study|Protocol Violation|0
7617098|NCT03376789|12027086|FG001|Overall Study|Protocol Violation|1
7617099|NCT03376789|12027085|FG000|Overall Study|Adverse Event|0
7617100|NCT03376789|12027086|FG001|Overall Study|Adverse Event|1
7617101|NCT03376789|12027085|FG000|Overall Study|Lost to Follow-up|1
7617102|NCT03376789|12027086|FG001|Overall Study|Lost to Follow-up|1
7617103|NCT03376789|12027085|FG000|Overall Study|Per sponsor due to noncompliance|1
7617104|NCT03376789|12027086|FG001|Overall Study|Per sponsor due to noncompliance|0
7617105|NCT03376789|12027085|FG000|Overall Study|Subject off study medication|0
7617106|NCT03376789|12027086|FG001|Overall Study|Subject off study medication|1
7617107|NCT03307967|12027114|FG000|Overall Study|Lost to Follow-up|4
7617108|NCT03288129|12027124|FG000|Overall Study|Adverse Event|10
7617109|NCT03288129|12027124|FG000|Overall Study|Lost to Follow-up|3
7617110|NCT03288129|12027124|FG000|Overall Study|Withdrawal by Subject|3
7617111|NCT03288129|12027124|FG000|Overall Study|Withdrawal of consent/assent|1
7617112|NCT03288129|12027124|FG000|Overall Study|Other|5
7617113|NCT03241225|12027165|FG000|Overall Study|Lost to Follow-up|2
7617114|NCT03241225|12027166|FG001|Overall Study|Lost to Follow-up|1
7617115|NCT03241225|12027165|FG000|Overall Study|Protocol Violation|4
7617116|NCT03241225|12027166|FG001|Overall Study|Protocol Violation|1
7617117|NCT03241225|12027165|FG000|Overall Study|Withdrawal by Subject|1
7617118|NCT03241225|12027166|FG001|Overall Study|Withdrawal by Subject|0
7617119|NCT03225846|12027179|FG000|Overall Study|Adverse Event|0
7617120|NCT03225846|12027180|FG001|Overall Study|Adverse Event|0
7617121|NCT03225846|12027181|FG002|Overall Study|Adverse Event|0
7617122|NCT03225846|12027182|FG003|Overall Study|Adverse Event|0
7617123|NCT03225846|12027183|FG004|Overall Study|Adverse Event|0
7617124|NCT03225846|12027184|FG005|Overall Study|Adverse Event|0
7617125|NCT03225846|12027185|FG006|Overall Study|Adverse Event|6
7617126|NCT03225846|12027179|FG000|Overall Study|Withdrawal by Subject|0
7617127|NCT03225846|12027180|FG001|Overall Study|Withdrawal by Subject|1
7279680|NCT00467779|11495043|FG007|Stage 3|Adverse Event|0
7617128|NCT03225846|12027181|FG002|Overall Study|Withdrawal by Subject|0
7617129|NCT03225846|12027182|FG003|Overall Study|Withdrawal by Subject|0
7617130|NCT03225846|12027183|FG004|Overall Study|Withdrawal by Subject|0
7617131|NCT03225846|12027184|FG005|Overall Study|Withdrawal by Subject|0
7617132|NCT03225846|12027185|FG006|Overall Study|Withdrawal by Subject|0
7617133|NCT03225846|12027179|FG000|Overall Study|Death|0
7617134|NCT03225846|12027180|FG001|Overall Study|Death|1
7617135|NCT03225846|12027181|FG002|Overall Study|Death|0
7617136|NCT03225846|12027182|FG003|Overall Study|Death|0
7617137|NCT03225846|12027183|FG004|Overall Study|Death|0
7617138|NCT03225846|12027184|FG005|Overall Study|Death|0
7617139|NCT03225846|12027185|FG006|Overall Study|Death|0
7617140|NCT03225846|12027179|FG000|Overall Study|Patient did not wish to comply with IC/EC|0
7279681|NCT00467779|11495044|FG008|Stage 3|Adverse Event|0
7279682|NCT00467779|11495045|FG009|Stage 3|Adverse Event|0
7279683|NCT00467779|11495046|FG010|Stage 3|Adverse Event|0
7279684|NCT00467779|11495047|FG011|Stage 3|Adverse Event|0
7279685|NCT00467779|11495048|FG012|Stage 3|Adverse Event|0
7279686|NCT00467779|11495049|FG013|Stage 3|Adverse Event|0
7279687|NCT00467779|11495050|FG014|Stage 3|Adverse Event|2
7279688|NCT00467779|11495036|FG000|Stage 3|Death|0
7279689|NCT00467779|11495037|FG001|Stage 3|Death|0
7617141|NCT03225846|12027180|FG001|Overall Study|Patient did not wish to comply with IC/EC|0
7279690|NCT00467779|11495038|FG002|Stage 3|Death|0
7279691|NCT00467779|11495039|FG003|Stage 3|Death|0
7279692|NCT00467779|11495040|FG004|Stage 3|Death|0
7279693|NCT00467779|11495041|FG005|Stage 3|Death|0
7279694|NCT00467779|11495042|FG006|Stage 3|Death|0
7617142|NCT03225846|12027181|FG002|Overall Study|Patient did not wish to comply with IC/EC|1
7617143|NCT03225846|12027182|FG003|Overall Study|Patient did not wish to comply with IC/EC|0
7617144|NCT03225846|12027183|FG004|Overall Study|Patient did not wish to comply with IC/EC|0
7617145|NCT03225846|12027184|FG005|Overall Study|Patient did not wish to comply with IC/EC|0
7617146|NCT03225846|12027185|FG006|Overall Study|Patient did not wish to comply with IC/EC|0
7617147|NCT03225846|12027179|FG000|Overall Study|Patient decision|0
7617148|NCT03225846|12027180|FG001|Overall Study|Patient decision|0
7617149|NCT03225846|12027181|FG002|Overall Study|Patient decision|0
7617150|NCT03225846|12027182|FG003|Overall Study|Patient decision|0
7617151|NCT03225846|12027183|FG004|Overall Study|Patient decision|0
7617152|NCT03225846|12027184|FG005|Overall Study|Patient decision|0
7617153|NCT03225846|12027185|FG006|Overall Study|Patient decision|1
7617154|NCT03191903|12027228|FG000|Overall Study|Withdrawal by Subject|6
7617155|NCT03191903|12027229|FG001|Overall Study|Withdrawal by Subject|5
7617156|NCT03191903|12027230|FG002|Overall Study|Withdrawal by Subject|4
7617157|NCT03191903|12027228|FG000|Overall Study|Adverse Event|1
7617158|NCT03191903|12027229|FG001|Overall Study|Adverse Event|0
7617159|NCT03191903|12027230|FG002|Overall Study|Adverse Event|0
7617160|NCT03186794|12027243|FG000|Overall Study|Physician Decision|2
7617161|NCT03186794|12027243|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2
7617162|NCT04289051|12027248|FG000|Overall Study|Lost to Follow-up|0
7617163|NCT04289051|12027249|FG001|Overall Study|Lost to Follow-up|0
7617164|NCT04289051|12027250|FG002|Overall Study|Lost to Follow-up|2
7617165|NCT04210180|12027258|FG000|Overall Study|Withdrawal by Subject|2
7617166|NCT03675308|12027301|FG000|Overall Study|Adverse Event|3
7617167|NCT03675308|12027302|FG001|Overall Study|Adverse Event|2
7617168|NCT03675308|12027301|FG000|Overall Study|Withdrawal by Subject|6
7617169|NCT03675308|12027302|FG001|Overall Study|Withdrawal by Subject|4
7617170|NCT03675308|12027301|FG000|Overall Study|Lost to Follow-up|3
7617171|NCT03675308|12027302|FG001|Overall Study|Lost to Follow-up|0
7617172|NCT03675308|12027301|FG000|Overall Study|Lack of Efficacy|1
7617173|NCT03675308|12027302|FG001|Overall Study|Lack of Efficacy|1
7617174|NCT03675308|12027301|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1
7617175|NCT03675308|12027302|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2
7617176|NCT03675308|12027301|FG000|Overall Study|Other|0
7617177|NCT03675308|12027302|FG001|Overall Study|Other|1
7617178|NCT03573817|12027310|FG000|Overall Study|Adverse Event|0
7617179|NCT03573817|12027311|FG001|Overall Study|Adverse Event|2
7617180|NCT03573817|12027310|FG000|Overall Study|Protocol Violation|0
7617181|NCT03573817|12027311|FG001|Overall Study|Protocol Violation|1
7617182|NCT03573817|12027310|FG000|Overall Study|Withdrawal by Subject|1
7617183|NCT03573817|12027311|FG001|Overall Study|Withdrawal by Subject|1
7617203|NCT02919683|12027388|FG000|Post-Surgery Follow-Up|Death|2
7617204|NCT02919683|12027389|FG001|Post-Surgery Follow-Up|Death|2
7617205|NCT02919683|12027388|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
7617206|NCT02919683|12027389|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
7617208|NCT02790138|12027402|FG000|Overall Study|Adverse Event|5
7617209|NCT02790138|12027403|FG001|Overall Study|Adverse Event|2
7617210|NCT02790138|12027402|FG000|Overall Study|Significant Protocol Deviation|0
7617211|NCT02790138|12027403|FG001|Overall Study|Significant Protocol Deviation|1
7617212|NCT02790138|12027402|FG000|Overall Study|Lost to Follow-up|1
7617213|NCT02790138|12027403|FG001|Overall Study|Lost to Follow-up|0
7617214|NCT02790138|12027402|FG000|Overall Study|Voluntary Withdrawal|8
7617215|NCT02790138|12027403|FG001|Overall Study|Voluntary Withdrawal|9
7617216|NCT02790138|12027402|FG000|Overall Study|Lack of Efficacy|6
7617217|NCT02790138|12027403|FG001|Overall Study|Lack of Efficacy|7
7617218|NCT02790138|12027402|FG000|Overall Study|Reason not Specified|1
7617219|NCT02790138|12027403|FG001|Overall Study|Reason not Specified|0
7617220|NCT02514239|12027437|FG000|Overall Study|Refused to continue trial medication|0
7617221|NCT02514239|12027438|FG001|Overall Study|Refused to continue trial medication|0
7617222|NCT02514239|12027439|FG002|Overall Study|Refused to continue trial medication|0
7617223|NCT02514239|12027440|FG003|Overall Study|Refused to continue trial medication|0
7617224|NCT02514239|12027441|FG004|Overall Study|Refused to continue trial medication|0
7617225|NCT02514239|12027442|FG005|Overall Study|Refused to continue trial medication|0
7617226|NCT02514239|12027443|FG006|Overall Study|Refused to continue trial medication|0
7617227|NCT02514239|12027444|FG007|Overall Study|Refused to continue trial medication|0
7617228|NCT02514239|12027445|FG008|Overall Study|Refused to continue trial medication|0
7617229|NCT02514239|12027446|FG009|Overall Study|Refused to continue trial medication|1
7617230|NCT02514239|12027437|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
7617231|NCT02514239|12027438|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
7617232|NCT02514239|12027439|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
7617233|NCT02514239|12027440|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
7617234|NCT02514239|12027441|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
7617235|NCT02514239|12027442|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
7617236|NCT02514239|12027443|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
7617237|NCT02514239|12027444|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
7617238|NCT02514239|12027445|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
7617239|NCT02514239|12027446|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
7617240|NCT02514239|12027437|FG000|Overall Study|Not treated|0
7617241|NCT02514239|12027438|FG001|Overall Study|Not treated|1
7617242|NCT02514239|12027439|FG002|Overall Study|Not treated|0
7617243|NCT02514239|12027440|FG003|Overall Study|Not treated|0
7617244|NCT02514239|12027441|FG004|Overall Study|Not treated|0
7617245|NCT02514239|12027442|FG005|Overall Study|Not treated|0
7617246|NCT02514239|12027443|FG006|Overall Study|Not treated|0
7617247|NCT02514239|12027444|FG007|Overall Study|Not treated|0
7279695|NCT00467779|11495043|FG007|Stage 3|Death|0
7279696|NCT00467779|11495044|FG008|Stage 3|Death|0
7279697|NCT00467779|11495045|FG009|Stage 3|Death|0
7279698|NCT00467779|11495046|FG010|Stage 3|Death|0
7279699|NCT00467779|11495047|FG011|Stage 3|Death|0
7279700|NCT00467779|11495048|FG012|Stage 3|Death|0
7279701|NCT00467779|11495049|FG013|Stage 3|Death|0
7279702|NCT00467779|11495050|FG014|Stage 3|Death|1
7279703|NCT00467779|11495036|FG000|Stage 3|Disease Progression|0
7279704|NCT00467779|11495037|FG001|Stage 3|Disease Progression|0
7279705|NCT00467779|11495038|FG002|Stage 3|Disease Progression|0
7279706|NCT00467779|11495039|FG003|Stage 3|Disease Progression|0
7279707|NCT00467779|11495040|FG004|Stage 3|Disease Progression|0
7279708|NCT00467779|11495041|FG005|Stage 3|Disease Progression|0
7279709|NCT00467779|11495042|FG006|Stage 3|Disease Progression|0
7279710|NCT00467779|11495043|FG007|Stage 3|Disease Progression|0
7279711|NCT00467779|11495044|FG008|Stage 3|Disease Progression|0
7279712|NCT00467779|11495045|FG009|Stage 3|Disease Progression|0
7279713|NCT00467779|11495046|FG010|Stage 3|Disease Progression|0
7279714|NCT00467779|11495047|FG011|Stage 3|Disease Progression|0
7279715|NCT00467779|11495048|FG012|Stage 3|Disease Progression|0
7279716|NCT00467779|11495049|FG013|Stage 3|Disease Progression|0
7279717|NCT00467779|11495050|FG014|Stage 3|Disease Progression|9
7279718|NCT00467779|11495036|FG000|Stage 3|Unspecified Reason|0
7279719|NCT00467779|11495037|FG001|Stage 3|Unspecified Reason|0
7279720|NCT00467779|11495038|FG002|Stage 3|Unspecified Reason|0
7279721|NCT00467779|11495039|FG003|Stage 3|Unspecified Reason|0
7279722|NCT00467779|11495040|FG004|Stage 3|Unspecified Reason|0
7279723|NCT00467779|11495041|FG005|Stage 3|Unspecified Reason|0
7279724|NCT00467779|11495042|FG006|Stage 3|Unspecified Reason|0
7279725|NCT00467779|11495043|FG007|Stage 3|Unspecified Reason|0
7279726|NCT00467779|11495044|FG008|Stage 3|Unspecified Reason|0
7279727|NCT00467779|11495045|FG009|Stage 3|Unspecified Reason|0
7279728|NCT00467779|11495046|FG010|Stage 3|Unspecified Reason|0
7279729|NCT00467779|11495047|FG011|Stage 3|Unspecified Reason|0
7279730|NCT00467779|11495048|FG012|Stage 3|Unspecified Reason|0
7279731|NCT00467779|11495049|FG013|Stage 3|Unspecified Reason|0
7279732|NCT00467779|11495050|FG014|Stage 3|Unspecified Reason|5
7279733|NCT00467818|11495090|FG000|Overall Study|Adverse Event|1
7279734|NCT00467818|11495091|FG001|Overall Study|Adverse Event|0
7279735|NCT00467818|11495090|FG000|Overall Study|Lost to Follow-up|2
7279736|NCT00467818|11495091|FG001|Overall Study|Lost to Follow-up|2
7617248|NCT02514239|12027445|FG008|Overall Study|Not treated|0
7617249|NCT02514239|12027446|FG009|Overall Study|Not treated|0
7617250|NCT02514239|12027437|FG000|Overall Study|Other Adverse Events|2
7279737|NCT00467831|11495099|FG000|Overall Study|Death|2
7279738|NCT00467831|11495099|FG000|Overall Study|Withdrawal by Subject|1
7279739|NCT00467857|11495121|FG000|Overall Study|Adverse Event|1
7279740|NCT00467857|11495122|FG001|Overall Study|Adverse Event|0
7279741|NCT00467857|11495121|FG000|Overall Study|Withdrew consent|2
7279742|NCT00467857|11495122|FG001|Overall Study|Withdrew consent|0
7279743|NCT00467857|11495121|FG000|Overall Study|Death|0
7279744|NCT00467857|11495122|FG001|Overall Study|Death|1
7279745|NCT00467857|11495121|FG000|Overall Study|Discharged from court service|0
7279746|NCT00467857|11495122|FG001|Overall Study|Discharged from court service|1
7279747|NCT00467857|11495121|FG000|Overall Study|Emergency care required|0
7279748|NCT00467857|11495122|FG001|Overall Study|Emergency care required|1
7279749|NCT00467857|11495121|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
7279750|NCT00467857|11495122|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
7279751|NCT00467857|11495121|FG000|Overall Study|Discontinuation reason missing|0
7279752|NCT00467857|11495122|FG001|Overall Study|Discontinuation reason missing|3
7279753|NCT00467870|11495134|FG000|Overall Study|Adverse Event|13
7279754|NCT00467870|11495135|FG001|Overall Study|Adverse Event|9
7279755|NCT00467870|11495136|FG002|Overall Study|Adverse Event|1
7617251|NCT02514239|12027438|FG001|Overall Study|Other Adverse Events|0
7617252|NCT02514239|12027439|FG002|Overall Study|Other Adverse Events|0
7617253|NCT02514239|12027440|FG003|Overall Study|Other Adverse Events|1
7279756|NCT00467870|11495137|FG003|Overall Study|Adverse Event|15
7279757|NCT00467870|11495138|FG004|Overall Study|Adverse Event|15
7617254|NCT02514239|12027441|FG004|Overall Study|Other Adverse Events|0
7617255|NCT02514239|12027442|FG005|Overall Study|Other Adverse Events|1
7617256|NCT02514239|12027443|FG006|Overall Study|Other Adverse Events|0
7617257|NCT02514239|12027444|FG007|Overall Study|Other Adverse Events|1
7617258|NCT02514239|12027445|FG008|Overall Study|Other Adverse Events|2
7617259|NCT02514239|12027446|FG009|Overall Study|Other Adverse Events|0
7617260|NCT02514239|12027437|FG000|Overall Study|Progressive disease|3
7617261|NCT02514239|12027438|FG001|Overall Study|Progressive disease|3
7617262|NCT02514239|12027439|FG002|Overall Study|Progressive disease|2
7617263|NCT02514239|12027440|FG003|Overall Study|Progressive disease|2
7617264|NCT02514239|12027441|FG004|Overall Study|Progressive disease|3
7617265|NCT02514239|12027442|FG005|Overall Study|Progressive disease|3
7617266|NCT02514239|12027443|FG006|Overall Study|Progressive disease|4
7617267|NCT02514239|12027444|FG007|Overall Study|Progressive disease|2
7617268|NCT02514239|12027445|FG008|Overall Study|Progressive disease|5
7617269|NCT02514239|12027446|FG009|Overall Study|Progressive disease|0
7617270|NCT02245672|12027515|FG000|Overall Study|Adverse Event|4
7617271|NCT02245672|12027516|FG001|Overall Study|Adverse Event|4
7617272|NCT02245672|12027517|FG002|Overall Study|Adverse Event|4
7617273|NCT02245672|12027515|FG000|Overall Study|Lost to Follow-up|3
7617274|NCT02245672|12027516|FG001|Overall Study|Lost to Follow-up|5
7617275|NCT02245672|12027517|FG002|Overall Study|Lost to Follow-up|1
7617276|NCT02245672|12027515|FG000|Overall Study|Withdrawal by Subject|6
7617277|NCT02245672|12027516|FG001|Overall Study|Withdrawal by Subject|3
7617278|NCT02245672|12027517|FG002|Overall Study|Withdrawal by Subject|0
7617279|NCT02245672|12027515|FG000|Overall Study|Randomized in error (not treated)|0
7617280|NCT02245672|12027516|FG001|Overall Study|Randomized in error (not treated)|1
7617281|NCT02245672|12027517|FG002|Overall Study|Randomized in error (not treated)|0
7617282|NCT02109172|12027525|FG000|Overall Study|Withdrawal by Subject|1
7617283|NCT02109172|12027526|FG001|Overall Study|Withdrawal by Subject|0
7617284|NCT02109172|12027527|FG002|Overall Study|Withdrawal by Subject|0
7617285|NCT02109172|12027528|FG003|Overall Study|Withdrawal by Subject|1
7617286|NCT02109172|12027529|FG004|Overall Study|Withdrawal by Subject|0
7617287|NCT02109172|12027530|FG005|Overall Study|Withdrawal by Subject|0
7617288|NCT02109172|12027525|FG000|Overall Study|Adverse Event|0
7617289|NCT02109172|12027526|FG001|Overall Study|Adverse Event|0
7617290|NCT02109172|12027527|FG002|Overall Study|Adverse Event|1
7617291|NCT02109172|12027528|FG003|Overall Study|Adverse Event|0
7617292|NCT02109172|12027529|FG004|Overall Study|Adverse Event|0
7617293|NCT02109172|12027530|FG005|Overall Study|Adverse Event|1
7617294|NCT02109172|12027525|FG000|Overall Study|Death|0
7279758|NCT00467870|11495139|FG005|Overall Study|Adverse Event|1
7279759|NCT00467870|11495134|FG000|Overall Study|Protocol Violation|2
7279760|NCT00467870|11495135|FG001|Overall Study|Protocol Violation|1
7279761|NCT00467870|11495136|FG002|Overall Study|Protocol Violation|1
7617295|NCT02109172|12027526|FG001|Overall Study|Death|0
7617296|NCT02109172|12027527|FG002|Overall Study|Death|0
7617297|NCT02109172|12027528|FG003|Overall Study|Death|0
7617298|NCT02109172|12027529|FG004|Overall Study|Death|1
7617299|NCT02109172|12027530|FG005|Overall Study|Death|0
7617300|NCT00799396|12027588|FG000|Clopidogrel Treatment|Adverse Event|6
7617301|NCT00799396|12027588|FG000|Clopidogrel Treatment|Physician Decision|5
7617302|NCT00799396|12027588|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
7617303|NCT00799396|12027588|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
7617304|NCT00799396|12027588|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
7617305|NCT00069238|12027592|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
7617306|NCT00069238|12027593|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7617307|NCT00069238|12027594|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
7617308|NCT00069238|12027592|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7617309|NCT00069238|12027593|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
7617310|NCT00069238|12027594|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
7617311|NCT00069238|12027592|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7617312|NCT00069238|12027593|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
7617313|NCT00069238|12027594|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
7617314|NCT03138499|12027601|FG000|Overall Study|Lost to Follow-up|1
7617315|NCT03138499|12027602|FG001|Overall Study|Lost to Follow-up|0
7617316|NCT03138499|12027601|FG000|Overall Study|Participants withdrew consent|1
7617317|NCT03138499|12027602|FG001|Overall Study|Participants withdrew consent|0
7617318|NCT03138499|12027601|FG000|Overall Study|Participant discontinued study before treatment|0
7617319|NCT03138499|12027602|FG001|Overall Study|Participant discontinued study before treatment|1
7617320|NCT03138499|12027601|FG000|Overall Study|Disease Progression|2
7617321|NCT03138499|12027602|FG001|Overall Study|Disease Progression|6
7617322|NCT03138499|12027601|FG000|Overall Study|Study drug toxicity|2
7617323|NCT03138499|12027602|FG001|Overall Study|Study drug toxicity|2
7617324|NCT03138499|12027601|FG000|Overall Study|Participant request to discontinue study treatment|1
7617325|NCT03138499|12027602|FG001|Overall Study|Participant request to discontinue study treatment|1
7617326|NCT03138499|12027601|FG000|Overall Study|Other reasons|2
7617327|NCT03138499|12027602|FG001|Overall Study|Other reasons|0
7617328|NCT04466384|12027637|FG000|First Phase|Protocol Violation|1
7617329|NCT04466384|12027638|FG001|First Phase|Protocol Violation|0
7617330|NCT04466384|12027637|FG000|First Phase|Missing data|1
7617331|NCT04466384|12027638|FG001|First Phase|Missing data|0
7617332|NCT04466384|12027637|FG000|Cross Over Phase|Physician Decision|1
7617333|NCT04466384|12027638|FG001|Cross Over Phase|Physician Decision|0
7617334|NCT04466384|12027637|FG000|Cross Over Phase|Withdrawal by Subject|0
7617335|NCT04466384|12027638|FG001|Cross Over Phase|Withdrawal by Subject|1
7279762|NCT00467870|11495137|FG003|Overall Study|Protocol Violation|2
7279763|NCT00467870|11495138|FG004|Overall Study|Protocol Violation|0
7279764|NCT00467870|11495139|FG005|Overall Study|Protocol Violation|0
7279765|NCT00467870|11495134|FG000|Overall Study|Withdrawal by Subject|14
7279766|NCT00467870|11495135|FG001|Overall Study|Withdrawal by Subject|21
7279767|NCT00467870|11495136|FG002|Overall Study|Withdrawal by Subject|0
7279768|NCT00467870|11495137|FG003|Overall Study|Withdrawal by Subject|9
7279769|NCT00467870|11495138|FG004|Overall Study|Withdrawal by Subject|10
7279770|NCT00467870|11495139|FG005|Overall Study|Withdrawal by Subject|1
7279771|NCT00467870|11495134|FG000|Overall Study|Lost to Follow-up|5
7279772|NCT00467870|11495135|FG001|Overall Study|Lost to Follow-up|3
7279773|NCT00467870|11495136|FG002|Overall Study|Lost to Follow-up|1
7279774|NCT00467870|11495137|FG003|Overall Study|Lost to Follow-up|1
7279775|NCT00467870|11495138|FG004|Overall Study|Lost to Follow-up|3
7279776|NCT00467870|11495139|FG005|Overall Study|Lost to Follow-up|0
7279777|NCT00467870|11495134|FG000|Overall Study|Subject Non-compliance|3
7279778|NCT00467870|11495135|FG001|Overall Study|Subject Non-compliance|4
7279779|NCT00467870|11495136|FG002|Overall Study|Subject Non-compliance|0
7279780|NCT00467870|11495137|FG003|Overall Study|Subject Non-compliance|1
7279781|NCT00467870|11495138|FG004|Overall Study|Subject Non-compliance|5
7279782|NCT00467870|11495139|FG005|Overall Study|Subject Non-compliance|0
7279783|NCT00467870|11495134|FG000|Overall Study|Other/Unknown|8
7279784|NCT00467870|11495135|FG001|Overall Study|Other/Unknown|5
7279785|NCT00467870|11495136|FG002|Overall Study|Other/Unknown|1
7279786|NCT00467870|11495137|FG003|Overall Study|Other/Unknown|5
7279787|NCT00467870|11495138|FG004|Overall Study|Other/Unknown|4
7279788|NCT00467870|11495139|FG005|Overall Study|Other/Unknown|0
7279789|NCT00467896|11495149|FG000|Overall Study|Consent Withdrawal|18
7279790|NCT00467896|11495149|FG000|Overall Study|Adverse Event|7
7279791|NCT00467896|11495149|FG000|Overall Study|Serious Adverse Event|13
7279792|NCT00467896|11495149|FG000|Overall Study|Non-compliance|3
7279793|NCT00467896|11495149|FG000|Overall Study|Changed therapy|2
7279794|NCT00467896|11495149|FG000|Overall Study|Patient received transplant|2
7279795|NCT00467896|11495149|FG000|Overall Study|Patient had atrial septostomy|1
7279796|NCT00467896|11495149|FG000|Overall Study|Patient weaned off iloprost|1
7279797|NCT00467896|11495149|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
7279798|NCT00467896|11495149|FG000|Overall Study|Started intravenous prostacyclin|1
7279799|NCT00467896|11495149|FG000|Overall Study|Started inhaled Remodulin|1
7279800|NCT00467896|11495149|FG000|Overall Study|Patient had no improvement|1
7279801|NCT00467961|11495155|FG000|Overall Study|Technical Failures|5
7279802|NCT00467961|11495155|FG000|Overall Study|Disease Progression|2
7279803|NCT00468052|11495161|FG000|Overall Study|Protocol Violation|7
7279804|NCT00468052|11495162|FG001|Overall Study|Protocol Violation|8
7279805|NCT00468104|11495170|FG000|First Intervention|Protocol Violation|2
7279806|NCT00468104|11495171|FG001|First Intervention|Protocol Violation|1
7279807|NCT00468104|11495170|FG000|First Intervention|bleeding at chest tube site--first dose|1
7279808|NCT00468104|11495171|FG001|First Intervention|bleeding at chest tube site--first dose|0
7279809|NCT00468104|11495170|FG000|First Intervention|died within 3 weeks|1
7279810|NCT00468104|11495171|FG001|First Intervention|died within 3 weeks|0
7279811|NCT00468104|11495170|FG000|First Intervention|malposition/blocked chest tube tube|2
7279812|NCT00468104|11495171|FG001|First Intervention|malposition/blocked chest tube tube|0
7279813|NCT00468104|11495170|FG000|First Intervention|large lung mass with minimal effusion|1
7279814|NCT00468104|11495171|FG001|First Intervention|large lung mass with minimal effusion|0
7279815|NCT00468104|11495170|FG000|First Intervention|associated prolonged pneumothorax|1
7279816|NCT00468104|11495171|FG001|First Intervention|associated prolonged pneumothorax|0
7279817|NCT00468104|11495170|FG000|First Intervention|trapped lung|1
7279818|NCT00468104|11495171|FG001|First Intervention|trapped lung|0
7279819|NCT00468104|11495170|FG000|Second Intervention|Withdrawal by Subject|5
7617364|NCT04428645|12027662|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1
7617365|NCT04157751|12027674|FG000|Overall Study|Withdrawal by Subject|12
7617366|NCT04157751|12027675|FG001|Overall Study|Withdrawal by Subject|17
7617367|NCT04157751|12027674|FG000|Overall Study|Lost to Follow-up|6
7617368|NCT04157751|12027675|FG001|Overall Study|Lost to Follow-up|2
7617369|NCT04157751|12027674|FG000|Overall Study|Adverse Event|34
7617370|NCT04157751|12027675|FG001|Overall Study|Adverse Event|23
7617371|NCT04157751|12027674|FG000|Overall Study|Not treated|1
7617372|NCT04157751|12027675|FG001|Overall Study|Not treated|5
7617373|NCT04157751|12027674|FG000|Overall Study|Other reason not stated above|10
7617374|NCT04157751|12027675|FG001|Overall Study|Other reason not stated above|10
7617375|NCT04086121|12027691|FG000|Overall Study|Other than listed|8
7617376|NCT04086121|12027691|FG000|Overall Study|Withdrawal by Subject|3
7617377|NCT04086121|12027691|FG000|Overall Study|Lost to Follow-up|2
7617378|NCT04086121|12027691|FG000|Overall Study|Adverse Event|1
7617379|NCT03965962|12027711|FG000|Overall Study|Adverse Event|1
7617380|NCT03965962|12027712|FG001|Overall Study|Adverse Event|0
7617381|NCT03965962|12027713|FG002|Overall Study|Adverse Event|0
7617382|NCT03965962|12027714|FG003|Overall Study|Adverse Event|0
7617383|NCT03965962|12027711|FG000|Overall Study|Protocol Violation|21
7617384|NCT03965962|12027712|FG001|Overall Study|Protocol Violation|4
7617385|NCT03965962|12027713|FG002|Overall Study|Protocol Violation|10
7617386|NCT03965962|12027714|FG003|Overall Study|Protocol Violation|5
7617387|NCT03965962|12027711|FG000|Overall Study|Lost to Follow-up|0
7617388|NCT03965962|12027712|FG001|Overall Study|Lost to Follow-up|1
7617389|NCT03965962|12027713|FG002|Overall Study|Lost to Follow-up|0
7617390|NCT03965962|12027714|FG003|Overall Study|Lost to Follow-up|0
7617391|NCT03965962|12027711|FG000|Overall Study|Withdrawal by Subject|3
7617392|NCT03965962|12027712|FG001|Overall Study|Withdrawal by Subject|0
7617393|NCT03965962|12027713|FG002|Overall Study|Withdrawal by Subject|0
7617394|NCT03965962|12027714|FG003|Overall Study|Withdrawal by Subject|1
7617405|NCT03112590|12027755|FG000|Overall Study|Adverse Event|0
7617406|NCT03112590|12027756|FG001|Overall Study|Adverse Event|1
7617407|NCT03112590|12027757|FG002|Overall Study|Adverse Event|0
7617408|NCT03086343|12027767|FG000|Overall Study|Adverse Event|7
7617409|NCT03086343|12027768|FG001|Overall Study|Adverse Event|7
7617410|NCT03086343|12027767|FG000|Overall Study|Withdrawal by Subject|10
7617411|NCT03086343|12027768|FG001|Overall Study|Withdrawal by Subject|6
7617412|NCT03086343|12027767|FG000|Overall Study|Lost to Follow-up|3
7617413|NCT03086343|12027768|FG001|Overall Study|Lost to Follow-up|1
7617414|NCT03086343|12027767|FG000|Overall Study|Lack of Efficacy|4
7617415|NCT03086343|12027768|FG001|Overall Study|Lack of Efficacy|6
7617416|NCT03086343|12027767|FG000|Overall Study|Other, not specified|8
7617417|NCT03086343|12027768|FG001|Overall Study|Other, not specified|4
7617418|NCT03086343|12027767|FG000|Overall Study|Missing|0
7617419|NCT03086343|12027768|FG001|Overall Study|Missing|1
7617450|NCT02657434|12027785|FG000|Overall Study|On-Going in Study|77
7617451|NCT02657434|12027786|FG001|Overall Study|On-Going in Study|91
7617452|NCT02657434|12027785|FG000|Overall Study|Death|177
7617453|NCT02657434|12027786|FG001|Overall Study|Death|183
7279820|NCT00468104|11495171|FG001|Second Intervention|Withdrawal by Subject|2
7279821|NCT00468104|11495170|FG000|Second Intervention|discarded for malposition of chest tube|0
7617454|NCT02657434|12027785|FG000|Overall Study|Lost to Follow-up|2
7617455|NCT02657434|12027786|FG001|Overall Study|Lost to Follow-up|2
7617456|NCT02657434|12027785|FG000|Overall Study|Randomization by Error|2
7617457|NCT02657434|12027786|FG001|Overall Study|Randomization by Error|0
7617458|NCT02657434|12027785|FG000|Overall Study|Withdrawal by Subject|27
7617459|NCT02657434|12027786|FG001|Overall Study|Withdrawal by Subject|16
7617460|NCT02657434|12027785|FG000|Overall Study|Protocol Violation|1
7617461|NCT02657434|12027786|FG001|Overall Study|Protocol Violation|0
7617462|NCT02583269|12027798|FG000|Overall Study|Patient hospitalized prior to start|1
7617463|NCT02583269|12027799|FG001|Overall Study|Patient hospitalized prior to start|0
7617464|NCT02583269|12027800|FG002|Overall Study|Patient hospitalized prior to start|0
7617465|NCT02583269|12027801|FG003|Overall Study|Patient hospitalized prior to start|0
7617466|NCT02583269|12027802|FG004|Overall Study|Patient hospitalized prior to start|0
7617469|NCT02576847|12027823|FG000|Overall Study|Adverse Event|27
7617470|NCT02576847|12027823|FG000|Overall Study|Lost to Follow-up|22
7617471|NCT02576847|12027823|FG000|Overall Study|Physician Decision|1
7617472|NCT02576847|12027823|FG000|Overall Study|Pregnancy|1
7617473|NCT02576847|12027823|FG000|Overall Study|Protocol Violation|3
7617474|NCT02576847|12027823|FG000|Overall Study|Withdrawal by Subject|78
7617475|NCT02576847|12027823|FG000|Overall Study|Other|5
7617479|NCT02425891|12027856|FG000|Overall Study|Death|333
7617480|NCT02425891|12027857|FG001|Overall Study|Death|314
7279822|NCT00468104|11495171|FG001|Second Intervention|discarded for malposition of chest tube|2
7279823|NCT00468143|11495180|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
7279824|NCT00468143|11495181|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
7279825|NCT00468143|11495180|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7279826|NCT00468143|11495181|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
7279827|NCT00468169|11495189|FG000|Overall Study|Withdrawal by Subject|1
7279828|NCT00468169|11495190|FG001|Overall Study|Withdrawal by Subject|0
7279829|NCT00468286|11495204|FG000|Overall Study|Adverse Event|1
7279830|NCT00468286|11495205|FG001|Overall Study|Adverse Event|6
7279831|NCT00468286|11495204|FG000|Overall Study|Protocol Violation|2
7279832|NCT00468286|11495205|FG001|Overall Study|Protocol Violation|2
7279833|NCT00468286|11495204|FG000|Overall Study|Withdrawal by Subject|4
7279834|NCT00468286|11495205|FG001|Overall Study|Withdrawal by Subject|3
7279835|NCT00468286|11495204|FG000|Overall Study|Physician Decision|0
7279836|NCT00468286|11495205|FG001|Overall Study|Physician Decision|1
7279837|NCT00468299|11495213|FG000|Overall Study|Withdrawal by Subject|0
7279838|NCT00468299|11495214|FG001|Overall Study|Withdrawal by Subject|1
7469809|NCT01927055|11771695|FG000|Double-Blind|Study Stopped|0
7469810|NCT01927055|11771696|FG001|Double-Blind|Study Stopped|7
7469811|NCT01927055|11771697|FG002|Double-Blind|Study Stopped|7
7469812|NCT01927055|11771695|FG000|Double-Blind|Supine Hypertension|0
7469813|NCT01927055|11771696|FG001|Double-Blind|Supine Hypertension|0
7469814|NCT01927055|11771697|FG002|Double-Blind|Supine Hypertension|1
7469815|NCT01927055|11771695|FG000|Double-Blind|Extended Vacation|0
7469816|NCT01927055|11771696|FG001|Double-Blind|Extended Vacation|1
7469817|NCT01927055|11771697|FG002|Double-Blind|Extended Vacation|0
7469818|NCT01927341|11771713|FG000|Phase 1b|Lost to Follow-up|1
7469819|NCT01927341|11771714|FG001|Phase 1b|Lost to Follow-up|0
7469820|NCT01927341|11771715|FG002|Phase 1b|Lost to Follow-up|0
7469821|NCT01927341|11771716|FG003|Phase 1b|Lost to Follow-up|0
7469822|NCT01927341|11771717|FG004|Phase 1b|Lost to Follow-up|0
7469823|NCT01927341|11771713|FG000|Phase 1b|Death|2
7469824|NCT01927341|11771714|FG001|Phase 1b|Death|0
7469825|NCT01927341|11771715|FG002|Phase 1b|Death|0
7469826|NCT01927341|11771716|FG003|Phase 1b|Death|0
7469827|NCT01927341|11771717|FG004|Phase 1b|Death|0
7469828|NCT01927341|11771713|FG000|Phase 1b|Follow-up completed|7
7469829|NCT01927341|11771714|FG001|Phase 1b|Follow-up completed|0
7617481|NCT02425891|12027856|FG000|Overall Study|Lost to Follow-up|4
7617482|NCT02425891|12027857|FG001|Overall Study|Lost to Follow-up|6
7617483|NCT02425891|12027856|FG000|Overall Study|Non-Compliance|1
7617484|NCT02425891|12027857|FG001|Overall Study|Non-Compliance|1
7617485|NCT02425891|12027856|FG000|Overall Study|Accidentally randomized screen failure participant|0
7617486|NCT02425891|12027857|FG001|Overall Study|Accidentally randomized screen failure participant|1
7617487|NCT02425891|12027856|FG000|Overall Study|Physician Decision|0
7469830|NCT01927341|11771715|FG002|Phase 1b|Follow-up completed|0
7469831|NCT01927341|11771716|FG003|Phase 1b|Follow-up completed|0
7617488|NCT02425891|12027857|FG001|Overall Study|Physician Decision|1
7617489|NCT02425891|12027856|FG000|Overall Study|Protocol Violation|1
7617490|NCT02425891|12027857|FG001|Overall Study|Protocol Violation|1
7617491|NCT02425891|12027856|FG000|Overall Study|Study Terminated By Sponsor|85
7617492|NCT02425891|12027857|FG001|Overall Study|Study Terminated By Sponsor|95
7617493|NCT02425891|12027856|FG000|Overall Study|Withdrawal by Subject|27
7617494|NCT02425891|12027857|FG001|Overall Study|Withdrawal by Subject|32
7617531|NCT02352948|12027889|FG000|Overall Study|Death|47
7617532|NCT02352948|12027890|FG001|Overall Study|Death|48
7617533|NCT02352948|12027891|FG002|Overall Study|Death|114
7617534|NCT02352948|12027892|FG003|Overall Study|Death|74
7617535|NCT02352948|12027893|FG004|Overall Study|Death|77
7617536|NCT02352948|12027894|FG005|Overall Study|Death|44
7617537|NCT02352948|12027889|FG000|Overall Study|Lost to Follow-up|1
7617538|NCT02352948|12027890|FG001|Overall Study|Lost to Follow-up|0
7617539|NCT02352948|12027891|FG002|Overall Study|Lost to Follow-up|2
7617540|NCT02352948|12027892|FG003|Overall Study|Lost to Follow-up|1
7617541|NCT02352948|12027893|FG004|Overall Study|Lost to Follow-up|2
7617542|NCT02352948|12027894|FG005|Overall Study|Lost to Follow-up|1
7617543|NCT02352948|12027889|FG000|Overall Study|Withdrawal by Subject|1
7617544|NCT02352948|12027890|FG001|Overall Study|Withdrawal by Subject|10
7617545|NCT02352948|12027891|FG002|Overall Study|Withdrawal by Subject|11
7617546|NCT02352948|12027892|FG003|Overall Study|Withdrawal by Subject|23
7617547|NCT02352948|12027893|FG004|Overall Study|Withdrawal by Subject|9
7279839|NCT00468481|11495224|FG000|Overall Study|Adverse Event|13
7279840|NCT00468481|11495225|FG001|Overall Study|Adverse Event|3
7279841|NCT00468481|11495224|FG000|Overall Study|Lost to Follow-up|25
7279842|NCT00468481|11495225|FG001|Overall Study|Lost to Follow-up|8
7279843|NCT00468481|11495224|FG000|Overall Study|Pregnancy|2
7279844|NCT00468481|11495225|FG001|Overall Study|Pregnancy|0
7279845|NCT00468481|11495224|FG000|Overall Study|Protocol Violation|18
7279846|NCT00468481|11495225|FG001|Overall Study|Protocol Violation|8
7279847|NCT00468481|11495224|FG000|Overall Study|Withdrawal by Subject|12
7279848|NCT00468481|11495225|FG001|Overall Study|Withdrawal by Subject|3
7617548|NCT02352948|12027894|FG005|Overall Study|Withdrawal by Subject|4
7617549|NCT02352948|12027889|FG000|Overall Study|Eligibility criteria not fulfilled|0
7617550|NCT02352948|12027890|FG001|Overall Study|Eligibility criteria not fulfilled|1
7617551|NCT02352948|12027891|FG002|Overall Study|Eligibility criteria not fulfilled|0
7617552|NCT02352948|12027892|FG003|Overall Study|Eligibility criteria not fulfilled|1
7617553|NCT02352948|12027893|FG004|Overall Study|Eligibility criteria not fulfilled|0
7617554|NCT02352948|12027894|FG005|Overall Study|Eligibility criteria not fulfilled|0
7617555|NCT02352948|12027889|FG000|Overall Study|Other|0
7617556|NCT02352948|12027890|FG001|Overall Study|Other|0
7617557|NCT02352948|12027891|FG002|Overall Study|Other|2
7617558|NCT02352948|12027892|FG003|Overall Study|Other|0
7617559|NCT02352948|12027893|FG004|Overall Study|Other|0
7617560|NCT02352948|12027894|FG005|Overall Study|Other|0
7617561|NCT02315703|12027926|FG000|Overall Study|Adverse Event|0
7617562|NCT02315703|12027927|FG001|Overall Study|Adverse Event|0
7617563|NCT02315703|12027928|FG002|Overall Study|Adverse Event|0
7617564|NCT02315703|12027929|FG003|Overall Study|Adverse Event|1
7617565|NCT02315703|12027930|FG004|Overall Study|Adverse Event|1
7617566|NCT02315703|12027931|FG005|Overall Study|Adverse Event|0
7617567|NCT02315703|12027932|FG006|Overall Study|Adverse Event|1
7617568|NCT02315703|12027933|FG007|Overall Study|Adverse Event|0
7617569|NCT02315703|12027926|FG000|Overall Study|Lost to Follow-up|1
7617570|NCT02315703|12027927|FG001|Overall Study|Lost to Follow-up|5
7617571|NCT02315703|12027928|FG002|Overall Study|Lost to Follow-up|3
7617572|NCT02315703|12027929|FG003|Overall Study|Lost to Follow-up|3
7617573|NCT02315703|12027930|FG004|Overall Study|Lost to Follow-up|2
7617574|NCT02315703|12027931|FG005|Overall Study|Lost to Follow-up|1
7617575|NCT02315703|12027932|FG006|Overall Study|Lost to Follow-up|2
7617576|NCT02315703|12027933|FG007|Overall Study|Lost to Follow-up|2
7617577|NCT02315703|12027926|FG000|Overall Study|Pregnancy|0
7617578|NCT02315703|12027927|FG001|Overall Study|Pregnancy|0
7617579|NCT02315703|12027928|FG002|Overall Study|Pregnancy|0
7617580|NCT02315703|12027929|FG003|Overall Study|Pregnancy|0
7617581|NCT02315703|12027930|FG004|Overall Study|Pregnancy|0
7617582|NCT02315703|12027931|FG005|Overall Study|Pregnancy|0
7617583|NCT02315703|12027932|FG006|Overall Study|Pregnancy|0
7617584|NCT02315703|12027933|FG007|Overall Study|Pregnancy|1
7617585|NCT02315703|12027926|FG000|Overall Study|Withdrawal by Subject|1
7617586|NCT02315703|12027927|FG001|Overall Study|Withdrawal by Subject|3
7617587|NCT02315703|12027928|FG002|Overall Study|Withdrawal by Subject|0
7617588|NCT02315703|12027929|FG003|Overall Study|Withdrawal by Subject|3
7617589|NCT02315703|12027930|FG004|Overall Study|Withdrawal by Subject|4
7617590|NCT02315703|12027931|FG005|Overall Study|Withdrawal by Subject|1
7617591|NCT02315703|12027932|FG006|Overall Study|Withdrawal by Subject|1
7617592|NCT02315703|12027933|FG007|Overall Study|Withdrawal by Subject|2
7617593|NCT02315703|12027926|FG000|Overall Study|Physician Decision|0
7617594|NCT02315703|12027927|FG001|Overall Study|Physician Decision|0
7617595|NCT02315703|12027928|FG002|Overall Study|Physician Decision|0
7617596|NCT02315703|12027929|FG003|Overall Study|Physician Decision|0
7617597|NCT02315703|12027930|FG004|Overall Study|Physician Decision|0
7617598|NCT02315703|12027931|FG005|Overall Study|Physician Decision|2
7617599|NCT02315703|12027932|FG006|Overall Study|Physician Decision|1
7617600|NCT02315703|12027933|FG007|Overall Study|Physician Decision|0
7617601|NCT02315703|12027926|FG000|Overall Study|Other|4
7617602|NCT02315703|12027927|FG001|Overall Study|Other|2
7279849|NCT00468481|11495224|FG000|Overall Study|susp/diag malignant/premalignant disease|1
7279850|NCT00468481|11495225|FG001|Overall Study|susp/diag malignant/premalignant disease|0
7279851|NCT00468481|11495224|FG000|Overall Study|Prohibited Medication|1
7617603|NCT02315703|12027928|FG002|Overall Study|Other|2
7617604|NCT02315703|12027929|FG003|Overall Study|Other|2
7617605|NCT02315703|12027930|FG004|Overall Study|Other|1
7617606|NCT02315703|12027931|FG005|Overall Study|Other|2
7617607|NCT02315703|12027932|FG006|Overall Study|Other|8
7617608|NCT02315703|12027933|FG007|Overall Study|Other|2
7617625|NCT02214160|12027971|FG000|Overall Study|Withdrawal by Subject|1
7617626|NCT02214160|12027972|FG001|Overall Study|Withdrawal by Subject|0
7617627|NCT02214160|12027973|FG002|Overall Study|Withdrawal by Subject|6
7617628|NCT02214160|12027971|FG000|Overall Study|Death|2
7617629|NCT02214160|12027972|FG001|Overall Study|Death|2
7617630|NCT02214160|12027973|FG002|Overall Study|Death|1
7617631|NCT02214160|12027971|FG000|Overall Study|Subject Non-Compliance|0
7617632|NCT02214160|12027972|FG001|Overall Study|Subject Non-Compliance|3
7617633|NCT02214160|12027973|FG002|Overall Study|Subject Non-Compliance|1
7617634|NCT02214160|12027971|FG000|Overall Study|Adverse Event|0
7617635|NCT02214160|12027972|FG001|Overall Study|Adverse Event|1
7617636|NCT02214160|12027973|FG002|Overall Study|Adverse Event|1
7617637|NCT02214160|12027971|FG000|Overall Study|Sponsor Decision|0
7617638|NCT02214160|12027972|FG001|Overall Study|Sponsor Decision|2
7617639|NCT02214160|12027973|FG002|Overall Study|Sponsor Decision|0
7617640|NCT02214160|12027971|FG000|Overall Study|Protocol Violation|1
7617641|NCT02214160|12027972|FG001|Overall Study|Protocol Violation|0
7617642|NCT02214160|12027973|FG002|Overall Study|Protocol Violation|0
7617643|NCT02214160|12027971|FG000|Overall Study|Physician Decision|0
7617644|NCT02214160|12027972|FG001|Overall Study|Physician Decision|0
7617645|NCT02214160|12027973|FG002|Overall Study|Physician Decision|1
7617646|NCT02167945|12027985|FG000|Overall Study|Adverse Event|16
7617647|NCT02167945|12027985|FG000|Overall Study|Withdrew Consent|42
7617648|NCT02167945|12027985|FG000|Overall Study|Lost to Follow-up|122
7617649|NCT02167945|12027985|FG000|Overall Study|COVID-19 logistical restrictions|6
7617650|NCT02167945|12027985|FG000|Overall Study|Other, not specified|63
7617651|NCT02128763|12027999|FG000|Overall Study|Death|1
7617652|NCT02128763|12028000|FG001|Overall Study|Death|0
7617653|NCT02128763|12027999|FG000|Overall Study|Lost to Follow-up|19
7617654|NCT02128763|12028000|FG001|Overall Study|Lost to Follow-up|16
7617655|NCT01991977|12028018|FG000|Overall Study|Withdrew prior to receiving treatment|7
7617656|NCT01991977|12028018|FG000|Overall Study|Withdrew after start of treatment|5
7617657|NCT01903733|12028037|FG000|Overall Study|Death|23
7617658|NCT01903733|12028038|FG001|Overall Study|Death|54
7617659|NCT01903733|12028039|FG002|Overall Study|Death|30
7617660|NCT01903733|12028040|FG003|Overall Study|Death|98
7617661|NCT01903733|12028037|FG000|Overall Study|Participant refused further follow-up|35
7617662|NCT01903733|12028038|FG001|Overall Study|Participant refused further follow-up|38
7617663|NCT01903733|12028039|FG002|Overall Study|Participant refused further follow-up|13
7617664|NCT01903733|12028040|FG003|Overall Study|Participant refused further follow-up|9
7617665|NCT01903733|12028037|FG000|Overall Study|Lost to Follow-up|18
7617666|NCT01903733|12028038|FG001|Overall Study|Lost to Follow-up|19
7617667|NCT01903733|12028039|FG002|Overall Study|Lost to Follow-up|6
7617668|NCT01903733|12028040|FG003|Overall Study|Lost to Follow-up|9
7617669|NCT01903733|12028037|FG000|Overall Study|Other|10
7617670|NCT01903733|12028038|FG001|Overall Study|Other|15
7617671|NCT01903733|12028039|FG002|Overall Study|Other|12
7617672|NCT01903733|12028040|FG003|Overall Study|Other|3
7617673|NCT01903733|12028037|FG000|Overall Study|Missing|2
7617674|NCT01903733|12028038|FG001|Overall Study|Missing|0
7617675|NCT01903733|12028039|FG002|Overall Study|Missing|0
7617676|NCT01903733|12028040|FG003|Overall Study|Missing|0
7617677|NCT01903733|12028037|FG000|Overall Study|Investigator request|18
7617678|NCT01903733|12028038|FG001|Overall Study|Investigator request|0
7617679|NCT01903733|12028039|FG002|Overall Study|Investigator request|0
7617680|NCT01903733|12028040|FG003|Overall Study|Investigator request|0
7617693|NCT01575548|12028071|FG000|Overall Study|Adverse Event|15
7617694|NCT01575548|12028072|FG001|Overall Study|Adverse Event|2
7617695|NCT01575548|12028071|FG000|Overall Study|Disease progression|12
7617696|NCT01575548|12028072|FG001|Overall Study|Disease progression|25
7617697|NCT01575548|12028071|FG000|Overall Study|Death|1
7617698|NCT01575548|12028072|FG001|Overall Study|Death|0
7617699|NCT01575548|12028071|FG000|Overall Study|Other complicating disease|1
7617700|NCT01575548|12028072|FG001|Overall Study|Other complicating disease|0
7617701|NCT01575548|12028071|FG000|Overall Study|Withdrawal by Subject|7
7617702|NCT01575548|12028072|FG001|Overall Study|Withdrawal by Subject|3
7617703|NCT01575548|12028071|FG000|Overall Study|Noncompliance|1
7617704|NCT01575548|12028072|FG001|Overall Study|Noncompliance|0
7617705|NCT01575548|12028071|FG000|Overall Study|Anticipated surgery|0
7617706|NCT01575548|12028072|FG001|Overall Study|Anticipated surgery|1
7617707|NCT01575548|12028071|FG000|Overall Study|Never started protocol therapy|3
7617708|NCT01575548|12028072|FG001|Overall Study|Never started protocol therapy|2
7279852|NCT00468481|11495225|FG001|Overall Study|Prohibited Medication|1
7279853|NCT00468481|11495224|FG000|Overall Study|Egg Donor|1
7279854|NCT00468481|11495225|FG001|Overall Study|Egg Donor|0
7279855|NCT00468481|11495224|FG000|Overall Study|Moved out of area|4
7279856|NCT00468481|11495225|FG001|Overall Study|Moved out of area|1
7279857|NCT00468481|11495224|FG000|Overall Study|Non-Compliance|5
7279858|NCT00468481|11495225|FG001|Overall Study|Non-Compliance|0
7279859|NCT00468481|11495224|FG000|Overall Study|Other|6
7279860|NCT00468481|11495225|FG001|Overall Study|Other|0
7279861|NCT00468546|11495233|FG000|Week 24 Analysis|Lack of Efficacy|83
7279862|NCT00468546|11495234|FG001|Week 24 Analysis|Lack of Efficacy|37
7279863|NCT00468546|11495233|FG000|Week 24 Analysis|Refused treatment|5
7279864|NCT00468546|11495234|FG001|Week 24 Analysis|Refused treatment|5
7279865|NCT00468546|11495233|FG000|Week 24 Analysis|Adverse Event|1
7279866|NCT00468546|11495234|FG001|Week 24 Analysis|Adverse Event|8
7279867|NCT00468546|11495233|FG000|Week 24 Analysis|Failure to return|3
7279868|NCT00468546|11495234|FG001|Week 24 Analysis|Failure to return|4
7279869|NCT00468546|11495233|FG000|Week 24 Analysis|Rescue therapy|2
7279870|NCT00468546|11495234|FG001|Week 24 Analysis|Rescue therapy|0
7279871|NCT00468546|11495233|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
7279872|NCT00468546|11495234|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
7279873|NCT00468546|11495233|FG000|Week 24 Analysis|Due to clinical hold|1
7279874|NCT00468546|11495234|FG001|Week 24 Analysis|Due to clinical hold|0
7279875|NCT00468546|11495233|FG000|Week 24 Analysis|Went onto rescue therapy|1
7279876|NCT00468546|11495234|FG001|Week 24 Analysis|Went onto rescue therapy|0
7279877|NCT00468546|11495233|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
7279878|NCT00468546|11495234|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
7279879|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
7279880|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
7279881|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Death|1
7279882|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Death|0
7279883|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
7279884|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
7279885|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
7279886|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
7279887|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
7279888|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
7279889|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Failure to return|1
7279890|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Failure to return|2
7279891|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
7279892|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
7279893|NCT00468546|11495233|FG000|Week 24 to Week 104 Analysis|Other|17
7279894|NCT00468546|11495234|FG001|Week 24 to Week 104 Analysis|Other|14
7279895|NCT00468559|11495242|FG000|Open-label Treatment Phase|Adverse Event|5
7279896|NCT00468559|11495243|FG001|Open-label Treatment Phase|Adverse Event|0
7279897|NCT00468559|11495244|FG002|Open-label Treatment Phase|Adverse Event|0
7279898|NCT00468559|11495242|FG000|Open-label Treatment Phase|Lack of Efficacy|9
7279899|NCT00468559|11495243|FG001|Open-label Treatment Phase|Lack of Efficacy|0
7279900|NCT00468559|11495244|FG002|Open-label Treatment Phase|Lack of Efficacy|0
7279901|NCT00468559|11495242|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
7279902|NCT00468559|11495243|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7279903|NCT00468559|11495244|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
7279904|NCT00468559|11495242|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
7279905|NCT00468559|11495243|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
7279906|NCT00468559|11495244|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
7279907|NCT00468559|11495242|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7279908|NCT00468559|11495243|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
7279909|NCT00468559|11495244|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
7279910|NCT00468585|11495256|FG000|Overall Study|Patient not treated|1
7279911|NCT00468585|11495257|FG001|Overall Study|Patient not treated|0
7279912|NCT00468585|11495258|FG002|Overall Study|Patient not treated|1
7279913|NCT00468585|11495259|FG003|Overall Study|Patient not treated|0
7279914|NCT00468585|11495256|FG000|Overall Study|Patient found to be ineligible|0
7279915|NCT00468585|11495257|FG001|Overall Study|Patient found to be ineligible|0
7279916|NCT00468585|11495258|FG002|Overall Study|Patient found to be ineligible|1
7279917|NCT00468585|11495259|FG003|Overall Study|Patient found to be ineligible|0
7279918|NCT00468585|11495256|FG000|Overall Study|Adverse Event|0
7279919|NCT00468585|11495257|FG001|Overall Study|Adverse Event|0
7279920|NCT00468585|11495258|FG002|Overall Study|Adverse Event|1
7279921|NCT00468585|11495259|FG003|Overall Study|Adverse Event|0
7279922|NCT00468585|11495256|FG000|Overall Study|Withdrawal by Subject|0
7279923|NCT00468585|11495257|FG001|Overall Study|Withdrawal by Subject|0
7617793|NCT01321073|12028120|FG000|Overall Study|Did not attempt implant|4
7617794|NCT01321073|12028120|FG000|Overall Study|Death|3
7279924|NCT00468585|11495258|FG002|Overall Study|Withdrawal by Subject|2
7279925|NCT00468585|11495259|FG003|Overall Study|Withdrawal by Subject|1
7279926|NCT00468650|11495269|FG000|Overall Study|Lost to Follow-up|4
7279927|NCT00468650|11495269|FG000|Overall Study|Withdrawal by Subject|2
7279928|NCT00468650|11495269|FG000|Overall Study|Protocol Violation|1
7617843|NCT01236547|12028172|FG000|Overall Study|Protocol Violation|0
7617844|NCT01236547|12028173|FG001|Overall Study|Protocol Violation|1
7617845|NCT01236547|12028174|FG002|Overall Study|Protocol Violation|1
7617846|NCT01236547|12028175|FG003|Overall Study|Protocol Violation|6
7617847|NCT01236547|12028176|FG004|Overall Study|Protocol Violation|12
7617848|NCT01038778|12028219|FG000|Overall Study|Withdrawal by Subject|0
7617849|NCT01038778|12028220|FG001|Overall Study|Withdrawal by Subject|2
7617850|NCT01038778|12028221|FG002|Overall Study|Withdrawal by Subject|3
7279929|NCT00468676|11495276|FG000|Overall Study|Lost to Follow-up|14
7279930|NCT00468676|11495277|FG001|Overall Study|Lost to Follow-up|11
7279931|NCT00468676|11495276|FG000|Overall Study|Death|2
7279932|NCT00468676|11495277|FG001|Overall Study|Death|1
7279933|NCT00468728|11495287|FG000|Treatment|criteria for mITT population|4
7279934|NCT00468728|11495288|FG001|Treatment|criteria for mITT population|11
7279935|NCT00468728|11495287|FG000|Follow-up|mITT failure|34
7279936|NCT00468728|11495288|FG001|Follow-up|mITT failure|31
7279937|NCT00468819|11495299|FG000|Overall Study|Withdrawal by Subject|4
7279938|NCT00468819|11495300|FG001|Overall Study|Withdrawal by Subject|0
7279939|NCT00468819|11495301|FG002|Overall Study|Withdrawal by Subject|1
7279940|NCT00468819|11495299|FG000|Overall Study|Lost to Follow-up|0
7279941|NCT00468819|11495300|FG001|Overall Study|Lost to Follow-up|0
7279942|NCT00468819|11495301|FG002|Overall Study|Lost to Follow-up|1
7279943|NCT00468819|11495299|FG000|Overall Study|Drop-outs (Treatment never received)|2
7279944|NCT00468819|11495300|FG001|Overall Study|Drop-outs (Treatment never received)|0
7279945|NCT00468819|11495301|FG002|Overall Study|Drop-outs (Treatment never received)|0
7279946|NCT00468845|11495314|FG000|Overall Study|Adverse Event|9
7279947|NCT00468845|11495315|FG001|Overall Study|Adverse Event|14
7279948|NCT00468845|11495316|FG002|Overall Study|Adverse Event|11
7279949|NCT00468845|11495314|FG000|Overall Study|Lost to Follow-up|2
7279950|NCT00468845|11495315|FG001|Overall Study|Lost to Follow-up|1
7279951|NCT00468845|11495316|FG002|Overall Study|Lost to Follow-up|2
7279952|NCT00468845|11495314|FG000|Overall Study|Other|4
7279953|NCT00468845|11495315|FG001|Overall Study|Other|9
7279954|NCT00468845|11495316|FG002|Overall Study|Other|5
7279955|NCT00468845|11495314|FG000|Overall Study|No longer willing to participate|5
7279956|NCT00468845|11495315|FG001|Overall Study|No longer willing to participate|6
7279957|NCT00468845|11495316|FG002|Overall Study|No longer willing to participate|10
7279958|NCT00468845|11495314|FG000|Overall Study|Randomized, not treated|1
7279959|NCT00468845|11495315|FG001|Overall Study|Randomized, not treated|4
7279960|NCT00468845|11495316|FG002|Overall Study|Randomized, not treated|2
7279961|NCT00468858|11495327|FG000|Overall Study|Adverse Event|0
7279962|NCT00468858|11495328|FG001|Overall Study|Adverse Event|1
7279963|NCT00468858|11495329|FG002|Overall Study|Adverse Event|0
7279964|NCT00468858|11495327|FG000|Overall Study|Withdrawal by Subject|7
7279965|NCT00468858|11495328|FG001|Overall Study|Withdrawal by Subject|4
7279966|NCT00468858|11495329|FG002|Overall Study|Withdrawal by Subject|5
7279967|NCT00468858|11495327|FG000|Overall Study|Relocation|1
7279968|NCT00468858|11495328|FG001|Overall Study|Relocation|3
7279969|NCT00468858|11495329|FG002|Overall Study|Relocation|3
7279970|NCT00468858|11495327|FG000|Overall Study|Lost to Follow-up|1
7279971|NCT00468858|11495328|FG001|Overall Study|Lost to Follow-up|2
7279972|NCT00468858|11495329|FG002|Overall Study|Lost to Follow-up|5
7279973|NCT00468858|11495327|FG000|Overall Study|Other|0
7279974|NCT00468858|11495328|FG001|Overall Study|Other|0
7279975|NCT00468858|11495329|FG002|Overall Study|Other|1
7279976|NCT00468910|11495393|FG000|Overall Study|Lost to Follow-up|2
7279977|NCT00468910|11495394|FG001|Overall Study|Lost to Follow-up|1
7279978|NCT00468910|11495393|FG000|Overall Study|Withdrawal by Subject|2
7279979|NCT00468910|11495394|FG001|Overall Study|Withdrawal by Subject|1
7279980|NCT00468910|11495393|FG000|Overall Study|Medical Contraindication|0
7279981|NCT00468910|11495394|FG001|Overall Study|Medical Contraindication|1
7279982|NCT00469014|11495405|FG000|Initial Phase Randomization|Disease Progression|0
7279983|NCT00469014|11495406|FG001|Initial Phase Randomization|Disease Progression|1
7279984|NCT00469014|11495407|FG002|Initial Phase Randomization|Disease Progression|1
7279985|NCT00469014|11495408|FG003|Initial Phase Randomization|Disease Progression|0
7279986|NCT00469014|11495405|FG000|Initial Phase Randomization|No Response|1
7279987|NCT00469014|11495406|FG001|Initial Phase Randomization|No Response|0
7279988|NCT00469014|11495407|FG002|Initial Phase Randomization|No Response|0
7279989|NCT00469014|11495408|FG003|Initial Phase Randomization|No Response|1
7279990|NCT00469014|11495405|FG000|Adaptive Randomization|Not Evaluable|1
7279991|NCT00469014|11495406|FG001|Adaptive Randomization|Not Evaluable|0
7279992|NCT00469014|11495407|FG002|Adaptive Randomization|Not Evaluable|0
7279993|NCT00469014|11495408|FG003|Adaptive Randomization|Not Evaluable|1
7279994|NCT00469014|11495405|FG000|Adaptive Randomization|No Response|0
7617915|NCT00919763|12028290|FG000|Overall Study|Adverse Event|7
7617916|NCT00919763|12028291|FG001|Overall Study|Adverse Event|1
7617917|NCT00919763|12028290|FG000|Overall Study|Lost to Follow-up|1
7617918|NCT00919763|12028291|FG001|Overall Study|Lost to Follow-up|0
7617919|NCT00919763|12028290|FG000|Overall Study|Protocol Violation|1
7617920|NCT00919763|12028291|FG001|Overall Study|Protocol Violation|1
7279995|NCT00469014|11495406|FG001|Adaptive Randomization|No Response|1
7279996|NCT00469014|11495407|FG002|Adaptive Randomization|No Response|0
7279997|NCT00469014|11495408|FG003|Adaptive Randomization|No Response|0
7279998|NCT00469014|11495405|FG000|Adaptive Randomization|Death|0
7279999|NCT00469014|11495406|FG001|Adaptive Randomization|Death|0
7280000|NCT00469014|11495407|FG002|Adaptive Randomization|Death|1
7280001|NCT00469014|11495408|FG003|Adaptive Randomization|Death|0
7280002|NCT00469079|11495421|FG000|Overall Study|Lack of Efficacy|3
7280003|NCT00469079|11495422|FG001|Overall Study|Lack of Efficacy|8
7280004|NCT00469079|11495423|FG002|Overall Study|Lack of Efficacy|5
7617921|NCT00919763|12028290|FG000|Overall Study|Withdrawal by Subject|3
7617922|NCT00919763|12028291|FG001|Overall Study|Withdrawal by Subject|1
7617923|NCT00919763|12028290|FG000|Overall Study|Non-compliance|0
7617924|NCT00919763|12028291|FG001|Overall Study|Non-compliance|1
7280005|NCT00469079|11495421|FG000|Overall Study|Adverse Event|1
7280006|NCT00469079|11495422|FG001|Overall Study|Adverse Event|3
7280007|NCT00469079|11495423|FG002|Overall Study|Adverse Event|2
7280008|NCT00469079|11495421|FG000|Overall Study|Lost to Follow-up|4
7280009|NCT00469079|11495422|FG001|Overall Study|Lost to Follow-up|8
7280010|NCT00469079|11495423|FG002|Overall Study|Lost to Follow-up|10
7280011|NCT00469079|11495421|FG000|Overall Study|Withdrawal by Subject|1
7280012|NCT00469079|11495422|FG001|Overall Study|Withdrawal by Subject|2
7280013|NCT00469079|11495423|FG002|Overall Study|Withdrawal by Subject|2
7280014|NCT00469079|11495421|FG000|Overall Study|Ineligible|0
7280015|NCT00469079|11495422|FG001|Overall Study|Ineligible|1
7280016|NCT00469079|11495423|FG002|Overall Study|Ineligible|0
7280017|NCT00469092|11495439|FG000|Overall Study|Adverse Event|5
7280018|NCT00469092|11495440|FG001|Overall Study|Adverse Event|4
7280019|NCT00469092|11495439|FG000|Overall Study|Lack of Efficacy|1
7280020|NCT00469092|11495440|FG001|Overall Study|Lack of Efficacy|0
7280021|NCT00469092|11495439|FG000|Overall Study|Lost to Follow-up|1
7280022|NCT00469092|11495440|FG001|Overall Study|Lost to Follow-up|2
7280023|NCT00469092|11495439|FG000|Overall Study|Protocol Violation|3
7280024|NCT00469092|11495440|FG001|Overall Study|Protocol Violation|3
7280025|NCT00469092|11495439|FG000|Overall Study|Withdrawal by Subject|4
7280026|NCT00469092|11495440|FG001|Overall Study|Withdrawal by Subject|4
7280027|NCT00469092|11495439|FG000|Overall Study|Withdrawal Criteria|3
7280028|NCT00469092|11495440|FG001|Overall Study|Withdrawal Criteria|4
7280029|NCT00469092|11495439|FG000|Overall Study|Incorrectly Randomised|4
7280030|NCT00469092|11495440|FG001|Overall Study|Incorrectly Randomised|3
7280031|NCT00469092|11495439|FG000|Overall Study|Contraindication metformin/glimepiride|1
7280032|NCT00469092|11495440|FG001|Overall Study|Contraindication metformin/glimepiride|0
7280033|NCT00469092|11495439|FG000|Overall Study|Use of lipid lowering drug|1
7280034|NCT00469092|11495440|FG001|Overall Study|Use of lipid lowering drug|0
7280035|NCT00469092|11495439|FG000|Overall Study|Hypoglycaemic Episodes|1
7280036|NCT00469092|11495440|FG001|Overall Study|Hypoglycaemic Episodes|1
7280037|NCT00469092|11495439|FG000|Overall Study|Abnormal lab value|1
7280038|NCT00469092|11495440|FG001|Overall Study|Abnormal lab value|0
7280039|NCT00469092|11495439|FG000|Overall Study|Use of Corticosteroid|1
7280040|NCT00469092|11495440|FG001|Overall Study|Use of Corticosteroid|0
7280041|NCT00469144|11495448|FG000|Overall Study|Death|0
7280042|NCT00469144|11495449|FG001|Overall Study|Death|1
7280043|NCT00469144|11495448|FG000|Overall Study|No Response|5
7280044|NCT00469144|11495449|FG001|Overall Study|No Response|5
7280045|NCT00469144|11495448|FG000|Overall Study|Progressive Disease|1
7280046|NCT00469144|11495449|FG001|Overall Study|Progressive Disease|0
7280047|NCT00469209|11495462|FG000|Overall Study|Adverse Event|1
7280048|NCT00469209|11495463|FG001|Overall Study|Adverse Event|0
7280049|NCT00469209|11495464|FG002|Overall Study|Adverse Event|1
7280050|NCT00469456|11495492|FG000|Overall Study|Adverse Event|4
7280051|NCT00469456|11495493|FG001|Overall Study|Adverse Event|3
7280052|NCT00469456|11495492|FG000|Overall Study|Protocol Violation|1
7280053|NCT00469456|11495493|FG001|Overall Study|Protocol Violation|0
7280054|NCT00469456|11495492|FG000|Overall Study|Withdrawal by Subject|4
7280055|NCT00469456|11495493|FG001|Overall Study|Withdrawal by Subject|1
7280056|NCT00469833|11495508|FG000|Overall Study|No IV access|2
7280057|NCT00469859|11495520|FG000|Overall Study|Inevaluable|0
7280058|NCT00469859|11495521|FG001|Overall Study|Inevaluable|2
7280059|NCT00469898|11495527|FG000|Overall Study|Adverse Event|7
7280060|NCT00469898|11495527|FG000|Overall Study|Withdrawal by Subject|4
7280061|NCT00469898|11495527|FG000|Overall Study|Death|4
7280062|NCT00469898|11495527|FG000|Overall Study|Disease progression|9
7280063|NCT00469898|11495527|FG000|Overall Study|Decreased performance status|1
7280064|NCT00470054|11495539|FG000|Overall Study|Ineligible|1
7280065|NCT00470093|11495543|FG000|Overall Study|Adverse Event|2
7280066|NCT00470158|11495573|FG000|Overall Study|Death|0
7280067|NCT00470158|11495574|FG001|Overall Study|Death|0
7280068|NCT00470158|11495575|FG002|Overall Study|Death|0
7280069|NCT00470158|11495576|FG003|Overall Study|Death|0
7280070|NCT00470158|11495577|FG004|Overall Study|Death|2
7280071|NCT00470158|11495573|FG000|Overall Study|Lost to Follow-up|7
7280072|NCT00470158|11495574|FG001|Overall Study|Lost to Follow-up|8
7280073|NCT00470158|11495575|FG002|Overall Study|Lost to Follow-up|8
7280074|NCT00470158|11495576|FG003|Overall Study|Lost to Follow-up|5
7280075|NCT00470158|11495577|FG004|Overall Study|Lost to Follow-up|4
7280076|NCT00470158|11495573|FG000|Overall Study|Protocol Violation|1
7280077|NCT00470158|11495574|FG001|Overall Study|Protocol Violation|0
7280078|NCT00470158|11495575|FG002|Overall Study|Protocol Violation|0
7280079|NCT00470158|11495576|FG003|Overall Study|Protocol Violation|0
7280080|NCT00470158|11495577|FG004|Overall Study|Protocol Violation|0
7280081|NCT00470184|11495589|FG000|Overall Study|Not Treated(became ineligible)|4
7280082|NCT00470184|11495589|FG000|Overall Study|Not treated (other)|1
7280083|NCT00470184|11495589|FG000|Overall Study|disease Progression|4
7280084|NCT00470184|11495589|FG000|Overall Study|Adverse Event|3
7280085|NCT00470184|11495589|FG000|Overall Study|Withdrawal by Subject|4
7280086|NCT00470184|11495589|FG000|Overall Study|other|5
7280087|NCT00470184|11495589|FG000|Overall Study|recurrence|1
7280088|NCT00470262|11495596|FG000|Overall Study|Withdrawal by Subject|2
7280089|NCT00470262|11495597|FG001|Overall Study|Withdrawal by Subject|0
7280090|NCT00470275|11495604|FG000|Overall Study|Death|1
7280091|NCT00470275|11495604|FG000|Overall Study|Lack of Efficacy|7
7280092|NCT00470275|11495604|FG000|Overall Study|Withdrawal by Subject|2
7280093|NCT00470366|11495613|FG000|Overall Study|Adverse Event|3
7280094|NCT00470366|11495613|FG000|Overall Study|Poor compliance|1
7280095|NCT00470418|11495629|FG000|Overall Study|Withdrawal by Subject|1
7280096|NCT00470418|11495630|FG001|Overall Study|Withdrawal by Subject|0
7280097|NCT00470470|11495636|FG000|Overall Study|Adverse Event|2
7280098|NCT00470470|11495636|FG000|Overall Study|Death|2
7280099|NCT00470470|11495636|FG000|Overall Study|Not treated|1
7280100|NCT00470535|11495640|FG000|Overall Study|Disease Progression|13
7280101|NCT00470535|11495640|FG000|Overall Study|Withdrawal by Subject|1
7280102|NCT00470535|11495640|FG000|Overall Study|Adverse Event|1
7280103|NCT00470535|11495640|FG000|Overall Study|Death|1
7280104|NCT00470535|11495640|FG000|Overall Study|Other|2
7280105|NCT00470626|11495668|FG000|Overall Study|Lost to Follow-up|10
7280106|NCT00470626|11495668|FG000|Overall Study|Withdrawal by Subject|7
7280107|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
7280108|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
7280109|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Adverse Event|7
7280110|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Adverse Event|6
7280111|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
7280112|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
7280113|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Physician Decision|4
7280114|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Physician Decision|4
7280115|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Protocol Violation|3
7280116|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Protocol Violation|1
7280117|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
7280118|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
7280119|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
7280120|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
7280121|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Non-compliance|1
7280122|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Non-compliance|0
7280123|NCT00470834|11495678|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
7280124|NCT00470834|11495679|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
7280125|NCT00470834|11495678|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
7280126|NCT00470834|11495679|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
7280127|NCT00470834|11495678|FG000|Extension Period (24 Months)|Adverse Event|3
7280128|NCT00470834|11495679|FG001|Extension Period (24 Months)|Adverse Event|4
7280129|NCT00470834|11495678|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
7280130|NCT00470834|11495679|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
7280131|NCT00470834|11495678|FG000|Extension Period (24 Months)|Physician Decision|4
7469832|NCT01927341|11771717|FG004|Phase 1b|Follow-up completed|0
7280132|NCT00470834|11495679|FG001|Extension Period (24 Months)|Physician Decision|3
7280133|NCT00470834|11495678|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
7280134|NCT00470834|11495679|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
7280135|NCT00470834|11495678|FG000|Extension Period (24 Months)|Lost to Follow-up|0
7280136|NCT00470834|11495679|FG001|Extension Period (24 Months)|Lost to Follow-up|1
7280137|NCT00470834|11495678|FG000|Extension Period (24 Months)|Non-compliance|0
7280138|NCT00470834|11495679|FG001|Extension Period (24 Months)|Non-compliance|1
7280139|NCT00470834|11495678|FG000|Extension Period (24 Months)|Disease Progression|0
7280140|NCT00470834|11495679|FG001|Extension Period (24 Months)|Disease Progression|1
7280141|NCT00470847|11495685|FG000|Overall Study|Pt still receiving treatment|1
7280142|NCT00471081|11495702|FG000|Active Phase|Protocol Violation|1
7280143|NCT00471081|11495703|FG001|Active Phase|Protocol Violation|1
7280144|NCT00471081|11495702|FG000|Active Phase|Withdrawal by Subject|0
7280145|NCT00471081|11495703|FG001|Active Phase|Withdrawal by Subject|3
7280146|NCT00471081|11495702|FG000|Active Phase|Lost to Follow-up|0
7280147|NCT00471081|11495703|FG001|Active Phase|Lost to Follow-up|1
7280148|NCT00471081|11495702|FG000|Active Phase|Lost health plan/insurance|1
7280149|NCT00471081|11495703|FG001|Active Phase|Lost health plan/insurance|8
7280150|NCT00471081|11495702|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
7280151|NCT00471081|11495703|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
7280152|NCT00471081|11495702|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
7280153|NCT00471081|11495703|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
7280154|NCT00471081|11495702|FG000|Extended Safety Follow-Up|Missing confirmed|0
7280155|NCT00471081|11495703|FG001|Extended Safety Follow-Up|Missing confirmed|1
7280156|NCT00471107|11495713|FG000|Overall Study|Technical problems/data loss|3
7280157|NCT00471107|11495714|FG001|Overall Study|Technical problems/data loss|1
7280158|NCT00471107|11495715|FG002|Overall Study|Technical problems/data loss|3
7280159|NCT00471146|11495725|FG000|Overall Study|Adverse Event|32
7280160|NCT00471146|11495726|FG001|Overall Study|Adverse Event|33
7280161|NCT00471146|11495725|FG000|Overall Study|Withdrawal by Subject|14
7280162|NCT00471146|11495726|FG001|Overall Study|Withdrawal by Subject|11
7280163|NCT00471146|11495725|FG000|Overall Study|Death|11
7280164|NCT00471146|11495726|FG001|Overall Study|Death|12
7280165|NCT00471146|11495725|FG000|Overall Study|Lost to Follow-up|4
7280166|NCT00471146|11495726|FG001|Overall Study|Lost to Follow-up|2
7280167|NCT00471146|11495725|FG000|Overall Study|Protocol Violation|2
7280168|NCT00471146|11495726|FG001|Overall Study|Protocol Violation|2
7280169|NCT00471146|11495725|FG000|Overall Study|Objective progression or relapse|84
7280170|NCT00471146|11495726|FG001|Overall Study|Objective progression or relapse|87
7280171|NCT00471146|11495725|FG000|Overall Study|Global deterioration of health status|12
7280172|NCT00471146|11495726|FG001|Overall Study|Global deterioration of health status|14
7280173|NCT00471146|11495725|FG000|Overall Study|Randomized but not treated|9
7280174|NCT00471146|11495726|FG001|Overall Study|Randomized but not treated|8
7280175|NCT00471146|11495725|FG000|Overall Study|Other|4
7280176|NCT00471146|11495726|FG001|Overall Study|Other|5
7280177|NCT00471237|11495739|FG000|Overall Study|Adverse Event|6
7280178|NCT00471237|11495740|FG001|Overall Study|Adverse Event|5
7280179|NCT00471237|11495741|FG002|Overall Study|Adverse Event|4
7280180|NCT00471237|11495742|FG003|Overall Study|Adverse Event|8
7280181|NCT00471237|11495743|FG004|Overall Study|Adverse Event|7
7280182|NCT00471237|11495744|FG005|Overall Study|Adverse Event|5
7280183|NCT00471237|11495745|FG006|Overall Study|Adverse Event|0
7280184|NCT00471237|11495739|FG000|Overall Study|Lost to Follow-up|1
7280185|NCT00471237|11495740|FG001|Overall Study|Lost to Follow-up|1
7280186|NCT00471237|11495741|FG002|Overall Study|Lost to Follow-up|0
7280187|NCT00471237|11495742|FG003|Overall Study|Lost to Follow-up|2
7280188|NCT00471237|11495743|FG004|Overall Study|Lost to Follow-up|3
7280189|NCT00471237|11495744|FG005|Overall Study|Lost to Follow-up|0
7280190|NCT00471237|11495745|FG006|Overall Study|Lost to Follow-up|0
7280191|NCT00471237|11495739|FG000|Overall Study|Protocol Violation|3
7280192|NCT00471237|11495740|FG001|Overall Study|Protocol Violation|6
7280193|NCT00471237|11495741|FG002|Overall Study|Protocol Violation|3
7280194|NCT00471237|11495742|FG003|Overall Study|Protocol Violation|2
7280195|NCT00471237|11495743|FG004|Overall Study|Protocol Violation|2
7280196|NCT00471237|11495744|FG005|Overall Study|Protocol Violation|4
7280197|NCT00471237|11495745|FG006|Overall Study|Protocol Violation|1
7280198|NCT00471237|11495739|FG000|Overall Study|Withdrawal by Subject|8
7280199|NCT00471237|11495740|FG001|Overall Study|Withdrawal by Subject|6
7280200|NCT00471237|11495741|FG002|Overall Study|Withdrawal by Subject|5
7280201|NCT00471237|11495742|FG003|Overall Study|Withdrawal by Subject|8
7280202|NCT00471237|11495743|FG004|Overall Study|Withdrawal by Subject|7
7280203|NCT00471237|11495744|FG005|Overall Study|Withdrawal by Subject|4
7280204|NCT00471237|11495745|FG006|Overall Study|Withdrawal by Subject|2
7280205|NCT00471237|11495739|FG000|Overall Study|Sponsor terminated study|20
7280206|NCT00471237|11495740|FG001|Overall Study|Sponsor terminated study|23
7280207|NCT00471237|11495741|FG002|Overall Study|Sponsor terminated study|19
7280208|NCT00471237|11495742|FG003|Overall Study|Sponsor terminated study|22
7280209|NCT00471237|11495743|FG004|Overall Study|Sponsor terminated study|18
7280210|NCT00471237|11495744|FG005|Overall Study|Sponsor terminated study|24
7280211|NCT00471237|11495745|FG006|Overall Study|Sponsor terminated study|0
7280212|NCT00471237|11495739|FG000|Overall Study|Non-compliance|0
7280213|NCT00471237|11495740|FG001|Overall Study|Non-compliance|1
7280214|NCT00471237|11495741|FG002|Overall Study|Non-compliance|0
7280215|NCT00471237|11495742|FG003|Overall Study|Non-compliance|1
7280216|NCT00471237|11495743|FG004|Overall Study|Non-compliance|0
7280217|NCT00471237|11495744|FG005|Overall Study|Non-compliance|0
7280218|NCT00471237|11495745|FG006|Overall Study|Non-compliance|0
7280219|NCT00471237|11495739|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
7280220|NCT00471237|11495740|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
7280221|NCT00471237|11495741|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
7280222|NCT00471237|11495742|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
7280223|NCT00471237|11495743|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
7280224|NCT00471237|11495744|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
7280225|NCT00471237|11495745|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
7280226|NCT00471237|11495739|FG000|Overall Study|Early stopping due to non-efficacy|1
7280227|NCT00471237|11495740|FG001|Overall Study|Early stopping due to non-efficacy|0
7280228|NCT00471237|11495741|FG002|Overall Study|Early stopping due to non-efficacy|0
7280229|NCT00471237|11495742|FG003|Overall Study|Early stopping due to non-efficacy|0
7280230|NCT00471237|11495743|FG004|Overall Study|Early stopping due to non-efficacy|1
7280231|NCT00471237|11495744|FG005|Overall Study|Early stopping due to non-efficacy|0
7280232|NCT00471237|11495745|FG006|Overall Study|Early stopping due to non-efficacy|0
7280233|NCT00471237|11495739|FG000|Overall Study|Participant planned to travel to abraod|1
7280234|NCT00471237|11495740|FG001|Overall Study|Participant planned to travel to abraod|0
7280235|NCT00471237|11495741|FG002|Overall Study|Participant planned to travel to abraod|0
7280236|NCT00471237|11495742|FG003|Overall Study|Participant planned to travel to abraod|0
7280237|NCT00471237|11495743|FG004|Overall Study|Participant planned to travel to abraod|0
7618087|NCT00238420|12028427|FG000|Overall Study|Protocol Violation|1
7618088|NCT00238420|12028428|FG001|Overall Study|Protocol Violation|1
7280238|NCT00471237|11495744|FG005|Overall Study|Participant planned to travel to abraod|1
7618109|NCT04189588|12028504|FG000|Overall Study|Death|0
7618110|NCT04189588|12028505|FG001|Overall Study|Death|1
7618111|NCT04189588|12028504|FG000|Overall Study|Lost to Follow-up|0
7618112|NCT04189588|12028505|FG001|Overall Study|Lost to Follow-up|1
7618113|NCT04115748|12028520|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
7280239|NCT00471237|11495745|FG006|Overall Study|Participant planned to travel to abraod|0
7280240|NCT00471237|11495739|FG000|Overall Study|High parathyroid hormone|0
7280241|NCT00471237|11495740|FG001|Overall Study|High parathyroid hormone|0
7280242|NCT00471237|11495741|FG002|Overall Study|High parathyroid hormone|1
7280243|NCT00471237|11495742|FG003|Overall Study|High parathyroid hormone|0
7280244|NCT00471237|11495743|FG004|Overall Study|High parathyroid hormone|0
7280245|NCT00471237|11495744|FG005|Overall Study|High parathyroid hormone|0
7280246|NCT00471237|11495745|FG006|Overall Study|High parathyroid hormone|0
7280247|NCT00471237|11495739|FG000|Overall Study|Participant lost medication|0
7280248|NCT00471237|11495740|FG001|Overall Study|Participant lost medication|0
7280249|NCT00471237|11495741|FG002|Overall Study|Participant lost medication|0
7280250|NCT00471237|11495742|FG003|Overall Study|Participant lost medication|0
7280251|NCT00471237|11495743|FG004|Overall Study|Participant lost medication|1
7280252|NCT00471237|11495744|FG005|Overall Study|Participant lost medication|0
7280253|NCT00471237|11495745|FG006|Overall Study|Participant lost medication|0
7280254|NCT00471237|11495739|FG000|Overall Study|Administration of prohibited medicine|0
7280255|NCT00471237|11495740|FG001|Overall Study|Administration of prohibited medicine|0
7280256|NCT00471237|11495741|FG002|Overall Study|Administration of prohibited medicine|0
7280257|NCT00471237|11495742|FG003|Overall Study|Administration of prohibited medicine|0
7280258|NCT00471237|11495743|FG004|Overall Study|Administration of prohibited medicine|1
7280259|NCT00471237|11495744|FG005|Overall Study|Administration of prohibited medicine|0
7280260|NCT00471237|11495745|FG006|Overall Study|Administration of prohibited medicine|0
7280261|NCT00471237|11495739|FG000|Overall Study|Participant shifted residence|0
7280262|NCT00471237|11495740|FG001|Overall Study|Participant shifted residence|0
7280263|NCT00471237|11495741|FG002|Overall Study|Participant shifted residence|0
7280264|NCT00471237|11495742|FG003|Overall Study|Participant shifted residence|0
7280265|NCT00471237|11495743|FG004|Overall Study|Participant shifted residence|1
7280266|NCT00471237|11495744|FG005|Overall Study|Participant shifted residence|0
7280267|NCT00471237|11495745|FG006|Overall Study|Participant shifted residence|0
7280268|NCT00471237|11495739|FG000|Overall Study|Participant's decision|0
7280269|NCT00471237|11495740|FG001|Overall Study|Participant's decision|0
7280270|NCT00471237|11495741|FG002|Overall Study|Participant's decision|0
7280271|NCT00471237|11495742|FG003|Overall Study|Participant's decision|0
7280272|NCT00471237|11495743|FG004|Overall Study|Participant's decision|0
7280273|NCT00471237|11495744|FG005|Overall Study|Participant's decision|1
7280274|NCT00471237|11495745|FG006|Overall Study|Participant's decision|0
7280275|NCT00471276|11495765|FG000|Overall Study|Death|2
7280276|NCT00471276|11495765|FG000|Overall Study|Adverse Event|16
7280277|NCT00471276|11495765|FG000|Overall Study|Protocol Violation|1
7280278|NCT00471276|11495765|FG000|Overall Study|Objective progression or relapse|54
7280279|NCT00471276|11495765|FG000|Overall Study|Global deterioration of health status|1
7280280|NCT00471276|11495765|FG000|Overall Study|Other|3
7618114|NCT04115748|12028521|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16
7618115|NCT04115748|12028522|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7
7618116|NCT04115748|12028523|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15
7618117|NCT04115748|12028524|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618118|NCT04115748|12028525|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618119|NCT04115748|12028526|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618120|NCT04115748|12028527|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618121|NCT04115748|12028528|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7618122|NCT04115748|12028529|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0
7280281|NCT00471276|11495765|FG000|Overall Study|Refused treatment|6
7280282|NCT00471315|11495769|FG000|Overall Study|Adverse Event|7
7618123|NCT04115748|12028520|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618124|NCT04115748|12028521|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618125|NCT04115748|12028522|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618126|NCT04115748|12028523|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1
7280283|NCT00471315|11495769|FG000|Overall Study|Withdrawal by Subject|1
7618127|NCT04115748|12028524|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618128|NCT04115748|12028525|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618129|NCT04115748|12028526|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618130|NCT04115748|12028527|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618131|NCT04115748|12028528|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618132|NCT04115748|12028529|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0
7618133|NCT04115748|12028520|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618134|NCT04115748|12028521|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618135|NCT04115748|12028522|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618136|NCT04115748|12028523|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0
7618137|NCT04115748|12028524|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4
7618138|NCT04115748|12028525|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3
7618139|NCT04115748|12028526|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618140|NCT04115748|12028527|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618141|NCT04115748|12028528|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1
7618142|NCT04115748|12028529|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2
7618143|NCT04115748|12028520|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618144|NCT04115748|12028521|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618145|NCT04115748|12028522|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618146|NCT04115748|12028523|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618147|NCT04115748|12028524|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618148|NCT04115748|12028525|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618149|NCT04115748|12028526|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618150|NCT04115748|12028527|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7618151|NCT04115748|12028528|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1
7618152|NCT04115748|12028529|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0
7280284|NCT00471328|11495775|FG000|Core Phase|Adverse Event|18
7280285|NCT00471328|11495776|FG001|Core Phase|Adverse Event|6
7280286|NCT00471328|11495775|FG000|Core Phase|Death|8
7280287|NCT00471328|11495776|FG001|Core Phase|Death|4
7618153|NCT04044664|12028554|FG000|Stage 1|Adverse Event|3
7618154|NCT04044664|12028555|FG001|Stage 1|Adverse Event|3
7618155|NCT04044664|12028556|FG002|Stage 1|Adverse Event|1
7618156|NCT04044664|12028554|FG000|Stage 1|Lost to Follow-up|3
7618157|NCT04044664|12028555|FG001|Stage 1|Lost to Follow-up|2
7618158|NCT04044664|12028556|FG002|Stage 1|Lost to Follow-up|2
7618159|NCT04044664|12028554|FG000|Stage 1|Withdrawal by Subject|9
7618160|NCT04044664|12028555|FG001|Stage 1|Withdrawal by Subject|1
7618161|NCT04044664|12028556|FG002|Stage 1|Withdrawal by Subject|0
7618162|NCT04044664|12028554|FG000|Stage 1|noncompliance, personal reason|2
7618163|NCT04044664|12028555|FG001|Stage 1|noncompliance, personal reason|0
7618164|NCT04044664|12028556|FG002|Stage 1|noncompliance, personal reason|0
7618165|NCT04044664|12028554|FG000|Stage 1|randomization error|0
7618166|NCT04044664|12028555|FG001|Stage 1|randomization error|1
7618167|NCT04044664|12028556|FG002|Stage 1|randomization error|0
7618168|NCT04044664|12028554|FG000|Stage 2|Adverse Event|2
7618169|NCT04044664|12028555|FG001|Stage 2|Adverse Event|0
7618170|NCT04044664|12028556|FG002|Stage 2|Adverse Event|0
7618171|NCT04044664|12028554|FG000|Stage 2|Lost to Follow-up|3
7618172|NCT04044664|12028555|FG001|Stage 2|Lost to Follow-up|2
7618173|NCT04044664|12028556|FG002|Stage 2|Lost to Follow-up|1
7618174|NCT04044664|12028554|FG000|Stage 2|Withdrawal by Subject|3
7618175|NCT04044664|12028555|FG001|Stage 2|Withdrawal by Subject|0
7618176|NCT04044664|12028556|FG002|Stage 2|Withdrawal by Subject|0
7618177|NCT04044664|12028554|FG000|Stage 2|protocol deviation|1
7618178|NCT04044664|12028555|FG001|Stage 2|protocol deviation|0
7618179|NCT04044664|12028556|FG002|Stage 2|protocol deviation|0
7618180|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Death|2
7618181|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Death|0
7618182|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Lost to Follow-up|3
7618183|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Lost to Follow-up|6
7618184|NCT03994731|12028575|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15
7618185|NCT03994731|12028576|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9
7618186|NCT03924622|12028604|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2
7618187|NCT03924622|12028605|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618188|NCT03924622|12028606|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618223|NCT03367819|12028696|FG001|Overall Study|Progressive Disease|13
7618189|NCT03924622|12028607|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4
7618190|NCT03924622|12028608|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618191|NCT03924622|12028609|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3
7618194|NCT03802513|12028657|FG000|Overall Study|Lost to Follow-up|1
7280288|NCT00471328|11495775|FG000|Core Phase|Withdrawal by Subject|2
7280289|NCT00471328|11495776|FG001|Core Phase|Withdrawal by Subject|2
7280290|NCT00471328|11495775|FG000|Core Phase|Abnormal laboratory value|1
7280291|NCT00471328|11495776|FG001|Core Phase|Abnormal laboratory value|0
7280292|NCT00471328|11495775|FG000|Core Phase|Disease Progression|78
7280293|NCT00471328|11495776|FG001|Core Phase|Disease Progression|53
7280294|NCT00471328|11495775|FG000|Core Phase|Administrative Problem|0
7280295|NCT00471328|11495776|FG001|Core Phase|Administrative Problem|1
7280296|NCT00471328|11495775|FG000|Core Phase|Protocol Deviation|0
7280297|NCT00471328|11495776|FG001|Core Phase|Protocol Deviation|1
7280298|NCT00471328|11495775|FG000|Extension Phase|Adverse Event|3
7280299|NCT00471328|11495776|FG001|Extension Phase|Adverse Event|12
7280300|NCT00471328|11495775|FG000|Extension Phase|Withdrawal by Subject|0
7280301|NCT00471328|11495776|FG001|Extension Phase|Withdrawal by Subject|2
7280302|NCT00471328|11495775|FG000|Extension Phase|Death|1
7280303|NCT00471328|11495776|FG001|Extension Phase|Death|7
7280304|NCT00471328|11495775|FG000|Extension Phase|Protocol Deviation|3
7280305|NCT00471328|11495776|FG001|Extension Phase|Protocol Deviation|1
7280306|NCT00471328|11495775|FG000|Extension Phase|Treatment duration as per protocol|0
7280307|NCT00471328|11495776|FG001|Extension Phase|Treatment duration as per protocol|1
7280308|NCT00471328|11495775|FG000|Extension Phase|Disease Progression|32
7280309|NCT00471328|11495776|FG001|Extension Phase|Disease Progression|44
7280310|NCT00471328|11495775|FG000|Extension Phase|New cancer Therapy|1
7280311|NCT00471328|11495776|FG001|Extension Phase|New cancer Therapy|0
7280312|NCT00471328|11495775|FG000|Extension Phase|Administrative Problem|1
7280313|NCT00471328|11495776|FG001|Extension Phase|Administrative Problem|0
7280314|NCT00471354|11495784|FG000|Overall Study|Protocol Entry Criteria Not Met|1
7280315|NCT00471354|11495784|FG000|Overall Study|Adverse Event|13
7280316|NCT00471354|11495784|FG000|Overall Study|Protocol Violation|12
7280317|NCT00471354|11495784|FG000|Overall Study|Withdrawal by Subject|1
7280318|NCT00471354|11495784|FG000|Overall Study|Physician Decision|4
7280319|NCT00471354|11495784|FG000|Overall Study|Sponsor Decision|1
7280320|NCT00471354|11495784|FG000|Overall Study|Lost to Follow-up|3
7280321|NCT00471354|11495784|FG000|Overall Study|Lack of Efficacy|5
7280322|NCT00471354|11495784|FG000|Overall Study|Patient/Caregiver Decision|12
7280323|NCT00471445|11495797|FG000|Overall Study|Withdrawal by Subject|1
7280324|NCT00471445|11495798|FG001|Overall Study|Withdrawal by Subject|1
7280325|NCT00471445|11495797|FG000|Overall Study|Ineligible|1
7280326|NCT00471445|11495798|FG001|Overall Study|Ineligible|0
7280327|NCT00471445|11495797|FG000|Overall Study|Protocol Violation|0
7280328|NCT00471445|11495798|FG001|Overall Study|Protocol Violation|1
7280329|NCT00471497|11495807|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
7280330|NCT00471497|11495808|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
7280331|NCT00471497|11495809|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
7280332|NCT00471497|11495807|FG000|Core Treatment Phase|Abnormal Test Procedures|1
7280333|NCT00471497|11495808|FG001|Core Treatment Phase|Abnormal Test Procedures|0
7280334|NCT00471497|11495809|FG002|Core Treatment Phase|Abnormal Test Procedures|1
7280335|NCT00471497|11495807|FG000|Core Treatment Phase|Condition no longer requires study drug|0
7280336|NCT00471497|11495808|FG001|Core Treatment Phase|Condition no longer requires study drug|1
7280337|NCT00471497|11495809|FG002|Core Treatment Phase|Condition no longer requires study drug|0
7280338|NCT00471497|11495807|FG000|Core Treatment Phase|Withdrawal by Subject|31
7280339|NCT00471497|11495808|FG001|Core Treatment Phase|Withdrawal by Subject|29
7618215|NCT03576716|12028682|FG000|Overall Study|Withdrawal by Subject|0
7618216|NCT03576716|12028683|FG001|Overall Study|Withdrawal by Subject|1
7618220|NCT03367819|12028695|FG000|Overall Study|Adverse Event|4
7618221|NCT03367819|12028696|FG001|Overall Study|Adverse Event|4
7618222|NCT03367819|12028695|FG000|Overall Study|Progressive Disease|15
7618224|NCT03367819|12028695|FG000|Overall Study|Withdrawal by Subject|1
7618225|NCT03367819|12028696|FG001|Overall Study|Withdrawal by Subject|0
7618226|NCT03367819|12028695|FG000|Overall Study|Other|4
7618227|NCT03367819|12028696|FG001|Overall Study|Other|2
7618228|NCT03182868|12028712|FG000|Overall Study|Protocol Violation|3
7280340|NCT00471497|11495809|FG002|Core Treatment Phase|Withdrawal by Subject|34
7618229|NCT03182868|12028713|FG001|Overall Study|Protocol Violation|0
7618230|NCT03182868|12028714|FG002|Overall Study|Protocol Violation|4
7618231|NCT03182868|12028715|FG003|Overall Study|Protocol Violation|1
7618232|NCT03182868|12028716|FG004|Overall Study|Protocol Violation|8
7280341|NCT00471497|11495807|FG000|Core Treatment Phase|Lost to Follow-up|6
7618245|NCT03077620|12028741|FG000|Overall Study|Unable to place lumbar catheter|1
7618246|NCT03077620|12028742|FG001|Overall Study|Unable to place lumbar catheter|0
7618247|NCT03077620|12028743|FG002|Overall Study|Unable to place lumbar catheter|1
7618248|NCT03077620|12028744|FG003|Overall Study|Unable to place lumbar catheter|0
7280342|NCT00471497|11495808|FG001|Core Treatment Phase|Lost to Follow-up|6
7280343|NCT00471497|11495809|FG002|Core Treatment Phase|Lost to Follow-up|3
7280344|NCT00471497|11495807|FG000|Core Treatment Phase|Death|3
7280345|NCT00471497|11495808|FG001|Core Treatment Phase|Death|9
7280346|NCT00471497|11495809|FG002|Core Treatment Phase|Death|3
7280347|NCT00471497|11495807|FG000|Core Treatment Phase|Disease Progression|10
7280348|NCT00471497|11495808|FG001|Core Treatment Phase|Disease Progression|2
7280349|NCT00471497|11495809|FG002|Core Treatment Phase|Disease Progression|4
7280350|NCT00471497|11495807|FG000|Core Treatment Phase|Protocol Violation|6
7280351|NCT00471497|11495808|FG001|Core Treatment Phase|Protocol Violation|15
7280352|NCT00471497|11495809|FG002|Core Treatment Phase|Protocol Violation|11
7280353|NCT00471497|11495807|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
7280354|NCT00471497|11495808|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
7280355|NCT00471497|11495809|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
7280356|NCT00471497|11495807|FG000|Core Treatment Phase|Administrative problems|14
7280357|NCT00471497|11495808|FG001|Core Treatment Phase|Administrative problems|14
7280358|NCT00471497|11495809|FG002|Core Treatment Phase|Administrative problems|12
7280359|NCT00471497|11495807|FG000|Core Treatment Phase|Adverse Event|43
7280360|NCT00471497|11495808|FG001|Core Treatment Phase|Adverse Event|53
7280361|NCT00471497|11495809|FG002|Core Treatment Phase|Adverse Event|89
7280362|NCT00471497|11495807|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
7280363|NCT00471497|11495808|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7280364|NCT00471497|11495809|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
7280365|NCT00471497|11495807|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
7280366|NCT00471497|11495808|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
7280367|NCT00471497|11495809|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
7280368|NCT00471497|11495807|FG000|Extension Phase|Adverse Event|9
7280369|NCT00471497|11495808|FG001|Extension Phase|Adverse Event|5
7280370|NCT00471497|11495809|FG002|Extension Phase|Adverse Event|1
7280371|NCT00471497|11495807|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
7280372|NCT00471497|11495808|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
7280373|NCT00471497|11495809|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
7280374|NCT00471497|11495807|FG000|Extension Phase|Withdrawal by Subject|3
7280375|NCT00471497|11495808|FG001|Extension Phase|Withdrawal by Subject|1
7280376|NCT00471497|11495809|FG002|Extension Phase|Withdrawal by Subject|0
7280377|NCT00471497|11495807|FG000|Extension Phase|Lost to Follow-up|2
7280378|NCT00471497|11495808|FG001|Extension Phase|Lost to Follow-up|0
7280379|NCT00471497|11495809|FG002|Extension Phase|Lost to Follow-up|0
7280380|NCT00471497|11495807|FG000|Extension Phase|Death|1
7280381|NCT00471497|11495808|FG001|Extension Phase|Death|0
7280382|NCT00471497|11495809|FG002|Extension Phase|Death|0
7280383|NCT00471497|11495807|FG000|Extension Phase|Disease progression|2
7280384|NCT00471497|11495808|FG001|Extension Phase|Disease progression|0
7280385|NCT00471497|11495809|FG002|Extension Phase|Disease progression|0
7280386|NCT00471497|11495807|FG000|Extension Phase|Protocol Violation|2
7280387|NCT00471497|11495808|FG001|Extension Phase|Protocol Violation|2
7280388|NCT00471497|11495809|FG002|Extension Phase|Protocol Violation|0
7280389|NCT00471536|11495820|FG000|Overall Study|Withdrawal by Subject|1
7280390|NCT00471718|11495837|FG000|Overall Study|Adverse Event|3
7280391|NCT00471718|11495837|FG000|Overall Study|other complicating disease|1
7280392|NCT00471718|11495837|FG000|Overall Study|disease progression|22
7280393|NCT00471718|11495837|FG000|Overall Study|Withdrawal by Subject|1
7280394|NCT00471822|11495845|FG000|Overall Study|Protocol Violation|2
7280395|NCT00471887|11495853|FG000|Overall Study|Adverse Event|9
7280396|NCT00472030|11495859|FG000|Overall Study|Physician Decision|1
7280397|NCT00472030|11495860|FG001|Overall Study|Physician Decision|0
7280398|NCT00472199|11495887|FG000|Overall Study|Adverse Event|19
7280399|NCT00472199|11495888|FG001|Overall Study|Adverse Event|23
7280400|NCT00472199|11495887|FG000|Overall Study|Lack of Efficacy|4
7280401|NCT00472199|11495888|FG001|Overall Study|Lack of Efficacy|25
7280402|NCT00472199|11495887|FG000|Overall Study|Lost to Follow-up|2
7280403|NCT00472199|11495888|FG001|Overall Study|Lost to Follow-up|4
7280404|NCT00472199|11495887|FG000|Overall Study|Protocol Violation|3
7618249|NCT03077620|12028741|FG000|Overall Study|Withdrawal by Subject|0
7618250|NCT03077620|12028742|FG001|Overall Study|Withdrawal by Subject|1
7618251|NCT03077620|12028743|FG002|Overall Study|Withdrawal by Subject|0
7618252|NCT03077620|12028744|FG003|Overall Study|Withdrawal by Subject|0
7618253|NCT03077620|12028741|FG000|Overall Study|Physician Decision|0
7618254|NCT03077620|12028742|FG001|Overall Study|Physician Decision|0
7618255|NCT03077620|12028743|FG002|Overall Study|Physician Decision|1
7618256|NCT03077620|12028744|FG003|Overall Study|Physician Decision|0
7618257|NCT02951052|12028769|FG000|Overall Study|Adverse Event|13
7618258|NCT02951052|12028770|FG001|Overall Study|Adverse Event|5
7618259|NCT02951052|12028769|FG000|Overall Study|Withdrawal by Subject|1
7280405|NCT00472199|11495888|FG001|Overall Study|Protocol Violation|2
7280406|NCT00472199|11495887|FG000|Overall Study|Withdrawal by Subject|6
7618260|NCT02951052|12028770|FG001|Overall Study|Withdrawal by Subject|5
7618261|NCT02951052|12028769|FG000|Overall Study|Physician Decision|2
7618262|NCT02951052|12028770|FG001|Overall Study|Physician Decision|0
7618263|NCT02951052|12028769|FG000|Overall Study|Lost to Follow-up|1
7618264|NCT02951052|12028770|FG001|Overall Study|Lost to Follow-up|1
7618265|NCT02951052|12028769|FG000|Overall Study|Protocol-specified withdrawal criterion|1
7618266|NCT02951052|12028770|FG001|Overall Study|Protocol-specified withdrawal criterion|0
7618267|NCT02951052|12028769|FG000|Overall Study|Protocol Violation|5
7618268|NCT02951052|12028770|FG001|Overall Study|Protocol Violation|3
7618269|NCT02951052|12028769|FG000|Overall Study|Lack of Efficacy|3
7618270|NCT02951052|12028770|FG001|Overall Study|Lack of Efficacy|4
7618271|NCT02951052|12028769|FG000|Overall Study|Ongoing|1
7618272|NCT02951052|12028770|FG001|Overall Study|Ongoing|0
7280407|NCT00472199|11495888|FG001|Overall Study|Withdrawal by Subject|5
7280408|NCT00472199|11495887|FG000|Overall Study|personal reason|0
7280409|NCT00472199|11495888|FG001|Overall Study|personal reason|1
7280410|NCT00472199|11495887|FG000|Overall Study|patient was asymptomatic|1
7280411|NCT00472199|11495888|FG001|Overall Study|patient was asymptomatic|0
7280412|NCT00472290|11495894|FG000|Overall Study|Progression of Therapy-Related MDS|1
7280413|NCT00472290|11495894|FG000|Overall Study|Protocol Specified Criteria|7
7280414|NCT00472290|11495894|FG000|Overall Study|Administrative Decision|37
7280415|NCT00472290|11495894|FG000|Overall Study|Death|3
7280416|NCT00472290|11495894|FG000|Overall Study|Lost to Follow-up|1
7280417|NCT00472290|11495894|FG000|Overall Study|Lack of Efficacy|1
7280418|NCT00472290|11495894|FG000|Overall Study|Disease Progression|4
7280419|NCT00472290|11495894|FG000|Overall Study|Withdrawal by Subject|5
7280420|NCT00472290|11495894|FG000|Overall Study|Adverse Event|6
7280421|NCT00472290|11495894|FG000|Overall Study|Requirement for alternative therapy|7
7280422|NCT00472303|11495900|FG000|Titration Phase|Adverse Event|22
7280423|NCT00472303|11495901|FG001|Titration Phase|Adverse Event|12
7280424|NCT00472303|11495902|FG002|Titration Phase|Adverse Event|0
7280425|NCT00472303|11495900|FG000|Titration Phase|Death|4
7280426|NCT00472303|11495901|FG001|Titration Phase|Death|2
7280427|NCT00472303|11495902|FG002|Titration Phase|Death|0
7280428|NCT00472303|11495900|FG000|Titration Phase|Lack of Efficacy|10
7280429|NCT00472303|11495901|FG001|Titration Phase|Lack of Efficacy|0
7280430|NCT00472303|11495902|FG002|Titration Phase|Lack of Efficacy|0
7280431|NCT00472303|11495900|FG000|Titration Phase|Withdrawal by Subject|16
7280432|NCT00472303|11495901|FG001|Titration Phase|Withdrawal by Subject|13
7280433|NCT00472303|11495902|FG002|Titration Phase|Withdrawal by Subject|0
7280434|NCT00472303|11495900|FG000|Titration Phase|Trial Medication non-compliant|4
7280435|NCT00472303|11495901|FG001|Titration Phase|Trial Medication non-compliant|1
7280436|NCT00472303|11495902|FG002|Titration Phase|Trial Medication non-compliant|0
7618273|NCT02598583|12028791|FG000|Extension Period|Withdrawal by Subject|1
7618274|NCT02598583|12028792|FG001|Extension Period|Withdrawal by Subject|0
7618275|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Adverse Event|2
7618276|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Progressive Disease|2
7618277|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
7618278|NCT02536794|12028807|FG000|Reached 1st Response Assessment|Protocol Violation|1
7618279|NCT02536794|12028807|FG000|Continued Treatment After 1st Response|Progressive disease|7
7618280|NCT02536794|12028807|FG000|Continued Treatment After 1st Response|Adverse Event|1
7618281|NCT02285114|12028827|FG000|Overall Study|Investigator's Discretion|0
7618282|NCT02285114|12028828|FG001|Overall Study|Investigator's Discretion|2
7618283|NCT02285114|12028829|FG002|Overall Study|Investigator's Discretion|0
7618284|NCT02285114|12028827|FG000|Overall Study|Withdrew Consent|0
7618285|NCT02285114|12028828|FG001|Overall Study|Withdrew Consent|0
7618286|NCT02285114|12028829|FG002|Overall Study|Withdrew Consent|1
7618287|NCT02285114|12028827|FG000|Overall Study|Enrolled but not treated|1
7618288|NCT02285114|12028828|FG001|Overall Study|Enrolled but not treated|0
7618289|NCT02285114|12028829|FG002|Overall Study|Enrolled but not treated|0
7618290|NCT02285114|12028827|FG000|Overall Study|Still on study|21
7618291|NCT02285114|12028828|FG001|Overall Study|Still on study|5
7618292|NCT02285114|12028829|FG002|Overall Study|Still on study|2
7618293|NCT02263508|12028846|FG000|Overall Study|Withdrawal by Subject|1
7618294|NCT02263508|12028847|FG001|Overall Study|Withdrawal by Subject|23
7618295|NCT02263508|12028848|FG002|Overall Study|Withdrawal by Subject|17
7618296|NCT02263508|12028846|FG000|Overall Study|Sponsor Decision|12
7618297|NCT02263508|12028847|FG001|Overall Study|Sponsor Decision|165
7618298|NCT02263508|12028848|FG002|Overall Study|Sponsor Decision|182
7618299|NCT02263508|12028846|FG000|Overall Study|Lost to Follow-up|2
7280437|NCT00472303|11495900|FG000|Titration Phase|Other|3
7280438|NCT00472303|11495901|FG001|Titration Phase|Other|1
7280439|NCT00472303|11495902|FG002|Titration Phase|Other|0
7280440|NCT00472303|11495900|FG000|Discontinuations After Titration Phase|Adverse Event|6
7280441|NCT00472303|11495901|FG001|Discontinuations After Titration Phase|Adverse Event|0
7280442|NCT00472303|11495902|FG002|Discontinuations After Titration Phase|Adverse Event|0
7280443|NCT00472303|11495900|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
7280444|NCT00472303|11495901|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
7618300|NCT02263508|12028847|FG001|Overall Study|Lost to Follow-up|7
7618301|NCT02263508|12028848|FG002|Overall Study|Lost to Follow-up|7
7618302|NCT02263508|12028846|FG000|Overall Study|Death|6
7618303|NCT02263508|12028847|FG001|Overall Study|Death|151
7618304|NCT02263508|12028848|FG002|Overall Study|Death|140
7280445|NCT00472303|11495902|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
7280446|NCT00472303|11495900|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
7618305|NCT02246530|12028861|FG000|Overall Study|Lost to Follow-up|4
7618306|NCT02246530|12028862|FG001|Overall Study|Lost to Follow-up|0
7618307|NCT01936857|12028895|FG000|Overall Study|Sent to prison or 06 center|11
7618308|NCT01936857|12028896|FG001|Overall Study|Sent to prison or 06 center|12
7618309|NCT01936857|12028895|FG000|Overall Study|Lost to Follow-up|10
7618310|NCT01936857|12028896|FG001|Overall Study|Lost to Follow-up|7
7618311|NCT01936857|12028895|FG000|Overall Study|Death|7
7618312|NCT01936857|12028896|FG001|Overall Study|Death|3
7618313|NCT01936857|12028895|FG000|Overall Study|Moved|2
7618314|NCT01936857|12028896|FG001|Overall Study|Moved|1
7618315|NCT01936857|12028895|FG000|Overall Study|Withdrawal by Subject|1
7618316|NCT01936857|12028896|FG001|Overall Study|Withdrawal by Subject|0
7618317|NCT01936857|12028895|FG000|Overall Study|Side effect of medication|1
7618318|NCT01936857|12028896|FG001|Overall Study|Side effect of medication|0
7618319|NCT01936857|12028895|FG000|Overall Study|Other|2
7618320|NCT01936857|12028896|FG001|Overall Study|Other|2
7618321|NCT01715285|12028913|FG000|Treatment Period|Adverse Event|60
7618322|NCT01715285|12028914|FG001|Treatment Period|Adverse Event|33
7618323|NCT01715285|12028915|FG002|Treatment Period|Adverse Event|0
7618324|NCT01715285|12028913|FG000|Treatment Period|Lost to Follow-up|3
7618325|NCT01715285|12028914|FG001|Treatment Period|Lost to Follow-up|2
7618326|NCT01715285|12028915|FG002|Treatment Period|Lost to Follow-up|0
7618327|NCT01715285|12028913|FG000|Treatment Period|Death|36
7618328|NCT01715285|12028914|FG001|Treatment Period|Death|23
7618329|NCT01715285|12028915|FG002|Treatment Period|Death|0
7618330|NCT01715285|12028913|FG000|Treatment Period|Noncompliance With Study Drug|4
7618331|NCT01715285|12028914|FG001|Treatment Period|Noncompliance With Study Drug|2
7618332|NCT01715285|12028915|FG002|Treatment Period|Noncompliance With Study Drug|0
7618333|NCT01715285|12028913|FG000|Treatment Period|Progressive Disease|254
7618334|NCT01715285|12028914|FG001|Treatment Period|Progressive Disease|388
7618335|NCT01715285|12028915|FG002|Treatment Period|Progressive Disease|0
7618336|NCT01715285|12028913|FG000|Treatment Period|Withdrawal Of Consent|52
7618337|NCT01715285|12028914|FG001|Treatment Period|Withdrawal Of Consent|47
7618338|NCT01715285|12028915|FG002|Treatment Period|Withdrawal Of Consent|0
7280447|NCT00472303|11495901|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
7469833|NCT01927341|11771713|FG000|Phase 2|Lost to Follow-up|0
7618339|NCT01715285|12028913|FG000|Treatment Period|Physician Decision|21
7618340|NCT01715285|12028914|FG001|Treatment Period|Physician Decision|23
7618341|NCT01715285|12028915|FG002|Treatment Period|Physician Decision|0
7618342|NCT01715285|12028913|FG000|Treatment Period|Ongoing|157
7618343|NCT01715285|12028914|FG001|Treatment Period|Ongoing|0
7618344|NCT01715285|12028915|FG002|Treatment Period|Ongoing|0
7618345|NCT01715285|12028913|FG000|Treatment Period|Other|10
7618346|NCT01715285|12028914|FG001|Treatment Period|Other|12
7618347|NCT01715285|12028915|FG002|Treatment Period|Other|0
7618348|NCT01715285|12028913|FG000|Treatment Period|Placebo Cross-over|0
7618349|NCT01715285|12028914|FG001|Treatment Period|Placebo Cross-over|72
7618350|NCT01715285|12028915|FG002|Treatment Period|Placebo Cross-over|0
7618351|NCT01715285|12028913|FG000|Open-label (OL) Extension Phase|Ongoing|157
7618352|NCT01715285|12028914|FG001|Open-label (OL) Extension Phase|Ongoing|0
7618353|NCT01715285|12028915|FG002|Open-label (OL) Extension Phase|Ongoing|72
7215382|NCT04755595|11422914|FG000|Overall Study|Lost to Follow-up|1
7215383|NCT04749745|11422919|FG000|Overall Study|Withdrawal by Subject|1
7215384|NCT04749745|11422920|FG001|Overall Study|Withdrawal by Subject|0
7215385|NCT04748341|11422928|FG000|Overall Study|Lost to Follow-up|1
7215386|NCT04748341|11422929|FG001|Overall Study|Lost to Follow-up|1
7215387|NCT04737278|11422937|FG000|Overall Study|Lost to Follow-up|1
7215388|NCT04737278|11422938|FG001|Overall Study|Lost to Follow-up|1
7215389|NCT04737278|11422937|FG000|Overall Study|Withdrawal by Subject|1
7215390|NCT04737278|11422938|FG001|Overall Study|Withdrawal by Subject|0
7215391|NCT04737278|11422937|FG000|Overall Study|Protocol Violation|1
7215392|NCT04737278|11422938|FG001|Overall Study|Protocol Violation|1
7215393|NCT04737278|11422937|FG000|Overall Study|failure to complete questionnaire|1
7215394|NCT04737278|11422938|FG001|Overall Study|failure to complete questionnaire|1
7280448|NCT00472303|11495902|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
7280449|NCT00472303|11495900|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7280450|NCT00472303|11495901|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
7280451|NCT00472303|11495902|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
7280452|NCT00472303|11495900|FG000|Discontinuations After Titration Phase|Other|5
7280453|NCT00472303|11495901|FG001|Discontinuations After Titration Phase|Other|0
7280454|NCT00472303|11495902|FG002|Discontinuations After Titration Phase|Other|0
7280455|NCT00472303|11495900|FG000|Maintenance Phase|Adverse Event|5
7280456|NCT00472303|11495901|FG001|Maintenance Phase|Adverse Event|6
7280457|NCT00472303|11495902|FG002|Maintenance Phase|Adverse Event|6
7280458|NCT00472303|11495900|FG000|Maintenance Phase|Death|3
7280459|NCT00472303|11495901|FG001|Maintenance Phase|Death|0
7280460|NCT00472303|11495902|FG002|Maintenance Phase|Death|2
7280461|NCT00472303|11495900|FG000|Maintenance Phase|Lack of Efficacy|2
7280462|NCT00472303|11495901|FG001|Maintenance Phase|Lack of Efficacy|2
7280463|NCT00472303|11495902|FG002|Maintenance Phase|Lack of Efficacy|4
7618354|NCT04209725|12028944|FG000|Overall Study|Adverse Event|1
7618355|NCT04185909|12028948|FG000|Overall Study|Lost to Follow-up|1
7618356|NCT04076943|12028952|FG000|Overall Study|Withdrawal by Subject|12
7618357|NCT04076943|12028952|FG000|Overall Study|Adverse Event|1
7618358|NCT04076943|12028952|FG000|Overall Study|Progressive Disease|2
7618359|NCT04076943|12028952|FG000|Overall Study|Death|13
7618360|NCT04076943|12028952|FG000|Overall Study|Other than specified|6
7618361|NCT03332498|12028969|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
7215430|NCT04334460|11422992|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4
7215431|NCT04334460|11422993|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1
7215432|NCT04334460|11422992|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4
7215433|NCT04334460|11422993|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1
7280464|NCT00472303|11495900|FG000|Maintenance Phase|Withdrawal by Subject|6
7280465|NCT00472303|11495901|FG001|Maintenance Phase|Withdrawal by Subject|7
7280466|NCT00472303|11495902|FG002|Maintenance Phase|Withdrawal by Subject|3
7618362|NCT03332498|12028970|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
7618363|NCT03332498|12028971|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
7618364|NCT02900976|12028989|FG000|Overall Study|Adverse Event|0
7618365|NCT02900976|12028990|FG001|Overall Study|Adverse Event|1
7618366|NCT02900976|12028989|FG000|Overall Study|Physician Decision|0
7618367|NCT02900976|12028990|FG001|Overall Study|Physician Decision|2
7618368|NCT02900976|12028989|FG000|Overall Study|Progressive disease|0
7618369|NCT02900976|12028990|FG001|Overall Study|Progressive disease|6
7618370|NCT02720185|12029006|FG000|Overall Study|Lost to Follow-up|1
7618371|NCT02710669|12029013|FG000|Overall Study|Physician Decision|2
7618372|NCT02710669|12029014|FG001|Overall Study|Physician Decision|1
7618373|NCT02710669|12029015|FG002|Overall Study|Physician Decision|0
7618374|NCT02710669|12029013|FG000|Overall Study|Institutional delays (including COVID)|2
7618375|NCT02710669|12029014|FG001|Overall Study|Institutional delays (including COVID)|2
7618376|NCT02710669|12029015|FG002|Overall Study|Institutional delays (including COVID)|0
7618377|NCT02710669|12029013|FG000|Overall Study|arrived in afib/aflutter|10
7618378|NCT02710669|12029014|FG001|Overall Study|arrived in afib/aflutter|8
7618379|NCT02710669|12029015|FG002|Overall Study|arrived in afib/aflutter|2
7618380|NCT02684461|12029026|FG000|Overall Study|Adverse Event|1
7280467|NCT00472303|11495900|FG000|Maintenance Phase|Trial medication non-compliant|0
7280468|NCT00472303|11495901|FG001|Maintenance Phase|Trial medication non-compliant|0
7280469|NCT00472303|11495902|FG002|Maintenance Phase|Trial medication non-compliant|1
7280470|NCT00472303|11495900|FG000|Maintenance Phase|Resolution of pain|0
7280471|NCT00472303|11495901|FG001|Maintenance Phase|Resolution of pain|0
7280472|NCT00472303|11495902|FG002|Maintenance Phase|Resolution of pain|1
7280473|NCT00472303|11495900|FG000|Maintenance Phase|Other|1
7280474|NCT00472303|11495901|FG001|Maintenance Phase|Other|1
7280475|NCT00472303|11495902|FG002|Maintenance Phase|Other|0
7280476|NCT00472420|11495930|FG000|Induction Treatment Period|Physician Decision|9
7618381|NCT02684461|12029027|FG001|Overall Study|Adverse Event|0
7618382|NCT02684461|12029028|FG002|Overall Study|Adverse Event|0
7618383|NCT02684461|12029026|FG000|Overall Study|Lack of Efficacy|1
7618384|NCT02684461|12029027|FG001|Overall Study|Lack of Efficacy|2
7618385|NCT02684461|12029028|FG002|Overall Study|Lack of Efficacy|0
7215434|NCT04247828|11423000|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9
7215435|NCT04084769|11423008|FG000|Overall Study|Protocol Violation|1
7215436|NCT04084769|11423009|FG001|Overall Study|Protocol Violation|3
7280477|NCT00472420|11495930|FG000|Induction Treatment Period|Adverse Event|3
7280478|NCT00472420|11495930|FG000|Induction Treatment Period|Non-compliance|1
7280479|NCT00472420|11495930|FG000|Induction Treatment Period|Death|3
7280480|NCT00472420|11495930|FG000|Follow-up Period|Death|5
7280481|NCT00472420|11495930|FG000|Follow-up Period|Physician Decision|9
7280482|NCT00472420|11495930|FG000|Follow-up Period|Lost to Follow-up|2
7280483|NCT00472420|11495930|FG000|Follow-up Period|Protocol Violation|1
7280484|NCT00472446|11495938|FG000|Overall Study|Protocol Violation|0
7280485|NCT00472446|11495939|FG001|Overall Study|Protocol Violation|0
7280486|NCT00472446|11495940|FG002|Overall Study|Protocol Violation|0
7280487|NCT00472446|11495941|FG003|Overall Study|Protocol Violation|1
7280488|NCT00472446|11495938|FG000|Overall Study|Reintervention|0
7280489|NCT00472446|11495939|FG001|Overall Study|Reintervention|0
7280490|NCT00472446|11495940|FG002|Overall Study|Reintervention|1
7280491|NCT00472446|11495941|FG003|Overall Study|Reintervention|1
7280492|NCT00472446|11495938|FG000|Overall Study|Questionnaires not returned|5
7280493|NCT00472446|11495939|FG001|Overall Study|Questionnaires not returned|6
7280494|NCT00472446|11495940|FG002|Overall Study|Questionnaires not returned|6
7280495|NCT00472446|11495941|FG003|Overall Study|Questionnaires not returned|4
7280496|NCT00472641|11495960|FG000|Overall Study|Lack of Efficacy|3
7280497|NCT00472641|11495960|FG000|Overall Study|Adverse Event|3
7280498|NCT00472641|11495960|FG000|Overall Study|Lost to Follow-up|1
7280499|NCT00473083|11495997|FG000|Overall Study|Adverse Event|1
7280500|NCT00473083|11495998|FG001|Overall Study|Adverse Event|0
7280501|NCT00473083|11495999|FG002|Overall Study|Adverse Event|0
7280502|NCT00473265|11496010|FG000|Overall Study|Unrelated adverse event|5
7280503|NCT00473265|11496010|FG000|Overall Study|Off treatment early|15
7280504|NCT00473330|11496017|FG000|Core Study|Adverse Event|4
7280505|NCT00473330|11496018|FG001|Core Study|Adverse Event|4
7280506|NCT00473330|11496019|FG002|Core Study|Adverse Event|1
7280507|NCT00473330|11496017|FG000|Core Study|Death|6
7280508|NCT00473330|11496018|FG001|Core Study|Death|4
7280509|NCT00473330|11496019|FG002|Core Study|Death|4
7280510|NCT00473330|11496017|FG000|Core Study|Lost to Follow-up|5
7280511|NCT00473330|11496018|FG001|Core Study|Lost to Follow-up|5
7280512|NCT00473330|11496019|FG002|Core Study|Lost to Follow-up|10
7280513|NCT00473330|11496017|FG000|Core Study|Physician Decision|2
7280514|NCT00473330|11496018|FG001|Core Study|Physician Decision|1
7215437|NCT04084769|11423010|FG002|Overall Study|Protocol Violation|0
7215438|NCT04084769|11423011|FG003|Overall Study|Protocol Violation|1
7215439|NCT04084769|11423008|FG000|Overall Study|Withdrawal by Subject|0
7215440|NCT04084769|11423009|FG001|Overall Study|Withdrawal by Subject|1
7215441|NCT04084769|11423010|FG002|Overall Study|Withdrawal by Subject|0
7215442|NCT04084769|11423011|FG003|Overall Study|Withdrawal by Subject|0
7215443|NCT04084769|11423008|FG000|Overall Study|Withdrawal by parent/guardian|1
7215444|NCT04084769|11423009|FG001|Overall Study|Withdrawal by parent/guardian|0
7215445|NCT04084769|11423010|FG002|Overall Study|Withdrawal by parent/guardian|0
7215446|NCT04084769|11423011|FG003|Overall Study|Withdrawal by parent/guardian|1
7215447|NCT04084769|11423008|FG000|Overall Study|Lost to Follow-up|2
7215448|NCT04084769|11423009|FG001|Overall Study|Lost to Follow-up|0
7215449|NCT04084769|11423010|FG002|Overall Study|Lost to Follow-up|0
7280515|NCT00473330|11496019|FG002|Core Study|Physician Decision|3
7280516|NCT00473330|11496017|FG000|Core Study|Subject Non-compliance|1
7280517|NCT00473330|11496018|FG001|Core Study|Subject Non-compliance|2
7215450|NCT04084769|11423011|FG003|Overall Study|Lost to Follow-up|0
7280518|NCT00473330|11496019|FG002|Core Study|Subject Non-compliance|1
7280519|NCT00473330|11496017|FG000|Core Study|Subject Required Other Therapy|0
7280520|NCT00473330|11496018|FG001|Core Study|Subject Required Other Therapy|1
7280521|NCT00473330|11496019|FG002|Core Study|Subject Required Other Therapy|3
7280522|NCT00473330|11496017|FG000|Core Study|Subject's Decision|9
7618405|NCT01295944|12029122|FG000|Overall Study|Switched to alternative treatment|1
7618406|NCT01295944|12029122|FG000|Overall Study|Ineligible|9
7618407|NCT01295944|12029122|FG000|Overall Study|Withdrawal by Subject|4
7618408|NCT01295944|12029122|FG000|Overall Study|Participant chose to be treated in Peru|1
7618409|NCT01295944|12029122|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
7618410|NCT01295944|12029122|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
7618411|NCT01295944|12029122|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
7618412|NCT01285557|12029128|FG000|Overall Study|Death|173
7618413|NCT01285557|12029129|FG001|Overall Study|Death|90
7618414|NCT01285557|12029128|FG000|Overall Study|Lost to Follow-up|6
7618415|NCT01285557|12029129|FG001|Overall Study|Lost to Follow-up|2
7618416|NCT01285557|12029128|FG000|Overall Study|Withdrew Consent|6
7618417|NCT01285557|12029129|FG001|Overall Study|Withdrew Consent|1
7618418|NCT01285557|12029128|FG000|Overall Study|Sponsor Study Termination|23
7618419|NCT01285557|12029129|FG001|Overall Study|Sponsor Study Termination|13
7618420|NCT01285557|12029128|FG000|Overall Study|Randomized but not treated|1
7618421|NCT01285557|12029129|FG001|Overall Study|Randomized but not treated|1
7618422|NCT01285557|12029128|FG000|Overall Study|Study follow-up ongoing|28
7618423|NCT01285557|12029129|FG001|Overall Study|Study follow-up ongoing|14
7618424|NCT01285557|12029128|FG000|Overall Study|Sponsor Decision|2
7618425|NCT01285557|12029129|FG001|Overall Study|Sponsor Decision|1
7618426|NCT00964002|12029159|FG000|Overall Study|Protocol Violation|8
7618427|NCT00790218|12029172|FG000|Overall Study|Death|1
7618428|NCT00790218|12029173|FG001|Overall Study|Death|0
7618429|NCT00790218|12029174|FG002|Overall Study|Death|0
7618430|NCT00145600|12029227|FG000|Overall Study|Death|1
7618431|NCT00145600|12029228|FG001|Overall Study|Death|2
7618432|NCT00145600|12029229|FG002|Overall Study|Death|2
7618433|NCT00145600|12029230|FG003|Overall Study|Death|6
7280523|NCT00473330|11496018|FG001|Core Study|Subject's Decision|8
7280524|NCT00473330|11496019|FG002|Core Study|Subject's Decision|19
7280525|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Adverse Event|0
7280526|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Adverse Event|0
7280527|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Adverse Event|2
7280528|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Death|2
7280529|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Death|0
7280530|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Death|0
7280531|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
7280532|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
7280533|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
7280534|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Physician's Decision|2
7280535|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Physician's Decision|1
7280536|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Physician's Decision|3
7280537|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Subject's Decision|1
7280538|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Subject's Decision|3
7280539|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Subject's Decision|3
7280540|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
7280541|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
7280542|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
7280543|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
7280544|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
7280545|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
7280546|NCT00473330|11496017|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7280547|NCT00473330|11496018|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
7280548|NCT00473330|11496019|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
7618434|NCT00145600|12029227|FG000|Overall Study|Ineligible|3
7618435|NCT00145600|12029228|FG001|Overall Study|Ineligible|0
7618436|NCT00145600|12029229|FG002|Overall Study|Ineligible|1
7618437|NCT00145600|12029230|FG003|Overall Study|Ineligible|5
7618438|NCT00145600|12029227|FG000|Overall Study|Lost to Follow-up|2
7618439|NCT00145600|12029228|FG001|Overall Study|Lost to Follow-up|6
7618440|NCT00145600|12029229|FG002|Overall Study|Lost to Follow-up|2
7618441|NCT00145600|12029230|FG003|Overall Study|Lost to Follow-up|4
7618442|NCT00145600|12029227|FG000|Overall Study|Noncompliance|1
7618443|NCT00145600|12029228|FG001|Overall Study|Noncompliance|0
7618444|NCT00145600|12029229|FG002|Overall Study|Noncompliance|0
7618445|NCT00145600|12029230|FG003|Overall Study|Noncompliance|0
7618446|NCT00145600|12029227|FG000|Overall Study|Withdrawal by Subject|1
7215451|NCT04024228|11423028|FG000|Overall Study|Adverse Event|1
7215452|NCT04024228|11423029|FG001|Overall Study|Adverse Event|0
7215453|NCT04024228|11423028|FG000|Overall Study|Protocol Deviation|0
7215454|NCT04024228|11423029|FG001|Overall Study|Protocol Deviation|2
7215455|NCT04024228|11423028|FG000|Overall Study|Withdrawal by Subject|3
7215456|NCT04024228|11423029|FG001|Overall Study|Withdrawal by Subject|4
7215457|NCT03980938|11423052|FG000|Treatment Period 1|Study Terminated|1
7215458|NCT03980938|11423053|FG001|Treatment Period 1|Study Terminated|1
7215459|NCT03980938|11423052|FG000|Treatment Period 2|Study Terminated|2
7618447|NCT00145600|12029228|FG001|Overall Study|Withdrawal by Subject|2
7618448|NCT00145600|12029229|FG002|Overall Study|Withdrawal by Subject|0
7618449|NCT00145600|12029230|FG003|Overall Study|Withdrawal by Subject|1
7618450|NCT03084367|12029276|FG000|Overall Study|Lost to Follow-up|32
7618451|NCT03084367|12029276|FG000|Overall Study|Withdrawal by Subject|4
7618452|NCT03084367|12029276|FG000|Overall Study|Other|1
7618453|NCT04980040|12029365|FG000|Overall Study|Violated the Inclusion Criteria|260
7618454|NCT04980040|12029365|FG000|Overall Study|Violated the Administration & Dosage|225
7618455|NCT04980040|12029365|FG000|Overall Study|Lost to Safety-Follow-up|4
7618456|NCT04980040|12029365|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3
7618457|NCT04167670|12029381|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1
7618458|NCT04167670|12029382|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7
7618459|NCT04167670|12029383|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4
7618460|NCT04167670|12029381|FG000|Overall Study|Significant protocol deviation|3
7618461|NCT04167670|12029382|FG001|Overall Study|Significant protocol deviation|1
7618462|NCT04167670|12029383|FG002|Overall Study|Significant protocol deviation|0
7618463|NCT04167670|12029381|FG000|Overall Study|Lost to Follow-up|0
7618464|NCT04167670|12029382|FG001|Overall Study|Lost to Follow-up|3
7618465|NCT04167670|12029383|FG002|Overall Study|Lost to Follow-up|3
7618466|NCT04167670|12029381|FG000|Overall Study|Voluntary Withdrawal|0
7618467|NCT04167670|12029382|FG001|Overall Study|Voluntary Withdrawal|1
7618468|NCT04167670|12029383|FG002|Overall Study|Voluntary Withdrawal|1
7618469|NCT04167670|12029381|FG000|Overall Study|Withdrawal of Consent|4
7618470|NCT04167670|12029382|FG001|Overall Study|Withdrawal of Consent|1
7215460|NCT03980938|11423053|FG001|Treatment Period 2|Study Terminated|2
7215461|NCT03863353|11423061|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24
7215462|NCT03863353|11423062|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20
7280549|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Adverse Event|0
7280550|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Adverse Event|0
7280551|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Adverse Event|2
7280552|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Death|2
7280553|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Death|2
7280554|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Death|1
7280555|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
7280556|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
7280557|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
7280558|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Physician's Decision|2
7280559|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Physician's Decision|1
7280560|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Physician's Decision|3
7280561|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Subject's Decision|1
7280562|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Subject's Decision|3
7280563|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Subject's Decision|4
7280564|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
7280565|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
7280566|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
7280567|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
7280568|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
7280569|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
7280570|NCT00473330|11496017|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7280571|NCT00473330|11496018|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
7280572|NCT00473330|11496019|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
7280573|NCT00473382|11496050|FG000|Core Study|Adverse Event|3
7280574|NCT00473382|11496051|FG001|Core Study|Adverse Event|1
7280575|NCT00473382|11496052|FG002|Core Study|Adverse Event|1
7280576|NCT00473382|11496050|FG000|Core Study|Death|3
7280577|NCT00473382|11496051|FG001|Core Study|Death|5
7280578|NCT00473382|11496052|FG002|Core Study|Death|10
7280579|NCT00473382|11496050|FG000|Core Study|Lost to Follow-up|3
7280580|NCT00473382|11496051|FG001|Core Study|Lost to Follow-up|3
7280581|NCT00473382|11496052|FG002|Core Study|Lost to Follow-up|3
7280582|NCT00473382|11496050|FG000|Core Study|Physician Decision|1
7280583|NCT00473382|11496051|FG001|Core Study|Physician Decision|2
7280584|NCT00473382|11496052|FG002|Core Study|Physician Decision|2
7280585|NCT00473382|11496050|FG000|Core Study|Subject non-compliance|5
7280586|NCT00473382|11496051|FG001|Core Study|Subject non-compliance|2
7280587|NCT00473382|11496052|FG002|Core Study|Subject non-compliance|1
7280588|NCT00473382|11496050|FG000|Core Study|Subject needed other treatment|1
7280589|NCT00473382|11496051|FG001|Core Study|Subject needed other treatment|3
7280590|NCT00473382|11496052|FG002|Core Study|Subject needed other treatment|2
7280591|NCT00473382|11496050|FG000|Core Study|Subject's decision|12
7280592|NCT00473382|11496051|FG001|Core Study|Subject's decision|11
7280593|NCT00473382|11496052|FG002|Core Study|Subject's decision|10
7280594|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Adverse Event|0
7280595|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Adverse Event|0
7280596|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Adverse Event|1
7280597|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Death|1
7618471|NCT04167670|12029383|FG002|Overall Study|Withdrawal of Consent|3
7618472|NCT04167670|12029381|FG000|Overall Study|Miscellaneous|7
7618473|NCT04167670|12029382|FG001|Overall Study|Miscellaneous|5
7618474|NCT04167670|12029383|FG002|Overall Study|Miscellaneous|3
7618475|NCT04076917|12029391|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49
7618476|NCT04076917|12029391|FG000|Overall Study|Study closure|13
7618477|NCT04076917|12029391|FG000|Overall Study|Physician Decision|3
7618478|NCT04076917|12029391|FG000|Overall Study|Death|1
7618479|NCT04076917|12029391|FG000|Overall Study|Lost to Follow-up|1
7618480|NCT04076917|12029391|FG000|Overall Study|Withdrawal by Subject|1
7618481|NCT04076917|12029391|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1
7215508|NCT03333928|11423127|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0
7215509|NCT03333928|11423128|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0
7215510|NCT03333928|11423129|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1
7215511|NCT03333928|11423127|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0
7215512|NCT03333928|11423128|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
7215513|NCT03333928|11423129|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
7215514|NCT03333928|11423127|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
7215515|NCT03333928|11423128|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0
7215516|NCT03333928|11423129|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
7215517|NCT03333928|11423127|FG000|Initial Dosing Period (Period 1)|Adverse Event|0
7215518|NCT03333928|11423128|FG001|Initial Dosing Period (Period 1)|Adverse Event|3
7215519|NCT03333928|11423129|FG002|Initial Dosing Period (Period 1)|Adverse Event|1
7215520|NCT03333928|11423127|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2
7215521|NCT03333928|11423128|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1
7215522|NCT03333928|11423129|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0
7215523|NCT03333928|11423127|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1
7215524|NCT03333928|11423128|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
7215525|NCT03333928|11423129|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
7618482|NCT04000009|12029395|FG000|Overall Study|Adverse Event|13
7618483|NCT04000009|12029395|FG000|Overall Study|Lack of Efficacy|7
7618484|NCT04000009|12029395|FG000|Overall Study|Lost to Follow-up|8
7618485|NCT04000009|12029395|FG000|Overall Study|Noncompliance with study drug|4
7618486|NCT04000009|12029395|FG000|Overall Study|Physician Decision|1
7618487|NCT04000009|12029395|FG000|Overall Study|Use of prohibited medication|3
7618488|NCT04000009|12029395|FG000|Overall Study|Pregnancy|1
7618489|NCT04000009|12029395|FG000|Overall Study|Withdrawal by Subject|22
7618490|NCT04000009|12029395|FG000|Overall Study|Study terminated by sponsor|98
7618491|NCT04000009|12029395|FG000|Overall Study|Not further specified|8
7618496|NCT03205371|12029476|FG000|Overall Study|Withdrawal by Subject|4
7618497|NCT03205371|12029477|FG001|Overall Study|Withdrawal by Subject|1
7618498|NCT03205371|12029478|FG002|Overall Study|Withdrawal by Subject|0
7618499|NCT03205371|12029479|FG003|Overall Study|Withdrawal by Subject|0
7618500|NCT03205371|12029480|FG004|Overall Study|Withdrawal by Subject|0
7618501|NCT03205371|12029481|FG005|Overall Study|Withdrawal by Subject|0
7618502|NCT03205371|12029482|FG006|Overall Study|Withdrawal by Subject|4
7618503|NCT03205371|12029483|FG007|Overall Study|Withdrawal by Subject|0
7618504|NCT03205371|12029484|FG008|Overall Study|Withdrawal by Subject|2
7618505|NCT03205371|12029485|FG009|Overall Study|Withdrawal by Subject|0
7618506|NCT03205371|12029486|FG010|Overall Study|Withdrawal by Subject|0
7618507|NCT03205371|12029487|FG011|Overall Study|Withdrawal by Subject|1
7618508|NCT03205371|12029476|FG000|Overall Study|Lost to Follow-up|0
7215526|NCT03333928|11423127|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1
7215527|NCT03333928|11423128|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0
7215528|NCT03333928|11423129|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0
7215529|NCT03333928|11423127|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
7215530|NCT03333928|11423128|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0
7215531|NCT03333928|11423129|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
7215532|NCT03298984|11423149|FG000|Overall Study|Physician Decision|1
7215533|NCT03298984|11423150|FG001|Overall Study|Physician Decision|0
7215534|NCT03298984|11423151|FG002|Overall Study|Physician Decision|0
7215535|NCT03298984|11423152|FG003|Overall Study|Physician Decision|6
7215536|NCT03298984|11423149|FG000|Overall Study|Lack of Efficacy|0
7215537|NCT03298984|11423150|FG001|Overall Study|Lack of Efficacy|1
7215538|NCT03298984|11423151|FG002|Overall Study|Lack of Efficacy|1
7215539|NCT03298984|11423152|FG003|Overall Study|Lack of Efficacy|4
7215540|NCT03298984|11423149|FG000|Overall Study|Relapsed disease (following remission)|0
7215541|NCT03298984|11423150|FG001|Overall Study|Relapsed disease (following remission)|0
7215542|NCT03298984|11423151|FG002|Overall Study|Relapsed disease (following remission)|1
7215543|NCT03298984|11423152|FG003|Overall Study|Relapsed disease (following remission)|1
7215544|NCT03298984|11423149|FG000|Overall Study|Adverse Event|0
7215545|NCT03298984|11423150|FG001|Overall Study|Adverse Event|0
7215546|NCT03298984|11423151|FG002|Overall Study|Adverse Event|0
7215547|NCT03298984|11423152|FG003|Overall Study|Adverse Event|1
7215548|NCT03298984|11423149|FG000|Overall Study|Death|0
7215549|NCT03298984|11423150|FG001|Overall Study|Death|0
7215550|NCT03298984|11423151|FG002|Overall Study|Death|0
7215551|NCT03298984|11423152|FG003|Overall Study|Death|2
7215552|NCT03298984|11423149|FG000|Overall Study|Insurance Company Decision|0
7215553|NCT03298984|11423150|FG001|Overall Study|Insurance Company Decision|0
7215554|NCT03298984|11423151|FG002|Overall Study|Insurance Company Decision|0
7215555|NCT03298984|11423152|FG003|Overall Study|Insurance Company Decision|1
7280598|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Death|3
7280599|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Death|3
7280600|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
7280601|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
7280602|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
7280603|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Subject's Decision|5
7280604|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Subject's Decision|1
7280605|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Subject's Decision|6
7280606|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
7280607|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
7280608|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
7280609|NCT00473382|11496050|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
7280610|NCT00473382|11496051|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
7280611|NCT00473382|11496052|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
7280612|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Adverse Event|0
7469834|NCT01927341|11771714|FG001|Phase 2|Lost to Follow-up|1
7618509|NCT03205371|12029477|FG001|Overall Study|Lost to Follow-up|0
7618510|NCT03205371|12029478|FG002|Overall Study|Lost to Follow-up|0
7618511|NCT03205371|12029479|FG003|Overall Study|Lost to Follow-up|0
7618512|NCT03205371|12029480|FG004|Overall Study|Lost to Follow-up|0
7618513|NCT03205371|12029481|FG005|Overall Study|Lost to Follow-up|0
7618514|NCT03205371|12029482|FG006|Overall Study|Lost to Follow-up|5
7618515|NCT03205371|12029483|FG007|Overall Study|Lost to Follow-up|2
7618516|NCT03205371|12029484|FG008|Overall Study|Lost to Follow-up|3
7618517|NCT03205371|12029485|FG009|Overall Study|Lost to Follow-up|0
7618518|NCT03205371|12029486|FG010|Overall Study|Lost to Follow-up|0
7618519|NCT03205371|12029487|FG011|Overall Study|Lost to Follow-up|0
7618520|NCT03205371|12029476|FG000|Overall Study|Protocol Violation|0
7618521|NCT03205371|12029477|FG001|Overall Study|Protocol Violation|0
7618522|NCT03205371|12029478|FG002|Overall Study|Protocol Violation|0
7618523|NCT03205371|12029479|FG003|Overall Study|Protocol Violation|0
7618524|NCT03205371|12029480|FG004|Overall Study|Protocol Violation|0
7618525|NCT03205371|12029481|FG005|Overall Study|Protocol Violation|0
7215556|NCT03175198|11423163|FG000|Overall Study|Adverse Event|480
7215557|NCT03175198|11423163|FG000|Overall Study|No actual visit|120
7215558|NCT03175198|11423163|FG000|Overall Study|Registration rule not followed|4
7215559|NCT03175198|11423163|FG000|Overall Study|Patients received Prazaxa treatment before|5
7215560|NCT03175198|11423163|FG000|Overall Study|Other personal reason|509
7469835|NCT01927341|11771715|FG002|Phase 2|Lost to Follow-up|0
7618526|NCT03205371|12029482|FG006|Overall Study|Protocol Violation|1
7618527|NCT03205371|12029483|FG007|Overall Study|Protocol Violation|0
7618528|NCT03205371|12029484|FG008|Overall Study|Protocol Violation|0
7618529|NCT03205371|12029485|FG009|Overall Study|Protocol Violation|0
7618530|NCT03205371|12029486|FG010|Overall Study|Protocol Violation|0
7618531|NCT03205371|12029487|FG011|Overall Study|Protocol Violation|0
7618532|NCT03205371|12029476|FG000|Overall Study|Adverse Event|0
7618533|NCT03205371|12029477|FG001|Overall Study|Adverse Event|0
7618534|NCT03205371|12029478|FG002|Overall Study|Adverse Event|0
7618535|NCT03205371|12029479|FG003|Overall Study|Adverse Event|0
7618536|NCT03205371|12029480|FG004|Overall Study|Adverse Event|0
7618537|NCT03205371|12029481|FG005|Overall Study|Adverse Event|0
7618538|NCT03205371|12029482|FG006|Overall Study|Adverse Event|0
7215561|NCT03175198|11423163|FG000|Overall Study|To take a contraindication/careful administration drug|8
7215562|NCT03175198|11423163|FG000|Overall Study|Lost to follow-up (changing hospital)|373
7215563|NCT03175198|11423163|FG000|Overall Study|Lost to follow-up (unknown reason)|146
7215564|NCT03175198|11423163|FG000|Overall Study|To conduct invasive treatment of operation|53
7215565|NCT03175198|11423163|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629
7215566|NCT03158727|11423169|FG000|Overall Study|Withdrawal by Subject|2
7215567|NCT03158727|11423170|FG001|Overall Study|Withdrawal by Subject|6
7215568|NCT03158727|11423169|FG000|Overall Study|Death|11
7215569|NCT03158727|11423170|FG001|Overall Study|Death|12
7215570|NCT03158727|11423169|FG000|Overall Study|Lost to Follow-up|1
7215571|NCT03158727|11423170|FG001|Overall Study|Lost to Follow-up|0
7215572|NCT03158727|11423169|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2
7215573|NCT03158727|11423170|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0
7215574|NCT03158727|11423169|FG000|Overall Study|Visit 11 not done by mistake|0
7215575|NCT03158727|11423170|FG001|Overall Study|Visit 11 not done by mistake|1
7215576|NCT03158727|11423169|FG000|Overall Study|Enrolled, not treated|1
7215577|NCT03158727|11423170|FG001|Overall Study|Enrolled, not treated|0
7215578|NCT03075826|11423176|FG000|Overall Study|Withdrawal by Subject|1
7215579|NCT03075826|11423176|FG000|Overall Study|Received less than 3 cycles of study drug|5
7215580|NCT02993731|11423182|FG000|Overall Study|Study Termination|101
7215581|NCT02993731|11423183|FG001|Overall Study|Study Termination|105
7618539|NCT03205371|12029483|FG007|Overall Study|Adverse Event|1
7618540|NCT03205371|12029484|FG008|Overall Study|Adverse Event|0
7618541|NCT03205371|12029485|FG009|Overall Study|Adverse Event|0
7618542|NCT03205371|12029486|FG010|Overall Study|Adverse Event|0
7618543|NCT03205371|12029487|FG011|Overall Study|Adverse Event|0
7618544|NCT03165721|12029536|FG000|Overall Study|Refused further treatment|3
7618545|NCT03165721|12029537|FG001|Overall Study|Refused further treatment|0
7618546|NCT03165721|12029538|FG002|Overall Study|Refused further treatment|0
7618547|NCT03165721|12029536|FG000|Overall Study|Physician Decision|1
7618548|NCT03165721|12029537|FG001|Overall Study|Physician Decision|0
7618549|NCT03165721|12029538|FG002|Overall Study|Physician Decision|0
7215604|NCT02520011|11423219|FG000|Overall Study|Adverse Event|0
7215605|NCT02520011|11423220|FG001|Overall Study|Adverse Event|1
7215606|NCT02520011|11423221|FG002|Overall Study|Adverse Event|2
7215607|NCT02520011|11423219|FG000|Overall Study|Death|0
7215608|NCT02520011|11423220|FG001|Overall Study|Death|8
7215609|NCT02520011|11423221|FG002|Overall Study|Death|1
7215610|NCT02520011|11423219|FG000|Overall Study|Lack of Efficacy|4
7215611|NCT02520011|11423220|FG001|Overall Study|Lack of Efficacy|26
7215612|NCT02520011|11423221|FG002|Overall Study|Lack of Efficacy|4
7215613|NCT02520011|11423219|FG000|Overall Study|Physician Decision|0
7215614|NCT02520011|11423220|FG001|Overall Study|Physician Decision|2
7215615|NCT02520011|11423221|FG002|Overall Study|Physician Decision|0
7215616|NCT02520011|11423219|FG000|Overall Study|Withdrawal by Subject|1
7215617|NCT02520011|11423220|FG001|Overall Study|Withdrawal by Subject|3
7215618|NCT02520011|11423221|FG002|Overall Study|Withdrawal by Subject|0
7215619|NCT02520011|11423219|FG000|Overall Study|Protocol Deviation|0
7215620|NCT02520011|11423220|FG001|Overall Study|Protocol Deviation|1
7215621|NCT02520011|11423221|FG002|Overall Study|Protocol Deviation|0
7215622|NCT02520011|11423219|FG000|Overall Study|Patient went to hospice|0
7215623|NCT02520011|11423220|FG001|Overall Study|Patient went to hospice|1
7215624|NCT02520011|11423221|FG002|Overall Study|Patient went to hospice|0
7215625|NCT02520011|11423219|FG000|Overall Study|Progressive disease following response|0
7215626|NCT02520011|11423220|FG001|Overall Study|Progressive disease following response|4
7215627|NCT02520011|11423221|FG002|Overall Study|Progressive disease following response|2
7215628|NCT02279719|11423258|FG000|Overall Study|Patients randomized but never treated|0
7215629|NCT02279719|11423259|FG001|Overall Study|Patients randomized but never treated|0
7215630|NCT02279719|11423260|FG002|Overall Study|Patients randomized but never treated|0
7215631|NCT02279719|11423261|FG003|Overall Study|Patients randomized but never treated|0
7215632|NCT02279719|11423262|FG004|Overall Study|Patients randomized but never treated|3
7215633|NCT02279719|11423263|FG005|Overall Study|Patients randomized but never treated|0
7280613|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Adverse Event|0
7280614|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Adverse Event|2
7280615|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Death|1
7280616|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Death|7
7280617|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Death|4
7280618|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
7280619|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
7280620|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
7280621|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Subject's Decision|7
7280622|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Subject's Decision|1
7280623|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Subject's Decision|6
7280624|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
7280625|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
7280626|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
7280627|NCT00473382|11496050|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
7280628|NCT00473382|11496051|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
7280629|NCT00473382|11496052|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
7215634|NCT02279719|11423264|FG006|Overall Study|Patients randomized but never treated|3
7215635|NCT02178956|11423299|FG000|Overall Study|Lost to Follow-up|4
7215636|NCT02178956|11423300|FG001|Overall Study|Lost to Follow-up|4
7215637|NCT02178956|11423299|FG000|Overall Study|Sponsor terminated study|49
7215638|NCT02178956|11423300|FG001|Overall Study|Sponsor terminated study|58
7215639|NCT02178956|11423299|FG000|Overall Study|Withdrawal by Subject|15
7215640|NCT02178956|11423300|FG001|Overall Study|Withdrawal by Subject|11
7215641|NCT02178956|11423299|FG000|Overall Study|Various Reasons|3
7215642|NCT02178956|11423300|FG001|Overall Study|Various Reasons|5
7215648|NCT02097420|11423322|FG000|Overall Study|Death|4
7215649|NCT02097420|11423322|FG000|Overall Study|Device explanted|3
7215650|NCT02097420|11423322|FG000|Overall Study|Not reached 12-month visit|7
7215651|NCT01925131|11423379|FG000|Overall Study|Death|0
7215652|NCT01925131|11423380|FG001|Overall Study|Death|0
7215653|NCT01925131|11423381|FG002|Overall Study|Death|1
7215654|NCT01925131|11423382|FG003|Overall Study|Death|0
7215655|NCT01925131|11423383|FG004|Overall Study|Death|0
7215656|NCT01925131|11423384|FG005|Overall Study|Death|0
7215657|NCT01925131|11423379|FG000|Overall Study|Progression/Relapse|1
7215658|NCT01925131|11423380|FG001|Overall Study|Progression/Relapse|1
7215659|NCT01925131|11423381|FG002|Overall Study|Progression/Relapse|4
7215660|NCT01925131|11423382|FG003|Overall Study|Progression/Relapse|0
7215661|NCT01925131|11423383|FG004|Overall Study|Progression/Relapse|0
7215662|NCT01925131|11423384|FG005|Overall Study|Progression/Relapse|1
7215663|NCT01925131|11423379|FG000|Overall Study|Patient Refusal|1
7215664|NCT01925131|11423380|FG001|Overall Study|Patient Refusal|0
7215665|NCT01925131|11423381|FG002|Overall Study|Patient Refusal|0
7215666|NCT01925131|11423382|FG003|Overall Study|Patient Refusal|0
7215667|NCT01925131|11423383|FG004|Overall Study|Patient Refusal|0
7215668|NCT01925131|11423384|FG005|Overall Study|Patient Refusal|0
7215669|NCT01925131|11423379|FG000|Overall Study|Adverse Event|0
7215670|NCT01925131|11423380|FG001|Overall Study|Adverse Event|0
7215671|NCT01925131|11423381|FG002|Overall Study|Adverse Event|2
7215672|NCT01925131|11423382|FG003|Overall Study|Adverse Event|0
7215673|NCT01925131|11423383|FG004|Overall Study|Adverse Event|1
7215674|NCT01925131|11423384|FG005|Overall Study|Adverse Event|3
7215675|NCT01925131|11423379|FG000|Overall Study|Other - Not Protocol Specified|3
7215676|NCT01925131|11423380|FG001|Overall Study|Other - Not Protocol Specified|1
7215677|NCT01925131|11423381|FG002|Overall Study|Other - Not Protocol Specified|2
7215678|NCT01925131|11423382|FG003|Overall Study|Other - Not Protocol Specified|5
7215679|NCT01925131|11423383|FG004|Overall Study|Other - Not Protocol Specified|10
7215680|NCT01925131|11423384|FG005|Overall Study|Other - Not Protocol Specified|6
7215681|NCT01776307|11423403|FG000|Overall Study|Not dosed|0
7215682|NCT01776307|11423404|FG001|Overall Study|Not dosed|0
7215683|NCT01776307|11423405|FG002|Overall Study|Not dosed|1
7215684|NCT01535274|11423449|FG000|Overall Study|Determined to be ineligible|0
7215685|NCT01535274|11423450|FG001|Overall Study|Determined to be ineligible|1
7215686|NCT01535274|11423449|FG000|Overall Study|Misallocated to propofol intervention|0
7215687|NCT01535274|11423450|FG001|Overall Study|Misallocated to propofol intervention|1
7280630|NCT00473434|11496078|FG000|Overall Study|Physician Decision|3
7280631|NCT00473434|11496078|FG000|Overall Study|Withdrawal by Subject|9
7280632|NCT00473434|11496078|FG000|Overall Study|Compliance|3
7280633|NCT00473434|11496078|FG000|Overall Study|Lack of Efficacy|3
7280634|NCT00473434|11496078|FG000|Overall Study|Adverse Event|3
7280635|NCT00473434|11496078|FG000|Overall Study|Patient was selling medication to others|1
7280636|NCT00473434|11496078|FG000|Overall Study|Safety evaluation|1
7280637|NCT00473434|11496078|FG000|Overall Study|Reason not specified|6
7280638|NCT00473434|11496078|FG000|Overall Study|Ceased in favor of Paliperidone|1
7280639|NCT00473434|11496078|FG000|Overall Study|Switching to trial medication|1
7280640|NCT00473434|11496078|FG000|Overall Study|No longer required|1
7280641|NCT00473512|11496100|FG000|Period 1 (Phase 1)|Adverse Event|0
7280642|NCT00473512|11496101|FG001|Period 1 (Phase 1)|Adverse Event|0
7280643|NCT00473512|11496102|FG002|Period 1 (Phase 1)|Adverse Event|0
7280644|NCT00473512|11496103|FG003|Period 1 (Phase 1)|Adverse Event|5
7280645|NCT00473512|11496104|FG004|Period 1 (Phase 1)|Adverse Event|0
7280646|NCT00473512|11496100|FG000|Period 1 (Phase 1)|Death|0
7618660|NCT02955797|12029606|FG000|Overall Study|Protocol Violation|1
7618661|NCT02955797|12029607|FG001|Overall Study|Protocol Violation|0
7618662|NCT02955797|12029608|FG002|Overall Study|Protocol Violation|0
7618663|NCT02955797|12029609|FG003|Overall Study|Protocol Violation|1
7618664|NCT02955797|12029606|FG000|Overall Study|Withdrawal by Subject|2
7618665|NCT02955797|12029607|FG001|Overall Study|Withdrawal by Subject|2
7618666|NCT02955797|12029608|FG002|Overall Study|Withdrawal by Subject|0
7618667|NCT02955797|12029609|FG003|Overall Study|Withdrawal by Subject|1
7618668|NCT02955797|12029606|FG000|Overall Study|Lost to Follow-up|0
7618669|NCT02955797|12029607|FG001|Overall Study|Lost to Follow-up|1
7618670|NCT02955797|12029608|FG002|Overall Study|Lost to Follow-up|0
7215688|NCT00539981|11423464|FG000|Overall Study|Adverse events (AE)|3
7215689|NCT00539981|11423465|FG001|Overall Study|Adverse events (AE)|3
7215690|NCT00539981|11423464|FG000|Overall Study|Lost to Follow-up|260
7215691|NCT00539981|11423465|FG001|Overall Study|Lost to Follow-up|251
7215692|NCT00539981|11423464|FG000|Overall Study|Withdrew consent|22
7215693|NCT00539981|11423465|FG001|Overall Study|Withdrew consent|14
7215694|NCT00539981|11423464|FG000|Overall Study|Death|1
7618671|NCT02955797|12029609|FG003|Overall Study|Lost to Follow-up|0
7215695|NCT00539981|11423465|FG001|Overall Study|Death|1
7215696|NCT00539981|11423464|FG000|Overall Study|Other reason-unspecified|9
7215697|NCT00539981|11423465|FG001|Overall Study|Other reason-unspecified|13
7618672|NCT02859415|12029624|FG000|Overall Study|Physician Decision|1
7618673|NCT02859415|12029625|FG001|Overall Study|Physician Decision|0
7618674|NCT02859415|12029624|FG000|Overall Study|Off treatment due to cardiac event|0
7618675|NCT02859415|12029625|FG001|Overall Study|Off treatment due to cardiac event|1
7618676|NCT02842866|12029634|FG000|Overall Study|Serious Adverse Event|0
7618677|NCT02842866|12029635|FG001|Overall Study|Serious Adverse Event|1
7618678|NCT02842866|12029634|FG000|Overall Study|Protocol Violation|4
7618679|NCT02842866|12029635|FG001|Overall Study|Protocol Violation|2
7618680|NCT02842866|12029634|FG000|Overall Study|Lost to Follow-up|2
7618681|NCT02842866|12029635|FG001|Overall Study|Lost to Follow-up|0
7618682|NCT02842866|12029634|FG000|Overall Study|Withdrawal by Subject|1
7618683|NCT02842866|12029635|FG001|Overall Study|Withdrawal by Subject|0
7618684|NCT02842853|12029645|FG000|Overall Study|Non-compliance with the protocol|3
7618685|NCT02842853|12029646|FG001|Overall Study|Non-compliance with the protocol|7
7618686|NCT02842853|12029647|FG002|Overall Study|Non-compliance with the protocol|2
7618687|NCT02842853|12029648|FG003|Overall Study|Non-compliance with the protocol|5
7618688|NCT02842853|12029645|FG000|Overall Study|Subject met exclusion criteria|0
7618689|NCT02842853|12029646|FG001|Overall Study|Subject met exclusion criteria|1
7618690|NCT02842853|12029647|FG002|Overall Study|Subject met exclusion criteria|0
7618691|NCT02842853|12029648|FG003|Overall Study|Subject met exclusion criteria|0
7618692|NCT02842853|12029645|FG000|Overall Study|Withdrawal by Subject|11
7618693|NCT02842853|12029646|FG001|Overall Study|Withdrawal by Subject|13
7618694|NCT02842853|12029647|FG002|Overall Study|Withdrawal by Subject|9
7618695|NCT02842853|12029648|FG003|Overall Study|Withdrawal by Subject|8
7618696|NCT02842853|12029645|FG000|Overall Study|Lost to Follow-up|9
7618697|NCT02842853|12029646|FG001|Overall Study|Lost to Follow-up|13
7618698|NCT02842853|12029647|FG002|Overall Study|Lost to Follow-up|10
7618699|NCT02842853|12029648|FG003|Overall Study|Lost to Follow-up|11
7618700|NCT02752906|12029662|FG000|Overall Study|Protocol Violation|2
7618701|NCT02752906|12029663|FG001|Overall Study|Protocol Violation|1
7618702|NCT02752906|12029662|FG000|Overall Study|Withdrawal by Subject|2
7618703|NCT02752906|12029663|FG001|Overall Study|Withdrawal by Subject|2
7618704|NCT02752906|12029662|FG000|Overall Study|Lost to Follow-up|3
7618705|NCT02752906|12029663|FG001|Overall Study|Lost to Follow-up|2
7618706|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Death|30
7618707|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
7618708|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
7618709|NCT02693691|12029669|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
7618710|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
7618711|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
7618712|NCT02693691|12029669|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
7215698|NCT04732338|11423485|FG000|Overall Study|Lost to Follow-up|3
7215699|NCT04732338|11423486|FG001|Overall Study|Lost to Follow-up|3
7618713|NCT04889625|12029673|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2
7618714|NCT04889625|12029674|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1
7618715|NCT04889625|12029673|FG000|Period 1|Subject out of window|0
7618716|NCT04889625|12029674|FG001|Period 1|Subject out of window|1
7618717|NCT04889625|12029673|FG000|Period 1|Wrong add power dispensed|0
7618718|NCT04889625|12029674|FG001|Period 1|Wrong add power dispensed|1
7618719|NCT04889625|12029673|FG000|Period 1|Discontinued due to fitting guide error|1
7618720|NCT04889625|12029674|FG001|Period 1|Discontinued due to fitting guide error|1
7618721|NCT04889625|12029673|FG000|Period 2|Test article no longer available|1
7618722|NCT04889625|12029674|FG001|Period 2|Test article no longer available|0
7618723|NCT04889625|12029673|FG000|Period 2|Incorrect lens dispensed|1
7618724|NCT04889625|12029674|FG001|Period 2|Incorrect lens dispensed|0
7618725|NCT04889625|12029673|FG000|Period 2|Wrong add power dispensed|0
7618726|NCT04889625|12029674|FG001|Period 2|Wrong add power dispensed|1
7618727|NCT04602000|12029715|FG000|Overall Study|Withdrawal by Subject|3
7618728|NCT04602000|12029716|FG001|Overall Study|Withdrawal by Subject|6
7618729|NCT04602000|12029717|FG002|Overall Study|Withdrawal by Subject|3
7618730|NCT04602000|12029718|FG003|Overall Study|Withdrawal by Subject|27
7618731|NCT04602000|12029719|FG004|Overall Study|Withdrawal by Subject|39
7618732|NCT04602000|12029715|FG000|Overall Study|Physician Decision|1
7618733|NCT04602000|12029716|FG001|Overall Study|Physician Decision|0
7618734|NCT04602000|12029717|FG002|Overall Study|Physician Decision|0
7618735|NCT04602000|12029718|FG003|Overall Study|Physician Decision|2
7618736|NCT04602000|12029719|FG004|Overall Study|Physician Decision|2
7618737|NCT04602000|12029715|FG000|Overall Study|Death|0
7618738|NCT04602000|12029716|FG001|Overall Study|Death|1
7618739|NCT04602000|12029717|FG002|Overall Study|Death|0
7618740|NCT04602000|12029718|FG003|Overall Study|Death|1
7618741|NCT04602000|12029719|FG004|Overall Study|Death|2
7215700|NCT04728802|11423494|FG000|Overall Study|Withdrawal by Subject|4
7215701|NCT04728802|11423495|FG001|Overall Study|Withdrawal by Subject|20
7215702|NCT04728802|11423494|FG000|Overall Study|Physician Decision|7
7215703|NCT04728802|11423495|FG001|Overall Study|Physician Decision|7
7215704|NCT04728802|11423494|FG000|Overall Study|Protocol Violation|10
7215705|NCT04728802|11423495|FG001|Overall Study|Protocol Violation|4
7215706|NCT04728802|11423494|FG000|Overall Study|Transfer|1
7215707|NCT04728802|11423495|FG001|Overall Study|Transfer|0
7280647|NCT00473512|11496101|FG001|Period 1 (Phase 1)|Death|0
7280648|NCT00473512|11496102|FG002|Period 1 (Phase 1)|Death|0
7280649|NCT00473512|11496103|FG003|Period 1 (Phase 1)|Death|1
7280650|NCT00473512|11496104|FG004|Period 1 (Phase 1)|Death|0
7280651|NCT00473512|11496100|FG000|Period 1 (Phase 1)|Disease Progression|1
7280652|NCT00473512|11496101|FG001|Period 1 (Phase 1)|Disease Progression|1
7280653|NCT00473512|11496102|FG002|Period 1 (Phase 1)|Disease Progression|0
7280654|NCT00473512|11496103|FG003|Period 1 (Phase 1)|Disease Progression|10
7280655|NCT00473512|11496104|FG004|Period 1 (Phase 1)|Disease Progression|1
7280656|NCT00473512|11496100|FG000|Period 1 (Phase 1)|Other|0
7280657|NCT00473512|11496101|FG001|Period 1 (Phase 1)|Other|0
7280658|NCT00473512|11496102|FG002|Period 1 (Phase 1)|Other|0
7280659|NCT00473512|11496103|FG003|Period 1 (Phase 1)|Other|1
7280660|NCT00473512|11496104|FG004|Period 1 (Phase 1)|Other|0
7280661|NCT00473512|11496100|FG000|Period 2 (Phase 2)|Adverse Event|0
7280662|NCT00473512|11496101|FG001|Period 2 (Phase 2)|Adverse Event|0
7280663|NCT00473512|11496102|FG002|Period 2 (Phase 2)|Adverse Event|0
7280664|NCT00473512|11496103|FG003|Period 2 (Phase 2)|Adverse Event|1
7280665|NCT00473512|11496104|FG004|Period 2 (Phase 2)|Adverse Event|0
7280666|NCT00473512|11496100|FG000|Period 2 (Phase 2)|Death|0
7280667|NCT00473512|11496101|FG001|Period 2 (Phase 2)|Death|0
7280668|NCT00473512|11496102|FG002|Period 2 (Phase 2)|Death|0
7280669|NCT00473512|11496103|FG003|Period 2 (Phase 2)|Death|1
7280670|NCT00473512|11496104|FG004|Period 2 (Phase 2)|Death|1
7280671|NCT00473512|11496100|FG000|Period 2 (Phase 2)|Disease Progression|0
7215708|NCT04728802|11423494|FG000|Overall Study|Death|4
7215709|NCT04728802|11423495|FG001|Overall Study|Death|5
7215710|NCT04728802|11423494|FG000|Overall Study|Other|3
7215711|NCT04728802|11423495|FG001|Overall Study|Other|0
7215712|NCT04725500|11423516|FG000|Screening|Screen Failure|26
7215713|NCT04725500|11423516|FG000|Screening|Withdrawal by Subject|1
7215714|NCT04725500|11423516|FG000|2 Week Take Home|Screen Fail|5
7280672|NCT00473512|11496101|FG001|Period 2 (Phase 2)|Disease Progression|2
7280673|NCT00473512|11496102|FG002|Period 2 (Phase 2)|Disease Progression|2
7618742|NCT04602000|12029715|FG000|Overall Study|Lost to Follow-up|0
7618743|NCT04602000|12029716|FG001|Overall Study|Lost to Follow-up|0
7618744|NCT04602000|12029717|FG002|Overall Study|Lost to Follow-up|0
7618745|NCT04602000|12029718|FG003|Overall Study|Lost to Follow-up|3
7618746|NCT04602000|12029719|FG004|Overall Study|Lost to Follow-up|4
7280674|NCT00473512|11496103|FG003|Period 2 (Phase 2)|Disease Progression|17
7280675|NCT00473512|11496104|FG004|Period 2 (Phase 2)|Disease Progression|1
7280676|NCT00473512|11496100|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
7280677|NCT00473512|11496101|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
7280678|NCT00473512|11496102|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
7280679|NCT00473512|11496103|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
7280680|NCT00473512|11496104|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
7280681|NCT00473512|11496100|FG000|Period 2 (Phase 2)|Other|1
7280682|NCT00473512|11496101|FG001|Period 2 (Phase 2)|Other|0
7280683|NCT00473512|11496102|FG002|Period 2 (Phase 2)|Other|0
7618747|NCT04602000|12029715|FG000|Overall Study|Other|4
7618748|NCT04602000|12029716|FG001|Overall Study|Other|1
7618749|NCT04602000|12029717|FG002|Overall Study|Other|2
7618750|NCT04602000|12029718|FG003|Overall Study|Other|5
7618751|NCT04602000|12029719|FG004|Overall Study|Other|4
7618752|NCT04602000|12029715|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618753|NCT04602000|12029716|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618754|NCT04602000|12029717|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1
7618755|NCT04602000|12029718|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618756|NCT04602000|12029719|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0
7618757|NCT04540887|12029733|FG000|Overall Study|Withdrawal by Subject|2
7618758|NCT04428333|12029740|FG000|Overall Study|Physician Decision|2
7618759|NCT04428333|12029741|FG001|Overall Study|Physician Decision|0
7618760|NCT04428333|12029740|FG000|Overall Study|Withdrawal by Subject|0
7618761|NCT04428333|12029741|FG001|Overall Study|Withdrawal by Subject|1
7618762|NCT04428333|12029740|FG000|Overall Study|In Follow-Up|5
7618763|NCT04428333|12029741|FG001|Overall Study|In Follow-Up|10
7618764|NCT04428333|12029740|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
7618765|NCT04428333|12029741|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47
7618766|NCT04167085|12029749|FG000|Baseline|Withdrawal by Subject|2
7618767|NCT04167085|12029750|FG001|Baseline|Withdrawal by Subject|1
7618768|NCT04167085|12029749|FG000|Washout (1 Month)|Withdrawal by Subject|1
7618769|NCT04167085|12029750|FG001|Washout (1 Month)|Withdrawal by Subject|0
7618770|NCT04146467|12029758|FG000|Overall Study|Adverse Event|0
7618771|NCT04146467|12029759|FG001|Overall Study|Adverse Event|1
7618772|NCT04146467|12029758|FG000|Overall Study|Lost to Follow-up|0
7618773|NCT04146467|12029759|FG001|Overall Study|Lost to Follow-up|2
7618774|NCT03912337|12029774|FG000|Overall Study|Withdrawal of Consent From Study|1
7618775|NCT03912337|12029775|FG001|Overall Study|Withdrawal of Consent From Study|0
7618776|NCT03912337|12029774|FG000|Overall Study|Lost to Follow-up|1
7618777|NCT03912337|12029775|FG001|Overall Study|Lost to Follow-up|1
7618778|NCT03292588|12029789|FG000|Overall Study|Death|1
7618779|NCT03292588|12029790|FG001|Overall Study|Death|0
7618780|NCT03292588|12029789|FG000|Overall Study|Lost to Follow-up|12
7618781|NCT03292588|12029790|FG001|Overall Study|Lost to Follow-up|16
7618782|NCT03292588|12029789|FG000|Overall Study|Physician Decision|0
7618783|NCT03292588|12029790|FG001|Overall Study|Physician Decision|1
7618784|NCT03292588|12029789|FG000|Overall Study|Withdrawal by Subject|4
7618785|NCT03292588|12029790|FG001|Overall Study|Withdrawal by Subject|4
7618786|NCT03292588|12029789|FG000|Overall Study|Move out of town|1
7618787|NCT03292588|12029790|FG001|Overall Study|Move out of town|0
7618788|NCT03292588|12029789|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2
7618789|NCT03292588|12029790|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1
7618790|NCT03131960|12029804|FG000|Overall Study|Adverse Event|0
7618791|NCT03131960|12029805|FG001|Overall Study|Adverse Event|1
7618802|NCT03090737|12029820|FG000|Overall Study|Participant withdrew consent|4
7618803|NCT03090737|12029820|FG000|Overall Study|Death|27
7618804|NCT02906930|12029828|FG000|Overall Study|Withdrawal by Subject|0
7618805|NCT02906930|12029829|FG001|Overall Study|Withdrawal by Subject|5
7618806|NCT02906930|12029830|FG002|Overall Study|Withdrawal by Subject|5
7618807|NCT02906930|12029831|FG003|Overall Study|Withdrawal by Subject|4
7618808|NCT02906930|12029828|FG000|Overall Study|Lost to Follow-up|5
7618809|NCT02906930|12029829|FG001|Overall Study|Lost to Follow-up|7
7618810|NCT02906930|12029830|FG002|Overall Study|Lost to Follow-up|5
7618811|NCT02906930|12029831|FG003|Overall Study|Lost to Follow-up|2
7618812|NCT02906930|12029828|FG000|Overall Study|Death|0
7618813|NCT02906930|12029829|FG001|Overall Study|Death|0
7618814|NCT02906930|12029830|FG002|Overall Study|Death|1
7618815|NCT02906930|12029831|FG003|Overall Study|Death|0
7618816|NCT02906930|12029828|FG000|Overall Study|Other|1
7618817|NCT02906930|12029829|FG001|Overall Study|Other|2
7618818|NCT02906930|12029830|FG002|Overall Study|Other|1
7618819|NCT02906930|12029831|FG003|Overall Study|Other|2
7215715|NCT04716426|11423531|FG000|Overall Study|Vaccination|1
7215716|NCT04716426|11423532|FG001|Overall Study|Vaccination|1
7215717|NCT04716426|11423531|FG000|Overall Study|Contamination|1
7215718|NCT04716426|11423532|FG001|Overall Study|Contamination|0
7215719|NCT04698993|11423553|FG000|Overall Study|PCR results not accessible|2
7215720|NCT04698993|11423554|FG001|Overall Study|PCR results not accessible|7
7215721|NCT04698993|11423553|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
7215722|NCT04698993|11423554|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
7215723|NCT04674644|11423581|FG000|Overall Study|with missing data|37
7215724|NCT04668989|11423599|FG000|First Intervention|Covid-19 related self-isolation|0
7215725|NCT04668989|11423600|FG001|First Intervention|Covid-19 related self-isolation|1
7215726|NCT04668989|11423599|FG000|Second Intervention|Adverse Event|0
7215727|NCT04668989|11423600|FG001|Second Intervention|Adverse Event|1
7215728|NCT04646109|11423666|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
7215729|NCT04646109|11423667|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
7215730|NCT04633642|11423702|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
7215731|NCT04633642|11423703|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
7215732|NCT04615507|11423758|FG000|Period 1|Covid-19 exposure|2
7215733|NCT04615507|11423759|FG001|Period 1|Covid-19 exposure|1
7215734|NCT04615507|11423758|FG000|Period 2|Covid-19 exposure|0
7215735|NCT04615507|11423759|FG001|Period 2|Covid-19 exposure|1
7215736|NCT04615507|11423758|FG000|Period 2|Protocol Violation|1
7215737|NCT04615507|11423759|FG001|Period 2|Protocol Violation|0
7215738|NCT04615507|11423758|FG000|Period 2|Withdrawal by Subject|1
7215739|NCT04615507|11423759|FG001|Period 2|Withdrawal by Subject|0
7215740|NCT04615507|11423758|FG000|Period 2|Adverse Event|0
7215741|NCT04615507|11423759|FG001|Period 2|Adverse Event|1
7215742|NCT04615507|11423758|FG000|Period 3|Covid-19 exposure|0
7215743|NCT04615507|11423759|FG001|Period 3|Covid-19 exposure|1
7215744|NCT04608500|11423772|FG000|Overall Study|Adverse Event|2
7215745|NCT04608500|11423773|FG001|Overall Study|Adverse Event|0
7215746|NCT04608500|11423772|FG000|Overall Study|Lost to Follow-up|15
7215747|NCT04608500|11423773|FG001|Overall Study|Lost to Follow-up|9
7215748|NCT04608500|11423772|FG000|Overall Study|Participant request|11
7215749|NCT04608500|11423773|FG001|Overall Study|Participant request|7
7215750|NCT04608500|11423772|FG000|Overall Study|Protocol Violation|1
7215751|NCT04608500|11423773|FG001|Overall Study|Protocol Violation|0
7215752|NCT04608500|11423772|FG000|Overall Study|Other|6
7215753|NCT04608500|11423773|FG001|Overall Study|Other|2
7215756|NCT04590027|11423811|FG000|Overall Study|Lost to Follow-up|17
7215757|NCT04590027|11423812|FG001|Overall Study|Lost to Follow-up|14
7215758|NCT04590027|11423811|FG000|Overall Study|Protocol Violation|0
7215759|NCT04590027|11423812|FG001|Overall Study|Protocol Violation|3
7215760|NCT04578457|11423822|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
7215761|NCT04578457|11423822|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
7215762|NCT04578457|11423822|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
7215763|NCT04578457|11423822|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
7215782|NCT04542694|11423926|FG000|Overall Study|The need for prohibited therapy|2
7215783|NCT04542694|11423927|FG001|Overall Study|The need for prohibited therapy|0
7215784|NCT04542694|11423926|FG000|Overall Study|Adverse Event|1
7215785|NCT04542694|11423927|FG001|Overall Study|Adverse Event|0
7215786|NCT04542694|11423926|FG000|Overall Study|Protocol Violation|1
7215787|NCT04542694|11423927|FG001|Overall Study|Protocol Violation|0
7215788|NCT04534491|11423969|FG000|Overall Study|Not completed end-of-study interview|24
7215789|NCT04534491|11423969|FG000|Overall Study|Non-users|70
7215790|NCT04534491|11423969|FG000|Overall Study|Non-verifiable users|58
7215805|NCT04093258|11424023|FG000|Period 2|Subject no longer meets the eligibility criteria|1
7215806|NCT04093258|11424024|FG001|Period 2|Subject no longer meets the eligibility criteria|0
7215807|NCT03993379|11424038|FG000|Overall Study|The study was terminated early due to business decision.|0
7215808|NCT03993379|11424039|FG001|Overall Study|The study was terminated early due to business decision.|2
7215809|NCT03993379|11424040|FG002|Overall Study|The study was terminated early due to business decision.|0
7280684|NCT00473512|11496103|FG003|Period 2 (Phase 2)|Other|3
7215754|NCT04605588|11423785|FG000|Overall Study|Withdrawal by Subject|1
7215755|NCT04605588|11423786|FG001|Overall Study|Withdrawal by Subject|0
7215764|NCT04577183|11423834|FG000|Overall Study|Death|1
7215765|NCT04577183|11423834|FG000|Overall Study|Withdrawal by Subject|3
7215766|NCT04577183|11423834|FG000|Overall Study|Early termination|2
7215791|NCT04533204|11423991|FG000|Overall Study|Unable to understand training instructions|1
7215792|NCT04533204|11423992|FG001|Overall Study|Unable to understand training instructions|1
7215793|NCT04532164|11423998|FG000|Overall Study|Adverse Event|1
7215794|NCT04532164|11423998|FG000|Overall Study|Protocol Violation|5
7215795|NCT04532164|11423998|FG000|Overall Study|Lost to Follow-up|1
7215796|NCT04532164|11423998|FG000|Overall Study|Found to be Ineligible|3
7215797|NCT04532164|11423998|FG000|Overall Study|Withdrawal by Subject|14
7215810|NCT03993379|11424041|FG003|Overall Study|The study was terminated early due to business decision.|0
7215811|NCT03993379|11424038|FG000|Overall Study|Withdrawal by Subject|0
7215812|NCT03993379|11424039|FG001|Overall Study|Withdrawal by Subject|1
7215813|NCT03993379|11424040|FG002|Overall Study|Withdrawal by Subject|0
7215814|NCT03993379|11424041|FG003|Overall Study|Withdrawal by Subject|0
7215815|NCT03956615|11424051|FG000|Overall Study|No multiple myeloma confirmed|2
7215816|NCT03956615|11424051|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
7215817|NCT03956615|11424051|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
7215818|NCT03956615|11424051|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
7215819|NCT03803059|11424055|FG000|Overall Study|Protocol Violation|2
7215820|NCT03803059|11424055|FG000|Overall Study|Lost to Follow-up|1
7215821|NCT03723590|11424060|FG000|Overall Study|Withdrawal by Subject|3
7215822|NCT03430895|11424083|FG000|Overall Study|Not Treated|2
7215823|NCT03230838|11424106|FG000|Overall Study|Withdrawal by Subject|3
7215824|NCT03230838|11424107|FG001|Overall Study|Withdrawal by Subject|0
7215825|NCT03230838|11424106|FG000|Overall Study|Temperature excursion|1
7215826|NCT03230838|11424107|FG001|Overall Study|Temperature excursion|0
7215827|NCT03183778|11424113|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
7280685|NCT00473512|11496104|FG004|Period 2 (Phase 2)|Other|0
7280686|NCT00473564|11496124|FG000|Overall Study|robot surgery aborted in OR|23
7280687|NCT00473590|11496130|FG000|Overall Study|Adverse Event|3
7280688|NCT00473590|11496131|FG001|Overall Study|Adverse Event|3
7280689|NCT00473590|11496130|FG000|Overall Study|Death|4
7280690|NCT00473590|11496131|FG001|Overall Study|Death|2
7280691|NCT00473590|11496130|FG000|Overall Study|Progression not resulting in death|24
7280692|NCT00473590|11496131|FG001|Overall Study|Progression not resulting in death|20
7280693|NCT00473590|11496130|FG000|Overall Study|Non-protocol-specified therapy|7
7280694|NCT00473590|11496131|FG001|Overall Study|Non-protocol-specified therapy|5
7280695|NCT00473590|11496130|FG000|Overall Study|Physician Decision|2
7280696|NCT00473590|11496131|FG001|Overall Study|Physician Decision|4
7280697|NCT00473590|11496130|FG000|Overall Study|Withdrawal by Subject|5
7280698|NCT00473590|11496131|FG001|Overall Study|Withdrawal by Subject|3
7280699|NCT00473590|11496130|FG000|Overall Study|Other|0
7280700|NCT00473590|11496131|FG001|Overall Study|Other|1
7280701|NCT00473655|11496156|FG000|Overall Study|Lost to Follow-up|9
7280702|NCT00473655|11496157|FG001|Overall Study|Lost to Follow-up|5
7280703|NCT00473655|11496158|FG002|Overall Study|Lost to Follow-up|8
7280704|NCT00473668|11496169|FG000|Overall Study|Withdrawal by Subject|0
7215767|NCT04574999|11423840|FG000|Overall Study|Adverse Event|1
7215768|NCT04574999|11423841|FG001|Overall Study|Adverse Event|0
7215769|NCT04574999|11423840|FG000|Overall Study|Lack of Efficacy|2
7215770|NCT04574999|11423841|FG001|Overall Study|Lack of Efficacy|3
7215771|NCT04574999|11423840|FG000|Overall Study|Protocol Violation|1
7215772|NCT04574999|11423841|FG001|Overall Study|Protocol Violation|0
7215773|NCT04574999|11423840|FG000|Overall Study|Withdrawal by Subject|2
7215774|NCT04574999|11423841|FG001|Overall Study|Withdrawal by Subject|2
7215775|NCT04574999|11423840|FG000|Overall Study|Lost to Follow-up|1
7215776|NCT04574999|11423841|FG001|Overall Study|Lost to Follow-up|0
7215777|NCT04574999|11423840|FG000|Overall Study|Personal problems|1
7215778|NCT04574999|11423841|FG001|Overall Study|Personal problems|0
7215779|NCT04574999|11423840|FG000|Overall Study|Previous planned surgery|1
7215780|NCT04574999|11423841|FG001|Overall Study|Previous planned surgery|0
7215798|NCT04531813|11424003|FG000|Overall Study|Protocol Violation|1
7215799|NCT04531813|11424003|FG000|Overall Study|Withdrawal by Subject|1
7215800|NCT04531527|11424007|FG000|Overall Study|Found to be Ineligible|3
7215801|NCT04531540|11424011|FG000|Overall Study|Adverse Event|1
7215802|NCT04531540|11424011|FG000|Overall Study|Protocol Violation|3
7215803|NCT04531540|11424011|FG000|Overall Study|Withdrawal by Subject|4
7215804|NCT04531540|11424011|FG000|Overall Study|Found to be Ineligible|1
7215828|NCT02700698|11424139|FG000|Overall Study|Withdrawal by Subject|1
7215829|NCT02700698|11424140|FG001|Overall Study|Withdrawal by Subject|0
7215830|NCT02698865|11424157|FG000|Overall Study|Other|11
7215831|NCT02698865|11424158|FG001|Overall Study|Other|11
7215832|NCT02698865|11424157|FG000|Overall Study|Withdrawal by Subject|20
7215833|NCT02698865|11424158|FG001|Overall Study|Withdrawal by Subject|16
7215834|NCT02698865|11424157|FG000|Overall Study|Physician Decision|0
7215835|NCT02698865|11424158|FG001|Overall Study|Physician Decision|4
7215836|NCT02698865|11424157|FG000|Overall Study|Lost to Follow-up|4
7215837|NCT02698865|11424158|FG001|Overall Study|Lost to Follow-up|2
7215838|NCT02660086|11424166|FG000|Overall Study- 12-month|Withdrawal by Subject|5
7215839|NCT02660086|11424167|FG001|Overall Study- 12-month|Withdrawal by Subject|5
7215840|NCT02660086|11424166|FG000|Overall Study- 12-month|Left full-time employment|12
7215841|NCT02660086|11424167|FG001|Overall Study- 12-month|Left full-time employment|20
7215842|NCT02660086|11424166|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
7215843|NCT02660086|11424167|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
7215844|NCT02660086|11424166|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
7215845|NCT02660086|11424167|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
7215846|NCT02660086|11424166|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
7215847|NCT02660086|11424167|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
7215848|NCT02660086|11424166|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
7215849|NCT02660086|11424167|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
7215850|NCT02129647|11424177|FG000|Overall Study|Adverse Event|2
7215851|NCT02129647|11424177|FG000|Overall Study|surgical intervention for clinically progressive disease|1
7215852|NCT01959139|11424189|FG000|Phase II|Disease progression|0
7215853|NCT01959139|11424190|FG001|Phase II|Disease progression|0
7215854|NCT01959139|11424191|FG002|Phase II|Disease progression|26
7215855|NCT01959139|11424192|FG003|Phase II|Disease progression|34
7215856|NCT01959139|11424189|FG000|Phase II|Adverse Event|0
7215857|NCT01959139|11424190|FG001|Phase II|Adverse Event|0
7215858|NCT01959139|11424191|FG002|Phase II|Adverse Event|10
7215859|NCT01959139|11424192|FG003|Phase II|Adverse Event|11
7215860|NCT01959139|11424189|FG000|Phase II|Patient Refusal|0
7215861|NCT01959139|11424190|FG001|Phase II|Patient Refusal|0
7215862|NCT01959139|11424191|FG002|Phase II|Patient Refusal|5
7215863|NCT01959139|11424192|FG003|Phase II|Patient Refusal|4
7215864|NCT01959139|11424189|FG000|Phase II|Death|0
7215865|NCT01959139|11424190|FG001|Phase II|Death|0
7215866|NCT01959139|11424191|FG002|Phase II|Death|3
7215867|NCT01959139|11424192|FG003|Phase II|Death|1
7215868|NCT01959139|11424189|FG000|Phase II|Other/Unknown|0
7215869|NCT01959139|11424190|FG001|Phase II|Other/Unknown|0
7215870|NCT01959139|11424191|FG002|Phase II|Other/Unknown|8
7215871|NCT01959139|11424192|FG003|Phase II|Other/Unknown|5
7215872|NCT01959139|11424189|FG000|Phase II|On treatment|0
7215873|NCT01959139|11424190|FG001|Phase II|On treatment|0
7215874|NCT01959139|11424191|FG002|Phase II|On treatment|4
7215875|NCT01959139|11424192|FG003|Phase II|On treatment|0
7215876|NCT01597778|11424209|FG000|Overall Study|Death|7
7215877|NCT01597778|11424210|FG001|Overall Study|Death|10
7215878|NCT01597778|11424209|FG000|Overall Study|Withdrawal by Subject|3
7215879|NCT01597778|11424210|FG001|Overall Study|Withdrawal by Subject|4
7215880|NCT01597778|11424209|FG000|Overall Study|Adverse Event|1
7215881|NCT01597778|11424210|FG001|Overall Study|Adverse Event|1
7215882|NCT01597778|11424209|FG000|Overall Study|Protocol Violation|1
7215883|NCT01597778|11424210|FG001|Overall Study|Protocol Violation|11
7215781|NCT04572997|11423847|FG000|Overall Study|Adverse Event|1
7215884|NCT01597778|11424209|FG000|Overall Study|Transplanted off protocol|2
7215885|NCT01597778|11424210|FG001|Overall Study|Transplanted off protocol|3
7215886|NCT00879086|11424227|FG000|Overall Study|Adverse Event|3
7215887|NCT00879086|11424228|FG001|Overall Study|Adverse Event|15
7215888|NCT00879086|11424227|FG000|Overall Study|Participant choice|2
7215889|NCT00879086|11424228|FG001|Overall Study|Participant choice|2
7215890|NCT00879086|11424227|FG000|Overall Study|Progression of disease|40
7215891|NCT00879086|11424228|FG001|Overall Study|Progression of disease|26
7215892|NCT00879086|11424227|FG000|Overall Study|Withdrawal of consent|2
7215893|NCT00879086|11424228|FG001|Overall Study|Withdrawal of consent|1
7215894|NCT00879086|11424227|FG000|Overall Study|Other|4
7215895|NCT00879086|11424228|FG001|Overall Study|Other|6
7215896|NCT00879086|11424227|FG000|Overall Study|Death|1
7215897|NCT00879086|11424228|FG001|Overall Study|Death|2
7215898|NCT00864227|11424234|FG000|Overall Study|Withdrawal by Subject|1
7215899|NCT00864227|11424234|FG000|Overall Study|Disease Relapse/Progression|3
7215900|NCT00685360|11424241|FG000|Overall Study|Lost to Follow-up|0
7215901|NCT00685360|11424242|FG001|Overall Study|Lost to Follow-up|1
7215902|NCT00685360|11424243|FG002|Overall Study|Lost to Follow-up|2
7215903|NCT00685360|11424241|FG000|Overall Study|Adverse Event|4
7215904|NCT00685360|11424242|FG001|Overall Study|Adverse Event|6
7215905|NCT00685360|11424243|FG002|Overall Study|Adverse Event|4
7215906|NCT00685360|11424241|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
7215907|NCT00685360|11424242|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
7215908|NCT00685360|11424243|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
7215909|NCT00685360|11424241|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
7215910|NCT00685360|11424242|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
7215911|NCT00685360|11424243|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
7215912|NCT00685360|11424241|FG000|Overall Study|Subject Withdrew Consent to Participate|13
7215913|NCT00685360|11424242|FG001|Overall Study|Subject Withdrew Consent to Participate|2
7215914|NCT00685360|11424243|FG002|Overall Study|Subject Withdrew Consent to Participate|5
7215915|NCT00685360|11424241|FG000|Overall Study|Protocol Deviation|0
7215916|NCT00685360|11424242|FG001|Overall Study|Protocol Deviation|1
7215917|NCT00685360|11424243|FG002|Overall Study|Protocol Deviation|1
7215918|NCT00299728|11424253|FG000|Overall Study|Lost to Follow-up|0
7215919|NCT00299728|11424254|FG001|Overall Study|Lost to Follow-up|1
7215920|NCT00299728|11424253|FG000|Overall Study|Withdrawal by Subject|0
7215921|NCT00299728|11424254|FG001|Overall Study|Withdrawal by Subject|1
7215922|NCT00299728|11424253|FG000|Overall Study|Progressive disease|0
7215923|NCT00299728|11424254|FG001|Overall Study|Progressive disease|1
7280705|NCT00473668|11496170|FG001|Overall Study|Withdrawal by Subject|2
7280706|NCT00473668|11496171|FG002|Overall Study|Withdrawal by Subject|0
7280707|NCT00473668|11496169|FG000|Overall Study|Migrated/moved from study area|3
7280708|NCT00473668|11496170|FG001|Overall Study|Migrated/moved from study area|2
7280709|NCT00473668|11496171|FG002|Overall Study|Migrated/moved from study area|0
7280710|NCT00473668|11496169|FG000|Overall Study|Lost to Follow-up|0
7280711|NCT00473668|11496170|FG001|Overall Study|Lost to Follow-up|4
7280712|NCT00473668|11496171|FG002|Overall Study|Lost to Follow-up|6
7280713|NCT00473668|11496169|FG000|Overall Study|Other|2
7280714|NCT00473668|11496170|FG001|Overall Study|Other|3
7280715|NCT00473668|11496171|FG002|Overall Study|Other|4
7215924|NCT04330157|11424281|FG000|Overall Study|Protocol Violation|4
7215925|NCT04330157|11424281|FG000|Overall Study|Not extubated within 24 h postoperatively|3
7215931|NCT04160988|11424323|FG000|Overall Study|poor image quality|28
7215932|NCT04079114|11424332|FG000|Overall Study|Study prematuely terminated.|166
7215933|NCT04461795|11424457|FG000|Overall Study|Lost to Follow-up|2
7215934|NCT04461795|11424457|FG000|Overall Study|Withdrawal by Subject|2
7215935|NCT04461795|11424457|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1
7215936|NCT04035473|11424478|FG000|Screening/Baseline|Death|0
7215937|NCT04035473|11424479|FG001|Screening/Baseline|Death|1
7280716|NCT00473694|11496183|FG000|Overall Study|Adverse Event|0
7280717|NCT00473694|11496184|FG001|Overall Study|Adverse Event|1
7280718|NCT00473694|11496185|FG002|Overall Study|Adverse Event|0
7280719|NCT00473694|11496186|FG003|Overall Study|Adverse Event|0
7280720|NCT00473694|11496183|FG000|Overall Study|Participants did not receive treatment|11
7280721|NCT00473694|11496184|FG001|Overall Study|Participants did not receive treatment|3
7280722|NCT00473694|11496185|FG002|Overall Study|Participants did not receive treatment|5
7280723|NCT00473694|11496186|FG003|Overall Study|Participants did not receive treatment|6
7280724|NCT00473694|11496183|FG000|Overall Study|Lost to Follow-up|0
7280725|NCT00473694|11496184|FG001|Overall Study|Lost to Follow-up|0
7280726|NCT00473694|11496185|FG002|Overall Study|Lost to Follow-up|0
7280727|NCT00473694|11496186|FG003|Overall Study|Lost to Follow-up|1
7280728|NCT00473746|11496204|FG000|Period 1 (Phase 1)|Adverse Event|1
7280729|NCT00473746|11496205|FG001|Period 1 (Phase 1)|Adverse Event|0
7280730|NCT00473746|11496206|FG002|Period 1 (Phase 1)|Adverse Event|0
7280731|NCT00473746|11496207|FG003|Period 1 (Phase 1)|Adverse Event|0
7280732|NCT00473746|11496208|FG004|Period 1 (Phase 1)|Adverse Event|0
7280733|NCT00473746|11496204|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
7280734|NCT00473746|11496205|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
7280735|NCT00473746|11496206|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
7280736|NCT00473746|11496207|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
7280737|NCT00473746|11496208|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
7280738|NCT00473746|11496204|FG000|Period 1 (Phase 1)|Progressive Disease|5
7280739|NCT00473746|11496205|FG001|Period 1 (Phase 1)|Progressive Disease|6
7280740|NCT00473746|11496206|FG002|Period 1 (Phase 1)|Progressive Disease|6
7280741|NCT00473746|11496207|FG003|Period 1 (Phase 1)|Progressive Disease|10
7280742|NCT00473746|11496208|FG004|Period 1 (Phase 1)|Progressive Disease|0
7280743|NCT00473746|11496204|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
7280744|NCT00473746|11496205|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
7280745|NCT00473746|11496206|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
7280746|NCT00473746|11496207|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
7280747|NCT00473746|11496208|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
7280748|NCT00473746|11496204|FG000|Period 1 (Phase 1)|Reason not specified|0
7280749|NCT00473746|11496205|FG001|Period 1 (Phase 1)|Reason not specified|1
7280750|NCT00473746|11496206|FG002|Period 1 (Phase 1)|Reason not specified|0
7280751|NCT00473746|11496207|FG003|Period 1 (Phase 1)|Reason not specified|0
7280752|NCT00473746|11496208|FG004|Period 1 (Phase 1)|Reason not specified|0
7280753|NCT00473746|11496204|FG000|Period 2 (Phase 2)|Adverse Event|0
7280754|NCT00473746|11496205|FG001|Period 2 (Phase 2)|Adverse Event|0
7280755|NCT00473746|11496206|FG002|Period 2 (Phase 2)|Adverse Event|0
7280756|NCT00473746|11496207|FG003|Period 2 (Phase 2)|Adverse Event|0
7215938|NCT04035473|11424478|FG000|Screening/Baseline|Adverse Event|0
7215939|NCT04035473|11424479|FG001|Screening/Baseline|Adverse Event|1
7280757|NCT00473746|11496208|FG004|Period 2 (Phase 2)|Adverse Event|3
7619228|NCT02863419|12029889|FG002|Overall Study|Died|1
7215926|NCT04317690|11424295|FG000|Overall Study|did not have complete information for primary outcome|0
7215927|NCT04317690|11424296|FG001|Overall Study|did not have complete information for primary outcome|4
7215928|NCT04317690|11424297|FG002|Overall Study|did not have complete information for primary outcome|0
7215929|NCT04317690|11424298|FG003|Overall Study|did not have complete information for primary outcome|2
7215930|NCT04317690|11424299|FG004|Overall Study|did not have complete information for primary outcome|0
7215940|NCT04035473|11424478|FG000|Follow-up Period|Adverse Event|2
7215941|NCT04035473|11424479|FG001|Follow-up Period|Adverse Event|0
7215942|NCT03796676|11424488|FG000|Overall Study|Adverse Event|2
7215943|NCT03796676|11424489|FG001|Overall Study|Adverse Event|1
7215944|NCT03796676|11424490|FG002|Overall Study|Adverse Event|2
7215945|NCT03796676|11424488|FG000|Overall Study|Lost to Follow-up|2
7280758|NCT00473746|11496204|FG000|Period 2 (Phase 2)|Death|0
7280759|NCT00473746|11496205|FG001|Period 2 (Phase 2)|Death|0
7280760|NCT00473746|11496206|FG002|Period 2 (Phase 2)|Death|0
7280761|NCT00473746|11496207|FG003|Period 2 (Phase 2)|Death|0
7280762|NCT00473746|11496208|FG004|Period 2 (Phase 2)|Death|1
7280763|NCT00473746|11496204|FG000|Period 2 (Phase 2)|Progressive Disease|0
7280764|NCT00473746|11496205|FG001|Period 2 (Phase 2)|Progressive Disease|0
7280765|NCT00473746|11496206|FG002|Period 2 (Phase 2)|Progressive Disease|0
7280766|NCT00473746|11496207|FG003|Period 2 (Phase 2)|Progressive Disease|0
7280767|NCT00473746|11496208|FG004|Period 2 (Phase 2)|Progressive Disease|20
7280768|NCT00473746|11496204|FG000|Period 2 (Phase 2)|Reason not specified|0
7280769|NCT00473746|11496205|FG001|Period 2 (Phase 2)|Reason not specified|0
7280770|NCT00473746|11496206|FG002|Period 2 (Phase 2)|Reason not specified|0
7280771|NCT00473746|11496207|FG003|Period 2 (Phase 2)|Reason not specified|0
7280772|NCT00473746|11496208|FG004|Period 2 (Phase 2)|Reason not specified|3
7280773|NCT00473824|11496224|FG000|Overall Study|Virologic Breakthrough|1
7280774|NCT00473824|11496225|FG001|Overall Study|Virologic Breakthrough|0
7280775|NCT00473824|11496224|FG000|Overall Study|Adverse Event|1
7280776|NCT00473824|11496225|FG001|Overall Study|Adverse Event|0
7280777|NCT00473824|11496224|FG000|Overall Study|Death|1
7280778|NCT00473824|11496225|FG001|Overall Study|Death|0
7280779|NCT00473824|11496224|FG000|Overall Study|Lost to Follow-up|1
7280780|NCT00473824|11496225|FG001|Overall Study|Lost to Follow-up|0
7280781|NCT00473824|11496224|FG000|Overall Study|Withdrawal by physician|1
7280782|NCT00473824|11496225|FG001|Overall Study|Withdrawal by physician|0
7215946|NCT03796676|11424489|FG001|Overall Study|Lost to Follow-up|1
7280783|NCT00473876|11496242|FG000|Overall Study|Lost to Follow-up|3
7280784|NCT00473876|11496243|FG001|Overall Study|Lost to Follow-up|1
7215947|NCT03796676|11424490|FG002|Overall Study|Lost to Follow-up|0
7215948|NCT03796676|11424488|FG000|Overall Study|Protocol Violation|0
7215949|NCT03796676|11424489|FG001|Overall Study|Protocol Violation|0
7215950|NCT03796676|11424490|FG002|Overall Study|Protocol Violation|1
7215951|NCT03796676|11424488|FG000|Overall Study|Withdrawal by Subject|1
7215952|NCT03796676|11424489|FG001|Overall Study|Withdrawal by Subject|1
7215953|NCT03796676|11424490|FG002|Overall Study|Withdrawal by Subject|0
7215954|NCT03796676|11424488|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
7215955|NCT03796676|11424489|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7215956|NCT03796676|11424490|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
7280785|NCT00473889|11496253|FG000|Overall Study|Did not receive study medication|1
7280786|NCT00473889|11496254|FG001|Overall Study|Did not receive study medication|4
7280787|NCT00473889|11496253|FG000|Overall Study|Adverse Event|30
7280788|NCT00473889|11496254|FG001|Overall Study|Adverse Event|17
7280789|NCT00473889|11496253|FG000|Overall Study|Protocol Violation|4
7280790|NCT00473889|11496254|FG001|Overall Study|Protocol Violation|2
7280791|NCT00473889|11496253|FG000|Overall Study|Lack of Efficacy|28
7280792|NCT00473889|11496254|FG001|Overall Study|Lack of Efficacy|29
7280793|NCT00473889|11496253|FG000|Overall Study|Lost to Follow-up|2
7280794|NCT00473889|11496254|FG001|Overall Study|Lost to Follow-up|1
7280795|NCT00473889|11496253|FG000|Overall Study|Physician Decision|10
7280796|NCT00473889|11496254|FG001|Overall Study|Physician Decision|5
7280797|NCT00473889|11496253|FG000|Overall Study|Trial Terminated|3
7280798|NCT00473889|11496254|FG001|Overall Study|Trial Terminated|6
7280799|NCT00473889|11496253|FG000|Overall Study|Withdrawal by Subject|5
7280800|NCT00473889|11496254|FG001|Overall Study|Withdrawal by Subject|0
7280801|NCT00474045|11496262|FG000|Overall Study|Adverse Event|18
7280802|NCT00474045|11496263|FG001|Overall Study|Adverse Event|8
7280803|NCT00474045|11496262|FG000|Overall Study|Unclassified|1
7280804|NCT00474045|11496263|FG001|Overall Study|Unclassified|3
7280805|NCT00474045|11496262|FG000|Overall Study|Lack of Efficacy|0
7280806|NCT00474045|11496263|FG001|Overall Study|Lack of Efficacy|9
7280807|NCT00474045|11496262|FG000|Overall Study|Lost to Follow-up|1
7280808|NCT00474045|11496263|FG001|Overall Study|Lost to Follow-up|1
7280809|NCT00474045|11496262|FG000|Overall Study|Protocol Violation|10
7280810|NCT00474045|11496263|FG001|Overall Study|Protocol Violation|12
7280811|NCT00474045|11496262|FG000|Overall Study|Withdrawal by Subject|16
7280812|NCT00474045|11496263|FG001|Overall Study|Withdrawal by Subject|18
7280813|NCT00474045|11496262|FG000|Overall Study|Withdrawal criteria|60
7280814|NCT00474045|11496263|FG001|Overall Study|Withdrawal criteria|50
7280815|NCT00474058|11496271|FG000|Overall Study|Adverse Event|11
7280816|NCT00474058|11496272|FG001|Overall Study|Adverse Event|6
7280817|NCT00474058|11496271|FG000|Overall Study|Lack of Efficacy|0
7280818|NCT00474058|11496272|FG001|Overall Study|Lack of Efficacy|4
7280819|NCT00474058|11496271|FG000|Overall Study|Withdrawal by Subject|11
7280820|NCT00474058|11496272|FG001|Overall Study|Withdrawal by Subject|7
7280821|NCT00474058|11496271|FG000|Overall Study|Other|2
7280822|NCT00474058|11496272|FG001|Overall Study|Other|0
7280823|NCT00474175|11496290|FG000|Overall Study|Lack of Efficacy|0
7280824|NCT00474175|11496291|FG001|Overall Study|Lack of Efficacy|0
7280825|NCT00474175|11496292|FG002|Overall Study|Lack of Efficacy|1
7280826|NCT00474175|11496290|FG000|Overall Study|Withdrawal by Subject|0
7280827|NCT00474175|11496291|FG001|Overall Study|Withdrawal by Subject|1
7280828|NCT00474175|11496292|FG002|Overall Study|Withdrawal by Subject|1
7280829|NCT00474175|11496290|FG000|Overall Study|Ineligible|1
7280830|NCT00474175|11496291|FG001|Overall Study|Ineligible|3
7280831|NCT00474175|11496292|FG002|Overall Study|Ineligible|1
7280832|NCT00474175|11496290|FG000|Overall Study|Protocol Violation|0
7280833|NCT00474175|11496291|FG001|Overall Study|Protocol Violation|2
7280834|NCT00474175|11496292|FG002|Overall Study|Protocol Violation|1
7280835|NCT00474175|11496290|FG000|Overall Study|Administrative|0
7280836|NCT00474175|11496291|FG001|Overall Study|Administrative|1
7280837|NCT00474175|11496292|FG002|Overall Study|Administrative|0
7280838|NCT00474240|11496311|FG000|Overall Study|Withdrawal by Subject|1
7280839|NCT00474240|11496312|FG001|Overall Study|Withdrawal by Subject|1
7280840|NCT00474240|11496313|FG002|Overall Study|Withdrawal by Subject|0
7280841|NCT00474240|11496314|FG003|Overall Study|Withdrawal by Subject|2
7280842|NCT00474240|11496315|FG004|Overall Study|Withdrawal by Subject|3
7280843|NCT00474240|11496316|FG005|Overall Study|Withdrawal by Subject|1
7280844|NCT00474240|11496311|FG000|Overall Study|Adverse Event|0
7280845|NCT00474240|11496312|FG001|Overall Study|Adverse Event|0
7280846|NCT00474240|11496313|FG002|Overall Study|Adverse Event|9
7280847|NCT00474240|11496314|FG003|Overall Study|Adverse Event|14
7280848|NCT00474240|11496315|FG004|Overall Study|Adverse Event|5
7280849|NCT00474240|11496316|FG005|Overall Study|Adverse Event|16
7280850|NCT00474240|11496311|FG000|Overall Study|Removed due to lab value|0
7280851|NCT00474240|11496312|FG001|Overall Study|Removed due to lab value|0
7280852|NCT00474240|11496313|FG002|Overall Study|Removed due to lab value|0
7280853|NCT00474240|11496314|FG003|Overall Study|Removed due to lab value|0
7280854|NCT00474240|11496315|FG004|Overall Study|Removed due to lab value|0
7280855|NCT00474240|11496316|FG005|Overall Study|Removed due to lab value|1
7280856|NCT00474253|11496332|FG000|Overall Study|Withdrew consent|2
7280857|NCT00474253|11496333|FG001|Overall Study|Withdrew consent|0
7280858|NCT00474253|11496332|FG000|Overall Study|Withdrew due to surgery-related issues|0
7280859|NCT00474253|11496333|FG001|Overall Study|Withdrew due to surgery-related issues|3
7280860|NCT00474253|11496332|FG000|Overall Study|Lost to Follow-up|1
7280861|NCT00474253|11496333|FG001|Overall Study|Lost to Follow-up|0
7280862|NCT00474253|11496332|FG000|Overall Study|Discharged prior to study completion|0
7280863|NCT00474253|11496333|FG001|Overall Study|Discharged prior to study completion|1
7280864|NCT00474266|11496343|FG000|Overall Study|Withdrawal by Subject|7
7280865|NCT00474266|11496344|FG001|Overall Study|Withdrawal by Subject|20
7280866|NCT00474266|11496345|FG002|Overall Study|Withdrawal by Subject|4
7280867|NCT00474266|11496346|FG003|Overall Study|Withdrawal by Subject|7
7280868|NCT00474383|11496359|FG000|Main Study|Adverse Event|11
7280869|NCT00474383|11496360|FG001|Main Study|Adverse Event|0
7280870|NCT00474383|11496359|FG000|Main Study|Symptomatic Deterioration|1
7280871|NCT00474383|11496360|FG001|Main Study|Symptomatic Deterioration|0
7280872|NCT00474383|11496359|FG000|Main Study|Progressive Disease|23
7280873|NCT00474383|11496360|FG001|Main Study|Progressive Disease|0
7280874|NCT00474383|11496359|FG000|Main Study|Other|1
7280875|NCT00474383|11496360|FG001|Main Study|Other|0
7280876|NCT00474383|11496359|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
7280877|NCT00474383|11496360|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
7280878|NCT00474383|11496359|FG000|Extension|Progressive Disease|0
7280879|NCT00474383|11496360|FG001|Extension|Progressive Disease|5
7280880|NCT00474487|11496368|FG000|Overall Study|Withdrawal by Subject|6
7280881|NCT00474487|11496369|FG001|Overall Study|Withdrawal by Subject|0
7280882|NCT00474487|11496370|FG002|Overall Study|Withdrawal by Subject|0
7280883|NCT00474487|11496371|FG003|Overall Study|Withdrawal by Subject|0
7280884|NCT00474487|11496368|FG000|Overall Study|Lost to Follow-up|20
7280885|NCT00474487|11496369|FG001|Overall Study|Lost to Follow-up|1
7280886|NCT00474487|11496370|FG002|Overall Study|Lost to Follow-up|7
7280887|NCT00474487|11496371|FG003|Overall Study|Lost to Follow-up|0
7280888|NCT00474487|11496368|FG000|Overall Study|Inappropriate enrollment|4
7280889|NCT00474487|11496369|FG001|Overall Study|Inappropriate enrollment|0
7280890|NCT00474487|11496370|FG002|Overall Study|Inappropriate enrollment|7
7280891|NCT00474487|11496371|FG003|Overall Study|Inappropriate enrollment|0
7280892|NCT00474487|11496368|FG000|Overall Study|Death|0
7280893|NCT00474487|11496369|FG001|Overall Study|Death|1
7280894|NCT00474487|11496370|FG002|Overall Study|Death|0
7215957|NCT02989857|11424512|FG000|Randomization Phase|Adverse Event|8
7215958|NCT02989857|11424513|FG001|Randomization Phase|Adverse Event|4
7215959|NCT02989857|11424514|FG002|Randomization Phase|Adverse Event|0
7215960|NCT02989857|11424512|FG000|Randomization Phase|Death|6
7215961|NCT02989857|11424513|FG001|Randomization Phase|Death|0
7215962|NCT02989857|11424514|FG002|Randomization Phase|Death|0
7215963|NCT02989857|11424512|FG000|Randomization Phase|Progressive Disease|98
7215964|NCT02989857|11424513|FG001|Randomization Phase|Progressive Disease|51
7215965|NCT02989857|11424514|FG002|Randomization Phase|Progressive Disease|0
7619229|NCT02863328|12029899|FG000|Overall Study|Lost to Follow-up|4
7215966|NCT02989857|11424512|FG000|Randomization Phase|Withdrawal by Subject|6
7215967|NCT02989857|11424513|FG001|Randomization Phase|Withdrawal by Subject|2
7215968|NCT02989857|11424514|FG002|Randomization Phase|Withdrawal by Subject|0
7215969|NCT02989857|11424512|FG000|Randomization Phase|Withdrawal of Consent|2
7215970|NCT02989857|11424513|FG001|Randomization Phase|Withdrawal of Consent|1
7215971|NCT02989857|11424514|FG002|Randomization Phase|Withdrawal of Consent|0
7215972|NCT02989857|11424512|FG000|Randomization Phase|Reason not specified|3
7215973|NCT02989857|11424513|FG001|Randomization Phase|Reason not specified|1
7215974|NCT02989857|11424514|FG002|Randomization Phase|Reason not specified|0
7215975|NCT02989857|11424512|FG000|Randomization Phase|Not Treated|3
7215976|NCT02989857|11424513|FG001|Randomization Phase|Not Treated|2
7215977|NCT02989857|11424514|FG002|Randomization Phase|Not Treated|0
7215978|NCT02989857|11424512|FG000|Cross Over Phase|Adverse Event|0
7215979|NCT02989857|11424513|FG001|Cross Over Phase|Adverse Event|0
7215980|NCT02989857|11424514|FG002|Cross Over Phase|Adverse Event|2
7215981|NCT02989857|11424512|FG000|Cross Over Phase|Physician Decision|0
7215982|NCT02989857|11424513|FG001|Cross Over Phase|Physician Decision|0
7215983|NCT02989857|11424514|FG002|Cross Over Phase|Physician Decision|2
7215984|NCT02989857|11424512|FG000|Cross Over Phase|Progressive Disease|0
7215985|NCT02989857|11424513|FG001|Cross Over Phase|Progressive Disease|0
7215986|NCT02989857|11424514|FG002|Cross Over Phase|Progressive Disease|36
7215987|NCT02989857|11424512|FG000|Cross Over Phase|Withdrawal by Consent|0
7215988|NCT02989857|11424513|FG001|Cross Over Phase|Withdrawal by Consent|0
7215989|NCT02989857|11424514|FG002|Cross Over Phase|Withdrawal by Consent|3
7215990|NCT02983799|11424526|FG000|Overall Study|Withdrawn from study before data cut-off|28
7215991|NCT02983799|11424527|FG001|Overall Study|Withdrawn from study before data cut-off|12
7215992|NCT02983799|11424528|FG002|Overall Study|Withdrawn from study before data cut-off|23
7215993|NCT02983799|11424529|FG003|Overall Study|Withdrawn from study before data cut-off|25
7215994|NCT02983799|11424530|FG004|Overall Study|Withdrawn from study before data cut-off|1
7215995|NCT02983799|11424526|FG000|Overall Study|Death|20
7215996|NCT02983799|11424527|FG001|Overall Study|Death|5
7215997|NCT02983799|11424528|FG002|Overall Study|Death|23
7215998|NCT02983799|11424529|FG003|Overall Study|Death|47
7215999|NCT02983799|11424530|FG004|Overall Study|Death|7
7216000|NCT02983799|11424526|FG000|Overall Study|Withdrawal by Subject|1
7216001|NCT02983799|11424527|FG001|Overall Study|Withdrawal by Subject|0
7216002|NCT02983799|11424528|FG002|Overall Study|Withdrawal by Subject|3
7216003|NCT02983799|11424529|FG003|Overall Study|Withdrawal by Subject|4
7216004|NCT02983799|11424530|FG004|Overall Study|Withdrawal by Subject|1
7216005|NCT02983799|11424526|FG000|Overall Study|Protocol Violation|0
7216006|NCT02983799|11424527|FG001|Overall Study|Protocol Violation|1
7216007|NCT02983799|11424528|FG002|Overall Study|Protocol Violation|0
7216008|NCT02983799|11424529|FG003|Overall Study|Protocol Violation|0
7216009|NCT02983799|11424530|FG004|Overall Study|Protocol Violation|1
7216010|NCT02983799|11424526|FG000|Overall Study|Lost to Follow-up|1
7216011|NCT02983799|11424527|FG001|Overall Study|Lost to Follow-up|0
7216012|NCT02983799|11424528|FG002|Overall Study|Lost to Follow-up|1
7216013|NCT02983799|11424529|FG003|Overall Study|Lost to Follow-up|0
7216014|NCT02983799|11424530|FG004|Overall Study|Lost to Follow-up|0
7216029|NCT02631577|11424561|FG000|Overall Study|Death|1
7216030|NCT02631577|11424562|FG001|Overall Study|Death|7
7216031|NCT02631577|11424561|FG000|Overall Study|Withdrawal by Subject|0
7619220|NCT02863419|12029887|FG000|Overall Study|Lost to Follow-up|0
7619221|NCT02863419|12029888|FG001|Overall Study|Lost to Follow-up|1
7619222|NCT02863419|12029889|FG002|Overall Study|Lost to Follow-up|4
7619223|NCT02863419|12029887|FG000|Overall Study|Withdrawal by Subject|5
7619224|NCT02863419|12029888|FG001|Overall Study|Withdrawal by Subject|5
7619225|NCT02863419|12029889|FG002|Overall Study|Withdrawal by Subject|3
7619226|NCT02863419|12029887|FG000|Overall Study|Died|3
7619227|NCT02863419|12029888|FG001|Overall Study|Died|4
7619230|NCT02863328|12029900|FG001|Overall Study|Lost to Follow-up|10
7619231|NCT02863328|12029899|FG000|Overall Study|Withdrawal by Subject|7
7619232|NCT02863328|12029900|FG001|Overall Study|Withdrawal by Subject|12
7619233|NCT02863328|12029899|FG000|Overall Study|Died|0
7619234|NCT02863328|12029900|FG001|Overall Study|Died|1
7619235|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
7619236|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
7619237|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7619238|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
7619239|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
7619240|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
7619241|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7619242|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
7619243|NCT02849080|12029908|FG000|Main Phase: 0 - 52 Weeks|Death|0
7619244|NCT02849080|12029909|FG001|Main Phase: 0 - 52 Weeks|Death|2
7619245|NCT02849080|12029910|FG002|Main Phase: 0 - 52 Weeks|Death|0
7619246|NCT02849080|12029911|FG003|Main Phase: 0 - 52 Weeks|Death|0
7619247|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
7619248|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619249|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619250|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
7619251|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Other|0
7619252|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Other|0
7619253|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Other|1
7619254|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Other|0
7619255|NCT02849080|12029908|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
7619256|NCT02849080|12029909|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619257|NCT02849080|12029910|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619258|NCT02849080|12029911|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
7619259|NCT02764762|12029923|FG000|Overall Study|Adverse Event|5
7619260|NCT02764762|12029923|FG000|Overall Study|Voluntary Withdrawal|3
7619261|NCT02764762|12029923|FG000|Overall Study|Significant Deviation|1
7619271|NCT02692716|12029942|FG000|Overall Study|Lost to Follow-up|2
7619272|NCT02692716|12029943|FG001|Overall Study|Lost to Follow-up|5
7619273|NCT02692716|12029942|FG000|Overall Study|Withdrawal by Subject|3
7619274|NCT02692716|12029943|FG001|Overall Study|Withdrawal by Subject|1
7619275|NCT02607865|12029953|FG000|Overall Study|Lost to Follow-up|9
7619276|NCT02607865|12029954|FG001|Overall Study|Lost to Follow-up|7
7619277|NCT02607865|12029955|FG002|Overall Study|Lost to Follow-up|7
7216032|NCT02631577|11424562|FG001|Overall Study|Withdrawal by Subject|3
7216033|NCT02300233|11424589|FG000|Overall Study|Adverse Event or Serious Adverse Event|3
7216034|NCT02300233|11424590|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
7216035|NCT02300233|11424591|FG002|Overall Study|Adverse Event or Serious Adverse Event|14
7216036|NCT02300233|11424589|FG000|Overall Study|Withdrawal by Subject|1
7216037|NCT02300233|11424590|FG001|Overall Study|Withdrawal by Subject|0
7216038|NCT02300233|11424591|FG002|Overall Study|Withdrawal by Subject|3
7216039|NCT02300233|11424589|FG000|Overall Study|Investigator Judgement|0
7216040|NCT02300233|11424590|FG001|Overall Study|Investigator Judgement|0
7216041|NCT02300233|11424591|FG002|Overall Study|Investigator Judgement|1
7216042|NCT02300233|11424589|FG000|Overall Study|Reason Not Specified|0
7216043|NCT02300233|11424590|FG001|Overall Study|Reason Not Specified|0
7216044|NCT02300233|11424591|FG002|Overall Study|Reason Not Specified|5
7216045|NCT02211209|11424602|FG000|Overall Study|Investigator judgment|0
7216046|NCT02211209|11424603|FG001|Overall Study|Investigator judgment|1
7216047|NCT02211209|11424602|FG000|Overall Study|Voluntary withdrawal|1
7216048|NCT02211209|11424603|FG001|Overall Study|Voluntary withdrawal|4
7216049|NCT02211209|11424602|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
7619278|NCT02607865|12029956|FG003|Overall Study|Lost to Follow-up|5
7619279|NCT02607865|12029953|FG000|Overall Study|Withdrawal by Subject|18
7619280|NCT02607865|12029954|FG001|Overall Study|Withdrawal by Subject|18
7619281|NCT02607865|12029955|FG002|Overall Study|Withdrawal by Subject|17
7619282|NCT02607865|12029956|FG003|Overall Study|Withdrawal by Subject|8
7619283|NCT02607865|12029953|FG000|Overall Study|Death|5
7619284|NCT02607865|12029954|FG001|Overall Study|Death|4
7619285|NCT02607865|12029955|FG002|Overall Study|Death|1
7619286|NCT02607865|12029956|FG003|Overall Study|Death|3
7619287|NCT02607865|12029953|FG000|Overall Study|Unclassified|1
7619288|NCT02607865|12029954|FG001|Overall Study|Unclassified|1
7619289|NCT02607865|12029955|FG002|Overall Study|Unclassified|2
7619290|NCT02607865|12029956|FG003|Overall Study|Unclassified|0
7216050|NCT02211209|11424603|FG001|Overall Study|Adverse Event or Serious Adverse Event|9
7216051|NCT02211209|11424602|FG000|Overall Study|Reason Not Specified|1
7216052|NCT02211209|11424603|FG001|Overall Study|Reason Not Specified|0
7216061|NCT02000115|11424621|FG000|Overall Study|Death|56
7216062|NCT02000115|11424622|FG001|Overall Study|Death|45
7216063|NCT02000115|11424623|FG002|Overall Study|Death|0
7216064|NCT02000115|11424624|FG003|Overall Study|Death|0
7216065|NCT02000115|11424621|FG000|Overall Study|Missed Visit|6
7216066|NCT02000115|11424622|FG001|Overall Study|Missed Visit|8
7216067|NCT02000115|11424623|FG002|Overall Study|Missed Visit|1
7216068|NCT02000115|11424624|FG003|Overall Study|Missed Visit|0
7216069|NCT02000115|11424621|FG000|Overall Study|Protocol Violation|2
7216070|NCT02000115|11424622|FG001|Overall Study|Protocol Violation|1
7216071|NCT02000115|11424623|FG002|Overall Study|Protocol Violation|0
7216072|NCT02000115|11424624|FG003|Overall Study|Protocol Violation|0
7216073|NCT02000115|11424621|FG000|Overall Study|Physician Decision|2
7216074|NCT02000115|11424622|FG001|Overall Study|Physician Decision|0
7216075|NCT02000115|11424623|FG002|Overall Study|Physician Decision|0
7216076|NCT02000115|11424624|FG003|Overall Study|Physician Decision|0
7216077|NCT02000115|11424621|FG000|Overall Study|Withdrawal by Subject|11
7216078|NCT02000115|11424622|FG001|Overall Study|Withdrawal by Subject|11
7216079|NCT02000115|11424623|FG002|Overall Study|Withdrawal by Subject|0
7216080|NCT02000115|11424624|FG003|Overall Study|Withdrawal by Subject|0
7216081|NCT02000115|11424621|FG000|Overall Study|Lost to Follow-up|0
7216082|NCT02000115|11424622|FG001|Overall Study|Lost to Follow-up|1
7216083|NCT02000115|11424623|FG002|Overall Study|Lost to Follow-up|0
7216084|NCT02000115|11424624|FG003|Overall Study|Lost to Follow-up|0
7216085|NCT02000115|11424621|FG000|Overall Study|Non-compliance|2
7280895|NCT00474487|11496371|FG003|Overall Study|Death|0
7469836|NCT01927341|11771716|FG003|Phase 2|Lost to Follow-up|0
7469837|NCT01927341|11771717|FG004|Phase 2|Lost to Follow-up|0
7469838|NCT01927341|11771713|FG000|Phase 2|Participant withdrew consent|0
7469839|NCT01927341|11771714|FG001|Phase 2|Participant withdrew consent|2
7469840|NCT01927341|11771715|FG002|Phase 2|Participant withdrew consent|1
7216086|NCT02000115|11424622|FG001|Overall Study|Non-compliance|1
7216087|NCT02000115|11424623|FG002|Overall Study|Non-compliance|0
7216088|NCT02000115|11424624|FG003|Overall Study|Non-compliance|0
7216089|NCT02000115|11424621|FG000|Overall Study|Withdrawn on day of randomization|0
7216090|NCT02000115|11424622|FG001|Overall Study|Withdrawn on day of randomization|1
7216091|NCT02000115|11424623|FG002|Overall Study|Withdrawn on day of randomization|0
7216092|NCT02000115|11424624|FG003|Overall Study|Withdrawn on day of randomization|0
7216093|NCT02000115|11424621|FG000|Overall Study|Still on Study|0
7216094|NCT02000115|11424622|FG001|Overall Study|Still on Study|0
7216095|NCT02000115|11424623|FG002|Overall Study|Still on Study|0
7216096|NCT02000115|11424624|FG003|Overall Study|Still on Study|53
7216097|NCT01695317|11424648|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2
7216098|NCT01695317|11424649|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1
7216099|NCT01695317|11424648|FG000|Cross-over to Period 2|Withdrawal by Subject|4
7216100|NCT01695317|11424649|FG001|Cross-over to Period 2|Withdrawal by Subject|34
7216101|NCT01127451|11424680|FG000|Overall Study|Other|2
7216102|NCT01127451|11424681|FG001|Overall Study|Other|1
7216103|NCT01127451|11424680|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14
7216104|NCT01127451|11424681|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12
7216105|NCT01127451|11424680|FG000|Overall Study|Death|22
7216106|NCT01127451|11424681|FG001|Overall Study|Death|17
7216107|NCT01127451|11424680|FG000|Overall Study|Lost to Follow-up|3
7216108|NCT01127451|11424681|FG001|Overall Study|Lost to Follow-up|0
7216109|NCT01127451|11424680|FG000|Overall Study|Administrative Reason by Sponsor|2
7216110|NCT01127451|11424681|FG001|Overall Study|Administrative Reason by Sponsor|2
7469841|NCT01927341|11771716|FG003|Phase 2|Participant withdrew consent|2
7469842|NCT01927341|11771717|FG004|Phase 2|Participant withdrew consent|3
7469843|NCT01927341|11771713|FG000|Phase 2|Death|0
7469844|NCT01927341|11771714|FG001|Phase 2|Death|4
7469845|NCT01927341|11771715|FG002|Phase 2|Death|0
7469846|NCT01927341|11771716|FG003|Phase 2|Death|3
7469847|NCT01927341|11771717|FG004|Phase 2|Death|2
7469848|NCT01927341|11771713|FG000|Phase 2|New cancer therapy|0
7216145|NCT04280705|11424756|FG000|Overall Study|Withdrawal by Subject|7
7216111|NCT04559698|11424713|FG000|Overall Study|Lost to Follow-up|14
7216112|NCT04559698|11424714|FG001|Overall Study|Lost to Follow-up|15
7216113|NCT04559698|11424713|FG000|Overall Study|Withdrawal by Subject|0
7216114|NCT04559698|11424714|FG001|Overall Study|Withdrawal by Subject|1
7216115|NCT04492475|11424722|FG000|Overall Study|Enrolled but not treated|8
7216116|NCT04492475|11424723|FG001|Overall Study|Enrolled but not treated|8
7216117|NCT04492475|11424722|FG000|Overall Study|Withdrawal by Subject|4
7216118|NCT04492475|11424723|FG001|Overall Study|Withdrawal by Subject|0
7216119|NCT04492475|11424722|FG000|Overall Study|Became ineligible after enrollment|2
7216120|NCT04492475|11424723|FG001|Overall Study|Became ineligible after enrollment|0
7216121|NCT04401579|11424738|FG000|Overall Study|Death|23
7216122|NCT04401579|11424739|FG001|Overall Study|Death|36
7216123|NCT04401579|11424738|FG000|Overall Study|Lost to Follow-up|40
7216124|NCT04401579|11424739|FG001|Overall Study|Lost to Follow-up|41
7216125|NCT04401579|11424738|FG000|Overall Study|Withdrawal by Subject|8
7216126|NCT04401579|11424739|FG001|Overall Study|Withdrawal by Subject|16
7216127|NCT04401579|11424738|FG000|Overall Study|Physician Decision|1
7216128|NCT04401579|11424739|FG001|Overall Study|Physician Decision|2
7216129|NCT04401579|11424738|FG000|Overall Study|Became ineligible after enrollment|1
7216130|NCT04401579|11424739|FG001|Overall Study|Became ineligible after enrollment|1
7216131|NCT04401579|11424738|FG000|Overall Study|Enrolled but treatment not administered|7
7216132|NCT04401579|11424739|FG001|Overall Study|Enrolled but treatment not administered|9
7216133|NCT04401579|11424738|FG000|Overall Study|Adverse Event|2
7216134|NCT04401579|11424739|FG001|Overall Study|Adverse Event|1
7216135|NCT04401579|11424738|FG000|Overall Study|Scheduling error|1
7216136|NCT04401579|11424739|FG001|Overall Study|Scheduling error|2
7216137|NCT04401579|11424738|FG000|Overall Study|Transferred to another hospital|1
7216138|NCT04401579|11424739|FG001|Overall Study|Transferred to another hospital|2
7216139|NCT04321460|11424747|FG000|Overall Study|Participants who had no defecation or no data about it|1
7280896|NCT00474526|11496398|FG000|Overall Study|ADMINISTRATIVE REASON|11
7280897|NCT00474526|11496399|FG001|Overall Study|ADMINISTRATIVE REASON|9
7280898|NCT00474526|11496400|FG002|Overall Study|ADMINISTRATIVE REASON|9
7280899|NCT00474526|11496401|FG003|Overall Study|ADMINISTRATIVE REASON|20
7280900|NCT00474526|11496402|FG004|Overall Study|ADMINISTRATIVE REASON|9
7280901|NCT00474526|11496403|FG005|Overall Study|ADMINISTRATIVE REASON|1
7280902|NCT00474526|11496404|FG006|Overall Study|ADMINISTRATIVE REASON|1
7280903|NCT00474526|11496405|FG007|Overall Study|ADMINISTRATIVE REASON|0
7280904|NCT00474526|11496406|FG008|Overall Study|ADMINISTRATIVE REASON|2
7280905|NCT00474526|11496407|FG009|Overall Study|ADMINISTRATIVE REASON|1
7280906|NCT00474526|11496408|FG010|Overall Study|ADMINISTRATIVE REASON|1
7280907|NCT00474526|11496409|FG011|Overall Study|ADMINISTRATIVE REASON|1
7280908|NCT00474526|11496410|FG012|Overall Study|ADMINISTRATIVE REASON|1
7280909|NCT00474526|11496411|FG013|Overall Study|ADMINISTRATIVE REASON|1
7280910|NCT00474526|11496412|FG014|Overall Study|ADMINISTRATIVE REASON|2
7280911|NCT00474526|11496413|FG015|Overall Study|ADMINISTRATIVE REASON|0
7280912|NCT00474526|11496414|FG016|Overall Study|ADMINISTRATIVE REASON|0
7280913|NCT00474526|11496398|FG000|Overall Study|Adverse Event|2
7280914|NCT00474526|11496399|FG001|Overall Study|Adverse Event|0
7280915|NCT00474526|11496400|FG002|Overall Study|Adverse Event|2
7280916|NCT00474526|11496401|FG003|Overall Study|Adverse Event|4
7280917|NCT00474526|11496402|FG004|Overall Study|Adverse Event|2
7280918|NCT00474526|11496403|FG005|Overall Study|Adverse Event|1
7280919|NCT00474526|11496404|FG006|Overall Study|Adverse Event|1
7280920|NCT00474526|11496405|FG007|Overall Study|Adverse Event|0
7280921|NCT00474526|11496406|FG008|Overall Study|Adverse Event|0
7280922|NCT00474526|11496407|FG009|Overall Study|Adverse Event|0
7280923|NCT00474526|11496408|FG010|Overall Study|Adverse Event|0
7280924|NCT00474526|11496409|FG011|Overall Study|Adverse Event|0
7280925|NCT00474526|11496410|FG012|Overall Study|Adverse Event|0
7280926|NCT00474526|11496411|FG013|Overall Study|Adverse Event|0
7280927|NCT00474526|11496412|FG014|Overall Study|Adverse Event|1
7280928|NCT00474526|11496413|FG015|Overall Study|Adverse Event|1
7280929|NCT00474526|11496414|FG016|Overall Study|Adverse Event|0
7280930|NCT00474526|11496398|FG000|Overall Study|Death|0
7280931|NCT00474526|11496399|FG001|Overall Study|Death|0
7280932|NCT00474526|11496400|FG002|Overall Study|Death|0
7280933|NCT00474526|11496401|FG003|Overall Study|Death|0
7280934|NCT00474526|11496402|FG004|Overall Study|Death|0
7280935|NCT00474526|11496403|FG005|Overall Study|Death|0
7280936|NCT00474526|11496404|FG006|Overall Study|Death|0
7280937|NCT00474526|11496405|FG007|Overall Study|Death|0
7280938|NCT00474526|11496406|FG008|Overall Study|Death|0
7280939|NCT00474526|11496407|FG009|Overall Study|Death|0
7619307|NCT02430480|12029984|FG000|Overall Study|Death|1
7619308|NCT02430480|12029984|FG000|Overall Study|Anesthesia concerns|1
7619309|NCT02430480|12029984|FG000|Overall Study|Progressed on treatment|1
7216140|NCT04321460|11424748|FG001|Overall Study|Participants who had no defecation or no data about it|1
7216141|NCT04280705|11424756|FG000|Overall Study|Enrolled but not treated|4
7216142|NCT04280705|11424757|FG001|Overall Study|Enrolled but not treated|10
7216143|NCT04280705|11424756|FG000|Overall Study|Physician Decision|1
7216144|NCT04280705|11424757|FG001|Overall Study|Physician Decision|0
7216146|NCT04280705|11424757|FG001|Overall Study|Withdrawal by Subject|9
7216147|NCT04280705|11424756|FG000|Overall Study|Adverse Event|0
7216148|NCT04280705|11424757|FG001|Overall Study|Adverse Event|4
7216149|NCT04280705|11424756|FG000|Overall Study|Transferred to another hospital|1
7216150|NCT04280705|11424757|FG001|Overall Study|Transferred to another hospital|1
7216151|NCT04208750|11424765|FG000|Overall Study|Lost to Follow-up|16
7216152|NCT04208750|11424766|FG001|Overall Study|Lost to Follow-up|15
7280940|NCT00474526|11496408|FG010|Overall Study|Death|0
7280941|NCT00474526|11496409|FG011|Overall Study|Death|0
7280942|NCT00474526|11496410|FG012|Overall Study|Death|0
7280943|NCT00474526|11496411|FG013|Overall Study|Death|3
7280944|NCT00474526|11496412|FG014|Overall Study|Death|0
7280945|NCT00474526|11496413|FG015|Overall Study|Death|0
7280946|NCT00474526|11496414|FG016|Overall Study|Death|0
7280947|NCT00474526|11496398|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280948|NCT00474526|11496399|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
7280949|NCT00474526|11496400|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280950|NCT00474526|11496401|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
7280951|NCT00474526|11496402|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
7280952|NCT00474526|11496403|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280953|NCT00474526|11496404|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280954|NCT00474526|11496405|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280955|NCT00474526|11496406|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280956|NCT00474526|11496407|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280957|NCT00474526|11496408|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280958|NCT00474526|11496409|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280959|NCT00474526|11496410|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280960|NCT00474526|11496411|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
7280961|NCT00474526|11496412|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
7280962|NCT00474526|11496413|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280963|NCT00474526|11496414|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
7280964|NCT00474526|11496398|FG000|Overall Study|Lost to Follow-up|8
7280965|NCT00474526|11496399|FG001|Overall Study|Lost to Follow-up|6
7280966|NCT00474526|11496400|FG002|Overall Study|Lost to Follow-up|13
7280967|NCT00474526|11496401|FG003|Overall Study|Lost to Follow-up|29
7280968|NCT00474526|11496402|FG004|Overall Study|Lost to Follow-up|11
7280969|NCT00474526|11496403|FG005|Overall Study|Lost to Follow-up|5
7280970|NCT00474526|11496404|FG006|Overall Study|Lost to Follow-up|8
7280971|NCT00474526|11496405|FG007|Overall Study|Lost to Follow-up|1
7280972|NCT00474526|11496406|FG008|Overall Study|Lost to Follow-up|0
7280973|NCT00474526|11496407|FG009|Overall Study|Lost to Follow-up|6
7280974|NCT00474526|11496408|FG010|Overall Study|Lost to Follow-up|2
7280975|NCT00474526|11496409|FG011|Overall Study|Lost to Follow-up|4
7280976|NCT00474526|11496410|FG012|Overall Study|Lost to Follow-up|6
7280977|NCT00474526|11496411|FG013|Overall Study|Lost to Follow-up|74
7280978|NCT00474526|11496412|FG014|Overall Study|Lost to Follow-up|29
7280979|NCT00474526|11496413|FG015|Overall Study|Lost to Follow-up|4
7280980|NCT00474526|11496414|FG016|Overall Study|Lost to Follow-up|5
7280981|NCT00474526|11496398|FG000|Overall Study|Protocol Violation|2
7280982|NCT00474526|11496399|FG001|Overall Study|Protocol Violation|6
7280983|NCT00474526|11496400|FG002|Overall Study|Protocol Violation|4
7280984|NCT00474526|11496401|FG003|Overall Study|Protocol Violation|12
7280985|NCT00474526|11496402|FG004|Overall Study|Protocol Violation|3
7280986|NCT00474526|11496403|FG005|Overall Study|Protocol Violation|1
7280987|NCT00474526|11496404|FG006|Overall Study|Protocol Violation|3
7280988|NCT00474526|11496405|FG007|Overall Study|Protocol Violation|0
7280989|NCT00474526|11496406|FG008|Overall Study|Protocol Violation|0
7280990|NCT00474526|11496407|FG009|Overall Study|Protocol Violation|4
7280991|NCT00474526|11496408|FG010|Overall Study|Protocol Violation|2
7280992|NCT00474526|11496409|FG011|Overall Study|Protocol Violation|2
7280993|NCT00474526|11496410|FG012|Overall Study|Protocol Violation|4
7280994|NCT00474526|11496411|FG013|Overall Study|Protocol Violation|19
7280995|NCT00474526|11496412|FG014|Overall Study|Protocol Violation|9
7280996|NCT00474526|11496413|FG015|Overall Study|Protocol Violation|6
7280997|NCT00474526|11496414|FG016|Overall Study|Protocol Violation|2
7280998|NCT00474526|11496398|FG000|Overall Study|UNABLE TO CLASSIFY|1
7280999|NCT00474526|11496399|FG001|Overall Study|UNABLE TO CLASSIFY|0
7281000|NCT00474526|11496400|FG002|Overall Study|UNABLE TO CLASSIFY|0
7281001|NCT00474526|11496401|FG003|Overall Study|UNABLE TO CLASSIFY|1
7281002|NCT00474526|11496402|FG004|Overall Study|UNABLE TO CLASSIFY|3
7619329|NCT01964430|12030036|FG000|Overall Study|Adverse Event|71
7619330|NCT01964430|12030037|FG001|Overall Study|Adverse Event|37
7619331|NCT01964430|12030036|FG000|Overall Study|Withdrawal by Subject|36
7619332|NCT01964430|12030037|FG001|Overall Study|Withdrawal by Subject|27
7619333|NCT01964430|12030036|FG000|Overall Study|Death|1
7619334|NCT01964430|12030037|FG001|Overall Study|Death|3
7619335|NCT01964430|12030036|FG000|Overall Study|Protocol Deviation|0
7619336|NCT01964430|12030037|FG001|Overall Study|Protocol Deviation|1
7619337|NCT01964430|12030036|FG000|Overall Study|Physician Decision|5
7619338|NCT01964430|12030037|FG001|Overall Study|Physician Decision|4
7619339|NCT01964430|12030036|FG000|Overall Study|Disease Relapse|28
7619340|NCT01964430|12030037|FG001|Overall Study|Disease Relapse|38
7619341|NCT01964430|12030036|FG000|Overall Study|Miscellaneous|1
7619342|NCT01964430|12030037|FG001|Overall Study|Miscellaneous|3
7619343|NCT01964430|12030036|FG000|Overall Study|Randomized but not Treated|3
7619344|NCT01964430|12030037|FG001|Overall Study|Randomized but not Treated|11
7619345|NCT01880957|12030045|FG000|Overall Study|Diagnosis: Unipolar Depression|12
7619346|NCT01880957|12030046|FG001|Overall Study|Diagnosis: Unipolar Depression|0
7619347|NCT01880957|12030045|FG000|Overall Study|Lost to Follow-up|11
7619348|NCT01880957|12030046|FG001|Overall Study|Lost to Follow-up|0
7619349|NCT01880957|12030045|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5
7619350|NCT01880957|12030046|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0
7619351|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7619352|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
7619353|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7619354|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
7619355|NCT01651403|12030063|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
7619356|NCT01651403|12030064|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
7619357|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
7619358|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
7619359|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
7619360|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
7619361|NCT01651403|12030063|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
7619362|NCT01651403|12030064|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
7216153|NCT03713281|11424772|FG000|Overall Study|Lens handling difficuluties|2
7216154|NCT03713281|11424772|FG000|Overall Study|Subject was not dispensed enough lenses|1
7216155|NCT03608254|11424776|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2
7216156|NCT03608254|11424776|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1
7216157|NCT03512275|11424782|FG000|Overall Study|Withdrawal by Subject|1
7216158|NCT03512275|11424783|FG001|Overall Study|Withdrawal by Subject|3
7216159|NCT03512275|11424782|FG000|Overall Study|Physician Decision|0
7216160|NCT03512275|11424783|FG001|Overall Study|Physician Decision|1
7216161|NCT03512275|11424782|FG000|Overall Study|Lost to Follow-up|0
7216162|NCT03512275|11424783|FG001|Overall Study|Lost to Follow-up|3
7216163|NCT03512275|11424782|FG000|Overall Study|Other|1
7216164|NCT03512275|11424783|FG001|Overall Study|Other|0
7216165|NCT03414983|11424791|FG000|Pre-Treatment|Other reasons|1
7216166|NCT03414983|11424792|FG001|Pre-Treatment|Other reasons|0
7216167|NCT03414983|11424791|FG000|Pre-Treatment|Participant no longer meets study criteria|2
7216168|NCT03414983|11424792|FG001|Pre-Treatment|Participant no longer meets study criteria|3
7216169|NCT03414983|11424791|FG000|Pre-Treatment|Participant withdrew consent|1
7216170|NCT03414983|11424792|FG001|Pre-Treatment|Participant withdrew consent|3
7216171|NCT03414983|11424791|FG000|Treatment|Participant withdrew consent|4
7216172|NCT03414983|11424792|FG001|Treatment|Participant withdrew consent|3
7216173|NCT03414983|11424791|FG000|Treatment|Participant request to discontinue study treatment|8
7216174|NCT03414983|11424792|FG001|Treatment|Participant request to discontinue study treatment|10
7216175|NCT03414983|11424791|FG000|Treatment|Adverse Event Unrelated to Study Drug|5
7216176|NCT03414983|11424792|FG001|Treatment|Adverse Event Unrelated to Study Drug|2
7216177|NCT03414983|11424791|FG000|Treatment|Death|0
7216178|NCT03414983|11424792|FG001|Treatment|Death|2
7216179|NCT03414983|11424791|FG000|Treatment|Study Drug Toxicity|11
7216180|NCT03414983|11424792|FG001|Treatment|Study Drug Toxicity|4
7216181|NCT03414983|11424791|FG000|Treatment|Disease Progression|72
7216182|NCT03414983|11424792|FG001|Treatment|Disease Progression|27
7216183|NCT03414983|11424791|FG000|Treatment|Not reported|1
7216184|NCT03414983|11424792|FG001|Treatment|Not reported|0
7216185|NCT03414983|11424791|FG000|Treatment|Other reasons|3
7216186|NCT03414983|11424792|FG001|Treatment|Other reasons|2
7216187|NCT03414983|11424791|FG000|Treatment|Completed treatment as per protocol|8
7216188|NCT03414983|11424792|FG001|Treatment|Completed treatment as per protocol|0
7216189|NCT03414983|11424791|FG000|Treatment|Poor/non-compliance|2
7216190|NCT03414983|11424792|FG001|Treatment|Poor/non-compliance|0
7216191|NCT03414983|11424791|FG000|Treatment|Maximum clinical benefit|5
7216192|NCT03414983|11424792|FG001|Treatment|Maximum clinical benefit|9
7216193|NCT03414983|11424791|FG000|Treatment|Lost to Follow-up|0
7216194|NCT03414983|11424792|FG001|Treatment|Lost to Follow-up|1
7216195|NCT03383692|11424800|FG000|Overall Study|Progressive disease as per RECIST|3
7216196|NCT03383692|11424801|FG001|Overall Study|Progressive disease as per RECIST|3
7216197|NCT03383692|11424800|FG000|Overall Study|Clinical progression|0
7216198|NCT03383692|11424801|FG001|Overall Study|Clinical progression|1
7216199|NCT03383692|11424800|FG000|Overall Study|Adverse Event|3
7216200|NCT03383692|11424801|FG001|Overall Study|Adverse Event|0
7216201|NCT03371251|11424815|FG000|Overall Study|Withdrawal by Subject|1
7216202|NCT03371251|11424816|FG001|Overall Study|Withdrawal by Subject|0
7216203|NCT03371251|11424817|FG002|Overall Study|Withdrawal by Subject|1
7216204|NCT03371251|11424818|FG003|Overall Study|Withdrawal by Subject|0
7216205|NCT03371251|11424819|FG004|Overall Study|Withdrawal by Subject|2
7216206|NCT03371251|11424820|FG005|Overall Study|Withdrawal by Subject|2
7216207|NCT03371251|11424815|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1
7216208|NCT03371251|11424816|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7216209|NCT03371251|11424817|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7216210|NCT03371251|11424818|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
7216211|NCT03371251|11424819|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2
7216212|NCT03371251|11424820|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3
7216213|NCT03371251|11424815|FG000|Overall Study|Adverse Event|0
7216214|NCT03371251|11424816|FG001|Overall Study|Adverse Event|0
7216215|NCT03371251|11424817|FG002|Overall Study|Adverse Event|0
7216216|NCT03371251|11424818|FG003|Overall Study|Adverse Event|0
7216217|NCT03371251|11424819|FG004|Overall Study|Adverse Event|1
7216218|NCT03371251|11424820|FG005|Overall Study|Adverse Event|0
7216219|NCT03371251|11424815|FG000|Overall Study|Decision by Sponsor|0
7216220|NCT03371251|11424816|FG001|Overall Study|Decision by Sponsor|0
7216221|NCT03371251|11424817|FG002|Overall Study|Decision by Sponsor|0
7216222|NCT03371251|11424818|FG003|Overall Study|Decision by Sponsor|0
7216223|NCT03371251|11424819|FG004|Overall Study|Decision by Sponsor|2
7216224|NCT03371251|11424820|FG005|Overall Study|Decision by Sponsor|0
7281003|NCT00474526|11496403|FG005|Overall Study|UNABLE TO CLASSIFY|2
7281004|NCT00474526|11496404|FG006|Overall Study|UNABLE TO CLASSIFY|0
7281005|NCT00474526|11496405|FG007|Overall Study|UNABLE TO CLASSIFY|1
7281006|NCT00474526|11496406|FG008|Overall Study|UNABLE TO CLASSIFY|0
7619438|NCT01335399|12030142|FG000|Pre-treatment Period|No longer meeting study criteria|0
7619439|NCT01335399|12030143|FG001|Pre-treatment Period|No longer meeting study criteria|1
7619440|NCT01335399|12030142|FG000|Pre-treatment Period|Participant request to discontinue|0
7619441|NCT01335399|12030143|FG001|Pre-treatment Period|Participant request to discontinue|1
7619442|NCT01335399|12030142|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
7619443|NCT01335399|12030143|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
7619444|NCT01335399|12030142|FG000|Pre-treatment Period|Consent withdrawal|3
7619445|NCT01335399|12030143|FG001|Pre-treatment Period|Consent withdrawal|0
7619446|NCT01335399|12030142|FG000|Treatment Period|Disease progression|114
7619447|NCT01335399|12030143|FG001|Treatment Period|Disease progression|141
7619448|NCT01335399|12030142|FG000|Treatment Period|Adverse event unrelated to study drug|105
7619449|NCT01335399|12030143|FG001|Treatment Period|Adverse event unrelated to study drug|65
7619450|NCT01335399|12030142|FG000|Treatment Period|Study drug toxicity|51
7619451|NCT01335399|12030143|FG001|Treatment Period|Study drug toxicity|64
7619452|NCT01335399|12030142|FG000|Treatment Period|Participant request to discontinue|27
7619453|NCT01335399|12030143|FG001|Treatment Period|Participant request to discontinue|21
7619454|NCT01335399|12030142|FG000|Treatment Period|Other reasons|14
7619455|NCT01335399|12030143|FG001|Treatment Period|Other reasons|26
7619456|NCT01335399|12030142|FG000|Treatment Period|Consent withdrawal|10
7619457|NCT01335399|12030143|FG001|Treatment Period|Consent withdrawal|6
7619458|NCT01335399|12030142|FG000|Treatment Period|Death|7
7619459|NCT01335399|12030143|FG001|Treatment Period|Death|8
7619460|NCT01335399|12030142|FG000|Treatment Period|Poor/Non-compliance|3
7619461|NCT01335399|12030143|FG001|Treatment Period|Poor/Non-compliance|4
7619462|NCT01335399|12030142|FG000|Treatment Period|Lost to Follow-up|0
7619463|NCT01335399|12030143|FG001|Treatment Period|Lost to Follow-up|2
7619464|NCT01335399|12030142|FG000|Treatment Period|Maximum clinical benefit|1
7619465|NCT01335399|12030143|FG001|Treatment Period|Maximum clinical benefit|1
7619466|NCT01335399|12030142|FG000|Treatment Period|No longer meet study criteria|0
7619467|NCT01335399|12030143|FG001|Treatment Period|No longer meet study criteria|1
7619468|NCT01335399|12030142|FG000|Treatment Period|Not reported|1
7619469|NCT01335399|12030143|FG001|Treatment Period|Not reported|0
7619470|NCT01241786|12030149|FG000|Overall Study|Lack of Efficacy|5
7281007|NCT00474526|11496407|FG009|Overall Study|UNABLE TO CLASSIFY|3
7619572|NCT00606294|12030222|FG000|Overall Study|Withdrawal by Subject|36
7619573|NCT00606294|12030223|FG001|Overall Study|Withdrawal by Subject|0
7281008|NCT00474526|11496408|FG010|Overall Study|UNABLE TO CLASSIFY|0
7281009|NCT00474526|11496409|FG011|Overall Study|UNABLE TO CLASSIFY|0
7281010|NCT00474526|11496410|FG012|Overall Study|UNABLE TO CLASSIFY|0
7281011|NCT00474526|11496411|FG013|Overall Study|UNABLE TO CLASSIFY|20
7281012|NCT00474526|11496412|FG014|Overall Study|UNABLE TO CLASSIFY|12
7281013|NCT00474526|11496413|FG015|Overall Study|UNABLE TO CLASSIFY|6
7281014|NCT00474526|11496414|FG016|Overall Study|UNABLE TO CLASSIFY|1
7281015|NCT00474526|11496398|FG000|Overall Study|Withdrawal by Subject|9
7281016|NCT00474526|11496399|FG001|Overall Study|Withdrawal by Subject|24
7281017|NCT00474526|11496400|FG002|Overall Study|Withdrawal by Subject|21
7281018|NCT00474526|11496401|FG003|Overall Study|Withdrawal by Subject|52
7281019|NCT00474526|11496402|FG004|Overall Study|Withdrawal by Subject|38
7281020|NCT00474526|11496403|FG005|Overall Study|Withdrawal by Subject|6
7281021|NCT00474526|11496404|FG006|Overall Study|Withdrawal by Subject|12
7281022|NCT00474526|11496405|FG007|Overall Study|Withdrawal by Subject|4
7619616|NCT00464178|12030247|FG000|Overall Study|Protocol Violation|1
7281023|NCT00474526|11496406|FG008|Overall Study|Withdrawal by Subject|4
7281024|NCT00474526|11496407|FG009|Overall Study|Withdrawal by Subject|13
7281025|NCT00474526|11496408|FG010|Overall Study|Withdrawal by Subject|5
7281026|NCT00474526|11496409|FG011|Overall Study|Withdrawal by Subject|4
7281027|NCT00474526|11496410|FG012|Overall Study|Withdrawal by Subject|4
7619617|NCT00464178|12030247|FG000|Overall Study|Withdrawal by Subject|1
7281028|NCT00474526|11496411|FG013|Overall Study|Withdrawal by Subject|37
7281029|NCT00474526|11496412|FG014|Overall Study|Withdrawal by Subject|22
7281030|NCT00474526|11496413|FG015|Overall Study|Withdrawal by Subject|1
7281031|NCT00474526|11496414|FG016|Overall Study|Withdrawal by Subject|1
7619624|NCT04516746|12030267|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090
7619625|NCT04516746|12030268|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305
7619626|NCT04516746|12030267|FG000|Overall Study|Withdrawal by Subject|362
7619627|NCT04516746|12030268|FG001|Overall Study|Withdrawal by Subject|408
7619628|NCT04516746|12030267|FG000|Overall Study|Lost to Follow-up|157
7619629|NCT04516746|12030268|FG001|Overall Study|Lost to Follow-up|86
7619630|NCT04516746|12030267|FG000|Overall Study|Protocol deviation|18
7619631|NCT04516746|12030268|FG001|Overall Study|Protocol deviation|7
7281032|NCT00474539|11496502|FG000|Infant Series|Withdrawal by Subject|3
7281033|NCT00474539|11496503|FG001|Infant Series|Withdrawal by Subject|4
7281034|NCT00474539|11496502|FG000|Infant Series|Randomization error|5
7281035|NCT00474539|11496503|FG001|Infant Series|Randomization error|0
7281036|NCT00474539|11496502|FG000|Infant Series|Lost to Follow-up|2
7281037|NCT00474539|11496503|FG001|Infant Series|Lost to Follow-up|1
7281038|NCT00474539|11496502|FG000|Infant Series|Protocol Violation|0
7281039|NCT00474539|11496503|FG001|Infant Series|Protocol Violation|1
7281040|NCT00474539|11496502|FG000|After Infant Series|Lost to Follow-up|3
7281041|NCT00474539|11496503|FG001|After Infant Series|Lost to Follow-up|0
7281042|NCT00474539|11496502|FG000|After Infant Series|Withdrawal by Subject|1
7281043|NCT00474539|11496503|FG001|After Infant Series|Withdrawal by Subject|0
7281044|NCT00474539|11496502|FG000|Toddler Dose|Protocol Violation|1
7281045|NCT00474539|11496503|FG001|Toddler Dose|Protocol Violation|0
7281046|NCT00474630|11496549|FG000|Overall Study|Adverse Event|98
7281047|NCT00474630|11496550|FG001|Overall Study|Adverse Event|26
7281048|NCT00474630|11496549|FG000|Overall Study|Lost to Follow-up|22
7281049|NCT00474630|11496550|FG001|Overall Study|Lost to Follow-up|15
7281050|NCT00474630|11496549|FG000|Overall Study|Withdrawal by Subject|21
7281051|NCT00474630|11496550|FG001|Overall Study|Withdrawal by Subject|15
7281052|NCT00474630|11496549|FG000|Overall Study|Protocol Violation|3
7281053|NCT00474630|11496550|FG001|Overall Study|Protocol Violation|4
7281054|NCT00474630|11496549|FG000|Overall Study|Lack of Efficacy|5
7281055|NCT00474630|11496550|FG001|Overall Study|Lack of Efficacy|6
7281056|NCT00474630|11496549|FG000|Overall Study|Drug noncompliance, other|11
7281057|NCT00474630|11496550|FG001|Overall Study|Drug noncompliance, other|4
7281058|NCT00474708|11496559|FG000|Overall Study|Lack of Efficacy|11
7281059|NCT00474708|11496560|FG001|Overall Study|Lack of Efficacy|5
7281060|NCT00474708|11496559|FG000|Overall Study|Suicide ideation/behavior|0
7281061|NCT00474708|11496560|FG001|Overall Study|Suicide ideation/behavior|1
7281062|NCT00474708|11496559|FG000|Overall Study|Withdrawal by Subject|7
7281063|NCT00474708|11496560|FG001|Overall Study|Withdrawal by Subject|0
7281064|NCT00474708|11496559|FG000|Overall Study|Lack of compliance|12
7281065|NCT00474708|11496560|FG001|Overall Study|Lack of compliance|4
7281066|NCT00474708|11496559|FG000|Overall Study|Lost to Follow-up|18
7281067|NCT00474708|11496560|FG001|Overall Study|Lost to Follow-up|9
7619632|NCT04516746|12030267|FG000|Overall Study|Death|8
7619633|NCT04516746|12030268|FG001|Overall Study|Death|7
7619634|NCT04516746|12030267|FG000|Overall Study|Physician Decision|0
7619635|NCT04516746|12030268|FG001|Overall Study|Physician Decision|2
7619636|NCT04516746|12030267|FG000|Overall Study|Other|0
7619637|NCT04516746|12030268|FG001|Overall Study|Other|1
7619638|NCT04447417|12030276|FG000|Overall Study|Withdrawal by Subject|1
7619639|NCT04447417|12030277|FG001|Overall Study|Withdrawal by Subject|0
7619640|NCT04447417|12030276|FG000|Overall Study|Failure to meet inclusion criteria|1
7619641|NCT04447417|12030277|FG001|Overall Study|Failure to meet inclusion criteria|0
7619642|NCT04447417|12030276|FG000|Overall Study|Lost to Follow-up|1
7619643|NCT04447417|12030277|FG001|Overall Study|Lost to Follow-up|0
7619644|NCT04418765|12030296|FG000|Overall Study|Adverse Event|1
7619645|NCT04418765|12030297|FG001|Overall Study|Adverse Event|1
7619646|NCT04418765|12030298|FG002|Overall Study|Adverse Event|6
7619647|NCT04418765|12030296|FG000|Overall Study|Lack of Efficacy|1
7619648|NCT04418765|12030297|FG001|Overall Study|Lack of Efficacy|3
7619649|NCT04418765|12030298|FG002|Overall Study|Lack of Efficacy|0
7619650|NCT04418765|12030296|FG000|Overall Study|Protocol Violation|0
7619651|NCT04418765|12030297|FG001|Overall Study|Protocol Violation|1
7619652|NCT04418765|12030298|FG002|Overall Study|Protocol Violation|1
7619653|NCT04418765|12030296|FG000|Overall Study|Withdrawal by Subject|1
7619654|NCT04418765|12030297|FG001|Overall Study|Withdrawal by Subject|5
7619655|NCT04418765|12030298|FG002|Overall Study|Withdrawal by Subject|2
7619656|NCT04418765|12030296|FG000|Overall Study|Lost to Follow-up|0
7619657|NCT04418765|12030297|FG001|Overall Study|Lost to Follow-up|1
7619658|NCT04418765|12030298|FG002|Overall Study|Lost to Follow-up|0
7619659|NCT04418765|12030296|FG000|Overall Study|Other than specified|2
7619660|NCT04418765|12030297|FG001|Overall Study|Other than specified|0
7619661|NCT04418765|12030298|FG002|Overall Study|Other than specified|1
7619662|NCT04418765|12030296|FG000|Overall Study|Randomized but not treated|1
7619663|NCT04418765|12030297|FG001|Overall Study|Randomized but not treated|0
7619664|NCT04418765|12030298|FG002|Overall Study|Randomized but not treated|0
7619665|NCT04343976|12030317|FG000|Overall Study|Withdrawal by Subject|0
7619666|NCT04343976|12030318|FG001|Overall Study|Withdrawal by Subject|1
7619675|NCT04000581|12030335|FG000|Overall Study|Withdrawal by Subject|0
7619676|NCT04000581|12030336|FG001|Overall Study|Withdrawal by Subject|1
7619677|NCT03935880|12030344|FG000|Overall Study|Lost to Follow-up|0
7619678|NCT03935880|12030345|FG001|Overall Study|Lost to Follow-up|1
7619679|NCT03834350|12030351|FG000|Overall Study|Withdrawal by Subject|1
7619680|NCT03761056|12030368|FG000|Overall Study|Still on Study|34
7619681|NCT03761056|12030368|FG000|Overall Study|Death|6
7619682|NCT03761056|12030368|FG000|Overall Study|Investigator Decision|1
7619683|NCT03761056|12030368|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1
7619684|NCT03710564|12030380|FG000|Overall Study|Study Terminated by Sponsor|104
7619685|NCT03710564|12030381|FG001|Overall Study|Study Terminated by Sponsor|55
7619686|NCT03710564|12030380|FG000|Overall Study|Withdrawal by Subject|57
7619687|NCT03710564|12030381|FG001|Overall Study|Withdrawal by Subject|25
7619688|NCT03710564|12030380|FG000|Overall Study|Death|10
7619689|NCT03710564|12030381|FG001|Overall Study|Death|4
7619690|NCT03710564|12030380|FG000|Overall Study|Lost to Follow-up|5
7619691|NCT03710564|12030381|FG001|Overall Study|Lost to Follow-up|4
7619692|NCT03710564|12030380|FG000|Overall Study|Protocol Violation|3
7281068|NCT00474708|11496559|FG000|Overall Study|Physician Decision|9
7281069|NCT00474708|11496560|FG001|Overall Study|Physician Decision|6
7281070|NCT00474760|11496573|FG000|Overall Study|Death|0
7281071|NCT00474760|11496574|FG001|Overall Study|Death|0
7281072|NCT00474760|11496575|FG002|Overall Study|Death|0
7281073|NCT00474760|11496576|FG003|Overall Study|Death|0
7281074|NCT00474760|11496577|FG004|Overall Study|Death|2
7281075|NCT00474760|11496578|FG005|Overall Study|Death|0
7281076|NCT00474760|11496579|FG006|Overall Study|Death|0
7281077|NCT00474760|11496573|FG000|Overall Study|Adverse Event|0
7281078|NCT00474760|11496574|FG001|Overall Study|Adverse Event|0
7281079|NCT00474760|11496575|FG002|Overall Study|Adverse Event|0
7281080|NCT00474760|11496576|FG003|Overall Study|Adverse Event|0
7281081|NCT00474760|11496577|FG004|Overall Study|Adverse Event|1
7281082|NCT00474760|11496578|FG005|Overall Study|Adverse Event|7
7281083|NCT00474760|11496579|FG006|Overall Study|Adverse Event|0
7281084|NCT00474760|11496573|FG000|Overall Study|Laboratory abnormality|0
7281085|NCT00474760|11496574|FG001|Overall Study|Laboratory abnormality|0
7281086|NCT00474760|11496575|FG002|Overall Study|Laboratory abnormality|0
7281087|NCT00474760|11496576|FG003|Overall Study|Laboratory abnormality|0
7281088|NCT00474760|11496577|FG004|Overall Study|Laboratory abnormality|0
7281089|NCT00474760|11496578|FG005|Overall Study|Laboratory abnormality|1
7281090|NCT00474760|11496579|FG006|Overall Study|Laboratory abnormality|0
7281091|NCT00474760|11496573|FG000|Overall Study|Withdrawal by Subject|0
7281092|NCT00474760|11496574|FG001|Overall Study|Withdrawal by Subject|0
7281093|NCT00474760|11496575|FG002|Overall Study|Withdrawal by Subject|0
7281094|NCT00474760|11496576|FG003|Overall Study|Withdrawal by Subject|1
7281095|NCT00474760|11496577|FG004|Overall Study|Withdrawal by Subject|0
7281096|NCT00474760|11496578|FG005|Overall Study|Withdrawal by Subject|1
7281097|NCT00474760|11496579|FG006|Overall Study|Withdrawal by Subject|1
7281098|NCT00474760|11496573|FG000|Overall Study|Other|0
7281099|NCT00474760|11496574|FG001|Overall Study|Other|1
7281100|NCT00474760|11496575|FG002|Overall Study|Other|0
7281101|NCT00474760|11496576|FG003|Overall Study|Other|0
7281102|NCT00474760|11496577|FG004|Overall Study|Other|1
7281103|NCT00474760|11496578|FG005|Overall Study|Other|0
7619693|NCT03710564|12030381|FG001|Overall Study|Protocol Violation|2
7619694|NCT03710564|12030380|FG000|Overall Study|Adverse Event|3
7619695|NCT03710564|12030381|FG001|Overall Study|Adverse Event|0
7619696|NCT03710564|12030380|FG000|Overall Study|Physician Decision|2
7619697|NCT03710564|12030381|FG001|Overall Study|Physician Decision|3
7281104|NCT00474760|11496579|FG006|Overall Study|Other|0
7281105|NCT00474760|11496573|FG000|Overall Study|Progressive disease|3
7281106|NCT00474760|11496574|FG001|Overall Study|Progressive disease|2
7281107|NCT00474760|11496575|FG002|Overall Study|Progressive disease|3
7281108|NCT00474760|11496576|FG003|Overall Study|Progressive disease|2
7281109|NCT00474760|11496577|FG004|Overall Study|Progressive disease|8
7281110|NCT00474760|11496578|FG005|Overall Study|Progressive disease|20
7281111|NCT00474760|11496579|FG006|Overall Study|Progressive disease|7
7281112|NCT00474760|11496573|FG000|Overall Study|Terminated by sponsor|0
7281113|NCT00474760|11496574|FG001|Overall Study|Terminated by sponsor|0
7281114|NCT00474760|11496575|FG002|Overall Study|Terminated by sponsor|0
7281115|NCT00474760|11496576|FG003|Overall Study|Terminated by sponsor|0
7281116|NCT00474760|11496577|FG004|Overall Study|Terminated by sponsor|0
7281117|NCT00474760|11496578|FG005|Overall Study|Terminated by sponsor|0
7281118|NCT00474760|11496579|FG006|Overall Study|Terminated by sponsor|2
7281119|NCT00474786|11496604|FG000|Overall Study|Not Meeting Study Criteria|0
7619698|NCT03693404|12030390|FG000|Overall Study|Withdrawal by Subject|1
7619699|NCT03693404|12030391|FG001|Overall Study|Withdrawal by Subject|0
7281120|NCT00474786|11496605|FG001|Overall Study|Not Meeting Study Criteria|1
7281121|NCT00474786|11496604|FG000|Overall Study|Investigator Request|2
7281122|NCT00474786|11496605|FG001|Overall Study|Investigator Request|1
7619700|NCT03693404|12030390|FG000|Overall Study|Lost to Follow-up|0
7619701|NCT03693404|12030391|FG001|Overall Study|Lost to Follow-up|5
7619702|NCT03693404|12030390|FG000|Overall Study|Excluded from Analysis|0
7619703|NCT03693404|12030391|FG001|Overall Study|Excluded from Analysis|1
7619704|NCT03660943|12030399|FG000|Overall Study|Adverse Event|5
7619705|NCT03660943|12030400|FG001|Overall Study|Adverse Event|3
7619706|NCT03660943|12030399|FG000|Overall Study|Death|0
7619707|NCT03660943|12030400|FG001|Overall Study|Death|2
7619708|NCT03660943|12030399|FG000|Overall Study|Lost to Follow-up|7
7619709|NCT03660943|12030400|FG001|Overall Study|Lost to Follow-up|3
7619710|NCT03660943|12030399|FG000|Overall Study|Protocol Violation|3
7619711|NCT03660943|12030400|FG001|Overall Study|Protocol Violation|5
7619712|NCT03660943|12030399|FG000|Overall Study|Withdrawal by Subject|8
7619713|NCT03660943|12030400|FG001|Overall Study|Withdrawal by Subject|15
7619714|NCT03660943|12030399|FG000|Overall Study|Lack of Efficacy|9
7619715|NCT03660943|12030400|FG001|Overall Study|Lack of Efficacy|12
7619716|NCT03660943|12030399|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4
7619717|NCT03660943|12030400|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13
7619718|NCT03658889|12030408|FG000|Overall Study|Protocol Violation|2
7619719|NCT03658889|12030409|FG001|Overall Study|Protocol Violation|0
7619720|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5
7619721|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3
7619722|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0
7619723|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3
7619724|NCT03654885|12030416|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7
7619725|NCT03654885|12030417|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1
7619726|NCT03654885|12030416|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7
7619727|NCT03654885|12030417|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1
7619728|NCT03654885|12030416|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1
7619729|NCT03654885|12030417|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0
7619730|NCT03654885|12030416|FG000|Overall Study|Adverse Event in Study Eye|3
7619731|NCT03654885|12030417|FG001|Overall Study|Adverse Event in Study Eye|0
7619732|NCT03654885|12030416|FG000|Overall Study|Consent Withdrawn|1
7619733|NCT03654885|12030417|FG001|Overall Study|Consent Withdrawn|0
7619734|NCT03654885|12030416|FG000|Overall Study|Death|3
7619735|NCT03654885|12030417|FG001|Overall Study|Death|1
7619736|NCT03654885|12030416|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0
7619737|NCT03654885|12030417|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1
7619738|NCT03654885|12030416|FG000|Overall Study|Lost to Follow-up|3
7619739|NCT03654885|12030417|FG001|Overall Study|Lost to Follow-up|3
7619740|NCT03568461|12030423|FG000|Overall Study|Death|7
7619741|NCT03568461|12030423|FG000|Overall Study|Physician Decision|5
7619742|NCT03568461|12030423|FG000|Overall Study|Subject decision|5
7281123|NCT00474786|11496604|FG000|Overall Study|Death|189
7281124|NCT00474786|11496605|FG001|Overall Study|Death|170
7281125|NCT00474786|11496604|FG000|Overall Study|Discontinuation of Study by Sponsor|42
7281126|NCT00474786|11496605|FG001|Overall Study|Discontinuation of Study by Sponsor|59
7281127|NCT00474786|11496604|FG000|Overall Study|Lost to Follow-up|4
7281128|NCT00474786|11496605|FG001|Overall Study|Lost to Follow-up|7
7281129|NCT00474786|11496604|FG000|Overall Study|Protocol Violation|2
7281130|NCT00474786|11496605|FG001|Overall Study|Protocol Violation|0
7281131|NCT00474786|11496604|FG000|Overall Study|Withdrawal by Subject|15
7281132|NCT00474786|11496605|FG001|Overall Study|Withdrawal by Subject|15
7281133|NCT00474786|11496604|FG000|Overall Study|Other|5
7281134|NCT00474786|11496605|FG001|Overall Study|Other|0
7281135|NCT00474812|11496611|FG000|Overall Study|Withdrawal by Subject|5
7281136|NCT00474812|11496611|FG000|Overall Study|No Initiation of treatment|2
7281137|NCT00474903|11496628|FG000|Overall Study|Protocol Violation|1
7281138|NCT00474903|11496629|FG001|Overall Study|Protocol Violation|5
7281139|NCT00474903|11496630|FG002|Overall Study|Protocol Violation|2
7281140|NCT00474929|11496643|FG000|Overall Study|Withdrawal by Subject|0
7281141|NCT00474929|11496644|FG001|Overall Study|Withdrawal by Subject|1
7281142|NCT00474929|11496645|FG002|Overall Study|Withdrawal by Subject|0
7281143|NCT00474929|11496646|FG003|Overall Study|Withdrawal by Subject|0
7281144|NCT00474929|11496647|FG004|Overall Study|Withdrawal by Subject|0
7281145|NCT00474929|11496643|FG000|Overall Study|Unrelated medical condition|0
7281146|NCT00474929|11496644|FG001|Overall Study|Unrelated medical condition|0
7619743|NCT03568461|12030423|FG000|Overall Study|Lost to Follow-up|1
7619744|NCT03500692|12030436|FG000|Overall Study|Death|76
7619745|NCT03500692|12030436|FG000|Overall Study|Missed visit|30
7281147|NCT00474929|11496645|FG002|Overall Study|Unrelated medical condition|1
7281148|NCT00474929|11496646|FG003|Overall Study|Unrelated medical condition|0
7619746|NCT03500692|12030436|FG000|Overall Study|Termination Reasons|3
7216473|NCT01252953|11424973|FG000|Overall Study|Withdrawal by Subject|16
7216474|NCT01252953|11424974|FG001|Overall Study|Withdrawal by Subject|17
7216475|NCT01252953|11424973|FG000|Overall Study|Lost to Follow-up|22
7216476|NCT01252953|11424974|FG001|Overall Study|Lost to Follow-up|21
7216477|NCT01012609|11424983|FG000|Overall Study|Withdrawal by Subject|1
7216478|NCT01012609|11424984|FG001|Overall Study|Withdrawal by Subject|1
7216482|NCT00403559|11425023|FG000|Overall Study|Adverse Event|0
7216483|NCT00403559|11425024|FG001|Overall Study|Adverse Event|1
7216484|NCT00403559|11425023|FG000|Overall Study|Lost to Follow-up|3
7216485|NCT00403559|11425024|FG001|Overall Study|Lost to Follow-up|3
7216486|NCT00403559|11425023|FG000|Overall Study|Withdrawal by Subject|1
7216487|NCT00403559|11425024|FG001|Overall Study|Withdrawal by Subject|0
7281149|NCT00474929|11496647|FG004|Overall Study|Unrelated medical condition|0
7281150|NCT00474929|11496643|FG000|Overall Study|Physician Decision|0
7281151|NCT00474929|11496644|FG001|Overall Study|Physician Decision|0
7281152|NCT00474929|11496645|FG002|Overall Study|Physician Decision|1
7281153|NCT00474929|11496646|FG003|Overall Study|Physician Decision|2
7281154|NCT00474929|11496647|FG004|Overall Study|Physician Decision|0
7281155|NCT00474955|11496660|FG000|Overall Study|Adverse Event|2
7281156|NCT00474955|11496660|FG000|Overall Study|Drug unavailability|1
7281157|NCT00474955|11496660|FG000|Overall Study|Personal reasons|5
7281158|NCT00474968|11496666|FG000|Overall Study|Withdrawal by Subject|8
7281159|NCT00474968|11496667|FG001|Overall Study|Withdrawal by Subject|7
7281160|NCT00474968|11496666|FG000|Overall Study|Protocol Violation|9
7281161|NCT00474968|11496667|FG001|Overall Study|Protocol Violation|8
7281162|NCT00474968|11496666|FG000|Overall Study|Sample not collected|1
7281163|NCT00474968|11496667|FG001|Overall Study|Sample not collected|1
7281164|NCT00474994|11496673|FG000|Overall Study|Patient Not treated|1
7281165|NCT00474994|11496673|FG000|Overall Study|Patient evaluable for toxicity only|3
7281166|NCT00474994|11496673|FG000|Overall Study|Patient found to be ineligible|1
7281167|NCT00475020|11496677|FG000|Overall Study|Physician Decision|3
7281168|NCT00475020|11496677|FG000|Overall Study|Insurance Denial|1
7281169|NCT00475020|11496677|FG000|Overall Study|Donor not able to donate the last minute|1
7281170|NCT00475033|11496683|FG000|Infant Series|Failed to return|3
7281171|NCT00475033|11496684|FG001|Infant Series|Failed to return|4
7281172|NCT00475033|11496683|FG000|Infant Series|Parent or legal guardian request|1
7281173|NCT00475033|11496684|FG001|Infant Series|Parent or legal guardian request|5
7281174|NCT00475033|11496683|FG000|Infant Series|Protocol Violation|1
7281175|NCT00475033|11496684|FG001|Infant Series|Protocol Violation|2
7281176|NCT00475033|11496683|FG000|Infant Series|Lost to Follow-up|2
7281177|NCT00475033|11496684|FG001|Infant Series|Lost to Follow-up|0
7281178|NCT00475033|11496683|FG000|Infant Series|Adverse Event|0
7281179|NCT00475033|11496684|FG001|Infant Series|Adverse Event|2
7281180|NCT00475033|11496683|FG000|After the Infant Series|Adverse Event|0
7281181|NCT00475033|11496684|FG001|After the Infant Series|Adverse Event|4
7281182|NCT00475033|11496683|FG000|After the Infant Series|Parent or legal guardian request|2
7281183|NCT00475033|11496684|FG001|After the Infant Series|Parent or legal guardian request|2
7281184|NCT00475033|11496683|FG000|After the Infant Series|Failed to return|2
7281185|NCT00475033|11496684|FG001|After the Infant Series|Failed to return|1
7281186|NCT00475033|11496683|FG000|After the Infant Series|Protocol Violation|1
7281187|NCT00475033|11496684|FG001|After the Infant Series|Protocol Violation|0
7281188|NCT00475033|11496683|FG000|After the Infant Series|Lost to Follow-up|1
7281189|NCT00475033|11496684|FG001|After the Infant Series|Lost to Follow-up|0
7281190|NCT00475033|11496683|FG000|After the Infant Series|Other|0
7281191|NCT00475033|11496684|FG001|After the Infant Series|Other|1
7281192|NCT00475033|11496683|FG000|Toddler Dose|Parent or legal guardian request|2
7281193|NCT00475033|11496684|FG001|Toddler Dose|Parent or legal guardian request|0
7281194|NCT00475033|11496683|FG000|Toddler Dose|Failed to return|1
7281195|NCT00475033|11496684|FG001|Toddler Dose|Failed to return|0
7281196|NCT00475033|11496683|FG000|Toddler Dose|Lost to Follow-up|1
7281197|NCT00475033|11496684|FG001|Toddler Dose|Lost to Follow-up|0
7281198|NCT00475176|11496722|FG000|Overall Study|Adverse Event|2
7281199|NCT00475176|11496722|FG000|Overall Study|Withdrawal by Subject|1
7281200|NCT00475176|11496722|FG000|Overall Study|Protocol Violation|1
7281201|NCT00475228|11496737|FG000|Overall Study|Lost to Follow-up|17
7281202|NCT00475228|11496738|FG001|Overall Study|Lost to Follow-up|17
7281203|NCT00475306|11496762|FG000|Overall Study|Protocol Violation|1
7281204|NCT00475306|11496763|FG001|Overall Study|Protocol Violation|1
7619763|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7619764|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
7619765|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3
7619766|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Death|0
7619767|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Death|0
7216488|NCT04702984|11425065|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1
7216489|NCT04633564|11425073|FG000|Period 1|Adverse Event|28
7216490|NCT04633564|11425074|FG001|Period 1|Adverse Event|19
7216491|NCT04633564|11425073|FG000|Period 1|Death|8
7216492|NCT04633564|11425074|FG001|Period 1|Death|7
7216493|NCT04633564|11425073|FG000|Period 1|Lost to Follow-up|3
7216494|NCT04633564|11425074|FG001|Period 1|Lost to Follow-up|5
7216495|NCT04633564|11425073|FG000|Period 1|Physician Decision|4
7216496|NCT04633564|11425074|FG001|Period 1|Physician Decision|12
7216497|NCT04633564|11425073|FG000|Period 1|Protocol Violation|0
7216498|NCT04633564|11425074|FG001|Period 1|Protocol Violation|1
7216499|NCT04633564|11425073|FG000|Period 1|Withdrawal by Subject|10
7216500|NCT04633564|11425074|FG001|Period 1|Withdrawal by Subject|8
7216501|NCT04633564|11425073|FG000|Period 1|Progressive disease|47
7619768|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Death|1
7619769|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7619770|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
7619771|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1
7619772|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7619773|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
7619774|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2
7619775|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0
7619776|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2
7619777|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1
7619778|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4
7619779|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7619780|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
7619781|NCT03412747|12030452|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1
7619782|NCT03412747|12030453|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7216502|NCT04633564|11425074|FG001|Period 1|Progressive disease|51
7216503|NCT04633564|11425073|FG000|Period 1|Terminated by Sponsor|8
7216504|NCT04633564|11425074|FG001|Period 1|Terminated by Sponsor|6
7216505|NCT04633564|11425073|FG000|Period 2|Adverse Event|3
7216506|NCT04633564|11425074|FG001|Period 2|Adverse Event|4
7216507|NCT04633564|11425073|FG000|Period 2|Death|0
7216508|NCT04633564|11425074|FG001|Period 2|Death|2
7216509|NCT04633564|11425073|FG000|Period 2|Lost to Follow-up|0
7216510|NCT04633564|11425074|FG001|Period 2|Lost to Follow-up|1
7216511|NCT04633564|11425073|FG000|Period 2|Physician Decision|2
7216512|NCT04633564|11425074|FG001|Period 2|Physician Decision|4
7216513|NCT04633564|11425073|FG000|Period 2|Withdrawal by Subject|5
7216514|NCT04633564|11425074|FG001|Period 2|Withdrawal by Subject|1
7216515|NCT04633564|11425073|FG000|Period 2|Progressive Disease|74
7216516|NCT04633564|11425074|FG001|Period 2|Progressive Disease|82
7216517|NCT04633564|11425073|FG000|Period 2|Terminated by Sponsor|9
7216518|NCT04633564|11425074|FG001|Period 2|Terminated by Sponsor|3
7216519|NCT04191148|11425095|FG000|Overall Study|Withdrawal by Subject|1
7216520|NCT04191148|11425096|FG001|Overall Study|Withdrawal by Subject|0
7216521|NCT04191148|11425095|FG000|Overall Study|Adverse Event|1
7216522|NCT04191148|11425096|FG001|Overall Study|Adverse Event|0
7216523|NCT04022733|11425129|FG000|Overall Study|conversion to open surgery|3
7216524|NCT04022733|11425130|FG001|Overall Study|conversion to open surgery|2
7216525|NCT04022733|11425129|FG000|Overall Study|bradycardia|0
7216526|NCT04022733|11425130|FG001|Overall Study|bradycardia|1
7216527|NCT04021524|11425138|FG000|Overall Study|Change in surgical intervention|0
7216528|NCT04021524|11425139|FG001|Overall Study|Change in surgical intervention|1
7216529|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
7216530|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7216531|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7216532|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
7216533|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
7216534|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7216535|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7216536|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
7216537|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
7216538|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7216539|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7216540|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
7216541|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
7216542|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7216543|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7216544|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
7216545|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
7619783|NCT03412747|12030454|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
7619784|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3
7619785|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1
7619786|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0
7619787|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1
7619788|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7619789|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
7619790|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7619791|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
7619792|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1
7619793|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1
7281205|NCT00475306|11496764|FG002|Overall Study|Protocol Violation|0
7281206|NCT00475306|11496765|FG003|Overall Study|Protocol Violation|1
7281207|NCT00475423|11496791|FG000|Overall Study|Protocol Violation|5
7281208|NCT00475423|11496791|FG000|Overall Study|Adverse Event|4
7281209|NCT00475423|11496791|FG000|Overall Study|Withdrawal by Subject|6
7281210|NCT00475423|11496791|FG000|Overall Study|Lack of Efficacy|8
7619794|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7619795|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
7619796|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3
7619797|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4
7619798|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6
7619799|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0
7619800|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7619801|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
7619802|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0
7619803|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2
7216546|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7216547|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7216548|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
7216549|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
7216550|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7216551|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7216552|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
7216553|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1
7216554|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7216555|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7216556|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
7216557|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
7216558|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7216559|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7216560|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
7216561|NCT03605680|11425163|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
7216562|NCT03605680|11425164|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7216563|NCT03605680|11425165|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7216564|NCT03605680|11425166|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
7216565|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
7216566|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
7216567|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
7216568|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
7216569|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
7216570|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7216571|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
7216572|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
7216573|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7216574|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7216575|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7216576|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7216577|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7216578|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7216579|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
7216580|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
7216581|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
7216582|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
7216583|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
7216584|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
7281211|NCT00475423|11496791|FG000|Overall Study|Death|1
7281212|NCT00475423|11496791|FG000|Overall Study|Reason not specified|1
7619804|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5
7619805|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3
7619806|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1
7619807|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4
7619808|NCT03412747|12030452|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7619809|NCT03412747|12030453|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1
7619810|NCT03412747|12030454|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
7619811|NCT03326193|12030472|FG000|Overall Study|Treatment ongoing at the time of analysis|26
7619812|NCT03326193|12030472|FG000|Overall Study|Death|19
7619813|NCT03326193|12030472|FG000|Overall Study|Withdrawal by Subject|8
7619814|NCT03230292|12030493|FG000|Overall Study|Adverse Event|1
7619815|NCT03230292|12030493|FG000|Overall Study|Protocol Violation|1
7619816|NCT03230292|12030493|FG000|Overall Study|Lost to Follow-up|1
7619817|NCT03230292|12030493|FG000|Overall Study|Withdrawal by Subject|3
7216585|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
7216586|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
7216587|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
7216588|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
7216589|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
7216590|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7216591|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7216592|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
7216593|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7216594|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
7281213|NCT00475423|11496791|FG000|Overall Study|Lost to Follow-up|7
7281214|NCT00475644|11496844|FG000|Overall Study|Protocol Violation|13
7281215|NCT00475670|11496850|FG000|Overall Study|Death|0
7281216|NCT00475670|11496851|FG001|Overall Study|Death|1
7281217|NCT00475670|11496850|FG000|Overall Study|Lack of Efficacy|3
7281218|NCT00475670|11496851|FG001|Overall Study|Lack of Efficacy|34
7281219|NCT00475670|11496850|FG000|Overall Study|Refused treatment|0
7281220|NCT00475670|11496851|FG001|Overall Study|Refused treatment|2
7281221|NCT00475670|11496850|FG000|Overall Study|Failure to Return|0
7281222|NCT00475670|11496851|FG001|Overall Study|Failure to Return|1
7281223|NCT00475670|11496850|FG000|Overall Study|Other|0
7281224|NCT00475670|11496851|FG001|Overall Study|Other|3
7281225|NCT00475709|11496857|FG000|Overall Study|Did not meet eligibility criteria|8
7281226|NCT00475709|11496857|FG000|Overall Study|Death|41
7281227|NCT00475709|11496857|FG000|Overall Study|Device Explant|6
7281228|NCT00475709|11496857|FG000|Overall Study|Lost to Follow-up|21
7281229|NCT00475722|11496863|FG000|Overall Study|Withdrawal by Subject|12
7281230|NCT00475722|11496864|FG001|Overall Study|Withdrawal by Subject|12
7281231|NCT00475722|11496863|FG000|Overall Study|Protocol Violation|3
7281232|NCT00475722|11496864|FG001|Overall Study|Protocol Violation|0
7281233|NCT00475735|11496876|FG000|Treatment Period 1|Adverse Event|2
7281234|NCT00475735|11496877|FG001|Treatment Period 1|Adverse Event|0
7281235|NCT00475735|11496878|FG002|Treatment Period 1|Adverse Event|0
7281236|NCT00475735|11496879|FG003|Treatment Period 1|Adverse Event|0
7281237|NCT00475735|11496880|FG004|Treatment Period 1|Adverse Event|0
7281238|NCT00475735|11496881|FG005|Treatment Period 1|Adverse Event|0
7281239|NCT00475735|11496876|FG000|Treatment Period 1|Lack of Efficacy|1
7281240|NCT00475735|11496877|FG001|Treatment Period 1|Lack of Efficacy|0
7619818|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7619819|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7619820|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
7619821|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
7619822|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
7619823|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
7619824|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
7216653|NCT03289143|11425219|FG002|Overall Study|Protocol Deviation|3
7619825|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
7619826|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
7619827|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
7619828|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
7619829|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
7619830|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7619831|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7619832|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7619833|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7216595|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
7281241|NCT00475735|11496878|FG002|Treatment Period 1|Lack of Efficacy|0
7281242|NCT00475735|11496879|FG003|Treatment Period 1|Lack of Efficacy|0
7281243|NCT00475735|11496880|FG004|Treatment Period 1|Lack of Efficacy|0
7281244|NCT00475735|11496881|FG005|Treatment Period 1|Lack of Efficacy|0
7281245|NCT00475735|11496876|FG000|Treatment Period 1|Lost to Follow-up|0
7281246|NCT00475735|11496877|FG001|Treatment Period 1|Lost to Follow-up|0
7281247|NCT00475735|11496878|FG002|Treatment Period 1|Lost to Follow-up|0
7619834|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619835|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619836|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1
7619837|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
7619838|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2
7619839|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
7619840|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
7619841|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4
7619842|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2
7619843|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
7619844|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0
7619845|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
7619846|NCT03227224|12030503|FG000|Double-blind Treatment Period (6 Weeks)|Other|4
7619847|NCT03227224|12030504|FG001|Double-blind Treatment Period (6 Weeks)|Other|0
7619848|NCT03227224|12030505|FG002|Double-blind Treatment Period (6 Weeks)|Other|1
7619849|NCT03227224|12030506|FG003|Double-blind Treatment Period (6 Weeks)|Other|0
7619850|NCT03227224|12030503|FG000|Follow-up Phase (2 Weeks)|Other|4
7619851|NCT03227224|12030504|FG001|Follow-up Phase (2 Weeks)|Other|4
7619852|NCT03227224|12030505|FG002|Follow-up Phase (2 Weeks)|Other|6
7619853|NCT03227224|12030506|FG003|Follow-up Phase (2 Weeks)|Other|3
7619854|NCT03069352|12030559|FG000|Overall Study|Ongoing|12
7619855|NCT03069352|12030560|FG001|Overall Study|Ongoing|40
7619856|NCT03056040|12030568|FG000|Primary Evaluation Period|Withdrawal by Subject|1
7619857|NCT03056040|12030569|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7619858|NCT03056040|12030568|FG000|Primary Evaluation Period|Lack of Efficacy|0
7619859|NCT03056040|12030569|FG001|Primary Evaluation Period|Lack of Efficacy|1
7619860|NCT03056040|12030568|FG000|Primary Evaluation Period|Pregnancy|0
7619861|NCT03056040|12030569|FG001|Primary Evaluation Period|Pregnancy|1
7216596|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
7216597|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
7216598|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
7216599|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
7216600|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
7216601|NCT03605680|11425163|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
7216602|NCT03605680|11425164|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
7216603|NCT03605680|11425165|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
7216604|NCT03605680|11425166|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
7281248|NCT00475735|11496879|FG003|Treatment Period 1|Lost to Follow-up|0
7281249|NCT00475735|11496880|FG004|Treatment Period 1|Lost to Follow-up|0
7281250|NCT00475735|11496881|FG005|Treatment Period 1|Lost to Follow-up|1
7281251|NCT00475735|11496876|FG000|Treatment Period 1|Protocol Violation|0
7281252|NCT00475735|11496877|FG001|Treatment Period 1|Protocol Violation|0
7281253|NCT00475735|11496878|FG002|Treatment Period 1|Protocol Violation|0
7281254|NCT00475735|11496879|FG003|Treatment Period 1|Protocol Violation|1
7281255|NCT00475735|11496880|FG004|Treatment Period 1|Protocol Violation|0
7281256|NCT00475735|11496881|FG005|Treatment Period 1|Protocol Violation|0
7281257|NCT00475735|11496876|FG000|Treatment Period 1|Withdrawal by Subject|1
7281258|NCT00475735|11496877|FG001|Treatment Period 1|Withdrawal by Subject|1
7281259|NCT00475735|11496878|FG002|Treatment Period 1|Withdrawal by Subject|0
7281260|NCT00475735|11496879|FG003|Treatment Period 1|Withdrawal by Subject|0
7281261|NCT00475735|11496880|FG004|Treatment Period 1|Withdrawal by Subject|0
7281262|NCT00475735|11496881|FG005|Treatment Period 1|Withdrawal by Subject|0
7281263|NCT00475735|11496876|FG000|Treatment Period 1|DC due to AE but continuing|0
7281264|NCT00475735|11496877|FG001|Treatment Period 1|DC due to AE but continuing|0
7281265|NCT00475735|11496878|FG002|Treatment Period 1|DC due to AE but continuing|0
7281266|NCT00475735|11496879|FG003|Treatment Period 1|DC due to AE but continuing|1
7281267|NCT00475735|11496880|FG004|Treatment Period 1|DC due to AE but continuing|2
7281268|NCT00475735|11496881|FG005|Treatment Period 1|DC due to AE but continuing|2
7281269|NCT00475735|11496876|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
7281270|NCT00475735|11496877|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
7281271|NCT00475735|11496878|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
7281272|NCT00475735|11496879|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
7281273|NCT00475735|11496880|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
7281274|NCT00475735|11496881|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
7281275|NCT00475735|11496876|FG000|Treatment Washout|Lost to Follow-up|0
7281276|NCT00475735|11496877|FG001|Treatment Washout|Lost to Follow-up|1
7281277|NCT00475735|11496878|FG002|Treatment Washout|Lost to Follow-up|0
7281278|NCT00475735|11496879|FG003|Treatment Washout|Lost to Follow-up|0
7281279|NCT00475735|11496880|FG004|Treatment Washout|Lost to Follow-up|0
7281280|NCT00475735|11496881|FG005|Treatment Washout|Lost to Follow-up|0
7619868|NCT03010527|12030619|FG000|Overall Study|Death|0
7619869|NCT03010527|12030620|FG001|Overall Study|Death|0
7619870|NCT03010527|12030621|FG002|Overall Study|Death|1
7619871|NCT03010527|12030619|FG000|Overall Study|Adverse Event|0
7619872|NCT03010527|12030620|FG001|Overall Study|Adverse Event|4
7619873|NCT03010527|12030621|FG002|Overall Study|Adverse Event|2
7619874|NCT03010527|12030619|FG000|Overall Study|Protocol Violation|0
7619875|NCT03010527|12030620|FG001|Overall Study|Protocol Violation|1
7619876|NCT03010527|12030621|FG002|Overall Study|Protocol Violation|0
7619877|NCT03010527|12030619|FG000|Overall Study|Lost to Follow-up|0
7619878|NCT03010527|12030620|FG001|Overall Study|Lost to Follow-up|2
7216605|NCT03485950|11425177|FG000|Overall Study|Adverse Event|1
7216606|NCT03485950|11425178|FG001|Overall Study|Adverse Event|0
7216607|NCT03485950|11425177|FG000|Overall Study|Death|3
7216608|NCT03485950|11425178|FG001|Overall Study|Death|2
7216609|NCT03485950|11425177|FG000|Overall Study|Withdrawal by Subject|3
7216610|NCT03485950|11425178|FG001|Overall Study|Withdrawal by Subject|0
7216611|NCT03404518|11425186|FG000|Overall Study|Lost to Follow-up|28
7216612|NCT03404518|11425187|FG001|Overall Study|Lost to Follow-up|30
7216613|NCT03404518|11425186|FG000|Overall Study|Protocol Violation|13
7216614|NCT03404518|11425187|FG001|Overall Study|Protocol Violation|6
7216615|NCT03289143|11425217|FG000|Overall Study|Caregiver Unavailability|1
7216616|NCT03289143|11425218|FG001|Overall Study|Caregiver Unavailability|1
7216617|NCT03289143|11425219|FG002|Overall Study|Caregiver Unavailability|0
7216618|NCT03289143|11425220|FG003|Overall Study|Caregiver Unavailability|0
7216619|NCT03289143|11425217|FG000|Overall Study|Research Department Closure|0
7216620|NCT03289143|11425218|FG001|Overall Study|Research Department Closure|0
7216621|NCT03289143|11425219|FG002|Overall Study|Research Department Closure|1
7216622|NCT03289143|11425220|FG003|Overall Study|Research Department Closure|0
7216623|NCT03289143|11425217|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0
7216624|NCT03289143|11425218|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0
7216625|NCT03289143|11425219|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1
7216626|NCT03289143|11425220|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0
7216627|NCT03289143|11425217|FG000|Overall Study|Medical Monitor Decision|1
7216628|NCT03289143|11425218|FG001|Overall Study|Medical Monitor Decision|0
7216629|NCT03289143|11425219|FG002|Overall Study|Medical Monitor Decision|0
7216630|NCT03289143|11425220|FG003|Overall Study|Medical Monitor Decision|0
7216631|NCT03289143|11425217|FG000|Overall Study|Participant Non-Compliance|0
7216632|NCT03289143|11425218|FG001|Overall Study|Participant Non-Compliance|0
7216633|NCT03289143|11425219|FG002|Overall Study|Participant Non-Compliance|1
7216634|NCT03289143|11425220|FG003|Overall Study|Participant Non-Compliance|0
7216635|NCT03289143|11425217|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7216636|NCT03289143|11425218|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7216637|NCT03289143|11425219|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1
7216638|NCT03289143|11425220|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
7216639|NCT03289143|11425217|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0
7216640|NCT03289143|11425218|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0
7216641|NCT03289143|11425219|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1
7216642|NCT03289143|11425220|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0
7216643|NCT03289143|11425217|FG000|Overall Study|Caregiver Passed Away|1
7216644|NCT03289143|11425218|FG001|Overall Study|Caregiver Passed Away|0
7216645|NCT03289143|11425219|FG002|Overall Study|Caregiver Passed Away|0
7216646|NCT03289143|11425220|FG003|Overall Study|Caregiver Passed Away|0
7216647|NCT03289143|11425217|FG000|Overall Study|Physician Decision|0
7216648|NCT03289143|11425218|FG001|Overall Study|Physician Decision|2
7216649|NCT03289143|11425219|FG002|Overall Study|Physician Decision|2
7216650|NCT03289143|11425220|FG003|Overall Study|Physician Decision|2
7216651|NCT03289143|11425217|FG000|Overall Study|Protocol Deviation|2
7216652|NCT03289143|11425218|FG001|Overall Study|Protocol Deviation|1
7216654|NCT03289143|11425220|FG003|Overall Study|Protocol Deviation|1
7216655|NCT03289143|11425217|FG000|Overall Study|Study Terminated By Sponsor|101
7216656|NCT03289143|11425218|FG001|Overall Study|Study Terminated By Sponsor|75
7216657|NCT03289143|11425219|FG002|Overall Study|Study Terminated By Sponsor|100
7216658|NCT03289143|11425220|FG003|Overall Study|Study Terminated By Sponsor|69
7216659|NCT03289143|11425217|FG000|Overall Study|Withdrawal by Subject|14
7619879|NCT03010527|12030621|FG002|Overall Study|Lost to Follow-up|1
7619880|NCT03010527|12030619|FG000|Overall Study|Withdrawal by Subject|0
7619881|NCT03010527|12030620|FG001|Overall Study|Withdrawal by Subject|3
7216660|NCT03289143|11425218|FG001|Overall Study|Withdrawal by Subject|6
7216661|NCT03289143|11425219|FG002|Overall Study|Withdrawal by Subject|14
7216662|NCT03289143|11425220|FG003|Overall Study|Withdrawal by Subject|12
7216663|NCT03289143|11425217|FG000|Overall Study|Adverse Event|10
7216664|NCT03289143|11425218|FG001|Overall Study|Adverse Event|7
7216665|NCT03289143|11425219|FG002|Overall Study|Adverse Event|6
7216666|NCT03289143|11425220|FG003|Overall Study|Adverse Event|5
7216667|NCT03289143|11425217|FG000|Overall Study|Death|2
7216668|NCT03289143|11425218|FG001|Overall Study|Death|0
7216669|NCT03289143|11425219|FG002|Overall Study|Death|2
7619882|NCT03010527|12030621|FG002|Overall Study|Withdrawal by Subject|4
7619883|NCT03010527|12030619|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
7619884|NCT03010527|12030620|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
7619885|NCT03010527|12030621|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
7619886|NCT03010527|12030619|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
7619887|NCT03010527|12030620|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
7619888|NCT03010527|12030621|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
7619889|NCT03010527|12030619|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7619890|NCT03010527|12030620|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
7619891|NCT03010527|12030621|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
7619892|NCT03007979|12030638|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
7619894|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619895|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4
7619896|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619897|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5
7619898|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1
7619899|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2
7619900|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1
7619901|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619902|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619903|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619904|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619905|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619906|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619907|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619908|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619909|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0
7619910|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Death|0
7619911|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Death|1
7619912|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Death|0
7619913|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Death|0
7619914|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Death|0
7619915|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Death|0
7619916|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Death|0
7619917|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Death|0
7619918|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Death|0
7619919|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Death|0
7619920|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Death|0
7619921|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Death|0
7619922|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Death|0
7619923|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Death|0
7619924|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Death|0
7619925|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Death|0
7619926|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1
7619927|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1
7619928|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619929|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619930|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619931|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619932|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619933|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619934|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619935|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619936|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619937|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619938|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619939|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619940|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619941|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0
7619942|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2
7619943|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619944|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3
7619945|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619946|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619947|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7216670|NCT03289143|11425220|FG003|Overall Study|Death|1
7216671|NCT03289143|11425217|FG000|Overall Study|Lost to Follow-up|2
7216672|NCT03289143|11425218|FG001|Overall Study|Lost to Follow-up|1
7216673|NCT03289143|11425219|FG002|Overall Study|Lost to Follow-up|1
7216674|NCT03289143|11425220|FG003|Overall Study|Lost to Follow-up|0
7216675|NCT03289143|11425217|FG000|Overall Study|Participant No Longer Has Study Partner|0
7216676|NCT03289143|11425218|FG001|Overall Study|Participant No Longer Has Study Partner|0
7619948|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1
7619949|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7216677|NCT03289143|11425219|FG002|Overall Study|Participant No Longer Has Study Partner|0
7619950|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619951|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619952|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619953|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619954|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619955|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619956|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7216678|NCT03289143|11425220|FG003|Overall Study|Participant No Longer Has Study Partner|1
7216679|NCT03289143|11425217|FG000|Overall Study|Withdrawal by Caregiver|0
7216680|NCT03289143|11425218|FG001|Overall Study|Withdrawal by Caregiver|1
7216681|NCT03289143|11425219|FG002|Overall Study|Withdrawal by Caregiver|0
7216682|NCT03289143|11425220|FG003|Overall Study|Withdrawal by Caregiver|0
7216683|NCT03289143|11425217|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7216684|NCT03289143|11425218|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7216685|NCT03289143|11425219|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1
7216686|NCT03289143|11425220|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
7216687|NCT03289143|11425217|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0
7216688|NCT03289143|11425218|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0
7216689|NCT03289143|11425219|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0
7216690|NCT03289143|11425220|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1
7216691|NCT03156504|11425235|FG000|Overall Study|Withdrawal by Subject|1
7281281|NCT00475735|11496876|FG000|Treatment Washout|Protocol Violation|0
7281282|NCT00475735|11496877|FG001|Treatment Washout|Protocol Violation|1
7281283|NCT00475735|11496878|FG002|Treatment Washout|Protocol Violation|0
7281284|NCT00475735|11496879|FG003|Treatment Washout|Protocol Violation|0
7281285|NCT00475735|11496880|FG004|Treatment Washout|Protocol Violation|0
7281286|NCT00475735|11496881|FG005|Treatment Washout|Protocol Violation|0
7281287|NCT00475735|11496876|FG000|Treatment Period 2|Adverse Event|0
7281288|NCT00475735|11496877|FG001|Treatment Period 2|Adverse Event|1
7281289|NCT00475735|11496878|FG002|Treatment Period 2|Adverse Event|0
7281290|NCT00475735|11496879|FG003|Treatment Period 2|Adverse Event|2
7281291|NCT00475735|11496880|FG004|Treatment Period 2|Adverse Event|0
7281292|NCT00475735|11496881|FG005|Treatment Period 2|Adverse Event|0
7281293|NCT00475735|11496876|FG000|Treatment Period 2|Lack of Efficacy|0
7281294|NCT00475735|11496877|FG001|Treatment Period 2|Lack of Efficacy|0
7281295|NCT00475735|11496878|FG002|Treatment Period 2|Lack of Efficacy|0
7281296|NCT00475735|11496879|FG003|Treatment Period 2|Lack of Efficacy|0
7281297|NCT00475735|11496880|FG004|Treatment Period 2|Lack of Efficacy|0
7281298|NCT00475735|11496881|FG005|Treatment Period 2|Lack of Efficacy|1
7281299|NCT00475735|11496876|FG000|Treatment Period 2|Withdrawal by Subject|0
7281300|NCT00475735|11496877|FG001|Treatment Period 2|Withdrawal by Subject|0
7281301|NCT00475735|11496878|FG002|Treatment Period 2|Withdrawal by Subject|0
7281302|NCT00475735|11496879|FG003|Treatment Period 2|Withdrawal by Subject|0
7281303|NCT00475735|11496880|FG004|Treatment Period 2|Withdrawal by Subject|1
7281304|NCT00475735|11496881|FG005|Treatment Period 2|Withdrawal by Subject|0
7281305|NCT00475852|11496902|FG000|Overall Study|Death|444
7281306|NCT00475852|11496903|FG001|Overall Study|Death|456
7281307|NCT00475852|11496902|FG000|Overall Study|Withdrawal by Subject|19
7281308|NCT00475852|11496903|FG001|Overall Study|Withdrawal by Subject|24
7281309|NCT00475852|11496902|FG000|Overall Study|Lost to Follow-up|54
7281310|NCT00475852|11496903|FG001|Overall Study|Lost to Follow-up|68
7281311|NCT00475865|11496912|FG000|Overall Study|Adverse Event|0
7281312|NCT00475865|11496913|FG001|Overall Study|Adverse Event|3
7281313|NCT00475865|11496914|FG002|Overall Study|Adverse Event|4
7281314|NCT00475865|11496912|FG000|Overall Study|Lack of Efficacy|1
7281315|NCT00475865|11496913|FG001|Overall Study|Lack of Efficacy|0
7281316|NCT00475865|11496914|FG002|Overall Study|Lack of Efficacy|0
7281317|NCT00475865|11496912|FG000|Overall Study|Progressive disease|0
7281318|NCT00475865|11496913|FG001|Overall Study|Progressive disease|1
7281319|NCT00475865|11496914|FG002|Overall Study|Progressive disease|2
7281320|NCT00475865|11496912|FG000|Overall Study|Participant did not wish to continue|1
7281321|NCT00475865|11496913|FG001|Overall Study|Participant did not wish to continue|0
7281322|NCT00475865|11496914|FG002|Overall Study|Participant did not wish to continue|0
7281323|NCT00475865|11496912|FG000|Overall Study|Other than above|0
7281324|NCT00475865|11496913|FG001|Overall Study|Other than above|1
7281325|NCT00475865|11496914|FG002|Overall Study|Other than above|0
7281326|NCT00475982|11496950|FG000|Overall Study|surgery rescheduled|7
7281327|NCT00475982|11496951|FG001|Overall Study|surgery rescheduled|3
7281328|NCT00476008|11496959|FG000|Overall Study|Adverse Event|4
7281329|NCT00476008|11496960|FG001|Overall Study|Adverse Event|4
7281330|NCT00476008|11496959|FG000|Overall Study|Placebo concerns|2
7281331|NCT00476008|11496960|FG001|Overall Study|Placebo concerns|2
7281332|NCT00476008|11496959|FG000|Overall Study|Physician Decision: Medication Noncompli|2
7281333|NCT00476008|11496960|FG001|Overall Study|Physician Decision: Medication Noncompli|1
7281334|NCT00476008|11496959|FG000|Overall Study|Withdrawal by Subject|0
7281335|NCT00476008|11496960|FG001|Overall Study|Withdrawal by Subject|1
7281336|NCT00476008|11496959|FG000|Overall Study|Death|1
7281337|NCT00476008|11496960|FG001|Overall Study|Death|0
7281338|NCT00476047|11496985|FG000|Overall Study|Lost to Follow-up|1
7619957|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0
7619958|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619959|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619960|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619961|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1
7619962|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619963|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619964|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1
7619965|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619966|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7216702|NCT02993926|11425250|FG000|Enantone Treatment Phase|Adverse Event|1
7216703|NCT02993926|11425251|FG001|Enantone Treatment Phase|Adverse Event|0
7216704|NCT02993926|11425252|FG002|Enantone Treatment Phase|Adverse Event|0
7216705|NCT02993926|11425250|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
7216706|NCT02993926|11425251|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7216707|NCT02993926|11425252|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
7216708|NCT02993926|11425250|FG000|Enantone Treatment Phase|Investigator Judgment|1
7216709|NCT02993926|11425251|FG001|Enantone Treatment Phase|Investigator Judgment|0
7216710|NCT02993926|11425252|FG002|Enantone Treatment Phase|Investigator Judgment|0
7216711|NCT02993926|11425250|FG000|Enantone Treatment Phase|Reason Not Specified|4
7216712|NCT02993926|11425251|FG001|Enantone Treatment Phase|Reason Not Specified|0
7216713|NCT02993926|11425252|FG002|Enantone Treatment Phase|Reason Not Specified|0
7216714|NCT02932579|11425264|FG000|Overall Study|Withdrawal by Subject|4
7216715|NCT02932579|11425265|FG001|Overall Study|Withdrawal by Subject|1
7216760|NCT02852967|11425303|FG000|Overall Study|Adverse Event|3
7619967|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619968|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619969|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7216761|NCT02852967|11425304|FG001|Overall Study|Adverse Event|1
7216762|NCT02852967|11425305|FG002|Overall Study|Adverse Event|0
7216763|NCT02852967|11425306|FG003|Overall Study|Adverse Event|1
7216764|NCT02852967|11425307|FG004|Overall Study|Adverse Event|0
7216765|NCT02852967|11425303|FG000|Overall Study|Death|1
7216766|NCT02852967|11425304|FG001|Overall Study|Death|0
7216767|NCT02852967|11425305|FG002|Overall Study|Death|0
7216768|NCT02852967|11425306|FG003|Overall Study|Death|0
7216769|NCT02852967|11425307|FG004|Overall Study|Death|0
7216770|NCT02852967|11425303|FG000|Overall Study|Lost to Follow-up|1
7216771|NCT02852967|11425304|FG001|Overall Study|Lost to Follow-up|2
7216772|NCT02852967|11425305|FG002|Overall Study|Lost to Follow-up|3
7216773|NCT02852967|11425306|FG003|Overall Study|Lost to Follow-up|4
7216774|NCT02852967|11425307|FG004|Overall Study|Lost to Follow-up|4
7216775|NCT02852967|11425303|FG000|Overall Study|Withdrawal by Subject|6
7216776|NCT02852967|11425304|FG001|Overall Study|Withdrawal by Subject|12
7216777|NCT02852967|11425305|FG002|Overall Study|Withdrawal by Subject|7
7216778|NCT02852967|11425306|FG003|Overall Study|Withdrawal by Subject|10
7216779|NCT02852967|11425307|FG004|Overall Study|Withdrawal by Subject|10
7216780|NCT02852967|11425303|FG000|Overall Study|SAE|0
7216781|NCT02852967|11425304|FG001|Overall Study|SAE|0
7216782|NCT02852967|11425305|FG002|Overall Study|SAE|0
7216783|NCT02852967|11425306|FG003|Overall Study|SAE|3
7216784|NCT02852967|11425307|FG004|Overall Study|SAE|0
7216785|NCT02852967|11425303|FG000|Overall Study|Elevated Liver Enzymes|2
7216786|NCT02852967|11425304|FG001|Overall Study|Elevated Liver Enzymes|0
7216787|NCT02852967|11425305|FG002|Overall Study|Elevated Liver Enzymes|0
7216788|NCT02852967|11425306|FG003|Overall Study|Elevated Liver Enzymes|2
7216789|NCT02852967|11425307|FG004|Overall Study|Elevated Liver Enzymes|2
7216790|NCT02852967|11425303|FG000|Overall Study|Physician Decision|0
7216791|NCT02852967|11425304|FG001|Overall Study|Physician Decision|0
7216792|NCT02852967|11425305|FG002|Overall Study|Physician Decision|0
7216793|NCT02852967|11425306|FG003|Overall Study|Physician Decision|1
7216794|NCT02852967|11425307|FG004|Overall Study|Physician Decision|0
7216795|NCT02852967|11425303|FG000|Overall Study|Lack of Efficacy|0
7216796|NCT02852967|11425304|FG001|Overall Study|Lack of Efficacy|1
7216797|NCT02852967|11425305|FG002|Overall Study|Lack of Efficacy|0
7216798|NCT02852967|11425306|FG003|Overall Study|Lack of Efficacy|0
7216799|NCT02852967|11425307|FG004|Overall Study|Lack of Efficacy|0
7216800|NCT02852967|11425303|FG000|Overall Study|Non-compliance|0
7216801|NCT02852967|11425304|FG001|Overall Study|Non-compliance|0
7216802|NCT02852967|11425305|FG002|Overall Study|Non-compliance|1
7216803|NCT02852967|11425306|FG003|Overall Study|Non-compliance|1
7216804|NCT02852967|11425307|FG004|Overall Study|Non-compliance|0
7216805|NCT02852967|11425303|FG000|Overall Study|Dispensing Drug Violation|0
7216806|NCT02852967|11425304|FG001|Overall Study|Dispensing Drug Violation|0
7216807|NCT02852967|11425305|FG002|Overall Study|Dispensing Drug Violation|1
7216808|NCT02852967|11425306|FG003|Overall Study|Dispensing Drug Violation|0
7216809|NCT02852967|11425307|FG004|Overall Study|Dispensing Drug Violation|0
7216810|NCT02852967|11425303|FG000|Overall Study|Inclusion/Exclusion Violation|1
7216811|NCT02852967|11425304|FG001|Overall Study|Inclusion/Exclusion Violation|0
7619970|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619971|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619972|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619973|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0
7619974|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619975|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619976|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1
7619977|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619978|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619979|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619980|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619981|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619982|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619983|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619984|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619985|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619986|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619987|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619988|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619989|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0
7619990|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7619991|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7216812|NCT02852967|11425305|FG002|Overall Study|Inclusion/Exclusion Violation|0
7216813|NCT02852967|11425306|FG003|Overall Study|Inclusion/Exclusion Violation|0
7216814|NCT02852967|11425307|FG004|Overall Study|Inclusion/Exclusion Violation|0
7619992|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1
7619993|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619994|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619995|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619996|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619997|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619998|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7619999|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620000|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620001|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620002|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620003|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620004|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620005|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0
7620006|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Other|0
7620007|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Other|0
7620008|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Other|1
7620009|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Other|2
7620010|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Other|0
7620011|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Other|1
7620012|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Other|0
7620013|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Other|0
7620014|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Other|0
7620015|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Other|0
7620016|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Other|0
7620017|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Other|0
7620018|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Other|0
7620019|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Other|0
7620020|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Other|0
7620021|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Other|0
7620022|NCT02958865|12030653|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620023|NCT02958865|12030654|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620024|NCT02958865|12030655|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620025|NCT02958865|12030656|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620026|NCT02958865|12030657|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1
7620027|NCT02958865|12030658|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620028|NCT02958865|12030659|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620029|NCT02958865|12030660|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620030|NCT02958865|12030661|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620031|NCT02958865|12030662|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620032|NCT02958865|12030663|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620033|NCT02958865|12030664|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620034|NCT02958865|12030665|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620035|NCT02958865|12030666|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620036|NCT02958865|12030667|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620037|NCT02958865|12030668|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0
7620038|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620039|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620040|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620041|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620042|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620043|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620044|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7620045|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620046|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620047|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2
7620048|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0
7216815|NCT02810418|11425334|FG000|Arm A Dose Escalation|Adverse Event|2
7216816|NCT02810418|11425335|FG001|Arm A Dose Escalation|Adverse Event|1
7216817|NCT02810418|11425336|FG002|Arm A Dose Escalation|Adverse Event|0
7216818|NCT02810418|11425337|FG003|Arm A Dose Escalation|Adverse Event|0
7216819|NCT02810418|11425338|FG004|Arm A Dose Escalation|Adverse Event|0
7216820|NCT02810418|11425339|FG005|Arm A Dose Escalation|Adverse Event|0
7281339|NCT00476086|11496991|FG000|Overall Study|Alternative therapy|1
7281340|NCT00476086|11496991|FG000|Overall Study|Progressive Disease|4
7281341|NCT00476151|11496999|FG000|Overall Study|Adverse Event|0
7281342|NCT00476151|11497000|FG001|Overall Study|Adverse Event|2
7281343|NCT00476151|11496999|FG000|Overall Study|Protocol Violation|1
7281344|NCT00476151|11497000|FG001|Overall Study|Protocol Violation|3
7281345|NCT00476151|11496999|FG000|Overall Study|Withdrawal by Subject|2
7216821|NCT02810418|11425340|FG006|Arm A Dose Escalation|Adverse Event|0
7216822|NCT02810418|11425334|FG000|Dose Expansion|Adverse Event|0
7216823|NCT02810418|11425335|FG001|Dose Expansion|Adverse Event|1
7216824|NCT02810418|11425336|FG002|Dose Expansion|Adverse Event|1
7216825|NCT02810418|11425337|FG003|Dose Expansion|Adverse Event|0
7281346|NCT00476151|11497000|FG001|Overall Study|Withdrawal by Subject|0
7620049|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620050|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4
7620051|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620052|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1
7620053|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5
7620054|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620055|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620056|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620057|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620058|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620059|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620060|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620061|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620062|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2
7620063|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1
7620064|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620065|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5
7620066|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620067|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2
7620068|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0
7620069|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8
7620070|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620071|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620072|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620073|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620074|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620075|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620076|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620077|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620078|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620079|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1
7620080|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7216826|NCT02810418|11425338|FG004|Dose Expansion|Adverse Event|0
7216827|NCT02810418|11425339|FG005|Dose Expansion|Adverse Event|0
7216828|NCT02810418|11425340|FG006|Dose Expansion|Adverse Event|0
7216829|NCT02810418|11425334|FG000|Dose Expansion|Physician Decision|0
7216830|NCT02810418|11425335|FG001|Dose Expansion|Physician Decision|0
7216831|NCT02810418|11425336|FG002|Dose Expansion|Physician Decision|2
7216832|NCT02810418|11425337|FG003|Dose Expansion|Physician Decision|0
7216833|NCT02810418|11425338|FG004|Dose Expansion|Physician Decision|0
7216834|NCT02810418|11425339|FG005|Dose Expansion|Physician Decision|0
7216835|NCT02810418|11425340|FG006|Dose Expansion|Physician Decision|0
7216836|NCT02810418|11425334|FG000|Arm B Dose Escalation|Adverse Event|0
7216837|NCT02810418|11425335|FG001|Arm B Dose Escalation|Adverse Event|0
7216838|NCT02810418|11425336|FG002|Arm B Dose Escalation|Adverse Event|0
7216839|NCT02810418|11425337|FG003|Arm B Dose Escalation|Adverse Event|0
7216840|NCT02810418|11425338|FG004|Arm B Dose Escalation|Adverse Event|1
7216841|NCT02810418|11425339|FG005|Arm B Dose Escalation|Adverse Event|2
7216842|NCT02810418|11425340|FG006|Arm B Dose Escalation|Adverse Event|0
7281347|NCT00476151|11496999|FG000|Overall Study|Physician Decision|0
7281348|NCT00476151|11497000|FG001|Overall Study|Physician Decision|2
7281349|NCT00476229|11497006|FG000|Overall Study|Progressive shortness of breath|1
7281350|NCT00476476|11497023|FG000|Overall Study|Adverse Event|2
7281351|NCT00476476|11497024|FG001|Overall Study|Adverse Event|7
7281352|NCT00476476|11497023|FG000|Overall Study|Progressive Disease|0
7281353|NCT00476476|11497024|FG001|Overall Study|Progressive Disease|17
7620081|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620082|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7281354|NCT00476593|11497033|FG000|Overall Study|Lost to Follow-up|10
7281355|NCT00476593|11497034|FG001|Overall Study|Lost to Follow-up|2
7281356|NCT00476593|11497035|FG002|Overall Study|Lost to Follow-up|8
7281357|NCT00476593|11497036|FG003|Overall Study|Lost to Follow-up|22
7281358|NCT00476957|11497056|FG000|Overall Study|Lost to Follow-up|176
7281359|NCT00476957|11497057|FG001|Overall Study|Lost to Follow-up|193
7281360|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
7281361|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7281362|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
7281363|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
7281364|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
7281365|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
7281366|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7281367|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
7281368|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
7216843|NCT02781584|11425421|FG000|Pre-treatment Phase|Investigator's Discretion|0
7216844|NCT02781584|11425422|FG001|Pre-treatment Phase|Investigator's Discretion|0
7216845|NCT02781584|11425423|FG002|Pre-treatment Phase|Investigator's Discretion|0
7620083|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620084|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0
7620085|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1
7620086|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620087|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620088|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620089|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620090|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620091|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620092|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620093|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620094|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620095|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620096|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0
7620097|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1
7620098|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6
7620099|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3
7620100|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3
7620101|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2
7620102|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Other|0
7620103|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Other|0
7620104|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Other|0
7620105|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Other|0
7620106|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Other|0
7620107|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Other|0
7620108|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Other|0
7620109|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Other|1
7620110|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Other|0
7620111|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Other|1
7620112|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Other|0
7620113|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Other|0
7620114|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Other|1
7620115|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Other|0
7620116|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Other|0
7620117|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Other|1
7620118|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620119|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620120|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620121|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7216846|NCT02781584|11425424|FG003|Pre-treatment Phase|Investigator's Discretion|0
7216847|NCT02781584|11425425|FG004|Pre-treatment Phase|Investigator's Discretion|0
7216848|NCT02781584|11425426|FG005|Pre-treatment Phase|Investigator's Discretion|0
7216849|NCT02781584|11425427|FG006|Pre-treatment Phase|Investigator's Discretion|0
7216850|NCT02781584|11425428|FG007|Pre-treatment Phase|Investigator's Discretion|0
7216851|NCT02781584|11425429|FG008|Pre-treatment Phase|Investigator's Discretion|0
7216852|NCT02781584|11425430|FG009|Pre-treatment Phase|Investigator's Discretion|0
7216853|NCT02781584|11425431|FG010|Pre-treatment Phase|Investigator's Discretion|0
7216854|NCT02781584|11425432|FG011|Pre-treatment Phase|Investigator's Discretion|2
7216855|NCT02781584|11425433|FG012|Pre-treatment Phase|Investigator's Discretion|1
7216856|NCT02781584|11425421|FG000|Pre-treatment Phase|Adverse Event|0
7216857|NCT02781584|11425422|FG001|Pre-treatment Phase|Adverse Event|0
7216858|NCT02781584|11425423|FG002|Pre-treatment Phase|Adverse Event|0
7216859|NCT02781584|11425424|FG003|Pre-treatment Phase|Adverse Event|0
7216860|NCT02781584|11425425|FG004|Pre-treatment Phase|Adverse Event|0
7216861|NCT02781584|11425426|FG005|Pre-treatment Phase|Adverse Event|0
7216862|NCT02781584|11425427|FG006|Pre-treatment Phase|Adverse Event|0
7216863|NCT02781584|11425428|FG007|Pre-treatment Phase|Adverse Event|0
7216864|NCT02781584|11425429|FG008|Pre-treatment Phase|Adverse Event|0
7216865|NCT02781584|11425430|FG009|Pre-treatment Phase|Adverse Event|0
7216866|NCT02781584|11425431|FG010|Pre-treatment Phase|Adverse Event|0
7216867|NCT02781584|11425432|FG011|Pre-treatment Phase|Adverse Event|1
7216868|NCT02781584|11425433|FG012|Pre-treatment Phase|Adverse Event|0
7216869|NCT02781584|11425421|FG000|Treatment Phase|Withdrew Consent|0
7216870|NCT02781584|11425422|FG001|Treatment Phase|Withdrew Consent|0
7216871|NCT02781584|11425423|FG002|Treatment Phase|Withdrew Consent|0
7216872|NCT02781584|11425424|FG003|Treatment Phase|Withdrew Consent|0
7216873|NCT02781584|11425425|FG004|Treatment Phase|Withdrew Consent|0
7216874|NCT02781584|11425426|FG005|Treatment Phase|Withdrew Consent|1
7216875|NCT02781584|11425427|FG006|Treatment Phase|Withdrew Consent|0
7281369|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
7281370|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
7281371|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
7620122|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7216876|NCT02781584|11425428|FG007|Treatment Phase|Withdrew Consent|0
7216877|NCT02781584|11425429|FG008|Treatment Phase|Withdrew Consent|0
7216878|NCT02781584|11425430|FG009|Treatment Phase|Withdrew Consent|0
7620123|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620124|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620125|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620126|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620127|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620128|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620129|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620130|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620131|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1
7620132|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620133|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0
7620134|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620135|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620136|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620137|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620138|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620139|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620140|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620141|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620142|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620143|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620144|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620145|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620146|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620147|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1
7620148|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620149|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0
7620150|NCT02958865|12030653|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620151|NCT02958865|12030654|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620152|NCT02958865|12030655|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620153|NCT02958865|12030656|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620154|NCT02958865|12030657|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620155|NCT02958865|12030658|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620156|NCT02958865|12030659|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620157|NCT02958865|12030660|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620158|NCT02958865|12030661|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620159|NCT02958865|12030662|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1
7620160|NCT02958865|12030663|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620161|NCT02958865|12030664|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620162|NCT02958865|12030665|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620163|NCT02958865|12030666|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620164|NCT02958865|12030667|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620165|NCT02958865|12030668|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0
7620166|NCT02949700|12030715|FG000|Phase I|Withdrawal by Subject|1
7620167|NCT02949700|12030716|FG001|Phase I|Withdrawal by Subject|1
7620168|NCT02949700|12030717|FG002|Phase I|Withdrawal by Subject|0
7620169|NCT02949700|12030718|FG003|Phase I|Withdrawal by Subject|0
7620170|NCT02949700|12030715|FG000|Phase I|Protocol Violation|1
7620171|NCT02949700|12030716|FG001|Phase I|Protocol Violation|0
7620172|NCT02949700|12030717|FG002|Phase I|Protocol Violation|0
7620173|NCT02949700|12030718|FG003|Phase I|Protocol Violation|0
7620174|NCT02949700|12030715|FG000|Phase II|Withdrawal by Subject|0
7620175|NCT02949700|12030716|FG001|Phase II|Withdrawal by Subject|0
7620176|NCT02949700|12030717|FG002|Phase II|Withdrawal by Subject|0
7620177|NCT02949700|12030718|FG003|Phase II|Withdrawal by Subject|2
7620178|NCT02949700|12030715|FG000|Phase II|Protocol Violation|0
7620179|NCT02949700|12030716|FG001|Phase II|Protocol Violation|0
7620180|NCT02949700|12030717|FG002|Phase II|Protocol Violation|1
7620181|NCT02949700|12030718|FG003|Phase II|Protocol Violation|3
7620182|NCT02905006|12030733|FG000|Overall Study|Adverse Event|1
7620183|NCT02905006|12030734|FG001|Overall Study|Adverse Event|1
7620184|NCT02905006|12030735|FG002|Overall Study|Adverse Event|1
7620185|NCT02905006|12030736|FG003|Overall Study|Adverse Event|1
7620186|NCT02905006|12030737|FG004|Overall Study|Adverse Event|0
7620187|NCT02905006|12030738|FG005|Overall Study|Adverse Event|1
7620188|NCT02905006|12030733|FG000|Overall Study|Lack of Efficacy|1
7620189|NCT02905006|12030734|FG001|Overall Study|Lack of Efficacy|0
7620190|NCT02905006|12030735|FG002|Overall Study|Lack of Efficacy|0
7216879|NCT02781584|11425431|FG010|Treatment Phase|Withdrew Consent|1
7216880|NCT02781584|11425432|FG011|Treatment Phase|Withdrew Consent|2
7216881|NCT02781584|11425433|FG012|Treatment Phase|Withdrew Consent|0
7620191|NCT02905006|12030736|FG003|Overall Study|Lack of Efficacy|0
7216882|NCT02781584|11425421|FG000|Treatment Phase|Adverse Event|0
7216883|NCT02781584|11425422|FG001|Treatment Phase|Adverse Event|0
7620192|NCT02905006|12030737|FG004|Overall Study|Lack of Efficacy|0
7620193|NCT02905006|12030738|FG005|Overall Study|Lack of Efficacy|0
7620194|NCT02905006|12030733|FG000|Overall Study|Protocol Violation|2
7620195|NCT02905006|12030734|FG001|Overall Study|Protocol Violation|0
7620196|NCT02905006|12030735|FG002|Overall Study|Protocol Violation|0
7620197|NCT02905006|12030736|FG003|Overall Study|Protocol Violation|0
7620198|NCT02905006|12030737|FG004|Overall Study|Protocol Violation|0
7620199|NCT02905006|12030738|FG005|Overall Study|Protocol Violation|0
7620200|NCT02905006|12030733|FG000|Overall Study|Lost to Follow-up|0
7620201|NCT02905006|12030734|FG001|Overall Study|Lost to Follow-up|0
7620202|NCT02905006|12030735|FG002|Overall Study|Lost to Follow-up|0
7620203|NCT02905006|12030736|FG003|Overall Study|Lost to Follow-up|1
7620204|NCT02905006|12030737|FG004|Overall Study|Lost to Follow-up|1
7620205|NCT02905006|12030738|FG005|Overall Study|Lost to Follow-up|0
7620206|NCT02905006|12030733|FG000|Overall Study|Withdrawal by Subject|0
7620207|NCT02905006|12030734|FG001|Overall Study|Withdrawal by Subject|0
7620208|NCT02905006|12030735|FG002|Overall Study|Withdrawal by Subject|1
7620209|NCT02905006|12030736|FG003|Overall Study|Withdrawal by Subject|1
7620210|NCT02905006|12030737|FG004|Overall Study|Withdrawal by Subject|0
7620211|NCT02905006|12030738|FG005|Overall Study|Withdrawal by Subject|1
7620212|NCT02905006|12030733|FG000|Overall Study|Screening exclusion criteria met|1
7620213|NCT02905006|12030734|FG001|Overall Study|Screening exclusion criteria met|0
7620214|NCT02905006|12030735|FG002|Overall Study|Screening exclusion criteria met|0
7620215|NCT02905006|12030736|FG003|Overall Study|Screening exclusion criteria met|0
7620216|NCT02905006|12030737|FG004|Overall Study|Screening exclusion criteria met|0
7620217|NCT02905006|12030738|FG005|Overall Study|Screening exclusion criteria met|0
7620218|NCT02905006|12030733|FG000|Overall Study|Lab withdrawal criterion met|0
7620219|NCT02905006|12030734|FG001|Overall Study|Lab withdrawal criterion met|1
7620220|NCT02905006|12030735|FG002|Overall Study|Lab withdrawal criterion met|2
7620221|NCT02905006|12030736|FG003|Overall Study|Lab withdrawal criterion met|2
7620222|NCT02905006|12030737|FG004|Overall Study|Lab withdrawal criterion met|2
7620223|NCT02905006|12030738|FG005|Overall Study|Lab withdrawal criterion met|1
7620224|NCT02905006|12030733|FG000|Overall Study|Positive for Tuberculosis|0
7620225|NCT02905006|12030734|FG001|Overall Study|Positive for Tuberculosis|1
7620226|NCT02905006|12030735|FG002|Overall Study|Positive for Tuberculosis|0
7620227|NCT02905006|12030736|FG003|Overall Study|Positive for Tuberculosis|0
7620228|NCT02905006|12030737|FG004|Overall Study|Positive for Tuberculosis|0
7620229|NCT02905006|12030738|FG005|Overall Study|Positive for Tuberculosis|0
7620230|NCT02905006|12030733|FG000|Overall Study|Subject positive for Hep B|0
7620231|NCT02905006|12030734|FG001|Overall Study|Subject positive for Hep B|0
7620232|NCT02905006|12030735|FG002|Overall Study|Subject positive for Hep B|1
7620233|NCT02905006|12030736|FG003|Overall Study|Subject positive for Hep B|0
7620234|NCT02905006|12030737|FG004|Overall Study|Subject positive for Hep B|0
7620235|NCT02905006|12030738|FG005|Overall Study|Subject positive for Hep B|0
7620236|NCT02905006|12030733|FG000|Overall Study|Patient moved abroad|0
7620237|NCT02905006|12030734|FG001|Overall Study|Patient moved abroad|0
7620238|NCT02905006|12030735|FG002|Overall Study|Patient moved abroad|0
7620239|NCT02905006|12030736|FG003|Overall Study|Patient moved abroad|1
7620240|NCT02905006|12030737|FG004|Overall Study|Patient moved abroad|0
7620241|NCT02905006|12030738|FG005|Overall Study|Patient moved abroad|0
7620242|NCT02905006|12030733|FG000|Overall Study|Patient randomized by mistake|0
7620243|NCT02905006|12030734|FG001|Overall Study|Patient randomized by mistake|0
7620244|NCT02905006|12030735|FG002|Overall Study|Patient randomized by mistake|0
7620245|NCT02905006|12030736|FG003|Overall Study|Patient randomized by mistake|0
7620246|NCT02905006|12030737|FG004|Overall Study|Patient randomized by mistake|0
7620247|NCT02905006|12030738|FG005|Overall Study|Patient randomized by mistake|1
7620248|NCT02833844|12030778|FG000|Double-Blind Period|Withdrawal by Subject|2
7620249|NCT02833844|12030779|FG001|Double-Blind Period|Withdrawal by Subject|3
7620250|NCT02833844|12030778|FG000|Double-Blind Period|Protocol Violation|0
7620251|NCT02833844|12030779|FG001|Double-Blind Period|Protocol Violation|4
7620252|NCT02833844|12030778|FG000|Open-Label Period|Death|0
7620253|NCT02833844|12030779|FG001|Open-Label Period|Death|2
7620254|NCT02833844|12030778|FG000|Open-Label Period|Lost to Follow-up|1
7620255|NCT02833844|12030779|FG001|Open-Label Period|Lost to Follow-up|0
7620256|NCT02833844|12030778|FG000|Open-Label Period|Withdrawal by Subject|1
7620257|NCT02833844|12030779|FG001|Open-Label Period|Withdrawal by Subject|0
7620258|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Adverse Event|1
7620259|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Adverse Event|2
7620260|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Adverse Event|3
7620261|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Adverse Event|2
7216884|NCT02781584|11425423|FG002|Treatment Phase|Adverse Event|0
7216885|NCT02781584|11425424|FG003|Treatment Phase|Adverse Event|0
7216886|NCT02781584|11425425|FG004|Treatment Phase|Adverse Event|0
7216887|NCT02781584|11425426|FG005|Treatment Phase|Adverse Event|0
7216888|NCT02781584|11425427|FG006|Treatment Phase|Adverse Event|0
7216889|NCT02781584|11425428|FG007|Treatment Phase|Adverse Event|1
7281372|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7620262|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Adverse Event|3
7216890|NCT02781584|11425429|FG008|Treatment Phase|Adverse Event|0
7216891|NCT02781584|11425430|FG009|Treatment Phase|Adverse Event|0
7216892|NCT02781584|11425431|FG010|Treatment Phase|Adverse Event|0
7620263|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Adverse Event|3
7620264|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5
7620265|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2
7620266|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1
7620267|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4
7620268|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2
7620269|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3
7620270|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Protocol Violation|0
7620271|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Protocol Violation|0
7620272|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Protocol Violation|0
7620273|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Protocol Violation|0
7620274|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Protocol Violation|1
7620275|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Protocol Violation|0
7620276|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3
7620277|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620278|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620279|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620280|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0
7620281|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2
7620282|NCT02778399|12030793|FG000|Up to Week 12 Treatment Period|other - reason not stated|0
7620283|NCT02778399|12030794|FG001|Up to Week 12 Treatment Period|other - reason not stated|0
7620284|NCT02778399|12030795|FG002|Up to Week 12 Treatment Period|other - reason not stated|0
7620285|NCT02778399|12030796|FG003|Up to Week 12 Treatment Period|other - reason not stated|1
7620286|NCT02778399|12030797|FG004|Up to Week 12 Treatment Period|other - reason not stated|2
7620287|NCT02778399|12030798|FG005|Up to Week 12 Treatment Period|other - reason not stated|0
7216893|NCT02781584|11425432|FG011|Treatment Phase|Adverse Event|0
7216894|NCT02781584|11425433|FG012|Treatment Phase|Adverse Event|0
7216904|NCT02707055|11425482|FG000|Phase 1|Withdrawal by Subject|1
7216905|NCT02707055|11425483|FG001|Phase 1|Withdrawal by Subject|2
7216906|NCT02707055|11425482|FG000|Phase 1|Physician Decision|0
7216907|NCT02707055|11425483|FG001|Phase 1|Physician Decision|1
7216908|NCT02707055|11425482|FG000|Phase 2|Adverse Event|1
7216909|NCT02707055|11425483|FG001|Phase 2|Adverse Event|2
7216910|NCT02656290|11425493|FG000|Overall Study|Subjects Remain On Study|26
7216911|NCT02652130|11425497|FG000|Overall Study|Death|1
7216912|NCT02616393|11425504|FG000|Overall Study|Death|5
7216913|NCT02616393|11425505|FG001|Overall Study|Death|12
7216914|NCT02616393|11425506|FG002|Overall Study|Death|1
7216915|NCT02616393|11425504|FG000|Overall Study|Termination by Sponsor|4
7216916|NCT02616393|11425505|FG001|Overall Study|Termination by Sponsor|5
7216917|NCT02616393|11425506|FG002|Overall Study|Termination by Sponsor|2
7216918|NCT02616393|11425504|FG000|Overall Study|Other|3
7216919|NCT02616393|11425505|FG001|Overall Study|Other|0
7216920|NCT02616393|11425506|FG002|Overall Study|Other|0
7216921|NCT02616393|11425504|FG000|Overall Study|Withdrawal by Subject|1
7216922|NCT02616393|11425505|FG001|Overall Study|Withdrawal by Subject|1
7216923|NCT02616393|11425506|FG002|Overall Study|Withdrawal by Subject|0
7216924|NCT02616393|11425504|FG000|Overall Study|Lost to Follow-up|0
7216925|NCT02616393|11425505|FG001|Overall Study|Lost to Follow-up|2
7216926|NCT02616393|11425506|FG002|Overall Study|Lost to Follow-up|0
7216927|NCT02602288|11425532|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14
7216928|NCT02602288|11425533|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10
7216929|NCT02602288|11425532|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
7216930|NCT02602288|11425533|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
7216931|NCT02602288|11425532|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9
7216932|NCT02602288|11425533|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6
7216933|NCT02602288|11425532|FG000|12 Month Follow-up|Lost to Follow-up|0
7216934|NCT02602288|11425533|FG001|12 Month Follow-up|Lost to Follow-up|4
7620288|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2
7620289|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0
7620290|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2
7216935|NCT02602288|11425532|FG000|12 Month Follow-up|Withdrawal by Subject|2
7216936|NCT02602288|11425533|FG001|12 Month Follow-up|Withdrawal by Subject|0
7216937|NCT02577523|11425541|FG000|Overall Study|Adverse Event|1
7216938|NCT02577523|11425542|FG001|Overall Study|Adverse Event|1
7216939|NCT02577523|11425541|FG000|Overall Study|Lack of Efficacy|1
7216940|NCT02577523|11425542|FG001|Overall Study|Lack of Efficacy|1
7216941|NCT02577523|11425541|FG000|Overall Study|Withdrawal by Subject|1
7216942|NCT02577523|11425542|FG001|Overall Study|Withdrawal by Subject|0
7620291|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1
7620292|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3
7620293|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2
7620294|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3
7620295|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7216951|NCT02427958|11425569|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
7216952|NCT02427958|11425569|FG000|Overall Study|Lost to Follow-up|6
7216953|NCT02427958|11425569|FG000|Overall Study|Withdrawal by Subject|14
7216954|NCT02427958|11425569|FG000|Overall Study|Lack of Efficacy|1
7216955|NCT02425826|11425575|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
7216956|NCT02425826|11425576|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
7216957|NCT02425826|11425577|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
7216958|NCT02425826|11425575|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7216959|NCT02425826|11425576|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
7216960|NCT02425826|11425577|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
7216961|NCT02425826|11425575|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
7216962|NCT02425826|11425576|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
7216963|NCT02425826|11425577|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
7216964|NCT02425826|11425575|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
7216965|NCT02425826|11425576|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
7216966|NCT02425826|11425577|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
7216967|NCT02425826|11425575|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
7216968|NCT02425826|11425576|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
7216969|NCT02425826|11425577|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
7216970|NCT02425826|11425575|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
7620296|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0
7620297|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3
7620298|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7620299|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2
7620300|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620301|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1
7216971|NCT02425826|11425576|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
7216972|NCT02425826|11425577|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
7216973|NCT02425826|11425575|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
7216974|NCT02425826|11425576|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
7216975|NCT02425826|11425577|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
7216976|NCT02425826|11425575|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
7216977|NCT02425826|11425576|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
7216978|NCT02425826|11425577|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
7216979|NCT02425826|11425575|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
7216980|NCT02425826|11425576|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
7216981|NCT02425826|11425577|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
7620302|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620303|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620304|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620305|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0
7620306|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2
7620307|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1
7620308|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0
7620309|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1
7620310|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0
7620311|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2
7620312|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1
7216982|NCT02425826|11425575|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7216983|NCT02425826|11425576|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
7216984|NCT02425826|11425577|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
7281373|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
7281374|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7281375|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
7281376|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7281377|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
7281378|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
7281379|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
7281380|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
7469849|NCT01927341|11771714|FG001|Phase 2|New cancer therapy|1
7620313|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620314|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2
7620315|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620316|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620317|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0
7620318|NCT02778399|12030793|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620319|NCT02778399|12030794|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620320|NCT02778399|12030795|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620321|NCT02778399|12030796|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0
7620322|NCT02778399|12030797|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620323|NCT02778399|12030798|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1
7620324|NCT02701777|12030834|FG000|Overall Study|Some subjects did not like the stimulation.|4
7620325|NCT02701777|12030835|FG001|Overall Study|Some subjects did not like the stimulation.|0
7620326|NCT02701777|12030836|FG002|Overall Study|Some subjects did not like the stimulation.|0
7620327|NCT02701777|12030837|FG003|Overall Study|Some subjects did not like the stimulation.|2
7620328|NCT02701777|12030834|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
7620329|NCT02701777|12030835|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
7620330|NCT02701777|12030836|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
7620331|NCT02701777|12030837|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
7620332|NCT02546674|12030857|FG000|Overall Study|Adverse Event|19
7620333|NCT02546674|12030857|FG000|Overall Study|Death|1
7620334|NCT02546674|12030857|FG000|Overall Study|Lost to Follow-up|1
7620335|NCT02546674|12030857|FG000|Overall Study|Physician Decision|13
7620336|NCT02546674|12030857|FG000|Overall Study|Pregnancy|1
7620337|NCT02546674|12030857|FG000|Overall Study|Progressive Disease|2
7620338|NCT02546674|12030857|FG000|Overall Study|Protocol Deviation|2
7620339|NCT02546674|12030857|FG000|Overall Study|Subject/Guardian Decision|6
7620340|NCT02546674|12030857|FG000|Overall Study|Withdrawal of Informed Consent|3
7620341|NCT02520661|12030864|FG000|Overall Study|Lost to Follow-up|7
7620342|NCT02520661|12030865|FG001|Overall Study|Lost to Follow-up|3
7620343|NCT02520661|12030864|FG000|Overall Study|Admitted from ED|49
7620344|NCT02520661|12030865|FG001|Overall Study|Admitted from ED|48
7620345|NCT02520661|12030864|FG000|Overall Study|ED greater than 24 hours|29
7620346|NCT02520661|12030865|FG001|Overall Study|ED greater than 24 hours|38
7620347|NCT02520661|12030864|FG000|Overall Study|other ineligibility|14
7620348|NCT02520661|12030865|FG001|Overall Study|other ineligibility|22
7620349|NCT02520661|12030864|FG000|Overall Study|Withdrawal by Subject|7
7620350|NCT02520661|12030865|FG001|Overall Study|Withdrawal by Subject|16
7620351|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
7620352|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
7620353|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
7620354|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
7620355|NCT02483585|12030891|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
7620356|NCT02483585|12030892|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
7620357|NCT02483585|12030891|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
7620358|NCT02483585|12030892|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
7216999|NCT01927068|11425665|FG000|Overall Study|Death|37
7217000|NCT01927068|11425666|FG001|Overall Study|Death|3
7217001|NCT01927068|11425665|FG000|Overall Study|Withdrawal by Subject|50
7217002|NCT01927068|11425666|FG001|Overall Study|Withdrawal by Subject|3
7217003|NCT01927068|11425665|FG000|Overall Study|Lost to Follow-up|10
7217004|NCT01927068|11425666|FG001|Overall Study|Lost to Follow-up|2
7217005|NCT01927068|11425665|FG000|Overall Study|Physician Decision|9
7217006|NCT01927068|11425666|FG001|Overall Study|Physician Decision|0
7217007|NCT01927068|11425665|FG000|Overall Study|Missed last follow-up visit|2
7217008|NCT01927068|11425666|FG001|Overall Study|Missed last follow-up visit|0
7217009|NCT01813435|11425684|FG000|Overall Study|did not finish experimental regimen|1902
7217010|NCT01813435|11425685|FG001|Overall Study|did not finish experimental regimen|770
7217011|NCT01813435|11425684|FG000|Overall Study|Lost to Follow-up|268
7217012|NCT01813435|11425685|FG001|Overall Study|Lost to Follow-up|237
7217013|NCT01690299|11425699|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7217014|NCT01690299|11425700|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
7217015|NCT01690299|11425701|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
7217016|NCT01690299|11425702|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7217017|NCT01690299|11425703|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7217018|NCT01690299|11425704|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
7217019|NCT01690299|11425699|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
7217020|NCT01690299|11425700|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217021|NCT01690299|11425701|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217022|NCT01690299|11425702|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217023|NCT01690299|11425703|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217024|NCT01690299|11425704|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217025|NCT01690299|11425699|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
7217026|NCT01690299|11425700|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
7217027|NCT01690299|11425701|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7620359|NCT02483585|12030891|FG000|Open-label Treatment Phase|Decision by Sponsor|0
7620360|NCT02483585|12030892|FG001|Open-label Treatment Phase|Decision by Sponsor|1
7620361|NCT02483585|12030891|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
7620362|NCT02483585|12030892|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
7620363|NCT02483585|12030891|FG000|Open-label Treatment Phase|Lost to Follow-up|3
7620364|NCT02483585|12030892|FG001|Open-label Treatment Phase|Lost to Follow-up|5
7217028|NCT01690299|11425702|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217029|NCT01690299|11425703|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217030|NCT01690299|11425704|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217031|NCT01690299|11425699|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
7217032|NCT01690299|11425700|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
7217033|NCT01690299|11425701|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
7217034|NCT01690299|11425702|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
7217035|NCT01690299|11425703|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
7217036|NCT01690299|11425704|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
7217037|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7217038|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7217039|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
7217040|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7217041|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
7217042|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
7217043|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7217044|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7217045|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
7217046|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
7217047|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
7217048|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
7217049|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7217050|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7217051|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7217052|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
7217053|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7217054|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
7217055|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7217056|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7217057|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
7217058|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
7217059|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
7217060|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
7217061|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7217062|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7217063|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
7217064|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7217065|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
7217066|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
7217067|NCT01690299|11425699|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7217068|NCT01690299|11425700|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7217069|NCT01690299|11425701|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7217070|NCT01690299|11425702|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7217071|NCT01690299|11425703|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
7217072|NCT01690299|11425704|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
7217073|NCT01452152|11425758|FG000|Overall Study|Study termination by sponsor|5
7217074|NCT01452152|11425759|FG001|Overall Study|Study termination by sponsor|0
7217075|NCT01452152|11425760|FG002|Overall Study|Study termination by sponsor|4
7217076|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
7217077|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
7217078|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217079|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217080|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217081|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217082|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217083|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217084|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217085|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
7217086|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
7217087|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
7217088|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217089|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217090|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217091|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217092|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217093|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217094|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217095|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
7217096|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
7217097|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217098|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217099|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217100|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217101|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217102|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217103|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217104|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217105|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
7217106|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
7217107|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
7217108|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217109|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217110|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217111|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217112|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217113|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217114|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217115|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
7217116|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7217117|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
7217118|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217119|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217120|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217121|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217122|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217123|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217124|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217125|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
7217126|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
7217127|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
7217128|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217129|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217130|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217131|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217132|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217133|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217134|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217135|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
7217136|NCT01232283|11425775|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
7217137|NCT01232283|11425776|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
7217138|NCT01232283|11425777|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217139|NCT01232283|11425778|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217140|NCT01232283|11425779|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217141|NCT01232283|11425780|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217142|NCT01232283|11425781|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217143|NCT01232283|11425782|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217144|NCT01232283|11425783|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217145|NCT01232283|11425784|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
7217146|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217147|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217148|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
7217149|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
7217150|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217151|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217152|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217153|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217154|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217155|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
7217156|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217157|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217158|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
7217159|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
7217160|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217161|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217162|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217163|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217164|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217165|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
7217166|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217167|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217168|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
7620428|NCT02399215|12030923|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1
7620429|NCT02399215|12030923|FG000|Overall Study|Withdrawal by Subject|1
7620438|NCT02202577|12030939|FG000|Overall Study|Lost to Follow-up|6
7620439|NCT02202577|12030940|FG001|Overall Study|Lost to Follow-up|16
7620440|NCT02202577|12030939|FG000|Overall Study|Protocol Violation|7
7620441|NCT02202577|12030940|FG001|Overall Study|Protocol Violation|3
7620442|NCT02130427|12030946|FG000|Overall Study|Imaging results not interpretable|30
7620443|NCT01959698|12030966|FG000|Overall Study|Adverse Event|0
7620444|NCT01959698|12030967|FG001|Overall Study|Adverse Event|0
7620445|NCT01959698|12030968|FG002|Overall Study|Adverse Event|0
7620446|NCT01959698|12030969|FG003|Overall Study|Adverse Event|0
7620447|NCT01959698|12030970|FG004|Overall Study|Adverse Event|0
7620448|NCT01959698|12030971|FG005|Overall Study|Adverse Event|0
7620449|NCT01959698|12030972|FG006|Overall Study|Adverse Event|1
7217169|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217170|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217171|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217172|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217173|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217174|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217175|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
7217176|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217177|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217178|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
7217179|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
7217180|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7620450|NCT01959698|12030966|FG000|Overall Study|Physician Decision|1
7620451|NCT01959698|12030967|FG001|Overall Study|Physician Decision|0
7620452|NCT01959698|12030968|FG002|Overall Study|Physician Decision|1
7620453|NCT01959698|12030969|FG003|Overall Study|Physician Decision|2
7217181|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217182|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217183|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217184|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217185|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
7217186|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217187|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217188|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
7217189|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
7217190|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217191|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217192|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217193|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217194|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217195|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
7217196|NCT01232283|11425775|FG000|Maintenance Phase (Weeks16-32)|Other|0
7281381|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
7281382|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
7281383|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
7281384|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
7281385|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
7281386|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
7281387|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
7281388|NCT00476996|11497066|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
7281389|NCT00476996|11497067|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
7281390|NCT00476996|11497068|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
7281391|NCT00476996|11497069|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
7281392|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
7281393|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
7281394|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
7217197|NCT01232283|11425776|FG001|Maintenance Phase (Weeks16-32)|Other|0
7620454|NCT01959698|12030970|FG004|Overall Study|Physician Decision|0
7620455|NCT01959698|12030971|FG005|Overall Study|Physician Decision|3
7620456|NCT01959698|12030972|FG006|Overall Study|Physician Decision|3
7620457|NCT01942837|12030989|FG000|Overall Study|Death|1
7620458|NCT01942837|12030989|FG000|Overall Study|Symptomatic or radiographic progression|49
7620459|NCT01942837|12030989|FG000|Overall Study|Adverse Event|6
7620460|NCT01942837|12030989|FG000|Overall Study|Physician Decision|3
7620461|NCT01942837|12030989|FG000|Overall Study|Withdrawal by Subject|2
7620462|NCT01942837|12030989|FG000|Overall Study|Intercurrent Illness|1
7620463|NCT01942837|12030989|FG000|Overall Study|On treatment|3
7620464|NCT01942837|12030989|FG000|Overall Study|Never initiate the treatment|2
7620465|NCT01906489|12030996|FG000|Overall Study|Adverse Event|10
7620466|NCT01906489|12030997|FG001|Overall Study|Adverse Event|3
7620467|NCT01906489|12030996|FG000|Overall Study|Worsening of CKD|6
7620468|NCT01906489|12030997|FG001|Overall Study|Worsening of CKD|4
7620469|NCT01906489|12030996|FG000|Overall Study|Withdrawal by Subject|5
7620470|NCT01906489|12030997|FG001|Overall Study|Withdrawal by Subject|0
7620471|NCT01906489|12030996|FG000|Overall Study|Worsening of Anemia|1
7620472|NCT01906489|12030997|FG001|Overall Study|Worsening of Anemia|0
7620473|NCT01906489|12030996|FG000|Overall Study|Protocol Violation|0
7620474|NCT01906489|12030997|FG001|Overall Study|Protocol Violation|1
7620475|NCT01906489|12030996|FG000|Overall Study|Non- Compliance|1
7217198|NCT01232283|11425777|FG002|Maintenance Phase (Weeks16-32)|Other|2
7217199|NCT01232283|11425778|FG003|Maintenance Phase (Weeks16-32)|Other|0
7217200|NCT01232283|11425779|FG004|Maintenance Phase (Weeks16-32)|Other|0
7217201|NCT01232283|11425780|FG005|Maintenance Phase (Weeks16-32)|Other|0
7217202|NCT01232283|11425781|FG006|Maintenance Phase (Weeks16-32)|Other|0
7217203|NCT01232283|11425782|FG007|Maintenance Phase (Weeks16-32)|Other|0
7217204|NCT01232283|11425783|FG008|Maintenance Phase (Weeks16-32)|Other|0
7217205|NCT01232283|11425784|FG009|Maintenance Phase (Weeks16-32)|Other|0
7217206|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217207|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217208|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217209|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217210|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
7217211|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7217212|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217213|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
7217214|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217215|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
7217216|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217217|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217218|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217219|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217220|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
7217221|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217222|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
7217223|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
7217224|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217225|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
7217226|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217227|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217228|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217229|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217230|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7217231|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7217232|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
7217233|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
7217234|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217235|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
7217236|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217237|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7620476|NCT01906489|12030997|FG001|Overall Study|Non- Compliance|0
7620477|NCT01906489|12030996|FG000|Overall Study|Sponsor Decision|1
7620478|NCT01906489|12030997|FG001|Overall Study|Sponsor Decision|0
7217238|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217239|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217240|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
7217241|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7620479|NCT01906489|12030996|FG000|Overall Study|Lost to Follow-up|1
7620480|NCT01906489|12030997|FG001|Overall Study|Lost to Follow-up|1
7620481|NCT01906489|12030996|FG000|Overall Study|Other|1
7620482|NCT01906489|12030997|FG001|Overall Study|Other|0
7620483|NCT01855412|12031006|FG000|Overall Study|Death|77
7620484|NCT01855412|12031007|FG001|Overall Study|Death|123
7620485|NCT01855412|12031008|FG002|Overall Study|Death|30
7620486|NCT01855412|12031006|FG000|Overall Study|Lost to Follow-up|28
7620487|NCT01855412|12031007|FG001|Overall Study|Lost to Follow-up|46
7620488|NCT01855412|12031008|FG002|Overall Study|Lost to Follow-up|15
7620489|NCT01855412|12031006|FG000|Overall Study|Withdrawal by Subject|77
7620490|NCT01855412|12031007|FG001|Overall Study|Withdrawal by Subject|123
7620491|NCT01855412|12031008|FG002|Overall Study|Withdrawal by Subject|24
7620492|NCT01855412|12031006|FG000|Overall Study|Physician Decision|25
7620493|NCT01855412|12031007|FG001|Overall Study|Physician Decision|31
7620494|NCT01855412|12031008|FG002|Overall Study|Physician Decision|3
7620495|NCT01855412|12031006|FG000|Overall Study|Site Closure|4
7620496|NCT01855412|12031007|FG001|Overall Study|Site Closure|18
7620497|NCT01855412|12031008|FG002|Overall Study|Site Closure|1
7620498|NCT01855412|12031006|FG000|Overall Study|Reason not Specified|1
7620499|NCT01855412|12031007|FG001|Overall Study|Reason not Specified|2
7620500|NCT01855412|12031008|FG002|Overall Study|Reason not Specified|3
7620501|NCT01845805|12031024|FG000|Overall Study|Withdrawal by Subject|1
7620502|NCT01845805|12031025|FG001|Overall Study|Withdrawal by Subject|2
7620503|NCT01845805|12031024|FG000|Overall Study|Disease Progression|13
7620504|NCT01845805|12031025|FG001|Overall Study|Disease Progression|14
7217242|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217243|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217244|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217245|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
7217246|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217247|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217248|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217249|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217250|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
7217251|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217252|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7217253|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
7217254|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217255|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
7217256|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217257|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217258|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217259|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217260|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217261|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217262|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217263|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
7217264|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217265|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
7217266|NCT01232283|11425775|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217267|NCT01232283|11425776|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217268|NCT01232283|11425777|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217269|NCT01232283|11425778|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217270|NCT01232283|11425779|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217271|NCT01232283|11425780|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
7217272|NCT01232283|11425781|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217273|NCT01232283|11425782|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217274|NCT01232283|11425783|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217275|NCT01232283|11425784|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
7217276|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217277|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217278|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217279|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217280|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217281|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217282|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217283|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
7217284|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
7217285|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
7217286|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217287|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217288|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217289|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7620505|NCT01845805|12031024|FG000|Overall Study|Drug-related Toxicity|4
7620506|NCT01845805|12031025|FG001|Overall Study|Drug-related Toxicity|0
7620507|NCT01764633|12031061|FG000|Overall Study|Withdrawal by Subject|105
7620508|NCT01764633|12031062|FG001|Overall Study|Withdrawal by Subject|88
7620509|NCT01764633|12031061|FG000|Overall Study|Lost to Follow-up|13
7620510|NCT01764633|12031062|FG001|Overall Study|Lost to Follow-up|5
7620511|NCT01744093|12031070|FG000|Overall Study|Withdrawal by Subject|6
7620512|NCT01744093|12031071|FG001|Overall Study|Withdrawal by Subject|1
7217290|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217291|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217292|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7217293|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
7281395|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
7281396|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Adverse Event|0
7281397|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Adverse Event|0
7281398|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Adverse Event|0
7281399|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Adverse Event|8
7281400|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Death|0
7281401|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Death|0
7281402|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Death|0
7281403|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Death|7
7281404|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
7281405|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
7281406|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
7281407|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
7281408|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
7281409|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
7281410|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
7281411|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
7281412|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7281413|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7281414|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
7281415|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
7281416|NCT00476996|11497066|FG000|OLE Phase (From Week 48)|Early termination of the study|0
7281417|NCT00476996|11497067|FG001|OLE Phase (From Week 48)|Early termination of the study|0
7281418|NCT00476996|11497068|FG002|OLE Phase (From Week 48)|Early termination of the study|0
7281419|NCT00476996|11497069|FG003|OLE Phase (From Week 48)|Early termination of the study|578
7281420|NCT00477152|11497082|FG000|Overall Study|Parent withdrew consent|2
7281421|NCT00477152|11497082|FG000|Overall Study|Adverse Event|1
7281422|NCT00477165|11497088|FG000|Overall Study|Adverse Event|7
7281423|NCT00477165|11497089|FG001|Overall Study|Adverse Event|2
7281424|NCT00477269|11497110|FG000|Core Study|Adverse Event|6
7281425|NCT00477269|11497111|FG001|Core Study|Adverse Event|4
7620551|NCT01622868|12031135|FG000|Overall Study|Protocol Violation|7
7620552|NCT01622868|12031136|FG001|Overall Study|Protocol Violation|0
7217294|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
7217295|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
7217296|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217297|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7620553|NCT01609790|12031145|FG000|Overall Study|Protocol Violation|1
7620554|NCT01609790|12031146|FG001|Overall Study|Protocol Violation|7
7620555|NCT01609790|12031147|FG002|Overall Study|Protocol Violation|8
7620562|NCT01516879|12031175|FG000|Overall Study|Withdrawal by Subject|9
7620563|NCT01516879|12031176|FG001|Overall Study|Withdrawal by Subject|11
7620564|NCT01516879|12031175|FG000|Overall Study|Death|0
7620565|NCT01516879|12031176|FG001|Overall Study|Death|2
7620566|NCT01516879|12031175|FG000|Overall Study|Lost to Follow-up|2
7620567|NCT01516879|12031176|FG001|Overall Study|Lost to Follow-up|11
7620568|NCT01516879|12031175|FG000|Overall Study|Other|5
7620569|NCT01516879|12031176|FG001|Overall Study|Other|10
7217298|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217299|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217300|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217301|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217302|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217303|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
7217304|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
7217305|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
7217306|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217307|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217308|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217309|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217310|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217311|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217312|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217313|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
7217314|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
7281426|NCT00477269|11497112|FG002|Core Study|Adverse Event|0
7281427|NCT00477269|11497110|FG000|Core Study|Death|3
7281428|NCT00477269|11497111|FG001|Core Study|Death|3
7281429|NCT00477269|11497112|FG002|Core Study|Death|0
7281430|NCT00477269|11497110|FG000|Core Study|Withdrawn Consent|0
7281431|NCT00477269|11497111|FG001|Core Study|Withdrawn Consent|1
7281432|NCT00477269|11497112|FG002|Core Study|Withdrawn Consent|0
7281433|NCT00477269|11497110|FG000|Open Label Extension|Adverse Event|0
7217315|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
7281434|NCT00477269|11497111|FG001|Open Label Extension|Adverse Event|0
7281435|NCT00477269|11497112|FG002|Open Label Extension|Adverse Event|4
7281436|NCT00477269|11497110|FG000|Open Label Extension|Abnormal laboratory values|0
7281437|NCT00477269|11497111|FG001|Open Label Extension|Abnormal laboratory values|0
7620612|NCT01261325|12031215|FG000|Overall Study|Lack of Efficacy|1
7620613|NCT01261325|12031216|FG001|Overall Study|Lack of Efficacy|1
7620614|NCT01261325|12031217|FG002|Overall Study|Lack of Efficacy|0
7620615|NCT01261325|12031215|FG000|Overall Study|Withdrawal by Subject|2
7620616|NCT01261325|12031216|FG001|Overall Study|Withdrawal by Subject|2
7620617|NCT01261325|12031217|FG002|Overall Study|Withdrawal by Subject|4
7620618|NCT01261325|12031215|FG000|Overall Study|SAE, non-fatal|1
7620619|NCT01261325|12031216|FG001|Overall Study|SAE, non-fatal|5
7620620|NCT01261325|12031217|FG002|Overall Study|SAE, non-fatal|1
7620621|NCT01261325|12031215|FG000|Overall Study|AE, non-serious non-fatal|9
7620622|NCT01261325|12031216|FG001|Overall Study|AE, non-serious non-fatal|15
7620623|NCT01261325|12031217|FG002|Overall Study|AE, non-serious non-fatal|13
7620624|NCT01261325|12031215|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
7620625|NCT01261325|12031216|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7620626|NCT01261325|12031217|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
7620627|NCT01261325|12031215|FG000|Overall Study|Non Compliance|2
7620628|NCT01261325|12031216|FG001|Overall Study|Non Compliance|0
7620629|NCT01261325|12031217|FG002|Overall Study|Non Compliance|0
7620630|NCT01261325|12031215|FG000|Overall Study|Patient Randomized by Mistake|0
7620631|NCT01261325|12031216|FG001|Overall Study|Patient Randomized by Mistake|1
7620632|NCT01261325|12031217|FG002|Overall Study|Patient Randomized by Mistake|0
7620633|NCT01261325|12031215|FG000|Overall Study|Erroneously Randomized|1
7620634|NCT01261325|12031216|FG001|Overall Study|Erroneously Randomized|0
7620635|NCT01261325|12031217|FG002|Overall Study|Erroneously Randomized|0
7620636|NCT01261325|12031215|FG000|Overall Study|Screen Failure|1
7620637|NCT01261325|12031216|FG001|Overall Study|Screen Failure|0
7620638|NCT01261325|12031217|FG002|Overall Study|Screen Failure|0
7620639|NCT01261325|12031215|FG000|Overall Study|Randomized in Error|0
7620640|NCT01261325|12031216|FG001|Overall Study|Randomized in Error|0
7620641|NCT01261325|12031217|FG002|Overall Study|Randomized in Error|1
7620642|NCT01261325|12031215|FG000|Overall Study|Protocol Violation|0
7620643|NCT01261325|12031216|FG001|Overall Study|Protocol Violation|3
7620644|NCT01261325|12031217|FG002|Overall Study|Protocol Violation|1
7620645|NCT01261325|12031215|FG000|Overall Study|Lost to Follow-up|0
7620646|NCT01261325|12031216|FG001|Overall Study|Lost to Follow-up|1
7620647|NCT01261325|12031217|FG002|Overall Study|Lost to Follow-up|3
7620648|NCT01261325|12031215|FG000|Overall Study|AE, serious fatal|0
7620649|NCT01261325|12031216|FG001|Overall Study|AE, serious fatal|0
7620650|NCT01261325|12031217|FG002|Overall Study|AE, serious fatal|2
7217316|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217317|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217318|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217319|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217320|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217321|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217322|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217323|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
7217324|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
7217325|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
7217326|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217327|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217328|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217329|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217330|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217331|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217332|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217333|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217334|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
7217335|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
7217336|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217337|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217338|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217339|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217340|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217341|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217342|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217343|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217344|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
7217345|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
7217346|NCT01232283|11425775|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217347|NCT01232283|11425776|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217348|NCT01232283|11425777|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217349|NCT01232283|11425778|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217350|NCT01232283|11425779|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217351|NCT01232283|11425780|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217352|NCT01232283|11425781|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217353|NCT01232283|11425782|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
7217354|NCT01232283|11425783|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
7217355|NCT01232283|11425784|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
7217356|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4
7217357|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11
7217358|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20
7217359|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42
7217360|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9
7217361|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6
7217362|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5
7217363|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3
7217364|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5
7217365|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10
7620708|NCT00746590|12031277|FG000|Overall Study|Death|1
7620725|NCT00490035|12031303|FG000|Overall Study|AE, non-serious non-fatal|3
7620726|NCT00490035|12031304|FG001|Overall Study|AE, non-serious non-fatal|4
7620727|NCT00490035|12031305|FG002|Overall Study|AE, non-serious non-fatal|4
7620728|NCT00490035|12031306|FG003|Overall Study|AE, non-serious non-fatal|5
7620729|NCT00490035|12031303|FG000|Overall Study|Lost to Follow-up|2
7620730|NCT00490035|12031304|FG001|Overall Study|Lost to Follow-up|0
7620731|NCT00490035|12031305|FG002|Overall Study|Lost to Follow-up|1
7620732|NCT00490035|12031306|FG003|Overall Study|Lost to Follow-up|0
7620733|NCT00490035|12031303|FG000|Overall Study|Withdrawal by Subject|2
7620734|NCT00490035|12031304|FG001|Overall Study|Withdrawal by Subject|1
7620735|NCT00490035|12031305|FG002|Overall Study|Withdrawal by Subject|1
7620736|NCT00490035|12031306|FG003|Overall Study|Withdrawal by Subject|0
7620737|NCT00490035|12031303|FG000|Overall Study|Other reason|0
7620738|NCT00490035|12031304|FG001|Overall Study|Other reason|1
7620739|NCT00490035|12031305|FG002|Overall Study|Other reason|3
7620740|NCT00490035|12031306|FG003|Overall Study|Other reason|1
7620741|NCT00490035|12031303|FG000|Overall Study|AE, serious fatal|1
7620742|NCT00490035|12031304|FG001|Overall Study|AE, serious fatal|0
7620743|NCT00490035|12031305|FG002|Overall Study|AE, serious fatal|0
7620744|NCT00490035|12031306|FG003|Overall Study|AE, serious fatal|0
7620745|NCT00490035|12031303|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
7620746|NCT00490035|12031304|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
7620747|NCT00490035|12031305|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
7217366|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
7217367|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
7217368|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11
7217369|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5
7217370|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3
7217371|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1
7217372|NCT01231516|11425808|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3
7217373|NCT01231516|11425809|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2
7217374|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5
7217375|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0
7217376|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27
7217377|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11
7217378|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10
7217379|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0
7217380|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6
7217381|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3
7217382|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2
7217383|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0
7217384|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6
7217385|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1
7217386|NCT01231516|11425808|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12
7217387|NCT01231516|11425809|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2
7217388|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
7217389|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
7217390|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7620748|NCT00490035|12031306|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
7620749|NCT00490035|12031303|FG000|Overall Study|AE of unknown type|0
7620750|NCT00490035|12031304|FG001|Overall Study|AE of unknown type|0
7620751|NCT00490035|12031305|FG002|Overall Study|AE of unknown type|2
7217391|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217392|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217393|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217394|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7620752|NCT00490035|12031306|FG003|Overall Study|AE of unknown type|0
7620753|NCT00464269|12031320|FG000|Overall Study|Lack of Efficacy|1
7620754|NCT00464269|12031321|FG001|Overall Study|Lack of Efficacy|0
7620755|NCT00464269|12031322|FG002|Overall Study|Lack of Efficacy|0
7620756|NCT00464269|12031323|FG003|Overall Study|Lack of Efficacy|0
7620757|NCT00464269|12031320|FG000|Overall Study|Lost to Follow-up|0
7620758|NCT00464269|12031321|FG001|Overall Study|Lost to Follow-up|4
7620759|NCT00464269|12031322|FG002|Overall Study|Lost to Follow-up|0
7620760|NCT00464269|12031323|FG003|Overall Study|Lost to Follow-up|1
7620761|NCT00464269|12031320|FG000|Overall Study|Withdrawal by Subject|0
7620762|NCT00464269|12031321|FG001|Overall Study|Withdrawal by Subject|2
7620763|NCT00464269|12031322|FG002|Overall Study|Withdrawal by Subject|1
7620764|NCT00464269|12031323|FG003|Overall Study|Withdrawal by Subject|1
7620765|NCT00464269|12031320|FG000|Overall Study|Other reason|3
7620766|NCT00464269|12031321|FG001|Overall Study|Other reason|3
7620767|NCT00464269|12031322|FG002|Overall Study|Other reason|1
7620768|NCT00464269|12031323|FG003|Overall Study|Other reason|1
7620769|NCT00464269|12031320|FG000|Overall Study|AE, serious fatal|0
7620770|NCT00464269|12031321|FG001|Overall Study|AE, serious fatal|0
7620771|NCT00464269|12031322|FG002|Overall Study|AE, serious fatal|1
7620772|NCT00464269|12031323|FG003|Overall Study|AE, serious fatal|1
7620773|NCT00464269|12031320|FG000|Overall Study|SAE, non-fatal|0
7620774|NCT00464269|12031321|FG001|Overall Study|SAE, non-fatal|0
7620775|NCT00464269|12031322|FG002|Overall Study|SAE, non-fatal|0
7281438|NCT00477269|11497112|FG002|Open Label Extension|Abnormal laboratory values|1
7281439|NCT00477269|11497110|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
7281440|NCT00477269|11497111|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
7281441|NCT00477269|11497112|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
7281442|NCT00477269|11497110|FG000|Open Label Extension|Adminiatrative problems|0
7620776|NCT00464269|12031323|FG003|Overall Study|SAE, non-fatal|1
7217395|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217396|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217397|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
7217398|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
7217399|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
7217400|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217401|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217402|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217403|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217404|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217405|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217406|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217407|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
7217408|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
7217409|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217410|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217411|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7281443|NCT00477269|11497111|FG001|Open Label Extension|Adminiatrative problems|0
7281444|NCT00477269|11497112|FG002|Open Label Extension|Adminiatrative problems|2
7281445|NCT00477269|11497110|FG000|Open Label Extension|Death|0
7281446|NCT00477269|11497111|FG001|Open Label Extension|Death|0
7281447|NCT00477269|11497112|FG002|Open Label Extension|Death|4
7281448|NCT00477295|11497122|FG000|Overall Study|Adverse Event|31
7281449|NCT00477295|11497123|FG001|Overall Study|Adverse Event|35
7281450|NCT00477295|11497122|FG000|Overall Study|Withdrawal by Subject|35
7281451|NCT00477295|11497123|FG001|Overall Study|Withdrawal by Subject|24
7281452|NCT00477295|11497122|FG000|Overall Study|Lack of Efficacy|23
7281453|NCT00477295|11497123|FG001|Overall Study|Lack of Efficacy|23
7281454|NCT00477295|11497122|FG000|Overall Study|Protocol Violation|3
7281455|NCT00477295|11497123|FG001|Overall Study|Protocol Violation|8
7281456|NCT00477295|11497122|FG000|Overall Study|Physician Decision|4
7620777|NCT00464269|12031320|FG000|Overall Study|AE, non-serious non-fatal|2
7620778|NCT00464269|12031321|FG001|Overall Study|AE, non-serious non-fatal|8
7620779|NCT00464269|12031322|FG002|Overall Study|AE, non-serious non-fatal|3
7620780|NCT00464269|12031323|FG003|Overall Study|AE, non-serious non-fatal|4
7620781|NCT00464269|12031320|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620782|NCT00464269|12031321|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620783|NCT00464269|12031322|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
7620784|NCT00464269|12031323|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7620785|NCT00334815|12031337|FG000|Overall Study|Adverse Event|3
7620786|NCT00334815|12031338|FG001|Overall Study|Adverse Event|2
7620787|NCT00334815|12031337|FG000|Overall Study|Death|0
7620788|NCT00334815|12031338|FG001|Overall Study|Death|2
7620789|NCT00334815|12031337|FG000|Overall Study|Progression|1
7620790|NCT00334815|12031338|FG001|Overall Study|Progression|0
7620791|NCT00334815|12031337|FG000|Overall Study|ineligible|1
7620792|NCT00334815|12031338|FG001|Overall Study|ineligible|1
7620793|NCT00334815|12031337|FG000|Overall Study|patient refused treatment|0
7620794|NCT00334815|12031338|FG001|Overall Study|patient refused treatment|1
7620795|NCT00334815|12031337|FG000|Overall Study|Physician Decision|2
7620796|NCT00334815|12031338|FG001|Overall Study|Physician Decision|4
7620797|NCT00042289|12031393|FG000|Overall Study|Lost to Follow-up|3
7620798|NCT00042289|12031394|FG001|Overall Study|Lost to Follow-up|0
7620799|NCT00042289|12031395|FG002|Overall Study|Lost to Follow-up|0
7620800|NCT00042289|12031396|FG003|Overall Study|Lost to Follow-up|1
7620801|NCT00042289|12031397|FG004|Overall Study|Lost to Follow-up|3
7620802|NCT00042289|12031398|FG005|Overall Study|Lost to Follow-up|3
7281457|NCT00477295|11497123|FG001|Overall Study|Physician Decision|5
7281458|NCT00477295|11497122|FG000|Overall Study|Lost to Follow-up|21
7620803|NCT00042289|12031399|FG006|Overall Study|Lost to Follow-up|6
7620804|NCT00042289|12031400|FG007|Overall Study|Lost to Follow-up|1
7620805|NCT00042289|12031401|FG008|Overall Study|Lost to Follow-up|1
7620806|NCT00042289|12031402|FG009|Overall Study|Lost to Follow-up|0
7620807|NCT00042289|12031403|FG010|Overall Study|Lost to Follow-up|0
7620808|NCT00042289|12031404|FG011|Overall Study|Lost to Follow-up|0
7620809|NCT00042289|12031405|FG012|Overall Study|Lost to Follow-up|0
7620810|NCT00042289|12031406|FG013|Overall Study|Lost to Follow-up|0
7620811|NCT00042289|12031407|FG014|Overall Study|Lost to Follow-up|0
7620812|NCT00042289|12031408|FG015|Overall Study|Lost to Follow-up|1
7620813|NCT00042289|12031409|FG016|Overall Study|Lost to Follow-up|1
7620814|NCT00042289|12031410|FG017|Overall Study|Lost to Follow-up|0
7620815|NCT00042289|12031411|FG018|Overall Study|Lost to Follow-up|3
7620816|NCT00042289|12031412|FG019|Overall Study|Lost to Follow-up|2
7620817|NCT00042289|12031413|FG020|Overall Study|Lost to Follow-up|0
7620818|NCT00042289|12031414|FG021|Overall Study|Lost to Follow-up|0
7620819|NCT00042289|12031415|FG022|Overall Study|Lost to Follow-up|0
7620820|NCT00042289|12031416|FG023|Overall Study|Lost to Follow-up|0
7620821|NCT00042289|12031417|FG024|Overall Study|Lost to Follow-up|0
7620822|NCT00042289|12031418|FG025|Overall Study|Lost to Follow-up|0
7620823|NCT00042289|12031419|FG026|Overall Study|Lost to Follow-up|2
7620824|NCT00042289|12031420|FG027|Overall Study|Lost to Follow-up|2
7620825|NCT00042289|12031421|FG028|Overall Study|Lost to Follow-up|2
7620826|NCT00042289|12031422|FG029|Overall Study|Lost to Follow-up|0
7620827|NCT00042289|12031423|FG030|Overall Study|Lost to Follow-up|0
7620828|NCT00042289|12031424|FG031|Overall Study|Lost to Follow-up|2
7620829|NCT00042289|12031425|FG032|Overall Study|Lost to Follow-up|1
7620830|NCT00042289|12031426|FG033|Overall Study|Lost to Follow-up|1
7620831|NCT00042289|12031427|FG034|Overall Study|Lost to Follow-up|1
7620832|NCT00042289|12031428|FG035|Overall Study|Lost to Follow-up|2
7620833|NCT00042289|12031429|FG036|Overall Study|Lost to Follow-up|1
7620834|NCT00042289|12031430|FG037|Overall Study|Lost to Follow-up|1
7620835|NCT00042289|12031431|FG038|Overall Study|Lost to Follow-up|0
7620836|NCT00042289|12031432|FG039|Overall Study|Lost to Follow-up|5
7620837|NCT00042289|12031433|FG040|Overall Study|Lost to Follow-up|0
7620838|NCT00042289|12031434|FG041|Overall Study|Lost to Follow-up|2
7620839|NCT00042289|12031435|FG042|Overall Study|Lost to Follow-up|2
7620840|NCT00042289|12031436|FG043|Overall Study|Lost to Follow-up|0
7620841|NCT00042289|12031437|FG044|Overall Study|Lost to Follow-up|0
7620842|NCT00042289|12031438|FG045|Overall Study|Lost to Follow-up|1
7620843|NCT00042289|12031439|FG046|Overall Study|Lost to Follow-up|0
7620844|NCT00042289|12031393|FG000|Overall Study|Other reason|0
7620845|NCT00042289|12031394|FG001|Overall Study|Other reason|0
7620846|NCT00042289|12031395|FG002|Overall Study|Other reason|0
7620847|NCT00042289|12031396|FG003|Overall Study|Other reason|2
7620848|NCT00042289|12031397|FG004|Overall Study|Other reason|0
7620849|NCT00042289|12031398|FG005|Overall Study|Other reason|0
7620850|NCT00042289|12031399|FG006|Overall Study|Other reason|0
7620851|NCT00042289|12031400|FG007|Overall Study|Other reason|0
7620852|NCT00042289|12031401|FG008|Overall Study|Other reason|0
7620853|NCT00042289|12031402|FG009|Overall Study|Other reason|0
7620854|NCT00042289|12031403|FG010|Overall Study|Other reason|0
7620855|NCT00042289|12031404|FG011|Overall Study|Other reason|0
7620856|NCT00042289|12031405|FG012|Overall Study|Other reason|0
7620857|NCT00042289|12031406|FG013|Overall Study|Other reason|0
7620858|NCT00042289|12031407|FG014|Overall Study|Other reason|0
7620859|NCT00042289|12031408|FG015|Overall Study|Other reason|0
7620860|NCT00042289|12031409|FG016|Overall Study|Other reason|0
7620861|NCT00042289|12031410|FG017|Overall Study|Other reason|0
7620862|NCT00042289|12031411|FG018|Overall Study|Other reason|1
7620863|NCT00042289|12031412|FG019|Overall Study|Other reason|0
7620864|NCT00042289|12031413|FG020|Overall Study|Other reason|0
7620865|NCT00042289|12031414|FG021|Overall Study|Other reason|0
7620866|NCT00042289|12031415|FG022|Overall Study|Other reason|0
7620867|NCT00042289|12031416|FG023|Overall Study|Other reason|1
7620868|NCT00042289|12031417|FG024|Overall Study|Other reason|0
7620869|NCT00042289|12031418|FG025|Overall Study|Other reason|0
7620870|NCT00042289|12031419|FG026|Overall Study|Other reason|1
7620871|NCT00042289|12031420|FG027|Overall Study|Other reason|0
7620872|NCT00042289|12031421|FG028|Overall Study|Other reason|3
7620873|NCT00042289|12031422|FG029|Overall Study|Other reason|0
7217412|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217413|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217414|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217415|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7217416|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7620874|NCT00042289|12031423|FG030|Overall Study|Other reason|0
7217417|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
7620875|NCT00042289|12031424|FG031|Overall Study|Other reason|1
7620876|NCT00042289|12031425|FG032|Overall Study|Other reason|0
7620877|NCT00042289|12031426|FG033|Overall Study|Other reason|1
7620878|NCT00042289|12031427|FG034|Overall Study|Other reason|0
7620879|NCT00042289|12031428|FG035|Overall Study|Other reason|2
7620880|NCT00042289|12031429|FG036|Overall Study|Other reason|0
7620881|NCT00042289|12031430|FG037|Overall Study|Other reason|0
7620882|NCT00042289|12031431|FG038|Overall Study|Other reason|0
7620883|NCT00042289|12031432|FG039|Overall Study|Other reason|0
7620884|NCT00042289|12031433|FG040|Overall Study|Other reason|0
7620885|NCT00042289|12031434|FG041|Overall Study|Other reason|0
7620886|NCT00042289|12031435|FG042|Overall Study|Other reason|0
7620887|NCT00042289|12031436|FG043|Overall Study|Other reason|1
7620888|NCT00042289|12031437|FG044|Overall Study|Other reason|0
7620889|NCT00042289|12031438|FG045|Overall Study|Other reason|0
7217418|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
7217419|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
7217420|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217421|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217422|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217423|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217424|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217425|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217426|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217427|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
7217428|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
7217429|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
7217430|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
7217431|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
7217432|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
7217433|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
7217434|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
7217435|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
7217436|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
7217437|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
7217438|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
7217439|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
7217440|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217441|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217442|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217443|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217444|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217445|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217446|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217447|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
7217448|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
7217449|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
7217450|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217451|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217452|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217453|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217454|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217455|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217456|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217457|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
7217458|NCT01194219|11425828|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7217459|NCT01194219|11425829|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
7217460|NCT01194219|11425830|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217461|NCT01194219|11425831|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217462|NCT01194219|11425832|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217463|NCT01194219|11425833|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217464|NCT01194219|11425834|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217465|NCT01194219|11425835|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217466|NCT01194219|11425836|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217467|NCT01194219|11425837|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
7217468|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
7217469|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
7217470|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
7217471|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
7217472|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
7217473|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
7217474|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
7217475|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
7217476|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
7217477|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
7217478|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217479|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217480|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
7217481|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
7217482|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7281459|NCT00477295|11497123|FG001|Overall Study|Lost to Follow-up|11
7620890|NCT00042289|12031439|FG046|Overall Study|Other reason|0
7620891|NCT00042289|12031393|FG000|Overall Study|Severe debilitation, unable to continue|0
7620892|NCT00042289|12031394|FG001|Overall Study|Severe debilitation, unable to continue|0
7217483|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217484|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217485|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217486|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217487|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
7217488|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217489|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217490|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
7217491|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
7217492|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217493|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217494|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217495|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217496|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217497|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
7217498|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217499|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217500|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
7217501|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
7217502|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217503|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217504|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217505|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217506|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217507|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
7217508|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217509|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217510|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
7217511|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217512|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217513|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217514|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217515|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217516|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217517|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
7217518|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
7217519|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
7217520|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
7620893|NCT00042289|12031395|FG002|Overall Study|Severe debilitation, unable to continue|0
7620894|NCT00042289|12031396|FG003|Overall Study|Severe debilitation, unable to continue|0
7620895|NCT00042289|12031397|FG004|Overall Study|Severe debilitation, unable to continue|0
7620896|NCT00042289|12031398|FG005|Overall Study|Severe debilitation, unable to continue|0
7620897|NCT00042289|12031399|FG006|Overall Study|Severe debilitation, unable to continue|0
7620898|NCT00042289|12031400|FG007|Overall Study|Severe debilitation, unable to continue|0
7620899|NCT00042289|12031401|FG008|Overall Study|Severe debilitation, unable to continue|0
7620900|NCT00042289|12031402|FG009|Overall Study|Severe debilitation, unable to continue|0
7620901|NCT00042289|12031403|FG010|Overall Study|Severe debilitation, unable to continue|0
7620902|NCT00042289|12031404|FG011|Overall Study|Severe debilitation, unable to continue|0
7620903|NCT00042289|12031405|FG012|Overall Study|Severe debilitation, unable to continue|0
7620904|NCT00042289|12031406|FG013|Overall Study|Severe debilitation, unable to continue|0
7620905|NCT00042289|12031407|FG014|Overall Study|Severe debilitation, unable to continue|0
7620906|NCT00042289|12031408|FG015|Overall Study|Severe debilitation, unable to continue|0
7620907|NCT00042289|12031409|FG016|Overall Study|Severe debilitation, unable to continue|0
7620908|NCT00042289|12031410|FG017|Overall Study|Severe debilitation, unable to continue|0
7620909|NCT00042289|12031411|FG018|Overall Study|Severe debilitation, unable to continue|0
7620910|NCT00042289|12031412|FG019|Overall Study|Severe debilitation, unable to continue|0
7620911|NCT00042289|12031413|FG020|Overall Study|Severe debilitation, unable to continue|0
7620912|NCT00042289|12031414|FG021|Overall Study|Severe debilitation, unable to continue|1
7620913|NCT00042289|12031415|FG022|Overall Study|Severe debilitation, unable to continue|0
7620914|NCT00042289|12031416|FG023|Overall Study|Severe debilitation, unable to continue|1
7620915|NCT00042289|12031417|FG024|Overall Study|Severe debilitation, unable to continue|0
7620916|NCT00042289|12031418|FG025|Overall Study|Severe debilitation, unable to continue|0
7620917|NCT00042289|12031419|FG026|Overall Study|Severe debilitation, unable to continue|0
7620918|NCT00042289|12031420|FG027|Overall Study|Severe debilitation, unable to continue|1
7620919|NCT00042289|12031421|FG028|Overall Study|Severe debilitation, unable to continue|0
7620920|NCT00042289|12031422|FG029|Overall Study|Severe debilitation, unable to continue|0
7620921|NCT00042289|12031423|FG030|Overall Study|Severe debilitation, unable to continue|0
7620922|NCT00042289|12031424|FG031|Overall Study|Severe debilitation, unable to continue|1
7620923|NCT00042289|12031425|FG032|Overall Study|Severe debilitation, unable to continue|1
7620924|NCT00042289|12031426|FG033|Overall Study|Severe debilitation, unable to continue|0
7620925|NCT00042289|12031427|FG034|Overall Study|Severe debilitation, unable to continue|0
7620926|NCT00042289|12031428|FG035|Overall Study|Severe debilitation, unable to continue|0
7620927|NCT00042289|12031429|FG036|Overall Study|Severe debilitation, unable to continue|0
7620928|NCT00042289|12031430|FG037|Overall Study|Severe debilitation, unable to continue|0
7620929|NCT00042289|12031431|FG038|Overall Study|Severe debilitation, unable to continue|0
7620930|NCT00042289|12031432|FG039|Overall Study|Severe debilitation, unable to continue|0
7620931|NCT00042289|12031433|FG040|Overall Study|Severe debilitation, unable to continue|0
7620932|NCT00042289|12031434|FG041|Overall Study|Severe debilitation, unable to continue|0
7620933|NCT00042289|12031435|FG042|Overall Study|Severe debilitation, unable to continue|0
7620934|NCT00042289|12031436|FG043|Overall Study|Severe debilitation, unable to continue|0
7620935|NCT00042289|12031437|FG044|Overall Study|Severe debilitation, unable to continue|0
7620936|NCT00042289|12031438|FG045|Overall Study|Severe debilitation, unable to continue|0
7620937|NCT00042289|12031439|FG046|Overall Study|Severe debilitation, unable to continue|0
7620938|NCT00042289|12031393|FG000|Overall Study|Site closed|0
7620939|NCT00042289|12031394|FG001|Overall Study|Site closed|0
7620940|NCT00042289|12031395|FG002|Overall Study|Site closed|0
7620941|NCT00042289|12031396|FG003|Overall Study|Site closed|0
7620942|NCT00042289|12031397|FG004|Overall Study|Site closed|0
7620943|NCT00042289|12031398|FG005|Overall Study|Site closed|0
7620944|NCT00042289|12031399|FG006|Overall Study|Site closed|0
7620945|NCT00042289|12031400|FG007|Overall Study|Site closed|0
7620946|NCT00042289|12031401|FG008|Overall Study|Site closed|0
7620947|NCT00042289|12031402|FG009|Overall Study|Site closed|0
7620948|NCT00042289|12031403|FG010|Overall Study|Site closed|0
7620949|NCT00042289|12031404|FG011|Overall Study|Site closed|0
7620950|NCT00042289|12031405|FG012|Overall Study|Site closed|0
7620951|NCT00042289|12031406|FG013|Overall Study|Site closed|0
7620952|NCT00042289|12031407|FG014|Overall Study|Site closed|0
7620953|NCT00042289|12031408|FG015|Overall Study|Site closed|0
7620954|NCT00042289|12031409|FG016|Overall Study|Site closed|0
7620955|NCT00042289|12031410|FG017|Overall Study|Site closed|0
7620956|NCT00042289|12031411|FG018|Overall Study|Site closed|0
7620957|NCT00042289|12031412|FG019|Overall Study|Site closed|0
7620958|NCT00042289|12031413|FG020|Overall Study|Site closed|0
7620959|NCT00042289|12031414|FG021|Overall Study|Site closed|0
7620960|NCT00042289|12031415|FG022|Overall Study|Site closed|0
7620961|NCT00042289|12031416|FG023|Overall Study|Site closed|0
7620962|NCT00042289|12031417|FG024|Overall Study|Site closed|0
7620963|NCT00042289|12031418|FG025|Overall Study|Site closed|0
7620964|NCT00042289|12031419|FG026|Overall Study|Site closed|0
7620965|NCT00042289|12031420|FG027|Overall Study|Site closed|0
7620966|NCT00042289|12031421|FG028|Overall Study|Site closed|0
7620967|NCT00042289|12031422|FG029|Overall Study|Site closed|0
7620968|NCT00042289|12031423|FG030|Overall Study|Site closed|0
7217521|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
7217522|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
7217523|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
7217524|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
7217525|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
7217526|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
7217527|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
7217528|NCT01194219|11425828|FG000|Maintenance Phase Weeks16-32|Other|0
7217529|NCT01194219|11425829|FG001|Maintenance Phase Weeks16-32|Other|0
7217530|NCT01194219|11425830|FG002|Maintenance Phase Weeks16-32|Other|2
7217531|NCT01194219|11425831|FG003|Maintenance Phase Weeks16-32|Other|1
7217532|NCT01194219|11425832|FG004|Maintenance Phase Weeks16-32|Other|0
7217533|NCT01194219|11425833|FG005|Maintenance Phase Weeks16-32|Other|0
7217534|NCT01194219|11425834|FG006|Maintenance Phase Weeks16-32|Other|0
7217535|NCT01194219|11425835|FG007|Maintenance Phase Weeks16-32|Other|0
7217536|NCT01194219|11425836|FG008|Maintenance Phase Weeks16-32|Other|0
7217537|NCT01194219|11425837|FG009|Maintenance Phase Weeks16-32|Other|0
7217538|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217539|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217540|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217541|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217542|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217543|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
7620969|NCT00042289|12031424|FG031|Overall Study|Site closed|3
7620970|NCT00042289|12031425|FG032|Overall Study|Site closed|0
7620971|NCT00042289|12031426|FG033|Overall Study|Site closed|0
7620972|NCT00042289|12031427|FG034|Overall Study|Site closed|0
7620973|NCT00042289|12031428|FG035|Overall Study|Site closed|0
7620974|NCT00042289|12031429|FG036|Overall Study|Site closed|1
7620975|NCT00042289|12031430|FG037|Overall Study|Site closed|0
7620976|NCT00042289|12031431|FG038|Overall Study|Site closed|0
7620977|NCT00042289|12031432|FG039|Overall Study|Site closed|0
7620978|NCT00042289|12031433|FG040|Overall Study|Site closed|0
7620979|NCT00042289|12031434|FG041|Overall Study|Site closed|0
7620980|NCT00042289|12031435|FG042|Overall Study|Site closed|1
7620981|NCT00042289|12031436|FG043|Overall Study|Site closed|0
7620982|NCT00042289|12031437|FG044|Overall Study|Site closed|0
7620983|NCT00042289|12031438|FG045|Overall Study|Site closed|0
7620984|NCT00042289|12031439|FG046|Overall Study|Site closed|0
7620985|NCT00042289|12031393|FG000|Overall Study|Participant not willing to adhere to requirements|0
7620986|NCT00042289|12031394|FG001|Overall Study|Participant not willing to adhere to requirements|0
7620987|NCT00042289|12031395|FG002|Overall Study|Participant not willing to adhere to requirements|0
7620988|NCT00042289|12031396|FG003|Overall Study|Participant not willing to adhere to requirements|3
7620989|NCT00042289|12031397|FG004|Overall Study|Participant not willing to adhere to requirements|0
7620990|NCT00042289|12031398|FG005|Overall Study|Participant not willing to adhere to requirements|0
7620991|NCT00042289|12031399|FG006|Overall Study|Participant not willing to adhere to requirements|0
7620992|NCT00042289|12031400|FG007|Overall Study|Participant not willing to adhere to requirements|0
7620993|NCT00042289|12031401|FG008|Overall Study|Participant not willing to adhere to requirements|0
7620994|NCT00042289|12031402|FG009|Overall Study|Participant not willing to adhere to requirements|0
7620995|NCT00042289|12031403|FG010|Overall Study|Participant not willing to adhere to requirements|0
7620996|NCT00042289|12031404|FG011|Overall Study|Participant not willing to adhere to requirements|0
7620997|NCT00042289|12031405|FG012|Overall Study|Participant not willing to adhere to requirements|0
7620998|NCT00042289|12031406|FG013|Overall Study|Participant not willing to adhere to requirements|0
7620999|NCT00042289|12031407|FG014|Overall Study|Participant not willing to adhere to requirements|0
7621000|NCT00042289|12031408|FG015|Overall Study|Participant not willing to adhere to requirements|0
7621001|NCT00042289|12031409|FG016|Overall Study|Participant not willing to adhere to requirements|0
7621002|NCT00042289|12031410|FG017|Overall Study|Participant not willing to adhere to requirements|0
7621003|NCT00042289|12031411|FG018|Overall Study|Participant not willing to adhere to requirements|4
7621004|NCT00042289|12031412|FG019|Overall Study|Participant not willing to adhere to requirements|2
7217544|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
7217545|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
7217546|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217547|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
7217548|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217549|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217550|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217551|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217552|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7217553|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
7217554|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
7217555|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
7217556|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217557|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
7217558|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217559|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217560|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217561|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217562|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
7217563|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217564|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
7217565|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217566|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217567|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
7217568|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217569|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217570|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217571|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217572|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
7217573|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217574|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
7217575|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
7217576|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217577|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
7217578|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217579|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217580|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217581|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217582|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
7217583|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
7217584|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
7217585|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217586|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7217587|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
7281460|NCT00477295|11497122|FG000|Overall Study|Other|4
7621005|NCT00042289|12031413|FG020|Overall Study|Participant not willing to adhere to requirements|0
7621006|NCT00042289|12031414|FG021|Overall Study|Participant not willing to adhere to requirements|2
7621007|NCT00042289|12031415|FG022|Overall Study|Participant not willing to adhere to requirements|1
7621008|NCT00042289|12031416|FG023|Overall Study|Participant not willing to adhere to requirements|1
7621009|NCT00042289|12031417|FG024|Overall Study|Participant not willing to adhere to requirements|0
7621010|NCT00042289|12031418|FG025|Overall Study|Participant not willing to adhere to requirements|1
7621011|NCT00042289|12031419|FG026|Overall Study|Participant not willing to adhere to requirements|2
7621012|NCT00042289|12031420|FG027|Overall Study|Participant not willing to adhere to requirements|0
7621013|NCT00042289|12031421|FG028|Overall Study|Participant not willing to adhere to requirements|1
7621014|NCT00042289|12031422|FG029|Overall Study|Participant not willing to adhere to requirements|0
7621015|NCT00042289|12031423|FG030|Overall Study|Participant not willing to adhere to requirements|0
7621016|NCT00042289|12031424|FG031|Overall Study|Participant not willing to adhere to requirements|1
7621017|NCT00042289|12031425|FG032|Overall Study|Participant not willing to adhere to requirements|1
7621018|NCT00042289|12031426|FG033|Overall Study|Participant not willing to adhere to requirements|3
7621019|NCT00042289|12031427|FG034|Overall Study|Participant not willing to adhere to requirements|1
7621020|NCT00042289|12031428|FG035|Overall Study|Participant not willing to adhere to requirements|1
7621021|NCT00042289|12031429|FG036|Overall Study|Participant not willing to adhere to requirements|2
7621022|NCT00042289|12031430|FG037|Overall Study|Participant not willing to adhere to requirements|0
7621023|NCT00042289|12031431|FG038|Overall Study|Participant not willing to adhere to requirements|2
7621024|NCT00042289|12031432|FG039|Overall Study|Participant not willing to adhere to requirements|0
7621025|NCT00042289|12031433|FG040|Overall Study|Participant not willing to adhere to requirements|0
7217588|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217589|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217590|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217591|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217592|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217593|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217594|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217595|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
7217596|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217597|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
7217598|NCT01194219|11425828|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217599|NCT01194219|11425829|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217600|NCT01194219|11425830|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217601|NCT01194219|11425831|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217602|NCT01194219|11425832|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217603|NCT01194219|11425833|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217604|NCT01194219|11425834|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
7217605|NCT01194219|11425835|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217606|NCT01194219|11425836|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217607|NCT01194219|11425837|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
7217608|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217609|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217610|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217611|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217612|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217613|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217614|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217615|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
7217616|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
7217617|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
7217618|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217619|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217620|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217621|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217622|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217623|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217624|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217625|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
7217626|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
7217627|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
7217628|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217629|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217630|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217631|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217632|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7621066|NCT00042289|12031427|FG034|Overall Study|Protocol Violation|0
7217633|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217634|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7217635|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
7621026|NCT00042289|12031434|FG041|Overall Study|Participant not willing to adhere to requirements|0
7621027|NCT00042289|12031435|FG042|Overall Study|Participant not willing to adhere to requirements|2
7621028|NCT00042289|12031436|FG043|Overall Study|Participant not willing to adhere to requirements|1
7621029|NCT00042289|12031437|FG044|Overall Study|Participant not willing to adhere to requirements|0
7621030|NCT00042289|12031438|FG045|Overall Study|Participant not willing to adhere to requirements|0
7621031|NCT00042289|12031439|FG046|Overall Study|Participant not willing to adhere to requirements|1
7621032|NCT00042289|12031393|FG000|Overall Study|Protocol Violation|0
7217636|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
7217637|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
7217638|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217639|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217640|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217641|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217642|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217643|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217644|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217645|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
7217646|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
7217647|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
7217648|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Death|0
7217649|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Death|0
7217650|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Death|0
7217651|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Death|0
7217652|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Death|0
7217653|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Death|0
7217654|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Death|0
7217655|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Death|0
7217656|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Death|1
7217657|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Death|1
7217658|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217659|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217660|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217661|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217662|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217663|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217664|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217665|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
7217666|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
7217667|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
7217668|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217669|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217670|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7621033|NCT00042289|12031394|FG001|Overall Study|Protocol Violation|0
7621034|NCT00042289|12031395|FG002|Overall Study|Protocol Violation|0
7621035|NCT00042289|12031396|FG003|Overall Study|Protocol Violation|0
7621036|NCT00042289|12031397|FG004|Overall Study|Protocol Violation|0
7621037|NCT00042289|12031398|FG005|Overall Study|Protocol Violation|1
7621038|NCT00042289|12031399|FG006|Overall Study|Protocol Violation|0
7621039|NCT00042289|12031400|FG007|Overall Study|Protocol Violation|1
7621040|NCT00042289|12031401|FG008|Overall Study|Protocol Violation|0
7621041|NCT00042289|12031402|FG009|Overall Study|Protocol Violation|0
7621042|NCT00042289|12031403|FG010|Overall Study|Protocol Violation|0
7621043|NCT00042289|12031404|FG011|Overall Study|Protocol Violation|0
7621044|NCT00042289|12031405|FG012|Overall Study|Protocol Violation|0
7621045|NCT00042289|12031406|FG013|Overall Study|Protocol Violation|0
7621046|NCT00042289|12031407|FG014|Overall Study|Protocol Violation|0
7621047|NCT00042289|12031408|FG015|Overall Study|Protocol Violation|0
7621048|NCT00042289|12031409|FG016|Overall Study|Protocol Violation|0
7621049|NCT00042289|12031410|FG017|Overall Study|Protocol Violation|0
7621050|NCT00042289|12031411|FG018|Overall Study|Protocol Violation|0
7621051|NCT00042289|12031412|FG019|Overall Study|Protocol Violation|0
7621052|NCT00042289|12031413|FG020|Overall Study|Protocol Violation|0
7621053|NCT00042289|12031414|FG021|Overall Study|Protocol Violation|0
7621054|NCT00042289|12031415|FG022|Overall Study|Protocol Violation|0
7621055|NCT00042289|12031416|FG023|Overall Study|Protocol Violation|1
7621056|NCT00042289|12031417|FG024|Overall Study|Protocol Violation|1
7621057|NCT00042289|12031418|FG025|Overall Study|Protocol Violation|0
7621058|NCT00042289|12031419|FG026|Overall Study|Protocol Violation|2
7621059|NCT00042289|12031420|FG027|Overall Study|Protocol Violation|0
7621060|NCT00042289|12031421|FG028|Overall Study|Protocol Violation|0
7621061|NCT00042289|12031422|FG029|Overall Study|Protocol Violation|0
7621062|NCT00042289|12031423|FG030|Overall Study|Protocol Violation|1
7621063|NCT00042289|12031424|FG031|Overall Study|Protocol Violation|0
7621064|NCT00042289|12031425|FG032|Overall Study|Protocol Violation|0
7621065|NCT00042289|12031426|FG033|Overall Study|Protocol Violation|0
7621067|NCT00042289|12031428|FG035|Overall Study|Protocol Violation|0
7621068|NCT00042289|12031429|FG036|Overall Study|Protocol Violation|0
7621069|NCT00042289|12031430|FG037|Overall Study|Protocol Violation|0
7621070|NCT00042289|12031431|FG038|Overall Study|Protocol Violation|0
7621071|NCT00042289|12031432|FG039|Overall Study|Protocol Violation|0
7621072|NCT00042289|12031433|FG040|Overall Study|Protocol Violation|0
7621073|NCT00042289|12031434|FG041|Overall Study|Protocol Violation|1
7621074|NCT00042289|12031435|FG042|Overall Study|Protocol Violation|1
7621075|NCT00042289|12031436|FG043|Overall Study|Protocol Violation|1
7621076|NCT00042289|12031437|FG044|Overall Study|Protocol Violation|0
7621077|NCT00042289|12031438|FG045|Overall Study|Protocol Violation|0
7621078|NCT00042289|12031439|FG046|Overall Study|Protocol Violation|0
7621079|NCT00042289|12031393|FG000|Overall Study|Withdrawal by Subject|4
7621080|NCT00042289|12031394|FG001|Overall Study|Withdrawal by Subject|1
7621081|NCT00042289|12031395|FG002|Overall Study|Withdrawal by Subject|0
7621082|NCT00042289|12031396|FG003|Overall Study|Withdrawal by Subject|2
7621083|NCT00042289|12031397|FG004|Overall Study|Withdrawal by Subject|0
7621084|NCT00042289|12031398|FG005|Overall Study|Withdrawal by Subject|2
7621085|NCT00042289|12031399|FG006|Overall Study|Withdrawal by Subject|0
7621086|NCT00042289|12031400|FG007|Overall Study|Withdrawal by Subject|0
7621087|NCT00042289|12031401|FG008|Overall Study|Withdrawal by Subject|0
7621088|NCT00042289|12031402|FG009|Overall Study|Withdrawal by Subject|1
7621089|NCT00042289|12031403|FG010|Overall Study|Withdrawal by Subject|0
7621090|NCT00042289|12031404|FG011|Overall Study|Withdrawal by Subject|0
7621091|NCT00042289|12031405|FG012|Overall Study|Withdrawal by Subject|2
7621092|NCT00042289|12031406|FG013|Overall Study|Withdrawal by Subject|0
7621093|NCT00042289|12031407|FG014|Overall Study|Withdrawal by Subject|0
7621094|NCT00042289|12031408|FG015|Overall Study|Withdrawal by Subject|0
7621095|NCT00042289|12031409|FG016|Overall Study|Withdrawal by Subject|0
7621096|NCT00042289|12031410|FG017|Overall Study|Withdrawal by Subject|0
7621097|NCT00042289|12031411|FG018|Overall Study|Withdrawal by Subject|0
7217671|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217672|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217673|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217674|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217675|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217676|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
7217677|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
7217678|NCT01194219|11425828|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217679|NCT01194219|11425829|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217680|NCT01194219|11425830|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217681|NCT01194219|11425831|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217682|NCT01194219|11425832|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217683|NCT01194219|11425833|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217684|NCT01194219|11425834|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217685|NCT01194219|11425835|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
7217686|NCT01194219|11425836|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
7217687|NCT01194219|11425837|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
7217688|NCT01193842|11425865|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7217689|NCT01193842|11425866|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
7217690|NCT01193842|11425867|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7621098|NCT00042289|12031412|FG019|Overall Study|Withdrawal by Subject|0
7621099|NCT00042289|12031413|FG020|Overall Study|Withdrawal by Subject|0
7621100|NCT00042289|12031414|FG021|Overall Study|Withdrawal by Subject|1
7621101|NCT00042289|12031415|FG022|Overall Study|Withdrawal by Subject|1
7621102|NCT00042289|12031416|FG023|Overall Study|Withdrawal by Subject|1
7621103|NCT00042289|12031417|FG024|Overall Study|Withdrawal by Subject|0
7621104|NCT00042289|12031418|FG025|Overall Study|Withdrawal by Subject|0
7621105|NCT00042289|12031419|FG026|Overall Study|Withdrawal by Subject|1
7621106|NCT00042289|12031420|FG027|Overall Study|Withdrawal by Subject|0
7621107|NCT00042289|12031421|FG028|Overall Study|Withdrawal by Subject|2
7621108|NCT00042289|12031422|FG029|Overall Study|Withdrawal by Subject|0
7621109|NCT00042289|12031423|FG030|Overall Study|Withdrawal by Subject|0
7621110|NCT00042289|12031424|FG031|Overall Study|Withdrawal by Subject|1
7621111|NCT00042289|12031425|FG032|Overall Study|Withdrawal by Subject|2
7621112|NCT00042289|12031426|FG033|Overall Study|Withdrawal by Subject|1
7621113|NCT00042289|12031427|FG034|Overall Study|Withdrawal by Subject|0
7621114|NCT00042289|12031428|FG035|Overall Study|Withdrawal by Subject|0
7621115|NCT00042289|12031429|FG036|Overall Study|Withdrawal by Subject|0
7621116|NCT00042289|12031430|FG037|Overall Study|Withdrawal by Subject|1
7621117|NCT00042289|12031431|FG038|Overall Study|Withdrawal by Subject|0
7621118|NCT00042289|12031432|FG039|Overall Study|Withdrawal by Subject|0
7621119|NCT00042289|12031433|FG040|Overall Study|Withdrawal by Subject|0
7621120|NCT00042289|12031434|FG041|Overall Study|Withdrawal by Subject|0
7621121|NCT00042289|12031435|FG042|Overall Study|Withdrawal by Subject|1
7621122|NCT00042289|12031436|FG043|Overall Study|Withdrawal by Subject|0
7621123|NCT00042289|12031437|FG044|Overall Study|Withdrawal by Subject|0
7621124|NCT00042289|12031438|FG045|Overall Study|Withdrawal by Subject|0
7621125|NCT00042289|12031439|FG046|Overall Study|Withdrawal by Subject|0
7621126|NCT02384993|12031625|FG000|Overall Study|Adverse Event|0
7621127|NCT02384993|12031626|FG001|Overall Study|Adverse Event|1
7621128|NCT02304302|12031635|FG000|Overall Study|Adverse Event|2
7621129|NCT02304302|12031636|FG001|Overall Study|Adverse Event|3
7621130|NCT02304302|12031635|FG000|Overall Study|Lost to Follow-up|1
7621131|NCT02304302|12031636|FG001|Overall Study|Lost to Follow-up|4
7621132|NCT02304302|12031635|FG000|Overall Study|Removed from analysis due to low medication compliance|0
7621133|NCT02304302|12031636|FG001|Overall Study|Removed from analysis due to low medication compliance|1
7621134|NCT02269670|12031646|FG000|Overall Study|All subjects have not completed all research related interventions|3
7621135|NCT01860976|12031656|FG000|Blinded Treatment|Adverse Event|1
7621136|NCT01860976|12031657|FG001|Blinded Treatment|Adverse Event|3
7621137|NCT01860976|12031656|FG000|Blinded Treatment|Lack of Efficacy|5
7621138|NCT01860976|12031657|FG001|Blinded Treatment|Lack of Efficacy|12
7621139|NCT01860976|12031656|FG000|Blinded Treatment|Subject request to discontinue treatment|2
7621140|NCT01860976|12031657|FG001|Blinded Treatment|Subject request to discontinue treatment|3
7621141|NCT01860976|12031656|FG000|Blinded Treatment|Withdrawal by Subject|3
7621142|NCT01860976|12031657|FG001|Blinded Treatment|Withdrawal by Subject|5
7621143|NCT01860976|12031656|FG000|Blinded Treatment|Subject no longer met criteria|1
7621144|NCT01860976|12031657|FG001|Blinded Treatment|Subject no longer met criteria|0
7621145|NCT01860976|12031656|FG000|Blinded Treatment|Entered Open-Label in error|0
7621146|NCT01860976|12031657|FG001|Blinded Treatment|Entered Open-Label in error|1
7621147|NCT01860976|12031656|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
7621148|NCT01860976|12031657|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
7621149|NCT01860976|12031656|FG000|Open-Label|Adverse Event|2
7621150|NCT01860976|12031657|FG001|Open-Label|Adverse Event|4
7621151|NCT01860976|12031656|FG000|Open-Label|Lack of Efficacy|16
7621152|NCT01860976|12031657|FG001|Open-Label|Lack of Efficacy|8
7621153|NCT01860976|12031656|FG000|Open-Label|Lost to Follow-up|1
7621154|NCT01860976|12031657|FG001|Open-Label|Lost to Follow-up|2
7621155|NCT01860976|12031656|FG000|Open-Label|Subject request discontinue treatment|4
7621156|NCT01860976|12031657|FG001|Open-Label|Subject request discontinue treatment|3
7621157|NCT01860976|12031656|FG000|Open-Label|Withdrawal by Subject|4
7621158|NCT01860976|12031657|FG001|Open-Label|Withdrawal by Subject|1
7621159|NCT01860976|12031656|FG000|Open-Label|Other Reasons|1
7621160|NCT01860976|12031657|FG001|Open-Label|Other Reasons|1
7621161|NCT01860976|12031656|FG000|Long Term Extension|Adverse Event|4
7621162|NCT01860976|12031657|FG001|Long Term Extension|Adverse Event|0
7621163|NCT01860976|12031656|FG000|Long Term Extension|Lack of Efficacy|2
7621164|NCT01860976|12031657|FG001|Long Term Extension|Lack of Efficacy|0
7621165|NCT01860976|12031656|FG000|Long Term Extension|Subject request to discontinue treatment|10
7621166|NCT01860976|12031657|FG001|Long Term Extension|Subject request to discontinue treatment|0
7621167|NCT01860976|12031656|FG000|Long Term Extension|Lost to Follow-up|2
7621168|NCT01860976|12031657|FG001|Long Term Extension|Lost to Follow-up|0
7621169|NCT01860976|12031656|FG000|Long Term Extension|subject withdrew consent|7
7621170|NCT01860976|12031657|FG001|Long Term Extension|subject withdrew consent|0
7621171|NCT01761266|12031668|FG000|Overall Study|Death|415
7621172|NCT01761266|12031669|FG001|Overall Study|Death|402
7621173|NCT01761266|12031668|FG000|Overall Study|Lost to Follow-up|8
7621174|NCT01761266|12031669|FG001|Overall Study|Lost to Follow-up|12
7621175|NCT01761266|12031668|FG000|Overall Study|Withdrawal by Subject|14
7621176|NCT01761266|12031669|FG001|Overall Study|Withdrawal by Subject|10
7621177|NCT01761266|12031668|FG000|Overall Study|Sponsor Decision|41
7621178|NCT01761266|12031669|FG001|Overall Study|Sponsor Decision|52
7621179|NCT01550289|12031680|FG000|Overall Study|Protocol Violation|1
7621180|NCT01550289|12031681|FG001|Overall Study|Protocol Violation|0
7621181|NCT01550289|12031680|FG000|Overall Study|Lost to Follow-up|1
7621182|NCT01550289|12031681|FG001|Overall Study|Lost to Follow-up|1
7621183|NCT01550289|12031680|FG000|Overall Study|Withdrawal by Subject|11
7621184|NCT01550289|12031681|FG001|Overall Study|Withdrawal by Subject|3
7621185|NCT01346709|12031689|FG000|Overall Study|Protocol Violation|35
7621186|NCT01346709|12031689|FG000|Overall Study|Lost to Follow-up|31
7281461|NCT00477295|11497123|FG001|Overall Study|Other|3
7281462|NCT00477334|11497133|FG000|Overall Study|Discontinued prior to taking study drug|106
7281463|NCT00477334|11497134|FG001|Overall Study|Discontinued prior to taking study drug|53
7281464|NCT00477334|11497133|FG000|Overall Study|Adverse Event|1
7281465|NCT00477334|11497134|FG001|Overall Study|Adverse Event|2
7281466|NCT00477334|11497133|FG000|Overall Study|Withdrawal by Subject|2
7281467|NCT00477334|11497134|FG001|Overall Study|Withdrawal by Subject|1
7281468|NCT00477334|11497133|FG000|Overall Study|Lost to Follow-up|15
7621187|NCT01346709|12031689|FG000|Overall Study|Missing data in candidate risk factor|285
7621188|NCT01074190|12031696|FG000|Overall Study|Emergency Cesarean Delivery|1
7621189|NCT01074190|12031697|FG001|Overall Study|Emergency Cesarean Delivery|2
7621190|NCT01074190|12031698|FG002|Overall Study|Emergency Cesarean Delivery|1
7621191|NCT01074190|12031696|FG000|Overall Study|Protocol Violation|2
7621192|NCT01074190|12031697|FG001|Overall Study|Protocol Violation|1
7621193|NCT01074190|12031698|FG002|Overall Study|Protocol Violation|0
7621194|NCT01074190|12031696|FG000|Overall Study|Delivered in under 90 minutes|0
7621195|NCT01074190|12031697|FG001|Overall Study|Delivered in under 90 minutes|2
7621196|NCT01074190|12031698|FG002|Overall Study|Delivered in under 90 minutes|1
7621197|NCT01074190|12031696|FG000|Overall Study|Subject withdrew consent|1
7621198|NCT01074190|12031697|FG001|Overall Study|Subject withdrew consent|1
7621199|NCT01074190|12031698|FG002|Overall Study|Subject withdrew consent|1
7621200|NCT00875524|12031711|FG000|Overall Study|Serious adverse event|0
7621201|NCT00875524|12031712|FG001|Overall Study|Serious adverse event|1
7621202|NCT00875524|12031711|FG000|Overall Study|Protocol Violation|4
7621203|NCT00875524|12031712|FG001|Overall Study|Protocol Violation|0
7621204|NCT00875524|12031711|FG000|Overall Study|Lost to Follow-up|1
7621205|NCT00875524|12031712|FG001|Overall Study|Lost to Follow-up|0
7621206|NCT00875524|12031711|FG000|Overall Study|Withdrawal by Subject|3
7621207|NCT00875524|12031712|FG001|Overall Study|Withdrawal by Subject|5
7621208|NCT00842530|12031720|FG000|Overall Study|Serious adverse event|0
7621209|NCT00842530|12031721|FG001|Overall Study|Serious adverse event|6
7621210|NCT00842530|12031720|FG000|Overall Study|Other adverse event|6
7621211|NCT00842530|12031721|FG001|Overall Study|Other adverse event|1
7621212|NCT00842530|12031720|FG000|Overall Study|Protocol Violation|32
7621213|NCT00842530|12031721|FG001|Overall Study|Protocol Violation|14
7621214|NCT00842530|12031720|FG000|Overall Study|Lost to Follow-up|6
7621215|NCT00842530|12031721|FG001|Overall Study|Lost to Follow-up|8
7621216|NCT00842530|12031720|FG000|Overall Study|Withdrawal by Subject|73
7621217|NCT00842530|12031721|FG001|Overall Study|Withdrawal by Subject|28
7621218|NCT00788151|12031730|FG000|Overall Study|Other adverse event|0
7621219|NCT00788151|12031731|FG001|Overall Study|Other adverse event|2
7621220|NCT00788151|12031730|FG000|Overall Study|Protocol Violation|0
7621221|NCT00788151|12031731|FG001|Overall Study|Protocol Violation|1
7621222|NCT00788151|12031730|FG000|Overall Study|Withdrawal by Subject|13
7621223|NCT00788151|12031731|FG001|Overall Study|Withdrawal by Subject|6
7621224|NCT00788151|12031730|FG000|Overall Study|Enrolled but not treated|1
7621225|NCT00788151|12031731|FG001|Overall Study|Enrolled but not treated|1
7621226|NCT00539591|12031740|FG000|Overall Study|Toxicity|3
7621227|NCT00539591|12031741|FG001|Overall Study|Toxicity|0
7621228|NCT00539591|12031742|FG002|Overall Study|Toxicity|0
7621229|NCT00539591|12031740|FG000|Overall Study|Disease progression|2
7621230|NCT00539591|12031741|FG001|Overall Study|Disease progression|2
7621231|NCT00539591|12031742|FG002|Overall Study|Disease progression|3
7281469|NCT00477334|11497134|FG001|Overall Study|Lost to Follow-up|4
7281470|NCT00477334|11497133|FG000|Overall Study|Administrative Problems|39
7281471|NCT00477334|11497134|FG001|Overall Study|Administrative Problems|15
7281472|NCT00477334|11497133|FG000|Overall Study|Protocol Violation|7
7281473|NCT00477334|11497134|FG001|Overall Study|Protocol Violation|1
7281474|NCT00477386|11497146|FG000|Overall Study|Adverse Event|4
7281475|NCT00477386|11497147|FG001|Overall Study|Adverse Event|8
7281476|NCT00477386|11497146|FG000|Overall Study|Disease progression, relapse|3
7281477|NCT00477386|11497147|FG001|Overall Study|Disease progression, relapse|4
7281478|NCT00477386|11497146|FG000|Overall Study|Disease progression, refractory|1
7281479|NCT00477386|11497147|FG001|Overall Study|Disease progression, refractory|3
7281480|NCT00477386|11497146|FG000|Overall Study|Other|1
7281481|NCT00477386|11497147|FG001|Overall Study|Other|2
7281482|NCT00477386|11497146|FG000|Overall Study|Physician Decision|1
7281483|NCT00477386|11497147|FG001|Overall Study|Physician Decision|0
7281484|NCT00477386|11497146|FG000|Overall Study|Withdrawal by Subject|1
7281485|NCT00477386|11497147|FG001|Overall Study|Withdrawal by Subject|0
7281486|NCT00477464|11497168|FG000|Overall Study|Lost to Follow-up|1
7281487|NCT00477464|11497168|FG000|Overall Study|Death|36
7621232|NCT04794751|12031778|FG000|Period 1|incorrect fitting guide was used to fit subject|2
7621233|NCT04794751|12031779|FG001|Period 1|incorrect fitting guide was used to fit subject|1
7621234|NCT04794751|12031778|FG000|Period 1|Subject no longer meets eligibility criteria|0
7621235|NCT04794751|12031779|FG001|Period 1|Subject no longer meets eligibility criteria|1
7621236|NCT04794751|12031778|FG000|Period 1|Protocol Violation|0
7621237|NCT04794751|12031779|FG001|Period 1|Protocol Violation|2
7621238|NCT04794751|12031778|FG000|Period 1|Withdrawal by Subject|0
7621239|NCT04794751|12031779|FG001|Period 1|Withdrawal by Subject|1
7621240|NCT04794751|12031778|FG000|Period 2|Withdrawal by Subject|0
7621241|NCT04794751|12031779|FG001|Period 2|Withdrawal by Subject|1
7621242|NCT04794751|12031778|FG000|Period 2|incorrect fitting guide was used to fit subject|0
7621243|NCT04794751|12031779|FG001|Period 2|incorrect fitting guide was used to fit subject|2
7621244|NCT04794751|12031778|FG000|Period 2|Protocol Violation|1
7621245|NCT04794751|12031779|FG001|Period 2|Protocol Violation|0
7621246|NCT04584645|12031787|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995
7621247|NCT04584645|12031788|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906
7621248|NCT04538170|12031814|FG000|Overall Study|Withdrawal by Subject|104
7621249|NCT04538170|12031815|FG001|Overall Study|Withdrawal by Subject|210
7621250|NCT04461015|12031827|FG000|Overall Study|IV access lost during the study|0
7621251|NCT04461015|12031828|FG001|Overall Study|IV access lost during the study|1
7621252|NCT04461015|12031827|FG000|Overall Study|Withdrawal by Subject|0
7621253|NCT04461015|12031828|FG001|Overall Study|Withdrawal by Subject|1
7621254|NCT04380961|12031836|FG000|Overall Study|Lost to Follow-up|17
7621255|NCT04380961|12031837|FG001|Overall Study|Lost to Follow-up|11
7621256|NCT04380961|12031836|FG000|Overall Study|Withdrawal by Subject|3
7621257|NCT04380961|12031837|FG001|Overall Study|Withdrawal by Subject|0
7621258|NCT04380961|12031836|FG000|Overall Study|Death|22
7621259|NCT04380961|12031837|FG001|Overall Study|Death|16
7621260|NCT04380961|12031836|FG000|Overall Study|Other|1
7621261|NCT04380961|12031837|FG001|Overall Study|Other|0
7621262|NCT04380961|12031836|FG000|Overall Study|Randomized but Not Treated|1
7621263|NCT04380961|12031837|FG001|Overall Study|Randomized but Not Treated|2
7621264|NCT04332419|12031862|FG000|Overall Study|Withdrawal by Subject|1
7621265|NCT04239872|12031866|FG000|Overall Study|Lost to Follow-up|0
7621266|NCT04239872|12031867|FG001|Overall Study|Lost to Follow-up|1
7621267|NCT04091581|12031886|FG000|Overall Study|Lost to Follow-up|0
7621268|NCT04091581|12031887|FG001|Overall Study|Lost to Follow-up|1
7621269|NCT03839628|12031923|FG000|Overall Study|Withdrawal by Subject|1
7621270|NCT03791398|12031930|FG000|Overall Study|Progression of Disease Under Study|2
7281488|NCT00477464|11497168|FG000|Overall Study|Completion of protocol-defined follow-up|14
7281489|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Adverse Event|1
7281490|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Adverse Event|4
7281491|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Adverse Event|0
7281492|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Adverse Event|5
7281493|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Adverse Event|6
7281494|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Adverse Event|0
7281495|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Adverse Event|0
7281496|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Adverse Event|0
7281497|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Adverse Event|0
7281498|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
7281499|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281500|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281501|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
7281502|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
7281503|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281504|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281505|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281506|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
7281507|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
7281508|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
7281509|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
7281510|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
7281511|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
7281512|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
7281513|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
7281514|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
7281515|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
7281516|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7281517|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
7281518|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
7281519|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
7281520|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
7281521|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7281522|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7281523|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7621271|NCT03791398|12031931|FG001|Overall Study|Progression of Disease Under Study|0
7621272|NCT03791398|12031932|FG002|Overall Study|Progression of Disease Under Study|0
7621306|NCT03703882|12031964|FG000|Overall Study|Adverse Event|1
7621307|NCT03703882|12031965|FG001|Overall Study|Adverse Event|0
7621308|NCT03703882|12031964|FG000|Overall Study|Lost to Follow-up|0
7621309|NCT03703882|12031965|FG001|Overall Study|Lost to Follow-up|2
7621310|NCT03703882|12031964|FG000|Overall Study|Non-compliance with study drug|0
7621311|NCT03703882|12031965|FG001|Overall Study|Non-compliance with study drug|1
7621312|NCT03703882|12031964|FG000|Overall Study|Physician Decision|0
7621313|NCT03703882|12031965|FG001|Overall Study|Physician Decision|1
7621314|NCT03703882|12031964|FG000|Overall Study|Progressive disease|1
7621315|NCT03703882|12031965|FG001|Overall Study|Progressive disease|0
7621316|NCT03703882|12031964|FG000|Overall Study|Withdrawal by parent/guardian|1
7621317|NCT03703882|12031965|FG001|Overall Study|Withdrawal by parent/guardian|0
7621318|NCT03703882|12031964|FG000|Overall Study|Starting another treatment|0
7621319|NCT03703882|12031965|FG001|Overall Study|Starting another treatment|1
7621320|NCT03703882|12031964|FG000|Overall Study|noncompliance with study procedures|0
7621321|NCT03703882|12031965|FG001|Overall Study|noncompliance with study procedures|1
7621322|NCT03615040|12031973|FG000|Overall Study|Withdrawal by Subject|2
7621323|NCT03615040|12031974|FG001|Overall Study|Withdrawal by Subject|1
7621324|NCT03615040|12031973|FG000|Overall Study|Physician Decision|2
7621325|NCT03615040|12031974|FG001|Overall Study|Physician Decision|2
7621326|NCT03615040|12031973|FG000|Overall Study|Clinical diagnosis of lung cancer|1
7621327|NCT03615040|12031974|FG001|Overall Study|Clinical diagnosis of lung cancer|0
7621328|NCT03615040|12031973|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1
7621329|NCT03615040|12031974|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0
7621330|NCT03615040|12031973|FG000|Overall Study|Death|0
7621331|NCT03615040|12031974|FG001|Overall Study|Death|2
7621332|NCT03611075|12031989|FG000|Overall Study|Physician Decision|0
7621333|NCT03611075|12031990|FG001|Overall Study|Physician Decision|1
7621334|NCT03611075|12031991|FG002|Overall Study|Physician Decision|1
7621335|NCT03611075|12031992|FG003|Overall Study|Physician Decision|0
7621336|NCT03611075|12031993|FG004|Overall Study|Physician Decision|0
7621337|NCT03611075|12031994|FG005|Overall Study|Physician Decision|0
7621338|NCT03611075|12031995|FG006|Overall Study|Physician Decision|0
7621339|NCT03611075|12031996|FG007|Overall Study|Physician Decision|0
7621340|NCT03611075|12031997|FG008|Overall Study|Physician Decision|0
7621341|NCT03611075|12031989|FG000|Overall Study|Lost to Follow-up|1
7621342|NCT03611075|12031990|FG001|Overall Study|Lost to Follow-up|0
7621343|NCT03611075|12031991|FG002|Overall Study|Lost to Follow-up|0
7621344|NCT03611075|12031992|FG003|Overall Study|Lost to Follow-up|2
7621345|NCT03611075|12031993|FG004|Overall Study|Lost to Follow-up|0
7621346|NCT03611075|12031994|FG005|Overall Study|Lost to Follow-up|0
7621347|NCT03611075|12031995|FG006|Overall Study|Lost to Follow-up|0
7621348|NCT03611075|12031996|FG007|Overall Study|Lost to Follow-up|0
7621349|NCT03611075|12031997|FG008|Overall Study|Lost to Follow-up|0
7621350|NCT03611075|12031989|FG000|Overall Study|Withdrawal by Subject|0
7621351|NCT03611075|12031990|FG001|Overall Study|Withdrawal by Subject|1
7621352|NCT03611075|12031991|FG002|Overall Study|Withdrawal by Subject|1
7621353|NCT03611075|12031992|FG003|Overall Study|Withdrawal by Subject|1
7621354|NCT03611075|12031993|FG004|Overall Study|Withdrawal by Subject|0
7621355|NCT03611075|12031994|FG005|Overall Study|Withdrawal by Subject|0
7621356|NCT03611075|12031995|FG006|Overall Study|Withdrawal by Subject|1
7621357|NCT03611075|12031996|FG007|Overall Study|Withdrawal by Subject|0
7621358|NCT03611075|12031997|FG008|Overall Study|Withdrawal by Subject|0
7281524|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
7281525|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
7281526|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
7281527|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
7281528|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
7281529|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
7281530|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
7281531|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
7281532|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
7281533|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
7281534|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Other, not specified|2
7281535|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Other, not specified|4
7281536|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Other, not specified|0
7281537|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Other, not specified|1
7281538|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Other, not specified|1
7281539|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Other, not specified|0
7281540|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Other, not specified|0
7281541|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Other, not specified|0
7281542|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Other, not specified|0
7281543|NCT00477490|11497179|FG000|Part I: 4 Week Efficacy|Not Reported|1
7281544|NCT00477490|11497180|FG001|Part I: 4 Week Efficacy|Not Reported|2
7281545|NCT00477490|11497181|FG002|Part I: 4 Week Efficacy|Not Reported|3
7281546|NCT00477490|11497182|FG003|Part I: 4 Week Efficacy|Not Reported|0
7281547|NCT00477490|11497183|FG004|Part I: 4 Week Efficacy|Not Reported|1
7281548|NCT00477490|11497184|FG005|Part I: 4 Week Efficacy|Not Reported|0
7281549|NCT00477490|11497185|FG006|Part I: 4 Week Efficacy|Not Reported|0
7281550|NCT00477490|11497186|FG007|Part I: 4 Week Efficacy|Not Reported|0
7281551|NCT00477490|11497187|FG008|Part I: 4 Week Efficacy|Not Reported|0
7281552|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
7281553|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
7281554|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7281555|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
7281556|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
7281557|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
7281558|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7281559|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
7281560|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
7281561|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
7281562|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
7281563|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
7281564|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7281565|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7281566|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7281567|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7281568|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
7281569|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
7281570|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7281571|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
7281572|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
7281573|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7281574|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
7281575|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7281576|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
7281577|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7281578|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
7281579|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7621359|NCT03611075|12031989|FG000|Overall Study|Reason unknown|0
7621360|NCT03611075|12031990|FG001|Overall Study|Reason unknown|0
7621361|NCT03611075|12031991|FG002|Overall Study|Reason unknown|0
7621362|NCT03611075|12031992|FG003|Overall Study|Reason unknown|1
7621363|NCT03611075|12031993|FG004|Overall Study|Reason unknown|0
7281580|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7281581|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7281582|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7281583|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7281584|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7281585|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
7281586|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7281587|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
7281588|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7621364|NCT03611075|12031994|FG005|Overall Study|Reason unknown|0
7621365|NCT03611075|12031995|FG006|Overall Study|Reason unknown|1
7621366|NCT03611075|12031996|FG007|Overall Study|Reason unknown|0
7621367|NCT03611075|12031997|FG008|Overall Study|Reason unknown|0
7621368|NCT03595176|12032042|FG000|Overall Study|Death|0
7621369|NCT03595176|12032043|FG001|Overall Study|Death|2
7621370|NCT03595176|12032042|FG000|Overall Study|Lost to Follow-up|0
7621371|NCT03595176|12032043|FG001|Overall Study|Lost to Follow-up|1
7281589|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
7281590|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281591|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281592|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281593|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281594|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281595|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281596|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
7281597|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7281598|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7281599|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7281600|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
7281601|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
7281602|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7281603|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7281604|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
7281605|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
7281606|NCT00477490|11497179|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
7281607|NCT00477490|11497180|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
7281608|NCT00477490|11497181|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
7281609|NCT00477490|11497182|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
7281610|NCT00477490|11497183|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
7281611|NCT00477490|11497184|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
7281612|NCT00477490|11497185|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
7281613|NCT00477490|11497186|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
7281614|NCT00477490|11497187|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
7281615|NCT00477594|11497217|FG000|Year 1 and Year 2|Adverse Event|4
7281616|NCT00477594|11497218|FG001|Year 1 and Year 2|Adverse Event|2
7281617|NCT00477594|11497217|FG000|Year 1 and Year 2|Physician Decision|2
7281618|NCT00477594|11497218|FG001|Year 1 and Year 2|Physician Decision|1
7281619|NCT00477594|11497217|FG000|Year 1 and Year 2|Withdrawal by Subject|2
7281620|NCT00477594|11497218|FG001|Year 1 and Year 2|Withdrawal by Subject|1
7281621|NCT00477594|11497217|FG000|Year 1 and Year 2|Other|1
7281622|NCT00477594|11497218|FG001|Year 1 and Year 2|Other|0
7281623|NCT00477594|11497217|FG000|Year 3|Adverse Event|1
7281624|NCT00477594|11497218|FG001|Year 3|Adverse Event|0
7281625|NCT00477594|11497217|FG000|Year 3|Withdrawal by Subject|1
7281626|NCT00477594|11497218|FG001|Year 3|Withdrawal by Subject|0
7281627|NCT00477594|11497217|FG000|Follow-up Period|Withdrawal by Subject|2
7281628|NCT00477594|11497218|FG001|Follow-up Period|Withdrawal by Subject|1
7281629|NCT00477594|11497217|FG000|Follow-up Period|Other|1
7281630|NCT00477594|11497218|FG001|Follow-up Period|Other|0
7281631|NCT00477607|11497226|FG000|Overall Study|Lost to Follow-up|7
7281632|NCT00477607|11497227|FG001|Overall Study|Lost to Follow-up|7
7281633|NCT00477633|11497233|FG000|Overall Study|Did not receive treatment|23
7281634|NCT00477633|11497233|FG000|Overall Study|Adverse Event|143
7281635|NCT00477633|11497233|FG000|Overall Study|Pregnancy|23
7281636|NCT00477633|11497233|FG000|Overall Study|Lost to Follow-up|271
7281637|NCT00477633|11497233|FG000|Overall Study|Withdrawal by Subject|149
7281638|NCT00477633|11497233|FG000|Overall Study|Protocol Violation|25
7281639|NCT00477633|11497233|FG000|Overall Study|Various (Moving, Enrollment closed)|75
7281640|NCT00477672|11497244|FG000|Overall Study|Adverse Event|3
7281641|NCT00477672|11497245|FG001|Overall Study|Adverse Event|5
7281642|NCT00477672|11497246|FG002|Overall Study|Adverse Event|6
7281643|NCT00477672|11497244|FG000|Overall Study|Death|0
7281644|NCT00477672|11497245|FG001|Overall Study|Death|1
7281645|NCT00477672|11497246|FG002|Overall Study|Death|0
7281646|NCT00477672|11497244|FG000|Overall Study|Disease progression|0
7281647|NCT00477672|11497245|FG001|Overall Study|Disease progression|1
7621372|NCT03541317|12032051|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
7621373|NCT03541317|12032052|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
7621374|NCT03541317|12032053|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
7621375|NCT03541317|12032054|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
7621376|NCT03541317|12032055|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
7621377|NCT03541317|12032056|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
7621378|NCT03400943|12032081|FG000|Treatment Period 1|Adverse Event|0
7621379|NCT03400943|12032082|FG001|Treatment Period 1|Adverse Event|0
7621380|NCT03400943|12032083|FG002|Treatment Period 1|Adverse Event|0
7621381|NCT03400943|12032084|FG003|Treatment Period 1|Adverse Event|1
7621382|NCT03400943|12032081|FG000|Treatment Period 1|Lost to Follow-up|1
7621383|NCT03400943|12032082|FG001|Treatment Period 1|Lost to Follow-up|0
7621384|NCT03400943|12032083|FG002|Treatment Period 1|Lost to Follow-up|0
7621385|NCT03400943|12032084|FG003|Treatment Period 1|Lost to Follow-up|0
7621386|NCT03400943|12032081|FG000|Treatment Period 1|Protocol Violation|0
7621387|NCT03400943|12032082|FG001|Treatment Period 1|Protocol Violation|1
7621388|NCT03400943|12032083|FG002|Treatment Period 1|Protocol Violation|1
7621389|NCT03400943|12032084|FG003|Treatment Period 1|Protocol Violation|0
7621390|NCT03400943|12032081|FG000|Treatment Period 1|Study terminated by sponsor|2
7621391|NCT03400943|12032082|FG001|Treatment Period 1|Study terminated by sponsor|0
7621392|NCT03400943|12032083|FG002|Treatment Period 1|Study terminated by sponsor|0
7621393|NCT03400943|12032084|FG003|Treatment Period 1|Study terminated by sponsor|1
7621394|NCT03400943|12032081|FG000|Treatment Period 1|Withdrawal by Subject|0
7621395|NCT03400943|12032082|FG001|Treatment Period 1|Withdrawal by Subject|0
7621396|NCT03400943|12032083|FG002|Treatment Period 1|Withdrawal by Subject|3
7621397|NCT03400943|12032084|FG003|Treatment Period 1|Withdrawal by Subject|1
7621398|NCT03400943|12032081|FG000|Treatment Period 1|Other|2
7621399|NCT03400943|12032082|FG001|Treatment Period 1|Other|1
7621400|NCT03400943|12032083|FG002|Treatment Period 1|Other|2
7621401|NCT03400943|12032084|FG003|Treatment Period 1|Other|2
7621402|NCT03400943|12032081|FG000|Post-treatment Period 1|Adverse Event|2
7621403|NCT03400943|12032082|FG001|Post-treatment Period 1|Adverse Event|0
7621404|NCT03400943|12032083|FG002|Post-treatment Period 1|Adverse Event|0
7621405|NCT03400943|12032084|FG003|Post-treatment Period 1|Adverse Event|0
7621406|NCT03400943|12032081|FG000|Post-treatment Period 1|Protocol Violation|1
7621407|NCT03400943|12032082|FG001|Post-treatment Period 1|Protocol Violation|0
7621408|NCT03400943|12032083|FG002|Post-treatment Period 1|Protocol Violation|0
7621409|NCT03400943|12032084|FG003|Post-treatment Period 1|Protocol Violation|0
7621410|NCT03400943|12032081|FG000|Post-treatment Period 1|Study terminated by sponsor|5
7621411|NCT03400943|12032082|FG001|Post-treatment Period 1|Study terminated by sponsor|0
7621412|NCT03400943|12032083|FG002|Post-treatment Period 1|Study terminated by sponsor|5
7621413|NCT03400943|12032084|FG003|Post-treatment Period 1|Study terminated by sponsor|6
7621414|NCT03400943|12032081|FG000|Post-treatment Period 1|Withdrawal by Subject|1
7621415|NCT03400943|12032082|FG001|Post-treatment Period 1|Withdrawal by Subject|0
7621416|NCT03400943|12032083|FG002|Post-treatment Period 1|Withdrawal by Subject|2
7621417|NCT03400943|12032084|FG003|Post-treatment Period 1|Withdrawal by Subject|2
7621418|NCT03400943|12032081|FG000|Post-treatment Period 1|Other|2
7217691|NCT01193842|11425868|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7217692|NCT01193842|11425869|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
7217693|NCT01193842|11425865|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
7217694|NCT01193842|11425866|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7217695|NCT01193842|11425867|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7217696|NCT01193842|11425868|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7217697|NCT01193842|11425869|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
7217698|NCT01193842|11425865|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7217699|NCT01193842|11425866|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7217700|NCT01193842|11425867|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
7217701|NCT01193842|11425868|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7281648|NCT00477672|11497246|FG002|Overall Study|Disease progression|0
7281649|NCT00477672|11497244|FG000|Overall Study|Physician Decision|1
7281650|NCT00477672|11497245|FG001|Overall Study|Physician Decision|0
7281651|NCT00477672|11497246|FG002|Overall Study|Physician Decision|0
7281652|NCT00477672|11497244|FG000|Overall Study|Protocol noncompliance|0
7281653|NCT00477672|11497245|FG001|Overall Study|Protocol noncompliance|2
7281654|NCT00477672|11497246|FG002|Overall Study|Protocol noncompliance|0
7281655|NCT00477672|11497244|FG000|Overall Study|Consent withdrawn|2
7281656|NCT00477672|11497245|FG001|Overall Study|Consent withdrawn|5
7281657|NCT00477672|11497246|FG002|Overall Study|Consent withdrawn|10
7281658|NCT00477672|11497244|FG000|Overall Study|Discretion of Sponsor|1
7281659|NCT00477672|11497245|FG001|Overall Study|Discretion of Sponsor|2
7281660|NCT00477672|11497246|FG002|Overall Study|Discretion of Sponsor|0
7281661|NCT00477750|11497258|FG000|Overall Study|Currently Receiving Treatment|11
7281662|NCT00477971|11497266|FG000|Overall Study|Disease progression|6
7621419|NCT03400943|12032082|FG001|Post-treatment Period 1|Other|0
7621420|NCT03400943|12032083|FG002|Post-treatment Period 1|Other|4
7621421|NCT03400943|12032084|FG003|Post-treatment Period 1|Other|5
7621422|NCT03400943|12032081|FG000|Treatment Period 2|Study terminated by sponsor|0
7621423|NCT03400943|12032082|FG001|Treatment Period 2|Study terminated by sponsor|1
7621424|NCT03400943|12032083|FG002|Treatment Period 2|Study terminated by sponsor|0
7621425|NCT03400943|12032084|FG003|Treatment Period 2|Study terminated by sponsor|0
7621426|NCT03400943|12032081|FG000|Treatment Period 2|Withdrawal by Subject|0
7621427|NCT03400943|12032082|FG001|Treatment Period 2|Withdrawal by Subject|1
7621428|NCT03400943|12032083|FG002|Treatment Period 2|Withdrawal by Subject|0
7621429|NCT03400943|12032084|FG003|Treatment Period 2|Withdrawal by Subject|0
7621430|NCT03400943|12032081|FG000|Treatment Period 2|Other|1
7621431|NCT03400943|12032082|FG001|Treatment Period 2|Other|6
7621432|NCT03400943|12032083|FG002|Treatment Period 2|Other|0
7621433|NCT03400943|12032084|FG003|Treatment Period 2|Other|0
7621434|NCT03400943|12032081|FG000|Follow-up Period|Withdrawal by Subject|1
7621435|NCT03400943|12032082|FG001|Follow-up Period|Withdrawal by Subject|0
7621436|NCT03400943|12032083|FG002|Follow-up Period|Withdrawal by Subject|0
7621437|NCT03400943|12032084|FG003|Follow-up Period|Withdrawal by Subject|0
7621438|NCT03302234|12032102|FG000|Overall Study|Death|137
7621439|NCT03302234|12032103|FG001|Overall Study|Death|135
7621440|NCT03302234|12032102|FG000|Overall Study|Withdrawal by Subject|1
7621441|NCT03302234|12032103|FG001|Overall Study|Withdrawal by Subject|1
7621442|NCT03302234|12032102|FG000|Overall Study|Laryngeal carcinoma|0
7621443|NCT03302234|12032103|FG001|Overall Study|Laryngeal carcinoma|1
7621444|NCT03208244|12032123|FG000|Overall Study|Death|1
7621445|NCT03050060|12032150|FG000|Overall Study|Adverse Event|7
7621446|NCT03050060|12032150|FG000|Overall Study|Withdrawal by Subject|1
7621447|NCT03050060|12032150|FG000|Overall Study|Progression|7
7621448|NCT02847637|12032167|FG000|Overall Study|Withdrew from treatment due to AE|0
7621449|NCT02847637|12032168|FG001|Overall Study|Withdrew from treatment due to AE|0
7621450|NCT02847637|12032169|FG002|Overall Study|Withdrew from treatment due to AE|1
7621451|NCT02847637|12032170|FG003|Overall Study|Withdrew from treatment due to AE|0
7621452|NCT02847637|12032167|FG000|Overall Study|Ongoing treatment with emicizumab|16
7621453|NCT02847637|12032168|FG001|Overall Study|Ongoing treatment with emicizumab|35
7621454|NCT02847637|12032169|FG002|Overall Study|Ongoing treatment with emicizumab|34
7621455|NCT02847637|12032170|FG003|Overall Study|Ongoing treatment with emicizumab|63
7621456|NCT02847637|12032167|FG000|Overall Study|First emicizumab dose delayed|1
7621457|NCT02847637|12032168|FG001|Overall Study|First emicizumab dose delayed|0
7621458|NCT02847637|12032169|FG002|Overall Study|First emicizumab dose delayed|0
7621459|NCT02847637|12032170|FG003|Overall Study|First emicizumab dose delayed|0
7621460|NCT02770391|12032194|FG000|Overall Study|Lost to Follow-up|2
7621461|NCT02770391|12032194|FG000|Overall Study|Withdrawal by Subject|1
7621462|NCT02770391|12032194|FG000|Overall Study|Surgery delayed unevaluable|2
7621463|NCT02770391|12032194|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1
7281663|NCT00477971|11497267|FG001|Overall Study|Disease progression|0
7281664|NCT00477971|11497266|FG000|Overall Study|Withdrawal by Subject|3
7281665|NCT00477971|11497267|FG001|Overall Study|Withdrawal by Subject|1
7281666|NCT00477971|11497266|FG000|Overall Study|Adverse Event|3
7621464|NCT02648724|12032222|FG000|Overall Study|Withdrawal by Subject|0
7621465|NCT02648724|12032223|FG001|Overall Study|Withdrawal by Subject|1
7621466|NCT02648724|12032224|FG002|Overall Study|Withdrawal by Subject|1
7621467|NCT02648724|12032225|FG003|Overall Study|Withdrawal by Subject|0
7621468|NCT02648724|12032226|FG004|Overall Study|Withdrawal by Subject|1
7621469|NCT02648724|12032227|FG005|Overall Study|Withdrawal by Subject|0
7621470|NCT02648724|12032228|FG006|Overall Study|Withdrawal by Subject|0
7621471|NCT02648724|12032222|FG000|Overall Study|Progressive disease|2
7621472|NCT02648724|12032223|FG001|Overall Study|Progressive disease|2
7621473|NCT02648724|12032224|FG002|Overall Study|Progressive disease|2
7621474|NCT02648724|12032225|FG003|Overall Study|Progressive disease|3
7621475|NCT02648724|12032226|FG004|Overall Study|Progressive disease|22
7621476|NCT02648724|12032227|FG005|Overall Study|Progressive disease|7
7621477|NCT02648724|12032228|FG006|Overall Study|Progressive disease|8
7621478|NCT02648724|12032222|FG000|Overall Study|Other reason (unknown)|1
7621479|NCT02648724|12032223|FG001|Overall Study|Other reason (unknown)|0
7621480|NCT02648724|12032224|FG002|Overall Study|Other reason (unknown)|0
7621481|NCT02648724|12032225|FG003|Overall Study|Other reason (unknown)|0
7281667|NCT00477971|11497267|FG001|Overall Study|Adverse Event|0
7281668|NCT00477971|11497266|FG000|Overall Study|Death|2
7281669|NCT00477971|11497267|FG001|Overall Study|Death|4
7281670|NCT00477971|11497266|FG000|Overall Study|Alternative treatment|3
7281671|NCT00477971|11497267|FG001|Overall Study|Alternative treatment|1
7281672|NCT00478023|11497278|FG000|Overall Study|Adverse Event|11
7281673|NCT00478023|11497279|FG001|Overall Study|Adverse Event|7
7281674|NCT00478023|11497280|FG002|Overall Study|Adverse Event|8
7281675|NCT00478023|11497281|FG003|Overall Study|Adverse Event|14
7281676|NCT00478023|11497282|FG004|Overall Study|Adverse Event|6
7281677|NCT00478023|11497278|FG000|Overall Study|Death|1
7281678|NCT00478023|11497279|FG001|Overall Study|Death|0
7281679|NCT00478023|11497280|FG002|Overall Study|Death|0
7281680|NCT00478023|11497281|FG003|Overall Study|Death|0
7281681|NCT00478023|11497282|FG004|Overall Study|Death|0
7281682|NCT00478023|11497278|FG000|Overall Study|Lack of Efficacy|11
7281683|NCT00478023|11497279|FG001|Overall Study|Lack of Efficacy|10
7281684|NCT00478023|11497280|FG002|Overall Study|Lack of Efficacy|4
7281685|NCT00478023|11497281|FG003|Overall Study|Lack of Efficacy|5
7281686|NCT00478023|11497282|FG004|Overall Study|Lack of Efficacy|41
7281687|NCT00478023|11497278|FG000|Overall Study|Lost to Follow-up|3
7281688|NCT00478023|11497279|FG001|Overall Study|Lost to Follow-up|1
7281689|NCT00478023|11497280|FG002|Overall Study|Lost to Follow-up|1
7281690|NCT00478023|11497281|FG003|Overall Study|Lost to Follow-up|1
7281691|NCT00478023|11497282|FG004|Overall Study|Lost to Follow-up|0
7281692|NCT00478023|11497278|FG000|Overall Study|Withdrawal by Subject|2
7281693|NCT00478023|11497279|FG001|Overall Study|Withdrawal by Subject|3
7281694|NCT00478023|11497280|FG002|Overall Study|Withdrawal by Subject|2
7281695|NCT00478023|11497281|FG003|Overall Study|Withdrawal by Subject|4
7281696|NCT00478023|11497282|FG004|Overall Study|Withdrawal by Subject|5
7281697|NCT00478023|11497278|FG000|Overall Study|Lack of pain, Technical difficulties|7
7281698|NCT00478023|11497279|FG001|Overall Study|Lack of pain, Technical difficulties|3
7281699|NCT00478023|11497280|FG002|Overall Study|Lack of pain, Technical difficulties|5
7281700|NCT00478023|11497281|FG003|Overall Study|Lack of pain, Technical difficulties|6
7281701|NCT00478023|11497282|FG004|Overall Study|Lack of pain, Technical difficulties|3
7281702|NCT00478140|11497307|FG000|Overall Study|Clinical Disease Progression|1
7281703|NCT00478205|11497327|FG000|Overall Study|Adverse Event|182
7281704|NCT00478205|11497328|FG001|Overall Study|Adverse Event|39
7281705|NCT00478205|11497327|FG000|Overall Study|Medication Non-compliance|9
7281706|NCT00478205|11497328|FG001|Overall Study|Medication Non-compliance|4
7281707|NCT00478205|11497327|FG000|Overall Study|Protocol Violation|15
7281708|NCT00478205|11497328|FG001|Overall Study|Protocol Violation|5
7281709|NCT00478205|11497327|FG000|Overall Study|Request of Investigator or Sponsor|4
7621482|NCT02648724|12032226|FG004|Overall Study|Other reason (unknown)|0
7621483|NCT02648724|12032227|FG005|Overall Study|Other reason (unknown)|0
7621484|NCT02648724|12032228|FG006|Overall Study|Other reason (unknown)|0
7621485|NCT02648724|12032222|FG000|Overall Study|Protocol Violation|0
7621486|NCT02648724|12032223|FG001|Overall Study|Protocol Violation|0
7621487|NCT02648724|12032224|FG002|Overall Study|Protocol Violation|0
7621488|NCT02648724|12032225|FG003|Overall Study|Protocol Violation|0
7621489|NCT02648724|12032226|FG004|Overall Study|Protocol Violation|1
7621490|NCT02648724|12032227|FG005|Overall Study|Protocol Violation|0
7621491|NCT02648724|12032228|FG006|Overall Study|Protocol Violation|0
7621492|NCT02648724|12032222|FG000|Overall Study|Death|0
7621493|NCT02648724|12032223|FG001|Overall Study|Death|0
7621494|NCT02648724|12032224|FG002|Overall Study|Death|0
7621495|NCT02648724|12032225|FG003|Overall Study|Death|0
7621496|NCT02648724|12032226|FG004|Overall Study|Death|0
7621497|NCT02648724|12032227|FG005|Overall Study|Death|0
7621498|NCT02648724|12032228|FG006|Overall Study|Death|3
7621499|NCT02648724|12032222|FG000|Overall Study|Physician Decision|0
7621500|NCT02648724|12032223|FG001|Overall Study|Physician Decision|0
7621501|NCT02648724|12032224|FG002|Overall Study|Physician Decision|0
7621502|NCT02648724|12032225|FG003|Overall Study|Physician Decision|0
7621503|NCT02648724|12032226|FG004|Overall Study|Physician Decision|1
7621504|NCT02648724|12032227|FG005|Overall Study|Physician Decision|0
7621505|NCT02648724|12032228|FG006|Overall Study|Physician Decision|1
7621506|NCT02648724|12032222|FG000|Overall Study|Transferred to named patient program|0
7621507|NCT02648724|12032223|FG001|Overall Study|Transferred to named patient program|0
7621508|NCT02648724|12032224|FG002|Overall Study|Transferred to named patient program|0
7621509|NCT02648724|12032225|FG003|Overall Study|Transferred to named patient program|0
7621510|NCT02648724|12032226|FG004|Overall Study|Transferred to named patient program|0
7621511|NCT02648724|12032227|FG005|Overall Study|Transferred to named patient program|1
7621512|NCT02648724|12032228|FG006|Overall Study|Transferred to named patient program|0
7621525|NCT02554474|12032271|FG000|Overall Study|Protocol Violation|1
7621526|NCT02554474|12032272|FG001|Overall Study|Protocol Violation|1
7281710|NCT00478205|11497328|FG001|Overall Study|Request of Investigator or Sponsor|5
7281711|NCT00478205|11497327|FG000|Overall Study|Withdrawal by Subject|61
7281712|NCT00478205|11497328|FG001|Overall Study|Withdrawal by Subject|22
7281713|NCT00478205|11497327|FG000|Overall Study|Lack of Efficacy|1
7281714|NCT00478205|11497328|FG001|Overall Study|Lack of Efficacy|0
7281715|NCT00478205|11497327|FG000|Overall Study|Other|24
7281716|NCT00478205|11497328|FG001|Overall Study|Other|12
7281717|NCT00478231|11497343|FG000|Overall Study|Death|7
7281718|NCT00478231|11497343|FG000|Overall Study|Lack of Efficacy|47
7281719|NCT00478231|11497343|FG000|Overall Study|Lost to Follow-up|7
7281720|NCT00478231|11497343|FG000|Overall Study|Withdrawal by Subject|6
7281721|NCT00478231|11497343|FG000|Overall Study|Other|9
7281722|NCT00478231|11497343|FG000|Overall Study|Adverse Event|5
7281723|NCT00478231|11497343|FG000|Overall Study|Randomized, not treated|3
7281724|NCT00478244|11497347|FG000|Overall Study|Did not receive transplant|1
7281725|NCT00478257|11497353|FG000|Overall Study|Withdrawal by Subject|8
7281726|NCT00478257|11497354|FG001|Overall Study|Withdrawal by Subject|3
7281727|NCT00478426|11497373|FG000|Overall Study|Withdrawal by Subject|1
7281728|NCT00478608|11497398|FG000|Overall Study|Adverse Event|1
7281729|NCT00478608|11497398|FG000|Overall Study|Serious Adverse Event|14
7281730|NCT00478608|11497398|FG000|Overall Study|Withdrawal by Subject|2
7281731|NCT00478608|11497398|FG000|Overall Study|Protocol Violation|3
7281732|NCT00478647|11497402|FG000|Overall Study|Adverse Event|1
7281733|NCT00478647|11497402|FG000|Overall Study|Withdrawal by Subject|1
7621527|NCT02554474|12032271|FG000|Overall Study|Health issue not related to the study|1
7621528|NCT02554474|12032272|FG001|Overall Study|Health issue not related to the study|0
7621529|NCT02554474|12032271|FG000|Overall Study|Withdrawal by Subject|1
7621530|NCT02554474|12032272|FG001|Overall Study|Withdrawal by Subject|1
7621531|NCT02554318|12032280|FG000|Overall Study|Withdrawal by Subject|10
7621532|NCT02554318|12032281|FG001|Overall Study|Withdrawal by Subject|8
7621533|NCT02508532|12032294|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621534|NCT02508532|12032295|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621535|NCT02508532|12032296|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621536|NCT02508532|12032297|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621537|NCT02508532|12032298|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7281734|NCT00478673|11497406|FG000|30-Days Post-Procedure|Death|2
7621538|NCT02508532|12032299|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7281735|NCT00478673|11497406|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
7621539|NCT02508532|12032300|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
7281736|NCT00478673|11497406|FG000|30-Days Post-Procedure|Missed Visit|7
7281737|NCT00478673|11497406|FG000|12-Months Post-Procedure|Death|23
7281738|NCT00478673|11497406|FG000|12-Months Post-Procedure|Lost to Follow-up|4
7281739|NCT00478673|11497406|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
7281740|NCT00478673|11497406|FG000|12-Months Post-Procedure|Missed Visit|25
7281741|NCT00478673|11497406|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
7281742|NCT00478777|11497410|FG000|Overall Study|Adverse Event|29
7281743|NCT00478777|11497410|FG000|Overall Study|Lack of Efficacy|23
7281744|NCT00478777|11497410|FG000|Overall Study|Withdrawal by Subject|4
7281745|NCT00478777|11497410|FG000|Overall Study|Death|3
7281746|NCT00478777|11497410|FG000|Overall Study|Protocol Violation|3
7281747|NCT00478777|11497410|FG000|Overall Study|Lost to Follow-up|3
7281748|NCT00478777|11497410|FG000|Overall Study|Physician Decision|1
7281749|NCT00478777|11497410|FG000|Overall Study|Intolerance of therapy|1
7281750|NCT00478777|11497410|FG000|Overall Study|Lack of compliance|1
7281751|NCT00478777|11497410|FG000|Overall Study|Lymphocytes infusion|1
7281752|NCT00478777|11497410|FG000|Overall Study|End of therapy|2
7281753|NCT00478777|11497410|FG000|Overall Study|Not treated with lenalidomide|6
7281754|NCT00478881|11497416|FG000|Overall Study|Adverse Event|31
7281755|NCT00478881|11497417|FG001|Overall Study|Adverse Event|12
7281756|NCT00478881|11497416|FG000|Overall Study|Lack of Efficacy|0
7281757|NCT00478881|11497417|FG001|Overall Study|Lack of Efficacy|3
7281758|NCT00478881|11497416|FG000|Overall Study|Lost to Follow-up|0
7281759|NCT00478881|11497417|FG001|Overall Study|Lost to Follow-up|1
7281760|NCT00478881|11497416|FG000|Overall Study|Protocol Violation|2
7281761|NCT00478881|11497417|FG001|Overall Study|Protocol Violation|2
7281762|NCT00478881|11497416|FG000|Overall Study|Withdrawal by Subject|6
7281763|NCT00478881|11497417|FG001|Overall Study|Withdrawal by Subject|2
7281764|NCT00478881|11497416|FG000|Overall Study|Non-Compliance with Study Medication|0
7281765|NCT00478881|11497417|FG001|Overall Study|Non-Compliance with Study Medication|2
7281766|NCT00478933|11497423|FG000|Overall Study|Protocol Violation|22
7281767|NCT00478933|11497423|FG000|Overall Study|Informed consent not verified|3
7281768|NCT00478933|11497423|FG000|Overall Study|Inadequate data available|53
7281769|NCT00479232|11497480|FG000|Overall Study|Adverse Event|0
7281770|NCT00479232|11497481|FG001|Overall Study|Adverse Event|0
7281771|NCT00479232|11497482|FG002|Overall Study|Adverse Event|5
7281772|NCT00479232|11497483|FG003|Overall Study|Adverse Event|0
7281773|NCT00479232|11497484|FG004|Overall Study|Adverse Event|0
7281774|NCT00479232|11497485|FG005|Overall Study|Adverse Event|10
7281775|NCT00479232|11497480|FG000|Overall Study|Deviation from Protocol|0
7281776|NCT00479232|11497481|FG001|Overall Study|Deviation from Protocol|0
7281777|NCT00479232|11497482|FG002|Overall Study|Deviation from Protocol|1
7281778|NCT00479232|11497483|FG003|Overall Study|Deviation from Protocol|0
7281779|NCT00479232|11497484|FG004|Overall Study|Deviation from Protocol|0
7281780|NCT00479232|11497485|FG005|Overall Study|Deviation from Protocol|0
7281781|NCT00479232|11497480|FG000|Overall Study|Lack of Efficacy|0
7281782|NCT00479232|11497481|FG001|Overall Study|Lack of Efficacy|0
7281783|NCT00479232|11497482|FG002|Overall Study|Lack of Efficacy|2
7281784|NCT00479232|11497483|FG003|Overall Study|Lack of Efficacy|0
7281785|NCT00479232|11497484|FG004|Overall Study|Lack of Efficacy|0
7281786|NCT00479232|11497485|FG005|Overall Study|Lack of Efficacy|4
7281787|NCT00479232|11497480|FG000|Overall Study|Physician Decision|0
7281788|NCT00479232|11497481|FG001|Overall Study|Physician Decision|0
7281789|NCT00479232|11497482|FG002|Overall Study|Physician Decision|2
7281790|NCT00479232|11497483|FG003|Overall Study|Physician Decision|0
7281791|NCT00479232|11497484|FG004|Overall Study|Physician Decision|0
7281792|NCT00479232|11497485|FG005|Overall Study|Physician Decision|1
7281793|NCT00479232|11497480|FG000|Overall Study|Progressive Disease|3
7281794|NCT00479232|11497481|FG001|Overall Study|Progressive Disease|1
7281795|NCT00479232|11497482|FG002|Overall Study|Progressive Disease|12
7281796|NCT00479232|11497483|FG003|Overall Study|Progressive Disease|3
7281797|NCT00479232|11497484|FG004|Overall Study|Progressive Disease|3
7281798|NCT00479232|11497485|FG005|Overall Study|Progressive Disease|12
7281799|NCT00479232|11497480|FG000|Overall Study|Withdrew Consent|0
7281800|NCT00479232|11497481|FG001|Overall Study|Withdrew Consent|2
7281801|NCT00479232|11497482|FG002|Overall Study|Withdrew Consent|6
7281802|NCT00479232|11497483|FG003|Overall Study|Withdrew Consent|0
7281803|NCT00479232|11497484|FG004|Overall Study|Withdrew Consent|1
7281804|NCT00479232|11497485|FG005|Overall Study|Withdrew Consent|3
7281805|NCT00479336|11497507|FG000|Overall Study|Adverse Event|1
7281806|NCT00479336|11497508|FG001|Overall Study|Adverse Event|1
7281807|NCT00479336|11497509|FG002|Overall Study|Adverse Event|1
7281808|NCT00479336|11497510|FG003|Overall Study|Adverse Event|3
7281809|NCT00479336|11497507|FG000|Overall Study|Lack of Efficacy|1
7281810|NCT00479336|11497508|FG001|Overall Study|Lack of Efficacy|0
7621540|NCT02508532|12032301|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7281811|NCT00479336|11497509|FG002|Overall Study|Lack of Efficacy|0
7281812|NCT00479336|11497510|FG003|Overall Study|Lack of Efficacy|0
7281813|NCT00479336|11497507|FG000|Overall Study|Protocol Violation|0
7281814|NCT00479336|11497508|FG001|Overall Study|Protocol Violation|1
7281815|NCT00479336|11497509|FG002|Overall Study|Protocol Violation|0
7281816|NCT00479336|11497510|FG003|Overall Study|Protocol Violation|0
7281817|NCT00479336|11497507|FG000|Overall Study|Withdrawal by Subject|1
7281818|NCT00479336|11497508|FG001|Overall Study|Withdrawal by Subject|2
7621541|NCT02508532|12032302|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
7621542|NCT02508532|12032294|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
7621543|NCT02508532|12032295|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
7621544|NCT02508532|12032296|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
7621545|NCT02508532|12032297|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
7621546|NCT02508532|12032298|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
7621547|NCT02508532|12032299|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
7621548|NCT02508532|12032300|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
7621549|NCT02508532|12032301|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
7621550|NCT02508532|12032302|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
7621551|NCT02508532|12032294|FG000|Part 2 - Treatment|Disease Progression|0
7621552|NCT02508532|12032295|FG001|Part 2 - Treatment|Disease Progression|0
7621553|NCT02508532|12032296|FG002|Part 2 - Treatment|Disease Progression|0
7621554|NCT02508532|12032297|FG003|Part 2 - Treatment|Disease Progression|0
7621555|NCT02508532|12032298|FG004|Part 2 - Treatment|Disease Progression|0
7621556|NCT02508532|12032299|FG005|Part 2 - Treatment|Disease Progression|0
7621557|NCT02508532|12032300|FG006|Part 2 - Treatment|Disease Progression|0
7621558|NCT02508532|12032301|FG007|Part 2 - Treatment|Disease Progression|0
7621559|NCT02508532|12032302|FG008|Part 2 - Treatment|Disease Progression|118
7621560|NCT02508532|12032294|FG000|Part 2 - Treatment|Adverse Event|0
7621561|NCT02508532|12032295|FG001|Part 2 - Treatment|Adverse Event|0
7621562|NCT02508532|12032296|FG002|Part 2 - Treatment|Adverse Event|0
7621563|NCT02508532|12032297|FG003|Part 2 - Treatment|Adverse Event|0
7621564|NCT02508532|12032298|FG004|Part 2 - Treatment|Adverse Event|0
7621565|NCT02508532|12032299|FG005|Part 2 - Treatment|Adverse Event|0
7621566|NCT02508532|12032300|FG006|Part 2 - Treatment|Adverse Event|0
7621567|NCT02508532|12032301|FG007|Part 2 - Treatment|Adverse Event|0
7621568|NCT02508532|12032302|FG008|Part 2 - Treatment|Adverse Event|49
7621569|NCT02508532|12032294|FG000|Part 2 - Treatment|Physician Decision|0
7621570|NCT02508532|12032295|FG001|Part 2 - Treatment|Physician Decision|0
7621571|NCT02508532|12032296|FG002|Part 2 - Treatment|Physician Decision|0
7621572|NCT02508532|12032297|FG003|Part 2 - Treatment|Physician Decision|0
7621573|NCT02508532|12032298|FG004|Part 2 - Treatment|Physician Decision|0
7621574|NCT02508532|12032299|FG005|Part 2 - Treatment|Physician Decision|0
7621575|NCT02508532|12032300|FG006|Part 2 - Treatment|Physician Decision|0
7621576|NCT02508532|12032301|FG007|Part 2 - Treatment|Physician Decision|0
7621577|NCT02508532|12032302|FG008|Part 2 - Treatment|Physician Decision|12
7621578|NCT02508532|12032294|FG000|Part 2 - Treatment|Administrative|0
7621579|NCT02508532|12032295|FG001|Part 2 - Treatment|Administrative|0
7621580|NCT02508532|12032296|FG002|Part 2 - Treatment|Administrative|0
7281819|NCT00479336|11497509|FG002|Overall Study|Withdrawal by Subject|0
7281820|NCT00479336|11497510|FG003|Overall Study|Withdrawal by Subject|0
7281821|NCT00479336|11497507|FG000|Overall Study|Physician Decision|0
7281822|NCT00479336|11497508|FG001|Overall Study|Physician Decision|1
7281823|NCT00479336|11497509|FG002|Overall Study|Physician Decision|0
7281824|NCT00479336|11497510|FG003|Overall Study|Physician Decision|2
7281825|NCT00479336|11497507|FG000|Overall Study|Resolution of all hepatic edema findings|1
7281826|NCT00479336|11497508|FG001|Overall Study|Resolution of all hepatic edema findings|1
7281827|NCT00479336|11497509|FG002|Overall Study|Resolution of all hepatic edema findings|0
7281828|NCT00479336|11497510|FG003|Overall Study|Resolution of all hepatic edema findings|0
7281829|NCT00479388|11497522|FG000|Overall Study|Adverse Event|90
7281830|NCT00479388|11497523|FG001|Overall Study|Adverse Event|45
7281831|NCT00479388|11497522|FG000|Overall Study|Lost to Follow-up|0
7281832|NCT00479388|11497523|FG001|Overall Study|Lost to Follow-up|2
7281833|NCT00479388|11497522|FG000|Overall Study|Protocol Violation|10
7281834|NCT00479388|11497523|FG001|Overall Study|Protocol Violation|9
7281835|NCT00479388|11497522|FG000|Overall Study|Withdrawal by Subject|32
7281836|NCT00479388|11497523|FG001|Overall Study|Withdrawal by Subject|17
7281837|NCT00479401|11497532|FG000|Overall Study|Adverse Event|24
7281838|NCT00479401|11497533|FG001|Overall Study|Adverse Event|20
7281839|NCT00479401|11497534|FG002|Overall Study|Adverse Event|4
7281840|NCT00479401|11497532|FG000|Overall Study|Lack of Efficacy|2
7281841|NCT00479401|11497533|FG001|Overall Study|Lack of Efficacy|2
7281842|NCT00479401|11497534|FG002|Overall Study|Lack of Efficacy|4
7281843|NCT00479401|11497532|FG000|Overall Study|Protocol Violation|2
7281844|NCT00479401|11497533|FG001|Overall Study|Protocol Violation|1
7281845|NCT00479401|11497534|FG002|Overall Study|Protocol Violation|1
7281846|NCT00479401|11497532|FG000|Overall Study|Lost to Follow-up|1
7281847|NCT00479401|11497533|FG001|Overall Study|Lost to Follow-up|1
7281848|NCT00479401|11497534|FG002|Overall Study|Lost to Follow-up|1
7281849|NCT00479401|11497532|FG000|Overall Study|Withdrawal by Subject|16
7281850|NCT00479401|11497533|FG001|Overall Study|Withdrawal by Subject|10
7281851|NCT00479401|11497534|FG002|Overall Study|Withdrawal by Subject|2
7281852|NCT00479401|11497532|FG000|Overall Study|Exclusion criteria, relocation|4
7621581|NCT02508532|12032297|FG003|Part 2 - Treatment|Administrative|0
7621582|NCT02508532|12032298|FG004|Part 2 - Treatment|Administrative|0
7281853|NCT00479401|11497533|FG001|Overall Study|Exclusion criteria, relocation|3
7281854|NCT00479401|11497534|FG002|Overall Study|Exclusion criteria, relocation|0
7621583|NCT02508532|12032299|FG005|Part 2 - Treatment|Administrative|0
7621584|NCT02508532|12032300|FG006|Part 2 - Treatment|Administrative|0
7621585|NCT02508532|12032301|FG007|Part 2 - Treatment|Administrative|0
7621586|NCT02508532|12032302|FG008|Part 2 - Treatment|Administrative|3
7621587|NCT02508532|12032294|FG000|Part 2 - Treatment|Sponsor Decision|0
7621588|NCT02508532|12032295|FG001|Part 2 - Treatment|Sponsor Decision|0
7621589|NCT02508532|12032296|FG002|Part 2 - Treatment|Sponsor Decision|0
7621590|NCT02508532|12032297|FG003|Part 2 - Treatment|Sponsor Decision|0
7621591|NCT02508532|12032298|FG004|Part 2 - Treatment|Sponsor Decision|0
7621592|NCT02508532|12032299|FG005|Part 2 - Treatment|Sponsor Decision|0
7621593|NCT02508532|12032300|FG006|Part 2 - Treatment|Sponsor Decision|0
7621594|NCT02508532|12032301|FG007|Part 2 - Treatment|Sponsor Decision|0
7621595|NCT02508532|12032302|FG008|Part 2 - Treatment|Sponsor Decision|28
7621596|NCT02508532|12032294|FG000|Part 2 - Treatment|Death|0
7621597|NCT02508532|12032295|FG001|Part 2 - Treatment|Death|0
7621598|NCT02508532|12032296|FG002|Part 2 - Treatment|Death|0
7621599|NCT02508532|12032297|FG003|Part 2 - Treatment|Death|0
7621600|NCT02508532|12032298|FG004|Part 2 - Treatment|Death|0
7621601|NCT02508532|12032299|FG005|Part 2 - Treatment|Death|0
7621602|NCT02508532|12032300|FG006|Part 2 - Treatment|Death|0
7621603|NCT02508532|12032301|FG007|Part 2 - Treatment|Death|0
7621604|NCT02508532|12032302|FG008|Part 2 - Treatment|Death|1
7621605|NCT02508532|12032294|FG000|Part 2 - Treatment|Withdrawal by Subject|0
7621606|NCT02508532|12032295|FG001|Part 2 - Treatment|Withdrawal by Subject|0
7621607|NCT02508532|12032296|FG002|Part 2 - Treatment|Withdrawal by Subject|0
7621608|NCT02508532|12032297|FG003|Part 2 - Treatment|Withdrawal by Subject|0
7621609|NCT02508532|12032298|FG004|Part 2 - Treatment|Withdrawal by Subject|0
7621610|NCT02508532|12032299|FG005|Part 2 - Treatment|Withdrawal by Subject|0
7621611|NCT02508532|12032300|FG006|Part 2 - Treatment|Withdrawal by Subject|0
7621612|NCT02508532|12032301|FG007|Part 2 - Treatment|Withdrawal by Subject|0
7621613|NCT02508532|12032302|FG008|Part 2 - Treatment|Withdrawal by Subject|6
7621614|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
7621615|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
7621616|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
7621617|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
7621618|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
7621619|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
7621620|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
7621621|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
7621622|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
7621623|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
7621624|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
7621625|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
7621626|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
7621627|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
7621628|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
7621629|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
7621630|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
7621631|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
7621632|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Death|0
7621633|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Death|4
7621634|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Death|2
7621635|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Death|4
7621636|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Death|3
7621637|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Death|0
7621638|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Death|0
7621639|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Death|1
7621640|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Death|111
7621641|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621642|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621643|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
7621644|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621645|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621646|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621647|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621648|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
7621649|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
7621650|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621651|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621652|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621653|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621654|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621655|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621656|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621657|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
7621658|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
7621659|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
7621660|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
7621661|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
7621662|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
7621663|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
7621664|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
7621665|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
7621666|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
7621667|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
7621668|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621669|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621670|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621671|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621672|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621673|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621674|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621675|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
7621676|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
7621677|NCT02508532|12032294|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621678|NCT02508532|12032295|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621679|NCT02508532|12032296|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621680|NCT02508532|12032297|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621681|NCT02508532|12032298|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
7621682|NCT02508532|12032299|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
7621683|NCT02508532|12032300|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
7621684|NCT02508532|12032301|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
7621685|NCT02508532|12032302|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68
7621692|NCT02426684|12032339|FG000|Overall Study|Physician Decision|1
7281855|NCT00479466|11497548|FG000|Overall Study|Adverse Event|5
7281856|NCT00479466|11497549|FG001|Overall Study|Adverse Event|1
7281857|NCT00479466|11497550|FG002|Overall Study|Adverse Event|0
7281858|NCT00479466|11497551|FG003|Overall Study|Adverse Event|1
7281859|NCT00479466|11497552|FG004|Overall Study|Adverse Event|2
7281860|NCT00479466|11497553|FG005|Overall Study|Adverse Event|0
7281861|NCT00479466|11497548|FG000|Overall Study|Hyperglycemia|0
7281862|NCT00479466|11497549|FG001|Overall Study|Hyperglycemia|0
7281863|NCT00479466|11497550|FG002|Overall Study|Hyperglycemia|0
7281864|NCT00479466|11497551|FG003|Overall Study|Hyperglycemia|0
7281865|NCT00479466|11497552|FG004|Overall Study|Hyperglycemia|0
7281866|NCT00479466|11497553|FG005|Overall Study|Hyperglycemia|1
7281867|NCT00479466|11497548|FG000|Overall Study|Lack of Efficacy|2
7281868|NCT00479466|11497549|FG001|Overall Study|Lack of Efficacy|0
7281869|NCT00479466|11497550|FG002|Overall Study|Lack of Efficacy|1
7281870|NCT00479466|11497551|FG003|Overall Study|Lack of Efficacy|0
7281871|NCT00479466|11497552|FG004|Overall Study|Lack of Efficacy|0
7281872|NCT00479466|11497553|FG005|Overall Study|Lack of Efficacy|0
7281873|NCT00479466|11497548|FG000|Overall Study|Lost to Follow-up|0
7281874|NCT00479466|11497549|FG001|Overall Study|Lost to Follow-up|1
7281875|NCT00479466|11497550|FG002|Overall Study|Lost to Follow-up|1
7621705|NCT02337751|12032358|FG000|Overall Study|Pretreatment Event/Adverse Event|2
7621706|NCT02337751|12032359|FG001|Overall Study|Pretreatment Event/Adverse Event|3
7621707|NCT02337751|12032358|FG000|Overall Study|Voluntary Withdrawal|6
7621708|NCT02337751|12032359|FG001|Overall Study|Voluntary Withdrawal|8
7621709|NCT02337751|12032358|FG000|Overall Study|Lack of Efficacy|2
7621710|NCT02337751|12032359|FG001|Overall Study|Lack of Efficacy|5
7621711|NCT02337751|12032358|FG000|Overall Study|Investigator's Judgement|1
7621712|NCT02337751|12032359|FG001|Overall Study|Investigator's Judgement|0
7621713|NCT02337725|12032368|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
7621714|NCT02337725|12032369|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
7621715|NCT02337725|12032368|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
7621716|NCT02337725|12032369|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
7621717|NCT02337725|12032368|FG000|Overall Study|Major Protocol Deviation|0
7621718|NCT02337725|12032369|FG001|Overall Study|Major Protocol Deviation|1
7621719|NCT02337725|12032368|FG000|Overall Study|Voluntary Withdrawal|14
7621720|NCT02337725|12032369|FG001|Overall Study|Voluntary Withdrawal|3
7621721|NCT02337725|12032368|FG000|Overall Study|Lack of Efficacy|4
7621722|NCT02337725|12032369|FG001|Overall Study|Lack of Efficacy|0
7621723|NCT02332655|12032375|FG000|Overall Study|Lack of Efficacy|1
7621724|NCT02317705|12032379|FG000|Overall Study|Withdrawal by Subject|3
7621725|NCT02317705|12032379|FG000|Overall Study|Physician Decision|1
7621726|NCT02317705|12032379|FG000|Overall Study|Drug not usable|1
7281876|NCT00479466|11497551|FG003|Overall Study|Lost to Follow-up|0
7281877|NCT00479466|11497552|FG004|Overall Study|Lost to Follow-up|2
7281878|NCT00479466|11497553|FG005|Overall Study|Lost to Follow-up|2
7281879|NCT00479466|11497548|FG000|Overall Study|Physician Decision|2
7281880|NCT00479466|11497549|FG001|Overall Study|Physician Decision|1
7281881|NCT00479466|11497550|FG002|Overall Study|Physician Decision|1
7281882|NCT00479466|11497551|FG003|Overall Study|Physician Decision|0
7281883|NCT00479466|11497552|FG004|Overall Study|Physician Decision|0
7281884|NCT00479466|11497553|FG005|Overall Study|Physician Decision|0
7281885|NCT00479466|11497548|FG000|Overall Study|Pregnancy|0
7281886|NCT00479466|11497549|FG001|Overall Study|Pregnancy|0
7281887|NCT00479466|11497550|FG002|Overall Study|Pregnancy|0
7281888|NCT00479466|11497551|FG003|Overall Study|Pregnancy|0
7281889|NCT00479466|11497552|FG004|Overall Study|Pregnancy|1
7281890|NCT00479466|11497553|FG005|Overall Study|Pregnancy|0
7281891|NCT00479466|11497548|FG000|Overall Study|Protocol Violation|1
7281892|NCT00479466|11497549|FG001|Overall Study|Protocol Violation|0
7281893|NCT00479466|11497550|FG002|Overall Study|Protocol Violation|0
7281894|NCT00479466|11497551|FG003|Overall Study|Protocol Violation|0
7281895|NCT00479466|11497552|FG004|Overall Study|Protocol Violation|0
7281896|NCT00479466|11497553|FG005|Overall Study|Protocol Violation|0
7281897|NCT00479466|11497548|FG000|Overall Study|Withdrawal by Subject|3
7281898|NCT00479466|11497549|FG001|Overall Study|Withdrawal by Subject|5
7281899|NCT00479466|11497550|FG002|Overall Study|Withdrawal by Subject|0
7281900|NCT00479466|11497551|FG003|Overall Study|Withdrawal by Subject|2
7281901|NCT00479466|11497552|FG004|Overall Study|Withdrawal by Subject|3
7281902|NCT00479466|11497553|FG005|Overall Study|Withdrawal by Subject|1
7281903|NCT00479557|11497574|FG000|Overall Study|Death|0
7621727|NCT02272803|12032385|FG000|Overall Study|Disease progression|16
7621728|NCT02272803|12032386|FG001|Overall Study|Disease progression|8
7621729|NCT02272803|12032385|FG000|Overall Study|Adverse Event unrelated to study drug|3
7621730|NCT02272803|12032386|FG001|Overall Study|Adverse Event unrelated to study drug|5
7621731|NCT02272803|12032385|FG000|Overall Study|Study drug toxicity|4
7281904|NCT00479557|11497575|FG001|Overall Study|Death|0
7281905|NCT00479557|11497576|FG002|Overall Study|Death|0
7281906|NCT00479557|11497577|FG003|Overall Study|Death|0
7281907|NCT00479557|11497578|FG004|Overall Study|Death|0
7281908|NCT00479557|11497579|FG005|Overall Study|Death|1
7281909|NCT00479557|11497580|FG006|Overall Study|Death|0
7281910|NCT00479557|11497574|FG000|Overall Study|Lack of Efficacy|1
7281911|NCT00479557|11497575|FG001|Overall Study|Lack of Efficacy|0
7281912|NCT00479557|11497576|FG002|Overall Study|Lack of Efficacy|0
7281913|NCT00479557|11497577|FG003|Overall Study|Lack of Efficacy|0
7281914|NCT00479557|11497578|FG004|Overall Study|Lack of Efficacy|0
7281915|NCT00479557|11497579|FG005|Overall Study|Lack of Efficacy|0
7281916|NCT00479557|11497580|FG006|Overall Study|Lack of Efficacy|0
7281917|NCT00479557|11497574|FG000|Overall Study|Lost to Follow-up|0
7281918|NCT00479557|11497575|FG001|Overall Study|Lost to Follow-up|2
7281919|NCT00479557|11497576|FG002|Overall Study|Lost to Follow-up|0
7281920|NCT00479557|11497577|FG003|Overall Study|Lost to Follow-up|2
7281921|NCT00479557|11497578|FG004|Overall Study|Lost to Follow-up|0
7281922|NCT00479557|11497579|FG005|Overall Study|Lost to Follow-up|0
7281923|NCT00479557|11497580|FG006|Overall Study|Lost to Follow-up|0
7281924|NCT00479557|11497574|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
7281925|NCT00479557|11497575|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
7281926|NCT00479557|11497576|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
7281927|NCT00479557|11497577|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
7281928|NCT00479557|11497578|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
7281929|NCT00479557|11497579|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
7281930|NCT00479557|11497580|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
7281931|NCT00479557|11497574|FG000|Overall Study|AE not related to Study Drug|1
7281932|NCT00479557|11497575|FG001|Overall Study|AE not related to Study Drug|3
7281933|NCT00479557|11497576|FG002|Overall Study|AE not related to Study Drug|0
7281934|NCT00479557|11497577|FG003|Overall Study|AE not related to Study Drug|0
7281935|NCT00479557|11497578|FG004|Overall Study|AE not related to Study Drug|2
7281936|NCT00479557|11497579|FG005|Overall Study|AE not related to Study Drug|2
7281937|NCT00479557|11497580|FG006|Overall Study|AE not related to Study Drug|1
7281938|NCT00479557|11497574|FG000|Overall Study|Caregiver Request|2
7281939|NCT00479557|11497575|FG001|Overall Study|Caregiver Request|2
7281940|NCT00479557|11497576|FG002|Overall Study|Caregiver Request|2
7281941|NCT00479557|11497577|FG003|Overall Study|Caregiver Request|0
7281942|NCT00479557|11497578|FG004|Overall Study|Caregiver Request|1
7281943|NCT00479557|11497579|FG005|Overall Study|Caregiver Request|2
7281944|NCT00479557|11497580|FG006|Overall Study|Caregiver Request|0
7281945|NCT00479557|11497574|FG000|Overall Study|Investigator Request|0
7281946|NCT00479557|11497575|FG001|Overall Study|Investigator Request|0
7281947|NCT00479557|11497576|FG002|Overall Study|Investigator Request|1
7281948|NCT00479557|11497577|FG003|Overall Study|Investigator Request|0
7281949|NCT00479557|11497578|FG004|Overall Study|Investigator Request|0
7281950|NCT00479557|11497579|FG005|Overall Study|Investigator Request|0
7281951|NCT00479557|11497580|FG006|Overall Study|Investigator Request|0
7281952|NCT00479557|11497574|FG000|Overall Study|Subject Request|3
7281953|NCT00479557|11497575|FG001|Overall Study|Subject Request|0
7281954|NCT00479557|11497576|FG002|Overall Study|Subject Request|1
7281955|NCT00479557|11497577|FG003|Overall Study|Subject Request|1
7281956|NCT00479557|11497578|FG004|Overall Study|Subject Request|1
7281957|NCT00479557|11497579|FG005|Overall Study|Subject Request|4
7281958|NCT00479557|11497580|FG006|Overall Study|Subject Request|1
7281959|NCT00479557|11497574|FG000|Overall Study|Other|2
7281960|NCT00479557|11497575|FG001|Overall Study|Other|3
7281961|NCT00479557|11497576|FG002|Overall Study|Other|1
7281962|NCT00479557|11497577|FG003|Overall Study|Other|0
7281963|NCT00479557|11497578|FG004|Overall Study|Other|0
7281964|NCT00479557|11497579|FG005|Overall Study|Other|3
7281965|NCT00479557|11497580|FG006|Overall Study|Other|0
7469850|NCT01927341|11771715|FG002|Phase 2|New cancer therapy|0
7469851|NCT01927341|11771716|FG003|Phase 2|New cancer therapy|4
7469852|NCT01927341|11771717|FG004|Phase 2|New cancer therapy|1
7469853|NCT01927341|11771713|FG000|Phase 2|Disease progression|0
7469854|NCT01927341|11771714|FG001|Phase 2|Disease progression|1
7469855|NCT01927341|11771715|FG002|Phase 2|Disease progression|1
7469856|NCT01927341|11771716|FG003|Phase 2|Disease progression|1
7469857|NCT01927341|11771717|FG004|Phase 2|Disease progression|0
7469858|NCT01927341|11771713|FG000|Phase 2|Follow-up completed|0
7469859|NCT01927341|11771714|FG001|Phase 2|Follow-up completed|6
7469860|NCT01927341|11771715|FG002|Phase 2|Follow-up completed|3
7469861|NCT01927341|11771716|FG003|Phase 2|Follow-up completed|5
7621732|NCT02272803|12032386|FG001|Overall Study|Study drug toxicity|9
7469862|NCT01927341|11771717|FG004|Phase 2|Follow-up completed|2
7621733|NCT02272803|12032385|FG000|Overall Study|Participant request to discontinue study treatment|3
7469863|NCT01927367|11771735|FG000|Overall Study|Withdrawal by Subject|7
7469864|NCT01927367|11771736|FG001|Overall Study|Withdrawal by Subject|4
7469865|NCT01927367|11771735|FG000|Overall Study|No baseline data|0
7621734|NCT02272803|12032386|FG001|Overall Study|Participant request to discontinue study treatment|7
7621735|NCT02272803|12032385|FG000|Overall Study|Maximum clinical benefit|4
7621736|NCT02272803|12032386|FG001|Overall Study|Maximum clinical benefit|2
7621737|NCT02272803|12032385|FG000|Overall Study|Poor/non-compliance|2
7621738|NCT02272803|12032386|FG001|Overall Study|Poor/non-compliance|2
7621739|NCT02272803|12032385|FG000|Overall Study|Withdrawal by Subject|2
7621740|NCT02272803|12032386|FG001|Overall Study|Withdrawal by Subject|1
7621741|NCT02272803|12032385|FG000|Overall Study|Death|0
7621742|NCT02272803|12032386|FG001|Overall Study|Death|1
7621743|NCT02272803|12032385|FG000|Overall Study|Other reasons|1
7621744|NCT02272803|12032386|FG001|Overall Study|Other reasons|3
7621745|NCT02272803|12032385|FG000|Overall Study|Administrative reason by sponsor|5
7621746|NCT02272803|12032386|FG001|Overall Study|Administrative reason by sponsor|4
7281966|NCT00479674|11497602|FG000|Overall Study|Adverse Event|18
7281967|NCT00479674|11497602|FG000|Overall Study|Withdrawal by Subject|6
7281968|NCT00479674|11497602|FG000|Overall Study|Physician Decision|14
7281969|NCT00479674|11497602|FG000|Overall Study|none provided|3
7281970|NCT00479687|11497608|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7281971|NCT00479687|11497609|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
7281972|NCT00479687|11497610|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
7281973|NCT00479687|11497608|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
7281974|NCT00479687|11497609|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
7469866|NCT01927367|11771736|FG001|Overall Study|No baseline data|1
7621754|NCT01994382|12032470|FG000|Overall Study|Informed consent withdrawn|0
7621755|NCT01994382|12032471|FG001|Overall Study|Informed consent withdrawn|0
7621756|NCT01994382|12032472|FG002|Overall Study|Informed consent withdrawn|0
7621757|NCT01994382|12032473|FG003|Overall Study|Informed consent withdrawn|0
7621758|NCT01994382|12032474|FG004|Overall Study|Informed consent withdrawn|0
7621759|NCT01994382|12032475|FG005|Overall Study|Informed consent withdrawn|0
7621760|NCT01994382|12032476|FG006|Overall Study|Informed consent withdrawn|1
7621761|NCT01994382|12032477|FG007|Overall Study|Informed consent withdrawn|0
7621762|NCT01994382|12032478|FG008|Overall Study|Informed consent withdrawn|0
7621763|NCT01994382|12032479|FG009|Overall Study|Informed consent withdrawn|0
7621764|NCT01994382|12032480|FG010|Overall Study|Informed consent withdrawn|0
7281975|NCT00479687|11497610|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
7281976|NCT00479687|11497608|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
7281977|NCT00479687|11497609|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
7281978|NCT00479687|11497610|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
7281979|NCT00479687|11497608|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
7281980|NCT00479687|11497609|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7281981|NCT00479687|11497610|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
7621765|NCT01994382|12032481|FG011|Overall Study|Informed consent withdrawn|0
7621766|NCT01994382|12032482|FG012|Overall Study|Informed consent withdrawn|0
7621767|NCT01994382|12032483|FG013|Overall Study|Informed consent withdrawn|0
7621768|NCT01994382|12032484|FG014|Overall Study|Informed consent withdrawn|0
7621769|NCT01994382|12032485|FG015|Overall Study|Informed consent withdrawn|0
7621770|NCT01994382|12032486|FG016|Overall Study|Informed consent withdrawn|0
7621771|NCT01994382|12032470|FG000|Overall Study|Progressive disease|3
7621772|NCT01994382|12032471|FG001|Overall Study|Progressive disease|4
7621773|NCT01994382|12032472|FG002|Overall Study|Progressive disease|4
7621774|NCT01994382|12032473|FG003|Overall Study|Progressive disease|3
7621775|NCT01994382|12032474|FG004|Overall Study|Progressive disease|2
7281982|NCT00479687|11497608|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
7281983|NCT00479687|11497609|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
7281984|NCT00479687|11497610|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
7281985|NCT00479687|11497608|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7281986|NCT00479687|11497609|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
7281987|NCT00479687|11497610|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
7281988|NCT00479687|11497608|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7281989|NCT00479687|11497609|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
7281990|NCT00479687|11497610|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
7281991|NCT00479687|11497608|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7281992|NCT00479687|11497609|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
7281993|NCT00479687|11497610|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
7281994|NCT00479687|11497608|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7281995|NCT00479687|11497609|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
7282040|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Other|5
7281996|NCT00479687|11497610|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
7281997|NCT00479856|11497617|FG000|Overall Study|Adverse Event|1
7281998|NCT00479856|11497617|FG000|Overall Study|Withdrawal by Subject|1
7281999|NCT00479856|11497617|FG000|Overall Study|Physician Decision|1
7282000|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
7282001|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
7282002|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
7282003|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
7282004|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
7282005|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7282006|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7282007|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
7282008|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
7282009|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7282010|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
7282011|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
7282012|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
7282013|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
7282014|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
7282015|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
7282016|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
7282017|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
7282018|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
7282019|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
7282020|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
7282021|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
7282022|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
7282023|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
7621776|NCT01994382|12032475|FG005|Overall Study|Progressive disease|3
7621777|NCT01994382|12032476|FG006|Overall Study|Progressive disease|3
7621778|NCT01994382|12032477|FG007|Overall Study|Progressive disease|6
7621779|NCT01994382|12032478|FG008|Overall Study|Progressive disease|2
7621780|NCT01994382|12032479|FG009|Overall Study|Progressive disease|2
7621781|NCT01994382|12032480|FG010|Overall Study|Progressive disease|13
7621782|NCT01994382|12032481|FG011|Overall Study|Progressive disease|8
7621783|NCT01994382|12032482|FG012|Overall Study|Progressive disease|7
7621784|NCT01994382|12032483|FG013|Overall Study|Progressive disease|3
7621785|NCT01994382|12032484|FG014|Overall Study|Progressive disease|6
7621786|NCT01994382|12032485|FG015|Overall Study|Progressive disease|44
7282024|NCT00479882|11497625|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
7621787|NCT01994382|12032486|FG016|Overall Study|Progressive disease|28
7621788|NCT01994382|12032470|FG000|Overall Study|Physician Decision|0
7621789|NCT01994382|12032471|FG001|Overall Study|Physician Decision|1
7621790|NCT01994382|12032472|FG002|Overall Study|Physician Decision|0
7621791|NCT01994382|12032473|FG003|Overall Study|Physician Decision|0
7621792|NCT01994382|12032474|FG004|Overall Study|Physician Decision|0
7621793|NCT01994382|12032475|FG005|Overall Study|Physician Decision|0
7621794|NCT01994382|12032476|FG006|Overall Study|Physician Decision|0
7621795|NCT01994382|12032477|FG007|Overall Study|Physician Decision|0
7621796|NCT01994382|12032478|FG008|Overall Study|Physician Decision|0
7621797|NCT01994382|12032479|FG009|Overall Study|Physician Decision|0
7621798|NCT01994382|12032480|FG010|Overall Study|Physician Decision|3
7621799|NCT01994382|12032481|FG011|Overall Study|Physician Decision|1
7282025|NCT00479882|11497626|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7282026|NCT00479882|11497627|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
7282027|NCT00479882|11497628|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
7282028|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7282029|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
7282030|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
7282031|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
7282032|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
7282033|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
7621800|NCT01994382|12032482|FG012|Overall Study|Physician Decision|1
7621801|NCT01994382|12032483|FG013|Overall Study|Physician Decision|0
7621802|NCT01994382|12032484|FG014|Overall Study|Physician Decision|1
7621803|NCT01994382|12032485|FG015|Overall Study|Physician Decision|4
7621804|NCT01994382|12032486|FG016|Overall Study|Physician Decision|2
7621805|NCT01994382|12032470|FG000|Overall Study|Death|0
7621806|NCT01994382|12032471|FG001|Overall Study|Death|0
7621807|NCT01994382|12032472|FG002|Overall Study|Death|0
7282034|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7282035|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
7282036|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7282037|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
7282038|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7282039|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
7282041|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Other|0
7282042|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Other|2
7282043|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Other|2
7282044|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
7282045|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
7282046|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
7282047|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
7282048|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7282049|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7282050|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
7282051|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
7282052|NCT00479882|11497625|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7282053|NCT00479882|11497626|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7282054|NCT00479882|11497627|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
7282055|NCT00479882|11497628|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
7282056|NCT00480025|11497656|FG000|Overall Study|Protocol Violation|12
7282057|NCT00480025|11497657|FG001|Overall Study|Protocol Violation|7
7282058|NCT00480025|11497656|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
7282059|NCT00480025|11497657|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
7282060|NCT00480025|11497656|FG000|Overall Study|Disease Progression / Recurrence|449
7282061|NCT00480025|11497657|FG001|Overall Study|Disease Progression / Recurrence|224
7282062|NCT00480025|11497656|FG000|Overall Study|Adverse Event|44
7282063|NCT00480025|11497657|FG001|Overall Study|Adverse Event|12
7282064|NCT00480025|11497656|FG000|Overall Study|Other|70
7282065|NCT00480025|11497657|FG001|Overall Study|Other|29
7621808|NCT01994382|12032473|FG003|Overall Study|Death|0
7621809|NCT01994382|12032474|FG004|Overall Study|Death|1
7621810|NCT01994382|12032475|FG005|Overall Study|Death|0
7621811|NCT01994382|12032476|FG006|Overall Study|Death|0
7621812|NCT01994382|12032477|FG007|Overall Study|Death|0
7621813|NCT01994382|12032478|FG008|Overall Study|Death|1
7621814|NCT01994382|12032479|FG009|Overall Study|Death|1
7621815|NCT01994382|12032480|FG010|Overall Study|Death|0
7621816|NCT01994382|12032481|FG011|Overall Study|Death|0
7621817|NCT01994382|12032482|FG012|Overall Study|Death|0
7621818|NCT01994382|12032483|FG013|Overall Study|Death|0
7621819|NCT01994382|12032484|FG014|Overall Study|Death|0
7621820|NCT01994382|12032485|FG015|Overall Study|Death|1
7621821|NCT01994382|12032486|FG016|Overall Study|Death|0
7621822|NCT01994382|12032470|FG000|Overall Study|Adverse Event|0
7621823|NCT01994382|12032471|FG001|Overall Study|Adverse Event|1
7621824|NCT01994382|12032472|FG002|Overall Study|Adverse Event|2
7621825|NCT01994382|12032473|FG003|Overall Study|Adverse Event|0
7282066|NCT00480025|11497656|FG000|Overall Study|SAE including intercurrent illness|76
7282067|NCT00480025|11497657|FG001|Overall Study|SAE including intercurrent illness|42
7282068|NCT00480077|11497671|FG000|Overall Study|Death|19
7282069|NCT00480077|11497672|FG001|Overall Study|Death|15
7621826|NCT01994382|12032474|FG004|Overall Study|Adverse Event|0
7621827|NCT01994382|12032475|FG005|Overall Study|Adverse Event|0
7621828|NCT01994382|12032476|FG006|Overall Study|Adverse Event|0
7621829|NCT01994382|12032477|FG007|Overall Study|Adverse Event|0
7621830|NCT01994382|12032478|FG008|Overall Study|Adverse Event|0
7621831|NCT01994382|12032479|FG009|Overall Study|Adverse Event|0
7621832|NCT01994382|12032480|FG010|Overall Study|Adverse Event|15
7621833|NCT01994382|12032481|FG011|Overall Study|Adverse Event|2
7282070|NCT00480077|11497671|FG000|Overall Study|early exit|12
7282071|NCT00480077|11497672|FG001|Overall Study|early exit|11
7282072|NCT00480324|11497680|FG000|Overall Study|Adverse Event|1
7282073|NCT00480324|11497681|FG001|Overall Study|Adverse Event|1
7282074|NCT00480324|11497680|FG000|Overall Study|Protocol Violation|0
7282075|NCT00480324|11497681|FG001|Overall Study|Protocol Violation|1
7282076|NCT00480324|11497680|FG000|Overall Study|Withdrawal by Subject|14
7282077|NCT00480324|11497681|FG001|Overall Study|Withdrawal by Subject|5
7621834|NCT01994382|12032482|FG012|Overall Study|Adverse Event|7
7621835|NCT01994382|12032483|FG013|Overall Study|Adverse Event|3
7282078|NCT00480324|11497680|FG000|Overall Study|Lost to Follow-up|17
7282079|NCT00480324|11497681|FG001|Overall Study|Lost to Follow-up|8
7282080|NCT00480324|11497680|FG000|Overall Study|Subject's mother pregnant|0
7282081|NCT00480324|11497681|FG001|Overall Study|Subject's mother pregnant|1
7282082|NCT00480441|11497689|FG000|Screening|Not Eligible|37
7282083|NCT00480441|11497690|FG001|Screening|Not Eligible|0
7282084|NCT00480441|11497691|FG002|Screening|Not Eligible|0
7282085|NCT00480441|11497689|FG000|Baseline Functional MRI|Functional MRI data not usable|4
7282086|NCT00480441|11497690|FG001|Baseline Functional MRI|Functional MRI data not usable|0
7282087|NCT00480441|11497691|FG002|Baseline Functional MRI|Functional MRI data not usable|0
7282088|NCT00480441|11497689|FG000|Baseline Functional MRI|Lost to Follow-up|4
7282089|NCT00480441|11497690|FG001|Baseline Functional MRI|Lost to Follow-up|0
7282090|NCT00480441|11497691|FG002|Baseline Functional MRI|Lost to Follow-up|0
7282091|NCT00480441|11497689|FG000|Baseline Functional MRI|physical contraindication|4
7282092|NCT00480441|11497690|FG001|Baseline Functional MRI|physical contraindication|0
7282093|NCT00480441|11497691|FG002|Baseline Functional MRI|physical contraindication|0
7282094|NCT00480441|11497689|FG000|Randomization|Lost to Follow-up|0
7282095|NCT00480441|11497690|FG001|Randomization|Lost to Follow-up|7
7282096|NCT00480441|11497691|FG002|Randomization|Lost to Follow-up|2
7282097|NCT00480493|11497700|FG000|Overall Study|moved|2
7282098|NCT00480493|11497701|FG001|Overall Study|moved|7
7282099|NCT00480532|11497713|FG000|Overall Study|Withdrawal by Subject|2
7282100|NCT00480532|11497714|FG001|Overall Study|Withdrawal by Subject|4
7282101|NCT00480532|11497715|FG002|Overall Study|Withdrawal by Subject|3
7282102|NCT00480532|11497716|FG003|Overall Study|Withdrawal by Subject|1
7282103|NCT00480532|11497713|FG000|Overall Study|Protocol Violation|0
7282104|NCT00480532|11497714|FG001|Overall Study|Protocol Violation|0
7282105|NCT00480532|11497715|FG002|Overall Study|Protocol Violation|1
7282106|NCT00480532|11497716|FG003|Overall Study|Protocol Violation|0
7282107|NCT00480636|11497726|FG000|Overall Study|Death|12
7282108|NCT00480636|11497726|FG000|Overall Study|Lost to Follow-up|4
7282109|NCT00480636|11497726|FG000|Overall Study|Other|2
7282110|NCT00480636|11497726|FG000|Overall Study|Lost to follow-up; subsequently died|1
7282111|NCT00480779|11497745|FG000|Overall Study|Other|2
7282112|NCT00480779|11497746|FG001|Overall Study|Other|0
7282113|NCT00480779|11497745|FG000|Overall Study|Job and Health-related|0
7282114|NCT00480779|11497746|FG001|Overall Study|Job and Health-related|3
7282115|NCT00480857|11497752|FG000|Overall Study|Lack of Efficacy|2
7282116|NCT00481065|11497768|FG000|Overall Study|Adverse event or death|1
7282117|NCT00481065|11497769|FG001|Overall Study|Adverse event or death|1
7282118|NCT00481065|11497770|FG002|Overall Study|Adverse event or death|3
7282119|NCT00481065|11497771|FG003|Overall Study|Adverse event or death|0
7282120|NCT00481065|11497772|FG004|Overall Study|Adverse event or death|2
7282121|NCT00481065|11497773|FG005|Overall Study|Adverse event or death|0
7282122|NCT00481065|11497774|FG006|Overall Study|Adverse event or death|1
7282123|NCT00481065|11497775|FG007|Overall Study|Adverse event or death|1
7282124|NCT00481065|11497768|FG000|Overall Study|Withdrawal by Subject|11
7621836|NCT01994382|12032484|FG014|Overall Study|Adverse Event|17
7621837|NCT01994382|12032485|FG015|Overall Study|Adverse Event|6
7621838|NCT01994382|12032486|FG016|Overall Study|Adverse Event|3
7621839|NCT01994382|12032470|FG000|Overall Study|Other than specified|0
7621840|NCT01994382|12032471|FG001|Overall Study|Other than specified|0
7621841|NCT01994382|12032472|FG002|Overall Study|Other than specified|0
7621842|NCT01994382|12032473|FG003|Overall Study|Other than specified|0
7621843|NCT01994382|12032474|FG004|Overall Study|Other than specified|0
7621844|NCT01994382|12032475|FG005|Overall Study|Other than specified|0
7621845|NCT01994382|12032476|FG006|Overall Study|Other than specified|0
7621846|NCT01994382|12032477|FG007|Overall Study|Other than specified|0
7621847|NCT01994382|12032478|FG008|Overall Study|Other than specified|0
7621848|NCT01994382|12032479|FG009|Overall Study|Other than specified|0
7621849|NCT01994382|12032480|FG010|Overall Study|Other than specified|2
7621850|NCT01994382|12032481|FG011|Overall Study|Other than specified|0
7621851|NCT01994382|12032482|FG012|Overall Study|Other than specified|2
7621852|NCT01994382|12032483|FG013|Overall Study|Other than specified|0
7621853|NCT01994382|12032484|FG014|Overall Study|Other than specified|0
7621854|NCT01994382|12032485|FG015|Overall Study|Other than specified|4
7621855|NCT01994382|12032486|FG016|Overall Study|Other than specified|4
7621856|NCT01994382|12032470|FG000|Overall Study|Withdrawal by Subject|0
7621857|NCT01994382|12032471|FG001|Overall Study|Withdrawal by Subject|0
7621858|NCT01994382|12032472|FG002|Overall Study|Withdrawal by Subject|0
7621859|NCT01994382|12032473|FG003|Overall Study|Withdrawal by Subject|0
7282125|NCT00481065|11497769|FG001|Overall Study|Withdrawal by Subject|12
7282126|NCT00481065|11497770|FG002|Overall Study|Withdrawal by Subject|7
7282127|NCT00481065|11497771|FG003|Overall Study|Withdrawal by Subject|11
7282128|NCT00481065|11497772|FG004|Overall Study|Withdrawal by Subject|13
7282129|NCT00481065|11497773|FG005|Overall Study|Withdrawal by Subject|12
7282130|NCT00481065|11497774|FG006|Overall Study|Withdrawal by Subject|9
7282131|NCT00481065|11497775|FG007|Overall Study|Withdrawal by Subject|10
7282132|NCT00481065|11497768|FG000|Overall Study|Lost to Follow-up|4
7282133|NCT00481065|11497769|FG001|Overall Study|Lost to Follow-up|2
7282134|NCT00481065|11497770|FG002|Overall Study|Lost to Follow-up|4
7282135|NCT00481065|11497771|FG003|Overall Study|Lost to Follow-up|3
7282136|NCT00481065|11497772|FG004|Overall Study|Lost to Follow-up|3
7282137|NCT00481065|11497773|FG005|Overall Study|Lost to Follow-up|3
7282138|NCT00481065|11497774|FG006|Overall Study|Lost to Follow-up|2
7282139|NCT00481065|11497775|FG007|Overall Study|Lost to Follow-up|5
7282140|NCT00481065|11497768|FG000|Overall Study|Inappropriate enrollment|4
7282141|NCT00481065|11497769|FG001|Overall Study|Inappropriate enrollment|0
7282142|NCT00481065|11497770|FG002|Overall Study|Inappropriate enrollment|2
7282143|NCT00481065|11497771|FG003|Overall Study|Inappropriate enrollment|0
7282144|NCT00481065|11497772|FG004|Overall Study|Inappropriate enrollment|2
7282145|NCT00481065|11497773|FG005|Overall Study|Inappropriate enrollment|1
7282146|NCT00481065|11497774|FG006|Overall Study|Inappropriate enrollment|0
7282147|NCT00481065|11497775|FG007|Overall Study|Inappropriate enrollment|1
7282148|NCT00481065|11497768|FG000|Overall Study|Administrative reason|0
7621860|NCT01994382|12032474|FG004|Overall Study|Withdrawal by Subject|0
7621861|NCT01994382|12032475|FG005|Overall Study|Withdrawal by Subject|0
7621862|NCT01994382|12032476|FG006|Overall Study|Withdrawal by Subject|0
7621863|NCT01994382|12032477|FG007|Overall Study|Withdrawal by Subject|0
7621864|NCT01994382|12032478|FG008|Overall Study|Withdrawal by Subject|0
7621865|NCT01994382|12032479|FG009|Overall Study|Withdrawal by Subject|0
7621866|NCT01994382|12032480|FG010|Overall Study|Withdrawal by Subject|6
7621867|NCT01994382|12032481|FG011|Overall Study|Withdrawal by Subject|0
7621868|NCT01994382|12032482|FG012|Overall Study|Withdrawal by Subject|2
7621869|NCT01994382|12032483|FG013|Overall Study|Withdrawal by Subject|0
7621870|NCT01994382|12032484|FG014|Overall Study|Withdrawal by Subject|4
7621871|NCT01994382|12032485|FG015|Overall Study|Withdrawal by Subject|3
7621872|NCT01994382|12032486|FG016|Overall Study|Withdrawal by Subject|0
7621873|NCT01994382|12032470|FG000|Overall Study|Lost to Follow-up|0
7282149|NCT00481065|11497769|FG001|Overall Study|Administrative reason|0
7282150|NCT00481065|11497770|FG002|Overall Study|Administrative reason|0
7282151|NCT00481065|11497771|FG003|Overall Study|Administrative reason|0
7282152|NCT00481065|11497772|FG004|Overall Study|Administrative reason|0
7282153|NCT00481065|11497773|FG005|Overall Study|Administrative reason|2
7282154|NCT00481065|11497774|FG006|Overall Study|Administrative reason|1
7282155|NCT00481065|11497775|FG007|Overall Study|Administrative reason|0
7282156|NCT00481065|11497768|FG000|Overall Study|Protocol Violation|2
7282157|NCT00481065|11497769|FG001|Overall Study|Protocol Violation|1
7282158|NCT00481065|11497770|FG002|Overall Study|Protocol Violation|1
7282159|NCT00481065|11497771|FG003|Overall Study|Protocol Violation|1
7282160|NCT00481065|11497772|FG004|Overall Study|Protocol Violation|2
7282161|NCT00481065|11497773|FG005|Overall Study|Protocol Violation|6
7282162|NCT00481065|11497774|FG006|Overall Study|Protocol Violation|3
7282163|NCT00481065|11497775|FG007|Overall Study|Protocol Violation|2
7282164|NCT00481065|11497768|FG000|Overall Study|Unable to classify|0
7282165|NCT00481065|11497769|FG001|Overall Study|Unable to classify|1
7621874|NCT01994382|12032471|FG001|Overall Study|Lost to Follow-up|0
7621875|NCT01994382|12032472|FG002|Overall Study|Lost to Follow-up|0
7621876|NCT01994382|12032473|FG003|Overall Study|Lost to Follow-up|0
7621877|NCT01994382|12032474|FG004|Overall Study|Lost to Follow-up|0
7621878|NCT01994382|12032475|FG005|Overall Study|Lost to Follow-up|0
7621879|NCT01994382|12032476|FG006|Overall Study|Lost to Follow-up|0
7621880|NCT01994382|12032477|FG007|Overall Study|Lost to Follow-up|0
7621881|NCT01994382|12032478|FG008|Overall Study|Lost to Follow-up|0
7621882|NCT01994382|12032479|FG009|Overall Study|Lost to Follow-up|0
7621883|NCT01994382|12032480|FG010|Overall Study|Lost to Follow-up|1
7621884|NCT01994382|12032481|FG011|Overall Study|Lost to Follow-up|0
7621885|NCT01994382|12032482|FG012|Overall Study|Lost to Follow-up|0
7621886|NCT01994382|12032483|FG013|Overall Study|Lost to Follow-up|0
7621887|NCT01994382|12032484|FG014|Overall Study|Lost to Follow-up|0
7621888|NCT01994382|12032485|FG015|Overall Study|Lost to Follow-up|0
7621889|NCT01994382|12032486|FG016|Overall Study|Lost to Follow-up|0
7621890|NCT01994382|12032470|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621891|NCT01994382|12032471|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621892|NCT01994382|12032472|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621893|NCT01994382|12032473|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621894|NCT01994382|12032474|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621895|NCT01994382|12032475|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621896|NCT01994382|12032476|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621897|NCT01994382|12032477|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621898|NCT01994382|12032478|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621899|NCT01994382|12032479|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621900|NCT01994382|12032480|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
7621901|NCT01994382|12032481|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7217702|NCT01193842|11425869|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
7217703|NCT01193842|11425865|FG000|Phase II: Randomized Groups|Death|0
7217704|NCT01193842|11425866|FG001|Phase II: Randomized Groups|Death|0
7217705|NCT01193842|11425867|FG002|Phase II: Randomized Groups|Death|0
7217706|NCT01193842|11425868|FG003|Phase II: Randomized Groups|Death|1
7217707|NCT01193842|11425869|FG004|Phase II: Randomized Groups|Death|1
7217708|NCT01193842|11425865|FG000|Phase II: Randomized Groups|Adverse Event|0
7217709|NCT01193842|11425866|FG001|Phase II: Randomized Groups|Adverse Event|0
7217710|NCT01193842|11425867|FG002|Phase II: Randomized Groups|Adverse Event|0
7217711|NCT01193842|11425868|FG003|Phase II: Randomized Groups|Adverse Event|5
7217712|NCT01193842|11425869|FG004|Phase II: Randomized Groups|Adverse Event|3
7217713|NCT01193842|11425865|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
7217714|NCT01193842|11425866|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
7217715|NCT01193842|11425867|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
7217716|NCT01193842|11425868|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
7217717|NCT01193842|11425869|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
7217718|NCT01193842|11425865|FG000|Phase II: Randomized Groups|Ineligible|0
7217719|NCT01193842|11425866|FG001|Phase II: Randomized Groups|Ineligible|0
7217720|NCT01193842|11425867|FG002|Phase II: Randomized Groups|Ineligible|0
7217721|NCT01193842|11425868|FG003|Phase II: Randomized Groups|Ineligible|0
7217722|NCT01193842|11425869|FG004|Phase II: Randomized Groups|Ineligible|1
7217723|NCT01193842|11425865|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7217724|NCT01193842|11425866|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7217725|NCT01193842|11425867|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
7217726|NCT01193842|11425868|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
7217727|NCT01193842|11425869|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
7217728|NCT00855803|11425886|FG000|Overall Study|Death|2
7217729|NCT00855803|11425886|FG000|Overall Study|Lost to Follow-up|2
7217730|NCT00855803|11425886|FG000|Overall Study|Technical inability to undergo procedure|2
7217731|NCT00855803|11425886|FG000|Overall Study|Not evaluable at 3 month timepoint|2
7217732|NCT00855803|11425886|FG000|Overall Study|Withdrawal by Subject|3
7217733|NCT00855803|11425886|FG000|Overall Study|Physician Decision|3
7217734|NCT00740116|11425896|FG000|Overall Study|Withdrawal by Subject|1
7217735|NCT00740116|11425897|FG001|Overall Study|Withdrawal by Subject|1
7217736|NCT00740116|11425896|FG000|Overall Study|Protocol Violation|1
7217737|NCT00740116|11425897|FG001|Overall Study|Protocol Violation|4
7217738|NCT00565617|11425905|FG000|Overall Study|Withdrawal by Subject|1
7217745|NCT00142584|11425940|FG000|Overall Study|Sponsor Termination of Study, etc.|72
7217746|NCT00142584|11425941|FG001|Overall Study|Sponsor Termination of Study, etc.|16
7217747|NCT00142584|11425940|FG000|Overall Study|Withdrawal by Subject|30
7282166|NCT00481065|11497770|FG002|Overall Study|Unable to classify|2
7282167|NCT00481065|11497771|FG003|Overall Study|Unable to classify|0
7282168|NCT00481065|11497772|FG004|Overall Study|Unable to classify|1
7282169|NCT00481065|11497773|FG005|Overall Study|Unable to classify|0
7282170|NCT00481065|11497774|FG006|Overall Study|Unable to classify|0
7282171|NCT00481065|11497775|FG007|Overall Study|Unable to classify|0
7282172|NCT00481078|11497797|FG000|Overall Study|Progression of disease|11
7217748|NCT00142584|11425941|FG001|Overall Study|Withdrawal by Subject|16
7621902|NCT01994382|12032482|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7
7621903|NCT01994382|12032483|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621904|NCT01994382|12032484|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
7621905|NCT01994382|12032485|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3
7621906|NCT01994382|12032486|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
7621907|NCT01994382|12032470|FG000|Overall Study|Protocol violation/noncompliance|0
7621908|NCT01994382|12032471|FG001|Overall Study|Protocol violation/noncompliance|0
7621909|NCT01994382|12032472|FG002|Overall Study|Protocol violation/noncompliance|0
7621910|NCT01994382|12032473|FG003|Overall Study|Protocol violation/noncompliance|0
7621911|NCT01994382|12032474|FG004|Overall Study|Protocol violation/noncompliance|0
7621912|NCT01994382|12032475|FG005|Overall Study|Protocol violation/noncompliance|0
7621913|NCT01994382|12032476|FG006|Overall Study|Protocol violation/noncompliance|0
7621914|NCT01994382|12032477|FG007|Overall Study|Protocol violation/noncompliance|0
7621915|NCT01994382|12032478|FG008|Overall Study|Protocol violation/noncompliance|0
7621916|NCT01994382|12032479|FG009|Overall Study|Protocol violation/noncompliance|0
7282173|NCT00481078|11497798|FG001|Overall Study|Progression of disease|11
7282174|NCT00481078|11497797|FG000|Overall Study|Adverse Event|15
7282175|NCT00481078|11497798|FG001|Overall Study|Adverse Event|3
7282176|NCT00481078|11497797|FG000|Overall Study|Death|5
7282177|NCT00481078|11497798|FG001|Overall Study|Death|3
7282178|NCT00481078|11497797|FG000|Overall Study|Intercurrent illness|1
7282179|NCT00481078|11497798|FG001|Overall Study|Intercurrent illness|0
7282180|NCT00481078|11497797|FG000|Overall Study|Withdrawal by Subject|7
7282181|NCT00481078|11497798|FG001|Overall Study|Withdrawal by Subject|1
7282182|NCT00481078|11497797|FG000|Overall Study|Information not available|1
7282183|NCT00481078|11497798|FG001|Overall Study|Information not available|0
7282184|NCT00481078|11497797|FG000|Overall Study|Received other treatment|2
7282185|NCT00481078|11497798|FG001|Overall Study|Received other treatment|1
7282186|NCT00481078|11497797|FG000|Overall Study|Brain metastasis|0
7282187|NCT00481078|11497798|FG001|Overall Study|Brain metastasis|1
7282188|NCT00481195|11497806|FG000|Overall Study|Adverse Event|16
7282189|NCT00481195|11497807|FG001|Overall Study|Adverse Event|11
7282190|NCT00481195|11497806|FG000|Overall Study|Lack of Efficacy|1
7282191|NCT00481195|11497807|FG001|Overall Study|Lack of Efficacy|3
7282192|NCT00481195|11497806|FG000|Overall Study|Lost to Follow-up|4
7282193|NCT00481195|11497807|FG001|Overall Study|Lost to Follow-up|6
7282194|NCT00481195|11497806|FG000|Overall Study|Physician Decision|3
7282195|NCT00481195|11497807|FG001|Overall Study|Physician Decision|1
7282196|NCT00481195|11497806|FG000|Overall Study|Protocol Violation|10
7282197|NCT00481195|11497807|FG001|Overall Study|Protocol Violation|7
7282198|NCT00481195|11497806|FG000|Overall Study|Withdrawal by Subject|3
7282199|NCT00481195|11497807|FG001|Overall Study|Withdrawal by Subject|9
7282200|NCT00481195|11497806|FG000|Overall Study|Miscellaneous|2
7282201|NCT00481195|11497807|FG001|Overall Study|Miscellaneous|2
7282202|NCT00481247|11497815|FG000|Overall Study|Death|0
7282203|NCT00481247|11497816|FG001|Overall Study|Death|1
7282204|NCT00481247|11497815|FG000|Overall Study|Disease progression|18
7282205|NCT00481247|11497816|FG001|Overall Study|Disease progression|22
7282206|NCT00481247|11497815|FG000|Overall Study|Intolerance|42
7282207|NCT00481247|11497816|FG001|Overall Study|Intolerance|17
7282208|NCT00481247|11497815|FG000|Overall Study|Treatment failure|10
7282209|NCT00481247|11497816|FG001|Overall Study|Treatment failure|14
7282210|NCT00481247|11497815|FG000|Overall Study|AE unrelated to study drug|13
7282211|NCT00481247|11497816|FG001|Overall Study|AE unrelated to study drug|4
7282212|NCT00481247|11497815|FG000|Overall Study|Withdrawal by Subject|8
7282213|NCT00481247|11497816|FG001|Overall Study|Withdrawal by Subject|13
7282214|NCT00481247|11497815|FG000|Overall Study|Pregnancy|2
7282215|NCT00481247|11497816|FG001|Overall Study|Pregnancy|1
7282216|NCT00481247|11497815|FG000|Overall Study|Lost to Follow-up|1
7282217|NCT00481247|11497816|FG001|Overall Study|Lost to Follow-up|2
7282218|NCT00481247|11497815|FG000|Overall Study|Poor compliance/noncompliance|1
7282219|NCT00481247|11497816|FG001|Overall Study|Poor compliance/noncompliance|7
7282220|NCT00481247|11497815|FG000|Overall Study|Administrative reason by sponsor|157
7282221|NCT00481247|11497816|FG001|Overall Study|Administrative reason by sponsor|162
7282222|NCT00481247|11497815|FG000|Overall Study|Varied|6
7282223|NCT00481247|11497816|FG001|Overall Study|Varied|15
7282224|NCT00481247|11497815|FG000|Overall Study|Did not receive treatment|1
7282225|NCT00481247|11497816|FG001|Overall Study|Did not receive treatment|2
7282226|NCT00481676|11497842|FG000|Overall Study|Adverse Event|0
7282227|NCT00481676|11497843|FG001|Overall Study|Adverse Event|1
7282228|NCT00481676|11497842|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7282229|NCT00481676|11497843|FG001|Overall Study|Unsatisfactory therapeutic effect|4
7282230|NCT00481676|11497842|FG000|Overall Study|Administrative problem|1
7282231|NCT00481676|11497843|FG001|Overall Study|Administrative problem|0
7282232|NCT00481767|11497851|FG000|Overall Study|Withdrawal by Subject|16
7282233|NCT00481767|11497852|FG001|Overall Study|Withdrawal by Subject|11
7282234|NCT00481767|11497851|FG000|Overall Study|Lost to Follow-up|16
7282235|NCT00481767|11497852|FG001|Overall Study|Lost to Follow-up|10
7282236|NCT00481832|11497858|FG000|Enrollment|Physician Decision|8
7282237|NCT00481832|11497858|FG000|Enrollment|Unable to collect enough stem cells|2
7282238|NCT00481832|11497858|FG000|Inter-transplant Period|Adverse Event|4
7621917|NCT01994382|12032480|FG010|Overall Study|Protocol violation/noncompliance|0
7621918|NCT01994382|12032481|FG011|Overall Study|Protocol violation/noncompliance|1
7621919|NCT01994382|12032482|FG012|Overall Study|Protocol violation/noncompliance|0
7621920|NCT01994382|12032483|FG013|Overall Study|Protocol violation/noncompliance|0
7621921|NCT01994382|12032484|FG014|Overall Study|Protocol violation/noncompliance|0
7621922|NCT01994382|12032485|FG015|Overall Study|Protocol violation/noncompliance|0
7621923|NCT01994382|12032486|FG016|Overall Study|Protocol violation/noncompliance|2
7621924|NCT01994382|12032470|FG000|Overall Study|Rolled over to Phase 2a|0
7621925|NCT01994382|12032471|FG001|Overall Study|Rolled over to Phase 2a|0
7621926|NCT01994382|12032472|FG002|Overall Study|Rolled over to Phase 2a|1
7621927|NCT01994382|12032473|FG003|Overall Study|Rolled over to Phase 2a|0
7621928|NCT01994382|12032474|FG004|Overall Study|Rolled over to Phase 2a|0
7282239|NCT00481832|11497858|FG000|Inter-transplant Period|Death|3
7282240|NCT00481832|11497858|FG000|Inter-transplant Period|Physician Decision|4
7282241|NCT00481832|11497858|FG000|Inter-transplant Period|Disease relapse|11
7282242|NCT00481832|11497858|FG000|Inter-transplant Period|Lack of allogeneic donor|5
7282243|NCT00481871|11497876|FG000|Overall Study|Progressive Disease - pt withdrew|0
7282244|NCT00481871|11497877|FG001|Overall Study|Progressive Disease - pt withdrew|0
7282245|NCT00481871|11497878|FG002|Overall Study|Progressive Disease - pt withdrew|1
7282246|NCT00481871|11497879|FG003|Overall Study|Progressive Disease - pt withdrew|0
7282247|NCT00481871|11497880|FG004|Overall Study|Progressive Disease - pt withdrew|0
7282248|NCT00481988|11497890|FG000|Overall Study|Withdrawal by Subject|1
7282249|NCT00481988|11497891|FG001|Overall Study|Withdrawal by Subject|1
7282250|NCT00482001|11497899|FG000|Overall Study|Protocol Violation|1
7282251|NCT00482001|11497900|FG001|Overall Study|Protocol Violation|1
7282252|NCT00482014|11497912|FG000|Overall Study|Withdrawal by Subject|1
7282253|NCT00482014|11497913|FG001|Overall Study|Withdrawal by Subject|2
7282254|NCT00482014|11497914|FG002|Overall Study|Withdrawal by Subject|3
7282255|NCT00482014|11497915|FG003|Overall Study|Withdrawal by Subject|4
7282256|NCT00482014|11497912|FG000|Overall Study|Adverse Event|3
7282257|NCT00482014|11497913|FG001|Overall Study|Adverse Event|0
7282258|NCT00482014|11497914|FG002|Overall Study|Adverse Event|2
7282259|NCT00482014|11497915|FG003|Overall Study|Adverse Event|8
7282260|NCT00482014|11497912|FG000|Overall Study|Death|1
7282261|NCT00482014|11497913|FG001|Overall Study|Death|2
7282262|NCT00482014|11497914|FG002|Overall Study|Death|1
7282263|NCT00482014|11497915|FG003|Overall Study|Death|4
7282264|NCT00482014|11497912|FG000|Overall Study|Lack of Efficacy|1
7282265|NCT00482014|11497913|FG001|Overall Study|Lack of Efficacy|0
7621929|NCT01994382|12032475|FG005|Overall Study|Rolled over to Phase 2a|0
7621930|NCT01994382|12032476|FG006|Overall Study|Rolled over to Phase 2a|0
7621931|NCT01994382|12032477|FG007|Overall Study|Rolled over to Phase 2a|0
7621932|NCT01994382|12032478|FG008|Overall Study|Rolled over to Phase 2a|0
7621933|NCT01994382|12032479|FG009|Overall Study|Rolled over to Phase 2a|2
7621934|NCT01994382|12032480|FG010|Overall Study|Rolled over to Phase 2a|0
7621935|NCT01994382|12032481|FG011|Overall Study|Rolled over to Phase 2a|0
7621936|NCT01994382|12032482|FG012|Overall Study|Rolled over to Phase 2a|0
7621937|NCT01994382|12032483|FG013|Overall Study|Rolled over to Phase 2a|0
7621938|NCT01994382|12032484|FG014|Overall Study|Rolled over to Phase 2a|0
7621939|NCT01994382|12032485|FG015|Overall Study|Rolled over to Phase 2a|0
7621940|NCT01994382|12032486|FG016|Overall Study|Rolled over to Phase 2a|0
7282266|NCT00482014|11497914|FG002|Overall Study|Lack of Efficacy|4
7282267|NCT00482014|11497915|FG003|Overall Study|Lack of Efficacy|6
7282268|NCT00482014|11497912|FG000|Overall Study|Sponsor Decision|1
7282269|NCT00482014|11497913|FG001|Overall Study|Sponsor Decision|2
7282270|NCT00482014|11497914|FG002|Overall Study|Sponsor Decision|1
7282271|NCT00482014|11497915|FG003|Overall Study|Sponsor Decision|1
7282272|NCT00482053|11497927|FG000|Inter-treatment Period|Disease progression|1
7282273|NCT00482170|11497933|FG000|Overall Study|Adverse Event|5
7282274|NCT00482170|11497934|FG001|Overall Study|Adverse Event|14
7282275|NCT00482170|11497933|FG000|Overall Study|Withdrawal by Subject|6
7282276|NCT00482170|11497934|FG001|Overall Study|Withdrawal by Subject|1
7282277|NCT00482170|11497933|FG000|Overall Study|Protocol Violation|2
7282278|NCT00482170|11497934|FG001|Overall Study|Protocol Violation|3
7282279|NCT00482170|11497933|FG000|Overall Study|Lost to Follow-up|2
7282280|NCT00482170|11497934|FG001|Overall Study|Lost to Follow-up|0
7282281|NCT00482170|11497933|FG000|Overall Study|Unspecified reason|0
7282282|NCT00482170|11497934|FG001|Overall Study|Unspecified reason|2
7282283|NCT00482274|11497940|FG000|Overall Study|Adverse Event|1
7282284|NCT00482391|11497944|FG000|Overall Study|Withdrawal by Subject|1
7282285|NCT00482391|11497944|FG000|Overall Study|Adverse Event|1
7282286|NCT00482391|11497944|FG000|Overall Study|Death|1
7282287|NCT00482612|11497962|FG000|In-treatment Period|No study medication administered|0
7282288|NCT00482612|11497963|FG001|In-treatment Period|No study medication administered|0
7282289|NCT00482612|11497964|FG002|In-treatment Period|No study medication administered|1
7282290|NCT00482612|11497965|FG003|In-treatment Period|No study medication administered|0
7282291|NCT00482612|11497962|FG000|Follow-up Period|Other|4
7282292|NCT00482612|11497963|FG001|Follow-up Period|Other|2
7282293|NCT00482612|11497964|FG002|Follow-up Period|Other|1
7621941|NCT01896531|12032531|FG000|Overall Study|Death|57
7621942|NCT01896531|12032532|FG001|Overall Study|Death|59
7621943|NCT01896531|12032531|FG000|Overall Study|Lost to Follow-up|3
7621944|NCT01896531|12032532|FG001|Overall Study|Lost to Follow-up|0
7621945|NCT01896531|12032531|FG000|Overall Study|Non-compliance|0
7621946|NCT01896531|12032532|FG001|Overall Study|Non-compliance|1
7621947|NCT01896531|12032531|FG000|Overall Study|Study Ended by Sponsor|7
7621948|NCT01896531|12032532|FG001|Overall Study|Study Ended by Sponsor|20
7621949|NCT01896531|12032531|FG000|Overall Study|Withdrawal by Subject|3
7621950|NCT01896531|12032532|FG001|Overall Study|Withdrawal by Subject|2
7621951|NCT01896531|12032531|FG000|Overall Study|Death Prior to Treatment|1
7621952|NCT01896531|12032532|FG001|Overall Study|Death Prior to Treatment|0
7282294|NCT00482612|11497965|FG003|Follow-up Period|Other|2
7282295|NCT00482612|11497962|FG000|Follow-up Period|Lack of compliance|0
7282296|NCT00482612|11497963|FG001|Follow-up Period|Lack of compliance|0
7282297|NCT00482612|11497964|FG002|Follow-up Period|Lack of compliance|1
7282298|NCT00482612|11497965|FG003|Follow-up Period|Lack of compliance|0
7282299|NCT00482612|11497962|FG000|Follow-up Period|Lost to Follow-up|0
7282300|NCT00482612|11497963|FG001|Follow-up Period|Lost to Follow-up|4
7282301|NCT00482612|11497964|FG002|Follow-up Period|Lost to Follow-up|2
7282302|NCT00482612|11497965|FG003|Follow-up Period|Lost to Follow-up|1
7282303|NCT00482612|11497962|FG000|Follow-up Period|Adverse Event|4
7282304|NCT00482612|11497963|FG001|Follow-up Period|Adverse Event|7
7282305|NCT00482612|11497964|FG002|Follow-up Period|Adverse Event|9
7282306|NCT00482612|11497965|FG003|Follow-up Period|Adverse Event|0
7282307|NCT00482612|11497962|FG000|Follow-up Period|Lack of Efficacy|2
7282308|NCT00482612|11497963|FG001|Follow-up Period|Lack of Efficacy|0
7282309|NCT00482612|11497964|FG002|Follow-up Period|Lack of Efficacy|1
7282310|NCT00482612|11497965|FG003|Follow-up Period|Lack of Efficacy|0
7282311|NCT00482612|11497962|FG000|Follow-up Period|Withdrawal by Subject|3
7282312|NCT00482612|11497963|FG001|Follow-up Period|Withdrawal by Subject|5
7282313|NCT00482612|11497964|FG002|Follow-up Period|Withdrawal by Subject|7
7282314|NCT00482612|11497965|FG003|Follow-up Period|Withdrawal by Subject|2
7282315|NCT00482612|11497962|FG000|Follow-up Period|Reasons not related to trial|1
7282316|NCT00482612|11497963|FG001|Follow-up Period|Reasons not related to trial|0
7282317|NCT00482612|11497964|FG002|Follow-up Period|Reasons not related to trial|1
7282318|NCT00482612|11497965|FG003|Follow-up Period|Reasons not related to trial|3
7282319|NCT00482703|11497994|FG000|Overall Study|Poor compliance|1
7282320|NCT00482703|11497995|FG001|Overall Study|Poor compliance|0
7282321|NCT00482729|11498010|FG000|Overall Study|Adverse Event|29
7282322|NCT00482729|11498011|FG001|Overall Study|Adverse Event|33
7282323|NCT00482729|11498010|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
7282324|NCT00482729|11498011|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
7282325|NCT00482729|11498010|FG000|Overall Study|Hyperglycemia Criteria|7
7282326|NCT00482729|11498011|FG001|Overall Study|Hyperglycemia Criteria|5
7282327|NCT00482729|11498010|FG000|Overall Study|Lack of Efficacy|4
7282328|NCT00482729|11498011|FG001|Overall Study|Lack of Efficacy|16
7282329|NCT00482729|11498010|FG000|Overall Study|Lost to Follow-up|86
7282330|NCT00482729|11498011|FG001|Overall Study|Lost to Follow-up|66
7282331|NCT00482729|11498010|FG000|Overall Study|Physician Decision|10
7282332|NCT00482729|11498011|FG001|Overall Study|Physician Decision|7
7282333|NCT00482729|11498010|FG000|Overall Study|Pregnancy|4
7282334|NCT00482729|11498011|FG001|Overall Study|Pregnancy|2
7282335|NCT00482729|11498010|FG000|Overall Study|Protocol Violation|10
7621953|NCT01864603|12032540|FG000|Stage 2|DSMB design modification|86056
7621954|NCT01864603|12032541|FG001|Stage 2|DSMB design modification|92558
7282336|NCT00482729|11498011|FG001|Overall Study|Protocol Violation|18
7282337|NCT00482729|11498010|FG000|Overall Study|Withdrawal by Subject|67
7282338|NCT00482729|11498011|FG001|Overall Study|Withdrawal by Subject|69
7282339|NCT00483002|11498026|FG000|Overall Study|Adverse Event|68
7282340|NCT00483002|11498026|FG000|Overall Study|Lack of Efficacy|555
7282341|NCT00483002|11498026|FG000|Overall Study|Lost to Follow-up|962
7282342|NCT00483002|11498026|FG000|Overall Study|Other|2
7282343|NCT00483002|11498026|FG000|Overall Study|Other|967
7282344|NCT00483041|11498032|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
7282345|NCT00483041|11498033|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
7282346|NCT00483184|11498042|FG000|Overall Study|Withdrawal by Subject|2
7282347|NCT00483184|11498043|FG001|Overall Study|Withdrawal by Subject|2
7282348|NCT00483184|11498044|FG002|Overall Study|Withdrawal by Subject|0
7282349|NCT00483184|11498042|FG000|Overall Study|Lost to Follow-up|1
7282350|NCT00483184|11498043|FG001|Overall Study|Lost to Follow-up|0
7282351|NCT00483184|11498044|FG002|Overall Study|Lost to Follow-up|0
7282352|NCT00483184|11498042|FG000|Overall Study|Adverse Event|1
7282353|NCT00483184|11498043|FG001|Overall Study|Adverse Event|2
7282354|NCT00483184|11498044|FG002|Overall Study|Adverse Event|2
7282355|NCT00483184|11498042|FG000|Overall Study|Protocol Violation|1
7282356|NCT00483184|11498043|FG001|Overall Study|Protocol Violation|0
7282357|NCT00483184|11498044|FG002|Overall Study|Protocol Violation|1
7282358|NCT00483327|11498069|FG000|Overall Study|Adverse Event|1
7282359|NCT00483327|11498069|FG000|Overall Study|Withdrawal by Subject|3
7282360|NCT00483327|11498069|FG000|Overall Study|Lost to Follow-up|4
7282361|NCT00483327|11498069|FG000|Overall Study|Patient Non Compliance|2
7282362|NCT00483379|11498077|FG000|Treatment Period|Adverse Event|1
7282363|NCT00483379|11498078|FG001|Treatment Period|Adverse Event|0
7282364|NCT00483379|11498077|FG000|Treatment Period|Withdrawal by Subject|1
7282365|NCT00483379|11498078|FG001|Treatment Period|Withdrawal by Subject|0
7282366|NCT00483405|11498086|FG000|Overall Study|Adverse Event|8
7282367|NCT00483405|11498086|FG000|Overall Study|Lack of Efficacy|14
7282368|NCT00483405|11498086|FG000|Overall Study|Death|3
7282369|NCT00483405|11498086|FG000|Overall Study|Withdrawal by Subject|2
7282370|NCT00483405|11498086|FG000|Overall Study|Other complicating disease|1
7282371|NCT00483548|11498108|FG000|Overall Study|Randomized; not treated with study drug|1
7282372|NCT00483548|11498109|FG001|Overall Study|Randomized; not treated with study drug|3
7282373|NCT00483548|11498108|FG000|Overall Study|Adverse Event|25
7282374|NCT00483548|11498109|FG001|Overall Study|Adverse Event|14
7282375|NCT00483548|11498108|FG000|Overall Study|Laboratory abnormality|1
7282376|NCT00483548|11498109|FG001|Overall Study|Laboratory abnormality|2
7282377|NCT00483548|11498108|FG000|Overall Study|Lack of Efficacy|4
7282378|NCT00483548|11498109|FG001|Overall Study|Lack of Efficacy|8
7282379|NCT00483548|11498108|FG000|Overall Study|Protocol Violation|11
7282380|NCT00483548|11498109|FG001|Overall Study|Protocol Violation|7
7282381|NCT00483548|11498108|FG000|Overall Study|Pregnancy|1
7282382|NCT00483548|11498109|FG001|Overall Study|Pregnancy|0
7282383|NCT00483548|11498108|FG000|Overall Study|Protocol required discontinuation|6
7282384|NCT00483548|11498109|FG001|Overall Study|Protocol required discontinuation|6
7282385|NCT00483548|11498108|FG000|Overall Study|Unable to comply with protocol schedule|1
7282386|NCT00483548|11498109|FG001|Overall Study|Unable to comply with protocol schedule|0
7282387|NCT00483548|11498108|FG000|Overall Study|Non-compliance with medication|2
7282388|NCT00483548|11498109|FG001|Overall Study|Non-compliance with medication|0
7282389|NCT00483548|11498108|FG000|Overall Study|Lost to Follow-up|3
7282390|NCT00483548|11498109|FG001|Overall Study|Lost to Follow-up|4
7282391|NCT00483548|11498108|FG000|Overall Study|Withdrawal by Subject|5
7282392|NCT00483548|11498109|FG001|Overall Study|Withdrawal by Subject|2
7282393|NCT00483574|11498121|FG000|Overall Study|Adverse Event|6
7282394|NCT00483574|11498122|FG001|Overall Study|Adverse Event|0
7282395|NCT00483574|11498121|FG000|Overall Study|Protocol Violation|28
7282396|NCT00483574|11498122|FG001|Overall Study|Protocol Violation|9
7621971|NCT01684722|12032569|FG000|Overall Study|Lost to Follow-up|78
7282397|NCT00483574|11498121|FG000|Overall Study|Lost to Follow-up|16
7282398|NCT00483574|11498122|FG001|Overall Study|Lost to Follow-up|4
7282399|NCT00483574|11498121|FG000|Overall Study|Withdrawal by Subject|52
7282400|NCT00483574|11498122|FG001|Overall Study|Withdrawal by Subject|0
7282401|NCT00483652|11498132|FG000|Double-blind Treatment Period|Protocol Violation|2
7282402|NCT00483652|11498133|FG001|Double-blind Treatment Period|Protocol Violation|1
7282403|NCT00483652|11498132|FG000|Double-blind Treatment Period|Adverse Event|3
7282404|NCT00483652|11498133|FG001|Double-blind Treatment Period|Adverse Event|4
7282405|NCT00483652|11498132|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
7282478|NCT00483756|11498169|FG002|Overall Study|Withdrawal by Subject|4
7282406|NCT00483652|11498133|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
7282407|NCT00483652|11498132|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
7282408|NCT00483652|11498133|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
7282409|NCT00483704|11498142|FG000|Randomization|Withdrawal by Subject|19
7282410|NCT00483704|11498143|FG001|Randomization|Withdrawal by Subject|28
7282411|NCT00483704|11498144|FG002|Randomization|Withdrawal by Subject|18
7282412|NCT00483704|11498142|FG000|Randomization|Protocol Violation|14
7282413|NCT00483704|11498143|FG001|Randomization|Protocol Violation|25
7282414|NCT00483704|11498144|FG002|Randomization|Protocol Violation|22
7282415|NCT00483704|11498142|FG000|Randomization|Lost to Follow-up|14
7282416|NCT00483704|11498143|FG001|Randomization|Lost to Follow-up|14
7282417|NCT00483704|11498144|FG002|Randomization|Lost to Follow-up|19
7282418|NCT00483704|11498142|FG000|Randomization|Pregnancy|1
7282419|NCT00483704|11498143|FG001|Randomization|Pregnancy|0
7282420|NCT00483704|11498144|FG002|Randomization|Pregnancy|0
7282421|NCT00483704|11498142|FG000|Randomization|Physician Decision|2
7282422|NCT00483704|11498143|FG001|Randomization|Physician Decision|4
7282423|NCT00483704|11498144|FG002|Randomization|Physician Decision|0
7282424|NCT00483704|11498142|FG000|Randomization|Progressive disease|0
7282425|NCT00483704|11498143|FG001|Randomization|Progressive disease|0
7282426|NCT00483704|11498144|FG002|Randomization|Progressive disease|1
7282427|NCT00483704|11498142|FG000|Randomization|Lack of qualifying migraines|21
7282428|NCT00483704|11498143|FG001|Randomization|Lack of qualifying migraines|25
7282429|NCT00483704|11498144|FG002|Randomization|Lack of qualifying migraines|31
7282430|NCT00483704|11498142|FG000|Treatment|Lack of qualifying migraines|101
7282431|NCT00483704|11498143|FG001|Treatment|Lack of qualifying migraines|99
7282432|NCT00483704|11498144|FG002|Treatment|Lack of qualifying migraines|116
7282433|NCT00483704|11498142|FG000|Treatment|Adverse Event|3
7282434|NCT00483704|11498143|FG001|Treatment|Adverse Event|5
7282435|NCT00483704|11498144|FG002|Treatment|Adverse Event|4
7282436|NCT00483704|11498142|FG000|Treatment|Withdrawal by Subject|16
7282437|NCT00483704|11498143|FG001|Treatment|Withdrawal by Subject|12
7282438|NCT00483704|11498144|FG002|Treatment|Withdrawal by Subject|21
7282439|NCT00483704|11498142|FG000|Treatment|Protocol Violation|6
7282440|NCT00483704|11498143|FG001|Treatment|Protocol Violation|3
7282441|NCT00483704|11498144|FG002|Treatment|Protocol Violation|5
7282442|NCT00483704|11498142|FG000|Treatment|Lost to Follow-up|2
7282443|NCT00483704|11498143|FG001|Treatment|Lost to Follow-up|7
7282444|NCT00483704|11498144|FG002|Treatment|Lost to Follow-up|5
7282445|NCT00483704|11498142|FG000|Treatment|Lack of Efficacy|1
7282446|NCT00483704|11498143|FG001|Treatment|Lack of Efficacy|1
7282447|NCT00483704|11498144|FG002|Treatment|Lack of Efficacy|1
7282448|NCT00483704|11498142|FG000|Treatment|Pregnancy|0
7282449|NCT00483704|11498143|FG001|Treatment|Pregnancy|1
7282450|NCT00483704|11498144|FG002|Treatment|Pregnancy|0
7282451|NCT00483704|11498142|FG000|Treatment|Physician Decision|0
7282452|NCT00483704|11498143|FG001|Treatment|Physician Decision|1
7282453|NCT00483704|11498144|FG002|Treatment|Physician Decision|4
7282454|NCT00483717|11498157|FG000|Overall Study|Protocol Violation|5
7282455|NCT00483717|11498158|FG001|Overall Study|Protocol Violation|7
7282456|NCT00483717|11498157|FG000|Overall Study|Time of dosing missing|1
7282457|NCT00483717|11498158|FG001|Overall Study|Time of dosing missing|1
7282458|NCT00483717|11498157|FG000|Overall Study|No treatment for migraine|16
7282459|NCT00483717|11498158|FG001|Overall Study|No treatment for migraine|13
7282460|NCT00483717|11498157|FG000|Overall Study|Lost to Follow-up|1
7282461|NCT00483717|11498158|FG001|Overall Study|Lost to Follow-up|0
7282462|NCT00483717|11498157|FG000|Overall Study|Withdrawal by Subject|1
7282463|NCT00483717|11498158|FG001|Overall Study|Withdrawal by Subject|0
7282464|NCT00483756|11498167|FG000|Overall Study|Death|2
7282465|NCT00483756|11498168|FG001|Overall Study|Death|0
7282466|NCT00483756|11498169|FG002|Overall Study|Death|1
7282467|NCT00483756|11498167|FG000|Overall Study|Adverse Event|19
7282468|NCT00483756|11498168|FG001|Overall Study|Adverse Event|38
7282469|NCT00483756|11498169|FG002|Overall Study|Adverse Event|40
7282470|NCT00483756|11498167|FG000|Overall Study|Lack of Efficacy|1
7282471|NCT00483756|11498168|FG001|Overall Study|Lack of Efficacy|0
7282472|NCT00483756|11498169|FG002|Overall Study|Lack of Efficacy|0
7217749|NCT00142584|11425940|FG000|Overall Study|Lost to Follow-up|22
7217750|NCT00142584|11425941|FG001|Overall Study|Lost to Follow-up|12
7217751|NCT00142584|11425940|FG000|Overall Study|Adverse Event|14
7217752|NCT00142584|11425941|FG001|Overall Study|Adverse Event|5
7217753|NCT00142584|11425940|FG000|Overall Study|Protocol Violation|4
7217754|NCT00142584|11425941|FG001|Overall Study|Protocol Violation|7
7217755|NCT00142584|11425940|FG000|Overall Study|Treatment Failure|2
7217756|NCT00142584|11425941|FG001|Overall Study|Treatment Failure|0
7621972|NCT01684722|12032570|FG001|Overall Study|Lost to Follow-up|56
7621973|NCT01684722|12032571|FG002|Overall Study|Lost to Follow-up|75
7621974|NCT01684722|12032572|FG003|Overall Study|Lost to Follow-up|89
7621975|NCT01684722|12032569|FG000|Overall Study|Death|19
7621976|NCT01684722|12032570|FG001|Overall Study|Death|21
7621977|NCT01684722|12032571|FG002|Overall Study|Death|19
7621978|NCT01684722|12032572|FG003|Overall Study|Death|21
7282473|NCT00483756|11498167|FG000|Overall Study|Lost to Follow-up|3
7282474|NCT00483756|11498168|FG001|Overall Study|Lost to Follow-up|1
7282475|NCT00483756|11498169|FG002|Overall Study|Lost to Follow-up|0
7282476|NCT00483756|11498167|FG000|Overall Study|Withdrawal by Subject|5
7282477|NCT00483756|11498168|FG001|Overall Study|Withdrawal by Subject|3
7282479|NCT00483756|11498167|FG000|Overall Study|Other|2
7282480|NCT00483756|11498168|FG001|Overall Study|Other|4
7282481|NCT00483756|11498169|FG002|Overall Study|Other|3
7282482|NCT00483756|11498167|FG000|Overall Study|Randomized, Not Treated|1
7282483|NCT00483756|11498168|FG001|Overall Study|Randomized, Not Treated|4
7282484|NCT00483756|11498169|FG002|Overall Study|Randomized, Not Treated|4
7282485|NCT00483938|11498184|FG000|Overall Study|Protocol Violation|0
7282486|NCT00483938|11498185|FG001|Overall Study|Protocol Violation|0
7282487|NCT00483938|11498186|FG002|Overall Study|Protocol Violation|0
7282488|NCT00483938|11498187|FG003|Overall Study|Protocol Violation|0
7282489|NCT00483938|11498188|FG004|Overall Study|Protocol Violation|0
7282490|NCT00483938|11498189|FG005|Overall Study|Protocol Violation|0
7282491|NCT00483938|11498190|FG006|Overall Study|Protocol Violation|3
7282492|NCT00483938|11498184|FG000|Overall Study|Withdrawal by Subject|1
7282493|NCT00483938|11498185|FG001|Overall Study|Withdrawal by Subject|6
7282494|NCT00483938|11498186|FG002|Overall Study|Withdrawal by Subject|0
7282495|NCT00483938|11498187|FG003|Overall Study|Withdrawal by Subject|0
7282496|NCT00483938|11498188|FG004|Overall Study|Withdrawal by Subject|1
7282497|NCT00483938|11498189|FG005|Overall Study|Withdrawal by Subject|3
7282498|NCT00483938|11498190|FG006|Overall Study|Withdrawal by Subject|2
7282499|NCT00483938|11498184|FG000|Overall Study|Lost to Follow-up|1
7282500|NCT00483938|11498185|FG001|Overall Study|Lost to Follow-up|2
7282501|NCT00483938|11498186|FG002|Overall Study|Lost to Follow-up|0
7282502|NCT00483938|11498187|FG003|Overall Study|Lost to Follow-up|2
7282503|NCT00483938|11498188|FG004|Overall Study|Lost to Follow-up|1
7282504|NCT00483938|11498189|FG005|Overall Study|Lost to Follow-up|1
7282505|NCT00483938|11498190|FG006|Overall Study|Lost to Follow-up|3
7282506|NCT00483938|11498184|FG000|Overall Study|Death|0
7282507|NCT00483938|11498185|FG001|Overall Study|Death|2
7282508|NCT00483938|11498186|FG002|Overall Study|Death|0
7282509|NCT00483938|11498187|FG003|Overall Study|Death|0
7282510|NCT00483938|11498188|FG004|Overall Study|Death|0
7282511|NCT00483938|11498189|FG005|Overall Study|Death|0
7282512|NCT00483938|11498190|FG006|Overall Study|Death|0
7282513|NCT00483938|11498184|FG000|Overall Study|Other|3
7282514|NCT00483938|11498185|FG001|Overall Study|Other|9
7282515|NCT00483938|11498186|FG002|Overall Study|Other|0
7282516|NCT00483938|11498187|FG003|Overall Study|Other|4
7282517|NCT00483938|11498188|FG004|Overall Study|Other|0
7282518|NCT00483938|11498189|FG005|Overall Study|Other|4
7282519|NCT00483938|11498190|FG006|Overall Study|Other|32
7282520|NCT00484094|11498209|FG000|Overall Study|Discontinued|39
7282521|NCT00484094|11498209|FG000|Overall Study|Other|3
7282522|NCT00484159|11498216|FG000|Overall Study|Lost to Follow-up|1
7282523|NCT00484159|11498217|FG001|Overall Study|Lost to Follow-up|1
7282524|NCT00484159|11498218|FG002|Overall Study|Lost to Follow-up|0
7282525|NCT00484185|11498226|FG000|Overall Study|Lost to Follow-up|44
7282526|NCT00484185|11498226|FG000|Overall Study|Other|20
7282527|NCT00484185|11498226|FG000|Overall Study|Randomized but not treated|5
7282528|NCT00484185|11498226|FG000|Overall Study|Death|2
7282529|NCT00484198|11498234|FG000|Overall Study|Participant Withdrew Consent|12
7282530|NCT00484198|11498235|FG001|Overall Study|Participant Withdrew Consent|21
7282531|NCT00484198|11498236|FG002|Overall Study|Participant Withdrew Consent|47
7282532|NCT00484198|11498237|FG003|Overall Study|Participant Withdrew Consent|59
7282533|NCT00484198|11498234|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
7282534|NCT00484198|11498235|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
7282535|NCT00484198|11498236|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
7282536|NCT00484198|11498237|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
7621979|NCT01399372|12032602|FG000|Overall Study|Protocol Violation|3
7621980|NCT01399372|12032603|FG001|Overall Study|Protocol Violation|1
7621983|NCT01082211|12032638|FG000|Overall Study|Protocol Violation|4
7621984|NCT01082211|12032638|FG000|Overall Study|No protocol treatment received|3
7621985|NCT00976911|12032658|FG000|Overall Study|Withdrawal by Subject|4
7621986|NCT00976911|12032659|FG001|Overall Study|Withdrawal by Subject|6
7621987|NCT00976911|12032658|FG000|Overall Study|Death|138
7621988|NCT00976911|12032659|FG001|Overall Study|Death|126
7621989|NCT00976911|12032658|FG000|Overall Study|Adverse Event|0
7621990|NCT00976911|12032659|FG001|Overall Study|Adverse Event|1
7621991|NCT00976911|12032658|FG000|Overall Study|Protocol Violation|2
7621992|NCT00976911|12032659|FG001|Overall Study|Protocol Violation|0
7621993|NCT00976911|12032658|FG000|Overall Study|Other|8
7621994|NCT00976911|12032659|FG001|Overall Study|Other|9
7621995|NCT00976911|12032658|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
7621996|NCT00976911|12032659|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
7282537|NCT00484198|11498234|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
7282538|NCT00484198|11498235|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
7622032|NCT00573131|12032718|FG000|Overall Study|Withdrawal by Subject|10
7622033|NCT00573131|12032719|FG001|Overall Study|Withdrawal by Subject|8
7622034|NCT00533949|12032729|FG000|Overall Study|Protocol Violation|12
7622035|NCT00533949|12032730|FG001|Overall Study|Protocol Violation|12
7622036|NCT00533949|12032731|FG002|Overall Study|Protocol Violation|9
7622037|NCT00533949|12032732|FG003|Overall Study|Protocol Violation|9
7622038|NCT00533949|12032729|FG000|Overall Study|Withdrawal by Subject|3
7622039|NCT00533949|12032730|FG001|Overall Study|Withdrawal by Subject|2
7622040|NCT00533949|12032731|FG002|Overall Study|Withdrawal by Subject|1
7622041|NCT00533949|12032732|FG003|Overall Study|Withdrawal by Subject|1
7622042|NCT00529763|12032753|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
7622043|NCT00529763|12032754|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
7622044|NCT00529763|12032755|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
7622045|NCT00529763|12032753|FG000|Overall Study|Death|0
7622046|NCT00529763|12032754|FG001|Overall Study|Death|1
7622047|NCT00529763|12032755|FG002|Overall Study|Death|1
7622048|NCT00529763|12032753|FG000|Overall Study|Disease Progression|6
7622049|NCT00529763|12032754|FG001|Overall Study|Disease Progression|16
7622050|NCT00529763|12032755|FG002|Overall Study|Disease Progression|1
7622051|NCT00529763|12032753|FG000|Overall Study|Lost to Follow-up|0
7622052|NCT00529763|12032754|FG001|Overall Study|Lost to Follow-up|1
7622053|NCT00529763|12032755|FG002|Overall Study|Lost to Follow-up|1
7282539|NCT00484198|11498236|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
7622054|NCT00529763|12032753|FG000|Overall Study|Stem Cell Transplant|0
7622055|NCT00529763|12032754|FG001|Overall Study|Stem Cell Transplant|3
7622056|NCT00529763|12032755|FG002|Overall Study|Stem Cell Transplant|0
7622057|NCT00529763|12032753|FG000|Overall Study|Study Drug Toxicity|1
7622058|NCT00529763|12032754|FG001|Overall Study|Study Drug Toxicity|6
7622059|NCT00529763|12032755|FG002|Overall Study|Study Drug Toxicity|1
7622060|NCT00529763|12032753|FG000|Overall Study|Patient Withdrew Consent|2
7622061|NCT00529763|12032754|FG001|Overall Study|Patient Withdrew Consent|3
7622062|NCT00529763|12032755|FG002|Overall Study|Patient Withdrew Consent|2
7622063|NCT00479765|12032770|FG000|Overall Study|study terminated|4
7622064|NCT00450411|12032774|FG000|Overall Study|Protocol Violation|6
7622065|NCT00450411|12032774|FG000|Overall Study|No protocol treatment|2
7622066|NCT00412880|12032778|FG000|Overall Study|Withdrew, overdose of study treatment|1
7622067|NCT00412880|12032778|FG000|Overall Study|Consent withdrawn|1
7622068|NCT00412880|12032778|FG000|Overall Study|Adverse Event|1
7282540|NCT00484198|11498237|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
7282541|NCT00484198|11498234|FG000|Overall Study|Adverse Event|3
7282542|NCT00484198|11498235|FG001|Overall Study|Adverse Event|11
7282543|NCT00484198|11498236|FG002|Overall Study|Adverse Event|32
7282544|NCT00484198|11498237|FG003|Overall Study|Adverse Event|31
7282545|NCT00484198|11498234|FG000|Overall Study|Protocol Violation|0
7282546|NCT00484198|11498235|FG001|Overall Study|Protocol Violation|5
7282547|NCT00484198|11498236|FG002|Overall Study|Protocol Violation|6
7282548|NCT00484198|11498237|FG003|Overall Study|Protocol Violation|8
7282549|NCT00484198|11498234|FG000|Overall Study|Other|7
7282550|NCT00484198|11498235|FG001|Overall Study|Other|10
7282551|NCT00484198|11498236|FG002|Overall Study|Other|31
7282552|NCT00484198|11498237|FG003|Overall Study|Other|28
7282553|NCT00484289|11498255|FG000|Long Term Phase|Adverse Event|1
7282554|NCT00484289|11498256|FG001|Long Term Phase|Adverse Event|17
7282555|NCT00484289|11498257|FG002|Long Term Phase|Adverse Event|5
7282556|NCT00484289|11498255|FG000|Long Term Phase|Withdrawal by Subject|0
7282557|NCT00484289|11498256|FG001|Long Term Phase|Withdrawal by Subject|7
7282558|NCT00484289|11498257|FG002|Long Term Phase|Withdrawal by Subject|6
7282559|NCT00484289|11498255|FG000|Long Term Phase|Inadequate response|2
7282560|NCT00484289|11498256|FG001|Long Term Phase|Inadequate response|7
7282561|NCT00484289|11498257|FG002|Long Term Phase|Inadequate response|4
7282562|NCT00484289|11498255|FG000|Long Term Phase|Other Reason|0
7282563|NCT00484289|11498256|FG001|Long Term Phase|Other Reason|5
7282564|NCT00484289|11498257|FG002|Long Term Phase|Other Reason|1
7282565|NCT00484289|11498255|FG000|Post Marketing Phase|Adverse Event|0
7282566|NCT00484289|11498256|FG001|Post Marketing Phase|Adverse Event|1
7282567|NCT00484289|11498257|FG002|Post Marketing Phase|Adverse Event|0
7282568|NCT00484315|11498268|FG000|12-Month Clinical Follow-up|Death|6
7282569|NCT00484315|11498269|FG001|12-Month Clinical Follow-up|Death|2
7282570|NCT00484315|11498268|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
7282571|NCT00484315|11498269|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
7282572|NCT00484315|11498268|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
7282573|NCT00484315|11498269|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
7282574|NCT00484315|11498268|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
7282575|NCT00484315|11498269|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
7282576|NCT00484315|11498268|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
7282577|NCT00484315|11498269|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
7282578|NCT00484315|11498268|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
7282579|NCT00484315|11498269|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
7282580|NCT00484315|11498268|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
7282581|NCT00484315|11498269|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
7282582|NCT00484679|11498293|FG000|Overall Study|Withdrawal by Subject|3
7282583|NCT00484939|11498306|FG000|Overall Study|Death|9
7282584|NCT00484939|11498307|FG001|Overall Study|Death|13
7282585|NCT00484939|11498306|FG000|Overall Study|Adverse Event|22
7282586|NCT00484939|11498307|FG001|Overall Study|Adverse Event|12
7282587|NCT00484939|11498306|FG000|Overall Study|Patient Withdrew Consent|19
7282588|NCT00484939|11498307|FG001|Overall Study|Patient Withdrew Consent|10
7282589|NCT00484939|11498306|FG000|Overall Study|Protocol Violation|3
7282590|NCT00484939|11498307|FG001|Overall Study|Protocol Violation|3
7282591|NCT00484939|11498306|FG000|Overall Study|Lost to Follow-up|0
7282592|NCT00484939|11498307|FG001|Overall Study|Lost to Follow-up|3
7282593|NCT00484939|11498306|FG000|Overall Study|Discretion of Investigator or Sponsor|7
7282594|NCT00484939|11498307|FG001|Overall Study|Discretion of Investigator or Sponsor|3
7282595|NCT00484939|11498306|FG000|Overall Study|Disease progression|67
7282596|NCT00484939|11498307|FG001|Overall Study|Disease progression|88
7282597|NCT00484939|11498306|FG000|Overall Study|Screen Failure|2
7282598|NCT00484939|11498307|FG001|Overall Study|Screen Failure|2
7282599|NCT00484939|11498306|FG000|Overall Study|Reason Not Specified|11
7282600|NCT00484939|11498307|FG001|Overall Study|Reason Not Specified|6
7282601|NCT00485069|11498315|FG000|Overall Study|Adverse Event|10
7282602|NCT00485069|11498316|FG001|Overall Study|Adverse Event|4
7282603|NCT00485069|11498315|FG000|Overall Study|Lack of Efficacy|2
7282604|NCT00485069|11498316|FG001|Overall Study|Lack of Efficacy|1
7282605|NCT00485069|11498315|FG000|Overall Study|Protocol Violation|0
7282606|NCT00485069|11498316|FG001|Overall Study|Protocol Violation|1
7282607|NCT00485069|11498315|FG000|Overall Study|Withdrawal by Subject|6
7282608|NCT00485069|11498316|FG001|Overall Study|Withdrawal by Subject|6
7282609|NCT00485134|11498337|FG000|Overall Study|Lost to Follow-up|1
7282610|NCT00485134|11498338|FG001|Overall Study|Lost to Follow-up|0
7282611|NCT00485134|11498339|FG002|Overall Study|Lost to Follow-up|0
7622069|NCT00412880|12032778|FG000|Overall Study|Progressive disease|20
7622070|NCT00376623|12032785|FG000|Overall Study|Progressive disease|35
7622071|NCT00376623|12032786|FG001|Overall Study|Progressive disease|22
7622072|NCT00376623|12032787|FG002|Overall Study|Progressive disease|17
7622073|NCT00376623|12032785|FG000|Overall Study|Lost to Follow-up|0
7622074|NCT00376623|12032786|FG001|Overall Study|Lost to Follow-up|1
7622075|NCT00376623|12032787|FG002|Overall Study|Lost to Follow-up|0
7622076|NCT00376623|12032785|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6
7622077|NCT00376623|12032786|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1
7622078|NCT00376623|12032787|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2
7622079|NCT00376623|12032785|FG000|Overall Study|Not treated with BI 2536|1
7622080|NCT00376623|12032786|FG001|Overall Study|Not treated with BI 2536|0
7622081|NCT00376623|12032787|FG002|Overall Study|Not treated with BI 2536|0
7622082|NCT00376623|12032785|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1
7622083|NCT00376623|12032786|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622084|NCT00376623|12032787|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622085|NCT00376623|12032785|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1
7622086|NCT00376623|12032786|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
7622087|NCT00376623|12032787|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0
7622088|NCT00376623|12032785|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2
7622089|NCT00376623|12032786|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
7622090|NCT00376623|12032787|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0
7622091|NCT00376623|12032785|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0
7622092|NCT00376623|12032786|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1
7622093|NCT00376623|12032787|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0
7622094|NCT00376623|12032785|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622095|NCT00376623|12032786|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0
7622096|NCT00376623|12032787|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1
7622097|NCT00376623|12032785|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2
7622098|NCT00376623|12032786|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0
7622099|NCT00376623|12032787|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1
7622100|NCT00376623|12032785|FG000|Overall Study|Increase of tumour markers|0
7622101|NCT00376623|12032786|FG001|Overall Study|Increase of tumour markers|1
7622102|NCT00376623|12032787|FG002|Overall Study|Increase of tumour markers|0
7622103|NCT00376623|12032785|FG000|Overall Study|Bone metastasis|1
7622104|NCT00376623|12032786|FG001|Overall Study|Bone metastasis|0
7622105|NCT00376623|12032787|FG002|Overall Study|Bone metastasis|0
7622106|NCT00288080|12032803|FG000|Overall Study|Withdrawal by Subject|1
7622107|NCT00288080|12032804|FG001|Overall Study|Withdrawal by Subject|3
7622108|NCT00288080|12032803|FG000|Overall Study|Protocol Violation|25
7622109|NCT00288080|12032804|FG001|Overall Study|Protocol Violation|20
7282612|NCT00485134|11498340|FG003|Overall Study|Lost to Follow-up|0
7282613|NCT00485134|11498341|FG004|Overall Study|Lost to Follow-up|0
7282614|NCT00485134|11498342|FG005|Overall Study|Lost to Follow-up|0
7282615|NCT00485134|11498343|FG006|Overall Study|Lost to Follow-up|0
7282616|NCT00485134|11498344|FG007|Overall Study|Lost to Follow-up|0
7282617|NCT00485134|11498337|FG000|Overall Study|Withdrawal by Subject|0
7282618|NCT00485134|11498338|FG001|Overall Study|Withdrawal by Subject|1
7282619|NCT00485134|11498339|FG002|Overall Study|Withdrawal by Subject|0
7282620|NCT00485134|11498340|FG003|Overall Study|Withdrawal by Subject|0
7282621|NCT00485134|11498341|FG004|Overall Study|Withdrawal by Subject|0
7282622|NCT00485134|11498342|FG005|Overall Study|Withdrawal by Subject|0
7622118|NCT04794270|12032853|FG000|Period 1|Non Compliance|1
7622119|NCT04794270|12032854|FG001|Period 1|Non Compliance|0
7622120|NCT04794270|12032853|FG000|Period 1|Adverse Event|1
7622121|NCT04794270|12032854|FG001|Period 1|Adverse Event|0
7622122|NCT04794270|12032853|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
7622123|NCT04794270|12032854|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
7622124|NCT04327986|12032893|FG000|Overall Study|Physician Decision|2
7622125|NCT04327986|12032894|FG001|Overall Study|Physician Decision|0
7622126|NCT04327986|12032895|FG002|Overall Study|Physician Decision|0
7622127|NCT04327986|12032893|FG000|Overall Study|Death|1
7622128|NCT04327986|12032894|FG001|Overall Study|Death|0
7622129|NCT04327986|12032895|FG002|Overall Study|Death|0
7622130|NCT03655054|12032926|FG000|Overall Study|Lost to Follow-up|1
7622131|NCT03542266|12032941|FG000|Treatment Phase|Withdrawal by Subject|1
7622132|NCT03542266|12032941|FG000|Treatment Phase|Adverse Event|1
7622133|NCT03542266|12032941|FG000|Treatment Phase|PD|1
7622134|NCT03529409|12032948|FG000|Randomized|Lost to Follow-up|0
7622135|NCT03529409|12032949|FG001|Randomized|Lost to Follow-up|0
7622136|NCT03529409|12032950|FG002|Randomized|Lost to Follow-up|4
7622137|NCT03529409|12032948|FG000|Randomized|Excluded|0
7622138|NCT03529409|12032949|FG001|Randomized|Excluded|0
7622139|NCT03529409|12032950|FG002|Randomized|Excluded|1
7622140|NCT03529409|12032948|FG000|Post-treatment Assessment|Death|1
7622141|NCT03529409|12032949|FG001|Post-treatment Assessment|Death|0
7622142|NCT03529409|12032950|FG002|Post-treatment Assessment|Death|0
7622143|NCT03529409|12032948|FG000|Post-treatment Assessment|Lost to Follow-up|1
7622144|NCT03529409|12032949|FG001|Post-treatment Assessment|Lost to Follow-up|1
7622145|NCT03529409|12032950|FG002|Post-treatment Assessment|Lost to Follow-up|0
7622146|NCT03529409|12032948|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
7622147|NCT03529409|12032949|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
7622148|NCT03529409|12032950|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
7622149|NCT03529409|12032948|FG000|Follow-up Assessment|Death|1
7622150|NCT03529409|12032949|FG001|Follow-up Assessment|Death|0
7622151|NCT03529409|12032950|FG002|Follow-up Assessment|Death|0
7622152|NCT03529409|12032948|FG000|Follow-up Assessment|Withdrawal by Subject|0
7622153|NCT03529409|12032949|FG001|Follow-up Assessment|Withdrawal by Subject|1
7622154|NCT03529409|12032950|FG002|Follow-up Assessment|Withdrawal by Subject|0
7622155|NCT03516812|12032957|FG000|Overall Study|Adverse Event|4
7622156|NCT03516812|12032957|FG000|Overall Study|Lack of Efficacy|2
7622157|NCT03463577|12032971|FG000|Overall Study|Lost to Follow-up|238
7622158|NCT03463577|12032972|FG001|Overall Study|Lost to Follow-up|435
7622159|NCT03463577|12032973|FG002|Overall Study|Lost to Follow-up|0
7622160|NCT03463577|12032974|FG003|Overall Study|Lost to Follow-up|0
7622161|NCT03463577|12032975|FG004|Overall Study|Lost to Follow-up|0
7622162|NCT03463577|12032976|FG005|Overall Study|Lost to Follow-up|0
7622163|NCT03463577|12032971|FG000|Overall Study|With unknown pregnancy outcome|0
7622164|NCT03463577|12032972|FG001|Overall Study|With unknown pregnancy outcome|5
7622165|NCT03463577|12032973|FG002|Overall Study|With unknown pregnancy outcome|0
7622166|NCT03463577|12032974|FG003|Overall Study|With unknown pregnancy outcome|0
7282623|NCT00485134|11498343|FG006|Overall Study|Withdrawal by Subject|0
7282624|NCT00485134|11498344|FG007|Overall Study|Withdrawal by Subject|0
7282625|NCT00485134|11498337|FG000|Overall Study|Change in health status|0
7282626|NCT00485134|11498338|FG001|Overall Study|Change in health status|1
7282627|NCT00485134|11498339|FG002|Overall Study|Change in health status|2
7282628|NCT00485134|11498340|FG003|Overall Study|Change in health status|1
7282629|NCT00485134|11498341|FG004|Overall Study|Change in health status|0
7282630|NCT00485134|11498342|FG005|Overall Study|Change in health status|1
7282631|NCT00485134|11498343|FG006|Overall Study|Change in health status|0
7282632|NCT00485134|11498344|FG007|Overall Study|Change in health status|0
7282633|NCT00485134|11498337|FG000|Overall Study|Withdrew for adverse event|0
7282634|NCT00485134|11498338|FG001|Overall Study|Withdrew for adverse event|0
7282635|NCT00485134|11498339|FG002|Overall Study|Withdrew for adverse event|1
7282636|NCT00485134|11498340|FG003|Overall Study|Withdrew for adverse event|0
7282637|NCT00485134|11498341|FG004|Overall Study|Withdrew for adverse event|0
7282638|NCT00485134|11498342|FG005|Overall Study|Withdrew for adverse event|0
7282639|NCT00485134|11498343|FG006|Overall Study|Withdrew for adverse event|0
7282640|NCT00485134|11498344|FG007|Overall Study|Withdrew for adverse event|0
7282641|NCT00485134|11498337|FG000|Overall Study|Positive drug test|0
7282642|NCT00485134|11498338|FG001|Overall Study|Positive drug test|0
7282643|NCT00485134|11498339|FG002|Overall Study|Positive drug test|0
7282644|NCT00485134|11498340|FG003|Overall Study|Positive drug test|0
7282645|NCT00485134|11498341|FG004|Overall Study|Positive drug test|2
7282646|NCT00485134|11498342|FG005|Overall Study|Positive drug test|1
7282647|NCT00485134|11498343|FG006|Overall Study|Positive drug test|0
7282648|NCT00485134|11498344|FG007|Overall Study|Positive drug test|0
7282649|NCT00485134|11498337|FG000|Overall Study|Non-compliance|0
7622167|NCT03463577|12032975|FG004|Overall Study|With unknown pregnancy outcome|0
7622168|NCT03463577|12032976|FG005|Overall Study|With unknown pregnancy outcome|0
7622169|NCT03463577|12032971|FG000|Overall Study|Maternal death|2
7622170|NCT03463577|12032972|FG001|Overall Study|Maternal death|0
7622171|NCT03463577|12032973|FG002|Overall Study|Maternal death|0
7622172|NCT03463577|12032974|FG003|Overall Study|Maternal death|0
7282650|NCT00485134|11498338|FG001|Overall Study|Non-compliance|0
7622173|NCT03463577|12032975|FG004|Overall Study|Maternal death|0
7622174|NCT03463577|12032976|FG005|Overall Study|Maternal death|0
7622175|NCT03463577|12032971|FG000|Overall Study|Neonatal death|0
7622176|NCT03463577|12032972|FG001|Overall Study|Neonatal death|0
7622177|NCT03463577|12032973|FG002|Overall Study|Neonatal death|0
7622178|NCT03463577|12032974|FG003|Overall Study|Neonatal death|15
7622179|NCT03463577|12032975|FG004|Overall Study|Neonatal death|17
7622180|NCT03463577|12032976|FG005|Overall Study|Neonatal death|0
7622181|NCT03373760|12032992|FG000|Overall Study|Adverse Event|8
7622182|NCT03373760|12032992|FG000|Overall Study|Disease Progression|46
7622183|NCT03373760|12032992|FG000|Overall Study|Death|4
7622184|NCT03253627|12033001|FG000|Overall Study|Lost to Follow-up|1
7622185|NCT03253627|12033002|FG001|Overall Study|Lost to Follow-up|2
7622186|NCT03253627|12033001|FG000|Overall Study|Withdrawal by Subject|0
7622187|NCT03253627|12033002|FG001|Overall Study|Withdrawal by Subject|2
7622188|NCT03253627|12033001|FG000|Overall Study|Inability to complete MRI|1
7622189|NCT03253627|12033002|FG001|Overall Study|Inability to complete MRI|0
7622190|NCT03168555|12033008|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1
7622191|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1
7622192|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Adverse Event|1
7622193|NCT03168555|12033008|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2
7282651|NCT00485134|11498339|FG002|Overall Study|Non-compliance|0
7282652|NCT00485134|11498340|FG003|Overall Study|Non-compliance|0
7282653|NCT00485134|11498341|FG004|Overall Study|Non-compliance|1
7282654|NCT00485134|11498342|FG005|Overall Study|Non-compliance|2
7282655|NCT00485134|11498343|FG006|Overall Study|Non-compliance|2
7282656|NCT00485134|11498344|FG007|Overall Study|Non-compliance|0
7282657|NCT00485134|11498337|FG000|Overall Study|Unable to comply with study schedule|0
7282658|NCT00485134|11498338|FG001|Overall Study|Unable to comply with study schedule|0
7282659|NCT00485134|11498339|FG002|Overall Study|Unable to comply with study schedule|0
7282660|NCT00485134|11498340|FG003|Overall Study|Unable to comply with study schedule|0
7282661|NCT00485134|11498341|FG004|Overall Study|Unable to comply with study schedule|0
7282662|NCT00485134|11498342|FG005|Overall Study|Unable to comply with study schedule|0
7282663|NCT00485134|11498343|FG006|Overall Study|Unable to comply with study schedule|0
7282664|NCT00485134|11498344|FG007|Overall Study|Unable to comply with study schedule|1
7282665|NCT00485134|11498337|FG000|Overall Study|Pregnancy|0
7282666|NCT00485134|11498338|FG001|Overall Study|Pregnancy|0
7282667|NCT00485134|11498339|FG002|Overall Study|Pregnancy|0
7282668|NCT00485134|11498340|FG003|Overall Study|Pregnancy|0
7282669|NCT00485134|11498341|FG004|Overall Study|Pregnancy|0
7282670|NCT00485134|11498342|FG005|Overall Study|Pregnancy|0
7282671|NCT00485134|11498343|FG006|Overall Study|Pregnancy|1
7282672|NCT00485134|11498344|FG007|Overall Study|Pregnancy|0
7282673|NCT00485173|11498358|FG000|Overall Study|Death|4
7282674|NCT00485173|11498359|FG001|Overall Study|Death|3
7282675|NCT00485173|11498358|FG000|Overall Study|Lost to Follow-up|32
7282676|NCT00485173|11498359|FG001|Overall Study|Lost to Follow-up|61
7282677|NCT00485264|11498371|FG000|Overall Study|Enrolled But Not Given Treatment|0
7282678|NCT00485264|11498372|FG001|Overall Study|Enrolled But Not Given Treatment|0
7282679|NCT00485264|11498373|FG002|Overall Study|Enrolled But Not Given Treatment|0
7282680|NCT00485264|11498374|FG003|Overall Study|Enrolled But Not Given Treatment|0
7282681|NCT00485264|11498375|FG004|Overall Study|Enrolled But Not Given Treatment|1
7282682|NCT00485264|11498376|FG005|Overall Study|Enrolled But Not Given Treatment|0
7282683|NCT00485264|11498371|FG000|Overall Study|Death|1
7282684|NCT00485264|11498372|FG001|Overall Study|Death|0
7282685|NCT00485264|11498373|FG002|Overall Study|Death|0
7622194|NCT03135119|12033017|FG000|Overall Study|Lost to Follow-up|2
7622195|NCT03135119|12033018|FG001|Overall Study|Lost to Follow-up|0
7622196|NCT03135119|12033017|FG000|Overall Study|Physician Decision|1
7622197|NCT03135119|12033018|FG001|Overall Study|Physician Decision|1
7622198|NCT03135119|12033017|FG000|Overall Study|COVID-19 Shutdown|2
7622199|NCT03135119|12033018|FG001|Overall Study|COVID-19 Shutdown|2
7622200|NCT03128411|12033024|FG000|Treatment Phase|Adverse Event|21
7622201|NCT03128411|12033024|FG000|Treatment Phase|Physician Decision|1
7622202|NCT03128411|12033024|FG000|Treatment Phase|Other|2
7622203|NCT03128411|12033024|FG000|Long Term Follow-up Phase|Death|2
7622204|NCT03097328|12033028|FG000|Overall Study|Still on Therapy|2
7622205|NCT03097328|12033028|FG000|Overall Study|Progressive Disease|29
7622206|NCT03097328|12033028|FG000|Overall Study|Adverse Event|4
7622207|NCT03097328|12033028|FG000|Overall Study|Withdrawal by Subject|1
7622208|NCT03097328|12033028|FG000|Overall Study|Physician Decision|1
7622209|NCT03097328|12033028|FG000|Overall Study|Patient Decision|1
7622210|NCT03097328|12033028|FG000|Overall Study|Ineligible for Study Drug|1
7622211|NCT03068715|12033034|FG000|Overall Study|No longer met inclusion criteria|1
7622212|NCT03068715|12033035|FG001|Overall Study|No longer met inclusion criteria|0
7622213|NCT02981472|12033045|FG000|Pre-Treatment Period|Participant withdrew consent|2
7622214|NCT02981472|12033046|FG001|Pre-Treatment Period|Participant withdrew consent|1
7622215|NCT02981472|12033045|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1
7622216|NCT02981472|12033046|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
7622217|NCT02981472|12033045|FG000|Treatment Period|Adverse Event|6
7282686|NCT00485264|11498374|FG003|Overall Study|Death|0
7282687|NCT00485264|11498375|FG004|Overall Study|Death|1
7282688|NCT00485264|11498376|FG005|Overall Study|Death|0
7282689|NCT00485264|11498371|FG000|Overall Study|Adverse Event|1
7282690|NCT00485264|11498372|FG001|Overall Study|Adverse Event|0
7282691|NCT00485264|11498373|FG002|Overall Study|Adverse Event|2
7282692|NCT00485264|11498374|FG003|Overall Study|Adverse Event|3
7282693|NCT00485264|11498375|FG004|Overall Study|Adverse Event|1
7282694|NCT00485264|11498376|FG005|Overall Study|Adverse Event|3
7282695|NCT00485264|11498371|FG000|Overall Study|Pregnancy|4
7282696|NCT00485264|11498372|FG001|Overall Study|Pregnancy|0
7282697|NCT00485264|11498373|FG002|Overall Study|Pregnancy|0
7282698|NCT00485264|11498374|FG003|Overall Study|Pregnancy|0
7282699|NCT00485264|11498375|FG004|Overall Study|Pregnancy|0
7282700|NCT00485264|11498376|FG005|Overall Study|Pregnancy|0
7282701|NCT00485264|11498371|FG000|Overall Study|Disallowed Medication|0
7282702|NCT00485264|11498372|FG001|Overall Study|Disallowed Medication|0
7282703|NCT00485264|11498373|FG002|Overall Study|Disallowed Medication|0
7282704|NCT00485264|11498374|FG003|Overall Study|Disallowed Medication|0
7282705|NCT00485264|11498375|FG004|Overall Study|Disallowed Medication|0
7282706|NCT00485264|11498376|FG005|Overall Study|Disallowed Medication|1
7282707|NCT00485264|11498371|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
7282708|NCT00485264|11498372|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
7282709|NCT00485264|11498373|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
7282710|NCT00485264|11498374|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
7282711|NCT00485264|11498375|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
7282712|NCT00485264|11498376|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
7282713|NCT00485264|11498371|FG000|Overall Study|Lack of Efficacy|0
7282714|NCT00485264|11498372|FG001|Overall Study|Lack of Efficacy|1
7282715|NCT00485264|11498373|FG002|Overall Study|Lack of Efficacy|0
7622218|NCT02981472|12033046|FG001|Treatment Period|Adverse Event|1
7622219|NCT02981472|12033045|FG000|Treatment Period|Participant withdrew consent|1
7622220|NCT02981472|12033046|FG001|Treatment Period|Participant withdrew consent|0
7622221|NCT02981472|12033045|FG000|Treatment Period|Lost to Follow-up|0
7622222|NCT02981472|12033046|FG001|Treatment Period|Lost to Follow-up|1
7622223|NCT02853760|12033058|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
7622224|NCT02853760|12033059|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
7622225|NCT02853760|12033060|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
7622226|NCT02853760|12033061|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
7622227|NCT02853760|12033062|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
7622228|NCT02853760|12033063|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
7622229|NCT02789657|12033075|FG000|Overall Study|Withdrawal by Subject|2
7622230|NCT02789657|12033076|FG001|Overall Study|Withdrawal by Subject|0
7622231|NCT02789657|12033077|FG002|Overall Study|Withdrawal by Subject|0
7622232|NCT02789657|12033078|FG003|Overall Study|Withdrawal by Subject|0
7622233|NCT02743871|12033101|FG000|Overall Study|Lost to Follow-up|0
7622234|NCT02743871|12033102|FG001|Overall Study|Lost to Follow-up|0
7622235|NCT02743871|12033103|FG002|Overall Study|Lost to Follow-up|0
7622236|NCT02743871|12033104|FG003|Overall Study|Lost to Follow-up|1
7622237|NCT02743871|12033105|FG004|Overall Study|Lost to Follow-up|0
7622238|NCT02743871|12033106|FG005|Overall Study|Lost to Follow-up|0
7622239|NCT02743871|12033107|FG006|Overall Study|Lost to Follow-up|1
7622240|NCT02743871|12033108|FG007|Overall Study|Lost to Follow-up|0
7622241|NCT02743871|12033109|FG008|Overall Study|Lost to Follow-up|0
7622242|NCT02743871|12033110|FG009|Overall Study|Lost to Follow-up|0
7622243|NCT02743871|12033111|FG010|Overall Study|Lost to Follow-up|0
7622244|NCT02743871|12033112|FG011|Overall Study|Lost to Follow-up|2
7622245|NCT02743871|12033113|FG012|Overall Study|Lost to Follow-up|0
7282716|NCT00485264|11498374|FG003|Overall Study|Lack of Efficacy|0
7622246|NCT02743871|12033114|FG013|Overall Study|Lost to Follow-up|0
7622247|NCT02743871|12033101|FG000|Overall Study|Withdrawal by Subject|0
7622248|NCT02743871|12033102|FG001|Overall Study|Withdrawal by Subject|0
7622249|NCT02743871|12033103|FG002|Overall Study|Withdrawal by Subject|0
7622250|NCT02743871|12033104|FG003|Overall Study|Withdrawal by Subject|0
7622251|NCT02743871|12033105|FG004|Overall Study|Withdrawal by Subject|0
7622252|NCT02743871|12033106|FG005|Overall Study|Withdrawal by Subject|0
7622253|NCT02743871|12033107|FG006|Overall Study|Withdrawal by Subject|0
7622254|NCT02743871|12033108|FG007|Overall Study|Withdrawal by Subject|0
7622255|NCT02743871|12033109|FG008|Overall Study|Withdrawal by Subject|0
7622256|NCT02743871|12033110|FG009|Overall Study|Withdrawal by Subject|0
7622257|NCT02743871|12033111|FG010|Overall Study|Withdrawal by Subject|1
7622258|NCT02743871|12033112|FG011|Overall Study|Withdrawal by Subject|0
7622259|NCT02743871|12033113|FG012|Overall Study|Withdrawal by Subject|12
7622260|NCT02743871|12033114|FG013|Overall Study|Withdrawal by Subject|6
7622261|NCT02743871|12033101|FG000|Overall Study|Adverse Event|1
7622262|NCT02743871|12033102|FG001|Overall Study|Adverse Event|0
7622263|NCT02743871|12033103|FG002|Overall Study|Adverse Event|0
7622264|NCT02743871|12033104|FG003|Overall Study|Adverse Event|0
7622265|NCT02743871|12033105|FG004|Overall Study|Adverse Event|0
7622266|NCT02743871|12033106|FG005|Overall Study|Adverse Event|0
7622267|NCT02743871|12033107|FG006|Overall Study|Adverse Event|0
7622268|NCT02743871|12033108|FG007|Overall Study|Adverse Event|0
7622269|NCT02743871|12033109|FG008|Overall Study|Adverse Event|0
7622270|NCT02743871|12033110|FG009|Overall Study|Adverse Event|0
7622271|NCT02743871|12033111|FG010|Overall Study|Adverse Event|0
7622272|NCT02743871|12033112|FG011|Overall Study|Adverse Event|0
7622273|NCT02743871|12033113|FG012|Overall Study|Adverse Event|0
7622274|NCT02743871|12033114|FG013|Overall Study|Adverse Event|0
7622275|NCT02743871|12033101|FG000|Overall Study|Other|0
7622276|NCT02743871|12033102|FG001|Overall Study|Other|0
7622277|NCT02743871|12033103|FG002|Overall Study|Other|0
7622278|NCT02743871|12033104|FG003|Overall Study|Other|0
7622279|NCT02743871|12033105|FG004|Overall Study|Other|0
7622280|NCT02743871|12033106|FG005|Overall Study|Other|0
7622281|NCT02743871|12033107|FG006|Overall Study|Other|0
7622282|NCT02743871|12033108|FG007|Overall Study|Other|0
7622283|NCT02743871|12033109|FG008|Overall Study|Other|0
7622284|NCT02743871|12033110|FG009|Overall Study|Other|0
7622285|NCT02743871|12033111|FG010|Overall Study|Other|0
7622286|NCT02743871|12033112|FG011|Overall Study|Other|1
7622287|NCT02743871|12033113|FG012|Overall Study|Other|1
7622288|NCT02743871|12033114|FG013|Overall Study|Other|1
7622289|NCT02743871|12033101|FG000|Overall Study|Protocol Violation|0
7622290|NCT02743871|12033102|FG001|Overall Study|Protocol Violation|0
7622291|NCT02743871|12033103|FG002|Overall Study|Protocol Violation|0
7622292|NCT02743871|12033104|FG003|Overall Study|Protocol Violation|0
7622293|NCT02743871|12033105|FG004|Overall Study|Protocol Violation|0
7622294|NCT02743871|12033106|FG005|Overall Study|Protocol Violation|0
7622295|NCT02743871|12033107|FG006|Overall Study|Protocol Violation|0
7622296|NCT02743871|12033108|FG007|Overall Study|Protocol Violation|0
7622297|NCT02743871|12033109|FG008|Overall Study|Protocol Violation|0
7622298|NCT02743871|12033110|FG009|Overall Study|Protocol Violation|0
7622299|NCT02743871|12033111|FG010|Overall Study|Protocol Violation|0
7622300|NCT02743871|12033112|FG011|Overall Study|Protocol Violation|0
7622301|NCT02743871|12033113|FG012|Overall Study|Protocol Violation|2
7622302|NCT02743871|12033114|FG013|Overall Study|Protocol Violation|0
7622303|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Adverse Event|7
7622304|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Adverse Event|3
7622305|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Adverse Event|2
7622306|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Adverse Event|0
7622307|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4
7622308|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
7622309|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
7622310|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
7217757|NCT04551898|11425971|FG000|Overall Study|Participant randomized but did not receive study drug|0
7217758|NCT04551898|11425972|FG001|Overall Study|Participant randomized but did not receive study drug|1
7217759|NCT04551898|11425973|FG002|Overall Study|Participant randomized but did not receive study drug|3
7217760|NCT04551898|11425974|FG003|Overall Study|Participant randomized but did not receive study drug|1
7217761|NCT04551898|11425971|FG000|Overall Study|Withdrawal by Subject|5
7217762|NCT04551898|11425972|FG001|Overall Study|Withdrawal by Subject|1
7217763|NCT04551898|11425973|FG002|Overall Study|Withdrawal by Subject|2
7217764|NCT04551898|11425974|FG003|Overall Study|Withdrawal by Subject|2
7217765|NCT04551898|11425971|FG000|Overall Study|Lost to Follow-up|2
7217766|NCT04551898|11425972|FG001|Overall Study|Lost to Follow-up|1
7217767|NCT04551898|11425973|FG002|Overall Study|Lost to Follow-up|2
7217768|NCT04551898|11425974|FG003|Overall Study|Lost to Follow-up|2
7217769|NCT04551898|11425971|FG000|Overall Study|Death|1
7217770|NCT04551898|11425972|FG001|Overall Study|Death|0
7217771|NCT04551898|11425973|FG002|Overall Study|Death|0
7217772|NCT04551898|11425974|FG003|Overall Study|Death|0
7217773|NCT04551898|11425971|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7217774|NCT04551898|11425972|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7217775|NCT04551898|11425973|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1
7217776|NCT04551898|11425974|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
7282717|NCT00485264|11498375|FG004|Overall Study|Lack of Efficacy|0
7282718|NCT00485264|11498376|FG005|Overall Study|Lack of Efficacy|0
7282719|NCT00485264|11498371|FG000|Overall Study|Guardian Consent Withdrawn|1
7282720|NCT00485264|11498372|FG001|Overall Study|Guardian Consent Withdrawn|0
7282721|NCT00485264|11498373|FG002|Overall Study|Guardian Consent Withdrawn|0
7282722|NCT00485264|11498374|FG003|Overall Study|Guardian Consent Withdrawn|0
7282723|NCT00485264|11498375|FG004|Overall Study|Guardian Consent Withdrawn|1
7282724|NCT00485264|11498376|FG005|Overall Study|Guardian Consent Withdrawn|0
7282725|NCT00485264|11498371|FG000|Overall Study|Physician Decision|0
7282726|NCT00485264|11498372|FG001|Overall Study|Physician Decision|2
7282727|NCT00485264|11498373|FG002|Overall Study|Physician Decision|0
7282728|NCT00485264|11498374|FG003|Overall Study|Physician Decision|0
7282729|NCT00485264|11498375|FG004|Overall Study|Physician Decision|0
7282730|NCT00485264|11498376|FG005|Overall Study|Physician Decision|0
7282731|NCT00485264|11498371|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
7282732|NCT00485264|11498372|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
7282733|NCT00485264|11498373|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
7282734|NCT00485264|11498374|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
7282735|NCT00485264|11498375|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
7282736|NCT00485264|11498376|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
7282737|NCT00485264|11498371|FG000|Overall Study|Not Able to Attend Clinic|5
7282738|NCT00485264|11498372|FG001|Overall Study|Not Able to Attend Clinic|0
7282739|NCT00485264|11498373|FG002|Overall Study|Not Able to Attend Clinic|0
7282740|NCT00485264|11498374|FG003|Overall Study|Not Able to Attend Clinic|1
7282741|NCT00485264|11498375|FG004|Overall Study|Not Able to Attend Clinic|1
7282742|NCT00485264|11498376|FG005|Overall Study|Not Able to Attend Clinic|2
7282743|NCT00485264|11498371|FG000|Overall Study|Non-Compliant|17
7282744|NCT00485264|11498372|FG001|Overall Study|Non-Compliant|2
7282745|NCT00485264|11498373|FG002|Overall Study|Non-Compliant|1
7282746|NCT00485264|11498374|FG003|Overall Study|Non-Compliant|0
7282747|NCT00485264|11498375|FG004|Overall Study|Non-Compliant|1
7282748|NCT00485264|11498376|FG005|Overall Study|Non-Compliant|0
7282749|NCT00485264|11498371|FG000|Overall Study|Lost to Follow-up|2
7282750|NCT00485264|11498372|FG001|Overall Study|Lost to Follow-up|1
7282751|NCT00485264|11498373|FG002|Overall Study|Lost to Follow-up|1
7282752|NCT00485264|11498374|FG003|Overall Study|Lost to Follow-up|0
7282753|NCT00485264|11498375|FG004|Overall Study|Lost to Follow-up|0
7282754|NCT00485264|11498376|FG005|Overall Study|Lost to Follow-up|1
7282755|NCT00485264|11498371|FG000|Overall Study|Other Reason|3
7282756|NCT00485264|11498372|FG001|Overall Study|Other Reason|0
7282757|NCT00485264|11498373|FG002|Overall Study|Other Reason|0
7282758|NCT00485264|11498374|FG003|Overall Study|Other Reason|0
7282759|NCT00485264|11498375|FG004|Overall Study|Other Reason|0
7282760|NCT00485264|11498376|FG005|Overall Study|Other Reason|0
7282761|NCT00485303|11498395|FG000|Overall Study|Adverse Event|5
7282762|NCT00485303|11498395|FG000|Overall Study|Progressive Disease|44
7282763|NCT00485303|11498395|FG000|Overall Study|Other|3
7282764|NCT00485303|11498395|FG000|Overall Study|Initiation of new anti-cancer treatment|2
7282765|NCT00485303|11498395|FG000|Overall Study|Treatment ongoing at cutoff date|2
7282766|NCT00485472|11498416|FG000|Overall Study|Adverse Event|8
7282767|NCT00485472|11498417|FG001|Overall Study|Adverse Event|5
7282768|NCT00485472|11498416|FG000|Overall Study|Lack of Efficacy|5
7622311|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9
7622312|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4
7622313|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
7622314|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
7622315|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Physician Decision|2
7622316|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Physician Decision|1
7622317|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Physician Decision|1
7622318|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Physician Decision|0
7622319|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Pregnancy|2
7622320|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Pregnancy|2
7622321|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Pregnancy|0
7622322|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Pregnancy|0
7622323|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Protocol Violation|6
7622324|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Protocol Violation|1
7622325|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Protocol Violation|0
7622326|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Protocol Violation|0
7622327|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Screen failure|0
7622328|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Screen failure|1
7622329|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Screen failure|2
7622330|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Screen failure|0
7622331|NCT02614261|12033176|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20
7622332|NCT02614261|12033177|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5
7622333|NCT02614261|12033178|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7
7622334|NCT02614261|12033179|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
7622335|NCT02614261|12033176|FG000|Open-Label Extension Phase|Adverse Event|23
7622336|NCT02614261|12033177|FG001|Open-Label Extension Phase|Adverse Event|12
7622337|NCT02614261|12033178|FG002|Open-Label Extension Phase|Adverse Event|11
7622338|NCT02614261|12033179|FG003|Open-Label Extension Phase|Adverse Event|0
7622339|NCT02614261|12033176|FG000|Open-Label Extension Phase|Lack of Efficacy|14
7622340|NCT02614261|12033177|FG001|Open-Label Extension Phase|Lack of Efficacy|12
7622341|NCT02614261|12033178|FG002|Open-Label Extension Phase|Lack of Efficacy|14
7622342|NCT02614261|12033179|FG003|Open-Label Extension Phase|Lack of Efficacy|0
7622343|NCT02614261|12033176|FG000|Open-Label Extension Phase|Lost to Follow-up|15
7622344|NCT02614261|12033177|FG001|Open-Label Extension Phase|Lost to Follow-up|7
7282769|NCT00485472|11498417|FG001|Overall Study|Lack of Efficacy|4
7282770|NCT00485472|11498416|FG000|Overall Study|Withdrawal by Subject|1
7282771|NCT00485472|11498417|FG001|Overall Study|Withdrawal by Subject|0
7282772|NCT00485472|11498416|FG000|Overall Study|Protocol Violation|0
7282773|NCT00485472|11498417|FG001|Overall Study|Protocol Violation|1
7282774|NCT00485472|11498416|FG000|Overall Study|Other|2
7282775|NCT00485472|11498417|FG001|Overall Study|Other|1
7282776|NCT00485472|11498416|FG000|Overall Study|Lost to Follow-up|0
7282777|NCT00485472|11498417|FG001|Overall Study|Lost to Follow-up|1
7282778|NCT00485589|11498430|FG000|Overall Study|Death|2
7282779|NCT00485589|11498431|FG001|Overall Study|Death|2
7282780|NCT00485589|11498432|FG002|Overall Study|Death|0
7282781|NCT00485589|11498430|FG000|Overall Study|Failure to return|6
7282782|NCT00485589|11498431|FG001|Overall Study|Failure to return|5
7282783|NCT00485589|11498432|FG002|Overall Study|Failure to return|1
7282784|NCT00485589|11498430|FG000|Overall Study|Protocol Violation|1
7282785|NCT00485589|11498431|FG001|Overall Study|Protocol Violation|0
7282786|NCT00485589|11498432|FG002|Overall Study|Protocol Violation|0
7282787|NCT00485589|11498430|FG000|Overall Study|Violation of selection criteria at entry|0
7282788|NCT00485589|11498431|FG001|Overall Study|Violation of selection criteria at entry|3
7282789|NCT00485589|11498432|FG002|Overall Study|Violation of selection criteria at entry|1
7282790|NCT00485589|11498430|FG000|Overall Study|Administrative/Other|1
7282791|NCT00485589|11498431|FG001|Overall Study|Administrative/Other|2
7282792|NCT00485589|11498432|FG002|Overall Study|Administrative/Other|1
7282793|NCT00485589|11498430|FG000|Overall Study|Insufficient therapeutic response|10
7282794|NCT00485589|11498431|FG001|Overall Study|Insufficient therapeutic response|3
7282795|NCT00485589|11498432|FG002|Overall Study|Insufficient therapeutic response|1
7282796|NCT00485589|11498430|FG000|Overall Study|Refused treatment/did not cooperate|1
7282797|NCT00485589|11498431|FG001|Overall Study|Refused treatment/did not cooperate|0
7282798|NCT00485589|11498432|FG002|Overall Study|Refused treatment/did not cooperate|2
7282799|NCT00485589|11498430|FG000|Overall Study|Withdrawal by Subject|3
7282800|NCT00485589|11498431|FG001|Overall Study|Withdrawal by Subject|2
7282801|NCT00485589|11498432|FG002|Overall Study|Withdrawal by Subject|2
7282802|NCT00485589|11498430|FG000|Overall Study|Adverse Event|3
7282803|NCT00485589|11498431|FG001|Overall Study|Adverse Event|3
7282804|NCT00485589|11498432|FG002|Overall Study|Adverse Event|10
7282805|NCT00485732|11498451|FG000|Overall Study|Protocol Violation|1
7282806|NCT00485732|11498452|FG001|Overall Study|Protocol Violation|3
7282807|NCT00485732|11498451|FG000|Overall Study|Withdrawal by Subject|5
7282808|NCT00485732|11498452|FG001|Overall Study|Withdrawal by Subject|4
7282809|NCT00485732|11498451|FG000|Overall Study|Lost to Follow-up|2
7282810|NCT00485732|11498452|FG001|Overall Study|Lost to Follow-up|2
7622345|NCT02614261|12033178|FG002|Open-Label Extension Phase|Lost to Follow-up|9
7622346|NCT02614261|12033179|FG003|Open-Label Extension Phase|Lost to Follow-up|0
7622347|NCT02614261|12033176|FG000|Open-Label Extension Phase|Physician Decision|2
7282811|NCT00485758|11498460|FG000|Overall Study|Adverse Event|102
7282812|NCT00485758|11498461|FG001|Overall Study|Adverse Event|31
7282813|NCT00485758|11498460|FG000|Overall Study|Death|0
7282814|NCT00485758|11498461|FG001|Overall Study|Death|1
7282815|NCT00485758|11498460|FG000|Overall Study|Lost to Follow-up|5
7282816|NCT00485758|11498461|FG001|Overall Study|Lost to Follow-up|1
7282817|NCT00485758|11498460|FG000|Overall Study|Physician Decision|3
7282818|NCT00485758|11498461|FG001|Overall Study|Physician Decision|3
7282819|NCT00485758|11498460|FG000|Overall Study|Protocol Violation|11
7282820|NCT00485758|11498461|FG001|Overall Study|Protocol Violation|2
7282821|NCT00485758|11498460|FG000|Overall Study|Withdrawal by Subject|32
7282822|NCT00485758|11498461|FG001|Overall Study|Withdrawal by Subject|27
7282823|NCT00485758|11498460|FG000|Overall Study|Study Terminated by Sponsor|3
7282824|NCT00485758|11498461|FG001|Overall Study|Study Terminated by Sponsor|0
7282825|NCT00486044|11498511|FG000|Overall Study|Withdrawal by Subject|2
7282826|NCT00486044|11498512|FG001|Overall Study|Withdrawal by Subject|1
7282827|NCT00486044|11498511|FG000|Overall Study|Adverse Event|0
7282828|NCT00486044|11498512|FG001|Overall Study|Adverse Event|1
7282829|NCT00486044|11498511|FG000|Overall Study|Lost to Follow-up|0
7282830|NCT00486044|11498512|FG001|Overall Study|Lost to Follow-up|1
7282831|NCT00486226|11498518|FG000|Overall Study|Death|3
7282832|NCT00486226|11498518|FG000|Overall Study|Adverse Event|1
7282833|NCT00486226|11498518|FG000|Overall Study|Withdrawal by Subject|1
7282834|NCT00486226|11498518|FG000|Overall Study|Lost to Follow-up|8
7282835|NCT00486252|11498525|FG000|Overall Study|Adverse Event|7
7282836|NCT00486252|11498525|FG000|Overall Study|Lack of Efficacy|9
7282837|NCT00486252|11498525|FG000|Overall Study|Lost to Follow-up|24
7282838|NCT00486252|11498525|FG000|Overall Study|Other|18
7282839|NCT00486265|11498531|FG000|Overall Study|Adverse Event|1
7282840|NCT00486265|11498531|FG000|Overall Study|Lack of Efficacy|8
7282841|NCT00486278|11498535|FG000|Overall Study|Adverse Event|5
7282842|NCT00486278|11498535|FG000|Overall Study|Withdrawal by Subject|2
7282843|NCT00486278|11498535|FG000|Overall Study|Physician Decision|2
7282844|NCT00486291|11498551|FG000|Overall Study|Adverse Event|3
7282845|NCT00486291|11498552|FG001|Overall Study|Adverse Event|4
7282846|NCT00486291|11498551|FG000|Overall Study|Lost to Follow-up|3
7282847|NCT00486291|11498552|FG001|Overall Study|Lost to Follow-up|7
7282848|NCT00486291|11498551|FG000|Overall Study|protocol non-compliance|10
7282849|NCT00486291|11498552|FG001|Overall Study|protocol non-compliance|15
7282850|NCT00486291|11498551|FG000|Overall Study|requirement for restricted medication|0
7282851|NCT00486291|11498552|FG001|Overall Study|requirement for restricted medication|3
7282852|NCT00486330|11498558|FG000|Overall Study|Adverse Event|2
7282853|NCT00486434|11498564|FG000|Overall Study|Withdrawal by Subject|34
7282854|NCT00486434|11498565|FG001|Overall Study|Withdrawal by Subject|39
7282855|NCT00486434|11498564|FG000|Overall Study|Adverse Event|118
7282856|NCT00486434|11498565|FG001|Overall Study|Adverse Event|44
7282857|NCT00486434|11498564|FG000|Overall Study|Protocol Violation|22
7282858|NCT00486434|11498565|FG001|Overall Study|Protocol Violation|21
7282859|NCT00486434|11498564|FG000|Overall Study|Lack of Efficacy|12
7282860|NCT00486434|11498565|FG001|Overall Study|Lack of Efficacy|19
7282861|NCT00486434|11498564|FG000|Overall Study|Lost to Follow-up|2
7282862|NCT00486434|11498565|FG001|Overall Study|Lost to Follow-up|3
7282863|NCT00486434|11498564|FG000|Overall Study|Death|1
7282864|NCT00486434|11498565|FG001|Overall Study|Death|2
7282865|NCT00486434|11498564|FG000|Overall Study|Personal reasons|5
7282866|NCT00486434|11498565|FG001|Overall Study|Personal reasons|6
7282867|NCT00486603|11498588|FG000|Overall Study|Withdrawal by Subject|1
7282868|NCT00486603|11498589|FG001|Overall Study|Withdrawal by Subject|0
7282869|NCT00486603|11498590|FG002|Overall Study|Withdrawal by Subject|0
7282870|NCT00486603|11498591|FG003|Overall Study|Withdrawal by Subject|0
7282871|NCT00486603|11498592|FG004|Overall Study|Withdrawal by Subject|0
7282872|NCT00486603|11498588|FG000|Overall Study|Physician Decision|0
7282873|NCT00486603|11498589|FG001|Overall Study|Physician Decision|1
7282874|NCT00486603|11498590|FG002|Overall Study|Physician Decision|0
7282875|NCT00486603|11498591|FG003|Overall Study|Physician Decision|0
7282876|NCT00486603|11498592|FG004|Overall Study|Physician Decision|0
7282877|NCT00486720|11498620|FG000|Overall Study|Adverse Event|1
7282878|NCT00486720|11498621|FG001|Overall Study|Adverse Event|2
7282879|NCT00486720|11498620|FG000|Overall Study|Lack of Efficacy|4
7282880|NCT00486720|11498621|FG001|Overall Study|Lack of Efficacy|6
7282881|NCT00486720|11498620|FG000|Overall Study|Physician Decision|1
7282882|NCT00486720|11498621|FG001|Overall Study|Physician Decision|2
7282883|NCT00486720|11498620|FG000|Overall Study|Protocol Violation|1
7282884|NCT00486720|11498621|FG001|Overall Study|Protocol Violation|0
7282885|NCT00486720|11498620|FG000|Overall Study|Withdrawal by Subject|3
7282886|NCT00486720|11498621|FG001|Overall Study|Withdrawal by Subject|1
7282887|NCT00486720|11498620|FG000|Overall Study|Progressive Disease|0
7282888|NCT00486720|11498621|FG001|Overall Study|Progressive Disease|1
7282889|NCT00486759|11498629|FG000|Treatment|Adverse event/intercurrent illness|86
7282890|NCT00486759|11498630|FG001|Treatment|Adverse event/intercurrent illness|39
7282891|NCT00486759|11498629|FG000|Treatment|Insufficient therapeutic response|37
7282892|NCT00486759|11498630|FG001|Treatment|Insufficient therapeutic response|39
7282893|NCT00486759|11498629|FG000|Treatment|Death|17
7282894|NCT00486759|11498630|FG001|Treatment|Death|10
7282895|NCT00486759|11498629|FG000|Treatment|Withdrew consent|15
7282896|NCT00486759|11498630|FG001|Treatment|Withdrew consent|12
7282897|NCT00486759|11498629|FG000|Treatment|Administrative/reason not specified|17
7282898|NCT00486759|11498630|FG001|Treatment|Administrative/reason not specified|21
7282899|NCT00486759|11498629|FG000|Treatment|Refused treatment|10
7282900|NCT00486759|11498630|FG001|Treatment|Refused treatment|7
7282901|NCT00486759|11498629|FG000|Treatment|Violation of selection criteria at entry|3
7282902|NCT00486759|11498630|FG001|Treatment|Violation of selection criteria at entry|3
7282903|NCT00486759|11498629|FG000|Treatment|Other protocol violation|1
7282904|NCT00486759|11498630|FG001|Treatment|Other protocol violation|5
7282905|NCT00486759|11498629|FG000|Treatment|Failure to return|1
7282906|NCT00486759|11498630|FG001|Treatment|Failure to return|1
7282907|NCT00486759|11498629|FG000|Safety Follow-up|Insufficient therapeutic response|40
7282908|NCT00486759|11498630|FG001|Safety Follow-up|Insufficient therapeutic response|50
7282909|NCT00486759|11498629|FG000|Safety Follow-up|Death|40
7282910|NCT00486759|11498630|FG001|Safety Follow-up|Death|29
7282911|NCT00486759|11498629|FG000|Safety Follow-up|Withdrew consent|32
7282912|NCT00486759|11498630|FG001|Safety Follow-up|Withdrew consent|23
7282913|NCT00486759|11498629|FG000|Safety Follow-up|Failure to return|9
7282914|NCT00486759|11498630|FG001|Safety Follow-up|Failure to return|6
7282915|NCT00486759|11498629|FG000|Safety Follow-up|Administrative/not specified|8
7282916|NCT00486759|11498630|FG001|Safety Follow-up|Administrative/not specified|6
7282917|NCT00486759|11498629|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
7282918|NCT00486759|11498630|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
7282919|NCT00486759|11498629|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
7282920|NCT00486759|11498630|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
7282921|NCT00486811|11498639|FG000|Overall Study|Adverse Event|28
7282922|NCT00486811|11498640|FG001|Overall Study|Adverse Event|60
7282923|NCT00486811|11498641|FG002|Overall Study|Adverse Event|135
7282924|NCT00486811|11498639|FG000|Overall Study|Lack of Efficacy|34
7282925|NCT00486811|11498640|FG001|Overall Study|Lack of Efficacy|14
7282926|NCT00486811|11498641|FG002|Overall Study|Lack of Efficacy|7
7282927|NCT00486811|11498639|FG000|Overall Study|Lost to Follow-up|4
7282928|NCT00486811|11498640|FG001|Overall Study|Lost to Follow-up|6
7282929|NCT00486811|11498641|FG002|Overall Study|Lost to Follow-up|4
7282930|NCT00486811|11498639|FG000|Overall Study|Withdrawal by Subject|33
7282931|NCT00486811|11498640|FG001|Overall Study|Withdrawal by Subject|44
7282932|NCT00486811|11498641|FG002|Overall Study|Withdrawal by Subject|58
7282933|NCT00486811|11498639|FG000|Overall Study|Study drug non-compliant|5
7282934|NCT00486811|11498640|FG001|Overall Study|Study drug non-compliant|6
7282935|NCT00486811|11498641|FG002|Overall Study|Study drug non-compliant|3
7282936|NCT00486811|11498639|FG000|Overall Study|All other|18
7282937|NCT00486811|11498640|FG001|Overall Study|All other|11
7282938|NCT00486811|11498641|FG002|Overall Study|All other|7
7469867|NCT01927497|11771744|FG000|Overall Study|Death|0
7469868|NCT01927497|11771745|FG001|Overall Study|Death|1
7469869|NCT01927497|11771744|FG000|Overall Study|Protocol Violation|2
7469870|NCT01927497|11771745|FG001|Overall Study|Protocol Violation|0
7469871|NCT01927562|11771751|FG000|Overall Study|Lost to Follow-up|30
7469872|NCT01927562|11771751|FG000|Overall Study|Withdrawal by Subject|3
7469873|NCT01927562|11771751|FG000|Overall Study|Physician Decision|5
7469874|NCT01927627|11771763|FG000|Overall Study|Adverse Event|3
7469875|NCT01927627|11771763|FG000|Overall Study|Lack of Efficacy|1
7469876|NCT01927627|11771763|FG000|Overall Study|Financial Concerns|1
7469877|NCT01927757|11771771|FG000|Overall Study|Withdrawal by Subject|14
7469878|NCT01927757|11771771|FG000|Overall Study|Lost to Follow-up|2
7469879|NCT01927757|11771771|FG000|Overall Study|Decision by Sponsor|2
7469880|NCT01927757|11771771|FG000|Overall Study|Other|1
7469881|NCT01927757|11771771|FG000|Overall Study|Ethical Reasons|4
7469882|NCT01927861|11771781|FG000|Extension Phase (104 Weeks)|Adverse Event|0
7469883|NCT01927861|11771782|FG001|Extension Phase (104 Weeks)|Adverse Event|2
7469884|NCT01927861|11771781|FG000|Extension Phase (104 Weeks)|Unclassified|0
7469885|NCT01927861|11771782|FG001|Extension Phase (104 Weeks)|Unclassified|1
7469886|NCT01928225|11771817|FG000|Overall Study|Pregnancy|1
7469887|NCT01928225|11771818|FG001|Overall Study|Pregnancy|0
7469888|NCT01928225|11771817|FG000|Overall Study|basaloid cervical cancer|1
7469889|NCT01928225|11771818|FG001|Overall Study|basaloid cervical cancer|0
7469890|NCT01928225|11771817|FG000|Overall Study|Lost to Follow-up|1
7469891|NCT01928225|11771818|FG001|Overall Study|Lost to Follow-up|3
7551229|NCT02966834|11910256|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7551230|NCT02966834|11910257|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7551231|NCT02966834|11910258|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7551232|NCT02966834|11910259|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
7551233|NCT02966834|11910254|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7551234|NCT02966834|11910255|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7551235|NCT02966834|11910256|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
7551236|NCT02966834|11910257|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
7551237|NCT02966834|11910258|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
7551238|NCT02966834|11910259|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
7551239|NCT02966834|11910254|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
7551240|NCT02966834|11910255|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
7282939|NCT00486837|11498660|FG000|Overall Study|Withdrawal by Subject|1
7282940|NCT00486837|11498661|FG001|Overall Study|Withdrawal by Subject|0
7282941|NCT00486837|11498660|FG000|Overall Study|Adverse Event|1
7282942|NCT00486837|11498661|FG001|Overall Study|Adverse Event|1
7282943|NCT00486837|11498660|FG000|Overall Study|Protocol Violation|4
7282944|NCT00486837|11498661|FG001|Overall Study|Protocol Violation|2
7282945|NCT00486837|11498660|FG000|Overall Study|No sputum, devise issues, exacerbation|3
7282946|NCT00486837|11498661|FG001|Overall Study|No sputum, devise issues, exacerbation|4
7282947|NCT00486902|11498681|FG000|Overall Study|Withdrawal by Subject|1
7282948|NCT00486902|11498682|FG001|Overall Study|Withdrawal by Subject|2
7282949|NCT00486902|11498681|FG000|Overall Study|decision for postpartum tubal ligation|3
7282950|NCT00486902|11498682|FG001|Overall Study|decision for postpartum tubal ligation|1
7282951|NCT00486902|11498681|FG000|Overall Study|spinal anesthetic protocal violation|1
7282952|NCT00486902|11498682|FG001|Overall Study|spinal anesthetic protocal violation|1
7282953|NCT00486902|11498681|FG000|Overall Study|Did not meet inclusion criteria|1
7282954|NCT00486902|11498682|FG001|Overall Study|Did not meet inclusion criteria|0
7282955|NCT00486902|11498681|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
7282956|NCT00486902|11498682|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
7282957|NCT00486954|11498692|FG000|Pilot Part|Adverse Event|4
7282958|NCT00486954|11498693|FG001|Pilot Part|Adverse Event|0
7282959|NCT00486954|11498694|FG002|Pilot Part|Adverse Event|5
7282960|NCT00486954|11498695|FG003|Pilot Part|Adverse Event|0
7282961|NCT00486954|11498696|FG004|Pilot Part|Adverse Event|0
7282962|NCT00486954|11498692|FG000|Pilot Part|Disease Progression|2
7282963|NCT00486954|11498693|FG001|Pilot Part|Disease Progression|0
7282964|NCT00486954|11498694|FG002|Pilot Part|Disease Progression|1
7282965|NCT00486954|11498695|FG003|Pilot Part|Disease Progression|0
7282966|NCT00486954|11498696|FG004|Pilot Part|Disease Progression|0
7282967|NCT00486954|11498692|FG000|Randomized Part|Lost to Follow-up|0
7282968|NCT00486954|11498693|FG001|Randomized Part|Lost to Follow-up|0
7282969|NCT00486954|11498694|FG002|Randomized Part|Lost to Follow-up|0
7282970|NCT00486954|11498695|FG003|Randomized Part|Lost to Follow-up|0
7282971|NCT00486954|11498696|FG004|Randomized Part|Lost to Follow-up|1
7282972|NCT00486954|11498692|FG000|Randomized Part|Withdrawal by Subject|0
7282973|NCT00486954|11498693|FG001|Randomized Part|Withdrawal by Subject|0
7282974|NCT00486954|11498694|FG002|Randomized Part|Withdrawal by Subject|0
7282975|NCT00486954|11498695|FG003|Randomized Part|Withdrawal by Subject|1
7282976|NCT00486954|11498696|FG004|Randomized Part|Withdrawal by Subject|0
7282977|NCT00486954|11498692|FG000|Randomized Part|Sponsor Terminated Study|0
7282978|NCT00486954|11498693|FG001|Randomized Part|Sponsor Terminated Study|0
7282979|NCT00486954|11498694|FG002|Randomized Part|Sponsor Terminated Study|0
7282980|NCT00486954|11498695|FG003|Randomized Part|Sponsor Terminated Study|19
7282981|NCT00486954|11498696|FG004|Randomized Part|Sponsor Terminated Study|13
7282982|NCT00487084|11498709|FG000|Overall Study|Did not receive intervention|4
7282983|NCT00487084|11498710|FG001|Overall Study|Did not receive intervention|3
7282984|NCT00487084|11498711|FG002|Overall Study|Did not receive intervention|5
7282985|NCT00487188|11498721|FG000|Induction Phase|Abnormality of Laboratory Test|0
7282986|NCT00487188|11498722|FG001|Induction Phase|Abnormality of Laboratory Test|1
7282987|NCT00487188|11498723|FG002|Induction Phase|Abnormality of Laboratory Test|0
7282988|NCT00487188|11498721|FG000|Induction Phase|Adverse Event|5
7282989|NCT00487188|11498722|FG001|Induction Phase|Adverse Event|0
7282990|NCT00487188|11498723|FG002|Induction Phase|Adverse Event|0
7282991|NCT00487188|11498721|FG000|Induction Phase|Lack of Efficacy|0
7282992|NCT00487188|11498722|FG001|Induction Phase|Lack of Efficacy|1
7282993|NCT00487188|11498723|FG002|Induction Phase|Lack of Efficacy|0
7282994|NCT00487188|11498721|FG000|Induction Phase|Protocol Violation|1
7282995|NCT00487188|11498722|FG001|Induction Phase|Protocol Violation|0
7282996|NCT00487188|11498723|FG002|Induction Phase|Protocol Violation|0
7282997|NCT00487188|11498721|FG000|Induction Phase|Refused Treatment|1
7282998|NCT00487188|11498722|FG001|Induction Phase|Refused Treatment|2
7282999|NCT00487188|11498723|FG002|Induction Phase|Refused Treatment|0
7283000|NCT00487188|11498721|FG000|Induction Phase|Lost to Follow-up|2
7283001|NCT00487188|11498722|FG001|Induction Phase|Lost to Follow-up|2
7283002|NCT00487188|11498723|FG002|Induction Phase|Lost to Follow-up|0
7283003|NCT00487188|11498721|FG000|Induction Phase|Administrative|0
7283004|NCT00487188|11498722|FG001|Induction Phase|Administrative|1
7283005|NCT00487188|11498723|FG002|Induction Phase|Administrative|0
7283006|NCT00487188|11498721|FG000|Maintenance Phase|Adverse Event|1
7283007|NCT00487188|11498722|FG001|Maintenance Phase|Adverse Event|0
7283008|NCT00487188|11498723|FG002|Maintenance Phase|Adverse Event|0
7283009|NCT00487188|11498721|FG000|Maintenance Phase|Death|1
7283010|NCT00487188|11498722|FG001|Maintenance Phase|Death|0
7283011|NCT00487188|11498723|FG002|Maintenance Phase|Death|0
7283012|NCT00487188|11498721|FG000|Maintenance Phase|Lost to Follow-up|1
7283013|NCT00487188|11498722|FG001|Maintenance Phase|Lost to Follow-up|0
7283014|NCT00487188|11498723|FG002|Maintenance Phase|Lost to Follow-up|0
7283015|NCT00487188|11498721|FG000|Maintenance Phase|Administrative|0
7283016|NCT00487188|11498722|FG001|Maintenance Phase|Administrative|0
7283017|NCT00487188|11498723|FG002|Maintenance Phase|Administrative|1
7283018|NCT00487240|11498741|FG000|Overall Study|Withdrawal by Subject|12
7283019|NCT00487240|11498742|FG001|Overall Study|Withdrawal by Subject|6
7283020|NCT00487240|11498741|FG000|Overall Study|Lost to Follow-up|7
7283021|NCT00487240|11498742|FG001|Overall Study|Lost to Follow-up|6
7283022|NCT00487240|11498741|FG000|Overall Study|Adverse Event|0
7283023|NCT00487240|11498742|FG001|Overall Study|Adverse Event|4
7283024|NCT00487240|11498741|FG000|Overall Study|Protocol Violation|5
7283025|NCT00487240|11498742|FG001|Overall Study|Protocol Violation|5
7283026|NCT00487240|11498741|FG000|Overall Study|Entry Criteria Not Met|3
7283027|NCT00487240|11498742|FG001|Overall Study|Entry Criteria Not Met|4
7283028|NCT00487240|11498741|FG000|Overall Study|Sponsor Decision|2
7283029|NCT00487240|11498742|FG001|Overall Study|Sponsor Decision|1
7283030|NCT00487240|11498741|FG000|Overall Study|Physician Decision|2
7283031|NCT00487240|11498742|FG001|Overall Study|Physician Decision|0
7283032|NCT00487279|11498750|FG000|Overall Study|Death|1
7283033|NCT00487279|11498751|FG001|Overall Study|Death|0
7283034|NCT00487279|11498750|FG000|Overall Study|Withdrawal by Subject|0
7283035|NCT00487279|11498751|FG001|Overall Study|Withdrawal by Subject|2
7283036|NCT00487435|11498766|FG000|Overall Study|Adverse Event|146
7283037|NCT00487435|11498766|FG000|Overall Study|Death|2
7283038|NCT00487435|11498766|FG000|Overall Study|Lack of Efficacy|33
7283039|NCT00487435|11498766|FG000|Overall Study|Lost to Follow-up|54
7283040|NCT00487435|11498766|FG000|Overall Study|Pregnancy|2
7283041|NCT00487435|11498766|FG000|Overall Study|Withdrawal by Subject|132
7283042|NCT00487435|11498766|FG000|Overall Study|Resolution Of Pain|1
7283043|NCT00487435|11498766|FG000|Overall Study|Study Medication Non-Compliant|32
7283044|NCT00487435|11498766|FG000|Overall Study|Other|83
7283045|NCT00487539|11498774|FG000|Overall Study|Adverse Event|3
7283046|NCT00487539|11498775|FG001|Overall Study|Adverse Event|2
7283047|NCT00487539|11498776|FG002|Overall Study|Adverse Event|1
7283048|NCT00487539|11498777|FG003|Overall Study|Adverse Event|1
7283049|NCT00487539|11498774|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7283050|NCT00487539|11498775|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7283051|NCT00487539|11498776|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7283052|NCT00487539|11498777|FG003|Overall Study|Unsatisfactory therapeutic effect|1
7283053|NCT00487539|11498774|FG000|Overall Study|Other|3
7283054|NCT00487539|11498775|FG001|Overall Study|Other|1
7283055|NCT00487539|11498776|FG002|Overall Study|Other|2
7283056|NCT00487539|11498777|FG003|Overall Study|Other|2
7283057|NCT00487552|11498786|FG000|Overall Study|Unsuccessful magnet placements|3
7283058|NCT00487552|11498786|FG000|Overall Study|Death due to progressive malignancy|2
7283059|NCT00487552|11498786|FG000|Overall Study|Stent not placed|1
7283060|NCT00487695|11498801|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
7622348|NCT02614261|12033177|FG001|Open-Label Extension Phase|Physician Decision|0
7622349|NCT02614261|12033178|FG002|Open-Label Extension Phase|Physician Decision|0
7622350|NCT02614261|12033179|FG003|Open-Label Extension Phase|Physician Decision|0
7622351|NCT02614261|12033176|FG000|Open-Label Extension Phase|Pregnancy|1
7622352|NCT02614261|12033177|FG001|Open-Label Extension Phase|Pregnancy|2
7622353|NCT02614261|12033178|FG002|Open-Label Extension Phase|Pregnancy|1
7622354|NCT02614261|12033179|FG003|Open-Label Extension Phase|Pregnancy|0
7283061|NCT00487695|11498802|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
7283062|NCT00487695|11498801|FG000|First Procedure|active wheezing (did not have procedure)|1
7283063|NCT00487695|11498802|FG001|First Procedure|active wheezing (did not have procedure)|0
7283064|NCT00487695|11498801|FG000|First Procedure|esophageal stricture found (excl crit)|1
7283065|NCT00487695|11498802|FG001|First Procedure|esophageal stricture found (excl crit)|0
7283066|NCT00487695|11498801|FG000|Second Procedure|active wheezing|0
7283067|NCT00487695|11498802|FG001|Second Procedure|active wheezing|1
7283068|NCT00487695|11498801|FG000|Second Procedure|Withdrawal by Subject|1
7283069|NCT00487695|11498802|FG001|Second Procedure|Withdrawal by Subject|2
7283070|NCT00487747|11498816|FG000|Overall Study|Adverse Event|1
7283071|NCT00487747|11498816|FG000|Overall Study|Lost to Follow-up|9
7283072|NCT00487747|11498816|FG000|Overall Study|Lack of Efficacy|1
7283073|NCT00487825|11498822|FG000|Overall Study|Adverse Event|2
7283074|NCT00487825|11498823|FG001|Overall Study|Adverse Event|2
7283075|NCT00487825|11498822|FG000|Overall Study|Lack of Efficacy|1
7283076|NCT00487825|11498823|FG001|Overall Study|Lack of Efficacy|1
7283077|NCT00487825|11498822|FG000|Overall Study|Other|3
7283078|NCT00487825|11498823|FG001|Overall Study|Other|2
7283079|NCT00487942|11498833|FG000|Overall Study|Adverse Event|1
7283080|NCT00487942|11498834|FG001|Overall Study|Adverse Event|1
7283081|NCT00487942|11498835|FG002|Overall Study|Adverse Event|1
7283082|NCT00487942|11498836|FG003|Overall Study|Adverse Event|1
7283083|NCT00487942|11498833|FG000|Overall Study|Lost to Follow-up|1
7283084|NCT00487942|11498834|FG001|Overall Study|Lost to Follow-up|0
7283085|NCT00487942|11498835|FG002|Overall Study|Lost to Follow-up|0
7283086|NCT00487942|11498836|FG003|Overall Study|Lost to Follow-up|1
7283087|NCT00487942|11498833|FG000|Overall Study|Protocol Violation|1
7283088|NCT00487942|11498834|FG001|Overall Study|Protocol Violation|1
7283089|NCT00487942|11498835|FG002|Overall Study|Protocol Violation|0
7283090|NCT00487942|11498836|FG003|Overall Study|Protocol Violation|0
7283091|NCT00487942|11498833|FG000|Overall Study|Withdrawal by Subject|0
7283092|NCT00487942|11498834|FG001|Overall Study|Withdrawal by Subject|1
7283093|NCT00487942|11498835|FG002|Overall Study|Withdrawal by Subject|2
7283094|NCT00487942|11498836|FG003|Overall Study|Withdrawal by Subject|0
7283095|NCT00488033|11498848|FG000|Overall Study|Withdrawal by Subject|1
7283096|NCT00488033|11498849|FG001|Overall Study|Withdrawal by Subject|0
7283097|NCT00488293|11498872|FG000|Overall Study|Lost to Follow-up|28
7283098|NCT00488293|11498873|FG001|Overall Study|Lost to Follow-up|25
7283099|NCT00488293|11498872|FG000|Overall Study|Withdrawal by Subject|5
7283100|NCT00488293|11498873|FG001|Overall Study|Withdrawal by Subject|3
7283101|NCT00488293|11498872|FG000|Overall Study|Death|2
7283102|NCT00488293|11498873|FG001|Overall Study|Death|1
7283103|NCT00488293|11498872|FG000|Overall Study|Misrandomization/Other Unspecified|1
7283104|NCT00488293|11498873|FG001|Overall Study|Misrandomization/Other Unspecified|1
7283105|NCT00488319|11498882|FG000|Overall Study|Adverse Event|1
7283106|NCT00488319|11498883|FG001|Overall Study|Adverse Event|2
7283107|NCT00488319|11498884|FG002|Overall Study|Adverse Event|23
7283108|NCT00488319|11498882|FG000|Overall Study|Lack of Efficacy|6
7283109|NCT00488319|11498883|FG001|Overall Study|Lack of Efficacy|12
7283110|NCT00488319|11498884|FG002|Overall Study|Lack of Efficacy|27
7283111|NCT00488319|11498882|FG000|Overall Study|Lost to Follow-up|3
7283112|NCT00488319|11498883|FG001|Overall Study|Lost to Follow-up|5
7283113|NCT00488319|11498884|FG002|Overall Study|Lost to Follow-up|16
7283114|NCT00488319|11498882|FG000|Overall Study|Withdrawal by Subject|5
7283115|NCT00488319|11498883|FG001|Overall Study|Withdrawal by Subject|20
7283116|NCT00488319|11498884|FG002|Overall Study|Withdrawal by Subject|44
7283117|NCT00488319|11498882|FG000|Overall Study|Other reasons for withdrawal|0
7283118|NCT00488319|11498883|FG001|Overall Study|Other reasons for withdrawal|4
7283119|NCT00488319|11498884|FG002|Overall Study|Other reasons for withdrawal|12
7283120|NCT00488345|11498896|FG000|Overall Study|Adverse Event|0
7283121|NCT00488345|11498897|FG001|Overall Study|Adverse Event|1
7283122|NCT00488345|11498898|FG002|Overall Study|Adverse Event|1
7283123|NCT00488345|11498896|FG000|Overall Study|Unable to administer antibiotics at home|0
7283124|NCT00488345|11498897|FG001|Overall Study|Unable to administer antibiotics at home|1
7283125|NCT00488345|11498898|FG002|Overall Study|Unable to administer antibiotics at home|0
7283126|NCT00488345|11498896|FG000|Overall Study|Institutional Review Board review|0
7283127|NCT00488345|11498897|FG001|Overall Study|Institutional Review Board review|0
7283128|NCT00488345|11498898|FG002|Overall Study|Institutional Review Board review|1
7283129|NCT00488345|11498896|FG000|Overall Study|Surgical team recommendation|0
7283130|NCT00488345|11498897|FG001|Overall Study|Surgical team recommendation|1
7283131|NCT00488345|11498898|FG002|Overall Study|Surgical team recommendation|0
7283132|NCT00488345|11498896|FG000|Overall Study|Parent/legal guardian request|0
7283133|NCT00488345|11498897|FG001|Overall Study|Parent/legal guardian request|1
7283134|NCT00488345|11498898|FG002|Overall Study|Parent/legal guardian request|1
7283135|NCT00488475|11498907|FG000|Overall Study|Other|1754
7283136|NCT00488514|11498915|FG000|Overall Study|Adverse Event|41
7283137|NCT00488514|11498915|FG000|Overall Study|Lost to Follow-up|44
7283138|NCT00488514|11498915|FG000|Overall Study|Protocol Violation|32
7283139|NCT00488514|11498915|FG000|Overall Study|Withdrawal by Subject|106
7283140|NCT00488514|11498915|FG000|Overall Study|Lack of Efficacy|28
7283141|NCT00488514|11498915|FG000|Overall Study|Did not meet criteria for treatment|30
7283142|NCT00488514|11498915|FG000|Overall Study|Postive drug screen|1
7283143|NCT00488514|11498915|FG000|Overall Study|Withdrawn per medical monitor decision|2
7283144|NCT00488514|11498915|FG000|Overall Study|Investigator decision|1
7283145|NCT00488514|11498915|FG000|Overall Study|Participant had too few migraines|5
7283146|NCT00488514|11498915|FG000|Overall Study|Increase in number of migraines|2
7283147|NCT00488514|11498915|FG000|Overall Study|Increased use of concomitant medication|1
7283148|NCT00488592|11498936|FG000|Overall Study|Withdrawal by Subject|1
7283149|NCT00488592|11498936|FG000|Overall Study|Disease progression|1
7283150|NCT00488592|11498936|FG000|Overall Study|Enrolled but not treated|1
7283151|NCT00488618|11498942|FG000|Overall Study|Adverse Event|13
7283152|NCT00488618|11498943|FG001|Overall Study|Adverse Event|17
7283153|NCT00488618|11498942|FG000|Overall Study|Insufficient Therapeutic Response|18
7283154|NCT00488618|11498943|FG001|Overall Study|Insufficient Therapeutic Response|11
7283155|NCT00488618|11498942|FG000|Overall Study|Protocol Violation|0
7283156|NCT00488618|11498943|FG001|Overall Study|Protocol Violation|2
7283157|NCT00488618|11498942|FG000|Overall Study|Withdrawal of Consent|15
7283158|NCT00488618|11498943|FG001|Overall Study|Withdrawal of Consent|13
7283159|NCT00488618|11498942|FG000|Overall Study|Lost to Follow-up|1
7283160|NCT00488618|11498943|FG001|Overall Study|Lost to Follow-up|0
7283161|NCT00488631|11498955|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
7283162|NCT00488631|11498956|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
7283163|NCT00488631|11498957|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
7283164|NCT00488631|11498958|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
7283165|NCT00488631|11498959|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
7283166|NCT00488631|11498960|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
7283167|NCT00488631|11498961|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
7283168|NCT00488631|11498962|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
7283169|NCT00488631|11498963|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
7283170|NCT00488631|11498964|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
7283171|NCT00488631|11498955|FG000|Double Blind Period (Week 0-54)|Death|0
7283172|NCT00488631|11498956|FG001|Double Blind Period (Week 0-54)|Death|0
7283173|NCT00488631|11498957|FG002|Double Blind Period (Week 0-54)|Death|0
7283174|NCT00488631|11498958|FG003|Double Blind Period (Week 0-54)|Death|0
7283175|NCT00488631|11498959|FG004|Double Blind Period (Week 0-54)|Death|0
7283176|NCT00488631|11498960|FG005|Double Blind Period (Week 0-54)|Death|1
7283177|NCT00488631|11498961|FG006|Double Blind Period (Week 0-54)|Death|0
7283178|NCT00488631|11498962|FG007|Double Blind Period (Week 0-54)|Death|0
7283179|NCT00488631|11498963|FG008|Double Blind Period (Week 0-54)|Death|0
7283180|NCT00488631|11498964|FG009|Double Blind Period (Week 0-54)|Death|0
7283181|NCT00488631|11498955|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
7283182|NCT00488631|11498956|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
7283183|NCT00488631|11498957|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
7283184|NCT00488631|11498958|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
7283185|NCT00488631|11498959|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
7283186|NCT00488631|11498960|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
7283187|NCT00488631|11498961|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7283188|NCT00488631|11498962|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7283189|NCT00488631|11498963|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7283190|NCT00488631|11498964|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
7283191|NCT00488631|11498955|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7283192|NCT00488631|11498956|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
7283193|NCT00488631|11498957|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
7283194|NCT00488631|11498958|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7283195|NCT00488631|11498959|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
7283196|NCT00488631|11498960|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
7283197|NCT00488631|11498961|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7283198|NCT00488631|11498962|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7283199|NCT00488631|11498963|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7283200|NCT00488631|11498964|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
7283201|NCT00488631|11498955|FG000|Double Blind Period (Week 0-54)|Other|6
7283202|NCT00488631|11498956|FG001|Double Blind Period (Week 0-54)|Other|12
7283203|NCT00488631|11498957|FG002|Double Blind Period (Week 0-54)|Other|10
7283204|NCT00488631|11498958|FG003|Double Blind Period (Week 0-54)|Other|11
7283205|NCT00488631|11498959|FG004|Double Blind Period (Week 0-54)|Other|14
7283206|NCT00488631|11498960|FG005|Double Blind Period (Week 0-54)|Other|34
7283207|NCT00488631|11498961|FG006|Double Blind Period (Week 0-54)|Other|0
7622355|NCT02614261|12033176|FG000|Open-Label Extension Phase|Protocol Violation|3
7622356|NCT02614261|12033177|FG001|Open-Label Extension Phase|Protocol Violation|4
7622357|NCT02614261|12033178|FG002|Open-Label Extension Phase|Protocol Violation|1
7622358|NCT02614261|12033179|FG003|Open-Label Extension Phase|Protocol Violation|0
7622359|NCT02614261|12033176|FG000|Open-Label Extension Phase|Withdrawal by Subject|30
7622360|NCT02614261|12033177|FG001|Open-Label Extension Phase|Withdrawal by Subject|18
7622361|NCT02614261|12033178|FG002|Open-Label Extension Phase|Withdrawal by Subject|18
7622362|NCT02614261|12033179|FG003|Open-Label Extension Phase|Withdrawal by Subject|0
7622363|NCT02614261|12033176|FG000|Follow-up Phase|Adverse Event|2
7622364|NCT02614261|12033177|FG001|Follow-up Phase|Adverse Event|0
7622365|NCT02614261|12033178|FG002|Follow-up Phase|Adverse Event|1
7622366|NCT02614261|12033179|FG003|Follow-up Phase|Adverse Event|0
7622367|NCT02614261|12033176|FG000|Follow-up Phase|Lost to Follow-up|12
7622368|NCT02614261|12033177|FG001|Follow-up Phase|Lost to Follow-up|5
7622369|NCT02614261|12033178|FG002|Follow-up Phase|Lost to Follow-up|2
7622370|NCT02614261|12033179|FG003|Follow-up Phase|Lost to Follow-up|0
7622371|NCT02614261|12033176|FG000|Follow-up Phase|Physician Decision|5
7622372|NCT02614261|12033177|FG001|Follow-up Phase|Physician Decision|1
7622373|NCT02614261|12033178|FG002|Follow-up Phase|Physician Decision|0
7622374|NCT02614261|12033179|FG003|Follow-up Phase|Physician Decision|0
7622375|NCT02614261|12033176|FG000|Follow-up Phase|Pregnancy|0
7622376|NCT02614261|12033177|FG001|Follow-up Phase|Pregnancy|1
7622377|NCT02614261|12033178|FG002|Follow-up Phase|Pregnancy|0
7622378|NCT02614261|12033179|FG003|Follow-up Phase|Pregnancy|0
7622379|NCT02614261|12033176|FG000|Follow-up Phase|Protocol Violation|1
7622380|NCT02614261|12033177|FG001|Follow-up Phase|Protocol Violation|0
7622381|NCT02614261|12033178|FG002|Follow-up Phase|Protocol Violation|0
7622382|NCT02614261|12033179|FG003|Follow-up Phase|Protocol Violation|0
7622383|NCT02614261|12033176|FG000|Follow-up Phase|Withdrawal by Subject|12
7622384|NCT02614261|12033177|FG001|Follow-up Phase|Withdrawal by Subject|4
7622385|NCT02614261|12033178|FG002|Follow-up Phase|Withdrawal by Subject|11
7622386|NCT02614261|12033179|FG003|Follow-up Phase|Withdrawal by Subject|0
7622387|NCT02614261|12033176|FG000|Israel Addendum|Withdrawal by Subject|0
7622388|NCT02614261|12033177|FG001|Israel Addendum|Withdrawal by Subject|0
7283208|NCT00488631|11498962|FG007|Double Blind Period (Week 0-54)|Other|0
7283209|NCT00488631|11498963|FG008|Double Blind Period (Week 0-54)|Other|0
7283210|NCT00488631|11498964|FG009|Double Blind Period (Week 0-54)|Other|0
7283211|NCT00488631|11498955|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283212|NCT00488631|11498956|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283213|NCT00488631|11498957|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283214|NCT00488631|11498958|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283215|NCT00488631|11498959|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283216|NCT00488631|11498960|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283217|NCT00488631|11498961|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
7283218|NCT00488631|11498962|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
7622389|NCT02614261|12033178|FG002|Israel Addendum|Withdrawal by Subject|0
7622390|NCT02614261|12033179|FG003|Israel Addendum|Withdrawal by Subject|4
7283219|NCT00488631|11498963|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
7283220|NCT00488631|11498964|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
7283221|NCT00488631|11498955|FG000|Open Label Study Extension (Week 54-228)|Death|0
7283222|NCT00488631|11498956|FG001|Open Label Study Extension (Week 54-228)|Death|0
7283223|NCT00488631|11498957|FG002|Open Label Study Extension (Week 54-228)|Death|0
7283224|NCT00488631|11498958|FG003|Open Label Study Extension (Week 54-228)|Death|0
7283225|NCT00488631|11498959|FG004|Open Label Study Extension (Week 54-228)|Death|0
7283226|NCT00488631|11498960|FG005|Open Label Study Extension (Week 54-228)|Death|0
7283227|NCT00488631|11498961|FG006|Open Label Study Extension (Week 54-228)|Death|0
7283228|NCT00488631|11498962|FG007|Open Label Study Extension (Week 54-228)|Death|0
7283229|NCT00488631|11498963|FG008|Open Label Study Extension (Week 54-228)|Death|1
7283230|NCT00488631|11498964|FG009|Open Label Study Extension (Week 54-228)|Death|0
7283231|NCT00488631|11498955|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283232|NCT00488631|11498956|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283233|NCT00488631|11498957|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283234|NCT00488631|11498958|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283235|NCT00488631|11498959|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283236|NCT00488631|11498960|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
7283237|NCT00488631|11498961|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7283238|NCT00488631|11498962|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
7283239|NCT00488631|11498963|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
7283240|NCT00488631|11498964|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
7283241|NCT00488631|11498955|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283242|NCT00488631|11498956|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283243|NCT00488631|11498957|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283244|NCT00488631|11498958|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283245|NCT00488631|11498959|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283246|NCT00488631|11498960|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283247|NCT00488631|11498961|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
7283248|NCT00488631|11498962|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283249|NCT00488631|11498963|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
7283250|NCT00488631|11498964|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
7283251|NCT00488631|11498955|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283252|NCT00488631|11498956|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283253|NCT00488631|11498957|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283254|NCT00488631|11498958|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283255|NCT00488631|11498959|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283256|NCT00488631|11498960|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283257|NCT00488631|11498961|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
7283258|NCT00488631|11498962|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
7283259|NCT00488631|11498963|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
7283260|NCT00488631|11498964|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
7283261|NCT00488644|11498987|FG000|Overall Study|Not Eligible|1
7283262|NCT00488644|11498987|FG000|Overall Study|Not Evaluable|1
7283263|NCT00488683|11498994|FG000|Overall Study|Withdrawal by Subject|1
7283264|NCT00488683|11498995|FG001|Overall Study|Withdrawal by Subject|2
7283265|NCT00488683|11498996|FG002|Overall Study|Withdrawal by Subject|2
7283266|NCT00488683|11498994|FG000|Overall Study|Lost to Follow-up|5
7283267|NCT00488683|11498995|FG001|Overall Study|Lost to Follow-up|3
7283268|NCT00488683|11498996|FG002|Overall Study|Lost to Follow-up|0
7283269|NCT00488683|11498994|FG000|Overall Study|Protocol Violation|5
7283270|NCT00488683|11498995|FG001|Overall Study|Protocol Violation|1
7283271|NCT00488683|11498996|FG002|Overall Study|Protocol Violation|0
7283272|NCT00488683|11498994|FG000|Overall Study|Unable to Classify|1
7283273|NCT00488683|11498995|FG001|Overall Study|Unable to Classify|0
7283274|NCT00488683|11498996|FG002|Overall Study|Unable to Classify|0
7283275|NCT00488774|11499012|FG000|Overall Study|Withdrawal of consent|2
7283276|NCT00488774|11499013|FG001|Overall Study|Withdrawal of consent|2
7283277|NCT00488774|11499014|FG002|Overall Study|Withdrawal of consent|2
7283278|NCT00488774|11499015|FG003|Overall Study|Withdrawal of consent|0
7283279|NCT00488774|11499012|FG000|Overall Study|Other|6
7283280|NCT00488774|11499013|FG001|Overall Study|Other|3
7283281|NCT00488774|11499014|FG002|Overall Study|Other|2
7283282|NCT00488774|11499015|FG003|Overall Study|Other|2
7283283|NCT00488774|11499012|FG000|Overall Study|Lost to Follow-up|0
7283284|NCT00488774|11499013|FG001|Overall Study|Lost to Follow-up|0
7283285|NCT00488774|11499014|FG002|Overall Study|Lost to Follow-up|1
7283286|NCT00488774|11499015|FG003|Overall Study|Lost to Follow-up|1
7283287|NCT00488826|11499029|FG000|Overall Study|Withdrawal by Subject|40
7283288|NCT00488826|11499030|FG001|Overall Study|Withdrawal by Subject|35
7283289|NCT00488826|11499031|FG002|Overall Study|Withdrawal by Subject|19
7283290|NCT00488826|11499029|FG000|Overall Study|Protocol Violation|0
7283291|NCT00488826|11499030|FG001|Overall Study|Protocol Violation|0
7283292|NCT00488826|11499031|FG002|Overall Study|Protocol Violation|2
7283293|NCT00488826|11499029|FG000|Overall Study|Adverse Event|9
7283294|NCT00488826|11499030|FG001|Overall Study|Adverse Event|15
7283295|NCT00488826|11499031|FG002|Overall Study|Adverse Event|4
7283296|NCT00488826|11499029|FG000|Overall Study|Lost to Follow-up|5
7283297|NCT00488826|11499030|FG001|Overall Study|Lost to Follow-up|1
7283298|NCT00488826|11499031|FG002|Overall Study|Lost to Follow-up|0
7283299|NCT00488826|11499029|FG000|Overall Study|Protocol Deviations|2
7283300|NCT00488826|11499030|FG001|Overall Study|Protocol Deviations|1
7283301|NCT00488826|11499031|FG002|Overall Study|Protocol Deviations|1
7283302|NCT00488982|11499043|FG000|Course 1|Physician Decision|0
7283303|NCT00488982|11499044|FG001|Course 1|Physician Decision|2
7283304|NCT00488982|11499045|FG002|Course 1|Physician Decision|4
7283305|NCT00488982|11499043|FG000|Course 1|Withdrawal by Subject|0
7283306|NCT00488982|11499044|FG001|Course 1|Withdrawal by Subject|8
7283307|NCT00488982|11499045|FG002|Course 1|Withdrawal by Subject|2
7283308|NCT00488982|11499043|FG000|Course 1|nonprotocol therapy|0
7283309|NCT00488982|11499044|FG001|Course 1|nonprotocol therapy|2
7283310|NCT00488982|11499045|FG002|Course 1|nonprotocol therapy|2
7283311|NCT00488982|11499043|FG000|Course 1|Adverse Event|0
7283312|NCT00488982|11499044|FG001|Course 1|Adverse Event|0
7283313|NCT00488982|11499045|FG002|Course 1|Adverse Event|6
7283314|NCT00489216|11499063|FG000|Overall Study|Adverse Event|1
7283354|NCT00489411|11499123|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7283315|NCT00489255|11499069|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
7283316|NCT00489255|11499070|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
7283317|NCT00489255|11499069|FG000|Period 1: Days 1 to 28|Adverse Event|21
7283318|NCT00489255|11499070|FG001|Period 1: Days 1 to 28|Adverse Event|8
7283319|NCT00489255|11499069|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
7283320|NCT00489255|11499070|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
7283321|NCT00489255|11499069|FG000|Period 1: Days 1 to 28|Physician Decision|1
7283322|NCT00489255|11499070|FG001|Period 1: Days 1 to 28|Physician Decision|4
7283323|NCT00489255|11499069|FG000|Period 1: Days 1 to 28|Noncompliance|2
7283324|NCT00489255|11499070|FG001|Period 1: Days 1 to 28|Noncompliance|0
7283325|NCT00489255|11499069|FG000|Period 2: Days 29 to 56|Adverse Event|3
7283326|NCT00489255|11499070|FG001|Period 2: Days 29 to 56|Adverse Event|1
7283327|NCT00489255|11499069|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
7283328|NCT00489255|11499070|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
7283329|NCT00489255|11499069|FG000|Period 3: Days 57 to 84|Adverse Event|3
7283330|NCT00489255|11499070|FG001|Period 3: Days 57 to 84|Adverse Event|3
7283331|NCT00489255|11499069|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
7283332|NCT00489255|11499070|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
7622406|NCT02513667|12033230|FG000|Overall Study|Withdrawal by Subject|0
7622407|NCT02513667|12033231|FG001|Overall Study|Withdrawal by Subject|1
7622408|NCT02415556|12033241|FG000|Overall Study|Adverse Event|3
7622409|NCT02415556|12033242|FG001|Overall Study|Adverse Event|4
7622410|NCT02415556|12033243|FG002|Overall Study|Adverse Event|2
7622411|NCT02415556|12033244|FG003|Overall Study|Adverse Event|4
7622412|NCT02415556|12033241|FG000|Overall Study|Lost to Follow-up|4
7622413|NCT02415556|12033242|FG001|Overall Study|Lost to Follow-up|5
7622414|NCT02415556|12033243|FG002|Overall Study|Lost to Follow-up|4
7622415|NCT02415556|12033244|FG003|Overall Study|Lost to Follow-up|1
7622416|NCT02415556|12033241|FG000|Overall Study|Withdrawal by Subject|13
7622417|NCT02415556|12033242|FG001|Overall Study|Withdrawal by Subject|4
7622418|NCT02415556|12033243|FG002|Overall Study|Withdrawal by Subject|14
7622419|NCT02415556|12033244|FG003|Overall Study|Withdrawal by Subject|12
7622420|NCT02415556|12033241|FG000|Overall Study|Physician Decision|1
7622421|NCT02415556|12033242|FG001|Overall Study|Physician Decision|3
7622422|NCT02415556|12033243|FG002|Overall Study|Physician Decision|1
7622423|NCT02415556|12033244|FG003|Overall Study|Physician Decision|2
7283333|NCT00489255|11499069|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
7283334|NCT00489255|11499070|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
7622424|NCT02415556|12033241|FG000|Overall Study|Censored - study completion|4
7622425|NCT02415556|12033242|FG001|Overall Study|Censored - study completion|5
7622426|NCT02415556|12033243|FG002|Overall Study|Censored - study completion|1
7622427|NCT02415556|12033244|FG003|Overall Study|Censored - study completion|0
7622428|NCT02415556|12033241|FG000|Overall Study|Family-related issues|0
7622429|NCT02415556|12033242|FG001|Overall Study|Family-related issues|0
7622430|NCT02415556|12033243|FG002|Overall Study|Family-related issues|0
7622431|NCT02415556|12033244|FG003|Overall Study|Family-related issues|1
7283335|NCT00489359|11499108|FG000|Overall Study|Death|0
7283336|NCT00489359|11499109|FG001|Overall Study|Death|2
7283337|NCT00489359|11499108|FG000|Overall Study|Progressive Disease|5
7283338|NCT00489359|11499109|FG001|Overall Study|Progressive Disease|6
7283339|NCT00489359|11499108|FG000|Overall Study|Lost to Follow-up|1
7283340|NCT00489359|11499109|FG001|Overall Study|Lost to Follow-up|0
7283341|NCT00489359|11499108|FG000|Overall Study|Withdrawal by Subject|1
7283342|NCT00489359|11499109|FG001|Overall Study|Withdrawal by Subject|5
7283343|NCT00489359|11499108|FG000|Overall Study|Adverse Event|0
7283344|NCT00489359|11499109|FG001|Overall Study|Adverse Event|16
7283345|NCT00489411|11499122|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
7283346|NCT00489411|11499123|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
7283347|NCT00489411|11499122|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
7283348|NCT00489411|11499123|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
7283349|NCT00489411|11499122|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
7283350|NCT00489411|11499123|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
7283351|NCT00489411|11499122|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
7283352|NCT00489411|11499123|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
7283353|NCT00489411|11499122|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
7283355|NCT00489424|11499132|FG000|Overall Study|Adverse Event|3
7283356|NCT00489424|11499133|FG001|Overall Study|Adverse Event|3
7283357|NCT00489424|11499134|FG002|Overall Study|Adverse Event|4
7283358|NCT00489424|11499132|FG000|Overall Study|Lack of Efficacy|1
7283359|NCT00489424|11499133|FG001|Overall Study|Lack of Efficacy|0
7283360|NCT00489424|11499134|FG002|Overall Study|Lack of Efficacy|0
7283361|NCT00489424|11499132|FG000|Overall Study|Administrative problems|0
7283362|NCT00489424|11499133|FG001|Overall Study|Administrative problems|2
7283363|NCT00489424|11499134|FG002|Overall Study|Administrative problems|1
7283364|NCT00489476|11499146|FG000|Overall Study|Lost to Follow-up|0
7283365|NCT00489476|11499147|FG001|Overall Study|Lost to Follow-up|1
7283366|NCT00489476|11499148|FG002|Overall Study|Lost to Follow-up|0
7283367|NCT00489476|11499149|FG003|Overall Study|Lost to Follow-up|0
7283368|NCT00489489|11499162|FG000|Overall Study|Not treated due to protocol violation|0
7283369|NCT00489489|11499163|FG001|Overall Study|Not treated due to protocol violation|1
7283370|NCT00489489|11499164|FG002|Overall Study|Not treated due to protocol violation|1
7622432|NCT02386839|12033270|FG000|Overall Study|Death|1
7622433|NCT02386839|12033271|FG001|Overall Study|Death|0
7622434|NCT02386839|12033270|FG000|Overall Study|Withdrawal by Subject|9
7622435|NCT02386839|12033271|FG001|Overall Study|Withdrawal by Subject|10
7622436|NCT02386839|12033270|FG000|Overall Study|Lost to Follow-up|4
7622437|NCT02386839|12033271|FG001|Overall Study|Lost to Follow-up|4
7622438|NCT02386839|12033270|FG000|Overall Study|Other (Site Terminated by Sponsor)|1
7622439|NCT02386839|12033271|FG001|Overall Study|Other (Site Terminated by Sponsor)|0
7622440|NCT02386839|12033270|FG000|Overall Study|Other (Covid 19 Pandemic)|0
7622441|NCT02386839|12033271|FG001|Overall Study|Other (Covid 19 Pandemic)|1
7622442|NCT02386839|12033270|FG000|Overall Study|Other (unspecified)|1
7622443|NCT02386839|12033271|FG001|Overall Study|Other (unspecified)|0
7283371|NCT00489489|11499162|FG000|Overall Study|Adverse Event|1
7283372|NCT00489489|11499163|FG001|Overall Study|Adverse Event|1
7283373|NCT00489489|11499164|FG002|Overall Study|Adverse Event|1
7283374|NCT00489489|11499162|FG000|Overall Study|Protocol Violation|1
7283375|NCT00489489|11499163|FG001|Overall Study|Protocol Violation|0
7283376|NCT00489489|11499164|FG002|Overall Study|Protocol Violation|1
7283377|NCT00489489|11499162|FG000|Overall Study|Progressive disease|0
7283378|NCT00489489|11499163|FG001|Overall Study|Progressive disease|1
7283379|NCT00489489|11499164|FG002|Overall Study|Progressive disease|0
7283380|NCT00489489|11499162|FG000|Overall Study|Participant did not wish to continue|1
7283381|NCT00489489|11499163|FG001|Overall Study|Participant did not wish to continue|1
7283382|NCT00489489|11499164|FG002|Overall Study|Participant did not wish to continue|0
7283383|NCT00489489|11499162|FG000|Overall Study|Other than above|0
7283384|NCT00489489|11499163|FG001|Overall Study|Other than above|1
7283385|NCT00489489|11499164|FG002|Overall Study|Other than above|0
7283386|NCT00489541|11499176|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
7283387|NCT00489541|11499177|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
7283388|NCT00489541|11499176|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
7283389|NCT00489541|11499177|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
7283390|NCT00489541|11499176|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
7283391|NCT00489541|11499177|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
7283392|NCT00489541|11499176|FG000|12-Month Clinical Follow-up|Death|3
7283393|NCT00489541|11499177|FG001|12-Month Clinical Follow-up|Death|2
7283394|NCT00489541|11499176|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
7283395|NCT00489541|11499177|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
7283396|NCT00489541|11499176|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
7283397|NCT00489541|11499177|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
7283398|NCT00489554|11499183|FG000|Overall Study|Adverse Event|2
7283399|NCT00489554|11499183|FG000|Overall Study|Withdrawal by Subject|1
7283400|NCT00489554|11499183|FG000|Overall Study|Lost to Follow-up|1
7283401|NCT00489736|11499189|FG000|Overall Study|Lack of Efficacy|53
7283402|NCT00489736|11499190|FG001|Overall Study|Lack of Efficacy|14
7283403|NCT00489736|11499189|FG000|Overall Study|Adverse Event|32
7283404|NCT00489736|11499190|FG001|Overall Study|Adverse Event|45
7283405|NCT00489736|11499189|FG000|Overall Study|Poor compliance|6
7283406|NCT00489736|11499190|FG001|Overall Study|Poor compliance|2
7283407|NCT00489736|11499189|FG000|Overall Study|Not coded/ Not pre-specified|5
7283408|NCT00489736|11499190|FG001|Overall Study|Not coded/ Not pre-specified|8
7283409|NCT00489853|11499196|FG000|Wash-out Period 1|Withdrawal by Subject|1
7283410|NCT00489853|11499197|FG001|Wash-out Period 1|Withdrawal by Subject|0
7283411|NCT00489853|11499198|FG002|Wash-out Period 1|Withdrawal by Subject|0
7283412|NCT00489853|11499196|FG000|Wash-out Period 1|Adverse Event|0
7283413|NCT00489853|11499197|FG001|Wash-out Period 1|Adverse Event|1
7283414|NCT00489853|11499198|FG002|Wash-out Period 1|Adverse Event|1
7283415|NCT00489853|11499196|FG000|Wash-out Period 1|Protocol Violation|0
7283416|NCT00489853|11499197|FG001|Wash-out Period 1|Protocol Violation|1
7283417|NCT00489853|11499198|FG002|Wash-out Period 1|Protocol Violation|1
7283418|NCT00489853|11499196|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
7283419|NCT00489853|11499197|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
7283420|NCT00489853|11499198|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
7283421|NCT00489853|11499196|FG000|Wash-out Period 2|Adverse Event|1
7283422|NCT00489853|11499197|FG001|Wash-out Period 2|Adverse Event|1
7283423|NCT00489853|11499198|FG002|Wash-out Period 2|Adverse Event|0
7283424|NCT00489853|11499196|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
7283425|NCT00489853|11499197|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
7283426|NCT00489853|11499198|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
7283427|NCT00489853|11499196|FG000|Treatment Period 3|Study specific discontinuation criteria|0
7283428|NCT00489853|11499197|FG001|Treatment Period 3|Study specific discontinuation criteria|1
7283429|NCT00489853|11499198|FG002|Treatment Period 3|Study specific discontinuation criteria|0
7283430|NCT00489918|11499228|FG000|Overall Study|Withdrawal by Subject|2
7283431|NCT00489918|11499229|FG001|Overall Study|Withdrawal by Subject|1
7283432|NCT00489918|11499230|FG002|Overall Study|Withdrawal by Subject|1
7283433|NCT00489918|11499231|FG003|Overall Study|Withdrawal by Subject|0
7283434|NCT00489918|11499232|FG004|Overall Study|Withdrawal by Subject|1
7283435|NCT00489918|11499228|FG000|Overall Study|Adverse Event|0
7283436|NCT00489918|11499229|FG001|Overall Study|Adverse Event|1
7283437|NCT00489918|11499230|FG002|Overall Study|Adverse Event|1
7283438|NCT00489918|11499231|FG003|Overall Study|Adverse Event|0
7283439|NCT00489918|11499232|FG004|Overall Study|Adverse Event|0
7283440|NCT00489918|11499228|FG000|Overall Study|Lost to Follow-up|0
7283441|NCT00489918|11499229|FG001|Overall Study|Lost to Follow-up|0
7283442|NCT00489918|11499230|FG002|Overall Study|Lost to Follow-up|1
7283443|NCT00489918|11499231|FG003|Overall Study|Lost to Follow-up|1
7283444|NCT00489918|11499232|FG004|Overall Study|Lost to Follow-up|0
7283445|NCT00489918|11499228|FG000|Overall Study|Physician Decision|0
7283446|NCT00489918|11499229|FG001|Overall Study|Physician Decision|0
7283447|NCT00489918|11499230|FG002|Overall Study|Physician Decision|1
7283448|NCT00489918|11499231|FG003|Overall Study|Physician Decision|0
7283449|NCT00489918|11499232|FG004|Overall Study|Physician Decision|0
7283450|NCT00489970|11499247|FG000|Persistence Year 9|Lost to Follow-up|2
7283451|NCT00489970|11499248|FG001|Persistence Year 9|Lost to Follow-up|2
7283452|NCT00489970|11499249|FG002|Persistence Year 9|Lost to Follow-up|3
7283453|NCT00489970|11499247|FG000|Persistence Year 9|Other|1
7283454|NCT00489970|11499248|FG001|Persistence Year 9|Other|0
7283455|NCT00489970|11499249|FG002|Persistence Year 9|Other|2
7283456|NCT00490022|11499267|FG000|Overall Study|Adverse Event|0
7283457|NCT00490022|11499268|FG001|Overall Study|Adverse Event|2
7283458|NCT00490022|11499267|FG000|Overall Study|Withdrawal by Subject|1
7283459|NCT00490022|11499268|FG001|Overall Study|Withdrawal by Subject|0
7283460|NCT00490022|11499267|FG000|Overall Study|Subject failed to disclose concommitant|0
7283461|NCT00490022|11499268|FG001|Overall Study|Subject failed to disclose concommitant|1
7283490|NCT00490061|11499291|FG000|Overall Study|Physician Decision|1
7283491|NCT00490139|11499304|FG000|Overall Study|Death|106
7283492|NCT00490139|11499305|FG001|Overall Study|Death|119
7283493|NCT00490139|11499306|FG002|Overall Study|Death|168
7283494|NCT00490139|11499307|FG003|Overall Study|Death|135
7283495|NCT00490139|11499304|FG000|Overall Study|Lost to Follow-up|56
7283496|NCT00490139|11499305|FG001|Overall Study|Lost to Follow-up|46
7283497|NCT00490139|11499306|FG002|Overall Study|Lost to Follow-up|58
7283498|NCT00490139|11499307|FG003|Overall Study|Lost to Follow-up|56
7283499|NCT00490139|11499304|FG000|Overall Study|Participant Withdrew Consent|146
7283500|NCT00490139|11499305|FG001|Overall Study|Participant Withdrew Consent|110
7283501|NCT00490139|11499306|FG002|Overall Study|Participant Withdrew Consent|208
7283502|NCT00490139|11499307|FG003|Overall Study|Participant Withdrew Consent|116
7283503|NCT00490282|11499337|FG000|Overall Study|Withdrawal by Subject|3
7283504|NCT00490451|11499344|FG000|Overall Study|Adverse Event|3
7283505|NCT00490451|11499345|FG001|Overall Study|Adverse Event|3
7283506|NCT00490451|11499344|FG000|Overall Study|Death|3
7283507|NCT00490451|11499345|FG001|Overall Study|Death|1
7283508|NCT00490451|11499344|FG000|Overall Study|Withdrawal by Subject|2
7283509|NCT00490451|11499345|FG001|Overall Study|Withdrawal by Subject|0
7283510|NCT00490451|11499344|FG000|Overall Study|Investigator Decision|1
7283511|NCT00490451|11499345|FG001|Overall Study|Investigator Decision|0
7283512|NCT00490451|11499344|FG000|Overall Study|Protocol Violation|1
7283513|NCT00490451|11499345|FG001|Overall Study|Protocol Violation|0
7283514|NCT00490451|11499344|FG000|Overall Study|Progressive Disease|53
7283515|NCT00490451|11499345|FG001|Overall Study|Progressive Disease|34
7283516|NCT00490490|11499360|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
7283517|NCT00490490|11499360|FG000|Completed Assessment for TTP|Lost to Follow-up|2
7283518|NCT00490529|11499364|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
7283519|NCT00490529|11499364|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
7283520|NCT00490529|11499364|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
7283521|NCT00490529|11499364|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
7283522|NCT00490529|11499364|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
7283523|NCT00490529|11499364|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
7283524|NCT00490542|11499370|FG000|Overall Study|Lost to Follow-up|3
7283525|NCT00490542|11499371|FG001|Overall Study|Lost to Follow-up|0
7283526|NCT00490542|11499370|FG000|Overall Study|Adverse Event|3
7283527|NCT00490542|11499371|FG001|Overall Study|Adverse Event|3
7283528|NCT00490542|11499370|FG000|Overall Study|Lack of Efficacy|1
7283529|NCT00490542|11499371|FG001|Overall Study|Lack of Efficacy|1
7283530|NCT00490555|11499381|FG000|Overall Study|noncompliant with drug administration|0
7283531|NCT00490555|11499382|FG001|Overall Study|noncompliant with drug administration|0
7283532|NCT00490555|11499383|FG002|Overall Study|noncompliant with drug administration|2
7283533|NCT00490555|11499384|FG003|Overall Study|noncompliant with drug administration|0
7283534|NCT00490568|11499394|FG000|Overall Study|Adverse Event|116
7283535|NCT00490568|11499394|FG000|Overall Study|Lost to Follow-up|13
7283536|NCT00490568|11499394|FG000|Overall Study|Protocol Violation|45
7283537|NCT00490568|11499394|FG000|Overall Study|Withdrawal by Subject|135
7283538|NCT00490568|11499394|FG000|Overall Study|Still in the study at termination|974
7283539|NCT00490568|11499394|FG000|Overall Study|Other|1
7283540|NCT00490568|11499394|FG000|Overall Study|Exclusion criteria met|1
7283541|NCT00490568|11499394|FG000|Overall Study|Caregiver related|20
7283542|NCT00490568|11499394|FG000|Overall Study|Abnormal ECG|25
7283543|NCT00490568|11499394|FG000|Overall Study|Participant refused follow-up|9
7283544|NCT00490568|11499394|FG000|Overall Study|Legal representative withdrew consent|1
7283545|NCT00490568|11499394|FG000|Overall Study|Disease progression|4
7283546|NCT00490568|11499394|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
7283547|NCT00490568|11499394|FG000|Overall Study|Investigator decision|3
7283548|NCT00490568|11499394|FG000|Overall Study|Non-Compliance|7
7283549|NCT00490568|11499394|FG000|Overall Study|Efficacy related|3
7283550|NCT00490568|11499394|FG000|Overall Study|Participant died|1
7283551|NCT00490568|11499394|FG000|Overall Study|Participant withdrawal due to surgery|1
7283552|NCT00490646|11499401|FG000|Overall Study|Still on trastuzumab monotherapy|1
7283553|NCT00490646|11499402|FG001|Overall Study|Still on trastuzumab monotherapy|1
7622486|NCT02312258|12033299|FG000|Overall Study|Adverse Event|15
7622487|NCT02312258|12033300|FG001|Overall Study|Adverse Event|47
7622488|NCT02312258|12033299|FG000|Overall Study|Lost to Follow-up|0
7622489|NCT02312258|12033300|FG001|Overall Study|Lost to Follow-up|1
7622490|NCT02312258|12033299|FG000|Overall Study|Progressive Disease|174
7622491|NCT02312258|12033300|FG001|Overall Study|Progressive Disease|188
7622492|NCT02312258|12033299|FG000|Overall Study|Withdrawal by Subject|8
7622493|NCT02312258|12033300|FG001|Overall Study|Withdrawal by Subject|9
7622494|NCT02312258|12033299|FG000|Overall Study|Reason not Specified|11
7622495|NCT02312258|12033300|FG001|Overall Study|Reason not Specified|31
7622496|NCT02312258|12033299|FG000|Overall Study|Participants Ongoing Treatment|43
7622497|NCT02312258|12033300|FG001|Overall Study|Participants Ongoing Treatment|83
7622498|NCT02213380|12033308|FG000|Underwent Randomization|Withdrawal by Subject|2
7622499|NCT02213380|12033309|FG001|Underwent Randomization|Withdrawal by Subject|0
7622500|NCT02213380|12033308|FG000|Underwent Randomization|Not treated|3
7622501|NCT02213380|12033309|FG001|Underwent Randomization|Not treated|3
7622502|NCT02213380|12033308|FG000|Per-protocol Analysis|Protocol Violation|32
7622503|NCT02213380|12033309|FG001|Per-protocol Analysis|Protocol Violation|36
7283554|NCT00490646|11499401|FG000|Overall Study|Never Treated (had an adverse event)|1
7283555|NCT00490646|11499402|FG001|Overall Study|Never Treated (had an adverse event)|0
7283556|NCT00490646|11499401|FG000|Overall Study|Never Treated (withdrew consent)|0
7283557|NCT00490646|11499402|FG001|Overall Study|Never Treated (withdrew consent)|1
7283558|NCT00490698|11499408|FG000|Overall Study|Withdrawal by Subject|1
7283559|NCT00490698|11499408|FG000|Overall Study|Disease Progression|7
7283560|NCT00490698|11499408|FG000|Overall Study|Physician Decision|2
7283561|NCT00490724|11499415|FG000|Period I|Physician Decision|0
7283562|NCT00490724|11499416|FG001|Period I|Physician Decision|0
7283563|NCT00490724|11499417|FG002|Period I|Physician Decision|1
7283564|NCT00490724|11499415|FG000|Period II|Treatment Discontinuation|3
7283565|NCT00490724|11499416|FG001|Period II|Treatment Discontinuation|1
7283566|NCT00490724|11499417|FG002|Period II|Treatment Discontinuation|3
7283567|NCT00490815|11499437|FG000|Overall Study|Adverse Event|2
7283568|NCT00490815|11499438|FG001|Overall Study|Adverse Event|3
7283569|NCT00490815|11499437|FG000|Overall Study|Withdrawal by Subject|4
7283570|NCT00490815|11499438|FG001|Overall Study|Withdrawal by Subject|0
7283571|NCT00490815|11499437|FG000|Overall Study|Lost to Follow-up|1
7283572|NCT00490815|11499438|FG001|Overall Study|Lost to Follow-up|3
7283573|NCT00490815|11499437|FG000|Overall Study|Death|1
7283574|NCT00490815|11499438|FG001|Overall Study|Death|3
7283575|NCT00490841|11499444|FG000|Overall Study|Death|5
7283576|NCT00490841|11499444|FG000|Overall Study|Withdrawal by Subject|4
7283577|NCT00490841|11499444|FG000|Overall Study|Lost to Follow-up|1
7283578|NCT00490841|11499444|FG000|Overall Study|30 day f/u, only non-study stent used|3
7283579|NCT00490919|11499451|FG000|Open-label Run-in Period|Adverse Event|239
7283580|NCT00490919|11499452|FG001|Open-label Run-in Period|Adverse Event|0
7283581|NCT00490919|11499453|FG002|Open-label Run-in Period|Adverse Event|0
7283582|NCT00490919|11499451|FG000|Open-label Run-in Period|Withdrawal by Subject|37
7283583|NCT00490919|11499452|FG001|Open-label Run-in Period|Withdrawal by Subject|0
7283584|NCT00490919|11499453|FG002|Open-label Run-in Period|Withdrawal by Subject|0
7283585|NCT00490919|11499451|FG000|Open-label Run-in Period|Lost to Follow-up|21
7283586|NCT00490919|11499452|FG001|Open-label Run-in Period|Lost to Follow-up|0
7283587|NCT00490919|11499453|FG002|Open-label Run-in Period|Lost to Follow-up|0
7283588|NCT00490919|11499451|FG000|Open-label Run-in Period|Lack of Efficacy|143
7283589|NCT00490919|11499452|FG001|Open-label Run-in Period|Lack of Efficacy|0
7283590|NCT00490919|11499453|FG002|Open-label Run-in Period|Lack of Efficacy|0
7283591|NCT00490919|11499451|FG000|Open-label Run-in Period|Administrative|40
7283592|NCT00490919|11499452|FG001|Open-label Run-in Period|Administrative|0
7283593|NCT00490919|11499453|FG002|Open-label Run-in Period|Administrative|0
7283594|NCT00490919|11499451|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
7283595|NCT00490919|11499452|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
7283596|NCT00490919|11499453|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
7283597|NCT00490919|11499451|FG000|Double-blind Phase|Adverse Event|0
7283598|NCT00490919|11499452|FG001|Double-blind Phase|Adverse Event|40
7283599|NCT00490919|11499453|FG002|Double-blind Phase|Adverse Event|20
7283600|NCT00490919|11499451|FG000|Double-blind Phase|Withdrawal by Subject|0
7283601|NCT00490919|11499452|FG001|Double-blind Phase|Withdrawal by Subject|10
7283602|NCT00490919|11499453|FG002|Double-blind Phase|Withdrawal by Subject|11
7283603|NCT00490919|11499451|FG000|Double-blind Phase|Lost to Follow-up|0
7283604|NCT00490919|11499452|FG001|Double-blind Phase|Lost to Follow-up|8
7283605|NCT00490919|11499453|FG002|Double-blind Phase|Lost to Follow-up|11
7283606|NCT00490919|11499451|FG000|Double-blind Phase|Lack of Efficacy|0
7283607|NCT00490919|11499452|FG001|Double-blind Phase|Lack of Efficacy|22
7283608|NCT00490919|11499453|FG002|Double-blind Phase|Lack of Efficacy|36
7283609|NCT00490919|11499451|FG000|Double-blind Phase|Administrative|0
7283610|NCT00490919|11499452|FG001|Double-blind Phase|Administrative|6
7283611|NCT00490919|11499453|FG002|Double-blind Phase|Administrative|6
7283612|NCT00490945|11499465|FG000|Overall Study|Adverse Event|0
7283613|NCT00490945|11499466|FG001|Overall Study|Adverse Event|1
7283614|NCT00490945|11499467|FG002|Overall Study|Adverse Event|0
7283615|NCT00490945|11499468|FG003|Overall Study|Adverse Event|0
7283616|NCT00490945|11499469|FG004|Overall Study|Adverse Event|0
7283617|NCT00490971|11499489|FG000|Acute/Continuation|Adverse Event|62
7283618|NCT00490971|11499490|FG001|Acute/Continuation|Adverse Event|13
7283619|NCT00490971|11499491|FG002|Acute/Continuation|Adverse Event|0
7283620|NCT00490971|11499492|FG003|Acute/Continuation|Adverse Event|0
7283621|NCT00490971|11499493|FG004|Acute/Continuation|Adverse Event|0
7283622|NCT00490971|11499489|FG000|Acute/Continuation|Death|2
7283623|NCT00490971|11499490|FG001|Acute/Continuation|Death|0
7283624|NCT00490971|11499491|FG002|Acute/Continuation|Death|0
7283625|NCT00490971|11499492|FG003|Acute/Continuation|Death|0
7283626|NCT00490971|11499493|FG004|Acute/Continuation|Death|0
7283627|NCT00490971|11499489|FG000|Acute/Continuation|Lack of Efficacy|106
7283628|NCT00490971|11499490|FG001|Acute/Continuation|Lack of Efficacy|12
7283629|NCT00490971|11499491|FG002|Acute/Continuation|Lack of Efficacy|0
7283630|NCT00490971|11499492|FG003|Acute/Continuation|Lack of Efficacy|0
7283631|NCT00490971|11499493|FG004|Acute/Continuation|Lack of Efficacy|0
7283632|NCT00490971|11499489|FG000|Acute/Continuation|Lost to Follow-up|23
7283633|NCT00490971|11499490|FG001|Acute/Continuation|Lost to Follow-up|7
7283634|NCT00490971|11499491|FG002|Acute/Continuation|Lost to Follow-up|0
7283635|NCT00490971|11499492|FG003|Acute/Continuation|Lost to Follow-up|0
7283636|NCT00490971|11499493|FG004|Acute/Continuation|Lost to Follow-up|0
7283637|NCT00490971|11499489|FG000|Acute/Continuation|Protocol Violation|10
7283638|NCT00490971|11499490|FG001|Acute/Continuation|Protocol Violation|2
7283639|NCT00490971|11499491|FG002|Acute/Continuation|Protocol Violation|0
7283640|NCT00490971|11499492|FG003|Acute/Continuation|Protocol Violation|0
7283641|NCT00490971|11499493|FG004|Acute/Continuation|Protocol Violation|0
7283642|NCT00490971|11499489|FG000|Acute/Continuation|Withdrawal by Subject|92
7283643|NCT00490971|11499490|FG001|Acute/Continuation|Withdrawal by Subject|24
7283644|NCT00490971|11499491|FG002|Acute/Continuation|Withdrawal by Subject|0
7283645|NCT00490971|11499492|FG003|Acute/Continuation|Withdrawal by Subject|0
7283646|NCT00490971|11499493|FG004|Acute/Continuation|Withdrawal by Subject|0
7283647|NCT00490971|11499489|FG000|Acute/Continuation|Other|11
7283648|NCT00490971|11499490|FG001|Acute/Continuation|Other|4
7283649|NCT00490971|11499491|FG002|Acute/Continuation|Other|0
7283650|NCT00490971|11499492|FG003|Acute/Continuation|Other|0
7283651|NCT00490971|11499493|FG004|Acute/Continuation|Other|0
7283652|NCT00490971|11499489|FG000|Maintenance|Adverse Event|0
7283653|NCT00490971|11499490|FG001|Maintenance|Adverse Event|0
7283654|NCT00490971|11499491|FG002|Maintenance|Adverse Event|4
7283655|NCT00490971|11499492|FG003|Maintenance|Adverse Event|5
7283656|NCT00490971|11499493|FG004|Maintenance|Adverse Event|7
7283657|NCT00490971|11499489|FG000|Maintenance|Death|0
7283658|NCT00490971|11499490|FG001|Maintenance|Death|0
7283659|NCT00490971|11499491|FG002|Maintenance|Death|0
7283660|NCT00490971|11499492|FG003|Maintenance|Death|2
7283661|NCT00490971|11499493|FG004|Maintenance|Death|0
7283662|NCT00490971|11499489|FG000|Maintenance|Lost to Follow-up|0
7283663|NCT00490971|11499490|FG001|Maintenance|Lost to Follow-up|0
7283664|NCT00490971|11499491|FG002|Maintenance|Lost to Follow-up|5
7283665|NCT00490971|11499492|FG003|Maintenance|Lost to Follow-up|8
7283666|NCT00490971|11499493|FG004|Maintenance|Lost to Follow-up|10
7283667|NCT00490971|11499489|FG000|Maintenance|Pregnancy|0
7283668|NCT00490971|11499490|FG001|Maintenance|Pregnancy|0
7283669|NCT00490971|11499491|FG002|Maintenance|Pregnancy|1
7283670|NCT00490971|11499492|FG003|Maintenance|Pregnancy|0
7283671|NCT00490971|11499493|FG004|Maintenance|Pregnancy|0
7283672|NCT00490971|11499489|FG000|Maintenance|Protocol Violation|0
7283673|NCT00490971|11499490|FG001|Maintenance|Protocol Violation|0
7283674|NCT00490971|11499491|FG002|Maintenance|Protocol Violation|4
7283675|NCT00490971|11499492|FG003|Maintenance|Protocol Violation|1
7283676|NCT00490971|11499493|FG004|Maintenance|Protocol Violation|1
7283677|NCT00490971|11499489|FG000|Maintenance|Withdrawal by Subject|0
7283678|NCT00490971|11499490|FG001|Maintenance|Withdrawal by Subject|0
7283679|NCT00490971|11499491|FG002|Maintenance|Withdrawal by Subject|26
7283680|NCT00490971|11499492|FG003|Maintenance|Withdrawal by Subject|28
7283681|NCT00490971|11499493|FG004|Maintenance|Withdrawal by Subject|18
7283682|NCT00490971|11499489|FG000|Maintenance|Other|0
7283683|NCT00490971|11499490|FG001|Maintenance|Other|0
7283684|NCT00490971|11499491|FG002|Maintenance|Other|11
7283685|NCT00490971|11499492|FG003|Maintenance|Other|9
7283686|NCT00490971|11499493|FG004|Maintenance|Other|3
7283687|NCT00491075|11499505|FG000|Overall Study|Withdrawal by Subject|1
7283688|NCT00491075|11499505|FG000|Overall Study|Physician Decision|1
7283689|NCT00491179|11499511|FG000|Overall Study|Adverse Event|5
7283690|NCT00491179|11499512|FG001|Overall Study|Adverse Event|1
7283691|NCT00491179|11499511|FG000|Overall Study|Withdrawal by Subject|2
7283692|NCT00491179|11499512|FG001|Overall Study|Withdrawal by Subject|1
7283693|NCT00491322|11499529|FG000|Overall Study|Protocol Violation|1
7283694|NCT00491322|11499530|FG001|Overall Study|Protocol Violation|0
7283695|NCT00491322|11499529|FG000|Overall Study|Pregnancy|0
7283696|NCT00491322|11499530|FG001|Overall Study|Pregnancy|1
7283697|NCT00491530|11499557|FG000|Overall Study|Adverse Event|6
7283698|NCT00491530|11499558|FG001|Overall Study|Adverse Event|1
7283699|NCT00491530|11499559|FG002|Overall Study|Adverse Event|2
7283700|NCT00491530|11499557|FG000|Overall Study|Withdrawal by Subject|3
7283701|NCT00491530|11499558|FG001|Overall Study|Withdrawal by Subject|0
7283702|NCT00491530|11499559|FG002|Overall Study|Withdrawal by Subject|0
7283703|NCT00491530|11499557|FG000|Overall Study|Lost to Follow-up|3
7283704|NCT00491530|11499558|FG001|Overall Study|Lost to Follow-up|2
7283705|NCT00491530|11499559|FG002|Overall Study|Lost to Follow-up|2
7283706|NCT00491530|11499557|FG000|Overall Study|Lack of Efficacy|0
7283707|NCT00491530|11499558|FG001|Overall Study|Lack of Efficacy|1
7283708|NCT00491530|11499559|FG002|Overall Study|Lack of Efficacy|0
7283709|NCT00491530|11499557|FG000|Overall Study|Investigator Discretion|0
7283710|NCT00491530|11499558|FG001|Overall Study|Investigator Discretion|1
7283711|NCT00491530|11499559|FG002|Overall Study|Investigator Discretion|0
7283712|NCT00491530|11499557|FG000|Overall Study|Patient Request|0
7283713|NCT00491530|11499558|FG001|Overall Study|Patient Request|1
7283714|NCT00491530|11499559|FG002|Overall Study|Patient Request|0
7283715|NCT00491530|11499557|FG000|Overall Study|Use of Prohibited Medication|0
7283716|NCT00491530|11499558|FG001|Overall Study|Use of Prohibited Medication|0
7283717|NCT00491530|11499559|FG002|Overall Study|Use of Prohibited Medication|1
7283718|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
7283719|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
7283720|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
7283721|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
7283722|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
7283723|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
7283724|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
7283725|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
7283726|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
7283727|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
7283728|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
7283729|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
7283730|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
7283731|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
7283732|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
7283733|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
7283734|NCT00491556|11499569|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
7283735|NCT00491556|11499570|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
7283736|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7283737|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
7283738|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
7283739|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
7283740|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
7283741|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
7283742|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
7283743|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
7283744|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
7283745|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
7283746|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
7283747|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
7283748|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
7283749|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
7283750|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
7283751|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
7283752|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
7283753|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
7283754|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
7283755|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
7283756|NCT00491556|11499569|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
7283757|NCT00491556|11499570|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
7283758|NCT00491608|11499576|FG000|Overall Study|Death|2
7283759|NCT00491608|11499576|FG000|Overall Study|Withdrawal by Subject|1
7283760|NCT00491764|11499601|FG000|Overall Study|Adverse Event|1
7283761|NCT00491764|11499602|FG001|Overall Study|Adverse Event|2
7283762|NCT00491764|11499603|FG002|Overall Study|Adverse Event|4
7283763|NCT00491764|11499604|FG003|Overall Study|Adverse Event|4
7283764|NCT00491764|11499605|FG004|Overall Study|Adverse Event|0
7283765|NCT00491764|11499606|FG005|Overall Study|Adverse Event|1
7283766|NCT00491764|11499601|FG000|Overall Study|Lost to Follow-up|0
7283767|NCT00491764|11499602|FG001|Overall Study|Lost to Follow-up|1
7283768|NCT00491764|11499603|FG002|Overall Study|Lost to Follow-up|0
7283769|NCT00491764|11499604|FG003|Overall Study|Lost to Follow-up|1
7283770|NCT00491764|11499605|FG004|Overall Study|Lost to Follow-up|0
7283771|NCT00491764|11499606|FG005|Overall Study|Lost to Follow-up|3
7283772|NCT00491764|11499601|FG000|Overall Study|Withdrawal by Subject|2
7283773|NCT00491764|11499602|FG001|Overall Study|Withdrawal by Subject|3
7283774|NCT00491764|11499603|FG002|Overall Study|Withdrawal by Subject|1
7283775|NCT00491764|11499604|FG003|Overall Study|Withdrawal by Subject|2
7283776|NCT00491764|11499605|FG004|Overall Study|Withdrawal by Subject|2
7283777|NCT00491764|11499606|FG005|Overall Study|Withdrawal by Subject|4
7283778|NCT00491764|11499601|FG000|Overall Study|Non Compliance with the Protocol|1
7283779|NCT00491764|11499602|FG001|Overall Study|Non Compliance with the Protocol|0
7283780|NCT00491764|11499603|FG002|Overall Study|Non Compliance with the Protocol|0
7283781|NCT00491764|11499604|FG003|Overall Study|Non Compliance with the Protocol|0
7283782|NCT00491764|11499605|FG004|Overall Study|Non Compliance with the Protocol|0
7283783|NCT00491764|11499606|FG005|Overall Study|Non Compliance with the Protocol|0
7283784|NCT00491764|11499601|FG000|Overall Study|Did not Meet Protocol Eligibility|0
7283785|NCT00491764|11499602|FG001|Overall Study|Did not Meet Protocol Eligibility|1
7283786|NCT00491764|11499603|FG002|Overall Study|Did not Meet Protocol Eligibility|1
7283787|NCT00491764|11499604|FG003|Overall Study|Did not Meet Protocol Eligibility|0
7283788|NCT00491764|11499605|FG004|Overall Study|Did not Meet Protocol Eligibility|1
7283789|NCT00491764|11499606|FG005|Overall Study|Did not Meet Protocol Eligibility|1
7283790|NCT00491764|11499601|FG000|Overall Study|Administrative|1
7283791|NCT00491764|11499602|FG001|Overall Study|Administrative|0
7283792|NCT00491764|11499603|FG002|Overall Study|Administrative|2
7283793|NCT00491764|11499604|FG003|Overall Study|Administrative|1
7283794|NCT00491764|11499605|FG004|Overall Study|Administrative|0
7283795|NCT00491764|11499606|FG005|Overall Study|Administrative|0
7283796|NCT00491894|11499633|FG000|Overall Study|Adverse Event|14
7283797|NCT00491894|11499633|FG000|Overall Study|Withdrawal by Subject|5
7283798|NCT00491894|11499633|FG000|Overall Study|Death|3
7283799|NCT00491894|11499633|FG000|Overall Study|Lost to Follow-up|3
7283800|NCT00491894|11499633|FG000|Overall Study|Lack of Efficacy|2
7283801|NCT00491894|11499633|FG000|Overall Study|Other-Failed to meet any criteria|2
7283802|NCT00491894|11499633|FG000|Overall Study|Physician Decision|2
7283803|NCT00491894|11499633|FG000|Overall Study|Protocol Violation|2
7283804|NCT00491894|11499633|FG000|Overall Study|Other-Intake of prohibited medication|1
7283805|NCT00492024|11499639|FG000|Treatment|Adverse Event|3
7283806|NCT00492024|11499640|FG001|Treatment|Adverse Event|1
7622580|NCT02075320|12033368|FG000|Overall Study|Withdrawal by Subject|2
7622581|NCT02007512|12033376|FG000|Double Blind Treatment Period|Adverse Event|4
7622582|NCT02007512|12033377|FG001|Double Blind Treatment Period|Adverse Event|2
7622583|NCT02007512|12033378|FG002|Double Blind Treatment Period|Adverse Event|6
7622584|NCT02007512|12033379|FG003|Double Blind Treatment Period|Adverse Event|2
7622585|NCT02007512|12033376|FG000|Double Blind Treatment Period|Death|1
7622586|NCT02007512|12033377|FG001|Double Blind Treatment Period|Death|0
7622587|NCT02007512|12033378|FG002|Double Blind Treatment Period|Death|0
7622588|NCT02007512|12033379|FG003|Double Blind Treatment Period|Death|0
7622589|NCT02007512|12033376|FG000|Double Blind Treatment Period|Disease progression|44
7622590|NCT02007512|12033377|FG001|Double Blind Treatment Period|Disease progression|49
7622591|NCT02007512|12033378|FG002|Double Blind Treatment Period|Disease progression|45
7622592|NCT02007512|12033379|FG003|Double Blind Treatment Period|Disease progression|51
7622593|NCT02007512|12033376|FG000|Double Blind Treatment Period|Withdrawal by Subject|4
7622594|NCT02007512|12033377|FG001|Double Blind Treatment Period|Withdrawal by Subject|2
7622595|NCT02007512|12033378|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
7622596|NCT02007512|12033379|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
7622597|NCT02007512|12033376|FG000|Double Blind Treatment Period|Protocol Violation|0
7622598|NCT02007512|12033377|FG001|Double Blind Treatment Period|Protocol Violation|0
7622599|NCT02007512|12033378|FG002|Double Blind Treatment Period|Protocol Violation|0
7622600|NCT02007512|12033379|FG003|Double Blind Treatment Period|Protocol Violation|1
7622601|NCT02007512|12033376|FG000|Double Blind Treatment Period|Other|0
7622602|NCT02007512|12033377|FG001|Double Blind Treatment Period|Other|0
7622603|NCT02007512|12033378|FG002|Double Blind Treatment Period|Other|1
7622604|NCT02007512|12033379|FG003|Double Blind Treatment Period|Other|2
7622605|NCT02007512|12033376|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
7283807|NCT00492024|11499639|FG000|Treatment|Lack of Efficacy|21
7283808|NCT00492024|11499640|FG001|Treatment|Lack of Efficacy|20
7283809|NCT00492024|11499639|FG000|Treatment|Lost to Follow-up|3
7283810|NCT00492024|11499640|FG001|Treatment|Lost to Follow-up|1
7283811|NCT00492024|11499639|FG000|Treatment|Withdrawal by Subject|2
7283812|NCT00492024|11499640|FG001|Treatment|Withdrawal by Subject|0
7283813|NCT00492024|11499639|FG000|Follow up|Lack of Efficacy|0
7283814|NCT00492024|11499640|FG001|Follow up|Lack of Efficacy|1
7283815|NCT00492024|11499639|FG000|Follow up|Lost to Follow-up|1
7283816|NCT00492024|11499640|FG001|Follow up|Lost to Follow-up|1
7283817|NCT00492063|11499650|FG000|Overall Study|Death|0
7283818|NCT00492063|11499651|FG001|Overall Study|Death|0
7283819|NCT00492063|11499652|FG002|Overall Study|Death|1
7283820|NCT00492063|11499653|FG003|Overall Study|Death|2
7283821|NCT00492063|11499650|FG000|Overall Study|Withdrawal by Subject|4
7283822|NCT00492063|11499651|FG001|Overall Study|Withdrawal by Subject|3
7283823|NCT00492063|11499652|FG002|Overall Study|Withdrawal by Subject|5
7283824|NCT00492063|11499653|FG003|Overall Study|Withdrawal by Subject|4
7283825|NCT00492063|11499650|FG000|Overall Study|Lost to Follow-up|6
7283826|NCT00492063|11499651|FG001|Overall Study|Lost to Follow-up|11
7283827|NCT00492063|11499652|FG002|Overall Study|Lost to Follow-up|5
7283828|NCT00492063|11499653|FG003|Overall Study|Lost to Follow-up|3
7283829|NCT00492063|11499650|FG000|Overall Study|Protocol Violation|0
7283830|NCT00492063|11499651|FG001|Overall Study|Protocol Violation|0
7283831|NCT00492063|11499652|FG002|Overall Study|Protocol Violation|0
7283832|NCT00492063|11499653|FG003|Overall Study|Protocol Violation|1
7283833|NCT00492115|11499674|FG000|Overall Study|Withdrawal by Subject|3
7283834|NCT00492115|11499675|FG001|Overall Study|Withdrawal by Subject|4
7283835|NCT00492232|11499689|FG000|Placebo Run-in|Adverse Event|0
7283836|NCT00492232|11499690|FG001|Placebo Run-in|Adverse Event|2
7283837|NCT00492232|11499689|FG000|Placebo Run-in|Protocol Violation|0
7283838|NCT00492232|11499690|FG001|Placebo Run-in|Protocol Violation|3
7283839|NCT00492232|11499689|FG000|Placebo Run-in|Lost to Follow-up|0
7283840|NCT00492232|11499690|FG001|Placebo Run-in|Lost to Follow-up|3
7283841|NCT00492232|11499689|FG000|Placebo Run-in|Withdrawal by Subject|0
7283842|NCT00492232|11499690|FG001|Placebo Run-in|Withdrawal by Subject|8
7283843|NCT00492232|11499689|FG000|Placebo Run-in|Pregnancy|0
7283844|NCT00492232|11499690|FG001|Placebo Run-in|Pregnancy|1
7283845|NCT00492232|11499689|FG000|Placebo Run-in|Entrance criteria not met|0
7283846|NCT00492232|11499690|FG001|Placebo Run-in|Entrance criteria not met|45
7283847|NCT00492232|11499689|FG000|Placebo Run-in|Other|0
7283848|NCT00492232|11499690|FG001|Placebo Run-in|Other|6
7283849|NCT00492232|11499689|FG000|Placebo Run-in|Missing|0
7283850|NCT00492232|11499690|FG001|Placebo Run-in|Missing|2
7283851|NCT00492232|11499689|FG000|Double-Blind Treatment|Adverse Event|1
7283852|NCT00492232|11499690|FG001|Double-Blind Treatment|Adverse Event|2
7283853|NCT00492232|11499689|FG000|Double-Blind Treatment|Protocol Violation|3
7283854|NCT00492232|11499690|FG001|Double-Blind Treatment|Protocol Violation|7
7283855|NCT00492232|11499689|FG000|Double-Blind Treatment|Lost to Follow-up|2
7283856|NCT00492232|11499690|FG001|Double-Blind Treatment|Lost to Follow-up|3
7283857|NCT00492232|11499689|FG000|Double-Blind Treatment|Withdrawal by Subject|4
7283858|NCT00492232|11499690|FG001|Double-Blind Treatment|Withdrawal by Subject|8
7283859|NCT00492232|11499689|FG000|Double-Blind Treatment|Lack of Efficacy|1
7283860|NCT00492232|11499690|FG001|Double-Blind Treatment|Lack of Efficacy|0
7283861|NCT00492232|11499689|FG000|Double-Blind Treatment|Other|6
7283862|NCT00492232|11499690|FG001|Double-Blind Treatment|Other|5
7283863|NCT00492232|11499689|FG000|Double-Blind Treatment|Randomized not treated|1
7283864|NCT00492232|11499690|FG001|Double-Blind Treatment|Randomized not treated|0
7283865|NCT00492232|11499689|FG000|Open-Label Treatment|Withdrawal by Subject|1
7283866|NCT00492232|11499690|FG001|Open-Label Treatment|Withdrawal by Subject|0
7283867|NCT00492284|11499700|FG000|Overall Study|Adverse Event|0
7283868|NCT00492284|11499701|FG001|Overall Study|Adverse Event|1
7283869|NCT00492284|11499702|FG002|Overall Study|Adverse Event|1
7283870|NCT00492284|11499703|FG003|Overall Study|Adverse Event|2
7283871|NCT00492284|11499700|FG000|Overall Study|Lost to Follow-up|0
7283872|NCT00492284|11499701|FG001|Overall Study|Lost to Follow-up|0
7283873|NCT00492284|11499702|FG002|Overall Study|Lost to Follow-up|3
7283874|NCT00492284|11499703|FG003|Overall Study|Lost to Follow-up|1
7283875|NCT00492284|11499700|FG000|Overall Study|Death|0
7283876|NCT00492284|11499701|FG001|Overall Study|Death|3
7283877|NCT00492284|11499702|FG002|Overall Study|Death|2
7283878|NCT00492284|11499703|FG003|Overall Study|Death|5
7283879|NCT00492284|11499700|FG000|Overall Study|Withdrawal by Subject|1
7283880|NCT00492284|11499701|FG001|Overall Study|Withdrawal by Subject|0
7283881|NCT00492284|11499702|FG002|Overall Study|Withdrawal by Subject|0
7283882|NCT00492284|11499703|FG003|Overall Study|Withdrawal by Subject|2
7283883|NCT00492297|11499713|FG000|Treatment|Death|2
7283884|NCT00492297|11499713|FG000|Treatment|Study terminated by sponsor|3
7283885|NCT00492297|11499713|FG000|Active Follow-up 30(+4) Days Duration|Death|17
7283886|NCT00492297|11499713|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
7283887|NCT00492297|11499713|FG000|Survival Only Follow-up|Death|46
7283888|NCT00492297|11499713|FG000|Survival Only Follow-up|Lack of Efficacy|1
7283889|NCT00492297|11499713|FG000|Survival Only Follow-up|Study terminated by sponsor|12
7469892|NCT01928329|11771836|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
7469893|NCT01928329|11771837|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
7283890|NCT00492531|11499734|FG000|Overall Study|Withdrawn(More than one reason selected)|22
7283891|NCT00492531|11499735|FG001|Overall Study|Withdrawn(More than one reason selected)|23
7283892|NCT00492557|11499747|FG000|Overall Study|Subject request|12
7283893|NCT00492557|11499748|FG001|Overall Study|Subject request|11
7283894|NCT00492557|11499747|FG000|Overall Study|Protocol Violation|7
7283895|NCT00492557|11499748|FG001|Overall Study|Protocol Violation|8
7283896|NCT00492557|11499747|FG000|Overall Study|Other|2
7283897|NCT00492557|11499748|FG001|Overall Study|Other|2
7283898|NCT00492557|11499747|FG000|Overall Study|Death|1
7283899|NCT00492557|11499748|FG001|Overall Study|Death|1
7283900|NCT00492557|11499747|FG000|Overall Study|Adverse Event|1
7283901|NCT00492557|11499748|FG001|Overall Study|Adverse Event|0
7283902|NCT00492557|11499747|FG000|Overall Study|Failed to return|1
7283903|NCT00492557|11499748|FG001|Overall Study|Failed to return|0
7283904|NCT00492557|11499747|FG000|Overall Study|Lost to Follow-up|0
7283905|NCT00492557|11499748|FG001|Overall Study|Lost to Follow-up|1
7283906|NCT00492648|11499776|FG000|Month 30 (109671 Study)|Protocol Violation|0
7283907|NCT00492648|11499777|FG001|Month 30 (109671 Study)|Protocol Violation|1
7283908|NCT00492726|11499785|FG000|Overall Study|Adverse Event|10
7283909|NCT00492726|11499786|FG001|Overall Study|Adverse Event|6
7283910|NCT00492726|11499785|FG000|Overall Study|Death|7
7283911|NCT00492726|11499786|FG001|Overall Study|Death|2
7283912|NCT00492726|11499785|FG000|Overall Study|Lack of Efficacy|0
7283913|NCT00492726|11499786|FG001|Overall Study|Lack of Efficacy|2
7283914|NCT00492726|11499785|FG000|Overall Study|Lost to Follow-up|27
7283915|NCT00492726|11499786|FG001|Overall Study|Lost to Follow-up|19
7283916|NCT00492726|11499785|FG000|Overall Study|Physician Decision|0
7283917|NCT00492726|11499786|FG001|Overall Study|Physician Decision|1
7283918|NCT00492726|11499785|FG000|Overall Study|Withdrawal by Subject|6
7283919|NCT00492726|11499786|FG001|Overall Study|Withdrawal by Subject|3
7283920|NCT00492726|11499785|FG000|Overall Study|Non compliant with study medication|0
7283921|NCT00492726|11499786|FG001|Overall Study|Non compliant with study medication|3
7283922|NCT00492752|11499794|FG000|Double Blind Treatment|Death|13
7283923|NCT00492752|11499795|FG001|Double Blind Treatment|Death|0
7283924|NCT00492752|11499796|FG002|Double Blind Treatment|Death|2
7283925|NCT00492752|11499797|FG003|Double Blind Treatment|Death|0
7283926|NCT00492752|11499794|FG000|Double Blind Treatment|Adverse Event|1
7283927|NCT00492752|11499795|FG001|Double Blind Treatment|Adverse Event|0
7283928|NCT00492752|11499796|FG002|Double Blind Treatment|Adverse Event|0
7283929|NCT00492752|11499797|FG003|Double Blind Treatment|Adverse Event|0
7283930|NCT00492752|11499794|FG000|Double Blind Treatment|Protocol Violation|0
7283931|NCT00492752|11499795|FG001|Double Blind Treatment|Protocol Violation|0
7283932|NCT00492752|11499796|FG002|Double Blind Treatment|Protocol Violation|1
7283933|NCT00492752|11499797|FG003|Double Blind Treatment|Protocol Violation|0
7283934|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7283935|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7283936|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
7283937|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
7283938|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Death|75
7283939|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Death|5
7283940|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Death|45
7283941|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Death|1
7283942|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
7622606|NCT02007512|12033377|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
7622607|NCT02007512|12033378|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
7622608|NCT02007512|12033379|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
7622609|NCT02007512|12033376|FG000|Open Label Treatment Period|Adverse Event|0
7622610|NCT02007512|12033377|FG001|Open Label Treatment Period|Adverse Event|1
7622611|NCT02007512|12033378|FG002|Open Label Treatment Period|Adverse Event|0
7622612|NCT02007512|12033379|FG003|Open Label Treatment Period|Adverse Event|0
7622613|NCT02007512|12033376|FG000|Open Label Treatment Period|Other|0
7622614|NCT02007512|12033377|FG001|Open Label Treatment Period|Other|0
7622615|NCT02007512|12033378|FG002|Open Label Treatment Period|Other|0
7622616|NCT02007512|12033379|FG003|Open Label Treatment Period|Other|1
7622617|NCT02007512|12033376|FG000|Open Label Treatment Period|Disease progression|0
7622618|NCT02007512|12033377|FG001|Open Label Treatment Period|Disease progression|17
7622619|NCT02007512|12033378|FG002|Open Label Treatment Period|Disease progression|0
7622620|NCT02007512|12033379|FG003|Open Label Treatment Period|Disease progression|11
7622621|NCT02007512|12033376|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622622|NCT02007512|12033377|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
7622623|NCT02007512|12033378|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622624|NCT02007512|12033379|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
7622625|NCT01999179|12033392|FG000|Overall Study|Adverse Event|1
7622626|NCT01999179|12033392|FG000|Overall Study|Lost to Follow-up|1
7622627|NCT01999179|12033392|FG000|Overall Study|Change in Therapy|3
7622628|NCT01999179|12033392|FG000|Overall Study|New catheter|2
7622629|NCT01858688|12033396|FG000|Overall Study|Withdrawal by Subject|8
7622630|NCT01858688|12033396|FG000|Overall Study|Participant began another therapy|3
7622631|NCT01858688|12033396|FG000|Overall Study|Physician Decision|2
7622632|NCT01858688|12033396|FG000|Overall Study|Progressive Disease|2
7283943|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
7283944|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
7283945|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
7283946|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
7283947|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
7283948|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7283949|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
7283950|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7283951|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
7283952|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
7283953|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
7283954|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7283955|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7283956|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
7283957|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
7283958|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7283959|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
7551241|NCT02966834|11910256|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
7551242|NCT02966834|11910257|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
7551243|NCT02966834|11910258|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
7622633|NCT01858688|12033396|FG000|Overall Study|Reason not reproted|5
7622634|NCT01796197|12033400|FG000|Overall Study|Lost to Follow-up|1
7622635|NCT01796197|12033400|FG000|Overall Study|Lack of Efficacy|1
7551244|NCT02966834|11910259|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
7551245|NCT02966834|11910254|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7551246|NCT02966834|11910255|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7551247|NCT02966834|11910256|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7551248|NCT02966834|11910257|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
7551249|NCT02966834|11910258|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7551250|NCT02966834|11910259|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
7551251|NCT02966834|11910254|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7551252|NCT02966834|11910255|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7551253|NCT02966834|11910256|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7551254|NCT02966834|11910257|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
7551255|NCT02966834|11910258|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7551256|NCT02966834|11910259|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
7551257|NCT02967055|11910317|FG000|Overall Study|Excluded|40
7551258|NCT02967055|11910317|FG000|Overall Study|Screen fail|3
7551259|NCT02967055|11910317|FG000|Overall Study|Lost to Follow-up|2
7551260|NCT02967055|11910317|FG000|Overall Study|Stopped due to side effects|3
7551261|NCT02967055|11910317|FG000|Overall Study|Stopped due to drug cost|1
7551262|NCT02967562|11910386|FG000|Overall Study|Consent not obtained|1
7551263|NCT02967562|11910387|FG001|Overall Study|Consent not obtained|0
7551264|NCT02967562|11910386|FG000|Overall Study|High leak precluding analysis|1
7551265|NCT02967562|11910387|FG001|Overall Study|High leak precluding analysis|1
7551266|NCT02967679|11910393|FG000|Overall Study|Adverse Event|1
7283960|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7283961|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
7283962|NCT00492752|11499794|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
7283963|NCT00492752|11499795|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7283964|NCT00492752|11499796|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7283965|NCT00492752|11499797|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
7283966|NCT00492856|11499804|FG000|Induction|Adverse Event|2
7283967|NCT00492856|11499805|FG001|Induction|Adverse Event|0
7283968|NCT00492856|11499806|FG002|Induction|Adverse Event|0
7283969|NCT00492856|11499807|FG003|Induction|Adverse Event|0
7283970|NCT00492856|11499804|FG000|Induction|Withdrawal by Subject|1
7283971|NCT00492856|11499805|FG001|Induction|Withdrawal by Subject|0
7283972|NCT00492856|11499806|FG002|Induction|Withdrawal by Subject|0
7283973|NCT00492856|11499807|FG003|Induction|Withdrawal by Subject|0
7283974|NCT00492856|11499804|FG000|Induction|Death|3
7283975|NCT00492856|11499805|FG001|Induction|Death|0
7283976|NCT00492856|11499806|FG002|Induction|Death|0
7283977|NCT00492856|11499807|FG003|Induction|Death|0
7283978|NCT00492856|11499804|FG000|Consolidation|Adverse Event|6
7283979|NCT00492856|11499805|FG001|Consolidation|Adverse Event|0
7283980|NCT00492856|11499806|FG002|Consolidation|Adverse Event|0
7283981|NCT00492856|11499807|FG003|Consolidation|Adverse Event|0
7283982|NCT00492856|11499804|FG000|Consolidation|Not protocol specified|2
7283983|NCT00492856|11499805|FG001|Consolidation|Not protocol specified|0
7283984|NCT00492856|11499806|FG002|Consolidation|Not protocol specified|0
7283985|NCT00492856|11499807|FG003|Consolidation|Not protocol specified|0
7283986|NCT00492856|11499804|FG000|Consolidation|Lost to Follow-up|1
7283987|NCT00492856|11499805|FG001|Consolidation|Lost to Follow-up|0
7283988|NCT00492856|11499806|FG002|Consolidation|Lost to Follow-up|0
7283989|NCT00492856|11499807|FG003|Consolidation|Lost to Follow-up|0
7283990|NCT00492856|11499804|FG000|Post-consolidation|Adverse Event|0
7283991|NCT00492856|11499805|FG001|Post-consolidation|Adverse Event|4
7283992|NCT00492856|11499806|FG002|Post-consolidation|Adverse Event|0
7283993|NCT00492856|11499807|FG003|Post-consolidation|Adverse Event|1
7283994|NCT00492856|11499804|FG000|Post-consolidation|Withdrawal by Subject|0
7283995|NCT00492856|11499805|FG001|Post-consolidation|Withdrawal by Subject|4
7283996|NCT00492856|11499806|FG002|Post-consolidation|Withdrawal by Subject|0
7283997|NCT00492856|11499807|FG003|Post-consolidation|Withdrawal by Subject|0
7283998|NCT00492856|11499804|FG000|Post-consolidation|Death|0
7283999|NCT00492856|11499805|FG001|Post-consolidation|Death|1
7284000|NCT00492856|11499806|FG002|Post-consolidation|Death|0
7284001|NCT00492856|11499807|FG003|Post-consolidation|Death|0
7284002|NCT00492856|11499804|FG000|Post-consolidation|Not protocol specified|0
7284003|NCT00492856|11499805|FG001|Post-consolidation|Not protocol specified|1
7284004|NCT00492856|11499806|FG002|Post-consolidation|Not protocol specified|0
7284005|NCT00492856|11499807|FG003|Post-consolidation|Not protocol specified|0
7284006|NCT00492856|11499804|FG000|Post-consolidation|Lost to Follow-up|0
7284007|NCT00492856|11499805|FG001|Post-consolidation|Lost to Follow-up|2
7284008|NCT00492856|11499806|FG002|Post-consolidation|Lost to Follow-up|0
7284009|NCT00492856|11499807|FG003|Post-consolidation|Lost to Follow-up|0
7284010|NCT00492856|11499804|FG000|Post-consolidation|Observation Arm|0
7284011|NCT00492856|11499805|FG001|Post-consolidation|Observation Arm|0
7284012|NCT00492856|11499806|FG002|Post-consolidation|Observation Arm|27
7284013|NCT00492856|11499807|FG003|Post-consolidation|Observation Arm|0
7284014|NCT00492921|11499819|FG000|Overall Study|Death|1
7284015|NCT00492921|11499820|FG001|Overall Study|Death|0
7284016|NCT00492921|11499821|FG002|Overall Study|Death|1
7284017|NCT00493012|11499840|FG000|Overall Study|Lost to Follow-up|18
7284018|NCT00493012|11499841|FG001|Overall Study|Lost to Follow-up|17
7284019|NCT00493038|11499849|FG000|Treatment|Adverse Event|8
7284020|NCT00493038|11499850|FG001|Treatment|Adverse Event|4
7284021|NCT00493038|11499849|FG000|Treatment|Lost to Follow-up|5
7284022|NCT00493038|11499850|FG001|Treatment|Lost to Follow-up|3
7284023|NCT00493038|11499849|FG000|Treatment|Withdrawal by Subject|11
7284024|NCT00493038|11499850|FG001|Treatment|Withdrawal by Subject|12
7284025|NCT00493038|11499849|FG000|Treatment|Other|0
7284026|NCT00493038|11499850|FG001|Treatment|Other|1
7622636|NCT01751906|12033406|FG000|Overall Study|Lost to Follow-up|151
7284027|NCT00493038|11499849|FG000|Follow-up|Lost to Follow-up|1
7284028|NCT00493038|11499850|FG001|Follow-up|Lost to Follow-up|0
7284029|NCT00493220|11499870|FG000|Third Intervention|Withdrawal by Subject|1
7284030|NCT00493220|11499871|FG001|Third Intervention|Withdrawal by Subject|0
7284031|NCT00493220|11499872|FG002|Third Intervention|Withdrawal by Subject|0
7284032|NCT00493220|11499873|FG003|Third Intervention|Withdrawal by Subject|0
7284033|NCT00493220|11499874|FG004|Third Intervention|Withdrawal by Subject|0
7284034|NCT00493220|11499875|FG005|Third Intervention|Withdrawal by Subject|0
7284035|NCT00493246|11499893|FG000|Overall Study|Withdrawal by Subject|0
7284036|NCT00493246|11499894|FG001|Overall Study|Withdrawal by Subject|0
7284037|NCT00493246|11499895|FG002|Overall Study|Withdrawal by Subject|0
7284038|NCT00493246|11499896|FG003|Overall Study|Withdrawal by Subject|0
7284039|NCT00493246|11499897|FG004|Overall Study|Withdrawal by Subject|1
7284040|NCT00493246|11499898|FG005|Overall Study|Withdrawal by Subject|0
7284041|NCT00493246|11499899|FG006|Overall Study|Withdrawal by Subject|0
7284042|NCT00493246|11499900|FG007|Overall Study|Withdrawal by Subject|0
7284043|NCT00493246|11499893|FG000|Overall Study|No access to draw blood|0
7284044|NCT00493246|11499894|FG001|Overall Study|No access to draw blood|0
7284045|NCT00493246|11499895|FG002|Overall Study|No access to draw blood|0
7284046|NCT00493246|11499896|FG003|Overall Study|No access to draw blood|0
7284047|NCT00493246|11499897|FG004|Overall Study|No access to draw blood|0
7284048|NCT00493246|11499898|FG005|Overall Study|No access to draw blood|1
7284049|NCT00493246|11499899|FG006|Overall Study|No access to draw blood|0
7284050|NCT00493246|11499900|FG007|Overall Study|No access to draw blood|0
7284051|NCT00493246|11499893|FG000|Overall Study|Lost to Follow-up|0
7284052|NCT00493246|11499894|FG001|Overall Study|Lost to Follow-up|0
7284053|NCT00493246|11499895|FG002|Overall Study|Lost to Follow-up|0
7284054|NCT00493246|11499896|FG003|Overall Study|Lost to Follow-up|0
7284055|NCT00493246|11499897|FG004|Overall Study|Lost to Follow-up|0
7284056|NCT00493246|11499898|FG005|Overall Study|Lost to Follow-up|0
7284057|NCT00493246|11499899|FG006|Overall Study|Lost to Follow-up|1
7284058|NCT00493246|11499900|FG007|Overall Study|Lost to Follow-up|0
7284059|NCT00493285|11499924|FG000|Overall Study|Lost to Follow-up|0
7284060|NCT00493285|11499925|FG001|Overall Study|Lost to Follow-up|0
7284061|NCT00493285|11499926|FG002|Overall Study|Lost to Follow-up|0
7284062|NCT00493285|11499927|FG003|Overall Study|Lost to Follow-up|0
7284063|NCT00493285|11499928|FG004|Overall Study|Lost to Follow-up|1
7284064|NCT00493285|11499929|FG005|Overall Study|Lost to Follow-up|0
7622637|NCT01751906|12033407|FG001|Overall Study|Lost to Follow-up|68
7622638|NCT01751906|12033406|FG000|Overall Study|Withdrawal by Subject|22
7622639|NCT01751906|12033407|FG001|Overall Study|Withdrawal by Subject|18
7622640|NCT01751906|12033406|FG000|Overall Study|Physician Decision|5
7622641|NCT01751906|12033407|FG001|Overall Study|Physician Decision|2
7622642|NCT01751906|12033406|FG000|Overall Study|Death|84
7622643|NCT01751906|12033407|FG001|Overall Study|Death|43
7622644|NCT01751906|12033406|FG000|Overall Study|Denied on premises for follow-up by law|1
7622645|NCT01751906|12033407|FG001|Overall Study|Denied on premises for follow-up by law|0
7622646|NCT00669669|12033448|FG000|Overall Study|To late to start treatment|1
7622671|NCT00314366|12033475|FG000|Overall Study|not treated due to patient medical condi|1
7622672|NCT00314366|12033476|FG001|Overall Study|not treated due to patient medical condi|0
7284065|NCT00493311|11499945|FG000|Overall Study|Need for rescue medication|2
7284066|NCT00493311|11499946|FG001|Overall Study|Need for rescue medication|2
7284067|NCT00493454|11499952|FG000|Overall Study|Withdrawal by Subject|1
7284069|NCT00493636|11499962|FG000|Overall Study|Withdrawal by Subject|1
7284070|NCT00493636|11499963|FG001|Overall Study|Withdrawal by Subject|0
7284071|NCT00493636|11499962|FG000|Overall Study|Disease progression/recurrence/relapse|0
7284072|NCT00493636|11499963|FG001|Overall Study|Disease progression/recurrence/relapse|1
7284073|NCT00493636|11499962|FG000|Overall Study|Mis-randomization|1
7284074|NCT00493636|11499963|FG001|Overall Study|Mis-randomization|1
7284075|NCT00493649|11499969|FG000|Overall Study|Adverse Event|44
7284076|NCT00493649|11499969|FG000|Overall Study|Patient Request|21
7284077|NCT00493649|11499969|FG000|Overall Study|Investigator Request|2
7284078|NCT00493649|11499969|FG000|Overall Study|Disease Progression|1
7284079|NCT00493649|11499969|FG000|Overall Study|Lost to Follow-up|1
7284080|NCT00493649|11499969|FG000|Overall Study|Other|13
7284081|NCT00493779|11499976|FG000|Overall Study|Logistical issue at site|1
7284082|NCT00493974|11499990|FG000|Overall Study|Death|1
7284083|NCT00493974|11499991|FG001|Overall Study|Death|2
7284084|NCT00493974|11499990|FG000|Overall Study|Withdrawal by Subject|8
7284085|NCT00493974|11499991|FG001|Overall Study|Withdrawal by Subject|6
7284086|NCT00493974|11499990|FG000|Overall Study|Lost to Follow-up|4
7284087|NCT00493974|11499991|FG001|Overall Study|Lost to Follow-up|6
7284088|NCT00494013|11499999|FG000|Overall Study|Adverse Event|0
7284089|NCT00494013|11500000|FG001|Overall Study|Adverse Event|1
7284090|NCT00494013|11499999|FG000|Overall Study|Entry Criteria Not Met|1
7284091|NCT00494013|11500000|FG001|Overall Study|Entry Criteria Not Met|4
7284092|NCT00494013|11499999|FG000|Overall Study|Lost to Follow-up|5
7284093|NCT00494013|11500000|FG001|Overall Study|Lost to Follow-up|6
7284094|NCT00494013|11499999|FG000|Overall Study|Physician Decision|3
7284095|NCT00494013|11500000|FG001|Overall Study|Physician Decision|5
7284096|NCT00494013|11499999|FG000|Overall Study|Protocol Violation|8
7284097|NCT00494013|11500000|FG001|Overall Study|Protocol Violation|5
7284098|NCT00494013|11499999|FG000|Overall Study|Withdrawal by Subject|13
7284099|NCT00494013|11500000|FG001|Overall Study|Withdrawal by Subject|14
7284100|NCT00494013|11499999|FG000|Overall Study|Sponsor Decision|0
7284101|NCT00494013|11500000|FG001|Overall Study|Sponsor Decision|1
7284102|NCT00494026|11500006|FG000|Overall Study|Sponsor Decision|4
7284103|NCT00494091|11500012|FG000|Overall Study|Death|5
7284104|NCT00494091|11500013|FG001|Overall Study|Death|54
7284105|NCT00494091|11500012|FG000|Overall Study|Lost to Follow-up|0
7284106|NCT00494091|11500013|FG001|Overall Study|Lost to Follow-up|4
7284107|NCT00494091|11500012|FG000|Overall Study|Other|1
7284108|NCT00494091|11500013|FG001|Overall Study|Other|11
7284109|NCT00494091|11500012|FG000|Overall Study|Withdrawal by Subject|0
7284110|NCT00494091|11500013|FG001|Overall Study|Withdrawal by Subject|7
7284111|NCT00494221|11500040|FG000|Overall Study|Death|15
7284112|NCT00494221|11500041|FG001|Overall Study|Death|9
7284113|NCT00494221|11500042|FG002|Overall Study|Death|14
7284114|NCT00494221|11500040|FG000|Overall Study|Withdrawal by Subject|1
7284115|NCT00494221|11500041|FG001|Overall Study|Withdrawal by Subject|2
7284116|NCT00494221|11500042|FG002|Overall Study|Withdrawal by Subject|0
7284117|NCT00494299|11500052|FG000|Overall Study|Adverse Event|93
7284118|NCT00494299|11500053|FG001|Overall Study|Adverse Event|13
7284119|NCT00494299|11500052|FG000|Overall Study|Lost to Follow-up|1
7284120|NCT00494299|11500053|FG001|Overall Study|Lost to Follow-up|0
7284121|NCT00494299|11500052|FG000|Overall Study|Physician Decision|0
7284122|NCT00494299|11500053|FG001|Overall Study|Physician Decision|2
7284123|NCT00494299|11500052|FG000|Overall Study|Protocol Violation|1
7284124|NCT00494299|11500053|FG001|Overall Study|Protocol Violation|2
7284125|NCT00494299|11500052|FG000|Overall Study|Withdrawal by Subject|8
7284126|NCT00494299|11500053|FG001|Overall Study|Withdrawal by Subject|3
7284127|NCT00494299|11500052|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
7284128|NCT00494299|11500053|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
7284129|NCT00494299|11500052|FG000|Overall Study|Participant Did Not Take Study Drug|0
7284130|NCT00494299|11500053|FG001|Overall Study|Participant Did Not Take Study Drug|2
7284131|NCT00494299|11500052|FG000|Overall Study|Site Closed by Sponsor|6
7284132|NCT00494299|11500053|FG001|Overall Study|Site Closed by Sponsor|0
7284133|NCT00494299|11500052|FG000|Overall Study|Protocol Driven Decision Point|11
7284134|NCT00494299|11500053|FG001|Overall Study|Protocol Driven Decision Point|22
7284135|NCT00494442|11500061|FG000|Overall Study|Death|1
7284136|NCT00494442|11500062|FG001|Overall Study|Death|1
7284137|NCT00494442|11500061|FG000|Overall Study|Lack of Efficacy|16
7284138|NCT00494442|11500062|FG001|Overall Study|Lack of Efficacy|10
7284139|NCT00494442|11500061|FG000|Overall Study|Adverse Event|0
7284140|NCT00494442|11500062|FG001|Overall Study|Adverse Event|2
7284141|NCT00494442|11500061|FG000|Overall Study|Physician Decision|0
7284142|NCT00494442|11500062|FG001|Overall Study|Physician Decision|1
7284143|NCT00494442|11500061|FG000|Overall Study|Non-compliance|0
7284144|NCT00494442|11500062|FG001|Overall Study|Non-compliance|1
7284145|NCT00494442|11500061|FG000|Overall Study|Intercurrent illness|0
7284146|NCT00494442|11500062|FG001|Overall Study|Intercurrent illness|1
7284147|NCT00494481|11500070|FG000|Overall Study|Condition under investigation worsened|11
7284148|NCT00494481|11500071|FG001|Overall Study|Condition under investigation worsened|13
7284149|NCT00494481|11500070|FG000|Overall Study|Adverse Event|15
7284150|NCT00494481|11500071|FG001|Overall Study|Adverse Event|11
7284151|NCT00494481|11500070|FG000|Overall Study|Other|1
7284152|NCT00494481|11500071|FG001|Overall Study|Other|0
7284153|NCT00494481|11500070|FG000|Overall Study|Never received IP|2
7284154|NCT00494481|11500071|FG001|Overall Study|Never received IP|0
7284155|NCT00494507|11500090|FG000|Double-Blind Phase|Adverse Event|2
7284156|NCT00494507|11500091|FG001|Double-Blind Phase|Adverse Event|0
7284157|NCT00494507|11500092|FG002|Double-Blind Phase|Adverse Event|1
7284158|NCT00494507|11500093|FG003|Double-Blind Phase|Adverse Event|0
7284159|NCT00494507|11500090|FG000|Double-Blind Phase|Withdrawal by Subject|1
7284160|NCT00494507|11500091|FG001|Double-Blind Phase|Withdrawal by Subject|0
7284161|NCT00494507|11500092|FG002|Double-Blind Phase|Withdrawal by Subject|0
7284162|NCT00494507|11500093|FG003|Double-Blind Phase|Withdrawal by Subject|0
7284163|NCT00494507|11500090|FG000|Double-Blind Phase|Subject Non-compliance|0
7284164|NCT00494507|11500091|FG001|Double-Blind Phase|Subject Non-compliance|0
7284165|NCT00494507|11500092|FG002|Double-Blind Phase|Subject Non-compliance|1
7284166|NCT00494507|11500093|FG003|Double-Blind Phase|Subject Non-compliance|0
7284167|NCT00494507|11500090|FG000|Double-Blind Phase|Negative DNA test|0
7284168|NCT00494507|11500091|FG001|Double-Blind Phase|Negative DNA test|0
7284169|NCT00494507|11500092|FG002|Double-Blind Phase|Negative DNA test|0
7284170|NCT00494507|11500093|FG003|Double-Blind Phase|Negative DNA test|1
7284171|NCT00494507|11500090|FG000|Open-Label Phase|Adverse Event|0
7284172|NCT00494507|11500091|FG001|Open-Label Phase|Adverse Event|1
7284173|NCT00494507|11500092|FG002|Open-Label Phase|Adverse Event|5
7284174|NCT00494507|11500093|FG003|Open-Label Phase|Adverse Event|3
7284175|NCT00494507|11500090|FG000|Open-Label Phase|Worsening Disease|0
7284176|NCT00494507|11500091|FG001|Open-Label Phase|Worsening Disease|0
7284177|NCT00494507|11500092|FG002|Open-Label Phase|Worsening Disease|0
7284178|NCT00494507|11500093|FG003|Open-Label Phase|Worsening Disease|2
7284179|NCT00494676|11500117|FG000|Allocation|Withdrawal by Subject|2
7284180|NCT00494676|11500118|FG001|Allocation|Withdrawal by Subject|4
7284181|NCT00494676|11500117|FG000|First Intervention|Withdrawal by Subject|1
7284182|NCT00494676|11500118|FG001|First Intervention|Withdrawal by Subject|3
7284183|NCT00494676|11500117|FG000|Second Intervention|Withdrawal by Subject|1
7284184|NCT00494676|11500118|FG001|Second Intervention|Withdrawal by Subject|1
7284185|NCT00494780|11500126|FG000|Overall Study|Adverse Event|1
7284186|NCT00494780|11500127|FG001|Overall Study|Adverse Event|0
7284187|NCT00494780|11500126|FG000|Overall Study|Withdrew before Dosed|0
7284188|NCT00494780|11500127|FG001|Overall Study|Withdrew before Dosed|1
7284189|NCT00494780|11500126|FG000|Overall Study|Progression of Study Disease|7
7284190|NCT00494780|11500127|FG001|Overall Study|Progression of Study Disease|8
7284191|NCT00494780|11500126|FG000|Overall Study|New Treatment|2
7284192|NCT00494780|11500127|FG001|Overall Study|New Treatment|2
7284193|NCT00494780|11500126|FG000|Overall Study|Non-compliance|1
7284194|NCT00494780|11500127|FG001|Overall Study|Non-compliance|0
7284195|NCT00494780|11500126|FG000|Overall Study|Residual Tumour Mass|0
7284196|NCT00494780|11500127|FG001|Overall Study|Residual Tumour Mass|1
7284197|NCT00494780|11500126|FG000|Overall Study|Insurance Issues|0
7284198|NCT00494780|11500127|FG001|Overall Study|Insurance Issues|1
7284199|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
7284200|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
7284201|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
7284202|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
7284203|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Death|8
7284204|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Death|3
7284205|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
7284206|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
7284207|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
7284208|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
7284209|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
7284210|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
7284211|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
7284212|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
7284213|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
7284214|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
7284215|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
7284216|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
7284217|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
7284218|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
7284219|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7284220|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
7284221|NCT00494871|11500146|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7284222|NCT00494871|11500147|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
7284223|NCT00494871|11500146|FG000|Follow-up (FU) Period|Adverse Event|1
7284224|NCT00494871|11500147|FG001|Follow-up (FU) Period|Adverse Event|1
7284225|NCT00494871|11500146|FG000|Follow-up (FU) Period|Death|13
7284226|NCT00494871|11500147|FG001|Follow-up (FU) Period|Death|12
7284227|NCT00494871|11500146|FG000|Follow-up (FU) Period|Lost to Follow-up|6
7284228|NCT00494871|11500147|FG001|Follow-up (FU) Period|Lost to Follow-up|2
7284229|NCT00494871|11500146|FG000|Follow-up (FU) Period|Physician Decision|0
7284230|NCT00494871|11500147|FG001|Follow-up (FU) Period|Physician Decision|1
7284231|NCT00494871|11500146|FG000|Follow-up (FU) Period|Protocol Violation|1
7284232|NCT00494871|11500147|FG001|Follow-up (FU) Period|Protocol Violation|0
7284233|NCT00494871|11500146|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
7284234|NCT00494871|11500147|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
7284235|NCT00494871|11500146|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
7284236|NCT00494871|11500147|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
7284237|NCT00495040|11500164|FG000|Overall Study|Withdrawal by Subject|3
7284238|NCT00495170|11500188|FG000|Overall Study|Lost to Follow-up|9
7284239|NCT00495170|11500188|FG000|Overall Study|Withdrawal by Subject|3
7284240|NCT00495170|11500188|FG000|Overall Study|Inappropriate staging|8
7284241|NCT00495391|11500194|FG000|Overall Study|Lack of Efficacy|34
7284242|NCT00495391|11500195|FG001|Overall Study|Lack of Efficacy|18
7284243|NCT00495391|11500194|FG000|Overall Study|Withdrawal by Subject|2
7284244|NCT00495391|11500195|FG001|Overall Study|Withdrawal by Subject|3
7284245|NCT00495469|11500208|FG000|Overall Study|Adverse Event|0
7284246|NCT00495469|11500209|FG001|Overall Study|Adverse Event|1
7284247|NCT00495469|11500210|FG002|Overall Study|Adverse Event|3
7284248|NCT00495469|11500211|FG003|Overall Study|Adverse Event|0
7284249|NCT00495469|11500212|FG004|Overall Study|Adverse Event|1
7284250|NCT00495469|11500213|FG005|Overall Study|Adverse Event|1
7284251|NCT00495469|11500214|FG006|Overall Study|Adverse Event|1
7284252|NCT00495469|11500208|FG000|Overall Study|Lost to Follow-up|1
7284253|NCT00495469|11500209|FG001|Overall Study|Lost to Follow-up|1
7284254|NCT00495469|11500210|FG002|Overall Study|Lost to Follow-up|3
7284255|NCT00495469|11500211|FG003|Overall Study|Lost to Follow-up|1
7284256|NCT00495469|11500212|FG004|Overall Study|Lost to Follow-up|0
7284257|NCT00495469|11500213|FG005|Overall Study|Lost to Follow-up|0
7284258|NCT00495469|11500214|FG006|Overall Study|Lost to Follow-up|0
7284259|NCT00495469|11500208|FG000|Overall Study|Protocol Violation|0
7284260|NCT00495469|11500209|FG001|Overall Study|Protocol Violation|0
7284261|NCT00495469|11500210|FG002|Overall Study|Protocol Violation|0
7284262|NCT00495469|11500211|FG003|Overall Study|Protocol Violation|0
7284263|NCT00495469|11500212|FG004|Overall Study|Protocol Violation|1
7284264|NCT00495469|11500213|FG005|Overall Study|Protocol Violation|2
7284265|NCT00495469|11500214|FG006|Overall Study|Protocol Violation|0
7284266|NCT00495469|11500208|FG000|Overall Study|Withdrawal by Subject|5
7284267|NCT00495469|11500209|FG001|Overall Study|Withdrawal by Subject|3
7284268|NCT00495469|11500210|FG002|Overall Study|Withdrawal by Subject|1
7284269|NCT00495469|11500211|FG003|Overall Study|Withdrawal by Subject|3
7284270|NCT00495469|11500212|FG004|Overall Study|Withdrawal by Subject|3
7284271|NCT00495469|11500213|FG005|Overall Study|Withdrawal by Subject|2
7284272|NCT00495469|11500214|FG006|Overall Study|Withdrawal by Subject|3
7284273|NCT00495469|11500208|FG000|Overall Study|Lack of Efficacy|0
7284274|NCT00495469|11500209|FG001|Overall Study|Lack of Efficacy|0
7284275|NCT00495469|11500210|FG002|Overall Study|Lack of Efficacy|0
7284276|NCT00495469|11500211|FG003|Overall Study|Lack of Efficacy|0
7284277|NCT00495469|11500212|FG004|Overall Study|Lack of Efficacy|0
7284278|NCT00495469|11500213|FG005|Overall Study|Lack of Efficacy|0
7284279|NCT00495469|11500214|FG006|Overall Study|Lack of Efficacy|1
7284280|NCT00495469|11500208|FG000|Overall Study|Liver function test abnormality|0
7284281|NCT00495469|11500209|FG001|Overall Study|Liver function test abnormality|1
7284282|NCT00495469|11500210|FG002|Overall Study|Liver function test abnormality|0
7284283|NCT00495469|11500211|FG003|Overall Study|Liver function test abnormality|0
7284284|NCT00495469|11500212|FG004|Overall Study|Liver function test abnormality|0
7284285|NCT00495469|11500213|FG005|Overall Study|Liver function test abnormality|0
7284286|NCT00495469|11500214|FG006|Overall Study|Liver function test abnormality|0
7284287|NCT00495469|11500208|FG000|Overall Study|ST depression at randomisation in ECG|0
7284288|NCT00495469|11500209|FG001|Overall Study|ST depression at randomisation in ECG|1
7284289|NCT00495469|11500210|FG002|Overall Study|ST depression at randomisation in ECG|0
7284290|NCT00495469|11500211|FG003|Overall Study|ST depression at randomisation in ECG|0
7284291|NCT00495469|11500212|FG004|Overall Study|ST depression at randomisation in ECG|0
7284292|NCT00495469|11500213|FG005|Overall Study|ST depression at randomisation in ECG|0
7284293|NCT00495469|11500214|FG006|Overall Study|ST depression at randomisation in ECG|0
7284294|NCT00495495|11500237|FG000|Overall Study|Protocol Violation|99
7284295|NCT00495521|11500244|FG000|Overall Study|Physician Decision|0
7284296|NCT00495521|11500245|FG001|Overall Study|Physician Decision|1
7284297|NCT00495586|11500253|FG000|Overall Study|Withdrawal by Subject|4
7284298|NCT00495586|11500254|FG001|Overall Study|Withdrawal by Subject|4
7284299|NCT00495612|11500264|FG000|Overall Study|Lost to Follow-up|1
7284300|NCT00495612|11500265|FG001|Overall Study|Lost to Follow-up|0
7284301|NCT00495612|11500264|FG000|Overall Study|Subject's Decision to Withdraw|3
7284302|NCT00495612|11500265|FG001|Overall Study|Subject's Decision to Withdraw|0
7284303|NCT00495625|11500271|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
7284304|NCT00495677|11500282|FG000|Stage 1 (25 Days)|Adverse Event|0
7284305|NCT00495677|11500283|FG001|Stage 1 (25 Days)|Adverse Event|0
7284306|NCT00495677|11500284|FG002|Stage 1 (25 Days)|Adverse Event|1
7284307|NCT00495677|11500285|FG003|Stage 1 (25 Days)|Adverse Event|0
7284308|NCT00495677|11500286|FG004|Stage 1 (25 Days)|Adverse Event|0
7284309|NCT00495677|11500287|FG005|Stage 1 (25 Days)|Adverse Event|0
7284310|NCT00495677|11500288|FG006|Stage 1 (25 Days)|Adverse Event|0
7284311|NCT00495755|11500304|FG000|Overall Study|Adverse Event|3
7284312|NCT00495794|11500311|FG000|Overall Study|Pharmacist did not activate patient|522
7284313|NCT00495794|11500312|FG001|Overall Study|Pharmacist did not activate patient|0
7284314|NCT00495820|11500320|FG000|Overall Study|Adverse Event|1
7284315|NCT00495820|11500321|FG001|Overall Study|Adverse Event|1
7284316|NCT00496015|11500332|FG000|Overall Study|Other|1
7284317|NCT00496015|11500333|FG001|Overall Study|Other|0
7284318|NCT00496015|11500334|FG002|Overall Study|Other|0
7284319|NCT00496015|11500335|FG003|Overall Study|Other|1
7284320|NCT00496015|11500336|FG004|Overall Study|Other|0
7284321|NCT00496054|11500356|FG000|Overall Study|Adverse Event|1
7284322|NCT00496054|11500356|FG000|Overall Study|Lost to Follow-up|7
7284323|NCT00496080|11500360|FG000|Overall Study|Lost to Follow-up|9
7284324|NCT00496080|11500360|FG000|Overall Study|Surgical re-intervention|7
7284325|NCT00496080|11500360|FG000|Overall Study|Withdrawal by Subject|5
7284326|NCT00496080|11500360|FG000|Overall Study|Physician Decision|6
7284327|NCT00496197|11500365|FG000|Overall Study|Discontinued study due to death|43
7284328|NCT00496197|11500365|FG000|Overall Study|Adverse Event|13
7284329|NCT00496197|11500365|FG000|Overall Study|Does not meet entrance criteria|5
7284330|NCT00496197|11500365|FG000|Overall Study|Insufficient clinical response|3
7284331|NCT00496197|11500365|FG000|Overall Study|Insufficient bacteriological response|10
7284332|NCT00496197|11500365|FG000|Overall Study|Lost to Follow-up|11
7284333|NCT00496197|11500365|FG000|Overall Study|Withdrawal by Subject|11
7284334|NCT00496197|11500365|FG000|Overall Study|Pathogen not isolated baseline specimen|4
7284335|NCT00496197|11500365|FG000|Overall Study|Other|14
7284336|NCT00496197|11500365|FG000|Overall Study|Protocol Violation|8
7284337|NCT00496366|11500379|FG000|Overall Study|Death|1
7284338|NCT00496470|11500389|FG000|Overall Study|Adverse Event|8
7284339|NCT00496470|11500390|FG001|Overall Study|Adverse Event|10
7284340|NCT00496470|11500389|FG000|Overall Study|Withdrawal by Subject|5
7284341|NCT00496470|11500390|FG001|Overall Study|Withdrawal by Subject|12
7284342|NCT00496470|11500389|FG000|Overall Study|Incorrectly enrolled|13
7284343|NCT00496470|11500390|FG001|Overall Study|Incorrectly enrolled|5
7284344|NCT00496470|11500389|FG000|Overall Study|Other reason|0
7284345|NCT00496470|11500390|FG001|Overall Study|Other reason|2
7284346|NCT00496483|11500396|FG000|Overall Study|Not dosed|9
7284347|NCT00496483|11500396|FG000|Overall Study|Adverse Event|2
7284348|NCT00496483|11500396|FG000|Overall Study|Lack of Efficacy|1
7284349|NCT00496587|11500403|FG000|Overall Study|Adverse Event|2
7284350|NCT00496587|11500403|FG000|Overall Study|Progressive Disease|24
7284351|NCT00496587|11500403|FG000|Overall Study|Withdrawal by Subject|2
7284352|NCT00496587|11500403|FG000|Overall Study|Death|1
7284353|NCT00496587|11500403|FG000|Overall Study|Complications unrelated|2
7284354|NCT00496626|11500409|FG000|Overall Study|Lost to Follow-up|0
7284355|NCT00496626|11500410|FG001|Overall Study|Lost to Follow-up|1
7284356|NCT00496626|11500409|FG000|Overall Study|Protocol Violation|1
7284357|NCT00496626|11500410|FG001|Overall Study|Protocol Violation|0
7284358|NCT00496626|11500409|FG000|Overall Study|Withdrawal by Subject|5
7284359|NCT00496626|11500410|FG001|Overall Study|Withdrawal by Subject|4
7284360|NCT00496626|11500409|FG000|Overall Study|Relocated|0
7284361|NCT00496626|11500410|FG001|Overall Study|Relocated|1
7284362|NCT00496769|11500422|FG000|Double Blind|>=1 reason assigned per patient|558
7284363|NCT00496769|11500423|FG001|Double Blind|>=1 reason assigned per patient|649
7284364|NCT00496769|11500424|FG002|Double Blind|>=1 reason assigned per patient|0
7284365|NCT00496769|11500422|FG000|Open Label|>=1 reason assigned per patient|0
7284366|NCT00496769|11500423|FG001|Open Label|>=1 reason assigned per patient|0
7284367|NCT00496769|11500424|FG002|Open Label|>=1 reason assigned per patient|1011
7284368|NCT00496873|11500450|FG000|Overall Study|Ineligible|2
7284369|NCT00496873|11500450|FG000|Overall Study|Death|2
7284370|NCT00496873|11500450|FG000|Overall Study|Withdrawal by Subject|3
7284371|NCT00496964|11500456|FG000|Overall Study|Withdrawal by Subject|0
7284372|NCT00496964|11500457|FG001|Overall Study|Withdrawal by Subject|1
7284373|NCT00497146|11500485|FG000|Treatment Period|Adverse Event|6
7284374|NCT00497146|11500486|FG001|Treatment Period|Adverse Event|2
7284375|NCT00497146|11500485|FG000|Treatment Period|Withdrawal by Subject|5
7284376|NCT00497146|11500486|FG001|Treatment Period|Withdrawal by Subject|9
7284377|NCT00497146|11500485|FG000|Treatment Period|Lost to Follow-up|1
7284378|NCT00497146|11500486|FG001|Treatment Period|Lost to Follow-up|3
7284379|NCT00497146|11500485|FG000|Treatment Period|Required dialysis|4
7284380|NCT00497146|11500486|FG001|Treatment Period|Required dialysis|1
7284381|NCT00497146|11500485|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
7284382|NCT00497146|11500486|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
7284383|NCT00497146|11500485|FG000|Treatment Period|Unable to dose reduce per protocol|4
7284384|NCT00497146|11500486|FG001|Treatment Period|Unable to dose reduce per protocol|1
7284385|NCT00497146|11500485|FG000|Treatment Period|Other Reason|2
7284386|NCT00497146|11500486|FG001|Treatment Period|Other Reason|3
7284387|NCT00497146|11500485|FG000|Long-term Follow-up Period|Adverse Event|2
7284388|NCT00497146|11500486|FG001|Long-term Follow-up Period|Adverse Event|2
7284389|NCT00497146|11500485|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
7284390|NCT00497146|11500486|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
7284391|NCT00497146|11500485|FG000|Long-term Follow-up Period|Lost to Follow-up|5
7284392|NCT00497146|11500486|FG001|Long-term Follow-up Period|Lost to Follow-up|1
7622678|NCT04405570|12033549|FG000|Overall Study|Adverse Event|0
7622679|NCT04405570|12033550|FG001|Overall Study|Adverse Event|1
7622680|NCT04405570|12033551|FG002|Overall Study|Adverse Event|1
7622681|NCT04405570|12033552|FG003|Overall Study|Adverse Event|1
7622682|NCT04405570|12033549|FG000|Overall Study|Lost to Follow-up|0
7622683|NCT04405570|12033550|FG001|Overall Study|Lost to Follow-up|1
7622684|NCT04405570|12033551|FG002|Overall Study|Lost to Follow-up|0
7622685|NCT04405570|12033552|FG003|Overall Study|Lost to Follow-up|0
7284393|NCT00497146|11500485|FG000|Long-term Follow-up Period|Other|0
7284394|NCT00497146|11500486|FG001|Long-term Follow-up Period|Other|1
7284395|NCT00497198|11500496|FG000|Overall Study|Adverse Event|4
7284396|NCT00497198|11500497|FG001|Overall Study|Adverse Event|2
7284397|NCT00497198|11500496|FG000|Overall Study|Physician Decision|1
7284398|NCT00497198|11500497|FG001|Overall Study|Physician Decision|2
7284399|NCT00497198|11500496|FG000|Overall Study|Withdrawal by Subject|0
7284400|NCT00497198|11500497|FG001|Overall Study|Withdrawal by Subject|1
7284401|NCT00497796|11500534|FG000|Overall Study|Adverse event (not related)|9
7284402|NCT00497796|11500535|FG001|Overall Study|Adverse event (not related)|9
7284403|NCT00497796|11500534|FG000|Overall Study|Adverse event (related)|5
7284404|NCT00497796|11500535|FG001|Overall Study|Adverse event (related)|4
7284405|NCT00497796|11500534|FG000|Overall Study|CMV infection or disease treatment|30
7284406|NCT00497796|11500535|FG001|Overall Study|CMV infection or disease treatment|4
7284407|NCT00497796|11500534|FG000|Overall Study|Consent withdrawn|10
7284408|NCT00497796|11500535|FG001|Overall Study|Consent withdrawn|3
7284409|NCT00497796|11500534|FG000|Overall Study|Investigator/sponsor discretion|31
7284410|NCT00497796|11500535|FG001|Overall Study|Investigator/sponsor discretion|34
7284411|NCT00497796|11500534|FG000|Overall Study|Lost to Follow-up|0
7284412|NCT00497796|11500535|FG001|Overall Study|Lost to Follow-up|1
7284413|NCT00497796|11500534|FG000|Overall Study|Not applicable (randomized not treated)|0
7284414|NCT00497796|11500535|FG001|Overall Study|Not applicable (randomized not treated)|4
7284415|NCT00497874|11500543|FG000|Overall Study|Withdrawal by Subject|48
7284416|NCT00497874|11500544|FG001|Overall Study|Withdrawal by Subject|17
7284417|NCT00497874|11500543|FG000|Overall Study|Illness|8
7284418|NCT00497874|11500544|FG001|Overall Study|Illness|4
7284419|NCT00497874|11500543|FG000|Overall Study|Death|2
7284420|NCT00497874|11500544|FG001|Overall Study|Death|4
7284421|NCT00497874|11500543|FG000|Overall Study|Unable to contact|52
7284422|NCT00497874|11500544|FG001|Overall Study|Unable to contact|67
7284423|NCT00497874|11500543|FG000|Overall Study|Unable to schedule|37
7284424|NCT00497874|11500544|FG001|Overall Study|Unable to schedule|24
7284425|NCT00498173|11500554|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
7284426|NCT00498173|11500555|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
7284427|NCT00498173|11500556|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
7284428|NCT00498186|11500564|FG000|Overall Study|Protocol Violation|10
7284429|NCT00498186|11500564|FG000|Overall Study|Lack of Efficacy|31
7284430|NCT00498186|11500564|FG000|Overall Study|Adverse Event|89
7284431|NCT00498186|11500564|FG000|Overall Study|Unsatisfactory compliance of subject|12
7284432|NCT00498186|11500564|FG000|Overall Study|Withdrawal by Subject|18
7284433|NCT00498186|11500564|FG000|Overall Study|Lost to Follow-up|3
7284434|NCT00498186|11500564|FG000|Overall Study|Other|10
7284435|NCT00498355|11500568|FG000|Overall Study|Lost to Follow-up|1
7284436|NCT00498368|11500575|FG000|Overall Study|Withdrawal by Subject|3
7284437|NCT00498368|11500576|FG001|Overall Study|Withdrawal by Subject|2
7284438|NCT00498433|11500585|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
7284439|NCT00498433|11500586|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7284440|NCT00498433|11500587|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
7284441|NCT00498433|11500585|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
7284442|NCT00498433|11500586|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7284443|NCT00498433|11500587|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
7284444|NCT00498433|11500585|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
7284445|NCT00498433|11500586|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7284446|NCT00498433|11500587|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
7284447|NCT00498433|11500585|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
7284448|NCT00498433|11500586|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7284449|NCT00498433|11500587|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
7284450|NCT00498485|11500606|FG000|Overall Study|Adverse Event|1
7284451|NCT00498485|11500607|FG001|Overall Study|Adverse Event|5
7284452|NCT00498602|11500631|FG000|Overall Study|Death|0
7284453|NCT00498602|11500632|FG001|Overall Study|Death|0
7284454|NCT00498602|11500633|FG002|Overall Study|Death|0
7284455|NCT00498602|11500634|FG003|Overall Study|Death|0
7284456|NCT00498602|11500635|FG004|Overall Study|Death|0
7284457|NCT00498602|11500636|FG005|Overall Study|Death|1
7284458|NCT00498602|11500637|FG006|Overall Study|Death|0
7622686|NCT04405570|12033549|FG000|Overall Study|Physician Decision|0
7622687|NCT04405570|12033550|FG001|Overall Study|Physician Decision|0
7622688|NCT04405570|12033551|FG002|Overall Study|Physician Decision|1
7622689|NCT04405570|12033552|FG003|Overall Study|Physician Decision|0
7622690|NCT04405570|12033549|FG000|Overall Study|Withdrawal by Subject|0
7622691|NCT04405570|12033550|FG001|Overall Study|Withdrawal by Subject|1
7622692|NCT04405570|12033551|FG002|Overall Study|Withdrawal by Subject|1
7622693|NCT04405570|12033552|FG003|Overall Study|Withdrawal by Subject|0
7284459|NCT00498602|11500631|FG000|Overall Study|Lack of Efficacy|1
7284460|NCT00498602|11500632|FG001|Overall Study|Lack of Efficacy|0
7284461|NCT00498602|11500633|FG002|Overall Study|Lack of Efficacy|0
7284462|NCT00498602|11500634|FG003|Overall Study|Lack of Efficacy|0
7284463|NCT00498602|11500635|FG004|Overall Study|Lack of Efficacy|0
7622694|NCT04405570|12033549|FG000|Overall Study|Randomized not dosed|0
7622695|NCT04405570|12033550|FG001|Overall Study|Randomized not dosed|2
7622696|NCT04405570|12033551|FG002|Overall Study|Randomized not dosed|0
7622697|NCT04405570|12033552|FG003|Overall Study|Randomized not dosed|0
7284464|NCT00498602|11500636|FG005|Overall Study|Lack of Efficacy|0
7284465|NCT00498602|11500637|FG006|Overall Study|Lack of Efficacy|0
7284466|NCT00498602|11500631|FG000|Overall Study|Lost to Follow-up|0
7284467|NCT00498602|11500632|FG001|Overall Study|Lost to Follow-up|2
7284468|NCT00498602|11500633|FG002|Overall Study|Lost to Follow-up|0
7284469|NCT00498602|11500634|FG003|Overall Study|Lost to Follow-up|2
7284470|NCT00498602|11500635|FG004|Overall Study|Lost to Follow-up|0
7284471|NCT00498602|11500636|FG005|Overall Study|Lost to Follow-up|0
7284472|NCT00498602|11500637|FG006|Overall Study|Lost to Follow-up|0
7284473|NCT00498602|11500631|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
7284474|NCT00498602|11500632|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
7284475|NCT00498602|11500633|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
7284476|NCT00498602|11500634|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
7284477|NCT00498602|11500635|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
7284602|NCT00499616|11500857|FG001|Overall Study|Patient/Parent Refusal|5
7284478|NCT00498602|11500636|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
7284479|NCT00498602|11500637|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
7284480|NCT00498602|11500631|FG000|Overall Study|AE not related to Study Drug|1
7284481|NCT00498602|11500632|FG001|Overall Study|AE not related to Study Drug|3
7284482|NCT00498602|11500633|FG002|Overall Study|AE not related to Study Drug|0
7284483|NCT00498602|11500634|FG003|Overall Study|AE not related to Study Drug|0
7284484|NCT00498602|11500635|FG004|Overall Study|AE not related to Study Drug|2
7284485|NCT00498602|11500636|FG005|Overall Study|AE not related to Study Drug|2
7284486|NCT00498602|11500637|FG006|Overall Study|AE not related to Study Drug|1
7284487|NCT00498602|11500631|FG000|Overall Study|Caregiver Request|2
7284488|NCT00498602|11500632|FG001|Overall Study|Caregiver Request|2
7284489|NCT00498602|11500633|FG002|Overall Study|Caregiver Request|2
7284490|NCT00498602|11500634|FG003|Overall Study|Caregiver Request|0
7284491|NCT00498602|11500635|FG004|Overall Study|Caregiver Request|1
7284492|NCT00498602|11500636|FG005|Overall Study|Caregiver Request|2
7284493|NCT00498602|11500637|FG006|Overall Study|Caregiver Request|0
7284494|NCT00498602|11500631|FG000|Overall Study|Investigator Request|0
7284495|NCT00498602|11500632|FG001|Overall Study|Investigator Request|0
7284496|NCT00498602|11500633|FG002|Overall Study|Investigator Request|1
7284497|NCT00498602|11500634|FG003|Overall Study|Investigator Request|0
7284498|NCT00498602|11500635|FG004|Overall Study|Investigator Request|0
7284499|NCT00498602|11500636|FG005|Overall Study|Investigator Request|0
7284500|NCT00498602|11500637|FG006|Overall Study|Investigator Request|0
7284501|NCT00498602|11500631|FG000|Overall Study|Subject Request|3
7284502|NCT00498602|11500632|FG001|Overall Study|Subject Request|0
7284503|NCT00498602|11500633|FG002|Overall Study|Subject Request|1
7284504|NCT00498602|11500634|FG003|Overall Study|Subject Request|1
7284505|NCT00498602|11500635|FG004|Overall Study|Subject Request|1
7284506|NCT00498602|11500636|FG005|Overall Study|Subject Request|4
7284507|NCT00498602|11500637|FG006|Overall Study|Subject Request|1
7284508|NCT00498602|11500631|FG000|Overall Study|Other|2
7284509|NCT00498602|11500632|FG001|Overall Study|Other|3
7284510|NCT00498602|11500633|FG002|Overall Study|Other|1
7284511|NCT00498602|11500634|FG003|Overall Study|Other|0
7284512|NCT00498602|11500635|FG004|Overall Study|Other|0
7284513|NCT00498602|11500636|FG005|Overall Study|Other|3
7284514|NCT00498602|11500637|FG006|Overall Study|Other|0
7284515|NCT00498797|11500696|FG000|Overall Study|Withdrawal by Subject|4
7284516|NCT00498797|11500697|FG001|Overall Study|Withdrawal by Subject|2
7284517|NCT00498797|11500696|FG000|Overall Study|Adverse Event|12
7284518|NCT00498797|11500697|FG001|Overall Study|Adverse Event|5
7284519|NCT00498797|11500696|FG000|Overall Study|Condition under investigation worsened|19
7284520|NCT00498797|11500697|FG001|Overall Study|Condition under investigation worsened|21
7284521|NCT00498797|11500696|FG000|Overall Study|Other|3
7284522|NCT00498797|11500697|FG001|Overall Study|Other|1
7284523|NCT00499031|11500716|FG000|Overall Study|Improper pre-protocol treatment|1
7284524|NCT00499031|11500716|FG000|Overall Study|Required test not done|1
7284525|NCT00499031|11500716|FG000|Overall Study|Never treated|1
7284526|NCT00499083|11500720|FG000|Overall Study|Not evaluable|3
7622698|NCT04135937|12033565|FG000|Overall Study|Lost to Follow-up|2
7469894|NCT01928329|11771836|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
7469895|NCT01928329|11771837|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
7469896|NCT01928329|11771836|FG000|Overall Study|Adverse Event|5
7469897|NCT01928329|11771837|FG001|Overall Study|Adverse Event|3
7469898|NCT01928329|11771836|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
7469899|NCT01928329|11771837|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
7469900|NCT01928329|11771836|FG000|Overall Study|Withdrawal by Subject|1
7469901|NCT01928329|11771837|FG001|Overall Study|Withdrawal by Subject|5
7469902|NCT01928329|11771836|FG000|Overall Study|Physician Decision|1
7469903|NCT01928329|11771837|FG001|Overall Study|Physician Decision|1
7469904|NCT01928381|11771843|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
7469905|NCT01928381|11771844|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469906|NCT01928381|11771845|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469907|NCT01928381|11771846|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469908|NCT01928381|11771847|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469909|NCT01928381|11771848|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469910|NCT01928381|11771849|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
7469911|NCT01928381|11771843|FG000|Part 1 - Pain Training|Pain training criteria not met|29
7622699|NCT04135937|12033565|FG000|Overall Study|Withdrawal by Subject|1
7469912|NCT01928381|11771844|FG001|Part 1 - Pain Training|Pain training criteria not met|0
7469913|NCT01928381|11771845|FG002|Part 1 - Pain Training|Pain training criteria not met|0
7469914|NCT01928381|11771846|FG003|Part 1 - Pain Training|Pain training criteria not met|0
7469915|NCT01928381|11771847|FG004|Part 1 - Pain Training|Pain training criteria not met|0
7469916|NCT01928381|11771848|FG005|Part 1 - Pain Training|Pain training criteria not met|0
7469917|NCT01928381|11771849|FG006|Part 1 - Pain Training|Pain training criteria not met|0
7469918|NCT01928381|11771843|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
7469919|NCT01928381|11771844|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
7469920|NCT01928381|11771845|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
7469921|NCT01928381|11771846|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
7469922|NCT01928381|11771847|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
7469923|NCT01928381|11771848|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
7469924|NCT01928381|11771849|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
7469925|NCT01928381|11771843|FG000|Part 1 - Pain Training|Lost to Follow-up|4
7469926|NCT01928381|11771844|FG001|Part 1 - Pain Training|Lost to Follow-up|0
7469927|NCT01928381|11771845|FG002|Part 1 - Pain Training|Lost to Follow-up|0
7469928|NCT01928381|11771846|FG003|Part 1 - Pain Training|Lost to Follow-up|0
7469929|NCT01928381|11771847|FG004|Part 1 - Pain Training|Lost to Follow-up|0
7469930|NCT01928381|11771848|FG005|Part 1 - Pain Training|Lost to Follow-up|0
7469931|NCT01928381|11771849|FG006|Part 1 - Pain Training|Lost to Follow-up|0
7469932|NCT01928381|11771843|FG000|Part 1 - Pain Training|Protocol Violation|1
7622700|NCT03989232|12033571|FG000|Overall Study|Lost to Follow-up|3
7284527|NCT00499122|11500747|FG000|Overall Study|Withdrawal by Subject|2
7284528|NCT00499174|11500754|FG000|Overall Study|Physician Decision|78
7284529|NCT00499174|11500755|FG001|Overall Study|Physician Decision|9
7284530|NCT00499252|11500763|FG000|Overall Study|Adverse Event|3
7284531|NCT00499252|11500763|FG000|Overall Study|Refused further treatment|2
7284532|NCT00499252|11500763|FG000|Overall Study|Ineligible|4
7284533|NCT00499252|11500763|FG000|Overall Study|<no further label>|3
7284534|NCT00499369|11500785|FG000|Overall Study|Adverse Event|2
7284535|NCT00499369|11500786|FG001|Overall Study|Adverse Event|2
7284536|NCT00499369|11500787|FG002|Overall Study|Adverse Event|3
7284537|NCT00499369|11500788|FG003|Overall Study|Adverse Event|1
7284538|NCT00499369|11500789|FG004|Overall Study|Adverse Event|2
7284539|NCT00499369|11500785|FG000|Overall Study|Withdrawal by Subject|0
7284540|NCT00499369|11500786|FG001|Overall Study|Withdrawal by Subject|1
7284541|NCT00499369|11500787|FG002|Overall Study|Withdrawal by Subject|1
7284542|NCT00499369|11500788|FG003|Overall Study|Withdrawal by Subject|0
7284543|NCT00499369|11500789|FG004|Overall Study|Withdrawal by Subject|0
7284544|NCT00499369|11500785|FG000|Overall Study|Progression|10
7284545|NCT00499369|11500786|FG001|Overall Study|Progression|12
7284546|NCT00499369|11500787|FG002|Overall Study|Progression|9
7284547|NCT00499369|11500788|FG003|Overall Study|Progression|6
7284548|NCT00499369|11500789|FG004|Overall Study|Progression|10
7284549|NCT00499369|11500785|FG000|Overall Study|Death|0
7284550|NCT00499369|11500786|FG001|Overall Study|Death|1
7284551|NCT00499369|11500787|FG002|Overall Study|Death|0
7284552|NCT00499369|11500788|FG003|Overall Study|Death|0
7284553|NCT00499369|11500789|FG004|Overall Study|Death|0
7284554|NCT00499369|11500785|FG000|Overall Study|Not protocol specified|2
7284555|NCT00499369|11500786|FG001|Overall Study|Not protocol specified|0
7284556|NCT00499369|11500787|FG002|Overall Study|Not protocol specified|3
7284557|NCT00499369|11500788|FG003|Overall Study|Not protocol specified|1
7284558|NCT00499369|11500789|FG004|Overall Study|Not protocol specified|0
7284559|NCT00499369|11500785|FG000|Overall Study|Ineligible|2
7284560|NCT00499369|11500786|FG001|Overall Study|Ineligible|2
7284561|NCT00499369|11500787|FG002|Overall Study|Ineligible|1
7284562|NCT00499369|11500788|FG003|Overall Study|Ineligible|1
7284563|NCT00499369|11500789|FG004|Overall Study|Ineligible|0
7284564|NCT00499460|11500811|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
7284565|NCT00499460|11500812|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
7284566|NCT00499460|11500811|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
7284567|NCT00499460|11500812|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
7284568|NCT00499460|11500811|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
7284569|NCT00499460|11500812|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
7284570|NCT00499486|11500837|FG000|Overall Study|Withdrawal by Subject|16
7284571|NCT00499603|11500843|FG000|Overall Study|Adverse Event|0
7284572|NCT00499603|11500844|FG001|Overall Study|Adverse Event|1
7284573|NCT00499616|11500856|FG000|Overall Study|Death|1
7284574|NCT00499616|11500857|FG001|Overall Study|Death|5
7284575|NCT00499616|11500858|FG002|Overall Study|Death|3
7284576|NCT00499616|11500859|FG003|Overall Study|Death|1
7284577|NCT00499616|11500856|FG000|Overall Study|Lack of Efficacy|5
7284578|NCT00499616|11500857|FG001|Overall Study|Lack of Efficacy|0
7284579|NCT00499616|11500858|FG002|Overall Study|Lack of Efficacy|19
7284580|NCT00499616|11500859|FG003|Overall Study|Lack of Efficacy|0
7284581|NCT00499616|11500856|FG000|Overall Study|Lost to Follow-up|0
7284582|NCT00499616|11500857|FG001|Overall Study|Lost to Follow-up|0
7284583|NCT00499616|11500858|FG002|Overall Study|Lost to Follow-up|1
7284584|NCT00499616|11500859|FG003|Overall Study|Lost to Follow-up|0
7284585|NCT00499616|11500856|FG000|Overall Study|Physician Decision|6
7284586|NCT00499616|11500857|FG001|Overall Study|Physician Decision|16
7284587|NCT00499616|11500858|FG002|Overall Study|Physician Decision|9
7284588|NCT00499616|11500859|FG003|Overall Study|Physician Decision|0
7284589|NCT00499616|11500856|FG000|Overall Study|Withdrawal by Subject|1
7284590|NCT00499616|11500857|FG001|Overall Study|Withdrawal by Subject|0
7284591|NCT00499616|11500858|FG002|Overall Study|Withdrawal by Subject|1
7284592|NCT00499616|11500859|FG003|Overall Study|Withdrawal by Subject|0
7284593|NCT00499616|11500856|FG000|Overall Study|Ineligible|1
7284594|NCT00499616|11500857|FG001|Overall Study|Ineligible|2
7284595|NCT00499616|11500858|FG002|Overall Study|Ineligible|0
7284596|NCT00499616|11500859|FG003|Overall Study|Ineligible|15
7284597|NCT00499616|11500856|FG000|Overall Study|Not evaluable|0
7284598|NCT00499616|11500857|FG001|Overall Study|Not evaluable|0
7284599|NCT00499616|11500858|FG002|Overall Study|Not evaluable|0
7284600|NCT00499616|11500859|FG003|Overall Study|Not evaluable|41
7284601|NCT00499616|11500856|FG000|Overall Study|Patient/Parent Refusal|1
7284603|NCT00499616|11500858|FG002|Overall Study|Patient/Parent Refusal|3
7284604|NCT00499616|11500859|FG003|Overall Study|Patient/Parent Refusal|0
7284605|NCT00499681|11500884|FG000|Overall Study|toxicity|0
7284606|NCT00499681|11500885|FG001|Overall Study|toxicity|1
7284607|NCT00499681|11500884|FG000|Overall Study|disease progression|0
7284608|NCT00499681|11500885|FG001|Overall Study|disease progression|1
7284609|NCT00499694|11500891|FG000|Overall Study|Patient never received treatment.|1
7284610|NCT00499746|11500896|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
7284611|NCT00499746|11500896|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
7284612|NCT00499746|11500896|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
7469933|NCT01928381|11771844|FG001|Part 1 - Pain Training|Protocol Violation|0
7284613|NCT00499746|11500896|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
7284614|NCT00499863|11500912|FG000|Overall Study|Lack of Efficacy|21
7284615|NCT00499863|11500913|FG001|Overall Study|Lack of Efficacy|27
7284616|NCT00499863|11500912|FG000|Overall Study|Protocol Violation|12
7284617|NCT00499863|11500913|FG001|Overall Study|Protocol Violation|7
7284618|NCT00499863|11500912|FG000|Overall Study|Withdrawal by Subject|6
7284619|NCT00499863|11500913|FG001|Overall Study|Withdrawal by Subject|4
7284620|NCT00499863|11500912|FG000|Overall Study|Adverse Event|8
7284621|NCT00499863|11500913|FG001|Overall Study|Adverse Event|2
7284622|NCT00499863|11500912|FG000|Overall Study|Sponsor decision|2
7284623|NCT00499863|11500913|FG001|Overall Study|Sponsor decision|2
7284624|NCT00499863|11500912|FG000|Overall Study|Lost to Follow-up|1
7284625|NCT00499863|11500913|FG001|Overall Study|Lost to Follow-up|1
7284626|NCT00499889|11500919|FG000|Overall Study|Infection prior to treatment|1
7284627|NCT00500110|11500932|FG000|Overall Study|Withdrawal by Subject|3
7284628|NCT00500149|11500936|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
7284629|NCT00500149|11500937|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
7284630|NCT00500149|11500936|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
7284631|NCT00500149|11500937|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
7284632|NCT00500149|11500936|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
7284633|NCT00500149|11500937|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
7284634|NCT00500149|11500936|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
7284635|NCT00500149|11500937|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
7284636|NCT00500149|11500936|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7284637|NCT00500149|11500937|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
7284638|NCT00500149|11500936|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
7284639|NCT00500149|11500937|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
7284640|NCT00500149|11500936|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
7284641|NCT00500149|11500937|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
7284642|NCT00500266|11500954|FG000|Overall Study|Death|3
7284643|NCT00500266|11500954|FG000|Overall Study|Lost to Follow-up|3
7284644|NCT00500266|11500954|FG000|Overall Study|Withdrawal by Subject|3
7284645|NCT00500266|11500954|FG000|Overall Study|Assigned, not treated|4
7284646|NCT00500292|11500962|FG000|Overall Study|Adverse Event|3
7284647|NCT00500292|11500963|FG001|Overall Study|Adverse Event|6
7284648|NCT00500292|11500964|FG002|Overall Study|Adverse Event|4
7284649|NCT00500292|11500962|FG000|Overall Study|Condition under investigation worsened|21
7284650|NCT00500292|11500963|FG001|Overall Study|Condition under investigation worsened|23
7284651|NCT00500292|11500964|FG002|Overall Study|Condition under investigation worsened|19
7284652|NCT00500292|11500962|FG000|Overall Study|Withdrawal by Subject|0
7284653|NCT00500292|11500963|FG001|Overall Study|Withdrawal by Subject|1
7284654|NCT00500292|11500964|FG002|Overall Study|Withdrawal by Subject|0
7284655|NCT00500292|11500962|FG000|Overall Study|Other|1
7284656|NCT00500292|11500963|FG001|Overall Study|Other|1
7284657|NCT00500292|11500964|FG002|Overall Study|Other|4
7284658|NCT00500318|11500974|FG000|Overall Study|Adverse Event|3
7284659|NCT00500318|11500975|FG001|Overall Study|Adverse Event|8
7284660|NCT00500318|11500974|FG000|Overall Study|Protocol Violation|1
7284661|NCT00500318|11500975|FG001|Overall Study|Protocol Violation|3
7284662|NCT00500318|11500974|FG000|Overall Study|Withdrawal by Subject|1
7284663|NCT00500318|11500975|FG001|Overall Study|Withdrawal by Subject|2
7284664|NCT00500318|11500974|FG000|Overall Study|Lack of Efficacy|0
7284665|NCT00500318|11500975|FG001|Overall Study|Lack of Efficacy|3
7284666|NCT00500318|11500974|FG000|Overall Study|Other Reason|0
7284667|NCT00500318|11500975|FG001|Overall Study|Other Reason|1
7284668|NCT00500331|11500988|FG000|Overall Study|Adverse Event|0
7284669|NCT00500331|11500989|FG001|Overall Study|Adverse Event|2
7284670|NCT00500331|11500990|FG002|Overall Study|Adverse Event|0
7284671|NCT00500331|11500991|FG003|Overall Study|Adverse Event|1
7284672|NCT00500331|11500992|FG004|Overall Study|Adverse Event|2
7284673|NCT00500331|11500993|FG005|Overall Study|Adverse Event|2
7284674|NCT00500331|11500994|FG006|Overall Study|Adverse Event|0
7284675|NCT00500331|11500988|FG000|Overall Study|Lost to Follow-up|1
7284676|NCT00500331|11500989|FG001|Overall Study|Lost to Follow-up|1
7284677|NCT00500331|11500990|FG002|Overall Study|Lost to Follow-up|1
7284678|NCT00500331|11500991|FG003|Overall Study|Lost to Follow-up|2
7284679|NCT00500331|11500992|FG004|Overall Study|Lost to Follow-up|1
7284680|NCT00500331|11500993|FG005|Overall Study|Lost to Follow-up|0
7284681|NCT00500331|11500994|FG006|Overall Study|Lost to Follow-up|0
7284682|NCT00500331|11500988|FG000|Overall Study|Protocol Violation|3
7284683|NCT00500331|11500989|FG001|Overall Study|Protocol Violation|1
7284684|NCT00500331|11500990|FG002|Overall Study|Protocol Violation|1
7284685|NCT00500331|11500991|FG003|Overall Study|Protocol Violation|0
7284686|NCT00500331|11500992|FG004|Overall Study|Protocol Violation|1
7284687|NCT00500331|11500993|FG005|Overall Study|Protocol Violation|1
7284688|NCT00500331|11500994|FG006|Overall Study|Protocol Violation|1
7284689|NCT00500331|11500988|FG000|Overall Study|Withdrawal by Subject|4
7284690|NCT00500331|11500989|FG001|Overall Study|Withdrawal by Subject|0
7284691|NCT00500331|11500990|FG002|Overall Study|Withdrawal by Subject|1
7284692|NCT00500331|11500991|FG003|Overall Study|Withdrawal by Subject|5
7284693|NCT00500331|11500992|FG004|Overall Study|Withdrawal by Subject|0
7284694|NCT00500331|11500993|FG005|Overall Study|Withdrawal by Subject|1
7622701|NCT03989232|12033572|FG001|Overall Study|Lost to Follow-up|10
7622702|NCT03989232|12033571|FG000|Overall Study|Withdrawal by Subject|6
7622703|NCT03989232|12033572|FG001|Overall Study|Withdrawal by Subject|6
7622704|NCT03989232|12033571|FG000|Overall Study|Death|1
7622705|NCT03989232|12033572|FG001|Overall Study|Death|2
7622706|NCT03896295|12033580|FG000|Overall Study|Adverse Event|0
7622707|NCT03896295|12033581|FG001|Overall Study|Adverse Event|1
7622708|NCT03896295|12033580|FG000|Overall Study|COVID-19|7
7622709|NCT03896295|12033581|FG001|Overall Study|COVID-19|29
7622710|NCT03213457|12033595|FG000|Overall Study|Not Treated|1
7622711|NCT03213457|12033596|FG001|Overall Study|Not Treated|1
7622712|NCT03213457|12033597|FG002|Overall Study|Not Treated|0
7622713|NCT03213457|12033595|FG000|Overall Study|Adverse Event|16
7622714|NCT03213457|12033596|FG001|Overall Study|Adverse Event|9
7622715|NCT03213457|12033597|FG002|Overall Study|Adverse Event|41
7622716|NCT03213457|12033595|FG000|Overall Study|Non-Compliance With Study Drug|1
7622717|NCT03213457|12033596|FG001|Overall Study|Non-Compliance With Study Drug|2
7284695|NCT00500331|11500994|FG006|Overall Study|Withdrawal by Subject|1
7284696|NCT00500331|11500988|FG000|Overall Study|Lack of Efficacy|3
7284697|NCT00500331|11500989|FG001|Overall Study|Lack of Efficacy|1
7284698|NCT00500331|11500990|FG002|Overall Study|Lack of Efficacy|0
7284699|NCT00500331|11500991|FG003|Overall Study|Lack of Efficacy|0
7284700|NCT00500331|11500992|FG004|Overall Study|Lack of Efficacy|0
7284701|NCT00500331|11500993|FG005|Overall Study|Lack of Efficacy|0
7284702|NCT00500331|11500994|FG006|Overall Study|Lack of Efficacy|0
7284703|NCT00500331|11500988|FG000|Overall Study|Liver function test abnormality|0
7284704|NCT00500331|11500989|FG001|Overall Study|Liver function test abnormality|0
7284705|NCT00500331|11500990|FG002|Overall Study|Liver function test abnormality|1
7284706|NCT00500331|11500991|FG003|Overall Study|Liver function test abnormality|0
7284707|NCT00500331|11500992|FG004|Overall Study|Liver function test abnormality|0
7284708|NCT00500331|11500993|FG005|Overall Study|Liver function test abnormality|0
7284709|NCT00500331|11500994|FG006|Overall Study|Liver function test abnormality|0
7284710|NCT00500331|11500988|FG000|Overall Study|Increased serum creatinine from Baseline|0
7284711|NCT00500331|11500989|FG001|Overall Study|Increased serum creatinine from Baseline|0
7284712|NCT00500331|11500990|FG002|Overall Study|Increased serum creatinine from Baseline|0
7284713|NCT00500331|11500991|FG003|Overall Study|Increased serum creatinine from Baseline|0
7284714|NCT00500331|11500992|FG004|Overall Study|Increased serum creatinine from Baseline|0
7284715|NCT00500331|11500993|FG005|Overall Study|Increased serum creatinine from Baseline|1
7284716|NCT00500331|11500994|FG006|Overall Study|Increased serum creatinine from Baseline|0
7284717|NCT00500331|11500988|FG000|Overall Study|Didn't return for continuation of study|1
7284718|NCT00500331|11500989|FG001|Overall Study|Didn't return for continuation of study|0
7284719|NCT00500331|11500990|FG002|Overall Study|Didn't return for continuation of study|0
7284720|NCT00500331|11500991|FG003|Overall Study|Didn't return for continuation of study|0
7284721|NCT00500331|11500992|FG004|Overall Study|Didn't return for continuation of study|0
7284722|NCT00500331|11500993|FG005|Overall Study|Didn't return for continuation of study|0
7284723|NCT00500331|11500994|FG006|Overall Study|Didn't return for continuation of study|0
7284724|NCT00500331|11500988|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
7284725|NCT00500331|11500989|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
7284726|NCT00500331|11500990|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
7284727|NCT00500331|11500991|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
7284728|NCT00500331|11500992|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
7284729|NCT00500331|11500993|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
7284730|NCT00500331|11500994|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
7284731|NCT00500331|11500988|FG000|Overall Study|Sponsor decided to withdraw participant|1
7284732|NCT00500331|11500989|FG001|Overall Study|Sponsor decided to withdraw participant|0
7284733|NCT00500331|11500990|FG002|Overall Study|Sponsor decided to withdraw participant|0
7284734|NCT00500331|11500991|FG003|Overall Study|Sponsor decided to withdraw participant|0
7284735|NCT00500331|11500992|FG004|Overall Study|Sponsor decided to withdraw participant|0
7284736|NCT00500331|11500993|FG005|Overall Study|Sponsor decided to withdraw participant|0
7284737|NCT00500331|11500994|FG006|Overall Study|Sponsor decided to withdraw participant|0
7284738|NCT00500331|11500988|FG000|Overall Study|Participant was randomized by mistake|1
7284739|NCT00500331|11500989|FG001|Overall Study|Participant was randomized by mistake|0
7284740|NCT00500331|11500990|FG002|Overall Study|Participant was randomized by mistake|0
7284741|NCT00500331|11500991|FG003|Overall Study|Participant was randomized by mistake|0
7284742|NCT00500331|11500992|FG004|Overall Study|Participant was randomized by mistake|0
7284743|NCT00500331|11500993|FG005|Overall Study|Participant was randomized by mistake|0
7622746|NCT02982720|12033605|FG000|Overall Study|Adverse Event|3
7284744|NCT00500331|11500994|FG006|Overall Study|Participant was randomized by mistake|0
7284745|NCT00500331|11500988|FG000|Overall Study|Diabetologist nurse in the study|0
7284746|NCT00500331|11500989|FG001|Overall Study|Diabetologist nurse in the study|0
7284747|NCT00500331|11500990|FG002|Overall Study|Diabetologist nurse in the study|1
7284748|NCT00500331|11500991|FG003|Overall Study|Diabetologist nurse in the study|0
7284749|NCT00500331|11500992|FG004|Overall Study|Diabetologist nurse in the study|0
7284750|NCT00500331|11500993|FG005|Overall Study|Diabetologist nurse in the study|0
7622718|NCT03213457|12033597|FG002|Overall Study|Non-Compliance With Study Drug|7
7622719|NCT03213457|12033595|FG000|Overall Study|Non-Compliance Other, Not Specified|0
7622720|NCT03213457|12033596|FG001|Overall Study|Non-Compliance Other, Not Specified|1
7284751|NCT00500331|11500994|FG006|Overall Study|Diabetologist nurse in the study|0
7284752|NCT00500331|11500988|FG000|Overall Study|State ban of biological samples export|0
7284753|NCT00500331|11500989|FG001|Overall Study|State ban of biological samples export|0
7284754|NCT00500331|11500990|FG002|Overall Study|State ban of biological samples export|0
7284755|NCT00500331|11500991|FG003|Overall Study|State ban of biological samples export|1
7284756|NCT00500331|11500992|FG004|Overall Study|State ban of biological samples export|0
7284757|NCT00500331|11500993|FG005|Overall Study|State ban of biological samples export|0
7284758|NCT00500331|11500994|FG006|Overall Study|State ban of biological samples export|0
7284759|NCT00500331|11500988|FG000|Overall Study|Protocol violated|0
7284760|NCT00500331|11500989|FG001|Overall Study|Protocol violated|0
7284761|NCT00500331|11500990|FG002|Overall Study|Protocol violated|0
7284762|NCT00500331|11500991|FG003|Overall Study|Protocol violated|1
7284763|NCT00500331|11500992|FG004|Overall Study|Protocol violated|0
7284764|NCT00500331|11500993|FG005|Overall Study|Protocol violated|0
7284765|NCT00500331|11500994|FG006|Overall Study|Protocol violated|0
7284766|NCT00500357|11501011|FG000|Overall Study|Death|1
7284767|NCT00500370|11501028|FG000|Overall Study|Adverse Event|9
7284768|NCT00500370|11501029|FG001|Overall Study|Adverse Event|3
7284769|NCT00500370|11501028|FG000|Overall Study|Lost to Follow-up|10
7284770|NCT00500370|11501029|FG001|Overall Study|Lost to Follow-up|10
7284771|NCT00500370|11501028|FG000|Overall Study|Protocol Violation|2
7284772|NCT00500370|11501029|FG001|Overall Study|Protocol Violation|4
7284773|NCT00500370|11501028|FG000|Overall Study|Sponsor Decision|2
7284774|NCT00500370|11501029|FG001|Overall Study|Sponsor Decision|0
7284775|NCT00500370|11501028|FG000|Overall Study|Subject Decision|10
7284776|NCT00500370|11501029|FG001|Overall Study|Subject Decision|17
7284777|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Adverse Event|4
7284778|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
7284779|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
7284780|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
7284781|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Administrative problems|2
7284782|NCT00500539|11501044|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
7284783|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
7284784|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
7284785|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
7284786|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
7284787|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Death|1
7284788|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
7284789|NCT00500539|11501044|FG000|Follow-up Period (16 Weeks)|Missing|3
7284790|NCT00500760|11501079|FG000|Overall Study|Death|32
7284791|NCT00500760|11501080|FG001|Overall Study|Death|15
7284792|NCT00500760|11501079|FG000|Overall Study|Withdrawal by Subject|5
7284793|NCT00500760|11501080|FG001|Overall Study|Withdrawal by Subject|7
7284794|NCT00500760|11501079|FG000|Overall Study|Administrative decision|2
7622721|NCT03213457|12033597|FG002|Overall Study|Non-Compliance Other, Not Specified|5
7622722|NCT03213457|12033595|FG000|Overall Study|Withdrawal by Subject|18
7622723|NCT03213457|12033596|FG001|Overall Study|Withdrawal by Subject|7
7622724|NCT03213457|12033597|FG002|Overall Study|Withdrawal by Subject|35
7622725|NCT03213457|12033595|FG000|Overall Study|Lost to Follow-up|12
7622726|NCT03213457|12033596|FG001|Overall Study|Lost to Follow-up|12
7622727|NCT03213457|12033597|FG002|Overall Study|Lost to Follow-up|33
7622728|NCT03213457|12033595|FG000|Overall Study|Pregnancy|11
7622729|NCT03213457|12033596|FG001|Overall Study|Pregnancy|0
7622730|NCT03213457|12033597|FG002|Overall Study|Pregnancy|7
7622731|NCT03213457|12033595|FG000|Overall Study|Protocol Violation|1
7622732|NCT03213457|12033596|FG001|Overall Study|Protocol Violation|1
7622733|NCT03213457|12033597|FG002|Overall Study|Protocol Violation|6
7622734|NCT03213457|12033595|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
7622735|NCT03213457|12033596|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
7622736|NCT03213457|12033597|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
7622737|NCT03213457|12033595|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7622738|NCT03213457|12033596|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
7622739|NCT03213457|12033597|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
7622740|NCT03213457|12033595|FG000|Overall Study|Lack of Efficacy|12
7622741|NCT03213457|12033596|FG001|Overall Study|Lack of Efficacy|2
7622742|NCT03213457|12033597|FG002|Overall Study|Lack of Efficacy|9
7622743|NCT03213457|12033595|FG000|Overall Study|Other, Not Specified|11
7622744|NCT03213457|12033596|FG001|Overall Study|Other, Not Specified|3
7622745|NCT03213457|12033597|FG002|Overall Study|Other, Not Specified|26
7622747|NCT02982720|12033605|FG000|Overall Study|Death|1
7284795|NCT00500760|11501080|FG001|Overall Study|Administrative decision|0
7284796|NCT00500760|11501079|FG000|Overall Study|Lost to Follow-up|3
7284797|NCT00500760|11501080|FG001|Overall Study|Lost to Follow-up|0
7284798|NCT00500760|11501079|FG000|Overall Study|Other|1
7284799|NCT00500760|11501080|FG001|Overall Study|Other|2
7284800|NCT00500903|11501089|FG000|Overall Study|Occurrence of Adverse Event(s)|10
7284801|NCT00500903|11501090|FG001|Overall Study|Occurrence of Adverse Event(s)|0
7284802|NCT00500903|11501091|FG002|Overall Study|Occurrence of Adverse Event(s)|0
7284803|NCT00500903|11501089|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
7284804|NCT00500903|11501090|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
7284805|NCT00500903|11501091|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
7284806|NCT00500903|11501089|FG000|Overall Study|Progressive Disease|41
7284807|NCT00500903|11501090|FG001|Overall Study|Progressive Disease|2
7284808|NCT00500903|11501091|FG002|Overall Study|Progressive Disease|15
7284809|NCT00500903|11501089|FG000|Overall Study|Patient Declined Further Treatment|0
7284810|NCT00500903|11501090|FG001|Overall Study|Patient Declined Further Treatment|0
7284811|NCT00500903|11501091|FG002|Overall Study|Patient Declined Further Treatment|3
7284812|NCT00500903|11501089|FG000|Overall Study|Symptomatic Deterioration|2
7284813|NCT00500903|11501090|FG001|Overall Study|Symptomatic Deterioration|0
7284814|NCT00500903|11501091|FG002|Overall Study|Symptomatic Deterioration|0
7284815|NCT00500903|11501089|FG000|Overall Study|Reason Not Specified|10
7284816|NCT00500903|11501090|FG001|Overall Study|Reason Not Specified|0
7284817|NCT00500903|11501091|FG002|Overall Study|Reason Not Specified|2
7284818|NCT00501007|11501129|FG000|Overall Study|Inclusion criteria not met.|29
7284819|NCT00501007|11501130|FG001|Overall Study|Inclusion criteria not met.|25
7284820|NCT00501059|11501138|FG000|Overall Study|Protocol Violation|80
7284821|NCT00501059|11501139|FG001|Overall Study|Protocol Violation|69
7284822|NCT00501059|11501138|FG000|Overall Study|Death|140
7284823|NCT00501059|11501139|FG001|Overall Study|Death|137
7284824|NCT00501059|11501138|FG000|Overall Study|Other|236
7284825|NCT00501059|11501139|FG001|Overall Study|Other|239
7284826|NCT00501059|11501138|FG000|Overall Study|Missing end-of-study page|91
7284827|NCT00501059|11501139|FG001|Overall Study|Missing end-of-study page|92
7284828|NCT00501059|11501138|FG000|Overall Study|Clinical endpoint reached|110
7284829|NCT00501059|11501139|FG001|Overall Study|Clinical endpoint reached|123
7284830|NCT00501059|11501138|FG000|Overall Study|Insufficient therapeutic effect|4
7284831|NCT00501059|11501139|FG001|Overall Study|Insufficient therapeutic effect|5
7284832|NCT00501059|11501138|FG000|Overall Study|Consent withdrawn by subject|817
7284833|NCT00501059|11501139|FG001|Overall Study|Consent withdrawn by subject|873
7284834|NCT00501059|11501138|FG000|Overall Study|Non-compliant with study treatment|23
7284835|NCT00501059|11501139|FG001|Overall Study|Non-compliant with study treatment|16
7284836|NCT00501059|11501138|FG000|Overall Study|Reason not given|3
7284837|NCT00501059|11501139|FG001|Overall Study|Reason not given|1
7284838|NCT00501059|11501138|FG000|Overall Study|Adverse Event|129
7284839|NCT00501059|11501139|FG001|Overall Study|Adverse Event|122
7284840|NCT00501059|11501138|FG000|Overall Study|Lost to Follow-up|210
7284841|NCT00501059|11501139|FG001|Overall Study|Lost to Follow-up|198
7284842|NCT00501059|11501138|FG000|Overall Study|Not treated|25
7284843|NCT00501059|11501139|FG001|Overall Study|Not treated|17
7284844|NCT00501085|11501147|FG000|Overall Study|Lost to Follow-up|195
7284845|NCT00501085|11501147|FG000|Overall Study|Withdrawal by Subject|34
7284846|NCT00501085|11501147|FG000|Overall Study|Subject Decision|1
7284847|NCT00501085|11501147|FG000|Overall Study|Revision Surgery|7
7284848|NCT00501085|11501147|FG000|Overall Study|Explantation Surgery|26
7284849|NCT00501085|11501147|FG000|Overall Study|Adverse Event|4
7284850|NCT00501085|11501147|FG000|Overall Study|Non-Compliance|24
7284851|NCT00501085|11501147|FG000|Overall Study|Study closed by sponsor|109
7284852|NCT00501085|11501147|FG000|Overall Study|Other loss to follow-up|32
7284853|NCT00501293|11501153|FG000|Optimization Period|Enrolled in error|1
7284854|NCT00501293|11501154|FG001|Optimization Period|Enrolled in error|0
7284855|NCT00501293|11501153|FG000|Maintenance Period|Withdrawal by Subject|14
7284856|NCT00501293|11501154|FG001|Maintenance Period|Withdrawal by Subject|13
7284857|NCT00501293|11501153|FG000|Maintenance Period|Lost to Follow-up|12
7284858|NCT00501293|11501154|FG001|Maintenance Period|Lost to Follow-up|7
7284859|NCT00501293|11501153|FG000|Maintenance Period|Adverse Event|6
7284860|NCT00501293|11501154|FG001|Maintenance Period|Adverse Event|6
7284861|NCT00501293|11501153|FG000|Maintenance Period|Protocol Violation|2
7284862|NCT00501293|11501154|FG001|Maintenance Period|Protocol Violation|1
7284863|NCT00501293|11501153|FG000|Maintenance Period|Lack of Efficacy|4
7284864|NCT00501293|11501154|FG001|Maintenance Period|Lack of Efficacy|1
7284865|NCT00501293|11501153|FG000|Maintenance Period|Noncompliant with study medication|5
7284866|NCT00501293|11501154|FG001|Maintenance Period|Noncompliant with study medication|0
7284867|NCT00501293|11501153|FG000|Maintenance Period|Went into rehabilitation|1
7284868|NCT00501293|11501154|FG001|Maintenance Period|Went into rehabilitation|0
7284869|NCT00501293|11501153|FG000|Maintenance Period|Would not wear patch|1
7284870|NCT00501293|11501154|FG001|Maintenance Period|Would not wear patch|0
7284871|NCT00501293|11501153|FG000|Maintenance Period|Application site reaction|1
7284872|NCT00501293|11501154|FG001|Maintenance Period|Application site reaction|0
7284873|NCT00501540|11501161|FG000|Overall Study|Death|5
7284874|NCT00501644|11501187|FG000|Overall Study|Adverse Event|4
7284875|NCT00501644|11501187|FG000|Overall Study|Withdrawal by Subject|1
7284876|NCT00501852|11501191|FG000|Overall Study|Adverse Event|3
7284877|NCT00501852|11501191|FG000|Overall Study|Withdrawal by Subject|2
7284878|NCT00501969|11501221|FG000|Overall Study|Major Protocol Violation|4
7284879|NCT00501969|11501221|FG000|Overall Study|Lack of Efficacy|29
7284880|NCT00501969|11501221|FG000|Overall Study|Adverse Event|76
7284881|NCT00501969|11501221|FG000|Overall Study|Unsatisfactory compliance of subject|7
7284882|NCT00501969|11501221|FG000|Overall Study|Subject withdrew consent|51
7284883|NCT00501969|11501221|FG000|Overall Study|Lost to Follow-up|4
7284884|NCT00501969|11501221|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
7284885|NCT00501969|11501221|FG000|Overall Study|Other: Sponsors Request|10
7284886|NCT00501969|11501221|FG000|Overall Study|Other: Sponsor Termination at Site|1
7284887|NCT00501969|11501221|FG000|Overall Study|Other: Sponsor Stopped Study|12
7284888|NCT00501969|11501221|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
7284889|NCT00501969|11501221|FG000|Overall Study|Other: Patients + Investigator Agreement|1
7284890|NCT00501969|11501221|FG000|Overall Study|Other: Patient is Going to Have DBS|1
7284891|NCT00501969|11501221|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
7284892|NCT00501969|11501221|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
7284893|NCT00501969|11501221|FG000|Overall Study|Other: As Required by Local EC|2
7284894|NCT00501969|11501221|FG000|Overall Study|Other: Admin Request from the Sponsor|3
7284895|NCT00501969|11501221|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
7284896|NCT00502203|11501229|FG000|Overall Study|Inevaluable|1
7284897|NCT00502242|11501244|FG000|Overall Study|Lack of Efficacy|1
7284898|NCT00502242|11501245|FG001|Overall Study|Lack of Efficacy|11
7284899|NCT00502242|11501244|FG000|Overall Study|Adverse Event|31
7284900|NCT00502242|11501245|FG001|Overall Study|Adverse Event|20
7284901|NCT00502242|11501244|FG000|Overall Study|Physician Decision|2
7284902|NCT00502242|11501245|FG001|Overall Study|Physician Decision|3
7284903|NCT00502242|11501244|FG000|Overall Study|Other - Unspecified|8
7284904|NCT00502242|11501245|FG001|Overall Study|Other - Unspecified|14
7284905|NCT00502242|11501244|FG000|Overall Study|Protocol Violation|3
7284906|NCT00502242|11501245|FG001|Overall Study|Protocol Violation|1
7284907|NCT00502242|11501244|FG000|Overall Study|Withdrawal by Subject|6
7284908|NCT00502242|11501245|FG001|Overall Study|Withdrawal by Subject|7
7284909|NCT00502307|11501251|FG000|Open Label Period (16 Weeks)|Progressive disease|50
7284910|NCT00502307|11501252|FG001|Open Label Period (16 Weeks)|Progressive disease|0
7284911|NCT00502307|11501253|FG002|Open Label Period (16 Weeks)|Progressive disease|0
7284912|NCT00502307|11501251|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
7284913|NCT00502307|11501252|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7284914|NCT00502307|11501253|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
7284915|NCT00502307|11501251|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
7284916|NCT00502307|11501252|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
7284917|NCT00502307|11501253|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
7284918|NCT00502307|11501251|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
7284919|NCT00502307|11501252|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
7284920|NCT00502307|11501253|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
7284921|NCT00502307|11501251|FG000|Maintenance Period|Progressive disease|80
7284922|NCT00502307|11501252|FG001|Maintenance Period|Progressive disease|0
7284923|NCT00502307|11501253|FG002|Maintenance Period|Progressive disease|0
7284924|NCT00502307|11501251|FG000|Maintenance Period|Discontinued due to other reasons|68
7284925|NCT00502307|11501252|FG001|Maintenance Period|Discontinued due to other reasons|0
7284926|NCT00502307|11501253|FG002|Maintenance Period|Discontinued due to other reasons|0
7284927|NCT00502320|11501272|FG000|Overall Study|Lost to Follow-up|1
7284928|NCT00502320|11501273|FG001|Overall Study|Lost to Follow-up|1
7284929|NCT00502320|11501272|FG000|Overall Study|Withdrew Consent|1
7284930|NCT00502320|11501273|FG001|Overall Study|Withdrew Consent|0
7284931|NCT00502320|11501272|FG000|Overall Study|No longer met criteria|1
7284932|NCT00502320|11501273|FG001|Overall Study|No longer met criteria|0
7284933|NCT00502320|11501272|FG000|Overall Study|Screen Failure|0
7622748|NCT02375672|12033618|FG000|Overall Study|remain on follow up|20
7622749|NCT02329327|12033624|FG000|Overall Study|Death|78
7622750|NCT02329327|12033625|FG001|Overall Study|Death|0
7622751|NCT02329327|12033624|FG000|Overall Study|Withdrawal by Subject|3
7622752|NCT02329327|12033625|FG001|Overall Study|Withdrawal by Subject|0
7622753|NCT02329327|12033624|FG000|Overall Study|Lost to Follow-up|4
7622754|NCT02329327|12033625|FG001|Overall Study|Lost to Follow-up|0
7622755|NCT01566149|12033683|FG000|Overall Study|Adverse Event|0
7622756|NCT01566149|12033684|FG001|Overall Study|Adverse Event|1
7622757|NCT01566149|12033683|FG000|Overall Study|Non-compliance with study medication|2
7622758|NCT01566149|12033684|FG001|Overall Study|Non-compliance with study medication|0
7622759|NCT01566149|12033683|FG000|Overall Study|Protocol Violation|0
7622760|NCT01566149|12033684|FG001|Overall Study|Protocol Violation|1
7622761|NCT01566149|12033683|FG000|Overall Study|Withdrawal by Subject|1
7622762|NCT01566149|12033684|FG001|Overall Study|Withdrawal by Subject|0
7622763|NCT01386125|12033701|FG000|Overall Study|Lost to Follow-up|3
7284934|NCT00502320|11501273|FG001|Overall Study|Screen Failure|1
7284935|NCT00502320|11501272|FG000|Overall Study|Adverse Event|3
7284936|NCT00502320|11501273|FG001|Overall Study|Adverse Event|5
7622764|NCT01386125|12033702|FG001|Overall Study|Lost to Follow-up|9
7622765|NCT01386125|12033701|FG000|Overall Study|Physician Decision|0
7622766|NCT01386125|12033702|FG001|Overall Study|Physician Decision|1
7284937|NCT00502593|11501291|FG000|Overall Study|Withdrawn unspecified reason|1
7284938|NCT00502593|11501292|FG001|Overall Study|Withdrawn unspecified reason|1
7284939|NCT00502593|11501293|FG002|Overall Study|Withdrawn unspecified reason|3
7284940|NCT00502593|11501294|FG003|Overall Study|Withdrawn unspecified reason|1
7284941|NCT00502593|11501295|FG004|Overall Study|Withdrawn unspecified reason|2
7284942|NCT00502593|11501296|FG005|Overall Study|Withdrawn unspecified reason|0
7284943|NCT00502593|11501297|FG006|Overall Study|Withdrawn unspecified reason|2
7284944|NCT00502593|11501298|FG007|Overall Study|Withdrawn unspecified reason|0
7284945|NCT00502593|11501299|FG008|Overall Study|Withdrawn unspecified reason|0
7284946|NCT00502593|11501300|FG009|Overall Study|Withdrawn unspecified reason|0
7284947|NCT00502593|11501301|FG010|Overall Study|Withdrawn unspecified reason|0
7284948|NCT00502593|11501302|FG011|Overall Study|Withdrawn unspecified reason|0
7284949|NCT00502593|11501291|FG000|Overall Study|Withdrawal by Subject|0
7284950|NCT00502593|11501292|FG001|Overall Study|Withdrawal by Subject|0
7284951|NCT00502593|11501293|FG002|Overall Study|Withdrawal by Subject|6
7284952|NCT00502593|11501294|FG003|Overall Study|Withdrawal by Subject|2
7284953|NCT00502593|11501295|FG004|Overall Study|Withdrawal by Subject|2
7284954|NCT00502593|11501296|FG005|Overall Study|Withdrawal by Subject|0
7284955|NCT00502593|11501297|FG006|Overall Study|Withdrawal by Subject|3
7284956|NCT00502593|11501298|FG007|Overall Study|Withdrawal by Subject|0
7284957|NCT00502593|11501299|FG008|Overall Study|Withdrawal by Subject|3
7284958|NCT00502593|11501300|FG009|Overall Study|Withdrawal by Subject|0
7284959|NCT00502593|11501301|FG010|Overall Study|Withdrawal by Subject|1
7284960|NCT00502593|11501302|FG011|Overall Study|Withdrawal by Subject|0
7284961|NCT00502593|11501291|FG000|Overall Study|Lost to Follow-up|2
7284962|NCT00502593|11501292|FG001|Overall Study|Lost to Follow-up|1
7284963|NCT00502593|11501293|FG002|Overall Study|Lost to Follow-up|1
7284964|NCT00502593|11501294|FG003|Overall Study|Lost to Follow-up|1
7284965|NCT00502593|11501295|FG004|Overall Study|Lost to Follow-up|0
7284966|NCT00502593|11501296|FG005|Overall Study|Lost to Follow-up|0
7284967|NCT00502593|11501297|FG006|Overall Study|Lost to Follow-up|0
7284968|NCT00502593|11501298|FG007|Overall Study|Lost to Follow-up|0
7284969|NCT00502593|11501299|FG008|Overall Study|Lost to Follow-up|3
7284970|NCT00502593|11501300|FG009|Overall Study|Lost to Follow-up|0
7284971|NCT00502593|11501301|FG010|Overall Study|Lost to Follow-up|1
7284972|NCT00502593|11501302|FG011|Overall Study|Lost to Follow-up|0
7284973|NCT00502671|11501351|FG000|Overall Study|Disease Progression|13
7284974|NCT00502671|11501351|FG000|Overall Study|Personal Reasons|22
7284975|NCT00502671|11501351|FG000|Overall Study|Lost to Follow-up|7
7284976|NCT00502671|11501351|FG000|Overall Study|Protocol Violation|16
7284977|NCT00502671|11501351|FG000|Overall Study|Adverse Event|19
7284978|NCT00502697|11501357|FG000|Overall Study|Withdrawal by Subject|3
7284979|NCT00502697|11501358|FG001|Overall Study|Withdrawal by Subject|1
7284980|NCT00502697|11501357|FG000|Overall Study|disenrolled due to pregnancy loss|3
7284981|NCT00502697|11501358|FG001|Overall Study|disenrolled due to pregnancy loss|5
7284982|NCT00502697|11501357|FG000|Overall Study|found not to meet eligibility criteria|3
7284983|NCT00502697|11501358|FG001|Overall Study|found not to meet eligibility criteria|4
7284984|NCT00502697|11501357|FG000|Overall Study|did not meet assignment criteria|4
7284985|NCT00502697|11501358|FG001|Overall Study|did not meet assignment criteria|2
7284986|NCT00502775|11501367|FG000|Overall Study|Adverse Event|1
7284987|NCT00502775|11501368|FG001|Overall Study|Adverse Event|2
7284988|NCT00502775|11501369|FG002|Overall Study|Adverse Event|1
7284989|NCT00502775|11501367|FG000|Overall Study|Protocol Violation|1
7284990|NCT00502775|11501368|FG001|Overall Study|Protocol Violation|5
7284991|NCT00502775|11501369|FG002|Overall Study|Protocol Violation|2
7284992|NCT00502775|11501367|FG000|Overall Study|Withdrawal by Subject|1
7284993|NCT00502775|11501368|FG001|Overall Study|Withdrawal by Subject|1
7284994|NCT00502775|11501369|FG002|Overall Study|Withdrawal by Subject|2
7284995|NCT00502775|11501367|FG000|Overall Study|Sponsor Terminated Study|1
7284996|NCT00502775|11501368|FG001|Overall Study|Sponsor Terminated Study|0
7284997|NCT00502775|11501369|FG002|Overall Study|Sponsor Terminated Study|1
7284998|NCT00502775|11501367|FG000|Overall Study|Non-compliance with eDiary|4
7284999|NCT00502775|11501368|FG001|Overall Study|Non-compliance with eDiary|1
7285000|NCT00502775|11501369|FG002|Overall Study|Non-compliance with eDiary|1
7285001|NCT00502775|11501367|FG000|Overall Study|Subject unable to swallow capsule|1
7285002|NCT00502775|11501368|FG001|Overall Study|Subject unable to swallow capsule|0
7285003|NCT00502775|11501369|FG002|Overall Study|Subject unable to swallow capsule|1
7285004|NCT00502775|11501367|FG000|Overall Study|Logpad compliance <80%|1
7285005|NCT00502775|11501368|FG001|Overall Study|Logpad compliance <80%|0
7285006|NCT00502775|11501369|FG002|Overall Study|Logpad compliance <80%|0
7285007|NCT00502775|11501367|FG000|Overall Study|Randomized in error|0
7285008|NCT00502775|11501368|FG001|Overall Study|Randomized in error|1
7285009|NCT00502775|11501369|FG002|Overall Study|Randomized in error|1
7285010|NCT00502775|11501367|FG000|Overall Study|Non-compliance|0
7285011|NCT00502775|11501368|FG001|Overall Study|Non-compliance|2
7285012|NCT00502775|11501369|FG002|Overall Study|Non-compliance|2
7285013|NCT00502775|11501367|FG000|Overall Study|Outside pollen area more than 48 hours|0
7285014|NCT00502775|11501368|FG001|Overall Study|Outside pollen area more than 48 hours|1
7285015|NCT00502775|11501369|FG002|Overall Study|Outside pollen area more than 48 hours|0
7285016|NCT00502775|11501367|FG000|Overall Study|Declining pollen counts|0
7285017|NCT00502775|11501368|FG001|Overall Study|Declining pollen counts|1
7285018|NCT00502775|11501369|FG002|Overall Study|Declining pollen counts|1
7285019|NCT00502775|11501367|FG000|Overall Study|Subject in jail|0
7285020|NCT00502775|11501368|FG001|Overall Study|Subject in jail|1
7285021|NCT00502775|11501369|FG002|Overall Study|Subject in jail|0
7285022|NCT00502775|11501367|FG000|Overall Study|Subject took disallowed drug|0
7285023|NCT00502775|11501368|FG001|Overall Study|Subject took disallowed drug|0
7285024|NCT00502775|11501369|FG002|Overall Study|Subject took disallowed drug|1
7285025|NCT00502801|11501377|FG000|Treatment Period|Withdrawal by Subject|3
7285026|NCT00502801|11501377|FG000|Treatment Period|Adverse Event|7
7285027|NCT00502801|11501377|FG000|Treatment Period|Death|14
7285028|NCT00502801|11501377|FG000|Treatment Period|OTHER|30
7285029|NCT00502801|11501377|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
7285030|NCT00502801|11501377|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
7285031|NCT00502801|11501377|FG000|End of Therapy to Test of Cure|Death|3
7285032|NCT00502801|11501377|FG000|End of Therapy to Test of Cure|OTHER|2
7285033|NCT00502840|11501381|FG000|Overall Study|Adverse Event|5
7285034|NCT00502840|11501381|FG000|Overall Study|Additional or changed therapy|48
7285035|NCT00502840|11501381|FG000|Overall Study|Lack of Efficacy|11
7285036|NCT00502840|11501381|FG000|Overall Study|Protocol Violation|4
7285037|NCT00502840|11501381|FG000|Overall Study|Withdrawal by Subject|5
7285038|NCT00502840|11501381|FG000|Overall Study|Lost to Follow-up|6
7285039|NCT00502840|11501381|FG000|Overall Study|Administrative problems|1
7285040|NCT00502840|11501381|FG000|Overall Study|Other|20
7285041|NCT00502996|11501404|FG000|Overall Study|Lost to Follow-up|9
7285042|NCT00502996|11501404|FG000|Overall Study|Protocol Violation|2
7285043|NCT00502996|11501404|FG000|Overall Study|Treatment failure|25
7285044|NCT00502996|11501404|FG000|Overall Study|Withdrawal Informed Consent|6
7285045|NCT00502996|11501404|FG000|Overall Study|Adverse Event|2
7285046|NCT00503139|11501421|FG000|Overall Study|Case Report Forms were not collected|4
7285047|NCT00503139|11501421|FG000|Overall Study|Protocol Violation|4
7285048|NCT00503308|11501427|FG000|Overall Study|Protocol Violation|2
7285049|NCT00503308|11501428|FG001|Overall Study|Protocol Violation|1
7285050|NCT00503399|11501436|FG000|Overall Study|Death|2
7285051|NCT00503399|11501437|FG001|Overall Study|Death|1
7285052|NCT00503399|11501436|FG000|Overall Study|Protocol Violation|1
7285053|NCT00503399|11501437|FG001|Overall Study|Protocol Violation|0
7285054|NCT00503399|11501436|FG000|Overall Study|Withdrawal by Subject|4
7622767|NCT01386125|12033701|FG000|Overall Study|Protocol Violation|5
7622768|NCT01386125|12033702|FG001|Overall Study|Protocol Violation|7
7622769|NCT01386125|12033701|FG000|Overall Study|Disease Progress|1
7622770|NCT01386125|12033702|FG001|Overall Study|Disease Progress|2
7622771|NCT01386125|12033701|FG000|Overall Study|Withdrawal by Subject|13
7622772|NCT01386125|12033702|FG001|Overall Study|Withdrawal by Subject|12
7622773|NCT01386125|12033701|FG000|Overall Study|Adverse Event|2
7622774|NCT01386125|12033702|FG001|Overall Study|Adverse Event|5
7622775|NCT01386125|12033701|FG000|Overall Study|Lack of Efficacy|0
7622776|NCT01386125|12033702|FG001|Overall Study|Lack of Efficacy|1
7622777|NCT01386125|12033701|FG000|Overall Study|Participant Leaving Country|1
7622778|NCT01386125|12033702|FG001|Overall Study|Participant Leaving Country|0
7622779|NCT01257568|12033708|FG000|Overall Study|Lost to Follow-up|2
7622780|NCT01257568|12033708|FG000|Overall Study|Withdrawal by Subject|6
7622781|NCT01257568|12033708|FG000|Overall Study|Terminated|1
7622782|NCT01257568|12033708|FG000|Overall Study|Component Revision|24
7622783|NCT01165424|12033714|FG000|Overall Study|Clinical adverse experiences|1
7622784|NCT01165424|12033714|FG000|Overall Study|Laboratory adverse experiences|1
7622785|NCT01165424|12033714|FG000|Overall Study|Did not meet entry criteria|1
7622786|NCT01165424|12033714|FG000|Overall Study|Participant moved (relocated)|1
7622787|NCT01135134|12033720|FG000|Overall Study|Adverse Event|1
7622788|NCT01135134|12033721|FG001|Overall Study|Adverse Event|1
7622789|NCT01135134|12033720|FG000|Overall Study|Did not meet protocol eligibility|1
7622790|NCT01135134|12033721|FG001|Overall Study|Did not meet protocol eligibility|0
7622791|NCT00867165|12033729|FG000|Overall Study|Adverse Event|3
7622792|NCT00867165|12033730|FG001|Overall Study|Adverse Event|0
7622793|NCT00867165|12033729|FG000|Overall Study|Withdrawal by Subject|1
7622794|NCT00867165|12033730|FG001|Overall Study|Withdrawal by Subject|0
7622795|NCT00733005|12033738|FG000|Overall Study|Adverse Event|0
7622796|NCT00733005|12033739|FG001|Overall Study|Adverse Event|1
7622797|NCT00733005|12033738|FG000|Overall Study|Treatment Failure|0
7622798|NCT00733005|12033739|FG001|Overall Study|Treatment Failure|1
7622799|NCT00733005|12033738|FG000|Overall Study|Withdrawal by Subject|0
7622800|NCT00733005|12033739|FG001|Overall Study|Withdrawal by Subject|1
7622801|NCT00733005|12033738|FG000|Overall Study|Protocol Violation|2
7622802|NCT00733005|12033739|FG001|Overall Study|Protocol Violation|0
7622803|NCT00732381|12033747|FG000|Overall Study|Adverse Event|1
7622804|NCT00732381|12033748|FG001|Overall Study|Adverse Event|0
7622805|NCT00732381|12033747|FG000|Overall Study|Treatment Failure|1
7622806|NCT00732381|12033748|FG001|Overall Study|Treatment Failure|1
7285055|NCT00503399|11501437|FG001|Overall Study|Withdrawal by Subject|2
7285056|NCT00503399|11501436|FG000|Overall Study|Adverse Event|0
7285057|NCT00503399|11501437|FG001|Overall Study|Adverse Event|3
7622807|NCT00654095|12033754|FG000|Overall Study|Drop in low density lipoprotein (1)|2
7622808|NCT00654095|12033754|FG000|Overall Study|Elevated triglyceride level (2)|1
7622809|NCT00654095|12033754|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
7622810|NCT00654095|12033754|FG000|Overall Study|Adverse Event|11
7285058|NCT00503399|11501436|FG000|Overall Study|Lost to Follow-up|0
7285059|NCT00503399|11501437|FG001|Overall Study|Lost to Follow-up|2
7285060|NCT00503425|11501443|FG000|Overall Study|Participant files lost|6
7285061|NCT00503425|11501443|FG000|Overall Study|Adverse Event|5
7285062|NCT00503425|11501443|FG000|Overall Study|Lack of Efficacy|25
7285063|NCT00503425|11501443|FG000|Overall Study|Withdrawal by Subject|8
7285064|NCT00503425|11501443|FG000|Overall Study|Lost to Follow-up|3
7285065|NCT00503425|11501443|FG000|Overall Study|Death|3
7285066|NCT00503425|11501443|FG000|Overall Study|Missing Data/Unknown|4
7285067|NCT00503685|11501451|FG000|Overall Study|Adverse Event|0
7285068|NCT00503685|11501452|FG001|Overall Study|Adverse Event|0
7285069|NCT00503685|11501453|FG002|Overall Study|Adverse Event|2
7285070|NCT00503685|11501451|FG000|Overall Study|Withdrawal by Subject|0
7285071|NCT00503685|11501452|FG001|Overall Study|Withdrawal by Subject|1
7285072|NCT00503685|11501453|FG002|Overall Study|Withdrawal by Subject|0
7285073|NCT00503685|11501451|FG000|Overall Study|Protocol Violation|0
7285074|NCT00503685|11501452|FG001|Overall Study|Protocol Violation|1
7285075|NCT00503685|11501453|FG002|Overall Study|Protocol Violation|0
7285076|NCT00503685|11501451|FG000|Overall Study|Eligibility Criteria Not Met|0
7285077|NCT00503685|11501452|FG001|Overall Study|Eligibility Criteria Not Met|1
7285078|NCT00503685|11501453|FG002|Overall Study|Eligibility Criteria Not Met|0
7285079|NCT00503698|11501464|FG000|Overall Study|Protocol Violation|5
7285080|NCT00503698|11501465|FG001|Overall Study|Protocol Violation|6
7285081|NCT00503698|11501464|FG000|Overall Study|Adverse Event|52
7285082|NCT00503698|11501465|FG001|Overall Study|Adverse Event|41
7285083|NCT00503698|11501464|FG000|Overall Study|Death|1
7285084|NCT00503698|11501465|FG001|Overall Study|Death|0
7285085|NCT00503698|11501464|FG000|Overall Study|Lack of Efficacy|3
7285086|NCT00503698|11501465|FG001|Overall Study|Lack of Efficacy|4
7285087|NCT00503698|11501464|FG000|Overall Study|Trial terminated|216
7285088|NCT00503698|11501465|FG001|Overall Study|Trial terminated|253
7285089|NCT00503698|11501464|FG000|Overall Study|End hemodialysis due to renal transplant|10
7285090|NCT00503698|11501465|FG001|Overall Study|End hemodialysis due to renal transplant|4
7285091|NCT00503698|11501464|FG000|Overall Study|Pregnancy/intention to become pregnant|1
7285092|NCT00503698|11501465|FG001|Overall Study|Pregnancy/intention to become pregnant|0
7285093|NCT00503698|11501464|FG000|Overall Study|Any condition in exclusion criteria|4
7285094|NCT00503698|11501465|FG001|Overall Study|Any condition in exclusion criteria|6
7285095|NCT00503698|11501464|FG000|Overall Study|Switch to peritoneal or home dialysis|2
7285096|NCT00503698|11501465|FG001|Overall Study|Switch to peritoneal or home dialysis|2
7285097|NCT00503698|11501464|FG000|Overall Study|Move to nonparticipating dialysis center|2
7285098|NCT00503698|11501465|FG001|Overall Study|Move to nonparticipating dialysis center|1
7285099|NCT00503698|11501464|FG000|Overall Study|Critically ill|2
7285100|NCT00503698|11501465|FG001|Overall Study|Critically ill|0
7285101|NCT00503698|11501464|FG000|Overall Study|Unclassified|48
7285102|NCT00503698|11501465|FG001|Overall Study|Unclassified|32
7285103|NCT00503698|11501464|FG000|Overall Study|Not exposed to trial drug|11
7285104|NCT00503698|11501465|FG001|Overall Study|Not exposed to trial drug|6
7285105|NCT00503776|11501479|FG000|Overall Study|Withdrawal by Subject|1
7622811|NCT00654095|12033754|FG000|Overall Study|Withdrawal by Subject|5
7622812|NCT00654095|12033754|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
7622813|NCT00654095|12033754|FG000|Overall Study|Adverse reaction did not improve (5)|4
7622814|NCT00654095|12033754|FG000|Overall Study|Did not meet inclusion criteria|1
7622815|NCT00653523|12033758|FG000|Overall Study|Drop in low density lipoprotein (1)|2
7622816|NCT00653523|12033758|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
7622817|NCT00653523|12033758|FG000|Overall Study|Adverse Event|7
7622818|NCT00653523|12033758|FG000|Overall Study|Withdrawal by Subject|6
7622819|NCT00653523|12033758|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
7622820|NCT00653523|12033758|FG000|Overall Study|Adverse reaction did not improve (4)|1
7285106|NCT00503776|11501480|FG001|Overall Study|Withdrawal by Subject|0
7285107|NCT00503776|11501481|FG002|Overall Study|Withdrawal by Subject|1
7285108|NCT00503776|11501482|FG003|Overall Study|Withdrawal by Subject|1
7285109|NCT00503776|11501479|FG000|Overall Study|Physician Decision|0
7285110|NCT00503776|11501480|FG001|Overall Study|Physician Decision|0
7285111|NCT00503776|11501481|FG002|Overall Study|Physician Decision|1
7285112|NCT00503776|11501482|FG003|Overall Study|Physician Decision|1
7285113|NCT00503867|11501497|FG000|Overall Study|Lost to Follow-up|1
7285114|NCT00503867|11501497|FG000|Overall Study|Adverse Event|1
7285115|NCT00503906|11501501|FG000|Overall Study|Withdrawal by Subject|1
7285116|NCT00503984|11501508|FG000|Overall Study|Protocol Violation|0
7285117|NCT00503984|11501509|FG001|Overall Study|Protocol Violation|1
7285118|NCT00503984|11501510|FG002|Overall Study|Protocol Violation|0
7285119|NCT00503984|11501511|FG003|Overall Study|Protocol Violation|0
7285120|NCT00503984|11501512|FG004|Overall Study|Protocol Violation|0
7285121|NCT00503984|11501513|FG005|Overall Study|Protocol Violation|0
7285122|NCT00503984|11501508|FG000|Overall Study|Adverse Event|0
7285123|NCT00503984|11501509|FG001|Overall Study|Adverse Event|1
7285124|NCT00503984|11501510|FG002|Overall Study|Adverse Event|0
7285125|NCT00503984|11501511|FG003|Overall Study|Adverse Event|0
7285126|NCT00503984|11501512|FG004|Overall Study|Adverse Event|0
7285127|NCT00503984|11501513|FG005|Overall Study|Adverse Event|0
7285128|NCT00503984|11501508|FG000|Overall Study|Death|0
7285129|NCT00503984|11501509|FG001|Overall Study|Death|0
7622821|NCT00599027|12033764|FG000|Overall Study|Withdrawal by Subject|1
7285130|NCT00503984|11501510|FG002|Overall Study|Death|0
7285131|NCT00503984|11501511|FG003|Overall Study|Death|0
7285132|NCT00503984|11501512|FG004|Overall Study|Death|1
7285133|NCT00503984|11501513|FG005|Overall Study|Death|0
7285134|NCT00503997|11501537|FG000|Overall Study|disease progression|1
7285135|NCT00503997|11501537|FG000|Overall Study|Adverse Event|5
7285136|NCT00503997|11501537|FG000|Overall Study|Death|1
7285137|NCT00503997|11501537|FG000|Overall Study|Withdrawal by Subject|1
7285138|NCT00504075|11501545|FG000|Overall Study|Adverse Event|1
7285139|NCT00504075|11501545|FG000|Overall Study|Lost to Follow-up|5
7285140|NCT00504075|11501545|FG000|Overall Study|Withdrawal by Subject|1
7285141|NCT00504075|11501545|FG000|Overall Study|Required other therapeutic intervention|1
7285142|NCT00504153|11501550|FG000|Overall Study|Withdrawal by Subject|1
7285143|NCT00504153|11501550|FG000|Overall Study|Adverse Event|4
7285144|NCT00504153|11501550|FG000|Overall Study|Death|1
7285145|NCT00504166|11501556|FG000|Overall Study|Adverse Event|1
7285146|NCT00504166|11501557|FG001|Overall Study|Adverse Event|4
7285147|NCT00504166|11501556|FG000|Overall Study|Withdrawal by Subject|3
7285148|NCT00504166|11501557|FG001|Overall Study|Withdrawal by Subject|6
7285149|NCT00504166|11501556|FG000|Overall Study|Physician Decision|1
7285150|NCT00504166|11501557|FG001|Overall Study|Physician Decision|1
7285151|NCT00504166|11501556|FG000|Overall Study|Lost to Follow-up|1
7285152|NCT00504166|11501557|FG001|Overall Study|Lost to Follow-up|3
7285153|NCT00504231|11501567|FG000|Overall Study|Discrepant chart documentation re route|0
7285154|NCT00504231|11501568|FG001|Overall Study|Discrepant chart documentation re route|0
7285155|NCT00504231|11501569|FG002|Overall Study|Discrepant chart documentation re route|1
7285156|NCT00504231|11501570|FG003|Overall Study|Discrepant chart documentation re route|0
7285157|NCT00504257|11501584|FG000|Overall Study|Withdrawal by Subject|2
7285158|NCT00504257|11501584|FG000|Overall Study|ineligible histology|2
7285159|NCT00504309|11501594|FG000|Overall Study|Death|0
7285160|NCT00504309|11501595|FG001|Overall Study|Death|0
7285161|NCT00504309|11501596|FG002|Overall Study|Death|0
7285162|NCT00504309|11501597|FG003|Overall Study|Death|0
7285163|NCT00504309|11501598|FG004|Overall Study|Death|1
7285164|NCT00504309|11501599|FG005|Overall Study|Death|0
7285165|NCT00504309|11501594|FG000|Overall Study|Withdrawal by Subject|0
7285166|NCT00504309|11501595|FG001|Overall Study|Withdrawal by Subject|0
7285167|NCT00504309|11501596|FG002|Overall Study|Withdrawal by Subject|1
7285168|NCT00504309|11501597|FG003|Overall Study|Withdrawal by Subject|0
7285169|NCT00504309|11501598|FG004|Overall Study|Withdrawal by Subject|0
7285170|NCT00504309|11501599|FG005|Overall Study|Withdrawal by Subject|0
7285171|NCT00504348|11501611|FG000|Overall Study|Adverse Event|3
7285172|NCT00504348|11501611|FG000|Overall Study|Lack of Efficacy|4
7285173|NCT00504348|11501611|FG000|Overall Study|Physician Decision|1
7285174|NCT00504426|11501619|FG000|Overall Study|Adverse Event|0
7285175|NCT00504426|11501620|FG001|Overall Study|Adverse Event|0
7285176|NCT00504426|11501621|FG002|Overall Study|Adverse Event|2
7285177|NCT00504426|11501622|FG003|Overall Study|Adverse Event|0
7285178|NCT00504426|11501619|FG000|Overall Study|Protocol Violation|1
7285179|NCT00504426|11501620|FG001|Overall Study|Protocol Violation|1
7285180|NCT00504426|11501621|FG002|Overall Study|Protocol Violation|2
7285181|NCT00504426|11501622|FG003|Overall Study|Protocol Violation|0
7285182|NCT00504426|11501619|FG000|Overall Study|Withdrawal by Subject|2
7285183|NCT00504426|11501620|FG001|Overall Study|Withdrawal by Subject|0
7285184|NCT00504426|11501621|FG002|Overall Study|Withdrawal by Subject|0
7285185|NCT00504426|11501622|FG003|Overall Study|Withdrawal by Subject|0
7285186|NCT00504556|11501644|FG000|Overall Study|Adverse Event|11
7285187|NCT00504556|11501645|FG001|Overall Study|Adverse Event|11
7285188|NCT00504556|11501646|FG002|Overall Study|Adverse Event|14
7285189|NCT00504556|11501647|FG003|Overall Study|Adverse Event|13
7285190|NCT00504556|11501648|FG004|Overall Study|Adverse Event|5
7285191|NCT00504556|11501644|FG000|Overall Study|Death|3
7285192|NCT00504556|11501645|FG001|Overall Study|Death|3
7285193|NCT00504556|11501646|FG002|Overall Study|Death|1
7285194|NCT00504556|11501647|FG003|Overall Study|Death|0
7285195|NCT00504556|11501648|FG004|Overall Study|Death|2
7285196|NCT00504556|11501644|FG000|Overall Study|Protocol Violation|1
7285197|NCT00504556|11501645|FG001|Overall Study|Protocol Violation|3
7285198|NCT00504556|11501646|FG002|Overall Study|Protocol Violation|2
7285199|NCT00504556|11501647|FG003|Overall Study|Protocol Violation|1
7285200|NCT00504556|11501648|FG004|Overall Study|Protocol Violation|2
7285201|NCT00504556|11501644|FG000|Overall Study|Lost to Follow-up|0
7285202|NCT00504556|11501645|FG001|Overall Study|Lost to Follow-up|0
7285203|NCT00504556|11501646|FG002|Overall Study|Lost to Follow-up|1
7285204|NCT00504556|11501647|FG003|Overall Study|Lost to Follow-up|1
7285205|NCT00504556|11501648|FG004|Overall Study|Lost to Follow-up|1
7285206|NCT00504556|11501644|FG000|Overall Study|Withdrawal by Subject|16
7285207|NCT00504556|11501645|FG001|Overall Study|Withdrawal by Subject|16
7285208|NCT00504556|11501646|FG002|Overall Study|Withdrawal by Subject|7
7285209|NCT00504556|11501647|FG003|Overall Study|Withdrawal by Subject|8
7285210|NCT00504556|11501648|FG004|Overall Study|Withdrawal by Subject|12
7285211|NCT00504556|11501644|FG000|Overall Study|administrative reasons|0
7285212|NCT00504556|11501645|FG001|Overall Study|administrative reasons|2
7285213|NCT00504556|11501646|FG002|Overall Study|administrative reasons|2
7285214|NCT00504556|11501647|FG003|Overall Study|administrative reasons|1
7285215|NCT00504556|11501648|FG004|Overall Study|administrative reasons|2
7285216|NCT00504556|11501644|FG000|Overall Study|did not meet entry criteria|2
7285217|NCT00504556|11501645|FG001|Overall Study|did not meet entry criteria|0
7285218|NCT00504556|11501646|FG002|Overall Study|did not meet entry criteria|1
7285219|NCT00504556|11501647|FG003|Overall Study|did not meet entry criteria|1
7285220|NCT00504556|11501648|FG004|Overall Study|did not meet entry criteria|0
7285221|NCT00504556|11501644|FG000|Overall Study|data monitor committee decision|0
7285222|NCT00504556|11501645|FG001|Overall Study|data monitor committee decision|0
7285223|NCT00504556|11501646|FG002|Overall Study|data monitor committee decision|0
7285224|NCT00504556|11501647|FG003|Overall Study|data monitor committee decision|100
7285225|NCT00504556|11501648|FG004|Overall Study|data monitor committee decision|0
7285226|NCT00504556|11501644|FG000|Overall Study|Other|2
7285227|NCT00504556|11501645|FG001|Overall Study|Other|2
7285228|NCT00504556|11501646|FG002|Overall Study|Other|2
7285229|NCT00504556|11501647|FG003|Overall Study|Other|3
7285230|NCT00504556|11501648|FG004|Overall Study|Other|0
7285231|NCT00504556|11501644|FG000|Overall Study|not in safety analysis set|0
7285232|NCT00504556|11501645|FG001|Overall Study|not in safety analysis set|1
7285233|NCT00504556|11501646|FG002|Overall Study|not in safety analysis set|1
7285234|NCT00504556|11501647|FG003|Overall Study|not in safety analysis set|0
7285235|NCT00504556|11501648|FG004|Overall Study|not in safety analysis set|1
7285236|NCT00504595|11501664|FG000|Overall Study|Lack of Efficacy|1
7285237|NCT00504595|11501665|FG001|Overall Study|Lack of Efficacy|0
7285238|NCT00504595|11501666|FG002|Overall Study|Lack of Efficacy|0
7285239|NCT00504595|11501667|FG003|Overall Study|Lack of Efficacy|0
7285240|NCT00504595|11501664|FG000|Overall Study|Other|0
7285241|NCT00504595|11501665|FG001|Overall Study|Other|0
7285242|NCT00504595|11501666|FG002|Overall Study|Other|2
7285243|NCT00504595|11501667|FG003|Overall Study|Other|0
7285244|NCT00504725|11501688|FG000|Overall Study|Protocol Violation|1
7285245|NCT00504725|11501689|FG001|Overall Study|Protocol Violation|0
7285246|NCT00504777|11501699|FG000|Overall Study|Adverse Event|1
7285247|NCT00504829|11501706|FG000|Overall Study|Protocol Violation|6
7285248|NCT00504829|11501707|FG001|Overall Study|Protocol Violation|4
7285249|NCT00504829|11501708|FG002|Overall Study|Protocol Violation|10
7285250|NCT00504881|11501718|FG000|Overall Study|Lack of Efficacy|1
7285251|NCT00504881|11501719|FG001|Overall Study|Lack of Efficacy|5
7285252|NCT00504881|11501718|FG000|Overall Study|Lost to Follow-up|0
7285253|NCT00504881|11501719|FG001|Overall Study|Lost to Follow-up|2
7285254|NCT00504881|11501718|FG000|Overall Study|Withdrawal by Subject|1
7285255|NCT00504881|11501719|FG001|Overall Study|Withdrawal by Subject|4
7285256|NCT00504881|11501718|FG000|Overall Study|Non-Compliance|1
7285257|NCT00504881|11501719|FG001|Overall Study|Non-Compliance|0
7285258|NCT00504881|11501718|FG000|Overall Study|No Birth Control|0
7285259|NCT00504881|11501719|FG001|Overall Study|No Birth Control|1
7285260|NCT00504881|11501718|FG000|Overall Study|Safety Visit not performed|0
7285261|NCT00504881|11501719|FG001|Overall Study|Safety Visit not performed|1
7285262|NCT00504881|11501718|FG000|Overall Study|AE, serious fatal|0
7285263|NCT00504881|11501719|FG001|Overall Study|AE, serious fatal|1
7285264|NCT00504881|11501718|FG000|Overall Study|SAE, non-fatal|2
7285265|NCT00504881|11501719|FG001|Overall Study|SAE, non-fatal|6
7285266|NCT00504881|11501718|FG000|Overall Study|AE, non-serious non-fatal|4
7285267|NCT00504881|11501719|FG001|Overall Study|AE, non-serious non-fatal|14
7285268|NCT00504881|11501718|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
7285269|NCT00504881|11501719|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
7285270|NCT00504881|11501718|FG000|Overall Study|AE of unknown type|1
7285271|NCT00504881|11501719|FG001|Overall Study|AE of unknown type|0
7285272|NCT00504894|11501730|FG000|Overall Study|fMRI technical problems|1
7622822|NCT00599027|12033765|FG001|Overall Study|Withdrawal by Subject|1
7622823|NCT00599027|12033764|FG000|Overall Study|Adverse Event|0
7622824|NCT00599027|12033765|FG001|Overall Study|Adverse Event|1
7622825|NCT00599027|12033764|FG000|Overall Study|Treatment Failure|0
7622826|NCT00599027|12033765|FG001|Overall Study|Treatment Failure|1
7622827|NCT00552032|12033773|FG000|Overall Study|Withdrawal by Subject|2
7622828|NCT00552032|12033774|FG001|Overall Study|Withdrawal by Subject|2
7622829|NCT00552032|12033773|FG000|Overall Study|Protocol Violation|7
7622830|NCT00552032|12033774|FG001|Overall Study|Protocol Violation|12
7622831|NCT00552032|12033773|FG000|Overall Study|Lost to Follow-up|8
7622832|NCT00552032|12033774|FG001|Overall Study|Lost to Follow-up|5
7622833|NCT00546052|12033780|FG000|Overall Study|Adverse Event|47
7622834|NCT00546052|12033780|FG000|Overall Study|Lost to Follow-up|144
7622835|NCT00546052|12033780|FG000|Overall Study|Protocol Violation|9
7285273|NCT00504894|11501731|FG001|Overall Study|fMRI technical problems|1
7285274|NCT00504894|11501732|FG002|Overall Study|fMRI technical problems|0
7285275|NCT00504894|11501730|FG000|Overall Study|Withdrawal by Subject|0
7285276|NCT00504894|11501731|FG001|Overall Study|Withdrawal by Subject|1
7285277|NCT00504894|11501732|FG002|Overall Study|Withdrawal by Subject|0
7285278|NCT00504894|11501730|FG000|Overall Study|Infusion technical problems|0
7285279|NCT00504894|11501731|FG001|Overall Study|Infusion technical problems|1
7285280|NCT00504894|11501732|FG002|Overall Study|Infusion technical problems|0
7285281|NCT00504894|11501730|FG000|Overall Study|poor subject data|2
7285282|NCT00504894|11501731|FG001|Overall Study|poor subject data|0
7285283|NCT00504894|11501732|FG002|Overall Study|poor subject data|0
7285284|NCT00505076|11501743|FG000|Overall Study|Adverse Event|1
7622836|NCT00546052|12033780|FG000|Overall Study|Withdrawal by Subject|20
7622837|NCT00546052|12033780|FG000|Overall Study|Non Compliance|7
7285285|NCT00505076|11501744|FG001|Overall Study|Adverse Event|0
7285286|NCT00505076|11501745|FG002|Overall Study|Adverse Event|1
7285287|NCT00505076|11501743|FG000|Overall Study|Protocol Violation|2
7285288|NCT00505076|11501744|FG001|Overall Study|Protocol Violation|1
7285289|NCT00505076|11501745|FG002|Overall Study|Protocol Violation|2
7285290|NCT00505076|11501743|FG000|Overall Study|Withdrawal by Subject|0
7285291|NCT00505076|11501744|FG001|Overall Study|Withdrawal by Subject|1
7285292|NCT00505076|11501745|FG002|Overall Study|Withdrawal by Subject|2
7285293|NCT00505284|11501758|FG000|Overall Study|Adverse Event|3
7285294|NCT00505284|11501759|FG001|Overall Study|Adverse Event|7
7285295|NCT00505284|11501760|FG002|Overall Study|Adverse Event|9
7285296|NCT00505284|11501761|FG003|Overall Study|Adverse Event|14
7285297|NCT00505284|11501762|FG004|Overall Study|Adverse Event|22
7285298|NCT00505284|11501758|FG000|Overall Study|Protocol Violation|0
7285299|NCT00505284|11501759|FG001|Overall Study|Protocol Violation|1
7285300|NCT00505284|11501760|FG002|Overall Study|Protocol Violation|1
7285301|NCT00505284|11501761|FG003|Overall Study|Protocol Violation|0
7285302|NCT00505284|11501762|FG004|Overall Study|Protocol Violation|0
7285303|NCT00505284|11501758|FG000|Overall Study|Withdrawal by Subject|2
7285304|NCT00505284|11501759|FG001|Overall Study|Withdrawal by Subject|6
7285305|NCT00505284|11501760|FG002|Overall Study|Withdrawal by Subject|1
7285306|NCT00505284|11501761|FG003|Overall Study|Withdrawal by Subject|0
7285307|NCT00505284|11501762|FG004|Overall Study|Withdrawal by Subject|6
7285308|NCT00505284|11501758|FG000|Overall Study|Lack of Efficacy|0
7285309|NCT00505284|11501759|FG001|Overall Study|Lack of Efficacy|1
7285310|NCT00505284|11501760|FG002|Overall Study|Lack of Efficacy|1
7285311|NCT00505284|11501761|FG003|Overall Study|Lack of Efficacy|1
7285312|NCT00505284|11501762|FG004|Overall Study|Lack of Efficacy|1
7285313|NCT00505284|11501758|FG000|Overall Study|Physician Decision|0
7285314|NCT00505284|11501759|FG001|Overall Study|Physician Decision|1
7285315|NCT00505284|11501760|FG002|Overall Study|Physician Decision|0
7285316|NCT00505284|11501761|FG003|Overall Study|Physician Decision|0
7285317|NCT00505284|11501762|FG004|Overall Study|Physician Decision|0
7285318|NCT00505284|11501758|FG000|Overall Study|Other|5
7285319|NCT00505284|11501759|FG001|Overall Study|Other|0
7285320|NCT00505284|11501760|FG002|Overall Study|Other|0
7285321|NCT00505284|11501761|FG003|Overall Study|Other|4
7285322|NCT00505284|11501762|FG004|Overall Study|Other|4
7285323|NCT00505375|11501785|FG000|Overall Study|Death|1
7285324|NCT00505375|11501786|FG001|Overall Study|Death|0
7285325|NCT00505375|11501785|FG000|Overall Study|Withdrawal by Subject|2
7285326|NCT00505375|11501786|FG001|Overall Study|Withdrawal by Subject|2
7285327|NCT00505375|11501785|FG000|Overall Study|Lost to Follow-up|0
7285328|NCT00505375|11501786|FG001|Overall Study|Lost to Follow-up|2
7285329|NCT00505375|11501785|FG000|Overall Study|Pregnancy|1
7285330|NCT00505375|11501786|FG001|Overall Study|Pregnancy|0
7285331|NCT00505375|11501785|FG000|Overall Study|Travel issues|0
7285332|NCT00505375|11501786|FG001|Overall Study|Travel issues|1
7285333|NCT00505414|11501794|FG000|Titration Phase|Adverse Event|0
7285334|NCT00505414|11501795|FG001|Titration Phase|Adverse Event|0
7285335|NCT00505414|11501796|FG002|Titration Phase|Adverse Event|0
7285336|NCT00505414|11501797|FG003|Titration Phase|Adverse Event|8
7285337|NCT00505414|11501798|FG004|Titration Phase|Adverse Event|3
7285338|NCT00505414|11501794|FG000|Titration Phase|Death|0
7285339|NCT00505414|11501795|FG001|Titration Phase|Death|0
7285340|NCT00505414|11501796|FG002|Titration Phase|Death|0
7285341|NCT00505414|11501797|FG003|Titration Phase|Death|2
7285342|NCT00505414|11501798|FG004|Titration Phase|Death|0
7285343|NCT00505414|11501794|FG000|Titration Phase|Lack of Efficacy|0
7285344|NCT00505414|11501795|FG001|Titration Phase|Lack of Efficacy|0
7285345|NCT00505414|11501796|FG002|Titration Phase|Lack of Efficacy|0
7285346|NCT00505414|11501797|FG003|Titration Phase|Lack of Efficacy|10
7285347|NCT00505414|11501798|FG004|Titration Phase|Lack of Efficacy|1
7285348|NCT00505414|11501794|FG000|Titration Phase|Protocol Violation|0
7285349|NCT00505414|11501795|FG001|Titration Phase|Protocol Violation|0
7285350|NCT00505414|11501796|FG002|Titration Phase|Protocol Violation|0
7285351|NCT00505414|11501797|FG003|Titration Phase|Protocol Violation|0
7285352|NCT00505414|11501798|FG004|Titration Phase|Protocol Violation|1
7285353|NCT00505414|11501794|FG000|Titration Phase|Withdrawal by Subject|0
7285354|NCT00505414|11501795|FG001|Titration Phase|Withdrawal by Subject|0
7285355|NCT00505414|11501796|FG002|Titration Phase|Withdrawal by Subject|0
7285356|NCT00505414|11501797|FG003|Titration Phase|Withdrawal by Subject|3
7285357|NCT00505414|11501798|FG004|Titration Phase|Withdrawal by Subject|4
7285358|NCT00505414|11501794|FG000|Titration Phase|Underlying disease and therapy required|0
7285359|NCT00505414|11501795|FG001|Titration Phase|Underlying disease and therapy required|0
7285360|NCT00505414|11501796|FG002|Titration Phase|Underlying disease and therapy required|0
7285361|NCT00505414|11501797|FG003|Titration Phase|Underlying disease and therapy required|7
7285362|NCT00505414|11501798|FG004|Titration Phase|Underlying disease and therapy required|3
7285363|NCT00505414|11501794|FG000|Maintenance Phase|Adverse Event|2
7285364|NCT00505414|11501795|FG001|Maintenance Phase|Adverse Event|2
7285365|NCT00505414|11501796|FG002|Maintenance Phase|Adverse Event|3
7285366|NCT00505414|11501797|FG003|Maintenance Phase|Adverse Event|0
7285367|NCT00505414|11501798|FG004|Maintenance Phase|Adverse Event|0
7285368|NCT00505414|11501794|FG000|Maintenance Phase|Death|2
7285369|NCT00505414|11501795|FG001|Maintenance Phase|Death|0
7285370|NCT00505414|11501796|FG002|Maintenance Phase|Death|1
7285371|NCT00505414|11501797|FG003|Maintenance Phase|Death|0
7285372|NCT00505414|11501798|FG004|Maintenance Phase|Death|0
7285373|NCT00505414|11501794|FG000|Maintenance Phase|Lack of Efficacy|2
7285374|NCT00505414|11501795|FG001|Maintenance Phase|Lack of Efficacy|1
7285375|NCT00505414|11501796|FG002|Maintenance Phase|Lack of Efficacy|1
7285376|NCT00505414|11501797|FG003|Maintenance Phase|Lack of Efficacy|0
7285377|NCT00505414|11501798|FG004|Maintenance Phase|Lack of Efficacy|0
7285378|NCT00505414|11501794|FG000|Maintenance Phase|Withdrawal by Subject|0
7285379|NCT00505414|11501795|FG001|Maintenance Phase|Withdrawal by Subject|0
7285380|NCT00505414|11501796|FG002|Maintenance Phase|Withdrawal by Subject|1
7285381|NCT00505414|11501797|FG003|Maintenance Phase|Withdrawal by Subject|0
7285382|NCT00505414|11501798|FG004|Maintenance Phase|Withdrawal by Subject|0
7285383|NCT00505414|11501794|FG000|Maintenance Phase|underlying disease and therapy required|0
7285384|NCT00505414|11501795|FG001|Maintenance Phase|underlying disease and therapy required|2
7285385|NCT00505414|11501796|FG002|Maintenance Phase|underlying disease and therapy required|2
7285386|NCT00505414|11501797|FG003|Maintenance Phase|underlying disease and therapy required|0
7285387|NCT00505414|11501798|FG004|Maintenance Phase|underlying disease and therapy required|0
7469934|NCT01928381|11771845|FG002|Part 1 - Pain Training|Protocol Violation|0
7469935|NCT01928381|11771846|FG003|Part 1 - Pain Training|Protocol Violation|0
7469936|NCT01928381|11771847|FG004|Part 1 - Pain Training|Protocol Violation|0
7469937|NCT01928381|11771848|FG005|Part 1 - Pain Training|Protocol Violation|0
7469938|NCT01928381|11771849|FG006|Part 1 - Pain Training|Protocol Violation|0
7469939|NCT01928381|11771843|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
7469940|NCT01928381|11771844|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469941|NCT01928381|11771845|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469942|NCT01928381|11771846|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469943|NCT01928381|11771847|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469944|NCT01928381|11771848|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469945|NCT01928381|11771849|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
7469946|NCT01928381|11771843|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
7469947|NCT01928381|11771844|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469948|NCT01928381|11771845|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469949|NCT01928381|11771846|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469950|NCT01928381|11771847|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469951|NCT01928381|11771848|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469952|NCT01928381|11771849|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
7469953|NCT01928381|11771843|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
7469954|NCT01928381|11771844|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469955|NCT01928381|11771845|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469956|NCT01928381|11771846|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469957|NCT01928381|11771847|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469958|NCT01928381|11771848|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469959|NCT01928381|11771849|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
7469960|NCT01928381|11771843|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
7469961|NCT01928381|11771844|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7469962|NCT01928381|11771845|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7622838|NCT00442117|12033789|FG000|Overall Study|Adverse Event|3
7622839|NCT00442117|12033790|FG001|Overall Study|Adverse Event|2
7622840|NCT00442117|12033789|FG000|Overall Study|Lack of Efficacy|2
7622841|NCT00442117|12033790|FG001|Overall Study|Lack of Efficacy|6
7622842|NCT00442117|12033789|FG000|Overall Study|Lost to Follow-up|1
7622843|NCT00442117|12033790|FG001|Overall Study|Lost to Follow-up|2
7622844|NCT00442117|12033789|FG000|Overall Study|Withdrawal by Subject|2
7622845|NCT00442117|12033790|FG001|Overall Study|Withdrawal by Subject|2
7622846|NCT00442117|12033789|FG000|Overall Study|Major Deviation|25
7622847|NCT00442117|12033790|FG001|Overall Study|Major Deviation|20
7622848|NCT00442117|12033789|FG000|Overall Study|Non compliance with protocol|3
7622849|NCT00442117|12033790|FG001|Overall Study|Non compliance with protocol|5
7622850|NCT00442117|12033789|FG000|Overall Study|Met Withdrawal Criteria|2
7622851|NCT00442117|12033790|FG001|Overall Study|Met Withdrawal Criteria|1
7622852|NCT00424008|12033798|FG000|Overall Study|Adverse Event|8
7622853|NCT00424008|12033799|FG001|Overall Study|Adverse Event|6
7622854|NCT00424008|12033798|FG000|Overall Study|Lack of Efficacy|40
7622855|NCT00424008|12033799|FG001|Overall Study|Lack of Efficacy|34
7622856|NCT00424008|12033798|FG000|Overall Study|Lost to Follow-up|1
7622857|NCT00424008|12033799|FG001|Overall Study|Lost to Follow-up|2
7622858|NCT00424008|12033798|FG000|Overall Study|Withdrawal by Subject|5
7622859|NCT00424008|12033799|FG001|Overall Study|Withdrawal by Subject|8
7622860|NCT00424008|12033798|FG000|Overall Study|Noncompliance with protocol|13
7622861|NCT00424008|12033799|FG001|Overall Study|Noncompliance with protocol|7
7622862|NCT00424008|12033798|FG000|Overall Study|Did not meet protocol eligibility|16
7622863|NCT00424008|12033799|FG001|Overall Study|Did not meet protocol eligibility|21
7622864|NCT00424008|12033798|FG000|Overall Study|Administrative|266
7622865|NCT00424008|12033799|FG001|Overall Study|Administrative|257
7622866|NCT00423176|12033808|FG000|Overall Study|Adverse Event|4
7622867|NCT00423176|12033809|FG001|Overall Study|Adverse Event|6
7622868|NCT00423176|12033808|FG000|Overall Study|Treatment Failure|1
7622869|NCT00423176|12033809|FG001|Overall Study|Treatment Failure|6
7622870|NCT00423176|12033808|FG000|Overall Study|Lost to Follow-up|4
7285388|NCT00505622|11501817|FG000|Overall Study|Adverse Event|5
7285389|NCT00505622|11501818|FG001|Overall Study|Adverse Event|6
7285390|NCT00505622|11501819|FG002|Overall Study|Adverse Event|4
7285391|NCT00505622|11501817|FG000|Overall Study|Protocol Violation|1
7285392|NCT00505622|11501818|FG001|Overall Study|Protocol Violation|1
7285393|NCT00505622|11501819|FG002|Overall Study|Protocol Violation|0
7285394|NCT00505622|11501817|FG000|Overall Study|Withdrawal by Subject|0
7285395|NCT00505622|11501818|FG001|Overall Study|Withdrawal by Subject|3
7285396|NCT00505622|11501819|FG002|Overall Study|Withdrawal by Subject|2
7285397|NCT00505622|11501817|FG000|Overall Study|Study termination by sponsor|115
7285398|NCT00505622|11501818|FG001|Overall Study|Study termination by sponsor|98
7285399|NCT00505622|11501819|FG002|Overall Study|Study termination by sponsor|90
7285400|NCT00505661|11501831|FG000|Overall Study|Not Eligible|4
7285401|NCT00505687|11501835|FG000|Overall Study|Important protocol violation|2
7285402|NCT00505687|11501835|FG000|Overall Study|Lack of Efficacy|15
7285403|NCT00505687|11501835|FG000|Overall Study|Adverse Event|48
7285404|NCT00505687|11501835|FG000|Overall Study|Subject withdrew consent|15
7285405|NCT00505687|11501835|FG000|Overall Study|Lost to Follow-up|1
7285406|NCT00505687|11501835|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
7285407|NCT00505687|11501835|FG000|Overall Study|Other: Scheduled DBS Surgery|1
7285408|NCT00505687|11501835|FG000|Overall Study|Other: Prolonged Hospitalization|1
7285409|NCT00505687|11501835|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
7285410|NCT00505687|11501835|FG000|Overall Study|Other: Neupro Given In Hospital|1
7622871|NCT00423176|12033809|FG001|Overall Study|Lost to Follow-up|7
7622872|NCT00423176|12033808|FG000|Overall Study|Withdrawal by Subject|4
7622873|NCT00423176|12033809|FG001|Overall Study|Withdrawal by Subject|3
7622874|NCT00423176|12033808|FG000|Overall Study|Protocol Violation|1
7622875|NCT00423176|12033809|FG001|Overall Study|Protocol Violation|3
7622876|NCT00423176|12033808|FG000|Overall Study|Did not meet protocol eligibility|2
7622877|NCT00423176|12033809|FG001|Overall Study|Did not meet protocol eligibility|4
7622878|NCT00383240|12033819|FG000|Overall Study|Adverse Event|4
7622879|NCT00383240|12033820|FG001|Overall Study|Adverse Event|6
7622880|NCT00383240|12033821|FG002|Overall Study|Adverse Event|9
7622881|NCT00383240|12033822|FG003|Overall Study|Adverse Event|7
7622882|NCT00383240|12033819|FG000|Overall Study|Treatment Failure|8
7622883|NCT00383240|12033820|FG001|Overall Study|Treatment Failure|13
7622884|NCT00383240|12033821|FG002|Overall Study|Treatment Failure|47
7622885|NCT00383240|12033822|FG003|Overall Study|Treatment Failure|46
7622886|NCT00383240|12033819|FG000|Overall Study|Lost to Follow-up|3
7622887|NCT00383240|12033820|FG001|Overall Study|Lost to Follow-up|0
7622888|NCT00383240|12033821|FG002|Overall Study|Lost to Follow-up|0
7622889|NCT00383240|12033822|FG003|Overall Study|Lost to Follow-up|2
7622890|NCT00383240|12033819|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
7622891|NCT00383240|12033820|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
7622892|NCT00383240|12033821|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
7622893|NCT00383240|12033822|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
7622894|NCT00383240|12033819|FG000|Overall Study|Withdrawal by subjects, reasons related|0
7622895|NCT00383240|12033820|FG001|Overall Study|Withdrawal by subjects, reasons related|1
7622896|NCT00383240|12033821|FG002|Overall Study|Withdrawal by subjects, reasons related|3
7622897|NCT00383240|12033822|FG003|Overall Study|Withdrawal by subjects, reasons related|5
7285411|NCT00505687|11501835|FG000|Overall Study|Other: Disease Progression|1
7285412|NCT00505687|11501835|FG000|Overall Study|Other: As Per Sponsor|8
7285413|NCT00505752|11501843|FG000|Overall Study|Adverse Event|1
7285414|NCT00505752|11501844|FG001|Overall Study|Adverse Event|0
7285415|NCT00505752|11501845|FG002|Overall Study|Adverse Event|1
7285416|NCT00505752|11501846|FG003|Overall Study|Adverse Event|0
7285417|NCT00505752|11501843|FG000|Overall Study|Lost to Follow-up|1
7285418|NCT00505752|11501844|FG001|Overall Study|Lost to Follow-up|0
7285419|NCT00505752|11501845|FG002|Overall Study|Lost to Follow-up|0
7285420|NCT00505752|11501846|FG003|Overall Study|Lost to Follow-up|0
7285421|NCT00505752|11501843|FG000|Overall Study|Lack of ovarian response|1
7285422|NCT00505752|11501844|FG001|Overall Study|Lack of ovarian response|3
7285423|NCT00505752|11501845|FG002|Overall Study|Lack of ovarian response|0
7285424|NCT00505752|11501846|FG003|Overall Study|Lack of ovarian response|0
7285425|NCT00505752|11501843|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
7285426|NCT00505752|11501844|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
7285427|NCT00505752|11501845|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
7285428|NCT00505752|11501846|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
7285429|NCT00505752|11501843|FG000|Overall Study|No oocytes retrieved|0
7285430|NCT00505752|11501844|FG001|Overall Study|No oocytes retrieved|2
7285431|NCT00505752|11501845|FG002|Overall Study|No oocytes retrieved|0
7285432|NCT00505752|11501846|FG003|Overall Study|No oocytes retrieved|1
7285433|NCT00505752|11501843|FG000|Overall Study|No Fertilization|1
7285434|NCT00505752|11501844|FG001|Overall Study|No Fertilization|1
7285435|NCT00505752|11501845|FG002|Overall Study|No Fertilization|2
7285436|NCT00505752|11501846|FG003|Overall Study|No Fertilization|1
7285437|NCT00505752|11501843|FG000|Overall Study|All embryos/blastocysts discarded|0
7285438|NCT00505752|11501844|FG001|Overall Study|All embryos/blastocysts discarded|0
7622898|NCT00383240|12033819|FG000|Overall Study|Protocol Violation|4
7622899|NCT00383240|12033820|FG001|Overall Study|Protocol Violation|5
7622900|NCT00383240|12033821|FG002|Overall Study|Protocol Violation|9
7285439|NCT00505752|11501845|FG002|Overall Study|All embryos/blastocysts discarded|1
7285440|NCT00505752|11501846|FG003|Overall Study|All embryos/blastocysts discarded|1
7285441|NCT00505752|11501843|FG000|Overall Study|Other|1
7285442|NCT00505752|11501844|FG001|Overall Study|Other|2
7285443|NCT00505752|11501845|FG002|Overall Study|Other|1
7285444|NCT00505752|11501846|FG003|Overall Study|Other|2
7285445|NCT00505765|11501859|FG000|Overall Study|Withdrawal by Subject|1
7285446|NCT00505765|11501860|FG001|Overall Study|Withdrawal by Subject|0
7285447|NCT00505765|11501861|FG002|Overall Study|Withdrawal by Subject|0
7285448|NCT00505765|11501859|FG000|Overall Study|Adverse Event|1
7285449|NCT00505765|11501860|FG001|Overall Study|Adverse Event|2
7285450|NCT00505765|11501861|FG002|Overall Study|Adverse Event|0
7285451|NCT00505765|11501859|FG000|Overall Study|Noncompliance|0
7285452|NCT00505765|11501860|FG001|Overall Study|Noncompliance|1
7285453|NCT00505765|11501861|FG002|Overall Study|Noncompliance|3
7285454|NCT00505778|11501871|FG000|Overall Study|Adverse Event|2
7285455|NCT00505778|11501872|FG001|Overall Study|Adverse Event|7
7285456|NCT00505778|11501871|FG000|Overall Study|Physician Decision|8
7285457|NCT00505778|11501872|FG001|Overall Study|Physician Decision|14
7285458|NCT00505778|11501871|FG000|Overall Study|Lost to Follow-up|17
7285459|NCT00505778|11501872|FG001|Overall Study|Lost to Follow-up|23
7285460|NCT00505778|11501871|FG000|Overall Study|Unable to Meet Protocol Criteria|4
7285461|NCT00505778|11501872|FG001|Overall Study|Unable to Meet Protocol Criteria|1
7285462|NCT00505778|11501871|FG000|Overall Study|Protocol Violation|7
7285463|NCT00505778|11501872|FG001|Overall Study|Protocol Violation|9
7285464|NCT00505778|11501871|FG000|Overall Study|Withdrawal by Subject|29
7285465|NCT00505778|11501872|FG001|Overall Study|Withdrawal by Subject|14
7285466|NCT00505778|11501871|FG000|Overall Study|Relapse|65
7285467|NCT00505778|11501872|FG001|Overall Study|Relapse|65
7285468|NCT00505778|11501871|FG000|Overall Study|Took No Study Drug|2
7285469|NCT00505778|11501872|FG001|Overall Study|Took No Study Drug|2
7285470|NCT00505921|11501887|FG000|Overall Study|Ineligible|1
7285471|NCT00505921|11501887|FG000|Overall Study|Failed to Mobilize|8
7285472|NCT00505934|11501891|FG000|Overall Study|Adverse Event|1
7285473|NCT00505934|11501891|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
7285474|NCT00505934|11501891|FG000|Overall Study|Other: IV dose needed to be changed|1
7285475|NCT00506077|11501910|FG000|Treatment Period 1|Adverse Event|2
7285476|NCT00506077|11501911|FG001|Treatment Period 1|Adverse Event|1
7285477|NCT00506077|11501910|FG000|Treatment Period 1|Lost to Follow-up|0
7285478|NCT00506077|11501911|FG001|Treatment Period 1|Lost to Follow-up|2
7285479|NCT00506077|11501910|FG000|Treatment Period 1|Withdrawal by Subject|2
7285480|NCT00506077|11501911|FG001|Treatment Period 1|Withdrawal by Subject|0
7285481|NCT00506077|11501910|FG000|Treatment Period 2|Adverse Event|0
7285482|NCT00506077|11501911|FG001|Treatment Period 2|Adverse Event|1
7285483|NCT00506077|11501910|FG000|Treatment Period 2|Withdrawal by Subject|1
7285484|NCT00506077|11501911|FG001|Treatment Period 2|Withdrawal by Subject|0
7285485|NCT00506129|11501917|FG000|Overall Study|Disease Progression/Relapse|15
7285486|NCT00506129|11501917|FG000|Overall Study|Death|7
7285487|NCT00506142|11501923|FG000|Overall Study|Adverse Event|8
7285488|NCT00506142|11501924|FG001|Overall Study|Adverse Event|7
7285489|NCT00506142|11501923|FG000|Overall Study|Lack of Efficacy|21
7285490|NCT00506142|11501924|FG001|Overall Study|Lack of Efficacy|7
7285491|NCT00506142|11501923|FG000|Overall Study|Withdrawal by Subject|4
7285492|NCT00506142|11501924|FG001|Overall Study|Withdrawal by Subject|5
7285493|NCT00506142|11501923|FG000|Overall Study|Physician Decision|1
7622901|NCT00383240|12033822|FG003|Overall Study|Protocol Violation|6
7622902|NCT00383240|12033819|FG000|Overall Study|Did not meet protocol eligibility|9
7622903|NCT00383240|12033820|FG001|Overall Study|Did not meet protocol eligibility|4
7622904|NCT00383240|12033821|FG002|Overall Study|Did not meet protocol eligibility|9
7622905|NCT00383240|12033822|FG003|Overall Study|Did not meet protocol eligibility|3
7622906|NCT00383240|12033819|FG000|Overall Study|Administrative|1
7622907|NCT00383240|12033820|FG001|Overall Study|Administrative|1
7622908|NCT00383240|12033821|FG002|Overall Study|Administrative|0
7622909|NCT00383240|12033822|FG003|Overall Study|Administrative|0
7285494|NCT00506142|11501924|FG001|Overall Study|Physician Decision|0
7285495|NCT00506142|11501923|FG000|Overall Study|New health condition|1
7285496|NCT00506142|11501924|FG001|Overall Study|New health condition|0
7285497|NCT00506285|11501936|FG000|3 Week Screening Phase|Withdrawal by Subject|17
7285498|NCT00506285|11501937|FG001|3 Week Screening Phase|Withdrawal by Subject|10
7285499|NCT00506285|11501936|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
7285500|NCT00506285|11501937|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
7285501|NCT00506285|11501936|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
7285502|NCT00506285|11501937|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
7285503|NCT00506285|11501936|FG000|6-month Open Label Phase|Lost to Follow-up|1
7285504|NCT00506285|11501937|FG001|6-month Open Label Phase|Lost to Follow-up|7
7285505|NCT00506285|11501936|FG000|6-month Open Label Phase|Withdrawal by Subject|9
7285506|NCT00506285|11501937|FG001|6-month Open Label Phase|Withdrawal by Subject|5
7285507|NCT00506350|11501954|FG000|Overall Study|Serious Adverse Event|1
7285508|NCT00506350|11501955|FG001|Overall Study|Serious Adverse Event|0
7285509|NCT00506350|11501956|FG002|Overall Study|Serious Adverse Event|0
7285510|NCT00506350|11501957|FG003|Overall Study|Serious Adverse Event|0
7285511|NCT00506350|11501958|FG004|Overall Study|Serious Adverse Event|0
7285512|NCT00506350|11501959|FG005|Overall Study|Serious Adverse Event|0
7285513|NCT00506350|11501960|FG006|Overall Study|Serious Adverse Event|0
7285514|NCT00506350|11501961|FG007|Overall Study|Serious Adverse Event|0
7285515|NCT00506350|11501962|FG008|Overall Study|Serious Adverse Event|0
7285516|NCT00506350|11501954|FG000|Overall Study|Adverse Event|0
7285517|NCT00506350|11501955|FG001|Overall Study|Adverse Event|0
7285518|NCT00506350|11501956|FG002|Overall Study|Adverse Event|0
7285519|NCT00506350|11501957|FG003|Overall Study|Adverse Event|0
7285520|NCT00506350|11501958|FG004|Overall Study|Adverse Event|0
7285521|NCT00506350|11501959|FG005|Overall Study|Adverse Event|0
7285522|NCT00506350|11501960|FG006|Overall Study|Adverse Event|0
7285523|NCT00506350|11501961|FG007|Overall Study|Adverse Event|1
7285524|NCT00506350|11501962|FG008|Overall Study|Adverse Event|1
7285525|NCT00506350|11501954|FG000|Overall Study|Protocol Violation|0
7285526|NCT00506350|11501955|FG001|Overall Study|Protocol Violation|0
7285527|NCT00506350|11501956|FG002|Overall Study|Protocol Violation|1
7285528|NCT00506350|11501957|FG003|Overall Study|Protocol Violation|0
7285529|NCT00506350|11501958|FG004|Overall Study|Protocol Violation|0
7285530|NCT00506350|11501959|FG005|Overall Study|Protocol Violation|0
7285531|NCT00506350|11501960|FG006|Overall Study|Protocol Violation|1
7285532|NCT00506350|11501961|FG007|Overall Study|Protocol Violation|0
7285533|NCT00506350|11501962|FG008|Overall Study|Protocol Violation|0
7285534|NCT00506350|11501954|FG000|Overall Study|Withdrawal by Subject|0
7285535|NCT00506350|11501955|FG001|Overall Study|Withdrawal by Subject|1
7285536|NCT00506350|11501956|FG002|Overall Study|Withdrawal by Subject|1
7285537|NCT00506350|11501957|FG003|Overall Study|Withdrawal by Subject|1
7285538|NCT00506350|11501958|FG004|Overall Study|Withdrawal by Subject|4
7285539|NCT00506350|11501959|FG005|Overall Study|Withdrawal by Subject|1
7285540|NCT00506350|11501960|FG006|Overall Study|Withdrawal by Subject|1
7285541|NCT00506350|11501961|FG007|Overall Study|Withdrawal by Subject|2
7285542|NCT00506350|11501962|FG008|Overall Study|Withdrawal by Subject|0
7285543|NCT00506350|11501954|FG000|Overall Study|Lost to Follow-up|1
7285544|NCT00506350|11501955|FG001|Overall Study|Lost to Follow-up|1
7285545|NCT00506350|11501956|FG002|Overall Study|Lost to Follow-up|1
7285546|NCT00506350|11501957|FG003|Overall Study|Lost to Follow-up|1
7285547|NCT00506350|11501958|FG004|Overall Study|Lost to Follow-up|2
7285548|NCT00506350|11501959|FG005|Overall Study|Lost to Follow-up|1
7285549|NCT00506350|11501960|FG006|Overall Study|Lost to Follow-up|0
7285550|NCT00506350|11501961|FG007|Overall Study|Lost to Follow-up|0
7285551|NCT00506350|11501962|FG008|Overall Study|Lost to Follow-up|2
7285552|NCT00506350|11501954|FG000|Overall Study|Medical Reason|0
7285553|NCT00506350|11501955|FG001|Overall Study|Medical Reason|0
7285554|NCT00506350|11501956|FG002|Overall Study|Medical Reason|0
7285555|NCT00506350|11501957|FG003|Overall Study|Medical Reason|0
7285556|NCT00506350|11501958|FG004|Overall Study|Medical Reason|1
7285557|NCT00506350|11501959|FG005|Overall Study|Medical Reason|0
7285558|NCT00506350|11501960|FG006|Overall Study|Medical Reason|0
7285559|NCT00506350|11501961|FG007|Overall Study|Medical Reason|0
7285560|NCT00506350|11501962|FG008|Overall Study|Medical Reason|0
7285561|NCT00506350|11501954|FG000|Overall Study|Other|1
7285562|NCT00506350|11501955|FG001|Overall Study|Other|1
7285563|NCT00506350|11501956|FG002|Overall Study|Other|3
7285564|NCT00506350|11501957|FG003|Overall Study|Other|0
7285565|NCT00506350|11501958|FG004|Overall Study|Other|3
7285566|NCT00506350|11501959|FG005|Overall Study|Other|0
7285567|NCT00506350|11501960|FG006|Overall Study|Other|0
7285568|NCT00506350|11501961|FG007|Overall Study|Other|2
7285569|NCT00506350|11501962|FG008|Overall Study|Other|2
7285570|NCT00506389|11501992|FG000|In-treatment Period|Other|3
7285571|NCT00506389|11501993|FG001|In-treatment Period|Other|3
7285572|NCT00506389|11501994|FG002|In-treatment Period|Other|4
7285573|NCT00506389|11501992|FG000|In-treatment Period|Lost to Follow-up|0
7285574|NCT00506389|11501993|FG001|In-treatment Period|Lost to Follow-up|0
7285575|NCT00506389|11501994|FG002|In-treatment Period|Lost to Follow-up|1
7285576|NCT00506389|11501992|FG000|In-treatment Period|Lack of compliance|1
7285577|NCT00506389|11501993|FG001|In-treatment Period|Lack of compliance|0
7285578|NCT00506389|11501994|FG002|In-treatment Period|Lack of compliance|0
7285579|NCT00506389|11501992|FG000|In-treatment Period|Reasons not related to trial|4
7285580|NCT00506389|11501993|FG001|In-treatment Period|Reasons not related to trial|1
7285581|NCT00506389|11501994|FG002|In-treatment Period|Reasons not related to trial|0
7285582|NCT00506389|11501992|FG000|In-treatment Period|Withdrawal by Subject|3
7285583|NCT00506389|11501993|FG001|In-treatment Period|Withdrawal by Subject|3
7285584|NCT00506389|11501994|FG002|In-treatment Period|Withdrawal by Subject|4
7285585|NCT00506389|11501992|FG000|In-treatment Period|Lack of Efficacy|0
7285586|NCT00506389|11501993|FG001|In-treatment Period|Lack of Efficacy|2
7285587|NCT00506389|11501994|FG002|In-treatment Period|Lack of Efficacy|0
7285588|NCT00506389|11501992|FG000|In-treatment Period|Adverse Event|11
7285589|NCT00506389|11501993|FG001|In-treatment Period|Adverse Event|5
7285590|NCT00506389|11501994|FG002|In-treatment Period|Adverse Event|2
7285591|NCT00506389|11501992|FG000|In-treatment Period|Randomized but not treated|4
7285592|NCT00506389|11501993|FG001|In-treatment Period|Randomized but not treated|1
7285593|NCT00506389|11501994|FG002|In-treatment Period|Randomized but not treated|1
7285594|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
7285595|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7285596|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7285597|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
7285598|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
7285599|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7285600|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7285601|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
7285602|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
7285603|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7285604|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7285605|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
7285606|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
7285607|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285608|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285609|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285610|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
7285611|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285612|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285613|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285614|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
7285615|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285616|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285617|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285618|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
7285619|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7285620|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7285621|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
7285622|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
7285623|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
7285624|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
7285625|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
7285626|NCT00506415|11502005|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
7285627|NCT00506415|11502006|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285628|NCT00506415|11502007|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285629|NCT00506415|11502008|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285630|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7285631|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
7285632|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
7285633|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
7285634|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Death|0
7285635|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Death|5
7285636|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Death|3
7285637|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Death|0
7285638|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7285639|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7285640|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
7285641|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
7285642|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7285643|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
7285644|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
7285645|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
7285646|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7285647|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
7285648|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
7285649|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
7285650|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7285651|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
7285652|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
7285653|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
7285654|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7285655|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
7285656|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
7285657|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
7285658|NCT00506415|11502005|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7285659|NCT00506415|11502006|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7285660|NCT00506415|11502007|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
7285661|NCT00506415|11502008|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
7285662|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7285663|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7285664|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
7285665|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
7285666|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7285667|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7285668|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
7285669|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
7285670|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285671|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285672|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
7285673|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
7285674|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285675|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285676|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
7285677|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
7285678|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285679|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285680|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
7285681|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
7285682|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285683|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285684|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
7285685|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
7285686|NCT00506415|11502005|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
7285687|NCT00506415|11502006|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
7285688|NCT00506415|11502007|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
7285689|NCT00506415|11502008|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
7285690|NCT00506441|11502021|FG000|Period 1; Open-label Period|Adverse Event|21
7285691|NCT00506441|11502022|FG001|Period 1; Open-label Period|Adverse Event|0
7285692|NCT00506441|11502021|FG000|Period 1; Open-label Period|Lack of Efficacy|13
7285693|NCT00506441|11502022|FG001|Period 1; Open-label Period|Lack of Efficacy|0
7285694|NCT00506441|11502021|FG000|Period 1; Open-label Period|Lost to Follow-up|2
7285695|NCT00506441|11502022|FG001|Period 1; Open-label Period|Lost to Follow-up|0
7285696|NCT00506441|11502021|FG000|Period 1; Open-label Period|Physician Decision|5
7285697|NCT00506441|11502022|FG001|Period 1; Open-label Period|Physician Decision|0
7285698|NCT00506441|11502021|FG000|Period 1; Open-label Period|Protocol Violation|9
7285699|NCT00506441|11502022|FG001|Period 1; Open-label Period|Protocol Violation|0
7285700|NCT00506441|11502021|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
7285701|NCT00506441|11502022|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
7285702|NCT00506441|11502021|FG000|Period 1; Open-label Period|Other Reasons|13
7285703|NCT00506441|11502022|FG001|Period 1; Open-label Period|Other Reasons|0
7285704|NCT00506441|11502021|FG000|Period 2; Double-blind Period|Adverse Event|0
7285705|NCT00506441|11502022|FG001|Period 2; Double-blind Period|Adverse Event|1
7285706|NCT00506441|11502021|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
7285707|NCT00506441|11502022|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
7285708|NCT00506441|11502021|FG000|Period 2; Double-blind Period|Physician Decision|1
7285709|NCT00506441|11502022|FG001|Period 2; Double-blind Period|Physician Decision|1
7285710|NCT00506441|11502021|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
7285711|NCT00506441|11502022|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
7285712|NCT00506441|11502021|FG000|Period 2; Double-blind Period|Other Reason|1
7285713|NCT00506441|11502022|FG001|Period 2; Double-blind Period|Other Reason|1
7285714|NCT00506454|11502032|FG000|Overall Study|Withdrawal by Subject|1
7285715|NCT00506454|11502033|FG001|Overall Study|Withdrawal by Subject|1
7285716|NCT00506493|11502039|FG000|Overall Study|Death|6
7285717|NCT00506493|11502039|FG000|Overall Study|Withdrawal by Subject|5
7285718|NCT00506519|11502048|FG000|Overall Study|Death|4
7285719|NCT00506519|11502049|FG001|Overall Study|Death|6
7285720|NCT00506519|11502050|FG002|Overall Study|Death|0
7285721|NCT00506519|11502048|FG000|Overall Study|Adverse Event|1
7285722|NCT00506519|11502049|FG001|Overall Study|Adverse Event|0
7285723|NCT00506519|11502050|FG002|Overall Study|Adverse Event|0
7285724|NCT00506662|11502067|FG000|Overall Study|Adverse Event|0
7285725|NCT00506662|11502068|FG001|Overall Study|Adverse Event|2
7285726|NCT00506662|11502067|FG000|Overall Study|Lack of Efficacy|1
7285727|NCT00506662|11502068|FG001|Overall Study|Lack of Efficacy|0
7285728|NCT00506662|11502067|FG000|Overall Study|Protocol Violation|2
7285729|NCT00506662|11502068|FG001|Overall Study|Protocol Violation|4
7285730|NCT00506662|11502067|FG000|Overall Study|Trial terminated|10
7285731|NCT00506662|11502068|FG001|Overall Study|Trial terminated|16
7285732|NCT00506662|11502067|FG000|Overall Study|Not recorded|4
7285733|NCT00506662|11502068|FG001|Overall Study|Not recorded|6
7285734|NCT00506753|11502096|FG000|Overall Study|Lost to Follow-up|21
7285735|NCT00506753|11502097|FG001|Overall Study|Lost to Follow-up|15
7285736|NCT00506779|11502105|FG000|Overall Study|Withdrawal by Subject|1
7285737|NCT00506779|11502106|FG001|Overall Study|Withdrawal by Subject|0
7285738|NCT00506779|11502107|FG002|Overall Study|Withdrawal by Subject|1
7285739|NCT00506779|11502108|FG003|Overall Study|Withdrawal by Subject|0
7285740|NCT00506779|11502105|FG000|Overall Study|Adverse Event|0
7285741|NCT00506779|11502106|FG001|Overall Study|Adverse Event|1
7285742|NCT00506779|11502107|FG002|Overall Study|Adverse Event|1
7285743|NCT00506779|11502108|FG003|Overall Study|Adverse Event|1
7285744|NCT00506831|11502119|FG000|Overall Study|Death|1
7285745|NCT00506831|11502119|FG000|Overall Study|Withdrawal by Subject|1
7285746|NCT00506883|11502131|FG000|Overall Study|Lost to Follow-up|1
7285747|NCT00506883|11502132|FG001|Overall Study|Lost to Follow-up|1
7285748|NCT00506883|11502133|FG002|Overall Study|Lost to Follow-up|1
7285749|NCT00506883|11502131|FG000|Overall Study|Withdrawal by Subject|1
7285750|NCT00506883|11502132|FG001|Overall Study|Withdrawal by Subject|0
7285751|NCT00506883|11502133|FG002|Overall Study|Withdrawal by Subject|1
7285752|NCT00506883|11502131|FG000|Overall Study|Lack of Efficacy|0
7285753|NCT00506883|11502132|FG001|Overall Study|Lack of Efficacy|1
7285754|NCT00506883|11502133|FG002|Overall Study|Lack of Efficacy|1
7285755|NCT00506883|11502131|FG000|Overall Study|Other|5
7285756|NCT00506883|11502132|FG001|Overall Study|Other|1
7285757|NCT00506883|11502133|FG002|Overall Study|Other|1
7285758|NCT00506922|11502146|FG000|Overall Study|Physician Decision|0
7285759|NCT00506922|11502147|FG001|Overall Study|Physician Decision|0
7285760|NCT00506922|11502148|FG002|Overall Study|Physician Decision|0
7285761|NCT00506922|11502149|FG003|Overall Study|Physician Decision|2
7285762|NCT00506922|11502150|FG004|Overall Study|Physician Decision|0
7285763|NCT00506922|11502146|FG000|Overall Study|Withdrawal by Subject|0
7285764|NCT00506922|11502147|FG001|Overall Study|Withdrawal by Subject|0
7285765|NCT00506922|11502148|FG002|Overall Study|Withdrawal by Subject|0
7285766|NCT00506922|11502149|FG003|Overall Study|Withdrawal by Subject|0
7285767|NCT00506922|11502150|FG004|Overall Study|Withdrawal by Subject|1
7285768|NCT00506948|11502158|FG000|Overall Study|Death|4
7285769|NCT00506948|11502158|FG000|Overall Study|Adverse Event|5
7285770|NCT00506948|11502158|FG000|Overall Study|Physician Decision|1
7285771|NCT00507026|11502165|FG000|Overall Study|Lack of Efficacy|6
7285772|NCT00507026|11502166|FG001|Overall Study|Lack of Efficacy|4
7285773|NCT00507026|11502167|FG002|Overall Study|Lack of Efficacy|21
7285774|NCT00507026|11502165|FG000|Overall Study|Withdrawal by Subject|2
7285775|NCT00507026|11502166|FG001|Overall Study|Withdrawal by Subject|0
7285776|NCT00507026|11502167|FG002|Overall Study|Withdrawal by Subject|0
7285777|NCT00507026|11502165|FG000|Overall Study|Investigator Decision|1
7285778|NCT00507026|11502166|FG001|Overall Study|Investigator Decision|0
7285779|NCT00507026|11502167|FG002|Overall Study|Investigator Decision|0
7285780|NCT00507026|11502165|FG000|Overall Study|Adverse Event|2
7285781|NCT00507026|11502166|FG001|Overall Study|Adverse Event|0
7285782|NCT00507026|11502167|FG002|Overall Study|Adverse Event|0
7285783|NCT00507026|11502165|FG000|Overall Study|Protocol Violation|1
7285784|NCT00507026|11502166|FG001|Overall Study|Protocol Violation|0
7285785|NCT00507026|11502167|FG002|Overall Study|Protocol Violation|0
7285786|NCT00507026|11502165|FG000|Overall Study|Other|1
7285787|NCT00507026|11502166|FG001|Overall Study|Other|0
7285788|NCT00507026|11502167|FG002|Overall Study|Other|0
7285789|NCT00507130|11502179|FG000|Overall Study|Lost to Follow-up|0
7285790|NCT00507130|11502180|FG001|Overall Study|Lost to Follow-up|0
7285791|NCT00507130|11502181|FG002|Overall Study|Lost to Follow-up|1
7285792|NCT00507130|11502182|FG003|Overall Study|Lost to Follow-up|1
7285793|NCT00507130|11502179|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
7285794|NCT00507130|11502180|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7285795|NCT00507130|11502181|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7285796|NCT00507130|11502182|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
7285797|NCT00507416|11502204|FG000|Overall Study|Adverse Event|58
7285798|NCT00507416|11502205|FG001|Overall Study|Adverse Event|67
7285799|NCT00507416|11502206|FG002|Overall Study|Adverse Event|65
7285800|NCT00507416|11502204|FG000|Overall Study|Protocol Violation|1
7285801|NCT00507416|11502205|FG001|Overall Study|Protocol Violation|2
7285802|NCT00507416|11502206|FG002|Overall Study|Protocol Violation|0
7285803|NCT00507416|11502204|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
7285804|NCT00507416|11502205|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
7285805|NCT00507416|11502206|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
7285806|NCT00507416|11502204|FG000|Overall Study|Progressive Disease|20
7285807|NCT00507416|11502205|FG001|Overall Study|Progressive Disease|10
7285808|NCT00507416|11502206|FG002|Overall Study|Progressive Disease|13
7285809|NCT00507416|11502204|FG000|Overall Study|Patient declined further treatment|18
7285810|NCT00507416|11502205|FG001|Overall Study|Patient declined further treatment|14
7285811|NCT00507416|11502206|FG002|Overall Study|Patient declined further treatment|11
7285812|NCT00507416|11502204|FG000|Overall Study|Other|11
7285813|NCT00507416|11502205|FG001|Overall Study|Other|16
7285814|NCT00507416|11502206|FG002|Overall Study|Other|13
7285815|NCT00507416|11502204|FG000|Overall Study|Did not Receive Study Treatment|3
7285816|NCT00507416|11502205|FG001|Overall Study|Did not Receive Study Treatment|9
7285817|NCT00507416|11502206|FG002|Overall Study|Did not Receive Study Treatment|4
7285818|NCT00507429|11502216|FG000|Treatment Phase|Disease Progression|12
7285819|NCT00507429|11502217|FG001|Treatment Phase|Disease Progression|5
7285820|NCT00507429|11502216|FG000|Treatment Phase|Adverse Event|12
7285821|NCT00507429|11502217|FG001|Treatment Phase|Adverse Event|5
7285822|NCT00507429|11502216|FG000|Treatment Phase|Withdrawal by Subject|3
7285823|NCT00507429|11502217|FG001|Treatment Phase|Withdrawal by Subject|3
7285824|NCT00507429|11502216|FG000|Treatment Phase|Physician Decision|4
7285825|NCT00507429|11502217|FG001|Treatment Phase|Physician Decision|2
7285826|NCT00507429|11502216|FG000|Treatment Phase|Other|6
7285827|NCT00507429|11502217|FG001|Treatment Phase|Other|3
7285828|NCT00507429|11502216|FG000|Maintenance Phase|Progressive Disease|14
7285829|NCT00507429|11502217|FG001|Maintenance Phase|Progressive Disease|0
7285830|NCT00507442|11502229|FG000|Overall Study|Adverse Event|8
7285831|NCT00507442|11502230|FG001|Overall Study|Adverse Event|11
7285832|NCT00507442|11502231|FG002|Overall Study|Adverse Event|4
7285833|NCT00507442|11502232|FG003|Overall Study|Adverse Event|1
7285834|NCT00507442|11502229|FG000|Overall Study|Protocol Violation|0
7285835|NCT00507442|11502230|FG001|Overall Study|Protocol Violation|1
7285836|NCT00507442|11502231|FG002|Overall Study|Protocol Violation|0
7285837|NCT00507442|11502232|FG003|Overall Study|Protocol Violation|0
7285838|NCT00507442|11502229|FG000|Overall Study|Lost to Follow-up|0
7285839|NCT00507442|11502230|FG001|Overall Study|Lost to Follow-up|0
7285840|NCT00507442|11502231|FG002|Overall Study|Lost to Follow-up|1
7285841|NCT00507442|11502232|FG003|Overall Study|Lost to Follow-up|0
7285842|NCT00507442|11502229|FG000|Overall Study|Physician Decision|0
7285843|NCT00507442|11502230|FG001|Overall Study|Physician Decision|2
7285844|NCT00507442|11502231|FG002|Overall Study|Physician Decision|4
7285845|NCT00507442|11502232|FG003|Overall Study|Physician Decision|1
7285846|NCT00507442|11502229|FG000|Overall Study|Progressive Disease|2
7285847|NCT00507442|11502230|FG001|Overall Study|Progressive Disease|4
7285848|NCT00507442|11502231|FG002|Overall Study|Progressive Disease|2
7285849|NCT00507442|11502232|FG003|Overall Study|Progressive Disease|0
7285850|NCT00507442|11502229|FG000|Overall Study|Withdrawal by Subject|4
7285851|NCT00507442|11502230|FG001|Overall Study|Withdrawal by Subject|4
7285852|NCT00507442|11502231|FG002|Overall Study|Withdrawal by Subject|2
7285853|NCT00507442|11502232|FG003|Overall Study|Withdrawal by Subject|1
7285854|NCT00507442|11502229|FG000|Overall Study|Other|2
7285855|NCT00507442|11502230|FG001|Overall Study|Other|5
7285856|NCT00507442|11502231|FG002|Overall Study|Other|2
7285857|NCT00507442|11502232|FG003|Overall Study|Other|2
7285858|NCT00507455|11502249|FG000|Overall Study|Adverse Event|3
7285859|NCT00507455|11502250|FG001|Overall Study|Adverse Event|3
7285860|NCT00507455|11502251|FG002|Overall Study|Adverse Event|6
7285861|NCT00507455|11502249|FG000|Overall Study|Withdrawal by Subject|2
7285862|NCT00507455|11502250|FG001|Overall Study|Withdrawal by Subject|1
7285863|NCT00507455|11502251|FG002|Overall Study|Withdrawal by Subject|2
7285864|NCT00507455|11502249|FG000|Overall Study|Protocol Violation|4
7285865|NCT00507455|11502250|FG001|Overall Study|Protocol Violation|1
7285866|NCT00507455|11502251|FG002|Overall Study|Protocol Violation|1
7285867|NCT00507455|11502249|FG000|Overall Study|Lost to Follow-up|2
7285868|NCT00507455|11502250|FG001|Overall Study|Lost to Follow-up|0
7285869|NCT00507455|11502251|FG002|Overall Study|Lost to Follow-up|2
7285870|NCT00507455|11502249|FG000|Overall Study|Lack of Efficacy|0
7285871|NCT00507455|11502250|FG001|Overall Study|Lack of Efficacy|1
7285872|NCT00507455|11502251|FG002|Overall Study|Lack of Efficacy|0
7285873|NCT00507455|11502249|FG000|Overall Study|Other - miscellaneous reason|1
7285874|NCT00507455|11502250|FG001|Overall Study|Other - miscellaneous reason|0
7285875|NCT00507455|11502251|FG002|Overall Study|Other - miscellaneous reason|1
7285876|NCT00507507|11502261|FG000|Treatment Period|Lost to Follow-up|0
7285877|NCT00507507|11502262|FG001|Treatment Period|Lost to Follow-up|2
7285878|NCT00507507|11502261|FG000|Treatment Period|Physician Decision|4
7285879|NCT00507507|11502262|FG001|Treatment Period|Physician Decision|1
7285880|NCT00507507|11502261|FG000|Treatment Period|Protocol Violation|1
7285881|NCT00507507|11502262|FG001|Treatment Period|Protocol Violation|2
7285882|NCT00507507|11502261|FG000|Treatment Period|Adverse Event|1
7285883|NCT00507507|11502262|FG001|Treatment Period|Adverse Event|1
7285884|NCT00507507|11502261|FG000|Treatment Period|Withdrawal by Subject|46
7285885|NCT00507507|11502262|FG001|Treatment Period|Withdrawal by Subject|47
7285886|NCT00507507|11502261|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
7285887|NCT00507507|11502262|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
7285888|NCT00507507|11502261|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
7285889|NCT00507507|11502262|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
7285890|NCT00507507|11502261|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
7285891|NCT00507507|11502262|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
7285892|NCT00507546|11502272|FG000|Overall Study|Withdrawal by Subject|1
7285893|NCT00507546|11502273|FG001|Overall Study|Withdrawal by Subject|0
7285894|NCT00507546|11502272|FG000|Overall Study|Protocol Violation|1
7285895|NCT00507546|11502273|FG001|Overall Study|Protocol Violation|0
7285896|NCT00507546|11502272|FG000|Overall Study|Physician Decision|0
7285897|NCT00507546|11502273|FG001|Overall Study|Physician Decision|1
7285898|NCT00507689|11502288|FG000|Pre-Randomization Period|Adverse Event|1
7285899|NCT00507689|11502289|FG001|Pre-Randomization Period|Adverse Event|0
7285900|NCT00507689|11502288|FG000|Pre-Randomization Period|Physician Decision|1
7285901|NCT00507689|11502289|FG001|Pre-Randomization Period|Physician Decision|0
7285902|NCT00507689|11502288|FG000|Pre-Randomization Period|Withdrawal by Subject|1
7285903|NCT00507689|11502289|FG001|Pre-Randomization Period|Withdrawal by Subject|0
7285904|NCT00507689|11502288|FG000|Randomized Period|Adverse Event|1
7285905|NCT00507689|11502289|FG001|Randomized Period|Adverse Event|1
7285906|NCT00507689|11502288|FG000|Randomized Period|Withdrawal by Subject|0
7285907|NCT00507689|11502289|FG001|Randomized Period|Withdrawal by Subject|1
7285908|NCT00507728|11502299|FG000|Randomization to Month 3|Lost to Follow-up|15
7285909|NCT00507728|11502300|FG001|Randomization to Month 3|Lost to Follow-up|14
7285910|NCT00507728|11502301|FG002|Randomization to Month 3|Lost to Follow-up|20
7285911|NCT00507728|11502299|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
7285912|NCT00507728|11502300|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
7285913|NCT00507728|11502301|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
7285914|NCT00507819|11502319|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
7285915|NCT00507819|11502320|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
7285916|NCT00508001|11502329|FG000|Overall Study|Adverse Event|2
7285917|NCT00508001|11502330|FG001|Overall Study|Adverse Event|0
7285918|NCT00508001|11502331|FG002|Overall Study|Adverse Event|4
7285919|NCT00508001|11502329|FG000|Overall Study|condition under investigation worsened|13
7285920|NCT00508001|11502330|FG001|Overall Study|condition under investigation worsened|7
7285921|NCT00508001|11502331|FG002|Overall Study|condition under investigation worsened|1
7285922|NCT00508001|11502329|FG000|Overall Study|Death|0
7285923|NCT00508001|11502330|FG001|Overall Study|Death|1
7285924|NCT00508001|11502331|FG002|Overall Study|Death|1
7285925|NCT00508001|11502329|FG000|Overall Study|Withdrawal by Subject|4
7285926|NCT00508001|11502330|FG001|Overall Study|Withdrawal by Subject|4
7285927|NCT00508001|11502331|FG002|Overall Study|Withdrawal by Subject|1
7285928|NCT00508027|11502339|FG000|Dose Level 1|Lost to Follow-up|4
7285929|NCT00508027|11502339|FG000|Dose Level 1|Withdrawal by Subject|2
7622910|NCT02765399|12033853|FG000|Overall Study|Nausea|1
7622911|NCT02765399|12033854|FG001|Overall Study|Nausea|0
7622936|NCT03894969|12033892|FG000|Overall Study|Adverse Event|0
7622937|NCT03894969|12033893|FG001|Overall Study|Adverse Event|2
7622938|NCT03894969|12033894|FG002|Overall Study|Adverse Event|0
7622939|NCT03894969|12033895|FG003|Overall Study|Adverse Event|1
7622940|NCT03894969|12033896|FG004|Overall Study|Adverse Event|2
7622941|NCT03894969|12033892|FG000|Overall Study|Lost to Follow-up|3
7622942|NCT03894969|12033893|FG001|Overall Study|Lost to Follow-up|1
7622943|NCT03894969|12033894|FG002|Overall Study|Lost to Follow-up|1
7622944|NCT03894969|12033895|FG003|Overall Study|Lost to Follow-up|0
7622945|NCT03894969|12033896|FG004|Overall Study|Lost to Follow-up|0
7622946|NCT03894969|12033892|FG000|Overall Study|Withdrawal by Subject|2
7622947|NCT03894969|12033893|FG001|Overall Study|Withdrawal by Subject|1
7622948|NCT03894969|12033894|FG002|Overall Study|Withdrawal by Subject|3
7622949|NCT03894969|12033895|FG003|Overall Study|Withdrawal by Subject|4
7622950|NCT03894969|12033896|FG004|Overall Study|Withdrawal by Subject|8
7622951|NCT03894969|12033892|FG000|Overall Study|Other|0
7622952|NCT03894969|12033893|FG001|Overall Study|Other|0
7285930|NCT00508027|11502339|FG000|Dose Level 1|Physician Decision|2
7285931|NCT00508027|11502339|FG000|Dose Level 2|Lost to Follow-up|2
7285932|NCT00508027|11502339|FG000|Dose Level 2|Withdrawal by Subject|2
7285933|NCT00508144|11502372|FG000|Overall Study|Not eligible|6
7622953|NCT03894969|12033894|FG002|Overall Study|Other|0
7622954|NCT03894969|12033895|FG003|Overall Study|Other|0
7622955|NCT03894969|12033896|FG004|Overall Study|Other|3
7622956|NCT03894969|12033892|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0
7622957|NCT03894969|12033893|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0
7622958|NCT03894969|12033894|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0
7622959|NCT03894969|12033895|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2
7285934|NCT00508144|11502372|FG000|Overall Study|Death|5
7285935|NCT00508157|11502378|FG000|Overall Study|Adverse Event|0
7285936|NCT00508157|11502379|FG001|Overall Study|Adverse Event|1
7285937|NCT00508157|11502378|FG000|Overall Study|Subject Withdrew Consent|1
7622960|NCT03894969|12033896|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1
7622961|NCT03894969|12033892|FG000|Overall Study|Solicited Adverse Event|0
7622962|NCT03894969|12033893|FG001|Overall Study|Solicited Adverse Event|1
7622963|NCT03894969|12033894|FG002|Overall Study|Solicited Adverse Event|0
7622964|NCT03894969|12033895|FG003|Overall Study|Solicited Adverse Event|0
7622965|NCT03894969|12033896|FG004|Overall Study|Solicited Adverse Event|0
7622966|NCT03464136|12033921|FG000|Overall Study|Lost to Follow-up|5
7285938|NCT00508157|11502379|FG001|Overall Study|Subject Withdrew Consent|0
7285939|NCT00508157|11502378|FG000|Overall Study|Lost to Follow-up|1
7285940|NCT00508157|11502379|FG001|Overall Study|Lost to Follow-up|0
7285941|NCT00508157|11502378|FG000|Overall Study|Subject no longer met study criteria|0
7285942|NCT00508157|11502379|FG001|Overall Study|Subject no longer met study criteria|1
7285943|NCT00508157|11502378|FG000|Overall Study|Other known cause|0
7285944|NCT00508157|11502379|FG001|Overall Study|Other known cause|1
7285945|NCT00508261|11502405|FG000|Overall Study|Other|0
7285946|NCT00508261|11502406|FG001|Overall Study|Other|1
7285947|NCT00508261|11502407|FG002|Overall Study|Other|1
7285948|NCT00508261|11502408|FG003|Overall Study|Other|0
7285949|NCT00508261|11502405|FG000|Overall Study|Serious Adverse Event|0
7285950|NCT00508261|11502406|FG001|Overall Study|Serious Adverse Event|1
7285951|NCT00508261|11502407|FG002|Overall Study|Serious Adverse Event|0
7285952|NCT00508261|11502408|FG003|Overall Study|Serious Adverse Event|0
7285953|NCT00508261|11502405|FG000|Overall Study|Withdrawal by Subject|3
7285954|NCT00508261|11502406|FG001|Overall Study|Withdrawal by Subject|4
7285955|NCT00508261|11502407|FG002|Overall Study|Withdrawal by Subject|4
7285956|NCT00508261|11502408|FG003|Overall Study|Withdrawal by Subject|0
7285957|NCT00508261|11502405|FG000|Overall Study|Migrated/ moved from study area|0
7285958|NCT00508261|11502406|FG001|Overall Study|Migrated/ moved from study area|1
7285959|NCT00508261|11502407|FG002|Overall Study|Migrated/ moved from study area|0
7285960|NCT00508261|11502408|FG003|Overall Study|Migrated/ moved from study area|0
7285961|NCT00508261|11502405|FG000|Overall Study|Lost to Follow-up|0
7285962|NCT00508261|11502406|FG001|Overall Study|Lost to Follow-up|1
7285963|NCT00508261|11502407|FG002|Overall Study|Lost to Follow-up|1
7285964|NCT00508261|11502408|FG003|Overall Study|Lost to Follow-up|1
7285965|NCT00508274|11502422|FG000|Overall Study|Adverse Event|5
7285966|NCT00508274|11502422|FG000|Overall Study|Death|7
7285967|NCT00508274|11502422|FG000|Overall Study|Disease progression|32
7285968|NCT00508274|11502422|FG000|Overall Study|Withdrawal by Subject|1
7285969|NCT00508274|11502422|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
7285970|NCT00508274|11502422|FG000|Overall Study|Missing|3
7285971|NCT00508391|11502437|FG000|First Treatment|Withdrawal by Subject|6
7285972|NCT00508391|11502438|FG001|First Treatment|Withdrawal by Subject|3
7285973|NCT00508391|11502437|FG000|Second Treatment|Withdrawal by Subject|2
7285974|NCT00508391|11502438|FG001|Second Treatment|Withdrawal by Subject|0
7285975|NCT00508404|11502446|FG000|Overall Study|Ongoing at Data Cut-off|12
7285976|NCT00508404|11502446|FG000|Overall Study|Adverse Event|2
7285977|NCT00508404|11502446|FG000|Overall Study|Death|16
7285978|NCT00508404|11502446|FG000|Overall Study|Physician Decision|2
7285979|NCT00508404|11502446|FG000|Overall Study|Withdrawal by Subject|3
7285980|NCT00508404|11502446|FG000|Overall Study|Protocol-specified Criteria|2
7285981|NCT00508404|11502446|FG000|Overall Study|Lost to Follow-up|2
7285982|NCT00508404|11502446|FG000|Overall Study|Other - Not Specified|3
7285983|NCT00508482|11502463|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
7285984|NCT00508482|11502464|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
7285985|NCT00508482|11502465|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
7285986|NCT00508482|11502463|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
7285987|NCT00508482|11502464|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
7285988|NCT00508482|11502465|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
7285989|NCT00508482|11502463|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
7285990|NCT00508482|11502464|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
7285991|NCT00508482|11502465|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
7285992|NCT00508651|11502480|FG000|Overall Study|Lost to Follow-up|3
7285993|NCT00508651|11502481|FG001|Overall Study|Lost to Follow-up|1
7285994|NCT00508651|11502480|FG000|Overall Study|Withdrawal by Subject|1
7285995|NCT00508651|11502481|FG001|Overall Study|Withdrawal by Subject|1
7285996|NCT00508742|11502498|FG000|Period 1: Infant Series|Adverse Event|5
7285997|NCT00508742|11502499|FG001|Period 1: Infant Series|Adverse Event|4
7285998|NCT00508742|11502498|FG000|Period 1: Infant Series|Protocol Violation|1
7285999|NCT00508742|11502499|FG001|Period 1: Infant Series|Protocol Violation|0
7286000|NCT00508742|11502498|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
7286001|NCT00508742|11502499|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
7286002|NCT00508742|11502498|FG000|Period 1: Infant Series|Physician Decision|1
7286003|NCT00508742|11502499|FG001|Period 1: Infant Series|Physician Decision|0
7286004|NCT00508742|11502498|FG000|Period 1: Infant Series|Other|4
7286005|NCT00508742|11502499|FG001|Period 1: Infant Series|Other|1
7622967|NCT03464136|12033922|FG001|Overall Study|Lost to Follow-up|8
7286006|NCT00508742|11502498|FG000|Period 2: After Infant Series|Adverse Event|2
7286007|NCT00508742|11502499|FG001|Period 2: After Infant Series|Adverse Event|6
7286008|NCT00508742|11502498|FG000|Period 2: After Infant Series|Lost to Follow-up|1
7286009|NCT00508742|11502499|FG001|Period 2: After Infant Series|Lost to Follow-up|1
7286010|NCT00508742|11502498|FG000|Period 2: After Infant Series|Protocol Violation|1
7286011|NCT00508742|11502499|FG001|Period 2: After Infant Series|Protocol Violation|0
7286012|NCT00508742|11502498|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
7286013|NCT00508742|11502499|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
7286014|NCT00508742|11502498|FG000|Period 2: After Infant Series|Failed to Return|1
7286015|NCT00508742|11502499|FG001|Period 2: After Infant Series|Failed to Return|0
7286016|NCT00508742|11502498|FG000|Period 2: After Infant Series|Other|2
7286017|NCT00508742|11502499|FG001|Period 2: After Infant Series|Other|1
7286018|NCT00508742|11502498|FG000|Period 3: Toddler Dose|Adverse Event|1
7286019|NCT00508742|11502499|FG001|Period 3: Toddler Dose|Adverse Event|0
7286020|NCT00508742|11502498|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
7286021|NCT00508742|11502499|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
7286022|NCT00508742|11502498|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
7286023|NCT00508742|11502499|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
7286024|NCT00508742|11502498|FG000|Period 3: Toddler Dose|Other|5
7286025|NCT00508742|11502499|FG001|Period 3: Toddler Dose|Other|4
7286026|NCT00508755|11502511|FG000|Overall Study|Withdrawal by Subject|1
7286049|NCT00508924|11502530|FG000|Overall Study|Protocol Violation|0
7286050|NCT00508924|11502531|FG001|Overall Study|Protocol Violation|0
7286051|NCT00508924|11502532|FG002|Overall Study|Protocol Violation|1
7286052|NCT00508924|11502533|FG003|Overall Study|Protocol Violation|1
7286053|NCT00509028|11502549|FG000|Overall Study|Adverse Event|2
7286054|NCT00509028|11502550|FG001|Overall Study|Adverse Event|0
7286055|NCT00509028|11502549|FG000|Overall Study|Withdrawal by Subject|4
7286056|NCT00509028|11502550|FG001|Overall Study|Withdrawal by Subject|3
7286057|NCT00509028|11502549|FG000|Overall Study|Lost to Follow-up|0
7286058|NCT00509028|11502550|FG001|Overall Study|Lost to Follow-up|1
7286059|NCT00509028|11502549|FG000|Overall Study|Protocol Violation|4
7286060|NCT00509028|11502550|FG001|Overall Study|Protocol Violation|2
7286061|NCT00509028|11502549|FG000|Overall Study|Non-compliance|2
7286062|NCT00509028|11502550|FG001|Overall Study|Non-compliance|1
7286063|NCT00509067|11502562|FG000|Overall Study|Lost to Follow-up|1
7286064|NCT00509067|11502563|FG001|Overall Study|Lost to Follow-up|1
7286065|NCT00509067|11502562|FG000|Overall Study|Adverse Event|3
7286066|NCT00509067|11502563|FG001|Overall Study|Adverse Event|1
7286067|NCT00509067|11502562|FG000|Overall Study|Protocol Violation|0
7286068|NCT00509067|11502563|FG001|Overall Study|Protocol Violation|3
7286069|NCT00509093|11502573|FG000|Overall Study|Adverse Event|10
7286070|NCT00509093|11502573|FG000|Overall Study|Disease Progression|9
7286071|NCT00509093|11502573|FG000|Overall Study|Transformed into MDS|1
7286072|NCT00509093|11502573|FG000|Overall Study|Withdrawal by Subject|3
7286073|NCT00509093|11502573|FG000|Overall Study|Physician Decision|1
7286074|NCT00509106|11502579|FG000|Overall Study|Adverse Event|3
7286075|NCT00509106|11502580|FG001|Overall Study|Adverse Event|2
7286076|NCT00509106|11502579|FG000|Overall Study|Noncompliance|0
7286077|NCT00509106|11502580|FG001|Overall Study|Noncompliance|1
7286078|NCT00509106|11502579|FG000|Overall Study|At the request of sponsor/investigator|1
7286079|NCT00509106|11502580|FG001|Overall Study|At the request of sponsor/investigator|2
7286080|NCT00509106|11502579|FG000|Overall Study|Withdrew consent|4
7286081|NCT00509106|11502580|FG001|Overall Study|Withdrew consent|8
7286082|NCT00509106|11502579|FG000|Overall Study|Lost to Follow-up|16
7286083|NCT00509106|11502580|FG001|Overall Study|Lost to Follow-up|10
7286084|NCT00509106|11502579|FG000|Overall Study|Other|1
7286085|NCT00509106|11502580|FG001|Overall Study|Other|0
7286086|NCT00509106|11502579|FG000|Overall Study|Death|6
7286087|NCT00509106|11502580|FG001|Overall Study|Death|6
7286088|NCT00509145|11502588|FG000|Overall Study|Death|0
7286089|NCT00509145|11502589|FG001|Overall Study|Death|2
7286090|NCT00509145|11502588|FG000|Overall Study|Adverse Event|42
7286091|NCT00509145|11502589|FG001|Overall Study|Adverse Event|28
7286092|NCT00509145|11502588|FG000|Overall Study|Withdrawal by Subject|32
7286093|NCT00509145|11502589|FG001|Overall Study|Withdrawal by Subject|38
7286094|NCT00509145|11502588|FG000|Overall Study|Physician Decision|11
7286095|NCT00509145|11502589|FG001|Overall Study|Physician Decision|14
7286096|NCT00509145|11502588|FG000|Overall Study|Protocol Violation|1
7286097|NCT00509145|11502589|FG001|Overall Study|Protocol Violation|6
7286098|NCT00509145|11502588|FG000|Overall Study|Pregnancy|3
7286099|NCT00509145|11502589|FG001|Overall Study|Pregnancy|8
7286100|NCT00509145|11502588|FG000|Overall Study|Lost to Follow-up|6
7286101|NCT00509145|11502589|FG001|Overall Study|Lost to Follow-up|5
7286187|NCT00509899|11502757|FG003|Overall Study|Progressive disease|1
7286102|NCT00509145|11502588|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
7286103|NCT00509145|11502589|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
7286104|NCT00509145|11502588|FG000|Overall Study|Other|6
7286105|NCT00509145|11502589|FG001|Overall Study|Other|6
7286106|NCT00509223|11502617|FG000|Overall Study|Lost to Follow-up|1
7286107|NCT00509223|11502618|FG001|Overall Study|Lost to Follow-up|1
7286108|NCT00509223|11502617|FG000|Overall Study|Adverse Event|1
7286109|NCT00509223|11502618|FG001|Overall Study|Adverse Event|1
7286110|NCT00509223|11502617|FG000|Overall Study|Withdrawal by Subject|25
7286111|NCT00509223|11502618|FG001|Overall Study|Withdrawal by Subject|6
7286112|NCT00509223|11502617|FG000|Overall Study|Including: subject change of address|5
7286113|NCT00509223|11502618|FG001|Overall Study|Including: subject change of address|2
7286114|NCT00509223|11502617|FG000|Overall Study|Did not meet revised inclusion criteria|56
7286115|NCT00509223|11502618|FG001|Overall Study|Did not meet revised inclusion criteria|62
7286116|NCT00509236|11502626|FG000|Overall Study|Adverse Event|7
7286117|NCT00509236|11502627|FG001|Overall Study|Adverse Event|9
7286118|NCT00509236|11502626|FG000|Overall Study|Withdrawal by Subject|5
7286119|NCT00509236|11502627|FG001|Overall Study|Withdrawal by Subject|10
7286120|NCT00509236|11502626|FG000|Overall Study|Protocol Violation|3
7286121|NCT00509236|11502627|FG001|Overall Study|Protocol Violation|0
7286122|NCT00509236|11502626|FG000|Overall Study|Excluded Medication|1
7286123|NCT00509236|11502627|FG001|Overall Study|Excluded Medication|1
7286124|NCT00509236|11502626|FG000|Overall Study|Scheduled Kidney Transplant|1
7286125|NCT00509236|11502627|FG001|Overall Study|Scheduled Kidney Transplant|0
7286126|NCT00509262|11502639|FG000|Overall Study|Adverse Event|16
7286127|NCT00509262|11502640|FG001|Overall Study|Adverse Event|18
7286128|NCT00509262|11502639|FG000|Overall Study|Other|2
7286129|NCT00509262|11502640|FG001|Overall Study|Other|2
7286130|NCT00509262|11502639|FG000|Overall Study|Lack of Efficacy|1
7286131|NCT00509262|11502640|FG001|Overall Study|Lack of Efficacy|0
7286132|NCT00509262|11502639|FG000|Overall Study|Lost to Follow-up|1
7286133|NCT00509262|11502640|FG001|Overall Study|Lost to Follow-up|6
7286134|NCT00509262|11502639|FG000|Overall Study|Physician Decision|1
7286135|NCT00509262|11502640|FG001|Overall Study|Physician Decision|3
7286136|NCT00509262|11502639|FG000|Overall Study|Protocol Violation|2
7286137|NCT00509262|11502640|FG001|Overall Study|Protocol Violation|2
7286138|NCT00509262|11502639|FG000|Overall Study|Withdrawal by Subject|24
7286139|NCT00509262|11502640|FG001|Overall Study|Withdrawal by Subject|11
7286140|NCT00509366|11502660|FG000|Overall Study|Not Treated (Screen Failure)|1
7286141|NCT00509366|11502661|FG001|Overall Study|Not Treated (Screen Failure)|1
7286142|NCT00509366|11502662|FG002|Overall Study|Not Treated (Screen Failure)|1
7286143|NCT00509366|11502663|FG003|Overall Study|Not Treated (Screen Failure)|0
7286144|NCT00509366|11502664|FG004|Overall Study|Not Treated (Screen Failure)|0
7286145|NCT00509769|11502701|FG000|Overall Study|Progressive disease|77
7286146|NCT00509769|11502701|FG000|Overall Study|Adverse Event|4
7286147|NCT00509769|11502701|FG000|Overall Study|Patient's decision|1
7286148|NCT00509769|11502701|FG000|Overall Study|Physician Decision|8
7286149|NCT00509769|11502701|FG000|Overall Study|Use of prohibited therapies during study|1
7286150|NCT00509795|11502709|FG000|Overall Study|Adverse Event|4
7286151|NCT00509795|11502710|FG001|Overall Study|Adverse Event|3
7286152|NCT00509795|11502711|FG002|Overall Study|Adverse Event|5
7286153|NCT00509795|11502712|FG003|Overall Study|Adverse Event|4
7286154|NCT00509795|11502709|FG000|Overall Study|Death|3
7286155|NCT00509795|11502710|FG001|Overall Study|Death|1
7286156|NCT00509795|11502711|FG002|Overall Study|Death|2
7286157|NCT00509795|11502712|FG003|Overall Study|Death|7
7286158|NCT00509795|11502709|FG000|Overall Study|Lack of Efficacy|0
7286159|NCT00509795|11502710|FG001|Overall Study|Lack of Efficacy|0
7286160|NCT00509795|11502711|FG002|Overall Study|Lack of Efficacy|2
7286161|NCT00509795|11502712|FG003|Overall Study|Lack of Efficacy|2
7286162|NCT00509795|11502709|FG000|Overall Study|Lost to Follow-up|1
7286163|NCT00509795|11502710|FG001|Overall Study|Lost to Follow-up|2
7286164|NCT00509795|11502711|FG002|Overall Study|Lost to Follow-up|4
7286165|NCT00509795|11502712|FG003|Overall Study|Lost to Follow-up|4
7286166|NCT00509795|11502709|FG000|Overall Study|OTHER|1
7286167|NCT00509795|11502710|FG001|Overall Study|OTHER|0
7286168|NCT00509795|11502711|FG002|Overall Study|OTHER|4
7286169|NCT00509795|11502712|FG003|Overall Study|OTHER|1
7286170|NCT00509795|11502709|FG000|Overall Study|Protocol Violation|3
7286171|NCT00509795|11502710|FG001|Overall Study|Protocol Violation|0
7286172|NCT00509795|11502711|FG002|Overall Study|Protocol Violation|3
7286173|NCT00509795|11502712|FG003|Overall Study|Protocol Violation|1
7286174|NCT00509795|11502709|FG000|Overall Study|Withdrawal by Subject|10
7286175|NCT00509795|11502710|FG001|Overall Study|Withdrawal by Subject|5
7286176|NCT00509795|11502711|FG002|Overall Study|Withdrawal by Subject|7
7286177|NCT00509795|11502712|FG003|Overall Study|Withdrawal by Subject|8
7286178|NCT00509821|11502725|FG000|Study Period 1 (Induction)|Death|0
7286179|NCT00509821|11502726|FG001|Study Period 1 (Induction)|Death|1
7286180|NCT00509821|11502725|FG000|Study Period 1 (Induction)|Adverse Event|0
7286181|NCT00509821|11502726|FG001|Study Period 1 (Induction)|Adverse Event|2
7286182|NCT00509821|11502725|FG000|Study Period 1 (Induction)|Progressive Disease|0
7286183|NCT00509821|11502726|FG001|Study Period 1 (Induction)|Progressive Disease|1
7286184|NCT00509899|11502754|FG000|Overall Study|Progressive disease|1
7286185|NCT00509899|11502755|FG001|Overall Study|Progressive disease|3
7286186|NCT00509899|11502756|FG002|Overall Study|Progressive disease|5
7286188|NCT00509899|11502758|FG004|Overall Study|Progressive disease|0
7286189|NCT00509899|11502759|FG005|Overall Study|Progressive disease|1
7286190|NCT00509899|11502760|FG006|Overall Study|Progressive disease|0
7286191|NCT00509899|11502761|FG007|Overall Study|Progressive disease|0
7286192|NCT00509899|11502754|FG000|Overall Study|Unacceptable Toxicity|1
7286193|NCT00509899|11502755|FG001|Overall Study|Unacceptable Toxicity|0
7286194|NCT00509899|11502756|FG002|Overall Study|Unacceptable Toxicity|0
7286195|NCT00509899|11502757|FG003|Overall Study|Unacceptable Toxicity|2
7286196|NCT00509899|11502758|FG004|Overall Study|Unacceptable Toxicity|0
7286197|NCT00509899|11502759|FG005|Overall Study|Unacceptable Toxicity|0
7286198|NCT00509899|11502760|FG006|Overall Study|Unacceptable Toxicity|0
7286199|NCT00509899|11502761|FG007|Overall Study|Unacceptable Toxicity|0
7286200|NCT00509899|11502754|FG000|Overall Study|Withdrawal by Subject|6
7286201|NCT00509899|11502755|FG001|Overall Study|Withdrawal by Subject|2
7286202|NCT00509899|11502756|FG002|Overall Study|Withdrawal by Subject|3
7286203|NCT00509899|11502757|FG003|Overall Study|Withdrawal by Subject|0
7286204|NCT00509899|11502758|FG004|Overall Study|Withdrawal by Subject|3
7286205|NCT00509899|11502759|FG005|Overall Study|Withdrawal by Subject|2
7286206|NCT00509899|11502760|FG006|Overall Study|Withdrawal by Subject|0
7286207|NCT00509899|11502761|FG007|Overall Study|Withdrawal by Subject|0
7286208|NCT00509899|11502754|FG000|Overall Study|Physician Decision|4
7286209|NCT00509899|11502755|FG001|Overall Study|Physician Decision|2
7286210|NCT00509899|11502756|FG002|Overall Study|Physician Decision|7
7286211|NCT00509899|11502757|FG003|Overall Study|Physician Decision|0
7286212|NCT00509899|11502758|FG004|Overall Study|Physician Decision|1
7286213|NCT00509899|11502759|FG005|Overall Study|Physician Decision|4
7286214|NCT00509899|11502760|FG006|Overall Study|Physician Decision|0
7286215|NCT00509899|11502761|FG007|Overall Study|Physician Decision|0
7286216|NCT00509899|11502754|FG000|Overall Study|Intercurrent Illness|1
7286217|NCT00509899|11502755|FG001|Overall Study|Intercurrent Illness|0
7286218|NCT00509899|11502756|FG002|Overall Study|Intercurrent Illness|0
7286219|NCT00509899|11502757|FG003|Overall Study|Intercurrent Illness|1
7286220|NCT00509899|11502758|FG004|Overall Study|Intercurrent Illness|0
7286221|NCT00509899|11502759|FG005|Overall Study|Intercurrent Illness|1
7286222|NCT00509899|11502760|FG006|Overall Study|Intercurrent Illness|0
7286223|NCT00509899|11502761|FG007|Overall Study|Intercurrent Illness|0
7286224|NCT00509899|11502754|FG000|Overall Study|Death|2
7286225|NCT00509899|11502755|FG001|Overall Study|Death|2
7286226|NCT00509899|11502756|FG002|Overall Study|Death|3
7286227|NCT00509899|11502757|FG003|Overall Study|Death|0
7286228|NCT00509899|11502758|FG004|Overall Study|Death|1
7286229|NCT00509899|11502759|FG005|Overall Study|Death|1
7286230|NCT00509899|11502760|FG006|Overall Study|Death|1
7286231|NCT00509899|11502761|FG007|Overall Study|Death|1
7286232|NCT00509899|11502754|FG000|Overall Study|Lack of Efficacy|1
7286233|NCT00509899|11502755|FG001|Overall Study|Lack of Efficacy|0
7286234|NCT00509899|11502756|FG002|Overall Study|Lack of Efficacy|2
7286235|NCT00509899|11502757|FG003|Overall Study|Lack of Efficacy|0
7286236|NCT00509899|11502758|FG004|Overall Study|Lack of Efficacy|0
7286237|NCT00509899|11502759|FG005|Overall Study|Lack of Efficacy|1
7286238|NCT00509899|11502760|FG006|Overall Study|Lack of Efficacy|0
7286239|NCT00509899|11502761|FG007|Overall Study|Lack of Efficacy|0
7286240|NCT00509925|11502775|FG000|Overall Study|Personal reasons|0
7622968|NCT03464136|12033921|FG000|Overall Study|Withdrawal by Subject|16
7622969|NCT03464136|12033922|FG001|Overall Study|Withdrawal by Subject|13
7622970|NCT03464136|12033921|FG000|Overall Study|Death|1
7622971|NCT03464136|12033922|FG001|Overall Study|Death|0
7622972|NCT03464136|12033921|FG000|Overall Study|Other|8
7622973|NCT03464136|12033922|FG001|Overall Study|Other|4
7622974|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622975|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622976|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2
7622977|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0
7622978|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Death|0
7622979|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Death|0
7622980|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Death|0
7286241|NCT00509925|11502776|FG001|Overall Study|Personal reasons|1
7286242|NCT00510068|11502786|FG000|Double-blind Period|Disease progression|98
7622981|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Death|1
7622982|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7622983|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7286243|NCT00510068|11502787|FG001|Double-blind Period|Disease progression|169
7286244|NCT00510068|11502786|FG000|Double-blind Period|Final primary analysis|52
7286245|NCT00510068|11502787|FG001|Double-blind Period|Final primary analysis|18
7286246|NCT00510068|11502786|FG000|Double-blind Period|Adverse Event|37
7286247|NCT00510068|11502787|FG001|Double-blind Period|Adverse Event|7
7286248|NCT00510068|11502786|FG000|Double-blind Period|Withdrawal by Subject|8
7286249|NCT00510068|11502787|FG001|Double-blind Period|Withdrawal by Subject|6
7286250|NCT00510068|11502786|FG000|Double-blind Period|Death|4
7286251|NCT00510068|11502787|FG001|Double-blind Period|Death|3
7286252|NCT00510068|11502786|FG000|Double-blind Period|Abnormal test result (s)|1
7286253|NCT00510068|11502787|FG001|Double-blind Period|Abnormal test result (s)|0
7286254|NCT00510068|11502786|FG000|Double-blind Period|Lost to Follow-up|1
7286255|NCT00510068|11502787|FG001|Double-blind Period|Lost to Follow-up|0
7286256|NCT00510068|11502786|FG000|Double-blind Period|Protocol Violation|6
7286257|NCT00510068|11502787|FG001|Double-blind Period|Protocol Violation|0
7286258|NCT00510068|11502786|FG000|Open-label Period|Disease Progression|124
7286259|NCT00510068|11502787|FG001|Open-label Period|Disease Progression|0
7286260|NCT00510068|11502786|FG000|Open-label Period|Adverse Event|46
7286261|NCT00510068|11502787|FG001|Open-label Period|Adverse Event|0
7286262|NCT00510068|11502786|FG000|Open-label Period|Withdrawal by Subject|21
7286263|NCT00510068|11502787|FG001|Open-label Period|Withdrawal by Subject|0
7286264|NCT00510068|11502786|FG000|Open-label Period|Administrative problems|17
7286265|NCT00510068|11502787|FG001|Open-label Period|Administrative problems|0
7286266|NCT00510068|11502786|FG000|Open-label Period|Death|7
7286267|NCT00510068|11502787|FG001|Open-label Period|Death|0
7286268|NCT00510068|11502786|FG000|Open-label Period|New cancer therapy|7
7286269|NCT00510068|11502787|FG001|Open-label Period|New cancer therapy|0
7286270|NCT00510068|11502786|FG000|Open-label Period|Protocol Violation|2
7286271|NCT00510068|11502787|FG001|Open-label Period|Protocol Violation|0
7286272|NCT00510068|11502786|FG000|Open-label Period|Abnormal laboratory value (s)|1
7286273|NCT00510068|11502787|FG001|Open-label Period|Abnormal laboratory value (s)|0
7286274|NCT00510146|11502797|FG000|Double-Blind Treatment|Adverse Event|30
7286275|NCT00510146|11502798|FG001|Double-Blind Treatment|Adverse Event|13
7286276|NCT00510146|11502797|FG000|Double-Blind Treatment|Lack of Efficacy|6
7286277|NCT00510146|11502798|FG001|Double-Blind Treatment|Lack of Efficacy|13
7286278|NCT00510146|11502797|FG000|Double-Blind Treatment|Lost to Follow-up|3
7286279|NCT00510146|11502798|FG001|Double-Blind Treatment|Lost to Follow-up|7
7286280|NCT00510146|11502797|FG000|Double-Blind Treatment|Physician Decision|6
7286281|NCT00510146|11502798|FG001|Double-Blind Treatment|Physician Decision|0
7286282|NCT00510146|11502797|FG000|Double-Blind Treatment|Protocol Violation|1
7286283|NCT00510146|11502798|FG001|Double-Blind Treatment|Protocol Violation|2
7286284|NCT00510146|11502797|FG000|Double-Blind Treatment|Withdrawal by Subject|27
7286285|NCT00510146|11502798|FG001|Double-Blind Treatment|Withdrawal by Subject|13
7286286|NCT00510146|11502797|FG000|Double-Blind Treatment|Clinical Relapse|0
7286287|NCT00510146|11502798|FG001|Double-Blind Treatment|Clinical Relapse|1
7286288|NCT00510146|11502797|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
7286289|NCT00510146|11502798|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
7286290|NCT00510146|11502797|FG000|Open-Label Treatment|Adverse Event|22
7286291|NCT00510146|11502798|FG001|Open-Label Treatment|Adverse Event|8
7286292|NCT00510146|11502797|FG000|Open-Label Treatment|Death|1
7286293|NCT00510146|11502798|FG001|Open-Label Treatment|Death|1
7286294|NCT00510146|11502797|FG000|Open-Label Treatment|Lack of Efficacy|4
7286295|NCT00510146|11502798|FG001|Open-Label Treatment|Lack of Efficacy|0
7286296|NCT00510146|11502797|FG000|Open-Label Treatment|Lost to Follow-up|10
7286297|NCT00510146|11502798|FG001|Open-Label Treatment|Lost to Follow-up|1
7286298|NCT00510146|11502797|FG000|Open-Label Treatment|Physician Decision|3
7286299|NCT00510146|11502798|FG001|Open-Label Treatment|Physician Decision|1
7286300|NCT00510146|11502797|FG000|Open-Label Treatment|Protocol Violation|4
7286301|NCT00510146|11502798|FG001|Open-Label Treatment|Protocol Violation|2
7286302|NCT00510146|11502797|FG000|Open-Label Treatment|Withdrawal by Subject|24
7286303|NCT00510146|11502798|FG001|Open-Label Treatment|Withdrawal by Subject|12
7286304|NCT00510146|11502797|FG000|Open-Label Treatment|Clinical Relapse|1
7286305|NCT00510146|11502798|FG001|Open-Label Treatment|Clinical Relapse|1
7286306|NCT00510146|11502797|FG000|Open-Label Treatment|Sponsor Decision|2
7286307|NCT00510146|11502798|FG001|Open-Label Treatment|Sponsor Decision|0
7286308|NCT00510198|11502808|FG000|Overall Study|Withdrawal by Subject|5
7286309|NCT00510198|11502809|FG001|Overall Study|Withdrawal by Subject|4
7469963|NCT01928381|11771846|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7469964|NCT01928381|11771847|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7622984|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1
7622985|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0
7469965|NCT01928381|11771848|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7469966|NCT01928381|11771849|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
7469967|NCT01928381|11771843|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
7469968|NCT01928381|11771844|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
7469969|NCT01928381|11771845|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
7469970|NCT01928381|11771846|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
7469971|NCT01928381|11771847|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
7469972|NCT01928381|11771848|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
7286310|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Adverse Event|21
7286311|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Adverse Event|6
7286312|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
7286313|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
7286314|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
7286315|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
7286316|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
7286317|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
7286318|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Physician Decision|0
7286319|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Physician Decision|3
7286320|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Protocol Violation|4
7286321|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Protocol Violation|3
7286322|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Sponsor Decision|2
7286323|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Sponsor Decision|1
7286324|NCT00510276|11502823|FG000|Acute Double-Blind Phase|Subject Decision|26
7286325|NCT00510276|11502824|FG001|Acute Double-Blind Phase|Subject Decision|28
7286326|NCT00510276|11502823|FG000|Extension Open-Label Phase|Adverse Event|9
7286327|NCT00510276|11502824|FG001|Extension Open-Label Phase|Adverse Event|18
7622986|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622987|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622988|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1
7622989|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0
7622990|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0
7622991|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0
7622992|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1
7622993|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1
7622994|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
7622995|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0
7622996|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
7622997|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3
7622998|NCT03338816|12033930|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7622999|NCT03338816|12033931|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7623000|NCT03338816|12033932|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0
7623001|NCT03338816|12033933|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1
7623002|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2
7623003|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4
7623004|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1
7623005|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0
7623006|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0
7623007|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1
7623008|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1
7623009|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0
7623010|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0
7217777|NCT04402866|11425996|FG000|Overall Study|Discontinued Prior to Treatment|0
7217778|NCT04402866|11425997|FG001|Overall Study|Discontinued Prior to Treatment|0
7217779|NCT04402866|11425998|FG002|Overall Study|Discontinued Prior to Treatment|0
7217780|NCT04402866|11425999|FG003|Overall Study|Discontinued Prior to Treatment|0
7217781|NCT04402866|11426000|FG004|Overall Study|Discontinued Prior to Treatment|2
7217782|NCT04402866|11426001|FG005|Overall Study|Discontinued Prior to Treatment|3
7217783|NCT04402866|11425996|FG000|Overall Study|Adverse Event|2
7217784|NCT04402866|11425997|FG001|Overall Study|Adverse Event|1
7217785|NCT04402866|11425998|FG002|Overall Study|Adverse Event|0
7217786|NCT04402866|11425999|FG003|Overall Study|Adverse Event|0
7217787|NCT04402866|11426000|FG004|Overall Study|Adverse Event|13
7217788|NCT04402866|11426001|FG005|Overall Study|Adverse Event|8
7217789|NCT04402866|11425996|FG000|Overall Study|Miscellaneous|0
7217790|NCT04402866|11425997|FG001|Overall Study|Miscellaneous|0
7217791|NCT04402866|11425998|FG002|Overall Study|Miscellaneous|1
7286328|NCT00510276|11502823|FG000|Extension Open-Label Phase|Lack of Efficacy|2
7286329|NCT00510276|11502824|FG001|Extension Open-Label Phase|Lack of Efficacy|7
7286330|NCT00510276|11502823|FG000|Extension Open-Label Phase|Lost to Follow-up|12
7286331|NCT00510276|11502824|FG001|Extension Open-Label Phase|Lost to Follow-up|10
7286332|NCT00510276|11502823|FG000|Extension Open-Label Phase|Physician Decision|2
7286333|NCT00510276|11502824|FG001|Extension Open-Label Phase|Physician Decision|3
7286334|NCT00510276|11502823|FG000|Extension Open-Label Phase|Protocol Violation|0
7286335|NCT00510276|11502824|FG001|Extension Open-Label Phase|Protocol Violation|1
7286336|NCT00510276|11502823|FG000|Extension Open-Label Phase|Sponsor Decision|1
7286337|NCT00510276|11502824|FG001|Extension Open-Label Phase|Sponsor Decision|0
7286338|NCT00510276|11502823|FG000|Extension Open-Label Phase|Subject Decision|7
7286339|NCT00510276|11502824|FG001|Extension Open-Label Phase|Subject Decision|9
7286340|NCT00510289|11502837|FG000|Overall Study|Withdrawal by Subject|7
7286341|NCT00510289|11502837|FG000|Overall Study|Refused bone marrow biopsy|2
7286342|NCT00510289|11502837|FG000|Overall Study|Lost to Follow-up|1
7286343|NCT00510289|11502837|FG000|Overall Study|Progressed prior to starting drug|2
7623011|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0
7286344|NCT00510458|11502842|FG000|Overall Study|5 year not evaluable/missed|21
7286345|NCT00510458|11502842|FG000|Overall Study|Death|1
7286346|NCT00510458|11502842|FG000|Overall Study|Terminated|14
7286347|NCT00510458|11502842|FG000|Overall Study|Lost to Follow-up|6
7286348|NCT00510458|11502842|FG000|Overall Study|Withdrawal by Subject|3
7286349|NCT00510458|11502842|FG000|Overall Study|Revision|2
7286350|NCT00510484|11502849|FG000|Wash-out Period|Adverse Event|0
7286351|NCT00510484|11502850|FG001|Wash-out Period|Adverse Event|1
7286352|NCT00510510|11502863|FG000|Overall Study|Adverse Event|4
7286353|NCT00510510|11502864|FG001|Overall Study|Adverse Event|3
7286354|NCT00510510|11502865|FG002|Overall Study|Adverse Event|6
7286355|NCT00510510|11502863|FG000|Overall Study|Lack of Efficacy|0
7286356|NCT00510510|11502864|FG001|Overall Study|Lack of Efficacy|1
7286357|NCT00510510|11502865|FG002|Overall Study|Lack of Efficacy|1
7286358|NCT00510510|11502863|FG000|Overall Study|Subjects no longer requires study drug|0
7286359|NCT00510510|11502864|FG001|Overall Study|Subjects no longer requires study drug|0
7286360|NCT00510510|11502865|FG002|Overall Study|Subjects no longer requires study drug|2
7286361|NCT00510510|11502863|FG000|Overall Study|Withdrawal by Subject|1
7286362|NCT00510510|11502864|FG001|Overall Study|Withdrawal by Subject|2
7286363|NCT00510510|11502865|FG002|Overall Study|Withdrawal by Subject|3
7286364|NCT00510510|11502863|FG000|Overall Study|Lost to Follow-up|0
7286365|NCT00510510|11502864|FG001|Overall Study|Lost to Follow-up|0
7286366|NCT00510510|11502865|FG002|Overall Study|Lost to Follow-up|1
7286367|NCT00510510|11502863|FG000|Overall Study|Protocol Violation|0
7286368|NCT00510510|11502864|FG001|Overall Study|Protocol Violation|3
7286369|NCT00510510|11502865|FG002|Overall Study|Protocol Violation|4
7286370|NCT00510653|11502873|FG000|Overall Study|Withdrawal by Subject|8
7286371|NCT00510653|11502873|FG000|Overall Study|Monetary|3
7286372|NCT00510692|11502879|FG000|Overall Study|Adverse Event|1
7286373|NCT00510692|11502880|FG001|Overall Study|Adverse Event|3
7286374|NCT00510692|11502879|FG000|Overall Study|Withdrawal by Subject|1
7286375|NCT00510692|11502880|FG001|Overall Study|Withdrawal by Subject|0
7286376|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
7286377|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
7286378|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
7286379|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
7286380|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
7286381|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
7286382|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
7286383|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
7286384|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
7286385|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
7286386|NCT00510718|11502895|FG000|Multiple Dose Period: 12 Weeks|Other|1
7286387|NCT00510718|11502896|FG001|Multiple Dose Period: 12 Weeks|Other|1
7286388|NCT00510783|11502921|FG000|Overall Study|Lost to Follow-up|29
7286389|NCT00510783|11502922|FG001|Overall Study|Lost to Follow-up|25
7286390|NCT00510783|11502921|FG000|Overall Study|Withdrawal by Subject|2
7286391|NCT00510783|11502922|FG001|Overall Study|Withdrawal by Subject|3
7286392|NCT00510783|11502921|FG000|Overall Study|Protocol Violation|0
7286393|NCT00510783|11502922|FG001|Overall Study|Protocol Violation|1
7286394|NCT00510835|11502944|FG000|Overall Study|Withdrawal by Subject|6
7286395|NCT00510835|11502945|FG001|Overall Study|Withdrawal by Subject|2
7286396|NCT00510835|11502946|FG002|Overall Study|Withdrawal by Subject|2
7286397|NCT00510874|11502961|FG000|Overall Study|Withdrawal by Subject|1
7286398|NCT00510874|11502962|FG001|Overall Study|Withdrawal by Subject|1
7286399|NCT00510874|11502963|FG002|Overall Study|Withdrawal by Subject|0
7286400|NCT00510874|11502964|FG003|Overall Study|Withdrawal by Subject|0
7286401|NCT00510874|11502965|FG004|Overall Study|Withdrawal by Subject|3
7286402|NCT00510874|11502966|FG005|Overall Study|Withdrawal by Subject|0
7286403|NCT00510874|11502967|FG006|Overall Study|Withdrawal by Subject|0
7286404|NCT00510874|11502961|FG000|Overall Study|Lost to Follow-up|2
7286405|NCT00510874|11502962|FG001|Overall Study|Lost to Follow-up|3
7286406|NCT00510874|11502963|FG002|Overall Study|Lost to Follow-up|1
7286407|NCT00510874|11502964|FG003|Overall Study|Lost to Follow-up|3
7286408|NCT00510874|11502965|FG004|Overall Study|Lost to Follow-up|4
7286409|NCT00510874|11502966|FG005|Overall Study|Lost to Follow-up|0
7286410|NCT00510874|11502967|FG006|Overall Study|Lost to Follow-up|1
7286411|NCT00510887|11502984|FG000|Overall Study|Lost to Follow-up|1
7286412|NCT00510952|11502990|FG000|Overall Study|Adverse Event|1
7286413|NCT00510952|11502991|FG001|Overall Study|Adverse Event|0
7286414|NCT00510952|11502990|FG000|Overall Study|Entry Criteria Not Met|3
7286415|NCT00510952|11502991|FG001|Overall Study|Entry Criteria Not Met|1
7286416|NCT00510952|11502990|FG000|Overall Study|Lost to Follow-up|5
7286417|NCT00510952|11502991|FG001|Overall Study|Lost to Follow-up|3
7286418|NCT00510952|11502990|FG000|Overall Study|Physician Decision|1
7286419|NCT00510952|11502991|FG001|Overall Study|Physician Decision|1
7286420|NCT00510952|11502990|FG000|Overall Study|Protocol Violation|7
7286421|NCT00510952|11502991|FG001|Overall Study|Protocol Violation|4
7286422|NCT00510952|11502990|FG000|Overall Study|Sponsor Decision|1
7286423|NCT00510952|11502991|FG001|Overall Study|Sponsor Decision|0
7286424|NCT00510952|11502990|FG000|Overall Study|Withdrawal by Subject|6
7286425|NCT00510952|11502991|FG001|Overall Study|Withdrawal by Subject|7
7286426|NCT00510952|11502990|FG000|Overall Study|Did Not Receive Study Drug|2
7286427|NCT00510952|11502991|FG001|Overall Study|Did Not Receive Study Drug|0
7286428|NCT00511004|11503000|FG000|Overall Study|Lost to Follow-up|0
7286429|NCT00511004|11503001|FG001|Overall Study|Lost to Follow-up|0
7286430|NCT00511004|11503002|FG002|Overall Study|Lost to Follow-up|4
7286431|NCT00511108|11503027|FG000|Overall Study|Adverse Event|2
7286432|NCT00511108|11503028|FG001|Overall Study|Adverse Event|0
7286433|NCT00511108|11503029|FG002|Overall Study|Adverse Event|1
7286434|NCT00511108|11503030|FG003|Overall Study|Adverse Event|2
7286435|NCT00511108|11503027|FG000|Overall Study|Lost to Follow-up|0
7286436|NCT00511108|11503028|FG001|Overall Study|Lost to Follow-up|2
7286437|NCT00511108|11503029|FG002|Overall Study|Lost to Follow-up|1
7286438|NCT00511108|11503030|FG003|Overall Study|Lost to Follow-up|0
7286439|NCT00511108|11503027|FG000|Overall Study|Physician Decision|0
7286440|NCT00511108|11503028|FG001|Overall Study|Physician Decision|0
7286441|NCT00511108|11503029|FG002|Overall Study|Physician Decision|0
7286442|NCT00511108|11503030|FG003|Overall Study|Physician Decision|1
7286443|NCT00511108|11503027|FG000|Overall Study|Withdrawal by Subject|4
7286444|NCT00511108|11503028|FG001|Overall Study|Withdrawal by Subject|0
7286445|NCT00511108|11503029|FG002|Overall Study|Withdrawal by Subject|3
7286446|NCT00511108|11503030|FG003|Overall Study|Withdrawal by Subject|2
7286447|NCT00511147|11503040|FG000|Overall Study|Withdrawal by Subject|1
7286448|NCT00511147|11503040|FG000|Overall Study|Disease progression|5
7286449|NCT00511147|11503040|FG000|Overall Study|Required platelet transfusion|1
7286450|NCT00511238|11503051|FG000|Overall Study|Adverse Event|13
7286451|NCT00511238|11503052|FG001|Overall Study|Adverse Event|33
7286452|NCT00511238|11503051|FG000|Overall Study|Withdrawal by Subject|2
7286453|NCT00511238|11503052|FG001|Overall Study|Withdrawal by Subject|22
7286454|NCT00511238|11503051|FG000|Overall Study|Progressive Disease|23
7286455|NCT00511238|11503052|FG001|Overall Study|Progressive Disease|157
7286456|NCT00511238|11503051|FG000|Overall Study|various reasons|4
7286457|NCT00511238|11503052|FG001|Overall Study|various reasons|14
7286458|NCT00511472|11503070|FG000|Overall Study|Clinical Adverse Event|1
7286459|NCT00511472|11503071|FG001|Overall Study|Clinical Adverse Event|2
7286460|NCT00511472|11503070|FG000|Overall Study|Laboratory Adverse Event|0
7286461|NCT00511472|11503071|FG001|Overall Study|Laboratory Adverse Event|2
7286462|NCT00511472|11503070|FG000|Overall Study|Not reported|2
7286463|NCT00511472|11503071|FG001|Overall Study|Not reported|2
7286464|NCT00511667|11503088|FG000|Overall Study|Adverse Event|1
7286465|NCT00511667|11503089|FG001|Overall Study|Adverse Event|0
7286466|NCT00511667|11503088|FG000|Overall Study|Protocol Violation|1
7286467|NCT00511667|11503089|FG001|Overall Study|Protocol Violation|1
7286468|NCT00511667|11503088|FG000|Overall Study|Withdrawal by Subject|2
7286469|NCT00511667|11503089|FG001|Overall Study|Withdrawal by Subject|0
7286470|NCT00511667|11503088|FG000|Overall Study|Site terminated|6
7286471|NCT00511667|11503089|FG001|Overall Study|Site terminated|1
7286472|NCT00511667|11503088|FG000|Overall Study|Other|2
7286473|NCT00511667|11503089|FG001|Overall Study|Other|1
7286474|NCT00511797|11503114|FG000|Overall Study|Adverse Event|1
7286475|NCT00511797|11503115|FG001|Overall Study|Adverse Event|2
7286476|NCT00511797|11503116|FG002|Overall Study|Adverse Event|2
7286477|NCT00511797|11503117|FG003|Overall Study|Adverse Event|2
7286478|NCT00511797|11503114|FG000|Overall Study|Lost to Follow-up|1
7286479|NCT00511797|11503115|FG001|Overall Study|Lost to Follow-up|0
7286480|NCT00511797|11503116|FG002|Overall Study|Lost to Follow-up|0
7286481|NCT00511797|11503117|FG003|Overall Study|Lost to Follow-up|1
7286482|NCT00511797|11503114|FG000|Overall Study|Pregnancy|0
7286483|NCT00511797|11503115|FG001|Overall Study|Pregnancy|0
7286484|NCT00511797|11503116|FG002|Overall Study|Pregnancy|0
7286485|NCT00511797|11503117|FG003|Overall Study|Pregnancy|1
7286486|NCT00511797|11503114|FG000|Overall Study|Protocol Violation|0
7286487|NCT00511797|11503115|FG001|Overall Study|Protocol Violation|2
7286488|NCT00511797|11503116|FG002|Overall Study|Protocol Violation|2
7286489|NCT00511797|11503117|FG003|Overall Study|Protocol Violation|3
7286490|NCT00511797|11503114|FG000|Overall Study|Withdrawal by Subject|3
7286491|NCT00511797|11503115|FG001|Overall Study|Withdrawal by Subject|3
7286492|NCT00511797|11503116|FG002|Overall Study|Withdrawal by Subject|4
7286493|NCT00511797|11503117|FG003|Overall Study|Withdrawal by Subject|2
7286494|NCT00511797|11503114|FG000|Overall Study|Never dispensed|1
7286495|NCT00511797|11503115|FG001|Overall Study|Never dispensed|0
7286496|NCT00511797|11503116|FG002|Overall Study|Never dispensed|1
7286497|NCT00511797|11503117|FG003|Overall Study|Never dispensed|3
7286498|NCT00511797|11503114|FG000|Overall Study|Study drug not taken|0
7286499|NCT00511797|11503115|FG001|Overall Study|Study drug not taken|1
7286500|NCT00511797|11503116|FG002|Overall Study|Study drug not taken|0
7286501|NCT00511797|11503117|FG003|Overall Study|Study drug not taken|1
7286502|NCT00511797|11503114|FG000|Overall Study|Partially missing diary|0
7286503|NCT00511797|11503115|FG001|Overall Study|Partially missing diary|0
7286504|NCT00511797|11503116|FG002|Overall Study|Partially missing diary|1
7286505|NCT00511797|11503117|FG003|Overall Study|Partially missing diary|0
7286506|NCT00511797|11503114|FG000|Overall Study|Other (moving etc)|1
7286507|NCT00511797|11503115|FG001|Overall Study|Other (moving etc)|0
7286508|NCT00511797|11503116|FG002|Overall Study|Other (moving etc)|1
7286509|NCT00511797|11503117|FG003|Overall Study|Other (moving etc)|2
7286510|NCT00511810|11503129|FG000|Overall Study|Lost to Follow-up|1
7286511|NCT00511810|11503130|FG001|Overall Study|Lost to Follow-up|2
7286512|NCT00511810|11503129|FG000|Overall Study|Lack of Efficacy|0
7286513|NCT00511810|11503130|FG001|Overall Study|Lack of Efficacy|2
7286514|NCT00511810|11503129|FG000|Overall Study|Refused second scn|0
7286515|NCT00511810|11503130|FG001|Overall Study|Refused second scn|1
7286516|NCT00511836|11503138|FG000|Double-blind Period|Lost to Follow-up|1
7286517|NCT00511836|11503139|FG001|Double-blind Period|Lost to Follow-up|0
7286518|NCT00511875|11503163|FG000|Overall Study|Lost to Follow-up|4
7286519|NCT00511875|11503164|FG001|Overall Study|Lost to Follow-up|0
7286520|NCT00511875|11503163|FG000|Overall Study|Missing variables|1
7286521|NCT00511875|11503164|FG001|Overall Study|Missing variables|0
7286522|NCT00511901|11503172|FG000|Overall Study|Withdrawal by Subject|1
7286523|NCT00511901|11503173|FG001|Overall Study|Withdrawal by Subject|3
7286524|NCT00512096|11503192|FG000|Overall Study|Adverse Event|2
7286525|NCT00512096|11503192|FG000|Overall Study|Withdrawal by Subject|2
7286526|NCT00512096|11503192|FG000|Overall Study|Lack of Efficacy|3
7286527|NCT00512135|11503196|FG000|Overall Study|Not Treated|5
7286528|NCT00512135|11503196|FG000|Overall Study|Lack of Efficacy|2
7286529|NCT00512135|11503196|FG000|Overall Study|Adverse Event|6
7286530|NCT00512135|11503196|FG000|Overall Study|Withdrawal by Subject|22
7286531|NCT00512135|11503196|FG000|Overall Study|Lost to Follow-up|27
7286532|NCT00512135|11503196|FG000|Overall Study|Other|22
7286533|NCT00512148|11503201|FG000|Primay Study Period|Withdrawal by Subject|1
7286534|NCT00512252|11503210|FG000|Overall Study|Lost to Follow-up|0
7286535|NCT00512252|11503211|FG001|Overall Study|Lost to Follow-up|0
7286536|NCT00512252|11503212|FG002|Overall Study|Lost to Follow-up|1
7286537|NCT00512252|11503210|FG000|Overall Study|Protocol Violation|0
7286538|NCT00512252|11503211|FG001|Overall Study|Protocol Violation|0
7286539|NCT00512252|11503212|FG002|Overall Study|Protocol Violation|1
7286540|NCT00512252|11503210|FG000|Overall Study|Death|0
7286541|NCT00512252|11503211|FG001|Overall Study|Death|0
7286542|NCT00512252|11503212|FG002|Overall Study|Death|1
7286543|NCT00512707|11503240|FG000|Overall Study|Lost to Follow-up|5
7286544|NCT00512707|11503241|FG001|Overall Study|Lost to Follow-up|11
7286545|NCT00512707|11503240|FG000|Overall Study|Developed skin irritation|2
7286546|NCT00512707|11503241|FG001|Overall Study|Developed skin irritation|1
7286547|NCT00512707|11503240|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
7286548|NCT00512707|11503241|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
7286549|NCT00512707|11503240|FG000|Overall Study|Unable to tolerate the smell of the gel|1
7286550|NCT00512707|11503241|FG001|Overall Study|Unable to tolerate the smell of the gel|0
7286551|NCT00512798|11503249|FG000|Overall Study|Death|0
7286552|NCT00512798|11503250|FG001|Overall Study|Death|3
7286553|NCT00512798|11503249|FG000|Overall Study|Adverse Event|2
7286554|NCT00512798|11503250|FG001|Overall Study|Adverse Event|4
7286555|NCT00512798|11503249|FG000|Overall Study|Progression of disease|14
7286556|NCT00512798|11503250|FG001|Overall Study|Progression of disease|20
7286557|NCT00512798|11503249|FG000|Overall Study|Withdrawal by Subject|3
7286558|NCT00512798|11503250|FG001|Overall Study|Withdrawal by Subject|0
7623012|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Death|0
7623013|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Death|0
7623014|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Death|1
7623015|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Death|0
7623016|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Death|0
7623017|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1
7623018|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6
7623019|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3
7623020|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4
7623021|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0
7623022|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623023|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623024|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1
7623025|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623026|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0
7623027|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Other|0
7623028|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Other|1
7623029|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Other|0
7623030|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Other|0
7623031|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Other|0
7623032|NCT03317496|12033955|FG000|Phase 1b Lead-in: Treatment|Ongoing|2
7623033|NCT03317496|12033956|FG001|Phase 1b Lead-in: Treatment|Ongoing|1
7623034|NCT03317496|12033957|FG002|Phase 1b Lead-in: Treatment|Ongoing|0
7623035|NCT03317496|12033958|FG003|Phase 1b Lead-in: Treatment|Ongoing|2
7623036|NCT03317496|12033959|FG004|Phase 1b Lead-in: Treatment|Ongoing|0
7623037|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Death|2
7623038|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Death|7
7623039|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Death|4
7623040|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Death|3
7623041|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Death|0
7623042|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1
7623043|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623044|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623045|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7623046|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0
7286559|NCT00512902|11503261|FG000|Overall Study|Adverse Event|7
7286560|NCT00512902|11503261|FG000|Overall Study|Lost to Follow-up|1
7286561|NCT00513019|11503267|FG000|Overall Study|Adverse Event|1
7286562|NCT00513019|11503268|FG001|Overall Study|Adverse Event|0
7286563|NCT00513019|11503267|FG000|Overall Study|Withdrawal by Subject|4
7286564|NCT00513019|11503268|FG001|Overall Study|Withdrawal by Subject|5
7286565|NCT00513071|11503274|FG000|Overall Study|Adverse Event|1
7286566|NCT00513071|11503274|FG000|Overall Study|Withdrawal by Subject|1
7286567|NCT00513071|11503274|FG000|Overall Study|Physician Decision|3
7286568|NCT00513240|11503280|FG000|Overall Study|Did not have intended surgery|3
7286569|NCT00513240|11503281|FG001|Overall Study|Did not have intended surgery|0
7286570|NCT00513240|11503280|FG000|Overall Study|Death|3
7286571|NCT00513240|11503281|FG001|Overall Study|Death|3
7286572|NCT00513240|11503280|FG000|Overall Study|Withdrawal by Subject|7
7286573|NCT00513240|11503281|FG001|Overall Study|Withdrawal by Subject|4
7286574|NCT00513305|11503301|FG000|Overall Study|Adverse Event|6
7286575|NCT00513305|11503302|FG001|Overall Study|Adverse Event|2
7286576|NCT00513305|11503301|FG000|Overall Study|Death (through Consolidation Treatment)|2
7286577|NCT00513305|11503302|FG001|Overall Study|Death (through Consolidation Treatment)|2
7286578|NCT00513305|11503301|FG000|Overall Study|Lack of Efficacy|8
7286579|NCT00513305|11503302|FG001|Overall Study|Lack of Efficacy|13
7286580|NCT00513305|11503301|FG000|Overall Study|Withdrawal by Subject|1
7286581|NCT00513305|11503302|FG001|Overall Study|Withdrawal by Subject|2
7286582|NCT00513305|11503301|FG000|Overall Study|Disease progression|8
7286583|NCT00513305|11503302|FG001|Overall Study|Disease progression|5
7286584|NCT00513305|11503301|FG000|Overall Study|Eligible for stem cell transplant|1
7286585|NCT00513305|11503302|FG001|Overall Study|Eligible for stem cell transplant|0
7286586|NCT00513305|11503301|FG000|Overall Study|Hematologic counts did not recover|1
7286587|NCT00513305|11503302|FG001|Overall Study|Hematologic counts did not recover|0
7286588|NCT00513305|11503301|FG000|Overall Study|Physician Decision|1
7286589|NCT00513305|11503302|FG001|Overall Study|Physician Decision|0
7286590|NCT00513305|11503301|FG000|Overall Study|Persistent hypocellularity|0
7286591|NCT00513305|11503302|FG001|Overall Study|Persistent hypocellularity|1
7286592|NCT00513305|11503301|FG000|Overall Study|Sponsor Decision|0
7286593|NCT00513305|11503302|FG001|Overall Study|Sponsor Decision|2
7286594|NCT00513357|11503318|FG000|Overall Study|did not receive allocated placebo|2
7286595|NCT00513357|11503319|FG001|Overall Study|did not receive allocated placebo|3
7286596|NCT00513357|11503318|FG000|Overall Study|Adverse Event|4
7286597|NCT00513357|11503319|FG001|Overall Study|Adverse Event|2
7286598|NCT00513357|11503318|FG000|Overall Study|Death|2
7286599|NCT00513357|11503319|FG001|Overall Study|Death|0
7286600|NCT00513357|11503318|FG000|Overall Study|Withdrawal by Subject|5
7286601|NCT00513357|11503319|FG001|Overall Study|Withdrawal by Subject|4
7286602|NCT00513357|11503318|FG000|Overall Study|Disease Progression|2
7286603|NCT00513357|11503319|FG001|Overall Study|Disease Progression|1
7286604|NCT00513409|11503333|FG000|Overall Study|Adverse Event|0
7286605|NCT00513409|11503334|FG001|Overall Study|Adverse Event|1
7286606|NCT00513409|11503333|FG000|Overall Study|Withdrawal by Subject|0
7286607|NCT00513409|11503334|FG001|Overall Study|Withdrawal by Subject|2
7286608|NCT00513409|11503333|FG000|Overall Study|Lost to Follow-up|0
7286609|NCT00513409|11503334|FG001|Overall Study|Lost to Follow-up|1
7286610|NCT00513409|11503333|FG000|Overall Study|Physician Decision|1
7286611|NCT00513409|11503334|FG001|Overall Study|Physician Decision|0
7286612|NCT00513409|11503333|FG000|Overall Study|Visit 3 not done|1
7286613|NCT00513409|11503334|FG001|Overall Study|Visit 3 not done|2
7286614|NCT00513474|11503355|FG000|Overall Study|Death|6
7286615|NCT00513474|11503356|FG001|Overall Study|Death|9
7286616|NCT00513474|11503355|FG000|Overall Study|Participant Withdrew Consent|1
7286617|NCT00513474|11503356|FG001|Overall Study|Participant Withdrew Consent|0
7286618|NCT00513500|11503364|FG000|Overall Study|Lost to Follow-up|35
7286619|NCT00513500|11503365|FG001|Overall Study|Lost to Follow-up|39
7286620|NCT00513500|11503364|FG000|Overall Study|Death|2
7286621|NCT00513500|11503365|FG001|Overall Study|Death|1
7286622|NCT00513500|11503364|FG000|Overall Study|Hospitalized|4
7286623|NCT00513500|11503365|FG001|Overall Study|Hospitalized|14
7286624|NCT00513604|11503382|FG000|Overall Study|Not treated|2
7286625|NCT00513604|11503383|FG001|Overall Study|Not treated|0
7286626|NCT00513604|11503384|FG002|Overall Study|Not treated|1
7286627|NCT00513604|11503385|FG003|Overall Study|Not treated|0
7286628|NCT00513604|11503386|FG004|Overall Study|Not treated|0
7286629|NCT00513604|11503382|FG000|Overall Study|Death during treatment|0
7286630|NCT00513604|11503383|FG001|Overall Study|Death during treatment|3
7286631|NCT00513604|11503384|FG002|Overall Study|Death during treatment|2
7286632|NCT00513604|11503385|FG003|Overall Study|Death during treatment|0
7286633|NCT00513604|11503386|FG004|Overall Study|Death during treatment|0
7286634|NCT00513682|11503398|FG000|Washout Phase|Adverse Event|2
7286635|NCT00513695|11503405|FG000|Overall Study|Discontinued therapy|2
7286636|NCT00513695|11503405|FG000|Overall Study|Progression prior to surgery|3
7286637|NCT00513708|11503412|FG000|Overall Study|Lost to Follow-up|4
7286638|NCT00513708|11503413|FG001|Overall Study|Lost to Follow-up|4
7286639|NCT00513708|11503414|FG002|Overall Study|Lost to Follow-up|4
7286640|NCT00514020|11503458|FG000|Overall Study|Adverse Event|6
7286641|NCT00514020|11503458|FG000|Overall Study|Withdrawal by Subject|3
7286642|NCT00514020|11503458|FG000|Overall Study|Physician Decision|1
7286643|NCT00514020|11503458|FG000|Overall Study|disease progression|9
7286644|NCT00514020|11503458|FG000|Overall Study|other complicating disease|2
7286645|NCT00514020|11503458|FG000|Overall Study|patient went to radiation treatment|1
7286646|NCT00514020|11503458|FG000|Overall Study|"patients moved to the no tx group"|6
7286647|NCT00514046|11503471|FG000|Overall Study|transferred to another protocol|2
7286648|NCT00514046|11503472|FG001|Overall Study|transferred to another protocol|1
7286649|NCT00514046|11503473|FG002|Overall Study|transferred to another protocol|3
7286650|NCT00514046|11503474|FG003|Overall Study|transferred to another protocol|0
7286651|NCT00514046|11503475|FG004|Overall Study|transferred to another protocol|1
7286652|NCT00514046|11503476|FG005|Overall Study|transferred to another protocol|0
7286653|NCT00514046|11503477|FG006|Overall Study|transferred to another protocol|0
7286654|NCT00514046|11503478|FG007|Overall Study|transferred to another protocol|0
7286655|NCT00514046|11503479|FG008|Overall Study|transferred to another protocol|0
7286656|NCT00514046|11503471|FG000|Overall Study|Getting vandetanib via the REMS program|1
7286657|NCT00514046|11503472|FG001|Overall Study|Getting vandetanib via the REMS program|0
7286658|NCT00514046|11503473|FG002|Overall Study|Getting vandetanib via the REMS program|0
7286659|NCT00514046|11503474|FG003|Overall Study|Getting vandetanib via the REMS program|0
7286660|NCT00514046|11503475|FG004|Overall Study|Getting vandetanib via the REMS program|0
7286661|NCT00514046|11503476|FG005|Overall Study|Getting vandetanib via the REMS program|0
7286662|NCT00514046|11503477|FG006|Overall Study|Getting vandetanib via the REMS program|0
7286663|NCT00514046|11503478|FG007|Overall Study|Getting vandetanib via the REMS program|1
7286664|NCT00514046|11503479|FG008|Overall Study|Getting vandetanib via the REMS program|1
7286665|NCT00514046|11503471|FG000|Overall Study|Disease progression on study|0
7286666|NCT00514046|11503472|FG001|Overall Study|Disease progression on study|0
7286667|NCT00514046|11503473|FG002|Overall Study|Disease progression on study|2
7286668|NCT00514046|11503474|FG003|Overall Study|Disease progression on study|0
7286669|NCT00514046|11503475|FG004|Overall Study|Disease progression on study|0
7286670|NCT00514046|11503476|FG005|Overall Study|Disease progression on study|1
7286671|NCT00514046|11503477|FG006|Overall Study|Disease progression on study|0
7286672|NCT00514046|11503478|FG007|Overall Study|Disease progression on study|0
7286673|NCT00514046|11503479|FG008|Overall Study|Disease progression on study|0
7286674|NCT00514449|11503511|FG000|Overall Study|Withdrawal by Subject|1
7286675|NCT00514449|11503512|FG001|Overall Study|Withdrawal by Subject|2
7286676|NCT00514449|11503511|FG000|Overall Study|Protocol Violation|1
7286677|NCT00514449|11503512|FG001|Overall Study|Protocol Violation|2
7286678|NCT00514449|11503511|FG000|Overall Study|Lost to Follow-up|1
7286679|NCT00514449|11503512|FG001|Overall Study|Lost to Follow-up|0
7286680|NCT00514514|11503528|FG000|Pre-phase|Death|10
7286681|NCT00514514|11503529|FG001|Pre-phase|Death|0
7286682|NCT00514514|11503530|FG002|Pre-phase|Death|0
7286683|NCT00514514|11503528|FG000|Pre-phase|administrative problems|2
7286684|NCT00514514|11503529|FG001|Pre-phase|administrative problems|0
7286685|NCT00514514|11503530|FG002|Pre-phase|administrative problems|0
7286686|NCT00514514|11503528|FG000|Pre-phase|Protocol Violation|6
7286687|NCT00514514|11503529|FG001|Pre-phase|Protocol Violation|0
7286688|NCT00514514|11503530|FG002|Pre-phase|Protocol Violation|0
7286689|NCT00514514|11503528|FG000|Pre-phase|condition no longer requires study drug|7
7286690|NCT00514514|11503529|FG001|Pre-phase|condition no longer requires study drug|0
7286691|NCT00514514|11503530|FG002|Pre-phase|condition no longer requires study drug|0
7286692|NCT00514514|11503528|FG000|Pre-phase|abnormal test procedure results|15
7286693|NCT00514514|11503529|FG001|Pre-phase|abnormal test procedure results|0
7286694|NCT00514514|11503530|FG002|Pre-phase|abnormal test procedure results|0
7286695|NCT00514514|11503528|FG000|Pre-phase|Lost to Follow-up|2
7286696|NCT00514514|11503529|FG001|Pre-phase|Lost to Follow-up|0
7286697|NCT00514514|11503530|FG002|Pre-phase|Lost to Follow-up|0
7286698|NCT00514514|11503528|FG000|Pre-phase|abnormal lab values|23
7286699|NCT00514514|11503529|FG001|Pre-phase|abnormal lab values|0
7286700|NCT00514514|11503530|FG002|Pre-phase|abnormal lab values|0
7286701|NCT00514514|11503528|FG000|Pre-phase|Lack of Efficacy|35
7286702|NCT00514514|11503529|FG001|Pre-phase|Lack of Efficacy|0
7286703|NCT00514514|11503530|FG002|Pre-phase|Lack of Efficacy|0
7286704|NCT00514514|11503528|FG000|Pre-phase|Adverse Event|137
7286705|NCT00514514|11503529|FG001|Pre-phase|Adverse Event|0
7286706|NCT00514514|11503530|FG002|Pre-phase|Adverse Event|0
7286707|NCT00514514|11503528|FG000|Pre-phase|Withdrawal by Subject|66
7286708|NCT00514514|11503529|FG001|Pre-phase|Withdrawal by Subject|0
7286709|NCT00514514|11503530|FG002|Pre-phase|Withdrawal by Subject|0
7286710|NCT00514514|11503528|FG000|Randomized - 9 Month|Death|3
7286711|NCT00514514|11503529|FG001|Randomized - 9 Month|Death|2
7286712|NCT00514514|11503530|FG002|Randomized - 9 Month|Death|2
7286713|NCT00514514|11503528|FG000|Randomized - 9 Month|Administrative problems|1
7623047|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623048|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623049|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1
7286714|NCT00514514|11503529|FG001|Randomized - 9 Month|Administrative problems|1
7286715|NCT00514514|11503530|FG002|Randomized - 9 Month|Administrative problems|2
7286716|NCT00514514|11503528|FG000|Randomized - 9 Month|Withdrawal by Subject|7
7286717|NCT00514514|11503529|FG001|Randomized - 9 Month|Withdrawal by Subject|7
7286718|NCT00514514|11503530|FG002|Randomized - 9 Month|Withdrawal by Subject|5
7286719|NCT00514514|11503528|FG000|Randomized - 9 Month|Protocol Violation|1
7286720|NCT00514514|11503529|FG001|Randomized - 9 Month|Protocol Violation|1
7286721|NCT00514514|11503530|FG002|Randomized - 9 Month|Protocol Violation|0
7286722|NCT00514514|11503528|FG000|Randomized - 9 Month|Lack of Efficacy|2
7286723|NCT00514514|11503529|FG001|Randomized - 9 Month|Lack of Efficacy|3
7286724|NCT00514514|11503530|FG002|Randomized - 9 Month|Lack of Efficacy|1
7286725|NCT00514514|11503528|FG000|Randomized - 9 Month|Abnormal laboratory values|0
7286726|NCT00514514|11503529|FG001|Randomized - 9 Month|Abnormal laboratory values|3
7286727|NCT00514514|11503530|FG002|Randomized - 9 Month|Abnormal laboratory values|1
7286728|NCT00514514|11503528|FG000|Randomized - 9 Month|Adverse Event|25
7286729|NCT00514514|11503529|FG001|Randomized - 9 Month|Adverse Event|44
7286730|NCT00514514|11503530|FG002|Randomized - 9 Month|Adverse Event|27
7286731|NCT00514514|11503528|FG000|Extension - 4 Years|Withdrawal by Subject|5
7286732|NCT00514514|11503529|FG001|Extension - 4 Years|Withdrawal by Subject|2
7286733|NCT00514514|11503530|FG002|Extension - 4 Years|Withdrawal by Subject|2
7286734|NCT00514514|11503528|FG000|Extension - 4 Years|Lost to Follow-up|12
7286735|NCT00514514|11503529|FG001|Extension - 4 Years|Lost to Follow-up|10
7286736|NCT00514514|11503530|FG002|Extension - 4 Years|Lost to Follow-up|9
7286737|NCT00514514|11503528|FG000|Extension - 4 Years|Administrative problems|3
7286738|NCT00514514|11503529|FG001|Extension - 4 Years|Administrative problems|1
7286739|NCT00514514|11503530|FG002|Extension - 4 Years|Administrative problems|1
7286740|NCT00514514|11503528|FG000|Extension - 4 Years|Death|8
7286741|NCT00514514|11503529|FG001|Extension - 4 Years|Death|3
7286742|NCT00514514|11503530|FG002|Extension - 4 Years|Death|6
7623050|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623051|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0
7623052|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Other|1
7623053|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Other|3
7623054|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Other|0
7623055|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Other|1
7623056|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Other|0
7623057|NCT03317496|12033955|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0
7623058|NCT03317496|12033956|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1
7623059|NCT03317496|12033957|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0
7623060|NCT03317496|12033958|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0
7623061|NCT03317496|12033959|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0
7623062|NCT03317496|12033955|FG000|Phase 2: Treatment|Adverse Event|0
7623063|NCT03317496|12033956|FG001|Phase 2: Treatment|Adverse Event|0
7623064|NCT03317496|12033957|FG002|Phase 2: Treatment|Adverse Event|0
7623065|NCT03317496|12033958|FG003|Phase 2: Treatment|Adverse Event|0
7623066|NCT03317496|12033959|FG004|Phase 2: Treatment|Adverse Event|4
7623067|NCT03317496|12033955|FG000|Phase 2: Treatment|Death|0
7623068|NCT03317496|12033956|FG001|Phase 2: Treatment|Death|0
7623069|NCT03317496|12033957|FG002|Phase 2: Treatment|Death|0
7623070|NCT03317496|12033958|FG003|Phase 2: Treatment|Death|0
7623071|NCT03317496|12033959|FG004|Phase 2: Treatment|Death|1
7623072|NCT03317496|12033955|FG000|Phase 2: Treatment|Physician Decision|0
7623073|NCT03317496|12033956|FG001|Phase 2: Treatment|Physician Decision|0
7623074|NCT03317496|12033957|FG002|Phase 2: Treatment|Physician Decision|0
7623075|NCT03317496|12033958|FG003|Phase 2: Treatment|Physician Decision|0
7623076|NCT03317496|12033959|FG004|Phase 2: Treatment|Physician Decision|1
7623077|NCT03317496|12033955|FG000|Phase 2: Treatment|Progressive Disease|0
7623078|NCT03317496|12033956|FG001|Phase 2: Treatment|Progressive Disease|0
7623079|NCT03317496|12033957|FG002|Phase 2: Treatment|Progressive Disease|0
7623080|NCT03317496|12033958|FG003|Phase 2: Treatment|Progressive Disease|0
7623081|NCT03317496|12033959|FG004|Phase 2: Treatment|Progressive Disease|18
7623082|NCT03317496|12033955|FG000|Phase 2: Treatment|Withdrawal by Subject|0
7623083|NCT03317496|12033956|FG001|Phase 2: Treatment|Withdrawal by Subject|0
7623084|NCT03317496|12033957|FG002|Phase 2: Treatment|Withdrawal by Subject|0
7623085|NCT03317496|12033958|FG003|Phase 2: Treatment|Withdrawal by Subject|0
7623086|NCT03317496|12033959|FG004|Phase 2: Treatment|Withdrawal by Subject|1
7623087|NCT03317496|12033955|FG000|Phase 2: Treatment|Other|0
7623088|NCT03317496|12033956|FG001|Phase 2: Treatment|Other|0
7623089|NCT03317496|12033957|FG002|Phase 2: Treatment|Other|0
7623090|NCT03317496|12033958|FG003|Phase 2: Treatment|Other|0
7623091|NCT03317496|12033959|FG004|Phase 2: Treatment|Other|2
7623092|NCT03317496|12033955|FG000|Phase 2: Treatment|Ongoing|0
7623093|NCT03317496|12033956|FG001|Phase 2: Treatment|Ongoing|0
7623094|NCT03317496|12033957|FG002|Phase 2: Treatment|Ongoing|0
7623095|NCT03317496|12033958|FG003|Phase 2: Treatment|Ongoing|0
7623096|NCT03317496|12033959|FG004|Phase 2: Treatment|Ongoing|8
7623097|NCT03317496|12033955|FG000|Phase 2: Follow-up|Death|0
7623098|NCT03317496|12033956|FG001|Phase 2: Follow-up|Death|0
7623099|NCT03317496|12033957|FG002|Phase 2: Follow-up|Death|0
7623100|NCT03317496|12033958|FG003|Phase 2: Follow-up|Death|0
7623101|NCT03317496|12033959|FG004|Phase 2: Follow-up|Death|16
7623102|NCT03317496|12033955|FG000|Phase 2: Follow-up|Withdrawal by Subject|0
7623103|NCT03317496|12033956|FG001|Phase 2: Follow-up|Withdrawal by Subject|0
7623104|NCT03317496|12033957|FG002|Phase 2: Follow-up|Withdrawal by Subject|0
7623105|NCT03317496|12033958|FG003|Phase 2: Follow-up|Withdrawal by Subject|0
7623106|NCT03317496|12033959|FG004|Phase 2: Follow-up|Withdrawal by Subject|1
7623107|NCT03317496|12033955|FG000|Phase 2: Follow-up|Lost to Follow-up|0
7286743|NCT00514514|11503528|FG000|Extension - 4 Years|Adverse Event|9
7286744|NCT00514514|11503529|FG001|Extension - 4 Years|Adverse Event|6
7286745|NCT00514514|11503530|FG002|Extension - 4 Years|Adverse Event|3
7286746|NCT00514540|11503538|FG000|First-Line Chemo|Withdrawal by Subject|1
7286747|NCT00514540|11503538|FG000|First-Line Chemo|Protocol Violation|7
7623108|NCT03317496|12033956|FG001|Phase 2: Follow-up|Lost to Follow-up|0
7286748|NCT00514540|11503538|FG000|Second-Line|Physician/Patient Decision|31
7286749|NCT00514683|11503555|FG000|Overall Study|Not treated|2
7286750|NCT00514683|11503556|FG001|Overall Study|Not treated|1
7286751|NCT00514683|11503557|FG002|Overall Study|Not treated|0
7286752|NCT00514683|11503558|FG003|Overall Study|Not treated|0
7286753|NCT00514683|11503559|FG004|Overall Study|Not treated|1
7286754|NCT00514683|11503555|FG000|Overall Study|Adverse Event|21
7286755|NCT00514683|11503556|FG001|Overall Study|Adverse Event|20
7286756|NCT00514683|11503557|FG002|Overall Study|Adverse Event|15
7286757|NCT00514683|11503558|FG003|Overall Study|Adverse Event|13
7286758|NCT00514683|11503559|FG004|Overall Study|Adverse Event|27
7286759|NCT00514683|11503555|FG000|Overall Study|Protocol Violation|1
7286760|NCT00514683|11503556|FG001|Overall Study|Protocol Violation|1
7286761|NCT00514683|11503557|FG002|Overall Study|Protocol Violation|0
7286762|NCT00514683|11503558|FG003|Overall Study|Protocol Violation|1
7286763|NCT00514683|11503559|FG004|Overall Study|Protocol Violation|0
7286764|NCT00514683|11503555|FG000|Overall Study|Withdrawal by Subject|2
7286765|NCT00514683|11503556|FG001|Overall Study|Withdrawal by Subject|2
7286766|NCT00514683|11503557|FG002|Overall Study|Withdrawal by Subject|1
7286767|NCT00514683|11503558|FG003|Overall Study|Withdrawal by Subject|0
7286768|NCT00514683|11503559|FG004|Overall Study|Withdrawal by Subject|4
7286769|NCT00514683|11503555|FG000|Overall Study|Reason other than listed above|0
7286770|NCT00514683|11503556|FG001|Overall Study|Reason other than listed above|1
7286771|NCT00514683|11503557|FG002|Overall Study|Reason other than listed above|2
7286772|NCT00514683|11503558|FG003|Overall Study|Reason other than listed above|0
7286773|NCT00514683|11503559|FG004|Overall Study|Reason other than listed above|1
7286774|NCT00514735|11503588|FG000|Overall Study|Withdrawal by Subject|13
7286775|NCT00514735|11503589|FG001|Overall Study|Withdrawal by Subject|5
7286776|NCT00514735|11503588|FG000|Overall Study|Death|1
7286777|NCT00514735|11503589|FG001|Overall Study|Death|0
7286778|NCT00514735|11503588|FG000|Overall Study|Lost to Follow-up|0
7286779|NCT00514735|11503589|FG001|Overall Study|Lost to Follow-up|1
7286780|NCT00514904|11503608|FG000|Overall Study|Withdrawal by Subject|3
7286781|NCT00514904|11503609|FG001|Overall Study|Withdrawal by Subject|2
7286782|NCT00514904|11503608|FG000|Overall Study|Lost to Follow-up|21
7286783|NCT00514904|11503609|FG001|Overall Study|Lost to Follow-up|3
7286784|NCT00514917|11503617|FG000|Overall Study|Death|4
7286785|NCT00514917|11503618|FG001|Overall Study|Death|10
7286786|NCT00514917|11503617|FG000|Overall Study|Protocol Violation|1
7286787|NCT00514917|11503618|FG001|Overall Study|Protocol Violation|0
7286788|NCT00514917|11503617|FG000|Overall Study|Lost to Follow-up|4
7286789|NCT00514917|11503618|FG001|Overall Study|Lost to Follow-up|3
7286790|NCT00514917|11503617|FG000|Overall Study|Withdrawal by Subject|18
7286791|NCT00514917|11503618|FG001|Overall Study|Withdrawal by Subject|16
7286792|NCT00514917|11503617|FG000|Overall Study|Discontinued due to study closure|88
7286793|NCT00514917|11503618|FG001|Overall Study|Discontinued due to study closure|81
7286794|NCT00514917|11503617|FG000|Overall Study|Undefined|11
7286795|NCT00514917|11503618|FG001|Overall Study|Undefined|5
7286796|NCT00514943|11503628|FG000|Stage 1|Progressive disease|4
7286797|NCT00514943|11503629|FG001|Stage 1|Progressive disease|8
7286798|NCT00514943|11503628|FG000|Stage 1|Other Adverse Event|16
7286799|NCT00514943|11503629|FG001|Stage 1|Other Adverse Event|6
7286800|NCT00514943|11503628|FG000|Stage 1|Not treated|1
7286801|NCT00514943|11503629|FG001|Stage 1|Not treated|2
7286802|NCT00514943|11503628|FG000|Stage 1|Patient refused to continue study meds|8
7286803|NCT00514943|11503629|FG001|Stage 1|Patient refused to continue study meds|3
7286804|NCT00514943|11503628|FG000|Stage 1|Other than stated above|1
7286805|NCT00514943|11503629|FG001|Stage 1|Other than stated above|7
7286806|NCT00514943|11503628|FG000|Stage 2|Progressive disease|27
7286807|NCT00514943|11503629|FG001|Stage 2|Progressive disease|24
7286808|NCT00514943|11503628|FG000|Stage 2|Other Adverse Event|3
7286809|NCT00514943|11503629|FG001|Stage 2|Other Adverse Event|10
7286810|NCT00514943|11503628|FG000|Stage 2|Patient refused to continue study meds|2
7286811|NCT00514943|11503629|FG001|Stage 2|Patient refused to continue study meds|0
7286812|NCT00514943|11503628|FG000|Stage 2|Other than stated above|0
7286813|NCT00514943|11503629|FG001|Stage 2|Other than stated above|2
7286814|NCT00515008|11503652|FG000|Overall Study|Lost to Follow-up|1
7286815|NCT00515008|11503653|FG001|Overall Study|Lost to Follow-up|0
7286816|NCT00515008|11503652|FG000|Overall Study|Declined|0
7286817|NCT00515008|11503653|FG001|Overall Study|Declined|3
7286818|NCT00515008|11503652|FG000|Overall Study|Left the Boston Area|1
7286819|NCT00515008|11503653|FG001|Overall Study|Left the Boston Area|1
7286820|NCT00515008|11503652|FG000|Overall Study|Scheduling conflict|1
7286821|NCT00515008|11503653|FG001|Overall Study|Scheduling conflict|0
7286822|NCT00515034|11503677|FG000|Overall Study|Adverse Event|2
7286823|NCT00515034|11503678|FG001|Overall Study|Adverse Event|0
7286824|NCT00515034|11503679|FG002|Overall Study|Adverse Event|1
7286825|NCT00515034|11503680|FG003|Overall Study|Adverse Event|0
7286826|NCT00515034|11503677|FG000|Overall Study|Death|4
7286827|NCT00515034|11503678|FG001|Overall Study|Death|2
7286828|NCT00515034|11503679|FG002|Overall Study|Death|1
7286829|NCT00515034|11503680|FG003|Overall Study|Death|3
7286830|NCT00515034|11503677|FG000|Overall Study|Withdrawal by Subject|1
7286831|NCT00515034|11503678|FG001|Overall Study|Withdrawal by Subject|0
7286832|NCT00515034|11503679|FG002|Overall Study|Withdrawal by Subject|3
7286833|NCT00515034|11503680|FG003|Overall Study|Withdrawal by Subject|0
7286834|NCT00515034|11503677|FG000|Overall Study|Physician Decision|0
7286835|NCT00515034|11503678|FG001|Overall Study|Physician Decision|0
7286836|NCT00515034|11503679|FG002|Overall Study|Physician Decision|1
7286837|NCT00515034|11503680|FG003|Overall Study|Physician Decision|1
7286838|NCT00515034|11503677|FG000|Overall Study|Other|1
7286839|NCT00515034|11503678|FG001|Overall Study|Other|0
7286840|NCT00515034|11503679|FG002|Overall Study|Other|2
7286841|NCT00515034|11503680|FG003|Overall Study|Other|1
7286842|NCT00515073|11503690|FG000|Overall Study|Withdrawal by Subject|1
7286843|NCT00515073|11503690|FG000|Overall Study|Physician Decision|1
7286844|NCT00515086|11503698|FG000|Overall Study|Adverse Event|1
7286845|NCT00515086|11503699|FG001|Overall Study|Adverse Event|1
7286846|NCT00515086|11503700|FG002|Overall Study|Adverse Event|2
7286847|NCT00515086|11503701|FG003|Overall Study|Adverse Event|3
7286848|NCT00515086|11503698|FG000|Overall Study|Administrative|1
7286849|NCT00515086|11503699|FG001|Overall Study|Administrative|1
7286850|NCT00515086|11503700|FG002|Overall Study|Administrative|0
7286851|NCT00515086|11503701|FG003|Overall Study|Administrative|0
7286852|NCT00515086|11503698|FG000|Overall Study|Withdrawal by Subject|1
7286853|NCT00515086|11503699|FG001|Overall Study|Withdrawal by Subject|0
7286854|NCT00515086|11503700|FG002|Overall Study|Withdrawal by Subject|0
7286855|NCT00515086|11503701|FG003|Overall Study|Withdrawal by Subject|1
7286856|NCT00515086|11503698|FG000|Overall Study|Unsatisfactory therapeutic effect|18
7286857|NCT00515086|11503699|FG001|Overall Study|Unsatisfactory therapeutic effect|3
7286858|NCT00515086|11503700|FG002|Overall Study|Unsatisfactory therapeutic effect|3
7286859|NCT00515086|11503701|FG003|Overall Study|Unsatisfactory therapeutic effect|2
7286860|NCT00515086|11503698|FG000|Overall Study|Lost to Follow-up|1
7286861|NCT00515086|11503699|FG001|Overall Study|Lost to Follow-up|0
7286862|NCT00515086|11503700|FG002|Overall Study|Lost to Follow-up|0
7286863|NCT00515086|11503701|FG003|Overall Study|Lost to Follow-up|0
7286864|NCT00515086|11503698|FG000|Overall Study|Study drug no longer required|0
7286865|NCT00515086|11503699|FG001|Overall Study|Study drug no longer required|1
7286866|NCT00515086|11503700|FG002|Overall Study|Study drug no longer required|0
7286867|NCT00515086|11503701|FG003|Overall Study|Study drug no longer required|0
7286868|NCT00515086|11503698|FG000|Overall Study|Death|2
7286869|NCT00515086|11503699|FG001|Overall Study|Death|0
7286870|NCT00515086|11503700|FG002|Overall Study|Death|0
7286871|NCT00515086|11503701|FG003|Overall Study|Death|0
7286872|NCT00515099|11503719|FG000|Overall Study|Lost to Follow-up|0
7286873|NCT00515099|11503720|FG001|Overall Study|Lost to Follow-up|4
7286874|NCT00515099|11503719|FG000|Overall Study|Withdrawal by Subject|2
7286875|NCT00515099|11503720|FG001|Overall Study|Withdrawal by Subject|0
7286876|NCT00515099|11503719|FG000|Overall Study|IRB Recommendation|1
7286877|NCT00515099|11503720|FG001|Overall Study|IRB Recommendation|0
7286878|NCT00515216|11503745|FG000|Overall Study|Withdrawal by Subject|1
7286879|NCT00515294|11503754|FG000|Overall Study|Lost to Follow-up|3
7286880|NCT00515294|11503755|FG001|Overall Study|Lost to Follow-up|2
7286881|NCT00515294|11503756|FG002|Overall Study|Lost to Follow-up|3
7286882|NCT00515294|11503757|FG003|Overall Study|Lost to Follow-up|1
7286883|NCT00515294|11503754|FG000|Overall Study|Driver simulator problems|1
7286884|NCT00515294|11503755|FG001|Overall Study|Driver simulator problems|1
7286885|NCT00515294|11503756|FG002|Overall Study|Driver simulator problems|1
7286886|NCT00515294|11503757|FG003|Overall Study|Driver simulator problems|3
7286887|NCT00515294|11503754|FG000|Overall Study|Caffeine amount inaccurate|5
7623109|NCT03317496|12033957|FG002|Phase 2: Follow-up|Lost to Follow-up|0
7623110|NCT03317496|12033958|FG003|Phase 2: Follow-up|Lost to Follow-up|0
7623111|NCT03317496|12033959|FG004|Phase 2: Follow-up|Lost to Follow-up|1
7623112|NCT03317496|12033955|FG000|Phase 2: Follow-up|Other|0
7623113|NCT03317496|12033956|FG001|Phase 2: Follow-up|Other|0
7623114|NCT03317496|12033957|FG002|Phase 2: Follow-up|Other|0
7623115|NCT03317496|12033958|FG003|Phase 2: Follow-up|Other|0
7623116|NCT03317496|12033959|FG004|Phase 2: Follow-up|Other|6
7623117|NCT03317496|12033955|FG000|Phase 2: Follow-up|Ongoing|0
7623118|NCT03317496|12033956|FG001|Phase 2: Follow-up|Ongoing|0
7623119|NCT03317496|12033957|FG002|Phase 2: Follow-up|Ongoing|0
7623120|NCT03317496|12033958|FG003|Phase 2: Follow-up|Ongoing|0
7623121|NCT03317496|12033959|FG004|Phase 2: Follow-up|Ongoing|1
7623122|NCT03260894|12033972|FG000|Overall Study|Death|6
7623123|NCT03260894|12033973|FG001|Overall Study|Death|8
7623124|NCT03260894|12033972|FG000|Overall Study|Withdrawal by Subject|4
7286888|NCT00515294|11503755|FG001|Overall Study|Caffeine amount inaccurate|0
7286889|NCT00515294|11503756|FG002|Overall Study|Caffeine amount inaccurate|7
7286890|NCT00515294|11503757|FG003|Overall Study|Caffeine amount inaccurate|0
7286891|NCT00515463|11503799|FG000|Overall Study|Physician Decision|4
7286892|NCT00515463|11503800|FG001|Overall Study|Physician Decision|2
7286893|NCT00515463|11503799|FG000|Overall Study|Adverse Event|1
7286894|NCT00515463|11503800|FG001|Overall Study|Adverse Event|2
7286895|NCT00515463|11503799|FG000|Overall Study|Withdrawal by Subject|3
7286896|NCT00515463|11503800|FG001|Overall Study|Withdrawal by Subject|4
7286897|NCT00515463|11503799|FG000|Overall Study|Lost to Follow-up|6
7286898|NCT00515463|11503800|FG001|Overall Study|Lost to Follow-up|5
7286899|NCT00515463|11503799|FG000|Overall Study|Other|0
7623125|NCT03260894|12033973|FG001|Overall Study|Withdrawal by Subject|11
7623126|NCT03260894|12033972|FG000|Overall Study|On-going at clinical cut off date|36
7623127|NCT03260894|12033973|FG001|Overall Study|On-going at clinical cut off date|31
7286900|NCT00515463|11503800|FG001|Overall Study|Other|1
7286901|NCT00515502|11503807|FG000|Treatment Period 1|Adverse Event|0
7286902|NCT00515502|11503808|FG001|Treatment Period 1|Adverse Event|0
7286903|NCT00515502|11503809|FG002|Treatment Period 1|Adverse Event|0
7286904|NCT00515502|11503810|FG003|Treatment Period 1|Adverse Event|0
7286905|NCT00515502|11503811|FG004|Treatment Period 1|Adverse Event|0
7286906|NCT00515502|11503812|FG005|Treatment Period 1|Adverse Event|0
7286907|NCT00515502|11503813|FG006|Treatment Period 1|Adverse Event|1
7286908|NCT00515502|11503814|FG007|Treatment Period 1|Adverse Event|0
7286909|NCT00515502|11503815|FG008|Treatment Period 1|Adverse Event|1
7286910|NCT00515502|11503816|FG009|Treatment Period 1|Adverse Event|0
7286911|NCT00515502|11503817|FG010|Treatment Period 1|Adverse Event|0
7286912|NCT00515502|11503818|FG011|Treatment Period 1|Adverse Event|1
7286913|NCT00515502|11503807|FG000|Treatment Period 2|Adverse Event|0
7286914|NCT00515502|11503808|FG001|Treatment Period 2|Adverse Event|1
7286915|NCT00515502|11503809|FG002|Treatment Period 2|Adverse Event|0
7286916|NCT00515502|11503810|FG003|Treatment Period 2|Adverse Event|0
7286917|NCT00515502|11503811|FG004|Treatment Period 2|Adverse Event|0
7286918|NCT00515502|11503812|FG005|Treatment Period 2|Adverse Event|0
7286919|NCT00515502|11503813|FG006|Treatment Period 2|Adverse Event|0
7286920|NCT00515502|11503814|FG007|Treatment Period 2|Adverse Event|0
7286921|NCT00515502|11503815|FG008|Treatment Period 2|Adverse Event|0
7286922|NCT00515502|11503816|FG009|Treatment Period 2|Adverse Event|0
7286923|NCT00515502|11503817|FG010|Treatment Period 2|Adverse Event|0
7286924|NCT00515502|11503818|FG011|Treatment Period 2|Adverse Event|0
7286925|NCT00515541|11503848|FG000|Overall Study|Physician Decision|0
7286926|NCT00515541|11503849|FG001|Overall Study|Physician Decision|2
7286927|NCT00515541|11503850|FG002|Overall Study|Physician Decision|0
7286928|NCT00515541|11503851|FG003|Overall Study|Physician Decision|1
7286929|NCT00515541|11503848|FG000|Overall Study|No show for appointments|0
7286930|NCT00515541|11503849|FG001|Overall Study|No show for appointments|1
7286931|NCT00515541|11503850|FG002|Overall Study|No show for appointments|0
7286932|NCT00515541|11503851|FG003|Overall Study|No show for appointments|2
7286933|NCT00515541|11503848|FG000|Overall Study|Withdrawal by Subject|0
7286934|NCT00515541|11503849|FG001|Overall Study|Withdrawal by Subject|2
7286935|NCT00515541|11503850|FG002|Overall Study|Withdrawal by Subject|0
7286936|NCT00515541|11503851|FG003|Overall Study|Withdrawal by Subject|2
7286937|NCT00515619|11503861|FG000|Overall Study|Adverse Event|34
7286938|NCT00515619|11503861|FG000|Overall Study|Lack of Efficacy|92
7286939|NCT00515619|11503861|FG000|Overall Study|Withdrawal by Subject|66
7286940|NCT00515619|11503861|FG000|Overall Study|Protocol Violation|3
7286941|NCT00515619|11503861|FG000|Overall Study|Lost to Follow-up|4
7286942|NCT00515619|11503861|FG000|Overall Study|Unsatisfactory compliance|6
7286943|NCT00515619|11503861|FG000|Overall Study|Other: Site discontinuing trials|2
7286944|NCT00515619|11503861|FG000|Overall Study|Other: Subject cannot attend visits|2
7286945|NCT00515619|11503861|FG000|Overall Study|Other: Subject required surgery|1
7286946|NCT00515619|11503861|FG000|Overall Study|Other: Subject moved to another country|1
7286947|NCT00515619|11503861|FG000|Overall Study|Other: Investigator decision|1
7286948|NCT00515619|11503861|FG000|Overall Study|Other: Subject became pregnant|1
7286949|NCT00515619|11503861|FG000|Overall Study|Other: Request from sponsor|1
7286950|NCT00515619|11503861|FG000|Overall Study|Other: Drug available on license|1
7286951|NCT00515619|11503861|FG000|Overall Study|Other: Subject interested in other AED|1
7286952|NCT00515827|11503889|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7286953|NCT00515827|11503890|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
7286954|NCT00515827|11503889|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
7286955|NCT00515827|11503890|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
7286956|NCT00516048|11503911|FG000|Overall Study|Death|0
7286957|NCT00516048|11503912|FG001|Overall Study|Death|0
7286958|NCT00516048|11503913|FG002|Overall Study|Death|1
7286959|NCT00516048|11503911|FG000|Overall Study|Subject Decision|0
7286960|NCT00516048|11503912|FG001|Overall Study|Subject Decision|2
7286961|NCT00516048|11503913|FG002|Overall Study|Subject Decision|0
7469973|NCT01928381|11771849|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
7469974|NCT01928381|11771843|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469975|NCT01928381|11771844|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469976|NCT01928381|11771845|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
7469977|NCT01928381|11771846|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469978|NCT01928381|11771847|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469979|NCT01928381|11771848|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469980|NCT01928381|11771849|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
7469981|NCT01928381|11771843|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
7469982|NCT01928381|11771844|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
7469983|NCT01928381|11771845|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
7469984|NCT01928381|11771846|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
7469985|NCT01928381|11771847|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
7469986|NCT01928381|11771848|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
7469987|NCT01928381|11771849|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
7469988|NCT01928381|11771843|FG000|Part 2 - First Intervention|Lost to Follow-up|0
7469989|NCT01928381|11771844|FG001|Part 2 - First Intervention|Lost to Follow-up|0
7286962|NCT00516074|11503923|FG000|Overall Study|Adverse Event|0
7286963|NCT00516074|11503924|FG001|Overall Study|Adverse Event|1
7286964|NCT00516074|11503923|FG000|Overall Study|Subject Decision|4
7286965|NCT00516074|11503924|FG001|Overall Study|Subject Decision|2
7286966|NCT00516074|11503923|FG000|Overall Study|Loss of Glucose Control|2
7286967|NCT00516074|11503924|FG001|Overall Study|Loss of Glucose Control|0
7286968|NCT00516139|11503930|FG000|Overall Study|Adverse Event|27
7286969|NCT00516139|11503930|FG000|Overall Study|Lost to Follow-up|1
7286970|NCT00516139|11503930|FG000|Overall Study|Protocol Violation|1
7286971|NCT00516139|11503930|FG000|Overall Study|Withdrawal by Subject|8
7286972|NCT00516139|11503930|FG000|Overall Study|Lack of Efficacy|1
7286973|NCT00516269|11503948|FG000|Overall Study|Adverse Event|2
7286974|NCT00516269|11503949|FG001|Overall Study|Adverse Event|1
7286975|NCT00516269|11503948|FG000|Overall Study|Lost to Follow-up|0
7286976|NCT00516269|11503949|FG001|Overall Study|Lost to Follow-up|1
7286977|NCT00516269|11503948|FG000|Overall Study|Protocol Violation|0
7286978|NCT00516269|11503949|FG001|Overall Study|Protocol Violation|1
7286979|NCT00516295|11503958|FG000|Overall Study|Lack of Efficacy|2
7286980|NCT00516295|11503959|FG001|Overall Study|Lack of Efficacy|0
7286981|NCT00516295|11503960|FG002|Overall Study|Lack of Efficacy|0
7286982|NCT00516295|11503958|FG000|Overall Study|Ineligible|1
7286983|NCT00516295|11503959|FG001|Overall Study|Ineligible|0
7286984|NCT00516295|11503960|FG002|Overall Study|Ineligible|0
7286985|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
7286986|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7286987|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
7286988|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
7286989|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7286990|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
7286991|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
7286992|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7286993|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
7286994|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
7286995|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7286996|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
7286997|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
7286998|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7286999|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
7287000|NCT00516321|11503970|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
7287001|NCT00516321|11503971|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7287002|NCT00516321|11503972|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
7287003|NCT00516321|11503970|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
7287004|NCT00516321|11503971|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
7287005|NCT00516321|11503972|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
7287006|NCT00516321|11503970|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
7287007|NCT00516321|11503971|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
7287008|NCT00516321|11503972|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
7287009|NCT00516321|11503970|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
7287010|NCT00516321|11503971|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
7287011|NCT00516321|11503972|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
7287012|NCT00516321|11503970|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7287013|NCT00516321|11503971|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
7287014|NCT00516321|11503972|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
7287015|NCT00516321|11503970|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7287016|NCT00516321|11503971|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
7287017|NCT00516321|11503972|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
7287018|NCT00516386|11503980|FG000|Overall Study|not interested in the study|4
7287019|NCT00516386|11503980|FG000|Overall Study|Lost to Follow-up|2
7287020|NCT00516893|11503993|FG000|Overall Study|Lost to Follow-up|4
7287021|NCT00516893|11503993|FG000|Overall Study|Adverse Event|3
7287022|NCT00516893|11503993|FG000|Overall Study|Withdrawal by Subject|2
7287023|NCT00516893|11503993|FG000|Overall Study|Noncompliance|2
7287024|NCT00516893|11503993|FG000|Overall Study|Death|1
7287025|NCT00516893|11503993|FG000|Overall Study|Persistent Antibodies per Protocol|6
7287026|NCT00516893|11503993|FG000|Overall Study|Relocated|1
7287027|NCT00516893|11503993|FG000|Overall Study|Pregnancy|1
7287028|NCT00516893|11503993|FG000|Overall Study|Received Medication From Another Study|1
7287029|NCT00516906|11503999|FG000|Overall Study|Final Dressing Removal Data not captured|6
7287030|NCT00516906|11504000|FG001|Overall Study|Final Dressing Removal Data not captured|2
7287031|NCT00517296|11504019|FG000|Overall Study|Withdrawal by Subject|1
7287032|NCT00517296|11504020|FG001|Overall Study|Withdrawal by Subject|0
7287033|NCT00517413|11504026|FG000|Overall Study|Adverse Event|7
7287034|NCT00517413|11504026|FG000|Overall Study|Death|13
7287035|NCT00517413|11504026|FG000|Overall Study|Protocol Violation|15
7287036|NCT00517413|11504026|FG000|Overall Study|Withdrawal by Subject|2
7287037|NCT00517413|11504026|FG000|Overall Study|Failure to return|1
7287038|NCT00517413|11504026|FG000|Overall Study|Other-Reasons|23
7287039|NCT00517634|11504087|FG000|Second Treatment Period|Withdrawal by Subject|0
7287040|NCT00517634|11504088|FG001|Second Treatment Period|Withdrawal by Subject|0
7287041|NCT00517634|11504089|FG002|Second Treatment Period|Withdrawal by Subject|0
7287042|NCT00517634|11504090|FG003|Second Treatment Period|Withdrawal by Subject|0
7287043|NCT00517634|11504091|FG004|Second Treatment Period|Withdrawal by Subject|1
7287044|NCT00517634|11504092|FG005|Second Treatment Period|Withdrawal by Subject|0
7287045|NCT00517751|11504100|FG000|Overall Study|Death|3
7287046|NCT00517751|11504100|FG000|Overall Study|Withdrawal by Subject|37
7287047|NCT00517751|11504100|FG000|Overall Study|Lost to Follow-up|4
7287048|NCT00517751|11504100|FG000|Overall Study|patient not over due|6
7287049|NCT00517751|11504100|FG000|Overall Study|Patient not due for visit|76
7287050|NCT00517751|11504100|FG000|Overall Study|Missing|3
7287051|NCT00517829|11504106|FG000|Overall Study|Adverse Event|22
7287052|NCT00517829|11504107|FG001|Overall Study|Adverse Event|34
7287053|NCT00517829|11504106|FG000|Overall Study|Disease Progression|39
7287054|NCT00517829|11504107|FG001|Overall Study|Disease Progression|32
7287055|NCT00517829|11504106|FG000|Overall Study|Patient Request|6
7287056|NCT00517829|11504107|FG001|Overall Study|Patient Request|5
7287057|NCT00517829|11504106|FG000|Overall Study|Investigator Request|5
7287058|NCT00517829|11504107|FG001|Overall Study|Investigator Request|3
7287059|NCT00517829|11504106|FG000|Overall Study|Other|3
7287060|NCT00517829|11504107|FG001|Overall Study|Other|1
7287061|NCT00517881|11504113|FG000|Overall Study|Protocol Violation|2
7287062|NCT00517881|11504113|FG000|Overall Study|Adverse Event|1
7287063|NCT00517881|11504113|FG000|Overall Study|Renal transplantation|2
7287064|NCT00517933|11504119|FG000|Period 1|Death|2
7287065|NCT00517933|11504120|FG001|Period 1|Death|1
7287066|NCT00517933|11504119|FG000|Period 1|Adverse Event|4
7287067|NCT00517933|11504120|FG001|Period 1|Adverse Event|4
7287068|NCT00517933|11504119|FG000|Period 1|Lost to Follow-up|2
7287069|NCT00517933|11504120|FG001|Period 1|Lost to Follow-up|0
7287070|NCT00517933|11504119|FG000|Period 1|Underwent lung transplant|0
7287071|NCT00517933|11504120|FG001|Period 1|Underwent lung transplant|1
7287072|NCT00517933|11504119|FG000|Period 2|Death|2
7287073|NCT00517933|11504120|FG001|Period 2|Death|4
7287074|NCT00517933|11504119|FG000|Period 2|Adverse Event|2
7287075|NCT00517933|11504120|FG001|Period 2|Adverse Event|4
7287076|NCT00517933|11504119|FG000|Period 2|Physician Decision|1
7287077|NCT00517933|11504120|FG001|Period 2|Physician Decision|0
7287078|NCT00517933|11504119|FG000|Period 2|Withdrawal by Subject|1
7287079|NCT00517933|11504120|FG001|Period 2|Withdrawal by Subject|3
7287080|NCT00517933|11504119|FG000|Period 2|Underwent lung transplant|0
7287081|NCT00517933|11504120|FG001|Period 2|Underwent lung transplant|2
7287082|NCT00518011|11504131|FG000|Overall Study|Death|1
7287083|NCT00518011|11504132|FG001|Overall Study|Death|1
7287084|NCT00518011|11504131|FG000|Overall Study|Adverse Event|2
7287085|NCT00518011|11504132|FG001|Overall Study|Adverse Event|3
7287086|NCT00518011|11504131|FG000|Overall Study|Disease Progression|2
7287087|NCT00518011|11504132|FG001|Overall Study|Disease Progression|2
7287088|NCT00518011|11504131|FG000|Overall Study|Other Reasons|3
7287089|NCT00518011|11504132|FG001|Overall Study|Other Reasons|2
7287090|NCT00518011|11504131|FG000|Overall Study|Withdrawal by Subject|1
7287091|NCT00518011|11504132|FG001|Overall Study|Withdrawal by Subject|0
7287092|NCT00518115|11504158|FG000|Overall Study|Adverse Event|6
7287093|NCT00518115|11504159|FG001|Overall Study|Adverse Event|1
7287094|NCT00518115|11504160|FG002|Overall Study|Adverse Event|5
7287095|NCT00518115|11504161|FG003|Overall Study|Adverse Event|6
7287096|NCT00518115|11504162|FG004|Overall Study|Adverse Event|5
7287097|NCT00518115|11504163|FG005|Overall Study|Adverse Event|5
7287098|NCT00518115|11504164|FG006|Overall Study|Adverse Event|5
7287099|NCT00518115|11504165|FG007|Overall Study|Adverse Event|10
7287100|NCT00518115|11504166|FG008|Overall Study|Adverse Event|2
7287101|NCT00518115|11504167|FG009|Overall Study|Adverse Event|9
7287102|NCT00518115|11504158|FG000|Overall Study|Lost to Follow-up|0
7287103|NCT00518115|11504159|FG001|Overall Study|Lost to Follow-up|0
7287104|NCT00518115|11504160|FG002|Overall Study|Lost to Follow-up|2
7287105|NCT00518115|11504161|FG003|Overall Study|Lost to Follow-up|3
7287106|NCT00518115|11504162|FG004|Overall Study|Lost to Follow-up|1
7287107|NCT00518115|11504163|FG005|Overall Study|Lost to Follow-up|3
7287108|NCT00518115|11504164|FG006|Overall Study|Lost to Follow-up|0
7287109|NCT00518115|11504165|FG007|Overall Study|Lost to Follow-up|1
7287110|NCT00518115|11504166|FG008|Overall Study|Lost to Follow-up|1
7287111|NCT00518115|11504167|FG009|Overall Study|Lost to Follow-up|1
7287112|NCT00518115|11504158|FG000|Overall Study|Protocol Violation|1
7287113|NCT00518115|11504159|FG001|Overall Study|Protocol Violation|3
7287114|NCT00518115|11504160|FG002|Overall Study|Protocol Violation|1
7287115|NCT00518115|11504161|FG003|Overall Study|Protocol Violation|0
7287116|NCT00518115|11504162|FG004|Overall Study|Protocol Violation|0
7287117|NCT00518115|11504163|FG005|Overall Study|Protocol Violation|0
7287118|NCT00518115|11504164|FG006|Overall Study|Protocol Violation|0
7287119|NCT00518115|11504165|FG007|Overall Study|Protocol Violation|0
7287120|NCT00518115|11504166|FG008|Overall Study|Protocol Violation|0
7287121|NCT00518115|11504167|FG009|Overall Study|Protocol Violation|0
7287122|NCT00518115|11504158|FG000|Overall Study|Withdrawal by Subject|1
7287123|NCT00518115|11504159|FG001|Overall Study|Withdrawal by Subject|1
7287124|NCT00518115|11504160|FG002|Overall Study|Withdrawal by Subject|5
7287125|NCT00518115|11504161|FG003|Overall Study|Withdrawal by Subject|0
7287126|NCT00518115|11504162|FG004|Overall Study|Withdrawal by Subject|2
7287127|NCT00518115|11504163|FG005|Overall Study|Withdrawal by Subject|1
7287128|NCT00518115|11504164|FG006|Overall Study|Withdrawal by Subject|0
7287129|NCT00518115|11504165|FG007|Overall Study|Withdrawal by Subject|2
7287130|NCT00518115|11504166|FG008|Overall Study|Withdrawal by Subject|1
7287131|NCT00518115|11504167|FG009|Overall Study|Withdrawal by Subject|3
7287132|NCT00518115|11504158|FG000|Overall Study|Lack of Efficacy|1
7287133|NCT00518115|11504159|FG001|Overall Study|Lack of Efficacy|0
7287134|NCT00518115|11504160|FG002|Overall Study|Lack of Efficacy|1
7287135|NCT00518115|11504161|FG003|Overall Study|Lack of Efficacy|1
7287136|NCT00518115|11504162|FG004|Overall Study|Lack of Efficacy|0
7287137|NCT00518115|11504163|FG005|Overall Study|Lack of Efficacy|0
7287138|NCT00518115|11504164|FG006|Overall Study|Lack of Efficacy|0
7287139|NCT00518115|11504165|FG007|Overall Study|Lack of Efficacy|1
7287140|NCT00518115|11504166|FG008|Overall Study|Lack of Efficacy|0
7287141|NCT00518115|11504167|FG009|Overall Study|Lack of Efficacy|0
7287142|NCT00518115|11504158|FG000|Overall Study|Non-Compliance|1
7287143|NCT00518115|11504159|FG001|Overall Study|Non-Compliance|0
7287144|NCT00518115|11504160|FG002|Overall Study|Non-Compliance|1
7287145|NCT00518115|11504161|FG003|Overall Study|Non-Compliance|0
7287146|NCT00518115|11504162|FG004|Overall Study|Non-Compliance|1
7287147|NCT00518115|11504163|FG005|Overall Study|Non-Compliance|1
7287148|NCT00518115|11504164|FG006|Overall Study|Non-Compliance|1
7287149|NCT00518115|11504165|FG007|Overall Study|Non-Compliance|1
7287150|NCT00518115|11504166|FG008|Overall Study|Non-Compliance|0
7287151|NCT00518115|11504167|FG009|Overall Study|Non-Compliance|1
7287152|NCT00518115|11504158|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
7287153|NCT00518115|11504159|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
7287154|NCT00518115|11504160|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
7287155|NCT00518115|11504161|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
7287156|NCT00518115|11504162|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
7287157|NCT00518115|11504163|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
7287158|NCT00518115|11504164|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
7287159|NCT00518115|11504165|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
7287160|NCT00518115|11504166|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
7287161|NCT00518115|11504167|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
7287162|NCT00518115|11504158|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
7287163|NCT00518115|11504159|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
7623128|NCT03215810|12033979|FG000|Overall Study|Still responding to nivolumab|1
7623129|NCT03215810|12033979|FG000|Overall Study|Insufficient TIL growth|1
7623130|NCT03215810|12033979|FG000|Overall Study|Decline in performance status|1
7623131|NCT03215810|12033979|FG000|Overall Study|Withdrawal by Subject|1
7623132|NCT03067129|12034000|FG000|Overall Study|Ongoing|45
7623133|NCT03067129|12034001|FG001|Overall Study|Ongoing|28
7623134|NCT03067129|12034002|FG002|Overall Study|Ongoing|27
7623135|NCT03067129|12034003|FG003|Overall Study|Ongoing|23
7623136|NCT03067129|12034000|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
7623137|NCT03067129|12034001|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
7623138|NCT03067129|12034002|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
7623139|NCT03067129|12034003|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
7623140|NCT03053102|12034021|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
7623141|NCT03053102|12034021|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
7287164|NCT00518115|11504160|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287165|NCT00518115|11504161|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287166|NCT00518115|11504162|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287167|NCT00518115|11504163|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287168|NCT00518115|11504164|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287169|NCT00518115|11504165|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287170|NCT00518115|11504166|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287171|NCT00518115|11504167|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
7287172|NCT00518115|11504158|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
7287173|NCT00518115|11504159|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
7287174|NCT00518115|11504160|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
7287175|NCT00518115|11504161|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
7287176|NCT00518115|11504162|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
7287177|NCT00518115|11504163|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
7287178|NCT00518115|11504164|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
7287179|NCT00518115|11504165|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
7287180|NCT00518115|11504166|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
7287181|NCT00518115|11504167|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
7287182|NCT00518115|11504158|FG000|Overall Study|Wrong Monotherapy Administered|0
7287183|NCT00518115|11504159|FG001|Overall Study|Wrong Monotherapy Administered|0
7287184|NCT00518115|11504160|FG002|Overall Study|Wrong Monotherapy Administered|1
7287185|NCT00518115|11504161|FG003|Overall Study|Wrong Monotherapy Administered|0
7287186|NCT00518115|11504162|FG004|Overall Study|Wrong Monotherapy Administered|0
7287187|NCT00518115|11504163|FG005|Overall Study|Wrong Monotherapy Administered|0
7287188|NCT00518115|11504164|FG006|Overall Study|Wrong Monotherapy Administered|1
7287189|NCT00518115|11504165|FG007|Overall Study|Wrong Monotherapy Administered|0
7287190|NCT00518115|11504166|FG008|Overall Study|Wrong Monotherapy Administered|0
7287191|NCT00518115|11504167|FG009|Overall Study|Wrong Monotherapy Administered|0
7287192|NCT00518115|11504158|FG000|Overall Study|Violation of Exclusion Criteria|0
7287193|NCT00518115|11504159|FG001|Overall Study|Violation of Exclusion Criteria|0
7287194|NCT00518115|11504160|FG002|Overall Study|Violation of Exclusion Criteria|0
7287195|NCT00518115|11504161|FG003|Overall Study|Violation of Exclusion Criteria|1
7287196|NCT00518115|11504162|FG004|Overall Study|Violation of Exclusion Criteria|0
7287197|NCT00518115|11504163|FG005|Overall Study|Violation of Exclusion Criteria|0
7287198|NCT00518115|11504164|FG006|Overall Study|Violation of Exclusion Criteria|1
7287199|NCT00518115|11504165|FG007|Overall Study|Violation of Exclusion Criteria|0
7287200|NCT00518115|11504166|FG008|Overall Study|Violation of Exclusion Criteria|0
7287201|NCT00518115|11504167|FG009|Overall Study|Violation of Exclusion Criteria|0
7287202|NCT00518115|11504158|FG000|Overall Study|Family Emergency; Had to Go to England|0
7287203|NCT00518115|11504159|FG001|Overall Study|Family Emergency; Had to Go to England|0
7287204|NCT00518115|11504160|FG002|Overall Study|Family Emergency; Had to Go to England|0
7287205|NCT00518115|11504161|FG003|Overall Study|Family Emergency; Had to Go to England|0
7287206|NCT00518115|11504162|FG004|Overall Study|Family Emergency; Had to Go to England|1
7287207|NCT00518115|11504163|FG005|Overall Study|Family Emergency; Had to Go to England|0
7287208|NCT00518115|11504164|FG006|Overall Study|Family Emergency; Had to Go to England|0
7287209|NCT00518115|11504165|FG007|Overall Study|Family Emergency; Had to Go to England|0
7287210|NCT00518115|11504166|FG008|Overall Study|Family Emergency; Had to Go to England|0
7287211|NCT00518115|11504167|FG009|Overall Study|Family Emergency; Had to Go to England|0
7287212|NCT00518115|11504158|FG000|Overall Study|Withdrew Consent|0
7287213|NCT00518115|11504159|FG001|Overall Study|Withdrew Consent|0
7287214|NCT00518115|11504160|FG002|Overall Study|Withdrew Consent|0
7287215|NCT00518115|11504161|FG003|Overall Study|Withdrew Consent|0
7287216|NCT00518115|11504162|FG004|Overall Study|Withdrew Consent|0
7287217|NCT00518115|11504163|FG005|Overall Study|Withdrew Consent|1
7287218|NCT00518115|11504164|FG006|Overall Study|Withdrew Consent|0
7287219|NCT00518115|11504165|FG007|Overall Study|Withdrew Consent|0
7287220|NCT00518115|11504166|FG008|Overall Study|Withdrew Consent|0
7287221|NCT00518115|11504167|FG009|Overall Study|Withdrew Consent|0
7287222|NCT00518115|11504158|FG000|Overall Study|Moved Out of State|0
7287223|NCT00518115|11504159|FG001|Overall Study|Moved Out of State|0
7287224|NCT00518115|11504160|FG002|Overall Study|Moved Out of State|0
7287225|NCT00518115|11504161|FG003|Overall Study|Moved Out of State|0
7287226|NCT00518115|11504162|FG004|Overall Study|Moved Out of State|0
7287227|NCT00518115|11504163|FG005|Overall Study|Moved Out of State|0
7287228|NCT00518115|11504164|FG006|Overall Study|Moved Out of State|0
7287229|NCT00518115|11504165|FG007|Overall Study|Moved Out of State|0
7287230|NCT00518115|11504166|FG008|Overall Study|Moved Out of State|0
7287231|NCT00518115|11504167|FG009|Overall Study|Moved Out of State|1
7287232|NCT00518180|11504197|FG000|Overall Study|Withdrawal by Subject|29
7287233|NCT00518180|11504198|FG001|Overall Study|Withdrawal by Subject|30
7287234|NCT00518180|11504199|FG002|Overall Study|Withdrawal by Subject|42
7287235|NCT00518180|11504197|FG000|Overall Study|Lost to Follow-up|30
7287236|NCT00518180|11504198|FG001|Overall Study|Lost to Follow-up|28
7287237|NCT00518180|11504199|FG002|Overall Study|Lost to Follow-up|34
7287238|NCT00518180|11504197|FG000|Overall Study|Administrative reason|0
7287239|NCT00518180|11504198|FG001|Overall Study|Administrative reason|2
7287240|NCT00518180|11504199|FG002|Overall Study|Administrative reason|2
7287241|NCT00518180|11504197|FG000|Overall Study|Protocol Violation|5
7287242|NCT00518180|11504198|FG001|Overall Study|Protocol Violation|7
7623166|NCT02875860|12034056|FG000|Overall Study|Withdrawal by Subject|0
7623167|NCT02875860|12034057|FG001|Overall Study|Withdrawal by Subject|1
7623168|NCT02779855|12034066|FG000|Overall Study|Withdrawal by patient prior to treatment|1
7623169|NCT02779855|12034067|FG001|Overall Study|Withdrawal by patient prior to treatment|0
7623170|NCT02779855|12034068|FG002|Overall Study|Withdrawal by patient prior to treatment|0
7623171|NCT02663271|12034077|FG000|Overall Study|Withdrawal by Subject|5
7287243|NCT00518180|11504199|FG002|Overall Study|Protocol Violation|4
7287244|NCT00518180|11504197|FG000|Overall Study|Unable to classify|0
7287245|NCT00518180|11504198|FG001|Overall Study|Unable to classify|2
7287246|NCT00518180|11504199|FG002|Overall Study|Unable to classify|0
7287247|NCT00518180|11504197|FG000|Overall Study|Adverse Event|1
7287248|NCT00518180|11504198|FG001|Overall Study|Adverse Event|0
7287249|NCT00518180|11504199|FG002|Overall Study|Adverse Event|0
7287250|NCT00518206|11504218|FG000|Overall Study|Disease Progression Requiring Therapy|6
7287251|NCT00518206|11504219|FG001|Overall Study|Disease Progression Requiring Therapy|6
7287252|NCT00518206|11504218|FG000|Overall Study|Withdrawal by Subject|2
7287253|NCT00518206|11504219|FG001|Overall Study|Withdrawal by Subject|0
7287254|NCT00518206|11504218|FG000|Overall Study|Drug Supply Issue|1
7287255|NCT00518206|11504219|FG001|Overall Study|Drug Supply Issue|0
7287256|NCT00518206|11504218|FG000|Overall Study|Reason Unknown|1
7287257|NCT00518206|11504219|FG001|Overall Study|Reason Unknown|0
7287258|NCT00518206|11504218|FG000|Overall Study|Completion Status Unknown|1
7287259|NCT00518206|11504219|FG001|Overall Study|Completion Status Unknown|0
7287260|NCT00518284|11504229|FG000|Overall Study|Adverse Event|0
7287261|NCT00518284|11504230|FG001|Overall Study|Adverse Event|1
7287262|NCT00518284|11504231|FG002|Overall Study|Adverse Event|0
7287263|NCT00518284|11504232|FG003|Overall Study|Adverse Event|0
7287264|NCT00518284|11504229|FG000|Overall Study|Study Termination|0
7287265|NCT00518284|11504230|FG001|Overall Study|Study Termination|2
7287266|NCT00518284|11504231|FG002|Overall Study|Study Termination|1
7287267|NCT00518284|11504232|FG003|Overall Study|Study Termination|2
7287268|NCT00518323|11504246|FG000|Overall Study|Lack of Efficacy|14
7287269|NCT00518323|11504247|FG001|Overall Study|Lack of Efficacy|2
7287270|NCT00518323|11504248|FG002|Overall Study|Lack of Efficacy|4
7287271|NCT00518323|11504249|FG003|Overall Study|Lack of Efficacy|20
7287272|NCT00518323|11504246|FG000|Overall Study|Withdrawal by Subject|1
7287273|NCT00518323|11504247|FG001|Overall Study|Withdrawal by Subject|2
7287274|NCT00518323|11504248|FG002|Overall Study|Withdrawal by Subject|4
7287275|NCT00518323|11504249|FG003|Overall Study|Withdrawal by Subject|2
7287276|NCT00518323|11504246|FG000|Overall Study|Lost to Follow-up|0
7287277|NCT00518323|11504247|FG001|Overall Study|Lost to Follow-up|2
7287278|NCT00518323|11504248|FG002|Overall Study|Lost to Follow-up|1
7287279|NCT00518323|11504249|FG003|Overall Study|Lost to Follow-up|3
7287280|NCT00518323|11504246|FG000|Overall Study|Adverse Event|1
7287281|NCT00518323|11504247|FG001|Overall Study|Adverse Event|1
7287282|NCT00518323|11504248|FG002|Overall Study|Adverse Event|1
7287283|NCT00518323|11504249|FG003|Overall Study|Adverse Event|0
7287284|NCT00518323|11504246|FG000|Overall Study|Prohibited medication and others|3
7287285|NCT00518323|11504247|FG001|Overall Study|Prohibited medication and others|1
7287286|NCT00518323|11504248|FG002|Overall Study|Prohibited medication and others|1
7287287|NCT00518323|11504249|FG003|Overall Study|Prohibited medication and others|0
7287288|NCT00518336|11504261|FG000|Year 7|Lost to Follow-up|2
7287289|NCT00518336|11504262|FG001|Year 7|Lost to Follow-up|0
7287290|NCT00518336|11504261|FG000|Year 7|Could not attend in time|0
7287291|NCT00518336|11504262|FG001|Year 7|Could not attend in time|3
7287292|NCT00518336|11504261|FG000|Year 8|Lost to Follow-up|1
7287293|NCT00518336|11504262|FG001|Year 8|Lost to Follow-up|1
7287294|NCT00518336|11504261|FG000|Year 8|Could not attend in time|0
7287295|NCT00518336|11504262|FG001|Year 8|Could not attend in time|1
7287296|NCT00518336|11504261|FG000|Year 9|Migrated/moved from study area|1
7287297|NCT00518336|11504262|FG001|Year 9|Migrated/moved from study area|1
7287298|NCT00518336|11504261|FG000|Year 9|Lost to Follow-up|3
7287299|NCT00518336|11504262|FG001|Year 9|Lost to Follow-up|0
7287300|NCT00518336|11504261|FG000|Year 9|Personal reasons|1
7287301|NCT00518336|11504262|FG001|Year 9|Personal reasons|0
7287302|NCT00518531|11504279|FG000|Treatment Period 1|Adverse Event|5
7287303|NCT00518531|11504280|FG001|Treatment Period 1|Adverse Event|0
7287304|NCT00518531|11504279|FG000|Treatment Period 1|Lost to Follow-up|5
7287305|NCT00518531|11504280|FG001|Treatment Period 1|Lost to Follow-up|3
7287306|NCT00518531|11504279|FG000|Treatment Period 1|Physician Decision|1
7287307|NCT00518531|11504280|FG001|Treatment Period 1|Physician Decision|0
7287308|NCT00518531|11504279|FG000|Treatment Period 1|Protocol Violation|2
7287309|NCT00518531|11504280|FG001|Treatment Period 1|Protocol Violation|0
7287310|NCT00518531|11504279|FG000|Treatment Period 1|Withdrawal by Subject|4
7287311|NCT00518531|11504280|FG001|Treatment Period 1|Withdrawal by Subject|6
7287312|NCT00518531|11504279|FG000|Treatment Period 1|Early crossover|1
7287313|NCT00518531|11504280|FG001|Treatment Period 1|Early crossover|3
7287314|NCT00518531|11504279|FG000|Treatment Period 2|Withdrawal by Subject|0
7287315|NCT00518531|11504280|FG001|Treatment Period 2|Withdrawal by Subject|8
7287316|NCT00518531|11504279|FG000|Treatment Period 2|Complete out of scheduled visit window|1
7287317|NCT00518531|11504280|FG001|Treatment Period 2|Complete out of scheduled visit window|2
7287318|NCT00518531|11504279|FG000|Treatment Period 2|Adverse Event|1
7287319|NCT00518531|11504280|FG001|Treatment Period 2|Adverse Event|7
7287320|NCT00518531|11504279|FG000|Treatment Period 2|Protocol-specified criteria|0
7287321|NCT00518531|11504280|FG001|Treatment Period 2|Protocol-specified criteria|1
7287322|NCT00518531|11504279|FG000|Treatment Period 2|Non-compliance|1
7287323|NCT00518531|11504280|FG001|Treatment Period 2|Non-compliance|2
7287324|NCT00518622|11504296|FG000|Overall Study|Lost to Follow-up|0
7287325|NCT00518622|11504297|FG001|Overall Study|Lost to Follow-up|0
7287326|NCT00518622|11504298|FG002|Overall Study|Lost to Follow-up|1
7287327|NCT00518622|11504299|FG003|Overall Study|Lost to Follow-up|0
7287328|NCT00518622|11504300|FG004|Overall Study|Lost to Follow-up|0
7287329|NCT00518622|11504301|FG005|Overall Study|Lost to Follow-up|0
7287330|NCT00518622|11504302|FG006|Overall Study|Lost to Follow-up|0
7287331|NCT00518622|11504303|FG007|Overall Study|Lost to Follow-up|0
7287332|NCT00518622|11504296|FG000|Overall Study|Study medication taken incorrectly|0
7287333|NCT00518622|11504297|FG001|Overall Study|Study medication taken incorrectly|1
7287334|NCT00518622|11504298|FG002|Overall Study|Study medication taken incorrectly|0
7287335|NCT00518622|11504299|FG003|Overall Study|Study medication taken incorrectly|0
7287336|NCT00518622|11504300|FG004|Overall Study|Study medication taken incorrectly|0
7287337|NCT00518622|11504301|FG005|Overall Study|Study medication taken incorrectly|0
7287338|NCT00518622|11504302|FG006|Overall Study|Study medication taken incorrectly|0
7287339|NCT00518622|11504303|FG007|Overall Study|Study medication taken incorrectly|0
7287340|NCT00518687|11504323|FG000|Overall Study|Adverse Event|201
7287341|NCT00518687|11504324|FG001|Overall Study|Adverse Event|177
7287342|NCT00518687|11504323|FG000|Overall Study|Lost to Follow-up|144
7287343|NCT00518687|11504324|FG001|Overall Study|Lost to Follow-up|155
7287344|NCT00518687|11504323|FG000|Overall Study|Physician Decision|42
7287345|NCT00518687|11504324|FG001|Overall Study|Physician Decision|48
7287346|NCT00518687|11504323|FG000|Overall Study|Progressive disease|2
7287347|NCT00518687|11504324|FG001|Overall Study|Progressive disease|2
7287348|NCT00518687|11504323|FG000|Overall Study|Protocol Violation|8
7287349|NCT00518687|11504324|FG001|Overall Study|Protocol Violation|10
7287350|NCT00518687|11504323|FG000|Overall Study|Study terminated by sponsor|930
7287351|NCT00518687|11504324|FG001|Overall Study|Study terminated by sponsor|918
7287352|NCT00518687|11504323|FG000|Overall Study|Withdrawal by Subject|110
7287353|NCT00518687|11504324|FG001|Overall Study|Withdrawal by Subject|110
7287354|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Adverse Event|23
7287355|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Adverse Event|31
7287356|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
7287357|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
7287358|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Protocol Violation|4
7287359|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Protocol Violation|3
7287360|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
7287361|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
7287362|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Lost to follow up|2
7287363|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Lost to follow up|1
7287364|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Subject decision|1
7287365|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Subject decision|1
7287366|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
7287367|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
7287368|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Loss of trust|0
7287369|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Loss of trust|1
7287370|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
7287371|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
7287372|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
7287373|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
7287374|NCT00518882|11504349|FG000|Double-Blind, Week 0-26|Mutual consent|0
7287375|NCT00518882|11504350|FG001|Double-Blind, Week 0-26|Mutual consent|1
7287376|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
7287377|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
7287378|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
7287379|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
7287380|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
7287381|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
7287382|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
7287383|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
7287384|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
7287385|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
7287386|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
7287387|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
7287388|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
7287389|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
7287390|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
7623172|NCT02663271|12034077|FG000|Overall Study|Lack of Efficacy|1
7287391|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
7287392|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
7287393|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
7287394|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
7287395|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
7287396|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
7287397|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
7287398|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Subject decision|2
7287399|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Subject decision|0
7287400|NCT00518882|11504349|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
7287401|NCT00518882|11504350|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
7287402|NCT00518973|11504358|FG000|Overall Study|Withdrawal by Subject|3
7287403|NCT00518973|11504359|FG001|Overall Study|Withdrawal by Subject|2
7287404|NCT00518986|11504367|FG000|Overall Study|Adverse Event|12
7287405|NCT00518986|11504368|FG001|Overall Study|Adverse Event|7
7287406|NCT00518986|11504367|FG000|Overall Study|Lack of Efficacy|0
7287407|NCT00518986|11504368|FG001|Overall Study|Lack of Efficacy|2
7287408|NCT00518986|11504367|FG000|Overall Study|Lost to Follow-up|3
7287409|NCT00518986|11504368|FG001|Overall Study|Lost to Follow-up|2
7287410|NCT00518986|11504367|FG000|Overall Study|Physician Decision|0
7287411|NCT00518986|11504368|FG001|Overall Study|Physician Decision|3
7287412|NCT00518986|11504367|FG000|Overall Study|Protocol Violation|5
7287413|NCT00518986|11504368|FG001|Overall Study|Protocol Violation|7
7623173|NCT02573493|12034094|FG000|Overall Study|Determined to not be eligible after enrollment|0
7623174|NCT02573493|12034095|FG001|Overall Study|Determined to not be eligible after enrollment|0
7623175|NCT02573493|12034096|FG002|Overall Study|Determined to not be eligible after enrollment|0
7623176|NCT02573493|12034097|FG003|Overall Study|Determined to not be eligible after enrollment|1
7287414|NCT00518986|11504367|FG000|Overall Study|Withdrawal by Subject|4
7287415|NCT00518986|11504368|FG001|Overall Study|Withdrawal by Subject|4
7287416|NCT00518986|11504367|FG000|Overall Study|Non-Specific|2
7287417|NCT00518986|11504368|FG001|Overall Study|Non-Specific|1
7287418|NCT00519077|11504374|FG000|Overall Study|Death|6
7287419|NCT00519077|11504374|FG000|Overall Study|Other|2
7287420|NCT00519194|11504378|FG000|Overall Study|Withdrawal by Subject|9
7287421|NCT00519194|11504378|FG000|Overall Study|Death|9
7287422|NCT00519194|11504378|FG000|Overall Study|Lost to Follow-up|3
7287423|NCT00519285|11504384|FG000|Overall Study|Adverse Event|127
7287424|NCT00519285|11504385|FG001|Overall Study|Adverse Event|266
7287425|NCT00519285|11504384|FG000|Overall Study|Disease progression|334
7287426|NCT00519285|11504385|FG001|Overall Study|Disease progression|186
7287427|NCT00519285|11504384|FG000|Overall Study|Physician Decision|75
7287428|NCT00519285|11504385|FG001|Overall Study|Physician Decision|47
7287429|NCT00519285|11504384|FG000|Overall Study|Participant's request|53
7287430|NCT00519285|11504385|FG001|Overall Study|Participant's request|84
7287431|NCT00519285|11504384|FG000|Overall Study|Consent withdrawn|4
7287432|NCT00519285|11504385|FG001|Overall Study|Consent withdrawn|5
7287433|NCT00519285|11504384|FG000|Overall Study|Poor compliance to protocol|5
7287434|NCT00519285|11504385|FG001|Overall Study|Poor compliance to protocol|7
7287435|NCT00519285|11504384|FG000|Overall Study|Reason unspecified|5
7287436|NCT00519285|11504385|FG001|Overall Study|Reason unspecified|8
7287437|NCT00519285|11504384|FG000|Overall Study|Not treated|8
7287438|NCT00519285|11504385|FG001|Overall Study|Not treated|7
7287439|NCT00519285|11504384|FG000|Overall Study|Treatment ongoing|1
7287440|NCT00519285|11504385|FG001|Overall Study|Treatment ongoing|2
7287441|NCT00519376|11504391|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287442|NCT00519376|11504392|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287443|NCT00519376|11504393|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287444|NCT00519376|11504394|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287445|NCT00519376|11504395|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287446|NCT00519376|11504396|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287447|NCT00519376|11504397|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287448|NCT00519376|11504398|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287449|NCT00519376|11504399|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287450|NCT00519376|11504400|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287451|NCT00519376|11504401|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287452|NCT00519376|11504402|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287453|NCT00519376|11504403|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
7287454|NCT00519376|11504404|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287455|NCT00519376|11504405|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287456|NCT00519376|11504406|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
7287457|NCT00519376|11504391|FG000|Treatment Period 4|Lost to Follow-up|0
7287458|NCT00519376|11504392|FG001|Treatment Period 4|Lost to Follow-up|0
7287459|NCT00519376|11504393|FG002|Treatment Period 4|Lost to Follow-up|1
7287460|NCT00519376|11504394|FG003|Treatment Period 4|Lost to Follow-up|0
7287461|NCT00519376|11504395|FG004|Treatment Period 4|Lost to Follow-up|0
7623177|NCT02279173|12034130|FG000|Overall Study|Protocol-specified Criteria|67
7623178|NCT02279173|12034130|FG000|Overall Study|Withdrawal by Subject|20
7623179|NCT02279173|12034130|FG000|Overall Study|Decision by Sponsor|4
7623180|NCT02279173|12034130|FG000|Overall Study|Lost to Follow-up|3
7287462|NCT00519376|11504396|FG005|Treatment Period 4|Lost to Follow-up|0
7287463|NCT00519376|11504397|FG006|Treatment Period 4|Lost to Follow-up|0
7287464|NCT00519376|11504398|FG007|Treatment Period 4|Lost to Follow-up|0
7287465|NCT00519376|11504399|FG008|Treatment Period 4|Lost to Follow-up|0
7287466|NCT00519376|11504400|FG009|Treatment Period 4|Lost to Follow-up|0
7287467|NCT00519376|11504401|FG010|Treatment Period 4|Lost to Follow-up|0
7287468|NCT00519376|11504402|FG011|Treatment Period 4|Lost to Follow-up|0
7287469|NCT00519376|11504403|FG012|Treatment Period 4|Lost to Follow-up|0
7287470|NCT00519376|11504404|FG013|Treatment Period 4|Lost to Follow-up|0
7287471|NCT00519376|11504405|FG014|Treatment Period 4|Lost to Follow-up|0
7287472|NCT00519376|11504406|FG015|Treatment Period 4|Lost to Follow-up|0
7287473|NCT00519428|11504421|FG000|Overall Study|Adverse Event|5
7287474|NCT00519428|11504422|FG001|Overall Study|Adverse Event|2
7287475|NCT00519428|11504423|FG002|Overall Study|Adverse Event|10
7287476|NCT00519428|11504421|FG000|Overall Study|Lost to Follow-up|7
7287477|NCT00519428|11504422|FG001|Overall Study|Lost to Follow-up|7
7287478|NCT00519428|11504423|FG002|Overall Study|Lost to Follow-up|6
7287479|NCT00519428|11504421|FG000|Overall Study|Withdrawal by Subject|8
7287480|NCT00519428|11504422|FG001|Overall Study|Withdrawal by Subject|3
7287481|NCT00519428|11504423|FG002|Overall Study|Withdrawal by Subject|7
7287482|NCT00519428|11504421|FG000|Overall Study|unstated|1
7287483|NCT00519428|11504422|FG001|Overall Study|unstated|3
7287484|NCT00519428|11504423|FG002|Overall Study|unstated|2
7287485|NCT00519532|11504434|FG000|Overall Study|Adverse Event|11
7287486|NCT00519532|11504434|FG000|Overall Study|Withdrawal by Subject|5
7287487|NCT00519532|11504434|FG000|Overall Study|Lost to Follow-up|2
7287488|NCT00519623|11504455|FG000|Overall Study|Adverse Event|1
7287489|NCT00519636|11504463|FG000|Treatment Period 1|Adverse Event|1
7287490|NCT00519636|11504464|FG001|Treatment Period 1|Adverse Event|0
7287491|NCT00519636|11504465|FG002|Treatment Period 1|Adverse Event|1
7287492|NCT00519636|11504466|FG003|Treatment Period 1|Adverse Event|0
7287493|NCT00519636|11504463|FG000|Treatment Period 1|Sponsor request due to missed visit|1
7287494|NCT00519636|11504464|FG001|Treatment Period 1|Sponsor request due to missed visit|0
7287495|NCT00519636|11504465|FG002|Treatment Period 1|Sponsor request due to missed visit|0
7287496|NCT00519636|11504466|FG003|Treatment Period 1|Sponsor request due to missed visit|0
7287497|NCT00519636|11504463|FG000|Washout Period|Adverse Event|2
7287498|NCT00519636|11504464|FG001|Washout Period|Adverse Event|1
7287499|NCT00519636|11504465|FG002|Washout Period|Adverse Event|1
7287500|NCT00519636|11504466|FG003|Washout Period|Adverse Event|0
7287501|NCT00519636|11504463|FG000|Washout Period|Lost to Follow-up|1
7287502|NCT00519636|11504464|FG001|Washout Period|Lost to Follow-up|0
7287503|NCT00519636|11504465|FG002|Washout Period|Lost to Follow-up|0
7287504|NCT00519636|11504466|FG003|Washout Period|Lost to Follow-up|0
7287505|NCT00519636|11504463|FG000|Washout Period|Protocol Violation|0
7287506|NCT00519636|11504464|FG001|Washout Period|Protocol Violation|0
7287507|NCT00519636|11504465|FG002|Washout Period|Protocol Violation|1
7287508|NCT00519636|11504466|FG003|Washout Period|Protocol Violation|2
7287509|NCT00519636|11504463|FG000|Washout Period|Withdrawal by Subject|1
7287510|NCT00519636|11504464|FG001|Washout Period|Withdrawal by Subject|0
7287511|NCT00519636|11504465|FG002|Washout Period|Withdrawal by Subject|1
7287512|NCT00519636|11504466|FG003|Washout Period|Withdrawal by Subject|0
7287513|NCT00519636|11504463|FG000|Washout Period|Failed to meet continuation criteria|14
7287514|NCT00519636|11504464|FG001|Washout Period|Failed to meet continuation criteria|11
7287515|NCT00519636|11504465|FG002|Washout Period|Failed to meet continuation criteria|9
7287516|NCT00519636|11504466|FG003|Washout Period|Failed to meet continuation criteria|3
7287517|NCT00519636|11504463|FG000|Washout Period|Out of pollen area > 48 hours|1
7287518|NCT00519636|11504464|FG001|Washout Period|Out of pollen area > 48 hours|0
7287519|NCT00519636|11504465|FG002|Washout Period|Out of pollen area > 48 hours|0
7287520|NCT00519636|11504466|FG003|Washout Period|Out of pollen area > 48 hours|0
7287521|NCT00519636|11504463|FG000|Washout Period|Participating in study at another site|1
7287522|NCT00519636|11504464|FG001|Washout Period|Participating in study at another site|0
7287523|NCT00519636|11504465|FG002|Washout Period|Participating in study at another site|0
7287524|NCT00519636|11504466|FG003|Washout Period|Participating in study at another site|0
7287525|NCT00519636|11504463|FG000|Washout Period|Non-compliant|0
7287526|NCT00519636|11504464|FG001|Washout Period|Non-compliant|1
7287527|NCT00519636|11504465|FG002|Washout Period|Non-compliant|0
7287528|NCT00519636|11504466|FG003|Washout Period|Non-compliant|0
7287529|NCT00519636|11504463|FG000|Washout Period|Per doctors request|0
7287530|NCT00519636|11504464|FG001|Washout Period|Per doctors request|1
7287531|NCT00519636|11504465|FG002|Washout Period|Per doctors request|0
7287532|NCT00519636|11504466|FG003|Washout Period|Per doctors request|0
7287533|NCT00519636|11504463|FG000|Washout Period|Subject randomized in error|0
7287534|NCT00519636|11504464|FG001|Washout Period|Subject randomized in error|0
7287535|NCT00519636|11504465|FG002|Washout Period|Subject randomized in error|1
7287536|NCT00519636|11504466|FG003|Washout Period|Subject randomized in error|0
7287537|NCT00519636|11504463|FG000|Washout Period|Prohibited medications|0
7287538|NCT00519636|11504464|FG001|Washout Period|Prohibited medications|0
7287539|NCT00519636|11504465|FG002|Washout Period|Prohibited medications|1
7287540|NCT00519636|11504466|FG003|Washout Period|Prohibited medications|0
7287541|NCT00519636|11504463|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
7287542|NCT00519636|11504464|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
7287543|NCT00519636|11504465|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
7287544|NCT00519636|11504466|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
7287545|NCT00519636|11504463|FG000|Treatment Period 2|Subject randomized in error|0
7287546|NCT00519636|11504464|FG001|Treatment Period 2|Subject randomized in error|1
7287547|NCT00519636|11504465|FG002|Treatment Period 2|Subject randomized in error|0
7287548|NCT00519636|11504466|FG003|Treatment Period 2|Subject randomized in error|0
7287549|NCT00519636|11504463|FG000|Treatment Period 2|Per doctors request|0
7287550|NCT00519636|11504464|FG001|Treatment Period 2|Per doctors request|0
7287551|NCT00519636|11504465|FG002|Treatment Period 2|Per doctors request|1
7287552|NCT00519636|11504466|FG003|Treatment Period 2|Per doctors request|0
7287553|NCT00519636|11504463|FG000|Treatment Period 2|Subject misrandomized|0
7287554|NCT00519636|11504464|FG001|Treatment Period 2|Subject misrandomized|0
7287555|NCT00519636|11504465|FG002|Treatment Period 2|Subject misrandomized|0
7287556|NCT00519636|11504466|FG003|Treatment Period 2|Subject misrandomized|1
7287557|NCT00519636|11504463|FG000|Post Study Period|Subject randomized in error|0
7287558|NCT00519636|11504464|FG001|Post Study Period|Subject randomized in error|0
7287559|NCT00519636|11504465|FG002|Post Study Period|Subject randomized in error|0
7287560|NCT00519636|11504466|FG003|Post Study Period|Subject randomized in error|1
7287561|NCT00519649|11504480|FG000|Overall Study|Withdrawal by Subject|1
7287562|NCT00519779|11504486|FG000|Overall Study|Withdrawal by Subject|0
7287563|NCT00519779|11504487|FG001|Overall Study|Withdrawal by Subject|1
7287564|NCT00519831|11504493|FG000|Overall Study|Adverse Event|3
7287565|NCT00519896|11504497|FG000|Overall Study|Protocol Violation|1
7287566|NCT00519896|11504497|FG000|Overall Study|Adverse Event|1
7287567|NCT00520013|11504504|FG000|Overall Study|Withdrawal by Subject|0
7287568|NCT00520013|11504505|FG001|Overall Study|Withdrawal by Subject|0
7287569|NCT00520013|11504506|FG002|Overall Study|Withdrawal by Subject|1
7287570|NCT00520013|11504504|FG000|Overall Study|Adverse Event|2
7287571|NCT00520013|11504505|FG001|Overall Study|Adverse Event|10
7287572|NCT00520013|11504506|FG002|Overall Study|Adverse Event|7
7287573|NCT00520013|11504504|FG000|Overall Study|Progressive Disease|7
7287574|NCT00520013|11504505|FG001|Overall Study|Progressive Disease|3
7287575|NCT00520013|11504506|FG002|Overall Study|Progressive Disease|0
7287576|NCT00520013|11504504|FG000|Overall Study|Clinical Progression|3
7287577|NCT00520013|11504505|FG001|Overall Study|Clinical Progression|1
7287578|NCT00520013|11504506|FG002|Overall Study|Clinical Progression|0
7287579|NCT00520013|11504504|FG000|Overall Study|Death|0
7287580|NCT00520013|11504505|FG001|Overall Study|Death|1
7287581|NCT00520013|11504506|FG002|Overall Study|Death|0
7287582|NCT00520013|11504504|FG000|Overall Study|Physician Decision|0
7287583|NCT00520013|11504505|FG001|Overall Study|Physician Decision|0
7287584|NCT00520013|11504506|FG002|Overall Study|Physician Decision|3
7287585|NCT00520039|11504514|FG000|Overall Study|Exclusion criteria met at first visit|7
7287586|NCT00520039|11504515|FG001|Overall Study|Exclusion criteria met at first visit|5
7287587|NCT00520130|11504525|FG000|Overall Study|Disease progression on study|4
7287588|NCT00520130|11504526|FG001|Overall Study|Disease progression on study|0
7287589|NCT00520130|11504525|FG000|Overall Study|Physician Decision|1
7287590|NCT00520130|11504526|FG001|Overall Study|Physician Decision|1
7287591|NCT00520299|11504558|FG000|Overall Study|Withdrawal by Subject|0
7287592|NCT00520299|11504559|FG001|Overall Study|Withdrawal by Subject|0
7287593|NCT00520299|11504560|FG002|Overall Study|Withdrawal by Subject|2
7287594|NCT00520299|11504558|FG000|Overall Study|Progressive disease|0
7287595|NCT00520299|11504559|FG001|Overall Study|Progressive disease|3
7287596|NCT00520299|11504560|FG002|Overall Study|Progressive disease|4
7287597|NCT00520351|11504570|FG000|First Intervention|Withdrawal by Subject|1
7287598|NCT00520351|11504571|FG001|First Intervention|Withdrawal by Subject|1
7287599|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
7287600|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
7287601|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
7287602|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Death|2
7287603|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
7287604|NCT00520403|11504577|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
7287605|NCT00520403|11504577|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
7287606|NCT00520403|11504577|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
7287607|NCT00520481|11504587|FG000|Overall Study|Adverse Event|4
7287608|NCT00520481|11504588|FG001|Overall Study|Adverse Event|1
7287609|NCT00520481|11504587|FG000|Overall Study|Withdrawal by Subject|3
7287610|NCT00520481|11504588|FG001|Overall Study|Withdrawal by Subject|0
7287611|NCT00520494|11504596|FG000|Overall Study|Withdrawal by Subject|1
7287612|NCT00520533|11504600|FG000|Overall Study|Death|1
7287613|NCT00520533|11504600|FG000|Overall Study|Suspension of the study for safety reasons|1
7287614|NCT00520533|11504600|FG000|Overall Study|Withdrawal by Subject|1
7287615|NCT00520533|11504600|FG000|Overall Study|Physician Decision|1
7287616|NCT00520546|11504605|FG000|Overall Study|Withdrawal by Subject|1
7287617|NCT00520546|11504605|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
7287618|NCT00520572|11504620|FG000|Overall Study|Adverse Event|9
7287619|NCT00520572|11504621|FG001|Overall Study|Adverse Event|3
7287620|NCT00520572|11504622|FG002|Overall Study|Adverse Event|6
7287621|NCT00520572|11504623|FG003|Overall Study|Adverse Event|9
7287622|NCT00520572|11504624|FG004|Overall Study|Adverse Event|7
7287623|NCT00520572|11504625|FG005|Overall Study|Adverse Event|2
7287624|NCT00520572|11504620|FG000|Overall Study|Withdrawal by Subject|0
7287625|NCT00520572|11504621|FG001|Overall Study|Withdrawal by Subject|9
7287626|NCT00520572|11504622|FG002|Overall Study|Withdrawal by Subject|5
7287627|NCT00520572|11504623|FG003|Overall Study|Withdrawal by Subject|2
7287628|NCT00520572|11504624|FG004|Overall Study|Withdrawal by Subject|2
7287629|NCT00520572|11504625|FG005|Overall Study|Withdrawal by Subject|0
7287630|NCT00520572|11504620|FG000|Overall Study|Protocol Violation|0
7287631|NCT00520572|11504621|FG001|Overall Study|Protocol Violation|0
7287632|NCT00520572|11504622|FG002|Overall Study|Protocol Violation|1
7287633|NCT00520572|11504623|FG003|Overall Study|Protocol Violation|0
7287634|NCT00520572|11504624|FG004|Overall Study|Protocol Violation|0
7287635|NCT00520572|11504625|FG005|Overall Study|Protocol Violation|0
7287636|NCT00520572|11504620|FG000|Overall Study|Lack of Efficacy|1
7287637|NCT00520572|11504621|FG001|Overall Study|Lack of Efficacy|1
7287638|NCT00520572|11504622|FG002|Overall Study|Lack of Efficacy|1
7287639|NCT00520572|11504623|FG003|Overall Study|Lack of Efficacy|2
7287640|NCT00520572|11504624|FG004|Overall Study|Lack of Efficacy|1
7287641|NCT00520572|11504625|FG005|Overall Study|Lack of Efficacy|0
7287642|NCT00520572|11504620|FG000|Overall Study|Lost to Follow-up|0
7287643|NCT00520572|11504621|FG001|Overall Study|Lost to Follow-up|0
7287644|NCT00520572|11504622|FG002|Overall Study|Lost to Follow-up|0
7287645|NCT00520572|11504623|FG003|Overall Study|Lost to Follow-up|0
7287646|NCT00520572|11504624|FG004|Overall Study|Lost to Follow-up|1
7287647|NCT00520572|11504625|FG005|Overall Study|Lost to Follow-up|0
7287648|NCT00520572|11504620|FG000|Overall Study|Incorrect enrollment|1
7287649|NCT00520572|11504621|FG001|Overall Study|Incorrect enrollment|0
7287650|NCT00520572|11504622|FG002|Overall Study|Incorrect enrollment|1
7287651|NCT00520572|11504623|FG003|Overall Study|Incorrect enrollment|0
7287652|NCT00520572|11504624|FG004|Overall Study|Incorrect enrollment|1
7287653|NCT00520572|11504625|FG005|Overall Study|Incorrect enrollment|0
7287654|NCT00520572|11504620|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
7287655|NCT00520572|11504621|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
7287656|NCT00520572|11504622|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
7287657|NCT00520572|11504623|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
7287658|NCT00520572|11504624|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
7287659|NCT00520572|11504625|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
7287660|NCT00520572|11504620|FG000|Overall Study|Long break in taking Medication|0
7287661|NCT00520572|11504621|FG001|Overall Study|Long break in taking Medication|0
7287662|NCT00520572|11504622|FG002|Overall Study|Long break in taking Medication|0
7287663|NCT00520572|11504623|FG003|Overall Study|Long break in taking Medication|1
7287664|NCT00520572|11504624|FG004|Overall Study|Long break in taking Medication|0
7287665|NCT00520572|11504625|FG005|Overall Study|Long break in taking Medication|0
7287666|NCT00520572|11504620|FG000|Overall Study|Did not receive Treatment|1
7287667|NCT00520572|11504621|FG001|Overall Study|Did not receive Treatment|0
7287668|NCT00520572|11504622|FG002|Overall Study|Did not receive Treatment|1
7287669|NCT00520572|11504623|FG003|Overall Study|Did not receive Treatment|0
7287670|NCT00520572|11504624|FG004|Overall Study|Did not receive Treatment|0
7287671|NCT00520572|11504625|FG005|Overall Study|Did not receive Treatment|0
7287672|NCT00520676|11504641|FG000|Overall Study|Death|84
7287673|NCT00520676|11504642|FG001|Overall Study|Death|81
7287674|NCT00520676|11504641|FG000|Overall Study|Lost to Follow-up|6
7287675|NCT00520676|11504642|FG001|Overall Study|Lost to Follow-up|10
7287676|NCT00520676|11504641|FG000|Overall Study|Physician Decision|4
7287677|NCT00520676|11504642|FG001|Overall Study|Physician Decision|1
7287678|NCT00520676|11504641|FG000|Overall Study|Withdrawal by Subject|7
7287679|NCT00520676|11504642|FG001|Overall Study|Withdrawal by Subject|11
7287680|NCT00520741|11504650|FG000|Overall Study|Adverse Event|16
7287681|NCT00520741|11504651|FG001|Overall Study|Adverse Event|56
7287682|NCT00520741|11504650|FG000|Overall Study|Lack of Efficacy|11
7287683|NCT00520741|11504651|FG001|Overall Study|Lack of Efficacy|30
7287684|NCT00520741|11504650|FG000|Overall Study|Withdrawal by Subject|0
7287685|NCT00520741|11504651|FG001|Overall Study|Withdrawal by Subject|11
7287686|NCT00520741|11504650|FG000|Overall Study|Protocol Violation|2
7287687|NCT00520741|11504651|FG001|Overall Study|Protocol Violation|15
7287688|NCT00520741|11504650|FG000|Overall Study|Unsatisfactory compliance of subject|4
7287689|NCT00520741|11504651|FG001|Overall Study|Unsatisfactory compliance of subject|3
7287690|NCT00520741|11504650|FG000|Overall Study|Lost to Follow-up|4
7287691|NCT00520741|11504651|FG001|Overall Study|Lost to Follow-up|4
7287692|NCT00520741|11504650|FG000|Overall Study|Other reasons for premature termination|0
7287693|NCT00520741|11504651|FG001|Overall Study|Other reasons for premature termination|6
7287694|NCT00520845|11504659|FG000|Overall Study|Death|3
7287695|NCT00520845|11504659|FG000|Overall Study|Adverse Event|4
7287696|NCT00520845|11504659|FG000|Overall Study|Disease Progression, relapse|13
7287697|NCT00520845|11504659|FG000|Overall Study|Withdrawal by Subject|1
7287698|NCT00520845|11504659|FG000|Overall Study|Alternative Therapy|1
7287699|NCT00520936|11504692|FG000|Overall Study|Physician Decision|0
7287700|NCT00520936|11504693|FG001|Overall Study|Physician Decision|2
7287701|NCT00520936|11504694|FG002|Overall Study|Physician Decision|1
7287702|NCT00520936|11504695|FG003|Overall Study|Physician Decision|0
7287703|NCT00520936|11504696|FG004|Overall Study|Physician Decision|0
7287704|NCT00520936|11504697|FG005|Overall Study|Physician Decision|0
7287705|NCT00520936|11504698|FG006|Overall Study|Physician Decision|0
7287706|NCT00520936|11504699|FG007|Overall Study|Physician Decision|0
7287707|NCT00520936|11504692|FG000|Overall Study|Withdrawal by Subject|0
7287708|NCT00520936|11504693|FG001|Overall Study|Withdrawal by Subject|0
7287709|NCT00520936|11504694|FG002|Overall Study|Withdrawal by Subject|0
7287710|NCT00520936|11504695|FG003|Overall Study|Withdrawal by Subject|0
7287711|NCT00520936|11504696|FG004|Overall Study|Withdrawal by Subject|0
7287712|NCT00520936|11504697|FG005|Overall Study|Withdrawal by Subject|0
7287713|NCT00520936|11504698|FG006|Overall Study|Withdrawal by Subject|0
7287714|NCT00520936|11504699|FG007|Overall Study|Withdrawal by Subject|1
7287715|NCT00520936|11504692|FG000|Overall Study|Toxicity Requiring Removal from Study|0
7287716|NCT00520936|11504693|FG001|Overall Study|Toxicity Requiring Removal from Study|1
7287717|NCT00520936|11504694|FG002|Overall Study|Toxicity Requiring Removal from Study|0
7287718|NCT00520936|11504695|FG003|Overall Study|Toxicity Requiring Removal from Study|0
7287719|NCT00520936|11504696|FG004|Overall Study|Toxicity Requiring Removal from Study|0
7287720|NCT00520936|11504697|FG005|Overall Study|Toxicity Requiring Removal from Study|0
7287721|NCT00520936|11504698|FG006|Overall Study|Toxicity Requiring Removal from Study|2
7287722|NCT00520936|11504699|FG007|Overall Study|Toxicity Requiring Removal from Study|0
7287723|NCT00520936|11504692|FG000|Overall Study|Death|0
7287724|NCT00520936|11504693|FG001|Overall Study|Death|0
7287725|NCT00520936|11504694|FG002|Overall Study|Death|0
7287726|NCT00520936|11504695|FG003|Overall Study|Death|0
7287727|NCT00520936|11504696|FG004|Overall Study|Death|0
7287728|NCT00520936|11504697|FG005|Overall Study|Death|0
7287729|NCT00520936|11504698|FG006|Overall Study|Death|1
7287730|NCT00520936|11504699|FG007|Overall Study|Death|0
7287731|NCT00520936|11504692|FG000|Overall Study|Protocol Violation|0
7287732|NCT00520936|11504693|FG001|Overall Study|Protocol Violation|1
7287733|NCT00520936|11504694|FG002|Overall Study|Protocol Violation|1
7287734|NCT00520936|11504695|FG003|Overall Study|Protocol Violation|0
7287735|NCT00520936|11504696|FG004|Overall Study|Protocol Violation|1
7287736|NCT00520936|11504697|FG005|Overall Study|Protocol Violation|0
7287737|NCT00520936|11504698|FG006|Overall Study|Protocol Violation|1
7287738|NCT00520936|11504699|FG007|Overall Study|Protocol Violation|0
7287739|NCT00520975|11504712|FG000|Overall Study|Disease progression|31
7287740|NCT00520975|11504713|FG001|Overall Study|Disease progression|23
7287741|NCT00520975|11504712|FG000|Overall Study|Adverse Event|7
7287742|NCT00520975|11504713|FG001|Overall Study|Adverse Event|10
7287743|NCT00520975|11504712|FG000|Overall Study|Death|0
7287744|NCT00520975|11504713|FG001|Overall Study|Death|2
7287745|NCT00520975|11504712|FG000|Overall Study|Withdrawal by Subject|3
7287746|NCT00520975|11504713|FG001|Overall Study|Withdrawal by Subject|5
7287747|NCT00520975|11504712|FG000|Overall Study|Other therapy|2
7287748|NCT00520975|11504713|FG001|Overall Study|Other therapy|4
7287749|NCT00520975|11504712|FG000|Overall Study|Other reasons|4
7287750|NCT00520975|11504713|FG001|Overall Study|Other reasons|2
7287751|NCT00520975|11504712|FG000|Overall Study|Not start protocol therapy|1
7287752|NCT00520975|11504713|FG001|Overall Study|Not start protocol therapy|2
7287753|NCT00521001|11504719|FG000|Overall Study|Ineligible|1
7287754|NCT00521014|11504723|FG000|Overall Study|Inevaluable, not treated|1
7287755|NCT00521053|11504727|FG000|Observation Phase|Disease Progression|55
7287756|NCT00521053|11504727|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
7287757|NCT00521053|11504727|FG000|Observation Phase|Death|2
7287758|NCT00521053|11504727|FG000|Observation Phase|Adverse Event|1
7287759|NCT00521053|11504727|FG000|Observation Phase|Other non-study melanoma treatment|1
7287760|NCT00521053|11504727|FG000|Observation Phase|Physician Decision|1
7287761|NCT00521079|11504736|FG000|Overall Study|Adverse Event|7
7287762|NCT00521079|11504737|FG001|Overall Study|Adverse Event|1
7287763|NCT00521079|11504736|FG000|Overall Study|Lost to Follow-up|2
7287764|NCT00521079|11504737|FG001|Overall Study|Lost to Follow-up|1
7287765|NCT00521079|11504736|FG000|Overall Study|Withdrawal by Subject|5
7287766|NCT00521079|11504737|FG001|Overall Study|Withdrawal by Subject|3
7287767|NCT00521144|11504748|FG000|Overall Study|Not Treated|0
7287768|NCT00521144|11504749|FG001|Overall Study|Not Treated|0
7287769|NCT00521144|11504750|FG002|Overall Study|Not Treated|0
7287770|NCT00521144|11504751|FG003|Overall Study|Not Treated|1
7287771|NCT00521144|11504752|FG004|Overall Study|Not Treated|0
7287772|NCT00521144|11504748|FG000|Overall Study|Adverse Event|0
7287773|NCT00521144|11504749|FG001|Overall Study|Adverse Event|1
7287774|NCT00521144|11504750|FG002|Overall Study|Adverse Event|0
7287775|NCT00521144|11504751|FG003|Overall Study|Adverse Event|0
7287776|NCT00521144|11504752|FG004|Overall Study|Adverse Event|1
7287777|NCT00521144|11504748|FG000|Overall Study|Progressive Disease|4
7287778|NCT00521144|11504749|FG001|Overall Study|Progressive Disease|2
7287779|NCT00521144|11504750|FG002|Overall Study|Progressive Disease|2
7287780|NCT00521144|11504751|FG003|Overall Study|Progressive Disease|0
7287781|NCT00521144|11504752|FG004|Overall Study|Progressive Disease|6
7287782|NCT00521339|11504764|FG000|Treatment Phase|Adverse Event|2
7287783|NCT00521339|11504765|FG001|Treatment Phase|Adverse Event|0
7287784|NCT00521339|11504766|FG002|Treatment Phase|Adverse Event|0
7287785|NCT00521339|11504764|FG000|Treatment Phase|Intolerability to study drug|2
7287786|NCT00521339|11504765|FG001|Treatment Phase|Intolerability to study drug|0
7287787|NCT00521339|11504766|FG002|Treatment Phase|Intolerability to study drug|0
7287788|NCT00521339|11504764|FG000|Treatment Phase|Lack of Efficacy|3
7287789|NCT00521339|11504765|FG001|Treatment Phase|Lack of Efficacy|0
7287790|NCT00521339|11504766|FG002|Treatment Phase|Lack of Efficacy|0
7287791|NCT00521339|11504764|FG000|Treatment Phase|Withdrawal by Subject|3
7287792|NCT00521339|11504765|FG001|Treatment Phase|Withdrawal by Subject|0
7287793|NCT00521339|11504766|FG002|Treatment Phase|Withdrawal by Subject|0
7287794|NCT00521339|11504764|FG000|Treatment Phase|Lost to Follow-up|1
7287795|NCT00521339|11504765|FG001|Treatment Phase|Lost to Follow-up|0
7287796|NCT00521339|11504766|FG002|Treatment Phase|Lost to Follow-up|0
7287797|NCT00521339|11504764|FG000|Treatment Phase|Protocol Violation|1
7287798|NCT00521339|11504765|FG001|Treatment Phase|Protocol Violation|0
7287799|NCT00521339|11504766|FG002|Treatment Phase|Protocol Violation|0
7287800|NCT00521339|11504764|FG000|Treatment Extension Phase|Withdrawal by Subject|0
7287801|NCT00521339|11504765|FG001|Treatment Extension Phase|Withdrawal by Subject|0
7287802|NCT00521339|11504766|FG002|Treatment Extension Phase|Withdrawal by Subject|2
7287803|NCT00521339|11504764|FG000|Treatment Extension Phase|Death|0
7287804|NCT00521339|11504765|FG001|Treatment Extension Phase|Death|0
7287805|NCT00521339|11504766|FG002|Treatment Extension Phase|Death|1
7287806|NCT00521365|11504796|FG000|Overall Study|Adverse Event|3
7287807|NCT00521365|11504796|FG000|Overall Study|Lost to Follow-up|6
7287808|NCT00521365|11504796|FG000|Overall Study|Protocol deviation|2
7287809|NCT00521365|11504796|FG000|Overall Study|Drug compliance|3
7287810|NCT00521365|11504796|FG000|Overall Study|Usage of not allowed drugs|6
7287811|NCT00521404|11504800|FG000|Overall Study|Adverse Event|13
7287812|NCT00521404|11504800|FG000|Overall Study|Disease Progression|33
7287813|NCT00521404|11504800|FG000|Overall Study|Investigator decision|5
7287814|NCT00521404|11504800|FG000|Overall Study|Withdrawal of consent|3
7287815|NCT00521404|11504800|FG000|Overall Study|Noncompliance or lack of cooperation|1
7287816|NCT00521404|11504800|FG000|Overall Study|Other|7
7287817|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Subject request|8
7287818|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Subject request|11
7287819|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
7287820|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
7287821|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
7287822|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
7287823|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
7287824|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
7287825|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Investigator request|2
7287826|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Investigator request|0
7287827|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Adverse Event|0
7287828|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Adverse Event|1
7287829|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Death|1
7287830|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Death|0
7287831|NCT00521586|11504815|FG000|Initial Vaccination (Year 0)|Failed to return|0
7287832|NCT00521586|11504816|FG001|Initial Vaccination (Year 0)|Failed to return|1
7287833|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
7287834|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
7287835|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
7287836|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
7287837|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
7287838|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
7287839|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7287840|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
7287841|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
7287842|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
7287843|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
7287844|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
7287845|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
7287846|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
7287847|NCT00521586|11504815|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
7287848|NCT00521586|11504816|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
7287849|NCT00521586|11504815|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
7287850|NCT00521586|11504816|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
7287851|NCT00521586|11504815|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
7287852|NCT00521586|11504816|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
7287853|NCT00521586|11504815|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
7287854|NCT00521586|11504816|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
7287855|NCT00522041|11504861|FG000|Overall Study|Adverse Event|9
7287856|NCT00522041|11504862|FG001|Overall Study|Adverse Event|3
7287857|NCT00522041|11504861|FG000|Overall Study|Protocol Violation|2
7287858|NCT00522041|11504862|FG001|Overall Study|Protocol Violation|0
7287859|NCT00522041|11504861|FG000|Overall Study|Lost to Follow-up|1
7287860|NCT00522041|11504862|FG001|Overall Study|Lost to Follow-up|4
7287861|NCT00522041|11504861|FG000|Overall Study|Voluntary withdrawal|5
7287862|NCT00522041|11504862|FG001|Overall Study|Voluntary withdrawal|4
7287863|NCT00522041|11504861|FG000|Overall Study|Did not receive treatment|0
7287864|NCT00522041|11504862|FG001|Overall Study|Did not receive treatment|1
7287865|NCT00522275|11504878|FG000|Overall Study|Adverse Event|35
7287866|NCT00522275|11504878|FG000|Overall Study|Lack of Efficacy|80
7287867|NCT00522275|11504878|FG000|Overall Study|Subject withdrew consent|16
7287868|NCT00522275|11504878|FG000|Overall Study|Protocol deviation|1
7287869|NCT00522275|11504878|FG000|Overall Study|Unsatisfactory compliance|11
7287870|NCT00522275|11504878|FG000|Overall Study|Lost to Follow-up|8
7287871|NCT00522275|11504878|FG000|Overall Study|Other: Subject wants to become pregnant|2
7287872|NCT00522275|11504878|FG000|Overall Study|Other: Subject is pregnant|2
7287873|NCT00522275|11504878|FG000|Overall Study|Other: Subject relocated|2
7287874|NCT00522275|11504878|FG000|Overall Study|Other: Subject arrested|1
7287875|NCT00522275|11504878|FG000|Overall Study|Other: Site / clinic closed|4
7287876|NCT00522275|11504878|FG000|Overall Study|Other: Travel to / from site difficulty|3
7287877|NCT00522275|11504878|FG000|Overall Study|Other: Sponsor request|2
7287878|NCT00522275|11504878|FG000|Overall Study|Other: Subject ran out of medication|1
7287879|NCT00522275|11504878|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
7287880|NCT00522379|11504887|FG000|Overall Study|Adverse Event|12
7287881|NCT00522379|11504888|FG001|Overall Study|Adverse Event|15
7287882|NCT00522379|11504889|FG002|Overall Study|Adverse Event|12
7287883|NCT00522379|11504890|FG003|Overall Study|Adverse Event|5
7287884|NCT00522379|11504891|FG004|Overall Study|Adverse Event|17
7287885|NCT00522379|11504887|FG000|Overall Study|Lack of Efficacy|3
7287886|NCT00522379|11504888|FG001|Overall Study|Lack of Efficacy|0
7287887|NCT00522379|11504889|FG002|Overall Study|Lack of Efficacy|2
7287888|NCT00522379|11504890|FG003|Overall Study|Lack of Efficacy|2
7287889|NCT00522379|11504891|FG004|Overall Study|Lack of Efficacy|7
7287890|NCT00522379|11504887|FG000|Overall Study|Withdrawal by Subject|2
7287891|NCT00522379|11504888|FG001|Overall Study|Withdrawal by Subject|3
7287892|NCT00522379|11504889|FG002|Overall Study|Withdrawal by Subject|1
7287893|NCT00522379|11504890|FG003|Overall Study|Withdrawal by Subject|2
7287894|NCT00522379|11504891|FG004|Overall Study|Withdrawal by Subject|0
7287895|NCT00522379|11504887|FG000|Overall Study|Protocol Violation|1
7287896|NCT00522379|11504888|FG001|Overall Study|Protocol Violation|1
7287897|NCT00522379|11504889|FG002|Overall Study|Protocol Violation|2
7287898|NCT00522379|11504890|FG003|Overall Study|Protocol Violation|0
7287899|NCT00522379|11504891|FG004|Overall Study|Protocol Violation|0
7287900|NCT00522379|11504887|FG000|Overall Study|Unsatisfactory Subject Compliance|1
7287901|NCT00522379|11504888|FG001|Overall Study|Unsatisfactory Subject Compliance|2
7287902|NCT00522379|11504889|FG002|Overall Study|Unsatisfactory Subject Compliance|0
7287903|NCT00522379|11504890|FG003|Overall Study|Unsatisfactory Subject Compliance|0
7287904|NCT00522379|11504891|FG004|Overall Study|Unsatisfactory Subject Compliance|0
7287905|NCT00522379|11504887|FG000|Overall Study|Lost to Follow-up|1
7287906|NCT00522379|11504888|FG001|Overall Study|Lost to Follow-up|0
7287907|NCT00522379|11504889|FG002|Overall Study|Lost to Follow-up|4
7287908|NCT00522379|11504890|FG003|Overall Study|Lost to Follow-up|2
7287909|NCT00522379|11504891|FG004|Overall Study|Lost to Follow-up|2
7287910|NCT00522379|11504887|FG000|Overall Study|Randomization error|0
7287911|NCT00522379|11504888|FG001|Overall Study|Randomization error|0
7287912|NCT00522379|11504889|FG002|Overall Study|Randomization error|0
7287913|NCT00522379|11504890|FG003|Overall Study|Randomization error|0
7287914|NCT00522379|11504891|FG004|Overall Study|Randomization error|1
7287915|NCT00522379|11504887|FG000|Overall Study|Dispensing error|1
7287916|NCT00522379|11504888|FG001|Overall Study|Dispensing error|0
7287917|NCT00522379|11504889|FG002|Overall Study|Dispensing error|0
7287918|NCT00522379|11504890|FG003|Overall Study|Dispensing error|1
7287919|NCT00522379|11504891|FG004|Overall Study|Dispensing error|0
7287920|NCT00522379|11504887|FG000|Overall Study|Subject Moved|1
7287921|NCT00522379|11504888|FG001|Overall Study|Subject Moved|1
7287922|NCT00522379|11504889|FG002|Overall Study|Subject Moved|0
7287923|NCT00522379|11504890|FG003|Overall Study|Subject Moved|0
7287924|NCT00522379|11504891|FG004|Overall Study|Subject Moved|0
7287925|NCT00522379|11504887|FG000|Overall Study|Sponsor Request|0
7287926|NCT00522379|11504888|FG001|Overall Study|Sponsor Request|1
7287927|NCT00522379|11504889|FG002|Overall Study|Sponsor Request|0
7287928|NCT00522379|11504890|FG003|Overall Study|Sponsor Request|0
7287929|NCT00522379|11504891|FG004|Overall Study|Sponsor Request|0
7287930|NCT00522379|11504887|FG000|Overall Study|Family Problem|0
7287931|NCT00522379|11504888|FG001|Overall Study|Family Problem|0
7287932|NCT00522379|11504889|FG002|Overall Study|Family Problem|1
7287933|NCT00522379|11504890|FG003|Overall Study|Family Problem|0
7287934|NCT00522379|11504891|FG004|Overall Study|Family Problem|0
7287935|NCT00522379|11504887|FG000|Overall Study|Site Closed|0
7287936|NCT00522379|11504888|FG001|Overall Study|Site Closed|0
7287937|NCT00522379|11504889|FG002|Overall Study|Site Closed|0
7287938|NCT00522379|11504890|FG003|Overall Study|Site Closed|1
7287939|NCT00522379|11504891|FG004|Overall Study|Site Closed|0
7287940|NCT00522379|11504887|FG000|Overall Study|Subject Withdrawal|0
7287941|NCT00522379|11504888|FG001|Overall Study|Subject Withdrawal|0
7287942|NCT00522379|11504889|FG002|Overall Study|Subject Withdrawal|0
7287943|NCT00522379|11504890|FG003|Overall Study|Subject Withdrawal|1
7287944|NCT00522379|11504891|FG004|Overall Study|Subject Withdrawal|0
7287945|NCT00522392|11504905|FG000|Overall Study|Disease progression|0
7287946|NCT00522392|11504906|FG001|Overall Study|Disease progression|3
7287947|NCT00522392|11504905|FG000|Overall Study|Adverse Event|7
7287948|NCT00522392|11504906|FG001|Overall Study|Adverse Event|7
7287949|NCT00522392|11504905|FG000|Overall Study|Withdrawal by Subject|1
7287950|NCT00522392|11504906|FG001|Overall Study|Withdrawal by Subject|1
7287951|NCT00522392|11504905|FG000|Overall Study|Physician Decision|0
7287952|NCT00522392|11504906|FG001|Overall Study|Physician Decision|1
7287953|NCT00522392|11504905|FG000|Overall Study|Non-compliance|0
7287954|NCT00522392|11504906|FG001|Overall Study|Non-compliance|1
7287955|NCT00522418|11504914|FG000|Overall Study|Local IRB Consent Violation|5
7287956|NCT00522418|11504915|FG001|Overall Study|Local IRB Consent Violation|5
7287957|NCT00522418|11504914|FG000|Overall Study|Early Study Termination|46
7287958|NCT00522418|11504915|FG001|Overall Study|Early Study Termination|47
7287959|NCT00522418|11504914|FG000|Overall Study|Noncompliance|2
7287960|NCT00522418|11504915|FG001|Overall Study|Noncompliance|2
7287961|NCT00522418|11504914|FG000|Overall Study|Reason Not Specified|3
7287962|NCT00522418|11504915|FG001|Overall Study|Reason Not Specified|1
7287963|NCT00522418|11504914|FG000|Overall Study|Consent Withdraw|1
7287964|NCT00522418|11504915|FG001|Overall Study|Consent Withdraw|2
7287965|NCT00522418|11504914|FG000|Overall Study|Lack of Efficacy|0
7287966|NCT00522418|11504915|FG001|Overall Study|Lack of Efficacy|1
7287967|NCT00522431|11504923|FG000|Overall Study|Adverse Event|5
7287968|NCT00522431|11504923|FG000|Overall Study|Protocol Violation|2
7287969|NCT00522431|11504923|FG000|Overall Study|Withdrawal by Subject|2
7287970|NCT00522431|11504923|FG000|Overall Study|Subject non-compliance|1
7287971|NCT00522431|11504923|FG000|Overall Study|Other/unknown|1
7287972|NCT00522548|11504929|FG000|Overall Study|Adverse Event|2
7287973|NCT00522548|11504930|FG001|Overall Study|Adverse Event|2
7287974|NCT00522548|11504929|FG000|Overall Study|Withdrawal by Subject|0
7287975|NCT00522548|11504930|FG001|Overall Study|Withdrawal by Subject|2
7287976|NCT00522626|11504936|FG000|Overall Study|Lost to Follow-up|7
7287977|NCT00522873|11504946|FG000|Overall Study|Adverse Event|41
7287978|NCT00522873|11504947|FG001|Overall Study|Adverse Event|26
7287979|NCT00522873|11504946|FG000|Overall Study|Withdrawal by Subject|20
7287980|NCT00522873|11504947|FG001|Overall Study|Withdrawal by Subject|9
7287981|NCT00522873|11504946|FG000|Overall Study|Protocol Violation|14
7287982|NCT00522873|11504947|FG001|Overall Study|Protocol Violation|4
7287983|NCT00522873|11504946|FG000|Overall Study|Lost to Follow-up|11
7287984|NCT00522873|11504947|FG001|Overall Study|Lost to Follow-up|3
7287985|NCT00522873|11504946|FG000|Overall Study|Personal Reasons|8
7287986|NCT00522873|11504947|FG001|Overall Study|Personal Reasons|1
7287987|NCT00522873|11504946|FG000|Overall Study|Medication Errors|1
7287988|NCT00522873|11504947|FG001|Overall Study|Medication Errors|1
7287989|NCT00522873|11504946|FG000|Overall Study|Never Received Medication|1
7287990|NCT00522873|11504947|FG001|Overall Study|Never Received Medication|0
7287991|NCT00522951|11504966|FG000|Period 1|body motion|0
7287992|NCT00522951|11504967|FG001|Period 1|body motion|1
7287993|NCT00522951|11504966|FG000|Washout Period|Adverse Event|0
7287994|NCT00522951|11504967|FG001|Washout Period|Adverse Event|1
7287995|NCT00522951|11504966|FG000|Washout Period|Death|0
7287996|NCT00522951|11504967|FG001|Washout Period|Death|1
7287997|NCT00522951|11504966|FG000|Period 2|Withdrawal by Subject|1
7287998|NCT00522951|11504967|FG001|Period 2|Withdrawal by Subject|0
7287999|NCT00522951|11504966|FG000|Period 2|residual contrast medium|1
7288000|NCT00522951|11504967|FG001|Period 2|residual contrast medium|1
7469990|NCT01928381|11771845|FG002|Part 2 - First Intervention|Lost to Follow-up|0
7469991|NCT01928381|11771846|FG003|Part 2 - First Intervention|Lost to Follow-up|1
7469992|NCT01928381|11771847|FG004|Part 2 - First Intervention|Lost to Follow-up|0
7469993|NCT01928381|11771848|FG005|Part 2 - First Intervention|Lost to Follow-up|0
7469994|NCT01928381|11771849|FG006|Part 2 - First Intervention|Lost to Follow-up|0
7469995|NCT01928381|11771843|FG000|Washout First Intervention|Protocol Violation|0
7469996|NCT01928381|11771844|FG001|Washout First Intervention|Protocol Violation|0
7469997|NCT01928381|11771845|FG002|Washout First Intervention|Protocol Violation|0
7469998|NCT01928381|11771846|FG003|Washout First Intervention|Protocol Violation|0
7469999|NCT01928381|11771847|FG004|Washout First Intervention|Protocol Violation|1
7470000|NCT01928381|11771848|FG005|Washout First Intervention|Protocol Violation|0
7470001|NCT01928381|11771849|FG006|Washout First Intervention|Protocol Violation|0
7470002|NCT01928381|11771843|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
7470003|NCT01928381|11771844|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
7470004|NCT01928381|11771845|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
7470005|NCT01928381|11771846|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
7470006|NCT01928381|11771847|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
7470007|NCT01928381|11771848|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
7470008|NCT01928381|11771849|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
7470009|NCT01928381|11771843|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
7470010|NCT01928381|11771844|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
7470011|NCT01928381|11771845|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
7470012|NCT01928381|11771846|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
7470013|NCT01928381|11771847|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
7470014|NCT01928381|11771848|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
7470015|NCT01928381|11771849|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
7470016|NCT01928433|11771862|FG000|Overall Study|Adverse Event|5
7470017|NCT01928433|11771863|FG001|Overall Study|Adverse Event|2
7470018|NCT01928433|11771864|FG002|Overall Study|Adverse Event|5
7470019|NCT01928433|11771862|FG000|Overall Study|Protocol Violation|0
7470020|NCT01928433|11771863|FG001|Overall Study|Protocol Violation|0
7470021|NCT01928433|11771864|FG002|Overall Study|Protocol Violation|2
7470022|NCT01928433|11771862|FG000|Overall Study|Lack of Efficacy|5
7470023|NCT01928433|11771863|FG001|Overall Study|Lack of Efficacy|4
7470024|NCT01928433|11771864|FG002|Overall Study|Lack of Efficacy|4
7470025|NCT01928433|11771862|FG000|Overall Study|Withdrawal by Subject|0
7470026|NCT01928433|11771863|FG001|Overall Study|Withdrawal by Subject|4
7470027|NCT01928433|11771864|FG002|Overall Study|Withdrawal by Subject|0
7470028|NCT01928433|11771862|FG000|Overall Study|Negative screening urine culture|7
7470029|NCT01928433|11771863|FG001|Overall Study|Negative screening urine culture|6
7470030|NCT01928433|11771864|FG002|Overall Study|Negative screening urine culture|10
7470031|NCT01928433|11771862|FG000|Overall Study|Lost to Follow-up|0
7470032|NCT01928433|11771863|FG001|Overall Study|Lost to Follow-up|2
7470033|NCT01928433|11771864|FG002|Overall Study|Lost to Follow-up|3
7470034|NCT01928433|11771862|FG000|Overall Study|Other reasons|3
7470035|NCT01928433|11771863|FG001|Overall Study|Other reasons|3
7470036|NCT01928433|11771864|FG002|Overall Study|Other reasons|4
7470037|NCT01928472|11771890|FG000|Overall Study|Death|0
7470038|NCT01928472|11771891|FG001|Overall Study|Death|0
7470039|NCT01928472|11771892|FG002|Overall Study|Death|1
7470040|NCT01928472|11771893|FG003|Overall Study|Death|0
7470041|NCT01928472|11771890|FG000|Overall Study|Withdrawal by Subject|4
7470042|NCT01928472|11771891|FG001|Overall Study|Withdrawal by Subject|4
7470043|NCT01928472|11771892|FG002|Overall Study|Withdrawal by Subject|1
7470044|NCT01928472|11771893|FG003|Overall Study|Withdrawal by Subject|2
7470045|NCT01928472|11771890|FG000|Overall Study|Lost to Follow-up|2
7470046|NCT01928472|11771891|FG001|Overall Study|Lost to Follow-up|3
7470047|NCT01928472|11771892|FG002|Overall Study|Lost to Follow-up|4
7470048|NCT01928472|11771893|FG003|Overall Study|Lost to Follow-up|0
7470049|NCT01928472|11771890|FG000|Overall Study|Administrative Reason|2
7470050|NCT01928472|11771891|FG001|Overall Study|Administrative Reason|1
7470051|NCT01928472|11771892|FG002|Overall Study|Administrative Reason|0
7470052|NCT01928472|11771893|FG003|Overall Study|Administrative Reason|0
7470053|NCT01928472|11771890|FG000|Overall Study|Unclassified|0
7470054|NCT01928472|11771891|FG001|Overall Study|Unclassified|0
7470055|NCT01928472|11771892|FG002|Overall Study|Unclassified|1
7470056|NCT01928472|11771893|FG003|Overall Study|Unclassified|0
7470057|NCT01928485|11771906|FG000|Overall Study|Physician Decision|0
7470058|NCT01928485|11771907|FG001|Overall Study|Physician Decision|1
7288023|NCT00523367|11504999|FG000|Overall Study|19 screen failures|19
7288024|NCT00523367|11504999|FG000|Overall Study|4 Withdrawn by PI|4
7288025|NCT00523419|11505003|FG000|Overall Study|Adverse Event|1
7288026|NCT00523419|11505003|FG000|Overall Study|Withdrawal by Subject|1
7288027|NCT00523419|11505003|FG000|Overall Study|Physician Decision|2
7288028|NCT00523419|11505003|FG000|Overall Study|Progressive Disease|22
7288029|NCT00523419|11505003|FG000|Overall Study|Death due to Study Disease|4
7288030|NCT00523419|11505003|FG000|Overall Study|Death due to Adverse Event|2
7288031|NCT00523549|11505009|FG000|Overall Study|Adverse Event|6
7288032|NCT00523549|11505010|FG001|Overall Study|Adverse Event|3
7288033|NCT00523549|11505009|FG000|Overall Study|Unsatisfactory therapeutic effect|0
7288034|NCT00523549|11505010|FG001|Overall Study|Unsatisfactory therapeutic effect|1
7288035|NCT00523549|11505009|FG000|Overall Study|Protocol Deviation|3
7288036|NCT00523549|11505010|FG001|Overall Study|Protocol Deviation|1
7623221|NCT01844505|12034175|FG000|Overall Study|Disease progression|170
7623222|NCT01844505|12034176|FG001|Overall Study|Disease progression|88
7623223|NCT01844505|12034177|FG002|Overall Study|Disease progression|224
7623224|NCT01844505|12034175|FG000|Overall Study|Study drug toxicity|40
7623225|NCT01844505|12034176|FG001|Overall Study|Study drug toxicity|131
7623226|NCT01844505|12034177|FG002|Overall Study|Study drug toxicity|50
7623227|NCT01844505|12034175|FG000|Overall Study|Death|1
7623228|NCT01844505|12034176|FG001|Overall Study|Death|3
7623229|NCT01844505|12034177|FG002|Overall Study|Death|1
7623230|NCT01844505|12034175|FG000|Overall Study|Adverse event unrelated to study drug|7
7623231|NCT01844505|12034176|FG001|Overall Study|Adverse event unrelated to study drug|15
7623232|NCT01844505|12034177|FG002|Overall Study|Adverse event unrelated to study drug|6
7623233|NCT01844505|12034175|FG000|Overall Study|Subject request discontinue treatment|17
7623234|NCT01844505|12034176|FG001|Overall Study|Subject request discontinue treatment|14
7623235|NCT01844505|12034177|FG002|Overall Study|Subject request discontinue treatment|8
7623236|NCT01844505|12034175|FG000|Overall Study|Withdrawal by Subject|0
7623237|NCT01844505|12034176|FG001|Overall Study|Withdrawal by Subject|3
7288037|NCT00523549|11505009|FG000|Overall Study|Patient withdrew consent|7
7288038|NCT00523549|11505010|FG001|Overall Study|Patient withdrew consent|6
7288039|NCT00523549|11505009|FG000|Overall Study|Lost to Follow-up|3
7288040|NCT00523549|11505010|FG001|Overall Study|Lost to Follow-up|5
7288041|NCT00523640|11505025|FG000|Overall Study|Death|1
7288042|NCT00523705|11505031|FG000|Overall Study|No time for study.|0
7288043|NCT00523705|11505032|FG001|Overall Study|No time for study.|1
7288044|NCT00523718|11505040|FG000|Overall Study|Withdrawal by Subject|1
7288045|NCT00523718|11505041|FG001|Overall Study|Withdrawal by Subject|0
7288046|NCT00523718|11505040|FG000|Overall Study|Protocol Violation|2
7288047|NCT00523718|11505041|FG001|Overall Study|Protocol Violation|0
7288048|NCT00523744|11505047|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
7288049|NCT00523744|11505047|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
7288050|NCT00523744|11505047|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
7288051|NCT00523744|11505047|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
7288052|NCT00523744|11505047|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
7288053|NCT00523744|11505047|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
7288054|NCT00523848|11505054|FG000|Overall Study|Adverse Event|11
7288055|NCT00523848|11505054|FG000|Overall Study|Withdrawal by Subject|2
7288056|NCT00523848|11505054|FG000|Overall Study|NOT TREATED (Became ineligible)|2
7288057|NCT00523848|11505054|FG000|Overall Study|Disease Progression|5
7288058|NCT00523848|11505054|FG000|Overall Study|Other, unspecified|4
7288059|NCT00523978|11505060|FG000|Overall Study|Withdrawal by Subject|3
7288060|NCT00523978|11505061|FG001|Overall Study|Withdrawal by Subject|7
7288061|NCT00523978|11505060|FG000|Overall Study|Screen Failures|5
7288062|NCT00523978|11505061|FG001|Overall Study|Screen Failures|1
7288063|NCT00523978|11505060|FG000|Overall Study|Death|1
7288064|NCT00523978|11505061|FG001|Overall Study|Death|0
7288065|NCT00523991|11505070|FG000|Overall Study|Adverse Event|6
7288066|NCT00523991|11505071|FG001|Overall Study|Adverse Event|5
7288067|NCT00523991|11505070|FG000|Overall Study|Protocol Violation|1
7288068|NCT00523991|11505071|FG001|Overall Study|Protocol Violation|4
7288069|NCT00523991|11505070|FG000|Overall Study|Lost to Follow-up|4
7288070|NCT00523991|11505071|FG001|Overall Study|Lost to Follow-up|1
7288071|NCT00523991|11505070|FG000|Overall Study|Withdrawal by Subject|7
7288072|NCT00523991|11505071|FG001|Overall Study|Withdrawal by Subject|17
7288073|NCT00523991|11505070|FG000|Overall Study|Other reason (not specified)|3
7288074|NCT00523991|11505071|FG001|Overall Study|Other reason (not specified)|0
7288075|NCT00524030|11505088|FG000|Overall Study|Lack of Efficacy|10
7288076|NCT00524030|11505089|FG001|Overall Study|Lack of Efficacy|24
7288077|NCT00524030|11505088|FG000|Overall Study|Lost to Follow-up|0
7288078|NCT00524030|11505089|FG001|Overall Study|Lost to Follow-up|2
7288079|NCT00524030|11505088|FG000|Overall Study|Withdrawal by Subject|3
7288080|NCT00524030|11505089|FG001|Overall Study|Withdrawal by Subject|8
7288081|NCT00524030|11505088|FG000|Overall Study|Noncompliance/Investigator discretion|0
7623238|NCT01844505|12034177|FG002|Overall Study|Withdrawal by Subject|0
7623239|NCT01844505|12034175|FG000|Overall Study|Lost to Follow-up|1
7623240|NCT01844505|12034176|FG001|Overall Study|Lost to Follow-up|0
7623241|NCT01844505|12034177|FG002|Overall Study|Lost to Follow-up|0
7623242|NCT01844505|12034175|FG000|Overall Study|Maximum clinical benefit|8
7623243|NCT01844505|12034176|FG001|Overall Study|Maximum clinical benefit|11
7623244|NCT01844505|12034177|FG002|Overall Study|Maximum clinical benefit|2
7623245|NCT01844505|12034175|FG000|Overall Study|Poor/non-compliance|1
7623246|NCT01844505|12034176|FG001|Overall Study|Poor/non-compliance|1
7623247|NCT01844505|12034177|FG002|Overall Study|Poor/non-compliance|1
7623248|NCT01844505|12034175|FG000|Overall Study|Subject no longer meets criteria|0
7288082|NCT00524030|11505089|FG001|Overall Study|Noncompliance/Investigator discretion|2
7288083|NCT00524030|11505088|FG000|Overall Study|Protocol Violation|0
7288084|NCT00524030|11505089|FG001|Overall Study|Protocol Violation|1
7288085|NCT00524030|11505088|FG000|Overall Study|Pregnancy|1
7288086|NCT00524030|11505089|FG001|Overall Study|Pregnancy|0
7288087|NCT00524030|11505088|FG000|Overall Study|Adverse Event|3
7288088|NCT00524030|11505089|FG001|Overall Study|Adverse Event|21
7288089|NCT00524030|11505088|FG000|Overall Study|Death|0
7288090|NCT00524030|11505089|FG001|Overall Study|Death|1
7288091|NCT00524043|11505099|FG000|Overall Study|Lack of Efficacy|15
7288092|NCT00524043|11505100|FG001|Overall Study|Lack of Efficacy|13
7288093|NCT00524043|11505101|FG002|Overall Study|Lack of Efficacy|14
7288094|NCT00524043|11505099|FG000|Overall Study|Withdrawal by Subject|5
7288095|NCT00524043|11505100|FG001|Overall Study|Withdrawal by Subject|7
7288096|NCT00524043|11505101|FG002|Overall Study|Withdrawal by Subject|7
7288097|NCT00524043|11505099|FG000|Overall Study|Adverse Event|5
7288098|NCT00524043|11505100|FG001|Overall Study|Adverse Event|2
7288099|NCT00524043|11505101|FG002|Overall Study|Adverse Event|7
7288100|NCT00524043|11505099|FG000|Overall Study|Lost to Follow-up|3
7288101|NCT00524043|11505100|FG001|Overall Study|Lost to Follow-up|5
7288102|NCT00524043|11505101|FG002|Overall Study|Lost to Follow-up|3
7288103|NCT00524043|11505099|FG000|Overall Study|Various (eg, incarceration)|2
7288104|NCT00524043|11505100|FG001|Overall Study|Various (eg, incarceration)|1
7288105|NCT00524043|11505101|FG002|Overall Study|Various (eg, incarceration)|0
7288106|NCT00524121|11505109|FG000|Overall Study|Disease progression|6
7288107|NCT00524121|11505109|FG000|Overall Study|Adverse Event|4
7288108|NCT00524121|11505109|FG000|Overall Study|Patient refused|2
7288109|NCT00524121|11505109|FG000|Overall Study|Other|1
7288110|NCT00524121|11505109|FG000|Overall Study|Death|1
7288111|NCT00524121|11505109|FG000|Overall Study|Not treated (became ineligible)|4
7288112|NCT00524121|11505109|FG000|Overall Study|Not treated (changed mind)|1
7288113|NCT00524173|11505126|FG000|Overall Study|Lost to Follow-up|0
7288114|NCT00524173|11505127|FG001|Overall Study|Lost to Follow-up|1
7288115|NCT00524173|11505126|FG000|Overall Study|Death|1
7288116|NCT00524173|11505127|FG001|Overall Study|Death|0
7288117|NCT00524173|11505126|FG000|Overall Study|Had not reached endpoint at study close|4
7288118|NCT00524173|11505127|FG001|Overall Study|Had not reached endpoint at study close|1
7288119|NCT00524303|11505150|FG000|Overall Study|Lost to Follow-up|6
7288120|NCT00524303|11505151|FG001|Overall Study|Lost to Follow-up|0
7623249|NCT01844505|12034176|FG001|Overall Study|Subject no longer meets criteria|1
7288121|NCT00524303|11505152|FG002|Overall Study|Lost to Follow-up|3
7288122|NCT00524303|11505150|FG000|Overall Study|Protocol Violation|0
7288123|NCT00524303|11505151|FG001|Overall Study|Protocol Violation|1
7623250|NCT01844505|12034177|FG002|Overall Study|Subject no longer meets criteria|0
7288124|NCT00524303|11505152|FG002|Overall Study|Protocol Violation|1
7288125|NCT00524303|11505150|FG000|Overall Study|Withdrawal by Subject|3
7288126|NCT00524303|11505151|FG001|Overall Study|Withdrawal by Subject|0
7288127|NCT00524303|11505152|FG002|Overall Study|Withdrawal by Subject|4
7288128|NCT00524303|11505150|FG000|Overall Study|Death|0
7288129|NCT00524303|11505151|FG001|Overall Study|Death|2
7288130|NCT00524303|11505152|FG002|Overall Study|Death|3
7288131|NCT00524303|11505150|FG000|Overall Study|Adverse Event|1
7288132|NCT00524303|11505151|FG001|Overall Study|Adverse Event|2
7288133|NCT00524303|11505152|FG002|Overall Study|Adverse Event|3
7288134|NCT00524303|11505150|FG000|Overall Study|Did not Complete Study Dosing|1
7288135|NCT00524303|11505151|FG001|Overall Study|Did not Complete Study Dosing|0
7288136|NCT00524303|11505152|FG002|Overall Study|Did not Complete Study Dosing|0
7288137|NCT00524303|11505150|FG000|Overall Study|Worsening Peripheral Neuropathy|1
7288138|NCT00524303|11505151|FG001|Overall Study|Worsening Peripheral Neuropathy|0
7288139|NCT00524303|11505152|FG002|Overall Study|Worsening Peripheral Neuropathy|0
7288140|NCT00524303|11505150|FG000|Overall Study|Disease Progression|0
7288141|NCT00524303|11505151|FG001|Overall Study|Disease Progression|4
7288142|NCT00524303|11505152|FG002|Overall Study|Disease Progression|1
7288143|NCT00524303|11505150|FG000|Overall Study|Disease Recurrence|0
7288144|NCT00524303|11505151|FG001|Overall Study|Disease Recurrence|1
7288145|NCT00524303|11505152|FG002|Overall Study|Disease Recurrence|0
7288146|NCT00524303|11505150|FG000|Overall Study|Sponsor Request|0
7288147|NCT00524303|11505151|FG001|Overall Study|Sponsor Request|0
7288148|NCT00524303|11505152|FG002|Overall Study|Sponsor Request|1
7288149|NCT00524303|11505150|FG000|Overall Study|Physician Decision|0
7288150|NCT00524303|11505151|FG001|Overall Study|Physician Decision|0
7288151|NCT00524303|11505152|FG002|Overall Study|Physician Decision|1
7288152|NCT00524303|11505150|FG000|Overall Study|Completed 5 years|0
7288153|NCT00524303|11505151|FG001|Overall Study|Completed 5 years|0
7288154|NCT00524303|11505152|FG002|Overall Study|Completed 5 years|1
7288155|NCT00524316|11505163|FG000|Overall Study|Withdrawal by Subject|2
7288156|NCT00524316|11505163|FG000|Overall Study|Adverse Event|7
7288157|NCT00524316|11505163|FG000|Overall Study|Disease Progression|7
7288158|NCT00524368|11505173|FG000|Overall Study|Adverse Event|10
7288159|NCT00524368|11505174|FG001|Overall Study|Adverse Event|12
7288160|NCT00524368|11505173|FG000|Overall Study|Lost to Follow-up|9
7288161|NCT00524368|11505174|FG001|Overall Study|Lost to Follow-up|13
7288162|NCT00524368|11505173|FG000|Overall Study|Withdrawal by Subject|4
7288163|NCT00524368|11505174|FG001|Overall Study|Withdrawal by Subject|5
7288164|NCT00524368|11505173|FG000|Overall Study|Non-compliant|8
7288165|NCT00524368|11505174|FG001|Overall Study|Non-compliant|9
7288166|NCT00524368|11505173|FG000|Overall Study|Reached a Virologic Endpoint|3
7288167|NCT00524368|11505174|FG001|Overall Study|Reached a Virologic Endpoint|2
7288168|NCT00524368|11505173|FG000|Overall Study|Sponsor's Decision|2
7288169|NCT00524368|11505174|FG001|Overall Study|Sponsor's Decision|0
7288170|NCT00524368|11505173|FG000|Overall Study|Ineligible to Continue the study|2
7288171|NCT00524368|11505174|FG001|Overall Study|Ineligible to Continue the study|5
7288172|NCT00524368|11505173|FG000|Overall Study|Other|3
7288173|NCT00524368|11505174|FG001|Overall Study|Other|2
7288174|NCT00524420|11505182|FG000|Overall Study|Lack of Efficacy|1
7288175|NCT00524420|11505183|FG001|Overall Study|Lack of Efficacy|0
7288176|NCT00524589|11505213|FG000|Overall Study|Withdrawal by Subject|2
7288177|NCT00524589|11505213|FG000|Overall Study|Disease Progression|16
7288178|NCT00524680|11505221|FG000|Overall Study|progression|0
7288179|NCT00524680|11505222|FG001|Overall Study|progression|0
7288180|NCT00524680|11505223|FG002|Overall Study|progression|0
7288181|NCT00524680|11505224|FG003|Overall Study|progression|1
7288182|NCT00524680|11505221|FG000|Overall Study|Adverse Event|2
7288183|NCT00524680|11505222|FG001|Overall Study|Adverse Event|0
7288184|NCT00524680|11505223|FG002|Overall Study|Adverse Event|0
7288185|NCT00524680|11505224|FG003|Overall Study|Adverse Event|1
7288186|NCT00524680|11505221|FG000|Overall Study|Other|0
7288187|NCT00524680|11505222|FG001|Overall Study|Other|1
7288188|NCT00524680|11505223|FG002|Overall Study|Other|2
7288189|NCT00524680|11505224|FG003|Overall Study|Other|3
7288190|NCT00524680|11505221|FG000|Overall Study|Withdrawal by Subject|1
7288191|NCT00524680|11505222|FG001|Overall Study|Withdrawal by Subject|0
7288192|NCT00524680|11505223|FG002|Overall Study|Withdrawal by Subject|1
7288193|NCT00524680|11505224|FG003|Overall Study|Withdrawal by Subject|1
7288194|NCT00524745|11505238|FG000|Overall Study|subject withdrawal or lost to follow up|34
7288195|NCT00524745|11505239|FG001|Overall Study|subject withdrawal or lost to follow up|13
7288196|NCT00524745|11505240|FG002|Overall Study|subject withdrawal or lost to follow up|29
7288197|NCT00524745|11505241|FG003|Overall Study|subject withdrawal or lost to follow up|22
7288198|NCT00524771|11505253|FG000|Overall Study|Protocol Violation|220
7288199|NCT00524771|11505254|FG001|Overall Study|Protocol Violation|585
7288200|NCT00525031|11505267|FG000|Overall Study|Disease Progression|1
7288201|NCT00525031|11505268|FG001|Overall Study|Disease Progression|1
7288202|NCT00525044|11505277|FG000|Overall Study|Lost to Follow-up|0
7288203|NCT00525044|11505278|FG001|Overall Study|Lost to Follow-up|1
7288204|NCT00525148|11505301|FG000|Overall Study|Other Adverse Event|3
7288205|NCT00525148|11505302|FG001|Overall Study|Other Adverse Event|5
7288206|NCT00525148|11505303|FG002|Overall Study|Other Adverse Event|1
7288207|NCT00525148|11505304|FG003|Overall Study|Other Adverse Event|8
7288208|NCT00525148|11505301|FG000|Overall Study|Progressive disease|18
7288209|NCT00525148|11505302|FG001|Overall Study|Progressive disease|30
7288210|NCT00525148|11505303|FG002|Overall Study|Progressive disease|6
7288211|NCT00525148|11505304|FG003|Overall Study|Progressive disease|49
7288212|NCT00525148|11505301|FG000|Overall Study|Refused continuation of study medication|0
7288213|NCT00525148|11505302|FG001|Overall Study|Refused continuation of study medication|2
7288214|NCT00525148|11505303|FG002|Overall Study|Refused continuation of study medication|0
7288215|NCT00525148|11505304|FG003|Overall Study|Refused continuation of study medication|1
7288216|NCT00525148|11505301|FG000|Overall Study|Other than stated|2
7288217|NCT00525148|11505302|FG001|Overall Study|Other than stated|1
7288218|NCT00525148|11505303|FG002|Overall Study|Other than stated|0
7288219|NCT00525148|11505304|FG003|Overall Study|Other than stated|3
7288220|NCT00525161|11505314|FG000|Overall Study|Adverse Event|1
7288221|NCT00525265|11505329|FG000|Overall Study|Protocol Violation|1
7288222|NCT00525265|11505330|FG001|Overall Study|Protocol Violation|0
7288223|NCT00525499|11505349|FG000|Overall Study|Lost to Follow-up|2
7288224|NCT00525499|11505350|FG001|Overall Study|Lost to Follow-up|4
7288225|NCT00525499|11505351|FG002|Overall Study|Lost to Follow-up|1
7288226|NCT00525499|11505352|FG003|Overall Study|Lost to Follow-up|4
7288227|NCT00525499|11505349|FG000|Overall Study|Adverse Event|0
7288228|NCT00525499|11505350|FG001|Overall Study|Adverse Event|1
7288229|NCT00525499|11505351|FG002|Overall Study|Adverse Event|0
7288230|NCT00525499|11505352|FG003|Overall Study|Adverse Event|1
7288231|NCT00525499|11505349|FG000|Overall Study|Withdrawal by Subject|5
7288232|NCT00525499|11505350|FG001|Overall Study|Withdrawal by Subject|1
7288233|NCT00525499|11505351|FG002|Overall Study|Withdrawal by Subject|5
7288234|NCT00525499|11505352|FG003|Overall Study|Withdrawal by Subject|2
7288235|NCT00525499|11505349|FG000|Overall Study|Protocol Violation|0
7288236|NCT00525499|11505350|FG001|Overall Study|Protocol Violation|1
7288237|NCT00525499|11505351|FG002|Overall Study|Protocol Violation|1
7288238|NCT00525499|11505352|FG003|Overall Study|Protocol Violation|0
7288239|NCT00525512|11505364|FG000|Double-Blind Phase|Adverse Event|48
7288240|NCT00525512|11505365|FG001|Double-Blind Phase|Adverse Event|28
7288241|NCT00525512|11505366|FG002|Double-Blind Phase|Adverse Event|0
7288242|NCT00525512|11505367|FG003|Double-Blind Phase|Adverse Event|0
7288243|NCT00525512|11505364|FG000|Double-Blind Phase|Protocol Violation|3
7288244|NCT00525512|11505365|FG001|Double-Blind Phase|Protocol Violation|1
7288245|NCT00525512|11505366|FG002|Double-Blind Phase|Protocol Violation|0
7288246|NCT00525512|11505367|FG003|Double-Blind Phase|Protocol Violation|0
7288247|NCT00525512|11505364|FG000|Double-Blind Phase|Lost to Follow-up|3
7288248|NCT00525512|11505365|FG001|Double-Blind Phase|Lost to Follow-up|7
7288249|NCT00525512|11505366|FG002|Double-Blind Phase|Lost to Follow-up|0
7288250|NCT00525512|11505367|FG003|Double-Blind Phase|Lost to Follow-up|0
7288251|NCT00525512|11505364|FG000|Double-Blind Phase|Withdrawal by Subject|17
7288252|NCT00525512|11505365|FG001|Double-Blind Phase|Withdrawal by Subject|12
7288253|NCT00525512|11505366|FG002|Double-Blind Phase|Withdrawal by Subject|0
7288254|NCT00525512|11505367|FG003|Double-Blind Phase|Withdrawal by Subject|0
7288255|NCT00525512|11505364|FG000|Double-Blind Phase|Lack of Efficacy|13
7288256|NCT00525512|11505365|FG001|Double-Blind Phase|Lack of Efficacy|5
7288257|NCT00525512|11505366|FG002|Double-Blind Phase|Lack of Efficacy|0
7288258|NCT00525512|11505367|FG003|Double-Blind Phase|Lack of Efficacy|0
7288259|NCT00525512|11505364|FG000|Double-Blind Phase|Other reason (not specified)|12
7288260|NCT00525512|11505365|FG001|Double-Blind Phase|Other reason (not specified)|13
7288261|NCT00525512|11505366|FG002|Double-Blind Phase|Other reason (not specified)|0
7288262|NCT00525512|11505367|FG003|Double-Blind Phase|Other reason (not specified)|0
7288263|NCT00525512|11505364|FG000|Open-Label Phase|Adverse Event|0
7288264|NCT00525512|11505365|FG001|Open-Label Phase|Adverse Event|0
7288265|NCT00525512|11505366|FG002|Open-Label Phase|Adverse Event|1
7288266|NCT00525512|11505367|FG003|Open-Label Phase|Adverse Event|0
7288267|NCT00525512|11505364|FG000|Open-Label Phase|Lost to Follow-up|0
7288268|NCT00525512|11505365|FG001|Open-Label Phase|Lost to Follow-up|0
7288269|NCT00525512|11505366|FG002|Open-Label Phase|Lost to Follow-up|1
7288270|NCT00525512|11505367|FG003|Open-Label Phase|Lost to Follow-up|0
7288271|NCT00525512|11505364|FG000|Open-Label Phase|Other reason (not specified)|0
7288272|NCT00525512|11505365|FG001|Open-Label Phase|Other reason (not specified)|0
7288273|NCT00525512|11505366|FG002|Open-Label Phase|Other reason (not specified)|4
7288274|NCT00525512|11505367|FG003|Open-Label Phase|Other reason (not specified)|5
7288275|NCT00525590|11505388|FG000|Overall Study|Adverse Event|3
7288276|NCT00525590|11505388|FG000|Overall Study|Physician Decision|3
7288277|NCT00525590|11505388|FG000|Overall Study|Withdrawal by Subject|16
7288278|NCT00525590|11505388|FG000|Overall Study|Lost to Follow-up|1
7288279|NCT00525590|11505388|FG000|Overall Study|Death|9
7288280|NCT00525590|11505388|FG000|Overall Study|Other|13
7288281|NCT00525785|11505412|FG000|Overall Study|Withdrawal by Subject|1
7288282|NCT00525785|11505412|FG000|Overall Study|Lack of Efficacy|1
7288283|NCT00525785|11505412|FG000|Overall Study|Physician Decision|1
7288284|NCT00525824|11505429|FG000|Overall Study|Adverse Event|7
7288285|NCT00525824|11505430|FG001|Overall Study|Adverse Event|11
7288286|NCT00525824|11505431|FG002|Overall Study|Adverse Event|6
7288287|NCT00525824|11505432|FG003|Overall Study|Adverse Event|7
7288288|NCT00525824|11505429|FG000|Overall Study|Withdrawal by Subject|5
7288289|NCT00525824|11505430|FG001|Overall Study|Withdrawal by Subject|9
7288290|NCT00525824|11505431|FG002|Overall Study|Withdrawal by Subject|3
7288291|NCT00525824|11505432|FG003|Overall Study|Withdrawal by Subject|4
7288292|NCT00525824|11505429|FG000|Overall Study|Lost to Follow-up|4
7288293|NCT00525824|11505430|FG001|Overall Study|Lost to Follow-up|2
7288294|NCT00525824|11505431|FG002|Overall Study|Lost to Follow-up|4
7288295|NCT00525824|11505432|FG003|Overall Study|Lost to Follow-up|0
7288296|NCT00525824|11505429|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
7288297|NCT00525824|11505430|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
7288298|NCT00525824|11505431|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
7288299|NCT00525824|11505432|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
7288300|NCT00525824|11505429|FG000|Overall Study|Severe non-compliance|0
7288301|NCT00525824|11505430|FG001|Overall Study|Severe non-compliance|1
7288302|NCT00525824|11505431|FG002|Overall Study|Severe non-compliance|1
7288303|NCT00525824|11505432|FG003|Overall Study|Severe non-compliance|1
7288304|NCT00525824|11505429|FG000|Overall Study|Safety reasons|1
7288305|NCT00525824|11505430|FG001|Overall Study|Safety reasons|0
7288306|NCT00525824|11505431|FG002|Overall Study|Safety reasons|1
7288307|NCT00525824|11505432|FG003|Overall Study|Safety reasons|0
7288308|NCT00525824|11505429|FG000|Overall Study|Other|1
7288309|NCT00525824|11505430|FG001|Overall Study|Other|3
7288310|NCT00525824|11505431|FG002|Overall Study|Other|3
7288311|NCT00525824|11505432|FG003|Overall Study|Other|1
7288312|NCT00525902|11505460|FG000|Overall Study|Lack of Efficacy|1
7288313|NCT00525915|11505466|FG000|Overall Study|Non-Compliance|0
7288314|NCT00525915|11505467|FG001|Overall Study|Non-Compliance|1
7288315|NCT00525915|11505466|FG000|Overall Study|Disease Progression|5
7288316|NCT00525915|11505467|FG001|Overall Study|Disease Progression|6
7288317|NCT00525915|11505466|FG000|Overall Study|Withdrawal by Subject|1
7288318|NCT00525915|11505467|FG001|Overall Study|Withdrawal by Subject|0
7288319|NCT00525915|11505466|FG000|Overall Study|Refused Surgery|1
7288320|NCT00525915|11505467|FG001|Overall Study|Refused Surgery|2
7288321|NCT00525915|11505466|FG000|Overall Study|Unrelated illness|1
7288322|NCT00525915|11505467|FG001|Overall Study|Unrelated illness|0
7288323|NCT00526071|11505482|FG000|Overall Study|Adverse Event|1
7288324|NCT00526071|11505482|FG000|Overall Study|Withdrawal by Subject|1
7288325|NCT00526071|11505482|FG000|Overall Study|Lack of Response to Study Drug|4
7288326|NCT00526097|11505492|FG000|Overall Study|Adverse Event|6
7288327|NCT00526097|11505493|FG001|Overall Study|Adverse Event|44
7288328|NCT00526097|11505492|FG000|Overall Study|Protocol Violation|4
7288329|NCT00526097|11505493|FG001|Overall Study|Protocol Violation|10
7288330|NCT00526097|11505492|FG000|Overall Study|Withdrawal by Subject|3
7288331|NCT00526097|11505493|FG001|Overall Study|Withdrawal by Subject|1
7288332|NCT00526097|11505492|FG000|Overall Study|Other|2
7288333|NCT00526097|11505493|FG001|Overall Study|Other|1
7288334|NCT00526110|11505501|FG000|Overall Study|Adverse Event|2
7288335|NCT00526110|11505502|FG001|Overall Study|Adverse Event|9
7288336|NCT00526110|11505501|FG000|Overall Study|Disease Progression|0
7288337|NCT00526110|11505502|FG001|Overall Study|Disease Progression|19
7288338|NCT00526110|11505501|FG000|Overall Study|Maximal Response|0
7288339|NCT00526110|11505502|FG001|Overall Study|Maximal Response|6
7288340|NCT00526110|11505501|FG000|Overall Study|Withdrawal by Subject|0
7288341|NCT00526110|11505502|FG001|Overall Study|Withdrawal by Subject|2
7288342|NCT00526110|11505501|FG000|Overall Study|Poor Tolerance|0
7288343|NCT00526110|11505502|FG001|Overall Study|Poor Tolerance|5
7288344|NCT00526162|11505517|FG000|Overall Study|Device not implanted|3
7288345|NCT00526630|11505553|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
7288346|NCT00526630|11505554|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
7288347|NCT00526630|11505553|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
7288348|NCT00526630|11505554|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
7288349|NCT00526656|11505562|FG000|Overall Study|Death|1
7288350|NCT00526656|11505562|FG000|Overall Study|Refused surgery|1
7288351|NCT00526669|11505567|FG000|Combined Treatment Phase|Lost to Follow-up|0
7288352|NCT00526669|11505568|FG001|Combined Treatment Phase|Lost to Follow-up|2
7288353|NCT00526669|11505567|FG000|Combined Treatment Phase|Withdrawal by Subject|0
7288354|NCT00526669|11505568|FG001|Combined Treatment Phase|Withdrawal by Subject|2
7288355|NCT00526669|11505567|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
7288356|NCT00526669|11505568|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
7288357|NCT00526669|11505567|FG000|Combined Treatment Phase|Death|0
7288358|NCT00526669|11505568|FG001|Combined Treatment Phase|Death|2
7288359|NCT00526799|11505576|FG000|Overall Study|Withdrawal by Subject|1
7288360|NCT00526799|11505577|FG001|Overall Study|Withdrawal by Subject|0
7288361|NCT00526799|11505576|FG000|Overall Study|Intercurrent Complicating Disease|0
7288362|NCT00526799|11505577|FG001|Overall Study|Intercurrent Complicating Disease|1
7288363|NCT00526890|11505583|FG000|Overall Study|Adverse Event|2
7288364|NCT00526994|11505590|FG000|Overall Study|Lost to Follow-up|98
7288365|NCT00526994|11505591|FG001|Overall Study|Lost to Follow-up|108
7288366|NCT00526994|11505592|FG002|Overall Study|Lost to Follow-up|96
7288367|NCT00526994|11505590|FG000|Overall Study|Death|4
7288368|NCT00526994|11505591|FG001|Overall Study|Death|3
7288369|NCT00526994|11505592|FG002|Overall Study|Death|3
7288370|NCT00526994|11505590|FG000|Overall Study|Withdrawal by Subject|2
7288371|NCT00526994|11505591|FG001|Overall Study|Withdrawal by Subject|7
7288372|NCT00526994|11505592|FG002|Overall Study|Withdrawal by Subject|5
7288373|NCT00526994|11505590|FG000|Overall Study|incarcerated, impaired, incomplete|4
7288374|NCT00526994|11505591|FG001|Overall Study|incarcerated, impaired, incomplete|3
7288375|NCT00526994|11505592|FG002|Overall Study|incarcerated, impaired, incomplete|3
7288376|NCT00527072|11505600|FG000|Overall Study|Adverse Event|13
7288377|NCT00527072|11505600|FG000|Overall Study|Lack of Efficacy|11
7288378|NCT00527072|11505600|FG000|Overall Study|Lost to Follow-up|3
7288379|NCT00527072|11505600|FG000|Overall Study|Protocol Violation|2
7288380|NCT00527072|11505600|FG000|Overall Study|Withdrawal by Subject|7
7288381|NCT00527111|11505615|FG000|Overall Study|Adverse Event|14
7288382|NCT00527111|11505616|FG001|Overall Study|Adverse Event|13
7288383|NCT00527111|11505615|FG000|Overall Study|Death|0
7288384|NCT00527111|11505616|FG001|Overall Study|Death|1
7288385|NCT00527111|11505615|FG000|Overall Study|Investigator Request|2
7288386|NCT00527111|11505616|FG001|Overall Study|Investigator Request|1
7288387|NCT00527111|11505615|FG000|Overall Study|Patient Request|2
7288388|NCT00527111|11505616|FG001|Overall Study|Patient Request|5
7288389|NCT00527111|11505615|FG000|Overall Study|Other|2
7288390|NCT00527111|11505616|FG001|Overall Study|Other|2
7288391|NCT00527319|11505634|FG000|Overall Study|Withdrawal by Subject|5
7288392|NCT00527319|11505635|FG001|Overall Study|Withdrawal by Subject|0
7288393|NCT00527319|11505636|FG002|Overall Study|Withdrawal by Subject|1
7288394|NCT00527319|11505634|FG000|Overall Study|Lost to Follow-up|1
7288395|NCT00527319|11505635|FG001|Overall Study|Lost to Follow-up|0
7288396|NCT00527319|11505636|FG002|Overall Study|Lost to Follow-up|0
7288397|NCT00527319|11505634|FG000|Overall Study|Death|0
7288398|NCT00527319|11505635|FG001|Overall Study|Death|3
7288399|NCT00527319|11505636|FG002|Overall Study|Death|1
7288400|NCT00527319|11505634|FG000|Overall Study|Intercurrent Medical Illness|0
7288401|NCT00527319|11505635|FG001|Overall Study|Intercurrent Medical Illness|1
7288402|NCT00527319|11505636|FG002|Overall Study|Intercurrent Medical Illness|3
7288403|NCT00527319|11505634|FG000|Overall Study|Adverse Event|0
7288404|NCT00527319|11505635|FG001|Overall Study|Adverse Event|0
7288405|NCT00527319|11505636|FG002|Overall Study|Adverse Event|1
7288406|NCT00527332|11505646|FG000|Overall Study|Protocol Violation|4
7288407|NCT00527332|11505647|FG001|Overall Study|Protocol Violation|8
7288408|NCT00527332|11505646|FG000|Overall Study|Withdrew consent|5
7288409|NCT00527332|11505647|FG001|Overall Study|Withdrew consent|1
7288410|NCT00527397|11505653|FG000|Overall Study|Adverse Event|3
7288411|NCT00527397|11505653|FG000|Overall Study|Lack of Efficacy|1
7288412|NCT00527397|11505653|FG000|Overall Study|Protocol Violation|1
7288413|NCT00527397|11505653|FG000|Overall Study|Withdrawal by Subject|6
7288414|NCT00527397|11505653|FG000|Overall Study|Study terminated by sponsor|13
7288415|NCT00527423|11505660|FG000|Overall Study|Protocol Violation|1
7288416|NCT00527423|11505660|FG000|Overall Study|Adverse Event|5
7288417|NCT00527423|11505660|FG000|Overall Study|Physician Decision|4
7288418|NCT00527423|11505660|FG000|Overall Study|Withdrawal by Subject|10
7288419|NCT00527423|11505660|FG000|Overall Study|Lost to Follow-up|4
7288420|NCT00527423|11505660|FG000|Overall Study|OTHER|4
7288421|NCT00527423|11505660|FG000|Overall Study|Death|9
7288422|NCT00527488|11505679|FG000|Overall Study|Withdrawn prior to dosing|0
7288423|NCT00527488|11505680|FG001|Overall Study|Withdrawn prior to dosing|1
7288424|NCT00527488|11505681|FG002|Overall Study|Withdrawn prior to dosing|1
7288425|NCT00527488|11505682|FG003|Overall Study|Withdrawn prior to dosing|0
7288426|NCT00527514|11505692|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
7288427|NCT00527514|11505692|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
7288428|NCT00527514|11505692|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
7288429|NCT00527514|11505692|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
7288430|NCT00527514|11505692|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
7288431|NCT00527514|11505692|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
7288432|NCT00527514|11505692|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
7288433|NCT00527605|11505717|FG000|Overall Study|Adverse Event|3
7288434|NCT00527605|11505718|FG001|Overall Study|Adverse Event|0
7288435|NCT00527605|11505717|FG000|Overall Study|Withdrawal by Subject|3
7288436|NCT00527605|11505718|FG001|Overall Study|Withdrawal by Subject|7
7288437|NCT00527605|11505717|FG000|Overall Study|Lost to Follow-up|6
7288438|NCT00527605|11505718|FG001|Overall Study|Lost to Follow-up|2
7288439|NCT00527605|11505717|FG000|Overall Study|Protocol Violation|1
7288440|NCT00527605|11505718|FG001|Overall Study|Protocol Violation|2
7288441|NCT00527618|11505724|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
7288442|NCT00527618|11505725|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
7288443|NCT00527618|11505724|FG000|Week 1-12 (First Intervention)|Adverse Event|0
7288444|NCT00527618|11505725|FG001|Week 1-12 (First Intervention)|Adverse Event|1
7288445|NCT00527618|11505724|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
7288446|NCT00527618|11505725|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
7288447|NCT00527618|11505724|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
7288448|NCT00527618|11505725|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
7288449|NCT00527618|11505724|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
7288450|NCT00527618|11505725|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
7288451|NCT00527618|11505724|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
7288452|NCT00527618|11505725|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
7288453|NCT00527735|11505748|FG000|Overall Study|Disease progression|47
7288454|NCT00527735|11505749|FG001|Overall Study|Disease progression|61
7288455|NCT00527735|11505750|FG002|Overall Study|Disease progression|53
7288456|NCT00527735|11505748|FG000|Overall Study|Death|23
7288457|NCT00527735|11505749|FG001|Overall Study|Death|13
7288458|NCT00527735|11505750|FG002|Overall Study|Death|15
7470059|NCT01928719|11771961|FG000|Overall Study|Lost to Follow-up|26
7288459|NCT00527735|11505748|FG000|Overall Study|Completed treatment in treatment phase|14
7288460|NCT00527735|11505749|FG001|Overall Study|Completed treatment in treatment phase|13
7288461|NCT00527735|11505750|FG002|Overall Study|Completed treatment in treatment phase|18
7288462|NCT00527735|11505748|FG000|Overall Study|Adverse Event|10
7288463|NCT00527735|11505749|FG001|Overall Study|Adverse Event|6
7288464|NCT00527735|11505750|FG002|Overall Study|Adverse Event|7
7288465|NCT00527735|11505748|FG000|Overall Study|Not identified|5
7288466|NCT00527735|11505749|FG001|Overall Study|Not identified|5
7288467|NCT00527735|11505750|FG002|Overall Study|Not identified|5
7288468|NCT00527735|11505748|FG000|Overall Study|Withdrawal by Subject|5
7288469|NCT00527735|11505749|FG001|Overall Study|Withdrawal by Subject|4
7288470|NCT00527735|11505750|FG002|Overall Study|Withdrawal by Subject|3
7288471|NCT00527735|11505748|FG000|Overall Study|No longer met study criteria|2
7288472|NCT00527735|11505749|FG001|Overall Study|No longer met study criteria|2
7288473|NCT00527735|11505750|FG002|Overall Study|No longer met study criteria|1
7288474|NCT00527735|11505748|FG000|Overall Study|Lost to Follow-up|0
7288475|NCT00527735|11505749|FG001|Overall Study|Lost to Follow-up|0
7288476|NCT00527735|11505750|FG002|Overall Study|Lost to Follow-up|3
7288477|NCT00527735|11505748|FG000|Overall Study|Poor compliance or noncompliance|0
7288478|NCT00527735|11505749|FG001|Overall Study|Poor compliance or noncompliance|1
7288479|NCT00527735|11505750|FG002|Overall Study|Poor compliance or noncompliance|1
7288480|NCT00527735|11505748|FG000|Overall Study|Completed treatment during maintenance|2
7288481|NCT00527735|11505749|FG001|Overall Study|Completed treatment during maintenance|2
7288482|NCT00527735|11505750|FG002|Overall Study|Completed treatment during maintenance|1
7288483|NCT00527787|11505772|FG000|Overall Study|Adverse Event|14
7288484|NCT00527787|11505773|FG001|Overall Study|Adverse Event|24
7288485|NCT00527787|11505772|FG000|Overall Study|Withdrawal by Subject|13
7288486|NCT00527787|11505773|FG001|Overall Study|Withdrawal by Subject|25
7288487|NCT00527787|11505772|FG000|Overall Study|Lost to Follow-up|5
7288488|NCT00527787|11505773|FG001|Overall Study|Lost to Follow-up|2
7288489|NCT00527787|11505772|FG000|Overall Study|Duodenal Ulcer|1
7288490|NCT00527787|11505773|FG001|Overall Study|Duodenal Ulcer|10
7288491|NCT00527787|11505772|FG000|Overall Study|misc|5
7288492|NCT00527787|11505773|FG001|Overall Study|misc|2
7288493|NCT00527826|11505781|FG000|Overall Study|Adverse Event|10
7288494|NCT00527826|11505782|FG001|Overall Study|Adverse Event|10
7288495|NCT00527826|11505781|FG000|Overall Study|Lost to Follow-up|3
7288496|NCT00527826|11505782|FG001|Overall Study|Lost to Follow-up|2
7288497|NCT00527826|11505781|FG000|Overall Study|Withdrawal by Subject|5
7288498|NCT00527826|11505782|FG001|Overall Study|Withdrawal by Subject|8
7288499|NCT00527826|11505781|FG000|Overall Study|Inclusion Criteria Not Met|3
7288500|NCT00527826|11505782|FG001|Overall Study|Inclusion Criteria Not Met|3
7288501|NCT00527826|11505781|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
7288502|NCT00527826|11505782|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
7288503|NCT00527826|11505781|FG000|Overall Study|Additional Intake of Viani forte|0
7288504|NCT00527826|11505782|FG001|Overall Study|Additional Intake of Viani forte|1
7288505|NCT00527826|11505781|FG000|Overall Study|Participant moved away|0
7288506|NCT00527826|11505782|FG001|Overall Study|Participant moved away|1
7288507|NCT00527904|11505798|FG000|Overall Study|Adverse Event|45
7288508|NCT00527904|11505798|FG000|Overall Study|Withdrawal by Subject|21
7288509|NCT00527904|11505798|FG000|Overall Study|Lost to Follow-up|8
7288510|NCT00527904|11505798|FG000|Overall Study|misc|22
7288511|NCT00528112|11505813|FG000|Treatment up to 3 Years|Adverse Event|313
7288512|NCT00528112|11505814|FG001|Treatment up to 3 Years|Adverse Event|278
7288513|NCT00528112|11505813|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
7288514|NCT00528112|11505814|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
7288515|NCT00528112|11505813|FG000|Treatment up to 3 Years|Protocol Violation|16
7288516|NCT00528112|11505814|FG001|Treatment up to 3 Years|Protocol Violation|16
7288517|NCT00528112|11505813|FG000|Treatment up to 3 Years|Death|0
7288518|NCT00528112|11505814|FG001|Treatment up to 3 Years|Death|1
7288519|NCT00528112|11505813|FG000|Treatment up to 3 Years|Lost to Follow-up|63
7288520|NCT00528112|11505814|FG001|Treatment up to 3 Years|Lost to Follow-up|61
7288521|NCT00528112|11505813|FG000|Treatment up to 3 Years|Pregnancy|9
7288522|NCT00528112|11505814|FG001|Treatment up to 3 Years|Pregnancy|10
7288523|NCT00528112|11505813|FG000|Treatment up to 3 Years|Other reasons|186
7288524|NCT00528112|11505814|FG001|Treatment up to 3 Years|Other reasons|186
7288525|NCT00528112|11505813|FG000|Extension Phase|Withdrawal by Subject|0
7288526|NCT00528112|11505814|FG001|Extension Phase|Withdrawal by Subject|3
7288527|NCT00528112|11505813|FG000|Extension Phase|Other reasons|0
7288528|NCT00528112|11505814|FG001|Extension Phase|Other reasons|100
7288529|NCT00528112|11505813|FG000|Extension Phase|Pregnancy|0
7288530|NCT00528112|11505814|FG001|Extension Phase|Pregnancy|3
7288531|NCT00528112|11505813|FG000|Extension Phase|Lost to Follow-up|0
7288532|NCT00528112|11505814|FG001|Extension Phase|Lost to Follow-up|12
7288533|NCT00528112|11505813|FG000|Extension Phase|Death|0
7288534|NCT00528112|11505814|FG001|Extension Phase|Death|1
7288535|NCT00528112|11505813|FG000|Extension Phase|Adverse Event|0
7288536|NCT00528112|11505814|FG001|Extension Phase|Adverse Event|36
7288537|NCT00528112|11505813|FG000|Extension Phase|Protocol Violation|0
7288538|NCT00528112|11505814|FG001|Extension Phase|Protocol Violation|2
7288539|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
7288540|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288541|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288542|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288543|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288544|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288545|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288546|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288547|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
7288548|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7288549|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7288550|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
7288551|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
7288552|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7288553|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7288554|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
7288555|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7288556|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
7288557|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7288558|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7288559|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
7288560|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
7288561|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7288562|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7288563|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
7288564|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
7288565|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
7470060|NCT01928719|11771962|FG001|Overall Study|Lost to Follow-up|11
7623251|NCT01844505|12034175|FG000|Overall Study|Other Reasons|4
7623252|NCT01844505|12034176|FG001|Overall Study|Other Reasons|2
7623253|NCT01844505|12034177|FG002|Overall Study|Other Reasons|2
7623254|NCT01844505|12034175|FG000|Overall Study|Not Reported|0
7623255|NCT01844505|12034176|FG001|Overall Study|Not Reported|0
7623256|NCT01844505|12034177|FG002|Overall Study|Not Reported|1
7623257|NCT01781390|12034188|FG000|Overall Study|Withdrawal of Consent|0
7623258|NCT01781390|12034189|FG001|Overall Study|Withdrawal of Consent|3
7623259|NCT01781390|12034190|FG002|Overall Study|Withdrawal of Consent|1
7623260|NCT01781390|12034188|FG000|Overall Study|Lost to Follow-up|1
7623261|NCT01781390|12034189|FG001|Overall Study|Lost to Follow-up|1
7623262|NCT01781390|12034190|FG002|Overall Study|Lost to Follow-up|1
7623263|NCT01781390|12034188|FG000|Overall Study|Adverse Event|1
7623264|NCT01781390|12034189|FG001|Overall Study|Adverse Event|2
7623265|NCT01781390|12034190|FG002|Overall Study|Adverse Event|1
7623266|NCT01781390|12034188|FG000|Overall Study|Participants who were Randomized and Not Treated|1
7623267|NCT01781390|12034189|FG001|Overall Study|Participants who were Randomized and Not Treated|1
7623268|NCT01781390|12034190|FG002|Overall Study|Participants who were Randomized and Not Treated|1
7623269|NCT01701674|12034198|FG000|Overall Study|Unable to safely complete treatment|1
7623270|NCT01575860|12034202|FG000|Overall Study|Withdrawal by Subject|1
7623271|NCT01575860|12034202|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
7623272|NCT01402908|12034209|FG000|Overall Study|Withdrawal by Subject|30
7623273|NCT01402908|12034210|FG001|Overall Study|Withdrawal by Subject|17
7623274|NCT01402908|12034209|FG000|Overall Study|Lost to Follow-up|3
7623275|NCT01402908|12034210|FG001|Overall Study|Lost to Follow-up|1
7623276|NCT01402908|12034209|FG000|Overall Study|Physician Decision|1
7623277|NCT01402908|12034210|FG001|Overall Study|Physician Decision|0
7623278|NCT01397201|12034221|FG000|Overall Study|Not treated|0
7623279|NCT01397201|12034222|FG001|Overall Study|Not treated|0
7623280|NCT01397201|12034223|FG002|Overall Study|Not treated|1
7623281|NCT01397201|12034224|FG003|Overall Study|Not treated|0
7623282|NCT01397201|12034225|FG004|Overall Study|Not treated|0
7623283|NCT01397201|12034221|FG000|Overall Study|Not yet defined|3
7623284|NCT01397201|12034222|FG001|Overall Study|Not yet defined|6
7623285|NCT01397201|12034223|FG002|Overall Study|Not yet defined|5
7623286|NCT01397201|12034224|FG003|Overall Study|Not yet defined|5
7623287|NCT01397201|12034225|FG004|Overall Study|Not yet defined|4
7623288|NCT01397201|12034221|FG000|Overall Study|Adverse Event|2
7623289|NCT01397201|12034222|FG001|Overall Study|Adverse Event|0
7623290|NCT01397201|12034223|FG002|Overall Study|Adverse Event|0
7623291|NCT01397201|12034224|FG003|Overall Study|Adverse Event|0
7623292|NCT01397201|12034225|FG004|Overall Study|Adverse Event|0
7623293|NCT01397162|12034242|FG000|Overall Study|Adverse Event|4
7623294|NCT01397162|12034243|FG001|Overall Study|Adverse Event|0
7623295|NCT01397162|12034244|FG002|Overall Study|Adverse Event|0
7623296|NCT01397162|12034245|FG003|Overall Study|Adverse Event|0
7623297|NCT01397162|12034246|FG004|Overall Study|Adverse Event|0
7623298|NCT01397162|12034242|FG000|Overall Study|Not yet defined|3
7623299|NCT01397162|12034243|FG001|Overall Study|Not yet defined|4
7623300|NCT01397162|12034244|FG002|Overall Study|Not yet defined|3
7623301|NCT01397162|12034245|FG003|Overall Study|Not yet defined|5
7623302|NCT01397162|12034246|FG004|Overall Study|Not yet defined|3
7623303|NCT01396278|12034268|FG000|Overall Study|Adverse Event|0
7288566|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
7288567|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7288568|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7288569|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7288570|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7288571|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7288572|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
7288573|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
7288574|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
7288575|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288576|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288577|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288578|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
7288579|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288580|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
7288581|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288582|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288583|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
7288584|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7288585|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288586|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7288587|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288588|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288589|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
7288590|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288591|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288592|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
7288593|NCT00528372|11505849|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
7288594|NCT00528372|11505850|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288595|NCT00528372|11505851|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288596|NCT00528372|11505852|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
7288597|NCT00528372|11505853|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288598|NCT00528372|11505854|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288599|NCT00528372|11505855|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288600|NCT00528372|11505856|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
7288601|NCT00528372|11505857|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
7288602|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7288603|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
7288604|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
7288605|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7288606|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7288607|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
7288608|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
7288609|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7288610|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
7288611|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7288612|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7288613|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
7288614|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7288615|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
7288616|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
7288617|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
7288618|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7288619|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
7288620|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7288621|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
7288622|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7288623|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
7288624|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
7288625|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
7288626|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7288627|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
7288628|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
7288629|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7288630|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7288631|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7288632|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7623304|NCT01396278|12034269|FG001|Overall Study|Adverse Event|0
7288633|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
7288634|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
7288635|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
7288636|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
7288637|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
7288638|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7288639|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7288640|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7288641|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7288642|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7288643|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7288644|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
7288645|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7288646|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
7288647|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288648|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288649|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288650|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288651|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
7288652|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
7288653|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288654|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288655|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
7288656|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288657|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7288658|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288659|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288660|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288661|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288662|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7288663|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
7288664|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
7288665|NCT00528372|11505849|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
7288666|NCT00528372|11505850|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
7288667|NCT00528372|11505851|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
7288668|NCT00528372|11505852|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
7288669|NCT00528372|11505853|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
7288670|NCT00528372|11505854|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
7288671|NCT00528372|11505855|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
7623305|NCT01396278|12034270|FG002|Overall Study|Adverse Event|0
7623306|NCT01396278|12034271|FG003|Overall Study|Adverse Event|2
7623307|NCT01396278|12034272|FG004|Overall Study|Adverse Event|0
7623308|NCT01396278|12034268|FG000|Overall Study|Withdraw due to trial termination|2
7623309|NCT01396278|12034269|FG001|Overall Study|Withdraw due to trial termination|1
7623310|NCT01396278|12034270|FG002|Overall Study|Withdraw due to trial termination|1
7623311|NCT01396278|12034271|FG003|Overall Study|Withdraw due to trial termination|0
7623312|NCT01396278|12034272|FG004|Overall Study|Withdraw due to trial termination|2
7623313|NCT00130442|12034310|FG000|Overall Study|Withdrawal by Subject|0
7623314|NCT00130442|12034311|FG001|Overall Study|Withdrawal by Subject|1
7623315|NCT00130442|12034310|FG000|Overall Study|did not meet criteria|1
7623316|NCT00130442|12034311|FG001|Overall Study|did not meet criteria|1
7288672|NCT00528372|11505856|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
7288673|NCT00528372|11505857|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
7470061|NCT01928719|11771961|FG000|Overall Study|Withdrawal by Subject|22
7470062|NCT01928719|11771962|FG001|Overall Study|Withdrawal by Subject|7
7470063|NCT01928719|11771961|FG000|Overall Study|Protocol Violation|3
7470064|NCT01928719|11771962|FG001|Overall Study|Protocol Violation|1
7470065|NCT01928719|11771961|FG000|Overall Study|Adverse Event|1
7470066|NCT01928719|11771962|FG001|Overall Study|Adverse Event|0
7470067|NCT01928758|11771972|FG000|Overall Study|Lost to Follow-up|14
7470068|NCT01928758|11771973|FG001|Overall Study|Lost to Follow-up|9
7470069|NCT01928758|11771972|FG000|Overall Study|Withdrawal by Subject|5
7470070|NCT01928758|11771973|FG001|Overall Study|Withdrawal by Subject|2
7470071|NCT01928758|11771972|FG000|Overall Study|Adverse Event|3
7470072|NCT01928758|11771973|FG001|Overall Study|Adverse Event|5
7470073|NCT01928758|11771972|FG000|Overall Study|Protocol Violation|3
7470074|NCT01928758|11771973|FG001|Overall Study|Protocol Violation|4
7470075|NCT01928771|11771983|FG000|Overall Study|Adverse Event|6
7470076|NCT01928771|11771984|FG001|Overall Study|Adverse Event|5
7470077|NCT01928771|11771985|FG002|Overall Study|Adverse Event|1
7470078|NCT01928771|11771983|FG000|Overall Study|Death|2
7470079|NCT01928771|11771984|FG001|Overall Study|Death|2
7470080|NCT01928771|11771985|FG002|Overall Study|Death|2
7470081|NCT01928771|11771983|FG000|Overall Study|Lost to Follow-up|5
7470082|NCT01928771|11771984|FG001|Overall Study|Lost to Follow-up|6
7470083|NCT01928771|11771985|FG002|Overall Study|Lost to Follow-up|3
7470084|NCT01928771|11771983|FG000|Overall Study|Withdrawal by Subject|20
7470085|NCT01928771|11771984|FG001|Overall Study|Withdrawal by Subject|15
7470086|NCT01928771|11771985|FG002|Overall Study|Withdrawal by Subject|17
7470087|NCT01928771|11771983|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
7470088|NCT01928771|11771984|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
7470089|NCT01928771|11771985|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
7470090|NCT01928771|11771983|FG000|Overall Study|Other Reasons|9
7470091|NCT01928771|11771984|FG001|Overall Study|Other Reasons|9
7470092|NCT01928771|11771985|FG002|Overall Study|Other Reasons|14
7470093|NCT01928771|11771983|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7470094|NCT01928771|11771984|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7470095|NCT01928771|11771985|FG002|Overall Study|Severe Non-Compliance to Protocol|2
7470096|NCT01928862|11772018|FG000|Overall Study|Lost to Follow-up|1
7470097|NCT01928862|11772019|FG001|Overall Study|Lost to Follow-up|0
7470098|NCT01928862|11772020|FG002|Overall Study|Lost to Follow-up|0
7470099|NCT01928862|11772021|FG003|Overall Study|Lost to Follow-up|0
7470100|NCT01928862|11772022|FG004|Overall Study|Lost to Follow-up|1
7470101|NCT01928927|11772037|FG000|Overall Study|Lost to Follow-up|1
7470102|NCT01928927|11772038|FG001|Overall Study|Lost to Follow-up|0
7470103|NCT01928927|11772037|FG000|Overall Study|Withdrawal by Subject|1
7470104|NCT01928927|11772038|FG001|Overall Study|Withdrawal by Subject|1
7551271|NCT02968173|11910421|FG000|Overall Study|Withdrawal by Subject|1
7551272|NCT02968433|11910467|FG000|Overall Study|Withdrawal by Subject|1
7551273|NCT02968576|11910477|FG000|Overall Study|Pregnancy|0
7551274|NCT02968576|11910478|FG001|Overall Study|Pregnancy|1
7551275|NCT02968979|11910499|FG000|Overall Study|Protocol Violation|7
7551276|NCT02968979|11910499|FG000|Overall Study|Withdrawal by Subject|1
7551277|NCT02969018|11910566|FG000|Overall Study|Adverse Event|2
7551278|NCT02969018|11910567|FG001|Overall Study|Adverse Event|4
7551279|NCT02969018|11910568|FG002|Overall Study|Adverse Event|1
7551280|NCT02969018|11910569|FG003|Overall Study|Adverse Event|2
7551281|NCT02969018|11910570|FG004|Overall Study|Adverse Event|0
7551282|NCT02969018|11910571|FG005|Overall Study|Adverse Event|1
7551283|NCT02969018|11910572|FG006|Overall Study|Adverse Event|2
7551284|NCT02969018|11910573|FG007|Overall Study|Adverse Event|0
7551285|NCT02969018|11910566|FG000|Overall Study|Lack of Efficacy|0
7551286|NCT02969018|11910567|FG001|Overall Study|Lack of Efficacy|1
7551287|NCT02969018|11910568|FG002|Overall Study|Lack of Efficacy|0
7551288|NCT02969018|11910569|FG003|Overall Study|Lack of Efficacy|0
7551289|NCT02969018|11910570|FG004|Overall Study|Lack of Efficacy|1
7551290|NCT02969018|11910571|FG005|Overall Study|Lack of Efficacy|1
7551291|NCT02969018|11910572|FG006|Overall Study|Lack of Efficacy|1
7551292|NCT02969018|11910573|FG007|Overall Study|Lack of Efficacy|1
7551293|NCT02969018|11910566|FG000|Overall Study|Lost to Follow-up|1
7551294|NCT02969018|11910567|FG001|Overall Study|Lost to Follow-up|2
7551295|NCT02969018|11910568|FG002|Overall Study|Lost to Follow-up|2
7551296|NCT02969018|11910569|FG003|Overall Study|Lost to Follow-up|0
7551297|NCT02969018|11910570|FG004|Overall Study|Lost to Follow-up|1
7551298|NCT02969018|11910571|FG005|Overall Study|Lost to Follow-up|1
7551299|NCT02969018|11910572|FG006|Overall Study|Lost to Follow-up|0
7551300|NCT02969018|11910573|FG007|Overall Study|Lost to Follow-up|1
7551301|NCT02969018|11910566|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
7551302|NCT02969018|11910567|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7551303|NCT02969018|11910568|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
7551304|NCT02969018|11910569|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
7551305|NCT02969018|11910570|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
7551306|NCT02969018|11910571|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
7551307|NCT02969018|11910572|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
7288674|NCT00528411|11505910|FG000|Overall Study|Adverse Event|4
7288675|NCT00528411|11505911|FG001|Overall Study|Adverse Event|0
7288676|NCT00528411|11505912|FG002|Overall Study|Adverse Event|1
7288677|NCT00528411|11505910|FG000|Overall Study|Incorrect Enrolment|1
7288678|NCT00528411|11505911|FG001|Overall Study|Incorrect Enrolment|1
7288679|NCT00528411|11505912|FG002|Overall Study|Incorrect Enrolment|0
7288680|NCT00528411|11505910|FG000|Overall Study|Severe non-compliance to protocol|0
7288681|NCT00528411|11505911|FG001|Overall Study|Severe non-compliance to protocol|1
7288682|NCT00528411|11505912|FG002|Overall Study|Severe non-compliance to protocol|0
7288683|NCT00528411|11505910|FG000|Overall Study|Prior commitment medication|0
7288684|NCT00528411|11505911|FG001|Overall Study|Prior commitment medication|1
7288685|NCT00528411|11505912|FG002|Overall Study|Prior commitment medication|0
7288686|NCT00528424|11505920|FG000|Overall Study|Lost to Follow-up|13
7288687|NCT00528424|11505920|FG000|Overall Study|Withdrew consent|2
7288688|NCT00528424|11505920|FG000|Overall Study|Administrative reason|2
7288689|NCT00528424|11505920|FG000|Overall Study|Other|12
7288690|NCT00528528|11505932|FG000|Overall Study|Lost to Follow-up|0
7288691|NCT00528528|11505933|FG001|Overall Study|Lost to Follow-up|0
7288692|NCT00528528|11505934|FG002|Overall Study|Lost to Follow-up|1
7288693|NCT00528528|11505935|FG003|Overall Study|Lost to Follow-up|1
7288694|NCT00528528|11505932|FG000|Overall Study|Ineligible to continue the trial|0
7288695|NCT00528528|11505933|FG001|Overall Study|Ineligible to continue the trial|0
7288696|NCT00528528|11505934|FG002|Overall Study|Ineligible to continue the trial|0
7288697|NCT00528528|11505935|FG003|Overall Study|Ineligible to continue the trial|1
7288698|NCT00528528|11505932|FG000|Overall Study|Other|0
7288699|NCT00528528|11505933|FG001|Overall Study|Other|1
7288700|NCT00528528|11505934|FG002|Overall Study|Other|0
7288701|NCT00528528|11505935|FG003|Overall Study|Other|0
7288702|NCT00528528|11505932|FG000|Overall Study|Withdrawal by Subject|3
7288703|NCT00528528|11505933|FG001|Overall Study|Withdrawal by Subject|2
7288704|NCT00528528|11505934|FG002|Overall Study|Withdrawal by Subject|1
7288705|NCT00528528|11505935|FG003|Overall Study|Withdrawal by Subject|1
7288706|NCT00528528|11505932|FG000|Overall Study|Ongoing participant|0
7288707|NCT00528528|11505933|FG001|Overall Study|Ongoing participant|0
7288708|NCT00528528|11505934|FG002|Overall Study|Ongoing participant|1
7288709|NCT00528528|11505935|FG003|Overall Study|Ongoing participant|0
7288710|NCT00528567|11505958|FG000|Overall Study|Death|4
7288711|NCT00528567|11505959|FG001|Overall Study|Death|5
7288712|NCT00528567|11505958|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
7288713|NCT00528567|11505959|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
7288714|NCT00528567|11505958|FG000|Overall Study|Adverse Event/Intermittent Illness|255
7288715|NCT00528567|11505959|FG001|Overall Study|Adverse Event/Intermittent Illness|29
7288716|NCT00528567|11505958|FG000|Overall Study|Violation Criteria at Entry|3
7288717|NCT00528567|11505959|FG001|Overall Study|Violation Criteria at Entry|17
7288718|NCT00528567|11505958|FG000|Overall Study|Withdrew Consent|59
7288719|NCT00528567|11505959|FG001|Overall Study|Withdrew Consent|55
7288720|NCT00528567|11505958|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
7288721|NCT00528567|11505959|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
7288722|NCT00528567|11505958|FG000|Overall Study|Failure to Return|1
7288723|NCT00528567|11505959|FG001|Overall Study|Failure to Return|4
7288724|NCT00528567|11505958|FG000|Overall Study|Other Protocol Violation|5
7288725|NCT00528567|11505959|FG001|Overall Study|Other Protocol Violation|21
7288726|NCT00528567|11505958|FG000|Overall Study|Administrative/Other|22
7288727|NCT00528567|11505959|FG001|Overall Study|Administrative/Other|75
7288728|NCT00528606|11505983|FG000|Overall Study|Withdrew consent|4
7288729|NCT00528606|11505984|FG001|Overall Study|Withdrew consent|3
7288730|NCT00528606|11505983|FG000|Overall Study|Lost to Follow-up|4
7288731|NCT00528606|11505984|FG001|Overall Study|Lost to Follow-up|1
7288732|NCT00528606|11505983|FG000|Overall Study|Adverse Event|3
7288733|NCT00528606|11505984|FG001|Overall Study|Adverse Event|0
7288734|NCT00528606|11505983|FG000|Overall Study|Other|2
7288735|NCT00528606|11505984|FG001|Overall Study|Other|0
7288736|NCT00528645|11505990|FG000|Overall Study|Adverse Event|3
7288737|NCT00528801|11506001|FG000|Overall Study|Withdrawal by Subject|1
7288738|NCT00528801|11506002|FG001|Overall Study|Withdrawal by Subject|1
7288739|NCT00528801|11506001|FG000|Overall Study|Protocol Violation|11
7288740|NCT00528801|11506002|FG001|Overall Study|Protocol Violation|5
7288741|NCT00528801|11506001|FG000|Overall Study|Lost to Follow-up|15
7288742|NCT00528801|11506002|FG001|Overall Study|Lost to Follow-up|4
7288743|NCT00528801|11506001|FG000|Overall Study|Administrative Reasons|0
7288744|NCT00528801|11506002|FG001|Overall Study|Administrative Reasons|1
7288745|NCT00528840|11506008|FG000|Overall Study|Lost to Follow-up|10
7288746|NCT00528840|11506008|FG000|Overall Study|Adverse Event|1
7288747|NCT00528840|11506008|FG000|Overall Study|Withdrawal by Subject|17
7288748|NCT00528840|11506008|FG000|Overall Study|Death|2
7288749|NCT00528840|11506008|FG000|Overall Study|Administrative Reasons|1
7288750|NCT00528840|11506008|FG000|Overall Study|Other|2
7288751|NCT00528866|11506012|FG000|Overall Study|Protocol Violation|6
7288752|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
7288753|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7288754|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
7288755|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
7288756|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7623317|NCT04539262|12034327|FG000|Overall Study|Adverse Event|0
7288757|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7288758|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
7288759|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
7288760|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
7288761|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7288762|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
7288763|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
7288764|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7288765|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7288766|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
7288767|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
7288768|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7288769|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7288770|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
7288771|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
7288772|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7288773|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
7288774|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
7288775|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
7288776|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7288777|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7288778|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
7288779|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
7288780|NCT00528879|11506021|FG000|Short-term Period (Day 1 to Week 24)|Other|0
7288781|NCT00528879|11506022|FG001|Short-term Period (Day 1 to Week 24)|Other|0
7288782|NCT00528879|11506023|FG002|Short-term Period (Day 1 to Week 24)|Other|1
7288783|NCT00528879|11506024|FG003|Short-term Period (Day 1 to Week 24)|Other|1
7288784|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
7288785|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
7288786|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
7288787|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
7288788|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
7288789|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
7288790|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
7288791|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
7288792|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7288793|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
7288794|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
7288795|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
7288796|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Death|0
7288797|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Death|1
7288798|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Death|0
7288799|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Death|0
7288800|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
7288801|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
7288802|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
7623318|NCT04539262|12034328|FG001|Overall Study|Adverse Event|0
7623319|NCT04539262|12034329|FG002|Overall Study|Adverse Event|1
7623320|NCT04539262|12034330|FG003|Overall Study|Adverse Event|0
7623321|NCT04539262|12034331|FG004|Overall Study|Adverse Event|0
7623322|NCT04539262|12034332|FG005|Overall Study|Adverse Event|0
7623323|NCT04539262|12034333|FG006|Overall Study|Adverse Event|0
7623324|NCT04539262|12034334|FG007|Overall Study|Adverse Event|0
7623325|NCT04539262|12034327|FG000|Overall Study|Withdrew Consent|0
7623326|NCT04539262|12034328|FG001|Overall Study|Withdrew Consent|0
7623327|NCT04539262|12034329|FG002|Overall Study|Withdrew Consent|0
7623328|NCT04539262|12034330|FG003|Overall Study|Withdrew Consent|1
7623329|NCT04539262|12034331|FG004|Overall Study|Withdrew Consent|0
7623330|NCT04539262|12034332|FG005|Overall Study|Withdrew Consent|0
7623331|NCT04539262|12034333|FG006|Overall Study|Withdrew Consent|0
7623332|NCT04539262|12034334|FG007|Overall Study|Withdrew Consent|0
7623333|NCT04539262|12034327|FG000|Overall Study|Randomized, Not treated|0
7623334|NCT04539262|12034328|FG001|Overall Study|Randomized, Not treated|1
7623335|NCT04539262|12034329|FG002|Overall Study|Randomized, Not treated|0
7623336|NCT04539262|12034330|FG003|Overall Study|Randomized, Not treated|0
7623337|NCT04539262|12034331|FG004|Overall Study|Randomized, Not treated|0
7623338|NCT04539262|12034332|FG005|Overall Study|Randomized, Not treated|0
7623339|NCT04539262|12034333|FG006|Overall Study|Randomized, Not treated|1
7623340|NCT04539262|12034334|FG007|Overall Study|Randomized, Not treated|0
7288803|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
7288804|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
7288805|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
7288806|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
7288807|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
7288808|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
7288809|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7288810|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7288811|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
7288812|NCT00528879|11506021|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7288813|NCT00528879|11506022|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7288814|NCT00528879|11506023|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
7288815|NCT00528879|11506024|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
7288816|NCT00528931|11506034|FG000|Overall Study|Lost to Follow-up|1
7288817|NCT00528957|11506041|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
7288818|NCT00528957|11506042|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
7288819|NCT00528957|11506041|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
7288820|NCT00528957|11506042|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
7288821|NCT00528957|11506041|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
7288822|NCT00528957|11506042|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
7288823|NCT00528957|11506041|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
7288824|NCT00528957|11506042|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
7288825|NCT00528957|11506041|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
7288826|NCT00528957|11506042|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
7288827|NCT00528957|11506041|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
7288828|NCT00528957|11506042|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
7288829|NCT00528957|11506041|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
7288830|NCT00528957|11506042|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
7288831|NCT00528957|11506041|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
7288832|NCT00528957|11506042|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
7288833|NCT00528957|11506041|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
7288834|NCT00528957|11506042|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
7288835|NCT00528957|11506041|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7288836|NCT00528957|11506042|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
7288837|NCT00528957|11506041|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
7288838|NCT00528957|11506042|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
7288839|NCT00528957|11506041|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
7288840|NCT00528957|11506042|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
7288841|NCT00528957|11506041|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
7288842|NCT00528957|11506042|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
7288843|NCT00528957|11506041|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
7288844|NCT00528957|11506042|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
7288845|NCT00528957|11506041|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
7288846|NCT00528957|11506042|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
7288847|NCT00528957|11506041|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7288848|NCT00528957|11506042|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
7288849|NCT00528970|11506061|FG000|Overall Study|Adverse Event|6
7288850|NCT00528970|11506062|FG001|Overall Study|Adverse Event|8
7288851|NCT00528970|11506063|FG002|Overall Study|Adverse Event|5
7288852|NCT00528970|11506061|FG000|Overall Study|Lost to Follow-up|0
7288853|NCT00528970|11506062|FG001|Overall Study|Lost to Follow-up|0
7288854|NCT00528970|11506063|FG002|Overall Study|Lost to Follow-up|1
7288855|NCT00528970|11506061|FG000|Overall Study|Other than specified|2
7288856|NCT00528970|11506062|FG001|Overall Study|Other than specified|3
7288857|NCT00528970|11506063|FG002|Overall Study|Other than specified|3
7288858|NCT00528970|11506061|FG000|Overall Study|Protocol Violation|2
7288859|NCT00528970|11506062|FG001|Overall Study|Protocol Violation|1
7288860|NCT00528970|11506063|FG002|Overall Study|Protocol Violation|4
7288861|NCT00528970|11506061|FG000|Overall Study|Lack of Efficacy|0
7288862|NCT00528970|11506062|FG001|Overall Study|Lack of Efficacy|0
7288863|NCT00528970|11506063|FG002|Overall Study|Lack of Efficacy|1
7288864|NCT00528970|11506061|FG000|Overall Study|Withdrawal by Subject|4
7288865|NCT00528970|11506062|FG001|Overall Study|Withdrawal by Subject|3
7288866|NCT00528970|11506063|FG002|Overall Study|Withdrawal by Subject|5
7288867|NCT00528970|11506061|FG000|Overall Study|Randomized but not treated|0
7288868|NCT00528970|11506062|FG001|Overall Study|Randomized but not treated|0
7288869|NCT00528970|11506063|FG002|Overall Study|Randomized but not treated|1
7288870|NCT00528996|11506076|FG000|Overall Study|Other reasons than listing|6
7288871|NCT00528996|11506077|FG001|Overall Study|Other reasons than listing|7
7623341|NCT04482439|12034355|FG000|Overall Study|Lost to Follow-up|1
7288872|NCT00528996|11506078|FG002|Overall Study|Other reasons than listing|14
7288873|NCT00528996|11506079|FG003|Overall Study|Other reasons than listing|11
7288874|NCT00528996|11506080|FG004|Overall Study|Other reasons than listing|5
7288875|NCT00528996|11506076|FG000|Overall Study|Refused continue medication|16
7623342|NCT04482439|12034355|FG000|Overall Study|Unrelated illness|1
7623343|NCT04404725|12034364|FG000|First Intervention|Withdrawal by Subject|0
7623344|NCT04404725|12034365|FG001|First Intervention|Withdrawal by Subject|2
7623345|NCT04404725|12034364|FG000|Second Intervention|Adverse Event|1
7288876|NCT00528996|11506077|FG001|Overall Study|Refused continue medication|0
7288877|NCT00528996|11506078|FG002|Overall Study|Refused continue medication|3
7288878|NCT00528996|11506079|FG003|Overall Study|Refused continue medication|3
7288879|NCT00528996|11506080|FG004|Overall Study|Refused continue medication|6
7288880|NCT00528996|11506076|FG000|Overall Study|Lost to Follow-up|2
7288881|NCT00528996|11506077|FG001|Overall Study|Lost to Follow-up|0
7288882|NCT00528996|11506078|FG002|Overall Study|Lost to Follow-up|4
7288883|NCT00528996|11506079|FG003|Overall Study|Lost to Follow-up|1
7288884|NCT00528996|11506080|FG004|Overall Study|Lost to Follow-up|3
7288885|NCT00528996|11506076|FG000|Overall Study|Protocol Violation|1
7288886|NCT00528996|11506077|FG001|Overall Study|Protocol Violation|2
7288887|NCT00528996|11506078|FG002|Overall Study|Protocol Violation|3
7288888|NCT00528996|11506079|FG003|Overall Study|Protocol Violation|3
7288889|NCT00528996|11506080|FG004|Overall Study|Protocol Violation|2
7288890|NCT00528996|11506076|FG000|Overall Study|Lack of Efficacy|7
7288891|NCT00528996|11506077|FG001|Overall Study|Lack of Efficacy|2
7288892|NCT00528996|11506078|FG002|Overall Study|Lack of Efficacy|1
7288893|NCT00528996|11506079|FG003|Overall Study|Lack of Efficacy|3
7288894|NCT00528996|11506080|FG004|Overall Study|Lack of Efficacy|3
7288895|NCT00528996|11506076|FG000|Overall Study|Adverse Event|32
7288896|NCT00528996|11506077|FG001|Overall Study|Adverse Event|13
7288897|NCT00528996|11506078|FG002|Overall Study|Adverse Event|18
7288898|NCT00528996|11506079|FG003|Overall Study|Adverse Event|29
7288899|NCT00528996|11506080|FG004|Overall Study|Adverse Event|18
7288900|NCT00529035|11506095|FG000|Overall Study|Withdrawal by Subject|1
7288901|NCT00529087|11506109|FG000|Overall Study|Adverse Event|10
7288902|NCT00529087|11506110|FG001|Overall Study|Adverse Event|13
7288903|NCT00529087|11506111|FG002|Overall Study|Adverse Event|4
7288904|NCT00529087|11506109|FG000|Overall Study|Lost to Follow-up|6
7288905|NCT00529087|11506110|FG001|Overall Study|Lost to Follow-up|4
7288906|NCT00529087|11506111|FG002|Overall Study|Lost to Follow-up|1
7288907|NCT00529087|11506109|FG000|Overall Study|Protocol Violation|8
7288908|NCT00529087|11506110|FG001|Overall Study|Protocol Violation|7
7288909|NCT00529087|11506111|FG002|Overall Study|Protocol Violation|6
7288910|NCT00529087|11506109|FG000|Overall Study|Withdrawal by Subject|3
7288911|NCT00529087|11506110|FG001|Overall Study|Withdrawal by Subject|3
7288912|NCT00529087|11506111|FG002|Overall Study|Withdrawal by Subject|3
7288913|NCT00529087|11506109|FG000|Overall Study|Protocol deviation|1
7288914|NCT00529087|11506110|FG001|Overall Study|Protocol deviation|1
7288915|NCT00529087|11506111|FG002|Overall Study|Protocol deviation|2
7288916|NCT00529100|11506132|FG000|Overall Study|Adverse Event|0
7288917|NCT00529100|11506133|FG001|Overall Study|Adverse Event|5
7288918|NCT00529100|11506132|FG000|Overall Study|Protocol Violation|0
7288919|NCT00529100|11506133|FG001|Overall Study|Protocol Violation|1
7288920|NCT00529100|11506132|FG000|Overall Study|Progressive Disease|0
7288921|NCT00529100|11506133|FG001|Overall Study|Progressive Disease|1
7288922|NCT00529100|11506132|FG000|Overall Study|Withdrawal by Subject|0
7288923|NCT00529100|11506133|FG001|Overall Study|Withdrawal by Subject|1
7288924|NCT00529100|11506132|FG000|Overall Study|Participant Ineligibility|0
7288925|NCT00529100|11506133|FG001|Overall Study|Participant Ineligibility|1
7288926|NCT00529217|11506182|FG000|Overall Study|Lack of Efficacy|2
7288927|NCT00529217|11506182|FG000|Overall Study|Unable to adhere to study schedule|2
7288928|NCT00529243|11506187|FG000|Overall Study|Adverse Event|1
7288929|NCT00529243|11506187|FG000|Overall Study|Death|1
7288930|NCT00529243|11506187|FG000|Overall Study|Relocated|1
7288931|NCT00529308|11506193|FG000|Overall Study|Withdrawal by Subject|1
7288932|NCT00529308|11506194|FG001|Overall Study|Withdrawal by Subject|1
7288933|NCT00529373|11506202|FG000|Base Study|Adverse Event|525
7288934|NCT00529373|11506203|FG001|Base Study|Adverse Event|470
7288935|NCT00529373|11506202|FG000|Base Study|Lack of Efficacy|16
7288936|NCT00529373|11506203|FG001|Base Study|Lack of Efficacy|75
7288937|NCT00529373|11506202|FG000|Base Study|Lost to Follow-up|221
7288938|NCT00529373|11506203|FG001|Base Study|Lost to Follow-up|208
7288939|NCT00529373|11506202|FG000|Base Study|Other Protocol Specified Criteria|19
7288940|NCT00529373|11506203|FG001|Base Study|Other Protocol Specified Criteria|20
7288941|NCT00529373|11506202|FG000|Base Study|Physician Decision|60
7288942|NCT00529373|11506203|FG001|Base Study|Physician Decision|52
7288943|NCT00529373|11506202|FG000|Base Study|Protocol Violation|48
7288944|NCT00529373|11506203|FG001|Base Study|Protocol Violation|38
7288945|NCT00529373|11506202|FG000|Base Study|Withdrawal by Subject|1062
7288946|NCT00529373|11506203|FG001|Base Study|Withdrawal by Subject|967
7288947|NCT00529373|11506202|FG000|Base Study|Did not continue into Extension|1795
7288948|NCT00529373|11506203|FG001|Base Study|Did not continue into Extension|2238
7288949|NCT00529373|11506202|FG000|First Extension Study|Adverse Event|162
7288950|NCT00529373|11506203|FG001|First Extension Study|Adverse Event|142
7288951|NCT00529373|11506202|FG000|First Extension Study|Lack of Efficacy|65
7288952|NCT00529373|11506203|FG001|First Extension Study|Lack of Efficacy|427
7623346|NCT04404725|12034365|FG001|Second Intervention|Adverse Event|1
7288953|NCT00529373|11506202|FG000|First Extension Study|Lost to Follow-up|41
7288954|NCT00529373|11506203|FG001|First Extension Study|Lost to Follow-up|37
7288955|NCT00529373|11506202|FG000|First Extension Study|Other|27
7288956|NCT00529373|11506203|FG001|First Extension Study|Other|47
7288957|NCT00529373|11506202|FG000|First Extension Study|Physician Decision|50
7288958|NCT00529373|11506203|FG001|First Extension Study|Physician Decision|45
7288959|NCT00529373|11506202|FG000|First Extension Study|Protocol Violation|16
7288960|NCT00529373|11506203|FG001|First Extension Study|Protocol Violation|13
7288961|NCT00529373|11506202|FG000|First Extension Study|Withdrawal by Subject|296
7288962|NCT00529373|11506203|FG001|First Extension Study|Withdrawal by Subject|287
7288963|NCT00529373|11506202|FG000|First Extension Study|Disposition record non-existing|0
7288964|NCT00529373|11506203|FG001|First Extension Study|Disposition record non-existing|1
7288965|NCT00529373|11506202|FG000|First Extension Study|Discontinued after 5 years completion|208
7288966|NCT00529373|11506203|FG001|First Extension Study|Discontinued after 5 years completion|346
7288967|NCT00529373|11506202|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
7288968|NCT00529373|11506203|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
7288969|NCT00529373|11506202|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
7288970|NCT00529373|11506203|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
7288971|NCT00529373|11506202|FG000|Second Extension Study|Adverse Event|101
7288972|NCT00529373|11506203|FG001|Second Extension Study|Adverse Event|51
7288973|NCT00529373|11506202|FG000|Second Extension Study|Lack of Efficacy|7
7288974|NCT00529373|11506203|FG001|Second Extension Study|Lack of Efficacy|15
7288975|NCT00529373|11506202|FG000|Second Extension Study|Lost to Follow-up|18
7288976|NCT00529373|11506203|FG001|Second Extension Study|Lost to Follow-up|12
7288977|NCT00529373|11506202|FG000|Second Extension Study|Other|7
7288978|NCT00529373|11506203|FG001|Second Extension Study|Other|12
7288979|NCT00529373|11506202|FG000|Second Extension Study|Physician Decision|63
7288980|NCT00529373|11506203|FG001|Second Extension Study|Physician Decision|26
7288981|NCT00529373|11506202|FG000|Second Extension Study|Protocol Violation|2
7288982|NCT00529373|11506203|FG001|Second Extension Study|Protocol Violation|1
7288983|NCT00529373|11506202|FG000|Second Extension Study|Withdrawal by Subject|97
7288984|NCT00529373|11506203|FG001|Second Extension Study|Withdrawal by Subject|75
7288985|NCT00529373|11506202|FG000|Second Extension Study|Status Missing|5
7288986|NCT00529373|11506203|FG001|Second Extension Study|Status Missing|5
7288987|NCT00529386|11506217|FG000|Overall Study|Lost to Follow-up|1
7288988|NCT00529399|11506224|FG000|Overall Study|Lost to Follow-up|1
7288989|NCT00529399|11506225|FG001|Overall Study|Lost to Follow-up|0
7288990|NCT00529399|11506226|FG002|Overall Study|Lost to Follow-up|1
7288991|NCT00529399|11506224|FG000|Overall Study|Withdrawal by Subject|1
7288992|NCT00529399|11506225|FG001|Overall Study|Withdrawal by Subject|0
7288993|NCT00529399|11506226|FG002|Overall Study|Withdrawal by Subject|1
7288994|NCT00529399|11506224|FG000|Overall Study|Non-compliant|0
7288995|NCT00529399|11506225|FG001|Overall Study|Non-compliant|1
7288996|NCT00529399|11506226|FG002|Overall Study|Non-compliant|0
7288997|NCT00529451|11506238|FG000|Overall Study|Subject withdrew consent|16
7288998|NCT00529451|11506239|FG001|Overall Study|Subject withdrew consent|21
7288999|NCT00529451|11506240|FG002|Overall Study|Subject withdrew consent|13
7289000|NCT00529451|11506241|FG003|Overall Study|Subject withdrew consent|12
7289001|NCT00529451|11506238|FG000|Overall Study|Adverse Event|9
7289002|NCT00529451|11506239|FG001|Overall Study|Adverse Event|16
7289003|NCT00529451|11506240|FG002|Overall Study|Adverse Event|14
7289004|NCT00529451|11506241|FG003|Overall Study|Adverse Event|8
7289005|NCT00529451|11506238|FG000|Overall Study|Unsatisfactory therapeutic response|6
7289006|NCT00529451|11506239|FG001|Overall Study|Unsatisfactory therapeutic response|2
7289007|NCT00529451|11506240|FG002|Overall Study|Unsatisfactory therapeutic response|5
7289008|NCT00529451|11506241|FG003|Overall Study|Unsatisfactory therapeutic response|4
7289009|NCT00529451|11506238|FG000|Overall Study|Lost to Follow-up|4
7289010|NCT00529451|11506239|FG001|Overall Study|Lost to Follow-up|7
7289011|NCT00529451|11506240|FG002|Overall Study|Lost to Follow-up|4
7289012|NCT00529451|11506241|FG003|Overall Study|Lost to Follow-up|4
7289013|NCT00529451|11506238|FG000|Overall Study|Protocol deviation|1
7289014|NCT00529451|11506239|FG001|Overall Study|Protocol deviation|1
7289015|NCT00529451|11506240|FG002|Overall Study|Protocol deviation|4
7289016|NCT00529451|11506241|FG003|Overall Study|Protocol deviation|1
7289017|NCT00529451|11506238|FG000|Overall Study|Administrative problems|1
7289018|NCT00529451|11506239|FG001|Overall Study|Administrative problems|1
7289019|NCT00529451|11506240|FG002|Overall Study|Administrative problems|0
7289020|NCT00529451|11506241|FG003|Overall Study|Administrative problems|2
7289021|NCT00529516|11506257|FG000|Overall Study|Adverse Event|2
7289022|NCT00529516|11506258|FG001|Overall Study|Adverse Event|1
7289023|NCT00529516|11506259|FG002|Overall Study|Adverse Event|0
7289024|NCT00529516|11506257|FG000|Overall Study|Withdrawal by Subject|1
7289025|NCT00529516|11506258|FG001|Overall Study|Withdrawal by Subject|1
7289026|NCT00529516|11506259|FG002|Overall Study|Withdrawal by Subject|0
7289027|NCT00529516|11506257|FG000|Overall Study|Lost to Follow-up|0
7289028|NCT00529516|11506258|FG001|Overall Study|Lost to Follow-up|0
7289029|NCT00529516|11506259|FG002|Overall Study|Lost to Follow-up|1
7289030|NCT00529529|11506270|FG000|Overall Study|Adverse Event|12
7289031|NCT00529529|11506271|FG001|Overall Study|Adverse Event|17
7289032|NCT00529529|11506272|FG002|Overall Study|Adverse Event|8
7289033|NCT00529529|11506270|FG000|Overall Study|Subject withdrew consent|12
7289034|NCT00529529|11506271|FG001|Overall Study|Subject withdrew consent|9
7289035|NCT00529529|11506272|FG002|Overall Study|Subject withdrew consent|12
7289036|NCT00529529|11506270|FG000|Overall Study|Protocol deviation|8
7289037|NCT00529529|11506271|FG001|Overall Study|Protocol deviation|12
7289038|NCT00529529|11506272|FG002|Overall Study|Protocol deviation|5
7289039|NCT00529529|11506270|FG000|Overall Study|Lost to Follow-up|5
7289040|NCT00529529|11506271|FG001|Overall Study|Lost to Follow-up|3
7289041|NCT00529529|11506272|FG002|Overall Study|Lost to Follow-up|1
7289042|NCT00529529|11506270|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7289043|NCT00529529|11506271|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7289044|NCT00529529|11506272|FG002|Overall Study|Unsatisfactory therapeutic effect|2
7289045|NCT00529529|11506270|FG000|Overall Study|Death|2
7289046|NCT00529529|11506271|FG001|Overall Study|Death|0
7289047|NCT00529529|11506272|FG002|Overall Study|Death|0
7289048|NCT00529529|11506270|FG000|Overall Study|Abnormal test procedure result(s)|1
7289049|NCT00529529|11506271|FG001|Overall Study|Abnormal test procedure result(s)|0
7289050|NCT00529529|11506272|FG002|Overall Study|Abnormal test procedure result(s)|0
7289051|NCT00529529|11506270|FG000|Overall Study|Administrative problems|1
7289052|NCT00529529|11506271|FG001|Overall Study|Administrative problems|0
7289053|NCT00529529|11506272|FG002|Overall Study|Administrative problems|3
7289054|NCT00529542|11506282|FG000|Overall Study|Withdrawal by Subject|1
7289055|NCT00529542|11506283|FG001|Overall Study|Withdrawal by Subject|0
7289056|NCT00529542|11506282|FG000|Overall Study|Lost to Follow-up|0
7289057|NCT00529542|11506283|FG001|Overall Study|Lost to Follow-up|1
7289058|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
7289059|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7289060|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
7289061|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
7289062|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7289063|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
7289064|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
7289065|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7289066|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
7289067|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
7289068|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7289069|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
7289070|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
7289071|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7289072|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
7623347|NCT04404725|12034364|FG000|Second Intervention|Withdrawal by Subject|0
7623348|NCT04404725|12034365|FG001|Second Intervention|Withdrawal by Subject|1
7623349|NCT04382586|12034373|FG000|Overall Study|Death|3
7623350|NCT04382586|12034374|FG001|Overall Study|Death|4
7623351|NCT04382586|12034373|FG000|Overall Study|Lost to Follow-up|11
7623352|NCT04382586|12034374|FG001|Overall Study|Lost to Follow-up|8
7623353|NCT04382586|12034373|FG000|Overall Study|Withdrawal by Subject|3
7623354|NCT04382586|12034374|FG001|Overall Study|Withdrawal by Subject|1
7623355|NCT04382586|12034373|FG000|Overall Study|Physician Decision|0
7623356|NCT04382586|12034374|FG001|Overall Study|Physician Decision|3
7623357|NCT04348656|12034382|FG000|Overall Study|Withdrawal by Subject|2
7623358|NCT04348656|12034383|FG001|Overall Study|Withdrawal by Subject|0
7623359|NCT04348656|12034382|FG000|Overall Study|Lost to Follow-up|11
7623360|NCT04348656|12034383|FG001|Overall Study|Lost to Follow-up|6
7289073|NCT00529568|11506304|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
7289074|NCT00529568|11506305|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7289075|NCT00529568|11506306|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
7289076|NCT00529568|11506304|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
7289077|NCT00529568|11506305|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
7289078|NCT00529568|11506306|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
7289079|NCT00529568|11506304|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7289080|NCT00529568|11506305|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
7289081|NCT00529568|11506306|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
7289082|NCT00529568|11506304|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
7289083|NCT00529568|11506305|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
7289084|NCT00529568|11506306|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
7289085|NCT00529568|11506304|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
7289086|NCT00529568|11506305|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
7289087|NCT00529568|11506306|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
7289088|NCT00529568|11506304|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
7289089|NCT00529568|11506305|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
7289090|NCT00529568|11506306|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
7289091|NCT00529633|11506317|FG000|Overall Study|Withdrawal by Subject|1
7289092|NCT00529633|11506318|FG001|Overall Study|Withdrawal by Subject|1
7289093|NCT00529659|11506326|FG000|Overall Study|Adverse Event|8
7289094|NCT00529659|11506327|FG001|Overall Study|Adverse Event|7
7289095|NCT00529659|11506326|FG000|Overall Study|Lost to Follow-up|0
7289096|NCT00529659|11506327|FG001|Overall Study|Lost to Follow-up|2
7289097|NCT00529659|11506326|FG000|Overall Study|Physician Decision|0
7289098|NCT00529659|11506327|FG001|Overall Study|Physician Decision|2
7289099|NCT00529659|11506326|FG000|Overall Study|Protocol Violation|2
7289100|NCT00529659|11506327|FG001|Overall Study|Protocol Violation|6
7289101|NCT00529659|11506326|FG000|Overall Study|Withdrawal by Subject|1
7289102|NCT00529659|11506327|FG001|Overall Study|Withdrawal by Subject|6
7289103|NCT00529789|11506333|FG000|Study Period II/III|Parent/Caregiver Decision|9
7289104|NCT00529789|11506333|FG000|Study Period II/III|Adverse Event|3
7289105|NCT00529789|11506333|FG000|Study Period II/III|Lack of Efficacy|2
7289106|NCT00529789|11506333|FG000|Study Period II/III|Withdrawal by Subject|1
7289107|NCT00529789|11506333|FG000|Study Period II/III|Protocol Violation|3
7289108|NCT00529789|11506333|FG000|Study Period II/III|Physician Decision|3
7289109|NCT00529789|11506333|FG000|Study Period II/III|Lost to Follow-up|3
7289110|NCT00529789|11506333|FG000|Study Period IV|Parent/Caregiver Decision|1
7289111|NCT00529789|11506333|FG000|Study Period IV|Adverse Event|1
7289112|NCT00529789|11506333|FG000|Study Period IV|Lack of Efficacy|1
7289113|NCT00529789|11506333|FG000|Study Period IV|Lost to Follow-up|3
7289114|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
7289115|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
7289116|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Adverse Event|2
7289117|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Death|1
7289118|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
7289119|NCT00529802|11506343|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
7289120|NCT00529802|11506343|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
7289121|NCT00529958|11506352|FG000|2-Year Follow-up|Lost to Follow-up|1
7289122|NCT00529958|11506353|FG001|2-Year Follow-up|Lost to Follow-up|2
7289123|NCT00529958|11506354|FG002|2-Year Follow-up|Lost to Follow-up|2
7289124|NCT00529958|11506352|FG000|2-Year Follow-up|Withdrawal by Subject|3
7289125|NCT00529958|11506353|FG001|2-Year Follow-up|Withdrawal by Subject|0
7289126|NCT00529958|11506354|FG002|2-Year Follow-up|Withdrawal by Subject|0
7289127|NCT00529958|11506352|FG000|5-Year Follow-up|Lost to Follow-up|2
7289128|NCT00529958|11506353|FG001|5-Year Follow-up|Lost to Follow-up|3
7289129|NCT00529958|11506354|FG002|5-Year Follow-up|Lost to Follow-up|1
7289130|NCT00529958|11506352|FG000|5-Year Follow-up|Withdrawal by Subject|1
7289131|NCT00529958|11506353|FG001|5-Year Follow-up|Withdrawal by Subject|0
7289132|NCT00529958|11506354|FG002|5-Year Follow-up|Withdrawal by Subject|0
7289133|NCT00530023|11506364|FG000|Overall Study|Withdrawal by Subject|0
7289134|NCT00530023|11506365|FG001|Overall Study|Withdrawal by Subject|1
7289135|NCT00530075|11506371|FG000|Overall Study|Adverse Event|1
7289136|NCT00530075|11506371|FG000|Overall Study|Death|1
7289137|NCT00530075|11506371|FG000|Overall Study|Lack of Efficacy|3
7289138|NCT00530075|11506371|FG000|Overall Study|Protocol Violation|1
7289139|NCT00530075|11506371|FG000|Overall Study|Withdrawal by Subject|1
7289140|NCT00530088|11506375|FG000|Overall Study|Disease Progression|4
7289141|NCT00530088|11506375|FG000|Overall Study|Physician Decision|4
7289142|NCT00530088|11506375|FG000|Overall Study|Other Not Specified|2
7289143|NCT00530218|11506379|FG000|Overall Study|CMV Not Detected|13
7289144|NCT00530218|11506379|FG000|Overall Study|Death|12
7289145|NCT00530257|11506386|FG000|Overall Study|Lost to Follow-up|1
7289146|NCT00530270|11506395|FG000|Overall Study|Protocol Violation|1
7289147|NCT00530270|11506396|FG001|Overall Study|Protocol Violation|0
7289148|NCT00530335|11506402|FG000|Overall Study|Adverse Event|3
7289149|NCT00530335|11506402|FG000|Overall Study|Protocol Violation|1
7289150|NCT00530335|11506402|FG000|Overall Study|Withdrawal by Subject|1
7289151|NCT00530335|11506402|FG000|Overall Study|Physician Decision|1
7289152|NCT00530348|11506408|FG000|Overall Study|Adverse Event|5
7289153|NCT00530348|11506409|FG001|Overall Study|Adverse Event|1
7289154|NCT00530348|11506408|FG000|Overall Study|Death|0
7289155|NCT00530348|11506409|FG001|Overall Study|Death|1
7289156|NCT00530348|11506408|FG000|Overall Study|Lack of Efficacy|2
7289157|NCT00530348|11506409|FG001|Overall Study|Lack of Efficacy|0
7289158|NCT00530348|11506408|FG000|Overall Study|Lost to Follow-up|0
7289159|NCT00530348|11506409|FG001|Overall Study|Lost to Follow-up|2
7289160|NCT00530348|11506408|FG000|Overall Study|Physician Decision|1
7289161|NCT00530348|11506409|FG001|Overall Study|Physician Decision|2
7289162|NCT00530348|11506408|FG000|Overall Study|Pregnancy|1
7289163|NCT00530348|11506409|FG001|Overall Study|Pregnancy|0
7289164|NCT00530348|11506408|FG000|Overall Study|Withdrawal by Subject|12
7289165|NCT00530348|11506409|FG001|Overall Study|Withdrawal by Subject|12
7289166|NCT00530348|11506408|FG000|Overall Study|Randomised in error|1
7289167|NCT00530348|11506409|FG001|Overall Study|Randomised in error|0
7289168|NCT00530348|11506408|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
7289169|NCT00530348|11506409|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
7289170|NCT00530439|11506417|FG000|Overall Study|GDM|9
7289171|NCT00530439|11506418|FG001|Overall Study|GDM|3
7289172|NCT00530439|11506417|FG000|Overall Study|Withdraw|18
7289173|NCT00530439|11506418|FG001|Overall Study|Withdraw|14
7289174|NCT00530439|11506417|FG000|Overall Study|Missed abortion|1
7289175|NCT00530439|11506418|FG001|Overall Study|Missed abortion|4
7289176|NCT00530439|11506417|FG000|Overall Study|Misclassification|2
7289177|NCT00530439|11506418|FG001|Overall Study|Misclassification|0
7289178|NCT00530439|11506417|FG000|Overall Study|Twin pregnancy|0
7289179|NCT00530439|11506418|FG001|Overall Study|Twin pregnancy|2
7289180|NCT00530439|11506417|FG000|Overall Study|Severe malformation/abortion|0
7289181|NCT00530439|11506418|FG001|Overall Study|Severe malformation/abortion|3
7289182|NCT00530504|11506424|FG000|Overall Study|Death|54
7289183|NCT00530504|11506424|FG000|Overall Study|Lost to Follow-up|26
7289184|NCT00530504|11506424|FG000|Overall Study|Withdrawal by Subject|39
7289185|NCT00530504|11506424|FG000|Overall Study|Exited study due to other reasons|33
7289186|NCT00530621|11506430|FG000|Overall Study|Adverse Event|11
7289187|NCT00530621|11506431|FG001|Overall Study|Adverse Event|8
7289188|NCT00530621|11506430|FG000|Overall Study|Physician Decision|2
7289189|NCT00530621|11506431|FG001|Overall Study|Physician Decision|4
7623375|NCT03671148|12034456|FG001|Overall Study|Lack of Efficacy|2
7623376|NCT03671148|12034455|FG000|Overall Study|COVID-19 Logistical Restrictions|0
7623377|NCT03671148|12034456|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7623378|NCT03671148|12034455|FG000|Overall Study|Other|1
7623379|NCT03671148|12034456|FG001|Overall Study|Other|0
7623380|NCT03671148|12034455|FG000|Overall Study|Incomplete Randomization Visit|1
7623381|NCT03671148|12034456|FG001|Overall Study|Incomplete Randomization Visit|0
7623386|NCT03529773|12034547|FG000|Overall Study|Adverse Event|0
7623387|NCT03529773|12034548|FG001|Overall Study|Adverse Event|0
7623388|NCT03529773|12034549|FG002|Overall Study|Adverse Event|0
7623389|NCT03529773|12034550|FG003|Overall Study|Adverse Event|0
7623390|NCT03529773|12034551|FG004|Overall Study|Adverse Event|0
7623391|NCT03529773|12034552|FG005|Overall Study|Adverse Event|0
7623392|NCT03529773|12034553|FG006|Overall Study|Adverse Event|0
7623393|NCT03529773|12034554|FG007|Overall Study|Adverse Event|0
7623394|NCT03529773|12034555|FG008|Overall Study|Adverse Event|0
7623395|NCT03529773|12034556|FG009|Overall Study|Adverse Event|0
7289190|NCT00530621|11506430|FG000|Overall Study|Progressive Disease (PD)|47
7289191|NCT00530621|11506431|FG001|Overall Study|Progressive Disease (PD)|40
7289192|NCT00530621|11506430|FG000|Overall Study|Sponsor Decision|12
7289193|NCT00530621|11506431|FG001|Overall Study|Sponsor Decision|15
7289194|NCT00530621|11506430|FG000|Overall Study|Subject Decision|4
7289195|NCT00530621|11506431|FG001|Overall Study|Subject Decision|7
7289196|NCT00530621|11506430|FG000|Overall Study|Death|3
7289197|NCT00530621|11506431|FG001|Overall Study|Death|6
7289198|NCT00530621|11506430|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
7289199|NCT00530621|11506431|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
7289200|NCT00530712|11506445|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
7289201|NCT00530712|11506445|FG000|30 Day Follow-up Visit|Missed Visit|5
7289202|NCT00530712|11506445|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
7289203|NCT00530712|11506445|FG000|6 Month Follow-up Visit|Missed Visit|3
7289204|NCT00530712|11506445|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
7289205|NCT00530712|11506445|FG000|6 Month Follow-up Visit|Death|2
7623396|NCT03529773|12034557|FG010|Overall Study|Adverse Event|0
7623397|NCT03529773|12034558|FG011|Overall Study|Adverse Event|0
7623398|NCT03529773|12034559|FG012|Overall Study|Adverse Event|0
7623399|NCT03529773|12034560|FG013|Overall Study|Adverse Event|0
7623400|NCT03529773|12034561|FG014|Overall Study|Adverse Event|0
7623401|NCT03529773|12034562|FG015|Overall Study|Adverse Event|0
7623402|NCT03529773|12034563|FG016|Overall Study|Adverse Event|0
7289206|NCT00530712|11506445|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
7289207|NCT00530712|11506445|FG000|12 Month Follow-up Visit|Missed Visit|3
7289208|NCT00530712|11506445|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
7289209|NCT00530712|11506445|FG000|12 Month Follow-up Visit|Death|9
7289210|NCT00530777|11506472|FG000|Overall Study|Lost to Follow-up|0
7289211|NCT00530777|11506473|FG001|Overall Study|Lost to Follow-up|1
7289212|NCT00530777|11506472|FG000|Overall Study|Death|1
7289213|NCT00530777|11506473|FG001|Overall Study|Death|2
7289214|NCT00530777|11506472|FG000|Overall Study|Physician Decision|1
7289215|NCT00530777|11506473|FG001|Overall Study|Physician Decision|0
7289216|NCT00530777|11506472|FG000|Overall Study|Withdrawal by Subject|0
7289217|NCT00530777|11506473|FG001|Overall Study|Withdrawal by Subject|1
7289218|NCT00530777|11506472|FG000|Overall Study|Unable to adhere to visit schedule|5
7289219|NCT00530777|11506473|FG001|Overall Study|Unable to adhere to visit schedule|1
7289220|NCT00530790|11506479|FG000|Overall Study|Adverse Event|2
7289221|NCT00530790|11506479|FG000|Overall Study|Withdrawal by Subject|2
7289222|NCT00530790|11506479|FG000|Overall Study|Physician Decision|1
7289223|NCT00530816|11506495|FG000|Overall Study|Progressive Disease|16
7289224|NCT00530816|11506496|FG001|Overall Study|Progressive Disease|24
7289225|NCT00530816|11506497|FG002|Overall Study|Progressive Disease|24
7289226|NCT00530816|11506495|FG000|Overall Study|Adverse Event|6
7289227|NCT00530816|11506496|FG001|Overall Study|Adverse Event|13
7289228|NCT00530816|11506497|FG002|Overall Study|Adverse Event|7
7289229|NCT00530816|11506495|FG000|Overall Study|Other|3
7289230|NCT00530816|11506496|FG001|Overall Study|Other|3
7289231|NCT00530816|11506497|FG002|Overall Study|Other|4
7289232|NCT00530816|11506495|FG000|Overall Study|Withdrawal by Subject|1
7289233|NCT00530816|11506496|FG001|Overall Study|Withdrawal by Subject|2
7289234|NCT00530816|11506497|FG002|Overall Study|Withdrawal by Subject|6
7289235|NCT00530842|11506507|FG000|Overall Study|Adverse Event|10
7289236|NCT00530842|11506508|FG001|Overall Study|Adverse Event|6
7289237|NCT00530842|11506507|FG000|Overall Study|Lack of Efficacy|2
7289238|NCT00530842|11506508|FG001|Overall Study|Lack of Efficacy|1
7289239|NCT00530842|11506507|FG000|Overall Study|Lost to Follow-up|0
7289240|NCT00530842|11506508|FG001|Overall Study|Lost to Follow-up|4
7289241|NCT00530842|11506507|FG000|Overall Study|Protocol Violation|3
7289242|NCT00530842|11506508|FG001|Overall Study|Protocol Violation|2
7289243|NCT00530842|11506507|FG000|Overall Study|Withdrawal by Subject|4
7289244|NCT00530842|11506508|FG001|Overall Study|Withdrawal by Subject|5
7289245|NCT00530842|11506507|FG000|Overall Study|Individual different reasons|4
7289246|NCT00530842|11506508|FG001|Overall Study|Individual different reasons|3
7289247|NCT00530842|11506507|FG000|Period 1|Adverse Event|7
7289248|NCT00530842|11506508|FG001|Period 1|Adverse Event|3
7289249|NCT00530842|11506507|FG000|Period 1|Lack of Efficacy|1
7289250|NCT00530842|11506508|FG001|Period 1|Lack of Efficacy|1
7289251|NCT00530842|11506507|FG000|Period 1|Protocol Violation|2
7289252|NCT00530842|11506508|FG001|Period 1|Protocol Violation|1
7289253|NCT00530842|11506507|FG000|Period 1|Withdrawal by Subject|2
7289254|NCT00530842|11506508|FG001|Period 1|Withdrawal by Subject|3
7289255|NCT00530842|11506507|FG000|Period 1|Individual different reasons|2
7289256|NCT00530842|11506508|FG001|Period 1|Individual different reasons|3
7289257|NCT00530842|11506507|FG000|Period 2|Adverse Event|3
7289258|NCT00530842|11506508|FG001|Period 2|Adverse Event|3
7289259|NCT00530842|11506507|FG000|Period 2|Lack of Efficacy|1
7289260|NCT00530842|11506508|FG001|Period 2|Lack of Efficacy|0
7289261|NCT00530842|11506507|FG000|Period 2|Lost to Follow-up|0
7289262|NCT00530842|11506508|FG001|Period 2|Lost to Follow-up|4
7289263|NCT00530842|11506507|FG000|Period 2|Protocol Violation|1
7289264|NCT00530842|11506508|FG001|Period 2|Protocol Violation|0
7289265|NCT00530842|11506507|FG000|Period 2|Withdrawal by Subject|1
7289266|NCT00530842|11506508|FG001|Period 2|Withdrawal by Subject|2
7289267|NCT00530842|11506507|FG000|Period 2|Individual different reasons|2
7289268|NCT00530842|11506508|FG001|Period 2|Individual different reasons|0
7289269|NCT00530855|11506516|FG000|Overall Study|Lack of Efficacy|20
7289270|NCT00530855|11506516|FG000|Overall Study|Withdrawal by Subject|30
7289271|NCT00530855|11506516|FG000|Overall Study|Fatal Serious AE|3
7289272|NCT00530855|11506516|FG000|Overall Study|Non Fatal Serious AE|7
7289273|NCT00530855|11506516|FG000|Overall Study|Non Fatal Non Serious AE|12
7289274|NCT00530855|11506516|FG000|Overall Study|Protocol Violation|3
7289275|NCT00530855|11506516|FG000|Overall Study|Unsatisfactory compliance of subject|11
7289276|NCT00530855|11506516|FG000|Overall Study|Lost to Follow-up|9
7623365|NCT03847974|12034426|FG000|Overall Study|relocated out of region|3
7623366|NCT03847974|12034426|FG000|Overall Study|Withdrawal by Subject|2
7623367|NCT03847974|12034426|FG000|Overall Study|Adverse Event|1
7623368|NCT03671148|12034455|FG000|Overall Study|Adverse Event|3
7623369|NCT03671148|12034456|FG001|Overall Study|Adverse Event|2
7623370|NCT03671148|12034455|FG000|Overall Study|Withdrawal by Subject|8
7623371|NCT03671148|12034456|FG001|Overall Study|Withdrawal by Subject|2
7623372|NCT03671148|12034455|FG000|Overall Study|Lost to Follow-up|1
7623373|NCT03671148|12034456|FG001|Overall Study|Lost to Follow-up|2
7289277|NCT00530855|11506516|FG000|Overall Study|Other reason for premature termination|17
7289278|NCT00530894|11506524|FG000|Overall Study|Death|84
7289279|NCT00530894|11506525|FG001|Overall Study|Death|89
7289280|NCT00530894|11506526|FG002|Overall Study|Death|55
7289281|NCT00530894|11506527|FG003|Overall Study|Death|89
7623374|NCT03671148|12034455|FG000|Overall Study|Lack of Efficacy|7
7289282|NCT00530894|11506524|FG000|Overall Study|Lost to Follow-up|1
7289283|NCT00530894|11506525|FG001|Overall Study|Lost to Follow-up|3
7289284|NCT00530894|11506526|FG002|Overall Study|Lost to Follow-up|0
7289285|NCT00530894|11506527|FG003|Overall Study|Lost to Follow-up|0
7289286|NCT00530894|11506524|FG000|Overall Study|Withdrawal by Subject|1
7289287|NCT00530894|11506525|FG001|Overall Study|Withdrawal by Subject|23
7289288|NCT00530894|11506526|FG002|Overall Study|Withdrawal by Subject|0
7289289|NCT00530894|11506527|FG003|Overall Study|Withdrawal by Subject|5
7289290|NCT00530894|11506524|FG000|Overall Study|Alive and censored prior to 1 year|2
7289291|NCT00530894|11506525|FG001|Overall Study|Alive and censored prior to 1 year|0
7289292|NCT00530894|11506526|FG002|Overall Study|Alive and censored prior to 1 year|0
7289293|NCT00530894|11506527|FG003|Overall Study|Alive and censored prior to 1 year|0
7289294|NCT00530920|11506542|FG000|Overall Study|Randomized but not treated|0
7289295|NCT00530920|11506543|FG001|Overall Study|Randomized but not treated|2
7289296|NCT00530920|11506544|FG002|Overall Study|Randomized but not treated|0
7289297|NCT00530920|11506542|FG000|Overall Study|Adverse Event|0
7289298|NCT00530920|11506543|FG001|Overall Study|Adverse Event|0
7289299|NCT00530920|11506544|FG002|Overall Study|Adverse Event|3
7289300|NCT00530920|11506542|FG000|Overall Study|Withdrawal by Subject|0
7289301|NCT00530920|11506543|FG001|Overall Study|Withdrawal by Subject|0
7289302|NCT00530920|11506544|FG002|Overall Study|Withdrawal by Subject|1
7289303|NCT00530946|11506557|FG000|Overall Study|Adverse Event|1
7289304|NCT00530946|11506558|FG001|Overall Study|Adverse Event|2
7289305|NCT00530946|11506559|FG002|Overall Study|Adverse Event|1
7289306|NCT00530946|11506560|FG003|Overall Study|Adverse Event|1
7289307|NCT00530946|11506557|FG000|Overall Study|Protocol Violation|0
7289308|NCT00530946|11506558|FG001|Overall Study|Protocol Violation|0
7289309|NCT00530946|11506559|FG002|Overall Study|Protocol Violation|0
7289310|NCT00530946|11506560|FG003|Overall Study|Protocol Violation|1
7289311|NCT00530946|11506557|FG000|Overall Study|Noncompliance|1
7289312|NCT00530946|11506558|FG001|Overall Study|Noncompliance|0
7289313|NCT00530946|11506559|FG002|Overall Study|Noncompliance|0
7289314|NCT00530946|11506560|FG003|Overall Study|Noncompliance|0
7289315|NCT00531011|11506572|FG000|Overall Study|Withdrawal by Subject|2
7289316|NCT00531011|11506573|FG001|Overall Study|Withdrawal by Subject|4
7289317|NCT00531011|11506572|FG000|Overall Study|Death|1
7289318|NCT00531011|11506573|FG001|Overall Study|Death|0
7289319|NCT00531011|11506572|FG000|Overall Study|Lost to Follow-up|1
7289320|NCT00531011|11506573|FG001|Overall Study|Lost to Follow-up|0
7289321|NCT00531011|11506572|FG000|Overall Study|Physician Decision|0
7289322|NCT00531011|11506573|FG001|Overall Study|Physician Decision|3
7289323|NCT00531050|11506585|FG000|Part 1: Period 1|Adverse Event|0
7289324|NCT00531050|11506586|FG001|Part 1: Period 1|Adverse Event|1
7289325|NCT00531050|11506587|FG002|Part 1: Period 1|Adverse Event|0
7289326|NCT00531050|11506588|FG003|Part 1: Period 1|Adverse Event|0
7289327|NCT00531050|11506589|FG004|Part 1: Period 1|Adverse Event|0
7289328|NCT00531050|11506590|FG005|Part 1: Period 1|Adverse Event|0
7289329|NCT00531050|11506585|FG000|Part 1: Period 1|Protocol Deviation|0
7289330|NCT00531050|11506586|FG001|Part 1: Period 1|Protocol Deviation|0
7289331|NCT00531050|11506587|FG002|Part 1: Period 1|Protocol Deviation|0
7289332|NCT00531050|11506588|FG003|Part 1: Period 1|Protocol Deviation|1
7289333|NCT00531050|11506589|FG004|Part 1: Period 1|Protocol Deviation|0
7289334|NCT00531050|11506590|FG005|Part 1: Period 1|Protocol Deviation|0
7289335|NCT00531050|11506585|FG000|Part 1: Period 3|Adverse Event|1
7289336|NCT00531050|11506586|FG001|Part 1: Period 3|Adverse Event|0
7289337|NCT00531050|11506587|FG002|Part 1: Period 3|Adverse Event|0
7289338|NCT00531050|11506588|FG003|Part 1: Period 3|Adverse Event|0
7289339|NCT00531050|11506589|FG004|Part 1: Period 3|Adverse Event|0
7289340|NCT00531050|11506590|FG005|Part 1: Period 3|Adverse Event|0
7289341|NCT00531050|11506585|FG000|Part 2: Period 1|Adverse Event|0
7289342|NCT00531050|11506586|FG001|Part 2: Period 1|Adverse Event|0
7289343|NCT00531050|11506587|FG002|Part 2: Period 1|Adverse Event|0
7289344|NCT00531050|11506588|FG003|Part 2: Period 1|Adverse Event|0
7289345|NCT00531050|11506589|FG004|Part 2: Period 1|Adverse Event|0
7289346|NCT00531050|11506590|FG005|Part 2: Period 1|Adverse Event|1
7289347|NCT00531050|11506585|FG000|Part 2: Period 3|Abnormal test procedure|1
7289348|NCT00531050|11506586|FG001|Part 2: Period 3|Abnormal test procedure|0
7289349|NCT00531050|11506587|FG002|Part 2: Period 3|Abnormal test procedure|0
7289350|NCT00531050|11506588|FG003|Part 2: Period 3|Abnormal test procedure|0
7289351|NCT00531050|11506589|FG004|Part 2: Period 3|Abnormal test procedure|0
7289352|NCT00531050|11506590|FG005|Part 2: Period 3|Abnormal test procedure|1
7289353|NCT00531206|11506607|FG000|Overall Study|Adverse Event related|5
7289354|NCT00531206|11506607|FG000|Overall Study|Lack of Efficacy|2
7289355|NCT00531206|11506607|FG000|Overall Study|Lost to Follow-up|5
7289356|NCT00531206|11506607|FG000|Overall Study|including non-related adverse events|8
7289357|NCT00531284|11506628|FG000|Overall Study|Progressive Disease|1
7289358|NCT00531284|11506629|FG001|Overall Study|Progressive Disease|3
7289359|NCT00531284|11506630|FG002|Overall Study|Progressive Disease|5
7289360|NCT00531284|11506631|FG003|Overall Study|Progressive Disease|42
7289361|NCT00531284|11506632|FG004|Overall Study|Progressive Disease|4
7289362|NCT00531284|11506633|FG005|Overall Study|Progressive Disease|4
7289363|NCT00531284|11506634|FG006|Overall Study|Progressive Disease|3
7289364|NCT00531284|11506635|FG007|Overall Study|Progressive Disease|8
7289365|NCT00531284|11506636|FG008|Overall Study|Progressive Disease|6
7289366|NCT00531284|11506637|FG009|Overall Study|Progressive Disease|3
7289367|NCT00531284|11506638|FG010|Overall Study|Progressive Disease|3
7289368|NCT00531284|11506639|FG011|Overall Study|Progressive Disease|14
7289369|NCT00531284|11506640|FG012|Overall Study|Progressive Disease|2
7289370|NCT00531284|11506641|FG013|Overall Study|Progressive Disease|1
7289371|NCT00531284|11506642|FG014|Overall Study|Progressive Disease|2
7289372|NCT00531284|11506643|FG015|Overall Study|Progressive Disease|11
7289373|NCT00531284|11506644|FG016|Overall Study|Progressive Disease|5
7289374|NCT00531284|11506628|FG000|Overall Study|Adverse Event|0
7289375|NCT00531284|11506629|FG001|Overall Study|Adverse Event|1
7289376|NCT00531284|11506630|FG002|Overall Study|Adverse Event|1
7289377|NCT00531284|11506631|FG003|Overall Study|Adverse Event|7
7289378|NCT00531284|11506632|FG004|Overall Study|Adverse Event|0
7289379|NCT00531284|11506633|FG005|Overall Study|Adverse Event|2
7289380|NCT00531284|11506634|FG006|Overall Study|Adverse Event|3
7289381|NCT00531284|11506635|FG007|Overall Study|Adverse Event|2
7289382|NCT00531284|11506636|FG008|Overall Study|Adverse Event|3
7289383|NCT00531284|11506637|FG009|Overall Study|Adverse Event|0
7289384|NCT00531284|11506638|FG010|Overall Study|Adverse Event|0
7289385|NCT00531284|11506639|FG011|Overall Study|Adverse Event|5
7289386|NCT00531284|11506640|FG012|Overall Study|Adverse Event|0
7289387|NCT00531284|11506641|FG013|Overall Study|Adverse Event|1
7289388|NCT00531284|11506642|FG014|Overall Study|Adverse Event|1
7289389|NCT00531284|11506643|FG015|Overall Study|Adverse Event|0
7289390|NCT00531284|11506644|FG016|Overall Study|Adverse Event|2
7289391|NCT00531284|11506628|FG000|Overall Study|Withdrawal by Subject|1
7289392|NCT00531284|11506629|FG001|Overall Study|Withdrawal by Subject|0
7289393|NCT00531284|11506630|FG002|Overall Study|Withdrawal by Subject|0
7289394|NCT00531284|11506631|FG003|Overall Study|Withdrawal by Subject|4
7289395|NCT00531284|11506632|FG004|Overall Study|Withdrawal by Subject|0
7289396|NCT00531284|11506633|FG005|Overall Study|Withdrawal by Subject|0
7289397|NCT00531284|11506634|FG006|Overall Study|Withdrawal by Subject|0
7289398|NCT00531284|11506635|FG007|Overall Study|Withdrawal by Subject|0
7289399|NCT00531284|11506636|FG008|Overall Study|Withdrawal by Subject|0
7289400|NCT00531284|11506637|FG009|Overall Study|Withdrawal by Subject|0
7289401|NCT00531284|11506638|FG010|Overall Study|Withdrawal by Subject|0
7289402|NCT00531284|11506639|FG011|Overall Study|Withdrawal by Subject|3
7289403|NCT00531284|11506640|FG012|Overall Study|Withdrawal by Subject|0
7289404|NCT00531284|11506641|FG013|Overall Study|Withdrawal by Subject|1
7289405|NCT00531284|11506642|FG014|Overall Study|Withdrawal by Subject|0
7289406|NCT00531284|11506643|FG015|Overall Study|Withdrawal by Subject|1
7289407|NCT00531284|11506644|FG016|Overall Study|Withdrawal by Subject|1
7289408|NCT00531284|11506628|FG000|Overall Study|Other|1
7289409|NCT00531284|11506629|FG001|Overall Study|Other|0
7289410|NCT00531284|11506630|FG002|Overall Study|Other|0
7289411|NCT00531284|11506631|FG003|Overall Study|Other|10
7289412|NCT00531284|11506632|FG004|Overall Study|Other|2
7289413|NCT00531284|11506633|FG005|Overall Study|Other|1
7289414|NCT00531284|11506634|FG006|Overall Study|Other|0
7289415|NCT00531284|11506635|FG007|Overall Study|Other|0
7289416|NCT00531284|11506636|FG008|Overall Study|Other|2
7289417|NCT00531284|11506637|FG009|Overall Study|Other|1
7289418|NCT00531284|11506638|FG010|Overall Study|Other|0
7289419|NCT00531284|11506639|FG011|Overall Study|Other|2
7289420|NCT00531284|11506640|FG012|Overall Study|Other|0
7289421|NCT00531284|11506641|FG013|Overall Study|Other|0
7289422|NCT00531284|11506642|FG014|Overall Study|Other|1
7289423|NCT00531284|11506643|FG015|Overall Study|Other|0
7289424|NCT00531284|11506644|FG016|Overall Study|Other|0
7289425|NCT00531427|11506702|FG000|Overall Study|Withdrawal by Subject|7
7289426|NCT00531427|11506703|FG001|Overall Study|Withdrawal by Subject|13
7289427|NCT00531427|11506702|FG000|Overall Study|Adverse Event|44
7289428|NCT00531427|11506703|FG001|Overall Study|Adverse Event|30
7289429|NCT00531427|11506702|FG000|Overall Study|Lost to Follow-up|4
7289430|NCT00531427|11506703|FG001|Overall Study|Lost to Follow-up|3
7289431|NCT00531427|11506702|FG000|Overall Study|Lack of Efficacy|14
7289432|NCT00531427|11506703|FG001|Overall Study|Lack of Efficacy|39
7289433|NCT00531427|11506702|FG000|Overall Study|Administrative|4
7289434|NCT00531427|11506703|FG001|Overall Study|Administrative|9
7289435|NCT00531479|11506721|FG000|Overall Study|Death|68
7289436|NCT00531479|11506722|FG001|Overall Study|Death|71
7289437|NCT00531479|11506721|FG000|Overall Study|Lost to Follow-up|0
7289438|NCT00531479|11506722|FG001|Overall Study|Lost to Follow-up|2
7289439|NCT00531479|11506721|FG000|Overall Study|Other|0
7289440|NCT00531479|11506722|FG001|Overall Study|Other|1
7289441|NCT00531479|11506721|FG000|Overall Study|Withdrawal by Subject|6
7289442|NCT00531479|11506722|FG001|Overall Study|Withdrawal by Subject|6
7289443|NCT00531479|11506721|FG000|Overall Study|Did not receive treatment|2
7289444|NCT00531479|11506722|FG001|Overall Study|Did not receive treatment|3
7289445|NCT00531752|11506753|FG000|First Double-blind Intervention Period|Adverse Event|2
7289446|NCT00531752|11506754|FG001|First Double-blind Intervention Period|Adverse Event|0
7289447|NCT00531752|11506755|FG002|First Double-blind Intervention Period|Adverse Event|1
7289448|NCT00531752|11506756|FG003|First Double-blind Intervention Period|Adverse Event|1
7289449|NCT00531752|11506753|FG000|First Double-blind Intervention Period|Other|1
7289450|NCT00531752|11506754|FG001|First Double-blind Intervention Period|Other|4
7289451|NCT00531752|11506755|FG002|First Double-blind Intervention Period|Other|4
7289452|NCT00531752|11506756|FG003|First Double-blind Intervention Period|Other|0
7289453|NCT00531752|11506753|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
7289454|NCT00531752|11506754|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
7289455|NCT00531752|11506755|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
7289456|NCT00531752|11506756|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
7289457|NCT00531752|11506753|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
7289458|NCT00531752|11506754|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
7289459|NCT00531752|11506755|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
7289460|NCT00531752|11506756|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
7289461|NCT00531752|11506753|FG000|First Double-blind Intervention Period|Randomized but not treated|1
7289462|NCT00531752|11506754|FG001|First Double-blind Intervention Period|Randomized but not treated|0
7289463|NCT00531752|11506755|FG002|First Double-blind Intervention Period|Randomized but not treated|0
7289464|NCT00531752|11506756|FG003|First Double-blind Intervention Period|Randomized but not treated|0
7289465|NCT00531752|11506753|FG000|Second Double-blind Intervention Period|Adverse Event|1
7623403|NCT03529773|12034564|FG017|Overall Study|Adverse Event|0
7623404|NCT03529773|12034565|FG018|Overall Study|Adverse Event|0
7623405|NCT03529773|12034566|FG019|Overall Study|Adverse Event|0
7623406|NCT03529773|12034567|FG020|Overall Study|Adverse Event|0
7623407|NCT03529773|12034568|FG021|Overall Study|Adverse Event|0
7623408|NCT03529773|12034569|FG022|Overall Study|Adverse Event|0
7623409|NCT03529773|12034570|FG023|Overall Study|Adverse Event|0
7623410|NCT03529773|12034571|FG024|Overall Study|Adverse Event|0
7623411|NCT03529773|12034572|FG025|Overall Study|Adverse Event|0
7623412|NCT03529773|12034573|FG026|Overall Study|Adverse Event|0
7623413|NCT03529773|12034574|FG027|Overall Study|Adverse Event|0
7623414|NCT03529773|12034575|FG028|Overall Study|Adverse Event|0
7623415|NCT03529773|12034576|FG029|Overall Study|Adverse Event|0
7623416|NCT03529773|12034577|FG030|Overall Study|Adverse Event|1
7623417|NCT03529773|12034578|FG031|Overall Study|Adverse Event|0
7623418|NCT03529773|12034579|FG032|Overall Study|Adverse Event|0
7623419|NCT03529773|12034580|FG033|Overall Study|Adverse Event|0
7623420|NCT03529773|12034581|FG034|Overall Study|Adverse Event|0
7623421|NCT03529773|12034582|FG035|Overall Study|Adverse Event|1
7623422|NCT03529773|12034583|FG036|Overall Study|Adverse Event|0
7623423|NCT03529773|12034584|FG037|Overall Study|Adverse Event|0
7623424|NCT03529773|12034585|FG038|Overall Study|Adverse Event|1
7623425|NCT03529773|12034586|FG039|Overall Study|Adverse Event|1
7623426|NCT03529773|12034547|FG000|Overall Study|Death|0
7623427|NCT03529773|12034548|FG001|Overall Study|Death|0
7623428|NCT03529773|12034549|FG002|Overall Study|Death|0
7623429|NCT03529773|12034550|FG003|Overall Study|Death|0
7623430|NCT03529773|12034551|FG004|Overall Study|Death|0
7623431|NCT03529773|12034552|FG005|Overall Study|Death|0
7623432|NCT03529773|12034553|FG006|Overall Study|Death|0
7623433|NCT03529773|12034554|FG007|Overall Study|Death|0
7623434|NCT03529773|12034555|FG008|Overall Study|Death|0
7623435|NCT03529773|12034556|FG009|Overall Study|Death|0
7623436|NCT03529773|12034557|FG010|Overall Study|Death|0
7623437|NCT03529773|12034558|FG011|Overall Study|Death|0
7623438|NCT03529773|12034559|FG012|Overall Study|Death|1
7623439|NCT03529773|12034560|FG013|Overall Study|Death|0
7623440|NCT03529773|12034561|FG014|Overall Study|Death|0
7623441|NCT03529773|12034562|FG015|Overall Study|Death|0
7623442|NCT03529773|12034563|FG016|Overall Study|Death|0
7623443|NCT03529773|12034564|FG017|Overall Study|Death|0
7623444|NCT03529773|12034565|FG018|Overall Study|Death|0
7623445|NCT03529773|12034566|FG019|Overall Study|Death|1
7623446|NCT03529773|12034567|FG020|Overall Study|Death|0
7623447|NCT03529773|12034568|FG021|Overall Study|Death|0
7623448|NCT03529773|12034569|FG022|Overall Study|Death|1
7623449|NCT03529773|12034570|FG023|Overall Study|Death|0
7623450|NCT03529773|12034571|FG024|Overall Study|Death|0
7623451|NCT03529773|12034572|FG025|Overall Study|Death|0
7623452|NCT03529773|12034573|FG026|Overall Study|Death|0
7623453|NCT03529773|12034574|FG027|Overall Study|Death|0
7623454|NCT03529773|12034575|FG028|Overall Study|Death|0
7623455|NCT03529773|12034576|FG029|Overall Study|Death|0
7623456|NCT03529773|12034577|FG030|Overall Study|Death|0
7623457|NCT03529773|12034578|FG031|Overall Study|Death|0
7623458|NCT03529773|12034579|FG032|Overall Study|Death|0
7623459|NCT03529773|12034580|FG033|Overall Study|Death|1
7623460|NCT03529773|12034581|FG034|Overall Study|Death|1
7623461|NCT03529773|12034582|FG035|Overall Study|Death|0
7623462|NCT03529773|12034583|FG036|Overall Study|Death|1
7623463|NCT03529773|12034584|FG037|Overall Study|Death|0
7623464|NCT03529773|12034585|FG038|Overall Study|Death|0
7623465|NCT03529773|12034586|FG039|Overall Study|Death|0
7623466|NCT03529773|12034547|FG000|Overall Study|Lost to Follow-up|0
7623467|NCT03529773|12034548|FG001|Overall Study|Lost to Follow-up|0
7623468|NCT03529773|12034549|FG002|Overall Study|Lost to Follow-up|1
7623469|NCT03529773|12034550|FG003|Overall Study|Lost to Follow-up|0
7623470|NCT03529773|12034551|FG004|Overall Study|Lost to Follow-up|1
7623471|NCT03529773|12034552|FG005|Overall Study|Lost to Follow-up|1
7623472|NCT03529773|12034553|FG006|Overall Study|Lost to Follow-up|0
7623473|NCT03529773|12034554|FG007|Overall Study|Lost to Follow-up|0
7623474|NCT03529773|12034555|FG008|Overall Study|Lost to Follow-up|0
7623475|NCT03529773|12034556|FG009|Overall Study|Lost to Follow-up|0
7623476|NCT03529773|12034557|FG010|Overall Study|Lost to Follow-up|0
7623477|NCT03529773|12034558|FG011|Overall Study|Lost to Follow-up|0
7289466|NCT00531752|11506754|FG001|Second Double-blind Intervention Period|Adverse Event|1
7289467|NCT00531752|11506755|FG002|Second Double-blind Intervention Period|Adverse Event|0
7289468|NCT00531752|11506756|FG003|Second Double-blind Intervention Period|Adverse Event|0
7289469|NCT00531752|11506753|FG000|Second Double-blind Intervention Period|Other|1
7289470|NCT00531752|11506754|FG001|Second Double-blind Intervention Period|Other|1
7289471|NCT00531752|11506755|FG002|Second Double-blind Intervention Period|Other|0
7289472|NCT00531752|11506756|FG003|Second Double-blind Intervention Period|Other|0
7289473|NCT00531752|11506753|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
7289474|NCT00531752|11506754|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
7289475|NCT00531752|11506755|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
7289476|NCT00531752|11506756|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
7289477|NCT00531752|11506753|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
7289478|NCT00531752|11506754|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
7289479|NCT00531752|11506755|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
7289480|NCT00531752|11506756|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
7289481|NCT00531934|11506798|FG000|Overall Study|Adverse Event|4
7289482|NCT00531934|11506799|FG001|Overall Study|Adverse Event|8
7289483|NCT00531934|11506798|FG000|Overall Study|Progression|52
7289484|NCT00531934|11506799|FG001|Overall Study|Progression|42
7289485|NCT00531934|11506798|FG000|Overall Study|Death|7
7289486|NCT00531934|11506799|FG001|Overall Study|Death|10
7289487|NCT00531934|11506798|FG000|Overall Study|Withdrawal by Subject|1
7289488|NCT00531934|11506799|FG001|Overall Study|Withdrawal by Subject|1
7289489|NCT00531934|11506798|FG000|Overall Study|Other|2
7289490|NCT00531934|11506799|FG001|Overall Study|Other|2
7289491|NCT00531947|11506807|FG000|Overall Study|Adverse Event|5
7289492|NCT00531947|11506808|FG001|Overall Study|Adverse Event|10
7289493|NCT00531947|11506807|FG000|Overall Study|Lost to Follow-up|12
7289494|NCT00531947|11506808|FG001|Overall Study|Lost to Follow-up|9
7289495|NCT00531947|11506807|FG000|Overall Study|Withdrawal by Subject|14
7289496|NCT00531947|11506808|FG001|Overall Study|Withdrawal by Subject|19
7289497|NCT00531947|11506807|FG000|Overall Study|Protocol Violation|2
7289498|NCT00531947|11506808|FG001|Overall Study|Protocol Violation|1
7289499|NCT00531947|11506807|FG000|Overall Study|Non-Compliance|4
7289500|NCT00531947|11506808|FG001|Overall Study|Non-Compliance|7
7289501|NCT00531947|11506807|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
7289502|NCT00531947|11506808|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
7289503|NCT00531960|11506816|FG000|Overall Study|Adverse Event|5
7289504|NCT00531960|11506817|FG001|Overall Study|Adverse Event|4
7289505|NCT00531960|11506816|FG000|Overall Study|Death|3
7289506|NCT00531960|11506817|FG001|Overall Study|Death|2
7289507|NCT00531960|11506816|FG000|Overall Study|Lack of Efficacy|42
7289508|NCT00531960|11506817|FG001|Overall Study|Lack of Efficacy|41
7289509|NCT00531960|11506816|FG000|Overall Study|Violation of Selection Criteria|2
7289510|NCT00531960|11506817|FG001|Overall Study|Violation of Selection Criteria|0
7289511|NCT00531960|11506816|FG000|Overall Study|Refused Treatment|5
7289512|NCT00531960|11506817|FG001|Overall Study|Refused Treatment|6
7289513|NCT00531960|11506816|FG000|Overall Study|Other|4
7289514|NCT00531960|11506817|FG001|Overall Study|Other|10
7289515|NCT00532129|11506823|FG000|Treatment Period|Adverse event/Serious adverse event|25
7289516|NCT00532129|11506823|FG000|Treatment Period|Physician Decision|15
7289517|NCT00532129|11506823|FG000|Treatment Period|Disease progression|3
7289518|NCT00532129|11506823|FG000|Treatment Period|Protocol Violation|1
7289519|NCT00532129|11506823|FG000|Treatment Period|Other|5
7289520|NCT00532129|11506823|FG000|Follow-up Period|Adverse event/Serious adverse event|1
7289521|NCT00532129|11506823|FG000|Follow-up Period|Disease progression|57
7289522|NCT00532129|11506823|FG000|Follow-up Period|Lost to Follow-up|1
7289523|NCT00532129|11506823|FG000|Follow-up Period|Other|6
7289524|NCT00532155|11506829|FG000|Overall Study|Adverse Event|66
7289525|NCT00532155|11506830|FG001|Overall Study|Adverse Event|123
7289526|NCT00532155|11506829|FG000|Overall Study|Lack of Efficacy|332
7289527|NCT00532155|11506830|FG001|Overall Study|Lack of Efficacy|255
7289528|NCT00532155|11506829|FG000|Overall Study|Protocol Violation|1
7289529|NCT00532155|11506830|FG001|Overall Study|Protocol Violation|3
7289530|NCT00532155|11506829|FG000|Overall Study|Lost to Follow-up|2
7289531|NCT00532155|11506830|FG001|Overall Study|Lost to Follow-up|0
7289532|NCT00532155|11506829|FG000|Overall Study|Physician Decision|16
7289533|NCT00532155|11506830|FG001|Overall Study|Physician Decision|15
7289534|NCT00532155|11506829|FG000|Overall Study|Withdrawal by Subject|23
7289535|NCT00532155|11506830|FG001|Overall Study|Withdrawal by Subject|44
7289536|NCT00532155|11506829|FG000|Overall Study|Consent withdrawn|5
7289537|NCT00532155|11506830|FG001|Overall Study|Consent withdrawn|7
7289538|NCT00532155|11506829|FG000|Overall Study|Moved|1
7289539|NCT00532155|11506830|FG001|Overall Study|Moved|0
7289540|NCT00532155|11506829|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
7289541|NCT00532155|11506830|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
7289542|NCT00532155|11506829|FG000|Overall Study|Occurence of a second cancer|0
7289543|NCT00532155|11506830|FG001|Overall Study|Occurence of a second cancer|1
7289544|NCT00532155|11506829|FG000|Overall Study|Occurence of a secondary cancer|0
7289545|NCT00532155|11506830|FG001|Overall Study|Occurence of a secondary cancer|1
7289546|NCT00532155|11506829|FG000|Overall Study|Promotor ended study|1
7289547|NCT00532155|11506830|FG001|Overall Study|Promotor ended study|0
7289548|NCT00532155|11506829|FG000|Overall Study|Progressive disease (by incorrect scan)|0
7289549|NCT00532155|11506830|FG001|Overall Study|Progressive disease (by incorrect scan)|1
7289550|NCT00532155|11506829|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
7289551|NCT00532155|11506830|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
7289552|NCT00532155|11506829|FG000|Overall Study|Study stopped|1
7289553|NCT00532155|11506830|FG001|Overall Study|Study stopped|0
7289554|NCT00532155|11506829|FG000|Overall Study|Study terminated by sponsor|1
7289555|NCT00532155|11506830|FG001|Overall Study|Study terminated by sponsor|0
7289556|NCT00532155|11506829|FG000|Overall Study|Study termination stop further treatment|4
7289557|NCT00532155|11506830|FG001|Overall Study|Study termination stop further treatment|0
7289558|NCT00532155|11506829|FG000|Overall Study|Did not receive study medication|2
7289559|NCT00532155|11506830|FG001|Overall Study|Did not receive study medication|6
7289560|NCT00532259|11506836|FG000|Overall Study|Withdrawal by Subject|2
7289561|NCT00532259|11506836|FG000|Overall Study|Adverse Event|1
7289562|NCT00532259|11506836|FG000|Overall Study|Death|1
7289563|NCT00532259|11506836|FG000|Overall Study|Lack of Efficacy|21
7289564|NCT00532259|11506836|FG000|Overall Study|Lost to Follow-up|3
7289565|NCT00532259|11506836|FG000|Overall Study|Physician Decision|3
7289566|NCT00532259|11506836|FG000|Overall Study|Protocol Violation|1
7289567|NCT00532298|11506847|FG000|Overall Study|Adverse Event|1
7289568|NCT00532298|11506848|FG001|Overall Study|Adverse Event|0
7289569|NCT00532298|11506849|FG002|Overall Study|Adverse Event|0
7289570|NCT00532298|11506850|FG003|Overall Study|Adverse Event|0
7289571|NCT00532298|11506851|FG004|Overall Study|Adverse Event|1
7289572|NCT00532298|11506852|FG005|Overall Study|Adverse Event|1
7289573|NCT00532298|11506847|FG000|Overall Study|Lost to Follow-up|1
7289574|NCT00532298|11506848|FG001|Overall Study|Lost to Follow-up|1
7289575|NCT00532298|11506849|FG002|Overall Study|Lost to Follow-up|1
7289576|NCT00532298|11506850|FG003|Overall Study|Lost to Follow-up|0
7289577|NCT00532298|11506851|FG004|Overall Study|Lost to Follow-up|0
7289578|NCT00532298|11506852|FG005|Overall Study|Lost to Follow-up|1
7289579|NCT00532441|11506866|FG000|Overall Study|Death|1
7289580|NCT00532441|11506867|FG001|Overall Study|Death|0
7289581|NCT00532493|11506882|FG000|Overall Study|Death|1
7289582|NCT00532493|11506883|FG001|Overall Study|Death|1
7289583|NCT00532493|11506882|FG000|Overall Study|Lost to Follow-up|10
7289584|NCT00532493|11506883|FG001|Overall Study|Lost to Follow-up|7
7289585|NCT00532493|11506882|FG000|Overall Study|Withdrawal by Subject|7
7289586|NCT00532493|11506883|FG001|Overall Study|Withdrawal by Subject|9
7289587|NCT00532493|11506882|FG000|Overall Study|Physician Decision|1
7289588|NCT00532493|11506883|FG001|Overall Study|Physician Decision|6
7289589|NCT00532493|11506882|FG000|Overall Study|Adverse Event|6
7289590|NCT00532493|11506883|FG001|Overall Study|Adverse Event|5
7289591|NCT00532493|11506882|FG000|Overall Study|Protocol Deviation|1
7289592|NCT00532493|11506883|FG001|Overall Study|Protocol Deviation|0
7289593|NCT00532493|11506882|FG000|Overall Study|Subject Moved Away|3
7289594|NCT00532493|11506883|FG001|Overall Study|Subject Moved Away|1
7289595|NCT00532493|11506882|FG000|Overall Study|Contraindicative Medication|1
7289596|NCT00532493|11506883|FG001|Overall Study|Contraindicative Medication|0
7289597|NCT00532779|11506894|FG000|Overall Study|Adverse Event|122
7289598|NCT00532779|11506895|FG001|Overall Study|Adverse Event|112
7289599|NCT00532779|11506896|FG002|Overall Study|Adverse Event|56
7289600|NCT00532779|11506894|FG000|Overall Study|Lost to Follow-up|76
7289601|NCT00532779|11506895|FG001|Overall Study|Lost to Follow-up|65
7289602|NCT00532779|11506896|FG002|Overall Study|Lost to Follow-up|66
7289603|NCT00532779|11506894|FG000|Overall Study|Withdrawal by Subject|63
7289604|NCT00532779|11506895|FG001|Overall Study|Withdrawal by Subject|60
7289605|NCT00532779|11506896|FG002|Overall Study|Withdrawal by Subject|90
7289606|NCT00532779|11506894|FG000|Overall Study|Lack of Efficacy|12
7289607|NCT00532779|11506895|FG001|Overall Study|Lack of Efficacy|12
7289608|NCT00532779|11506896|FG002|Overall Study|Lack of Efficacy|40
7289609|NCT00532779|11506894|FG000|Overall Study|Protocol Violation|5
7289610|NCT00532779|11506895|FG001|Overall Study|Protocol Violation|9
7289611|NCT00532779|11506896|FG002|Overall Study|Protocol Violation|7
7289612|NCT00532779|11506894|FG000|Overall Study|Pregnancy|2
7289613|NCT00532779|11506895|FG001|Overall Study|Pregnancy|5
7289614|NCT00532779|11506896|FG002|Overall Study|Pregnancy|3
7289615|NCT00532779|11506894|FG000|Overall Study|Death|0
7289616|NCT00532779|11506895|FG001|Overall Study|Death|1
7289617|NCT00532779|11506896|FG002|Overall Study|Death|0
7289618|NCT00532779|11506894|FG000|Overall Study|Drug noncompliance, moved, other|14
7289619|NCT00532779|11506895|FG001|Overall Study|Drug noncompliance, moved, other|23
7289620|NCT00532779|11506896|FG002|Overall Study|Drug noncompliance, moved, other|29
7289621|NCT00532844|11506906|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
7289622|NCT00532844|11506907|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
7289623|NCT00532844|11506906|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
7289624|NCT00532844|11506907|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
7289625|NCT00532844|11506906|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
7289626|NCT00532844|11506907|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
7289627|NCT00532844|11506906|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
7289628|NCT00532844|11506907|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
7289629|NCT00532844|11506906|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
7289630|NCT00532844|11506907|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
7289631|NCT00532883|11506930|FG000|Overall Study|Adverse Event|1
7289632|NCT00532883|11506931|FG001|Overall Study|Adverse Event|0
7289633|NCT00532883|11506932|FG002|Overall Study|Adverse Event|0
7289634|NCT00532883|11506933|FG003|Overall Study|Adverse Event|1
7289635|NCT00532883|11506930|FG000|Overall Study|Lost to Follow-up|1
7289636|NCT00532883|11506931|FG001|Overall Study|Lost to Follow-up|1
7289637|NCT00532883|11506932|FG002|Overall Study|Lost to Follow-up|1
7289638|NCT00532883|11506933|FG003|Overall Study|Lost to Follow-up|0
7289639|NCT00532883|11506930|FG000|Overall Study|Withdrawal by Subject|0
7289640|NCT00532883|11506931|FG001|Overall Study|Withdrawal by Subject|1
7289641|NCT00532883|11506932|FG002|Overall Study|Withdrawal by Subject|1
7289642|NCT00532883|11506933|FG003|Overall Study|Withdrawal by Subject|0
7289643|NCT00532883|11506930|FG000|Overall Study|Subject was Nonadherent|0
7289644|NCT00532883|11506931|FG001|Overall Study|Subject was Nonadherent|1
7289645|NCT00532883|11506932|FG002|Overall Study|Subject was Nonadherent|1
7289646|NCT00532883|11506933|FG003|Overall Study|Subject was Nonadherent|0
7289647|NCT00532883|11506930|FG000|Overall Study|Early Study Termination|4
7289648|NCT00532883|11506931|FG001|Overall Study|Early Study Termination|4
7289649|NCT00532883|11506932|FG002|Overall Study|Early Study Termination|1
7289650|NCT00532883|11506933|FG003|Overall Study|Early Study Termination|4
7289651|NCT00532935|11506945|FG000|Overall Study|Adverse Event|11
7289652|NCT00532935|11506946|FG001|Overall Study|Adverse Event|12
7289653|NCT00532935|11506945|FG000|Overall Study|Lack of Efficacy|0
7289654|NCT00532935|11506946|FG001|Overall Study|Lack of Efficacy|3
7289655|NCT00532935|11506945|FG000|Overall Study|Lost to Follow-up|10
7289656|NCT00532935|11506946|FG001|Overall Study|Lost to Follow-up|6
7289657|NCT00532935|11506945|FG000|Overall Study|Physician Decision|4
7289658|NCT00532935|11506946|FG001|Overall Study|Physician Decision|5
7289659|NCT00532935|11506945|FG000|Overall Study|Pregnancy|1
7289660|NCT00532935|11506946|FG001|Overall Study|Pregnancy|0
7289661|NCT00532935|11506945|FG000|Overall Study|Protocol Violation|4
7289662|NCT00532935|11506946|FG001|Overall Study|Protocol Violation|2
7289663|NCT00532935|11506945|FG000|Overall Study|Withdrawal by Subject|10
7289664|NCT00532935|11506946|FG001|Overall Study|Withdrawal by Subject|9
7289665|NCT00532935|11506945|FG000|Overall Study|Protocol Specific Criteria|11
7289666|NCT00532935|11506946|FG001|Overall Study|Protocol Specific Criteria|15
7289667|NCT00532948|11506955|FG000|Overall Study|Protocol Violation|1
7289668|NCT00532948|11506956|FG001|Overall Study|Protocol Violation|0
7289669|NCT00532948|11506957|FG002|Overall Study|Protocol Violation|0
7289670|NCT00532948|11506955|FG000|Overall Study|Death|3
7289671|NCT00532948|11506956|FG001|Overall Study|Death|3
7289672|NCT00532948|11506957|FG002|Overall Study|Death|4
7289673|NCT00532948|11506955|FG000|Overall Study|Violation of selection criteria at entry|0
7289674|NCT00532948|11506956|FG001|Overall Study|Violation of selection criteria at entry|1
7289675|NCT00532948|11506957|FG002|Overall Study|Violation of selection criteria at entry|0
7289676|NCT00532948|11506955|FG000|Overall Study|Failure to return|0
7289677|NCT00532948|11506956|FG001|Overall Study|Failure to return|1
7289678|NCT00532948|11506957|FG002|Overall Study|Failure to return|0
7289679|NCT00533273|11506988|FG000|Double-blind|Withdrew consent|0
7289680|NCT00533273|11506989|FG001|Double-blind|Withdrew consent|2
7289681|NCT00533273|11506988|FG000|Open-label|Withdrawal by Subject|6
7289682|NCT00533273|11506989|FG001|Open-label|Withdrawal by Subject|0
7289683|NCT00533429|11506997|FG000|Overall Study|Adverse Event|3
7289684|NCT00533429|11506998|FG001|Overall Study|Adverse Event|1
7289685|NCT00533429|11506997|FG000|Overall Study|Death|1
7289686|NCT00533429|11506998|FG001|Overall Study|Death|0
7289687|NCT00533429|11506997|FG000|Overall Study|Withdrawal by Subject|2
7289688|NCT00533429|11506998|FG001|Overall Study|Withdrawal by Subject|0
7289689|NCT00533429|11506997|FG000|Overall Study|Progressive Disease|12
7289690|NCT00533429|11506998|FG001|Overall Study|Progressive Disease|13
7289691|NCT00533429|11506997|FG000|Overall Study|Symptomatic deterioration|1
7289692|NCT00533429|11506998|FG001|Overall Study|Symptomatic deterioration|2
7289693|NCT00533507|11507017|FG000|Overall Study|Withdrawal by Subject|1
7289694|NCT00533702|11507028|FG000|Overall Study|Withdrawal by Subject|3
7289695|NCT00533702|11507029|FG001|Overall Study|Withdrawal by Subject|1
7289696|NCT00533702|11507028|FG000|Overall Study|Found ineligible after randomization|2
7289697|NCT00533702|11507029|FG001|Overall Study|Found ineligible after randomization|1
7551308|NCT02969018|11910573|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
7551309|NCT02969018|11910566|FG000|Overall Study|Non-Compliance With Study Drug|1
7551310|NCT02969018|11910567|FG001|Overall Study|Non-Compliance With Study Drug|0
7551311|NCT02969018|11910568|FG002|Overall Study|Non-Compliance With Study Drug|0
7551312|NCT02969018|11910569|FG003|Overall Study|Non-Compliance With Study Drug|0
7551313|NCT02969018|11910570|FG004|Overall Study|Non-Compliance With Study Drug|0
7551314|NCT02969018|11910571|FG005|Overall Study|Non-Compliance With Study Drug|0
7551315|NCT02969018|11910572|FG006|Overall Study|Non-Compliance With Study Drug|0
7551316|NCT02969018|11910573|FG007|Overall Study|Non-Compliance With Study Drug|0
7551317|NCT02969018|11910566|FG000|Overall Study|Other|0
7551318|NCT02969018|11910567|FG001|Overall Study|Other|0
7551319|NCT02969018|11910568|FG002|Overall Study|Other|0
7551320|NCT02969018|11910569|FG003|Overall Study|Other|1
7551321|NCT02969018|11910570|FG004|Overall Study|Other|0
7551322|NCT02969018|11910571|FG005|Overall Study|Other|0
7551323|NCT02969018|11910572|FG006|Overall Study|Other|0
7551324|NCT02969018|11910573|FG007|Overall Study|Other|2
7551325|NCT02969018|11910566|FG000|Overall Study|Pregnancy|0
7551326|NCT02969018|11910567|FG001|Overall Study|Pregnancy|0
7289698|NCT00533845|11507037|FG000|Overall Study|Physician Decision|1
7289699|NCT00533845|11507038|FG001|Overall Study|Physician Decision|0
7289700|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Adverse Event|1
7289701|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Adverse Event|0
7289702|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Adverse Event|0
7289703|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Adverse Event|0
7289704|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Adverse Event|0
7289705|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Adverse Event|0
7289706|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Adverse Event|0
7289707|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Adverse Event|0
7289708|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
7289709|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289710|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289711|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289712|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289713|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289714|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289715|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
7289716|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
7289717|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
7289718|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
7289719|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
7289720|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
7289721|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
7289722|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
7289723|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
7289724|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
7289725|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289726|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289727|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289728|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289729|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289730|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289731|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
7289732|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
7289733|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
7289734|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
7289735|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
7289736|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
7289737|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
7289738|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
7289739|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
7289740|NCT00533897|11507047|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
7289741|NCT00533897|11507048|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289742|NCT00533897|11507049|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289743|NCT00533897|11507050|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289744|NCT00533897|11507051|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289745|NCT00533897|11507052|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289746|NCT00533897|11507053|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289747|NCT00533897|11507054|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
7289748|NCT00533897|11507047|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289749|NCT00533897|11507048|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
7289750|NCT00533897|11507049|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
7289751|NCT00533897|11507050|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289752|NCT00533897|11507051|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289753|NCT00533897|11507052|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289754|NCT00533897|11507053|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289755|NCT00533897|11507054|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
7289756|NCT00533897|11507047|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289757|NCT00533897|11507048|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289758|NCT00533897|11507049|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
7289759|NCT00533897|11507050|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289760|NCT00533897|11507051|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289761|NCT00533897|11507052|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289762|NCT00533897|11507053|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289763|NCT00533897|11507054|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
7289764|NCT00533897|11507047|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289765|NCT00533897|11507048|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289766|NCT00533897|11507049|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289767|NCT00533897|11507050|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289768|NCT00533897|11507051|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289769|NCT00533897|11507052|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
7289770|NCT00533897|11507053|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289771|NCT00533897|11507054|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
7289772|NCT00533897|11507047|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289773|NCT00533897|11507048|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289774|NCT00533897|11507049|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289775|NCT00533897|11507050|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289776|NCT00533897|11507051|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289777|NCT00533897|11507052|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
7289778|NCT00533897|11507053|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289779|NCT00533897|11507054|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
7289780|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289781|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289782|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289783|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289784|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289785|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
7289786|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
7289787|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
7289788|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Death|0
7289789|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Death|0
7289790|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Death|0
7289791|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Death|0
7289792|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Death|0
7289793|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Death|0
7289794|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Death|1
7289795|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Death|3
7289796|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
7289797|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
7289798|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
7289799|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
7289800|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
7289801|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
7289802|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
7289803|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
7289804|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
7289805|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
7289806|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
7289807|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
7289808|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
7289809|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
7289810|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
7289811|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
7289812|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Adverse Event|0
7289813|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Adverse Event|0
7289814|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Adverse Event|0
7289815|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Adverse Event|0
7289816|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Adverse Event|0
7289817|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Adverse Event|0
7289818|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Adverse Event|2
7289819|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Adverse Event|5
7289820|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Pregnancy|0
7289821|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Pregnancy|0
7289822|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Pregnancy|0
7289823|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Pregnancy|0
7289824|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Pregnancy|0
7289825|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Pregnancy|0
7289826|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Pregnancy|0
7289827|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Pregnancy|2
7289828|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
7289829|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
7289830|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
7289831|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
7289832|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
7289833|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
7289834|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
7289835|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
7289836|NCT00533897|11507047|FG000|Long Term Extension (LTE)|Other|0
7289837|NCT00533897|11507048|FG001|Long Term Extension (LTE)|Other|0
7289838|NCT00533897|11507049|FG002|Long Term Extension (LTE)|Other|0
7289839|NCT00533897|11507050|FG003|Long Term Extension (LTE)|Other|0
7289840|NCT00533897|11507051|FG004|Long Term Extension (LTE)|Other|0
7289841|NCT00533897|11507052|FG005|Long Term Extension (LTE)|Other|0
7289842|NCT00533897|11507053|FG006|Long Term Extension (LTE)|Other|1
7289843|NCT00533897|11507054|FG007|Long Term Extension (LTE)|Other|6
7289844|NCT00534092|11507105|FG000|Overall Study|Lost to Follow-up|1
7289845|NCT00534092|11507106|FG001|Overall Study|Lost to Follow-up|0
7551327|NCT02969018|11910568|FG002|Overall Study|Pregnancy|0
7289846|NCT00534092|11507105|FG000|Overall Study|personal reasons/family concerns|1
7289847|NCT00534092|11507106|FG001|Overall Study|personal reasons/family concerns|0
7289848|NCT00534105|11507116|FG000|Overall Study|Lost to Follow-up|23
7289849|NCT00534105|11507117|FG001|Overall Study|Lost to Follow-up|39
7289850|NCT00534248|11507152|FG000|Overall Study|Adverse Event|19
7289851|NCT00534248|11507153|FG001|Overall Study|Adverse Event|29
7289852|NCT00534248|11507152|FG000|Overall Study|Lost to Follow-up|353
7289853|NCT00534248|11507153|FG001|Overall Study|Lost to Follow-up|375
7289854|NCT00534248|11507152|FG000|Overall Study|Other protocol specified criteria|13
7289855|NCT00534248|11507153|FG001|Overall Study|Other protocol specified criteria|3
7289856|NCT00534248|11507152|FG000|Overall Study|Physician Decision|10
7289857|NCT00534248|11507153|FG001|Overall Study|Physician Decision|7
7623478|NCT03529773|12034559|FG012|Overall Study|Lost to Follow-up|0
7623479|NCT03529773|12034560|FG013|Overall Study|Lost to Follow-up|1
7623480|NCT03529773|12034561|FG014|Overall Study|Lost to Follow-up|4
7623481|NCT03529773|12034562|FG015|Overall Study|Lost to Follow-up|1
7623482|NCT03529773|12034563|FG016|Overall Study|Lost to Follow-up|1
7623483|NCT03529773|12034564|FG017|Overall Study|Lost to Follow-up|0
7623484|NCT03529773|12034565|FG018|Overall Study|Lost to Follow-up|1
7623485|NCT03529773|12034566|FG019|Overall Study|Lost to Follow-up|1
7623486|NCT03529773|12034567|FG020|Overall Study|Lost to Follow-up|2
7623487|NCT03529773|12034568|FG021|Overall Study|Lost to Follow-up|4
7623488|NCT03529773|12034569|FG022|Overall Study|Lost to Follow-up|3
7623489|NCT03529773|12034570|FG023|Overall Study|Lost to Follow-up|4
7623490|NCT03529773|12034571|FG024|Overall Study|Lost to Follow-up|3
7623491|NCT03529773|12034572|FG025|Overall Study|Lost to Follow-up|5
7623492|NCT03529773|12034573|FG026|Overall Study|Lost to Follow-up|5
7623493|NCT03529773|12034574|FG027|Overall Study|Lost to Follow-up|0
7623494|NCT03529773|12034575|FG028|Overall Study|Lost to Follow-up|0
7623495|NCT03529773|12034576|FG029|Overall Study|Lost to Follow-up|0
7623496|NCT03529773|12034577|FG030|Overall Study|Lost to Follow-up|1
7623497|NCT03529773|12034578|FG031|Overall Study|Lost to Follow-up|0
7623498|NCT03529773|12034579|FG032|Overall Study|Lost to Follow-up|0
7623499|NCT03529773|12034580|FG033|Overall Study|Lost to Follow-up|1
7623500|NCT03529773|12034581|FG034|Overall Study|Lost to Follow-up|1
7623501|NCT03529773|12034582|FG035|Overall Study|Lost to Follow-up|0
7623502|NCT03529773|12034583|FG036|Overall Study|Lost to Follow-up|0
7623503|NCT03529773|12034584|FG037|Overall Study|Lost to Follow-up|3
7623504|NCT03529773|12034585|FG038|Overall Study|Lost to Follow-up|1
7623505|NCT03529773|12034586|FG039|Overall Study|Lost to Follow-up|1
7623506|NCT03529773|12034547|FG000|Overall Study|No longer meets eligibility criteria|0
7623507|NCT03529773|12034548|FG001|Overall Study|No longer meets eligibility criteria|0
7623508|NCT03529773|12034549|FG002|Overall Study|No longer meets eligibility criteria|0
7623509|NCT03529773|12034550|FG003|Overall Study|No longer meets eligibility criteria|0
7623510|NCT03529773|12034551|FG004|Overall Study|No longer meets eligibility criteria|0
7623511|NCT03529773|12034552|FG005|Overall Study|No longer meets eligibility criteria|0
7623512|NCT03529773|12034553|FG006|Overall Study|No longer meets eligibility criteria|0
7623513|NCT03529773|12034554|FG007|Overall Study|No longer meets eligibility criteria|0
7623514|NCT03529773|12034555|FG008|Overall Study|No longer meets eligibility criteria|0
7623515|NCT03529773|12034556|FG009|Overall Study|No longer meets eligibility criteria|0
7623516|NCT03529773|12034557|FG010|Overall Study|No longer meets eligibility criteria|0
7623517|NCT03529773|12034558|FG011|Overall Study|No longer meets eligibility criteria|0
7623518|NCT03529773|12034559|FG012|Overall Study|No longer meets eligibility criteria|0
7623519|NCT03529773|12034560|FG013|Overall Study|No longer meets eligibility criteria|0
7623520|NCT03529773|12034561|FG014|Overall Study|No longer meets eligibility criteria|0
7623521|NCT03529773|12034562|FG015|Overall Study|No longer meets eligibility criteria|0
7623522|NCT03529773|12034563|FG016|Overall Study|No longer meets eligibility criteria|0
7623523|NCT03529773|12034564|FG017|Overall Study|No longer meets eligibility criteria|0
7217792|NCT04402866|11425999|FG003|Overall Study|Miscellaneous|0
7217793|NCT04402866|11426000|FG004|Overall Study|Miscellaneous|0
7217794|NCT04402866|11426001|FG005|Overall Study|Miscellaneous|0
7217795|NCT04402866|11425996|FG000|Overall Study|Lost to Follow-up|0
7217796|NCT04402866|11425997|FG001|Overall Study|Lost to Follow-up|0
7217797|NCT04402866|11425998|FG002|Overall Study|Lost to Follow-up|0
7217798|NCT04402866|11425999|FG003|Overall Study|Lost to Follow-up|0
7217799|NCT04402866|11426000|FG004|Overall Study|Lost to Follow-up|0
7217800|NCT04402866|11426001|FG005|Overall Study|Lost to Follow-up|1
7217801|NCT04402866|11425996|FG000|Overall Study|Withdrawal by Subject|0
7217802|NCT04402866|11425997|FG001|Overall Study|Withdrawal by Subject|0
7217803|NCT04402866|11425998|FG002|Overall Study|Withdrawal by Subject|0
7217804|NCT04402866|11425999|FG003|Overall Study|Withdrawal by Subject|0
7217805|NCT04402866|11426000|FG004|Overall Study|Withdrawal by Subject|0
7217806|NCT04402866|11426001|FG005|Overall Study|Withdrawal by Subject|2
7217807|NCT04327388|11426014|FG000|Overall Study|Adverse Event|17
7217808|NCT04327388|11426015|FG001|Overall Study|Adverse Event|18
7217809|NCT04327388|11426016|FG002|Overall Study|Adverse Event|9
7217810|NCT04327388|11426014|FG000|Overall Study|Other|1
7217811|NCT04327388|11426015|FG001|Overall Study|Other|2
7217812|NCT04327388|11426016|FG002|Overall Study|Other|0
7217813|NCT04327388|11426014|FG000|Overall Study|Randomized and not treated|2
7217814|NCT04327388|11426015|FG001|Overall Study|Randomized and not treated|0
7217815|NCT04327388|11426016|FG002|Overall Study|Randomized and not treated|2
7289858|NCT00534248|11507152|FG000|Overall Study|Protocol Violation|3
7289859|NCT00534248|11507153|FG001|Overall Study|Protocol Violation|4
7289860|NCT00534248|11507152|FG000|Overall Study|Withdrawal by Subject|263
7289861|NCT00534248|11507153|FG001|Overall Study|Withdrawal by Subject|255
7289862|NCT00534313|11507163|FG000|Short-term Period|Adverse Event|1
7289863|NCT00534313|11507164|FG001|Short-term Period|Adverse Event|2
7289864|NCT00534313|11507165|FG002|Short-term Period|Adverse Event|1
7289865|NCT00534313|11507166|FG003|Short-term Period|Adverse Event|3
7289866|NCT00534313|11507163|FG000|Short-term Period|Lack of Efficacy|3
7289867|NCT00534313|11507164|FG001|Short-term Period|Lack of Efficacy|4
7289868|NCT00534313|11507165|FG002|Short-term Period|Lack of Efficacy|0
7289869|NCT00534313|11507166|FG003|Short-term Period|Lack of Efficacy|3
7289870|NCT00534313|11507163|FG000|Short-term Period|Participant not meeting study criteria|0
7289871|NCT00534313|11507164|FG001|Short-term Period|Participant not meeting study criteria|0
7289872|NCT00534313|11507165|FG002|Short-term Period|Participant not meeting study criteria|0
7289873|NCT00534313|11507166|FG003|Short-term Period|Participant not meeting study criteria|1
7289874|NCT00534313|11507163|FG000|Short-term Period|Participant withdrew consent|2
7289875|NCT00534313|11507164|FG001|Short-term Period|Participant withdrew consent|0
7289876|NCT00534313|11507165|FG002|Short-term Period|Participant withdrew consent|0
7289877|NCT00534313|11507166|FG003|Short-term Period|Participant withdrew consent|2
7289878|NCT00534313|11507163|FG000|Short-term Period|Pregnancy|0
7289879|NCT00534313|11507164|FG001|Short-term Period|Pregnancy|0
7289880|NCT00534313|11507165|FG002|Short-term Period|Pregnancy|1
7289881|NCT00534313|11507166|FG003|Short-term Period|Pregnancy|0
7289882|NCT00534313|11507163|FG000|Long-term Period|Adverse Event|2
7289883|NCT00534313|11507164|FG001|Long-term Period|Adverse Event|1
7289884|NCT00534313|11507165|FG002|Long-term Period|Adverse Event|0
7289885|NCT00534313|11507166|FG003|Long-term Period|Adverse Event|1
7289886|NCT00534313|11507163|FG000|Long-term Period|Lack of Efficacy|14
7289887|NCT00534313|11507164|FG001|Long-term Period|Lack of Efficacy|10
7289888|NCT00534313|11507165|FG002|Long-term Period|Lack of Efficacy|14
7289889|NCT00534313|11507166|FG003|Long-term Period|Lack of Efficacy|12
7289890|NCT00534313|11507163|FG000|Long-term Period|Lost to Follow-up|1
7289891|NCT00534313|11507164|FG001|Long-term Period|Lost to Follow-up|2
7289892|NCT00534313|11507165|FG002|Long-term Period|Lost to Follow-up|0
7289893|NCT00534313|11507166|FG003|Long-term Period|Lost to Follow-up|0
7289894|NCT00534313|11507163|FG000|Long-term Period|Withdrawal by Subject|2
7289895|NCT00534313|11507164|FG001|Long-term Period|Withdrawal by Subject|2
7289896|NCT00534313|11507165|FG002|Long-term Period|Withdrawal by Subject|0
7289897|NCT00534313|11507166|FG003|Long-term Period|Withdrawal by Subject|0
7289898|NCT00534313|11507163|FG000|Long-term Period|No longer meets study criteria|0
7289899|NCT00534313|11507164|FG001|Long-term Period|No longer meets study criteria|1
7289900|NCT00534313|11507165|FG002|Long-term Period|No longer meets study criteria|0
7289901|NCT00534313|11507166|FG003|Long-term Period|No longer meets study criteria|0
7289902|NCT00534313|11507163|FG000|Long-term Period|Poor compliance/noncompliance|0
7289903|NCT00534313|11507164|FG001|Long-term Period|Poor compliance/noncompliance|1
7289904|NCT00534313|11507165|FG002|Long-term Period|Poor compliance/noncompliance|1
7289905|NCT00534313|11507166|FG003|Long-term Period|Poor compliance/noncompliance|0
7289906|NCT00534313|11507163|FG000|Long-term Period|Administrative reason by sponsor|17
7289907|NCT00534313|11507164|FG001|Long-term Period|Administrative reason by sponsor|15
7289908|NCT00534313|11507165|FG002|Long-term Period|Administrative reason by sponsor|26
7289909|NCT00534313|11507166|FG003|Long-term Period|Administrative reason by sponsor|18
7289910|NCT00534313|11507163|FG000|Long-term Period|Other|1
7289911|NCT00534313|11507164|FG001|Long-term Period|Other|2
7289912|NCT00534313|11507165|FG002|Long-term Period|Other|2
7289913|NCT00534313|11507166|FG003|Long-term Period|Other|2
7289914|NCT00534352|11507211|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
7289915|NCT00534352|11507211|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
7289916|NCT00534352|11507211|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
7289917|NCT00534352|11507211|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
7289918|NCT00534352|11507211|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
7289919|NCT00534352|11507211|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
7289920|NCT00534404|11507238|FG000|Overall Study|Death|0
7289921|NCT00534404|11507239|FG001|Overall Study|Death|0
7289922|NCT00534404|11507240|FG002|Overall Study|Death|2
7289923|NCT00534404|11507238|FG000|Overall Study|Withdrawal by Subject|8
7289924|NCT00534404|11507239|FG001|Overall Study|Withdrawal by Subject|2
7289925|NCT00534404|11507240|FG002|Overall Study|Withdrawal by Subject|38
7289926|NCT00534404|11507238|FG000|Overall Study|Removed by study staff|2
7289927|NCT00534404|11507239|FG001|Overall Study|Removed by study staff|3
7289928|NCT00534404|11507240|FG002|Overall Study|Removed by study staff|1
7289929|NCT00534404|11507238|FG000|Overall Study|Lost to Follow-up|170
7289930|NCT00534404|11507239|FG001|Overall Study|Lost to Follow-up|138
7289931|NCT00534404|11507240|FG002|Overall Study|Lost to Follow-up|201
7289932|NCT00534495|11507254|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
7289933|NCT00534495|11507255|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
7289934|NCT00534495|11507256|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
7289935|NCT00534495|11507254|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
7289936|NCT00534495|11507255|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
7289937|NCT00534495|11507256|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
7289938|NCT00534495|11507254|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
7289939|NCT00534495|11507255|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
7289940|NCT00534495|11507256|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
7289941|NCT00534495|11507254|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7289942|NCT00534495|11507255|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
7289943|NCT00534495|11507256|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
7289944|NCT00534495|11507254|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7289945|NCT00534495|11507255|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
7289946|NCT00534495|11507256|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
7289947|NCT00534495|11507254|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7289948|NCT00534495|11507255|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
7289949|NCT00534495|11507256|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
7289950|NCT00534495|11507254|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7289951|NCT00534495|11507255|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
7289952|NCT00534495|11507256|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
7289953|NCT00534495|11507254|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7289954|NCT00534495|11507255|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
7289955|NCT00534495|11507256|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
7289956|NCT00534495|11507254|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
7289957|NCT00534495|11507255|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
7289958|NCT00534495|11507256|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
7289959|NCT00534599|11507269|FG000|Overall Study|Adverse Event|25
7289960|NCT00534599|11507270|FG001|Overall Study|Adverse Event|4
7289961|NCT00534599|11507269|FG000|Overall Study|Incorrect enrollment|2
7289962|NCT00534599|11507270|FG001|Overall Study|Incorrect enrollment|1
7289963|NCT00534599|11507269|FG000|Overall Study|Mis-randomization|2
7289964|NCT00534599|11507270|FG001|Overall Study|Mis-randomization|2
7289965|NCT00534599|11507269|FG000|Overall Study|Developed study-specific d/c criteria|5
7289966|NCT00534599|11507270|FG001|Overall Study|Developed study-specific d/c criteria|0
7289967|NCT00534599|11507269|FG000|Overall Study|Lack of Efficacy|0
7289968|NCT00534599|11507270|FG001|Overall Study|Lack of Efficacy|1
7289969|NCT00534599|11507269|FG000|Overall Study|Generalized anxiety disorder worsened|0
7289970|NCT00534599|11507270|FG001|Overall Study|Generalized anxiety disorder worsened|1
7289971|NCT00534599|11507269|FG000|Overall Study|Protocol Violation|1
7289972|NCT00534599|11507270|FG001|Overall Study|Protocol Violation|3
7289973|NCT00534599|11507269|FG000|Overall Study|Lost to Follow-up|11
7289974|NCT00534599|11507270|FG001|Overall Study|Lost to Follow-up|14
7289975|NCT00534599|11507269|FG000|Overall Study|Withdrawal by Subject|4
7289976|NCT00534599|11507270|FG001|Overall Study|Withdrawal by Subject|6
7289977|NCT00534599|11507269|FG000|Overall Study|Other|7
7289978|NCT00534599|11507270|FG001|Overall Study|Other|0
7289979|NCT00534638|11507278|FG000|Overall Study|Withdrawal by Subject|3
7289980|NCT00534638|11507279|FG001|Overall Study|Withdrawal by Subject|4
7289981|NCT00534638|11507278|FG000|Overall Study|Migrated/moved from study area|13
7289982|NCT00534638|11507279|FG001|Overall Study|Migrated/moved from study area|11
7289983|NCT00534638|11507278|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
7289984|NCT00534638|11507279|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
7289985|NCT00534638|11507278|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
7289986|NCT00534638|11507279|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
7289987|NCT00534638|11507278|FG000|Overall Study|Other|1685
7289988|NCT00534638|11507279|FG001|Overall Study|Other|902
7289989|NCT00535132|11507363|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
7289990|NCT00535132|11507364|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
7289991|NCT00535132|11507363|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7289992|NCT00535132|11507364|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
7289993|NCT00535145|11507372|FG000|Phase I|Adverse Event|3
7289994|NCT00535145|11507372|FG000|Phase I|Lost to Follow-up|7
7289995|NCT00535145|11507372|FG000|Phase I|Withdrawal by Subject|6
7289996|NCT00535145|11507372|FG000|Phase I|(eligibility)|8
7289997|NCT00535145|11507372|FG000|Phase I|(protocol violation)|1
7289998|NCT00535145|11507372|FG000|Phase I|(PI decision)|1
7289999|NCT00535145|11507372|FG000|Phase I|(diagnosis)|3
7290000|NCT00535145|11507372|FG000|Phase II|Adverse Event|2
7290001|NCT00535145|11507372|FG000|Phase II|Lack of Efficacy|1
7290002|NCT00535145|11507372|FG000|Phase II|Lost to Follow-up|5
7290003|NCT00535145|11507372|FG000|Phase II|Withdrawal by Subject|5
7290004|NCT00535145|11507372|FG000|Phase II|Subject non-compliance|2
7290005|NCT00535223|11507382|FG000|Overall Study|Withdrawal by Subject|4
7290006|NCT00535223|11507383|FG001|Overall Study|Withdrawal by Subject|1
7290007|NCT00535236|11507399|FG000|Overall Study|Adverse Event|1
7290008|NCT00535236|11507400|FG001|Overall Study|Adverse Event|0
7290009|NCT00535236|11507401|FG002|Overall Study|Adverse Event|9
7290010|NCT00535236|11507402|FG003|Overall Study|Adverse Event|3
7290011|NCT00535236|11507403|FG004|Overall Study|Adverse Event|3
7290012|NCT00535236|11507404|FG005|Overall Study|Adverse Event|0
7290013|NCT00535236|11507405|FG006|Overall Study|Adverse Event|5
7290014|NCT00535236|11507406|FG007|Overall Study|Adverse Event|1
7290015|NCT00535236|11507407|FG008|Overall Study|Adverse Event|2
7290016|NCT00535236|11507408|FG009|Overall Study|Adverse Event|1
7290017|NCT00535236|11507399|FG000|Overall Study|Lost to Follow-up|1
7623524|NCT03529773|12034565|FG018|Overall Study|No longer meets eligibility criteria|0
7623525|NCT03529773|12034566|FG019|Overall Study|No longer meets eligibility criteria|0
7623526|NCT03529773|12034567|FG020|Overall Study|No longer meets eligibility criteria|0
7623527|NCT03529773|12034568|FG021|Overall Study|No longer meets eligibility criteria|0
7623528|NCT03529773|12034569|FG022|Overall Study|No longer meets eligibility criteria|1
7623529|NCT03529773|12034570|FG023|Overall Study|No longer meets eligibility criteria|0
7623530|NCT03529773|12034571|FG024|Overall Study|No longer meets eligibility criteria|0
7623531|NCT03529773|12034572|FG025|Overall Study|No longer meets eligibility criteria|0
7623532|NCT03529773|12034573|FG026|Overall Study|No longer meets eligibility criteria|0
7623533|NCT03529773|12034574|FG027|Overall Study|No longer meets eligibility criteria|0
7623534|NCT03529773|12034575|FG028|Overall Study|No longer meets eligibility criteria|0
7623535|NCT03529773|12034576|FG029|Overall Study|No longer meets eligibility criteria|0
7623536|NCT03529773|12034577|FG030|Overall Study|No longer meets eligibility criteria|0
7623537|NCT03529773|12034578|FG031|Overall Study|No longer meets eligibility criteria|0
7623538|NCT03529773|12034579|FG032|Overall Study|No longer meets eligibility criteria|0
7623539|NCT03529773|12034580|FG033|Overall Study|No longer meets eligibility criteria|0
7217816|NCT03860259|11426026|FG000|Overall Study|Lost to Follow-up|5
7217817|NCT03860259|11426027|FG001|Overall Study|Lost to Follow-up|5
7217818|NCT03860259|11426026|FG000|Overall Study|Protocol Violation|1
7217819|NCT03860259|11426027|FG001|Overall Study|Protocol Violation|0
7217834|NCT03388138|11426061|FG000|Overall Study|Protocol Violation|1
7217835|NCT03388138|11426062|FG001|Overall Study|Protocol Violation|0
7217836|NCT02981082|11426128|FG000|Overall Study|Withdrawal by Subject|2
7217837|NCT02981082|11426129|FG001|Overall Study|Withdrawal by Subject|0
7217838|NCT02981082|11426128|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1
7217839|NCT02981082|11426129|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0
7217840|NCT02981082|11426128|FG000|Overall Study|Adverse Event|0
7217841|NCT02981082|11426129|FG001|Overall Study|Adverse Event|1
7217842|NCT02924129|11426137|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
7217843|NCT02924129|11426138|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
7217844|NCT02924129|11426137|FG000|Overall Study|Withdrawal by Subject|2
7217845|NCT02924129|11426138|FG001|Overall Study|Withdrawal by Subject|2
7217846|NCT02924129|11426137|FG000|Overall Study|Physician Decision|1
7217847|NCT02924129|11426138|FG001|Overall Study|Physician Decision|0
7217848|NCT02924129|11426137|FG000|Overall Study|Missed Visit|0
7217849|NCT02924129|11426138|FG001|Overall Study|Missed Visit|1
7217850|NCT02741700|11426146|FG000|Overall Study|Lost to Follow-up|17
7217851|NCT02741700|11426147|FG001|Overall Study|Lost to Follow-up|8
7217852|NCT02741700|11426146|FG000|Overall Study|Withdrawal by Subject|2
7217853|NCT02741700|11426147|FG001|Overall Study|Withdrawal by Subject|5
7217854|NCT02741700|11426146|FG000|Overall Study|Physician Decision|3
7217855|NCT02741700|11426147|FG001|Overall Study|Physician Decision|0
7217856|NCT02741700|11426146|FG000|Overall Study|Moved out of State|0
7217857|NCT02741700|11426147|FG001|Overall Study|Moved out of State|1
7217858|NCT02741700|11426146|FG000|Overall Study|Death|4
7217859|NCT02741700|11426147|FG001|Overall Study|Death|5
7217860|NCT02635776|11426155|FG000|Overall Study|Physician Decision|1
7217861|NCT02635776|11426156|FG001|Overall Study|Physician Decision|0
7217862|NCT02635776|11426155|FG000|Overall Study|Adverse Event|51
7217863|NCT02635776|11426156|FG001|Overall Study|Adverse Event|3
7217864|NCT02635776|11426155|FG000|Overall Study|Withdrawal by Subject|41
7217865|NCT02635776|11426156|FG001|Overall Study|Withdrawal by Subject|7
7217866|NCT02635776|11426155|FG000|Overall Study|Lost to Follow-up|4
7217867|NCT02635776|11426156|FG001|Overall Study|Lost to Follow-up|0
7217868|NCT02635776|11426155|FG000|Overall Study|Other reasons|5
7217869|NCT02635776|11426156|FG001|Overall Study|Other reasons|1
7217870|NCT02609724|11426167|FG000|Overall Study|Death|2
7217871|NCT02609724|11426168|FG001|Overall Study|Death|0
7217872|NCT02609724|11426169|FG002|Overall Study|Death|1
7217873|NCT02609724|11426167|FG000|Overall Study|Withdrawal by Subject|1
7217874|NCT02609724|11426168|FG001|Overall Study|Withdrawal by Subject|2
7217875|NCT02609724|11426169|FG002|Overall Study|Withdrawal by Subject|3
7217876|NCT02609724|11426167|FG000|Overall Study|Illness|2
7217877|NCT02609724|11426168|FG001|Overall Study|Illness|1
7217878|NCT02609724|11426169|FG002|Overall Study|Illness|0
7217879|NCT02359994|11426179|FG000|Overall Population Study|Adverse Event|1
7217880|NCT02359994|11426180|FG001|Overall Population Study|Adverse Event|1
7217881|NCT02359994|11426179|FG000|Overall Population Study|Death|1
7217882|NCT02359994|11426180|FG001|Overall Population Study|Death|5
7217883|NCT02359994|11426179|FG000|Overall Population Study|Lost to Follow-up|1
7217884|NCT02359994|11426180|FG001|Overall Population Study|Lost to Follow-up|1
7217885|NCT02359994|11426179|FG000|Overall Population Study|Withdrawal by Subject|1
7217886|NCT02359994|11426180|FG001|Overall Population Study|Withdrawal by Subject|0
7217887|NCT02359994|11426179|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1
7217888|NCT02359994|11426180|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0
7290018|NCT00535236|11507400|FG001|Overall Study|Lost to Follow-up|2
7290019|NCT00535236|11507401|FG002|Overall Study|Lost to Follow-up|0
7290020|NCT00535236|11507402|FG003|Overall Study|Lost to Follow-up|0
7290021|NCT00535236|11507403|FG004|Overall Study|Lost to Follow-up|2
7290022|NCT00535236|11507404|FG005|Overall Study|Lost to Follow-up|0
7290023|NCT00535236|11507405|FG006|Overall Study|Lost to Follow-up|0
7290024|NCT00535236|11507406|FG007|Overall Study|Lost to Follow-up|0
7290025|NCT00535236|11507407|FG008|Overall Study|Lost to Follow-up|6
7290026|NCT00535236|11507408|FG009|Overall Study|Lost to Follow-up|1
7290027|NCT00535236|11507399|FG000|Overall Study|Physician Decision|0
7290028|NCT00535236|11507400|FG001|Overall Study|Physician Decision|0
7290029|NCT00535236|11507401|FG002|Overall Study|Physician Decision|0
7290030|NCT00535236|11507402|FG003|Overall Study|Physician Decision|0
7290031|NCT00535236|11507403|FG004|Overall Study|Physician Decision|1
7290032|NCT00535236|11507404|FG005|Overall Study|Physician Decision|0
7290033|NCT00535236|11507405|FG006|Overall Study|Physician Decision|1
7290034|NCT00535236|11507406|FG007|Overall Study|Physician Decision|0
7290035|NCT00535236|11507407|FG008|Overall Study|Physician Decision|0
7290036|NCT00535236|11507408|FG009|Overall Study|Physician Decision|0
7290037|NCT00535236|11507399|FG000|Overall Study|Protocol Violation|2
7290038|NCT00535236|11507400|FG001|Overall Study|Protocol Violation|0
7290039|NCT00535236|11507401|FG002|Overall Study|Protocol Violation|1
7290040|NCT00535236|11507402|FG003|Overall Study|Protocol Violation|0
7290041|NCT00535236|11507403|FG004|Overall Study|Protocol Violation|0
7290042|NCT00535236|11507404|FG005|Overall Study|Protocol Violation|0
7623540|NCT03529773|12034581|FG034|Overall Study|No longer meets eligibility criteria|0
7623541|NCT03529773|12034582|FG035|Overall Study|No longer meets eligibility criteria|0
7623542|NCT03529773|12034583|FG036|Overall Study|No longer meets eligibility criteria|0
7623543|NCT03529773|12034584|FG037|Overall Study|No longer meets eligibility criteria|0
7623544|NCT03529773|12034585|FG038|Overall Study|No longer meets eligibility criteria|1
7623545|NCT03529773|12034586|FG039|Overall Study|No longer meets eligibility criteria|0
7623546|NCT03529773|12034547|FG000|Overall Study|Other|0
7623547|NCT03529773|12034548|FG001|Overall Study|Other|0
7623548|NCT03529773|12034549|FG002|Overall Study|Other|0
7623549|NCT03529773|12034550|FG003|Overall Study|Other|0
7623550|NCT03529773|12034551|FG004|Overall Study|Other|0
7623551|NCT03529773|12034552|FG005|Overall Study|Other|0
7623552|NCT03529773|12034553|FG006|Overall Study|Other|0
7623553|NCT03529773|12034554|FG007|Overall Study|Other|0
7623554|NCT03529773|12034555|FG008|Overall Study|Other|0
7623555|NCT03529773|12034556|FG009|Overall Study|Other|0
7623556|NCT03529773|12034557|FG010|Overall Study|Other|0
7623557|NCT03529773|12034558|FG011|Overall Study|Other|0
7623558|NCT03529773|12034559|FG012|Overall Study|Other|1
7623559|NCT03529773|12034560|FG013|Overall Study|Other|0
7623560|NCT03529773|12034561|FG014|Overall Study|Other|2
7623561|NCT03529773|12034562|FG015|Overall Study|Other|0
7623562|NCT03529773|12034563|FG016|Overall Study|Other|0
7623563|NCT03529773|12034564|FG017|Overall Study|Other|3
7623564|NCT03529773|12034565|FG018|Overall Study|Other|0
7623565|NCT03529773|12034566|FG019|Overall Study|Other|0
7623566|NCT03529773|12034567|FG020|Overall Study|Other|1
7623567|NCT03529773|12034568|FG021|Overall Study|Other|0
7623568|NCT03529773|12034569|FG022|Overall Study|Other|1
7623569|NCT03529773|12034570|FG023|Overall Study|Other|0
7623570|NCT03529773|12034571|FG024|Overall Study|Other|3
7623571|NCT03529773|12034572|FG025|Overall Study|Other|2
7623572|NCT03529773|12034573|FG026|Overall Study|Other|2
7623573|NCT03529773|12034574|FG027|Overall Study|Other|0
7623574|NCT03529773|12034575|FG028|Overall Study|Other|0
7623575|NCT03529773|12034576|FG029|Overall Study|Other|0
7623576|NCT03529773|12034577|FG030|Overall Study|Other|0
7623577|NCT03529773|12034578|FG031|Overall Study|Other|0
7623578|NCT03529773|12034579|FG032|Overall Study|Other|0
7623579|NCT03529773|12034580|FG033|Overall Study|Other|0
7623580|NCT03529773|12034581|FG034|Overall Study|Other|1
7623581|NCT03529773|12034582|FG035|Overall Study|Other|1
7623582|NCT03529773|12034583|FG036|Overall Study|Other|0
7623583|NCT03529773|12034584|FG037|Overall Study|Other|0
7623584|NCT03529773|12034585|FG038|Overall Study|Other|0
7623585|NCT03529773|12034586|FG039|Overall Study|Other|0
7623586|NCT03529773|12034547|FG000|Overall Study|Physician Decision|0
7623587|NCT03529773|12034548|FG001|Overall Study|Physician Decision|0
7623588|NCT03529773|12034549|FG002|Overall Study|Physician Decision|0
7623589|NCT03529773|12034550|FG003|Overall Study|Physician Decision|0
7623590|NCT03529773|12034551|FG004|Overall Study|Physician Decision|0
7623591|NCT03529773|12034552|FG005|Overall Study|Physician Decision|0
7623592|NCT03529773|12034553|FG006|Overall Study|Physician Decision|0
7623593|NCT03529773|12034554|FG007|Overall Study|Physician Decision|0
7290043|NCT00535236|11507405|FG006|Overall Study|Protocol Violation|0
7290044|NCT00535236|11507406|FG007|Overall Study|Protocol Violation|0
7290045|NCT00535236|11507407|FG008|Overall Study|Protocol Violation|1
7290046|NCT00535236|11507408|FG009|Overall Study|Protocol Violation|0
7623594|NCT03529773|12034555|FG008|Overall Study|Physician Decision|0
7623595|NCT03529773|12034556|FG009|Overall Study|Physician Decision|0
7623596|NCT03529773|12034557|FG010|Overall Study|Physician Decision|0
7623597|NCT03529773|12034558|FG011|Overall Study|Physician Decision|0
7623598|NCT03529773|12034559|FG012|Overall Study|Physician Decision|0
7623599|NCT03529773|12034560|FG013|Overall Study|Physician Decision|0
7623600|NCT03529773|12034561|FG014|Overall Study|Physician Decision|0
7290047|NCT00535236|11507399|FG000|Overall Study|Withdrawal by Subject|3
7290048|NCT00535236|11507400|FG001|Overall Study|Withdrawal by Subject|0
7290049|NCT00535236|11507401|FG002|Overall Study|Withdrawal by Subject|2
7290050|NCT00535236|11507402|FG003|Overall Study|Withdrawal by Subject|1
7290051|NCT00535236|11507403|FG004|Overall Study|Withdrawal by Subject|6
7290052|NCT00535236|11507404|FG005|Overall Study|Withdrawal by Subject|1
7290053|NCT00535236|11507405|FG006|Overall Study|Withdrawal by Subject|5
7290054|NCT00535236|11507406|FG007|Overall Study|Withdrawal by Subject|0
7290055|NCT00535236|11507407|FG008|Overall Study|Withdrawal by Subject|4
7290056|NCT00535236|11507408|FG009|Overall Study|Withdrawal by Subject|2
7290057|NCT00535288|11507438|FG000|Overall Study|Adverse Event|20
7290058|NCT00535288|11507439|FG001|Overall Study|Adverse Event|19
7290059|NCT00535288|11507440|FG002|Overall Study|Adverse Event|25
7290060|NCT00535288|11507441|FG003|Overall Study|Adverse Event|20
7290061|NCT00535288|11507442|FG004|Overall Study|Adverse Event|30
7290062|NCT00535288|11507438|FG000|Overall Study|Lost to Follow-up|0
7290063|NCT00535288|11507439|FG001|Overall Study|Lost to Follow-up|3
7290064|NCT00535288|11507440|FG002|Overall Study|Lost to Follow-up|0
7290065|NCT00535288|11507441|FG003|Overall Study|Lost to Follow-up|0
7290066|NCT00535288|11507442|FG004|Overall Study|Lost to Follow-up|0
7290067|NCT00535288|11507438|FG000|Overall Study|Lack of Efficacy|26
7290068|NCT00535288|11507439|FG001|Overall Study|Lack of Efficacy|3
7290069|NCT00535288|11507440|FG002|Overall Study|Lack of Efficacy|4
7290070|NCT00535288|11507441|FG003|Overall Study|Lack of Efficacy|4
7290071|NCT00535288|11507442|FG004|Overall Study|Lack of Efficacy|7
7290072|NCT00535288|11507438|FG000|Overall Study|Unwilling to cooperate|6
7290073|NCT00535288|11507439|FG001|Overall Study|Unwilling to cooperate|6
7290074|NCT00535288|11507440|FG002|Overall Study|Unwilling to cooperate|3
7290075|NCT00535288|11507441|FG003|Overall Study|Unwilling to cooperate|3
7290076|NCT00535288|11507442|FG004|Overall Study|Unwilling to cooperate|4
7290077|NCT00535288|11507438|FG000|Overall Study|Other|2
7290078|NCT00535288|11507439|FG001|Overall Study|Other|1
7290079|NCT00535288|11507440|FG002|Overall Study|Other|1
7290080|NCT00535288|11507441|FG003|Overall Study|Other|2
7290081|NCT00535288|11507442|FG004|Overall Study|Other|1
7290082|NCT00535496|11507476|FG000|Overall Study|Lost to Follow-up|0
7290083|NCT00535496|11507477|FG001|Overall Study|Lost to Follow-up|1
7290084|NCT00535496|11507478|FG002|Overall Study|Lost to Follow-up|0
7290085|NCT00535496|11507479|FG003|Overall Study|Lost to Follow-up|0
7290086|NCT00535496|11507476|FG000|Overall Study|Not treated with sugammadex|0
7290087|NCT00535496|11507477|FG001|Overall Study|Not treated with sugammadex|1
7290088|NCT00535496|11507478|FG002|Overall Study|Not treated with sugammadex|0
7290089|NCT00535496|11507479|FG003|Overall Study|Not treated with sugammadex|0
7290090|NCT00535626|11507510|FG000|Overall Study|Death|15
7290091|NCT00535626|11507510|FG000|Overall Study|Lost to Follow-up|29
7290092|NCT00535626|11507510|FG000|Overall Study|Withdrawal by Subject|20
7290093|NCT00535626|11507510|FG000|Overall Study|Removal/revision of study component|8
7290094|NCT00535626|11507510|FG000|Overall Study|Subject terminated|31
7290095|NCT00535626|11507510|FG000|Overall Study|Unable to return|2
7290096|NCT00535730|11507521|FG000|Overall Study|Adverse Event|1
7290097|NCT00535730|11507522|FG001|Overall Study|Adverse Event|1
7290098|NCT00535730|11507521|FG000|Overall Study|Lost to Follow-up|0
7290099|NCT00535730|11507522|FG001|Overall Study|Lost to Follow-up|1
7290100|NCT00535730|11507521|FG000|Overall Study|Physician Decision|0
7290101|NCT00535730|11507522|FG001|Overall Study|Physician Decision|1
7290102|NCT00535730|11507521|FG000|Overall Study|Protocol Violation|1
7290103|NCT00535730|11507522|FG001|Overall Study|Protocol Violation|0
7290104|NCT00535730|11507521|FG000|Overall Study|Withdrawal by Subject|0
7290105|NCT00535730|11507522|FG001|Overall Study|Withdrawal by Subject|4
7290106|NCT00535847|11507659|FG000|Overall Study|Adverse Event|5
7290107|NCT00535847|11507660|FG001|Overall Study|Adverse Event|3
7290108|NCT00535847|11507661|FG002|Overall Study|Adverse Event|2
7290109|NCT00535847|11507659|FG000|Overall Study|Non compliance|1
7290110|NCT00535847|11507660|FG001|Overall Study|Non compliance|1
7290111|NCT00535847|11507661|FG002|Overall Study|Non compliance|0
7290112|NCT00535847|11507659|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
7290113|NCT00535847|11507660|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
7290114|NCT00535847|11507661|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
7290115|NCT00536107|11507699|FG000|Overall Study|Death|5
7290116|NCT00536107|11507700|FG001|Overall Study|Death|1
7290117|NCT00536107|11507699|FG000|Overall Study|Incorrect enrolment|1
7290118|NCT00536107|11507700|FG001|Overall Study|Incorrect enrolment|0
7290119|NCT00536107|11507699|FG000|Overall Study|Withdrawal by Subject|0
7290120|NCT00536107|11507700|FG001|Overall Study|Withdrawal by Subject|1
7290121|NCT00536107|11507699|FG000|Overall Study|Study Termination|2
7290122|NCT00536107|11507700|FG001|Overall Study|Study Termination|4
7290123|NCT00536120|11507708|FG000|Overall Study|Lost to Follow-up|1
7290124|NCT00536120|11507709|FG001|Overall Study|Lost to Follow-up|0
7290125|NCT00536120|11507708|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
7290126|NCT00536120|11507709|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
7290127|NCT00536120|11507708|FG000|Overall Study|Non-compliance|1
7290128|NCT00536120|11507709|FG001|Overall Study|Non-compliance|0
7290129|NCT00536120|11507708|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
7290130|NCT00536120|11507709|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
7290131|NCT00536120|11507708|FG000|Overall Study|Steroid Use|0
7290132|NCT00536120|11507709|FG001|Overall Study|Steroid Use|2
7290133|NCT00536120|11507708|FG000|Overall Study|Missed Study Visit|0
7290134|NCT00536120|11507709|FG001|Overall Study|Missed Study Visit|1
7290135|NCT00536198|11507726|FG000|Overall Study|Lost to Follow-up|15
7290136|NCT00536198|11507727|FG001|Overall Study|Lost to Follow-up|14
7290137|NCT00536198|11507726|FG000|Overall Study|Withdrawal by Subject|16
7290138|NCT00536198|11507727|FG001|Overall Study|Withdrawal by Subject|12
7290139|NCT00536198|11507726|FG000|Overall Study|Adverse Event|2
7290140|NCT00536198|11507727|FG001|Overall Study|Adverse Event|2
7290141|NCT00536198|11507726|FG000|Overall Study|Rescue|3
7290142|NCT00536198|11507727|FG001|Overall Study|Rescue|9
7290143|NCT00536198|11507726|FG000|Overall Study|Pregnancy|1
7290144|NCT00536198|11507727|FG001|Overall Study|Pregnancy|1
7290145|NCT00536198|11507726|FG000|Overall Study|Protocol Violation|0
7290146|NCT00536198|11507727|FG001|Overall Study|Protocol Violation|1
7290147|NCT00536263|11507738|FG000|Overall Study|Adverse Event|5
7290148|NCT00536263|11507739|FG001|Overall Study|Adverse Event|5
7290149|NCT00536263|11507740|FG002|Overall Study|Adverse Event|7
7290150|NCT00536263|11507738|FG000|Overall Study|Lost to Follow-up|3
7290151|NCT00536263|11507739|FG001|Overall Study|Lost to Follow-up|4
7290152|NCT00536263|11507740|FG002|Overall Study|Lost to Follow-up|4
7290153|NCT00536263|11507738|FG000|Overall Study|Subject withdrew - not treatment related|2
7290154|NCT00536263|11507739|FG001|Overall Study|Subject withdrew - not treatment related|0
7290155|NCT00536263|11507740|FG002|Overall Study|Subject withdrew - not treatment related|5
7290156|NCT00536263|11507738|FG000|Overall Study|Subject withdrew - treatment related|0
7290157|NCT00536263|11507739|FG001|Overall Study|Subject withdrew - treatment related|3
7290158|NCT00536263|11507740|FG002|Overall Study|Subject withdrew - treatment related|2
7290159|NCT00536263|11507738|FG000|Overall Study|Noncompliance with protocol|0
7290160|NCT00536263|11507739|FG001|Overall Study|Noncompliance with protocol|0
7290161|NCT00536263|11507740|FG002|Overall Study|Noncompliance with protocol|1
7290162|NCT00536263|11507738|FG000|Overall Study|Did not meet protocol eligibility|1
7290163|NCT00536263|11507739|FG001|Overall Study|Did not meet protocol eligibility|2
7290164|NCT00536263|11507740|FG002|Overall Study|Did not meet protocol eligibility|2
7290165|NCT00536471|11507762|FG000|Overall Study|Lost to Follow-up|48
7290166|NCT00536471|11507763|FG001|Overall Study|Lost to Follow-up|23
7290167|NCT00536471|11507764|FG002|Overall Study|Lost to Follow-up|48
7290168|NCT00536471|11507765|FG003|Overall Study|Lost to Follow-up|22
7290169|NCT00536471|11507762|FG000|Overall Study|Adverse Event|32
7290170|NCT00536471|11507763|FG001|Overall Study|Adverse Event|16
7290171|NCT00536471|11507764|FG002|Overall Study|Adverse Event|28
7290172|NCT00536471|11507765|FG003|Overall Study|Adverse Event|13
7290173|NCT00536471|11507762|FG000|Overall Study|Withdrawal by Subject|40
7290174|NCT00536471|11507763|FG001|Overall Study|Withdrawal by Subject|24
7290175|NCT00536471|11507764|FG002|Overall Study|Withdrawal by Subject|43
7290176|NCT00536471|11507765|FG003|Overall Study|Withdrawal by Subject|21
7290177|NCT00536471|11507762|FG000|Overall Study|Lack of Efficacy|17
7290178|NCT00536471|11507763|FG001|Overall Study|Lack of Efficacy|18
7290179|NCT00536471|11507764|FG002|Overall Study|Lack of Efficacy|11
7290180|NCT00536471|11507765|FG003|Overall Study|Lack of Efficacy|9
7290181|NCT00536471|11507762|FG000|Overall Study|Protocol Violation|8
7290182|NCT00536471|11507763|FG001|Overall Study|Protocol Violation|1
7290183|NCT00536471|11507764|FG002|Overall Study|Protocol Violation|2
7290184|NCT00536471|11507765|FG003|Overall Study|Protocol Violation|3
7290185|NCT00536471|11507762|FG000|Overall Study|Physician Decision|11
7290186|NCT00536471|11507763|FG001|Overall Study|Physician Decision|1
7290187|NCT00536471|11507764|FG002|Overall Study|Physician Decision|3
7290188|NCT00536471|11507765|FG003|Overall Study|Physician Decision|2
7290189|NCT00536471|11507762|FG000|Overall Study|Death|0
7290190|NCT00536471|11507763|FG001|Overall Study|Death|0
7290191|NCT00536471|11507764|FG002|Overall Study|Death|1
7290192|NCT00536471|11507765|FG003|Overall Study|Death|2
7290193|NCT00536471|11507762|FG000|Overall Study|Sponsor Decision|0
7290194|NCT00536471|11507763|FG001|Overall Study|Sponsor Decision|1
7290195|NCT00536471|11507764|FG002|Overall Study|Sponsor Decision|3
7290196|NCT00536471|11507765|FG003|Overall Study|Sponsor Decision|2
7290197|NCT00536484|11507784|FG000|Overall Study|Adverse Event|21
7290198|NCT00536484|11507785|FG001|Overall Study|Adverse Event|34
7290199|NCT00536484|11507784|FG000|Overall Study|Withdrawal by Subject|11
7290200|NCT00536484|11507785|FG001|Overall Study|Withdrawal by Subject|11
7290201|NCT00536484|11507784|FG000|Overall Study|Lost to Follow-up|8
7290202|NCT00536484|11507785|FG001|Overall Study|Lost to Follow-up|6
7290203|NCT00536484|11507784|FG000|Overall Study|Lack of Efficacy|16
7290204|NCT00536484|11507785|FG001|Overall Study|Lack of Efficacy|5
7290205|NCT00536484|11507784|FG000|Overall Study|Other|4
7290206|NCT00536484|11507785|FG001|Overall Study|Other|0
7290207|NCT00536510|11507793|FG000|Overall Study|Adverse Event|27
7290208|NCT00536510|11507794|FG001|Overall Study|Adverse Event|4
7290209|NCT00536510|11507793|FG000|Overall Study|Lost to Follow-up|11
7290210|NCT00536510|11507794|FG001|Overall Study|Lost to Follow-up|8
7290211|NCT00536510|11507793|FG000|Overall Study|Protocol Violation|4
7290212|NCT00536510|11507794|FG001|Overall Study|Protocol Violation|5
7290213|NCT00536510|11507793|FG000|Overall Study|Withdrawal by Subject|16
7290214|NCT00536510|11507794|FG001|Overall Study|Withdrawal by Subject|9
7290215|NCT00536510|11507793|FG000|Overall Study|Flushing with Product|20
7290216|NCT00536510|11507794|FG001|Overall Study|Flushing with Product|0
7290217|NCT00536510|11507793|FG000|Overall Study|Laboratory Adverse Event|2
7290218|NCT00536510|11507794|FG001|Overall Study|Laboratory Adverse Event|1
7290219|NCT00536510|11507793|FG000|Overall Study|Patient Discontinued for Other Reasons|2
7290220|NCT00536510|11507794|FG001|Overall Study|Patient Discontinued for Other Reasons|2
7290221|NCT00536575|11507800|FG000|Overall Study|Withdrawal by Subject|1
7290222|NCT00536575|11507800|FG000|Overall Study|Death|1
7290223|NCT00536731|11507828|FG000|Overall Study|Adverse Event|3
7290224|NCT00536731|11507829|FG001|Overall Study|Adverse Event|2
7290225|NCT00536731|11507830|FG002|Overall Study|Adverse Event|3
7290226|NCT00536731|11507828|FG000|Overall Study|Withdrawal by Subject|0
7290227|NCT00536731|11507829|FG001|Overall Study|Withdrawal by Subject|2
7290228|NCT00536731|11507830|FG002|Overall Study|Withdrawal by Subject|0
7290229|NCT00536731|11507828|FG000|Overall Study|Intake of prohibited conc. medication|0
7290230|NCT00536731|11507829|FG001|Overall Study|Intake of prohibited conc. medication|0
7290231|NCT00536731|11507830|FG002|Overall Study|Intake of prohibited conc. medication|1
7290232|NCT00536731|11507828|FG000|Overall Study|Safety reasons|0
7290233|NCT00536731|11507829|FG001|Overall Study|Safety reasons|0
7290234|NCT00536731|11507830|FG002|Overall Study|Safety reasons|1
7290235|NCT00536731|11507828|FG000|Overall Study|Other|1
7290236|NCT00536731|11507829|FG001|Overall Study|Other|1
7290237|NCT00536731|11507830|FG002|Overall Study|Other|0
7290238|NCT00536744|11507840|FG000|Overall Study|Adverse Event|13
7290239|NCT00536744|11507841|FG001|Overall Study|Adverse Event|10
7290240|NCT00536744|11507840|FG000|Overall Study|Death|2
7290241|NCT00536744|11507841|FG001|Overall Study|Death|1
7290242|NCT00536744|11507840|FG000|Overall Study|Physician Decision|3
7290243|NCT00536744|11507841|FG001|Overall Study|Physician Decision|1
7290244|NCT00536744|11507840|FG000|Overall Study|Lost to Follow-up|3
7290245|NCT00536744|11507841|FG001|Overall Study|Lost to Follow-up|5
7290246|NCT00536744|11507840|FG000|Overall Study|Withdrawal by Subject|7
7290247|NCT00536744|11507841|FG001|Overall Study|Withdrawal by Subject|8
7290248|NCT00536744|11507840|FG000|Overall Study|PI tried alternative treatment|1
7290249|NCT00536744|11507841|FG001|Overall Study|PI tried alternative treatment|3
7290250|NCT00536809|11507847|FG000|Phase II|Adverse Event|1
7290251|NCT00536809|11507847|FG000|Phase II|Referred for surgical resection|1
7290252|NCT00536874|11507851|FG000|Overall Study|Adverse Event|1
7290253|NCT00536874|11507851|FG000|Overall Study|Death|2
7290254|NCT00536874|11507851|FG000|Overall Study|Withdrawal by Subject|1
7290255|NCT00536939|11507864|FG000|Overall Study|Withdrawal by Subject|1
7290256|NCT00536939|11507865|FG001|Overall Study|Withdrawal by Subject|0
7290257|NCT00536939|11507864|FG000|Overall Study|Other Complicating Disease|1
7290258|NCT00536939|11507865|FG001|Overall Study|Other Complicating Disease|0
7290259|NCT00536991|11507870|FG000|Overall Study|Withdrawal by Subject|10
7290260|NCT00536991|11507870|FG000|Overall Study|Physician Decision|1
7290261|NCT00536991|11507870|FG000|Overall Study|patient ineligible|2
7290262|NCT00537017|11507875|FG000|Treatment Phase|Adverse Event|19
7290263|NCT00537017|11507875|FG000|Treatment Phase|Withdrawal by Subject|13
7290264|NCT00537017|11507875|FG000|Treatment Phase|Protocol Violation|2
7290265|NCT00537017|11507875|FG000|Follow-up Phase|Withdrawal by Subject|9
7290266|NCT00537030|11507879|FG000|Overall Study|Physician Decision|2
7290267|NCT00537030|11507879|FG000|Overall Study|Withdrawal by Subject|2
7290268|NCT00537030|11507879|FG000|Overall Study|≥ Grade 2 allergy|7
7290269|NCT00537030|11507879|FG000|Overall Study|Disease progression/ relapse during Tx|1
7290270|NCT00537030|11507879|FG000|Overall Study|Ineligible|2
7290271|NCT00537030|11507879|FG000|Overall Study|Inevaluable|2
7290272|NCT00537056|11507883|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
7290273|NCT00537082|11507892|FG000|Overall Study|Adverse Event|6
7290274|NCT00537082|11507893|FG001|Overall Study|Adverse Event|6
7290275|NCT00537082|11507894|FG002|Overall Study|Adverse Event|3
7290276|NCT00537082|11507892|FG000|Overall Study|Protocol Violation|0
7290277|NCT00537082|11507893|FG001|Overall Study|Protocol Violation|2
7290278|NCT00537082|11507894|FG002|Overall Study|Protocol Violation|1
7290279|NCT00537082|11507892|FG000|Overall Study|Lack of Efficacy|0
7290280|NCT00537082|11507893|FG001|Overall Study|Lack of Efficacy|0
7290281|NCT00537082|11507894|FG002|Overall Study|Lack of Efficacy|2
7290282|NCT00537082|11507892|FG000|Overall Study|Withdrawal by Subject|0
7290283|NCT00537082|11507893|FG001|Overall Study|Withdrawal by Subject|1
7290284|NCT00537082|11507894|FG002|Overall Study|Withdrawal by Subject|0
7290285|NCT00537082|11507892|FG000|Overall Study|Discontinued before initiating treatment|3
7290286|NCT00537082|11507893|FG001|Overall Study|Discontinued before initiating treatment|0
7290287|NCT00537082|11507894|FG002|Overall Study|Discontinued before initiating treatment|0
7290288|NCT00537095|11507904|FG000|Overall Study|surgery|1
7290289|NCT00537095|11507905|FG001|Overall Study|surgery|0
7290290|NCT00537095|11507904|FG000|Overall Study|Adverse Event|24
7290291|NCT00537095|11507905|FG001|Overall Study|Adverse Event|4
7290292|NCT00537095|11507904|FG000|Overall Study|disease progression|21
7290293|NCT00537095|11507905|FG001|Overall Study|disease progression|48
7290294|NCT00537095|11507904|FG000|Overall Study|Death|3
7290295|NCT00537095|11507905|FG001|Overall Study|Death|1
7290296|NCT00537095|11507904|FG000|Overall Study|Withdrawal by Subject|2
7290297|NCT00537095|11507905|FG001|Overall Study|Withdrawal by Subject|2
7290298|NCT00537095|11507904|FG000|Overall Study|subjective disease progression|0
7290299|NCT00537095|11507905|FG001|Overall Study|subjective disease progression|1
7290300|NCT00537095|11507904|FG000|Overall Study|Incorrect enrolment|0
7290301|NCT00537095|11507905|FG001|Overall Study|Incorrect enrolment|1
7290302|NCT00537238|11507913|FG000|Overall Study|Death|1
7290303|NCT00537238|11507914|FG001|Overall Study|Death|2
7290304|NCT00537238|11507913|FG000|Overall Study|Adverse Event|31
7290305|NCT00537238|11507914|FG001|Overall Study|Adverse Event|22
7290306|NCT00537238|11507913|FG000|Overall Study|Lack of Efficacy|20
7290307|NCT00537238|11507914|FG001|Overall Study|Lack of Efficacy|21
7290308|NCT00537238|11507913|FG000|Overall Study|Lost to Follow-up|12
7290309|NCT00537238|11507914|FG001|Overall Study|Lost to Follow-up|8
7290310|NCT00537238|11507913|FG000|Overall Study|Withdrawal by Subject|51
7290311|NCT00537238|11507914|FG001|Overall Study|Withdrawal by Subject|47
7290312|NCT00537238|11507913|FG000|Overall Study|Protocol Violation|15
7290313|NCT00537238|11507914|FG001|Overall Study|Protocol Violation|19
7290314|NCT00537238|11507913|FG000|Overall Study|Does not meet entrance criteria|0
7290315|NCT00537238|11507914|FG001|Overall Study|Does not meet entrance criteria|2
7290316|NCT00537238|11507913|FG000|Overall Study|Other|44
7290317|NCT00537238|11507914|FG001|Overall Study|Other|52
7290318|NCT00537277|11507920|FG000|Overall Study|Adverse Event|1
7290319|NCT00537277|11507920|FG000|Overall Study|Lack of Efficacy|2
7290320|NCT00537277|11507920|FG000|Overall Study|Lost to Follow-up|12
7290321|NCT00537277|11507920|FG000|Overall Study|Protocol Violation|11
7290322|NCT00537277|11507920|FG000|Overall Study|Unclassified|4
7290323|NCT00537277|11507920|FG000|Overall Study|Inability to tolerate trial medication|4
7623601|NCT03529773|12034562|FG015|Overall Study|Physician Decision|0
7623602|NCT03529773|12034563|FG016|Overall Study|Physician Decision|0
7623603|NCT03529773|12034564|FG017|Overall Study|Physician Decision|0
7623604|NCT03529773|12034565|FG018|Overall Study|Physician Decision|0
7623605|NCT03529773|12034566|FG019|Overall Study|Physician Decision|1
7623606|NCT03529773|12034567|FG020|Overall Study|Physician Decision|1
7623607|NCT03529773|12034568|FG021|Overall Study|Physician Decision|0
7623608|NCT03529773|12034569|FG022|Overall Study|Physician Decision|0
7623609|NCT03529773|12034570|FG023|Overall Study|Physician Decision|0
7623610|NCT03529773|12034571|FG024|Overall Study|Physician Decision|0
7623611|NCT03529773|12034572|FG025|Overall Study|Physician Decision|0
7623612|NCT03529773|12034573|FG026|Overall Study|Physician Decision|0
7623613|NCT03529773|12034574|FG027|Overall Study|Physician Decision|0
7623614|NCT03529773|12034575|FG028|Overall Study|Physician Decision|0
7623615|NCT03529773|12034576|FG029|Overall Study|Physician Decision|0
7623616|NCT03529773|12034577|FG030|Overall Study|Physician Decision|0
7623617|NCT03529773|12034578|FG031|Overall Study|Physician Decision|0
7623618|NCT03529773|12034579|FG032|Overall Study|Physician Decision|0
7623619|NCT03529773|12034580|FG033|Overall Study|Physician Decision|0
7623620|NCT03529773|12034581|FG034|Overall Study|Physician Decision|0
7623621|NCT03529773|12034582|FG035|Overall Study|Physician Decision|0
7623622|NCT03529773|12034583|FG036|Overall Study|Physician Decision|0
7623623|NCT03529773|12034584|FG037|Overall Study|Physician Decision|0
7623624|NCT03529773|12034585|FG038|Overall Study|Physician Decision|0
7623625|NCT03529773|12034586|FG039|Overall Study|Physician Decision|0
7623626|NCT03529773|12034547|FG000|Overall Study|Protocol Violation|0
7623627|NCT03529773|12034548|FG001|Overall Study|Protocol Violation|0
7623628|NCT03529773|12034549|FG002|Overall Study|Protocol Violation|0
7623629|NCT03529773|12034550|FG003|Overall Study|Protocol Violation|0
7623630|NCT03529773|12034551|FG004|Overall Study|Protocol Violation|0
7623631|NCT03529773|12034552|FG005|Overall Study|Protocol Violation|0
7623632|NCT03529773|12034553|FG006|Overall Study|Protocol Violation|0
7623633|NCT03529773|12034554|FG007|Overall Study|Protocol Violation|0
7623634|NCT03529773|12034555|FG008|Overall Study|Protocol Violation|0
7623635|NCT03529773|12034556|FG009|Overall Study|Protocol Violation|0
7623636|NCT03529773|12034557|FG010|Overall Study|Protocol Violation|0
7623637|NCT03529773|12034558|FG011|Overall Study|Protocol Violation|0
7623638|NCT03529773|12034559|FG012|Overall Study|Protocol Violation|0
7623639|NCT03529773|12034560|FG013|Overall Study|Protocol Violation|0
7623640|NCT03529773|12034561|FG014|Overall Study|Protocol Violation|0
7623641|NCT03529773|12034562|FG015|Overall Study|Protocol Violation|0
7623642|NCT03529773|12034563|FG016|Overall Study|Protocol Violation|0
7623643|NCT03529773|12034564|FG017|Overall Study|Protocol Violation|0
7623644|NCT03529773|12034565|FG018|Overall Study|Protocol Violation|0
7623645|NCT03529773|12034566|FG019|Overall Study|Protocol Violation|0
7623646|NCT03529773|12034567|FG020|Overall Study|Protocol Violation|0
7623647|NCT03529773|12034568|FG021|Overall Study|Protocol Violation|0
7623648|NCT03529773|12034569|FG022|Overall Study|Protocol Violation|0
7623649|NCT03529773|12034570|FG023|Overall Study|Protocol Violation|0
7623650|NCT03529773|12034571|FG024|Overall Study|Protocol Violation|0
7623651|NCT03529773|12034572|FG025|Overall Study|Protocol Violation|0
7623652|NCT03529773|12034573|FG026|Overall Study|Protocol Violation|0
7623653|NCT03529773|12034574|FG027|Overall Study|Protocol Violation|0
7290324|NCT00537277|11507920|FG000|Overall Study|Non-compliance with trial procedures|15
7290325|NCT00537303|11507930|FG000|Overall Study|Adverse Event|1
7290326|NCT00537303|11507931|FG001|Overall Study|Adverse Event|4
7290327|NCT00537303|11507930|FG000|Overall Study|Lack of Efficacy|6
7290328|NCT00537303|11507931|FG001|Overall Study|Lack of Efficacy|7
7290329|NCT00537303|11507930|FG000|Overall Study|Protocol Violation|8
7623654|NCT03529773|12034575|FG028|Overall Study|Protocol Violation|0
7623655|NCT03529773|12034576|FG029|Overall Study|Protocol Violation|0
7623656|NCT03529773|12034577|FG030|Overall Study|Protocol Violation|1
7623657|NCT03529773|12034578|FG031|Overall Study|Protocol Violation|0
7623658|NCT03529773|12034579|FG032|Overall Study|Protocol Violation|0
7623659|NCT03529773|12034580|FG033|Overall Study|Protocol Violation|0
7290330|NCT00537303|11507931|FG001|Overall Study|Protocol Violation|4
7290331|NCT00537303|11507930|FG000|Overall Study|Withdrawal criteria|3
7290332|NCT00537303|11507931|FG001|Overall Study|Withdrawal criteria|3
7290333|NCT00537303|11507930|FG000|Overall Study|Unclassified|8
7290334|NCT00537303|11507931|FG001|Overall Study|Unclassified|7
7290335|NCT00537316|11507943|FG000|Part 1|Adverse Event|7
7290336|NCT00537316|11507944|FG001|Part 1|Adverse Event|11
7290337|NCT00537316|11507945|FG002|Part 1|Adverse Event|8
7290338|NCT00537316|11507946|FG003|Part 1|Adverse Event|0
7290339|NCT00537316|11507947|FG004|Part 1|Adverse Event|0
7290340|NCT00537316|11507948|FG005|Part 1|Adverse Event|0
7290341|NCT00537316|11507949|FG006|Part 1|Adverse Event|0
7290342|NCT00537316|11507943|FG000|Part 1|Protocol defined clinical event|1
7290343|NCT00537316|11507944|FG001|Part 1|Protocol defined clinical event|0
7290344|NCT00537316|11507945|FG002|Part 1|Protocol defined clinical event|0
7290345|NCT00537316|11507946|FG003|Part 1|Protocol defined clinical event|0
7290346|NCT00537316|11507947|FG004|Part 1|Protocol defined clinical event|0
7290347|NCT00537316|11507948|FG005|Part 1|Protocol defined clinical event|0
7290348|NCT00537316|11507949|FG006|Part 1|Protocol defined clinical event|0
7290349|NCT00537316|11507943|FG000|Part 1|Lost to Follow-up|1
7290350|NCT00537316|11507944|FG001|Part 1|Lost to Follow-up|0
7290351|NCT00537316|11507945|FG002|Part 1|Lost to Follow-up|0
7290352|NCT00537316|11507946|FG003|Part 1|Lost to Follow-up|0
7290353|NCT00537316|11507947|FG004|Part 1|Lost to Follow-up|0
7290354|NCT00537316|11507948|FG005|Part 1|Lost to Follow-up|0
7290355|NCT00537316|11507949|FG006|Part 1|Lost to Follow-up|0
7290356|NCT00537316|11507943|FG000|Part 1|Withdrawal by Subject|3
7290357|NCT00537316|11507944|FG001|Part 1|Withdrawal by Subject|8
7290358|NCT00537316|11507945|FG002|Part 1|Withdrawal by Subject|4
7290359|NCT00537316|11507946|FG003|Part 1|Withdrawal by Subject|0
7290360|NCT00537316|11507947|FG004|Part 1|Withdrawal by Subject|0
7290361|NCT00537316|11507948|FG005|Part 1|Withdrawal by Subject|0
7290362|NCT00537316|11507949|FG006|Part 1|Withdrawal by Subject|0
7290363|NCT00537316|11507943|FG000|Part 1|Protocol Violation|1
7290364|NCT00537316|11507944|FG001|Part 1|Protocol Violation|5
7290365|NCT00537316|11507945|FG002|Part 1|Protocol Violation|1
7290366|NCT00537316|11507946|FG003|Part 1|Protocol Violation|0
7290367|NCT00537316|11507947|FG004|Part 1|Protocol Violation|0
7290368|NCT00537316|11507948|FG005|Part 1|Protocol Violation|0
7290369|NCT00537316|11507949|FG006|Part 1|Protocol Violation|0
7290370|NCT00537316|11507943|FG000|Part 1|Did not meet protocol eligibility|1
7290371|NCT00537316|11507944|FG001|Part 1|Did not meet protocol eligibility|3
7290372|NCT00537316|11507945|FG002|Part 1|Did not meet protocol eligibility|2
7290373|NCT00537316|11507946|FG003|Part 1|Did not meet protocol eligibility|0
7290374|NCT00537316|11507947|FG004|Part 1|Did not meet protocol eligibility|0
7290375|NCT00537316|11507948|FG005|Part 1|Did not meet protocol eligibility|0
7290376|NCT00537316|11507949|FG006|Part 1|Did not meet protocol eligibility|0
7290377|NCT00537316|11507943|FG000|Part 1|Administrative|0
7290378|NCT00537316|11507944|FG001|Part 1|Administrative|0
7290379|NCT00537316|11507945|FG002|Part 1|Administrative|2
7290380|NCT00537316|11507946|FG003|Part 1|Administrative|0
7290381|NCT00537316|11507947|FG004|Part 1|Administrative|0
7290382|NCT00537316|11507948|FG005|Part 1|Administrative|0
7290383|NCT00537316|11507949|FG006|Part 1|Administrative|0
7290384|NCT00537316|11507943|FG000|Part 2|Never entered follow-up|0
7290385|NCT00537316|11507944|FG001|Part 2|Never entered follow-up|0
7290386|NCT00537316|11507945|FG002|Part 2|Never entered follow-up|0
7290387|NCT00537316|11507946|FG003|Part 2|Never entered follow-up|0
7290388|NCT00537316|11507947|FG004|Part 2|Never entered follow-up|0
7290389|NCT00537316|11507948|FG005|Part 2|Never entered follow-up|0
7290390|NCT00537316|11507949|FG006|Part 2|Never entered follow-up|1
7290391|NCT00537316|11507943|FG000|Part 2|Adverse Event|4
7290392|NCT00537316|11507944|FG001|Part 2|Adverse Event|0
7290393|NCT00537316|11507945|FG002|Part 2|Adverse Event|2
7290394|NCT00537316|11507946|FG003|Part 2|Adverse Event|0
7290395|NCT00537316|11507947|FG004|Part 2|Adverse Event|0
7290396|NCT00537316|11507948|FG005|Part 2|Adverse Event|0
7290397|NCT00537316|11507949|FG006|Part 2|Adverse Event|0
7290398|NCT00537316|11507943|FG000|Part 2|Lost to Follow-up|1
7290399|NCT00537316|11507944|FG001|Part 2|Lost to Follow-up|0
7290400|NCT00537316|11507945|FG002|Part 2|Lost to Follow-up|2
7290401|NCT00537316|11507946|FG003|Part 2|Lost to Follow-up|0
7290402|NCT00537316|11507947|FG004|Part 2|Lost to Follow-up|0
7290403|NCT00537316|11507948|FG005|Part 2|Lost to Follow-up|0
7290404|NCT00537316|11507949|FG006|Part 2|Lost to Follow-up|0
7290405|NCT00537316|11507943|FG000|Part 2|Withdrawal by Subject|5
7290406|NCT00537316|11507944|FG001|Part 2|Withdrawal by Subject|1
7290407|NCT00537316|11507945|FG002|Part 2|Withdrawal by Subject|4
7290408|NCT00537316|11507946|FG003|Part 2|Withdrawal by Subject|0
7290409|NCT00537316|11507947|FG004|Part 2|Withdrawal by Subject|0
7290410|NCT00537316|11507948|FG005|Part 2|Withdrawal by Subject|0
7290411|NCT00537316|11507949|FG006|Part 2|Withdrawal by Subject|0
7290412|NCT00537316|11507943|FG000|Part 2|Administrative|16
7290413|NCT00537316|11507944|FG001|Part 2|Administrative|8
7290414|NCT00537316|11507945|FG002|Part 2|Administrative|24
7290415|NCT00537316|11507946|FG003|Part 2|Administrative|3
7290416|NCT00537316|11507947|FG004|Part 2|Administrative|1
7290417|NCT00537316|11507948|FG005|Part 2|Administrative|4
7290418|NCT00537316|11507949|FG006|Part 2|Administrative|1
7290419|NCT00537329|11507968|FG000|Overall Study|Death|10
7290420|NCT00537329|11507968|FG000|Overall Study|Adverse Event|3
7290421|NCT00537329|11507968|FG000|Overall Study|Lack of Efficacy|2
7290422|NCT00537329|11507968|FG000|Overall Study|Lost to Follow-up|6
7290423|NCT00537329|11507968|FG000|Overall Study|Withdrawal by Subject|4
7290424|NCT00537329|11507968|FG000|Overall Study|Other|1
7290425|NCT00537381|11507974|FG000|Overall Study|Adverse Event|13
7290426|NCT00537381|11507975|FG001|Overall Study|Adverse Event|9
7290427|NCT00537381|11507974|FG000|Overall Study|Death|3
7290428|NCT00537381|11507975|FG001|Overall Study|Death|3
7290429|NCT00537381|11507974|FG000|Overall Study|Withdrawal by Subject|5
7290430|NCT00537381|11507975|FG001|Overall Study|Withdrawal by Subject|14
7290431|NCT00537381|11507974|FG000|Overall Study|Physician Decision|7
7290432|NCT00537381|11507975|FG001|Overall Study|Physician Decision|6
7290433|NCT00537381|11507974|FG000|Overall Study|Disease Progression|9
7290434|NCT00537381|11507975|FG001|Overall Study|Disease Progression|18
7290435|NCT00537381|11507974|FG000|Overall Study|Sponsor decision|14
7290436|NCT00537381|11507975|FG001|Overall Study|Sponsor decision|9
7290437|NCT00537381|11507974|FG000|Overall Study|Other|5
7290438|NCT00537381|11507975|FG001|Overall Study|Other|3
7290439|NCT00537394|11507986|FG000|First Year of Follow-up|Death|7
7290440|NCT00537394|11507987|FG001|First Year of Follow-up|Death|0
7290441|NCT00537394|11507988|FG002|First Year of Follow-up|Death|0
7290442|NCT00537394|11507986|FG000|First Year of Follow-up|Severe debilitation|1
7290443|NCT00537394|11507987|FG001|First Year of Follow-up|Severe debilitation|0
7290444|NCT00537394|11507988|FG002|First Year of Follow-up|Severe debilitation|1
7290445|NCT00537394|11507986|FG000|First Year of Follow-up|Withdrawal by Subject|3
7290446|NCT00537394|11507987|FG001|First Year of Follow-up|Withdrawal by Subject|6
7290447|NCT00537394|11507988|FG002|First Year of Follow-up|Withdrawal by Subject|1
7290448|NCT00537394|11507986|FG000|First Year of Follow-up|Lost to Follow-up|1
7290449|NCT00537394|11507987|FG001|First Year of Follow-up|Lost to Follow-up|5
7290450|NCT00537394|11507988|FG002|First Year of Follow-up|Lost to Follow-up|1
7290451|NCT00537394|11507986|FG000|2nd Year of Follow-up|Death|4
7290452|NCT00537394|11507987|FG001|2nd Year of Follow-up|Death|1
7290453|NCT00537394|11507988|FG002|2nd Year of Follow-up|Death|2
7290454|NCT00537394|11507986|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
7290455|NCT00537394|11507987|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
7290456|NCT00537394|11507988|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
7290457|NCT00537394|11507986|FG000|2nd Year of Follow-up|Lost to Follow-up|6
7290458|NCT00537394|11507987|FG001|2nd Year of Follow-up|Lost to Follow-up|7
7290459|NCT00537394|11507988|FG002|2nd Year of Follow-up|Lost to Follow-up|2
7290460|NCT00537394|11507986|FG000|2nd Year of Follow-up|Clinic site closure|1
7290461|NCT00537394|11507987|FG001|2nd Year of Follow-up|Clinic site closure|0
7290462|NCT00537394|11507988|FG002|2nd Year of Follow-up|Clinic site closure|0
7290463|NCT00537485|11508021|FG000|Overall Study|Adverse Event|10
7290464|NCT00537485|11508022|FG001|Overall Study|Adverse Event|5
7290465|NCT00537485|11508021|FG000|Overall Study|Withdrawal by Subject|3
7290466|NCT00537485|11508022|FG001|Overall Study|Withdrawal by Subject|2
7290467|NCT00537485|11508021|FG000|Overall Study|Withdrawal by Subject|1
7290468|NCT00537485|11508022|FG001|Overall Study|Withdrawal by Subject|3
7290469|NCT00537485|11508021|FG000|Overall Study|Physician Decision|1
7290470|NCT00537485|11508022|FG001|Overall Study|Physician Decision|0
7290471|NCT00537745|11508083|FG000|Overall Study|Did not meet eligibility criteria|2
7290472|NCT00537745|11508083|FG000|Overall Study|Withdrawal by Subject|2
7290473|NCT00537745|11508083|FG000|Overall Study|Subject unable to provide Interlock info|1
7290474|NCT00537771|11508090|FG000|Overall Study|Withdrawal by Subject|6
7290475|NCT00537771|11508091|FG001|Overall Study|Withdrawal by Subject|23
7290476|NCT00537771|11508090|FG000|Overall Study|Adverse Event|8
7290477|NCT00537771|11508091|FG001|Overall Study|Adverse Event|15
7290478|NCT00537771|11508090|FG000|Overall Study|Lost to Follow-up|9
7290479|NCT00537771|11508091|FG001|Overall Study|Lost to Follow-up|15
7290480|NCT00537771|11508090|FG000|Overall Study|Protocol Violation|2
7290481|NCT00537771|11508091|FG001|Overall Study|Protocol Violation|6
7290482|NCT00537771|11508090|FG000|Overall Study|Severe Non-Compliance to Protocol|4
7290483|NCT00537771|11508091|FG001|Overall Study|Severe Non-Compliance to Protocol|2
7290484|NCT00537810|11508101|FG000|Overall Study|Withdrawal by Subject|4
7290485|NCT00537810|11508102|FG001|Overall Study|Withdrawal by Subject|11
7290486|NCT00537810|11508103|FG002|Overall Study|Withdrawal by Subject|4
7290487|NCT00537810|11508104|FG003|Overall Study|Withdrawal by Subject|3
7290488|NCT00537810|11508101|FG000|Overall Study|Medically withdrawn|2
7290489|NCT00537810|11508102|FG001|Overall Study|Medically withdrawn|2
7290490|NCT00537810|11508103|FG002|Overall Study|Medically withdrawn|0
7290491|NCT00537810|11508104|FG003|Overall Study|Medically withdrawn|1
7290492|NCT00537823|11508116|FG000|Overall Study|Adverse Event|2
7290493|NCT00537823|11508117|FG001|Overall Study|Adverse Event|0
7290494|NCT00537940|11508126|FG000|Overall Study|Adverse Event|20
7290495|NCT00537940|11508127|FG001|Overall Study|Adverse Event|19
7290496|NCT00537940|11508126|FG000|Overall Study|Lack of Efficacy|8
7290497|NCT00537940|11508127|FG001|Overall Study|Lack of Efficacy|16
7290498|NCT00537940|11508126|FG000|Overall Study|Lost to Follow-up|23
7290499|NCT00537940|11508127|FG001|Overall Study|Lost to Follow-up|29
7290500|NCT00537940|11508126|FG000|Overall Study|Withdrawal by Subject|113
7290501|NCT00537940|11508127|FG001|Overall Study|Withdrawal by Subject|95
7290502|NCT00537940|11508126|FG000|Overall Study|Protocol Violation|6
7290503|NCT00537940|11508127|FG001|Overall Study|Protocol Violation|4
7290504|NCT00537940|11508126|FG000|Overall Study|Pregnancy|1
7290505|NCT00537940|11508127|FG001|Overall Study|Pregnancy|1
7290506|NCT00537940|11508126|FG000|Overall Study|Study terminated by sponsor|2
7290507|NCT00537940|11508127|FG001|Overall Study|Study terminated by sponsor|3
7290508|NCT00537940|11508126|FG000|Overall Study|Other|10
7290509|NCT00537940|11508127|FG001|Overall Study|Other|12
7290510|NCT00537979|11508135|FG000|Overall Study|Adverse Event|2
7290511|NCT00537979|11508136|FG001|Overall Study|Adverse Event|2
7290512|NCT00537979|11508135|FG000|Overall Study|Withdrawal by Subject|1
7290513|NCT00537979|11508136|FG001|Overall Study|Withdrawal by Subject|4
7290514|NCT00537979|11508135|FG000|Overall Study|Lost to Follow-up|1
7290515|NCT00537979|11508136|FG001|Overall Study|Lost to Follow-up|4
7290516|NCT00537979|11508135|FG000|Overall Study|Lack of Efficacy|0
7290517|NCT00537979|11508136|FG001|Overall Study|Lack of Efficacy|1
7290518|NCT00537979|11508135|FG000|Overall Study|Non-compliance with treatment/procedure|2
7290519|NCT00537979|11508136|FG001|Overall Study|Non-compliance with treatment/procedure|2
7290520|NCT00537979|11508135|FG000|Overall Study|Death|0
7290521|NCT00537979|11508136|FG001|Overall Study|Death|3
7290522|NCT00537979|11508135|FG000|Overall Study|Kidney transplant|0
7290523|NCT00537979|11508136|FG001|Overall Study|Kidney transplant|3
7290524|NCT00537979|11508135|FG000|Overall Study|Heart failure|0
7290525|NCT00537979|11508136|FG001|Overall Study|Heart failure|1
7290526|NCT00538291|11508157|FG000|Overall Study|Adverse Event|2
7290527|NCT00538291|11508157|FG000|Overall Study|Withdrawal by Subject|1
7290528|NCT00538473|11508190|FG000|Overall Study|Adverse Event|1
7290529|NCT00538473|11508191|FG001|Overall Study|Adverse Event|0
7290530|NCT00538590|11508212|FG000|Overall Study|Death|1
7290531|NCT00538590|11508213|FG001|Overall Study|Death|0
7290532|NCT00538629|11508228|FG000|Overall Study|At subject's request|1
7290533|NCT00538629|11508228|FG000|Overall Study|Adverse Event|2
7290534|NCT00538629|11508228|FG000|Overall Study|Lack of Efficacy|12
7290535|NCT00538629|11508228|FG000|Overall Study|Lost to Follow-up|6
7290536|NCT00538629|11508228|FG000|Overall Study|Subject's untimely distrust of medicine|1
7290537|NCT00538681|11508246|FG000|Overall Study|Progressive Disease|7
7290538|NCT00538681|11508247|FG001|Overall Study|Progressive Disease|0
7290539|NCT00538681|11508248|FG002|Overall Study|Progressive Disease|1
7290540|NCT00538681|11508249|FG003|Overall Study|Progressive Disease|0
7290541|NCT00538681|11508246|FG000|Overall Study|Sponsor Decision|1
7290542|NCT00538681|11508247|FG001|Overall Study|Sponsor Decision|3
7290543|NCT00538681|11508248|FG002|Overall Study|Sponsor Decision|8
7290544|NCT00538681|11508249|FG003|Overall Study|Sponsor Decision|9
7290545|NCT00538681|11508246|FG000|Overall Study|Adverse Event|1
7290546|NCT00538681|11508247|FG001|Overall Study|Adverse Event|1
7290547|NCT00538681|11508248|FG002|Overall Study|Adverse Event|1
7290548|NCT00538681|11508249|FG003|Overall Study|Adverse Event|0
7290549|NCT00538681|11508246|FG000|Overall Study|Death|0
7290550|NCT00538681|11508247|FG001|Overall Study|Death|0
7290551|NCT00538681|11508248|FG002|Overall Study|Death|1
7290552|NCT00538681|11508249|FG003|Overall Study|Death|1
7290553|NCT00538681|11508246|FG000|Overall Study|Investigator Decision|0
7290554|NCT00538681|11508247|FG001|Overall Study|Investigator Decision|0
7290555|NCT00538681|11508248|FG002|Overall Study|Investigator Decision|0
7290556|NCT00538681|11508249|FG003|Overall Study|Investigator Decision|1
7290557|NCT00538733|11508260|FG000|Overall Study|Adverse Event|8
7290558|NCT00538733|11508260|FG000|Overall Study|Death|1
7290559|NCT00538733|11508260|FG000|Overall Study|declined to participate|2
7290560|NCT00538733|11508260|FG000|Overall Study|still on therapy|1
7290561|NCT00538785|11508278|FG000|Overall Study|Death|9
7290562|NCT00538785|11508279|FG001|Overall Study|Death|10
7290563|NCT00538785|11508278|FG000|Overall Study|Withdrawal of consent|9
7290564|NCT00538785|11508279|FG001|Overall Study|Withdrawal of consent|7
7290565|NCT00538785|11508278|FG000|Overall Study|Lost to Follow-up|1
7290566|NCT00538785|11508279|FG001|Overall Study|Lost to Follow-up|0
7551328|NCT02969018|11910569|FG003|Overall Study|Pregnancy|0
7551329|NCT02969018|11910570|FG004|Overall Study|Pregnancy|0
7551330|NCT02969018|11910571|FG005|Overall Study|Pregnancy|1
7551331|NCT02969018|11910572|FG006|Overall Study|Pregnancy|0
7551332|NCT02969018|11910573|FG007|Overall Study|Pregnancy|0
7551333|NCT02969018|11910566|FG000|Overall Study|Protocol Violation|0
7551334|NCT02969018|11910567|FG001|Overall Study|Protocol Violation|0
7551335|NCT02969018|11910568|FG002|Overall Study|Protocol Violation|1
7551336|NCT02969018|11910569|FG003|Overall Study|Protocol Violation|1
7551337|NCT02969018|11910570|FG004|Overall Study|Protocol Violation|0
7551338|NCT02969018|11910571|FG005|Overall Study|Protocol Violation|0
7551339|NCT02969018|11910572|FG006|Overall Study|Protocol Violation|0
7551340|NCT02969018|11910573|FG007|Overall Study|Protocol Violation|0
7551341|NCT02969018|11910566|FG000|Overall Study|Withdrawal by Subject|0
7551342|NCT02969018|11910567|FG001|Overall Study|Withdrawal by Subject|1
7551343|NCT02969018|11910568|FG002|Overall Study|Withdrawal by Subject|2
7551344|NCT02969018|11910569|FG003|Overall Study|Withdrawal by Subject|1
7551345|NCT02969018|11910570|FG004|Overall Study|Withdrawal by Subject|0
7551346|NCT02969018|11910571|FG005|Overall Study|Withdrawal by Subject|4
7551347|NCT02969018|11910572|FG006|Overall Study|Withdrawal by Subject|4
7551348|NCT02969018|11910573|FG007|Overall Study|Withdrawal by Subject|3
7551349|NCT02969044|11910605|FG000|Overall Study|Withdrawal by Subject|2
7551350|NCT02969044|11910606|FG001|Overall Study|Withdrawal by Subject|6
7551351|NCT02969044|11910605|FG000|Overall Study|Adverse Event|3
7551352|NCT02969044|11910606|FG001|Overall Study|Adverse Event|0
7290567|NCT00538902|11508306|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
7290568|NCT00538902|11508307|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
7290569|NCT00538902|11508308|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
7290570|NCT00538902|11508306|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7290571|NCT00538902|11508307|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
7290572|NCT00538902|11508308|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
7290573|NCT00538902|11508306|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7290574|NCT00538902|11508307|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
7290575|NCT00538902|11508308|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
7290576|NCT00538902|11508306|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7290577|NCT00538902|11508307|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7290578|NCT00538902|11508308|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
7290579|NCT00538902|11508306|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
7290580|NCT00538902|11508307|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
7290581|NCT00538902|11508308|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
7290582|NCT00538902|11508306|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
7290583|NCT00538902|11508307|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
7290584|NCT00538902|11508308|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
7290585|NCT00538902|11508306|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
7290586|NCT00538902|11508307|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
7290587|NCT00538902|11508308|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
7290588|NCT00538902|11508306|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
7290589|NCT00538902|11508307|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
7290590|NCT00538902|11508308|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
7290591|NCT00539006|11508326|FG000|Pre-treatment|Other|0
7290592|NCT00539006|11508327|FG001|Pre-treatment|Other|1
7290593|NCT00539006|11508328|FG002|Pre-treatment|Other|0
7290594|NCT00539006|11508329|FG003|Pre-treatment|Other|0
7290595|NCT00539006|11508326|FG000|Treatment Period 1|Lost to Follow-up|0
7290596|NCT00539006|11508327|FG001|Treatment Period 1|Lost to Follow-up|0
7290597|NCT00539006|11508328|FG002|Treatment Period 1|Lost to Follow-up|1
7290598|NCT00539006|11508329|FG003|Treatment Period 1|Lost to Follow-up|0
7290599|NCT00539006|11508326|FG000|Treatment Period 1|Protocol Violation|0
7290600|NCT00539006|11508327|FG001|Treatment Period 1|Protocol Violation|0
7290601|NCT00539006|11508328|FG002|Treatment Period 1|Protocol Violation|1
7290602|NCT00539006|11508329|FG003|Treatment Period 1|Protocol Violation|0
7290603|NCT00539006|11508326|FG000|Treatment Period 1|Lack of Efficacy|0
7290604|NCT00539006|11508327|FG001|Treatment Period 1|Lack of Efficacy|0
7290605|NCT00539006|11508328|FG002|Treatment Period 1|Lack of Efficacy|0
7290606|NCT00539006|11508329|FG003|Treatment Period 1|Lack of Efficacy|1
7290607|NCT00539006|11508326|FG000|Washout|Adverse Event|2
7290608|NCT00539006|11508327|FG001|Washout|Adverse Event|1
7290609|NCT00539006|11508328|FG002|Washout|Adverse Event|0
7290610|NCT00539006|11508329|FG003|Washout|Adverse Event|0
7290611|NCT00539006|11508326|FG000|Washout|Protocol Violation|1
7290612|NCT00539006|11508327|FG001|Washout|Protocol Violation|1
7290613|NCT00539006|11508328|FG002|Washout|Protocol Violation|0
7290614|NCT00539006|11508329|FG003|Washout|Protocol Violation|0
7290615|NCT00539006|11508326|FG000|Washout|Withdrawal by Subject|0
7290616|NCT00539006|11508327|FG001|Washout|Withdrawal by Subject|2
7290617|NCT00539006|11508328|FG002|Washout|Withdrawal by Subject|0
7290618|NCT00539006|11508329|FG003|Washout|Withdrawal by Subject|0
7290619|NCT00539006|11508326|FG000|Washout|Failed to meet continuation criteria|16
7290620|NCT00539006|11508327|FG001|Washout|Failed to meet continuation criteria|5
7290621|NCT00539006|11508328|FG002|Washout|Failed to meet continuation criteria|14
7290622|NCT00539006|11508329|FG003|Washout|Failed to meet continuation criteria|6
7290623|NCT00539006|11508326|FG000|Washout|Other|1
7290624|NCT00539006|11508327|FG001|Washout|Other|1
7290625|NCT00539006|11508328|FG002|Washout|Other|2
7290626|NCT00539006|11508329|FG003|Washout|Other|3
7290627|NCT00539006|11508326|FG000|Treatment Period 2|Protocol Violation|1
7290628|NCT00539006|11508327|FG001|Treatment Period 2|Protocol Violation|0
7623660|NCT03529773|12034581|FG034|Overall Study|Protocol Violation|0
7623661|NCT03529773|12034582|FG035|Overall Study|Protocol Violation|0
7623662|NCT03529773|12034583|FG036|Overall Study|Protocol Violation|0
7623663|NCT03529773|12034584|FG037|Overall Study|Protocol Violation|0
7623664|NCT03529773|12034585|FG038|Overall Study|Protocol Violation|0
7623665|NCT03529773|12034586|FG039|Overall Study|Protocol Violation|0
7623666|NCT03529773|12034547|FG000|Overall Study|Withdrawal by Subject|0
7623667|NCT03529773|12034548|FG001|Overall Study|Withdrawal by Subject|0
7623668|NCT03529773|12034549|FG002|Overall Study|Withdrawal by Subject|0
7623669|NCT03529773|12034550|FG003|Overall Study|Withdrawal by Subject|0
7623670|NCT03529773|12034551|FG004|Overall Study|Withdrawal by Subject|0
7623671|NCT03529773|12034552|FG005|Overall Study|Withdrawal by Subject|0
7623672|NCT03529773|12034553|FG006|Overall Study|Withdrawal by Subject|0
7623673|NCT03529773|12034554|FG007|Overall Study|Withdrawal by Subject|1
7623674|NCT03529773|12034555|FG008|Overall Study|Withdrawal by Subject|0
7623675|NCT03529773|12034556|FG009|Overall Study|Withdrawal by Subject|1
7290629|NCT00539006|11508328|FG002|Treatment Period 2|Protocol Violation|0
7290630|NCT00539006|11508329|FG003|Treatment Period 2|Protocol Violation|0
7290631|NCT00539006|11508326|FG000|Treatment Period 2|Other|0
7290632|NCT00539006|11508327|FG001|Treatment Period 2|Other|1
7290633|NCT00539006|11508328|FG002|Treatment Period 2|Other|0
7290634|NCT00539006|11508329|FG003|Treatment Period 2|Other|0
7290635|NCT00539032|11508347|FG000|Overall Study|Withdrawal by Subject|2
7290636|NCT00539032|11508348|FG001|Overall Study|Withdrawal by Subject|1
7290637|NCT00539188|11508365|FG000|Overall Study|Withdrawal by Subject|1
7290638|NCT00539188|11508366|FG001|Overall Study|Withdrawal by Subject|0
7290639|NCT00539188|11508365|FG000|Overall Study|Lost to Follow-up|2
7290640|NCT00539188|11508366|FG001|Overall Study|Lost to Follow-up|1
7290641|NCT00539240|11508375|FG000|Overall Study|Withdrawal by Subject|0
7290642|NCT00539240|11508376|FG001|Overall Study|Withdrawal by Subject|2
7290643|NCT00539240|11508377|FG002|Overall Study|Withdrawal by Subject|0
7290644|NCT00539240|11508375|FG000|Overall Study|Protocol Violation|1
7290645|NCT00539240|11508376|FG001|Overall Study|Protocol Violation|1
7290646|NCT00539240|11508377|FG002|Overall Study|Protocol Violation|4
7290647|NCT00539240|11508375|FG000|Overall Study|Lost to Follow-up|2
7290648|NCT00539240|11508376|FG001|Overall Study|Lost to Follow-up|3
7290649|NCT00539240|11508377|FG002|Overall Study|Lost to Follow-up|1
7290650|NCT00539240|11508375|FG000|Overall Study|Adverse Event|3
7290651|NCT00539240|11508376|FG001|Overall Study|Adverse Event|1
7290652|NCT00539240|11508377|FG002|Overall Study|Adverse Event|10
7290653|NCT00539279|11508391|FG000|Treatment|Withdrawal by Subject|10
7290654|NCT00539279|11508392|FG001|Treatment|Withdrawal by Subject|8
7290655|NCT00539279|11508391|FG000|Treatment|Death|1
7290656|NCT00539279|11508392|FG001|Treatment|Death|0
7290657|NCT00539279|11508391|FG000|Post-Treatment Assessment|Lost to Follow-up|12
7290658|NCT00539279|11508392|FG001|Post-Treatment Assessment|Lost to Follow-up|9
7290659|NCT00539279|11508391|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
7290660|NCT00539279|11508392|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
7290661|NCT00539305|11508400|FG000|Overall Study|Adverse Event|1
7290662|NCT00539305|11508401|FG001|Overall Study|Adverse Event|0
7290663|NCT00539305|11508400|FG000|Overall Study|Substance Use|0
7290664|NCT00539305|11508401|FG001|Overall Study|Substance Use|1
7290665|NCT00539305|11508400|FG000|Overall Study|Withdrawal by Subject|0
7290666|NCT00539305|11508401|FG001|Overall Study|Withdrawal by Subject|1
7290667|NCT00539500|11508407|FG000|Overall Study|Disease Progression|1
7290668|NCT00539500|11508407|FG000|Overall Study|Lost to Follow-up|2
7290669|NCT00539513|11508413|FG000|Overall Study|Withdrawal by Subject|2
7290670|NCT00539513|11508414|FG001|Overall Study|Withdrawal by Subject|1
7290671|NCT00539513|11508413|FG000|Overall Study|Lost to Follow-up|0
7290672|NCT00539513|11508414|FG001|Overall Study|Lost to Follow-up|1
7290673|NCT00539734|11508450|FG000|Overall Study|Protocol Violation|1
7290674|NCT00539864|11508456|FG000|Overall Study|Lost to Follow-up|0
7290675|NCT00539864|11508457|FG001|Overall Study|Lost to Follow-up|1
7290676|NCT00539864|11508456|FG000|Overall Study|Withdrawal by Subject|1
7290677|NCT00539864|11508457|FG001|Overall Study|Withdrawal by Subject|1
7290678|NCT00539994|11508475|FG000|Overall Study|Lost to Follow-up|2
7290679|NCT00539994|11508476|FG001|Overall Study|Lost to Follow-up|1
7290680|NCT00539994|11508477|FG002|Overall Study|Lost to Follow-up|0
7290681|NCT00539994|11508475|FG000|Overall Study|Withdrawal by Subject|1
7290682|NCT00539994|11508476|FG001|Overall Study|Withdrawal by Subject|0
7623676|NCT03529773|12034557|FG010|Overall Study|Withdrawal by Subject|1
7623677|NCT03529773|12034558|FG011|Overall Study|Withdrawal by Subject|0
7623678|NCT03529773|12034559|FG012|Overall Study|Withdrawal by Subject|0
7623679|NCT03529773|12034560|FG013|Overall Study|Withdrawal by Subject|0
7623680|NCT03529773|12034561|FG014|Overall Study|Withdrawal by Subject|0
7623681|NCT03529773|12034562|FG015|Overall Study|Withdrawal by Subject|3
7623682|NCT03529773|12034563|FG016|Overall Study|Withdrawal by Subject|0
7623683|NCT03529773|12034564|FG017|Overall Study|Withdrawal by Subject|2
7623684|NCT03529773|12034565|FG018|Overall Study|Withdrawal by Subject|3
7623685|NCT03529773|12034566|FG019|Overall Study|Withdrawal by Subject|1
7623686|NCT03529773|12034567|FG020|Overall Study|Withdrawal by Subject|3
7623687|NCT03529773|12034568|FG021|Overall Study|Withdrawal by Subject|1
7623688|NCT03529773|12034569|FG022|Overall Study|Withdrawal by Subject|1
7623689|NCT03529773|12034570|FG023|Overall Study|Withdrawal by Subject|2
7623690|NCT03529773|12034571|FG024|Overall Study|Withdrawal by Subject|2
7290683|NCT00539994|11508477|FG002|Overall Study|Withdrawal by Subject|1
7290684|NCT00539994|11508475|FG000|Overall Study|Physician Decision|0
7290685|NCT00539994|11508476|FG001|Overall Study|Physician Decision|0
7290686|NCT00539994|11508477|FG002|Overall Study|Physician Decision|1
7290687|NCT00540046|11508504|FG000|Overall Study|Lost to Follow-up|33
7290688|NCT00540046|11508505|FG001|Overall Study|Lost to Follow-up|23
7290689|NCT00540124|11508516|FG000|Overall Study|Adverse Event|0
7290690|NCT00540124|11508517|FG001|Overall Study|Adverse Event|2
7290691|NCT00540124|11508518|FG002|Overall Study|Adverse Event|1
7290692|NCT00540124|11508516|FG000|Overall Study|Entry Criteria Not Met|2
7290693|NCT00540124|11508517|FG001|Overall Study|Entry Criteria Not Met|0
7290694|NCT00540124|11508518|FG002|Overall Study|Entry Criteria Not Met|0
7290695|NCT00540124|11508516|FG000|Overall Study|Lack of Efficacy|1
7290696|NCT00540124|11508517|FG001|Overall Study|Lack of Efficacy|0
7290697|NCT00540124|11508518|FG002|Overall Study|Lack of Efficacy|0
7290698|NCT00540124|11508516|FG000|Overall Study|Withdrawal by Subject|1
7290699|NCT00540124|11508517|FG001|Overall Study|Withdrawal by Subject|1
7290700|NCT00540124|11508518|FG002|Overall Study|Withdrawal by Subject|0
7290701|NCT00540228|11508531|FG000|Overall Study|Adverse Event|2
7290702|NCT00540228|11508532|FG001|Overall Study|Adverse Event|0
7290703|NCT00540228|11508533|FG002|Overall Study|Adverse Event|0
7290704|NCT00540228|11508534|FG003|Overall Study|Adverse Event|0
7290705|NCT00540228|11508535|FG004|Overall Study|Adverse Event|0
7290706|NCT00540228|11508531|FG000|Overall Study|Lost to Follow-up|1
7290707|NCT00540228|11508532|FG001|Overall Study|Lost to Follow-up|1
7290708|NCT00540228|11508533|FG002|Overall Study|Lost to Follow-up|0
7290709|NCT00540228|11508534|FG003|Overall Study|Lost to Follow-up|0
7290710|NCT00540228|11508535|FG004|Overall Study|Lost to Follow-up|0
7290711|NCT00540293|11508547|FG000|Overall Study|Adverse event related to study drug|10
7290712|NCT00540293|11508547|FG000|Overall Study|Adverse event not related to study drug|7
7290713|NCT00540293|11508547|FG000|Overall Study|Withdrawal by Subject|6
7290714|NCT00540293|11508547|FG000|Overall Study|Protocol violation, & subject schedule|12
7290715|NCT00540423|11508559|FG000|Double-Blind Treatment Period|Adverse Event|0
7290716|NCT00540423|11508560|FG001|Double-Blind Treatment Period|Adverse Event|1
7290717|NCT00540423|11508561|FG002|Double-Blind Treatment Period|Adverse Event|0
7290718|NCT00540423|11508559|FG000|Open-Label Treatment Period|Lack of Efficacy|0
7290719|NCT00540423|11508560|FG001|Open-Label Treatment Period|Lack of Efficacy|0
7290720|NCT00540423|11508561|FG002|Open-Label Treatment Period|Lack of Efficacy|2
7290721|NCT00540436|11508579|FG000|First 12-Week Treatment Period|Adverse Event|1
7290722|NCT00540436|11508579|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
7623693|NCT03529773|12034574|FG027|Overall Study|Withdrawal by Subject|1
7290723|NCT00540436|11508579|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
7290724|NCT00540436|11508579|FG000|Second 12-Week Treatment Period|Adverse Event|1
7290725|NCT00540449|11508585|FG000|Overall Study|Adverse Event|12
7290726|NCT00540449|11508586|FG001|Overall Study|Adverse Event|32
7290727|NCT00540449|11508585|FG000|Overall Study|Sponsor's Decision|1
7290728|NCT00540449|11508586|FG001|Overall Study|Sponsor's Decision|1
7290729|NCT00540449|11508585|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7290730|NCT00540449|11508586|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
7290731|NCT00540449|11508585|FG000|Overall Study|Lost to Follow-up|19
7290732|NCT00540449|11508586|FG001|Overall Study|Lost to Follow-up|17
7290733|NCT00540449|11508585|FG000|Overall Study|Subject Non-Compliant|7
7290734|NCT00540449|11508586|FG001|Overall Study|Subject Non-Compliant|5
7290735|NCT00540449|11508585|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
7290736|NCT00540449|11508586|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
7290737|NCT00540449|11508585|FG000|Overall Study|Withdrawal by Subject|10
7290738|NCT00540449|11508586|FG001|Overall Study|Withdrawal by Subject|10
7290739|NCT00540449|11508585|FG000|Overall Study|Other|1
7290740|NCT00540449|11508586|FG001|Overall Study|Other|4
7290741|NCT00540514|11508594|FG000|Overall Study|Still on treatment|3
7290742|NCT00540514|11508595|FG001|Overall Study|Still on treatment|0
7290743|NCT00540514|11508594|FG000|Overall Study|Unacceptable Toxicity|61
7290744|NCT00540514|11508595|FG001|Overall Study|Unacceptable Toxicity|62
7290745|NCT00540514|11508594|FG000|Overall Study|Adverse Event|20
7290746|NCT00540514|11508595|FG001|Overall Study|Adverse Event|24
7290747|NCT00540514|11508594|FG000|Overall Study|Physician Decision|86
7290748|NCT00540514|11508595|FG001|Overall Study|Physician Decision|99
7290749|NCT00540514|11508594|FG000|Overall Study|Protocol Deviation|3
7290750|NCT00540514|11508595|FG001|Overall Study|Protocol Deviation|4
7290751|NCT00540514|11508594|FG000|Overall Study|Lost to Follow-up|1
7290752|NCT00540514|11508595|FG001|Overall Study|Lost to Follow-up|1
7290753|NCT00540514|11508594|FG000|Overall Study|Withdrawal by Subject|65
7290754|NCT00540514|11508595|FG001|Overall Study|Withdrawal by Subject|67
7290755|NCT00540514|11508594|FG000|Overall Study|Excluded prior to treatment|7
7290756|NCT00540514|11508595|FG001|Overall Study|Excluded prior to treatment|7
7290757|NCT00540514|11508594|FG000|Overall Study|Paclitaxel not available|0
7290758|NCT00540514|11508595|FG001|Overall Study|Paclitaxel not available|2
7290759|NCT00540592|11508616|FG000|Overall Study|Adverse Event|0
7290760|NCT00540592|11508617|FG001|Overall Study|Adverse Event|1
7290761|NCT00540592|11508618|FG002|Overall Study|Adverse Event|0
7290762|NCT00540592|11508619|FG003|Overall Study|Adverse Event|0
7290763|NCT00540592|11508620|FG004|Overall Study|Adverse Event|1
7290764|NCT00540592|11508621|FG005|Overall Study|Adverse Event|0
7290765|NCT00540592|11508622|FG006|Overall Study|Adverse Event|0
7290766|NCT00540592|11508623|FG007|Overall Study|Adverse Event|1
7290767|NCT00540592|11508624|FG008|Overall Study|Adverse Event|1
7290768|NCT00540592|11508625|FG009|Overall Study|Adverse Event|2
7290769|NCT00540592|11508616|FG000|Overall Study|Lost to Follow-up|2
7290770|NCT00540592|11508617|FG001|Overall Study|Lost to Follow-up|0
7290771|NCT00540592|11508618|FG002|Overall Study|Lost to Follow-up|0
7290772|NCT00540592|11508619|FG003|Overall Study|Lost to Follow-up|0
7290773|NCT00540592|11508620|FG004|Overall Study|Lost to Follow-up|0
7290774|NCT00540592|11508621|FG005|Overall Study|Lost to Follow-up|0
7290775|NCT00540592|11508622|FG006|Overall Study|Lost to Follow-up|0
7290776|NCT00540592|11508623|FG007|Overall Study|Lost to Follow-up|0
7290777|NCT00540592|11508624|FG008|Overall Study|Lost to Follow-up|0
7290778|NCT00540592|11508625|FG009|Overall Study|Lost to Follow-up|0
7290779|NCT00540592|11508616|FG000|Overall Study|Withdrawal by Subject|0
7290780|NCT00540592|11508617|FG001|Overall Study|Withdrawal by Subject|0
7290781|NCT00540592|11508618|FG002|Overall Study|Withdrawal by Subject|1
7290782|NCT00540592|11508619|FG003|Overall Study|Withdrawal by Subject|1
7290783|NCT00540592|11508620|FG004|Overall Study|Withdrawal by Subject|0
7290784|NCT00540592|11508621|FG005|Overall Study|Withdrawal by Subject|0
7290785|NCT00540592|11508622|FG006|Overall Study|Withdrawal by Subject|0
7290786|NCT00540592|11508623|FG007|Overall Study|Withdrawal by Subject|0
7290787|NCT00540592|11508624|FG008|Overall Study|Withdrawal by Subject|0
7290788|NCT00540592|11508625|FG009|Overall Study|Withdrawal by Subject|0
7290789|NCT00540644|11508649|FG000|Overall Study|Adverse Event|3
7290790|NCT00540644|11508650|FG001|Overall Study|Adverse Event|1
7290791|NCT00540644|11508649|FG000|Overall Study|Disease Progression|3
7290792|NCT00540644|11508650|FG001|Overall Study|Disease Progression|1
7290793|NCT00540644|11508649|FG000|Overall Study|Physician Decision|0
7290794|NCT00540644|11508650|FG001|Overall Study|Physician Decision|5
7290795|NCT00540644|11508649|FG000|Overall Study|Withdrawal by Subject|2
7290796|NCT00540644|11508650|FG001|Overall Study|Withdrawal by Subject|2
7290797|NCT00540644|11508649|FG000|Overall Study|Noncomplilance|1
7290798|NCT00540644|11508650|FG001|Overall Study|Noncomplilance|0
7290799|NCT00541034|11508683|FG000|Overall Study|Non-Compliance|3
7290800|NCT00541099|11508687|FG000|Overall Study|Ineligible|3
7290801|NCT00541229|11508708|FG000|Treatment Period I (Week 1)|Physician Decision|0
7290802|NCT00541229|11508709|FG001|Treatment Period I (Week 1)|Physician Decision|0
7290803|NCT00541229|11508710|FG002|Treatment Period I (Week 1)|Physician Decision|1
7290804|NCT00541229|11508711|FG003|Treatment Period I (Week 1)|Physician Decision|0
7290805|NCT00541229|11508712|FG004|Treatment Period I (Week 1)|Physician Decision|0
7290806|NCT00541229|11508713|FG005|Treatment Period I (Week 1)|Physician Decision|0
7290807|NCT00541229|11508708|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
7290808|NCT00541229|11508709|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
7290809|NCT00541229|11508710|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
7290810|NCT00541229|11508711|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
7290811|NCT00541229|11508712|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
7290812|NCT00541229|11508713|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
7290813|NCT00541229|11508708|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7290814|NCT00541229|11508709|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7290815|NCT00541229|11508710|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7290816|NCT00541229|11508711|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7290817|NCT00541229|11508712|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
7290818|NCT00541229|11508713|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
7290819|NCT00541229|11508708|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7290820|NCT00541229|11508709|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7290821|NCT00541229|11508710|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
7290822|NCT00541229|11508711|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
7290823|NCT00541229|11508712|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7290824|NCT00541229|11508713|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
7290825|NCT00541229|11508708|FG000|Washout Period I (Week 2-5)|Adverse Event|1
7290826|NCT00541229|11508709|FG001|Washout Period I (Week 2-5)|Adverse Event|0
7290827|NCT00541229|11508710|FG002|Washout Period I (Week 2-5)|Adverse Event|1
7290828|NCT00541229|11508711|FG003|Washout Period I (Week 2-5)|Adverse Event|0
7290829|NCT00541229|11508712|FG004|Washout Period I (Week 2-5)|Adverse Event|0
7290830|NCT00541229|11508713|FG005|Washout Period I (Week 2-5)|Adverse Event|0
7290831|NCT00541229|11508708|FG000|Washout Period I (Week 2-5)|Physician Decision|0
7290832|NCT00541229|11508709|FG001|Washout Period I (Week 2-5)|Physician Decision|0
7290833|NCT00541229|11508710|FG002|Washout Period I (Week 2-5)|Physician Decision|0
7290834|NCT00541229|11508711|FG003|Washout Period I (Week 2-5)|Physician Decision|1
7290835|NCT00541229|11508712|FG004|Washout Period I (Week 2-5)|Physician Decision|0
7290836|NCT00541229|11508713|FG005|Washout Period I (Week 2-5)|Physician Decision|0
7290837|NCT00541229|11508708|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
7290838|NCT00541229|11508709|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
7290839|NCT00541229|11508710|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
7290840|NCT00541229|11508711|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
7290841|NCT00541229|11508712|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
7290842|NCT00541229|11508713|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
7290843|NCT00541229|11508708|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7290844|NCT00541229|11508709|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
7290845|NCT00541229|11508710|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7290846|NCT00541229|11508711|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
7290847|NCT00541229|11508712|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
7290848|NCT00541229|11508713|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
7290849|NCT00541229|11508708|FG000|Treatment Period II (Week 6)|Protocol Violation|0
7290850|NCT00541229|11508709|FG001|Treatment Period II (Week 6)|Protocol Violation|0
7290851|NCT00541229|11508710|FG002|Treatment Period II (Week 6)|Protocol Violation|0
7290852|NCT00541229|11508711|FG003|Treatment Period II (Week 6)|Protocol Violation|0
7290853|NCT00541229|11508712|FG004|Treatment Period II (Week 6)|Protocol Violation|1
7290854|NCT00541229|11508713|FG005|Treatment Period II (Week 6)|Protocol Violation|1
7290855|NCT00541229|11508708|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7290856|NCT00541229|11508709|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7290857|NCT00541229|11508710|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7290858|NCT00541229|11508711|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7551353|NCT02969187|11910614|FG000|Overall Study|Physician Decision|12
7290859|NCT00541229|11508712|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
7290860|NCT00541229|11508713|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
7290861|NCT00541229|11508708|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
7290862|NCT00541229|11508709|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
7290863|NCT00541229|11508710|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
7290864|NCT00541229|11508711|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
7290865|NCT00541229|11508712|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
7290866|NCT00541229|11508713|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
7290867|NCT00541229|11508708|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7290868|NCT00541229|11508709|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7290869|NCT00541229|11508710|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7290870|NCT00541229|11508711|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7290871|NCT00541229|11508712|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
7290872|NCT00541229|11508713|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
7290873|NCT00541229|11508708|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7290874|NCT00541229|11508709|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7290875|NCT00541229|11508710|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
7290876|NCT00541229|11508711|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
7623691|NCT03529773|12034572|FG025|Overall Study|Withdrawal by Subject|4
7623692|NCT03529773|12034573|FG026|Overall Study|Withdrawal by Subject|2
7623694|NCT03529773|12034575|FG028|Overall Study|Withdrawal by Subject|1
7623695|NCT03529773|12034576|FG029|Overall Study|Withdrawal by Subject|0
7623696|NCT03529773|12034577|FG030|Overall Study|Withdrawal by Subject|0
7623697|NCT03529773|12034578|FG031|Overall Study|Withdrawal by Subject|0
7623698|NCT03529773|12034579|FG032|Overall Study|Withdrawal by Subject|0
7623699|NCT03529773|12034580|FG033|Overall Study|Withdrawal by Subject|0
7623700|NCT03529773|12034581|FG034|Overall Study|Withdrawal by Subject|1
7623701|NCT03529773|12034582|FG035|Overall Study|Withdrawal by Subject|2
7623702|NCT03529773|12034583|FG036|Overall Study|Withdrawal by Subject|0
7623703|NCT03529773|12034584|FG037|Overall Study|Withdrawal by Subject|2
7623704|NCT03529773|12034585|FG038|Overall Study|Withdrawal by Subject|1
7623705|NCT03529773|12034586|FG039|Overall Study|Withdrawal by Subject|1
7623706|NCT03529773|12034547|FG000|Overall Study|Screen Failure|0
7623707|NCT03529773|12034548|FG001|Overall Study|Screen Failure|0
7623708|NCT03529773|12034549|FG002|Overall Study|Screen Failure|0
7623709|NCT03529773|12034550|FG003|Overall Study|Screen Failure|0
7623710|NCT03529773|12034551|FG004|Overall Study|Screen Failure|0
7623711|NCT03529773|12034552|FG005|Overall Study|Screen Failure|0
7623712|NCT03529773|12034553|FG006|Overall Study|Screen Failure|0
7623713|NCT03529773|12034554|FG007|Overall Study|Screen Failure|0
7623714|NCT03529773|12034555|FG008|Overall Study|Screen Failure|0
7623715|NCT03529773|12034556|FG009|Overall Study|Screen Failure|0
7623716|NCT03529773|12034557|FG010|Overall Study|Screen Failure|0
7623717|NCT03529773|12034558|FG011|Overall Study|Screen Failure|0
7623718|NCT03529773|12034559|FG012|Overall Study|Screen Failure|0
7623719|NCT03529773|12034560|FG013|Overall Study|Screen Failure|0
7623720|NCT03529773|12034561|FG014|Overall Study|Screen Failure|0
7623721|NCT03529773|12034562|FG015|Overall Study|Screen Failure|0
7623722|NCT03529773|12034563|FG016|Overall Study|Screen Failure|0
7623723|NCT03529773|12034564|FG017|Overall Study|Screen Failure|0
7623724|NCT03529773|12034565|FG018|Overall Study|Screen Failure|0
7623725|NCT03529773|12034566|FG019|Overall Study|Screen Failure|0
7623726|NCT03529773|12034567|FG020|Overall Study|Screen Failure|0
7623727|NCT03529773|12034568|FG021|Overall Study|Screen Failure|0
7623728|NCT03529773|12034569|FG022|Overall Study|Screen Failure|0
7623729|NCT03529773|12034570|FG023|Overall Study|Screen Failure|0
7623730|NCT03529773|12034571|FG024|Overall Study|Screen Failure|0
7623731|NCT03529773|12034572|FG025|Overall Study|Screen Failure|0
7623732|NCT03529773|12034573|FG026|Overall Study|Screen Failure|0
7623733|NCT03529773|12034574|FG027|Overall Study|Screen Failure|0
7623734|NCT03529773|12034575|FG028|Overall Study|Screen Failure|0
7623735|NCT03529773|12034576|FG029|Overall Study|Screen Failure|0
7290877|NCT00541229|11508712|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7290878|NCT00541229|11508713|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
7290879|NCT00541229|11508708|FG000|Treatment Period III (Week 11)|Adverse Event|0
7290880|NCT00541229|11508709|FG001|Treatment Period III (Week 11)|Adverse Event|0
7623736|NCT03529773|12034577|FG030|Overall Study|Screen Failure|0
7623737|NCT03529773|12034578|FG031|Overall Study|Screen Failure|0
7623738|NCT03529773|12034579|FG032|Overall Study|Screen Failure|0
7623739|NCT03529773|12034580|FG033|Overall Study|Screen Failure|0
7623740|NCT03529773|12034581|FG034|Overall Study|Screen Failure|0
7623741|NCT03529773|12034582|FG035|Overall Study|Screen Failure|0
7623742|NCT03529773|12034583|FG036|Overall Study|Screen Failure|1
7623743|NCT03529773|12034584|FG037|Overall Study|Screen Failure|1
7623744|NCT03529773|12034585|FG038|Overall Study|Screen Failure|0
7623745|NCT03529773|12034586|FG039|Overall Study|Screen Failure|1
7623746|NCT03529773|12034547|FG000|Overall Study|Randomized but not vaccinated|0
7623747|NCT03529773|12034548|FG001|Overall Study|Randomized but not vaccinated|0
7623748|NCT03529773|12034549|FG002|Overall Study|Randomized but not vaccinated|0
7623749|NCT03529773|12034550|FG003|Overall Study|Randomized but not vaccinated|0
7290881|NCT00541229|11508710|FG002|Treatment Period III (Week 11)|Adverse Event|0
7290882|NCT00541229|11508711|FG003|Treatment Period III (Week 11)|Adverse Event|0
7290883|NCT00541229|11508712|FG004|Treatment Period III (Week 11)|Adverse Event|1
7290884|NCT00541229|11508713|FG005|Treatment Period III (Week 11)|Adverse Event|0
7290885|NCT00541229|11508708|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7290886|NCT00541229|11508709|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7290887|NCT00541229|11508710|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7290888|NCT00541229|11508711|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7290889|NCT00541229|11508712|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
7290890|NCT00541229|11508713|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
7290891|NCT00541229|11508708|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7290892|NCT00541229|11508709|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7290893|NCT00541229|11508710|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
7290894|NCT00541229|11508711|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7290895|NCT00541229|11508712|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7290896|NCT00541229|11508713|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
7290897|NCT00541307|11508730|FG000|Overall Study|Death|5
7290898|NCT00541307|11508730|FG000|Overall Study|Physician Decision|3
7290899|NCT00541307|11508730|FG000|Overall Study|Withdrawal by Subject|6
7290900|NCT00541307|11508730|FG000|Overall Study|Lost to Follow-up|4
7290901|NCT00541307|11508730|FG000|Overall Study|Subject returned early (outside window)|1
7290902|NCT00541307|11508730|FG000|Overall Study|Surgical Bypass|5
7290903|NCT00541346|11508734|FG000|Follow-up|Adverse Event|1
7290904|NCT00541385|11508740|FG000|Overall Study|Adverse Event|6
7290905|NCT00541385|11508741|FG001|Overall Study|Adverse Event|3
7290906|NCT00541385|11508740|FG000|Overall Study|Withdrawal by Subject|2
7290907|NCT00541385|11508741|FG001|Overall Study|Withdrawal by Subject|2
7290908|NCT00541385|11508740|FG000|Overall Study|Lost to Follow-up|6
7623750|NCT03529773|12034551|FG004|Overall Study|Randomized but not vaccinated|0
7623751|NCT03529773|12034552|FG005|Overall Study|Randomized but not vaccinated|0
7623752|NCT03529773|12034553|FG006|Overall Study|Randomized but not vaccinated|0
7623753|NCT03529773|12034554|FG007|Overall Study|Randomized but not vaccinated|0
7623754|NCT03529773|12034555|FG008|Overall Study|Randomized but not vaccinated|0
7623755|NCT03529773|12034556|FG009|Overall Study|Randomized but not vaccinated|0
7623756|NCT03529773|12034557|FG010|Overall Study|Randomized but not vaccinated|0
7623757|NCT03529773|12034558|FG011|Overall Study|Randomized but not vaccinated|0
7623758|NCT03529773|12034559|FG012|Overall Study|Randomized but not vaccinated|0
7623759|NCT03529773|12034560|FG013|Overall Study|Randomized but not vaccinated|0
7623760|NCT03529773|12034561|FG014|Overall Study|Randomized but not vaccinated|0
7623761|NCT03529773|12034562|FG015|Overall Study|Randomized but not vaccinated|0
7623762|NCT03529773|12034563|FG016|Overall Study|Randomized but not vaccinated|0
7623763|NCT03529773|12034564|FG017|Overall Study|Randomized but not vaccinated|1
7623764|NCT03529773|12034565|FG018|Overall Study|Randomized but not vaccinated|0
7623765|NCT03529773|12034566|FG019|Overall Study|Randomized but not vaccinated|0
7623766|NCT03529773|12034567|FG020|Overall Study|Randomized but not vaccinated|0
7623767|NCT03529773|12034568|FG021|Overall Study|Randomized but not vaccinated|0
7623768|NCT03529773|12034569|FG022|Overall Study|Randomized but not vaccinated|0
7623769|NCT03529773|12034570|FG023|Overall Study|Randomized but not vaccinated|0
7623770|NCT03529773|12034571|FG024|Overall Study|Randomized but not vaccinated|0
7623771|NCT03529773|12034572|FG025|Overall Study|Randomized but not vaccinated|0
7623772|NCT03529773|12034573|FG026|Overall Study|Randomized but not vaccinated|0
7623773|NCT03529773|12034574|FG027|Overall Study|Randomized but not vaccinated|1
7623774|NCT03529773|12034575|FG028|Overall Study|Randomized but not vaccinated|0
7623775|NCT03529773|12034576|FG029|Overall Study|Randomized but not vaccinated|0
7623776|NCT03529773|12034577|FG030|Overall Study|Randomized but not vaccinated|0
7623777|NCT03529773|12034578|FG031|Overall Study|Randomized but not vaccinated|0
7623778|NCT03529773|12034579|FG032|Overall Study|Randomized but not vaccinated|0
7623779|NCT03529773|12034580|FG033|Overall Study|Randomized but not vaccinated|0
7623780|NCT03529773|12034581|FG034|Overall Study|Randomized but not vaccinated|0
7623781|NCT03529773|12034582|FG035|Overall Study|Randomized but not vaccinated|0
7623782|NCT03529773|12034583|FG036|Overall Study|Randomized but not vaccinated|0
7623783|NCT03529773|12034584|FG037|Overall Study|Randomized but not vaccinated|0
7623784|NCT03529773|12034585|FG038|Overall Study|Randomized but not vaccinated|0
7623785|NCT03529773|12034586|FG039|Overall Study|Randomized but not vaccinated|0
7623786|NCT03502070|12034689|FG000|Overall Study|Withdrawal by Subject|1
7623787|NCT03502070|12034689|FG000|Overall Study|Screen Failure|1
7623788|NCT03485911|12034696|FG000|Overall Study|Withdrawal by Subject|0
7623789|NCT03485911|12034697|FG001|Overall Study|Withdrawal by Subject|2
7623790|NCT03485911|12034698|FG002|Overall Study|Withdrawal by Subject|2
7623791|NCT03485911|12034696|FG000|Overall Study|Adverse Event|1
7623792|NCT03485911|12034697|FG001|Overall Study|Adverse Event|0
7623793|NCT03485911|12034698|FG002|Overall Study|Adverse Event|1
7623794|NCT03485911|12034696|FG000|Overall Study|High frequency of HAE attacks|0
7623795|NCT03485911|12034697|FG001|Overall Study|High frequency of HAE attacks|0
7623796|NCT03485911|12034698|FG002|Overall Study|High frequency of HAE attacks|1
7290909|NCT00541385|11508741|FG001|Overall Study|Lost to Follow-up|1
7290910|NCT00541385|11508740|FG000|Overall Study|Parasite reappearance/malaria|67
7290911|NCT00541385|11508741|FG001|Overall Study|Parasite reappearance/malaria|32
7290912|NCT00541450|11508749|FG000|Phase A|Adverse Event|3
7290913|NCT00541450|11508750|FG001|Phase A|Adverse Event|0
7290914|NCT00541450|11508749|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
7290915|NCT00541450|11508750|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
7290916|NCT00541450|11508749|FG000|Phase A|Hyperglycemia|0
7290917|NCT00541450|11508750|FG001|Phase A|Hyperglycemia|1
7290918|NCT00541450|11508749|FG000|Phase A|Lost to Follow-up|6
7290919|NCT00541450|11508750|FG001|Phase A|Lost to Follow-up|4
7290920|NCT00541450|11508749|FG000|Phase A|Physician Decision|2
7290921|NCT00541450|11508750|FG001|Phase A|Physician Decision|0
7290922|NCT00541450|11508749|FG000|Phase A|Protocol Violation|2
7290923|NCT00541450|11508750|FG001|Phase A|Protocol Violation|3
7290924|NCT00541450|11508749|FG000|Phase A|Withdrawal by Subject|7
7290925|NCT00541450|11508750|FG001|Phase A|Withdrawal by Subject|7
7290926|NCT00541450|11508749|FG000|Phase B|Adverse Event|6
7290927|NCT00541450|11508750|FG001|Phase B|Adverse Event|6
7290928|NCT00541450|11508749|FG000|Phase B|Hyperglycemia|10
7290929|NCT00541450|11508750|FG001|Phase B|Hyperglycemia|9
7290930|NCT00541450|11508749|FG000|Phase B|Lost to Follow-up|6
7290931|NCT00541450|11508750|FG001|Phase B|Lost to Follow-up|4
7290932|NCT00541450|11508749|FG000|Phase B|Physician Decision|4
7290933|NCT00541450|11508750|FG001|Phase B|Physician Decision|2
7290934|NCT00541450|11508749|FG000|Phase B|Pregnancy|0
7290935|NCT00541450|11508750|FG001|Phase B|Pregnancy|1
7290936|NCT00541450|11508749|FG000|Phase B|Protocol Violation|3
7290937|NCT00541450|11508750|FG001|Phase B|Protocol Violation|3
7290938|NCT00541450|11508749|FG000|Phase B|Withdrawal by Subject|8
7290939|NCT00541450|11508750|FG001|Phase B|Withdrawal by Subject|6
7290940|NCT00541658|11508767|FG000|Overall Study|Adverse Event|28
7290941|NCT00541658|11508768|FG001|Overall Study|Adverse Event|37
7290942|NCT00541658|11508769|FG002|Overall Study|Adverse Event|25
7290943|NCT00541658|11508767|FG000|Overall Study|Physician Decision|0
7290944|NCT00541658|11508768|FG001|Overall Study|Physician Decision|0
7290945|NCT00541658|11508769|FG002|Overall Study|Physician Decision|4
7290946|NCT00541658|11508767|FG000|Overall Study|Lost to Follow-up|3
7290947|NCT00541658|11508768|FG001|Overall Study|Lost to Follow-up|3
7290948|NCT00541658|11508769|FG002|Overall Study|Lost to Follow-up|6
7290949|NCT00541658|11508767|FG000|Overall Study|Protocol Violation|0
7290950|NCT00541658|11508768|FG001|Overall Study|Protocol Violation|1
7290951|NCT00541658|11508769|FG002|Overall Study|Protocol Violation|1
7290952|NCT00541658|11508767|FG000|Overall Study|Withdrawal by Subject|28
7290953|NCT00541658|11508768|FG001|Overall Study|Withdrawal by Subject|32
7290954|NCT00541658|11508769|FG002|Overall Study|Withdrawal by Subject|32
7290955|NCT00541658|11508767|FG000|Overall Study|Took No Study Drug|1
7290956|NCT00541658|11508768|FG001|Overall Study|Took No Study Drug|0
7290957|NCT00541658|11508769|FG002|Overall Study|Took No Study Drug|0
7290958|NCT00541775|11508791|FG000|Overall Study|Adverse Event|3
7290959|NCT00541775|11508792|FG001|Overall Study|Adverse Event|2
7290960|NCT00541775|11508793|FG002|Overall Study|Adverse Event|1
7290961|NCT00541775|11508791|FG000|Overall Study|Lack of Efficacy|0
7290962|NCT00541775|11508792|FG001|Overall Study|Lack of Efficacy|0
7290963|NCT00541775|11508793|FG002|Overall Study|Lack of Efficacy|3
7290964|NCT00541775|11508791|FG000|Overall Study|Lost to Follow-up|0
7290965|NCT00541775|11508792|FG001|Overall Study|Lost to Follow-up|0
7290966|NCT00541775|11508793|FG002|Overall Study|Lost to Follow-up|2
7290967|NCT00541775|11508791|FG000|Overall Study|Protocol Violation|1
7290968|NCT00541775|11508792|FG001|Overall Study|Protocol Violation|0
7290969|NCT00541775|11508793|FG002|Overall Study|Protocol Violation|0
7290970|NCT00541775|11508791|FG000|Overall Study|Withdrawal by Subject and Other|5
7290971|NCT00541775|11508792|FG001|Overall Study|Withdrawal by Subject and Other|0
7290972|NCT00541775|11508793|FG002|Overall Study|Withdrawal by Subject and Other|2
7290973|NCT00541866|11508806|FG000|Overall Study|Adverse Event|3
7290974|NCT00541866|11508807|FG001|Overall Study|Adverse Event|0
7290975|NCT00541866|11508808|FG002|Overall Study|Adverse Event|0
7290976|NCT00541866|11508809|FG003|Overall Study|Adverse Event|0
7290977|NCT00541866|11508810|FG004|Overall Study|Adverse Event|0
7290978|NCT00541866|11508806|FG000|Overall Study|Death|1
7290979|NCT00541866|11508807|FG001|Overall Study|Death|0
7290980|NCT00541866|11508808|FG002|Overall Study|Death|0
7290981|NCT00541866|11508809|FG003|Overall Study|Death|0
7290982|NCT00541866|11508810|FG004|Overall Study|Death|0
7290983|NCT00541866|11508806|FG000|Overall Study|Lack of Efficacy|19
7290984|NCT00541866|11508807|FG001|Overall Study|Lack of Efficacy|15
7290985|NCT00541866|11508808|FG002|Overall Study|Lack of Efficacy|10
7290986|NCT00541866|11508809|FG003|Overall Study|Lack of Efficacy|12
7290987|NCT00541866|11508810|FG004|Overall Study|Lack of Efficacy|14
7290988|NCT00541866|11508806|FG000|Overall Study|Not Reported or Other|11
7290989|NCT00541866|11508807|FG001|Overall Study|Not Reported or Other|3
7290990|NCT00541866|11508808|FG002|Overall Study|Not Reported or Other|3
7290991|NCT00541866|11508809|FG003|Overall Study|Not Reported or Other|3
7290992|NCT00541866|11508810|FG004|Overall Study|Not Reported or Other|1
7290993|NCT00541866|11508806|FG000|Overall Study|Physician Decision|0
7290994|NCT00541866|11508807|FG001|Overall Study|Physician Decision|0
7290995|NCT00541866|11508808|FG002|Overall Study|Physician Decision|2
7290996|NCT00541866|11508809|FG003|Overall Study|Physician Decision|1
7290997|NCT00541866|11508810|FG004|Overall Study|Physician Decision|0
7290998|NCT00541931|11508840|FG000|Overall Study|Adverse Event|1
7290999|NCT00541931|11508841|FG001|Overall Study|Adverse Event|0
7291000|NCT00541931|11508840|FG000|Overall Study|Lost to Follow-up|3
7291001|NCT00541931|11508841|FG001|Overall Study|Lost to Follow-up|3
7291002|NCT00541931|11508840|FG000|Overall Study|Withdrawal by Subject|1
7291003|NCT00541931|11508841|FG001|Overall Study|Withdrawal by Subject|0
7291004|NCT00541931|11508840|FG000|Overall Study|Transportation Issue|0
7291005|NCT00541931|11508841|FG001|Overall Study|Transportation Issue|1
7291006|NCT00541970|11508853|FG000|Month 7|Protocol Violation|9
7291007|NCT00541970|11508854|FG001|Month 7|Protocol Violation|13
7291008|NCT00541970|11508855|FG002|Month 7|Protocol Violation|11
7291009|NCT00541970|11508856|FG003|Month 7|Protocol Violation|5
7291010|NCT00541970|11508853|FG000|Month 12|Adverse Event|0
7291011|NCT00541970|11508854|FG001|Month 12|Adverse Event|1
7291012|NCT00541970|11508855|FG002|Month 12|Adverse Event|1
7291013|NCT00541970|11508856|FG003|Month 12|Adverse Event|1
7291014|NCT00541970|11508853|FG000|Month 12|Protocol Violation|12
7291015|NCT00541970|11508854|FG001|Month 12|Protocol Violation|21
7291016|NCT00541970|11508855|FG002|Month 12|Protocol Violation|20
7291017|NCT00541970|11508856|FG003|Month 12|Protocol Violation|15
7291018|NCT00541970|11508853|FG000|Month 18|Adverse Event|0
7291019|NCT00541970|11508854|FG001|Month 18|Adverse Event|1
7291020|NCT00541970|11508855|FG002|Month 18|Adverse Event|1
7291021|NCT00541970|11508856|FG003|Month 18|Adverse Event|1
7291022|NCT00541970|11508853|FG000|Month 18|Protocol Violation|14
7291023|NCT00541970|11508854|FG001|Month 18|Protocol Violation|23
7291024|NCT00541970|11508855|FG002|Month 18|Protocol Violation|24
7291025|NCT00541970|11508856|FG003|Month 18|Protocol Violation|16
7291026|NCT00541970|11508853|FG000|Month 24|Adverse Event|0
7291027|NCT00541970|11508854|FG001|Month 24|Adverse Event|1
7291028|NCT00541970|11508855|FG002|Month 24|Adverse Event|1
7291029|NCT00541970|11508856|FG003|Month 24|Adverse Event|1
7291030|NCT00541970|11508853|FG000|Month 24|Protocol Violation|29
7291031|NCT00541970|11508854|FG001|Month 24|Protocol Violation|31
7291032|NCT00541970|11508855|FG002|Month 24|Protocol Violation|31
7291033|NCT00541970|11508856|FG003|Month 24|Protocol Violation|21
7291034|NCT00541970|11508853|FG000|Month 36|Protocol Violation|61
7291035|NCT00541970|11508854|FG001|Month 36|Protocol Violation|66
7291036|NCT00541970|11508855|FG002|Month 36|Protocol Violation|66
7291037|NCT00541970|11508856|FG003|Month 36|Protocol Violation|60
7291038|NCT00541970|11508853|FG000|Month 48|Withdrawal by Subject|2
7291039|NCT00541970|11508854|FG001|Month 48|Withdrawal by Subject|4
7291040|NCT00541970|11508855|FG002|Month 48|Withdrawal by Subject|4
7291041|NCT00541970|11508856|FG003|Month 48|Withdrawal by Subject|2
7291042|NCT00541970|11508853|FG000|Month 48|Other|3
7291043|NCT00541970|11508854|FG001|Month 48|Other|1
7291044|NCT00541970|11508855|FG002|Month 48|Other|1
7291045|NCT00541970|11508856|FG003|Month 48|Other|0
7291046|NCT00541970|11508853|FG000|Month 48|Lost to Follow-up|66
7291047|NCT00541970|11508854|FG001|Month 48|Lost to Follow-up|68
7291048|NCT00541970|11508855|FG002|Month 48|Lost to Follow-up|68
7291049|NCT00541970|11508856|FG003|Month 48|Lost to Follow-up|73
7291050|NCT00541970|11508853|FG000|Month 60|Protocol Violation|78
7291051|NCT00541970|11508854|FG001|Month 60|Protocol Violation|77
7291052|NCT00541970|11508855|FG002|Month 60|Protocol Violation|82
7291053|NCT00541970|11508856|FG003|Month 60|Protocol Violation|72
7291054|NCT00542178|11508872|FG000|Overall Study|did not complete year 4 follow-up|75
7291055|NCT00542178|11508873|FG001|Overall Study|did not complete year 4 follow-up|80
7291056|NCT00542178|11508874|FG002|Overall Study|did not complete year 4 follow-up|74
7291057|NCT00542178|11508875|FG003|Overall Study|did not complete year 4 follow-up|62
7291058|NCT00542178|11508876|FG004|Overall Study|did not complete year 4 follow-up|64
7291059|NCT00542178|11508877|FG005|Overall Study|did not complete year 4 follow-up|89
7291060|NCT00542178|11508878|FG006|Overall Study|did not complete year 4 follow-up|87
7291061|NCT00542178|11508879|FG007|Overall Study|did not complete year 4 follow-up|85
7291062|NCT00542191|11508893|FG000|Overall Study|Death|3
7291063|NCT00542269|11508900|FG000|Overall Study|Adverse Event|10
7291064|NCT00542269|11508901|FG001|Overall Study|Adverse Event|4
7291065|NCT00542269|11508902|FG002|Overall Study|Adverse Event|5
7291066|NCT00542269|11508900|FG000|Overall Study|Protocol Violation|1
7291067|NCT00542269|11508901|FG001|Overall Study|Protocol Violation|1
7291068|NCT00542269|11508902|FG002|Overall Study|Protocol Violation|0
7291069|NCT00542269|11508900|FG000|Overall Study|Withdrawal by Subject|1
7291070|NCT00542269|11508901|FG001|Overall Study|Withdrawal by Subject|0
7291071|NCT00542269|11508902|FG002|Overall Study|Withdrawal by Subject|0
7291072|NCT00542269|11508900|FG000|Overall Study|Administrative problems|1
7291073|NCT00542269|11508901|FG001|Overall Study|Administrative problems|1
7291074|NCT00542269|11508902|FG002|Overall Study|Administrative problems|1
7291075|NCT00542321|11508918|FG000|Overall Study|Death|0
7291076|NCT00542321|11508919|FG001|Overall Study|Death|1
7291077|NCT00542386|11508931|FG000|Overall Study|Adverse Event|1
7291078|NCT00542386|11508932|FG001|Overall Study|Adverse Event|7
7291079|NCT00542386|11508933|FG002|Overall Study|Adverse Event|7
7291080|NCT00542386|11508934|FG003|Overall Study|Adverse Event|8
7291081|NCT00542386|11508935|FG004|Overall Study|Adverse Event|13
7291082|NCT00542386|11508936|FG005|Overall Study|Adverse Event|4
7291083|NCT00542386|11508931|FG000|Overall Study|Death|0
7291084|NCT00542386|11508932|FG001|Overall Study|Death|0
7291085|NCT00542386|11508933|FG002|Overall Study|Death|1
7291086|NCT00542386|11508934|FG003|Overall Study|Death|2
7291087|NCT00542386|11508935|FG004|Overall Study|Death|1
7291088|NCT00542386|11508936|FG005|Overall Study|Death|2
7291089|NCT00542386|11508931|FG000|Overall Study|Lack of Efficacy|32
7291090|NCT00542386|11508932|FG001|Overall Study|Lack of Efficacy|12
7291091|NCT00542386|11508933|FG002|Overall Study|Lack of Efficacy|10
7291092|NCT00542386|11508934|FG003|Overall Study|Lack of Efficacy|13
7291093|NCT00542386|11508935|FG004|Overall Study|Lack of Efficacy|7
7291094|NCT00542386|11508936|FG005|Overall Study|Lack of Efficacy|31
7291095|NCT00542386|11508931|FG000|Overall Study|Physician Decision|1
7291096|NCT00542386|11508932|FG001|Overall Study|Physician Decision|0
7291097|NCT00542386|11508933|FG002|Overall Study|Physician Decision|0
7291098|NCT00542386|11508934|FG003|Overall Study|Physician Decision|1
7291099|NCT00542386|11508935|FG004|Overall Study|Physician Decision|0
7291100|NCT00542386|11508936|FG005|Overall Study|Physician Decision|0
7291101|NCT00542386|11508931|FG000|Overall Study|Protocol Violation|0
7291102|NCT00542386|11508932|FG001|Overall Study|Protocol Violation|0
7291103|NCT00542386|11508933|FG002|Overall Study|Protocol Violation|1
7291104|NCT00542386|11508934|FG003|Overall Study|Protocol Violation|0
7291105|NCT00542386|11508935|FG004|Overall Study|Protocol Violation|0
7291106|NCT00542386|11508936|FG005|Overall Study|Protocol Violation|4
7291107|NCT00542386|11508931|FG000|Overall Study|Withdrawal by Subject|5
7291108|NCT00542386|11508932|FG001|Overall Study|Withdrawal by Subject|8
7291109|NCT00542386|11508933|FG002|Overall Study|Withdrawal by Subject|10
7291110|NCT00542386|11508934|FG003|Overall Study|Withdrawal by Subject|11
7291111|NCT00542386|11508935|FG004|Overall Study|Withdrawal by Subject|15
7291112|NCT00542386|11508936|FG005|Overall Study|Withdrawal by Subject|7
7291113|NCT00542386|11508931|FG000|Overall Study|Other Reasons|4
7291114|NCT00542386|11508932|FG001|Overall Study|Other Reasons|1
7291115|NCT00542386|11508933|FG002|Overall Study|Other Reasons|4
7291116|NCT00542386|11508934|FG003|Overall Study|Other Reasons|3
7291117|NCT00542386|11508935|FG004|Overall Study|Other Reasons|4
7291118|NCT00542386|11508936|FG005|Overall Study|Other Reasons|2
7291119|NCT00542425|11508955|FG000|Initial 24 Weeks|Administrative reasons|0
7291120|NCT00542425|11508956|FG001|Initial 24 Weeks|Administrative reasons|0
7291121|NCT00542425|11508957|FG002|Initial 24 Weeks|Administrative reasons|1
7291122|NCT00542425|11508958|FG003|Initial 24 Weeks|Administrative reasons|1
7291123|NCT00542425|11508959|FG004|Initial 24 Weeks|Administrative reasons|0
7291124|NCT00542425|11508955|FG000|Initial 24 Weeks|Adverse Event|0
7291125|NCT00542425|11508956|FG001|Initial 24 Weeks|Adverse Event|1
7291126|NCT00542425|11508957|FG002|Initial 24 Weeks|Adverse Event|1
7291127|NCT00542425|11508958|FG003|Initial 24 Weeks|Adverse Event|3
7291128|NCT00542425|11508959|FG004|Initial 24 Weeks|Adverse Event|2
7291129|NCT00542425|11508955|FG000|Initial 24 Weeks|Inability to complete procedures|0
7291130|NCT00542425|11508956|FG001|Initial 24 Weeks|Inability to complete procedures|3
7291131|NCT00542425|11508957|FG002|Initial 24 Weeks|Inability to complete procedures|2
7291132|NCT00542425|11508958|FG003|Initial 24 Weeks|Inability to complete procedures|1
7291133|NCT00542425|11508959|FG004|Initial 24 Weeks|Inability to complete procedures|2
7291134|NCT00542425|11508955|FG000|Initial 24 Weeks|Lost to Follow-up|2
7291135|NCT00542425|11508956|FG001|Initial 24 Weeks|Lost to Follow-up|2
7291136|NCT00542425|11508957|FG002|Initial 24 Weeks|Lost to Follow-up|1
7291137|NCT00542425|11508958|FG003|Initial 24 Weeks|Lost to Follow-up|0
7291138|NCT00542425|11508959|FG004|Initial 24 Weeks|Lost to Follow-up|0
7291139|NCT00542425|11508955|FG000|Initial 24 Weeks|Non-compliance|0
7291140|NCT00542425|11508956|FG001|Initial 24 Weeks|Non-compliance|0
7291141|NCT00542425|11508957|FG002|Initial 24 Weeks|Non-compliance|0
7291142|NCT00542425|11508958|FG003|Initial 24 Weeks|Non-compliance|1
7291143|NCT00542425|11508959|FG004|Initial 24 Weeks|Non-compliance|1
7291144|NCT00542425|11508955|FG000|Initial 24 Weeks|Protocol Violation|0
7291145|NCT00542425|11508956|FG001|Initial 24 Weeks|Protocol Violation|0
7291146|NCT00542425|11508957|FG002|Initial 24 Weeks|Protocol Violation|0
7291147|NCT00542425|11508958|FG003|Initial 24 Weeks|Protocol Violation|1
7291148|NCT00542425|11508959|FG004|Initial 24 Weeks|Protocol Violation|0
7291149|NCT00542425|11508955|FG000|Initial 24 Weeks|Refusal of treatment|2
7291150|NCT00542425|11508956|FG001|Initial 24 Weeks|Refusal of treatment|2
7291151|NCT00542425|11508957|FG002|Initial 24 Weeks|Refusal of treatment|1
7291152|NCT00542425|11508958|FG003|Initial 24 Weeks|Refusal of treatment|4
7291153|NCT00542425|11508959|FG004|Initial 24 Weeks|Refusal of treatment|1
7291154|NCT00542425|11508955|FG000|Initial 24 Weeks|Other|0
7291155|NCT00542425|11508956|FG001|Initial 24 Weeks|Other|2
7291156|NCT00542425|11508957|FG002|Initial 24 Weeks|Other|1
7291157|NCT00542425|11508958|FG003|Initial 24 Weeks|Other|0
7291158|NCT00542425|11508959|FG004|Initial 24 Weeks|Other|0
7291159|NCT00542425|11508955|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
7291160|NCT00542425|11508956|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
7291161|NCT00542425|11508957|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
7291162|NCT00542425|11508958|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
7291163|NCT00542425|11508959|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
7291164|NCT00542425|11508955|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
7291165|NCT00542425|11508956|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
7291166|NCT00542425|11508957|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
7291167|NCT00542425|11508958|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
7291168|NCT00542425|11508959|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
7291169|NCT00542425|11508955|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
7291170|NCT00542425|11508956|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
7291171|NCT00542425|11508957|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
7291172|NCT00542425|11508958|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
7291173|NCT00542425|11508959|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
7291174|NCT00542425|11508955|FG000|Extended 24 Weeks of Treatment|Other|1
7291175|NCT00542425|11508956|FG001|Extended 24 Weeks of Treatment|Other|1
7291176|NCT00542425|11508957|FG002|Extended 24 Weeks of Treatment|Other|0
7291177|NCT00542425|11508958|FG003|Extended 24 Weeks of Treatment|Other|0
7291178|NCT00542425|11508959|FG004|Extended 24 Weeks of Treatment|Other|1
7291179|NCT00542789|11508990|FG000|Overall Study|Adverse Event|18
7291180|NCT00542789|11508991|FG001|Overall Study|Adverse Event|17
7291181|NCT00542789|11508990|FG000|Overall Study|Withdrawal by Subject|7
7291182|NCT00542789|11508991|FG001|Overall Study|Withdrawal by Subject|3
7291183|NCT00542789|11508990|FG000|Overall Study|Protocol Violation|8
7291184|NCT00542789|11508991|FG001|Overall Study|Protocol Violation|1
7291185|NCT00542789|11508990|FG000|Overall Study|Recurrence of Gastric Ulcer|8
7291186|NCT00542789|11508991|FG001|Overall Study|Recurrence of Gastric Ulcer|57
7291187|NCT00542815|11509000|FG000|Overall Study|Adverse Event|19
7291188|NCT00542815|11509001|FG001|Overall Study|Adverse Event|6
7291189|NCT00542815|11509002|FG002|Overall Study|Adverse Event|9
7291190|NCT00542815|11509000|FG000|Overall Study|Death|10
7291191|NCT00542815|11509001|FG001|Overall Study|Death|7
7291192|NCT00542815|11509002|FG002|Overall Study|Death|3
7291193|NCT00542815|11509000|FG000|Overall Study|Lack of Efficacy|9
7291194|NCT00542815|11509001|FG001|Overall Study|Lack of Efficacy|2
7291195|NCT00542815|11509002|FG002|Overall Study|Lack of Efficacy|0
7291196|NCT00542815|11509000|FG000|Overall Study|Physician Decision|2
7291197|NCT00542815|11509001|FG001|Overall Study|Physician Decision|1
7291198|NCT00542815|11509002|FG002|Overall Study|Physician Decision|0
7291199|NCT00542815|11509000|FG000|Overall Study|Protocol Violation|1
7291200|NCT00542815|11509001|FG001|Overall Study|Protocol Violation|1
7291201|NCT00542815|11509002|FG002|Overall Study|Protocol Violation|2
7291202|NCT00542815|11509000|FG000|Overall Study|Withdrawal by Subject|41
7291203|NCT00542815|11509001|FG001|Overall Study|Withdrawal by Subject|5
7291204|NCT00542815|11509002|FG002|Overall Study|Withdrawal by Subject|8
7291205|NCT00542815|11509000|FG000|Overall Study|Other reasons|24
7291206|NCT00542815|11509001|FG001|Overall Study|Other reasons|10
7291207|NCT00542815|11509002|FG002|Overall Study|Other reasons|10
7291208|NCT00542828|11509010|FG000|Overall Study|Physician Decision|1
7291209|NCT00542828|11509010|FG000|Overall Study|Need for Prohibited Treatment|3
7291210|NCT00542828|11509010|FG000|Overall Study|Study Prematurely Discontinued|7
7291211|NCT00542828|11509010|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
7291212|NCT00542880|11509016|FG000|Period 1|Eligibility criteria not fulfilled|2
7291213|NCT00542880|11509017|FG001|Period 1|Eligibility criteria not fulfilled|6
7291214|NCT00542880|11509016|FG000|Period 1|Adverse Event|2
7291215|NCT00542880|11509017|FG001|Period 1|Adverse Event|2
7291216|NCT00542880|11509016|FG000|Period 1|Development of study-specific criteria|1
7291217|NCT00542880|11509017|FG001|Period 1|Development of study-specific criteria|2
7291218|NCT00542880|11509016|FG000|Period 1|Withdrawal by Subject|1
7291219|NCT00542880|11509017|FG001|Period 1|Withdrawal by Subject|1
7291220|NCT00542880|11509016|FG000|Period 1|Protocol Violation|0
7291221|NCT00542880|11509017|FG001|Period 1|Protocol Violation|1
7291222|NCT00542880|11509016|FG000|Period 2|Adverse Event|5
7291223|NCT00542880|11509017|FG001|Period 2|Adverse Event|7
7291224|NCT00542880|11509016|FG000|Period 2|Eligibility not fulfilled|0
7291225|NCT00542880|11509017|FG001|Period 2|Eligibility not fulfilled|1
7291226|NCT00542880|11509016|FG000|Period 2|Discontinuation criteria|2
7291227|NCT00542880|11509017|FG001|Period 2|Discontinuation criteria|0
7291228|NCT00542880|11509016|FG000|Period 2|Severe non-compliance|0
7291229|NCT00542880|11509017|FG001|Period 2|Severe non-compliance|1
7291230|NCT00542880|11509016|FG000|Period 2|Other|0
7291231|NCT00542880|11509017|FG001|Period 2|Other|1
7291232|NCT00542880|11509016|FG000|Period 3|Adverse Event|0
7291233|NCT00542880|11509017|FG001|Period 3|Adverse Event|2
7291234|NCT00542919|11509027|FG000|Overall Study|Adverse Event|1
7291235|NCT00542919|11509028|FG001|Overall Study|Adverse Event|5
7291236|NCT00542919|11509029|FG002|Overall Study|Adverse Event|1
7291237|NCT00542919|11509027|FG000|Overall Study|Withdrawal by Subject|1
7291238|NCT00542919|11509028|FG001|Overall Study|Withdrawal by Subject|0
7291239|NCT00542919|11509029|FG002|Overall Study|Withdrawal by Subject|3
7291240|NCT00542919|11509027|FG000|Overall Study|Physician Decision|2
7623797|NCT03403634|12034706|FG000|Overall Study|Disease progression|3
7623798|NCT03403634|12034706|FG000|Overall Study|Did not meet eligibility criteria|4
7291241|NCT00542919|11509028|FG001|Overall Study|Physician Decision|2
7291242|NCT00542919|11509029|FG002|Overall Study|Physician Decision|1
7291243|NCT00542919|11509027|FG000|Overall Study|Sponsor Decision|1
7291244|NCT00542919|11509028|FG001|Overall Study|Sponsor Decision|0
7291245|NCT00542919|11509029|FG002|Overall Study|Sponsor Decision|0
7291246|NCT00542919|11509027|FG000|Overall Study|Lost to Follow-up|2
7291247|NCT00542919|11509028|FG001|Overall Study|Lost to Follow-up|0
7291248|NCT00542919|11509029|FG002|Overall Study|Lost to Follow-up|1
7291249|NCT00542997|11509056|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
7291250|NCT00542997|11509056|FG000|Wash in / Wash Out Period|Adverse Event|3
7291251|NCT00542997|11509056|FG000|Efficacy Period|Adverse Event|3
7291252|NCT00543062|11509063|FG000|Overall Study|Withdrawal by Subject|1
7291253|NCT00543062|11509064|FG001|Overall Study|Withdrawal by Subject|0
7291254|NCT00543062|11509065|FG002|Overall Study|Withdrawal by Subject|2
7291255|NCT00543062|11509066|FG003|Overall Study|Withdrawal by Subject|0
7291256|NCT00543062|11509063|FG000|Overall Study|Adverse Event|0
7291257|NCT00543062|11509064|FG001|Overall Study|Adverse Event|1
7291258|NCT00543062|11509065|FG002|Overall Study|Adverse Event|1
7291259|NCT00543062|11509066|FG003|Overall Study|Adverse Event|1
7291260|NCT00543062|11509063|FG000|Overall Study|Protocol Violation|1
7291261|NCT00543062|11509064|FG001|Overall Study|Protocol Violation|0
7291262|NCT00543062|11509065|FG002|Overall Study|Protocol Violation|0
7291263|NCT00543062|11509066|FG003|Overall Study|Protocol Violation|0
7291264|NCT00543140|11509103|FG000|Overall Study|Lost to Follow-up|33
7291265|NCT00543140|11509103|FG000|Overall Study|Withdrawal by Subject|13
7291266|NCT00543140|11509103|FG000|Overall Study|Protocol Violation|10
7291267|NCT00543140|11509103|FG000|Overall Study|Insufficient weight loss|10
7291268|NCT00543140|11509103|FG000|Overall Study|SAE leading to explant of SAGB|3
7291269|NCT00543140|11509103|FG000|Overall Study|Death|1
7291270|NCT00543140|11509103|FG000|Overall Study|Subject moved|1
7291271|NCT00543140|11509103|FG000|Overall Study|Conversion to different procedure|1
7291272|NCT00543296|11509107|FG000|Overall Study|Physician Decision|7
7291273|NCT00543309|11509114|FG000|Overall Study|Physician Decision|0
7291274|NCT00543309|11509115|FG001|Overall Study|Physician Decision|1
7291275|NCT00543309|11509116|FG002|Overall Study|Physician Decision|0
7291276|NCT00543387|11509134|FG000|Panel 1 + Panel 2|Adverse Event|0
7291277|NCT00543387|11509135|FG001|Panel 1 + Panel 2|Adverse Event|1
7291278|NCT00543387|11509136|FG002|Panel 1 + Panel 2|Adverse Event|0
7291279|NCT00543387|11509137|FG003|Panel 1 + Panel 2|Adverse Event|0
7291280|NCT00543387|11509138|FG004|Panel 1 + Panel 2|Adverse Event|0
7291281|NCT00543387|11509139|FG005|Panel 1 + Panel 2|Adverse Event|0
7291282|NCT00543387|11509140|FG006|Panel 1 + Panel 2|Adverse Event|0
7291283|NCT00543387|11509141|FG007|Panel 1 + Panel 2|Adverse Event|1
7291284|NCT00543387|11509142|FG008|Panel 1 + Panel 2|Adverse Event|1
7291285|NCT00543387|11509143|FG009|Panel 1 + Panel 2|Adverse Event|0
7291286|NCT00543387|11509144|FG010|Panel 1 + Panel 2|Adverse Event|0
7291287|NCT00543387|11509134|FG000|Panel 1 + Panel 2|Physician Decision|0
7291288|NCT00543387|11509135|FG001|Panel 1 + Panel 2|Physician Decision|0
7291289|NCT00543387|11509136|FG002|Panel 1 + Panel 2|Physician Decision|1
7291290|NCT00543387|11509137|FG003|Panel 1 + Panel 2|Physician Decision|0
7291291|NCT00543387|11509138|FG004|Panel 1 + Panel 2|Physician Decision|0
7291292|NCT00543387|11509139|FG005|Panel 1 + Panel 2|Physician Decision|0
7291293|NCT00543387|11509140|FG006|Panel 1 + Panel 2|Physician Decision|0
7291294|NCT00543387|11509141|FG007|Panel 1 + Panel 2|Physician Decision|1
7291295|NCT00543387|11509142|FG008|Panel 1 + Panel 2|Physician Decision|0
7291296|NCT00543387|11509143|FG009|Panel 1 + Panel 2|Physician Decision|0
7291297|NCT00543387|11509144|FG010|Panel 1 + Panel 2|Physician Decision|0
7291298|NCT00543387|11509134|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
7291299|NCT00543387|11509135|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
7291300|NCT00543387|11509136|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
7291301|NCT00543387|11509137|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
7291302|NCT00543387|11509138|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
7291303|NCT00543387|11509139|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
7291304|NCT00543387|11509140|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
7291305|NCT00543387|11509141|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
7291306|NCT00543387|11509142|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
7291307|NCT00543387|11509143|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
7291308|NCT00543387|11509144|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
7291309|NCT00543387|11509134|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
7291310|NCT00543387|11509135|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
7291311|NCT00543387|11509136|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
7291312|NCT00543387|11509137|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
7291313|NCT00543387|11509138|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
7291314|NCT00543387|11509139|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
7291315|NCT00543387|11509140|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
7291316|NCT00543387|11509141|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
7291317|NCT00543387|11509142|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
7291318|NCT00543387|11509143|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
7291319|NCT00543387|11509144|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
7623799|NCT03382041|12034712|FG000|Overall Study|Consent Form Lost|2
7291320|NCT00543387|11509134|FG000|Crossover Participants|Progressive Disease|0
7291321|NCT00543387|11509135|FG001|Crossover Participants|Progressive Disease|0
7291322|NCT00543387|11509136|FG002|Crossover Participants|Progressive Disease|0
7291323|NCT00543387|11509137|FG003|Crossover Participants|Progressive Disease|0
7291324|NCT00543387|11509138|FG004|Crossover Participants|Progressive Disease|0
7291325|NCT00543387|11509139|FG005|Crossover Participants|Progressive Disease|0
7291326|NCT00543387|11509140|FG006|Crossover Participants|Progressive Disease|0
7291327|NCT00543387|11509141|FG007|Crossover Participants|Progressive Disease|0
7291328|NCT00543387|11509142|FG008|Crossover Participants|Progressive Disease|0
7291329|NCT00543387|11509143|FG009|Crossover Participants|Progressive Disease|1
7291330|NCT00543387|11509144|FG010|Crossover Participants|Progressive Disease|2
7291331|NCT00543387|11509134|FG000|Crossover Participants|Study Terminated by Sponsor|0
7291332|NCT00543387|11509135|FG001|Crossover Participants|Study Terminated by Sponsor|0
7291333|NCT00543387|11509136|FG002|Crossover Participants|Study Terminated by Sponsor|0
7291334|NCT00543387|11509137|FG003|Crossover Participants|Study Terminated by Sponsor|0
7291335|NCT00543387|11509138|FG004|Crossover Participants|Study Terminated by Sponsor|0
7291336|NCT00543387|11509139|FG005|Crossover Participants|Study Terminated by Sponsor|0
7291337|NCT00543387|11509140|FG006|Crossover Participants|Study Terminated by Sponsor|0
7291338|NCT00543387|11509141|FG007|Crossover Participants|Study Terminated by Sponsor|0
7291339|NCT00543387|11509142|FG008|Crossover Participants|Study Terminated by Sponsor|0
7291340|NCT00543387|11509143|FG009|Crossover Participants|Study Terminated by Sponsor|0
7291341|NCT00543387|11509144|FG010|Crossover Participants|Study Terminated by Sponsor|1
7291342|NCT00543439|11509188|FG000|Period 1|Adverse Event|0
7291343|NCT00543439|11509189|FG001|Period 1|Adverse Event|2
7291344|NCT00543439|11509190|FG002|Period 1|Adverse Event|1
7291345|NCT00543439|11509188|FG000|Period 1|Withdrawal by Subject|1
7623800|NCT03382041|12034713|FG001|Overall Study|Consent Form Lost|1
7623801|NCT03382041|12034712|FG000|Overall Study|Withdrawal by Subject|1
7623802|NCT03382041|12034713|FG001|Overall Study|Withdrawal by Subject|4
7623803|NCT03382041|12034712|FG000|Overall Study|Lost to Follow-up|1
7623804|NCT03382041|12034713|FG001|Overall Study|Lost to Follow-up|4
7623805|NCT03201419|12034728|FG000|Overall Study|Adverse Event|3
7623806|NCT03201419|12034729|FG001|Overall Study|Adverse Event|1
7623807|NCT03201419|12034730|FG002|Overall Study|Adverse Event|0
7623808|NCT03201419|12034731|FG003|Overall Study|Adverse Event|0
7623809|NCT03201419|12034732|FG004|Overall Study|Adverse Event|1
7623810|NCT03201419|12034733|FG005|Overall Study|Adverse Event|1
7623811|NCT03201419|12034734|FG006|Overall Study|Adverse Event|5
7623812|NCT03201419|12034735|FG007|Overall Study|Adverse Event|0
7623813|NCT03201419|12034736|FG008|Overall Study|Adverse Event|0
7623814|NCT03201419|12034728|FG000|Overall Study|Lost to Follow-up|1
7623815|NCT03201419|12034729|FG001|Overall Study|Lost to Follow-up|0
7623816|NCT03201419|12034730|FG002|Overall Study|Lost to Follow-up|0
7623817|NCT03201419|12034731|FG003|Overall Study|Lost to Follow-up|0
7623818|NCT03201419|12034732|FG004|Overall Study|Lost to Follow-up|0
7623819|NCT03201419|12034733|FG005|Overall Study|Lost to Follow-up|0
7623820|NCT03201419|12034734|FG006|Overall Study|Lost to Follow-up|0
7623821|NCT03201419|12034735|FG007|Overall Study|Lost to Follow-up|0
7623822|NCT03201419|12034736|FG008|Overall Study|Lost to Follow-up|0
7623823|NCT03201419|12034728|FG000|Overall Study|Protocol Deviation|0
7623824|NCT03201419|12034729|FG001|Overall Study|Protocol Deviation|0
7623825|NCT03201419|12034730|FG002|Overall Study|Protocol Deviation|0
7623826|NCT03201419|12034731|FG003|Overall Study|Protocol Deviation|0
7623827|NCT03201419|12034732|FG004|Overall Study|Protocol Deviation|0
7623828|NCT03201419|12034733|FG005|Overall Study|Protocol Deviation|0
7623829|NCT03201419|12034734|FG006|Overall Study|Protocol Deviation|1
7623830|NCT03201419|12034735|FG007|Overall Study|Protocol Deviation|0
7623831|NCT03201419|12034736|FG008|Overall Study|Protocol Deviation|0
7623832|NCT03201419|12034728|FG000|Overall Study|Withdrawal by Subject|4
7623833|NCT03201419|12034729|FG001|Overall Study|Withdrawal by Subject|2
7623834|NCT03201419|12034730|FG002|Overall Study|Withdrawal by Subject|1
7623835|NCT03201419|12034731|FG003|Overall Study|Withdrawal by Subject|0
7623836|NCT03201419|12034732|FG004|Overall Study|Withdrawal by Subject|0
7623837|NCT03201419|12034733|FG005|Overall Study|Withdrawal by Subject|0
7623838|NCT03201419|12034734|FG006|Overall Study|Withdrawal by Subject|0
7623839|NCT03201419|12034735|FG007|Overall Study|Withdrawal by Subject|1
7623840|NCT03201419|12034736|FG008|Overall Study|Withdrawal by Subject|2
7623841|NCT03201419|12034728|FG000|Overall Study|Other|0
7623842|NCT03201419|12034729|FG001|Overall Study|Other|0
7623843|NCT03201419|12034730|FG002|Overall Study|Other|1
7623844|NCT03201419|12034731|FG003|Overall Study|Other|0
7623845|NCT03201419|12034732|FG004|Overall Study|Other|0
7623846|NCT03201419|12034733|FG005|Overall Study|Other|0
7623847|NCT03201419|12034734|FG006|Overall Study|Other|0
7623848|NCT03201419|12034735|FG007|Overall Study|Other|0
7623849|NCT03201419|12034736|FG008|Overall Study|Other|0
7623850|NCT03197766|12034772|FG000|Overall Study|Withdrawal by Subject|2
7623851|NCT03197766|12034773|FG001|Overall Study|Withdrawal by Subject|0
7217889|NCT02359994|11426179|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0
7217890|NCT02359994|11426180|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1
7217891|NCT02359994|11426179|FG000|Extended Oncology 24-Month Survival|Death|19
7217892|NCT02359994|11426180|FG001|Extended Oncology 24-Month Survival|Death|21
7217893|NCT02359994|11426179|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1
7217894|NCT02359994|11426180|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0
7217895|NCT02336230|11426186|FG000|Overall Study|Adverse Event|1
7217896|NCT02336230|11426186|FG000|Overall Study|Withdrawal of consent|1
7217897|NCT02336230|11426186|FG000|Overall Study|Death|9
7217898|NCT02336230|11426186|FG000|Overall Study|Dose not received due to shipping delay|1
7217899|NCT02336230|11426186|FG000|Overall Study|Discontinuation of MSC infusion|1
7291346|NCT00543439|11509189|FG001|Period 1|Withdrawal by Subject|1
7291347|NCT00543439|11509190|FG002|Period 1|Withdrawal by Subject|0
7291348|NCT00543439|11509188|FG000|Period 1|Physician Decision|0
7291349|NCT00543439|11509189|FG001|Period 1|Physician Decision|0
7291350|NCT00543439|11509190|FG002|Period 1|Physician Decision|1
7291351|NCT00543439|11509188|FG000|Period 2|Protocol Violation|1
7291352|NCT00543439|11509189|FG001|Period 2|Protocol Violation|0
7291353|NCT00543439|11509190|FG002|Period 2|Protocol Violation|1
7291354|NCT00543439|11509188|FG000|Period 2|Adverse Event|0
7291355|NCT00543439|11509189|FG001|Period 2|Adverse Event|1
7291356|NCT00543439|11509190|FG002|Period 2|Adverse Event|1
7291357|NCT00543543|11509211|FG000|Base Study|Adverse Event|1
7291358|NCT00543543|11509212|FG001|Base Study|Adverse Event|11
7291359|NCT00543543|11509213|FG002|Base Study|Adverse Event|0
7291360|NCT00543543|11509214|FG003|Base Study|Adverse Event|5
7291361|NCT00543543|11509211|FG000|Base Study|Lost to Follow-up|12
7291362|NCT00543543|11509212|FG001|Base Study|Lost to Follow-up|749
7291363|NCT00543543|11509213|FG002|Base Study|Lost to Follow-up|9
7291364|NCT00543543|11509214|FG003|Base Study|Lost to Follow-up|701
7291365|NCT00543543|11509211|FG000|Base Study|Physician Decision|0
7291366|NCT00543543|11509212|FG001|Base Study|Physician Decision|4
7291367|NCT00543543|11509213|FG002|Base Study|Physician Decision|0
7291368|NCT00543543|11509214|FG003|Base Study|Physician Decision|7
7291369|NCT00543543|11509211|FG000|Base Study|Protocol Violation|0
7291370|NCT00543543|11509212|FG001|Base Study|Protocol Violation|6
7291371|NCT00543543|11509213|FG002|Base Study|Protocol Violation|0
7291372|NCT00543543|11509214|FG003|Base Study|Protocol Violation|6
7291373|NCT00543543|11509211|FG000|Base Study|Withdrawal by Subject|7
7291374|NCT00543543|11509212|FG001|Base Study|Withdrawal by Subject|482
7291375|NCT00543543|11509213|FG002|Base Study|Withdrawal by Subject|5
7291376|NCT00543543|11509214|FG003|Base Study|Withdrawal by Subject|503
7291377|NCT00543543|11509211|FG000|Extension Study|Adverse Event|0
7291378|NCT00543543|11509212|FG001|Extension Study|Adverse Event|0
7291379|NCT00543543|11509213|FG002|Extension Study|Adverse Event|0
7291380|NCT00543543|11509214|FG003|Extension Study|Adverse Event|5
7291381|NCT00543543|11509211|FG000|Extension Study|Lost to Follow-up|0
7291382|NCT00543543|11509212|FG001|Extension Study|Lost to Follow-up|0
7291383|NCT00543543|11509213|FG002|Extension Study|Lost to Follow-up|0
7291384|NCT00543543|11509214|FG003|Extension Study|Lost to Follow-up|77
7291385|NCT00543543|11509211|FG000|Extension Study|Physician Decision|0
7291386|NCT00543543|11509212|FG001|Extension Study|Physician Decision|0
7291387|NCT00543543|11509213|FG002|Extension Study|Physician Decision|0
7291388|NCT00543543|11509214|FG003|Extension Study|Physician Decision|7
7291389|NCT00543543|11509211|FG000|Extension Study|Pregnancy|0
7291390|NCT00543543|11509212|FG001|Extension Study|Pregnancy|0
7291391|NCT00543543|11509213|FG002|Extension Study|Pregnancy|0
7291392|NCT00543543|11509214|FG003|Extension Study|Pregnancy|6
7291393|NCT00543543|11509211|FG000|Extension Study|Protocol Violation|0
7291394|NCT00543543|11509212|FG001|Extension Study|Protocol Violation|0
7291395|NCT00543543|11509213|FG002|Extension Study|Protocol Violation|0
7291396|NCT00543543|11509214|FG003|Extension Study|Protocol Violation|11
7291397|NCT00543543|11509211|FG000|Extension Study|Withdrawal by Subject|0
7291398|NCT00543543|11509212|FG001|Extension Study|Withdrawal by Subject|0
7291399|NCT00543543|11509213|FG002|Extension Study|Withdrawal by Subject|0
7291400|NCT00543543|11509214|FG003|Extension Study|Withdrawal by Subject|120
7291401|NCT00543569|11509233|FG000|Overall Study|Death|2
7291402|NCT00543569|11509234|FG001|Overall Study|Death|2
7291403|NCT00543569|11509235|FG002|Overall Study|Death|3
7291404|NCT00543569|11509236|FG003|Overall Study|Death|1
7291405|NCT00543569|11509233|FG000|Overall Study|Lost to Follow-up|0
7291406|NCT00543569|11509234|FG001|Overall Study|Lost to Follow-up|0
7291407|NCT00543569|11509235|FG002|Overall Study|Lost to Follow-up|1
7291408|NCT00543569|11509236|FG003|Overall Study|Lost to Follow-up|1
7291409|NCT00543569|11509233|FG000|Overall Study|Miscellaneous Reasons|7
7291410|NCT00543569|11509234|FG001|Overall Study|Miscellaneous Reasons|3
7623852|NCT04516759|12034791|FG000|Overall Study|Withdrawal by Subject|1
7291411|NCT00543569|11509235|FG002|Overall Study|Miscellaneous Reasons|11
7291412|NCT00543569|11509236|FG003|Overall Study|Miscellaneous Reasons|4
7291413|NCT00543569|11509233|FG000|Overall Study|Randomized but never received study drug|3
7291414|NCT00543569|11509234|FG001|Overall Study|Randomized but never received study drug|3
7291415|NCT00543569|11509235|FG002|Overall Study|Randomized but never received study drug|5
7291416|NCT00543569|11509236|FG003|Overall Study|Randomized but never received study drug|3
7291417|NCT00543725|11509248|FG000|Overall Study|Adverse Event|18
7291418|NCT00543725|11509249|FG001|Overall Study|Adverse Event|27
7291419|NCT00543725|11509248|FG000|Overall Study|Sponsor's Decision|0
7291420|NCT00543725|11509249|FG001|Overall Study|Sponsor's Decision|1
7291421|NCT00543725|11509248|FG000|Overall Study|Subject Non-Compliant|4
7291422|NCT00543725|11509249|FG001|Overall Study|Subject Non-Compliant|4
7291423|NCT00543725|11509248|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
7291424|NCT00543725|11509249|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
7291425|NCT00543725|11509248|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
7291426|NCT00543725|11509249|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
7291427|NCT00543725|11509248|FG000|Overall Study|Protocol Violation|0
7291428|NCT00543725|11509249|FG001|Overall Study|Protocol Violation|1
7291429|NCT00543725|11509248|FG000|Overall Study|Withdrawal by Subject|4
7291430|NCT00543725|11509249|FG001|Overall Study|Withdrawal by Subject|13
7291431|NCT00543725|11509248|FG000|Overall Study|Lost to Follow-up|15
7291432|NCT00543725|11509249|FG001|Overall Study|Lost to Follow-up|11
7291433|NCT00543725|11509248|FG000|Overall Study|Other|3
7291434|NCT00543725|11509249|FG001|Overall Study|Other|3
7291435|NCT00543803|11509268|FG000|Overall Study|Adverse Event|14
7291436|NCT00543803|11509268|FG000|Overall Study|Lack of Efficacy|22
7291437|NCT00543803|11509268|FG000|Overall Study|Lost to Follow-up|20
7291438|NCT00543803|11509268|FG000|Overall Study|Other|86
7291439|NCT00543855|11509278|FG000|Overall Study|Adverse Event|3
7291440|NCT00543855|11509279|FG001|Overall Study|Adverse Event|1
7291441|NCT00543855|11509280|FG002|Overall Study|Adverse Event|3
7291442|NCT00543855|11509281|FG003|Overall Study|Adverse Event|4
7291443|NCT00543855|11509278|FG000|Overall Study|Lost to Follow-up|0
7291444|NCT00543855|11509279|FG001|Overall Study|Lost to Follow-up|0
7291445|NCT00543855|11509280|FG002|Overall Study|Lost to Follow-up|1
7291446|NCT00543855|11509281|FG003|Overall Study|Lost to Follow-up|0
7291447|NCT00543855|11509278|FG000|Overall Study|Withdrawal by Subject|0
7291448|NCT00543855|11509279|FG001|Overall Study|Withdrawal by Subject|1
7291449|NCT00543855|11509280|FG002|Overall Study|Withdrawal by Subject|2
7291450|NCT00543855|11509281|FG003|Overall Study|Withdrawal by Subject|0
7291451|NCT00543855|11509278|FG000|Overall Study|Protocol Violation|1
7291452|NCT00543855|11509279|FG001|Overall Study|Protocol Violation|0
7291453|NCT00543855|11509280|FG002|Overall Study|Protocol Violation|0
7291454|NCT00543855|11509281|FG003|Overall Study|Protocol Violation|0
7291455|NCT00543985|11509291|FG000|Overall Study|Withdrawal by Subject|4
7291456|NCT00544167|11509312|FG000|Overall Study|Adverse Event|21
7291457|NCT00544167|11509312|FG000|Overall Study|Physician Decision|8
7291458|NCT00544440|11509316|FG000|Overall Study|Other|1
7291459|NCT00544440|11509316|FG000|Overall Study|Adverse Event|1
7291460|NCT00544440|11509316|FG000|Overall Study|Withdrawal by Subject|2
7291461|NCT00544440|11509316|FG000|Overall Study|Subject Non-compliance|1
7291462|NCT00544440|11509316|FG000|Overall Study|Progressive Disease|47
7291463|NCT00544440|11509316|FG000|Overall Study|Other|5
7291464|NCT00544544|11509320|FG000|Overall Study|Withdrawal by Subject|1
7291465|NCT00544544|11509320|FG000|Overall Study|Adverse Event|1
7291466|NCT00544544|11509320|FG000|Overall Study|Lost to Follow-up|1
7291467|NCT00544557|11509324|FG000|Overall Study|Adverse Event|140
7291468|NCT00544557|11509324|FG000|Overall Study|Lack of Efficacy|196
7291469|NCT00544557|11509324|FG000|Overall Study|Other|98
7291470|NCT00544648|11509330|FG000|Overall Study|Withdrawal by Subject|1
7291471|NCT00544648|11509331|FG001|Overall Study|Withdrawal by Subject|0
7291472|NCT00544648|11509330|FG000|Overall Study|Adverse Event|1
7291473|NCT00544648|11509331|FG001|Overall Study|Adverse Event|1
7291474|NCT00544648|11509330|FG000|Overall Study|progression of disease|1
7291475|NCT00544648|11509331|FG001|Overall Study|progression of disease|0
7291476|NCT00544817|11509356|FG000|Combined Modality|Lack of Efficacy|2
7291477|NCT00544817|11509356|FG000|Combined Modality|Worsening Neurologic Symptoms|2
7291478|NCT00544817|11509356|FG000|Combined Modality|Adverse Event|2
7291479|NCT00544817|11509356|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
7291480|NCT00544817|11509356|FG000|No Treatment Interval|Lack of Efficacy|8
7291481|NCT00544817|11509356|FG000|No Treatment Interval|Physician Decision|3
7291482|NCT00544817|11509356|FG000|No Treatment Interval|Adverse Event|1
7291483|NCT00544817|11509356|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
7291484|NCT00544817|11509356|FG000|Follow-up Systemic Therapy|Physician Decision|3
7291485|NCT00544817|11509356|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
7291486|NCT00544869|11509363|FG000|Overall Study|Rsolution of congenitive symptoms|3
7291487|NCT00544869|11509364|FG001|Overall Study|Rsolution of congenitive symptoms|0
7291488|NCT00544869|11509365|FG002|Overall Study|Rsolution of congenitive symptoms|0
7291489|NCT00544869|11509363|FG000|Overall Study|Adverse Event|6
7291490|NCT00544869|11509364|FG001|Overall Study|Adverse Event|1
7291491|NCT00544869|11509365|FG002|Overall Study|Adverse Event|0
7291492|NCT00544869|11509363|FG000|Overall Study|Lack of Efficacy|1
7291493|NCT00544869|11509364|FG001|Overall Study|Lack of Efficacy|1
7291494|NCT00544869|11509365|FG002|Overall Study|Lack of Efficacy|0
7291495|NCT00544869|11509363|FG000|Overall Study|Physician Decision|2
7291496|NCT00544869|11509364|FG001|Overall Study|Physician Decision|0
7291497|NCT00544869|11509365|FG002|Overall Study|Physician Decision|0
7291498|NCT00544882|11509375|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
7291499|NCT00544882|11509376|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7291500|NCT00544882|11509377|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
7291501|NCT00544882|11509375|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
7291502|NCT00544882|11509376|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
7291503|NCT00544882|11509377|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
7291504|NCT00544882|11509375|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7291505|NCT00544882|11509376|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
7291506|NCT00544882|11509377|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
7291507|NCT00544882|11509375|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7291508|NCT00544882|11509376|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
7291509|NCT00544882|11509377|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
7291510|NCT00544882|11509375|FG000|Cycle 3: Follow-up|Noncompliance|0
7291511|NCT00544882|11509376|FG001|Cycle 3: Follow-up|Noncompliance|1
7291512|NCT00544882|11509377|FG002|Cycle 3: Follow-up|Noncompliance|0
7291513|NCT00544882|11509375|FG000|Cycle 3: Follow-up|Pregnancy|0
7291514|NCT00544882|11509376|FG001|Cycle 3: Follow-up|Pregnancy|1
7291515|NCT00544882|11509377|FG002|Cycle 3: Follow-up|Pregnancy|0
7623853|NCT04516759|12034792|FG001|Overall Study|Withdrawal by Subject|1
7623854|NCT04516759|12034791|FG000|Overall Study|Other|0
7623855|NCT04516759|12034792|FG001|Overall Study|Other|1
7291516|NCT00545051|11509398|FG000|Overall Study|Adverse Event|7
7291517|NCT00545051|11509399|FG001|Overall Study|Adverse Event|3
7291518|NCT00545051|11509398|FG000|Overall Study|Death|1
7291519|NCT00545051|11509399|FG001|Overall Study|Death|0
7291520|NCT00545051|11509398|FG000|Overall Study|Violation of inclusion/exclusion|0
7291521|NCT00545051|11509399|FG001|Overall Study|Violation of inclusion/exclusion|2
7291522|NCT00545051|11509398|FG000|Overall Study|Protocol Violation|1
7291523|NCT00545051|11509399|FG001|Overall Study|Protocol Violation|0
7291524|NCT00545051|11509398|FG000|Overall Study|Withdrawal by Subject|0
7291525|NCT00545051|11509399|FG001|Overall Study|Withdrawal by Subject|1
7291526|NCT00545051|11509398|FG000|Overall Study|Administrative reasons|0
7291527|NCT00545051|11509399|FG001|Overall Study|Administrative reasons|1
7291528|NCT00545064|11509405|FG000|Overall Study|Lost to Follow-up|3
7291529|NCT00545064|11509405|FG000|Overall Study|Withdrawal by Subject|2
7291530|NCT00545064|11509405|FG000|Overall Study|did not complete course of treatment|1
7291531|NCT00545064|11509405|FG000|Overall Study|cancel all appointments, no rebooking|1
7291532|NCT00545064|11509405|FG000|Overall Study|inclement weather|1
7291533|NCT00545077|11509413|FG000|Overall Study|Treatment not received|5
7291534|NCT00545077|11509414|FG001|Overall Study|Treatment not received|1
7291535|NCT00545077|11509413|FG000|Overall Study|Disease Progression|131
7291536|NCT00545077|11509414|FG001|Overall Study|Disease Progression|98
7291537|NCT00545077|11509413|FG000|Overall Study|Withdrawal by Subject|3
7291538|NCT00545077|11509414|FG001|Overall Study|Withdrawal by Subject|14
7291539|NCT00545077|11509413|FG000|Overall Study|Physician Decision|6
7291540|NCT00545077|11509414|FG001|Overall Study|Physician Decision|3
7291541|NCT00545077|11509413|FG000|Overall Study|Lost to Follow-up|2
7291542|NCT00545077|11509414|FG001|Overall Study|Lost to Follow-up|0
7291543|NCT00545077|11509413|FG000|Overall Study|Protocol Violation|1
7291544|NCT00545077|11509414|FG001|Overall Study|Protocol Violation|0
7291545|NCT00545077|11509413|FG000|Overall Study|Adverse Event|0
7291546|NCT00545077|11509414|FG001|Overall Study|Adverse Event|31
7291547|NCT00545077|11509413|FG000|Overall Study|Death|0
7291548|NCT00545077|11509414|FG001|Overall Study|Death|8
7291549|NCT00545103|11509424|FG000|Overall Study|Lack of Efficacy|48
7291550|NCT00545103|11509425|FG001|Overall Study|Lack of Efficacy|45
7291551|NCT00545103|11509426|FG002|Overall Study|Lack of Efficacy|31
7291552|NCT00545103|11509427|FG003|Overall Study|Lack of Efficacy|27
7291553|NCT00545103|11509424|FG000|Overall Study|Withdrawal by Subject|6
7291554|NCT00545103|11509425|FG001|Overall Study|Withdrawal by Subject|10
7291555|NCT00545103|11509426|FG002|Overall Study|Withdrawal by Subject|18
7291556|NCT00545103|11509427|FG003|Overall Study|Withdrawal by Subject|22
7291557|NCT00545103|11509424|FG000|Overall Study|Adverse Event|11
7291558|NCT00545103|11509425|FG001|Overall Study|Adverse Event|12
7291559|NCT00545103|11509426|FG002|Overall Study|Adverse Event|17
7291560|NCT00545103|11509427|FG003|Overall Study|Adverse Event|10
7291561|NCT00545103|11509424|FG000|Overall Study|Lost to Follow-up|4
7291562|NCT00545103|11509425|FG001|Overall Study|Lost to Follow-up|6
7291563|NCT00545103|11509426|FG002|Overall Study|Lost to Follow-up|3
7291564|NCT00545103|11509427|FG003|Overall Study|Lost to Follow-up|4
7291565|NCT00545103|11509424|FG000|Overall Study|Protocol Violation|1
7291566|NCT00545103|11509425|FG001|Overall Study|Protocol Violation|2
7291567|NCT00545103|11509426|FG002|Overall Study|Protocol Violation|3
7291568|NCT00545103|11509427|FG003|Overall Study|Protocol Violation|0
7291569|NCT00545103|11509424|FG000|Overall Study|Suspected recurrence of diverticulitis|1
7291570|NCT00545103|11509425|FG001|Overall Study|Suspected recurrence of diverticulitis|0
7291571|NCT00545103|11509426|FG002|Overall Study|Suspected recurrence of diverticulitis|0
7291572|NCT00545103|11509427|FG003|Overall Study|Suspected recurrence of diverticulitis|3
7623856|NCT03409276|12034817|FG000|Overall Study|Withdrawal by Subject|0
7291573|NCT00545103|11509424|FG000|Overall Study|Difficult to open package|0
7291574|NCT00545103|11509425|FG001|Overall Study|Difficult to open package|0
7291575|NCT00545103|11509426|FG002|Overall Study|Difficult to open package|0
7291576|NCT00545103|11509427|FG003|Overall Study|Difficult to open package|1
7291577|NCT00545103|11509424|FG000|Overall Study|Investigational product not taken|1
7291578|NCT00545103|11509425|FG001|Overall Study|Investigational product not taken|0
7291579|NCT00545103|11509426|FG002|Overall Study|Investigational product not taken|0
7291580|NCT00545103|11509427|FG003|Overall Study|Investigational product not taken|1
7291581|NCT00545103|11509424|FG000|Overall Study|Wish to start a family|0
7291582|NCT00545103|11509425|FG001|Overall Study|Wish to start a family|0
7291583|NCT00545103|11509426|FG002|Overall Study|Wish to start a family|0
7291584|NCT00545103|11509427|FG003|Overall Study|Wish to start a family|1
7291585|NCT00545103|11509424|FG000|Overall Study|Diverticulitis crisis|0
7291586|NCT00545103|11509425|FG001|Overall Study|Diverticulitis crisis|0
7291587|NCT00545103|11509426|FG002|Overall Study|Diverticulitis crisis|0
7291588|NCT00545103|11509427|FG003|Overall Study|Diverticulitis crisis|1
7291589|NCT00545103|11509424|FG000|Overall Study|Personal reasons|1
7291590|NCT00545103|11509425|FG001|Overall Study|Personal reasons|0
7291591|NCT00545103|11509426|FG002|Overall Study|Personal reasons|0
7291592|NCT00545103|11509427|FG003|Overall Study|Personal reasons|0
7291593|NCT00545103|11509424|FG000|Overall Study|Subject's decision|1
7291594|NCT00545103|11509425|FG001|Overall Study|Subject's decision|0
7291595|NCT00545103|11509426|FG002|Overall Study|Subject's decision|0
7291596|NCT00545103|11509427|FG003|Overall Study|Subject's decision|0
7291597|NCT00545103|11509424|FG000|Overall Study|Noncompliance|0
7291598|NCT00545103|11509425|FG001|Overall Study|Noncompliance|1
7291599|NCT00545103|11509426|FG002|Overall Study|Noncompliance|0
7291600|NCT00545103|11509427|FG003|Overall Study|Noncompliance|0
7291601|NCT00545103|11509424|FG000|Overall Study|Investigator decision|0
7291602|NCT00545103|11509425|FG001|Overall Study|Investigator decision|0
7291603|NCT00545103|11509426|FG002|Overall Study|Investigator decision|1
7291604|NCT00545103|11509427|FG003|Overall Study|Investigator decision|0
7291605|NCT00545103|11509424|FG000|Overall Study|Subject moved|0
7291606|NCT00545103|11509425|FG001|Overall Study|Subject moved|1
7291607|NCT00545103|11509426|FG002|Overall Study|Subject moved|0
7291608|NCT00545103|11509427|FG003|Overall Study|Subject moved|0
7291609|NCT00545103|11509424|FG000|Overall Study|Use of prohibited medication|0
7291610|NCT00545103|11509425|FG001|Overall Study|Use of prohibited medication|0
7291611|NCT00545103|11509426|FG002|Overall Study|Use of prohibited medication|1
7291612|NCT00545103|11509427|FG003|Overall Study|Use of prohibited medication|0
7291613|NCT00545103|11509424|FG000|Overall Study|Does not want to take study drug anymore|1
7291614|NCT00545103|11509425|FG001|Overall Study|Does not want to take study drug anymore|0
7291615|NCT00545103|11509426|FG002|Overall Study|Does not want to take study drug anymore|1
7291616|NCT00545103|11509427|FG003|Overall Study|Does not want to take study drug anymore|0
7291617|NCT00545103|11509424|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
7291618|NCT00545103|11509425|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
7291619|NCT00545103|11509426|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
7291620|NCT00545103|11509427|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
7291621|NCT00545103|11509424|FG000|Overall Study|Death|0
7291622|NCT00545103|11509425|FG001|Overall Study|Death|1
7291623|NCT00545103|11509426|FG002|Overall Study|Death|0
7291624|NCT00545103|11509427|FG003|Overall Study|Death|0
7291625|NCT00545168|11509444|FG000|Overall Study|Lost to Follow-up|5
7291626|NCT00545168|11509445|FG001|Overall Study|Lost to Follow-up|5
7291627|NCT00545168|11509446|FG002|Overall Study|Lost to Follow-up|5
7291628|NCT00545168|11509444|FG000|Overall Study|Withdrawal by Subject|9
7291629|NCT00545168|11509445|FG001|Overall Study|Withdrawal by Subject|0
7291630|NCT00545168|11509446|FG002|Overall Study|Withdrawal by Subject|13
7291631|NCT00545168|11509444|FG000|Overall Study|Protocol Violation|1
7291632|NCT00545168|11509445|FG001|Overall Study|Protocol Violation|0
7291633|NCT00545168|11509446|FG002|Overall Study|Protocol Violation|1
7291634|NCT00545168|11509444|FG000|Overall Study|Visit for Day 21 was not done in error|1
7291635|NCT00545168|11509445|FG001|Overall Study|Visit for Day 21 was not done in error|0
7291636|NCT00545168|11509446|FG002|Overall Study|Visit for Day 21 was not done in error|2
7291637|NCT00545233|11509466|FG000|Overall Study|Adverse Event|10
7291638|NCT00545233|11509467|FG001|Overall Study|Adverse Event|5
7291639|NCT00545233|11509466|FG000|Overall Study|Violation of Selection Criteria at Entry|5
7291640|NCT00545233|11509467|FG001|Overall Study|Violation of Selection Criteria at Entry|1
7291641|NCT00545233|11509466|FG000|Overall Study|Protocol Violation|2
7291642|NCT00545233|11509467|FG001|Overall Study|Protocol Violation|0
7291643|NCT00545233|11509466|FG000|Overall Study|Refused Treatment|9
7291644|NCT00545233|11509467|FG001|Overall Study|Refused Treatment|7
7291645|NCT00545233|11509466|FG000|Overall Study|Failure to Return|4
7291646|NCT00545233|11509467|FG001|Overall Study|Failure to Return|6
7291647|NCT00545233|11509466|FG000|Overall Study|Insufficient response|14
7291648|NCT00545233|11509467|FG001|Overall Study|Insufficient response|15
7291649|NCT00545233|11509466|FG000|Overall Study|Physician Decision|2
7291650|NCT00545233|11509467|FG001|Overall Study|Physician Decision|1
7291651|NCT00545272|11509480|FG000|Overall Study|Protocol deviation|0
7291652|NCT00545272|11509481|FG001|Overall Study|Protocol deviation|1
7291653|NCT00545272|11509482|FG002|Overall Study|Protocol deviation|0
7291654|NCT00545272|11509483|FG003|Overall Study|Protocol deviation|1
7291655|NCT00545272|11509484|FG004|Overall Study|Protocol deviation|0
7291656|NCT00545272|11509485|FG005|Overall Study|Protocol deviation|1
7291657|NCT00545272|11509480|FG000|Overall Study|Adverse Event|0
7291658|NCT00545272|11509481|FG001|Overall Study|Adverse Event|0
7291659|NCT00545272|11509482|FG002|Overall Study|Adverse Event|1
7291660|NCT00545272|11509483|FG003|Overall Study|Adverse Event|0
7291661|NCT00545272|11509484|FG004|Overall Study|Adverse Event|0
7291662|NCT00545272|11509485|FG005|Overall Study|Adverse Event|1
7291663|NCT00545272|11509480|FG000|Overall Study|Abnormal laboratory value(s)|0
7291664|NCT00545272|11509481|FG001|Overall Study|Abnormal laboratory value(s)|0
7291665|NCT00545272|11509482|FG002|Overall Study|Abnormal laboratory value(s)|0
7291666|NCT00545272|11509483|FG003|Overall Study|Abnormal laboratory value(s)|0
7291667|NCT00545272|11509484|FG004|Overall Study|Abnormal laboratory value(s)|0
7291668|NCT00545272|11509485|FG005|Overall Study|Abnormal laboratory value(s)|1
7291669|NCT00545272|11509480|FG000|Overall Study|Abnormal test procedure result(s)|0
7291670|NCT00545272|11509481|FG001|Overall Study|Abnormal test procedure result(s)|0
7291671|NCT00545272|11509482|FG002|Overall Study|Abnormal test procedure result(s)|0
7217900|NCT01557751|11426190|FG000|Overall Study|Physician Decision|3
7291672|NCT00545272|11509483|FG003|Overall Study|Abnormal test procedure result(s)|0
7291673|NCT00545272|11509484|FG004|Overall Study|Abnormal test procedure result(s)|1
7291674|NCT00545272|11509485|FG005|Overall Study|Abnormal test procedure result(s)|0
7291675|NCT00545272|11509480|FG000|Overall Study|Lost to Follow-up|0
7291676|NCT00545272|11509481|FG001|Overall Study|Lost to Follow-up|0
7291677|NCT00545272|11509482|FG002|Overall Study|Lost to Follow-up|0
7291678|NCT00545272|11509483|FG003|Overall Study|Lost to Follow-up|0
7291679|NCT00545272|11509484|FG004|Overall Study|Lost to Follow-up|1
7291680|NCT00545272|11509485|FG005|Overall Study|Lost to Follow-up|0
7291681|NCT00545298|11509502|FG000|Overall Study|Issues with Standard of Care|2
7291682|NCT00545298|11509503|FG001|Overall Study|Issues with Standard of Care|0
7291683|NCT00545298|11509504|FG002|Overall Study|Issues with Standard of Care|1
7291684|NCT00545363|11509517|FG000|Overall Study|Adverse Event|6
7291685|NCT00545363|11509518|FG001|Overall Study|Adverse Event|7
7291686|NCT00545363|11509517|FG000|Overall Study|Withdrawal by Subject|6
7291687|NCT00545363|11509518|FG001|Overall Study|Withdrawal by Subject|5
7291688|NCT00545363|11509517|FG000|Overall Study|Non-compliance|3
7291689|NCT00545363|11509518|FG001|Overall Study|Non-compliance|1
7291690|NCT00545363|11509517|FG000|Overall Study|Did not meet entry criteria|1
7291691|NCT00545363|11509518|FG001|Overall Study|Did not meet entry criteria|1
7291692|NCT00545363|11509517|FG000|Overall Study|Lost to Follow-up|2
7291693|NCT00545363|11509518|FG001|Overall Study|Lost to Follow-up|0
7291694|NCT00545363|11509517|FG000|Overall Study|Other|1
7291695|NCT00545363|11509518|FG001|Overall Study|Other|1
7291696|NCT00545402|11509526|FG000|Overall Study|Discontinuation of treatment|17
7291697|NCT00545402|11509527|FG001|Overall Study|Discontinuation of treatment|9
7291698|NCT00545402|11509526|FG000|Overall Study|Use of unauthorized immunosuppressant|8
7291699|NCT00545402|11509527|FG001|Overall Study|Use of unauthorized immunosuppressant|7
7291700|NCT00545402|11509526|FG000|Overall Study|Death|5
7291701|NCT00545402|11509527|FG001|Overall Study|Death|7
7291702|NCT00545402|11509526|FG000|Overall Study|Graft loss|2
7291703|NCT00545402|11509527|FG001|Overall Study|Graft loss|4
7291704|NCT00545402|11509526|FG000|Overall Study|Withdrawal by Subject|0
7291705|NCT00545402|11509527|FG001|Overall Study|Withdrawal by Subject|1
7291706|NCT00545402|11509526|FG000|Overall Study|Protocol Violation|1
7291707|NCT00545402|11509527|FG001|Overall Study|Protocol Violation|0
7291708|NCT00545402|11509526|FG000|Overall Study|Reason not specified|1
7291709|NCT00545402|11509527|FG001|Overall Study|Reason not specified|1
7291710|NCT00545441|11509535|FG000|Overall Study|Fistula draining at 6 months|2
7291711|NCT00545441|11509536|FG001|Overall Study|Fistula draining at 6 months|4
7291712|NCT00545441|11509535|FG000|Overall Study|Lost to Follow-up|9
7291713|NCT00545441|11509536|FG001|Overall Study|Lost to Follow-up|5
7291714|NCT00545441|11509535|FG000|Overall Study|Technical failure|0
7291715|NCT00545441|11509536|FG001|Overall Study|Technical failure|1
7291716|NCT00545441|11509535|FG000|Overall Study|Withdrawal by Subject|1
7291717|NCT00545441|11509536|FG001|Overall Study|Withdrawal by Subject|1
7291718|NCT00545441|11509535|FG000|Overall Study|Persistence or recurrence of fistula|5
7291719|NCT00545441|11509536|FG001|Overall Study|Persistence or recurrence of fistula|2
7291720|NCT00545441|11509535|FG000|Overall Study|Patients were not treated|1
7291721|NCT00545441|11509536|FG001|Overall Study|Patients were not treated|3
7291722|NCT00545532|11509544|FG000|Overall Study|Withdrawal by Subject|1
7291723|NCT00545532|11509545|FG001|Overall Study|Withdrawal by Subject|3
7291724|NCT00545532|11509544|FG000|Overall Study|Lost to Follow-up|5
7291725|NCT00545532|11509545|FG001|Overall Study|Lost to Follow-up|6
7291726|NCT00545532|11509544|FG000|Overall Study|Death|0
7291727|NCT00545532|11509545|FG001|Overall Study|Death|1
7291728|NCT00545571|11509553|FG000|Overall Study|Administrative Reasons|1
7291729|NCT00545571|11509553|FG000|Overall Study|Adverse Event|2
7291730|NCT00545571|11509553|FG000|Overall Study|Death|5
7291731|NCT00545571|11509553|FG000|Overall Study|Lack of Efficacy|1
7291732|NCT00545571|11509553|FG000|Overall Study|Protocol Violation|2
7291733|NCT00545571|11509553|FG000|Overall Study|Refused Treatment|1
7291734|NCT00545571|11509553|FG000|Overall Study|Screen Failure|16
7291735|NCT00545571|11509553|FG000|Overall Study|Transfusion|12
7291736|NCT00545571|11509553|FG000|Overall Study|Early Termination of Study|24
7291737|NCT00545571|11509553|FG000|Overall Study|Kidney Transplantation|3
7291738|NCT00545584|11509560|FG000|Overall Study|Only one reason for discontinuation|62
7291739|NCT00545584|11509561|FG001|Overall Study|Only one reason for discontinuation|61
7291740|NCT00545584|11509562|FG002|Overall Study|Only one reason for discontinuation|48
7291741|NCT00545584|11509560|FG000|Overall Study|Two or more reasons for discontinuation|17
7291742|NCT00545584|11509561|FG001|Overall Study|Two or more reasons for discontinuation|19
7291743|NCT00545584|11509562|FG002|Overall Study|Two or more reasons for discontinuation|8
7291744|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
7291745|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
7291746|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
7291747|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
7291748|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
7291749|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
7291750|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
7291751|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
7291752|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
7291753|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7291754|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7291755|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
7291756|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Death|0
7291757|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Death|1
7291758|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Death|0
7291759|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Death|0
7291760|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
7291761|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
7291762|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
7291763|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
7291764|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
7291765|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
7291766|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
7291767|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
7291768|NCT00545688|11509600|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
7291769|NCT00545688|11509601|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
7291770|NCT00545688|11509602|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
7291771|NCT00545688|11509603|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
7291772|NCT00545688|11509600|FG000|Adjuvant Treatment Period|Disease Progression|3
7291773|NCT00545688|11509601|FG001|Adjuvant Treatment Period|Disease Progression|3
7291774|NCT00545688|11509602|FG002|Adjuvant Treatment Period|Disease Progression|0
7291775|NCT00545688|11509603|FG003|Adjuvant Treatment Period|Disease Progression|7
7291776|NCT00545688|11509600|FG000|Adjuvant Treatment Period|Refused Treatment|1
7291777|NCT00545688|11509601|FG001|Adjuvant Treatment Period|Refused Treatment|1
7291778|NCT00545688|11509602|FG002|Adjuvant Treatment Period|Refused Treatment|1
7291779|NCT00545688|11509603|FG003|Adjuvant Treatment Period|Refused Treatment|5
7291780|NCT00545688|11509600|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
7291781|NCT00545688|11509601|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
7291782|NCT00545688|11509602|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
7291783|NCT00545688|11509603|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
7291784|NCT00545688|11509600|FG000|Adjuvant Treatment Period|Adverse Event|0
7291785|NCT00545688|11509601|FG001|Adjuvant Treatment Period|Adverse Event|3
7291786|NCT00545688|11509602|FG002|Adjuvant Treatment Period|Adverse Event|2
7291787|NCT00545688|11509603|FG003|Adjuvant Treatment Period|Adverse Event|2
7291788|NCT00545688|11509600|FG000|Adjuvant Treatment Period|Unknown Reason|0
7291789|NCT00545688|11509601|FG001|Adjuvant Treatment Period|Unknown Reason|1
7291790|NCT00545688|11509602|FG002|Adjuvant Treatment Period|Unknown Reason|0
7291791|NCT00545688|11509603|FG003|Adjuvant Treatment Period|Unknown Reason|0
7291792|NCT00545688|11509600|FG000|Follow-Up Period|Death|4
7291793|NCT00545688|11509601|FG001|Follow-Up Period|Death|2
7291794|NCT00545688|11509602|FG002|Follow-Up Period|Death|2
7291795|NCT00545688|11509603|FG003|Follow-Up Period|Death|6
7291796|NCT00545688|11509600|FG000|Follow-Up Period|Disease Progression|6
7291797|NCT00545688|11509601|FG001|Follow-Up Period|Disease Progression|5
7291798|NCT00545688|11509602|FG002|Follow-Up Period|Disease Progression|9
7291799|NCT00545688|11509603|FG003|Follow-Up Period|Disease Progression|9
7291800|NCT00545688|11509600|FG000|Follow-Up Period|Refused Treatment|6
7291801|NCT00545688|11509601|FG001|Follow-Up Period|Refused Treatment|2
7291802|NCT00545688|11509602|FG002|Follow-Up Period|Refused Treatment|0
7291803|NCT00545688|11509603|FG003|Follow-Up Period|Refused Treatment|2
7291804|NCT00545688|11509600|FG000|Follow-Up Period|Lost to Follow-up|3
7291805|NCT00545688|11509601|FG001|Follow-Up Period|Lost to Follow-up|3
7291806|NCT00545688|11509602|FG002|Follow-Up Period|Lost to Follow-up|3
7291807|NCT00545688|11509603|FG003|Follow-Up Period|Lost to Follow-up|1
7291808|NCT00545688|11509600|FG000|Follow-Up Period|Unspecified Reason|2
7291809|NCT00545688|11509601|FG001|Follow-Up Period|Unspecified Reason|5
7291810|NCT00545688|11509602|FG002|Follow-Up Period|Unspecified Reason|6
7291811|NCT00545688|11509603|FG003|Follow-Up Period|Unspecified Reason|8
7291812|NCT00545688|11509600|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
7291813|NCT00545688|11509601|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
7291814|NCT00545688|11509602|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
7291815|NCT00545688|11509603|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
7291816|NCT00545714|11509616|FG000|Induction Phase (6 Months)|Physician Decision|3
7291817|NCT00545714|11509616|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
7291818|NCT00545714|11509616|FG000|Induction Phase (6 Months)|Disease Progression|1
7291819|NCT00545714|11509616|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
7291820|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
7291821|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Disease Progression|9
7291822|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Physician Decision|1
7291823|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
7291824|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
7291825|NCT00545714|11509616|FG000|Maintenance Phase (36 Months)|Death|2
7291826|NCT00545740|11509624|FG000|Overall Study|Lack of Efficacy|34
7291827|NCT00545740|11509625|FG001|Overall Study|Lack of Efficacy|35
7291828|NCT00545740|11509626|FG002|Overall Study|Lack of Efficacy|47
7291829|NCT00545740|11509627|FG003|Overall Study|Lack of Efficacy|36
7291830|NCT00545740|11509624|FG000|Overall Study|Withdrawal by Subject|17
7291831|NCT00545740|11509625|FG001|Overall Study|Withdrawal by Subject|15
7291832|NCT00545740|11509626|FG002|Overall Study|Withdrawal by Subject|16
7291833|NCT00545740|11509627|FG003|Overall Study|Withdrawal by Subject|18
7291834|NCT00545740|11509624|FG000|Overall Study|Adverse Event|10
7291835|NCT00545740|11509625|FG001|Overall Study|Adverse Event|18
7291836|NCT00545740|11509626|FG002|Overall Study|Adverse Event|19
7291837|NCT00545740|11509627|FG003|Overall Study|Adverse Event|9
7291838|NCT00545740|11509624|FG000|Overall Study|Lost to Follow-up|7
7291839|NCT00545740|11509625|FG001|Overall Study|Lost to Follow-up|5
7291840|NCT00545740|11509626|FG002|Overall Study|Lost to Follow-up|5
7291841|NCT00545740|11509627|FG003|Overall Study|Lost to Follow-up|6
7291842|NCT00545740|11509624|FG000|Overall Study|Protocol Violation|1
7291843|NCT00545740|11509625|FG001|Overall Study|Protocol Violation|3
7291844|NCT00545740|11509626|FG002|Overall Study|Protocol Violation|1
7291845|NCT00545740|11509627|FG003|Overall Study|Protocol Violation|0
7291846|NCT00545740|11509624|FG000|Overall Study|Non-compliance|0
7291847|NCT00545740|11509625|FG001|Overall Study|Non-compliance|2
7291848|NCT00545740|11509626|FG002|Overall Study|Non-compliance|1
7291849|NCT00545740|11509627|FG003|Overall Study|Non-compliance|0
7291850|NCT00545740|11509624|FG000|Overall Study|Moved|2
7291851|NCT00545740|11509625|FG001|Overall Study|Moved|0
7291852|NCT00545740|11509626|FG002|Overall Study|Moved|1
7291853|NCT00545740|11509627|FG003|Overall Study|Moved|0
7291854|NCT00545740|11509624|FG000|Overall Study|Diverticulitis attack|0
7291855|NCT00545740|11509625|FG001|Overall Study|Diverticulitis attack|0
7291856|NCT00545740|11509626|FG002|Overall Study|Diverticulitis attack|1
7291857|NCT00545740|11509627|FG003|Overall Study|Diverticulitis attack|1
7291858|NCT00545740|11509624|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
7291859|NCT00545740|11509625|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
7291860|NCT00545740|11509626|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
7291861|NCT00545740|11509627|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
7291862|NCT00545740|11509624|FG000|Overall Study|Site closure|1
7291863|NCT00545740|11509625|FG001|Overall Study|Site closure|0
7291864|NCT00545740|11509626|FG002|Overall Study|Site closure|0
7291865|NCT00545740|11509627|FG003|Overall Study|Site closure|0
7291866|NCT00545740|11509624|FG000|Overall Study|Missed visit|1
7291867|NCT00545740|11509625|FG001|Overall Study|Missed visit|0
7291868|NCT00545740|11509626|FG002|Overall Study|Missed visit|0
7291869|NCT00545740|11509627|FG003|Overall Study|Missed visit|0
7291870|NCT00545740|11509624|FG000|Overall Study|Physician Decision|0
7291871|NCT00545740|11509625|FG001|Overall Study|Physician Decision|0
7291872|NCT00545740|11509626|FG002|Overall Study|Physician Decision|3
7291873|NCT00545740|11509627|FG003|Overall Study|Physician Decision|0
7291874|NCT00545740|11509624|FG000|Overall Study|Accepted only monthly telephone calls|1
7291875|NCT00545740|11509625|FG001|Overall Study|Accepted only monthly telephone calls|0
7291876|NCT00545740|11509626|FG002|Overall Study|Accepted only monthly telephone calls|0
7291877|NCT00545740|11509627|FG003|Overall Study|Accepted only monthly telephone calls|0
7291878|NCT00545740|11509624|FG000|Overall Study|Sponsor decision|0
7291879|NCT00545740|11509625|FG001|Overall Study|Sponsor decision|1
7291880|NCT00545740|11509626|FG002|Overall Study|Sponsor decision|0
7291881|NCT00545740|11509627|FG003|Overall Study|Sponsor decision|0
7291882|NCT00545740|11509624|FG000|Overall Study|Lack of time|0
7291883|NCT00545740|11509625|FG001|Overall Study|Lack of time|1
7291884|NCT00545740|11509626|FG002|Overall Study|Lack of time|0
7291885|NCT00545740|11509627|FG003|Overall Study|Lack of time|0
7291886|NCT00545740|11509624|FG000|Overall Study|Non-adherence to visits|0
7291887|NCT00545740|11509625|FG001|Overall Study|Non-adherence to visits|1
7291888|NCT00545740|11509626|FG002|Overall Study|Non-adherence to visits|0
7291889|NCT00545740|11509627|FG003|Overall Study|Non-adherence to visits|0
7291890|NCT00545740|11509624|FG000|Overall Study|Patient difficulties|0
7291891|NCT00545740|11509625|FG001|Overall Study|Patient difficulties|1
7291892|NCT00545740|11509626|FG002|Overall Study|Patient difficulties|0
7291893|NCT00545740|11509627|FG003|Overall Study|Patient difficulties|0
7291894|NCT00545740|11509624|FG000|Overall Study|Husband against study|0
7291895|NCT00545740|11509625|FG001|Overall Study|Husband against study|0
7291896|NCT00545740|11509626|FG002|Overall Study|Husband against study|1
7291897|NCT00545740|11509627|FG003|Overall Study|Husband against study|0
7291898|NCT00545753|11509640|FG000|Overall Study|Withdrawal by Subject|0
7291899|NCT00545753|11509641|FG001|Overall Study|Withdrawal by Subject|1
7291900|NCT00545753|11509642|FG002|Overall Study|Withdrawal by Subject|10
7291901|NCT00545753|11509640|FG000|Overall Study|Lost to Follow-up|13
7291902|NCT00545753|11509641|FG001|Overall Study|Lost to Follow-up|3
7291903|NCT00545753|11509642|FG002|Overall Study|Lost to Follow-up|12
7291904|NCT00545753|11509640|FG000|Overall Study|Protocol Violation|3
7291905|NCT00545753|11509641|FG001|Overall Study|Protocol Violation|1
7291906|NCT00545753|11509642|FG002|Overall Study|Protocol Violation|4
7291907|NCT00545779|11509651|FG000|Overall Study|Violation of selection criteria at entry|8
7291908|NCT00545779|11509651|FG000|Overall Study|Other protocol violation|1
7291909|NCT00545779|11509651|FG000|Overall Study|Did not cooperate|7
7291910|NCT00545779|11509651|FG000|Overall Study|Withdrawal by Subject|20
7291911|NCT00545779|11509651|FG000|Overall Study|Adverse Event/intercurrent illness|5
7291912|NCT00545779|11509651|FG000|Overall Study|Failure to return|3
7291913|NCT00545792|11509655|FG000|Overall Study|Withdrawal by Subject|1
7291914|NCT00545818|11509661|FG000|Overall Study|Protocol Violation|1
7291915|NCT00545818|11509662|FG001|Overall Study|Protocol Violation|0
7291916|NCT00545818|11509661|FG000|Overall Study|Adverse Event|1
7291917|NCT00545818|11509662|FG001|Overall Study|Adverse Event|1
7291918|NCT00545818|11509661|FG000|Overall Study|Lost to Follow-up|1
7291919|NCT00545818|11509662|FG001|Overall Study|Lost to Follow-up|6
7291920|NCT00545948|11509671|FG000|Overall Study|Not Treated|1
7291921|NCT00545948|11509672|FG001|Overall Study|Not Treated|1
7291922|NCT00545948|11509673|FG002|Overall Study|Not Treated|7
7291923|NCT00546000|11509691|FG000|Overall Study|Adverse Event|1
7291924|NCT00546000|11509691|FG000|Overall Study|Lost to Follow-up|1
7291925|NCT00546000|11509691|FG000|Overall Study|Baseline HPA Axis Supression|2
7291926|NCT00546078|11509697|FG000|Overall Study|Lost to Follow-up|1
7291927|NCT00546078|11509698|FG001|Overall Study|Lost to Follow-up|3
7291928|NCT00546078|11509697|FG000|Overall Study|Withdrawal by Subject|2
7291929|NCT00546078|11509698|FG001|Overall Study|Withdrawal by Subject|3
7291930|NCT00546078|11509697|FG000|Overall Study|Other reason|1
7291931|NCT00546078|11509698|FG001|Overall Study|Other reason|1
7291932|NCT00546117|11509710|FG000|Overall Study|Withdrawal by Subject|3
7291933|NCT00546117|11509711|FG001|Overall Study|Withdrawal by Subject|0
7291934|NCT00546117|11509710|FG000|Overall Study|Inability to schedule follow-up visit|1
7291935|NCT00546117|11509711|FG001|Overall Study|Inability to schedule follow-up visit|0
7291936|NCT00546260|11509729|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
7291937|NCT00546260|11509730|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
7291938|NCT00546351|11509736|FG000|Overall Study|Adverse Event|76
7291939|NCT00546351|11509736|FG000|Overall Study|Lack of Efficacy|15
7291940|NCT00546351|11509736|FG000|Overall Study|Withdrawal by Subject|109
7291941|NCT00546351|11509736|FG000|Overall Study|Lost to Follow-up|9
7291942|NCT00546351|11509736|FG000|Overall Study|Protocol Deviation|1
7291943|NCT00546351|11509736|FG000|Overall Study|Unsatisfactory compliance|9
7291944|NCT00546351|11509736|FG000|Overall Study|Other reasons for premature termination|17
7291945|NCT00546364|11509743|FG000|Overall Study|Disease progression|5
7291946|NCT00546364|11509744|FG001|Overall Study|Disease progression|11
7291947|NCT00546364|11509745|FG002|Overall Study|Disease progression|8
7291948|NCT00546364|11509743|FG000|Overall Study|Completed and off treatment|1
7291949|NCT00546364|11509744|FG001|Overall Study|Completed and off treatment|0
7291950|NCT00546364|11509745|FG002|Overall Study|Completed and off treatment|2
7291951|NCT00546364|11509743|FG000|Overall Study|Administrative reason by sponsor|1
7291952|NCT00546364|11509744|FG001|Overall Study|Administrative reason by sponsor|0
7291953|NCT00546364|11509745|FG002|Overall Study|Administrative reason by sponsor|0
7291954|NCT00546364|11509743|FG000|Overall Study|Poor compliance/noncompliance|0
7291955|NCT00546364|11509744|FG001|Overall Study|Poor compliance/noncompliance|0
7291956|NCT00546364|11509745|FG002|Overall Study|Poor compliance/noncompliance|1
7291957|NCT00546364|11509743|FG000|Overall Study|No longer meets study criteria|1
7291958|NCT00546364|11509744|FG001|Overall Study|No longer meets study criteria|1
7291959|NCT00546364|11509745|FG002|Overall Study|No longer meets study criteria|0
7291960|NCT00546364|11509743|FG000|Overall Study|Withdrawal by Subject|5
7291961|NCT00546364|11509744|FG001|Overall Study|Withdrawal by Subject|6
7291962|NCT00546364|11509745|FG002|Overall Study|Withdrawal by Subject|3
7291963|NCT00546364|11509743|FG000|Overall Study|Prior taxotere|1
7291964|NCT00546364|11509744|FG001|Overall Study|Prior taxotere|0
7291965|NCT00546364|11509745|FG002|Overall Study|Prior taxotere|0
7291966|NCT00546364|11509743|FG000|Overall Study|Mixed response|1
7291967|NCT00546364|11509744|FG001|Overall Study|Mixed response|0
7291968|NCT00546364|11509745|FG002|Overall Study|Mixed response|0
7291969|NCT00546364|11509743|FG000|Overall Study|Palliative treatment|1
7291970|NCT00546364|11509744|FG001|Overall Study|Palliative treatment|0
7291971|NCT00546364|11509745|FG002|Overall Study|Palliative treatment|1
7291972|NCT00546364|11509743|FG000|Overall Study|Target lesions resected|1
7291973|NCT00546364|11509744|FG001|Overall Study|Target lesions resected|0
7291974|NCT00546364|11509745|FG002|Overall Study|Target lesions resected|0
7291975|NCT00546364|11509743|FG000|Overall Study|Physician Decision|0
7291976|NCT00546364|11509744|FG001|Overall Study|Physician Decision|0
7291977|NCT00546364|11509745|FG002|Overall Study|Physician Decision|1
7291978|NCT00546364|11509743|FG000|Overall Study|Sponsor decision|0
7291979|NCT00546364|11509744|FG001|Overall Study|Sponsor decision|0
7291980|NCT00546364|11509745|FG002|Overall Study|Sponsor decision|1
7291981|NCT00546377|11509753|FG000|Overall Study|Deemed ineligible|1
7291982|NCT00546377|11509753|FG000|Overall Study|Adverse Event|6
7291983|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
7291984|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7291985|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
7291986|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
7291987|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
7291988|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
7291989|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
7291990|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7291991|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
7291992|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
7291993|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7291994|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
7291995|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7291996|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
7291997|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
7291998|NCT00546481|11509773|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7291999|NCT00546481|11509774|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
7292000|NCT00546481|11509775|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
7551354|NCT02969187|11910615|FG001|Overall Study|Physician Decision|13
7292001|NCT00546481|11509773|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
7292002|NCT00546481|11509774|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
7292003|NCT00546481|11509775|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
7292004|NCT00546481|11509773|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
7292005|NCT00546481|11509774|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
7292006|NCT00546481|11509775|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
7292007|NCT00546481|11509773|FG000|Maintenance Phase (CERA)|Other Reason|0
7292008|NCT00546481|11509774|FG001|Maintenance Phase (CERA)|Other Reason|0
7292009|NCT00546481|11509775|FG002|Maintenance Phase (CERA)|Other Reason|1
7292010|NCT00546572|11509785|FG000|Vax 1 / Year 0|Randomized, not treated|1
7292011|NCT00546572|11509786|FG001|Vax 1 / Year 0|Randomized, not treated|1
7292012|NCT00546572|11509785|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
7292013|NCT00546572|11509786|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
7292014|NCT00546572|11509785|FG000|Vax 1 / Year 0|Protocol Violation|3
7292015|NCT00546572|11509786|FG001|Vax 1 / Year 0|Protocol Violation|4
7292016|NCT00546572|11509785|FG000|Vax 1 / Year 0|Death|2
7292017|NCT00546572|11509786|FG001|Vax 1 / Year 0|Death|2
7292018|NCT00546572|11509785|FG000|Vax 1 / Year 0|Adverse Event|0
7292019|NCT00546572|11509786|FG001|Vax 1 / Year 0|Adverse Event|1
7292020|NCT00546572|11509785|FG000|Vax 1 / Year 0|Lost to Follow-up|0
7292021|NCT00546572|11509786|FG001|Vax 1 / Year 0|Lost to Follow-up|1
7292022|NCT00546572|11509785|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
7292023|NCT00546572|11509786|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
7292024|NCT00546572|11509785|FG000|Vax 2 / Year 1|Other|1
7292025|NCT00546572|11509786|FG001|Vax 2 / Year 1|Other|1
7292026|NCT00546572|11509785|FG000|Vax 2 / Year 1|Adverse Event|1
7292027|NCT00546572|11509786|FG001|Vax 2 / Year 1|Adverse Event|0
7292028|NCT00546572|11509785|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
7292029|NCT00546572|11509786|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
7292030|NCT00546637|11509805|FG000|Overall Study|Adverse Event|46
7292031|NCT00546637|11509806|FG001|Overall Study|Adverse Event|20
7292032|NCT00546637|11509805|FG000|Overall Study|Lack of Efficacy|5
7292033|NCT00546637|11509806|FG001|Overall Study|Lack of Efficacy|5
7292034|NCT00546637|11509805|FG000|Overall Study|Lost to Follow-up|2
7292035|NCT00546637|11509806|FG001|Overall Study|Lost to Follow-up|2
7292036|NCT00546637|11509805|FG000|Overall Study|Other|10
7292037|NCT00546637|11509806|FG001|Overall Study|Other|12
7292038|NCT00546637|11509805|FG000|Overall Study|Withdrawal by Subject|7
7292039|NCT00546637|11509806|FG001|Overall Study|Withdrawal by Subject|9
7292040|NCT00546637|11509805|FG000|Overall Study|Randomized, but not treated|3
7292041|NCT00546637|11509806|FG001|Overall Study|Randomized, but not treated|1
7292042|NCT00546715|11509816|FG000|Overall Study|Withdrawal by Subject|0
7292043|NCT00546715|11509817|FG001|Overall Study|Withdrawal by Subject|1
7292044|NCT00546715|11509818|FG002|Overall Study|Withdrawal by Subject|0
7292045|NCT00546715|11509819|FG003|Overall Study|Withdrawal by Subject|0
7292046|NCT00546819|11509840|FG000|Overall Study|Adverse Event|2
7292047|NCT00546819|11509841|FG001|Overall Study|Adverse Event|3
7292048|NCT00546819|11509840|FG000|Overall Study|Lost to Follow-up|2
7292049|NCT00546819|11509841|FG001|Overall Study|Lost to Follow-up|1
7292050|NCT00546819|11509840|FG000|Overall Study|Withdrawal by Subject|4
7292051|NCT00546819|11509841|FG001|Overall Study|Withdrawal by Subject|2
7292052|NCT00546871|11509847|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
7292053|NCT00546871|11509848|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
7292054|NCT00546871|11509847|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
7292055|NCT00546871|11509848|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
7292056|NCT00546871|11509847|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
7292057|NCT00546871|11509848|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
7292058|NCT00546871|11509847|FG000|Study Extension Period|Protocol Violation|1
7292059|NCT00546871|11509848|FG001|Study Extension Period|Protocol Violation|0
7292060|NCT00546871|11509847|FG000|Study Extension Period|Withdrawal by Subject|0
7292061|NCT00546871|11509848|FG001|Study Extension Period|Withdrawal by Subject|1
7292062|NCT00546910|11509897|FG000|Overall Study|Adverse Event|2
7292063|NCT00546910|11509898|FG001|Overall Study|Adverse Event|3
7292064|NCT00546910|11509897|FG000|Overall Study|Lack of Efficacy|5
7292065|NCT00546910|11509898|FG001|Overall Study|Lack of Efficacy|7
7292066|NCT00546910|11509897|FG000|Overall Study|Physician Decision|0
7292067|NCT00546910|11509898|FG001|Overall Study|Physician Decision|1
7292068|NCT00546910|11509897|FG000|Overall Study|Withdrawal by Subject|2
7292069|NCT00546910|11509898|FG001|Overall Study|Withdrawal by Subject|0
7292070|NCT00547118|11509910|FG000|Overall Study|Did not qualify prior to starting drug|1
7292071|NCT00547118|11509911|FG001|Overall Study|Did not qualify prior to starting drug|1
7292072|NCT00547118|11509910|FG000|Overall Study|Study suspended|7
7292073|NCT00547118|11509911|FG001|Overall Study|Study suspended|8
7292074|NCT00547157|11509921|FG000|Overall Study|Other|1
7292075|NCT00547157|11509922|FG001|Overall Study|Other|0
7292076|NCT00547157|11509921|FG000|Overall Study|Death|38
7292077|NCT00547157|11509922|FG001|Overall Study|Death|18
7292078|NCT00547157|11509921|FG000|Overall Study|Withdrawal by Subject|3
7292079|NCT00547157|11509922|FG001|Overall Study|Withdrawal by Subject|1
7292080|NCT00547157|11509921|FG000|Overall Study|Administrative decision|3
7292081|NCT00547157|11509922|FG001|Overall Study|Administrative decision|2
7292082|NCT00547157|11509921|FG000|Overall Study|Lost to Follow-up|4
7292083|NCT00547157|11509922|FG001|Overall Study|Lost to Follow-up|2
7292084|NCT00547248|11509932|FG000|Overall Study|Protocol Violation|0
7292085|NCT00547248|11509933|FG001|Overall Study|Protocol Violation|0
7292086|NCT00547248|11509934|FG002|Overall Study|Protocol Violation|1
7292087|NCT00547248|11509935|FG003|Overall Study|Protocol Violation|1
7292088|NCT00547248|11509932|FG000|Overall Study|Migrated/moved from study area|0
7292089|NCT00547248|11509933|FG001|Overall Study|Migrated/moved from study area|0
7292090|NCT00547248|11509934|FG002|Overall Study|Migrated/moved from study area|2
7292091|NCT00547248|11509935|FG003|Overall Study|Migrated/moved from study area|0
7292092|NCT00547248|11509932|FG000|Overall Study|Withdrawal by Subject|0
7292093|NCT00547248|11509933|FG001|Overall Study|Withdrawal by Subject|0
7292094|NCT00547248|11509934|FG002|Overall Study|Withdrawal by Subject|7
7292095|NCT00547248|11509935|FG003|Overall Study|Withdrawal by Subject|1
7292096|NCT00547365|11509948|FG000|Overall Study|Physician Decision|1
7292097|NCT00547365|11509948|FG000|Overall Study|Lost to Follow-up|1
7292098|NCT00547365|11509948|FG000|Overall Study|Protocol Violation|2
7292099|NCT00547365|11509948|FG000|Overall Study|death (not related to study)|4
7292100|NCT00547378|11509956|FG000|Randomized Cohort|Withdrawal by Subject|7
7292101|NCT00547378|11509957|FG001|Randomized Cohort|Withdrawal by Subject|5
7292102|NCT00547378|11509958|FG002|Randomized Cohort|Withdrawal by Subject|0
7292103|NCT00547378|11509956|FG000|Randomized Cohort|Death|0
7292104|NCT00547378|11509957|FG001|Randomized Cohort|Death|1
7292105|NCT00547378|11509958|FG002|Randomized Cohort|Death|0
7292106|NCT00547378|11509956|FG000|Randomized Cohort|Lost to Follow-up|1
7292107|NCT00547378|11509957|FG001|Randomized Cohort|Lost to Follow-up|0
7292108|NCT00547378|11509958|FG002|Randomized Cohort|Lost to Follow-up|0
7292109|NCT00547378|11509956|FG000|Randomized Cohort|Adverse Event|1
7292110|NCT00547378|11509957|FG001|Randomized Cohort|Adverse Event|0
7292111|NCT00547378|11509958|FG002|Randomized Cohort|Adverse Event|0
7292112|NCT00547378|11509956|FG000|Randomized Cohort|Other reasons|2
7292113|NCT00547378|11509957|FG001|Randomized Cohort|Other reasons|0
7292114|NCT00547378|11509958|FG002|Randomized Cohort|Other reasons|0
7292115|NCT00547378|11509956|FG000|All Implanted Cohort|Withdrawal by Subject|5
7292116|NCT00547378|11509957|FG001|All Implanted Cohort|Withdrawal by Subject|4
7292117|NCT00547378|11509958|FG002|All Implanted Cohort|Withdrawal by Subject|27
7292118|NCT00547378|11509956|FG000|All Implanted Cohort|Adverse Event|4
7292119|NCT00547378|11509957|FG001|All Implanted Cohort|Adverse Event|10
7292120|NCT00547378|11509958|FG002|All Implanted Cohort|Adverse Event|17
7292121|NCT00547378|11509956|FG000|All Implanted Cohort|Lost to Follow-up|0
7292122|NCT00547378|11509957|FG001|All Implanted Cohort|Lost to Follow-up|1
7292123|NCT00547378|11509958|FG002|All Implanted Cohort|Lost to Follow-up|14
7292124|NCT00547378|11509956|FG000|All Implanted Cohort|Death|3
7292125|NCT00547378|11509957|FG001|All Implanted Cohort|Death|1
7292126|NCT00547378|11509958|FG002|All Implanted Cohort|Death|4
7292127|NCT00547378|11509956|FG000|All Implanted Cohort|Physician Decision|0
7292128|NCT00547378|11509957|FG001|All Implanted Cohort|Physician Decision|2
7292129|NCT00547378|11509958|FG002|All Implanted Cohort|Physician Decision|6
7292130|NCT00547378|11509956|FG000|All Implanted Cohort|Site closure|2
7292131|NCT00547378|11509957|FG001|All Implanted Cohort|Site closure|0
7292132|NCT00547378|11509958|FG002|All Implanted Cohort|Site closure|1
7292133|NCT00547378|11509956|FG000|All Implanted Cohort|Other reasons|1
7292134|NCT00547378|11509957|FG001|All Implanted Cohort|Other reasons|0
7292135|NCT00547378|11509958|FG002|All Implanted Cohort|Other reasons|1
7292136|NCT00547521|11509968|FG000|Short Term Study (4 Months)|Adverse Event|1
7292137|NCT00547521|11509969|FG001|Short Term Study (4 Months)|Adverse Event|0
7292138|NCT00547521|11509968|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
7292139|NCT00547521|11509969|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
7292140|NCT00547521|11509968|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
7292141|NCT00547521|11509969|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
7292142|NCT00547521|11509968|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
7292143|NCT00547521|11509969|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
7292144|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
7292145|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
7292146|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Adverse Event|0
7292147|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Adverse Event|9
7292148|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
7292149|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
7292150|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
7292151|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
7292152|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Other|0
7292153|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Other|2
7292154|NCT00547521|11509968|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
7292155|NCT00547521|11509969|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
7292156|NCT00547534|11509982|FG000|Overall Study|Adverse Event|7
7292157|NCT00547534|11509982|FG000|Overall Study|Disease Progression|4
7292158|NCT00547703|11510019|FG000|Overall Study|Lost to Follow-up|1
7292159|NCT00547703|11510020|FG001|Overall Study|Lost to Follow-up|0
7292160|NCT00547911|11510053|FG000|Overall Study|Adverse Event|0
7292161|NCT00547911|11510054|FG001|Overall Study|Adverse Event|0
7292162|NCT00547911|11510055|FG002|Overall Study|Adverse Event|0
7292163|NCT00547911|11510056|FG003|Overall Study|Adverse Event|1
7292164|NCT00547911|11510057|FG004|Overall Study|Adverse Event|0
7292165|NCT00547911|11510058|FG005|Overall Study|Adverse Event|0
7623857|NCT03409276|12034818|FG001|Overall Study|Withdrawal by Subject|0
7623858|NCT03409276|12034819|FG002|Overall Study|Withdrawal by Subject|0
7623859|NCT03409276|12034820|FG003|Overall Study|Withdrawal by Subject|0
7623860|NCT03409276|12034821|FG004|Overall Study|Withdrawal by Subject|1
7623861|NCT03409276|12034817|FG000|Overall Study|Lost to Follow-up|0
7623862|NCT03409276|12034818|FG001|Overall Study|Lost to Follow-up|0
7623863|NCT03409276|12034819|FG002|Overall Study|Lost to Follow-up|0
7623864|NCT03409276|12034820|FG003|Overall Study|Lost to Follow-up|2
7623865|NCT03409276|12034821|FG004|Overall Study|Lost to Follow-up|2
7623866|NCT03312907|12034840|FG000|Overall Study|Adverse Event|1
7623867|NCT03312907|12034841|FG001|Overall Study|Adverse Event|6
7623868|NCT03312907|12034842|FG002|Overall Study|Adverse Event|1
7623869|NCT03312907|12034840|FG000|Overall Study|Protocol Violation|2
7623870|NCT03312907|12034841|FG001|Overall Study|Protocol Violation|3
7623871|NCT03312907|12034842|FG002|Overall Study|Protocol Violation|4
7623872|NCT03312907|12034840|FG000|Overall Study|Lost to Follow-up|2
7623873|NCT03312907|12034841|FG001|Overall Study|Lost to Follow-up|3
7623874|NCT03312907|12034842|FG002|Overall Study|Lost to Follow-up|2
7623875|NCT03312907|12034840|FG000|Overall Study|Physician Decision|3
7623876|NCT03312907|12034841|FG001|Overall Study|Physician Decision|4
7623877|NCT03312907|12034842|FG002|Overall Study|Physician Decision|2
7623878|NCT03312907|12034840|FG000|Overall Study|Withdrawal by Subject|9
7623879|NCT03312907|12034841|FG001|Overall Study|Withdrawal by Subject|14
7623880|NCT03312907|12034842|FG002|Overall Study|Withdrawal by Subject|10
7623881|NCT03148756|12034852|FG000|Overall Study|Study Terminated|0
7623882|NCT03148756|12034853|FG001|Overall Study|Study Terminated|1
7623883|NCT03079102|12034861|FG000|Overall Study|Physician Decision|0
7623884|NCT03079102|12034862|FG001|Overall Study|Physician Decision|1
7623885|NCT02944513|12034870|FG000|Overall Study|Withdrawal by Subject|4
7623886|NCT02944513|12034871|FG001|Overall Study|Withdrawal by Subject|1
7623887|NCT02734433|12034888|FG000|Overall Study|Disease progression|1
7623888|NCT02734433|12034889|FG001|Overall Study|Disease progression|5
7623889|NCT02734433|12034888|FG000|Overall Study|Clinical progression|0
7623890|NCT02734433|12034889|FG001|Overall Study|Clinical progression|1
7623891|NCT02734433|12034888|FG000|Overall Study|Withdrawal by Subject|1
7623892|NCT02734433|12034889|FG001|Overall Study|Withdrawal by Subject|2
7623893|NCT02048722|12034913|FG000|2 Cycles of Treatment|Adverse Event|2
7623894|NCT02048722|12034913|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
7623895|NCT02048722|12034913|FG000|2 Cycles of Treatment|Progressive Disease|2
7623896|NCT02048722|12034913|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
7623897|NCT02048722|12034913|FG000|Follow up 5 Years or Cut of Timepoint|Death|24
7623898|NCT02048722|12034913|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3
7623899|NCT01896102|12034917|FG000|Overall Study|Death|1
7623900|NCT01896102|12034917|FG000|Overall Study|Participant to receive allogenic transplant|2
7623901|NCT01885078|12034930|FG000|Treatment Period|Adverse Event|52
7623902|NCT01885078|12034931|FG001|Treatment Period|Adverse Event|136
7623903|NCT01885078|12034932|FG002|Treatment Period|Adverse Event|30
7623904|NCT01885078|12034933|FG003|Treatment Period|Adverse Event|73
7623905|NCT01885078|12034934|FG004|Treatment Period|Adverse Event|17
7623906|NCT01885078|12034935|FG005|Treatment Period|Adverse Event|72
7623907|NCT01885078|12034936|FG006|Treatment Period|Adverse Event|24
7623908|NCT01885078|12034937|FG007|Treatment Period|Adverse Event|5
7623909|NCT01885078|12034938|FG008|Treatment Period|Adverse Event|0
7623910|NCT01885078|12034939|FG009|Treatment Period|Adverse Event|0
7623911|NCT01885078|12034930|FG000|Treatment Period|Death|13
7623912|NCT01885078|12034931|FG001|Treatment Period|Death|33
7623913|NCT01885078|12034932|FG002|Treatment Period|Death|5
7623914|NCT01885078|12034933|FG003|Treatment Period|Death|9
7623915|NCT01885078|12034934|FG004|Treatment Period|Death|2
7623916|NCT01885078|12034935|FG005|Treatment Period|Death|10
7623917|NCT01885078|12034936|FG006|Treatment Period|Death|3
7623918|NCT01885078|12034937|FG007|Treatment Period|Death|2
7623919|NCT01885078|12034938|FG008|Treatment Period|Death|0
7623920|NCT01885078|12034939|FG009|Treatment Period|Death|0
7623921|NCT01885078|12034930|FG000|Treatment Period|Lack of Efficacy|12
7623922|NCT01885078|12034931|FG001|Treatment Period|Lack of Efficacy|33
7217901|NCT03790917|11426229|FG000|Overall Study|Death|1
7217902|NCT05017493|11426245|FG000|Overall Study|Withdrawal by Subject|26
7217903|NCT05017493|11426246|FG001|Overall Study|Withdrawal by Subject|0
7217904|NCT05017493|11426245|FG000|Overall Study|Physician Decision|15
7217905|NCT05017493|11426246|FG001|Overall Study|Physician Decision|0
7217906|NCT05017493|11426245|FG000|Overall Study|Protocol Violation|81
7217907|NCT05017493|11426246|FG001|Overall Study|Protocol Violation|0
7217908|NCT04348500|11426279|FG000|Overall Study|Death|2
7217909|NCT04348500|11426280|FG001|Overall Study|Death|2
7217910|NCT04348500|11426279|FG000|Overall Study|Withdrawn by subject due to dementia|0
7217911|NCT04348500|11426280|FG001|Overall Study|Withdrawn by subject due to dementia|1
7217912|NCT03799198|11426323|FG000|Overall Study|Lost to Follow-up|4
7217913|NCT03799198|11426324|FG001|Overall Study|Lost to Follow-up|8
7217914|NCT03799198|11426323|FG000|Overall Study|Death|0
7217915|NCT03799198|11426324|FG001|Overall Study|Death|1
7217916|NCT03770728|11426334|FG000|Overall Study|Adverse Event|1
7217917|NCT03770728|11426335|FG001|Overall Study|Adverse Event|0
7217918|NCT03770728|11426336|FG002|Overall Study|Adverse Event|1
7623923|NCT01885078|12034932|FG002|Treatment Period|Lack of Efficacy|10
7623924|NCT01885078|12034933|FG003|Treatment Period|Lack of Efficacy|23
7623925|NCT01885078|12034934|FG004|Treatment Period|Lack of Efficacy|24
7623926|NCT01885078|12034935|FG005|Treatment Period|Lack of Efficacy|58
7623927|NCT01885078|12034936|FG006|Treatment Period|Lack of Efficacy|9
7623928|NCT01885078|12034937|FG007|Treatment Period|Lack of Efficacy|5
7623929|NCT01885078|12034938|FG008|Treatment Period|Lack of Efficacy|0
7623930|NCT01885078|12034939|FG009|Treatment Period|Lack of Efficacy|0
7623931|NCT01885078|12034930|FG000|Treatment Period|Lost to Follow-up|16
7623932|NCT01885078|12034931|FG001|Treatment Period|Lost to Follow-up|19
7623933|NCT01885078|12034932|FG002|Treatment Period|Lost to Follow-up|7
7623934|NCT01885078|12034933|FG003|Treatment Period|Lost to Follow-up|9
7623935|NCT01885078|12034934|FG004|Treatment Period|Lost to Follow-up|2
7623936|NCT01885078|12034935|FG005|Treatment Period|Lost to Follow-up|8
7623937|NCT01885078|12034936|FG006|Treatment Period|Lost to Follow-up|2
7623938|NCT01885078|12034937|FG007|Treatment Period|Lost to Follow-up|0
7623939|NCT01885078|12034938|FG008|Treatment Period|Lost to Follow-up|0
7623940|NCT01885078|12034939|FG009|Treatment Period|Lost to Follow-up|0
7623941|NCT01885078|12034930|FG000|Treatment Period|Physician Decision|19
7623942|NCT01885078|12034931|FG001|Treatment Period|Physician Decision|21
7623943|NCT01885078|12034932|FG002|Treatment Period|Physician Decision|5
7623944|NCT01885078|12034933|FG003|Treatment Period|Physician Decision|12
7623945|NCT01885078|12034934|FG004|Treatment Period|Physician Decision|9
7623946|NCT01885078|12034935|FG005|Treatment Period|Physician Decision|24
7623947|NCT01885078|12034936|FG006|Treatment Period|Physician Decision|4
7623948|NCT01885078|12034937|FG007|Treatment Period|Physician Decision|3
7623949|NCT01885078|12034938|FG008|Treatment Period|Physician Decision|0
7623950|NCT01885078|12034939|FG009|Treatment Period|Physician Decision|0
7623951|NCT01885078|12034930|FG000|Treatment Period|Protocol Violation|3
7623952|NCT01885078|12034931|FG001|Treatment Period|Protocol Violation|5
7623953|NCT01885078|12034932|FG002|Treatment Period|Protocol Violation|0
7623954|NCT01885078|12034933|FG003|Treatment Period|Protocol Violation|3
7623955|NCT01885078|12034934|FG004|Treatment Period|Protocol Violation|1
7623956|NCT01885078|12034935|FG005|Treatment Period|Protocol Violation|6
7623957|NCT01885078|12034936|FG006|Treatment Period|Protocol Violation|0
7623958|NCT01885078|12034937|FG007|Treatment Period|Protocol Violation|0
7623959|NCT01885078|12034938|FG008|Treatment Period|Protocol Violation|0
7623960|NCT01885078|12034939|FG009|Treatment Period|Protocol Violation|0
7623961|NCT01885078|12034930|FG000|Treatment Period|Sponsor Decision|245
7623962|NCT01885078|12034931|FG001|Treatment Period|Sponsor Decision|648
7623963|NCT01885078|12034932|FG002|Treatment Period|Sponsor Decision|49
7623964|NCT01885078|12034933|FG003|Treatment Period|Sponsor Decision|90
7623965|NCT01885078|12034934|FG004|Treatment Period|Sponsor Decision|20
7623966|NCT01885078|12034935|FG005|Treatment Period|Sponsor Decision|38
7623967|NCT01885078|12034936|FG006|Treatment Period|Sponsor Decision|162
7623968|NCT01885078|12034937|FG007|Treatment Period|Sponsor Decision|3
7623969|NCT01885078|12034938|FG008|Treatment Period|Sponsor Decision|0
7623970|NCT01885078|12034939|FG009|Treatment Period|Sponsor Decision|0
7623971|NCT01885078|12034930|FG000|Treatment Period|Withdrawal by Subject|72
7623972|NCT01885078|12034931|FG001|Treatment Period|Withdrawal by Subject|132
7623973|NCT01885078|12034932|FG002|Treatment Period|Withdrawal by Subject|25
7623974|NCT01885078|12034933|FG003|Treatment Period|Withdrawal by Subject|63
7623975|NCT01885078|12034934|FG004|Treatment Period|Withdrawal by Subject|15
7623976|NCT01885078|12034935|FG005|Treatment Period|Withdrawal by Subject|34
7623977|NCT01885078|12034936|FG006|Treatment Period|Withdrawal by Subject|17
7623978|NCT01885078|12034937|FG007|Treatment Period|Withdrawal by Subject|10
7623979|NCT01885078|12034938|FG008|Treatment Period|Withdrawal by Subject|0
7623980|NCT01885078|12034939|FG009|Treatment Period|Withdrawal by Subject|0
7623981|NCT01885078|12034930|FG000|Treatment Period|Other|0
7623982|NCT01885078|12034931|FG001|Treatment Period|Other|0
7623983|NCT01885078|12034932|FG002|Treatment Period|Other|0
7623984|NCT01885078|12034933|FG003|Treatment Period|Other|1
7623985|NCT01885078|12034934|FG004|Treatment Period|Other|0
7623986|NCT01885078|12034935|FG005|Treatment Period|Other|0
7623987|NCT01885078|12034936|FG006|Treatment Period|Other|0
7623988|NCT01885078|12034937|FG007|Treatment Period|Other|0
7623989|NCT01885078|12034938|FG008|Treatment Period|Other|0
7623990|NCT01885078|12034939|FG009|Treatment Period|Other|0
7623991|NCT01885078|12034930|FG000|Step-down Period|Sponsor Decision|0
7623992|NCT01885078|12034931|FG001|Step-down Period|Sponsor Decision|0
7623993|NCT01885078|12034932|FG002|Step-down Period|Sponsor Decision|0
7623994|NCT01885078|12034933|FG003|Step-down Period|Sponsor Decision|0
7623995|NCT01885078|12034934|FG004|Step-down Period|Sponsor Decision|0
7623996|NCT01885078|12034935|FG005|Step-down Period|Sponsor Decision|0
7623997|NCT01885078|12034936|FG006|Step-down Period|Sponsor Decision|0
7623998|NCT01885078|12034937|FG007|Step-down Period|Sponsor Decision|0
7623999|NCT01885078|12034938|FG008|Step-down Period|Sponsor Decision|1
7624000|NCT01885078|12034939|FG009|Step-down Period|Sponsor Decision|1
7624001|NCT01885078|12034930|FG000|Step-down Period|Adverse Event|0
7624002|NCT01885078|12034931|FG001|Step-down Period|Adverse Event|0
7624003|NCT01885078|12034932|FG002|Step-down Period|Adverse Event|0
7624004|NCT01885078|12034933|FG003|Step-down Period|Adverse Event|0
7624005|NCT01885078|12034934|FG004|Step-down Period|Adverse Event|0
7624006|NCT01885078|12034935|FG005|Step-down Period|Adverse Event|0
7624007|NCT01885078|12034936|FG006|Step-down Period|Adverse Event|0
7624008|NCT01885078|12034937|FG007|Step-down Period|Adverse Event|0
7624009|NCT01885078|12034938|FG008|Step-down Period|Adverse Event|29
7624010|NCT01885078|12034939|FG009|Step-down Period|Adverse Event|38
7624011|NCT01885078|12034930|FG000|Step-down Period|Withdrawal by Subject|0
7624012|NCT01885078|12034931|FG001|Step-down Period|Withdrawal by Subject|0
7624013|NCT01885078|12034932|FG002|Step-down Period|Withdrawal by Subject|0
7624014|NCT01885078|12034933|FG003|Step-down Period|Withdrawal by Subject|0
7624015|NCT01885078|12034934|FG004|Step-down Period|Withdrawal by Subject|0
7624016|NCT01885078|12034935|FG005|Step-down Period|Withdrawal by Subject|0
7624017|NCT01885078|12034936|FG006|Step-down Period|Withdrawal by Subject|0
7624018|NCT01885078|12034937|FG007|Step-down Period|Withdrawal by Subject|0
7624019|NCT01885078|12034938|FG008|Step-down Period|Withdrawal by Subject|25
7624020|NCT01885078|12034939|FG009|Step-down Period|Withdrawal by Subject|15
7624021|NCT01885078|12034930|FG000|Step-down Period|Physician Decision|0
7624022|NCT01885078|12034931|FG001|Step-down Period|Physician Decision|0
7624023|NCT01885078|12034932|FG002|Step-down Period|Physician Decision|0
7624024|NCT01885078|12034933|FG003|Step-down Period|Physician Decision|0
7624025|NCT01885078|12034934|FG004|Step-down Period|Physician Decision|0
7624026|NCT01885078|12034935|FG005|Step-down Period|Physician Decision|0
7624027|NCT01885078|12034936|FG006|Step-down Period|Physician Decision|0
7624028|NCT01885078|12034937|FG007|Step-down Period|Physician Decision|0
7624029|NCT01885078|12034938|FG008|Step-down Period|Physician Decision|7
7624030|NCT01885078|12034939|FG009|Step-down Period|Physician Decision|2
7624031|NCT01885078|12034930|FG000|Step-down Period|Death|0
7624032|NCT01885078|12034931|FG001|Step-down Period|Death|0
7624033|NCT01885078|12034932|FG002|Step-down Period|Death|0
7624034|NCT01885078|12034933|FG003|Step-down Period|Death|0
7624035|NCT01885078|12034934|FG004|Step-down Period|Death|0
7624036|NCT01885078|12034935|FG005|Step-down Period|Death|0
7624037|NCT01885078|12034936|FG006|Step-down Period|Death|0
7624038|NCT01885078|12034937|FG007|Step-down Period|Death|0
7624039|NCT01885078|12034938|FG008|Step-down Period|Death|4
7624040|NCT01885078|12034939|FG009|Step-down Period|Death|3
7624041|NCT01885078|12034930|FG000|Step-down Period|Lost to Follow-up|0
7624042|NCT01885078|12034931|FG001|Step-down Period|Lost to Follow-up|0
7624043|NCT01885078|12034932|FG002|Step-down Period|Lost to Follow-up|0
7624044|NCT01885078|12034933|FG003|Step-down Period|Lost to Follow-up|0
7624045|NCT01885078|12034934|FG004|Step-down Period|Lost to Follow-up|0
7624046|NCT01885078|12034935|FG005|Step-down Period|Lost to Follow-up|0
7624047|NCT01885078|12034936|FG006|Step-down Period|Lost to Follow-up|0
7624048|NCT01885078|12034937|FG007|Step-down Period|Lost to Follow-up|0
7624049|NCT01885078|12034938|FG008|Step-down Period|Lost to Follow-up|1
7624050|NCT01885078|12034939|FG009|Step-down Period|Lost to Follow-up|1
7624051|NCT01885078|12034930|FG000|Step-down Period|Lack of Efficacy|0
7624052|NCT01885078|12034931|FG001|Step-down Period|Lack of Efficacy|0
7624053|NCT01885078|12034932|FG002|Step-down Period|Lack of Efficacy|0
7624054|NCT01885078|12034933|FG003|Step-down Period|Lack of Efficacy|0
7624055|NCT01885078|12034934|FG004|Step-down Period|Lack of Efficacy|0
7624056|NCT01885078|12034935|FG005|Step-down Period|Lack of Efficacy|0
7624057|NCT01885078|12034936|FG006|Step-down Period|Lack of Efficacy|0
7624058|NCT01885078|12034937|FG007|Step-down Period|Lack of Efficacy|0
7624059|NCT01885078|12034938|FG008|Step-down Period|Lack of Efficacy|1
7624060|NCT01885078|12034939|FG009|Step-down Period|Lack of Efficacy|0
7624061|NCT01885078|12034930|FG000|Step-down Period|Protocol Violation|0
7624062|NCT01885078|12034931|FG001|Step-down Period|Protocol Violation|0
7624063|NCT01885078|12034932|FG002|Step-down Period|Protocol Violation|0
7624064|NCT01885078|12034933|FG003|Step-down Period|Protocol Violation|0
7624065|NCT01885078|12034934|FG004|Step-down Period|Protocol Violation|0
7624066|NCT01885078|12034935|FG005|Step-down Period|Protocol Violation|0
7624067|NCT01885078|12034936|FG006|Step-down Period|Protocol Violation|0
7624068|NCT01885078|12034937|FG007|Step-down Period|Protocol Violation|0
7624069|NCT01885078|12034938|FG008|Step-down Period|Protocol Violation|1
7624070|NCT01885078|12034939|FG009|Step-down Period|Protocol Violation|1
7624071|NCT01047683|12034963|FG000|Overall Study|Adverse Event|3
7624072|NCT01047683|12034964|FG001|Overall Study|Adverse Event|1
7624073|NCT01047683|12034965|FG002|Overall Study|Adverse Event|0
7624074|NCT01047683|12034963|FG000|Overall Study|Withdrew Consent|1
7624075|NCT01047683|12034964|FG001|Overall Study|Withdrew Consent|4
7624076|NCT01047683|12034965|FG002|Overall Study|Withdrew Consent|2
7624077|NCT01047683|12034963|FG000|Overall Study|Lost to Follow-up|0
7624078|NCT01047683|12034964|FG001|Overall Study|Lost to Follow-up|1
7624079|NCT01047683|12034965|FG002|Overall Study|Lost to Follow-up|0
7624080|NCT01047683|12034963|FG000|Overall Study|Triglycerides >2000 mg/dL|1
7624081|NCT01047683|12034964|FG001|Overall Study|Triglycerides >2000 mg/dL|0
7624082|NCT01047683|12034965|FG002|Overall Study|Triglycerides >2000 mg/dL|1
7624083|NCT01047501|12034976|FG000|Overall Study|Adverse Event|7
7624084|NCT01047501|12034977|FG001|Overall Study|Adverse Event|8
7624085|NCT01047501|12034978|FG002|Overall Study|Adverse Event|5
7624086|NCT01047501|12034976|FG000|Overall Study|Withdrew Consent|6
7624087|NCT01047501|12034977|FG001|Overall Study|Withdrew Consent|2
7624088|NCT01047501|12034978|FG002|Overall Study|Withdrew Consent|4
7624089|NCT01047501|12034976|FG000|Overall Study|Lost to Follow-up|0
7624090|NCT01047501|12034977|FG001|Overall Study|Lost to Follow-up|1
7624091|NCT01047501|12034978|FG002|Overall Study|Lost to Follow-up|1
7624092|NCT01047501|12034976|FG000|Overall Study|Triglycerides >800 mg/dL|1
7624093|NCT01047501|12034977|FG001|Overall Study|Triglycerides >800 mg/dL|0
7624094|NCT01047501|12034978|FG002|Overall Study|Triglycerides >800 mg/dL|0
7624095|NCT01047501|12034976|FG000|Overall Study|Death|1
7624096|NCT01047501|12034977|FG001|Overall Study|Death|0
7624097|NCT01047501|12034978|FG002|Overall Study|Death|0
7624098|NCT01047501|12034976|FG000|Overall Study|Other discontinuation|1
7624099|NCT01047501|12034977|FG001|Overall Study|Other discontinuation|0
7624100|NCT01047501|12034978|FG002|Overall Study|Other discontinuation|1
7624101|NCT01047501|12034976|FG000|Overall Study|Investigator judgement|0
7624102|NCT01047501|12034977|FG001|Overall Study|Investigator judgement|0
7624103|NCT01047501|12034978|FG002|Overall Study|Investigator judgement|1
7624104|NCT00981656|12034986|FG000|Overall Study|Protocol Violation|1
7624105|NCT00981656|12034986|FG000|Overall Study|Did not start protocol treatment|2
7624106|NCT00838526|12034992|FG000|Overall Study|Adverse Event|3
7624107|NCT00838526|12034993|FG001|Overall Study|Adverse Event|12
7624108|NCT00838526|12034992|FG000|Overall Study|Lost to Follow-up|4
7624109|NCT00838526|12034993|FG001|Overall Study|Lost to Follow-up|12
7624110|NCT00838526|12034992|FG000|Overall Study|Withdrawal by Subject|4
7624111|NCT00838526|12034993|FG001|Overall Study|Withdrawal by Subject|5
7624112|NCT00838526|12034992|FG000|Overall Study|Lack of Efficacy|2
7624113|NCT00838526|12034993|FG001|Overall Study|Lack of Efficacy|3
7624114|NCT00838526|12034992|FG000|Overall Study|Other|11
7624115|NCT00838526|12034993|FG001|Overall Study|Other|7
7624116|NCT00126672|12034999|FG000|Overall Study|Adverse Event|4
7624117|NCT00126672|12034999|FG000|Overall Study|Lost to Follow-up|4
7624118|NCT03151304|12035016|FG000|Overall Study|Termination of study by Sponsor|23
7624119|NCT03151304|12035016|FG000|Overall Study|missing|3
7624120|NCT03151304|12035016|FG000|Overall Study|Withdrawal by Subject|8
7624121|NCT03151304|12035016|FG000|Overall Study|multiple reasons|30
7624122|NCT03113409|12035020|FG000|Overall Study|Withdrawal by Subject|5
7624123|NCT03113409|12035021|FG001|Overall Study|Withdrawal by Subject|0
7624124|NCT03113409|12035022|FG002|Overall Study|Withdrawal by Subject|0
7624125|NCT02953340|12035028|FG000|Overall Study|Death|0
7624126|NCT02953340|12035029|FG001|Overall Study|Death|1
7624127|NCT02953340|12035028|FG000|Overall Study|Investigator Decision|3
7624128|NCT02953340|12035029|FG001|Overall Study|Investigator Decision|3
7624129|NCT02953340|12035028|FG000|Overall Study|Initiated Non-Protocol Therapy|5
7624130|NCT02953340|12035029|FG001|Overall Study|Initiated Non-Protocol Therapy|14
7624131|NCT02953340|12035028|FG000|Overall Study|Myeloid Growth Factors Treatment|0
7624132|NCT02953340|12035029|FG001|Overall Study|Myeloid Growth Factors Treatment|1
7624133|NCT02953340|12035028|FG000|Overall Study|Withdrawal by Subject|9
7624134|NCT02953340|12035029|FG001|Overall Study|Withdrawal by Subject|9
7624135|NCT02953340|12035028|FG000|Overall Study|Sponsor decision|0
7624136|NCT02953340|12035029|FG001|Overall Study|Sponsor decision|2
7624137|NCT02953340|12035028|FG000|Overall Study|Lost to Follow-up|3
7624138|NCT02953340|12035029|FG001|Overall Study|Lost to Follow-up|2
7624139|NCT02953340|12035028|FG000|Overall Study|Reason not specified|2
7624140|NCT02953340|12035029|FG001|Overall Study|Reason not specified|2
7624141|NCT02855944|12035043|FG000|Period 1: Treatment|Ongoing|44
7624142|NCT02855944|12035044|FG001|Period 1: Treatment|Ongoing|5
7624143|NCT02855944|12035043|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1
7624144|NCT02855944|12035044|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3
7624145|NCT02855944|12035043|FG000|Period 2: Crossover to Rucaparib|Ongoing|0
7624146|NCT02855944|12035044|FG001|Period 2: Crossover to Rucaparib|Ongoing|27
7624147|NCT02851407|12035053|FG000|Overall Study|Withdrawal by parent/guardian|2
7624148|NCT02851407|12035054|FG001|Overall Study|Withdrawal by parent/guardian|7
7624149|NCT02851407|12035053|FG000|Overall Study|Protocol deviation|0
7624150|NCT02851407|12035054|FG001|Overall Study|Protocol deviation|1
7624151|NCT02851407|12035053|FG000|Overall Study|Transferred to another hospital to continue|1
7624152|NCT02851407|12035054|FG001|Overall Study|Transferred to another hospital to continue|0
7624153|NCT02851407|12035053|FG000|Overall Study|Other Death|30
7624154|NCT02851407|12035054|FG001|Overall Study|Other Death|20
7624155|NCT02851407|12035053|FG000|Overall Study|Adverse event, serious fatal|6
7624156|NCT02851407|12035054|FG001|Overall Study|Adverse event, serious fatal|8
7624157|NCT02851407|12035053|FG000|Overall Study|Consent withdrawn by participant|5
7624158|NCT02851407|12035054|FG001|Overall Study|Consent withdrawn by participant|3
7624159|NCT02851407|12035053|FG000|Overall Study|Screen failure|2
7624160|NCT02851407|12035054|FG001|Overall Study|Screen failure|1
7624161|NCT02851407|12035053|FG000|Overall Study|Disease relapse|9
7624162|NCT02851407|12035054|FG001|Overall Study|Disease relapse|6
7624163|NCT02851407|12035053|FG000|Overall Study|Physician Decision|7
7624164|NCT02851407|12035054|FG001|Overall Study|Physician Decision|6
7624165|NCT02851407|12035053|FG000|Overall Study|Transferred to hospital closer to home|0
7624166|NCT02851407|12035054|FG001|Overall Study|Transferred to hospital closer to home|1
7624167|NCT02851407|12035053|FG000|Overall Study|Enrolled in an investigational study|0
7624168|NCT02851407|12035054|FG001|Overall Study|Enrolled in an investigational study|1
7624169|NCT02851407|12035053|FG000|Overall Study|Early recovery|1
7624170|NCT02851407|12035054|FG001|Overall Study|Early recovery|0
7624171|NCT02851407|12035053|FG000|Overall Study|Adverse event, non-fatal|7
7624172|NCT02851407|12035054|FG001|Overall Study|Adverse event, non-fatal|5
7624173|NCT02851407|12035053|FG000|Overall Study|Lost to Follow-up|0
7624174|NCT02851407|12035054|FG001|Overall Study|Lost to Follow-up|2
7624175|NCT02666430|12035079|FG000|Period 1|Lost to Follow-up|1
7624176|NCT02666430|12035080|FG001|Period 1|Lost to Follow-up|0
7624177|NCT02666430|12035079|FG000|Period 1|Adverse Event|0
7624178|NCT02666430|12035080|FG001|Period 1|Adverse Event|1
7624179|NCT02666430|12035079|FG000|Period 2|Withdrawal by Subject|1
7624180|NCT02666430|12035080|FG001|Period 2|Withdrawal by Subject|4
7624181|NCT02666430|12035079|FG000|Period 3|Lost to Follow-up|1
7624182|NCT02666430|12035080|FG001|Period 3|Lost to Follow-up|0
7624183|NCT02643420|12035088|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6
7624184|NCT02643420|12035089|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12
7624185|NCT02643420|12035088|FG000|Overall Study|Withdrawal by Subject|25
7624186|NCT02643420|12035089|FG001|Overall Study|Withdrawal by Subject|19
7624187|NCT02643420|12035088|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6
7624188|NCT02643420|12035089|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10
7624189|NCT02643420|12035088|FG000|Overall Study|Lost to Follow-up|6
7624190|NCT02643420|12035089|FG001|Overall Study|Lost to Follow-up|10
7624191|NCT02643420|12035088|FG000|Overall Study|Investigator Decision|2
7624192|NCT02643420|12035089|FG001|Overall Study|Investigator Decision|4
7624193|NCT02643420|12035088|FG000|Overall Study|Sponsor decision|1
7624194|NCT02643420|12035089|FG001|Overall Study|Sponsor decision|1
7624195|NCT02643420|12035088|FG000|Overall Study|Death|0
7624196|NCT02643420|12035089|FG001|Overall Study|Death|2
7624197|NCT02643420|12035088|FG000|Overall Study|Reason not Specified|8
7624198|NCT02643420|12035089|FG001|Overall Study|Reason not Specified|7
7624199|NCT02639559|12035103|FG000|Overall Study|Mobilization failure|0
7624200|NCT02639559|12035104|FG001|Overall Study|Mobilization failure|3
7624201|NCT02639559|12035103|FG000|Overall Study|Issues with vascular acess|1
7624202|NCT02639559|12035104|FG001|Overall Study|Issues with vascular acess|0
7624203|NCT02569476|12035110|FG000|Overall Study|Roll over to Long-Term Extension Study|73
7624204|NCT02569476|12035110|FG000|Overall Study|Death|33
7624205|NCT02569476|12035110|FG000|Overall Study|Withdrawal by Subject|9
7624206|NCT02569476|12035110|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
7624207|NCT02569476|12035110|FG000|Overall Study|Palliative care|1
7624208|NCT02569476|12035110|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
7624209|NCT02569476|12035110|FG000|Overall Study|Transitioned to Long Term Extension Study|1
7624210|NCT02496676|12035126|FG000|Phase 1 - Period 1|Adverse Event|0
7624211|NCT02496676|12035127|FG001|Phase 1 - Period 1|Adverse Event|1
7624212|NCT02496676|12035126|FG000|Phase 2 - IV MgSO4|Adverse Event|0
7624213|NCT02496676|12035127|FG001|Phase 2 - IV MgSO4|Adverse Event|1
7624214|NCT02412618|12035152|FG000|Overall Study|Withdrawal by Subject|1
7624215|NCT02412618|12035153|FG001|Overall Study|Withdrawal by Subject|1
7624216|NCT02412618|12035152|FG000|Overall Study|Expulsion|1
7624217|NCT02412618|12035153|FG001|Overall Study|Expulsion|1
7624218|NCT02351180|12035170|FG000|Overall Study|Withdrawal by Subject|1
7624219|NCT02351180|12035171|FG001|Overall Study|Withdrawal by Subject|0
7624220|NCT02337764|12035177|FG000|Overall Study|Pretreatment Event/Adverse Event|46
7624221|NCT02337764|12035177|FG000|Overall Study|Voluntary Withdrawal|12
7624222|NCT02337764|12035177|FG000|Overall Study|Lack of Efficacy|2
7624223|NCT02337738|12035184|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7624224|NCT02337738|12035185|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
7624225|NCT02337738|12035186|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
7624226|NCT02337738|12035184|FG000|Overall Study|Pretreatment Event/Adverse Event|9
7624227|NCT02337738|12035185|FG001|Overall Study|Pretreatment Event/Adverse Event|18
7624228|NCT02337738|12035186|FG002|Overall Study|Pretreatment Event/Adverse Event|21
7624229|NCT02337738|12035184|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
7624230|NCT02337738|12035185|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
7624231|NCT02337738|12035186|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
7624232|NCT02337738|12035184|FG000|Overall Study|Voluntary Withdrawal|10
7624233|NCT02337738|12035185|FG001|Overall Study|Voluntary Withdrawal|5
7624234|NCT02337738|12035186|FG002|Overall Study|Voluntary Withdrawal|2
7624235|NCT02337738|12035184|FG000|Overall Study|Lack of Efficacy|2
7624236|NCT02337738|12035185|FG001|Overall Study|Lack of Efficacy|4
7624237|NCT02337738|12035186|FG002|Overall Study|Lack of Efficacy|0
7624238|NCT02337738|12035184|FG000|Overall Study|Investigator's Judgment|1
7624239|NCT02337738|12035185|FG001|Overall Study|Investigator's Judgment|1
7624240|NCT02337738|12035186|FG002|Overall Study|Investigator's Judgment|3
7624241|NCT02332187|12035196|FG000|Overall Study|Withdrawal by Subject|2
7624242|NCT02332187|12035197|FG001|Overall Study|Withdrawal by Subject|2
7624243|NCT02332187|12035196|FG000|Overall Study|Adverse Event|0
7624244|NCT02332187|12035197|FG001|Overall Study|Adverse Event|1
7624245|NCT02227875|12035205|FG000|Overall Study|Protocol Violation|10
7624246|NCT02227875|12035206|FG001|Overall Study|Protocol Violation|7
7624247|NCT02227875|12035205|FG000|Overall Study|Other|1
7624248|NCT02227875|12035206|FG001|Overall Study|Other|3
7624249|NCT02227875|12035205|FG000|Overall Study|Physician Decision|1
7624250|NCT02227875|12035206|FG001|Overall Study|Physician Decision|0
7624251|NCT02227875|12035205|FG000|Overall Study|Adverse Event|3
7624252|NCT02227875|12035206|FG001|Overall Study|Adverse Event|0
7624253|NCT02227875|12035205|FG000|Overall Study|Withdrawal by Subject|12
7624254|NCT02227875|12035206|FG001|Overall Study|Withdrawal by Subject|13
7624255|NCT02227875|12035205|FG000|Overall Study|Lost to Follow-up|10
7624256|NCT02227875|12035206|FG001|Overall Study|Lost to Follow-up|10
7624257|NCT02227862|12035214|FG000|Overall Study|Protocol Violation|7
7624258|NCT02227862|12035215|FG001|Overall Study|Protocol Violation|9
7624259|NCT02227862|12035214|FG000|Overall Study|Other|0
7624260|NCT02227862|12035215|FG001|Overall Study|Other|2
7624261|NCT02227862|12035214|FG000|Overall Study|Adverse Event|4
7624262|NCT02227862|12035215|FG001|Overall Study|Adverse Event|3
7624263|NCT02227862|12035214|FG000|Overall Study|Withdrawal by Subject|7
7624264|NCT02227862|12035215|FG001|Overall Study|Withdrawal by Subject|6
7624265|NCT02227862|12035214|FG000|Overall Study|Lost to Follow-up|1
7624266|NCT02227862|12035215|FG001|Overall Study|Lost to Follow-up|2
7624267|NCT02200939|12035223|FG000|Overall Study|Participant withdrew consent|0
7624268|NCT02200939|12035224|FG001|Overall Study|Participant withdrew consent|1
7624269|NCT02200939|12035223|FG000|Overall Study|Lost to Follow-up|2
7624270|NCT02200939|12035224|FG001|Overall Study|Lost to Follow-up|9
7624271|NCT02200939|12035223|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0
7624272|NCT02200939|12035224|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1
7624273|NCT02108964|12035242|FG000|Overall Study|Progressive disease|12
7624274|NCT02108964|12035243|FG001|Overall Study|Progressive disease|25
7624275|NCT02108964|12035244|FG002|Overall Study|Progressive disease|50
7624276|NCT02108964|12035245|FG003|Overall Study|Progressive disease|6
7624277|NCT02108964|12035246|FG004|Overall Study|Progressive disease|18
7624278|NCT02108964|12035247|FG005|Overall Study|Progressive disease|5
7624279|NCT02108964|12035248|FG006|Overall Study|Progressive disease|7
7624280|NCT02108964|12035249|FG007|Overall Study|Progressive disease|9
7624281|NCT02108964|12035242|FG000|Overall Study|Physician Decision|1
7624282|NCT02108964|12035243|FG001|Overall Study|Physician Decision|5
7624283|NCT02108964|12035244|FG002|Overall Study|Physician Decision|6
7624284|NCT02108964|12035245|FG003|Overall Study|Physician Decision|0
7624285|NCT02108964|12035246|FG004|Overall Study|Physician Decision|1
7624286|NCT02108964|12035247|FG005|Overall Study|Physician Decision|0
7624287|NCT02108964|12035248|FG006|Overall Study|Physician Decision|0
7624288|NCT02108964|12035249|FG007|Overall Study|Physician Decision|0
7624289|NCT02108964|12035242|FG000|Overall Study|Adverse Event|0
7624290|NCT02108964|12035243|FG001|Overall Study|Adverse Event|0
7624291|NCT02108964|12035244|FG002|Overall Study|Adverse Event|4
7624292|NCT02108964|12035245|FG003|Overall Study|Adverse Event|0
7624293|NCT02108964|12035246|FG004|Overall Study|Adverse Event|1
7624294|NCT02108964|12035247|FG005|Overall Study|Adverse Event|0
7624295|NCT02108964|12035248|FG006|Overall Study|Adverse Event|3
7624296|NCT02108964|12035249|FG007|Overall Study|Adverse Event|1
7624297|NCT02108964|12035242|FG000|Overall Study|Death|1
7624298|NCT02108964|12035243|FG001|Overall Study|Death|1
7624299|NCT02108964|12035244|FG002|Overall Study|Death|2
7624300|NCT02108964|12035245|FG003|Overall Study|Death|0
7624301|NCT02108964|12035246|FG004|Overall Study|Death|3
7624302|NCT02108964|12035247|FG005|Overall Study|Death|0
7624303|NCT02108964|12035248|FG006|Overall Study|Death|0
7624304|NCT02108964|12035249|FG007|Overall Study|Death|1
7624305|NCT02108964|12035242|FG000|Overall Study|Subject/Guardian decision|0
7624306|NCT02108964|12035243|FG001|Overall Study|Subject/Guardian decision|1
7624307|NCT02108964|12035244|FG002|Overall Study|Subject/Guardian decision|3
7624308|NCT02108964|12035245|FG003|Overall Study|Subject/Guardian decision|0
7624309|NCT02108964|12035246|FG004|Overall Study|Subject/Guardian decision|2
7624310|NCT02108964|12035247|FG005|Overall Study|Subject/Guardian decision|0
7624311|NCT02108964|12035248|FG006|Overall Study|Subject/Guardian decision|1
7624312|NCT02108964|12035249|FG007|Overall Study|Subject/Guardian decision|1
7624313|NCT01922895|12035292|FG000|Overall Study|Death|0
7217919|NCT03770728|11426337|FG003|Overall Study|Adverse Event|0
7217920|NCT03770728|11426334|FG000|Overall Study|Poor compliance to protocol|0
7217921|NCT03770728|11426335|FG001|Overall Study|Poor compliance to protocol|0
7217922|NCT03770728|11426336|FG002|Overall Study|Poor compliance to protocol|1
7217923|NCT03770728|11426337|FG003|Overall Study|Poor compliance to protocol|0
7217924|NCT03770728|11426334|FG000|Overall Study|Withdrawal by Subject|13
7217925|NCT03770728|11426335|FG001|Overall Study|Withdrawal by Subject|8
7217926|NCT03770728|11426336|FG002|Overall Study|Withdrawal by Subject|9
7217927|NCT03770728|11426337|FG003|Overall Study|Withdrawal by Subject|13
7217928|NCT03770728|11426334|FG000|Overall Study|Other than specified|24
7217929|NCT03770728|11426335|FG001|Overall Study|Other than specified|23
7217930|NCT03770728|11426336|FG002|Overall Study|Other than specified|21
7217931|NCT03770728|11426337|FG003|Overall Study|Other than specified|22
7217932|NCT03760146|11426355|FG000|Overall Study|Adverse Event|11
7217933|NCT03760146|11426356|FG001|Overall Study|Adverse Event|8
7217934|NCT03760146|11426357|FG002|Overall Study|Adverse Event|0
7217935|NCT03760146|11426358|FG003|Overall Study|Adverse Event|0
7217936|NCT03760146|11426359|FG004|Overall Study|Adverse Event|0
7217937|NCT03760146|11426360|FG005|Overall Study|Adverse Event|0
7217938|NCT03760146|11426355|FG000|Overall Study|Death|1
7217939|NCT03760146|11426356|FG001|Overall Study|Death|0
7217940|NCT03760146|11426357|FG002|Overall Study|Death|0
7217941|NCT03760146|11426358|FG003|Overall Study|Death|0
7217942|NCT03760146|11426359|FG004|Overall Study|Death|0
7217943|NCT03760146|11426360|FG005|Overall Study|Death|0
7217944|NCT03760146|11426355|FG000|Overall Study|Lost to Follow-up|41
7217945|NCT03760146|11426356|FG001|Overall Study|Lost to Follow-up|28
7217946|NCT03760146|11426357|FG002|Overall Study|Lost to Follow-up|9
7217947|NCT03760146|11426358|FG003|Overall Study|Lost to Follow-up|2
7217948|NCT03760146|11426359|FG004|Overall Study|Lost to Follow-up|14
7217949|NCT03760146|11426360|FG005|Overall Study|Lost to Follow-up|8
7217950|NCT03760146|11426355|FG000|Overall Study|No longer met eligibility criteria|3
7217951|NCT03760146|11426356|FG001|Overall Study|No longer met eligibility criteria|9
7217952|NCT03760146|11426357|FG002|Overall Study|No longer met eligibility criteria|0
7217953|NCT03760146|11426358|FG003|Overall Study|No longer met eligibility criteria|0
7217954|NCT03760146|11426359|FG004|Overall Study|No longer met eligibility criteria|1
7217955|NCT03760146|11426360|FG005|Overall Study|No longer met eligibility criteria|0
7217956|NCT03760146|11426355|FG000|Overall Study|Protocol Violation|21
7217957|NCT03760146|11426356|FG001|Overall Study|Protocol Violation|13
7217958|NCT03760146|11426357|FG002|Overall Study|Protocol Violation|1
7217959|NCT03760146|11426358|FG003|Overall Study|Protocol Violation|0
7217960|NCT03760146|11426359|FG004|Overall Study|Protocol Violation|1
7217961|NCT03760146|11426360|FG005|Overall Study|Protocol Violation|0
7217962|NCT03760146|11426355|FG000|Overall Study|Withdrawal by Subject|19
7217963|NCT03760146|11426356|FG001|Overall Study|Withdrawal by Subject|20
7217964|NCT03760146|11426357|FG002|Overall Study|Withdrawal by Subject|1
7217965|NCT03760146|11426358|FG003|Overall Study|Withdrawal by Subject|0
7217966|NCT03760146|11426359|FG004|Overall Study|Withdrawal by Subject|1
7217967|NCT03760146|11426360|FG005|Overall Study|Withdrawal by Subject|0
7217968|NCT03760081|11426380|FG000|Overall Study|Miscellaneous|0
7217969|NCT03760081|11426381|FG001|Overall Study|Miscellaneous|1
7217970|NCT03760081|11426380|FG000|Overall Study|Progressive Disease|5
7217971|NCT03760081|11426381|FG001|Overall Study|Progressive Disease|10
7217972|NCT03760081|11426380|FG000|Overall Study|Death|1
7624314|NCT01922895|12035293|FG001|Overall Study|Death|1
7624315|NCT01922895|12035292|FG000|Overall Study|Withdrawal by Subject|1
7292166|NCT00548145|11510088|FG000|Overall Study|Death|0
7292167|NCT00548145|11510089|FG001|Overall Study|Death|1
7292168|NCT00548145|11510088|FG000|Overall Study|Withdrawal by Subject|0
7292169|NCT00548145|11510089|FG001|Overall Study|Withdrawal by Subject|2
7292170|NCT00548145|11510088|FG000|Overall Study|Physician Decision|1
7292171|NCT00548145|11510089|FG001|Overall Study|Physician Decision|1
7292172|NCT00548184|11510104|FG000|Overall Study|Adverse Event|3
7292173|NCT00548184|11510104|FG000|Overall Study|took other drug|1
7292174|NCT00548184|11510104|FG000|Overall Study|Found Her2 negative|1
7292175|NCT00548249|11510124|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
7292176|NCT00548249|11510125|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7292177|NCT00548249|11510126|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7292178|NCT00548249|11510127|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
7292179|NCT00548249|11510128|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
7292180|NCT00548249|11510124|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
7292181|NCT00548249|11510125|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
7292182|NCT00548249|11510126|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
7292183|NCT00548249|11510127|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
7292184|NCT00548249|11510128|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
7292185|NCT00548249|11510124|FG000|Overall Study|Protocol Violation|1
7292186|NCT00548249|11510125|FG001|Overall Study|Protocol Violation|1
7292187|NCT00548249|11510126|FG002|Overall Study|Protocol Violation|4
7292188|NCT00548249|11510127|FG003|Overall Study|Protocol Violation|0
7292189|NCT00548249|11510128|FG004|Overall Study|Protocol Violation|3
7292190|NCT00548249|11510124|FG000|Overall Study|Miscellaneous|2
7292191|NCT00548249|11510125|FG001|Overall Study|Miscellaneous|3
7292192|NCT00548249|11510126|FG002|Overall Study|Miscellaneous|2
7292193|NCT00548249|11510127|FG003|Overall Study|Miscellaneous|0
7292194|NCT00548249|11510128|FG004|Overall Study|Miscellaneous|2
7292195|NCT00548249|11510124|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7292196|NCT00548249|11510125|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
7292197|NCT00548249|11510126|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
7292198|NCT00548249|11510127|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
7292199|NCT00548249|11510128|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
7292200|NCT00548249|11510124|FG000|Overall Study|Adverse Event|2
7292201|NCT00548249|11510125|FG001|Overall Study|Adverse Event|2
7292202|NCT00548249|11510126|FG002|Overall Study|Adverse Event|0
7292203|NCT00548249|11510127|FG003|Overall Study|Adverse Event|1
7292204|NCT00548249|11510128|FG004|Overall Study|Adverse Event|1
7292205|NCT00548249|11510124|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
7292206|NCT00548249|11510125|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
7292207|NCT00548249|11510126|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
7292208|NCT00548249|11510127|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
7292209|NCT00548249|11510128|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
7292210|NCT00548249|11510124|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7292211|NCT00548249|11510125|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
7292212|NCT00548249|11510126|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
7292213|NCT00548249|11510127|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7292214|NCT00548249|11510128|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
7292215|NCT00548249|11510124|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7292216|NCT00548249|11510125|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7292217|NCT00548249|11510126|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7292218|NCT00548249|11510127|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
7292219|NCT00548249|11510128|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
7292220|NCT00548249|11510124|FG000|Overall Study|Prolonged hospitalization|0
7292221|NCT00548249|11510125|FG001|Overall Study|Prolonged hospitalization|0
7292222|NCT00548249|11510126|FG002|Overall Study|Prolonged hospitalization|2
7292223|NCT00548249|11510127|FG003|Overall Study|Prolonged hospitalization|1
7292224|NCT00548249|11510128|FG004|Overall Study|Prolonged hospitalization|0
7292225|NCT00548249|11510124|FG000|Overall Study|Withdrawal by Subject|2
7292226|NCT00548249|11510125|FG001|Overall Study|Withdrawal by Subject|0
7292227|NCT00548249|11510126|FG002|Overall Study|Withdrawal by Subject|0
7292228|NCT00548249|11510127|FG003|Overall Study|Withdrawal by Subject|0
7292229|NCT00548249|11510128|FG004|Overall Study|Withdrawal by Subject|0
7292230|NCT00548249|11510124|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7292231|NCT00548249|11510125|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7292232|NCT00548249|11510126|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7292233|NCT00548249|11510127|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
7292234|NCT00548249|11510128|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
7292235|NCT00548249|11510124|FG000|Overall Study|Sponsor's request|0
7292236|NCT00548249|11510125|FG001|Overall Study|Sponsor's request|0
7292237|NCT00548249|11510126|FG002|Overall Study|Sponsor's request|0
7292238|NCT00548249|11510127|FG003|Overall Study|Sponsor's request|1
7292239|NCT00548249|11510128|FG004|Overall Study|Sponsor's request|0
7292240|NCT00548262|11510140|FG000|Overall Study|Death|21
7292241|NCT00548262|11510140|FG000|Overall Study|Adverse Event|2
7217973|NCT03760081|11426381|FG001|Overall Study|Death|1
7217989|NCT03713684|11426415|FG000|Overall Study|Adverse Event|1
7217990|NCT03713684|11426416|FG001|Overall Study|Adverse Event|3
7217991|NCT03713684|11426417|FG002|Overall Study|Adverse Event|1
7217992|NCT03713684|11426418|FG003|Overall Study|Adverse Event|0
7217993|NCT03713684|11426415|FG000|Overall Study|Poor compliance to protocol|2
7217994|NCT03713684|11426416|FG001|Overall Study|Poor compliance to protocol|1
7217995|NCT03713684|11426417|FG002|Overall Study|Poor compliance to protocol|0
7217996|NCT03713684|11426418|FG003|Overall Study|Poor compliance to protocol|1
7217997|NCT03713684|11426415|FG000|Overall Study|Withdrawal by Subject|14
7217998|NCT03713684|11426416|FG001|Overall Study|Withdrawal by Subject|6
7217999|NCT03713684|11426417|FG002|Overall Study|Withdrawal by Subject|14
7218000|NCT03713684|11426418|FG003|Overall Study|Withdrawal by Subject|16
7218001|NCT03713684|11426415|FG000|Overall Study|Other than specified|69
7218002|NCT03713684|11426416|FG001|Overall Study|Other than specified|77
7218003|NCT03713684|11426417|FG002|Overall Study|Other than specified|73
7218004|NCT03713684|11426418|FG003|Overall Study|Other than specified|70
7218005|NCT03644550|11426428|FG000|Overall Study|Withdrawal by Subject|3
7218006|NCT03644550|11426428|FG000|Overall Study|Progressive disease|15
7292242|NCT00548262|11510140|FG000|Overall Study|Lack of Efficacy|4
7292243|NCT00548262|11510140|FG000|Overall Study|Lost to Follow-up|1
7292244|NCT00548262|11510140|FG000|Overall Study|Other|3
7292245|NCT00548262|11510140|FG000|Overall Study|Withdrawal by Subject|1
7292246|NCT00548340|11510147|FG000|Overall Study|Protocol Violation|2
7292247|NCT00548340|11510148|FG001|Overall Study|Protocol Violation|3
7292248|NCT00548340|11510149|FG002|Overall Study|Protocol Violation|3
7292249|NCT00548340|11510147|FG000|Overall Study|Adverse Event|2
7292250|NCT00548340|11510148|FG001|Overall Study|Adverse Event|2
7292251|NCT00548340|11510149|FG002|Overall Study|Adverse Event|2
7292252|NCT00548340|11510147|FG000|Overall Study|Lost to Follow-up|1
7292253|NCT00548340|11510148|FG001|Overall Study|Lost to Follow-up|1
7292254|NCT00548340|11510149|FG002|Overall Study|Lost to Follow-up|0
7292255|NCT00548340|11510147|FG000|Overall Study|Withdrawal by Subject|2
7292256|NCT00548340|11510148|FG001|Overall Study|Withdrawal by Subject|4
7292257|NCT00548340|11510149|FG002|Overall Study|Withdrawal by Subject|3
7292258|NCT00548340|11510147|FG000|Overall Study|Other|1
7292259|NCT00548340|11510148|FG001|Overall Study|Other|1
7292260|NCT00548340|11510149|FG002|Overall Study|Other|1
7292261|NCT00548405|11510160|FG000|Overall Study|Adverse Event|6
7292262|NCT00548405|11510161|FG001|Overall Study|Adverse Event|2
7292263|NCT00548405|11510162|FG002|Overall Study|Adverse Event|0
7292264|NCT00548405|11510160|FG000|Overall Study|Lack of Efficacy|6
7292265|NCT00548405|11510161|FG001|Overall Study|Lack of Efficacy|0
7292266|NCT00548405|11510162|FG002|Overall Study|Lack of Efficacy|0
7292267|NCT00548405|11510160|FG000|Overall Study|Physician Decision|3
7292268|NCT00548405|11510161|FG001|Overall Study|Physician Decision|4
7292269|NCT00548405|11510162|FG002|Overall Study|Physician Decision|1
7292270|NCT00548405|11510160|FG000|Overall Study|Pregnancy|1
7292271|NCT00548405|11510161|FG001|Overall Study|Pregnancy|0
7292272|NCT00548405|11510162|FG002|Overall Study|Pregnancy|0
7292273|NCT00548405|11510160|FG000|Overall Study|Protocol Violation|1
7292274|NCT00548405|11510161|FG001|Overall Study|Protocol Violation|0
7292275|NCT00548405|11510162|FG002|Overall Study|Protocol Violation|0
7292276|NCT00548405|11510160|FG000|Overall Study|Withdrawal by Subject|36
7292277|NCT00548405|11510161|FG001|Overall Study|Withdrawal by Subject|12
7292278|NCT00548405|11510162|FG002|Overall Study|Withdrawal by Subject|5
7292279|NCT00548405|11510160|FG000|Overall Study|Lost to Follow-up|1
7292280|NCT00548405|11510161|FG001|Overall Study|Lost to Follow-up|1
7292281|NCT00548405|11510162|FG002|Overall Study|Lost to Follow-up|2
7292282|NCT00548405|11510160|FG000|Overall Study|Death|0
7292283|NCT00548405|11510161|FG001|Overall Study|Death|1
7292284|NCT00548405|11510162|FG002|Overall Study|Death|1
7292285|NCT00548405|11510160|FG000|Overall Study|Sponsor decision|1
7292286|NCT00548405|11510161|FG001|Overall Study|Sponsor decision|0
7292287|NCT00548405|11510162|FG002|Overall Study|Sponsor decision|0
7292288|NCT00548405|11510160|FG000|Overall Study|Randomized but not treated|1
7292289|NCT00548405|11510161|FG001|Overall Study|Randomized but not treated|0
7292290|NCT00548405|11510162|FG002|Overall Study|Randomized but not treated|0
7292291|NCT00548548|11510185|FG000|Overall Study|Death|345
7218007|NCT03557970|11426435|FG000|Overall Study|Study closure|1
7218008|NCT03557970|11426436|FG001|Overall Study|Study closure|0
7218009|NCT03557970|11426435|FG000|Overall Study|Physician Decision|0
7218010|NCT03557970|11426436|FG001|Overall Study|Physician Decision|1
7218011|NCT03557970|11426435|FG000|Overall Study|Death|0
7218012|NCT03557970|11426436|FG001|Overall Study|Death|1
7218013|NCT02964039|11426466|FG000|Overall Study|Medical reason unrelated to study participation|1
7218014|NCT02964039|11426467|FG001|Overall Study|Medical reason unrelated to study participation|0
7218015|NCT02964039|11426468|FG002|Overall Study|Medical reason unrelated to study participation|3
7218016|NCT02964039|11426466|FG000|Overall Study|Research shutdown due to pandemic|2
7218017|NCT02964039|11426467|FG001|Overall Study|Research shutdown due to pandemic|0
7218018|NCT02964039|11426468|FG002|Overall Study|Research shutdown due to pandemic|1
7218019|NCT02964039|11426466|FG000|Overall Study|Withdrawal by Subject|0
7218020|NCT02964039|11426467|FG001|Overall Study|Withdrawal by Subject|1
7218021|NCT02964039|11426468|FG002|Overall Study|Withdrawal by Subject|0
7218022|NCT02964039|11426466|FG000|Overall Study|Lost to Follow-up|1
7218023|NCT02964039|11426467|FG001|Overall Study|Lost to Follow-up|0
7218024|NCT02964039|11426468|FG002|Overall Study|Lost to Follow-up|1
7218025|NCT02930889|11426476|FG000|Overall Study|Lost to Follow-up|2
7218026|NCT02930889|11426476|FG000|Overall Study|Withdrawal by Subject|6
7218027|NCT02930889|11426476|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
7218028|NCT02919618|11426480|FG000|Overall Study|Death|1
7218029|NCT02844946|11426497|FG000|Overall Study|Lost to Follow-up|7
7218030|NCT02844946|11426498|FG001|Overall Study|Lost to Follow-up|0
7218031|NCT02564796|11426515|FG000|Overall Study|Physician Decision|2
7218032|NCT02564796|11426516|FG001|Overall Study|Physician Decision|2
7218033|NCT02562716|11426524|FG000|Overall Study|Adverse Event|7
7218034|NCT02562716|11426525|FG001|Overall Study|Adverse Event|14
7218035|NCT02562716|11426524|FG000|Overall Study|Withdrawal unrelated to AE|7
7218036|NCT02562716|11426525|FG001|Overall Study|Withdrawal unrelated to AE|1
7218037|NCT02562716|11426524|FG000|Overall Study|Progression|8
7218038|NCT02562716|11426525|FG001|Overall Study|Progression|10
7218039|NCT02562716|11426524|FG000|Overall Study|Death|2
7218040|NCT02562716|11426525|FG001|Overall Study|Death|1
7218041|NCT02562716|11426524|FG000|Overall Study|Not protocol specified|4
7218042|NCT02562716|11426525|FG001|Overall Study|Not protocol specified|2
7218043|NCT01472081|11426544|FG000|Overall Study|Continuing treatment at time of analysis|1
7218044|NCT01472081|11426545|FG001|Overall Study|Continuing treatment at time of analysis|4
7218045|NCT01472081|11426546|FG002|Overall Study|Continuing treatment at time of analysis|1
7218046|NCT01472081|11426547|FG003|Overall Study|Continuing treatment at time of analysis|8
7218047|NCT01472081|11426548|FG004|Overall Study|Continuing treatment at time of analysis|9
7218048|NCT01472081|11426549|FG005|Overall Study|Continuing treatment at time of analysis|0
7218049|NCT01472081|11426544|FG000|Overall Study|Disease Progression|4
7218050|NCT01472081|11426545|FG001|Overall Study|Disease Progression|10
7218051|NCT01472081|11426546|FG002|Overall Study|Disease Progression|12
7218052|NCT01472081|11426547|FG003|Overall Study|Disease Progression|31
7218053|NCT01472081|11426548|FG004|Overall Study|Disease Progression|22
7218054|NCT01472081|11426549|FG005|Overall Study|Disease Progression|3
7218055|NCT01472081|11426544|FG000|Overall Study|Study drug toxicity|2
7218056|NCT01472081|11426545|FG001|Overall Study|Study drug toxicity|9
7218057|NCT01472081|11426546|FG002|Overall Study|Study drug toxicity|4
7218058|NCT01472081|11426547|FG003|Overall Study|Study drug toxicity|6
7218059|NCT01472081|11426548|FG004|Overall Study|Study drug toxicity|13
7218060|NCT01472081|11426549|FG005|Overall Study|Study drug toxicity|2
7218061|NCT01472081|11426544|FG000|Overall Study|Death|0
7218062|NCT01472081|11426545|FG001|Overall Study|Death|0
7218063|NCT01472081|11426546|FG002|Overall Study|Death|0
7218064|NCT01472081|11426547|FG003|Overall Study|Death|0
7218065|NCT01472081|11426548|FG004|Overall Study|Death|1
7218066|NCT01472081|11426549|FG005|Overall Study|Death|0
7218067|NCT01472081|11426544|FG000|Overall Study|Adverse Event unrelated to study drug|0
7218068|NCT01472081|11426545|FG001|Overall Study|Adverse Event unrelated to study drug|0
7218069|NCT01472081|11426546|FG002|Overall Study|Adverse Event unrelated to study drug|0
7218070|NCT01472081|11426547|FG003|Overall Study|Adverse Event unrelated to study drug|0
7218071|NCT01472081|11426548|FG004|Overall Study|Adverse Event unrelated to study drug|1
7218072|NCT01472081|11426549|FG005|Overall Study|Adverse Event unrelated to study drug|0
7218073|NCT01472081|11426544|FG000|Overall Study|Withdrawal by Subject|0
7218074|NCT01472081|11426545|FG001|Overall Study|Withdrawal by Subject|0
7218075|NCT01472081|11426546|FG002|Overall Study|Withdrawal by Subject|0
7218076|NCT01472081|11426547|FG003|Overall Study|Withdrawal by Subject|0
7218077|NCT01472081|11426548|FG004|Overall Study|Withdrawal by Subject|0
7218078|NCT01472081|11426549|FG005|Overall Study|Withdrawal by Subject|1
7218079|NCT01472081|11426544|FG000|Overall Study|Poor/non-compliance|0
7218080|NCT01472081|11426545|FG001|Overall Study|Poor/non-compliance|0
7218081|NCT01472081|11426546|FG002|Overall Study|Poor/non-compliance|1
7218082|NCT01472081|11426547|FG003|Overall Study|Poor/non-compliance|0
7218083|NCT01472081|11426548|FG004|Overall Study|Poor/non-compliance|1
7218084|NCT01472081|11426549|FG005|Overall Study|Poor/non-compliance|0
7218085|NCT01472081|11426544|FG000|Overall Study|No longer meets study criteria|0
7218086|NCT01472081|11426545|FG001|Overall Study|No longer meets study criteria|0
7218087|NCT01472081|11426546|FG002|Overall Study|No longer meets study criteria|1
7218088|NCT01472081|11426547|FG003|Overall Study|No longer meets study criteria|0
7218089|NCT01472081|11426548|FG004|Overall Study|No longer meets study criteria|0
7218090|NCT01472081|11426549|FG005|Overall Study|No longer meets study criteria|0
7218091|NCT01472081|11426544|FG000|Overall Study|Subject request to discontinue treatment|0
7218092|NCT01472081|11426545|FG001|Overall Study|Subject request to discontinue treatment|3
7218093|NCT01472081|11426546|FG002|Overall Study|Subject request to discontinue treatment|1
7218094|NCT01472081|11426547|FG003|Overall Study|Subject request to discontinue treatment|1
7218095|NCT01472081|11426548|FG004|Overall Study|Subject request to discontinue treatment|0
7218096|NCT01472081|11426549|FG005|Overall Study|Subject request to discontinue treatment|0
7218097|NCT01309672|11426562|FG000|Overall Study|Lack of Efficacy|20
7218098|NCT01309672|11426562|FG000|Overall Study|Other|9
7218099|NCT01309672|11426562|FG000|Overall Study|Adverse Event|5
7218100|NCT01309672|11426562|FG000|Overall Study|Withdrawal by Subject|3
7218101|NCT00774345|11426579|FG000|Pre-treatment|Other reasons|2
7218102|NCT00774345|11426580|FG001|Pre-treatment|Other reasons|0
7218103|NCT00774345|11426579|FG000|Treatment|Adverse Event|61
7218104|NCT00774345|11426580|FG001|Treatment|Adverse Event|15
7218105|NCT00774345|11426579|FG000|Treatment|Progressive Disease without histologic transformation|51
7218106|NCT00774345|11426580|FG001|Treatment|Progressive Disease without histologic transformation|111
7218107|NCT00774345|11426579|FG000|Treatment|Progressive Disease with histologic transformation|4
7218108|NCT00774345|11426580|FG001|Treatment|Progressive Disease with histologic transformation|2
7218109|NCT00774345|11426579|FG000|Treatment|Withdrawal by Subject|5
7218110|NCT00774345|11426580|FG001|Treatment|Withdrawal by Subject|2
7218111|NCT00774345|11426579|FG000|Treatment|Lost to Follow-up|1
7218112|NCT00774345|11426580|FG001|Treatment|Lost to Follow-up|1
7218113|NCT00774345|11426579|FG000|Treatment|Death|4
7218114|NCT00774345|11426580|FG001|Treatment|Death|0
7218115|NCT00774345|11426579|FG000|Treatment|Other Reasons|32
7218116|NCT00774345|11426580|FG001|Treatment|Other Reasons|26
7292292|NCT00548548|11510186|FG001|Overall Study|Death|348
7292293|NCT00548548|11510185|FG000|Overall Study|Lost to Follow-up|17
7292294|NCT00548548|11510186|FG001|Overall Study|Lost to Follow-up|18
7292295|NCT00548717|11510216|FG000|Overall Study|Death|5
7292296|NCT00548717|11510217|FG001|Overall Study|Death|2
7292297|NCT00548717|11510216|FG000|Overall Study|Relapse|3
7292298|NCT00548717|11510217|FG001|Overall Study|Relapse|0
7292299|NCT00548717|11510216|FG000|Overall Study|Alternative treatment for GVHD|1
7292300|NCT00548717|11510217|FG001|Overall Study|Alternative treatment for GVHD|0
7292301|NCT00548808|11510228|FG000|Overall Study|Lost to Follow-up|9
7292302|NCT00548808|11510229|FG001|Overall Study|Lost to Follow-up|3
7292303|NCT00548808|11510228|FG000|Overall Study|Protocol Violation|8
7292304|NCT00548808|11510229|FG001|Overall Study|Protocol Violation|8
7292305|NCT00548808|11510228|FG000|Overall Study|Withdrawal by Subject|8
7292306|NCT00548808|11510229|FG001|Overall Study|Withdrawal by Subject|4
7292307|NCT00548808|11510228|FG000|Overall Study|Physician Decision|6
7292308|NCT00548808|11510229|FG001|Overall Study|Physician Decision|3
7292309|NCT00548808|11510228|FG000|Overall Study|Adverse Event|4
7292310|NCT00548808|11510229|FG001|Overall Study|Adverse Event|5
7292311|NCT00548808|11510228|FG000|Overall Study|Death|2
7292312|NCT00548808|11510229|FG001|Overall Study|Death|0
7292313|NCT00548808|11510228|FG000|Overall Study|Entry Criteria Not Met|2
7292314|NCT00548808|11510229|FG001|Overall Study|Entry Criteria Not Met|2
7292315|NCT00548808|11510228|FG000|Overall Study|Lack of Efficacy|2
7292316|NCT00548808|11510229|FG001|Overall Study|Lack of Efficacy|0
7292317|NCT00548808|11510228|FG000|Overall Study|Sponsor Decision|1
7292318|NCT00548808|11510229|FG001|Overall Study|Sponsor Decision|1
7292319|NCT00548847|11510235|FG000|Overall Study|Disease progression|7
7292320|NCT00549055|11510258|FG000|Overall Study|Adverse Event|4
7292321|NCT00549055|11510258|FG000|Overall Study|Lack of Efficacy|18
7292322|NCT00549055|11510258|FG000|Overall Study|Stabilization|5
7292323|NCT00549055|11510258|FG000|Overall Study|Progression to fibrosis|2
7292324|NCT00549055|11510258|FG000|Overall Study|Decrease of size|1
7292325|NCT00549055|11510258|FG000|Overall Study|Active choroidal neovascula increased|1
7292326|NCT00549055|11510258|FG000|Overall Study|Vitreous hemorrhage|1
7292327|NCT00549055|11510258|FG000|Overall Study|Growth choroidal neovascularisation|1
7292328|NCT00549055|11510258|FG000|Overall Study|Choroidal neovascularization|1
7292329|NCT00549055|11510258|FG000|Overall Study|Very low visual acuity (VA)|1
7292330|NCT00549198|11510273|FG000|Overall Study|Adverse Event|28
7292331|NCT00549198|11510274|FG001|Overall Study|Adverse Event|26
7292332|NCT00549198|11510273|FG000|Overall Study|Insufficient Viral Load Response|4
7292333|NCT00549198|11510274|FG001|Overall Study|Insufficient Viral Load Response|2
7292334|NCT00549198|11510273|FG000|Overall Study|Protocol-defined Virological Failure|7
7292335|NCT00549198|11510274|FG001|Overall Study|Protocol-defined Virological Failure|0
7292336|NCT00549198|11510273|FG000|Overall Study|Non-compliance|2
7292337|NCT00549198|11510274|FG001|Overall Study|Non-compliance|4
7292338|NCT00549198|11510273|FG000|Overall Study|Lost to Follow-up|7
7292339|NCT00549198|11510274|FG001|Overall Study|Lost to Follow-up|8
7292340|NCT00549198|11510273|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
7292341|NCT00549198|11510274|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
7292342|NCT00549198|11510273|FG000|Overall Study|Protocol Violation|7
7292343|NCT00549198|11510274|FG001|Overall Study|Protocol Violation|2
7292344|NCT00549198|11510273|FG000|Overall Study|Investigator Decision|4
7292345|NCT00549198|11510274|FG001|Overall Study|Investigator Decision|3
7292346|NCT00549198|11510273|FG000|Overall Study|Withdrawal by Subject|7
7218117|NCT00000135|11426664|FG000|Overall Study|Death|27
7218118|NCT00000135|11426665|FG001|Overall Study|Death|14
7218119|NCT00000378|11426713|FG000|Overall Study|Lack of Efficacy|16
7218120|NCT00000378|11426714|FG001|Overall Study|Lack of Efficacy|14
7218121|NCT00000620|11426761|FG000|Overall Study|Death|86
7218122|NCT00000620|11426762|FG001|Overall Study|Death|67
7218123|NCT00000620|11426763|FG002|Overall Study|Death|112
7218124|NCT00000620|11426764|FG003|Overall Study|Death|126
7218125|NCT00000620|11426765|FG004|Overall Study|Death|64
7218126|NCT00000620|11426766|FG005|Overall Study|Death|77
7218127|NCT00000620|11426767|FG006|Overall Study|Death|91
7218128|NCT00000620|11426768|FG007|Overall Study|Death|95
7218129|NCT00000620|11426761|FG000|Overall Study|Lost to Follow-up|14
7218130|NCT00000620|11426762|FG001|Overall Study|Lost to Follow-up|14
7218131|NCT00000620|11426763|FG002|Overall Study|Lost to Follow-up|14
7218132|NCT00000620|11426764|FG003|Overall Study|Lost to Follow-up|14
7218133|NCT00000620|11426765|FG004|Overall Study|Lost to Follow-up|15
7218134|NCT00000620|11426766|FG005|Overall Study|Lost to Follow-up|15
7218135|NCT00000620|11426767|FG006|Overall Study|Lost to Follow-up|13
7218136|NCT00000620|11426768|FG007|Overall Study|Lost to Follow-up|14
7218137|NCT00000620|11426761|FG000|Overall Study|Withdrawal by Subject|40
7218138|NCT00000620|11426762|FG001|Overall Study|Withdrawal by Subject|27
7218139|NCT00000620|11426763|FG002|Overall Study|Withdrawal by Subject|28
7218140|NCT00000620|11426764|FG003|Overall Study|Withdrawal by Subject|27
7218141|NCT00000620|11426765|FG004|Overall Study|Withdrawal by Subject|30
7218142|NCT00000620|11426766|FG005|Overall Study|Withdrawal by Subject|32
7218143|NCT00000620|11426767|FG006|Overall Study|Withdrawal by Subject|32
7218144|NCT00000620|11426768|FG007|Overall Study|Withdrawal by Subject|21
7218145|NCT00000620|11426761|FG000|Overall Study|missed closeout visit|22
7218146|NCT00000620|11426762|FG001|Overall Study|missed closeout visit|28
7218147|NCT00000620|11426763|FG002|Overall Study|missed closeout visit|16
7218148|NCT00000620|11426764|FG003|Overall Study|missed closeout visit|11
7218149|NCT00000620|11426765|FG004|Overall Study|missed closeout visit|26
7218150|NCT00000620|11426766|FG005|Overall Study|missed closeout visit|28
7218151|NCT00000620|11426767|FG006|Overall Study|missed closeout visit|13
7218152|NCT00000620|11426768|FG007|Overall Study|missed closeout visit|16
7218153|NCT00001213|11426784|FG000|Overall Study|Death|18
7218154|NCT00001262|11426791|FG000|Overall Study|Death|10
7218155|NCT00001262|11426792|FG001|Overall Study|Death|11
7218156|NCT00001262|11426793|FG002|Overall Study|Death|0
7218157|NCT00001262|11426791|FG000|Overall Study|Withdrawal by Subject|0
7218158|NCT00001262|11426792|FG001|Overall Study|Withdrawal by Subject|3
7218159|NCT00001262|11426793|FG002|Overall Study|Withdrawal by Subject|0
7218160|NCT00001566|11426814|FG000|Overall Study|patients' choice to discontinue protocol|3
7218161|NCT00001566|11426814|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
7218162|NCT00001566|11426814|FG000|Overall Study|Death|13
7218163|NCT00001566|11426814|FG000|Overall Study|Lost to Follow-up|1
7218164|NCT00001566|11426814|FG000|Overall Study|unable to complete initial apheresis|1
7218165|NCT00001575|11426818|FG000|Overall Study|Screening failures-Ph I portion|22
7218166|NCT00001575|11426818|FG000|Overall Study|Withdrawn/deaths|23
7218167|NCT00001596|11426833|FG000|Overall Study|Death|1
7218168|NCT00001596|11426834|FG001|Overall Study|Death|0
7218169|NCT00001596|11426833|FG000|Overall Study|Withdrawal by Subject|3
7218170|NCT00001596|11426834|FG001|Overall Study|Withdrawal by Subject|1
7218171|NCT00001596|11426833|FG000|Overall Study|Study Termination|12
7218172|NCT00001596|11426834|FG001|Overall Study|Study Termination|9
7218173|NCT00001596|11426833|FG000|Overall Study|Adverse Event|1
7218174|NCT00001596|11426834|FG001|Overall Study|Adverse Event|0
7218175|NCT00001703|11426849|FG000|Overall Study|progressed disease|2
7218176|NCT00001703|11426849|FG000|Overall Study|No evidence of disease|1
7218177|NCT00001703|11426849|FG000|Overall Study|recurrent disease|2
7218178|NCT00001723|11426855|FG000|Overall Study|Lack of Efficacy|6
7218179|NCT00001723|11426856|FG001|Overall Study|Lack of Efficacy|7
7218180|NCT00001723|11426855|FG000|Overall Study|Lack of family interest|4
7218181|NCT00001723|11426856|FG001|Overall Study|Lack of family interest|5
7218182|NCT00001723|11426855|FG000|Overall Study|Lost to Follow-up|2
7218183|NCT00001723|11426856|FG001|Overall Study|Lost to Follow-up|2
7218184|NCT00001723|11426855|FG000|Overall Study|medication intolerance|1
7218185|NCT00001723|11426856|FG001|Overall Study|medication intolerance|2
7218186|NCT00001832|11426880|FG000|Apheresis Period|not able to manufacture treatment cells|60
7218187|NCT00001832|11426881|FG001|Apheresis Period|not able to manufacture treatment cells|0
7218188|NCT00001832|11426882|FG002|Apheresis Period|not able to manufacture treatment cells|0
7218189|NCT00001832|11426883|FG003|Apheresis Period|not able to manufacture treatment cells|0
7218190|NCT00001832|11426884|FG004|Apheresis Period|not able to manufacture treatment cells|0
7218191|NCT00001832|11426885|FG005|Apheresis Period|not able to manufacture treatment cells|0
7218192|NCT00001832|11426886|FG006|Apheresis Period|not able to manufacture treatment cells|0
7218193|NCT00001832|11426887|FG007|Apheresis Period|not able to manufacture treatment cells|0
7218194|NCT00001832|11426888|FG008|Apheresis Period|not able to manufacture treatment cells|0
7218195|NCT00001832|11426889|FG009|Apheresis Period|not able to manufacture treatment cells|0
7218196|NCT00001832|11426890|FG010|Apheresis Period|not able to manufacture treatment cells|0
7218197|NCT00001832|11426891|FG011|Apheresis Period|not able to manufacture treatment cells|0
7218198|NCT00001832|11426892|FG012|Apheresis Period|not able to manufacture treatment cells|0
7218199|NCT00001832|11426893|FG013|Apheresis Period|not able to manufacture treatment cells|0
7218200|NCT00001832|11426894|FG014|Apheresis Period|not able to manufacture treatment cells|0
7218201|NCT00001832|11426880|FG000|Treatment Period|Death during treatment|0
7218202|NCT00001832|11426881|FG001|Treatment Period|Death during treatment|0
7218203|NCT00001832|11426882|FG002|Treatment Period|Death during treatment|0
7218204|NCT00001832|11426883|FG003|Treatment Period|Death during treatment|0
7218205|NCT00001832|11426884|FG004|Treatment Period|Death during treatment|0
7218206|NCT00001832|11426885|FG005|Treatment Period|Death during treatment|1
7218207|NCT00001832|11426886|FG006|Treatment Period|Death during treatment|0
7218208|NCT00001832|11426887|FG007|Treatment Period|Death during treatment|0
7218209|NCT00001832|11426888|FG008|Treatment Period|Death during treatment|0
7218210|NCT00001832|11426889|FG009|Treatment Period|Death during treatment|0
7218211|NCT00001832|11426890|FG010|Treatment Period|Death during treatment|0
7218212|NCT00001832|11426891|FG011|Treatment Period|Death during treatment|0
7218213|NCT00001832|11426892|FG012|Treatment Period|Death during treatment|0
7218214|NCT00001832|11426893|FG013|Treatment Period|Death during treatment|0
7218215|NCT00001832|11426894|FG014|Treatment Period|Death during treatment|0
7218216|NCT00001832|11426880|FG000|Treatment Period|Not treated|0
7218217|NCT00001832|11426881|FG001|Treatment Period|Not treated|0
7218218|NCT00001832|11426882|FG002|Treatment Period|Not treated|0
7218219|NCT00001832|11426883|FG003|Treatment Period|Not treated|0
7218220|NCT00001832|11426884|FG004|Treatment Period|Not treated|0
7218221|NCT00001832|11426885|FG005|Treatment Period|Not treated|0
7218222|NCT00001832|11426886|FG006|Treatment Period|Not treated|0
7218223|NCT00001832|11426887|FG007|Treatment Period|Not treated|1
7218224|NCT00001832|11426888|FG008|Treatment Period|Not treated|0
7218225|NCT00001832|11426889|FG009|Treatment Period|Not treated|0
7218226|NCT00001832|11426890|FG010|Treatment Period|Not treated|0
7218227|NCT00001832|11426891|FG011|Treatment Period|Not treated|0
7218228|NCT00001832|11426892|FG012|Treatment Period|Not treated|0
7218229|NCT00001832|11426893|FG013|Treatment Period|Not treated|0
7218230|NCT00001832|11426894|FG014|Treatment Period|Not treated|0
7218231|NCT00001849|11426924|FG000|Overall Study|Death|4
7218232|NCT00001849|11426924|FG000|Overall Study|Lost to Follow-up|2
7218233|NCT00001849|11426924|FG000|Overall Study|Withdrawal by Subject|2
7218234|NCT00001849|11426924|FG000|Overall Study|tumor remained occult|6
7218235|NCT00001880|11426937|FG000|Overall Study|Death|14
7218236|NCT00001941|11426941|FG000|Overall Study|not treated- rapidly progressing disease|0
7218237|NCT00001941|11426942|FG001|Overall Study|not treated- rapidly progressing disease|0
7218238|NCT00001941|11426943|FG002|Overall Study|not treated- rapidly progressing disease|0
7218239|NCT00001941|11426944|FG003|Overall Study|not treated- rapidly progressing disease|0
7218240|NCT00001941|11426945|FG004|Overall Study|not treated- rapidly progressing disease|1
7218241|NCT00001959|11426950|FG000|Overall Study|newly diagnosed colon cancer|1
7218242|NCT00001959|11426950|FG000|Overall Study|disabling sedation|1
7218243|NCT00001959|11426950|FG000|Overall Study|non-compliance|1
7218244|NCT00001962|11426954|FG000|Overall Study|Lack of Efficacy|18
7218245|NCT00001962|11426954|FG000|Overall Study|Lack of Accrual|6
7218246|NCT00001962|11426954|FG000|Overall Study|Death|1
7218247|NCT00001962|11426954|FG000|Overall Study|Lost to Follow-up|2
7218248|NCT00001962|11426954|FG000|Overall Study|Adverse Event|1
7218249|NCT00002525|11426964|FG000|Overall Study|Adverse Event|36
7218250|NCT00002525|11426965|FG001|Overall Study|Adverse Event|0
7218251|NCT00002525|11426964|FG000|Overall Study|Death|5
7218252|NCT00002525|11426965|FG001|Overall Study|Death|0
7218253|NCT00002525|11426964|FG000|Overall Study|Withdrawal by Subject|11
7218254|NCT00002525|11426965|FG001|Overall Study|Withdrawal by Subject|0
7218255|NCT00002525|11426964|FG000|Overall Study|Start non-protocol therapy|1
7218256|NCT00002525|11426965|FG001|Overall Study|Start non-protocol therapy|0
7218257|NCT00002525|11426964|FG000|Overall Study|Other complicating disease|1
7218258|NCT00002525|11426965|FG001|Overall Study|Other complicating disease|0
7218259|NCT00002525|11426964|FG000|Overall Study|Duke's A, B1, D disease|92
7218260|NCT00002525|11426965|FG001|Overall Study|Duke's A, B1, D disease|0
7218261|NCT00002525|11426964|FG000|Overall Study|Error|6
7218262|NCT00002525|11426965|FG001|Overall Study|Error|0
7218263|NCT00002525|11426964|FG000|Overall Study|Other|26
7218264|NCT00002525|11426965|FG001|Overall Study|Other|0
7218265|NCT00002525|11426964|FG000|Overall Study|Never start protocol therapy|8
7218266|NCT00002525|11426965|FG001|Overall Study|Never start protocol therapy|0
7218267|NCT00002558|11426975|FG000|Overall Study|Withdrawal by Subject|0
7218268|NCT00002558|11426976|FG001|Overall Study|Withdrawal by Subject|1
7218269|NCT00002597|11426984|FG000|Overall Study|Protocol Violation|19
7218270|NCT00002597|11426985|FG001|Overall Study|Protocol Violation|17
7218271|NCT00002597|11426984|FG000|Overall Study|Withdrawal by Subject|7
7218272|NCT00002597|11426985|FG001|Overall Study|Withdrawal by Subject|6
7218273|NCT00002651|11426999|FG000|Induction|Adverse Event|44
7218274|NCT00002651|11427000|FG001|Induction|Adverse Event|0
7218275|NCT00002651|11427001|FG002|Induction|Adverse Event|0
7218276|NCT00002651|11426999|FG000|Induction|Refusal unrelated to adverse event|50
7218277|NCT00002651|11427000|FG001|Induction|Refusal unrelated to adverse event|0
7218278|NCT00002651|11427001|FG002|Induction|Refusal unrelated to adverse event|0
7218279|NCT00002651|11426999|FG000|Induction|Progression/relapse|274
7218280|NCT00002651|11427000|FG001|Induction|Progression/relapse|0
7218281|NCT00002651|11427001|FG002|Induction|Progression/relapse|0
7218282|NCT00002651|11426999|FG000|Induction|Death|62
7218283|NCT00002651|11427000|FG001|Induction|Death|0
7218284|NCT00002651|11427001|FG002|Induction|Death|0
7218285|NCT00002651|11426999|FG000|Induction|Other|823
7218286|NCT00002651|11427000|FG001|Induction|Other|0
7218287|NCT00002651|11427001|FG002|Induction|Other|0
7218288|NCT00002651|11426999|FG000|Induction|not eligible|90
7218289|NCT00002651|11427000|FG001|Induction|not eligible|0
7218290|NCT00002651|11427001|FG002|Induction|not eligible|0
7218291|NCT00002651|11426999|FG000|Consolidation and Randomization|Adverse Event|0
7218292|NCT00002651|11427000|FG001|Consolidation and Randomization|Adverse Event|36
7218293|NCT00002651|11427001|FG002|Consolidation and Randomization|Adverse Event|14
7218294|NCT00002651|11426999|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
7292397|NCT00549302|11510284|FG002|Open-Label|Death|40
7218295|NCT00002651|11427000|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
7218296|NCT00002651|11427001|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
7218297|NCT00002651|11426999|FG000|Consolidation and Randomization|Progression/relapse|0
7218298|NCT00002651|11427000|FG001|Consolidation and Randomization|Progression/relapse|295
7218299|NCT00002651|11427001|FG002|Consolidation and Randomization|Progression/relapse|298
7218300|NCT00002651|11426999|FG000|Consolidation and Randomization|Death|0
7218301|NCT00002651|11427000|FG001|Consolidation and Randomization|Death|38
7218302|NCT00002651|11427001|FG002|Consolidation and Randomization|Death|48
7218303|NCT00002651|11426999|FG000|Consolidation and Randomization|Other|0
7218304|NCT00002651|11427000|FG001|Consolidation and Randomization|Other|314
7218305|NCT00002651|11427001|FG002|Consolidation and Randomization|Other|313
7218306|NCT00002651|11426999|FG000|Consolidation and Randomization|not eligible|0
7218307|NCT00002651|11427000|FG001|Consolidation and Randomization|not eligible|102
7218308|NCT00002651|11427001|FG002|Consolidation and Randomization|not eligible|112
7218309|NCT00002766|11427011|FG000|Overall Study|Withdrawal by Subject|0
7218310|NCT00002766|11427012|FG001|Overall Study|Withdrawal by Subject|1
7218311|NCT00002766|11427011|FG000|Overall Study|Patient Not Treated|1
7218312|NCT00002766|11427012|FG001|Overall Study|Patient Not Treated|2
7292347|NCT00549198|11510274|FG001|Overall Study|Withdrawal by Subject|7
7292348|NCT00549198|11510273|FG000|Overall Study|Disease Progression|1
7292349|NCT00549198|11510274|FG001|Overall Study|Disease Progression|0
7292350|NCT00549198|11510273|FG000|Overall Study|Participant Moved|2
7292351|NCT00549198|11510274|FG001|Overall Study|Participant Moved|0
7292352|NCT00549198|11510273|FG000|Overall Study|Participant not able to perform Week 96|1
7292353|NCT00549198|11510274|FG001|Overall Study|Participant not able to perform Week 96|0
7292354|NCT00549198|11510273|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
7292355|NCT00549198|11510274|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
7292356|NCT00549198|11510273|FG000|Overall Study|Prohibited Medication|1
7292357|NCT00549198|11510274|FG001|Overall Study|Prohibited Medication|2
7292358|NCT00549198|11510273|FG000|Overall Study|Participant planning pregnancy|1
7292359|NCT00549198|11510274|FG001|Overall Study|Participant planning pregnancy|0
7292360|NCT00549198|11510273|FG000|Overall Study|Participant overweight, no scan possible|1
7292361|NCT00549198|11510274|FG001|Overall Study|Participant overweight, no scan possible|0
7292362|NCT00549198|11510273|FG000|Overall Study|No scan facilities|0
7292363|NCT00549198|11510274|FG001|Overall Study|No scan facilities|2
7292364|NCT00549198|11510273|FG000|Overall Study|Pregnancy|0
7292365|NCT00549198|11510274|FG001|Overall Study|Pregnancy|3
7292366|NCT00549198|11510273|FG000|Overall Study|Not Exposed to Study Drug|3
7292367|NCT00549198|11510274|FG001|Overall Study|Not Exposed to Study Drug|4
7292368|NCT00549302|11510282|FG000|Double-Blind|Death|2
7292369|NCT00549302|11510283|FG001|Double-Blind|Death|9
7292370|NCT00549302|11510284|FG002|Double-Blind|Death|0
7292371|NCT00549302|11510282|FG000|Double-Blind|Adverse Event|3
7292372|NCT00549302|11510283|FG001|Double-Blind|Adverse Event|16
7292373|NCT00549302|11510284|FG002|Double-Blind|Adverse Event|0
7292374|NCT00549302|11510282|FG000|Double-Blind|Withdrawal by Subject|3
7292375|NCT00549302|11510283|FG001|Double-Blind|Withdrawal by Subject|8
7218313|NCT00002766|11427011|FG000|Overall Study|Adverse Event|1
7218314|NCT00002766|11427012|FG001|Overall Study|Adverse Event|1
7218315|NCT00002766|11427011|FG000|Overall Study|Protocol Violation|1
7218316|NCT00002766|11427012|FG001|Overall Study|Protocol Violation|0
7218317|NCT00002842|11427018|FG000|Overall Study|ineligible for surgical resection|27
7218318|NCT00002850|11427025|FG000|Overall Study|Death|4
7218319|NCT00002850|11427026|FG001|Overall Study|Death|1
7218320|NCT00002850|11427027|FG002|Overall Study|Death|3
7218321|NCT00002850|11427025|FG000|Overall Study|Protocol Violation|1
7218322|NCT00002850|11427026|FG001|Overall Study|Protocol Violation|0
7218323|NCT00002850|11427027|FG002|Overall Study|Protocol Violation|1
7218324|NCT00002850|11427025|FG000|Overall Study|Withdrawal by Subject|0
7218325|NCT00002850|11427026|FG001|Overall Study|Withdrawal by Subject|1
7218326|NCT00002850|11427027|FG002|Overall Study|Withdrawal by Subject|0
7292376|NCT00549302|11510284|FG002|Double-Blind|Withdrawal by Subject|0
7292377|NCT00549302|11510282|FG000|Double-Blind|Investigator Decision|1
7292378|NCT00549302|11510283|FG001|Double-Blind|Investigator Decision|5
7292379|NCT00549302|11510284|FG002|Double-Blind|Investigator Decision|0
7292380|NCT00549302|11510282|FG000|Double-Blind|Sponsor Decision|0
7292381|NCT00549302|11510283|FG001|Double-Blind|Sponsor Decision|1
7292382|NCT00549302|11510284|FG002|Double-Blind|Sponsor Decision|0
7292383|NCT00549302|11510282|FG000|Double-Blind|Lost to Follow-up|1
7292384|NCT00549302|11510283|FG001|Double-Blind|Lost to Follow-up|2
7292385|NCT00549302|11510284|FG002|Double-Blind|Lost to Follow-up|0
7292386|NCT00549302|11510282|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
7292387|NCT00549302|11510283|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
7292388|NCT00549302|11510284|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
7292389|NCT00549302|11510282|FG000|Double-Blind|New condition or starts new therapy|0
7292390|NCT00549302|11510283|FG001|Double-Blind|New condition or starts new therapy|2
7292391|NCT00549302|11510284|FG002|Double-Blind|New condition or starts new therapy|0
7292392|NCT00549302|11510282|FG000|Open-Label|Adverse Event|0
7292393|NCT00549302|11510283|FG001|Open-Label|Adverse Event|0
7292394|NCT00549302|11510284|FG002|Open-Label|Adverse Event|11
7292395|NCT00549302|11510282|FG000|Open-Label|Death|0
7292396|NCT00549302|11510283|FG001|Open-Label|Death|0
7292398|NCT00549302|11510282|FG000|Open-Label|Investigator Decision|0
7292399|NCT00549302|11510283|FG001|Open-Label|Investigator Decision|0
7292400|NCT00549302|11510284|FG002|Open-Label|Investigator Decision|5
7292401|NCT00549302|11510282|FG000|Open-Label|Lost to Follow-up|0
7292402|NCT00549302|11510283|FG001|Open-Label|Lost to Follow-up|0
7292403|NCT00549302|11510284|FG002|Open-Label|Lost to Follow-up|2
7292404|NCT00549302|11510282|FG000|Open-Label|Other|0
7292405|NCT00549302|11510283|FG001|Open-Label|Other|0
7292406|NCT00549302|11510284|FG002|Open-Label|Other|3
7292407|NCT00549302|11510282|FG000|Open-Label|New drug pulmonary atrial hypertension|0
7292408|NCT00549302|11510283|FG001|Open-Label|New drug pulmonary atrial hypertension|0
7292409|NCT00549302|11510284|FG002|Open-Label|New drug pulmonary atrial hypertension|2
7292410|NCT00549302|11510282|FG000|Open-Label|Withdrawal by Subject|0
7292411|NCT00549302|11510283|FG001|Open-Label|Withdrawal by Subject|0
7292412|NCT00549302|11510284|FG002|Open-Label|Withdrawal by Subject|6
7292413|NCT00549445|11510305|FG000|Overall Study|Sputum & Blood Samples Not Available|15
7292414|NCT00549445|11510306|FG001|Overall Study|Sputum & Blood Samples Not Available|17
7292415|NCT00549549|11510316|FG000|Overall Study|Adverse Event|5
7292416|NCT00549549|11510317|FG001|Overall Study|Adverse Event|3
7292417|NCT00549549|11510318|FG002|Overall Study|Adverse Event|1
7292418|NCT00549549|11510319|FG003|Overall Study|Adverse Event|9
7292419|NCT00549549|11510316|FG000|Overall Study|Lack of Efficacy|9
7292420|NCT00549549|11510317|FG001|Overall Study|Lack of Efficacy|6
7292421|NCT00549549|11510318|FG002|Overall Study|Lack of Efficacy|4
7292422|NCT00549549|11510319|FG003|Overall Study|Lack of Efficacy|2
7292423|NCT00549549|11510316|FG000|Overall Study|Lost to Follow-up|1
7292424|NCT00549549|11510317|FG001|Overall Study|Lost to Follow-up|0
7292425|NCT00549549|11510318|FG002|Overall Study|Lost to Follow-up|1
7292426|NCT00549549|11510319|FG003|Overall Study|Lost to Follow-up|2
7292427|NCT00549549|11510316|FG000|Overall Study|Withdrawal by Subject|0
7292428|NCT00549549|11510317|FG001|Overall Study|Withdrawal by Subject|4
7292429|NCT00549549|11510318|FG002|Overall Study|Withdrawal by Subject|1
7292430|NCT00549549|11510319|FG003|Overall Study|Withdrawal by Subject|0
7292431|NCT00549549|11510316|FG000|Overall Study|Other|9
7292432|NCT00549549|11510317|FG001|Overall Study|Other|9
7292433|NCT00549549|11510318|FG002|Overall Study|Other|9
7292434|NCT00549549|11510319|FG003|Overall Study|Other|11
7292435|NCT00549549|11510316|FG000|Overall Study|Randomized but not treated|0
7292436|NCT00549549|11510317|FG001|Overall Study|Randomized but not treated|0
7292437|NCT00549549|11510318|FG002|Overall Study|Randomized but not treated|1
7292438|NCT00549549|11510319|FG003|Overall Study|Randomized but not treated|1
7292439|NCT00549562|11510329|FG000|Overall Study|Adverse Event|1
7292440|NCT00549562|11510329|FG000|Overall Study|Lack of Efficacy|1
7218327|NCT03666988|11427041|FG000|Part 1 (Up to 28 Months)|Adverse Event|0
7218328|NCT03666988|11427042|FG001|Part 1 (Up to 28 Months)|Adverse Event|1
7218329|NCT03666988|11427043|FG002|Part 1 (Up to 28 Months)|Adverse Event|3
7218330|NCT03666988|11427044|FG003|Part 1 (Up to 28 Months)|Adverse Event|0
7218331|NCT03666988|11427045|FG004|Part 1 (Up to 28 Months)|Adverse Event|0
7218332|NCT03666988|11427046|FG005|Part 1 (Up to 28 Months)|Adverse Event|0
7218333|NCT03666988|11427041|FG000|Part 1 (Up to 28 Months)|Other|0
7218334|NCT03666988|11427042|FG001|Part 1 (Up to 28 Months)|Other|1
7218335|NCT03666988|11427043|FG002|Part 1 (Up to 28 Months)|Other|1
7218336|NCT03666988|11427044|FG003|Part 1 (Up to 28 Months)|Other|0
7218337|NCT03666988|11427045|FG004|Part 1 (Up to 28 Months)|Other|0
7218338|NCT03666988|11427046|FG005|Part 1 (Up to 28 Months)|Other|0
7218339|NCT03666988|11427041|FG000|Part 1 (Up to 28 Months)|Disease Progression|2
7218340|NCT03666988|11427042|FG001|Part 1 (Up to 28 Months)|Disease Progression|14
7218341|NCT03666988|11427043|FG002|Part 1 (Up to 28 Months)|Disease Progression|7
7218342|NCT03666988|11427044|FG003|Part 1 (Up to 28 Months)|Disease Progression|0
7218343|NCT03666988|11427045|FG004|Part 1 (Up to 28 Months)|Disease Progression|0
7218344|NCT03666988|11427046|FG005|Part 1 (Up to 28 Months)|Disease Progression|0
7218345|NCT03666988|11427041|FG000|Part 1 (Up to 28 Months)|Physician Decision|0
7218346|NCT03666988|11427042|FG001|Part 1 (Up to 28 Months)|Physician Decision|0
7218347|NCT03666988|11427043|FG002|Part 1 (Up to 28 Months)|Physician Decision|1
7218348|NCT03666988|11427044|FG003|Part 1 (Up to 28 Months)|Physician Decision|0
7218349|NCT03666988|11427045|FG004|Part 1 (Up to 28 Months)|Physician Decision|0
7218350|NCT03666988|11427046|FG005|Part 1 (Up to 28 Months)|Physician Decision|0
7218351|NCT03666988|11427041|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1
7218352|NCT03666988|11427042|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7292441|NCT00549601|11510336|FG000|Randomized|Protocol Violation|0
7292442|NCT00549601|11510337|FG001|Randomized|Protocol Violation|0
7292443|NCT00549601|11510338|FG002|Randomized|Protocol Violation|1
7292444|NCT00549601|11510336|FG000|Randomized|Withdrawal by Subject|0
7292445|NCT00549601|11510337|FG001|Randomized|Withdrawal by Subject|1
7292446|NCT00549601|11510338|FG002|Randomized|Withdrawal by Subject|1
7292447|NCT00549601|11510336|FG000|Received Study Drug|Adverse Event|2
7292448|NCT00549601|11510337|FG001|Received Study Drug|Adverse Event|5
7292449|NCT00549601|11510338|FG002|Received Study Drug|Adverse Event|1
7292450|NCT00549601|11510336|FG000|Received Study Drug|Death|0
7292451|NCT00549601|11510337|FG001|Received Study Drug|Death|1
7292452|NCT00549601|11510338|FG002|Received Study Drug|Death|0
7292453|NCT00549601|11510336|FG000|Received Study Drug|Lost to Follow-up|0
7292454|NCT00549601|11510337|FG001|Received Study Drug|Lost to Follow-up|1
7292455|NCT00549601|11510338|FG002|Received Study Drug|Lost to Follow-up|1
7292456|NCT00549601|11510336|FG000|Received Study Drug|Protocol Violation|3
7292457|NCT00549601|11510337|FG001|Received Study Drug|Protocol Violation|4
7292458|NCT00549601|11510338|FG002|Received Study Drug|Protocol Violation|1
7292459|NCT00549601|11510336|FG000|Received Study Drug|Withdrawal by Subject|2
7292460|NCT00549601|11510337|FG001|Received Study Drug|Withdrawal by Subject|0
7292461|NCT00549601|11510338|FG002|Received Study Drug|Withdrawal by Subject|1
7292462|NCT00549640|11510350|FG000|Overall Study|Withdrawal by Subject|6
7292463|NCT00549640|11510351|FG001|Overall Study|Withdrawal by Subject|12
7292464|NCT00549640|11510350|FG000|Overall Study|Adverse Event|5
7292465|NCT00549640|11510351|FG001|Overall Study|Adverse Event|0
7292466|NCT00549640|11510350|FG000|Overall Study|Lost to Follow-up|7
7292467|NCT00549640|11510351|FG001|Overall Study|Lost to Follow-up|4
7292468|NCT00549718|11510361|FG000|Overall Study|Insufficient clinical response|20
7292469|NCT00549718|11510362|FG001|Overall Study|Insufficient clinical response|7
7292470|NCT00549718|11510363|FG002|Overall Study|Insufficient clinical response|18
7292471|NCT00549718|11510364|FG003|Overall Study|Insufficient clinical response|32
7292472|NCT00549718|11510361|FG000|Overall Study|Adverse Event|6
7292473|NCT00549718|11510362|FG001|Overall Study|Adverse Event|8
7292474|NCT00549718|11510363|FG002|Overall Study|Adverse Event|7
7292475|NCT00549718|11510364|FG003|Overall Study|Adverse Event|3
7292476|NCT00549718|11510361|FG000|Overall Study|Lost to Follow-up|4
7292477|NCT00549718|11510362|FG001|Overall Study|Lost to Follow-up|2
7292478|NCT00549718|11510363|FG002|Overall Study|Lost to Follow-up|0
7292479|NCT00549718|11510364|FG003|Overall Study|Lost to Follow-up|6
7292480|NCT00549718|11510361|FG000|Overall Study|Withdrawal by Subject|9
7292481|NCT00549718|11510362|FG001|Overall Study|Withdrawal by Subject|18
7292482|NCT00549718|11510363|FG002|Overall Study|Withdrawal by Subject|12
7292483|NCT00549718|11510364|FG003|Overall Study|Withdrawal by Subject|13
7292484|NCT00549718|11510361|FG000|Overall Study|Administrative|2
7292485|NCT00549718|11510362|FG001|Overall Study|Administrative|2
7292486|NCT00549718|11510363|FG002|Overall Study|Administrative|2
7292487|NCT00549718|11510364|FG003|Overall Study|Administrative|1
7292488|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
7292489|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
7292490|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
7292491|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
7292492|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7292493|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
7218353|NCT03666988|11427043|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7218354|NCT03666988|11427044|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7218355|NCT03666988|11427045|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7292494|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
7218356|NCT03666988|11427046|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0
7218357|NCT03552029|11427066|FG000|Overall Study|Death|3
7218358|NCT03552029|11427067|FG001|Overall Study|Death|0
7218359|NCT03552029|11427066|FG000|Overall Study|Adverse Event|1
7218360|NCT03552029|11427067|FG001|Overall Study|Adverse Event|0
7218361|NCT03552029|11427066|FG000|Overall Study|Lack of Efficacy|0
7218362|NCT03552029|11427067|FG001|Overall Study|Lack of Efficacy|2
7218363|NCT03552029|11427066|FG000|Overall Study|Physician Decision|0
7218364|NCT03552029|11427067|FG001|Overall Study|Physician Decision|1
7218365|NCT03552029|11427066|FG000|Overall Study|Study terminated by Sponsor|0
7218366|NCT03552029|11427067|FG001|Overall Study|Study terminated by Sponsor|1
7218367|NCT03552029|11427066|FG000|Overall Study|Other|0
7218368|NCT03552029|11427067|FG001|Overall Study|Other|2
7218369|NCT03549104|11427075|FG000|Overall Study|Physician Decision|2
7218370|NCT03549104|11427076|FG001|Overall Study|Physician Decision|0
7218371|NCT03549104|11427075|FG000|Overall Study|Withdrawal by Subject|5
7218372|NCT03549104|11427076|FG001|Overall Study|Withdrawal by Subject|2
7218373|NCT03549104|11427075|FG000|Overall Study|Covid shelter in place|1
7218374|NCT03549104|11427076|FG001|Overall Study|Covid shelter in place|2
7218379|NCT03332589|11427094|FG000|Overall Study|Lack of Efficacy|2
7218380|NCT03332589|11427095|FG001|Overall Study|Lack of Efficacy|0
7218381|NCT03332589|11427096|FG002|Overall Study|Lack of Efficacy|0
7218382|NCT03332589|11427094|FG000|Overall Study|Adverse Event|1
7218383|NCT03332589|11427095|FG001|Overall Study|Adverse Event|0
7218384|NCT03332589|11427096|FG002|Overall Study|Adverse Event|0
7218385|NCT03332589|11427094|FG000|Overall Study|Death|1
7292495|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
7292496|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7292497|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
7292498|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
7292499|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
7292500|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
7292501|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
7292502|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Death|188
7292503|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Death|200
7292504|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
7292505|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
7292506|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
7292507|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
7292508|NCT00549757|11510376|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
7292509|NCT00549757|11510377|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
7292510|NCT00549757|11510376|FG000|Extension Period (in Average 9 Months)|Death|143
7292511|NCT00549757|11510377|FG001|Extension Period (in Average 9 Months)|Death|136
7292512|NCT00549757|11510376|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
7292513|NCT00549757|11510377|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
7292514|NCT00549757|11510376|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
7292515|NCT00549757|11510377|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
7292516|NCT00549757|11510376|FG000|Extension Period (in Average 9 Months)|Patient's request|421
7292517|NCT00549757|11510377|FG001|Extension Period (in Average 9 Months)|Patient's request|436
7292518|NCT00549770|11510397|FG000|Overall Study|Protocol deviation|1
7292519|NCT00549770|11510398|FG001|Overall Study|Protocol deviation|1
7292520|NCT00549770|11510399|FG002|Overall Study|Protocol deviation|1
7292521|NCT00549770|11510400|FG003|Overall Study|Protocol deviation|2
7292522|NCT00549770|11510401|FG004|Overall Study|Protocol deviation|2
7292523|NCT00549770|11510402|FG005|Overall Study|Protocol deviation|2
7292524|NCT00549770|11510403|FG006|Overall Study|Protocol deviation|1
7292525|NCT00549770|11510404|FG007|Overall Study|Protocol deviation|2
7292526|NCT00549770|11510397|FG000|Overall Study|Administrative problems|0
7292527|NCT00549770|11510398|FG001|Overall Study|Administrative problems|1
7292528|NCT00549770|11510399|FG002|Overall Study|Administrative problems|0
7292529|NCT00549770|11510400|FG003|Overall Study|Administrative problems|0
7292530|NCT00549770|11510401|FG004|Overall Study|Administrative problems|0
7292531|NCT00549770|11510402|FG005|Overall Study|Administrative problems|0
7292532|NCT00549770|11510403|FG006|Overall Study|Administrative problems|0
7292533|NCT00549770|11510404|FG007|Overall Study|Administrative problems|1
7292534|NCT00549770|11510397|FG000|Overall Study|Lost to Follow-up|0
7292535|NCT00549770|11510398|FG001|Overall Study|Lost to Follow-up|0
7292536|NCT00549770|11510399|FG002|Overall Study|Lost to Follow-up|2
7292537|NCT00549770|11510400|FG003|Overall Study|Lost to Follow-up|2
7292538|NCT00549770|11510401|FG004|Overall Study|Lost to Follow-up|3
7292539|NCT00549770|11510402|FG005|Overall Study|Lost to Follow-up|2
7292540|NCT00549770|11510403|FG006|Overall Study|Lost to Follow-up|0
7292541|NCT00549770|11510404|FG007|Overall Study|Lost to Follow-up|0
7292542|NCT00549770|11510397|FG000|Overall Study|Withdrawal by Subject|4
7292543|NCT00549770|11510398|FG001|Overall Study|Withdrawal by Subject|6
7292544|NCT00549770|11510399|FG002|Overall Study|Withdrawal by Subject|4
7292545|NCT00549770|11510400|FG003|Overall Study|Withdrawal by Subject|5
7292546|NCT00549770|11510401|FG004|Overall Study|Withdrawal by Subject|6
7292547|NCT00549770|11510402|FG005|Overall Study|Withdrawal by Subject|6
7292548|NCT00549770|11510403|FG006|Overall Study|Withdrawal by Subject|4
7292549|NCT00549770|11510404|FG007|Overall Study|Withdrawal by Subject|9
7292550|NCT00549770|11510397|FG000|Overall Study|Lack of Efficacy|1
7292551|NCT00549770|11510398|FG001|Overall Study|Lack of Efficacy|0
7292552|NCT00549770|11510399|FG002|Overall Study|Lack of Efficacy|2
7292553|NCT00549770|11510400|FG003|Overall Study|Lack of Efficacy|3
7292554|NCT00549770|11510401|FG004|Overall Study|Lack of Efficacy|5
7292555|NCT00549770|11510402|FG005|Overall Study|Lack of Efficacy|1
7292556|NCT00549770|11510403|FG006|Overall Study|Lack of Efficacy|3
7292557|NCT00549770|11510404|FG007|Overall Study|Lack of Efficacy|8
7292558|NCT00549770|11510397|FG000|Overall Study|Abnormal test procedure results|0
7292559|NCT00549770|11510398|FG001|Overall Study|Abnormal test procedure results|0
7292560|NCT00549770|11510399|FG002|Overall Study|Abnormal test procedure results|0
7292561|NCT00549770|11510400|FG003|Overall Study|Abnormal test procedure results|2
7292562|NCT00549770|11510401|FG004|Overall Study|Abnormal test procedure results|0
7218386|NCT03332589|11427095|FG001|Overall Study|Death|0
7218387|NCT03332589|11427096|FG002|Overall Study|Death|0
7292563|NCT00549770|11510402|FG005|Overall Study|Abnormal test procedure results|1
7292564|NCT00549770|11510403|FG006|Overall Study|Abnormal test procedure results|1
7292565|NCT00549770|11510404|FG007|Overall Study|Abnormal test procedure results|1
7292566|NCT00549770|11510397|FG000|Overall Study|Abnormal laboratory values|0
7292567|NCT00549770|11510398|FG001|Overall Study|Abnormal laboratory values|0
7292568|NCT00549770|11510399|FG002|Overall Study|Abnormal laboratory values|0
7292569|NCT00549770|11510400|FG003|Overall Study|Abnormal laboratory values|0
7292570|NCT00549770|11510401|FG004|Overall Study|Abnormal laboratory values|0
7292571|NCT00549770|11510402|FG005|Overall Study|Abnormal laboratory values|1
7292572|NCT00549770|11510403|FG006|Overall Study|Abnormal laboratory values|0
7292573|NCT00549770|11510404|FG007|Overall Study|Abnormal laboratory values|0
7292574|NCT00549770|11510397|FG000|Overall Study|Adverse Event|1
7292575|NCT00549770|11510398|FG001|Overall Study|Adverse Event|3
7292576|NCT00549770|11510399|FG002|Overall Study|Adverse Event|1
7292577|NCT00549770|11510400|FG003|Overall Study|Adverse Event|2
7292578|NCT00549770|11510401|FG004|Overall Study|Adverse Event|1
7292579|NCT00549770|11510402|FG005|Overall Study|Adverse Event|0
7292580|NCT00549770|11510403|FG006|Overall Study|Adverse Event|5
7292581|NCT00549770|11510404|FG007|Overall Study|Adverse Event|4
7292582|NCT00549900|11510435|FG000|Overall Study|Adverse Event|1
7551360|NCT02969382|11910634|FG000|Overall Study|Adverse Event|8
7218400|NCT02301156|11427119|FG000|Overall Study|Adverse Event|13
7218401|NCT02301156|11427120|FG001|Overall Study|Adverse Event|14
7218402|NCT02301156|11427119|FG000|Overall Study|Death|1
7218403|NCT02301156|11427120|FG001|Overall Study|Death|5
7218404|NCT02301156|11427119|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
7218405|NCT02301156|11427120|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2
7218406|NCT02301156|11427119|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27
7218407|NCT02301156|11427120|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16
7218408|NCT02301156|11427119|FG000|Overall Study|Withdrawal of Consent by Subject|4
7218409|NCT02301156|11427120|FG001|Overall Study|Withdrawal of Consent by Subject|12
7218410|NCT02301156|11427119|FG000|Overall Study|Reason not Specified|6
7218411|NCT02301156|11427120|FG001|Overall Study|Reason not Specified|3
7624316|NCT01922895|12035293|FG001|Overall Study|Withdrawal by Subject|2
7624317|NCT01922895|12035292|FG000|Overall Study|Lost to Follow-up|5
7624318|NCT01922895|12035293|FG001|Overall Study|Lost to Follow-up|11
7551361|NCT02969382|11910635|FG001|Overall Study|Adverse Event|10
7551362|NCT02969382|11910634|FG000|Overall Study|Lack of Efficacy|4
7551363|NCT02969382|11910635|FG001|Overall Study|Lack of Efficacy|5
7624319|NCT01901289|12035299|FG000|Overall Study|Death|32
7624320|NCT01901289|12035299|FG000|Overall Study|Lost to Follow-up|16
7624321|NCT01901289|12035299|FG000|Overall Study|Withdrawal by Subject|35
7624322|NCT01901289|12035299|FG000|Overall Study|Other type of endpoint met|2
7292583|NCT00549939|11510442|FG000|12-week Double Blind Treatment Period|Adverse Event|1
7292584|NCT00549939|11510443|FG001|12-week Double Blind Treatment Period|Adverse Event|1
7292585|NCT00549939|11510444|FG002|12-week Double Blind Treatment Period|Adverse Event|2
7292586|NCT00549939|11510442|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
7292587|NCT00549939|11510443|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
7292588|NCT00549939|11510444|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
7292589|NCT00549939|11510442|FG000|40-week Open Label Treatment Period|Adverse Event|0
7292590|NCT00549939|11510443|FG001|40-week Open Label Treatment Period|Adverse Event|2
7292591|NCT00549939|11510444|FG002|40-week Open Label Treatment Period|Adverse Event|1
7292592|NCT00549939|11510442|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
7292593|NCT00549939|11510443|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
7292594|NCT00549939|11510444|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
7292595|NCT00549939|11510442|FG000|40-week Open Label Treatment Period|Protocol Violation|0
7292596|NCT00549939|11510443|FG001|40-week Open Label Treatment Period|Protocol Violation|1
7292597|NCT00549939|11510444|FG002|40-week Open Label Treatment Period|Protocol Violation|0
7292598|NCT00549939|11510442|FG000|40-week Open Label Treatment Period|Other|0
7292599|NCT00549939|11510443|FG001|40-week Open Label Treatment Period|Other|1
7292600|NCT00549939|11510444|FG002|40-week Open Label Treatment Period|Other|4
7292601|NCT00550043|11510459|FG000|Overall Study|Adverse Event|0
7292602|NCT00550043|11510460|FG001|Overall Study|Adverse Event|0
7292603|NCT00550043|11510461|FG002|Overall Study|Adverse Event|0
7292604|NCT00550043|11510462|FG003|Overall Study|Adverse Event|1
7292605|NCT00550043|11510463|FG004|Overall Study|Adverse Event|1
7292606|NCT00550043|11510459|FG000|Overall Study|Subject Withdrew Consent|0
7292607|NCT00550043|11510460|FG001|Overall Study|Subject Withdrew Consent|2
7292608|NCT00550043|11510461|FG002|Overall Study|Subject Withdrew Consent|1
7292609|NCT00550043|11510462|FG003|Overall Study|Subject Withdrew Consent|0
7292610|NCT00550043|11510463|FG004|Overall Study|Subject Withdrew Consent|0
7292611|NCT00550043|11510459|FG000|Overall Study|Other Reasons- Unspecified|0
7292612|NCT00550043|11510460|FG001|Overall Study|Other Reasons- Unspecified|1
7292613|NCT00550043|11510461|FG002|Overall Study|Other Reasons- Unspecified|0
7292614|NCT00550043|11510462|FG003|Overall Study|Other Reasons- Unspecified|1
7292615|NCT00550043|11510463|FG004|Overall Study|Other Reasons- Unspecified|0
7292616|NCT00550147|11510475|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
7292617|NCT00550147|11510475|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
7292618|NCT00550147|11510475|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
7292619|NCT00550147|11510475|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
7292620|NCT00550147|11510475|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
7292621|NCT00550173|11510491|FG000|Overall Study|Death|45
7292622|NCT00550173|11510492|FG001|Overall Study|Death|38
7292623|NCT00550173|11510493|FG002|Overall Study|Death|50
7292624|NCT00550173|11510491|FG000|Overall Study|Physician Decision|1
7292625|NCT00550173|11510492|FG001|Overall Study|Physician Decision|2
7292626|NCT00550173|11510493|FG002|Overall Study|Physician Decision|2
7292627|NCT00550173|11510491|FG000|Overall Study|Withdrawal by Subject|9
7292628|NCT00550173|11510492|FG001|Overall Study|Withdrawal by Subject|12
7292629|NCT00550173|11510493|FG002|Overall Study|Withdrawal by Subject|17
7292630|NCT00550173|11510491|FG000|Overall Study|Sponsor Decision|13
7292631|NCT00550173|11510492|FG001|Overall Study|Sponsor Decision|7
7292632|NCT00550173|11510493|FG002|Overall Study|Sponsor Decision|1
7292633|NCT00550173|11510491|FG000|Overall Study|Lost to Follow-up|4
7292634|NCT00550173|11510492|FG001|Overall Study|Lost to Follow-up|4
7292635|NCT00550173|11510493|FG002|Overall Study|Lost to Follow-up|3
7292636|NCT00550238|11510502|FG000|Overall Study|Adverse Event|88
7292637|NCT00550238|11510502|FG000|Overall Study|Death|34
7292638|NCT00550238|11510502|FG000|Overall Study|Disease progression|46
7292639|NCT00550238|11510502|FG000|Overall Study|Withdrawal by Subject|167
7292640|NCT00550238|11510502|FG000|Overall Study|Physician Decision|31
7292641|NCT00550238|11510502|FG000|Overall Study|Patient noncompliance|25
7292642|NCT00550238|11510502|FG000|Overall Study|Lost to Follow-up|13
7292643|NCT00550238|11510502|FG000|Overall Study|Sponsor decision|55
7292644|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
7292645|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7292646|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
7292647|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
7292648|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7292649|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
7292650|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
7292651|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7292652|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
7292653|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
7292654|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7292655|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
7292656|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
7292657|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7292658|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
7292659|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
7292660|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7292661|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
7292662|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
7292663|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7292664|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
7292665|NCT00550407|11510541|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
7292666|NCT00550407|11510542|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7624323|NCT01595581|12035318|FG000|Overall Study|Withdrawal by Subject|1
7624324|NCT01595581|12035319|FG001|Overall Study|Withdrawal by Subject|0
7624325|NCT01514682|12035329|FG000|Overall Study|Withdrawal by Subject|2
7624326|NCT01514682|12035330|FG001|Overall Study|Withdrawal by Subject|3
7624327|NCT01514682|12035329|FG000|Overall Study|Physician Decision|4
7624328|NCT01514682|12035330|FG001|Overall Study|Physician Decision|3
7218466|NCT01590628|11427193|FG000|Overall Study|Death|2
7218467|NCT01590628|11427194|FG001|Overall Study|Death|0
7218468|NCT01533714|11427210|FG000|Overall Study|Adverse Event|0
7218469|NCT01533714|11427211|FG001|Overall Study|Adverse Event|1
7218470|NCT01533714|11427212|FG002|Overall Study|Adverse Event|2
7218471|NCT01533714|11427213|FG003|Overall Study|Adverse Event|2
7218472|NCT01533714|11427214|FG004|Overall Study|Adverse Event|2
7218473|NCT01533714|11427215|FG005|Overall Study|Adverse Event|1
7218474|NCT01533714|11427210|FG000|Overall Study|Lack of Efficacy|0
7218475|NCT01533714|11427211|FG001|Overall Study|Lack of Efficacy|0
7218476|NCT01533714|11427212|FG002|Overall Study|Lack of Efficacy|0
7218477|NCT01533714|11427213|FG003|Overall Study|Lack of Efficacy|0
7218478|NCT01533714|11427214|FG004|Overall Study|Lack of Efficacy|0
7218479|NCT01533714|11427215|FG005|Overall Study|Lack of Efficacy|1
7218480|NCT01533714|11427210|FG000|Overall Study|Withdrawal by Subject|0
7218481|NCT01533714|11427211|FG001|Overall Study|Withdrawal by Subject|1
7218482|NCT01533714|11427212|FG002|Overall Study|Withdrawal by Subject|0
7218483|NCT01533714|11427213|FG003|Overall Study|Withdrawal by Subject|1
7218484|NCT01533714|11427214|FG004|Overall Study|Withdrawal by Subject|1
7218485|NCT01533714|11427215|FG005|Overall Study|Withdrawal by Subject|0
7218486|NCT01533714|11427210|FG000|Overall Study|Exclusion criteria|0
7218487|NCT01533714|11427211|FG001|Overall Study|Exclusion criteria|1
7218488|NCT01533714|11427212|FG002|Overall Study|Exclusion criteria|0
7218489|NCT01533714|11427213|FG003|Overall Study|Exclusion criteria|0
7218490|NCT01533714|11427214|FG004|Overall Study|Exclusion criteria|0
7218491|NCT01533714|11427215|FG005|Overall Study|Exclusion criteria|0
7218492|NCT01533714|11427210|FG000|Overall Study|Positive for purified protein derivative|0
7218493|NCT01533714|11427211|FG001|Overall Study|Positive for purified protein derivative|0
7218494|NCT01533714|11427212|FG002|Overall Study|Positive for purified protein derivative|1
7218495|NCT01533714|11427213|FG003|Overall Study|Positive for purified protein derivative|0
7218496|NCT01533714|11427214|FG004|Overall Study|Positive for purified protein derivative|1
7218497|NCT01533714|11427215|FG005|Overall Study|Positive for purified protein derivative|0
7218498|NCT01533714|11427210|FG000|Overall Study|Withdrawal criteria|0
7218499|NCT01533714|11427211|FG001|Overall Study|Withdrawal criteria|0
7218500|NCT01533714|11427212|FG002|Overall Study|Withdrawal criteria|1
7218501|NCT01533714|11427213|FG003|Overall Study|Withdrawal criteria|0
7218502|NCT01533714|11427214|FG004|Overall Study|Withdrawal criteria|3
7218503|NCT01533714|11427215|FG005|Overall Study|Withdrawal criteria|1
7218504|NCT01533714|11427210|FG000|Overall Study|Ineligibility reason|0
7218505|NCT01533714|11427211|FG001|Overall Study|Ineligibility reason|0
7218506|NCT01533714|11427212|FG002|Overall Study|Ineligibility reason|0
7218507|NCT01533714|11427213|FG003|Overall Study|Ineligibility reason|1
7218508|NCT01533714|11427214|FG004|Overall Study|Ineligibility reason|0
7218509|NCT01533714|11427215|FG005|Overall Study|Ineligibility reason|0
7218510|NCT00002931|11427229|FG000|Overall Study|rapidly progressing disease during|2
7218511|NCT00003138|11427235|FG000|Step 1|Reasons off treatment not documented|60
7218512|NCT00003138|11427236|FG001|Step 1|Reasons off treatment not documented|57
7218513|NCT00003138|11427235|FG000|Step 1|Never started treatment|1
7218514|NCT00003138|11427236|FG001|Step 1|Never started treatment|0
7218515|NCT00003138|11427235|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
7218516|NCT00003138|11427236|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
7218517|NCT00003138|11427235|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
7218518|NCT00003138|11427236|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
7218519|NCT00003138|11427235|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
7292667|NCT00550407|11510543|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
7292668|NCT00550407|11510541|FG000|26-Week Randomized Phase|Adverse Event|0
7292669|NCT00550407|11510542|FG001|26-Week Randomized Phase|Adverse Event|5
7292670|NCT00550407|11510543|FG002|26-Week Randomized Phase|Adverse Event|2
7292671|NCT00550407|11510541|FG000|26-Week Randomized Phase|Lack of Efficacy|0
7292672|NCT00550407|11510542|FG001|26-Week Randomized Phase|Lack of Efficacy|36
7292673|NCT00550407|11510543|FG002|26-Week Randomized Phase|Lack of Efficacy|19
7292674|NCT00550407|11510541|FG000|26-Week Randomized Phase|Investigator Discretion|0
7292675|NCT00550407|11510542|FG001|26-Week Randomized Phase|Investigator Discretion|1
7292676|NCT00550407|11510543|FG002|26-Week Randomized Phase|Investigator Discretion|0
7292677|NCT00550407|11510541|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
7292678|NCT00550407|11510542|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
7292679|NCT00550407|11510543|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
7292680|NCT00550420|11510551|FG000|Overall Study|Adverse Event|28
7292681|NCT00550420|11510551|FG000|Overall Study|Lost to Follow-up|8
7292682|NCT00550420|11510551|FG000|Overall Study|Protocol Violation|11
7292683|NCT00550420|11510551|FG000|Overall Study|Withdrawal by Subject|30
7292684|NCT00550420|11510551|FG000|Overall Study|Still in study at termination|206
7292685|NCT00550420|11510551|FG000|Overall Study|Missing|2
7292686|NCT00550420|11510551|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
7292687|NCT00550420|11510551|FG000|Overall Study|Investigators opinion|1
7292688|NCT00550420|11510551|FG000|Overall Study|Lack of curative effect|1
7292689|NCT00550420|11510551|FG000|Overall Study|Unethical stop of enrollment|2
7292690|NCT00550420|11510551|FG000|Overall Study|Caregiver's decision to withdraw|1
7292769|NCT00550446|11510573|FG009|Post Week 12|Adverse Event|4
7292691|NCT00550420|11510551|FG000|Overall Study|Out of Electrocardiogram criteria|1
7292692|NCT00550420|11510551|FG000|Overall Study|Exclusion criteria|1
7292693|NCT00550420|11510551|FG000|Overall Study|Prohibited medicine|1
7292694|NCT00550446|11510564|FG000|Up To Week 12|Adverse Event|2
7292695|NCT00550446|11510565|FG001|Up To Week 12|Adverse Event|2
7292696|NCT00550446|11510566|FG002|Up To Week 12|Adverse Event|0
7292697|NCT00550446|11510567|FG003|Up To Week 12|Adverse Event|0
7292698|NCT00550446|11510568|FG004|Up To Week 12|Adverse Event|2
7292699|NCT00550446|11510569|FG005|Up To Week 12|Adverse Event|2
7292700|NCT00550446|11510570|FG006|Up To Week 12|Adverse Event|1
7292701|NCT00550446|11510571|FG007|Up To Week 12|Adverse Event|0
7292702|NCT00550446|11510572|FG008|Up To Week 12|Adverse Event|0
7292703|NCT00550446|11510573|FG009|Up To Week 12|Adverse Event|0
7292704|NCT00550446|11510574|FG010|Up To Week 12|Adverse Event|0
7292705|NCT00550446|11510564|FG000|Up To Week 12|Lack of Efficacy|3
7292706|NCT00550446|11510565|FG001|Up To Week 12|Lack of Efficacy|1
7292707|NCT00550446|11510566|FG002|Up To Week 12|Lack of Efficacy|0
7292708|NCT00550446|11510567|FG003|Up To Week 12|Lack of Efficacy|1
7292709|NCT00550446|11510568|FG004|Up To Week 12|Lack of Efficacy|0
7292710|NCT00550446|11510569|FG005|Up To Week 12|Lack of Efficacy|3
7292711|NCT00550446|11510570|FG006|Up To Week 12|Lack of Efficacy|3
7292712|NCT00550446|11510571|FG007|Up To Week 12|Lack of Efficacy|0
7292713|NCT00550446|11510572|FG008|Up To Week 12|Lack of Efficacy|0
7292714|NCT00550446|11510573|FG009|Up To Week 12|Lack of Efficacy|0
7292715|NCT00550446|11510574|FG010|Up To Week 12|Lack of Efficacy|0
7292716|NCT00550446|11510564|FG000|Up To Week 12|Lost to Follow-up|0
7292717|NCT00550446|11510565|FG001|Up To Week 12|Lost to Follow-up|1
7292718|NCT00550446|11510566|FG002|Up To Week 12|Lost to Follow-up|0
7292719|NCT00550446|11510567|FG003|Up To Week 12|Lost to Follow-up|0
7292720|NCT00550446|11510568|FG004|Up To Week 12|Lost to Follow-up|1
7292721|NCT00550446|11510569|FG005|Up To Week 12|Lost to Follow-up|1
7292722|NCT00550446|11510570|FG006|Up To Week 12|Lost to Follow-up|2
7292723|NCT00550446|11510571|FG007|Up To Week 12|Lost to Follow-up|0
7292724|NCT00550446|11510572|FG008|Up To Week 12|Lost to Follow-up|0
7292725|NCT00550446|11510573|FG009|Up To Week 12|Lost to Follow-up|0
7292726|NCT00550446|11510574|FG010|Up To Week 12|Lost to Follow-up|0
7292727|NCT00550446|11510564|FG000|Up To Week 12|Withdrawal by Subject|2
7292728|NCT00550446|11510565|FG001|Up To Week 12|Withdrawal by Subject|0
7292729|NCT00550446|11510566|FG002|Up To Week 12|Withdrawal by Subject|3
7218520|NCT00003138|11427236|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
7218521|NCT00003138|11427235|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
7218522|NCT00003138|11427236|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
7218523|NCT00003199|11427245|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
7218524|NCT00003199|11427245|FG000|Overall Study|Lack of insurance clearance|2
7218525|NCT00003199|11427245|FG000|Overall Study|Screen fail|15
7218526|NCT00003222|11427251|FG000|Overall Study|Physician Decision|0
7218527|NCT00003222|11427252|FG001|Overall Study|Physician Decision|1
7292730|NCT00550446|11510567|FG003|Up To Week 12|Withdrawal by Subject|2
7292731|NCT00550446|11510568|FG004|Up To Week 12|Withdrawal by Subject|0
7292732|NCT00550446|11510569|FG005|Up To Week 12|Withdrawal by Subject|1
7292733|NCT00550446|11510570|FG006|Up To Week 12|Withdrawal by Subject|3
7292734|NCT00550446|11510571|FG007|Up To Week 12|Withdrawal by Subject|0
7292735|NCT00550446|11510572|FG008|Up To Week 12|Withdrawal by Subject|0
7292736|NCT00550446|11510573|FG009|Up To Week 12|Withdrawal by Subject|0
7292737|NCT00550446|11510574|FG010|Up To Week 12|Withdrawal by Subject|0
7292738|NCT00550446|11510564|FG000|Up To Week 12|Other|3
7292739|NCT00550446|11510565|FG001|Up To Week 12|Other|0
7292740|NCT00550446|11510566|FG002|Up To Week 12|Other|0
7292741|NCT00550446|11510567|FG003|Up To Week 12|Other|0
7292742|NCT00550446|11510568|FG004|Up To Week 12|Other|0
7292743|NCT00550446|11510569|FG005|Up To Week 12|Other|1
7292744|NCT00550446|11510570|FG006|Up To Week 12|Other|4
7292745|NCT00550446|11510571|FG007|Up To Week 12|Other|0
7292746|NCT00550446|11510572|FG008|Up To Week 12|Other|0
7292747|NCT00550446|11510573|FG009|Up To Week 12|Other|0
7292748|NCT00550446|11510574|FG010|Up To Week 12|Other|0
7292749|NCT00550446|11510564|FG000|Up To Week 12|Randomized not treated|0
7292750|NCT00550446|11510565|FG001|Up To Week 12|Randomized not treated|1
7292751|NCT00550446|11510566|FG002|Up To Week 12|Randomized not treated|1
7292752|NCT00550446|11510567|FG003|Up To Week 12|Randomized not treated|0
7292753|NCT00550446|11510568|FG004|Up To Week 12|Randomized not treated|0
7292754|NCT00550446|11510569|FG005|Up To Week 12|Randomized not treated|0
7292755|NCT00550446|11510570|FG006|Up To Week 12|Randomized not treated|0
7292756|NCT00550446|11510571|FG007|Up To Week 12|Randomized not treated|0
7292757|NCT00550446|11510572|FG008|Up To Week 12|Randomized not treated|0
7292758|NCT00550446|11510573|FG009|Up To Week 12|Randomized not treated|0
7292759|NCT00550446|11510574|FG010|Up To Week 12|Randomized not treated|0
7292760|NCT00550446|11510564|FG000|Post Week 12|Adverse Event|2
7292761|NCT00550446|11510565|FG001|Post Week 12|Adverse Event|1
7292762|NCT00550446|11510566|FG002|Post Week 12|Adverse Event|1
7292763|NCT00550446|11510567|FG003|Post Week 12|Adverse Event|1
7292764|NCT00550446|11510568|FG004|Post Week 12|Adverse Event|1
7292765|NCT00550446|11510569|FG005|Post Week 12|Adverse Event|1
7292766|NCT00550446|11510570|FG006|Post Week 12|Adverse Event|0
7292767|NCT00550446|11510571|FG007|Post Week 12|Adverse Event|0
7292768|NCT00550446|11510572|FG008|Post Week 12|Adverse Event|0
7292770|NCT00550446|11510574|FG010|Post Week 12|Adverse Event|0
7292771|NCT00550446|11510564|FG000|Post Week 12|Lack of Efficacy|0
7292772|NCT00550446|11510565|FG001|Post Week 12|Lack of Efficacy|0
7292773|NCT00550446|11510566|FG002|Post Week 12|Lack of Efficacy|1
7292774|NCT00550446|11510567|FG003|Post Week 12|Lack of Efficacy|0
7292775|NCT00550446|11510568|FG004|Post Week 12|Lack of Efficacy|0
7292776|NCT00550446|11510569|FG005|Post Week 12|Lack of Efficacy|0
7292777|NCT00550446|11510570|FG006|Post Week 12|Lack of Efficacy|0
7292778|NCT00550446|11510571|FG007|Post Week 12|Lack of Efficacy|1
7292779|NCT00550446|11510572|FG008|Post Week 12|Lack of Efficacy|1
7292780|NCT00550446|11510573|FG009|Post Week 12|Lack of Efficacy|2
7292781|NCT00550446|11510574|FG010|Post Week 12|Lack of Efficacy|1
7292782|NCT00550446|11510564|FG000|Post Week 12|Lost to Follow-up|0
7292783|NCT00550446|11510565|FG001|Post Week 12|Lost to Follow-up|0
7292784|NCT00550446|11510566|FG002|Post Week 12|Lost to Follow-up|1
7292785|NCT00550446|11510567|FG003|Post Week 12|Lost to Follow-up|1
7292786|NCT00550446|11510568|FG004|Post Week 12|Lost to Follow-up|0
7292787|NCT00550446|11510569|FG005|Post Week 12|Lost to Follow-up|0
7292788|NCT00550446|11510570|FG006|Post Week 12|Lost to Follow-up|1
7292789|NCT00550446|11510571|FG007|Post Week 12|Lost to Follow-up|0
7292790|NCT00550446|11510572|FG008|Post Week 12|Lost to Follow-up|0
7292791|NCT00550446|11510573|FG009|Post Week 12|Lost to Follow-up|0
7292792|NCT00550446|11510574|FG010|Post Week 12|Lost to Follow-up|0
7292793|NCT00550446|11510564|FG000|Post Week 12|Withdrawal by Subject|0
7292794|NCT00550446|11510565|FG001|Post Week 12|Withdrawal by Subject|0
7292795|NCT00550446|11510566|FG002|Post Week 12|Withdrawal by Subject|0
7292796|NCT00550446|11510567|FG003|Post Week 12|Withdrawal by Subject|0
7292797|NCT00550446|11510568|FG004|Post Week 12|Withdrawal by Subject|1
7292798|NCT00550446|11510569|FG005|Post Week 12|Withdrawal by Subject|0
7292799|NCT00550446|11510570|FG006|Post Week 12|Withdrawal by Subject|0
7292800|NCT00550446|11510571|FG007|Post Week 12|Withdrawal by Subject|0
7292801|NCT00550446|11510572|FG008|Post Week 12|Withdrawal by Subject|0
7292802|NCT00550446|11510573|FG009|Post Week 12|Withdrawal by Subject|0
7292803|NCT00550446|11510574|FG010|Post Week 12|Withdrawal by Subject|0
7292804|NCT00550446|11510564|FG000|Post Week 12|Other|1
7292805|NCT00550446|11510565|FG001|Post Week 12|Other|1
7292806|NCT00550446|11510566|FG002|Post Week 12|Other|0
7292807|NCT00550446|11510567|FG003|Post Week 12|Other|1
7292808|NCT00550446|11510568|FG004|Post Week 12|Other|0
7292809|NCT00550446|11510569|FG005|Post Week 12|Other|0
7292810|NCT00550446|11510570|FG006|Post Week 12|Other|1
7292811|NCT00550446|11510571|FG007|Post Week 12|Other|0
7292812|NCT00550446|11510572|FG008|Post Week 12|Other|1
7292813|NCT00550446|11510573|FG009|Post Week 12|Other|1
7292814|NCT00550446|11510574|FG010|Post Week 12|Other|0
7292815|NCT00550459|11510614|FG000|Overall Study|Adverse Event|0
7292816|NCT00550459|11510615|FG001|Overall Study|Adverse Event|2
7292817|NCT00550459|11510614|FG000|Overall Study|Withdrawal by Subject|1
7292818|NCT00550459|11510615|FG001|Overall Study|Withdrawal by Subject|1
7292819|NCT00550537|11510621|FG000|Overall Study|Death|18
7292820|NCT00550537|11510621|FG000|Overall Study|Adverse Event|20
7292821|NCT00550537|11510621|FG000|Overall Study|Disease progression before|46
7292822|NCT00550537|11510621|FG000|Overall Study|Withdrawal by Subject|7
7292823|NCT00550537|11510621|FG000|Overall Study|Change in treatment plan|4
7292824|NCT00550537|11510621|FG000|Overall Study|Other complicating ilness|3
7292825|NCT00550537|11510621|FG000|Overall Study|Declining performance status|2
7292826|NCT00550537|11510621|FG000|Overall Study|Treated closer to home|4
7292827|NCT00550550|11510632|FG000|Overall Study|Adverse Event|13
7292828|NCT00550550|11510633|FG001|Overall Study|Adverse Event|5
7292829|NCT00550550|11510632|FG000|Overall Study|Treatment Failure|0
7292830|NCT00550550|11510633|FG001|Overall Study|Treatment Failure|1
7292831|NCT00550550|11510632|FG000|Overall Study|Lost to Follow-up|4
7292832|NCT00550550|11510633|FG001|Overall Study|Lost to Follow-up|0
7292833|NCT00550550|11510632|FG000|Overall Study|Withdrawal by Subject|10
7292834|NCT00550550|11510633|FG001|Overall Study|Withdrawal by Subject|8
7292835|NCT00550550|11510632|FG000|Overall Study|Protocol Violation|5
7292836|NCT00550550|11510633|FG001|Overall Study|Protocol Violation|14
7292837|NCT00550550|11510632|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
7292838|NCT00550550|11510633|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
7292839|NCT00550550|11510632|FG000|Overall Study|Randomized But Not Treated|1
7292840|NCT00550550|11510633|FG001|Overall Study|Randomized But Not Treated|0
7292841|NCT00550615|11510647|FG000|Overall Study|Withdrawal by Subject|0
7292842|NCT00550615|11510648|FG001|Overall Study|Withdrawal by Subject|0
7292843|NCT00550615|11510649|FG002|Overall Study|Withdrawal by Subject|2
7292844|NCT00550615|11510650|FG003|Overall Study|Withdrawal by Subject|3
7292845|NCT00550615|11510647|FG000|Overall Study|Not evaluable|0
7292846|NCT00550615|11510648|FG001|Overall Study|Not evaluable|0
7292847|NCT00550615|11510649|FG002|Overall Study|Not evaluable|2
7292848|NCT00550615|11510650|FG003|Overall Study|Not evaluable|7
7292849|NCT00550680|11510660|FG000|Overall Study|Administrative Reasons|1
7292850|NCT00550680|11510660|FG000|Overall Study|Adverse Event|5
7292851|NCT00550680|11510660|FG000|Overall Study|Death|3
7292852|NCT00550680|11510660|FG000|Overall Study|Early Improvement|1
7292853|NCT00550680|11510660|FG000|Overall Study|Lost to Follow-up|3
7292854|NCT00550680|11510660|FG000|Overall Study|Lack of Efficacy|1
7292855|NCT00550680|11510660|FG000|Overall Study|Other|10
7292856|NCT00550680|11510660|FG000|Overall Study|Protocol Violation|7
7292857|NCT00550680|11510660|FG000|Overall Study|Refused Treatment|19
7292858|NCT00550680|11510660|FG000|Overall Study|Screen Failure|6
7292859|NCT00550732|11510664|FG000|Overall Study|Death|4
7292860|NCT00550732|11510664|FG000|Overall Study|Withdrawal by Subject|2
7292861|NCT00550732|11510664|FG000|Overall Study|Physician Decision|2
7292862|NCT00550732|11510664|FG000|Overall Study|Lost to Follow-up|1
7292863|NCT00550732|11510664|FG000|Overall Study|Palliative care|1
7292864|NCT00550732|11510664|FG000|Overall Study|Adverse Event|1
7292865|NCT00550745|11510671|FG000|Overall Study|Death|20
7292866|NCT00550745|11510672|FG001|Overall Study|Death|16
7292867|NCT00550745|11510671|FG000|Overall Study|Lost to Follow-up|45
7292868|NCT00550745|11510672|FG001|Overall Study|Lost to Follow-up|30
7292869|NCT00550745|11510671|FG000|Overall Study|Physician Decision|0
7292870|NCT00550745|11510672|FG001|Overall Study|Physician Decision|2
7292871|NCT00550745|11510671|FG000|Overall Study|Protocol Violation|4
7292872|NCT00550745|11510672|FG001|Overall Study|Protocol Violation|2
7292873|NCT00550745|11510671|FG000|Overall Study|Withdrawal by Subject|17
7292874|NCT00550745|11510672|FG001|Overall Study|Withdrawal by Subject|10
7292875|NCT00550745|11510671|FG000|Overall Study|Screen failure|1
7292876|NCT00550745|11510672|FG001|Overall Study|Screen failure|0
7292877|NCT00550771|11510680|FG000|Overall Study|Adverse Event|11
7292878|NCT00550771|11510681|FG001|Overall Study|Adverse Event|3
7292879|NCT00550771|11510680|FG000|Overall Study|Discontinued for study-related reasons|0
7292880|NCT00550771|11510681|FG001|Overall Study|Discontinued for study-related reasons|1
7292881|NCT00550771|11510680|FG000|Overall Study|Physician Decision|2
7292882|NCT00550771|11510681|FG001|Overall Study|Physician Decision|0
7292883|NCT00550771|11510680|FG000|Overall Study|Withdrawal by Subject|0
7292884|NCT00550771|11510681|FG001|Overall Study|Withdrawal by Subject|1
7292885|NCT00550771|11510680|FG000|Overall Study|Protocol Violation|4
7292886|NCT00550771|11510681|FG001|Overall Study|Protocol Violation|5
7292887|NCT00550836|11510689|FG000|Overall Study|Withdrawal by Subject|3
7292888|NCT00550836|11510690|FG001|Overall Study|Withdrawal by Subject|9
7292889|NCT00550953|11510715|FG000|Overall Study|Adverse Event|4
7292890|NCT00550953|11510716|FG001|Overall Study|Adverse Event|3
7292891|NCT00550953|11510715|FG000|Overall Study|Not able to visit the site|2
7292892|NCT00550953|11510716|FG001|Overall Study|Not able to visit the site|3
7292893|NCT00551031|11510727|FG000|Overall Study|Adverse Event|0
7292894|NCT00551031|11510728|FG001|Overall Study|Adverse Event|1
7292895|NCT00551031|11510729|FG002|Overall Study|Adverse Event|0
7292896|NCT00551031|11510730|FG003|Overall Study|Adverse Event|0
7292897|NCT00551031|11510731|FG004|Overall Study|Adverse Event|0
7292898|NCT00551031|11510727|FG000|Overall Study|Protocol Violation|1
7292899|NCT00551031|11510728|FG001|Overall Study|Protocol Violation|1
7292900|NCT00551031|11510729|FG002|Overall Study|Protocol Violation|0
7292901|NCT00551031|11510730|FG003|Overall Study|Protocol Violation|0
7292902|NCT00551031|11510731|FG004|Overall Study|Protocol Violation|0
7292903|NCT00551031|11510727|FG000|Overall Study|Lost to Follow-up|0
7292904|NCT00551031|11510728|FG001|Overall Study|Lost to Follow-up|1
7292905|NCT00551031|11510729|FG002|Overall Study|Lost to Follow-up|0
7292906|NCT00551031|11510730|FG003|Overall Study|Lost to Follow-up|1
7292907|NCT00551031|11510731|FG004|Overall Study|Lost to Follow-up|1
7292908|NCT00551031|11510727|FG000|Overall Study|Withdrawal by Subject|0
7292909|NCT00551031|11510728|FG001|Overall Study|Withdrawal by Subject|4
7292910|NCT00551031|11510729|FG002|Overall Study|Withdrawal by Subject|1
7292911|NCT00551031|11510730|FG003|Overall Study|Withdrawal by Subject|2
7292912|NCT00551031|11510731|FG004|Overall Study|Withdrawal by Subject|0
7292913|NCT00551031|11510727|FG000|Overall Study|Serious Adverse Event|0
7292914|NCT00551031|11510728|FG001|Overall Study|Serious Adverse Event|2
7292915|NCT00551031|11510729|FG002|Overall Study|Serious Adverse Event|1
7292916|NCT00551031|11510730|FG003|Overall Study|Serious Adverse Event|0
7292917|NCT00551031|11510731|FG004|Overall Study|Serious Adverse Event|0
7292918|NCT00551031|11510727|FG000|Overall Study|Did not receive vaccine|1
7292919|NCT00551031|11510728|FG001|Overall Study|Did not receive vaccine|2
7292920|NCT00551031|11510729|FG002|Overall Study|Did not receive vaccine|0
7292921|NCT00551031|11510730|FG003|Overall Study|Did not receive vaccine|0
7292922|NCT00551031|11510731|FG004|Overall Study|Did not receive vaccine|0
7292923|NCT00551135|11510751|FG000|Overall Study|Adverse Event|1
7292924|NCT00551135|11510752|FG001|Overall Study|Adverse Event|0
7292925|NCT00551135|11510753|FG002|Overall Study|Adverse Event|1
7292926|NCT00551135|11510754|FG003|Overall Study|Adverse Event|1
7292927|NCT00551135|11510751|FG000|Overall Study|Lost to Follow-up|0
7292928|NCT00551135|11510752|FG001|Overall Study|Lost to Follow-up|0
7292929|NCT00551135|11510753|FG002|Overall Study|Lost to Follow-up|0
7292930|NCT00551135|11510754|FG003|Overall Study|Lost to Follow-up|1
7292931|NCT00551135|11510751|FG000|Overall Study|Other|3
7292932|NCT00551135|11510752|FG001|Overall Study|Other|2
7292933|NCT00551135|11510753|FG002|Overall Study|Other|1
7292934|NCT00551135|11510754|FG003|Overall Study|Other|2
7292935|NCT00551135|11510751|FG000|Overall Study|Withdrawal by Subject|1
7292936|NCT00551135|11510752|FG001|Overall Study|Withdrawal by Subject|0
7292937|NCT00551135|11510753|FG002|Overall Study|Withdrawal by Subject|3
7292938|NCT00551135|11510754|FG003|Overall Study|Withdrawal by Subject|1
7292939|NCT00551161|11510764|FG000|Overall Study|Withdrawal by Subject|1
7292940|NCT00551213|11510789|FG000|Overall Study|Adverse Event|6
7292941|NCT00551213|11510790|FG001|Overall Study|Adverse Event|3
7292942|NCT00551213|11510789|FG000|Overall Study|Progressive Disease|41
7292943|NCT00551213|11510790|FG001|Overall Study|Progressive Disease|12
7292944|NCT00551213|11510789|FG000|Overall Study|Withdrawal by Subject|2
7292945|NCT00551213|11510790|FG001|Overall Study|Withdrawal by Subject|0
7292946|NCT00551213|11510789|FG000|Overall Study|Not Treated|1
7292947|NCT00551213|11510790|FG001|Overall Study|Not Treated|2
7292948|NCT00551291|11510796|FG000|Overall Study|Physician Decision|1
7292949|NCT00551369|11510800|FG000|Overall Study|Protocol Violation|5
7292950|NCT00551369|11510800|FG000|Overall Study|Withdrawal by Subject|1
7292951|NCT00551369|11510800|FG000|Overall Study|Not treated per protocol and re|1
7292952|NCT00551421|11510804|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
7292953|NCT00551460|11510809|FG000|Overall Study|Adverse Event|1
7292954|NCT00551460|11510809|FG000|Overall Study|Withdrawal by Subject|1
7292955|NCT00551460|11510809|FG000|Overall Study|Physician Decision|1
7292956|NCT00551460|11510809|FG000|Overall Study|Death|7
7292957|NCT00551460|11510809|FG000|Overall Study|Ineligible|4
7292958|NCT00551460|11510809|FG000|Overall Study|Not analyzable (did not start treatment)|4
7292959|NCT00551525|11510813|FG000|Overall Study|Protocol Violation|5
7292960|NCT00551642|11510819|FG000|Treatment Period|Protocol Deviation|6
7292961|NCT00551642|11510820|FG001|Treatment Period|Protocol Deviation|11
7292962|NCT00551642|11510819|FG000|Treatment Period|Delivery device failure|1
7292963|NCT00551642|11510820|FG001|Treatment Period|Delivery device failure|3
7292964|NCT00551642|11510819|FG000|Treatment Period|Physician Decision|0
7292965|NCT00551642|11510820|FG001|Treatment Period|Physician Decision|1
7292966|NCT00551642|11510819|FG000|Treatment Period|Death|33
7292967|NCT00551642|11510820|FG001|Treatment Period|Death|31
7292968|NCT00551642|11510819|FG000|Treatment Period|Inclusion/Exclusion criteria|4
7292969|NCT00551642|11510820|FG001|Treatment Period|Inclusion/Exclusion criteria|4
7292970|NCT00551642|11510819|FG000|Treatment Period|Adverse Event|15
7292971|NCT00551642|11510820|FG001|Treatment Period|Adverse Event|12
7292972|NCT00551642|11510819|FG000|Treatment Period|Withdrawal by Subject|2
7292973|NCT00551642|11510820|FG001|Treatment Period|Withdrawal by Subject|1
7292974|NCT00551759|11510858|FG000|Overall Study|Adverse Event|7
7292975|NCT00551759|11510858|FG000|Overall Study|Death|5
7292976|NCT00551759|11510858|FG000|Overall Study|Ineligible|1
7292977|NCT00552058|11510864|FG000|Overall Study|Adverse Event|8
7292978|NCT00552058|11510865|FG001|Overall Study|Adverse Event|7
7292979|NCT00552058|11510864|FG000|Overall Study|Lack of Efficacy|1
7292980|NCT00552058|11510865|FG001|Overall Study|Lack of Efficacy|5
7292981|NCT00552058|11510864|FG000|Overall Study|Lost to Follow-up|1
7292982|NCT00552058|11510865|FG001|Overall Study|Lost to Follow-up|0
7292983|NCT00552058|11510864|FG000|Overall Study|Withdrawal by Subject|4
7292984|NCT00552058|11510865|FG001|Overall Study|Withdrawal by Subject|4
7292985|NCT00552058|11510864|FG000|Overall Study|Other: Protocol Violation|0
7292986|NCT00552058|11510865|FG001|Overall Study|Other: Protocol Violation|1
7292987|NCT00552058|11510864|FG000|Overall Study|Other: Non Compliance|1
7292988|NCT00552058|11510865|FG001|Overall Study|Other: Non Compliance|2
7292989|NCT00552058|11510864|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
7292990|NCT00552058|11510865|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
7292991|NCT00552058|11510864|FG000|Overall Study|Other: Low CDAI score, entry violation|0
7292992|NCT00552058|11510865|FG001|Overall Study|Other: Low CDAI score, entry violation|1
7292993|NCT00552058|11510864|FG000|Overall Study|Other: Positive Stool Result|0
7292994|NCT00552058|11510865|FG001|Overall Study|Other: Positive Stool Result|1
7292995|NCT00552058|11510864|FG000|Overall Study|Other: Randomized in error|0
7292996|NCT00552058|11510865|FG001|Overall Study|Other: Randomized in error|1
7292997|NCT00552058|11510864|FG000|Overall Study|Other: Sponsors Decision|0
7292998|NCT00552058|11510865|FG001|Overall Study|Other: Sponsors Decision|1
7292999|NCT00552058|11510864|FG000|Overall Study|Other: Early Roll Over|1
7293000|NCT00552058|11510865|FG001|Overall Study|Other: Early Roll Over|0
7293001|NCT00552071|11510873|FG000|Overall Study|Adverse Event|1
7293002|NCT00552071|11510874|FG001|Overall Study|Adverse Event|0
7293003|NCT00552071|11510873|FG000|Overall Study|Lack of Efficacy|1
7293004|NCT00552071|11510874|FG001|Overall Study|Lack of Efficacy|0
7293005|NCT00552071|11510873|FG000|Overall Study|Physician Decision|1
7293006|NCT00552071|11510874|FG001|Overall Study|Physician Decision|0
7293007|NCT00552071|11510873|FG000|Overall Study|Pregnancy|1
7293008|NCT00552071|11510874|FG001|Overall Study|Pregnancy|0
7293009|NCT00552071|11510873|FG000|Overall Study|Death|0
7293010|NCT00552071|11510874|FG001|Overall Study|Death|1
7293011|NCT00552071|11510873|FG000|Overall Study|Withdrawal by Subject|0
7293012|NCT00552071|11510874|FG001|Overall Study|Withdrawal by Subject|1
7293013|NCT00552084|11510884|FG000|Overall Study|Adverse Event|2
7293014|NCT00552084|11510885|FG001|Overall Study|Adverse Event|3
7293015|NCT00552084|11510884|FG000|Overall Study|Withdrawal by Subject|4
7293016|NCT00552084|11510885|FG001|Overall Study|Withdrawal by Subject|5
7293017|NCT00552084|11510884|FG000|Overall Study|Protocol Violation|1
7293018|NCT00552084|11510885|FG001|Overall Study|Protocol Violation|0
7293019|NCT00552084|11510884|FG000|Overall Study|change in anti-arrythmic drug|1
7293020|NCT00552084|11510885|FG001|Overall Study|change in anti-arrythmic drug|1
7293021|NCT00552110|11510896|FG000|Overall Study|Serious or Life-Threatening AE|0
7293022|NCT00552110|11510897|FG001|Overall Study|Serious or Life-Threatening AE|0
7218528|NCT04848662|11427287|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1
7218529|NCT04848662|11427288|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0
7218530|NCT03969719|11427301|FG000|Overall Study|Other reasons not specified|1
7218531|NCT03969719|11427302|FG001|Overall Study|Other reasons not specified|1
7218532|NCT03969719|11427303|FG002|Overall Study|Other reasons not specified|3
7218533|NCT03969719|11427301|FG000|Overall Study|Withdrawal by Subject|2
7218534|NCT03969719|11427302|FG001|Overall Study|Withdrawal by Subject|3
7218535|NCT03969719|11427303|FG002|Overall Study|Withdrawal by Subject|2
7218536|NCT03969719|11427301|FG000|Overall Study|Protocol Violation|1
7218537|NCT03969719|11427302|FG001|Overall Study|Protocol Violation|2
7218538|NCT03969719|11427303|FG002|Overall Study|Protocol Violation|0
7218539|NCT03969719|11427301|FG000|Overall Study|Adverse Event|0
7218540|NCT03969719|11427302|FG001|Overall Study|Adverse Event|2
7218541|NCT03969719|11427303|FG002|Overall Study|Adverse Event|0
7218542|NCT03969719|11427301|FG000|Overall Study|Lost to Follow-up|0
7218543|NCT03969719|11427302|FG001|Overall Study|Lost to Follow-up|1
7218544|NCT03969719|11427303|FG002|Overall Study|Lost to Follow-up|0
7218545|NCT03883477|11427313|FG000|Overall Study|Death|1
7218546|NCT03883477|11427314|FG001|Overall Study|Death|0
7218547|NCT03883477|11427313|FG000|Overall Study|Protocol Violation|0
7218548|NCT03883477|11427314|FG001|Overall Study|Protocol Violation|1
7218549|NCT03809611|11427343|FG000|Overall Study|Withdrawal by Subject|1
7218550|NCT03809611|11427344|FG001|Overall Study|Withdrawal by Subject|1
7218551|NCT03721705|11427353|FG000|Overall Study|Adverse Event|2
7218552|NCT03721705|11427354|FG001|Overall Study|Adverse Event|0
7218553|NCT03721705|11427353|FG000|Overall Study|Withdrawal by Subject|4
7218554|NCT03721705|11427354|FG001|Overall Study|Withdrawal by Subject|10
7218555|NCT03721705|11427353|FG000|Overall Study|No Suitable Study Partner|1
7218556|NCT03721705|11427354|FG001|Overall Study|No Suitable Study Partner|0
7218557|NCT03721705|11427353|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3
7218558|NCT03721705|11427354|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7
7218559|NCT03721705|11427353|FG000|Overall Study|Death|0
7218560|NCT03721705|11427354|FG001|Overall Study|Death|1
7218561|NCT03505021|11427362|FG000|Overall Study|Protocol Violation|1
7218562|NCT03505021|11427363|FG001|Overall Study|Protocol Violation|0
7218563|NCT03505021|11427362|FG000|Overall Study|Death|9
7218564|NCT03505021|11427363|FG001|Overall Study|Death|8
7218565|NCT03505021|11427362|FG000|Overall Study|Consent withdrawn by subject|6
7218566|NCT03505021|11427363|FG001|Overall Study|Consent withdrawn by subject|1
7218567|NCT03505021|11427362|FG000|Overall Study|Lost to Follow-up|5
7218568|NCT03505021|11427363|FG001|Overall Study|Lost to Follow-up|3
7218569|NCT03505021|11427362|FG000|Overall Study|Adverse Event|26
7218570|NCT03505021|11427363|FG001|Overall Study|Adverse Event|9
7218571|NCT03505021|11427362|FG000|Overall Study|Disease progression|33
7218572|NCT03505021|11427363|FG001|Overall Study|Disease progression|17
7218573|NCT03505021|11427362|FG000|Overall Study|Other|11
7218574|NCT03505021|11427363|FG001|Overall Study|Other|5
7218575|NCT03505021|11427362|FG000|Overall Study|Personal reason|21
7218576|NCT03505021|11427363|FG001|Overall Study|Personal reason|12
7218577|NCT03366194|11427392|FG000|Overall Study|Lost to Follow-up|2
7218578|NCT03203473|11427406|FG000|Induction Phase|Never started primary treatment|2
7218579|NCT03203473|11427407|FG001|Induction Phase|Never started primary treatment|0
7218580|NCT03203473|11427408|FG002|Induction Phase|Never started primary treatment|0
7218581|NCT03203473|11427406|FG000|Induction Phase|Withdrew from study due to progressive disease|7
7218582|NCT03203473|11427407|FG001|Induction Phase|Withdrew from study due to progressive disease|0
7218583|NCT03203473|11427408|FG002|Induction Phase|Withdrew from study due to progressive disease|0
7218584|NCT03203473|11427406|FG000|Induction Phase|Withdrew from study due to toxicity|7
7293023|NCT00552110|11510898|FG002|Overall Study|Serious or Life-Threatening AE|1
7293024|NCT00552110|11510899|FG003|Overall Study|Serious or Life-Threatening AE|0
7293025|NCT00552110|11510900|FG004|Overall Study|Serious or Life-Threatening AE|0
7293026|NCT00552110|11510896|FG000|Overall Study|Lack of Efficacy|1
7293027|NCT00552110|11510897|FG001|Overall Study|Lack of Efficacy|0
7293028|NCT00552110|11510898|FG002|Overall Study|Lack of Efficacy|0
7293029|NCT00552110|11510899|FG003|Overall Study|Lack of Efficacy|1
7293030|NCT00552110|11510900|FG004|Overall Study|Lack of Efficacy|4
7293031|NCT00552110|11510896|FG000|Overall Study|Withdrawal by Subject|0
7293032|NCT00552110|11510897|FG001|Overall Study|Withdrawal by Subject|2
7293033|NCT00552110|11510898|FG002|Overall Study|Withdrawal by Subject|0
7293034|NCT00552110|11510899|FG003|Overall Study|Withdrawal by Subject|3
7293035|NCT00552110|11510900|FG004|Overall Study|Withdrawal by Subject|2
7293036|NCT00552110|11510896|FG000|Overall Study|Lost to Follow-up|0
7293037|NCT00552110|11510897|FG001|Overall Study|Lost to Follow-up|0
7293038|NCT00552110|11510898|FG002|Overall Study|Lost to Follow-up|0
7293039|NCT00552110|11510899|FG003|Overall Study|Lost to Follow-up|1
7293040|NCT00552110|11510900|FG004|Overall Study|Lost to Follow-up|1
7293041|NCT00552110|11510896|FG000|Overall Study|Failed to Comply With Study Requirements|1
7293042|NCT00552110|11510897|FG001|Overall Study|Failed to Comply With Study Requirements|1
7293043|NCT00552110|11510898|FG002|Overall Study|Failed to Comply With Study Requirements|1
7293044|NCT00552110|11510899|FG003|Overall Study|Failed to Comply With Study Requirements|0
7293045|NCT00552110|11510900|FG004|Overall Study|Failed to Comply With Study Requirements|1
7293046|NCT00552110|11510896|FG000|Overall Study|Withdrawn per Sponsor|0
7293047|NCT00552110|11510897|FG001|Overall Study|Withdrawn per Sponsor|1
7293048|NCT00552110|11510898|FG002|Overall Study|Withdrawn per Sponsor|0
7293049|NCT00552110|11510899|FG003|Overall Study|Withdrawn per Sponsor|0
7293050|NCT00552110|11510900|FG004|Overall Study|Withdrawn per Sponsor|1
7293051|NCT00552110|11510896|FG000|Overall Study|Use of Prohibited Medication|1
7293052|NCT00552110|11510897|FG001|Overall Study|Use of Prohibited Medication|1
7293053|NCT00552110|11510898|FG002|Overall Study|Use of Prohibited Medication|0
7293054|NCT00552110|11510899|FG003|Overall Study|Use of Prohibited Medication|0
7293055|NCT00552110|11510900|FG004|Overall Study|Use of Prohibited Medication|0
7293056|NCT00552110|11510896|FG000|Overall Study|Delay of Study due to Relabeling|0
7293057|NCT00552110|11510897|FG001|Overall Study|Delay of Study due to Relabeling|0
7293058|NCT00552110|11510898|FG002|Overall Study|Delay of Study due to Relabeling|0
7293059|NCT00552110|11510899|FG003|Overall Study|Delay of Study due to Relabeling|1
7293060|NCT00552110|11510900|FG004|Overall Study|Delay of Study due to Relabeling|0
7293061|NCT00552110|11510896|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
7293062|NCT00552110|11510897|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
7293063|NCT00552110|11510898|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
7293064|NCT00552110|11510899|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
7293065|NCT00552110|11510900|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
7293066|NCT00552110|11510896|FG000|Overall Study|Nonserious Adverse Event (AE)|1
7293067|NCT00552110|11510897|FG001|Overall Study|Nonserious Adverse Event (AE)|0
7293068|NCT00552110|11510898|FG002|Overall Study|Nonserious Adverse Event (AE)|0
7293069|NCT00552110|11510899|FG003|Overall Study|Nonserious Adverse Event (AE)|1
7293070|NCT00552110|11510900|FG004|Overall Study|Nonserious Adverse Event (AE)|0
7293071|NCT00552175|11510915|FG000|Overall Study|Lack of Efficacy|2
7293072|NCT00552175|11510916|FG001|Overall Study|Lack of Efficacy|0
7293073|NCT00552175|11510917|FG002|Overall Study|Lack of Efficacy|1
7293074|NCT00552175|11510915|FG000|Overall Study|Adverse Event|9
7293075|NCT00552175|11510916|FG001|Overall Study|Adverse Event|9
7293076|NCT00552175|11510917|FG002|Overall Study|Adverse Event|10
7293077|NCT00552175|11510915|FG000|Overall Study|Withdrawal by Subject|2
7293078|NCT00552175|11510916|FG001|Overall Study|Withdrawal by Subject|2
7293079|NCT00552175|11510917|FG002|Overall Study|Withdrawal by Subject|1
7293080|NCT00552175|11510915|FG000|Overall Study|Lost to Follow-up|0
7293081|NCT00552175|11510916|FG001|Overall Study|Lost to Follow-up|0
7293082|NCT00552175|11510917|FG002|Overall Study|Lost to Follow-up|1
7293083|NCT00552175|11510915|FG000|Overall Study|Entry Criteria Not Met|1
7293084|NCT00552175|11510916|FG001|Overall Study|Entry Criteria Not Met|1
7293085|NCT00552175|11510917|FG002|Overall Study|Entry Criteria Not Met|0
7293086|NCT00552175|11510915|FG000|Overall Study|Reason Not Specified|3
7293087|NCT00552175|11510916|FG001|Overall Study|Reason Not Specified|1
7293088|NCT00552175|11510917|FG002|Overall Study|Reason Not Specified|1
7293089|NCT00552188|11510928|FG000|Overall Study|Adverse Event|0
7293090|NCT00552188|11510929|FG001|Overall Study|Adverse Event|2
7293091|NCT00552188|11510928|FG000|Overall Study|Lost to Follow-up|2
7293092|NCT00552188|11510929|FG001|Overall Study|Lost to Follow-up|1
7293093|NCT00552188|11510928|FG000|Overall Study|Withdrawal of consent|0
7293094|NCT00552188|11510929|FG001|Overall Study|Withdrawal of consent|1
7293095|NCT00552188|11510928|FG000|Overall Study|Subject returned to home country|0
7293096|NCT00552188|11510929|FG001|Overall Study|Subject returned to home country|1
7293097|NCT00552240|11510937|FG000|Overall Study|Adverse Event|9
7293098|NCT00552240|11510938|FG001|Overall Study|Adverse Event|9
7293099|NCT00552240|11510937|FG000|Overall Study|Protocol Violation|1
7293100|NCT00552240|11510938|FG001|Overall Study|Protocol Violation|1
7293101|NCT00552240|11510937|FG000|Overall Study|Lost to Follow-up|5
7293102|NCT00552240|11510938|FG001|Overall Study|Lost to Follow-up|6
7293103|NCT00552240|11510937|FG000|Overall Study|Withdrawal by Subject|2
7293104|NCT00552240|11510938|FG001|Overall Study|Withdrawal by Subject|2
7293105|NCT00552240|11510937|FG000|Overall Study|Lack of Efficacy|6
7293106|NCT00552240|11510938|FG001|Overall Study|Lack of Efficacy|0
7293107|NCT00552240|11510937|FG000|Overall Study|Other|1
7293108|NCT00552240|11510938|FG001|Overall Study|Other|0
7293109|NCT00552279|11510946|FG000|Overall Study|Adverse Event|0
7293110|NCT00552279|11510947|FG001|Overall Study|Adverse Event|1
7293111|NCT00552279|11510946|FG000|Overall Study|Withdrawal by Subject|12
7293112|NCT00552279|11510947|FG001|Overall Study|Withdrawal by Subject|1
7293113|NCT00552279|11510946|FG000|Overall Study|Lost to Follow-up|1
7293114|NCT00552279|11510947|FG001|Overall Study|Lost to Follow-up|0
7293115|NCT00552279|11510946|FG000|Overall Study|Other|1
7293116|NCT00552279|11510947|FG001|Overall Study|Other|1
7293117|NCT00552305|11510953|FG000|Overall Study|Adverse Event|43
7293118|NCT00552305|11510953|FG000|Overall Study|Lack of Efficacy|120
7293119|NCT00552305|11510953|FG000|Overall Study|Lost to Follow-up|4
7293120|NCT00552305|11510953|FG000|Overall Study|Protocol Violation|3
7293121|NCT00552305|11510953|FG000|Overall Study|Withdrawal by Subject|44
7293122|NCT00552305|11510953|FG000|Overall Study|Lack of efficacy/withdrew consent|1
7293123|NCT00552305|11510953|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
7293124|NCT00552305|11510953|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
7293125|NCT00552305|11510953|FG000|Overall Study|Unsatisfactory compliance|11
7293126|NCT00552305|11510953|FG000|Overall Study|Poor compliance/lost to follow-up|1
7293127|NCT00552305|11510953|FG000|Overall Study|AE/Other: prohibited drug required|1
7293128|NCT00552305|11510953|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
7293129|NCT00552305|11510953|FG000|Overall Study|Other: Site closed|4
7293130|NCT00552305|11510953|FG000|Overall Study|Other: Personal problems|1
7293131|NCT00552305|11510953|FG000|Overall Study|Other: Unable to attend visits|1
7293132|NCT00552305|11510953|FG000|Overall Study|Other: Subject underwent surgery|4
7293133|NCT00552305|11510953|FG000|Overall Study|Other: Subject became pregnant|1
7293134|NCT00552305|11510953|FG000|Overall Study|Other: Health problems, not drug related|1
7293135|NCT00552305|11510953|FG000|Overall Study|Other: Subject moved from area|2
7293136|NCT00552305|11510953|FG000|Overall Study|Other: Subject incarcerated|1
7293137|NCT00552305|11510953|FG000|Overall Study|Other: Subject went to rehab|1
7293138|NCT00552344|11510957|FG000|Overall Study|Lack of Efficacy|55
7293139|NCT00552344|11510957|FG000|Overall Study|Loss of efficacy|75
7293140|NCT00552344|11510957|FG000|Overall Study|Lost to Follow-up|8
7293141|NCT00552344|11510957|FG000|Overall Study|Withdrawal by Subject|48
7293142|NCT00552344|11510957|FG000|Overall Study|SAE, non-fatal|6
7293143|NCT00552344|11510957|FG000|Overall Study|AE, non-serious non-fatal|38
7293144|NCT00552344|11510957|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
7293145|NCT00552344|11510957|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
7293146|NCT00552344|11510957|FG000|Overall Study|Other Reason|22
7293147|NCT00552396|11510969|FG000|Overall Study|protocol withdrawal criteria|3
7293148|NCT00552396|11510970|FG001|Overall Study|protocol withdrawal criteria|3
7293149|NCT00552396|11510971|FG002|Overall Study|protocol withdrawal criteria|3
7293150|NCT00552396|11510972|FG003|Overall Study|protocol withdrawal criteria|6
7293151|NCT00552396|11510973|FG004|Overall Study|protocol withdrawal criteria|3
7293152|NCT00552396|11510974|FG005|Overall Study|protocol withdrawal criteria|3
7293153|NCT00552396|11510975|FG006|Overall Study|protocol withdrawal criteria|9
7293154|NCT00552578|11511033|FG000|Overall Study|Lost to Follow-up|1
7293155|NCT00552578|11511034|FG001|Overall Study|Lost to Follow-up|1
7293156|NCT00552617|11511050|FG000|Overall Study|Not Treated|0
7293157|NCT00552617|11511051|FG001|Overall Study|Not Treated|0
7293158|NCT00552617|11511052|FG002|Overall Study|Not Treated|1
7293159|NCT00552617|11511053|FG003|Overall Study|Not Treated|0
7293160|NCT00552617|11511054|FG004|Overall Study|Not Treated|0
7293161|NCT00552617|11511055|FG005|Overall Study|Not Treated|0
7293162|NCT00552617|11511056|FG006|Overall Study|Not Treated|0
7293163|NCT00552617|11511057|FG007|Overall Study|Not Treated|0
7293164|NCT00552617|11511058|FG008|Overall Study|Not Treated|0
7293165|NCT00552617|11511059|FG009|Overall Study|Not Treated|1
7293166|NCT00552617|11511050|FG000|Overall Study|Lost to Follow-up|0
7293167|NCT00552617|11511051|FG001|Overall Study|Lost to Follow-up|0
7293168|NCT00552617|11511052|FG002|Overall Study|Lost to Follow-up|0
7293169|NCT00552617|11511053|FG003|Overall Study|Lost to Follow-up|1
7293170|NCT00552617|11511054|FG004|Overall Study|Lost to Follow-up|0
7293171|NCT00552617|11511055|FG005|Overall Study|Lost to Follow-up|2
7293172|NCT00552617|11511056|FG006|Overall Study|Lost to Follow-up|0
7293173|NCT00552617|11511057|FG007|Overall Study|Lost to Follow-up|0
7293174|NCT00552617|11511058|FG008|Overall Study|Lost to Follow-up|2
7293175|NCT00552617|11511059|FG009|Overall Study|Lost to Follow-up|0
7293176|NCT00552669|11511083|FG000|Overall Study|Death|3
7293177|NCT00552669|11511084|FG001|Overall Study|Death|7
7293178|NCT00552760|11511101|FG000|Overall Study|Adverse Event|3
7293179|NCT00552760|11511102|FG001|Overall Study|Adverse Event|5
7293180|NCT00552760|11511101|FG000|Overall Study|Relapsed- Depressed Event|10
7293181|NCT00552760|11511102|FG001|Overall Study|Relapsed- Depressed Event|16
7293182|NCT00552760|11511101|FG000|Overall Study|Relapse- Manic Event|3
7293183|NCT00552760|11511102|FG001|Overall Study|Relapse- Manic Event|3
7293184|NCT00552760|11511101|FG000|Overall Study|Relapsed- Mixed Event|3
7293185|NCT00552760|11511102|FG001|Overall Study|Relapsed- Mixed Event|5
7293186|NCT00552760|11511101|FG000|Overall Study|Protocol Violation|0
7293187|NCT00552760|11511102|FG001|Overall Study|Protocol Violation|1
7293188|NCT00552760|11511101|FG000|Overall Study|Lost to Follow-up|1
7293189|NCT00552760|11511102|FG001|Overall Study|Lost to Follow-up|1
7293190|NCT00552760|11511101|FG000|Overall Study|Non-compliance|1
7293191|NCT00552760|11511102|FG001|Overall Study|Non-compliance|1
7293192|NCT00552760|11511101|FG000|Overall Study|Medical Condition|1
7293193|NCT00552760|11511102|FG001|Overall Study|Medical Condition|1
7218585|NCT03203473|11427407|FG001|Induction Phase|Withdrew from study due to toxicity|0
7218586|NCT03203473|11427408|FG002|Induction Phase|Withdrew from study due to toxicity|0
7218587|NCT03203473|11427406|FG000|Arm Allocation Phase|Still on Arm A-observation|0
7218588|NCT03203473|11427407|FG001|Arm Allocation Phase|Still on Arm A-observation|7
7218589|NCT03203473|11427408|FG002|Arm Allocation Phase|Still on Arm A-observation|0
7218590|NCT03203473|11427406|FG000|Arm Allocation Phase|started salvage therapy|0
7218591|NCT03203473|11427407|FG001|Arm Allocation Phase|started salvage therapy|5
7218592|NCT03203473|11427408|FG002|Arm Allocation Phase|started salvage therapy|0
7218593|NCT03203473|11427406|FG000|Arm Allocation Phase|Disease progression|0
7218594|NCT03203473|11427407|FG001|Arm Allocation Phase|Disease progression|0
7218595|NCT03203473|11427408|FG002|Arm Allocation Phase|Disease progression|37
7218596|NCT03203473|11427406|FG000|Arm Allocation Phase|Adverse Event|0
7218597|NCT03203473|11427407|FG001|Arm Allocation Phase|Adverse Event|0
7218598|NCT03203473|11427408|FG002|Arm Allocation Phase|Adverse Event|11
7218599|NCT03203473|11427406|FG000|Arm Allocation Phase|Physician Decision|0
7218600|NCT03203473|11427407|FG001|Arm Allocation Phase|Physician Decision|0
7218601|NCT03203473|11427408|FG002|Arm Allocation Phase|Physician Decision|3
7218602|NCT03203473|11427406|FG000|Arm Allocation Phase|Death|0
7218603|NCT03203473|11427407|FG001|Arm Allocation Phase|Death|0
7218604|NCT03203473|11427408|FG002|Arm Allocation Phase|Death|1
7218605|NCT03203473|11427406|FG000|Arm Allocation Phase|Developed 2nd cancer|0
7218606|NCT03203473|11427407|FG001|Arm Allocation Phase|Developed 2nd cancer|0
7218607|NCT03203473|11427408|FG002|Arm Allocation Phase|Developed 2nd cancer|1
7218608|NCT03203473|11427406|FG000|Arm Allocation Phase|Intercurrent illness|0
7218609|NCT03203473|11427407|FG001|Arm Allocation Phase|Intercurrent illness|0
7218610|NCT03203473|11427408|FG002|Arm Allocation Phase|Intercurrent illness|1
7293194|NCT00552760|11511101|FG000|Overall Study|Withdrawal by Subject|3
7293195|NCT00552760|11511102|FG001|Overall Study|Withdrawal by Subject|0
7293196|NCT00552760|11511101|FG000|Overall Study|Medication Change|1
7293197|NCT00552760|11511102|FG001|Overall Study|Medication Change|0
7293198|NCT00552929|11511131|FG000|Overall Study|Lost to Follow-up|0
7293199|NCT00552929|11511132|FG001|Overall Study|Lost to Follow-up|0
7293200|NCT00552929|11511133|FG002|Overall Study|Lost to Follow-up|0
7293201|NCT00552929|11511134|FG003|Overall Study|Lost to Follow-up|0
7293202|NCT00552929|11511135|FG004|Overall Study|Lost to Follow-up|0
7293203|NCT00552929|11511136|FG005|Overall Study|Lost to Follow-up|0
7293204|NCT00552929|11511137|FG006|Overall Study|Lost to Follow-up|0
7293205|NCT00552929|11511138|FG007|Overall Study|Lost to Follow-up|0
7293206|NCT00552929|11511139|FG008|Overall Study|Lost to Follow-up|1
7293207|NCT00552929|11511140|FG009|Overall Study|Lost to Follow-up|0
7293208|NCT00552929|11511131|FG000|Overall Study|Not Eligible|0
7293209|NCT00552929|11511132|FG001|Overall Study|Not Eligible|0
7293210|NCT00552929|11511133|FG002|Overall Study|Not Eligible|0
7293211|NCT00552929|11511134|FG003|Overall Study|Not Eligible|0
7293212|NCT00552929|11511135|FG004|Overall Study|Not Eligible|0
7293213|NCT00552929|11511136|FG005|Overall Study|Not Eligible|1
7293214|NCT00552929|11511137|FG006|Overall Study|Not Eligible|0
7293215|NCT00552929|11511138|FG007|Overall Study|Not Eligible|0
7293216|NCT00552929|11511139|FG008|Overall Study|Not Eligible|0
7293217|NCT00552929|11511140|FG009|Overall Study|Not Eligible|0
7293218|NCT00553059|11511164|FG000|Overall Study|Deemed ineligible|1
7293219|NCT00553059|11511165|FG001|Overall Study|Deemed ineligible|1
7293220|NCT00553059|11511164|FG000|Overall Study|Drug supply not available|0
7293221|NCT00553059|11511165|FG001|Overall Study|Drug supply not available|1
7293222|NCT00553150|11511181|FG000|Overall Study|Withdrawal by Subject|0
7293223|NCT00553150|11511182|FG001|Overall Study|Withdrawal by Subject|0
7293224|NCT00553150|11511183|FG002|Overall Study|Withdrawal by Subject|0
7293225|NCT00553150|11511184|FG003|Overall Study|Withdrawal by Subject|2
7293226|NCT00553150|11511181|FG000|Overall Study|Protocol Violation|0
7293227|NCT00553150|11511182|FG001|Overall Study|Protocol Violation|0
7293228|NCT00553150|11511183|FG002|Overall Study|Protocol Violation|0
7293229|NCT00553150|11511184|FG003|Overall Study|Protocol Violation|1
7293230|NCT00553150|11511181|FG000|Overall Study|Ineligible|0
7293231|NCT00553150|11511182|FG001|Overall Study|Ineligible|0
7293232|NCT00553150|11511183|FG002|Overall Study|Ineligible|0
7293233|NCT00553150|11511184|FG003|Overall Study|Ineligible|1
7293234|NCT00553202|11511206|FG000|Overall Study|Death|16
7293235|NCT00553202|11511206|FG000|Overall Study|Lost to Follow-up|1
7293236|NCT00553202|11511206|FG000|Overall Study|Physician Decision|28
7293237|NCT00553202|11511206|FG000|Overall Study|Withdrawal by Subject|1
7293238|NCT00553202|11511206|FG000|Overall Study|No donor identified|16
7293239|NCT00553202|11511206|FG000|Overall Study|Fails to meet organ function|6
7293240|NCT00553254|11511213|FG000|Overall Study|Death|3
7293241|NCT00553254|11511214|FG001|Overall Study|Death|6
7293242|NCT00553254|11511215|FG002|Overall Study|Death|25
7293243|NCT00553254|11511213|FG000|Overall Study|Lost to Follow-up|0
7293244|NCT00553254|11511214|FG001|Overall Study|Lost to Follow-up|0
7293245|NCT00553254|11511215|FG002|Overall Study|Lost to Follow-up|2
7293246|NCT00553254|11511213|FG000|Overall Study|Withdrawal by Subject|2
7293247|NCT00553254|11511214|FG001|Overall Study|Withdrawal by Subject|0
7293248|NCT00553254|11511215|FG002|Overall Study|Withdrawal by Subject|2
7293249|NCT00553254|11511213|FG000|Overall Study|Study terminated by Sponsor|0
7293250|NCT00553254|11511214|FG001|Overall Study|Study terminated by Sponsor|0
7293251|NCT00553254|11511215|FG002|Overall Study|Study terminated by Sponsor|1
7293252|NCT00553254|11511213|FG000|Overall Study|Other|1
7293253|NCT00553254|11511214|FG001|Overall Study|Other|0
7293254|NCT00553254|11511215|FG002|Overall Study|Other|13
7293255|NCT00553267|11511230|FG000|Overall Study|Adverse Event|8
7293256|NCT00553267|11511231|FG001|Overall Study|Adverse Event|10
7293257|NCT00553267|11511232|FG002|Overall Study|Adverse Event|5
7293258|NCT00553267|11511230|FG000|Overall Study|Non compliant with protocol|3
7293259|NCT00553267|11511231|FG001|Overall Study|Non compliant with protocol|3
7293260|NCT00553267|11511232|FG002|Overall Study|Non compliant with protocol|2
7293261|NCT00553267|11511230|FG000|Overall Study|Lost to Follow-up|0
7293262|NCT00553267|11511231|FG001|Overall Study|Lost to Follow-up|0
7293263|NCT00553267|11511232|FG002|Overall Study|Lost to Follow-up|1
7293264|NCT00553267|11511230|FG000|Overall Study|Consent withdrawn|2
7293265|NCT00553267|11511231|FG001|Overall Study|Consent withdrawn|3
7293266|NCT00553267|11511232|FG002|Overall Study|Consent withdrawn|1
7293267|NCT00553267|11511230|FG000|Overall Study|Specified category|1
7293268|NCT00553267|11511231|FG001|Overall Study|Specified category|2
7293269|NCT00553267|11511232|FG002|Overall Study|Specified category|1
7293270|NCT00553280|11511240|FG000|Overall Study|Adverse Event|19
7293271|NCT00553280|11511240|FG000|Overall Study|Lack of Efficacy|3
7293272|NCT00553280|11511240|FG000|Overall Study|Withdrawal by Subject|3
7293273|NCT00553280|11511240|FG000|Overall Study|Physician Decision|1
7293274|NCT00553319|11511247|FG000|Overall Study|Lost to Follow-up|10
7293275|NCT00553319|11511248|FG001|Overall Study|Lost to Follow-up|9
7293276|NCT00553319|11511249|FG002|Overall Study|Lost to Follow-up|5
7293277|NCT00553319|11511247|FG000|Overall Study|wanted treatment elsewhere|2
7293278|NCT00553319|11511248|FG001|Overall Study|wanted treatment elsewhere|1
7293279|NCT00553319|11511249|FG002|Overall Study|wanted treatment elsewhere|1
7293280|NCT00553319|11511247|FG000|Overall Study|non-compliance|0
7293281|NCT00553319|11511248|FG001|Overall Study|non-compliance|0
7293282|NCT00553319|11511249|FG002|Overall Study|non-compliance|2
7293283|NCT00553319|11511247|FG000|Overall Study|incarceration|1
7293284|NCT00553319|11511248|FG001|Overall Study|incarceration|0
7293285|NCT00553319|11511249|FG002|Overall Study|incarceration|0
7293286|NCT00553319|11511247|FG000|Overall Study|moved|1
7293287|NCT00553319|11511248|FG001|Overall Study|moved|0
7293288|NCT00553319|11511249|FG002|Overall Study|moved|1
7293289|NCT00553332|11511257|FG000|Overall Study|ineligible, incorrect diagnosis|1
7293290|NCT00553358|11511264|FG000|Overall Study|Randomized but did not receive treatment|3
7293291|NCT00553358|11511265|FG001|Overall Study|Randomized but did not receive treatment|3
7293292|NCT00553358|11511266|FG002|Overall Study|Randomized but did not receive treatment|1
7293293|NCT00553358|11511264|FG000|Overall Study|Lost to Follow-up|22
7293294|NCT00553358|11511265|FG001|Overall Study|Lost to Follow-up|26
7293295|NCT00553358|11511266|FG002|Overall Study|Lost to Follow-up|18
7293296|NCT00553358|11511264|FG000|Overall Study|Withdrew completely|23
7293297|NCT00553358|11511265|FG001|Overall Study|Withdrew completely|33
7293298|NCT00553358|11511266|FG002|Overall Study|Withdrew completely|34
7293299|NCT00553358|11511264|FG000|Overall Study|Died during clinical follow-up|25
7293300|NCT00553358|11511265|FG001|Overall Study|Died during clinical follow-up|29
7293301|NCT00553358|11511266|FG002|Overall Study|Died during clinical follow-up|32
7293302|NCT00553358|11511264|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
7293303|NCT00553358|11511265|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7293304|NCT00553358|11511266|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
7293305|NCT00553358|11511264|FG000|Overall Study|Died after clinical follow-up ended|1
7293306|NCT00553358|11511265|FG001|Overall Study|Died after clinical follow-up ended|2
7293307|NCT00553358|11511266|FG002|Overall Study|Died after clinical follow-up ended|0
7293308|NCT00553358|11511264|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7293309|NCT00553358|11511265|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7293310|NCT00553358|11511266|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
7293311|NCT00553436|11511289|FG000|Overall Study|Conversion to another procedure|1
7293312|NCT00553462|11511293|FG000|Overall Study|Adverse Event|4
7293313|NCT00553462|11511293|FG000|Overall Study|Progression|4
7293314|NCT00553462|11511293|FG000|Overall Study|Withdrawal by Subject|5
7293315|NCT00553462|11511293|FG000|Overall Study|Physician Decision|1
7293316|NCT00553475|11511300|FG000|Overall Study|Adverse Event|7
7293317|NCT00553475|11511301|FG001|Overall Study|Adverse Event|17
7293318|NCT00553475|11511302|FG002|Overall Study|Adverse Event|13
7293319|NCT00553475|11511300|FG000|Overall Study|Lack of Efficacy|7
7293320|NCT00553475|11511301|FG001|Overall Study|Lack of Efficacy|1
7293321|NCT00553475|11511302|FG002|Overall Study|Lack of Efficacy|0
7293322|NCT00553475|11511300|FG000|Overall Study|Withdrawal by Subject|1
7293323|NCT00553475|11511301|FG001|Overall Study|Withdrawal by Subject|1
7293324|NCT00553475|11511302|FG002|Overall Study|Withdrawal by Subject|0
7293325|NCT00553475|11511300|FG000|Overall Study|Physician Decision|1
7293326|NCT00553475|11511301|FG001|Overall Study|Physician Decision|0
7293327|NCT00553475|11511302|FG002|Overall Study|Physician Decision|0
7293328|NCT00553475|11511300|FG000|Overall Study|Due to moving|0
7293329|NCT00553475|11511301|FG001|Overall Study|Due to moving|1
7293330|NCT00553475|11511302|FG002|Overall Study|Due to moving|0
7293331|NCT00553501|11511312|FG000|Overall Study|Adverse Event|2
7293332|NCT00553501|11511312|FG000|Overall Study|Death|1
7293333|NCT00553501|11511312|FG000|Overall Study|Progression|1
7293334|NCT00553514|11511321|FG000|Overall Study|Protocol deviation|0
7293335|NCT00553514|11511322|FG001|Overall Study|Protocol deviation|0
7293336|NCT00553514|11511323|FG002|Overall Study|Protocol deviation|0
7293337|NCT00553514|11511324|FG003|Overall Study|Protocol deviation|1
7293338|NCT00553514|11511325|FG004|Overall Study|Protocol deviation|0
7293339|NCT00553514|11511321|FG000|Overall Study|Lack of ovarian response|4
7293340|NCT00553514|11511322|FG001|Overall Study|Lack of ovarian response|5
7218611|NCT03203473|11427406|FG000|Arm Allocation Phase|Still on arm-B treatment|0
7218612|NCT03203473|11427407|FG001|Arm Allocation Phase|Still on arm-B treatment|0
7218613|NCT03203473|11427408|FG002|Arm Allocation Phase|Still on arm-B treatment|3
7218614|NCT03180736|11427421|FG000|Overall Study|Adverse Event|3
7218615|NCT03180736|11427422|FG001|Overall Study|Adverse Event|4
7218616|NCT03180736|11427421|FG000|Overall Study|Death|10
7218617|NCT03180736|11427422|FG001|Overall Study|Death|7
7218618|NCT03180736|11427421|FG000|Overall Study|Withdrawal by Subject|5
7218619|NCT03180736|11427422|FG001|Overall Study|Withdrawal by Subject|12
7218620|NCT03180736|11427421|FG000|Overall Study|Lost to Follow-up|1
7218621|NCT03180736|11427422|FG001|Overall Study|Lost to Follow-up|0
7218622|NCT03180736|11427421|FG000|Overall Study|Lack of Efficacy|66
7218623|NCT03180736|11427422|FG001|Overall Study|Lack of Efficacy|87
7218624|NCT03180736|11427421|FG000|Overall Study|Physician Decision|4
7218625|NCT03180736|11427422|FG001|Overall Study|Physician Decision|7
7218626|NCT03180736|11427421|FG000|Overall Study|randomized but not treated|2
7218627|NCT03180736|11427422|FG001|Overall Study|randomized but not treated|3
7218628|NCT03051659|11427435|FG000|Treatment Period|Withdrawal by Subject|0
7218629|NCT03051659|11427436|FG001|Treatment Period|Withdrawal by Subject|2
7218630|NCT03051659|11427435|FG000|Survival Follow-up|Lost to Follow-up|23
7218631|NCT03051659|11427436|FG001|Survival Follow-up|Lost to Follow-up|22
7624329|NCT01453140|12035336|FG000|Overall Study|Adverse Event|3
7218633|NCT02886884|11427467|FG000|Follow-up|Withdrawal by Subject|0
7218634|NCT02886884|11427468|FG001|Follow-up|Withdrawal by Subject|0
7218635|NCT02886884|11427469|FG002|Follow-up|Withdrawal by Subject|0
7218636|NCT02886884|11427470|FG003|Follow-up|Withdrawal by Subject|1
7218637|NCT02717832|11427498|FG000|Overall Study|Inability to place IV|3
7218638|NCT02677324|11427503|FG000|Overall Study|Disease Progression|6
7218639|NCT02677324|11427503|FG000|Overall Study|Inability to Swallow pills|1
7218640|NCT02677324|11427503|FG000|Overall Study|Non-compliance|1
7218641|NCT02677324|11427503|FG000|Overall Study|Lack of Efficacy|1
7218642|NCT02677324|11427503|FG000|Overall Study|Medical insurance coverage|1
7218643|NCT02677324|11427503|FG000|Overall Study|Adverse Event|1
7218644|NCT02677324|11427503|FG000|Overall Study|IgM Myeloma diagnosis|1
7218645|NCT02563028|11427509|FG000|Overall Study|Lack of equipment|1
7218646|NCT02563028|11427509|FG000|Overall Study|Unable to elicit VEP post induction|1
7293341|NCT00553514|11511323|FG002|Overall Study|Lack of ovarian response|5
7293342|NCT00553514|11511324|FG003|Overall Study|Lack of ovarian response|5
7293343|NCT00553514|11511325|FG004|Overall Study|Lack of ovarian response|6
7293344|NCT00553514|11511321|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
7293345|NCT00553514|11511322|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
7293346|NCT00553514|11511323|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
7293347|NCT00553514|11511324|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
7293348|NCT00553514|11511325|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
7293349|NCT00553514|11511321|FG000|Overall Study|Risk of multiple pregnancy|0
7293350|NCT00553514|11511322|FG001|Overall Study|Risk of multiple pregnancy|2
7293351|NCT00553514|11511323|FG002|Overall Study|Risk of multiple pregnancy|0
7293352|NCT00553514|11511324|FG003|Overall Study|Risk of multiple pregnancy|1
7293353|NCT00553514|11511325|FG004|Overall Study|Risk of multiple pregnancy|0
7293354|NCT00553514|11511321|FG000|Overall Study|Other|1
7293355|NCT00553514|11511322|FG001|Overall Study|Other|1
7293356|NCT00553514|11511323|FG002|Overall Study|Other|0
7293357|NCT00553514|11511324|FG003|Overall Study|Other|0
7293358|NCT00553514|11511325|FG004|Overall Study|Other|1
7293359|NCT00553540|11511339|FG000|Overall Study|discharged after first visit|2
7293360|NCT00553540|11511340|FG001|Overall Study|discharged after first visit|5
7293361|NCT00553605|11511348|FG000|Overall Study|Did not meet entrance criteria|1
7293362|NCT00553605|11511349|FG001|Overall Study|Did not meet entrance criteria|3
7293363|NCT00553605|11511348|FG000|Overall Study|Did not receive full dose|1
7293364|NCT00553605|11511349|FG001|Overall Study|Did not receive full dose|0
7293365|NCT00553605|11511348|FG000|Overall Study|Randomized but not treated|2
7293366|NCT00553605|11511349|FG001|Overall Study|Randomized but not treated|0
7293367|NCT00553631|11511357|FG000|Overall Study|Withdrawal by Subject|0
7293368|NCT00553631|11511358|FG001|Overall Study|Withdrawal by Subject|1
7293369|NCT00553631|11511357|FG000|Overall Study|Lost to Follow-up|1
7293370|NCT00553631|11511358|FG001|Overall Study|Lost to Follow-up|0
7293371|NCT00553644|11511364|FG000|Overall Study|Adverse Event|17
7293372|NCT00553644|11511364|FG000|Overall Study|Withdrawal by Subject|4
7293373|NCT00553644|11511364|FG000|Overall Study|Physician Decision|1
7293374|NCT00553644|11511364|FG000|Overall Study|Alternative therapy|6
7293375|NCT00553696|11511372|FG000|Overall Study|Adverse Event|2
7293376|NCT00553696|11511373|FG001|Overall Study|Adverse Event|4
7293377|NCT00553696|11511374|FG002|Overall Study|Adverse Event|0
7293378|NCT00553696|11511375|FG003|Overall Study|Adverse Event|1
7293379|NCT00553696|11511372|FG000|Overall Study|Global deterioration of health status|0
7293380|NCT00553696|11511373|FG001|Overall Study|Global deterioration of health status|2
7293381|NCT00553696|11511374|FG002|Overall Study|Global deterioration of health status|0
7293382|NCT00553696|11511375|FG003|Overall Study|Global deterioration of health status|0
7293383|NCT00553696|11511372|FG000|Overall Study|Objective progression or relapse|2
7293384|NCT00553696|11511373|FG001|Overall Study|Objective progression or relapse|9
7293385|NCT00553696|11511374|FG002|Overall Study|Objective progression or relapse|6
7293386|NCT00553696|11511375|FG003|Overall Study|Objective progression or relapse|0
7293387|NCT00553696|11511372|FG000|Overall Study|Withdrawal by Subject|0
7293388|NCT00553696|11511373|FG001|Overall Study|Withdrawal by Subject|1
7293389|NCT00553696|11511374|FG002|Overall Study|Withdrawal by Subject|0
7293390|NCT00553696|11511375|FG003|Overall Study|Withdrawal by Subject|0
7293391|NCT00553787|11511398|FG000|Overall Study|Adverse Event|34
7293392|NCT00553787|11511399|FG001|Overall Study|Adverse Event|21
7293393|NCT00553787|11511400|FG002|Overall Study|Adverse Event|67
7293394|NCT00553787|11511398|FG000|Overall Study|Lost to Follow-up|132
7293395|NCT00553787|11511399|FG001|Overall Study|Lost to Follow-up|44
7293396|NCT00553787|11511400|FG002|Overall Study|Lost to Follow-up|78
7293397|NCT00553787|11511398|FG000|Overall Study|Withdrawal by Subject|151
7293398|NCT00553787|11511399|FG001|Overall Study|Withdrawal by Subject|40
7293399|NCT00553787|11511400|FG002|Overall Study|Withdrawal by Subject|83
7293400|NCT00553787|11511398|FG000|Overall Study|Lack of Efficacy|31
7293401|NCT00553787|11511399|FG001|Overall Study|Lack of Efficacy|1
7293402|NCT00553787|11511400|FG002|Overall Study|Lack of Efficacy|3
7293403|NCT00553787|11511398|FG000|Overall Study|Pregnancy|0
7293404|NCT00553787|11511399|FG001|Overall Study|Pregnancy|1
7293405|NCT00553787|11511400|FG002|Overall Study|Pregnancy|2
7293406|NCT00553787|11511398|FG000|Overall Study|non compliance|4
7293407|NCT00553787|11511399|FG001|Overall Study|non compliance|0
7293408|NCT00553787|11511400|FG002|Overall Study|non compliance|11
7293409|NCT00553787|11511398|FG000|Overall Study|Requirement for restricted medication|8
7293410|NCT00553787|11511399|FG001|Overall Study|Requirement for restricted medication|7
7293411|NCT00553787|11511400|FG002|Overall Study|Requirement for restricted medication|5
7293412|NCT00553787|11511398|FG000|Overall Study|Other|18
7293413|NCT00553787|11511399|FG001|Overall Study|Other|10
7293414|NCT00553787|11511400|FG002|Overall Study|Other|13
7293415|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Adverse Event|3
7293416|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Adverse Event|5
7293417|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Adverse Event|1
7293418|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Physician Decision|3
7293419|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Physician Decision|0
7293420|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Physician Decision|0
7293421|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
7293422|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
7293423|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
7293424|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
7293425|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
7293426|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
7293427|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
7293428|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
7293429|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
7293430|NCT00554099|11511432|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7293431|NCT00554099|11511433|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
7293432|NCT00554099|11511434|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
7293433|NCT00554099|11511432|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
7293434|NCT00554099|11511433|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
7293435|NCT00554099|11511434|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
7293436|NCT00554099|11511432|FG000|Non-Treatment Phase (9 Months)|Relapse|2
7293437|NCT00554099|11511433|FG001|Non-Treatment Phase (9 Months)|Relapse|1
7293438|NCT00554099|11511434|FG002|Non-Treatment Phase (9 Months)|Relapse|1
7293439|NCT00554099|11511432|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
7293440|NCT00554099|11511433|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7293441|NCT00554099|11511434|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
7293442|NCT00554216|11511445|FG000|Overall Study|Lost to Follow-up|92
7293443|NCT00554216|11511446|FG001|Overall Study|Lost to Follow-up|31
7293444|NCT00554216|11511447|FG002|Overall Study|Lost to Follow-up|63
7293445|NCT00554216|11511445|FG000|Overall Study|Adverse Event|16
7218710|NCT02411448|11427554|FG000|Overall Study|Withdrawal by Subject|1
7218711|NCT02411448|11427555|FG001|Overall Study|Withdrawal by Subject|14
7218712|NCT02411448|11427556|FG002|Overall Study|Withdrawal by Subject|9
7218713|NCT02411448|11427554|FG000|Overall Study|Other|0
7218714|NCT02411448|11427555|FG001|Overall Study|Other|2
7218715|NCT02411448|11427556|FG002|Overall Study|Other|0
7218716|NCT02411448|11427554|FG000|Overall Study|Did not receive study treatment|0
7218717|NCT02411448|11427555|FG001|Overall Study|Did not receive study treatment|3
7218718|NCT02411448|11427556|FG002|Overall Study|Did not receive study treatment|0
7218719|NCT02411448|11427554|FG000|Overall Study|Alive on study treatment|3
7218720|NCT02411448|11427555|FG001|Overall Study|Alive on study treatment|64
7218721|NCT02411448|11427556|FG002|Overall Study|Alive on study treatment|43
7218722|NCT02371369|11427570|FG000|Part 1|Physician Decision|0
7218723|NCT02371369|11427571|FG001|Part 1|Physician Decision|3
7218724|NCT02371369|11427570|FG000|Part 1|Adverse Event|8
7293446|NCT00554216|11511446|FG001|Overall Study|Adverse Event|16
7293447|NCT00554216|11511447|FG002|Overall Study|Adverse Event|36
7293448|NCT00554216|11511445|FG000|Overall Study|Withdrawal by Subject|92
7293449|NCT00554216|11511446|FG001|Overall Study|Withdrawal by Subject|31
7293450|NCT00554216|11511447|FG002|Overall Study|Withdrawal by Subject|43
7293451|NCT00554216|11511445|FG000|Overall Study|Non compliance|10
7293452|NCT00554216|11511446|FG001|Overall Study|Non compliance|4
7293453|NCT00554216|11511447|FG002|Overall Study|Non compliance|5
7293454|NCT00554216|11511445|FG000|Overall Study|Pregnancy|2
7293455|NCT00554216|11511446|FG001|Overall Study|Pregnancy|1
7293456|NCT00554216|11511447|FG002|Overall Study|Pregnancy|14
7293457|NCT00554216|11511445|FG000|Overall Study|Restricted med|3
7293458|NCT00554216|11511446|FG001|Overall Study|Restricted med|1
7293459|NCT00554216|11511447|FG002|Overall Study|Restricted med|1
7293460|NCT00554216|11511445|FG000|Overall Study|Other|12
7293461|NCT00554216|11511446|FG001|Overall Study|Other|7
7293462|NCT00554216|11511447|FG002|Overall Study|Other|10
7293463|NCT00554216|11511445|FG000|Overall Study|Lack of Efficacy|15
7293464|NCT00554216|11511446|FG001|Overall Study|Lack of Efficacy|3
7293465|NCT00554216|11511447|FG002|Overall Study|Lack of Efficacy|0
7293466|NCT00554229|11511457|FG000|Overall Study|Lost to Follow-up|3
7293467|NCT00554229|11511458|FG001|Overall Study|Lost to Follow-up|6
7293468|NCT00554229|11511457|FG000|Overall Study|Withdrawal by Subject|29
7293469|NCT00554229|11511458|FG001|Overall Study|Withdrawal by Subject|37
7293470|NCT00554229|11511457|FG000|Overall Study|Adverse Event|71
7293471|NCT00554229|11511458|FG001|Overall Study|Adverse Event|39
7293472|NCT00554229|11511457|FG000|Overall Study|Protocol Violation|3
7293473|NCT00554229|11511458|FG001|Overall Study|Protocol Violation|3
7293474|NCT00554229|11511457|FG000|Overall Study|Reason not otherwise captured, eg; death|119
7293475|NCT00554229|11511458|FG001|Overall Study|Reason not otherwise captured, eg; death|140
7293476|NCT00554229|11511457|FG000|Overall Study|Randomised but no treatment received|1
7293477|NCT00554229|11511458|FG001|Overall Study|Randomised but no treatment received|0
7218725|NCT02371369|11427571|FG001|Part 1|Adverse Event|0
7293487|NCT00554619|11511504|FG000|Overall Study|Adverse Event|1
7293488|NCT00554619|11511504|FG000|Overall Study|Physician Decision|1
7293489|NCT00554619|11511504|FG000|Overall Study|Liver Function Test Abnormality|1
7624330|NCT01408641|12035346|FG000|Overall Study|Physician Decision|1
7624331|NCT01408641|12035347|FG001|Overall Study|Physician Decision|0
7624332|NCT00653068|12035366|FG000|Overall Study|Death|9
7624333|NCT00653068|12035366|FG000|Overall Study|Lack of Efficacy|34
7624334|NCT00653068|12035366|FG000|Overall Study|Physician Decision|4
7624335|NCT00653068|12035366|FG000|Overall Study|Withdrawal by Subject|1
7624336|NCT00653068|12035366|FG000|Overall Study|Ineligible|2
7624337|NCT00193479|12035373|FG000|Induction Chemotherapy|Adverse Event|2
7624338|NCT00193479|12035373|FG000|Induction Chemotherapy|Disease Progression|1
7624339|NCT00193479|12035373|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2
7624340|NCT00193479|12035373|FG000|Maintenance Rituximab|Withdrawal by Subject|2
7624341|NCT00085735|12035392|FG000|Overall Study|Adverse Event|1
7624342|NCT00085735|12035393|FG001|Overall Study|Adverse Event|0
7218726|NCT02371369|11427570|FG000|Part 1|Withdrawal by Subject|1
7218727|NCT02371369|11427571|FG001|Part 1|Withdrawal by Subject|6
7218728|NCT02371369|11427570|FG000|Part 1|Disease progression|0
7218729|NCT02371369|11427571|FG001|Part 1|Disease progression|1
7218730|NCT02371369|11427570|FG000|Part 1|Protocol Violation|0
7218731|NCT02371369|11427571|FG001|Part 1|Protocol Violation|1
7218732|NCT02371369|11427570|FG000|Part 2|Adverse Event|6
7218733|NCT02371369|11427571|FG001|Part 2|Adverse Event|5
7218734|NCT02371369|11427570|FG000|Part 2|Withdrawal by Subject|16
7218735|NCT02371369|11427571|FG001|Part 2|Withdrawal by Subject|6
7218736|NCT02371369|11427570|FG000|Part 2|Investigator decision|1
7218737|NCT02371369|11427571|FG001|Part 2|Investigator decision|2
7218738|NCT02371369|11427570|FG000|Part 2|Death|0
7218739|NCT02371369|11427571|FG001|Part 2|Death|1
7218740|NCT02371369|11427570|FG000|Part 2|Disease progression|1
7218741|NCT02371369|11427571|FG001|Part 2|Disease progression|0
7218742|NCT02371369|11427570|FG000|Part 2|Subject Noncompliance|1
7218743|NCT02371369|11427571|FG001|Part 2|Subject Noncompliance|0
7218744|NCT02371369|11427570|FG000|Part 2|Lost to Follow-up|1
7218745|NCT02371369|11427571|FG001|Part 2|Lost to Follow-up|1
7218746|NCT02371369|11427570|FG000|Part 2|Subject transitioned to commercial supply|6
7218747|NCT02371369|11427571|FG001|Part 2|Subject transitioned to commercial supply|4
7218748|NCT02371369|11427570|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15
7218749|NCT02371369|11427571|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9
7218750|NCT02371369|11427570|FG000|Part 2|Surgical resection of tumor|1
7218751|NCT02371369|11427571|FG001|Part 2|Surgical resection of tumor|1
7218752|NCT02371369|11427570|FG000|Part 2|Other|0
7218753|NCT02371369|11427571|FG001|Part 2|Other|1
7218754|NCT02282917|11427593|FG000|Overall Study|Withdrawal by Subject|1
7218755|NCT02282917|11427593|FG000|Overall Study|Screen Failure/Not Eligible|1
7218756|NCT01849783|11427597|FG000|Overall Study|Adverse Event|5
7218757|NCT01849783|11427597|FG000|Overall Study|Death|2
7218758|NCT01849783|11427597|FG000|Overall Study|Physician Decision|1
7218759|NCT01849783|11427597|FG000|Overall Study|Withdrawal by Subject|1
7218760|NCT01849783|11427597|FG000|Overall Study|Unable to comply|2
7218761|NCT01849783|11427597|FG000|Overall Study|Disease progression|11
7624343|NCT00085735|12035394|FG002|Overall Study|Adverse Event|0
7624344|NCT00085735|12035395|FG003|Overall Study|Adverse Event|0
7624345|NCT00085735|12035396|FG004|Overall Study|Adverse Event|0
7624346|NCT00085735|12035397|FG005|Overall Study|Adverse Event|0
7624347|NCT00085735|12035392|FG000|Overall Study|Lack of Efficacy|2
7624348|NCT00085735|12035393|FG001|Overall Study|Lack of Efficacy|4
7624349|NCT00085735|12035394|FG002|Overall Study|Lack of Efficacy|6
7624350|NCT00085735|12035395|FG003|Overall Study|Lack of Efficacy|3
7624351|NCT00085735|12035396|FG004|Overall Study|Lack of Efficacy|4
7624352|NCT00085735|12035397|FG005|Overall Study|Lack of Efficacy|3
7624353|NCT00085735|12035392|FG000|Overall Study|Lost to Follow-up|0
7624354|NCT00085735|12035393|FG001|Overall Study|Lost to Follow-up|1
7624355|NCT00085735|12035394|FG002|Overall Study|Lost to Follow-up|0
7624356|NCT00085735|12035395|FG003|Overall Study|Lost to Follow-up|0
7624357|NCT00085735|12035396|FG004|Overall Study|Lost to Follow-up|1
7624358|NCT00085735|12035397|FG005|Overall Study|Lost to Follow-up|0
7293511|NCT00554801|11511538|FG000|Overall Study|left area before completion|5
7293512|NCT00554801|11511539|FG001|Overall Study|left area before completion|0
7293513|NCT00554801|11511538|FG000|Overall Study|Withdrawal by Subject|14
7293514|NCT00554801|11511539|FG001|Overall Study|Withdrawal by Subject|0
7551364|NCT02969382|11910634|FG000|Overall Study|Death|0
7551365|NCT02969382|11910635|FG001|Overall Study|Death|1
7551366|NCT02969382|11910634|FG000|Overall Study|PROTOCOL DEVIATION|0
7551367|NCT02969382|11910635|FG001|Overall Study|PROTOCOL DEVIATION|1
7551368|NCT02969382|11910634|FG000|Overall Study|Withdrawal by Subject|14
7551369|NCT02969382|11910635|FG001|Overall Study|Withdrawal by Subject|9
7551370|NCT02969408|11910641|FG000|Overall Study|Adverse Event|2
7551371|NCT02969408|11910641|FG000|Overall Study|Withdrawal by Subject|8
7551372|NCT02969408|11910641|FG000|Overall Study|Lost to Follow-up|4
7551373|NCT02969408|11910641|FG000|Overall Study|Protocol Violation|1
7551374|NCT02969408|11910641|FG000|Overall Study|Other than specified|1
7551375|NCT02969525|11910663|FG000|Double-Blind Period|Adverse Event|0
7551376|NCT02969525|11910664|FG001|Double-Blind Period|Adverse Event|0
7551377|NCT02969525|11910665|FG002|Double-Blind Period|Adverse Event|1
7551378|NCT02969525|11910666|FG003|Double-Blind Period|Adverse Event|1
7551379|NCT02969525|11910667|FG004|Double-Blind Period|Adverse Event|0
7551380|NCT02969525|11910668|FG005|Double-Blind Period|Adverse Event|0
7551381|NCT02969525|11910669|FG006|Double-Blind Period|Adverse Event|0
7551382|NCT02969525|11910670|FG007|Double-Blind Period|Adverse Event|0
7551383|NCT02969525|11910671|FG008|Double-Blind Period|Adverse Event|0
7551384|NCT02969525|11910672|FG009|Double-Blind Period|Adverse Event|0
7551385|NCT02969525|11910673|FG010|Double-Blind Period|Adverse Event|0
7551386|NCT02969525|11910674|FG011|Double-Blind Period|Adverse Event|0
7551387|NCT02969525|11910663|FG000|Double-Blind Period|LOW EGFR|0
7551388|NCT02969525|11910664|FG001|Double-Blind Period|LOW EGFR|0
7551389|NCT02969525|11910665|FG002|Double-Blind Period|LOW EGFR|0
7551390|NCT02969525|11910666|FG003|Double-Blind Period|LOW EGFR|1
7551391|NCT02969525|11910667|FG004|Double-Blind Period|LOW EGFR|0
7551392|NCT02969525|11910668|FG005|Double-Blind Period|LOW EGFR|0
7551393|NCT02969525|11910669|FG006|Double-Blind Period|LOW EGFR|0
7551394|NCT02969525|11910670|FG007|Double-Blind Period|LOW EGFR|0
7551395|NCT02969525|11910671|FG008|Double-Blind Period|LOW EGFR|0
7551396|NCT02969525|11910672|FG009|Double-Blind Period|LOW EGFR|0
7551397|NCT02969525|11910673|FG010|Double-Blind Period|LOW EGFR|0
7551398|NCT02969525|11910674|FG011|Double-Blind Period|LOW EGFR|0
7551399|NCT02969525|11910663|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
7551400|NCT02969525|11910664|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
7551401|NCT02969525|11910665|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
7551402|NCT02969525|11910666|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
7551403|NCT02969525|11910667|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
7551404|NCT02969525|11910668|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
7551405|NCT02969525|11910669|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
7551406|NCT02969525|11910670|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
7551407|NCT02969525|11910671|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
7551408|NCT02969525|11910672|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
7551409|NCT02969525|11910673|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
7551410|NCT02969525|11910674|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
7551411|NCT02969525|11910663|FG000|Dose-Blind Period|Adverse Event|0
7551412|NCT02969525|11910664|FG001|Dose-Blind Period|Adverse Event|0
7551413|NCT02969525|11910665|FG002|Dose-Blind Period|Adverse Event|0
7551414|NCT02969525|11910666|FG003|Dose-Blind Period|Adverse Event|0
7551415|NCT02969525|11910667|FG004|Dose-Blind Period|Adverse Event|0
7551416|NCT02969525|11910668|FG005|Dose-Blind Period|Adverse Event|0
7551417|NCT02969525|11910669|FG006|Dose-Blind Period|Adverse Event|0
7551418|NCT02969525|11910670|FG007|Dose-Blind Period|Adverse Event|0
7551419|NCT02969525|11910671|FG008|Dose-Blind Period|Adverse Event|0
7551420|NCT02969525|11910672|FG009|Dose-Blind Period|Adverse Event|1
7551421|NCT02969525|11910673|FG010|Dose-Blind Period|Adverse Event|1
7551422|NCT02969525|11910674|FG011|Dose-Blind Period|Adverse Event|1
7551423|NCT02969525|11910663|FG000|Dose-Blind Period|Withdrawal by Subject|0
7551424|NCT02969525|11910664|FG001|Dose-Blind Period|Withdrawal by Subject|0
7551425|NCT02969525|11910665|FG002|Dose-Blind Period|Withdrawal by Subject|0
7551426|NCT02969525|11910666|FG003|Dose-Blind Period|Withdrawal by Subject|0
7293515|NCT00555061|11511587|FG000|Overall Study|Adverse Event|3
7293516|NCT00555061|11511587|FG000|Overall Study|Protocol Violation|1
7293517|NCT00555061|11511587|FG000|Overall Study|Lost to Follow-up|2
7293518|NCT00555061|11511587|FG000|Overall Study|Withdrawal by Subject|2
7293519|NCT00555061|11511587|FG000|Overall Study|Participant enrolled, but never treated|1
7293520|NCT00555217|11511610|FG000|Overall Study|Withdrawal by Subject|35
7293521|NCT00555217|11511611|FG001|Overall Study|Withdrawal by Subject|31
7293522|NCT00555217|11511610|FG000|Overall Study|Lost to Follow-up|19
7293523|NCT00555217|11511611|FG001|Overall Study|Lost to Follow-up|20
7293524|NCT00555217|11511610|FG000|Overall Study|close out sites|21
7293525|NCT00555217|11511611|FG001|Overall Study|close out sites|17
7293526|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Adverse Event|6
7293527|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Adverse Event|7
7293528|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Adverse Event|11
7293529|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Adverse Event|7
7293530|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Adverse Event|18
7293531|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
7293532|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
7293533|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
7293534|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
7293535|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
7293536|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Death|2
7293537|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Death|1
7293538|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Death|4
7293539|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Death|0
7293540|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Death|0
7293541|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
7293542|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
7293543|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
7293544|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
7293545|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
7293546|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Other Reason|1
7293712|NCT00556322|11511826|FG001|Overall Study|Withdrawal by Subject|7
7293547|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Other Reason|3
7293548|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Other Reason|2
7293549|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Other Reason|0
7293550|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Other Reason|0
7293551|NCT00555321|11511622|FG000|Treatment Phase up to 12-months|Never treated|2
7293552|NCT00555321|11511623|FG001|Treatment Phase up to 12-months|Never treated|3
7293553|NCT00555321|11511624|FG002|Treatment Phase up to 12-months|Never treated|1
7293554|NCT00555321|11511625|FG003|Treatment Phase up to 12-months|Never treated|0
7293555|NCT00555321|11511626|FG004|Treatment Phase up to 12-months|Never treated|4
7293556|NCT00555321|11511622|FG000|Long-term Extension Phase|Adverse Event|2
7293557|NCT00555321|11511623|FG001|Long-term Extension Phase|Adverse Event|5
7293558|NCT00555321|11511624|FG002|Long-term Extension Phase|Adverse Event|2
7293559|NCT00555321|11511625|FG003|Long-term Extension Phase|Adverse Event|1
7293560|NCT00555321|11511626|FG004|Long-term Extension Phase|Adverse Event|0
7293561|NCT00555321|11511622|FG000|Long-term Extension Phase|Withdrawal by Subject|2
7293562|NCT00555321|11511623|FG001|Long-term Extension Phase|Withdrawal by Subject|1
7293563|NCT00555321|11511624|FG002|Long-term Extension Phase|Withdrawal by Subject|2
7293564|NCT00555321|11511625|FG003|Long-term Extension Phase|Withdrawal by Subject|3
7293565|NCT00555321|11511626|FG004|Long-term Extension Phase|Withdrawal by Subject|2
7293566|NCT00555321|11511622|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
7293567|NCT00555321|11511623|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
7293568|NCT00555321|11511624|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
7293569|NCT00555321|11511625|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
7293570|NCT00555321|11511626|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
7293571|NCT00555321|11511622|FG000|Long-term Extension Phase|Death|2
7293572|NCT00555321|11511623|FG001|Long-term Extension Phase|Death|0
7293573|NCT00555321|11511624|FG002|Long-term Extension Phase|Death|0
7293574|NCT00555321|11511625|FG003|Long-term Extension Phase|Death|3
7293575|NCT00555321|11511626|FG004|Long-term Extension Phase|Death|0
7293576|NCT00555321|11511622|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
7293577|NCT00555321|11511623|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
7293578|NCT00555321|11511624|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
7293579|NCT00555321|11511625|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
7293580|NCT00555321|11511626|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
7293581|NCT00555321|11511622|FG000|Long-term Extension Phase|Other Reason|1
7293582|NCT00555321|11511623|FG001|Long-term Extension Phase|Other Reason|0
7293583|NCT00555321|11511624|FG002|Long-term Extension Phase|Other Reason|2
7293584|NCT00555321|11511625|FG003|Long-term Extension Phase|Other Reason|0
7293585|NCT00555321|11511626|FG004|Long-term Extension Phase|Other Reason|0
7293586|NCT00555425|11511655|FG000|Overall Study|Missed Medication > 1 wk|34
7293587|NCT00555425|11511656|FG001|Overall Study|Missed Medication > 1 wk|15
7293588|NCT00555425|11511655|FG000|Overall Study|Missed 3 physician management visits|1
7293589|NCT00555425|11511656|FG001|Overall Study|Missed 3 physician management visits|0
7293590|NCT00555425|11511655|FG000|Overall Study|Met criteria for protective transfer|16
7293591|NCT00555425|11511656|FG001|Overall Study|Met criteria for protective transfer|3
7293592|NCT00555425|11511655|FG000|Overall Study|Became pregnant and transferred care|0
7293593|NCT00555425|11511656|FG001|Overall Study|Became pregnant and transferred care|1
7293594|NCT00555438|11511662|FG000|10 Days Post-operative|Death|4
7293595|NCT00555438|11511662|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
7293596|NCT00555477|11511677|FG000|Overall Study|Adverse Event|0
7293597|NCT00555477|11511678|FG001|Overall Study|Adverse Event|9
7293598|NCT00555477|11511677|FG000|Overall Study|Withdrawal by Subject|1
7293599|NCT00555477|11511678|FG001|Overall Study|Withdrawal by Subject|2
7293600|NCT00555477|11511677|FG000|Overall Study|Physician Decision|1
7293601|NCT00555477|11511678|FG001|Overall Study|Physician Decision|2
7293602|NCT00555568|11511686|FG000|Overall Study|Lost to Follow-up|26
7293603|NCT00555568|11511687|FG001|Overall Study|Lost to Follow-up|16
7293604|NCT00555568|11511688|FG002|Overall Study|Lost to Follow-up|16
7293605|NCT00555620|11511706|FG000|Overall Study|Death|0
7293606|NCT00555620|11511707|FG001|Overall Study|Death|1
7293607|NCT00555620|11511708|FG002|Overall Study|Death|0
7293608|NCT00555620|11511709|FG003|Overall Study|Death|0
7293609|NCT00555620|11511710|FG004|Overall Study|Death|0
7293610|NCT00555620|11511711|FG005|Overall Study|Death|1
7293611|NCT00555620|11511706|FG000|Overall Study|Study terminated by sponsor|0
7293612|NCT00555620|11511707|FG001|Overall Study|Study terminated by sponsor|0
7293613|NCT00555620|11511708|FG002|Overall Study|Study terminated by sponsor|1
7293614|NCT00555620|11511709|FG003|Overall Study|Study terminated by sponsor|0
7293615|NCT00555620|11511710|FG004|Overall Study|Study terminated by sponsor|0
7293616|NCT00555620|11511711|FG005|Overall Study|Study terminated by sponsor|0
7293617|NCT00555620|11511706|FG000|Overall Study|Adverse Event|0
7293618|NCT00555620|11511707|FG001|Overall Study|Adverse Event|0
7293619|NCT00555620|11511708|FG002|Overall Study|Adverse Event|1
7293620|NCT00555620|11511709|FG003|Overall Study|Adverse Event|5
7293621|NCT00555620|11511710|FG004|Overall Study|Adverse Event|0
7293622|NCT00555620|11511711|FG005|Overall Study|Adverse Event|1
7293623|NCT00555620|11511706|FG000|Overall Study|Objective progression or relapse|6
7293624|NCT00555620|11511707|FG001|Overall Study|Objective progression or relapse|5
7293625|NCT00555620|11511708|FG002|Overall Study|Objective progression or relapse|12
7293626|NCT00555620|11511709|FG003|Overall Study|Objective progression or relapse|17
7293627|NCT00555620|11511710|FG004|Overall Study|Objective progression or relapse|3
7293628|NCT00555620|11511711|FG005|Overall Study|Objective progression or relapse|16
7293629|NCT00555620|11511706|FG000|Overall Study|Participant refused treatment|0
7293630|NCT00555620|11511707|FG001|Overall Study|Participant refused treatment|1
7293631|NCT00555620|11511708|FG002|Overall Study|Participant refused treatment|1
7293632|NCT00555620|11511709|FG003|Overall Study|Participant refused treatment|0
7293633|NCT00555620|11511710|FG004|Overall Study|Participant refused treatment|0
7293634|NCT00555620|11511711|FG005|Overall Study|Participant refused treatment|1
7293635|NCT00555620|11511706|FG000|Overall Study|Other|0
7293636|NCT00555620|11511707|FG001|Overall Study|Other|0
7293637|NCT00555620|11511708|FG002|Overall Study|Other|0
7293638|NCT00555620|11511709|FG003|Overall Study|Other|1
7293639|NCT00555620|11511710|FG004|Overall Study|Other|0
7293640|NCT00555620|11511711|FG005|Overall Study|Other|3
7293641|NCT00555672|11511731|FG000|Overall Study|Death|0
7293642|NCT00555672|11511732|FG001|Overall Study|Death|2
7293643|NCT00555672|11511731|FG000|Overall Study|Adverse Event|8
7293644|NCT00555672|11511732|FG001|Overall Study|Adverse Event|2
7293645|NCT00555672|11511731|FG000|Overall Study|Objective progression or relapse|11
7293646|NCT00555672|11511732|FG001|Overall Study|Objective progression or relapse|5
7293647|NCT00555672|11511731|FG000|Overall Study|Other|3
7293648|NCT00555672|11511732|FG001|Overall Study|Other|1
7293649|NCT00555672|11511731|FG000|Overall Study|Participant refused|2
7293650|NCT00555672|11511732|FG001|Overall Study|Participant refused|0
7293651|NCT00555906|11511769|FG000|Phase 1|Objective Progression or Relapse|3
7293652|NCT00555906|11511770|FG001|Phase 1|Objective Progression or Relapse|5
7293653|NCT00555906|11511771|FG002|Phase 1|Objective Progression or Relapse|3
7293654|NCT00555906|11511772|FG003|Phase 1|Objective Progression or Relapse|1
7293655|NCT00555906|11511773|FG004|Phase 1|Objective Progression or Relapse|0
7293656|NCT00555906|11511769|FG000|Phase 1|Global Deterioration of Health Status|0
7293657|NCT00555906|11511770|FG001|Phase 1|Global Deterioration of Health Status|1
7293658|NCT00555906|11511771|FG002|Phase 1|Global Deterioration of Health Status|1
7293659|NCT00555906|11511772|FG003|Phase 1|Global Deterioration of Health Status|1
7293660|NCT00555906|11511773|FG004|Phase 1|Global Deterioration of Health Status|0
7293661|NCT00555906|11511769|FG000|Phase 1|Adverse Event|0
7293662|NCT00555906|11511770|FG001|Phase 1|Adverse Event|0
7293663|NCT00555906|11511771|FG002|Phase 1|Adverse Event|3
7293664|NCT00555906|11511772|FG003|Phase 1|Adverse Event|2
7293665|NCT00555906|11511773|FG004|Phase 1|Adverse Event|0
7293666|NCT00555906|11511769|FG000|Phase 1|Withdrawal by Subject|0
7293667|NCT00555906|11511770|FG001|Phase 1|Withdrawal by Subject|0
7293668|NCT00555906|11511771|FG002|Phase 1|Withdrawal by Subject|0
7293669|NCT00555906|11511772|FG003|Phase 1|Withdrawal by Subject|1
7293670|NCT00555906|11511773|FG004|Phase 1|Withdrawal by Subject|0
7293671|NCT00555906|11511769|FG000|Phase 2|Adverse Event|0
7293672|NCT00555906|11511770|FG001|Phase 2|Adverse Event|0
7293673|NCT00555906|11511771|FG002|Phase 2|Adverse Event|0
7293674|NCT00555906|11511772|FG003|Phase 2|Adverse Event|0
7293675|NCT00555906|11511773|FG004|Phase 2|Adverse Event|4
7293676|NCT00555906|11511769|FG000|Phase 2|Global Deterioration of Health Status|0
7293677|NCT00555906|11511770|FG001|Phase 2|Global Deterioration of Health Status|0
7293678|NCT00555906|11511771|FG002|Phase 2|Global Deterioration of Health Status|0
7293679|NCT00555906|11511772|FG003|Phase 2|Global Deterioration of Health Status|0
7293680|NCT00555906|11511773|FG004|Phase 2|Global Deterioration of Health Status|2
7293681|NCT00555906|11511769|FG000|Phase 2|Objective Progression or Relapse|0
7293682|NCT00555906|11511770|FG001|Phase 2|Objective Progression or Relapse|0
7293683|NCT00555906|11511771|FG002|Phase 2|Objective Progression or Relapse|0
7293684|NCT00555906|11511772|FG003|Phase 2|Objective Progression or Relapse|0
7293685|NCT00555906|11511773|FG004|Phase 2|Objective Progression or Relapse|16
7293686|NCT00555906|11511769|FG000|Phase 2|Withdrawal by Subject|0
7293687|NCT00555906|11511770|FG001|Phase 2|Withdrawal by Subject|0
7293688|NCT00555906|11511771|FG002|Phase 2|Withdrawal by Subject|0
7293689|NCT00555906|11511772|FG003|Phase 2|Withdrawal by Subject|0
7293690|NCT00555906|11511773|FG004|Phase 2|Withdrawal by Subject|2
7293691|NCT00555906|11511769|FG000|Phase 2|Other|0
7293692|NCT00555906|11511770|FG001|Phase 2|Other|0
7293693|NCT00555906|11511771|FG002|Phase 2|Other|0
7293694|NCT00555906|11511772|FG003|Phase 2|Other|0
7293695|NCT00555906|11511773|FG004|Phase 2|Other|6
7293696|NCT00555906|11511769|FG000|Phase 2|Randomized but not Treated|0
7293697|NCT00555906|11511770|FG001|Phase 2|Randomized but not Treated|0
7293698|NCT00555906|11511771|FG002|Phase 2|Randomized but not Treated|0
7293699|NCT00555906|11511772|FG003|Phase 2|Randomized but not Treated|0
7293700|NCT00555906|11511773|FG004|Phase 2|Randomized but not Treated|2
7293701|NCT00555971|11511790|FG000|Overall Study|Adverse Event|1
7293702|NCT00555971|11511791|FG001|Overall Study|Adverse Event|1
7293703|NCT00556322|11511825|FG000|Overall Study|Insufficient therapeutic response|158
7293704|NCT00556322|11511826|FG001|Overall Study|Insufficient therapeutic response|168
7293705|NCT00556322|11511825|FG000|Overall Study|Adverse Event|7
7293706|NCT00556322|11511826|FG001|Overall Study|Adverse Event|4
7293707|NCT00556322|11511825|FG000|Overall Study|Other|4
7293708|NCT00556322|11511826|FG001|Overall Study|Other|1
7293709|NCT00556322|11511825|FG000|Overall Study|Lost to Follow-up|5
7293710|NCT00556322|11511826|FG001|Overall Study|Lost to Follow-up|3
7293711|NCT00556322|11511825|FG000|Overall Study|Withdrawal by Subject|19
7293713|NCT00556322|11511825|FG000|Overall Study|Protocol Violation|5
7293714|NCT00556322|11511826|FG001|Overall Study|Protocol Violation|1
7293715|NCT00556322|11511825|FG000|Overall Study|Ongoing at data cutoff|3
7293716|NCT00556322|11511826|FG001|Overall Study|Ongoing at data cutoff|5
7293717|NCT00556322|11511825|FG000|Overall Study|Death|20
7293718|NCT00556322|11511826|FG001|Overall Study|Death|14
7293725|NCT00556426|11511844|FG000|Overall Study|Withdrawal by Subject|3
7293726|NCT00556426|11511844|FG000|Overall Study|Death|6
7293727|NCT00556439|11511853|FG000|Study Entry to Week 12|Lack of Efficacy|5
7293728|NCT00556439|11511854|FG001|Study Entry to Week 12|Lack of Efficacy|0
7293729|NCT00556439|11511855|FG002|Study Entry to Week 12|Lack of Efficacy|6
7293730|NCT00556439|11511856|FG003|Study Entry to Week 12|Lack of Efficacy|0
7293731|NCT00556439|11511853|FG000|Study Entry to Week 12|Physician Decision|1
7293732|NCT00556439|11511854|FG001|Study Entry to Week 12|Physician Decision|0
7293733|NCT00556439|11511855|FG002|Study Entry to Week 12|Physician Decision|0
7293734|NCT00556439|11511856|FG003|Study Entry to Week 12|Physician Decision|0
7293735|NCT00556439|11511853|FG000|Study Entry to Week 12|Withdrawal by Subject|1
7293736|NCT00556439|11511854|FG001|Study Entry to Week 12|Withdrawal by Subject|0
7293737|NCT00556439|11511855|FG002|Study Entry to Week 12|Withdrawal by Subject|1
7293738|NCT00556439|11511856|FG003|Study Entry to Week 12|Withdrawal by Subject|0
7293739|NCT00556439|11511853|FG000|Study Entry to Week 12|Recurrent infection|1
7293740|NCT00556439|11511854|FG001|Study Entry to Week 12|Recurrent infection|0
7293741|NCT00556439|11511855|FG002|Study Entry to Week 12|Recurrent infection|0
7293742|NCT00556439|11511856|FG003|Study Entry to Week 12|Recurrent infection|0
7293743|NCT00556439|11511853|FG000|Study Entry to Week 12|Malignancy|0
7293744|NCT00556439|11511854|FG001|Study Entry to Week 12|Malignancy|0
7293745|NCT00556439|11511855|FG002|Study Entry to Week 12|Malignancy|1
7293746|NCT00556439|11511856|FG003|Study Entry to Week 12|Malignancy|0
7293747|NCT00556439|11511853|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
7293748|NCT00556439|11511854|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
7293749|NCT00556439|11511855|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7293750|NCT00556439|11511856|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
7293751|NCT00556439|11511853|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
7293752|NCT00556439|11511854|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
7293753|NCT00556439|11511855|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
7293754|NCT00556439|11511856|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
7293755|NCT00556439|11511853|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
7293756|NCT00556439|11511854|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
7293757|NCT00556439|11511855|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
7293758|NCT00556439|11511856|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
7293759|NCT00556439|11511853|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
7293760|NCT00556439|11511854|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
7293761|NCT00556439|11511855|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
7293762|NCT00556439|11511856|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
7293763|NCT00556673|11511925|FG000|Overall Study|Protocol deviation|3
7293764|NCT00556673|11511926|FG001|Overall Study|Protocol deviation|2
7293765|NCT00556712|11511936|FG000|Overall Study|Adverse Event|7
7293766|NCT00556712|11511937|FG001|Overall Study|Adverse Event|19
7293767|NCT00556712|11511936|FG000|Overall Study|Death|5
7293768|NCT00556712|11511937|FG001|Overall Study|Death|10
7293769|NCT00556712|11511936|FG000|Overall Study|Progressive Disease|383
7293770|NCT00556712|11511937|FG001|Overall Study|Progressive Disease|320
7293771|NCT00556712|11511936|FG000|Overall Study|Protocol Violation|3
7293772|NCT00556712|11511937|FG001|Overall Study|Protocol Violation|2
7293773|NCT00556712|11511936|FG000|Overall Study|Refused Treatment|17
7293774|NCT00556712|11511937|FG001|Overall Study|Refused Treatment|16
7293775|NCT00556712|11511936|FG000|Overall Study|Failure to Return|2
7293776|NCT00556712|11511937|FG001|Overall Study|Failure to Return|3
7293777|NCT00556712|11511936|FG000|Overall Study|Other|2
7293778|NCT00556712|11511937|FG001|Overall Study|Other|2
7293779|NCT00556712|11511936|FG000|Overall Study|Ongoing at Data Cutoff|32
7293780|NCT00556712|11511937|FG001|Overall Study|Ongoing at Data Cutoff|66
7293781|NCT00556894|11511963|FG000|Overall Study|Adverse Event|2
7293782|NCT00556894|11511964|FG001|Overall Study|Adverse Event|3
7293783|NCT00556894|11511965|FG002|Overall Study|Adverse Event|3
7293784|NCT00556894|11511963|FG000|Overall Study|Death|1
7293785|NCT00556894|11511964|FG001|Overall Study|Death|0
7293786|NCT00556894|11511965|FG002|Overall Study|Death|0
7293787|NCT00556894|11511963|FG000|Overall Study|regulatory decision in Bulgaria|10
7293788|NCT00556894|11511964|FG001|Overall Study|regulatory decision in Bulgaria|14
7293789|NCT00556894|11511965|FG002|Overall Study|regulatory decision in Bulgaria|13
7293790|NCT00556894|11511963|FG000|Overall Study|Change in therapy|2
7293791|NCT00556894|11511964|FG001|Overall Study|Change in therapy|1
7293792|NCT00556894|11511965|FG002|Overall Study|Change in therapy|2
7293793|NCT00556894|11511963|FG000|Overall Study|Withdrawal by Subject|1
7293794|NCT00556894|11511964|FG001|Overall Study|Withdrawal by Subject|1
7293795|NCT00556894|11511965|FG002|Overall Study|Withdrawal by Subject|1
7293796|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
7293797|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7293798|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
7293799|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
7293800|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7293801|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7293802|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
7293803|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
7293804|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
7293805|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7293806|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7293807|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
7293808|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Death|0
7293809|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Death|1
7293810|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Death|0
7293811|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Death|0
7293812|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7293813|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
7293814|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7293815|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
7293816|NCT00556933|11511977|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7293817|NCT00556933|11511978|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
7293818|NCT00556933|11511979|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7293819|NCT00556933|11511980|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
7293820|NCT00556933|11511977|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7293821|NCT00556933|11511978|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
7293822|NCT00556933|11511979|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7293823|NCT00556933|11511980|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
7293824|NCT00556933|11511977|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7293825|NCT00556933|11511978|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7293826|NCT00556933|11511979|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
7293827|NCT00556933|11511980|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
7293828|NCT00556933|11511977|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7293829|NCT00556933|11511978|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7293830|NCT00556933|11511979|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
7293831|NCT00556933|11511980|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
7293832|NCT00556933|11511977|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
7293833|NCT00556933|11511978|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
7293834|NCT00556933|11511979|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
7293835|NCT00556933|11511980|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
7293836|NCT00556933|11511977|FG000|CNI Withdrawal vs. Minimization|Death|0
7293837|NCT00556933|11511978|FG001|CNI Withdrawal vs. Minimization|Death|0
7293838|NCT00556933|11511979|FG002|CNI Withdrawal vs. Minimization|Death|0
7293839|NCT00556933|11511980|FG003|CNI Withdrawal vs. Minimization|Death|1
7293840|NCT00556998|11512007|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
7293841|NCT00556998|11512007|FG000|Voriconazole Intravenous (IV)|Other|4
7293842|NCT00556998|11512007|FG000|Voriconazole Oral|Adverse Event|1
7293843|NCT00556998|11512007|FG000|Voriconazole Oral|Intolerant of oral treatment|1
7293844|NCT00557076|11512017|FG000|Overall Study|Unblinding|0
7218762|NCT01737021|11427618|FG000|Overall Study|Lost to Follow-up|5
7218763|NCT01737021|11427619|FG001|Overall Study|Lost to Follow-up|3
7218764|NCT01333943|11427636|FG000|Overall Study|Known neuropathy|1
7218765|NCT01333943|11427637|FG001|Overall Study|Known neuropathy|0
7218766|NCT01090024|11427652|FG000|Period 1|Met exclusion criteria|0
7218767|NCT01090024|11427653|FG001|Period 1|Met exclusion criteria|0
7218768|NCT01090024|11427654|FG002|Period 1|Met exclusion criteria|0
7218769|NCT01090024|11427655|FG003|Period 1|Met exclusion criteria|0
7218770|NCT01090024|11427656|FG004|Period 1|Met exclusion criteria|0
7218771|NCT01090024|11427657|FG005|Period 1|Met exclusion criteria|0
7218772|NCT01090024|11427658|FG006|Period 1|Met exclusion criteria|0
7218773|NCT01090024|11427659|FG007|Period 1|Met exclusion criteria|0
7218774|NCT01090024|11427660|FG008|Period 1|Met exclusion criteria|0
7218775|NCT01090024|11427661|FG009|Period 1|Met exclusion criteria|0
7218776|NCT01090024|11427662|FG010|Period 1|Met exclusion criteria|0
7218777|NCT01090024|11427663|FG011|Period 1|Met exclusion criteria|0
7218778|NCT01090024|11427664|FG012|Period 1|Met exclusion criteria|0
7218779|NCT01090024|11427665|FG013|Period 1|Met exclusion criteria|0
7218780|NCT01090024|11427666|FG014|Period 1|Met exclusion criteria|1
7218781|NCT01090024|11427667|FG015|Period 1|Met exclusion criteria|0
7218782|NCT01090024|11427668|FG016|Period 1|Met exclusion criteria|0
7218783|NCT01090024|11427669|FG017|Period 1|Met exclusion criteria|0
7218784|NCT01090024|11427652|FG000|Period 1|Adverse Event|0
7218785|NCT01090024|11427653|FG001|Period 1|Adverse Event|0
7218786|NCT01090024|11427654|FG002|Period 1|Adverse Event|0
7218787|NCT01090024|11427655|FG003|Period 1|Adverse Event|0
7218788|NCT01090024|11427656|FG004|Period 1|Adverse Event|0
7218789|NCT01090024|11427657|FG005|Period 1|Adverse Event|0
7218790|NCT01090024|11427658|FG006|Period 1|Adverse Event|0
7218791|NCT01090024|11427659|FG007|Period 1|Adverse Event|0
7218792|NCT01090024|11427660|FG008|Period 1|Adverse Event|0
7218793|NCT01090024|11427661|FG009|Period 1|Adverse Event|1
7218794|NCT01090024|11427662|FG010|Period 1|Adverse Event|0
7218795|NCT01090024|11427663|FG011|Period 1|Adverse Event|1
7218796|NCT01090024|11427664|FG012|Period 1|Adverse Event|0
7218797|NCT01090024|11427665|FG013|Period 1|Adverse Event|0
7218798|NCT01090024|11427666|FG014|Period 1|Adverse Event|0
7218799|NCT01090024|11427667|FG015|Period 1|Adverse Event|0
7218800|NCT01090024|11427668|FG016|Period 1|Adverse Event|0
7218801|NCT01090024|11427669|FG017|Period 1|Adverse Event|1
7218802|NCT01090024|11427652|FG000|Period 1|Withdrawal by Subject|0
7218803|NCT01090024|11427653|FG001|Period 1|Withdrawal by Subject|0
7218804|NCT01090024|11427654|FG002|Period 1|Withdrawal by Subject|0
7218805|NCT01090024|11427655|FG003|Period 1|Withdrawal by Subject|1
7218806|NCT01090024|11427656|FG004|Period 1|Withdrawal by Subject|0
7218807|NCT01090024|11427657|FG005|Period 1|Withdrawal by Subject|0
7218808|NCT01090024|11427658|FG006|Period 1|Withdrawal by Subject|0
7218809|NCT01090024|11427659|FG007|Period 1|Withdrawal by Subject|0
7218810|NCT01090024|11427660|FG008|Period 1|Withdrawal by Subject|0
7218811|NCT01090024|11427661|FG009|Period 1|Withdrawal by Subject|0
7218812|NCT01090024|11427662|FG010|Period 1|Withdrawal by Subject|0
7218813|NCT01090024|11427663|FG011|Period 1|Withdrawal by Subject|0
7218814|NCT01090024|11427664|FG012|Period 1|Withdrawal by Subject|0
7218815|NCT01090024|11427665|FG013|Period 1|Withdrawal by Subject|0
7218816|NCT01090024|11427666|FG014|Period 1|Withdrawal by Subject|0
7218817|NCT01090024|11427667|FG015|Period 1|Withdrawal by Subject|0
7218818|NCT01090024|11427668|FG016|Period 1|Withdrawal by Subject|0
7218819|NCT01090024|11427669|FG017|Period 1|Withdrawal by Subject|0
7218820|NCT01090024|11427652|FG000|Period 1|Lost to Follow-up|0
7218821|NCT01090024|11427653|FG001|Period 1|Lost to Follow-up|1
7218822|NCT01090024|11427654|FG002|Period 1|Lost to Follow-up|0
7218823|NCT01090024|11427655|FG003|Period 1|Lost to Follow-up|0
7218824|NCT01090024|11427656|FG004|Period 1|Lost to Follow-up|0
7218825|NCT01090024|11427657|FG005|Period 1|Lost to Follow-up|0
7218826|NCT01090024|11427658|FG006|Period 1|Lost to Follow-up|0
7218827|NCT01090024|11427659|FG007|Period 1|Lost to Follow-up|0
7218828|NCT01090024|11427660|FG008|Period 1|Lost to Follow-up|0
7218829|NCT01090024|11427661|FG009|Period 1|Lost to Follow-up|0
7218830|NCT01090024|11427662|FG010|Period 1|Lost to Follow-up|0
7218831|NCT01090024|11427663|FG011|Period 1|Lost to Follow-up|0
7218832|NCT01090024|11427664|FG012|Period 1|Lost to Follow-up|0
7293845|NCT00557076|11512018|FG001|Overall Study|Unblinding|1
7293846|NCT00557245|11512027|FG000|Overall Study|Lost to Follow-up|7
7218833|NCT01090024|11427665|FG013|Period 1|Lost to Follow-up|0
7218834|NCT01090024|11427666|FG014|Period 1|Lost to Follow-up|0
7218835|NCT01090024|11427667|FG015|Period 1|Lost to Follow-up|0
7218836|NCT01090024|11427668|FG016|Period 1|Lost to Follow-up|0
7293847|NCT00557245|11512028|FG001|Overall Study|Lost to Follow-up|8
7293848|NCT00557245|11512029|FG002|Overall Study|Lost to Follow-up|10
7293849|NCT00557245|11512027|FG000|Overall Study|Ineligible|5
7293850|NCT00557245|11512028|FG001|Overall Study|Ineligible|4
7293851|NCT00557245|11512029|FG002|Overall Study|Ineligible|2
7293852|NCT00557310|11512049|FG000|Main Study (0 - 18 Months)|Adverse Event|4
7293853|NCT00557310|11512049|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
7293854|NCT00557310|11512049|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
7293855|NCT00557310|11512049|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
7293856|NCT00557310|11512049|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
7293857|NCT00557310|11512049|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
7293858|NCT00557323|11512053|FG000|Overall Study|Death|3
7293859|NCT00557323|11512053|FG000|Overall Study|Withdrawal by Subject|2
7293860|NCT00557323|11512053|FG000|Overall Study|Administrative change|2
7293861|NCT00557440|11512089|FG000|Treatment Period 1|Adverse Event|0
7293862|NCT00557440|11512090|FG001|Treatment Period 1|Adverse Event|0
7293863|NCT00557440|11512091|FG002|Treatment Period 1|Adverse Event|1
7293864|NCT00557466|11512105|FG000|Overall Study|Adverse Event|3
7293865|NCT00557466|11512106|FG001|Overall Study|Adverse Event|1
7293866|NCT00557466|11512107|FG002|Overall Study|Adverse Event|4
7293867|NCT00557466|11512108|FG003|Overall Study|Adverse Event|1
7293868|NCT00557466|11512109|FG004|Overall Study|Adverse Event|2
7293869|NCT00557466|11512110|FG005|Overall Study|Adverse Event|4
7293870|NCT00557466|11512105|FG000|Overall Study|Abnormal laboratory value(s)|1
7293871|NCT00557466|11512106|FG001|Overall Study|Abnormal laboratory value(s)|2
7293872|NCT00557466|11512107|FG002|Overall Study|Abnormal laboratory value(s)|0
7293873|NCT00557466|11512108|FG003|Overall Study|Abnormal laboratory value(s)|0
7293874|NCT00557466|11512109|FG004|Overall Study|Abnormal laboratory value(s)|0
7293875|NCT00557466|11512110|FG005|Overall Study|Abnormal laboratory value(s)|0
7293876|NCT00557466|11512105|FG000|Overall Study|Protocol deviation|0
7293877|NCT00557466|11512106|FG001|Overall Study|Protocol deviation|1
7293878|NCT00557466|11512107|FG002|Overall Study|Protocol deviation|0
7293879|NCT00557466|11512108|FG003|Overall Study|Protocol deviation|2
7293880|NCT00557466|11512109|FG004|Overall Study|Protocol deviation|0
7293881|NCT00557466|11512110|FG005|Overall Study|Protocol deviation|0
7293882|NCT00557466|11512105|FG000|Overall Study|Subject withdrew consent|0
7293883|NCT00557466|11512106|FG001|Overall Study|Subject withdrew consent|0
7293884|NCT00557466|11512107|FG002|Overall Study|Subject withdrew consent|0
7293885|NCT00557466|11512108|FG003|Overall Study|Subject withdrew consent|0
7293886|NCT00557466|11512109|FG004|Overall Study|Subject withdrew consent|1
7293887|NCT00557466|11512110|FG005|Overall Study|Subject withdrew consent|2
7293888|NCT00557466|11512105|FG000|Overall Study|Administrative problems|0
7293889|NCT00557466|11512106|FG001|Overall Study|Administrative problems|1
7293890|NCT00557466|11512107|FG002|Overall Study|Administrative problems|1
7293891|NCT00557466|11512108|FG003|Overall Study|Administrative problems|0
7293892|NCT00557466|11512109|FG004|Overall Study|Administrative problems|0
7293893|NCT00557466|11512110|FG005|Overall Study|Administrative problems|0
7293894|NCT00557466|11512105|FG000|Overall Study|Abnormal test procedure results|0
7293895|NCT00557466|11512106|FG001|Overall Study|Abnormal test procedure results|0
7293896|NCT00557466|11512107|FG002|Overall Study|Abnormal test procedure results|1
7293897|NCT00557466|11512108|FG003|Overall Study|Abnormal test procedure results|0
7293898|NCT00557466|11512109|FG004|Overall Study|Abnormal test procedure results|0
7293899|NCT00557466|11512110|FG005|Overall Study|Abnormal test procedure results|0
7293900|NCT00557466|11512105|FG000|Overall Study|Lost to Follow-up|0
7293901|NCT00557466|11512106|FG001|Overall Study|Lost to Follow-up|0
7293902|NCT00557466|11512107|FG002|Overall Study|Lost to Follow-up|0
7293903|NCT00557466|11512108|FG003|Overall Study|Lost to Follow-up|1
7293904|NCT00557466|11512109|FG004|Overall Study|Lost to Follow-up|0
7293905|NCT00557466|11512110|FG005|Overall Study|Lost to Follow-up|0
7218837|NCT01090024|11427669|FG017|Period 1|Lost to Follow-up|0
7218838|NCT01090024|11427652|FG000|Period 2|Lost to Follow-up|0
7218839|NCT01090024|11427653|FG001|Period 2|Lost to Follow-up|0
7218840|NCT01090024|11427654|FG002|Period 2|Lost to Follow-up|0
7218841|NCT01090024|11427655|FG003|Period 2|Lost to Follow-up|1
7218842|NCT01090024|11427656|FG004|Period 2|Lost to Follow-up|0
7218843|NCT01090024|11427657|FG005|Period 2|Lost to Follow-up|0
7218844|NCT01090024|11427658|FG006|Period 2|Lost to Follow-up|0
7218845|NCT01090024|11427659|FG007|Period 2|Lost to Follow-up|0
7218846|NCT01090024|11427660|FG008|Period 2|Lost to Follow-up|0
7218847|NCT01090024|11427661|FG009|Period 2|Lost to Follow-up|0
7218848|NCT01090024|11427662|FG010|Period 2|Lost to Follow-up|0
7218849|NCT01090024|11427663|FG011|Period 2|Lost to Follow-up|0
7218850|NCT01090024|11427664|FG012|Period 2|Lost to Follow-up|0
7218851|NCT01090024|11427665|FG013|Period 2|Lost to Follow-up|0
7293906|NCT00557492|11512124|FG000|Overall Study|Change in health insurance|1
7293907|NCT00557505|11512137|FG000|Overall Study|Death|0
7293908|NCT00557505|11512138|FG001|Overall Study|Death|0
7293909|NCT00557505|11512139|FG002|Overall Study|Death|0
7293910|NCT00557505|11512140|FG003|Overall Study|Death|0
7293911|NCT00557505|11512141|FG004|Overall Study|Death|0
7293912|NCT00557505|11512142|FG005|Overall Study|Death|0
7293913|NCT00557505|11512143|FG006|Overall Study|Death|0
7293914|NCT00557505|11512144|FG007|Overall Study|Death|0
7218852|NCT01090024|11427666|FG014|Period 2|Lost to Follow-up|0
7218853|NCT01090024|11427667|FG015|Period 2|Lost to Follow-up|0
7293915|NCT00557505|11512145|FG008|Overall Study|Death|1
7293916|NCT00557505|11512137|FG000|Overall Study|Adverse Event|0
7293917|NCT00557505|11512138|FG001|Overall Study|Adverse Event|0
7293918|NCT00557505|11512139|FG002|Overall Study|Adverse Event|1
7293919|NCT00557505|11512140|FG003|Overall Study|Adverse Event|0
7293920|NCT00557505|11512141|FG004|Overall Study|Adverse Event|0
7293921|NCT00557505|11512142|FG005|Overall Study|Adverse Event|0
7293922|NCT00557505|11512143|FG006|Overall Study|Adverse Event|1
7293923|NCT00557505|11512144|FG007|Overall Study|Adverse Event|0
7293924|NCT00557505|11512145|FG008|Overall Study|Adverse Event|0
7293925|NCT00557505|11512137|FG000|Overall Study|Global deterioration of health|1
7293926|NCT00557505|11512138|FG001|Overall Study|Global deterioration of health|0
7293927|NCT00557505|11512139|FG002|Overall Study|Global deterioration of health|0
7293928|NCT00557505|11512140|FG003|Overall Study|Global deterioration of health|0
7293929|NCT00557505|11512141|FG004|Overall Study|Global deterioration of health|0
7293930|NCT00557505|11512142|FG005|Overall Study|Global deterioration of health|0
7293931|NCT00557505|11512143|FG006|Overall Study|Global deterioration of health|0
7293932|NCT00557505|11512144|FG007|Overall Study|Global deterioration of health|0
7293933|NCT00557505|11512145|FG008|Overall Study|Global deterioration of health|0
7293934|NCT00557505|11512137|FG000|Overall Study|Objective progression or relapse|2
7293935|NCT00557505|11512138|FG001|Overall Study|Objective progression or relapse|3
7293936|NCT00557505|11512139|FG002|Overall Study|Objective progression or relapse|3
7293937|NCT00557505|11512140|FG003|Overall Study|Objective progression or relapse|2
7293938|NCT00557505|11512141|FG004|Overall Study|Objective progression or relapse|2
7293939|NCT00557505|11512142|FG005|Overall Study|Objective progression or relapse|3
7293940|NCT00557505|11512143|FG006|Overall Study|Objective progression or relapse|2
7293941|NCT00557505|11512144|FG007|Overall Study|Objective progression or relapse|5
7293942|NCT00557505|11512145|FG008|Overall Study|Objective progression or relapse|15
7293943|NCT00557505|11512137|FG000|Overall Study|Withdrawal by Subject|0
7293944|NCT00557505|11512138|FG001|Overall Study|Withdrawal by Subject|0
7293945|NCT00557505|11512139|FG002|Overall Study|Withdrawal by Subject|0
7293946|NCT00557505|11512140|FG003|Overall Study|Withdrawal by Subject|1
7218854|NCT01090024|11427668|FG016|Period 2|Lost to Follow-up|0
7218855|NCT01090024|11427669|FG017|Period 2|Lost to Follow-up|0
7218856|NCT01090024|11427652|FG000|Period 2|Adverse Event|1
7218857|NCT01090024|11427653|FG001|Period 2|Adverse Event|0
7218858|NCT01090024|11427654|FG002|Period 2|Adverse Event|0
7218859|NCT01090024|11427655|FG003|Period 2|Adverse Event|0
7218860|NCT01090024|11427656|FG004|Period 2|Adverse Event|0
7218861|NCT01090024|11427657|FG005|Period 2|Adverse Event|0
7218862|NCT01090024|11427658|FG006|Period 2|Adverse Event|0
7218863|NCT01090024|11427659|FG007|Period 2|Adverse Event|0
7218864|NCT01090024|11427660|FG008|Period 2|Adverse Event|0
7218865|NCT01090024|11427661|FG009|Period 2|Adverse Event|0
7218866|NCT01090024|11427662|FG010|Period 2|Adverse Event|0
7218867|NCT01090024|11427663|FG011|Period 2|Adverse Event|0
7218868|NCT01090024|11427664|FG012|Period 2|Adverse Event|0
7218869|NCT01090024|11427665|FG013|Period 2|Adverse Event|0
7218870|NCT01090024|11427666|FG014|Period 2|Adverse Event|0
7218871|NCT01090024|11427667|FG015|Period 2|Adverse Event|0
7218872|NCT01090024|11427668|FG016|Period 2|Adverse Event|0
7218873|NCT01090024|11427669|FG017|Period 2|Adverse Event|0
7218874|NCT01090024|11427652|FG000|Period 3|Withdrawal by Subject|0
7218875|NCT01090024|11427653|FG001|Period 3|Withdrawal by Subject|0
7218876|NCT01090024|11427654|FG002|Period 3|Withdrawal by Subject|0
7218877|NCT01090024|11427655|FG003|Period 3|Withdrawal by Subject|0
7218878|NCT01090024|11427656|FG004|Period 3|Withdrawal by Subject|0
7218879|NCT01090024|11427657|FG005|Period 3|Withdrawal by Subject|0
7218880|NCT01090024|11427658|FG006|Period 3|Withdrawal by Subject|0
7218881|NCT01090024|11427659|FG007|Period 3|Withdrawal by Subject|0
7218882|NCT01090024|11427660|FG008|Period 3|Withdrawal by Subject|0
7218883|NCT01090024|11427661|FG009|Period 3|Withdrawal by Subject|0
7218884|NCT01090024|11427662|FG010|Period 3|Withdrawal by Subject|0
7218885|NCT01090024|11427663|FG011|Period 3|Withdrawal by Subject|0
7218886|NCT01090024|11427664|FG012|Period 3|Withdrawal by Subject|0
7218887|NCT01090024|11427665|FG013|Period 3|Withdrawal by Subject|0
7218888|NCT01090024|11427666|FG014|Period 3|Withdrawal by Subject|0
7218889|NCT01090024|11427667|FG015|Period 3|Withdrawal by Subject|1
7218890|NCT01090024|11427668|FG016|Period 3|Withdrawal by Subject|0
7218891|NCT01090024|11427669|FG017|Period 3|Withdrawal by Subject|0
7218892|NCT01090024|11427652|FG000|Period 3|Protocol Violation|0
7218893|NCT01090024|11427653|FG001|Period 3|Protocol Violation|0
7218894|NCT01090024|11427654|FG002|Period 3|Protocol Violation|0
7218895|NCT01090024|11427655|FG003|Period 3|Protocol Violation|0
7218896|NCT01090024|11427656|FG004|Period 3|Protocol Violation|0
7218897|NCT01090024|11427657|FG005|Period 3|Protocol Violation|0
7218898|NCT01090024|11427658|FG006|Period 3|Protocol Violation|0
7218899|NCT01090024|11427659|FG007|Period 3|Protocol Violation|0
7218900|NCT01090024|11427660|FG008|Period 3|Protocol Violation|1
7218901|NCT01090024|11427661|FG009|Period 3|Protocol Violation|0
7218902|NCT01090024|11427662|FG010|Period 3|Protocol Violation|0
7218903|NCT01090024|11427663|FG011|Period 3|Protocol Violation|0
7218904|NCT01090024|11427664|FG012|Period 3|Protocol Violation|0
7218905|NCT01090024|11427665|FG013|Period 3|Protocol Violation|0
7218906|NCT01090024|11427666|FG014|Period 3|Protocol Violation|0
7218907|NCT01090024|11427667|FG015|Period 3|Protocol Violation|0
7293947|NCT00557505|11512141|FG004|Overall Study|Withdrawal by Subject|0
7293948|NCT00557505|11512142|FG005|Overall Study|Withdrawal by Subject|0
7293949|NCT00557505|11512143|FG006|Overall Study|Withdrawal by Subject|0
7293950|NCT00557505|11512144|FG007|Overall Study|Withdrawal by Subject|0
7293951|NCT00557505|11512145|FG008|Overall Study|Withdrawal by Subject|1
7293952|NCT00557622|11512170|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
7293953|NCT00557622|11512171|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
7293954|NCT00557622|11512170|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
7293955|NCT00557622|11512171|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
7293956|NCT00557622|11512170|FG000|12-Week Treatment Phase|Lost to Follow-up|0
7293957|NCT00557622|11512171|FG001|12-Week Treatment Phase|Lost to Follow-up|1
7293958|NCT00557830|11512180|FG000|Screening Treatment Phase|Withdrawal by Subject|1
7293959|NCT00557830|11512181|FG001|Screening Treatment Phase|Withdrawal by Subject|0
7293960|NCT00557830|11512182|FG002|Screening Treatment Phase|Withdrawal by Subject|0
7293961|NCT00557830|11512180|FG000|Screening Treatment Phase|Adverse Event|2
7293962|NCT00557830|11512181|FG001|Screening Treatment Phase|Adverse Event|0
7293963|NCT00557830|11512182|FG002|Screening Treatment Phase|Adverse Event|0
7293964|NCT00557830|11512180|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
7293965|NCT00557830|11512181|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
7293966|NCT00557830|11512182|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
7293967|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
7293968|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
7293969|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
7293970|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
7293971|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
7293972|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
7293973|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
7293974|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
7293975|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
7293976|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7293977|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293978|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
7293979|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293980|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293981|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293982|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293983|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293984|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
7293985|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
7293986|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
7293987|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
7293988|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
7293989|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
7293990|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
7293991|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
7293992|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
7293993|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
7293994|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|Other|0
7293995|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|Other|0
7293996|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|Other|1
7293997|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|Other|1
7293998|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|Other|0
7293999|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|Other|0
7294000|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|Other|0
7294001|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|Other|1
7294002|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|Other|0
7294003|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|Death|0
7294004|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|Death|0
7294005|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|Death|0
7294006|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|Death|0
7294007|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|Death|0
7294008|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|Death|1
7294009|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|Death|0
7294010|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|Death|0
7294011|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|Death|0
7294012|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294013|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294014|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294015|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294016|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294017|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
7294018|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
7294019|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294020|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
7294021|NCT00557856|11512190|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
7294022|NCT00557856|11512191|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
7294023|NCT00557856|11512192|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
7294024|NCT00557856|11512193|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
7294025|NCT00557856|11512194|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
7294026|NCT00557856|11512195|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
7294027|NCT00557856|11512196|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
7294028|NCT00557856|11512197|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
7294029|NCT00557856|11512198|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
7294030|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
7294031|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
7294032|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
7294033|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
7294034|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
7294035|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
7294036|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
7294037|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
7294038|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
7294039|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294040|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294041|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294042|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294043|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294044|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294045|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294046|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
7294047|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
7294048|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|Adverse Event|0
7294049|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|Adverse Event|0
7294050|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|Adverse Event|0
7294051|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|Adverse Event|0
7294052|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|Adverse Event|0
7294053|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|Adverse Event|0
7294054|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|Adverse Event|0
7294055|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|Adverse Event|0
7294056|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|Adverse Event|4
7294057|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|Other|0
7294058|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|Other|0
7294059|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|Other|0
7294060|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|Other|0
7294061|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|Other|0
7294062|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|Other|0
7294063|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|Other|0
7294064|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|Other|0
7294065|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|Other|1
7294066|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|Death|0
7294067|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|Death|0
7294068|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|Death|0
7294069|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|Death|0
7294070|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|Death|0
7294071|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|Death|0
7294072|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|Death|0
7294073|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|Death|0
7294074|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|Death|2
7294075|NCT00557856|11512190|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
7294076|NCT00557856|11512191|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
7294077|NCT00557856|11512192|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
7294078|NCT00557856|11512193|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
7294079|NCT00557856|11512194|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
7294080|NCT00557856|11512195|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
7294081|NCT00557856|11512196|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
7294082|NCT00557856|11512197|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
7294083|NCT00557856|11512198|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
7294084|NCT00558025|11512241|FG000|Overall Study|Adverse Event|1
7294085|NCT00558025|11512242|FG001|Overall Study|Adverse Event|1
7294086|NCT00558025|11512241|FG000|Overall Study|Withdrawal by Subject|2
7294087|NCT00558025|11512242|FG001|Overall Study|Withdrawal by Subject|2
7294088|NCT00558025|11512241|FG000|Overall Study|Protocol Violation|1
7294089|NCT00558025|11512242|FG001|Overall Study|Protocol Violation|0
7294090|NCT00558064|11512250|FG000|Overall Study|Adverse Event|3
7294091|NCT00558064|11512251|FG001|Overall Study|Adverse Event|2
7294092|NCT00558064|11512250|FG000|Overall Study|Lack of Efficacy|0
7294093|NCT00558064|11512251|FG001|Overall Study|Lack of Efficacy|1
7294094|NCT00558064|11512250|FG000|Overall Study|Protocol Violation|1
7294095|NCT00558064|11512251|FG001|Overall Study|Protocol Violation|0
7294096|NCT00558064|11512250|FG000|Overall Study|Lost to Follow-up|0
7294097|NCT00558064|11512251|FG001|Overall Study|Lost to Follow-up|1
7294098|NCT00558064|11512250|FG000|Overall Study|Withdrawal by Subject|0
7294099|NCT00558064|11512251|FG001|Overall Study|Withdrawal by Subject|1
7294100|NCT00558064|11512250|FG000|Overall Study|No visit within allowance period|1
7294101|NCT00558064|11512251|FG001|Overall Study|No visit within allowance period|0
7294102|NCT00558103|11512262|FG000|Randomized Treatment Phase|Lost to Follow-up|2
7294103|NCT00558103|11512263|FG001|Randomized Treatment Phase|Lost to Follow-up|2
7294104|NCT00558103|11512264|FG002|Randomized Treatment Phase|Lost to Follow-up|2
7294105|NCT00558103|11512265|FG003|Randomized Treatment Phase|Lost to Follow-up|1
7294106|NCT00558103|11512266|FG004|Randomized Treatment Phase|Lost to Follow-up|3
7294107|NCT00558103|11512267|FG005|Randomized Treatment Phase|Lost to Follow-up|0
7294108|NCT00558103|11512262|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
7294109|NCT00558103|11512263|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
7294110|NCT00558103|11512264|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
7294111|NCT00558103|11512265|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
7294112|NCT00558103|11512266|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
7294113|NCT00558103|11512267|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
7294114|NCT00558103|11512262|FG000|Randomized Treatment Phase|Disease Progression|1
7294115|NCT00558103|11512263|FG001|Randomized Treatment Phase|Disease Progression|0
7294116|NCT00558103|11512264|FG002|Randomized Treatment Phase|Disease Progression|1
7294117|NCT00558103|11512265|FG003|Randomized Treatment Phase|Disease Progression|0
7294118|NCT00558103|11512266|FG004|Randomized Treatment Phase|Disease Progression|0
7294119|NCT00558103|11512267|FG005|Randomized Treatment Phase|Disease Progression|0
7294120|NCT00558103|11512262|FG000|Randomized Treatment Phase|Adverse Event|0
7294121|NCT00558103|11512263|FG001|Randomized Treatment Phase|Adverse Event|0
7294122|NCT00558103|11512264|FG002|Randomized Treatment Phase|Adverse Event|0
7294123|NCT00558103|11512265|FG003|Randomized Treatment Phase|Adverse Event|1
7294124|NCT00558103|11512266|FG004|Randomized Treatment Phase|Adverse Event|1
7294125|NCT00558103|11512267|FG005|Randomized Treatment Phase|Adverse Event|0
7294126|NCT00558103|11512262|FG000|Monotherapy Extension Phase|Protocol Violation|0
7294127|NCT00558103|11512263|FG001|Monotherapy Extension Phase|Protocol Violation|0
7294128|NCT00558103|11512264|FG002|Monotherapy Extension Phase|Protocol Violation|0
7294129|NCT00558103|11512265|FG003|Monotherapy Extension Phase|Protocol Violation|0
7218916|NCT01090024|11427658|FG006|Period 3|Adverse Event|0
7294130|NCT00558103|11512266|FG004|Monotherapy Extension Phase|Protocol Violation|0
7294131|NCT00558103|11512267|FG005|Monotherapy Extension Phase|Protocol Violation|1
7294132|NCT00558103|11512262|FG000|Monotherapy Extension Phase|Disease Progression|0
7294133|NCT00558103|11512263|FG001|Monotherapy Extension Phase|Disease Progression|0
7294134|NCT00558103|11512264|FG002|Monotherapy Extension Phase|Disease Progression|0
7294135|NCT00558103|11512265|FG003|Monotherapy Extension Phase|Disease Progression|0
7294136|NCT00558103|11512266|FG004|Monotherapy Extension Phase|Disease Progression|0
7294137|NCT00558103|11512267|FG005|Monotherapy Extension Phase|Disease Progression|8
7294138|NCT00558259|11512289|FG000|Overall Study|Adverse Event|50
7294139|NCT00558259|11512290|FG001|Overall Study|Adverse Event|81
7294140|NCT00558259|11512289|FG000|Overall Study|Protocol Violation|9
7294141|NCT00558259|11512290|FG001|Overall Study|Protocol Violation|5
7294142|NCT00558259|11512289|FG000|Overall Study|Withdrawal by Subject|12
7294143|NCT00558259|11512290|FG001|Overall Study|Withdrawal by Subject|13
7294144|NCT00558272|11512298|FG000|Overall Study|Adverse Event|10
7294145|NCT00558272|11512299|FG001|Overall Study|Adverse Event|0
7294146|NCT00558272|11512298|FG000|Overall Study|Death|1
7294147|NCT00558272|11512299|FG001|Overall Study|Death|0
7294148|NCT00558272|11512298|FG000|Overall Study|Dev. of study specific discon. criteria|1
7294149|NCT00558272|11512299|FG001|Overall Study|Dev. of study specific discon. criteria|0
7294150|NCT00558272|11512298|FG000|Overall Study|AZ study team decision|0
7294151|NCT00558272|11512299|FG001|Overall Study|AZ study team decision|1
7294152|NCT00558272|11512298|FG000|Overall Study|Incorrectly enrolled|1
7294153|NCT00558272|11512299|FG001|Overall Study|Incorrectly enrolled|0
7294154|NCT00558272|11512298|FG000|Overall Study|Withdrawal by Subject|0
7294155|NCT00558272|11512299|FG001|Overall Study|Withdrawal by Subject|1
7294156|NCT00558285|11512310|FG000|Overall Study|Adverse Event|1
7294157|NCT00558285|11512311|FG001|Overall Study|Adverse Event|1
7294158|NCT00558285|11512312|FG002|Overall Study|Adverse Event|4
7294159|NCT00558285|11512313|FG003|Overall Study|Adverse Event|1
7294160|NCT00558285|11512314|FG004|Overall Study|Adverse Event|2
7294161|NCT00558285|11512310|FG000|Overall Study|Abnormal test procedure result(s)|1
7294162|NCT00558285|11512311|FG001|Overall Study|Abnormal test procedure result(s)|0
7294163|NCT00558285|11512312|FG002|Overall Study|Abnormal test procedure result(s)|0
7294164|NCT00558285|11512313|FG003|Overall Study|Abnormal test procedure result(s)|0
7294165|NCT00558285|11512314|FG004|Overall Study|Abnormal test procedure result(s)|0
7294166|NCT00558285|11512310|FG000|Overall Study|Subject withdrew consent|2
7294167|NCT00558285|11512311|FG001|Overall Study|Subject withdrew consent|0
7294168|NCT00558285|11512312|FG002|Overall Study|Subject withdrew consent|1
7294169|NCT00558285|11512313|FG003|Overall Study|Subject withdrew consent|1
7294170|NCT00558285|11512314|FG004|Overall Study|Subject withdrew consent|1
7294171|NCT00558285|11512310|FG000|Overall Study|Lost to Follow-up|1
7294172|NCT00558285|11512311|FG001|Overall Study|Lost to Follow-up|1
7294173|NCT00558285|11512312|FG002|Overall Study|Lost to Follow-up|0
7294174|NCT00558285|11512313|FG003|Overall Study|Lost to Follow-up|0
7294175|NCT00558285|11512314|FG004|Overall Study|Lost to Follow-up|0
7294176|NCT00558285|11512310|FG000|Overall Study|Administrative problems|0
7294177|NCT00558285|11512311|FG001|Overall Study|Administrative problems|0
7294178|NCT00558285|11512312|FG002|Overall Study|Administrative problems|0
7294179|NCT00558285|11512313|FG003|Overall Study|Administrative problems|1
7294180|NCT00558285|11512314|FG004|Overall Study|Administrative problems|1
7294181|NCT00558285|11512310|FG000|Overall Study|Protocol deviation|1
7294182|NCT00558285|11512311|FG001|Overall Study|Protocol deviation|1
7294183|NCT00558285|11512312|FG002|Overall Study|Protocol deviation|0
7294184|NCT00558285|11512313|FG003|Overall Study|Protocol deviation|1
7294185|NCT00558285|11512314|FG004|Overall Study|Protocol deviation|0
7294186|NCT00558363|11512328|FG000|Overall Study|Physician Decision|18
7294187|NCT00558363|11512329|FG001|Overall Study|Physician Decision|4
7294188|NCT00558363|11512328|FG000|Overall Study|Withdrawal by Subject|11
7294189|NCT00558363|11512329|FG001|Overall Study|Withdrawal by Subject|4
7294190|NCT00558363|11512328|FG000|Overall Study|Adverse Event|5
7294191|NCT00558363|11512329|FG001|Overall Study|Adverse Event|5
7294192|NCT00558363|11512328|FG000|Overall Study|Lack of Efficacy|2
7294193|NCT00558363|11512329|FG001|Overall Study|Lack of Efficacy|2
7294194|NCT00558363|11512328|FG000|Overall Study|Protocol Violation|2
7294195|NCT00558363|11512329|FG001|Overall Study|Protocol Violation|1
7294196|NCT00558363|11512328|FG000|Overall Study|Lost to Follow-up|0
7294197|NCT00558363|11512329|FG001|Overall Study|Lost to Follow-up|1
7294198|NCT00558363|11512328|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
7294199|NCT00558363|11512329|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
7294200|NCT00558363|11512328|FG000|Overall Study|Randomized in Error|1
7294201|NCT00558363|11512329|FG001|Overall Study|Randomized in Error|2
7294202|NCT00558363|11512328|FG000|Overall Study|Hospitalized; Unable to Continue|0
7294203|NCT00558363|11512329|FG001|Overall Study|Hospitalized; Unable to Continue|1
7294204|NCT00558428|11512339|FG000|Overall Study|Adverse Event|6
7294205|NCT00558428|11512340|FG001|Overall Study|Adverse Event|22
7218908|NCT01090024|11427668|FG016|Period 3|Protocol Violation|0
7218909|NCT01090024|11427669|FG017|Period 3|Protocol Violation|0
7218910|NCT01090024|11427652|FG000|Period 3|Adverse Event|0
7218911|NCT01090024|11427653|FG001|Period 3|Adverse Event|0
7218912|NCT01090024|11427654|FG002|Period 3|Adverse Event|0
7218913|NCT01090024|11427655|FG003|Period 3|Adverse Event|0
7218914|NCT01090024|11427656|FG004|Period 3|Adverse Event|0
7218915|NCT01090024|11427657|FG005|Period 3|Adverse Event|1
7218917|NCT01090024|11427659|FG007|Period 3|Adverse Event|0
7218918|NCT01090024|11427660|FG008|Period 3|Adverse Event|0
7218919|NCT01090024|11427661|FG009|Period 3|Adverse Event|0
7218920|NCT01090024|11427662|FG010|Period 3|Adverse Event|0
7218921|NCT01090024|11427663|FG011|Period 3|Adverse Event|0
7218922|NCT01090024|11427664|FG012|Period 3|Adverse Event|0
7218923|NCT01090024|11427665|FG013|Period 3|Adverse Event|0
7218924|NCT01090024|11427666|FG014|Period 3|Adverse Event|0
7218925|NCT01090024|11427667|FG015|Period 3|Adverse Event|0
7218926|NCT01090024|11427668|FG016|Period 3|Adverse Event|0
7218927|NCT01090024|11427669|FG017|Period 3|Adverse Event|0
7218928|NCT00943722|11427684|FG000|Base Study|Adverse Event|0
7218929|NCT00943722|11427685|FG001|Base Study|Adverse Event|0
7218930|NCT00943722|11427686|FG002|Base Study|Adverse Event|0
7218931|NCT00943722|11427687|FG003|Base Study|Adverse Event|1
7218932|NCT00943722|11427688|FG004|Base Study|Adverse Event|0
7218933|NCT00943722|11427689|FG005|Base Study|Adverse Event|0
7218934|NCT00943722|11427690|FG006|Base Study|Adverse Event|0
7218935|NCT00943722|11427684|FG000|Base Study|Lost to Follow-up|12
7218936|NCT00943722|11427685|FG001|Base Study|Lost to Follow-up|8
7218937|NCT00943722|11427686|FG002|Base Study|Lost to Follow-up|10
7218938|NCT00943722|11427687|FG003|Base Study|Lost to Follow-up|8
7218939|NCT00943722|11427688|FG004|Base Study|Lost to Follow-up|11
7218940|NCT00943722|11427689|FG005|Base Study|Lost to Follow-up|0
7218941|NCT00943722|11427690|FG006|Base Study|Lost to Follow-up|0
7218942|NCT00943722|11427684|FG000|Base Study|Physician Decision|1
7218943|NCT00943722|11427685|FG001|Base Study|Physician Decision|0
7218944|NCT00943722|11427686|FG002|Base Study|Physician Decision|0
7218945|NCT00943722|11427687|FG003|Base Study|Physician Decision|0
7218946|NCT00943722|11427688|FG004|Base Study|Physician Decision|1
7218947|NCT00943722|11427689|FG005|Base Study|Physician Decision|0
7218948|NCT00943722|11427690|FG006|Base Study|Physician Decision|0
7218949|NCT00943722|11427684|FG000|Base Study|Pregnancy|0
7218950|NCT00943722|11427685|FG001|Base Study|Pregnancy|0
7218951|NCT00943722|11427686|FG002|Base Study|Pregnancy|1
7218952|NCT00943722|11427687|FG003|Base Study|Pregnancy|0
7218953|NCT00943722|11427688|FG004|Base Study|Pregnancy|2
7218954|NCT00943722|11427689|FG005|Base Study|Pregnancy|0
7218955|NCT00943722|11427690|FG006|Base Study|Pregnancy|0
7218956|NCT00943722|11427684|FG000|Base Study|Protocol Violation|0
7218957|NCT00943722|11427685|FG001|Base Study|Protocol Violation|1
7218958|NCT00943722|11427686|FG002|Base Study|Protocol Violation|0
7218959|NCT00943722|11427687|FG003|Base Study|Protocol Violation|0
7218960|NCT00943722|11427688|FG004|Base Study|Protocol Violation|2
7218961|NCT00943722|11427689|FG005|Base Study|Protocol Violation|0
7218962|NCT00943722|11427690|FG006|Base Study|Protocol Violation|0
7218963|NCT00943722|11427684|FG000|Base Study|Withdrawal by Subject|12
7294206|NCT00558428|11512341|FG002|Overall Study|Adverse Event|3
7294207|NCT00558428|11512342|FG003|Overall Study|Adverse Event|4
7294208|NCT00558428|11512339|FG000|Overall Study|Lost to Follow-up|0
7294209|NCT00558428|11512340|FG001|Overall Study|Lost to Follow-up|1
7294210|NCT00558428|11512341|FG002|Overall Study|Lost to Follow-up|0
7294211|NCT00558428|11512342|FG003|Overall Study|Lost to Follow-up|0
7294212|NCT00558428|11512339|FG000|Overall Study|Lack of Efficacy|0
7294213|NCT00558428|11512340|FG001|Overall Study|Lack of Efficacy|0
7294214|NCT00558428|11512341|FG002|Overall Study|Lack of Efficacy|1
7294215|NCT00558428|11512342|FG003|Overall Study|Lack of Efficacy|2
7294216|NCT00558428|11512339|FG000|Overall Study|Non compliant with protocol|1
7294217|NCT00558428|11512340|FG001|Overall Study|Non compliant with protocol|0
7294218|NCT00558428|11512341|FG002|Overall Study|Non compliant with protocol|0
7294219|NCT00558428|11512342|FG003|Overall Study|Non compliant with protocol|3
7294220|NCT00558428|11512339|FG000|Overall Study|Consent withdrawn|2
7294221|NCT00558428|11512340|FG001|Overall Study|Consent withdrawn|1
7294222|NCT00558428|11512341|FG002|Overall Study|Consent withdrawn|0
7294223|NCT00558428|11512342|FG003|Overall Study|Consent withdrawn|1
7294224|NCT00558428|11512339|FG000|Overall Study|Other|3
7294225|NCT00558428|11512340|FG001|Overall Study|Other|0
7294226|NCT00558428|11512341|FG002|Overall Study|Other|0
7294227|NCT00558428|11512342|FG003|Overall Study|Other|1
7294228|NCT00558467|11512354|FG000|Overall Study|Adverse Event|1
7294229|NCT00558467|11512355|FG001|Overall Study|Adverse Event|2
7294230|NCT00558467|11512354|FG000|Overall Study|Lack of Efficacy|0
7294231|NCT00558467|11512355|FG001|Overall Study|Lack of Efficacy|1
7294232|NCT00558467|11512354|FG000|Overall Study|Patient moving out of state|0
7294233|NCT00558467|11512355|FG001|Overall Study|Patient moving out of state|1
7294234|NCT00558519|11512361|FG000|Overall Study|Ph+|20
7294235|NCT00558519|11512361|FG000|Overall Study|Ineligible|1
7294236|NCT00558519|11512361|FG000|Overall Study|Insufficient data|1
7294237|NCT00558519|11512361|FG000|Overall Study|Never received treatment|1
7294238|NCT00558636|11512395|FG000|Treatment|Adverse Event|9
7294239|NCT00558636|11512396|FG001|Treatment|Adverse Event|2
7294240|NCT00558636|11512395|FG000|Treatment|Withdrawal by Subject|2
7294241|NCT00558636|11512396|FG001|Treatment|Withdrawal by Subject|0
7294242|NCT00558636|11512395|FG000|Treatment|Premature termination of the study|35
7294243|NCT00558636|11512396|FG001|Treatment|Premature termination of the study|37
7294244|NCT00558636|11512395|FG000|Treatment|Disease progression|1
7294245|NCT00558636|11512396|FG001|Treatment|Disease progression|5
7294246|NCT00558636|11512395|FG000|Follow-up|Premature termination of the study|12
7294247|NCT00558636|11512396|FG001|Follow-up|Premature termination of the study|7
7294248|NCT00558701|11512404|FG000|Overall Study|Protocol Deviations|1
7294249|NCT00558701|11512405|FG001|Overall Study|Protocol Deviations|4
7294250|NCT00558753|11512413|FG000|Overall Study|Lost to Follow-up|5
7294251|NCT00558753|11512414|FG001|Overall Study|Lost to Follow-up|7
7294252|NCT00558831|11512436|FG000|Overall Study|Lost to Follow-up|1
7294253|NCT00558896|11512471|FG000|Overall Study|Adverse Event|1
7294254|NCT00558896|11512472|FG001|Overall Study|Adverse Event|1
7294255|NCT00558896|11512473|FG002|Overall Study|Adverse Event|1
7294256|NCT00558896|11512474|FG003|Overall Study|Adverse Event|3
7294257|NCT00558896|11512475|FG004|Overall Study|Adverse Event|4
7294258|NCT00558896|11512476|FG005|Overall Study|Adverse Event|10
7294259|NCT00558896|11512477|FG006|Overall Study|Adverse Event|3
7294260|NCT00558896|11512471|FG000|Overall Study|Death|3
7294261|NCT00558896|11512472|FG001|Overall Study|Death|0
7294262|NCT00558896|11512473|FG002|Overall Study|Death|2
7294263|NCT00558896|11512474|FG003|Overall Study|Death|3
7294264|NCT00558896|11512475|FG004|Overall Study|Death|2
7294265|NCT00558896|11512476|FG005|Overall Study|Death|2
7294266|NCT00558896|11512477|FG006|Overall Study|Death|6
7294267|NCT00558896|11512471|FG000|Overall Study|Withdrawal by Subject|2
7294268|NCT00558896|11512472|FG001|Overall Study|Withdrawal by Subject|1
7294269|NCT00558896|11512473|FG002|Overall Study|Withdrawal by Subject|1
7294270|NCT00558896|11512474|FG003|Overall Study|Withdrawal by Subject|1
7294271|NCT00558896|11512475|FG004|Overall Study|Withdrawal by Subject|1
7294272|NCT00558896|11512476|FG005|Overall Study|Withdrawal by Subject|5
7294273|NCT00558896|11512477|FG006|Overall Study|Withdrawal by Subject|5
7294274|NCT00558896|11512471|FG000|Overall Study|Alternative Treatment|2
7294275|NCT00558896|11512472|FG001|Overall Study|Alternative Treatment|2
7294276|NCT00558896|11512473|FG002|Overall Study|Alternative Treatment|0
7294277|NCT00558896|11512474|FG003|Overall Study|Alternative Treatment|2
7294278|NCT00558896|11512475|FG004|Overall Study|Alternative Treatment|6
7294279|NCT00558896|11512476|FG005|Overall Study|Alternative Treatment|7
7294280|NCT00558896|11512477|FG006|Overall Study|Alternative Treatment|1
7294281|NCT00558896|11512471|FG000|Overall Study|Physician discretion|3
7294282|NCT00558896|11512472|FG001|Overall Study|Physician discretion|2
7294283|NCT00558896|11512473|FG002|Overall Study|Physician discretion|1
7294284|NCT00558896|11512474|FG003|Overall Study|Physician discretion|2
7294285|NCT00558896|11512475|FG004|Overall Study|Physician discretion|1
7294286|NCT00558896|11512476|FG005|Overall Study|Physician discretion|3
7294287|NCT00558896|11512477|FG006|Overall Study|Physician discretion|3
7294288|NCT00558896|11512471|FG000|Overall Study|Continues on treatment|10
7294289|NCT00558896|11512472|FG001|Overall Study|Continues on treatment|1
7294290|NCT00558896|11512473|FG002|Overall Study|Continues on treatment|0
7294291|NCT00558896|11512474|FG003|Overall Study|Continues on treatment|1
7294292|NCT00558896|11512475|FG004|Overall Study|Continues on treatment|9
7294293|NCT00558896|11512476|FG005|Overall Study|Continues on treatment|25
7294294|NCT00558896|11512477|FG006|Overall Study|Continues on treatment|6
7294295|NCT00559104|11512499|FG000|Overall Study|Lack of Efficacy|9
7294296|NCT00559104|11512500|FG001|Overall Study|Lack of Efficacy|0
7294297|NCT00559273|11512508|FG000|Correction Period (20 Weeks)|Death|3
7294298|NCT00559273|11512509|FG001|Correction Period (20 Weeks)|Death|4
7294299|NCT00559273|11512508|FG000|Correction Period (20 Weeks)|Adverse Event|2
7294300|NCT00559273|11512509|FG001|Correction Period (20 Weeks)|Adverse Event|1
7294301|NCT00559273|11512508|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
7294302|NCT00559273|11512509|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
7294303|NCT00559273|11512508|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
7294304|NCT00559273|11512509|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
7294305|NCT00559273|11512508|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
7294306|NCT00559273|11512509|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
7294307|NCT00559273|11512508|FG000|Evaluation Period (8 Weeks)|Death|1
7294308|NCT00559273|11512509|FG001|Evaluation Period (8 Weeks)|Death|3
7294309|NCT00559273|11512508|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
7294310|NCT00559273|11512509|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
7294311|NCT00559273|11512508|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
7294312|NCT00559273|11512509|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
7294313|NCT00559273|11512508|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
7294314|NCT00559273|11512509|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
7294315|NCT00559364|11512517|FG000|Overall Study|Inclusion/exclusion criteria failure|1
7294316|NCT00559364|11512518|FG001|Overall Study|Inclusion/exclusion criteria failure|0
7294317|NCT00559377|11512524|FG000|Overall Study|Withdrawal by Subject|9
7294318|NCT00559507|11512540|FG000|Overall Study|Not treated, patient ineligible|3
7218964|NCT00943722|11427685|FG001|Base Study|Withdrawal by Subject|13
7218965|NCT00943722|11427686|FG002|Base Study|Withdrawal by Subject|2
7218966|NCT00943722|11427687|FG003|Base Study|Withdrawal by Subject|13
7218967|NCT00943722|11427688|FG004|Base Study|Withdrawal by Subject|8
7218968|NCT00943722|11427689|FG005|Base Study|Withdrawal by Subject|0
7218969|NCT00943722|11427690|FG006|Base Study|Withdrawal by Subject|0
7218970|NCT00943722|11427684|FG000|Base Study|Month 12 visit not completed|0
7218971|NCT00943722|11427685|FG001|Base Study|Month 12 visit not completed|0
7218972|NCT00943722|11427686|FG002|Base Study|Month 12 visit not completed|0
7218973|NCT00943722|11427687|FG003|Base Study|Month 12 visit not completed|0
7218974|NCT00943722|11427688|FG004|Base Study|Month 12 visit not completed|2
7218975|NCT00943722|11427689|FG005|Base Study|Month 12 visit not completed|0
7218976|NCT00943722|11427690|FG006|Base Study|Month 12 visit not completed|0
7218977|NCT00943722|11427684|FG000|First Extension Study: EXT 1|Adverse Event|0
7218978|NCT00943722|11427685|FG001|First Extension Study: EXT 1|Adverse Event|0
7218979|NCT00943722|11427686|FG002|First Extension Study: EXT 1|Adverse Event|0
7218980|NCT00943722|11427687|FG003|First Extension Study: EXT 1|Adverse Event|0
7218981|NCT00943722|11427688|FG004|First Extension Study: EXT 1|Adverse Event|0
7218982|NCT00943722|11427689|FG005|First Extension Study: EXT 1|Adverse Event|1
7218983|NCT00943722|11427690|FG006|First Extension Study: EXT 1|Adverse Event|0
7218984|NCT00943722|11427684|FG000|First Extension Study: EXT 1|Lost to Follow-up|0
7218985|NCT00943722|11427685|FG001|First Extension Study: EXT 1|Lost to Follow-up|0
7218986|NCT00943722|11427686|FG002|First Extension Study: EXT 1|Lost to Follow-up|0
7218987|NCT00943722|11427687|FG003|First Extension Study: EXT 1|Lost to Follow-up|0
7218988|NCT00943722|11427688|FG004|First Extension Study: EXT 1|Lost to Follow-up|0
7218989|NCT00943722|11427689|FG005|First Extension Study: EXT 1|Lost to Follow-up|38
7218990|NCT00943722|11427690|FG006|First Extension Study: EXT 1|Lost to Follow-up|10
7218991|NCT00943722|11427684|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0
7218992|NCT00943722|11427685|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0
7218993|NCT00943722|11427686|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0
7218994|NCT00943722|11427687|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0
7218995|NCT00943722|11427688|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0
7218996|NCT00943722|11427689|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32
7218997|NCT00943722|11427690|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10
7218998|NCT00943722|11427684|FG000|First Extension Study: EXT 1|Disposition Unknown|0
7218999|NCT00943722|11427685|FG001|First Extension Study: EXT 1|Disposition Unknown|0
7219000|NCT00943722|11427686|FG002|First Extension Study: EXT 1|Disposition Unknown|0
7219001|NCT00943722|11427687|FG003|First Extension Study: EXT 1|Disposition Unknown|0
7219002|NCT00943722|11427688|FG004|First Extension Study: EXT 1|Disposition Unknown|0
7219003|NCT00943722|11427689|FG005|First Extension Study: EXT 1|Disposition Unknown|44
7219004|NCT00943722|11427690|FG006|First Extension Study: EXT 1|Disposition Unknown|21
7219005|NCT00943722|11427684|FG000|Second Extension Study: EXT 2|Adverse Event|0
7219006|NCT00943722|11427685|FG001|Second Extension Study: EXT 2|Adverse Event|0
7219007|NCT00943722|11427686|FG002|Second Extension Study: EXT 2|Adverse Event|0
7219008|NCT00943722|11427687|FG003|Second Extension Study: EXT 2|Adverse Event|0
7219009|NCT00943722|11427688|FG004|Second Extension Study: EXT 2|Adverse Event|0
7219010|NCT00943722|11427689|FG005|Second Extension Study: EXT 2|Adverse Event|1
7219011|NCT00943722|11427690|FG006|Second Extension Study: EXT 2|Adverse Event|0
7219012|NCT00943722|11427684|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0
7294319|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Adverse Event|17
7294320|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Adverse Event|25
7294321|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
7294322|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
7294323|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
7294324|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
7294325|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
7294326|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
7294327|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Death|1
7294328|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Death|1
7294329|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
7294330|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
7294331|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
7294332|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
7294333|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
7294334|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
7294335|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Missed Doses|0
7294336|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Missed Doses|1
7294337|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
7294338|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
7294339|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
7294340|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
7294341|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
7294342|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
7294343|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
7294344|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
7294345|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
7294346|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
7294347|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Investigator Decision|0
7294348|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Investigator Decision|1
7294349|NCT00559585|11512546|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
7294350|NCT00559585|11512547|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
7294351|NCT00559585|11512546|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7294352|NCT00559585|11512547|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
7294353|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
7294354|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
7294355|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
7294356|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
7294357|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
7294358|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
7294359|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
7294360|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
7294361|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
7294362|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
7294363|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Death|20
7294364|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Death|0
7294365|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
7294366|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
7294367|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
7294368|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
7294369|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
7294370|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
7294371|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
7294372|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
7294373|NCT00559585|11512546|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
7294374|NCT00559585|11512547|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
7294375|NCT00559637|11512564|FG000|Overall Study|Adverse Event|22
7294376|NCT00559637|11512564|FG000|Overall Study|Withdrawal by Subject|4
7294377|NCT00559637|11512564|FG000|Overall Study|Protocol Violation|6
7294378|NCT00559637|11512564|FG000|Overall Study|Withdrawal criteria fulfilled|4
7294379|NCT00559637|11512564|FG000|Overall Study|Failure to return|6
7294380|NCT00559637|11512564|FG000|Overall Study|Insufficient response|3
7294381|NCT00559637|11512564|FG000|Overall Study|Started requiring dialysis after month 7|2
7294382|NCT00559637|11512564|FG000|Overall Study|Suspected lung cancer|1
7294383|NCT00559637|11512564|FG000|Overall Study|Participation in another study|1
7294384|NCT00559637|11512564|FG000|Overall Study|Delayed administration of C.E.R.A|1
7294385|NCT00559637|11512564|FG000|Overall Study|Change of center|1
7294386|NCT00559637|11512564|FG000|Overall Study|Change of home|1
7294387|NCT00559637|11512564|FG000|Overall Study|Inclusion or exclusion criteria violated|2
7294388|NCT00559754|11512568|FG000|Overall Study|Disease progression|1
7294389|NCT00559754|11512568|FG000|Overall Study|Adverse Event|5
7294390|NCT00559754|11512568|FG000|Overall Study|Protocol Violation|1
7294391|NCT00559754|11512568|FG000|Overall Study|Investigator criteria|2
7219013|NCT00943722|11427685|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0
7219014|NCT00943722|11427686|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0
7219015|NCT00943722|11427687|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0
7219016|NCT00943722|11427688|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0
7219017|NCT00943722|11427689|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111
7219018|NCT00943722|11427690|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46
7219019|NCT00943722|11427684|FG000|Second Extension Study: EXT 2|Physician Decision|0
7219020|NCT00943722|11427685|FG001|Second Extension Study: EXT 2|Physician Decision|0
7219021|NCT00943722|11427686|FG002|Second Extension Study: EXT 2|Physician Decision|0
7219022|NCT00943722|11427687|FG003|Second Extension Study: EXT 2|Physician Decision|0
7219023|NCT00943722|11427688|FG004|Second Extension Study: EXT 2|Physician Decision|0
7219024|NCT00943722|11427689|FG005|Second Extension Study: EXT 2|Physician Decision|1
7219025|NCT00943722|11427690|FG006|Second Extension Study: EXT 2|Physician Decision|3
7219026|NCT00943722|11427684|FG000|Second Extension Study: EXT 2|Pregnancy|0
7219027|NCT00943722|11427685|FG001|Second Extension Study: EXT 2|Pregnancy|0
7219028|NCT00943722|11427686|FG002|Second Extension Study: EXT 2|Pregnancy|0
7219029|NCT00943722|11427687|FG003|Second Extension Study: EXT 2|Pregnancy|0
7219030|NCT00943722|11427688|FG004|Second Extension Study: EXT 2|Pregnancy|0
7219031|NCT00943722|11427689|FG005|Second Extension Study: EXT 2|Pregnancy|1
7219032|NCT00943722|11427690|FG006|Second Extension Study: EXT 2|Pregnancy|0
7219033|NCT00943722|11427684|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0
7219034|NCT00943722|11427685|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0
7219035|NCT00943722|11427686|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0
7219036|NCT00943722|11427687|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0
7219037|NCT00943722|11427688|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0
7219038|NCT00943722|11427689|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137
7219039|NCT00943722|11427690|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50
7219040|NCT00676663|11427715|FG000|Overall Study|Death|43
7219041|NCT00676663|11427716|FG001|Overall Study|Death|27
7219042|NCT00676663|11427715|FG000|Overall Study|Withdrew Consent|1
7219043|NCT00676663|11427716|FG001|Overall Study|Withdrew Consent|8
7219044|NCT00676663|11427715|FG000|Overall Study|Lost to Follow-up|1
7219045|NCT00676663|11427716|FG001|Overall Study|Lost to Follow-up|3
7294392|NCT00559754|11512568|FG000|Overall Study|Withdrawal by Subject|2
7294393|NCT00559845|11512572|FG000|Overall Study|Withdrew Consent|1
7294394|NCT00559845|11512572|FG000|Overall Study|Disease Progression|1
7294395|NCT00559845|11512572|FG000|Overall Study|Adverse Event|3
7294396|NCT00559845|11512572|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
7294397|NCT00559845|11512572|FG000|Overall Study|Premature Surgery-Investigator Decision|1
7294398|NCT00559949|11512576|FG000|Overall Study|Progressive Disease during cycle 1|1
7294399|NCT00559949|11512576|FG000|Overall Study|Adverse Event|1
7294400|NCT00559949|11512576|FG000|Overall Study|Withdrawal by Subject|4
7294401|NCT00559949|11512576|FG000|Overall Study|No disease evaluation per protocol|1
7294402|NCT00559962|11512588|FG000|Overall Study|Adverse Event|1
7294403|NCT00559962|11512589|FG001|Overall Study|Adverse Event|7
7294404|NCT00559962|11512590|FG002|Overall Study|Adverse Event|8
7294405|NCT00559962|11512591|FG003|Overall Study|Adverse Event|5
7294406|NCT00559962|11512592|FG004|Overall Study|Adverse Event|11
7294407|NCT00559962|11512593|FG005|Overall Study|Adverse Event|4
7294408|NCT00559962|11512594|FG006|Overall Study|Adverse Event|4
7294409|NCT00559962|11512595|FG007|Overall Study|Adverse Event|2
7294410|NCT00559962|11512588|FG000|Overall Study|Lost to Follow-up|0
7294411|NCT00559962|11512589|FG001|Overall Study|Lost to Follow-up|1
7294412|NCT00559962|11512590|FG002|Overall Study|Lost to Follow-up|0
7294413|NCT00559962|11512591|FG003|Overall Study|Lost to Follow-up|0
7294414|NCT00559962|11512592|FG004|Overall Study|Lost to Follow-up|0
7294415|NCT00559962|11512593|FG005|Overall Study|Lost to Follow-up|0
7294416|NCT00559962|11512594|FG006|Overall Study|Lost to Follow-up|0
7294417|NCT00559962|11512595|FG007|Overall Study|Lost to Follow-up|0
7294418|NCT00559962|11512588|FG000|Overall Study|Withdrawal by Subject|1
7294419|NCT00559962|11512589|FG001|Overall Study|Withdrawal by Subject|1
7294420|NCT00559962|11512590|FG002|Overall Study|Withdrawal by Subject|2
7294421|NCT00559962|11512591|FG003|Overall Study|Withdrawal by Subject|0
7294422|NCT00559962|11512592|FG004|Overall Study|Withdrawal by Subject|3
7294423|NCT00559962|11512593|FG005|Overall Study|Withdrawal by Subject|1
7294424|NCT00559962|11512594|FG006|Overall Study|Withdrawal by Subject|0
7294425|NCT00559962|11512595|FG007|Overall Study|Withdrawal by Subject|2
7294426|NCT00559962|11512588|FG000|Overall Study|Inclusion/exclusion criteria not met|0
7294427|NCT00559962|11512589|FG001|Overall Study|Inclusion/exclusion criteria not met|0
7294428|NCT00559962|11512590|FG002|Overall Study|Inclusion/exclusion criteria not met|0
7294429|NCT00559962|11512591|FG003|Overall Study|Inclusion/exclusion criteria not met|0
7294430|NCT00559962|11512592|FG004|Overall Study|Inclusion/exclusion criteria not met|0
7294431|NCT00559962|11512593|FG005|Overall Study|Inclusion/exclusion criteria not met|0
7294432|NCT00559962|11512594|FG006|Overall Study|Inclusion/exclusion criteria not met|1
7294433|NCT00559962|11512595|FG007|Overall Study|Inclusion/exclusion criteria not met|0
7294434|NCT00559988|11512616|FG000|Overall Study|Death|147
7294435|NCT00559988|11512617|FG001|Overall Study|Death|140
7294436|NCT00559988|11512616|FG000|Overall Study|Withdrawal by Subject|152
7294437|NCT00559988|11512617|FG001|Overall Study|Withdrawal by Subject|139
7294438|NCT00559988|11512616|FG000|Overall Study|Lost to Follow-up|42
7294439|NCT00559988|11512617|FG001|Overall Study|Lost to Follow-up|56
7294440|NCT00559988|11512616|FG000|Overall Study|ICD device explanted|10
7294441|NCT00559988|11512617|FG001|Overall Study|ICD device explanted|17
7294442|NCT00560066|11512625|FG000|Overall Study|Death|2
7294443|NCT00560066|11512626|FG001|Overall Study|Death|1
7294444|NCT00560066|11512625|FG000|Overall Study|Withdrawal by Subject|0
7294445|NCT00560066|11512626|FG001|Overall Study|Withdrawal by Subject|3
7294446|NCT00560066|11512625|FG000|Overall Study|Lost to Follow-up|4
7294447|NCT00560066|11512626|FG001|Overall Study|Lost to Follow-up|10
7294448|NCT00560066|11512625|FG000|Overall Study|Protocol Violation|0
7294449|NCT00560066|11512626|FG001|Overall Study|Protocol Violation|1
7294450|NCT00560066|11512625|FG000|Overall Study|Administrative reason|0
7294451|NCT00560066|11512626|FG001|Overall Study|Administrative reason|5
7294452|NCT00560066|11512625|FG000|Overall Study|Missing primary reason|0
7294453|NCT00560066|11512626|FG001|Overall Study|Missing primary reason|2
7294454|NCT00560105|11512639|FG000|Overall Study|musculoskeletal chest discomfort with us|1
7294455|NCT00560105|11512640|FG001|Overall Study|musculoskeletal chest discomfort with us|2
7294456|NCT00560235|11512649|FG000|Phase 1|Discontinued|8
7294457|NCT00560235|11512650|FG001|Phase 1|Discontinued|0
7294458|NCT00560235|11512651|FG002|Phase 1|Discontinued|0
7294459|NCT00560235|11512649|FG000|Phase 1B|Discontinued|0
7294460|NCT00560235|11512650|FG001|Phase 1B|Discontinued|19
7294461|NCT00560235|11512651|FG002|Phase 1B|Discontinued|0
7294462|NCT00560235|11512649|FG000|Phase 2|Discontinued|0
7294463|NCT00560235|11512650|FG001|Phase 2|Discontinued|0
7294464|NCT00560235|11512651|FG002|Phase 2|Discontinued|96
7294465|NCT00560235|11512649|FG000|Phase 2|Ongoing at Date of Cut-Off|0
7294466|NCT00560235|11512650|FG001|Phase 2|Ongoing at Date of Cut-Off|0
7294467|NCT00560235|11512651|FG002|Phase 2|Ongoing at Date of Cut-Off|1
7294468|NCT00560313|11512669|FG000|Overall Study|Adverse Events or Death|2
7294469|NCT00560313|11512669|FG000|Overall Study|Withdrawal by Subject|2
7294470|NCT00560313|11512669|FG000|Overall Study|Lost to Follow-up|1
7294471|NCT00560313|11512669|FG000|Overall Study|Protocol Violation|1
7294472|NCT00560352|11512691|FG000|Overall Study|Adverse event unrelated to study drug|2
7294473|NCT00560352|11512692|FG001|Overall Study|Adverse event unrelated to study drug|1
7294474|NCT00560352|11512693|FG002|Overall Study|Adverse event unrelated to study drug|1
7294475|NCT00560352|11512691|FG000|Overall Study|Study drug toxicity|3
7294476|NCT00560352|11512692|FG001|Overall Study|Study drug toxicity|0
7294477|NCT00560352|11512693|FG002|Overall Study|Study drug toxicity|1
7294478|NCT00560352|11512691|FG000|Overall Study|Disease progression|0
7294479|NCT00560352|11512692|FG001|Overall Study|Disease progression|1
7294480|NCT00560352|11512693|FG002|Overall Study|Disease progression|1
7294481|NCT00560352|11512691|FG000|Overall Study|Withdrawal by Subject|1
7294482|NCT00560352|11512692|FG001|Overall Study|Withdrawal by Subject|1
7294483|NCT00560352|11512693|FG002|Overall Study|Withdrawal by Subject|1
7294484|NCT00560352|11512691|FG000|Overall Study|Maximum clinical benefit|1
7294485|NCT00560352|11512692|FG001|Overall Study|Maximum clinical benefit|0
7294486|NCT00560352|11512693|FG002|Overall Study|Maximum clinical benefit|0
7294487|NCT00560391|11512710|FG000|Overall Study|Still on treatment|0
7294488|NCT00560391|11512711|FG001|Overall Study|Still on treatment|0
7294489|NCT00560391|11512712|FG002|Overall Study|Still on treatment|0
7294490|NCT00560391|11512713|FG003|Overall Study|Still on treatment|1
7294491|NCT00560391|11512714|FG004|Overall Study|Still on treatment|2
7294492|NCT00560404|11512729|FG000|Overall Study|Adverse Event|2
7294493|NCT00560404|11512730|FG001|Overall Study|Adverse Event|3
7294494|NCT00560404|11512729|FG000|Overall Study|Death|3
7294495|NCT00560404|11512730|FG001|Overall Study|Death|3
7294496|NCT00560404|11512729|FG000|Overall Study|Protocol Violation|12
7294497|NCT00560404|11512730|FG001|Overall Study|Protocol Violation|7
7294498|NCT00560404|11512729|FG000|Overall Study|Administrative Reasons|1
7294499|NCT00560404|11512730|FG001|Overall Study|Administrative Reasons|1
7294500|NCT00560404|11512729|FG000|Overall Study|Withdrew Consent|4
7294501|NCT00560404|11512730|FG001|Overall Study|Withdrew Consent|0
7294502|NCT00560404|11512729|FG000|Overall Study|Failure to return|1
7294503|NCT00560404|11512730|FG001|Overall Study|Failure to return|2
7294504|NCT00560404|11512729|FG000|Overall Study|Other withdrawal reason|13
7294505|NCT00560404|11512730|FG001|Overall Study|Other withdrawal reason|5
7294506|NCT00560417|11512738|FG000|Overall Study|Adverse Event|3
7294507|NCT00560417|11512739|FG001|Overall Study|Adverse Event|2
7294508|NCT00560417|11512738|FG000|Overall Study|Entry Criteria Not Met|1
7294509|NCT00560417|11512739|FG001|Overall Study|Entry Criteria Not Met|0
7294510|NCT00560417|11512738|FG000|Overall Study|Lost to Follow-up|0
7294511|NCT00560417|11512739|FG001|Overall Study|Lost to Follow-up|1
7294512|NCT00560417|11512738|FG000|Overall Study|Physician Decision|2
7294513|NCT00560417|11512739|FG001|Overall Study|Physician Decision|6
7294514|NCT00560417|11512738|FG000|Overall Study|Protocol Violation|6
7294515|NCT00560417|11512739|FG001|Overall Study|Protocol Violation|5
7294516|NCT00560417|11512738|FG000|Overall Study|Sponsor Decision|2
7294517|NCT00560417|11512739|FG001|Overall Study|Sponsor Decision|0
7294518|NCT00560417|11512738|FG000|Overall Study|Withdrawal by Subject|3
7294519|NCT00560417|11512739|FG001|Overall Study|Withdrawal by Subject|3
7551427|NCT02969525|11910667|FG004|Dose-Blind Period|Withdrawal by Subject|0
7551428|NCT02969525|11910668|FG005|Dose-Blind Period|Withdrawal by Subject|0
7294520|NCT00560508|11512747|FG000|12 Week Double-blind Period|Adverse Event|3
7294521|NCT00560508|11512748|FG001|12 Week Double-blind Period|Adverse Event|2
7294522|NCT00560508|11512747|FG000|12 Week Double-blind Period|Protocol Violation|1
7294523|NCT00560508|11512748|FG001|12 Week Double-blind Period|Protocol Violation|0
7294524|NCT00560508|11512747|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
7294525|NCT00560508|11512748|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
7294526|NCT00560508|11512747|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
7294527|NCT00560508|11512748|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
7294528|NCT00560508|11512747|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7294529|NCT00560508|11512748|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
7294530|NCT00560508|11512747|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
7294531|NCT00560508|11512748|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
7294532|NCT00560508|11512747|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7294533|NCT00560508|11512748|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
7294534|NCT00560573|11512768|FG000|Overall Study|Death|4
7294535|NCT00560573|11512769|FG001|Overall Study|Death|1
7294536|NCT00560573|11512770|FG002|Overall Study|Death|4
7294537|NCT00560573|11512771|FG003|Overall Study|Death|5
7294538|NCT00560573|11512772|FG004|Overall Study|Death|1
7294539|NCT00560573|11512773|FG005|Overall Study|Death|10
7294540|NCT00560573|11512768|FG000|Overall Study|Lost to Follow-up|0
7294541|NCT00560573|11512769|FG001|Overall Study|Lost to Follow-up|0
7294542|NCT00560573|11512770|FG002|Overall Study|Lost to Follow-up|0
7294543|NCT00560573|11512771|FG003|Overall Study|Lost to Follow-up|1
7294544|NCT00560573|11512772|FG004|Overall Study|Lost to Follow-up|1
7294545|NCT00560573|11512773|FG005|Overall Study|Lost to Follow-up|0
7294546|NCT00560573|11512768|FG000|Overall Study|Withdrawal by Subject|0
7294547|NCT00560573|11512769|FG001|Overall Study|Withdrawal by Subject|0
7294548|NCT00560573|11512770|FG002|Overall Study|Withdrawal by Subject|0
7294549|NCT00560573|11512771|FG003|Overall Study|Withdrawal by Subject|1
7294550|NCT00560573|11512772|FG004|Overall Study|Withdrawal by Subject|1
7294551|NCT00560573|11512773|FG005|Overall Study|Withdrawal by Subject|0
7294552|NCT00560573|11512768|FG000|Overall Study|Other|2
7294553|NCT00560573|11512769|FG001|Overall Study|Other|2
7294554|NCT00560573|11512770|FG002|Overall Study|Other|2
7294555|NCT00560573|11512771|FG003|Overall Study|Other|3
7294556|NCT00560573|11512772|FG004|Overall Study|Other|3
7294557|NCT00560573|11512773|FG005|Overall Study|Other|3
7294558|NCT00560573|11512768|FG000|Overall Study|Enrolled, not treated|0
7294559|NCT00560573|11512769|FG001|Overall Study|Enrolled, not treated|0
7294560|NCT00560573|11512770|FG002|Overall Study|Enrolled, not treated|0
7294561|NCT00560573|11512771|FG003|Overall Study|Enrolled, not treated|0
7294562|NCT00560573|11512772|FG004|Overall Study|Enrolled, not treated|1
7294563|NCT00560573|11512773|FG005|Overall Study|Enrolled, not treated|0
7294564|NCT00560703|11512814|FG000|Overall Study|Adverse Event|0
7294565|NCT00560703|11512815|FG001|Overall Study|Adverse Event|2
7294566|NCT00560703|11512814|FG000|Overall Study|Protocol Violation|0
7294567|NCT00560703|11512815|FG001|Overall Study|Protocol Violation|2
7294568|NCT00560703|11512814|FG000|Overall Study|Withdrawal by Subject|0
7294569|NCT00560703|11512815|FG001|Overall Study|Withdrawal by Subject|1
7294570|NCT00560703|11512814|FG000|Overall Study|non-compliance|0
7294571|NCT00560703|11512815|FG001|Overall Study|non-compliance|1
7294572|NCT00560755|11512821|FG000|Overall Study|Protocol Violation|15
7294573|NCT00560755|11512821|FG000|Overall Study|Withdrawal by Subject|26
7294574|NCT00560755|11512821|FG000|Overall Study|Lost to Follow-up|9
7294575|NCT00560755|11512821|FG000|Overall Study|Adverse Event|8
7294576|NCT00560755|11512821|FG000|Overall Study|Physician Decision|2
7294577|NCT00560794|11512826|FG000|Overall Study|Adverse Event|2
7294578|NCT00560794|11512826|FG000|Overall Study|Patient was not Compliant|1
7294579|NCT00560794|11512826|FG000|Overall Study|Minimal Residual Disease Relapse|1
7294580|NCT00560794|11512826|FG000|Overall Study|Hematological Relapse|1
7294581|NCT00560794|11512826|FG000|Overall Study|Received Bone Marrow Transplant|6
7294582|NCT00560833|11512837|FG000|Overall Study|Adverse Event|16
7294583|NCT00560833|11512838|FG001|Overall Study|Adverse Event|10
7294584|NCT00560833|11512839|FG002|Overall Study|Adverse Event|25
7294585|NCT00560833|11512840|FG003|Overall Study|Adverse Event|23
7294586|NCT00560833|11512841|FG004|Overall Study|Adverse Event|35
7294587|NCT00560833|11512837|FG000|Overall Study|Lost to Follow-up|0
7219046|NCT04617860|11427737|FG000|Overall Study|Adverse Event|0
7219047|NCT04617860|11427738|FG001|Overall Study|Adverse Event|2
7219048|NCT04617860|11427739|FG002|Overall Study|Adverse Event|2
7219049|NCT04617860|11427737|FG000|Overall Study|Withdrawal by Subject|0
7219050|NCT04617860|11427738|FG001|Overall Study|Withdrawal by Subject|0
7219051|NCT04617860|11427739|FG002|Overall Study|Withdrawal by Subject|2
7219052|NCT04617860|11427737|FG000|Overall Study|Physician Decision|0
7219053|NCT04617860|11427738|FG001|Overall Study|Physician Decision|1
7219054|NCT04617860|11427739|FG002|Overall Study|Physician Decision|0
7219055|NCT04617860|11427737|FG000|Overall Study|Sponsor Decision|0
7219056|NCT04617860|11427738|FG001|Overall Study|Sponsor Decision|3
7219057|NCT04617860|11427739|FG002|Overall Study|Sponsor Decision|1
7219058|NCT04617860|11427737|FG000|Overall Study|Termination of Study by Sponsor|8
7219059|NCT04617860|11427738|FG001|Overall Study|Termination of Study by Sponsor|4
7219060|NCT04617860|11427739|FG002|Overall Study|Termination of Study by Sponsor|13
7294588|NCT00560833|11512838|FG001|Overall Study|Lost to Follow-up|0
7294589|NCT00560833|11512839|FG002|Overall Study|Lost to Follow-up|1
7294590|NCT00560833|11512840|FG003|Overall Study|Lost to Follow-up|0
7294591|NCT00560833|11512841|FG004|Overall Study|Lost to Follow-up|0
7294592|NCT00560833|11512837|FG000|Overall Study|Lack of Efficacy|22
7294593|NCT00560833|11512838|FG001|Overall Study|Lack of Efficacy|9
7294594|NCT00560833|11512839|FG002|Overall Study|Lack of Efficacy|6
7294595|NCT00560833|11512840|FG003|Overall Study|Lack of Efficacy|4
7294596|NCT00560833|11512841|FG004|Overall Study|Lack of Efficacy|4
7294597|NCT00560833|11512837|FG000|Overall Study|Participant uncooperative|5
7294598|NCT00560833|11512838|FG001|Overall Study|Participant uncooperative|5
7294599|NCT00560833|11512839|FG002|Overall Study|Participant uncooperative|4
7294600|NCT00560833|11512840|FG003|Overall Study|Participant uncooperative|4
7294601|NCT00560833|11512841|FG004|Overall Study|Participant uncooperative|2
7294602|NCT00560833|11512837|FG000|Overall Study|Other|1
7294603|NCT00560833|11512838|FG001|Overall Study|Other|1
7294604|NCT00560833|11512839|FG002|Overall Study|Other|3
7294605|NCT00560833|11512840|FG003|Overall Study|Other|0
7294606|NCT00560833|11512841|FG004|Overall Study|Other|0
7294607|NCT00560833|11512837|FG000|Overall Study|Never received drug|0
7294608|NCT00560833|11512838|FG001|Overall Study|Never received drug|1
7294609|NCT00560833|11512839|FG002|Overall Study|Never received drug|0
7294610|NCT00560833|11512840|FG003|Overall Study|Never received drug|0
7294611|NCT00560833|11512841|FG004|Overall Study|Never received drug|1
7294612|NCT00560885|11512863|FG000|Overall Study|Death|7
7294613|NCT00560885|11512863|FG000|Overall Study|Withdrawal by Subject|1
7294614|NCT00560937|11512869|FG000|Overall Study|Withdrawal by Subject|0
7294615|NCT00560937|11512870|FG001|Overall Study|Withdrawal by Subject|1
7294616|NCT00560937|11512869|FG000|Overall Study|Physician Decision|1
7294617|NCT00560937|11512870|FG001|Overall Study|Physician Decision|1
7294618|NCT00560950|11512878|FG000|Overall Study|Lost to Follow-up|1
7294619|NCT00560950|11512879|FG001|Overall Study|Lost to Follow-up|0
7294620|NCT00561015|11512902|FG000|Overall Study|Adverse Event|0
7294621|NCT00561015|11512903|FG001|Overall Study|Adverse Event|0
7294622|NCT00561015|11512904|FG002|Overall Study|Adverse Event|0
7294623|NCT00561015|11512905|FG003|Overall Study|Adverse Event|0
7294624|NCT00561015|11512906|FG004|Overall Study|Adverse Event|1
7294625|NCT00561015|11512907|FG005|Overall Study|Adverse Event|0
7294626|NCT00561015|11512902|FG000|Overall Study|Lost to Follow-up|2
7294627|NCT00561015|11512903|FG001|Overall Study|Lost to Follow-up|0
7294628|NCT00561015|11512904|FG002|Overall Study|Lost to Follow-up|0
7294629|NCT00561015|11512905|FG003|Overall Study|Lost to Follow-up|1
7294630|NCT00561015|11512906|FG004|Overall Study|Lost to Follow-up|0
7294631|NCT00561015|11512907|FG005|Overall Study|Lost to Follow-up|3
7294632|NCT00561015|11512902|FG000|Overall Study|Participant non-compliance|2
7294633|NCT00561015|11512903|FG001|Overall Study|Participant non-compliance|0
7294634|NCT00561015|11512904|FG002|Overall Study|Participant non-compliance|0
7294635|NCT00561015|11512905|FG003|Overall Study|Participant non-compliance|0
7294636|NCT00561015|11512906|FG004|Overall Study|Participant non-compliance|0
7294637|NCT00561015|11512907|FG005|Overall Study|Participant non-compliance|0
7294638|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
7294639|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
7294640|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
7294641|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
7294642|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
7294643|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
7294644|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
7294645|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
7294646|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
7294647|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
7294648|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
7294649|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
7294650|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7294651|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
7294652|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
7294653|NCT00561080|11512928|FG000|Vaccination Period (up to Month 4)|Other|0
7294654|NCT00561080|11512929|FG001|Vaccination Period (up to Month 4)|Other|2
7294655|NCT00561080|11512930|FG002|Vaccination Period (up to Month 4)|Other|1
7294656|NCT00561080|11512928|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
7294657|NCT00561080|11512929|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
7294658|NCT00561080|11512930|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
7294659|NCT00561080|11512928|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
7294660|NCT00561080|11512929|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
7294661|NCT00561080|11512930|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
7294662|NCT00561080|11512928|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
7294663|NCT00561080|11512929|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
7294664|NCT00561080|11512930|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
7294665|NCT00561080|11512928|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
7294666|NCT00561080|11512929|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7294667|NCT00561080|11512930|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
7294668|NCT00561340|11512951|FG000|Overall Study|refused to drink pediasure|6
7294669|NCT00561340|11512952|FG001|Overall Study|refused to drink pediasure|0
7294670|NCT00561353|11512968|FG000|Overall Study|Subject reached a virologic endpoint|2
7294671|NCT00561353|11512969|FG001|Overall Study|Subject reached a virologic endpoint|1
7294672|NCT00561353|11512970|FG002|Overall Study|Subject reached a virologic endpoint|1
7294673|NCT00561353|11512971|FG003|Overall Study|Subject reached a virologic endpoint|4
7294674|NCT00561353|11512972|FG004|Overall Study|Subject reached a virologic endpoint|1
7294675|NCT00561353|11512973|FG005|Overall Study|Subject reached a virologic endpoint|3
7294676|NCT00561353|11512974|FG006|Overall Study|Subject reached a virologic endpoint|4
7294677|NCT00561353|11512975|FG007|Overall Study|Subject reached a virologic endpoint|4
7294678|NCT00561353|11512976|FG008|Overall Study|Subject reached a virologic endpoint|5
7294679|NCT00561353|11512977|FG009|Overall Study|Subject reached a virologic endpoint|0
7294680|NCT00561353|11512968|FG000|Overall Study|Subject ineligible to continue the trial|0
7294681|NCT00561353|11512969|FG001|Overall Study|Subject ineligible to continue the trial|0
7294682|NCT00561353|11512970|FG002|Overall Study|Subject ineligible to continue the trial|0
7294683|NCT00561353|11512971|FG003|Overall Study|Subject ineligible to continue the trial|0
7294684|NCT00561353|11512972|FG004|Overall Study|Subject ineligible to continue the trial|0
7294685|NCT00561353|11512973|FG005|Overall Study|Subject ineligible to continue the trial|1
7294686|NCT00561353|11512974|FG006|Overall Study|Subject ineligible to continue the trial|1
7294687|NCT00561353|11512975|FG007|Overall Study|Subject ineligible to continue the trial|0
7294688|NCT00561353|11512976|FG008|Overall Study|Subject ineligible to continue the trial|2
7294689|NCT00561353|11512977|FG009|Overall Study|Subject ineligible to continue the trial|1
7294690|NCT00561353|11512968|FG000|Overall Study|Other|1
7294691|NCT00561353|11512969|FG001|Overall Study|Other|0
7294692|NCT00561353|11512970|FG002|Overall Study|Other|1
7294693|NCT00561353|11512971|FG003|Overall Study|Other|0
7294694|NCT00561353|11512972|FG004|Overall Study|Other|0
7294695|NCT00561353|11512973|FG005|Overall Study|Other|2
7294696|NCT00561353|11512974|FG006|Overall Study|Other|0
7294697|NCT00561353|11512975|FG007|Overall Study|Other|0
7294698|NCT00561353|11512976|FG008|Overall Study|Other|0
7294699|NCT00561353|11512977|FG009|Overall Study|Other|0
7294700|NCT00561353|11512968|FG000|Overall Study|Adverse Event|0
7294701|NCT00561353|11512969|FG001|Overall Study|Adverse Event|0
7294702|NCT00561353|11512970|FG002|Overall Study|Adverse Event|0
7294703|NCT00561353|11512971|FG003|Overall Study|Adverse Event|2
7294704|NCT00561353|11512972|FG004|Overall Study|Adverse Event|0
7294705|NCT00561353|11512973|FG005|Overall Study|Adverse Event|0
7294706|NCT00561353|11512974|FG006|Overall Study|Adverse Event|1
7294707|NCT00561353|11512975|FG007|Overall Study|Adverse Event|0
7294708|NCT00561353|11512976|FG008|Overall Study|Adverse Event|0
7294709|NCT00561353|11512977|FG009|Overall Study|Adverse Event|1
7294710|NCT00561353|11512968|FG000|Overall Study|Lost to Follow-up|2
7294711|NCT00561353|11512969|FG001|Overall Study|Lost to Follow-up|0
7294712|NCT00561353|11512970|FG002|Overall Study|Lost to Follow-up|1
7294713|NCT00561353|11512971|FG003|Overall Study|Lost to Follow-up|0
7294714|NCT00561353|11512972|FG004|Overall Study|Lost to Follow-up|0
7294715|NCT00561353|11512973|FG005|Overall Study|Lost to Follow-up|0
7294716|NCT00561353|11512974|FG006|Overall Study|Lost to Follow-up|0
7294717|NCT00561353|11512975|FG007|Overall Study|Lost to Follow-up|0
7294718|NCT00561353|11512976|FG008|Overall Study|Lost to Follow-up|0
7294719|NCT00561353|11512977|FG009|Overall Study|Lost to Follow-up|0
7294720|NCT00561353|11512968|FG000|Overall Study|Withdrawal by Subject|0
7294721|NCT00561353|11512969|FG001|Overall Study|Withdrawal by Subject|2
7294722|NCT00561353|11512970|FG002|Overall Study|Withdrawal by Subject|0
7294723|NCT00561353|11512971|FG003|Overall Study|Withdrawal by Subject|0
7294724|NCT00561353|11512972|FG004|Overall Study|Withdrawal by Subject|0
7294725|NCT00561353|11512973|FG005|Overall Study|Withdrawal by Subject|0
7294726|NCT00561353|11512974|FG006|Overall Study|Withdrawal by Subject|0
7294727|NCT00561353|11512975|FG007|Overall Study|Withdrawal by Subject|0
7294728|NCT00561353|11512976|FG008|Overall Study|Withdrawal by Subject|0
7294729|NCT00561353|11512977|FG009|Overall Study|Withdrawal by Subject|0
7294730|NCT00561392|11513039|FG000|Overall Study|Adverse Event|38
7294731|NCT00561392|11513039|FG000|Overall Study|Lack of Efficacy|2
7294732|NCT00561392|11513039|FG000|Overall Study|Protocol Violation|1
7294733|NCT00561392|11513039|FG000|Overall Study|Withdrawal by Subject|8
7294734|NCT00561392|11513039|FG000|Overall Study|Administrative problems|4
7294735|NCT00561470|11513062|FG000|Overall Study|Adverse Event|74
7294736|NCT00561470|11513063|FG001|Overall Study|Adverse Event|163
7294737|NCT00561470|11513062|FG000|Overall Study|Disease progression|437
7294738|NCT00561470|11513063|FG001|Overall Study|Disease progression|305
7294739|NCT00561470|11513062|FG000|Overall Study|poor compliance to protocol|4
7294740|NCT00561470|11513063|FG001|Overall Study|poor compliance to protocol|4
7294741|NCT00561470|11513062|FG000|Overall Study|Lost to Follow-up|2
7294742|NCT00561470|11513063|FG001|Overall Study|Lost to Follow-up|0
7294743|NCT00561470|11513062|FG000|Overall Study|Physician Decision|21
7294744|NCT00561470|11513063|FG001|Overall Study|Physician Decision|20
7294745|NCT00561470|11513062|FG000|Overall Study|Consent Withdrawn|2
7294746|NCT00561470|11513063|FG001|Overall Study|Consent Withdrawn|6
7294747|NCT00561470|11513062|FG000|Overall Study|Subject request|43
7294748|NCT00561470|11513063|FG001|Overall Study|Subject request|77
7294749|NCT00561470|11513062|FG000|Overall Study|Metastatic surgery|10
7294750|NCT00561470|11513063|FG001|Overall Study|Metastatic surgery|12
7294751|NCT00561470|11513062|FG000|Overall Study|Unauthorized procedure|3
7294752|NCT00561470|11513063|FG001|Overall Study|Unauthorized procedure|1
7294753|NCT00561470|11513062|FG000|Overall Study|Randomized but not treated|5
7294754|NCT00561470|11513063|FG001|Overall Study|Randomized but not treated|5
7294755|NCT00561470|11513062|FG000|Overall Study|Missed visit window|1
7294756|NCT00561470|11513063|FG001|Overall Study|Missed visit window|4
7294757|NCT00561470|11513062|FG000|Overall Study|Planning surgery|1
7294758|NCT00561470|11513063|FG001|Overall Study|Planning surgery|1
7294759|NCT00561470|11513062|FG000|Overall Study|Ongoing Treatment|11
7294760|NCT00561470|11513063|FG001|Overall Study|Ongoing Treatment|14
7294761|NCT00561574|11513073|FG000|Overall Study|Adverse Event|21
7294762|NCT00561574|11513074|FG001|Overall Study|Adverse Event|24
7294763|NCT00561574|11513073|FG000|Overall Study|Lack of Efficacy|11
7294764|NCT00561574|11513074|FG001|Overall Study|Lack of Efficacy|21
7294765|NCT00561574|11513073|FG000|Overall Study|Withdrawal by Subject|4
7294766|NCT00561574|11513074|FG001|Overall Study|Withdrawal by Subject|4
7294767|NCT00561574|11513073|FG000|Overall Study|Reason Unrelated to Trial|6
7294768|NCT00561574|11513074|FG001|Overall Study|Reason Unrelated to Trial|2
7294769|NCT00561574|11513073|FG000|Overall Study|Lost to Follow-up|1
7294770|NCT00561574|11513074|FG001|Overall Study|Lost to Follow-up|0
7294771|NCT00561574|11513073|FG000|Overall Study|Other|5
7294772|NCT00561574|11513074|FG001|Overall Study|Other|7
7294773|NCT00561652|11513093|FG000|Overall Study|Withdrawal by Subject|0
7294774|NCT00561652|11513094|FG001|Overall Study|Withdrawal by Subject|1
7294775|NCT00561678|11513102|FG000|Overall Study|Withdrawal by Subject|4
7294776|NCT00561678|11513103|FG001|Overall Study|Withdrawal by Subject|3
7294777|NCT00561678|11513102|FG000|Overall Study|surgery cancelled|1
7294778|NCT00561678|11513103|FG001|Overall Study|surgery cancelled|1
7294779|NCT00561678|11513102|FG000|Overall Study|surgery rescheduled to different site|2
7294780|NCT00561678|11513103|FG001|Overall Study|surgery rescheduled to different site|2
7294781|NCT00561678|11513102|FG000|Overall Study|anesthesia provider refusal|1
7294782|NCT00561678|11513103|FG001|Overall Study|anesthesia provider refusal|0
7294783|NCT00561730|11513109|FG000|Overall Study|Adverse Event|2
7294784|NCT00561730|11513109|FG000|Overall Study|Handling of the drug|1
7294785|NCT00561730|11513109|FG000|Overall Study|Lost to Follow-up|5
7294786|NCT00561730|11513109|FG000|Overall Study|Not specified reasons|1
7294787|NCT00561821|11513119|FG000|Overall Study|Not treated|0
7294788|NCT00561821|11513120|FG001|Overall Study|Not treated|0
7294789|NCT00561821|11513121|FG002|Overall Study|Not treated|1
7294790|NCT00561821|11513122|FG003|Overall Study|Not treated|0
7294791|NCT00561821|11513119|FG000|Overall Study|Withdrawal by Subject|0
7294792|NCT00561821|11513120|FG001|Overall Study|Withdrawal by Subject|1
7294793|NCT00561821|11513121|FG002|Overall Study|Withdrawal by Subject|0
7294794|NCT00561821|11513122|FG003|Overall Study|Withdrawal by Subject|2
7294795|NCT00561821|11513119|FG000|Overall Study|Reasons not related to trial|2
7294796|NCT00561821|11513120|FG001|Overall Study|Reasons not related to trial|1
7294797|NCT00561821|11513121|FG002|Overall Study|Reasons not related to trial|0
7294798|NCT00561821|11513122|FG003|Overall Study|Reasons not related to trial|0
7294799|NCT00561821|11513119|FG000|Overall Study|Other (reason not specified)|1
7294800|NCT00561821|11513120|FG001|Overall Study|Other (reason not specified)|1
7294801|NCT00561821|11513121|FG002|Overall Study|Other (reason not specified)|0
7294802|NCT00561821|11513122|FG003|Overall Study|Other (reason not specified)|0
7294803|NCT00561821|11513119|FG000|Overall Study|Adverse Event|2
7294804|NCT00561821|11513120|FG001|Overall Study|Adverse Event|3
7294805|NCT00561821|11513121|FG002|Overall Study|Adverse Event|1
7294806|NCT00561821|11513122|FG003|Overall Study|Adverse Event|1
7294807|NCT00561925|11513139|FG000|14 Day Lead-In Period|Adverse Event|38
7294808|NCT00561925|11513140|FG001|14 Day Lead-In Period|Adverse Event|0
7294809|NCT00561925|11513141|FG002|14 Day Lead-In Period|Adverse Event|0
7294810|NCT00561925|11513142|FG003|14 Day Lead-In Period|Adverse Event|0
7294811|NCT00561925|11513143|FG004|14 Day Lead-In Period|Adverse Event|0
7294812|NCT00561925|11513139|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
7294813|NCT00561925|11513140|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
7294814|NCT00561925|11513141|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
7294815|NCT00561925|11513142|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
7294816|NCT00561925|11513143|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
7294817|NCT00561925|11513139|FG000|14 Day Lead-In Period|Lost to Follow-up|4
7294818|NCT00561925|11513140|FG001|14 Day Lead-In Period|Lost to Follow-up|0
7294819|NCT00561925|11513141|FG002|14 Day Lead-In Period|Lost to Follow-up|0
7294820|NCT00561925|11513142|FG003|14 Day Lead-In Period|Lost to Follow-up|0
7294821|NCT00561925|11513143|FG004|14 Day Lead-In Period|Lost to Follow-up|0
7294822|NCT00561925|11513139|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
7294823|NCT00561925|11513140|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
7294824|NCT00561925|11513141|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
7294825|NCT00561925|11513142|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
7294826|NCT00561925|11513143|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
7294827|NCT00561925|11513139|FG000|14 Day Lead-In Period|Other|5
7294828|NCT00561925|11513140|FG001|14 Day Lead-In Period|Other|0
7294829|NCT00561925|11513141|FG002|14 Day Lead-In Period|Other|0
7294830|NCT00561925|11513142|FG003|14 Day Lead-In Period|Other|0
7294831|NCT00561925|11513143|FG004|14 Day Lead-In Period|Other|0
7294832|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
7294833|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
7294834|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
7294835|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
7294836|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
7294837|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
7294838|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
7294839|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
7219061|NCT04617847|11427751|FG000|Overall Study|Withdrawal by Subject|1
7219062|NCT04617847|11427752|FG001|Overall Study|Withdrawal by Subject|0
7219063|NCT04617847|11427751|FG000|Overall Study|Adverse Event|0
7219064|NCT04617847|11427752|FG001|Overall Study|Adverse Event|2
7294840|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
7294841|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
7294842|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7294843|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
7294844|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
7294845|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7294846|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
7294847|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7294848|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
7294849|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
7294850|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7294851|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
7294852|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7294853|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
7294854|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
7294855|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7294856|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
7294857|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
7294858|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
7294859|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
7294860|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
7294861|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
7294862|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Death|0
7294863|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Death|6
7294864|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Death|3
7294865|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Death|0
7294866|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Death|0
7294867|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
7294868|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
7294869|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
7294870|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
7294871|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
7294872|NCT00561925|11513139|FG000|144-week Double-blind, Double-dummy|Other|0
7294873|NCT00561925|11513140|FG001|144-week Double-blind, Double-dummy|Other|8
7294874|NCT00561925|11513141|FG002|144-week Double-blind, Double-dummy|Other|11
7294875|NCT00561925|11513142|FG003|144-week Double-blind, Double-dummy|Other|0
7294876|NCT00561925|11513143|FG004|144-week Double-blind, Double-dummy|Other|0
7294877|NCT00561925|11513139|FG000|Open-Label Extension Period|Declined entry into extension period|0
7294878|NCT00561925|11513140|FG001|Open-Label Extension Period|Declined entry into extension period|0
7294879|NCT00561925|11513141|FG002|Open-Label Extension Period|Declined entry into extension period|0
7294880|NCT00561925|11513142|FG003|Open-Label Extension Period|Declined entry into extension period|43
7294881|NCT00561925|11513143|FG004|Open-Label Extension Period|Declined entry into extension period|50
7294882|NCT00561951|11513164|FG000|Overall Study|Adverse Event|11
7294883|NCT00561951|11513165|FG001|Overall Study|Adverse Event|14
7294884|NCT00561951|11513166|FG002|Overall Study|Adverse Event|14
7294885|NCT00561951|11513164|FG000|Overall Study|Lack of Efficacy|5
7294886|NCT00561951|11513165|FG001|Overall Study|Lack of Efficacy|3
7294887|NCT00561951|11513166|FG002|Overall Study|Lack of Efficacy|2
7294888|NCT00561951|11513164|FG000|Overall Study|Lost to Follow-up|1
7294889|NCT00561951|11513165|FG001|Overall Study|Lost to Follow-up|1
7294890|NCT00561951|11513166|FG002|Overall Study|Lost to Follow-up|0
7294891|NCT00561951|11513164|FG000|Overall Study|Withdrawal by Subject|10
7294892|NCT00561951|11513165|FG001|Overall Study|Withdrawal by Subject|9
7294893|NCT00561951|11513166|FG002|Overall Study|Withdrawal by Subject|10
7294894|NCT00561951|11513164|FG000|Overall Study|Protocol Violation|4
7294895|NCT00561951|11513165|FG001|Overall Study|Protocol Violation|3
7294896|NCT00561951|11513166|FG002|Overall Study|Protocol Violation|4
7294897|NCT00561951|11513164|FG000|Overall Study|Physician Decision|1
7294898|NCT00561951|11513165|FG001|Overall Study|Physician Decision|0
7294899|NCT00561951|11513166|FG002|Overall Study|Physician Decision|0
7219065|NCT04617847|11427751|FG000|Overall Study|Death|0
7219066|NCT04617847|11427752|FG001|Overall Study|Death|1
7219067|NCT04617847|11427751|FG000|Overall Study|Termination of Study by Sponsor|2
7219068|NCT04617847|11427752|FG001|Overall Study|Termination of Study by Sponsor|21
7294900|NCT00561951|11513164|FG000|Overall Study|Pregnancy|0
7294901|NCT00561951|11513165|FG001|Overall Study|Pregnancy|1
7294902|NCT00561951|11513166|FG002|Overall Study|Pregnancy|0
7294903|NCT00561951|11513164|FG000|Overall Study|Meet Withdrawal Criterion|0
7294904|NCT00561951|11513165|FG001|Overall Study|Meet Withdrawal Criterion|1
7294905|NCT00561951|11513166|FG002|Overall Study|Meet Withdrawal Criterion|1
7294906|NCT00561951|11513164|FG000|Overall Study|Adverse Event Occured Before Treatment|1
7294907|NCT00561951|11513165|FG001|Overall Study|Adverse Event Occured Before Treatment|2
7294908|NCT00561951|11513166|FG002|Overall Study|Adverse Event Occured Before Treatment|1
7294909|NCT00561977|11513177|FG000|Overall Study|Withdrawal by Subject|0
7294910|NCT00561977|11513178|FG001|Overall Study|Withdrawal by Subject|2
7294911|NCT00561977|11513179|FG002|Overall Study|Withdrawal by Subject|1
7294912|NCT00561977|11513177|FG000|Overall Study|Pregnancy|0
7294913|NCT00561977|11513178|FG001|Overall Study|Pregnancy|1
7294914|NCT00561977|11513179|FG002|Overall Study|Pregnancy|1
7294915|NCT00562094|11513187|FG000|Overall Study|Lost to Follow-up|62
7294916|NCT00562120|11513195|FG000|First Intervention Period|Adverse Event|1
7294917|NCT00562120|11513196|FG001|First Intervention Period|Adverse Event|0
7294918|NCT00562120|11513197|FG002|First Intervention Period|Adverse Event|0
7294919|NCT00562120|11513198|FG003|First Intervention Period|Adverse Event|0
7294920|NCT00562120|11513195|FG000|First Intervention Period|Randomized but not Treated|1
7294921|NCT00562120|11513196|FG001|First Intervention Period|Randomized but not Treated|0
7294922|NCT00562120|11513197|FG002|First Intervention Period|Randomized but not Treated|0
7294923|NCT00562120|11513198|FG003|First Intervention Period|Randomized but not Treated|0
7294924|NCT00562159|11513210|FG000|Overall Study|Adverse Event|11
7294925|NCT00562159|11513211|FG001|Overall Study|Adverse Event|8
7294926|NCT00562159|11513210|FG000|Overall Study|Lost to Follow-up|5
7294927|NCT00562159|11513211|FG001|Overall Study|Lost to Follow-up|4
7294928|NCT00562159|11513210|FG000|Overall Study|Withdrawal by Subject|9
7294929|NCT00562159|11513211|FG001|Overall Study|Withdrawal by Subject|8
7294930|NCT00562159|11513210|FG000|Overall Study|Protocol Violation|12
7294931|NCT00562159|11513211|FG001|Overall Study|Protocol Violation|12
7294932|NCT00562159|11513210|FG000|Overall Study|Did not meet protocol eligibility|1
7294933|NCT00562159|11513211|FG001|Overall Study|Did not meet protocol eligibility|1
7294934|NCT00562302|11513220|FG000|Overall Study|Lost to Follow-up|3
7294935|NCT00562302|11513221|FG001|Overall Study|Lost to Follow-up|3
7294936|NCT00562302|11513220|FG000|Overall Study|Adverse Event|0
7294937|NCT00562302|11513221|FG001|Overall Study|Adverse Event|6
7294938|NCT00562302|11513220|FG000|Overall Study|Non-compliance|1
7294939|NCT00562302|11513221|FG001|Overall Study|Non-compliance|2
7294940|NCT00562302|11513220|FG000|Overall Study|Withdrawal by Subject|7
7294941|NCT00562302|11513221|FG001|Overall Study|Withdrawal by Subject|8
7294942|NCT00562302|11513220|FG000|Overall Study|Death|1
7294943|NCT00562302|11513221|FG001|Overall Study|Death|2
7294944|NCT00562302|11513220|FG000|Overall Study|Lung resection prior to study completion|7
7294945|NCT00562302|11513221|FG001|Overall Study|Lung resection prior to study completion|7
7294946|NCT00562302|11513220|FG000|Overall Study|Not stated|1
7294947|NCT00562302|11513221|FG001|Overall Study|Not stated|4
7294948|NCT00562354|11513239|FG000|Overall Study|Physician Decision|0
7294949|NCT00562354|11513240|FG001|Overall Study|Physician Decision|1
7294950|NCT00562354|11513239|FG000|Overall Study|Lost to Follow-up|0
7294951|NCT00562354|11513240|FG001|Overall Study|Lost to Follow-up|1
7294952|NCT00562484|11513250|FG000|Overall Study|Adverse Event|6
7294953|NCT00562484|11513251|FG001|Overall Study|Adverse Event|1
7294954|NCT00562484|11513250|FG000|Overall Study|Protocol Violation|11
7294955|NCT00562484|11513251|FG001|Overall Study|Protocol Violation|2
7294956|NCT00562484|11513250|FG000|Overall Study|Withdrawal by Subject|12
7294957|NCT00562484|11513251|FG001|Overall Study|Withdrawal by Subject|9
7294958|NCT00562484|11513250|FG000|Overall Study|Moved away from the study area|20
7294959|NCT00562484|11513251|FG001|Overall Study|Moved away from the study area|9
7294960|NCT00562484|11513250|FG000|Overall Study|Lost to Follow-up|132
7294961|NCT00562484|11513251|FG001|Overall Study|Lost to Follow-up|71
7294962|NCT00562484|11513250|FG000|Overall Study|Reason not provided or not specified|25
7294963|NCT00562484|11513251|FG001|Overall Study|Reason not provided or not specified|12
7294964|NCT00562588|11513259|FG000|Overall Study|Adverse Event|40
7294965|NCT00562588|11513260|FG001|Overall Study|Adverse Event|58
7294966|NCT00562588|11513259|FG000|Overall Study|Protocol Violation|30
7294967|NCT00562588|11513260|FG001|Overall Study|Protocol Violation|26
7294968|NCT00562588|11513259|FG000|Overall Study|Lost to Follow-up|12
7294969|NCT00562588|11513260|FG001|Overall Study|Lost to Follow-up|4
7294970|NCT00562588|11513259|FG000|Overall Study|Withdrawal by Subject|10
7294971|NCT00562588|11513260|FG001|Overall Study|Withdrawal by Subject|9
7294972|NCT00562588|11513259|FG000|Overall Study|Other|0
7294973|NCT00562588|11513260|FG001|Overall Study|Other|2
7294974|NCT00562627|11513269|FG000|Overall Study|Protocol Violation|1
7294975|NCT00562627|11513270|FG001|Overall Study|Protocol Violation|1
7294976|NCT00562627|11513271|FG002|Overall Study|Protocol Violation|1
7294977|NCT00562718|11513279|FG000|Overall Study|Death|1
7294978|NCT00562718|11513279|FG000|Overall Study|Withdrawal by Subject|3
7294979|NCT00562718|11513279|FG000|Overall Study|Adverse Event|4
7294980|NCT00562718|11513279|FG000|Overall Study|Lack of Efficacy|2
7294981|NCT00562718|11513279|FG000|Overall Study|not stated|1
7294982|NCT00562861|11513285|FG000|Overall Study|Adverse Event|1
7294983|NCT00562861|11513286|FG001|Overall Study|Adverse Event|1
7294984|NCT00562861|11513285|FG000|Overall Study|Lack of Efficacy|5
7294985|NCT00562861|11513286|FG001|Overall Study|Lack of Efficacy|5
7294986|NCT00562861|11513285|FG000|Overall Study|noncompliance, moved|7
7294987|NCT00562861|11513286|FG001|Overall Study|noncompliance, moved|2
7294988|NCT00562861|11513285|FG000|Overall Study|Lost to Follow-up|7
7294989|NCT00562861|11513286|FG001|Overall Study|Lost to Follow-up|3
7294990|NCT00562965|11513294|FG000|Overall Study|Withdrawal by Subject|0
7294991|NCT00562965|11513295|FG001|Overall Study|Withdrawal by Subject|1
7294992|NCT00562965|11513294|FG000|Overall Study|Death|2
7294993|NCT00562965|11513295|FG001|Overall Study|Death|4
7294994|NCT00562965|11513294|FG000|Overall Study|Lost to Follow-up|1
7294995|NCT00562965|11513295|FG001|Overall Study|Lost to Follow-up|0
7294996|NCT00562965|11513294|FG000|Overall Study|Other|0
7294997|NCT00562965|11513295|FG001|Overall Study|Other|1
7294998|NCT00562978|11513303|FG000|Overall Study|Patient had imaging dose only|1
7294999|NCT00562978|11513304|FG001|Overall Study|Patient had imaging dose only|11
7295000|NCT00563186|11513312|FG000|Overall Study|LOS<48 hours|97
7295001|NCT00563186|11513313|FG001|Overall Study|LOS<48 hours|74
7295002|NCT00563186|11513312|FG000|Overall Study|Incomplete data|1
7295003|NCT00563186|11513313|FG001|Overall Study|Incomplete data|1
7295004|NCT00563316|11513333|FG000|Overall Study|Adverse Event|2
7295005|NCT00563316|11513333|FG000|Overall Study|Physician Decision|1
7295006|NCT00563316|11513333|FG000|Overall Study|Lost to Follow-up|2
7295007|NCT00563316|11513333|FG000|Overall Study|Death|1
7295008|NCT00563316|11513333|FG000|Overall Study|On-going in study as of 16 July 2009.|5
7295009|NCT00563316|11513333|FG000|Overall Study|Other|1
7295010|NCT00563368|11513348|FG000|Overall Study|Lost to Follow-up|14
7295011|NCT00563368|11513349|FG001|Overall Study|Lost to Follow-up|14
7295012|NCT00563368|11513350|FG002|Overall Study|Lost to Follow-up|12
7295013|NCT00563368|11513351|FG003|Overall Study|Lost to Follow-up|6
7295014|NCT00563368|11513352|FG004|Overall Study|Lost to Follow-up|9
7295015|NCT00563368|11513353|FG005|Overall Study|Lost to Follow-up|8
7295016|NCT00563368|11513354|FG006|Overall Study|Lost to Follow-up|9
7295017|NCT00563368|11513348|FG000|Overall Study|Adverse Event|3
7295018|NCT00563368|11513349|FG001|Overall Study|Adverse Event|4
7295019|NCT00563368|11513350|FG002|Overall Study|Adverse Event|5
7295020|NCT00563368|11513351|FG003|Overall Study|Adverse Event|9
7295021|NCT00563368|11513352|FG004|Overall Study|Adverse Event|6
7295022|NCT00563368|11513353|FG005|Overall Study|Adverse Event|10
7219069|NCT04426318|11427762|FG000|Overall Study|failed attention checks and had their data removed from analyses|2
7219070|NCT04426318|11427763|FG001|Overall Study|failed attention checks and had their data removed from analyses|2
7219071|NCT04063657|11427771|FG000|Overall Study|Lost to Follow-up|1
7219072|NCT04063657|11427772|FG001|Overall Study|Lost to Follow-up|0
7295023|NCT00563368|11513354|FG006|Overall Study|Adverse Event|17
7295024|NCT00563368|11513348|FG000|Overall Study|Withdrawal by Subject|11
7295025|NCT00563368|11513349|FG001|Overall Study|Withdrawal by Subject|6
7295026|NCT00563368|11513350|FG002|Overall Study|Withdrawal by Subject|5
7295027|NCT00563368|11513351|FG003|Overall Study|Withdrawal by Subject|7
7295028|NCT00563368|11513352|FG004|Overall Study|Withdrawal by Subject|8
7295029|NCT00563368|11513353|FG005|Overall Study|Withdrawal by Subject|5
7295030|NCT00563368|11513354|FG006|Overall Study|Withdrawal by Subject|4
7295031|NCT00563368|11513348|FG000|Overall Study|protocol non-compliance|1
7295032|NCT00563368|11513349|FG001|Overall Study|protocol non-compliance|1
7295033|NCT00563368|11513350|FG002|Overall Study|protocol non-compliance|2
7295034|NCT00563368|11513351|FG003|Overall Study|protocol non-compliance|1
7295035|NCT00563368|11513352|FG004|Overall Study|protocol non-compliance|0
7295036|NCT00563368|11513353|FG005|Overall Study|protocol non-compliance|1
7295037|NCT00563368|11513354|FG006|Overall Study|protocol non-compliance|3
7295038|NCT00563368|11513348|FG000|Overall Study|Pregnancy|1
7295039|NCT00563368|11513349|FG001|Overall Study|Pregnancy|0
7295040|NCT00563368|11513350|FG002|Overall Study|Pregnancy|1
7295041|NCT00563368|11513351|FG003|Overall Study|Pregnancy|2
7295042|NCT00563368|11513352|FG004|Overall Study|Pregnancy|1
7295043|NCT00563368|11513353|FG005|Overall Study|Pregnancy|2
7295044|NCT00563368|11513354|FG006|Overall Study|Pregnancy|0
7295045|NCT00563368|11513348|FG000|Overall Study|requirement for restricted medication|0
7295046|NCT00563368|11513349|FG001|Overall Study|requirement for restricted medication|0
7295047|NCT00563368|11513350|FG002|Overall Study|requirement for restricted medication|2
7295048|NCT00563368|11513351|FG003|Overall Study|requirement for restricted medication|0
7295049|NCT00563368|11513352|FG004|Overall Study|requirement for restricted medication|0
7295050|NCT00563368|11513353|FG005|Overall Study|requirement for restricted medication|0
7295051|NCT00563368|11513354|FG006|Overall Study|requirement for restricted medication|0
7295052|NCT00563368|11513348|FG000|Overall Study|Other|5
7295053|NCT00563368|11513349|FG001|Overall Study|Other|5
7295054|NCT00563368|11513350|FG002|Overall Study|Other|3
7295055|NCT00563368|11513351|FG003|Overall Study|Other|4
7295056|NCT00563368|11513352|FG004|Overall Study|Other|4
7295057|NCT00563368|11513353|FG005|Overall Study|Other|4
7295058|NCT00563368|11513354|FG006|Overall Study|Other|0
7295059|NCT00563381|11513372|FG000|Overall Study|Adverse Event|264
7295060|NCT00563381|11513373|FG001|Overall Study|Adverse Event|292
7295061|NCT00563381|11513372|FG000|Overall Study|Protocol Violation|66
7295062|NCT00563381|11513373|FG001|Overall Study|Protocol Violation|74
7295063|NCT00563381|11513372|FG000|Overall Study|Lost to Follow-up|7
7295064|NCT00563381|11513373|FG001|Overall Study|Lost to Follow-up|15
7295065|NCT00563381|11513372|FG000|Overall Study|Withdrawal by Subject|192
7295066|NCT00563381|11513373|FG001|Overall Study|Withdrawal by Subject|209
7295067|NCT00563381|11513372|FG000|Overall Study|Lack of Efficacy|32
7295068|NCT00563381|11513373|FG001|Overall Study|Lack of Efficacy|24
7295069|NCT00563381|11513372|FG000|Overall Study|Individual different reasons|24
7295070|NCT00563381|11513373|FG001|Overall Study|Individual different reasons|34
7295071|NCT00563706|11513388|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
7295072|NCT00563706|11513389|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7295073|NCT00563706|11513390|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7295074|NCT00563706|11513391|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7295075|NCT00563706|11513392|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7295076|NCT00563706|11513393|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7295077|NCT00563706|11513394|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
7295078|NCT00563706|11513395|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
7295079|NCT00563706|11513396|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
7295080|NCT00563706|11513388|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7295081|NCT00563706|11513389|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7295082|NCT00563706|11513390|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7295083|NCT00563706|11513391|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
7295084|NCT00563706|11513392|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7295085|NCT00563706|11513393|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7295086|NCT00563706|11513394|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
7295087|NCT00563706|11513395|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
7295088|NCT00563706|11513396|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
7295089|NCT00563706|11513388|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
7295090|NCT00563706|11513389|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7295091|NCT00563706|11513390|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
7295092|NCT00563706|11513391|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
7295093|NCT00563706|11513392|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
7295094|NCT00563706|11513393|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7295095|NCT00563706|11513394|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
7295096|NCT00563706|11513395|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
7295097|NCT00563706|11513396|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
7295098|NCT00563706|11513388|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
7295099|NCT00563706|11513389|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295100|NCT00563706|11513390|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7219195|NCT03578809|11427909|FG002|Overall Study|Lost to Follow-up|0
7295101|NCT00563706|11513391|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295102|NCT00563706|11513392|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295103|NCT00563706|11513393|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295104|NCT00563706|11513394|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295105|NCT00563706|11513395|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
7295106|NCT00563706|11513396|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
7295107|NCT00563706|11513388|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295108|NCT00563706|11513389|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295109|NCT00563706|11513390|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295110|NCT00563706|11513391|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295111|NCT00563706|11513392|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295112|NCT00563706|11513393|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295113|NCT00563706|11513394|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
7295114|NCT00563706|11513395|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
7295115|NCT00563706|11513396|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
7295116|NCT00563784|11513416|FG000|Overall Study|Withdrawal by Subject|2
7295117|NCT00563784|11513416|FG000|Overall Study|Screen Failures|20
7295118|NCT00563797|11513422|FG000|Overall Study|Lost to Follow-up|7
7295119|NCT00563797|11513423|FG001|Overall Study|Lost to Follow-up|2
7295120|NCT00564018|11513434|FG000|Overall Study|Withdrawal by Subject|2
7295121|NCT00564018|11513435|FG001|Overall Study|Withdrawal by Subject|3
7295122|NCT00564018|11513436|FG002|Overall Study|Withdrawal by Subject|1
7295123|NCT00564070|11513446|FG000|Overall Study|Lost to Follow-up|9
7295124|NCT00564070|11513447|FG001|Overall Study|Lost to Follow-up|7
7295125|NCT00564070|11513446|FG000|Overall Study|Worsening depression, referred to care|3
7295126|NCT00564070|11513447|FG001|Overall Study|Worsening depression, referred to care|0
7295127|NCT00564278|11513459|FG000|Overall Study|Lost to Follow-up|35
7295128|NCT00564278|11513460|FG001|Overall Study|Lost to Follow-up|33
7295129|NCT00564278|11513459|FG000|Overall Study|Physician Decision|1
7295130|NCT00564278|11513460|FG001|Overall Study|Physician Decision|2
7295131|NCT00564278|11513459|FG000|Overall Study|Withdrawal by Subject|11
7295132|NCT00564278|11513460|FG001|Overall Study|Withdrawal by Subject|7
7295133|NCT00564395|11513466|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
7295134|NCT00564395|11513467|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
7295135|NCT00564395|11513466|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
7219073|NCT03882047|11427785|FG000|Overall Study|Adverse Event|0
7219074|NCT03882047|11427786|FG001|Overall Study|Adverse Event|2
7219075|NCT03882047|11427787|FG002|Overall Study|Adverse Event|2
7219076|NCT03882047|11427785|FG000|Overall Study|Treatment Failure|3
7219077|NCT03882047|11427786|FG001|Overall Study|Treatment Failure|3
7219078|NCT03882047|11427787|FG002|Overall Study|Treatment Failure|12
7219079|NCT03882047|11427785|FG000|Overall Study|Lost to Follow-up|0
7219080|NCT03882047|11427786|FG001|Overall Study|Lost to Follow-up|1
7219081|NCT03882047|11427787|FG002|Overall Study|Lost to Follow-up|0
7219082|NCT03882047|11427785|FG000|Overall Study|Did Not Wish to Continue|1
7219083|NCT03882047|11427786|FG001|Overall Study|Did Not Wish to Continue|4
7219084|NCT03882047|11427787|FG002|Overall Study|Did Not Wish to Continue|1
7219085|NCT03882047|11427785|FG000|Overall Study|Noncompliance With Protocol|2
7219086|NCT03882047|11427786|FG001|Overall Study|Noncompliance With Protocol|0
7219087|NCT03882047|11427787|FG002|Overall Study|Noncompliance With Protocol|0
7219088|NCT03882047|11427785|FG000|Overall Study|Did Not Meet Eligibility|0
7219089|NCT03882047|11427786|FG001|Overall Study|Did Not Meet Eligibility|0
7219090|NCT03882047|11427787|FG002|Overall Study|Did Not Meet Eligibility|1
7219091|NCT03879772|11427800|FG000|Overall Study|Adverse Event|2
7219092|NCT03879772|11427801|FG001|Overall Study|Adverse Event|2
7219093|NCT03879772|11427802|FG002|Overall Study|Adverse Event|3
7219094|NCT03879772|11427803|FG003|Overall Study|Adverse Event|4
7219095|NCT03879772|11427804|FG004|Overall Study|Adverse Event|3
7219096|NCT03879772|11427800|FG000|Overall Study|Treatment Failure|1
7219097|NCT03879772|11427801|FG001|Overall Study|Treatment Failure|0
7219098|NCT03879772|11427802|FG002|Overall Study|Treatment Failure|0
7219099|NCT03879772|11427803|FG003|Overall Study|Treatment Failure|2
7219100|NCT03879772|11427804|FG004|Overall Study|Treatment Failure|1
7219101|NCT03879772|11427800|FG000|Overall Study|Lost to Follow-up|0
7219102|NCT03879772|11427801|FG001|Overall Study|Lost to Follow-up|0
7219103|NCT03879772|11427802|FG002|Overall Study|Lost to Follow-up|0
7219104|NCT03879772|11427803|FG003|Overall Study|Lost to Follow-up|0
7219105|NCT03879772|11427804|FG004|Overall Study|Lost to Follow-up|1
7219106|NCT03879772|11427800|FG000|Overall Study|Withdrawal by Subject|0
7219107|NCT03879772|11427801|FG001|Overall Study|Withdrawal by Subject|1
7219108|NCT03879772|11427802|FG002|Overall Study|Withdrawal by Subject|3
7219109|NCT03879772|11427803|FG003|Overall Study|Withdrawal by Subject|1
7219110|NCT03879772|11427804|FG004|Overall Study|Withdrawal by Subject|1
7219111|NCT03879772|11427800|FG000|Overall Study|Protocol Violation|0
7219112|NCT03879772|11427801|FG001|Overall Study|Protocol Violation|0
7219113|NCT03879772|11427802|FG002|Overall Study|Protocol Violation|3
7219114|NCT03879772|11427803|FG003|Overall Study|Protocol Violation|1
7219115|NCT03879772|11427804|FG004|Overall Study|Protocol Violation|2
7219116|NCT03879772|11427800|FG000|Overall Study|Did Not Meet Entry Requirements|1
7219117|NCT03879772|11427801|FG001|Overall Study|Did Not Meet Entry Requirements|0
7219118|NCT03879772|11427802|FG002|Overall Study|Did Not Meet Entry Requirements|1
7219119|NCT03879772|11427803|FG003|Overall Study|Did Not Meet Entry Requirements|0
7219120|NCT03879772|11427804|FG004|Overall Study|Did Not Meet Entry Requirements|0
7219121|NCT03861559|11427818|FG000|Overall Study|Adverse Event|0
7219122|NCT03861559|11427819|FG001|Overall Study|Adverse Event|2
7219123|NCT03861559|11427818|FG000|Overall Study|Treatment failure|0
7219124|NCT03861559|11427819|FG001|Overall Study|Treatment failure|2
7219125|NCT03861559|11427818|FG000|Overall Study|Noncompliance|1
7219126|NCT03861559|11427819|FG001|Overall Study|Noncompliance|1
7219127|NCT03861559|11427818|FG000|Overall Study|Did not meet eligibility requirements|1
7219128|NCT03861559|11427819|FG001|Overall Study|Did not meet eligibility requirements|0
7219129|NCT03855228|11427829|FG000|Overall Study|Adverse Event|2
7219130|NCT03855228|11427830|FG001|Overall Study|Adverse Event|4
7219131|NCT03855228|11427831|FG002|Overall Study|Adverse Event|4
7219132|NCT03855228|11427832|FG003|Overall Study|Adverse Event|8
7219133|NCT03855228|11427829|FG000|Overall Study|Treatment Failure|1
7219134|NCT03855228|11427830|FG001|Overall Study|Treatment Failure|2
7219135|NCT03855228|11427831|FG002|Overall Study|Treatment Failure|1
7219136|NCT03855228|11427832|FG003|Overall Study|Treatment Failure|8
7219137|NCT03855228|11427829|FG000|Overall Study|Lost to Follow-up|0
7219138|NCT03855228|11427830|FG001|Overall Study|Lost to Follow-up|0
7219139|NCT03855228|11427831|FG002|Overall Study|Lost to Follow-up|0
7219140|NCT03855228|11427832|FG003|Overall Study|Lost to Follow-up|1
7219141|NCT03855228|11427829|FG000|Overall Study|Protocol Violation|0
7219142|NCT03855228|11427830|FG001|Overall Study|Protocol Violation|1
7219143|NCT03855228|11427831|FG002|Overall Study|Protocol Violation|2
7219144|NCT03855228|11427832|FG003|Overall Study|Protocol Violation|1
7219145|NCT03855228|11427829|FG000|Overall Study|Did Not Meet Entry Requirements|0
7219146|NCT03855228|11427830|FG001|Overall Study|Did Not Meet Entry Requirements|2
7219147|NCT03855228|11427831|FG002|Overall Study|Did Not Meet Entry Requirements|1
7219148|NCT03855228|11427832|FG003|Overall Study|Did Not Meet Entry Requirements|1
7219149|NCT03855189|11427845|FG000|Overall Study|Adverse Event|5
7219150|NCT03855189|11427846|FG001|Overall Study|Adverse Event|2
7219151|NCT03855189|11427847|FG002|Overall Study|Adverse Event|4
7219152|NCT03855189|11427845|FG000|Overall Study|Treatment Failure|1
7219153|NCT03855189|11427846|FG001|Overall Study|Treatment Failure|1
7219154|NCT03855189|11427847|FG002|Overall Study|Treatment Failure|2
7295136|NCT00564395|11513467|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
7295137|NCT00564486|11513509|FG000|Overall Study|Adverse Event|0
7295138|NCT00564486|11513510|FG001|Overall Study|Adverse Event|1
7295139|NCT00564486|11513511|FG002|Overall Study|Adverse Event|0
7295140|NCT00564486|11513512|FG003|Overall Study|Adverse Event|0
7219155|NCT03855189|11427845|FG000|Overall Study|Noncompliance with Protocol|0
7219156|NCT03855189|11427846|FG001|Overall Study|Noncompliance with Protocol|1
7219157|NCT03855189|11427847|FG002|Overall Study|Noncompliance with Protocol|0
7219158|NCT03855189|11427845|FG000|Overall Study|Did Not Return|4
7219159|NCT03855189|11427846|FG001|Overall Study|Did Not Return|3
7219160|NCT03855189|11427847|FG002|Overall Study|Did Not Return|0
7219161|NCT03764631|11427857|FG000|Overall Study|Personal Reasons|3
7219162|NCT03764631|11427858|FG001|Overall Study|Personal Reasons|2
7219163|NCT03764631|11427857|FG000|Overall Study|Switching Therapy|3
7219164|NCT03764631|11427858|FG001|Overall Study|Switching Therapy|3
7219165|NCT03764631|11427857|FG000|Overall Study|Adverse Event|0
7219166|NCT03764631|11427858|FG001|Overall Study|Adverse Event|1
7219167|NCT03764631|11427857|FG000|Overall Study|Lost to Follow-up|33
7219168|NCT03764631|11427858|FG001|Overall Study|Lost to Follow-up|41
7219169|NCT03764631|11427857|FG000|Overall Study|No data as study site was closed|2
7219170|NCT03764631|11427858|FG001|Overall Study|No data as study site was closed|6
7219171|NCT03764072|11427870|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7219172|NCT03764072|11427871|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7219173|NCT03764072|11427872|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
7219174|NCT03764072|11427873|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7219175|NCT03764072|11427874|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7219176|NCT03764072|11427875|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
7219177|NCT03764072|11427870|FG000|Overall Study|Withdrawal of consent (for other reason)|0
7219178|NCT03764072|11427871|FG001|Overall Study|Withdrawal of consent (for other reason)|0
7219179|NCT03764072|11427872|FG002|Overall Study|Withdrawal of consent (for other reason)|0
7219180|NCT03764072|11427873|FG003|Overall Study|Withdrawal of consent (for other reason)|0
7219181|NCT03764072|11427874|FG004|Overall Study|Withdrawal of consent (for other reason)|0
7219182|NCT03764072|11427875|FG005|Overall Study|Withdrawal of consent (for other reason)|1
7219183|NCT03764072|11427870|FG000|Overall Study|Lost to Follow-up|0
7219184|NCT03764072|11427871|FG001|Overall Study|Lost to Follow-up|0
7219185|NCT03764072|11427872|FG002|Overall Study|Lost to Follow-up|0
7219186|NCT03764072|11427873|FG003|Overall Study|Lost to Follow-up|0
7219187|NCT03764072|11427874|FG004|Overall Study|Lost to Follow-up|1
7219188|NCT03764072|11427875|FG005|Overall Study|Lost to Follow-up|0
7219189|NCT03578809|11427907|FG000|Overall Study|Death|0
7219190|NCT03578809|11427908|FG001|Overall Study|Death|2
7219191|NCT03578809|11427909|FG002|Overall Study|Death|0
7219192|NCT03578809|11427910|FG003|Overall Study|Death|1
7219193|NCT03578809|11427907|FG000|Overall Study|Lost to Follow-up|0
7219194|NCT03578809|11427908|FG001|Overall Study|Lost to Follow-up|1
7219196|NCT03578809|11427910|FG003|Overall Study|Lost to Follow-up|0
7219197|NCT03578809|11427907|FG000|Overall Study|Withdrawal by Subject|3
7219198|NCT03578809|11427908|FG001|Overall Study|Withdrawal by Subject|5
7219199|NCT03578809|11427909|FG002|Overall Study|Withdrawal by Subject|2
7219200|NCT03578809|11427910|FG003|Overall Study|Withdrawal by Subject|0
7219201|NCT03578809|11427907|FG000|Overall Study|Other|3
7219202|NCT03578809|11427908|FG001|Overall Study|Other|6
7219203|NCT03578809|11427909|FG002|Overall Study|Other|2
7219204|NCT03578809|11427910|FG003|Overall Study|Other|8
7295141|NCT00564486|11513509|FG000|Overall Study|Withdrawal by Subject|4
7295142|NCT00564486|11513510|FG001|Overall Study|Withdrawal by Subject|0
7295143|NCT00564486|11513511|FG002|Overall Study|Withdrawal by Subject|0
7295144|NCT00564486|11513512|FG003|Overall Study|Withdrawal by Subject|5
7295145|NCT00564486|11513509|FG000|Overall Study|Subject refused to have blood drawn|0
7295146|NCT00564486|11513510|FG001|Overall Study|Subject refused to have blood drawn|0
7295147|NCT00564486|11513511|FG002|Overall Study|Subject refused to have blood drawn|1
7295148|NCT00564486|11513512|FG003|Overall Study|Subject refused to have blood drawn|0
7295149|NCT00564486|11513509|FG000|Overall Study|Lost to Follow-up|3
7295150|NCT00564486|11513510|FG001|Overall Study|Lost to Follow-up|0
7295151|NCT00564486|11513511|FG002|Overall Study|Lost to Follow-up|2
7295152|NCT00564486|11513512|FG003|Overall Study|Lost to Follow-up|2
7295153|NCT00564629|11513528|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
7295154|NCT00564629|11513529|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
7295155|NCT00564733|11513551|FG000|Overall Study|Withdrawal by Subject|4
7295156|NCT00564733|11513551|FG000|Overall Study|Ineligible|5
7295157|NCT00564850|11513555|FG000|Overall Study|Protocol Violation|2
7295158|NCT00564889|11513559|FG000|Overall Study|Death|7
7295159|NCT00564889|11513559|FG000|Overall Study|Adverse Event|12
7295160|NCT00564889|11513559|FG000|Overall Study|Alternative treatment|3
7295161|NCT00564889|11513559|FG000|Overall Study|Disease progression|3
7295162|NCT00564889|11513559|FG000|Overall Study|Other, not specified|4
7295163|NCT00564902|11513566|FG000|Overall Study|Withdrawal by Subject|0
7295164|NCT00564902|11513567|FG001|Overall Study|Withdrawal by Subject|3
7295165|NCT00564902|11513568|FG002|Overall Study|Withdrawal by Subject|4
7295166|NCT00564902|11513566|FG000|Overall Study|Death|1
7295167|NCT00564902|11513567|FG001|Overall Study|Death|1
7295168|NCT00564902|11513568|FG002|Overall Study|Death|0
7295169|NCT00565058|11513596|FG000|Overall Study|Adverse Event|1
7295170|NCT00565058|11513597|FG001|Overall Study|Adverse Event|0
7295171|NCT00565136|11513622|FG000|Overall Study|Lost to Follow-up|1
7295172|NCT00565136|11513622|FG000|Overall Study|Withdrawal by Subject|1
7295173|NCT00565136|11513622|FG000|Overall Study|Protocol Violation|1
7295174|NCT00565409|11513638|FG000|Period 1 Open Label|Adverse Event|17
7295175|NCT00565409|11513639|FG001|Period 1 Open Label|Adverse Event|0
7295176|NCT00565409|11513640|FG002|Period 1 Open Label|Adverse Event|0
7295177|NCT00565409|11513641|FG003|Period 1 Open Label|Adverse Event|0
7295178|NCT00565409|11513638|FG000|Period 1 Open Label|Death|2
7295179|NCT00565409|11513639|FG001|Period 1 Open Label|Death|0
7295180|NCT00565409|11513640|FG002|Period 1 Open Label|Death|0
7295181|NCT00565409|11513641|FG003|Period 1 Open Label|Death|0
7295182|NCT00565409|11513638|FG000|Period 1 Open Label|Lost to Follow-up|1
7295183|NCT00565409|11513639|FG001|Period 1 Open Label|Lost to Follow-up|0
7295184|NCT00565409|11513640|FG002|Period 1 Open Label|Lost to Follow-up|0
7295185|NCT00565409|11513641|FG003|Period 1 Open Label|Lost to Follow-up|0
7295186|NCT00565409|11513638|FG000|Period 1 Open Label|Other|21
7295187|NCT00565409|11513639|FG001|Period 1 Open Label|Other|0
7295188|NCT00565409|11513640|FG002|Period 1 Open Label|Other|0
7295189|NCT00565409|11513641|FG003|Period 1 Open Label|Other|0
7295190|NCT00565409|11513638|FG000|Period 1 Open Label|Protocol Violation|14
7295191|NCT00565409|11513639|FG001|Period 1 Open Label|Protocol Violation|0
7295192|NCT00565409|11513640|FG002|Period 1 Open Label|Protocol Violation|0
7295193|NCT00565409|11513641|FG003|Period 1 Open Label|Protocol Violation|0
7295194|NCT00565409|11513638|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
7295195|NCT00565409|11513639|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7295196|NCT00565409|11513640|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7295197|NCT00565409|11513641|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
7295198|NCT00565409|11513638|FG000|Period 1 Open Label|no conclusion of participation record|1
7295199|NCT00565409|11513639|FG001|Period 1 Open Label|no conclusion of participation record|0
7295200|NCT00565409|11513640|FG002|Period 1 Open Label|no conclusion of participation record|0
7295201|NCT00565409|11513641|FG003|Period 1 Open Label|no conclusion of participation record|0
7295202|NCT00565409|11513638|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
7295203|NCT00565409|11513639|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
7295204|NCT00565409|11513640|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
7295205|NCT00565409|11513641|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
7295206|NCT00565409|11513638|FG000|Period 2 Double-Blind|Adverse Event|0
7295207|NCT00565409|11513639|FG001|Period 2 Double-Blind|Adverse Event|7
7295208|NCT00565409|11513640|FG002|Period 2 Double-Blind|Adverse Event|4
7295209|NCT00565409|11513641|FG003|Period 2 Double-Blind|Adverse Event|5
7295210|NCT00565409|11513638|FG000|Period 2 Double-Blind|Death|0
7295211|NCT00565409|11513639|FG001|Period 2 Double-Blind|Death|2
7295212|NCT00565409|11513640|FG002|Period 2 Double-Blind|Death|0
7295213|NCT00565409|11513641|FG003|Period 2 Double-Blind|Death|0
7295214|NCT00565409|11513638|FG000|Period 2 Double-Blind|Protocol Violation|0
7295215|NCT00565409|11513639|FG001|Period 2 Double-Blind|Protocol Violation|4
7295216|NCT00565409|11513640|FG002|Period 2 Double-Blind|Protocol Violation|6
7295217|NCT00565409|11513641|FG003|Period 2 Double-Blind|Protocol Violation|2
7295218|NCT00565409|11513638|FG000|Period 2 Double-Blind|Lost to Follow-up|0
7295219|NCT00565409|11513639|FG001|Period 2 Double-Blind|Lost to Follow-up|0
7295220|NCT00565409|11513640|FG002|Period 2 Double-Blind|Lost to Follow-up|1
7295221|NCT00565409|11513641|FG003|Period 2 Double-Blind|Lost to Follow-up|0
7295222|NCT00565409|11513638|FG000|Period 2 Double-Blind|Other|0
7295223|NCT00565409|11513639|FG001|Period 2 Double-Blind|Other|4
7295224|NCT00565409|11513640|FG002|Period 2 Double-Blind|Other|5
7295225|NCT00565409|11513641|FG003|Period 2 Double-Blind|Other|9
7295226|NCT00565409|11513638|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
7295227|NCT00565409|11513639|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
7295228|NCT00565409|11513640|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
7295229|NCT00565409|11513641|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
7295230|NCT00565448|11513653|FG000|Overall Study|Adverse Event|1
7295231|NCT00565448|11513654|FG001|Overall Study|Adverse Event|2
7295232|NCT00565448|11513653|FG000|Overall Study|Disease progression|1
7295233|NCT00565448|11513654|FG001|Overall Study|Disease progression|0
7295234|NCT00565448|11513653|FG000|Overall Study|Withdrawal by Subject|1
7295235|NCT00565448|11513654|FG001|Overall Study|Withdrawal by Subject|0
7295236|NCT00565604|11513663|FG000|Overall Study|Failure to treat|2
7295237|NCT00565604|11513663|FG000|Overall Study|Lost to Follow-up|2
7295238|NCT00565721|11513686|FG000|Overall Study|Screen Failure|2
7295239|NCT00565721|11513686|FG000|Overall Study|Lost to Follow-up|6
7295240|NCT00565721|11513686|FG000|Overall Study|Technical Problems|1
7295241|NCT00565721|11513686|FG000|Overall Study|Physician Decision|2
7295242|NCT00565721|11513686|FG000|Overall Study|Other reasons|6
7295243|NCT00565747|11513707|FG000|Overall Study|No embryo transfer|67
7295244|NCT00565747|11513708|FG001|Overall Study|No embryo transfer|73
7295245|NCT00565773|11513714|FG000|Overall Study|Withdrawal by Subject|1
7295246|NCT00565773|11513714|FG000|Overall Study|Physician Decision|1
7295247|NCT00565812|11513721|FG000|Overall Study|Death|2
7295248|NCT00565812|11513722|FG001|Overall Study|Death|1
7295249|NCT00565812|11513723|FG002|Overall Study|Death|3
7295250|NCT00565812|11513721|FG000|Overall Study|Did not Meet Entrance Criteria|1
7295251|NCT00565812|11513722|FG001|Overall Study|Did not Meet Entrance Criteria|0
7295252|NCT00565812|11513723|FG002|Overall Study|Did not Meet Entrance Criteria|1
7295253|NCT00565812|11513721|FG000|Overall Study|Lost to Follow-up|10
7295254|NCT00565812|11513722|FG001|Overall Study|Lost to Follow-up|8
7295255|NCT00565812|11513723|FG002|Overall Study|Lost to Follow-up|8
7295256|NCT00565812|11513721|FG000|Overall Study|Withdrawal by Subject|58
7295257|NCT00565812|11513722|FG001|Overall Study|Withdrawal by Subject|47
7295258|NCT00565812|11513723|FG002|Overall Study|Withdrawal by Subject|48
7295259|NCT00565812|11513721|FG000|Overall Study|Work Schedule|5
7295260|NCT00565812|11513722|FG001|Overall Study|Work Schedule|3
7295261|NCT00565812|11513723|FG002|Overall Study|Work Schedule|1
7295262|NCT00565812|11513721|FG000|Overall Study|Protocol Violation|2
7295263|NCT00565812|11513722|FG001|Overall Study|Protocol Violation|6
7295264|NCT00565812|11513723|FG002|Overall Study|Protocol Violation|4
7295265|NCT00565812|11513721|FG000|Overall Study|Adverse Event|41
7295266|NCT00565812|11513722|FG001|Overall Study|Adverse Event|54
7295267|NCT00565812|11513723|FG002|Overall Study|Adverse Event|40
7295268|NCT00565812|11513721|FG000|Overall Study|Jury Duty|1
7295269|NCT00565812|11513722|FG001|Overall Study|Jury Duty|0
7295270|NCT00565812|11513723|FG002|Overall Study|Jury Duty|0
7295271|NCT00565812|11513721|FG000|Overall Study|Relocated Out of Area|5
7295272|NCT00565812|11513722|FG001|Overall Study|Relocated Out of Area|8
7295273|NCT00565812|11513723|FG002|Overall Study|Relocated Out of Area|9
7295274|NCT00565812|11513721|FG000|Overall Study|Sponsor Decision|1
7295275|NCT00565812|11513722|FG001|Overall Study|Sponsor Decision|5
7295276|NCT00565812|11513723|FG002|Overall Study|Sponsor Decision|1
7295277|NCT00565812|11513721|FG000|Overall Study|Domestic Reasons|7
7295278|NCT00565812|11513722|FG001|Overall Study|Domestic Reasons|1
7295279|NCT00565812|11513723|FG002|Overall Study|Domestic Reasons|3
7295280|NCT00565812|11513721|FG000|Overall Study|Research Site Closure|6
7295281|NCT00565812|11513722|FG001|Overall Study|Research Site Closure|1
7295282|NCT00565812|11513723|FG002|Overall Study|Research Site Closure|8
7295283|NCT00565812|11513721|FG000|Overall Study|Surgical Intervention|0
7295284|NCT00565812|11513722|FG001|Overall Study|Surgical Intervention|1
7295285|NCT00565812|11513723|FG002|Overall Study|Surgical Intervention|2
7295286|NCT00565812|11513721|FG000|Overall Study|Low Compliance|1
7295287|NCT00565812|11513722|FG001|Overall Study|Low Compliance|0
7295288|NCT00565812|11513723|FG002|Overall Study|Low Compliance|1
7295289|NCT00565812|11513721|FG000|Overall Study|Follow-up Visit Not Completed|2
7295290|NCT00565812|11513722|FG001|Overall Study|Follow-up Visit Not Completed|0
7295291|NCT00565812|11513723|FG002|Overall Study|Follow-up Visit Not Completed|1
7295292|NCT00565812|11513721|FG000|Overall Study|Physician Decision|2
7295293|NCT00565812|11513722|FG001|Overall Study|Physician Decision|0
7295294|NCT00565812|11513723|FG002|Overall Study|Physician Decision|0
7295295|NCT00566020|11513755|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
7295296|NCT00566020|11513756|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
7295297|NCT00566020|11513755|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
7295298|NCT00566020|11513756|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
7295299|NCT00566020|11513755|FG000|46-week Long-term Administration Phase|Adverse Event|0
7295300|NCT00566020|11513756|FG001|46-week Long-term Administration Phase|Adverse Event|7
7295301|NCT00566020|11513755|FG000|46-week Long-term Administration Phase|Physician Decision|0
7295302|NCT00566020|11513756|FG001|46-week Long-term Administration Phase|Physician Decision|7
7295303|NCT00566020|11513755|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
7295304|NCT00566020|11513756|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
7295305|NCT00566020|11513755|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
7295306|NCT00566020|11513756|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
7295307|NCT00566098|11513761|FG000|Collection of MILs|Withdrawal by Subject|1
7295308|NCT00566098|11513761|FG000|Collection of MILs|Relapsed|1
7295309|NCT00566098|11513761|FG000|Generation of MILs Product|Relapsed|1
7295310|NCT00566098|11513761|FG000|Administration of ASCT+MILs|Death|10
7295311|NCT00566098|11513761|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
7295312|NCT00566111|11513768|FG000|Overall Study|Adverse Event|0
7295313|NCT00566111|11513769|FG001|Overall Study|Adverse Event|2
7295314|NCT00566228|11513786|FG000|Overall Study|Withdrawal by Subject|1
7295315|NCT00566228|11513787|FG001|Overall Study|Withdrawal by Subject|0
7295316|NCT00566228|11513786|FG000|Overall Study|Attempt to mobilize stem cells failed|2
7295317|NCT00566228|11513787|FG001|Overall Study|Attempt to mobilize stem cells failed|2
7295318|NCT00566228|11513786|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
7295319|NCT00566228|11513787|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
7295320|NCT00566228|11513786|FG000|Overall Study|progressed before infusion could occur|0
7295321|NCT00566228|11513787|FG001|Overall Study|progressed before infusion could occur|1
7295322|NCT00566254|11513795|FG000|Overall Study|Adverse Event|3
7295323|NCT00566254|11513796|FG001|Overall Study|Adverse Event|1
7295324|NCT00566254|11513795|FG000|Overall Study|Protocol Violation|1
7295325|NCT00566254|11513796|FG001|Overall Study|Protocol Violation|3
7295326|NCT00566254|11513795|FG000|Overall Study|Withdrawal by Subject|1
7295327|NCT00566254|11513796|FG001|Overall Study|Withdrawal by Subject|2
7295328|NCT00566254|11513795|FG000|Overall Study|Lack of Efficacy|5
7295329|NCT00566254|11513796|FG001|Overall Study|Lack of Efficacy|6
7295330|NCT00566254|11513795|FG000|Overall Study|Other|0
7295331|NCT00566254|11513796|FG001|Overall Study|Other|2
7295332|NCT00566501|11513804|FG000|Overall Study|Adverse Event|68
7295333|NCT00566501|11513805|FG001|Overall Study|Adverse Event|59
7295334|NCT00566501|11513804|FG000|Overall Study|Medication Non-compliance|5
7295335|NCT00566501|11513805|FG001|Overall Study|Medication Non-compliance|0
7295336|NCT00566501|11513804|FG000|Overall Study|Protocol Violation|2
7295337|NCT00566501|11513805|FG001|Overall Study|Protocol Violation|2
7295338|NCT00566501|11513804|FG000|Overall Study|Request of Investigator or Sponsor|6
7295339|NCT00566501|11513805|FG001|Overall Study|Request of Investigator or Sponsor|7
7295340|NCT00566501|11513804|FG000|Overall Study|Withdrawal by Subject|33
7295341|NCT00566501|11513805|FG001|Overall Study|Withdrawal by Subject|30
7295342|NCT00566501|11513804|FG000|Overall Study|Lack of Efficacy|8
7295343|NCT00566501|11513805|FG001|Overall Study|Lack of Efficacy|3
7295344|NCT00566501|11513804|FG000|Overall Study|Other|25
7295345|NCT00566501|11513805|FG001|Overall Study|Other|21
7295346|NCT00566527|11513814|FG000|Overall Study|Reason not provided|3
7295347|NCT00566527|11513815|FG001|Overall Study|Reason not provided|11
7295348|NCT00566527|11513816|FG002|Overall Study|Reason not provided|10
7295349|NCT00566527|11513814|FG000|Overall Study|Adverse Event|2
7295350|NCT00566527|11513815|FG001|Overall Study|Adverse Event|0
7295351|NCT00566527|11513816|FG002|Overall Study|Adverse Event|1
7295352|NCT00566527|11513814|FG000|Overall Study|Physician Decision|3
7295353|NCT00566527|11513815|FG001|Overall Study|Physician Decision|8
7295354|NCT00566527|11513816|FG002|Overall Study|Physician Decision|20
7295355|NCT00566527|11513814|FG000|Overall Study|Lost to Follow-up|3
7295356|NCT00566527|11513815|FG001|Overall Study|Lost to Follow-up|4
7295357|NCT00566527|11513816|FG002|Overall Study|Lost to Follow-up|4
7295358|NCT00566527|11513814|FG000|Overall Study|Withdrawal by Subject|6
7295359|NCT00566527|11513815|FG001|Overall Study|Withdrawal by Subject|43
7295360|NCT00566527|11513816|FG002|Overall Study|Withdrawal by Subject|43
7295361|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
7295362|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Physician Decision|1
7295363|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Adverse Event|9
7295364|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
7295365|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
7295366|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
7295367|NCT00566631|11513839|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
7295368|NCT00566631|11513839|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
7295369|NCT00566631|11513839|FG000|Part 2: Extension Phase|Lack of Efficacy|25
7295370|NCT00566631|11513839|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
7295371|NCT00566631|11513839|FG000|Part 2: Extension Phase|Adverse Event|11
7295372|NCT00566631|11513839|FG000|Part 2: Extension Phase|Lost to Follow-up|6
7295373|NCT00566631|11513839|FG000|Part 2: Extension Phase|Death|1
7295374|NCT00566631|11513839|FG000|Part 2: Extension Phase|Other|5
7295375|NCT00566696|11513843|FG000|Overall Study|Met Exclusion Criteria|2
7295376|NCT00566696|11513843|FG000|Overall Study|Muromonab not available|1
7295377|NCT00566696|11513843|FG000|Overall Study|Health Status Change|1
7295378|NCT00566696|11513843|FG000|Overall Study|Physician Decision|1
7295379|NCT00566696|11513843|FG000|Overall Study|Non-Patient Donors|37
7295380|NCT00566709|11513849|FG000|Overall Study|Protocol Violation|5
7295381|NCT00566709|11513850|FG001|Overall Study|Protocol Violation|0
7551429|NCT02969525|11910669|FG006|Dose-Blind Period|Withdrawal by Subject|2
7551430|NCT02969525|11910670|FG007|Dose-Blind Period|Withdrawal by Subject|0
7551431|NCT02969525|11910671|FG008|Dose-Blind Period|Withdrawal by Subject|1
7551432|NCT02969525|11910672|FG009|Dose-Blind Period|Withdrawal by Subject|2
7551433|NCT02969525|11910673|FG010|Dose-Blind Period|Withdrawal by Subject|0
7551434|NCT02969525|11910674|FG011|Dose-Blind Period|Withdrawal by Subject|0
7551435|NCT02969525|11910663|FG000|Dose-Blind Period|Non-cooperating patient|0
7551436|NCT02969525|11910664|FG001|Dose-Blind Period|Non-cooperating patient|0
7551437|NCT02969525|11910665|FG002|Dose-Blind Period|Non-cooperating patient|0
7551438|NCT02969525|11910666|FG003|Dose-Blind Period|Non-cooperating patient|0
7551439|NCT02969525|11910667|FG004|Dose-Blind Period|Non-cooperating patient|0
7551440|NCT02969525|11910668|FG005|Dose-Blind Period|Non-cooperating patient|0
7551441|NCT02969525|11910669|FG006|Dose-Blind Period|Non-cooperating patient|0
7551442|NCT02969525|11910670|FG007|Dose-Blind Period|Non-cooperating patient|0
7551443|NCT02969525|11910671|FG008|Dose-Blind Period|Non-cooperating patient|0
7551444|NCT02969525|11910672|FG009|Dose-Blind Period|Non-cooperating patient|0
7551445|NCT02969525|11910673|FG010|Dose-Blind Period|Non-cooperating patient|0
7551446|NCT02969525|11910674|FG011|Dose-Blind Period|Non-cooperating patient|1
7551447|NCT02969525|11910663|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551448|NCT02969525|11910664|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551449|NCT02969525|11910665|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551450|NCT02969525|11910666|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551451|NCT02969525|11910667|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551452|NCT02969525|11910668|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551453|NCT02969525|11910669|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551454|NCT02969525|11910670|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551455|NCT02969525|11910671|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551456|NCT02969525|11910672|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7551457|NCT02969525|11910673|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
7551458|NCT02969525|11910674|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
7295382|NCT00566722|11513859|FG000|Overall Study|Adverse Event|0
7295383|NCT00566722|11513860|FG001|Overall Study|Adverse Event|1
7295384|NCT00566722|11513861|FG002|Overall Study|Adverse Event|0
7295385|NCT00566722|11513859|FG000|Overall Study|Withdrawal by Subject|0
7295386|NCT00566722|11513860|FG001|Overall Study|Withdrawal by Subject|0
7295387|NCT00566722|11513861|FG002|Overall Study|Withdrawal by Subject|1
7295388|NCT00566722|11513859|FG000|Overall Study|Lost to Follow-up|1
7295389|NCT00566722|11513860|FG001|Overall Study|Lost to Follow-up|1
7295390|NCT00566722|11513861|FG002|Overall Study|Lost to Follow-up|1
7295391|NCT00566722|11513859|FG000|Overall Study|Lack of Efficacy|1
7295392|NCT00566722|11513860|FG001|Overall Study|Lack of Efficacy|2
7295393|NCT00566722|11513861|FG002|Overall Study|Lack of Efficacy|4
7295394|NCT00566722|11513859|FG000|Overall Study|Did not meet exclusion criteria|0
7295395|NCT00566722|11513860|FG001|Overall Study|Did not meet exclusion criteria|0
7295396|NCT00566722|11513861|FG002|Overall Study|Did not meet exclusion criteria|2
7295397|NCT00566722|11513859|FG000|Overall Study|Serious adverse event|0
7295398|NCT00566722|11513860|FG001|Overall Study|Serious adverse event|1
7295399|NCT00566722|11513861|FG002|Overall Study|Serious adverse event|0
7295400|NCT00566722|11513859|FG000|Overall Study|Noncompliant with drug administration|0
7295401|NCT00566722|11513860|FG001|Overall Study|Noncompliant with drug administration|0
7295402|NCT00566722|11513861|FG002|Overall Study|Noncompliant with drug administration|1
7295403|NCT00566735|11513874|FG000|Overall Study|Withdrawal by Subject|0
7295404|NCT00566735|11513875|FG001|Overall Study|Withdrawal by Subject|1
7295405|NCT00566735|11513874|FG000|Overall Study|Refused neuropsychological testing|2
7295406|NCT00566735|11513875|FG001|Overall Study|Refused neuropsychological testing|5
7295407|NCT00566735|11513874|FG000|Overall Study|Switched into a manic episode|0
7295408|NCT00566735|11513875|FG001|Overall Study|Switched into a manic episode|1
7295409|NCT00566852|11513892|FG000|Overall Study|Protocol Violation|22
7295410|NCT00566852|11513893|FG001|Overall Study|Protocol Violation|24
7295411|NCT00566852|11513892|FG000|Overall Study|Death|95
7295412|NCT00566852|11513893|FG001|Overall Study|Death|78
7295413|NCT00566852|11513892|FG000|Overall Study|Withdrawal by Subject|30
7295414|NCT00566852|11513893|FG001|Overall Study|Withdrawal by Subject|25
7295415|NCT00566852|11513892|FG000|Overall Study|Patient refusal|37
7295416|NCT00566852|11513893|FG001|Overall Study|Patient refusal|37
7295417|NCT00566852|11513892|FG000|Overall Study|Not tested due to disability|6
7295418|NCT00566852|11513893|FG001|Overall Study|Not tested due to disability|12
7295419|NCT00566852|11513892|FG000|Overall Study|Missing reason not specified|1
7295420|NCT00566852|11513893|FG001|Overall Study|Missing reason not specified|2
7295421|NCT00566852|11513892|FG000|Overall Study|Missing reason not reported|16
7295422|NCT00566852|11513893|FG001|Overall Study|Missing reason not reported|20
7295423|NCT00566982|11513942|FG000|Overall Study|Adverse Event|6
7295424|NCT00566982|11513943|FG001|Overall Study|Adverse Event|48
7295425|NCT00566982|11513942|FG000|Overall Study|Withdrawal by Subject|1
7295426|NCT00566982|11513943|FG001|Overall Study|Withdrawal by Subject|14
7295427|NCT00566982|11513942|FG000|Overall Study|Protocol Violation|1
7295428|NCT00566982|11513943|FG001|Overall Study|Protocol Violation|4
7295429|NCT00566982|11513942|FG000|Overall Study|Lost to Follow-up|0
7295430|NCT00566982|11513943|FG001|Overall Study|Lost to Follow-up|1
7295431|NCT00566982|11513942|FG000|Overall Study|Other-family problems & doctor's request|0
7295432|NCT00566982|11513943|FG001|Overall Study|Other-family problems & doctor's request|2
7295433|NCT00567112|11513961|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
7295434|NCT00567112|11513962|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
7295435|NCT00567112|11513963|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
7295436|NCT00567112|11513961|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
7295437|NCT00567112|11513962|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
7295438|NCT00567112|11513963|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
7295439|NCT00567112|11513961|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
7295440|NCT00567112|11513962|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
7295441|NCT00567112|11513963|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
7295442|NCT00567164|11513975|FG000|Overall Study|Withdrawal by Subject|171
7295443|NCT00567164|11513976|FG001|Overall Study|Withdrawal by Subject|21
7295444|NCT00567164|11513977|FG002|Overall Study|Withdrawal by Subject|17
7295445|NCT00567164|11513975|FG000|Overall Study|Protocol Violation|23
7295446|NCT00567164|11513976|FG001|Overall Study|Protocol Violation|4
7295447|NCT00567164|11513977|FG002|Overall Study|Protocol Violation|2
7295448|NCT00567164|11513975|FG000|Overall Study|Adverse Event|92
7295449|NCT00567164|11513976|FG001|Overall Study|Adverse Event|13
7295450|NCT00567164|11513977|FG002|Overall Study|Adverse Event|9
7295451|NCT00567164|11513975|FG000|Overall Study|Death|0
7295452|NCT00567164|11513976|FG001|Overall Study|Death|0
7295453|NCT00567164|11513977|FG002|Overall Study|Death|1
7295454|NCT00567164|11513975|FG000|Overall Study|Lost to Follow-up|202
7295455|NCT00567164|11513976|FG001|Overall Study|Lost to Follow-up|23
7295456|NCT00567164|11513977|FG002|Overall Study|Lost to Follow-up|21
7295457|NCT00567164|11513975|FG000|Overall Study|Pregnancy|20
7295458|NCT00567164|11513976|FG001|Overall Study|Pregnancy|4
7295459|NCT00567164|11513977|FG002|Overall Study|Pregnancy|6
7295460|NCT00567164|11513975|FG000|Overall Study|Primary Reason coded as 'Other'|37
7295461|NCT00567164|11513976|FG001|Overall Study|Primary Reason coded as 'Other'|8
7295462|NCT00567164|11513977|FG002|Overall Study|Primary Reason coded as 'Other'|16
7295463|NCT00567164|11513975|FG000|Overall Study|Missing|1
7295464|NCT00567164|11513976|FG001|Overall Study|Missing|0
7295465|NCT00567164|11513977|FG002|Overall Study|Missing|0
7295466|NCT00567190|11513991|FG000|Overall Study|Death|235
7295467|NCT00567190|11513992|FG001|Overall Study|Death|280
7295468|NCT00567190|11513991|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
7295469|NCT00567190|11513992|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
7295470|NCT00567255|11514018|FG000|Overall Study|Adverse Event|241
7295471|NCT00567255|11514019|FG001|Overall Study|Adverse Event|68
7295472|NCT00567255|11514018|FG000|Overall Study|Lost to Follow-up|77
7219205|NCT03571204|11427926|FG000|Overall Study|Stopped due to COVID-19 pandemic|1
7219206|NCT03571204|11427927|FG001|Overall Study|Stopped due to COVID-19 pandemic|1
7219207|NCT03571204|11427928|FG002|Overall Study|Stopped due to COVID-19 pandemic|0
7219208|NCT03571204|11427926|FG000|Overall Study|Physician Decision|0
7219209|NCT03571204|11427927|FG001|Overall Study|Physician Decision|1
7219210|NCT03571204|11427928|FG002|Overall Study|Physician Decision|0
7219211|NCT03523091|11427939|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1
7219212|NCT03523091|11427940|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0
7219213|NCT03523091|11427939|FG000|Overall Study|Withdrawal by Subject|0
7219214|NCT03523091|11427940|FG001|Overall Study|Withdrawal by Subject|3
7219215|NCT03523091|11427939|FG000|Overall Study|Increase Botox dose|0
7219216|NCT03523091|11427940|FG001|Overall Study|Increase Botox dose|1
7219217|NCT03391960|11427968|FG000|Overall Study|Protocol Violation|0
7219218|NCT03391960|11427969|FG001|Overall Study|Protocol Violation|
7219219|NCT03362190|11427988|FG000|Overall Study|Adverse Event|0
7219220|NCT03362190|11427989|FG001|Overall Study|Adverse Event|0
7219221|NCT03362190|11427990|FG002|Overall Study|Adverse Event|0
7219222|NCT03362190|11427991|FG003|Overall Study|Adverse Event|1
7219223|NCT03362190|11427988|FG000|Overall Study|Withdrawal by Subject|0
7219224|NCT03362190|11427989|FG001|Overall Study|Withdrawal by Subject|0
7219225|NCT03362190|11427990|FG002|Overall Study|Withdrawal by Subject|0
7219226|NCT03362190|11427991|FG003|Overall Study|Withdrawal by Subject|1
7219227|NCT03252522|11428006|FG000|Overall Study|Adverse Event|3
7219228|NCT03252522|11428007|FG001|Overall Study|Adverse Event|1
7219229|NCT03252522|11428008|FG002|Overall Study|Adverse Event|0
7219230|NCT03252522|11428006|FG000|Overall Study|Unable to swallow pills|4
7219231|NCT03252522|11428007|FG001|Overall Study|Unable to swallow pills|1
7219232|NCT03252522|11428008|FG002|Overall Study|Unable to swallow pills|0
7219233|NCT03252522|11428006|FG000|Overall Study|Commenced stimulant medication|1
7219234|NCT03252522|11428007|FG001|Overall Study|Commenced stimulant medication|1
7219235|NCT03252522|11428008|FG002|Overall Study|Commenced stimulant medication|0
7219236|NCT03252522|11428006|FG000|Overall Study|Protocol Violation|1
7219237|NCT03252522|11428007|FG001|Overall Study|Protocol Violation|0
7219238|NCT03252522|11428008|FG002|Overall Study|Protocol Violation|0
7624359|NCT00085735|12035392|FG000|Overall Study|Physician Decision|2
7624360|NCT00085735|12035393|FG001|Overall Study|Physician Decision|3
7624361|NCT00085735|12035394|FG002|Overall Study|Physician Decision|2
7624362|NCT00085735|12035395|FG003|Overall Study|Physician Decision|3
7624363|NCT00085735|12035396|FG004|Overall Study|Physician Decision|11
7624364|NCT00085735|12035397|FG005|Overall Study|Physician Decision|8
7624365|NCT00085735|12035392|FG000|Overall Study|Protocol Violation|1
7624366|NCT00085735|12035393|FG001|Overall Study|Protocol Violation|0
7624367|NCT00085735|12035394|FG002|Overall Study|Protocol Violation|0
7624368|NCT00085735|12035395|FG003|Overall Study|Protocol Violation|0
7624369|NCT00085735|12035396|FG004|Overall Study|Protocol Violation|0
7624370|NCT00085735|12035397|FG005|Overall Study|Protocol Violation|0
7624371|NCT00085735|12035392|FG000|Overall Study|Withdrawal by Subject|1
7624372|NCT00085735|12035393|FG001|Overall Study|Withdrawal by Subject|0
7624373|NCT00085735|12035394|FG002|Overall Study|Withdrawal by Subject|4
7624374|NCT00085735|12035395|FG003|Overall Study|Withdrawal by Subject|5
7624375|NCT00085735|12035396|FG004|Overall Study|Withdrawal by Subject|7
7624376|NCT00085735|12035397|FG005|Overall Study|Withdrawal by Subject|8
7624377|NCT00085735|12035392|FG000|Overall Study|Patient ineligible|1
7624378|NCT00085735|12035393|FG001|Overall Study|Patient ineligible|0
7219259|NCT03225833|11428043|FG000|Overall Study|Adverse Event|0
7219260|NCT03225833|11428044|FG001|Overall Study|Adverse Event|1
7219261|NCT03225833|11428045|FG002|Overall Study|Adverse Event|2
7219262|NCT03225833|11428046|FG003|Overall Study|Adverse Event|0
7219263|NCT03225833|11428047|FG004|Overall Study|Adverse Event|0
7219264|NCT03225833|11428048|FG005|Overall Study|Adverse Event|2
7219265|NCT03225833|11428043|FG000|Overall Study|Withdrawal by Subject|1
7219266|NCT03225833|11428044|FG001|Overall Study|Withdrawal by Subject|0
7219267|NCT03225833|11428045|FG002|Overall Study|Withdrawal by Subject|0
7295473|NCT00567255|11514019|FG001|Overall Study|Lost to Follow-up|48
7295474|NCT00567255|11514018|FG000|Overall Study|Withdrawal by Subject|75
7295475|NCT00567255|11514019|FG001|Overall Study|Withdrawal by Subject|56
7219268|NCT03225833|11428046|FG003|Overall Study|Withdrawal by Subject|0
7219269|NCT03225833|11428047|FG004|Overall Study|Withdrawal by Subject|1
7219270|NCT03225833|11428048|FG005|Overall Study|Withdrawal by Subject|0
7219271|NCT03225833|11428043|FG000|Overall Study|Termination of Study by Sponsor|4
7219272|NCT03225833|11428044|FG001|Overall Study|Termination of Study by Sponsor|0
7219273|NCT03225833|11428045|FG002|Overall Study|Termination of Study by Sponsor|0
7219274|NCT03225833|11428046|FG003|Overall Study|Termination of Study by Sponsor|0
7295476|NCT00567255|11514018|FG000|Overall Study|Lack of Efficacy|19
7624379|NCT00085735|12035394|FG002|Overall Study|Patient ineligible|3
7295477|NCT00567255|11514019|FG001|Overall Study|Lack of Efficacy|33
7295478|NCT00567255|11514018|FG000|Overall Study|Protocol Violation|20
7295479|NCT00567255|11514019|FG001|Overall Study|Protocol Violation|8
7295480|NCT00567255|11514018|FG000|Overall Study|Pregnancy|6
7295481|NCT00567255|11514019|FG001|Overall Study|Pregnancy|0
7295482|NCT00567255|11514018|FG000|Overall Study|Drug noncompliance,moved,other|25
7295483|NCT00567255|11514019|FG001|Overall Study|Drug noncompliance,moved,other|15
7295484|NCT00567268|11514025|FG000|Overall Study|Protocol Violation|7
7295485|NCT00567268|11514025|FG000|Overall Study|Lost to Follow-up|36
7295486|NCT00567268|11514025|FG000|Overall Study|No Visit After First Day of Treatment|2
7295487|NCT00567268|11514025|FG000|Overall Study|No Drug Administration|4
7295488|NCT00567268|11514025|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
7295489|NCT00567359|11514082|FG000|Overall Study|Withdrawal by Subject|1
7295490|NCT00567398|11514088|FG000|Overall Study|Adverse Event|6
7295491|NCT00567398|11514089|FG001|Overall Study|Adverse Event|14
7295492|NCT00567398|11514088|FG000|Overall Study|Physician Decision|0
7295493|NCT00567398|11514089|FG001|Overall Study|Physician Decision|4
7295494|NCT00567398|11514088|FG000|Overall Study|Withdrawal by Subject|0
7295495|NCT00567398|11514089|FG001|Overall Study|Withdrawal by Subject|2
7295496|NCT00567398|11514088|FG000|Overall Study|Renal Transplantation|0
7295497|NCT00567398|11514089|FG001|Overall Study|Renal Transplantation|3
7295498|NCT00567398|11514088|FG000|Overall Study|Other|1
7295499|NCT00567398|11514089|FG001|Overall Study|Other|0
7295500|NCT00567476|11514097|FG000|Overall Study|Adverse Event|2
7295501|NCT00567476|11514098|FG001|Overall Study|Adverse Event|0
7295502|NCT00567476|11514097|FG000|Overall Study|Pregnancy|1
7295503|NCT00567476|11514098|FG001|Overall Study|Pregnancy|0
7295504|NCT00567476|11514097|FG000|Overall Study|Protocol Violation|4
7295505|NCT00567476|11514098|FG001|Overall Study|Protocol Violation|1
7295506|NCT00567476|11514097|FG000|Overall Study|Lost to Follow-up|0
7295507|NCT00567476|11514098|FG001|Overall Study|Lost to Follow-up|1
7295508|NCT00567476|11514097|FG000|Overall Study|Administrative issues|1
7295509|NCT00567476|11514098|FG001|Overall Study|Administrative issues|0
7295510|NCT00567476|11514097|FG000|Overall Study|Medical Decision|0
7295511|NCT00567476|11514098|FG001|Overall Study|Medical Decision|1
7295512|NCT00567476|11514097|FG000|Overall Study|Non-adherence to protocol|0
7295513|NCT00567476|11514098|FG001|Overall Study|Non-adherence to protocol|1
7295514|NCT00567489|11514106|FG000|Overall Study|Adverse Event|6
7295515|NCT00567489|11514107|FG001|Overall Study|Adverse Event|14
7295516|NCT00567489|11514106|FG000|Overall Study|Physician Decision|0
7295517|NCT00567489|11514107|FG001|Overall Study|Physician Decision|4
7295518|NCT00567489|11514106|FG000|Overall Study|Withdrawal by Subject|0
7295519|NCT00567489|11514107|FG001|Overall Study|Withdrawal by Subject|2
7295520|NCT00567489|11514106|FG000|Overall Study|Renal Transplantation|0
7295521|NCT00567489|11514107|FG001|Overall Study|Renal Transplantation|3
7295522|NCT00567489|11514106|FG000|Overall Study|Other|1
7295523|NCT00567489|11514107|FG001|Overall Study|Other|0
7295524|NCT00567502|11514117|FG000|Overall Study|Lost to Follow-up|91
7295525|NCT00567502|11514118|FG001|Overall Study|Lost to Follow-up|14
7295526|NCT00567502|11514119|FG002|Overall Study|Lost to Follow-up|351
7295527|NCT00567502|11514120|FG003|Overall Study|Lost to Follow-up|2
7295528|NCT00567502|11514117|FG000|Overall Study|Death|65
7295529|NCT00567502|11514118|FG001|Overall Study|Death|16
7295530|NCT00567502|11514119|FG002|Overall Study|Death|360
7295531|NCT00567502|11514120|FG003|Overall Study|Death|5
7295532|NCT00567502|11514117|FG000|Overall Study|Other|64
7295533|NCT00567502|11514118|FG001|Overall Study|Other|2
7295534|NCT00567502|11514119|FG002|Overall Study|Other|134
7295535|NCT00567502|11514120|FG003|Overall Study|Other|6
7295536|NCT00567502|11514117|FG000|Overall Study|Participant request|12
7295537|NCT00567502|11514118|FG001|Overall Study|Participant request|1
7295538|NCT00567502|11514119|FG002|Overall Study|Participant request|33
7295539|NCT00567502|11514120|FG003|Overall Study|Participant request|1
7295540|NCT00567502|11514117|FG000|Overall Study|Sponsor request|9
7295541|NCT00567502|11514118|FG001|Overall Study|Sponsor request|0
7295542|NCT00567502|11514119|FG002|Overall Study|Sponsor request|30
7295543|NCT00567502|11514120|FG003|Overall Study|Sponsor request|1
7295544|NCT00567502|11514117|FG000|Overall Study|Never Initiated Treatment|0
7295545|NCT00567502|11514118|FG001|Overall Study|Never Initiated Treatment|0
7295546|NCT00567502|11514119|FG002|Overall Study|Never Initiated Treatment|0
7295547|NCT00567502|11514120|FG003|Overall Study|Never Initiated Treatment|72
7295548|NCT00567541|11514143|FG000|Overall Study|Adverse Event|0
7295549|NCT00567541|11514144|FG001|Overall Study|Adverse Event|1
7295550|NCT00567593|11514150|FG000|Overall Study|Adverse Event|1
7295551|NCT00567593|11514150|FG000|Overall Study|Physician Decision|1
7295552|NCT00567879|11514181|FG000|Overall Study|Adverse Event|2
7295553|NCT00567879|11514182|FG001|Overall Study|Adverse Event|0
7295554|NCT00567879|11514183|FG002|Overall Study|Adverse Event|1
7295555|NCT00567879|11514184|FG003|Overall Study|Adverse Event|0
7295556|NCT00567879|11514185|FG004|Overall Study|Adverse Event|1
7295557|NCT00567879|11514186|FG005|Overall Study|Adverse Event|0
7295558|NCT00567879|11514181|FG000|Overall Study|Abnormal test procedure(s)|0
7295559|NCT00567879|11514182|FG001|Overall Study|Abnormal test procedure(s)|0
7295560|NCT00567879|11514183|FG002|Overall Study|Abnormal test procedure(s)|1
7295561|NCT00567879|11514184|FG003|Overall Study|Abnormal test procedure(s)|0
7295562|NCT00567879|11514185|FG004|Overall Study|Abnormal test procedure(s)|0
7295563|NCT00567879|11514186|FG005|Overall Study|Abnormal test procedure(s)|0
7295564|NCT00567879|11514181|FG000|Overall Study|Withdrawal by Subject|0
7295565|NCT00567879|11514182|FG001|Overall Study|Withdrawal by Subject|0
7295566|NCT00567879|11514183|FG002|Overall Study|Withdrawal by Subject|3
7295567|NCT00567879|11514184|FG003|Overall Study|Withdrawal by Subject|1
7295568|NCT00567879|11514185|FG004|Overall Study|Withdrawal by Subject|0
7295569|NCT00567879|11514186|FG005|Overall Study|Withdrawal by Subject|0
7295570|NCT00567879|11514181|FG000|Overall Study|New cancer therapy|0
7295571|NCT00567879|11514182|FG001|Overall Study|New cancer therapy|0
7295572|NCT00567879|11514183|FG002|Overall Study|New cancer therapy|1
7295573|NCT00567879|11514184|FG003|Overall Study|New cancer therapy|0
7295574|NCT00567879|11514185|FG004|Overall Study|New cancer therapy|0
7295575|NCT00567879|11514186|FG005|Overall Study|New cancer therapy|0
7295576|NCT00567879|11514181|FG000|Overall Study|Disease progression|5
7295577|NCT00567879|11514182|FG001|Overall Study|Disease progression|7
7295578|NCT00567879|11514183|FG002|Overall Study|Disease progression|15
7295579|NCT00567879|11514184|FG003|Overall Study|Disease progression|5
7295580|NCT00567879|11514185|FG004|Overall Study|Disease progression|11
7295581|NCT00567879|11514186|FG005|Overall Study|Disease progression|3
7295582|NCT00567892|11514206|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7295583|NCT00567892|11514207|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7295584|NCT00567892|11514208|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7295585|NCT00567892|11514209|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
7295586|NCT00567892|11514206|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7295587|NCT00567892|11514207|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7295588|NCT00567892|11514208|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
7295589|NCT00567892|11514209|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
7295590|NCT00567996|11514224|FG000|Overall Study|Adverse Event|18
7295591|NCT00567996|11514225|FG001|Overall Study|Adverse Event|16
7295592|NCT00567996|11514226|FG002|Overall Study|Adverse Event|13
7295593|NCT00567996|11514224|FG000|Overall Study|Protocol Deviation|9
7295594|NCT00567996|11514225|FG001|Overall Study|Protocol Deviation|11
7295595|NCT00567996|11514226|FG002|Overall Study|Protocol Deviation|13
7295596|NCT00567996|11514224|FG000|Overall Study|Withdrawal by Subject|8
7295597|NCT00567996|11514225|FG001|Overall Study|Withdrawal by Subject|12
7295598|NCT00567996|11514226|FG002|Overall Study|Withdrawal by Subject|22
7295599|NCT00567996|11514224|FG000|Overall Study|Abnormal Lab value(s)|2
7295600|NCT00567996|11514225|FG001|Overall Study|Abnormal Lab value(s)|1
7295601|NCT00567996|11514226|FG002|Overall Study|Abnormal Lab value(s)|2
7295602|NCT00567996|11514224|FG000|Overall Study|Abnormal test procedure result(s)|2
7295603|NCT00567996|11514225|FG001|Overall Study|Abnormal test procedure result(s)|1
7295604|NCT00567996|11514226|FG002|Overall Study|Abnormal test procedure result(s)|1
7295605|NCT00567996|11514224|FG000|Overall Study|Lost to Follow-up|2
7295606|NCT00567996|11514225|FG001|Overall Study|Lost to Follow-up|5
7295607|NCT00567996|11514226|FG002|Overall Study|Lost to Follow-up|2
7295608|NCT00567996|11514224|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7295609|NCT00567996|11514225|FG001|Overall Study|Unsatisfactory therapeutic effect|2
7295610|NCT00567996|11514226|FG002|Overall Study|Unsatisfactory therapeutic effect|15
7295611|NCT00567996|11514224|FG000|Overall Study|Administrative problems|1
7295612|NCT00567996|11514225|FG001|Overall Study|Administrative problems|1
7295613|NCT00567996|11514226|FG002|Overall Study|Administrative problems|0
7295614|NCT00567996|11514224|FG000|Overall Study|Death|1
7295615|NCT00567996|11514225|FG001|Overall Study|Death|0
7295616|NCT00567996|11514226|FG002|Overall Study|Death|2
7295617|NCT00567996|11514224|FG000|Overall Study|Patient's inability to use the device|0
7295618|NCT00567996|11514225|FG001|Overall Study|Patient's inability to use the device|1
7295619|NCT00567996|11514226|FG002|Overall Study|Patient's inability to use the device|0
7295620|NCT00568061|11514250|FG000|Overall Study|Inclusion / exclusion criteria|5
7295621|NCT00568061|11514251|FG001|Overall Study|Inclusion / exclusion criteria|1
7295622|NCT00568061|11514250|FG000|Overall Study|Adverse Event|0
7295623|NCT00568061|11514251|FG001|Overall Study|Adverse Event|1
7295624|NCT00568126|11514269|FG000|Overall Study|Adverse Event|3
7295625|NCT00568126|11514270|FG001|Overall Study|Adverse Event|0
7295626|NCT00568126|11514269|FG000|Overall Study|Withdrawal by Subject|2
7295627|NCT00568126|11514270|FG001|Overall Study|Withdrawal by Subject|3
7295628|NCT00568126|11514269|FG000|Overall Study|Lost to Follow-up|4
7295629|NCT00568126|11514270|FG001|Overall Study|Lost to Follow-up|3
7295630|NCT00568126|11514269|FG000|Overall Study|Lack of Efficacy|0
7295631|NCT00568126|11514270|FG001|Overall Study|Lack of Efficacy|1
7295632|NCT00568126|11514269|FG000|Overall Study|Physician Decision|2
7295633|NCT00568126|11514270|FG001|Overall Study|Physician Decision|2
7295634|NCT00568321|11514279|FG000|Overall Study|Adverse Event|1
7295635|NCT00568321|11514280|FG001|Overall Study|Adverse Event|0
7295636|NCT00568321|11514281|FG002|Overall Study|Adverse Event|0
7295637|NCT00568321|11514279|FG000|Overall Study|Lack of Efficacy|8
7295638|NCT00568321|11514280|FG001|Overall Study|Lack of Efficacy|5
7295639|NCT00568321|11514281|FG002|Overall Study|Lack of Efficacy|6
7295640|NCT00568321|11514279|FG000|Overall Study|Lost to Follow-up|0
7295641|NCT00568321|11514280|FG001|Overall Study|Lost to Follow-up|0
7295642|NCT00568321|11514281|FG002|Overall Study|Lost to Follow-up|1
7295643|NCT00568321|11514279|FG000|Overall Study|Withdrawal by Subject|2
7295644|NCT00568321|11514280|FG001|Overall Study|Withdrawal by Subject|0
7295645|NCT00568321|11514281|FG002|Overall Study|Withdrawal by Subject|0
7295646|NCT00568321|11514279|FG000|Overall Study|Protocol Violation|0
7295647|NCT00568321|11514280|FG001|Overall Study|Protocol Violation|0
7295648|NCT00568321|11514281|FG002|Overall Study|Protocol Violation|1
7295649|NCT00568321|11514279|FG000|Overall Study|Randomized, not treated|2
7295650|NCT00568321|11514280|FG001|Overall Study|Randomized, not treated|0
7295651|NCT00568321|11514281|FG002|Overall Study|Randomized, not treated|1
7295652|NCT00568334|11514293|FG000|Overall Study|Withdrawal by Subject|0
7295653|NCT00568334|11514294|FG001|Overall Study|Withdrawal by Subject|1
7295654|NCT00568334|11514293|FG000|Overall Study|Lost to Follow-up|1
7295655|NCT00568334|11514294|FG001|Overall Study|Lost to Follow-up|0
7295656|NCT00568399|11514309|FG000|Overall Study|Death|2
7295657|NCT00568399|11514309|FG000|Overall Study|Adverse Event|5
7295658|NCT00568399|11514309|FG000|Overall Study|Withdrawal by Subject|8
7295659|NCT00568451|11514317|FG000|Overall Study|Disease Progression|0
7295660|NCT00568451|11514318|FG001|Overall Study|Disease Progression|0
7295661|NCT00568451|11514319|FG002|Overall Study|Disease Progression|2
7295662|NCT00568451|11514320|FG003|Overall Study|Disease Progression|7
7295663|NCT00568555|11514333|FG000|Overall Study|Withdrawal by Subject|1
7295664|NCT00568555|11514334|FG001|Overall Study|Withdrawal by Subject|1
7295665|NCT00568685|11514354|FG000|Overall Study|Adverse Event|2
7295666|NCT00568685|11514355|FG001|Overall Study|Adverse Event|3
7295667|NCT00568685|11514356|FG002|Overall Study|Adverse Event|3
7295668|NCT00568685|11514354|FG000|Overall Study|Withdrawal by Subject|7
7295669|NCT00568685|11514355|FG001|Overall Study|Withdrawal by Subject|2
7295670|NCT00568685|11514356|FG002|Overall Study|Withdrawal by Subject|2
7295671|NCT00568685|11514354|FG000|Overall Study|Protocol Violation|1
7295672|NCT00568685|11514355|FG001|Overall Study|Protocol Violation|0
7295673|NCT00568685|11514356|FG002|Overall Study|Protocol Violation|0
7295674|NCT00568776|11514372|FG000|Overall Study|Adverse Event|8
7295675|NCT00568776|11514373|FG001|Overall Study|Adverse Event|8
7295676|NCT00568776|11514374|FG002|Overall Study|Adverse Event|10
7295677|NCT00568776|11514375|FG003|Overall Study|Adverse Event|8
7295678|NCT00568776|11514372|FG000|Overall Study|Death|0
7295679|NCT00568776|11514373|FG001|Overall Study|Death|1
7295680|NCT00568776|11514374|FG002|Overall Study|Death|4
7295681|NCT00568776|11514375|FG003|Overall Study|Death|3
7295682|NCT00568776|11514372|FG000|Overall Study|Physician Decision|0
7295683|NCT00568776|11514373|FG001|Overall Study|Physician Decision|2
7295684|NCT00568776|11514374|FG002|Overall Study|Physician Decision|0
7295685|NCT00568776|11514375|FG003|Overall Study|Physician Decision|0
7295686|NCT00568776|11514372|FG000|Overall Study|Lack of Efficacy|2
7295687|NCT00568776|11514373|FG001|Overall Study|Lack of Efficacy|2
7295688|NCT00568776|11514374|FG002|Overall Study|Lack of Efficacy|2
7295689|NCT00568776|11514375|FG003|Overall Study|Lack of Efficacy|4
7295690|NCT00568776|11514372|FG000|Overall Study|Lost to Follow-up|1
7295691|NCT00568776|11514373|FG001|Overall Study|Lost to Follow-up|1
7295692|NCT00568776|11514374|FG002|Overall Study|Lost to Follow-up|1
7295693|NCT00568776|11514375|FG003|Overall Study|Lost to Follow-up|1
7295694|NCT00568776|11514372|FG000|Overall Study|Protocol Violation|1
7295695|NCT00568776|11514373|FG001|Overall Study|Protocol Violation|0
7295696|NCT00568776|11514374|FG002|Overall Study|Protocol Violation|1
7295697|NCT00568776|11514375|FG003|Overall Study|Protocol Violation|1
7295698|NCT00568776|11514372|FG000|Overall Study|Withdrawal by Subject|13
7295699|NCT00568776|11514373|FG001|Overall Study|Withdrawal by Subject|15
7295700|NCT00568776|11514374|FG002|Overall Study|Withdrawal by Subject|13
7295701|NCT00568776|11514375|FG003|Overall Study|Withdrawal by Subject|7
7295702|NCT00568776|11514372|FG000|Overall Study|Loss of Caregiver|0
7295703|NCT00568776|11514373|FG001|Overall Study|Loss of Caregiver|2
7295704|NCT00568776|11514374|FG002|Overall Study|Loss of Caregiver|1
7295705|NCT00568776|11514375|FG003|Overall Study|Loss of Caregiver|2
7295706|NCT00568776|11514372|FG000|Overall Study|Sponsor Decision|2
7295707|NCT00568776|11514373|FG001|Overall Study|Sponsor Decision|2
7295708|NCT00568776|11514374|FG002|Overall Study|Sponsor Decision|41
7295709|NCT00568776|11514375|FG003|Overall Study|Sponsor Decision|42
7219275|NCT03225833|11428047|FG004|Overall Study|Termination of Study by Sponsor|0
7219276|NCT03225833|11428048|FG005|Overall Study|Termination of Study by Sponsor|7
7219277|NCT03225833|11428043|FG000|Overall Study|Sponsor Decision|0
7219278|NCT03225833|11428044|FG001|Overall Study|Sponsor Decision|0
7219279|NCT03225833|11428045|FG002|Overall Study|Sponsor Decision|0
7219280|NCT03225833|11428046|FG003|Overall Study|Sponsor Decision|0
7219281|NCT03225833|11428047|FG004|Overall Study|Sponsor Decision|0
7219282|NCT03225833|11428048|FG005|Overall Study|Sponsor Decision|1
7219283|NCT03167242|11428079|FG000|Overall Study|Patient/Guardian Decision|0
7219284|NCT03167242|11428080|FG001|Overall Study|Patient/Guardian Decision|1
7219285|NCT03167242|11428081|FG002|Overall Study|Patient/Guardian Decision|2
7219286|NCT03167242|11428082|FG003|Overall Study|Patient/Guardian Decision|1
7219287|NCT03167242|11428083|FG004|Overall Study|Patient/Guardian Decision|1
7219288|NCT03167242|11428084|FG005|Overall Study|Patient/Guardian Decision|1
7219289|NCT03167242|11428085|FG006|Overall Study|Patient/Guardian Decision|0
7219290|NCT03167242|11428086|FG007|Overall Study|Patient/Guardian Decision|0
7219291|NCT03167242|11428087|FG008|Overall Study|Patient/Guardian Decision|0
7219292|NCT03167242|11428088|FG009|Overall Study|Patient/Guardian Decision|0
7219293|NCT03167242|11428089|FG010|Overall Study|Patient/Guardian Decision|1
7219294|NCT03167242|11428090|FG011|Overall Study|Patient/Guardian Decision|0
7219295|NCT03167242|11428079|FG000|Overall Study|Lost to Follow-up|0
7295710|NCT00568776|11514372|FG000|Overall Study|Miscellaeneous|3
7295711|NCT00568776|11514373|FG001|Overall Study|Miscellaeneous|3
7295712|NCT00568776|11514374|FG002|Overall Study|Miscellaeneous|1
7295713|NCT00568776|11514375|FG003|Overall Study|Miscellaeneous|4
7551459|NCT02969590|11910696|FG000|Screening Period|Hormones not suppressed post Lupron|1
7551460|NCT02969590|11910697|FG001|Screening Period|Hormones not suppressed post Lupron|0
7551461|NCT02969590|11910698|FG002|Screening Period|Hormones not suppressed post Lupron|0
7551462|NCT02969655|11910710|FG000|Overall Study|Withdrawal by Subject|3
7551463|NCT02969655|11910711|FG001|Overall Study|Withdrawal by Subject|2
7551464|NCT02969655|11910710|FG000|Overall Study|Physician Decision|4
7551465|NCT02969655|11910711|FG001|Overall Study|Physician Decision|3
7551466|NCT02969655|11910710|FG000|Overall Study|Protocol-specified withdrawal criteria|4
7551467|NCT02969655|11910711|FG001|Overall Study|Protocol-specified withdrawal criteria|2
7551468|NCT02969655|11910710|FG000|Overall Study|Adverse Event|10
7551469|NCT02969655|11910711|FG001|Overall Study|Adverse Event|8
7551470|NCT02969707|11910720|FG000|Overall Study|Adverse Event|1
7551471|NCT02969707|11910721|FG001|Overall Study|Adverse Event|2
7551472|NCT02969707|11910720|FG000|Overall Study|Lost to Follow-up|3
7551473|NCT02969707|11910721|FG001|Overall Study|Lost to Follow-up|0
7551474|NCT02969707|11910720|FG000|Overall Study|Physician Decision|0
7551475|NCT02969707|11910721|FG001|Overall Study|Physician Decision|1
7551476|NCT02969707|11910720|FG000|Overall Study|Protocol Violation|1
7551477|NCT02969707|11910721|FG001|Overall Study|Protocol Violation|1
7551478|NCT02969707|11910720|FG000|Overall Study|Withdrawal by Subject|3
7551479|NCT02969707|11910721|FG001|Overall Study|Withdrawal by Subject|4
7551480|NCT02969863|11910732|FG000|Overall Study|Physician Decision|1
7551481|NCT02969863|11910733|FG001|Overall Study|Physician Decision|0
7551482|NCT02969863|11910734|FG002|Overall Study|Physician Decision|0
7551483|NCT02969863|11910735|FG003|Overall Study|Physician Decision|0
7551484|NCT02969863|11910736|FG004|Overall Study|Physician Decision|0
7551485|NCT02969863|11910737|FG005|Overall Study|Physician Decision|0
7551486|NCT02970292|11910776|FG000|Overall Study|Physician Decision|1
7551487|NCT02970292|11910777|FG001|Overall Study|Physician Decision|1
7551488|NCT02970292|11910776|FG000|Overall Study|Withdrawal by Subject|11
7551489|NCT02970292|11910777|FG001|Overall Study|Withdrawal by Subject|5
7551490|NCT02970292|11910776|FG000|Overall Study|Noncompliance with study drug|2
7551491|NCT02970292|11910777|FG001|Overall Study|Noncompliance with study drug|2
7551492|NCT02970292|11910776|FG000|Overall Study|Adverse Event|5
7551493|NCT02970292|11910777|FG001|Overall Study|Adverse Event|0
7551494|NCT02970292|11910776|FG000|Overall Study|Lack of Efficacy|1
7551495|NCT02970292|11910777|FG001|Overall Study|Lack of Efficacy|0
7551496|NCT02970292|11910776|FG000|Overall Study|Lost to Follow-up|1
7551497|NCT02970292|11910777|FG001|Overall Study|Lost to Follow-up|0
7551498|NCT02970292|11910776|FG000|Overall Study|Protocol Violation|2
7551499|NCT02970292|11910777|FG001|Overall Study|Protocol Violation|0
7551500|NCT02970292|11910776|FG000|Overall Study|Other|1
7551501|NCT02970292|11910777|FG001|Overall Study|Other|0
7551502|NCT02970305|11910785|FG000|Overall Study|Adverse Event|10
7551503|NCT02970305|11910786|FG001|Overall Study|Adverse Event|6
7551504|NCT02970305|11910785|FG000|Overall Study|Lack of Efficacy|1
7551505|NCT02970305|11910786|FG001|Overall Study|Lack of Efficacy|1
7551506|NCT02970305|11910785|FG000|Overall Study|Noncompliance with study drug|2
7551507|NCT02970305|11910786|FG001|Overall Study|Noncompliance with study drug|4
7551508|NCT02970305|11910785|FG000|Overall Study|Protocol Violation|2
7551509|NCT02970305|11910786|FG001|Overall Study|Protocol Violation|2
7551510|NCT02970305|11910785|FG000|Overall Study|Withdrawal by Subject|12
7551511|NCT02970305|11910786|FG001|Overall Study|Withdrawal by Subject|11
7551512|NCT02970305|11910785|FG000|Overall Study|Not further specified|1
7551513|NCT02970305|11910786|FG001|Overall Study|Not further specified|2
7551514|NCT02970305|11910785|FG000|Overall Study|Lost to Follow-up|1
7551515|NCT02970305|11910786|FG001|Overall Study|Lost to Follow-up|2
7624380|NCT00085735|12035395|FG003|Overall Study|Patient ineligible|7
7624381|NCT00085735|12035396|FG004|Overall Study|Patient ineligible|17
7624382|NCT00085735|12035397|FG005|Overall Study|Patient ineligible|8
7624383|NCT00085735|12035392|FG000|Overall Study|Excess residual disease|2
7624384|NCT00085735|12035393|FG001|Overall Study|Excess residual disease|2
7624385|NCT00085735|12035394|FG002|Overall Study|Excess residual disease|1
7624386|NCT00085735|12035395|FG003|Overall Study|Excess residual disease|1
7624387|NCT00085735|12035396|FG004|Overall Study|Excess residual disease|1
7624388|NCT00085735|12035397|FG005|Overall Study|Excess residual disease|4
7624389|NCT00085735|12035392|FG000|Overall Study|Reason not documented|1
7624390|NCT00085735|12035393|FG001|Overall Study|Reason not documented|0
7624391|NCT00085735|12035394|FG002|Overall Study|Reason not documented|1
7624392|NCT00085735|12035395|FG003|Overall Study|Reason not documented|0
7624393|NCT00085735|12035396|FG004|Overall Study|Reason not documented|1
7624394|NCT00085735|12035397|FG005|Overall Study|Reason not documented|0
7624395|NCT00085735|12035392|FG000|Overall Study|Pt transferred to inst w/out study open|1
7624396|NCT00085735|12035393|FG001|Overall Study|Pt transferred to inst w/out study open|0
7624397|NCT00085735|12035394|FG002|Overall Study|Pt transferred to inst w/out study open|0
7624398|NCT00085735|12035395|FG003|Overall Study|Pt transferred to inst w/out study open|0
7624399|NCT00085735|12035396|FG004|Overall Study|Pt transferred to inst w/out study open|0
7624400|NCT00085735|12035397|FG005|Overall Study|Pt transferred to inst w/out study open|0
7295714|NCT04274192|11514387|FG000|Overall Study|Protocol Violation|1
7295715|NCT04274192|11514388|FG001|Overall Study|Protocol Violation|0
7295716|NCT04110314|11514406|FG000|Overall Study|Did not meet inclusion criteria|35255
7295717|NCT04110314|11514407|FG001|Overall Study|Did not meet inclusion criteria|35104
7295718|NCT04110314|11514408|FG002|Overall Study|Did not meet inclusion criteria|35636
7295719|NCT04110314|11514409|FG003|Overall Study|Did not meet inclusion criteria|35135
7295720|NCT04110314|11514410|FG004|Overall Study|Did not meet inclusion criteria|35247
7295721|NCT04110314|11514411|FG005|Overall Study|Did not meet inclusion criteria|35727
7295742|NCT03961204|11514453|FG000|Overall Study|Withdrawal by Subject|2
7295743|NCT03961204|11514453|FG000|Overall Study|Lost to Follow-up|3
7295744|NCT03961204|11514453|FG000|Overall Study|Other|1
7295745|NCT03961204|11514453|FG000|Overall Study|Missing|1
7295746|NCT03895840|11514457|FG000|Overall Study|Withdrawal by Subject|21
7295747|NCT03818399|11514461|FG000|Overall Study|Lost to Follow-up|11
7295748|NCT03818399|11514461|FG000|Overall Study|Withdrawal by Subject|1
7295749|NCT03818399|11514461|FG000|Overall Study|Protocol Violation|2
7295750|NCT03603496|11514467|FG000|Overall Study|Death|19
7295751|NCT03603496|11514468|FG001|Overall Study|Death|24
7295752|NCT03603496|11514467|FG000|Overall Study|Lost to Follow-up|141
7295753|NCT03603496|11514468|FG001|Overall Study|Lost to Follow-up|141
7295754|NCT03603496|11514467|FG000|Overall Study|Withdrawal by Subject|26
7295755|NCT03603496|11514468|FG001|Overall Study|Withdrawal by Subject|20
7295756|NCT03480802|11514476|FG000|Overall Study|Lost to Follow-up|5
7295757|NCT03480802|11514477|FG001|Overall Study|Lost to Follow-up|1
7295758|NCT03480802|11514476|FG000|Overall Study|Withdrawal by Subject|2
7295759|NCT03480802|11514477|FG001|Overall Study|Withdrawal by Subject|1
7295760|NCT03480802|11514476|FG000|Overall Study|Relocated|0
7295761|NCT03480802|11514477|FG001|Overall Study|Relocated|1
7295762|NCT03472521|11514487|FG000|Overall Study|Lost to Follow-up|3
7295763|NCT03472521|11514488|FG001|Overall Study|Lost to Follow-up|2
7295764|NCT03472521|11514487|FG000|Overall Study|Discontinued intervention|3
7295765|NCT03472521|11514488|FG001|Overall Study|Discontinued intervention|1
7295766|NCT02664441|11514510|FG000|Randomization|Withdrawal by Subject|0
7295767|NCT02664441|11514511|FG001|Randomization|Withdrawal by Subject|1
7295768|NCT02664441|11514510|FG000|36-week Randomized Trial|Adverse Event|2
7295769|NCT02664441|11514511|FG001|36-week Randomized Trial|Adverse Event|0
7295770|NCT02664441|11514510|FG000|36-week Randomized Trial|Lost to Follow-up|1
7295771|NCT02664441|11514511|FG001|36-week Randomized Trial|Lost to Follow-up|0
7295772|NCT02664441|11514510|FG000|36-week Randomized Trial|Withdrawal by Subject|0
7295773|NCT02664441|11514511|FG001|36-week Randomized Trial|Withdrawal by Subject|3
7295774|NCT02664441|11514510|FG000|18-week Open Label Extension|Adverse Event|1
7295775|NCT02664441|11514511|FG001|18-week Open Label Extension|Adverse Event|0
7295776|NCT02664441|11514510|FG000|18-week Open Label Extension|Physician Decision|1
7219296|NCT03167242|11428080|FG001|Overall Study|Lost to Follow-up|0
7219297|NCT03167242|11428081|FG002|Overall Study|Lost to Follow-up|1
7219298|NCT03167242|11428082|FG003|Overall Study|Lost to Follow-up|0
7219299|NCT03167242|11428083|FG004|Overall Study|Lost to Follow-up|0
7219300|NCT03167242|11428084|FG005|Overall Study|Lost to Follow-up|1
7219301|NCT03167242|11428085|FG006|Overall Study|Lost to Follow-up|2
7219302|NCT03167242|11428086|FG007|Overall Study|Lost to Follow-up|1
7219303|NCT03167242|11428087|FG008|Overall Study|Lost to Follow-up|0
7219304|NCT03167242|11428088|FG009|Overall Study|Lost to Follow-up|0
7219305|NCT03167242|11428089|FG010|Overall Study|Lost to Follow-up|1
7219306|NCT03167242|11428090|FG011|Overall Study|Lost to Follow-up|1
7219307|NCT03167242|11428079|FG000|Overall Study|Reason not provided|0
7219308|NCT03167242|11428080|FG001|Overall Study|Reason not provided|0
7219309|NCT03167242|11428081|FG002|Overall Study|Reason not provided|0
7219310|NCT03167242|11428082|FG003|Overall Study|Reason not provided|0
7219311|NCT03167242|11428083|FG004|Overall Study|Reason not provided|0
7295777|NCT02664441|11514511|FG001|18-week Open Label Extension|Physician Decision|0
7295778|NCT02664441|11514510|FG000|18-week Open Label Extension|Death|1
7295779|NCT02664441|11514511|FG001|18-week Open Label Extension|Death|0
7295780|NCT02664441|11514510|FG000|18-week Open Label Extension|Lost to Follow-up|0
7295781|NCT02664441|11514511|FG001|18-week Open Label Extension|Lost to Follow-up|1
7295782|NCT02513472|11514531|FG000|Overall Study|Radiological Disease Progression|45
7295783|NCT02513472|11514532|FG001|Overall Study|Radiological Disease Progression|57
7295784|NCT02513472|11514531|FG000|Overall Study|Clinical Disease Progression|5
7295785|NCT02513472|11514532|FG001|Overall Study|Clinical Disease Progression|13
7295786|NCT02513472|11514531|FG000|Overall Study|Adverse Event|8
7295787|NCT02513472|11514532|FG001|Overall Study|Adverse Event|11
7295788|NCT02513472|11514531|FG000|Overall Study|Withdrawal by Subject|0
7295789|NCT02513472|11514532|FG001|Overall Study|Withdrawal by Subject|4
7295790|NCT02513472|11514531|FG000|Overall Study|Subject Choice|2
7295791|NCT02513472|11514532|FG001|Overall Study|Subject Choice|7
7295792|NCT02513472|11514531|FG000|Overall Study|Treatment Completed as per Protocol|3
7295793|NCT02513472|11514532|FG001|Overall Study|Treatment Completed as per Protocol|3
7295794|NCT02513472|11514531|FG000|Overall Study|Other|3
7295795|NCT02513472|11514532|FG001|Overall Study|Other|6
7295796|NCT01559935|11514571|FG000|Car Phase|Toxicity|4
7295797|NCT01559935|11514571|FG000|Car Phase|Death|1
7295798|NCT01559935|11514571|FG000|Car Phase|Lack of Efficacy|2
7295799|NCT01559935|11514571|FG000|Car Phase|Lost to Follow-up|1
7295800|NCT01559935|11514571|FG000|Car Phase|Physician Decision|1
7295801|NCT01559935|11514571|FG000|Car Phase|Withdrawal by Subject|2
7295802|NCT01559935|11514571|FG000|Car Phase|Per protocol|1
7295803|NCT01559935|11514571|FG000|Car Phase|Insurance|1
7295804|NCT01559935|11514571|FG000|Car Phase|non-compliance|1
7295805|NCT01559935|11514571|FG000|BiRD Phase|Toxicity|1
7295806|NCT01559935|11514571|FG000|BiRD Phase|Lack of Efficacy|1
7295807|NCT01559935|11514571|FG000|BiRD Phase|Withdrawal by Subject|2
7295808|NCT01559935|11514571|FG000|Maintenance Phase|Remains on study|28
7295809|NCT01559935|11514571|FG000|Maintenance Phase|Toxicity|1
7295810|NCT01559935|11514571|FG000|Maintenance Phase|Lack of Efficacy|18
7295811|NCT01559935|11514571|FG000|Maintenance Phase|Withdrawal by Subject|5
7295812|NCT01559935|11514571|FG000|Maintenance Phase|Non-compliance|2
7295813|NCT01067144|11514586|FG000|Treatment|Did not receive allocated intervention|4
7295814|NCT01067144|11514587|FG001|Treatment|Did not receive allocated intervention|7
7295815|NCT01067144|11514586|FG000|Follow-up|Lost to Follow-up|22
7295816|NCT01067144|11514587|FG001|Follow-up|Lost to Follow-up|12
7295817|NCT01067144|11514586|FG000|Follow-up|Censored owing to second surgery|19
7295818|NCT01067144|11514587|FG001|Follow-up|Censored owing to second surgery|28
7295819|NCT01067144|11514586|FG000|Follow-up|Withdrawal by Subject|18
7295820|NCT01067144|11514587|FG001|Follow-up|Withdrawal by Subject|14
7295821|NCT01067144|11514586|FG000|Follow-up|Surgery cancelled|0
7295822|NCT01067144|11514587|FG001|Follow-up|Surgery cancelled|1
7295823|NCT01067144|11514586|FG000|Follow-up|Death|0
7295824|NCT01067144|11514587|FG001|Follow-up|Death|1
7295825|NCT00600483|11514595|FG000|Overall Study|Lost to Follow-up|26
7295826|NCT00600483|11514596|FG001|Overall Study|Lost to Follow-up|47
7295827|NCT00600483|11514595|FG000|Overall Study|Randomized but not treated|10
7295828|NCT00600483|11514596|FG001|Overall Study|Randomized but not treated|0
7295829|NCT00568958|11514613|FG000|Allocation|Withdrawal by Subject|7
7295830|NCT00568958|11514614|FG001|Allocation|Withdrawal by Subject|3
7295831|NCT00568958|11514613|FG000|Allocation|Physician Decision|2
7295832|NCT00568958|11514614|FG001|Allocation|Physician Decision|0
7295833|NCT00568958|11514613|FG000|Follow-Up|Withdrawal by Subject|6
7295834|NCT00568958|11514614|FG001|Follow-Up|Withdrawal by Subject|6
7295835|NCT00568958|11514613|FG000|Follow-Up|Physician Decision|1
7295836|NCT00568958|11514614|FG001|Follow-Up|Physician Decision|1
7295837|NCT00568958|11514613|FG000|Follow-Up|Family Emergency|1
7295838|NCT00568958|11514614|FG001|Follow-Up|Family Emergency|0
7295839|NCT00568958|11514613|FG000|Follow-Up|Adverse Event|1
7295840|NCT00568958|11514614|FG001|Follow-Up|Adverse Event|0
7295841|NCT00569166|11514640|FG000|Overall Study|Withdrawal by Subject|7
7295842|NCT00569166|11514641|FG001|Overall Study|Withdrawal by Subject|5
7295843|NCT00569166|11514642|FG002|Overall Study|Withdrawal by Subject|3
7295844|NCT00569166|11514640|FG000|Overall Study|Lost to Follow-up|2
7295845|NCT00569166|11514641|FG001|Overall Study|Lost to Follow-up|1
7295846|NCT00569166|11514642|FG002|Overall Study|Lost to Follow-up|1
7295847|NCT00569231|11514663|FG000|Overall Study|Study unrelated surgery|1
7295848|NCT00569231|11514663|FG000|Overall Study|Airfare expense|2
7295849|NCT00569231|11514663|FG000|Overall Study|Withdrawal by Subject|1
7295850|NCT00569231|11514663|FG000|Overall Study|Car accident injury|1
7295851|NCT00569231|11514663|FG000|Overall Study|Non-compliance|2
7295852|NCT00569270|11514667|FG000|Period: First Intervention|Protocol Violation|0
7295853|NCT00569270|11514668|FG001|Period: First Intervention|Protocol Violation|1
7295854|NCT00569374|11514687|FG000|Overall Study|Withdrawal by Subject|4
7295855|NCT00569582|11514700|FG000|Overall Study|Withdrawal by Subject|5
7295856|NCT00569582|11514700|FG000|Overall Study|Death|2
7295857|NCT00569582|11514700|FG000|Overall Study|Adverse Event|7
7295858|NCT00569582|11514700|FG000|Overall Study|Subject was too ill to travel.|1
7295859|NCT00569582|11514700|FG000|Overall Study|Subject was non-compliant.|1
7295860|NCT00569777|11514714|FG000|Overall Study|Withdrawal by Subject|4
7295861|NCT00569777|11514715|FG001|Overall Study|Withdrawal by Subject|0
7295862|NCT00569777|11514714|FG000|Overall Study|Adverse Event|3
7295863|NCT00569777|11514715|FG001|Overall Study|Adverse Event|0
7295864|NCT00569777|11514714|FG000|Overall Study|Lost to Follow-up|1
7295865|NCT00569777|11514715|FG001|Overall Study|Lost to Follow-up|0
7295866|NCT00569777|11514714|FG000|Overall Study|scheduled eye surgery|0
7295867|NCT00569777|11514715|FG001|Overall Study|scheduled eye surgery|1
7295868|NCT00569777|11514714|FG000|Overall Study|did not meet exclusion criteria|1
7295869|NCT00569777|11514715|FG001|Overall Study|did not meet exclusion criteria|2
7295870|NCT00569777|11514714|FG000|Overall Study|pregnant|1
7295871|NCT00569777|11514715|FG001|Overall Study|pregnant|0
7295872|NCT00569803|11514729|FG000|Overall Study|Lost to Follow-up|1
7295873|NCT00569803|11514730|FG001|Overall Study|Lost to Follow-up|0
7295874|NCT00569803|11514731|FG002|Overall Study|Lost to Follow-up|0
7295875|NCT00569803|11514732|FG003|Overall Study|Lost to Follow-up|0
7295876|NCT00569803|11514733|FG004|Overall Study|Lost to Follow-up|0
7295877|NCT00569803|11514734|FG005|Overall Study|Lost to Follow-up|0
7295878|NCT00569803|11514735|FG006|Overall Study|Lost to Follow-up|0
7295879|NCT00569803|11514736|FG007|Overall Study|Lost to Follow-up|0
7295880|NCT00569803|11514729|FG000|Overall Study|injection syringe leaked during dosing|0
7295881|NCT00569803|11514730|FG001|Overall Study|injection syringe leaked during dosing|0
7295882|NCT00569803|11514731|FG002|Overall Study|injection syringe leaked during dosing|0
7295883|NCT00569803|11514732|FG003|Overall Study|injection syringe leaked during dosing|1
7295884|NCT00569803|11514733|FG004|Overall Study|injection syringe leaked during dosing|0
7295885|NCT00569803|11514734|FG005|Overall Study|injection syringe leaked during dosing|0
7295886|NCT00569803|11514735|FG006|Overall Study|injection syringe leaked during dosing|0
7295887|NCT00569803|11514736|FG007|Overall Study|injection syringe leaked during dosing|0
7295888|NCT00569803|11514729|FG000|Overall Study|Withdrawal by Subject|0
7295889|NCT00569803|11514730|FG001|Overall Study|Withdrawal by Subject|0
7295890|NCT00569803|11514731|FG002|Overall Study|Withdrawal by Subject|0
7295891|NCT00569803|11514732|FG003|Overall Study|Withdrawal by Subject|0
7295892|NCT00569803|11514733|FG004|Overall Study|Withdrawal by Subject|0
7295893|NCT00569803|11514734|FG005|Overall Study|Withdrawal by Subject|0
7295894|NCT00569803|11514735|FG006|Overall Study|Withdrawal by Subject|0
7295895|NCT00569803|11514736|FG007|Overall Study|Withdrawal by Subject|1
7295896|NCT00569946|11514762|FG000|Overall Study|Adverse Event|16
7295897|NCT00569946|11514762|FG000|Overall Study|Objective Progression or Relapse|42
7295898|NCT00569946|11514762|FG000|Overall Study|Global Deterioration of Health Status|1
7295899|NCT00570037|11514768|FG000|Overall Study|Could not reach for 6-8 week contact|44
7295900|NCT00570037|11514769|FG001|Overall Study|Could not reach for 6-8 week contact|69
7295901|NCT00570063|11514777|FG000|Overall Study|Adverse Event|4
7295902|NCT00570063|11514778|FG001|Overall Study|Adverse Event|1
7295903|NCT00570063|11514777|FG000|Overall Study|Lack of Efficacy|0
7295904|NCT00570063|11514778|FG001|Overall Study|Lack of Efficacy|1
7295905|NCT00570063|11514777|FG000|Overall Study|Withdrawal by Subject|4
7295906|NCT00570063|11514778|FG001|Overall Study|Withdrawal by Subject|3
7295907|NCT00570063|11514777|FG000|Overall Study|Sponsor's Decision|7
7295908|NCT00570063|11514778|FG001|Overall Study|Sponsor's Decision|3
7295909|NCT00570128|11514795|FG000|Overall Study|Adverse Event|1
7295910|NCT00570128|11514796|FG001|Overall Study|Adverse Event|0
7295911|NCT00570128|11514795|FG000|Overall Study|Lost to Follow-up|1
7295912|NCT00570128|11514796|FG001|Overall Study|Lost to Follow-up|0
7295913|NCT00570128|11514795|FG000|Overall Study|Withdrawal by Subject|2
7295914|NCT00570128|11514796|FG001|Overall Study|Withdrawal by Subject|0
7295915|NCT00570141|11514802|FG000|Overall Study|Adverse Event|1
7295916|NCT00570141|11514802|FG000|Overall Study|Missed visits|1
7295917|NCT00570141|11514802|FG000|Overall Study|Lost to Follow-up|1
7295918|NCT00570232|11514806|FG000|Overall Study|Adverse Event|10
7295919|NCT00570232|11514806|FG000|Overall Study|discontinued due to medical condition|3
7295920|NCT00570232|11514806|FG000|Overall Study|discontinued due to recurrence|8
7295921|NCT00570232|11514806|FG000|Overall Study|discontinued due to noncompliance|2
7295922|NCT00570310|11514812|FG000|Overall Study|Adverse Event|1
7295923|NCT00570310|11514813|FG001|Overall Study|Adverse Event|2
7295924|NCT00570310|11514812|FG000|Overall Study|Lack of Efficacy|1
7295925|NCT00570310|11514813|FG001|Overall Study|Lack of Efficacy|4
7295926|NCT00570323|11514821|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
7295927|NCT00570323|11514822|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
7295928|NCT00570323|11514821|FG000|Started Treatment After Randomization|Protocol Violation|1
7295929|NCT00570323|11514822|FG001|Started Treatment After Randomization|Protocol Violation|0
7295930|NCT00570323|11514821|FG000|Started Treatment After Randomization|Physician Decision|1
7295931|NCT00570323|11514822|FG001|Started Treatment After Randomization|Physician Decision|0
7295932|NCT00570323|11514821|FG000|Complete Study After Start|Lost to Follow-up|0
7295933|NCT00570323|11514822|FG001|Complete Study After Start|Lost to Follow-up|1
7295934|NCT00570323|11514821|FG000|Complete Study After Start|Withdrawal by Subject|2
7295935|NCT00570323|11514822|FG001|Complete Study After Start|Withdrawal by Subject|0
7295936|NCT00570323|11514821|FG000|Complete Study After Start|Physician Decision|1
7295937|NCT00570323|11514822|FG001|Complete Study After Start|Physician Decision|0
7551516|NCT02970669|11910830|FG000|Double-blind Period|Adverse Event|4
7551517|NCT02970669|11910831|FG001|Double-blind Period|Adverse Event|0
7551518|NCT02970669|11910830|FG000|Double-blind Period|Death|1
7551519|NCT02970669|11910831|FG001|Double-blind Period|Death|0
7551520|NCT02970669|11910830|FG000|Double-blind Period|Study terminated by sponsor|1
7551521|NCT02970669|11910831|FG001|Double-blind Period|Study terminated by sponsor|2
7551522|NCT02970669|11910830|FG000|Double-blind Period|Physician Decision|0
7551523|NCT02970669|11910831|FG001|Double-blind Period|Physician Decision|2
7551524|NCT02970669|11910830|FG000|Double-blind Period|Withdrawal by Subject|2
7551525|NCT02970669|11910831|FG001|Double-blind Period|Withdrawal by Subject|2
7295938|NCT00570401|11514852|FG000|Overall Study|Adverse Event|2
7295939|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
7295940|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7295941|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
7295942|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
7295943|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7295944|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
7295945|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
7295946|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7295947|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
7295948|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
7295949|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
7295950|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
7295951|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
7295952|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
7295953|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
7295954|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Adverse Event|1
7295955|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Adverse Event|0
7295956|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Adverse Event|0
7295957|NCT00570492|11514858|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
7295958|NCT00570492|11514859|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7295959|NCT00570492|11514860|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
7295960|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
7295961|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7295962|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
7295963|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
7295964|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
7295965|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
7295966|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
7295967|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
7295968|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
7295969|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Adverse Event|0
7295970|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Adverse Event|5
7295971|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Adverse Event|5
7295972|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Physician Decision|0
7295973|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Physician Decision|2
7295974|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Physician Decision|4
7295975|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
7295976|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
7295977|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
7296044|NCT00570739|11514937|FG003|Overall Study|Lost to Follow-up|1
7295978|NCT00570492|11514858|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7295979|NCT00570492|11514859|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
7295980|NCT00570492|11514860|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
7295981|NCT00570505|11514866|FG000|Overall Study|Adverse Event|7
7295982|NCT00570505|11514866|FG000|Overall Study|Withdrawal by Subject|7
7295983|NCT00570505|11514866|FG000|Overall Study|Lost to Follow-up|23
7295984|NCT00570505|11514866|FG000|Overall Study|Other loss to follow-up|4
7295985|NCT00570661|11514870|FG000|Overall Study|Disease worsening|5
7295986|NCT00570661|11514870|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
7295987|NCT00570661|11514870|FG000|Overall Study|Adverse Event|1
7295988|NCT00570674|11514875|FG000|Overall Study|Withdrawal by Subject|0
7295989|NCT00570674|11514876|FG001|Overall Study|Withdrawal by Subject|0
7295990|NCT00570674|11514877|FG002|Overall Study|Withdrawal by Subject|1
7295991|NCT00570674|11514878|FG003|Overall Study|Withdrawal by Subject|0
7295992|NCT00570674|11514879|FG004|Overall Study|Withdrawal by Subject|0
7295993|NCT00570674|11514880|FG005|Overall Study|Withdrawal by Subject|0
7295994|NCT00570674|11514881|FG006|Overall Study|Withdrawal by Subject|0
7295995|NCT00570687|11514894|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7295996|NCT00570687|11514895|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7295997|NCT00570687|11514896|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7295998|NCT00570687|11514897|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7295999|NCT00570687|11514898|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7296000|NCT00570687|11514899|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7296001|NCT00570687|11514900|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7296002|NCT00570687|11514901|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7296003|NCT00570687|11514902|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
7296004|NCT00570687|11514903|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
7296005|NCT00570687|11514894|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296006|NCT00570687|11514895|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296007|NCT00570687|11514896|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296008|NCT00570687|11514897|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296009|NCT00570687|11514898|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296010|NCT00570687|11514899|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296011|NCT00570687|11514900|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296012|NCT00570687|11514901|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296013|NCT00570687|11514902|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7296014|NCT00570687|11514903|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296015|NCT00570687|11514894|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296016|NCT00570687|11514895|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296017|NCT00570687|11514896|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296018|NCT00570687|11514897|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296019|NCT00570687|11514898|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296020|NCT00570687|11514899|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296021|NCT00570687|11514900|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
7296022|NCT00570687|11514901|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296023|NCT00570687|11514902|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296024|NCT00570687|11514903|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
7296025|NCT00570713|11514923|FG000|Overall Study|Adverse Event|16
7296026|NCT00570713|11514924|FG001|Overall Study|Adverse Event|9
7296027|NCT00570713|11514923|FG000|Overall Study|Death|7
7296028|NCT00570713|11514924|FG001|Overall Study|Death|7
7296029|NCT00570713|11514923|FG000|Overall Study|Lack of Efficacy|40
7296030|NCT00570713|11514924|FG001|Overall Study|Lack of Efficacy|49
7296031|NCT00570713|11514923|FG000|Overall Study|Physician Decision|2
7296032|NCT00570713|11514924|FG001|Overall Study|Physician Decision|2
7296033|NCT00570713|11514923|FG000|Overall Study|Withdrawal by Subject|3
7296034|NCT00570713|11514924|FG001|Overall Study|Withdrawal by Subject|3
7296035|NCT00570713|11514923|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
7296036|NCT00570713|11514924|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
7296037|NCT00570739|11514934|FG000|Overall Study|Adverse Event|8
7296038|NCT00570739|11514935|FG001|Overall Study|Adverse Event|6
7296039|NCT00570739|11514936|FG002|Overall Study|Adverse Event|2
7219312|NCT03167242|11428084|FG005|Overall Study|Reason not provided|0
7219313|NCT03167242|11428085|FG006|Overall Study|Reason not provided|0
7219314|NCT03167242|11428086|FG007|Overall Study|Reason not provided|0
7219315|NCT03167242|11428087|FG008|Overall Study|Reason not provided|1
7219316|NCT03167242|11428088|FG009|Overall Study|Reason not provided|0
7219317|NCT03167242|11428089|FG010|Overall Study|Reason not provided|0
7219318|NCT03167242|11428090|FG011|Overall Study|Reason not provided|0
7219319|NCT03137537|11428128|FG000|Overall Study|Adverse Event|0
7219320|NCT03137537|11428129|FG001|Overall Study|Adverse Event|1
7219331|NCT03113383|11428145|FG000|Overall Study|Death|4
7219332|NCT03113383|11428146|FG001|Overall Study|Death|0
7296040|NCT00570739|11514937|FG003|Overall Study|Adverse Event|2
7296041|NCT00570739|11514934|FG000|Overall Study|Lost to Follow-up|4
7296042|NCT00570739|11514935|FG001|Overall Study|Lost to Follow-up|5
7296043|NCT00570739|11514936|FG002|Overall Study|Lost to Follow-up|4
7296045|NCT00570739|11514934|FG000|Overall Study|Physician Decision|1
7296046|NCT00570739|11514935|FG001|Overall Study|Physician Decision|1
7296047|NCT00570739|11514936|FG002|Overall Study|Physician Decision|0
7296048|NCT00570739|11514937|FG003|Overall Study|Physician Decision|0
7296049|NCT00570739|11514934|FG000|Overall Study|Withdrawal by Subject|7
7296050|NCT00570739|11514935|FG001|Overall Study|Withdrawal by Subject|7
7296051|NCT00570739|11514936|FG002|Overall Study|Withdrawal by Subject|3
7296052|NCT00570739|11514937|FG003|Overall Study|Withdrawal by Subject|5
7296053|NCT00570739|11514934|FG000|Overall Study|Required restricted medication|0
7296054|NCT00570739|11514935|FG001|Overall Study|Required restricted medication|0
7296055|NCT00570739|11514936|FG002|Overall Study|Required restricted medication|1
7296056|NCT00570739|11514937|FG003|Overall Study|Required restricted medication|0
7296057|NCT00570739|11514934|FG000|Overall Study|Met discontinuation criteria|1
7296058|NCT00570739|11514935|FG001|Overall Study|Met discontinuation criteria|0
7296059|NCT00570739|11514936|FG002|Overall Study|Met discontinuation criteria|1
7296060|NCT00570739|11514937|FG003|Overall Study|Met discontinuation criteria|1
7296061|NCT00570739|11514934|FG000|Overall Study|Other|0
7296062|NCT00570739|11514935|FG001|Overall Study|Other|2
7296063|NCT00570739|11514936|FG002|Overall Study|Other|5
7296064|NCT00570739|11514937|FG003|Overall Study|Other|3
7296065|NCT00570765|11514970|FG000|DB Phase|Withdrawal by Subject|1
7296066|NCT00570765|11514971|FG001|DB Phase|Withdrawal by Subject|0
7296067|NCT00570765|11514972|FG002|DB Phase|Withdrawal by Subject|0
7296068|NCT00570765|11514973|FG003|DB Phase|Withdrawal by Subject|0
7296069|NCT00570765|11514970|FG000|DB Phase|Protocol Violation|0
7296070|NCT00570765|11514971|FG001|DB Phase|Protocol Violation|1
7296071|NCT00570765|11514972|FG002|DB Phase|Protocol Violation|0
7296072|NCT00570765|11514973|FG003|DB Phase|Protocol Violation|0
7296073|NCT00570765|11514970|FG000|DB Phase|Adverse Event|3
7296074|NCT00570765|11514971|FG001|DB Phase|Adverse Event|6
7296075|NCT00570765|11514972|FG002|DB Phase|Adverse Event|0
7296076|NCT00570765|11514973|FG003|DB Phase|Adverse Event|0
7296077|NCT00570765|11514970|FG000|DB Phase|Did Not Receive Study Drug|0
7296078|NCT00570765|11514971|FG001|DB Phase|Did Not Receive Study Drug|0
7296079|NCT00570765|11514972|FG002|DB Phase|Did Not Receive Study Drug|1
7296080|NCT00570765|11514973|FG003|DB Phase|Did Not Receive Study Drug|0
7296081|NCT00570765|11514970|FG000|LTSE Phase|Withdrawal by Subject|0
7296082|NCT00570765|11514971|FG001|LTSE Phase|Withdrawal by Subject|0
7296083|NCT00570765|11514972|FG002|LTSE Phase|Withdrawal by Subject|0
7296084|NCT00570765|11514973|FG003|LTSE Phase|Withdrawal by Subject|1
7296085|NCT00570765|11514970|FG000|LTSE Phase|Adverse Event|0
7296086|NCT00570765|11514971|FG001|LTSE Phase|Adverse Event|0
7296087|NCT00570765|11514972|FG002|LTSE Phase|Adverse Event|0
7296088|NCT00570765|11514973|FG003|LTSE Phase|Adverse Event|7
7296089|NCT00570765|11514970|FG000|LTSE Phase|Physician Decision|0
7296090|NCT00570765|11514971|FG001|LTSE Phase|Physician Decision|0
7296091|NCT00570765|11514972|FG002|LTSE Phase|Physician Decision|0
7296092|NCT00570765|11514973|FG003|LTSE Phase|Physician Decision|4
7296093|NCT00570778|11514984|FG000|Overall Study|Protocol deviation|2
7296094|NCT00570778|11514985|FG001|Overall Study|Protocol deviation|1
7296095|NCT00570778|11514986|FG002|Overall Study|Protocol deviation|2
7296096|NCT00570778|11514987|FG003|Overall Study|Protocol deviation|2
7296097|NCT00570778|11514984|FG000|Overall Study|Adverse Event|0
7296098|NCT00570778|11514985|FG001|Overall Study|Adverse Event|1
7296099|NCT00570778|11514986|FG002|Overall Study|Adverse Event|4
7296100|NCT00570778|11514987|FG003|Overall Study|Adverse Event|1
7296101|NCT00570778|11514984|FG000|Overall Study|Subject withdrew consent|0
7296102|NCT00570778|11514985|FG001|Overall Study|Subject withdrew consent|1
7296103|NCT00570778|11514986|FG002|Overall Study|Subject withdrew consent|0
7296104|NCT00570778|11514987|FG003|Overall Study|Subject withdrew consent|1
7296105|NCT00570778|11514984|FG000|Overall Study|Abnormal test procedure|1
7296106|NCT00570778|11514985|FG001|Overall Study|Abnormal test procedure|0
7296107|NCT00570778|11514986|FG002|Overall Study|Abnormal test procedure|0
7296108|NCT00570778|11514987|FG003|Overall Study|Abnormal test procedure|0
7296109|NCT00570778|11514984|FG000|Overall Study|Unsatisfactory therapeutic effect|1
7296110|NCT00570778|11514985|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7296111|NCT00570778|11514986|FG002|Overall Study|Unsatisfactory therapeutic effect|0
7296112|NCT00570778|11514987|FG003|Overall Study|Unsatisfactory therapeutic effect|0
7296113|NCT00570778|11514984|FG000|Overall Study|Lost to Follow-up|0
7296114|NCT00570778|11514985|FG001|Overall Study|Lost to Follow-up|0
7296115|NCT00570778|11514986|FG002|Overall Study|Lost to Follow-up|1
7296116|NCT00570778|11514987|FG003|Overall Study|Lost to Follow-up|0
7296117|NCT00570778|11514984|FG000|Overall Study|Subject no longer requires study drug|0
7296118|NCT00570778|11514985|FG001|Overall Study|Subject no longer requires study drug|1
7296119|NCT00570778|11514986|FG002|Overall Study|Subject no longer requires study drug|0
7296120|NCT00570778|11514987|FG003|Overall Study|Subject no longer requires study drug|0
7296121|NCT00570908|11514997|FG000|Overall Study|Adverse Event|5
7296122|NCT00570908|11514997|FG000|Overall Study|Withdrawal by Subject|2
7296123|NCT00570921|11515001|FG000|Overall Study|Protocol Violation|1
7296124|NCT00570921|11515001|FG000|Overall Study|Physician Decision|1
7296125|NCT00571038|11515016|FG000|Overall Study|Lost to Follow-up|1
7296126|NCT00571038|11515017|FG001|Overall Study|Lost to Follow-up|4
7296127|NCT00571038|11515016|FG000|Overall Study|Death|7
7296128|NCT00571038|11515017|FG001|Overall Study|Death|5
7296129|NCT00571038|11515016|FG000|Overall Study|Withdrawal by Subject|1
7296130|NCT00571038|11515017|FG001|Overall Study|Withdrawal by Subject|3
7296131|NCT00571038|11515016|FG000|Overall Study|Moved out of state|2
7296132|NCT00571038|11515017|FG001|Overall Study|Moved out of state|2
7296133|NCT00571064|11515023|FG000|Overall Study|Adverse Event|13
7296134|NCT00571064|11515023|FG000|Overall Study|Protocol Violation|4
7219333|NCT02978326|11428168|FG000|Part B (Up to 45 Days)|Adverse Event|0
7296135|NCT00571064|11515023|FG000|Overall Study|Withdrawal by Subject|2
7296136|NCT00571064|11515023|FG000|Overall Study|Other|2
7296137|NCT00571103|11515028|FG000|Overall Study|Withdrawal by Subject|1
7296138|NCT00571103|11515028|FG000|Overall Study|Lost to Follow-up|1
7219334|NCT02978326|11428169|FG001|Part B (Up to 45 Days)|Adverse Event|0
7219335|NCT02978326|11428170|FG002|Part B (Up to 45 Days)|Adverse Event|1
7219336|NCT02978326|11428168|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
7219337|NCT02978326|11428169|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
7219338|NCT02978326|11428170|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
7296139|NCT00571519|11515080|FG000|Overall Study|Subject withdrew consent|0
7296140|NCT00571519|11515081|FG001|Overall Study|Subject withdrew consent|1
7296141|NCT00571519|11515082|FG002|Overall Study|Subject withdrew consent|0
7296142|NCT00571519|11515083|FG003|Overall Study|Subject withdrew consent|2
7296143|NCT00571519|11515084|FG004|Overall Study|Subject withdrew consent|1
7296144|NCT00571519|11515085|FG005|Overall Study|Subject withdrew consent|1
7296145|NCT00571519|11515086|FG006|Overall Study|Subject withdrew consent|2
7296146|NCT00571519|11515080|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7296147|NCT00571519|11515081|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7296148|NCT00571519|11515082|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7296149|NCT00571519|11515083|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
7296150|NCT00571519|11515084|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7296151|NCT00571519|11515085|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7296152|NCT00571519|11515086|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
7296153|NCT00571519|11515080|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
7296154|NCT00571519|11515081|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
7296155|NCT00571519|11515082|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
7296156|NCT00571519|11515083|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
7296157|NCT00571519|11515084|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
7296158|NCT00571519|11515085|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
7296159|NCT00571519|11515086|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
7296160|NCT00571519|11515080|FG000|Overall Study|Termination of study by Sponsor|2
7296161|NCT00571519|11515081|FG001|Overall Study|Termination of study by Sponsor|7
7296162|NCT00571519|11515082|FG002|Overall Study|Termination of study by Sponsor|10
7296163|NCT00571519|11515083|FG003|Overall Study|Termination of study by Sponsor|24
7296164|NCT00571519|11515084|FG004|Overall Study|Termination of study by Sponsor|8
7296165|NCT00571519|11515085|FG005|Overall Study|Termination of study by Sponsor|9
7296166|NCT00571519|11515086|FG006|Overall Study|Termination of study by Sponsor|22
7296167|NCT00571519|11515080|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296168|NCT00571519|11515081|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296169|NCT00571519|11515082|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
7296170|NCT00571519|11515083|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296171|NCT00571519|11515084|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296172|NCT00571519|11515085|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296173|NCT00571519|11515086|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
7296174|NCT00571649|11515104|FG000|Treatment Period|Adverse Event|438
7296175|NCT00571649|11515105|FG001|Treatment Period|Adverse Event|385
7296176|NCT00571649|11515104|FG000|Treatment Period|Clinical endpoint reached|50
7296177|NCT00571649|11515105|FG001|Treatment Period|Clinical endpoint reached|56
7296178|NCT00571649|11515104|FG000|Treatment Period|Withdrawal by Subject|285
7296179|NCT00571649|11515105|FG001|Treatment Period|Withdrawal by Subject|255
7296180|NCT00571649|11515104|FG000|Treatment Period|Death|76
7296181|NCT00571649|11515105|FG001|Treatment Period|Death|59
7296182|NCT00571649|11515104|FG000|Treatment Period|Physician Decision|8
7296183|NCT00571649|11515105|FG001|Treatment Period|Physician Decision|9
7296184|NCT00571649|11515104|FG000|Treatment Period|Lost to Follow-up|43
7296185|NCT00571649|11515105|FG001|Treatment Period|Lost to Follow-up|41
7296186|NCT00571649|11515104|FG000|Treatment Period|Non-compliant with study medication|88
7296187|NCT00571649|11515105|FG001|Treatment Period|Non-compliant with study medication|89
7296188|NCT00571649|11515104|FG000|Treatment Period|Patient convenience|11
7296189|NCT00571649|11515105|FG001|Treatment Period|Patient convenience|13
7296190|NCT00571649|11515104|FG000|Treatment Period|Protocol Violation|90
7296191|NCT00571649|11515105|FG001|Treatment Period|Protocol Violation|92
7296192|NCT00571649|11515104|FG000|Treatment Period|Technical problems|3
7296193|NCT00571649|11515105|FG001|Treatment Period|Technical problems|5
7296194|NCT00571649|11515104|FG000|Follow-up Period|Adverse Event|46
7296195|NCT00571649|11515105|FG001|Follow-up Period|Adverse Event|40
7296196|NCT00571649|11515104|FG000|Follow-up Period|Clinical endpoint reached|5
7296197|NCT00571649|11515105|FG001|Follow-up Period|Clinical endpoint reached|2
7296198|NCT00571649|11515104|FG000|Follow-up Period|Withdrawal by Subject|119
7296199|NCT00571649|11515105|FG001|Follow-up Period|Withdrawal by Subject|115
7296200|NCT00571649|11515104|FG000|Follow-up Period|Death|132
7296201|NCT00571649|11515105|FG001|Follow-up Period|Death|133
7296202|NCT00571649|11515104|FG000|Follow-up Period|Physician Decision|7
7296203|NCT00571649|11515105|FG001|Follow-up Period|Physician Decision|13
7296204|NCT00571649|11515104|FG000|Follow-up Period|Lost to Follow-up|95
7296205|NCT00571649|11515105|FG001|Follow-up Period|Lost to Follow-up|92
7296206|NCT00571649|11515104|FG000|Follow-up Period|Patient convenience|136
7296207|NCT00571649|11515105|FG001|Follow-up Period|Patient convenience|121
7219339|NCT02978326|11428168|FG000|Part B (Up to 45 Days)|Non-compliance|0
7219340|NCT02978326|11428169|FG001|Part B (Up to 45 Days)|Non-compliance|2
7219341|NCT02978326|11428170|FG002|Part B (Up to 45 Days)|Non-compliance|0
7219342|NCT02978326|11428168|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
7219343|NCT02978326|11428169|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
7219344|NCT02978326|11428170|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
7219345|NCT02970929|11428180|FG000|Overall Study|Adverse Event|18
7219346|NCT02970929|11428180|FG000|Overall Study|Lack of Efficacy|8
7219347|NCT02970929|11428180|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1
7219348|NCT02970929|11428180|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1
7219349|NCT02970929|11428180|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1
7296208|NCT00571649|11515104|FG000|Follow-up Period|Protocol Violation|5
7296209|NCT00571649|11515105|FG001|Follow-up Period|Protocol Violation|12
7296210|NCT00571662|11515111|FG000|Overall Study|Withdrawal by Subject|2
7296211|NCT00571662|11515111|FG000|Overall Study|psychiatric instability|1
7296212|NCT00571662|11515111|FG000|Overall Study|Adverse Event|5
7296213|NCT00571688|11515119|FG000|Overall Study|Lost to Follow-up|3
7296214|NCT00571688|11515120|FG001|Overall Study|Lost to Follow-up|6
7296215|NCT00571688|11515119|FG000|Overall Study|subject did not tolerate Consta|1
7296216|NCT00571688|11515120|FG001|Overall Study|subject did not tolerate Consta|0
7296217|NCT00571688|11515119|FG000|Overall Study|subject moved out of the area|1
7296218|NCT00571688|11515120|FG001|Overall Study|subject moved out of the area|0
7296219|NCT00571701|11515128|FG000|First Intervention 12 Months|Withdrawal by Subject|2
7296220|NCT00571701|11515129|FG001|First Intervention 12 Months|Withdrawal by Subject|1
7296221|NCT00571701|11515128|FG000|First Intervention 12 Months|Death|1
7296222|NCT00571701|11515129|FG001|First Intervention 12 Months|Death|0
7296223|NCT00571701|11515128|FG000|Second Intervention 12 Months|Adverse Event|0
7296224|NCT00571701|11515129|FG001|Second Intervention 12 Months|Adverse Event|1
7296225|NCT00571701|11515128|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
7296226|NCT00571701|11515129|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
7296227|NCT00571948|11515155|FG000|Overall Study|Lost to Follow-up|2
7296228|NCT00571948|11515156|FG001|Overall Study|Lost to Follow-up|0
7296229|NCT00571948|11515155|FG000|Overall Study|Withdrawal by Subject|1
7296230|NCT00571948|11515156|FG001|Overall Study|Withdrawal by Subject|2
7296231|NCT00571948|11515155|FG000|Overall Study|Protocol Violation|3
7296232|NCT00571948|11515156|FG001|Overall Study|Protocol Violation|3
7296233|NCT00571948|11515155|FG000|Overall Study|infant refused study meal|3
7296234|NCT00571948|11515156|FG001|Overall Study|infant refused study meal|4
7296235|NCT00571948|11515155|FG000|Overall Study|Parent were afraid of blood colection|2
7296236|NCT00571948|11515156|FG001|Overall Study|Parent were afraid of blood colection|5
7296237|NCT00572039|11515182|FG000|Overall Study|Withdrawal by Subject|9
7296238|NCT00572039|11515183|FG001|Overall Study|Withdrawal by Subject|6
7296239|NCT00572039|11515182|FG000|Overall Study|Death|2
7296240|NCT00572039|11515183|FG001|Overall Study|Death|3
7296241|NCT00572039|11515182|FG000|Overall Study|Ill|5
7296242|NCT00572039|11515183|FG001|Overall Study|Ill|1
7296243|NCT00572156|11515206|FG000|Overall Study|Adverse Event|3
7296244|NCT00572156|11515207|FG001|Overall Study|Adverse Event|1
7296245|NCT00572156|11515208|FG002|Overall Study|Adverse Event|5
7296246|NCT00572156|11515209|FG003|Overall Study|Adverse Event|1
7296247|NCT00572156|11515206|FG000|Overall Study|Lost to Follow-up|1
7296248|NCT00572156|11515207|FG001|Overall Study|Lost to Follow-up|1
7296249|NCT00572156|11515208|FG002|Overall Study|Lost to Follow-up|1
7296250|NCT00572156|11515209|FG003|Overall Study|Lost to Follow-up|0
7296251|NCT00572156|11515206|FG000|Overall Study|Protocol Violation|1
7296252|NCT00572156|11515207|FG001|Overall Study|Protocol Violation|2
7296253|NCT00572156|11515208|FG002|Overall Study|Protocol Violation|0
7296254|NCT00572156|11515209|FG003|Overall Study|Protocol Violation|2
7296255|NCT00572156|11515206|FG000|Overall Study|Patient/Parent Decision|1
7296256|NCT00572156|11515207|FG001|Overall Study|Patient/Parent Decision|6
7219350|NCT02970929|11428180|FG000|Overall Study|LOST TO FOLLOWUP|6
7219351|NCT02970929|11428180|FG000|Overall Study|MOVED OUT OF STATE|1
7219352|NCT02970929|11428180|FG000|Overall Study|Withdrawal by Subject|16
7219353|NCT02797951|11428214|FG000|Overall Study|Adverse Event|4
7219354|NCT02797951|11428214|FG000|Overall Study|Death|1
7219355|NCT02797951|11428214|FG000|Overall Study|Lack of Efficacy|19
7219356|NCT02797951|11428214|FG000|Overall Study|Lost to Follow-up|4
7219357|NCT02797951|11428214|FG000|Overall Study|Physician Decision|6
7219358|NCT02797951|11428214|FG000|Overall Study|Withdrawal by Subject|15
7219359|NCT02748057|11428229|FG000|Overall Study|Adverse Event|1
7219360|NCT02748057|11428230|FG001|Overall Study|Adverse Event|0
7219361|NCT02748057|11428229|FG000|Overall Study|Physician Decision|0
7219362|NCT02748057|11428230|FG001|Overall Study|Physician Decision|1
7219363|NCT02748057|11428229|FG000|Overall Study|Protocol Violation|2
7219364|NCT02748057|11428230|FG001|Overall Study|Protocol Violation|1
7219365|NCT02748057|11428229|FG000|Overall Study|Participant Moved|1
7219366|NCT02748057|11428230|FG001|Overall Study|Participant Moved|0
7219367|NCT02748057|11428229|FG000|Overall Study|Withdrawal by Subject|1
7219368|NCT02748057|11428230|FG001|Overall Study|Withdrawal by Subject|0
7219369|NCT02741271|11428238|FG000|Overall Study|Lost to Follow-up|2
7219370|NCT02741271|11428239|FG001|Overall Study|Lost to Follow-up|0
7219371|NCT02741271|11428238|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7219372|NCT02741271|11428239|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7219373|NCT02741245|11428252|FG000|Overall Study|Adverse Event|0
7219374|NCT02741245|11428253|FG001|Overall Study|Adverse Event|0
7219375|NCT02741245|11428254|FG002|Overall Study|Adverse Event|0
7219376|NCT02741245|11428255|FG003|Overall Study|Adverse Event|2
7219377|NCT02741245|11428256|FG004|Overall Study|Adverse Event|2
7219378|NCT02741245|11428252|FG000|Overall Study|Protocol Violation|0
7296257|NCT00572156|11515208|FG002|Overall Study|Patient/Parent Decision|4
7296258|NCT00572156|11515209|FG003|Overall Study|Patient/Parent Decision|3
7296259|NCT00572156|11515206|FG000|Overall Study|Sponsor Decision|20
7296260|NCT00572156|11515207|FG001|Overall Study|Sponsor Decision|16
7296261|NCT00572156|11515208|FG002|Overall Study|Sponsor Decision|17
7296262|NCT00572156|11515209|FG003|Overall Study|Sponsor Decision|19
7296263|NCT00572195|11515219|FG000|Overall Study|Withdrawal by Subject|50
7296264|NCT00572195|11515219|FG000|Overall Study|Death|9
7296265|NCT00572195|11515219|FG000|Overall Study|Adverse Event|4
7296266|NCT00572195|11515219|FG000|Overall Study|Lost to Follow-up|5
7296267|NCT00572455|11515246|FG000|Stage I (14 Days)|Adverse Event|0
7296268|NCT00572455|11515247|FG001|Stage I (14 Days)|Adverse Event|0
7296269|NCT00572455|11515248|FG002|Stage I (14 Days)|Adverse Event|0
7296270|NCT00572455|11515249|FG003|Stage I (14 Days)|Adverse Event|0
7296271|NCT00572455|11515250|FG004|Stage I (14 Days)|Adverse Event|0
7296272|NCT00572455|11515251|FG005|Stage I (14 Days)|Adverse Event|3
7296273|NCT00572455|11515252|FG006|Stage I (14 Days)|Adverse Event|0
7296274|NCT00572455|11515253|FG007|Stage I (14 Days)|Adverse Event|0
7296275|NCT00572455|11515254|FG008|Stage I (14 Days)|Adverse Event|0
7296276|NCT00572455|11515255|FG009|Stage I (14 Days)|Adverse Event|0
7296277|NCT00572455|11515256|FG010|Stage I (14 Days)|Adverse Event|0
7296278|NCT00572455|11515257|FG011|Stage I (14 Days)|Adverse Event|0
7296279|NCT00572455|11515258|FG012|Stage I (14 Days)|Adverse Event|0
7296280|NCT00572455|11515259|FG013|Stage I (14 Days)|Adverse Event|0
7296281|NCT00572455|11515246|FG000|Stage I (14 Days)|Other|0
7296282|NCT00572455|11515247|FG001|Stage I (14 Days)|Other|0
7296283|NCT00572455|11515248|FG002|Stage I (14 Days)|Other|0
7296284|NCT00572455|11515249|FG003|Stage I (14 Days)|Other|0
7296285|NCT00572455|11515250|FG004|Stage I (14 Days)|Other|1
7296286|NCT00572455|11515251|FG005|Stage I (14 Days)|Other|0
7296287|NCT00572455|11515252|FG006|Stage I (14 Days)|Other|0
7296288|NCT00572455|11515253|FG007|Stage I (14 Days)|Other|0
7296289|NCT00572455|11515254|FG008|Stage I (14 Days)|Other|0
7296290|NCT00572455|11515255|FG009|Stage I (14 Days)|Other|0
7296291|NCT00572455|11515256|FG010|Stage I (14 Days)|Other|0
7296292|NCT00572455|11515257|FG011|Stage I (14 Days)|Other|0
7296293|NCT00572455|11515258|FG012|Stage I (14 Days)|Other|0
7296294|NCT00572455|11515259|FG013|Stage I (14 Days)|Other|0
7296295|NCT00572455|11515246|FG000|Stage II (28 Days)|Adverse Event|0
7296296|NCT00572455|11515247|FG001|Stage II (28 Days)|Adverse Event|0
7296297|NCT00572455|11515248|FG002|Stage II (28 Days)|Adverse Event|0
7296298|NCT00572455|11515249|FG003|Stage II (28 Days)|Adverse Event|0
7296299|NCT00572455|11515250|FG004|Stage II (28 Days)|Adverse Event|0
7296300|NCT00572455|11515251|FG005|Stage II (28 Days)|Adverse Event|0
7296301|NCT00572455|11515252|FG006|Stage II (28 Days)|Adverse Event|0
7296302|NCT00572455|11515253|FG007|Stage II (28 Days)|Adverse Event|0
7296303|NCT00572455|11515254|FG008|Stage II (28 Days)|Adverse Event|1
7296304|NCT00572455|11515255|FG009|Stage II (28 Days)|Adverse Event|3
7296305|NCT00572455|11515256|FG010|Stage II (28 Days)|Adverse Event|3
7296306|NCT00572455|11515257|FG011|Stage II (28 Days)|Adverse Event|4
7296307|NCT00572455|11515258|FG012|Stage II (28 Days)|Adverse Event|5
7296308|NCT00572455|11515259|FG013|Stage II (28 Days)|Adverse Event|1
7296309|NCT00572455|11515246|FG000|Stage II (28 Days)|Death|0
7296310|NCT00572455|11515247|FG001|Stage II (28 Days)|Death|0
7296311|NCT00572455|11515248|FG002|Stage II (28 Days)|Death|0
7296312|NCT00572455|11515249|FG003|Stage II (28 Days)|Death|0
7296313|NCT00572455|11515250|FG004|Stage II (28 Days)|Death|0
7296314|NCT00572455|11515251|FG005|Stage II (28 Days)|Death|0
7296315|NCT00572455|11515252|FG006|Stage II (28 Days)|Death|0
7296316|NCT00572455|11515253|FG007|Stage II (28 Days)|Death|0
7296317|NCT00572455|11515254|FG008|Stage II (28 Days)|Death|1
7296318|NCT00572455|11515255|FG009|Stage II (28 Days)|Death|0
7296319|NCT00572455|11515256|FG010|Stage II (28 Days)|Death|0
7296320|NCT00572455|11515257|FG011|Stage II (28 Days)|Death|0
7296321|NCT00572455|11515258|FG012|Stage II (28 Days)|Death|0
7296322|NCT00572455|11515259|FG013|Stage II (28 Days)|Death|0
7296323|NCT00572455|11515246|FG000|Stage II (28 Days)|Withdrawal by Subject|0
7296324|NCT00572455|11515247|FG001|Stage II (28 Days)|Withdrawal by Subject|0
7296325|NCT00572455|11515248|FG002|Stage II (28 Days)|Withdrawal by Subject|0
7296326|NCT00572455|11515249|FG003|Stage II (28 Days)|Withdrawal by Subject|0
7296327|NCT00572455|11515250|FG004|Stage II (28 Days)|Withdrawal by Subject|0
7296328|NCT00572455|11515251|FG005|Stage II (28 Days)|Withdrawal by Subject|0
7219379|NCT02741245|11428253|FG001|Overall Study|Protocol Violation|1
7296329|NCT00572455|11515252|FG006|Stage II (28 Days)|Withdrawal by Subject|0
7296330|NCT00572455|11515253|FG007|Stage II (28 Days)|Withdrawal by Subject|1
7296331|NCT00572455|11515254|FG008|Stage II (28 Days)|Withdrawal by Subject|0
7296332|NCT00572455|11515255|FG009|Stage II (28 Days)|Withdrawal by Subject|0
7219380|NCT02741245|11428254|FG002|Overall Study|Protocol Violation|0
7219381|NCT02741245|11428255|FG003|Overall Study|Protocol Violation|1
7219382|NCT02741245|11428256|FG004|Overall Study|Protocol Violation|0
7219383|NCT02741245|11428252|FG000|Overall Study|Withdrawal by Subject|0
7219384|NCT02741245|11428253|FG001|Overall Study|Withdrawal by Subject|0
7219385|NCT02741245|11428254|FG002|Overall Study|Withdrawal by Subject|0
7219386|NCT02741245|11428255|FG003|Overall Study|Withdrawal by Subject|1
7219387|NCT02741245|11428256|FG004|Overall Study|Withdrawal by Subject|0
7219388|NCT02688608|11428268|FG000|Overall Study|Lost to Follow-up|1
7296333|NCT00572455|11515256|FG010|Stage II (28 Days)|Withdrawal by Subject|2
7296334|NCT00572455|11515257|FG011|Stage II (28 Days)|Withdrawal by Subject|0
7296335|NCT00572455|11515258|FG012|Stage II (28 Days)|Withdrawal by Subject|0
7296336|NCT00572455|11515259|FG013|Stage II (28 Days)|Withdrawal by Subject|0
7296337|NCT00572455|11515246|FG000|Stage II (28 Days)|Other|0
7219398|NCT02605967|11428297|FG000|Overall Study|subject / guardian decision|1
7219399|NCT02605967|11428298|FG001|Overall Study|subject / guardian decision|2
7219400|NCT02605967|11428297|FG000|Overall Study|Physician Decision|10
7219401|NCT02605967|11428298|FG001|Overall Study|Physician Decision|1
7219402|NCT02605967|11428297|FG000|Overall Study|Death|4
7219403|NCT02605967|11428298|FG001|Overall Study|Death|2
7219404|NCT02605967|11428297|FG000|Overall Study|Adverse Event|1
7219405|NCT02605967|11428298|FG001|Overall Study|Adverse Event|0
7219406|NCT02605967|11428297|FG000|Overall Study|progressive disease|66
7219407|NCT02605967|11428298|FG001|Overall Study|progressive disease|35
7219424|NCT02553265|11428329|FG000|Enrollment|Death|0
7219425|NCT02553265|11428330|FG001|Enrollment|Death|0
7219426|NCT02553265|11428331|FG002|Enrollment|Death|1
7219427|NCT02553265|11428329|FG000|First Intervention (28 Days)|Adverse Event|1
7219428|NCT02553265|11428330|FG001|First Intervention (28 Days)|Adverse Event|0
7219429|NCT02553265|11428331|FG002|First Intervention (28 Days)|Adverse Event|0
7219430|NCT02553265|11428329|FG000|First Intervention (28 Days)|Withdrawal by Subject|0
7219431|NCT02553265|11428330|FG001|First Intervention (28 Days)|Withdrawal by Subject|0
7219432|NCT02553265|11428331|FG002|First Intervention (28 Days)|Withdrawal by Subject|1
7219433|NCT02553265|11428329|FG000|Second Intervention (28 Days)|Adverse Event|1
7219434|NCT02553265|11428330|FG001|Second Intervention (28 Days)|Adverse Event|0
7219435|NCT02553265|11428331|FG002|Second Intervention (28 Days)|Adverse Event|0
7219436|NCT02553265|11428329|FG000|Third Intervention (28 Days)|Adverse Event|1
7219437|NCT02553265|11428330|FG001|Third Intervention (28 Days)|Adverse Event|0
7219438|NCT02553265|11428331|FG002|Third Intervention (28 Days)|Adverse Event|0
7219439|NCT02553265|11428329|FG000|Third Intervention (28 Days)|Lost to Follow-up|0
7219440|NCT02553265|11428330|FG001|Third Intervention (28 Days)|Lost to Follow-up|0
7219441|NCT02553265|11428331|FG002|Third Intervention (28 Days)|Lost to Follow-up|1
7219442|NCT02550288|11428347|FG000|Overall Study|Adverse Event|0
7219443|NCT02550288|11428348|FG001|Overall Study|Adverse Event|1
7219444|NCT02550288|11428349|FG002|Overall Study|Adverse Event|0
7219445|NCT02550288|11428350|FG003|Overall Study|Adverse Event|0
7219446|NCT02550288|11428351|FG004|Overall Study|Adverse Event|0
7219447|NCT02550288|11428347|FG000|Overall Study|Physician Decision|0
7219448|NCT02550288|11428348|FG001|Overall Study|Physician Decision|0
7219449|NCT02550288|11428349|FG002|Overall Study|Physician Decision|0
7219450|NCT02550288|11428350|FG003|Overall Study|Physician Decision|1
7219451|NCT02550288|11428351|FG004|Overall Study|Physician Decision|0
7219452|NCT02550288|11428347|FG000|Overall Study|Protocol Violation|2
7219453|NCT02550288|11428348|FG001|Overall Study|Protocol Violation|2
7219454|NCT02550288|11428349|FG002|Overall Study|Protocol Violation|1
7219455|NCT02550288|11428350|FG003|Overall Study|Protocol Violation|0
7219456|NCT02550288|11428351|FG004|Overall Study|Protocol Violation|3
7219457|NCT02550288|11428347|FG000|Overall Study|Participant moved|0
7219458|NCT02550288|11428348|FG001|Overall Study|Participant moved|0
7219459|NCT02550288|11428349|FG002|Overall Study|Participant moved|0
7219460|NCT02550288|11428350|FG003|Overall Study|Participant moved|1
7219461|NCT02550288|11428351|FG004|Overall Study|Participant moved|0
7219462|NCT02550288|11428347|FG000|Overall Study|Withdrawal by Subject|0
7219463|NCT02550288|11428348|FG001|Overall Study|Withdrawal by Subject|0
7219464|NCT02550288|11428349|FG002|Overall Study|Withdrawal by Subject|0
7219465|NCT02550288|11428350|FG003|Overall Study|Withdrawal by Subject|1
7219466|NCT02550288|11428351|FG004|Overall Study|Withdrawal by Subject|0
7296338|NCT00572455|11515247|FG001|Stage II (28 Days)|Other|0
7219467|NCT02510040|11428366|FG000|Overall Study|Deemed no longer eligible|18
7219468|NCT02510040|11428367|FG001|Overall Study|Deemed no longer eligible|3
7219469|NCT02510040|11428368|FG002|Overall Study|Deemed no longer eligible|1
7296339|NCT00572455|11515248|FG002|Stage II (28 Days)|Other|0
7296340|NCT00572455|11515249|FG003|Stage II (28 Days)|Other|0
7296341|NCT00572455|11515250|FG004|Stage II (28 Days)|Other|0
7296342|NCT00572455|11515251|FG005|Stage II (28 Days)|Other|0
7296343|NCT00572455|11515252|FG006|Stage II (28 Days)|Other|0
7296344|NCT00572455|11515253|FG007|Stage II (28 Days)|Other|0
7296345|NCT00572455|11515254|FG008|Stage II (28 Days)|Other|1
7296346|NCT00572455|11515255|FG009|Stage II (28 Days)|Other|0
7296347|NCT00572455|11515256|FG010|Stage II (28 Days)|Other|0
7296348|NCT00572455|11515257|FG011|Stage II (28 Days)|Other|0
7296349|NCT00572455|11515258|FG012|Stage II (28 Days)|Other|0
7296350|NCT00572455|11515259|FG013|Stage II (28 Days)|Other|0
7296351|NCT00572455|11515246|FG000|Stage II (28 Days)|Randomized, but not treated|0
7296352|NCT00572455|11515247|FG001|Stage II (28 Days)|Randomized, but not treated|0
7296353|NCT00572455|11515248|FG002|Stage II (28 Days)|Randomized, but not treated|0
7296354|NCT00572455|11515249|FG003|Stage II (28 Days)|Randomized, but not treated|0
7296355|NCT00572455|11515250|FG004|Stage II (28 Days)|Randomized, but not treated|0
7296356|NCT00572455|11515251|FG005|Stage II (28 Days)|Randomized, but not treated|0
7296357|NCT00572455|11515252|FG006|Stage II (28 Days)|Randomized, but not treated|0
7296358|NCT00572455|11515253|FG007|Stage II (28 Days)|Randomized, but not treated|0
7296359|NCT00572455|11515254|FG008|Stage II (28 Days)|Randomized, but not treated|0
7296360|NCT00572455|11515255|FG009|Stage II (28 Days)|Randomized, but not treated|0
7296361|NCT00572455|11515256|FG010|Stage II (28 Days)|Randomized, but not treated|0
7296362|NCT00572455|11515257|FG011|Stage II (28 Days)|Randomized, but not treated|0
7296363|NCT00572455|11515258|FG012|Stage II (28 Days)|Randomized, but not treated|0
7296364|NCT00572455|11515259|FG013|Stage II (28 Days)|Randomized, but not treated|1
7296365|NCT00572533|11515300|FG000|Overall Study|Death|4
7296366|NCT00572533|11515301|FG001|Overall Study|Death|1
7296367|NCT00572533|11515300|FG000|Overall Study|Received Kidney Transplant|2
7296368|NCT00572533|11515301|FG001|Overall Study|Received Kidney Transplant|1
7296369|NCT00572533|11515300|FG000|Overall Study|Social Issues|1
7296370|NCT00572533|11515301|FG001|Overall Study|Social Issues|0
7296371|NCT00572533|11515300|FG000|Overall Study|Transfer out of Facility|0
7296372|NCT00572533|11515301|FG001|Overall Study|Transfer out of Facility|1
7296373|NCT00572572|11515309|FG000|Overall Study|Withdrawal by Subject|3
7296374|NCT00572572|11515310|FG001|Overall Study|Withdrawal by Subject|6
7296375|NCT00572624|11515318|FG000|Overall Study|Lost to Follow-up|10
7296376|NCT00572624|11515319|FG001|Overall Study|Lost to Follow-up|4
7296377|NCT00572624|11515318|FG000|Overall Study|Wanted to do a different diet program|1
7296378|NCT00572624|11515319|FG001|Overall Study|Wanted to do a different diet program|0
7296379|NCT00572624|11515318|FG000|Overall Study|Medication change|1
7296380|NCT00572624|11515319|FG001|Overall Study|Medication change|0
7296381|NCT00572624|11515318|FG000|Overall Study|Started a new job-- no time for study|1
7296382|NCT00572624|11515319|FG001|Overall Study|Started a new job-- no time for study|0
7296383|NCT00572624|11515318|FG000|Overall Study|Admitted to being a smoker|1
7296384|NCT00572624|11515319|FG001|Overall Study|Admitted to being a smoker|0
7296385|NCT00572624|11515318|FG000|Overall Study|Refused to do the stress test|1
7296386|NCT00572624|11515319|FG001|Overall Study|Refused to do the stress test|0
7296387|NCT00572624|11515318|FG000|Overall Study|Problem with vascular access|1
7296388|NCT00572624|11515319|FG001|Overall Study|Problem with vascular access|0
7296389|NCT00572624|11515318|FG000|Overall Study|Health issues unrelated to the study|1
7296390|NCT00572624|11515319|FG001|Overall Study|Health issues unrelated to the study|0
7296391|NCT00572728|11515325|FG000|Overall Study|Withdrawal by Subject|10
7296392|NCT00572728|11515325|FG000|Overall Study|Ineligible|3
7296393|NCT00572728|11515325|FG000|Overall Study|Enrolled under Amendment 4|5
7296394|NCT00572728|11515325|FG000|Overall Study|Offstudy due to complicating disease|1
7296395|NCT00572728|11515325|FG000|Overall Study|FLT1 not completed|4
7296396|NCT00572728|11515325|FG000|Overall Study|First Chemotherapy not initiated|2
7296397|NCT00572728|11515325|FG000|Overall Study|FLT2 not completed|5
7296398|NCT00572728|11515325|FG000|Overall Study|Second chemotherapy not initiated|1
7296399|NCT00572728|11515325|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
7296400|NCT00572728|11515325|FG000|Overall Study|Pathology missing|1
7296401|NCT00572832|11515333|FG000|Overall Study|Lost to Follow-up|0
7296402|NCT00572832|11515334|FG001|Overall Study|Lost to Follow-up|11
7296403|NCT00572832|11515333|FG000|Overall Study|Pregnancy|0
7296404|NCT00572832|11515334|FG001|Overall Study|Pregnancy|1
7296405|NCT00572910|11515355|FG000|Overall Study|Adverse Event|1
7296406|NCT00572910|11515356|FG001|Overall Study|Adverse Event|2
7296407|NCT00572910|11515357|FG002|Overall Study|Adverse Event|0
7296408|NCT00572910|11515358|FG003|Overall Study|Adverse Event|2
7296409|NCT00572910|11515359|FG004|Overall Study|Adverse Event|0
7296410|NCT00572910|11515360|FG005|Overall Study|Adverse Event|0
7296411|NCT00572910|11515361|FG006|Overall Study|Adverse Event|4
7296412|NCT00572910|11515362|FG007|Overall Study|Adverse Event|2
7296413|NCT00572910|11515363|FG008|Overall Study|Adverse Event|1
7296414|NCT00572910|11515364|FG009|Overall Study|Adverse Event|3
7296415|NCT00572910|11515365|FG010|Overall Study|Adverse Event|2
7296416|NCT00572910|11515355|FG000|Overall Study|Lost to Follow-up|0
7296417|NCT00572910|11515356|FG001|Overall Study|Lost to Follow-up|1
7296418|NCT00572910|11515357|FG002|Overall Study|Lost to Follow-up|1
7296419|NCT00572910|11515358|FG003|Overall Study|Lost to Follow-up|2
7296420|NCT00572910|11515359|FG004|Overall Study|Lost to Follow-up|1
7296421|NCT00572910|11515360|FG005|Overall Study|Lost to Follow-up|0
7296422|NCT00572910|11515361|FG006|Overall Study|Lost to Follow-up|0
7296423|NCT00572910|11515362|FG007|Overall Study|Lost to Follow-up|0
7296424|NCT00572910|11515363|FG008|Overall Study|Lost to Follow-up|0
7296425|NCT00572910|11515364|FG009|Overall Study|Lost to Follow-up|1
7296426|NCT00572910|11515365|FG010|Overall Study|Lost to Follow-up|0
7296427|NCT00572910|11515355|FG000|Overall Study|Withdrawal by Subject|3
7296428|NCT00572910|11515356|FG001|Overall Study|Withdrawal by Subject|0
7296429|NCT00572910|11515357|FG002|Overall Study|Withdrawal by Subject|1
7296430|NCT00572910|11515358|FG003|Overall Study|Withdrawal by Subject|0
7296431|NCT00572910|11515359|FG004|Overall Study|Withdrawal by Subject|1
7296432|NCT00572910|11515360|FG005|Overall Study|Withdrawal by Subject|3
7296433|NCT00572910|11515361|FG006|Overall Study|Withdrawal by Subject|0
7296434|NCT00572910|11515362|FG007|Overall Study|Withdrawal by Subject|2
7296435|NCT00572910|11515363|FG008|Overall Study|Withdrawal by Subject|2
7296436|NCT00572910|11515364|FG009|Overall Study|Withdrawal by Subject|2
7296437|NCT00572910|11515365|FG010|Overall Study|Withdrawal by Subject|1
7296438|NCT00573066|11515413|FG000|Overall Study|Exclusion criteria|18
7296439|NCT00573066|11515413|FG000|Overall Study|IV malfunction|1
7296440|NCT00573066|11515413|FG000|Overall Study|Postoperative bleeding|1
7296441|NCT00573144|11515419|FG000|Overall Study|Withdrawal by Subject|2
7296442|NCT00573144|11515420|FG001|Overall Study|Withdrawal by Subject|3
7296443|NCT00573170|11515426|FG000|First Treatment Period|Did Not Treat Attack 1|0
7296444|NCT00573170|11515427|FG001|First Treatment Period|Did Not Treat Attack 1|0
7296445|NCT00573170|11515428|FG002|First Treatment Period|Did Not Treat Attack 1|0
7296446|NCT00573170|11515429|FG003|First Treatment Period|Did Not Treat Attack 1|0
7296447|NCT00573170|11515430|FG004|First Treatment Period|Did Not Treat Attack 1|1
7296448|NCT00573170|11515431|FG005|First Treatment Period|Did Not Treat Attack 1|0
7296449|NCT00573170|11515426|FG000|First Washout Period|Adverse Event|1
7296450|NCT00573170|11515427|FG001|First Washout Period|Adverse Event|1
7296451|NCT00573170|11515428|FG002|First Washout Period|Adverse Event|0
7296452|NCT00573170|11515429|FG003|First Washout Period|Adverse Event|0
7296453|NCT00573170|11515430|FG004|First Washout Period|Adverse Event|0
7296454|NCT00573170|11515431|FG005|First Washout Period|Adverse Event|1
7296455|NCT00573170|11515426|FG000|First Washout Period|Lack of Efficacy|0
7296456|NCT00573170|11515427|FG001|First Washout Period|Lack of Efficacy|0
7296457|NCT00573170|11515428|FG002|First Washout Period|Lack of Efficacy|0
7296458|NCT00573170|11515429|FG003|First Washout Period|Lack of Efficacy|0
7296459|NCT00573170|11515430|FG004|First Washout Period|Lack of Efficacy|0
7296460|NCT00573170|11515431|FG005|First Washout Period|Lack of Efficacy|1
7296461|NCT00573170|11515426|FG000|First Washout Period|Lost to Follow-up|1
7296462|NCT00573170|11515427|FG001|First Washout Period|Lost to Follow-up|1
7296463|NCT00573170|11515428|FG002|First Washout Period|Lost to Follow-up|0
7296464|NCT00573170|11515429|FG003|First Washout Period|Lost to Follow-up|2
7296465|NCT00573170|11515430|FG004|First Washout Period|Lost to Follow-up|0
7296466|NCT00573170|11515431|FG005|First Washout Period|Lost to Follow-up|2
7296467|NCT00573170|11515426|FG000|First Washout Period|Withdrawal by Subject|2
7296468|NCT00573170|11515427|FG001|First Washout Period|Withdrawal by Subject|0
7296469|NCT00573170|11515428|FG002|First Washout Period|Withdrawal by Subject|0
7296470|NCT00573170|11515429|FG003|First Washout Period|Withdrawal by Subject|2
7296471|NCT00573170|11515430|FG004|First Washout Period|Withdrawal by Subject|3
7296472|NCT00573170|11515431|FG005|First Washout Period|Withdrawal by Subject|3
7296473|NCT00573170|11515426|FG000|First Washout Period|Other|4
7296474|NCT00573170|11515427|FG001|First Washout Period|Other|0
7296475|NCT00573170|11515428|FG002|First Washout Period|Other|1
7296476|NCT00573170|11515429|FG003|First Washout Period|Other|1
7296477|NCT00573170|11515430|FG004|First Washout Period|Other|0
7296478|NCT00573170|11515431|FG005|First Washout Period|Other|0
7296479|NCT00573170|11515426|FG000|Second Washout Period|Adverse Event|1
7296480|NCT00573170|11515427|FG001|Second Washout Period|Adverse Event|0
7296481|NCT00573170|11515428|FG002|Second Washout Period|Adverse Event|0
7296482|NCT00573170|11515429|FG003|Second Washout Period|Adverse Event|0
7296483|NCT00573170|11515430|FG004|Second Washout Period|Adverse Event|1
7296484|NCT00573170|11515431|FG005|Second Washout Period|Adverse Event|0
7296485|NCT00573170|11515426|FG000|Second Washout Period|Protocol Violation|2
7296486|NCT00573170|11515427|FG001|Second Washout Period|Protocol Violation|1
7296487|NCT00573170|11515428|FG002|Second Washout Period|Protocol Violation|1
7296488|NCT00573170|11515429|FG003|Second Washout Period|Protocol Violation|0
7296489|NCT00573170|11515430|FG004|Second Washout Period|Protocol Violation|0
7296490|NCT00573170|11515431|FG005|Second Washout Period|Protocol Violation|0
7296491|NCT00573170|11515426|FG000|Second Washout Period|Withdrawal by Subject|1
7296492|NCT00573170|11515427|FG001|Second Washout Period|Withdrawal by Subject|1
7296493|NCT00573170|11515428|FG002|Second Washout Period|Withdrawal by Subject|2
7296494|NCT00573170|11515429|FG003|Second Washout Period|Withdrawal by Subject|0
7296495|NCT00573170|11515430|FG004|Second Washout Period|Withdrawal by Subject|1
7296496|NCT00573170|11515431|FG005|Second Washout Period|Withdrawal by Subject|0
7296497|NCT00573170|11515426|FG000|Second Washout Period|Lost to Follow-up|0
7296498|NCT00573170|11515427|FG001|Second Washout Period|Lost to Follow-up|0
7296499|NCT00573170|11515428|FG002|Second Washout Period|Lost to Follow-up|0
7296500|NCT00573170|11515429|FG003|Second Washout Period|Lost to Follow-up|1
7296501|NCT00573170|11515430|FG004|Second Washout Period|Lost to Follow-up|0
7296502|NCT00573170|11515431|FG005|Second Washout Period|Lost to Follow-up|0
7296503|NCT00573170|11515426|FG000|Second Washout Period|Other|1
7296504|NCT00573170|11515427|FG001|Second Washout Period|Other|2
7296505|NCT00573170|11515428|FG002|Second Washout Period|Other|1
7296506|NCT00573170|11515429|FG003|Second Washout Period|Other|4
7296507|NCT00573170|11515430|FG004|Second Washout Period|Other|6
7296508|NCT00573170|11515431|FG005|Second Washout Period|Other|2
7296509|NCT00573170|11515426|FG000|Third Treatment Period|Withdrawal by Subject|1
7296510|NCT00573170|11515427|FG001|Third Treatment Period|Withdrawal by Subject|0
7296511|NCT00573170|11515428|FG002|Third Treatment Period|Withdrawal by Subject|0
7296512|NCT00573170|11515429|FG003|Third Treatment Period|Withdrawal by Subject|0
7296513|NCT00573170|11515430|FG004|Third Treatment Period|Withdrawal by Subject|0
7296514|NCT00573170|11515431|FG005|Third Treatment Period|Withdrawal by Subject|0
7296515|NCT00573170|11515426|FG000|Third Treatment Period|Lost to Follow-up|0
7296516|NCT00573170|11515427|FG001|Third Treatment Period|Lost to Follow-up|0
7296517|NCT00573170|11515428|FG002|Third Treatment Period|Lost to Follow-up|0
7296518|NCT00573170|11515429|FG003|Third Treatment Period|Lost to Follow-up|0
7296519|NCT00573170|11515430|FG004|Third Treatment Period|Lost to Follow-up|0
7296520|NCT00573170|11515431|FG005|Third Treatment Period|Lost to Follow-up|2
7296521|NCT00573183|11515450|FG000|Overall Study|Lost to Follow-up|52
7296522|NCT00573183|11515451|FG001|Overall Study|Lost to Follow-up|50
7296523|NCT00573183|11515450|FG000|Overall Study|Withdrawal by Subject|8
7296524|NCT00573183|11515451|FG001|Overall Study|Withdrawal by Subject|2
7296525|NCT00573183|11515450|FG000|Overall Study|Death|0
7296526|NCT00573183|11515451|FG001|Overall Study|Death|1
7296527|NCT00573183|11515450|FG000|Overall Study|Adverse Event|2
7296528|NCT00573183|11515451|FG001|Overall Study|Adverse Event|0
7296529|NCT00573183|11515450|FG000|Overall Study|Incarceration|5
7296530|NCT00573183|11515451|FG001|Overall Study|Incarceration|8
7296531|NCT00573183|11515450|FG000|Overall Study|Other|5
7296532|NCT00573183|11515451|FG001|Overall Study|Other|2
7296533|NCT00573248|11515461|FG000|Overall Study|scheduling conflicts|15
7296534|NCT00573248|11515462|FG001|Overall Study|scheduling conflicts|11
7296535|NCT00573313|11515492|FG000|Overall Study|Protocol Violation|5
7296536|NCT00573313|11515493|FG001|Overall Study|Protocol Violation|0
7296537|NCT00573313|11515494|FG002|Overall Study|Protocol Violation|6
7296538|NCT00573313|11515495|FG003|Overall Study|Protocol Violation|0
7296539|NCT00573430|11515505|FG000|Overall Study|Incorrect enrollment of randomization|0
7296540|NCT00573430|11515506|FG001|Overall Study|Incorrect enrollment of randomization|4
7296541|NCT00573430|11515507|FG002|Overall Study|Incorrect enrollment of randomization|3
7296542|NCT00573430|11515505|FG000|Overall Study|Adverse Event|0
7296543|NCT00573430|11515506|FG001|Overall Study|Adverse Event|0
7296544|NCT00573430|11515507|FG002|Overall Study|Adverse Event|2
7296545|NCT00573430|11515505|FG000|Overall Study|Withdrawal by Subject|1
7296546|NCT00573430|11515506|FG001|Overall Study|Withdrawal by Subject|0
7296547|NCT00573430|11515507|FG002|Overall Study|Withdrawal by Subject|1
7296548|NCT00573430|11515505|FG000|Overall Study|Protocol Violation|0
7296549|NCT00573430|11515506|FG001|Overall Study|Protocol Violation|1
7296550|NCT00573430|11515507|FG002|Overall Study|Protocol Violation|1
7296551|NCT00573430|11515505|FG000|Overall Study|Eligibility criteria not fulfilled|0
7296552|NCT00573430|11515506|FG001|Overall Study|Eligibility criteria not fulfilled|0
7296553|NCT00573430|11515507|FG002|Overall Study|Eligibility criteria not fulfilled|3
7296554|NCT00573443|11515518|FG000|Double-Blind Phase|Lost to Follow-up|1
7296555|NCT00573443|11515519|FG001|Double-Blind Phase|Lost to Follow-up|3
7296556|NCT00573443|11515520|FG002|Double-Blind Phase|Lost to Follow-up|2
7296557|NCT00573443|11515518|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
7296558|NCT00573443|11515519|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
7296559|NCT00573443|11515520|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
7296560|NCT00573443|11515518|FG000|Double-Blind Phase|Adverse Event|1
7296561|NCT00573443|11515519|FG001|Double-Blind Phase|Adverse Event|5
7296562|NCT00573443|11515520|FG002|Double-Blind Phase|Adverse Event|0
7296563|NCT00573443|11515518|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
7296564|NCT00573443|11515519|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
7296565|NCT00573443|11515520|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
7296566|NCT00573443|11515518|FG000|Double-Blind Phase|Medication refusal due to AE|2
7296567|NCT00573443|11515519|FG001|Double-Blind Phase|Medication refusal due to AE|2
7296568|NCT00573443|11515520|FG002|Double-Blind Phase|Medication refusal due to AE|0
7296569|NCT00573443|11515518|FG000|Double-Blind Phase|Withdrawal by Subject|2
7296570|NCT00573443|11515519|FG001|Double-Blind Phase|Withdrawal by Subject|2
7296571|NCT00573443|11515520|FG002|Double-Blind Phase|Withdrawal by Subject|7
7296572|NCT00573443|11515518|FG000|Double-Blind Phase|Protocol Violation|0
7296573|NCT00573443|11515519|FG001|Double-Blind Phase|Protocol Violation|2
7296574|NCT00573443|11515520|FG002|Double-Blind Phase|Protocol Violation|1
7296575|NCT00573443|11515518|FG000|Double-Blind Phase|Other|0
7296576|NCT00573443|11515519|FG001|Double-Blind Phase|Other|2
7296577|NCT00573443|11515520|FG002|Double-Blind Phase|Other|3
7296578|NCT00573443|11515518|FG000|Open-Label Extension Phase|Lost to Follow-up|1
7296579|NCT00573443|11515519|FG001|Open-Label Extension Phase|Lost to Follow-up|0
7296580|NCT00573443|11515520|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7296581|NCT00573443|11515518|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
7296582|NCT00573443|11515519|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7296583|NCT00573443|11515520|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
7296584|NCT00573443|11515518|FG000|Open-Label Extension Phase|Adverse Event|3
7296585|NCT00573443|11515519|FG001|Open-Label Extension Phase|Adverse Event|0
7296586|NCT00573443|11515520|FG002|Open-Label Extension Phase|Adverse Event|0
7296587|NCT00573443|11515518|FG000|Open-Label Extension Phase|Serious Adverse Event|5
7296588|NCT00573443|11515519|FG001|Open-Label Extension Phase|Serious Adverse Event|0
7296589|NCT00573443|11515520|FG002|Open-Label Extension Phase|Serious Adverse Event|0
7296590|NCT00573443|11515518|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
7296591|NCT00573443|11515519|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
7296592|NCT00573443|11515520|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7296593|NCT00573443|11515518|FG000|Open-Label Extension Phase|Protocol Violation|2
7296594|NCT00573443|11515519|FG001|Open-Label Extension Phase|Protocol Violation|0
7296595|NCT00573443|11515520|FG002|Open-Label Extension Phase|Protocol Violation|0
7296596|NCT00573443|11515518|FG000|Open-Label Extension Phase|Other|2
7296597|NCT00573443|11515519|FG001|Open-Label Extension Phase|Other|0
7296598|NCT00573443|11515520|FG002|Open-Label Extension Phase|Other|0
7296599|NCT00573469|11515532|FG000|Overall Study|Adverse Event|1
7296600|NCT00573469|11515533|FG001|Overall Study|Adverse Event|1
7296601|NCT00573469|11515534|FG002|Overall Study|Adverse Event|1
7296602|NCT00573469|11515532|FG000|Overall Study|Withdrawal by Subject|0
7296603|NCT00573469|11515533|FG001|Overall Study|Withdrawal by Subject|2
7296604|NCT00573469|11515534|FG002|Overall Study|Withdrawal by Subject|0
7296605|NCT00573469|11515532|FG000|Overall Study|Other|5
7296606|NCT00573469|11515533|FG001|Overall Study|Other|1
7296607|NCT00573469|11515534|FG002|Overall Study|Other|3
7296608|NCT00573534|11515551|FG000|Overall Study|oppositional behavior|3
7296609|NCT00573755|11515558|FG000|Overall Study|Still receiving treatment|1
7296610|NCT00573755|11515559|FG001|Overall Study|Still receiving treatment|0
7296611|NCT00573768|11515568|FG000|Overall Study|Adverse Event|1
7296612|NCT00573768|11515569|FG001|Overall Study|Adverse Event|1
7296613|NCT00573768|11515570|FG002|Overall Study|Adverse Event|2
7296614|NCT00573768|11515568|FG000|Overall Study|Protocol Violation|1
7296615|NCT00573768|11515569|FG001|Overall Study|Protocol Violation|0
7296616|NCT00573768|11515570|FG002|Overall Study|Protocol Violation|1
7296617|NCT00573768|11515568|FG000|Overall Study|Withdrawal by Subject|0
7296618|NCT00573768|11515569|FG001|Overall Study|Withdrawal by Subject|1
7296619|NCT00573768|11515570|FG002|Overall Study|Withdrawal by Subject|0
7296620|NCT00573768|11515568|FG000|Overall Study|Lost to Follow-up|0
7296621|NCT00573768|11515569|FG001|Overall Study|Lost to Follow-up|0
7296622|NCT00573768|11515570|FG002|Overall Study|Lost to Follow-up|1
7296623|NCT00573794|11515578|FG000|Overall Study|Adverse Event|81
7296624|NCT00573794|11515578|FG000|Overall Study|Withdrew Consent|90
7296625|NCT00573794|11515578|FG000|Overall Study|Lost to Follow-up|13
7296626|NCT00573794|11515578|FG000|Overall Study|Protocol Violation|6
7296627|NCT00573794|11515578|FG000|Overall Study|Lack of Efficacy|94
7296628|NCT00573794|11515578|FG000|Overall Study|Other|46
7296629|NCT00573833|11515582|FG000|Overall Study|Not Treated|2
7296630|NCT00573859|11515586|FG000|Medication Versus Placebo|Scheduling conflicts|12
7296631|NCT00573859|11515586|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
7296632|NCT00574119|11515625|FG000|Overall Study|Adverse Event|1
7296633|NCT00574119|11515625|FG000|Overall Study|Protocol Violation|1
7296634|NCT00574119|11515625|FG000|Overall Study|Withdrawal by Subject|1
7296635|NCT00574119|11515625|FG000|Overall Study|Physician Decision|1
7296636|NCT00574145|11515631|FG000|Overall Study|Withdrawal by Subject|2
7296637|NCT00574145|11515632|FG001|Overall Study|Withdrawal by Subject|1
7296638|NCT00574249|11515652|FG000|Overall Study|Adverse Event|6
7296639|NCT00574249|11515653|FG001|Overall Study|Adverse Event|18
7296640|NCT00574249|11515652|FG000|Overall Study|Lack of Efficacy|5
7296641|NCT00574249|11515653|FG001|Overall Study|Lack of Efficacy|3
7296642|NCT00574249|11515652|FG000|Overall Study|Lost to Follow-up|4
7296643|NCT00574249|11515653|FG001|Overall Study|Lost to Follow-up|3
7296644|NCT00574249|11515652|FG000|Overall Study|Protocol Violation|5
7296645|NCT00574249|11515653|FG001|Overall Study|Protocol Violation|2
7296646|NCT00574249|11515652|FG000|Overall Study|History of carcinoma|1
7296647|NCT00574249|11515653|FG001|Overall Study|History of carcinoma|0
7296648|NCT00574249|11515652|FG000|Overall Study|Withdrawal by Subject|3
7296649|NCT00574249|11515653|FG001|Overall Study|Withdrawal by Subject|0
7296650|NCT00574249|11515652|FG000|Overall Study|Physician Decision|1
7296651|NCT00574249|11515653|FG001|Overall Study|Physician Decision|0
7296652|NCT00574249|11515652|FG000|Overall Study|Pregnancy|1
7296653|NCT00574249|11515653|FG001|Overall Study|Pregnancy|0
7296654|NCT00574249|11515652|FG000|Overall Study|Excluded by company|0
7296655|NCT00574249|11515653|FG001|Overall Study|Excluded by company|1
7296656|NCT00574249|11515652|FG000|Overall Study|PPD test taken twice|0
7296657|NCT00574249|11515653|FG001|Overall Study|PPD test taken twice|1
7296658|NCT00574275|11515661|FG000|Overall Study|Randomized but not treated|2
7296659|NCT00574275|11515662|FG001|Overall Study|Randomized but not treated|3
7296660|NCT00574275|11515661|FG000|Overall Study|Adverse Event|32
7296661|NCT00574275|11515662|FG001|Overall Study|Adverse Event|76
7296662|NCT00574275|11515661|FG000|Overall Study|Disease progression|160
7296663|NCT00574275|11515662|FG001|Overall Study|Disease progression|146
7296664|NCT00574275|11515661|FG000|Overall Study|Lost to Follow-up|2
7296665|NCT00574275|11515662|FG001|Overall Study|Lost to Follow-up|1
7296666|NCT00574275|11515661|FG000|Overall Study|Study stopped based on DMC decision|62
7296667|NCT00574275|11515662|FG001|Overall Study|Study stopped based on DMC decision|23
7296668|NCT00574275|11515661|FG000|Overall Study|Withdrawal by Subject|15
7296669|NCT00574275|11515662|FG001|Overall Study|Withdrawal by Subject|17
7296670|NCT00574275|11515661|FG000|Overall Study|Error calculating tumor measurement|1
7296671|NCT00574275|11515662|FG001|Overall Study|Error calculating tumor measurement|0
7296672|NCT00574275|11515661|FG000|Overall Study|Physician Decision|1
7296673|NCT00574275|11515662|FG001|Overall Study|Physician Decision|1
7296674|NCT00574275|11515661|FG000|Overall Study|Protocol Violation|0
7296675|NCT00574275|11515662|FG001|Overall Study|Protocol Violation|1
7296676|NCT00574275|11515661|FG000|Overall Study|Patient and Investigator decision|0
7296677|NCT00574275|11515662|FG001|Overall Study|Patient and Investigator decision|1
7296678|NCT00574275|11515661|FG000|Overall Study|Insurance change|0
7296679|NCT00574275|11515662|FG001|Overall Study|Insurance change|1
7296680|NCT00574275|11515661|FG000|Overall Study|Operation for curative intent|0
7296681|NCT00574275|11515662|FG001|Overall Study|Operation for curative intent|1
7296682|NCT00574288|11515675|FG000|Overall Study|Adverse Event|2
7296683|NCT00574288|11515676|FG001|Overall Study|Adverse Event|0
7296684|NCT00574288|11515677|FG002|Overall Study|Adverse Event|0
7296685|NCT00574288|11515678|FG003|Overall Study|Adverse Event|0
7296686|NCT00574288|11515679|FG004|Overall Study|Adverse Event|1
7296687|NCT00574288|11515680|FG005|Overall Study|Adverse Event|0
7296688|NCT00574288|11515681|FG006|Overall Study|Adverse Event|0
7296689|NCT00574288|11515675|FG000|Overall Study|Death|0
7296690|NCT00574288|11515676|FG001|Overall Study|Death|0
7296691|NCT00574288|11515677|FG002|Overall Study|Death|0
7296692|NCT00574288|11515678|FG003|Overall Study|Death|0
7296693|NCT00574288|11515679|FG004|Overall Study|Death|0
7296694|NCT00574288|11515680|FG005|Overall Study|Death|25
7296695|NCT00574288|11515681|FG006|Overall Study|Death|21
7296696|NCT00574288|11515675|FG000|Overall Study|Lost to Follow-up|0
7296697|NCT00574288|11515676|FG001|Overall Study|Lost to Follow-up|0
7296698|NCT00574288|11515677|FG002|Overall Study|Lost to Follow-up|0
7296699|NCT00574288|11515678|FG003|Overall Study|Lost to Follow-up|0
7296700|NCT00574288|11515679|FG004|Overall Study|Lost to Follow-up|0
7296701|NCT00574288|11515680|FG005|Overall Study|Lost to Follow-up|1
7296702|NCT00574288|11515681|FG006|Overall Study|Lost to Follow-up|2
7296703|NCT00574288|11515675|FG000|Overall Study|Study Terminated By Sponsor|0
7296704|NCT00574288|11515676|FG001|Overall Study|Study Terminated By Sponsor|0
7296705|NCT00574288|11515677|FG002|Overall Study|Study Terminated By Sponsor|0
7296706|NCT00574288|11515678|FG003|Overall Study|Study Terminated By Sponsor|0
7296707|NCT00574288|11515679|FG004|Overall Study|Study Terminated By Sponsor|0
7296708|NCT00574288|11515680|FG005|Overall Study|Study Terminated By Sponsor|0
7296709|NCT00574288|11515681|FG006|Overall Study|Study Terminated By Sponsor|5
7296710|NCT00574288|11515675|FG000|Overall Study|Progressive Disease|17
7296711|NCT00574288|11515676|FG001|Overall Study|Progressive Disease|2
7296712|NCT00574288|11515677|FG002|Overall Study|Progressive Disease|3
7296713|NCT00574288|11515678|FG003|Overall Study|Progressive Disease|2
7296714|NCT00574288|11515679|FG004|Overall Study|Progressive Disease|1
7296715|NCT00574288|11515680|FG005|Overall Study|Progressive Disease|0
7296716|NCT00574288|11515681|FG006|Overall Study|Progressive Disease|0
7296717|NCT00574288|11515675|FG000|Overall Study|Other|1
7296718|NCT00574288|11515676|FG001|Overall Study|Other|1
7296719|NCT00574288|11515677|FG002|Overall Study|Other|0
7296720|NCT00574288|11515678|FG003|Overall Study|Other|0
7296721|NCT00574288|11515679|FG004|Overall Study|Other|0
7296722|NCT00574288|11515680|FG005|Overall Study|Other|0
7296723|NCT00574288|11515681|FG006|Overall Study|Other|0
7296724|NCT00574405|11515716|FG000|Overall Study|Withdrawal by Subject|3
7296725|NCT00574405|11515717|FG001|Overall Study|Withdrawal by Subject|2
7296726|NCT00574795|11515785|FG000|Infant Series|Withdrawal by Subject|2
7296727|NCT00574795|11515785|FG000|Infant Series|Protocol Violation|2
7296728|NCT00574795|11515785|FG000|Infant Series|Adverse Event|1
7296729|NCT00574795|11515785|FG000|After Infant Series|Withdrawal by Subject|1
7296730|NCT00574795|11515785|FG000|After Infant Series|Adverse Event|2
7296731|NCT00574795|11515785|FG000|Toddler Dose|Withdrawal by Subject|1
7296732|NCT00574847|11515815|FG000|Overall Study|Adverse Event|2
7296733|NCT00574847|11515816|FG001|Overall Study|Adverse Event|0
7296734|NCT00574847|11515815|FG000|Overall Study|Death|1
7296735|NCT00574847|11515816|FG001|Overall Study|Death|0
7296736|NCT00574847|11515815|FG000|Overall Study|Withdrawal by Subject|2
7296737|NCT00574847|11515816|FG001|Overall Study|Withdrawal by Subject|2
7296738|NCT00574847|11515815|FG000|Overall Study|Physician Decision|1
7296739|NCT00574847|11515816|FG001|Overall Study|Physician Decision|0
7296740|NCT00574847|11515815|FG000|Overall Study|Did not receive medication (declined)|2
7296741|NCT00574847|11515816|FG001|Overall Study|Did not receive medication (declined)|5
7296742|NCT00574873|11515824|FG000|Overall Study|Withdrawal by Subject|18
7296743|NCT00574873|11515825|FG001|Overall Study|Withdrawal by Subject|19
7296744|NCT00574873|11515824|FG000|Overall Study|Investigator request|18
7296745|NCT00574873|11515825|FG001|Overall Study|Investigator request|8
7296746|NCT00574873|11515824|FG000|Overall Study|Death|15
7296747|NCT00574873|11515825|FG001|Overall Study|Death|14
7296748|NCT00574873|11515824|FG000|Overall Study|Lost to Follow-up|14
7296749|NCT00574873|11515825|FG001|Overall Study|Lost to Follow-up|5
7296750|NCT00574873|11515824|FG000|Overall Study|Other|40
7296751|NCT00574873|11515825|FG001|Overall Study|Other|4
7296752|NCT00574873|11515824|FG000|Overall Study|Discontinuation of study by sponsor|5
7296753|NCT00574873|11515825|FG001|Overall Study|Discontinuation of study by sponsor|199
7296754|NCT00574873|11515824|FG000|Overall Study|Blank, site closed per local regulations|2
7296755|NCT00574873|11515825|FG001|Overall Study|Blank, site closed per local regulations|2
7296756|NCT00574873|11515824|FG000|Overall Study|Extension Study|126
7296757|NCT00574873|11515825|FG001|Overall Study|Extension Study|0
7296758|NCT00574912|11515831|FG000|Overall Study|Could not place IV lines.|3
7296759|NCT00574912|11515831|FG000|Overall Study|scheduling conflicts|3
7296760|NCT00574912|11515831|FG000|Overall Study|Physician Decision|2
7296761|NCT00574951|11515843|FG000|Overall Study|Ineligible - improper prior treatment|1
7296762|NCT00575042|11515884|FG000|Overall Study|Adverse Event|2
7296763|NCT00575042|11515884|FG000|Overall Study|Lost to Follow-up|1
7296764|NCT00575094|11515889|FG000|Overall Study|Adverse Event|2
7296765|NCT00575094|11515889|FG000|Overall Study|Withdrawal by Subject|1
7296766|NCT00575328|11515926|FG000|Overall Study|Adverse Event|1
7296767|NCT00575328|11515927|FG001|Overall Study|Adverse Event|1
7296768|NCT00575328|11515926|FG000|Overall Study|Lost to Follow-up|2
7296769|NCT00575328|11515927|FG001|Overall Study|Lost to Follow-up|1
7296770|NCT00575380|11515944|FG000|Overall Study|Withdrawal by Subject|1
7296771|NCT00575380|11515945|FG001|Overall Study|Withdrawal by Subject|0
7296772|NCT00575380|11515944|FG000|Overall Study|Adverse Event|0
7296773|NCT00575380|11515945|FG001|Overall Study|Adverse Event|1
7296774|NCT00575380|11515944|FG000|Overall Study|Various|0
7296775|NCT00575380|11515945|FG001|Overall Study|Various|2
7296776|NCT00575510|11515954|FG000|Overall Study|Lost to Follow-up|4
7296777|NCT00575510|11515955|FG001|Overall Study|Lost to Follow-up|6
7296778|NCT00575510|11515956|FG002|Overall Study|Lost to Follow-up|9
7296779|NCT00575510|11515954|FG000|Overall Study|Withdrawal by Subject|1
7296780|NCT00575510|11515955|FG001|Overall Study|Withdrawal by Subject|0
7296781|NCT00575510|11515956|FG002|Overall Study|Withdrawal by Subject|0
7296782|NCT00575510|11515954|FG000|Overall Study|Clinic Called Patient|7
7296783|NCT00575510|11515955|FG001|Overall Study|Clinic Called Patient|7
7296784|NCT00575510|11515956|FG002|Overall Study|Clinic Called Patient|7
7296785|NCT00575510|11515954|FG000|Overall Study|Pregnancy|0
7296786|NCT00575510|11515955|FG001|Overall Study|Pregnancy|0
7296787|NCT00575510|11515956|FG002|Overall Study|Pregnancy|1
7296788|NCT00575588|11515967|FG000|Overall Study|Adverse Event|11
7296789|NCT00575588|11515968|FG001|Overall Study|Adverse Event|13
7296790|NCT00575588|11515967|FG000|Overall Study|Withdrawal by Subject|27
7296791|NCT00575588|11515968|FG001|Overall Study|Withdrawal by Subject|31
7296792|NCT00575588|11515967|FG000|Overall Study|Lost to Follow-up|1
7296793|NCT00575588|11515968|FG001|Overall Study|Lost to Follow-up|3
7296794|NCT00575588|11515967|FG000|Overall Study|Death|4
7296795|NCT00575588|11515968|FG001|Overall Study|Death|2
7219584|NCT02460224|11428535|FG000|Overall Study|Adverse Event|0
7219585|NCT02460224|11428536|FG001|Overall Study|Adverse Event|0
7219586|NCT02460224|11428537|FG002|Overall Study|Adverse Event|0
7219587|NCT02460224|11428538|FG003|Overall Study|Adverse Event|0
7219588|NCT02460224|11428539|FG004|Overall Study|Adverse Event|0
7219589|NCT02460224|11428540|FG005|Overall Study|Adverse Event|0
7219590|NCT02460224|11428541|FG006|Overall Study|Adverse Event|1
7219591|NCT02460224|11428542|FG007|Overall Study|Adverse Event|0
7219592|NCT02460224|11428543|FG008|Overall Study|Adverse Event|0
7219593|NCT02460224|11428544|FG009|Overall Study|Adverse Event|0
7219594|NCT02460224|11428545|FG010|Overall Study|Adverse Event|0
7219595|NCT02460224|11428546|FG011|Overall Study|Adverse Event|0
7219596|NCT02460224|11428547|FG012|Overall Study|Adverse Event|1
7219597|NCT02460224|11428548|FG013|Overall Study|Adverse Event|0
7219598|NCT02460224|11428549|FG014|Overall Study|Adverse Event|0
7219599|NCT02460224|11428550|FG015|Overall Study|Adverse Event|0
7219600|NCT02460224|11428551|FG016|Overall Study|Adverse Event|1
7219601|NCT02460224|11428552|FG017|Overall Study|Adverse Event|0
7219602|NCT02460224|11428553|FG018|Overall Study|Adverse Event|1
7219603|NCT02460224|11428554|FG019|Overall Study|Adverse Event|0
7219604|NCT02460224|11428555|FG020|Overall Study|Adverse Event|1
7296796|NCT00575588|11515967|FG000|Overall Study|Incorrect enrollment|8
7219605|NCT02460224|11428556|FG021|Overall Study|Adverse Event|1
7219606|NCT02460224|11428557|FG022|Overall Study|Adverse Event|1
7219607|NCT02460224|11428558|FG023|Overall Study|Adverse Event|0
7219608|NCT02460224|11428559|FG024|Overall Study|Adverse Event|0
7219609|NCT02460224|11428560|FG025|Overall Study|Adverse Event|0
7296797|NCT00575588|11515968|FG001|Overall Study|Incorrect enrollment|4
7296798|NCT00575588|11515967|FG000|Overall Study|Study specific discontinuation criteria|203
7296799|NCT00575588|11515968|FG001|Overall Study|Study specific discontinuation criteria|218
7296800|NCT00575588|11515967|FG000|Overall Study|Severe non-compliance to protocol|5
7296801|NCT00575588|11515968|FG001|Overall Study|Severe non-compliance to protocol|7
7296802|NCT00575588|11515967|FG000|Overall Study|Safety reasons|2
7296803|NCT00575588|11515968|FG001|Overall Study|Safety reasons|1
7296804|NCT00575588|11515967|FG000|Overall Study|Elevated triglyceride|1
7296805|NCT00575588|11515968|FG001|Overall Study|Elevated triglyceride|0
7296806|NCT00575588|11515967|FG000|Overall Study|Patient moved|1
7296807|NCT00575588|11515968|FG001|Overall Study|Patient moved|3
7296808|NCT00575588|11515967|FG000|Overall Study|Impossible to determine HbA1c|0
7296809|NCT00575588|11515968|FG001|Overall Study|Impossible to determine HbA1c|1
7296810|NCT00575666|11515976|FG000|Overall Study|Withdrawal by Subject|3
7296811|NCT00575666|11515977|FG001|Overall Study|Withdrawal by Subject|2
7296812|NCT00575666|11515976|FG000|Overall Study|Physician Decision|1
7219610|NCT02460224|11428561|FG026|Overall Study|Adverse Event|11
7219611|NCT02460224|11428562|FG027|Overall Study|Adverse Event|1
7219612|NCT02460224|11428563|FG028|Overall Study|Adverse Event|6
7219613|NCT02460224|11428535|FG000|Overall Study|Death|0
7219614|NCT02460224|11428536|FG001|Overall Study|Death|0
7219615|NCT02460224|11428537|FG002|Overall Study|Death|0
7219616|NCT02460224|11428538|FG003|Overall Study|Death|0
7219617|NCT02460224|11428539|FG004|Overall Study|Death|0
7219618|NCT02460224|11428540|FG005|Overall Study|Death|2
7219619|NCT02460224|11428541|FG006|Overall Study|Death|1
7219620|NCT02460224|11428542|FG007|Overall Study|Death|0
7219621|NCT02460224|11428543|FG008|Overall Study|Death|0
7219622|NCT02460224|11428544|FG009|Overall Study|Death|1
7219623|NCT02460224|11428545|FG010|Overall Study|Death|0
7219624|NCT02460224|11428546|FG011|Overall Study|Death|0
7219625|NCT02460224|11428547|FG012|Overall Study|Death|0
7219626|NCT02460224|11428548|FG013|Overall Study|Death|1
7219627|NCT02460224|11428549|FG014|Overall Study|Death|0
7219628|NCT02460224|11428550|FG015|Overall Study|Death|0
7219629|NCT02460224|11428551|FG016|Overall Study|Death|2
7219630|NCT02460224|11428552|FG017|Overall Study|Death|1
7219631|NCT02460224|11428553|FG018|Overall Study|Death|0
7219632|NCT02460224|11428554|FG019|Overall Study|Death|2
7219633|NCT02460224|11428555|FG020|Overall Study|Death|0
7219634|NCT02460224|11428556|FG021|Overall Study|Death|0
7219635|NCT02460224|11428557|FG022|Overall Study|Death|0
7219636|NCT02460224|11428558|FG023|Overall Study|Death|0
7219637|NCT02460224|11428559|FG024|Overall Study|Death|1
7219638|NCT02460224|11428560|FG025|Overall Study|Death|1
7219639|NCT02460224|11428561|FG026|Overall Study|Death|5
7219640|NCT02460224|11428562|FG027|Overall Study|Death|0
7219641|NCT02460224|11428563|FG028|Overall Study|Death|1
7219642|NCT02460224|11428535|FG000|Overall Study|Lost to Follow-up|0
7219643|NCT02460224|11428536|FG001|Overall Study|Lost to Follow-up|0
7219644|NCT02460224|11428537|FG002|Overall Study|Lost to Follow-up|0
7219645|NCT02460224|11428538|FG003|Overall Study|Lost to Follow-up|0
7219646|NCT02460224|11428539|FG004|Overall Study|Lost to Follow-up|0
7219647|NCT02460224|11428540|FG005|Overall Study|Lost to Follow-up|0
7219648|NCT02460224|11428541|FG006|Overall Study|Lost to Follow-up|0
7219649|NCT02460224|11428542|FG007|Overall Study|Lost to Follow-up|0
7219650|NCT02460224|11428543|FG008|Overall Study|Lost to Follow-up|0
7219651|NCT02460224|11428544|FG009|Overall Study|Lost to Follow-up|0
7219652|NCT02460224|11428545|FG010|Overall Study|Lost to Follow-up|0
7219653|NCT02460224|11428546|FG011|Overall Study|Lost to Follow-up|0
7219654|NCT02460224|11428547|FG012|Overall Study|Lost to Follow-up|0
7219655|NCT02460224|11428548|FG013|Overall Study|Lost to Follow-up|0
7219656|NCT02460224|11428549|FG014|Overall Study|Lost to Follow-up|0
7219657|NCT02460224|11428550|FG015|Overall Study|Lost to Follow-up|0
7219658|NCT02460224|11428551|FG016|Overall Study|Lost to Follow-up|0
7219659|NCT02460224|11428552|FG017|Overall Study|Lost to Follow-up|0
7219660|NCT02460224|11428553|FG018|Overall Study|Lost to Follow-up|0
7219661|NCT02460224|11428554|FG019|Overall Study|Lost to Follow-up|0
7219662|NCT02460224|11428555|FG020|Overall Study|Lost to Follow-up|0
7219663|NCT02460224|11428556|FG021|Overall Study|Lost to Follow-up|0
7219664|NCT02460224|11428557|FG022|Overall Study|Lost to Follow-up|1
7219665|NCT02460224|11428558|FG023|Overall Study|Lost to Follow-up|0
7219666|NCT02460224|11428559|FG024|Overall Study|Lost to Follow-up|0
7296813|NCT00575666|11515977|FG001|Overall Study|Physician Decision|1
7551526|NCT02970669|11910830|FG000|Open-label Period|Withdrawal by Subject|2
7219667|NCT02460224|11428560|FG025|Overall Study|Lost to Follow-up|0
7219668|NCT02460224|11428561|FG026|Overall Study|Lost to Follow-up|0
7219669|NCT02460224|11428562|FG027|Overall Study|Lost to Follow-up|0
7219670|NCT02460224|11428563|FG028|Overall Study|Lost to Follow-up|0
7219671|NCT02460224|11428535|FG000|Overall Study|Physician Decision|0
7219672|NCT02460224|11428536|FG001|Overall Study|Physician Decision|1
7219673|NCT02460224|11428537|FG002|Overall Study|Physician Decision|0
7219674|NCT02460224|11428538|FG003|Overall Study|Physician Decision|0
7219675|NCT02460224|11428539|FG004|Overall Study|Physician Decision|1
7219676|NCT02460224|11428540|FG005|Overall Study|Physician Decision|0
7219677|NCT02460224|11428541|FG006|Overall Study|Physician Decision|0
7219678|NCT02460224|11428542|FG007|Overall Study|Physician Decision|1
7219679|NCT02460224|11428543|FG008|Overall Study|Physician Decision|0
7219680|NCT02460224|11428544|FG009|Overall Study|Physician Decision|0
7219681|NCT02460224|11428545|FG010|Overall Study|Physician Decision|0
7219682|NCT02460224|11428546|FG011|Overall Study|Physician Decision|1
7296814|NCT00576056|11515991|FG000|Overall Study|Adverse Event|1
7296815|NCT00576056|11515991|FG000|Overall Study|Death|1
7296816|NCT00576056|11515991|FG000|Overall Study|Lack of Efficacy|1
7296817|NCT00576056|11515991|FG000|Overall Study|Withdrawal by Subject|2
7296818|NCT00576056|11515991|FG000|Overall Study|did not meet eligibility criteria|8
7296819|NCT00576056|11515991|FG000|Overall Study|Physician Decision|1
7296820|NCT00576199|11515999|FG000|Overall Study|Adverse Event|12
7296821|NCT00576199|11515999|FG000|Overall Study|Insufficient Therapeutic Response|14
7296822|NCT00576199|11515999|FG000|Overall Study|Refused Treatment|2
7296823|NCT00576199|11515999|FG000|Overall Study|Reason Unspecified|2
7296824|NCT00576303|11516012|FG000|Dose Titration Period|Early withdrawal|17
7296825|NCT00576303|11516012|FG000|Efficacy Evaluation Period|Early withdrawal|5
7296826|NCT00576303|11516012|FG000|Long Term Safety Period|Early withdrawal|16
7296827|NCT00576316|11516016|FG000|Overall Study|Adverse Event|9
7296828|NCT00576316|11516016|FG000|Overall Study|Withdrawal by Subject|2
7296829|NCT00576316|11516016|FG000|Overall Study|Protocol Violation|9
7296830|NCT00576381|11516020|FG000|Overall Study|Reoperation|3
7296831|NCT00576381|11516020|FG000|Overall Study|Adverse Event|4
7296832|NCT00576420|11516027|FG000|Overall Study|Death|0
7296833|NCT00576420|11516028|FG001|Overall Study|Death|0
7296834|NCT00576420|11516029|FG002|Overall Study|Death|1
7296835|NCT00576472|11516093|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
7219683|NCT02460224|11428547|FG012|Overall Study|Physician Decision|0
7219684|NCT02460224|11428548|FG013|Overall Study|Physician Decision|1
7219685|NCT02460224|11428549|FG014|Overall Study|Physician Decision|0
7219686|NCT02460224|11428550|FG015|Overall Study|Physician Decision|0
7219687|NCT02460224|11428551|FG016|Overall Study|Physician Decision|2
7219688|NCT02460224|11428552|FG017|Overall Study|Physician Decision|1
7219689|NCT02460224|11428553|FG018|Overall Study|Physician Decision|1
7219690|NCT02460224|11428554|FG019|Overall Study|Physician Decision|2
7219691|NCT02460224|11428555|FG020|Overall Study|Physician Decision|1
7219692|NCT02460224|11428556|FG021|Overall Study|Physician Decision|1
7219693|NCT02460224|11428557|FG022|Overall Study|Physician Decision|0
7219694|NCT02460224|11428558|FG023|Overall Study|Physician Decision|0
7219695|NCT02460224|11428559|FG024|Overall Study|Physician Decision|1
7219696|NCT02460224|11428560|FG025|Overall Study|Physician Decision|0
7219697|NCT02460224|11428561|FG026|Overall Study|Physician Decision|14
7219698|NCT02460224|11428562|FG027|Overall Study|Physician Decision|1
7219699|NCT02460224|11428563|FG028|Overall Study|Physician Decision|6
7219700|NCT02460224|11428535|FG000|Overall Study|Progressive disease|15
7219701|NCT02460224|11428536|FG001|Overall Study|Progressive disease|11
7219702|NCT02460224|11428537|FG002|Overall Study|Progressive disease|5
7219703|NCT02460224|11428538|FG003|Overall Study|Progressive disease|6
7219704|NCT02460224|11428539|FG004|Overall Study|Progressive disease|3
7219705|NCT02460224|11428540|FG005|Overall Study|Progressive disease|26
7219706|NCT02460224|11428541|FG006|Overall Study|Progressive disease|28
7219707|NCT02460224|11428542|FG007|Overall Study|Progressive disease|4
7219708|NCT02460224|11428543|FG008|Overall Study|Progressive disease|5
7219709|NCT02460224|11428544|FG009|Overall Study|Progressive disease|9
7219710|NCT02460224|11428545|FG010|Overall Study|Progressive disease|5
7219711|NCT02460224|11428546|FG011|Overall Study|Progressive disease|4
7219712|NCT02460224|11428547|FG012|Overall Study|Progressive disease|5
7219713|NCT02460224|11428548|FG013|Overall Study|Progressive disease|4
7219714|NCT02460224|11428549|FG014|Overall Study|Progressive disease|5
7219715|NCT02460224|11428550|FG015|Overall Study|Progressive disease|5
7219716|NCT02460224|11428551|FG016|Overall Study|Progressive disease|15
7219717|NCT02460224|11428552|FG017|Overall Study|Progressive disease|3
7219718|NCT02460224|11428553|FG018|Overall Study|Progressive disease|8
7219719|NCT02460224|11428554|FG019|Overall Study|Progressive disease|3
7219720|NCT02460224|11428555|FG020|Overall Study|Progressive disease|4
7219721|NCT02460224|11428556|FG021|Overall Study|Progressive disease|9
7219722|NCT02460224|11428557|FG022|Overall Study|Progressive disease|4
7219723|NCT02460224|11428558|FG023|Overall Study|Progressive disease|11
7219724|NCT02460224|11428559|FG024|Overall Study|Progressive disease|4
7219725|NCT02460224|11428560|FG025|Overall Study|Progressive disease|5
7219726|NCT02460224|11428561|FG026|Overall Study|Progressive disease|85
7219727|NCT02460224|11428562|FG027|Overall Study|Progressive disease|17
7219728|NCT02460224|11428563|FG028|Overall Study|Progressive disease|77
7219729|NCT02460224|11428535|FG000|Overall Study|Subject/guardian decision|2
7219730|NCT02460224|11428536|FG001|Overall Study|Subject/guardian decision|0
7219731|NCT02460224|11428537|FG002|Overall Study|Subject/guardian decision|1
7219732|NCT02460224|11428538|FG003|Overall Study|Subject/guardian decision|0
7219733|NCT02460224|11428539|FG004|Overall Study|Subject/guardian decision|2
7219734|NCT02460224|11428540|FG005|Overall Study|Subject/guardian decision|2
7219735|NCT02460224|11428541|FG006|Overall Study|Subject/guardian decision|0
7219736|NCT02460224|11428542|FG007|Overall Study|Subject/guardian decision|0
7219737|NCT02460224|11428543|FG008|Overall Study|Subject/guardian decision|1
7219738|NCT02460224|11428544|FG009|Overall Study|Subject/guardian decision|1
7219739|NCT02460224|11428545|FG010|Overall Study|Subject/guardian decision|0
7219740|NCT02460224|11428546|FG011|Overall Study|Subject/guardian decision|1
7219741|NCT02460224|11428547|FG012|Overall Study|Subject/guardian decision|0
7219742|NCT02460224|11428548|FG013|Overall Study|Subject/guardian decision|0
7219743|NCT02460224|11428549|FG014|Overall Study|Subject/guardian decision|0
7219744|NCT02460224|11428550|FG015|Overall Study|Subject/guardian decision|1
7296836|NCT00576472|11516094|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
7296837|NCT00576472|11516095|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
7296838|NCT00576472|11516096|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
7296839|NCT00576472|11516097|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
7296840|NCT00576472|11516098|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
7296841|NCT00576472|11516099|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
7296842|NCT00576472|11516100|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
7296843|NCT00576472|11516101|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
7296844|NCT00576472|11516102|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
7296845|NCT00576472|11516103|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
7296846|NCT00576472|11516104|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
7296847|NCT00576472|11516105|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
7296848|NCT00576472|11516106|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
7296849|NCT00576472|11516107|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
7296850|NCT00576472|11516093|FG000|MPH In-Lab Phase|Lost to Follow-up|0
7296851|NCT00576472|11516094|FG001|MPH In-Lab Phase|Lost to Follow-up|0
7296852|NCT00576472|11516095|FG002|MPH In-Lab Phase|Lost to Follow-up|0
7296853|NCT00576472|11516096|FG003|MPH In-Lab Phase|Lost to Follow-up|1
7296854|NCT00576472|11516097|FG004|MPH In-Lab Phase|Lost to Follow-up|0
7296855|NCT00576472|11516098|FG005|MPH In-Lab Phase|Lost to Follow-up|0
7296856|NCT00576472|11516099|FG006|MPH In-Lab Phase|Lost to Follow-up|0
7296857|NCT00576472|11516100|FG007|MPH In-Lab Phase|Lost to Follow-up|0
7296858|NCT00576472|11516101|FG008|MPH In-Lab Phase|Lost to Follow-up|0
7296859|NCT00576472|11516102|FG009|MPH In-Lab Phase|Lost to Follow-up|0
7296860|NCT00576472|11516103|FG010|MPH In-Lab Phase|Lost to Follow-up|0
7296861|NCT00576472|11516104|FG011|MPH In-Lab Phase|Lost to Follow-up|0
7296862|NCT00576472|11516105|FG012|MPH In-Lab Phase|Lost to Follow-up|0
7296863|NCT00576472|11516106|FG013|MPH In-Lab Phase|Lost to Follow-up|0
7296864|NCT00576472|11516107|FG014|MPH In-Lab Phase|Lost to Follow-up|0
7296865|NCT00576472|11516093|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296866|NCT00576472|11516094|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296867|NCT00576472|11516095|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296868|NCT00576472|11516096|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
7296869|NCT00576472|11516097|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296870|NCT00576472|11516098|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296871|NCT00576472|11516099|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296872|NCT00576472|11516100|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296873|NCT00576472|11516101|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296874|NCT00576472|11516102|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296875|NCT00576472|11516103|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296876|NCT00576472|11516104|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296877|NCT00576472|11516105|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296878|NCT00576472|11516106|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296879|NCT00576472|11516107|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
7296880|NCT00576472|11516093|FG000|MPH In-Lab Phase|No attention/academic problems|0
7296881|NCT00576472|11516094|FG001|MPH In-Lab Phase|No attention/academic problems|0
7296882|NCT00576472|11516095|FG002|MPH In-Lab Phase|No attention/academic problems|0
7296883|NCT00576472|11516096|FG003|MPH In-Lab Phase|No attention/academic problems|245
7296884|NCT00576472|11516097|FG004|MPH In-Lab Phase|No attention/academic problems|0
7296885|NCT00576472|11516098|FG005|MPH In-Lab Phase|No attention/academic problems|0
7296886|NCT00576472|11516099|FG006|MPH In-Lab Phase|No attention/academic problems|0
7296887|NCT00576472|11516100|FG007|MPH In-Lab Phase|No attention/academic problems|0
7296888|NCT00576472|11516101|FG008|MPH In-Lab Phase|No attention/academic problems|0
7296889|NCT00576472|11516102|FG009|MPH In-Lab Phase|No attention/academic problems|0
7296890|NCT00576472|11516103|FG010|MPH In-Lab Phase|No attention/academic problems|0
7296891|NCT00576472|11516104|FG011|MPH In-Lab Phase|No attention/academic problems|0
7296892|NCT00576472|11516105|FG012|MPH In-Lab Phase|No attention/academic problems|0
7296893|NCT00576472|11516106|FG013|MPH In-Lab Phase|No attention/academic problems|0
7296894|NCT00576472|11516107|FG014|MPH In-Lab Phase|No attention/academic problems|0
7296895|NCT00576472|11516093|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
7296896|NCT00576472|11516094|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
7296897|NCT00576472|11516095|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
7296898|NCT00576472|11516096|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
7296899|NCT00576472|11516097|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
7296900|NCT00576472|11516098|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
7296901|NCT00576472|11516099|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
7296902|NCT00576472|11516100|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
7296903|NCT00576472|11516101|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
7296904|NCT00576472|11516102|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
7296905|NCT00576472|11516103|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
7296906|NCT00576472|11516104|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
7296907|NCT00576472|11516105|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
7296908|NCT00576472|11516106|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
7296909|NCT00576472|11516107|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
7296910|NCT00576472|11516093|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
7296911|NCT00576472|11516094|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
7296912|NCT00576472|11516095|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
7296913|NCT00576472|11516096|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
7296914|NCT00576472|11516097|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
7296915|NCT00576472|11516098|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
7296916|NCT00576472|11516099|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
7296917|NCT00576472|11516100|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
7296918|NCT00576472|11516101|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
7296919|NCT00576472|11516102|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
7296920|NCT00576472|11516103|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
7296921|NCT00576472|11516104|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
7296922|NCT00576472|11516105|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
7296923|NCT00576472|11516106|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
7296924|NCT00576472|11516107|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
7296925|NCT00576472|11516093|FG000|MPH Cross Over Phase|Ineligible due to disease|0
7296926|NCT00576472|11516094|FG001|MPH Cross Over Phase|Ineligible due to disease|0
7296927|NCT00576472|11516095|FG002|MPH Cross Over Phase|Ineligible due to disease|0
7296928|NCT00576472|11516096|FG003|MPH Cross Over Phase|Ineligible due to disease|0
7296929|NCT00576472|11516097|FG004|MPH Cross Over Phase|Ineligible due to disease|0
7296930|NCT00576472|11516098|FG005|MPH Cross Over Phase|Ineligible due to disease|0
7296931|NCT00576472|11516099|FG006|MPH Cross Over Phase|Ineligible due to disease|2
7296932|NCT00576472|11516100|FG007|MPH Cross Over Phase|Ineligible due to disease|0
7296933|NCT00576472|11516101|FG008|MPH Cross Over Phase|Ineligible due to disease|0
7296934|NCT00576472|11516102|FG009|MPH Cross Over Phase|Ineligible due to disease|0
7296935|NCT00576472|11516103|FG010|MPH Cross Over Phase|Ineligible due to disease|0
7296936|NCT00576472|11516104|FG011|MPH Cross Over Phase|Ineligible due to disease|0
7296937|NCT00576472|11516105|FG012|MPH Cross Over Phase|Ineligible due to disease|0
7296938|NCT00576472|11516106|FG013|MPH Cross Over Phase|Ineligible due to disease|0
7296939|NCT00576472|11516107|FG014|MPH Cross Over Phase|Ineligible due to disease|0
7296940|NCT00576472|11516093|FG000|MPH Cross Over Phase|Physician Decision|0
7296941|NCT00576472|11516094|FG001|MPH Cross Over Phase|Physician Decision|0
7296942|NCT00576472|11516095|FG002|MPH Cross Over Phase|Physician Decision|0
7296943|NCT00576472|11516096|FG003|MPH Cross Over Phase|Physician Decision|0
7296944|NCT00576472|11516097|FG004|MPH Cross Over Phase|Physician Decision|0
7296945|NCT00576472|11516098|FG005|MPH Cross Over Phase|Physician Decision|0
7296946|NCT00576472|11516099|FG006|MPH Cross Over Phase|Physician Decision|4
7296947|NCT00576472|11516100|FG007|MPH Cross Over Phase|Physician Decision|0
7296948|NCT00576472|11516101|FG008|MPH Cross Over Phase|Physician Decision|0
7296949|NCT00576472|11516102|FG009|MPH Cross Over Phase|Physician Decision|0
7296950|NCT00576472|11516103|FG010|MPH Cross Over Phase|Physician Decision|0
7296951|NCT00576472|11516104|FG011|MPH Cross Over Phase|Physician Decision|0
7296952|NCT00576472|11516105|FG012|MPH Cross Over Phase|Physician Decision|0
7219745|NCT02460224|11428551|FG016|Overall Study|Subject/guardian decision|0
7219746|NCT02460224|11428552|FG017|Overall Study|Subject/guardian decision|1
7219747|NCT02460224|11428553|FG018|Overall Study|Subject/guardian decision|2
7219748|NCT02460224|11428554|FG019|Overall Study|Subject/guardian decision|0
7219749|NCT02460224|11428555|FG020|Overall Study|Subject/guardian decision|0
7219750|NCT02460224|11428556|FG021|Overall Study|Subject/guardian decision|1
7219751|NCT02460224|11428557|FG022|Overall Study|Subject/guardian decision|0
7219752|NCT02460224|11428558|FG023|Overall Study|Subject/guardian decision|0
7219753|NCT02460224|11428559|FG024|Overall Study|Subject/guardian decision|0
7219754|NCT02460224|11428560|FG025|Overall Study|Subject/guardian decision|0
7219755|NCT02460224|11428561|FG026|Overall Study|Subject/guardian decision|6
7219756|NCT02460224|11428562|FG027|Overall Study|Subject/guardian decision|2
7219757|NCT02460224|11428563|FG028|Overall Study|Subject/guardian decision|3
7219758|NCT02460159|11428637|FG000|Overall Study|Adverse Event|4
7219759|NCT02460159|11428638|FG001|Overall Study|Adverse Event|1
7219760|NCT02460159|11428637|FG000|Overall Study|Withdrawal by Subject|2
7219761|NCT02460159|11428638|FG001|Overall Study|Withdrawal by Subject|0
7296953|NCT00576472|11516106|FG013|MPH Cross Over Phase|Physician Decision|0
7296954|NCT00576472|11516107|FG014|MPH Cross Over Phase|Physician Decision|0
7296955|NCT00576472|11516093|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
7296956|NCT00576472|11516094|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
7296957|NCT00576472|11516095|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
7296958|NCT00576472|11516096|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
7296959|NCT00576472|11516097|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
7296960|NCT00576472|11516098|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
7296961|NCT00576472|11516099|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
7296962|NCT00576472|11516100|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
7296963|NCT00576472|11516101|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
7296964|NCT00576472|11516102|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
7296965|NCT00576472|11516103|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
7296966|NCT00576472|11516104|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
7296967|NCT00576472|11516105|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
7296968|NCT00576472|11516106|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
7296969|NCT00576472|11516107|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
7296970|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
7296971|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
7296972|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
7296973|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
7296974|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
7296975|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
7296976|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
7296977|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
7296978|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
7296979|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
7296980|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
7296981|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
7296982|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
7296983|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
7296984|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
7296985|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Declined to participate|0
7296986|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Declined to participate|0
7296987|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Declined to participate|0
7296988|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Declined to participate|0
7296989|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Declined to participate|0
7296990|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Declined to participate|0
7296991|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Declined to participate|0
7296992|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Declined to participate|0
7296993|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Declined to participate|0
7296994|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Declined to participate|0
7296995|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Declined to participate|0
7296996|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Declined to participate|0
7296997|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Declined to participate|0
7296998|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Declined to participate|7
7296999|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Declined to participate|0
7297000|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Insufficient data|0
7297001|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Insufficient data|0
7297002|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Insufficient data|0
7297003|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Insufficient data|0
7297004|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Insufficient data|0
7297005|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Insufficient data|0
7297006|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Insufficient data|0
7297007|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Insufficient data|0
7297008|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Insufficient data|0
7297009|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Insufficient data|0
7297010|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Insufficient data|0
7297011|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Insufficient data|0
7297012|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Insufficient data|0
7297013|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Insufficient data|4
7297014|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Insufficient data|0
7297015|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Side effects|0
7297016|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Side effects|0
7297017|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Side effects|0
7297018|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Side effects|0
7297019|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Side effects|0
7297020|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Side effects|0
7219880|NCT02320396|11428707|FG000|Overall Study|Adverse Event|2
7219881|NCT02320396|11428708|FG001|Overall Study|Adverse Event|2
7219882|NCT02320396|11428707|FG000|Overall Study|Pregnancy|0
7219883|NCT02320396|11428708|FG001|Overall Study|Pregnancy|1
7219884|NCT02320396|11428707|FG000|Overall Study|Protocol Violation|0
7219885|NCT02320396|11428708|FG001|Overall Study|Protocol Violation|1
7219886|NCT02320396|11428707|FG000|Overall Study|Withdrawal by Subject|2
7219887|NCT02320396|11428708|FG001|Overall Study|Withdrawal by Subject|0
7624401|NCT04399356|12035435|FG000|Overall Study|Lost to Follow-up|1
7624402|NCT04399356|12035436|FG001|Overall Study|Lost to Follow-up|1
7219890|NCT02230410|11428726|FG000|Overall Study|Screen Failure|3
7219891|NCT02053246|11428730|FG000|Overall Study|Withdrawal by Subject|3
7219892|NCT02053246|11428730|FG000|Overall Study|Physician Decision|1
7219893|NCT01980940|11428742|FG000|Overall Study|Protocol Violation|0
7219894|NCT01980940|11428743|FG001|Overall Study|Protocol Violation|0
7219895|NCT01980940|11428744|FG002|Overall Study|Protocol Violation|0
7219896|NCT01980940|11428745|FG003|Overall Study|Protocol Violation|0
7219897|NCT01980940|11428746|FG004|Overall Study|Protocol Violation|0
7219898|NCT01980940|11428747|FG005|Overall Study|Protocol Violation|2
7219899|NCT01980940|11428748|FG006|Overall Study|Protocol Violation|0
7219900|NCT01980940|11428749|FG007|Overall Study|Protocol Violation|0
7219901|NCT01918033|11428780|FG000|Overall Study|Adverse Event|1
7219902|NCT01918033|11428781|FG001|Overall Study|Adverse Event|0
7219903|NCT01918033|11428782|FG002|Overall Study|Adverse Event|2
7219904|NCT01918033|11428780|FG000|Overall Study|Lost to Follow-up|0
7219905|NCT01918033|11428781|FG001|Overall Study|Lost to Follow-up|1
7219906|NCT01918033|11428782|FG002|Overall Study|Lost to Follow-up|0
7219907|NCT01918033|11428780|FG000|Overall Study|Protocol Violation|2
7219908|NCT01918033|11428781|FG001|Overall Study|Protocol Violation|0
7219909|NCT01918033|11428782|FG002|Overall Study|Protocol Violation|1
7219910|NCT01918033|11428780|FG000|Overall Study|Withdrawal by Subject|2
7219911|NCT01918033|11428781|FG001|Overall Study|Withdrawal by Subject|1
7219912|NCT01918033|11428782|FG002|Overall Study|Withdrawal by Subject|0
7219913|NCT01916980|11428792|FG000|Overall Study|Adverse Event|4
7219914|NCT01916980|11428793|FG001|Overall Study|Adverse Event|2
7219915|NCT01916980|11428792|FG000|Overall Study|Lack of Efficacy|2
7219916|NCT01916980|11428793|FG001|Overall Study|Lack of Efficacy|2
7219917|NCT01916980|11428792|FG000|Overall Study|Withdrawal by Subject|1
7219918|NCT01916980|11428793|FG001|Overall Study|Withdrawal by Subject|0
7219919|NCT01916967|11428802|FG000|Overall Study|Adverse Event|0
7219920|NCT01916967|11428803|FG001|Overall Study|Adverse Event|0
7219921|NCT01916967|11428804|FG002|Overall Study|Adverse Event|2
7219922|NCT01916967|11428802|FG000|Overall Study|Lack of Efficacy|0
7219923|NCT01916967|11428803|FG001|Overall Study|Lack of Efficacy|0
7219924|NCT01916967|11428804|FG002|Overall Study|Lack of Efficacy|6
7219925|NCT01916967|11428802|FG000|Overall Study|Physician Decision|0
7219926|NCT01916967|11428803|FG001|Overall Study|Physician Decision|0
7219927|NCT01916967|11428804|FG002|Overall Study|Physician Decision|1
7219928|NCT01916967|11428802|FG000|Overall Study|Protocol Violation|0
7219929|NCT01916967|11428803|FG001|Overall Study|Protocol Violation|1
7219930|NCT01916967|11428804|FG002|Overall Study|Protocol Violation|0
7219951|NCT01870401|11428836|FG000|Overall Study|Death|48
7219952|NCT01870401|11428837|FG001|Overall Study|Death|24
7624403|NCT04399356|12035435|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1
7624404|NCT04399356|12035436|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2
7624405|NCT04399356|12035435|FG000|Overall Study|Withdrawal by Subject|1
7624406|NCT04399356|12035436|FG001|Overall Study|Withdrawal by Subject|0
7624407|NCT04156399|12035466|FG000|Overall Study|hospitalization unrelated to acupuncture|1
7624408|NCT04156399|12035466|FG000|Overall Study|study suspension due to COVID pandemic|3
7624409|NCT04052620|12035476|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1
7624410|NCT04052620|12035477|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0
7624411|NCT04052620|12035476|FG000|Overall Study|Withdrawal by Subject|1
7624412|NCT04052620|12035477|FG001|Overall Study|Withdrawal by Subject|0
7624413|NCT04052620|12035476|FG000|Overall Study|Lost to Follow-up|1
7624414|NCT04052620|12035477|FG001|Overall Study|Lost to Follow-up|1
7624415|NCT04052620|12035476|FG000|Overall Study|Adverse Event|1
7624416|NCT04052620|12035477|FG001|Overall Study|Adverse Event|0
7624417|NCT04052620|12035476|FG000|Overall Study|Subject did not meet study Criteria|0
7624418|NCT04052620|12035477|FG001|Overall Study|Subject did not meet study Criteria|1
7624419|NCT04052620|12035476|FG000|Overall Study|Screened failure, randomized by mistake|0
7219953|NCT01870401|11428836|FG000|Overall Study|Withdrawal by Subject|39
7219954|NCT01870401|11428837|FG001|Overall Study|Withdrawal by Subject|26
7219955|NCT01870401|11428836|FG000|Overall Study|Lost to Follow-up|19
7219956|NCT01870401|11428837|FG001|Overall Study|Lost to Follow-up|14
7219957|NCT01870401|11428836|FG000|Overall Study|Other|9
7219958|NCT01870401|11428837|FG001|Overall Study|Other|7
7219959|NCT01870401|11428836|FG000|Overall Study|On-going in the Study|35
7219960|NCT01870401|11428837|FG001|Overall Study|On-going in the Study|25
7219961|NCT01867606|11428847|FG000|Overall Study|Withdrawal by Subject|10
7219962|NCT01867606|11428848|FG001|Overall Study|Withdrawal by Subject|14
7219963|NCT01867606|11428847|FG000|Overall Study|Protocol Violation|0
7219964|NCT01867606|11428848|FG001|Overall Study|Protocol Violation|1
7219965|NCT01857063|11428862|FG000|Period 1 (7 Days)|Adverse Event|0
7219966|NCT01857063|11428863|FG001|Period 1 (7 Days)|Adverse Event|1
7219967|NCT01857063|11428862|FG000|Period 1 (7 Days)|Physician Decision|1
7219968|NCT01857063|11428863|FG001|Period 1 (7 Days)|Physician Decision|0
7219969|NCT01857063|11428862|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
7219970|NCT01857063|11428863|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
7219971|NCT01857063|11428862|FG000|Period 2 (7 Days)|Adverse Event|2
7219972|NCT01857063|11428863|FG001|Period 2 (7 Days)|Adverse Event|1
7219973|NCT01857063|11428862|FG000|Period 2 (7 Days)|Physician Decision|1
7219974|NCT01857063|11428863|FG001|Period 2 (7 Days)|Physician Decision|1
7219975|NCT01857063|11428862|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
7219976|NCT01857063|11428863|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
7219977|NCT01852812|11428876|FG000|Overall Study|Adverse Event|0
7219978|NCT01852812|11428877|FG001|Overall Study|Adverse Event|0
7219979|NCT01852812|11428878|FG002|Overall Study|Adverse Event|1
7219980|NCT01852812|11428876|FG000|Overall Study|Non-compliance With Study Drug|0
7219981|NCT01852812|11428877|FG001|Overall Study|Non-compliance With Study Drug|1
7219982|NCT01852812|11428878|FG002|Overall Study|Non-compliance With Study Drug|0
7297021|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Side effects|0
7297022|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Side effects|0
7297023|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Side effects|0
7297024|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Side effects|0
7297025|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Side effects|0
7297026|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Side effects|0
7297027|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Side effects|0
7297028|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Side effects|0
7297029|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Side effects|8
7297030|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297031|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297032|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297033|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297034|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297035|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297036|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297037|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297038|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297039|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297040|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297041|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297042|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297043|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
7297044|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
7297045|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Medical reasons|0
7297046|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Medical reasons|0
7297047|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Medical reasons|0
7297048|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Medical reasons|0
7297049|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Medical reasons|0
7297050|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Medical reasons|0
7297051|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Medical reasons|0
7297052|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Medical reasons|0
7297053|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Medical reasons|0
7297054|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Medical reasons|0
7297055|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Medical reasons|0
7297056|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Medical reasons|0
7297057|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Medical reasons|0
7297058|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Medical reasons|0
7297059|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Medical reasons|6
7297060|NCT00576472|11516093|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
7297061|NCT00576472|11516094|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
7297062|NCT00576472|11516095|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
7297063|NCT00576472|11516096|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
7297064|NCT00576472|11516097|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
7297065|NCT00576472|11516098|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
7297066|NCT00576472|11516099|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
7297067|NCT00576472|11516100|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
7551527|NCT02970669|11910831|FG001|Open-label Period|Withdrawal by Subject|2
7219983|NCT01828021|11428886|FG000|Overall Study|Adverse Event|5
7219984|NCT01828021|11428886|FG000|Overall Study|Lack of Efficacy|17
7219985|NCT01828021|11428886|FG000|Overall Study|Withdrawal by Subject|2
7219986|NCT01828021|11428886|FG000|Overall Study|Ileal obstruction, unrelated|1
7219987|NCT01709318|11428897|FG000|Overall Study|Adverse Event|3
7219988|NCT01709318|11428898|FG001|Overall Study|Adverse Event|4
7219989|NCT01709318|11428899|FG002|Overall Study|Adverse Event|2
7219990|NCT01709318|11428900|FG003|Overall Study|Adverse Event|2
7219991|NCT01709318|11428901|FG004|Overall Study|Adverse Event|0
7219992|NCT01709318|11428902|FG005|Overall Study|Adverse Event|1
7219993|NCT01709318|11428903|FG006|Overall Study|Adverse Event|2
7219994|NCT01709318|11428897|FG000|Overall Study|Lost to Follow-up|2
7219995|NCT01709318|11428898|FG001|Overall Study|Lost to Follow-up|0
7219996|NCT01709318|11428899|FG002|Overall Study|Lost to Follow-up|0
7219997|NCT01709318|11428900|FG003|Overall Study|Lost to Follow-up|0
7219998|NCT01709318|11428901|FG004|Overall Study|Lost to Follow-up|1
7219999|NCT01709318|11428902|FG005|Overall Study|Lost to Follow-up|1
7220000|NCT01709318|11428903|FG006|Overall Study|Lost to Follow-up|1
7220001|NCT01709318|11428897|FG000|Overall Study|Non-compliance with Study Drug|0
7220002|NCT01709318|11428898|FG001|Overall Study|Non-compliance with Study Drug|2
7220003|NCT01709318|11428899|FG002|Overall Study|Non-compliance with Study Drug|1
7220004|NCT01709318|11428900|FG003|Overall Study|Non-compliance with Study Drug|1
7220005|NCT01709318|11428901|FG004|Overall Study|Non-compliance with Study Drug|0
7220006|NCT01709318|11428902|FG005|Overall Study|Non-compliance with Study Drug|0
7220007|NCT01709318|11428903|FG006|Overall Study|Non-compliance with Study Drug|2
7220008|NCT01709318|11428897|FG000|Overall Study|Physician Decision|0
7220009|NCT01709318|11428898|FG001|Overall Study|Physician Decision|0
7220010|NCT01709318|11428899|FG002|Overall Study|Physician Decision|0
7220011|NCT01709318|11428900|FG003|Overall Study|Physician Decision|0
7220012|NCT01709318|11428901|FG004|Overall Study|Physician Decision|0
7220013|NCT01709318|11428902|FG005|Overall Study|Physician Decision|0
7220014|NCT01709318|11428903|FG006|Overall Study|Physician Decision|1
7220015|NCT01709318|11428897|FG000|Overall Study|Pregnancy|0
7220016|NCT01709318|11428898|FG001|Overall Study|Pregnancy|0
7220017|NCT01709318|11428899|FG002|Overall Study|Pregnancy|0
7220018|NCT01709318|11428900|FG003|Overall Study|Pregnancy|0
7220019|NCT01709318|11428901|FG004|Overall Study|Pregnancy|1
7220020|NCT01709318|11428902|FG005|Overall Study|Pregnancy|0
7220021|NCT01709318|11428903|FG006|Overall Study|Pregnancy|0
7220022|NCT01709318|11428897|FG000|Overall Study|Protocol Violation|0
7220023|NCT01709318|11428898|FG001|Overall Study|Protocol Violation|0
7220024|NCT01709318|11428899|FG002|Overall Study|Protocol Violation|0
7220025|NCT01709318|11428900|FG003|Overall Study|Protocol Violation|0
7220026|NCT01709318|11428901|FG004|Overall Study|Protocol Violation|2
7220027|NCT01709318|11428902|FG005|Overall Study|Protocol Violation|0
7220028|NCT01709318|11428903|FG006|Overall Study|Protocol Violation|1
7220029|NCT01709318|11428897|FG000|Overall Study|Technical Problems|1
7220030|NCT01709318|11428898|FG001|Overall Study|Technical Problems|0
7220031|NCT01709318|11428899|FG002|Overall Study|Technical Problems|0
7220032|NCT01709318|11428900|FG003|Overall Study|Technical Problems|0
7220033|NCT01709318|11428901|FG004|Overall Study|Technical Problems|0
7220034|NCT01709318|11428902|FG005|Overall Study|Technical Problems|0
7220035|NCT01709318|11428903|FG006|Overall Study|Technical Problems|0
7220036|NCT01709318|11428897|FG000|Overall Study|Withdrawal by Subject|3
7220037|NCT01709318|11428898|FG001|Overall Study|Withdrawal by Subject|0
7220038|NCT01709318|11428899|FG002|Overall Study|Withdrawal by Subject|3
7220039|NCT01709318|11428900|FG003|Overall Study|Withdrawal by Subject|3
7220040|NCT01709318|11428901|FG004|Overall Study|Withdrawal by Subject|0
7220041|NCT01709318|11428902|FG005|Overall Study|Withdrawal by Subject|2
7220042|NCT01709318|11428903|FG006|Overall Study|Withdrawal by Subject|4
7220043|NCT01709318|11428897|FG000|Overall Study|Other Protocol Specified Criteria|0
7220044|NCT01709318|11428898|FG001|Overall Study|Other Protocol Specified Criteria|1
7220045|NCT01709318|11428899|FG002|Overall Study|Other Protocol Specified Criteria|0
7220046|NCT01709318|11428900|FG003|Overall Study|Other Protocol Specified Criteria|0
7220047|NCT01709318|11428901|FG004|Overall Study|Other Protocol Specified Criteria|0
7220048|NCT01709318|11428902|FG005|Overall Study|Other Protocol Specified Criteria|0
7220049|NCT01709318|11428903|FG006|Overall Study|Other Protocol Specified Criteria|0
7220050|NCT01698918|11428919|FG000|First Line Treatment (Core+Extension)|Adverse Event|33
7220051|NCT01698918|11428919|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11
7220052|NCT01698918|11428919|FG000|First Line Treatment (Core+Extension)|Death|2
7220053|NCT01698918|11428919|FG000|First Line Treatment (Core+Extension)|Disease progression|120
7220054|NCT01698918|11428919|FG000|First Line Treatment (Core+Extension)|Physician Decision|7
7220055|NCT01698918|11428919|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3
7220056|NCT01698918|11428919|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1
7220057|NCT01698918|11428919|FG000|Second Line Treatment (Core+Extension)|Death|1
7220058|NCT01698918|11428919|FG000|Second Line Treatment (Core+Extension)|Disease progression|38
7220059|NCT01698918|11428919|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3
7220060|NCT01673620|11428933|FG000|Overall Study|Adverse Event|1
7220061|NCT01673620|11428934|FG001|Overall Study|Adverse Event|0
7220062|NCT01660243|11428944|FG000|Overall Study|Adverse Event|1
7220063|NCT01660243|11428945|FG001|Overall Study|Adverse Event|0
7220064|NCT01660243|11428946|FG002|Overall Study|Adverse Event|1
7220065|NCT01660243|11428947|FG003|Overall Study|Adverse Event|0
7220066|NCT01660243|11428944|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1
7220067|NCT01660243|11428945|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7220068|NCT01660243|11428946|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7220069|NCT01660243|11428947|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
7220070|NCT01660243|11428944|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7220071|NCT01660243|11428945|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7220072|NCT01660243|11428946|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1
7220073|NCT01660243|11428947|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
7220074|NCT01660243|11428944|FG000|Overall Study|Randomization error|0
7220075|NCT01660243|11428945|FG001|Overall Study|Randomization error|0
7220076|NCT01660243|11428946|FG002|Overall Study|Randomization error|0
7220077|NCT01660243|11428947|FG003|Overall Study|Randomization error|1
7220078|NCT01617187|11428961|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7220079|NCT01617187|11428962|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7220080|NCT01617187|11428963|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
7220081|NCT01617187|11428964|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
7220082|NCT01617187|11428961|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7220083|NCT01617187|11428962|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7220084|NCT01617187|11428963|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
7220085|NCT01617187|11428964|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
7220086|NCT01617187|11428961|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
7220087|NCT01617187|11428962|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7220088|NCT01617187|11428963|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7220089|NCT01617187|11428964|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
7220090|NCT01617187|11428961|FG000|Treatment Through Study Completion|Adverse Event|1
7220091|NCT01617187|11428962|FG001|Treatment Through Study Completion|Adverse Event|1
7220092|NCT01617187|11428963|FG002|Treatment Through Study Completion|Adverse Event|0
7220093|NCT01617187|11428964|FG003|Treatment Through Study Completion|Adverse Event|1
7220094|NCT01617187|11428961|FG000|Treatment Through Study Completion|Lost to Follow-up|4
7220095|NCT01617187|11428962|FG001|Treatment Through Study Completion|Lost to Follow-up|2
7220096|NCT01617187|11428963|FG002|Treatment Through Study Completion|Lost to Follow-up|2
7220097|NCT01617187|11428964|FG003|Treatment Through Study Completion|Lost to Follow-up|2
7220098|NCT01617187|11428961|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
7220099|NCT01617187|11428962|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
7220100|NCT01617187|11428963|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
7220101|NCT01617187|11428964|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
7220102|NCT01617187|11428961|FG000|Treatment Through Study Completion|Protocol Violation|1
7220103|NCT01617187|11428962|FG001|Treatment Through Study Completion|Protocol Violation|0
7220104|NCT01617187|11428963|FG002|Treatment Through Study Completion|Protocol Violation|0
7220105|NCT01617187|11428964|FG003|Treatment Through Study Completion|Protocol Violation|1
7220106|NCT01611883|11428976|FG000|Overall Study|Adverse Event|1
7220107|NCT01611883|11428977|FG001|Overall Study|Adverse Event|1
7220108|NCT01572675|11428985|FG000|Overall Study|End of prescribed treatment|140
7220109|NCT01572675|11428986|FG001|Overall Study|End of prescribed treatment|118
7220110|NCT01572675|11428985|FG000|Overall Study|Recovery|16
7220111|NCT01572675|11428986|FG001|Overall Study|Recovery|23
7220112|NCT01572675|11428985|FG000|Overall Study|Lack of Efficacy|31
7220113|NCT01572675|11428986|FG001|Overall Study|Lack of Efficacy|31
7220114|NCT01572675|11428985|FG000|Overall Study|Intolerance|6
7220115|NCT01572675|11428986|FG001|Overall Study|Intolerance|5
7220116|NCT01572675|11428985|FG000|Overall Study|Improved symptoms|8
7220117|NCT01572675|11428986|FG001|Overall Study|Improved symptoms|2
7220118|NCT01572675|11428985|FG000|Overall Study|Surgical intervention|3
7220119|NCT01572675|11428986|FG001|Overall Study|Surgical intervention|6
7220120|NCT01572675|11428985|FG000|Overall Study|Withdrawal by Subject|5
7220121|NCT01572675|11428986|FG001|Overall Study|Withdrawal by Subject|1
7220122|NCT01572675|11428985|FG000|Overall Study|Physician Decision|2
7220123|NCT01572675|11428986|FG001|Overall Study|Physician Decision|2
7220124|NCT01572675|11428985|FG000|Overall Study|Death unrelated to coxibs|1
7220125|NCT01572675|11428986|FG001|Overall Study|Death unrelated to coxibs|1
7220126|NCT01572675|11428985|FG000|Overall Study|Other disease detected|1
7220127|NCT01572675|11428986|FG001|Overall Study|Other disease detected|1
7220128|NCT01572675|11428985|FG000|Overall Study|Unknown reason|1
7220129|NCT01572675|11428986|FG001|Overall Study|Unknown reason|1
7220130|NCT01572675|11428985|FG000|Overall Study|Rheumatologist new evaluation|0
7220131|NCT01572675|11428986|FG001|Overall Study|Rheumatologist new evaluation|1
7220132|NCT01572675|11428985|FG000|Overall Study|Missing data|1
7220133|NCT01572675|11428986|FG001|Overall Study|Missing data|4
7220134|NCT01572675|11428985|FG000|Overall Study|Lost to Follow-up|22
7297068|NCT00576472|11516101|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
7220135|NCT01572675|11428986|FG001|Overall Study|Lost to Follow-up|27
7220136|NCT01554163|11429007|FG000|Overall Study|Adverse Event|3
7220137|NCT01554163|11429008|FG001|Overall Study|Adverse Event|0
7220138|NCT01554163|11429007|FG000|Overall Study|Lack of Efficacy|1
7220139|NCT01554163|11429008|FG001|Overall Study|Lack of Efficacy|0
7220140|NCT01554163|11429007|FG000|Overall Study|Lost to Follow-up|1
7220141|NCT01554163|11429008|FG001|Overall Study|Lost to Follow-up|0
7220142|NCT01554163|11429007|FG000|Overall Study|Non-Compliance With Study Drug|1
7220143|NCT01554163|11429008|FG001|Overall Study|Non-Compliance With Study Drug|1
7220144|NCT01554163|11429007|FG000|Overall Study|Protocol Violation|0
7220145|NCT01554163|11429008|FG001|Overall Study|Protocol Violation|4
7220146|NCT01554163|11429007|FG000|Overall Study|Withdrawal by Subject|1
7220147|NCT01554163|11429008|FG001|Overall Study|Withdrawal by Subject|5
7220148|NCT01554163|11429007|FG000|Overall Study|Not Treated|1
7220149|NCT01554163|11429008|FG001|Overall Study|Not Treated|0
7220150|NCT01502371|11429019|FG000|Overall Study|Withdrawal by Subject|1
7220151|NCT01502371|11429020|FG001|Overall Study|Withdrawal by Subject|2
7220152|NCT01502371|11429021|FG002|Overall Study|Withdrawal by Subject|1
7220153|NCT01502371|11429022|FG003|Overall Study|Withdrawal by Subject|1
7220154|NCT01502371|11429023|FG004|Overall Study|Withdrawal by Subject|1
7220155|NCT01502371|11429019|FG000|Overall Study|Adverse Event|2
7220156|NCT01502371|11429020|FG001|Overall Study|Adverse Event|1
7220157|NCT01502371|11429021|FG002|Overall Study|Adverse Event|0
7220158|NCT01502371|11429022|FG003|Overall Study|Adverse Event|4
7220159|NCT01502371|11429023|FG004|Overall Study|Adverse Event|3
7220160|NCT01502371|11429019|FG000|Overall Study|Treatment Failure|22
7220161|NCT01502371|11429020|FG001|Overall Study|Treatment Failure|20
7220162|NCT01502371|11429021|FG002|Overall Study|Treatment Failure|12
7220163|NCT01502371|11429022|FG003|Overall Study|Treatment Failure|19
7220164|NCT01502371|11429023|FG004|Overall Study|Treatment Failure|30
7220165|NCT01502371|11429019|FG000|Overall Study|Lack of Efficacy|3
7220166|NCT01502371|11429020|FG001|Overall Study|Lack of Efficacy|3
7220167|NCT01502371|11429021|FG002|Overall Study|Lack of Efficacy|2
7220168|NCT01502371|11429022|FG003|Overall Study|Lack of Efficacy|2
7220169|NCT01502371|11429023|FG004|Overall Study|Lack of Efficacy|4
7220170|NCT01502371|11429019|FG000|Overall Study|Physician Decision|3
7220171|NCT01502371|11429020|FG001|Overall Study|Physician Decision|0
7220172|NCT01502371|11429021|FG002|Overall Study|Physician Decision|0
7220173|NCT01502371|11429022|FG003|Overall Study|Physician Decision|0
7220174|NCT01502371|11429023|FG004|Overall Study|Physician Decision|1
7220175|NCT01502371|11429019|FG000|Overall Study|Noncompliance with Study Drug|0
7220176|NCT01502371|11429020|FG001|Overall Study|Noncompliance with Study Drug|0
7220177|NCT01502371|11429021|FG002|Overall Study|Noncompliance with Study Drug|1
7220178|NCT01502371|11429022|FG003|Overall Study|Noncompliance with Study Drug|2
7220179|NCT01502371|11429023|FG004|Overall Study|Noncompliance with Study Drug|1
7220180|NCT01502371|11429019|FG000|Overall Study|Technical Problems|1
7220181|NCT01502371|11429020|FG001|Overall Study|Technical Problems|0
7220182|NCT01502371|11429021|FG002|Overall Study|Technical Problems|2
7220183|NCT01502371|11429022|FG003|Overall Study|Technical Problems|4
7220184|NCT01502371|11429023|FG004|Overall Study|Technical Problems|1
7220185|NCT01502371|11429019|FG000|Overall Study|Protocol Violation|9
7220186|NCT01502371|11429020|FG001|Overall Study|Protocol Violation|5
7220187|NCT01502371|11429021|FG002|Overall Study|Protocol Violation|6
7220188|NCT01502371|11429022|FG003|Overall Study|Protocol Violation|5
7220189|NCT01502371|11429023|FG004|Overall Study|Protocol Violation|10
7220190|NCT01502371|11429019|FG000|Overall Study|Excluded Medication|0
7220191|NCT01502371|11429020|FG001|Overall Study|Excluded Medication|1
7220192|NCT01502371|11429021|FG002|Overall Study|Excluded Medication|1
7220193|NCT01502371|11429022|FG003|Overall Study|Excluded Medication|0
7220194|NCT01502371|11429023|FG004|Overall Study|Excluded Medication|1
7220195|NCT01490190|11429036|FG000|Overall Study|Withdrawal by Subject|9
7220196|NCT01490190|11429036|FG000|Overall Study|Adverse Event|17
7220197|NCT01490190|11429036|FG000|Overall Study|Protocol Violation|5
7220198|NCT01490190|11429036|FG000|Overall Study|Lost to Follow-up|13
7220199|NCT01490190|11429036|FG000|Overall Study|Relocation|1
7220200|NCT01490190|11429036|FG000|Overall Study|Inconvenience|1
7220201|NCT01490190|11429036|FG000|Overall Study|Ring expulsion|2
7220202|NCT01471340|11429042|FG000|Overall Study|Death|5
7220203|NCT01471340|11429043|FG001|Overall Study|Death|4
7220204|NCT01471340|11429042|FG000|Overall Study|Lost to Follow-up|0
7220205|NCT01471340|11429043|FG001|Overall Study|Lost to Follow-up|1
7220206|NCT01471340|11429042|FG000|Overall Study|Investigational site closure|0
7220207|NCT01471340|11429043|FG001|Overall Study|Investigational site closure|1
7220208|NCT01471340|11429042|FG000|Overall Study|Invalid informed consent|1
7220209|NCT01471340|11429043|FG001|Overall Study|Invalid informed consent|0
7220210|NCT01462370|11429049|FG000|Overall Study|Lack of Qualifying Event|1
7220211|NCT01462370|11429050|FG001|Overall Study|Lack of Qualifying Event|1
7220212|NCT01462370|11429049|FG000|Overall Study|Physician Decision|0
7220213|NCT01462370|11429050|FG001|Overall Study|Physician Decision|1
7220214|NCT01462370|11429049|FG000|Overall Study|Withdrawal by Subject|0
7220215|NCT01462370|11429050|FG001|Overall Study|Withdrawal by Subject|3
7220216|NCT01436253|11429056|FG000|Overall Study|Lost to Follow-up|182
7220217|NCT01436253|11429056|FG000|Overall Study|Not meeting all eligibility criteria|117
7220218|NCT01381679|11429090|FG000|Overall Study|Adverse Event|3
7220219|NCT01381679|11429090|FG000|Overall Study|Lost to Follow-up|885
7220220|NCT01370603|11429096|FG000|Period 1|Adverse Event|5
7220221|NCT01370603|11429097|FG001|Period 1|Adverse Event|3
7220222|NCT01370603|11429096|FG000|Period 1|Lost to Follow-up|2
7220223|NCT01370603|11429097|FG001|Period 1|Lost to Follow-up|0
7220224|NCT01370603|11429096|FG000|Period 1|Protocol Violation|2
7220225|NCT01370603|11429097|FG001|Period 1|Protocol Violation|2
7220226|NCT01370603|11429096|FG000|Period 1|Withdrawal by Subject|5
7220227|NCT01370603|11429097|FG001|Period 1|Withdrawal by Subject|5
7220228|NCT01370603|11429096|FG000|Crossover Washout|Adverse Event|2
7220229|NCT01370603|11429097|FG001|Crossover Washout|Adverse Event|1
7220230|NCT01370603|11429096|FG000|Crossover Washout|Lost to Follow-up|2
7220231|NCT01370603|11429097|FG001|Crossover Washout|Lost to Follow-up|0
7220232|NCT01370603|11429096|FG000|Crossover Washout|Protocol Violation|1
7220233|NCT01370603|11429097|FG001|Crossover Washout|Protocol Violation|0
7220234|NCT01370603|11429096|FG000|Crossover Washout|Withdrawal by Subject|4
7220235|NCT01370603|11429097|FG001|Crossover Washout|Withdrawal by Subject|1
7220236|NCT01370603|11429096|FG000|Crossover Washout|Non-compliance with Study Drug|0
7220237|NCT01370603|11429097|FG001|Crossover Washout|Non-compliance with Study Drug|2
7220238|NCT01370603|11429096|FG000|Period 2|Adverse Event|1
7220239|NCT01370603|11429097|FG001|Period 2|Adverse Event|4
7220240|NCT01370603|11429096|FG000|Period 2|Lost to Follow-up|1
7220241|NCT01370603|11429097|FG001|Period 2|Lost to Follow-up|0
7220242|NCT01370603|11429096|FG000|Period 2|Withdrawal by Subject|1
7220243|NCT01370603|11429097|FG001|Period 2|Withdrawal by Subject|0
7220244|NCT01370590|11429105|FG000|Period 1|Adverse Event|8
7220245|NCT01370590|11429106|FG001|Period 1|Adverse Event|4
7220246|NCT01370590|11429105|FG000|Period 1|Lost to Follow-up|2
7220247|NCT01370590|11429106|FG001|Period 1|Lost to Follow-up|2
7220248|NCT01370590|11429105|FG000|Period 1|Protocol Violation|2
7220249|NCT01370590|11429106|FG001|Period 1|Protocol Violation|2
7220250|NCT01370590|11429105|FG000|Period 1|Withdrawal by Subject|4
7220251|NCT01370590|11429106|FG001|Period 1|Withdrawal by Subject|2
7220252|NCT01370590|11429105|FG000|Period 1|Could not access randomization system|0
7220253|NCT01370590|11429106|FG001|Period 1|Could not access randomization system|1
7220254|NCT01370590|11429105|FG000|Crossover Washout Period|Adverse Event|1
7220255|NCT01370590|11429106|FG001|Crossover Washout Period|Adverse Event|4
7220256|NCT01370590|11429105|FG000|Crossover Washout Period|Lost to Follow-up|2
7220257|NCT01370590|11429106|FG001|Crossover Washout Period|Lost to Follow-up|0
7220258|NCT01370590|11429105|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
7220259|NCT01370590|11429106|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
7220260|NCT01370590|11429105|FG000|Crossover Washout Period|Withdrawal by Subject|2
7220261|NCT01370590|11429106|FG001|Crossover Washout Period|Withdrawal by Subject|2
7220262|NCT01370590|11429105|FG000|Period 2|Adverse Event|0
7220263|NCT01370590|11429106|FG001|Period 2|Adverse Event|1
7220264|NCT01370590|11429105|FG000|Period 2|Withdrawal by Subject|1
7220265|NCT01370590|11429106|FG001|Period 2|Withdrawal by Subject|1
7220266|NCT01349907|11429118|FG000|Overall Study|Adverse Event|37
7220267|NCT01349907|11429119|FG001|Overall Study|Adverse Event|11
7220268|NCT01349907|11429118|FG000|Overall Study|Treatment failure|13
7220269|NCT01349907|11429119|FG001|Overall Study|Treatment failure|4
7220270|NCT01349907|11429118|FG000|Overall Study|Lost to Follow-up|25
7220271|NCT01349907|11429119|FG001|Overall Study|Lost to Follow-up|6
7220272|NCT01349907|11429118|FG000|Overall Study|Withdrawal by Subject|30
7220273|NCT01349907|11429119|FG001|Overall Study|Withdrawal by Subject|8
7220274|NCT01349907|11429118|FG000|Overall Study|Protocol Violation|33
7220275|NCT01349907|11429119|FG001|Overall Study|Protocol Violation|13
7220276|NCT01349907|11429118|FG000|Overall Study|Administrative|1
7220277|NCT01349907|11429119|FG001|Overall Study|Administrative|1
7220278|NCT01345786|11429129|FG000|Overall Study|Adverse Event|0
7220279|NCT01345786|11429130|FG001|Overall Study|Adverse Event|1
7220280|NCT01345786|11429131|FG002|Overall Study|Adverse Event|3
7220281|NCT01345786|11429132|FG003|Overall Study|Adverse Event|1
7220282|NCT01345786|11429129|FG000|Overall Study|Subject withdrew consent|2
7220283|NCT01345786|11429130|FG001|Overall Study|Subject withdrew consent|2
7220284|NCT01345786|11429131|FG002|Overall Study|Subject withdrew consent|1
7220285|NCT01345786|11429132|FG003|Overall Study|Subject withdrew consent|0
7220286|NCT01345786|11429129|FG000|Overall Study|Noncompliance with protocol|1
7220287|NCT01345786|11429130|FG001|Overall Study|Noncompliance with protocol|0
7220288|NCT01345786|11429131|FG002|Overall Study|Noncompliance with protocol|1
7220289|NCT01345786|11429132|FG003|Overall Study|Noncompliance with protocol|0
7220290|NCT01345786|11429129|FG000|Overall Study|Administrative|3
7220291|NCT01345786|11429130|FG001|Overall Study|Administrative|5
7220292|NCT01345786|11429131|FG002|Overall Study|Administrative|0
7220293|NCT01345786|11429132|FG003|Overall Study|Administrative|0
7220294|NCT01345786|11429129|FG000|Overall Study|Lost to Follow-up|0
7220295|NCT01345786|11429130|FG001|Overall Study|Lost to Follow-up|0
7220296|NCT01345786|11429131|FG002|Overall Study|Lost to Follow-up|0
7220297|NCT01345786|11429132|FG003|Overall Study|Lost to Follow-up|2
7220298|NCT01306929|11429142|FG000|Overall Study|Withdrawal by Subject|23
7220299|NCT01306929|11429142|FG000|Overall Study|Adverse Event|21
7220300|NCT01306929|11429142|FG000|Overall Study|Physician Decision|13
7220301|NCT01306929|11429142|FG000|Overall Study|Death|8
7220302|NCT01306929|11429142|FG000|Overall Study|Withdrawal by parent/guardian|5
7220303|NCT01306929|11429142|FG000|Overall Study|Protocol Violation|3
7220304|NCT01306929|11429142|FG000|Overall Study|Non-compliance with study drug|2
7220305|NCT01306929|11429142|FG000|Overall Study|Lost to Follow-up|2
7220306|NCT01306929|11429142|FG000|Overall Study|Various|17
7220307|NCT01294696|11429148|FG000|Overall Study|Screening failures|7
7220308|NCT01294696|11429148|FG000|Overall Study|Protocol Violation|8
7220309|NCT01294696|11429148|FG000|Overall Study|Missing BPI Response|7
7220310|NCT01294696|11429148|FG000|Overall Study|Site closure|52
7220311|NCT01277822|11429155|FG000|Overall Study|Adverse Event|2
7220312|NCT01277822|11429156|FG001|Overall Study|Adverse Event|1
7220313|NCT01277822|11429155|FG000|Overall Study|Withdrawal by Subject|6
7220314|NCT01277822|11429156|FG001|Overall Study|Withdrawal by Subject|7
7220315|NCT01277822|11429155|FG000|Overall Study|Physician Decision|1
7220316|NCT01277822|11429156|FG001|Overall Study|Physician Decision|1
7220317|NCT01277822|11429155|FG000|Overall Study|Protocol Violation|1
7220318|NCT01277822|11429156|FG001|Overall Study|Protocol Violation|0
7220319|NCT01277822|11429155|FG000|Overall Study|Lost to Follow-up|2
7220320|NCT01277822|11429156|FG001|Overall Study|Lost to Follow-up|1
7220321|NCT01277822|11429155|FG000|Overall Study|Contraindicated medication used|2
7220322|NCT01277822|11429156|FG001|Overall Study|Contraindicated medication used|1
7220323|NCT01277822|11429155|FG000|Overall Study|Participant moved|1
7220324|NCT01277822|11429156|FG001|Overall Study|Participant moved|0
7220325|NCT01244763|11429168|FG000|Overall Study|Adverse Event|1
7220326|NCT01244763|11429169|FG001|Overall Study|Adverse Event|0
7220327|NCT01244763|11429170|FG002|Overall Study|Adverse Event|0
7220328|NCT01244763|11429171|FG003|Overall Study|Adverse Event|0
7220329|NCT01244763|11429172|FG004|Overall Study|Adverse Event|0
7220330|NCT01244763|11429173|FG005|Overall Study|Adverse Event|1
7220331|NCT01244763|11429168|FG000|Overall Study|Death|1
7220332|NCT01244763|11429169|FG001|Overall Study|Death|0
7220333|NCT01244763|11429170|FG002|Overall Study|Death|1
7220334|NCT01244763|11429171|FG003|Overall Study|Death|0
7220335|NCT01244763|11429172|FG004|Overall Study|Death|2
7220336|NCT01244763|11429173|FG005|Overall Study|Death|0
7220337|NCT01244763|11429168|FG000|Overall Study|Physician Decision|0
7220338|NCT01244763|11429169|FG001|Overall Study|Physician Decision|0
7220339|NCT01244763|11429170|FG002|Overall Study|Physician Decision|1
7220340|NCT01244763|11429171|FG003|Overall Study|Physician Decision|0
7220341|NCT01244763|11429172|FG004|Overall Study|Physician Decision|0
7220342|NCT01244763|11429173|FG005|Overall Study|Physician Decision|0
7220343|NCT01244763|11429168|FG000|Overall Study|Withdrawal by Subject|1
7220344|NCT01244763|11429169|FG001|Overall Study|Withdrawal by Subject|2
7220345|NCT01244763|11429170|FG002|Overall Study|Withdrawal by Subject|0
7220346|NCT01244763|11429171|FG003|Overall Study|Withdrawal by Subject|1
7220347|NCT01244763|11429172|FG004|Overall Study|Withdrawal by Subject|1
7220348|NCT01244763|11429173|FG005|Overall Study|Withdrawal by Subject|2
7220349|NCT01244763|11429168|FG000|Overall Study|Lost to Follow-up|0
7220350|NCT01244763|11429169|FG001|Overall Study|Lost to Follow-up|1
7220351|NCT01244763|11429170|FG002|Overall Study|Lost to Follow-up|0
7220352|NCT01244763|11429171|FG003|Overall Study|Lost to Follow-up|0
7220353|NCT01244763|11429172|FG004|Overall Study|Lost to Follow-up|0
7220354|NCT01244763|11429173|FG005|Overall Study|Lost to Follow-up|0
7220355|NCT01244763|11429168|FG000|Overall Study|Enrolled into the Extension Study|0
7220356|NCT01244763|11429169|FG001|Overall Study|Enrolled into the Extension Study|0
7220357|NCT01244763|11429170|FG002|Overall Study|Enrolled into the Extension Study|0
7220358|NCT01244763|11429171|FG003|Overall Study|Enrolled into the Extension Study|0
7220359|NCT01244763|11429172|FG004|Overall Study|Enrolled into the Extension Study|0
7220360|NCT01244763|11429173|FG005|Overall Study|Enrolled into the Extension Study|1
7220361|NCT01208207|11429190|FG000|Part I|Adverse Event|19
7220362|NCT01208207|11429191|FG001|Part I|Adverse Event|2
7220363|NCT01208207|11429192|FG002|Part I|Adverse Event|6
7220364|NCT01208207|11429193|FG003|Part I|Adverse Event|0
7220365|NCT01208207|11429194|FG004|Part I|Adverse Event|0
7220366|NCT01208207|11429195|FG005|Part I|Adverse Event|0
7220367|NCT01208207|11429196|FG006|Part I|Adverse Event|0
7220368|NCT01208207|11429190|FG000|Part I|Lack of Efficacy|21
7220369|NCT01208207|11429191|FG001|Part I|Lack of Efficacy|3
7220370|NCT01208207|11429192|FG002|Part I|Lack of Efficacy|2
7220371|NCT01208207|11429193|FG003|Part I|Lack of Efficacy|0
7220372|NCT01208207|11429194|FG004|Part I|Lack of Efficacy|0
7220373|NCT01208207|11429195|FG005|Part I|Lack of Efficacy|0
7220374|NCT01208207|11429196|FG006|Part I|Lack of Efficacy|0
7220375|NCT01208207|11429190|FG000|Part I|Lost to Follow-up|6
7220376|NCT01208207|11429191|FG001|Part I|Lost to Follow-up|1
7220377|NCT01208207|11429192|FG002|Part I|Lost to Follow-up|0
7220378|NCT01208207|11429193|FG003|Part I|Lost to Follow-up|0
7220379|NCT01208207|11429194|FG004|Part I|Lost to Follow-up|0
7220380|NCT01208207|11429195|FG005|Part I|Lost to Follow-up|0
7220381|NCT01208207|11429196|FG006|Part I|Lost to Follow-up|0
7220382|NCT01208207|11429190|FG000|Part I|Non-Compliance With Study Drug|1
7220383|NCT01208207|11429191|FG001|Part I|Non-Compliance With Study Drug|0
7220384|NCT01208207|11429192|FG002|Part I|Non-Compliance With Study Drug|1
7220385|NCT01208207|11429193|FG003|Part I|Non-Compliance With Study Drug|0
7220386|NCT01208207|11429194|FG004|Part I|Non-Compliance With Study Drug|0
7220387|NCT01208207|11429195|FG005|Part I|Non-Compliance With Study Drug|0
7220388|NCT01208207|11429196|FG006|Part I|Non-Compliance With Study Drug|0
7220389|NCT01208207|11429190|FG000|Part I|Physician Decision|0
7220390|NCT01208207|11429191|FG001|Part I|Physician Decision|1
7220391|NCT01208207|11429192|FG002|Part I|Physician Decision|0
7220392|NCT01208207|11429193|FG003|Part I|Physician Decision|0
7220393|NCT01208207|11429194|FG004|Part I|Physician Decision|0
7220394|NCT01208207|11429195|FG005|Part I|Physician Decision|0
7220395|NCT01208207|11429196|FG006|Part I|Physician Decision|0
7220396|NCT01208207|11429190|FG000|Part I|Progressive Disease|1
7220397|NCT01208207|11429191|FG001|Part I|Progressive Disease|0
7220398|NCT01208207|11429192|FG002|Part I|Progressive Disease|0
7220399|NCT01208207|11429193|FG003|Part I|Progressive Disease|0
7220400|NCT01208207|11429194|FG004|Part I|Progressive Disease|0
7220401|NCT01208207|11429195|FG005|Part I|Progressive Disease|0
7220402|NCT01208207|11429196|FG006|Part I|Progressive Disease|0
7220403|NCT01208207|11429190|FG000|Part I|Protocol Violation|8
7220404|NCT01208207|11429191|FG001|Part I|Protocol Violation|0
7220405|NCT01208207|11429192|FG002|Part I|Protocol Violation|2
7220406|NCT01208207|11429193|FG003|Part I|Protocol Violation|0
7220407|NCT01208207|11429194|FG004|Part I|Protocol Violation|0
7220408|NCT01208207|11429195|FG005|Part I|Protocol Violation|0
7220409|NCT01208207|11429196|FG006|Part I|Protocol Violation|0
7220410|NCT01208207|11429190|FG000|Part I|Withdrawal by Subject|14
7220411|NCT01208207|11429191|FG001|Part I|Withdrawal by Subject|4
7220412|NCT01208207|11429192|FG002|Part I|Withdrawal by Subject|4
7220413|NCT01208207|11429193|FG003|Part I|Withdrawal by Subject|0
7220414|NCT01208207|11429194|FG004|Part I|Withdrawal by Subject|0
7220415|NCT01208207|11429195|FG005|Part I|Withdrawal by Subject|0
7220416|NCT01208207|11429196|FG006|Part I|Withdrawal by Subject|0
7220417|NCT01208207|11429190|FG000|Part II|Withdrawal by Subject|0
7220418|NCT01208207|11429191|FG001|Part II|Withdrawal by Subject|0
7220419|NCT01208207|11429192|FG002|Part II|Withdrawal by Subject|0
7220420|NCT01208207|11429193|FG003|Part II|Withdrawal by Subject|10
7220421|NCT01208207|11429194|FG004|Part II|Withdrawal by Subject|9
7220422|NCT01208207|11429195|FG005|Part II|Withdrawal by Subject|3
7220423|NCT01208207|11429196|FG006|Part II|Withdrawal by Subject|5
7220424|NCT01208207|11429190|FG000|Part II|Adverse Event|0
7220425|NCT01208207|11429191|FG001|Part II|Adverse Event|0
7220426|NCT01208207|11429192|FG002|Part II|Adverse Event|0
7220427|NCT01208207|11429193|FG003|Part II|Adverse Event|5
7220428|NCT01208207|11429194|FG004|Part II|Adverse Event|9
7220429|NCT01208207|11429195|FG005|Part II|Adverse Event|4
7220430|NCT01208207|11429196|FG006|Part II|Adverse Event|2
7220431|NCT01208207|11429190|FG000|Part II|Lack of Efficacy|0
7220432|NCT01208207|11429191|FG001|Part II|Lack of Efficacy|0
7220433|NCT01208207|11429192|FG002|Part II|Lack of Efficacy|0
7220434|NCT01208207|11429193|FG003|Part II|Lack of Efficacy|6
7220435|NCT01208207|11429194|FG004|Part II|Lack of Efficacy|4
7220436|NCT01208207|11429195|FG005|Part II|Lack of Efficacy|3
7220437|NCT01208207|11429196|FG006|Part II|Lack of Efficacy|3
7220438|NCT01208207|11429190|FG000|Part II|Lost to Follow-up|0
7220439|NCT01208207|11429191|FG001|Part II|Lost to Follow-up|0
7220440|NCT01208207|11429192|FG002|Part II|Lost to Follow-up|0
7220441|NCT01208207|11429193|FG003|Part II|Lost to Follow-up|4
7220442|NCT01208207|11429194|FG004|Part II|Lost to Follow-up|0
7220443|NCT01208207|11429195|FG005|Part II|Lost to Follow-up|2
7220444|NCT01208207|11429196|FG006|Part II|Lost to Follow-up|1
7220445|NCT01208207|11429190|FG000|Part II|Non-Compliance With Study Drug|0
7220446|NCT01208207|11429191|FG001|Part II|Non-Compliance With Study Drug|0
7220447|NCT01208207|11429192|FG002|Part II|Non-Compliance With Study Drug|0
7220448|NCT01208207|11429193|FG003|Part II|Non-Compliance With Study Drug|4
7220449|NCT01208207|11429194|FG004|Part II|Non-Compliance With Study Drug|1
7220450|NCT01208207|11429195|FG005|Part II|Non-Compliance With Study Drug|1
7220451|NCT01208207|11429196|FG006|Part II|Non-Compliance With Study Drug|0
7220452|NCT01208207|11429190|FG000|Part II|Physician Decision|0
7220453|NCT01208207|11429191|FG001|Part II|Physician Decision|0
7220454|NCT01208207|11429192|FG002|Part II|Physician Decision|0
7220455|NCT01208207|11429193|FG003|Part II|Physician Decision|1
7220456|NCT01208207|11429194|FG004|Part II|Physician Decision|0
7220457|NCT01208207|11429195|FG005|Part II|Physician Decision|2
7220458|NCT01208207|11429196|FG006|Part II|Physician Decision|0
7220459|NCT01208207|11429190|FG000|Part II|Protocol Violation|0
7220460|NCT01208207|11429191|FG001|Part II|Protocol Violation|0
7220461|NCT01208207|11429192|FG002|Part II|Protocol Violation|0
7220462|NCT01208207|11429193|FG003|Part II|Protocol Violation|1
7220463|NCT01208207|11429194|FG004|Part II|Protocol Violation|0
7220464|NCT01208207|11429195|FG005|Part II|Protocol Violation|0
7220465|NCT01208207|11429196|FG006|Part II|Protocol Violation|0
7220466|NCT01208207|11429190|FG000|Part II|Technical Problems|0
7220467|NCT01208207|11429191|FG001|Part II|Technical Problems|0
7220468|NCT01208207|11429192|FG002|Part II|Technical Problems|0
7220469|NCT01208207|11429193|FG003|Part II|Technical Problems|1
7220470|NCT01208207|11429194|FG004|Part II|Technical Problems|0
7220471|NCT01208207|11429195|FG005|Part II|Technical Problems|1
7220472|NCT01208207|11429196|FG006|Part II|Technical Problems|0
7220473|NCT01208181|11429221|FG000|Part 1|Withdrawal by Subject|11
7220474|NCT01208181|11429222|FG001|Part 1|Withdrawal by Subject|10
7220475|NCT01208181|11429223|FG002|Part 1|Withdrawal by Subject|0
7220476|NCT01208181|11429224|FG003|Part 1|Withdrawal by Subject|0
7220477|NCT01208181|11429225|FG004|Part 1|Withdrawal by Subject|0
7220478|NCT01208181|11429221|FG000|Part 1|Technical problem|5
7220479|NCT01208181|11429222|FG001|Part 1|Technical problem|0
7220480|NCT01208181|11429223|FG002|Part 1|Technical problem|0
7220481|NCT01208181|11429224|FG003|Part 1|Technical problem|0
7220482|NCT01208181|11429225|FG004|Part 1|Technical problem|0
7220483|NCT01208181|11429221|FG000|Part 1|Protocol Violation|10
7220484|NCT01208181|11429222|FG001|Part 1|Protocol Violation|5
7220485|NCT01208181|11429223|FG002|Part 1|Protocol Violation|0
7220486|NCT01208181|11429224|FG003|Part 1|Protocol Violation|0
7220487|NCT01208181|11429225|FG004|Part 1|Protocol Violation|0
7220488|NCT01208181|11429221|FG000|Part 1|Physician Decision|4
7220489|NCT01208181|11429222|FG001|Part 1|Physician Decision|0
7220490|NCT01208181|11429223|FG002|Part 1|Physician Decision|0
7220491|NCT01208181|11429224|FG003|Part 1|Physician Decision|0
7220492|NCT01208181|11429225|FG004|Part 1|Physician Decision|0
7220493|NCT01208181|11429221|FG000|Part 1|Non-compliance with study drug|1
7220494|NCT01208181|11429222|FG001|Part 1|Non-compliance with study drug|1
7220495|NCT01208181|11429223|FG002|Part 1|Non-compliance with study drug|0
7220496|NCT01208181|11429224|FG003|Part 1|Non-compliance with study drug|0
7220497|NCT01208181|11429225|FG004|Part 1|Non-compliance with study drug|0
7220498|NCT01208181|11429221|FG000|Part 1|Lost to Follow-up|5
7220499|NCT01208181|11429222|FG001|Part 1|Lost to Follow-up|3
7220500|NCT01208181|11429223|FG002|Part 1|Lost to Follow-up|0
7220501|NCT01208181|11429224|FG003|Part 1|Lost to Follow-up|0
7220502|NCT01208181|11429225|FG004|Part 1|Lost to Follow-up|1
7220503|NCT01208181|11429221|FG000|Part 1|Lack of Efficacy|37
7220504|NCT01208181|11429222|FG001|Part 1|Lack of Efficacy|12
7220505|NCT01208181|11429223|FG002|Part 1|Lack of Efficacy|0
7220506|NCT01208181|11429224|FG003|Part 1|Lack of Efficacy|0
7220507|NCT01208181|11429225|FG004|Part 1|Lack of Efficacy|17
7220508|NCT01208181|11429221|FG000|Part 1|Adverse Event|26
7220509|NCT01208181|11429222|FG001|Part 1|Adverse Event|24
7220510|NCT01208181|11429223|FG002|Part 1|Adverse Event|0
7220511|NCT01208181|11429224|FG003|Part 1|Adverse Event|0
7220512|NCT01208181|11429225|FG004|Part 1|Adverse Event|4
7220513|NCT01208181|11429221|FG000|Part 2|Adverse Event|0
7220514|NCT01208181|11429222|FG001|Part 2|Adverse Event|0
7220515|NCT01208181|11429223|FG002|Part 2|Adverse Event|6
7220516|NCT01208181|11429224|FG003|Part 2|Adverse Event|7
7220517|NCT01208181|11429225|FG004|Part 2|Adverse Event|0
7220518|NCT01208181|11429221|FG000|Part 2|Withdrawal by Subject|0
7220519|NCT01208181|11429222|FG001|Part 2|Withdrawal by Subject|0
7220520|NCT01208181|11429223|FG002|Part 2|Withdrawal by Subject|1
7220521|NCT01208181|11429224|FG003|Part 2|Withdrawal by Subject|1
7220522|NCT01208181|11429225|FG004|Part 2|Withdrawal by Subject|0
7220523|NCT01208181|11429221|FG000|Part 2|Protocol Violation|0
7220524|NCT01208181|11429222|FG001|Part 2|Protocol Violation|0
7220525|NCT01208181|11429223|FG002|Part 2|Protocol Violation|1
7220526|NCT01208181|11429224|FG003|Part 2|Protocol Violation|0
7220527|NCT01208181|11429225|FG004|Part 2|Protocol Violation|0
7220528|NCT01208181|11429221|FG000|Part 2|Physician Decision|0
7220529|NCT01208181|11429222|FG001|Part 2|Physician Decision|0
7220530|NCT01208181|11429223|FG002|Part 2|Physician Decision|1
7220531|NCT01208181|11429224|FG003|Part 2|Physician Decision|2
7220532|NCT01208181|11429225|FG004|Part 2|Physician Decision|0
7220533|NCT01208181|11429221|FG000|Part 2|Non-compliance with study drug|0
7220534|NCT01208181|11429222|FG001|Part 2|Non-compliance with study drug|0
7220535|NCT01208181|11429223|FG002|Part 2|Non-compliance with study drug|1
7220536|NCT01208181|11429224|FG003|Part 2|Non-compliance with study drug|1
7220537|NCT01208181|11429225|FG004|Part 2|Non-compliance with study drug|0
7220538|NCT01208181|11429221|FG000|Part 2|Lost to Follow-up|0
7220539|NCT01208181|11429222|FG001|Part 2|Lost to Follow-up|0
7220540|NCT01208181|11429223|FG002|Part 2|Lost to Follow-up|1
7220541|NCT01208181|11429224|FG003|Part 2|Lost to Follow-up|2
7220542|NCT01208181|11429225|FG004|Part 2|Lost to Follow-up|0
7220543|NCT01208181|11429221|FG000|Part 2|Lack of Efficacy|0
7220544|NCT01208181|11429222|FG001|Part 2|Lack of Efficacy|0
7220545|NCT01208181|11429223|FG002|Part 2|Lack of Efficacy|5
7220546|NCT01208181|11429224|FG003|Part 2|Lack of Efficacy|7
7220547|NCT01208181|11429225|FG004|Part 2|Lack of Efficacy|0
7220548|NCT01206517|11429248|FG000|Overall Study|Withdrawal by Subject|0
7220549|NCT01206517|11429249|FG001|Overall Study|Withdrawal by Subject|0
7220550|NCT01206517|11429250|FG002|Overall Study|Withdrawal by Subject|2
7220551|NCT01206517|11429251|FG003|Overall Study|Withdrawal by Subject|0
7220552|NCT01206517|11429252|FG004|Overall Study|Withdrawal by Subject|1
7220553|NCT01206517|11429253|FG005|Overall Study|Withdrawal by Subject|0
7220554|NCT01190267|11429266|FG000|Overall Study|Adverse Event|10
7220555|NCT01190267|11429267|FG001|Overall Study|Adverse Event|0
7220556|NCT01190267|11429266|FG000|Overall Study|Treatment Failure|8
7220557|NCT01190267|11429267|FG001|Overall Study|Treatment Failure|2
7220558|NCT01190267|11429266|FG000|Overall Study|Lost to Follow-up|2
7220559|NCT01190267|11429267|FG001|Overall Study|Lost to Follow-up|0
7220560|NCT01190267|11429266|FG000|Overall Study|Withdrawal by Subject|13
7220561|NCT01190267|11429267|FG001|Overall Study|Withdrawal by Subject|1
7220562|NCT01190267|11429266|FG000|Overall Study|Protocol Violation|8
7220563|NCT01190267|11429267|FG001|Overall Study|Protocol Violation|1
7220564|NCT01190254|11429276|FG000|Overall Study|Adverse Event|3
7220565|NCT01190254|11429277|FG001|Overall Study|Adverse Event|6
7220566|NCT01190254|11429278|FG002|Overall Study|Adverse Event|8
7220567|NCT01190254|11429276|FG000|Overall Study|Lack of Efficacy|7
7220568|NCT01190254|11429277|FG001|Overall Study|Lack of Efficacy|4
7220569|NCT01190254|11429278|FG002|Overall Study|Lack of Efficacy|5
7220570|NCT01190254|11429276|FG000|Overall Study|Lost to Follow-up|4
7220571|NCT01190254|11429277|FG001|Overall Study|Lost to Follow-up|2
7220572|NCT01190254|11429278|FG002|Overall Study|Lost to Follow-up|0
7220573|NCT01190254|11429276|FG000|Overall Study|Withdrawal by Subject|4
7220574|NCT01190254|11429277|FG001|Overall Study|Withdrawal by Subject|5
7220575|NCT01190254|11429278|FG002|Overall Study|Withdrawal by Subject|7
7220576|NCT01190254|11429276|FG000|Overall Study|Protocol Violation|2
7220577|NCT01190254|11429277|FG001|Overall Study|Protocol Violation|0
7220578|NCT01190254|11429278|FG002|Overall Study|Protocol Violation|2
7220579|NCT01190254|11429276|FG000|Overall Study|Did not meet protocol eligibility|1
7220580|NCT01190254|11429277|FG001|Overall Study|Did not meet protocol eligibility|0
7220581|NCT01190254|11429278|FG002|Overall Study|Did not meet protocol eligibility|0
7220582|NCT01154036|11429289|FG000|Phase I|Physician Decision|0
7220583|NCT01154036|11429290|FG001|Phase I|Physician Decision|1
7220584|NCT01154036|11429291|FG002|Phase I|Physician Decision|0
7220585|NCT01154036|11429292|FG003|Phase I|Physician Decision|0
7220586|NCT01154036|11429293|FG004|Phase I|Physician Decision|0
7220587|NCT01154036|11429294|FG005|Phase I|Physician Decision|0
7220588|NCT01154036|11429295|FG006|Phase I|Physician Decision|0
7220589|NCT01154036|11429296|FG007|Phase I|Physician Decision|0
7220590|NCT01154036|11429289|FG000|Phase I|Lost to Follow-up|0
7220591|NCT01154036|11429290|FG001|Phase I|Lost to Follow-up|3
7220592|NCT01154036|11429291|FG002|Phase I|Lost to Follow-up|6
7220593|NCT01154036|11429292|FG003|Phase I|Lost to Follow-up|0
7220594|NCT01154036|11429293|FG004|Phase I|Lost to Follow-up|0
7220595|NCT01154036|11429294|FG005|Phase I|Lost to Follow-up|0
7220596|NCT01154036|11429295|FG006|Phase I|Lost to Follow-up|0
7220597|NCT01154036|11429296|FG007|Phase I|Lost to Follow-up|0
7220598|NCT01154036|11429289|FG000|Phase I|Protocol Violation|0
7220599|NCT01154036|11429290|FG001|Phase I|Protocol Violation|3
7220600|NCT01154036|11429291|FG002|Phase I|Protocol Violation|9
7220601|NCT01154036|11429292|FG003|Phase I|Protocol Violation|0
7220602|NCT01154036|11429293|FG004|Phase I|Protocol Violation|0
7220603|NCT01154036|11429294|FG005|Phase I|Protocol Violation|0
7220604|NCT01154036|11429295|FG006|Phase I|Protocol Violation|0
7220605|NCT01154036|11429296|FG007|Phase I|Protocol Violation|0
7220606|NCT01154036|11429289|FG000|Phase I|Withdrawal by Subject|2
7220607|NCT01154036|11429290|FG001|Phase I|Withdrawal by Subject|10
7220608|NCT01154036|11429291|FG002|Phase I|Withdrawal by Subject|29
7220609|NCT01154036|11429292|FG003|Phase I|Withdrawal by Subject|0
7220610|NCT01154036|11429293|FG004|Phase I|Withdrawal by Subject|0
7220611|NCT01154036|11429294|FG005|Phase I|Withdrawal by Subject|0
7220612|NCT01154036|11429295|FG006|Phase I|Withdrawal by Subject|0
7220613|NCT01154036|11429296|FG007|Phase I|Withdrawal by Subject|0
7220614|NCT01154036|11429289|FG000|Phase I|Adverse Event|1
7220615|NCT01154036|11429290|FG001|Phase I|Adverse Event|11
7220616|NCT01154036|11429291|FG002|Phase I|Adverse Event|12
7220617|NCT01154036|11429292|FG003|Phase I|Adverse Event|0
7220618|NCT01154036|11429293|FG004|Phase I|Adverse Event|0
7220619|NCT01154036|11429294|FG005|Phase I|Adverse Event|0
7220620|NCT01154036|11429295|FG006|Phase I|Adverse Event|0
7220621|NCT01154036|11429296|FG007|Phase I|Adverse Event|0
7220622|NCT01154036|11429289|FG000|Phase II|Adverse Event|0
7220623|NCT01154036|11429290|FG001|Phase II|Adverse Event|0
7220624|NCT01154036|11429291|FG002|Phase II|Adverse Event|0
7220625|NCT01154036|11429292|FG003|Phase II|Adverse Event|0
7220626|NCT01154036|11429293|FG004|Phase II|Adverse Event|1
7220627|NCT01154036|11429294|FG005|Phase II|Adverse Event|1
7220628|NCT01154036|11429295|FG006|Phase II|Adverse Event|1
7220629|NCT01154036|11429296|FG007|Phase II|Adverse Event|1
7220630|NCT01154036|11429289|FG000|Phase II|Physician Decision|0
7220631|NCT01154036|11429290|FG001|Phase II|Physician Decision|0
7220632|NCT01154036|11429291|FG002|Phase II|Physician Decision|0
7220633|NCT01154036|11429292|FG003|Phase II|Physician Decision|0
7220634|NCT01154036|11429293|FG004|Phase II|Physician Decision|0
7220635|NCT01154036|11429294|FG005|Phase II|Physician Decision|0
7220636|NCT01154036|11429295|FG006|Phase II|Physician Decision|1
7220637|NCT01154036|11429296|FG007|Phase II|Physician Decision|0
7220638|NCT01154036|11429289|FG000|Phase II|Lost to Follow-up|0
7220639|NCT01154036|11429290|FG001|Phase II|Lost to Follow-up|0
7220640|NCT01154036|11429291|FG002|Phase II|Lost to Follow-up|0
7220641|NCT01154036|11429292|FG003|Phase II|Lost to Follow-up|1
7220642|NCT01154036|11429293|FG004|Phase II|Lost to Follow-up|2
7220643|NCT01154036|11429294|FG005|Phase II|Lost to Follow-up|0
7220644|NCT01154036|11429295|FG006|Phase II|Lost to Follow-up|2
7220645|NCT01154036|11429296|FG007|Phase II|Lost to Follow-up|1
7220646|NCT01154036|11429289|FG000|Phase II|Protocol Violation|0
7220647|NCT01154036|11429290|FG001|Phase II|Protocol Violation|0
7220648|NCT01154036|11429291|FG002|Phase II|Protocol Violation|0
7220649|NCT01154036|11429292|FG003|Phase II|Protocol Violation|0
7220650|NCT01154036|11429293|FG004|Phase II|Protocol Violation|1
7220651|NCT01154036|11429294|FG005|Phase II|Protocol Violation|2
7220652|NCT01154036|11429295|FG006|Phase II|Protocol Violation|0
7220653|NCT01154036|11429296|FG007|Phase II|Protocol Violation|0
7220654|NCT01154036|11429289|FG000|Phase II|Withdrawal by Subject|0
7220655|NCT01154036|11429290|FG001|Phase II|Withdrawal by Subject|0
7220656|NCT01154036|11429291|FG002|Phase II|Withdrawal by Subject|0
7220657|NCT01154036|11429292|FG003|Phase II|Withdrawal by Subject|0
7220658|NCT01154036|11429293|FG004|Phase II|Withdrawal by Subject|4
7220659|NCT01154036|11429294|FG005|Phase II|Withdrawal by Subject|2
7220660|NCT01154036|11429295|FG006|Phase II|Withdrawal by Subject|5
7220661|NCT01154036|11429296|FG007|Phase II|Withdrawal by Subject|4
7220662|NCT01098071|11429327|FG000|Overall Study|Surgery (adenoidectomy)|2
7220663|NCT01098071|11429327|FG000|Overall Study|Lost to Follow-up|13
7220664|NCT01070966|11429340|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
7220665|NCT01070966|11429340|FG000|Participants for Safety Evaluation|Off-label use|9
7220666|NCT01070966|11429340|FG000|Participants for Safety Evaluation|Duplicate Participants|4
7220667|NCT01070966|11429340|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
7220668|NCT01070966|11429340|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
7220669|NCT01070966|11429340|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
7220670|NCT01070966|11429340|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
7220671|NCT01070966|11429340|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
7220672|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
7220673|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Off-label use|283
7220674|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Duplicated participants|22
7220675|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
7220676|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Uncontracted participants|4
7220677|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
7220678|NCT01070953|11429351|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
7220679|NCT01070953|11429351|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
7220680|NCT01070953|11429351|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
7220681|NCT01070953|11429351|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
7220682|NCT01030341|11429361|FG000|Overall Study|Withdrawal by Subject|1
7220683|NCT01030341|11429361|FG000|Overall Study|Lost to Follow-up|2
7220684|NCT00979901|11429369|FG000|Overall Study|Adverse Event|1
7220685|NCT00979901|11429370|FG001|Overall Study|Adverse Event|3
7220686|NCT00979901|11429371|FG002|Overall Study|Adverse Event|9
7220687|NCT00979901|11429372|FG003|Overall Study|Adverse Event|2
7220688|NCT00979901|11429369|FG000|Overall Study|Lack of Efficacy|8
7220689|NCT00979901|11429370|FG001|Overall Study|Lack of Efficacy|4
7220690|NCT00979901|11429371|FG002|Overall Study|Lack of Efficacy|9
7220691|NCT00979901|11429372|FG003|Overall Study|Lack of Efficacy|0
7220692|NCT00979901|11429369|FG000|Overall Study|Lost to Follow-up|1
7220693|NCT00979901|11429370|FG001|Overall Study|Lost to Follow-up|1
7220694|NCT00979901|11429371|FG002|Overall Study|Lost to Follow-up|2
7220695|NCT00979901|11429372|FG003|Overall Study|Lost to Follow-up|0
7220696|NCT00979901|11429369|FG000|Overall Study|Protocol Violation|2
7220697|NCT00979901|11429370|FG001|Overall Study|Protocol Violation|2
7220698|NCT00979901|11429371|FG002|Overall Study|Protocol Violation|7
7220699|NCT00979901|11429372|FG003|Overall Study|Protocol Violation|1
7220700|NCT00979901|11429369|FG000|Overall Study|Withdrawal by Subject|2
7220701|NCT00979901|11429370|FG001|Overall Study|Withdrawal by Subject|1
7220702|NCT00979901|11429371|FG002|Overall Study|Withdrawal by Subject|1
7220703|NCT00979901|11429372|FG003|Overall Study|Withdrawal by Subject|1
7220704|NCT00979901|11429369|FG000|Overall Study|Noncompliance|1
7220705|NCT00979901|11429370|FG001|Overall Study|Noncompliance|0
7220706|NCT00979901|11429371|FG002|Overall Study|Noncompliance|0
7220707|NCT00979901|11429372|FG003|Overall Study|Noncompliance|0
7220708|NCT00979901|11429369|FG000|Overall Study|out-of-state|1
7220709|NCT00979901|11429370|FG001|Overall Study|out-of-state|0
7220710|NCT00979901|11429371|FG002|Overall Study|out-of-state|0
7220711|NCT00979901|11429372|FG003|Overall Study|out-of-state|0
7220712|NCT00979901|11429369|FG000|Overall Study|vacation|1
7220713|NCT00979901|11429370|FG001|Overall Study|vacation|0
7220714|NCT00979901|11429371|FG002|Overall Study|vacation|0
7220715|NCT00979901|11429372|FG003|Overall Study|vacation|0
7220716|NCT00979901|11429369|FG000|Overall Study|elevated lab values pre-randomization|1
7220717|NCT00979901|11429370|FG001|Overall Study|elevated lab values pre-randomization|0
7220718|NCT00979901|11429371|FG002|Overall Study|elevated lab values pre-randomization|0
7220719|NCT00979901|11429372|FG003|Overall Study|elevated lab values pre-randomization|0
7220720|NCT00979901|11429369|FG000|Overall Study|Discontinued in Error|0
7220721|NCT00979901|11429370|FG001|Overall Study|Discontinued in Error|1
7220722|NCT00979901|11429371|FG002|Overall Study|Discontinued in Error|0
7220723|NCT00979901|11429372|FG003|Overall Study|Discontinued in Error|0
7220724|NCT00979901|11429369|FG000|Overall Study|Left Country|0
7220725|NCT00979901|11429370|FG001|Overall Study|Left Country|0
7220726|NCT00979901|11429371|FG002|Overall Study|Left Country|1
7220727|NCT00979901|11429372|FG003|Overall Study|Left Country|0
7220728|NCT00979901|11429369|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
7220729|NCT00979901|11429370|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
7220730|NCT00979901|11429371|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
7220731|NCT00979901|11429372|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
7220732|NCT00963599|11429385|FG000|Overall Study|Adverse Event|2
7220733|NCT00963599|11429386|FG001|Overall Study|Adverse Event|0
7220734|NCT00963599|11429387|FG002|Overall Study|Adverse Event|1
7220735|NCT00963599|11429388|FG003|Overall Study|Adverse Event|2
7220736|NCT00963599|11429385|FG000|Overall Study|Lack of Efficacy|0
7220737|NCT00963599|11429386|FG001|Overall Study|Lack of Efficacy|2
7220738|NCT00963599|11429387|FG002|Overall Study|Lack of Efficacy|1
7220739|NCT00963599|11429388|FG003|Overall Study|Lack of Efficacy|4
7220740|NCT00963599|11429385|FG000|Overall Study|Lost to Follow-up|0
7220741|NCT00963599|11429386|FG001|Overall Study|Lost to Follow-up|1
7220742|NCT00963599|11429387|FG002|Overall Study|Lost to Follow-up|1
7220743|NCT00963599|11429388|FG003|Overall Study|Lost to Follow-up|1
7220744|NCT00963599|11429385|FG000|Overall Study|Protocol Violation|2
7220745|NCT00963599|11429386|FG001|Overall Study|Protocol Violation|2
7220746|NCT00963599|11429387|FG002|Overall Study|Protocol Violation|3
7220747|NCT00963599|11429388|FG003|Overall Study|Protocol Violation|4
7220748|NCT00963599|11429385|FG000|Overall Study|Withdrawal by Subject|2
7220749|NCT00963599|11429386|FG001|Overall Study|Withdrawal by Subject|1
7220750|NCT00963599|11429387|FG002|Overall Study|Withdrawal by Subject|3
7220751|NCT00963599|11429388|FG003|Overall Study|Withdrawal by Subject|3
7220752|NCT00953680|11429403|FG000|Period 1|Withdrawal by Subject|0
7220753|NCT00953680|11429404|FG001|Period 1|Withdrawal by Subject|1
7220754|NCT00943852|11429417|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220755|NCT00943852|11429418|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220756|NCT00943852|11429419|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220757|NCT00943852|11429420|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
7220758|NCT00943852|11429421|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220759|NCT00943852|11429422|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220760|NCT00943852|11429423|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220761|NCT00943852|11429424|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220762|NCT00943852|11429425|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220763|NCT00943852|11429426|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
7220764|NCT00943852|11429417|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
7220765|NCT00943852|11429418|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
7220766|NCT00943852|11429419|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
7220767|NCT00943852|11429420|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
7220768|NCT00943852|11429421|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
7220769|NCT00943852|11429422|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
7220770|NCT00943852|11429423|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
7220771|NCT00943852|11429424|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
7220772|NCT00943852|11429425|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
7220773|NCT00943852|11429426|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
7220774|NCT00943852|11429417|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220775|NCT00943852|11429418|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220776|NCT00943852|11429419|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220777|NCT00943852|11429420|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220778|NCT00943852|11429421|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220779|NCT00943852|11429422|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220780|NCT00943852|11429423|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
7220781|NCT00943852|11429424|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220782|NCT00943852|11429425|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220783|NCT00943852|11429426|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
7220784|NCT00943852|11429417|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220785|NCT00943852|11429418|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220786|NCT00943852|11429419|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220787|NCT00943852|11429420|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220788|NCT00943852|11429421|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220789|NCT00943852|11429422|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220790|NCT00943852|11429423|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220791|NCT00943852|11429424|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
7220792|NCT00943852|11429425|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220793|NCT00943852|11429426|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
7220794|NCT00943852|11429417|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
7220795|NCT00943852|11429418|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
7220796|NCT00943852|11429419|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
7220797|NCT00943852|11429420|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
7220798|NCT00943852|11429421|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
7220799|NCT00943852|11429422|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
7297102|NCT00576732|11516167|FG004|DOUBLE BLIND|Lost to Follow-up|0
7220800|NCT00943852|11429423|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
7220801|NCT00943852|11429424|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
7220802|NCT00943852|11429425|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
7220803|NCT00943852|11429426|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
7220804|NCT00927953|11429438|FG000|Overall Study|Death|2
7220805|NCT00927953|11429439|FG001|Overall Study|Death|1
7220806|NCT00909389|11429446|FG000|Overall Study|Adverse Event|6
7220807|NCT00909389|11429446|FG000|Overall Study|Death|4
7220808|NCT00909389|11429446|FG000|Overall Study|Poor Compliance|16
7220809|NCT00909389|11429446|FG000|Overall Study|Lost to Follow-up|4
7220810|NCT00909389|11429446|FG000|Overall Study|No Information|103
7220811|NCT00820027|11429454|FG000|Overall Study|Adverse Event|15
7220812|NCT00820027|11429455|FG001|Overall Study|Adverse Event|8
7220813|NCT00820027|11429456|FG002|Overall Study|Adverse Event|10
7220814|NCT00820027|11429457|FG003|Overall Study|Adverse Event|5
7220815|NCT00820027|11429454|FG000|Overall Study|Lack of Efficacy|2
7220816|NCT00820027|11429455|FG001|Overall Study|Lack of Efficacy|1
7220817|NCT00820027|11429456|FG002|Overall Study|Lack of Efficacy|2
7220818|NCT00820027|11429457|FG003|Overall Study|Lack of Efficacy|2
7220819|NCT00820027|11429454|FG000|Overall Study|Physician Decision|0
7220820|NCT00820027|11429455|FG001|Overall Study|Physician Decision|1
7220821|NCT00820027|11429456|FG002|Overall Study|Physician Decision|1
7220822|NCT00820027|11429457|FG003|Overall Study|Physician Decision|0
7220823|NCT00820027|11429454|FG000|Overall Study|Protocol Violation|3
7220824|NCT00820027|11429455|FG001|Overall Study|Protocol Violation|0
7220825|NCT00820027|11429456|FG002|Overall Study|Protocol Violation|4
7220826|NCT00820027|11429457|FG003|Overall Study|Protocol Violation|0
7220827|NCT00820027|11429454|FG000|Overall Study|Withdrawal by Subject|6
7220828|NCT00820027|11429455|FG001|Overall Study|Withdrawal by Subject|4
7220829|NCT00820027|11429456|FG002|Overall Study|Withdrawal by Subject|4
7220830|NCT00820027|11429457|FG003|Overall Study|Withdrawal by Subject|6
7220831|NCT00788710|11429471|FG000|Overall Study|Adverse Event|1
7220832|NCT00788710|11429472|FG001|Overall Study|Adverse Event|3
7220833|NCT00788710|11429473|FG002|Overall Study|Adverse Event|4
7220834|NCT00788710|11429471|FG000|Overall Study|Lack of Efficacy|0
7220835|NCT00788710|11429472|FG001|Overall Study|Lack of Efficacy|0
7220836|NCT00788710|11429473|FG002|Overall Study|Lack of Efficacy|1
7220837|NCT00788710|11429471|FG000|Overall Study|Lost to Follow-up|0
7220838|NCT00788710|11429472|FG001|Overall Study|Lost to Follow-up|1
7220839|NCT00788710|11429473|FG002|Overall Study|Lost to Follow-up|0
7220840|NCT00788710|11429471|FG000|Overall Study|Physician Decision|2
7220841|NCT00788710|11429472|FG001|Overall Study|Physician Decision|1
7220842|NCT00788710|11429473|FG002|Overall Study|Physician Decision|0
7220843|NCT00788710|11429471|FG000|Overall Study|Protocol Violation|0
7220844|NCT00788710|11429472|FG001|Overall Study|Protocol Violation|1
7220845|NCT00788710|11429473|FG002|Overall Study|Protocol Violation|1
7220846|NCT00788710|11429471|FG000|Overall Study|Withdrawal by Subject|2
7220847|NCT00788710|11429472|FG001|Overall Study|Withdrawal by Subject|2
7220848|NCT00788710|11429473|FG002|Overall Study|Withdrawal by Subject|0
7220849|NCT00783224|11429485|FG000|Overall Study|Adverse Event|0
7220850|NCT00783224|11429486|FG001|Overall Study|Adverse Event|0
7220851|NCT00783224|11429487|FG002|Overall Study|Adverse Event|1
7297069|NCT00576472|11516102|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
7297070|NCT00576472|11516103|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
7297071|NCT00576472|11516104|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
7297072|NCT00576472|11516105|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
7297073|NCT00576472|11516106|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
7297074|NCT00576472|11516107|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
7297075|NCT00576576|11516138|FG000|Overall Study|Lost to Follow-up|6
7297076|NCT00576576|11516138|FG000|Overall Study|Protocol Violation|1
7297077|NCT00576628|11516142|FG000|Overall Study|Adverse Event|11
7297078|NCT00576628|11516142|FG000|Overall Study|Death|2
7297079|NCT00576628|11516142|FG000|Overall Study|Failure to return|1
7297080|NCT00576628|11516142|FG000|Overall Study|Refused Treatment|8
7297081|NCT00576628|11516142|FG000|Overall Study|Pregnancy|1
7297082|NCT00576628|11516142|FG000|Overall Study|RBC transfusion|1
7297083|NCT00576628|11516142|FG000|Overall Study|Progression of Kidney Disease|1
7297084|NCT00576628|11516142|FG000|Overall Study|Progression of Renal Failure|1
7297085|NCT00576628|11516142|FG000|Overall Study|The patient move into other town|1
7297086|NCT00576628|11516142|FG000|Overall Study|Transplantation|1
7297087|NCT00576628|11516142|FG000|Overall Study|Dialysis|15
7297088|NCT00576693|11516153|FG000|Overall Study|Lost to Follow-up|7
7297089|NCT00576693|11516154|FG001|Overall Study|Lost to Follow-up|11
7297090|NCT00576693|11516153|FG000|Overall Study|Withdrawal by Subject|3
7297091|NCT00576693|11516154|FG001|Overall Study|Withdrawal by Subject|13
7297092|NCT00576732|11516163|FG000|DOUBLE BLIND|Adverse Event|0
7297093|NCT00576732|11516164|FG001|DOUBLE BLIND|Adverse Event|0
7297094|NCT00576732|11516165|FG002|DOUBLE BLIND|Adverse Event|1
7297095|NCT00576732|11516166|FG003|DOUBLE BLIND|Adverse Event|0
7297096|NCT00576732|11516167|FG004|DOUBLE BLIND|Adverse Event|0
7297097|NCT00576732|11516168|FG005|DOUBLE BLIND|Adverse Event|0
7297098|NCT00576732|11516163|FG000|DOUBLE BLIND|Lost to Follow-up|0
7297099|NCT00576732|11516164|FG001|DOUBLE BLIND|Lost to Follow-up|1
7297100|NCT00576732|11516165|FG002|DOUBLE BLIND|Lost to Follow-up|1
7297101|NCT00576732|11516166|FG003|DOUBLE BLIND|Lost to Follow-up|0
7297103|NCT00576732|11516168|FG005|DOUBLE BLIND|Lost to Follow-up|0
7220852|NCT00783224|11429488|FG003|Overall Study|Adverse Event|0
7297104|NCT00576732|11516163|FG000|DOUBLE BLIND|Withdrawal by Subject|1
7297105|NCT00576732|11516164|FG001|DOUBLE BLIND|Withdrawal by Subject|1
7297106|NCT00576732|11516165|FG002|DOUBLE BLIND|Withdrawal by Subject|3
7297107|NCT00576732|11516166|FG003|DOUBLE BLIND|Withdrawal by Subject|0
7297108|NCT00576732|11516167|FG004|DOUBLE BLIND|Withdrawal by Subject|0
7297109|NCT00576732|11516168|FG005|DOUBLE BLIND|Withdrawal by Subject|0
7297110|NCT00576732|11516163|FG000|DOUBLE BLIND|OTHER|0
7220853|NCT00783224|11429485|FG000|Overall Study|Discarded the Investigational Drug Used|0
7220854|NCT00783224|11429486|FG001|Overall Study|Discarded the Investigational Drug Used|0
7220855|NCT00783224|11429487|FG002|Overall Study|Discarded the Investigational Drug Used|0
7220856|NCT00783224|11429488|FG003|Overall Study|Discarded the Investigational Drug Used|1
7220857|NCT00783224|11429485|FG000|Overall Study|Inappropriate as a study subject|0
7220858|NCT00783224|11429486|FG001|Overall Study|Inappropriate as a study subject|0
7220859|NCT00783224|11429487|FG002|Overall Study|Inappropriate as a study subject|0
7220860|NCT00783224|11429488|FG003|Overall Study|Inappropriate as a study subject|1
7220861|NCT00778700|11429517|FG000|Overall Study|Adverse Event|6
7220862|NCT00778700|11429518|FG001|Overall Study|Adverse Event|1
7220863|NCT00778700|11429519|FG002|Overall Study|Adverse Event|3
7220864|NCT00778700|11429520|FG003|Overall Study|Adverse Event|5
7220865|NCT00778700|11429517|FG000|Overall Study|Protocol Violation|1
7220866|NCT00778700|11429518|FG001|Overall Study|Protocol Violation|1
7220867|NCT00778700|11429519|FG002|Overall Study|Protocol Violation|0
7220868|NCT00778700|11429520|FG003|Overall Study|Protocol Violation|0
7220869|NCT00778700|11429517|FG000|Overall Study|Subject Withdrew Consent|6
7220870|NCT00778700|11429518|FG001|Overall Study|Subject Withdrew Consent|4
7220871|NCT00778700|11429519|FG002|Overall Study|Subject Withdrew Consent|1
7220872|NCT00778700|11429520|FG003|Overall Study|Subject Withdrew Consent|4
7220873|NCT00778700|11429517|FG000|Overall Study|Lost to Follow-up|3
7220874|NCT00778700|11429518|FG001|Overall Study|Lost to Follow-up|1
7220875|NCT00778700|11429519|FG002|Overall Study|Lost to Follow-up|0
7220876|NCT00778700|11429520|FG003|Overall Study|Lost to Follow-up|1
7220877|NCT00778700|11429517|FG000|Overall Study|Reason not Specified|2
7220878|NCT00778700|11429518|FG001|Overall Study|Reason not Specified|0
7220879|NCT00778700|11429519|FG002|Overall Study|Reason not Specified|1
7220880|NCT00778700|11429520|FG003|Overall Study|Reason not Specified|3
7220881|NCT00778700|11429517|FG000|Overall Study|Other|0
7220882|NCT00778700|11429518|FG001|Overall Study|Other|0
7220883|NCT00778700|11429519|FG002|Overall Study|Other|1
7220884|NCT00778700|11429520|FG003|Overall Study|Other|0
7220885|NCT00764478|11429537|FG000|Overall Study|Adverse Event|1
7220886|NCT00764478|11429538|FG001|Overall Study|Adverse Event|1
7220887|NCT00764478|11429539|FG002|Overall Study|Adverse Event|1
7220888|NCT00764478|11429537|FG000|Overall Study|Withdrawal by Subject|7
7220889|NCT00764478|11429538|FG001|Overall Study|Withdrawal by Subject|12
7220890|NCT00764478|11429539|FG002|Overall Study|Withdrawal by Subject|1
7220891|NCT00764478|11429537|FG000|Overall Study|Lost to Follow-up|7
7220892|NCT00764478|11429538|FG001|Overall Study|Lost to Follow-up|8
7220893|NCT00764478|11429539|FG002|Overall Study|Lost to Follow-up|5
7220894|NCT00764478|11429537|FG000|Overall Study|Protocol Violation|0
7220895|NCT00764478|11429538|FG001|Overall Study|Protocol Violation|1
7220896|NCT00764478|11429539|FG002|Overall Study|Protocol Violation|1
7220897|NCT00761527|11429547|FG000|Overall Study|Adverse Event|3
7220898|NCT00761527|11429547|FG000|Overall Study|Poor Compliance|8
7220899|NCT00761527|11429547|FG000|Overall Study|Lost to Follow-up|9
7220900|NCT00761527|11429547|FG000|Overall Study|Unknown reason|2
7220901|NCT00757627|11429551|FG000|Overall Study|Adverse Event|15
7220902|NCT00757627|11429551|FG000|Overall Study|Lack of Efficacy|10
7220903|NCT00757627|11429551|FG000|Overall Study|Lost to Follow-up|28
7220904|NCT00757627|11429551|FG000|Overall Study|Withdrawal by Subject|27
7220905|NCT00757627|11429551|FG000|Overall Study|Other|1
7220906|NCT00756938|11429563|FG000|12-week Base Study|Protocol-specific Criteria Met|1
7220907|NCT00756938|11429564|FG001|12-week Base Study|Protocol-specific Criteria Met|0
7220908|NCT00756938|11429565|FG002|12-week Base Study|Protocol-specific Criteria Met|1
7220909|NCT00756938|11429566|FG003|12-week Base Study|Protocol-specific Criteria Met|0
7220910|NCT00756938|11429563|FG000|12-week Base Study|Protocol Violation|0
7220911|NCT00756938|11429564|FG001|12-week Base Study|Protocol Violation|0
7220912|NCT00756938|11429565|FG002|12-week Base Study|Protocol Violation|1
7220913|NCT00756938|11429566|FG003|12-week Base Study|Protocol Violation|0
7220914|NCT00756938|11429563|FG000|12-week Base Study|Lost to Follow-up|1
7220915|NCT00756938|11429564|FG001|12-week Base Study|Lost to Follow-up|0
7220916|NCT00756938|11429565|FG002|12-week Base Study|Lost to Follow-up|0
7220917|NCT00756938|11429566|FG003|12-week Base Study|Lost to Follow-up|0
7220918|NCT00756938|11429563|FG000|Optional Extension|Lack of Efficacy|0
7220919|NCT00756938|11429564|FG001|Optional Extension|Lack of Efficacy|0
7220920|NCT00756938|11429565|FG002|Optional Extension|Lack of Efficacy|0
7220921|NCT00756938|11429566|FG003|Optional Extension|Lack of Efficacy|1
7220922|NCT00756938|11429563|FG000|Optional Extension|End of Study|0
7220923|NCT00756938|11429564|FG001|Optional Extension|End of Study|0
7220924|NCT00756938|11429565|FG002|Optional Extension|End of Study|0
7220925|NCT00756938|11429566|FG003|Optional Extension|End of Study|11
7220926|NCT00756938|11429563|FG000|Optional Extension|Protocol-specific criteria met|0
7221012|NCT00568178|11429680|FG002|Double Blind Base Study|Lost to Follow-up|0
7220927|NCT00756938|11429564|FG001|Optional Extension|Protocol-specific criteria met|0
7220928|NCT00756938|11429565|FG002|Optional Extension|Protocol-specific criteria met|0
7220929|NCT00756938|11429566|FG003|Optional Extension|Protocol-specific criteria met|9
7220930|NCT00756938|11429563|FG000|Optional Extension|Physician Decision|0
7220931|NCT00756938|11429564|FG001|Optional Extension|Physician Decision|0
7220932|NCT00756938|11429565|FG002|Optional Extension|Physician Decision|0
7220933|NCT00756938|11429566|FG003|Optional Extension|Physician Decision|3
7220934|NCT00756938|11429563|FG000|Optional Extension|Lost to Follow-up|0
7220935|NCT00756938|11429564|FG001|Optional Extension|Lost to Follow-up|0
7220936|NCT00756938|11429565|FG002|Optional Extension|Lost to Follow-up|0
7220937|NCT00756938|11429566|FG003|Optional Extension|Lost to Follow-up|1
7220938|NCT00756938|11429563|FG000|Optional Extension|Protocol Violation|0
7220939|NCT00756938|11429564|FG001|Optional Extension|Protocol Violation|0
7220940|NCT00756938|11429565|FG002|Optional Extension|Protocol Violation|0
7220941|NCT00756938|11429566|FG003|Optional Extension|Protocol Violation|1
7220942|NCT00756938|11429563|FG000|Optional Extension|Withdrawal by Subject|0
7220943|NCT00756938|11429564|FG001|Optional Extension|Withdrawal by Subject|0
7220944|NCT00756938|11429565|FG002|Optional Extension|Withdrawal by Subject|0
7220945|NCT00756938|11429566|FG003|Optional Extension|Withdrawal by Subject|10
7220946|NCT00756938|11429563|FG000|Optional Extension|Adverse Event|0
7220947|NCT00756938|11429564|FG001|Optional Extension|Adverse Event|0
7220948|NCT00756938|11429565|FG002|Optional Extension|Adverse Event|0
7220949|NCT00756938|11429566|FG003|Optional Extension|Adverse Event|1
7220950|NCT00730132|11429584|FG000|Overall Study|Protocol Violation|154
7220951|NCT00730132|11429584|FG000|Overall Study|Death|1
7220952|NCT00728416|11429593|FG000|Overall Study|Adverse Event|1
7220953|NCT00728416|11429594|FG001|Overall Study|Adverse Event|1
7220954|NCT00728416|11429593|FG000|Overall Study|Treatment Failure|0
7220955|NCT00728416|11429594|FG001|Overall Study|Treatment Failure|1
7220956|NCT00728416|11429593|FG000|Overall Study|Withdrawal by Subject|1
7220957|NCT00728416|11429594|FG001|Overall Study|Withdrawal by Subject|0
7220958|NCT00704535|11429621|FG000|Overall Study|Adverse Event|2
7220959|NCT00704535|11429621|FG000|Overall Study|Death|2
7220960|NCT00704535|11429621|FG000|Overall Study|Lost to Follow-up|8
7220961|NCT00704535|11429621|FG000|Overall Study|Protocol Violation|10
7220962|NCT00704535|11429621|FG000|Overall Study|Completed status not on Case Report Form|124
7220963|NCT00694369|11429630|FG000|Overall Study|Adverse Event|0
7220964|NCT00694369|11429631|FG001|Overall Study|Adverse Event|1
7220965|NCT00694369|11429632|FG002|Overall Study|Adverse Event|0
7220966|NCT00694369|11429633|FG003|Overall Study|Adverse Event|1
7220967|NCT00694369|11429634|FG004|Overall Study|Adverse Event|3
7220968|NCT00694369|11429630|FG000|Overall Study|Lost to Follow-up|0
7220969|NCT00694369|11429631|FG001|Overall Study|Lost to Follow-up|0
7220970|NCT00694369|11429632|FG002|Overall Study|Lost to Follow-up|1
7220971|NCT00694369|11429633|FG003|Overall Study|Lost to Follow-up|1
7220972|NCT00694369|11429634|FG004|Overall Study|Lost to Follow-up|0
7220973|NCT00694369|11429630|FG000|Overall Study|Physician Decision|0
7220974|NCT00694369|11429631|FG001|Overall Study|Physician Decision|0
7220975|NCT00694369|11429632|FG002|Overall Study|Physician Decision|0
7220976|NCT00694369|11429633|FG003|Overall Study|Physician Decision|0
7220977|NCT00694369|11429634|FG004|Overall Study|Physician Decision|1
7220978|NCT00694369|11429630|FG000|Overall Study|Protocol Violation|0
7220979|NCT00694369|11429631|FG001|Overall Study|Protocol Violation|1
7220980|NCT00694369|11429632|FG002|Overall Study|Protocol Violation|0
7220981|NCT00694369|11429633|FG003|Overall Study|Protocol Violation|0
7220982|NCT00694369|11429634|FG004|Overall Study|Protocol Violation|0
7220983|NCT00694369|11429630|FG000|Overall Study|Withdrawal by Subject|1
7220984|NCT00694369|11429631|FG001|Overall Study|Withdrawal by Subject|1
7220985|NCT00694369|11429632|FG002|Overall Study|Withdrawal by Subject|1
7220986|NCT00694369|11429633|FG003|Overall Study|Withdrawal by Subject|1
7220987|NCT00694369|11429634|FG004|Overall Study|Withdrawal by Subject|2
7220988|NCT00667823|11429659|FG000|Overall Study|Lost to Follow-up|5
7220989|NCT00667823|11429659|FG000|Overall Study|Adverse Event|7
7220990|NCT00667823|11429659|FG000|Overall Study|Death|182
7220991|NCT00667823|11429659|FG000|Overall Study|Withdrawal by Subject|12
7220992|NCT00667823|11429659|FG000|Overall Study|Other|8
7220993|NCT00667823|11429659|FG000|Overall Study|Missing (completion page missing)|2
7220994|NCT00652327|11429665|FG000|Overall Study|Adverse Event|0
7220995|NCT00652327|11429666|FG001|Overall Study|Adverse Event|2
7220996|NCT00652327|11429665|FG000|Overall Study|Lost to Follow-up|0
7220997|NCT00652327|11429666|FG001|Overall Study|Lost to Follow-up|3
7220998|NCT00604500|11429672|FG000|Overall Study|Adverse Event|2
7220999|NCT00604500|11429672|FG000|Overall Study|Protocol Violation|2
7221000|NCT00604500|11429672|FG000|Overall Study|Treatment Failure|1
7221001|NCT00604500|11429672|FG000|Overall Study|Withdrawal by Subject|4
7221002|NCT00604500|11429672|FG000|Overall Study|Administrative|1
7221003|NCT00604500|11429672|FG000|Overall Study|Did not meet protocol eligibility|1
7221004|NCT00568178|11429678|FG000|Double Blind Base Study|Adverse Event|0
7221005|NCT00568178|11429679|FG001|Double Blind Base Study|Adverse Event|2
7221006|NCT00568178|11429680|FG002|Double Blind Base Study|Adverse Event|1
7221007|NCT00568178|11429681|FG003|Double Blind Base Study|Adverse Event|2
7221008|NCT00568178|11429682|FG004|Double Blind Base Study|Adverse Event|0
7221009|NCT00568178|11429683|FG005|Double Blind Base Study|Adverse Event|0
7221010|NCT00568178|11429678|FG000|Double Blind Base Study|Lost to Follow-up|1
7221011|NCT00568178|11429679|FG001|Double Blind Base Study|Lost to Follow-up|0
7221013|NCT00568178|11429681|FG003|Double Blind Base Study|Lost to Follow-up|1
7221014|NCT00568178|11429682|FG004|Double Blind Base Study|Lost to Follow-up|0
7221015|NCT00568178|11429683|FG005|Double Blind Base Study|Lost to Follow-up|0
7221016|NCT00568178|11429678|FG000|Double Blind Base Study|Physician Decision|1
7221017|NCT00568178|11429679|FG001|Double Blind Base Study|Physician Decision|1
7221018|NCT00568178|11429680|FG002|Double Blind Base Study|Physician Decision|0
7221019|NCT00568178|11429681|FG003|Double Blind Base Study|Physician Decision|1
7297111|NCT00576732|11516164|FG001|DOUBLE BLIND|OTHER|2
7221020|NCT00568178|11429682|FG004|Double Blind Base Study|Physician Decision|0
7221021|NCT00568178|11429683|FG005|Double Blind Base Study|Physician Decision|0
7221022|NCT00568178|11429678|FG000|Double Blind Base Study|Protocol Violation|3
7221023|NCT00568178|11429679|FG001|Double Blind Base Study|Protocol Violation|2
7221024|NCT00568178|11429680|FG002|Double Blind Base Study|Protocol Violation|0
7221025|NCT00568178|11429681|FG003|Double Blind Base Study|Protocol Violation|0
7221026|NCT00568178|11429682|FG004|Double Blind Base Study|Protocol Violation|0
7221027|NCT00568178|11429683|FG005|Double Blind Base Study|Protocol Violation|0
7221028|NCT00568178|11429678|FG000|Double Blind Base Study|Withdrawal by Subject|1
7221029|NCT00568178|11429679|FG001|Double Blind Base Study|Withdrawal by Subject|1
7221030|NCT00568178|11429680|FG002|Double Blind Base Study|Withdrawal by Subject|0
7221031|NCT00568178|11429681|FG003|Double Blind Base Study|Withdrawal by Subject|0
7221032|NCT00568178|11429682|FG004|Double Blind Base Study|Withdrawal by Subject|0
7221033|NCT00568178|11429683|FG005|Double Blind Base Study|Withdrawal by Subject|0
7221034|NCT00568178|11429678|FG000|Double Blind Base Study|Progressive Disease|0
7221035|NCT00568178|11429679|FG001|Double Blind Base Study|Progressive Disease|0
7221036|NCT00568178|11429680|FG002|Double Blind Base Study|Progressive Disease|0
7221037|NCT00568178|11429681|FG003|Double Blind Base Study|Progressive Disease|1
7221038|NCT00568178|11429682|FG004|Double Blind Base Study|Progressive Disease|0
7221039|NCT00568178|11429683|FG005|Double Blind Base Study|Progressive Disease|0
7221040|NCT00568178|11429678|FG000|Open Label Extension|Adverse Event|0
7221041|NCT00568178|11429679|FG001|Open Label Extension|Adverse Event|0
7221042|NCT00568178|11429680|FG002|Open Label Extension|Adverse Event|0
7221043|NCT00568178|11429681|FG003|Open Label Extension|Adverse Event|0
7221044|NCT00568178|11429682|FG004|Open Label Extension|Adverse Event|11
7221045|NCT00568178|11429683|FG005|Open Label Extension|Adverse Event|8
7221046|NCT00568178|11429678|FG000|Open Label Extension|Protocol Violation|0
7221047|NCT00568178|11429679|FG001|Open Label Extension|Protocol Violation|0
7221048|NCT00568178|11429680|FG002|Open Label Extension|Protocol Violation|0
7221049|NCT00568178|11429681|FG003|Open Label Extension|Protocol Violation|0
7221050|NCT00568178|11429682|FG004|Open Label Extension|Protocol Violation|1
7221051|NCT00568178|11429683|FG005|Open Label Extension|Protocol Violation|0
7221052|NCT00568178|11429678|FG000|Open Label Extension|Lost to Follow-up|0
7221053|NCT00568178|11429679|FG001|Open Label Extension|Lost to Follow-up|0
7221054|NCT00568178|11429680|FG002|Open Label Extension|Lost to Follow-up|0
7221055|NCT00568178|11429681|FG003|Open Label Extension|Lost to Follow-up|0
7221056|NCT00568178|11429682|FG004|Open Label Extension|Lost to Follow-up|6
7221057|NCT00568178|11429683|FG005|Open Label Extension|Lost to Follow-up|11
7221058|NCT00568178|11429678|FG000|Open Label Extension|Physician Decision|0
7221059|NCT00568178|11429679|FG001|Open Label Extension|Physician Decision|0
7221060|NCT00568178|11429680|FG002|Open Label Extension|Physician Decision|0
7221061|NCT00568178|11429681|FG003|Open Label Extension|Physician Decision|0
7221062|NCT00568178|11429682|FG004|Open Label Extension|Physician Decision|9
7221063|NCT00568178|11429683|FG005|Open Label Extension|Physician Decision|8
7221064|NCT00568178|11429678|FG000|Open Label Extension|Pregnancy|0
7221065|NCT00568178|11429679|FG001|Open Label Extension|Pregnancy|0
7221066|NCT00568178|11429680|FG002|Open Label Extension|Pregnancy|0
7221067|NCT00568178|11429681|FG003|Open Label Extension|Pregnancy|0
7221068|NCT00568178|11429682|FG004|Open Label Extension|Pregnancy|0
7221069|NCT00568178|11429683|FG005|Open Label Extension|Pregnancy|1
7221070|NCT00568178|11429678|FG000|Open Label Extension|Progressive Disease|0
7221071|NCT00568178|11429679|FG001|Open Label Extension|Progressive Disease|0
7221072|NCT00568178|11429680|FG002|Open Label Extension|Progressive Disease|0
7221073|NCT00568178|11429681|FG003|Open Label Extension|Progressive Disease|0
7221074|NCT00568178|11429682|FG004|Open Label Extension|Progressive Disease|3
7221075|NCT00568178|11429683|FG005|Open Label Extension|Progressive Disease|1
7221076|NCT00568178|11429678|FG000|Open Label Extension|Termination of Trial|0
7221077|NCT00568178|11429679|FG001|Open Label Extension|Termination of Trial|0
7221078|NCT00568178|11429680|FG002|Open Label Extension|Termination of Trial|0
7221079|NCT00568178|11429681|FG003|Open Label Extension|Termination of Trial|0
7221080|NCT00568178|11429682|FG004|Open Label Extension|Termination of Trial|45
7221081|NCT00568178|11429683|FG005|Open Label Extension|Termination of Trial|47
7221082|NCT00568178|11429678|FG000|Open Label Extension|Withdrawal by Subject|0
7221083|NCT00568178|11429679|FG001|Open Label Extension|Withdrawal by Subject|0
7221084|NCT00568178|11429680|FG002|Open Label Extension|Withdrawal by Subject|0
7221085|NCT00568178|11429681|FG003|Open Label Extension|Withdrawal by Subject|0
7221086|NCT00568178|11429682|FG004|Open Label Extension|Withdrawal by Subject|4
7221087|NCT00568178|11429683|FG005|Open Label Extension|Withdrawal by Subject|4
7221088|NCT00545844|11429697|FG000|Overall Study|Lost to Follow-up|9
7221089|NCT00545844|11429697|FG000|Overall Study|Protocol Violation|1
7221090|NCT00545844|11429697|FG000|Overall Study|Withdrawal by Subject|2
7221091|NCT00511433|11429705|FG000|Overall Study|Adverse Event|5
7221092|NCT00511433|11429706|FG001|Overall Study|Adverse Event|0
7221093|NCT00511433|11429705|FG000|Overall Study|Other Reason|1
7221094|NCT00511433|11429706|FG001|Overall Study|Other Reason|1
7221095|NCT00511355|11429716|FG000|Overall Study|Adverse Event|4
7221096|NCT00511355|11429717|FG001|Overall Study|Adverse Event|4
7221097|NCT00511355|11429716|FG000|Overall Study|Pregnancy Wish|1
7221098|NCT00511355|11429717|FG001|Overall Study|Pregnancy Wish|0
7221099|NCT00511355|11429716|FG000|Overall Study|Lost to Follow-up|2
7221100|NCT00511355|11429717|FG001|Overall Study|Lost to Follow-up|1
7221101|NCT00511355|11429716|FG000|Overall Study|Other Reason|0
7221102|NCT00511355|11429717|FG001|Overall Study|Other Reason|1
7221103|NCT00511355|11429716|FG000|Overall Study|Pre-treatment (serious) adverse event|0
7221104|NCT00511355|11429717|FG001|Overall Study|Pre-treatment (serious) adverse event|1
7221105|NCT00511355|11429716|FG000|Overall Study|Withdrawal of informed consent|0
7221106|NCT00511355|11429717|FG001|Overall Study|Withdrawal of informed consent|1
7221107|NCT00511355|11429716|FG000|Overall Study|Other reason pre-treatment|0
7221108|NCT00511355|11429717|FG001|Overall Study|Other reason pre-treatment|1
7221109|NCT00511342|11429727|FG000|Overall Study|Unacceptable vaginal bleeding|2
7221110|NCT00511342|11429728|FG001|Overall Study|Unacceptable vaginal bleeding|1
7221111|NCT00511342|11429727|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
7221112|NCT00511342|11429728|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
7221113|NCT00511342|11429727|FG000|Overall Study|Pregnancy|0
7221114|NCT00511342|11429728|FG001|Overall Study|Pregnancy|1
7221115|NCT00511342|11429727|FG000|Overall Study|Pregnancy wish|0
7221116|NCT00511342|11429728|FG001|Overall Study|Pregnancy wish|1
7221117|NCT00511342|11429727|FG000|Overall Study|Lost to Follow-up|1
7221118|NCT00511342|11429728|FG001|Overall Study|Lost to Follow-up|5
7221119|NCT00511342|11429727|FG000|Overall Study|Other Reason|2
7221120|NCT00511342|11429728|FG001|Overall Study|Other Reason|2
7221121|NCT00511199|11429736|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
7221122|NCT00511199|11429737|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
7221123|NCT00511199|11429736|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
7221124|NCT00511199|11429737|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
7221125|NCT00511199|11429736|FG000|Overall Study|Withdrawal of Informed Consent|19
7221126|NCT00511199|11429737|FG001|Overall Study|Withdrawal of Informed Consent|4
7221127|NCT00511199|11429736|FG000|Overall Study|Pregnancy|6
7221128|NCT00511199|11429737|FG001|Overall Study|Pregnancy|3
7221129|NCT00511199|11429736|FG000|Overall Study|Pregnancy Wish|16
7221130|NCT00511199|11429737|FG001|Overall Study|Pregnancy Wish|8
7221131|NCT00511199|11429736|FG000|Overall Study|Lost to Follow-up|40
7221132|NCT00511199|11429737|FG001|Overall Study|Lost to Follow-up|17
7221133|NCT00511199|11429736|FG000|Overall Study|Other Reason|78
7221134|NCT00511199|11429737|FG001|Overall Study|Other Reason|37
7221135|NCT00491504|11429749|FG000|Overall Study|Adverse Event|0
7221136|NCT00491504|11429750|FG001|Overall Study|Adverse Event|1
7221137|NCT00491504|11429751|FG002|Overall Study|Adverse Event|0
7221138|NCT00491504|11429752|FG003|Overall Study|Adverse Event|0
7221139|NCT00491504|11429749|FG000|Overall Study|Withdrawal by Subject|0
7221140|NCT00491504|11429750|FG001|Overall Study|Withdrawal by Subject|0
7221141|NCT00491504|11429751|FG002|Overall Study|Withdrawal by Subject|1
7221142|NCT00491504|11429752|FG003|Overall Study|Withdrawal by Subject|2
7221143|NCT00491504|11429749|FG000|Overall Study|Protocol Violation|0
7221144|NCT00491504|11429750|FG001|Overall Study|Protocol Violation|0
7221145|NCT00491504|11429751|FG002|Overall Study|Protocol Violation|3
7221146|NCT00491504|11429752|FG003|Overall Study|Protocol Violation|2
7221147|NCT00468312|11429762|FG000|Overall Study|Adverse Event|2
7221148|NCT00468312|11429763|FG001|Overall Study|Adverse Event|1
7221149|NCT00468312|11429762|FG000|Overall Study|Lack of Efficacy|0
7221150|NCT00468312|11429763|FG001|Overall Study|Lack of Efficacy|1
7221151|NCT00468312|11429762|FG000|Overall Study|Withdrawal by Subject|0
7221152|NCT00468312|11429763|FG001|Overall Study|Withdrawal by Subject|1
7221153|NCT00468312|11429762|FG000|Overall Study|Protocol Violation|2
7221154|NCT00468312|11429763|FG001|Overall Study|Protocol Violation|1
7221155|NCT00468312|11429762|FG000|Overall Study|Did not meet protocol eligibility|0
7221156|NCT00468312|11429763|FG001|Overall Study|Did not meet protocol eligibility|1
7297112|NCT00576732|11516165|FG002|DOUBLE BLIND|OTHER|1
7297113|NCT00576732|11516166|FG003|DOUBLE BLIND|OTHER|0
7297114|NCT00576732|11516167|FG004|DOUBLE BLIND|OTHER|0
7297115|NCT00576732|11516168|FG005|DOUBLE BLIND|OTHER|0
7297116|NCT00576732|11516163|FG000|DOUBLE BLIND|Lack of Efficacy|6
7297117|NCT00576732|11516164|FG001|DOUBLE BLIND|Lack of Efficacy|1
7297118|NCT00576732|11516165|FG002|DOUBLE BLIND|Lack of Efficacy|0
7297119|NCT00576732|11516166|FG003|DOUBLE BLIND|Lack of Efficacy|0
7297120|NCT00576732|11516167|FG004|DOUBLE BLIND|Lack of Efficacy|0
7297121|NCT00576732|11516168|FG005|DOUBLE BLIND|Lack of Efficacy|0
7297122|NCT00576732|11516163|FG000|DOUBLE BLIND|Protocol Violation|1
7297123|NCT00576732|11516164|FG001|DOUBLE BLIND|Protocol Violation|0
7297124|NCT00576732|11516165|FG002|DOUBLE BLIND|Protocol Violation|0
7297125|NCT00576732|11516166|FG003|DOUBLE BLIND|Protocol Violation|0
7297126|NCT00576732|11516167|FG004|DOUBLE BLIND|Protocol Violation|0
7297127|NCT00576732|11516168|FG005|DOUBLE BLIND|Protocol Violation|0
7297128|NCT00576732|11516163|FG000|OPEN LABEL|Adverse Event|0
7297129|NCT00576732|11516164|FG001|OPEN LABEL|Adverse Event|0
7297130|NCT00576732|11516165|FG002|OPEN LABEL|Adverse Event|0
7297131|NCT00576732|11516166|FG003|OPEN LABEL|Adverse Event|4
7297132|NCT00576732|11516167|FG004|OPEN LABEL|Adverse Event|0
7297133|NCT00576732|11516168|FG005|OPEN LABEL|Adverse Event|1
7297134|NCT00576732|11516163|FG000|OPEN LABEL|Lost to Follow-up|0
7297135|NCT00576732|11516164|FG001|OPEN LABEL|Lost to Follow-up|0
7297136|NCT00576732|11516165|FG002|OPEN LABEL|Lost to Follow-up|0
7297137|NCT00576732|11516166|FG003|OPEN LABEL|Lost to Follow-up|2
7297138|NCT00576732|11516167|FG004|OPEN LABEL|Lost to Follow-up|1
7297139|NCT00576732|11516168|FG005|OPEN LABEL|Lost to Follow-up|1
7297140|NCT00576732|11516163|FG000|OPEN LABEL|Withdrawal by Subject|0
7221157|NCT00453063|11429771|FG000|Overall Study|Adverse Event|1
7221158|NCT00453063|11429772|FG001|Overall Study|Adverse Event|2
7221159|NCT00453063|11429771|FG000|Overall Study|Withdrawal by Subject|1
7221160|NCT00453063|11429772|FG001|Overall Study|Withdrawal by Subject|1
7221161|NCT00453063|11429771|FG000|Overall Study|Protocol Violation|1
7221162|NCT00453063|11429772|FG001|Overall Study|Protocol Violation|0
7221163|NCT00447603|11429778|FG000|Screening|Withdrawal by Subject|1
7221164|NCT00447603|11429779|FG001|Screening|Withdrawal by Subject|0
7221165|NCT00447603|11429780|FG002|Screening|Withdrawal by Subject|0
7221166|NCT00447603|11429778|FG000|Screening|Protocol Violation|1
7221167|NCT00447603|11429779|FG001|Screening|Protocol Violation|0
7221168|NCT00447603|11429780|FG002|Screening|Protocol Violation|0
7221169|NCT00447603|11429778|FG000|Screening|Screen Failure|4
7221170|NCT00447603|11429779|FG001|Screening|Screen Failure|0
7221171|NCT00447603|11429780|FG002|Screening|Screen Failure|0
7221172|NCT00447603|11429778|FG000|Screening|Study Terminated by Sponsor|15
7221173|NCT00447603|11429779|FG001|Screening|Study Terminated by Sponsor|0
7221174|NCT00447603|11429780|FG002|Screening|Study Terminated by Sponsor|0
7221175|NCT00447603|11429778|FG000|Filter Period|Adverse Event|0
7221176|NCT00447603|11429779|FG001|Filter Period|Adverse Event|0
7221177|NCT00447603|11429780|FG002|Filter Period|Adverse Event|1
7221178|NCT00447603|11429778|FG000|Filter Period|Screen Failure|0
7221179|NCT00447603|11429779|FG001|Filter Period|Screen Failure|3
7221180|NCT00447603|11429780|FG002|Filter Period|Screen Failure|4
7221181|NCT00447603|11429778|FG000|Filter Period|Study terminated by Sponsor|0
7221182|NCT00447603|11429779|FG001|Filter Period|Study terminated by Sponsor|1
7221183|NCT00447603|11429780|FG002|Filter Period|Study terminated by Sponsor|10
7221184|NCT00442351|11429790|FG000|Overall Study|Administrative|6
7221185|NCT00442351|11429791|FG001|Overall Study|Administrative|5
7221186|NCT00442351|11429790|FG000|Overall Study|Did not meet protocol eligibility|1
7221187|NCT00442351|11429791|FG001|Overall Study|Did not meet protocol eligibility|0
7221188|NCT00442351|11429790|FG000|Overall Study|Other|0
7221189|NCT00442351|11429791|FG001|Overall Study|Other|1
7221190|NCT00423488|11429799|FG000|Overall Study|No evidence of study drug intake|2
7221191|NCT00423488|11429800|FG001|Overall Study|No evidence of study drug intake|1
7221192|NCT00423488|11429799|FG000|Overall Study|No post baseline data|3
7221193|NCT00423488|11429800|FG001|Overall Study|No post baseline data|0
7221194|NCT00413972|11429810|FG000|Overall Study|Adverse Event|2
7221195|NCT00413972|11429811|FG001|Overall Study|Adverse Event|1
7221196|NCT00413972|11429812|FG002|Overall Study|Adverse Event|0
7221197|NCT00413972|11429813|FG003|Overall Study|Adverse Event|0
7221198|NCT00413972|11429810|FG000|Overall Study|Lost to Follow-up|1
7221199|NCT00413972|11429811|FG001|Overall Study|Lost to Follow-up|2
7221200|NCT00413972|11429812|FG002|Overall Study|Lost to Follow-up|1
7221201|NCT00413972|11429813|FG003|Overall Study|Lost to Follow-up|0
7221202|NCT00413972|11429810|FG000|Overall Study|Withdrawal by Subject|4
7221203|NCT00413972|11429811|FG001|Overall Study|Withdrawal by Subject|5
7221204|NCT00413972|11429812|FG002|Overall Study|Withdrawal by Subject|7
7221205|NCT00413972|11429813|FG003|Overall Study|Withdrawal by Subject|2
7221206|NCT00413972|11429810|FG000|Overall Study|Protocol Violation|0
7221207|NCT00413972|11429811|FG001|Overall Study|Protocol Violation|0
7221208|NCT00413972|11429812|FG002|Overall Study|Protocol Violation|2
7221209|NCT00413972|11429813|FG003|Overall Study|Protocol Violation|0
7221210|NCT00413972|11429810|FG000|Overall Study|Other|0
7221211|NCT00413972|11429811|FG001|Overall Study|Other|0
7221212|NCT00413972|11429812|FG002|Overall Study|Other|0
7221213|NCT00413972|11429813|FG003|Overall Study|Other|1
7221214|NCT00413062|11429825|FG000|Overall Study|Adverse event/serious adverse event|289
7221215|NCT00413062|11429826|FG001|Overall Study|Adverse event/serious adverse event|56
7221216|NCT00413062|11429825|FG000|Overall Study|Pre-treatment (serious) adverse event|1
7221217|NCT00413062|11429826|FG001|Overall Study|Pre-treatment (serious) adverse event|0
7221218|NCT00413062|11429825|FG000|Overall Study|Withdrawal of informed consent|111
7221219|NCT00413062|11429826|FG001|Overall Study|Withdrawal of informed consent|36
7221220|NCT00413062|11429825|FG000|Overall Study|Pregnancy|15
7221221|NCT00413062|11429826|FG001|Overall Study|Pregnancy|5
7221222|NCT00413062|11429825|FG000|Overall Study|Pregnancy wish|17
7221223|NCT00413062|11429826|FG001|Overall Study|Pregnancy wish|6
7221224|NCT00413062|11429825|FG000|Overall Study|Lost to Follow-up|175
7221225|NCT00413062|11429826|FG001|Overall Study|Lost to Follow-up|73
7221226|NCT00413062|11429825|FG000|Overall Study|Other reason|70
7221227|NCT00413062|11429826|FG001|Overall Study|Other reason|34
7221228|NCT00391170|11429836|FG000|Overall Study|Withdrawal by Subject|1
7221229|NCT00391170|11429837|FG001|Overall Study|Withdrawal by Subject|0
7221230|NCT00391170|11429836|FG000|Overall Study|Adverse Event|3
7221231|NCT00391170|11429837|FG001|Overall Study|Adverse Event|2
7221232|NCT00391170|11429836|FG000|Overall Study|Physician Decision|2
7221233|NCT00391170|11429837|FG001|Overall Study|Physician Decision|2
7221234|NCT00319449|11429871|FG000|Overall Study|Subject did not wish to continue|1
7221235|NCT00319449|11429872|FG001|Overall Study|Subject did not wish to continue|0
7221236|NCT00319449|11429871|FG000|Overall Study|Noncompliance with the protocol|1
7221237|NCT00319449|11429872|FG001|Overall Study|Noncompliance with the protocol|0
7221238|NCT00289887|11429884|FG000|Overall Study|Adverse Event|3
7221239|NCT00289887|11429885|FG001|Overall Study|Adverse Event|3
7221240|NCT00289887|11429884|FG000|Overall Study|Lack of Efficacy|3
7221241|NCT00289887|11429885|FG001|Overall Study|Lack of Efficacy|11
7221242|NCT00289887|11429884|FG000|Overall Study|Lost to Follow-up|3
7221243|NCT00289887|11429885|FG001|Overall Study|Lost to Follow-up|3
7221244|NCT00289887|11429884|FG000|Overall Study|Protocol Violation|3
7221245|NCT00289887|11429885|FG001|Overall Study|Protocol Violation|1
7221246|NCT00289887|11429884|FG000|Overall Study|Withdrawal by Subject|3
7221247|NCT00289887|11429885|FG001|Overall Study|Withdrawal by Subject|8
7221248|NCT00289887|11429884|FG000|Overall Study|Other|7
7221249|NCT00289887|11429885|FG001|Overall Study|Other|3
7221250|NCT00281320|11429893|FG000|Overall Study|Adverse Event|12
7221251|NCT00281320|11429894|FG001|Overall Study|Adverse Event|9
7221252|NCT00281320|11429893|FG000|Overall Study|Lack of Efficacy|4
7221253|NCT00281320|11429894|FG001|Overall Study|Lack of Efficacy|3
7221254|NCT00281320|11429893|FG000|Overall Study|Withdrawal by Subject|5
7221255|NCT00281320|11429894|FG001|Overall Study|Withdrawal by Subject|6
7221256|NCT00281320|11429893|FG000|Overall Study|Lost to Follow-up|1
7221257|NCT00281320|11429894|FG001|Overall Study|Lost to Follow-up|2
7221258|NCT00281320|11429893|FG000|Overall Study|Other|3
7221259|NCT00281320|11429894|FG001|Overall Study|Other|1
7221260|NCT00276016|11429912|FG000|Intervention 1|Withdrawal by Subject|0
7221261|NCT00276016|11429913|FG001|Intervention 1|Withdrawal by Subject|1
7221262|NCT00276016|11429914|FG002|Intervention 1|Withdrawal by Subject|0
7221263|NCT00276016|11429915|FG003|Intervention 1|Withdrawal by Subject|0
7221264|NCT00276016|11429916|FG004|Intervention 1|Withdrawal by Subject|0
7221265|NCT00276016|11429917|FG005|Intervention 1|Withdrawal by Subject|0
7221266|NCT00265343|11429928|FG000|Overall Study|Adverse Event|10
7221267|NCT00265343|11429929|FG001|Overall Study|Adverse Event|7
7221268|NCT00265343|11429928|FG000|Overall Study|Withdrawal by Subject|3
7221269|NCT00265343|11429929|FG001|Overall Study|Withdrawal by Subject|9
7221270|NCT00265343|11429928|FG000|Overall Study|Other|8
7221271|NCT00265343|11429929|FG001|Overall Study|Other|3
7221272|NCT00264147|11429940|FG000|Treatment I Period|Adverse Event|3
7221273|NCT00264147|11429941|FG001|Treatment I Period|Adverse Event|6
7221274|NCT00264147|11429942|FG002|Treatment I Period|Adverse Event|3
7221275|NCT00264147|11429943|FG003|Treatment I Period|Adverse Event|5
7221276|NCT00264147|11429944|FG004|Treatment I Period|Adverse Event|7
7221277|NCT00264147|11429945|FG005|Treatment I Period|Adverse Event|0
7221278|NCT00264147|11429940|FG000|Treatment I Period|Laboratory Adverse Event|0
7221279|NCT00264147|11429941|FG001|Treatment I Period|Laboratory Adverse Event|0
7221280|NCT00264147|11429942|FG002|Treatment I Period|Laboratory Adverse Event|0
7221281|NCT00264147|11429943|FG003|Treatment I Period|Laboratory Adverse Event|1
7221282|NCT00264147|11429944|FG004|Treatment I Period|Laboratory Adverse Event|0
7221283|NCT00264147|11429945|FG005|Treatment I Period|Laboratory Adverse Event|0
7221284|NCT00264147|11429940|FG000|Treatment I Period|Lack of Efficacy|6
7221285|NCT00264147|11429941|FG001|Treatment I Period|Lack of Efficacy|2
7221286|NCT00264147|11429942|FG002|Treatment I Period|Lack of Efficacy|8
7221287|NCT00264147|11429943|FG003|Treatment I Period|Lack of Efficacy|0
7221288|NCT00264147|11429944|FG004|Treatment I Period|Lack of Efficacy|1
7221289|NCT00264147|11429945|FG005|Treatment I Period|Lack of Efficacy|0
7221290|NCT00264147|11429940|FG000|Treatment I Period|Lost to Follow-up|1
7221291|NCT00264147|11429941|FG001|Treatment I Period|Lost to Follow-up|0
7221292|NCT00264147|11429942|FG002|Treatment I Period|Lost to Follow-up|0
7221293|NCT00264147|11429943|FG003|Treatment I Period|Lost to Follow-up|1
7221294|NCT00264147|11429944|FG004|Treatment I Period|Lost to Follow-up|1
7221295|NCT00264147|11429945|FG005|Treatment I Period|Lost to Follow-up|0
7221296|NCT00264147|11429940|FG000|Treatment I Period|Protocol Violation|2
7221297|NCT00264147|11429941|FG001|Treatment I Period|Protocol Violation|2
7221298|NCT00264147|11429942|FG002|Treatment I Period|Protocol Violation|0
7221299|NCT00264147|11429943|FG003|Treatment I Period|Protocol Violation|0
7221300|NCT00264147|11429944|FG004|Treatment I Period|Protocol Violation|0
7221301|NCT00264147|11429945|FG005|Treatment I Period|Protocol Violation|0
7221302|NCT00264147|11429940|FG000|Treatment I Period|Withdrawal by Subject|2
7221303|NCT00264147|11429941|FG001|Treatment I Period|Withdrawal by Subject|0
7221304|NCT00264147|11429942|FG002|Treatment I Period|Withdrawal by Subject|0
7221305|NCT00264147|11429943|FG003|Treatment I Period|Withdrawal by Subject|2
7221306|NCT00264147|11429944|FG004|Treatment I Period|Withdrawal by Subject|2
7221307|NCT00264147|11429945|FG005|Treatment I Period|Withdrawal by Subject|0
7221308|NCT00264147|11429940|FG000|Treatment I Period|Patient out of town for an extended time|0
7221309|NCT00264147|11429941|FG001|Treatment I Period|Patient out of town for an extended time|1
7221310|NCT00264147|11429942|FG002|Treatment I Period|Patient out of town for an extended time|0
7221311|NCT00264147|11429943|FG003|Treatment I Period|Patient out of town for an extended time|0
7221312|NCT00264147|11429944|FG004|Treatment I Period|Patient out of town for an extended time|0
7221313|NCT00264147|11429945|FG005|Treatment I Period|Patient out of town for an extended time|0
7221314|NCT00264147|11429940|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
7221396|NCT00159783|11429982|FG002|Overall Study|Other|4
7221315|NCT00264147|11429941|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
7221316|NCT00264147|11429942|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
7221317|NCT00264147|11429943|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
7221318|NCT00264147|11429944|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
7221319|NCT00264147|11429945|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
7221320|NCT00264147|11429940|FG000|Treatment I Period|Reassigned to Treatment II Period|84
7221321|NCT00264147|11429941|FG001|Treatment I Period|Reassigned to Treatment II Period|72
7221322|NCT00264147|11429942|FG002|Treatment I Period|Reassigned to Treatment II Period|65
7221323|NCT00264147|11429943|FG003|Treatment I Period|Reassigned to Treatment II Period|63
7221324|NCT00264147|11429944|FG004|Treatment I Period|Reassigned to Treatment II Period|45
7221325|NCT00264147|11429945|FG005|Treatment I Period|Reassigned to Treatment II Period|0
7221326|NCT00264147|11429940|FG000|Treatment II Period|Adverse Event|0
7221327|NCT00264147|11429941|FG001|Treatment II Period|Adverse Event|0
7221328|NCT00264147|11429942|FG002|Treatment II Period|Adverse Event|0
7221329|NCT00264147|11429943|FG003|Treatment II Period|Adverse Event|0
7221330|NCT00264147|11429944|FG004|Treatment II Period|Adverse Event|9
7221331|NCT00264147|11429945|FG005|Treatment II Period|Adverse Event|9
7221332|NCT00264147|11429940|FG000|Treatment II Period|Laboratory Adverse Event|0
7221333|NCT00264147|11429941|FG001|Treatment II Period|Laboratory Adverse Event|0
7221334|NCT00264147|11429942|FG002|Treatment II Period|Laboratory Adverse Event|0
7221335|NCT00264147|11429943|FG003|Treatment II Period|Laboratory Adverse Event|0
7221336|NCT00264147|11429944|FG004|Treatment II Period|Laboratory Adverse Event|0
7221337|NCT00264147|11429945|FG005|Treatment II Period|Laboratory Adverse Event|1
7221338|NCT00264147|11429940|FG000|Treatment II Period|Lack of Efficacy|0
7221339|NCT00264147|11429941|FG001|Treatment II Period|Lack of Efficacy|0
7221340|NCT00264147|11429942|FG002|Treatment II Period|Lack of Efficacy|0
7221341|NCT00264147|11429943|FG003|Treatment II Period|Lack of Efficacy|0
7221342|NCT00264147|11429944|FG004|Treatment II Period|Lack of Efficacy|20
7221343|NCT00264147|11429945|FG005|Treatment II Period|Lack of Efficacy|19
7221344|NCT00264147|11429940|FG000|Treatment II Period|Lost to Follow-up|0
7221345|NCT00264147|11429941|FG001|Treatment II Period|Lost to Follow-up|0
7221346|NCT00264147|11429942|FG002|Treatment II Period|Lost to Follow-up|0
7221347|NCT00264147|11429943|FG003|Treatment II Period|Lost to Follow-up|0
7221348|NCT00264147|11429944|FG004|Treatment II Period|Lost to Follow-up|1
7221349|NCT00264147|11429945|FG005|Treatment II Period|Lost to Follow-up|1
7221350|NCT00264147|11429940|FG000|Treatment II Period|Withdrawal by Subject|0
7221351|NCT00264147|11429941|FG001|Treatment II Period|Withdrawal by Subject|0
7221352|NCT00264147|11429942|FG002|Treatment II Period|Withdrawal by Subject|0
7221353|NCT00264147|11429943|FG003|Treatment II Period|Withdrawal by Subject|0
7221354|NCT00264147|11429944|FG004|Treatment II Period|Withdrawal by Subject|3
7221355|NCT00264147|11429945|FG005|Treatment II Period|Withdrawal by Subject|2
7221356|NCT00264147|11429940|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
7221357|NCT00264147|11429941|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
7221358|NCT00264147|11429942|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
7221359|NCT00264147|11429943|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
7221360|NCT00264147|11429944|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
7221361|NCT00264147|11429945|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
7221362|NCT00202878|11429961|FG000|Overall Study|Death|964
7221363|NCT00202878|11429962|FG001|Overall Study|Death|968
7221364|NCT00202878|11429961|FG000|Overall Study|Only Vital Status Known|357
7221365|NCT00202878|11429962|FG001|Overall Study|Only Vital Status Known|356
7221366|NCT00202878|11429961|FG000|Overall Study|Lost to Follow-up|44
7221367|NCT00202878|11429962|FG001|Overall Study|Lost to Follow-up|49
7221368|NCT00202878|11429961|FG000|Overall Study|Site Closure|39
7221369|NCT00202878|11429962|FG001|Overall Study|Site Closure|36
7221370|NCT00202878|11429961|FG000|Overall Study|Withdrawal by Subject|795
7221371|NCT00202878|11429962|FG001|Overall Study|Withdrawal by Subject|808
7221372|NCT00174265|11429970|FG000|Overall Study|Adverse Event|7
7221373|NCT00174265|11429971|FG001|Overall Study|Adverse Event|4
7221374|NCT00174265|11429970|FG000|Overall Study|Lack of Efficacy|2
7221375|NCT00174265|11429971|FG001|Overall Study|Lack of Efficacy|2
7221376|NCT00174265|11429970|FG000|Overall Study|Withdrawal by Subject|3
7221377|NCT00174265|11429971|FG001|Overall Study|Withdrawal by Subject|5
7221378|NCT00174265|11429970|FG000|Overall Study|Lost to Follow-up|1
7221379|NCT00174265|11429971|FG001|Overall Study|Lost to Follow-up|0
7221380|NCT00174265|11429970|FG000|Overall Study|Other (Not specified)|16
7221381|NCT00174265|11429971|FG001|Overall Study|Other (Not specified)|10
7221382|NCT00159783|11429980|FG000|Overall Study|Adverse Event|5
7221383|NCT00159783|11429981|FG001|Overall Study|Adverse Event|7
7221384|NCT00159783|11429982|FG002|Overall Study|Adverse Event|9
7221385|NCT00159783|11429980|FG000|Overall Study|Lack of Efficacy|1
7221386|NCT00159783|11429981|FG001|Overall Study|Lack of Efficacy|2
7221387|NCT00159783|11429982|FG002|Overall Study|Lack of Efficacy|3
7221388|NCT00159783|11429980|FG000|Overall Study|Withdrawal by Subject|7
7221389|NCT00159783|11429981|FG001|Overall Study|Withdrawal by Subject|11
7221390|NCT00159783|11429982|FG002|Overall Study|Withdrawal by Subject|12
7221391|NCT00159783|11429980|FG000|Overall Study|Lost to Follow-up|6
7221392|NCT00159783|11429981|FG001|Overall Study|Lost to Follow-up|5
7221393|NCT00159783|11429982|FG002|Overall Study|Lost to Follow-up|11
7221394|NCT00159783|11429980|FG000|Overall Study|Other|0
7221395|NCT00159783|11429981|FG001|Overall Study|Other|2
7221397|NCT00092677|11429993|FG000|Overall Study|Lost to Follow-up|0
7221398|NCT00092677|11429994|FG001|Overall Study|Lost to Follow-up|2
7221399|NCT00092677|11429993|FG000|Overall Study|Adminstrative|5
7221400|NCT00092677|11429994|FG001|Overall Study|Adminstrative|9
7221401|NCT00090259|11430002|FG000|Overall Study|Lost to Follow-up|30
7221402|NCT00090259|11430003|FG001|Overall Study|Lost to Follow-up|26
7221403|NCT00090259|11430002|FG000|Overall Study|Withdrawal by Subject|21
7221404|NCT00090259|11430003|FG001|Overall Study|Withdrawal by Subject|15
7221405|NCT00090259|11430002|FG000|Overall Study|Investigator site closed|11
7221406|NCT00090259|11430003|FG001|Overall Study|Investigator site closed|7
7221407|NCT00003298|11430009|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
7221408|NCT00003298|11430009|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
7221409|NCT00003298|11430009|FG000|Surgery|Unresectable at surgery|3
7221410|NCT00003298|11430009|FG000|Surgery|Progression before surgery|2
7221411|NCT00003298|11430009|FG000|Surgery|Unevaluable and off study|2
7221412|NCT00003298|11430009|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
7221413|NCT00003298|11430009|FG000|Re-register to Step 2 After Surgery|Positive margins|5
7221414|NCT00003298|11430009|FG000|Re-register to Step 2 After Surgery|Other complications|2
7221415|NCT00003298|11430009|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
7221416|NCT00003298|11430009|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
7221417|NCT00003298|11430009|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
7221418|NCT00003298|11430009|FG000|Step 2 (Adjuvant Therapy)|Death|1
7221419|NCT00003298|11430009|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
7221420|NCT00003298|11430009|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
7221421|NCT00003298|11430009|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
7221422|NCT00003377|11430019|FG000|Period I|Dose Limiting Toxicity(DLT)|0
7221423|NCT00003377|11430020|FG001|Period I|Dose Limiting Toxicity(DLT)|0
7221424|NCT00003377|11430021|FG002|Period I|Dose Limiting Toxicity(DLT)|1
7221425|NCT00003377|11430022|FG003|Period I|Dose Limiting Toxicity(DLT)|1
7221426|NCT00003377|11430023|FG004|Period I|Dose Limiting Toxicity(DLT)|0
7221427|NCT00003377|11430019|FG000|Period II|Ureteral stent complications|0
7221428|NCT00003377|11430020|FG001|Period II|Ureteral stent complications|0
7221429|NCT00003377|11430021|FG002|Period II|Ureteral stent complications|0
7221430|NCT00003377|11430022|FG003|Period II|Ureteral stent complications|0
7221431|NCT00003377|11430023|FG004|Period II|Ureteral stent complications|1
7221432|NCT00003389|11430038|FG000|Overall Study|Disease progression|6
7221433|NCT00003389|11430039|FG001|Overall Study|Disease progression|1
7221434|NCT00003389|11430038|FG000|Overall Study|Adverse Event|13
7221435|NCT00003389|11430039|FG001|Overall Study|Adverse Event|2
7221436|NCT00003389|11430038|FG000|Overall Study|Death|0
7221437|NCT00003389|11430039|FG001|Overall Study|Death|3
7221438|NCT00003389|11430038|FG000|Overall Study|Withdrawal by Subject|12
7221439|NCT00003389|11430039|FG001|Overall Study|Withdrawal by Subject|5
7221440|NCT00003389|11430038|FG000|Overall Study|Alternative therapy|2
7221441|NCT00003389|11430039|FG001|Overall Study|Alternative therapy|1
7221442|NCT00003389|11430038|FG000|Overall Study|Complicating disease|1
7221443|NCT00003389|11430039|FG001|Overall Study|Complicating disease|0
7221444|NCT00003389|11430038|FG000|Overall Study|Off-treatment reason missing|31
7221445|NCT00003389|11430039|FG001|Overall Study|Off-treatment reason missing|21
7221446|NCT00003389|11430038|FG000|Overall Study|Ineligible|33
7221447|NCT00003389|11430039|FG001|Overall Study|Ineligible|27
7221448|NCT00003456|11430054|FG000|Overall Study|Not evaluable|8
7221449|NCT00003457|11430058|FG000|Overall Study|Not evaluable|9
7221450|NCT00003470|11430078|FG000|Overall Study|Not evaluable|6
7221451|NCT00003471|11430082|FG000|Overall Study|Not evaluable|4
7221452|NCT00003472|11430086|FG000|Overall Study|Not evaluable|3
7221453|NCT00003473|11430090|FG000|Overall Study|Three patients were not evaluable.|3
7221454|NCT00003474|11430094|FG000|Overall Study|Not Evaluable|14
7221455|NCT00003475|11430098|FG000|Overall Study|Not evaluable|13
7221456|NCT00003476|11430103|FG000|Overall Study|Not evaluable|1
7221457|NCT00003477|11430107|FG000|Overall Study|Not evalauable|4
7221458|NCT00003483|11430111|FG000|Overall Study|Not evaluable|1
7221459|NCT00003487|11430115|FG000|Overall Study|Not evaluable|2
7221460|NCT00003492|11430119|FG000|Overall Study|Not evaluable|6
7221461|NCT00003498|11430123|FG000|Overall Study|Not evaluable.|4
7221462|NCT00003499|11430127|FG000|Overall Study|Not evaluable|8
7221463|NCT00003508|11430131|FG000|Overall Study|Not evaluable|5
7221464|NCT00003509|11430135|FG000|Overall Study|Not evaluable|5
7221465|NCT00003511|11430139|FG000|Overall Study|Not evaluable|4
7221466|NCT00003526|11430143|FG000|Overall Study|Not evaluable|6
7221467|NCT00003531|11430147|FG000|Overall Study|Not evaluable|10
7221468|NCT00003535|11430151|FG000|Overall Study|Not evaluable|5
7221469|NCT00003537|11430155|FG000|Overall Study|Not evalauable|1
7221470|NCT00003590|11430159|FG000|Overall Study|Ineligible Patient|1
7221471|NCT00003590|11430159|FG000|Overall Study|Adverse Event|7
7221472|NCT00003590|11430159|FG000|Overall Study|Withdrawal by Subject|1
7221473|NCT00003590|11430159|FG000|Overall Study|Lack of Efficacy|11
7221474|NCT00003590|11430159|FG000|Overall Study|Death|1
7221475|NCT00003590|11430159|FG000|Overall Study|Physician Decision|1
7221476|NCT00003631|11430166|FG000|Overall Study|Patient not treated|1
7221477|NCT00003631|11430167|FG001|Overall Study|Patient not treated|0
7221478|NCT00003631|11430168|FG002|Overall Study|Patient not treated|1
7221479|NCT00003631|11430166|FG000|Overall Study|Protocol Violation|1
7221480|NCT00003631|11430167|FG001|Overall Study|Protocol Violation|0
7221481|NCT00003631|11430168|FG002|Overall Study|Protocol Violation|0
7297141|NCT00576732|11516164|FG001|OPEN LABEL|Withdrawal by Subject|0
7297142|NCT00576732|11516165|FG002|OPEN LABEL|Withdrawal by Subject|0
7297143|NCT00576732|11516166|FG003|OPEN LABEL|Withdrawal by Subject|1
7297144|NCT00576732|11516167|FG004|OPEN LABEL|Withdrawal by Subject|0
7297145|NCT00576732|11516168|FG005|OPEN LABEL|Withdrawal by Subject|1
7221482|NCT00003631|11430166|FG000|Overall Study|Adverse Event|1
7221483|NCT00003631|11430167|FG001|Overall Study|Adverse Event|1
7221484|NCT00003631|11430168|FG002|Overall Study|Adverse Event|5
7221485|NCT00003631|11430166|FG000|Overall Study|Death|0
7221486|NCT00003631|11430167|FG001|Overall Study|Death|0
7221487|NCT00003631|11430168|FG002|Overall Study|Death|1
7221488|NCT00003631|11430166|FG000|Overall Study|Evaluable for toxicity only|0
7221489|NCT00003631|11430167|FG001|Overall Study|Evaluable for toxicity only|0
7221490|NCT00003631|11430168|FG002|Overall Study|Evaluable for toxicity only|2
7221491|NCT00003645|11430189|FG000|Overall Study|Death|4
7221492|NCT00003645|11430190|FG001|Overall Study|Death|1
7221493|NCT00003645|11430189|FG000|Overall Study|Lost to Follow-up|7
7221494|NCT00003645|11430190|FG001|Overall Study|Lost to Follow-up|8
7221495|NCT00003645|11430189|FG000|Overall Study|Withdrawal by Subject|1
7221496|NCT00003645|11430190|FG001|Overall Study|Withdrawal by Subject|3
7221497|NCT00003659|11430198|FG000|Overall Study|Withdrawal by Subject|3
7221498|NCT00003702|11430204|FG000|Overall Study|Ineligible cell types|2
7221499|NCT00003702|11430205|FG001|Overall Study|Ineligible cell types|2
7221500|NCT00003702|11430204|FG000|Overall Study|Did not meet criteria for persistence|8
7221501|NCT00003702|11430205|FG001|Overall Study|Did not meet criteria for persistence|5
7221502|NCT00003702|11430204|FG000|Overall Study|WHO score > 6|2
7221503|NCT00003702|11430205|FG001|Overall Study|WHO score > 6|1
7221504|NCT00003702|11430204|FG000|Overall Study|Inadequate documentation of disease|1
7221505|NCT00003702|11430205|FG001|Overall Study|Inadequate documentation of disease|3
7221506|NCT00003782|11430215|FG000|Overall Study|No follow up data|30
7221507|NCT00003782|11430216|FG001|Overall Study|No follow up data|31
7221508|NCT00003782|11430217|FG002|Overall Study|No follow up data|26
7221509|NCT00003830|11430255|FG000|Overall Study|No follow up data|3
7221510|NCT00003830|11430256|FG001|Overall Study|No follow up data|0
7221511|NCT00003830|11430255|FG000|Overall Study|Sentinel node positive patients|829
7221512|NCT00003830|11430256|FG001|Overall Study|Sentinel node positive patients|793
7221513|NCT00003869|11430266|FG000|Overall Study|Adverse Event|14
7221514|NCT00003869|11430267|FG001|Overall Study|Adverse Event|3
7221515|NCT00003869|11430266|FG000|Overall Study|Withdrawal by Subject|21
7221516|NCT00003869|11430267|FG001|Overall Study|Withdrawal by Subject|3
7221517|NCT00003869|11430266|FG000|Overall Study|Death|1
7221518|NCT00003869|11430267|FG001|Overall Study|Death|2
7221519|NCT00003869|11430266|FG000|Overall Study|Alternative treatmnt, medical problems|5
7221520|NCT00003869|11430267|FG001|Overall Study|Alternative treatmnt, medical problems|4
7221521|NCT00003875|11430273|FG000|Overall Study|Screen Failed|1
7221522|NCT00003895|11430279|FG000|Overall Study|Adverse Event|4
7221523|NCT00003895|11430280|FG001|Overall Study|Adverse Event|0
7221524|NCT00003895|11430279|FG000|Overall Study|Lack of Efficacy|1
7221525|NCT00003895|11430280|FG001|Overall Study|Lack of Efficacy|1
7221526|NCT00003895|11430279|FG000|Overall Study|Patient Vacation|2
7221527|NCT00003895|11430280|FG001|Overall Study|Patient Vacation|0
7221528|NCT00003895|11430279|FG000|Overall Study|Withdrawal by Subject|0
7221529|NCT00003895|11430280|FG001|Overall Study|Withdrawal by Subject|3
7221530|NCT00003896|11430286|FG000|Overall Study|Adverse Event|16
7221531|NCT00003896|11430286|FG000|Overall Study|Withdrawal by Subject|1
7221532|NCT00003896|11430286|FG000|Overall Study|Lack of Efficacy|1
7221533|NCT00003896|11430286|FG000|Overall Study|Death|3
7221534|NCT00003896|11430286|FG000|Overall Study|not protocol specified|3
7221535|NCT00003896|11430286|FG000|Overall Study|ineligible|5
7221536|NCT00003901|11430291|FG000|Overall Study|Adverse Event|1
7221537|NCT00003901|11430291|FG000|Overall Study|Withdrawal by Subject|1
7221538|NCT00003901|11430291|FG000|Overall Study|Ineligible|6
7221539|NCT00003901|11430291|FG000|Overall Study|CT Scan not within protocol requirement|2
7221540|NCT00003901|11430291|FG000|Overall Study|Chest X-Ray not done prior registration|1
7221541|NCT00003901|11430291|FG000|Overall Study|Medical problems|6
7221542|NCT00003907|11430300|FG000|Overall Study|Adverse Event|2
7221543|NCT00003907|11430301|FG001|Overall Study|Adverse Event|11
7221544|NCT00003907|11430300|FG000|Overall Study|Death|2
7221545|NCT00003907|11430301|FG001|Overall Study|Death|0
7221546|NCT00003907|11430300|FG000|Overall Study|Withdrawal by Subject|1
7221547|NCT00003907|11430301|FG001|Overall Study|Withdrawal by Subject|3
7221548|NCT00003907|11430300|FG000|Overall Study|Progressive disease|4
7221549|NCT00003907|11430301|FG001|Overall Study|Progressive disease|4
7221550|NCT00003907|11430300|FG000|Overall Study|Complicating disease|1
7221551|NCT00003907|11430301|FG001|Overall Study|Complicating disease|0
7221552|NCT00003907|11430300|FG000|Overall Study|Other|1
7221553|NCT00003907|11430301|FG001|Overall Study|Other|3
7221554|NCT00003907|11430300|FG000|Overall Study|ineligible or not treated|2
7221555|NCT00003907|11430301|FG001|Overall Study|ineligible or not treated|2
7221556|NCT00004031|11430316|FG000|Overall Study|Adverse Event|5
7221557|NCT00004031|11430317|FG001|Overall Study|Adverse Event|0
7221558|NCT00004031|11430316|FG000|Overall Study|Refusal unrelated to adverse events|2
7221559|NCT00004031|11430317|FG001|Overall Study|Refusal unrelated to adverse events|11
7221560|NCT00004031|11430316|FG000|Overall Study|Progression/relapse|9
7221561|NCT00004031|11430317|FG001|Overall Study|Progression/relapse|4
7221562|NCT00004031|11430316|FG000|Overall Study|Death|3
7221563|NCT00004031|11430317|FG001|Overall Study|Death|1
7221564|NCT00004031|11430316|FG000|Overall Study|Other- not protocol specified|3
7221565|NCT00004031|11430317|FG001|Overall Study|Other- not protocol specified|3
7221566|NCT00004031|11430316|FG000|Overall Study|Reason under review|3
7221567|NCT00004031|11430317|FG001|Overall Study|Reason under review|2
7221568|NCT00004088|11430334|FG000|Overall Study|No C2 given due to study on hold by IRB|4
7221569|NCT00004088|11430334|FG000|Overall Study|Withdrawal by Subject|1
7221570|NCT00004088|11430334|FG000|Overall Study|Protocol Violation|3
7221571|NCT00004088|11430334|FG000|Overall Study|Physician Decision|1
7221572|NCT00004124|11430349|FG000|Overall Study|Received no protocol therapy|12
7221573|NCT00004124|11430350|FG001|Overall Study|Received no protocol therapy|20
7221574|NCT00004228|11430373|FG000|Overall Study|Adverse Event|0
7221575|NCT00004228|11430374|FG001|Overall Study|Adverse Event|1
7221576|NCT00004228|11430375|FG002|Overall Study|Adverse Event|0
7221577|NCT00004228|11430376|FG003|Overall Study|Adverse Event|0
7221578|NCT00004228|11430377|FG004|Overall Study|Adverse Event|1
7221579|NCT00004228|11430378|FG005|Overall Study|Adverse Event|0
7221580|NCT00004228|11430379|FG006|Overall Study|Adverse Event|0
7221581|NCT00004228|11430373|FG000|Overall Study|Death|0
7221582|NCT00004228|11430374|FG001|Overall Study|Death|1
7221583|NCT00004228|11430375|FG002|Overall Study|Death|2
7221584|NCT00004228|11430376|FG003|Overall Study|Death|0
7221585|NCT00004228|11430377|FG004|Overall Study|Death|1
7221586|NCT00004228|11430378|FG005|Overall Study|Death|0
7221587|NCT00004228|11430379|FG006|Overall Study|Death|0
7221588|NCT00004228|11430373|FG000|Overall Study|Lack of Efficacy|1
7221589|NCT00004228|11430374|FG001|Overall Study|Lack of Efficacy|6
7221590|NCT00004228|11430375|FG002|Overall Study|Lack of Efficacy|5
7221591|NCT00004228|11430376|FG003|Overall Study|Lack of Efficacy|3
7221592|NCT00004228|11430377|FG004|Overall Study|Lack of Efficacy|9
7221593|NCT00004228|11430378|FG005|Overall Study|Lack of Efficacy|8
7221594|NCT00004228|11430379|FG006|Overall Study|Lack of Efficacy|4
7221595|NCT00004228|11430373|FG000|Overall Study|Lost to Follow-up|0
7221596|NCT00004228|11430374|FG001|Overall Study|Lost to Follow-up|0
7221597|NCT00004228|11430375|FG002|Overall Study|Lost to Follow-up|1
7221598|NCT00004228|11430376|FG003|Overall Study|Lost to Follow-up|0
7221599|NCT00004228|11430377|FG004|Overall Study|Lost to Follow-up|0
7221600|NCT00004228|11430378|FG005|Overall Study|Lost to Follow-up|0
7221601|NCT00004228|11430379|FG006|Overall Study|Lost to Follow-up|0
7221602|NCT00004228|11430373|FG000|Overall Study|Physician Decision|1
7221603|NCT00004228|11430374|FG001|Overall Study|Physician Decision|0
7221604|NCT00004228|11430375|FG002|Overall Study|Physician Decision|3
7221605|NCT00004228|11430376|FG003|Overall Study|Physician Decision|2
7221606|NCT00004228|11430377|FG004|Overall Study|Physician Decision|1
7221607|NCT00004228|11430378|FG005|Overall Study|Physician Decision|1
7221608|NCT00004228|11430379|FG006|Overall Study|Physician Decision|1
7221609|NCT00004228|11430373|FG000|Overall Study|Protocol Violation|0
7221610|NCT00004228|11430374|FG001|Overall Study|Protocol Violation|5
7221611|NCT00004228|11430375|FG002|Overall Study|Protocol Violation|2
7221612|NCT00004228|11430376|FG003|Overall Study|Protocol Violation|1
7221613|NCT00004228|11430377|FG004|Overall Study|Protocol Violation|1
7221614|NCT00004228|11430378|FG005|Overall Study|Protocol Violation|2
7221615|NCT00004228|11430379|FG006|Overall Study|Protocol Violation|0
7221616|NCT00004228|11430373|FG000|Overall Study|Withdrawal by Subject|3
7221617|NCT00004228|11430374|FG001|Overall Study|Withdrawal by Subject|0
7221618|NCT00004228|11430375|FG002|Overall Study|Withdrawal by Subject|1
7221619|NCT00004228|11430376|FG003|Overall Study|Withdrawal by Subject|0
7221620|NCT00004228|11430377|FG004|Overall Study|Withdrawal by Subject|2
7221621|NCT00004228|11430378|FG005|Overall Study|Withdrawal by Subject|1
7221622|NCT00004228|11430379|FG006|Overall Study|Withdrawal by Subject|2
7221623|NCT00004228|11430373|FG000|Overall Study|Other|0
7221624|NCT00004228|11430374|FG001|Overall Study|Other|0
7221625|NCT00004228|11430375|FG002|Overall Study|Other|1
7221626|NCT00004228|11430376|FG003|Overall Study|Other|0
7221627|NCT00004228|11430377|FG004|Overall Study|Other|0
7221628|NCT00004228|11430378|FG005|Overall Study|Other|0
7221629|NCT00004228|11430379|FG006|Overall Study|Other|0
7221630|NCT00004228|11430373|FG000|Overall Study|ineligible|4
7221631|NCT00004228|11430374|FG001|Overall Study|ineligible|2
7221632|NCT00004228|11430375|FG002|Overall Study|ineligible|4
7221633|NCT00004228|11430376|FG003|Overall Study|ineligible|1
7221634|NCT00004228|11430377|FG004|Overall Study|ineligible|1
7221635|NCT00004228|11430378|FG005|Overall Study|ineligible|2
7221636|NCT00004228|11430379|FG006|Overall Study|ineligible|5
7221637|NCT00004259|11430400|FG000|Overall Study|Protocol Violation|1
7221638|NCT00004259|11430401|FG001|Overall Study|Protocol Violation|2
7221639|NCT00004259|11430402|FG002|Overall Study|Protocol Violation|0
7221640|NCT00004259|11430403|FG003|Overall Study|Protocol Violation|0
7221641|NCT00004259|11430400|FG000|Overall Study|Withdrawal by Subject|0
7221642|NCT00004259|11430401|FG001|Overall Study|Withdrawal by Subject|2
7221643|NCT00004259|11430402|FG002|Overall Study|Withdrawal by Subject|0
7221644|NCT00004259|11430403|FG003|Overall Study|Withdrawal by Subject|0
7221645|NCT00004412|11430419|FG000|Randomized Period|Moved to Crossover Period|3
7221646|NCT00004412|11430420|FG001|Randomized Period|Moved to Crossover Period|0
7221647|NCT00004412|11430421|FG002|Randomized Period|Moved to Crossover Period|0
7221648|NCT00004445|11430431|FG000|Overall Study|Physician Decision|2
7221649|NCT00004445|11430431|FG000|Overall Study|Withdrawal by Subject|1
7221650|NCT00004562|11430460|FG000|Overall Study|Lost to Follow-up|102
7221651|NCT00004562|11430461|FG001|Overall Study|Lost to Follow-up|91
7221652|NCT00004563|11430469|FG000|Overall Study|Withdrawal by Subject|20
7221653|NCT00004563|11430470|FG001|Overall Study|Withdrawal by Subject|16
7221654|NCT00004563|11430469|FG000|Overall Study|Lack of Efficacy|3
7221655|NCT00004563|11430470|FG001|Overall Study|Lack of Efficacy|5
7221656|NCT00004563|11430469|FG000|Overall Study|Death|2
7221657|NCT00004563|11430470|FG001|Overall Study|Death|3
7221658|NCT00004635|11430478|FG000|Period One|refused|2
7221659|NCT00004635|11430479|FG001|Period One|refused|1
7221660|NCT00004635|11430478|FG000|Period One|Withdrawal by Subject|1
7221661|NCT00004635|11430479|FG001|Period One|Withdrawal by Subject|1
7221662|NCT00004635|11430478|FG000|Period One|Protocol Violation|1
7221663|NCT00004635|11430479|FG001|Period One|Protocol Violation|0
7221664|NCT00004635|11430478|FG000|Period One|PSA did not go <5 ng/mL|1
7221665|NCT00004635|11430479|FG001|Period One|PSA did not go <5 ng/mL|0
7221666|NCT00004635|11430478|FG000|Period One|second malignancy|1
7221667|NCT00004635|11430479|FG001|Period One|second malignancy|0
7221668|NCT00004635|11430478|FG000|Period One|progressed|0
7221669|NCT00004635|11430479|FG001|Period One|progressed|2
7221670|NCT00004635|11430478|FG000|Period One|health problem|0
7221671|NCT00004635|11430479|FG001|Period One|health problem|1
7221672|NCT00004635|11430478|FG000|Period One|discrepancy in data entry|0
7221673|NCT00004635|11430479|FG001|Period One|discrepancy in data entry|1
7221674|NCT00004635|11430478|FG000|Period Two|progression|2
7221675|NCT00004635|11430479|FG001|Period Two|progression|3
7221676|NCT00004635|11430478|FG000|Period Two|Adverse Event|1
7221677|NCT00004635|11430479|FG001|Period Two|Adverse Event|0
7221678|NCT00004635|11430478|FG000|Period Two|refused|0
7221679|NCT00004635|11430479|FG001|Period Two|refused|2
7221680|NCT00004635|11430478|FG000|Period Two|health problem|1
7221681|NCT00004635|11430479|FG001|Period Two|health problem|1
7221682|NCT00004635|11430478|FG000|Period Two|travel issues|0
7221683|NCT00004635|11430479|FG001|Period Two|travel issues|1
7221684|NCT00004635|11430478|FG000|Period Two|secondary malignancy|1
7221685|NCT00004635|11430479|FG001|Period Two|secondary malignancy|1
7221686|NCT00004635|11430478|FG000|Period Two|Lost to Follow-up|1
7221687|NCT00004635|11430479|FG001|Period Two|Lost to Follow-up|0
7221688|NCT00004635|11430478|FG000|Period Two|discrepancy in data entry|0
7221689|NCT00004635|11430479|FG001|Period Two|discrepancy in data entry|1
7221690|NCT00004732|11430490|FG000|Overall Study|Withdrawal by Subject|36
7221691|NCT00004732|11430491|FG001|Overall Study|Withdrawal by Subject|64
7221692|NCT00004732|11430490|FG000|Overall Study|Lost to Follow-up|33
7221693|NCT00004732|11430491|FG001|Overall Study|Lost to Follow-up|47
7221694|NCT00004859|11430501|FG000|Overall Study|Lack of Efficacy|43
7221695|NCT00004859|11430502|FG001|Overall Study|Lack of Efficacy|113
7221696|NCT00004859|11430501|FG000|Overall Study|Adverse Event|31
7221697|NCT00004859|11430502|FG001|Overall Study|Adverse Event|93
7221698|NCT00004859|11430501|FG000|Overall Study|Death|5
7221699|NCT00004859|11430502|FG001|Overall Study|Death|5
7221700|NCT00004859|11430501|FG000|Overall Study|Withdrawal by Subject|7
7221701|NCT00004859|11430502|FG001|Overall Study|Withdrawal by Subject|33
7221702|NCT00004859|11430501|FG000|Overall Study|Protocol Violation|2
7221703|NCT00004859|11430502|FG001|Overall Study|Protocol Violation|2
7221704|NCT00004859|11430501|FG000|Overall Study|other disease|0
7221705|NCT00004859|11430502|FG001|Overall Study|other disease|3
7221706|NCT00004859|11430501|FG000|Overall Study|error|3
7221707|NCT00004859|11430502|FG001|Overall Study|error|1
7221708|NCT00004859|11430501|FG000|Overall Study|missing data|14
7221709|NCT00004859|11430502|FG001|Overall Study|missing data|11
7221710|NCT00004859|11430501|FG000|Overall Study|Other|13
7221711|NCT00004859|11430502|FG001|Overall Study|Other|21
7221712|NCT00004888|11430512|FG000|Overall Study|Adverse Event|5
7221713|NCT00004888|11430513|FG001|Overall Study|Adverse Event|10
7221714|NCT00004888|11430512|FG000|Overall Study|Withdrawal by Subject|0
7221715|NCT00004888|11430513|FG001|Overall Study|Withdrawal by Subject|3
7221716|NCT00004888|11430512|FG000|Overall Study|Physician Decision|1
7221717|NCT00004888|11430513|FG001|Overall Study|Physician Decision|1
7221718|NCT00004888|11430512|FG000|Overall Study|Progressive Disease|4
7221719|NCT00004888|11430513|FG001|Overall Study|Progressive Disease|9
7221720|NCT00004888|11430512|FG000|Overall Study|Death without progressive disease|0
7221721|NCT00004888|11430513|FG001|Overall Study|Death without progressive disease|1
7221722|NCT00004888|11430512|FG000|Overall Study|Toxic death|1
7221723|NCT00004888|11430513|FG001|Overall Study|Toxic death|0
7221724|NCT00004978|11430521|FG000|Overall Study|Death|107
7221725|NCT00004978|11430522|FG001|Overall Study|Death|116
7221726|NCT00004978|11430521|FG000|Overall Study|Lost to Follow-up|101
7221727|NCT00004978|11430522|FG001|Overall Study|Lost to Follow-up|108
7221728|NCT00004978|11430521|FG000|Overall Study|Withdrawal by Subject|17
7221729|NCT00004978|11430522|FG001|Overall Study|Withdrawal by Subject|26
7221730|NCT00004978|11430521|FG000|Overall Study|site closure - not in analysis cohort|19
7221731|NCT00004978|11430522|FG001|Overall Study|site closure - not in analysis cohort|20
7221732|NCT00004980|11430530|FG000|Overall Study|Withdrawal by Subject|1
7221733|NCT00004980|11430531|FG001|Overall Study|Withdrawal by Subject|0
7221734|NCT00004980|11430530|FG000|Overall Study|memory difficulties|1
7221735|NCT00004980|11430531|FG001|Overall Study|memory difficulties|1
7221736|NCT00004980|11430530|FG000|Overall Study|Physician Decision|0
7221737|NCT00004980|11430531|FG001|Overall Study|Physician Decision|1
7221738|NCT00005047|11430541|FG000|Overall Study|Withdrawal by Subject|12
7221739|NCT00005047|11430542|FG001|Overall Study|Withdrawal by Subject|0
7221740|NCT00005047|11430543|FG002|Overall Study|Withdrawal by Subject|0
7221741|NCT00005047|11430544|FG003|Overall Study|Withdrawal by Subject|0
7221742|NCT00005047|11430541|FG000|Overall Study|Adverse Event|5
7221743|NCT00005047|11430542|FG001|Overall Study|Adverse Event|0
7221744|NCT00005047|11430543|FG002|Overall Study|Adverse Event|0
7221745|NCT00005047|11430544|FG003|Overall Study|Adverse Event|0
7221746|NCT00005047|11430541|FG000|Overall Study|Lost to Follow-up|1
7221747|NCT00005047|11430542|FG001|Overall Study|Lost to Follow-up|0
7221748|NCT00005047|11430543|FG002|Overall Study|Lost to Follow-up|0
7221749|NCT00005047|11430544|FG003|Overall Study|Lost to Follow-up|0
7221750|NCT00005047|11430541|FG000|Overall Study|Lack of Efficacy|1
7221751|NCT00005047|11430542|FG001|Overall Study|Lack of Efficacy|0
7221752|NCT00005047|11430543|FG002|Overall Study|Lack of Efficacy|0
7221753|NCT00005047|11430544|FG003|Overall Study|Lack of Efficacy|0
7221754|NCT00005879|11430572|FG000|Overall Study|Withdrawal by Subject|8
7221755|NCT00005879|11430573|FG001|Overall Study|Withdrawal by Subject|10
7221756|NCT00005906|11430588|FG000|Overall Study|Lack of Efficacy|3
7221757|NCT00005908|11430592|FG000|Overall Study|Withdrawal by Subject|1
7221758|NCT00005908|11430593|FG001|Overall Study|Withdrawal by Subject|0
7297146|NCT00576732|11516163|FG000|OPEN LABEL|OTHER|0
7297147|NCT00576732|11516164|FG001|OPEN LABEL|OTHER|0
7297148|NCT00576732|11516165|FG002|OPEN LABEL|OTHER|0
7297149|NCT00576732|11516166|FG003|OPEN LABEL|OTHER|0
7297150|NCT00576732|11516167|FG004|OPEN LABEL|OTHER|0
7297151|NCT00576732|11516168|FG005|OPEN LABEL|OTHER|2
7297152|NCT00576732|11516163|FG000|OPEN LABEL|Lack of Efficacy|0
7297153|NCT00576732|11516164|FG001|OPEN LABEL|Lack of Efficacy|0
7297154|NCT00576732|11516165|FG002|OPEN LABEL|Lack of Efficacy|0
7297155|NCT00576732|11516166|FG003|OPEN LABEL|Lack of Efficacy|2
7297156|NCT00576732|11516167|FG004|OPEN LABEL|Lack of Efficacy|2
7297157|NCT00576732|11516168|FG005|OPEN LABEL|Lack of Efficacy|3
7297158|NCT00576732|11516163|FG000|OPEN LABEL|Protocol Violation|0
7297159|NCT00576732|11516164|FG001|OPEN LABEL|Protocol Violation|0
7297160|NCT00576732|11516165|FG002|OPEN LABEL|Protocol Violation|0
7297161|NCT00576732|11516166|FG003|OPEN LABEL|Protocol Violation|2
7297162|NCT00576732|11516167|FG004|OPEN LABEL|Protocol Violation|1
7297163|NCT00576732|11516168|FG005|OPEN LABEL|Protocol Violation|0
7297164|NCT00576758|11516182|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
7297165|NCT00576758|11516183|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
7297166|NCT00576758|11516182|FG000|Induction Treatment Period|Insufficient therapeutic response|2
7297167|NCT00576758|11516183|FG001|Induction Treatment Period|Insufficient therapeutic response|0
7297168|NCT00576758|11516182|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
7297169|NCT00576758|11516183|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
7297170|NCT00576758|11516182|FG000|Induction Treatment Period|Death|1
7297171|NCT00576758|11516183|FG001|Induction Treatment Period|Death|0
7297172|NCT00576758|11516182|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
7297173|NCT00576758|11516183|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
7297174|NCT00576758|11516182|FG000|Induction Treatment Period|Withdrew consent|1
7297175|NCT00576758|11516183|FG001|Induction Treatment Period|Withdrew consent|0
7297176|NCT00576758|11516182|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
7297177|NCT00576758|11516183|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
7297178|NCT00576758|11516182|FG000|Extension Treatment Period|Death|1
7297179|NCT00576758|11516183|FG001|Extension Treatment Period|Death|1
7297180|NCT00576758|11516182|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
7297181|NCT00576758|11516183|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
7297182|NCT00576758|11516182|FG000|Extension Treatment Period|Insufficient therapeutic response|30
7297183|NCT00576758|11516183|FG001|Extension Treatment Period|Insufficient therapeutic response|33
7297184|NCT00576758|11516182|FG000|Extension Treatment Period|Administrative/Other|3
7297185|NCT00576758|11516183|FG001|Extension Treatment Period|Administrative/Other|1
7297186|NCT00576758|11516182|FG000|Follow-up Period|Administrative/Other|6
7297187|NCT00576758|11516183|FG001|Follow-up Period|Administrative/Other|8
7297188|NCT00576758|11516182|FG000|Follow-up Period|Death|3
7297189|NCT00576758|11516183|FG001|Follow-up Period|Death|3
7297190|NCT00576758|11516182|FG000|Follow-up Period|Insufficient therapeutic response|16
7297191|NCT00576758|11516183|FG001|Follow-up Period|Insufficient therapeutic response|5
7297192|NCT00576758|11516182|FG000|Follow-up Period|Withdrew consent|2
7297193|NCT00576758|11516183|FG001|Follow-up Period|Withdrew consent|1
7297194|NCT00576823|11516193|FG000|12-week Efficacy Phase|Parent's schedule issue|1
7297195|NCT00576823|11516194|FG001|12-week Efficacy Phase|Parent's schedule issue|0
7297196|NCT00576823|11516195|FG002|12-week Efficacy Phase|Parent's schedule issue|0
7297197|NCT00576823|11516193|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
7297198|NCT00576823|11516194|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
7297199|NCT00576823|11516195|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
7297200|NCT00576901|11516206|FG000|Overall Study|Withdrawal by Subject|1
7297201|NCT00576901|11516206|FG000|Overall Study|Disease course|1
7297202|NCT00576901|11516206|FG000|Overall Study|Protocol Violation|1
7297203|NCT00576927|11516212|FG000|Clinical Assessment|Lack of Efficacy|24
7297204|NCT00576927|11516212|FG000|Clinical Assessment|Death|1
7297205|NCT00576927|11516212|FG000|Clinical Assessment|Withdrawal by Subject|10
7297206|NCT00576927|11516212|FG000|Clinical Assessment|Physician Decision|1
7297207|NCT00576927|11516212|FG000|Baseline|Physician Decision|9
7297208|NCT00576927|11516212|FG000|Baseline|Medication Change by PCP of subject|1
7297209|NCT00576927|11516212|FG000|Baseline|Withdrawal by Subject|3
7297210|NCT00576927|11516212|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
7221759|NCT00005937|11430602|FG000|Overall Study|Lack of Efficacy|5
7221760|NCT00005947|11430608|FG000|Overall Study|Death|54
7221761|NCT00005947|11430609|FG001|Overall Study|Death|40
7221762|NCT00005947|11430608|FG000|Overall Study|Patient Refused to Continue|2
7221763|NCT00005947|11430609|FG001|Overall Study|Patient Refused to Continue|1
7221764|NCT00005947|11430608|FG000|Overall Study|Site Closure|1
7221765|NCT00005947|11430609|FG001|Overall Study|Site Closure|0
7221766|NCT00005957|11430619|FG000|Overall Study|No treated|3
7221767|NCT00005957|11430620|FG001|Overall Study|No treated|9
7221768|NCT00005957|11430619|FG000|Overall Study|Crossover to the other arm|5
7221769|NCT00005957|11430620|FG001|Overall Study|Crossover to the other arm|19
7221770|NCT00006011|11430629|FG000|Overall Study|Disease progression|13
7221771|NCT00006011|11430630|FG001|Overall Study|Disease progression|6
7221772|NCT00006011|11430631|FG002|Overall Study|Disease progression|26
7221773|NCT00006011|11430629|FG000|Overall Study|Refused further treatment|15
7221774|NCT00006011|11430630|FG001|Overall Study|Refused further treatment|13
7221775|NCT00006011|11430631|FG002|Overall Study|Refused further treatment|26
7221776|NCT00006011|11430629|FG000|Overall Study|Adverse Event|15
7221777|NCT00006011|11430630|FG001|Overall Study|Adverse Event|39
7221778|NCT00006011|11430631|FG002|Overall Study|Adverse Event|5
7221779|NCT00006011|11430629|FG000|Overall Study|Death|0
7221780|NCT00006011|11430630|FG001|Overall Study|Death|1
7221781|NCT00006011|11430631|FG002|Overall Study|Death|2
7221782|NCT00006011|11430629|FG000|Overall Study|Other|4
7221783|NCT00006011|11430630|FG001|Overall Study|Other|2
7221784|NCT00006011|11430631|FG002|Overall Study|Other|5
7221785|NCT00006011|11430629|FG000|Overall Study|Ineligible|18
7221786|NCT00006011|11430630|FG001|Overall Study|Ineligible|16
7221787|NCT00006011|11430631|FG002|Overall Study|Ineligible|9
7221788|NCT00006046|11430642|FG000|Overall Study|Adverse Event|3
7221789|NCT00006046|11430643|FG001|Overall Study|Adverse Event|0
7221790|NCT00006046|11430644|FG002|Overall Study|Adverse Event|0
7221791|NCT00006046|11430645|FG003|Overall Study|Adverse Event|0
7221792|NCT00006046|11430646|FG004|Overall Study|Adverse Event|0
7221793|NCT00006046|11430642|FG000|Overall Study|Disease Progression|2
7221794|NCT00006046|11430643|FG001|Overall Study|Disease Progression|0
7221795|NCT00006046|11430644|FG002|Overall Study|Disease Progression|0
7221796|NCT00006046|11430645|FG003|Overall Study|Disease Progression|0
7221797|NCT00006046|11430646|FG004|Overall Study|Disease Progression|0
7221798|NCT00006164|11430710|FG000|Overall Study|Withdrew or lost to follow-up|70
7221799|NCT00006164|11430711|FG001|Overall Study|Withdrew or lost to follow-up|81
7297211|NCT00576927|11516212|FG000|Sleep Hygiene Behavioral Intervention|Death|1
7297212|NCT00576927|11516212|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
7297213|NCT00576927|11516212|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
7297214|NCT00576927|11516212|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
7297215|NCT00577005|11516220|FG000|Overall Study|Lost to Follow-up|3
7297216|NCT00577005|11516221|FG001|Overall Study|Lost to Follow-up|2
7297217|NCT00577005|11516220|FG000|Overall Study|Withdrawal by Subject|2
7297218|NCT00577005|11516221|FG001|Overall Study|Withdrawal by Subject|1
7297219|NCT00577031|11516230|FG000|Overall Study|Adverse Event|52
7297220|NCT00577031|11516230|FG000|Overall Study|Progression of disease|93
7297221|NCT00577031|11516230|FG000|Overall Study|Protocol Violation|5
7297222|NCT00577031|11516230|FG000|Overall Study|Participant withdrew consent|13
7297223|NCT00577031|11516230|FG000|Overall Study|Participant non-compliance|5
7297224|NCT00577031|11516230|FG000|Overall Study|Need for surgery|17
7297225|NCT00577031|11516230|FG000|Overall Study|Medical decision|14
7297226|NCT00577031|11516230|FG000|Overall Study|Death|6
7297227|NCT00577096|11516254|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
7297228|NCT00577096|11516255|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
7297229|NCT00577096|11516254|FG000|Short Term Participation|Withdrawal by Subject|3
7297230|NCT00577096|11516255|FG001|Short Term Participation|Withdrawal by Subject|5
7297231|NCT00577096|11516254|FG000|Short Term Participation|Death|1
7297232|NCT00577096|11516255|FG001|Short Term Participation|Death|1
7297233|NCT00577122|11516263|FG000|Overall Study|Adverse Event|0
7297234|NCT00577122|11516264|FG001|Overall Study|Adverse Event|2
7297235|NCT00577122|11516263|FG000|Overall Study|Progression, relapse during active trt|6
7297236|NCT00577122|11516264|FG001|Overall Study|Progression, relapse during active trt|8
7297237|NCT00577122|11516263|FG000|Overall Study|Prog, refract disease during active trt|8
7297238|NCT00577122|11516264|FG001|Overall Study|Prog, refract disease during active trt|5
7297239|NCT00577122|11516263|FG000|Overall Study|Alternative Therapy|0
7297240|NCT00577122|11516264|FG001|Overall Study|Alternative Therapy|1
7297241|NCT00577382|11516290|FG000|Overall Study|Adverse Event|0
7297242|NCT00577382|11516291|FG001|Overall Study|Adverse Event|6
7297243|NCT00577382|11516290|FG000|Overall Study|Withdrawal by Subject|0
7297244|NCT00577382|11516291|FG001|Overall Study|Withdrawal by Subject|1
7297245|NCT00577382|11516290|FG000|Overall Study|Progressive Disease|17
7297246|NCT00577382|11516291|FG001|Overall Study|Progressive Disease|19
7297247|NCT00577382|11516290|FG000|Overall Study|Intercurrent Illness|1
7297248|NCT00577382|11516291|FG001|Overall Study|Intercurrent Illness|2
7297249|NCT00577382|11516290|FG000|Overall Study|Death|1
7297250|NCT00577382|11516291|FG001|Overall Study|Death|1
7297251|NCT00577382|11516290|FG000|Overall Study|Lost to Follow-up|2
7297252|NCT00577382|11516291|FG001|Overall Study|Lost to Follow-up|2
7297253|NCT00577408|11516299|FG000|Overall Study|Stopped attending study visits|9
7221800|NCT04323800|11430736|FG000|Overall Study|Withdrawal by Subject|4
7221801|NCT04323800|11430737|FG001|Overall Study|Withdrawal by Subject|4
7221802|NCT04323800|11430736|FG000|Overall Study|Incomplete transfusion|1
7221803|NCT04323800|11430737|FG001|Overall Study|Incomplete transfusion|0
7221804|NCT04323800|11430736|FG000|Overall Study|Other|0
7221805|NCT04323800|11430737|FG001|Overall Study|Other|1
7221806|NCT04323800|11430736|FG000|Overall Study|Positive RT-PCR at transfusion|1
7221807|NCT04323800|11430737|FG001|Overall Study|Positive RT-PCR at transfusion|1
7221808|NCT04110145|11430757|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7221809|NCT04110145|11430758|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7221810|NCT04110145|11430759|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7221811|NCT04110145|11430760|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1
7221812|NCT04110145|11430761|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
7221889|NCT03447314|11430838|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221890|NCT03447314|11430839|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221891|NCT03447314|11430840|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221892|NCT03447314|11430841|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221893|NCT03447314|11430842|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221894|NCT03447314|11430843|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221895|NCT03447314|11430826|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7221896|NCT03447314|11430827|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221897|NCT03447314|11430828|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7221898|NCT03447314|11430829|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221899|NCT03447314|11430830|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221900|NCT03447314|11430831|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
7221901|NCT03447314|11430832|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221902|NCT03447314|11430833|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221903|NCT03447314|11430834|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221904|NCT03447314|11430835|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221905|NCT03447314|11430836|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221906|NCT03447314|11430837|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221907|NCT03447314|11430838|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221908|NCT03447314|11430839|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221909|NCT03447314|11430840|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221910|NCT03447314|11430841|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221911|NCT03447314|11430842|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221912|NCT03447314|11430843|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
7221913|NCT03447314|11430826|FG000|Part 1 (Up to 27 Months)|Disease progression|0
7221914|NCT03447314|11430827|FG001|Part 1 (Up to 27 Months)|Disease progression|0
7221915|NCT03447314|11430828|FG002|Part 1 (Up to 27 Months)|Disease progression|1
7221916|NCT03447314|11430829|FG003|Part 1 (Up to 27 Months)|Disease progression|0
7221917|NCT03447314|11430830|FG004|Part 1 (Up to 27 Months)|Disease progression|0
7221918|NCT03447314|11430831|FG005|Part 1 (Up to 27 Months)|Disease progression|0
7221919|NCT03447314|11430832|FG006|Part 1 (Up to 27 Months)|Disease progression|0
7221920|NCT03447314|11430833|FG007|Part 1 (Up to 27 Months)|Disease progression|0
7221921|NCT03447314|11430834|FG008|Part 1 (Up to 27 Months)|Disease progression|0
7221922|NCT03447314|11430835|FG009|Part 1 (Up to 27 Months)|Disease progression|0
7221923|NCT03447314|11430836|FG010|Part 1 (Up to 27 Months)|Disease progression|0
7221924|NCT03447314|11430837|FG011|Part 1 (Up to 27 Months)|Disease progression|0
7221925|NCT03447314|11430838|FG012|Part 1 (Up to 27 Months)|Disease progression|0
7221926|NCT03447314|11430839|FG013|Part 1 (Up to 27 Months)|Disease progression|0
7221927|NCT03447314|11430840|FG014|Part 1 (Up to 27 Months)|Disease progression|0
7221928|NCT03447314|11430841|FG015|Part 1 (Up to 27 Months)|Disease progression|0
7221929|NCT03447314|11430842|FG016|Part 1 (Up to 27 Months)|Disease progression|0
7221930|NCT03447314|11430843|FG017|Part 1 (Up to 27 Months)|Disease progression|0
7221931|NCT03447314|11430826|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221932|NCT03447314|11430827|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221933|NCT03447314|11430828|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1
7221934|NCT03447314|11430829|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221935|NCT03447314|11430830|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221936|NCT03447314|11430831|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221937|NCT03447314|11430832|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221938|NCT03447314|11430833|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221939|NCT03447314|11430834|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221940|NCT03447314|11430835|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7297254|NCT00577408|11516300|FG001|Overall Study|Stopped attending study visits|11
7297255|NCT00577408|11516299|FG000|Overall Study|Continued opioid use|3
7297256|NCT00577408|11516300|FG001|Overall Study|Continued opioid use|2
7297257|NCT00577408|11516299|FG000|Overall Study|Non-compliance with study meds|0
7297258|NCT00577408|11516300|FG001|Overall Study|Non-compliance with study meds|3
7297259|NCT00577408|11516299|FG000|Overall Study|Refused Oral Naltrexone|0
7297260|NCT00577408|11516300|FG001|Overall Study|Refused Oral Naltrexone|1
7297261|NCT00577408|11516299|FG000|Overall Study|Moved out of state|0
7297262|NCT00577408|11516300|FG001|Overall Study|Moved out of state|1
7297263|NCT00577408|11516299|FG000|Overall Study|Scheduling Issues|0
7221813|NCT03986866|11430775|FG000|Overall Study|Withdrawal by Subject|0
7221814|NCT03986866|11430776|FG001|Overall Study|Withdrawal by Subject|3
7221815|NCT03986866|11430775|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
7221816|NCT03986866|11430776|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
7221817|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Adverse Event|13
7221818|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Adverse Event|7
7221819|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Adverse Event|0
7221820|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1
7221821|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0
7221822|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0
7221823|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2
7221824|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
7221825|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
7221826|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5
7221827|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1
7221828|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0
7221829|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Other|6
7221830|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Other|3
7221831|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Other|0
7221832|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1
7221833|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0
7221834|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0
7221835|NCT03636269|11430784|FG000|Period 1: Double-blind Phase|Subject non-compliance|1
7221836|NCT03636269|11430785|FG001|Period 1: Double-blind Phase|Subject non-compliance|2
7221837|NCT03636269|11430786|FG002|Period 1: Double-blind Phase|Subject non-compliance|0
7221838|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Adverse Event|0
7221839|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Adverse Event|0
7221840|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Adverse Event|21
7221841|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Lack of Efficacy|0
7221842|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Lack of Efficacy|0
7221843|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Lack of Efficacy|2
7221844|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
7221845|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
7221846|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2
7221847|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0
7221848|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0
7221849|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11
7221850|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Administrative|0
7221851|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Administrative|0
7221852|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Administrative|36
7221853|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Other|0
7221854|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Other|0
7221855|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Other|9
7221856|NCT03636269|11430784|FG000|Period 2: Open-label Phase|Sponsor stopping study|0
7221857|NCT03636269|11430785|FG001|Period 2: Open-label Phase|Sponsor stopping study|0
7221858|NCT03636269|11430786|FG002|Period 2: Open-label Phase|Sponsor stopping study|313
7221859|NCT03447314|11430826|FG000|Part 1 (Up to 27 Months)|Death|6
7221860|NCT03447314|11430827|FG001|Part 1 (Up to 27 Months)|Death|5
7221861|NCT03447314|11430828|FG002|Part 1 (Up to 27 Months)|Death|3
7221862|NCT03447314|11430829|FG003|Part 1 (Up to 27 Months)|Death|3
7221863|NCT03447314|11430830|FG004|Part 1 (Up to 27 Months)|Death|0
7221864|NCT03447314|11430831|FG005|Part 1 (Up to 27 Months)|Death|4
7221865|NCT03447314|11430832|FG006|Part 1 (Up to 27 Months)|Death|3
7221866|NCT03447314|11430833|FG007|Part 1 (Up to 27 Months)|Death|0
7221867|NCT03447314|11430834|FG008|Part 1 (Up to 27 Months)|Death|0
7221868|NCT03447314|11430835|FG009|Part 1 (Up to 27 Months)|Death|0
7221869|NCT03447314|11430836|FG010|Part 1 (Up to 27 Months)|Death|4
7221870|NCT03447314|11430837|FG011|Part 1 (Up to 27 Months)|Death|2
7221871|NCT03447314|11430838|FG012|Part 1 (Up to 27 Months)|Death|0
7221872|NCT03447314|11430839|FG013|Part 1 (Up to 27 Months)|Death|0
7221873|NCT03447314|11430840|FG014|Part 1 (Up to 27 Months)|Death|0
7221874|NCT03447314|11430841|FG015|Part 1 (Up to 27 Months)|Death|0
7221875|NCT03447314|11430842|FG016|Part 1 (Up to 27 Months)|Death|0
7221876|NCT03447314|11430843|FG017|Part 1 (Up to 27 Months)|Death|0
7221877|NCT03447314|11430826|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2
7221878|NCT03447314|11430827|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1
7221879|NCT03447314|11430828|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3
7221880|NCT03447314|11430829|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1
7221881|NCT03447314|11430830|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2
7221882|NCT03447314|11430831|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1
7221883|NCT03447314|11430832|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2
7221884|NCT03447314|11430833|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221885|NCT03447314|11430834|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221886|NCT03447314|11430835|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0
7221887|NCT03447314|11430836|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3
7221888|NCT03447314|11430837|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4
7221941|NCT03447314|11430836|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221942|NCT03447314|11430837|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221943|NCT03447314|11430838|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221944|NCT03447314|11430839|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221945|NCT03447314|11430840|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221946|NCT03447314|11430841|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221947|NCT03447314|11430842|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221948|NCT03447314|11430843|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0
7221949|NCT03320330|11430900|FG000|Overall Study|Lack of Efficacy|5
7221950|NCT03320330|11430901|FG001|Overall Study|Lack of Efficacy|5
7221951|NCT03320330|11430902|FG002|Overall Study|Lack of Efficacy|14
7221952|NCT03320330|11430900|FG000|Overall Study|Physician Decision|1
7221953|NCT03320330|11430901|FG001|Overall Study|Physician Decision|0
7221954|NCT03320330|11430902|FG002|Overall Study|Physician Decision|0
7221955|NCT03271151|11430913|FG000|Overall Study|Lost to Follow-up|1
7221956|NCT03271151|11430914|FG001|Overall Study|Lost to Follow-up|3
7221957|NCT03271151|11430913|FG000|Overall Study|Withdrawal by Subject|1
7221958|NCT03271151|11430914|FG001|Overall Study|Withdrawal by Subject|0
7221985|NCT03023813|11430946|FG000|Overall Study|Lost to Follow-up|1
7221986|NCT03023813|11430947|FG001|Overall Study|Lost to Follow-up|2
7221987|NCT03023813|11430948|FG002|Overall Study|Lost to Follow-up|0
7221988|NCT02993822|11430961|FG000|Overall Study|Lack of Efficacy|1
7221989|NCT02993822|11430962|FG001|Overall Study|Lack of Efficacy|1
7221990|NCT02993822|11430963|FG002|Overall Study|Lack of Efficacy|0
7221991|NCT02993822|11430964|FG003|Overall Study|Lack of Efficacy|0
7221992|NCT02993822|11430961|FG000|Overall Study|Protocol Violation|1
7221993|NCT02993822|11430962|FG001|Overall Study|Protocol Violation|0
7221994|NCT02993822|11430963|FG002|Overall Study|Protocol Violation|0
7221995|NCT02993822|11430964|FG003|Overall Study|Protocol Violation|0
7221996|NCT02993822|11430961|FG000|Overall Study|Unable to attend follow-up due to illness|0
7221997|NCT02993822|11430962|FG001|Overall Study|Unable to attend follow-up due to illness|0
7221998|NCT02993822|11430963|FG002|Overall Study|Unable to attend follow-up due to illness|0
7221999|NCT02993822|11430964|FG003|Overall Study|Unable to attend follow-up due to illness|1
7222000|NCT02993822|11430961|FG000|Overall Study|Adverse Event|3
7222001|NCT02993822|11430962|FG001|Overall Study|Adverse Event|1
7222002|NCT02993822|11430963|FG002|Overall Study|Adverse Event|7
7222003|NCT02993822|11430964|FG003|Overall Study|Adverse Event|0
7222004|NCT02993822|11430961|FG000|Overall Study|Withdrawal by Subject|4
7222005|NCT02993822|11430962|FG001|Overall Study|Withdrawal by Subject|2
7222006|NCT02993822|11430963|FG002|Overall Study|Withdrawal by Subject|2
7222007|NCT02993822|11430964|FG003|Overall Study|Withdrawal by Subject|3
7222008|NCT02993822|11430961|FG000|Overall Study|Lost to Follow-up|1
7222009|NCT02993822|11430962|FG001|Overall Study|Lost to Follow-up|0
7222010|NCT02993822|11430963|FG002|Overall Study|Lost to Follow-up|1
7222011|NCT02993822|11430964|FG003|Overall Study|Lost to Follow-up|0
7297264|NCT00577408|11516300|FG001|Overall Study|Scheduling Issues|3
7297265|NCT00577408|11516299|FG000|Overall Study|Death|0
7297266|NCT00577408|11516300|FG001|Overall Study|Death|1
7297267|NCT00577408|11516299|FG000|Overall Study|Psychiatric hospitalization|0
7297268|NCT00577408|11516300|FG001|Overall Study|Psychiatric hospitalization|1
7297269|NCT00577460|11516309|FG000|Overall Study|Adverse Event|11
7297270|NCT00577460|11516310|FG001|Overall Study|Adverse Event|7
7297271|NCT00577460|11516311|FG002|Overall Study|Adverse Event|14
7297272|NCT00577460|11516309|FG000|Overall Study|Protocol Violation|0
7297273|NCT00577460|11516310|FG001|Overall Study|Protocol Violation|1
7297274|NCT00577460|11516311|FG002|Overall Study|Protocol Violation|1
7297275|NCT00577460|11516309|FG000|Overall Study|Lost to Follow-up|0
7297276|NCT00577460|11516310|FG001|Overall Study|Lost to Follow-up|3
7222012|NCT02753127|11430989|FG000|Overall Study|Lost to Follow-up|13
7222013|NCT02753127|11430990|FG001|Overall Study|Lost to Follow-up|11
7222014|NCT02753127|11430989|FG000|Overall Study|Withdrawal by Subject|37
7222015|NCT02753127|11430990|FG001|Overall Study|Withdrawal by Subject|47
7222016|NCT02753127|11430989|FG000|Overall Study|Other|3
7222017|NCT02753127|11430990|FG001|Overall Study|Other|8
7222018|NCT02753127|11430989|FG000|Overall Study|Hospice|0
7222019|NCT02753127|11430990|FG001|Overall Study|Hospice|2
7222034|NCT01516216|11431080|FG000|Overall Study|Adverse Event|2
7222035|NCT01516216|11431081|FG001|Overall Study|Adverse Event|4
7222036|NCT01516216|11431080|FG000|Overall Study|Disease Progression|38
7222037|NCT01516216|11431081|FG001|Overall Study|Disease Progression|34
7222038|NCT01516216|11431080|FG000|Overall Study|Withdrawal by Subject|9
7222039|NCT01516216|11431081|FG001|Overall Study|Withdrawal by Subject|11
7222040|NCT01516216|11431080|FG000|Overall Study|Potentially Curative Resection|6
7222041|NCT01516216|11431081|FG001|Overall Study|Potentially Curative Resection|12
7222042|NCT01516216|11431080|FG000|Overall Study|Nonadherence|2
7222043|NCT01516216|11431081|FG001|Overall Study|Nonadherence|3
7222044|NCT01516216|11431080|FG000|Overall Study|Physician Decision|6
7222045|NCT01516216|11431081|FG001|Overall Study|Physician Decision|3
7222046|NCT01516216|11431080|FG000|Overall Study|Prolonged Treatment Delay|5
7222047|NCT01516216|11431081|FG001|Overall Study|Prolonged Treatment Delay|1
7222048|NCT01516216|11431080|FG000|Overall Study|Intercurrent Illness|1
7222049|NCT01516216|11431081|FG001|Overall Study|Intercurrent Illness|0
7222050|NCT01516216|11431080|FG000|Overall Study|Death|1
7222051|NCT01516216|11431081|FG001|Overall Study|Death|1
7222052|NCT00006184|11431101|FG000|Overall Study|Death|1
7222053|NCT00006184|11431102|FG001|Overall Study|Death|0
7222054|NCT00006237|11431114|FG000|Overall Study|Adverse Event|39
7222055|NCT00006237|11431115|FG001|Overall Study|Adverse Event|29
7222056|NCT00006237|11431114|FG000|Overall Study|Death|1
7222057|NCT00006237|11431115|FG001|Overall Study|Death|0
7222058|NCT00006237|11431114|FG000|Overall Study|Refusal unrelated to adverse effects|8
7222059|NCT00006237|11431115|FG001|Overall Study|Refusal unrelated to adverse effects|4
7222060|NCT00006237|11431114|FG000|Overall Study|Progression/relapse|54
7222061|NCT00006237|11431115|FG001|Overall Study|Progression/relapse|2
7222062|NCT00006237|11431114|FG000|Overall Study|Not eligible|9
7222063|NCT00006237|11431115|FG001|Overall Study|Not eligible|20
7222064|NCT00006237|11431114|FG000|Overall Study|Withdrawal by Subject|0
7222065|NCT00006237|11431115|FG001|Overall Study|Withdrawal by Subject|1
7222066|NCT00006237|11431114|FG000|Overall Study|Not protocol specified|14
7222067|NCT00006237|11431115|FG001|Overall Study|Not protocol specified|5
7222068|NCT00006289|11431130|FG000|First Intervention (5 Weeks)|Adverse Event|1
7222069|NCT00006289|11431131|FG001|First Intervention (5 Weeks)|Adverse Event|0
7222070|NCT00006289|11431130|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
7222071|NCT00006289|11431131|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
7222072|NCT00006305|11431151|FG000|Overall Study|Withdrawal by Subject|17
7222073|NCT00006305|11431152|FG001|Overall Study|Withdrawal by Subject|10
7222074|NCT00006305|11431153|FG002|Overall Study|Withdrawal by Subject|15
7222075|NCT00006305|11431154|FG003|Overall Study|Withdrawal by Subject|14
7222076|NCT00006389|11431164|FG000|Overall Study|Adverse Event|1
7222077|NCT00006392|11431173|FG000|Overall Study|Ineligible|11
7222078|NCT00006392|11431174|FG001|Overall Study|Ineligible|3
7222079|NCT00006392|11431175|FG002|Overall Study|Ineligible|5
7222080|NCT00006392|11431176|FG003|Overall Study|Ineligible|5
7222081|NCT00006392|11431173|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
7222082|NCT00006392|11431174|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7222083|NCT00006392|11431175|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7222084|NCT00006392|11431176|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
7222085|NCT00006409|11431201|FG000|Baseline|Protocol Violation|48
7222086|NCT00006409|11431202|FG001|Baseline|Protocol Violation|70
7222087|NCT00006409|11431203|FG002|Baseline|Protocol Violation|0
7222088|NCT00006409|11431204|FG003|Baseline|Protocol Violation|0
7222089|NCT00006409|11431205|FG004|Baseline|Protocol Violation|0
7222090|NCT00006409|11431206|FG005|Baseline|Protocol Violation|0
7222091|NCT00006409|11431201|FG000|Post-2 Year Intervention|Protocol Violation|0
7222092|NCT00006409|11431202|FG001|Post-2 Year Intervention|Protocol Violation|0
7222093|NCT00006409|11431203|FG002|Post-2 Year Intervention|Protocol Violation|251
7222094|NCT00006409|11431204|FG003|Post-2 Year Intervention|Protocol Violation|168
7222095|NCT00006409|11431205|FG004|Post-2 Year Intervention|Protocol Violation|0
7222096|NCT00006409|11431206|FG005|Post-2 Year Intervention|Protocol Violation|0
7222097|NCT00006409|11431201|FG000|Post-3 Year Intervention|Protocol Violation|0
7222098|NCT00006409|11431202|FG001|Post-3 Year Intervention|Protocol Violation|0
7222099|NCT00006409|11431203|FG002|Post-3 Year Intervention|Protocol Violation|0
7222100|NCT00006409|11431204|FG003|Post-3 Year Intervention|Protocol Violation|0
7222101|NCT00006409|11431205|FG004|Post-3 Year Intervention|Protocol Violation|62
7222102|NCT00006409|11431206|FG005|Post-3 Year Intervention|Protocol Violation|62
7222103|NCT00006489|11431233|FG000|Overall Study|Adverse Event|3
7222104|NCT00006489|11431234|FG001|Overall Study|Adverse Event|2
7222105|NCT00006489|11431235|FG002|Overall Study|Adverse Event|4
7222106|NCT00006489|11431236|FG003|Overall Study|Adverse Event|3
7222107|NCT00006489|11431233|FG000|Overall Study|Withdrawal by Subject|10
7222108|NCT00006489|11431234|FG001|Overall Study|Withdrawal by Subject|9
7222109|NCT00006489|11431235|FG002|Overall Study|Withdrawal by Subject|9
7222110|NCT00006489|11431236|FG003|Overall Study|Withdrawal by Subject|6
7222111|NCT00006489|11431233|FG000|Overall Study|Scheduling Conflict|0
7222112|NCT00006489|11431234|FG001|Overall Study|Scheduling Conflict|3
7222113|NCT00006489|11431235|FG002|Overall Study|Scheduling Conflict|2
7222114|NCT00006489|11431236|FG003|Overall Study|Scheduling Conflict|1
7222115|NCT00006489|11431233|FG000|Overall Study|Death|0
7222116|NCT00006489|11431234|FG001|Overall Study|Death|0
7222117|NCT00006489|11431235|FG002|Overall Study|Death|0
7222118|NCT00006489|11431236|FG003|Overall Study|Death|1
7222119|NCT00006604|11431253|FG000|Overall Study|Met study objective - no further FU|1
7222120|NCT00006604|11431254|FG001|Overall Study|Met study objective - no further FU|0
7222121|NCT00006604|11431255|FG002|Overall Study|Met study objective - no further FU|0
7222122|NCT00006604|11431256|FG003|Overall Study|Met study objective - no further FU|0
7222123|NCT00006604|11431257|FG004|Overall Study|Met study objective - no further FU|0
7222124|NCT00006604|11431258|FG005|Overall Study|Met study objective - no further FU|0
7222125|NCT00006604|11431259|FG006|Overall Study|Met study objective - no further FU|0
7222126|NCT00006604|11431260|FG007|Overall Study|Met study objective - no further FU|0
7222127|NCT00006604|11431261|FG008|Overall Study|Met study objective - no further FU|0
7222128|NCT00006604|11431262|FG009|Overall Study|Met study objective - no further FU|0
7222129|NCT00006604|11431263|FG010|Overall Study|Met study objective - no further FU|0
7222130|NCT00006604|11431264|FG011|Overall Study|Met study objective - no further FU|0
7222131|NCT00006604|11431265|FG012|Overall Study|Met study objective - no further FU|0
7222132|NCT00006604|11431266|FG013|Overall Study|Met study objective - no further FU|0
7222133|NCT00006604|11431267|FG014|Overall Study|Met study objective - no further FU|1
7222134|NCT00006604|11431268|FG015|Overall Study|Met study objective - no further FU|1
7222135|NCT00006604|11431269|FG016|Overall Study|Met study objective - no further FU|0
7222136|NCT00006604|11431253|FG000|Overall Study|Randomization entry error-no RX, no FU|0
7222137|NCT00006604|11431254|FG001|Overall Study|Randomization entry error-no RX, no FU|0
7222138|NCT00006604|11431255|FG002|Overall Study|Randomization entry error-no RX, no FU|0
7222139|NCT00006604|11431256|FG003|Overall Study|Randomization entry error-no RX, no FU|0
7222140|NCT00006604|11431257|FG004|Overall Study|Randomization entry error-no RX, no FU|0
7222141|NCT00006604|11431258|FG005|Overall Study|Randomization entry error-no RX, no FU|0
7222142|NCT00006604|11431259|FG006|Overall Study|Randomization entry error-no RX, no FU|0
7222143|NCT00006604|11431260|FG007|Overall Study|Randomization entry error-no RX, no FU|0
7222144|NCT00006604|11431261|FG008|Overall Study|Randomization entry error-no RX, no FU|0
7222145|NCT00006604|11431262|FG009|Overall Study|Randomization entry error-no RX, no FU|0
7222146|NCT00006604|11431263|FG010|Overall Study|Randomization entry error-no RX, no FU|0
7222147|NCT00006604|11431264|FG011|Overall Study|Randomization entry error-no RX, no FU|1
7222148|NCT00006604|11431265|FG012|Overall Study|Randomization entry error-no RX, no FU|0
7222149|NCT00006604|11431266|FG013|Overall Study|Randomization entry error-no RX, no FU|0
7222150|NCT00006604|11431267|FG014|Overall Study|Randomization entry error-no RX, no FU|0
7222151|NCT00006604|11431268|FG015|Overall Study|Randomization entry error-no RX, no FU|0
7222152|NCT00006604|11431269|FG016|Overall Study|Randomization entry error-no RX, no FU|0
7222153|NCT00006604|11431253|FG000|Overall Study|Death|0
7222154|NCT00006604|11431254|FG001|Overall Study|Death|0
7222155|NCT00006604|11431255|FG002|Overall Study|Death|0
7222156|NCT00006604|11431256|FG003|Overall Study|Death|0
7222157|NCT00006604|11431257|FG004|Overall Study|Death|0
7222158|NCT00006604|11431258|FG005|Overall Study|Death|0
7222159|NCT00006604|11431259|FG006|Overall Study|Death|0
7222160|NCT00006604|11431260|FG007|Overall Study|Death|0
7222161|NCT00006604|11431261|FG008|Overall Study|Death|0
7222162|NCT00006604|11431262|FG009|Overall Study|Death|1
7222163|NCT00006604|11431263|FG010|Overall Study|Death|1
7222164|NCT00006604|11431264|FG011|Overall Study|Death|1
7222165|NCT00006604|11431265|FG012|Overall Study|Death|0
7222166|NCT00006604|11431266|FG013|Overall Study|Death|0
7222167|NCT00006604|11431267|FG014|Overall Study|Death|0
7222168|NCT00006604|11431268|FG015|Overall Study|Death|0
7222169|NCT00006604|11431269|FG016|Overall Study|Death|0
7222170|NCT00006604|11431253|FG000|Overall Study|Severe debilitation, unable to continue|0
7222171|NCT00006604|11431254|FG001|Overall Study|Severe debilitation, unable to continue|0
7222172|NCT00006604|11431255|FG002|Overall Study|Severe debilitation, unable to continue|0
7222173|NCT00006604|11431256|FG003|Overall Study|Severe debilitation, unable to continue|0
7222174|NCT00006604|11431257|FG004|Overall Study|Severe debilitation, unable to continue|0
7297277|NCT00577460|11516311|FG002|Overall Study|Lost to Follow-up|4
7222175|NCT00006604|11431258|FG005|Overall Study|Severe debilitation, unable to continue|0
7222176|NCT00006604|11431259|FG006|Overall Study|Severe debilitation, unable to continue|3
7222177|NCT00006604|11431260|FG007|Overall Study|Severe debilitation, unable to continue|0
7222178|NCT00006604|11431261|FG008|Overall Study|Severe debilitation, unable to continue|0
7222179|NCT00006604|11431262|FG009|Overall Study|Severe debilitation, unable to continue|5
7222180|NCT00006604|11431263|FG010|Overall Study|Severe debilitation, unable to continue|0
7222181|NCT00006604|11431264|FG011|Overall Study|Severe debilitation, unable to continue|2
7222182|NCT00006604|11431265|FG012|Overall Study|Severe debilitation, unable to continue|1
7222183|NCT00006604|11431266|FG013|Overall Study|Severe debilitation, unable to continue|0
7222184|NCT00006604|11431267|FG014|Overall Study|Severe debilitation, unable to continue|2
7222185|NCT00006604|11431268|FG015|Overall Study|Severe debilitation, unable to continue|0
7222186|NCT00006604|11431269|FG016|Overall Study|Severe debilitation, unable to continue|0
7222187|NCT00006604|11431253|FG000|Overall Study|Subj/Parent not able to get to clinic|0
7222188|NCT00006604|11431254|FG001|Overall Study|Subj/Parent not able to get to clinic|0
7222189|NCT00006604|11431255|FG002|Overall Study|Subj/Parent not able to get to clinic|0
7222190|NCT00006604|11431256|FG003|Overall Study|Subj/Parent not able to get to clinic|1
7222191|NCT00006604|11431257|FG004|Overall Study|Subj/Parent not able to get to clinic|1
7222192|NCT00006604|11431258|FG005|Overall Study|Subj/Parent not able to get to clinic|0
7222193|NCT00006604|11431259|FG006|Overall Study|Subj/Parent not able to get to clinic|1
7222194|NCT00006604|11431260|FG007|Overall Study|Subj/Parent not able to get to clinic|0
7222195|NCT00006604|11431261|FG008|Overall Study|Subj/Parent not able to get to clinic|0
7222196|NCT00006604|11431262|FG009|Overall Study|Subj/Parent not able to get to clinic|1
7222197|NCT00006604|11431263|FG010|Overall Study|Subj/Parent not able to get to clinic|2
7222198|NCT00006604|11431264|FG011|Overall Study|Subj/Parent not able to get to clinic|1
7222199|NCT00006604|11431265|FG012|Overall Study|Subj/Parent not able to get to clinic|1
7222200|NCT00006604|11431266|FG013|Overall Study|Subj/Parent not able to get to clinic|1
7222201|NCT00006604|11431267|FG014|Overall Study|Subj/Parent not able to get to clinic|3
7222202|NCT00006604|11431268|FG015|Overall Study|Subj/Parent not able to get to clinic|0
7222203|NCT00006604|11431269|FG016|Overall Study|Subj/Parent not able to get to clinic|0
7222204|NCT00006604|11431253|FG000|Overall Study|Site closing|0
7222205|NCT00006604|11431254|FG001|Overall Study|Site closing|0
7222206|NCT00006604|11431255|FG002|Overall Study|Site closing|1
7222207|NCT00006604|11431256|FG003|Overall Study|Site closing|1
7222208|NCT00006604|11431257|FG004|Overall Study|Site closing|0
7222209|NCT00006604|11431258|FG005|Overall Study|Site closing|0
7222210|NCT00006604|11431259|FG006|Overall Study|Site closing|0
7222211|NCT00006604|11431260|FG007|Overall Study|Site closing|1
7222212|NCT00006604|11431261|FG008|Overall Study|Site closing|0
7222213|NCT00006604|11431262|FG009|Overall Study|Site closing|0
7222214|NCT00006604|11431263|FG010|Overall Study|Site closing|0
7222215|NCT00006604|11431264|FG011|Overall Study|Site closing|1
7222216|NCT00006604|11431265|FG012|Overall Study|Site closing|1
7222217|NCT00006604|11431266|FG013|Overall Study|Site closing|1
7222218|NCT00006604|11431267|FG014|Overall Study|Site closing|0
7222219|NCT00006604|11431268|FG015|Overall Study|Site closing|0
7222220|NCT00006604|11431269|FG016|Overall Study|Site closing|1
7222221|NCT00006604|11431253|FG000|Overall Study|Withdrawal by Subject|1
7222222|NCT00006604|11431254|FG001|Overall Study|Withdrawal by Subject|0
7222223|NCT00006604|11431255|FG002|Overall Study|Withdrawal by Subject|2
7222224|NCT00006604|11431256|FG003|Overall Study|Withdrawal by Subject|0
7222225|NCT00006604|11431257|FG004|Overall Study|Withdrawal by Subject|1
7222226|NCT00006604|11431258|FG005|Overall Study|Withdrawal by Subject|2
7222227|NCT00006604|11431259|FG006|Overall Study|Withdrawal by Subject|2
7222228|NCT00006604|11431260|FG007|Overall Study|Withdrawal by Subject|0
7222229|NCT00006604|11431261|FG008|Overall Study|Withdrawal by Subject|1
7222230|NCT00006604|11431262|FG009|Overall Study|Withdrawal by Subject|3
7222231|NCT00006604|11431263|FG010|Overall Study|Withdrawal by Subject|2
7222232|NCT00006604|11431264|FG011|Overall Study|Withdrawal by Subject|0
7222233|NCT00006604|11431265|FG012|Overall Study|Withdrawal by Subject|1
7222234|NCT00006604|11431266|FG013|Overall Study|Withdrawal by Subject|2
7222235|NCT00006604|11431267|FG014|Overall Study|Withdrawal by Subject|1
7222236|NCT00006604|11431268|FG015|Overall Study|Withdrawal by Subject|0
7222237|NCT00006604|11431269|FG016|Overall Study|Withdrawal by Subject|1
7222238|NCT00006604|11431253|FG000|Overall Study|Subj/parent not willing to adhere to req|0
7222239|NCT00006604|11431254|FG001|Overall Study|Subj/parent not willing to adhere to req|0
7222240|NCT00006604|11431255|FG002|Overall Study|Subj/parent not willing to adhere to req|1
7222241|NCT00006604|11431256|FG003|Overall Study|Subj/parent not willing to adhere to req|3
7222242|NCT00006604|11431257|FG004|Overall Study|Subj/parent not willing to adhere to req|0
7222243|NCT00006604|11431258|FG005|Overall Study|Subj/parent not willing to adhere to req|0
7222244|NCT00006604|11431259|FG006|Overall Study|Subj/parent not willing to adhere to req|3
7222245|NCT00006604|11431260|FG007|Overall Study|Subj/parent not willing to adhere to req|1
7222246|NCT00006604|11431261|FG008|Overall Study|Subj/parent not willing to adhere to req|0
7222247|NCT00006604|11431262|FG009|Overall Study|Subj/parent not willing to adhere to req|6
7222248|NCT00006604|11431263|FG010|Overall Study|Subj/parent not willing to adhere to req|3
7222249|NCT00006604|11431264|FG011|Overall Study|Subj/parent not willing to adhere to req|0
7297278|NCT00577460|11516309|FG000|Overall Study|Withdrawal by Subject|5
7222250|NCT00006604|11431265|FG012|Overall Study|Subj/parent not willing to adhere to req|0
7222251|NCT00006604|11431266|FG013|Overall Study|Subj/parent not willing to adhere to req|2
7222252|NCT00006604|11431267|FG014|Overall Study|Subj/parent not willing to adhere to req|3
7222253|NCT00006604|11431268|FG015|Overall Study|Subj/parent not willing to adhere to req|3
7222254|NCT00006604|11431269|FG016|Overall Study|Subj/parent not willing to adhere to req|4
7222255|NCT00006604|11431253|FG000|Overall Study|Lost to Follow-up|0
7222256|NCT00006604|11431254|FG001|Overall Study|Lost to Follow-up|0
7222257|NCT00006604|11431255|FG002|Overall Study|Lost to Follow-up|0
7222258|NCT00006604|11431256|FG003|Overall Study|Lost to Follow-up|0
7222259|NCT00006604|11431257|FG004|Overall Study|Lost to Follow-up|0
7222260|NCT00006604|11431258|FG005|Overall Study|Lost to Follow-up|0
7222261|NCT00006604|11431259|FG006|Overall Study|Lost to Follow-up|0
7222262|NCT00006604|11431260|FG007|Overall Study|Lost to Follow-up|1
7222263|NCT00006604|11431261|FG008|Overall Study|Lost to Follow-up|0
7222264|NCT00006604|11431262|FG009|Overall Study|Lost to Follow-up|2
7222265|NCT00006604|11431263|FG010|Overall Study|Lost to Follow-up|0
7222266|NCT00006604|11431264|FG011|Overall Study|Lost to Follow-up|0
7222267|NCT00006604|11431265|FG012|Overall Study|Lost to Follow-up|0
7222268|NCT00006604|11431266|FG013|Overall Study|Lost to Follow-up|0
7222269|NCT00006604|11431267|FG014|Overall Study|Lost to Follow-up|0
7222270|NCT00006604|11431268|FG015|Overall Study|Lost to Follow-up|1
7222271|NCT00006604|11431269|FG016|Overall Study|Lost to Follow-up|3
7222272|NCT00006604|11431253|FG000|Overall Study|Other Reason|0
7222273|NCT00006604|11431254|FG001|Overall Study|Other Reason|0
7222274|NCT00006604|11431255|FG002|Overall Study|Other Reason|0
7222275|NCT00006604|11431256|FG003|Overall Study|Other Reason|0
7222276|NCT00006604|11431257|FG004|Overall Study|Other Reason|0
7222277|NCT00006604|11431258|FG005|Overall Study|Other Reason|1
7222278|NCT00006604|11431259|FG006|Overall Study|Other Reason|0
7222279|NCT00006604|11431260|FG007|Overall Study|Other Reason|0
7222280|NCT00006604|11431261|FG008|Overall Study|Other Reason|0
7222281|NCT00006604|11431262|FG009|Overall Study|Other Reason|1
7222282|NCT00006604|11431263|FG010|Overall Study|Other Reason|0
7222283|NCT00006604|11431264|FG011|Overall Study|Other Reason|0
7222284|NCT00006604|11431265|FG012|Overall Study|Other Reason|0
7222285|NCT00006604|11431266|FG013|Overall Study|Other Reason|0
7222286|NCT00006604|11431267|FG014|Overall Study|Other Reason|0
7222287|NCT00006604|11431268|FG015|Overall Study|Other Reason|0
7222288|NCT00006604|11431269|FG016|Overall Study|Other Reason|0
7222310|NCT00006903|11431309|FG000|Overall Study|Still receiving treatment|0
7222311|NCT00006903|11431310|FG001|Overall Study|Still receiving treatment|0
7222312|NCT00006903|11431311|FG002|Overall Study|Still receiving treatment|1
7222313|NCT00006903|11431309|FG000|Overall Study|Refused further treatment|0
7222314|NCT00006903|11431310|FG001|Overall Study|Refused further treatment|2
7222315|NCT00006903|11431311|FG002|Overall Study|Refused further treatment|1
7222316|NCT00006903|11431309|FG000|Overall Study|Adverse Event|0
7222317|NCT00006903|11431310|FG001|Overall Study|Adverse Event|0
7222318|NCT00006903|11431311|FG002|Overall Study|Adverse Event|1
7222319|NCT00006903|11431309|FG000|Overall Study|Death|0
7222320|NCT00006903|11431310|FG001|Overall Study|Death|1
7222321|NCT00006903|11431311|FG002|Overall Study|Death|0
7222322|NCT00006903|11431309|FG000|Overall Study|Patient never treated|0
7222323|NCT00006903|11431310|FG001|Overall Study|Patient never treated|0
7222324|NCT00006903|11431311|FG002|Overall Study|Patient never treated|1
7222325|NCT00006903|11431309|FG000|Overall Study|Ineligible|10
7222326|NCT00006903|11431310|FG001|Overall Study|Ineligible|1
7222327|NCT00006903|11431311|FG002|Overall Study|Ineligible|2
7222328|NCT00007020|11431319|FG000|Overall Study|Death|16
7222329|NCT00007020|11431319|FG000|Overall Study|Lost to Follow-up|13
7222330|NCT00007020|11431319|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
7222331|NCT00007020|11431319|FG000|Overall Study|Pt withdrawn (liver transplant)|4
7222332|NCT00007020|11431319|FG000|Overall Study|Pt cared for by outside physician|4
7222333|NCT00007020|11431319|FG000|Overall Study|No evidence of treatment|6
7222334|NCT00007345|11431327|FG000|Overall Study|Refused further treatment|0
7222335|NCT00007345|11431328|FG001|Overall Study|Refused further treatment|7
7222336|NCT00007345|11431327|FG000|Overall Study|Switched to alternative treatment|0
7222337|NCT00007345|11431328|FG001|Overall Study|Switched to alternative treatment|3
7222338|NCT00007345|11431327|FG000|Overall Study|Intercurrent illness|1
7222339|NCT00007345|11431328|FG001|Overall Study|Intercurrent illness|0
7222340|NCT00007345|11431327|FG000|Overall Study|Death on study|1
7222341|NCT00007345|11431328|FG001|Overall Study|Death on study|1
7222342|NCT00007475|11431337|FG000|Overall Study|Withdrawal by Subject|1
7222343|NCT00007475|11431338|FG001|Overall Study|Withdrawal by Subject|0
7222344|NCT00007475|11431339|FG002|Overall Study|Withdrawal by Subject|0
7222345|NCT00007475|11431340|FG003|Overall Study|Withdrawal by Subject|0
7222346|NCT00007475|11431337|FG000|Overall Study|Adverse Event|3
7222347|NCT00007475|11431338|FG001|Overall Study|Adverse Event|0
7222348|NCT00007475|11431339|FG002|Overall Study|Adverse Event|0
7222349|NCT00007475|11431340|FG003|Overall Study|Adverse Event|0
7222350|NCT00008138|11431359|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
7222351|NCT00008138|11431359|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
7222352|NCT00008138|11431359|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
7222353|NCT00008138|11431359|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
7222354|NCT00008138|11431359|FG000|Interval Debulking|Withdrawal by Subject|2
7222355|NCT00008138|11431359|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
7222356|NCT00008138|11431359|FG000|Post-Cytoreduction Chemotherapy|Progression|1
7222357|NCT00008138|11431359|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
7222358|NCT00008385|11431366|FG000|Overall Study|Off treatment reasons not reported|79
7222359|NCT00008385|11431367|FG001|Overall Study|Off treatment reasons not reported|70
7222360|NCT00008385|11431366|FG000|Overall Study|Progressive disease|52
7222361|NCT00008385|11431367|FG001|Overall Study|Progressive disease|117
7222362|NCT00008385|11431366|FG000|Overall Study|Adverse Event|8
7222363|NCT00008385|11431367|FG001|Overall Study|Adverse Event|20
7222364|NCT00008385|11431366|FG000|Overall Study|Death|12
7222365|NCT00008385|11431367|FG001|Overall Study|Death|18
7222366|NCT00008385|11431366|FG000|Overall Study|Withdrawal by Subject|67
7222367|NCT00008385|11431367|FG001|Overall Study|Withdrawal by Subject|157
7222368|NCT00008385|11431366|FG000|Overall Study|Start non-protocol therapy|3
7222369|NCT00008385|11431367|FG001|Overall Study|Start non-protocol therapy|1
7222370|NCT00008385|11431366|FG000|Overall Study|Other complicating disease|17
7222371|NCT00008385|11431367|FG001|Overall Study|Other complicating disease|30
7222372|NCT00008385|11431366|FG000|Overall Study|Maximum dose reached|0
7222373|NCT00008385|11431367|FG001|Overall Study|Maximum dose reached|2
7222374|NCT00008385|11431366|FG000|Overall Study|Other|105
7222375|NCT00008385|11431367|FG001|Overall Study|Other|212
7222376|NCT00008385|11431366|FG000|Overall Study|Not start protocol therapy|44
7222377|NCT00008385|11431367|FG001|Overall Study|Not start protocol therapy|175
7222378|NCT00009737|11431375|FG000|Overall Study|Adverse Event|112
7222379|NCT00009737|11431376|FG001|Overall Study|Adverse Event|75
7222380|NCT00009737|11431375|FG000|Overall Study|Death|4
7222381|NCT00009737|11431376|FG001|Overall Study|Death|6
7222382|NCT00009737|11431375|FG000|Overall Study|Lack of Efficacy|17
7222383|NCT00009737|11431376|FG001|Overall Study|Lack of Efficacy|15
7222384|NCT00009737|11431375|FG000|Overall Study|Violation of Selection Criteria at Entry|13
7222385|NCT00009737|11431376|FG001|Overall Study|Violation of Selection Criteria at Entry|9
7222386|NCT00009737|11431375|FG000|Overall Study|Other Protocol Violation|1
7222387|NCT00009737|11431376|FG001|Overall Study|Other Protocol Violation|0
7222388|NCT00009737|11431375|FG000|Overall Study|Refused Treatment|15
7222389|NCT00009737|11431376|FG001|Overall Study|Refused Treatment|16
7222390|NCT00009737|11431375|FG000|Overall Study|Lost to Follow-up|1
7222391|NCT00009737|11431376|FG001|Overall Study|Lost to Follow-up|1
7222392|NCT00009737|11431375|FG000|Overall Study|Administrative/Other Reasons|7
7222393|NCT00009737|11431376|FG001|Overall Study|Administrative/Other Reasons|1
7222394|NCT00009945|11431384|FG000|Overall Study|no follow up data|7
7222395|NCT00009945|11431385|FG001|Overall Study|no follow up data|5
7222396|NCT00010257|11431393|FG000|Overall Study|Withdrawal by Subject|1
7222397|NCT00010257|11431394|FG001|Overall Study|Withdrawal by Subject|0
7222398|NCT00010374|11431400|FG000|Overall Study|False positive phrenic nerve test|1
7222399|NCT00010803|11431411|FG000|Overall Study|Withdrawal by Subject|97
7222400|NCT00010803|11431412|FG001|Overall Study|Withdrawal by Subject|98
7222401|NCT00012012|11431446|FG000|Overall Study|Protocol Violation|1
7222402|NCT00012012|11431447|FG001|Overall Study|Protocol Violation|1
7222403|NCT00012012|11431446|FG000|Overall Study|Withdrawal by Subject|0
7222404|NCT00012012|11431447|FG001|Overall Study|Withdrawal by Subject|2
7222405|NCT00013611|11431486|FG000|Overall Study|Lost to Follow-up|91
7222406|NCT00013611|11431487|FG001|Overall Study|Lost to Follow-up|100
7222407|NCT00014495|11431510|FG000|Overall Study|Death|0
7222408|NCT00014495|11431511|FG001|Overall Study|Death|0
7222409|NCT00014495|11431512|FG002|Overall Study|Death|1
7222410|NCT00014495|11431513|FG003|Overall Study|Death|0
7222411|NCT00014495|11431510|FG000|Overall Study|Clinical deterioration|0
7222412|NCT00014495|11431511|FG001|Overall Study|Clinical deterioration|0
7222413|NCT00014495|11431512|FG002|Overall Study|Clinical deterioration|0
7222414|NCT00014495|11431513|FG003|Overall Study|Clinical deterioration|1
7222415|NCT00014911|11431520|FG000|Overall Study|Adverse Event|1
7222416|NCT00014911|11431520|FG000|Overall Study|Lost to Follow-up|1
7222417|NCT00014911|11431520|FG000|Overall Study|Withdrawal by Subject|6
7222418|NCT00014911|11431520|FG000|Overall Study|Unknown Reasons|2
7222419|NCT00014911|11431520|FG000|Overall Study|Immunosuppression-related Side Effects|1
7297279|NCT00577460|11516310|FG001|Overall Study|Withdrawal by Subject|5
7297280|NCT00577460|11516311|FG002|Overall Study|Withdrawal by Subject|6
7297281|NCT00577460|11516309|FG000|Overall Study|Other|0
7297282|NCT00577460|11516310|FG001|Overall Study|Other|3
7297283|NCT00577460|11516311|FG002|Overall Study|Other|2
7297284|NCT00577473|11516328|FG000|Overall Study|Protocol Violation|1
7297285|NCT00577473|11516329|FG001|Overall Study|Protocol Violation|4
7297286|NCT00577473|11516328|FG000|Overall Study|Adverse Event|8
7297287|NCT00577473|11516329|FG001|Overall Study|Adverse Event|5
7297288|NCT00577473|11516328|FG000|Overall Study|Withdrawal by Subject|2
7297289|NCT00577473|11516329|FG001|Overall Study|Withdrawal by Subject|6
7297290|NCT00577473|11516328|FG000|Overall Study|Physician Decision|2
7297291|NCT00577473|11516329|FG001|Overall Study|Physician Decision|2
7297292|NCT00577473|11516328|FG000|Overall Study|Lack of Efficacy|8
7297293|NCT00577473|11516329|FG001|Overall Study|Lack of Efficacy|7
7297294|NCT00577629|11516352|FG000|Treatment Period|Death|1
7297295|NCT00577629|11516352|FG000|Long Term Follow-Up|Death|15
7297296|NCT00577629|11516352|FG000|Long Term Follow-Up|Lost to Follow-up|5
7297297|NCT00577629|11516352|FG000|Long Term Follow-Up|Withdrawal by Subject|4
7297298|NCT00577629|11516352|FG000|Long Term Follow-Up|Physician Decision|1
7297299|NCT00577642|11516358|FG000|Overall Study|Clinical Disease Progression|1
7297300|NCT00577655|11516364|FG000|Overall Study|Patient Request|0
7297301|NCT00577655|11516365|FG001|Overall Study|Patient Request|2
7297302|NCT00577655|11516364|FG000|Overall Study|Protocol Violation|0
7297303|NCT00577655|11516365|FG001|Overall Study|Protocol Violation|1
7297304|NCT00577655|11516364|FG000|Overall Study|Lost to Follow-up|1
7297305|NCT00577655|11516365|FG001|Overall Study|Lost to Follow-up|1
7297306|NCT00577707|11516372|FG000|Overall Study|Withdrawal by Subject|3
7297307|NCT00577720|11516380|FG000|Overall Study|Adverse Event|2
7297308|NCT00577720|11516381|FG001|Overall Study|Adverse Event|1
7297309|NCT00577720|11516382|FG002|Overall Study|Adverse Event|0
7297310|NCT00577720|11516383|FG003|Overall Study|Adverse Event|4
7297311|NCT00577720|11516380|FG000|Overall Study|Lost to Follow-up|0
7297312|NCT00577720|11516381|FG001|Overall Study|Lost to Follow-up|0
7297313|NCT00577720|11516382|FG002|Overall Study|Lost to Follow-up|1
7297314|NCT00577720|11516383|FG003|Overall Study|Lost to Follow-up|0
7297315|NCT00577720|11516380|FG000|Overall Study|Protocol Violation|0
7297316|NCT00577720|11516381|FG001|Overall Study|Protocol Violation|0
7297317|NCT00577720|11516382|FG002|Overall Study|Protocol Violation|0
7297318|NCT00577720|11516383|FG003|Overall Study|Protocol Violation|1
7297319|NCT00577720|11516380|FG000|Overall Study|Withdrawal by Subject|2
7297320|NCT00577720|11516381|FG001|Overall Study|Withdrawal by Subject|0
7297321|NCT00577720|11516382|FG002|Overall Study|Withdrawal by Subject|0
7297322|NCT00577720|11516383|FG003|Overall Study|Withdrawal by Subject|2
7297323|NCT00577824|11516396|FG000|Overall Study|Adverse Event|6
7297324|NCT00577824|11516397|FG001|Overall Study|Adverse Event|18
7297325|NCT00577824|11516398|FG002|Overall Study|Adverse Event|1
7297326|NCT00577824|11516396|FG000|Overall Study|Patient decision|0
7297327|NCT00577824|11516397|FG001|Overall Study|Patient decision|1
7297328|NCT00577824|11516398|FG002|Overall Study|Patient decision|1
7297329|NCT00577824|11516396|FG000|Overall Study|Protocol Violation|1
7297330|NCT00577824|11516397|FG001|Overall Study|Protocol Violation|1
7297331|NCT00577824|11516398|FG002|Overall Study|Protocol Violation|0
7297332|NCT00577863|11516408|FG000|Overall Study|Adverse Event|4
7297333|NCT00577863|11516409|FG001|Overall Study|Adverse Event|2
7297334|NCT00577863|11516408|FG000|Overall Study|Death|1
7297335|NCT00577863|11516409|FG001|Overall Study|Death|0
7297336|NCT00577863|11516408|FG000|Overall Study|Lost to Follow-up|2
7297337|NCT00577863|11516409|FG001|Overall Study|Lost to Follow-up|2
7297338|NCT00577863|11516408|FG000|Overall Study|Entry Criteria Exclusion|1
7297339|NCT00577863|11516409|FG001|Overall Study|Entry Criteria Exclusion|0
7297340|NCT00577863|11516408|FG000|Overall Study|Withdrawal by Subject|0
7297341|NCT00577863|11516409|FG001|Overall Study|Withdrawal by Subject|2
7297342|NCT00577863|11516408|FG000|Overall Study|Sponsor Decision|2
7297343|NCT00577863|11516409|FG001|Overall Study|Sponsor Decision|7
7297344|NCT00577863|11516408|FG000|Overall Study|Did Not Receive at Least One Injection|0
7297345|NCT00577863|11516409|FG001|Overall Study|Did Not Receive at Least One Injection|1
7297346|NCT00577889|11516418|FG000|Overall Study|Withdrawal by Subject|1
7297347|NCT00577889|11516419|FG001|Overall Study|Withdrawal by Subject|0
7297348|NCT00577889|11516420|FG002|Overall Study|Withdrawal by Subject|0
7297349|NCT00577993|11516431|FG000|Overall Study|Adverse Event|1
7297350|NCT00577993|11516432|FG001|Overall Study|Adverse Event|0
7297351|NCT00577993|11516433|FG002|Overall Study|Adverse Event|0
7297352|NCT00577993|11516431|FG000|Overall Study|Death|0
7297353|NCT00577993|11516432|FG001|Overall Study|Death|1
7297354|NCT00577993|11516433|FG002|Overall Study|Death|1
7297355|NCT00577993|11516431|FG000|Overall Study|Lack of Efficacy|0
7297356|NCT00577993|11516432|FG001|Overall Study|Lack of Efficacy|1
7297357|NCT00577993|11516433|FG002|Overall Study|Lack of Efficacy|0
7297358|NCT00577993|11516431|FG000|Overall Study|Protocol Violation|2
7297359|NCT00577993|11516432|FG001|Overall Study|Protocol Violation|3
7297360|NCT00577993|11516433|FG002|Overall Study|Protocol Violation|0
7297361|NCT00577993|11516431|FG000|Overall Study|Withdrawal by Subject|1
7297362|NCT00577993|11516432|FG001|Overall Study|Withdrawal by Subject|0
7222420|NCT00015457|11431524|FG000|First Intervention|Adverse Event|0
7222421|NCT00015457|11431525|FG001|First Intervention|Adverse Event|2
7222422|NCT00015457|11431524|FG000|First Intervention|Lack of Efficacy|0
7222423|NCT00015457|11431525|FG001|First Intervention|Lack of Efficacy|1
7222424|NCT00015457|11431524|FG000|Second Intervention|Withdrawal by Subject|1
7222425|NCT00015457|11431525|FG001|Second Intervention|Withdrawal by Subject|0
7222426|NCT00016354|11431535|FG000|Overall Study|Lack of Efficacy|0
7222427|NCT00016354|11431536|FG001|Overall Study|Lack of Efficacy|0
7222428|NCT00016354|11431537|FG002|Overall Study|Lack of Efficacy|0
7222429|NCT00016354|11431538|FG003|Overall Study|Lack of Efficacy|0
7222430|NCT00016354|11431539|FG004|Overall Study|Lack of Efficacy|0
7222431|NCT00016354|11431540|FG005|Overall Study|Lack of Efficacy|0
7222432|NCT00016354|11431541|FG006|Overall Study|Lack of Efficacy|0
7222433|NCT00016354|11431542|FG007|Overall Study|Lack of Efficacy|1
7222434|NCT00019604|11431571|FG000|Overall Study|Death|1
7222435|NCT00019604|11431571|FG000|Overall Study|Progressive disease|23
7222436|NCT00019604|11431571|FG000|Overall Study|Refused treatment|1
7222437|NCT00019604|11431571|FG000|Overall Study|Carcinoid tumor, not treatable|1
7222438|NCT00019604|11431571|FG000|Overall Study|Going to have liver transplant|1
7222439|NCT00019604|11431571|FG000|Overall Study|Move to a different study|1
7222440|NCT00019604|11431571|FG000|Overall Study|Non compliant on systemic CH|1
7222441|NCT00019604|11431571|FG000|Overall Study|Non compliant|1
7222442|NCT00019604|11431571|FG000|Overall Study|Resectable disease|1
7222443|NCT00019604|11431571|FG000|Overall Study|Started new chemo regimen|1
7222444|NCT00019604|11431571|FG000|Overall Study|Pt going to immunotherapy study|1
7222445|NCT00019604|11431571|FG000|Overall Study|Too much disease|1
7222446|NCT00019604|11431571|FG000|Overall Study|Unable to evaluate|1
7222447|NCT00019604|11431571|FG000|Overall Study|Details for other not available|4
7222448|NCT00021229|11431587|FG000|Overall Study|Adverse Event|10
7222449|NCT00021229|11431588|FG001|Overall Study|Adverse Event|5
7222450|NCT00021229|11431589|FG002|Overall Study|Adverse Event|2
7222451|NCT00021229|11431587|FG000|Overall Study|Death|0
7222452|NCT00021229|11431588|FG001|Overall Study|Death|1
7222453|NCT00021229|11431589|FG002|Overall Study|Death|0
7222454|NCT00021229|11431587|FG000|Overall Study|Withdrawal by Subject|7
7297363|NCT00577993|11516433|FG002|Overall Study|Withdrawal by Subject|2
7297364|NCT00577993|11516431|FG000|Overall Study|Conversion|2
7297365|NCT00577993|11516432|FG001|Overall Study|Conversion|5
7297366|NCT00577993|11516433|FG002|Overall Study|Conversion|0
7297367|NCT00577993|11516431|FG000|Overall Study|Uninsured|1
7297368|NCT00577993|11516432|FG001|Overall Study|Uninsured|0
7297369|NCT00577993|11516433|FG002|Overall Study|Uninsured|0
7297370|NCT00578136|11516446|FG000|Overall Study|Not given intervention|1
7297371|NCT00578136|11516447|FG001|Overall Study|Not given intervention|1
7297372|NCT00578175|11516456|FG000|Overall Study|Adverse Event|0
7297373|NCT00578175|11516457|FG001|Overall Study|Adverse Event|1
7297374|NCT00578175|11516458|FG002|Overall Study|Adverse Event|1
7297375|NCT00578175|11516456|FG000|Overall Study|Other reasons|70
7297376|NCT00578175|11516457|FG001|Overall Study|Other reasons|42
7297377|NCT00578175|11516458|FG002|Overall Study|Other reasons|23
7297378|NCT00578227|11516484|FG000|Overall Study|Lost to Follow-up|0
7297379|NCT00578227|11516485|FG001|Overall Study|Lost to Follow-up|1
7297380|NCT00578227|11516486|FG002|Overall Study|Lost to Follow-up|1
7297381|NCT00578227|11516484|FG000|Overall Study|Withdrawal by Subject|5
7297382|NCT00578227|11516485|FG001|Overall Study|Withdrawal by Subject|1
7297383|NCT00578227|11516486|FG002|Overall Study|Withdrawal by Subject|3
7297384|NCT00578292|11516505|FG000|Overall Study|Death|1
7297385|NCT00578292|11516505|FG000|Overall Study|Graft failure|2
7297386|NCT00578318|11516530|FG000|Overall Study|Lost to Follow-up|2
7297387|NCT00578318|11516531|FG001|Overall Study|Lost to Follow-up|0
7297388|NCT00578318|11516530|FG000|Overall Study|Physician Decision|1
7297389|NCT00578318|11516531|FG001|Overall Study|Physician Decision|0
7297390|NCT00578344|11516546|FG000|Overall Study|Insurance problems|1
7297391|NCT00578344|11516546|FG000|Overall Study|Graft failure|1
7297392|NCT00578448|11516571|FG000|Day 1 up to 3 Years of Planned Study|Death|1
7297393|NCT00578448|11516571|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
7297394|NCT00578448|11516571|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
7297395|NCT00578448|11516571|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
7297396|NCT00578565|11516598|FG000|Overall Study|Adverse Event|3
7297397|NCT00578643|11516612|FG000|Overall Study|Death|1
7297398|NCT00578643|11516612|FG000|Overall Study|Lost to Follow-up|1
7297399|NCT00578786|11516637|FG000|Overall Study|Adverse Event|27
7297400|NCT00578786|11516638|FG001|Overall Study|Adverse Event|37
7297401|NCT00578786|11516639|FG002|Overall Study|Adverse Event|17
7297402|NCT00578786|11516637|FG000|Overall Study|Lack of Efficacy|2
7297403|NCT00578786|11516638|FG001|Overall Study|Lack of Efficacy|5
7297404|NCT00578786|11516639|FG002|Overall Study|Lack of Efficacy|2
7297405|NCT00578786|11516637|FG000|Overall Study|Early Escape from Prior Study|2
7297406|NCT00578786|11516638|FG001|Overall Study|Early Escape from Prior Study|1
7297407|NCT00578786|11516639|FG002|Overall Study|Early Escape from Prior Study|2
7222455|NCT00021229|11431588|FG001|Overall Study|Withdrawal by Subject|7
7222456|NCT00021229|11431589|FG002|Overall Study|Withdrawal by Subject|1
7222457|NCT00021229|11431587|FG000|Overall Study|Progressive Disease|15
7222458|NCT00021229|11431588|FG001|Overall Study|Progressive Disease|19
7222459|NCT00021229|11431589|FG002|Overall Study|Progressive Disease|12
7222460|NCT00021229|11431587|FG000|Overall Study|Protocol Violation|1
7222461|NCT00021229|11431588|FG001|Overall Study|Protocol Violation|1
7222462|NCT00021229|11431589|FG002|Overall Study|Protocol Violation|0
7222463|NCT00021229|11431587|FG000|Overall Study|Physician Decision|0
7222464|NCT00021229|11431588|FG001|Overall Study|Physician Decision|0
7222465|NCT00021229|11431589|FG002|Overall Study|Physician Decision|1
7222466|NCT00021229|11431587|FG000|Overall Study|Punctate hemmorrhage post RT|2
7222467|NCT00021229|11431588|FG001|Overall Study|Punctate hemmorrhage post RT|0
7222468|NCT00021229|11431589|FG002|Overall Study|Punctate hemmorrhage post RT|0
7222469|NCT00021255|11431602|FG000|Overall Study|Death|1
7222470|NCT00021255|11431603|FG001|Overall Study|Death|0
7222471|NCT00021255|11431604|FG002|Overall Study|Death|2
7222472|NCT00021255|11431602|FG000|Overall Study|Breast cancer relapse|5
7222473|NCT00021255|11431603|FG001|Overall Study|Breast cancer relapse|18
7222474|NCT00021255|11431604|FG002|Overall Study|Breast cancer relapse|11
7222475|NCT00021255|11431602|FG000|Overall Study|Second primary malignancy|0
7222476|NCT00021255|11431603|FG001|Overall Study|Second primary malignancy|4
7222477|NCT00021255|11431604|FG002|Overall Study|Second primary malignancy|1
7222478|NCT00021255|11431602|FG000|Overall Study|Withdrawal by Subject|41
7222479|NCT00021255|11431603|FG001|Overall Study|Withdrawal by Subject|64
7222480|NCT00021255|11431604|FG002|Overall Study|Withdrawal by Subject|26
7222481|NCT00021255|11431602|FG000|Overall Study|Lost to Follow-up|0
7222482|NCT00021255|11431603|FG001|Overall Study|Lost to Follow-up|2
7222483|NCT00021255|11431604|FG002|Overall Study|Lost to Follow-up|3
7222484|NCT00021255|11431602|FG000|Overall Study|Cardiac toxicity|0
7222485|NCT00021255|11431603|FG001|Overall Study|Cardiac toxicity|61
7222486|NCT00021255|11431604|FG002|Overall Study|Cardiac toxicity|32
7222487|NCT00021255|11431602|FG000|Overall Study|Herceptin toxicity|0
7222488|NCT00021255|11431603|FG001|Overall Study|Herceptin toxicity|22
7222489|NCT00021255|11431604|FG002|Overall Study|Herceptin toxicity|6
7222490|NCT00021255|11431602|FG000|Overall Study|Adverse Event|46
7222491|NCT00021255|11431603|FG001|Overall Study|Adverse Event|30
7222492|NCT00021255|11431604|FG002|Overall Study|Adverse Event|18
7222493|NCT00021255|11431602|FG000|Overall Study|Protocol Violation|0
7222494|NCT00021255|11431603|FG001|Overall Study|Protocol Violation|2
7222495|NCT00021255|11431604|FG002|Overall Study|Protocol Violation|0
7222496|NCT00021255|11431602|FG000|Overall Study|Other than specified above|0
7222497|NCT00021255|11431603|FG001|Overall Study|Other than specified above|38
7222498|NCT00021255|11431604|FG002|Overall Study|Other than specified above|19
7222499|NCT00021255|11431602|FG000|Overall Study|Missing|0
7222500|NCT00021255|11431603|FG001|Overall Study|Missing|27
7222501|NCT00021255|11431604|FG002|Overall Study|Missing|13
7222502|NCT00021255|11431602|FG000|Overall Study|Randomized but not treated|28
7222503|NCT00021255|11431603|FG001|Overall Study|Randomized but not treated|2
7222504|NCT00021255|11431604|FG002|Overall Study|Randomized but not treated|18
7222505|NCT00021541|11431614|FG000|Period 1-First Treatment|Withdrawal by Subject|3
7222506|NCT00021541|11431615|FG001|Period 1-First Treatment|Withdrawal by Subject|3
7222507|NCT00021541|11431614|FG000|Period 1-First Treatment|Adverse Event|2
7222508|NCT00021541|11431615|FG001|Period 1-First Treatment|Adverse Event|1
7222509|NCT00021541|11431614|FG000|Period 1-First Treatment|non-adherence|3
7222510|NCT00021541|11431615|FG001|Period 1-First Treatment|non-adherence|0
7222511|NCT00021541|11431614|FG000|Period 1-First Treatment|Death|1
7222512|NCT00021541|11431615|FG001|Period 1-First Treatment|Death|0
7222513|NCT00021541|11431614|FG000|Period 1-First Treatment|Pts that did not progress|2
7222514|NCT00021541|11431615|FG001|Period 1-First Treatment|Pts that did not progress|2
7222515|NCT00021541|11431614|FG000|Period 1-First Treatment|Ineligible|0
7222516|NCT00021541|11431615|FG001|Period 1-First Treatment|Ineligible|2
7222517|NCT00021541|11431614|FG000|Period 2-crossover|refused phase B|2
7222518|NCT00021541|11431615|FG001|Period 2-crossover|refused phase B|2
7222519|NCT00021541|11431614|FG000|Period 2-crossover|Withdrawal by Subject|3
7222520|NCT00021541|11431615|FG001|Period 2-crossover|Withdrawal by Subject|4
7222521|NCT00021541|11431614|FG000|Period 2-crossover|Adverse Event|2
7222522|NCT00021541|11431615|FG001|Period 2-crossover|Adverse Event|2
7222523|NCT00021541|11431614|FG000|Period 2-crossover|non-adherence|1
7222524|NCT00021541|11431615|FG001|Period 2-crossover|non-adherence|0
7222525|NCT00021541|11431614|FG000|Period 2-crossover|Pts that did not progress|2
7222526|NCT00021541|11431615|FG001|Period 2-crossover|Pts that did not progress|3
7222527|NCT00022516|11431629|FG000|Overall Study|Adverse Event|0
7222528|NCT00022516|11431630|FG001|Overall Study|Adverse Event|59
7222529|NCT00022516|11431629|FG000|Overall Study|Lack of Efficacy|0
7222530|NCT00022516|11431630|FG001|Overall Study|Lack of Efficacy|27
7222531|NCT00022516|11431629|FG000|Overall Study|Physician Decision|0
7222532|NCT00022516|11431630|FG001|Overall Study|Physician Decision|1
7222533|NCT00022516|11431629|FG000|Overall Study|Protocol Violation|1
7222534|NCT00022516|11431630|FG001|Overall Study|Protocol Violation|3
7222535|NCT00022516|11431629|FG000|Overall Study|Withdrawal by Subject|2
7222536|NCT00022516|11431630|FG001|Overall Study|Withdrawal by Subject|113
7222537|NCT00022516|11431629|FG000|Overall Study|Incomplete documentation|0
7222538|NCT00022516|11431630|FG001|Overall Study|Incomplete documentation|27
7222539|NCT00022633|11431638|FG000|Overall Study|Adverse Event|11
7222540|NCT00022633|11431639|FG001|Overall Study|Adverse Event|1
7222541|NCT00022633|11431638|FG000|Overall Study|Refusal unrelated to adverse event|1
7222542|NCT00022633|11431639|FG001|Overall Study|Refusal unrelated to adverse event|0
7222543|NCT00022633|11431638|FG000|Overall Study|Progression/relapse|9
7222544|NCT00022633|11431639|FG001|Overall Study|Progression/relapse|2
7222545|NCT00022633|11431638|FG000|Overall Study|Death|4
7222546|NCT00022633|11431639|FG001|Overall Study|Death|0
7222547|NCT00022633|11431638|FG000|Overall Study|Other - not protocol specified|3
7222548|NCT00022633|11431639|FG001|Overall Study|Other - not protocol specified|2
7222549|NCT00022633|11431638|FG000|Overall Study|Ineligible|4
7222550|NCT00022633|11431639|FG001|Overall Study|Ineligible|0
7222551|NCT00022659|11431644|FG000|Overall Study|Ineligible: wrong primary|1
7222552|NCT00022659|11431644|FG000|Overall Study|Never treated|1
7222553|NCT00022672|11431654|FG000|Main Phase: 24 Months|Adverse Event|6
7222554|NCT00022672|11431655|FG001|Main Phase: 24 Months|Adverse Event|0
7222555|NCT00022672|11431654|FG000|Main Phase: 24 Months|Death|0
7222556|NCT00022672|11431655|FG001|Main Phase: 24 Months|Death|3
7222557|NCT00022672|11431654|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
7222558|NCT00022672|11431655|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
7222559|NCT00022672|11431654|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
7222560|NCT00022672|11431655|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
7222561|NCT00022672|11431654|FG000|Main Phase: 24 Months|Other Protocol Violation|1
7222562|NCT00022672|11431655|FG001|Main Phase: 24 Months|Other Protocol Violation|0
7222563|NCT00022672|11431654|FG000|Main Phase: 24 Months|Refused Treatment|3
7222564|NCT00022672|11431655|FG001|Main Phase: 24 Months|Refused Treatment|4
7222565|NCT00022672|11431654|FG000|Main Phase: 24 Months|Failure to Return|1
7222566|NCT00022672|11431655|FG001|Main Phase: 24 Months|Failure to Return|1
7222567|NCT00022672|11431654|FG000|Main Phase: 24 Months|Other|1
7222568|NCT00022672|11431655|FG001|Main Phase: 24 Months|Other|0
7222569|NCT00022672|11431654|FG000|Extension Phase|Adverse Event|1
7222570|NCT00022672|11431655|FG001|Extension Phase|Adverse Event|3
7222571|NCT00022672|11431654|FG000|Extension Phase|Death|0
7222572|NCT00022672|11431655|FG001|Extension Phase|Death|1
7222573|NCT00022672|11431654|FG000|Extension Phase|Insufficient Therapeutic Response|1
7222574|NCT00022672|11431655|FG001|Extension Phase|Insufficient Therapeutic Response|44
7222575|NCT00022672|11431654|FG000|Extension Phase|Refused Treatment|0
7222576|NCT00022672|11431655|FG001|Extension Phase|Refused Treatment|2
7222577|NCT00022672|11431654|FG000|Extension Phase|Other|1
7222578|NCT00022672|11431655|FG001|Extension Phase|Other|1
7222579|NCT00022698|11431664|FG000|Overall Study|Adverse Event|5
7222580|NCT00022698|11431665|FG001|Overall Study|Adverse Event|9
7222581|NCT00022698|11431664|FG000|Overall Study|Death|0
7222582|NCT00022698|11431665|FG001|Overall Study|Death|2
7222583|NCT00022698|11431664|FG000|Overall Study|Failure to return|0
7222584|NCT00022698|11431665|FG001|Overall Study|Failure to return|1
7222585|NCT00022698|11431664|FG000|Overall Study|Refused treatment|0
7222586|NCT00022698|11431665|FG001|Overall Study|Refused treatment|2
7222587|NCT00022698|11431664|FG000|Overall Study|Insufficient therapeutic response|2
7222588|NCT00022698|11431665|FG001|Overall Study|Insufficient therapeutic response|14
7222589|NCT00022698|11431664|FG000|Overall Study|Administrative /other|1
7222590|NCT00022698|11431665|FG001|Overall Study|Administrative /other|7
7222591|NCT00022763|11431675|FG000|Overall Study|Adverse Event|1
7222592|NCT00022763|11431676|FG001|Overall Study|Adverse Event|2
7222593|NCT00022763|11431675|FG000|Overall Study|Injection Site Reactions|0
7222594|NCT00022763|11431676|FG001|Overall Study|Injection Site Reactions|2
7222595|NCT00022763|11431675|FG000|Overall Study|Death|0
7222596|NCT00022763|11431676|FG001|Overall Study|Death|1
7222597|NCT00022763|11431675|FG000|Overall Study|Lost to Follow-up|0
7222598|NCT00022763|11431676|FG001|Overall Study|Lost to Follow-up|3
7222599|NCT00022763|11431675|FG000|Overall Study|Withdrawal by Subject|4
7222600|NCT00022763|11431676|FG001|Overall Study|Withdrawal by Subject|7
7222601|NCT00022763|11431675|FG000|Overall Study|Insufficient Therapy|1
7222602|NCT00022763|11431676|FG001|Overall Study|Insufficient Therapy|0
7222603|NCT00022763|11431675|FG000|Overall Study|Admin|3
7222604|NCT00022763|11431676|FG001|Overall Study|Admin|2
7222605|NCT00023322|11431690|FG000|Overall Study|Lost to Follow-up|1
7222606|NCT00023452|11431696|FG000|Overall Study|Ineligible for Study|163
7222607|NCT00023452|11431697|FG001|Overall Study|Ineligible for Study|159
7222608|NCT00023452|11431696|FG000|Overall Study|Out of Window|129
7222609|NCT00023452|11431697|FG001|Overall Study|Out of Window|69
7222610|NCT00023452|11431696|FG000|Overall Study|Death|2
7222611|NCT00023452|11431697|FG001|Overall Study|Death|0
7222612|NCT00023452|11431696|FG000|Overall Study|Withdrawal by Subject|66
7222613|NCT00023452|11431697|FG001|Overall Study|Withdrawal by Subject|54
7222614|NCT00023452|11431696|FG000|Overall Study|Adverse Event|139
7297408|NCT00578786|11516637|FG000|Overall Study|Withdrawal by Subject|7
7297409|NCT00578786|11516638|FG001|Overall Study|Withdrawal by Subject|8
7297410|NCT00578786|11516639|FG002|Overall Study|Withdrawal by Subject|5
7297411|NCT00578786|11516637|FG000|Overall Study|Protocol Violation|0
7297412|NCT00578786|11516638|FG001|Overall Study|Protocol Violation|3
7297413|NCT00578786|11516639|FG002|Overall Study|Protocol Violation|1
7297414|NCT00578786|11516637|FG000|Overall Study|Physician Decision|1
7297415|NCT00578786|11516638|FG001|Overall Study|Physician Decision|0
7297416|NCT00578786|11516639|FG002|Overall Study|Physician Decision|1
7297417|NCT00578786|11516637|FG000|Overall Study|Sponsor Decision|0
7297418|NCT00578786|11516638|FG001|Overall Study|Sponsor Decision|0
7297419|NCT00578786|11516639|FG002|Overall Study|Sponsor Decision|1
7297420|NCT00578786|11516637|FG000|Overall Study|Lost to Follow-up|0
7297421|NCT00578786|11516638|FG001|Overall Study|Lost to Follow-up|4
7297422|NCT00578786|11516639|FG002|Overall Study|Lost to Follow-up|0
7297423|NCT00578786|11516637|FG000|Overall Study|Pregnancy|0
7297424|NCT00578786|11516638|FG001|Overall Study|Pregnancy|1
7297425|NCT00578786|11516639|FG002|Overall Study|Pregnancy|0
7297426|NCT00578786|11516637|FG000|Overall Study|Not Otherwise Specified|0
7297427|NCT00578786|11516638|FG001|Overall Study|Not Otherwise Specified|4
7297428|NCT00578786|11516639|FG002|Overall Study|Not Otherwise Specified|1
7297429|NCT00578786|11516637|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
7297430|NCT00578786|11516638|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
7297431|NCT00578786|11516639|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
7297432|NCT00578812|11516659|FG000|Overall Study|Not treated|6
7297433|NCT00578812|11516660|FG001|Overall Study|Not treated|7
7297434|NCT00578864|11516669|FG000|Overall Study|Death|1
7297435|NCT00578864|11516670|FG001|Overall Study|Death|0
7297436|NCT00578877|11516678|FG000|Overall Study|Lost to Follow-up|8
7297437|NCT00578877|11516679|FG001|Overall Study|Lost to Follow-up|10
7297438|NCT00578877|11516678|FG000|Overall Study|early discontinue|61
7297439|NCT00578877|11516679|FG001|Overall Study|early discontinue|101
7297440|NCT00578877|11516678|FG000|Overall Study|did not provide follow-up data|12
7297441|NCT00578877|11516679|FG001|Overall Study|did not provide follow-up data|17
7297442|NCT00578942|11516707|FG000|Overall Study|Lost to Follow-up|1
7297443|NCT00579059|11516727|FG000|Overall Study|Study Canceled at 1 Year|21
7297444|NCT00579059|11516728|FG001|Overall Study|Study Canceled at 1 Year|10
7297445|NCT00579098|11516736|FG000|Overall Study|Lost to Follow-up|2
7297446|NCT00579098|11516737|FG001|Overall Study|Lost to Follow-up|0
7297447|NCT00579098|11516736|FG000|Overall Study|Adverse Event|2
7297448|NCT00579098|11516737|FG001|Overall Study|Adverse Event|3
7297449|NCT00579098|11516736|FG000|Overall Study|Withdrawal by Subject|2
7297450|NCT00579098|11516737|FG001|Overall Study|Withdrawal by Subject|3
7297451|NCT00579098|11516736|FG000|Overall Study|AF returned after ablation|3
7297452|NCT00579098|11516737|FG001|Overall Study|AF returned after ablation|2
7297453|NCT00579345|11516777|FG000|Overall Study|Withdrawal by Subject|2
7297454|NCT00579345|11516778|FG001|Overall Study|Withdrawal by Subject|0
7297455|NCT00579345|11516779|FG002|Overall Study|Withdrawal by Subject|0
7297456|NCT00579345|11516780|FG003|Overall Study|Withdrawal by Subject|0
7297457|NCT00579345|11516781|FG004|Overall Study|Withdrawal by Subject|0
7297458|NCT00579345|11516782|FG005|Overall Study|Withdrawal by Subject|0
7297459|NCT00579345|11516783|FG006|Overall Study|Withdrawal by Subject|0
7297460|NCT00579345|11516784|FG007|Overall Study|Withdrawal by Subject|1
7297461|NCT00579345|11516777|FG000|Overall Study|Lost to Follow-up|1
7297462|NCT00579345|11516778|FG001|Overall Study|Lost to Follow-up|0
7297463|NCT00579345|11516779|FG002|Overall Study|Lost to Follow-up|0
7297464|NCT00579345|11516780|FG003|Overall Study|Lost to Follow-up|0
7297465|NCT00579345|11516781|FG004|Overall Study|Lost to Follow-up|0
7297466|NCT00579345|11516782|FG005|Overall Study|Lost to Follow-up|0
7297467|NCT00579345|11516783|FG006|Overall Study|Lost to Follow-up|0
7297468|NCT00579345|11516784|FG007|Overall Study|Lost to Follow-up|0
7297469|NCT00579345|11516777|FG000|Overall Study|Adverse Event|0
7297470|NCT00579345|11516778|FG001|Overall Study|Adverse Event|0
7297471|NCT00579345|11516779|FG002|Overall Study|Adverse Event|1
7297472|NCT00579345|11516780|FG003|Overall Study|Adverse Event|0
7297473|NCT00579345|11516781|FG004|Overall Study|Adverse Event|0
7297474|NCT00579345|11516782|FG005|Overall Study|Adverse Event|0
7297475|NCT00579345|11516783|FG006|Overall Study|Adverse Event|0
7297476|NCT00579345|11516784|FG007|Overall Study|Adverse Event|0
7297477|NCT00579345|11516777|FG000|Overall Study|Protocol Violation|1
7297478|NCT00579345|11516778|FG001|Overall Study|Protocol Violation|0
7297479|NCT00579345|11516779|FG002|Overall Study|Protocol Violation|0
7297480|NCT00579345|11516780|FG003|Overall Study|Protocol Violation|0
7297481|NCT00579345|11516781|FG004|Overall Study|Protocol Violation|0
7297482|NCT00579345|11516782|FG005|Overall Study|Protocol Violation|0
7297483|NCT00579345|11516783|FG006|Overall Study|Protocol Violation|0
7297484|NCT00579345|11516784|FG007|Overall Study|Protocol Violation|1
7297485|NCT00579345|11516777|FG000|Overall Study|Death|1
7297486|NCT00579345|11516778|FG001|Overall Study|Death|1
7297487|NCT00579345|11516779|FG002|Overall Study|Death|1
7297488|NCT00579345|11516780|FG003|Overall Study|Death|1
7297489|NCT00579345|11516781|FG004|Overall Study|Death|0
7297490|NCT00579345|11516782|FG005|Overall Study|Death|0
7297491|NCT00579345|11516783|FG006|Overall Study|Death|0
7297492|NCT00579345|11516784|FG007|Overall Study|Death|0
7297493|NCT00579501|11516821|FG000|Overall Study|Death|1
7297494|NCT00579501|11516821|FG000|Overall Study|End of neoadjuvant therapy|25
7297495|NCT00579501|11516821|FG000|Overall Study|toxicity|1
7297496|NCT00579501|11516821|FG000|Overall Study|Secondary lesion|1
7297497|NCT00579501|11516821|FG000|Overall Study|Radiation therapy before surgery|1
7297498|NCT00579553|11516827|FG000|Overall Study|Lost to Follow-up|16
7297499|NCT00579553|11516828|FG001|Overall Study|Lost to Follow-up|13
7297500|NCT00579670|11516839|FG000|Overall Study|Death|1
7297501|NCT00579670|11516840|FG001|Overall Study|Death|0
7297502|NCT00579670|11516841|FG002|Overall Study|Death|0
7297503|NCT00579670|11516842|FG003|Overall Study|Death|0
7297504|NCT00579670|11516843|FG004|Overall Study|Death|0
7297505|NCT00579670|11516839|FG000|Overall Study|Adverse Event|1
7297506|NCT00579670|11516840|FG001|Overall Study|Adverse Event|0
7297507|NCT00579670|11516841|FG002|Overall Study|Adverse Event|1
7297508|NCT00579670|11516842|FG003|Overall Study|Adverse Event|2
7297509|NCT00579670|11516843|FG004|Overall Study|Adverse Event|0
7297510|NCT00579670|11516839|FG000|Overall Study|Lack of Efficacy|0
7297511|NCT00579670|11516840|FG001|Overall Study|Lack of Efficacy|0
7297512|NCT00579670|11516841|FG002|Overall Study|Lack of Efficacy|1
7297513|NCT00579670|11516842|FG003|Overall Study|Lack of Efficacy|14
7297514|NCT00579670|11516843|FG004|Overall Study|Lack of Efficacy|0
7297515|NCT00579670|11516839|FG000|Overall Study|Lost to Follow-up|0
7297516|NCT00579670|11516840|FG001|Overall Study|Lost to Follow-up|1
7297517|NCT00579670|11516841|FG002|Overall Study|Lost to Follow-up|0
7297518|NCT00579670|11516842|FG003|Overall Study|Lost to Follow-up|4
7297519|NCT00579670|11516843|FG004|Overall Study|Lost to Follow-up|0
7297520|NCT00579670|11516839|FG000|Overall Study|Other|0
7297521|NCT00579670|11516840|FG001|Overall Study|Other|0
7297522|NCT00579670|11516841|FG002|Overall Study|Other|1
7297523|NCT00579670|11516842|FG003|Overall Study|Other|2
7297524|NCT00579670|11516843|FG004|Overall Study|Other|0
7297525|NCT00579670|11516839|FG000|Overall Study|Withdrawal by Subject|0
7297526|NCT00579670|11516840|FG001|Overall Study|Withdrawal by Subject|0
7297527|NCT00579670|11516841|FG002|Overall Study|Withdrawal by Subject|1
7297528|NCT00579670|11516842|FG003|Overall Study|Withdrawal by Subject|0
7297529|NCT00579670|11516843|FG004|Overall Study|Withdrawal by Subject|0
7297530|NCT00579982|11516890|FG000|Overall Study|Adverse Event|4
7297531|NCT00579982|11516890|FG000|Overall Study|Protocol Violation|4
7297532|NCT00580034|11516894|FG000|Overall Study|Toxicity|10
7297533|NCT00580034|11516895|FG001|Overall Study|Toxicity|0
7297534|NCT00580047|11516902|FG000|Overall Study|Lost to Follow-up|1
7297535|NCT00580047|11516903|FG001|Overall Study|Lost to Follow-up|1
7297536|NCT00580047|11516904|FG002|Overall Study|Lost to Follow-up|0
7297537|NCT00580047|11516902|FG000|Overall Study|Withdrawal by Subject|1
7297538|NCT00580047|11516903|FG001|Overall Study|Withdrawal by Subject|1
7297539|NCT00580047|11516904|FG002|Overall Study|Withdrawal by Subject|2
7297540|NCT00580047|11516902|FG000|Overall Study|Withdrawal by Subject|1
7297541|NCT00580047|11516903|FG001|Overall Study|Withdrawal by Subject|0
7297542|NCT00580047|11516904|FG002|Overall Study|Withdrawal by Subject|0
7297543|NCT00580606|11516964|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
7297544|NCT00580606|11516965|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
7297545|NCT00580606|11516964|FG000|Open Label (OL)|Withdrawal by Subject|4
7297546|NCT00580606|11516965|FG001|Open Label (OL)|Withdrawal by Subject|6
7297547|NCT00580606|11516964|FG000|Open Label (OL)|Dosing Symptoms|0
7297548|NCT00580606|11516965|FG001|Open Label (OL)|Dosing Symptoms|1
7297549|NCT00580606|11516964|FG000|Open Label (OL)|Lost to Follow-up|0
7297550|NCT00580606|11516965|FG001|Open Label (OL)|Lost to Follow-up|1
7297551|NCT00580606|11516964|FG000|Open Label (OL)|Pregnancy|0
7297552|NCT00580606|11516965|FG001|Open Label (OL)|Pregnancy|1
7297553|NCT00580606|11516964|FG000|Open Label (OL)|Non-compliance|2
7297554|NCT00580606|11516965|FG001|Open Label (OL)|Non-compliance|0
7297555|NCT00580606|11516964|FG000|Open Label (OL)|Physician Decision|1
7297556|NCT00580606|11516965|FG001|Open Label (OL)|Physician Decision|1
7297557|NCT00580606|11516964|FG000|Open Label (OL)|Needed Prohibited Medication|0
7297558|NCT00580606|11516965|FG001|Open Label (OL)|Needed Prohibited Medication|1
7297559|NCT00580723|11517005|FG000|Overall Study|Did not want to participate in extension|3
7297560|NCT00580723|11517005|FG000|Overall Study|Lost to Follow-up|5
7297561|NCT00580788|11517013|FG000|Overall Study|Adverse Event|0
7297562|NCT00580788|11517014|FG001|Overall Study|Adverse Event|0
7297563|NCT00580788|11517015|FG002|Overall Study|Adverse Event|0
7297564|NCT00580788|11517016|FG003|Overall Study|Adverse Event|1
7297565|NCT00580801|11517036|FG000|Overall Study|Physician Decision|1
7297566|NCT00580801|11517037|FG001|Overall Study|Physician Decision|0
7297567|NCT00580801|11517038|FG002|Overall Study|Physician Decision|0
7297568|NCT00580801|11517036|FG000|Overall Study|Adverse Event|2
7297569|NCT00580801|11517037|FG001|Overall Study|Adverse Event|0
7297570|NCT00580801|11517038|FG002|Overall Study|Adverse Event|0
7297571|NCT00580801|11517036|FG000|Overall Study|Lost to Follow-up|2
7297572|NCT00580801|11517037|FG001|Overall Study|Lost to Follow-up|0
7297573|NCT00580801|11517038|FG002|Overall Study|Lost to Follow-up|0
7297574|NCT00580801|11517036|FG000|Overall Study|Reached a virologic endpoint|0
7297575|NCT00580801|11517037|FG001|Overall Study|Reached a virologic endpoint|1
7297576|NCT00580801|11517038|FG002|Overall Study|Reached a virologic endpoint|2
7297577|NCT00580801|11517036|FG000|Overall Study|Participant non-compliant|0
7297578|NCT00580801|11517037|FG001|Overall Study|Participant non-compliant|0
7297579|NCT00580801|11517038|FG002|Overall Study|Participant non-compliant|1
7297580|NCT00580801|11517036|FG000|Overall Study|Travel|1
7297581|NCT00580801|11517037|FG001|Overall Study|Travel|0
7297582|NCT00580801|11517038|FG002|Overall Study|Travel|0
7297583|NCT00580840|11517046|FG000|Run-in|Adverse Event|17
7297584|NCT00580840|11517047|FG001|Run-in|Adverse Event|0
7297585|NCT00580840|11517048|FG002|Run-in|Adverse Event|0
7297586|NCT00580840|11517049|FG003|Run-in|Adverse Event|0
7297587|NCT00580840|11517046|FG000|Run-in|Lack of Efficacy|93
7297588|NCT00580840|11517047|FG001|Run-in|Lack of Efficacy|0
7297589|NCT00580840|11517048|FG002|Run-in|Lack of Efficacy|0
7297590|NCT00580840|11517049|FG003|Run-in|Lack of Efficacy|0
7297591|NCT00580840|11517046|FG000|Run-in|Loss of Efficacy|1
7297592|NCT00580840|11517047|FG001|Run-in|Loss of Efficacy|0
7297593|NCT00580840|11517048|FG002|Run-in|Loss of Efficacy|0
7297594|NCT00580840|11517049|FG003|Run-in|Loss of Efficacy|0
7297595|NCT00580840|11517046|FG000|Run-in|Lost to Follow-up|4
7297596|NCT00580840|11517047|FG001|Run-in|Lost to Follow-up|0
7297597|NCT00580840|11517048|FG002|Run-in|Lost to Follow-up|0
7297598|NCT00580840|11517049|FG003|Run-in|Lost to Follow-up|0
7297599|NCT00580840|11517046|FG000|Run-in|Withdrawal by Subject|5
7297600|NCT00580840|11517047|FG001|Run-in|Withdrawal by Subject|0
7297601|NCT00580840|11517048|FG002|Run-in|Withdrawal by Subject|0
7297602|NCT00580840|11517049|FG003|Run-in|Withdrawal by Subject|0
7297603|NCT00580840|11517046|FG000|Run-in|Other: Per Sponsor Request|2
7297604|NCT00580840|11517047|FG001|Run-in|Other: Per Sponsor Request|0
7297605|NCT00580840|11517048|FG002|Run-in|Other: Per Sponsor Request|0
7297606|NCT00580840|11517049|FG003|Run-in|Other: Per Sponsor Request|0
7297607|NCT00580840|11517046|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
7297608|NCT00580840|11517047|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
7297609|NCT00580840|11517048|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
7297610|NCT00580840|11517049|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
7297611|NCT00580840|11517046|FG000|Run-in|Other: Exclusionary Lab Value|1
7297612|NCT00580840|11517047|FG001|Run-in|Other: Exclusionary Lab Value|0
7297613|NCT00580840|11517048|FG002|Run-in|Other: Exclusionary Lab Value|0
7297614|NCT00580840|11517049|FG003|Run-in|Other: Exclusionary Lab Value|0
7297615|NCT00580840|11517046|FG000|Double-Blind|Adverse Event|0
7297616|NCT00580840|11517047|FG001|Double-Blind|Adverse Event|3
7297617|NCT00580840|11517048|FG002|Double-Blind|Adverse Event|4
7297618|NCT00580840|11517049|FG003|Double-Blind|Adverse Event|1
7297619|NCT00580840|11517046|FG000|Double-Blind|Loss of Efficacy|0
7297620|NCT00580840|11517047|FG001|Double-Blind|Loss of Efficacy|1
7297621|NCT00580840|11517048|FG002|Double-Blind|Loss of Efficacy|2
7297622|NCT00580840|11517049|FG003|Double-Blind|Loss of Efficacy|10
7297623|NCT00580840|11517046|FG000|Double-Blind|Lost to Follow-up|0
7297624|NCT00580840|11517047|FG001|Double-Blind|Lost to Follow-up|1
7297625|NCT00580840|11517048|FG002|Double-Blind|Lost to Follow-up|0
7297626|NCT00580840|11517049|FG003|Double-Blind|Lost to Follow-up|2
7297627|NCT00580840|11517046|FG000|Double-Blind|Withdrawal by Subject|0
7297628|NCT00580840|11517047|FG001|Double-Blind|Withdrawal by Subject|1
7297629|NCT00580840|11517048|FG002|Double-Blind|Withdrawal by Subject|2
7297630|NCT00580840|11517049|FG003|Double-Blind|Withdrawal by Subject|2
7297631|NCT00580840|11517046|FG000|Double-Blind|Other: Discontinued Methotrexate|0
7297632|NCT00580840|11517047|FG001|Double-Blind|Other: Discontinued Methotrexate|1
7297633|NCT00580840|11517048|FG002|Double-Blind|Other: Discontinued Methotrexate|0
7297634|NCT00580840|11517049|FG003|Double-Blind|Other: Discontinued Methotrexate|0
7297635|NCT00580840|11517046|FG000|Double-Blind|Other: Forbidden Medication|0
7297636|NCT00580840|11517047|FG001|Double-Blind|Other: Forbidden Medication|0
7297637|NCT00580840|11517048|FG002|Double-Blind|Other: Forbidden Medication|1
7297638|NCT00580840|11517049|FG003|Double-Blind|Other: Forbidden Medication|0
7551528|NCT02970669|11910830|FG000|Open-label Period|Adverse Event|1
7551529|NCT02970669|11910831|FG001|Open-label Period|Adverse Event|0
7551530|NCT02970669|11910830|FG000|Open-label Period|Physician Decision|1
7551531|NCT02970669|11910831|FG001|Open-label Period|Physician Decision|0
7551532|NCT02970942|11910852|FG000|Overall Study|Death|0
7551533|NCT02970942|11910853|FG001|Overall Study|Death|1
7551534|NCT02970942|11910854|FG002|Overall Study|Death|0
7551535|NCT02970942|11910855|FG003|Overall Study|Death|0
7551536|NCT02970942|11910852|FG000|Overall Study|Lost to Follow-up|1
7551537|NCT02970942|11910853|FG001|Overall Study|Lost to Follow-up|0
7551538|NCT02970942|11910854|FG002|Overall Study|Lost to Follow-up|2
7551539|NCT02970942|11910855|FG003|Overall Study|Lost to Follow-up|1
7551540|NCT02970942|11910852|FG000|Overall Study|Withdrawal by Subject|3
7551541|NCT02970942|11910853|FG001|Overall Study|Withdrawal by Subject|5
7551542|NCT02970942|11910854|FG002|Overall Study|Withdrawal by Subject|3
7551543|NCT02970942|11910855|FG003|Overall Study|Withdrawal by Subject|2
7551544|NCT02971007|11910868|FG000|Overall Study|Adverse Event|1
7551545|NCT02971007|11910869|FG001|Overall Study|Adverse Event|0
7551546|NCT02971007|11910870|FG002|Overall Study|Adverse Event|0
7551547|NCT02971007|11910868|FG000|Overall Study|Lost to Follow-up|0
7551548|NCT02971007|11910869|FG001|Overall Study|Lost to Follow-up|1
7551549|NCT02971007|11910870|FG002|Overall Study|Lost to Follow-up|1
7551550|NCT02971007|11910868|FG000|Overall Study|Withdrawal by Subject|0
7551551|NCT02971007|11910869|FG001|Overall Study|Withdrawal by Subject|1
7551552|NCT02971007|11910870|FG002|Overall Study|Withdrawal by Subject|0
7551553|NCT02971007|11910868|FG000|Overall Study|Patient had yeast at Day 5 visit|1
7551554|NCT02971007|11910869|FG001|Overall Study|Patient had yeast at Day 5 visit|0
7551555|NCT02971007|11910870|FG002|Overall Study|Patient had yeast at Day 5 visit|0
7551556|NCT02971007|11910868|FG000|Overall Study|Patient discontinued study drug|0
7551557|NCT02971007|11910869|FG001|Overall Study|Patient discontinued study drug|1
7551558|NCT02971007|11910870|FG002|Overall Study|Patient discontinued study drug|0
7551559|NCT02971163|11910880|FG000|Overall Study|Lost to Follow-up|4
7551560|NCT02971163|11910881|FG001|Overall Study|Lost to Follow-up|2
7551561|NCT02971202|11910890|FG000|Overall Study|Pregnancy|1
7551562|NCT02971202|11910891|FG001|Overall Study|Pregnancy|0
7551563|NCT02971202|11910892|FG002|Overall Study|Pregnancy|0
7551564|NCT02971202|11910890|FG000|Overall Study|screen fail after consent|1
7551565|NCT02971202|11910891|FG001|Overall Study|screen fail after consent|0
7551566|NCT02971202|11910892|FG002|Overall Study|screen fail after consent|1
7551567|NCT02971228|11910900|FG000|Overall Study|Withdrawal by Subject|1
7551568|NCT02971228|11910901|FG001|Overall Study|Withdrawal by Subject|1
7551569|NCT02971228|11910902|FG002|Overall Study|Withdrawal by Subject|0
7297639|NCT00580866|11517074|FG000|Overall Study|Lost to Follow-up|2
7297640|NCT00580866|11517075|FG001|Overall Study|Lost to Follow-up|2
7297641|NCT00580970|11517092|FG000|Pre-treatment|Non-compliance|1
7297642|NCT00580970|11517092|FG000|Treatment (Lovastatin)|Non-compliance|6
7297643|NCT00580970|11517092|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
7297644|NCT00580970|11517092|FG000|Treatment (Lovastatin)|Physician Decision|4
7297645|NCT00580970|11517092|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
7297646|NCT00580970|11517092|FG000|Treatment (Lovastatin)|Death|1
7297647|NCT00580983|11517096|FG000|Overall Study|Did not complete 12 mon post RT studies|7
7297648|NCT00581100|11517113|FG000|Overall Study|Death|1
7297649|NCT00581100|11517114|FG001|Overall Study|Death|0
7297650|NCT00581100|11517113|FG000|Overall Study|Adverse Event|2
7297651|NCT00581100|11517114|FG001|Overall Study|Adverse Event|1
7297652|NCT00581100|11517113|FG000|Overall Study|Withdrawal by Subject|1
7297653|NCT00581100|11517114|FG001|Overall Study|Withdrawal by Subject|4
7297654|NCT00581100|11517113|FG000|Overall Study|Other|3
7297655|NCT00581100|11517114|FG001|Overall Study|Other|0
7297656|NCT00581308|11517136|FG000|Pre Discharge|Lost to Follow-up|1
7297657|NCT00581308|11517136|FG000|Pre Discharge|Device Removed|1
7297658|NCT00581308|11517136|FG000|Month 1|Lost to Follow-up|3
7297659|NCT00581308|11517136|FG000|Month 1|Withdrawal by Subject|2
7297660|NCT00581308|11517136|FG000|Month 1|Device Removed|2
7297661|NCT00581308|11517136|FG000|Month 1|Uknown|1
7297662|NCT00581308|11517136|FG000|Month 6|Lost to Follow-up|1
7297663|NCT00581308|11517136|FG000|Month 6|Withdrawal by Subject|2
7297664|NCT00581308|11517136|FG000|Month 12|Death|1
7297665|NCT00581308|11517136|FG000|Month 12|Lost to Follow-up|14
7297666|NCT00581308|11517136|FG000|Month 12|Withdrawal by Subject|3
7297667|NCT00581308|11517136|FG000|Month 12|Device Removed|1
7297668|NCT00581308|11517136|FG000|Month 12|Other|1
7297669|NCT00581360|11517152|FG000|Overall Study|Withdrawal by Subject|1
7297670|NCT00581542|11517184|FG000|Overall Study|they met an exclusion criteria|2
7297671|NCT00581542|11517185|FG001|Overall Study|they met an exclusion criteria|2
7297672|NCT00581542|11517184|FG000|Overall Study|Lost to Follow-up|9
7297673|NCT00581542|11517185|FG001|Overall Study|Lost to Follow-up|21
7297674|NCT00581555|11517195|FG000|Overall Study|Adverse Event|4
7297675|NCT00581555|11517196|FG001|Overall Study|Adverse Event|3
7297676|NCT00581555|11517195|FG000|Overall Study|Physician Decision|3
7297677|NCT00581555|11517196|FG001|Overall Study|Physician Decision|2
7297678|NCT00581555|11517195|FG000|Overall Study|Withdrawal by Subject|18
7297679|NCT00581555|11517196|FG001|Overall Study|Withdrawal by Subject|9
7297680|NCT00581555|11517195|FG000|Overall Study|Lost to Follow-up|2
7297681|NCT00581555|11517196|FG001|Overall Study|Lost to Follow-up|2
7297682|NCT00581555|11517195|FG000|Overall Study|Other reasons|16
7297683|NCT00581555|11517196|FG001|Overall Study|Other reasons|4
7297684|NCT00581776|11517211|FG000|Overall Study|Disease progression or no response|3
7297685|NCT00581828|11517215|FG000|Overall Study|Protocol Violation|1
7297686|NCT00581893|11517230|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
7297687|NCT00581893|11517231|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
7297688|NCT00581919|11517237|FG000|Overall Study|Adverse Event|8
7297689|NCT00581919|11517237|FG000|Overall Study|Death|1
7297690|NCT00581919|11517237|FG000|Overall Study|Disease Progression|10
7297691|NCT00581919|11517237|FG000|Overall Study|Physician Decision|1
7297692|NCT00581919|11517237|FG000|Overall Study|Other Complicating Disease|1
7297693|NCT00581919|11517237|FG000|Overall Study|Started Non-Protocol Therapy|2
7297694|NCT00581919|11517237|FG000|Overall Study|Withdrawal by Subject|1
7297695|NCT00581945|11517244|FG000|Overall Study|Adverse Event|4
7297696|NCT00581945|11517245|FG001|Overall Study|Adverse Event|4
7297697|NCT00581945|11517244|FG000|Overall Study|Unsatisfactory therapeutic effect|2
7297698|NCT00581945|11517245|FG001|Overall Study|Unsatisfactory therapeutic effect|0
7297699|NCT00581945|11517244|FG000|Overall Study|Withdrawal by Subject|2
7297700|NCT00581945|11517245|FG001|Overall Study|Withdrawal by Subject|6
7297701|NCT00581945|11517244|FG000|Overall Study|Death|1
7297702|NCT00581945|11517245|FG001|Overall Study|Death|0
7297703|NCT00582010|11517258|FG000|Overall Study|Death|0
7297704|NCT00582010|11517259|FG001|Overall Study|Death|1
7297705|NCT00582114|11517271|FG000|Overall Study|Death|4
7297706|NCT00582114|11517272|FG001|Overall Study|Death|4
7297707|NCT00582114|11517271|FG000|Overall Study|Kidney Transplant|3
7297708|NCT00582114|11517272|FG001|Overall Study|Kidney Transplant|1
7297709|NCT00582114|11517271|FG000|Overall Study|Lost to Follow-up|7
7297710|NCT00582114|11517272|FG001|Overall Study|Lost to Follow-up|6
7297711|NCT00582114|11517271|FG000|Overall Study|Withdrawal by Subject|8
7297712|NCT00582114|11517272|FG001|Overall Study|Withdrawal by Subject|16
7297713|NCT00582114|11517271|FG000|Overall Study|Adverse Event|1
7297714|NCT00582114|11517272|FG001|Overall Study|Adverse Event|1
7297715|NCT00582114|11517271|FG000|Overall Study|Physician Decision|0
7297716|NCT00582114|11517272|FG001|Overall Study|Physician Decision|6
7297717|NCT00582114|11517271|FG000|Overall Study|Stopped by data safety monitoring board|19
7297718|NCT00582114|11517272|FG001|Overall Study|Stopped by data safety monitoring board|20
7297719|NCT00582166|11517278|FG000|Overall Study|Death|1
7297720|NCT00582166|11517278|FG000|Overall Study|Ineligible pathology|1
7297721|NCT00582309|11517289|FG000|Overall Study|Protocol Violation|0
7297722|NCT00582309|11517290|FG001|Overall Study|Protocol Violation|0
7297723|NCT00582309|11517291|FG002|Overall Study|Protocol Violation|2
7297724|NCT00582426|11517314|FG000|Overall Study|Lost to Follow-up|0
7297725|NCT00582426|11517315|FG001|Overall Study|Lost to Follow-up|2
7297726|NCT00582426|11517314|FG000|Overall Study|Adverse Event|4
7297727|NCT00582426|11517315|FG001|Overall Study|Adverse Event|2
7297728|NCT00582426|11517314|FG000|Overall Study|Protocol Violation|6
7297729|NCT00582426|11517315|FG001|Overall Study|Protocol Violation|2
7297730|NCT00582426|11517314|FG000|Overall Study|Death|4
7297731|NCT00582426|11517315|FG001|Overall Study|Death|3
7297732|NCT00582426|11517314|FG000|Overall Study|Withdrawal by Subject|3
7297733|NCT00582426|11517315|FG001|Overall Study|Withdrawal by Subject|2
7297734|NCT00582426|11517314|FG000|Overall Study|Disease Progression|2
7297735|NCT00582426|11517315|FG001|Overall Study|Disease Progression|2
7297736|NCT00582426|11517314|FG000|Overall Study|Use of illicit drugs|1
7297737|NCT00582426|11517315|FG001|Overall Study|Use of illicit drugs|0
7297738|NCT00582491|11517323|FG000|Overall Study|Withdrawal by Subject|1
7297739|NCT00582491|11517324|FG001|Overall Study|Withdrawal by Subject|0
7297740|NCT00582556|11517342|FG000|Overall Study|Withdrawal by Subject|0
7297741|NCT00582556|11517343|FG001|Overall Study|Withdrawal by Subject|1
7297742|NCT00582556|11517344|FG002|Overall Study|Withdrawal by Subject|1
7297743|NCT00582556|11517342|FG000|Overall Study|Physician Decision|0
7297744|NCT00582556|11517343|FG001|Overall Study|Physician Decision|0
7297745|NCT00582556|11517344|FG002|Overall Study|Physician Decision|1
7297746|NCT00582608|11517353|FG000|Overall Study|Not Treated|7
7297747|NCT00582608|11517353|FG000|Overall Study|Patient Ineligible|1
7297748|NCT00582608|11517353|FG000|Overall Study|Lack of accrual|4
7297749|NCT00582738|11517368|FG000|Overall Study|Administrative Problems|7
7297750|NCT00582738|11517369|FG001|Overall Study|Administrative Problems|8
7297751|NCT00582738|11517368|FG000|Overall Study|Adverse Event|0
7297752|NCT00582738|11517369|FG001|Overall Study|Adverse Event|5
7297753|NCT00582738|11517368|FG000|Overall Study|Graft Lost|0
7297754|NCT00582738|11517369|FG001|Overall Study|Graft Lost|1
7297755|NCT00582738|11517368|FG000|Overall Study|Other|1
7297756|NCT00582738|11517369|FG001|Overall Study|Other|0
7297757|NCT00582738|11517368|FG000|Overall Study|Protocol Violation|1
7297758|NCT00582738|11517369|FG001|Overall Study|Protocol Violation|1
7297759|NCT00582738|11517368|FG000|Overall Study|Withdrawal by Subject|0
7297760|NCT00582738|11517369|FG001|Overall Study|Withdrawal by Subject|3
7297761|NCT00582790|11517381|FG000|Overall Study|Rapid progression of disease|1
7297762|NCT00582816|11517386|FG000|Overall Study|Engraftment Failure|3
7297763|NCT00582907|11517394|FG000|1st Course|Withdrawal by Subject|1
7297764|NCT00582907|11517395|FG001|1st Course|Withdrawal by Subject|0
7297765|NCT00582907|11517396|FG002|1st Course|Withdrawal by Subject|0
7297766|NCT00582907|11517397|FG003|1st Course|Withdrawal by Subject|0
7297767|NCT00582907|11517394|FG000|1st Course|Lost to Follow-up|0
7297768|NCT00582907|11517395|FG001|1st Course|Lost to Follow-up|0
7297769|NCT00582907|11517396|FG002|1st Course|Lost to Follow-up|0
7297770|NCT00582907|11517397|FG003|1st Course|Lost to Follow-up|1
7297771|NCT00582907|11517394|FG000|2nd Course|Lack of Efficacy|1
7297772|NCT00582907|11517395|FG001|2nd Course|Lack of Efficacy|0
7297773|NCT00582907|11517396|FG002|2nd Course|Lack of Efficacy|0
7297774|NCT00582907|11517397|FG003|2nd Course|Lack of Efficacy|0
7297775|NCT00582933|11517403|FG000|Overall Study|Physician Decision|3
7297776|NCT00582972|11517411|FG000|Overall Study|Protocol Violation|2
7297777|NCT00583102|11517439|FG000|Overall Study|Adverse Event|3
7297778|NCT00583219|11517443|FG000|Phase 2|Withdrawal by Subject|1
7297779|NCT00583362|11517447|FG000|Overall Study|Adverse Event|44
7297780|NCT00583362|11517447|FG000|Overall Study|Lack of Efficacy|22
7297781|NCT00583362|11517447|FG000|Overall Study|Lost to Follow-up|4
7297782|NCT00583362|11517447|FG000|Overall Study|Non-compliance with study drug|28
7297783|NCT00583362|11517447|FG000|Overall Study|Pregnancy|7
7297784|NCT00583362|11517447|FG000|Overall Study|Miscommunication of visit window|5
7297785|NCT00583362|11517447|FG000|Overall Study|Current site closed|7
7297786|NCT00583362|11517447|FG000|Overall Study|Subject not dosed in LBSL99|1
7297787|NCT00583362|11517447|FG000|Overall Study|Subject moved out of the country/state|2
7297788|NCT00583362|11517447|FG000|Overall Study|Missed visits due to staff changes|1
7297789|NCT00583362|11517447|FG000|Overall Study|Misunderstanding of protocol|1
7297790|NCT00583362|11517447|FG000|Overall Study|Behavioral problems and non-compliance|1
7297791|NCT00583362|11517447|FG000|Overall Study|Sponsor request due to missed doses|1
7297792|NCT00583362|11517447|FG000|Overall Study|Physician Decision|19
7297793|NCT00583362|11517447|FG000|Overall Study|Protocol Violation|2
7297794|NCT00583362|11517447|FG000|Overall Study|Withdrawal by Subject|57
7297795|NCT00583453|11517466|FG000|Overall Study|discontinued intervention|0
7297796|NCT00583453|11517467|FG001|Overall Study|discontinued intervention|2
7297797|NCT00583557|11517484|FG000|Overall Study|Withdrawal by Subject|18
7297798|NCT00583557|11517484|FG000|Overall Study|Adverse Event|9
7297799|NCT00583557|11517484|FG000|Overall Study|Lack of Efficacy|31
7297800|NCT00583557|11517484|FG000|Overall Study|Lack of Compliance|5
7297801|NCT00583557|11517484|FG000|Overall Study|Other|5
7297802|NCT00583557|11517484|FG000|Overall Study|Did not receive belimumab in LBRA99|2
7297803|NCT00583596|11517488|FG000|Overall Study|Lost to Follow-up|110
7297804|NCT00583596|11517488|FG000|Overall Study|Excluded due to Hurricane Katrina|30
7297805|NCT00583596|11517488|FG000|Overall Study|Death|2
7297806|NCT00583596|11517488|FG000|Overall Study|Withdrawal by Subject|6
7297807|NCT00583596|11517488|FG000|Overall Study|Lost to Follow-up|94
7297808|NCT00583596|11517488|FG000|Overall Study|Data not complete|1
7297809|NCT00583596|11517488|FG000|Overall Study|Not consented|15
7297810|NCT00583596|11517488|FG000|Overall Study|Outside f-up window|26
7297811|NCT00583791|11517524|FG000|Overall Study|Other|67
7297812|NCT00583791|11517524|FG000|Overall Study|Death|6
7297813|NCT00583947|11517559|FG000|Cross-over Period|Adverse Event|2
7297814|NCT00583947|11517560|FG001|Cross-over Period|Adverse Event|0
7297815|NCT00583947|11517559|FG000|Cross-over Period|Withdrawal by Subject|2
7297816|NCT00583947|11517560|FG001|Cross-over Period|Withdrawal by Subject|0
7297817|NCT00583947|11517559|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
7297818|NCT00583947|11517560|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
7297819|NCT00583947|11517559|FG000|Cross-over Period|Other|1
7297820|NCT00583947|11517560|FG001|Cross-over Period|Other|1
7297821|NCT00584194|11517573|FG000|Overall Study|Other|135
7297822|NCT00584415|11517592|FG000|Overall Study|Adverse Event|7
7297823|NCT00584454|11517597|FG000|Overall Study|Adverse Event|1
7297824|NCT00584454|11517597|FG000|Overall Study|Relocation|1
7297825|NCT00584454|11517597|FG000|Overall Study|Clinical Hold|2
7297826|NCT00584727|11517615|FG000|First Intervention|Discontinuation|0
7297827|NCT00584727|11517616|FG001|First Intervention|Discontinuation|0
7297828|NCT00584727|11517617|FG002|First Intervention|Discontinuation|1
7297829|NCT00584727|11517618|FG003|First Intervention|Discontinuation|0
7297830|NCT00584727|11517619|FG004|First Intervention|Discontinuation|0
7297831|NCT00584727|11517620|FG005|First Intervention|Discontinuation|0
7297832|NCT00584727|11517615|FG000|Third Intervention|Protocol Violation|0
7297833|NCT00584727|11517616|FG001|Third Intervention|Protocol Violation|0
7297834|NCT00584727|11517617|FG002|Third Intervention|Protocol Violation|1
7297835|NCT00584727|11517618|FG003|Third Intervention|Protocol Violation|0
7297836|NCT00584727|11517619|FG004|Third Intervention|Protocol Violation|4
7297837|NCT00584727|11517620|FG005|Third Intervention|Protocol Violation|2
7297838|NCT00584740|11517633|FG000|Overall Study|Adverse Event|1
7297839|NCT00584740|11517634|FG001|Overall Study|Adverse Event|1
7297840|NCT00584740|11517633|FG000|Overall Study|Lack of Efficacy|8
7297841|NCT00584740|11517634|FG001|Overall Study|Lack of Efficacy|2
7297842|NCT00584740|11517633|FG000|Overall Study|Withdrawal by Subject|3
7297843|NCT00584740|11517634|FG001|Overall Study|Withdrawal by Subject|2
7297844|NCT00584740|11517633|FG000|Overall Study|Lost to Follow-up|0
7297845|NCT00584740|11517634|FG001|Overall Study|Lost to Follow-up|1
7297846|NCT00584805|11517640|FG000|Overall Study|No longer at risk of exposure|39
7297847|NCT00584805|11517640|FG000|Overall Study|Relocation|36
7297848|NCT00584805|11517640|FG000|Overall Study|Withdrawal by Subject|18
7297849|NCT00584805|11517640|FG000|Overall Study|Non-compliance|1
7297850|NCT00584805|11517640|FG000|Overall Study|Lost to follow up|3
7297851|NCT00584805|11517640|FG000|Overall Study|Screen failures|2
7297852|NCT00584844|11517674|FG000|Overall Study|Withdrawal by Subject|59
7297853|NCT00584844|11517674|FG000|Overall Study|Screen Failure|20
7297854|NCT00584870|11517689|FG000|Overall Study|Adverse Event|4
7297855|NCT00584870|11517690|FG001|Overall Study|Adverse Event|3
7222615|NCT00023452|11431697|FG001|Overall Study|Adverse Event|196
7222616|NCT00023452|11431696|FG000|Overall Study|Lost to Follow-up|293
7222617|NCT00023452|11431697|FG001|Overall Study|Lost to Follow-up|60
7222618|NCT00023452|11431696|FG000|Overall Study|Physician Decision|49
7222619|NCT00023452|11431697|FG001|Overall Study|Physician Decision|21
7222620|NCT00023452|11431696|FG000|Overall Study|Refused Treatment (continued follow-up)|225
7222621|NCT00023452|11431697|FG001|Overall Study|Refused Treatment (continued follow-up)|224
7222622|NCT00023452|11431696|FG000|Overall Study|Pregnant|53
7222623|NCT00023452|11431697|FG001|Overall Study|Pregnant|20
7222624|NCT00023452|11431696|FG000|Overall Study|Other|204
7222625|NCT00023452|11431697|FG001|Overall Study|Other|69
7222626|NCT00023595|11431712|FG000|5 Year Follow up|Lost to Follow-up|2
7222627|NCT00023595|11431713|FG001|5 Year Follow up|Lost to Follow-up|2
7222628|NCT00023595|11431714|FG002|5 Year Follow up|Lost to Follow-up|1
7222629|NCT00023595|11431715|FG003|5 Year Follow up|Lost to Follow-up|7
7222630|NCT00023595|11431716|FG004|5 Year Follow up|Lost to Follow-up|3
7297856|NCT00584870|11517691|FG002|Overall Study|Adverse Event|2
7297857|NCT00584870|11517689|FG000|Overall Study|Lost to Follow-up|4
7297858|NCT00584870|11517690|FG001|Overall Study|Lost to Follow-up|1
7297859|NCT00584870|11517691|FG002|Overall Study|Lost to Follow-up|1
7297860|NCT00584870|11517689|FG000|Overall Study|Lack of Efficacy|7
7297861|NCT00584870|11517690|FG001|Overall Study|Lack of Efficacy|14
7297862|NCT00584870|11517691|FG002|Overall Study|Lack of Efficacy|8
7297863|NCT00584870|11517689|FG000|Overall Study|Withdrawal by Subject|10
7297864|NCT00584870|11517690|FG001|Overall Study|Withdrawal by Subject|5
7297865|NCT00584870|11517691|FG002|Overall Study|Withdrawal by Subject|3
7297866|NCT00584870|11517689|FG000|Overall Study|Protocol Violation|1
7297867|NCT00584870|11517690|FG001|Overall Study|Protocol Violation|1
7297868|NCT00584870|11517691|FG002|Overall Study|Protocol Violation|2
7297869|NCT00584870|11517689|FG000|Overall Study|Did not met entrance criteria|1
7297870|NCT00584870|11517690|FG001|Overall Study|Did not met entrance criteria|0
7297871|NCT00584870|11517691|FG002|Overall Study|Did not met entrance criteria|0
7222631|NCT00023595|11431712|FG000|10 Year Follow up|Lost to Follow-up|12
7222632|NCT00023595|11431713|FG001|10 Year Follow up|Lost to Follow-up|10
7297872|NCT00584870|11517689|FG000|Overall Study|Other|2
7297873|NCT00584870|11517690|FG001|Overall Study|Other|0
7297874|NCT00584870|11517691|FG002|Overall Study|Other|0
7297875|NCT00584870|11517689|FG000|Overall Study|Randomized but not treated|0
7297876|NCT00584870|11517690|FG001|Overall Study|Randomized but not treated|1
7297877|NCT00584870|11517691|FG002|Overall Study|Randomized but not treated|2
7297878|NCT00584909|11517699|FG000|Overall Study|Adverse Event|4
7297879|NCT00584987|11517720|FG000|Overall Study|Protocol Violation|1
7297880|NCT00584987|11517721|FG001|Overall Study|Protocol Violation|1
7297881|NCT00584987|11517722|FG002|Overall Study|Protocol Violation|1
7297882|NCT00584987|11517723|FG003|Overall Study|Protocol Violation|0
7297883|NCT00584987|11517720|FG000|Overall Study|Adverse Event|0
7297884|NCT00584987|11517721|FG001|Overall Study|Adverse Event|0
7297885|NCT00584987|11517722|FG002|Overall Study|Adverse Event|0
7297886|NCT00584987|11517723|FG003|Overall Study|Adverse Event|1
7297887|NCT00585039|11517746|FG000|Overall Study|medication spilled|2
7297888|NCT00585039|11517747|FG001|Overall Study|medication spilled|0
7297889|NCT00585052|11517755|FG000|Overall Study|Withdrawal by Subject|1
7297890|NCT00585078|11517759|FG000|Overall Study|Withdrawal by Subject|4
7297891|NCT00585078|11517759|FG000|Overall Study|Poor performance status|1
7297892|NCT00585078|11517759|FG000|Overall Study|Disease Progression|24
7297893|NCT00585078|11517759|FG000|Overall Study|Adverse Event|10
7297894|NCT00585078|11517759|FG000|Overall Study|Death|1
7297895|NCT00585169|11517767|FG000|Overall Study|Withdrawal by Subject|1
7297896|NCT00585286|11517786|FG000|Overall Study|Lost to Follow-up|1
7297897|NCT00585312|11517792|FG000|Overall Study|Adverse Event|3
7297898|NCT00585312|11517793|FG001|Overall Study|Adverse Event|0
7297899|NCT00585312|11517792|FG000|Overall Study|Lack of Efficacy|6
7297900|NCT00585312|11517793|FG001|Overall Study|Lack of Efficacy|11
7297901|NCT00585312|11517792|FG000|Overall Study|Lost to Follow-up|1
7297902|NCT00585312|11517793|FG001|Overall Study|Lost to Follow-up|1
7297903|NCT00585312|11517792|FG000|Overall Study|Reason not specified|2
7297904|NCT00585312|11517793|FG001|Overall Study|Reason not specified|0
7297905|NCT00585312|11517792|FG000|Overall Study|Withdrawal by Subject|5
7297906|NCT00585312|11517793|FG001|Overall Study|Withdrawal by Subject|1
7297907|NCT00585312|11517792|FG000|Overall Study|Study terminated by the sponsor|34
7297908|NCT00585312|11517793|FG001|Overall Study|Study terminated by the sponsor|31
7297909|NCT00585325|11517801|FG000|Overall Study|Withdrawal by Subject|1
7297910|NCT00585325|11517802|FG001|Overall Study|Withdrawal by Subject|1
7551570|NCT02971228|11910903|FG003|Overall Study|Withdrawal by Subject|0
7551571|NCT02971228|11910904|FG004|Overall Study|Withdrawal by Subject|0
7551572|NCT02971228|11910900|FG000|Overall Study|Logistical challenges|0
7551573|NCT02971228|11910901|FG001|Overall Study|Logistical challenges|1
7551574|NCT02971228|11910902|FG002|Overall Study|Logistical challenges|0
7551575|NCT02971228|11910903|FG003|Overall Study|Logistical challenges|0
7551576|NCT02971228|11910904|FG004|Overall Study|Logistical challenges|0
7551577|NCT02971605|11910930|FG000|Overall Study|Withdrawal by Subject|1
7551578|NCT02971670|11910948|FG000|Overall Study|Withdrawal by Subject|4
7551579|NCT02971670|11910949|FG001|Overall Study|Withdrawal by Subject|1
7551580|NCT02971670|11910950|FG002|Overall Study|Withdrawal by Subject|1
7551581|NCT02971670|11910951|FG003|Overall Study|Withdrawal by Subject|2
7551582|NCT02971800|11910970|FG000|Overall Study|Protocol Violation|1
7551583|NCT02971800|11910970|FG000|Overall Study|Withdrawal by Subject|1
7551584|NCT02971800|11910970|FG000|Overall Study|Exclusion criteria prior intervention|1
7551585|NCT02971800|11910970|FG000|Overall Study|Number evaluable participant already reached|4
7551586|NCT02972242|11910976|FG000|Overall Study|Withdrawal by Subject|1
7551587|NCT02972242|11910977|FG001|Overall Study|Withdrawal by Subject|0
7551588|NCT02972359|11910983|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
7551589|NCT02972359|11910983|FG000|Overall Study|Lack of Efficacy|1
7551590|NCT02972359|11910983|FG000|Overall Study|Adverse Event|4
7551591|NCT02972359|11910983|FG000|Overall Study|Death|1
7551592|NCT02972359|11910983|FG000|Overall Study|Withdrawal by Subject|30
7551593|NCT02972359|11910983|FG000|Overall Study|Protocol Violation|1
7551594|NCT02972359|11910983|FG000|Overall Study|Lost to Follow-up|26
7551595|NCT02972359|11910983|FG000|Overall Study|Other reasons|5
7551596|NCT02972359|11910983|FG000|Overall Study|Missing|1
7551597|NCT02972502|11910989|FG000|Overall Study|Lost to Follow-up|3
7551598|NCT02972502|11910990|FG001|Overall Study|Lost to Follow-up|1
7551599|NCT02972502|11910989|FG000|Overall Study|Withdrawal by Subject|1
7551600|NCT02972502|11910990|FG001|Overall Study|Withdrawal by Subject|1
7551601|NCT02972515|11910996|FG000|Overall Study|Lost to Follow-up|78
7551602|NCT02972632|11911009|FG000|Overall Study|Pretreatment Event/Adverse Event|3
7551603|NCT02972632|11911009|FG000|Overall Study|Lost to Follow-up|4
7551604|NCT02972632|11911009|FG000|Overall Study|Voluntary Withdrawal|10
7551605|NCT02972658|11911017|FG000|Overall Study|Adverse Event|0
7551606|NCT02972658|11911018|FG001|Overall Study|Adverse Event|3
7551607|NCT02972658|11911019|FG002|Overall Study|Adverse Event|0
7551608|NCT02972658|11911020|FG003|Overall Study|Adverse Event|2
7551609|NCT02972658|11911017|FG000|Overall Study|Other-determined by Investigator|1
7551610|NCT02972658|11911018|FG001|Overall Study|Other-determined by Investigator|1
7551611|NCT02972658|11911019|FG002|Overall Study|Other-determined by Investigator|0
7551612|NCT02972658|11911020|FG003|Overall Study|Other-determined by Investigator|0
7551613|NCT02972658|11911017|FG000|Overall Study|Death|0
7551614|NCT02972658|11911018|FG001|Overall Study|Death|0
7551615|NCT02972658|11911019|FG002|Overall Study|Death|0
7551616|NCT02972658|11911020|FG003|Overall Study|Death|1
7551617|NCT02972658|11911017|FG000|Overall Study|Lost to Follow-up|0
7551618|NCT02972658|11911018|FG001|Overall Study|Lost to Follow-up|1
7551619|NCT02972658|11911019|FG002|Overall Study|Lost to Follow-up|1
7551620|NCT02972658|11911020|FG003|Overall Study|Lost to Follow-up|2
7297911|NCT00585351|11517814|FG000|Notification Period (Informed Consent)|Physician Decision|0
7297912|NCT00585351|11517815|FG001|Notification Period (Informed Consent)|Physician Decision|2
7297913|NCT00585351|11517816|FG002|Notification Period (Informed Consent)|Physician Decision|0
7297914|NCT00585351|11517817|FG003|Notification Period (Informed Consent)|Physician Decision|0
7297915|NCT00585351|11517818|FG004|Notification Period (Informed Consent)|Physician Decision|0
7297916|NCT00585351|11517819|FG005|Notification Period (Informed Consent)|Physician Decision|0
7297917|NCT00585351|11517820|FG006|Notification Period (Informed Consent)|Physician Decision|0
7297918|NCT00585351|11517821|FG007|Notification Period (Informed Consent)|Physician Decision|0
7297919|NCT00585351|11517814|FG000|Notification Period (Informed Consent)|Flight aborted|2
7297920|NCT00585351|11517815|FG001|Notification Period (Informed Consent)|Flight aborted|1
7297921|NCT00585351|11517816|FG002|Notification Period (Informed Consent)|Flight aborted|0
7297922|NCT00585351|11517817|FG003|Notification Period (Informed Consent)|Flight aborted|0
7297923|NCT00585351|11517818|FG004|Notification Period (Informed Consent)|Flight aborted|0
7297924|NCT00585351|11517819|FG005|Notification Period (Informed Consent)|Flight aborted|0
7297925|NCT00585351|11517820|FG006|Notification Period (Informed Consent)|Flight aborted|0
7297926|NCT00585351|11517821|FG007|Notification Period (Informed Consent)|Flight aborted|0
7297927|NCT00585351|11517814|FG000|Notification Period (Informed Consent)|No study medication on flight|0
7297928|NCT00585351|11517815|FG001|Notification Period (Informed Consent)|No study medication on flight|1
7297929|NCT00585351|11517816|FG002|Notification Period (Informed Consent)|No study medication on flight|0
7297930|NCT00585351|11517817|FG003|Notification Period (Informed Consent)|No study medication on flight|0
7297931|NCT00585351|11517818|FG004|Notification Period (Informed Consent)|No study medication on flight|0
7297932|NCT00585351|11517819|FG005|Notification Period (Informed Consent)|No study medication on flight|0
7297933|NCT00585351|11517820|FG006|Notification Period (Informed Consent)|No study medication on flight|0
7297934|NCT00585351|11517821|FG007|Notification Period (Informed Consent)|No study medication on flight|0
7297935|NCT00585351|11517814|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7297936|NCT00585351|11517815|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
7297937|NCT00585351|11517816|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297938|NCT00585351|11517817|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297939|NCT00585351|11517818|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297940|NCT00585351|11517819|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297941|NCT00585351|11517820|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297942|NCT00585351|11517821|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
7297943|NCT00585351|11517814|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
7297944|NCT00585351|11517815|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
7297945|NCT00585351|11517816|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
7297946|NCT00585351|11517817|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
7297947|NCT00585351|11517818|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
7297948|NCT00585351|11517819|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
7297949|NCT00585351|11517820|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
7297950|NCT00585351|11517821|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
7297951|NCT00585351|11517814|FG000|Enrollment Period (Intervention)|Death|0
7297952|NCT00585351|11517815|FG001|Enrollment Period (Intervention)|Death|0
7297953|NCT00585351|11517816|FG002|Enrollment Period (Intervention)|Death|0
7297954|NCT00585351|11517817|FG003|Enrollment Period (Intervention)|Death|0
7297955|NCT00585351|11517818|FG004|Enrollment Period (Intervention)|Death|1
7297956|NCT00585351|11517819|FG005|Enrollment Period (Intervention)|Death|0
7297957|NCT00585351|11517820|FG006|Enrollment Period (Intervention)|Death|1
7297958|NCT00585351|11517821|FG007|Enrollment Period (Intervention)|Death|0
7297959|NCT00585351|11517814|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297960|NCT00585351|11517815|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297961|NCT00585351|11517816|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297962|NCT00585351|11517817|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297963|NCT00585351|11517818|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
7297964|NCT00585351|11517819|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
7297965|NCT00585351|11517820|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297966|NCT00585351|11517821|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
7297967|NCT00585468|11517839|FG000|First Intervention|Withdrawal by Subject|1
7297968|NCT00585468|11517840|FG001|First Intervention|Withdrawal by Subject|1
7297969|NCT00585533|11517852|FG000|Overall Study|objective or symptomatic progression|9
7297970|NCT00585546|11517856|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
7297971|NCT00585546|11517856|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
7297972|NCT00585689|11517886|FG000|Overall Study|Received different ABI-007 schedule|3
7297973|NCT00585689|11517886|FG000|Overall Study|Adverse Event|1
7297974|NCT00585689|11517886|FG000|Overall Study|Patient Declined Surgery|1
7297975|NCT00585689|11517886|FG000|Overall Study|Patient had unresectable disease|1
7297976|NCT00585689|11517886|FG000|Overall Study|Death|1
7297977|NCT00585923|11517927|FG000|Overall Study|Physician decided not to continue|31
7297978|NCT00585923|11517928|FG001|Overall Study|Physician decided not to continue|33
7297979|NCT00585975|11517936|FG000|Overall Study|Withdrawal by Subject|3
7297980|NCT00585975|11517937|FG001|Overall Study|Withdrawal by Subject|3
7297981|NCT00585975|11517936|FG000|Overall Study|Lost to Follow-up|2
7297982|NCT00585975|11517937|FG001|Overall Study|Lost to Follow-up|1
7297983|NCT00585975|11517936|FG000|Overall Study|Enrollment met/over-enrolled|10
7297984|NCT00585975|11517937|FG001|Overall Study|Enrollment met/over-enrolled|9
7297985|NCT00586066|11517955|FG000|Overall Study|Lost to Follow-up|6
7297986|NCT00586066|11517956|FG001|Overall Study|Lost to Follow-up|3
7297987|NCT00586066|11517955|FG000|Overall Study|Lack of Efficacy|5
7297988|NCT00586066|11517956|FG001|Overall Study|Lack of Efficacy|3
7297989|NCT00586066|11517955|FG000|Overall Study|Adverse Event|2
7297990|NCT00586066|11517956|FG001|Overall Study|Adverse Event|2
7297991|NCT00586066|11517955|FG000|Overall Study|Physician Decision|1
7297992|NCT00586066|11517956|FG001|Overall Study|Physician Decision|0
7297993|NCT00586066|11517955|FG000|Overall Study|Withdrawal of consent|4
7297994|NCT00586066|11517956|FG001|Overall Study|Withdrawal of consent|2
7297995|NCT00586105|11517962|FG000|Overall Study|Adverse Event|4
7297996|NCT00586105|11517962|FG000|Overall Study|Death|2
7297997|NCT00586105|11517962|FG000|Overall Study|Protocol Violation|1
7297998|NCT00586105|11517962|FG000|Overall Study|Withdrawal by Subject|3
7297999|NCT00586105|11517962|FG000|Overall Study|Disease progression|19
7298000|NCT00586105|11517962|FG000|Overall Study|Switched to commercial drug|9
7298001|NCT00586105|11517962|FG000|Overall Study|Reason not reported|1
7298002|NCT00586157|11517966|FG000|First Intervention|Worsening behavior|1
7298003|NCT00586157|11517967|FG001|First Intervention|Worsening behavior|0
7298004|NCT00586157|11517966|FG000|Second Intervention|Withdrawal by Subject|1
7298005|NCT00586157|11517967|FG001|Second Intervention|Withdrawal by Subject|0
7298006|NCT00586157|11517966|FG000|Second Intervention|Worsening behavior|1
7298007|NCT00586157|11517967|FG001|Second Intervention|Worsening behavior|0
7298008|NCT00586157|11517966|FG000|Second Intervention|Adverse Event|0
7298009|NCT00586157|11517967|FG001|Second Intervention|Adverse Event|1
7298010|NCT00586313|11518000|FG000|Overall Study|Lack of Efficacy|2
7298011|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
7298012|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
7298013|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
7298014|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
7298015|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
7298016|NCT00586326|11518004|FG000|Enrollment to Device Placement-Enrolled|Other|1
7298017|NCT00586326|11518004|FG000|Device Placed toTreatment-ITT|Skin Distance|7
7298018|NCT00586326|11518004|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
7298019|NCT00586326|11518004|FG000|Device Placed toTreatment-ITT|Microinvasion|1
7298020|NCT00586326|11518004|FG000|Device Placed toTreatment-ITT|Positive Margins|3
7298021|NCT00586326|11518004|FG000|Device Placed toTreatment-ITT|Physician Decision|1
7298022|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
7298023|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
7298024|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
7298025|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
7298026|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
7298027|NCT00586326|11518004|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
7298028|NCT00586339|11518015|FG000|Overall Study|Withdrawal by Subject|1
7298029|NCT00586339|11518016|FG001|Overall Study|Withdrawal by Subject|3
7298030|NCT00586339|11518017|FG002|Overall Study|Withdrawal by Subject|1
7298031|NCT00586339|11518015|FG000|Overall Study|Migrated/moved from study area|3
7298032|NCT00586339|11518016|FG001|Overall Study|Migrated/moved from study area|2
7298033|NCT00586339|11518017|FG002|Overall Study|Migrated/moved from study area|4
7298034|NCT00586339|11518015|FG000|Overall Study|Lost to Follow-up|3
7298035|NCT00586339|11518016|FG001|Overall Study|Lost to Follow-up|2
7298036|NCT00586339|11518017|FG002|Overall Study|Lost to Follow-up|1
7298037|NCT00586469|11518027|FG000|Overall Study|Adverse Event|0
7298038|NCT00586469|11518028|FG001|Overall Study|Adverse Event|1
7298039|NCT00586495|11518043|FG000|Treatment Period|Adverse Event|11
7298040|NCT00586495|11518043|FG000|Treatment Period|Death|1
7298041|NCT00586495|11518043|FG000|Treatment Period|Protocol Violation|1
7298042|NCT00586495|11518043|FG000|Treatment Period|Withdrawal by Subject|1
7298043|NCT00586495|11518043|FG000|Treatment Period|Disease progression, recurrence/relapse|71
7298044|NCT00586495|11518043|FG000|Treatment Period|Switch to commercial drug|10
7298045|NCT00586495|11518043|FG000|Follow-up|Death|40
7298046|NCT00586495|11518043|FG000|Follow-up|Lost to Follow-up|1
7298047|NCT00586495|11518043|FG000|Follow-up|Withdrawal by Subject|4
7298048|NCT00586495|11518043|FG000|Follow-up|Protocol driven decision point|37
7298049|NCT00586495|11518043|FG000|Follow-up|Switch to commercial drug|10
7298050|NCT00586508|11518049|FG000|Overall Study|Progressive disease|52
7298051|NCT00586508|11518050|FG001|Overall Study|Progressive disease|8
7298052|NCT00586508|11518049|FG000|Overall Study|Death|0
7298053|NCT00586508|11518050|FG001|Overall Study|Death|1
7298054|NCT00586508|11518049|FG000|Overall Study|Adverse Event|12
7298055|NCT00586508|11518050|FG001|Overall Study|Adverse Event|4
7298056|NCT00586508|11518049|FG000|Overall Study|Withdrawal by Subject|4
7298057|NCT00586508|11518050|FG001|Overall Study|Withdrawal by Subject|0
7298058|NCT00586521|11518056|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
7298059|NCT00586612|11518066|FG000|Primary Phase|Protocol Violation|1
7298060|NCT00586612|11518067|FG001|Primary Phase|Protocol Violation|0
7298061|NCT00586612|11518066|FG000|Primary Phase|Lost to Follow-up|0
7298062|NCT00586612|11518067|FG001|Primary Phase|Lost to Follow-up|1
7298063|NCT00586612|11518066|FG000|Primary Phase|Withdrawal by Subject|0
7298064|NCT00586612|11518067|FG001|Primary Phase|Withdrawal by Subject|2
7298065|NCT00586612|11518066|FG000|Booster Phase|Lost to Follow-up|3
7298066|NCT00586612|11518067|FG001|Booster Phase|Lost to Follow-up|1
7298067|NCT00586625|11518075|FG000|Overall Study|Adverse Event|6
7298068|NCT00586625|11518076|FG001|Overall Study|Adverse Event|6
7298069|NCT00586625|11518075|FG000|Overall Study|Protocol Violation|3
7298070|NCT00586625|11518076|FG001|Overall Study|Protocol Violation|0
7298071|NCT00586625|11518075|FG000|Overall Study|Withdrawal by Subject|32
7298072|NCT00586625|11518076|FG001|Overall Study|Withdrawal by Subject|10
7298073|NCT00586625|11518075|FG000|Overall Study|Subject non-compliance|0
7298074|NCT00586625|11518076|FG001|Overall Study|Subject non-compliance|1
7298075|NCT00586625|11518075|FG000|Overall Study|Subject unable to return for visit|2
7298076|NCT00586625|11518076|FG001|Overall Study|Subject unable to return for visit|0
7298077|NCT00586664|11518085|FG000|Overall Study|Withdrawal by Subject|3
7298078|NCT00586664|11518086|FG001|Overall Study|Withdrawal by Subject|7
7298079|NCT00586664|11518087|FG002|Overall Study|Withdrawal by Subject|1
7298080|NCT00586664|11518085|FG000|Overall Study|Exclusion criteria met|2
7298081|NCT00586664|11518086|FG001|Overall Study|Exclusion criteria met|0
7298082|NCT00586664|11518087|FG002|Overall Study|Exclusion criteria met|0
7298083|NCT00586690|11518097|FG000|Overall Study|Death|2
7298084|NCT00586690|11518098|FG001|Overall Study|Death|0
7298085|NCT00586690|11518097|FG000|Overall Study|Disease Progression|10
7298086|NCT00586690|11518098|FG001|Overall Study|Disease Progression|0
7298087|NCT00586690|11518097|FG000|Overall Study|Adverse Event|1
7298088|NCT00586690|11518098|FG001|Overall Study|Adverse Event|0
7298089|NCT00586690|11518097|FG000|Overall Study|Lack of Efficacy|2
7298090|NCT00586690|11518098|FG001|Overall Study|Lack of Efficacy|0
7298091|NCT00586690|11518097|FG000|Overall Study|Lab can't accommodate|1
7298092|NCT00586690|11518098|FG001|Overall Study|Lab can't accommodate|0
7298093|NCT00586703|11518103|FG000|Overall Study|Death|12
7298094|NCT00586820|11518118|FG000|Overall Study|Unsuccessful PCI|1
7298095|NCT00586820|11518119|FG001|Overall Study|Unsuccessful PCI|0
7298096|NCT00586846|11518125|FG000|Overall Study|Physician Decision|1
7298097|NCT00586846|11518125|FG000|Overall Study|Death|1
7298098|NCT00586846|11518125|FG000|Overall Study|Evaluable for Toxicity Only|4
7298099|NCT00586898|11518129|FG000|Overall Study|Adverse Event|1
7298100|NCT00586898|11518129|FG000|Overall Study|Patiemt Non-compliance|1
7298101|NCT00586898|11518129|FG000|Overall Study|Evaluable for Toxicity Only|5
7298102|NCT00587054|11518146|FG000|Overall Study|Patient not treated|9
7298103|NCT00587158|11518173|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
7298104|NCT00587158|11518174|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
7298105|NCT00587158|11518173|FG000|Overall Study|Physician Decision|0
7298106|NCT00587158|11518174|FG001|Overall Study|Physician Decision|1
7298107|NCT00587158|11518173|FG000|Overall Study|Lost to Follow-up|1
7298108|NCT00587158|11518174|FG001|Overall Study|Lost to Follow-up|2
7298109|NCT00587158|11518173|FG000|Overall Study|Death|0
7298110|NCT00587158|11518174|FG001|Overall Study|Death|1
7298111|NCT00587158|11518173|FG000|Overall Study|Subject did not want to take study med|0
7298112|NCT00587158|11518174|FG001|Overall Study|Subject did not want to take study med|1
7298113|NCT00587171|11518182|FG000|Overall Study|Lost to Follow-up|1
7298114|NCT00587171|11518183|FG001|Overall Study|Lost to Follow-up|1
7298115|NCT00587288|11518191|FG000|Overall Study|Adverse Event|0
7298116|NCT00587288|11518192|FG001|Overall Study|Adverse Event|1
7298117|NCT00587288|11518191|FG000|Overall Study|Lack of Efficacy|2
7298118|NCT00587288|11518192|FG001|Overall Study|Lack of Efficacy|8
7298119|NCT00587288|11518191|FG000|Overall Study|Protocol Violation|1
7298120|NCT00587288|11518192|FG001|Overall Study|Protocol Violation|0
7298121|NCT00587431|11518202|FG000|Overall Study|Adverse Event|1
7298122|NCT00587431|11518203|FG001|Overall Study|Adverse Event|0
7298123|NCT00587431|11518202|FG000|Overall Study|Withdrawal by Subject|0
7298124|NCT00587431|11518203|FG001|Overall Study|Withdrawal by Subject|1
7298125|NCT00587457|11518215|FG000|Overall Study|Adverse Event|1
7298126|NCT00587457|11518216|FG001|Overall Study|Adverse Event|2
7298127|NCT00587457|11518217|FG002|Overall Study|Adverse Event|1
7298128|NCT00587457|11518215|FG000|Overall Study|Disease progression|2
7298129|NCT00587457|11518216|FG001|Overall Study|Disease progression|0
7298130|NCT00587457|11518217|FG002|Overall Study|Disease progression|2
7298131|NCT00587457|11518215|FG000|Overall Study|Initiation of alternative therapy|0
7298132|NCT00587457|11518216|FG001|Overall Study|Initiation of alternative therapy|1
7298133|NCT00587457|11518217|FG002|Overall Study|Initiation of alternative therapy|0
7298134|NCT00587457|11518215|FG000|Overall Study|Undefined|0
7298135|NCT00587457|11518216|FG001|Overall Study|Undefined|0
7298136|NCT00587457|11518217|FG002|Overall Study|Undefined|1
7298137|NCT00587457|11518215|FG000|Overall Study|Development of neutralizing Abs|0
7298138|NCT00587457|11518216|FG001|Overall Study|Development of neutralizing Abs|0
7298139|NCT00587457|11518217|FG002|Overall Study|Development of neutralizing Abs|1
7298140|NCT00587587|11518240|FG000|Overall Study|Lost to Follow-up|6
7298141|NCT00587587|11518241|FG001|Overall Study|Lost to Follow-up|1
7298142|NCT00587639|11518249|FG000|Overall Study|Withdrawal by Subject|1
7298143|NCT00587847|11518285|FG000|Overall Study|Lack of Efficacy|5
7298144|NCT00587847|11518285|FG000|Overall Study|Adverse Event|2
7551621|NCT02972658|11911017|FG000|Overall Study|Progressive Disease|0
7298145|NCT04411680|11518296|FG000|Treatment Period|Adverse Event|3
7298146|NCT04411680|11518297|FG001|Treatment Period|Adverse Event|0
7298147|NCT04411680|11518296|FG000|Treatment Period|Discharged from hospital|18
7298148|NCT04411680|11518297|FG001|Treatment Period|Discharged from hospital|7
7298149|NCT04411680|11518296|FG000|Treatment Period|Missed 1 or more doses|8
7298150|NCT04411680|11518297|FG001|Treatment Period|Missed 1 or more doses|0
7298151|NCT04411680|11518296|FG000|Treatment Period|Transferred to another hospital|0
7298152|NCT04411680|11518297|FG001|Treatment Period|Transferred to another hospital|1
7298153|NCT04411680|11518296|FG000|Follow up Period|Withdrawal by Subject|2
7298154|NCT04411680|11518297|FG001|Follow up Period|Withdrawal by Subject|0
7298155|NCT04411680|11518296|FG000|Follow up Period|Lost to Follow-up|5
7298156|NCT04411680|11518297|FG001|Follow up Period|Lost to Follow-up|6
7298157|NCT04411680|11518296|FG000|Follow up Period|Death|11
7298158|NCT04411680|11518297|FG001|Follow up Period|Death|8
7298159|NCT04364984|11518306|FG000|Overall Study|Death|2
7298160|NCT04364984|11518307|FG001|Overall Study|Death|2
7298161|NCT04364984|11518308|FG002|Overall Study|Death|0
7298162|NCT03711266|11518352|FG000|Overall Study|Lost to Follow-up|10
7298163|NCT03630393|11518358|FG000|Overall Study|Death|1
7298164|NCT03630393|11518359|FG001|Overall Study|Death|0
7298165|NCT03359811|11518376|FG000|Overall Study|Protocol Violation|2
7298166|NCT03359811|11518377|FG001|Overall Study|Protocol Violation|0
7298167|NCT02954406|11518419|FG000|Overall Study|Adverse Event|0
7298168|NCT02954406|11518420|FG001|Overall Study|Adverse Event|1
7298169|NCT02954406|11518421|FG002|Overall Study|Adverse Event|0
7298170|NCT02954406|11518422|FG003|Overall Study|Adverse Event|0
7298171|NCT02954406|11518423|FG004|Overall Study|Adverse Event|1
7298172|NCT02954406|11518424|FG005|Overall Study|Adverse Event|0
7298173|NCT02954406|11518425|FG006|Overall Study|Adverse Event|0
7298174|NCT02954406|11518426|FG007|Overall Study|Adverse Event|0
7298175|NCT02954406|11518427|FG008|Overall Study|Adverse Event|1
7298176|NCT02954406|11518428|FG009|Overall Study|Adverse Event|1
7298177|NCT02954406|11518429|FG010|Overall Study|Adverse Event|0
7298178|NCT02954406|11518419|FG000|Overall Study|Progressive Disease|3
7298179|NCT02954406|11518420|FG001|Overall Study|Progressive Disease|4
7298180|NCT02954406|11518421|FG002|Overall Study|Progressive Disease|3
7298181|NCT02954406|11518422|FG003|Overall Study|Progressive Disease|4
7298182|NCT02954406|11518423|FG004|Overall Study|Progressive Disease|3
7298183|NCT02954406|11518424|FG005|Overall Study|Progressive Disease|3
7298184|NCT02954406|11518425|FG006|Overall Study|Progressive Disease|2
7298185|NCT02954406|11518426|FG007|Overall Study|Progressive Disease|2
7298186|NCT02954406|11518427|FG008|Overall Study|Progressive Disease|1
7298187|NCT02954406|11518428|FG009|Overall Study|Progressive Disease|1
7298188|NCT02954406|11518429|FG010|Overall Study|Progressive Disease|0
7298189|NCT02954406|11518419|FG000|Overall Study|Symptomatic Deterioration|0
7298190|NCT02954406|11518420|FG001|Overall Study|Symptomatic Deterioration|1
7298191|NCT02954406|11518421|FG002|Overall Study|Symptomatic Deterioration|0
7298192|NCT02954406|11518422|FG003|Overall Study|Symptomatic Deterioration|0
7298193|NCT02954406|11518423|FG004|Overall Study|Symptomatic Deterioration|0
7298194|NCT02954406|11518424|FG005|Overall Study|Symptomatic Deterioration|0
7298195|NCT02954406|11518425|FG006|Overall Study|Symptomatic Deterioration|0
7298196|NCT02954406|11518426|FG007|Overall Study|Symptomatic Deterioration|0
7298197|NCT02954406|11518427|FG008|Overall Study|Symptomatic Deterioration|0
7298198|NCT02954406|11518428|FG009|Overall Study|Symptomatic Deterioration|0
7298199|NCT02954406|11518429|FG010|Overall Study|Symptomatic Deterioration|0
7298200|NCT02954406|11518419|FG000|Overall Study|Death|0
7298201|NCT02954406|11518420|FG001|Overall Study|Death|0
7298202|NCT02954406|11518421|FG002|Overall Study|Death|0
7298203|NCT02954406|11518422|FG003|Overall Study|Death|0
7298204|NCT02954406|11518423|FG004|Overall Study|Death|1
7298205|NCT02954406|11518424|FG005|Overall Study|Death|0
7298206|NCT02954406|11518425|FG006|Overall Study|Death|0
7298207|NCT02954406|11518426|FG007|Overall Study|Death|0
7298208|NCT02954406|11518427|FG008|Overall Study|Death|1
7298209|NCT02954406|11518428|FG009|Overall Study|Death|1
7298210|NCT02954406|11518429|FG010|Overall Study|Death|0
7298211|NCT02954406|11518419|FG000|Overall Study|Reason Not Specified|0
7298212|NCT02954406|11518420|FG001|Overall Study|Reason Not Specified|0
7298213|NCT02954406|11518421|FG002|Overall Study|Reason Not Specified|3
7298214|NCT02954406|11518422|FG003|Overall Study|Reason Not Specified|2
7298215|NCT02954406|11518423|FG004|Overall Study|Reason Not Specified|2
7298216|NCT02954406|11518424|FG005|Overall Study|Reason Not Specified|0
7298217|NCT02954406|11518425|FG006|Overall Study|Reason Not Specified|1
7298218|NCT02954406|11518426|FG007|Overall Study|Reason Not Specified|0
7298219|NCT02954406|11518427|FG008|Overall Study|Reason Not Specified|1
7298220|NCT02954406|11518428|FG009|Overall Study|Reason Not Specified|0
7298221|NCT02954406|11518429|FG010|Overall Study|Reason Not Specified|0
7298222|NCT02927145|11518464|FG000|Initial Recruitment|Withdrawal by Subject|0
7298223|NCT02927145|11518465|FG001|Initial Recruitment|Withdrawal by Subject|1
7298224|NCT02927145|11518466|FG002|Initial Recruitment|Withdrawal by Subject|1
7298225|NCT02927145|11518467|FG003|Initial Recruitment|Withdrawal by Subject|4
7298226|NCT02927145|11518468|FG004|Initial Recruitment|Withdrawal by Subject|1
7298227|NCT02927145|11518469|FG005|Initial Recruitment|Withdrawal by Subject|1
7298228|NCT02927145|11518470|FG006|Initial Recruitment|Withdrawal by Subject|0
7298229|NCT02927145|11518471|FG007|Initial Recruitment|Withdrawal by Subject|0
7298230|NCT02927145|11518472|FG008|Initial Recruitment|Withdrawal by Subject|2
7298231|NCT02927145|11518464|FG000|Initial Recruitment|Adverse Event|0
7298232|NCT02927145|11518465|FG001|Initial Recruitment|Adverse Event|0
7298233|NCT02927145|11518466|FG002|Initial Recruitment|Adverse Event|0
7298234|NCT02927145|11518467|FG003|Initial Recruitment|Adverse Event|0
7298235|NCT02927145|11518468|FG004|Initial Recruitment|Adverse Event|2
7298236|NCT02927145|11518469|FG005|Initial Recruitment|Adverse Event|0
7298237|NCT02927145|11518470|FG006|Initial Recruitment|Adverse Event|0
7298238|NCT02927145|11518471|FG007|Initial Recruitment|Adverse Event|0
7298239|NCT02927145|11518472|FG008|Initial Recruitment|Adverse Event|0
7298240|NCT02927145|11518464|FG000|Invitation for Additional Challenge|Pregnancy|0
7298241|NCT02927145|11518465|FG001|Invitation for Additional Challenge|Pregnancy|0
7298242|NCT02927145|11518466|FG002|Invitation for Additional Challenge|Pregnancy|0
7298243|NCT02927145|11518467|FG003|Invitation for Additional Challenge|Pregnancy|0
7298244|NCT02927145|11518468|FG004|Invitation for Additional Challenge|Pregnancy|0
7298245|NCT02927145|11518469|FG005|Invitation for Additional Challenge|Pregnancy|0
7298246|NCT02927145|11518470|FG006|Invitation for Additional Challenge|Pregnancy|1
7298247|NCT02927145|11518471|FG007|Invitation for Additional Challenge|Pregnancy|0
7298248|NCT02927145|11518472|FG008|Invitation for Additional Challenge|Pregnancy|0
7298249|NCT02910583|11518495|FG000|Overall Study|Withdrawal by Subject|6
7298250|NCT02910583|11518496|FG001|Overall Study|Withdrawal by Subject|7
7298251|NCT02910583|11518495|FG000|Overall Study|Other, Not Specified|1
7298252|NCT02910583|11518496|FG001|Overall Study|Other, Not Specified|0
7298253|NCT02598388|11518553|FG000|Overall Study|Lost to Follow-up|1
7298254|NCT02598388|11518554|FG001|Overall Study|Lost to Follow-up|0
7298255|NCT02598388|11518555|FG002|Overall Study|Lost to Follow-up|1
7298256|NCT02598388|11518556|FG003|Overall Study|Lost to Follow-up|0
7298257|NCT02598388|11518557|FG004|Overall Study|Lost to Follow-up|5
7298258|NCT02598388|11518558|FG005|Overall Study|Lost to Follow-up|1
7298259|NCT02598388|11518559|FG006|Overall Study|Lost to Follow-up|2
7298260|NCT02598388|11518560|FG007|Overall Study|Lost to Follow-up|1
7298261|NCT02598388|11518561|FG008|Overall Study|Lost to Follow-up|0
7298262|NCT02598388|11518562|FG009|Overall Study|Lost to Follow-up|0
7298263|NCT02598388|11518563|FG010|Overall Study|Lost to Follow-up|1
7298264|NCT02598388|11518564|FG011|Overall Study|Lost to Follow-up|0
7298265|NCT02598388|11518553|FG000|Overall Study|Withdrawal by Subject|0
7298266|NCT02598388|11518554|FG001|Overall Study|Withdrawal by Subject|0
7298267|NCT02598388|11518555|FG002|Overall Study|Withdrawal by Subject|0
7298268|NCT02598388|11518556|FG003|Overall Study|Withdrawal by Subject|0
7298269|NCT02598388|11518557|FG004|Overall Study|Withdrawal by Subject|2
7298270|NCT02598388|11518558|FG005|Overall Study|Withdrawal by Subject|0
7298271|NCT02598388|11518559|FG006|Overall Study|Withdrawal by Subject|2
7298272|NCT02598388|11518560|FG007|Overall Study|Withdrawal by Subject|0
7298273|NCT02598388|11518561|FG008|Overall Study|Withdrawal by Subject|0
7222633|NCT00023595|11431714|FG002|10 Year Follow up|Lost to Follow-up|3
7222634|NCT00023595|11431715|FG003|10 Year Follow up|Lost to Follow-up|0
7222635|NCT00023595|11431716|FG004|10 Year Follow up|Lost to Follow-up|0
7222636|NCT00023673|11431742|FG000|Overall Study|Ineligible / no protocol treatment|0
7222637|NCT00023673|11431743|FG001|Overall Study|Ineligible / no protocol treatment|0
7222638|NCT00023673|11431744|FG002|Overall Study|Ineligible / no protocol treatment|0
7222639|NCT00023673|11431745|FG003|Overall Study|Ineligible / no protocol treatment|1
7222640|NCT00023673|11431742|FG000|Overall Study|Patient withdrew consent|0
7222641|NCT00023673|11431743|FG001|Overall Study|Patient withdrew consent|0
7222642|NCT00023673|11431744|FG002|Overall Study|Patient withdrew consent|0
7222643|NCT00023673|11431745|FG003|Overall Study|Patient withdrew consent|1
7222644|NCT00023712|11431757|FG000|Overall Study|Not platinum sensitive|1
7222645|NCT00023712|11431758|FG001|Overall Study|Not platinum sensitive|0
7298274|NCT02598388|11518562|FG009|Overall Study|Withdrawal by Subject|1
7298275|NCT02598388|11518563|FG010|Overall Study|Withdrawal by Subject|0
7298276|NCT02598388|11518564|FG011|Overall Study|Withdrawal by Subject|0
7298277|NCT02598388|11518553|FG000|Overall Study|Other|0
7298278|NCT02598388|11518554|FG001|Overall Study|Other|0
7298279|NCT02598388|11518555|FG002|Overall Study|Other|1
7298280|NCT02598388|11518556|FG003|Overall Study|Other|0
7298281|NCT02598388|11518557|FG004|Overall Study|Other|3
7298282|NCT02598388|11518558|FG005|Overall Study|Other|0
7298283|NCT02598388|11518559|FG006|Overall Study|Other|1
7298284|NCT02598388|11518560|FG007|Overall Study|Other|0
7298285|NCT02598388|11518561|FG008|Overall Study|Other|0
7298286|NCT02598388|11518562|FG009|Overall Study|Other|0
7298287|NCT02598388|11518563|FG010|Overall Study|Other|0
7298288|NCT02598388|11518564|FG011|Overall Study|Other|0
7298289|NCT02493751|11518597|FG000|Overall Study|Withdrawal by Subject|2
7298290|NCT02493751|11518598|FG001|Overall Study|Withdrawal by Subject|8
7222646|NCT00023712|11431757|FG000|Overall Study|Never treated|1
7222647|NCT00023712|11431758|FG001|Overall Study|Never treated|1
7222648|NCT00023764|11431774|FG000|Overall Study|Other|1
7222649|NCT00023764|11431774|FG000|Overall Study|Adverse Event|4
7298291|NCT02493751|11518597|FG000|Overall Study|Death|6
7298292|NCT02493751|11518598|FG001|Overall Study|Death|13
7298293|NCT02493751|11518597|FG000|Overall Study|Lost to Follow-up|2
7298294|NCT02493751|11518598|FG001|Overall Study|Lost to Follow-up|3
7298295|NCT02493751|11518597|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6
7298296|NCT02493751|11518598|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15
7298297|NCT02285166|11518605|FG000|Overall Study|Case Report Forms Uncollected|564
7298298|NCT02285166|11518605|FG000|Overall Study|Protocol Deviation|402
7298299|NCT02075593|11518611|FG000|Overall Study|Withdrawal by Subject|1
7298300|NCT02075593|11518611|FG000|Overall Study|Treatment ongoing at the time of analysis|2
7298301|NCT00587860|11518619|FG000|Overall Study|Lost to Follow-up|2
7298302|NCT00587860|11518620|FG001|Overall Study|Lost to Follow-up|2
7298303|NCT00587860|11518619|FG000|Overall Study|Withdrawal by Subject|3
7298304|NCT00587860|11518620|FG001|Overall Study|Withdrawal by Subject|3
7551622|NCT02972658|11911018|FG001|Overall Study|Progressive Disease|1
7551623|NCT02972658|11911019|FG002|Overall Study|Progressive Disease|0
7551624|NCT02972658|11911020|FG003|Overall Study|Progressive Disease|1
7551625|NCT02972658|11911017|FG000|Overall Study|Withdrawal by Subject|4
7551626|NCT02972658|11911018|FG001|Overall Study|Withdrawal by Subject|4
7551627|NCT02972658|11911019|FG002|Overall Study|Withdrawal by Subject|1
7551628|NCT02972658|11911020|FG003|Overall Study|Withdrawal by Subject|6
7551629|NCT02972658|11911017|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
7551630|NCT02972658|11911018|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
7551631|NCT02972658|11911019|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
7551632|NCT02972658|11911020|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
7551633|NCT02972658|11911017|FG000|Overall Study|Sponsor Decision|70
7551634|NCT02972658|11911018|FG001|Overall Study|Sponsor Decision|127
7551635|NCT02972658|11911019|FG002|Overall Study|Sponsor Decision|72
7551636|NCT02972658|11911020|FG003|Overall Study|Sponsor Decision|119
7551637|NCT02973048|11911032|FG000|Overall Study|Epidural catheter insertion failure|1
7551638|NCT02973048|11911033|FG001|Overall Study|Epidural catheter insertion failure|0
7551639|NCT02973048|11911032|FG000|Overall Study|Withdrawal by Subject|0
7551640|NCT02973048|11911033|FG001|Overall Study|Withdrawal by Subject|3
7551641|NCT02973087|11911041|FG000|Overall Study|Withdrawal by Subject|2
7551642|NCT02973087|11911042|FG001|Overall Study|Withdrawal by Subject|1
7551643|NCT02973087|11911041|FG000|Overall Study|Adverse Event|1
7551644|NCT02973087|11911042|FG001|Overall Study|Adverse Event|0
7551645|NCT02973087|11911041|FG000|Overall Study|other|1
7551646|NCT02973087|11911042|FG001|Overall Study|other|1
7551647|NCT02973100|11911053|FG000|Overall Study|Adverse Event|1
7551648|NCT02973100|11911054|FG001|Overall Study|Adverse Event|2
7551649|NCT02973100|11911055|FG002|Overall Study|Adverse Event|1
7551650|NCT02973100|11911056|FG003|Overall Study|Adverse Event|2
7551651|NCT02973100|11911053|FG000|Overall Study|Lost to Follow-up|3
7551652|NCT02973100|11911054|FG001|Overall Study|Lost to Follow-up|1
7551653|NCT02973100|11911055|FG002|Overall Study|Lost to Follow-up|1
7551654|NCT02973100|11911056|FG003|Overall Study|Lost to Follow-up|0
7551655|NCT02973100|11911053|FG000|Overall Study|Withdrawal by Subject|3
7551656|NCT02973100|11911054|FG001|Overall Study|Withdrawal by Subject|5
7551657|NCT02973100|11911055|FG002|Overall Study|Withdrawal by Subject|1
7551658|NCT02973100|11911056|FG003|Overall Study|Withdrawal by Subject|4
7551659|NCT02973100|11911053|FG000|Overall Study|Notification of change in address|0
7551660|NCT02973100|11911054|FG001|Overall Study|Notification of change in address|0
7551661|NCT02973100|11911055|FG002|Overall Study|Notification of change in address|0
7551662|NCT02973100|11911056|FG003|Overall Study|Notification of change in address|1
7551663|NCT02973100|11911053|FG000|Overall Study|Failed to attend Safety followup period|0
7551664|NCT02973100|11911054|FG001|Overall Study|Failed to attend Safety followup period|0
7551665|NCT02973100|11911055|FG002|Overall Study|Failed to attend Safety followup period|1
7551666|NCT02973100|11911056|FG003|Overall Study|Failed to attend Safety followup period|0
7551667|NCT02973477|11911089|FG000|First Intervention|Lost to Follow-up|0
7551668|NCT02973477|11911090|FG001|First Intervention|Lost to Follow-up|2
7551669|NCT02973477|11911089|FG000|Washout|Withdrawal by Subject|1
7551670|NCT02973477|11911090|FG001|Washout|Withdrawal by Subject|0
7551671|NCT02973477|11911089|FG000|Second Intervention|Lost to Follow-up|1
7551672|NCT02973477|11911090|FG001|Second Intervention|Lost to Follow-up|0
7551673|NCT02973802|11911120|FG000|Overall Study|Lost to Follow-up|1
7551674|NCT02973802|11911120|FG000|Overall Study|Withdrawal by Subject|1
7551675|NCT02974010|11911129|FG000|Overall Study|Lost to Follow-up|3
7551676|NCT02974010|11911130|FG001|Overall Study|Lost to Follow-up|1
7551677|NCT02974010|11911131|FG002|Overall Study|Lost to Follow-up|0
7551678|NCT02974010|11911132|FG003|Overall Study|Lost to Follow-up|0
7551679|NCT02974010|11911129|FG000|Overall Study|Withdrawal by Subject|2
7551680|NCT02974010|11911130|FG001|Overall Study|Withdrawal by Subject|1
7551681|NCT02974010|11911131|FG002|Overall Study|Withdrawal by Subject|0
7551682|NCT02974010|11911132|FG003|Overall Study|Withdrawal by Subject|0
7551683|NCT02974010|11911129|FG000|Overall Study|Adverse Event|0
7551684|NCT02974010|11911130|FG001|Overall Study|Adverse Event|1
7551685|NCT02974010|11911131|FG002|Overall Study|Adverse Event|0
7551686|NCT02974010|11911132|FG003|Overall Study|Adverse Event|0
7551687|NCT02974010|11911129|FG000|Overall Study|Completed day 42 but did not return for day 70|1
7551688|NCT02974010|11911130|FG001|Overall Study|Completed day 42 but did not return for day 70|0
7551689|NCT02974010|11911131|FG002|Overall Study|Completed day 42 but did not return for day 70|1
7551690|NCT02974010|11911132|FG003|Overall Study|Completed day 42 but did not return for day 70|0
7551691|NCT02974010|11911129|FG000|Overall Study|Lack of Efficacy|0
7551692|NCT02974010|11911130|FG001|Overall Study|Lack of Efficacy|0
7551693|NCT02974010|11911131|FG002|Overall Study|Lack of Efficacy|1
7551694|NCT02974010|11911132|FG003|Overall Study|Lack of Efficacy|0
7298305|NCT00587964|11518626|FG000|Overall Study|Withdrawal by Subject|1
7298306|NCT00587964|11518626|FG000|Overall Study|Lost to Follow-up|1
7298307|NCT00587964|11518626|FG000|Overall Study|Patient found to be ineligible|1
7298308|NCT00587964|11518626|FG000|Overall Study|Patient did not receive intervention|5
7298309|NCT00587964|11518626|FG000|Overall Study|Progression of Disease|4
7298310|NCT00587990|11518633|FG000|Overall Study|Death|0
7298311|NCT00587990|11518634|FG001|Overall Study|Death|0
7298312|NCT00587990|11518635|FG002|Overall Study|Death|1
7298313|NCT00588094|11518643|FG000|Overall Study|Adverse Event|3
7298314|NCT00588094|11518643|FG000|Overall Study|Progression of Disease|2
7298315|NCT00588237|11518656|FG000|Overall Study|Evaluable for toxicity only|3
7298316|NCT00588237|11518656|FG000|Overall Study|Patien not treated|1
7298317|NCT00588341|11518660|FG000|Overall Study|Withdrawal by Subject|3
7298318|NCT00588341|11518660|FG000|Overall Study|Not treated due to metastatic disease|1
7298319|NCT00588341|11518660|FG000|Overall Study|Patient ineligible|1
7298320|NCT00588354|11518666|FG000|Baseline to 2 Weeks|Adverse Event|1
7298321|NCT00588354|11518667|FG001|Baseline to 2 Weeks|Adverse Event|0
7298322|NCT00588354|11518666|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
7298323|NCT00588354|11518667|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
7298324|NCT00588354|11518666|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
7298325|NCT00588354|11518667|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
7298326|NCT00588445|11518688|FG000|Overall Study|Protocol Violation|1
7298327|NCT00588445|11518688|FG000|Overall Study|Withdrawal by Subject|3
7298328|NCT00588445|11518688|FG000|Overall Study|Disease Progression|1
7298329|NCT00588445|11518688|FG000|Overall Study|Not Treated|10
7298330|NCT00588640|11518698|FG000|Overall Study|Physician Decision|1
7298331|NCT00588640|11518698|FG000|Overall Study|Ineligible Patient|1
7298332|NCT00588666|11518702|FG000|Overall Study|Adverse Event|4
7298333|NCT00588692|11518708|FG000|Overall Study|Withdrawal by Subject|4
7298334|NCT00588692|11518709|FG001|Overall Study|Withdrawal by Subject|2
7298335|NCT00588692|11518708|FG000|Overall Study|Hip Surgery|0
7298336|NCT00588692|11518709|FG001|Overall Study|Hip Surgery|1
7298337|NCT00588692|11518708|FG000|Overall Study|Severe Peptic Ulcer Disease|1
7298338|NCT00588692|11518709|FG001|Overall Study|Severe Peptic Ulcer Disease|0
7298339|NCT00588692|11518708|FG000|Overall Study|Cancer|1
7298340|NCT00588692|11518709|FG001|Overall Study|Cancer|0
7298341|NCT00588692|11518708|FG000|Overall Study|Death|1
7298342|NCT00588692|11518709|FG001|Overall Study|Death|0
7298343|NCT00588731|11518719|FG000|Overall Study|Withdrawal by Subject|3
7298344|NCT00588731|11518720|FG001|Overall Study|Withdrawal by Subject|2
7298345|NCT00588822|11518730|FG000|Overall Study|progression of disease|8
7298346|NCT00588848|11518736|FG000|Overall Study|Physician Decision|0
7298347|NCT00588848|11518737|FG001|Overall Study|Physician Decision|3
7298348|NCT00588952|11518751|FG000|Overall Study|Adverse Event|0
7298349|NCT00588952|11518752|FG001|Overall Study|Adverse Event|2
7298350|NCT00588952|11518751|FG000|Overall Study|Withdrawal by Subject|3
7298351|NCT00588952|11518752|FG001|Overall Study|Withdrawal by Subject|5
7298352|NCT00589108|11518771|FG000|Overall Study|Lost to Follow-up|1
7298353|NCT00589108|11518772|FG001|Overall Study|Lost to Follow-up|1
7298354|NCT00589108|11518773|FG002|Overall Study|Lost to Follow-up|1
7298355|NCT00589108|11518771|FG000|Overall Study|Death|3
7298356|NCT00589108|11518772|FG001|Overall Study|Death|3
7298357|NCT00589108|11518773|FG002|Overall Study|Death|4
7298358|NCT00589121|11518783|FG000|Overall Study|Protocol Violation|2
7298359|NCT00589121|11518784|FG001|Overall Study|Protocol Violation|6
7298360|NCT00589121|11518783|FG000|Overall Study|No protocol treatment received|0
7298361|NCT00589121|11518784|FG001|Overall Study|No protocol treatment received|1
7298362|NCT00589290|11518802|FG000|Overall Study|Withdrawal by Subject|1
7298363|NCT00589303|11518810|FG000|Overall Study|Withdrawal by Subject|2
7298364|NCT00589303|11518811|FG001|Overall Study|Withdrawal by Subject|1
7298365|NCT00589472|11518827|FG000|Overall Study|Adverse Event|1
7298366|NCT00589602|11518835|FG000|Overall Study|Did not collect enough CD34+ cells|1
7298367|NCT00589628|11518843|FG000|Overall Study|Lost to Follow-up|0
7298368|NCT00589628|11518844|FG001|Overall Study|Lost to Follow-up|1
7298369|NCT00589667|11518850|FG000|Overall Study|Adverse Event|2
7298370|NCT00589667|11518850|FG000|Overall Study|Withdrawal by Subject|1
7298371|NCT00589693|11518856|FG000|Overall Study|randomized in error|12
7298372|NCT00589693|11518857|FG001|Overall Study|randomized in error|6
7298373|NCT00589693|11518856|FG000|Overall Study|Adverse Event|4
7298374|NCT00589693|11518857|FG001|Overall Study|Adverse Event|4
7298375|NCT00589693|11518856|FG000|Overall Study|Death|26
7298376|NCT00589693|11518857|FG001|Overall Study|Death|16
7298377|NCT00589693|11518856|FG000|Overall Study|Lack of Efficacy|0
7298378|NCT00589693|11518857|FG001|Overall Study|Lack of Efficacy|1
7298379|NCT00589693|11518856|FG000|Overall Study|Lost to Follow-up|1
7298380|NCT00589693|11518857|FG001|Overall Study|Lost to Follow-up|0
7298381|NCT00589693|11518856|FG000|Overall Study|Physician Decision|0
7298382|NCT00589693|11518857|FG001|Overall Study|Physician Decision|1
7298383|NCT00589693|11518856|FG000|Overall Study|Protocol Violation|1
7298384|NCT00589693|11518857|FG001|Overall Study|Protocol Violation|1
7298385|NCT00589784|11518865|FG000|Overall Study|Withdrawal by Subject|0
7298386|NCT00589784|11518866|FG001|Overall Study|Withdrawal by Subject|6
7298387|NCT00589784|11518865|FG000|Overall Study|Patient inevaluable|1
7298388|NCT00589784|11518866|FG001|Overall Study|Patient inevaluable|0
7298389|NCT00589784|11518865|FG000|Overall Study|Adverse Event|0
7298390|NCT00589784|11518866|FG001|Overall Study|Adverse Event|4
7298391|NCT00589797|11518873|FG000|Overall Study|Death|1
7298392|NCT00589797|11518874|FG001|Overall Study|Death|0
7298393|NCT00589797|11518873|FG000|Overall Study|Lost to Follow-up|12
7298394|NCT00589797|11518874|FG001|Overall Study|Lost to Follow-up|9
7298395|NCT00589797|11518873|FG000|Overall Study|Physician Decision|8
7298396|NCT00589797|11518874|FG001|Overall Study|Physician Decision|3
7298397|NCT00589797|11518873|FG000|Overall Study|Withdrawal by Subject|6
7298398|NCT00589797|11518874|FG001|Overall Study|Withdrawal by Subject|5
7298399|NCT00589797|11518873|FG000|Overall Study|Non-Randomized Training Subjects|46
7298400|NCT00589797|11518874|FG001|Overall Study|Non-Randomized Training Subjects|6
7298401|NCT00589914|11518911|FG000|Overall Study|Adverse Event|19
7298402|NCT00589914|11518912|FG001|Overall Study|Adverse Event|10
7298403|NCT00589914|11518911|FG000|Overall Study|Death|2
7298404|NCT00589914|11518912|FG001|Overall Study|Death|0
7298405|NCT00589914|11518911|FG000|Overall Study|Lack of Efficacy|40
7298406|NCT00589914|11518912|FG001|Overall Study|Lack of Efficacy|43
7298407|NCT00589914|11518911|FG000|Overall Study|Lost to Follow-up|11
7298408|NCT00589914|11518912|FG001|Overall Study|Lost to Follow-up|18
7298409|NCT00589914|11518911|FG000|Overall Study|Pregnancy|1
7298410|NCT00589914|11518912|FG001|Overall Study|Pregnancy|0
7298411|NCT00589914|11518911|FG000|Overall Study|Withdrawal by Subject|55
7298412|NCT00589914|11518912|FG001|Overall Study|Withdrawal by Subject|49
7298413|NCT00589914|11518911|FG000|Overall Study|Other|22
7298414|NCT00589914|11518912|FG001|Overall Study|Other|17
7298415|NCT00589979|11518920|FG000|Run-In Period|Adverse Event|5
7298416|NCT00589979|11518921|FG001|Run-In Period|Adverse Event|0
7298417|NCT00589979|11518922|FG002|Run-In Period|Adverse Event|0
7298418|NCT00589979|11518920|FG000|Run-In Period|Protocol Violation|3
7298419|NCT00589979|11518921|FG001|Run-In Period|Protocol Violation|0
7298420|NCT00589979|11518922|FG002|Run-In Period|Protocol Violation|0
7298421|NCT00589979|11518920|FG000|Run-In Period|Did not qualify for randomization|54
7298422|NCT00589979|11518921|FG001|Run-In Period|Did not qualify for randomization|0
7298423|NCT00589979|11518922|FG002|Run-In Period|Did not qualify for randomization|0
7298424|NCT00589979|11518920|FG000|Run-In Period|Withdrawal by Subject|10
7298425|NCT00589979|11518921|FG001|Run-In Period|Withdrawal by Subject|0
7298426|NCT00589979|11518922|FG002|Run-In Period|Withdrawal by Subject|0
7298427|NCT00589979|11518920|FG000|Run-In Period|Informed Consent Withdrawn|4
7298428|NCT00589979|11518921|FG001|Run-In Period|Informed Consent Withdrawn|0
7298429|NCT00589979|11518922|FG002|Run-In Period|Informed Consent Withdrawn|0
7298430|NCT00589979|11518920|FG000|Double-Blind Treatment Period 1|Adverse Event|0
7298431|NCT00589979|11518921|FG001|Double-Blind Treatment Period 1|Adverse Event|1
7298432|NCT00589979|11518922|FG002|Double-Blind Treatment Period 1|Adverse Event|0
7298433|NCT00589979|11518920|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
7298434|NCT00589979|11518921|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
7298435|NCT00589979|11518922|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
7298436|NCT00589979|11518920|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7298437|NCT00589979|11518921|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
7298438|NCT00589979|11518922|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
7298439|NCT00589979|11518920|FG000|Double-Blind Treatment Period 2|Adverse Event|0
7222650|NCT00023764|11431774|FG000|Overall Study|Withdrawal by Subject|1
7222651|NCT00023764|11431774|FG000|Overall Study|Progression of disease|6
7222652|NCT00023764|11431774|FG000|Overall Study|patient received other treatment|1
7222653|NCT00023764|11431774|FG000|Overall Study|delay in obtaining staging images|1
7222654|NCT00024167|11431795|FG000|Overall Study|Death|53
7222655|NCT00024167|11431796|FG001|Overall Study|Death|47
7222656|NCT00024258|11431803|FG000|Overall Study|Withdrawal by Subject|1
7222657|NCT00024258|11431803|FG000|Overall Study|Disease Progression|8
7222658|NCT00025155|11431807|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
7222659|NCT00025155|11431807|FG000|Overall Study|Ineligible: Second primary cancer site|1
7222660|NCT00025233|11431816|FG000|Overall Study|Ineligible: wrong cell type|1
7222661|NCT00025233|11431816|FG000|Overall Study|Ineligible: wrong primary|1
7222662|NCT00025233|11431816|FG000|Overall Study|Ineligible: improper prior treatment|1
7222663|NCT00025233|11431816|FG000|Overall Study|Never treated|1
7222664|NCT00025259|11431833|FG000|Overall Study|Death|1
7222665|NCT00025259|11431834|FG001|Overall Study|Death|3
7222666|NCT00025259|11431835|FG002|Overall Study|Death|0
7222667|NCT00025259|11431836|FG003|Overall Study|Death|3
7222668|NCT00025259|11431837|FG004|Overall Study|Death|0
7222669|NCT00025259|11431838|FG005|Overall Study|Death|1
7222670|NCT00025259|11431839|FG006|Overall Study|Death|2
7222671|NCT00025259|11431833|FG000|Overall Study|Lack of Efficacy|2
7222672|NCT00025259|11431834|FG001|Overall Study|Lack of Efficacy|46
7222673|NCT00025259|11431835|FG002|Overall Study|Lack of Efficacy|60
7222674|NCT00025259|11431836|FG003|Overall Study|Lack of Efficacy|78
7222675|NCT00025259|11431837|FG004|Overall Study|Lack of Efficacy|11
7222676|NCT00025259|11431838|FG005|Overall Study|Lack of Efficacy|30
7222677|NCT00025259|11431839|FG006|Overall Study|Lack of Efficacy|38
7222678|NCT00025259|11431833|FG000|Overall Study|Lost to Follow-up|2
7222679|NCT00025259|11431834|FG001|Overall Study|Lost to Follow-up|9
7222680|NCT00025259|11431835|FG002|Overall Study|Lost to Follow-up|13
7222681|NCT00025259|11431836|FG003|Overall Study|Lost to Follow-up|13
7222682|NCT00025259|11431837|FG004|Overall Study|Lost to Follow-up|1
7222683|NCT00025259|11431838|FG005|Overall Study|Lost to Follow-up|3
7222684|NCT00025259|11431839|FG006|Overall Study|Lost to Follow-up|1
7298440|NCT00589979|11518921|FG001|Double-Blind Treatment Period 2|Adverse Event|1
7298441|NCT00589979|11518922|FG002|Double-Blind Treatment Period 2|Adverse Event|0
7298442|NCT00589979|11518920|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7298443|NCT00589979|11518921|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
7298444|NCT00589979|11518922|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
7298445|NCT00589979|11518920|FG000|Double-Blind Treatment Period 2|Other|0
7298446|NCT00589979|11518921|FG001|Double-Blind Treatment Period 2|Other|0
7298447|NCT00589979|11518922|FG002|Double-Blind Treatment Period 2|Other|1
7298448|NCT00589979|11518920|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
7298449|NCT00589979|11518921|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
7298450|NCT00589979|11518922|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
7298451|NCT00589979|11518920|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7298452|NCT00589979|11518921|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
7298453|NCT00589979|11518922|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
7298454|NCT00590031|11518950|FG000|Overall Study|Adverse Event|3
7298455|NCT00590031|11518950|FG000|Overall Study|Withdrawal by Subject|1
7298456|NCT00590031|11518950|FG000|Overall Study|Metastatic Disease|1
7298457|NCT00590031|11518950|FG000|Overall Study|Admin Hold|1
7298458|NCT00590044|11518956|FG000|Overall Study|Withdrawal by Subject|2
7298459|NCT00590044|11518957|FG001|Overall Study|Withdrawal by Subject|2
7298460|NCT00590044|11518956|FG000|Overall Study|wrong insulin arm assigned|1
7298461|NCT00590044|11518957|FG001|Overall Study|wrong insulin arm assigned|0
7298462|NCT00590044|11518956|FG000|Overall Study|Protocol Violation|1
7298463|NCT00590044|11518957|FG001|Overall Study|Protocol Violation|0
7298464|NCT00590317|11518986|FG000|Overall Study|Lack of Efficacy|1
7298465|NCT00590317|11518987|FG001|Overall Study|Lack of Efficacy|5
7298466|NCT00590564|11519015|FG000|Overall Study|Withdrawal by Subject|4
7298467|NCT00590564|11519015|FG000|Overall Study|Lost to Follow-up|6
7298468|NCT00590564|11519015|FG000|Overall Study|Protocol Violation|1
7298469|NCT00590564|11519015|FG000|Overall Study|Patient Found to be Ineligible|1
7298470|NCT00590564|11519015|FG000|Overall Study|Patient Non-compliance|6
7298471|NCT00590577|11519023|FG000|Overall Study|Lack of Efficacy|31
7298472|NCT00590577|11519024|FG001|Overall Study|Lack of Efficacy|28
7298473|NCT00590577|11519025|FG002|Overall Study|Lack of Efficacy|23
7298474|NCT00590577|11519026|FG003|Overall Study|Lack of Efficacy|45
7298475|NCT00590577|11519023|FG000|Overall Study|Withdrawal by Subject|23
7298476|NCT00590577|11519024|FG001|Overall Study|Withdrawal by Subject|28
7298477|NCT00590577|11519025|FG002|Overall Study|Withdrawal by Subject|30
7298478|NCT00590577|11519026|FG003|Overall Study|Withdrawal by Subject|26
7298479|NCT00590577|11519023|FG000|Overall Study|Adverse Event|10
7298480|NCT00590577|11519024|FG001|Overall Study|Adverse Event|10
7298481|NCT00590577|11519025|FG002|Overall Study|Adverse Event|13
7298482|NCT00590577|11519026|FG003|Overall Study|Adverse Event|11
7298483|NCT00590577|11519023|FG000|Overall Study|Lost to Follow-up|12
7298484|NCT00590577|11519024|FG001|Overall Study|Lost to Follow-up|6
7298485|NCT00590577|11519025|FG002|Overall Study|Lost to Follow-up|6
7298486|NCT00590577|11519026|FG003|Overall Study|Lost to Follow-up|9
7298487|NCT00590577|11519023|FG000|Overall Study|Pregnancy|0
7298488|NCT00590577|11519024|FG001|Overall Study|Pregnancy|1
7298489|NCT00590577|11519025|FG002|Overall Study|Pregnancy|0
7298490|NCT00590577|11519026|FG003|Overall Study|Pregnancy|0
7298491|NCT00590577|11519023|FG000|Overall Study|Various reasons|1
7298492|NCT00590577|11519024|FG001|Overall Study|Various reasons|3
7298493|NCT00590577|11519025|FG002|Overall Study|Various reasons|1
7298494|NCT00590577|11519026|FG003|Overall Study|Various reasons|2
7298495|NCT00590590|11519039|FG000|Overall Study|Lack of Efficacy|1
7298496|NCT00590590|11519040|FG001|Overall Study|Lack of Efficacy|2
7298497|NCT00590590|11519041|FG002|Overall Study|Lack of Efficacy|0
7298498|NCT00590590|11519039|FG000|Overall Study|Adverse Event|1
7298499|NCT00590590|11519040|FG001|Overall Study|Adverse Event|0
7298500|NCT00590590|11519041|FG002|Overall Study|Adverse Event|0
7298501|NCT00590590|11519039|FG000|Overall Study|Protocol Violation|0
7298502|NCT00590590|11519040|FG001|Overall Study|Protocol Violation|0
7298503|NCT00590590|11519041|FG002|Overall Study|Protocol Violation|2
7298504|NCT00590590|11519039|FG000|Overall Study|Lost to Follow-up|4
7298505|NCT00590590|11519040|FG001|Overall Study|Lost to Follow-up|1
7298506|NCT00590590|11519041|FG002|Overall Study|Lost to Follow-up|2
7298507|NCT00590590|11519039|FG000|Overall Study|Withdrawal by Subject|0
7298508|NCT00590590|11519040|FG001|Overall Study|Withdrawal by Subject|1
7298509|NCT00590590|11519041|FG002|Overall Study|Withdrawal by Subject|1
7298510|NCT00590590|11519039|FG000|Overall Study|Did not complete due to study closure|1
7298511|NCT00590590|11519040|FG001|Overall Study|Did not complete due to study closure|1
7298512|NCT00590590|11519041|FG002|Overall Study|Did not complete due to study closure|1
7298513|NCT00590590|11519039|FG000|Overall Study|Did not complete study|0
7298514|NCT00590590|11519040|FG001|Overall Study|Did not complete study|1
7298515|NCT00590590|11519041|FG002|Overall Study|Did not complete study|0
7298516|NCT00590681|11519049|FG000|Overall Study|Withdrawal by Subject|7
7298517|NCT00590681|11519049|FG000|Overall Study|Adverse Event|8
7298518|NCT00590681|11519049|FG000|Overall Study|Death|3
7298519|NCT00590681|11519049|FG000|Overall Study|Lost to Follow-up|1
7298520|NCT00590681|11519049|FG000|Overall Study|disease progression|1
7298521|NCT00590720|11519064|FG000|Overall Study|Lost to Follow-up|1
7298522|NCT00590720|11519065|FG001|Overall Study|Lost to Follow-up|0
7298523|NCT00590720|11519064|FG000|Overall Study|Withdrawal by Subject|0
7298524|NCT00590720|11519065|FG001|Overall Study|Withdrawal by Subject|1
7298525|NCT00590759|11519071|FG000|Overall Study|Death|52
7298526|NCT00590759|11519071|FG000|Overall Study|Lost to Follow-up|28
7298527|NCT00590824|11519085|FG000|Overall Study|Disease could not be resected|0
7298528|NCT00590824|11519086|FG001|Overall Study|Disease could not be resected|2
7298529|NCT00590824|11519087|FG002|Overall Study|Disease could not be resected|1
7298530|NCT00590824|11519088|FG003|Overall Study|Disease could not be resected|0
7298531|NCT00590824|11519085|FG000|Overall Study|Adverse Event|0
7298532|NCT00590824|11519086|FG001|Overall Study|Adverse Event|0
7298533|NCT00590824|11519087|FG002|Overall Study|Adverse Event|0
7298534|NCT00590824|11519088|FG003|Overall Study|Adverse Event|1
7298535|NCT00590902|11519121|FG000|Overall Study|Death|1
7298536|NCT00590954|11519125|FG000|Overall Study|Inevaluable|2
7298537|NCT00590967|11519133|FG000|Overall Study|Withdrawal by Subject|1
7298538|NCT00590967|11519134|FG001|Overall Study|Withdrawal by Subject|1
7298539|NCT00590967|11519133|FG000|Overall Study|Ineligible|1
7298540|NCT00590967|11519134|FG001|Overall Study|Ineligible|0
7298541|NCT00590967|11519133|FG000|Overall Study|Poor performance status|0
7298542|NCT00590967|11519134|FG001|Overall Study|Poor performance status|1
7298543|NCT00590967|11519133|FG000|Overall Study|Non-compliant|0
7298544|NCT00590967|11519134|FG001|Overall Study|Non-compliant|2
7298545|NCT00590967|11519133|FG000|Overall Study|Did not sign consent form|0
7298546|NCT00590967|11519134|FG001|Overall Study|Did not sign consent form|1
7298547|NCT00590967|11519133|FG000|Overall Study|Did not receive chemo per protocol|1
7298548|NCT00590967|11519134|FG001|Overall Study|Did not receive chemo per protocol|0
7298549|NCT00590980|11519140|FG000|Overall Study|Did not meet all inclusion criteria|10
7298550|NCT00591006|11519144|FG000|Overall Study|Withdrawal by Subject|0
7298551|NCT00591006|11519145|FG001|Overall Study|Withdrawal by Subject|0
7298552|NCT00591006|11519146|FG002|Overall Study|Withdrawal by Subject|0
7298553|NCT00591006|11519147|FG003|Overall Study|Withdrawal by Subject|0
7298554|NCT00591006|11519148|FG004|Overall Study|Withdrawal by Subject|0
7298555|NCT00591006|11519149|FG005|Overall Study|Withdrawal by Subject|0
7298556|NCT00591006|11519150|FG006|Overall Study|Withdrawal by Subject|0
7298557|NCT00591006|11519151|FG007|Overall Study|Withdrawal by Subject|0
7298558|NCT00591006|11519152|FG008|Overall Study|Withdrawal by Subject|0
7298559|NCT00591006|11519153|FG009|Overall Study|Withdrawal by Subject|0
7298560|NCT00591006|11519154|FG010|Overall Study|Withdrawal by Subject|0
7298561|NCT00591006|11519155|FG011|Overall Study|Withdrawal by Subject|0
7298562|NCT00591006|11519156|FG012|Overall Study|Withdrawal by Subject|0
7298563|NCT00591006|11519157|FG013|Overall Study|Withdrawal by Subject|0
7298564|NCT00591006|11519158|FG014|Overall Study|Withdrawal by Subject|0
7298565|NCT00591006|11519159|FG015|Overall Study|Withdrawal by Subject|1
7298566|NCT00591006|11519160|FG016|Overall Study|Withdrawal by Subject|0
7298567|NCT00591006|11519161|FG017|Overall Study|Withdrawal by Subject|0
7298568|NCT00591006|11519162|FG018|Overall Study|Withdrawal by Subject|0
7298569|NCT00591006|11519163|FG019|Overall Study|Withdrawal by Subject|0
7298570|NCT00591006|11519164|FG020|Overall Study|Withdrawal by Subject|0
7298571|NCT00591006|11519165|FG021|Overall Study|Withdrawal by Subject|0
7298572|NCT00591006|11519166|FG022|Overall Study|Withdrawal by Subject|0
7298573|NCT00591006|11519167|FG023|Overall Study|Withdrawal by Subject|1
7298574|NCT00591006|11519144|FG000|Overall Study|Adverse Event|0
7298575|NCT00591006|11519145|FG001|Overall Study|Adverse Event|0
7298576|NCT00591006|11519146|FG002|Overall Study|Adverse Event|0
7298577|NCT00591006|11519147|FG003|Overall Study|Adverse Event|0
7298578|NCT00591006|11519148|FG004|Overall Study|Adverse Event|0
7298579|NCT00591006|11519149|FG005|Overall Study|Adverse Event|0
7298580|NCT00591006|11519150|FG006|Overall Study|Adverse Event|0
7298581|NCT00591006|11519151|FG007|Overall Study|Adverse Event|0
7298582|NCT00591006|11519152|FG008|Overall Study|Adverse Event|0
7298583|NCT00591006|11519153|FG009|Overall Study|Adverse Event|0
7298584|NCT00591006|11519154|FG010|Overall Study|Adverse Event|0
7298585|NCT00591006|11519155|FG011|Overall Study|Adverse Event|0
7298586|NCT00591006|11519156|FG012|Overall Study|Adverse Event|0
7298587|NCT00591006|11519157|FG013|Overall Study|Adverse Event|0
7298588|NCT00591006|11519158|FG014|Overall Study|Adverse Event|0
7298589|NCT00591006|11519159|FG015|Overall Study|Adverse Event|0
7298590|NCT00591006|11519160|FG016|Overall Study|Adverse Event|0
7298591|NCT00591006|11519161|FG017|Overall Study|Adverse Event|0
7298592|NCT00591006|11519162|FG018|Overall Study|Adverse Event|0
7298593|NCT00591006|11519163|FG019|Overall Study|Adverse Event|0
7298594|NCT00591006|11519164|FG020|Overall Study|Adverse Event|0
7298595|NCT00591006|11519165|FG021|Overall Study|Adverse Event|0
7298596|NCT00591006|11519166|FG022|Overall Study|Adverse Event|1
7298597|NCT00591006|11519167|FG023|Overall Study|Adverse Event|0
7298598|NCT00591149|11519197|FG000|Overall Study|Adverse Event|4
7298599|NCT00591149|11519197|FG000|Overall Study|Withdrawal by Subject|1
7298600|NCT00591214|11519201|FG000|Overall Study|Physician Decision|7
7298601|NCT00591214|11519201|FG000|Overall Study|Withdrawal by Subject|1
7298602|NCT00591253|11519217|FG000|Overall Study|Adverse Event|3
7298603|NCT00591253|11519218|FG001|Overall Study|Adverse Event|3
7298604|NCT00591253|11519219|FG002|Overall Study|Adverse Event|1
7298605|NCT00591253|11519217|FG000|Overall Study|Protocol Violation|2
7298606|NCT00591253|11519218|FG001|Overall Study|Protocol Violation|2
7298607|NCT00591253|11519219|FG002|Overall Study|Protocol Violation|2
7298608|NCT00591253|11519217|FG000|Overall Study|Lost to Follow-up|2
7298609|NCT00591253|11519218|FG001|Overall Study|Lost to Follow-up|4
7298610|NCT00591253|11519219|FG002|Overall Study|Lost to Follow-up|0
7298611|NCT00591253|11519217|FG000|Overall Study|Withdrawal by Subject|1
7298612|NCT00591253|11519218|FG001|Overall Study|Withdrawal by Subject|7
7298613|NCT00591253|11519219|FG002|Overall Study|Withdrawal by Subject|6
7298614|NCT00591253|11519217|FG000|Overall Study|Lack of Efficacy|1
7298615|NCT00591253|11519218|FG001|Overall Study|Lack of Efficacy|0
7298616|NCT00591253|11519219|FG002|Overall Study|Lack of Efficacy|3
7298617|NCT00591253|11519217|FG000|Overall Study|Other|5
7298618|NCT00591253|11519218|FG001|Overall Study|Other|5
7298619|NCT00591253|11519219|FG002|Overall Study|Other|3
7298620|NCT00591266|11519230|FG000|Overall Study|Adverse Event|2
7298621|NCT00591266|11519231|FG001|Overall Study|Adverse Event|2
7298622|NCT00591266|11519232|FG002|Overall Study|Adverse Event|3
7298623|NCT00591266|11519230|FG000|Overall Study|Lost to Follow-up|0
7298624|NCT00591266|11519231|FG001|Overall Study|Lost to Follow-up|1
7298625|NCT00591266|11519232|FG002|Overall Study|Lost to Follow-up|0
7298626|NCT00591266|11519230|FG000|Overall Study|Protocol Violation|0
7298627|NCT00591266|11519231|FG001|Overall Study|Protocol Violation|0
7298628|NCT00591266|11519232|FG002|Overall Study|Protocol Violation|1
7298629|NCT00591266|11519230|FG000|Overall Study|Withdrawal by Subject|6
7298630|NCT00591266|11519231|FG001|Overall Study|Withdrawal by Subject|2
7298631|NCT00591266|11519232|FG002|Overall Study|Withdrawal by Subject|5
7298632|NCT00591266|11519230|FG000|Overall Study|Lack of Efficacy|0
7298633|NCT00591266|11519231|FG001|Overall Study|Lack of Efficacy|2
7298634|NCT00591266|11519232|FG002|Overall Study|Lack of Efficacy|0
7298635|NCT00591266|11519230|FG000|Overall Study|Other|1
7298636|NCT00591266|11519231|FG001|Overall Study|Other|4
7298637|NCT00591266|11519232|FG002|Overall Study|Other|5
7298638|NCT00591344|11519252|FG000|Overall Study|Transportation issues|1
7298639|NCT00591344|11519253|FG001|Overall Study|Transportation issues|0
7298640|NCT00591344|11519252|FG000|Overall Study|Moved out of state|1
7298641|NCT00591344|11519253|FG001|Overall Study|Moved out of state|0
7298642|NCT00591344|11519252|FG000|Overall Study|Medical complications|1
7298643|NCT00591344|11519253|FG001|Overall Study|Medical complications|3
7298644|NCT00591344|11519252|FG000|Overall Study|Underwent DBS|2
7298645|NCT00591344|11519253|FG001|Overall Study|Underwent DBS|2
7298646|NCT00591344|11519252|FG000|Overall Study|Death|0
7298647|NCT00591344|11519253|FG001|Overall Study|Death|1
7298648|NCT00591344|11519252|FG000|Overall Study|Lost to Follow-up|0
7298649|NCT00591344|11519253|FG001|Overall Study|Lost to Follow-up|1
7298650|NCT00591344|11519252|FG000|Overall Study|Did not want to come off medication|0
7298651|NCT00591344|11519253|FG001|Overall Study|Did not want to come off medication|1
7298652|NCT00591370|11519263|FG000|Overall Study|Not Treated|2
7298653|NCT00591409|11519277|FG000|Overall Study|Not Treated|0
7298654|NCT00591409|11519278|FG001|Overall Study|Not Treated|0
7298655|NCT00591409|11519279|FG002|Overall Study|Not Treated|0
7298656|NCT00591409|11519280|FG003|Overall Study|Not Treated|0
7298657|NCT00591409|11519281|FG004|Overall Study|Not Treated|1
7298658|NCT00591409|11519282|FG005|Overall Study|Not Treated|0
7298659|NCT00591409|11519283|FG006|Overall Study|Not Treated|0
7298660|NCT00591409|11519284|FG007|Overall Study|Not Treated|0
7298661|NCT00591409|11519285|FG008|Overall Study|Not Treated|0
7298662|NCT00591409|11519286|FG009|Overall Study|Not Treated|1
7298663|NCT00591565|11519308|FG000|Overall Study|lost follow up, withdrawn|5
7298664|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Adverse Event|20
7298665|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Adverse Event|26
7298666|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Adverse Event|19
7298667|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Protocol Violation|3
7298668|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Protocol Violation|2
7298669|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Protocol Violation|3
7298670|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
7298671|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
7298672|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
7298673|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
7298674|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
7298675|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
7298676|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Pregnancy|1
7298677|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Pregnancy|0
7298678|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Pregnancy|0
7298679|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
7298680|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
7298681|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
7298682|NCT00591578|11519315|FG000|Double-Blind Treatment Phase|Other|4
7298683|NCT00591578|11519316|FG001|Double-Blind Treatment Phase|Other|9
7298684|NCT00591578|11519317|FG002|Double-Blind Treatment Phase|Other|4
7298685|NCT00591578|11519315|FG000|Open-Label Extension Phase|Adverse Event|3
7298686|NCT00591578|11519316|FG001|Open-Label Extension Phase|Adverse Event|5
7298687|NCT00591578|11519317|FG002|Open-Label Extension Phase|Adverse Event|0
7298688|NCT00591578|11519315|FG000|Open-Label Extension Phase|Lost to Follow-up|1
7298689|NCT00591578|11519316|FG001|Open-Label Extension Phase|Lost to Follow-up|4
7298690|NCT00591578|11519317|FG002|Open-Label Extension Phase|Lost to Follow-up|0
7298691|NCT00591578|11519315|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
7298692|NCT00591578|11519316|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
7298693|NCT00591578|11519317|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
7298694|NCT00591578|11519315|FG000|Open-Label Extension Phase|Other|1
7298695|NCT00591578|11519316|FG001|Open-Label Extension Phase|Other|0
7298696|NCT00591578|11519317|FG002|Open-Label Extension Phase|Other|0
7298697|NCT00591591|11519328|FG000|Overall Study|Withdrawal by Subject|1
7298698|NCT00591591|11519329|FG001|Overall Study|Withdrawal by Subject|37
7298699|NCT00591591|11519328|FG000|Overall Study|Lack of Efficacy|10
7298700|NCT00591591|11519329|FG001|Overall Study|Lack of Efficacy|2
7298701|NCT00591630|11519339|FG000|Overall Study|Death|0
7298702|NCT00591630|11519340|FG001|Overall Study|Death|0
7298703|NCT00591630|11519341|FG002|Overall Study|Death|1
7298704|NCT00591630|11519342|FG003|Overall Study|Death|0
7298705|NCT00591721|11519354|FG000|Overall Study|Withdrawal by Subject|10
7298706|NCT00591721|11519355|FG001|Overall Study|Withdrawal by Subject|10
7298707|NCT00591721|11519354|FG000|Overall Study|Lost to Follow-up|1
7298708|NCT00591721|11519355|FG001|Overall Study|Lost to Follow-up|4
7298709|NCT00591721|11519354|FG000|Overall Study|Intervention not received|10
7298710|NCT00591721|11519355|FG001|Overall Study|Intervention not received|8
7298711|NCT00591734|11519361|FG000|Overall Study|Lack of Efficacy|35
7298712|NCT00591734|11519361|FG000|Overall Study|Adverse Event|5
7298713|NCT00591734|11519361|FG000|Overall Study|Physician Decision|5
7298714|NCT00591734|11519361|FG000|Overall Study|Intercurrent Illness|8
7298715|NCT00591773|11519377|FG000|Overall Study|Adverse Event|9
7298716|NCT00591773|11519378|FG001|Overall Study|Adverse Event|9
7298717|NCT00591773|11519379|FG002|Overall Study|Adverse Event|6
7298718|NCT00591773|11519377|FG000|Overall Study|Protocol Violation|2
7298719|NCT00591773|11519378|FG001|Overall Study|Protocol Violation|3
7298720|NCT00591773|11519379|FG002|Overall Study|Protocol Violation|0
7298721|NCT00591773|11519377|FG000|Overall Study|Lost to Follow-up|1
7298722|NCT00591773|11519378|FG001|Overall Study|Lost to Follow-up|4
7298723|NCT00591773|11519379|FG002|Overall Study|Lost to Follow-up|1
7298724|NCT00591773|11519377|FG000|Overall Study|Withdrawal by Subject|2
7298725|NCT00591773|11519378|FG001|Overall Study|Withdrawal by Subject|5
7298726|NCT00591773|11519379|FG002|Overall Study|Withdrawal by Subject|3
7298727|NCT00591773|11519377|FG000|Overall Study|Lack of Efficacy|1
7298728|NCT00591773|11519378|FG001|Overall Study|Lack of Efficacy|2
7298729|NCT00591773|11519379|FG002|Overall Study|Lack of Efficacy|2
7298730|NCT00591773|11519377|FG000|Overall Study|Other|1
7298731|NCT00591773|11519378|FG001|Overall Study|Other|1
7298732|NCT00591773|11519379|FG002|Overall Study|Other|4
7298733|NCT00591786|11519397|FG000|Overall Study|Withdrawal of Informed Consent|0
7298734|NCT00591786|11519398|FG001|Overall Study|Withdrawal of Informed Consent|0
7298735|NCT00591786|11519399|FG002|Overall Study|Withdrawal of Informed Consent|1
7298736|NCT00591786|11519400|FG003|Overall Study|Withdrawal of Informed Consent|0
7298737|NCT00591786|11519401|FG004|Overall Study|Withdrawal of Informed Consent|0
7298738|NCT00591786|11519402|FG005|Overall Study|Withdrawal of Informed Consent|0
7298739|NCT00591786|11519403|FG006|Overall Study|Withdrawal of Informed Consent|0
7298740|NCT00591786|11519404|FG007|Overall Study|Withdrawal of Informed Consent|0
7298741|NCT00591786|11519405|FG008|Overall Study|Withdrawal of Informed Consent|0
7298742|NCT00591786|11519406|FG009|Overall Study|Withdrawal of Informed Consent|0
7298743|NCT00591838|11519460|FG000|Overall Study|Withdrawal by Subject|0
7298744|NCT00591838|11519461|FG001|Overall Study|Withdrawal by Subject|0
7298745|NCT00591838|11519462|FG002|Overall Study|Withdrawal by Subject|0
7298746|NCT00591838|11519463|FG003|Overall Study|Withdrawal by Subject|1
7298747|NCT00591838|11519464|FG004|Overall Study|Withdrawal by Subject|0
7298748|NCT00591851|11519477|FG000|Overall Study|Withdrawal by Subject|3
7298749|NCT00591851|11519477|FG000|Overall Study|Adverse Event|2
7298750|NCT00591851|11519477|FG000|Overall Study|Progressive Disease|1
7298751|NCT00591864|11519481|FG000|Overall Study|Incomplete Imaging|5
7551695|NCT02974088|11911144|FG000|Overall Study|Lost to Follow-up|0
7551696|NCT02974088|11911145|FG001|Overall Study|Lost to Follow-up|2
7551697|NCT02974088|11911144|FG000|Overall Study|Adverse Event|0
7551698|NCT02974088|11911145|FG001|Overall Study|Adverse Event|1
7551699|NCT02974114|11911154|FG000|Overall Study|Other (Not specified)|0
7551700|NCT02974114|11911155|FG001|Overall Study|Other (Not specified)|1
7551701|NCT02974114|11911156|FG002|Overall Study|Other (Not specified)|2
7551702|NCT02974140|11911166|FG000|Overall Study|Adverse Event|2
7551703|NCT02974140|11911166|FG000|Overall Study|Lost to Follow-up|1
7551704|NCT02974140|11911166|FG000|Overall Study|Study Terminated by Sponsor|36
7551705|NCT02974153|11911176|FG000|Overall Study|Adverse Event|6
7551706|NCT02974153|11911177|FG001|Overall Study|Adverse Event|0
7551707|NCT02974153|11911178|FG002|Overall Study|Adverse Event|1
7551708|NCT02974153|11911176|FG000|Overall Study|Lack of Efficacy|6
7551709|NCT02974153|11911177|FG001|Overall Study|Lack of Efficacy|5
7551710|NCT02974153|11911178|FG002|Overall Study|Lack of Efficacy|10
7551711|NCT02974153|11911176|FG000|Overall Study|Lost to Follow-up|9
7551712|NCT02974153|11911177|FG001|Overall Study|Lost to Follow-up|10
7551713|NCT02974153|11911178|FG002|Overall Study|Lost to Follow-up|17
7551714|NCT02974153|11911176|FG000|Overall Study|Physician Decision|0
7551715|NCT02974153|11911177|FG001|Overall Study|Physician Decision|2
7551716|NCT02974153|11911178|FG002|Overall Study|Physician Decision|1
7551717|NCT02974153|11911176|FG000|Overall Study|Withdrawal by Subject|9
7551718|NCT02974153|11911177|FG001|Overall Study|Withdrawal by Subject|16
7298752|NCT00592072|11519493|FG000|Wash Out Period|Lost to Follow-up|1
7298753|NCT00592072|11519494|FG001|Wash Out Period|Lost to Follow-up|1
7298754|NCT00592319|11519527|FG000|Overall Study|Lost to Follow-up|0
7298755|NCT00592319|11519528|FG001|Overall Study|Lost to Follow-up|3
7298756|NCT00592358|11519536|FG000|Overall Study|Withdrawal by Subject|2
7298757|NCT00592358|11519536|FG000|Overall Study|Adverse Event|1
7298758|NCT00592358|11519536|FG000|Overall Study|Lack of Efficacy|2
7298759|NCT00592358|11519536|FG000|Overall Study|Inability to swallow pills|1
7298760|NCT00592384|11519542|FG000|Overall Study|Withdrawal by Subject|5
7298761|NCT00592384|11519543|FG001|Overall Study|Withdrawal by Subject|6
7298762|NCT00592501|11519573|FG000|Overall Study|Withdrawal by Subject|1
7298763|NCT00592501|11519573|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
7298764|NCT00592553|11519580|FG000|Overall Study|Protocol Noncompliance|1
7298765|NCT00592553|11519581|FG001|Overall Study|Protocol Noncompliance|0
7298766|NCT00592553|11519582|FG002|Overall Study|Protocol Noncompliance|0
7298767|NCT00592631|11519592|FG000|Overall Study|Lost to Follow-up|0
7298768|NCT00592631|11519593|FG001|Overall Study|Lost to Follow-up|2
7298769|NCT00592683|11519601|FG000|Overall Study|Found ineligible|0
7298770|NCT00592683|11519602|FG001|Overall Study|Found ineligible|1
7298771|NCT00592683|11519601|FG000|Overall Study|Withdrawal by Subject|1
7298772|NCT00592683|11519602|FG001|Overall Study|Withdrawal by Subject|0
7298773|NCT00592683|11519601|FG000|Overall Study|Adverse Event|0
7298774|NCT00592683|11519602|FG001|Overall Study|Adverse Event|2
7298775|NCT00592683|11519601|FG000|Overall Study|Protocol Violation|1
7298776|NCT00592683|11519602|FG001|Overall Study|Protocol Violation|0
7298777|NCT00592683|11519601|FG000|Overall Study|Study drug expired|1
7298778|NCT00592683|11519602|FG001|Overall Study|Study drug expired|0
7298779|NCT00592683|11519601|FG000|Overall Study|Other|1
7298780|NCT00592683|11519602|FG001|Overall Study|Other|0
7298781|NCT00592683|11519601|FG000|Overall Study|Lost to Follow-up|0
7298782|NCT00592683|11519602|FG001|Overall Study|Lost to Follow-up|1
7298783|NCT00592774|11519620|FG000|Overall Study|Adverse Event|5
7298784|NCT00592774|11519621|FG001|Overall Study|Adverse Event|19
7298785|NCT00592774|11519622|FG002|Overall Study|Adverse Event|2
7298786|NCT00592774|11519623|FG003|Overall Study|Adverse Event|14
7298787|NCT00592774|11519624|FG004|Overall Study|Adverse Event|8
7298788|NCT00592774|11519620|FG000|Overall Study|Protocol Violation|0
7298789|NCT00592774|11519621|FG001|Overall Study|Protocol Violation|1
7298790|NCT00592774|11519622|FG002|Overall Study|Protocol Violation|0
7298791|NCT00592774|11519623|FG003|Overall Study|Protocol Violation|0
7298792|NCT00592774|11519624|FG004|Overall Study|Protocol Violation|1
7298793|NCT00592774|11519620|FG000|Overall Study|Withdrawal by Subject|3
7298794|NCT00592774|11519621|FG001|Overall Study|Withdrawal by Subject|7
7298795|NCT00592774|11519622|FG002|Overall Study|Withdrawal by Subject|0
7298796|NCT00592774|11519623|FG003|Overall Study|Withdrawal by Subject|0
7298797|NCT00592774|11519624|FG004|Overall Study|Withdrawal by Subject|0
7298798|NCT00592774|11519620|FG000|Overall Study|Lack of Efficacy|3
7298799|NCT00592774|11519621|FG001|Overall Study|Lack of Efficacy|3
7298800|NCT00592774|11519622|FG002|Overall Study|Lack of Efficacy|0
7298801|NCT00592774|11519623|FG003|Overall Study|Lack of Efficacy|0
7298802|NCT00592774|11519624|FG004|Overall Study|Lack of Efficacy|2
7298803|NCT00592774|11519620|FG000|Overall Study|Physician Decision|0
7298804|NCT00592774|11519621|FG001|Overall Study|Physician Decision|1
7298805|NCT00592774|11519622|FG002|Overall Study|Physician Decision|1
7298806|NCT00592774|11519623|FG003|Overall Study|Physician Decision|0
7298807|NCT00592774|11519624|FG004|Overall Study|Physician Decision|1
7298808|NCT00592774|11519620|FG000|Overall Study|Other|0
7298809|NCT00592774|11519621|FG001|Overall Study|Other|1
7298810|NCT00592774|11519622|FG002|Overall Study|Other|1
7298811|NCT00592774|11519623|FG003|Overall Study|Other|0
7298812|NCT00592774|11519624|FG004|Overall Study|Other|2
7298813|NCT00592839|11519639|FG000|Overall Study|Withdrawal by Subject|1
7298814|NCT00592839|11519640|FG001|Overall Study|Withdrawal by Subject|1
7298815|NCT00592839|11519641|FG002|Overall Study|Withdrawal by Subject|3
7298816|NCT00592839|11519639|FG000|Overall Study|Protocol Violation|1
7298817|NCT00592839|11519640|FG001|Overall Study|Protocol Violation|1
7298818|NCT00592839|11519641|FG002|Overall Study|Protocol Violation|2
7298819|NCT00592839|11519639|FG000|Overall Study|Adverse Event|0
7298820|NCT00592839|11519640|FG001|Overall Study|Adverse Event|1
7298821|NCT00592839|11519641|FG002|Overall Study|Adverse Event|0
7298822|NCT00592839|11519639|FG000|Overall Study|Lost to Follow-up|0
7298823|NCT00592839|11519640|FG001|Overall Study|Lost to Follow-up|1
7298824|NCT00592839|11519641|FG002|Overall Study|Lost to Follow-up|1
7298825|NCT00592852|11519649|FG000|Overall Study|Non-compliance|1
7298826|NCT00592852|11519649|FG000|Overall Study|Adverse Event|3
7298827|NCT00592852|11519649|FG000|Overall Study|Found ineligible|1
7298828|NCT00592852|11519649|FG000|Overall Study|Withdrawal by Subject|1
7298829|NCT00592904|11519657|FG000|Overall Study|Adverse Event|15
7298830|NCT00592904|11519658|FG001|Overall Study|Adverse Event|25
7298831|NCT00592904|11519659|FG002|Overall Study|Adverse Event|13
7298832|NCT00592904|11519660|FG003|Overall Study|Adverse Event|5
7298833|NCT00592904|11519657|FG000|Overall Study|Protocol Violation|1
7298834|NCT00592904|11519658|FG001|Overall Study|Protocol Violation|1
7298835|NCT00592904|11519659|FG002|Overall Study|Protocol Violation|0
7298836|NCT00592904|11519660|FG003|Overall Study|Protocol Violation|1
7298837|NCT00592904|11519657|FG000|Overall Study|Withdrawal by Subject|4
7298838|NCT00592904|11519658|FG001|Overall Study|Withdrawal by Subject|16
7298839|NCT00592904|11519659|FG002|Overall Study|Withdrawal by Subject|1
7298840|NCT00592904|11519660|FG003|Overall Study|Withdrawal by Subject|2
7298841|NCT00592904|11519657|FG000|Overall Study|Lack of Efficacy|2
7298842|NCT00592904|11519658|FG001|Overall Study|Lack of Efficacy|7
7298843|NCT00592904|11519659|FG002|Overall Study|Lack of Efficacy|2
7298844|NCT00592904|11519660|FG003|Overall Study|Lack of Efficacy|3
7298845|NCT00592904|11519657|FG000|Overall Study|Physician Decision|0
7298846|NCT00592904|11519658|FG001|Overall Study|Physician Decision|3
7298847|NCT00592904|11519659|FG002|Overall Study|Physician Decision|1
7298848|NCT00592904|11519660|FG003|Overall Study|Physician Decision|0
7298849|NCT00592904|11519657|FG000|Overall Study|Other|3
7298850|NCT00592904|11519658|FG001|Overall Study|Other|3
7298851|NCT00592904|11519659|FG002|Overall Study|Other|0
7298852|NCT00592904|11519660|FG003|Overall Study|Other|0
7298853|NCT00593112|11519681|FG000|Overall Study|Scan Anxiety|3
7298854|NCT00593112|11519682|FG001|Overall Study|Scan Anxiety|0
7298855|NCT00593112|11519681|FG000|Overall Study|Abnormal Scan|1
7298856|NCT00593112|11519682|FG001|Overall Study|Abnormal Scan|0
7298857|NCT00593112|11519681|FG000|Overall Study|Unreadable Scan|1
7298858|NCT00593112|11519682|FG001|Overall Study|Unreadable Scan|0
7298859|NCT00593112|11519681|FG000|Overall Study|Withdrawal by Subject|5
7298860|NCT00593112|11519682|FG001|Overall Study|Withdrawal by Subject|0
7298861|NCT00593333|11519690|FG000|Overall Study|Lost to Follow-up|10
7298862|NCT00593333|11519691|FG001|Overall Study|Lost to Follow-up|11
7298863|NCT00593385|11519711|FG000|Overall Study|Death|14
7298864|NCT00593385|11519711|FG000|Overall Study|Lost to Follow-up|17
7298865|NCT00593385|11519711|FG000|Overall Study|Withdrawal by Subject|9
7298866|NCT00593489|11519736|FG000|Allocation|did not attend workshop; allocation not|2
7298867|NCT00593489|11519737|FG001|Allocation|did not attend workshop; allocation not|1
7298868|NCT00593554|11519747|FG000|Overall Study|Death|1
7298869|NCT00593554|11519748|FG001|Overall Study|Death|2
7298870|NCT00593554|11519747|FG000|Overall Study|Physician Decision|0
7298871|NCT00593554|11519748|FG001|Overall Study|Physician Decision|1
7298872|NCT00593554|11519747|FG000|Overall Study|Withdrawal by Subject|1
7298873|NCT00593554|11519748|FG001|Overall Study|Withdrawal by Subject|0
7298874|NCT00593554|11519747|FG000|Overall Study|Disease Progression|1
7298875|NCT00593554|11519748|FG001|Overall Study|Disease Progression|2
7298876|NCT00593606|11519754|FG000|Overall Study|Adverse Event|13
7298877|NCT00593606|11519754|FG000|Overall Study|Withdrawal by Subject|1
7298878|NCT00593606|11519754|FG000|Overall Study|Protocol Violation|3
7298879|NCT00593606|11519754|FG000|Overall Study|Lost to Follow-up|2
7298880|NCT00593606|11519754|FG000|Overall Study|Run-In Failure|5
7298881|NCT00593606|11519754|FG000|Overall Study|Screen Failure|3
7298882|NCT00593684|11519764|FG000|Overall Study|Death|2
7298883|NCT00593684|11519765|FG001|Overall Study|Death|1
7298884|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Adverse Event|0
7298885|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Adverse Event|0
7298886|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Adverse Event|0
7298887|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Adverse Event|3
7298888|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
7298889|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
7298890|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
7298891|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
7298892|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7298893|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7298894|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
7298895|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
7298896|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Study Termination|0
7298897|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Study Termination|0
7298898|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Study Termination|0
7298899|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Study Termination|15
7298900|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7298901|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7298902|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
7298903|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
7298904|NCT00593736|11519775|FG000|Screening Period and Placebo Run-in|Various|0
7298905|NCT00593736|11519776|FG001|Screening Period and Placebo Run-in|Various|0
7298906|NCT00593736|11519777|FG002|Screening Period and Placebo Run-in|Various|0
7298907|NCT00593736|11519778|FG003|Screening Period and Placebo Run-in|Various|25
7298908|NCT00593736|11519775|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7298909|NCT00593736|11519776|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
7298910|NCT00593736|11519777|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
7298911|NCT00593736|11519778|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
7298912|NCT00593736|11519775|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
7298913|NCT00593736|11519776|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
7298914|NCT00593736|11519777|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
7298915|NCT00593736|11519778|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
7298916|NCT00593736|11519775|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7298917|NCT00593736|11519776|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
7298918|NCT00593736|11519777|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
7298919|NCT00593736|11519778|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
7298920|NCT00593736|11519775|FG000|Treatment Period and Placebo Run-out|Various|1
7298921|NCT00593736|11519776|FG001|Treatment Period and Placebo Run-out|Various|1
7298922|NCT00593736|11519777|FG002|Treatment Period and Placebo Run-out|Various|1
7298923|NCT00593736|11519778|FG003|Treatment Period and Placebo Run-out|Various|0
7298924|NCT00593814|11519790|FG000|Overall Study|Death|7
7298925|NCT00593814|11519791|FG001|Overall Study|Death|0
7298926|NCT00593814|11519790|FG000|Overall Study|Withdrawal by Subject|7
7298927|NCT00593814|11519791|FG001|Overall Study|Withdrawal by Subject|0
7298928|NCT00593814|11519790|FG000|Overall Study|Lost to Follow-up|7
7298929|NCT00593814|11519791|FG001|Overall Study|Lost to Follow-up|0
7298930|NCT00593814|11519790|FG000|Overall Study|Physician Decision|3
7298931|NCT00593814|11519791|FG001|Overall Study|Physician Decision|0
7298932|NCT00593827|11519799|FG000|Overall Study|On Active Treatment/Pending|0
7298933|NCT00593827|11519800|FG001|Overall Study|On Active Treatment/Pending|2
7298934|NCT00593918|11519812|FG000|Overall Study|Withdrawal by Subject|5
7298935|NCT00593918|11519813|FG001|Overall Study|Withdrawal by Subject|24
7298936|NCT00593957|11519822|FG000|Overall Study|Physician Decision|0
7298937|NCT00593957|11519823|FG001|Overall Study|Physician Decision|1
7298938|NCT00593957|11519824|FG002|Overall Study|Physician Decision|2
7298939|NCT00594035|11519861|FG000|Overall Study|Lost to Follow-up|1
7298940|NCT00594035|11519862|FG001|Overall Study|Lost to Follow-up|1
7298941|NCT00594035|11519861|FG000|Overall Study|Withdrawal by Subject|1
7298942|NCT00594035|11519862|FG001|Overall Study|Withdrawal by Subject|0
7298943|NCT00594035|11519861|FG000|Overall Study|Subject transferred to nursing home|0
7298944|NCT00594035|11519862|FG001|Overall Study|Subject transferred to nursing home|1
7298945|NCT00594035|11519861|FG000|Overall Study|Subject couldn't return due to job|0
7298946|NCT00594035|11519862|FG001|Overall Study|Subject couldn't return due to job|1
7298947|NCT00594100|11519872|FG000|Procedure|Technical Failure|9
7298948|NCT00594100|11519872|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
7298949|NCT00594100|11519872|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
7298950|NCT00594100|11519872|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
7298951|NCT00594165|11519876|FG000|Overall Study|Major protocol violation|1
7298952|NCT00594165|11519876|FG000|Overall Study|Lack of Efficacy|12
7298953|NCT00594165|11519876|FG000|Overall Study|Adverse Event|52
7298954|NCT00594165|11519876|FG000|Overall Study|Unsatisfactory compliance of subject|6
7298955|NCT00594165|11519876|FG000|Overall Study|Subject withdrew consent|27
7298956|NCT00594165|11519876|FG000|Overall Study|Study ended per sponsor|102
7298957|NCT00594165|11519876|FG000|Overall Study|Lost to Follow-up|4
7298958|NCT00594165|11519876|FG000|Overall Study|Other: PI discretion|5
7298959|NCT00594165|11519876|FG000|Overall Study|Other: Subject moving|3
7298960|NCT00594165|11519876|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
7298961|NCT00594165|11519876|FG000|Overall Study|Other: House bound; can't get to clinic|1
7298962|NCT00594165|11519876|FG000|Overall Study|Other: Subject enrolled in other trial|1
7298963|NCT00594165|11519876|FG000|Overall Study|Other: Site terminated participation|2
7298964|NCT00594178|11519880|FG000|Overall Study|Physician Decision|5
7298965|NCT00594204|11519886|FG000|Overall Study|Adverse Event|15
7298966|NCT00594204|11519887|FG001|Overall Study|Adverse Event|3
7298967|NCT00594204|11519886|FG000|Overall Study|Lost to Follow-up|9
7298968|NCT00594204|11519887|FG001|Overall Study|Lost to Follow-up|5
7298969|NCT00594204|11519886|FG000|Overall Study|Withdrawal by Subject|23
7298970|NCT00594204|11519887|FG001|Overall Study|Withdrawal by Subject|29
7298971|NCT00594204|11519886|FG000|Overall Study|Other|4
7298972|NCT00594204|11519887|FG001|Overall Study|Other|3
7298973|NCT00594204|11519886|FG000|Overall Study|Lack of Efficacy|3
7298974|NCT00594204|11519887|FG001|Overall Study|Lack of Efficacy|4
7298975|NCT00594204|11519886|FG000|Overall Study|Randomized but not treated|4
7298976|NCT00594204|11519887|FG001|Overall Study|Randomized but not treated|1
7298977|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Not ready to exercise|1
7298978|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Not ready to exercise|0
7298979|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Not ready to exercise|0
7298980|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Lack of Interest|3
7298981|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Lack of Interest|3
7298982|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Lack of Interest|0
7298983|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Personal issues|2
7298984|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Personal issues|0
7298985|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Personal issues|0
7298986|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Too busy|7
7298987|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Too busy|1
7298988|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Too busy|0
7298989|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Pain|2
7298990|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Pain|0
7298991|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Pain|0
7298992|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Moved|1
7298993|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Moved|0
7298994|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Moved|0
7298995|NCT00594399|11519913|FG000|Initial 3 Month Counseling|Family illness|1
7298996|NCT00594399|11519914|FG001|Initial 3 Month Counseling|Family illness|0
7298997|NCT00594399|11519915|FG002|Initial 3 Month Counseling|Family illness|0
7298998|NCT00594399|11519913|FG000|Rerandomization Arm 1 Only|Death|2
7298999|NCT00594399|11519914|FG001|Rerandomization Arm 1 Only|Death|1
7299000|NCT00594399|11519915|FG002|Rerandomization Arm 1 Only|Death|0
7299001|NCT00594399|11519913|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7299002|NCT00594399|11519914|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
7299003|NCT00594399|11519915|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
7299004|NCT00594464|11519934|FG000|Overall Study|Withdrawal by Subject|1
7299005|NCT00594464|11519934|FG000|Overall Study|Delay in operation|2
7299006|NCT00594516|11519944|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
7299007|NCT00594516|11519945|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7299008|NCT00594516|11519946|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
7299009|NCT00594516|11519944|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
7299010|NCT00594516|11519945|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7299011|NCT00594516|11519946|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
7299012|NCT00594516|11519944|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
7299013|NCT00594516|11519945|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
7299014|NCT00594516|11519946|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
7299015|NCT00594516|11519944|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
7299016|NCT00594516|11519945|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7299017|NCT00594516|11519946|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
7299018|NCT00594516|11519944|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
7299019|NCT00594516|11519945|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7299020|NCT00594516|11519946|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
7299021|NCT00594516|11519944|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
7299022|NCT00594516|11519945|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7299023|NCT00594516|11519946|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
7299024|NCT00594516|11519944|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
7299025|NCT00594516|11519945|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
7299026|NCT00594516|11519946|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
7299027|NCT00594516|11519944|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
7299028|NCT00594516|11519945|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7299029|NCT00594516|11519946|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
7299030|NCT00594516|11519944|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7299031|NCT00594516|11519945|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
7299032|NCT00594516|11519946|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
7299033|NCT00594568|11519953|FG000|Initial Treatment|Adverse Event|51
7299034|NCT00594568|11519954|FG001|Initial Treatment|Adverse Event|121
7299035|NCT00594568|11519955|FG002|Initial Treatment|Adverse Event|144
7299036|NCT00594568|11519953|FG000|Initial Treatment|Death|6
7299037|NCT00594568|11519954|FG001|Initial Treatment|Death|11
7299038|NCT00594568|11519955|FG002|Initial Treatment|Death|15
7299039|NCT00594568|11519953|FG000|Initial Treatment|Lost to Follow-up|4
7299040|NCT00594568|11519954|FG001|Initial Treatment|Lost to Follow-up|1
7299041|NCT00594568|11519955|FG002|Initial Treatment|Lost to Follow-up|4
7299042|NCT00594568|11519953|FG000|Initial Treatment|Physician Decision|3
7299043|NCT00594568|11519954|FG001|Initial Treatment|Physician Decision|2
7299044|NCT00594568|11519955|FG002|Initial Treatment|Physician Decision|4
7222685|NCT00025259|11431833|FG000|Overall Study|Physician Decision|12
7222686|NCT00025259|11431834|FG001|Overall Study|Physician Decision|1
7222687|NCT00025259|11431835|FG002|Overall Study|Physician Decision|0
7222688|NCT00025259|11431836|FG003|Overall Study|Physician Decision|5
7222689|NCT00025259|11431837|FG004|Overall Study|Physician Decision|4
7222690|NCT00025259|11431838|FG005|Overall Study|Physician Decision|2
7222691|NCT00025259|11431839|FG006|Overall Study|Physician Decision|1
7222692|NCT00025259|11431833|FG000|Overall Study|Protocol Violation|3
7222693|NCT00025259|11431834|FG001|Overall Study|Protocol Violation|2
7222694|NCT00025259|11431835|FG002|Overall Study|Protocol Violation|2
7222695|NCT00025259|11431836|FG003|Overall Study|Protocol Violation|1
7222696|NCT00025259|11431837|FG004|Overall Study|Protocol Violation|2
7222697|NCT00025259|11431838|FG005|Overall Study|Protocol Violation|1
7222698|NCT00025259|11431839|FG006|Overall Study|Protocol Violation|3
7222699|NCT00025259|11431833|FG000|Overall Study|Withdrawal by Subject|9
7222700|NCT00025259|11431834|FG001|Overall Study|Withdrawal by Subject|27
7222701|NCT00025259|11431835|FG002|Overall Study|Withdrawal by Subject|6
7222702|NCT00025259|11431836|FG003|Overall Study|Withdrawal by Subject|14
7222703|NCT00025259|11431837|FG004|Overall Study|Withdrawal by Subject|11
7222704|NCT00025259|11431838|FG005|Overall Study|Withdrawal by Subject|8
7222705|NCT00025259|11431839|FG006|Overall Study|Withdrawal by Subject|3
7222706|NCT00025259|11431833|FG000|Overall Study|Ineligible|14
7222707|NCT00025259|11431834|FG001|Overall Study|Ineligible|1
7222708|NCT00025259|11431835|FG002|Overall Study|Ineligible|0
7222709|NCT00025259|11431836|FG003|Overall Study|Ineligible|0
7222710|NCT00025259|11431837|FG004|Overall Study|Ineligible|6
7222711|NCT00025259|11431838|FG005|Overall Study|Ineligible|0
7222712|NCT00025259|11431839|FG006|Overall Study|Ineligible|1
7222713|NCT00025259|11431833|FG000|Overall Study|Randomization error|1
7222714|NCT00025259|11431834|FG001|Overall Study|Randomization error|0
7222715|NCT00025259|11431835|FG002|Overall Study|Randomization error|0
7222716|NCT00025259|11431836|FG003|Overall Study|Randomization error|0
7222717|NCT00025259|11431837|FG004|Overall Study|Randomization error|1
7299045|NCT00594568|11519953|FG000|Initial Treatment|Protocol Violation|2
7299046|NCT00594568|11519954|FG001|Initial Treatment|Protocol Violation|2
7299047|NCT00594568|11519955|FG002|Initial Treatment|Protocol Violation|5
7299048|NCT00594568|11519953|FG000|Initial Treatment|Withdrawal by Subject|25
7299049|NCT00594568|11519954|FG001|Initial Treatment|Withdrawal by Subject|31
7299050|NCT00594568|11519955|FG002|Initial Treatment|Withdrawal by Subject|46
7299051|NCT00594568|11519953|FG000|Initial Treatment|Sponsor decision|193
7299052|NCT00594568|11519954|FG001|Initial Treatment|Sponsor decision|142
7299053|NCT00594568|11519955|FG002|Initial Treatment|Sponsor decision|147
7299054|NCT00594568|11519953|FG000|Initial Treatment|Caregiver decision|21
7299055|NCT00594568|11519954|FG001|Initial Treatment|Caregiver decision|36
7299056|NCT00594568|11519955|FG002|Initial Treatment|Caregiver decision|36
7299057|NCT00594568|11519953|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7299058|NCT00594568|11519954|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
7299059|NCT00594568|11519955|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
7299060|NCT00594568|11519953|FG000|Initial Treatment|Entry criteria exclusion|0
7299061|NCT00594568|11519954|FG001|Initial Treatment|Entry criteria exclusion|1
7299062|NCT00594568|11519955|FG002|Initial Treatment|Entry criteria exclusion|1
7299063|NCT00594568|11519953|FG000|Delayed Start|Death|0
7299064|NCT00594568|11519954|FG001|Delayed Start|Death|0
7299065|NCT00594568|11519955|FG002|Delayed Start|Death|1
7299066|NCT00594568|11519953|FG000|Delayed Start|Adverse Event|12
7299067|NCT00594568|11519954|FG001|Delayed Start|Adverse Event|2
7299068|NCT00594568|11519955|FG002|Delayed Start|Adverse Event|2
7299069|NCT00594568|11519953|FG000|Delayed Start|Withdrawal by Subject|4
7299070|NCT00594568|11519954|FG001|Delayed Start|Withdrawal by Subject|3
7299071|NCT00594568|11519955|FG002|Delayed Start|Withdrawal by Subject|0
7299072|NCT00594568|11519953|FG000|Delayed Start|Physician Decision|0
7299073|NCT00594568|11519954|FG001|Delayed Start|Physician Decision|0
7299074|NCT00594568|11519955|FG002|Delayed Start|Physician Decision|1
7299075|NCT00594568|11519953|FG000|Delayed Start|Lost to Follow-up|0
7299076|NCT00594568|11519954|FG001|Delayed Start|Lost to Follow-up|0
7299077|NCT00594568|11519955|FG002|Delayed Start|Lost to Follow-up|1
7299078|NCT00594568|11519953|FG000|Delayed Start|Caregiver Decision|5
7299079|NCT00594568|11519954|FG001|Delayed Start|Caregiver Decision|6
7299080|NCT00594568|11519955|FG002|Delayed Start|Caregiver Decision|2
7299081|NCT00594568|11519953|FG000|Delayed Start|Sponsor Decision|77
7299082|NCT00594568|11519954|FG001|Delayed Start|Sponsor Decision|66
7299083|NCT00594568|11519955|FG002|Delayed Start|Sponsor Decision|59
7299084|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|Death|0
7299085|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|Death|1
7299086|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|Death|0
7299087|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
7299088|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
7299089|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
7299090|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
7299091|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
7299092|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
7299093|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7299094|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
7299095|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
7299096|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
7299097|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
7299098|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
7299099|NCT00594568|11519953|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
7299100|NCT00594568|11519954|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
7299101|NCT00594568|11519955|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
7299102|NCT00594646|11519971|FG000|Overall Study|Withdrawal by Subject|1
7299103|NCT00594646|11519971|FG000|Overall Study|Lost to Follow-up|15
7299104|NCT00594659|11519979|FG000|Overall Study|Lost to Follow-up|13
7299105|NCT00594659|11519980|FG001|Overall Study|Lost to Follow-up|9
7299106|NCT00594659|11519981|FG002|Overall Study|Lost to Follow-up|7
7299107|NCT00594815|11519993|FG000|Overall Study|Never Treated|3
7299108|NCT00594815|11519993|FG000|Overall Study|Withdrawal by Subject|2
7299109|NCT00594815|11519993|FG000|Overall Study|Toxicity|4
7299110|NCT00594854|11519999|FG000|Overall Study|Study terminated|7
7299111|NCT00594854|11520000|FG001|Overall Study|Study terminated|10
7299112|NCT00594880|11520008|FG000|Overall Study|Withdrawal by Subject|1
7299113|NCT00594880|11520009|FG001|Overall Study|Withdrawal by Subject|1
7299114|NCT00594880|11520008|FG000|Overall Study|Lost to Follow-up|1
7299115|NCT00594880|11520009|FG001|Overall Study|Lost to Follow-up|0
7299116|NCT00594906|11520021|FG000|Overall Study|Physician Decision|1
7299117|NCT00594906|11520022|FG001|Overall Study|Physician Decision|0
7299118|NCT00594906|11520021|FG000|Overall Study|Physician Decision|0
7299119|NCT00594906|11520022|FG001|Overall Study|Physician Decision|1
7299120|NCT00594906|11520021|FG000|Overall Study|Death|0
7299121|NCT00594906|11520022|FG001|Overall Study|Death|1
7299122|NCT00594932|11520030|FG000|First 3 Months|Withdrawal by Subject|1
7299123|NCT00594932|11520031|FG001|First 3 Months|Withdrawal by Subject|3
7299124|NCT00594932|11520030|FG000|Final 3 Months|Withdrawal by Subject|4
7299125|NCT00594932|11520031|FG001|Final 3 Months|Withdrawal by Subject|3
7299126|NCT00594958|11520051|FG000|Overall Study|Withdrawal by Subject|1
7299127|NCT00594958|11520052|FG001|Overall Study|Withdrawal by Subject|0
7299128|NCT00594958|11520053|FG002|Overall Study|Withdrawal by Subject|1
7299129|NCT00594958|11520051|FG000|Overall Study|Adverse Event|4
7299130|NCT00594958|11520052|FG001|Overall Study|Adverse Event|1
7299131|NCT00594958|11520053|FG002|Overall Study|Adverse Event|2
7299132|NCT00594958|11520051|FG000|Overall Study|Pregnancy|0
7299133|NCT00594958|11520052|FG001|Overall Study|Pregnancy|2
7299134|NCT00594958|11520053|FG002|Overall Study|Pregnancy|0
7299135|NCT00594958|11520051|FG000|Overall Study|Protocol Violation|1
7299136|NCT00594958|11520052|FG001|Overall Study|Protocol Violation|0
7299137|NCT00594958|11520053|FG002|Overall Study|Protocol Violation|2
7299138|NCT00594958|11520051|FG000|Overall Study|Lost to Follow-up|5
7299139|NCT00594958|11520052|FG001|Overall Study|Lost to Follow-up|0
7299140|NCT00594958|11520053|FG002|Overall Study|Lost to Follow-up|3
7299141|NCT00594958|11520051|FG000|Overall Study|administrative|3
7299142|NCT00594958|11520052|FG001|Overall Study|administrative|0
7299143|NCT00594958|11520053|FG002|Overall Study|administrative|2
7299144|NCT00595075|11520074|FG000|Overall Study|Withdrawal by Subject|1
7299145|NCT00595075|11520075|FG001|Overall Study|Withdrawal by Subject|0
7299146|NCT00595127|11520111|FG000|Overall Study|Death|6
7299147|NCT00595127|11520111|FG000|Overall Study|Relapsed|3
7299148|NCT00595127|11520111|FG000|Overall Study|joined another trial|1
7299149|NCT00595309|11520150|FG000|Overall Study|Lost to Follow-up|1
7299150|NCT00595309|11520150|FG000|Overall Study|planned vaccination against yellow fever|1
7299151|NCT00595309|11520150|FG000|Overall Study|acute infection after V0|1
7299152|NCT00595309|11520150|FG000|Overall Study|personal reason|1
7299153|NCT00595335|11520156|FG000|Baseline to Six Months|Withdrawal by Subject|0
7299154|NCT00595335|11520157|FG001|Baseline to Six Months|Withdrawal by Subject|1
7299155|NCT00595335|11520156|FG000|Baseline to Six Months|Disease Progression|1
7299156|NCT00595335|11520157|FG001|Baseline to Six Months|Disease Progression|1
7299157|NCT00595335|11520156|FG000|Baseline to Six Months|Adverse Event|1
7299158|NCT00595335|11520157|FG001|Baseline to Six Months|Adverse Event|0
7299159|NCT00595335|11520156|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
7299160|NCT00595335|11520157|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
7299161|NCT00595335|11520156|FG000|Six Months to Twelve Months|Disease Progression|1
7299162|NCT00595335|11520157|FG001|Six Months to Twelve Months|Disease Progression|0
7299163|NCT00595413|11520180|FG000|Overall Study|Adverse Event|0
7299164|NCT00595413|11520181|FG001|Overall Study|Adverse Event|2
7299165|NCT00595413|11520182|FG002|Overall Study|Adverse Event|1
7299166|NCT00595413|11520183|FG003|Overall Study|Adverse Event|1
7299167|NCT00595413|11520180|FG000|Overall Study|Lost to Follow-up|2
7299168|NCT00595413|11520181|FG001|Overall Study|Lost to Follow-up|2
7299169|NCT00595413|11520182|FG002|Overall Study|Lost to Follow-up|1
7299170|NCT00595413|11520183|FG003|Overall Study|Lost to Follow-up|3
7299171|NCT00595413|11520180|FG000|Overall Study|Death|0
7299172|NCT00595413|11520181|FG001|Overall Study|Death|0
7299173|NCT00595413|11520182|FG002|Overall Study|Death|1
7299174|NCT00595413|11520183|FG003|Overall Study|Death|0
7299175|NCT00595413|11520180|FG000|Overall Study|Other|5
7299176|NCT00595413|11520181|FG001|Overall Study|Other|1
7299177|NCT00595413|11520182|FG002|Overall Study|Other|5
7299178|NCT00595413|11520183|FG003|Overall Study|Other|0
7299179|NCT00595465|11520196|FG000|Overall Study|Adverse Event|4
7299180|NCT00595465|11520197|FG001|Overall Study|Adverse Event|3
7299181|NCT00595465|11520198|FG002|Overall Study|Adverse Event|3
7299182|NCT00595465|11520196|FG000|Overall Study|Pregnancy|0
7299183|NCT00595465|11520197|FG001|Overall Study|Pregnancy|0
7299184|NCT00595465|11520198|FG002|Overall Study|Pregnancy|1
7299185|NCT00595465|11520196|FG000|Overall Study|Protocol Violation|2
7299186|NCT00595465|11520197|FG001|Overall Study|Protocol Violation|1
7299187|NCT00595465|11520198|FG002|Overall Study|Protocol Violation|0
7299188|NCT00595465|11520196|FG000|Overall Study|Lost to Follow-up|0
7299189|NCT00595465|11520197|FG001|Overall Study|Lost to Follow-up|0
7299190|NCT00595465|11520198|FG002|Overall Study|Lost to Follow-up|2
7299191|NCT00595465|11520196|FG000|Overall Study|administrative reason|0
7299192|NCT00595465|11520197|FG001|Overall Study|administrative reason|0
7299193|NCT00595465|11520198|FG002|Overall Study|administrative reason|1
7299194|NCT00595478|11520208|FG000|36-week Follow-up Period|Lost to Follow-up|5
7299195|NCT00595478|11520209|FG001|36-week Follow-up Period|Lost to Follow-up|4
7299196|NCT00595478|11520208|FG000|36-week Follow-up Period|Withdrawal by Subject|4
7299197|NCT00595478|11520209|FG001|36-week Follow-up Period|Withdrawal by Subject|4
7299198|NCT00595504|11520217|FG000|Overall Study|Withdrawal by Subject|1
7299199|NCT00595504|11520218|FG001|Overall Study|Withdrawal by Subject|3
7299200|NCT00595504|11520217|FG000|Overall Study|Physician Decision|1
7299201|NCT00595504|11520218|FG001|Overall Study|Physician Decision|0
7299202|NCT00595517|11520224|FG000|Overall Study|Adverse Event|6
7299203|NCT00595517|11520224|FG000|Overall Study|Withdrawal by Subject|4
7299204|NCT00595517|11520224|FG000|Overall Study|Protocol Violation|2
7299205|NCT00595517|11520224|FG000|Overall Study|Recurrence of ulcer|5
7299206|NCT00595517|11520224|FG000|Overall Study|usage of prohibited treatment|1
7299207|NCT00595517|11520224|FG000|Overall Study|No intention to attend regularly|1
7299208|NCT00595621|11520244|FG000|Open Label Run in|Adverse Event|1
7299209|NCT00595621|11520245|FG001|Open Label Run in|Adverse Event|0
7299210|NCT00595621|11520244|FG000|Open Label Run in|Physician Decision|1
7299211|NCT00595621|11520245|FG001|Open Label Run in|Physician Decision|0
7299212|NCT00595621|11520244|FG000|Open Label Run in|Withdrawal by Subject|1
7299213|NCT00595621|11520245|FG001|Open Label Run in|Withdrawal by Subject|0
7299214|NCT00595621|11520244|FG000|Randomization and Study|Adverse Event|2
7299215|NCT00595621|11520245|FG001|Randomization and Study|Adverse Event|0
7299216|NCT00595621|11520244|FG000|Randomization and Study|Withdrawal by Subject|0
7299217|NCT00595621|11520245|FG001|Randomization and Study|Withdrawal by Subject|1
7299218|NCT00595764|11520254|FG000|Overall Study|Protocol Violation|24
7299219|NCT00595764|11520255|FG001|Overall Study|Protocol Violation|19
7299220|NCT00595764|11520254|FG000|Overall Study|Missed Medication >1 week|10
7299221|NCT00595764|11520255|FG001|Overall Study|Missed Medication >1 week|17
7299222|NCT00595764|11520254|FG000|Overall Study|Missed 3 PM visits|1
7299223|NCT00595764|11520255|FG001|Overall Study|Missed 3 PM visits|7
7299224|NCT00595764|11520254|FG000|Overall Study|Withdrawal by Subject|4
7299225|NCT00595764|11520255|FG001|Overall Study|Withdrawal by Subject|0
7299226|NCT00595868|11520276|FG000|Overall Study|Lost to Follow-up|45
7299227|NCT00595868|11520277|FG001|Overall Study|Lost to Follow-up|50
7299228|NCT00595959|11520297|FG000|Overall Study|Withdrawal by Subject|1
7299229|NCT00595959|11520297|FG000|Overall Study|Lost to Follow-up|1
7299230|NCT00596011|11520303|FG000|Overall Study|Withdrawal by Subject|2
7299231|NCT00596011|11520304|FG001|Overall Study|Withdrawal by Subject|3
7299232|NCT00596011|11520303|FG000|Overall Study|Adverse Event|11
7299233|NCT00596011|11520304|FG001|Overall Study|Adverse Event|7
7299234|NCT00596362|11520340|FG000|Overall Study|Progressive Disease|1
7299235|NCT00596427|11520346|FG000|Overall Study|Withdrawal by Subject|2
7299236|NCT00596427|11520347|FG001|Overall Study|Withdrawal by Subject|2
7299237|NCT00596427|11520346|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
7299238|NCT00596427|11520347|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
7299239|NCT00596427|11520346|FG000|Overall Study|Protocol Violation|1
7299240|NCT00596427|11520347|FG001|Overall Study|Protocol Violation|0
7299241|NCT00596466|11520372|FG000|Overall Study|Lack of Efficacy|5
7299242|NCT00596466|11520372|FG000|Overall Study|Adverse Event|4
7299243|NCT00596466|11520372|FG000|Overall Study|Withdrawal by Subject|2
7299244|NCT00596466|11520372|FG000|Overall Study|Protocol Violation|2
7299245|NCT00596466|11520372|FG000|Overall Study|Unpecified|2
7299246|NCT00596466|11520372|FG000|Overall Study|Enrolled, not treated|2
7299247|NCT00596635|11520391|FG000|Overall Study|Lost to Follow-up|0
7299248|NCT00596635|11520392|FG001|Overall Study|Lost to Follow-up|2
7299249|NCT00596635|11520393|FG002|Overall Study|Lost to Follow-up|0
7299250|NCT00596635|11520391|FG000|Overall Study|Treatment for symptomatic UTI|4
7299251|NCT00596635|11520392|FG001|Overall Study|Treatment for symptomatic UTI|6
7299252|NCT00596635|11520393|FG002|Overall Study|Treatment for symptomatic UTI|3
7299253|NCT00596635|11520391|FG000|Overall Study|Hip fracture|2
7299254|NCT00596635|11520392|FG001|Overall Study|Hip fracture|3
7299255|NCT00596635|11520393|FG002|Overall Study|Hip fracture|3
7299256|NCT00596635|11520391|FG000|Overall Study|Could not provide urine specimen|1
7299257|NCT00596635|11520392|FG001|Overall Study|Could not provide urine specimen|2
7299258|NCT00596635|11520393|FG002|Overall Study|Could not provide urine specimen|2
7299259|NCT00596687|11520403|FG000|Overall Study|< 24 hours of insulin treatment|8
7299260|NCT00596687|11520404|FG001|Overall Study|< 24 hours of insulin treatment|6
7299261|NCT00596687|11520403|FG000|Overall Study|continuous insulin infusion during TPN|2
7299262|NCT00596687|11520404|FG001|Overall Study|continuous insulin infusion during TPN|1
7299263|NCT00596687|11520403|FG000|Overall Study|Withdrawal by Subject|3
7299264|NCT00596687|11520404|FG001|Overall Study|Withdrawal by Subject|1
7299265|NCT00596687|11520403|FG000|Overall Study|cancelled surgery|1
7299266|NCT00596687|11520404|FG001|Overall Study|cancelled surgery|1
7551719|NCT02974153|11911178|FG002|Overall Study|Withdrawal by Subject|11
7551720|NCT02974153|11911176|FG000|Overall Study|Study Burden|8
7551721|NCT02974153|11911177|FG001|Overall Study|Study Burden|7
7551722|NCT02974153|11911178|FG002|Overall Study|Study Burden|3
7551723|NCT02974153|11911176|FG000|Overall Study|Other|14
7551724|NCT02974153|11911177|FG001|Overall Study|Other|8
7551725|NCT02974153|11911178|FG002|Overall Study|Other|7
7551726|NCT02974543|11911197|FG000|Overall Study|Withdrawal by Subject|1
7551727|NCT02974543|11911198|FG001|Overall Study|Withdrawal by Subject|0
7551728|NCT02974634|11911214|FG000|Overall Study|Advanced disease|12
7551729|NCT02974634|11911215|FG001|Overall Study|Advanced disease|3
7551730|NCT02974634|11911214|FG000|Overall Study|Noncompliance|3
7551731|NCT02974634|11911215|FG001|Overall Study|Noncompliance|7
7551732|NCT02974634|11911214|FG000|Overall Study|intervention technology related issues|5
7551733|NCT02974634|11911215|FG001|Overall Study|intervention technology related issues|0
7551734|NCT02974634|11911214|FG000|Overall Study|Death|8
7551735|NCT02974634|11911215|FG001|Overall Study|Death|11
7551736|NCT02974842|11911222|FG000|Overall Study|Withdrawal by Subject|4
7551737|NCT02974842|11911222|FG000|Overall Study|Screen failures|4
7551738|NCT02974855|11911230|FG000|Overall Study|Adverse Event|0
7551739|NCT02974855|11911231|FG001|Overall Study|Adverse Event|1
7551740|NCT02974855|11911232|FG002|Overall Study|Adverse Event|0
7551741|NCT02974855|11911233|FG003|Overall Study|Adverse Event|1
7551742|NCT02974868|11911250|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7551743|NCT02974868|11911251|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
7551744|NCT02974868|11911252|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
7299267|NCT00596752|11520412|FG000|Overall Study|Other Reason|44
7299268|NCT00596752|11520413|FG001|Overall Study|Other Reason|49
7299269|NCT00596752|11520412|FG000|Overall Study|Adverse Event|34
7299270|NCT00596752|11520413|FG001|Overall Study|Adverse Event|34
7299271|NCT00596752|11520412|FG000|Overall Study|Lost to Follow-up|22
7299272|NCT00596752|11520413|FG001|Overall Study|Lost to Follow-up|38
7299273|NCT00596752|11520412|FG000|Overall Study|Withdrawal by Subject|12
7299274|NCT00596752|11520413|FG001|Overall Study|Withdrawal by Subject|9
7299275|NCT00596752|11520412|FG000|Overall Study|Unsatisfactory Compliance|9
7299276|NCT00596752|11520413|FG001|Overall Study|Unsatisfactory Compliance|6
7299277|NCT00596752|11520412|FG000|Overall Study|Lack of Efficacy|4
7299278|NCT00596752|11520413|FG001|Overall Study|Lack of Efficacy|7
7299279|NCT00596752|11520412|FG000|Overall Study|Protocol Violation|1
7299280|NCT00596752|11520413|FG001|Overall Study|Protocol Violation|0
7299281|NCT00594386|11520419|FG000|Overall Study|Major protocol violation|2
7299282|NCT00594386|11520419|FG000|Overall Study|Lack of Efficacy|12
7299283|NCT00594386|11520419|FG000|Overall Study|Adverse Event|68
7299284|NCT00594386|11520419|FG000|Overall Study|Unsatisfactory compliance of subject|11
7299285|NCT00594386|11520419|FG000|Overall Study|Subject withdrew consent|35
7299286|NCT00594386|11520419|FG000|Overall Study|Study ended per sponsor|115
7299287|NCT00594386|11520419|FG000|Overall Study|Lost to Follow-up|6
7299288|NCT00594386|11520419|FG000|Overall Study|Other: Patient went off patch (hospital)|1
7299289|NCT00594386|11520419|FG000|Overall Study|Other: Subject moved to Seattle|1
7299290|NCT00594386|11520419|FG000|Overall Study|Other: Subject admitted to nursing home|1
7299291|NCT00594386|11520419|FG000|Overall Study|Other: Study terminated per investigator|2
7299292|NCT00594386|11520419|FG000|Overall Study|Other: Sponsor closure of study|1
7299293|NCT00594386|11520419|FG000|Overall Study|Other: Site terminated participation|1
7299294|NCT00594386|11520419|FG000|Overall Study|Other: Patient wants prescription Neupro|1
7299295|NCT00594386|11520419|FG000|Overall Study|Other: Loss of drivers license|1
7299296|NCT00596817|11520426|FG000|Open-label Period|Adverse Event|0
7299297|NCT00596817|11520427|FG001|Open-label Period|Adverse Event|49
7299298|NCT00596817|11520426|FG000|Open-label Period|Lack of Efficacy|0
7299299|NCT00596817|11520427|FG001|Open-label Period|Lack of Efficacy|33
7299300|NCT00596817|11520426|FG000|Open-label Period|Other Reasons|0
7299301|NCT00596817|11520427|FG001|Open-label Period|Other Reasons|65
7299302|NCT00596817|11520426|FG000|Open-label Period to Double-blind Period|Adverse Event|0
7299303|NCT00596817|11520427|FG001|Open-label Period to Double-blind Period|Adverse Event|5
7299304|NCT00596817|11520426|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
7299305|NCT00596817|11520427|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
7299306|NCT00596817|11520426|FG000|Open-label Period to Double-blind Period|Not Eligible|0
7299307|NCT00596817|11520427|FG001|Open-label Period to Double-blind Period|Not Eligible|49
7299308|NCT00596817|11520426|FG000|Open-label Period to Double-blind Period|Other Reasons|0
7299309|NCT00596817|11520427|FG001|Open-label Period to Double-blind Period|Other Reasons|14
7299310|NCT00596817|11520426|FG000|Double-blind Period|Adverse Event|5
7299311|NCT00596817|11520427|FG001|Double-blind Period|Adverse Event|16
7299312|NCT00596817|11520426|FG000|Double-blind Period|Lack of Efficacy|52
7299313|NCT00596817|11520427|FG001|Double-blind Period|Lack of Efficacy|28
7299314|NCT00596817|11520426|FG000|Double-blind Period|Non-compliance With Study Product|3
7299315|NCT00596817|11520427|FG001|Double-blind Period|Non-compliance With Study Product|4
7299316|NCT00596817|11520426|FG000|Double-blind Period|Protocol Violation|11
7299317|NCT00596817|11520427|FG001|Double-blind Period|Protocol Violation|8
7299318|NCT00596817|11520426|FG000|Double-blind Period|Withdrawal of Consent|7
7299319|NCT00596817|11520427|FG001|Double-blind Period|Withdrawal of Consent|3
7299320|NCT00596817|11520426|FG000|Double-blind Period|Lost to Follow-up|0
7299321|NCT00596817|11520427|FG001|Double-blind Period|Lost to Follow-up|2
7299322|NCT00596817|11520426|FG000|Double-blind Period|Other Reasons|10
7299323|NCT00596817|11520427|FG001|Double-blind Period|Other Reasons|18
7299324|NCT00596830|11520436|FG000|Overall Study|Death|258
7299325|NCT00596830|11520437|FG001|Overall Study|Death|247
7299326|NCT00596830|11520436|FG000|Overall Study|Lost to Follow-up|7
7299327|NCT00596830|11520437|FG001|Overall Study|Lost to Follow-up|11
7299328|NCT00596830|11520436|FG000|Overall Study|Withdrawal by Subject|22
7299329|NCT00596830|11520437|FG001|Overall Study|Withdrawal by Subject|12
7299330|NCT00596830|11520436|FG000|Overall Study|Study terminated by sponsor|51
7299331|NCT00596830|11520437|FG001|Overall Study|Study terminated by sponsor|62
7299332|NCT00596830|11520436|FG000|Overall Study|Follow-up was discontinued|1
7299333|NCT00596830|11520437|FG001|Overall Study|Follow-up was discontinued|0
7299334|NCT00596830|11520436|FG000|Overall Study|Randomized but not treated|3
7299335|NCT00596830|11520437|FG001|Overall Study|Randomized but not treated|7
7299336|NCT00596934|11520443|FG000|Overall Study|Protocol Violation|1
7299337|NCT00596934|11520443|FG000|Overall Study|Withdrawal by Subject|1
7299338|NCT00596960|11520451|FG000|Overall Study|Death|1
7299339|NCT00596960|11520452|FG001|Overall Study|Death|2
7299340|NCT00596960|11520451|FG000|Overall Study|Lost to Follow-up|6
7299341|NCT00596960|11520452|FG001|Overall Study|Lost to Follow-up|5
7299342|NCT00596960|11520451|FG000|Overall Study|Withdrawal by Subject|1
7299343|NCT00596960|11520452|FG001|Overall Study|Withdrawal by Subject|0
7299344|NCT00596960|11520451|FG000|Overall Study|Incarcerated|2
7299345|NCT00596960|11520452|FG001|Overall Study|Incarcerated|0
7299346|NCT00596960|11520451|FG000|Overall Study|Physician Decision|1
7299347|NCT00596960|11520452|FG001|Overall Study|Physician Decision|0
7299348|NCT00596960|11520451|FG000|Overall Study|Protocol Violation|0
7299349|NCT00596960|11520452|FG001|Overall Study|Protocol Violation|1
7299350|NCT00596960|11520451|FG000|Overall Study|No alcohol use data|0
7299351|NCT00596960|11520452|FG001|Overall Study|No alcohol use data|1
7299362|NCT00597116|11520482|FG000|Overall Study|Adverse Event|2
7299363|NCT00597116|11520483|FG001|Overall Study|Adverse Event|1
7299364|NCT00597116|11520482|FG000|Overall Study|Withdrawal by Subject|0
7299365|NCT00597116|11520483|FG001|Overall Study|Withdrawal by Subject|2
7299366|NCT00597116|11520482|FG000|Overall Study|Physician Decision|0
7299367|NCT00597116|11520483|FG001|Overall Study|Physician Decision|1
7299368|NCT00597116|11520482|FG000|Overall Study|Death|0
7299369|NCT00597116|11520483|FG001|Overall Study|Death|1
7299370|NCT00597116|11520482|FG000|Overall Study|Lost to Follow-up|1
7299371|NCT00597116|11520483|FG001|Overall Study|Lost to Follow-up|0
7299372|NCT00597116|11520482|FG000|Overall Study|Progressive disease|11
7299373|NCT00597116|11520483|FG001|Overall Study|Progressive disease|6
7299374|NCT00597207|11520491|FG000|Overall Study|Lost to Follow-up|5
7299375|NCT00597207|11520492|FG001|Overall Study|Lost to Follow-up|7
7299376|NCT00597376|11520533|FG000|Overall Study|Withdrawal by Subject|4
7299377|NCT00597376|11520534|FG001|Overall Study|Withdrawal by Subject|3
7299378|NCT00597376|11520533|FG000|Overall Study|Adverse Event|4
7299379|NCT00597376|11520534|FG001|Overall Study|Adverse Event|1
7299380|NCT00597506|11520561|FG000|Overall Study|Subject is being followed for survival|1
7299381|NCT00597519|11520565|FG000|Overall Study|Death|1
7299382|NCT00597584|11520584|FG000|Overall Study|Adverse Event|4
7299383|NCT00597584|11520585|FG001|Overall Study|Adverse Event|2
7299384|NCT00597584|11520584|FG000|Overall Study|Death|53
7299385|NCT00597584|11520585|FG001|Overall Study|Death|30
7299386|NCT00597584|11520584|FG000|Overall Study|Lack of Efficacy|1
7299387|NCT00597584|11520585|FG001|Overall Study|Lack of Efficacy|0
7299388|NCT00597584|11520584|FG000|Overall Study|Lost to Follow-up|2
7299389|NCT00597584|11520585|FG001|Overall Study|Lost to Follow-up|4
7299390|NCT00597584|11520584|FG000|Overall Study|Physician Decision|3
7299391|NCT00597584|11520585|FG001|Overall Study|Physician Decision|0
7299392|NCT00597584|11520584|FG000|Overall Study|Pregnancy|2
7299393|NCT00597584|11520585|FG001|Overall Study|Pregnancy|0
7299394|NCT00597584|11520584|FG000|Overall Study|Withdrawal by Subject|44
7299395|NCT00597584|11520585|FG001|Overall Study|Withdrawal by Subject|12
7299396|NCT00597584|11520584|FG000|Overall Study|Discontinued Dialysis|0
7299397|NCT00597584|11520585|FG001|Overall Study|Discontinued Dialysis|1
7299398|NCT00597584|11520584|FG000|Overall Study|Lost ability to consent|1
7299399|NCT00597584|11520585|FG001|Overall Study|Lost ability to consent|1
7299400|NCT00597584|11520584|FG000|Overall Study|Never dosed|1
7299401|NCT00597584|11520585|FG001|Overall Study|Never dosed|0
7299402|NCT00597584|11520584|FG000|Overall Study|Relocation|8
7299403|NCT00597584|11520585|FG001|Overall Study|Relocation|6
7299404|NCT00597584|11520584|FG000|Overall Study|Renal transplant|9
7299405|NCT00597584|11520585|FG001|Overall Study|Renal transplant|7
7299406|NCT00597701|11520604|FG000|Overall Study|Withdrawal by Subject|5
7299407|NCT00597701|11520605|FG001|Overall Study|Withdrawal by Subject|5
7299408|NCT00597701|11520604|FG000|Overall Study|Death|0
7299409|NCT00597701|11520605|FG001|Overall Study|Death|1
7299410|NCT00597701|11520604|FG000|Overall Study|Physician Decision|2
7299411|NCT00597701|11520605|FG001|Overall Study|Physician Decision|0
7299412|NCT00597701|11520604|FG000|Overall Study|Did not start intervention (pharmacy er)|0
7299413|NCT00597701|11520605|FG001|Overall Study|Did not start intervention (pharmacy er)|2
7299414|NCT00597714|11520613|FG000|Overall Study|Death|56
7299415|NCT00597714|11520614|FG001|Overall Study|Death|46
7299416|NCT00597714|11520615|FG002|Overall Study|Death|0
7299417|NCT00597714|11520613|FG000|Overall Study|Recipient death|0
7299418|NCT00597714|11520614|FG001|Overall Study|Recipient death|0
7299419|NCT00597714|11520615|FG002|Overall Study|Recipient death|10
7299420|NCT00597753|11520648|FG000|Overall Study|Adverse Event|6
7299421|NCT00597753|11520649|FG001|Overall Study|Adverse Event|2
7299422|NCT00597753|11520648|FG000|Overall Study|Death|55
7299423|NCT00597753|11520649|FG001|Overall Study|Death|29
7299424|NCT00597753|11520648|FG000|Overall Study|Lack of Efficacy|2
7299425|NCT00597753|11520649|FG001|Overall Study|Lack of Efficacy|0
7299426|NCT00597753|11520648|FG000|Overall Study|Lost to Follow-up|10
7299427|NCT00597753|11520649|FG001|Overall Study|Lost to Follow-up|3
7299428|NCT00597753|11520648|FG000|Overall Study|Physician Decision|5
7299429|NCT00597753|11520649|FG001|Overall Study|Physician Decision|1
7299430|NCT00597753|11520648|FG000|Overall Study|Pregnancy|1
7299431|NCT00597753|11520649|FG001|Overall Study|Pregnancy|0
7299432|NCT00597753|11520648|FG000|Overall Study|Withdrawal by Subject|35
7299433|NCT00597753|11520649|FG001|Overall Study|Withdrawal by Subject|12
7299434|NCT00597753|11520648|FG000|Overall Study|Discontinued Dialysis|0
7299435|NCT00597753|11520649|FG001|Overall Study|Discontinued Dialysis|1
7299436|NCT00597753|11520648|FG000|Overall Study|Never dosed|2
7299437|NCT00597753|11520649|FG001|Overall Study|Never dosed|0
7299438|NCT00597753|11520648|FG000|Overall Study|Noncompliance|2
7299439|NCT00597753|11520649|FG001|Overall Study|Noncompliance|1
7299440|NCT00597753|11520648|FG000|Overall Study|Relocation|17
7299441|NCT00597753|11520649|FG001|Overall Study|Relocation|6
7299442|NCT00597753|11520648|FG000|Overall Study|Renal transplant|10
7299443|NCT00597753|11520649|FG001|Overall Study|Renal transplant|3
7299444|NCT00597753|11520648|FG000|Overall Study|Site closed by sponsor|19
7299445|NCT00597753|11520649|FG001|Overall Study|Site closed by sponsor|7
7299446|NCT00597753|11520648|FG000|Overall Study|Site elected to close|2
7299447|NCT00597753|11520649|FG001|Overall Study|Site elected to close|4
7299448|NCT00597766|11520658|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
7299449|NCT00597766|11520659|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
7299450|NCT00597766|11520660|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
7299451|NCT00597766|11520658|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
7299452|NCT00597766|11520659|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
7299453|NCT00597766|11520660|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
7299454|NCT00598078|11520712|FG000|Period 2 (Day 2)|Adverse Event|1
7299455|NCT00598078|11520713|FG001|Period 2 (Day 2)|Adverse Event|0
7299456|NCT00598273|11520724|FG000|Overall Study|Adverse Event|4
7299457|NCT00598273|11520725|FG001|Overall Study|Adverse Event|5
7299458|NCT00598273|11520726|FG002|Overall Study|Adverse Event|2
7299459|NCT00598273|11520724|FG000|Overall Study|Death|6
7299460|NCT00598273|11520725|FG001|Overall Study|Death|12
7299461|NCT00598273|11520726|FG002|Overall Study|Death|8
7299462|NCT00598273|11520724|FG000|Overall Study|Lost to Follow-up|8
7299463|NCT00598273|11520725|FG001|Overall Study|Lost to Follow-up|3
7299464|NCT00598273|11520726|FG002|Overall Study|Lost to Follow-up|5
7299465|NCT00598273|11520724|FG000|Overall Study|Physician Decision|0
7299466|NCT00598273|11520725|FG001|Overall Study|Physician Decision|0
7299467|NCT00598273|11520726|FG002|Overall Study|Physician Decision|1
7299468|NCT00598273|11520724|FG000|Overall Study|Withdrawal by Subject|12
7299469|NCT00598273|11520725|FG001|Overall Study|Withdrawal by Subject|10
7299470|NCT00598273|11520726|FG002|Overall Study|Withdrawal by Subject|10
7299471|NCT00598273|11520724|FG000|Overall Study|Noncompliance|3
7299472|NCT00598273|11520725|FG001|Overall Study|Noncompliance|2
7299473|NCT00598273|11520726|FG002|Overall Study|Noncompliance|3
7299474|NCT00598273|11520724|FG000|Overall Study|Relocation|0
7299475|NCT00598273|11520725|FG001|Overall Study|Relocation|2
7299476|NCT00598273|11520726|FG002|Overall Study|Relocation|4
7299477|NCT00598273|11520724|FG000|Overall Study|Renal transplant|1
7299478|NCT00598273|11520725|FG001|Overall Study|Renal transplant|0
7299479|NCT00598273|11520726|FG002|Overall Study|Renal transplant|1
7299480|NCT00598273|11520724|FG000|Overall Study|Site elected to close|1
7299481|NCT00598273|11520725|FG001|Overall Study|Site elected to close|0
7299482|NCT00598273|11520726|FG002|Overall Study|Site elected to close|0
7299483|NCT00598273|11520724|FG000|Overall Study|Started dialysis|6
7299484|NCT00598273|11520725|FG001|Overall Study|Started dialysis|4
7299485|NCT00598273|11520726|FG002|Overall Study|Started dialysis|5
7299486|NCT00598442|11520737|FG000|Overall Study|Adverse Event|3
7299487|NCT00598442|11520738|FG001|Overall Study|Adverse Event|0
7299488|NCT00598442|11520739|FG002|Overall Study|Adverse Event|0
7299489|NCT00598442|11520737|FG000|Overall Study|Death|19
7299490|NCT00598442|11520738|FG001|Overall Study|Death|11
7299491|NCT00598442|11520739|FG002|Overall Study|Death|11
7299492|NCT00598442|11520737|FG000|Overall Study|Lost to Follow-up|4
7299493|NCT00598442|11520738|FG001|Overall Study|Lost to Follow-up|3
7299494|NCT00598442|11520739|FG002|Overall Study|Lost to Follow-up|3
7299495|NCT00598442|11520737|FG000|Overall Study|Physician Decision|2
7299496|NCT00598442|11520738|FG001|Overall Study|Physician Decision|1
7299497|NCT00598442|11520739|FG002|Overall Study|Physician Decision|1
7299498|NCT00598442|11520737|FG000|Overall Study|Withdrawal by Subject|8
7299499|NCT00598442|11520738|FG001|Overall Study|Withdrawal by Subject|16
7299500|NCT00598442|11520739|FG002|Overall Study|Withdrawal by Subject|6
7299501|NCT00598442|11520737|FG000|Overall Study|Noncompliance|0
7299502|NCT00598442|11520738|FG001|Overall Study|Noncompliance|2
7299503|NCT00598442|11520739|FG002|Overall Study|Noncompliance|1
7299504|NCT00598442|11520737|FG000|Overall Study|Relocation|1
7299505|NCT00598442|11520738|FG001|Overall Study|Relocation|4
7299506|NCT00598442|11520739|FG002|Overall Study|Relocation|0
7299507|NCT00598442|11520737|FG000|Overall Study|Renal transplant|0
7299508|NCT00598442|11520738|FG001|Overall Study|Renal transplant|0
7299509|NCT00598442|11520739|FG002|Overall Study|Renal transplant|1
7299510|NCT00598442|11520737|FG000|Overall Study|Site closed by sponsor|5
7299511|NCT00598442|11520738|FG001|Overall Study|Site closed by sponsor|2
7299512|NCT00598442|11520739|FG002|Overall Study|Site closed by sponsor|1
7299513|NCT00598442|11520737|FG000|Overall Study|Started dialysis|1
7299514|NCT00598442|11520738|FG001|Overall Study|Started dialysis|0
7299515|NCT00598442|11520739|FG002|Overall Study|Started dialysis|0
7299516|NCT00598481|11520747|FG000|Treatment|Physician Decision|1
7299517|NCT00598559|11520761|FG000|Overall Study|Adverse Event|11
7299518|NCT00598559|11520762|FG001|Overall Study|Adverse Event|7
7299519|NCT00598559|11520763|FG002|Overall Study|Adverse Event|0
7299520|NCT00598559|11520761|FG000|Overall Study|Withdrawal by Subject|2
7299521|NCT00598559|11520762|FG001|Overall Study|Withdrawal by Subject|2
7299522|NCT00598559|11520763|FG002|Overall Study|Withdrawal by Subject|0
7299523|NCT00598559|11520761|FG000|Overall Study|Protocol Non-compliance|1
7299524|NCT00598559|11520762|FG001|Overall Study|Protocol Non-compliance|0
7299525|NCT00598559|11520763|FG002|Overall Study|Protocol Non-compliance|0
7299526|NCT00598559|11520761|FG000|Overall Study|Early discharge from hospital|9
7299527|NCT00598559|11520762|FG001|Overall Study|Early discharge from hospital|12
7299528|NCT00598559|11520763|FG002|Overall Study|Early discharge from hospital|3
7299529|NCT00598559|11520761|FG000|Overall Study|Subject unable/unwilling to attend visit|4
7299530|NCT00598559|11520762|FG001|Overall Study|Subject unable/unwilling to attend visit|7
7299531|NCT00598559|11520763|FG002|Overall Study|Subject unable/unwilling to attend visit|0
7299532|NCT00598585|11520773|FG000|Overall Study|Lost to Follow-up|1
7299533|NCT00598585|11520774|FG001|Overall Study|Lost to Follow-up|0
7299534|NCT00598650|11520780|FG000|Overall Study|Withdrawal by Subject|3
7299535|NCT00598650|11520780|FG000|Overall Study|Adverse Event|18
7299536|NCT00598650|11520780|FG000|Overall Study|No treatment for 3 weeks|1
7299537|NCT00598650|11520780|FG000|Overall Study|Not eligible|1
7299538|NCT00598650|11520780|FG000|Overall Study|Prohibited Concomitant Medication|2
7299539|NCT00598650|11520780|FG000|Overall Study|Physician Decision|2
7299540|NCT00598702|11520814|FG000|Overall Study|Other|0
7299541|NCT00598702|11520815|FG001|Overall Study|Other|2
7299542|NCT00598702|11520816|FG002|Overall Study|Other|0
7299543|NCT00598702|11520817|FG003|Overall Study|Other|0
7299544|NCT00598702|11520818|FG004|Overall Study|Other|0
7299545|NCT00598702|11520819|FG005|Overall Study|Other|1
7299546|NCT00598702|11520820|FG006|Overall Study|Other|0
7299547|NCT00598702|11520821|FG007|Overall Study|Other|0
7299548|NCT00598702|11520814|FG000|Overall Study|Early discharge from hospital|0
7299549|NCT00598702|11520815|FG001|Overall Study|Early discharge from hospital|0
7299550|NCT00598702|11520816|FG002|Overall Study|Early discharge from hospital|2
7299551|NCT00598702|11520817|FG003|Overall Study|Early discharge from hospital|5
7299552|NCT00598702|11520818|FG004|Overall Study|Early discharge from hospital|0
7299553|NCT00598702|11520819|FG005|Overall Study|Early discharge from hospital|10
7299554|NCT00598702|11520820|FG006|Overall Study|Early discharge from hospital|1
7299555|NCT00598702|11520821|FG007|Overall Study|Early discharge from hospital|0
7299556|NCT00598702|11520814|FG000|Overall Study|Adverse Event|0
7299557|NCT00598702|11520815|FG001|Overall Study|Adverse Event|0
7299558|NCT00598702|11520816|FG002|Overall Study|Adverse Event|0
7299559|NCT00598702|11520817|FG003|Overall Study|Adverse Event|1
7299560|NCT00598702|11520818|FG004|Overall Study|Adverse Event|0
7299561|NCT00598702|11520819|FG005|Overall Study|Adverse Event|0
7299562|NCT00598702|11520820|FG006|Overall Study|Adverse Event|0
7299563|NCT00598702|11520821|FG007|Overall Study|Adverse Event|0
7299564|NCT00598702|11520814|FG000|Overall Study|Withdrawal by Subject|0
7299565|NCT00598702|11520815|FG001|Overall Study|Withdrawal by Subject|0
7299566|NCT00598702|11520816|FG002|Overall Study|Withdrawal by Subject|0
7299567|NCT00598702|11520817|FG003|Overall Study|Withdrawal by Subject|1
7299568|NCT00598702|11520818|FG004|Overall Study|Withdrawal by Subject|1
7299569|NCT00598702|11520819|FG005|Overall Study|Withdrawal by Subject|0
7299570|NCT00598702|11520820|FG006|Overall Study|Withdrawal by Subject|0
7299571|NCT00598702|11520821|FG007|Overall Study|Withdrawal by Subject|0
7299572|NCT00598702|11520814|FG000|Overall Study|Physician Decision|0
7299573|NCT00598702|11520815|FG001|Overall Study|Physician Decision|0
7299574|NCT00598702|11520816|FG002|Overall Study|Physician Decision|0
7299575|NCT00598702|11520817|FG003|Overall Study|Physician Decision|0
7299576|NCT00598702|11520818|FG004|Overall Study|Physician Decision|1
7299577|NCT00598702|11520819|FG005|Overall Study|Physician Decision|0
7299578|NCT00598702|11520820|FG006|Overall Study|Physician Decision|0
7299579|NCT00598702|11520821|FG007|Overall Study|Physician Decision|0
7299580|NCT00598702|11520814|FG000|Overall Study|Dose limiting toxicity|0
7299581|NCT00598702|11520815|FG001|Overall Study|Dose limiting toxicity|0
7299582|NCT00598702|11520816|FG002|Overall Study|Dose limiting toxicity|0
7299583|NCT00598702|11520817|FG003|Overall Study|Dose limiting toxicity|1
7299584|NCT00598702|11520818|FG004|Overall Study|Dose limiting toxicity|1
7299585|NCT00598702|11520819|FG005|Overall Study|Dose limiting toxicity|1
7299586|NCT00598702|11520820|FG006|Overall Study|Dose limiting toxicity|0
7299587|NCT00598702|11520821|FG007|Overall Study|Dose limiting toxicity|0
7299588|NCT00598832|11520854|FG000|Overall Study|Lack of Efficacy|3
7299589|NCT00598832|11520855|FG001|Overall Study|Lack of Efficacy|7
7299590|NCT00598832|11520854|FG000|Overall Study|Adverse Event|6
7299591|NCT00598832|11520855|FG001|Overall Study|Adverse Event|2
7299592|NCT00598832|11520854|FG000|Overall Study|Withdrawal by Subject|25
7299593|NCT00598832|11520855|FG001|Overall Study|Withdrawal by Subject|36
7299594|NCT00598832|11520854|FG000|Overall Study|Protocol Violation|0
7299595|NCT00598832|11520855|FG001|Overall Study|Protocol Violation|2
7299596|NCT00598832|11520854|FG000|Overall Study|Lost to Follow-up|24
7299597|NCT00598832|11520855|FG001|Overall Study|Lost to Follow-up|29
7299598|NCT00598832|11520854|FG000|Overall Study|Pregnancy|2
7299599|NCT00598832|11520855|FG001|Overall Study|Pregnancy|2
7299600|NCT00598832|11520854|FG000|Overall Study|Physician Decision|1
7299601|NCT00598832|11520855|FG001|Overall Study|Physician Decision|4
7299602|NCT00598832|11520854|FG000|Overall Study|Non compliance|1
7299603|NCT00598832|11520855|FG001|Overall Study|Non compliance|0
7299604|NCT00598871|11520863|FG000|Overall Study|Adverse Event|0
7299605|NCT00598871|11520864|FG001|Overall Study|Adverse Event|1
7299606|NCT00598975|11520872|FG000|Overall Study|Adverse Event|1
7299607|NCT00598975|11520873|FG001|Overall Study|Adverse Event|1
7299608|NCT00598975|11520872|FG000|Overall Study|Brain metastases|1
7299609|NCT00598975|11520873|FG001|Overall Study|Brain metastases|0
7299610|NCT00598975|11520872|FG000|Overall Study|Withdrawal by Subject|1
7299611|NCT00598975|11520873|FG001|Overall Study|Withdrawal by Subject|1
7299612|NCT00598975|11520872|FG000|Overall Study|Withdrawal of consent|0
7299613|NCT00598975|11520873|FG001|Overall Study|Withdrawal of consent|1
7299614|NCT00598975|11520872|FG000|Overall Study|Disease progression|8
7299615|NCT00598975|11520873|FG001|Overall Study|Disease progression|3
7299616|NCT00598975|11520872|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
7299617|NCT00598975|11520873|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
7299618|NCT00599196|11520894|FG000|Overall Study|Lack of Efficacy|22
7299619|NCT00599196|11520894|FG000|Overall Study|Adverse Event|93
7299620|NCT00599196|11520894|FG000|Overall Study|Unsatisfactory compliance of subject|3
7299621|NCT00599196|11520894|FG000|Overall Study|Subject withdrew consent|43
7299622|NCT00599196|11520894|FG000|Overall Study|Study ended per sponsor|197
7299623|NCT00599196|11520894|FG000|Overall Study|Lost to Follow-up|17
7299624|NCT00599196|11520894|FG000|Overall Study|Other: Patient Leaving For Israel|1
7299625|NCT00599196|11520894|FG000|Overall Study|Other: Spouse Withdrew Consent|1
7299626|NCT00599196|11520894|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
7299627|NCT00599196|11520894|FG000|Overall Study|Other: Pt Moved To Australia|1
7299628|NCT00599196|11520894|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
7299629|NCT00599196|11520894|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
7299630|NCT00599313|11520912|FG000|Overall Study|Adverse Event|19
7299631|NCT00599313|11520912|FG000|Overall Study|Disease Progression|12
7299632|NCT00599313|11520912|FG000|Overall Study|Patient Request|4
7299633|NCT00599313|11520912|FG000|Overall Study|Ineligible|1
7299634|NCT00599326|11520916|FG000|Overall Study|Lost to Follow-up|1
7299635|NCT00599326|11520916|FG000|Overall Study|Noncompliant|1
7299636|NCT00599339|11520920|FG000|Overall Study|Adverse Event|79
7299637|NCT00599339|11520920|FG000|Overall Study|Withdrawal by Subject|137
7299638|NCT00599339|11520920|FG000|Overall Study|Other Reason|179
7299639|NCT00599339|11520920|FG000|Overall Study|Lost to Follow-up|221
7299640|NCT00599339|11520920|FG000|Overall Study|No valid data consent|36
7299641|NCT00599339|11520920|FG000|Overall Study|Study Termination Status Unknown|12
7299642|NCT00599521|11520944|FG000|Overall Study|Lack of Efficacy|4
7299643|NCT00599521|11520945|FG001|Overall Study|Lack of Efficacy|8
7299644|NCT00599521|11520944|FG000|Overall Study|Adverse Event|4
7299645|NCT00599521|11520945|FG001|Overall Study|Adverse Event|1
7299646|NCT00599521|11520944|FG000|Overall Study|Withdrawal by Subject|28
7299647|NCT00599521|11520945|FG001|Overall Study|Withdrawal by Subject|34
7299648|NCT00599521|11520944|FG000|Overall Study|Protocol Violation|1
7299649|NCT00599521|11520945|FG001|Overall Study|Protocol Violation|1
7299650|NCT00599521|11520944|FG000|Overall Study|Lost to Follow-up|23
7299651|NCT00599521|11520945|FG001|Overall Study|Lost to Follow-up|23
7299652|NCT00599521|11520944|FG000|Overall Study|Pregnancy|0
7299653|NCT00599521|11520945|FG001|Overall Study|Pregnancy|2
7299654|NCT00599638|11520955|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
7299655|NCT00599638|11520956|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
7299656|NCT00599638|11520957|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
7299657|NCT00599638|11520958|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
7299658|NCT00599638|11520955|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7299659|NCT00599638|11520956|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7299660|NCT00599638|11520957|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
7299661|NCT00599638|11520958|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
7299662|NCT00599638|11520955|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
7299663|NCT00599638|11520956|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
7299664|NCT00599638|11520957|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
7299665|NCT00599638|11520958|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
7299666|NCT00599638|11520955|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7299667|NCT00599638|11520956|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7299668|NCT00599638|11520957|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
7299669|NCT00599638|11520958|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
7222718|NCT00025259|11431838|FG005|Overall Study|Randomization error|7
7222719|NCT00025259|11431839|FG006|Overall Study|Randomization error|2
7222720|NCT00025259|11431833|FG000|Overall Study|Adverse Event|1
7222721|NCT00025259|11431834|FG001|Overall Study|Adverse Event|0
7222722|NCT00025259|11431835|FG002|Overall Study|Adverse Event|0
7222723|NCT00025259|11431836|FG003|Overall Study|Adverse Event|0
7222724|NCT00025259|11431837|FG004|Overall Study|Adverse Event|0
7222725|NCT00025259|11431838|FG005|Overall Study|Adverse Event|0
7222726|NCT00025259|11431839|FG006|Overall Study|Adverse Event|0
7222727|NCT00025506|11431858|FG000|Overall Study|Ineligible: clerical error|1
7222728|NCT00025506|11431858|FG000|Overall Study|Ineligible: wrong cell type|5
7222729|NCT00025506|11431858|FG000|Overall Study|Ineligible: inadequate pathology|2
7222730|NCT00025506|11431858|FG000|Overall Study|Never Treated|2
7222731|NCT00025662|11431867|FG000|Overall Study|Withdrawal by Subject|2
7222732|NCT00025662|11431867|FG000|Overall Study|Technical failure of manipulation|1
7222733|NCT00025883|11431873|FG000|Overall Study|had atypical progeriod lipodystrophy|4
7222734|NCT00025883|11431873|FG000|Overall Study|no baseline data|1
7299670|NCT00599638|11520955|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
7299671|NCT00599638|11520956|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
7299672|NCT00599638|11520957|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
7299673|NCT00599638|11520958|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
7299674|NCT00599638|11520955|FG000|Washout Period (2 Weeks)|Adverse Event|0
7299675|NCT00599638|11520956|FG001|Washout Period (2 Weeks)|Adverse Event|0
7299676|NCT00599638|11520957|FG002|Washout Period (2 Weeks)|Adverse Event|0
7299677|NCT00599638|11520958|FG003|Washout Period (2 Weeks)|Adverse Event|1
7299678|NCT00599638|11520955|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
7299679|NCT00599638|11520956|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
7299680|NCT00599638|11520957|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
7299681|NCT00599638|11520958|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
7299682|NCT00599638|11520955|FG000|Washout Period (2 Weeks)|Protocol Violation|0
7299683|NCT00599638|11520956|FG001|Washout Period (2 Weeks)|Protocol Violation|1
7299684|NCT00599638|11520957|FG002|Washout Period (2 Weeks)|Protocol Violation|0
7299685|NCT00599638|11520958|FG003|Washout Period (2 Weeks)|Protocol Violation|0
7299686|NCT00599638|11520955|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
7299687|NCT00599638|11520956|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
7299688|NCT00599638|11520957|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
7299689|NCT00599638|11520958|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
7299690|NCT00599755|11520966|FG000|Overall Study|Adverse Event|11
7299691|NCT00599755|11520966|FG000|Overall Study|Withdrawal by Subject|2
7299692|NCT00599755|11520966|FG000|Overall Study|Progression of Disease|3
7299693|NCT00599755|11520966|FG000|Overall Study|Other Reason|2
7299694|NCT00599755|11520966|FG000|Overall Study|No data available|1
7299695|NCT00599924|11520990|FG000|Overall Study|Lack of Efficacy|3
7299696|NCT00599924|11520991|FG001|Overall Study|Lack of Efficacy|5
7299697|NCT00599924|11520992|FG002|Overall Study|Lack of Efficacy|1
7299698|NCT00599924|11520993|FG003|Overall Study|Lack of Efficacy|2
7299699|NCT00599924|11520994|FG004|Overall Study|Lack of Efficacy|3
7299700|NCT00599924|11520995|FG005|Overall Study|Lack of Efficacy|2
7299701|NCT00599924|11520996|FG006|Overall Study|Lack of Efficacy|0
7299702|NCT00599924|11520990|FG000|Overall Study|Adverse Event|0
7299703|NCT00599924|11520991|FG001|Overall Study|Adverse Event|0
7299704|NCT00599924|11520992|FG002|Overall Study|Adverse Event|0
7299705|NCT00599924|11520993|FG003|Overall Study|Adverse Event|2
7299706|NCT00599924|11520994|FG004|Overall Study|Adverse Event|0
7299707|NCT00599924|11520995|FG005|Overall Study|Adverse Event|0
7299708|NCT00599924|11520996|FG006|Overall Study|Adverse Event|2
7299709|NCT00599924|11520990|FG000|Overall Study|Death|0
7299710|NCT00599924|11520991|FG001|Overall Study|Death|0
7299711|NCT00599924|11520992|FG002|Overall Study|Death|0
7299712|NCT00599924|11520993|FG003|Overall Study|Death|2
7299713|NCT00599924|11520994|FG004|Overall Study|Death|0
7299714|NCT00599924|11520995|FG005|Overall Study|Death|2
7299715|NCT00599924|11520996|FG006|Overall Study|Death|1
7299716|NCT00599924|11520990|FG000|Overall Study|Protocol Violation|0
7299717|NCT00599924|11520991|FG001|Overall Study|Protocol Violation|0
7299718|NCT00599924|11520992|FG002|Overall Study|Protocol Violation|0
7299719|NCT00599924|11520993|FG003|Overall Study|Protocol Violation|1
7299720|NCT00599924|11520994|FG004|Overall Study|Protocol Violation|0
7299721|NCT00599924|11520995|FG005|Overall Study|Protocol Violation|0
7299722|NCT00599924|11520996|FG006|Overall Study|Protocol Violation|0
7299723|NCT00599924|11520990|FG000|Overall Study|Withdrawal by Subject|0
7299724|NCT00599924|11520991|FG001|Overall Study|Withdrawal by Subject|0
7299725|NCT00599924|11520992|FG002|Overall Study|Withdrawal by Subject|1
7299726|NCT00599924|11520993|FG003|Overall Study|Withdrawal by Subject|0
7299727|NCT00599924|11520994|FG004|Overall Study|Withdrawal by Subject|1
7299728|NCT00599924|11520995|FG005|Overall Study|Withdrawal by Subject|0
7299729|NCT00599924|11520996|FG006|Overall Study|Withdrawal by Subject|0
7299730|NCT00599924|11520990|FG000|Overall Study|Other|0
7299731|NCT00599924|11520991|FG001|Overall Study|Other|0
7299732|NCT00599924|11520992|FG002|Overall Study|Other|0
7299733|NCT00599924|11520993|FG003|Overall Study|Other|1
7299734|NCT00599924|11520994|FG004|Overall Study|Other|2
7299735|NCT00599924|11520995|FG005|Overall Study|Other|0
7299736|NCT00599924|11520996|FG006|Overall Study|Other|2
7299737|NCT00600028|11521019|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
7299738|NCT00600028|11521020|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
7299739|NCT00600028|11521019|FG000|First Intervention (12 Weeks)|Adverse Event|0
7299740|NCT00600028|11521020|FG001|First Intervention (12 Weeks)|Adverse Event|1
7299741|NCT00600028|11521019|FG000|Second Intervention (12 Weeks)|Adverse Event|0
7299742|NCT00600028|11521020|FG001|Second Intervention (12 Weeks)|Adverse Event|2
7299743|NCT00600067|11521031|FG000|Overall Study|Adverse Event|0
7299744|NCT00600067|11521032|FG001|Overall Study|Adverse Event|1
7299745|NCT00600067|11521031|FG000|Overall Study|Lost to Follow-up|2
7299746|NCT00600067|11521032|FG001|Overall Study|Lost to Follow-up|3
7299747|NCT00600067|11521031|FG000|Overall Study|protocol non-compliance|0
7299748|NCT00600067|11521032|FG001|Overall Study|protocol non-compliance|3
7299749|NCT00600067|11521031|FG000|Overall Study|Lack of Efficacy|1
7299750|NCT00600067|11521032|FG001|Overall Study|Lack of Efficacy|0
7299751|NCT00600106|11521048|FG000|Overall Study|Withdrawal by Subject|1
7299752|NCT00600106|11521049|FG001|Overall Study|Withdrawal by Subject|1
7299753|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
7299754|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
7299755|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
7299756|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
7299757|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
7299758|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
7299759|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7299760|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7299761|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
7299762|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7299763|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7299764|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
7299765|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
7299766|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
7299767|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
7299768|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
7299769|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
7299770|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
7299771|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
7299772|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
7299773|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
7299774|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
7299775|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
7299776|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
7299777|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Adverse Event|0
7299778|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Adverse Event|0
7299779|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Adverse Event|0
7299780|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Adverse Event|1
7299781|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Adverse Event|0
7299782|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Adverse Event|1
7299783|NCT00600119|11521061|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
7299784|NCT00600119|11521062|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
7299785|NCT00600119|11521063|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7299786|NCT00600119|11521064|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7299787|NCT00600119|11521065|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7299788|NCT00600119|11521066|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
7299789|NCT00600119|11521061|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
7299790|NCT00600119|11521062|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
7299791|NCT00600119|11521063|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
7299792|NCT00600119|11521064|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
7299793|NCT00600119|11521065|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
7299794|NCT00600119|11521066|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
7299795|NCT00600119|11521061|FG000|Double-blind Treatment Period|Other|0
7299796|NCT00600119|11521062|FG001|Double-blind Treatment Period|Other|0
7299797|NCT00600119|11521063|FG002|Double-blind Treatment Period|Other|0
7299798|NCT00600119|11521064|FG003|Double-blind Treatment Period|Other|0
7299799|NCT00600119|11521065|FG004|Double-blind Treatment Period|Other|2
7299800|NCT00600119|11521066|FG005|Double-blind Treatment Period|Other|1
7299801|NCT00600119|11521061|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7299802|NCT00600119|11521062|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7299803|NCT00600119|11521063|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7299804|NCT00600119|11521064|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7299805|NCT00600119|11521065|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
7299806|NCT00600119|11521066|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
7299807|NCT00600119|11521061|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7299808|NCT00600119|11521062|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
7299809|NCT00600119|11521063|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7299810|NCT00600119|11521064|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7299811|NCT00600119|11521065|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7299812|NCT00600119|11521066|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
7299813|NCT00600119|11521061|FG000|Double-blind Treatment Period|Sponsor Decision|0
7299814|NCT00600119|11521062|FG001|Double-blind Treatment Period|Sponsor Decision|1
7299815|NCT00600119|11521063|FG002|Double-blind Treatment Period|Sponsor Decision|0
7299816|NCT00600119|11521064|FG003|Double-blind Treatment Period|Sponsor Decision|0
7299817|NCT00600119|11521065|FG004|Double-blind Treatment Period|Sponsor Decision|1
7299818|NCT00600119|11521066|FG005|Double-blind Treatment Period|Sponsor Decision|0
7299819|NCT00600119|11521061|FG000|Double-blind Treatment Period|Physician Decision|2
7299820|NCT00600119|11521062|FG001|Double-blind Treatment Period|Physician Decision|0
7299821|NCT00600119|11521063|FG002|Double-blind Treatment Period|Physician Decision|0
7299822|NCT00600119|11521064|FG003|Double-blind Treatment Period|Physician Decision|0
7299823|NCT00600119|11521065|FG004|Double-blind Treatment Period|Physician Decision|0
7299824|NCT00600119|11521066|FG005|Double-blind Treatment Period|Physician Decision|0
7299825|NCT00600119|11521061|FG000|Double-blind Treatment Period|Lost to Follow-up|0
7299826|NCT00600119|11521062|FG001|Double-blind Treatment Period|Lost to Follow-up|1
7299827|NCT00600119|11521063|FG002|Double-blind Treatment Period|Lost to Follow-up|0
7299828|NCT00600119|11521064|FG003|Double-blind Treatment Period|Lost to Follow-up|0
7299829|NCT00600119|11521065|FG004|Double-blind Treatment Period|Lost to Follow-up|0
7299830|NCT00600119|11521066|FG005|Double-blind Treatment Period|Lost to Follow-up|0
7299831|NCT00600119|11521061|FG000|Double-blind Treatment Period|Adverse Event|1
7299832|NCT00600119|11521062|FG001|Double-blind Treatment Period|Adverse Event|1
7299833|NCT00600119|11521063|FG002|Double-blind Treatment Period|Adverse Event|0
7299834|NCT00600119|11521064|FG003|Double-blind Treatment Period|Adverse Event|1
7299835|NCT00600119|11521065|FG004|Double-blind Treatment Period|Adverse Event|2
7299836|NCT00600119|11521066|FG005|Double-blind Treatment Period|Adverse Event|10
7299837|NCT00600119|11521061|FG000|Follow-up Period|Adverse Event|0
7299838|NCT00600119|11521062|FG001|Follow-up Period|Adverse Event|0
7299839|NCT00600119|11521063|FG002|Follow-up Period|Adverse Event|0
7299840|NCT00600119|11521064|FG003|Follow-up Period|Adverse Event|0
7299841|NCT00600119|11521065|FG004|Follow-up Period|Adverse Event|0
7299842|NCT00600119|11521066|FG005|Follow-up Period|Adverse Event|1
7299843|NCT00600119|11521061|FG000|Follow-up Period|Other|1
7299844|NCT00600119|11521062|FG001|Follow-up Period|Other|0
7299845|NCT00600119|11521063|FG002|Follow-up Period|Other|0
7299846|NCT00600119|11521064|FG003|Follow-up Period|Other|0
7299847|NCT00600119|11521065|FG004|Follow-up Period|Other|0
7299848|NCT00600119|11521066|FG005|Follow-up Period|Other|0
7299849|NCT00600171|11521086|FG000|Overall Study|Adverse Event|0
7299850|NCT00600171|11521087|FG001|Overall Study|Adverse Event|1
7299851|NCT00600171|11521088|FG002|Overall Study|Adverse Event|0
7299852|NCT00600171|11521089|FG003|Overall Study|Adverse Event|0
7299853|NCT00600171|11521090|FG004|Overall Study|Adverse Event|1
7299854|NCT00600171|11521091|FG005|Overall Study|Adverse Event|0
7299855|NCT00600171|11521086|FG000|Overall Study|Lack of Efficacy|9
7299856|NCT00600171|11521087|FG001|Overall Study|Lack of Efficacy|12
7299857|NCT00600171|11521088|FG002|Overall Study|Lack of Efficacy|3
7299858|NCT00600171|11521089|FG003|Overall Study|Lack of Efficacy|5
7299859|NCT00600171|11521090|FG004|Overall Study|Lack of Efficacy|4
7299860|NCT00600171|11521091|FG005|Overall Study|Lack of Efficacy|0
7299861|NCT00600171|11521086|FG000|Overall Study|Protocol Violation|1
7299862|NCT00600171|11521087|FG001|Overall Study|Protocol Violation|2
7299863|NCT00600171|11521088|FG002|Overall Study|Protocol Violation|0
7299864|NCT00600171|11521089|FG003|Overall Study|Protocol Violation|1
7299865|NCT00600171|11521090|FG004|Overall Study|Protocol Violation|0
7299866|NCT00600171|11521091|FG005|Overall Study|Protocol Violation|0
7299867|NCT00600171|11521086|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
7299868|NCT00600171|11521087|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
7299869|NCT00600171|11521088|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
7299870|NCT00600171|11521089|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
7299871|NCT00600171|11521090|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
7299872|NCT00600171|11521091|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
7299873|NCT00600171|11521086|FG000|Overall Study|Withdrawal by Subject|3
7299874|NCT00600171|11521087|FG001|Overall Study|Withdrawal by Subject|0
7299875|NCT00600171|11521088|FG002|Overall Study|Withdrawal by Subject|0
7299876|NCT00600171|11521089|FG003|Overall Study|Withdrawal by Subject|1
7299877|NCT00600171|11521090|FG004|Overall Study|Withdrawal by Subject|1
7299878|NCT00600171|11521091|FG005|Overall Study|Withdrawal by Subject|1
7299879|NCT00600171|11521086|FG000|Overall Study|Physician Decision|0
7299880|NCT00600171|11521087|FG001|Overall Study|Physician Decision|1
7299881|NCT00600171|11521088|FG002|Overall Study|Physician Decision|0
7299882|NCT00600171|11521089|FG003|Overall Study|Physician Decision|1
7299883|NCT00600171|11521090|FG004|Overall Study|Physician Decision|0
7299884|NCT00600171|11521091|FG005|Overall Study|Physician Decision|2
7299885|NCT00600171|11521086|FG000|Overall Study|Lost to Follow-up|0
7299886|NCT00600171|11521087|FG001|Overall Study|Lost to Follow-up|0
7299887|NCT00600171|11521088|FG002|Overall Study|Lost to Follow-up|0
7299888|NCT00600171|11521089|FG003|Overall Study|Lost to Follow-up|1
7299889|NCT00600171|11521090|FG004|Overall Study|Lost to Follow-up|0
7299890|NCT00600171|11521091|FG005|Overall Study|Lost to Follow-up|0
7299891|NCT00600353|11521118|FG000|Overall Study|history of malignancy within 5 years|1
7299892|NCT00600353|11521119|FG001|Overall Study|history of malignancy within 5 years|0
7299893|NCT00600353|11521118|FG000|Overall Study|History of prepartive regimen|0
7299894|NCT00600353|11521119|FG001|Overall Study|History of prepartive regimen|1
7299895|NCT00600613|11521125|FG000|Overall Study|Protocol Deviation|1
7299896|NCT00600756|11521166|FG000|Analysis After 6 Months|Adverse Event|43
7299897|NCT00600756|11521167|FG001|Analysis After 6 Months|Adverse Event|33
7299898|NCT00600756|11521166|FG000|Analysis After 6 Months|Withdrawal by Subject|38
7299899|NCT00600756|11521167|FG001|Analysis After 6 Months|Withdrawal by Subject|30
7299900|NCT00600756|11521166|FG000|Analysis After 6 Months|Incorrect Enrollment|12
7299901|NCT00600756|11521167|FG001|Analysis After 6 Months|Incorrect Enrollment|21
7299902|NCT00600756|11521166|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
7299903|NCT00600756|11521167|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
7299904|NCT00600756|11521166|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
7299905|NCT00600756|11521167|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
7299906|NCT00600756|11521166|FG000|Analysis After 6 Months|Lost to Follow-up|10
7299907|NCT00600756|11521167|FG001|Analysis After 6 Months|Lost to Follow-up|8
7299908|NCT00600756|11521166|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
7299909|NCT00600756|11521167|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
7299910|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
7299911|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
7299912|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
7299913|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
7299914|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
7299915|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
7299916|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
7299917|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
7299918|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
7299919|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
7299920|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
7299921|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
7299922|NCT00600756|11521166|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7299923|NCT00600756|11521167|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
7299924|NCT00600821|11521175|FG000|Overall Study|Death|45
7299925|NCT00600821|11521176|FG001|Overall Study|Death|46
7299926|NCT00600821|11521175|FG000|Overall Study|Lost to Follow-up|2
7299927|NCT00600821|11521176|FG001|Overall Study|Lost to Follow-up|2
7299928|NCT00600821|11521175|FG000|Overall Study|Withdrawal by Subject|1
7299929|NCT00600821|11521176|FG001|Overall Study|Withdrawal by Subject|1
7299930|NCT00600821|11521175|FG000|Overall Study|Terminated by sponsor|8
7299931|NCT00600821|11521176|FG001|Overall Study|Terminated by sponsor|6
7299932|NCT00600821|11521175|FG000|Overall Study|Objective progression or relapse|0
7299933|NCT00600821|11521176|FG001|Overall Study|Objective progression or relapse|1
7299934|NCT00600821|11521175|FG000|Overall Study|Randomized but not treated|0
7299935|NCT00600821|11521176|FG001|Overall Study|Randomized but not treated|1
7299936|NCT00600821|11521175|FG000|Overall Study|Other|2
7299937|NCT00600821|11521176|FG001|Overall Study|Other|3
7299938|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
7299939|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
7299940|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
7299941|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
7299942|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
7299943|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
7299944|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
7299945|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
7299946|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
7299947|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
7299948|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
7299949|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
7299950|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
7299951|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
7299952|NCT00600886|11521186|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
7299953|NCT00600886|11521187|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
7299954|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
7299955|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
7299956|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7299957|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
7299958|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
7299959|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
7299960|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
7299961|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
7299962|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
7299963|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
7299964|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
7299965|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
7299966|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Death|1
7299967|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Death|1
7299968|NCT00600886|11521186|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
7299969|NCT00600886|11521187|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
7299970|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Adverse Event|19
7299971|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Adverse Event|1
7299972|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
7299973|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
7299974|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
7299975|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
7299976|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
7299977|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
7299978|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
7299979|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
7299980|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
7299981|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
7299982|NCT00600886|11521186|FG000|Extension - After Crossover (CAS)|Death|1
7299983|NCT00600886|11521187|FG001|Extension - After Crossover (CAS)|Death|0
7299984|NCT00600938|11521218|FG000|Core Study|Abnormal test procedure result(s)|3
7299985|NCT00600938|11521219|FG001|Core Study|Abnormal test procedure result(s)|2
7299986|NCT00600938|11521220|FG002|Core Study|Abnormal test procedure result(s)|0
7299987|NCT00600938|11521221|FG003|Core Study|Abnormal test procedure result(s)|0
7299988|NCT00600938|11521218|FG000|Core Study|Unsatisfactory therapeutic effect|1
7299989|NCT00600938|11521219|FG001|Core Study|Unsatisfactory therapeutic effect|2
7299990|NCT00600938|11521220|FG002|Core Study|Unsatisfactory therapeutic effect|0
7299991|NCT00600938|11521221|FG003|Core Study|Unsatisfactory therapeutic effect|0
7299992|NCT00600938|11521218|FG000|Core Study|Patient withdrew consent|7
7299993|NCT00600938|11521219|FG001|Core Study|Patient withdrew consent|12
7299994|NCT00600938|11521220|FG002|Core Study|Patient withdrew consent|0
7299995|NCT00600938|11521221|FG003|Core Study|Patient withdrew consent|0
7299996|NCT00600938|11521218|FG000|Core Study|Lost to Follow-up|3
7299997|NCT00600938|11521219|FG001|Core Study|Lost to Follow-up|2
7299998|NCT00600938|11521220|FG002|Core Study|Lost to Follow-up|0
7299999|NCT00600938|11521221|FG003|Core Study|Lost to Follow-up|0
7300000|NCT00600938|11521218|FG000|Core Study|Death|1
7300001|NCT00600938|11521219|FG001|Core Study|Death|1
7300002|NCT00600938|11521220|FG002|Core Study|Death|0
7300003|NCT00600938|11521221|FG003|Core Study|Death|0
7300004|NCT00600938|11521218|FG000|Core Study|Protocol Violation|1
7300005|NCT00600938|11521219|FG001|Core Study|Protocol Violation|2
7300006|NCT00600938|11521220|FG002|Core Study|Protocol Violation|0
7300007|NCT00600938|11521221|FG003|Core Study|Protocol Violation|0
7300008|NCT00600938|11521218|FG000|Extension Study|Adverse Event|1
7300009|NCT00600938|11521219|FG001|Extension Study|Adverse Event|0
7300010|NCT00600938|11521220|FG002|Extension Study|Adverse Event|2
7300011|NCT00600938|11521221|FG003|Extension Study|Adverse Event|0
7300012|NCT00600938|11521218|FG000|Extension Study|Abnormal test procedure results|0
7300013|NCT00600938|11521219|FG001|Extension Study|Abnormal test procedure results|1
7300014|NCT00600938|11521220|FG002|Extension Study|Abnormal test procedure results|1
7300015|NCT00600938|11521221|FG003|Extension Study|Abnormal test procedure results|1
7300016|NCT00600938|11521218|FG000|Extension Study|Unsatisfactory therapeutic effect|4
7300017|NCT00600938|11521219|FG001|Extension Study|Unsatisfactory therapeutic effect|1
7300018|NCT00600938|11521220|FG002|Extension Study|Unsatisfactory therapeutic effect|1
7300019|NCT00600938|11521221|FG003|Extension Study|Unsatisfactory therapeutic effect|0
7300020|NCT00600938|11521218|FG000|Extension Study|Withdrawal by Subject|2
7300021|NCT00600938|11521219|FG001|Extension Study|Withdrawal by Subject|2
7300022|NCT00600938|11521220|FG002|Extension Study|Withdrawal by Subject|3
7300023|NCT00600938|11521221|FG003|Extension Study|Withdrawal by Subject|0
7300024|NCT00600938|11521218|FG000|Extension Study|Lost to Follow-up|1
7300025|NCT00600938|11521219|FG001|Extension Study|Lost to Follow-up|1
7300026|NCT00600938|11521220|FG002|Extension Study|Lost to Follow-up|2
7300027|NCT00600938|11521221|FG003|Extension Study|Lost to Follow-up|0
7300028|NCT00600938|11521218|FG000|Extension Study|Death|1
7300029|NCT00600938|11521219|FG001|Extension Study|Death|0
7300030|NCT00600938|11521220|FG002|Extension Study|Death|0
7300031|NCT00600938|11521221|FG003|Extension Study|Death|0
7300032|NCT00601107|11521250|FG000|Overall Study|Adverse Event|0
7300033|NCT00601107|11521251|FG001|Overall Study|Adverse Event|1
7300034|NCT00601107|11521252|FG002|Overall Study|Adverse Event|3
7300035|NCT00601107|11521253|FG003|Overall Study|Adverse Event|0
7300036|NCT00601107|11521250|FG000|Overall Study|Withdrawal by Subject|5
7300037|NCT00601107|11521251|FG001|Overall Study|Withdrawal by Subject|4
7300038|NCT00601107|11521252|FG002|Overall Study|Withdrawal by Subject|7
7300039|NCT00601107|11521253|FG003|Overall Study|Withdrawal by Subject|4
7300040|NCT00601107|11521250|FG000|Overall Study|Lost to Follow-up|3
7300041|NCT00601107|11521251|FG001|Overall Study|Lost to Follow-up|3
7300042|NCT00601107|11521252|FG002|Overall Study|Lost to Follow-up|0
7300043|NCT00601107|11521253|FG003|Overall Study|Lost to Follow-up|3
7300044|NCT00601107|11521250|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7300045|NCT00601107|11521251|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7300046|NCT00601107|11521252|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
7300047|NCT00601107|11521253|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
7300048|NCT00601107|11521250|FG000|Overall Study|Worsening of Psoriasis|4
7300049|NCT00601107|11521251|FG001|Overall Study|Worsening of Psoriasis|1
7300050|NCT00601107|11521252|FG002|Overall Study|Worsening of Psoriasis|1
7300051|NCT00601107|11521253|FG003|Overall Study|Worsening of Psoriasis|4
7300052|NCT00601107|11521250|FG000|Overall Study|Undefined|1
7300053|NCT00601107|11521251|FG001|Overall Study|Undefined|0
7300054|NCT00601107|11521252|FG002|Overall Study|Undefined|1
7300055|NCT00601107|11521253|FG003|Overall Study|Undefined|0
7300056|NCT00601172|11521269|FG000|Overall Study|Adverse Event|43
7300057|NCT00601172|11521270|FG001|Overall Study|Adverse Event|32
7300058|NCT00601172|11521269|FG000|Overall Study|Lack of Efficacy|11
7300059|NCT00601172|11521270|FG001|Overall Study|Lack of Efficacy|12
7300060|NCT00601172|11521269|FG000|Overall Study|Protocol Violation|2
7300061|NCT00601172|11521270|FG001|Overall Study|Protocol Violation|5
7300062|NCT00601172|11521269|FG000|Overall Study|Lost to Follow-up|4
7300063|NCT00601172|11521270|FG001|Overall Study|Lost to Follow-up|3
7300064|NCT00601172|11521269|FG000|Overall Study|Physician Decision|27
7300065|NCT00601172|11521270|FG001|Overall Study|Physician Decision|28
7300066|NCT00601172|11521269|FG000|Overall Study|Withdrawal by Subject|35
7300067|NCT00601172|11521270|FG001|Overall Study|Withdrawal by Subject|27
7300068|NCT00601172|11521269|FG000|Overall Study|Did not meet continuation criteria|19
7300069|NCT00601172|11521270|FG001|Overall Study|Did not meet continuation criteria|20
7300070|NCT00601250|11521279|FG000|Overall Study|Adverse Event|3
7300071|NCT00601250|11521280|FG001|Overall Study|Adverse Event|9
7300072|NCT00601250|11521279|FG000|Overall Study|Protocol Violation|3
7300073|NCT00601250|11521280|FG001|Overall Study|Protocol Violation|2
7300074|NCT00601250|11521279|FG000|Overall Study|Lost to Follow-up|2
7300075|NCT00601250|11521280|FG001|Overall Study|Lost to Follow-up|6
7300076|NCT00601250|11521279|FG000|Overall Study|Withdrawal by Subject|4
7300077|NCT00601250|11521280|FG001|Overall Study|Withdrawal by Subject|13
7300078|NCT00601250|11521279|FG000|Overall Study|Other incl. lack of efficacy|2
7300079|NCT00601250|11521280|FG001|Overall Study|Other incl. lack of efficacy|9
7300080|NCT00601354|11521288|FG000|Overall Study|Lost to Follow-up|4
7300081|NCT00601354|11521289|FG001|Overall Study|Lost to Follow-up|5
7300082|NCT00601419|11521299|FG000|Overall Study|Lost to Follow-up|3
7300083|NCT00601419|11521299|FG000|Overall Study|Missed Visits|1
7300084|NCT00601458|11521322|FG000|Overall Study|Dosing Error|1
7300085|NCT00601458|11521323|FG001|Overall Study|Dosing Error|0
7300086|NCT00601458|11521324|FG002|Overall Study|Dosing Error|0
7300087|NCT00601458|11521322|FG000|Overall Study|Incomplete Data|0
7300088|NCT00601458|11521323|FG001|Overall Study|Incomplete Data|2
7300089|NCT00601458|11521324|FG002|Overall Study|Incomplete Data|0
7300090|NCT00601458|11521322|FG000|Overall Study|Protocol Violation|3
7300091|NCT00601458|11521323|FG001|Overall Study|Protocol Violation|2
7300092|NCT00601458|11521324|FG002|Overall Study|Protocol Violation|1
7300093|NCT00601458|11521322|FG000|Overall Study|Early Termination|0
7300094|NCT00601458|11521323|FG001|Overall Study|Early Termination|1
7300095|NCT00601458|11521324|FG002|Overall Study|Early Termination|1
7300096|NCT00601484|11521334|FG000|Overall Study|Adverse Event|0
7300097|NCT00601484|11521335|FG001|Overall Study|Adverse Event|1
7300098|NCT00601484|11521334|FG000|Overall Study|Lost to Follow-up|4
7300099|NCT00601484|11521335|FG001|Overall Study|Lost to Follow-up|3
7300100|NCT00601484|11521334|FG000|Overall Study|Lack of Efficacy|0
7300101|NCT00601484|11521335|FG001|Overall Study|Lack of Efficacy|2
7300102|NCT00601484|11521334|FG000|Overall Study|Withdrawal by Subject|1
7300103|NCT00601484|11521335|FG001|Overall Study|Withdrawal by Subject|1
7300104|NCT00601484|11521334|FG000|Overall Study|Randomized, but not treated|0
7300105|NCT00601484|11521335|FG001|Overall Study|Randomized, but not treated|1
7300106|NCT00601523|11521343|FG000|Overall Study|Adverse Event|42
7300107|NCT00601523|11521344|FG001|Overall Study|Adverse Event|14
7300108|NCT00601523|11521343|FG000|Overall Study|Lack of Efficacy|3
7300109|NCT00601523|11521344|FG001|Overall Study|Lack of Efficacy|0
7300110|NCT00601523|11521343|FG000|Overall Study|Protocol Violation|5
7300111|NCT00601523|11521344|FG001|Overall Study|Protocol Violation|1
7300112|NCT00601523|11521343|FG000|Overall Study|Lost to Follow-up|0
7300113|NCT00601523|11521344|FG001|Overall Study|Lost to Follow-up|1
7300114|NCT00601523|11521343|FG000|Overall Study|Withdrawal by Subject|18
7300115|NCT00601523|11521344|FG001|Overall Study|Withdrawal by Subject|9
7300116|NCT00601523|11521343|FG000|Overall Study|Other|9
7300117|NCT00601523|11521344|FG001|Overall Study|Other|1
7300118|NCT00601640|11521357|FG000|Overall Study|Withdrawal by Subject|3
7300119|NCT00601640|11521358|FG001|Overall Study|Withdrawal by Subject|0
7300120|NCT00601640|11521359|FG002|Overall Study|Withdrawal by Subject|7
7300121|NCT00601640|11521357|FG000|Overall Study|Death|1
7300122|NCT00601640|11521358|FG001|Overall Study|Death|0
7300123|NCT00601640|11521359|FG002|Overall Study|Death|0
7300124|NCT00601640|11521357|FG000|Overall Study|Adverse Event|0
7300125|NCT00601640|11521358|FG001|Overall Study|Adverse Event|4
7300126|NCT00601640|11521359|FG002|Overall Study|Adverse Event|2
7300127|NCT00601640|11521357|FG000|Overall Study|intercurrent illness|1
7300128|NCT00601640|11521358|FG001|Overall Study|intercurrent illness|0
7300129|NCT00601640|11521359|FG002|Overall Study|intercurrent illness|0
7300130|NCT00601640|11521357|FG000|Overall Study|change in eligibility status|0
7300131|NCT00601640|11521358|FG001|Overall Study|change in eligibility status|1
7300132|NCT00601640|11521359|FG002|Overall Study|change in eligibility status|1
7300133|NCT00601705|11521369|FG000|Overall Study|Withdrawal by Subject|1
7300134|NCT00601835|11521425|FG000|Overall Study|Withdrawal by Subject|9
7300135|NCT00601835|11521426|FG001|Overall Study|Withdrawal by Subject|6
7300136|NCT00601835|11521425|FG000|Overall Study|Physician Decision|1
7300137|NCT00601835|11521426|FG001|Overall Study|Physician Decision|0
7300138|NCT00601835|11521425|FG000|Overall Study|Lost to Follow-up|37
7300139|NCT00601835|11521426|FG001|Overall Study|Lost to Follow-up|5
7300140|NCT00601835|11521425|FG000|Overall Study|Adverse Event|1
7300141|NCT00601835|11521426|FG001|Overall Study|Adverse Event|1
7300142|NCT00601835|11521425|FG000|Overall Study|Relocate|12
7300143|NCT00601835|11521426|FG001|Overall Study|Relocate|2
7300144|NCT00602420|11521502|FG000|Overall Study|Death|1
7300145|NCT00602420|11521503|FG001|Overall Study|Death|4
7300146|NCT00602420|11521502|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
7300147|NCT00602420|11521503|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
7300148|NCT00602420|11521502|FG000|Overall Study|Withdrawal by Subject|18
7300149|NCT00602420|11521503|FG001|Overall Study|Withdrawal by Subject|17
7300150|NCT00602420|11521502|FG000|Overall Study|Adverse Event|1
7300151|NCT00602420|11521503|FG001|Overall Study|Adverse Event|0
7551745|NCT02974868|11911253|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
7551746|NCT02974868|11911250|FG000|Initial 24-Week Treatment Period (TP)|others|3
7551747|NCT02974868|11911251|FG001|Initial 24-Week Treatment Period (TP)|others|8
7551748|NCT02974868|11911252|FG002|Initial 24-Week Treatment Period (TP)|others|1
7551749|NCT02974868|11911253|FG003|Initial 24-Week Treatment Period (TP)|others|8
7551750|NCT02974868|11911250|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
7551751|NCT02974868|11911251|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
7551752|NCT02974868|11911252|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
7551753|NCT02974868|11911253|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
7551754|NCT02974868|11911250|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
7551755|NCT02974868|11911251|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
7551756|NCT02974868|11911252|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
7551757|NCT02974868|11911253|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
7551758|NCT02975206|11911297|FG000|Overall Study|Withdrawal by Subject|14
7551759|NCT02975206|11911298|FG001|Overall Study|Withdrawal by Subject|11
7551760|NCT02975206|11911299|FG002|Overall Study|Withdrawal by Subject|11
7551761|NCT02975206|11911297|FG000|Overall Study|Other (e.g., lost to follow up)|13
7551762|NCT02975206|11911298|FG001|Overall Study|Other (e.g., lost to follow up)|6
7551763|NCT02975206|11911299|FG002|Overall Study|Other (e.g., lost to follow up)|6
7551764|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Adverse Event|16
7551765|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Adverse Event|17
7551766|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Adverse Event|13
7551767|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Adverse Event|18
7551768|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Adverse Event|0
7551769|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Adverse Event|0
7551770|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Adverse Event|0
7551771|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Adverse Event|0
7551772|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
7551773|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
7551774|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
7551775|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
7551776|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
7551777|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
7551778|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
7551779|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
7551780|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Protocol Violation|4
7551781|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Protocol Violation|1
7551782|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Protocol Violation|3
7551783|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Protocol Violation|1
7551784|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Protocol Violation|0
7551785|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Protocol Violation|0
7551786|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Protocol Violation|0
7551787|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Protocol Violation|0
7551788|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
7551789|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
7551790|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
7551791|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
7551792|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
7551793|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
7551794|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
7551795|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
7551796|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
7551797|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
7551798|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
7551799|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
7551800|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
7551801|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
7551802|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
7551803|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
7551804|NCT02975336|11911320|FG000|DBPC (52 Weeks)|Premature termination of the study|5
7551805|NCT02975336|11911321|FG001|DBPC (52 Weeks)|Premature termination of the study|6
7551806|NCT02975336|11911322|FG002|DBPC (52 Weeks)|Premature termination of the study|6
7551807|NCT02975336|11911323|FG003|DBPC (52 Weeks)|Premature termination of the study|4
7551808|NCT02975336|11911324|FG004|DBPC (52 Weeks)|Premature termination of the study|0
7551809|NCT02975336|11911325|FG005|DBPC (52 Weeks)|Premature termination of the study|0
7551810|NCT02975336|11911326|FG006|DBPC (52 Weeks)|Premature termination of the study|0
7551811|NCT02975336|11911327|FG007|DBPC (52 Weeks)|Premature termination of the study|0
7551812|NCT02975336|11911320|FG000|LTE (104 Weeks)|Adverse Event|0
7300152|NCT00602472|11521515|FG000|Overall Study|Adverse Event|5
7300153|NCT00602472|11521516|FG001|Overall Study|Adverse Event|23
7300154|NCT00602472|11521515|FG000|Overall Study|Protocol Violation|4
7300155|NCT00602472|11521516|FG001|Overall Study|Protocol Violation|19
7300156|NCT00602472|11521515|FG000|Overall Study|Withdrawal by Subject|8
7300157|NCT00602472|11521516|FG001|Overall Study|Withdrawal by Subject|14
7300158|NCT00602472|11521515|FG000|Overall Study|Other incl. lack of efficacy|4
7300159|NCT00602472|11521516|FG001|Overall Study|Other incl. lack of efficacy|2
7300160|NCT00602537|11521524|FG000|12 Week Double Blind Comparison|Adverse Event|2
7300161|NCT00602537|11521525|FG001|12 Week Double Blind Comparison|Adverse Event|5
7300162|NCT00602537|11521524|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
7300163|NCT00602537|11521525|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
7300164|NCT00602537|11521524|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
7300165|NCT00602537|11521525|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
7300166|NCT00602537|11521524|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
7300167|NCT00602537|11521525|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
7300168|NCT00602537|11521524|FG000|Follow Up Study Comparison|Adverse Event|1
7300169|NCT00602537|11521525|FG001|Follow Up Study Comparison|Adverse Event|0
7300170|NCT00602537|11521524|FG000|Follow Up Study Comparison|Lost to Follow-up|8
7300171|NCT00602537|11521525|FG001|Follow Up Study Comparison|Lost to Follow-up|1
7300172|NCT00602537|11521524|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
7300173|NCT00602537|11521525|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
7300174|NCT00602797|11521540|FG000|Overall Study|Adverse Event|1
7300175|NCT00602927|11521551|FG000|Period 1: 13 Days|Protocol Violation|2
7300176|NCT00602927|11521552|FG001|Period 1: 13 Days|Protocol Violation|4
7300177|NCT00602927|11521551|FG000|Period 1: 13 Days|MRI scanner technical issue|1
7300178|NCT00602927|11521552|FG001|Period 1: 13 Days|MRI scanner technical issue|0
7300179|NCT00602927|11521551|FG000|Period 1: 13 Days|Time|1
7300180|NCT00602927|11521552|FG001|Period 1: 13 Days|Time|0
7300181|NCT00602927|11521551|FG000|Period 1: 13 Days|Claustrophobia|0
7300182|NCT00602927|11521552|FG001|Period 1: 13 Days|Claustrophobia|1
7300183|NCT00602927|11521551|FG000|Period 2: 14 Days|Protocol Violation|0
7300184|NCT00602927|11521552|FG001|Period 2: 14 Days|Protocol Violation|2
7300185|NCT00602927|11521551|FG000|Period 3: 13 Days|Protocol Violation|0
7300186|NCT00602927|11521552|FG001|Period 3: 13 Days|Protocol Violation|1
7300187|NCT00602927|11521551|FG000|Period 3: 13 Days|MRI data quality|2
7300188|NCT00602927|11521552|FG001|Period 3: 13 Days|MRI data quality|2
7300189|NCT00602979|11521584|FG000|Overall Study|Lost to Follow-up|3
7300190|NCT00602979|11521585|FG001|Overall Study|Lost to Follow-up|2
7300191|NCT00602979|11521586|FG002|Overall Study|Lost to Follow-up|3
7300192|NCT00602979|11521587|FG003|Overall Study|Lost to Follow-up|2
7300193|NCT00602979|11521588|FG004|Overall Study|Lost to Follow-up|3
7300194|NCT00602979|11521584|FG000|Overall Study|Failed Intubation|0
7300195|NCT00602979|11521585|FG001|Overall Study|Failed Intubation|1
7300196|NCT00602979|11521586|FG002|Overall Study|Failed Intubation|0
7300197|NCT00602979|11521587|FG003|Overall Study|Failed Intubation|1
7300198|NCT00602979|11521588|FG004|Overall Study|Failed Intubation|0
7300199|NCT00603239|11521620|FG000|Overall Study|Adverse Event|4
7300200|NCT00603239|11521621|FG001|Overall Study|Adverse Event|1
7300201|NCT00603239|11521620|FG000|Overall Study|Entry criteria not met|0
7300202|NCT00603239|11521621|FG001|Overall Study|Entry criteria not met|1
7300203|NCT00603239|11521620|FG000|Overall Study|Loss of glucose control|3
7300204|NCT00603239|11521621|FG001|Overall Study|Loss of glucose control|0
7300205|NCT00603239|11521620|FG000|Overall Study|Lost to Follow-up|2
7300206|NCT00603239|11521621|FG001|Overall Study|Lost to Follow-up|1
7300207|NCT00603239|11521620|FG000|Overall Study|Physician Decision|2
7300208|NCT00603239|11521621|FG001|Overall Study|Physician Decision|0
7300209|NCT00603239|11521620|FG000|Overall Study|Protocol Violation|2
7300210|NCT00603239|11521621|FG001|Overall Study|Protocol Violation|0
7300211|NCT00603239|11521620|FG000|Overall Study|Subject decision|2
7300212|NCT00603239|11521621|FG001|Overall Study|Subject decision|1
7300213|NCT00603265|11521630|FG000|Overall Study|Adverse Event|2
7300214|NCT00603265|11521631|FG001|Overall Study|Adverse Event|11
7300215|NCT00603265|11521632|FG002|Overall Study|Adverse Event|1
7300216|NCT00603265|11521630|FG000|Overall Study|Withdrawal by Subject|1
7300217|NCT00603265|11521631|FG001|Overall Study|Withdrawal by Subject|2
7300218|NCT00603265|11521632|FG002|Overall Study|Withdrawal by Subject|1
7300219|NCT00603265|11521630|FG000|Overall Study|Lack of Efficacy|3
7300220|NCT00603265|11521631|FG001|Overall Study|Lack of Efficacy|0
7300221|NCT00603265|11521632|FG002|Overall Study|Lack of Efficacy|3
7300222|NCT00603265|11521630|FG000|Overall Study|Lost to Follow-up|0
7300223|NCT00603265|11521631|FG001|Overall Study|Lost to Follow-up|1
7300224|NCT00603265|11521632|FG002|Overall Study|Lost to Follow-up|0
7300225|NCT00603265|11521630|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
7300226|NCT00603265|11521631|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
7300227|NCT00603265|11521632|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
7300228|NCT00603265|11521630|FG000|Overall Study|Participant Left Country, No Responses|0
7300229|NCT00603265|11521631|FG001|Overall Study|Participant Left Country, No Responses|1
7300230|NCT00603265|11521632|FG002|Overall Study|Participant Left Country, No Responses|0
7300231|NCT00603265|11521630|FG000|Overall Study|Protocol Violation|1
7300232|NCT00603265|11521631|FG001|Overall Study|Protocol Violation|0
7300233|NCT00603265|11521632|FG002|Overall Study|Protocol Violation|0
7300234|NCT00603278|11521646|FG000|Overall Study|Lack of Efficacy|35
7300235|NCT00603278|11521647|FG001|Overall Study|Lack of Efficacy|10
7300236|NCT00603278|11521648|FG002|Overall Study|Lack of Efficacy|11
7300237|NCT00603278|11521649|FG003|Overall Study|Lack of Efficacy|8
7300238|NCT00603278|11521650|FG004|Overall Study|Lack of Efficacy|7
7300239|NCT00603278|11521651|FG005|Overall Study|Lack of Efficacy|14
7300240|NCT00603278|11521646|FG000|Overall Study|Adverse Event|0
7300241|NCT00603278|11521647|FG001|Overall Study|Adverse Event|3
7300242|NCT00603278|11521648|FG002|Overall Study|Adverse Event|1
7300243|NCT00603278|11521649|FG003|Overall Study|Adverse Event|0
7300244|NCT00603278|11521650|FG004|Overall Study|Adverse Event|2
7300245|NCT00603278|11521651|FG005|Overall Study|Adverse Event|1
7300246|NCT00603278|11521646|FG000|Overall Study|Withdrawal by Subject|2
7300247|NCT00603278|11521647|FG001|Overall Study|Withdrawal by Subject|3
7300248|NCT00603278|11521648|FG002|Overall Study|Withdrawal by Subject|1
7300249|NCT00603278|11521649|FG003|Overall Study|Withdrawal by Subject|2
7300250|NCT00603278|11521650|FG004|Overall Study|Withdrawal by Subject|1
7300251|NCT00603278|11521651|FG005|Overall Study|Withdrawal by Subject|2
7300252|NCT00603278|11521646|FG000|Overall Study|Protocol Violation|3
7300253|NCT00603278|11521647|FG001|Overall Study|Protocol Violation|0
7300254|NCT00603278|11521648|FG002|Overall Study|Protocol Violation|1
7300255|NCT00603278|11521649|FG003|Overall Study|Protocol Violation|1
7300256|NCT00603278|11521650|FG004|Overall Study|Protocol Violation|0
7300257|NCT00603278|11521651|FG005|Overall Study|Protocol Violation|1
7300258|NCT00603278|11521646|FG000|Overall Study|Physician Decision|0
7300259|NCT00603278|11521647|FG001|Overall Study|Physician Decision|1
7300260|NCT00603278|11521648|FG002|Overall Study|Physician Decision|0
7300261|NCT00603278|11521649|FG003|Overall Study|Physician Decision|0
7300262|NCT00603278|11521650|FG004|Overall Study|Physician Decision|2
7300263|NCT00603278|11521651|FG005|Overall Study|Physician Decision|1
7300264|NCT00603278|11521646|FG000|Overall Study|Lost to Follow-up|1
7300265|NCT00603278|11521647|FG001|Overall Study|Lost to Follow-up|0
7300266|NCT00603278|11521648|FG002|Overall Study|Lost to Follow-up|0
7300267|NCT00603278|11521649|FG003|Overall Study|Lost to Follow-up|0
7300268|NCT00603278|11521650|FG004|Overall Study|Lost to Follow-up|1
7300269|NCT00603278|11521651|FG005|Overall Study|Lost to Follow-up|0
7300270|NCT00603304|11521680|FG000|Overall Study|Lost to Follow-up|5
7300271|NCT00603304|11521681|FG001|Overall Study|Lost to Follow-up|7
7300272|NCT00603304|11521680|FG000|Overall Study|Withdrawal by Subject|8
7300273|NCT00603304|11521681|FG001|Overall Study|Withdrawal by Subject|5
7300274|NCT00603304|11521680|FG000|Overall Study|Protocol Violation|1
7300275|NCT00603304|11521681|FG001|Overall Study|Protocol Violation|0
7300276|NCT00603304|11521680|FG000|Overall Study|Adverse Event|4
7300277|NCT00603304|11521681|FG001|Overall Study|Adverse Event|2
7300278|NCT00603304|11521680|FG000|Overall Study|Unacceptable Treatment Toxicity|5
7300279|NCT00603304|11521681|FG001|Overall Study|Unacceptable Treatment Toxicity|8
7300280|NCT00603304|11521680|FG000|Overall Study|Crossed Over to Open Label Therapy|3
7300281|NCT00603304|11521681|FG001|Overall Study|Crossed Over to Open Label Therapy|3
7300282|NCT00603304|11521680|FG000|Overall Study|Exclusionary Medication|2
7300283|NCT00603304|11521681|FG001|Overall Study|Exclusionary Medication|3
7300284|NCT00603304|11521680|FG000|Overall Study|Non-Compliant|0
7300285|NCT00603304|11521681|FG001|Overall Study|Non-Compliant|1
7300286|NCT00603304|11521680|FG000|Overall Study|Moved Away|0
7300287|NCT00603304|11521681|FG001|Overall Study|Moved Away|2
7300288|NCT00603304|11521680|FG000|Overall Study|Other|2
7300289|NCT00603304|11521681|FG001|Overall Study|Other|0
7300290|NCT00603304|11521680|FG000|Overall Study|Patient Decision|2
7300291|NCT00603304|11521681|FG001|Overall Study|Patient Decision|0
7300292|NCT00603382|11521695|FG000|Overall Study|Adverse Event|0
7300293|NCT00603382|11521696|FG001|Overall Study|Adverse Event|1
7300294|NCT00603382|11521697|FG002|Overall Study|Adverse Event|1
7300295|NCT00603382|11521698|FG003|Overall Study|Adverse Event|2
7300296|NCT00603382|11521699|FG004|Overall Study|Adverse Event|1
7300297|NCT00603382|11521700|FG005|Overall Study|Adverse Event|2
7300298|NCT00603382|11521695|FG000|Overall Study|Lack of Efficacy|14
7300299|NCT00603382|11521696|FG001|Overall Study|Lack of Efficacy|9
7300300|NCT00603382|11521697|FG002|Overall Study|Lack of Efficacy|3
7300301|NCT00603382|11521698|FG003|Overall Study|Lack of Efficacy|6
7300302|NCT00603382|11521699|FG004|Overall Study|Lack of Efficacy|6
7300303|NCT00603382|11521700|FG005|Overall Study|Lack of Efficacy|11
7300304|NCT00603382|11521695|FG000|Overall Study|Protocol Violation|1
7300305|NCT00603382|11521696|FG001|Overall Study|Protocol Violation|0
7300306|NCT00603382|11521697|FG002|Overall Study|Protocol Violation|1
7300307|NCT00603382|11521698|FG003|Overall Study|Protocol Violation|2
7300308|NCT00603382|11521699|FG004|Overall Study|Protocol Violation|1
7300309|NCT00603382|11521700|FG005|Overall Study|Protocol Violation|0
7300310|NCT00603382|11521695|FG000|Overall Study|Lost to Follow-up|0
7300311|NCT00603382|11521696|FG001|Overall Study|Lost to Follow-up|1
7300312|NCT00603382|11521697|FG002|Overall Study|Lost to Follow-up|1
7300313|NCT00603382|11521698|FG003|Overall Study|Lost to Follow-up|1
7300314|NCT00603382|11521699|FG004|Overall Study|Lost to Follow-up|0
7300315|NCT00603382|11521700|FG005|Overall Study|Lost to Follow-up|1
7300316|NCT00603382|11521695|FG000|Overall Study|Physician Decision|0
7300317|NCT00603382|11521696|FG001|Overall Study|Physician Decision|0
7300318|NCT00603382|11521697|FG002|Overall Study|Physician Decision|2
7300319|NCT00603382|11521698|FG003|Overall Study|Physician Decision|0
7300320|NCT00603382|11521699|FG004|Overall Study|Physician Decision|1
7300321|NCT00603382|11521700|FG005|Overall Study|Physician Decision|3
7300322|NCT00603382|11521695|FG000|Overall Study|Withdrawal by Subject|3
7300323|NCT00603382|11521696|FG001|Overall Study|Withdrawal by Subject|3
7300324|NCT00603382|11521697|FG002|Overall Study|Withdrawal by Subject|1
7300325|NCT00603382|11521698|FG003|Overall Study|Withdrawal by Subject|1
7300326|NCT00603382|11521699|FG004|Overall Study|Withdrawal by Subject|0
7300327|NCT00603382|11521700|FG005|Overall Study|Withdrawal by Subject|1
7300328|NCT00603447|11521726|FG000|Overall Study|Adverse Event|0
7300329|NCT00603447|11521727|FG001|Overall Study|Adverse Event|1
7300330|NCT00603447|11521728|FG002|Overall Study|Adverse Event|1
7300331|NCT00603447|11521729|FG003|Overall Study|Adverse Event|2
7300332|NCT00603447|11521730|FG004|Overall Study|Adverse Event|1
7300333|NCT00603447|11521731|FG005|Overall Study|Adverse Event|2
7300334|NCT00603447|11521732|FG006|Overall Study|Adverse Event|10
7300335|NCT00603447|11521726|FG000|Overall Study|Other|0
7300336|NCT00603447|11521727|FG001|Overall Study|Other|0
7300337|NCT00603447|11521728|FG002|Overall Study|Other|1
7300338|NCT00603447|11521729|FG003|Overall Study|Other|0
7300339|NCT00603447|11521730|FG004|Overall Study|Other|3
7300340|NCT00603447|11521731|FG005|Overall Study|Other|0
7300341|NCT00603447|11521732|FG006|Overall Study|Other|13
7300342|NCT00603447|11521726|FG000|Overall Study|Withdrew Consent|0
7300343|NCT00603447|11521727|FG001|Overall Study|Withdrew Consent|2
7300344|NCT00603447|11521728|FG002|Overall Study|Withdrew Consent|0
7300345|NCT00603447|11521729|FG003|Overall Study|Withdrew Consent|0
7300346|NCT00603447|11521730|FG004|Overall Study|Withdrew Consent|1
7300347|NCT00603447|11521731|FG005|Overall Study|Withdrew Consent|0
7300348|NCT00603447|11521732|FG006|Overall Study|Withdrew Consent|1
7300349|NCT00603473|11521748|FG000|Overall Study|Adverse Event|4
7300350|NCT00603473|11521748|FG000|Overall Study|Lack of Efficacy|4
7300351|NCT00603473|11521748|FG000|Overall Study|Protocol Violation|1
7300352|NCT00603512|11521757|FG000|Overall Study|Adverse Event|0
7300353|NCT00603512|11521758|FG001|Overall Study|Adverse Event|2
7300354|NCT00603512|11521759|FG002|Overall Study|Adverse Event|4
7300355|NCT00603512|11521760|FG003|Overall Study|Adverse Event|4
7300356|NCT00603512|11521761|FG004|Overall Study|Adverse Event|2
7300357|NCT00603512|11521757|FG000|Overall Study|Lack of Efficacy|0
7300358|NCT00603512|11521758|FG001|Overall Study|Lack of Efficacy|1
7300359|NCT00603512|11521759|FG002|Overall Study|Lack of Efficacy|0
7300360|NCT00603512|11521760|FG003|Overall Study|Lack of Efficacy|0
7300361|NCT00603512|11521761|FG004|Overall Study|Lack of Efficacy|1
7300362|NCT00603512|11521757|FG000|Overall Study|Other|2
7300363|NCT00603512|11521758|FG001|Overall Study|Other|1
7300364|NCT00603512|11521759|FG002|Overall Study|Other|0
7300365|NCT00603512|11521760|FG003|Overall Study|Other|1
7300366|NCT00603512|11521761|FG004|Overall Study|Other|1
7300367|NCT00603512|11521757|FG000|Overall Study|Withdrawal by Subject|0
7300368|NCT00603512|11521758|FG001|Overall Study|Withdrawal by Subject|0
7300369|NCT00603512|11521759|FG002|Overall Study|Withdrawal by Subject|0
7300370|NCT00603512|11521760|FG003|Overall Study|Withdrawal by Subject|0
7300371|NCT00603512|11521761|FG004|Overall Study|Withdrawal by Subject|1
7300372|NCT00603512|11521757|FG000|Overall Study|Randomized but not treated|0
7300373|NCT00603512|11521758|FG001|Overall Study|Randomized but not treated|1
7300374|NCT00603512|11521759|FG002|Overall Study|Randomized but not treated|1
7300375|NCT00603512|11521760|FG003|Overall Study|Randomized but not treated|2
7300376|NCT00603512|11521761|FG004|Overall Study|Randomized but not treated|0
7300377|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
7300378|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
7300379|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
7300380|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
7300381|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7300382|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7222735|NCT00025883|11431873|FG000|Overall Study|Death|1
7222736|NCT00025883|11431873|FG000|Overall Study|Adverse Event|1
7222737|NCT00025883|11431873|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
7222738|NCT00026208|11431880|FG000|Overall Study|Complications of auto accident|1
7222739|NCT00026208|11431881|FG001|Overall Study|Complications of auto accident|0
7222740|NCT00026494|11431904|FG000|Overall Study|Withdrawal by Subject|1
7222741|NCT00026494|11431905|FG001|Overall Study|Withdrawal by Subject|0
7222742|NCT00026494|11431906|FG002|Overall Study|Withdrawal by Subject|1
7222743|NCT00026494|11431907|FG003|Overall Study|Withdrawal by Subject|0
7222744|NCT00026494|11431904|FG000|Overall Study|Patient non-compliance|1
7222745|NCT00026494|11431905|FG001|Overall Study|Patient non-compliance|0
7222746|NCT00026494|11431906|FG002|Overall Study|Patient non-compliance|0
7222747|NCT00026494|11431907|FG003|Overall Study|Patient non-compliance|0
7222748|NCT00026494|11431904|FG000|Overall Study|Patient not treated|0
7300383|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
7300384|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
7300385|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
7300386|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
7300387|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
7300388|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
7300389|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
7300390|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
7300391|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7300392|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
7300393|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
7300394|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
7300395|NCT00603525|11521775|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7300396|NCT00603525|11521776|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
7300397|NCT00603525|11521777|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
7300398|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
7300399|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
7300400|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
7300401|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7300402|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
7300403|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7300404|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
7300405|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
7300406|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
7300407|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7300408|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
7300409|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7300410|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7300411|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
7300412|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7300413|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
7300414|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
7300415|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
7300416|NCT00603525|11521775|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7300417|NCT00603525|11521776|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
7300418|NCT00603525|11521777|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7300419|NCT00603525|11521775|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7300420|NCT00603525|11521776|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
7300421|NCT00603525|11521777|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
7300422|NCT00603538|11521791|FG000|Overall Study|Adverse Event|0
7300423|NCT00603538|11521792|FG001|Overall Study|Adverse Event|4
7300424|NCT00603538|11521793|FG002|Overall Study|Adverse Event|2
7300425|NCT00603538|11521791|FG000|Overall Study|Objective progression or relapse|3
7300426|NCT00603538|11521792|FG001|Overall Study|Objective progression or relapse|0
7300427|NCT00603538|11521793|FG002|Overall Study|Objective progression or relapse|0
7300428|NCT00603590|11521815|FG000|Overall Study|Did not attend study clinic|39
7300429|NCT00603590|11521816|FG001|Overall Study|Did not attend study clinic|30
7300430|NCT00603590|11521815|FG000|Overall Study|Refused blood test|5
7300431|NCT00603590|11521816|FG001|Overall Study|Refused blood test|1
7300432|NCT00603590|11521815|FG000|Overall Study|Patient discontinued study drug|22
7300433|NCT00603590|11521816|FG001|Overall Study|Patient discontinued study drug|15
7300434|NCT00603590|11521815|FG000|Overall Study|Adverse Event|2
7300435|NCT00603590|11521816|FG001|Overall Study|Adverse Event|0
7300436|NCT00603590|11521815|FG000|Overall Study|Lost to Follow-up|8
7300437|NCT00603590|11521816|FG001|Overall Study|Lost to Follow-up|4
7300438|NCT00603590|11521815|FG000|Overall Study|Cardiovascular event|0
7300439|NCT00603590|11521816|FG001|Overall Study|Cardiovascular event|1
7300440|NCT00603733|11521854|FG000|Active Phase ITT|Adverse Event|8
7300441|NCT00603733|11521855|FG001|Active Phase ITT|Adverse Event|7
7300442|NCT00603733|11521854|FG000|Active Phase ITT|Withdrawal by Subject|0
7300443|NCT00603733|11521855|FG001|Active Phase ITT|Withdrawal by Subject|3
7300444|NCT00603733|11521854|FG000|Active Phase ITT|Lost to Follow-up|0
7300445|NCT00603733|11521855|FG001|Active Phase ITT|Lost to Follow-up|1
7300446|NCT00603733|11521854|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
7300447|NCT00603733|11521855|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
7300448|NCT00603733|11521854|FG000|Active Phase ITT|Lack of Efficacy|1
7300449|NCT00603733|11521855|FG001|Active Phase ITT|Lack of Efficacy|2
7300450|NCT00603733|11521854|FG000|Active Phase ITT|Subject moved, site closed|1
7300451|NCT00603733|11521855|FG001|Active Phase ITT|Subject moved, site closed|1
7300452|NCT00603733|11521854|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
7300453|NCT00603733|11521855|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
7300454|NCT00603733|11521854|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
7300455|NCT00603733|11521855|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
7300456|NCT00603733|11521854|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
7300457|NCT00603733|11521855|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
7300458|NCT00603733|11521854|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
7300459|NCT00603733|11521855|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
7300460|NCT00603733|11521854|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
7300461|NCT00603733|11521855|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
7300462|NCT00603733|11521854|FG000|Maintenance Phase ITT|Adverse Event|3
7300463|NCT00603733|11521855|FG001|Maintenance Phase ITT|Adverse Event|6
7300464|NCT00603733|11521854|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
7300465|NCT00603733|11521855|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
7300466|NCT00603733|11521854|FG000|Maintenance Phase ITT|Protocol Violation|1
7300467|NCT00603733|11521855|FG001|Maintenance Phase ITT|Protocol Violation|1
7300468|NCT00603733|11521854|FG000|Maintenance Phase ITT|Lost to Follow-up|0
7300469|NCT00603733|11521855|FG001|Maintenance Phase ITT|Lost to Follow-up|1
7300470|NCT00603733|11521854|FG000|Maintenance Phase ITT|Lack of Efficacy|2
7300471|NCT00603733|11521855|FG001|Maintenance Phase ITT|Lack of Efficacy|2
7300472|NCT00603733|11521854|FG000|Maintenance Phase ITT|Physician Decision|0
7300473|NCT00603733|11521855|FG001|Maintenance Phase ITT|Physician Decision|1
7300474|NCT00603733|11521854|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
7300475|NCT00603733|11521855|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
7300476|NCT00603746|11521867|FG000|Overall Study|Adverse Event|2
7300477|NCT00603746|11521868|FG001|Overall Study|Adverse Event|3
7300478|NCT00603746|11521869|FG002|Overall Study|Adverse Event|0
7300479|NCT00603746|11521870|FG003|Overall Study|Adverse Event|1
7300480|NCT00603746|11521871|FG004|Overall Study|Adverse Event|0
7300481|NCT00603746|11521872|FG005|Overall Study|Adverse Event|4
7300482|NCT00603746|11521867|FG000|Overall Study|Lack of Efficacy|34
7300483|NCT00603746|11521868|FG001|Overall Study|Lack of Efficacy|11
7300484|NCT00603746|11521869|FG002|Overall Study|Lack of Efficacy|6
7300485|NCT00603746|11521870|FG003|Overall Study|Lack of Efficacy|11
7300486|NCT00603746|11521871|FG004|Overall Study|Lack of Efficacy|12
7300487|NCT00603746|11521872|FG005|Overall Study|Lack of Efficacy|8
7300488|NCT00603746|11521867|FG000|Overall Study|Protocol Violation|0
7300489|NCT00603746|11521868|FG001|Overall Study|Protocol Violation|3
7300490|NCT00603746|11521869|FG002|Overall Study|Protocol Violation|1
7300491|NCT00603746|11521870|FG003|Overall Study|Protocol Violation|0
7300492|NCT00603746|11521871|FG004|Overall Study|Protocol Violation|1
7300493|NCT00603746|11521872|FG005|Overall Study|Protocol Violation|0
7300494|NCT00603746|11521867|FG000|Overall Study|Lost to Follow-up|0
7300495|NCT00603746|11521868|FG001|Overall Study|Lost to Follow-up|1
7300496|NCT00603746|11521869|FG002|Overall Study|Lost to Follow-up|1
7300497|NCT00603746|11521870|FG003|Overall Study|Lost to Follow-up|0
7300498|NCT00603746|11521871|FG004|Overall Study|Lost to Follow-up|0
7300499|NCT00603746|11521872|FG005|Overall Study|Lost to Follow-up|0
7300500|NCT00603746|11521867|FG000|Overall Study|Physician Decision|1
7300501|NCT00603746|11521868|FG001|Overall Study|Physician Decision|0
7300502|NCT00603746|11521869|FG002|Overall Study|Physician Decision|0
7300503|NCT00603746|11521870|FG003|Overall Study|Physician Decision|0
7300504|NCT00603746|11521871|FG004|Overall Study|Physician Decision|1
7300505|NCT00603746|11521872|FG005|Overall Study|Physician Decision|0
7300506|NCT00603746|11521867|FG000|Overall Study|Withdrawal by Subject|1
7300507|NCT00603746|11521868|FG001|Overall Study|Withdrawal by Subject|0
7300508|NCT00603746|11521869|FG002|Overall Study|Withdrawal by Subject|0
7300509|NCT00603746|11521870|FG003|Overall Study|Withdrawal by Subject|1
7300510|NCT00603746|11521871|FG004|Overall Study|Withdrawal by Subject|3
7300511|NCT00603746|11521872|FG005|Overall Study|Withdrawal by Subject|1
7300512|NCT00603798|11521889|FG000|Overall Study|Adverse Event|4
7300513|NCT00603798|11521890|FG001|Overall Study|Adverse Event|2
7300514|NCT00603798|11521891|FG002|Overall Study|Adverse Event|1
7300515|NCT00603798|11521889|FG000|Overall Study|Withdrawal by Subject|4
7300516|NCT00603798|11521890|FG001|Overall Study|Withdrawal by Subject|3
7300517|NCT00603798|11521891|FG002|Overall Study|Withdrawal by Subject|4
7300518|NCT00603798|11521889|FG000|Overall Study|Lost to Follow-up|1
7300519|NCT00603798|11521890|FG001|Overall Study|Lost to Follow-up|0
7300520|NCT00603798|11521891|FG002|Overall Study|Lost to Follow-up|1
7300521|NCT00603798|11521889|FG000|Overall Study|Non-compliance with study procedures|0
7300522|NCT00603798|11521890|FG001|Overall Study|Non-compliance with study procedures|1
7300523|NCT00603798|11521891|FG002|Overall Study|Non-compliance with study procedures|0
7300524|NCT00603798|11521889|FG000|Overall Study|Not due to AE|1
7300525|NCT00603798|11521890|FG001|Overall Study|Not due to AE|1
7300526|NCT00603798|11521891|FG002|Overall Study|Not due to AE|4
7300527|NCT00603837|11521901|FG000|Overall Study|Physician Decision|3
7300528|NCT00603837|11521902|FG001|Overall Study|Physician Decision|0
7300529|NCT00603915|11521925|FG000|Overall Study|Physician Decision|1
7300530|NCT00603941|11521932|FG000|Overall Study|Disease progression|6
7300531|NCT00603941|11521933|FG001|Overall Study|Disease progression|7
7300532|NCT00603941|11521934|FG002|Overall Study|Disease progression|1
7300533|NCT00603941|11521932|FG000|Overall Study|Adverse Event|1
7300534|NCT00603941|11521933|FG001|Overall Study|Adverse Event|0
7300535|NCT00603941|11521934|FG002|Overall Study|Adverse Event|1
7300536|NCT00603941|11521932|FG000|Overall Study|Physician Decision|0
7300537|NCT00603941|11521933|FG001|Overall Study|Physician Decision|1
7300538|NCT00603941|11521934|FG002|Overall Study|Physician Decision|0
7300539|NCT00603941|11521932|FG000|Overall Study|Withdrawal by Subject|0
7300540|NCT00603941|11521933|FG001|Overall Study|Withdrawal by Subject|2
7300541|NCT00603941|11521934|FG002|Overall Study|Withdrawal by Subject|0
7300542|NCT00603980|11521943|FG000|Study Qualification|Protocol Violation|3
7300543|NCT00603980|11521943|FG000|Study Qualification|Inconsistent data reporting|13
7300544|NCT00603980|11521943|FG000|Main Study|14th subject completed trial|1
7300545|NCT00604162|11521985|FG000|Overall Study|Physician Decision|3
7300546|NCT00604162|11521985|FG000|Overall Study|Withdrawal by Subject|1
7300547|NCT00604175|11521995|FG000|Entry Through Week 28|Death|2
7300548|NCT00604175|11521996|FG001|Entry Through Week 28|Death|0
7300549|NCT00604175|11521997|FG002|Entry Through Week 28|Death|0
7300550|NCT00604175|11521995|FG000|Entry Through Week 28|Withdrawal by Subject|1
7300551|NCT00604175|11521996|FG001|Entry Through Week 28|Withdrawal by Subject|0
7300552|NCT00604175|11521997|FG002|Entry Through Week 28|Withdrawal by Subject|0
7300553|NCT00604175|11521995|FG000|Entry Through Week 28|Lost to Follow-up|4
7300554|NCT00604175|11521996|FG001|Entry Through Week 28|Lost to Follow-up|3
7300555|NCT00604175|11521997|FG002|Entry Through Week 28|Lost to Follow-up|0
7300556|NCT00604175|11521995|FG000|Entry Through Week 28|Ineligible|1
7300557|NCT00604175|11521996|FG001|Entry Through Week 28|Ineligible|0
7300558|NCT00604175|11521997|FG002|Entry Through Week 28|Ineligible|0
7300559|NCT00604175|11521995|FG000|Entry Through Week 28|Did not start intervention|2
7300560|NCT00604175|11521996|FG001|Entry Through Week 28|Did not start intervention|0
7300561|NCT00604175|11521997|FG002|Entry Through Week 28|Did not start intervention|1
7300562|NCT00604175|11521995|FG000|Week 29 Through Week 72|Death|0
7300563|NCT00604175|11521996|FG001|Week 29 Through Week 72|Death|0
7300564|NCT00604175|11521997|FG002|Week 29 Through Week 72|Death|1
7300565|NCT00604175|11521995|FG000|Week 29 Through Week 72|Lost to Follow-up|12
7300566|NCT00604175|11521996|FG001|Week 29 Through Week 72|Lost to Follow-up|6
7300567|NCT00604175|11521997|FG002|Week 29 Through Week 72|Lost to Follow-up|2
7300568|NCT00604175|11521995|FG000|Week 29 Through Week 72|Site closure|0
7300569|NCT00604175|11521996|FG001|Week 29 Through Week 72|Site closure|1
7300570|NCT00604175|11521997|FG002|Week 29 Through Week 72|Site closure|0
7300571|NCT00604175|11521995|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
7300572|NCT00604175|11521996|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
7300573|NCT00604175|11521997|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
7300574|NCT00604188|11522031|FG000|Overall Study|Adverse Event|1
7300575|NCT00604188|11522032|FG001|Overall Study|Adverse Event|4
7300576|NCT00604188|11522031|FG000|Overall Study|Lost to Follow-up|17
7300577|NCT00604188|11522032|FG001|Overall Study|Lost to Follow-up|15
7300578|NCT00604188|11522031|FG000|Overall Study|Withdrawal by Subject|5
7300579|NCT00604188|11522032|FG001|Overall Study|Withdrawal by Subject|1
7300580|NCT00604188|11522031|FG000|Overall Study|Non-compliance with protocol|4
7300581|NCT00604188|11522032|FG001|Overall Study|Non-compliance with protocol|4
7300582|NCT00604188|11522031|FG000|Overall Study|Did not receive study drug|0
7300583|NCT00604188|11522032|FG001|Overall Study|Did not receive study drug|1
7300584|NCT00604214|11522040|FG000|Baseline to Day 28|Death|223
7300585|NCT00604214|11522041|FG001|Baseline to Day 28|Death|202
7300586|NCT00604214|11522040|FG000|Baseline to Day 28|Lost to Follow-up|2
7300587|NCT00604214|11522041|FG001|Baseline to Day 28|Lost to Follow-up|4
7300588|NCT00604214|11522040|FG000|Baseline to Day 28|Withdrawal by Subject|3
7300589|NCT00604214|11522041|FG001|Baseline to Day 28|Withdrawal by Subject|7
7300590|NCT00604214|11522040|FG000|Day 29 to Day 90|Death|64
7300591|NCT00604214|11522041|FG001|Day 29 to Day 90|Death|67
7300592|NCT00604214|11522040|FG000|Day 29 to Day 90|Lost to Follow-up|4
7300593|NCT00604214|11522041|FG001|Day 29 to Day 90|Lost to Follow-up|6
7300594|NCT00604214|11522040|FG000|Day 29 to Day 90|Withdrawal by Subject|0
7300595|NCT00604214|11522041|FG001|Day 29 to Day 90|Withdrawal by Subject|6
7300596|NCT00604214|11522040|FG000|Day 91 to Day 180|Death|19
7300597|NCT00604214|11522041|FG001|Day 91 to Day 180|Death|23
7300598|NCT00604214|11522040|FG000|Day 91 to Day 180|Lost to Follow-up|6
7300599|NCT00604214|11522041|FG001|Day 91 to Day 180|Lost to Follow-up|8
7300600|NCT00604214|11522040|FG000|Day 91 to Day 180|Withdrawal by Subject|1
7300601|NCT00604214|11522041|FG001|Day 91 to Day 180|Withdrawal by Subject|1
7300602|NCT00604279|11522049|FG000|Overall Study|Lack of Efficacy|22
7300603|NCT00604279|11522050|FG001|Overall Study|Lack of Efficacy|9
7300604|NCT00604279|11522049|FG000|Overall Study|Lost to Follow-up|9
7300605|NCT00604279|11522050|FG001|Overall Study|Lost to Follow-up|14
7300606|NCT00604279|11522049|FG000|Overall Study|Pregnancy|2
7300607|NCT00604279|11522050|FG001|Overall Study|Pregnancy|0
7300608|NCT00604279|11522049|FG000|Overall Study|Protocol Violation|3
7300609|NCT00604279|11522050|FG001|Overall Study|Protocol Violation|1
7300610|NCT00604279|11522049|FG000|Overall Study|Withdrawal by Subject|16
7300611|NCT00604279|11522050|FG001|Overall Study|Withdrawal by Subject|5
7300612|NCT00604279|11522049|FG000|Overall Study|Adverse Event|4
7300613|NCT00604279|11522050|FG001|Overall Study|Adverse Event|5
7300614|NCT00604279|11522049|FG000|Overall Study|Other|8
7300615|NCT00604279|11522050|FG001|Overall Study|Other|4
7300616|NCT00604383|11522058|FG000|Overall Study|Withdrawal by Subject|33
7300617|NCT00604383|11522059|FG001|Overall Study|Withdrawal by Subject|31
7300618|NCT00604383|11522058|FG000|Overall Study|Lost to Follow-up|24
7300619|NCT00604383|11522059|FG001|Overall Study|Lost to Follow-up|19
7300620|NCT00604383|11522058|FG000|Overall Study|Death|14
7300621|NCT00604383|11522059|FG001|Overall Study|Death|22
7300622|NCT00604383|11522058|FG000|Overall Study|Adverse Event|16
7300623|NCT00604383|11522059|FG001|Overall Study|Adverse Event|9
7300624|NCT00604383|11522058|FG000|Overall Study|Physician Decision|0
7300625|NCT00604383|11522059|FG001|Overall Study|Physician Decision|3
7300626|NCT00604565|11522082|FG000|Overall Study|Study terminated|0
7300627|NCT00604565|11522083|FG001|Overall Study|Study terminated|3
7300628|NCT00604669|11522089|FG000|Overall Study|lack of information in chart|7
7300629|NCT00604695|11522095|FG000|Overall Study|Did not receive first bolus.|0
7300630|NCT00604695|11522096|FG001|Overall Study|Did not receive first bolus.|4
7300631|NCT00604708|11522104|FG000|Overall Study|Withdrawal by Subject|9
7300632|NCT00604708|11522105|FG001|Overall Study|Withdrawal by Subject|10
7300633|NCT00604708|11522104|FG000|Overall Study|Protocol Violation|2
7300634|NCT00604708|11522105|FG001|Overall Study|Protocol Violation|8
7300635|NCT00604708|11522104|FG000|Overall Study|Lost to Follow-up|5
7300636|NCT00604708|11522105|FG001|Overall Study|Lost to Follow-up|5
7300637|NCT00604708|11522104|FG000|Overall Study|administrative reasons|9
7300638|NCT00604708|11522105|FG001|Overall Study|administrative reasons|11
7300639|NCT00604708|11522104|FG000|Overall Study|Adverse Event|6
7300640|NCT00604708|11522105|FG001|Overall Study|Adverse Event|6
7300641|NCT00604721|11522111|FG000|Overall Study|Physician Decision|1
7300642|NCT00604721|11522111|FG000|Overall Study|Withdrawal by Subject|1
7300643|NCT00604786|11522118|FG000|Overall Study|Lost to Follow-up|2
7300644|NCT00604786|11522119|FG001|Overall Study|Lost to Follow-up|0
7300645|NCT00604825|11522129|FG000|Overall Study|Adverse Event|2
7300646|NCT00604825|11522130|FG001|Overall Study|Adverse Event|6
7300647|NCT00604825|11522131|FG002|Overall Study|Adverse Event|7
7300648|NCT00604825|11522132|FG003|Overall Study|Adverse Event|4
7300649|NCT00604825|11522129|FG000|Overall Study|Lost to Follow-up|0
7300650|NCT00604825|11522130|FG001|Overall Study|Lost to Follow-up|3
7300651|NCT00604825|11522131|FG002|Overall Study|Lost to Follow-up|1
7300652|NCT00604825|11522132|FG003|Overall Study|Lost to Follow-up|0
7300653|NCT00604825|11522129|FG000|Overall Study|Protocol Violation|0
7300654|NCT00604825|11522130|FG001|Overall Study|Protocol Violation|1
7300655|NCT00604825|11522131|FG002|Overall Study|Protocol Violation|0
7300656|NCT00604825|11522132|FG003|Overall Study|Protocol Violation|0
7300657|NCT00604825|11522129|FG000|Overall Study|Withdrawal by Subject|4
7300658|NCT00604825|11522130|FG001|Overall Study|Withdrawal by Subject|3
7300659|NCT00604825|11522131|FG002|Overall Study|Withdrawal by Subject|5
7300660|NCT00604825|11522132|FG003|Overall Study|Withdrawal by Subject|5
7300661|NCT00604825|11522129|FG000|Overall Study|Lack of Efficacy|3
7300662|NCT00604825|11522130|FG001|Overall Study|Lack of Efficacy|2
7300663|NCT00604825|11522131|FG002|Overall Study|Lack of Efficacy|1
7300664|NCT00604825|11522132|FG003|Overall Study|Lack of Efficacy|0
7300665|NCT00604825|11522129|FG000|Overall Study|Did not meet eligibility criteria|0
7300666|NCT00604825|11522130|FG001|Overall Study|Did not meet eligibility criteria|0
7300667|NCT00604825|11522131|FG002|Overall Study|Did not meet eligibility criteria|2
7300668|NCT00604825|11522132|FG003|Overall Study|Did not meet eligibility criteria|0
7300669|NCT00604825|11522129|FG000|Overall Study|Physician Decision|0
7300670|NCT00604825|11522130|FG001|Overall Study|Physician Decision|0
7300671|NCT00604825|11522131|FG002|Overall Study|Physician Decision|0
7300672|NCT00604825|11522132|FG003|Overall Study|Physician Decision|1
7300673|NCT00604825|11522129|FG000|Overall Study|Exclusion criterion met|0
7300674|NCT00604825|11522130|FG001|Overall Study|Exclusion criterion met|0
7300675|NCT00604825|11522131|FG002|Overall Study|Exclusion criterion met|0
7300676|NCT00604825|11522132|FG003|Overall Study|Exclusion criterion met|1
7300677|NCT00605033|11522166|FG000|Overall Study|Adverse Event|2
7300678|NCT00605033|11522167|FG001|Overall Study|Adverse Event|2
7300679|NCT00605033|11522166|FG000|Overall Study|Lost to Follow-up|1
7300680|NCT00605033|11522167|FG001|Overall Study|Lost to Follow-up|1
7300681|NCT00605033|11522166|FG000|Overall Study|Withdrawal by Subject|3
7300682|NCT00605033|11522167|FG001|Overall Study|Withdrawal by Subject|4
7300683|NCT00605033|11522166|FG000|Overall Study|Protocol Violation|1
7300684|NCT00605033|11522167|FG001|Overall Study|Protocol Violation|1
7300685|NCT00605085|11522188|FG000|Overall Study|Withdrawal by Subject|8
7300686|NCT00605085|11522189|FG001|Overall Study|Withdrawal by Subject|5
7300687|NCT00605085|11522188|FG000|Overall Study|Adverse Event|9
7300688|NCT00605085|11522189|FG001|Overall Study|Adverse Event|5
7300689|NCT00605085|11522188|FG000|Overall Study|Pregnancy|2
7300690|NCT00605085|11522189|FG001|Overall Study|Pregnancy|0
7300691|NCT00605085|11522188|FG000|Overall Study|Protocol Violation|3
7300692|NCT00605085|11522189|FG001|Overall Study|Protocol Violation|2
7300693|NCT00605085|11522188|FG000|Overall Study|Lost to Follow-up|10
7300694|NCT00605085|11522189|FG001|Overall Study|Lost to Follow-up|5
7300695|NCT00605085|11522188|FG000|Overall Study|administrative reasons|18
7300696|NCT00605085|11522189|FG001|Overall Study|administrative reasons|8
7300697|NCT00605176|11522198|FG000|Overall Study|Adverse Event|2
7300698|NCT00605176|11522199|FG001|Overall Study|Adverse Event|1
7300699|NCT00605176|11522200|FG002|Overall Study|Adverse Event|3
7300700|NCT00605176|11522198|FG000|Overall Study|Withdrawal by Subject|4
7300701|NCT00605176|11522199|FG001|Overall Study|Withdrawal by Subject|2
7300702|NCT00605176|11522200|FG002|Overall Study|Withdrawal by Subject|4
7300703|NCT00605176|11522198|FG000|Overall Study|Lost to Follow-up|2
7300704|NCT00605176|11522199|FG001|Overall Study|Lost to Follow-up|2
7300705|NCT00605176|11522200|FG002|Overall Study|Lost to Follow-up|1
7300706|NCT00605176|11522198|FG000|Overall Study|Non-complicance with study procedures|1
7300707|NCT00605176|11522199|FG001|Overall Study|Non-complicance with study procedures|0
7300708|NCT00605176|11522200|FG002|Overall Study|Non-complicance with study procedures|0
7300709|NCT00605176|11522198|FG000|Overall Study|Use of concomitant therapy|1
7300710|NCT00605176|11522199|FG001|Overall Study|Use of concomitant therapy|0
7300711|NCT00605176|11522200|FG002|Overall Study|Use of concomitant therapy|1
7300712|NCT00605176|11522198|FG000|Overall Study|Other (not due to AE)|1
7300713|NCT00605176|11522199|FG001|Overall Study|Other (not due to AE)|1
7300714|NCT00605176|11522200|FG002|Overall Study|Other (not due to AE)|0
7300721|NCT00605267|11522230|FG000|Overall Study|Adverse Event|0
7300722|NCT00605267|11522231|FG001|Overall Study|Adverse Event|1
7300723|NCT00605267|11522230|FG000|Overall Study|Lack of Efficacy|1
7300724|NCT00605267|11522231|FG001|Overall Study|Lack of Efficacy|5
7300725|NCT00605267|11522230|FG000|Overall Study|Withdrawal by Subject|2
7300726|NCT00605267|11522231|FG001|Overall Study|Withdrawal by Subject|3
7300727|NCT00605280|11522241|FG000|Year 1|Protocol Violation|0
7300728|NCT00605280|11522242|FG001|Year 1|Protocol Violation|0
7300729|NCT00605280|11522243|FG002|Year 1|Protocol Violation|0
7300730|NCT00605280|11522244|FG003|Year 1|Protocol Violation|1
7300731|NCT00605280|11522241|FG000|Year 1|Adverse Event|3
7300732|NCT00605280|11522242|FG001|Year 1|Adverse Event|1
7300733|NCT00605280|11522243|FG002|Year 1|Adverse Event|1
7300734|NCT00605280|11522244|FG003|Year 1|Adverse Event|5
7300735|NCT00605280|11522241|FG000|Year 1|Physician Decision|7
7300736|NCT00605280|11522242|FG001|Year 1|Physician Decision|4
7300737|NCT00605280|11522243|FG002|Year 1|Physician Decision|0
7300738|NCT00605280|11522244|FG003|Year 1|Physician Decision|6
7300739|NCT00605280|11522241|FG000|Year 1|Withdrawal by Subject|2
7300740|NCT00605280|11522242|FG001|Year 1|Withdrawal by Subject|4
7300741|NCT00605280|11522243|FG002|Year 1|Withdrawal by Subject|0
7300742|NCT00605280|11522244|FG003|Year 1|Withdrawal by Subject|4
7300743|NCT00605280|11522241|FG000|Year 1|Other|2
7300744|NCT00605280|11522242|FG001|Year 1|Other|1
7300745|NCT00605280|11522243|FG002|Year 1|Other|0
7300746|NCT00605280|11522244|FG003|Year 1|Other|1
7300747|NCT00605280|11522241|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
7300748|NCT00605280|11522242|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
7300749|NCT00605280|11522243|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
7300750|NCT00605280|11522244|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
7300751|NCT00605280|11522241|FG000|Year 2|Adverse Event|4
7300752|NCT00605280|11522242|FG001|Year 2|Adverse Event|0
7300753|NCT00605280|11522243|FG002|Year 2|Adverse Event|2
7300754|NCT00605280|11522244|FG003|Year 2|Adverse Event|4
7300755|NCT00605280|11522241|FG000|Year 2|Physician Decision|11
7300756|NCT00605280|11522242|FG001|Year 2|Physician Decision|6
7300757|NCT00605280|11522243|FG002|Year 2|Physician Decision|4
7300758|NCT00605280|11522244|FG003|Year 2|Physician Decision|11
7300759|NCT00605280|11522241|FG000|Year 2|Withdrawal by Subject|4
7300760|NCT00605280|11522242|FG001|Year 2|Withdrawal by Subject|0
7300761|NCT00605280|11522243|FG002|Year 2|Withdrawal by Subject|0
7300762|NCT00605280|11522244|FG003|Year 2|Withdrawal by Subject|4
7300763|NCT00605280|11522241|FG000|Year 2|Other|1
7300764|NCT00605280|11522242|FG001|Year 2|Other|0
7300765|NCT00605280|11522243|FG002|Year 2|Other|0
7300766|NCT00605280|11522244|FG003|Year 2|Other|1
7300767|NCT00605280|11522241|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
7300768|NCT00605280|11522242|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
7300769|NCT00605280|11522243|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
7300770|NCT00605280|11522244|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
7300771|NCT00605280|11522241|FG000|Year 3 Extension|Adverse Event|2
7300772|NCT00605280|11522242|FG001|Year 3 Extension|Adverse Event|0
7300773|NCT00605280|11522243|FG002|Year 3 Extension|Adverse Event|0
7300774|NCT00605280|11522244|FG003|Year 3 Extension|Adverse Event|2
7300775|NCT00605280|11522241|FG000|Year 3 Extension|Physician Decision|0
7300776|NCT00605280|11522242|FG001|Year 3 Extension|Physician Decision|0
7300777|NCT00605280|11522243|FG002|Year 3 Extension|Physician Decision|0
7300778|NCT00605280|11522244|FG003|Year 3 Extension|Physician Decision|2
7300779|NCT00605280|11522241|FG000|Year 3 Extension|Withdrawal by Subject|2
7300780|NCT00605280|11522242|FG001|Year 3 Extension|Withdrawal by Subject|0
7300781|NCT00605280|11522243|FG002|Year 3 Extension|Withdrawal by Subject|0
7300782|NCT00605280|11522244|FG003|Year 3 Extension|Withdrawal by Subject|5
7300783|NCT00605280|11522241|FG000|Year 3 Extension|Other|2
7300784|NCT00605280|11522242|FG001|Year 3 Extension|Other|0
7300785|NCT00605280|11522243|FG002|Year 3 Extension|Other|0
7300786|NCT00605280|11522244|FG003|Year 3 Extension|Other|0
7300787|NCT00605280|11522241|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
7300788|NCT00605280|11522242|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7300789|NCT00605280|11522243|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7300790|NCT00605280|11522244|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
7300791|NCT00605293|11522256|FG000|Overall Study|Death|2
7300792|NCT00605293|11522257|FG001|Overall Study|Death|1
7300793|NCT00605293|11522256|FG000|Overall Study|Insufficient Therapeutic Response|2
7300794|NCT00605293|11522257|FG001|Overall Study|Insufficient Therapeutic Response|0
7300795|NCT00605293|11522256|FG000|Overall Study|Adverse Event|1
7300796|NCT00605293|11522257|FG001|Overall Study|Adverse Event|0
7300797|NCT00605293|11522256|FG000|Overall Study|Holidays Dialysis Out|1
7300798|NCT00605293|11522257|FG001|Overall Study|Holidays Dialysis Out|0
7300799|NCT00605293|11522256|FG000|Overall Study|Blood Transfusion|7
7300800|NCT00605293|11522257|FG001|Overall Study|Blood Transfusion|1
7300801|NCT00605293|11522256|FG000|Overall Study|Renal Transplantation|3
7300802|NCT00605293|11522257|FG001|Overall Study|Renal Transplantation|1
7300803|NCT00605293|11522256|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
7300804|NCT00605293|11522257|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
7300805|NCT00605293|11522256|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
7300806|NCT00605293|11522257|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
7300807|NCT00605293|11522256|FG000|Overall Study|Principal Investigator Decision|0
7300808|NCT00605293|11522257|FG001|Overall Study|Principal Investigator Decision|1
7300809|NCT00605306|11522265|FG000|Overall Study|Adverse Event|0
7300810|NCT00605306|11522266|FG001|Overall Study|Adverse Event|1
7300811|NCT00605319|11522272|FG000|Overall Study|Adverse Event|6
7300812|NCT00605345|11522284|FG000|Overall Study|Withdrawal by Subject|1
7300813|NCT00605345|11522285|FG001|Overall Study|Withdrawal by Subject|0
7300814|NCT00605345|11522284|FG000|Overall Study|Adverse Event|0
7300815|NCT00605345|11522285|FG001|Overall Study|Adverse Event|1
7300816|NCT00605345|11522284|FG000|Overall Study|Protocol Violation|0
7300817|NCT00605345|11522285|FG001|Overall Study|Protocol Violation|2
7300818|NCT00605475|11522328|FG000|Overall Study|Abnormal Laboratory Values|0
7300819|NCT00605475|11522329|FG001|Overall Study|Abnormal Laboratory Values|0
7300820|NCT00605475|11522330|FG002|Overall Study|Abnormal Laboratory Values|0
7300821|NCT00605475|11522331|FG003|Overall Study|Abnormal Laboratory Values|0
7300822|NCT00605475|11522332|FG004|Overall Study|Abnormal Laboratory Values|0
7300823|NCT00605475|11522333|FG005|Overall Study|Abnormal Laboratory Values|0
7300824|NCT00605475|11522334|FG006|Overall Study|Abnormal Laboratory Values|0
7300825|NCT00605475|11522335|FG007|Overall Study|Abnormal Laboratory Values|0
7300826|NCT00605475|11522336|FG008|Overall Study|Abnormal Laboratory Values|1
7300827|NCT00605475|11522337|FG009|Overall Study|Abnormal Laboratory Values|0
7300828|NCT00605475|11522328|FG000|Overall Study|Administrative problems|0
7300829|NCT00605475|11522329|FG001|Overall Study|Administrative problems|0
7300830|NCT00605475|11522330|FG002|Overall Study|Administrative problems|0
7300831|NCT00605475|11522331|FG003|Overall Study|Administrative problems|0
7300832|NCT00605475|11522332|FG004|Overall Study|Administrative problems|0
7300833|NCT00605475|11522333|FG005|Overall Study|Administrative problems|0
7300834|NCT00605475|11522334|FG006|Overall Study|Administrative problems|1
7300835|NCT00605475|11522335|FG007|Overall Study|Administrative problems|0
7300836|NCT00605475|11522336|FG008|Overall Study|Administrative problems|0
7300837|NCT00605475|11522337|FG009|Overall Study|Administrative problems|0
7300838|NCT00605475|11522328|FG000|Overall Study|Lost to Follow-up|0
7300839|NCT00605475|11522329|FG001|Overall Study|Lost to Follow-up|0
7300840|NCT00605475|11522330|FG002|Overall Study|Lost to Follow-up|0
7300841|NCT00605475|11522331|FG003|Overall Study|Lost to Follow-up|0
7300842|NCT00605475|11522332|FG004|Overall Study|Lost to Follow-up|0
7300843|NCT00605475|11522333|FG005|Overall Study|Lost to Follow-up|0
7300844|NCT00605475|11522334|FG006|Overall Study|Lost to Follow-up|0
7300845|NCT00605475|11522335|FG007|Overall Study|Lost to Follow-up|0
7300846|NCT00605475|11522336|FG008|Overall Study|Lost to Follow-up|1
7300847|NCT00605475|11522337|FG009|Overall Study|Lost to Follow-up|1
7300848|NCT00605475|11522328|FG000|Overall Study|Protocol Violation|0
7300849|NCT00605475|11522329|FG001|Overall Study|Protocol Violation|0
7300850|NCT00605475|11522330|FG002|Overall Study|Protocol Violation|0
7300851|NCT00605475|11522331|FG003|Overall Study|Protocol Violation|0
7300852|NCT00605475|11522332|FG004|Overall Study|Protocol Violation|1
7300853|NCT00605475|11522333|FG005|Overall Study|Protocol Violation|0
7300854|NCT00605475|11522334|FG006|Overall Study|Protocol Violation|0
7300855|NCT00605475|11522335|FG007|Overall Study|Protocol Violation|0
7300856|NCT00605475|11522336|FG008|Overall Study|Protocol Violation|0
7300857|NCT00605475|11522337|FG009|Overall Study|Protocol Violation|0
7300858|NCT00605475|11522328|FG000|Overall Study|Withdrawal by Subject|0
7300859|NCT00605475|11522329|FG001|Overall Study|Withdrawal by Subject|0
7300860|NCT00605475|11522330|FG002|Overall Study|Withdrawal by Subject|0
7300861|NCT00605475|11522331|FG003|Overall Study|Withdrawal by Subject|0
7300862|NCT00605475|11522332|FG004|Overall Study|Withdrawal by Subject|0
7300863|NCT00605475|11522333|FG005|Overall Study|Withdrawal by Subject|2
7300864|NCT00605475|11522334|FG006|Overall Study|Withdrawal by Subject|0
7300865|NCT00605475|11522335|FG007|Overall Study|Withdrawal by Subject|0
7300866|NCT00605475|11522336|FG008|Overall Study|Withdrawal by Subject|0
7300867|NCT00605475|11522337|FG009|Overall Study|Withdrawal by Subject|1
7300868|NCT00605540|11522380|FG000|Overall Study|Death|15
7300869|NCT00605540|11522380|FG000|Overall Study|Lost to Follow-up|23
7300870|NCT00605566|11522384|FG000|Overall Study|Adverse Event|1
7300871|NCT00605566|11522384|FG000|Overall Study|Clinical deterioration|1
7300872|NCT00605566|11522384|FG000|Overall Study|Poor compliance in run-in period|1
7300873|NCT00605657|11522409|FG000|Overall Study|Adverse Event|1
7300874|NCT00605657|11522409|FG000|Overall Study|Protocol Violation|1
7300875|NCT00605722|11522422|FG000|Overall Study|Adverse Event|6
7300876|NCT00605722|11522422|FG000|Overall Study|Insufficient therapeutic response|44
7300877|NCT00605722|11522422|FG000|Overall Study|Failure to return|1
7300878|NCT00605813|11522426|FG000|Overall Study|Protocol Violation|25
7300879|NCT00605839|11522451|FG000|Overall Study|Protocol Violation|1
7300880|NCT00605839|11522452|FG001|Overall Study|Protocol Violation|0
7300881|NCT00605839|11522453|FG002|Overall Study|Protocol Violation|0
7300882|NCT00605865|11522461|FG000|Overall Study|Protocol Violation|115
7300883|NCT00605917|11522502|FG000|Overall Study|Protocol Violation|79
7300884|NCT00606008|11522537|FG000|Overall Study|Adverse Event|1
7300885|NCT00606008|11522537|FG000|Overall Study|Withdrawal by Subject|4
7300886|NCT00606021|11522547|FG000|Induction Phase|Death|73
7300887|NCT00606021|11522548|FG001|Induction Phase|Death|0
7300888|NCT00606021|11522549|FG002|Induction Phase|Death|0
7300889|NCT00606021|11522547|FG000|Induction Phase|Physician Decision|2
7300890|NCT00606021|11522548|FG001|Induction Phase|Physician Decision|0
7300891|NCT00606021|11522549|FG002|Induction Phase|Physician Decision|0
7300892|NCT00606021|11522547|FG000|Induction Phase|Withdrawal by Subject|2
7300893|NCT00606021|11522548|FG001|Induction Phase|Withdrawal by Subject|0
7300894|NCT00606021|11522549|FG002|Induction Phase|Withdrawal by Subject|0
7300895|NCT00606021|11522547|FG000|Induction Phase|Lost to Follow-up|10
7300896|NCT00606021|11522548|FG001|Induction Phase|Lost to Follow-up|0
7300897|NCT00606021|11522549|FG002|Induction Phase|Lost to Follow-up|0
7300898|NCT00606021|11522547|FG000|Maintenance Phase|Death|0
7300899|NCT00606021|11522548|FG001|Maintenance Phase|Death|17
7300900|NCT00606021|11522549|FG002|Maintenance Phase|Death|15
7300901|NCT00606021|11522547|FG000|Maintenance Phase|Physician Decision|0
7300902|NCT00606021|11522548|FG001|Maintenance Phase|Physician Decision|1
7300903|NCT00606021|11522549|FG002|Maintenance Phase|Physician Decision|0
7300904|NCT00606021|11522547|FG000|Maintenance Phase|Lost to Follow-up|0
7300905|NCT00606021|11522548|FG001|Maintenance Phase|Lost to Follow-up|5
7300906|NCT00606021|11522549|FG002|Maintenance Phase|Lost to Follow-up|2
7300907|NCT00606034|11522557|FG000|Overall Study|incarceration|1
7300908|NCT00606086|11522569|FG000|Overall Study|Adverse Event|1
7300909|NCT00606086|11522570|FG001|Overall Study|Adverse Event|1
7300910|NCT00606086|11522569|FG000|Overall Study|Lost to Follow-up|4
7300911|NCT00606086|11522570|FG001|Overall Study|Lost to Follow-up|8
7300912|NCT00606086|11522569|FG000|Overall Study|Protocol Violation|1
7300913|NCT00606086|11522570|FG001|Overall Study|Protocol Violation|0
7300914|NCT00606086|11522569|FG000|Overall Study|Withdrawal by Subject|5
7300915|NCT00606086|11522570|FG001|Overall Study|Withdrawal by Subject|3
7300916|NCT00606086|11522569|FG000|Overall Study|Non-compliance|0
7300917|NCT00606086|11522570|FG001|Overall Study|Non-compliance|1
7300918|NCT00606086|11522569|FG000|Overall Study|Randomized, not treated|1
7300919|NCT00606086|11522570|FG001|Overall Study|Randomized, not treated|2
7300920|NCT00606177|11522587|FG000|Overall Study|Adverse Event|9
7300921|NCT00606177|11522588|FG001|Overall Study|Adverse Event|5
7300922|NCT00606177|11522587|FG000|Overall Study|Lack of Efficacy|3
7300923|NCT00606177|11522588|FG001|Overall Study|Lack of Efficacy|7
7300924|NCT00606177|11522587|FG000|Overall Study|Physician Decision|1
7300925|NCT00606177|11522588|FG001|Overall Study|Physician Decision|0
7300926|NCT00606177|11522587|FG000|Overall Study|Protocol Violation|1
7300927|NCT00606177|11522588|FG001|Overall Study|Protocol Violation|4
7300928|NCT00606177|11522587|FG000|Overall Study|Withdrawal by Subject|5
7300929|NCT00606177|11522588|FG001|Overall Study|Withdrawal by Subject|6
7300930|NCT00606177|11522587|FG000|Overall Study|Progression to depressive phase|6
7300931|NCT00606177|11522588|FG001|Overall Study|Progression to depressive phase|1
7300932|NCT00606177|11522587|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7300933|NCT00606177|11522588|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
7300934|NCT00606177|11522587|FG000|Overall Study|Change of residence or other commitments|1
7300935|NCT00606177|11522588|FG001|Overall Study|Change of residence or other commitments|1
7300936|NCT00606229|11522594|FG000|Overall Study|Adverse Event|11
7300937|NCT00606229|11522594|FG000|Overall Study|Lack of Efficacy|1
7300938|NCT00606229|11522594|FG000|Overall Study|Withdrawal by Subject|4
7300939|NCT00606229|11522594|FG000|Overall Study|does not meet inclusion criterion 1-3|4
7300940|NCT00606229|11522594|FG000|Overall Study|change of residence or other commitments|2
7300941|NCT00606281|11522600|FG000|Overall Study|Adverse Event|11
7300942|NCT00606281|11522601|FG001|Overall Study|Adverse Event|12
7300943|NCT00606281|11522600|FG000|Overall Study|Death|1
7300944|NCT00606281|11522601|FG001|Overall Study|Death|0
7300945|NCT00606281|11522600|FG000|Overall Study|Lack of Efficacy|28
7300946|NCT00606281|11522601|FG001|Overall Study|Lack of Efficacy|35
7300947|NCT00606281|11522600|FG000|Overall Study|Physician Decision|0
7300948|NCT00606281|11522601|FG001|Overall Study|Physician Decision|1
7300949|NCT00606281|11522600|FG000|Overall Study|Protocol Violation|3
7300950|NCT00606281|11522601|FG001|Overall Study|Protocol Violation|3
7300951|NCT00606281|11522600|FG000|Overall Study|Withdrawal by Subject|11
7300952|NCT00606281|11522601|FG001|Overall Study|Withdrawal by Subject|13
7300953|NCT00606281|11522600|FG000|Overall Study|Progression to depressive phase|1
7300954|NCT00606281|11522601|FG001|Overall Study|Progression to depressive phase|1
7300955|NCT00606281|11522600|FG000|Overall Study|Change of residence or other commitments|1
7300956|NCT00606281|11522601|FG001|Overall Study|Change of residence or other commitments|1
7300959|NCT00606307|11522616|FG000|Overall Study|Adverse Event|2
7300960|NCT00606307|11522616|FG000|Overall Study|Withdrawal by Subject|2
7300961|NCT00606307|11522616|FG000|Overall Study|Disease progression|6
7300962|NCT00606307|11522616|FG000|Overall Study|QTc prolongation|1
7300963|NCT00606320|11522620|FG000|Overall Study|Adverse Event|3
7300964|NCT00606320|11522620|FG000|Overall Study|Lack of Efficacy|5
7300965|NCT00606320|11522620|FG000|Overall Study|Physician Decision|7
7300966|NCT00606320|11522620|FG000|Overall Study|Protocol Violation|8
7300967|NCT00606320|11522620|FG000|Overall Study|Withdrawal by Subject|10
7300968|NCT00606320|11522620|FG000|Overall Study|Progression to depressive phase|4
7300969|NCT00606502|11522635|FG000|Randomization|Randomized but not treated|3
7300970|NCT00606502|11522636|FG001|Randomization|Randomized but not treated|0
7300971|NCT00606502|11522635|FG000|Treatment|Treatment ongoing at time of data cutoff|0
7300972|NCT00606502|11522636|FG001|Treatment|Treatment ongoing at time of data cutoff|3
7300973|NCT00606580|11522658|FG000|Overall Study|Lost to Follow-up|1
7300974|NCT00606580|11522659|FG001|Overall Study|Lost to Follow-up|1
7300975|NCT00606580|11522660|FG002|Overall Study|Lost to Follow-up|4
7300976|NCT00606580|11522658|FG000|Overall Study|Clinical failures|1
7300977|NCT00606580|11522659|FG001|Overall Study|Clinical failures|0
7300978|NCT00606580|11522660|FG002|Overall Study|Clinical failures|12
7300979|NCT00606580|11522658|FG000|Overall Study|Withdrawal by investigator|0
7300980|NCT00606580|11522659|FG001|Overall Study|Withdrawal by investigator|1
7300981|NCT00606580|11522660|FG002|Overall Study|Withdrawal by investigator|6
7300982|NCT00606580|11522658|FG000|Overall Study|Withdrawal by Subject|0
7300983|NCT00606580|11522659|FG001|Overall Study|Withdrawal by Subject|1
7300984|NCT00606580|11522660|FG002|Overall Study|Withdrawal by Subject|0
7551813|NCT02975336|11911321|FG001|LTE (104 Weeks)|Adverse Event|0
7551814|NCT02975336|11911322|FG002|LTE (104 Weeks)|Adverse Event|0
7551815|NCT02975336|11911323|FG003|LTE (104 Weeks)|Adverse Event|0
7551816|NCT02975336|11911324|FG004|LTE (104 Weeks)|Adverse Event|7
7551817|NCT02975336|11911325|FG005|LTE (104 Weeks)|Adverse Event|4
7551818|NCT02975336|11911326|FG006|LTE (104 Weeks)|Adverse Event|2
7551819|NCT02975336|11911327|FG007|LTE (104 Weeks)|Adverse Event|0
7551820|NCT02975336|11911320|FG000|LTE (104 Weeks)|Lost to Follow-up|0
7551821|NCT02975336|11911321|FG001|LTE (104 Weeks)|Lost to Follow-up|0
7551822|NCT02975336|11911322|FG002|LTE (104 Weeks)|Lost to Follow-up|0
7551823|NCT02975336|11911323|FG003|LTE (104 Weeks)|Lost to Follow-up|0
7551824|NCT02975336|11911324|FG004|LTE (104 Weeks)|Lost to Follow-up|0
7551825|NCT02975336|11911325|FG005|LTE (104 Weeks)|Lost to Follow-up|1
7551826|NCT02975336|11911326|FG006|LTE (104 Weeks)|Lost to Follow-up|0
7551827|NCT02975336|11911327|FG007|LTE (104 Weeks)|Lost to Follow-up|0
7551828|NCT02975336|11911320|FG000|LTE (104 Weeks)|Lack of Efficacy|0
7551829|NCT02975336|11911321|FG001|LTE (104 Weeks)|Lack of Efficacy|0
7551830|NCT02975336|11911322|FG002|LTE (104 Weeks)|Lack of Efficacy|0
7551831|NCT02975336|11911323|FG003|LTE (104 Weeks)|Lack of Efficacy|0
7551832|NCT02975336|11911324|FG004|LTE (104 Weeks)|Lack of Efficacy|0
7551833|NCT02975336|11911325|FG005|LTE (104 Weeks)|Lack of Efficacy|1
7551834|NCT02975336|11911326|FG006|LTE (104 Weeks)|Lack of Efficacy|2
7551835|NCT02975336|11911327|FG007|LTE (104 Weeks)|Lack of Efficacy|0
7551836|NCT02975336|11911320|FG000|LTE (104 Weeks)|Other|0
7551837|NCT02975336|11911321|FG001|LTE (104 Weeks)|Other|0
7551838|NCT02975336|11911322|FG002|LTE (104 Weeks)|Other|0
7551839|NCT02975336|11911323|FG003|LTE (104 Weeks)|Other|0
7551840|NCT02975336|11911324|FG004|LTE (104 Weeks)|Other|55
7551841|NCT02975336|11911325|FG005|LTE (104 Weeks)|Other|63
7551842|NCT02975336|11911326|FG006|LTE (104 Weeks)|Other|76
7551843|NCT02975336|11911327|FG007|LTE (104 Weeks)|Other|72
7551844|NCT02975349|11911346|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7551845|NCT02975349|11911347|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7551846|NCT02975349|11911348|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7551847|NCT02975349|11911349|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
7551848|NCT02975349|11911350|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7551849|NCT02975349|11911351|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
7551850|NCT02975349|11911346|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
7551851|NCT02975349|11911347|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7551852|NCT02975349|11911348|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7551853|NCT02975349|11911349|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7551854|NCT02975349|11911350|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7551855|NCT02975349|11911351|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
7551856|NCT02975349|11911346|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
7551857|NCT02975349|11911347|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
7551858|NCT02975349|11911348|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
7551859|NCT02975349|11911349|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
7551860|NCT02975349|11911350|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
7551861|NCT02975349|11911351|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
7551862|NCT02975349|11911346|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
7551863|NCT02975349|11911347|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
7551864|NCT02975349|11911348|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
7551865|NCT02975349|11911349|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
7551866|NCT02975349|11911350|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
7551867|NCT02975349|11911351|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
7551868|NCT02975349|11911346|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
7551869|NCT02975349|11911347|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
7551870|NCT02975349|11911348|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
7551871|NCT02975349|11911349|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
7551872|NCT02975349|11911350|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
7551873|NCT02975349|11911351|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
7551874|NCT02975349|11911346|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7551875|NCT02975349|11911347|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
7551876|NCT02975349|11911348|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
7551877|NCT02975349|11911349|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7551878|NCT02975349|11911350|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
7551879|NCT02975349|11911351|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
7551880|NCT02975349|11911346|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7551881|NCT02975349|11911347|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7551882|NCT02975349|11911348|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
7300985|NCT00606593|11522668|FG000|Overall Study|Adverse Event|0
7300986|NCT00606593|11522669|FG001|Overall Study|Adverse Event|0
7300987|NCT00606593|11522670|FG002|Overall Study|Adverse Event|0
7300988|NCT00606593|11522671|FG003|Overall Study|Adverse Event|1
7300989|NCT00606593|11522672|FG004|Overall Study|Adverse Event|1
7300990|NCT00606593|11522673|FG005|Overall Study|Adverse Event|0
7300991|NCT00606593|11522674|FG006|Overall Study|Adverse Event|1
7300992|NCT00606593|11522675|FG007|Overall Study|Adverse Event|2
7300993|NCT00606593|11522676|FG008|Overall Study|Adverse Event|1
7300994|NCT00606593|11522677|FG009|Overall Study|Adverse Event|0
7300995|NCT00606593|11522668|FG000|Overall Study|Withdrawal of consent|1
7300996|NCT00606593|11522669|FG001|Overall Study|Withdrawal of consent|0
7300997|NCT00606593|11522670|FG002|Overall Study|Withdrawal of consent|1
7300998|NCT00606593|11522671|FG003|Overall Study|Withdrawal of consent|0
7300999|NCT00606593|11522672|FG004|Overall Study|Withdrawal of consent|0
7301000|NCT00606593|11522673|FG005|Overall Study|Withdrawal of consent|0
7301001|NCT00606593|11522674|FG006|Overall Study|Withdrawal of consent|0
7301002|NCT00606593|11522675|FG007|Overall Study|Withdrawal of consent|0
7301003|NCT00606593|11522676|FG008|Overall Study|Withdrawal of consent|0
7301004|NCT00606593|11522677|FG009|Overall Study|Withdrawal of consent|0
7301005|NCT00606593|11522668|FG000|Overall Study|Administrative/Other|0
7301006|NCT00606593|11522669|FG001|Overall Study|Administrative/Other|0
7301007|NCT00606593|11522670|FG002|Overall Study|Administrative/Other|1
7301008|NCT00606593|11522671|FG003|Overall Study|Administrative/Other|0
7301009|NCT00606593|11522672|FG004|Overall Study|Administrative/Other|0
7301010|NCT00606593|11522673|FG005|Overall Study|Administrative/Other|0
7301011|NCT00606593|11522674|FG006|Overall Study|Administrative/Other|0
7301012|NCT00606593|11522675|FG007|Overall Study|Administrative/Other|0
7301013|NCT00606593|11522676|FG008|Overall Study|Administrative/Other|0
7301014|NCT00606593|11522677|FG009|Overall Study|Administrative/Other|0
7301015|NCT00606632|11522690|FG000|Overall Study|Withdrawal by Subject|13
7301016|NCT00606632|11522690|FG000|Overall Study|Miscellaneous reasons|9
7301017|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
7301018|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301019|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301020|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301021|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301022|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301023|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
7301024|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
7301025|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301026|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301027|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301028|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301029|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301030|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
7301031|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
7301032|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
7301033|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
7301034|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
7301035|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
7301036|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
7301037|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
7301038|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
7301039|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301040|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301041|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301042|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301043|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301044|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
7301045|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
7301046|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301047|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301048|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301049|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301050|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301051|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
7301052|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
7301053|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
7301054|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
7301055|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
7301056|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
7301057|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
7301058|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
7301059|NCT00606684|11522705|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
7301060|NCT00606684|11522706|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301061|NCT00606684|11522707|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301062|NCT00606684|11522708|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301063|NCT00606684|11522709|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301064|NCT00606684|11522710|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301065|NCT00606684|11522711|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
7301066|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Adverse Event|0
7301067|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Adverse Event|3
7301068|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Adverse Event|2
7301069|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Adverse Event|4
7301070|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Adverse Event|2
7301071|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Adverse Event|0
7301072|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Adverse Event|1
7301073|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
7301074|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
7301075|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
7301076|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
7301077|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
7301078|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
7301079|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
7301080|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Protocol Violation|0
7301081|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Protocol Violation|5
7301082|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Protocol Violation|5
7301083|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Protocol Violation|3
7301084|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Protocol Violation|0
7301085|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Protocol Violation|3
7301086|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Protocol Violation|4
7301087|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
7301088|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7301089|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7301090|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7301091|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
7301092|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
7301093|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
7301094|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Physician Decision|0
7301095|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Physician Decision|5
7301096|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Physician Decision|1
7301097|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Physician Decision|0
7301098|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Physician Decision|3
7301099|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Physician Decision|1
7301100|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Physician Decision|2
7301101|NCT00606684|11522705|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
7301102|NCT00606684|11522706|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
7301103|NCT00606684|11522707|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
7301104|NCT00606684|11522708|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
7301105|NCT00606684|11522709|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
7301106|NCT00606684|11522710|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
7301107|NCT00606684|11522711|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
7301108|NCT00606801|11522727|FG000|Intervention|Protocol Violation|3
7301109|NCT00606801|11522728|FG001|Intervention|Protocol Violation|3
7301110|NCT00606892|11522738|FG000|First Intervention|Protocol Violation|1
7301111|NCT00606892|11522739|FG001|First Intervention|Protocol Violation|4
7301112|NCT00606905|11522773|FG000|Overall Study|No Pregnancy|9
7301113|NCT00606905|11522774|FG001|Overall Study|No Pregnancy|6
7301114|NCT00606905|11522773|FG000|Overall Study|Non-Index Pregnancy|1
7301115|NCT00606905|11522774|FG001|Overall Study|Non-Index Pregnancy|4
7301116|NCT00606905|11522773|FG000|Overall Study|Withdrew|5
7301117|NCT00606905|11522774|FG001|Overall Study|Withdrew|5
7301118|NCT00606931|11522780|FG000|Overall Study|Withdrawal by Subject|3
7301119|NCT00607022|11522796|FG000|Overall Study|Withdrawal by Subject|1
7301120|NCT00607022|11522797|FG001|Overall Study|Withdrawal by Subject|0
7301121|NCT00607022|11522798|FG002|Overall Study|Withdrawal by Subject|0
7301122|NCT00607048|11522808|FG000|Overall Study|Adverse Event|0
7301123|NCT00607048|11522809|FG001|Overall Study|Adverse Event|1
7301124|NCT00607048|11522810|FG002|Overall Study|Adverse Event|0
7301125|NCT00607048|11522811|FG003|Overall Study|Adverse Event|0
7301126|NCT00607048|11522812|FG004|Overall Study|Adverse Event|4
7301127|NCT00607048|11522813|FG005|Overall Study|Adverse Event|0
7301128|NCT00607048|11522808|FG000|Overall Study|Global deterioration of health|1
7301129|NCT00607048|11522809|FG001|Overall Study|Global deterioration of health|0
7301130|NCT00607048|11522810|FG002|Overall Study|Global deterioration of health|0
7301131|NCT00607048|11522811|FG003|Overall Study|Global deterioration of health|0
7301132|NCT00607048|11522812|FG004|Overall Study|Global deterioration of health|0
7301133|NCT00607048|11522813|FG005|Overall Study|Global deterioration of health|0
7301134|NCT00607048|11522808|FG000|Overall Study|Objective disease progression - relapse|1
7301135|NCT00607048|11522809|FG001|Overall Study|Objective disease progression - relapse|2
7301136|NCT00607048|11522810|FG002|Overall Study|Objective disease progression - relapse|4
7301137|NCT00607048|11522811|FG003|Overall Study|Objective disease progression - relapse|2
7301138|NCT00607048|11522812|FG004|Overall Study|Objective disease progression - relapse|2
7301139|NCT00607048|11522813|FG005|Overall Study|Objective disease progression - relapse|2
7301140|NCT00607048|11522808|FG000|Overall Study|Withdrawal by Subject|0
7301141|NCT00607048|11522809|FG001|Overall Study|Withdrawal by Subject|0
7301142|NCT00607048|11522810|FG002|Overall Study|Withdrawal by Subject|0
7301143|NCT00607048|11522811|FG003|Overall Study|Withdrawal by Subject|1
7301144|NCT00607048|11522812|FG004|Overall Study|Withdrawal by Subject|0
7301145|NCT00607048|11522813|FG005|Overall Study|Withdrawal by Subject|2
7301146|NCT00607048|11522808|FG000|Overall Study|Other|1
7301147|NCT00607048|11522809|FG001|Overall Study|Other|1
7301148|NCT00607048|11522810|FG002|Overall Study|Other|0
7301149|NCT00607048|11522811|FG003|Overall Study|Other|0
7301150|NCT00607048|11522812|FG004|Overall Study|Other|0
7301151|NCT00607048|11522813|FG005|Overall Study|Other|1
7301152|NCT00607087|11522832|FG000|Overall Study|Withdrawal by Subject|9
7301153|NCT00607087|11522833|FG001|Overall Study|Withdrawal by Subject|4
7301154|NCT00607087|11522834|FG002|Overall Study|Withdrawal by Subject|4
7301155|NCT00607087|11522832|FG000|Overall Study|Adverse Event|3
7301156|NCT00607087|11522833|FG001|Overall Study|Adverse Event|2
7301157|NCT00607087|11522834|FG002|Overall Study|Adverse Event|3
7301158|NCT00607087|11522832|FG000|Overall Study|Other reason|1
7301159|NCT00607087|11522833|FG001|Overall Study|Other reason|5
7301160|NCT00607087|11522834|FG002|Overall Study|Other reason|2
7301161|NCT00607087|11522832|FG000|Overall Study|Poor compliance to protocol|1
7301162|NCT00607087|11522833|FG001|Overall Study|Poor compliance to protocol|0
7301163|NCT00607087|11522834|FG002|Overall Study|Poor compliance to protocol|1
7301164|NCT00607087|11522832|FG000|Overall Study|Lost to Follow-up|1
7301165|NCT00607087|11522833|FG001|Overall Study|Lost to Follow-up|0
7301166|NCT00607087|11522834|FG002|Overall Study|Lost to Follow-up|0
7301167|NCT00607087|11522832|FG000|Period 1|Withdrawal by Subject|7
7301168|NCT00607087|11522833|FG001|Period 1|Withdrawal by Subject|2
7301169|NCT00607087|11522834|FG002|Period 1|Withdrawal by Subject|3
7301170|NCT00607087|11522832|FG000|Period 1|Adverse Event|3
7301171|NCT00607087|11522833|FG001|Period 1|Adverse Event|0
7301172|NCT00607087|11522834|FG002|Period 1|Adverse Event|0
7301173|NCT00607087|11522832|FG000|Period 1|Poor compliance to protocol|1
7301174|NCT00607087|11522833|FG001|Period 1|Poor compliance to protocol|0
7301175|NCT00607087|11522834|FG002|Period 1|Poor compliance to protocol|0
7301176|NCT00607087|11522832|FG000|Period 1|Lost to Follow-up|1
7301177|NCT00607087|11522833|FG001|Period 1|Lost to Follow-up|0
7301178|NCT00607087|11522834|FG002|Period 1|Lost to Follow-up|0
7301179|NCT00607087|11522832|FG000|Period 1|Other reason|0
7301180|NCT00607087|11522833|FG001|Period 1|Other reason|4
7301181|NCT00607087|11522834|FG002|Period 1|Other reason|2
7301182|NCT00607087|11522832|FG000|Period 2|Withdrawal by Subject|0
7301183|NCT00607087|11522833|FG001|Period 2|Withdrawal by Subject|1
7301184|NCT00607087|11522834|FG002|Period 2|Withdrawal by Subject|1
7301185|NCT00607087|11522832|FG000|Period 2|Other reason|1
7301186|NCT00607087|11522833|FG001|Period 2|Other reason|1
7301187|NCT00607087|11522834|FG002|Period 2|Other reason|0
7301188|NCT00607087|11522832|FG000|Period 2|Adverse Event|0
7301189|NCT00607087|11522833|FG001|Period 2|Adverse Event|1
7301190|NCT00607087|11522834|FG002|Period 2|Adverse Event|3
7301191|NCT00607087|11522832|FG000|Period 2|Poor compliance to protocol|0
7301192|NCT00607087|11522833|FG001|Period 2|Poor compliance to protocol|0
7301193|NCT00607087|11522834|FG002|Period 2|Poor compliance to protocol|1
7301194|NCT00607087|11522832|FG000|Period 3|Withdrawal by Subject|2
7301195|NCT00607087|11522833|FG001|Period 3|Withdrawal by Subject|1
7301196|NCT00607087|11522834|FG002|Period 3|Withdrawal by Subject|0
7301197|NCT00607087|11522832|FG000|Period 3|Adverse Event|0
7301198|NCT00607087|11522833|FG001|Period 3|Adverse Event|1
7301199|NCT00607087|11522834|FG002|Period 3|Adverse Event|0
7301200|NCT00607373|11522885|FG000|Treatment Period|Adverse Event|0
7301201|NCT00607373|11522886|FG001|Treatment Period|Adverse Event|4
7301202|NCT00607373|11522885|FG000|Treatment Period|Physician Decision|0
7301203|NCT00607373|11522886|FG001|Treatment Period|Physician Decision|1
7301204|NCT00607373|11522885|FG000|Treatment Period|Withdrawal by Subject|0
7301205|NCT00607373|11522886|FG001|Treatment Period|Withdrawal by Subject|1
7301206|NCT00607373|11522885|FG000|Follow-up Period|Other|0
7301207|NCT00607373|11522886|FG001|Follow-up Period|Other|1
7301208|NCT00607373|11522885|FG000|Follow-up Period|Protocol Violation|0
7301209|NCT00607373|11522886|FG001|Follow-up Period|Protocol Violation|1
7301210|NCT00607373|11522885|FG000|Follow-up Period|Withdrawal by Subject|1
7301211|NCT00607373|11522886|FG001|Follow-up Period|Withdrawal by Subject|3
7301212|NCT00607386|11522892|FG000|Overall Study|Physician Decision|1
7301213|NCT00607724|11522934|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
7301214|NCT00607724|11522935|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
7301215|NCT00607724|11522936|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
7301216|NCT00607724|11522937|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7301217|NCT00607724|11522938|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7301218|NCT00607724|11522939|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7301219|NCT00607724|11522940|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
7301220|NCT00607724|11522934|FG000|Stage 2: Expanded Cohort|Adverse Event|0
7301221|NCT00607724|11522935|FG001|Stage 2: Expanded Cohort|Adverse Event|0
7301222|NCT00607724|11522936|FG002|Stage 2: Expanded Cohort|Adverse Event|0
7301223|NCT00607724|11522937|FG003|Stage 2: Expanded Cohort|Adverse Event|0
7301224|NCT00607724|11522938|FG004|Stage 2: Expanded Cohort|Adverse Event|0
7301225|NCT00607724|11522939|FG005|Stage 2: Expanded Cohort|Adverse Event|0
7301226|NCT00607724|11522940|FG006|Stage 2: Expanded Cohort|Adverse Event|1
7301227|NCT00607724|11522934|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7301228|NCT00607724|11522935|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7301229|NCT00607724|11522936|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
7301230|NCT00607724|11522937|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
7301231|NCT00607724|11522938|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
7301232|NCT00607724|11522939|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
7301233|NCT00607724|11522940|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
7301234|NCT00607724|11522934|FG000|Stage 2: Expanded Cohort|Physician Decision|0
7301235|NCT00607724|11522935|FG001|Stage 2: Expanded Cohort|Physician Decision|0
7301236|NCT00607724|11522936|FG002|Stage 2: Expanded Cohort|Physician Decision|0
7301237|NCT00607724|11522937|FG003|Stage 2: Expanded Cohort|Physician Decision|0
7301238|NCT00607724|11522938|FG004|Stage 2: Expanded Cohort|Physician Decision|1
7301239|NCT00607724|11522939|FG005|Stage 2: Expanded Cohort|Physician Decision|1
7301240|NCT00607724|11522940|FG006|Stage 2: Expanded Cohort|Physician Decision|0
7301241|NCT00607724|11522934|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7301242|NCT00607724|11522935|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7222749|NCT00026494|11431905|FG001|Overall Study|Patient not treated|0
7222750|NCT00026494|11431906|FG002|Overall Study|Patient not treated|2
7222751|NCT00026494|11431907|FG003|Overall Study|Patient not treated|0
7222752|NCT00026494|11431904|FG000|Overall Study|Clinical progression|0
7222753|NCT00026494|11431905|FG001|Overall Study|Clinical progression|0
7222754|NCT00026494|11431906|FG002|Overall Study|Clinical progression|3
7222755|NCT00026494|11431907|FG003|Overall Study|Clinical progression|0
7222756|NCT00026793|11431917|FG000|Overall Study|Death on study due to underlying disease|4
7222757|NCT00026793|11431917|FG000|Overall Study|Physician Decision|2
7222758|NCT00026793|11431917|FG000|Overall Study|Off study|2
7222759|NCT00027027|11431926|FG000|Overall Study|Adverse Event|0
7222760|NCT00027027|11431927|FG001|Overall Study|Adverse Event|0
7222761|NCT00027027|11431928|FG002|Overall Study|Adverse Event|1
7222762|NCT00027027|11431929|FG003|Overall Study|Adverse Event|0
7222763|NCT00027027|11431930|FG004|Overall Study|Adverse Event|1
7222764|NCT00027027|11431926|FG000|Overall Study|Admitted for Signs of PD|0
7222765|NCT00027027|11431927|FG001|Overall Study|Admitted for Signs of PD|0
7222766|NCT00027027|11431928|FG002|Overall Study|Admitted for Signs of PD|0
7222767|NCT00027027|11431929|FG003|Overall Study|Admitted for Signs of PD|0
7222768|NCT00027027|11431930|FG004|Overall Study|Admitted for Signs of PD|1
7222769|NCT00027027|11431926|FG000|Overall Study|Clinical Symptoms Progression not PD|1
7222770|NCT00027027|11431927|FG001|Overall Study|Clinical Symptoms Progression not PD|0
7222771|NCT00027027|11431928|FG002|Overall Study|Clinical Symptoms Progression not PD|0
7222772|NCT00027027|11431929|FG003|Overall Study|Clinical Symptoms Progression not PD|0
7222773|NCT00027027|11431930|FG004|Overall Study|Clinical Symptoms Progression not PD|0
7222774|NCT00027027|11431926|FG000|Overall Study|PD Requiring Surgery|0
7222775|NCT00027027|11431927|FG001|Overall Study|PD Requiring Surgery|0
7222776|NCT00027027|11431928|FG002|Overall Study|PD Requiring Surgery|1
7222777|NCT00027027|11431929|FG003|Overall Study|PD Requiring Surgery|0
7222778|NCT00027027|11431930|FG004|Overall Study|PD Requiring Surgery|0
7222779|NCT00027027|11431926|FG000|Overall Study|Physician Decision Due To PD|2
7222780|NCT00027027|11431927|FG001|Overall Study|Physician Decision Due To PD|3
7222781|NCT00027027|11431928|FG002|Overall Study|Physician Decision Due To PD|2
7222782|NCT00027027|11431929|FG003|Overall Study|Physician Decision Due To PD|3
7222783|NCT00027027|11431930|FG004|Overall Study|Physician Decision Due To PD|5
7222784|NCT00027027|11431926|FG000|Overall Study|Withdrawal by Subject|0
7222785|NCT00027027|11431927|FG001|Overall Study|Withdrawal by Subject|0
7222786|NCT00027027|11431928|FG002|Overall Study|Withdrawal by Subject|0
7222787|NCT00027027|11431929|FG003|Overall Study|Withdrawal by Subject|0
7222788|NCT00027027|11431930|FG004|Overall Study|Withdrawal by Subject|1
7222789|NCT00027378|11431948|FG000|Overall Study|Physician Decision|0
7222790|NCT00027378|11431949|FG001|Overall Study|Physician Decision|3
7222791|NCT00027560|11431955|FG000|Overall Study|Withdrawal by Subject|1
7222792|NCT00027846|11431964|FG000|Overall Study|Lost to Follow-up|0
7222793|NCT00027846|11431965|FG001|Overall Study|Lost to Follow-up|41
7222794|NCT00027846|11431966|FG002|Overall Study|Lost to Follow-up|9
7222795|NCT00027846|11431964|FG000|Overall Study|Withdrawal by Subject|0
7222796|NCT00027846|11431965|FG001|Overall Study|Withdrawal by Subject|14
7222797|NCT00027846|11431966|FG002|Overall Study|Withdrawal by Subject|7
7222798|NCT00027846|11431964|FG000|Overall Study|Ineligible for study|2
7222799|NCT00027846|11431965|FG001|Overall Study|Ineligible for study|6
7222800|NCT00027846|11431966|FG002|Overall Study|Ineligible for study|14
7222801|NCT00027846|11431964|FG000|Overall Study|Entry into another COG therapeutic study|0
7301243|NCT00607724|11522936|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7301244|NCT00607724|11522937|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
7301245|NCT00607724|11522938|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7301246|NCT00607724|11522939|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7301247|NCT00607724|11522940|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
7301248|NCT00607789|11522966|FG000|Overall Study|Adverse Event|3
7301249|NCT00607789|11522967|FG001|Overall Study|Adverse Event|0
7301250|NCT00607789|11522966|FG000|Overall Study|Lack of Efficacy|0
7301251|NCT00607789|11522967|FG001|Overall Study|Lack of Efficacy|1
7301252|NCT00607789|11522966|FG000|Overall Study|Inadequate adherence|3
7301253|NCT00607789|11522967|FG001|Overall Study|Inadequate adherence|0
7301254|NCT00607789|11522966|FG000|Overall Study|Lost to Follow-up|0
7301255|NCT00607789|11522967|FG001|Overall Study|Lost to Follow-up|5
7301256|NCT00607789|11522966|FG000|Overall Study|Withdrawal by Subject|1
7301257|NCT00607789|11522967|FG001|Overall Study|Withdrawal by Subject|0
7301258|NCT00607880|11522995|FG000|Overall Study|Unable to place port due to occlusion|1
7301259|NCT00607880|11522996|FG001|Overall Study|Unable to place port due to occlusion|0
7301260|NCT00607893|11523004|FG000|Overall Study|Lost to Follow-up|4
7301261|NCT00607893|11523005|FG001|Overall Study|Lost to Follow-up|0
7301262|NCT00607893|11523004|FG000|Overall Study|withdrew due to loss of interest|0
7301263|NCT00607893|11523005|FG001|Overall Study|withdrew due to loss of interest|1
7301264|NCT00607893|11523004|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
7301265|NCT00607893|11523005|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
7301266|NCT00607893|11523004|FG000|Overall Study|withdrew could not tolerate CPAP|0
7301267|NCT00607893|11523005|FG001|Overall Study|withdrew could not tolerate CPAP|1
7301268|NCT00607893|11523004|FG000|Overall Study|Declined to be treated|1
7301269|NCT00607893|11523005|FG001|Overall Study|Declined to be treated|0
7301270|NCT00607893|11523004|FG000|Overall Study|Withdrew due to hypertensive urgency|1
7301271|NCT00607893|11523005|FG001|Overall Study|Withdrew due to hypertensive urgency|1
7301272|NCT00607919|11523015|FG000|Acute Phase|Adverse Event|9
7301273|NCT00607919|11523016|FG001|Acute Phase|Adverse Event|2
7301274|NCT00607919|11523015|FG000|Acute Phase|Entry Criteria Not Met|1
7301275|NCT00607919|11523016|FG001|Acute Phase|Entry Criteria Not Met|1
7301276|NCT00607919|11523015|FG000|Acute Phase|Lack of Efficacy|1
7301277|NCT00607919|11523016|FG001|Acute Phase|Lack of Efficacy|2
7301278|NCT00607919|11523015|FG000|Acute Phase|Lost to Follow-up|9
7301279|NCT00607919|11523016|FG001|Acute Phase|Lost to Follow-up|3
7301280|NCT00607919|11523015|FG000|Acute Phase|Parent/Caregiver Decision|6
7301281|NCT00607919|11523016|FG001|Acute Phase|Parent/Caregiver Decision|4
7301282|NCT00607919|11523015|FG000|Acute Phase|Protocol Violation|5
7301283|NCT00607919|11523016|FG001|Acute Phase|Protocol Violation|1
7301284|NCT00607919|11523015|FG000|Acute Phase|Withdrawal by Subject|3
7301285|NCT00607919|11523016|FG001|Acute Phase|Withdrawal by Subject|3
7301286|NCT00607919|11523015|FG000|Open-Label Phase|Adverse Event|1
7301287|NCT00607919|11523016|FG001|Open-Label Phase|Adverse Event|5
7301288|NCT00607919|11523015|FG000|Open-Label Phase|Lost to Follow-up|4
7301289|NCT00607919|11523016|FG001|Open-Label Phase|Lost to Follow-up|1
7301290|NCT00607919|11523015|FG000|Open-Label Phase|Protocol Violation|2
7301291|NCT00607919|11523016|FG001|Open-Label Phase|Protocol Violation|2
7301292|NCT00607919|11523015|FG000|Open-Label Phase|Withdrawal by Subject|2
7301293|NCT00607919|11523016|FG001|Open-Label Phase|Withdrawal by Subject|2
7301294|NCT00607919|11523015|FG000|Open-Label Phase|Parent/Caregiver Decision|1
7301295|NCT00607919|11523016|FG001|Open-Label Phase|Parent/Caregiver Decision|2
7301296|NCT00607997|11523028|FG000|Overall Study|Lack of Efficacy|6
7301297|NCT00607997|11523029|FG001|Overall Study|Lack of Efficacy|20
7301298|NCT00607997|11523030|FG002|Overall Study|Lack of Efficacy|14
7301299|NCT00607997|11523031|FG003|Overall Study|Lack of Efficacy|10
7301300|NCT00607997|11523028|FG000|Overall Study|Death|8
7301301|NCT00607997|11523029|FG001|Overall Study|Death|5
7301302|NCT00607997|11523030|FG002|Overall Study|Death|2
7301303|NCT00607997|11523031|FG003|Overall Study|Death|5
7301304|NCT00607997|11523028|FG000|Overall Study|Adverse Event|3
7301305|NCT00607997|11523029|FG001|Overall Study|Adverse Event|1
7301306|NCT00607997|11523030|FG002|Overall Study|Adverse Event|2
7301307|NCT00607997|11523031|FG003|Overall Study|Adverse Event|0
7301308|NCT00607997|11523028|FG000|Overall Study|Physician Decision|4
7301309|NCT00607997|11523029|FG001|Overall Study|Physician Decision|1
7301310|NCT00607997|11523030|FG002|Overall Study|Physician Decision|0
7301311|NCT00607997|11523031|FG003|Overall Study|Physician Decision|0
7301312|NCT00607997|11523028|FG000|Overall Study|Relapse, recurrent illness|4
7301313|NCT00607997|11523029|FG001|Overall Study|Relapse, recurrent illness|0
7301314|NCT00607997|11523030|FG002|Overall Study|Relapse, recurrent illness|2
7301315|NCT00607997|11523031|FG003|Overall Study|Relapse, recurrent illness|0
7301316|NCT00607997|11523028|FG000|Overall Study|Other without explanation|2
7301317|NCT00607997|11523029|FG001|Overall Study|Other without explanation|0
7301318|NCT00607997|11523030|FG002|Overall Study|Other without explanation|4
7301319|NCT00607997|11523031|FG003|Overall Study|Other without explanation|1
7301320|NCT00608205|11523093|FG000|Overall Study|Adverse Event|3
7301321|NCT00608205|11523094|FG001|Overall Study|Adverse Event|2
7301322|NCT00608205|11523093|FG000|Overall Study|Patient non-compliant|0
7301323|NCT00608205|11523094|FG001|Overall Study|Patient non-compliant|1
7301324|NCT00608244|11523102|FG000|Overall Study|Adverse Event|1
7301325|NCT00608244|11523102|FG000|Overall Study|Low trough levels|1
7301326|NCT00608322|11523110|FG000|Overall Study|Death|2
7301327|NCT00608322|11523111|FG001|Overall Study|Death|1
7301328|NCT00608426|11523119|FG000|Overall Study|Death|32
7301329|NCT00608426|11523120|FG001|Overall Study|Death|36
7301330|NCT00608426|11523119|FG000|Overall Study|Lost to Follow-up|485
7301331|NCT00608426|11523120|FG001|Overall Study|Lost to Follow-up|521
7301332|NCT00608426|11523119|FG000|Overall Study|refused, health issues, wrong address|319
7301333|NCT00608426|11523120|FG001|Overall Study|refused, health issues, wrong address|348
7301334|NCT00608517|11523138|FG000|Overall Study|Death|1
7301335|NCT00608517|11523139|FG001|Overall Study|Death|0
7301336|NCT00608517|11523140|FG002|Overall Study|Death|0
7301337|NCT00608530|11523153|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
7301338|NCT00608530|11523154|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
7301339|NCT00608530|11523155|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7301340|NCT00608530|11523156|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
7301341|NCT00608530|11523153|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7301342|NCT00608530|11523154|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
7301343|NCT00608530|11523155|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7301426|NCT00608985|11523288|FG003|Overall Study|Adverse Event|6
7301344|NCT00608530|11523156|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
7301345|NCT00608530|11523153|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7301346|NCT00608530|11523154|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
7301347|NCT00608530|11523155|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
7301348|NCT00608530|11523156|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
7301349|NCT00608530|11523153|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7301350|NCT00608530|11523154|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7301351|NCT00608530|11523155|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
7301352|NCT00608530|11523156|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
7301353|NCT00608530|11523153|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
7301354|NCT00608530|11523154|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
7301355|NCT00608530|11523155|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
7301356|NCT00608530|11523156|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
7301357|NCT00608530|11523153|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7301358|NCT00608530|11523154|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7301359|NCT00608530|11523155|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
7301360|NCT00608530|11523156|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
7301361|NCT00608543|11523171|FG000|Overall Study|Adverse Event|4
7301362|NCT00608569|11523178|FG000|Overall Study|Death|4
7301363|NCT00608569|11523179|FG001|Overall Study|Death|3
7301364|NCT00608569|11523178|FG000|Overall Study|Lost to Follow-up|4
7301365|NCT00608569|11523179|FG001|Overall Study|Lost to Follow-up|5
7301366|NCT00608569|11523178|FG000|Overall Study|Withdrawal by Subject|1
7301367|NCT00608569|11523179|FG001|Overall Study|Withdrawal by Subject|0
7301368|NCT00608569|11523178|FG000|Overall Study|Adverse Event|1
7301369|NCT00608569|11523179|FG001|Overall Study|Adverse Event|0
7301370|NCT00608569|11523178|FG000|Overall Study|Unable to adhere with study requirements|0
7301371|NCT00608569|11523179|FG001|Overall Study|Unable to adhere with study requirements|1
7301372|NCT00608582|11523187|FG000|Overall Study|Lost to Follow-up|2
7301373|NCT00608582|11523188|FG001|Overall Study|Lost to Follow-up|0
7301374|NCT00608582|11523187|FG000|Overall Study|No Best Response in Phase 1 located|1
7301375|NCT00608582|11523188|FG001|Overall Study|No Best Response in Phase 1 located|1
7301376|NCT00608582|11523187|FG000|Overall Study|Illicit Drug Use|1
7301377|NCT00608582|11523188|FG001|Overall Study|Illicit Drug Use|0
7301378|NCT00608582|11523187|FG000|Overall Study|Early stage Design Change|0
7301379|NCT00608582|11523188|FG001|Overall Study|Early stage Design Change|3
7301380|NCT00608829|11523211|FG000|Overall Study|Death|6
7301381|NCT00608829|11523211|FG000|Overall Study|Withdrawal by Subject|4
7301382|NCT00608829|11523211|FG000|Overall Study|Subject refuses to follow up or return.|5
7301383|NCT00608842|11523219|FG000|Overall Study|Participant's Request|0
7301384|NCT00608842|11523220|FG001|Overall Study|Participant's Request|1
7301385|NCT00608842|11523221|FG002|Overall Study|Participant's Request|2
7301386|NCT00608842|11523222|FG003|Overall Study|Participant's Request|1
7301387|NCT00608842|11523219|FG000|Overall Study|Lost to Follow-up|1
7301388|NCT00608842|11523220|FG001|Overall Study|Lost to Follow-up|0
7301389|NCT00608842|11523221|FG002|Overall Study|Lost to Follow-up|0
7301390|NCT00608842|11523222|FG003|Overall Study|Lost to Follow-up|0
7301391|NCT00608868|11523232|FG000|Overall Study|Withdrawal by Subject|7
7301392|NCT00608868|11523232|FG000|Overall Study|Protocol Violation|3
7301393|NCT00608868|11523232|FG000|Overall Study|Lost to Follow-up|2
7301394|NCT00608868|11523232|FG000|Overall Study|Adverse Event|1
7301395|NCT00608868|11523232|FG000|Overall Study|Physician Decision|2
7301396|NCT00608881|11523238|FG000|Overall Study|Death|22
7301397|NCT00608881|11523239|FG001|Overall Study|Death|13
7301398|NCT00608881|11523238|FG000|Overall Study|Adverse Event|5
7301399|NCT00608881|11523239|FG001|Overall Study|Adverse Event|3
7301400|NCT00608881|11523238|FG000|Overall Study|Lost to Follow-up|28
7301401|NCT00608881|11523239|FG001|Overall Study|Lost to Follow-up|14
7301402|NCT00608881|11523238|FG000|Overall Study|Withdrawal by Subject|18
7301403|NCT00608881|11523239|FG001|Overall Study|Withdrawal by Subject|29
7301404|NCT00608881|11523238|FG000|Overall Study|Physician Decision|5
7301405|NCT00608881|11523239|FG001|Overall Study|Physician Decision|5
7301406|NCT00608881|11523238|FG000|Overall Study|Institutionalized|1
7301407|NCT00608881|11523239|FG001|Overall Study|Institutionalized|2
7301408|NCT00608894|11523247|FG000|Overall Study|Withdrawal by Subject|0
7301409|NCT00608894|11523248|FG001|Overall Study|Withdrawal by Subject|2
7301410|NCT00608907|11523259|FG000|Overall Study|Adverse Event|6
7301411|NCT00608907|11523260|FG001|Overall Study|Adverse Event|0
7301412|NCT00608907|11523261|FG002|Overall Study|Adverse Event|1
7301413|NCT00608907|11523259|FG000|Overall Study|Death|1
7301414|NCT00608907|11523260|FG001|Overall Study|Death|0
7301415|NCT00608907|11523261|FG002|Overall Study|Death|0
7301416|NCT00608907|11523259|FG000|Overall Study|Withdrawal by Subject|4
7301417|NCT00608907|11523260|FG001|Overall Study|Withdrawal by Subject|0
7301418|NCT00608907|11523261|FG002|Overall Study|Withdrawal by Subject|0
7301419|NCT00608907|11523259|FG000|Overall Study|Progressive Disease|1
7301420|NCT00608907|11523260|FG001|Overall Study|Progressive Disease|0
7301421|NCT00608907|11523261|FG002|Overall Study|Progressive Disease|0
7301422|NCT00608959|11523271|FG000|Part 1|Did not meet eligibility criteria|1
7301423|NCT00608985|11523285|FG000|Overall Study|Adverse Event|2
7301424|NCT00608985|11523286|FG001|Overall Study|Adverse Event|7
7301425|NCT00608985|11523287|FG002|Overall Study|Adverse Event|4
7301427|NCT00608985|11523285|FG000|Overall Study|Administrative/Other|7
7301428|NCT00608985|11523286|FG001|Overall Study|Administrative/Other|4
7301429|NCT00608985|11523287|FG002|Overall Study|Administrative/Other|1
7301430|NCT00608985|11523288|FG003|Overall Study|Administrative/Other|2
7301431|NCT00608985|11523285|FG000|Overall Study|Withdrawal of Consent|5
7301432|NCT00608985|11523286|FG001|Overall Study|Withdrawal of Consent|1
7301433|NCT00608985|11523287|FG002|Overall Study|Withdrawal of Consent|1
7301434|NCT00608985|11523288|FG003|Overall Study|Withdrawal of Consent|1
7301435|NCT00608985|11523285|FG000|Overall Study|Lost to Follow-up|2
7301436|NCT00608985|11523286|FG001|Overall Study|Lost to Follow-up|1
7301437|NCT00608985|11523287|FG002|Overall Study|Lost to Follow-up|0
7301438|NCT00608985|11523288|FG003|Overall Study|Lost to Follow-up|0
7301439|NCT00609167|11523305|FG000|Overall Study|Withdrawal by Subject|1
7301440|NCT00609167|11523306|FG001|Overall Study|Withdrawal by Subject|0
7301441|NCT00609167|11523305|FG000|Overall Study|Lack of Efficacy|1
7301442|NCT00609167|11523306|FG001|Overall Study|Lack of Efficacy|0
7301443|NCT00609167|11523305|FG000|Overall Study|Adverse Event|5
7301444|NCT00609167|11523306|FG001|Overall Study|Adverse Event|1
7301445|NCT00609167|11523305|FG000|Overall Study|Disease Progression|1
7301446|NCT00609167|11523306|FG001|Overall Study|Disease Progression|0
7301447|NCT00609167|11523305|FG000|Overall Study|Stem Cell Transplant|0
7301448|NCT00609167|11523306|FG001|Overall Study|Stem Cell Transplant|6
7301449|NCT00609245|11523312|FG000|Overall Study|Adverse Event|1
7301450|NCT00609336|11523327|FG000|Overall Study|Protocol Violation|3
7301451|NCT00609336|11523327|FG000|Overall Study|Death|1
7301452|NCT00609336|11523327|FG000|Overall Study|LA or Met at Surgery|9
7301453|NCT00609362|11523334|FG000|Overall Study|Withdrawal by Subject|2
7301454|NCT00609362|11523335|FG001|Overall Study|Withdrawal by Subject|1
7301455|NCT00609362|11523334|FG000|Overall Study|Adverse Event|1
7301456|NCT00609362|11523335|FG001|Overall Study|Adverse Event|0
7301457|NCT00609466|11523344|FG000|Overall Study|Withdrawal by Subject|0
7301458|NCT00609466|11523345|FG001|Overall Study|Withdrawal by Subject|1
7301459|NCT00609466|11523346|FG002|Overall Study|Withdrawal by Subject|1
7301460|NCT00609466|11523344|FG000|Overall Study|Adverse Event|2
7301461|NCT00609466|11523345|FG001|Overall Study|Adverse Event|3
7301462|NCT00609466|11523346|FG002|Overall Study|Adverse Event|1
7301463|NCT00609466|11523344|FG000|Overall Study|Lack of Efficacy|0
7301464|NCT00609466|11523345|FG001|Overall Study|Lack of Efficacy|2
7301465|NCT00609466|11523346|FG002|Overall Study|Lack of Efficacy|2
7301466|NCT00609492|11523357|FG000|Overall Study|Withdrawal by Subject|0
7301467|NCT00609492|11523358|FG001|Overall Study|Withdrawal by Subject|2
7301468|NCT00609492|11523359|FG002|Overall Study|Withdrawal by Subject|3
7301469|NCT00609492|11523357|FG000|Overall Study|Lost to Follow-up|1
7301470|NCT00609492|11523358|FG001|Overall Study|Lost to Follow-up|1
7301471|NCT00609492|11523359|FG002|Overall Study|Lost to Follow-up|4
7301472|NCT00609518|11523371|FG000|Overall Study|Death from Study Disease|32
7301473|NCT00609518|11523372|FG001|Overall Study|Death from Study Disease|32
7301474|NCT00609518|11523371|FG000|Overall Study|Withdrawal by Subject|5
7301475|NCT00609518|11523372|FG001|Overall Study|Withdrawal by Subject|3
7301476|NCT00609518|11523371|FG000|Overall Study|Lost to Follow-up|3
7301477|NCT00609518|11523372|FG001|Overall Study|Lost to Follow-up|0
7301478|NCT00609518|11523371|FG000|Overall Study|Physician Decision|1
7301479|NCT00609518|11523372|FG001|Overall Study|Physician Decision|3
7301480|NCT00609518|11523371|FG000|Overall Study|Death from Adverse Event|2
7301481|NCT00609518|11523372|FG001|Overall Study|Death from Adverse Event|2
7301482|NCT00609609|11523380|FG000|Overall Study|Withdrawal by Subject|2
7301483|NCT00609609|11523381|FG001|Overall Study|Withdrawal by Subject|0
7301484|NCT00609609|11523380|FG000|Overall Study|Progression|4
7301485|NCT00609609|11523381|FG001|Overall Study|Progression|2
7301486|NCT00609622|11523389|FG000|Overall Study|Adverse Event|14
7301487|NCT00609622|11523390|FG001|Overall Study|Adverse Event|10
7301488|NCT00609622|11523389|FG000|Overall Study|Withdrawal by Subject|4
7301489|NCT00609622|11523390|FG001|Overall Study|Withdrawal by Subject|20
7301490|NCT00609622|11523389|FG000|Overall Study|Death|1
7301491|NCT00609622|11523390|FG001|Overall Study|Death|4
7301492|NCT00609622|11523389|FG000|Overall Study|Protocol Violation|1
7301493|NCT00609622|11523390|FG001|Overall Study|Protocol Violation|1
7301494|NCT00609622|11523389|FG000|Overall Study|Objective progression or relapse|47
7301495|NCT00609622|11523390|FG001|Overall Study|Objective progression or relapse|41
7301496|NCT00609622|11523389|FG000|Overall Study|Study terminated by sponsor|16
7301497|NCT00609622|11523390|FG001|Overall Study|Study terminated by sponsor|3
7301498|NCT00609622|11523389|FG000|Overall Study|Other|7
7301499|NCT00609622|11523390|FG001|Overall Study|Other|14
7301500|NCT00609622|11523389|FG000|Overall Study|Global deterioration of health status|6
7301501|NCT00609622|11523390|FG001|Overall Study|Global deterioration of health status|2
7301502|NCT00609674|11523398|FG000|Overall Study|Adverse Event|1
7301503|NCT00609674|11523399|FG001|Overall Study|Adverse Event|1
7301504|NCT00609674|11523398|FG000|Overall Study|Protocol Violation|3
7301505|NCT00609674|11523399|FG001|Overall Study|Protocol Violation|5
7301506|NCT00609674|11523398|FG000|Overall Study|Lost to Follow-up|1
7301507|NCT00609674|11523399|FG001|Overall Study|Lost to Follow-up|0
7301508|NCT00609674|11523398|FG000|Overall Study|Withdrew consent|2
7301509|NCT00609674|11523399|FG001|Overall Study|Withdrew consent|1
7301510|NCT00609869|11523421|FG000|Overall Study|Withdrawn, ischemic stroke|1
7301511|NCT00609869|11523421|FG000|Overall Study|Severe hematologic toxicity|1
7301512|NCT00609869|11523421|FG000|Overall Study|Withdrawal by Subject|1
7301513|NCT00609869|11523421|FG000|Overall Study|Seizures|1
7301514|NCT00609869|11523421|FG000|Overall Study|Severe tumor flare reaction|1
7301515|NCT00609869|11523421|FG000|Overall Study|Hepatitis B infection|1
7301516|NCT00609869|11523421|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
7301517|NCT00609869|11523421|FG000|Overall Study|Mantle cell: not evaluable|4
7301518|NCT00609947|11523425|FG000|Overall Study|Death|1
7301519|NCT00609973|11523432|FG000|Overall Study|Adverse Event|2
7301520|NCT00609973|11523433|FG001|Overall Study|Adverse Event|1
7301521|NCT00609973|11523432|FG000|Overall Study|Protocol Violation|4
7301522|NCT00609973|11523433|FG001|Overall Study|Protocol Violation|3
7301523|NCT00609973|11523432|FG000|Overall Study|Lost to Follow-up|2
7301524|NCT00609973|11523433|FG001|Overall Study|Lost to Follow-up|1
7301525|NCT00609973|11523432|FG000|Overall Study|Withdrawal by Subject|0
7301526|NCT00609973|11523433|FG001|Overall Study|Withdrawal by Subject|1
7301527|NCT00609986|11523441|FG000|Overall Study|Did not receive transplant or treatment|8
7301528|NCT00609986|11523442|FG001|Overall Study|Did not receive transplant or treatment|3
7301529|NCT00610129|11523452|FG000|Overall Study|Not treated since patients ineligible|3
7301530|NCT00610155|11523456|FG000|Period 1|Withdrawal by Subject|0
7301531|NCT00610155|11523457|FG001|Period 1|Withdrawal by Subject|0
7301532|NCT00610155|11523458|FG002|Period 1|Withdrawal by Subject|1
7301533|NCT00610155|11523459|FG003|Period 1|Withdrawal by Subject|0
7301534|NCT00610155|11523460|FG004|Period 1|Withdrawal by Subject|0
7301535|NCT00610155|11523461|FG005|Period 1|Withdrawal by Subject|0
7301536|NCT00610155|11523456|FG000|Period 3|Adverse Event|1
7301537|NCT00610155|11523457|FG001|Period 3|Adverse Event|0
7301538|NCT00610155|11523458|FG002|Period 3|Adverse Event|0
7301539|NCT00610155|11523459|FG003|Period 3|Adverse Event|0
7301540|NCT00610155|11523460|FG004|Period 3|Adverse Event|0
7301541|NCT00610155|11523461|FG005|Period 3|Adverse Event|0
7301542|NCT00610168|11523471|FG000|Overall Study|Withdrawal by Subject|2
7301543|NCT00610168|11523472|FG001|Overall Study|Withdrawal by Subject|0
7301544|NCT00610207|11523478|FG000|Overall Study|Lost to Follow-up|3
7301545|NCT00610363|11523488|FG000|Overall Study|Non-compliance with protocol|0
7301546|NCT00610363|11523489|FG001|Overall Study|Non-compliance with protocol|1
7301547|NCT00610363|11523488|FG000|Overall Study|Adverse Event|3
7301548|NCT00610363|11523489|FG001|Overall Study|Adverse Event|1
7301549|NCT00610363|11523488|FG000|Overall Study|Lack of Efficacy|2
7301550|NCT00610363|11523489|FG001|Overall Study|Lack of Efficacy|0
7301551|NCT00610363|11523488|FG000|Overall Study|Lost to Follow-up|4
7301552|NCT00610363|11523489|FG001|Overall Study|Lost to Follow-up|0
7301553|NCT00610363|11523488|FG000|Overall Study|Withdrawal by Subject|1
7301554|NCT00610363|11523489|FG001|Overall Study|Withdrawal by Subject|0
7301555|NCT00610363|11523488|FG000|Overall Study|Other than specified above|1
7301556|NCT00610363|11523489|FG001|Overall Study|Other than specified above|1
7301557|NCT00610441|11523513|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
7301558|NCT00610441|11523514|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
7301559|NCT00610441|11523515|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
7301560|NCT00610441|11523516|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
7301561|NCT00610441|11523513|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7301562|NCT00610441|11523514|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7301563|NCT00610441|11523515|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
7301564|NCT00610441|11523516|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
7301565|NCT00610441|11523513|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7301566|NCT00610441|11523514|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7301567|NCT00610441|11523515|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
7301568|NCT00610441|11523516|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
7301569|NCT00610441|11523513|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7301570|NCT00610441|11523514|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
7301571|NCT00610441|11523515|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7301572|NCT00610441|11523516|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
7301573|NCT00610441|11523513|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
7301574|NCT00610441|11523514|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
7301575|NCT00610441|11523515|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
7301576|NCT00610441|11523516|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
7301577|NCT00610441|11523513|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7301578|NCT00610441|11523514|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
7301579|NCT00610441|11523515|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7301580|NCT00610441|11523516|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
7301581|NCT00610441|11523513|FG000|Treatment Period 2 - 3 Weeks|Other|1
7301582|NCT00610441|11523514|FG001|Treatment Period 2 - 3 Weeks|Other|1
7301583|NCT00610441|11523515|FG002|Treatment Period 2 - 3 Weeks|Other|0
7301584|NCT00610441|11523516|FG003|Treatment Period 2 - 3 Weeks|Other|1
7301585|NCT00610441|11523513|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
7301586|NCT00610441|11523514|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
7301587|NCT00610441|11523515|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
7301588|NCT00610441|11523516|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
7301589|NCT00610441|11523513|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
7301590|NCT00610441|11523514|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7301591|NCT00610441|11523515|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7301592|NCT00610441|11523516|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
7301593|NCT00610649|11523548|FG000|Overall Study|Adverse Event|1
7301594|NCT00610649|11523549|FG001|Overall Study|Adverse Event|0
7301595|NCT00610649|11523550|FG002|Overall Study|Adverse Event|0
7301596|NCT00610649|11523551|FG003|Overall Study|Adverse Event|0
7301597|NCT00610649|11523552|FG004|Overall Study|Adverse Event|0
7301598|NCT00610649|11523553|FG005|Overall Study|Adverse Event|0
7301599|NCT00610649|11523554|FG006|Overall Study|Adverse Event|0
7301600|NCT00610649|11523555|FG007|Overall Study|Adverse Event|0
7301601|NCT00610649|11523556|FG008|Overall Study|Adverse Event|0
7301602|NCT00610649|11523557|FG009|Overall Study|Adverse Event|0
7301603|NCT00610649|11523558|FG010|Overall Study|Adverse Event|1
7301604|NCT00610649|11523548|FG000|Overall Study|Family Emergency|0
7301605|NCT00610649|11523549|FG001|Overall Study|Family Emergency|1
7301606|NCT00610649|11523550|FG002|Overall Study|Family Emergency|0
7301607|NCT00610649|11523551|FG003|Overall Study|Family Emergency|0
7301608|NCT00610649|11523552|FG004|Overall Study|Family Emergency|0
7301609|NCT00610649|11523553|FG005|Overall Study|Family Emergency|0
7301610|NCT00610649|11523554|FG006|Overall Study|Family Emergency|0
7301611|NCT00610649|11523555|FG007|Overall Study|Family Emergency|0
7301612|NCT00610649|11523556|FG008|Overall Study|Family Emergency|0
7301613|NCT00610649|11523557|FG009|Overall Study|Family Emergency|0
7301614|NCT00610649|11523558|FG010|Overall Study|Family Emergency|0
7301615|NCT00610649|11523548|FG000|Overall Study|Withdrawal by Subject|0
7301616|NCT00610649|11523549|FG001|Overall Study|Withdrawal by Subject|0
7301617|NCT00610649|11523550|FG002|Overall Study|Withdrawal by Subject|0
7301618|NCT00610649|11523551|FG003|Overall Study|Withdrawal by Subject|0
7301619|NCT00610649|11523552|FG004|Overall Study|Withdrawal by Subject|0
7301620|NCT00610649|11523553|FG005|Overall Study|Withdrawal by Subject|0
7301621|NCT00610649|11523554|FG006|Overall Study|Withdrawal by Subject|0
7301622|NCT00610649|11523555|FG007|Overall Study|Withdrawal by Subject|0
7301623|NCT00610649|11523556|FG008|Overall Study|Withdrawal by Subject|0
7301624|NCT00610649|11523557|FG009|Overall Study|Withdrawal by Subject|1
7301625|NCT00610649|11523558|FG010|Overall Study|Withdrawal by Subject|0
7301626|NCT00610675|11523582|FG000|Overall Study|Untreated|4
7301627|NCT00610675|11523582|FG000|Overall Study|Adverse Event|67
7301628|NCT00610675|11523582|FG000|Overall Study|Insufficient Effect|31
7301629|NCT00610675|11523582|FG000|Overall Study|Withdrawal by Subject|28
7301630|NCT00610675|11523582|FG000|Overall Study|Reasons unrelated to trial|27
7301631|NCT00610675|11523582|FG000|Overall Study|Lack of Compliance|7
7301632|NCT00610675|11523582|FG000|Overall Study|Lost to Follow-up|31
7301633|NCT00610675|11523582|FG000|Overall Study|Other reason (not specified)|25
7301634|NCT00610714|11523610|FG000|Overall Study|Adverse Event|3
7301635|NCT00610714|11523611|FG001|Overall Study|Adverse Event|1
7301636|NCT00610714|11523610|FG000|Overall Study|Death|12
7301637|NCT00610714|11523611|FG001|Overall Study|Death|18
7301638|NCT00610714|11523610|FG000|Overall Study|Withdrawal by Subject|9
7301639|NCT00610714|11523611|FG001|Overall Study|Withdrawal by Subject|3
7301640|NCT00610714|11523610|FG000|Overall Study|Study completion at 120 PFS events|2
7301641|NCT00610714|11523611|FG001|Overall Study|Study completion at 120 PFS events|2
7301642|NCT00610857|11523650|FG000|Overall Study|Not evaluable for response|2
7301643|NCT00610935|11523660|FG000|Overall Study|Lost to Follow-up|0
7301644|NCT00610935|11523661|FG001|Overall Study|Lost to Follow-up|1
7301645|NCT00610935|11523660|FG000|Overall Study|Withdrawal by Subject|0
7301646|NCT00610935|11523661|FG001|Overall Study|Withdrawal by Subject|2
7301647|NCT00610935|11523660|FG000|Overall Study|Sponsor Discontinuation|1
7301648|NCT00610935|11523661|FG001|Overall Study|Sponsor Discontinuation|0
7301649|NCT00611026|11523679|FG000|Randomized to Double-blind Treatment|Not treated|2
7301650|NCT00611026|11523680|FG001|Randomized to Double-blind Treatment|Not treated|1
7301651|NCT00611026|11523681|FG002|Randomized to Double-blind Treatment|Not treated|3
7301652|NCT00611026|11523679|FG000|Double-blind Treatment Period|Death|1
7301653|NCT00611026|11523680|FG001|Double-blind Treatment Period|Death|0
7301654|NCT00611026|11523681|FG002|Double-blind Treatment Period|Death|0
7301655|NCT00611026|11523679|FG000|Double-blind Treatment Period|Adverse Event|9
7301656|NCT00611026|11523680|FG001|Double-blind Treatment Period|Adverse Event|28
7301657|NCT00611026|11523681|FG002|Double-blind Treatment Period|Adverse Event|46
7301658|NCT00611026|11523679|FG000|Double-blind Treatment Period|Lack of Efficacy|11
7301659|NCT00611026|11523680|FG001|Double-blind Treatment Period|Lack of Efficacy|10
7301660|NCT00611026|11523681|FG002|Double-blind Treatment Period|Lack of Efficacy|4
7301661|NCT00611026|11523679|FG000|Double-blind Treatment Period|Lost to Follow-up|6
7301662|NCT00611026|11523680|FG001|Double-blind Treatment Period|Lost to Follow-up|11
7301663|NCT00611026|11523681|FG002|Double-blind Treatment Period|Lost to Follow-up|14
7301664|NCT00611026|11523679|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
7301665|NCT00611026|11523680|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
7301666|NCT00611026|11523681|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
7301667|NCT00611026|11523679|FG000|Double-blind Treatment Period|Other|13
7301668|NCT00611026|11523680|FG001|Double-blind Treatment Period|Other|20
7301669|NCT00611026|11523681|FG002|Double-blind Treatment Period|Other|18
7301670|NCT00611130|11523693|FG000|Overall Study|Lost to Follow-up|25
7301671|NCT00611130|11523694|FG001|Overall Study|Lost to Follow-up|29
7301672|NCT00611130|11523693|FG000|Overall Study|Protocol noncompliance|7
7301673|NCT00611130|11523694|FG001|Overall Study|Protocol noncompliance|6
7301674|NCT00611130|11523693|FG000|Overall Study|Withdrawal by Subject|6
7301675|NCT00611130|11523694|FG001|Overall Study|Withdrawal by Subject|5
7301676|NCT00611130|11523693|FG000|Overall Study|Other|5
7301677|NCT00611130|11523694|FG001|Overall Study|Other|4
7301678|NCT00611130|11523693|FG000|Overall Study|Incarceration|3
7301679|NCT00611130|11523694|FG001|Overall Study|Incarceration|2
7301680|NCT00611130|11523693|FG000|Overall Study|Administrative|1
7301681|NCT00611130|11523694|FG001|Overall Study|Administrative|1
7301682|NCT00611130|11523693|FG000|Overall Study|Adverse Event|1
7301683|NCT00611130|11523694|FG001|Overall Study|Adverse Event|0
7301684|NCT00611130|11523693|FG000|Overall Study|Death|1
7301685|NCT00611130|11523694|FG001|Overall Study|Death|0
7301686|NCT00611247|11523703|FG000|Overall Study|Death|1
7301687|NCT00611247|11523704|FG001|Overall Study|Death|5
7301688|NCT00611247|11523703|FG000|Overall Study|Lack of Efficacy|1
7301689|NCT00611247|11523704|FG001|Overall Study|Lack of Efficacy|16
7301690|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
7301691|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
7301692|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
7301693|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
7301694|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7301695|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
7301696|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
7301697|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
7301698|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
7301699|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
7301700|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
7301701|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
7301702|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7301703|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
7301704|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
7301705|NCT00611455|11523744|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
7301706|NCT00611455|11523745|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7301707|NCT00611455|11523746|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
7301708|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
7301709|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
7301710|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
7301711|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7301712|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
7301713|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
7301714|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
7301715|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
7301716|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
7301717|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7301718|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
7301719|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
7301720|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7301721|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
7301722|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
7301723|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7301724|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
7301725|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
7301726|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
7301727|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
7301728|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
7301729|NCT00611455|11523744|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7301730|NCT00611455|11523745|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
7301731|NCT00611455|11523746|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
7301732|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7301733|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
7301734|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
7301735|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7301736|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
7301737|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
7301738|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7301739|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
7301740|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
7301741|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7301742|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
7301743|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
7301744|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7301745|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
7301746|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
7301747|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7301748|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
7301749|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
7301750|NCT00611455|11523744|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7301751|NCT00611455|11523745|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
7301752|NCT00611455|11523746|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
7301753|NCT00611533|11523763|FG000|First Intervention (6 Weeks)|Never started study|0
7301754|NCT00611533|11523764|FG001|First Intervention (6 Weeks)|Never started study|1
7301755|NCT00611533|11523763|FG000|First Intervention (6 Weeks)|Adverse Event|0
7301756|NCT00611533|11523764|FG001|First Intervention (6 Weeks)|Adverse Event|1
7301757|NCT00611533|11523763|FG000|Second Intervention (6 Weeks)|Adverse Event|0
7301758|NCT00611533|11523764|FG001|Second Intervention (6 Weeks)|Adverse Event|2
7301759|NCT00611559|11523774|FG000|Overall Study|Lost to Follow-up|0
7301760|NCT00611559|11523775|FG001|Overall Study|Lost to Follow-up|1
7301761|NCT00611559|11523776|FG002|Overall Study|Lost to Follow-up|0
7301762|NCT00611559|11523774|FG000|Overall Study|Protocol Violation|1
7301763|NCT00611559|11523775|FG001|Overall Study|Protocol Violation|0
7301764|NCT00611559|11523776|FG002|Overall Study|Protocol Violation|1
7551883|NCT02975349|11911349|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7551884|NCT02975349|11911350|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7551885|NCT02975349|11911351|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
7551886|NCT02975349|11911346|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7551887|NCT02975349|11911347|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
7551888|NCT02975349|11911348|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7551889|NCT02975349|11911349|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7551890|NCT02975349|11911350|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7551891|NCT02975349|11911351|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
7551892|NCT02975349|11911346|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
7551893|NCT02975349|11911347|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
7551894|NCT02975349|11911348|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
7551895|NCT02975349|11911349|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
7551896|NCT02975349|11911350|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
7551897|NCT02975349|11911351|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
7551898|NCT02975973|11911396|FG000|Overall Study|Adverse Event|1
7551899|NCT02975973|11911397|FG001|Overall Study|Adverse Event|1
7551900|NCT02975973|11911398|FG002|Overall Study|Adverse Event|1
7551901|NCT02975973|11911399|FG003|Overall Study|Adverse Event|0
7551902|NCT02976103|11911411|FG000|Overall Study|Withdrawal by Subject|1
7551903|NCT02976103|11911412|FG001|Overall Study|Withdrawal by Subject|0
7551904|NCT02976103|11911411|FG000|Overall Study|Lost to Follow-up|12
7551905|NCT02976103|11911412|FG001|Overall Study|Lost to Follow-up|8
7551906|NCT02976519|11911431|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551907|NCT02976519|11911432|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
7551908|NCT02976519|11911433|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551909|NCT02976519|11911434|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551910|NCT02976519|11911435|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551911|NCT02976519|11911436|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551912|NCT02976519|11911437|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
7551913|NCT02976519|11911431|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7551914|NCT02976519|11911432|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7551915|NCT02976519|11911433|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7551916|NCT02976519|11911434|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
7551917|NCT02976519|11911435|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7551918|NCT02976519|11911436|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7551919|NCT02976519|11911437|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
7301765|NCT00611715|11523791|FG000|Overall Study|Disease Progression|24
7301766|NCT00611715|11523792|FG001|Overall Study|Disease Progression|4
7301767|NCT00611715|11523791|FG000|Overall Study|Withdrawal by Subject|5
7301768|NCT00611715|11523792|FG001|Overall Study|Withdrawal by Subject|1
7301769|NCT00611715|11523791|FG000|Overall Study|Adverse Event|9
7301770|NCT00611715|11523792|FG001|Overall Study|Adverse Event|1
7301771|NCT00611715|11523791|FG000|Overall Study|Death|1
7301772|NCT00611715|11523792|FG001|Overall Study|Death|0
7301773|NCT00611715|11523791|FG000|Overall Study|two patients are still on treatment|2
7301774|NCT00611715|11523792|FG001|Overall Study|two patients are still on treatment|0
7301775|NCT00611767|11523806|FG000|Overall Study|Withdrawal by Subject|4
7301776|NCT00611767|11523807|FG001|Overall Study|Withdrawal by Subject|1
7301777|NCT00611767|11523806|FG000|Overall Study|Thiopental not available|3
7301778|NCT00611767|11523807|FG001|Overall Study|Thiopental not available|0
7301779|NCT00611767|11523806|FG000|Overall Study|didn't like the medication|1
7301780|NCT00611767|11523807|FG001|Overall Study|didn't like the medication|1
7301781|NCT00611767|11523806|FG000|Overall Study|Physician Decision|1
7301782|NCT00611767|11523807|FG001|Overall Study|Physician Decision|0
7301783|NCT00611806|11523815|FG000|Overall Study|Withdrawal by Subject|8
7301784|NCT00611806|11523816|FG001|Overall Study|Withdrawal by Subject|2
7301785|NCT00611806|11523815|FG000|Overall Study|Adverse Event|2
7301786|NCT00611806|11523816|FG001|Overall Study|Adverse Event|1
7301787|NCT00611806|11523815|FG000|Overall Study|Lost to Follow-up|6
7301788|NCT00611806|11523816|FG001|Overall Study|Lost to Follow-up|0
7301789|NCT00611858|11523822|FG000|Overall Study|Adverse Event|2
7301790|NCT00611858|11523822|FG000|Overall Study|Withdrawal by Subject|2
7301791|NCT00611884|11523832|FG000|Overall Study|Adverse Event|1
7301792|NCT00611884|11523833|FG001|Overall Study|Adverse Event|0
7301793|NCT00611884|11523834|FG002|Overall Study|Adverse Event|0
7301794|NCT00611884|11523835|FG003|Overall Study|Adverse Event|1
7301795|NCT00611884|11523832|FG000|Overall Study|Non-Compliance|1
7301796|NCT00611884|11523833|FG001|Overall Study|Non-Compliance|4
7301797|NCT00611884|11523834|FG002|Overall Study|Non-Compliance|2
7301798|NCT00611884|11523835|FG003|Overall Study|Non-Compliance|2
7301799|NCT00611884|11523832|FG000|Overall Study|Lack of Efficacy|0
7301800|NCT00611884|11523833|FG001|Overall Study|Lack of Efficacy|1
7301801|NCT00611884|11523834|FG002|Overall Study|Lack of Efficacy|0
7301802|NCT00611884|11523835|FG003|Overall Study|Lack of Efficacy|0
7301803|NCT00611884|11523832|FG000|Overall Study|Unclassified|7
7301804|NCT00611884|11523833|FG001|Overall Study|Unclassified|4
7301805|NCT00611884|11523834|FG002|Overall Study|Unclassified|2
7301806|NCT00611884|11523835|FG003|Overall Study|Unclassified|3
7301807|NCT00611923|11523856|FG000|Overall Study|Withdrawal by Subject|2
7301808|NCT00611923|11523857|FG001|Overall Study|Withdrawal by Subject|2
7301809|NCT00611975|11523867|FG000|Overall Study|Withdrawal by Subject|3
7301810|NCT00611975|11523868|FG001|Overall Study|Withdrawal by Subject|7
7301811|NCT00611975|11523867|FG000|Overall Study|Pregnancy|2
7301812|NCT00611975|11523868|FG001|Overall Study|Pregnancy|1
7301813|NCT00612040|11523877|FG000|Overall Study|Adverse Event|0
7301814|NCT00612040|11523878|FG001|Overall Study|Adverse Event|2
7301815|NCT00612040|11523879|FG002|Overall Study|Adverse Event|1
7301816|NCT00612040|11523877|FG000|Overall Study|Protocol Violation|1
7301817|NCT00612040|11523878|FG001|Overall Study|Protocol Violation|2
7301818|NCT00612040|11523879|FG002|Overall Study|Protocol Violation|1
7301819|NCT00612040|11523877|FG000|Overall Study|Lack of Efficacy|2
7301820|NCT00612040|11523878|FG001|Overall Study|Lack of Efficacy|1
7301821|NCT00612040|11523879|FG002|Overall Study|Lack of Efficacy|0
7301822|NCT00612040|11523877|FG000|Overall Study|Unclassified|2
7301823|NCT00612040|11523878|FG001|Overall Study|Unclassified|2
7301824|NCT00612040|11523879|FG002|Overall Study|Unclassified|5
7301825|NCT00612066|11523887|FG000|Overall Study|Adverse Event|1
7301826|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
7301827|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
7301828|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
7301829|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
7301830|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
7301831|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
7301832|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7301833|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
7301834|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
7301835|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
7301836|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
7301837|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
7301838|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
7301839|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
7301840|NCT00612105|11523893|FG000|Period Title 1: 6-Week Titration Phase|Other|0
7301841|NCT00612105|11523894|FG001|Period Title 1: 6-Week Titration Phase|Other|1
7301842|NCT00612105|11523893|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
7301843|NCT00612105|11523894|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
7301844|NCT00612105|11523893|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7551920|NCT02976519|11911431|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
7301845|NCT00612105|11523894|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
7301846|NCT00612105|11523893|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
7301847|NCT00612105|11523894|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
7301848|NCT00612105|11523893|FG000|Period Title 3: 3-Week Taper Phase|Other|1
7301849|NCT00612105|11523894|FG001|Period Title 3: 3-Week Taper Phase|Other|0
7301850|NCT00612313|11523924|FG000|Overall Study|Withdrawal by Subject|6
7301851|NCT00612313|11523925|FG001|Overall Study|Withdrawal by Subject|9
7301852|NCT00612313|11523924|FG000|Overall Study|Lost to Follow-up|11
7301853|NCT00612313|11523925|FG001|Overall Study|Lost to Follow-up|4
7301854|NCT00612352|11523943|FG000|Overall Study|Adverse Event|1
7301855|NCT00612352|11523944|FG001|Overall Study|Adverse Event|0
7301856|NCT00612352|11523943|FG000|Overall Study|Withdrawal by Subject|3
7301857|NCT00612352|11523944|FG001|Overall Study|Withdrawal by Subject|5
7301858|NCT00612352|11523943|FG000|Overall Study|moved out of state|1
7301859|NCT00612352|11523944|FG001|Overall Study|moved out of state|0
7301860|NCT00612352|11523943|FG000|Overall Study|didn't return calls/show up on test date|4
7301861|NCT00612352|11523944|FG001|Overall Study|didn't return calls/show up on test date|1
7301862|NCT00612456|11523964|FG000|Overall Study|Adverse Event|1
7301863|NCT00612456|11523965|FG001|Overall Study|Adverse Event|0
7301864|NCT00612456|11523966|FG002|Overall Study|Adverse Event|0
7301865|NCT00612456|11523964|FG000|Overall Study|Lack of Efficacy|1
7301866|NCT00612456|11523965|FG001|Overall Study|Lack of Efficacy|1
7301867|NCT00612456|11523966|FG002|Overall Study|Lack of Efficacy|0
7301868|NCT00612456|11523964|FG000|Overall Study|Withdrawal by Subject|0
7301869|NCT00612456|11523965|FG001|Overall Study|Withdrawal by Subject|1
7301870|NCT00612456|11523966|FG002|Overall Study|Withdrawal by Subject|0
7301871|NCT00612508|11523978|FG000|Overall Study|Withdrawal by Subject|3
7301872|NCT00612508|11523979|FG001|Overall Study|Withdrawal by Subject|4
7301873|NCT00612534|11523991|FG000|Overall Study|Adverse Event|0
7301874|NCT00612534|11523992|FG001|Overall Study|Adverse Event|4
7301875|NCT00612534|11523993|FG002|Overall Study|Adverse Event|2
7301876|NCT00612534|11523994|FG003|Overall Study|Adverse Event|1
7301877|NCT00612534|11523991|FG000|Overall Study|Lack of Efficacy|13
7301878|NCT00612534|11523992|FG001|Overall Study|Lack of Efficacy|12
7301879|NCT00612534|11523993|FG002|Overall Study|Lack of Efficacy|5
7301880|NCT00612534|11523994|FG003|Overall Study|Lack of Efficacy|16
7301881|NCT00612534|11523991|FG000|Overall Study|Other Reason|0
7301882|NCT00612534|11523992|FG001|Overall Study|Other Reason|1
7301883|NCT00612534|11523993|FG002|Overall Study|Other Reason|0
7301884|NCT00612534|11523994|FG003|Overall Study|Other Reason|0
7301885|NCT00612586|11524040|FG000|Overall Study|Adverse Event|6
7301886|NCT00612586|11524041|FG001|Overall Study|Adverse Event|2
7301887|NCT00612586|11524040|FG000|Overall Study|Death|1
7301888|NCT00612586|11524041|FG001|Overall Study|Death|0
7301889|NCT00612586|11524040|FG000|Overall Study|Entry Criteria Not Met|0
7301890|NCT00612586|11524041|FG001|Overall Study|Entry Criteria Not Met|2
7301891|NCT00612586|11524040|FG000|Overall Study|Withdrawal by Subject|7
7301892|NCT00612586|11524041|FG001|Overall Study|Withdrawal by Subject|9
7301893|NCT00612586|11524040|FG000|Overall Study|Physician Decision|1
7301894|NCT00612586|11524041|FG001|Overall Study|Physician Decision|2
7301895|NCT00612586|11524040|FG000|Overall Study|Sponsor Decision|1
7301896|NCT00612586|11524041|FG001|Overall Study|Sponsor Decision|1
7301897|NCT00612586|11524040|FG000|Overall Study|Progressive Disease|26
7301898|NCT00612586|11524041|FG001|Overall Study|Progressive Disease|24
7301899|NCT00612586|11524040|FG000|Overall Study|Randomized and Not Treated|1
7301900|NCT00612586|11524041|FG001|Overall Study|Randomized and Not Treated|1
7301901|NCT00612690|11524050|FG000|Overall Study|Lost to Follow-up|72
7301902|NCT00612690|11524051|FG001|Overall Study|Lost to Follow-up|98
7301903|NCT00612690|11524050|FG000|Overall Study|Withdrawal by Subject|32
7301904|NCT00612690|11524051|FG001|Overall Study|Withdrawal by Subject|20
7301905|NCT00612690|11524050|FG000|Overall Study|Withdrawal by Site|11
7301906|NCT00612690|11524051|FG001|Overall Study|Withdrawal by Site|0
7301907|NCT00612807|11524090|FG000|Overall Study|Withdrawal by Subject|2
7301908|NCT00612807|11524091|FG001|Overall Study|Withdrawal by Subject|0
7301909|NCT00613015|11524113|FG000|Overall Study|Lost to Follow-up|0
7301910|NCT00613015|11524114|FG001|Overall Study|Lost to Follow-up|1
7301911|NCT00613015|11524115|FG002|Overall Study|Lost to Follow-up|3
7301912|NCT00613015|11524116|FG003|Overall Study|Lost to Follow-up|3
7301913|NCT00613015|11524117|FG004|Overall Study|Lost to Follow-up|2
7301914|NCT00613015|11524118|FG005|Overall Study|Lost to Follow-up|3
7301915|NCT00613080|11524141|FG000|Overall Study|Ineligible / no protocol treatment|11
7301916|NCT00613106|11524147|FG000|Overall Study|Adverse Event|3
7301917|NCT00613106|11524148|FG001|Overall Study|Adverse Event|1
7301918|NCT00613106|11524147|FG000|Overall Study|Withdrawal by Subject|6
7301919|NCT00613106|11524148|FG001|Overall Study|Withdrawal by Subject|3
7301920|NCT00613106|11524147|FG000|Overall Study|Lost to Follow-up|7
7301921|NCT00613106|11524148|FG001|Overall Study|Lost to Follow-up|2
7301922|NCT00613106|11524147|FG000|Overall Study|misc|4
7301923|NCT00613106|11524148|FG001|Overall Study|misc|3
7301924|NCT00613171|11524154|FG000|Overall Study|Adverse Event|7
7301925|NCT00613171|11524154|FG000|Overall Study|Withdrawal by Subject|3
7301926|NCT00613171|11524154|FG000|Overall Study|Reason not Specified|4
7301927|NCT00613301|11524159|FG000|Overall Study|Adverse Event|49
7301928|NCT00613301|11524159|FG000|Overall Study|Lost to Follow-up|88
7301929|NCT00613301|11524159|FG000|Overall Study|Withdrawal by Subject|5
7301930|NCT00613301|11524159|FG000|Overall Study|Death|6
7301931|NCT00613301|11524159|FG000|Overall Study|Lack of Efficacy|13
7301932|NCT00613301|11524159|FG000|Overall Study|Physician Decision|2
7301933|NCT00613301|11524159|FG000|Overall Study|No data was collected|53
7301934|NCT00613301|11524159|FG000|Overall Study|Irregularly enrolled patients|12
7301935|NCT00613314|11524164|FG000|Overall Study|Adverse Event|5
7301936|NCT00613314|11524164|FG000|Overall Study|Protocol Violation|14
7301937|NCT00613314|11524164|FG000|Overall Study|Lost to Follow-up|46
7301938|NCT00613314|11524164|FG000|Overall Study|Other reason not defined above|90
7301939|NCT00613327|11524168|FG000|Overall Study|Adverse Event|38
7301940|NCT00613327|11524168|FG000|Overall Study|Lost to Follow-up|8
7301941|NCT00613327|11524168|FG000|Overall Study|Withdrawal by Subject|6
7301942|NCT00613327|11524168|FG000|Overall Study|Protocol Violation|2
7301943|NCT00613327|11524168|FG000|Overall Study|Other|47
7301944|NCT00613366|11524174|FG000|Overall Study|Withdrawal by Subject|3
7301945|NCT00613366|11524175|FG001|Overall Study|Withdrawal by Subject|2
7301946|NCT00613509|11524205|FG000|Cycle 1|Adverse Event|2
7301947|NCT00613509|11524206|FG001|Cycle 1|Adverse Event|1
7301948|NCT00613509|11524205|FG000|Cycle 1|Disease Progression|2
7301949|NCT00613509|11524206|FG001|Cycle 1|Disease Progression|6
7301950|NCT00613509|11524205|FG000|Cycle 1|Unacceptable Toxicity|1
7301951|NCT00613509|11524206|FG001|Cycle 1|Unacceptable Toxicity|0
7301952|NCT00613509|11524205|FG000|Cycle 1|Other administrative reason|0
7301953|NCT00613509|11524206|FG001|Cycle 1|Other administrative reason|1
7301954|NCT00613574|11524212|FG000|Overall Study|Adverse Event|3
7301955|NCT00613574|11524212|FG000|Overall Study|Lost to Follow-up|2
7301956|NCT00613574|11524212|FG000|Overall Study|Other|1
7301957|NCT00613626|11524219|FG000|Overall Study|Ineligible|0
7301958|NCT00613626|11524220|FG001|Overall Study|Ineligible|1
7301959|NCT00613626|11524221|FG002|Overall Study|Ineligible|0
7301960|NCT00613821|11524230|FG000|Overall Study|Withdrawal by Subject|1
7301961|NCT00613821|11524231|FG001|Overall Study|Withdrawal by Subject|0
7301962|NCT00613821|11524230|FG000|Overall Study|Physician Decision|1
7301963|NCT00613821|11524231|FG001|Overall Study|Physician Decision|1
7301964|NCT00613834|11524239|FG000|Overall Study|Withdrawal by Subject|0
7301965|NCT00613834|11524240|FG001|Overall Study|Withdrawal by Subject|3
7301966|NCT00613925|11524250|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
7301967|NCT00613925|11524251|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
7301968|NCT00613938|11524261|FG000|Overall Study|Withdrawal by Subject|2
7301969|NCT00613938|11524262|FG001|Overall Study|Withdrawal by Subject|4
7301970|NCT00613938|11524263|FG002|Overall Study|Withdrawal by Subject|9
7301971|NCT00613938|11524264|FG003|Overall Study|Withdrawal by Subject|9
7301972|NCT00613938|11524261|FG000|Overall Study|Adverse Event|1
7301973|NCT00613938|11524262|FG001|Overall Study|Adverse Event|4
7301974|NCT00613938|11524263|FG002|Overall Study|Adverse Event|8
7301975|NCT00613938|11524264|FG003|Overall Study|Adverse Event|5
7301976|NCT00613938|11524261|FG000|Overall Study|Lack of Efficacy|16
7301977|NCT00613938|11524262|FG001|Overall Study|Lack of Efficacy|18
7301978|NCT00613938|11524263|FG002|Overall Study|Lack of Efficacy|5
7301979|NCT00613938|11524264|FG003|Overall Study|Lack of Efficacy|9
7301980|NCT00613938|11524261|FG000|Overall Study|Other|1
7301981|NCT00613938|11524262|FG001|Overall Study|Other|2
7301982|NCT00613938|11524263|FG002|Overall Study|Other|1
7301983|NCT00613938|11524264|FG003|Overall Study|Other|3
7301984|NCT00613951|11524277|FG000|Overall Study|Adverse Event|1
7301985|NCT00613951|11524278|FG001|Overall Study|Adverse Event|0
7301986|NCT00613951|11524279|FG002|Overall Study|Adverse Event|1
7301987|NCT00613951|11524277|FG000|Overall Study|Lack of Efficacy|0
7301988|NCT00613951|11524278|FG001|Overall Study|Lack of Efficacy|1
7301989|NCT00613951|11524279|FG002|Overall Study|Lack of Efficacy|1
7301990|NCT00613951|11524277|FG000|Overall Study|Protocol Violation|1
7301991|NCT00613951|11524278|FG001|Overall Study|Protocol Violation|1
7301992|NCT00613951|11524279|FG002|Overall Study|Protocol Violation|1
7301993|NCT00613951|11524277|FG000|Overall Study|Unclassified|5
7301994|NCT00613951|11524278|FG001|Overall Study|Unclassified|3
7301995|NCT00613951|11524279|FG002|Overall Study|Unclassified|2
7301996|NCT00614055|11524293|FG000|Overall Study|Adverse Event|1
7301997|NCT00614055|11524294|FG001|Overall Study|Adverse Event|0
7301998|NCT00614055|11524295|FG002|Overall Study|Adverse Event|0
7301999|NCT00614055|11524293|FG000|Overall Study|Protocol Violation|2
7302000|NCT00614055|11524294|FG001|Overall Study|Protocol Violation|2
7302001|NCT00614055|11524295|FG002|Overall Study|Protocol Violation|1
7302002|NCT00614055|11524293|FG000|Overall Study|Lack of Efficacy|0
7302003|NCT00614055|11524294|FG001|Overall Study|Lack of Efficacy|0
7302004|NCT00614055|11524295|FG002|Overall Study|Lack of Efficacy|2
7302005|NCT00614055|11524293|FG000|Overall Study|Unclassified|1
7302006|NCT00614055|11524294|FG001|Overall Study|Unclassified|4
7302007|NCT00614055|11524295|FG002|Overall Study|Unclassified|2
7302008|NCT00614120|11524310|FG000|Overall Study|Adverse Event|9
7302009|NCT00614120|11524311|FG001|Overall Study|Adverse Event|22
7302010|NCT00614120|11524312|FG002|Overall Study|Adverse Event|30
7302011|NCT00614120|11524313|FG003|Overall Study|Adverse Event|3
7302012|NCT00614120|11524310|FG000|Overall Study|Lack of Efficacy|3
7302013|NCT00614120|11524311|FG001|Overall Study|Lack of Efficacy|3
7302014|NCT00614120|11524312|FG002|Overall Study|Lack of Efficacy|2
7302015|NCT00614120|11524313|FG003|Overall Study|Lack of Efficacy|2
7302016|NCT00614120|11524310|FG000|Overall Study|Protocol Violation|2
7302017|NCT00614120|11524311|FG001|Overall Study|Protocol Violation|5
7302018|NCT00614120|11524312|FG002|Overall Study|Protocol Violation|3
7302019|NCT00614120|11524313|FG003|Overall Study|Protocol Violation|1
7302020|NCT00614120|11524310|FG000|Overall Study|Withdrawal criteria|1
7302021|NCT00614120|11524311|FG001|Overall Study|Withdrawal criteria|0
7302022|NCT00614120|11524312|FG002|Overall Study|Withdrawal criteria|0
7302023|NCT00614120|11524313|FG003|Overall Study|Withdrawal criteria|0
7302024|NCT00614120|11524310|FG000|Overall Study|Withdrawal by Subject|9
7302025|NCT00614120|11524311|FG001|Overall Study|Withdrawal by Subject|10
7302026|NCT00614120|11524312|FG002|Overall Study|Withdrawal by Subject|16
7302027|NCT00614120|11524313|FG003|Overall Study|Withdrawal by Subject|3
7302028|NCT00614120|11524310|FG000|Overall Study|Did not meet trial criteria|0
7302029|NCT00614120|11524311|FG001|Overall Study|Did not meet trial criteria|1
7302030|NCT00614120|11524312|FG002|Overall Study|Did not meet trial criteria|1
7302031|NCT00614120|11524313|FG003|Overall Study|Did not meet trial criteria|1
7302032|NCT00614120|11524310|FG000|Overall Study|hCG positive (not pregnant)|0
7302033|NCT00614120|11524311|FG001|Overall Study|hCG positive (not pregnant)|0
7302034|NCT00614120|11524312|FG002|Overall Study|hCG positive (not pregnant)|1
7302035|NCT00614120|11524313|FG003|Overall Study|hCG positive (not pregnant)|0
7302036|NCT00614120|11524310|FG000|Overall Study|Hypoglycaemia|0
7302037|NCT00614120|11524311|FG001|Overall Study|Hypoglycaemia|0
7302038|NCT00614120|11524312|FG002|Overall Study|Hypoglycaemia|0
7302039|NCT00614120|11524313|FG003|Overall Study|Hypoglycaemia|1
7302040|NCT00614120|11524310|FG000|Overall Study|Lack of trial product|3
7302041|NCT00614120|11524311|FG001|Overall Study|Lack of trial product|3
7302042|NCT00614120|11524312|FG002|Overall Study|Lack of trial product|2
7302043|NCT00614120|11524313|FG003|Overall Study|Lack of trial product|0
7302044|NCT00614120|11524310|FG000|Overall Study|Late syphilis, latent|1
7302045|NCT00614120|11524311|FG001|Overall Study|Late syphilis, latent|0
7302046|NCT00614120|11524312|FG002|Overall Study|Late syphilis, latent|0
7302047|NCT00614120|11524313|FG003|Overall Study|Late syphilis, latent|0
7302048|NCT00614120|11524310|FG000|Overall Study|Taken inhibition medication eg Prandin|0
7302049|NCT00614120|11524311|FG001|Overall Study|Taken inhibition medication eg Prandin|0
7302050|NCT00614120|11524312|FG002|Overall Study|Taken inhibition medication eg Prandin|1
7302051|NCT00614120|11524313|FG003|Overall Study|Taken inhibition medication eg Prandin|1
7302052|NCT00614120|11524310|FG000|Overall Study|Lost to Follow-up|1
7302053|NCT00614120|11524311|FG001|Overall Study|Lost to Follow-up|2
7302054|NCT00614120|11524312|FG002|Overall Study|Lost to Follow-up|3
7302055|NCT00614120|11524313|FG003|Overall Study|Lost to Follow-up|4
7302056|NCT00614380|11524340|FG000|Overall Study|Adverse Event|14
7302057|NCT00614380|11524341|FG001|Overall Study|Adverse Event|4
7302058|NCT00614380|11524342|FG002|Overall Study|Adverse Event|0
7302059|NCT00614380|11524343|FG003|Overall Study|Adverse Event|0
7302060|NCT00614380|11524340|FG000|Overall Study|Lost to Follow-up|6
7302061|NCT00614380|11524341|FG001|Overall Study|Lost to Follow-up|1
7302062|NCT00614380|11524342|FG002|Overall Study|Lost to Follow-up|0
7302063|NCT00614380|11524343|FG003|Overall Study|Lost to Follow-up|0
7302064|NCT00614380|11524340|FG000|Overall Study|Non compliant with the protocol|12
7302065|NCT00614380|11524341|FG001|Overall Study|Non compliant with the protocol|2
7302066|NCT00614380|11524342|FG002|Overall Study|Non compliant with the protocol|1
7302067|NCT00614380|11524343|FG003|Overall Study|Non compliant with the protocol|2
7302068|NCT00614380|11524340|FG000|Overall Study|Consent withdrawn|3
7302069|NCT00614380|11524341|FG001|Overall Study|Consent withdrawn|1
7302070|NCT00614380|11524342|FG002|Overall Study|Consent withdrawn|0
7302071|NCT00614380|11524343|FG003|Overall Study|Consent withdrawn|0
7302072|NCT00614393|11524363|FG000|Overall Study|Adverse Event|20
7302073|NCT00614393|11524364|FG001|Overall Study|Adverse Event|2
7302074|NCT00614393|11524365|FG002|Overall Study|Adverse Event|3
7302075|NCT00614393|11524366|FG003|Overall Study|Adverse Event|13
7302076|NCT00614393|11524367|FG004|Overall Study|Adverse Event|21
7302077|NCT00614393|11524363|FG000|Overall Study|Lost to Follow-up|0
7302078|NCT00614393|11524364|FG001|Overall Study|Lost to Follow-up|0
7302079|NCT00614393|11524365|FG002|Overall Study|Lost to Follow-up|0
7302080|NCT00614393|11524366|FG003|Overall Study|Lost to Follow-up|1
7302081|NCT00614393|11524367|FG004|Overall Study|Lost to Follow-up|2
7302082|NCT00614393|11524363|FG000|Overall Study|Physician Decision|17
7302083|NCT00614393|11524364|FG001|Overall Study|Physician Decision|0
7302084|NCT00614393|11524365|FG002|Overall Study|Physician Decision|1
7302085|NCT00614393|11524366|FG003|Overall Study|Physician Decision|8
7302086|NCT00614393|11524367|FG004|Overall Study|Physician Decision|9
7302087|NCT00614393|11524363|FG000|Overall Study|Progressive Disease|118
7302088|NCT00614393|11524364|FG001|Overall Study|Progressive Disease|5
7302089|NCT00614393|11524365|FG002|Overall Study|Progressive Disease|5
7302090|NCT00614393|11524366|FG003|Overall Study|Progressive Disease|138
7302091|NCT00614393|11524367|FG004|Overall Study|Progressive Disease|130
7302092|NCT00614393|11524363|FG000|Overall Study|Protocol Violation|1
7302093|NCT00614393|11524364|FG001|Overall Study|Protocol Violation|0
7302094|NCT00614393|11524365|FG002|Overall Study|Protocol Violation|0
7302095|NCT00614393|11524366|FG003|Overall Study|Protocol Violation|0
7302096|NCT00614393|11524367|FG004|Overall Study|Protocol Violation|0
7302097|NCT00614393|11524363|FG000|Overall Study|Terminated by Sponsor|0
7302098|NCT00614393|11524364|FG001|Overall Study|Terminated by Sponsor|0
7302099|NCT00614393|11524365|FG002|Overall Study|Terminated by Sponsor|0
7302100|NCT00614393|11524366|FG003|Overall Study|Terminated by Sponsor|0
7302101|NCT00614393|11524367|FG004|Overall Study|Terminated by Sponsor|1
7302102|NCT00614393|11524363|FG000|Overall Study|Withdrawal by Subject|20
7302103|NCT00614393|11524364|FG001|Overall Study|Withdrawal by Subject|1
7302104|NCT00614393|11524365|FG002|Overall Study|Withdrawal by Subject|1
7302105|NCT00614393|11524366|FG003|Overall Study|Withdrawal by Subject|16
7302106|NCT00614393|11524367|FG004|Overall Study|Withdrawal by Subject|13
7302107|NCT00614393|11524363|FG000|Overall Study|Other|4
7302108|NCT00614393|11524364|FG001|Overall Study|Other|0
7302109|NCT00614393|11524365|FG002|Overall Study|Other|0
7302110|NCT00614393|11524366|FG003|Overall Study|Other|4
7302111|NCT00614393|11524367|FG004|Overall Study|Other|2
7302112|NCT00614393|11524363|FG000|Overall Study|Not Treated|0
7302113|NCT00614393|11524364|FG001|Overall Study|Not Treated|0
7302114|NCT00614393|11524365|FG002|Overall Study|Not Treated|0
7302115|NCT00614393|11524366|FG003|Overall Study|Not Treated|0
7302116|NCT00614393|11524367|FG004|Overall Study|Not Treated|2
7302117|NCT00614523|11524417|FG000|Overall Study|Adverse Event|4
7302118|NCT00614523|11524418|FG001|Overall Study|Adverse Event|20
7302119|NCT00614523|11524417|FG000|Overall Study|Death|5
7302120|NCT00614523|11524418|FG001|Overall Study|Death|8
7302121|NCT00614523|11524417|FG000|Overall Study|Lack of Efficacy|9
7302122|NCT00614523|11524418|FG001|Overall Study|Lack of Efficacy|11
7302123|NCT00614523|11524417|FG000|Overall Study|Lost to Follow-up|0
7302124|NCT00614523|11524418|FG001|Overall Study|Lost to Follow-up|1
7302125|NCT00614523|11524417|FG000|Overall Study|Protocol Violation|3
7302126|NCT00614523|11524418|FG001|Overall Study|Protocol Violation|2
7302127|NCT00614523|11524417|FG000|Overall Study|Withdrawal by Subject|12
7302128|NCT00614523|11524418|FG001|Overall Study|Withdrawal by Subject|22
7302129|NCT00614523|11524417|FG000|Overall Study|Other|6
7302130|NCT00614523|11524418|FG001|Overall Study|Other|11
7302131|NCT00614523|11524417|FG000|Overall Study|Ineligibility Determined|1
7302132|NCT00614523|11524418|FG001|Overall Study|Ineligibility Determined|2
7302133|NCT00614523|11524417|FG000|Overall Study|Disease Progression|0
7302134|NCT00614523|11524418|FG001|Overall Study|Disease Progression|8
7302135|NCT00614523|11524417|FG000|Overall Study|Administrative Decision|23
7302136|NCT00614523|11524418|FG001|Overall Study|Administrative Decision|46
7302137|NCT00614575|11524424|FG000|Overall Study|Adverse Event|106
7302138|NCT00614575|11524424|FG000|Overall Study|Lost to Follow-up|55
7302139|NCT00614575|11524424|FG000|Overall Study|Lack of Efficacy|14
7302140|NCT00614575|11524424|FG000|Overall Study|Withdrawal by Subject|6
7302141|NCT00614575|11524424|FG000|Overall Study|Death|3
7302142|NCT00614575|11524424|FG000|Overall Study|Physician Decision|2
7302143|NCT00614575|11524424|FG000|Overall Study|No data were collected.|18
7302144|NCT00614575|11524424|FG000|Overall Study|Irregularly enrolled patients|23
7302145|NCT00614575|11524424|FG000|Overall Study|No treatment|1
7302146|NCT00614614|11524430|FG000|Primary Vaccination Phase|Adverse Event|6
7302147|NCT00614614|11524431|FG001|Primary Vaccination Phase|Adverse Event|0
7302148|NCT00614614|11524432|FG002|Primary Vaccination Phase|Adverse Event|0
7302149|NCT00614614|11524433|FG003|Primary Vaccination Phase|Adverse Event|0
7302150|NCT00614614|11524434|FG004|Primary Vaccination Phase|Adverse Event|0
7302151|NCT00614614|11524430|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
7302152|NCT00614614|11524431|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
7302153|NCT00614614|11524432|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
7302154|NCT00614614|11524433|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
7302155|NCT00614614|11524434|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
7302156|NCT00614614|11524430|FG000|Primary Vaccination Phase|Lost to Follow-up|26
7302157|NCT00614614|11524431|FG001|Primary Vaccination Phase|Lost to Follow-up|8
7302158|NCT00614614|11524432|FG002|Primary Vaccination Phase|Lost to Follow-up|0
7302159|NCT00614614|11524433|FG003|Primary Vaccination Phase|Lost to Follow-up|0
7302160|NCT00614614|11524434|FG004|Primary Vaccination Phase|Lost to Follow-up|0
7302161|NCT00614614|11524430|FG000|Primary Vaccination Phase|Protocol Violation|9
7302162|NCT00614614|11524431|FG001|Primary Vaccination Phase|Protocol Violation|3
7302163|NCT00614614|11524432|FG002|Primary Vaccination Phase|Protocol Violation|0
7302164|NCT00614614|11524433|FG003|Primary Vaccination Phase|Protocol Violation|0
7302165|NCT00614614|11524434|FG004|Primary Vaccination Phase|Protocol Violation|0
7302166|NCT00614614|11524430|FG000|Primary Vaccination Phase|Other|4
7302167|NCT00614614|11524431|FG001|Primary Vaccination Phase|Other|0
7302168|NCT00614614|11524432|FG002|Primary Vaccination Phase|Other|0
7302169|NCT00614614|11524433|FG003|Primary Vaccination Phase|Other|0
7302170|NCT00614614|11524434|FG004|Primary Vaccination Phase|Other|0
7302171|NCT00614614|11524430|FG000|Booster Vaccination Phase|Adverse Event|0
7302172|NCT00614614|11524431|FG001|Booster Vaccination Phase|Adverse Event|0
7302173|NCT00614614|11524432|FG002|Booster Vaccination Phase|Adverse Event|1
7302174|NCT00614614|11524433|FG003|Booster Vaccination Phase|Adverse Event|1
7302175|NCT00614614|11524434|FG004|Booster Vaccination Phase|Adverse Event|0
7302176|NCT00614614|11524430|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
7302177|NCT00614614|11524431|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
7302178|NCT00614614|11524432|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
7302179|NCT00614614|11524433|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
7302180|NCT00614614|11524434|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
7302181|NCT00614614|11524430|FG000|Booster Vaccination Phase|Lost to Follow-up|0
7302182|NCT00614614|11524431|FG001|Booster Vaccination Phase|Lost to Follow-up|5
7302183|NCT00614614|11524432|FG002|Booster Vaccination Phase|Lost to Follow-up|17
7302184|NCT00614614|11524433|FG003|Booster Vaccination Phase|Lost to Follow-up|10
7302185|NCT00614614|11524434|FG004|Booster Vaccination Phase|Lost to Follow-up|8
7302186|NCT00614614|11524430|FG000|Booster Vaccination Phase|Protocol Violation|0
7302187|NCT00614614|11524431|FG001|Booster Vaccination Phase|Protocol Violation|0
7302188|NCT00614614|11524432|FG002|Booster Vaccination Phase|Protocol Violation|2
7302189|NCT00614614|11524433|FG003|Booster Vaccination Phase|Protocol Violation|3
7302190|NCT00614614|11524434|FG004|Booster Vaccination Phase|Protocol Violation|0
7302191|NCT00614614|11524430|FG000|Booster Vaccination Phase|Other|0
7302192|NCT00614614|11524431|FG001|Booster Vaccination Phase|Other|1
7302193|NCT00614614|11524432|FG002|Booster Vaccination Phase|Other|3
7302194|NCT00614614|11524433|FG003|Booster Vaccination Phase|Other|2
7302195|NCT00614614|11524434|FG004|Booster Vaccination Phase|Other|1
7302196|NCT00614744|11524451|FG000|Overall Study|Lost to Follow-up|5
7302197|NCT00614744|11524452|FG001|Overall Study|Lost to Follow-up|4
7302198|NCT00614744|11524451|FG000|Overall Study|Incomplete for Behavior Issues|0
7302199|NCT00614744|11524452|FG001|Overall Study|Incomplete for Behavior Issues|2
7302200|NCT00614822|11524458|FG000|Overall Study|Adverse Event|3
7302201|NCT00614874|11524463|FG000|Overall Study|Protocol Violation|1
7302202|NCT00614874|11524463|FG000|Overall Study|Withdrawal by Subject|1
7302203|NCT00614926|11524473|FG000|Overall Study|Burden of travel|1
7302204|NCT00614926|11524474|FG001|Overall Study|Burden of travel|0
7302205|NCT00614926|11524473|FG000|Overall Study|Adverse Event|3
7302206|NCT00614926|11524474|FG001|Overall Study|Adverse Event|0
7302207|NCT00614939|11524482|FG000|Overall Study|Withdrawal by Subject|10
7302208|NCT00614939|11524483|FG001|Overall Study|Withdrawal by Subject|17
7302209|NCT00614939|11524482|FG000|Overall Study|Study specific discontinuation criteris|13
7302210|NCT00614939|11524483|FG001|Overall Study|Study specific discontinuation criteris|16
7302211|NCT00614939|11524482|FG000|Overall Study|Adverse Event|2
7302212|NCT00614939|11524483|FG001|Overall Study|Adverse Event|5
7302213|NCT00614939|11524482|FG000|Overall Study|Incorrect enrollment|1
7302214|NCT00614939|11524483|FG001|Overall Study|Incorrect enrollment|2
7302215|NCT00614939|11524482|FG000|Overall Study|Death|4
7302216|NCT00614939|11524483|FG001|Overall Study|Death|3
7302217|NCT00614939|11524482|FG000|Overall Study|Poor/non-compliance|4
7302218|NCT00614939|11524483|FG001|Overall Study|Poor/non-compliance|0
7302219|NCT00614939|11524482|FG000|Overall Study|Hospitalized due to kidney transplant|1
7302220|NCT00614939|11524483|FG001|Overall Study|Hospitalized due to kidney transplant|0
7302221|NCT00614991|11524495|FG000|Overall Study|Adverse Event|3
7302222|NCT00614991|11524496|FG001|Overall Study|Adverse Event|3
7302223|NCT00614991|11524497|FG002|Overall Study|Adverse Event|0
7302224|NCT00614991|11524498|FG003|Overall Study|Adverse Event|0
7302225|NCT00614991|11524499|FG004|Overall Study|Adverse Event|1
7302226|NCT00614991|11524500|FG005|Overall Study|Adverse Event|0
7302227|NCT00615017|11524525|FG000|Overall Study|Adverse Event|0
7302228|NCT00615017|11524526|FG001|Overall Study|Adverse Event|1
7302229|NCT00615017|11524527|FG002|Overall Study|Adverse Event|2
7302230|NCT00615017|11524528|FG003|Overall Study|Adverse Event|0
7302231|NCT00615017|11524529|FG004|Overall Study|Adverse Event|0
7302232|NCT00615017|11524530|FG005|Overall Study|Adverse Event|1
7302233|NCT00615017|11524525|FG000|Overall Study|Death|0
7302234|NCT00615017|11524526|FG001|Overall Study|Death|0
7302235|NCT00615017|11524527|FG002|Overall Study|Death|2
7302236|NCT00615017|11524528|FG003|Overall Study|Death|0
7302237|NCT00615017|11524529|FG004|Overall Study|Death|1
7302238|NCT00615017|11524530|FG005|Overall Study|Death|1
7302239|NCT00615017|11524525|FG000|Overall Study|Sepsis resolved|0
7302240|NCT00615017|11524526|FG001|Overall Study|Sepsis resolved|0
7302241|NCT00615017|11524527|FG002|Overall Study|Sepsis resolved|1
7302242|NCT00615017|11524528|FG003|Overall Study|Sepsis resolved|0
7302243|NCT00615017|11524529|FG004|Overall Study|Sepsis resolved|0
7302244|NCT00615017|11524530|FG005|Overall Study|Sepsis resolved|0
7302245|NCT00615017|11524525|FG000|Overall Study|Transferred out of Intensive Care Unit|0
7302246|NCT00615017|11524526|FG001|Overall Study|Transferred out of Intensive Care Unit|0
7302247|NCT00615017|11524527|FG002|Overall Study|Transferred out of Intensive Care Unit|0
7302248|NCT00615017|11524528|FG003|Overall Study|Transferred out of Intensive Care Unit|1
7302249|NCT00615017|11524529|FG004|Overall Study|Transferred out of Intensive Care Unit|0
7302250|NCT00615017|11524530|FG005|Overall Study|Transferred out of Intensive Care Unit|0
7302251|NCT00615017|11524525|FG000|Overall Study|Physician discontinued drug|0
7302252|NCT00615017|11524526|FG001|Overall Study|Physician discontinued drug|0
7302253|NCT00615017|11524527|FG002|Overall Study|Physician discontinued drug|0
7302254|NCT00615017|11524528|FG003|Overall Study|Physician discontinued drug|0
7302255|NCT00615017|11524529|FG004|Overall Study|Physician discontinued drug|0
7302256|NCT00615017|11524530|FG005|Overall Study|Physician discontinued drug|1
7302257|NCT00615030|11524544|FG000|Period I|Administrative problem|0
7302258|NCT00615030|11524545|FG001|Period I|Administrative problem|0
7302259|NCT00615030|11524546|FG002|Period I|Administrative problem|0
7302260|NCT00615030|11524547|FG003|Period I|Administrative problem|0
7302261|NCT00615030|11524548|FG004|Period I|Administrative problem|1
7302262|NCT00615030|11524549|FG005|Period I|Administrative problem|0
7302263|NCT00615030|11524550|FG006|Period I|Administrative problem|0
7302264|NCT00615030|11524551|FG007|Period I|Administrative problem|0
7302265|NCT00615030|11524552|FG008|Period I|Administrative problem|0
7302266|NCT00615030|11524553|FG009|Period I|Administrative problem|0
7302267|NCT00615030|11524554|FG010|Period I|Administrative problem|0
7302268|NCT00615030|11524555|FG011|Period I|Administrative problem|0
7302269|NCT00615030|11524544|FG000|Period I|Protocol deviation|1
7302270|NCT00615030|11524545|FG001|Period I|Protocol deviation|0
7302271|NCT00615030|11524546|FG002|Period I|Protocol deviation|0
7302272|NCT00615030|11524547|FG003|Period I|Protocol deviation|0
7302273|NCT00615030|11524548|FG004|Period I|Protocol deviation|0
7302274|NCT00615030|11524549|FG005|Period I|Protocol deviation|0
7302275|NCT00615030|11524550|FG006|Period I|Protocol deviation|0
7302276|NCT00615030|11524551|FG007|Period I|Protocol deviation|0
7302277|NCT00615030|11524552|FG008|Period I|Protocol deviation|0
7302278|NCT00615030|11524553|FG009|Period I|Protocol deviation|0
7302279|NCT00615030|11524554|FG010|Period I|Protocol deviation|0
7302280|NCT00615030|11524555|FG011|Period I|Protocol deviation|0
7302281|NCT00615030|11524544|FG000|Period I|Subject withdrew consent|0
7302282|NCT00615030|11524545|FG001|Period I|Subject withdrew consent|0
7302283|NCT00615030|11524546|FG002|Period I|Subject withdrew consent|0
7302284|NCT00615030|11524547|FG003|Period I|Subject withdrew consent|0
7302285|NCT00615030|11524548|FG004|Period I|Subject withdrew consent|0
7302286|NCT00615030|11524549|FG005|Period I|Subject withdrew consent|0
7302287|NCT00615030|11524550|FG006|Period I|Subject withdrew consent|0
7302288|NCT00615030|11524551|FG007|Period I|Subject withdrew consent|0
7302289|NCT00615030|11524552|FG008|Period I|Subject withdrew consent|1
7302290|NCT00615030|11524553|FG009|Period I|Subject withdrew consent|0
7302291|NCT00615030|11524554|FG010|Period I|Subject withdrew consent|1
7302292|NCT00615030|11524555|FG011|Period I|Subject withdrew consent|1
7302293|NCT00615030|11524544|FG000|Period I|Abnormal laboratory value(s)|0
7302294|NCT00615030|11524545|FG001|Period I|Abnormal laboratory value(s)|0
7302295|NCT00615030|11524546|FG002|Period I|Abnormal laboratory value(s)|0
7302296|NCT00615030|11524547|FG003|Period I|Abnormal laboratory value(s)|0
7302297|NCT00615030|11524548|FG004|Period I|Abnormal laboratory value(s)|0
7302298|NCT00615030|11524549|FG005|Period I|Abnormal laboratory value(s)|1
7302299|NCT00615030|11524550|FG006|Period I|Abnormal laboratory value(s)|0
7302300|NCT00615030|11524551|FG007|Period I|Abnormal laboratory value(s)|0
7302301|NCT00615030|11524552|FG008|Period I|Abnormal laboratory value(s)|0
7302302|NCT00615030|11524553|FG009|Period I|Abnormal laboratory value(s)|0
7302303|NCT00615030|11524554|FG010|Period I|Abnormal laboratory value(s)|0
7302304|NCT00615030|11524555|FG011|Period I|Abnormal laboratory value(s)|0
7302305|NCT00615030|11524544|FG000|Period II|Adverse Event|0
7302306|NCT00615030|11524545|FG001|Period II|Adverse Event|0
7302307|NCT00615030|11524546|FG002|Period II|Adverse Event|1
7302308|NCT00615030|11524547|FG003|Period II|Adverse Event|0
7302309|NCT00615030|11524548|FG004|Period II|Adverse Event|0
7302310|NCT00615030|11524549|FG005|Period II|Adverse Event|0
7302311|NCT00615030|11524550|FG006|Period II|Adverse Event|0
7302312|NCT00615030|11524551|FG007|Period II|Adverse Event|0
7302313|NCT00615030|11524552|FG008|Period II|Adverse Event|1
7302314|NCT00615030|11524553|FG009|Period II|Adverse Event|0
7302315|NCT00615030|11524554|FG010|Period II|Adverse Event|0
7302316|NCT00615030|11524555|FG011|Period II|Adverse Event|0
7302317|NCT00615030|11524544|FG000|Period II|Subject withdrew consent|0
7302318|NCT00615030|11524545|FG001|Period II|Subject withdrew consent|0
7302319|NCT00615030|11524546|FG002|Period II|Subject withdrew consent|0
7302320|NCT00615030|11524547|FG003|Period II|Subject withdrew consent|1
7302321|NCT00615030|11524548|FG004|Period II|Subject withdrew consent|0
7302322|NCT00615030|11524549|FG005|Period II|Subject withdrew consent|0
7302323|NCT00615030|11524550|FG006|Period II|Subject withdrew consent|1
7302324|NCT00615030|11524551|FG007|Period II|Subject withdrew consent|0
7302325|NCT00615030|11524552|FG008|Period II|Subject withdrew consent|0
7302326|NCT00615030|11524553|FG009|Period II|Subject withdrew consent|0
7302327|NCT00615030|11524554|FG010|Period II|Subject withdrew consent|0
7302328|NCT00615030|11524555|FG011|Period II|Subject withdrew consent|0
7302329|NCT00615030|11524544|FG000|Period III|Administrative problems|1
7302330|NCT00615030|11524545|FG001|Period III|Administrative problems|0
7302331|NCT00615030|11524546|FG002|Period III|Administrative problems|0
7302332|NCT00615030|11524547|FG003|Period III|Administrative problems|1
7302333|NCT00615030|11524548|FG004|Period III|Administrative problems|0
7302334|NCT00615030|11524549|FG005|Period III|Administrative problems|0
7302335|NCT00615030|11524550|FG006|Period III|Administrative problems|0
7302336|NCT00615030|11524551|FG007|Period III|Administrative problems|0
7302337|NCT00615030|11524552|FG008|Period III|Administrative problems|0
7302338|NCT00615030|11524553|FG009|Period III|Administrative problems|0
7302339|NCT00615030|11524554|FG010|Period III|Administrative problems|0
7302340|NCT00615030|11524555|FG011|Period III|Administrative problems|0
7302341|NCT00615056|11524573|FG000|Overall Study|Death|31
7302342|NCT00615056|11524574|FG001|Overall Study|Death|31
7302343|NCT00615056|11524575|FG002|Overall Study|Death|21
7302344|NCT00615056|11524576|FG003|Overall Study|Death|23
7302345|NCT00615056|11524573|FG000|Overall Study|Lost to Follow-up|1
7302346|NCT00615056|11524574|FG001|Overall Study|Lost to Follow-up|2
7302347|NCT00615056|11524575|FG002|Overall Study|Lost to Follow-up|4
7302348|NCT00615056|11524576|FG003|Overall Study|Lost to Follow-up|5
7302349|NCT00615056|11524573|FG000|Overall Study|Other|13
7302350|NCT00615056|11524574|FG001|Overall Study|Other|15
7302351|NCT00615056|11524575|FG002|Overall Study|Other|10
7302352|NCT00615056|11524576|FG003|Overall Study|Other|7
7302353|NCT00615056|11524573|FG000|Overall Study|Objective progression or relapse|0
7302354|NCT00615056|11524574|FG001|Overall Study|Objective progression or relapse|2
7302355|NCT00615056|11524575|FG002|Overall Study|Objective progression or relapse|0
7302356|NCT00615056|11524576|FG003|Overall Study|Objective progression or relapse|0
7302357|NCT00615056|11524573|FG000|Overall Study|Withdrawal by Subject|0
7302358|NCT00615056|11524574|FG001|Overall Study|Withdrawal by Subject|1
7302359|NCT00615056|11524575|FG002|Overall Study|Withdrawal by Subject|1
7302360|NCT00615056|11524576|FG003|Overall Study|Withdrawal by Subject|0
7302361|NCT00615056|11524573|FG000|Overall Study|Discontinued by Sponsor|1
7302362|NCT00615056|11524574|FG001|Overall Study|Discontinued by Sponsor|0
7302363|NCT00615056|11524575|FG002|Overall Study|Discontinued by Sponsor|0
7302364|NCT00615056|11524576|FG003|Overall Study|Discontinued by Sponsor|0
7302365|NCT00615056|11524573|FG000|Overall Study|Randomized but not treated|3
7302366|NCT00615056|11524574|FG001|Overall Study|Randomized but not treated|0
7302367|NCT00615056|11524575|FG002|Overall Study|Randomized but not treated|0
7302368|NCT00615056|11524576|FG003|Overall Study|Randomized but not treated|0
7302369|NCT00615069|11524586|FG000|Overall Study|Death|10
7302370|NCT00615069|11524586|FG000|Overall Study|Physician Decision|2
7302371|NCT00615069|11524586|FG000|Overall Study|Withdrawal by Subject|4
7302372|NCT00615108|11524590|FG000|Overall Study|Adverse Event|122
7302373|NCT00615108|11524590|FG000|Overall Study|Other|370
7302374|NCT00615108|11524590|FG000|Overall Study|Lost to Follow-up|15
7302375|NCT00615199|11524600|FG000|Overall Study|Adverse Event|3
7302376|NCT00615199|11524601|FG001|Overall Study|Adverse Event|1
7302377|NCT00615199|11524602|FG002|Overall Study|Adverse Event|1
7302378|NCT00615199|11524603|FG003|Overall Study|Adverse Event|0
7302379|NCT00615199|11524600|FG000|Overall Study|Lack of Efficacy|2
7302380|NCT00615199|11524601|FG001|Overall Study|Lack of Efficacy|0
7302381|NCT00615199|11524602|FG002|Overall Study|Lack of Efficacy|0
7302382|NCT00615199|11524603|FG003|Overall Study|Lack of Efficacy|1
7302383|NCT00615199|11524600|FG000|Overall Study|Lost to Follow-up|1
7302384|NCT00615199|11524601|FG001|Overall Study|Lost to Follow-up|0
7302385|NCT00615199|11524602|FG002|Overall Study|Lost to Follow-up|0
7302386|NCT00615199|11524603|FG003|Overall Study|Lost to Follow-up|0
7302387|NCT00615199|11524600|FG000|Overall Study|Other|0
7302388|NCT00615199|11524601|FG001|Overall Study|Other|0
7302389|NCT00615199|11524602|FG002|Overall Study|Other|0
7302390|NCT00615199|11524603|FG003|Overall Study|Other|1
7302391|NCT00615199|11524600|FG000|Overall Study|Withdrawal by Subject|2
7302392|NCT00615199|11524601|FG001|Overall Study|Withdrawal by Subject|1
7302393|NCT00615199|11524602|FG002|Overall Study|Withdrawal by Subject|0
7302394|NCT00615199|11524603|FG003|Overall Study|Withdrawal by Subject|0
7302395|NCT00615264|11524615|FG000|Overall Study|Withdrawal by Subject|17
7302396|NCT00615264|11524616|FG001|Overall Study|Withdrawal by Subject|19
7302397|NCT00615264|11524615|FG000|Overall Study|Lost to Follow-up|6
7302398|NCT00615264|11524616|FG001|Overall Study|Lost to Follow-up|13
7302399|NCT00615264|11524615|FG000|Overall Study|Adverse Event|8
7302400|NCT00615264|11524616|FG001|Overall Study|Adverse Event|5
7302401|NCT00615264|11524615|FG000|Overall Study|Death|1
7302402|NCT00615264|11524616|FG001|Overall Study|Death|1
7302403|NCT00615264|11524615|FG000|Overall Study|Protocol Violation|11
7302404|NCT00615264|11524616|FG001|Overall Study|Protocol Violation|7
7302405|NCT00615264|11524615|FG000|Overall Study|Not defined|7
7302406|NCT00615264|11524616|FG001|Overall Study|Not defined|4
7302407|NCT00615264|11524615|FG000|Overall Study|Dermal Hypersensitivity|0
7302408|NCT00615264|11524616|FG001|Overall Study|Dermal Hypersensitivity|3
7302409|NCT00615290|11524622|FG000|Overall Study|Adverse Event|2
7302410|NCT00615290|11524622|FG000|Overall Study|Lost to Follow-up|3
7302411|NCT00615290|11524622|FG000|Overall Study|Withdrawal by Subject|1
7302412|NCT00615290|11524622|FG000|Overall Study|Other|2
7302413|NCT00615459|11524653|FG000|Period I|Adverse Event|2
7302414|NCT00615459|11524654|FG001|Period I|Adverse Event|0
7302415|NCT00615459|11524655|FG002|Period I|Adverse Event|1
7302416|NCT00615459|11524656|FG003|Period I|Adverse Event|0
7302417|NCT00615459|11524653|FG000|Period I|Subject withdrew consent|1
7302418|NCT00615459|11524654|FG001|Period I|Subject withdrew consent|0
7302419|NCT00615459|11524655|FG002|Period I|Subject withdrew consent|0
7302420|NCT00615459|11524656|FG003|Period I|Subject withdrew consent|1
7302421|NCT00615459|11524653|FG000|Period I|Abnormal test procedure results|1
7302422|NCT00615459|11524654|FG001|Period I|Abnormal test procedure results|1
7302423|NCT00615459|11524655|FG002|Period I|Abnormal test procedure results|1
7302424|NCT00615459|11524656|FG003|Period I|Abnormal test procedure results|0
7302425|NCT00615459|11524653|FG000|Period II|Adverse Event|1
7302426|NCT00615459|11524654|FG001|Period II|Adverse Event|0
7302427|NCT00615459|11524655|FG002|Period II|Adverse Event|0
7302428|NCT00615459|11524656|FG003|Period II|Adverse Event|0
7302429|NCT00615459|11524653|FG000|Period II|Lost to Follow-up|0
7302430|NCT00615459|11524654|FG001|Period II|Lost to Follow-up|0
7302431|NCT00615459|11524655|FG002|Period II|Lost to Follow-up|0
7302432|NCT00615459|11524656|FG003|Period II|Lost to Follow-up|1
7302433|NCT00615459|11524653|FG000|Period III|Adverse Event|0
7302434|NCT00615459|11524654|FG001|Period III|Adverse Event|1
7302435|NCT00615459|11524655|FG002|Period III|Adverse Event|0
7302436|NCT00615459|11524656|FG003|Period III|Adverse Event|0
7302437|NCT00615459|11524653|FG000|Period III|Administrative problems|0
7302438|NCT00615459|11524654|FG001|Period III|Administrative problems|1
7302439|NCT00615459|11524655|FG002|Period III|Administrative problems|1
7302440|NCT00615459|11524656|FG003|Period III|Administrative problems|0
7302441|NCT00615459|11524653|FG000|Period III|Unsatisfactory therapeutic effect|0
7302442|NCT00615459|11524654|FG001|Period III|Unsatisfactory therapeutic effect|1
7302443|NCT00615459|11524655|FG002|Period III|Unsatisfactory therapeutic effect|0
7302444|NCT00615459|11524656|FG003|Period III|Unsatisfactory therapeutic effect|0
7302445|NCT00615550|11524677|FG000|Overall Study|Lost to Follow-up|6
7302446|NCT00615550|11524678|FG001|Overall Study|Lost to Follow-up|1
7302447|NCT00615719|11524689|FG000|Overall Study|Physician Decision|5
7302448|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
7302449|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
7302450|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
7302451|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
7302452|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
7302453|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
7302454|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7302455|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7302456|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
7302457|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
7302458|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7302459|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
7302540|NCT00616629|11524814|FG002|Overall Study|AV-block|0
7302460|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
7302461|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7302462|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
7302463|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
7302464|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
7302465|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
7302466|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
7302467|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
7302468|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
7302469|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
7302470|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
7302471|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
7302472|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
7302473|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7302474|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
7302475|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
7302476|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
7302477|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
7302478|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Other|10
7302479|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Other|7
7302480|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Other|8
7302481|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Other|8
7302482|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Other|0
7302483|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Not reported|6
7302484|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Not reported|4
7302485|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Not reported|1
7302486|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Not reported|4
7302487|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Not reported|0
7302488|NCT00615836|11524701|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
7302489|NCT00615836|11524702|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7302490|NCT00615836|11524703|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7302491|NCT00615836|11524704|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7302492|NCT00615836|11524705|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
7302493|NCT00615901|11524721|FG000|Overall Study|Withdrawal by Subject|2
7302494|NCT00615901|11524721|FG000|Overall Study|Adverse Event|7
7302495|NCT00615914|11524725|FG000|Overall Study|Adverse Event|274
7302496|NCT00615914|11524725|FG000|Overall Study|Death|20
7302497|NCT00615914|11524725|FG000|Overall Study|Lack of Efficacy|59
7302498|NCT00615914|11524725|FG000|Overall Study|Lost to Follow-up|187
7302499|NCT00615914|11524725|FG000|Overall Study|Withdrawal by Subject|16
7302500|NCT00615914|11524725|FG000|Overall Study|Physician Decision|4
7302501|NCT00615914|11524725|FG000|Overall Study|No data was collected.|65
7302502|NCT00615914|11524725|FG000|Overall Study|No treatment|2
7302503|NCT00615914|11524725|FG000|Overall Study|Irregularly enrolled patients|10
7302504|NCT00615992|11524739|FG000|Overall Study|Protocol Violation|67
7302505|NCT00616018|11524743|FG000|Overall Study|Protocol Violation|3
7302506|NCT00616239|11524767|FG000|Overall Study|Withdrawal by Subject|2
7302507|NCT00616421|11524774|FG000|Overall Study|Withdrawal by Subject|9
7302508|NCT00616421|11524775|FG001|Overall Study|Withdrawal by Subject|11
7302509|NCT00616421|11524776|FG002|Overall Study|Withdrawal by Subject|8
7302510|NCT00616421|11524774|FG000|Overall Study|Lost to Follow-up|12
7302511|NCT00616421|11524775|FG001|Overall Study|Lost to Follow-up|26
7302512|NCT00616421|11524776|FG002|Overall Study|Lost to Follow-up|30
7302513|NCT00616421|11524774|FG000|Overall Study|Inappropriate enrollment|3
7302514|NCT00616421|11524775|FG001|Overall Study|Inappropriate enrollment|0
7302515|NCT00616421|11524776|FG002|Overall Study|Inappropriate enrollment|1
7302516|NCT00616421|11524774|FG000|Overall Study|Administrative reason|1
7302517|NCT00616421|11524775|FG001|Overall Study|Administrative reason|0
7302518|NCT00616421|11524776|FG002|Overall Study|Administrative reason|0
7302519|NCT00616421|11524774|FG000|Overall Study|Protocol Violation|0
7302520|NCT00616421|11524775|FG001|Overall Study|Protocol Violation|1
7302521|NCT00616421|11524776|FG002|Overall Study|Protocol Violation|2
7302522|NCT00616421|11524774|FG000|Overall Study|Unable to classify|1
7302523|NCT00616421|11524775|FG001|Overall Study|Unable to classify|0
7302524|NCT00616421|11524776|FG002|Overall Study|Unable to classify|0
7302525|NCT00616434|11524800|FG000|Overall Study|Adverse Event|5
7302526|NCT00616434|11524801|FG001|Overall Study|Adverse Event|2
7302527|NCT00616434|11524800|FG000|Overall Study|Physician Decision|0
7302528|NCT00616434|11524801|FG001|Overall Study|Physician Decision|4
7302529|NCT00616434|11524800|FG000|Overall Study|Withdrawal by Subject|1
7302530|NCT00616434|11524801|FG001|Overall Study|Withdrawal by Subject|1
7302531|NCT00616434|11524800|FG000|Overall Study|Protocol deviation|0
7302532|NCT00616434|11524801|FG001|Overall Study|Protocol deviation|1
7302533|NCT00616629|11524812|FG000|Overall Study|Protocol Violation|1
7302534|NCT00616629|11524813|FG001|Overall Study|Protocol Violation|2
7302535|NCT00616629|11524814|FG002|Overall Study|Protocol Violation|1
7302536|NCT00616629|11524815|FG003|Overall Study|Protocol Violation|0
7302537|NCT00616629|11524816|FG004|Overall Study|Protocol Violation|0
7302538|NCT00616629|11524812|FG000|Overall Study|AV-block|1
7302539|NCT00616629|11524813|FG001|Overall Study|AV-block|0
7302541|NCT00616629|11524815|FG003|Overall Study|AV-block|0
7302542|NCT00616629|11524816|FG004|Overall Study|AV-block|0
7302543|NCT00616655|11524831|FG000|Overall Study|Adverse Event|10
7302544|NCT00616655|11524832|FG001|Overall Study|Adverse Event|7
7302545|NCT00616655|11524833|FG002|Overall Study|Adverse Event|12
7302546|NCT00616655|11524831|FG000|Overall Study|Lack of Efficacy|5
7302547|NCT00616655|11524832|FG001|Overall Study|Lack of Efficacy|5
7302548|NCT00616655|11524833|FG002|Overall Study|Lack of Efficacy|5
7302549|NCT00616655|11524831|FG000|Overall Study|Lost to Follow-up|3
7302550|NCT00616655|11524832|FG001|Overall Study|Lost to Follow-up|12
7302551|NCT00616655|11524833|FG002|Overall Study|Lost to Follow-up|10
7302552|NCT00616655|11524831|FG000|Overall Study|Protocol Violation|2
7302553|NCT00616655|11524832|FG001|Overall Study|Protocol Violation|4
7302554|NCT00616655|11524833|FG002|Overall Study|Protocol Violation|3
7302555|NCT00616655|11524831|FG000|Overall Study|Withdrawal by Subject|9
7302556|NCT00616655|11524832|FG001|Overall Study|Withdrawal by Subject|7
7302557|NCT00616655|11524833|FG002|Overall Study|Withdrawal by Subject|11
7302558|NCT00616655|11524831|FG000|Overall Study|Does not meet in/ex criteria|0
7302559|NCT00616655|11524832|FG001|Overall Study|Does not meet in/ex criteria|0
7302560|NCT00616655|11524833|FG002|Overall Study|Does not meet in/ex criteria|2
7302561|NCT00616655|11524831|FG000|Overall Study|Other|6
7302562|NCT00616655|11524832|FG001|Overall Study|Other|6
7302563|NCT00616655|11524833|FG002|Overall Study|Other|5
7551921|NCT02976519|11911432|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
7551922|NCT02976519|11911433|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
7551923|NCT02976519|11911434|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
7551924|NCT02976519|11911435|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
7551925|NCT02976519|11911436|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
7551926|NCT02976519|11911437|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
7551927|NCT02976519|11911431|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551928|NCT02976519|11911432|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551929|NCT02976519|11911433|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551930|NCT02976519|11911434|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551931|NCT02976519|11911435|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551932|NCT02976519|11911436|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
7551933|NCT02976519|11911437|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
7551934|NCT02976519|11911431|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551935|NCT02976519|11911432|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551936|NCT02976519|11911433|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551937|NCT02976519|11911434|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551938|NCT02976519|11911435|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551939|NCT02976519|11911436|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
7551940|NCT02976519|11911437|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
7551941|NCT02977507|11911457|FG000|Overall Study|Protocol Deviation|1
7551942|NCT02977507|11911458|FG001|Overall Study|Protocol Deviation|0
7551943|NCT02977507|11911457|FG000|Overall Study|Lost to Follow-up|1
7551944|NCT02977507|11911458|FG001|Overall Study|Lost to Follow-up|0
7551945|NCT02977572|11911467|FG000|Overall Study|Exclusion criterion|2
7551946|NCT02977572|11911468|FG001|Overall Study|Exclusion criterion|2
7551947|NCT02978417|11911502|FG000|Overall Study|Lost to Follow-up|2
7551948|NCT02978417|11911503|FG001|Overall Study|Lost to Follow-up|2
7551949|NCT02979197|11911530|FG000|Overall Study|Adverse Event|4
7551950|NCT02979197|11911531|FG001|Overall Study|Adverse Event|2
7551951|NCT02979197|11911532|FG002|Overall Study|Adverse Event|0
7551952|NCT02979197|11911530|FG000|Overall Study|Protocol Violation|0
7551953|NCT02979197|11911531|FG001|Overall Study|Protocol Violation|1
7551954|NCT02979197|11911532|FG002|Overall Study|Protocol Violation|0
7551955|NCT02979197|11911530|FG000|Overall Study|Subject unable to commit to study dates|0
7302564|NCT00616902|11524852|FG000|Overall Study|Termination of study|6
7302565|NCT00616902|11524853|FG001|Overall Study|Termination of study|6
7302566|NCT00616928|11524863|FG000|Overall Study|Adverse Event|6
7302567|NCT00616928|11524864|FG001|Overall Study|Adverse Event|3
7302568|NCT00616928|11524865|FG002|Overall Study|Adverse Event|2
7302569|NCT00616928|11524866|FG003|Overall Study|Adverse Event|2
7302570|NCT00616928|11524863|FG000|Overall Study|Other|51
7302571|NCT00616928|11524864|FG001|Overall Study|Other|8
7302572|NCT00616928|11524865|FG002|Overall Study|Other|15
7302573|NCT00616928|11524866|FG003|Overall Study|Other|5
7302574|NCT00616928|11524863|FG000|Overall Study|Lost to Follow-up|5
7302575|NCT00616928|11524864|FG001|Overall Study|Lost to Follow-up|7
7302576|NCT00616928|11524865|FG002|Overall Study|Lost to Follow-up|0
7302577|NCT00616928|11524866|FG003|Overall Study|Lost to Follow-up|0
7302578|NCT00616941|11524891|FG000|Overall Study|Progressive Disease|1
7302579|NCT00616941|11524892|FG001|Overall Study|Progressive Disease|2
7302580|NCT00616941|11524893|FG002|Overall Study|Progressive Disease|1
7302581|NCT00616941|11524891|FG000|Overall Study|Adverse Event|0
7302582|NCT00616941|11524892|FG001|Overall Study|Adverse Event|1
7302583|NCT00616941|11524893|FG002|Overall Study|Adverse Event|1
7302584|NCT00616941|11524891|FG000|Overall Study|Subject Non-compliance|0
7302585|NCT00616941|11524892|FG001|Overall Study|Subject Non-compliance|0
7302586|NCT00616941|11524893|FG002|Overall Study|Subject Non-compliance|1
7302587|NCT00616941|11524891|FG000|Overall Study|Unrelated Medical Illness/Complication|0
7302588|NCT00616941|11524892|FG001|Overall Study|Unrelated Medical Illness/Complication|2
7302589|NCT00616941|11524893|FG002|Overall Study|Unrelated Medical Illness/Complication|0
7302590|NCT00616941|11524891|FG000|Overall Study|Vaccination Suspended|0
7302591|NCT00616941|11524892|FG001|Overall Study|Vaccination Suspended|0
7302592|NCT00616941|11524893|FG002|Overall Study|Vaccination Suspended|3
7302593|NCT00617084|11524916|FG000|Overall Study|Withdrawal by Subject|5
7302594|NCT00617084|11524917|FG001|Overall Study|Withdrawal by Subject|7
7302595|NCT00617084|11524916|FG000|Overall Study|Missed 12 Months visit|16
7302596|NCT00617084|11524917|FG001|Overall Study|Missed 12 Months visit|19
7302597|NCT00617123|11524936|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
7302598|NCT00617123|11524937|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
7302599|NCT00617123|11524936|FG000|Referral Screening Period|Did Not Wish To Continue|3
7302600|NCT00617123|11524937|FG001|Referral Screening Period|Did Not Wish To Continue|1
7302601|NCT00617123|11524936|FG000|Referral Screening Period|Adverse Event|0
7302602|NCT00617123|11524937|FG001|Referral Screening Period|Adverse Event|1
7302603|NCT00617123|11524936|FG000|Study Treatment Period|Withdrawal by Subject|8
7302604|NCT00617123|11524937|FG001|Study Treatment Period|Withdrawal by Subject|12
7302605|NCT00617123|11524936|FG000|Study Treatment Period|Adverse Event|7
7302606|NCT00617123|11524937|FG001|Study Treatment Period|Adverse Event|3
7302607|NCT00617123|11524936|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
7302608|NCT00617123|11524937|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
7302609|NCT00617123|11524936|FG000|Study Treatment Period|Noncompliance with Protocol|0
7302610|NCT00617123|11524937|FG001|Study Treatment Period|Noncompliance with Protocol|1
7302611|NCT00617201|11524958|FG000|Overall Study|Lost to Follow-up|9
7302612|NCT00617201|11524959|FG001|Overall Study|Lost to Follow-up|13
7302613|NCT00617240|11524969|FG000|Overall Study|Lack of Efficacy|1
7302614|NCT00617240|11524970|FG001|Overall Study|Lack of Efficacy|0
7302615|NCT00617279|11524978|FG000|Overall Study|Study terminated by Sponsor|10
7302616|NCT00617279|11524979|FG001|Overall Study|Study terminated by Sponsor|15
7302617|NCT00617279|11524978|FG000|Overall Study|Graft abandonment|2
7302618|NCT00617279|11524979|FG001|Overall Study|Graft abandonment|0
7302619|NCT00617279|11524978|FG000|Overall Study|Lost to Follow-up|1
7302620|NCT00617279|11524979|FG001|Overall Study|Lost to Follow-up|0
7302621|NCT00617279|11524978|FG000|Overall Study|Death|1
7302622|NCT00617279|11524979|FG001|Overall Study|Death|2
7302623|NCT00617305|11524988|FG000|Overall Study|Adverse Event|4
7302624|NCT00617305|11524989|FG001|Overall Study|Adverse Event|0
7302625|NCT00617305|11524990|FG002|Overall Study|Adverse Event|0
7302626|NCT00617305|11524988|FG000|Overall Study|Death|1
7302627|NCT00617305|11524989|FG001|Overall Study|Death|0
7302628|NCT00617305|11524990|FG002|Overall Study|Death|0
7302629|NCT00617305|11524988|FG000|Overall Study|Physician Decision|1
7302630|NCT00617305|11524989|FG001|Overall Study|Physician Decision|0
7302631|NCT00617305|11524990|FG002|Overall Study|Physician Decision|0
7302632|NCT00617305|11524988|FG000|Overall Study|Protocol Violation|1
7302633|NCT00617305|11524989|FG001|Overall Study|Protocol Violation|0
7302634|NCT00617305|11524990|FG002|Overall Study|Protocol Violation|1
7302635|NCT00617305|11524988|FG000|Overall Study|Withdrawal by Subject|1
7302636|NCT00617305|11524989|FG001|Overall Study|Withdrawal by Subject|0
7302637|NCT00617305|11524990|FG002|Overall Study|Withdrawal by Subject|0
7302638|NCT00617344|11525004|FG000|Overall Study|Serious adverse event|1
7302639|NCT00617344|11525005|FG001|Overall Study|Serious adverse event|0
7302640|NCT00617344|11525006|FG002|Overall Study|Serious adverse event|0
7302641|NCT00617344|11525004|FG000|Overall Study|Other Adverse Event|1
7302642|NCT00617344|11525005|FG001|Overall Study|Other Adverse Event|1
7302643|NCT00617344|11525006|FG002|Overall Study|Other Adverse Event|0
7302644|NCT00617344|11525004|FG000|Overall Study|Protocol Violation|10
7302645|NCT00617344|11525005|FG001|Overall Study|Protocol Violation|8
7302646|NCT00617344|11525006|FG002|Overall Study|Protocol Violation|5
7302647|NCT00617344|11525004|FG000|Overall Study|Lost to Follow-up|5
7302648|NCT00617344|11525005|FG001|Overall Study|Lost to Follow-up|4
7302649|NCT00617344|11525006|FG002|Overall Study|Lost to Follow-up|1
7302650|NCT00617344|11525004|FG000|Overall Study|Withdrawal by Subject|8
7302651|NCT00617344|11525005|FG001|Overall Study|Withdrawal by Subject|9
7302652|NCT00617344|11525006|FG002|Overall Study|Withdrawal by Subject|2
7302653|NCT00617357|11525014|FG000|Overall Study|Lost to Follow-up|7
7302654|NCT00617357|11525014|FG000|Overall Study|Death|5
7302655|NCT00617357|11525014|FG000|Overall Study|insurance concerns|2
7302656|NCT00617357|11525014|FG000|Overall Study|Withdrawal by Subject|1
7302657|NCT00617357|11525014|FG000|Overall Study|Physician Decision|1
7302658|NCT00617409|11525026|FG000|Overall Study|Withdrawal by Subject|4
7302659|NCT00617409|11525027|FG001|Overall Study|Withdrawal by Subject|1
7302660|NCT00617409|11525028|FG002|Overall Study|Withdrawal by Subject|2
7302661|NCT00617409|11525026|FG000|Overall Study|Adverse Event|0
7302662|NCT00617409|11525027|FG001|Overall Study|Adverse Event|2
7302663|NCT00617409|11525028|FG002|Overall Study|Adverse Event|3
7302664|NCT00617409|11525026|FG000|Overall Study|Disease Progression|8
7302665|NCT00617409|11525027|FG001|Overall Study|Disease Progression|8
7302666|NCT00617409|11525028|FG002|Overall Study|Disease Progression|18
7302667|NCT00617409|11525026|FG000|Overall Study|Death|3
7302668|NCT00617409|11525027|FG001|Overall Study|Death|5
7302669|NCT00617409|11525028|FG002|Overall Study|Death|4
7302670|NCT00617409|11525026|FG000|Overall Study|Alternative Therapy|1
7302671|NCT00617409|11525027|FG001|Overall Study|Alternative Therapy|2
7302672|NCT00617409|11525028|FG002|Overall Study|Alternative Therapy|0
7302673|NCT00617461|11525037|FG000|First Treatment Intervention Period|Adverse Event|2
7302674|NCT00617461|11525038|FG001|First Treatment Intervention Period|Adverse Event|0
7302675|NCT00617461|11525037|FG000|First Treatment Intervention Period|Lack of Efficacy|1
7302676|NCT00617461|11525038|FG001|First Treatment Intervention Period|Lack of Efficacy|0
7302677|NCT00617461|11525037|FG000|First Treatment Intervention Period|Protocol Violation|2
7302678|NCT00617461|11525038|FG001|First Treatment Intervention Period|Protocol Violation|1
7302679|NCT00617461|11525037|FG000|First Treatment Intervention Period|Lost to Follow-up|0
7302680|NCT00617461|11525038|FG001|First Treatment Intervention Period|Lost to Follow-up|1
7302681|NCT00617461|11525037|FG000|First Treatment Intervention Period|Investigator Discretion|1
7302682|NCT00617461|11525038|FG001|First Treatment Intervention Period|Investigator Discretion|1
7302683|NCT00617461|11525037|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
7302684|NCT00617461|11525038|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
7302685|NCT00617461|11525037|FG000|4-Day Crossover Period|Withdrawal by Subject|1
7302686|NCT00617461|11525038|FG001|4-Day Crossover Period|Withdrawal by Subject|0
7302687|NCT00617461|11525037|FG000|Second Treatment Intervention Period|Adverse Event|0
7302688|NCT00617461|11525038|FG001|Second Treatment Intervention Period|Adverse Event|1
7302689|NCT00617461|11525037|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
7302690|NCT00617461|11525038|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
7302691|NCT00617461|11525037|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
7302692|NCT00617461|11525038|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
7302693|NCT00617461|11525037|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
7302694|NCT00617461|11525038|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
7302695|NCT00617591|11525065|FG000|Overall Study|Withdrew consent during Induction|4
7302696|NCT00617591|11525065|FG000|Overall Study|Withdrew consent during Maintenance|6
7302697|NCT00617604|11525072|FG000|Overall Study|Death|2
7302698|NCT00617604|11525073|FG001|Overall Study|Death|1
7302699|NCT00617604|11525072|FG000|Overall Study|Lost to Follow-up|1
7302700|NCT00617604|11525073|FG001|Overall Study|Lost to Follow-up|0
7302701|NCT00617604|11525072|FG000|Overall Study|Miscellaneous Reasons|8
7302702|NCT00617604|11525073|FG001|Overall Study|Miscellaneous Reasons|10
7302703|NCT00617604|11525072|FG000|Overall Study|Withdrawal by Subject|4
7302704|NCT00617604|11525073|FG001|Overall Study|Withdrawal by Subject|6
7302705|NCT00617604|11525072|FG000|Overall Study|Randomized but Never Received Study Drug|3
7302706|NCT00617604|11525073|FG001|Overall Study|Randomized but Never Received Study Drug|3
7302707|NCT00617669|11525081|FG000|Overall Study|Withdrawal by Subject|71
7302708|NCT00617669|11525082|FG001|Overall Study|Withdrawal by Subject|77
7302709|NCT00617669|11525081|FG000|Overall Study|Lost to Follow-up|3
7302710|NCT00617669|11525082|FG001|Overall Study|Lost to Follow-up|2
7302711|NCT00617669|11525081|FG000|Overall Study|Adverse Event|87
7302712|NCT00617669|11525082|FG001|Overall Study|Adverse Event|76
7302713|NCT00617669|11525081|FG000|Overall Study|Protocol Violation|2
7302714|NCT00617669|11525082|FG001|Overall Study|Protocol Violation|3
7302715|NCT00617669|11525081|FG000|Overall Study|Reason not otherwise captured, eg; death|265
7302716|NCT00617669|11525082|FG001|Overall Study|Reason not otherwise captured, eg; death|290
7302717|NCT00617669|11525081|FG000|Overall Study|Patients randomized but not treated|2
7302718|NCT00617669|11525082|FG001|Overall Study|Patients randomized but not treated|3
7302719|NCT00617734|11525090|FG000|Overall Study|Withdrew Consent|2
7302720|NCT00617734|11525091|FG001|Overall Study|Withdrew Consent|0
7302721|NCT00617734|11525090|FG000|Overall Study|Adverse Event|4
7302722|NCT00617734|11525091|FG001|Overall Study|Adverse Event|1
7302723|NCT00617734|11525090|FG000|Overall Study|Protocol Violation|1
7302724|NCT00617734|11525091|FG001|Overall Study|Protocol Violation|0
7302725|NCT00617734|11525090|FG000|Overall Study|Found Ineligible After Randomization|1
7302726|NCT00617734|11525091|FG001|Overall Study|Found Ineligible After Randomization|4
7302727|NCT00617734|11525090|FG000|Overall Study|Lost to Follow-up|0
7302728|NCT00617734|11525091|FG001|Overall Study|Lost to Follow-up|1
7302729|NCT00617773|11525097|FG000|Overall Study|Physician Decision|1
7302730|NCT00617773|11525097|FG000|Overall Study|Lack of compliance with the protocol|1
7302731|NCT00617773|11525097|FG000|Overall Study|Withdrawal by Subject|1
7302732|NCT00617773|11525097|FG000|Overall Study|Death|1
7302733|NCT00617773|11525097|FG000|Overall Study|Progressive disease|19
7302734|NCT00617773|11525097|FG000|Overall Study|Protocol Violation|1
7302735|NCT00617851|11525105|FG000|Overall Study|Death|0
7302736|NCT00617851|11525106|FG001|Overall Study|Death|0
7302737|NCT00617851|11525107|FG002|Overall Study|Death|0
7302738|NCT00617851|11525108|FG003|Overall Study|Death|1
7302739|NCT00617851|11525105|FG000|Overall Study|Withdrawal by Subject|14
7302740|NCT00617851|11525106|FG001|Overall Study|Withdrawal by Subject|7
7302741|NCT00617851|11525107|FG002|Overall Study|Withdrawal by Subject|12
7302742|NCT00617851|11525108|FG003|Overall Study|Withdrawal by Subject|4
7302743|NCT00617851|11525105|FG000|Overall Study|Lost to Follow-up|27
7302744|NCT00617851|11525106|FG001|Overall Study|Lost to Follow-up|29
7302745|NCT00617851|11525107|FG002|Overall Study|Lost to Follow-up|31
7302746|NCT00617851|11525108|FG003|Overall Study|Lost to Follow-up|19
7302747|NCT00617851|11525105|FG000|Overall Study|Inappropriate Enrollment|5
7302748|NCT00617851|11525106|FG001|Overall Study|Inappropriate Enrollment|4
7302749|NCT00617851|11525107|FG002|Overall Study|Inappropriate Enrollment|1
7302750|NCT00617851|11525108|FG003|Overall Study|Inappropriate Enrollment|1
7302751|NCT00617851|11525105|FG000|Overall Study|Unable to classify|1
7302752|NCT00617851|11525106|FG001|Overall Study|Unable to classify|0
7302753|NCT00617851|11525107|FG002|Overall Study|Unable to classify|1
7302754|NCT00617851|11525108|FG003|Overall Study|Unable to classify|0
7302755|NCT00617890|11525132|FG000|Overall Study|Treatment ongoing at data cut-off|0
7302756|NCT00617890|11525133|FG001|Overall Study|Treatment ongoing at data cut-off|0
7302757|NCT00617890|11525134|FG002|Overall Study|Treatment ongoing at data cut-off|0
7302758|NCT00617890|11525135|FG003|Overall Study|Treatment ongoing at data cut-off|5
7302759|NCT00617890|11525132|FG000|Overall Study|Lack of Efficacy|23
7302760|NCT00617890|11525133|FG001|Overall Study|Lack of Efficacy|26
7302761|NCT00617890|11525134|FG002|Overall Study|Lack of Efficacy|30
7302762|NCT00617890|11525135|FG003|Overall Study|Lack of Efficacy|97
7302763|NCT00617890|11525132|FG000|Overall Study|Lost to Follow-up|0
7302764|NCT00617890|11525133|FG001|Overall Study|Lost to Follow-up|0
7302765|NCT00617890|11525134|FG002|Overall Study|Lost to Follow-up|1
7302766|NCT00617890|11525135|FG003|Overall Study|Lost to Follow-up|2
7302767|NCT00617890|11525132|FG000|Overall Study|Withdrawal by Subject|4
7302768|NCT00617890|11525133|FG001|Overall Study|Withdrawal by Subject|1
7302769|NCT00617890|11525134|FG002|Overall Study|Withdrawal by Subject|0
7302770|NCT00617890|11525135|FG003|Overall Study|Withdrawal by Subject|2
7302771|NCT00617890|11525132|FG000|Overall Study|Protocol Violation|2
7302772|NCT00617890|11525133|FG001|Overall Study|Protocol Violation|1
7302773|NCT00617890|11525134|FG002|Overall Study|Protocol Violation|0
7302774|NCT00617890|11525135|FG003|Overall Study|Protocol Violation|0
7302775|NCT00617890|11525132|FG000|Overall Study|Adverse Event|1
7302776|NCT00617890|11525133|FG001|Overall Study|Adverse Event|0
7302777|NCT00617890|11525134|FG002|Overall Study|Adverse Event|3
7302778|NCT00617890|11525135|FG003|Overall Study|Adverse Event|8
7302779|NCT00617890|11525132|FG000|Overall Study|Not treated|1
7302780|NCT00617890|11525133|FG001|Overall Study|Not treated|0
7302781|NCT00617890|11525134|FG002|Overall Study|Not treated|1
7302782|NCT00617890|11525135|FG003|Overall Study|Not treated|1
7302783|NCT00617903|11525150|FG000|Overall Study|Withdrawal by Subject|2
7302784|NCT00617903|11525151|FG001|Overall Study|Withdrawal by Subject|3
7302785|NCT00617903|11525150|FG000|Overall Study|Lost to Follow-up|1
7302786|NCT00617903|11525151|FG001|Overall Study|Lost to Follow-up|1
7302787|NCT00617903|11525150|FG000|Overall Study|Lack of Efficacy|0
7222802|NCT00027846|11431965|FG001|Overall Study|Entry into another COG therapeutic study|5
7222803|NCT00027846|11431966|FG002|Overall Study|Entry into another COG therapeutic study|2
7222804|NCT00027846|11431964|FG000|Overall Study|Neuraxis dissemination during/after ther|0
7222805|NCT00027846|11431965|FG001|Overall Study|Neuraxis dissemination during/after ther|2
7222806|NCT00027846|11431966|FG002|Overall Study|Neuraxis dissemination during/after ther|5
7222807|NCT00028002|11431976|FG000|Overall Study|Withdrawal by Subject|3
7222808|NCT00028002|11431976|FG000|Overall Study|Ineligible|8
7222809|NCT00028769|11431994|FG000|Overall Study|Adverse Event|2
7302788|NCT00617903|11525151|FG001|Overall Study|Lack of Efficacy|1
7302789|NCT00617903|11525150|FG000|Overall Study|Adverse Event|0
7302790|NCT00617903|11525151|FG001|Overall Study|Adverse Event|1
7302791|NCT00617903|11525150|FG000|Overall Study|noncompliance|0
7302792|NCT00617903|11525151|FG001|Overall Study|noncompliance|1
7302793|NCT00617929|11525157|FG000|Overall Study|Physician Decision|1
7302794|NCT00618072|11525188|FG000|Overall Study|Lost to Follow-up|2
7302795|NCT00618072|11525189|FG001|Overall Study|Lost to Follow-up|0
7302796|NCT00618072|11525190|FG002|Overall Study|Lost to Follow-up|3
7302797|NCT00618072|11525188|FG000|Overall Study|Physician Decision|0
7302798|NCT00618072|11525189|FG001|Overall Study|Physician Decision|1
7302799|NCT00618072|11525190|FG002|Overall Study|Physician Decision|1
7302800|NCT00618371|11525207|FG000|Overall Study|Withdrawal by Subject|2
7302801|NCT00618410|11525212|FG000|Washout Period (2 Weeks)|Physician Decision|0
7302802|NCT00618410|11525213|FG001|Washout Period (2 Weeks)|Physician Decision|1
7302803|NCT00618449|11525230|FG000|Overall Study|Lost to Follow-up|98
7302804|NCT00618449|11525231|FG001|Overall Study|Lost to Follow-up|110
7302805|NCT00618514|11525239|FG000|Overall Study|Lost to Follow-up|11
7302806|NCT00618514|11525240|FG001|Overall Study|Lost to Follow-up|12
7302807|NCT00618514|11525241|FG002|Overall Study|Lost to Follow-up|4
7302808|NCT00618618|11525256|FG000|Overall Study|Patient Request|0
7302809|NCT00618618|11525257|FG001|Overall Study|Patient Request|0
7302810|NCT00618618|11525258|FG002|Overall Study|Patient Request|2
7302811|NCT00618618|11525259|FG003|Overall Study|Patient Request|0
7302812|NCT00618618|11525256|FG000|Overall Study|Inability to Complete Study Procedures|0
7302813|NCT00618618|11525257|FG001|Overall Study|Inability to Complete Study Procedures|1
7302814|NCT00618618|11525258|FG002|Overall Study|Inability to Complete Study Procedures|0
7302815|NCT00618618|11525259|FG003|Overall Study|Inability to Complete Study Procedures|0
7302816|NCT00618618|11525256|FG000|Overall Study|Lost to Follow-up|3
7302817|NCT00618618|11525257|FG001|Overall Study|Lost to Follow-up|0
7302818|NCT00618618|11525258|FG002|Overall Study|Lost to Follow-up|0
7302819|NCT00618618|11525259|FG003|Overall Study|Lost to Follow-up|1
7302820|NCT00618618|11525256|FG000|Overall Study|Non-compliance|1
7302821|NCT00618618|11525257|FG001|Overall Study|Non-compliance|1
7302822|NCT00618618|11525258|FG002|Overall Study|Non-compliance|0
7302823|NCT00618618|11525259|FG003|Overall Study|Non-compliance|0
7302824|NCT00618618|11525256|FG000|Overall Study|Did Not Meet Entry Criteria|0
7302825|NCT00618618|11525257|FG001|Overall Study|Did Not Meet Entry Criteria|0
7302826|NCT00618618|11525258|FG002|Overall Study|Did Not Meet Entry Criteria|1
7302827|NCT00618618|11525259|FG003|Overall Study|Did Not Meet Entry Criteria|0
7302828|NCT00618618|11525256|FG000|Overall Study|Death|0
7302829|NCT00618618|11525257|FG001|Overall Study|Death|1
7302830|NCT00618618|11525258|FG002|Overall Study|Death|0
7302831|NCT00618618|11525259|FG003|Overall Study|Death|0
7302832|NCT00618722|11525274|FG000|Overall Study|Refusal of Treatment|0
7302833|NCT00618722|11525275|FG001|Overall Study|Refusal of Treatment|0
7302834|NCT00618722|11525276|FG002|Overall Study|Refusal of Treatment|1
7302835|NCT00618722|11525277|FG003|Overall Study|Refusal of Treatment|0
7302836|NCT00618722|11525274|FG000|Overall Study|Patient Request|1
7302837|NCT00618722|11525275|FG001|Overall Study|Patient Request|1
7302838|NCT00618722|11525276|FG002|Overall Study|Patient Request|1
7302839|NCT00618722|11525277|FG003|Overall Study|Patient Request|1
7302840|NCT00618722|11525274|FG000|Overall Study|Inability to Complete Study Procedure|0
7302841|NCT00618722|11525275|FG001|Overall Study|Inability to Complete Study Procedure|1
7302842|NCT00618722|11525276|FG002|Overall Study|Inability to Complete Study Procedure|0
7302843|NCT00618722|11525277|FG003|Overall Study|Inability to Complete Study Procedure|0
7302844|NCT00618722|11525274|FG000|Overall Study|Lost to Follow-up|2
7302845|NCT00618722|11525275|FG001|Overall Study|Lost to Follow-up|0
7302846|NCT00618722|11525276|FG002|Overall Study|Lost to Follow-up|0
7302847|NCT00618722|11525277|FG003|Overall Study|Lost to Follow-up|2
7302848|NCT00618722|11525274|FG000|Overall Study|Miscellaneous Reasons|0
7302849|NCT00618722|11525275|FG001|Overall Study|Miscellaneous Reasons|0
7302850|NCT00618722|11525276|FG002|Overall Study|Miscellaneous Reasons|1
7302851|NCT00618722|11525277|FG003|Overall Study|Miscellaneous Reasons|1
7302852|NCT00618748|11525290|FG000|Overall Study|Adverse Event|4
7302853|NCT00618748|11525291|FG001|Overall Study|Adverse Event|3
7302854|NCT00618748|11525292|FG002|Overall Study|Adverse Event|8
7302855|NCT00618748|11525290|FG000|Overall Study|Physician Decision|3
7302856|NCT00618748|11525291|FG001|Overall Study|Physician Decision|1
7302857|NCT00618748|11525292|FG002|Overall Study|Physician Decision|1
7302858|NCT00618748|11525290|FG000|Overall Study|Withdrawal by Subject|4
7302859|NCT00618748|11525291|FG001|Overall Study|Withdrawal by Subject|1
7302860|NCT00618748|11525292|FG002|Overall Study|Withdrawal by Subject|5
7302861|NCT00618774|11525302|FG000|Overall Study|Adverse Event|5
7302862|NCT00618774|11525303|FG001|Overall Study|Adverse Event|3
7302863|NCT00618774|11525302|FG000|Overall Study|Withdrawal by Subject|1
7302864|NCT00618774|11525303|FG001|Overall Study|Withdrawal by Subject|0
7302865|NCT00618787|11525311|FG000|Overall Study|Adverse Event|0
7302866|NCT00618787|11525312|FG001|Overall Study|Adverse Event|1
7302867|NCT00618787|11525311|FG000|Overall Study|Withdrawal by Subject|2
7302868|NCT00618787|11525312|FG001|Overall Study|Withdrawal by Subject|1
7302869|NCT00618787|11525311|FG000|Overall Study|Lost to Follow-up|1
7302870|NCT00618787|11525312|FG001|Overall Study|Lost to Follow-up|0
7302871|NCT00618813|11525318|FG000|Overall Study|Lack of Efficacy|1
7302872|NCT00618813|11525318|FG000|Overall Study|Physician Decision|2
7302873|NCT00618813|11525318|FG000|Overall Study|Withdrawal by Subject|1
7302874|NCT00618826|11525322|FG000|Overall Study|Adverse Event|1
7302875|NCT00618956|11525349|FG000|Overall Study|Adverse Event|10
7302876|NCT00618956|11525350|FG001|Overall Study|Adverse Event|34
7302877|NCT00618956|11525349|FG000|Overall Study|Lack of Efficacy|2
7302878|NCT00618956|11525350|FG001|Overall Study|Lack of Efficacy|1
7302879|NCT00618956|11525349|FG000|Overall Study|Withdrawal by Subject|5
7302880|NCT00618956|11525350|FG001|Overall Study|Withdrawal by Subject|7
7302881|NCT00618956|11525349|FG000|Overall Study|Lost to Follow-up|4
7302882|NCT00618956|11525350|FG001|Overall Study|Lost to Follow-up|5
7302883|NCT00618956|11525349|FG000|Overall Study|Protocol Violation|2
7302884|NCT00618956|11525350|FG001|Overall Study|Protocol Violation|2
7302885|NCT00618956|11525349|FG000|Overall Study|did not meet criteria, non-compliance|2
7302886|NCT00618956|11525350|FG001|Overall Study|did not meet criteria, non-compliance|1
7302887|NCT00618982|11525362|FG000|Overall Study|Adverse Event|23
7302888|NCT00618982|11525362|FG000|Overall Study|Withdrawal by Subject|1
7302889|NCT00618982|11525362|FG000|Overall Study|Protocol Violation|1
7302890|NCT00618982|11525362|FG000|Overall Study|ongoing, still treated with study med.|25
7302891|NCT00618995|11525369|FG000|Period 1|Adverse Event|0
7302892|NCT00618995|11525370|FG001|Period 1|Adverse Event|0
7302893|NCT00618995|11525371|FG002|Period 1|Adverse Event|1
7302894|NCT00618995|11525372|FG003|Period 1|Adverse Event|0
7302895|NCT00618995|11525369|FG000|Period 1|Protocol Violation|0
7302896|NCT00618995|11525370|FG001|Period 1|Protocol Violation|1
7302897|NCT00618995|11525371|FG002|Period 1|Protocol Violation|1
7302898|NCT00618995|11525372|FG003|Period 1|Protocol Violation|0
7302899|NCT00618995|11525369|FG000|Period 2|Protocol Violation|0
7302900|NCT00618995|11525370|FG001|Period 2|Protocol Violation|0
7302901|NCT00618995|11525371|FG002|Period 2|Protocol Violation|1
7302902|NCT00618995|11525372|FG003|Period 2|Protocol Violation|0
7302903|NCT00618995|11525369|FG000|Period 4|Adverse Event|1
7302904|NCT00618995|11525370|FG001|Period 4|Adverse Event|0
7302905|NCT00618995|11525371|FG002|Period 4|Adverse Event|0
7302906|NCT00618995|11525372|FG003|Period 4|Adverse Event|0
7302907|NCT00619099|11525400|FG000|Overall Study|Progressive Disease|7
7302908|NCT00619099|11525401|FG001|Overall Study|Progressive Disease|5
7302909|NCT00619099|11525400|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
7302910|NCT00619099|11525401|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
7302911|NCT00619099|11525400|FG000|Overall Study|Adverse Event|4
7302912|NCT00619099|11525401|FG001|Overall Study|Adverse Event|3
7302913|NCT00619099|11525400|FG000|Overall Study|Emergence of Clinically Significant Lab|1
7302914|NCT00619099|11525401|FG001|Overall Study|Emergence of Clinically Significant Lab|2
7302915|NCT00619099|11525400|FG000|Overall Study|Withdrawal by Subject|10
7302916|NCT00619099|11525401|FG001|Overall Study|Withdrawal by Subject|2
7302917|NCT00619099|11525400|FG000|Overall Study|Physician Decision|9
7302918|NCT00619099|11525401|FG001|Overall Study|Physician Decision|6
7302919|NCT00619112|11525409|FG000|Overall Study|Adverse Event|1
7302920|NCT00619112|11525410|FG001|Overall Study|Adverse Event|2
7302921|NCT00619177|11525419|FG000|Overall Study|Adverse Event|18
7302922|NCT00619177|11525419|FG000|Overall Study|Lost to Follow-up|2
7302923|NCT00619177|11525419|FG000|Overall Study|Lack of Efficacy|1
7302924|NCT00619177|11525419|FG000|Overall Study|Missing termination information|481
7302925|NCT00619177|11525419|FG000|Overall Study|Not specified reasons|6
7302926|NCT00619229|11525434|FG000|Overall Study|Withdrawal by Subject|1
7302927|NCT00619229|11525435|FG001|Overall Study|Withdrawal by Subject|1
7302928|NCT00619229|11525434|FG000|Overall Study|Lost to Follow-up|1
7302929|NCT00619229|11525435|FG001|Overall Study|Lost to Follow-up|0
7302930|NCT00619229|11525434|FG000|Overall Study|Termination of the Study by the Sponsor|1
7302931|NCT00619229|11525435|FG001|Overall Study|Termination of the Study by the Sponsor|1
7302932|NCT00619229|11525434|FG000|Overall Study|Investigator planned Cataract Operation|1
7302933|NCT00619229|11525435|FG001|Overall Study|Investigator planned Cataract Operation|0
7302934|NCT00619307|11525452|FG000|Overall Study|Adverse Event|0
7302935|NCT00619307|11525453|FG001|Overall Study|Adverse Event|1
7302936|NCT00619307|11525452|FG000|Overall Study|Lost to Follow-up|0
7302937|NCT00619307|11525453|FG001|Overall Study|Lost to Follow-up|1
7302938|NCT00619307|11525452|FG000|Overall Study|Protocol Violation|3
7302939|NCT00619307|11525453|FG001|Overall Study|Protocol Violation|0
7302940|NCT00619307|11525452|FG000|Overall Study|Withdrew consent|1
7302941|NCT00619307|11525453|FG001|Overall Study|Withdrew consent|0
7302942|NCT00619307|11525452|FG000|Overall Study|Severe migraine|0
7302943|NCT00619307|11525453|FG001|Overall Study|Severe migraine|1
7302944|NCT00619307|11525452|FG000|Overall Study|MS attack plus steroids|0
7302945|NCT00619307|11525453|FG001|Overall Study|MS attack plus steroids|1
7302946|NCT00619359|11525461|FG000|Overall Study|Adverse Event|32
7302947|NCT00619359|11525462|FG001|Overall Study|Adverse Event|36
7302948|NCT00619359|11525461|FG000|Overall Study|Lost to Follow-up|12
7302949|NCT00619359|11525462|FG001|Overall Study|Lost to Follow-up|16
7302950|NCT00619359|11525461|FG000|Overall Study|Physician Decision|0
7302951|NCT00619359|11525462|FG001|Overall Study|Physician Decision|7
7302952|NCT00619359|11525461|FG000|Overall Study|Protocol Violation|1
7302953|NCT00619359|11525462|FG001|Overall Study|Protocol Violation|1
7302954|NCT00619359|11525461|FG000|Overall Study|Withdrawal by Subject|19
7302955|NCT00619359|11525462|FG001|Overall Study|Withdrawal by Subject|20
7302956|NCT00619359|11525461|FG000|Overall Study|Progressive Disease|3
7302957|NCT00619359|11525462|FG001|Overall Study|Progressive Disease|1
7302958|NCT00619385|11525471|FG000|Overall Study|Adverse Event|0
7302959|NCT00619385|11525472|FG001|Overall Study|Adverse Event|0
7302960|NCT00619385|11525473|FG002|Overall Study|Adverse Event|3
7302961|NCT00619385|11525471|FG000|Overall Study|Other|1
7302962|NCT00619385|11525472|FG001|Overall Study|Other|2
7302963|NCT00619385|11525473|FG002|Overall Study|Other|1
7302964|NCT00619476|11525488|FG000|Overall Study|Adverse Event|12
7302965|NCT00619476|11525489|FG001|Overall Study|Adverse Event|6
7302966|NCT00619476|11525490|FG002|Overall Study|Adverse Event|12
7302967|NCT00619476|11525491|FG003|Overall Study|Adverse Event|16
7302968|NCT00619476|11525488|FG000|Overall Study|Lack of Efficacy|6
7302969|NCT00619476|11525489|FG001|Overall Study|Lack of Efficacy|1
7302970|NCT00619476|11525490|FG002|Overall Study|Lack of Efficacy|1
7302971|NCT00619476|11525491|FG003|Overall Study|Lack of Efficacy|4
7302972|NCT00619476|11525488|FG000|Overall Study|Protocol Violation|5
7302973|NCT00619476|11525489|FG001|Overall Study|Protocol Violation|4
7302974|NCT00619476|11525490|FG002|Overall Study|Protocol Violation|4
7302975|NCT00619476|11525491|FG003|Overall Study|Protocol Violation|9
7302976|NCT00619476|11525488|FG000|Overall Study|Lost to Follow-up|1
7302977|NCT00619476|11525489|FG001|Overall Study|Lost to Follow-up|2
7302978|NCT00619476|11525490|FG002|Overall Study|Lost to Follow-up|0
7302979|NCT00619476|11525491|FG003|Overall Study|Lost to Follow-up|1
7302980|NCT00619476|11525488|FG000|Overall Study|Investigator Discretion|2
7302981|NCT00619476|11525489|FG001|Overall Study|Investigator Discretion|2
7302982|NCT00619476|11525490|FG002|Overall Study|Investigator Discretion|2
7302983|NCT00619476|11525491|FG003|Overall Study|Investigator Discretion|0
7302984|NCT00619476|11525488|FG000|Overall Study|Withdrawal by Subject|5
7302985|NCT00619476|11525489|FG001|Overall Study|Withdrawal by Subject|7
7302986|NCT00619476|11525490|FG002|Overall Study|Withdrawal by Subject|5
7302987|NCT00619476|11525491|FG003|Overall Study|Withdrawal by Subject|4
7302988|NCT00619489|11525503|FG000|Overall Study|Adverse Event|0
7302989|NCT00619489|11525504|FG001|Overall Study|Adverse Event|7
7302990|NCT00619489|11525503|FG000|Overall Study|Withdrawal by Subject|1
7302991|NCT00619489|11525504|FG001|Overall Study|Withdrawal by Subject|1
7302992|NCT00619489|11525503|FG000|Overall Study|Lack of Efficacy|0
7302993|NCT00619489|11525504|FG001|Overall Study|Lack of Efficacy|11
7302994|NCT00619489|11525503|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
7302995|NCT00619489|11525504|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
7302996|NCT00619502|11525512|FG000|Overall Study|Lost to Follow-up|8
7302997|NCT00619502|11525513|FG001|Overall Study|Lost to Follow-up|10
7302998|NCT00619619|11525529|FG000|Overall Study|Physician Decision|0
7302999|NCT00619619|11525530|FG001|Overall Study|Physician Decision|0
7303000|NCT00619619|11525531|FG002|Overall Study|Physician Decision|1
7303001|NCT00619619|11525532|FG003|Overall Study|Physician Decision|0
7303002|NCT00619619|11525533|FG004|Overall Study|Physician Decision|0
7303003|NCT00619619|11525534|FG005|Overall Study|Physician Decision|0
7303004|NCT00619619|11525535|FG006|Overall Study|Physician Decision|0
7303005|NCT00619619|11525536|FG007|Overall Study|Physician Decision|0
7303006|NCT00619619|11525529|FG000|Overall Study|Protocol Violation|0
7303007|NCT00619619|11525530|FG001|Overall Study|Protocol Violation|0
7303008|NCT00619619|11525531|FG002|Overall Study|Protocol Violation|0
7303009|NCT00619619|11525532|FG003|Overall Study|Protocol Violation|1
7303010|NCT00619619|11525533|FG004|Overall Study|Protocol Violation|0
7303011|NCT00619619|11525534|FG005|Overall Study|Protocol Violation|0
7303012|NCT00619619|11525535|FG006|Overall Study|Protocol Violation|1
7303013|NCT00619619|11525536|FG007|Overall Study|Protocol Violation|1
7303014|NCT00619619|11525529|FG000|Overall Study|Adverse Event|0
7303015|NCT00619619|11525530|FG001|Overall Study|Adverse Event|0
7303016|NCT00619619|11525531|FG002|Overall Study|Adverse Event|0
7303017|NCT00619619|11525532|FG003|Overall Study|Adverse Event|0
7303018|NCT00619619|11525533|FG004|Overall Study|Adverse Event|2
7303019|NCT00619619|11525534|FG005|Overall Study|Adverse Event|0
7303020|NCT00619619|11525535|FG006|Overall Study|Adverse Event|0
7303021|NCT00619619|11525536|FG007|Overall Study|Adverse Event|2
7303022|NCT00619645|11525557|FG000|Overall Study|Adverse Event|1
7303023|NCT00619801|11525581|FG000|Overall Study|Lack of Efficacy|0
7303024|NCT00619801|11525582|FG001|Overall Study|Lack of Efficacy|1
7303025|NCT00619801|11525581|FG000|Overall Study|Withdrawal by Subject|1
7303026|NCT00619801|11525582|FG001|Overall Study|Withdrawal by Subject|1
7303027|NCT00619801|11525581|FG000|Overall Study|Loss of efficacy|0
7303028|NCT00619801|11525582|FG001|Overall Study|Loss of efficacy|1
7303029|NCT00619827|11525590|FG000|Overall Study|Adverse Event|1
7303030|NCT00619827|11525591|FG001|Overall Study|Adverse Event|2
7303031|NCT00619827|11525590|FG000|Overall Study|Withdrawal by Subject|2
7303032|NCT00619827|11525591|FG001|Overall Study|Withdrawal by Subject|2
7303033|NCT00619866|11525600|FG000|Weeks 1 - 12|Adverse Event|0
7303034|NCT00619866|11525601|FG001|Weeks 1 - 12|Adverse Event|1
7303035|NCT00619866|11525602|FG002|Weeks 1 - 12|Adverse Event|2
7303036|NCT00619866|11525603|FG003|Weeks 1 - 12|Adverse Event|0
7303037|NCT00619866|11525604|FG004|Weeks 1 - 12|Adverse Event|0
7303038|NCT00619866|11525600|FG000|Weeks 1 - 12|Non-compliance|0
7303039|NCT00619866|11525601|FG001|Weeks 1 - 12|Non-compliance|0
7303040|NCT00619866|11525602|FG002|Weeks 1 - 12|Non-compliance|1
7303041|NCT00619866|11525603|FG003|Weeks 1 - 12|Non-compliance|0
7303042|NCT00619866|11525604|FG004|Weeks 1 - 12|Non-compliance|0
7303043|NCT00619866|11525600|FG000|Weeks 1 - 12|Withdrawal by Subject|7
7303044|NCT00619866|11525601|FG001|Weeks 1 - 12|Withdrawal by Subject|2
7303045|NCT00619866|11525602|FG002|Weeks 1 - 12|Withdrawal by Subject|4
7303046|NCT00619866|11525603|FG003|Weeks 1 - 12|Withdrawal by Subject|0
7303047|NCT00619866|11525604|FG004|Weeks 1 - 12|Withdrawal by Subject|0
7303048|NCT00619866|11525600|FG000|Weeks 1 - 12|Lack of Efficacy|3
7303049|NCT00619866|11525601|FG001|Weeks 1 - 12|Lack of Efficacy|2
7303050|NCT00619866|11525602|FG002|Weeks 1 - 12|Lack of Efficacy|1
7303051|NCT00619866|11525603|FG003|Weeks 1 - 12|Lack of Efficacy|0
7303052|NCT00619866|11525604|FG004|Weeks 1 - 12|Lack of Efficacy|0
7303053|NCT00619866|11525600|FG000|Weeks 1 - 12|Lost to Follow-up|4
7303054|NCT00619866|11525601|FG001|Weeks 1 - 12|Lost to Follow-up|0
7303055|NCT00619866|11525602|FG002|Weeks 1 - 12|Lost to Follow-up|2
7303056|NCT00619866|11525603|FG003|Weeks 1 - 12|Lost to Follow-up|0
7303057|NCT00619866|11525604|FG004|Weeks 1 - 12|Lost to Follow-up|0
7303058|NCT00619866|11525600|FG000|Weeks 1 - 12|Sponsor Decision|0
7303059|NCT00619866|11525601|FG001|Weeks 1 - 12|Sponsor Decision|1
7303060|NCT00619866|11525602|FG002|Weeks 1 - 12|Sponsor Decision|0
7303061|NCT00619866|11525603|FG003|Weeks 1 - 12|Sponsor Decision|0
7303062|NCT00619866|11525604|FG004|Weeks 1 - 12|Sponsor Decision|0
7303063|NCT00619866|11525600|FG000|Weeks 13 - 24|Adverse Event|0
7303064|NCT00619866|11525601|FG001|Weeks 13 - 24|Adverse Event|0
7303065|NCT00619866|11525602|FG002|Weeks 13 - 24|Adverse Event|2
7303066|NCT00619866|11525603|FG003|Weeks 13 - 24|Adverse Event|1
7303067|NCT00619866|11525604|FG004|Weeks 13 - 24|Adverse Event|0
7303068|NCT00619866|11525600|FG000|Weeks 13 - 24|Protocol Deviation|0
7303069|NCT00619866|11525601|FG001|Weeks 13 - 24|Protocol Deviation|0
7303070|NCT00619866|11525602|FG002|Weeks 13 - 24|Protocol Deviation|0
7303071|NCT00619866|11525603|FG003|Weeks 13 - 24|Protocol Deviation|1
7303072|NCT00619866|11525604|FG004|Weeks 13 - 24|Protocol Deviation|0
7303073|NCT00619866|11525600|FG000|Weeks 13 - 24|Withdrawal by Subject|0
7303074|NCT00619866|11525601|FG001|Weeks 13 - 24|Withdrawal by Subject|3
7303075|NCT00619866|11525602|FG002|Weeks 13 - 24|Withdrawal by Subject|2
7303076|NCT00619866|11525603|FG003|Weeks 13 - 24|Withdrawal by Subject|2
7303077|NCT00619866|11525604|FG004|Weeks 13 - 24|Withdrawal by Subject|2
7303078|NCT00619866|11525600|FG000|Weeks 13 - 24|Non-compliance|0
7303079|NCT00619866|11525601|FG001|Weeks 13 - 24|Non-compliance|1
7303080|NCT00619866|11525602|FG002|Weeks 13 - 24|Non-compliance|1
7303081|NCT00619866|11525603|FG003|Weeks 13 - 24|Non-compliance|0
7303082|NCT00619866|11525604|FG004|Weeks 13 - 24|Non-compliance|0
7303083|NCT00619866|11525600|FG000|Weeks 13 - 24|Lost to Follow-up|0
7303084|NCT00619866|11525601|FG001|Weeks 13 - 24|Lost to Follow-up|3
7303085|NCT00619866|11525602|FG002|Weeks 13 - 24|Lost to Follow-up|0
7303086|NCT00619866|11525603|FG003|Weeks 13 - 24|Lost to Follow-up|0
7303087|NCT00619866|11525604|FG004|Weeks 13 - 24|Lost to Follow-up|0
7303088|NCT00619892|11525618|FG000|Overall Study|Adverse Event|3
7303089|NCT00619892|11525619|FG001|Overall Study|Adverse Event|0
7303090|NCT00619892|11525618|FG000|Overall Study|Lost to Follow-up|0
7303091|NCT00619892|11525619|FG001|Overall Study|Lost to Follow-up|1
7303092|NCT00619892|11525618|FG000|Overall Study|Intercurrent illness|0
7303093|NCT00619892|11525619|FG001|Overall Study|Intercurrent illness|1
7303094|NCT00619918|11525629|FG000|Overall Study|Withdrawal by Subject|4
7303095|NCT00619918|11525630|FG001|Overall Study|Withdrawal by Subject|3
7303096|NCT00619918|11525629|FG000|Overall Study|Physician Decision|8
7303097|NCT00619918|11525630|FG001|Overall Study|Physician Decision|8
7303098|NCT00619918|11525629|FG000|Overall Study|Transfer to outside facility|3
7303099|NCT00619918|11525630|FG001|Overall Study|Transfer to outside facility|3
7303100|NCT00619918|11525629|FG000|Overall Study|Left before receiving first dose|5
7303101|NCT00619918|11525630|FG001|Overall Study|Left before receiving first dose|8
7303102|NCT00619957|11525638|FG000|Month 24 Double-Blind|Adverse Event|9
7303103|NCT00619957|11525639|FG001|Month 24 Double-Blind|Adverse Event|7
7303104|NCT00619957|11525638|FG000|Month 24 Double-Blind|Protocol Violation|1
7303105|NCT00619957|11525639|FG001|Month 24 Double-Blind|Protocol Violation|0
7303106|NCT00619957|11525638|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
7303107|NCT00619957|11525639|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
7303108|NCT00619957|11525638|FG000|Month 24 Double-Blind|Lost to Follow-up|1
7303109|NCT00619957|11525639|FG001|Month 24 Double-Blind|Lost to Follow-up|0
7303110|NCT00619957|11525638|FG000|Month 24 Double-Blind|Did not take any study medication|0
7303111|NCT00619957|11525639|FG001|Month 24 Double-Blind|Did not take any study medication|1
7303112|NCT00619957|11525638|FG000|Month 48 Open-Label|Adverse Event|4
7303113|NCT00619957|11525639|FG001|Month 48 Open-Label|Adverse Event|4
7303114|NCT00619957|11525638|FG000|Month 48 Open-Label|Lost to Follow-up|2
7303115|NCT00619957|11525639|FG001|Month 48 Open-Label|Lost to Follow-up|4
7303116|NCT00619957|11525638|FG000|Month 48 Open-Label|Withdrawal by Subject|6
7303117|NCT00619957|11525639|FG001|Month 48 Open-Label|Withdrawal by Subject|9
7303118|NCT00619983|11525666|FG000|Test Drug Alone|Withdrawal by Subject|1
7303119|NCT00619983|11525667|FG001|Test Drug Alone|Withdrawal by Subject|0
7303120|NCT00619983|11525668|FG002|Test Drug Alone|Withdrawal by Subject|0
7303121|NCT00619983|11525669|FG003|Test Drug Alone|Withdrawal by Subject|1
7303122|NCT00619983|11525666|FG000|Test Drug Alone|Failure of daily diary device|1
7303123|NCT00619983|11525667|FG001|Test Drug Alone|Failure of daily diary device|1
7303124|NCT00619983|11525668|FG002|Test Drug Alone|Failure of daily diary device|2
7303125|NCT00619983|11525669|FG003|Test Drug Alone|Failure of daily diary device|2
7303126|NCT00620022|11525679|FG000|Treatment Period 1|Adverse Event|4
7303127|NCT00620022|11525680|FG001|Treatment Period 1|Adverse Event|6
7303128|NCT00620022|11525679|FG000|Treatment Period 1|Subject withdrew consent|1
7303129|NCT00620022|11525680|FG001|Treatment Period 1|Subject withdrew consent|0
7303130|NCT00620022|11525679|FG000|Treatment Period 2|Adverse Event|2
7303131|NCT00620022|11525680|FG001|Treatment Period 2|Adverse Event|2
7303132|NCT00620074|11525691|FG000|Overall Study|Adverse Event|1
7303133|NCT00620113|11525699|FG000|Overall Study|Adverse Event|3
7303134|NCT00620113|11525700|FG001|Overall Study|Adverse Event|2
7303135|NCT00620113|11525701|FG002|Overall Study|Adverse Event|2
7303136|NCT00620113|11525702|FG003|Overall Study|Adverse Event|1
7303137|NCT00620113|11525699|FG000|Overall Study|Lack of Efficacy|2
7303138|NCT00620113|11525700|FG001|Overall Study|Lack of Efficacy|3
7303139|NCT00620113|11525701|FG002|Overall Study|Lack of Efficacy|0
7303140|NCT00620113|11525702|FG003|Overall Study|Lack of Efficacy|2
7303141|NCT00620113|11525699|FG000|Overall Study|Physician Decision|1
7303142|NCT00620113|11525700|FG001|Overall Study|Physician Decision|0
7303143|NCT00620113|11525701|FG002|Overall Study|Physician Decision|0
7303144|NCT00620113|11525702|FG003|Overall Study|Physician Decision|2
7303145|NCT00620113|11525699|FG000|Overall Study|Protocol Violation|2
7303146|NCT00620113|11525700|FG001|Overall Study|Protocol Violation|1
7303147|NCT00620113|11525701|FG002|Overall Study|Protocol Violation|0
7303148|NCT00620113|11525702|FG003|Overall Study|Protocol Violation|0
7303149|NCT00620113|11525699|FG000|Overall Study|Withdrawal by Subject|5
7303150|NCT00620113|11525700|FG001|Overall Study|Withdrawal by Subject|1
7303151|NCT00620113|11525701|FG002|Overall Study|Withdrawal by Subject|3
7303152|NCT00620113|11525702|FG003|Overall Study|Withdrawal by Subject|5
7303153|NCT00620282|11525738|FG000|Overall Study|Adverse Event|0
7303154|NCT00620282|11525739|FG001|Overall Study|Adverse Event|1
7303155|NCT00620282|11525740|FG002|Overall Study|Adverse Event|0
7303156|NCT00620282|11525738|FG000|Overall Study|Arterial line unable to be placed|0
7303157|NCT00620282|11525739|FG001|Overall Study|Arterial line unable to be placed|0
7303158|NCT00620282|11525740|FG002|Overall Study|Arterial line unable to be placed|1
7303159|NCT00620282|11525738|FG000|Overall Study|Withdrawal by Subject|0
7303160|NCT00620282|11525739|FG001|Overall Study|Withdrawal by Subject|1
7303161|NCT00620282|11525740|FG002|Overall Study|Withdrawal by Subject|0
7303162|NCT00620321|11525750|FG000|Overall Study|Adverse Event|1
7303163|NCT00620321|11525751|FG001|Overall Study|Adverse Event|1
7303164|NCT00620321|11525750|FG000|Overall Study|Death|1
7303165|NCT00620321|11525751|FG001|Overall Study|Death|1
7303166|NCT00620321|11525750|FG000|Overall Study|Physician Decision|0
7303167|NCT00620321|11525751|FG001|Overall Study|Physician Decision|7
7303168|NCT00620321|11525750|FG000|Overall Study|Progressive Disease|5
7303169|NCT00620321|11525751|FG001|Overall Study|Progressive Disease|5
7303170|NCT00620321|11525750|FG000|Overall Study|Sponsor Decision|0
7303171|NCT00620321|11525751|FG001|Overall Study|Sponsor Decision|1
7303172|NCT00620321|11525750|FG000|Overall Study|Withdrawal by Subject|1
7303173|NCT00620321|11525751|FG001|Overall Study|Withdrawal by Subject|1
7303174|NCT00620373|11525757|FG000|Overall Study|Unverified cancer status|33
7303175|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
7303176|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
7303177|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
7303178|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
7303179|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
7303180|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
7303181|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7303182|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7303183|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
7303184|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
7303185|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7303186|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
7303187|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
7303188|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
7303189|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7303190|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
7303191|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7303192|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
7303193|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7303194|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
7303195|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
7303196|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
7303197|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
7303198|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
7303199|NCT00620542|11525790|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
7303200|NCT00620542|11525791|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
7303201|NCT00620542|11525792|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
7303202|NCT00620542|11525793|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
7303203|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Adverse Event|0
7303204|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Adverse Event|0
7303205|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Adverse Event|46
7303206|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Adverse Event|49
7303207|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Protocol Violation|0
7303208|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Protocol Violation|0
7303209|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Protocol Violation|3
7303210|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Protocol Violation|5
7303211|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
7303212|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
7303213|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
7303214|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
7303215|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
7303216|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
7303217|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
7303218|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
7303219|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Protocol Violation|0
7303220|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Protocol Violation|0
7303221|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Protocol Violation|13
7222810|NCT00028769|11431994|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
7222811|NCT00028769|11431994|FG000|Overall Study|Progression or Death|31
7222812|NCT00028769|11431994|FG000|Overall Study|Other - Not Protocol Specified|1
7222813|NCT00028769|11431994|FG000|Overall Study|Ineligible|5
7222814|NCT00028769|11431994|FG000|Overall Study|Not Analyzable|1
7222815|NCT00029146|11432009|FG000|Overall Study|Lost to Follow-up|2
7222816|NCT00029146|11432010|FG001|Overall Study|Lost to Follow-up|1
7222817|NCT00030823|11432060|FG000|Overall Study|Withdrawal by Subject|1
7222818|NCT00030901|11432066|FG000|Initial Registration|Ineligible|167
7222819|NCT00030901|11432067|FG001|Initial Registration|Ineligible|0
7222820|NCT00030901|11432068|FG002|Initial Registration|Ineligible|0
7222821|NCT00030901|11432066|FG000|Randomization|Adverse Event|0
7222822|NCT00030901|11432067|FG001|Randomization|Adverse Event|11
7222823|NCT00030901|11432068|FG002|Randomization|Adverse Event|7
7222824|NCT00030901|11432066|FG000|Randomization|Refusal Unrelated to Adverse Event|0
7222825|NCT00030901|11432067|FG001|Randomization|Refusal Unrelated to Adverse Event|16
7222826|NCT00030901|11432068|FG002|Randomization|Refusal Unrelated to Adverse Event|10
7222827|NCT00030901|11432066|FG000|Randomization|Progression/Relapse|0
7222828|NCT00030901|11432067|FG001|Randomization|Progression/Relapse|22
7222829|NCT00030901|11432068|FG002|Randomization|Progression/Relapse|21
7222830|NCT00030901|11432066|FG000|Randomization|Death|0
7222831|NCT00030901|11432067|FG001|Randomization|Death|1
7222832|NCT00030901|11432068|FG002|Randomization|Death|3
7222833|NCT00030901|11432066|FG000|Randomization|Other|0
7222834|NCT00030901|11432067|FG001|Randomization|Other|36
7222835|NCT00030901|11432068|FG002|Randomization|Other|33
7222836|NCT00030901|11432066|FG000|Randomization|Ineligible|0
7222837|NCT00030901|11432067|FG001|Randomization|Ineligible|15
7222838|NCT00030901|11432068|FG002|Randomization|Ineligible|14
7222839|NCT00031447|11432080|FG000|Overall Study|Lost to Follow-up|0
7222840|NCT00031447|11432081|FG001|Overall Study|Lost to Follow-up|1
7222841|NCT00031447|11432080|FG000|Overall Study|Non-compliant|1
7222842|NCT00031447|11432081|FG001|Overall Study|Non-compliant|1
7222843|NCT00031447|11432080|FG000|Overall Study|Re-activation of Disease|2
7222844|NCT00031447|11432081|FG001|Overall Study|Re-activation of Disease|1
7222845|NCT00031447|11432080|FG000|Overall Study|Disruption of blinded study drug supply|7
7222846|NCT00031447|11432081|FG001|Overall Study|Disruption of blinded study drug supply|4
7222847|NCT00031460|11432089|FG000|Overall Study|Lost to Follow-up|0
7222848|NCT00031460|11432090|FG001|Overall Study|Lost to Follow-up|1
7222849|NCT00031460|11432089|FG000|Overall Study|Withdrawal by Subject|1
7222850|NCT00031460|11432090|FG001|Overall Study|Withdrawal by Subject|1
7222851|NCT00031460|11432089|FG000|Overall Study|Non-Compliant|1
7222852|NCT00031460|11432090|FG001|Overall Study|Non-Compliant|1
7222853|NCT00031460|11432089|FG000|Overall Study|Death|0
7222854|NCT00031460|11432090|FG001|Overall Study|Death|1
7222855|NCT00031460|11432089|FG000|Overall Study|Reactivation of Disease|5
7222856|NCT00031460|11432090|FG001|Overall Study|Reactivation of Disease|9
7222857|NCT00031460|11432089|FG000|Overall Study|Disruption of blinded drug supply|2
7222858|NCT00031460|11432090|FG001|Overall Study|Disruption of blinded drug supply|0
7222859|NCT00031460|11432089|FG000|Overall Study|Confirmed unevaluable|0
7222860|NCT00031460|11432090|FG001|Overall Study|Confirmed unevaluable|1
7222861|NCT00031486|11432098|FG000|Overall Study|Adverse Event|1
7222862|NCT00031486|11432099|FG001|Overall Study|Adverse Event|0
7222863|NCT00031486|11432098|FG000|Overall Study|Lost to Follow-up|0
7222864|NCT00031486|11432099|FG001|Overall Study|Lost to Follow-up|1
7222865|NCT00031486|11432098|FG000|Overall Study|Withdrawal by Subject|3
7222866|NCT00031486|11432099|FG001|Overall Study|Withdrawal by Subject|2
7222867|NCT00031486|11432098|FG000|Overall Study|Death|0
7222868|NCT00031486|11432099|FG001|Overall Study|Death|3
7222869|NCT00031486|11432098|FG000|Overall Study|Non-compliant|0
7222870|NCT00031486|11432099|FG001|Overall Study|Non-compliant|4
7222871|NCT00031486|11432098|FG000|Overall Study|Did not meet eligibility requirement|2
7222872|NCT00031486|11432099|FG001|Overall Study|Did not meet eligibility requirement|1
7222873|NCT00031486|11432098|FG000|Overall Study|Other|1
7222874|NCT00031486|11432099|FG001|Overall Study|Other|1
7222875|NCT00031551|11432109|FG000|Overall Study|Withdrew due to chemotherapy effects|2
7222876|NCT00031551|11432110|FG001|Overall Study|Withdrew due to chemotherapy effects|0
7222877|NCT00031590|11432120|FG000|Overall Study|Adverse Event|1
7222878|NCT00031590|11432120|FG000|Overall Study|Withdrawal by parents|2
7222879|NCT00031694|11432125|FG000|Overall Study|Adverse Event|12
7222880|NCT00031694|11432125|FG000|Overall Study|Death|2
7222881|NCT00031694|11432125|FG000|Overall Study|Withdrawal by Subject|5
7222882|NCT00032487|11432132|FG000|Overall Study|Withdrawal by Subject|67
7222883|NCT00032487|11432133|FG001|Overall Study|Withdrawal by Subject|43
7222884|NCT00032487|11432132|FG000|Overall Study|Adverse Event|3
7222885|NCT00032487|11432133|FG001|Overall Study|Adverse Event|7
7222886|NCT00032487|11432132|FG000|Overall Study|Lost to Follow-up|57
7222887|NCT00032487|11432133|FG001|Overall Study|Lost to Follow-up|58
7222888|NCT00032487|11432132|FG000|Overall Study|Had other reason|12
7222889|NCT00032487|11432133|FG001|Overall Study|Had other reason|12
7222890|NCT00033371|11432159|FG000|Overall Study|Adverse Event|1
7222891|NCT00033371|11432160|FG001|Overall Study|Adverse Event|5
7303222|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Protocol Violation|16
7303223|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Safety reasons|0
7303224|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Safety reasons|0
7303225|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Safety reasons|2
7303226|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Safety reasons|3
7303227|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7303228|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
7303229|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7303230|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
7303231|NCT00620542|11525790|FG000|Part B (2 Year Core Study)|IVUS not available|0
7303232|NCT00620542|11525791|FG001|Part B (2 Year Core Study)|IVUS not available|0
7303233|NCT00620542|11525792|FG002|Part B (2 Year Core Study)|IVUS not available|3
7303234|NCT00620542|11525793|FG003|Part B (2 Year Core Study)|IVUS not available|2
7303235|NCT00620555|11525801|FG000|Overall Study|Adverse Event|4
7303236|NCT00620555|11525801|FG000|Overall Study|Protocol Violation|2
7303237|NCT00620555|11525801|FG000|Overall Study|Lack of Efficacy|12
7303238|NCT00620555|11525801|FG000|Overall Study|Withdrawal by Subject|1
7303239|NCT00620555|11525801|FG000|Overall Study|Choice of other treatment|1
7303240|NCT00620555|11525801|FG000|Overall Study|Visit failure against planned|1
7303241|NCT00620659|11525805|FG000|Treatment Period 1|Adverse Event|1
7303242|NCT00620659|11525806|FG001|Treatment Period 1|Adverse Event|0
7303243|NCT00620659|11525807|FG002|Treatment Period 1|Adverse Event|0
7303244|NCT00620659|11525808|FG003|Treatment Period 1|Adverse Event|3
7303245|NCT00620659|11525809|FG004|Treatment Period 1|Adverse Event|0
7303246|NCT00620659|11525810|FG005|Treatment Period 1|Adverse Event|0
7303247|NCT00620659|11525805|FG000|Treatment Period 1|Protocol Violation|1
7303248|NCT00620659|11525806|FG001|Treatment Period 1|Protocol Violation|0
7303249|NCT00620659|11525807|FG002|Treatment Period 1|Protocol Violation|0
7303250|NCT00620659|11525808|FG003|Treatment Period 1|Protocol Violation|0
7303251|NCT00620659|11525809|FG004|Treatment Period 1|Protocol Violation|0
7303252|NCT00620659|11525810|FG005|Treatment Period 1|Protocol Violation|0
7303253|NCT00620659|11525805|FG000|Treatment Period 1|Withdrawal by Subject|1
7303254|NCT00620659|11525806|FG001|Treatment Period 1|Withdrawal by Subject|0
7303255|NCT00620659|11525807|FG002|Treatment Period 1|Withdrawal by Subject|1
7303256|NCT00620659|11525808|FG003|Treatment Period 1|Withdrawal by Subject|0
7303257|NCT00620659|11525809|FG004|Treatment Period 1|Withdrawal by Subject|1
7303258|NCT00620659|11525810|FG005|Treatment Period 1|Withdrawal by Subject|0
7303259|NCT00620659|11525805|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
7303260|NCT00620659|11525806|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
7303261|NCT00620659|11525807|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
7303262|NCT00620659|11525808|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
7303263|NCT00620659|11525809|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
7303264|NCT00620659|11525810|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
7303265|NCT00620659|11525805|FG000|Treatment Period 2|Adverse Event|0
7303266|NCT00620659|11525806|FG001|Treatment Period 2|Adverse Event|3
7303267|NCT00620659|11525807|FG002|Treatment Period 2|Adverse Event|0
7303268|NCT00620659|11525808|FG003|Treatment Period 2|Adverse Event|0
7303269|NCT00620659|11525809|FG004|Treatment Period 2|Adverse Event|2
7303270|NCT00620659|11525810|FG005|Treatment Period 2|Adverse Event|0
7303271|NCT00620659|11525805|FG000|Treatment Period 2|Withdrawal by Subject|0
7303272|NCT00620659|11525806|FG001|Treatment Period 2|Withdrawal by Subject|0
7303273|NCT00620659|11525807|FG002|Treatment Period 2|Withdrawal by Subject|1
7303274|NCT00620659|11525808|FG003|Treatment Period 2|Withdrawal by Subject|0
7303275|NCT00620659|11525809|FG004|Treatment Period 2|Withdrawal by Subject|3
7303276|NCT00620659|11525810|FG005|Treatment Period 2|Withdrawal by Subject|0
7303277|NCT00620659|11525805|FG000|Placebo Washout Period 2|Adverse Event|2
7303278|NCT00620659|11525806|FG001|Placebo Washout Period 2|Adverse Event|0
7303279|NCT00620659|11525807|FG002|Placebo Washout Period 2|Adverse Event|0
7303280|NCT00620659|11525808|FG003|Placebo Washout Period 2|Adverse Event|0
7303281|NCT00620659|11525809|FG004|Placebo Washout Period 2|Adverse Event|0
7303282|NCT00620659|11525810|FG005|Placebo Washout Period 2|Adverse Event|0
7303283|NCT00620659|11525805|FG000|Treatment Period 3|Adverse Event|0
7303284|NCT00620659|11525806|FG001|Treatment Period 3|Adverse Event|2
7303285|NCT00620659|11525807|FG002|Treatment Period 3|Adverse Event|0
7303286|NCT00620659|11525808|FG003|Treatment Period 3|Adverse Event|0
7303287|NCT00620659|11525809|FG004|Treatment Period 3|Adverse Event|0
7303288|NCT00620659|11525810|FG005|Treatment Period 3|Adverse Event|0
7303289|NCT00620659|11525805|FG000|Treatment Period 3|Withdrawal by Subject|0
7303290|NCT00620659|11525806|FG001|Treatment Period 3|Withdrawal by Subject|0
7303291|NCT00620659|11525807|FG002|Treatment Period 3|Withdrawal by Subject|0
7303292|NCT00620659|11525808|FG003|Treatment Period 3|Withdrawal by Subject|1
7303293|NCT00620659|11525809|FG004|Treatment Period 3|Withdrawal by Subject|0
7303294|NCT00620659|11525810|FG005|Treatment Period 3|Withdrawal by Subject|0
7303295|NCT00620750|11525831|FG000|Overall Study|Lost to Follow-up|25
7303296|NCT00620763|11525835|FG000|Period: First Intervention|Withdrawal by Subject|0
7303297|NCT00620763|11525836|FG001|Period: First Intervention|Withdrawal by Subject|2
7303298|NCT00620763|11525835|FG000|Period: First Intervention|Protocol Violation|0
7303299|NCT00620763|11525836|FG001|Period: First Intervention|Protocol Violation|3
7303300|NCT00620763|11525835|FG000|Period: Second Intervention|Withdrawal by Subject|1
7303301|NCT00620763|11525836|FG001|Period: Second Intervention|Withdrawal by Subject|0
7303302|NCT00620776|11525844|FG000|Overall Study|Did not receive treatment|3
7303303|NCT00620776|11525845|FG001|Overall Study|Did not receive treatment|5
7303304|NCT00620776|11525844|FG000|Overall Study|Adverse Event|2
7303305|NCT00620776|11525845|FG001|Overall Study|Adverse Event|3
7303306|NCT00620776|11525844|FG000|Overall Study|Lack of Efficacy|2
7303307|NCT00620776|11525845|FG001|Overall Study|Lack of Efficacy|1
7303308|NCT00620776|11525844|FG000|Overall Study|Lost to Follow-up|2
7303309|NCT00620776|11525845|FG001|Overall Study|Lost to Follow-up|5
7303310|NCT00620776|11525844|FG000|Overall Study|Withdrawal by Subject|3
7303311|NCT00620776|11525845|FG001|Overall Study|Withdrawal by Subject|2
7303312|NCT00620815|11525854|FG000|Overall Study|Adverse Event|1
7303313|NCT00620815|11525855|FG001|Overall Study|Adverse Event|1
7303314|NCT00620815|11525856|FG002|Overall Study|Adverse Event|2
7303315|NCT00620815|11525854|FG000|Overall Study|Withdrawal by Subject|1
7303316|NCT00620815|11525855|FG001|Overall Study|Withdrawal by Subject|2
7303317|NCT00620815|11525856|FG002|Overall Study|Withdrawal by Subject|0
7303318|NCT00620815|11525854|FG000|Overall Study|Lost to Follow-up|1
7303319|NCT00620815|11525855|FG001|Overall Study|Lost to Follow-up|6
7303320|NCT00620815|11525856|FG002|Overall Study|Lost to Follow-up|3
7303321|NCT00620815|11525854|FG000|Overall Study|Inappropriate enrolment|0
7303322|NCT00620815|11525855|FG001|Overall Study|Inappropriate enrolment|0
7303323|NCT00620815|11525856|FG002|Overall Study|Inappropriate enrolment|1
7303324|NCT00620815|11525854|FG000|Overall Study|Protocol Violation|1
7303325|NCT00620815|11525855|FG001|Overall Study|Protocol Violation|2
7303326|NCT00620815|11525856|FG002|Overall Study|Protocol Violation|1
7303327|NCT00620854|11525895|FG000|Washout 1|Withdrawal by Subject|0
7303328|NCT00620854|11525896|FG001|Washout 1|Withdrawal by Subject|0
7303329|NCT00620854|11525897|FG002|Washout 1|Withdrawal by Subject|1
7303330|NCT00620854|11525898|FG003|Washout 1|Withdrawal by Subject|1
7303331|NCT00620854|11525899|FG004|Washout 1|Withdrawal by Subject|0
7303332|NCT00620854|11525900|FG005|Washout 1|Withdrawal by Subject|0
7551956|NCT02979197|11911531|FG001|Overall Study|Subject unable to commit to study dates|1
7551957|NCT02979197|11911532|FG002|Overall Study|Subject unable to commit to study dates|0
7551958|NCT02979249|11911540|FG000|Overall Study|Lost to Follow-up|2
7551959|NCT02979249|11911540|FG000|Overall Study|Withdrawal by Subject|4
7551960|NCT02979431|11911566|FG000|Overall Study|Parent/guardian withdrew consent|2
7551961|NCT02979431|11911567|FG001|Overall Study|Parent/guardian withdrew consent|1
7551962|NCT02979431|11911568|FG002|Overall Study|Parent/guardian withdrew consent|1
7551963|NCT02979431|11911569|FG003|Overall Study|Parent/guardian withdrew consent|1
7551964|NCT02979431|11911566|FG000|Overall Study|Randomized but received no study drug|1
7551965|NCT02979431|11911567|FG001|Overall Study|Randomized but received no study drug|1
7551966|NCT02979431|11911568|FG002|Overall Study|Randomized but received no study drug|0
7551967|NCT02979431|11911569|FG003|Overall Study|Randomized but received no study drug|0
7551968|NCT02979431|11911566|FG000|Overall Study|Adverse Event|0
7551969|NCT02979431|11911567|FG001|Overall Study|Adverse Event|0
7551970|NCT02979431|11911568|FG002|Overall Study|Adverse Event|1
7551971|NCT02979431|11911569|FG003|Overall Study|Adverse Event|0
7551972|NCT02979431|11911566|FG000|Overall Study|Subject left country after Day14|1
7551973|NCT02979431|11911567|FG001|Overall Study|Subject left country after Day14|0
7551974|NCT02979431|11911568|FG002|Overall Study|Subject left country after Day14|0
7551975|NCT02979431|11911569|FG003|Overall Study|Subject left country after Day14|0
7551976|NCT02979613|11911594|FG000|Double-Blind Phase|Withdrew Consent|2
7551977|NCT02979613|11911595|FG001|Double-Blind Phase|Withdrew Consent|4
7551978|NCT02979613|11911594|FG000|Double-Blind Phase|Pregnancy|2
7551979|NCT02979613|11911595|FG001|Double-Blind Phase|Pregnancy|2
7551980|NCT02979613|11911594|FG000|Double-Blind Phase|Adverse Event|2
7551981|NCT02979613|11911595|FG001|Double-Blind Phase|Adverse Event|0
7551982|NCT02979613|11911594|FG000|Double-Blind Phase|Lost to Follow-up|1
7551983|NCT02979613|11911595|FG001|Double-Blind Phase|Lost to Follow-up|1
7551984|NCT02979613|11911594|FG000|Double-Blind Phase|Protocol Violation|1
7551985|NCT02979613|11911595|FG001|Double-Blind Phase|Protocol Violation|1
7551986|NCT02979613|11911594|FG000|Double-Blind Phase|Randomized but Never Treated|2
7551987|NCT02979613|11911595|FG001|Double-Blind Phase|Randomized but Never Treated|0
7551988|NCT02979613|11911594|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
7551989|NCT02979613|11911595|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
7551990|NCT02979613|11911594|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
7551991|NCT02979613|11911595|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
7551992|NCT02979613|11911594|FG000|Open-Label Extension (OLE) Phase|Death|0
7551993|NCT02979613|11911595|FG001|Open-Label Extension (OLE) Phase|Death|1
7551994|NCT02979613|11911594|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
7551995|NCT02979613|11911595|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
7551996|NCT02979639|11911612|FG000|Overall Study|Withdrawal based on medical judgement|1
7551997|NCT02979639|11911612|FG000|Overall Study|Lost to Follow-up|8
7551998|NCT02979639|11911612|FG000|Overall Study|Withdrawal by Subject|3
7551999|NCT02979639|11911612|FG000|Overall Study|Adverse Event|2
7552000|NCT02980042|11911636|FG000|Overall Study|Lost to Follow-up|5
7552001|NCT02980042|11911637|FG001|Overall Study|Lost to Follow-up|0
7552002|NCT02980042|11911636|FG000|Overall Study|Insurance issues/treatment plan changes|2
7552003|NCT02980042|11911637|FG001|Overall Study|Insurance issues/treatment plan changes|0
7552004|NCT02980107|11911657|FG000|Overall Study|Withdrawal by Subject|51
7552005|NCT02980107|11911658|FG001|Overall Study|Withdrawal by Subject|62
7303333|NCT00621023|11525915|FG000|Overall Study|Death|5
7303334|NCT00621023|11525915|FG000|Overall Study|Follow up discontinued|1
7303335|NCT00621140|11525930|FG000|Overall Study|Adverse Event|4
7303336|NCT00621140|11525931|FG001|Overall Study|Adverse Event|5
7303337|NCT00621140|11525930|FG000|Overall Study|Lost to Follow-up|1
7303338|NCT00621140|11525931|FG001|Overall Study|Lost to Follow-up|2
7303339|NCT00621140|11525930|FG000|Overall Study|Withdrawal by Subject|4
7303340|NCT00621140|11525931|FG001|Overall Study|Withdrawal by Subject|6
7303341|NCT00621140|11525930|FG000|Overall Study|Other incl. lack of efficacy|6
7303342|NCT00621140|11525931|FG001|Overall Study|Other incl. lack of efficacy|5
7303343|NCT00621153|11525939|FG000|Overall Study|Safety Reason|8
7303344|NCT00621153|11525940|FG001|Overall Study|Safety Reason|7
7303345|NCT00621153|11525939|FG000|Overall Study|Adverse Event|3
7303346|NCT00621153|11525940|FG001|Overall Study|Adverse Event|2
7303347|NCT00621153|11525939|FG000|Overall Study|Lost to Follow-up|5
7303348|NCT00621153|11525940|FG001|Overall Study|Lost to Follow-up|1
7303349|NCT00621153|11525939|FG000|Overall Study|Withdrawal by Subject|4
7303350|NCT00621153|11525940|FG001|Overall Study|Withdrawal by Subject|5
7303351|NCT00621192|11525967|FG000|Overall Study|Withdrawal by Subject|0
7303352|NCT00621192|11525968|FG001|Overall Study|Withdrawal by Subject|0
7303353|NCT00621192|11525969|FG002|Overall Study|Withdrawal by Subject|2
7303354|NCT00621192|11525970|FG003|Overall Study|Withdrawal by Subject|0
7303355|NCT00621192|11525967|FG000|Overall Study|Physician Decision|1
7303356|NCT00621192|11525968|FG001|Overall Study|Physician Decision|3
7303357|NCT00621192|11525969|FG002|Overall Study|Physician Decision|0
7303358|NCT00621192|11525970|FG003|Overall Study|Physician Decision|0
7303359|NCT00621192|11525967|FG000|Overall Study|Protocol Violation|1
7303360|NCT00621192|11525968|FG001|Overall Study|Protocol Violation|0
7303361|NCT00621192|11525969|FG002|Overall Study|Protocol Violation|0
7303362|NCT00621192|11525970|FG003|Overall Study|Protocol Violation|1
7303363|NCT00621192|11525967|FG000|Overall Study|Adverse Event|0
7303364|NCT00621192|11525968|FG001|Overall Study|Adverse Event|1
7303365|NCT00621192|11525969|FG002|Overall Study|Adverse Event|0
7303366|NCT00621192|11525970|FG003|Overall Study|Adverse Event|1
7303367|NCT00621192|11525967|FG000|Overall Study|Death|2
7303368|NCT00621192|11525968|FG001|Overall Study|Death|5
7303369|NCT00621192|11525969|FG002|Overall Study|Death|0
7303370|NCT00621192|11525970|FG003|Overall Study|Death|0
7303371|NCT00621192|11525967|FG000|Overall Study|Final Assessments not Completed|0
7303372|NCT00621192|11525968|FG001|Overall Study|Final Assessments not Completed|0
7303373|NCT00621192|11525969|FG002|Overall Study|Final Assessments not Completed|3
7303374|NCT00621192|11525970|FG003|Overall Study|Final Assessments not Completed|1
7303375|NCT00621244|11525984|FG000|Overall Study|Withdrawal by Subject|7
7303376|NCT00621244|11525985|FG001|Overall Study|Withdrawal by Subject|3
7303377|NCT00621244|11525986|FG002|Overall Study|Withdrawal by Subject|3
7303378|NCT00621244|11525987|FG003|Overall Study|Withdrawal by Subject|3
7303379|NCT00621244|11525984|FG000|Overall Study|Disease progression|44
7303380|NCT00621244|11525985|FG001|Overall Study|Disease progression|20
7303381|NCT00621244|11525986|FG002|Overall Study|Disease progression|20
7303382|NCT00621244|11525987|FG003|Overall Study|Disease progression|15
7303383|NCT00621244|11525984|FG000|Overall Study|Death|3
7303384|NCT00621244|11525985|FG001|Overall Study|Death|3
7303385|NCT00621244|11525986|FG002|Overall Study|Death|1
7303386|NCT00621244|11525987|FG003|Overall Study|Death|1
7303387|NCT00621244|11525984|FG000|Overall Study|Adverse Event|27
7303388|NCT00621244|11525985|FG001|Overall Study|Adverse Event|7
7303389|NCT00621244|11525986|FG002|Overall Study|Adverse Event|9
7303390|NCT00621244|11525987|FG003|Overall Study|Adverse Event|2
7303391|NCT00621244|11525984|FG000|Overall Study|Administrative problems|5
7303392|NCT00621244|11525985|FG001|Overall Study|Administrative problems|1
7303393|NCT00621244|11525986|FG002|Overall Study|Administrative problems|0
7303394|NCT00621244|11525987|FG003|Overall Study|Administrative problems|2
7303395|NCT00621257|11526066|FG000|Overall Study|Lost to Follow-up|4
7303396|NCT00621257|11526067|FG001|Overall Study|Lost to Follow-up|0
7303397|NCT00621257|11526068|FG002|Overall Study|Lost to Follow-up|2
7303398|NCT00621257|11526069|FG003|Overall Study|Lost to Follow-up|4
7303399|NCT00621257|11526070|FG004|Overall Study|Lost to Follow-up|7
7303400|NCT00621257|11526066|FG000|Overall Study|Adverse Event|0
7303401|NCT00621257|11526067|FG001|Overall Study|Adverse Event|1
7303402|NCT00621257|11526068|FG002|Overall Study|Adverse Event|1
7303403|NCT00621257|11526069|FG003|Overall Study|Adverse Event|0
7303404|NCT00621257|11526070|FG004|Overall Study|Adverse Event|0
7303405|NCT00621257|11526066|FG000|Overall Study|Physician Decision|0
7303406|NCT00621257|11526067|FG001|Overall Study|Physician Decision|2
7303407|NCT00621257|11526068|FG002|Overall Study|Physician Decision|0
7303408|NCT00621257|11526069|FG003|Overall Study|Physician Decision|1
7303409|NCT00621257|11526070|FG004|Overall Study|Physician Decision|1
7303410|NCT00621257|11526066|FG000|Overall Study|Withdrawal by Subject|0
7303411|NCT00621257|11526067|FG001|Overall Study|Withdrawal by Subject|0
7303412|NCT00621257|11526068|FG002|Overall Study|Withdrawal by Subject|0
7303413|NCT00621257|11526069|FG003|Overall Study|Withdrawal by Subject|1
7303414|NCT00621257|11526070|FG004|Overall Study|Withdrawal by Subject|1
7303415|NCT00621296|11526082|FG000|Overall Study|Adverse Event|2
7303416|NCT00621296|11526082|FG000|Overall Study|Lack of Efficacy|1
7303417|NCT00621296|11526082|FG000|Overall Study|Physician Decision|7
7303418|NCT00621296|11526082|FG000|Overall Study|Unmatch Criteria|1
7303419|NCT00621296|11526082|FG000|Overall Study|Stopping Criteria|3
7303420|NCT00621309|11526086|FG000|Overall Study|Withdrawal by Subject|2
7303421|NCT00621309|11526087|FG001|Overall Study|Withdrawal by Subject|0
7303422|NCT00621309|11526088|FG002|Overall Study|Withdrawal by Subject|1
7303423|NCT00621309|11526089|FG003|Overall Study|Withdrawal by Subject|1
7303424|NCT00621309|11526090|FG004|Overall Study|Withdrawal by Subject|1
7303425|NCT00621309|11526091|FG005|Overall Study|Withdrawal by Subject|1
7303426|NCT00621322|11526103|FG000|Overall Study|Lost to Follow-up|0
7303427|NCT00621322|11526104|FG001|Overall Study|Lost to Follow-up|0
7303428|NCT00621322|11526105|FG002|Overall Study|Lost to Follow-up|0
7303429|NCT00621322|11526106|FG003|Overall Study|Lost to Follow-up|0
7303430|NCT00621322|11526107|FG004|Overall Study|Lost to Follow-up|1
7303431|NCT00621322|11526108|FG005|Overall Study|Lost to Follow-up|0
7303432|NCT00621322|11526103|FG000|Overall Study|Physician Decision|0
7303433|NCT00621322|11526104|FG001|Overall Study|Physician Decision|0
7303434|NCT00621322|11526105|FG002|Overall Study|Physician Decision|1
7303435|NCT00621322|11526106|FG003|Overall Study|Physician Decision|1
7303436|NCT00621322|11526107|FG004|Overall Study|Physician Decision|0
7303437|NCT00621322|11526108|FG005|Overall Study|Physician Decision|0
7303438|NCT00621322|11526103|FG000|Overall Study|Withdrawal by Subject|0
7303439|NCT00621322|11526104|FG001|Overall Study|Withdrawal by Subject|0
7303440|NCT00621322|11526105|FG002|Overall Study|Withdrawal by Subject|0
7303441|NCT00621322|11526106|FG003|Overall Study|Withdrawal by Subject|1
7303442|NCT00621322|11526107|FG004|Overall Study|Withdrawal by Subject|0
7303443|NCT00621322|11526108|FG005|Overall Study|Withdrawal by Subject|2
7303444|NCT00621322|11526103|FG000|Overall Study|Migrated/moved from study area|1
7303445|NCT00621322|11526104|FG001|Overall Study|Migrated/moved from study area|0
7303446|NCT00621322|11526105|FG002|Overall Study|Migrated/moved from study area|1
7303447|NCT00621322|11526106|FG003|Overall Study|Migrated/moved from study area|1
7303448|NCT00621322|11526107|FG004|Overall Study|Migrated/moved from study area|0
7303449|NCT00621322|11526108|FG005|Overall Study|Migrated/moved from study area|2
7303450|NCT00621504|11526137|FG000|Overall Study|Adverse Event|1
7303451|NCT00621504|11526138|FG001|Overall Study|Adverse Event|3
7303452|NCT00621504|11526137|FG000|Overall Study|At the request of sponsor/investigator|1
7303453|NCT00621504|11526138|FG001|Overall Study|At the request of sponsor/investigator|0
7303454|NCT00621504|11526137|FG000|Overall Study|Withdrew consent|9
7303455|NCT00621504|11526138|FG001|Overall Study|Withdrew consent|6
7303456|NCT00621504|11526137|FG000|Overall Study|Lost to Follow-up|8
7303457|NCT00621504|11526138|FG001|Overall Study|Lost to Follow-up|10
7303458|NCT00621504|11526137|FG000|Overall Study|Other|1
7303459|NCT00621504|11526138|FG001|Overall Study|Other|0
7303460|NCT00621504|11526137|FG000|Overall Study|Death|6
7303461|NCT00621504|11526138|FG001|Overall Study|Death|6
7303462|NCT00621517|11526146|FG000|Overall Study|Lost to Follow-up|3
7303463|NCT00621517|11526147|FG001|Overall Study|Lost to Follow-up|3
7303464|NCT00621517|11526146|FG000|Overall Study|Withdrawal by Subject|3
7303465|NCT00621517|11526147|FG001|Overall Study|Withdrawal by Subject|4
7303466|NCT00621517|11526146|FG000|Overall Study|Adverse Event|1
7303467|NCT00621517|11526147|FG001|Overall Study|Adverse Event|0
7303468|NCT00621543|11526165|FG000|Overall Study|Lost to Follow-up|23
7303469|NCT00621582|11526169|FG000|Overall Study|Adverse Event|7
7303470|NCT00621582|11526169|FG000|Overall Study|Protocol Violation|57
7303471|NCT00621582|11526169|FG000|Overall Study|Lost to Follow-up|24
7303472|NCT00621582|11526169|FG000|Overall Study|issues not identified by investigators|18
7303473|NCT00621621|11526176|FG000|Overall Study|Subjects were exited at EP study|30
7303474|NCT00621621|11526177|FG001|Overall Study|Subjects were exited at EP study|0
7303475|NCT00621764|11526199|FG000|Overall Study|Protocol Violation|0
7222892|NCT00033371|11432159|FG000|Overall Study|Lost to Follow-up|2
7222893|NCT00033371|11432160|FG001|Overall Study|Lost to Follow-up|1
7222894|NCT00033371|11432159|FG000|Overall Study|Withdrawal by Subject|3
7222895|NCT00033371|11432160|FG001|Overall Study|Withdrawal by Subject|3
7222896|NCT00033371|11432159|FG000|Overall Study|Disease Progression|0
7222897|NCT00033371|11432160|FG001|Overall Study|Disease Progression|1
7222898|NCT00033514|11432172|FG000|Overall Study|Lost to Follow-up|1
7222899|NCT00033514|11432173|FG001|Overall Study|Lost to Follow-up|1
7222900|NCT00033514|11432172|FG000|Overall Study|Withdrawal by Subject|0
7222901|NCT00033514|11432173|FG001|Overall Study|Withdrawal by Subject|3
7222902|NCT00033540|11432180|FG000|Overall Study|Adverse Event|14
7222903|NCT00033540|11432180|FG000|Overall Study|Death|1
7222904|NCT00033540|11432180|FG000|Overall Study|Progression|26
7222905|NCT00033540|11432180|FG000|Overall Study|Withdrawal by Subject|6
7222906|NCT00033540|11432180|FG000|Overall Study|Other|5
7222907|NCT00033540|11432180|FG000|Overall Study|Ineligible|3
7303476|NCT00621764|11526200|FG001|Overall Study|Protocol Violation|0
7303477|NCT00621764|11526201|FG002|Overall Study|Protocol Violation|0
7303478|NCT00621764|11526202|FG003|Overall Study|Protocol Violation|1
7303479|NCT00621777|11526215|FG000|Open Phase|Adverse Event|20
7303480|NCT00621777|11526216|FG001|Open Phase|Adverse Event|0
7303481|NCT00621777|11526215|FG000|Open Phase|Did not abstain during open phase|56
7303482|NCT00621777|11526216|FG001|Open Phase|Did not abstain during open phase|0
7303483|NCT00621777|11526215|FG000|Open Phase|Withdrawal by Subject|17
7303484|NCT00621777|11526216|FG001|Open Phase|Withdrawal by Subject|0
7303485|NCT00621777|11526215|FG000|Open Phase|administrative|13
7303486|NCT00621777|11526216|FG001|Open Phase|administrative|0
7303487|NCT00621777|11526215|FG000|Open Phase|Lost to Follow-up|10
7303488|NCT00621777|11526216|FG001|Open Phase|Lost to Follow-up|0
7303489|NCT00621777|11526215|FG000|Randomized Phase|Adverse Event|3
7303490|NCT00621777|11526216|FG001|Randomized Phase|Adverse Event|3
7303491|NCT00621777|11526215|FG000|Randomized Phase|Lost to Follow-up|3
7303492|NCT00621777|11526216|FG001|Randomized Phase|Lost to Follow-up|3
7303493|NCT00621777|11526215|FG000|Randomized Phase|Withdrawal by Subject|1
7303494|NCT00621777|11526216|FG001|Randomized Phase|Withdrawal by Subject|9
7303495|NCT00621777|11526215|FG000|Randomized Phase|administrative|0
7222908|NCT00033540|11432180|FG000|Overall Study|Never received treatment|2
7624420|NCT04052620|12035477|FG001|Overall Study|Screened failure, randomized by mistake|1
7624421|NCT04052620|12035476|FG000|Overall Study|Personal reasons|2
7624422|NCT04052620|12035477|FG001|Overall Study|Personal reasons|4
7222913|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
7222914|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
7222915|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
7222916|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
7222917|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Death|1
7222918|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Death|1
7222919|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
7222920|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
7222921|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
7222922|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
7222923|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Ineligible|8
7222924|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Ineligible|4
7222925|NCT00033657|11432197|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
7222926|NCT00033657|11432198|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
7222927|NCT00033657|11432197|FG000|Surgical Resection|not complete resection|0
7222928|NCT00033657|11432198|FG001|Surgical Resection|not complete resection|3
7222929|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
7222930|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
7222931|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|Adverse Event|7
7222932|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|Adverse Event|10
7222933|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|Death|2
7222934|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|Death|1
7222935|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
7222936|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
7222937|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|alternative therapy|1
7222938|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|alternative therapy|0
7222939|NCT00033657|11432197|FG000|Adjuvant Chemotherapy|Other|0
7222940|NCT00033657|11432198|FG001|Adjuvant Chemotherapy|Other|2
7222941|NCT00035555|11432222|FG000|Overall Study|Adverse Event|5
7222942|NCT00035555|11432223|FG001|Overall Study|Adverse Event|8
7222943|NCT00035555|11432224|FG002|Overall Study|Adverse Event|9
7222944|NCT00035555|11432222|FG000|Overall Study|Allograft loss|1
7222945|NCT00035555|11432223|FG001|Overall Study|Allograft loss|1
7222946|NCT00035555|11432224|FG002|Overall Study|Allograft loss|2
7222947|NCT00035555|11432222|FG000|Overall Study|Death|0
7222948|NCT00035555|11432223|FG001|Overall Study|Death|0
7222949|NCT00035555|11432224|FG002|Overall Study|Death|2
7222950|NCT00035555|11432222|FG000|Overall Study|Lost to Follow-up|0
7222951|NCT00035555|11432223|FG001|Overall Study|Lost to Follow-up|0
7222952|NCT00035555|11432224|FG002|Overall Study|Lost to Follow-up|1
7222953|NCT00035555|11432222|FG000|Overall Study|Noncompliance|0
7222954|NCT00035555|11432223|FG001|Overall Study|Noncompliance|1
7222955|NCT00035555|11432224|FG002|Overall Study|Noncompliance|1
7222956|NCT00035555|11432222|FG000|Overall Study|Prohibited medication|1
7222957|NCT00035555|11432223|FG001|Overall Study|Prohibited medication|1
7222958|NCT00035555|11432224|FG002|Overall Study|Prohibited medication|0
7222959|NCT00035555|11432222|FG000|Overall Study|Treatment failure/lack of efficacy|7
7222960|NCT00035555|11432223|FG001|Overall Study|Treatment failure/lack of efficacy|5
7222961|NCT00035555|11432224|FG002|Overall Study|Treatment failure/lack of efficacy|3
7222962|NCT00035555|11432222|FG000|Overall Study|Withdrawal by Subject|2
7222963|NCT00035555|11432223|FG001|Overall Study|Withdrawal by Subject|0
7222964|NCT00035555|11432224|FG002|Overall Study|Withdrawal by Subject|2
7222965|NCT00035555|11432222|FG000|Overall Study|Investigator deemed not a good candidate|0
7222966|NCT00035555|11432223|FG001|Overall Study|Investigator deemed not a good candidate|0
7222967|NCT00035555|11432224|FG002|Overall Study|Investigator deemed not a good candidate|1
7303496|NCT00621777|11526216|FG001|Randomized Phase|administrative|3
7303497|NCT00621777|11526215|FG000|Randomized Phase|Death|0
7303498|NCT00621777|11526216|FG001|Randomized Phase|Death|1
7303499|NCT00621842|11526224|FG000|Overall Study|Adverse Event|6
7303500|NCT00621842|11526224|FG000|Overall Study|Withdrawal by Subject|7
7303501|NCT00621842|11526224|FG000|Overall Study|Protocol Violation|4
7303502|NCT00621842|11526224|FG000|Overall Study|Lack of Efficacy|2
7303503|NCT00621855|11526233|FG000|Overall Study|Adverse Event|32
7303504|NCT00621855|11526234|FG001|Overall Study|Adverse Event|31
7303505|NCT00621855|11526235|FG002|Overall Study|Adverse Event|48
7303506|NCT00621855|11526236|FG003|Overall Study|Adverse Event|34
7303507|NCT00621855|11526237|FG004|Overall Study|Adverse Event|31
7303508|NCT00621855|11526233|FG000|Overall Study|Lost to Follow-up|0
7303509|NCT00621855|11526234|FG001|Overall Study|Lost to Follow-up|1
7303510|NCT00621855|11526235|FG002|Overall Study|Lost to Follow-up|3
7222968|NCT00035555|11432222|FG000|Overall Study|Received cyclosporin in error|0
7222969|NCT00035555|11432223|FG001|Overall Study|Received cyclosporin in error|0
7222970|NCT00035555|11432224|FG002|Overall Study|Received cyclosporin in error|1
7222971|NCT00035815|11432235|FG000|Overall Study|Withdrawal by Subject|17
7222972|NCT00035815|11432236|FG001|Overall Study|Withdrawal by Subject|11
7222973|NCT00035932|11432245|FG000|Overall Study|Adverse Event|10
7222974|NCT00035932|11432246|FG001|Overall Study|Adverse Event|9
7222975|NCT00035932|11432247|FG002|Overall Study|Adverse Event|9
7222976|NCT00035932|11432245|FG000|Overall Study|Death|0
7222977|NCT00035932|11432246|FG001|Overall Study|Death|0
7222978|NCT00035932|11432247|FG002|Overall Study|Death|1
7222979|NCT00035932|11432245|FG000|Overall Study|Disease Progression / Relapse|1
7222980|NCT00035932|11432246|FG001|Overall Study|Disease Progression / Relapse|1
7222981|NCT00035932|11432247|FG002|Overall Study|Disease Progression / Relapse|0
7222982|NCT00035932|11432245|FG000|Overall Study|Lost to Follow-up|4
7222983|NCT00035932|11432246|FG001|Overall Study|Lost to Follow-up|4
7222984|NCT00035932|11432247|FG002|Overall Study|Lost to Follow-up|3
7222985|NCT00035932|11432245|FG000|Overall Study|Noncompliance|6
7222986|NCT00035932|11432246|FG001|Overall Study|Noncompliance|7
7222987|NCT00035932|11432247|FG002|Overall Study|Noncompliance|6
7222988|NCT00035932|11432245|FG000|Overall Study|Protocol Violation While on Study|0
7222989|NCT00035932|11432246|FG001|Overall Study|Protocol Violation While on Study|1
7222990|NCT00035932|11432247|FG002|Overall Study|Protocol Violation While on Study|2
7222991|NCT00035932|11432245|FG000|Overall Study|Withdrawal by Subject|1
7222992|NCT00035932|11432246|FG001|Overall Study|Withdrawal by Subject|5
7222993|NCT00035932|11432247|FG002|Overall Study|Withdrawal by Subject|0
7222994|NCT00035932|11432245|FG000|Overall Study|Study Termination by Sponsor|1
7222995|NCT00035932|11432246|FG001|Overall Study|Study Termination by Sponsor|0
7222996|NCT00035932|11432247|FG002|Overall Study|Study Termination by Sponsor|0
7222997|NCT00035932|11432245|FG000|Overall Study|Lack of Efficacy|33
7222998|NCT00035932|11432246|FG001|Overall Study|Lack of Efficacy|33
7222999|NCT00035932|11432247|FG002|Overall Study|Lack of Efficacy|28
7223000|NCT00036270|11432262|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
7223001|NCT00036270|11432263|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
7223002|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Ongoing|1081
7223003|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Ongoing|736
7223004|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
7223005|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
7223006|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Adverse Event|501
7223007|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Adverse Event|782
7223008|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Other|277
7223009|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Other|288
7223010|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
7223011|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
7223012|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
7223013|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
7223014|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
7223015|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
7223016|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
7223017|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
7223018|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|Too early switch|0
7223019|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|Too early switch|103
7223020|NCT00036270|11432262|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
7223021|NCT00036270|11432263|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
7223022|NCT00037830|11432282|FG000|Overall Study|Adverse Event|2
7223023|NCT00037830|11432283|FG001|Overall Study|Adverse Event|0
7223024|NCT00037830|11432284|FG002|Overall Study|Adverse Event|0
7223025|NCT00037830|11432282|FG000|Overall Study|Withdrawal by Subject|4
7223026|NCT00037830|11432283|FG001|Overall Study|Withdrawal by Subject|5
7223027|NCT00037830|11432284|FG002|Overall Study|Withdrawal by Subject|1
7223028|NCT00037830|11432282|FG000|Overall Study|Protocol Violation|2
7223029|NCT00037830|11432283|FG001|Overall Study|Protocol Violation|2
7223030|NCT00037830|11432284|FG002|Overall Study|Protocol Violation|0
7223031|NCT00037830|11432282|FG000|Overall Study|Unrelated Medical Problem|2
7223032|NCT00037830|11432283|FG001|Overall Study|Unrelated Medical Problem|0
7223033|NCT00037830|11432284|FG002|Overall Study|Unrelated Medical Problem|0
7223034|NCT00038103|11432294|FG000|Overall Study|Adverse Event|5
7223035|NCT00038103|11432295|FG001|Overall Study|Adverse Event|6
7223036|NCT00038103|11432294|FG000|Overall Study|Lack of Efficacy|48
7223037|NCT00038103|11432295|FG001|Overall Study|Lack of Efficacy|41
7223038|NCT00038103|11432294|FG000|Overall Study|Withdrawal by Subject|0
7223039|NCT00038103|11432295|FG001|Overall Study|Withdrawal by Subject|3
7223040|NCT00038103|11432294|FG000|Overall Study|Lost to Follow-up|0
7223041|NCT00038103|11432295|FG001|Overall Study|Lost to Follow-up|3
7223042|NCT00038103|11432294|FG000|Overall Study|Protocol Violation|0
7223043|NCT00038103|11432295|FG001|Overall Study|Protocol Violation|2
7223044|NCT00038103|11432294|FG000|Overall Study|Sponsor Decision|0
7223045|NCT00038103|11432295|FG001|Overall Study|Sponsor Decision|1
7223046|NCT00038103|11432294|FG000|Overall Study|Randomized/never treated|2
7223047|NCT00038103|11432295|FG001|Overall Study|Randomized/never treated|0
7223048|NCT00038467|11432303|FG000|Overall Study|Adverse Event|170
7223049|NCT00038467|11432304|FG001|Overall Study|Adverse Event|145
7223050|NCT00038467|11432303|FG000|Overall Study|Withdrawal by Subject|150
7223051|NCT00038467|11432304|FG001|Overall Study|Withdrawal by Subject|107
7223052|NCT00038467|11432303|FG000|Overall Study|Protocol Violation|19
7223053|NCT00038467|11432304|FG001|Overall Study|Protocol Violation|22
7223054|NCT00038467|11432303|FG000|Overall Study|Death|22
7223055|NCT00038467|11432304|FG001|Overall Study|Death|16
7223056|NCT00038467|11432303|FG000|Overall Study|Lost to Follow-up|15
7223057|NCT00038467|11432304|FG001|Overall Study|Lost to Follow-up|10
7223058|NCT00038467|11432303|FG000|Overall Study|Recurrence|109
7223059|NCT00038467|11432304|FG001|Overall Study|Recurrence|179
7223060|NCT00038467|11432303|FG000|Overall Study|Randomized, but not treated|31
7223061|NCT00038467|11432304|FG001|Overall Study|Randomized, but not treated|35
7223062|NCT00038467|11432303|FG000|Overall Study|Other|26
7223063|NCT00038467|11432304|FG001|Overall Study|Other|28
7223064|NCT00038649|11432314|FG000|Overall Study|Adverse Event|9
7223065|NCT00038948|11432324|FG000|Overall Study|Adverse Event|131
7223066|NCT00038948|11432325|FG001|Overall Study|Adverse Event|43
7223067|NCT00038948|11432324|FG000|Overall Study|Lost to Follow-up|4
7223068|NCT00038948|11432325|FG001|Overall Study|Lost to Follow-up|4
7223069|NCT00038948|11432324|FG000|Overall Study|Nonmedical event|5
7223070|NCT00038948|11432325|FG001|Overall Study|Nonmedical event|7
7223071|NCT00038948|11432324|FG000|Overall Study|Withdrawal by Subject|23
7223072|NCT00038948|11432325|FG001|Overall Study|Withdrawal by Subject|10
7223073|NCT00038948|11432324|FG000|Overall Study|Protocol Violation|3
7223074|NCT00038948|11432325|FG001|Overall Study|Protocol Violation|7
7223075|NCT00038948|11432324|FG000|Overall Study|Lack of Efficacy|3
7223076|NCT00038948|11432325|FG001|Overall Study|Lack of Efficacy|6
7223077|NCT00039130|11432337|FG000|Overall Study|Adverse Event|11
7223078|NCT00039130|11432337|FG000|Overall Study|Death|9
7223079|NCT00039130|11432337|FG000|Overall Study|Withdrawal by Subject|3
7223080|NCT00039130|11432337|FG000|Overall Study|Progression|2
7223081|NCT00039130|11432337|FG000|Overall Study|Subsequent treatment|2
7223082|NCT00039130|11432337|FG000|Overall Study|Physician Decision|3
7223083|NCT00039377|11432345|FG000|Initial Registration|Adverse Event|2
7223084|NCT00039377|11432346|FG001|Initial Registration|Adverse Event|0
7223085|NCT00039377|11432347|FG002|Initial Registration|Adverse Event|0
7223086|NCT00039377|11432348|FG003|Initial Registration|Adverse Event|0
7223087|NCT00039377|11432345|FG000|Initial Registration|Relapsed|6
7223088|NCT00039377|11432346|FG001|Initial Registration|Relapsed|0
7223089|NCT00039377|11432347|FG002|Initial Registration|Relapsed|0
7223090|NCT00039377|11432348|FG003|Initial Registration|Relapsed|0
7223091|NCT00039377|11432345|FG000|Initial Registration|Received non-protocol therapy|11
7223092|NCT00039377|11432346|FG001|Initial Registration|Received non-protocol therapy|0
7223093|NCT00039377|11432347|FG002|Initial Registration|Received non-protocol therapy|0
7223094|NCT00039377|11432348|FG003|Initial Registration|Received non-protocol therapy|0
7223095|NCT00039377|11432345|FG000|Initial Registration|Withdrawal by Subject|3
7223096|NCT00039377|11432346|FG001|Initial Registration|Withdrawal by Subject|0
7223097|NCT00039377|11432347|FG002|Initial Registration|Withdrawal by Subject|0
7223098|NCT00039377|11432348|FG003|Initial Registration|Withdrawal by Subject|0
7223099|NCT00039741|11432360|FG000|Overall Study|Death|0
7223100|NCT00039741|11432361|FG001|Overall Study|Death|1
7223101|NCT00039741|11432362|FG002|Overall Study|Death|0
7223102|NCT00039741|11432363|FG003|Overall Study|Death|0
7223103|NCT00039741|11432360|FG000|Overall Study|Lost to Follow-up|3
7223104|NCT00039741|11432361|FG001|Overall Study|Lost to Follow-up|1
7223105|NCT00039741|11432362|FG002|Overall Study|Lost to Follow-up|5
7223106|NCT00039741|11432363|FG003|Overall Study|Lost to Follow-up|2
7223107|NCT00039741|11432360|FG000|Overall Study|Confounding medical condition|1
7223108|NCT00039741|11432361|FG001|Overall Study|Confounding medical condition|0
7223109|NCT00039741|11432362|FG002|Overall Study|Confounding medical condition|0
7223110|NCT00039741|11432363|FG003|Overall Study|Confounding medical condition|0
7223111|NCT00039741|11432360|FG000|Overall Study|Not able to get to clinic|5
7223112|NCT00039741|11432361|FG001|Overall Study|Not able to get to clinic|2
7223113|NCT00039741|11432362|FG002|Overall Study|Not able to get to clinic|0
7223114|NCT00039741|11432363|FG003|Overall Study|Not able to get to clinic|3
7223115|NCT00039741|11432360|FG000|Overall Study|Moved|3
7223116|NCT00039741|11432361|FG001|Overall Study|Moved|2
7223117|NCT00039741|11432362|FG002|Overall Study|Moved|3
7223118|NCT00039741|11432363|FG003|Overall Study|Moved|6
7223119|NCT00039741|11432360|FG000|Overall Study|Non-compliance with protocol|1
7223120|NCT00039741|11432361|FG001|Overall Study|Non-compliance with protocol|0
7223121|NCT00039741|11432362|FG002|Overall Study|Non-compliance with protocol|1
7223122|NCT00039741|11432363|FG003|Overall Study|Non-compliance with protocol|0
7223123|NCT00039741|11432360|FG000|Overall Study|Withdrew consent|0
7223124|NCT00039741|11432361|FG001|Overall Study|Withdrew consent|5
7223125|NCT00039741|11432362|FG002|Overall Study|Withdrew consent|0
7223126|NCT00039741|11432363|FG003|Overall Study|Withdrew consent|1
7223127|NCT00039741|11432360|FG000|Overall Study|Missed final visit|2
7223128|NCT00039741|11432361|FG001|Overall Study|Missed final visit|1
7223129|NCT00039741|11432362|FG002|Overall Study|Missed final visit|2
7223130|NCT00039741|11432363|FG003|Overall Study|Missed final visit|2
7223131|NCT00039871|11432373|FG000|Overall Study|Adverse Event|165
7223132|NCT00039871|11432373|FG000|Overall Study|Lost to Follow-up|18
7223133|NCT00039871|11432373|FG000|Overall Study|Protocol Violation|24
7223134|NCT00039871|11432373|FG000|Overall Study|Withdrawal by Subject|97
7223135|NCT00039871|11432373|FG000|Overall Study|Did not meet eligibility criteria|11
7223136|NCT00039871|11432373|FG000|Overall Study|Administrative|1
7223137|NCT00039871|11432373|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
7223138|NCT00039871|11432373|FG000|Overall Study|Never entered follow-up|7
7223139|NCT00040365|11432377|FG000|Overall Study|Death|1
7223140|NCT00040365|11432377|FG000|Overall Study|Progressive disease|7
7223141|NCT00040365|11432377|FG000|Overall Study|Lost to Follow-up|3
7223142|NCT00040664|11432390|FG000|Overall Study|Adverse Event|12
7223143|NCT00040664|11432391|FG001|Overall Study|Adverse Event|3
7223144|NCT00040664|11432392|FG002|Overall Study|Adverse Event|2
7223145|NCT00040664|11432393|FG003|Overall Study|Adverse Event|7
7223146|NCT00040664|11432390|FG000|Overall Study|Lack of Efficacy|9
7223147|NCT00040664|11432391|FG001|Overall Study|Lack of Efficacy|2
7223148|NCT00040664|11432392|FG002|Overall Study|Lack of Efficacy|3
7223149|NCT00040664|11432393|FG003|Overall Study|Lack of Efficacy|4
7223150|NCT00040664|11432390|FG000|Overall Study|Insufficient CD4 response|1
7223151|NCT00040664|11432391|FG001|Overall Study|Insufficient CD4 response|0
7223152|NCT00040664|11432392|FG002|Overall Study|Insufficient CD4 response|1
7223153|NCT00040664|11432393|FG003|Overall Study|Insufficient CD4 response|0
7223154|NCT00040664|11432390|FG000|Overall Study|Lost to Follow-up|4
7223155|NCT00040664|11432391|FG001|Overall Study|Lost to Follow-up|2
7223156|NCT00040664|11432392|FG002|Overall Study|Lost to Follow-up|0
7223157|NCT00040664|11432393|FG003|Overall Study|Lost to Follow-up|2
7223158|NCT00040664|11432390|FG000|Overall Study|Protocol Violation|2
7223159|NCT00040664|11432391|FG001|Overall Study|Protocol Violation|1
7223160|NCT00040664|11432392|FG002|Overall Study|Protocol Violation|0
7223161|NCT00040664|11432393|FG003|Overall Study|Protocol Violation|1
7223162|NCT00040664|11432390|FG000|Overall Study|Withdrawal by Subject|7
7223163|NCT00040664|11432391|FG001|Overall Study|Withdrawal by Subject|0
7223164|NCT00040664|11432392|FG002|Overall Study|Withdrawal by Subject|3
7223165|NCT00040664|11432393|FG003|Overall Study|Withdrawal by Subject|4
7223166|NCT00040664|11432390|FG000|Overall Study|Pregnancy|3
7223167|NCT00040664|11432391|FG001|Overall Study|Pregnancy|0
7223168|NCT00040664|11432392|FG002|Overall Study|Pregnancy|0
7223169|NCT00040664|11432393|FG003|Overall Study|Pregnancy|3
7223170|NCT00040664|11432390|FG000|Overall Study|Medication adherence/compliance problems|8
7223171|NCT00040664|11432391|FG001|Overall Study|Medication adherence/compliance problems|2
7223172|NCT00040664|11432392|FG002|Overall Study|Medication adherence/compliance problems|1
7223173|NCT00040664|11432393|FG003|Overall Study|Medication adherence/compliance problems|5
7223174|NCT00040664|11432390|FG000|Overall Study|Poor taste|2
7223175|NCT00040664|11432391|FG001|Overall Study|Poor taste|0
7223176|NCT00040664|11432392|FG002|Overall Study|Poor taste|2
7223177|NCT00040664|11432393|FG003|Overall Study|Poor taste|0
7223178|NCT00040664|11432390|FG000|Overall Study|Pharmacokinetic target not achieved|2
7223179|NCT00040664|11432391|FG001|Overall Study|Pharmacokinetic target not achieved|1
7223180|NCT00040664|11432392|FG002|Overall Study|Pharmacokinetic target not achieved|0
7223181|NCT00040664|11432393|FG003|Overall Study|Pharmacokinetic target not achieved|1
7223182|NCT00040664|11432390|FG000|Overall Study|Change of formulation|2
7223183|NCT00040664|11432391|FG001|Overall Study|Change of formulation|2
7223184|NCT00040664|11432392|FG002|Overall Study|Change of formulation|0
7223185|NCT00040664|11432393|FG003|Overall Study|Change of formulation|0
7223186|NCT00040664|11432390|FG000|Overall Study|Non-viability of oral suspension|1
7223187|NCT00040664|11432391|FG001|Overall Study|Non-viability of oral suspension|0
7303511|NCT00621855|11526236|FG003|Overall Study|Lost to Follow-up|4
7303512|NCT00621855|11526237|FG004|Overall Study|Lost to Follow-up|1
7303513|NCT00621855|11526233|FG000|Overall Study|Protocol Violation|16
7303514|NCT00621855|11526234|FG001|Overall Study|Protocol Violation|8
7303515|NCT00621855|11526235|FG002|Overall Study|Protocol Violation|6
7303516|NCT00621855|11526236|FG003|Overall Study|Protocol Violation|7
7303517|NCT00621855|11526237|FG004|Overall Study|Protocol Violation|8
7303518|NCT00621855|11526233|FG000|Overall Study|Withdrawal by Subject|16
7303519|NCT00621855|11526234|FG001|Overall Study|Withdrawal by Subject|11
7303520|NCT00621855|11526235|FG002|Overall Study|Withdrawal by Subject|13
7303521|NCT00621855|11526236|FG003|Overall Study|Withdrawal by Subject|13
7303522|NCT00621855|11526237|FG004|Overall Study|Withdrawal by Subject|9
7303523|NCT00621855|11526233|FG000|Overall Study|Other|9
7303524|NCT00621855|11526234|FG001|Overall Study|Other|7
7303525|NCT00621855|11526235|FG002|Overall Study|Other|6
7303526|NCT00621855|11526236|FG003|Overall Study|Other|5
7303527|NCT00621855|11526237|FG004|Overall Study|Other|4
7303528|NCT00621855|11526233|FG000|Overall Study|Patients did not receive study drug|3
7303529|NCT00621855|11526234|FG001|Overall Study|Patients did not receive study drug|3
7303530|NCT00621855|11526235|FG002|Overall Study|Patients did not receive study drug|5
7303531|NCT00621855|11526236|FG003|Overall Study|Patients did not receive study drug|4
7303532|NCT00621855|11526237|FG004|Overall Study|Patients did not receive study drug|2
7303533|NCT00621959|11526265|FG000|Overall Study|Adverse Event|4
7303534|NCT00621959|11526266|FG001|Overall Study|Adverse Event|2
7303535|NCT00621959|11526265|FG000|Overall Study|Lack of Efficacy|1
7223188|NCT00040664|11432392|FG002|Overall Study|Non-viability of oral suspension|1
7223189|NCT00040664|11432393|FG003|Overall Study|Non-viability of oral suspension|0
7223190|NCT00040742|11432415|FG000|Overall Study|Death|0
7223191|NCT00040742|11432416|FG001|Overall Study|Death|0
7223192|NCT00040742|11432417|FG002|Overall Study|Death|1
7223193|NCT00040742|11432418|FG003|Overall Study|Death|0
7223194|NCT00040742|11432415|FG000|Overall Study|Adverse Event|15
7223195|NCT00040742|11432416|FG001|Overall Study|Adverse Event|16
7223196|NCT00040742|11432417|FG002|Overall Study|Adverse Event|21
7223197|NCT00040742|11432418|FG003|Overall Study|Adverse Event|9
7223198|NCT00040742|11432415|FG000|Overall Study|Withdrawal by Subject|7
7223199|NCT00040742|11432416|FG001|Overall Study|Withdrawal by Subject|15
7223200|NCT00040742|11432417|FG002|Overall Study|Withdrawal by Subject|10
7223201|NCT00040742|11432418|FG003|Overall Study|Withdrawal by Subject|13
7223202|NCT00040742|11432415|FG000|Overall Study|Chemotoxicity|4
7223203|NCT00040742|11432416|FG001|Overall Study|Chemotoxicity|3
7223204|NCT00040742|11432417|FG002|Overall Study|Chemotoxicity|5
7223205|NCT00040742|11432418|FG003|Overall Study|Chemotoxicity|2
7223206|NCT00040742|11432415|FG000|Overall Study|Incomplete Forms|6
7223207|NCT00040742|11432416|FG001|Overall Study|Incomplete Forms|10
7223208|NCT00040742|11432417|FG002|Overall Study|Incomplete Forms|4
7223209|NCT00040742|11432418|FG003|Overall Study|Incomplete Forms|5
7223210|NCT00040742|11432415|FG000|Overall Study|Other medical|7
7223211|NCT00040742|11432416|FG001|Overall Study|Other medical|5
7223212|NCT00040742|11432417|FG002|Overall Study|Other medical|5
7223213|NCT00040742|11432418|FG003|Overall Study|Other medical|5
7223214|NCT00041067|11432460|FG000|Overall Study|Adverse Event|20
7223215|NCT00041067|11432460|FG000|Overall Study|Progression|19
7223216|NCT00041067|11432460|FG000|Overall Study|Patient refusal|12
7223217|NCT00041067|11432460|FG000|Overall Study|Other reasons|23
7223218|NCT00041067|11432460|FG000|Overall Study|Ineligible|2
7223219|NCT00041080|11432467|FG000|Overall Study|Adverse Event|21
7223220|NCT00041080|11432468|FG001|Overall Study|Adverse Event|1
7223221|NCT00041080|11432467|FG000|Overall Study|Withdrawal by Subject|6
7303536|NCT00621959|11526266|FG001|Overall Study|Lack of Efficacy|1
7303537|NCT00621959|11526265|FG000|Overall Study|Lost to Follow-up|0
7303538|NCT00621959|11526266|FG001|Overall Study|Lost to Follow-up|2
7303539|NCT00621959|11526265|FG000|Overall Study|Withdrawal by Subject|1
7303540|NCT00621959|11526266|FG001|Overall Study|Withdrawal by Subject|1
7303541|NCT00621959|11526265|FG000|Overall Study|Other|1
7303542|NCT00621959|11526266|FG001|Overall Study|Other|3
7303543|NCT00621985|11526272|FG000|Dexamethasone Admission|Adverse Event|1
7303544|NCT00622180|11526278|FG000|Overall Study|Lost to Follow-up|1
7303545|NCT00622180|11526279|FG001|Overall Study|Lost to Follow-up|2
7303546|NCT00622284|11526287|FG000|Overall Study|Lack of Efficacy|45
7303547|NCT00622284|11526288|FG001|Overall Study|Lack of Efficacy|15
7303548|NCT00622284|11526287|FG000|Overall Study|Adverse Event|61
7303549|NCT00622284|11526288|FG001|Overall Study|Adverse Event|90
7303550|NCT00622284|11526287|FG000|Overall Study|Protocol Violation|12
7303551|NCT00622284|11526288|FG001|Overall Study|Protocol Violation|5
7303552|NCT00622284|11526287|FG000|Overall Study|Lost to Follow-up|11
7303553|NCT00622284|11526288|FG001|Overall Study|Lost to Follow-up|13
7303554|NCT00622284|11526287|FG000|Overall Study|Withdrawal by Subject|27
7303555|NCT00622284|11526288|FG001|Overall Study|Withdrawal by Subject|24
7303556|NCT00622284|11526287|FG000|Overall Study|Other reason (not specified)|33
7303557|NCT00622284|11526288|FG001|Overall Study|Other reason (not specified)|24
7303558|NCT00622336|11526294|FG000|Treatment Phase|Progression of Disease|181
7303559|NCT00622336|11526294|FG000|Treatment Phase|Adverse Event|46
7303560|NCT00622336|11526294|FG000|Treatment Phase|Other|40
7303561|NCT00622336|11526294|FG000|Treatment Phase|Death|14
7303562|NCT00622336|11526294|FG000|Treatment Phase|Lack of therapeutic effect|13
7303563|NCT00622336|11526294|FG000|Treatment Phase|Withdrawal by Subject|13
7303564|NCT00622336|11526294|FG000|Treatment Phase|Lost to Follow-up|2
7303565|NCT00622336|11526294|FG000|Extension Phase|Adverse Event|2
7303566|NCT00622336|11526294|FG000|Extension Phase|Progressive Disease|6
7303567|NCT00622336|11526294|FG000|Extension Phase|Lack of therapeutic effect|2
7303568|NCT00622336|11526294|FG000|Extension Phase|Withdrawal by Subject|1
7303569|NCT00622336|11526294|FG000|Extension Phase|Lost to Follow-up|1
7303570|NCT00622336|11526294|FG000|Extension Phase|Other|9
7303571|NCT00622388|11526300|FG000|Overall Study|Disease Progression|47
7303572|NCT00622388|11526300|FG000|Overall Study|Adverse Event|6
7303573|NCT00622388|11526300|FG000|Overall Study|Protocol Violation|3
7303574|NCT00622388|11526300|FG000|Overall Study|Participant Refusal|1
7303575|NCT00622388|11526300|FG000|Overall Study|Death|3
7303576|NCT00622388|11526300|FG000|Overall Study|Received Alternate Anticancer Therapy|8
7303577|NCT00622388|11526300|FG000|Overall Study|Took Prohibited Medication|2
7303578|NCT00622388|11526300|FG000|Overall Study|Withdrew Consent|1
7303579|NCT00622388|11526300|FG000|Overall Study|Insurance Expired|1
7303580|NCT00622401|11526308|FG000|Overall Study|Disease progression prior to treatment|3
7303581|NCT00622401|11526309|FG001|Overall Study|Disease progression prior to treatment|2
7303582|NCT00622401|11526310|FG002|Overall Study|Disease progression prior to treatment|0
7303583|NCT00622440|11526330|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
7223222|NCT00041080|11432468|FG001|Overall Study|Withdrawal by Subject|6
7223223|NCT00041080|11432467|FG000|Overall Study|Concommitant Illness/Other|1
7223224|NCT00041080|11432468|FG001|Overall Study|Concommitant Illness/Other|2
7223225|NCT00041080|11432467|FG000|Overall Study|Did not start therapy|1
7223226|NCT00041080|11432468|FG001|Overall Study|Did not start therapy|1
7223227|NCT00041080|11432467|FG000|Overall Study|Ineligible|1
7223228|NCT00041080|11432468|FG001|Overall Study|Ineligible|0
7223229|NCT00041132|11432495|FG000|Overall Study|Adverse Event|19
7223230|NCT00041132|11432495|FG000|Overall Study|Death|1
7223231|NCT00041132|11432495|FG000|Overall Study|Not Eligible|7
7223232|NCT00041132|11432495|FG000|Overall Study|Withdrawal by Subject|1
7223233|NCT00041132|11432495|FG000|Overall Study|Physician Decision|2
7223234|NCT00041470|11432499|FG000|Overall Study|Loss of Funding|38
7303584|NCT00622440|11526331|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
7303585|NCT00622440|11526330|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
7303586|NCT00622440|11526331|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
7303587|NCT00622440|11526330|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
7303588|NCT00622440|11526331|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
7303589|NCT00622440|11526330|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
7303590|NCT00622440|11526331|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
7303591|NCT00622466|11526337|FG000|Overall Study|Death|1
7303592|NCT00622466|11526337|FG000|Overall Study|Adverse Event|1
7303593|NCT00622466|11526337|FG000|Overall Study|Withdrawal by Subject|2
7303594|NCT00622505|11526343|FG000|Overall Study|Adverse Event|9
7303595|NCT00622505|11526344|FG001|Overall Study|Adverse Event|7
7303596|NCT00622505|11526343|FG000|Overall Study|Abnormal Laboratory Value(s)|3
7303597|NCT00622505|11526344|FG001|Overall Study|Abnormal Laboratory Value(s)|5
7303598|NCT00622505|11526343|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
7303599|NCT00622505|11526344|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
7303600|NCT00622505|11526343|FG000|Overall Study|Withdrawal by Subject|12
7303601|NCT00622505|11526344|FG001|Overall Study|Withdrawal by Subject|5
7303602|NCT00622505|11526343|FG000|Overall Study|Administrative Problems|2
7303603|NCT00622505|11526344|FG001|Overall Study|Administrative Problems|4
7303604|NCT00622505|11526343|FG000|Overall Study|Death|2
7303605|NCT00622505|11526344|FG001|Overall Study|Death|2
7303606|NCT00622635|11526363|FG000|Treatment Period 1|Adverse Event|0
7303607|NCT00622635|11526364|FG001|Treatment Period 1|Adverse Event|0
7303608|NCT00622635|11526365|FG002|Treatment Period 1|Adverse Event|1
7303609|NCT00622635|11526366|FG003|Treatment Period 1|Adverse Event|0
7303610|NCT00622635|11526367|FG004|Treatment Period 1|Adverse Event|0
7303611|NCT00622635|11526368|FG005|Treatment Period 1|Adverse Event|0
7303612|NCT00622635|11526363|FG000|Treatment Period 1|Withdrawal by Subject|0
7303613|NCT00622635|11526364|FG001|Treatment Period 1|Withdrawal by Subject|1
7303614|NCT00622635|11526365|FG002|Treatment Period 1|Withdrawal by Subject|0
7303615|NCT00622635|11526366|FG003|Treatment Period 1|Withdrawal by Subject|0
7303616|NCT00622635|11526367|FG004|Treatment Period 1|Withdrawal by Subject|0
7303617|NCT00622635|11526368|FG005|Treatment Period 1|Withdrawal by Subject|0
7303618|NCT00622635|11526363|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
7303619|NCT00622635|11526364|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
7303620|NCT00622635|11526365|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
7303621|NCT00622635|11526366|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
7303622|NCT00622635|11526367|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
7303623|NCT00622635|11526368|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
7303624|NCT00622635|11526363|FG000|Treatment Period 2|Adverse Event|1
7303625|NCT00622635|11526364|FG001|Treatment Period 2|Adverse Event|0
7303626|NCT00622635|11526365|FG002|Treatment Period 2|Adverse Event|0
7303627|NCT00622635|11526366|FG003|Treatment Period 2|Adverse Event|0
7303628|NCT00622635|11526367|FG004|Treatment Period 2|Adverse Event|0
7303629|NCT00622635|11526368|FG005|Treatment Period 2|Adverse Event|0
7303630|NCT00622635|11526363|FG000|Treatment Period 3|Adverse Event|0
7303631|NCT00622635|11526364|FG001|Treatment Period 3|Adverse Event|0
7303632|NCT00622635|11526365|FG002|Treatment Period 3|Adverse Event|0
7303633|NCT00622635|11526366|FG003|Treatment Period 3|Adverse Event|2
7303634|NCT00622635|11526367|FG004|Treatment Period 3|Adverse Event|0
7303635|NCT00622635|11526368|FG005|Treatment Period 3|Adverse Event|0
7303636|NCT00622635|11526363|FG000|Treatment Period 3|Withdrawal by Subject|0
7303637|NCT00622635|11526364|FG001|Treatment Period 3|Withdrawal by Subject|0
7303638|NCT00622635|11526365|FG002|Treatment Period 3|Withdrawal by Subject|0
7303639|NCT00622635|11526366|FG003|Treatment Period 3|Withdrawal by Subject|1
7303640|NCT00622635|11526367|FG004|Treatment Period 3|Withdrawal by Subject|0
7303641|NCT00622635|11526368|FG005|Treatment Period 3|Withdrawal by Subject|0
7303642|NCT00622700|11526379|FG000|Core Treatment Period|Randomized but Not Treated|0
7303643|NCT00622700|11526380|FG001|Core Treatment Period|Randomized but Not Treated|2
7303644|NCT00622700|11526381|FG002|Core Treatment Period|Randomized but Not Treated|2
7303645|NCT00622700|11526382|FG003|Core Treatment Period|Randomized but Not Treated|0
7303646|NCT00622700|11526383|FG004|Core Treatment Period|Randomized but Not Treated|0
7303647|NCT00622700|11526384|FG005|Core Treatment Period|Randomized but Not Treated|0
7303648|NCT00622700|11526385|FG006|Core Treatment Period|Randomized but Not Treated|0
7303649|NCT00622700|11526379|FG000|Core Treatment Period|Adverse Event|18
7303650|NCT00622700|11526380|FG001|Core Treatment Period|Adverse Event|25
7303651|NCT00622700|11526381|FG002|Core Treatment Period|Adverse Event|18
7303652|NCT00622700|11526382|FG003|Core Treatment Period|Adverse Event|0
7303653|NCT00622700|11526383|FG004|Core Treatment Period|Adverse Event|0
7303654|NCT00622700|11526384|FG005|Core Treatment Period|Adverse Event|0
7223235|NCT00041756|11432517|FG000|Overall Study|Adverse Event|4
7223236|NCT00041756|11432518|FG001|Overall Study|Adverse Event|10
7223237|NCT00041756|11432519|FG002|Overall Study|Adverse Event|6
7223238|NCT00041756|11432520|FG003|Overall Study|Adverse Event|11
7223239|NCT00041756|11432521|FG004|Overall Study|Adverse Event|34
7223240|NCT00041756|11432517|FG000|Overall Study|Protocol Violation|1
7223241|NCT00041756|11432518|FG001|Overall Study|Protocol Violation|1
7223242|NCT00041756|11432519|FG002|Overall Study|Protocol Violation|2
7223243|NCT00041756|11432520|FG003|Overall Study|Protocol Violation|2
7223244|NCT00041756|11432521|FG004|Overall Study|Protocol Violation|1
7223245|NCT00041756|11432517|FG000|Overall Study|Withdrawal by Subject|3
7223246|NCT00041756|11432518|FG001|Overall Study|Withdrawal by Subject|3
7223247|NCT00041756|11432519|FG002|Overall Study|Withdrawal by Subject|4
7223248|NCT00041756|11432520|FG003|Overall Study|Withdrawal by Subject|2
7223249|NCT00041756|11432521|FG004|Overall Study|Withdrawal by Subject|3
7223250|NCT00041756|11432517|FG000|Overall Study|Lost to Follow-up|0
7223251|NCT00041756|11432518|FG001|Overall Study|Lost to Follow-up|1
7223252|NCT00041756|11432519|FG002|Overall Study|Lost to Follow-up|0
7223253|NCT00041756|11432520|FG003|Overall Study|Lost to Follow-up|1
7223254|NCT00041756|11432521|FG004|Overall Study|Lost to Follow-up|0
7223255|NCT00041756|11432517|FG000|Overall Study|Unable to meet protocol criteria|0
7223256|NCT00041756|11432518|FG001|Overall Study|Unable to meet protocol criteria|0
7223257|NCT00041756|11432519|FG002|Overall Study|Unable to meet protocol criteria|1
7223258|NCT00041756|11432520|FG003|Overall Study|Unable to meet protocol criteria|0
7223259|NCT00041756|11432521|FG004|Overall Study|Unable to meet protocol criteria|1
7223260|NCT00041756|11432517|FG000|Overall Study|Data Monitoring Committee Recommendation|0
7223261|NCT00041756|11432518|FG001|Overall Study|Data Monitoring Committee Recommendation|0
7223262|NCT00041756|11432519|FG002|Overall Study|Data Monitoring Committee Recommendation|0
7223263|NCT00041756|11432520|FG003|Overall Study|Data Monitoring Committee Recommendation|0
7223264|NCT00041756|11432521|FG004|Overall Study|Data Monitoring Committee Recommendation|21
7223265|NCT00042432|11432553|FG000|Overall Study|Adverse Event|4
7223266|NCT00042432|11432554|FG001|Overall Study|Adverse Event|1
7223267|NCT00042432|11432553|FG000|Overall Study|Withdrawal by Subject|1
7223268|NCT00042432|11432554|FG001|Overall Study|Withdrawal by Subject|3
7223269|NCT00042432|11432553|FG000|Overall Study|Death|0
7223270|NCT00042432|11432554|FG001|Overall Study|Death|2
7223271|NCT00042432|11432553|FG000|Overall Study|Ineligibility determined|1
7223272|NCT00042432|11432554|FG001|Overall Study|Ineligibility determined|0
7223273|NCT00042432|11432553|FG000|Overall Study|Initiation of maintenance dialysis|1
7223274|NCT00042432|11432554|FG001|Overall Study|Initiation of maintenance dialysis|1
7223275|NCT00042432|11432553|FG000|Overall Study|Other|2
7223276|NCT00042432|11432554|FG001|Overall Study|Other|0
7223277|NCT00042666|11432560|FG000|Overall Study|Adverse Event|2
7223278|NCT00042666|11432560|FG000|Overall Study|Death|4
7223279|NCT00042666|11432560|FG000|Overall Study|Protocol Violation|1
7223280|NCT00042666|11432560|FG000|Overall Study|Participant/Physician Perception|1
7223281|NCT00042666|11432560|FG000|Overall Study|Progressive Disease|41
7223282|NCT00042666|11432560|FG000|Overall Study|Other|1
7223283|NCT00042666|11432560|FG000|Overall Study|Other|4
7223284|NCT00042939|11432567|FG000|Overall Study|Adverse Event|6
7223285|NCT00042939|11432568|FG001|Overall Study|Adverse Event|7
7223286|NCT00042939|11432567|FG000|Overall Study|Death|3
7223287|NCT00042939|11432568|FG001|Overall Study|Death|2
7223288|NCT00042939|11432567|FG000|Overall Study|Withdrawal by Subject|3
7223289|NCT00042939|11432568|FG001|Overall Study|Withdrawal by Subject|4
7223290|NCT00042939|11432567|FG000|Overall Study|Other disease|1
7223291|NCT00042939|11432568|FG001|Overall Study|Other disease|0
7223292|NCT00042939|11432567|FG000|Overall Study|Ineligible|2
7223293|NCT00042939|11432568|FG001|Overall Study|Ineligible|2
7223294|NCT00042939|11432567|FG000|Overall Study|Deterioration of health|3
7223295|NCT00042939|11432568|FG001|Overall Study|Deterioration of health|4
7223296|NCT00042939|11432567|FG000|Overall Study|QOL diminished|1
7223297|NCT00042939|11432568|FG001|Overall Study|QOL diminished|0
7223298|NCT00042939|11432567|FG000|Overall Study|Rising ca 19-9|1
7223299|NCT00042939|11432568|FG001|Overall Study|Rising ca 19-9|0
7223300|NCT00042939|11432567|FG000|Overall Study|Patient non-compliance|1
7223301|NCT00042939|11432568|FG001|Overall Study|Patient non-compliance|0
7223302|NCT00042939|11432567|FG000|Overall Study|Still on treatment|1
7223303|NCT00042939|11432568|FG001|Overall Study|Still on treatment|0
7223304|NCT00042939|11432567|FG000|Overall Study|Treatment break > 4 weeks|0
7223305|NCT00042939|11432568|FG001|Overall Study|Treatment break > 4 weeks|1
7223306|NCT00042939|11432567|FG000|Overall Study|Did not start treatment|2
7223307|NCT00042939|11432568|FG001|Overall Study|Did not start treatment|1
7223308|NCT00042991|11432581|FG000|Overall Study|Adverse Event|1
7223309|NCT00042991|11432582|FG001|Overall Study|Adverse Event|4
7223310|NCT00042991|11432583|FG002|Overall Study|Adverse Event|2
7223311|NCT00042991|11432584|FG003|Overall Study|Adverse Event|0
7223312|NCT00042991|11432585|FG004|Overall Study|Adverse Event|0
7223313|NCT00042991|11432586|FG005|Overall Study|Adverse Event|1
7223314|NCT00042991|11432587|FG006|Overall Study|Adverse Event|0
7223315|NCT00042991|11432581|FG000|Overall Study|Withdrawal by Subject|0
7223316|NCT00042991|11432582|FG001|Overall Study|Withdrawal by Subject|7
7223317|NCT00042991|11432583|FG002|Overall Study|Withdrawal by Subject|2
7223318|NCT00042991|11432584|FG003|Overall Study|Withdrawal by Subject|0
7223319|NCT00042991|11432585|FG004|Overall Study|Withdrawal by Subject|1
7223320|NCT00042991|11432586|FG005|Overall Study|Withdrawal by Subject|0
7223321|NCT00042991|11432587|FG006|Overall Study|Withdrawal by Subject|0
7223322|NCT00042991|11432581|FG000|Overall Study|Disease Progression|5
7223323|NCT00042991|11432582|FG001|Overall Study|Disease Progression|29
7223324|NCT00042991|11432583|FG002|Overall Study|Disease Progression|2
7223325|NCT00042991|11432584|FG003|Overall Study|Disease Progression|2
7223326|NCT00042991|11432585|FG004|Overall Study|Disease Progression|1
7223327|NCT00042991|11432586|FG005|Overall Study|Disease Progression|4
7223328|NCT00042991|11432587|FG006|Overall Study|Disease Progression|2
7223329|NCT00042991|11432581|FG000|Overall Study|Alternative Therapy|0
7303655|NCT00622700|11526385|FG006|Core Treatment Period|Adverse Event|0
7303656|NCT00622700|11526379|FG000|Core Treatment Period|Lack of Efficacy|19
7303657|NCT00622700|11526380|FG001|Core Treatment Period|Lack of Efficacy|6
7303658|NCT00622700|11526381|FG002|Core Treatment Period|Lack of Efficacy|12
7303659|NCT00622700|11526382|FG003|Core Treatment Period|Lack of Efficacy|0
7303660|NCT00622700|11526383|FG004|Core Treatment Period|Lack of Efficacy|0
7303661|NCT00622700|11526384|FG005|Core Treatment Period|Lack of Efficacy|0
7303662|NCT00622700|11526385|FG006|Core Treatment Period|Lack of Efficacy|0
7303663|NCT00622700|11526379|FG000|Core Treatment Period|Lost to Follow-up|1
7303664|NCT00622700|11526380|FG001|Core Treatment Period|Lost to Follow-up|1
7303665|NCT00622700|11526381|FG002|Core Treatment Period|Lost to Follow-up|1
7303666|NCT00622700|11526382|FG003|Core Treatment Period|Lost to Follow-up|0
7303667|NCT00622700|11526383|FG004|Core Treatment Period|Lost to Follow-up|0
7303668|NCT00622700|11526384|FG005|Core Treatment Period|Lost to Follow-up|0
7303669|NCT00622700|11526385|FG006|Core Treatment Period|Lost to Follow-up|0
7303670|NCT00622700|11526379|FG000|Core Treatment Period|Death|1
7303671|NCT00622700|11526380|FG001|Core Treatment Period|Death|0
7303672|NCT00622700|11526381|FG002|Core Treatment Period|Death|0
7303673|NCT00622700|11526382|FG003|Core Treatment Period|Death|0
7303674|NCT00622700|11526383|FG004|Core Treatment Period|Death|0
7303675|NCT00622700|11526384|FG005|Core Treatment Period|Death|0
7303676|NCT00622700|11526385|FG006|Core Treatment Period|Death|0
7303677|NCT00622700|11526379|FG000|Core Treatment Period|Progressive Disease|3
7303678|NCT00622700|11526380|FG001|Core Treatment Period|Progressive Disease|1
7303679|NCT00622700|11526381|FG002|Core Treatment Period|Progressive Disease|0
7303680|NCT00622700|11526382|FG003|Core Treatment Period|Progressive Disease|0
7303681|NCT00622700|11526383|FG004|Core Treatment Period|Progressive Disease|0
7303682|NCT00622700|11526384|FG005|Core Treatment Period|Progressive Disease|0
7303683|NCT00622700|11526385|FG006|Core Treatment Period|Progressive Disease|0
7303684|NCT00622700|11526379|FG000|Core Treatment Period|Withdrawal by Subject|12
7303685|NCT00622700|11526380|FG001|Core Treatment Period|Withdrawal by Subject|18
7303686|NCT00622700|11526381|FG002|Core Treatment Period|Withdrawal by Subject|15
7303687|NCT00622700|11526382|FG003|Core Treatment Period|Withdrawal by Subject|0
7303688|NCT00622700|11526383|FG004|Core Treatment Period|Withdrawal by Subject|0
7303689|NCT00622700|11526384|FG005|Core Treatment Period|Withdrawal by Subject|0
7303690|NCT00622700|11526385|FG006|Core Treatment Period|Withdrawal by Subject|0
7303691|NCT00622700|11526379|FG000|Core Treatment Period|Other than specified above|2
7303692|NCT00622700|11526380|FG001|Core Treatment Period|Other than specified above|2
7303693|NCT00622700|11526381|FG002|Core Treatment Period|Other than specified above|5
7303694|NCT00622700|11526382|FG003|Core Treatment Period|Other than specified above|0
7303695|NCT00622700|11526383|FG004|Core Treatment Period|Other than specified above|0
7303696|NCT00622700|11526384|FG005|Core Treatment Period|Other than specified above|0
7303697|NCT00622700|11526385|FG006|Core Treatment Period|Other than specified above|0
7303698|NCT00622700|11526379|FG000|Extension Treatment Period|Adverse Event|0
7303699|NCT00622700|11526380|FG001|Extension Treatment Period|Adverse Event|0
7303700|NCT00622700|11526381|FG002|Extension Treatment Period|Adverse Event|0
7303701|NCT00622700|11526382|FG003|Extension Treatment Period|Adverse Event|5
7303702|NCT00622700|11526383|FG004|Extension Treatment Period|Adverse Event|9
7303703|NCT00622700|11526384|FG005|Extension Treatment Period|Adverse Event|6
7303704|NCT00622700|11526385|FG006|Extension Treatment Period|Adverse Event|8
7303705|NCT00622700|11526379|FG000|Extension Treatment Period|Lack of Efficacy|0
7303706|NCT00622700|11526380|FG001|Extension Treatment Period|Lack of Efficacy|0
7303707|NCT00622700|11526381|FG002|Extension Treatment Period|Lack of Efficacy|0
7303708|NCT00622700|11526382|FG003|Extension Treatment Period|Lack of Efficacy|2
7303709|NCT00622700|11526383|FG004|Extension Treatment Period|Lack of Efficacy|8
7303710|NCT00622700|11526384|FG005|Extension Treatment Period|Lack of Efficacy|1
7303711|NCT00622700|11526385|FG006|Extension Treatment Period|Lack of Efficacy|9
7303712|NCT00622700|11526379|FG000|Extension Treatment Period|Protocol Violation|0
7303713|NCT00622700|11526380|FG001|Extension Treatment Period|Protocol Violation|0
7303714|NCT00622700|11526381|FG002|Extension Treatment Period|Protocol Violation|0
7303715|NCT00622700|11526382|FG003|Extension Treatment Period|Protocol Violation|0
7303716|NCT00622700|11526383|FG004|Extension Treatment Period|Protocol Violation|0
7303717|NCT00622700|11526384|FG005|Extension Treatment Period|Protocol Violation|2
7303718|NCT00622700|11526385|FG006|Extension Treatment Period|Protocol Violation|0
7303719|NCT00622700|11526379|FG000|Extension Treatment Period|Lost to Follow-up|0
7303720|NCT00622700|11526380|FG001|Extension Treatment Period|Lost to Follow-up|0
7303721|NCT00622700|11526381|FG002|Extension Treatment Period|Lost to Follow-up|0
7303722|NCT00622700|11526382|FG003|Extension Treatment Period|Lost to Follow-up|0
7303723|NCT00622700|11526383|FG004|Extension Treatment Period|Lost to Follow-up|1
7223330|NCT00042991|11432582|FG001|Overall Study|Alternative Therapy|0
7223331|NCT00042991|11432583|FG002|Overall Study|Alternative Therapy|0
7223332|NCT00042991|11432584|FG003|Overall Study|Alternative Therapy|0
7223333|NCT00042991|11432585|FG004|Overall Study|Alternative Therapy|1
7223334|NCT00042991|11432586|FG005|Overall Study|Alternative Therapy|0
7223335|NCT00042991|11432587|FG006|Overall Study|Alternative Therapy|0
7223336|NCT00043186|11432614|FG000|Overall Study|Physician Decision|0
7223337|NCT00043186|11432615|FG001|Overall Study|Physician Decision|0
7223338|NCT00043186|11432616|FG002|Overall Study|Physician Decision|3
7223339|NCT00043186|11432617|FG003|Overall Study|Physician Decision|0
7223340|NCT00043186|11432618|FG004|Overall Study|Physician Decision|1
7223341|NCT00043186|11432619|FG005|Overall Study|Physician Decision|0
7223342|NCT00043186|11432620|FG006|Overall Study|Physician Decision|0
7223343|NCT00043186|11432621|FG007|Overall Study|Physician Decision|1
7223344|NCT00043186|11432622|FG008|Overall Study|Physician Decision|1
7223345|NCT00043186|11432614|FG000|Overall Study|Adverse Event|2
7223346|NCT00043186|11432615|FG001|Overall Study|Adverse Event|2
7223347|NCT00043186|11432616|FG002|Overall Study|Adverse Event|2
7223348|NCT00043186|11432617|FG003|Overall Study|Adverse Event|3
7223349|NCT00043186|11432618|FG004|Overall Study|Adverse Event|2
7223350|NCT00043186|11432619|FG005|Overall Study|Adverse Event|1
7223351|NCT00043186|11432620|FG006|Overall Study|Adverse Event|2
7223352|NCT00043186|11432621|FG007|Overall Study|Adverse Event|1
7223353|NCT00043186|11432622|FG008|Overall Study|Adverse Event|3
7223354|NCT00043186|11432614|FG000|Overall Study|Withdrawal by Subject|11
7223355|NCT00043186|11432615|FG001|Overall Study|Withdrawal by Subject|8
7223356|NCT00043186|11432616|FG002|Overall Study|Withdrawal by Subject|11
7223357|NCT00043186|11432617|FG003|Overall Study|Withdrawal by Subject|13
7223358|NCT00043186|11432618|FG004|Overall Study|Withdrawal by Subject|14
7223359|NCT00043186|11432619|FG005|Overall Study|Withdrawal by Subject|6
7223360|NCT00043186|11432620|FG006|Overall Study|Withdrawal by Subject|12
7223361|NCT00043186|11432621|FG007|Overall Study|Withdrawal by Subject|9
7223362|NCT00043186|11432622|FG008|Overall Study|Withdrawal by Subject|10
7223363|NCT00043186|11432614|FG000|Overall Study|Death|0
7223364|NCT00043186|11432615|FG001|Overall Study|Death|0
7223365|NCT00043186|11432616|FG002|Overall Study|Death|1
7223366|NCT00043186|11432617|FG003|Overall Study|Death|0
7223367|NCT00043186|11432618|FG004|Overall Study|Death|0
7223368|NCT00043186|11432619|FG005|Overall Study|Death|0
7223369|NCT00043186|11432620|FG006|Overall Study|Death|2
7223370|NCT00043186|11432621|FG007|Overall Study|Death|0
7223371|NCT00043186|11432622|FG008|Overall Study|Death|0
7223372|NCT00043186|11432614|FG000|Overall Study|Disease progression|1
7223373|NCT00043186|11432615|FG001|Overall Study|Disease progression|0
7223374|NCT00043186|11432616|FG002|Overall Study|Disease progression|0
7223375|NCT00043186|11432617|FG003|Overall Study|Disease progression|3
7223376|NCT00043186|11432618|FG004|Overall Study|Disease progression|0
7223377|NCT00043186|11432619|FG005|Overall Study|Disease progression|0
7223378|NCT00043186|11432620|FG006|Overall Study|Disease progression|0
7223379|NCT00043186|11432621|FG007|Overall Study|Disease progression|4
7223380|NCT00043186|11432622|FG008|Overall Study|Disease progression|0
7223381|NCT00043186|11432614|FG000|Overall Study|Ineligibility determined|0
7223382|NCT00043186|11432615|FG001|Overall Study|Ineligibility determined|0
7223383|NCT00043186|11432616|FG002|Overall Study|Ineligibility determined|0
7223384|NCT00043186|11432617|FG003|Overall Study|Ineligibility determined|0
7223385|NCT00043186|11432618|FG004|Overall Study|Ineligibility determined|0
7223386|NCT00043186|11432619|FG005|Overall Study|Ineligibility determined|0
7223387|NCT00043186|11432620|FG006|Overall Study|Ineligibility determined|0
7223388|NCT00043186|11432621|FG007|Overall Study|Ineligibility determined|0
7223389|NCT00043186|11432622|FG008|Overall Study|Ineligibility determined|1
7223390|NCT00043186|11432614|FG000|Overall Study|Lost to Follow-up|3
7223391|NCT00043186|11432615|FG001|Overall Study|Lost to Follow-up|5
7223392|NCT00043186|11432616|FG002|Overall Study|Lost to Follow-up|1
7223393|NCT00043186|11432617|FG003|Overall Study|Lost to Follow-up|1
7223394|NCT00043186|11432618|FG004|Overall Study|Lost to Follow-up|1
7223395|NCT00043186|11432619|FG005|Overall Study|Lost to Follow-up|1
7223396|NCT00043186|11432620|FG006|Overall Study|Lost to Follow-up|1
7223397|NCT00043186|11432621|FG007|Overall Study|Lost to Follow-up|1
7223398|NCT00043186|11432622|FG008|Overall Study|Lost to Follow-up|2
7223399|NCT00043186|11432614|FG000|Overall Study|Noncompliance|0
7223400|NCT00043186|11432615|FG001|Overall Study|Noncompliance|0
7223401|NCT00043186|11432616|FG002|Overall Study|Noncompliance|1
7223402|NCT00043186|11432617|FG003|Overall Study|Noncompliance|1
7223403|NCT00043186|11432618|FG004|Overall Study|Noncompliance|0
7223404|NCT00043186|11432619|FG005|Overall Study|Noncompliance|0
7223405|NCT00043186|11432620|FG006|Overall Study|Noncompliance|0
7223406|NCT00043186|11432621|FG007|Overall Study|Noncompliance|0
7223407|NCT00043186|11432622|FG008|Overall Study|Noncompliance|0
7223408|NCT00043186|11432614|FG000|Overall Study|Other|0
7223409|NCT00043186|11432615|FG001|Overall Study|Other|0
7223410|NCT00043186|11432616|FG002|Overall Study|Other|1
7223411|NCT00043186|11432617|FG003|Overall Study|Other|1
7223412|NCT00043186|11432618|FG004|Overall Study|Other|0
7223413|NCT00043186|11432619|FG005|Overall Study|Other|0
7223414|NCT00043186|11432620|FG006|Overall Study|Other|0
7223415|NCT00043186|11432621|FG007|Overall Study|Other|0
7223416|NCT00043186|11432622|FG008|Overall Study|Other|0
7223417|NCT00043550|11432646|FG000|Overall Study|Withdrawal by Subject|22
7223418|NCT00043550|11432647|FG001|Overall Study|Withdrawal by Subject|12
7223419|NCT00043550|11432648|FG002|Overall Study|Withdrawal by Subject|20
7223420|NCT00043979|11432658|FG000|Period 1|recipient with progressive disease|7
7223421|NCT00043979|11432659|FG001|Period 1|recipient with progressive disease|4
7223422|NCT00043979|11432660|FG002|Period 1|recipient with progressive disease|3
7223423|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Adverse Event|1
7223424|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Adverse Event|0
7223425|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Not follow directions|2
7223426|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Not follow directions|2
7223427|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
7223428|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
7223429|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Pregnancy|1
7223430|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Pregnancy|0
7223431|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
7223432|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
7223433|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
7223434|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
7303724|NCT00622700|11526384|FG005|Extension Treatment Period|Lost to Follow-up|0
7303725|NCT00622700|11526385|FG006|Extension Treatment Period|Lost to Follow-up|0
7303726|NCT00622700|11526379|FG000|Extension Treatment Period|Progressive Disease|0
7303727|NCT00622700|11526380|FG001|Extension Treatment Period|Progressive Disease|0
7303728|NCT00622700|11526381|FG002|Extension Treatment Period|Progressive Disease|0
7303729|NCT00622700|11526382|FG003|Extension Treatment Period|Progressive Disease|1
7303730|NCT00622700|11526383|FG004|Extension Treatment Period|Progressive Disease|2
7303731|NCT00622700|11526384|FG005|Extension Treatment Period|Progressive Disease|0
7303732|NCT00622700|11526385|FG006|Extension Treatment Period|Progressive Disease|2
7303733|NCT00622700|11526379|FG000|Extension Treatment Period|Withdrawal by Subject|0
7303734|NCT00622700|11526380|FG001|Extension Treatment Period|Withdrawal by Subject|0
7303735|NCT00622700|11526381|FG002|Extension Treatment Period|Withdrawal by Subject|0
7303736|NCT00622700|11526382|FG003|Extension Treatment Period|Withdrawal by Subject|11
7303737|NCT00622700|11526383|FG004|Extension Treatment Period|Withdrawal by Subject|16
7303738|NCT00622700|11526384|FG005|Extension Treatment Period|Withdrawal by Subject|6
7303739|NCT00622700|11526385|FG006|Extension Treatment Period|Withdrawal by Subject|10
7303740|NCT00622700|11526379|FG000|Extension Treatment Period|Missing|0
7303741|NCT00622700|11526380|FG001|Extension Treatment Period|Missing|0
7303742|NCT00622700|11526381|FG002|Extension Treatment Period|Missing|0
7303743|NCT00622700|11526382|FG003|Extension Treatment Period|Missing|2
7303744|NCT00622700|11526383|FG004|Extension Treatment Period|Missing|3
7303745|NCT00622700|11526384|FG005|Extension Treatment Period|Missing|1
7303746|NCT00622700|11526385|FG006|Extension Treatment Period|Missing|0
7303747|NCT00622700|11526379|FG000|Extension Treatment Period|Other than specified above|0
7303748|NCT00622700|11526380|FG001|Extension Treatment Period|Other than specified above|0
7303749|NCT00622700|11526381|FG002|Extension Treatment Period|Other than specified above|0
7303750|NCT00622700|11526382|FG003|Extension Treatment Period|Other than specified above|0
7303751|NCT00622700|11526383|FG004|Extension Treatment Period|Other than specified above|0
7303752|NCT00622700|11526384|FG005|Extension Treatment Period|Other than specified above|1
7303753|NCT00622700|11526385|FG006|Extension Treatment Period|Other than specified above|1
7303754|NCT00622713|11526402|FG000|Overall Study|Adverse Event|35
7303755|NCT00622713|11526402|FG000|Overall Study|Administrative problems|4
7303756|NCT00622713|11526402|FG000|Overall Study|Withdrawal by Subject|11
7303757|NCT00622713|11526402|FG000|Overall Study|Lost to Follow-up|5
7303758|NCT00622713|11526402|FG000|Overall Study|Death|2
7303759|NCT00622713|11526402|FG000|Overall Study|Subject no longer required study drug|1
7303760|NCT00622713|11526402|FG000|Overall Study|Did not meet eligibility criteria|1
7303761|NCT00622726|11526408|FG000|March, 2008 to August, 2010|Death|5
7303762|NCT00622726|11526409|FG001|March, 2008 to August, 2010|Death|2
7303763|NCT00622726|11526408|FG000|August, 2010 to April, 2013|Death|1
7303764|NCT00622726|11526409|FG001|August, 2010 to April, 2013|Death|5
7303765|NCT00622739|11526421|FG000|Overall Study|Physician Decision|1
7303766|NCT00622739|11526422|FG001|Overall Study|Physician Decision|0
7303767|NCT00622739|11526421|FG000|Overall Study|Adverse Event|1
7303768|NCT00622739|11526422|FG001|Overall Study|Adverse Event|2
7303769|NCT00622739|11526421|FG000|Overall Study|Lack of Efficacy|0
7303770|NCT00622739|11526422|FG001|Overall Study|Lack of Efficacy|2
7303771|NCT00622739|11526421|FG000|Overall Study|Withdrawal by Subject|0
7303772|NCT00622739|11526422|FG001|Overall Study|Withdrawal by Subject|1
7303773|NCT00622739|11526421|FG000|Overall Study|Lost to Follow-up|0
7303774|NCT00622739|11526422|FG001|Overall Study|Lost to Follow-up|1
7303775|NCT00622869|11526433|FG000|Overall Study|Subject Withdrew Consent|13
7303776|NCT00622869|11526434|FG001|Overall Study|Subject Withdrew Consent|17
7303777|NCT00622869|11526435|FG002|Overall Study|Subject Withdrew Consent|11
7303778|NCT00622869|11526433|FG000|Overall Study|Administrative Problems|11
7303779|NCT00622869|11526434|FG001|Overall Study|Administrative Problems|17
7303780|NCT00622869|11526435|FG002|Overall Study|Administrative Problems|13
7303781|NCT00622869|11526433|FG000|Overall Study|Death|12
7303782|NCT00622869|11526434|FG001|Overall Study|Death|15
7303783|NCT00622869|11526435|FG002|Overall Study|Death|10
7303784|NCT00622869|11526433|FG000|Overall Study|Lost to Follow-up|2
7223435|NCT00044083|11432702|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
7223436|NCT00044083|11432703|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
7223437|NCT00044083|11432702|FG000|First Intervention (One Week) Patients|Not follow directions|0
7223438|NCT00044083|11432703|FG001|First Intervention (One Week) Patients|Not follow directions|2
7223439|NCT00044083|11432702|FG000|First Intervention (One Week) Patients|Used illegal drug|1
7223440|NCT00044083|11432703|FG001|First Intervention (One Week) Patients|Used illegal drug|0
7223441|NCT00044083|11432702|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
7223442|NCT00044083|11432703|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
7223443|NCT00044213|11432740|FG000|Overall Study|Withdrawal by Subject|50
7223444|NCT00044213|11432741|FG001|Overall Study|Withdrawal by Subject|65
7223445|NCT00044213|11432742|FG002|Overall Study|Withdrawal by Subject|91
7223446|NCT00044213|11432743|FG003|Overall Study|Withdrawal by Subject|83
7223447|NCT00044213|11432740|FG000|Overall Study|Death|42
7223448|NCT00044213|11432741|FG001|Overall Study|Death|42
7223449|NCT00044213|11432742|FG002|Overall Study|Death|42
7223450|NCT00044213|11432743|FG003|Overall Study|Death|49
7223451|NCT00044213|11432740|FG000|Overall Study|Lost to Follow-up|8
7223452|NCT00044213|11432741|FG001|Overall Study|Lost to Follow-up|5
7223453|NCT00044213|11432742|FG002|Overall Study|Lost to Follow-up|5
7223454|NCT00044213|11432743|FG003|Overall Study|Lost to Follow-up|4
7223455|NCT00044512|11432753|FG000|Follow Up|Lost to Follow-up|2
7223456|NCT00045032|11432769|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
7223457|NCT00045032|11432770|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
7223458|NCT00045032|11432771|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
7223459|NCT00045032|11432769|FG000|Overall Study|Death|22
7223460|NCT00045032|11432770|FG001|Overall Study|Death|24
7223461|NCT00045032|11432771|FG002|Overall Study|Death|17
7223462|NCT00045032|11432769|FG000|Overall Study|Insufficient Therapeutic Response|542
7223463|NCT00045032|11432770|FG001|Overall Study|Insufficient Therapeutic Response|437
7223464|NCT00045032|11432771|FG002|Overall Study|Insufficient Therapeutic Response|445
7223465|NCT00045032|11432769|FG000|Overall Study|Violation of Selection Criteria at Entry|3
7223466|NCT00045032|11432770|FG001|Overall Study|Violation of Selection Criteria at Entry|6
7223467|NCT00045032|11432771|FG002|Overall Study|Violation of Selection Criteria at Entry|6
7223468|NCT00045032|11432769|FG000|Overall Study|Other Protocol Violation|2
7223469|NCT00045032|11432770|FG001|Overall Study|Other Protocol Violation|0
7223470|NCT00045032|11432771|FG002|Overall Study|Other Protocol Violation|1
7223471|NCT00045032|11432769|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
7223472|NCT00045032|11432770|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
7223473|NCT00045032|11432771|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
7223474|NCT00045032|11432769|FG000|Overall Study|Failure to Return|57
7223475|NCT00045032|11432770|FG001|Overall Study|Failure to Return|62
7223476|NCT00045032|11432771|FG002|Overall Study|Failure to Return|61
7223477|NCT00045032|11432769|FG000|Overall Study|Other|93
7223478|NCT00045032|11432770|FG001|Overall Study|Other|84
7223479|NCT00045032|11432771|FG002|Overall Study|Other|105
7223480|NCT00045110|11432784|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
7223481|NCT00045110|11432785|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
7223482|NCT00045110|11432786|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
7223483|NCT00045110|11432784|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
7223484|NCT00045110|11432785|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
7223485|NCT00045110|11432786|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
7223486|NCT00045110|11432784|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
7223487|NCT00045110|11432785|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
7223488|NCT00045110|11432786|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
7223489|NCT00045162|11432805|FG000|Overall Study|Ineligible|12
7223490|NCT00045162|11432806|FG001|Overall Study|Ineligible|8
7223491|NCT00045162|11432805|FG000|Overall Study|Not treated|7
7223492|NCT00045162|11432806|FG001|Overall Study|Not treated|2
7223493|NCT00045162|11432805|FG000|Overall Study|Adverse Event|55
7223494|NCT00045162|11432806|FG001|Overall Study|Adverse Event|50
7223495|NCT00045162|11432805|FG000|Overall Study|Lack of Efficacy|32
7223496|NCT00045162|11432806|FG001|Overall Study|Lack of Efficacy|29
7223497|NCT00045162|11432805|FG000|Overall Study|Death|10
7223498|NCT00045162|11432806|FG001|Overall Study|Death|10
7223499|NCT00045162|11432805|FG000|Overall Study|Withdrawal by Subject|5
7223500|NCT00045162|11432806|FG001|Overall Study|Withdrawal by Subject|3
7223501|NCT00045162|11432805|FG000|Overall Study|Other|21
7223502|NCT00045162|11432806|FG001|Overall Study|Other|16
7223503|NCT00045305|11432812|FG000|Overall Study|Lack of Efficacy|6
7223504|NCT00045305|11432812|FG000|Overall Study|Adverse Event|3
7223505|NCT00045305|11432812|FG000|Overall Study|Death|3
7223506|NCT00045305|11432812|FG000|Overall Study|site error|2
7223507|NCT00045630|11432824|FG000|Overall Study|Adverse Event|1
7223508|NCT00045630|11432824|FG000|Overall Study|Refusal unrelated to adverse event|1
7223509|NCT00045630|11432824|FG000|Overall Study|Progression/relapse|1
7223510|NCT00045630|11432824|FG000|Overall Study|Death|1
7223511|NCT00045630|11432824|FG000|Overall Study|Ineligible|2
7223512|NCT00045708|11432831|FG000|Phase 1|early progressive disease|0
7223513|NCT00045708|11432832|FG001|Phase 1|early progressive disease|1
7223514|NCT00045708|11432833|FG002|Phase 1|early progressive disease|0
7223515|NCT00045734|11432850|FG000|Overall Study|Protocol Violation|1
7223516|NCT00045942|11432863|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
7223517|NCT00045942|11432864|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
7223518|NCT00045942|11432865|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
7223519|NCT00045942|11432866|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
7223520|NCT00045942|11432867|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
7223521|NCT00045942|11432868|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
7223522|NCT00045942|11432869|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
7223523|NCT00045942|11432870|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
7223524|NCT00045942|11432871|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
7223525|NCT00045942|11432863|FG000|PKC412A2104 (Core)|Adverse Event|5
7223526|NCT00045942|11432864|FG001|PKC412A2104 (Core)|Adverse Event|0
7223527|NCT00045942|11432865|FG002|PKC412A2104 (Core)|Adverse Event|0
7223528|NCT00045942|11432866|FG003|PKC412A2104 (Core)|Adverse Event|0
7223529|NCT00045942|11432867|FG004|PKC412A2104 (Core)|Adverse Event|0
7223530|NCT00045942|11432868|FG005|PKC412A2104 (Core)|Adverse Event|0
7223531|NCT00045942|11432869|FG006|PKC412A2104 (Core)|Adverse Event|0
7223532|NCT00045942|11432870|FG007|PKC412A2104 (Core)|Adverse Event|0
7223533|NCT00045942|11432871|FG008|PKC412A2104 (Core)|Adverse Event|0
7223534|NCT00045942|11432863|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
7223535|NCT00045942|11432864|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
7223536|NCT00045942|11432865|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
7223537|NCT00045942|11432866|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
7223538|NCT00045942|11432867|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
7223539|NCT00045942|11432868|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
7223540|NCT00045942|11432869|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
7223541|NCT00045942|11432870|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
7223542|NCT00045942|11432871|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
7223543|NCT00045942|11432863|FG000|PKC412A2104 (Core)|Death|1
7303785|NCT00622869|11526434|FG001|Overall Study|Lost to Follow-up|4
7303786|NCT00622869|11526435|FG002|Overall Study|Lost to Follow-up|2
7303787|NCT00622869|11526433|FG000|Overall Study|Graft Loss|5
7303788|NCT00622869|11526434|FG001|Overall Study|Graft Loss|3
7303789|NCT00622869|11526435|FG002|Overall Study|Graft Loss|2
7303790|NCT00622869|11526433|FG000|Overall Study|Missing|0
7303791|NCT00622869|11526434|FG001|Overall Study|Missing|1
7303792|NCT00622869|11526435|FG002|Overall Study|Missing|1
7303793|NCT00622908|11526452|FG000|Overall Study|Protocol Violation|1
7303794|NCT00622908|11526453|FG001|Overall Study|Protocol Violation|0
7303795|NCT00622908|11526452|FG000|Overall Study|Adverse Event|0
7303796|NCT00622908|11526453|FG001|Overall Study|Adverse Event|1
7303797|NCT00622908|11526452|FG000|Overall Study|Lack of Efficacy|1
7303798|NCT00622908|11526453|FG001|Overall Study|Lack of Efficacy|7
7303799|NCT00622908|11526452|FG000|Overall Study|Lost to Follow-up|1
7303800|NCT00622908|11526453|FG001|Overall Study|Lost to Follow-up|0
7303801|NCT00622908|11526452|FG000|Overall Study|Refusal|0
7303802|NCT00622908|11526453|FG001|Overall Study|Refusal|1
7303803|NCT00622908|11526452|FG000|Overall Study|Termination by study sponser|0
7303804|NCT00622908|11526453|FG001|Overall Study|Termination by study sponser|1
7303805|NCT00623103|11526465|FG000|Overall Study|Adverse Event|70
7303806|NCT00623103|11526466|FG001|Overall Study|Adverse Event|60
7303807|NCT00623103|11526465|FG000|Overall Study|Unsatisfactory therapeutic effect|4
7303808|NCT00623103|11526466|FG001|Overall Study|Unsatisfactory therapeutic effect|12
7303809|NCT00623103|11526465|FG000|Overall Study|Withdrawal by Subject|18
7303810|NCT00623103|11526466|FG001|Overall Study|Withdrawal by Subject|24
7303811|NCT00623103|11526465|FG000|Overall Study|Lost to Follow-up|4
7303812|NCT00623103|11526466|FG001|Overall Study|Lost to Follow-up|1
7303813|NCT00623103|11526465|FG000|Overall Study|Administrative problems|2
7303814|NCT00623103|11526466|FG001|Overall Study|Administrative problems|4
7303815|NCT00623103|11526465|FG000|Overall Study|Death|11
7303816|NCT00623103|11526466|FG001|Overall Study|Death|11
7303817|NCT00623103|11526465|FG000|Overall Study|Protocol deviation|2
7303818|NCT00623103|11526466|FG001|Overall Study|Protocol deviation|1
7303819|NCT00623194|11526485|FG000|Overall Study|Lack of Efficacy|1
7303820|NCT00623194|11526485|FG000|Overall Study|Protocol Violation|3
7303821|NCT00623194|11526485|FG000|Overall Study|Unclassified|1
7303822|NCT00623233|11526489|FG000|Overall Study|Adverse Event|10
7303823|NCT00623233|11526489|FG000|Overall Study|Physician Decision|10
7303824|NCT00623233|11526489|FG000|Overall Study|Lost to Follow-up|1
7303825|NCT00623233|11526489|FG000|Overall Study|Withdrawal by Subject|3
7303826|NCT00623363|11526495|FG000|Overall Study|Adverse Event|2
7303827|NCT00623363|11526496|FG001|Overall Study|Adverse Event|2
7303828|NCT00623428|11526505|FG000|Treatment Period|Adverse event/intercurrent illness|0
7303829|NCT00623428|11526506|FG001|Treatment Period|Adverse event/intercurrent illness|9
7303830|NCT00623428|11526505|FG000|Treatment Period|Death|0
7303831|NCT00623428|11526506|FG001|Treatment Period|Death|1
7303832|NCT00623428|11526505|FG000|Treatment Period|Did not cooperate / refused treatment|0
7303833|NCT00623428|11526506|FG001|Treatment Period|Did not cooperate / refused treatment|13
7303834|NCT00623428|11526505|FG000|Treatment Period|Insufficient therapeutic response|0
7303835|NCT00623428|11526506|FG001|Treatment Period|Insufficient therapeutic response|2
7303836|NCT00623428|11526505|FG000|Treatment Period|Other|0
7303837|NCT00623428|11526506|FG001|Treatment Period|Other|1
7303838|NCT00623428|11526505|FG000|Treatment Period|Withdrawal by Subject|0
7303839|NCT00623428|11526506|FG001|Treatment Period|Withdrawal by Subject|1
7303840|NCT00623428|11526505|FG000|Follow-up Period|Relapse post-treatment|11
7303841|NCT00623428|11526506|FG001|Follow-up Period|Relapse post-treatment|3
7303842|NCT00623428|11526505|FG000|Follow-up Period|Failure to return|10
7223544|NCT00045942|11432864|FG001|PKC412A2104 (Core)|Death|0
7223545|NCT00045942|11432865|FG002|PKC412A2104 (Core)|Death|0
7223546|NCT00045942|11432866|FG003|PKC412A2104 (Core)|Death|0
7223547|NCT00045942|11432867|FG004|PKC412A2104 (Core)|Death|0
7223548|NCT00045942|11432868|FG005|PKC412A2104 (Core)|Death|0
7223549|NCT00045942|11432869|FG006|PKC412A2104 (Core)|Death|0
7223550|NCT00045942|11432870|FG007|PKC412A2104 (Core)|Death|0
7223551|NCT00045942|11432871|FG008|PKC412A2104 (Core)|Death|0
7223552|NCT00045942|11432863|FG000|PKC412A2104E1|Withdrawal by Subject|0
7223553|NCT00045942|11432864|FG001|PKC412A2104E1|Withdrawal by Subject|0
7223554|NCT00045942|11432865|FG002|PKC412A2104E1|Withdrawal by Subject|2
7223555|NCT00045942|11432866|FG003|PKC412A2104E1|Withdrawal by Subject|5
7223556|NCT00045942|11432867|FG004|PKC412A2104E1|Withdrawal by Subject|2
7223557|NCT00045942|11432868|FG005|PKC412A2104E1|Withdrawal by Subject|0
7223558|NCT00045942|11432869|FG006|PKC412A2104E1|Withdrawal by Subject|0
7223559|NCT00045942|11432870|FG007|PKC412A2104E1|Withdrawal by Subject|0
7223560|NCT00045942|11432871|FG008|PKC412A2104E1|Withdrawal by Subject|0
7223561|NCT00045942|11432863|FG000|PKC412A2104E1|Condition no longer requires study drug|0
7223562|NCT00045942|11432864|FG001|PKC412A2104E1|Condition no longer requires study drug|1
7223563|NCT00045942|11432865|FG002|PKC412A2104E1|Condition no longer requires study drug|1
7223564|NCT00045942|11432866|FG003|PKC412A2104E1|Condition no longer requires study drug|0
7223565|NCT00045942|11432867|FG004|PKC412A2104E1|Condition no longer requires study drug|1
7223566|NCT00045942|11432868|FG005|PKC412A2104E1|Condition no longer requires study drug|0
7223567|NCT00045942|11432869|FG006|PKC412A2104E1|Condition no longer requires study drug|0
7223568|NCT00045942|11432870|FG007|PKC412A2104E1|Condition no longer requires study drug|0
7223569|NCT00045942|11432871|FG008|PKC412A2104E1|Condition no longer requires study drug|0
7223570|NCT00045942|11432863|FG000|PKC412A2104E1|Lack of Efficacy|0
7223571|NCT00045942|11432864|FG001|PKC412A2104E1|Lack of Efficacy|11
7223572|NCT00045942|11432865|FG002|PKC412A2104E1|Lack of Efficacy|11
7223573|NCT00045942|11432866|FG003|PKC412A2104E1|Lack of Efficacy|23
7223574|NCT00045942|11432867|FG004|PKC412A2104E1|Lack of Efficacy|17
7223575|NCT00045942|11432868|FG005|PKC412A2104E1|Lack of Efficacy|0
7223576|NCT00045942|11432869|FG006|PKC412A2104E1|Lack of Efficacy|0
7223577|NCT00045942|11432870|FG007|PKC412A2104E1|Lack of Efficacy|0
7223578|NCT00045942|11432871|FG008|PKC412A2104E1|Lack of Efficacy|0
7223579|NCT00045942|11432863|FG000|PKC412A2104E1|Abnormal laboratory value|0
7223580|NCT00045942|11432864|FG001|PKC412A2104E1|Abnormal laboratory value|1
7223581|NCT00045942|11432865|FG002|PKC412A2104E1|Abnormal laboratory value|0
7223582|NCT00045942|11432866|FG003|PKC412A2104E1|Abnormal laboratory value|0
7223583|NCT00045942|11432867|FG004|PKC412A2104E1|Abnormal laboratory value|0
7223584|NCT00045942|11432868|FG005|PKC412A2104E1|Abnormal laboratory value|0
7223585|NCT00045942|11432869|FG006|PKC412A2104E1|Abnormal laboratory value|0
7223586|NCT00045942|11432870|FG007|PKC412A2104E1|Abnormal laboratory value|0
7223587|NCT00045942|11432871|FG008|PKC412A2104E1|Abnormal laboratory value|0
7223588|NCT00045942|11432863|FG000|PKC412A2104E1|Adverse Event|0
7223589|NCT00045942|11432864|FG001|PKC412A2104E1|Adverse Event|1
7223590|NCT00045942|11432865|FG002|PKC412A2104E1|Adverse Event|1
7223591|NCT00045942|11432866|FG003|PKC412A2104E1|Adverse Event|3
7223592|NCT00045942|11432867|FG004|PKC412A2104E1|Adverse Event|6
7223593|NCT00045942|11432868|FG005|PKC412A2104E1|Adverse Event|0
7223594|NCT00045942|11432869|FG006|PKC412A2104E1|Adverse Event|0
7223595|NCT00045942|11432870|FG007|PKC412A2104E1|Adverse Event|0
7223596|NCT00045942|11432871|FG008|PKC412A2104E1|Adverse Event|0
7223597|NCT00045942|11432863|FG000|PKC412A2104E1|Death|0
7223598|NCT00045942|11432864|FG001|PKC412A2104E1|Death|4
7223599|NCT00045942|11432865|FG002|PKC412A2104E1|Death|1
7223600|NCT00045942|11432866|FG003|PKC412A2104E1|Death|1
7223601|NCT00045942|11432867|FG004|PKC412A2104E1|Death|1
7223602|NCT00045942|11432868|FG005|PKC412A2104E1|Death|0
7223603|NCT00045942|11432869|FG006|PKC412A2104E1|Death|0
7223604|NCT00045942|11432870|FG007|PKC412A2104E1|Death|0
7223605|NCT00045942|11432871|FG008|PKC412A2104E1|Death|0
7223606|NCT00045942|11432863|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223607|NCT00045942|11432864|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223608|NCT00045942|11432865|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7223609|NCT00045942|11432866|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
7223610|NCT00045942|11432867|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223611|NCT00045942|11432868|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223612|NCT00045942|11432869|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223613|NCT00045942|11432870|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223614|NCT00045942|11432871|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
7223615|NCT00045942|11432863|FG000|PKC412A2104E2|Lost to Follow-up|0
7223616|NCT00045942|11432864|FG001|PKC412A2104E2|Lost to Follow-up|0
7223617|NCT00045942|11432865|FG002|PKC412A2104E2|Lost to Follow-up|0
7223618|NCT00045942|11432866|FG003|PKC412A2104E2|Lost to Follow-up|0
7223619|NCT00045942|11432867|FG004|PKC412A2104E2|Lost to Follow-up|0
7223620|NCT00045942|11432868|FG005|PKC412A2104E2|Lost to Follow-up|0
7223621|NCT00045942|11432869|FG006|PKC412A2104E2|Lost to Follow-up|0
7223622|NCT00045942|11432870|FG007|PKC412A2104E2|Lost to Follow-up|3
7223623|NCT00045942|11432871|FG008|PKC412A2104E2|Lost to Follow-up|0
7223624|NCT00045942|11432863|FG000|PKC412A2104E2|Withdrawal by Subject|0
7223625|NCT00045942|11432864|FG001|PKC412A2104E2|Withdrawal by Subject|0
7223626|NCT00045942|11432865|FG002|PKC412A2104E2|Withdrawal by Subject|0
7223627|NCT00045942|11432866|FG003|PKC412A2104E2|Withdrawal by Subject|0
7223628|NCT00045942|11432867|FG004|PKC412A2104E2|Withdrawal by Subject|0
7223629|NCT00045942|11432868|FG005|PKC412A2104E2|Withdrawal by Subject|1
7223630|NCT00045942|11432869|FG006|PKC412A2104E2|Withdrawal by Subject|0
7223631|NCT00045942|11432870|FG007|PKC412A2104E2|Withdrawal by Subject|1
7223632|NCT00045942|11432871|FG008|PKC412A2104E2|Withdrawal by Subject|0
7223633|NCT00045942|11432863|FG000|PKC412A2104E2|Lack of Efficacy|0
7223634|NCT00045942|11432864|FG001|PKC412A2104E2|Lack of Efficacy|0
7223635|NCT00045942|11432865|FG002|PKC412A2104E2|Lack of Efficacy|0
7223636|NCT00045942|11432866|FG003|PKC412A2104E2|Lack of Efficacy|0
7223637|NCT00045942|11432867|FG004|PKC412A2104E2|Lack of Efficacy|0
7223638|NCT00045942|11432868|FG005|PKC412A2104E2|Lack of Efficacy|3
7223639|NCT00045942|11432869|FG006|PKC412A2104E2|Lack of Efficacy|2
7223640|NCT00045942|11432870|FG007|PKC412A2104E2|Lack of Efficacy|2
7223641|NCT00045942|11432871|FG008|PKC412A2104E2|Lack of Efficacy|6
7223642|NCT00045942|11432863|FG000|PKC412A2104E2|Adverse Event|0
7223643|NCT00045942|11432864|FG001|PKC412A2104E2|Adverse Event|0
7223644|NCT00045942|11432865|FG002|PKC412A2104E2|Adverse Event|0
7223645|NCT00045942|11432866|FG003|PKC412A2104E2|Adverse Event|0
7223646|NCT00045942|11432867|FG004|PKC412A2104E2|Adverse Event|0
7223647|NCT00045942|11432868|FG005|PKC412A2104E2|Adverse Event|4
7223648|NCT00045942|11432869|FG006|PKC412A2104E2|Adverse Event|3
7223649|NCT00045942|11432870|FG007|PKC412A2104E2|Adverse Event|1
7223650|NCT00045942|11432871|FG008|PKC412A2104E2|Adverse Event|0
7223651|NCT00045942|11432863|FG000|PKC412A2104E2|Death|0
7223652|NCT00045942|11432864|FG001|PKC412A2104E2|Death|0
7223653|NCT00045942|11432865|FG002|PKC412A2104E2|Death|0
7223654|NCT00045942|11432866|FG003|PKC412A2104E2|Death|0
7223655|NCT00045942|11432867|FG004|PKC412A2104E2|Death|0
7223656|NCT00045942|11432868|FG005|PKC412A2104E2|Death|1
7223657|NCT00045942|11432869|FG006|PKC412A2104E2|Death|2
7223658|NCT00045942|11432870|FG007|PKC412A2104E2|Death|0
7223659|NCT00045942|11432871|FG008|PKC412A2104E2|Death|0
7223660|NCT00046839|11432938|FG000|Overall Study|Ineligible / No protocol treatment|0
7223661|NCT00046839|11432939|FG001|Overall Study|Ineligible / No protocol treatment|2
7223662|NCT00046839|11432938|FG000|Overall Study|Withdrawal of consent|1
7223663|NCT00046839|11432939|FG001|Overall Study|Withdrawal of consent|0
7223664|NCT00046891|11432948|FG000|Overall Study|Cancels|5
7223665|NCT00046891|11432949|FG001|Overall Study|Cancels|9
7223666|NCT00046891|11432948|FG000|Overall Study|Ineligible|1
7223667|NCT00046891|11432949|FG001|Overall Study|Ineligible|1
7223668|NCT00046891|11432948|FG000|Overall Study|Withdrawal by Subject|18
7223669|NCT00046891|11432949|FG001|Overall Study|Withdrawal by Subject|15
7223670|NCT00046891|11432948|FG000|Overall Study|Adverse Event|5
7223671|NCT00046891|11432949|FG001|Overall Study|Adverse Event|5
7223672|NCT00046930|11432965|FG000|Overall Study|Ineligible|12
7223673|NCT00046930|11432966|FG001|Overall Study|Ineligible|4
7223674|NCT00047320|11432979|FG000|Overall Study|Lack of Efficacy|8
7223675|NCT00047320|11432979|FG000|Overall Study|Lost to Follow-up|1
7223676|NCT00047320|11432979|FG000|Overall Study|Physician Decision|8
7223677|NCT00047320|11432979|FG000|Overall Study|Withdrawal by Subject|9
7223678|NCT00047320|11432979|FG000|Overall Study|Ineligible|2
7223679|NCT00047385|11432985|FG000|Overall Study|Death before any screening|2
7223680|NCT00047385|11432986|FG001|Overall Study|Death before any screening|5
7223681|NCT00047385|11432985|FG000|Overall Study|Lung Cancer diagnosed before screening|5
7223682|NCT00047385|11432986|FG001|Overall Study|Lung Cancer diagnosed before screening|3
7223683|NCT00047385|11432985|FG000|Overall Study|Eligible for screening but had no screen|260
7223684|NCT00047385|11432986|FG001|Overall Study|Eligible for screening but had no screen|492
7223685|NCT00047463|11432994|FG000|Overall Study|Withdrawal by Subject|0
7223686|NCT00047463|11432995|FG001|Overall Study|Withdrawal by Subject|3
7223687|NCT00047879|11433025|FG000|Overall Study|Progressive disease|4
7223688|NCT00047879|11433026|FG001|Overall Study|Progressive disease|3
7223689|NCT00048035|11433038|FG000|Core Period|Early Withdrawals|4
7223690|NCT00048035|11433039|FG001|Core Period|Early Withdrawals|2
7223691|NCT00048035|11433040|FG002|Core Period|Early Withdrawals|1
7223692|NCT00048035|11433041|FG003|Core Period|Early Withdrawals|1
7223693|NCT00048035|11433042|FG004|Core Period|Early Withdrawals|1
7223694|NCT00048035|11433043|FG005|Core Period|Early Withdrawals|1
7223695|NCT00048035|11433044|FG006|Core Period|Early Withdrawals|0
7223696|NCT00048035|11433045|FG007|Core Period|Early Withdrawals|0
7223697|NCT00048035|11433038|FG000|Extension Year 1|Early Withdrawals|0
7223698|NCT00048035|11433039|FG001|Extension Year 1|Early Withdrawals|0
7223699|NCT00048035|11433040|FG002|Extension Year 1|Early Withdrawals|0
7223700|NCT00048035|11433041|FG003|Extension Year 1|Early Withdrawals|0
7223701|NCT00048035|11433042|FG004|Extension Year 1|Early Withdrawals|0
7223702|NCT00048035|11433043|FG005|Extension Year 1|Early Withdrawals|0
7223703|NCT00048035|11433044|FG006|Extension Year 1|Early Withdrawals|11
7223704|NCT00048035|11433045|FG007|Extension Year 1|Early Withdrawals|11
7223705|NCT00048035|11433038|FG000|Extension Year 2|Early Withdrawals|0
7223706|NCT00048035|11433039|FG001|Extension Year 2|Early Withdrawals|0
7223707|NCT00048035|11433040|FG002|Extension Year 2|Early Withdrawals|0
7223708|NCT00048035|11433041|FG003|Extension Year 2|Early Withdrawals|0
7223709|NCT00048035|11433042|FG004|Extension Year 2|Early Withdrawals|0
7223710|NCT00048035|11433043|FG005|Extension Year 2|Early Withdrawals|0
7223711|NCT00048035|11433044|FG006|Extension Year 2|Early Withdrawals|3
7223712|NCT00048035|11433045|FG007|Extension Year 2|Early Withdrawals|3
7223713|NCT00048048|11433069|FG000|Core Treatment|Withdrawal by Subject|0
7223714|NCT00048048|11433070|FG001|Core Treatment|Withdrawal by Subject|0
7223715|NCT00048048|11433071|FG002|Core Treatment|Withdrawal by Subject|1
7223716|NCT00048048|11433072|FG003|Core Treatment|Withdrawal by Subject|0
7223717|NCT00048048|11433073|FG004|Core Treatment|Withdrawal by Subject|0
7223718|NCT00048048|11433074|FG005|Core Treatment|Withdrawal by Subject|0
7223719|NCT00048048|11433075|FG006|Core Treatment|Withdrawal by Subject|0
7223720|NCT00048048|11433076|FG007|Core Treatment|Withdrawal by Subject|0
7223721|NCT00048048|11433077|FG008|Core Treatment|Withdrawal by Subject|0
7223722|NCT00048048|11433078|FG009|Core Treatment|Withdrawal by Subject|0
7223723|NCT00048048|11433079|FG010|Core Treatment|Withdrawal by Subject|0
7223724|NCT00048048|11433080|FG011|Core Treatment|Withdrawal by Subject|0
7223725|NCT00048048|11433069|FG000|Core Treatment|Adverse Event|0
7223726|NCT00048048|11433070|FG001|Core Treatment|Adverse Event|0
7223727|NCT00048048|11433071|FG002|Core Treatment|Adverse Event|0
7223728|NCT00048048|11433072|FG003|Core Treatment|Adverse Event|0
7223729|NCT00048048|11433073|FG004|Core Treatment|Adverse Event|0
7223730|NCT00048048|11433074|FG005|Core Treatment|Adverse Event|0
7223731|NCT00048048|11433075|FG006|Core Treatment|Adverse Event|0
7223732|NCT00048048|11433076|FG007|Core Treatment|Adverse Event|1
7223733|NCT00048048|11433077|FG008|Core Treatment|Adverse Event|0
7223734|NCT00048048|11433078|FG009|Core Treatment|Adverse Event|0
7223735|NCT00048048|11433079|FG010|Core Treatment|Adverse Event|0
7223736|NCT00048048|11433080|FG011|Core Treatment|Adverse Event|0
7223737|NCT00048048|11433069|FG000|Extension Year 1|Early withdrawals|0
7223738|NCT00048048|11433070|FG001|Extension Year 1|Early withdrawals|0
7223739|NCT00048048|11433071|FG002|Extension Year 1|Early withdrawals|0
7223740|NCT00048048|11433072|FG003|Extension Year 1|Early withdrawals|0
7223741|NCT00048048|11433073|FG004|Extension Year 1|Early withdrawals|0
7223742|NCT00048048|11433074|FG005|Extension Year 1|Early withdrawals|0
7223743|NCT00048048|11433075|FG006|Extension Year 1|Early withdrawals|0
7223744|NCT00048048|11433076|FG007|Extension Year 1|Early withdrawals|0
7223745|NCT00048048|11433077|FG008|Extension Year 1|Early withdrawals|0
7223746|NCT00048048|11433078|FG009|Extension Year 1|Early withdrawals|2
7223747|NCT00048048|11433079|FG010|Extension Year 1|Early withdrawals|2
7223748|NCT00048048|11433080|FG011|Extension Year 1|Early withdrawals|4
7223749|NCT00048048|11433069|FG000|Extension Year 2|Early withdrawals|0
7223750|NCT00048048|11433070|FG001|Extension Year 2|Early withdrawals|0
7223751|NCT00048048|11433071|FG002|Extension Year 2|Early withdrawals|0
7223752|NCT00048048|11433072|FG003|Extension Year 2|Early withdrawals|0
7223753|NCT00048048|11433073|FG004|Extension Year 2|Early withdrawals|0
7223754|NCT00048048|11433074|FG005|Extension Year 2|Early withdrawals|0
7223755|NCT00048048|11433075|FG006|Extension Year 2|Early withdrawals|0
7223756|NCT00048048|11433076|FG007|Extension Year 2|Early withdrawals|0
7223757|NCT00048048|11433077|FG008|Extension Year 2|Early withdrawals|0
7223758|NCT00048048|11433078|FG009|Extension Year 2|Early withdrawals|0
7223759|NCT00048048|11433079|FG010|Extension Year 2|Early withdrawals|4
7223760|NCT00048048|11433080|FG011|Extension Year 2|Early withdrawals|2
7223761|NCT00048061|11433111|FG000|Overall Study|Adverse Event|41
7223762|NCT00048061|11433112|FG001|Overall Study|Adverse Event|32
7223763|NCT00048061|11433113|FG002|Overall Study|Adverse Event|44
7223764|NCT00048061|11433114|FG003|Overall Study|Adverse Event|37
7223765|NCT00048061|11433111|FG000|Overall Study|Lost to Follow-up|3
7223766|NCT00048061|11433112|FG001|Overall Study|Lost to Follow-up|2
7223767|NCT00048061|11433113|FG002|Overall Study|Lost to Follow-up|4
7223768|NCT00048061|11433114|FG003|Overall Study|Lost to Follow-up|5
7223769|NCT00048061|11433111|FG000|Overall Study|Withdrawal by Subject|20
7223770|NCT00048061|11433112|FG001|Overall Study|Withdrawal by Subject|29
7223771|NCT00048061|11433113|FG002|Overall Study|Withdrawal by Subject|29
7223772|NCT00048061|11433114|FG003|Overall Study|Withdrawal by Subject|32
7223773|NCT00048061|11433111|FG000|Overall Study|Did not follow-up|5
7223774|NCT00048061|11433112|FG001|Overall Study|Did not follow-up|5
7223775|NCT00048061|11433113|FG002|Overall Study|Did not follow-up|4
7223776|NCT00048061|11433114|FG003|Overall Study|Did not follow-up|5
7223777|NCT00048061|11433111|FG000|Overall Study|Early improvement|6
7223778|NCT00048061|11433112|FG001|Overall Study|Early improvement|5
7223779|NCT00048061|11433113|FG002|Overall Study|Early improvement|3
7223780|NCT00048061|11433114|FG003|Overall Study|Early improvement|0
7223781|NCT00048074|11433127|FG000|Overall Study|Adverse Event|46
7223782|NCT00048074|11433128|FG001|Overall Study|Adverse Event|41
7223783|NCT00048074|11433129|FG002|Overall Study|Adverse Event|53
7223784|NCT00048074|11433127|FG000|Overall Study|Death|3
7223785|NCT00048074|11433128|FG001|Overall Study|Death|3
7223786|NCT00048074|11433129|FG002|Overall Study|Death|2
7223787|NCT00048074|11433127|FG000|Overall Study|Lost to Follow-up|2
7223788|NCT00048074|11433128|FG001|Overall Study|Lost to Follow-up|6
7223789|NCT00048074|11433129|FG002|Overall Study|Lost to Follow-up|6
7223790|NCT00048074|11433127|FG000|Overall Study|Withdrawal by Subject|28
7223791|NCT00048074|11433128|FG001|Overall Study|Withdrawal by Subject|30
7223792|NCT00048074|11433129|FG002|Overall Study|Withdrawal by Subject|35
7223793|NCT00048074|11433127|FG000|Overall Study|Protocol Violation|1
7223794|NCT00048074|11433128|FG001|Overall Study|Protocol Violation|3
7223795|NCT00048074|11433129|FG002|Overall Study|Protocol Violation|0
7223796|NCT00048074|11433127|FG000|Overall Study|Study participation was terminated|0
7223797|NCT00048074|11433128|FG001|Overall Study|Study participation was terminated|1
7223798|NCT00048074|11433129|FG002|Overall Study|Study participation was terminated|0
7223799|NCT00048074|11433127|FG000|Overall Study|Husband ill|0
7223800|NCT00048074|11433128|FG001|Overall Study|Husband ill|1
7223801|NCT00048074|11433129|FG002|Overall Study|Husband ill|0
7223802|NCT00048074|11433127|FG000|Overall Study|Poor compliance|0
7223803|NCT00048074|11433128|FG001|Overall Study|Poor compliance|1
7223804|NCT00048074|11433129|FG002|Overall Study|Poor compliance|0
7223805|NCT00048074|11433127|FG000|Overall Study|Out of station|0
7223806|NCT00048074|11433128|FG001|Overall Study|Out of station|1
7223807|NCT00048074|11433129|FG002|Overall Study|Out of station|1
7223808|NCT00048074|11433127|FG000|Overall Study|Social reasons|1
7223809|NCT00048074|11433128|FG001|Overall Study|Social reasons|0
7223810|NCT00048074|11433129|FG002|Overall Study|Social reasons|0
7223811|NCT00048165|11433139|FG000|Completed 6 Months Study|Administration/Other|8
7223812|NCT00048165|11433140|FG001|Completed 6 Months Study|Administration/Other|8
7223813|NCT00048165|11433139|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
7223814|NCT00048165|11433140|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
7303843|NCT00623428|11526506|FG001|Follow-up Period|Failure to return|2
7303844|NCT00623428|11526505|FG000|Follow-up Period|Patient withdrew consent|5
7303845|NCT00623428|11526506|FG001|Follow-up Period|Patient withdrew consent|4
7303846|NCT00623428|11526505|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
7303847|NCT00623428|11526506|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
7303848|NCT00623428|11526505|FG000|Follow-up Period|Did not cooperate|0
7303849|NCT00623428|11526506|FG001|Follow-up Period|Did not cooperate|3
7303850|NCT00623428|11526505|FG000|Follow-up Period|Reason not specified|1
7303851|NCT00623428|11526506|FG001|Follow-up Period|Reason not specified|1
7303852|NCT00623428|11526505|FG000|Follow-up Period|Death|0
7303853|NCT00623428|11526506|FG001|Follow-up Period|Death|1
7303854|NCT00623467|11526516|FG000|Overall Study|Lost to Follow-up|1
7303855|NCT00623467|11526516|FG000|Overall Study|Protocol Violation|4
7303856|NCT00623467|11526516|FG000|Overall Study|Withdrawal by Subject|2
7303857|NCT00623480|11526524|FG000|Overall Study|Lost to Follow-up|0
7303858|NCT00623480|11526525|FG001|Overall Study|Lost to Follow-up|1
7303859|NCT00623480|11526524|FG000|Overall Study|Withdrawal by Subject|2
7303860|NCT00623480|11526525|FG001|Overall Study|Withdrawal by Subject|4
7303861|NCT00623480|11526524|FG000|Overall Study|Lack of Efficacy|1
7303862|NCT00623480|11526525|FG001|Overall Study|Lack of Efficacy|0
7303863|NCT00623480|11526524|FG000|Overall Study|Non-compliant with study medication|4
7303864|NCT00623480|11526525|FG001|Overall Study|Non-compliant with study medication|0
7303865|NCT00623480|11526524|FG000|Overall Study|Protocol Violation|0
7303866|NCT00623480|11526525|FG001|Overall Study|Protocol Violation|1
7303867|NCT00623480|11526524|FG000|Overall Study|Site closed by sponsor|0
7303868|NCT00623480|11526525|FG001|Overall Study|Site closed by sponsor|1
7303869|NCT00623545|11526540|FG000|Overall Study|Adverse Event|6
7303870|NCT00623545|11526540|FG000|Overall Study|Withdrawal by Subject|4
7303871|NCT00623597|11526547|FG000|Overall Study|Failed to return|1
7303872|NCT00623597|11526548|FG001|Overall Study|Failed to return|0
7303873|NCT00623623|11526558|FG000|Overall Study|Previous enrolment into this study|1
7303874|NCT00623623|11526559|FG001|Overall Study|Previous enrolment into this study|1
7303875|NCT00623727|11526584|FG000|Double Blind (DB)|Adverse Event|1
7303876|NCT00623727|11526585|FG001|Double Blind (DB)|Adverse Event|3
7303877|NCT00623727|11526584|FG000|Double Blind (DB)|Physician Decision|0
7303878|NCT00623727|11526585|FG001|Double Blind (DB)|Physician Decision|1
7303879|NCT00623727|11526584|FG000|Double Blind (DB)|Withdrawal by Subject|8
7303880|NCT00623727|11526585|FG001|Double Blind (DB)|Withdrawal by Subject|2
7303881|NCT00623727|11526584|FG000|Double Blind (DB)|Lack of Efficacy|2
7303882|NCT00623727|11526585|FG001|Double Blind (DB)|Lack of Efficacy|2
7303883|NCT00623727|11526584|FG000|Double Blind (DB)|Termination of the double-blind period|22
7303884|NCT00623727|11526585|FG001|Double Blind (DB)|Termination of the double-blind period|21
7303885|NCT00623727|11526584|FG000|Double Blind (DB)|Lost to Follow-up|1
7303886|NCT00623727|11526585|FG001|Double Blind (DB)|Lost to Follow-up|1
7303887|NCT00623727|11526584|FG000|Double Blind (DB)|Protocol Violation|2
7303888|NCT00623727|11526585|FG001|Double Blind (DB)|Protocol Violation|2
7303889|NCT00623727|11526584|FG000|Open Label Follow-up|Withdrawal by Subject|0
7303890|NCT00623727|11526585|FG001|Open Label Follow-up|Withdrawal by Subject|1
7303891|NCT00623727|11526584|FG000|Open Label Follow-up|Study termination|0
7303892|NCT00623727|11526585|FG001|Open Label Follow-up|Study termination|6
7303893|NCT00623727|11526584|FG000|Open Label Follow-up|Participant convenience|0
7303894|NCT00623727|11526585|FG001|Open Label Follow-up|Participant convenience|1
7303895|NCT00623766|11526595|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
7303896|NCT00623766|11526596|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
7303897|NCT00623766|11526595|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
7303898|NCT00623766|11526596|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
7303899|NCT00623766|11526595|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
7303900|NCT00623766|11526596|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
7303901|NCT00623766|11526595|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
7303902|NCT00623766|11526596|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
7223815|NCT00048165|11433139|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
7303903|NCT00623766|11526595|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
7552006|NCT02980133|11911668|FG000|Overall Study|Other than specified|1
7223816|NCT00048165|11433140|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
7223817|NCT00048165|11433139|FG000|Completed 6 Months Study|Death|12
7223818|NCT00048165|11433140|FG001|Completed 6 Months Study|Death|6
7223819|NCT00048165|11433139|FG000|Completed 6 Months Study|Insufficient therapy|1
7223820|NCT00048165|11433140|FG001|Completed 6 Months Study|Insufficient therapy|4
7223821|NCT00048165|11433139|FG000|Completed 6 Months Study|Other violation|4
7223822|NCT00048165|11433140|FG001|Completed 6 Months Study|Other violation|6
7223823|NCT00048165|11433139|FG000|Completed 6 Months Study|Refused treatment|5
7223824|NCT00048165|11433140|FG001|Completed 6 Months Study|Refused treatment|5
7223825|NCT00048165|11433139|FG000|Completed 6 Months Study|Violation criteria|0
7223826|NCT00048165|11433140|FG001|Completed 6 Months Study|Violation criteria|2
7223827|NCT00048165|11433139|FG000|Completed 6 Months Study|Did not receive study drug|6
7223828|NCT00048165|11433140|FG001|Completed 6 Months Study|Did not receive study drug|6
7223829|NCT00048165|11433139|FG000|Completed 12 Months Study|Administration/Other|0
7223830|NCT00048165|11433140|FG001|Completed 12 Months Study|Administration/Other|2
7223831|NCT00048165|11433139|FG000|Completed 12 Months Study|Death|2
7223832|NCT00048165|11433140|FG001|Completed 12 Months Study|Death|1
7223833|NCT00048165|11433139|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
7223834|NCT00048165|11433140|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
7223835|NCT00048347|11433148|FG000|Overall Study|Screen failure|2
7223836|NCT00048542|11433156|FG000|Double-Blind Phase|Withdrawal by Subject|0
7223837|NCT00048542|11433157|FG001|Double-Blind Phase|Withdrawal by Subject|1
7223838|NCT00048542|11433158|FG002|Double-Blind Phase|Withdrawal by Subject|0
7223839|NCT00048542|11433159|FG003|Double-Blind Phase|Withdrawal by Subject|0
7223840|NCT00048542|11433160|FG004|Double-Blind Phase|Withdrawal by Subject|0
7223841|NCT00048542|11433161|FG005|Double-Blind Phase|Withdrawal by Subject|0
7223842|NCT00048542|11433162|FG006|Double-Blind Phase|Withdrawal by Subject|0
7223843|NCT00048542|11433163|FG007|Double-Blind Phase|Withdrawal by Subject|0
7223844|NCT00048542|11433156|FG000|Double-Blind Phase|Protocol Violation|0
7223845|NCT00048542|11433157|FG001|Double-Blind Phase|Protocol Violation|0
7223846|NCT00048542|11433158|FG002|Double-Blind Phase|Protocol Violation|1
7223847|NCT00048542|11433159|FG003|Double-Blind Phase|Protocol Violation|0
7223848|NCT00048542|11433160|FG004|Double-Blind Phase|Protocol Violation|0
7223849|NCT00048542|11433161|FG005|Double-Blind Phase|Protocol Violation|0
7223850|NCT00048542|11433162|FG006|Double-Blind Phase|Protocol Violation|0
7223851|NCT00048542|11433163|FG007|Double-Blind Phase|Protocol Violation|0
7223852|NCT00048542|11433156|FG000|Double-Blind Phase|Sponsor request or decision|2
7223853|NCT00048542|11433157|FG001|Double-Blind Phase|Sponsor request or decision|0
7223854|NCT00048542|11433158|FG002|Double-Blind Phase|Sponsor request or decision|0
7223855|NCT00048542|11433159|FG003|Double-Blind Phase|Sponsor request or decision|0
7223856|NCT00048542|11433160|FG004|Double-Blind Phase|Sponsor request or decision|0
7223857|NCT00048542|11433161|FG005|Double-Blind Phase|Sponsor request or decision|0
7223858|NCT00048542|11433162|FG006|Double-Blind Phase|Sponsor request or decision|0
7223859|NCT00048542|11433163|FG007|Double-Blind Phase|Sponsor request or decision|0
7223860|NCT00048542|11433156|FG000|Double-Blind Phase|Randomized in error|1
7223861|NCT00048542|11433157|FG001|Double-Blind Phase|Randomized in error|0
7223862|NCT00048542|11433158|FG002|Double-Blind Phase|Randomized in error|0
7223863|NCT00048542|11433159|FG003|Double-Blind Phase|Randomized in error|0
7223864|NCT00048542|11433160|FG004|Double-Blind Phase|Randomized in error|0
7223865|NCT00048542|11433161|FG005|Double-Blind Phase|Randomized in error|0
7223866|NCT00048542|11433162|FG006|Double-Blind Phase|Randomized in error|0
7223867|NCT00048542|11433163|FG007|Double-Blind Phase|Randomized in error|0
7223868|NCT00048542|11433156|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223869|NCT00048542|11433157|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223870|NCT00048542|11433158|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223871|NCT00048542|11433159|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223872|NCT00048542|11433160|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
7223873|NCT00048542|11433161|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
7223874|NCT00048542|11433162|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223875|NCT00048542|11433163|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
7223876|NCT00048542|11433156|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
7223877|NCT00048542|11433157|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
7223878|NCT00048542|11433158|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
7223879|NCT00048542|11433159|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
7223880|NCT00048542|11433160|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
7223881|NCT00048542|11433161|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
7223882|NCT00048542|11433162|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
7223883|NCT00048542|11433163|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
7223884|NCT00048542|11433156|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223885|NCT00048542|11433157|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223886|NCT00048542|11433158|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223887|NCT00048542|11433159|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223888|NCT00048542|11433160|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
7223889|NCT00048542|11433161|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
7223890|NCT00048542|11433162|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223891|NCT00048542|11433163|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
7223892|NCT00048542|11433156|FG000|Open-Label Extension BSA Phase|Adverse Event|0
7223893|NCT00048542|11433157|FG001|Open-Label Extension BSA Phase|Adverse Event|0
7223894|NCT00048542|11433158|FG002|Open-Label Extension BSA Phase|Adverse Event|0
7223895|NCT00048542|11433159|FG003|Open-Label Extension BSA Phase|Adverse Event|0
7223896|NCT00048542|11433160|FG004|Open-Label Extension BSA Phase|Adverse Event|1
7223897|NCT00048542|11433161|FG005|Open-Label Extension BSA Phase|Adverse Event|1
7223898|NCT00048542|11433162|FG006|Open-Label Extension BSA Phase|Adverse Event|0
7223899|NCT00048542|11433163|FG007|Open-Label Extension BSA Phase|Adverse Event|0
7223900|NCT00048542|11433156|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223901|NCT00048542|11433157|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223902|NCT00048542|11433158|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223903|NCT00048542|11433159|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223904|NCT00048542|11433160|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
7223905|NCT00048542|11433161|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
7223906|NCT00048542|11433162|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223907|NCT00048542|11433163|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
7223908|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223909|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223910|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223911|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223912|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223913|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
7223914|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
7223915|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
7223916|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223917|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223918|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223919|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223920|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223921|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
7223922|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7223923|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
7223924|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223925|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223926|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223927|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223928|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223929|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
7223930|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
7223931|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
7223932|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223933|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223934|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223935|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223936|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223937|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
7223938|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7223939|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
7223940|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223941|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223942|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223943|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223944|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223945|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
7223946|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
7223947|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
7223948|NCT00048542|11433156|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223949|NCT00048542|11433157|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223950|NCT00048542|11433158|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223951|NCT00048542|11433159|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223952|NCT00048542|11433160|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223953|NCT00048542|11433161|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
7223954|NCT00048542|11433162|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
7223955|NCT00048542|11433163|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
7223956|NCT00048568|11433194|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
7223957|NCT00048568|11433195|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
7223958|NCT00048568|11433196|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
7223959|NCT00048568|11433194|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
7223960|NCT00048568|11433195|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
7223961|NCT00048568|11433196|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
7223962|NCT00048568|11433194|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7223963|NCT00048568|11433195|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
7223964|NCT00048568|11433196|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
7223965|NCT00048568|11433194|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
7303904|NCT00623766|11526596|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
7303905|NCT00623779|11526609|FG000|Overall Study|Adverse Event|1
7303906|NCT00623779|11526610|FG001|Overall Study|Adverse Event|3
7303907|NCT00623779|11526611|FG002|Overall Study|Adverse Event|0
7303908|NCT00623779|11526609|FG000|Overall Study|Criteria from CSR|2
7303909|NCT00623779|11526610|FG001|Overall Study|Criteria from CSR|0
7303910|NCT00623779|11526611|FG002|Overall Study|Criteria from CSR|1
7303911|NCT00623805|11526621|FG000|Overall Study|Adverse Event|9
7303912|NCT00623805|11526622|FG001|Overall Study|Adverse Event|6
7303913|NCT00623805|11526621|FG000|Overall Study|Death|2
7303914|NCT00623805|11526622|FG001|Overall Study|Death|0
7303915|NCT00623805|11526621|FG000|Overall Study|Lack of Efficacy|3
7303916|NCT00623805|11526622|FG001|Overall Study|Lack of Efficacy|7
7303917|NCT00623805|11526621|FG000|Overall Study|Lost to Follow-up|2
7303918|NCT00623805|11526622|FG001|Overall Study|Lost to Follow-up|2
7303919|NCT00623805|11526621|FG000|Overall Study|Protocol Violation|1
7303920|NCT00623805|11526622|FG001|Overall Study|Protocol Violation|1
7303921|NCT00623805|11526621|FG000|Overall Study|Reason not Specified|3
7303922|NCT00623805|11526622|FG001|Overall Study|Reason not Specified|6
7303923|NCT00623831|11526630|FG000|Overall Study|Withdrawal by Subject|1
7303924|NCT00623831|11526631|FG001|Overall Study|Withdrawal by Subject|0
7303925|NCT00623831|11526630|FG000|Overall Study|Progressive Disease|0
7303926|NCT00623831|11526631|FG001|Overall Study|Progressive Disease|1
7303927|NCT00623935|11526640|FG000|Overall Study|Death|1
7303928|NCT00623935|11526640|FG000|Overall Study|Patient Declined Transplant|1
7303929|NCT00624052|11526659|FG000|Overall Study|Adverse Event|7
7303930|NCT00624052|11526660|FG001|Overall Study|Adverse Event|6
7303931|NCT00624052|11526661|FG002|Overall Study|Adverse Event|0
7303932|NCT00624052|11526662|FG003|Overall Study|Adverse Event|3
7303933|NCT00624052|11526659|FG000|Overall Study|Lack of Efficacy|1
7303934|NCT00624052|11526660|FG001|Overall Study|Lack of Efficacy|1
7303935|NCT00624052|11526661|FG002|Overall Study|Lack of Efficacy|0
7303936|NCT00624052|11526662|FG003|Overall Study|Lack of Efficacy|0
7303937|NCT00624052|11526659|FG000|Overall Study|Lost to Follow-up|2
7303938|NCT00624052|11526660|FG001|Overall Study|Lost to Follow-up|3
7303939|NCT00624052|11526661|FG002|Overall Study|Lost to Follow-up|1
7303940|NCT00624052|11526662|FG003|Overall Study|Lost to Follow-up|0
7303941|NCT00624052|11526659|FG000|Overall Study|Non compliant with the protocol|2
7303942|NCT00624052|11526660|FG001|Overall Study|Non compliant with the protocol|1
7303943|NCT00624052|11526661|FG002|Overall Study|Non compliant with the protocol|1
7303944|NCT00624052|11526662|FG003|Overall Study|Non compliant with the protocol|1
7303945|NCT00624052|11526659|FG000|Overall Study|Consent withdrawn|3
7303946|NCT00624052|11526660|FG001|Overall Study|Consent withdrawn|1
7303947|NCT00624052|11526661|FG002|Overall Study|Consent withdrawn|1
7303948|NCT00624052|11526662|FG003|Overall Study|Consent withdrawn|0
7303949|NCT00624052|11526659|FG000|Overall Study|Changed job/ran out if meds|0
7303950|NCT00624052|11526660|FG001|Overall Study|Changed job/ran out if meds|2
7303951|NCT00624052|11526661|FG002|Overall Study|Changed job/ran out if meds|0
7303952|NCT00624052|11526662|FG003|Overall Study|Changed job/ran out if meds|0
7303953|NCT00624065|11526678|FG000|Overall Study|Adverse Event|5
7303954|NCT00624065|11526679|FG001|Overall Study|Adverse Event|6
7303955|NCT00624065|11526678|FG000|Overall Study|Lost to Follow-up|4
7303956|NCT00624065|11526679|FG001|Overall Study|Lost to Follow-up|1
7303957|NCT00624065|11526678|FG000|Overall Study|Consent withdrawn|6
7303958|NCT00624065|11526679|FG001|Overall Study|Consent withdrawn|5
7303959|NCT00624065|11526678|FG000|Overall Study|Lack of Efficacy|0
7303960|NCT00624065|11526679|FG001|Overall Study|Lack of Efficacy|3
7303961|NCT00624065|11526678|FG000|Overall Study|Met protocol-defined stopping criteria|4
7303962|NCT00624065|11526679|FG001|Overall Study|Met protocol-defined stopping criteria|9
7303963|NCT00624286|11526705|FG000|Overall Study|Protocol Deviation|7
7303964|NCT00624286|11526706|FG001|Overall Study|Protocol Deviation|9
7303965|NCT00624286|11526705|FG000|Overall Study|Adverse Event|6
7303966|NCT00624286|11526706|FG001|Overall Study|Adverse Event|3
7303967|NCT00624286|11526705|FG000|Overall Study|Withdrawal by Subject|5
7303968|NCT00624286|11526706|FG001|Overall Study|Withdrawal by Subject|4
7303969|NCT00624286|11526705|FG000|Overall Study|Lost to Follow-up|3
7303970|NCT00624286|11526706|FG001|Overall Study|Lost to Follow-up|2
7303971|NCT00624286|11526705|FG000|Overall Study|Administrative problems|3
7303972|NCT00624286|11526706|FG001|Overall Study|Administrative problems|0
7303973|NCT00624286|11526705|FG000|Overall Study|Lack of Efficacy|1
7223966|NCT00048568|11433195|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
7223967|NCT00048568|11433196|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
7223968|NCT00048568|11433194|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
7223969|NCT00048568|11433195|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
7223970|NCT00048568|11433196|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
7223971|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Death|1
7223972|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Death|1
7223973|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Death|0
7223974|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
7223975|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
7223976|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
7223977|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
7223978|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
7223979|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
7223980|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
7223981|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
7223982|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
7223983|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7223984|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
7223985|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
7223986|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
7223987|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
7223988|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
7223989|NCT00048568|11433194|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7223990|NCT00048568|11433195|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
7223991|NCT00048568|11433196|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
7223992|NCT00048568|11433194|FG000|Open-Label Period|Death|0
7223993|NCT00048568|11433195|FG001|Open-Label Period|Death|0
7223994|NCT00048568|11433196|FG002|Open-Label Period|Death|13
7223995|NCT00048568|11433194|FG000|Open-Label Period|Adverse Event|0
7223996|NCT00048568|11433195|FG001|Open-Label Period|Adverse Event|0
7223997|NCT00048568|11433196|FG002|Open-Label Period|Adverse Event|49
7223998|NCT00048568|11433194|FG000|Open-Label Period|Lack of Efficacy|0
7223999|NCT00048568|11433195|FG001|Open-Label Period|Lack of Efficacy|0
7224000|NCT00048568|11433196|FG002|Open-Label Period|Lack of Efficacy|32
7224001|NCT00048568|11433194|FG000|Open-Label Period|Withdrawal by Subject|0
7224002|NCT00048568|11433195|FG001|Open-Label Period|Withdrawal by Subject|0
7224003|NCT00048568|11433196|FG002|Open-Label Period|Withdrawal by Subject|26
7224004|NCT00048568|11433194|FG000|Open-Label Period|Pregnancy|0
7224005|NCT00048568|11433195|FG001|Open-Label Period|Pregnancy|0
7224006|NCT00048568|11433196|FG002|Open-Label Period|Pregnancy|5
7224007|NCT00048568|11433194|FG000|Open-Label Period|No Longer Met Study Criteria|0
7224008|NCT00048568|11433195|FG001|Open-Label Period|No Longer Met Study Criteria|0
7224009|NCT00048568|11433196|FG002|Open-Label Period|No Longer Met Study Criteria|2
7224010|NCT00048568|11433194|FG000|Open-Label Period|Administrative Decision By Sponsor|0
7224011|NCT00048568|11433195|FG001|Open-Label Period|Administrative Decision By Sponsor|0
7224012|NCT00048568|11433196|FG002|Open-Label Period|Administrative Decision By Sponsor|1
7224013|NCT00048568|11433194|FG000|Open-Label Period|Unknown Reasons|0
7224014|NCT00048568|11433195|FG001|Open-Label Period|Unknown Reasons|0
7224015|NCT00048568|11433196|FG002|Open-Label Period|Unknown Reasons|25
7224016|NCT00048568|11433194|FG000|Open-Label Period|Lost to Follow-up|0
7224017|NCT00048568|11433195|FG001|Open-Label Period|Lost to Follow-up|0
7224018|NCT00048568|11433196|FG002|Open-Label Period|Lost to Follow-up|7
7224019|NCT00048581|11433219|FG000|Double-Blind Period|Adverse Event|9
7224020|NCT00048581|11433220|FG001|Double-Blind Period|Adverse Event|5
7224021|NCT00048581|11433221|FG002|Double-Blind Period|Adverse Event|0
7224022|NCT00048581|11433219|FG000|Double-Blind Period|Lack of Efficacy|14
7224023|NCT00048581|11433220|FG001|Double-Blind Period|Lack of Efficacy|27
7224024|NCT00048581|11433221|FG002|Double-Blind Period|Lack of Efficacy|0
7224025|NCT00048581|11433219|FG000|Double-Blind Period|Lost to Follow-up|5
7224026|NCT00048581|11433220|FG001|Double-Blind Period|Lost to Follow-up|0
7224027|NCT00048581|11433221|FG002|Double-Blind Period|Lost to Follow-up|0
7224028|NCT00048581|11433219|FG000|Double-Blind Period|Withdrawal by Subject|5
7224029|NCT00048581|11433220|FG001|Double-Blind Period|Withdrawal by Subject|2
7224030|NCT00048581|11433221|FG002|Double-Blind Period|Withdrawal by Subject|0
7224031|NCT00048581|11433219|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
7224032|NCT00048581|11433220|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
7224033|NCT00048581|11433221|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
7224034|NCT00048581|11433219|FG000|Double-Blind Period|Investigator Decision|1
7224035|NCT00048581|11433220|FG001|Double-Blind Period|Investigator Decision|0
7224036|NCT00048581|11433221|FG002|Double-Blind Period|Investigator Decision|0
7224037|NCT00048581|11433219|FG000|Open-Label Period|Death|0
7224038|NCT00048581|11433220|FG001|Open-Label Period|Death|0
7224039|NCT00048581|11433221|FG002|Open-Label Period|Death|4
7224040|NCT00048581|11433219|FG000|Open-Label Period|Adverse Event|0
7224041|NCT00048581|11433220|FG001|Open-Label Period|Adverse Event|0
7224042|NCT00048581|11433221|FG002|Open-Label Period|Adverse Event|37
7224043|NCT00048581|11433219|FG000|Open-Label Period|Lack of Efficacy|0
7224044|NCT00048581|11433220|FG001|Open-Label Period|Lack of Efficacy|0
7224045|NCT00048581|11433221|FG002|Open-Label Period|Lack of Efficacy|69
7224046|NCT00048581|11433219|FG000|Open-Label Period|Lost to Follow-up|0
7224047|NCT00048581|11433220|FG001|Open-Label Period|Lost to Follow-up|0
7224048|NCT00048581|11433221|FG002|Open-Label Period|Lost to Follow-up|14
7224049|NCT00048581|11433219|FG000|Open-Label Period|Withdrawal by Subject|0
7224050|NCT00048581|11433220|FG001|Open-Label Period|Withdrawal by Subject|0
7224051|NCT00048581|11433221|FG002|Open-Label Period|Withdrawal by Subject|20
7224052|NCT00048581|11433219|FG000|Open-Label Period|No Longer Meets Study Criteria|0
7224053|NCT00048581|11433220|FG001|Open-Label Period|No Longer Meets Study Criteria|0
7224054|NCT00048581|11433221|FG002|Open-Label Period|No Longer Meets Study Criteria|2
7224055|NCT00048581|11433219|FG000|Open-Label Period|Poor/Non-compliance|0
7224056|NCT00048581|11433220|FG001|Open-Label Period|Poor/Non-compliance|0
7224057|NCT00048581|11433221|FG002|Open-Label Period|Poor/Non-compliance|5
7224058|NCT00048581|11433219|FG000|Open-Label Period|Pregnancy|0
7224059|NCT00048581|11433220|FG001|Open-Label Period|Pregnancy|0
7224060|NCT00048581|11433221|FG002|Open-Label Period|Pregnancy|7
7224061|NCT00048581|11433219|FG000|Open-Label Period|Study Site Closure|0
7224062|NCT00048581|11433220|FG001|Open-Label Period|Study Site Closure|0
7224063|NCT00048581|11433221|FG002|Open-Label Period|Study Site Closure|2
7224064|NCT00048581|11433219|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7224065|NCT00048581|11433220|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
7224066|NCT00048581|11433221|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
7224067|NCT00048581|11433219|FG000|Open-Label Period|Problem With Transportation To Site|0
7224068|NCT00048581|11433220|FG001|Open-Label Period|Problem With Transportation To Site|0
7224069|NCT00048581|11433221|FG002|Open-Label Period|Problem With Transportation To Site|1
7224070|NCT00048581|11433219|FG000|Open-Label Period|Primary Investigator Retired|0
7224071|NCT00048581|11433220|FG001|Open-Label Period|Primary Investigator Retired|0
7224072|NCT00048581|11433221|FG002|Open-Label Period|Primary Investigator Retired|2
7224073|NCT00048581|11433219|FG000|Open-Label Period|Study Ended By Sponsor|0
7224074|NCT00048581|11433220|FG001|Open-Label Period|Study Ended By Sponsor|0
7224075|NCT00048581|11433221|FG002|Open-Label Period|Study Ended By Sponsor|1
7224076|NCT00048724|11433236|FG000|Overall Study|Adverse Event|53
7224077|NCT00048724|11433237|FG001|Overall Study|Adverse Event|12
7224078|NCT00048724|11433236|FG000|Overall Study|Withdrawal by Subject|34
7224079|NCT00048724|11433237|FG001|Overall Study|Withdrawal by Subject|54
7224080|NCT00048724|11433236|FG000|Overall Study|Lost to Follow-up|5
7224081|NCT00048724|11433237|FG001|Overall Study|Lost to Follow-up|5
7224082|NCT00048724|11433236|FG000|Overall Study|Protocol-defined Clinical Event|17
7224083|NCT00048724|11433237|FG001|Overall Study|Protocol-defined Clinical Event|32
7224084|NCT00048724|11433236|FG000|Overall Study|Noncompliance With Protocol|4
7224085|NCT00048724|11433237|FG001|Overall Study|Noncompliance With Protocol|12
7224086|NCT00048724|11433236|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
7224087|NCT00048724|11433237|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
7224088|NCT00048724|11433236|FG000|Overall Study|Administrative|1
7224089|NCT00048724|11433237|FG001|Overall Study|Administrative|1
7224090|NCT00048932|11433266|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
7224091|NCT00048932|11433267|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7224092|NCT00048932|11433268|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
7224093|NCT00048932|11433266|FG000|Double Blind Period (DB)|Adverse Event|51
7224094|NCT00048932|11433267|FG001|Double Blind Period (DB)|Adverse Event|19
7224095|NCT00048932|11433268|FG002|Double Blind Period (DB)|Adverse Event|0
7224096|NCT00048932|11433266|FG000|Double Blind Period (DB)|Death|5
7224097|NCT00048932|11433267|FG001|Double Blind Period (DB)|Death|3
7224098|NCT00048932|11433268|FG002|Double Blind Period (DB)|Death|0
7224099|NCT00048932|11433266|FG000|Double Blind Period (DB)|Lack of Efficacy|26
7224100|NCT00048932|11433267|FG001|Double Blind Period (DB)|Lack of Efficacy|44
7224101|NCT00048932|11433268|FG002|Double Blind Period (DB)|Lack of Efficacy|0
7224102|NCT00048932|11433266|FG000|Double Blind Period (DB)|Lost to Follow-up|3
7224103|NCT00048932|11433267|FG001|Double Blind Period (DB)|Lost to Follow-up|4
7224104|NCT00048932|11433268|FG002|Double Blind Period (DB)|Lost to Follow-up|0
7224105|NCT00048932|11433266|FG000|Double Blind Period (DB)|Relocation|1
7224106|NCT00048932|11433267|FG001|Double Blind Period (DB)|Relocation|0
7224107|NCT00048932|11433268|FG002|Double Blind Period (DB)|Relocation|0
7224108|NCT00048932|11433266|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
7224109|NCT00048932|11433267|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
7224110|NCT00048932|11433268|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
7224111|NCT00048932|11433266|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
7224112|NCT00048932|11433267|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7224113|NCT00048932|11433268|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
7224114|NCT00048932|11433266|FG000|Double Blind Period (DB)|Pregnancy|1
7224115|NCT00048932|11433267|FG001|Double Blind Period (DB)|Pregnancy|0
7224116|NCT00048932|11433268|FG002|Double Blind Period (DB)|Pregnancy|0
7224117|NCT00048932|11433266|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
7224118|NCT00048932|11433267|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
7224119|NCT00048932|11433268|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
7224120|NCT00048932|11433266|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
7303974|NCT00624286|11526706|FG001|Overall Study|Lack of Efficacy|6
7303975|NCT00624286|11526705|FG000|Overall Study|Not stated|0
7303976|NCT00624286|11526706|FG001|Overall Study|Not stated|1
7303977|NCT00624286|11526705|FG000|Overall Study|Abnormal test procedure result(s)|0
7303978|NCT00624286|11526706|FG001|Overall Study|Abnormal test procedure result(s)|1
7303979|NCT00624286|11526705|FG000|Overall Study|Death|0
7303980|NCT00624286|11526706|FG001|Overall Study|Death|1
7303981|NCT00624338|11526715|FG000|Overall Study|Adverse Event|14
7303982|NCT00624338|11526716|FG001|Overall Study|Adverse Event|14
7303983|NCT00624338|11526717|FG002|Overall Study|Adverse Event|18
7224121|NCT00048932|11433267|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
7224122|NCT00048932|11433268|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
7224123|NCT00048932|11433266|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
7224124|NCT00048932|11433267|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
7224125|NCT00048932|11433268|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
7224126|NCT00048932|11433266|FG000|Open Label Period (OL)|Death|0
7224127|NCT00048932|11433267|FG001|Open Label Period (OL)|Death|0
7224128|NCT00048932|11433268|FG002|Open Label Period (OL)|Death|25
7224129|NCT00048932|11433266|FG000|Open Label Period (OL)|Adverse Event|0
7224130|NCT00048932|11433267|FG001|Open Label Period (OL)|Adverse Event|0
7224131|NCT00048932|11433268|FG002|Open Label Period (OL)|Adverse Event|103
7224132|NCT00048932|11433266|FG000|Open Label Period (OL)|Lack of Efficacy|0
7224133|NCT00048932|11433267|FG001|Open Label Period (OL)|Lack of Efficacy|0
7224134|NCT00048932|11433268|FG002|Open Label Period (OL)|Lack of Efficacy|81
7224135|NCT00048932|11433266|FG000|Open Label Period (OL)|Lost to Follow-up|0
7224136|NCT00048932|11433267|FG001|Open Label Period (OL)|Lost to Follow-up|0
7224137|NCT00048932|11433268|FG002|Open Label Period (OL)|Lost to Follow-up|27
7224138|NCT00048932|11433266|FG000|Open Label Period (OL)|Withdrawal by Subject|0
7224139|NCT00048932|11433267|FG001|Open Label Period (OL)|Withdrawal by Subject|0
7224140|NCT00048932|11433268|FG002|Open Label Period (OL)|Withdrawal by Subject|117
7224141|NCT00048932|11433266|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
7224142|NCT00048932|11433267|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
7224143|NCT00048932|11433268|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
7224144|NCT00048932|11433266|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
7224145|NCT00048932|11433267|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
7224146|NCT00048932|11433268|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
7224147|NCT00048932|11433266|FG000|Open Label Period (OL)|Pregnancy|0
7224148|NCT00048932|11433267|FG001|Open Label Period (OL)|Pregnancy|0
7224149|NCT00048932|11433268|FG002|Open Label Period (OL)|Pregnancy|6
7224150|NCT00048932|11433266|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
7224151|NCT00048932|11433267|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
7224152|NCT00048932|11433268|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
7224153|NCT00048932|11433266|FG000|Open Label Period (OL)|Investigator Retiring|0
7224154|NCT00048932|11433267|FG001|Open Label Period (OL)|Investigator Retiring|0
7224155|NCT00048932|11433268|FG002|Open Label Period (OL)|Investigator Retiring|2
7224156|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Transportation Issues|0
7224157|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Transportation Issues|0
7224158|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Transportation Issues|1
7224159|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Relocated|0
7224160|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Relocated|0
7224161|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Relocated|6
7224162|NCT00048932|11433266|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
7224163|NCT00048932|11433267|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
7224164|NCT00048932|11433268|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
7224165|NCT00048932|11433266|FG000|Open Label Period (OL)|Site Closure|0
7224166|NCT00048932|11433267|FG001|Open Label Period (OL)|Site Closure|0
7224167|NCT00048932|11433268|FG002|Open Label Period (OL)|Site Closure|3
7224168|NCT00048932|11433266|FG000|Open Label Period (OL)|Trial Terminated|0
7224169|NCT00048932|11433267|FG001|Open Label Period (OL)|Trial Terminated|0
7224170|NCT00048932|11433268|FG002|Open Label Period (OL)|Trial Terminated|1
7224171|NCT00048932|11433266|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
7224172|NCT00048932|11433267|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
7224173|NCT00048932|11433268|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
7224174|NCT00048932|11433266|FG000|Open Label Period (OL)|Patient Decision|0
7224175|NCT00048932|11433267|FG001|Open Label Period (OL)|Patient Decision|0
7224176|NCT00048932|11433268|FG002|Open Label Period (OL)|Patient Decision|4
7224177|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
7224178|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
7224179|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
7224180|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
7224181|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
7224182|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
7224183|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7224184|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
7224185|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
7224186|NCT00048932|11433266|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
7224187|NCT00048932|11433267|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
7224188|NCT00048932|11433268|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
7224189|NCT00048932|11433266|FG000|Open Label Period (OL)|Investigator Decision|0
7224190|NCT00048932|11433267|FG001|Open Label Period (OL)|Investigator Decision|0
7224191|NCT00048932|11433268|FG002|Open Label Period (OL)|Investigator Decision|4
7224192|NCT00048932|11433266|FG000|Open Label Period (OL)|Site Staff Issues|0
7224193|NCT00048932|11433267|FG001|Open Label Period (OL)|Site Staff Issues|0
7224194|NCT00048932|11433268|FG002|Open Label Period (OL)|Site Staff Issues|2
7224195|NCT00048932|11433266|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
7224196|NCT00048932|11433267|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
7224197|NCT00048932|11433268|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
7224198|NCT00048932|11433266|FG000|Open Label Period (OL)|Participant Surgery|0
7224199|NCT00048932|11433267|FG001|Open Label Period (OL)|Participant Surgery|0
7224200|NCT00048932|11433268|FG002|Open Label Period (OL)|Participant Surgery|1
7224201|NCT00048997|11433279|FG000|Overall Study|Protocol Violation|7
7224202|NCT00048997|11433280|FG001|Overall Study|Protocol Violation|2
7224203|NCT00048997|11433279|FG000|Overall Study|Withdrawal by Subject|6
7224204|NCT00048997|11433280|FG001|Overall Study|Withdrawal by Subject|1
7224205|NCT00049127|11433299|FG000|Overall Study|Withdrawal by Subject|0
7224206|NCT00049127|11433300|FG001|Overall Study|Withdrawal by Subject|0
7224207|NCT00049127|11433301|FG002|Overall Study|Withdrawal by Subject|1
7224208|NCT00049127|11433302|FG003|Overall Study|Withdrawal by Subject|0
7224209|NCT00049127|11433303|FG004|Overall Study|Withdrawal by Subject|0
7224210|NCT00049257|11433315|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
7224211|NCT00049257|11433315|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
7224212|NCT00049257|11433315|FG000|Carboplatin, Paclitaxel|Death|2
7224213|NCT00049257|11433315|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
7224214|NCT00049322|11433321|FG000|Overall Study|disease burden|0
7224215|NCT00049322|11433322|FG001|Overall Study|disease burden|3
7224216|NCT00049322|11433321|FG000|Overall Study|Adverse Event|1
7224217|NCT00049322|11433322|FG001|Overall Study|Adverse Event|0
7224218|NCT00049322|11433321|FG000|Overall Study|refused angio|0
7224219|NCT00049322|11433322|FG001|Overall Study|refused angio|3
7224220|NCT00049517|11433336|FG000|Induction|Disease progression|0
7224221|NCT00049517|11433337|FG001|Induction|Disease progression|0
7224222|NCT00049517|11433338|FG002|Induction|Disease progression|0
7224223|NCT00049517|11433339|FG003|Induction|Disease progression|0
7224224|NCT00049517|11433340|FG004|Induction|Disease progression|18
7224225|NCT00049517|11433341|FG005|Induction|Disease progression|11
7224226|NCT00049517|11433336|FG000|Induction|Adverse Event|0
7224227|NCT00049517|11433337|FG001|Induction|Adverse Event|0
7224228|NCT00049517|11433338|FG002|Induction|Adverse Event|0
7224229|NCT00049517|11433339|FG003|Induction|Adverse Event|0
7224230|NCT00049517|11433340|FG004|Induction|Adverse Event|5
7224231|NCT00049517|11433341|FG005|Induction|Adverse Event|7
7224232|NCT00049517|11433336|FG000|Induction|Death|0
7224233|NCT00049517|11433337|FG001|Induction|Death|0
7224234|NCT00049517|11433338|FG002|Induction|Death|0
7224235|NCT00049517|11433339|FG003|Induction|Death|0
7224236|NCT00049517|11433340|FG004|Induction|Death|9
7224237|NCT00049517|11433341|FG005|Induction|Death|6
7224238|NCT00049517|11433336|FG000|Induction|Withdrawal by Subject|0
7224239|NCT00049517|11433337|FG001|Induction|Withdrawal by Subject|0
7224240|NCT00049517|11433338|FG002|Induction|Withdrawal by Subject|0
7224241|NCT00049517|11433339|FG003|Induction|Withdrawal by Subject|0
7224242|NCT00049517|11433340|FG004|Induction|Withdrawal by Subject|1
7224243|NCT00049517|11433341|FG005|Induction|Withdrawal by Subject|3
7224244|NCT00049517|11433336|FG000|Induction|Alternative therapy|0
7224245|NCT00049517|11433337|FG001|Induction|Alternative therapy|0
7224246|NCT00049517|11433338|FG002|Induction|Alternative therapy|0
7224247|NCT00049517|11433339|FG003|Induction|Alternative therapy|0
7224248|NCT00049517|11433340|FG004|Induction|Alternative therapy|2
7224249|NCT00049517|11433341|FG005|Induction|Alternative therapy|2
7224250|NCT00049517|11433336|FG000|Induction|Other complicating disease|0
7224251|NCT00049517|11433337|FG001|Induction|Other complicating disease|0
7224252|NCT00049517|11433338|FG002|Induction|Other complicating disease|0
7224253|NCT00049517|11433339|FG003|Induction|Other complicating disease|0
7224254|NCT00049517|11433340|FG004|Induction|Other complicating disease|3
7224255|NCT00049517|11433341|FG005|Induction|Other complicating disease|0
7224256|NCT00049517|11433336|FG000|Induction|Reasons not reported|0
7224257|NCT00049517|11433337|FG001|Induction|Reasons not reported|0
7224258|NCT00049517|11433338|FG002|Induction|Reasons not reported|0
7224259|NCT00049517|11433339|FG003|Induction|Reasons not reported|0
7224260|NCT00049517|11433340|FG004|Induction|Reasons not reported|22
7224261|NCT00049517|11433341|FG005|Induction|Reasons not reported|25
7224262|NCT00049517|11433336|FG000|Conditioning/Transplant|Disease progression|14
7224263|NCT00049517|11433337|FG001|Conditioning/Transplant|Disease progression|6
7224264|NCT00049517|11433338|FG002|Conditioning/Transplant|Disease progression|10
7224265|NCT00049517|11433339|FG003|Conditioning/Transplant|Disease progression|6
7224266|NCT00049517|11433340|FG004|Conditioning/Transplant|Disease progression|0
7224267|NCT00049517|11433341|FG005|Conditioning/Transplant|Disease progression|0
7224268|NCT00049517|11433336|FG000|Conditioning/Transplant|Adverse Event|2
7224269|NCT00049517|11433337|FG001|Conditioning/Transplant|Adverse Event|1
7224270|NCT00049517|11433338|FG002|Conditioning/Transplant|Adverse Event|4
7224271|NCT00049517|11433339|FG003|Conditioning/Transplant|Adverse Event|8
7224272|NCT00049517|11433340|FG004|Conditioning/Transplant|Adverse Event|0
7224273|NCT00049517|11433341|FG005|Conditioning/Transplant|Adverse Event|0
7224274|NCT00049517|11433336|FG000|Conditioning/Transplant|Death|1
7224275|NCT00049517|11433337|FG001|Conditioning/Transplant|Death|0
7224276|NCT00049517|11433338|FG002|Conditioning/Transplant|Death|0
7224277|NCT00049517|11433339|FG003|Conditioning/Transplant|Death|2
7224278|NCT00049517|11433340|FG004|Conditioning/Transplant|Death|0
7224279|NCT00049517|11433341|FG005|Conditioning/Transplant|Death|0
7224280|NCT00049517|11433336|FG000|Conditioning/Transplant|Withdrawal by Subject|4
7303984|NCT00624338|11526715|FG000|Overall Study|Lost to Follow-up|1
7303985|NCT00624338|11526716|FG001|Overall Study|Lost to Follow-up|0
7303986|NCT00624338|11526717|FG002|Overall Study|Lost to Follow-up|0
7303987|NCT00624338|11526715|FG000|Overall Study|Lack of Efficacy|11
7303988|NCT00624338|11526716|FG001|Overall Study|Lack of Efficacy|3
7303989|NCT00624338|11526717|FG002|Overall Study|Lack of Efficacy|14
7303990|NCT00624338|11526715|FG000|Overall Study|Protocol Violation|3
7303991|NCT00624338|11526716|FG001|Overall Study|Protocol Violation|3
7303992|NCT00624338|11526717|FG002|Overall Study|Protocol Violation|2
7303993|NCT00624338|11526715|FG000|Overall Study|Death|0
7303994|NCT00624338|11526716|FG001|Overall Study|Death|2
7303995|NCT00624338|11526717|FG002|Overall Study|Death|0
7303996|NCT00624338|11526715|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
7303997|NCT00624338|11526716|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
7303998|NCT00624338|11526717|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
7303999|NCT00624338|11526715|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
7304000|NCT00624338|11526716|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
7304001|NCT00624338|11526717|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
7304002|NCT00624338|11526715|FG000|Overall Study|Other|15
7304003|NCT00624338|11526716|FG001|Overall Study|Other|5
7304004|NCT00624338|11526717|FG002|Overall Study|Other|9
7304005|NCT00624338|11526715|FG000|Overall Study|Randomized but not treated|2
7304006|NCT00624338|11526716|FG001|Overall Study|Randomized but not treated|1
7304007|NCT00624338|11526717|FG002|Overall Study|Randomized but not treated|3
7304008|NCT00624377|11526725|FG000|Overall Study|Lost to Follow-up|355
7304009|NCT00624377|11526725|FG000|Overall Study|Withdrawal by Subject|100
7304010|NCT00624377|11526725|FG000|Overall Study|Adverse Event|14
7304011|NCT00624377|11526725|FG000|Overall Study|Other|91
7304012|NCT00624377|11526725|FG000|Overall Study|Non-evaluable population|84
7304013|NCT00624468|11526777|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
7304014|NCT00624468|11526778|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
7304015|NCT00624468|11526779|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
7304016|NCT00624468|11526780|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
7304017|NCT00624468|11526777|FG000|Double-blind Period|Withdrew Prematurely|1
7304018|NCT00624468|11526778|FG001|Double-blind Period|Withdrew Prematurely|1
7304019|NCT00624468|11526779|FG002|Double-blind Period|Withdrew Prematurely|0
7304020|NCT00624468|11526780|FG003|Double-blind Period|Withdrew Prematurely|0
7304021|NCT00624468|11526777|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7304022|NCT00624468|11526778|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
7304023|NCT00624468|11526779|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
7304024|NCT00624468|11526780|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
7304025|NCT00624468|11526777|FG000|Safety Follow-up (SFU) Period|Other|0
7304026|NCT00624468|11526778|FG001|Safety Follow-up (SFU) Period|Other|0
7304027|NCT00624468|11526779|FG002|Safety Follow-up (SFU) Period|Other|1
7304028|NCT00624468|11526780|FG003|Safety Follow-up (SFU) Period|Other|1
7304029|NCT00624520|11526790|FG000|Overall Study|Withdrawal by Subject|12
7304030|NCT00624520|11526791|FG001|Overall Study|Withdrawal by Subject|7
7304031|NCT00624520|11526790|FG000|Overall Study|Death|0
7304032|NCT00624520|11526791|FG001|Overall Study|Death|1
7304033|NCT00624585|11526814|FG000|Overall Study|Death|3
7304034|NCT00624585|11526814|FG000|Overall Study|Disease Progression|6
7304035|NCT00624585|11526814|FG000|Overall Study|Adverse Event|3
7304036|NCT00624780|11526824|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
7304037|NCT00624780|11526825|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
7304038|NCT00624780|11526826|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
7304039|NCT00624780|11526827|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
7304040|NCT00624780|11526828|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
7304041|NCT00624780|11526829|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
7304042|NCT00624780|11526824|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7304043|NCT00624780|11526825|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
7304044|NCT00624780|11526826|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
7304045|NCT00624780|11526827|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
7304046|NCT00624780|11526828|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
7304047|NCT00624780|11526829|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
7304048|NCT00624780|11526824|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7304049|NCT00624780|11526825|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7304050|NCT00624780|11526826|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7304051|NCT00624780|11526827|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
7304052|NCT00624780|11526828|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
7304053|NCT00624780|11526829|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
7304054|NCT00624780|11526824|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7304055|NCT00624780|11526825|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
7304056|NCT00624780|11526826|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
7304057|NCT00624780|11526827|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7304058|NCT00624780|11526828|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
7304059|NCT00624780|11526829|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
7224281|NCT00049517|11433337|FG001|Conditioning/Transplant|Withdrawal by Subject|8
7224282|NCT00049517|11433338|FG002|Conditioning/Transplant|Withdrawal by Subject|4
7224283|NCT00049517|11433339|FG003|Conditioning/Transplant|Withdrawal by Subject|7
7224284|NCT00049517|11433340|FG004|Conditioning/Transplant|Withdrawal by Subject|0
7224285|NCT00049517|11433341|FG005|Conditioning/Transplant|Withdrawal by Subject|0
7224286|NCT00049517|11433336|FG000|Conditioning/Transplant|Alternative therapy|4
7224287|NCT00049517|11433337|FG001|Conditioning/Transplant|Alternative therapy|4
7224288|NCT00049517|11433338|FG002|Conditioning/Transplant|Alternative therapy|2
7224289|NCT00049517|11433339|FG003|Conditioning/Transplant|Alternative therapy|1
7224290|NCT00049517|11433340|FG004|Conditioning/Transplant|Alternative therapy|1
7224291|NCT00049517|11433341|FG005|Conditioning/Transplant|Alternative therapy|0
7224292|NCT00049517|11433336|FG000|Conditioning/Transplant|Other complicating disease|2
7224293|NCT00049517|11433337|FG001|Conditioning/Transplant|Other complicating disease|0
7224294|NCT00049517|11433338|FG002|Conditioning/Transplant|Other complicating disease|0
7224295|NCT00049517|11433339|FG003|Conditioning/Transplant|Other complicating disease|4
7224296|NCT00049517|11433340|FG004|Conditioning/Transplant|Other complicating disease|0
7224297|NCT00049517|11433341|FG005|Conditioning/Transplant|Other complicating disease|1
7224298|NCT00049517|11433336|FG000|Conditioning/Transplant|Reasons not reported|25
7224299|NCT00049517|11433337|FG001|Conditioning/Transplant|Reasons not reported|31
7224300|NCT00049517|11433338|FG002|Conditioning/Transplant|Reasons not reported|18
7224301|NCT00049517|11433339|FG003|Conditioning/Transplant|Reasons not reported|15
7224302|NCT00049517|11433340|FG004|Conditioning/Transplant|Reasons not reported|5
7224303|NCT00049517|11433341|FG005|Conditioning/Transplant|Reasons not reported|5
7224304|NCT00049530|11433349|FG000|Overall Study|Lack of Efficacy|25
7224305|NCT00049530|11433349|FG000|Overall Study|Adverse Event|2
7224306|NCT00049530|11433349|FG000|Overall Study|Death|1
7224307|NCT00049530|11433349|FG000|Overall Study|symptomatic deterioration|1
7224308|NCT00049530|11433349|FG000|Overall Study|ineligible|3
7224309|NCT00049543|11433355|FG000|Overall Study|still on treatment|2
7224310|NCT00049543|11433356|FG001|Overall Study|still on treatment|9
7224311|NCT00049673|11433364|FG000|Overall Study|No receive treatment/lost to follow-up|1
7224312|NCT00049673|11433365|FG001|Overall Study|No receive treatment/lost to follow-up|3
7224313|NCT00049842|11433373|FG000|Treatment Phase|Adverse Event|47
7224314|NCT00049842|11433374|FG001|Treatment Phase|Adverse Event|12
7224315|NCT00049842|11433373|FG000|Treatment Phase|Withdrawal by Subject|35
7224316|NCT00049842|11433374|FG001|Treatment Phase|Withdrawal by Subject|46
7224317|NCT00049842|11433373|FG000|Treatment Phase|Non-compliance with protocol|7
7224318|NCT00049842|11433374|FG001|Treatment Phase|Non-compliance with protocol|8
7224319|NCT00049842|11433373|FG000|Treatment Phase|Lost to Follow-up|4
7224320|NCT00049842|11433374|FG001|Treatment Phase|Lost to Follow-up|8
7224321|NCT00049842|11433373|FG000|Treatment Phase|Administrative|0
7224322|NCT00049842|11433374|FG001|Treatment Phase|Administrative|3
7224323|NCT00049842|11433373|FG000|Treatment Phase|Did not meet protocol eligibility|0
7224324|NCT00049842|11433374|FG001|Treatment Phase|Did not meet protocol eligibility|1
7224325|NCT00049842|11433373|FG000|Follow-up Phase|Adverse Event|6
7224326|NCT00049842|11433374|FG001|Follow-up Phase|Adverse Event|1
7224327|NCT00049842|11433373|FG000|Follow-up Phase|Other|1
7224328|NCT00049842|11433374|FG001|Follow-up Phase|Other|4
7224329|NCT00050011|11433382|FG000|Overall Study|Adverse Event|41
7224330|NCT00050011|11433383|FG001|Overall Study|Adverse Event|46
7224331|NCT00050011|11433382|FG000|Overall Study|Abnormal laboratory value(s)|1
7224332|NCT00050011|11433383|FG001|Overall Study|Abnormal laboratory value(s)|1
7224333|NCT00050011|11433382|FG000|Overall Study|Abnormal test procedure results|0
7224334|NCT00050011|11433383|FG001|Overall Study|Abnormal test procedure results|1
7224335|NCT00050011|11433382|FG000|Overall Study|Lack of Efficacy|16
7224336|NCT00050011|11433383|FG001|Overall Study|Lack of Efficacy|21
7224337|NCT00050011|11433382|FG000|Overall Study|Participant condition no longer required|1
7224338|NCT00050011|11433383|FG001|Overall Study|Participant condition no longer required|0
7224339|NCT00050011|11433382|FG000|Overall Study|Protocol Violation|4
7224340|NCT00050011|11433383|FG001|Overall Study|Protocol Violation|10
7224341|NCT00050011|11433382|FG000|Overall Study|Withdrawal by Subject|34
7224342|NCT00050011|11433383|FG001|Overall Study|Withdrawal by Subject|26
7224343|NCT00050011|11433382|FG000|Overall Study|Lost to Follow-up|7
7224344|NCT00050011|11433383|FG001|Overall Study|Lost to Follow-up|9
7224345|NCT00050011|11433382|FG000|Overall Study|Administrative problems|10
7224346|NCT00050011|11433383|FG001|Overall Study|Administrative problems|6
7224347|NCT00050011|11433382|FG000|Overall Study|Death|7
7224348|NCT00050011|11433383|FG001|Overall Study|Death|4
7224349|NCT00050011|11433382|FG000|Overall Study|Unknown - Reason is missing|0
7224350|NCT00050011|11433383|FG001|Overall Study|Unknown - Reason is missing|2
7224351|NCT00050167|11433413|FG000|Overall Study|not eligible not invasive|1
7224352|NCT00050167|11433414|FG001|Overall Study|not eligible not invasive|1
7224353|NCT00050622|11433420|FG000|Overall Study|Adverse Event|1
7224354|NCT00050778|11433447|FG000|Overall Study|Adverse Event|13
7224355|NCT00050778|11433448|FG001|Overall Study|Adverse Event|3
7224356|NCT00050778|11433449|FG002|Overall Study|Adverse Event|2
7224357|NCT00050778|11433447|FG000|Overall Study|Death|0
7224358|NCT00050778|11433448|FG001|Overall Study|Death|1
7224359|NCT00050778|11433449|FG002|Overall Study|Death|1
7224360|NCT00050778|11433447|FG000|Overall Study|Lack of Efficacy|16
7224361|NCT00050778|11433448|FG001|Overall Study|Lack of Efficacy|2
7224362|NCT00050778|11433449|FG002|Overall Study|Lack of Efficacy|2
7224363|NCT00050778|11433447|FG000|Overall Study|Lost to Follow-up|0
7224364|NCT00050778|11433448|FG001|Overall Study|Lost to Follow-up|2
7224365|NCT00050778|11433449|FG002|Overall Study|Lost to Follow-up|4
7224366|NCT00050778|11433447|FG000|Overall Study|Physician Decision|3
7224367|NCT00050778|11433448|FG001|Overall Study|Physician Decision|0
7224368|NCT00050778|11433449|FG002|Overall Study|Physician Decision|2
7224369|NCT00050778|11433447|FG000|Overall Study|Protocol Violation|2
7224370|NCT00050778|11433448|FG001|Overall Study|Protocol Violation|0
7224371|NCT00050778|11433449|FG002|Overall Study|Protocol Violation|1
7224372|NCT00050778|11433447|FG000|Overall Study|Withdrawal by Subject|6
7224373|NCT00050778|11433448|FG001|Overall Study|Withdrawal by Subject|8
7224374|NCT00050778|11433449|FG002|Overall Study|Withdrawal by Subject|4
7224375|NCT00050778|11433447|FG000|Overall Study|Randomized but not treated|4
7224376|NCT00050778|11433448|FG001|Overall Study|Randomized but not treated|5
7224377|NCT00050778|11433449|FG002|Overall Study|Randomized but not treated|2
7224378|NCT00050778|11433447|FG000|Overall Study|Familial and personal reasons|1
7224379|NCT00050778|11433448|FG001|Overall Study|Familial and personal reasons|0
7224380|NCT00050778|11433449|FG002|Overall Study|Familial and personal reasons|0
7224381|NCT00050960|11433461|FG000|Overall Study|Progressive Disease|137
7224382|NCT00050960|11433462|FG001|Overall Study|Progressive Disease|93
7224383|NCT00050960|11433461|FG000|Overall Study|Stable Disease|19
7224384|NCT00050960|11433462|FG001|Overall Study|Stable Disease|48
7224385|NCT00050960|11433461|FG000|Overall Study|Partial Response|14
7224386|NCT00050960|11433462|FG001|Overall Study|Partial Response|19
7224387|NCT00050960|11433461|FG000|Overall Study|Complete Response|0
7224388|NCT00050960|11433462|FG001|Overall Study|Complete Response|2
7224389|NCT00050960|11433461|FG000|Overall Study|Adverse Event|62
7224390|NCT00050960|11433462|FG001|Overall Study|Adverse Event|61
7224391|NCT00050960|11433461|FG000|Overall Study|Lost to Follow-up|0
7224392|NCT00050960|11433462|FG001|Overall Study|Lost to Follow-up|1
7224393|NCT00050960|11433461|FG000|Overall Study|Withdrawal by Subject|23
7224394|NCT00050960|11433462|FG001|Overall Study|Withdrawal by Subject|18
7224395|NCT00050960|11433461|FG000|Overall Study|Administrative|31
7224396|NCT00050960|11433462|FG001|Overall Study|Administrative|46
7224397|NCT00050960|11433461|FG000|Overall Study|Non-compliance|3
7224398|NCT00050960|11433462|FG001|Overall Study|Non-compliance|1
7224399|NCT00050960|11433461|FG000|Overall Study|Death|13
7224400|NCT00050960|11433462|FG001|Overall Study|Death|15
7224401|NCT00051025|11433474|FG000|Overall Study|Progressive Disease|1
7224402|NCT00051025|11433475|FG001|Overall Study|Progressive Disease|1
7224403|NCT00051025|11433474|FG000|Overall Study|Adverse Event|1
7224404|NCT00051025|11433475|FG001|Overall Study|Adverse Event|1
7224405|NCT00051025|11433474|FG000|Overall Study|Withdrawal by Subject|0
7224406|NCT00051025|11433475|FG001|Overall Study|Withdrawal by Subject|1
7224407|NCT00051025|11433474|FG000|Overall Study|Death|0
7224408|NCT00051025|11433475|FG001|Overall Study|Death|1
7224409|NCT00051311|11433487|FG000|Overall Study|Starting new study|0
7224410|NCT00051311|11433488|FG001|Overall Study|Starting new study|1
7224411|NCT00051311|11433487|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
7224412|NCT00051311|11433488|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
7224413|NCT00051311|11433487|FG000|Overall Study|Death of recipient|8
7224414|NCT00051311|11433488|FG001|Overall Study|Death of recipient|8
7224415|NCT00051311|11433487|FG000|Overall Study|Recipient taken off study|4
7224416|NCT00051311|11433488|FG001|Overall Study|Recipient taken off study|4
7224417|NCT00051363|11433494|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
7224418|NCT00051363|11433495|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
7224419|NCT00051363|11433494|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
7224420|NCT00051363|11433495|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
7224421|NCT00051363|11433494|FG000|Overall Study|Death|2
7224422|NCT00051363|11433495|FG001|Overall Study|Death|2
7224423|NCT00051363|11433494|FG000|Overall Study|Excluded Pre-Randomization|2
7224424|NCT00051363|11433495|FG001|Overall Study|Excluded Pre-Randomization|5
7224425|NCT00051558|11433503|FG000|Overall Study|Adverse Event|30
7224426|NCT00051558|11433504|FG001|Overall Study|Adverse Event|18
7224427|NCT00051558|11433503|FG000|Overall Study|Withdrawal by Subject|29
7224428|NCT00051558|11433504|FG001|Overall Study|Withdrawal by Subject|42
7224429|NCT00051558|11433503|FG000|Overall Study|Death|9
7224430|NCT00051558|11433504|FG001|Overall Study|Death|15
7224431|NCT00051558|11433503|FG000|Overall Study|Lost to Follow-up|4
7224432|NCT00051558|11433504|FG001|Overall Study|Lost to Follow-up|13
7224433|NCT00051558|11433503|FG000|Overall Study|Protocol Violation|3
7224434|NCT00051558|11433504|FG001|Overall Study|Protocol Violation|4
7224435|NCT00051558|11433503|FG000|Overall Study|Protocol Entry Criteria Unmet|1
7224436|NCT00051558|11433504|FG001|Overall Study|Protocol Entry Criteria Unmet|2
7224437|NCT00051558|11433503|FG000|Overall Study|Sponsor Decision|6
7224438|NCT00051558|11433504|FG001|Overall Study|Sponsor Decision|1
7224439|NCT00051558|11433503|FG000|Overall Study|Other|2
7224440|NCT00051558|11433504|FG001|Overall Study|Other|1
7224441|NCT00051558|11433503|FG000|Overall Study|Significant Lab Value|2
7224442|NCT00051558|11433504|FG001|Overall Study|Significant Lab Value|0
7224443|NCT00051558|11433503|FG000|Overall Study|Physician Decision|5
7224444|NCT00051558|11433504|FG001|Overall Study|Physician Decision|0
7224445|NCT00051636|11433512|FG000|Period 1 - Core|Adverse Event|2
7224446|NCT00051636|11433513|FG001|Period 1 - Core|Adverse Event|2
7224447|NCT00051636|11433512|FG000|Period 1 - Core|Protocol Violation|1
7224448|NCT00051636|11433513|FG001|Period 1 - Core|Protocol Violation|0
7224449|NCT00051636|11433512|FG000|Period 1 - Core|Withdrawal by Subject|1
7224450|NCT00051636|11433513|FG001|Period 1 - Core|Withdrawal by Subject|2
7224451|NCT00051636|11433512|FG000|Period 1 - Core|Lost to Follow-up|0
7224452|NCT00051636|11433513|FG001|Period 1 - Core|Lost to Follow-up|2
7224453|NCT00051636|11433512|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
7224454|NCT00051636|11433513|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
7224455|NCT00051636|11433512|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
7224456|NCT00051636|11433513|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
7224457|NCT00051636|11433512|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
7224458|NCT00051636|11433513|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
7224459|NCT00051636|11433512|FG000|Period 2- Extended Observation Period|Death|4
7224460|NCT00051636|11433513|FG001|Period 2- Extended Observation Period|Death|5
7224461|NCT00051636|11433512|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
7224462|NCT00051636|11433513|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
7224463|NCT00052715|11433561|FG000|Overall Study|wrong histology|1
7224464|NCT00052962|11433576|FG000|Overall Study|Not evaluable|0
7224465|NCT00052962|11433577|FG001|Overall Study|Not evaluable|2
7224466|NCT00052962|11433576|FG000|Overall Study|Not randomized/not evaluable|1
7224467|NCT00052962|11433577|FG001|Overall Study|Not randomized/not evaluable|0
7224468|NCT00053352|11433589|FG000|Overall Study|Lost to Follow-up|0
7224469|NCT00053352|11433590|FG001|Overall Study|Lost to Follow-up|1
7224470|NCT00053352|11433589|FG000|Overall Study|Physician Decision|11
7224471|NCT00053352|11433590|FG001|Overall Study|Physician Decision|1
7224472|NCT00053352|11433589|FG000|Overall Study|Withdrawal by Subject|1
7224473|NCT00053352|11433590|FG001|Overall Study|Withdrawal by Subject|0
7224474|NCT00053352|11433589|FG000|Overall Study|Ineligible|8
7224475|NCT00053352|11433590|FG001|Overall Study|Ineligible|8
7224476|NCT00053352|11433589|FG000|Overall Study|Disease at new site|1
7224477|NCT00053352|11433590|FG001|Overall Study|Disease at new site|0
7224478|NCT00053365|11433597|FG000|Overall Study|Incorrect cell type|1
7224479|NCT00053365|11433597|FG000|Overall Study|Platinum-sensitive interval >12 months|1
7224480|NCT00053365|11433597|FG000|Overall Study|Never treated|4
7224481|NCT00053417|11433607|FG000|Overall Study|Adverse Event|1
7224482|NCT00053417|11433608|FG001|Overall Study|Adverse Event|0
7224483|NCT00053417|11433609|FG002|Overall Study|Adverse Event|1
7224484|NCT00053417|11433610|FG003|Overall Study|Adverse Event|5
7224485|NCT00053417|11433607|FG000|Overall Study|Non-Compliance|0
7224486|NCT00053417|11433608|FG001|Overall Study|Non-Compliance|0
7224487|NCT00053417|11433609|FG002|Overall Study|Non-Compliance|0
7224488|NCT00053417|11433610|FG003|Overall Study|Non-Compliance|1
7224489|NCT00053417|11433607|FG000|Overall Study|Withdrawal by Subject|0
7224490|NCT00053417|11433608|FG001|Overall Study|Withdrawal by Subject|1
7224491|NCT00053417|11433609|FG002|Overall Study|Withdrawal by Subject|0
7224492|NCT00053417|11433610|FG003|Overall Study|Withdrawal by Subject|0
7224493|NCT00053417|11433607|FG000|Overall Study|Lost to Follow-up|1
7224494|NCT00053417|11433608|FG001|Overall Study|Lost to Follow-up|1
7224495|NCT00053417|11433609|FG002|Overall Study|Lost to Follow-up|0
7224496|NCT00053417|11433610|FG003|Overall Study|Lost to Follow-up|0
7224497|NCT00053846|11433695|FG000|Overall Study|Changed mind|8
7224498|NCT00053846|11433696|FG001|Overall Study|Changed mind|13
7224499|NCT00053846|11433695|FG000|Overall Study|Became too ill|8
7224500|NCT00053846|11433696|FG001|Overall Study|Became too ill|7
7224501|NCT00053846|11433695|FG000|Overall Study|Expired|5
7224502|NCT00053846|11433696|FG001|Overall Study|Expired|0
7224503|NCT00053846|11433695|FG000|Overall Study|Became ineligible|3
7224504|NCT00053846|11433696|FG001|Overall Study|Became ineligible|1
7224505|NCT00053846|11433695|FG000|Overall Study|Did not return data|1
7224506|NCT00053846|11433696|FG001|Overall Study|Did not return data|2
7224507|NCT00053846|11433695|FG000|Overall Study|Quit due to side effects|1
7224508|NCT00053846|11433696|FG001|Overall Study|Quit due to side effects|3
7224509|NCT00053846|11433695|FG000|Overall Study|Pills too large|0
7224510|NCT00053846|11433696|FG001|Overall Study|Pills too large|1
7224511|NCT00053898|11433704|FG000|Overall Study|No follow-up data from any source|9
7224512|NCT00053898|11433705|FG001|Overall Study|No follow-up data from any source|12
7224513|NCT00053898|11433704|FG000|Overall Study|Follow-up from telephone contact only|5
7224514|NCT00053898|11433705|FG001|Overall Study|Follow-up from telephone contact only|1
7224515|NCT00054132|11433722|FG000|Overall Study|Not Treated|1
7304060|NCT00624780|11526824|FG000|Treatment Optimization (Up to Week 12)|Other|10
7304061|NCT00624780|11526825|FG001|Treatment Optimization (Up to Week 12)|Other|4
7304062|NCT00624780|11526826|FG002|Treatment Optimization (Up to Week 12)|Other|8
7304063|NCT00624780|11526827|FG003|Treatment Optimization (Up to Week 12)|Other|2
7304064|NCT00624780|11526828|FG004|Treatment Optimization (Up to Week 12)|Other|9
7304065|NCT00624780|11526829|FG005|Treatment Optimization (Up to Week 12)|Other|0
7304066|NCT00624780|11526824|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7304067|NCT00624780|11526825|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
7304068|NCT00624780|11526826|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
7552007|NCT02980133|11911669|FG001|Overall Study|Other than specified|1
7304069|NCT00624780|11526827|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
7304070|NCT00624780|11526828|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
7304071|NCT00624780|11526829|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
7304072|NCT00624780|11526824|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7304073|NCT00624780|11526825|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
7304074|NCT00624780|11526826|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7304075|NCT00624780|11526827|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7304076|NCT00624780|11526828|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
7304077|NCT00624780|11526829|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
7304078|NCT00624780|11526824|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7304079|NCT00624780|11526825|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7304080|NCT00624780|11526826|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7304081|NCT00624780|11526827|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
7304082|NCT00624780|11526828|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7304083|NCT00624780|11526829|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
7304084|NCT00624780|11526824|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7304085|NCT00624780|11526825|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7304086|NCT00624780|11526826|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7304087|NCT00624780|11526827|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
7304088|NCT00624780|11526828|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
7304089|NCT00624780|11526829|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
7304090|NCT00624780|11526824|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
7304091|NCT00624780|11526825|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
7304092|NCT00624780|11526826|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
7304093|NCT00624780|11526827|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
7304094|NCT00624780|11526828|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
7304095|NCT00624780|11526829|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
7304096|NCT00624780|11526824|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
7304097|NCT00624780|11526825|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
7304098|NCT00624780|11526826|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
7304099|NCT00624780|11526827|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
7304100|NCT00624780|11526828|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
7304101|NCT00624780|11526829|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
7304102|NCT00624780|11526824|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
7304103|NCT00624780|11526825|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7304104|NCT00624780|11526826|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7304105|NCT00624780|11526827|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7304106|NCT00624780|11526828|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7304107|NCT00624780|11526829|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
7304108|NCT00624780|11526824|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7304109|NCT00624780|11526825|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7304110|NCT00624780|11526826|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
7304111|NCT00624780|11526827|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7304112|NCT00624780|11526828|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7304113|NCT00624780|11526829|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
7304114|NCT00624780|11526824|FG000|Follow-up (Week 26)|Death|0
7304115|NCT00624780|11526825|FG001|Follow-up (Week 26)|Death|0
7304116|NCT00624780|11526826|FG002|Follow-up (Week 26)|Death|1
7304117|NCT00624780|11526827|FG003|Follow-up (Week 26)|Death|0
7304118|NCT00624780|11526828|FG004|Follow-up (Week 26)|Death|0
7304119|NCT00624780|11526829|FG005|Follow-up (Week 26)|Death|0
7304120|NCT00624780|11526824|FG000|Follow-up (Week 26)|Adverse Event|0
7304121|NCT00624780|11526825|FG001|Follow-up (Week 26)|Adverse Event|0
7304122|NCT00624780|11526826|FG002|Follow-up (Week 26)|Adverse Event|0
7304123|NCT00624780|11526827|FG003|Follow-up (Week 26)|Adverse Event|0
7304124|NCT00624780|11526828|FG004|Follow-up (Week 26)|Adverse Event|1
7304125|NCT00624780|11526829|FG005|Follow-up (Week 26)|Adverse Event|0
7304126|NCT00624780|11526824|FG000|Follow-up (Week 26)|Lost to Follow-up|0
7304127|NCT00624780|11526825|FG001|Follow-up (Week 26)|Lost to Follow-up|0
7304128|NCT00624780|11526826|FG002|Follow-up (Week 26)|Lost to Follow-up|1
7304129|NCT00624780|11526827|FG003|Follow-up (Week 26)|Lost to Follow-up|0
7304130|NCT00624780|11526828|FG004|Follow-up (Week 26)|Lost to Follow-up|1
7304131|NCT00624780|11526829|FG005|Follow-up (Week 26)|Lost to Follow-up|0
7304132|NCT00624780|11526824|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
7304133|NCT00624780|11526825|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
7304134|NCT00624780|11526826|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
7304135|NCT00624780|11526827|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
7304136|NCT00624780|11526828|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
7304137|NCT00624780|11526829|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
7304138|NCT00624780|11526824|FG000|Follow-up (Week 26)|Other|1
7304139|NCT00624780|11526825|FG001|Follow-up (Week 26)|Other|1
7304140|NCT00624780|11526826|FG002|Follow-up (Week 26)|Other|0
7304141|NCT00624780|11526827|FG003|Follow-up (Week 26)|Other|0
7304142|NCT00624780|11526828|FG004|Follow-up (Week 26)|Other|0
7304143|NCT00624780|11526829|FG005|Follow-up (Week 26)|Other|0
7304144|NCT00624819|11526859|FG000|Follow-up Period: Year 4|Parents decision|0
7304145|NCT00624819|11526860|FG001|Follow-up Period: Year 4|Parents decision|0
7304146|NCT00624819|11526861|FG002|Follow-up Period: Year 4|Parents decision|1
7304147|NCT00624819|11526862|FG003|Follow-up Period: Year 4|Parents decision|0
7304148|NCT00624819|11526859|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
7304149|NCT00624819|11526860|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
7304150|NCT00624819|11526861|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
7304151|NCT00624819|11526862|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
7304152|NCT00624832|11526876|FG000|Overall Study|Adverse Event|0
7304153|NCT00624832|11526877|FG001|Overall Study|Adverse Event|1
7304154|NCT00624832|11526878|FG002|Overall Study|Adverse Event|0
7304155|NCT00624832|11526879|FG003|Overall Study|Adverse Event|1
7304156|NCT00624832|11526876|FG000|Overall Study|Abnormal Laboratory Value|2
7304157|NCT00624832|11526877|FG001|Overall Study|Abnormal Laboratory Value|0
7304158|NCT00624832|11526878|FG002|Overall Study|Abnormal Laboratory Value|0
7304159|NCT00624832|11526879|FG003|Overall Study|Abnormal Laboratory Value|0
7304160|NCT00625131|11526914|FG000|Overall Study|Lost to Follow-up|3
7304161|NCT00625131|11526915|FG001|Overall Study|Lost to Follow-up|2
7304162|NCT00625131|11526916|FG002|Overall Study|Lost to Follow-up|0
7304163|NCT00625131|11526914|FG000|Overall Study|Withdrawal by Subject|1
7304164|NCT00625131|11526915|FG001|Overall Study|Withdrawal by Subject|0
7304165|NCT00625131|11526916|FG002|Overall Study|Withdrawal by Subject|5
7304166|NCT00625183|11526922|FG000|Overall Study|Disease Progression|1
7304167|NCT00625365|11526928|FG000|Overall Study|Withdrawal by Subject|1
7304168|NCT00625365|11526928|FG000|Overall Study|No IV access|5
7304169|NCT00625365|11526928|FG000|Overall Study|VSD|1
7304170|NCT00625443|11526965|FG000|Overall Study|Adverse Event|1
7304171|NCT00625443|11526966|FG001|Overall Study|Adverse Event|4
7304172|NCT00625443|11526967|FG002|Overall Study|Adverse Event|0
7304173|NCT00625443|11526965|FG000|Overall Study|Non-compliance with protocol|0
7304174|NCT00625443|11526966|FG001|Overall Study|Non-compliance with protocol|1
7304175|NCT00625443|11526967|FG002|Overall Study|Non-compliance with protocol|0
7304176|NCT00625443|11526965|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
7304177|NCT00625443|11526966|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
7304178|NCT00625443|11526967|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
7304179|NCT00625443|11526965|FG000|Overall Study|Withdrawal by Subject|0
7304180|NCT00625443|11526966|FG001|Overall Study|Withdrawal by Subject|1
7304181|NCT00625443|11526967|FG002|Overall Study|Withdrawal by Subject|2
7304182|NCT00625443|11526965|FG000|Overall Study|Physician Decision|0
7304183|NCT00625443|11526966|FG001|Overall Study|Physician Decision|4
7304184|NCT00625443|11526967|FG002|Overall Study|Physician Decision|2
7304185|NCT00625443|11526965|FG000|Overall Study|Other|0
7304186|NCT00625443|11526966|FG001|Overall Study|Other|1
7304187|NCT00625443|11526967|FG002|Overall Study|Other|1
7304188|NCT00625807|11526985|FG000|Overall Study|schedule conflict|2
7304189|NCT00625807|11526986|FG001|Overall Study|schedule conflict|8
7304190|NCT00625820|11526994|FG000|Overall Study|Withdrawal by Subject|1
7304191|NCT00625846|11527003|FG000|Overall Study|Withdrawal by Subject|2
7304192|NCT00625846|11527004|FG001|Overall Study|Withdrawal by Subject|0
7304193|NCT00625846|11527005|FG002|Overall Study|Withdrawal by Subject|1
7304194|NCT00625846|11527006|FG003|Overall Study|Withdrawal by Subject|2
7304195|NCT00625872|11527022|FG000|Overall Study|Withdrawal by Subject|1
7304196|NCT00625872|11527023|FG001|Overall Study|Withdrawal by Subject|0
7304197|NCT00625872|11527022|FG000|Overall Study|Does not meet inclusion criteria|1
7304198|NCT00625872|11527023|FG001|Overall Study|Does not meet inclusion criteria|0
7304199|NCT00625872|11527022|FG000|Overall Study|Terminated by sponsor|2
7304200|NCT00625872|11527023|FG001|Overall Study|Terminated by sponsor|5
7304201|NCT00625872|11527022|FG000|Overall Study|Randomized but not treated|0
7304202|NCT00625872|11527023|FG001|Overall Study|Randomized but not treated|1
7552008|NCT02980133|11911670|FG002|Overall Study|Other than specified|2
7552009|NCT02980133|11911671|FG003|Overall Study|Other than specified|2
7552010|NCT02980133|11911668|FG000|Overall Study|Lost to Follow-up|0
7552011|NCT02980133|11911669|FG001|Overall Study|Lost to Follow-up|0
7552012|NCT02980133|11911670|FG002|Overall Study|Lost to Follow-up|1
7552013|NCT02980133|11911671|FG003|Overall Study|Lost to Follow-up|3
7552014|NCT02980133|11911668|FG000|Overall Study|Protocol Violation|0
7552015|NCT02980133|11911669|FG001|Overall Study|Protocol Violation|1
7552016|NCT02980133|11911670|FG002|Overall Study|Protocol Violation|0
7552017|NCT02980133|11911671|FG003|Overall Study|Protocol Violation|0
7552018|NCT02980133|11911668|FG000|Overall Study|Withdrawal by parent/guardian|6
7552019|NCT02980133|11911669|FG001|Overall Study|Withdrawal by parent/guardian|3
7552020|NCT02980133|11911670|FG002|Overall Study|Withdrawal by parent/guardian|3
7552021|NCT02980133|11911671|FG003|Overall Study|Withdrawal by parent/guardian|1
7552022|NCT02980133|11911668|FG000|Overall Study|Withdrawal by Subject|0
7552023|NCT02980133|11911669|FG001|Overall Study|Withdrawal by Subject|0
7552024|NCT02980133|11911670|FG002|Overall Study|Withdrawal by Subject|1
7552025|NCT02980133|11911671|FG003|Overall Study|Withdrawal by Subject|0
7552026|NCT02980224|11911690|FG000|Overall Study|Adverse Event|4
7552027|NCT02980224|11911691|FG001|Overall Study|Adverse Event|1
7552028|NCT02980224|11911690|FG000|Overall Study|Withdrawal by Subject|0
7552029|NCT02980224|11911691|FG001|Overall Study|Withdrawal by Subject|2
7552030|NCT02980523|11911702|FG000|Overall Study|Lost to Follow-up|1
7552031|NCT02980523|11911703|FG001|Overall Study|Lost to Follow-up|4
7552032|NCT02980523|11911704|FG002|Overall Study|Lost to Follow-up|1
7552033|NCT02980523|11911705|FG003|Overall Study|Lost to Follow-up|2
7552034|NCT02980523|11911706|FG004|Overall Study|Lost to Follow-up|1
7304203|NCT00626028|11527037|FG000|Overall Study|Adverse Event|1
7304204|NCT00626028|11527038|FG001|Overall Study|Adverse Event|1
7304205|NCT00626028|11527037|FG000|Overall Study|Device Failure|0
7304206|NCT00626028|11527038|FG001|Overall Study|Device Failure|1
7304207|NCT00626028|11527037|FG000|Overall Study|Physician Decision|2
7304208|NCT00626028|11527038|FG001|Overall Study|Physician Decision|1
7304209|NCT00626028|11527037|FG000|Overall Study|Inclusion/Exclusion Criteria|3
7304210|NCT00626028|11527038|FG001|Overall Study|Inclusion/Exclusion Criteria|6
7304211|NCT00626093|11527044|FG000|Overall Study|Lost to Follow-up|5
7304212|NCT00626093|11527044|FG000|Overall Study|Death|1
7304213|NCT00626093|11527044|FG000|Overall Study|Physician Decision|4
7304214|NCT00626093|11527044|FG000|Overall Study|Withdrawal by Subject|6
7304215|NCT00626093|11527044|FG000|Overall Study|Protocol Violation|1
7304216|NCT00626093|11527044|FG000|Overall Study|One of the required devices not implante|6
7304217|NCT00626197|11527051|FG000|Overall Study|Did not cooperate|2
7304218|NCT00626197|11527052|FG001|Overall Study|Did not cooperate|6
7304219|NCT00626197|11527053|FG002|Overall Study|Did not cooperate|1
7304220|NCT00626197|11527051|FG000|Overall Study|Failure to return|6
7304221|NCT00626197|11527052|FG001|Overall Study|Failure to return|5
7304222|NCT00626197|11527053|FG002|Overall Study|Failure to return|6
7304223|NCT00626197|11527051|FG000|Overall Study|Adverse event, serious fatal|3
7304224|NCT00626197|11527052|FG001|Overall Study|Adverse event, serious fatal|6
7304225|NCT00626197|11527053|FG002|Overall Study|Adverse event, serious fatal|6
7304226|NCT00626197|11527051|FG000|Overall Study|Adverse Event|1
7304227|NCT00626197|11527052|FG001|Overall Study|Adverse Event|1
7304228|NCT00626197|11527053|FG002|Overall Study|Adverse Event|2
7304229|NCT00626197|11527051|FG000|Overall Study|Withdrawal by Subject|17
7304230|NCT00626197|11527052|FG001|Overall Study|Withdrawal by Subject|17
7304231|NCT00626197|11527053|FG002|Overall Study|Withdrawal by Subject|7
7304232|NCT00626197|11527051|FG000|Overall Study|Administrative reasons|15
7304233|NCT00626197|11527052|FG001|Overall Study|Administrative reasons|19
7304234|NCT00626197|11527053|FG002|Overall Study|Administrative reasons|55
7304235|NCT00626275|11527071|FG000|Part A - Treatment Period 1|Adverse Event|1
7304236|NCT00626275|11527072|FG001|Part A - Treatment Period 1|Adverse Event|0
7304237|NCT00626275|11527073|FG002|Part A - Treatment Period 1|Adverse Event|0
7304238|NCT00626275|11527074|FG003|Part A - Treatment Period 1|Adverse Event|0
7304239|NCT00626275|11527075|FG004|Part A - Treatment Period 1|Adverse Event|0
7304240|NCT00626275|11527076|FG005|Part A - Treatment Period 1|Adverse Event|0
7304241|NCT00626275|11527077|FG006|Part A - Treatment Period 1|Adverse Event|0
7304242|NCT00626275|11527078|FG007|Part A - Treatment Period 1|Adverse Event|0
7304243|NCT00626275|11527071|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
7304244|NCT00626275|11527072|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
7304245|NCT00626275|11527073|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
7304246|NCT00626275|11527074|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
7304247|NCT00626275|11527075|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
7304248|NCT00626275|11527076|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
7304249|NCT00626275|11527077|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
7304250|NCT00626275|11527078|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
7304251|NCT00626275|11527071|FG000|Part B|Lost to Follow-up|0
7304252|NCT00626275|11527072|FG001|Part B|Lost to Follow-up|0
7304253|NCT00626275|11527073|FG002|Part B|Lost to Follow-up|0
7304254|NCT00626275|11527074|FG003|Part B|Lost to Follow-up|0
7304255|NCT00626275|11527075|FG004|Part B|Lost to Follow-up|0
7304256|NCT00626275|11527076|FG005|Part B|Lost to Follow-up|0
7304257|NCT00626275|11527077|FG006|Part B|Lost to Follow-up|1
7304258|NCT00626275|11527078|FG007|Part B|Lost to Follow-up|0
7304259|NCT00626275|11527071|FG000|Part B|Withdrawal by Subject|0
7304260|NCT00626275|11527072|FG001|Part B|Withdrawal by Subject|0
7304261|NCT00626275|11527073|FG002|Part B|Withdrawal by Subject|0
7304262|NCT00626275|11527074|FG003|Part B|Withdrawal by Subject|0
7304263|NCT00626275|11527075|FG004|Part B|Withdrawal by Subject|0
7304264|NCT00626275|11527076|FG005|Part B|Withdrawal by Subject|0
7304265|NCT00626275|11527077|FG006|Part B|Withdrawal by Subject|0
7304266|NCT00626275|11527078|FG007|Part B|Withdrawal by Subject|1
7304267|NCT00626327|11527095|FG000|Overall Study|Withdrawal by Subject|21
7304268|NCT00626327|11527096|FG001|Overall Study|Withdrawal by Subject|29
7304269|NCT00626327|11527097|FG002|Overall Study|Withdrawal by Subject|30
7304270|NCT00626327|11527095|FG000|Overall Study|Adverse Event|1
7304271|NCT00626327|11527096|FG001|Overall Study|Adverse Event|0
7304272|NCT00626327|11527097|FG002|Overall Study|Adverse Event|0
7304273|NCT00626327|11527095|FG000|Overall Study|Lost to Follow-up|24
7304274|NCT00626327|11527096|FG001|Overall Study|Lost to Follow-up|21
7304275|NCT00626327|11527097|FG002|Overall Study|Lost to Follow-up|23
7304276|NCT00626327|11527095|FG000|Overall Study|Inappropriate enrollment|4
7304277|NCT00626327|11527096|FG001|Overall Study|Inappropriate enrollment|5
7304278|NCT00626327|11527097|FG002|Overall Study|Inappropriate enrollment|3
7304279|NCT00626327|11527095|FG000|Overall Study|Administrative Reason|2
7304280|NCT00626327|11527096|FG001|Overall Study|Administrative Reason|0
7304281|NCT00626327|11527097|FG002|Overall Study|Administrative Reason|6
7304282|NCT00626327|11527095|FG000|Overall Study|Protocol Violation|26
7304283|NCT00626327|11527096|FG001|Overall Study|Protocol Violation|4
7304284|NCT00626327|11527097|FG002|Overall Study|Protocol Violation|26
7304285|NCT00626392|11527132|FG000|Run-in Period|Adverse Event|0
7304286|NCT00626392|11527133|FG001|Run-in Period|Adverse Event|0
7304287|NCT00626392|11527134|FG002|Run-in Period|Adverse Event|1
7304288|NCT00626392|11527135|FG003|Run-in Period|Adverse Event|0
7304289|NCT00626392|11527136|FG004|Run-in Period|Adverse Event|1
7304290|NCT00626392|11527137|FG005|Run-in Period|Adverse Event|0
7304291|NCT00626392|11527132|FG000|Run-in Period|Withdrawal by Subject|0
7304292|NCT00626392|11527133|FG001|Run-in Period|Withdrawal by Subject|1
7304293|NCT00626392|11527134|FG002|Run-in Period|Withdrawal by Subject|1
7304294|NCT00626392|11527135|FG003|Run-in Period|Withdrawal by Subject|1
7304295|NCT00626392|11527136|FG004|Run-in Period|Withdrawal by Subject|3
7304296|NCT00626392|11527137|FG005|Run-in Period|Withdrawal by Subject|1
7304297|NCT00626392|11527132|FG000|Run-in Period|Noncompliance|1
7304298|NCT00626392|11527133|FG001|Run-in Period|Noncompliance|0
7304299|NCT00626392|11527134|FG002|Run-in Period|Noncompliance|1
7304300|NCT00626392|11527135|FG003|Run-in Period|Noncompliance|0
7304301|NCT00626392|11527136|FG004|Run-in Period|Noncompliance|0
7304302|NCT00626392|11527137|FG005|Run-in Period|Noncompliance|0
7304303|NCT00626392|11527132|FG000|Coadministration Period|Adverse Event|3
7304304|NCT00626392|11527133|FG001|Coadministration Period|Adverse Event|1
7304305|NCT00626392|11527134|FG002|Coadministration Period|Adverse Event|7
7304306|NCT00626392|11527135|FG003|Coadministration Period|Adverse Event|4
7304307|NCT00626392|11527136|FG004|Coadministration Period|Adverse Event|3
7304308|NCT00626392|11527137|FG005|Coadministration Period|Adverse Event|4
7304309|NCT00626392|11527132|FG000|Coadministration Period|Withdrawal by Subject|1
7304310|NCT00626392|11527133|FG001|Coadministration Period|Withdrawal by Subject|1
7304311|NCT00626392|11527134|FG002|Coadministration Period|Withdrawal by Subject|0
7304312|NCT00626392|11527135|FG003|Coadministration Period|Withdrawal by Subject|1
7304313|NCT00626392|11527136|FG004|Coadministration Period|Withdrawal by Subject|0
7304314|NCT00626392|11527137|FG005|Coadministration Period|Withdrawal by Subject|1
7304315|NCT00626392|11527132|FG000|Coadministration Period|Protocol Violation|0
7304316|NCT00626392|11527133|FG001|Coadministration Period|Protocol Violation|1
7304317|NCT00626392|11527134|FG002|Coadministration Period|Protocol Violation|0
7304318|NCT00626392|11527135|FG003|Coadministration Period|Protocol Violation|1
7304319|NCT00626392|11527136|FG004|Coadministration Period|Protocol Violation|1
7304320|NCT00626392|11527137|FG005|Coadministration Period|Protocol Violation|0
7304321|NCT00626392|11527132|FG000|Coadministration Period|Other|0
7304322|NCT00626392|11527133|FG001|Coadministration Period|Other|2
7304323|NCT00626392|11527134|FG002|Coadministration Period|Other|3
7304324|NCT00626392|11527135|FG003|Coadministration Period|Other|1
7304325|NCT00626392|11527136|FG004|Coadministration Period|Other|1
7304326|NCT00626392|11527137|FG005|Coadministration Period|Other|1
7304327|NCT00626405|11527145|FG000|Overall Study|Deemed Ineligible|1
7304328|NCT00626405|11527146|FG001|Overall Study|Deemed Ineligible|0
7304329|NCT00626405|11527145|FG000|Overall Study|Withdrawal by Subject|0
7304330|NCT00626405|11527146|FG001|Overall Study|Withdrawal by Subject|1
7304331|NCT00626522|11527167|FG000|Overall Study|Protocol Violation|0
7304332|NCT00626522|11527168|FG001|Overall Study|Protocol Violation|0
7304333|NCT00626522|11527169|FG002|Overall Study|Protocol Violation|0
7304334|NCT00626522|11527170|FG003|Overall Study|Protocol Violation|0
7304335|NCT00626522|11527171|FG004|Overall Study|Protocol Violation|1
7304336|NCT00626522|11527172|FG005|Overall Study|Protocol Violation|0
7304337|NCT00626522|11527167|FG000|Overall Study|Adverse Event|2
7304338|NCT00626522|11527168|FG001|Overall Study|Adverse Event|1
7304339|NCT00626522|11527169|FG002|Overall Study|Adverse Event|2
7304340|NCT00626522|11527170|FG003|Overall Study|Adverse Event|0
7304341|NCT00626522|11527171|FG004|Overall Study|Adverse Event|1
7304342|NCT00626522|11527172|FG005|Overall Study|Adverse Event|1
7304343|NCT00626522|11527167|FG000|Overall Study|Withdrawal by Subject|2
7304344|NCT00626522|11527168|FG001|Overall Study|Withdrawal by Subject|5
7304345|NCT00626522|11527169|FG002|Overall Study|Withdrawal by Subject|5
7304346|NCT00626522|11527170|FG003|Overall Study|Withdrawal by Subject|0
7304347|NCT00626522|11527171|FG004|Overall Study|Withdrawal by Subject|4
7304348|NCT00626522|11527172|FG005|Overall Study|Withdrawal by Subject|1
7304349|NCT00626522|11527167|FG000|Overall Study|COPD exacerbation|0
7304350|NCT00626522|11527168|FG001|Overall Study|COPD exacerbation|0
7304351|NCT00626522|11527169|FG002|Overall Study|COPD exacerbation|0
7304352|NCT00626522|11527170|FG003|Overall Study|COPD exacerbation|1
7304353|NCT00626522|11527171|FG004|Overall Study|COPD exacerbation|1
7304354|NCT00626522|11527172|FG005|Overall Study|COPD exacerbation|0
7304355|NCT00626522|11527167|FG000|Overall Study|Lost to Follow-up|0
7304356|NCT00626522|11527168|FG001|Overall Study|Lost to Follow-up|1
7304357|NCT00626522|11527169|FG002|Overall Study|Lost to Follow-up|0
7304358|NCT00626522|11527170|FG003|Overall Study|Lost to Follow-up|0
7304359|NCT00626522|11527171|FG004|Overall Study|Lost to Follow-up|0
7304360|NCT00626522|11527172|FG005|Overall Study|Lost to Follow-up|0
7304361|NCT00626522|11527167|FG000|Overall Study|Inconsistent reason reported|1
7304362|NCT00626522|11527168|FG001|Overall Study|Inconsistent reason reported|0
7304363|NCT00626522|11527169|FG002|Overall Study|Inconsistent reason reported|0
7304364|NCT00626522|11527170|FG003|Overall Study|Inconsistent reason reported|0
7304365|NCT00626522|11527171|FG004|Overall Study|Inconsistent reason reported|0
7304366|NCT00626522|11527172|FG005|Overall Study|Inconsistent reason reported|0
7304367|NCT00626522|11527167|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
7304368|NCT00626522|11527168|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
7304369|NCT00626522|11527169|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
7304370|NCT00626522|11527170|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
7304371|NCT00626522|11527171|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
7304372|NCT00626522|11527172|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
7304373|NCT00626548|11527188|FG000|Overall Study|Adverse Event|164
7304374|NCT00626548|11527189|FG001|Overall Study|Adverse Event|44
7304375|NCT00626548|11527188|FG000|Overall Study|Withdrawal by Subject|42
7304376|NCT00626548|11527189|FG001|Overall Study|Withdrawal by Subject|46
7304377|NCT00626548|11527188|FG000|Overall Study|Protocol Violation|4
7304378|NCT00626548|11527189|FG001|Overall Study|Protocol Violation|11
7304379|NCT00626548|11527188|FG000|Overall Study|Lost to Follow-up|2
7304380|NCT00626548|11527189|FG001|Overall Study|Lost to Follow-up|2
7304381|NCT00626548|11527188|FG000|Overall Study|Other termination reason|493
7304382|NCT00626548|11527189|FG001|Overall Study|Other termination reason|613
7304383|NCT00626639|11527218|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
7304384|NCT00626639|11527219|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
7304385|NCT00626795|11527250|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7304386|NCT00626795|11527251|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
7304387|NCT00626795|11527252|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
7304388|NCT00626795|11527250|FG000|Blinded Treatment|Lack of Efficacy|2
7304389|NCT00626795|11527251|FG001|Blinded Treatment|Lack of Efficacy|0
7304390|NCT00626795|11527252|FG002|Blinded Treatment|Lack of Efficacy|0
7304391|NCT00626795|11527250|FG000|Blinded Treatment|Unacceptable adverse event|0
7304392|NCT00626795|11527251|FG001|Blinded Treatment|Unacceptable adverse event|0
7304393|NCT00626795|11527252|FG002|Blinded Treatment|Unacceptable adverse event|1
7304394|NCT00626795|11527250|FG000|Blinded Treatment|Protocol Violation|0
7304395|NCT00626795|11527251|FG001|Blinded Treatment|Protocol Violation|1
7304396|NCT00626795|11527252|FG002|Blinded Treatment|Protocol Violation|1
7304397|NCT00626795|11527250|FG000|Blinded Treatment|Withdrawal by Subject|1
7304398|NCT00626795|11527251|FG001|Blinded Treatment|Withdrawal by Subject|1
7304399|NCT00626795|11527252|FG002|Blinded Treatment|Withdrawal by Subject|0
7304400|NCT00626795|11527250|FG000|Blinded Treatment|Other reasons|2
7304401|NCT00626795|11527251|FG001|Blinded Treatment|Other reasons|0
7304402|NCT00626795|11527252|FG002|Blinded Treatment|Other reasons|2
7304403|NCT00626795|11527250|FG000|Blinded Treatment|Missing reason for withdrawal|5
7304404|NCT00626795|11527251|FG001|Blinded Treatment|Missing reason for withdrawal|3
7304405|NCT00626795|11527252|FG002|Blinded Treatment|Missing reason for withdrawal|5
7304406|NCT00626821|11527281|FG000|Overall Study|Adverse Event|44
7304407|NCT00626821|11527281|FG000|Overall Study|Protocol Violation|33
7304408|NCT00626821|11527281|FG000|Overall Study|Withdrawal by Subject|10
7304409|NCT00626821|11527281|FG000|Overall Study|Physician Decision|9
7304410|NCT00626821|11527281|FG000|Overall Study|Product dysfunction|21
7304411|NCT00626821|11527281|FG000|Overall Study|other/unknown reason|104
7304412|NCT00626925|11527305|FG000|Overall Study|Lost to Follow-up|1
7304413|NCT00626925|11527306|FG001|Overall Study|Lost to Follow-up|2
7304414|NCT00626925|11527305|FG000|Overall Study|relapse|1
7304415|NCT00626925|11527306|FG001|Overall Study|relapse|0
7304416|NCT00626925|11527305|FG000|Overall Study|Adverse effect|6
7304417|NCT00626925|11527306|FG001|Overall Study|Adverse effect|2
7304418|NCT00626925|11527305|FG000|Overall Study|Lack of Efficacy|1
7304419|NCT00626925|11527306|FG001|Overall Study|Lack of Efficacy|4
7304420|NCT00626925|11527305|FG000|Overall Study|Time constraints|3
7304421|NCT00626925|11527306|FG001|Overall Study|Time constraints|1
7304422|NCT00627016|11527328|FG000|Overall Study|Adverse Event|1
7304423|NCT00627016|11527329|FG001|Overall Study|Adverse Event|1
7304424|NCT00627016|11527328|FG000|Overall Study|Protocol Violation|0
7304425|NCT00627016|11527329|FG001|Overall Study|Protocol Violation|2
7304426|NCT00627016|11527328|FG000|Overall Study|Lost to Follow-up|0
7304427|NCT00627016|11527329|FG001|Overall Study|Lost to Follow-up|1
7304428|NCT00627016|11527328|FG000|Overall Study|Withdrawal by Subject|2
7304429|NCT00627016|11527329|FG001|Overall Study|Withdrawal by Subject|1
7304430|NCT00627016|11527328|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
7304431|NCT00627016|11527329|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
7304432|NCT00627016|11527328|FG000|Overall Study|Lack of Efficacy|1
7304433|NCT00627016|11527329|FG001|Overall Study|Lack of Efficacy|0
7304434|NCT00627016|11527328|FG000|Overall Study|Placed on Excluded Drugs|1
7304435|NCT00627016|11527329|FG001|Overall Study|Placed on Excluded Drugs|0
7304436|NCT00627016|11527328|FG000|Overall Study|Pregnancy|1
7304437|NCT00627016|11527329|FG001|Overall Study|Pregnancy|0
7304438|NCT00627042|11527335|FG000|Overall Study|Withdrawal by Subject|2
7304439|NCT00627094|11527341|FG000|Overall Study|Adverse Event|8
7304440|NCT00627094|11527342|FG001|Overall Study|Adverse Event|7
7304441|NCT00627094|11527341|FG000|Overall Study|Lost to Follow-up|1
7304442|NCT00627094|11527342|FG001|Overall Study|Lost to Follow-up|0
7304443|NCT00627094|11527341|FG000|Overall Study|Withdrawal by Subject|1
7304444|NCT00627094|11527342|FG001|Overall Study|Withdrawal by Subject|1
7304445|NCT00627094|11527341|FG000|Overall Study|ulcer healed|1
7304446|NCT00627094|11527342|FG001|Overall Study|ulcer healed|7
7304447|NCT00627094|11527341|FG000|Overall Study|Other reason|1
7304448|NCT00627094|11527342|FG001|Overall Study|Other reason|0
7304449|NCT00627393|11527362|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
7304450|NCT00627393|11527363|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
7304451|NCT00627393|11527362|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
7304452|NCT00627393|11527363|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
7304453|NCT00627393|11527362|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
7304454|NCT00627393|11527363|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
7304455|NCT00627393|11527362|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
7304456|NCT00627393|11527363|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
7304457|NCT00627445|11527390|FG000|Overall Study|Adverse Event|3
7304458|NCT00627445|11527391|FG001|Overall Study|Adverse Event|3
7304459|NCT00627445|11527390|FG000|Overall Study|Lack of Efficacy|0
7304460|NCT00627445|11527391|FG001|Overall Study|Lack of Efficacy|1
7304461|NCT00627445|11527390|FG000|Overall Study|Other|6
7304462|NCT00627445|11527391|FG001|Overall Study|Other|8
7304463|NCT00627458|11527402|FG000|Overall Study|Migrated from study area|1
7304464|NCT00627458|11527403|FG001|Overall Study|Migrated from study area|0
7304465|NCT00627458|11527404|FG002|Overall Study|Migrated from study area|1
7304466|NCT00627458|11527402|FG000|Overall Study|Withdrawal by Subject|2
7304467|NCT00627458|11527403|FG001|Overall Study|Withdrawal by Subject|6
7304468|NCT00627458|11527404|FG002|Overall Study|Withdrawal by Subject|5
7304469|NCT00627458|11527402|FG000|Overall Study|Lost to Follow-up|1
7304470|NCT00627458|11527403|FG001|Overall Study|Lost to Follow-up|1
7304471|NCT00627458|11527404|FG002|Overall Study|Lost to Follow-up|0
7304472|NCT00627497|11527417|FG000|Overall Study|Lost to Follow-up|1
7304473|NCT00627497|11527418|FG001|Overall Study|Lost to Follow-up|1
7304474|NCT00627497|11527419|FG002|Overall Study|Lost to Follow-up|0
7304475|NCT00627497|11527420|FG003|Overall Study|Lost to Follow-up|0
7304476|NCT00627523|11527432|FG000|Overall Study|Lack of Efficacy|1
7304477|NCT00627523|11527433|FG001|Overall Study|Lack of Efficacy|0
7304478|NCT00627523|11527432|FG000|Overall Study|Withdrawal by Subject|0
7304479|NCT00627523|11527433|FG001|Overall Study|Withdrawal by Subject|2
7304480|NCT00627523|11527432|FG000|Overall Study|Other|1
7304481|NCT00627523|11527433|FG001|Overall Study|Other|0
7304482|NCT00627705|11527454|FG000|Overall Study|Unwilling to take the compound (taste)|1
7304483|NCT00627705|11527455|FG001|Overall Study|Unwilling to take the compound (taste)|3
7304484|NCT00627705|11527454|FG000|Overall Study|Adverse Event|1
7304485|NCT00627705|11527455|FG001|Overall Study|Adverse Event|0
7304486|NCT00627705|11527454|FG000|Overall Study|Withdrawal by Subject|0
7304487|NCT00627705|11527455|FG001|Overall Study|Withdrawal by Subject|2
7304488|NCT00627705|11527454|FG000|Overall Study|Lost to Follow-up|0
7304489|NCT00627705|11527455|FG001|Overall Study|Lost to Follow-up|1
7304490|NCT00627926|11527470|FG000|Overall Study|Adverse Event|26
7304491|NCT00627926|11527471|FG001|Overall Study|Adverse Event|37
7304492|NCT00627926|11527472|FG002|Overall Study|Adverse Event|36
7304493|NCT00627926|11527470|FG000|Overall Study|Death|1
7304494|NCT00627926|11527471|FG001|Overall Study|Death|0
7304495|NCT00627926|11527472|FG002|Overall Study|Death|0
7304496|NCT00627926|11527470|FG000|Overall Study|Lost to Follow-up|4
7304497|NCT00627926|11527471|FG001|Overall Study|Lost to Follow-up|3
7304498|NCT00627926|11527472|FG002|Overall Study|Lost to Follow-up|4
7304499|NCT00627926|11527470|FG000|Overall Study|Withdrawal by Subject|2
7304500|NCT00627926|11527471|FG001|Overall Study|Withdrawal by Subject|1
7304501|NCT00627926|11527472|FG002|Overall Study|Withdrawal by Subject|0
7304502|NCT00627926|11527470|FG000|Overall Study|Lack of Efficacy|118
7304503|NCT00627926|11527471|FG001|Overall Study|Lack of Efficacy|40
7304504|NCT00627926|11527472|FG002|Overall Study|Lack of Efficacy|38
7304505|NCT00627926|11527470|FG000|Overall Study|Noncompliance/unspecified|8
7304506|NCT00627926|11527471|FG001|Overall Study|Noncompliance/unspecified|23
7304507|NCT00627926|11527472|FG002|Overall Study|Noncompliance/unspecified|17
7304508|NCT00628030|11527491|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
7304509|NCT00628030|11527492|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
7304510|NCT00628030|11527491|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
7304511|NCT00628030|11527492|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
7304512|NCT00628030|11527491|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
7304513|NCT00628030|11527492|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
7304514|NCT00628108|11527500|FG000|Overall Study|Adverse Event|0
7304515|NCT00628108|11527501|FG001|Overall Study|Adverse Event|3
7304516|NCT00628108|11527500|FG000|Overall Study|Withdrawal by Subject|1
7304517|NCT00628108|11527501|FG001|Overall Study|Withdrawal by Subject|0
7304518|NCT00628212|11527527|FG000|Overall Study|Adverse Event|2
7304519|NCT00628212|11527528|FG001|Overall Study|Adverse Event|0
7304520|NCT00628212|11527529|FG002|Overall Study|Adverse Event|1
7304521|NCT00628212|11527530|FG003|Overall Study|Adverse Event|2
7304522|NCT00628212|11527527|FG000|Overall Study|Physician Decision|1
7304523|NCT00628212|11527528|FG001|Overall Study|Physician Decision|1
7304524|NCT00628212|11527529|FG002|Overall Study|Physician Decision|2
7304525|NCT00628212|11527530|FG003|Overall Study|Physician Decision|3
7304526|NCT00628251|11527543|FG000|Randomised Part|Withdrawal by Subject|0
7304527|NCT00628251|11527544|FG001|Randomised Part|Withdrawal by Subject|0
7304528|NCT00628251|11527545|FG002|Randomised Part|Withdrawal by Subject|1
7304529|NCT00628251|11527543|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
7304530|NCT00628251|11527544|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
7304531|NCT00628251|11527545|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
7304532|NCT00628251|11527543|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
7304533|NCT00628251|11527544|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
7304534|NCT00628251|11527545|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
7304535|NCT00628251|11527543|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7304536|NCT00628251|11527544|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
7304537|NCT00628251|11527545|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
7304538|NCT00628251|11527543|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
7304539|NCT00628251|11527544|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
7304540|NCT00628251|11527545|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
7304541|NCT00628251|11527543|FG000|Ongoing Initial Study Treatment at DCO|Other|1
7304542|NCT00628251|11527544|FG001|Ongoing Initial Study Treatment at DCO|Other|0
7304543|NCT00628251|11527545|FG002|Ongoing Initial Study Treatment at DCO|Other|2
7304544|NCT00628355|11527557|FG000|Overall Study|Withdrawal by Subject|1
7304545|NCT00628355|11527558|FG001|Overall Study|Withdrawal by Subject|1
7304546|NCT00628758|11527614|FG000|Overall Study|Adverse Event|2
7304547|NCT00628758|11527615|FG001|Overall Study|Adverse Event|3
7304548|NCT00628758|11527614|FG000|Overall Study|Withdrawal by Subject|6
7304549|NCT00628758|11527615|FG001|Overall Study|Withdrawal by Subject|3
7304550|NCT00628758|11527614|FG000|Overall Study|Death|1
7304551|NCT00628758|11527615|FG001|Overall Study|Death|0
7304552|NCT00628758|11527614|FG000|Overall Study|Protocol Violation|5
7304553|NCT00628758|11527615|FG001|Overall Study|Protocol Violation|1
7304554|NCT00628758|11527614|FG000|Overall Study|Lost to Follow-up|25
7304555|NCT00628758|11527615|FG001|Overall Study|Lost to Follow-up|31
7304556|NCT00628758|11527614|FG000|Overall Study|Pregnancy|2
7304557|NCT00628758|11527615|FG001|Overall Study|Pregnancy|2
7304558|NCT00628758|11527614|FG000|Overall Study|Investigator Moved|3
7304559|NCT00628758|11527615|FG001|Overall Study|Investigator Moved|0
7304560|NCT00628758|11527614|FG000|Overall Study|Treatment Failure|0
7304561|NCT00628758|11527615|FG001|Overall Study|Treatment Failure|2
7304562|NCT00628862|11527626|FG000|Overall Study|Adverse Event|6
7304563|NCT00628862|11527627|FG001|Overall Study|Adverse Event|8
7304564|NCT00628862|11527628|FG002|Overall Study|Adverse Event|10
7304565|NCT00628862|11527626|FG000|Overall Study|Withdrawal by Subject|4
7304566|NCT00628862|11527627|FG001|Overall Study|Withdrawal by Subject|6
7304567|NCT00628862|11527628|FG002|Overall Study|Withdrawal by Subject|11
7304568|NCT00628862|11527626|FG000|Overall Study|Lost to Follow-up|0
7304569|NCT00628862|11527627|FG001|Overall Study|Lost to Follow-up|2
7304570|NCT00628862|11527628|FG002|Overall Study|Lost to Follow-up|1
7304571|NCT00628862|11527626|FG000|Overall Study|Protocol Violation|1
7304572|NCT00628862|11527627|FG001|Overall Study|Protocol Violation|0
7304573|NCT00628862|11527628|FG002|Overall Study|Protocol Violation|0
7304574|NCT00628862|11527626|FG000|Overall Study|COPD Exacerbation|0
7304575|NCT00628862|11527627|FG001|Overall Study|COPD Exacerbation|1
7304576|NCT00628862|11527628|FG002|Overall Study|COPD Exacerbation|0
7304577|NCT00628927|11527647|FG000|Overall Study|Problems performing blood draw|6
7304578|NCT00628927|11527648|FG001|Overall Study|Problems performing blood draw|0
7304579|NCT00628927|11527647|FG000|Overall Study|Lost to Follow-up|1
7304580|NCT00628927|11527648|FG001|Overall Study|Lost to Follow-up|0
7304581|NCT00628927|11527647|FG000|Overall Study|Equipment failure|1
7304582|NCT00628927|11527648|FG001|Overall Study|Equipment failure|0
7304583|NCT00629083|11527670|FG000|Overall Study|Adverse Event|0
7304584|NCT00629083|11527671|FG001|Overall Study|Adverse Event|2
7304585|NCT00629083|11527670|FG000|Overall Study|Lack of Efficacy|3
7304586|NCT00629083|11527671|FG001|Overall Study|Lack of Efficacy|1
7304587|NCT00629083|11527670|FG000|Overall Study|Withdrawal by Subject|10
7304588|NCT00629083|11527671|FG001|Overall Study|Withdrawal by Subject|2
7304589|NCT00629083|11527670|FG000|Overall Study|Lost to Follow-up|12
7304590|NCT00629083|11527671|FG001|Overall Study|Lost to Follow-up|8
7304591|NCT00629083|11527670|FG000|Overall Study|Moved out of country/state|2
7304592|NCT00629083|11527671|FG001|Overall Study|Moved out of country/state|1
7304593|NCT00629083|11527670|FG000|Overall Study|Refused to return for 12 month visit|1
7304594|NCT00629083|11527671|FG001|Overall Study|Refused to return for 12 month visit|0
7304595|NCT00629239|11527690|FG000|Overall Study|Adverse Event|7
7304596|NCT00629239|11527691|FG001|Overall Study|Adverse Event|4
7304597|NCT00629239|11527690|FG000|Overall Study|Physician Decision|1
7304598|NCT00629239|11527691|FG001|Overall Study|Physician Decision|0
7304599|NCT00629265|11527699|FG000|Overall Study|Lost to Follow-up|4
7304600|NCT00629265|11527700|FG001|Overall Study|Lost to Follow-up|5
7304601|NCT00629265|11527699|FG000|Overall Study|Withdrawal by Subject|11
7304602|NCT00629265|11527700|FG001|Overall Study|Withdrawal by Subject|8
7304603|NCT00629265|11527699|FG000|Overall Study|Death|1
7304604|NCT00629265|11527700|FG001|Overall Study|Death|0
7304605|NCT00629265|11527699|FG000|Overall Study|Adverse Event|2
7304606|NCT00629265|11527700|FG001|Overall Study|Adverse Event|0
7304607|NCT00629265|11527699|FG000|Overall Study|HNC Recurrence|4
7304608|NCT00629265|11527700|FG001|Overall Study|HNC Recurrence|0
7304609|NCT00629265|11527699|FG000|Overall Study|Other CA Requiring Treatment|1
7304610|NCT00629265|11527700|FG001|Overall Study|Other CA Requiring Treatment|3
7304611|NCT00629265|11527699|FG000|Overall Study|Needed Esophageal Dilation|4
7304612|NCT00629265|11527700|FG001|Overall Study|Needed Esophageal Dilation|1
7304613|NCT00629265|11527699|FG000|Overall Study|Unrelated Medical Complications|3
7304614|NCT00629265|11527700|FG001|Overall Study|Unrelated Medical Complications|1
7304615|NCT00629265|11527699|FG000|Overall Study|Unknown Reason|2
7304616|NCT00629265|11527700|FG001|Overall Study|Unknown Reason|2
7304617|NCT00629707|11527716|FG000|Overall Study|Withdrawal by Subject|0
7304618|NCT00629707|11527717|FG001|Overall Study|Withdrawal by Subject|1
7304619|NCT00629707|11527716|FG000|Overall Study|Physician Decision|0
7304620|NCT00629707|11527717|FG001|Overall Study|Physician Decision|1
7304621|NCT00629772|11527725|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
7304622|NCT00629772|11527726|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
7304623|NCT00629772|11527725|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
7304624|NCT00629772|11527726|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
7304625|NCT00630032|11527735|FG000|Overall Study|Death|55
7304626|NCT00630032|11527736|FG001|Overall Study|Death|49
7304627|NCT00630032|11527735|FG000|Overall Study|Withdrawal by Subject|3
7304628|NCT00630032|11527736|FG001|Overall Study|Withdrawal by Subject|2
7304629|NCT00630032|11527735|FG000|Overall Study|Lost to Follow-up|18
7304630|NCT00630032|11527736|FG001|Overall Study|Lost to Follow-up|31
7304631|NCT00630032|11527735|FG000|Overall Study|Protocol Violation|1
7304632|NCT00630032|11527736|FG001|Overall Study|Protocol Violation|0
7304633|NCT00630032|11527735|FG000|Overall Study|Patient has moved|1
7304634|NCT00630032|11527736|FG001|Overall Study|Patient has moved|1
7304635|NCT00630032|11527735|FG000|Overall Study|Disease progression|1
7304636|NCT00630032|11527736|FG001|Overall Study|Disease progression|1
7304637|NCT00630032|11527735|FG000|Overall Study|End of monitoring in US centers|11
7304638|NCT00630032|11527736|FG001|Overall Study|End of monitoring in US centers|11
7304639|NCT00630058|11527744|FG000|Overall Study|Adverse Event|1
7304640|NCT00630058|11527745|FG001|Overall Study|Adverse Event|1
7304641|NCT00630058|11527744|FG000|Overall Study|Withdrawal by Subject|0
7304642|NCT00630058|11527745|FG001|Overall Study|Withdrawal by Subject|1
7304643|NCT00630058|11527744|FG000|Overall Study|stopping criteria|3
7304644|NCT00630058|11527745|FG001|Overall Study|stopping criteria|2
7304645|NCT00630305|11527764|FG000|Overall Study|Withdrawal by Subject|1
7304646|NCT00630305|11527764|FG000|Overall Study|Inability to insert contact lens|1
7304647|NCT00630331|11527780|FG000|Overall Study|Death|2
7304648|NCT00630331|11527781|FG001|Overall Study|Death|1
7304649|NCT00630331|11527782|FG002|Overall Study|Death|1
7304650|NCT00630331|11527780|FG000|Overall Study|Adverse Event|1
7304651|NCT00630331|11527781|FG001|Overall Study|Adverse Event|0
7304652|NCT00630331|11527782|FG002|Overall Study|Adverse Event|0
7304653|NCT00630331|11527780|FG000|Overall Study|Withdrawal by Subject|12
7304654|NCT00630331|11527781|FG001|Overall Study|Withdrawal by Subject|7
7304655|NCT00630331|11527782|FG002|Overall Study|Withdrawal by Subject|5
7304656|NCT00630331|11527780|FG000|Overall Study|Lost to Follow-up|175
7304657|NCT00630331|11527781|FG001|Overall Study|Lost to Follow-up|143
7304658|NCT00630331|11527782|FG002|Overall Study|Lost to Follow-up|170
7304659|NCT00630331|11527780|FG000|Overall Study|Inappropriate enrollment|3
7304660|NCT00630331|11527781|FG001|Overall Study|Inappropriate enrollment|6
7304661|NCT00630331|11527782|FG002|Overall Study|Inappropriate enrollment|3
7304662|NCT00630331|11527780|FG000|Overall Study|Unable to classify|9
7304663|NCT00630331|11527781|FG001|Overall Study|Unable to classify|4
7304664|NCT00630331|11527782|FG002|Overall Study|Unable to classify|3
7304665|NCT00630331|11527780|FG000|Overall Study|Protocol Violation|4
7304666|NCT00630331|11527781|FG001|Overall Study|Protocol Violation|5
7304667|NCT00630331|11527782|FG002|Overall Study|Protocol Violation|6
7304668|NCT00630344|11527790|FG000|Overall Study|Adverse Event|5
7304669|NCT00630344|11527790|FG000|Overall Study|Progressive Disease|19
7304670|NCT00630344|11527790|FG000|Overall Study|Physician Decision|9
7304671|NCT00630344|11527790|FG000|Overall Study|Withdrawal by Subject|1
7304672|NCT00630344|11527790|FG000|Overall Study|Intercurrent Illness|1
7304673|NCT00630344|11527790|FG000|Overall Study|Other|1
7304674|NCT00630396|11527795|FG000|Overall Study|Death|4
7304675|NCT00630396|11527795|FG000|Overall Study|Lost to Follow-up|3
7304676|NCT00630539|11527808|FG000|Overall Study|Adverse Event|1
7304677|NCT00630539|11527809|FG001|Overall Study|Adverse Event|3
7304678|NCT00630539|11527810|FG002|Overall Study|Adverse Event|1
7304679|NCT00630539|11527811|FG003|Overall Study|Adverse Event|2
7304680|NCT00630539|11527808|FG000|Overall Study|Withdrawal by Subject|0
7304681|NCT00630539|11527809|FG001|Overall Study|Withdrawal by Subject|1
7304682|NCT00630539|11527810|FG002|Overall Study|Withdrawal by Subject|0
7304683|NCT00630539|11527811|FG003|Overall Study|Withdrawal by Subject|1
7304684|NCT00630747|11527843|FG000|Overall Study|Death|1
7304685|NCT00630747|11527843|FG000|Overall Study|Transferred to Study TKT031NPU|7
7304686|NCT00630747|11527843|FG000|Overall Study|Returned to country of origin|1
7304687|NCT00630786|11527850|FG000|Overall Study|Physician Decision|0
7304688|NCT00630786|11527851|FG001|Overall Study|Physician Decision|0
7304689|NCT00630786|11527852|FG002|Overall Study|Physician Decision|1
7304690|NCT00630786|11527850|FG000|Overall Study|Withdrawal by Subject|0
7304691|NCT00630786|11527851|FG001|Overall Study|Withdrawal by Subject|1
7304692|NCT00630786|11527852|FG002|Overall Study|Withdrawal by Subject|1
7304693|NCT00630786|11527850|FG000|Overall Study|Lost to Follow-up|0
7304694|NCT00630786|11527851|FG001|Overall Study|Lost to Follow-up|1
7304695|NCT00630786|11527852|FG002|Overall Study|Lost to Follow-up|0
7304696|NCT00630786|11527850|FG000|Overall Study|Other|1
7304697|NCT00630786|11527851|FG001|Overall Study|Other|0
7304698|NCT00630786|11527852|FG002|Overall Study|Other|0
7304699|NCT00630812|11527860|FG000|Randomisation to First Dose|Adverse Event|1
7304700|NCT00630812|11527861|FG001|Randomisation to First Dose|Adverse Event|1
7304701|NCT00630812|11527860|FG000|Randomisation to First Dose|Withdrawal by Subject|2
7304702|NCT00630812|11527861|FG001|Randomisation to First Dose|Withdrawal by Subject|3
7304703|NCT00630812|11527860|FG000|Randomisation to First Dose|Lost to Follow-up|1
7304704|NCT00630812|11527861|FG001|Randomisation to First Dose|Lost to Follow-up|0
7304705|NCT00630812|11527860|FG000|Randomisation to First Dose|Protocol Violation|4
7304706|NCT00630812|11527861|FG001|Randomisation to First Dose|Protocol Violation|1
7304707|NCT00630812|11527860|FG000|Double Blind Treatment Period|Adverse Event|13
7304708|NCT00630812|11527861|FG001|Double Blind Treatment Period|Adverse Event|5
7304709|NCT00630812|11527860|FG000|Double Blind Treatment Period|Lost to Follow-up|1
7304710|NCT00630812|11527861|FG001|Double Blind Treatment Period|Lost to Follow-up|0
7304711|NCT00630812|11527860|FG000|Double Blind Treatment Period|Physician Decision|2
7304712|NCT00630812|11527861|FG001|Double Blind Treatment Period|Physician Decision|1
7304713|NCT00630812|11527860|FG000|Double Blind Treatment Period|Protocol Violation|1
7304714|NCT00630812|11527861|FG001|Double Blind Treatment Period|Protocol Violation|0
7304715|NCT00630812|11527860|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
7304716|NCT00630812|11527861|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
7304717|NCT00630812|11527860|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
7304718|NCT00630812|11527861|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
7304719|NCT00630812|11527860|FG000|Double Blind Treatment Period|Non-compliance|0
7304720|NCT00630812|11527861|FG001|Double Blind Treatment Period|Non-compliance|1
7304721|NCT00630825|11527871|FG000|Overall Study|Adverse Event|4
7304722|NCT00630825|11527872|FG001|Overall Study|Adverse Event|4
7304723|NCT00630825|11527873|FG002|Overall Study|Adverse Event|3
7304724|NCT00630825|11527874|FG003|Overall Study|Adverse Event|1
7304725|NCT00630825|11527871|FG000|Overall Study|Entry Criteria Not Met|1
7304726|NCT00630825|11527872|FG001|Overall Study|Entry Criteria Not Met|0
7304727|NCT00630825|11527873|FG002|Overall Study|Entry Criteria Not Met|2
7304728|NCT00630825|11527874|FG003|Overall Study|Entry Criteria Not Met|1
7304729|NCT00630825|11527871|FG000|Overall Study|Lost to Follow-up|1
7304730|NCT00630825|11527872|FG001|Overall Study|Lost to Follow-up|1
7304731|NCT00630825|11527873|FG002|Overall Study|Lost to Follow-up|1
7304732|NCT00630825|11527874|FG003|Overall Study|Lost to Follow-up|1
7304733|NCT00630825|11527871|FG000|Overall Study|Physician Decision|1
7304734|NCT00630825|11527872|FG001|Overall Study|Physician Decision|0
7304735|NCT00630825|11527873|FG002|Overall Study|Physician Decision|0
7304736|NCT00630825|11527874|FG003|Overall Study|Physician Decision|0
7304737|NCT00630825|11527871|FG000|Overall Study|Withdrawal by Subject|2
7304738|NCT00630825|11527872|FG001|Overall Study|Withdrawal by Subject|2
7304739|NCT00630825|11527873|FG002|Overall Study|Withdrawal by Subject|2
7304740|NCT00630825|11527874|FG003|Overall Study|Withdrawal by Subject|3
7304741|NCT00630838|11527886|FG000|Overall Study|Death|0
7304742|NCT00630838|11527887|FG001|Overall Study|Death|1
7304743|NCT00630838|11527886|FG000|Overall Study|Lost to Follow-up|0
7304744|NCT00630838|11527887|FG001|Overall Study|Lost to Follow-up|1
7304745|NCT00630864|11527895|FG000|Part 1 (up to Week 6)|Adverse Event|1
7304746|NCT00630864|11527895|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
7304747|NCT00630877|11527902|FG000|Overall Study|Adverse Event|11
7304748|NCT00630877|11527903|FG001|Overall Study|Adverse Event|8
7304749|NCT00630877|11527904|FG002|Overall Study|Adverse Event|7
7304750|NCT00630877|11527902|FG000|Overall Study|Withdrawal by Subject|3
7304751|NCT00630877|11527903|FG001|Overall Study|Withdrawal by Subject|4
7304752|NCT00630877|11527904|FG002|Overall Study|Withdrawal by Subject|0
7304753|NCT00630877|11527902|FG000|Overall Study|Lost to Follow-up|2
7304754|NCT00630877|11527903|FG001|Overall Study|Lost to Follow-up|0
7304755|NCT00630877|11527904|FG002|Overall Study|Lost to Follow-up|0
7304756|NCT00630877|11527902|FG000|Overall Study|Noncompliance|2
7304757|NCT00630877|11527903|FG001|Overall Study|Noncompliance|3
7304758|NCT00630877|11527904|FG002|Overall Study|Noncompliance|1
7304759|NCT00630877|11527902|FG000|Overall Study|Protocol violation|1
7304760|NCT00630877|11527903|FG001|Overall Study|Protocol violation|0
7304761|NCT00630877|11527904|FG002|Overall Study|Protocol violation|1
7304762|NCT00630877|11527902|FG000|Overall Study|Personal reasons|0
7304763|NCT00630877|11527903|FG001|Overall Study|Personal reasons|0
7304764|NCT00630877|11527904|FG002|Overall Study|Personal reasons|1
7304765|NCT00630916|11527916|FG000|Overall Study|Death|110
7304766|NCT00630916|11527916|FG000|Overall Study|Explant|8
7304767|NCT00630916|11527916|FG000|Overall Study|Lost to Follow-up|5
7304768|NCT00630916|11527916|FG000|Overall Study|Withdrawal by Subject|30
7304769|NCT00630916|11527916|FG000|Overall Study|Protocol Violation|7
7304770|NCT00630916|11527916|FG000|Overall Study|Physician Decision|47
7304771|NCT00630916|11527916|FG000|Overall Study|Lack of Efficacy|3
7304772|NCT00630994|11527933|FG000|Overall Study|Adverse Event|1
7304773|NCT00630994|11527933|FG000|Overall Study|Disease Progression|1
7304774|NCT00630994|11527933|FG000|Overall Study|Lack of Efficacy|1
7304775|NCT00630994|11527933|FG000|Overall Study|Other|1
7304776|NCT00631007|11527943|FG000|Overall Study|Adverse Event|0
7304777|NCT00631007|11527944|FG001|Overall Study|Adverse Event|2
7304778|NCT00631007|11527945|FG002|Overall Study|Adverse Event|0
7304779|NCT00631007|11527946|FG003|Overall Study|Adverse Event|2
7304780|NCT00631007|11527947|FG004|Overall Study|Adverse Event|3
7304781|NCT00631007|11527948|FG005|Overall Study|Adverse Event|2
7304782|NCT00631007|11527943|FG000|Overall Study|Lost to Follow-up|2
7304783|NCT00631007|11527944|FG001|Overall Study|Lost to Follow-up|1
7304784|NCT00631007|11527945|FG002|Overall Study|Lost to Follow-up|2
7304785|NCT00631007|11527946|FG003|Overall Study|Lost to Follow-up|4
7304786|NCT00631007|11527947|FG004|Overall Study|Lost to Follow-up|5
7304787|NCT00631007|11527948|FG005|Overall Study|Lost to Follow-up|3
7304788|NCT00631007|11527943|FG000|Overall Study|Physician Decision|1
7304789|NCT00631007|11527944|FG001|Overall Study|Physician Decision|0
7304790|NCT00631007|11527945|FG002|Overall Study|Physician Decision|1
7304791|NCT00631007|11527946|FG003|Overall Study|Physician Decision|0
7304792|NCT00631007|11527947|FG004|Overall Study|Physician Decision|0
7304793|NCT00631007|11527948|FG005|Overall Study|Physician Decision|2
7304794|NCT00631007|11527943|FG000|Overall Study|Persistent Hyperglycemia|2
7304795|NCT00631007|11527944|FG001|Overall Study|Persistent Hyperglycemia|2
7304796|NCT00631007|11527945|FG002|Overall Study|Persistent Hyperglycemia|5
7304797|NCT00631007|11527946|FG003|Overall Study|Persistent Hyperglycemia|1
7304798|NCT00631007|11527947|FG004|Overall Study|Persistent Hyperglycemia|2
7304799|NCT00631007|11527948|FG005|Overall Study|Persistent Hyperglycemia|5
7304800|NCT00631007|11527943|FG000|Overall Study|Withdrawal by Subject|4
7304801|NCT00631007|11527944|FG001|Overall Study|Withdrawal by Subject|5
7304802|NCT00631007|11527945|FG002|Overall Study|Withdrawal by Subject|2
7304803|NCT00631007|11527946|FG003|Overall Study|Withdrawal by Subject|2
7304804|NCT00631007|11527947|FG004|Overall Study|Withdrawal by Subject|1
7304805|NCT00631007|11527948|FG005|Overall Study|Withdrawal by Subject|3
7304806|NCT00631007|11527943|FG000|Overall Study|Other|2
7304807|NCT00631007|11527944|FG001|Overall Study|Other|1
7304808|NCT00631007|11527945|FG002|Overall Study|Other|0
7304809|NCT00631007|11527946|FG003|Overall Study|Other|0
7304810|NCT00631007|11527947|FG004|Overall Study|Other|1
7304811|NCT00631007|11527948|FG005|Overall Study|Other|0
7304812|NCT00631020|11527962|FG000|Overall Study|Lost to Follow-up|7
7304813|NCT00631020|11527962|FG000|Overall Study|Incarcerated|1
7304814|NCT00631163|11527966|FG000|Number of Participants in Year 1|Adverse Event|12
7304815|NCT00631163|11527966|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
7304816|NCT00631163|11527966|FG000|Number of Participants in Year 1|Death|6
7304817|NCT00631163|11527966|FG000|Number of Participants in Year 1|Lost to Follow-up|1
7304818|NCT00631163|11527966|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
7304819|NCT00631163|11527966|FG000|Number of Participants in Year 1|Administrative problems|6
7304820|NCT00631163|11527966|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
7304821|NCT00631163|11527966|FG000|Number of Participants in Year 2|Adverse Event|1
7304822|NCT00631163|11527966|FG000|Number of Participants in Year 2|Protocol Violation|1
7304823|NCT00631163|11527966|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
7304824|NCT00631189|11527981|FG000|Initial Phase|Protocol Violation|347
7304825|NCT00631189|11527982|FG001|Initial Phase|Protocol Violation|0
7304826|NCT00631189|11527983|FG002|Initial Phase|Protocol Violation|0
7304827|NCT00631189|11527984|FG003|Initial Phase|Protocol Violation|0
7304828|NCT00631189|11527981|FG000|Initial Phase|Withdrawal by Subject|4
7304829|NCT00631189|11527982|FG001|Initial Phase|Withdrawal by Subject|0
7304830|NCT00631189|11527983|FG002|Initial Phase|Withdrawal by Subject|0
7304831|NCT00631189|11527984|FG003|Initial Phase|Withdrawal by Subject|0
7304832|NCT00631189|11527981|FG000|Treatment Phase|Withdrawal by Subject|0
7304833|NCT00631189|11527982|FG001|Treatment Phase|Withdrawal by Subject|2
7304834|NCT00631189|11527983|FG002|Treatment Phase|Withdrawal by Subject|1
7304835|NCT00631189|11527984|FG003|Treatment Phase|Withdrawal by Subject|1
7304836|NCT00631189|11527981|FG000|Treatment Phase|Protocol Violation|0
7304837|NCT00631189|11527982|FG001|Treatment Phase|Protocol Violation|1
7304838|NCT00631189|11527983|FG002|Treatment Phase|Protocol Violation|6
7304839|NCT00631189|11527984|FG003|Treatment Phase|Protocol Violation|2
7304840|NCT00631189|11527981|FG000|Treatment Phase|Adverse Event|0
7304841|NCT00631189|11527982|FG001|Treatment Phase|Adverse Event|3
7304842|NCT00631189|11527983|FG002|Treatment Phase|Adverse Event|2
7304843|NCT00631189|11527984|FG003|Treatment Phase|Adverse Event|4
7304844|NCT00631189|11527981|FG000|Treatment Phase|Lost to Follow-up|0
7304845|NCT00631189|11527982|FG001|Treatment Phase|Lost to Follow-up|1
7304846|NCT00631189|11527983|FG002|Treatment Phase|Lost to Follow-up|0
7304847|NCT00631189|11527984|FG003|Treatment Phase|Lost to Follow-up|0
7304848|NCT00631189|11527981|FG000|Treatment Phase|Pregnancy|0
7304849|NCT00631189|11527982|FG001|Treatment Phase|Pregnancy|0
7304850|NCT00631189|11527983|FG002|Treatment Phase|Pregnancy|1
7304851|NCT00631189|11527984|FG003|Treatment Phase|Pregnancy|0
7304852|NCT00631189|11527981|FG000|Treatment Phase|patient did not take pravastatin|0
7304853|NCT00631189|11527982|FG001|Treatment Phase|patient did not take pravastatin|0
7304854|NCT00631189|11527983|FG002|Treatment Phase|patient did not take pravastatin|1
7304855|NCT00631189|11527984|FG003|Treatment Phase|patient did not take pravastatin|0
7304856|NCT00631371|11528015|FG000|Overall Study|Lost to Follow-up|24
7304857|NCT00631371|11528016|FG001|Overall Study|Lost to Follow-up|19
7304858|NCT00631371|11528015|FG000|Overall Study|Other reason|5
7304859|NCT00631371|11528016|FG001|Overall Study|Other reason|12
7304860|NCT00631371|11528015|FG000|Overall Study|subject request|38
7304861|NCT00631371|11528016|FG001|Overall Study|subject request|45
7304862|NCT00631371|11528015|FG000|Overall Study|Discontinuation of study by Sponsor|70
7304863|NCT00631371|11528016|FG001|Overall Study|Discontinuation of study by Sponsor|76
7304864|NCT00631371|11528015|FG000|Overall Study|Death|263
7304865|NCT00631371|11528016|FG001|Overall Study|Death|239
7304866|NCT00631410|11528024|FG000|Overall Study|Adverse Event|1
7304867|NCT00631410|11528025|FG001|Overall Study|Adverse Event|3
7304868|NCT00631410|11528024|FG000|Overall Study|Objective Progression or Relapse|4
7304869|NCT00631410|11528025|FG001|Overall Study|Objective Progression or Relapse|3
7304870|NCT00631410|11528024|FG000|Overall Study|Surgery|1
7304871|NCT00631410|11528025|FG001|Overall Study|Surgery|0
7304872|NCT00631475|11528045|FG000|Overall Study|Death|18
7304873|NCT00631475|11528045|FG000|Overall Study|Adverse Event|14
7304874|NCT00631475|11528045|FG000|Overall Study|Withdrew consent|5
7304875|NCT00631475|11528045|FG000|Overall Study|Preparation for lung transplant|8
7304876|NCT00631488|11528052|FG000|Overall Study|Adverse Event|1
7304877|NCT00631488|11528053|FG001|Overall Study|Adverse Event|0
7304878|NCT00631488|11528054|FG002|Overall Study|Adverse Event|0
7304879|NCT00631488|11528052|FG000|Overall Study|Lost to Follow-up|2
7304880|NCT00631488|11528053|FG001|Overall Study|Lost to Follow-up|2
7304881|NCT00631488|11528054|FG002|Overall Study|Lost to Follow-up|0
7304882|NCT00631488|11528052|FG000|Overall Study|Physician Decision|1
7304883|NCT00631488|11528053|FG001|Overall Study|Physician Decision|0
7304884|NCT00631488|11528054|FG002|Overall Study|Physician Decision|1
7304885|NCT00631488|11528052|FG000|Overall Study|Protocol Violation|0
7304886|NCT00631488|11528053|FG001|Overall Study|Protocol Violation|0
7304887|NCT00631488|11528054|FG002|Overall Study|Protocol Violation|1
7304888|NCT00631540|11528062|FG000|Overall Study|Withdrawal by Subject|5
7304889|NCT00631540|11528062|FG000|Overall Study|Death|4
7304890|NCT00631540|11528062|FG000|Overall Study|Lost to Follow-up|2
7304891|NCT00631540|11528062|FG000|Overall Study|Core Lab Data Unavailable|3
7304892|NCT00631657|11528081|FG000|6-Month Treatment Period|Adverse Event|47
7304893|NCT00631657|11528082|FG001|6-Month Treatment Period|Adverse Event|0
7304894|NCT00631657|11528083|FG002|6-Month Treatment Period|Adverse Event|7
7304895|NCT00631657|11528081|FG000|6-Month Treatment Period|Withdrawal by Subject|14
7304896|NCT00631657|11528082|FG001|6-Month Treatment Period|Withdrawal by Subject|0
7304897|NCT00631657|11528083|FG002|6-Month Treatment Period|Withdrawal by Subject|5
7304898|NCT00631657|11528081|FG000|6-Month Treatment Period|Lack of Efficacy|34
7304899|NCT00631657|11528082|FG001|6-Month Treatment Period|Lack of Efficacy|0
7304900|NCT00631657|11528083|FG002|6-Month Treatment Period|Lack of Efficacy|25
7304901|NCT00631657|11528081|FG000|6-Month Treatment Period|Lost to Follow-up|7
7304902|NCT00631657|11528082|FG001|6-Month Treatment Period|Lost to Follow-up|0
7304903|NCT00631657|11528083|FG002|6-Month Treatment Period|Lost to Follow-up|2
7304904|NCT00631657|11528081|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
7304905|NCT00631657|11528082|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
7304906|NCT00631657|11528083|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
7304907|NCT00631657|11528081|FG000|6-Month Treatment Period|Other|16
7304908|NCT00631657|11528082|FG001|6-Month Treatment Period|Other|0
7304909|NCT00631657|11528083|FG002|6-Month Treatment Period|Other|4
7304910|NCT00631657|11528081|FG000|6-Month Treatment Period|Not Treated|2
7304911|NCT00631657|11528082|FG001|6-Month Treatment Period|Not Treated|0
7304912|NCT00631657|11528083|FG002|6-Month Treatment Period|Not Treated|1
7304913|NCT00631657|11528081|FG000|7-Day Discontinuation Period|Not Treated|1
7304914|NCT00631657|11528082|FG001|7-Day Discontinuation Period|Not Treated|1
7304915|NCT00631657|11528083|FG002|7-Day Discontinuation Period|Not Treated|1
7304916|NCT00631657|11528081|FG000|7-Day Discontinuation Period|Other|1
7304917|NCT00631657|11528082|FG001|7-Day Discontinuation Period|Other|0
7304918|NCT00631657|11528083|FG002|7-Day Discontinuation Period|Other|0
7304919|NCT00631696|11528109|FG000|Overall Study|Entered, not randomized to treatment|1
7304920|NCT00631696|11528110|FG001|Overall Study|Entered, not randomized to treatment|1
7304921|NCT00631696|11528109|FG000|Overall Study|Discontinued after database release date|1
7304922|NCT00631696|11528110|FG001|Overall Study|Discontinued after database release date|0
7304923|NCT00631696|11528109|FG000|Overall Study|Follow up after database release date|1
7304924|NCT00631696|11528110|FG001|Overall Study|Follow up after database release date|0
7304925|NCT00631696|11528109|FG000|Overall Study|Lost to Follow-up|7
7304926|NCT00631696|11528110|FG001|Overall Study|Lost to Follow-up|10
7304927|NCT00631696|11528109|FG000|Overall Study|Withdrawal by Subject|2
7304928|NCT00631696|11528110|FG001|Overall Study|Withdrawal by Subject|9
7304929|NCT00631696|11528109|FG000|Overall Study|Other|8
7304930|NCT00631696|11528110|FG001|Overall Study|Other|8
7304931|NCT00631696|11528109|FG000|Overall Study|Protocol Violation|9
7304932|NCT00631696|11528110|FG001|Overall Study|Protocol Violation|9
7304933|NCT00631696|11528109|FG000|Overall Study|Study terminated by sponsor|3
7304934|NCT00631696|11528110|FG001|Overall Study|Study terminated by sponsor|3
7304935|NCT00631696|11528109|FG000|Overall Study|Adverse Event|5
7304936|NCT00631696|11528110|FG001|Overall Study|Adverse Event|0
7552035|NCT02980523|11911702|FG000|Overall Study|Excluded from analysis|1
7552036|NCT02980523|11911703|FG001|Overall Study|Excluded from analysis|3
7552037|NCT02980523|11911704|FG002|Overall Study|Excluded from analysis|1
7552038|NCT02980523|11911705|FG003|Overall Study|Excluded from analysis|1
7552039|NCT02980523|11911706|FG004|Overall Study|Excluded from analysis|1
7552040|NCT02980523|11911702|FG000|Overall Study|Lack of Efficacy|1
7552041|NCT02980523|11911703|FG001|Overall Study|Lack of Efficacy|4
7552042|NCT02980523|11911704|FG002|Overall Study|Lack of Efficacy|4
7552043|NCT02980523|11911705|FG003|Overall Study|Lack of Efficacy|5
7552044|NCT02980523|11911706|FG004|Overall Study|Lack of Efficacy|8
7552045|NCT02980523|11911702|FG000|Overall Study|Did not receive intervention|0
7552046|NCT02980523|11911703|FG001|Overall Study|Did not receive intervention|0
7552047|NCT02980523|11911704|FG002|Overall Study|Did not receive intervention|0
7304937|NCT00631917|11528132|FG000|Overall Study|Adverse Event|34
7304938|NCT00631917|11528133|FG001|Overall Study|Adverse Event|45
7304939|NCT00631917|11528132|FG000|Overall Study|Abnormal laboratory value(s)|2
7304940|NCT00631917|11528133|FG001|Overall Study|Abnormal laboratory value(s)|1
7304941|NCT00631917|11528132|FG000|Overall Study|Abnormal test procedure result(s)|3
7304942|NCT00631917|11528133|FG001|Overall Study|Abnormal test procedure result(s)|2
7304943|NCT00631917|11528132|FG000|Overall Study|Unsatisfactory therapeutic effect|8
7304944|NCT00631917|11528133|FG001|Overall Study|Unsatisfactory therapeutic effect|14
7304945|NCT00631917|11528132|FG000|Overall Study|No longer required study drug|0
7304946|NCT00631917|11528133|FG001|Overall Study|No longer required study drug|1
7304947|NCT00631917|11528132|FG000|Overall Study|Protocol deviation|6
7304948|NCT00631917|11528133|FG001|Overall Study|Protocol deviation|5
7304949|NCT00631917|11528132|FG000|Overall Study|Subject withdrew consent|25
7304950|NCT00631917|11528133|FG001|Overall Study|Subject withdrew consent|33
7304951|NCT00631917|11528132|FG000|Overall Study|Lost to Follow-up|7
7304952|NCT00631917|11528133|FG001|Overall Study|Lost to Follow-up|7
7304953|NCT00631917|11528132|FG000|Overall Study|Administrative problems|2
7304954|NCT00631917|11528133|FG001|Overall Study|Administrative problems|0
7304955|NCT00631917|11528132|FG000|Overall Study|Death|1
7304956|NCT00631917|11528133|FG001|Overall Study|Death|0
7304957|NCT00631969|11528141|FG000|Overall Study|Adverse Event|3
7304958|NCT00631969|11528142|FG001|Overall Study|Adverse Event|1
7304959|NCT00631969|11528141|FG000|Overall Study|Lack of Efficacy|2
7304960|NCT00631969|11528142|FG001|Overall Study|Lack of Efficacy|8
7304961|NCT00631969|11528141|FG000|Overall Study|Lost to Follow-up|2
7304962|NCT00631969|11528142|FG001|Overall Study|Lost to Follow-up|1
7304963|NCT00631969|11528141|FG000|Overall Study|Protocol Violation|1
7304964|NCT00631969|11528142|FG001|Overall Study|Protocol Violation|1
7304965|NCT00631969|11528141|FG000|Overall Study|Consent Withdrawn|5
7304966|NCT00631969|11528142|FG001|Overall Study|Consent Withdrawn|7
7304967|NCT00631969|11528141|FG000|Overall Study|Noncompliant With Study Medication|0
7304968|NCT00631969|11528142|FG001|Overall Study|Noncompliant With Study Medication|1
7304969|NCT00631969|11528141|FG000|Overall Study|No Drug Exposure|2
7304970|NCT00631969|11528142|FG001|Overall Study|No Drug Exposure|2
7304971|NCT00632021|11528152|FG000|Overall Study|Withdrawal/death|4
7304972|NCT00632021|11528153|FG001|Overall Study|Withdrawal/death|7
7304973|NCT00632099|11528162|FG000|Overall Study|Lost to Follow-up|3
7304974|NCT00632099|11528163|FG001|Overall Study|Lost to Follow-up|3
7304975|NCT00632125|11528169|FG000|Overall Study|Death|82
7304976|NCT00632125|11528169|FG000|Overall Study|Withdrawal by Subject|44
7304977|NCT00632125|11528169|FG000|Overall Study|Adverse Event|36
7304978|NCT00632125|11528169|FG000|Overall Study|Renal transplantation|17
7304979|NCT00632125|11528169|FG000|Overall Study|Need for systemic immunosuppressive medi|8
7304980|NCT00632125|11528169|FG000|Overall Study|Non-compliance|8
7305233|NCT00633984|11528603|FG001|Overall Study|Hospitalized|0
7304981|NCT00632125|11528169|FG000|Overall Study|Development of uncontrolled hypertension|5
7304982|NCT00632125|11528169|FG000|Overall Study|Moved to other dialysis unit, etc.|102
7304983|NCT00632203|11528175|FG000|Overall Study|Did not start study treatment|1
7304984|NCT00632203|11528176|FG001|Overall Study|Did not start study treatment|0
7304985|NCT00632229|11528184|FG000|Overall Study|Adverse Event|6
7304986|NCT00632229|11528185|FG001|Overall Study|Adverse Event|0
7304987|NCT00632229|11528184|FG000|Overall Study|Lost to Follow-up|0
7304988|NCT00632229|11528185|FG001|Overall Study|Lost to Follow-up|3
7304989|NCT00632229|11528184|FG000|Overall Study|Lack of Efficacy|0
7304990|NCT00632229|11528185|FG001|Overall Study|Lack of Efficacy|2
7304991|NCT00632229|11528184|FG000|Overall Study|Undisclosed reasons within the first wee|0
7304992|NCT00632229|11528185|FG001|Overall Study|Undisclosed reasons within the first wee|1
7304993|NCT00632359|11528195|FG000|Overall Study|Withdrawal by Subject|2
7304994|NCT00632424|11528212|FG000|Overall Study|Disease Progression|17
7304995|NCT00632424|11528212|FG000|Overall Study|Study Drug Toxicity|1
7304996|NCT00632463|11528229|FG000|Overall Study|Adverse Event|0
7304997|NCT00632463|11528230|FG001|Overall Study|Adverse Event|1
7304998|NCT00632463|11528231|FG002|Overall Study|Adverse Event|0
7304999|NCT00632502|11528254|FG000|Overall Study|Adverse Event|0
7305000|NCT00632502|11528255|FG001|Overall Study|Adverse Event|1
7305001|NCT00632502|11528254|FG000|Overall Study|Randomized not treated|3
7305002|NCT00632502|11528255|FG001|Overall Study|Randomized not treated|0
7305003|NCT00632541|11528262|FG000|Overall Study|Adverse Event|7
7305004|NCT00632736|11528284|FG000|Overall Study|Adverse Event|104
7305005|NCT00632736|11528284|FG000|Overall Study|Lost to Follow-up|15
7305006|NCT00632736|11528284|FG000|Overall Study|Protocol Violation|14
7305007|NCT00632736|11528284|FG000|Overall Study|Withdrawal by Subject|99
7305008|NCT00632736|11528284|FG000|Overall Study|Lack of Efficacy|5
7305009|NCT00632736|11528284|FG000|Overall Study|Sponsor terminated study|5
7305010|NCT00632736|11528284|FG000|Overall Study|Non-compliance|10
7305011|NCT00632736|11528284|FG000|Overall Study|Other|16
7305012|NCT00632749|11528302|FG000|Overall Study|Progressive disease|3
7305013|NCT00632749|11528303|FG001|Overall Study|Progressive disease|2
7305014|NCT00632749|11528304|FG002|Overall Study|Progressive disease|2
7305015|NCT00632749|11528305|FG003|Overall Study|Progressive disease|2
7305016|NCT00632749|11528306|FG004|Overall Study|Progressive disease|4
7305017|NCT00632749|11528307|FG005|Overall Study|Progressive disease|4
7305018|NCT00632749|11528308|FG006|Overall Study|Progressive disease|3
7305019|NCT00632749|11528309|FG007|Overall Study|Progressive disease|2
7305020|NCT00632749|11528310|FG008|Overall Study|Progressive disease|3
7305021|NCT00632749|11528311|FG009|Overall Study|Progressive disease|2
7305022|NCT00632749|11528312|FG010|Overall Study|Progressive disease|4
7305023|NCT00632749|11528313|FG011|Overall Study|Progressive disease|3
7305024|NCT00632749|11528314|FG012|Overall Study|Progressive disease|2
7305025|NCT00632749|11528315|FG013|Overall Study|Progressive disease|4
7305026|NCT00632749|11528302|FG000|Overall Study|Other Adverse event|1
7305027|NCT00632749|11528303|FG001|Overall Study|Other Adverse event|1
7305028|NCT00632749|11528304|FG002|Overall Study|Other Adverse event|1
7305029|NCT00632749|11528305|FG003|Overall Study|Other Adverse event|1
7305030|NCT00632749|11528306|FG004|Overall Study|Other Adverse event|2
7305031|NCT00632749|11528307|FG005|Overall Study|Other Adverse event|4
7305032|NCT00632749|11528308|FG006|Overall Study|Other Adverse event|1
7305033|NCT00632749|11528309|FG007|Overall Study|Other Adverse event|2
7305034|NCT00632749|11528310|FG008|Overall Study|Other Adverse event|2
7305035|NCT00632749|11528311|FG009|Overall Study|Other Adverse event|0
7305036|NCT00632749|11528312|FG010|Overall Study|Other Adverse event|1
7305037|NCT00632749|11528313|FG011|Overall Study|Other Adverse event|0
7305038|NCT00632749|11528314|FG012|Overall Study|Other Adverse event|1
7305039|NCT00632749|11528315|FG013|Overall Study|Other Adverse event|0
7305040|NCT00632749|11528302|FG000|Overall Study|Refuse to continue medication|0
7305041|NCT00632749|11528303|FG001|Overall Study|Refuse to continue medication|0
7305042|NCT00632749|11528304|FG002|Overall Study|Refuse to continue medication|0
7305043|NCT00632749|11528305|FG003|Overall Study|Refuse to continue medication|1
7305044|NCT00632749|11528306|FG004|Overall Study|Refuse to continue medication|0
7305045|NCT00632749|11528307|FG005|Overall Study|Refuse to continue medication|0
7305046|NCT00632749|11528308|FG006|Overall Study|Refuse to continue medication|0
7305047|NCT00632749|11528309|FG007|Overall Study|Refuse to continue medication|0
7305048|NCT00632749|11528310|FG008|Overall Study|Refuse to continue medication|0
7305049|NCT00632749|11528311|FG009|Overall Study|Refuse to continue medication|1
7305050|NCT00632749|11528312|FG010|Overall Study|Refuse to continue medication|0
7305051|NCT00632749|11528313|FG011|Overall Study|Refuse to continue medication|0
7305052|NCT00632749|11528314|FG012|Overall Study|Refuse to continue medication|0
7305053|NCT00632749|11528315|FG013|Overall Study|Refuse to continue medication|0
7305054|NCT00632749|11528302|FG000|Overall Study|Reason other than those specified above|0
7305055|NCT00632749|11528303|FG001|Overall Study|Reason other than those specified above|2
7305056|NCT00632749|11528304|FG002|Overall Study|Reason other than those specified above|0
7305057|NCT00632749|11528305|FG003|Overall Study|Reason other than those specified above|0
7305058|NCT00632749|11528306|FG004|Overall Study|Reason other than those specified above|1
7305059|NCT00632749|11528307|FG005|Overall Study|Reason other than those specified above|0
7305060|NCT00632749|11528308|FG006|Overall Study|Reason other than those specified above|1
7305061|NCT00632749|11528309|FG007|Overall Study|Reason other than those specified above|0
7305062|NCT00632749|11528310|FG008|Overall Study|Reason other than those specified above|0
7305063|NCT00632749|11528311|FG009|Overall Study|Reason other than those specified above|0
7305064|NCT00632749|11528312|FG010|Overall Study|Reason other than those specified above|2
7305065|NCT00632749|11528313|FG011|Overall Study|Reason other than those specified above|1
7305066|NCT00632749|11528314|FG012|Overall Study|Reason other than those specified above|0
7305067|NCT00632749|11528315|FG013|Overall Study|Reason other than those specified above|2
7305068|NCT00632827|11528364|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
7305069|NCT00632827|11528364|FG000|Overall Study|Death|2
7305070|NCT00632827|11528364|FG000|Overall Study|Adverse Event|5
7305071|NCT00632827|11528364|FG000|Overall Study|Lost to Follow-up|1
7305072|NCT00632931|11528369|FG000|Part 1, Period 1|Protocol Violation|1
7305073|NCT00632931|11528370|FG001|Part 1, Period 1|Protocol Violation|0
7305074|NCT00632931|11528371|FG002|Part 1, Period 1|Protocol Violation|0
7305075|NCT00632931|11528369|FG000|Part 1, Period 1|Withdrawal by Subject|1
7305076|NCT00632931|11528370|FG001|Part 1, Period 1|Withdrawal by Subject|0
7305077|NCT00632931|11528371|FG002|Part 1, Period 1|Withdrawal by Subject|0
7305078|NCT00632931|11528369|FG000|Part 2|Adverse Event|0
7305079|NCT00632931|11528370|FG001|Part 2|Adverse Event|0
7305080|NCT00632931|11528371|FG002|Part 2|Adverse Event|3
7305081|NCT00632931|11528369|FG000|Part 2|Death|0
7305082|NCT00632931|11528370|FG001|Part 2|Death|0
7305083|NCT00632931|11528371|FG002|Part 2|Death|1
7305084|NCT00632931|11528369|FG000|Part 2|Lack of Efficacy|0
7305085|NCT00632931|11528370|FG001|Part 2|Lack of Efficacy|0
7305086|NCT00632931|11528371|FG002|Part 2|Lack of Efficacy|17
7305087|NCT00632931|11528369|FG000|Part 2|Withdrawal by Subject|0
7305088|NCT00632931|11528370|FG001|Part 2|Withdrawal by Subject|0
7305089|NCT00632931|11528371|FG002|Part 2|Withdrawal by Subject|3
7305090|NCT00633022|11528404|FG000|Overall Study|Adverse Event|1
7305091|NCT00633022|11528405|FG001|Overall Study|Adverse Event|0
7305092|NCT00633022|11528406|FG002|Overall Study|Adverse Event|5
7305093|NCT00633022|11528404|FG000|Overall Study|Physician Decision|0
7305094|NCT00633022|11528405|FG001|Overall Study|Physician Decision|1
7305095|NCT00633022|11528406|FG002|Overall Study|Physician Decision|0
7305096|NCT00633074|11528416|FG000|Overall Study|Adverse Event|1
7305097|NCT00633074|11528417|FG001|Overall Study|Adverse Event|0
7305098|NCT00633126|11528423|FG000|Overall Study|Did not receive full dose|1
7305099|NCT00633139|11528430|FG000|Overall Study|Non compliance|0
7305100|NCT00633139|11528431|FG001|Overall Study|Non compliance|0
7305101|NCT00633139|11528432|FG002|Overall Study|Non compliance|1
7305102|NCT00633139|11528430|FG000|Overall Study|Withdrawal by Subject|0
7305103|NCT00633139|11528431|FG001|Overall Study|Withdrawal by Subject|1
7305104|NCT00633139|11528432|FG002|Overall Study|Withdrawal by Subject|0
7305105|NCT00633152|11528442|FG000|Overall Study|Adverse Event|1
7305106|NCT00633152|11528443|FG001|Overall Study|Adverse Event|0
7305107|NCT00633152|11528442|FG000|Overall Study|Randomized, did not receive study drug|5
7305108|NCT00633152|11528443|FG001|Overall Study|Randomized, did not receive study drug|2
7305109|NCT00633152|11528442|FG000|Overall Study|Withdrawal by Subject|1
7305110|NCT00633152|11528443|FG001|Overall Study|Withdrawal by Subject|1
7305111|NCT00633152|11528442|FG000|Overall Study|Lost to Follow-up|4
7305112|NCT00633152|11528443|FG001|Overall Study|Lost to Follow-up|1
7305113|NCT00633152|11528442|FG000|Overall Study|Miscellaneous Other|3
7305114|NCT00633152|11528443|FG001|Overall Study|Miscellaneous Other|2
7305115|NCT00633217|11528453|FG000|Overall Study|Adverse Event|5
7305116|NCT00633217|11528454|FG001|Overall Study|Adverse Event|9
7305117|NCT00633217|11528453|FG000|Overall Study|Lack of Efficacy|0
7305118|NCT00633217|11528454|FG001|Overall Study|Lack of Efficacy|2
7305119|NCT00633217|11528453|FG000|Overall Study|Protocol Violation|3
7305120|NCT00633217|11528454|FG001|Overall Study|Protocol Violation|7
7305121|NCT00633217|11528453|FG000|Overall Study|Lost to Follow-up|2
7305122|NCT00633217|11528454|FG001|Overall Study|Lost to Follow-up|2
7305123|NCT00633217|11528453|FG000|Overall Study|Investigator Discretion|2
7305124|NCT00633217|11528454|FG001|Overall Study|Investigator Discretion|0
7305125|NCT00633217|11528453|FG000|Overall Study|Withdrew Consent|3
7305126|NCT00633217|11528454|FG001|Overall Study|Withdrew Consent|3
7305127|NCT00633243|11528462|FG000|Overall Study|Withdrawal by Subject|0
7305128|NCT00633243|11528463|FG001|Overall Study|Withdrawal by Subject|1
7305129|NCT00633243|11528462|FG000|Overall Study|incarceration|0
7305130|NCT00633243|11528463|FG001|Overall Study|incarceration|2
7305131|NCT00633243|11528462|FG000|Overall Study|Homeless--no refrigeration for meds|0
7305132|NCT00633243|11528463|FG001|Overall Study|Homeless--no refrigeration for meds|1
7305133|NCT00633243|11528462|FG000|Overall Study|Not comfortable with self-injecting|0
7305134|NCT00633243|11528463|FG001|Overall Study|Not comfortable with self-injecting|1
7305135|NCT00633243|11528462|FG000|Overall Study|Mental Health--Depression|0
7305136|NCT00633243|11528463|FG001|Overall Study|Mental Health--Depression|1
7305137|NCT00633243|11528462|FG000|Overall Study|Couldn't tolerate side-effects|1
7305138|NCT00633243|11528463|FG001|Overall Study|Couldn't tolerate side-effects|1
7305139|NCT00633360|11528480|FG000|Overall Study|Lost to Follow-up|1
7305140|NCT00633360|11528481|FG001|Overall Study|Lost to Follow-up|1
7305141|NCT00633360|11528480|FG000|Overall Study|Adverse Event|3
7305142|NCT00633360|11528481|FG001|Overall Study|Adverse Event|1
7305143|NCT00633360|11528480|FG000|Overall Study|Protocol Violation|0
7305144|NCT00633360|11528481|FG001|Overall Study|Protocol Violation|1
7305145|NCT00633464|11528500|FG000|Overall Study|Never Treated (Not met study criteria)|0
7305146|NCT00633464|11528501|FG001|Overall Study|Never Treated (Not met study criteria)|1
7305147|NCT00633464|11528500|FG000|Overall Study|Never Treated (Randomized in error)|0
7305148|NCT00633464|11528501|FG001|Overall Study|Never Treated (Randomized in error)|1
7305149|NCT00633477|11528509|FG000|Overall Study|Death|1
7305150|NCT00633477|11528510|FG001|Overall Study|Death|0
7305151|NCT00633477|11528509|FG000|Overall Study|Randomized but not treated|1
7305152|NCT00633477|11528510|FG001|Overall Study|Randomized but not treated|0
7305153|NCT00633594|11528519|FG000|Overall Study|Adverse Event|0
7305154|NCT00633594|11528520|FG001|Overall Study|Adverse Event|4
7305155|NCT00633594|11528521|FG002|Overall Study|Adverse Event|7
7305156|NCT00633594|11528519|FG000|Overall Study|Death|0
7305157|NCT00633594|11528520|FG001|Overall Study|Death|1
7305158|NCT00633594|11528521|FG002|Overall Study|Death|2
7305159|NCT00633594|11528519|FG000|Overall Study|Disease Progression|0
7305160|NCT00633594|11528520|FG001|Overall Study|Disease Progression|0
7305161|NCT00633594|11528521|FG002|Overall Study|Disease Progression|1
7305162|NCT00633750|11528532|FG000|Overall Study|Adverse Event|2
7305163|NCT00633750|11528532|FG000|Overall Study|Withdrawal by Subject|3
7305164|NCT00633880|11528550|FG000|Open Label Titration|Lack of Efficacy|1
7305165|NCT00633880|11528551|FG001|Open Label Titration|Lack of Efficacy|0
7305166|NCT00633880|11528552|FG002|Open Label Titration|Lack of Efficacy|0
7305167|NCT00633880|11528550|FG000|Open Label Titration|Adverse Event|13
7305168|NCT00633880|11528551|FG001|Open Label Titration|Adverse Event|0
7305169|NCT00633880|11528552|FG002|Open Label Titration|Adverse Event|0
7305170|NCT00633880|11528550|FG000|Open Label Titration|Treatment Failure|55
7305171|NCT00633880|11528551|FG001|Open Label Titration|Treatment Failure|0
7305172|NCT00633880|11528552|FG002|Open Label Titration|Treatment Failure|0
7305173|NCT00633880|11528550|FG000|Open Label Titration|Protocol Violation|6
7305174|NCT00633880|11528551|FG001|Open Label Titration|Protocol Violation|0
7305175|NCT00633880|11528552|FG002|Open Label Titration|Protocol Violation|0
7305176|NCT00633880|11528550|FG000|Open Label Titration|Physician Decision|1
7305177|NCT00633880|11528551|FG001|Open Label Titration|Physician Decision|0
7305178|NCT00633880|11528552|FG002|Open Label Titration|Physician Decision|0
7305179|NCT00633880|11528550|FG000|Open Label Titration|Withdrawal by Subject|4
7305180|NCT00633880|11528551|FG001|Open Label Titration|Withdrawal by Subject|0
7305181|NCT00633880|11528552|FG002|Open Label Titration|Withdrawal by Subject|0
7305182|NCT00633893|11528562|FG000|Overall Study|Death|1
7305183|NCT00633893|11528563|FG001|Overall Study|Death|3
7305184|NCT00633893|11528564|FG002|Overall Study|Death|9
7305185|NCT00633893|11528562|FG000|Overall Study|Adverse Event|65
7305186|NCT00633893|11528563|FG001|Overall Study|Adverse Event|58
7305187|NCT00633893|11528564|FG002|Overall Study|Adverse Event|126
7305188|NCT00633893|11528562|FG000|Overall Study|Withdrawal by Subject|7
7305189|NCT00633893|11528563|FG001|Overall Study|Withdrawal by Subject|12
7305190|NCT00633893|11528564|FG002|Overall Study|Withdrawal by Subject|6
7305191|NCT00633893|11528562|FG000|Overall Study|Lost to Follow-up|2
7305192|NCT00633893|11528563|FG001|Overall Study|Lost to Follow-up|4
7305193|NCT00633893|11528564|FG002|Overall Study|Lost to Follow-up|8
7305194|NCT00633893|11528562|FG000|Overall Study|Poor/non-compliance|5
7305195|NCT00633893|11528563|FG001|Overall Study|Poor/non-compliance|12
7305196|NCT00633893|11528564|FG002|Overall Study|Poor/non-compliance|3
7305197|NCT00633893|11528562|FG000|Overall Study|Pregnancy|2
7305198|NCT00633893|11528563|FG001|Overall Study|Pregnancy|1
7305199|NCT00633893|11528564|FG002|Overall Study|Pregnancy|1
7305200|NCT00633893|11528562|FG000|Overall Study|Not meet/no longer meets criteria|4
7305201|NCT00633893|11528563|FG001|Overall Study|Not meet/no longer meets criteria|6
7305202|NCT00633893|11528564|FG002|Overall Study|Not meet/no longer meets criteria|4
7305203|NCT00633893|11528562|FG000|Overall Study|Other|28
7305204|NCT00633893|11528563|FG001|Overall Study|Other|33
7305205|NCT00633893|11528564|FG002|Overall Study|Other|31
7305206|NCT00633932|11528584|FG000|Overall Study|Adverse Event|1
7305207|NCT00633932|11528585|FG001|Overall Study|Adverse Event|3
7305208|NCT00633932|11528586|FG002|Overall Study|Adverse Event|4
7305209|NCT00633932|11528584|FG000|Overall Study|Withdrawal by Subject|3
7305210|NCT00633932|11528585|FG001|Overall Study|Withdrawal by Subject|9
7305211|NCT00633932|11528586|FG002|Overall Study|Withdrawal by Subject|1
7305212|NCT00633932|11528584|FG000|Overall Study|Lost to Follow-up|1
7305213|NCT00633932|11528585|FG001|Overall Study|Lost to Follow-up|0
7305214|NCT00633932|11528586|FG002|Overall Study|Lost to Follow-up|2
7305215|NCT00633932|11528584|FG000|Overall Study|Protocol Violation|5
7305216|NCT00633932|11528585|FG001|Overall Study|Protocol Violation|2
7305217|NCT00633932|11528586|FG002|Overall Study|Protocol Violation|3
7305218|NCT00633932|11528584|FG000|Overall Study|Physician Decision|0
7305219|NCT00633932|11528585|FG001|Overall Study|Physician Decision|0
7305220|NCT00633932|11528586|FG002|Overall Study|Physician Decision|1
7305221|NCT00633932|11528584|FG000|Overall Study|Doctor's judgement|1
7305222|NCT00633932|11528585|FG001|Overall Study|Doctor's judgement|0
7305223|NCT00633932|11528586|FG002|Overall Study|Doctor's judgement|0
7305224|NCT00633932|11528584|FG000|Overall Study|Moved Away|1
7305225|NCT00633932|11528585|FG001|Overall Study|Moved Away|0
7305226|NCT00633932|11528586|FG002|Overall Study|Moved Away|0
7305227|NCT00633945|11528594|FG000|Overall Study|Physician Decision|2
7305228|NCT00633984|11528602|FG000|Overall Study|Lost to Follow-up|0
7305229|NCT00633984|11528603|FG001|Overall Study|Lost to Follow-up|6
7305230|NCT00633984|11528602|FG000|Overall Study|Withdrawal by Subject|8
7305231|NCT00633984|11528603|FG001|Overall Study|Withdrawal by Subject|7
7305232|NCT00633984|11528602|FG000|Overall Study|Hospitalized|1
7305234|NCT00634036|11528611|FG000|Overall Study|Lost to Follow-up|1
7305235|NCT00634036|11528612|FG001|Overall Study|Lost to Follow-up|1
7305236|NCT00634036|11528611|FG000|Overall Study|Withdrawal by Subject|1
7305237|NCT00634036|11528612|FG001|Overall Study|Withdrawal by Subject|1
7305238|NCT00634049|11528618|FG000|Overall Study|Never received study drug|1
7305239|NCT00634049|11528618|FG000|Overall Study|Died prior to receiving study drug|1
7305240|NCT00634049|11528618|FG000|Overall Study|Screening failure|1
7305241|NCT00634088|11528655|FG000|Time Period 1: Dose Level 1|Disease progression|2
7305242|NCT00634088|11528656|FG001|Time Period 1: Dose Level 1|Disease progression|0
7305243|NCT00634088|11528657|FG002|Time Period 1: Dose Level 1|Disease progression|0
7305244|NCT00634088|11528658|FG003|Time Period 1: Dose Level 1|Disease progression|0
7305245|NCT00634088|11528655|FG000|Time Period 1: Dose Level 1|Physician Decision|1
7305246|NCT00634088|11528656|FG001|Time Period 1: Dose Level 1|Physician Decision|0
7305247|NCT00634088|11528657|FG002|Time Period 1: Dose Level 1|Physician Decision|0
7305248|NCT00634088|11528658|FG003|Time Period 1: Dose Level 1|Physician Decision|0
7305249|NCT00634088|11528655|FG000|Time Period 1: Dose Level 1|Adverse Event|3
7305250|NCT00634088|11528656|FG001|Time Period 1: Dose Level 1|Adverse Event|0
7305251|NCT00634088|11528657|FG002|Time Period 1: Dose Level 1|Adverse Event|0
7305252|NCT00634088|11528658|FG003|Time Period 1: Dose Level 1|Adverse Event|0
7305253|NCT00634088|11528655|FG000|Time Period 2: Dose Level 2|Adverse Event|0
7305254|NCT00634088|11528656|FG001|Time Period 2: Dose Level 2|Adverse Event|2
7305255|NCT00634088|11528657|FG002|Time Period 2: Dose Level 2|Adverse Event|0
7305256|NCT00634088|11528658|FG003|Time Period 2: Dose Level 2|Adverse Event|0
7305257|NCT00634088|11528655|FG000|Time Period 2: Dose Level 2|Progressive disease|0
7305258|NCT00634088|11528656|FG001|Time Period 2: Dose Level 2|Progressive disease|1
7305259|NCT00634088|11528657|FG002|Time Period 2: Dose Level 2|Progressive disease|0
7305260|NCT00634088|11528658|FG003|Time Period 2: Dose Level 2|Progressive disease|0
7305261|NCT00634088|11528655|FG000|Time Period 3: Dose Level 3|Progressive disease|0
7305262|NCT00634088|11528656|FG001|Time Period 3: Dose Level 3|Progressive disease|0
7305263|NCT00634088|11528657|FG002|Time Period 3: Dose Level 3|Progressive disease|1
7305264|NCT00634088|11528658|FG003|Time Period 3: Dose Level 3|Progressive disease|0
7305265|NCT00634101|11528670|FG000|Overall Study|Study Terminated|3
7305266|NCT00634101|11528671|FG001|Overall Study|Study Terminated|3
7305267|NCT00634101|11528670|FG000|Overall Study|Lost to Follow-up|2
7305268|NCT00634101|11528671|FG001|Overall Study|Lost to Follow-up|0
7305269|NCT00634114|11528680|FG000|Overall Study|Adverse Event|6
7305270|NCT00634114|11528681|FG001|Overall Study|Adverse Event|8
7305271|NCT00634114|11528682|FG002|Overall Study|Adverse Event|3
7305272|NCT00634114|11528680|FG000|Overall Study|Withdrawal by Subject|9
7305273|NCT00634114|11528681|FG001|Overall Study|Withdrawal by Subject|6
7305274|NCT00634114|11528682|FG002|Overall Study|Withdrawal by Subject|11
7305275|NCT00634114|11528680|FG000|Overall Study|Lost to Follow-up|0
7305276|NCT00634114|11528681|FG001|Overall Study|Lost to Follow-up|0
7305277|NCT00634114|11528682|FG002|Overall Study|Lost to Follow-up|1
7305278|NCT00634114|11528680|FG000|Overall Study|Protocol Violation|3
7305279|NCT00634114|11528681|FG001|Overall Study|Protocol Violation|3
7305280|NCT00634114|11528682|FG002|Overall Study|Protocol Violation|1
7305281|NCT00634114|11528680|FG000|Overall Study|Pregnancy|1
7305282|NCT00634114|11528681|FG001|Overall Study|Pregnancy|0
7305283|NCT00634114|11528682|FG002|Overall Study|Pregnancy|0
7305284|NCT00634114|11528680|FG000|Overall Study|Incorrect enrolment|0
7305285|NCT00634114|11528681|FG001|Overall Study|Incorrect enrolment|1
7305286|NCT00634114|11528682|FG002|Overall Study|Incorrect enrolment|0
7305287|NCT00634114|11528680|FG000|Overall Study|Recurrence of reflux esophagitis|5
7305288|NCT00634114|11528681|FG001|Overall Study|Recurrence of reflux esophagitis|15
7305289|NCT00634114|11528682|FG002|Overall Study|Recurrence of reflux esophagitis|21
7305290|NCT00634114|11528680|FG000|Overall Study|Difficult to continue|3
7305291|NCT00634114|11528681|FG001|Overall Study|Difficult to continue|1
7305292|NCT00634114|11528682|FG002|Overall Study|Difficult to continue|1
7305293|NCT00634114|11528680|FG000|Overall Study|Other reason|1
7305294|NCT00634114|11528681|FG001|Overall Study|Other reason|1
7305295|NCT00634114|11528682|FG002|Overall Study|Other reason|1
7305296|NCT00634179|11528699|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
7305297|NCT00634244|11528709|FG000|Overall Study|Never started treatment|0
7305298|NCT00634244|11528710|FG001|Overall Study|Never started treatment|1
7305299|NCT00634244|11528711|FG002|Overall Study|Never started treatment|0
7305300|NCT00634244|11528709|FG000|Overall Study|Death|1
7305301|NCT00634244|11528710|FG001|Overall Study|Death|6
7305302|NCT00634244|11528711|FG002|Overall Study|Death|0
7305303|NCT00634244|11528709|FG000|Overall Study|Adverse Event|0
7305304|NCT00634244|11528710|FG001|Overall Study|Adverse Event|2
7305305|NCT00634244|11528711|FG002|Overall Study|Adverse Event|0
7305306|NCT00634244|11528709|FG000|Overall Study|Withdrawal by Subject|0
7305307|NCT00634244|11528710|FG001|Overall Study|Withdrawal by Subject|1
7305308|NCT00634244|11528711|FG002|Overall Study|Withdrawal by Subject|0
7305309|NCT00634244|11528709|FG000|Overall Study|Physician Decision|0
7305310|NCT00634244|11528710|FG001|Overall Study|Physician Decision|1
7305311|NCT00634244|11528711|FG002|Overall Study|Physician Decision|0
7305312|NCT00634244|11528709|FG000|Overall Study|Disease progression/relapse|0
7305313|NCT00634244|11528710|FG001|Overall Study|Disease progression/relapse|1
7305314|NCT00634244|11528711|FG002|Overall Study|Disease progression/relapse|0
7305315|NCT00634244|11528709|FG000|Overall Study|Other complicating disease|0
7305316|NCT00634244|11528710|FG001|Overall Study|Other complicating disease|1
7305317|NCT00634244|11528711|FG002|Overall Study|Other complicating disease|0
7305318|NCT00634543|11528742|FG000|Overall Study|Other|1
7305319|NCT00634543|11528743|FG001|Overall Study|Other|2
7305320|NCT00634543|11528742|FG000|Overall Study|Protocol Violation|3
7305321|NCT00634543|11528743|FG001|Overall Study|Protocol Violation|3
7305322|NCT00634543|11528742|FG000|Overall Study|Adverse Event|11
7305323|NCT00634543|11528743|FG001|Overall Study|Adverse Event|11
7305324|NCT00634543|11528742|FG000|Overall Study|Withdrawal by Subject|4
7305325|NCT00634543|11528743|FG001|Overall Study|Withdrawal by Subject|4
7305326|NCT00634543|11528742|FG000|Overall Study|Lost to Follow-up|0
7305327|NCT00634543|11528743|FG001|Overall Study|Lost to Follow-up|1
7305328|NCT00634569|11528751|FG000|Overall Study|Withdrawal by Subject|0
7305329|NCT00634569|11528752|FG001|Overall Study|Withdrawal by Subject|4
7305330|NCT00634569|11528751|FG000|Overall Study|Physician Decision|0
7305331|NCT00634569|11528752|FG001|Overall Study|Physician Decision|1
7305332|NCT00634647|11528766|FG000|Overall Study|death on study|3
7305333|NCT00634647|11528766|FG000|Overall Study|refused further treatment|3
7305334|NCT00634647|11528766|FG000|Overall Study|declined to participate before treatment|1
7305335|NCT00634751|11528774|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
7305336|NCT00634751|11528775|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
7305337|NCT00634751|11528776|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
7305338|NCT00634751|11528777|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
7305339|NCT00634751|11528774|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7305340|NCT00634751|11528775|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
7305341|NCT00634751|11528776|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7305342|NCT00634751|11528777|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
7305343|NCT00634751|11528774|FG000|Pancreatic and Bilial Tract Cancer|Death|0
7305344|NCT00634751|11528775|FG001|Pancreatic and Bilial Tract Cancer|Death|0
7305345|NCT00634751|11528776|FG002|Pancreatic and Bilial Tract Cancer|Death|1
7305346|NCT00634751|11528777|FG003|Pancreatic and Bilial Tract Cancer|Death|1
7305347|NCT00634803|11528790|FG000|Overall Study|Lost to Follow-up|6
7305348|NCT00634803|11528791|FG001|Overall Study|Lost to Follow-up|7
7305349|NCT00634803|11528792|FG002|Overall Study|Lost to Follow-up|7
7305350|NCT00634842|11528802|FG000|Overall Study|Adverse Event|2
7305351|NCT00634842|11528803|FG001|Overall Study|Adverse Event|3
7305352|NCT00634842|11528802|FG000|Overall Study|Protocol Violation|8
7305353|NCT00634842|11528803|FG001|Overall Study|Protocol Violation|4
7305354|NCT00634842|11528802|FG000|Overall Study|Move to another state|1
7305355|NCT00634842|11528803|FG001|Overall Study|Move to another state|0
7305356|NCT00634842|11528802|FG000|Overall Study|Inclusion criteria were not met|1
7305357|NCT00634842|11528803|FG001|Overall Study|Inclusion criteria were not met|0
7305358|NCT00634842|11528802|FG000|Overall Study|Lost to Follow-up|1
7305359|NCT00634842|11528803|FG001|Overall Study|Lost to Follow-up|2
7305360|NCT00634842|11528802|FG000|Overall Study|Physician Decision|1
7305361|NCT00634842|11528803|FG001|Overall Study|Physician Decision|0
7305362|NCT00634842|11528802|FG000|Overall Study|Withdrawal by Subject|1
7305363|NCT00634842|11528803|FG001|Overall Study|Withdrawal by Subject|3
7305364|NCT00634842|11528802|FG000|Overall Study|Lack of time and intolerance to drug|0
7305365|NCT00634842|11528803|FG001|Overall Study|Lack of time and intolerance to drug|1
7305366|NCT00634842|11528802|FG000|Overall Study|Discontinued due to injection|0
7305367|NCT00634842|11528803|FG001|Overall Study|Discontinued due to injection|2
7305368|NCT00634842|11528802|FG000|Overall Study|No need of study drug to treat diabetes|0
7305369|NCT00634842|11528803|FG001|Overall Study|No need of study drug to treat diabetes|1
7305370|NCT00634842|11528802|FG000|Overall Study|No wish to keep taking Avandia|0
7305371|NCT00634842|11528803|FG001|Overall Study|No wish to keep taking Avandia|1
7305372|NCT00634842|11528802|FG000|Overall Study|Subject off study drug for too long|0
7305373|NCT00634842|11528803|FG001|Overall Study|Subject off study drug for too long|1
7305374|NCT00634907|11528811|FG000|Overall Study|Withdrawal by Subject|3
7305375|NCT00634907|11528812|FG001|Overall Study|Withdrawal by Subject|0
7305376|NCT00634907|11528811|FG000|Overall Study|Physician Decision|3
7305377|NCT00634907|11528812|FG001|Overall Study|Physician Decision|9
7305378|NCT00634907|11528811|FG000|Overall Study|Withdrawal by Subject|11
7305379|NCT00634907|11528812|FG001|Overall Study|Withdrawal by Subject|8
7305380|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Adverse Event|0
7305381|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Adverse Event|0
7305382|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Adverse Event|36
7305383|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
7305384|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
7305385|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
7305386|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Rejections|0
7305387|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Rejections|0
7305388|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Rejections|55
7305389|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7305390|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
7305391|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
7305392|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
7305393|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
7305394|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
7305395|NCT00634920|11528821|FG000|Period 1 - Pre-Randomization|Other issues|0
7305396|NCT00634920|11528822|FG001|Period 1 - Pre-Randomization|Other issues|0
7305397|NCT00634920|11528823|FG002|Period 1 - Pre-Randomization|Other issues|6
7305398|NCT00634920|11528821|FG000|Period 2 - Post-Randomization|Adverse Event|37
7305399|NCT00634920|11528822|FG001|Period 2 - Post-Randomization|Adverse Event|9
7305400|NCT00634920|11528823|FG002|Period 2 - Post-Randomization|Adverse Event|0
7305401|NCT00634920|11528821|FG000|Period 2 - Post-Randomization|Rejection|11
7305402|NCT00634920|11528822|FG001|Period 2 - Post-Randomization|Rejection|5
7305403|NCT00634920|11528823|FG002|Period 2 - Post-Randomization|Rejection|0
7305404|NCT00634920|11528821|FG000|Period 2 - Post-Randomization|Death|2
7305405|NCT00634920|11528822|FG001|Period 2 - Post-Randomization|Death|5
7305406|NCT00634920|11528823|FG002|Period 2 - Post-Randomization|Death|0
7305407|NCT00634920|11528821|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
7305408|NCT00634920|11528822|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
7305409|NCT00634920|11528823|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
7305410|NCT00634920|11528821|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
7305411|NCT00634920|11528822|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
7305412|NCT00634920|11528823|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
7305413|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Adverse Event|4
7305414|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Adverse Event|4
7305415|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Adverse Event|8
7305416|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Adverse Event|0
7305417|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Adverse Event|0
7305418|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Death|1
7305419|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Death|0
7305420|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Death|0
7305421|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Death|0
7305422|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Death|0
7305423|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Failed to Return|1
7305424|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Failed to Return|0
7305425|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Failed to Return|0
7305426|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Failed to Return|0
7305427|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Failed to Return|0
7305428|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Investigator Request|1
7305429|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Investigator Request|1
7305430|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Investigator Request|1
7305431|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Investigator Request|0
7305432|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Investigator Request|0
7305433|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
7305434|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
7305435|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
7305436|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
7305437|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
7305438|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
7305439|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
7305440|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
7305441|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
7305442|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
7305443|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
7305444|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
7305445|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
7305446|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
7305447|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
7305448|NCT00634933|11528832|FG000|Part A: Baseline to Week 24|Other|1
7305449|NCT00634933|11528833|FG001|Part A: Baseline to Week 24|Other|8
7305450|NCT00634933|11528834|FG002|Part A: Baseline to Week 24|Other|5
7305451|NCT00634933|11528835|FG003|Part A: Baseline to Week 24|Other|0
7305452|NCT00634933|11528836|FG004|Part A: Baseline to Week 24|Other|0
7305453|NCT00634933|11528832|FG000|Between Part A and Part B|Physician Decision|0
7305454|NCT00634933|11528833|FG001|Between Part A and Part B|Physician Decision|1
7305455|NCT00634933|11528834|FG002|Between Part A and Part B|Physician Decision|0
7305456|NCT00634933|11528835|FG003|Between Part A and Part B|Physician Decision|0
7305457|NCT00634933|11528836|FG004|Between Part A and Part B|Physician Decision|0
7305458|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Adverse Event|0
7305459|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Adverse Event|1
7305460|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Adverse Event|1
7305461|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Adverse Event|1
7305462|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Adverse Event|0
7305463|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
7305464|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
7305465|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
7305466|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
7305467|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
7305468|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Physician Decision|0
7305469|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Physician Decision|1
7305470|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Physician Decision|1
7305471|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Physician Decision|0
7305472|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Physician Decision|0
7305473|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
7305474|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
7305475|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
7305476|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
7305477|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
7305478|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7305479|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7305480|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
7305481|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
7305482|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
7305483|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
7305484|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
7305485|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
7305486|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
7305487|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
7305488|NCT00634933|11528832|FG000|Part B: Week 24 to Week 52|Other|0
7305489|NCT00634933|11528833|FG001|Part B: Week 24 to Week 52|Other|0
7305490|NCT00634933|11528834|FG002|Part B: Week 24 to Week 52|Other|5
7305491|NCT00634933|11528835|FG003|Part B: Week 24 to Week 52|Other|0
7305492|NCT00634933|11528836|FG004|Part B: Week 24 to Week 52|Other|1
7305493|NCT00635024|11528848|FG000|Overall Study|Adverse Event|1
7305494|NCT00635050|11528852|FG000|Overall Study|Withdrawal by Subject|1
7305495|NCT00635089|11528859|FG000|Overall Study|Adverse Event|7
7305496|NCT00635089|11528859|FG000|Overall Study|Lack of Efficacy|28
7305497|NCT00635089|11528859|FG000|Overall Study|Protocol Deviation|4
7305498|NCT00635089|11528859|FG000|Overall Study|Lost to Follow-up|8
7305499|NCT00635089|11528859|FG000|Overall Study|Other|31
7305500|NCT00635102|11528878|FG000|Overall Study|Withdrawal by Subject|7
7305501|NCT00635102|11528879|FG001|Overall Study|Withdrawal by Subject|8
7305502|NCT00635154|11528896|FG000|Overall Study|Alternative Treatment|8
7305503|NCT00635154|11528896|FG000|Overall Study|Other|4
7305504|NCT00635154|11528896|FG000|Overall Study|Still on treatment|21
7305505|NCT00635219|11528907|FG000|Overall Study|Adverse Event|12
7305506|NCT00635219|11528908|FG001|Overall Study|Adverse Event|10
7305507|NCT00635219|11528909|FG002|Overall Study|Adverse Event|18
7305508|NCT00635219|11528910|FG003|Overall Study|Adverse Event|15
7305509|NCT00635219|11528911|FG004|Overall Study|Adverse Event|19
7305510|NCT00635219|11528907|FG000|Overall Study|Lack of Efficacy|5
7305511|NCT00635219|11528908|FG001|Overall Study|Lack of Efficacy|6
7305512|NCT00635219|11528909|FG002|Overall Study|Lack of Efficacy|3
7305513|NCT00635219|11528910|FG003|Overall Study|Lack of Efficacy|4
7305514|NCT00635219|11528911|FG004|Overall Study|Lack of Efficacy|6
7305515|NCT00635219|11528907|FG000|Overall Study|Non-compliance With Study Product|0
7305516|NCT00635219|11528908|FG001|Overall Study|Non-compliance With Study Product|0
7305517|NCT00635219|11528909|FG002|Overall Study|Non-compliance With Study Product|0
7305518|NCT00635219|11528910|FG003|Overall Study|Non-compliance With Study Product|2
7305519|NCT00635219|11528911|FG004|Overall Study|Non-compliance With Study Product|1
7305520|NCT00635219|11528907|FG000|Overall Study|Protocol Violation|0
7305521|NCT00635219|11528908|FG001|Overall Study|Protocol Violation|2
7305522|NCT00635219|11528909|FG002|Overall Study|Protocol Violation|3
7305523|NCT00635219|11528910|FG003|Overall Study|Protocol Violation|2
7305524|NCT00635219|11528911|FG004|Overall Study|Protocol Violation|4
7305525|NCT00635219|11528907|FG000|Overall Study|Withdrawal of Consent|8
7305526|NCT00635219|11528908|FG001|Overall Study|Withdrawal of Consent|6
7305527|NCT00635219|11528909|FG002|Overall Study|Withdrawal of Consent|8
7305528|NCT00635219|11528910|FG003|Overall Study|Withdrawal of Consent|11
7305529|NCT00635219|11528911|FG004|Overall Study|Withdrawal of Consent|8
7305530|NCT00635219|11528907|FG000|Overall Study|Lost to Follow-up|0
7305531|NCT00635219|11528908|FG001|Overall Study|Lost to Follow-up|0
7305532|NCT00635219|11528909|FG002|Overall Study|Lost to Follow-up|2
7305533|NCT00635219|11528910|FG003|Overall Study|Lost to Follow-up|0
7305534|NCT00635219|11528911|FG004|Overall Study|Lost to Follow-up|3
7305535|NCT00635219|11528907|FG000|Overall Study|Administrative or Other Reasons|0
7305536|NCT00635219|11528908|FG001|Overall Study|Administrative or Other Reasons|1
7305537|NCT00635219|11528909|FG002|Overall Study|Administrative or Other Reasons|1
7305538|NCT00635219|11528910|FG003|Overall Study|Administrative or Other Reasons|0
7305539|NCT00635219|11528911|FG004|Overall Study|Administrative or Other Reasons|1
7305540|NCT00635349|11528946|FG000|Overall Study|Other|8
7305541|NCT00635349|11528947|FG001|Overall Study|Other|6
7305542|NCT00635349|11528946|FG000|Overall Study|Protocol Violation|18
7305543|NCT00635349|11528947|FG001|Overall Study|Protocol Violation|22
7305544|NCT00635349|11528946|FG000|Overall Study|Withdrawal by Subject|3
7305545|NCT00635349|11528947|FG001|Overall Study|Withdrawal by Subject|8
7305546|NCT00635349|11528946|FG000|Overall Study|Lost to Follow-up|4
7305547|NCT00635349|11528947|FG001|Overall Study|Lost to Follow-up|3
7305548|NCT00635349|11528946|FG000|Overall Study|Adverse Event|11
7305549|NCT00635349|11528947|FG001|Overall Study|Adverse Event|9
7305550|NCT00635427|11528967|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7305551|NCT00635427|11528968|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7305552|NCT00635427|11528969|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
7305553|NCT00635427|11528970|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7305554|NCT00635427|11528971|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
7305555|NCT00635427|11528967|FG000|Overall Study|Death|0
7305556|NCT00635427|11528968|FG001|Overall Study|Death|0
7305557|NCT00635427|11528969|FG002|Overall Study|Death|0
7305558|NCT00635427|11528970|FG003|Overall Study|Death|1
7305559|NCT00635427|11528971|FG004|Overall Study|Death|0
7305560|NCT00635427|11528967|FG000|Overall Study|Termination Of Study By Sponsor|12
7305561|NCT00635427|11528968|FG001|Overall Study|Termination Of Study By Sponsor|6
7305562|NCT00635427|11528969|FG002|Overall Study|Termination Of Study By Sponsor|10
7305563|NCT00635427|11528970|FG003|Overall Study|Termination Of Study By Sponsor|6
7305564|NCT00635427|11528971|FG004|Overall Study|Termination Of Study By Sponsor|6
7305565|NCT00635427|11528967|FG000|Overall Study|Withdrawal Of Consent|0
7305566|NCT00635427|11528968|FG001|Overall Study|Withdrawal Of Consent|0
7305567|NCT00635427|11528969|FG002|Overall Study|Withdrawal Of Consent|0
7305568|NCT00635427|11528970|FG003|Overall Study|Withdrawal Of Consent|2
7305569|NCT00635427|11528971|FG004|Overall Study|Withdrawal Of Consent|2
7305570|NCT00635492|11529001|FG000|Overall Study|Death|12
7305571|NCT00635492|11529002|FG001|Overall Study|Death|40
7305572|NCT00635492|11529001|FG000|Overall Study|Lost to Follow-up|151
7305573|NCT00635492|11529002|FG001|Overall Study|Lost to Follow-up|172
7305574|NCT00635492|11529001|FG000|Overall Study|Physician Decision|32
7305575|NCT00635492|11529002|FG001|Overall Study|Physician Decision|22
7305576|NCT00635492|11529001|FG000|Overall Study|Sponsor decision|2
7305577|NCT00635492|11529002|FG001|Overall Study|Sponsor decision|3
7305578|NCT00635492|11529001|FG000|Overall Study|Withdrawal by Subject|82
7305579|NCT00635492|11529002|FG001|Overall Study|Withdrawal by Subject|45
7305580|NCT00635570|11529014|FG000|Overall Study|Lost to Follow-up|8
7305581|NCT00635570|11529015|FG001|Overall Study|Lost to Follow-up|8
7305582|NCT00635570|11529014|FG000|Overall Study|Withdrawal by Subject|1
7305583|NCT00635570|11529015|FG001|Overall Study|Withdrawal by Subject|1
7305584|NCT00635570|11529014|FG000|Overall Study|Adverse Event|2
7305585|NCT00635570|11529015|FG001|Overall Study|Adverse Event|0
7305586|NCT00635570|11529014|FG000|Overall Study|Physician Decision|1
7305587|NCT00635570|11529015|FG001|Overall Study|Physician Decision|0
7305588|NCT00635570|11529014|FG000|Overall Study|Did not complete survey|2
7305589|NCT00635570|11529015|FG001|Overall Study|Did not complete survey|1
7305590|NCT00635570|11529014|FG000|Overall Study|Early termination(No sexual activity)|1
7305591|NCT00635570|11529015|FG001|Overall Study|Early termination(No sexual activity)|1
7305592|NCT00635648|11529030|FG000|Overall Study|Adverse Event|12
7305593|NCT00635648|11529030|FG000|Overall Study|Withdrawal by Subject|9
7305594|NCT00635648|11529030|FG000|Overall Study|Physician Decision|4
7305595|NCT00635648|11529030|FG000|Overall Study|Rapid progression of baseline disease|4
7305596|NCT00635648|11529030|FG000|Overall Study|Use of other antifungal agent needed|1
7305597|NCT00635648|11529030|FG000|Overall Study|No improvement after 7-10 days treatment|4
7305598|NCT00635648|11529030|FG000|Overall Study|Noncompliance with protocol|1
7305599|NCT00635648|11529030|FG000|Overall Study|Other reason|2
7305600|NCT00635661|11529034|FG000|Overall Study|Withdrawal by Subject|4
7305601|NCT00635778|11529063|FG000|Overall Study|Adverse Event|1
7305602|NCT00635778|11529064|FG001|Overall Study|Adverse Event|0
7305603|NCT00635778|11529065|FG002|Overall Study|Adverse Event|0
7305604|NCT00635778|11529066|FG003|Overall Study|Adverse Event|3
7305605|NCT00635778|11529067|FG004|Overall Study|Adverse Event|3
7305606|NCT00635778|11529068|FG005|Overall Study|Adverse Event|6
7305607|NCT00635778|11529069|FG006|Overall Study|Adverse Event|1
7305608|NCT00635778|11529063|FG000|Overall Study|Withdrawal by Subject|0
7305609|NCT00635778|11529064|FG001|Overall Study|Withdrawal by Subject|0
7305610|NCT00635778|11529065|FG002|Overall Study|Withdrawal by Subject|0
7305611|NCT00635778|11529066|FG003|Overall Study|Withdrawal by Subject|1
7305612|NCT00635778|11529067|FG004|Overall Study|Withdrawal by Subject|0
7305613|NCT00635778|11529068|FG005|Overall Study|Withdrawal by Subject|1
7305614|NCT00635778|11529069|FG006|Overall Study|Withdrawal by Subject|1
7305615|NCT00635778|11529063|FG000|Overall Study|Progressive disease|0
7305616|NCT00635778|11529064|FG001|Overall Study|Progressive disease|3
7305617|NCT00635778|11529065|FG002|Overall Study|Progressive disease|3
7305618|NCT00635778|11529066|FG003|Overall Study|Progressive disease|4
7305619|NCT00635778|11529067|FG004|Overall Study|Progressive disease|5
7305620|NCT00635778|11529068|FG005|Overall Study|Progressive disease|14
7305621|NCT00635778|11529069|FG006|Overall Study|Progressive disease|4
7305622|NCT00635804|11529094|FG000|Overall Study|Adverse Event|0
7305623|NCT00635804|11529095|FG001|Overall Study|Adverse Event|0
7305624|NCT00635804|11529096|FG002|Overall Study|Adverse Event|0
7305625|NCT00635804|11529097|FG003|Overall Study|Adverse Event|0
7305626|NCT00635804|11529098|FG004|Overall Study|Adverse Event|0
7305627|NCT00635804|11529099|FG005|Overall Study|Adverse Event|1
7305628|NCT00635804|11529100|FG006|Overall Study|Adverse Event|0
7305629|NCT00635804|11529101|FG007|Overall Study|Adverse Event|0
7305630|NCT00635804|11529094|FG000|Overall Study|Withdrawal by Subject|1
7305631|NCT00635804|11529095|FG001|Overall Study|Withdrawal by Subject|0
7305632|NCT00635804|11529096|FG002|Overall Study|Withdrawal by Subject|0
7305633|NCT00635804|11529097|FG003|Overall Study|Withdrawal by Subject|0
7305634|NCT00635804|11529098|FG004|Overall Study|Withdrawal by Subject|0
7305635|NCT00635804|11529099|FG005|Overall Study|Withdrawal by Subject|0
7305636|NCT00635804|11529100|FG006|Overall Study|Withdrawal by Subject|0
7305637|NCT00635804|11529101|FG007|Overall Study|Withdrawal by Subject|0
7305638|NCT00635999|11529153|FG000|Overall Study|Withdrawal by Subject|4
7305639|NCT00635999|11529154|FG001|Overall Study|Withdrawal by Subject|2
7305640|NCT00635999|11529155|FG002|Overall Study|Withdrawal by Subject|1
7305641|NCT00636155|11529176|FG000|Overall Study|Adverse Event|8
7305642|NCT00636155|11529176|FG000|Overall Study|Lack of Efficacy|1
7305643|NCT00636155|11529176|FG000|Overall Study|Withdrawal by Subject|3
7305644|NCT00636155|11529176|FG000|Overall Study|Stem cell transplant|1
7305645|NCT00636155|11529176|FG000|Overall Study|Physician Decision|5
7305646|NCT00636168|11529182|FG000|Randomized to Study Drug|Withdrawal by Subject|2
7305647|NCT00636168|11529183|FG001|Randomized to Study Drug|Withdrawal by Subject|2
7305648|NCT00636168|11529182|FG000|Randomized to Study Drug|Adverse Event|1
7305649|NCT00636168|11529183|FG001|Randomized to Study Drug|Adverse Event|0
7305650|NCT00636168|11529182|FG000|Randomized to Study Drug|No longer meets study criteria|1
7305651|NCT00636168|11529183|FG001|Randomized to Study Drug|No longer meets study criteria|0
7305652|NCT00636168|11529182|FG000|Treated With Study Drug|Recurrence of disease|135
7305653|NCT00636168|11529183|FG001|Treated With Study Drug|Recurrence of disease|282
7305654|NCT00636168|11529182|FG000|Treated With Study Drug|Adverse Event|250
7305655|NCT00636168|11529183|FG001|Treated With Study Drug|Adverse Event|22
7305656|NCT00636168|11529182|FG000|Treated With Study Drug|Participant withdrew consent|16
7305657|NCT00636168|11529183|FG001|Treated With Study Drug|Participant withdrew consent|21
7305658|NCT00636168|11529182|FG000|Treated With Study Drug|Poor/non-compliance|1
7305659|NCT00636168|11529183|FG001|Treated With Study Drug|Poor/non-compliance|3
7305660|NCT00636168|11529182|FG000|Treated With Study Drug|Death|3
7305661|NCT00636168|11529183|FG001|Treated With Study Drug|Death|0
7305662|NCT00636168|11529182|FG000|Treated With Study Drug|Pregnancy|1
7305663|NCT00636168|11529183|FG001|Treated With Study Drug|Pregnancy|0
7305664|NCT00636168|11529182|FG000|Treated With Study Drug|No longer meets study criteria|1
7305665|NCT00636168|11529183|FG001|Treated With Study Drug|No longer meets study criteria|0
7305666|NCT00636168|11529182|FG000|Treated With Study Drug|Other reason|1
7305667|NCT00636168|11529183|FG001|Treated With Study Drug|Other reason|3
7305668|NCT00636168|11529182|FG000|Long Term Follow-Up|Lost to Follow-up|3
7305669|NCT00636168|11529183|FG001|Long Term Follow-Up|Lost to Follow-up|3
7305670|NCT00636168|11529182|FG000|Long Term Follow-Up|Participant withdrew consent|0
7305671|NCT00636168|11529183|FG001|Long Term Follow-Up|Participant withdrew consent|2
7305672|NCT00636168|11529182|FG000|Long Term Follow-Up|Death|8
7305673|NCT00636168|11529183|FG001|Long Term Follow-Up|Death|9
7305674|NCT00636181|11529192|FG000|Overall Study|Withdrawal by Subject|8
7305675|NCT00636181|11529193|FG001|Overall Study|Withdrawal by Subject|6
7305676|NCT00636181|11529194|FG002|Overall Study|Withdrawal by Subject|10
7305677|NCT00636194|11529204|FG000|Overall Study|Study related symptoms and complaints|1
7305678|NCT00636194|11529205|FG001|Overall Study|Study related symptoms and complaints|0
7305679|NCT00636194|11529204|FG000|Overall Study|Protocol Violation|2
7305680|NCT00636194|11529205|FG001|Overall Study|Protocol Violation|0
7305681|NCT00636207|11529214|FG000|Overall Study|Adverse Event|1
7305682|NCT00636207|11529215|FG001|Overall Study|Adverse Event|0
7305683|NCT00636207|11529216|FG002|Overall Study|Adverse Event|0
7305684|NCT00636207|11529217|FG003|Overall Study|Adverse Event|0
7305685|NCT00636207|11529218|FG004|Overall Study|Adverse Event|0
7305686|NCT00636207|11529219|FG005|Overall Study|Adverse Event|0
7305687|NCT00636207|11529220|FG006|Overall Study|Adverse Event|0
7305688|NCT00636207|11529214|FG000|Overall Study|Withdrawal by Subject|0
7305689|NCT00636207|11529215|FG001|Overall Study|Withdrawal by Subject|1
7305690|NCT00636207|11529216|FG002|Overall Study|Withdrawal by Subject|0
7305691|NCT00636207|11529217|FG003|Overall Study|Withdrawal by Subject|0
7305692|NCT00636207|11529218|FG004|Overall Study|Withdrawal by Subject|1
7305693|NCT00636207|11529219|FG005|Overall Study|Withdrawal by Subject|0
7305694|NCT00636207|11529220|FG006|Overall Study|Withdrawal by Subject|0
7305695|NCT00636363|11529248|FG000|Overall Study|Conjunctivitis|0
7305696|NCT00636363|11529249|FG001|Overall Study|Conjunctivitis|0
7305697|NCT00636363|11529250|FG002|Overall Study|Conjunctivitis|1
7305698|NCT00636363|11529248|FG000|Overall Study|Adverse Event|0
7305699|NCT00636363|11529249|FG001|Overall Study|Adverse Event|0
7305700|NCT00636363|11529250|FG002|Overall Study|Adverse Event|1
7305701|NCT00636363|11529248|FG000|Overall Study|Positive slit lamp finding|0
7305702|NCT00636363|11529249|FG001|Overall Study|Positive slit lamp finding|2
7305703|NCT00636363|11529250|FG002|Overall Study|Positive slit lamp finding|1
7305704|NCT00636363|11529248|FG000|Overall Study|Study related symptoms/complaints|8
7305705|NCT00636363|11529249|FG001|Overall Study|Study related symptoms/complaints|7
7305706|NCT00636363|11529250|FG002|Overall Study|Study related symptoms/complaints|4
7305707|NCT00636363|11529248|FG000|Overall Study|Met ineligibility criteria|0
7305708|NCT00636363|11529249|FG001|Overall Study|Met ineligibility criteria|0
7305709|NCT00636363|11529250|FG002|Overall Study|Met ineligibility criteria|3
7305710|NCT00636363|11529248|FG000|Overall Study|Missed > 1 visit|0
7305711|NCT00636363|11529249|FG001|Overall Study|Missed > 1 visit|1
7305712|NCT00636363|11529250|FG002|Overall Study|Missed > 1 visit|3
7305713|NCT00636363|11529248|FG000|Overall Study|Lack of motivation|1
7305714|NCT00636363|11529249|FG001|Overall Study|Lack of motivation|0
7305715|NCT00636363|11529250|FG002|Overall Study|Lack of motivation|1
7305716|NCT00636363|11529248|FG000|Overall Study|Protocol Violation|0
7305717|NCT00636363|11529249|FG001|Overall Study|Protocol Violation|3
7305718|NCT00636363|11529250|FG002|Overall Study|Protocol Violation|0
7305719|NCT00636363|11529248|FG000|Overall Study|Lost to Follow-up|3
7305720|NCT00636363|11529249|FG001|Overall Study|Lost to Follow-up|4
7305721|NCT00636363|11529250|FG002|Overall Study|Lost to Follow-up|2
7305722|NCT00636363|11529248|FG000|Overall Study|Withdrawal by Subject|1
7305723|NCT00636363|11529249|FG001|Overall Study|Withdrawal by Subject|3
7305724|NCT00636363|11529250|FG002|Overall Study|Withdrawal by Subject|2
7552048|NCT02980523|11911705|FG003|Overall Study|Did not receive intervention|1
7552049|NCT02980523|11911706|FG004|Overall Study|Did not receive intervention|0
7552050|NCT02980601|11911723|FG000|Overall Study|Lost to Follow-up|2
7552051|NCT02980601|11911724|FG001|Overall Study|Lost to Follow-up|2
7552052|NCT02980601|11911723|FG000|Overall Study|Death|0
7552053|NCT02980601|11911724|FG001|Overall Study|Death|1
7552054|NCT02980601|11911723|FG000|Overall Study|Graft loss|1
7552055|NCT02980601|11911724|FG001|Overall Study|Graft loss|0
7552056|NCT02980601|11911723|FG000|Overall Study|Failed to sign consent|2
7552057|NCT02980601|11911724|FG001|Overall Study|Failed to sign consent|0
7552058|NCT02980692|11911735|FG000|Overall Study|Adverse Event|0
7552059|NCT02980692|11911736|FG001|Overall Study|Adverse Event|2
7552060|NCT02980692|11911737|FG002|Overall Study|Adverse Event|0
7552061|NCT02980692|11911738|FG003|Overall Study|Adverse Event|0
7552062|NCT02980692|11911739|FG004|Overall Study|Adverse Event|1
7552063|NCT02980692|11911735|FG000|Overall Study|Withdrawal by Subject|4
7552064|NCT02980692|11911736|FG001|Overall Study|Withdrawal by Subject|3
7552065|NCT02980692|11911737|FG002|Overall Study|Withdrawal by Subject|6
7552066|NCT02980692|11911738|FG003|Overall Study|Withdrawal by Subject|6
7552067|NCT02980692|11911739|FG004|Overall Study|Withdrawal by Subject|7
7552068|NCT02980692|11911735|FG000|Overall Study|Lost to Follow-up|3
7552069|NCT02980692|11911736|FG001|Overall Study|Lost to Follow-up|0
7552070|NCT02980692|11911737|FG002|Overall Study|Lost to Follow-up|4
7552071|NCT02980692|11911738|FG003|Overall Study|Lost to Follow-up|1
7552072|NCT02980692|11911739|FG004|Overall Study|Lost to Follow-up|1
7552073|NCT02980692|11911735|FG000|Overall Study|Death|1
7552074|NCT02980692|11911736|FG001|Overall Study|Death|0
7552075|NCT02980692|11911737|FG002|Overall Study|Death|0
7552076|NCT02980692|11911738|FG003|Overall Study|Death|0
7552077|NCT02980692|11911739|FG004|Overall Study|Death|0
7552078|NCT02980692|11911735|FG000|Overall Study|Physician Decision|0
7552079|NCT02980692|11911736|FG001|Overall Study|Physician Decision|0
7552080|NCT02980692|11911737|FG002|Overall Study|Physician Decision|1
7305725|NCT00636441|11529272|FG000|Overall Study|Adverse Event|0
7305726|NCT00636441|11529273|FG001|Overall Study|Adverse Event|1
7305727|NCT00636441|11529274|FG002|Overall Study|Adverse Event|1
7305728|NCT00636441|11529275|FG003|Overall Study|Adverse Event|0
7305729|NCT00636441|11529276|FG004|Overall Study|Adverse Event|0
7305730|NCT00636441|11529277|FG005|Overall Study|Adverse Event|1
7305731|NCT00636441|11529278|FG006|Overall Study|Adverse Event|0
7305732|NCT00636441|11529272|FG000|Overall Study|Late, ineligible|0
7305733|NCT00636441|11529273|FG001|Overall Study|Late, ineligible|0
7305734|NCT00636441|11529274|FG002|Overall Study|Late, ineligible|0
7305735|NCT00636441|11529275|FG003|Overall Study|Late, ineligible|0
7305736|NCT00636441|11529276|FG004|Overall Study|Late, ineligible|0
7305737|NCT00636441|11529277|FG005|Overall Study|Late, ineligible|0
7305738|NCT00636441|11529278|FG006|Overall Study|Late, ineligible|1
7305739|NCT00636441|11529272|FG000|Overall Study|Screen Failure|0
7305740|NCT00636441|11529273|FG001|Overall Study|Screen Failure|0
7305741|NCT00636441|11529274|FG002|Overall Study|Screen Failure|0
7305742|NCT00636441|11529275|FG003|Overall Study|Screen Failure|0
7305743|NCT00636441|11529276|FG004|Overall Study|Screen Failure|0
7305744|NCT00636441|11529277|FG005|Overall Study|Screen Failure|0
7305745|NCT00636441|11529278|FG006|Overall Study|Screen Failure|17
7305746|NCT00636506|11529289|FG000|Overall Study|Lost to Follow-up|8
7305747|NCT00636506|11529289|FG000|Overall Study|Explanted|1
7305748|NCT00636506|11529289|FG000|Overall Study|Withdrawal by Subject|6
7305749|NCT00636506|11529289|FG000|Overall Study|Procedure aborted|1
7305750|NCT00636610|11529313|FG000|Overall Study|Adverse Event|4
7305751|NCT00636610|11529314|FG001|Overall Study|Adverse Event|4
7305752|NCT00636610|11529313|FG000|Overall Study|Death|6
7305753|NCT00636610|11529314|FG001|Overall Study|Death|3
7305754|NCT00636610|11529313|FG000|Overall Study|Physician decision to withdraw patient|15
7305755|NCT00636610|11529314|FG001|Overall Study|Physician decision to withdraw patient|9
7305756|NCT00636610|11529313|FG000|Overall Study|Subject decision to withdraw|15
7305757|NCT00636610|11529314|FG001|Overall Study|Subject decision to withdraw|11
7305758|NCT00636610|11529313|FG000|Overall Study|Disease progression - radiographic|41
7305759|NCT00636610|11529314|FG001|Overall Study|Disease progression - radiographic|51
7305760|NCT00636610|11529313|FG000|Overall Study|Disease progression - clinical|8
7305761|NCT00636610|11529314|FG001|Overall Study|Disease progression - clinical|3
7305762|NCT00636610|11529313|FG000|Overall Study|Reason for discontinuation not available|3
7305763|NCT00636610|11529314|FG001|Overall Study|Reason for discontinuation not available|2
7305764|NCT00636636|11529324|FG000|Overall Study|Other reason|4
7305765|NCT00636636|11529325|FG001|Overall Study|Other reason|6
7305766|NCT00636636|11529324|FG000|Overall Study|Adverse Event|19
7305767|NCT00636636|11529325|FG001|Overall Study|Adverse Event|8
7305768|NCT00636636|11529324|FG000|Overall Study|Lack of Efficacy|7
7305769|NCT00636636|11529325|FG001|Overall Study|Lack of Efficacy|12
7305770|NCT00636636|11529324|FG000|Overall Study|Protocol Violation|2
7305771|NCT00636636|11529325|FG001|Overall Study|Protocol Violation|2
7305772|NCT00636636|11529324|FG000|Overall Study|Lost to Follow-up|0
7305773|NCT00636636|11529325|FG001|Overall Study|Lost to Follow-up|1
7305774|NCT00636636|11529324|FG000|Overall Study|Death|0
7305775|NCT00636636|11529325|FG001|Overall Study|Death|1
7305776|NCT00636636|11529324|FG000|Overall Study|Withdrawal by Subject|4
7305777|NCT00636636|11529325|FG001|Overall Study|Withdrawal by Subject|9
7305778|NCT00636675|11529346|FG000|Overall Study|Lost to Follow-up|121
7305779|NCT00636675|11529347|FG001|Overall Study|Lost to Follow-up|31
7305780|NCT00636675|11529346|FG000|Overall Study|Withdrawal by Subject|19
7305781|NCT00636675|11529347|FG001|Overall Study|Withdrawal by Subject|10
7305782|NCT00636792|11529362|FG000|Overall Study|Adverse Event|16
7305783|NCT00636792|11529362|FG000|Overall Study|Physician Decision|7
7305784|NCT00636792|11529362|FG000|Overall Study|Progressive Disease|4
7305785|NCT00636792|11529362|FG000|Overall Study|Withdrawal by Subject|3
7305786|NCT00636792|11529362|FG000|Overall Study|Other|3
7305787|NCT00636818|11529370|FG000|Overall Study|Adverse Event|1
7305788|NCT00636818|11529370|FG000|Overall Study|Lost to Follow-up|2
7305789|NCT00636818|11529370|FG000|Overall Study|Entry Criteria Exclusion|3
7305790|NCT00636818|11529370|FG000|Overall Study|Protocol Violation|1
7305791|NCT00636818|11529370|FG000|Overall Study|Withdrawal by Subject|4
7305792|NCT00636961|11529376|FG000|Period 1|Administrative problems|1
7305793|NCT00636961|11529377|FG001|Period 1|Administrative problems|1
7305794|NCT00636961|11529376|FG000|Period 2|Adverse Event|1
7305795|NCT00636961|11529377|FG001|Period 2|Adverse Event|0
7305796|NCT00636987|11529383|FG000|Overall Study|Death|44
7305797|NCT00636987|11529383|FG000|Overall Study|Explanted|13
7305798|NCT00636987|11529383|FG000|Overall Study|Lost to Follow-up|63
7305799|NCT00636987|11529383|FG000|Overall Study|5 year visit window not complete|69
7305800|NCT00637000|11529393|FG000|Overall Study|Withdrawal by Subject|4
7305801|NCT00637000|11529394|FG001|Overall Study|Withdrawal by Subject|3
7305802|NCT00637156|11529402|FG000|Overall Study|Withdrawal by Subject|0
7305803|NCT00637156|11529403|FG001|Overall Study|Withdrawal by Subject|7
7305804|NCT00637156|11529402|FG000|Overall Study|Death|0
7305805|NCT00637156|11529403|FG001|Overall Study|Death|1
7305806|NCT00637156|11529402|FG000|Overall Study|Lost to Follow-up|10
7305807|NCT00637156|11529403|FG001|Overall Study|Lost to Follow-up|16
7305808|NCT00637195|11529411|FG000|Overall Study|Lost to Follow-up|1
7305809|NCT00637195|11529412|FG001|Overall Study|Lost to Follow-up|0
7305810|NCT00637195|11529411|FG000|Overall Study|Other|2
7305811|NCT00637195|11529412|FG001|Overall Study|Other|0
7305812|NCT00637195|11529411|FG000|Overall Study|Withdrawal by Subject|0
7305813|NCT00637195|11529412|FG001|Overall Study|Withdrawal by Subject|1
7305814|NCT00637273|11529432|FG000|Overall Study|Adverse Event|11
7305815|NCT00637273|11529433|FG001|Overall Study|Adverse Event|5
7305816|NCT00637273|11529434|FG002|Overall Study|Adverse Event|7
7305817|NCT00637273|11529432|FG000|Overall Study|Lost to Follow-up|8
7305818|NCT00637273|11529433|FG001|Overall Study|Lost to Follow-up|9
7305819|NCT00637273|11529434|FG002|Overall Study|Lost to Follow-up|13
7305820|NCT00637273|11529432|FG000|Overall Study|Protocol Violation|2
7305821|NCT00637273|11529433|FG001|Overall Study|Protocol Violation|4
7305822|NCT00637273|11529434|FG002|Overall Study|Protocol Violation|1
7305823|NCT00637273|11529432|FG000|Overall Study|Withdrawal of Consent|18
7305824|NCT00637273|11529433|FG001|Overall Study|Withdrawal of Consent|6
7305825|NCT00637273|11529434|FG002|Overall Study|Withdrawal of Consent|18
7305826|NCT00637273|11529432|FG000|Overall Study|Investigator Decision|1
7305827|NCT00637273|11529433|FG001|Overall Study|Investigator Decision|3
7305828|NCT00637273|11529434|FG002|Overall Study|Investigator Decision|1
7305829|NCT00637273|11529432|FG000|Overall Study|Administrative|2
7305830|NCT00637273|11529433|FG001|Overall Study|Administrative|0
7305831|NCT00637273|11529434|FG002|Overall Study|Administrative|0
7305832|NCT00637273|11529432|FG000|Overall Study|Loss of Glucose Control|1
7305833|NCT00637273|11529433|FG001|Overall Study|Loss of Glucose Control|1
7305834|NCT00637273|11529434|FG002|Overall Study|Loss of Glucose Control|1
7305835|NCT00637377|11529455|FG000|Overall Study|Adverse Event|2
7305836|NCT00637377|11529456|FG001|Overall Study|Adverse Event|6
7305837|NCT00637377|11529457|FG002|Overall Study|Adverse Event|8
7305838|NCT00637377|11529458|FG003|Overall Study|Adverse Event|9
7305839|NCT00637377|11529455|FG000|Overall Study|Death|1
7305840|NCT00637377|11529456|FG001|Overall Study|Death|3
7305841|NCT00637377|11529457|FG002|Overall Study|Death|2
7305842|NCT00637377|11529458|FG003|Overall Study|Death|1
7305843|NCT00637377|11529455|FG000|Overall Study|Lack of Efficacy|0
7305844|NCT00637377|11529456|FG001|Overall Study|Lack of Efficacy|0
7305845|NCT00637377|11529457|FG002|Overall Study|Lack of Efficacy|1
7305846|NCT00637377|11529458|FG003|Overall Study|Lack of Efficacy|1
7305847|NCT00637377|11529455|FG000|Overall Study|Lost to Follow-up|4
7305848|NCT00637377|11529456|FG001|Overall Study|Lost to Follow-up|1
7305849|NCT00637377|11529457|FG002|Overall Study|Lost to Follow-up|2
7305850|NCT00637377|11529458|FG003|Overall Study|Lost to Follow-up|2
7305851|NCT00637377|11529455|FG000|Overall Study|Protocol Violation|2
7305852|NCT00637377|11529456|FG001|Overall Study|Protocol Violation|1
7305853|NCT00637377|11529457|FG002|Overall Study|Protocol Violation|1
7305854|NCT00637377|11529458|FG003|Overall Study|Protocol Violation|0
7305855|NCT00637377|11529455|FG000|Overall Study|Withdrawal by Subject|11
7305856|NCT00637377|11529456|FG001|Overall Study|Withdrawal by Subject|15
7305857|NCT00637377|11529457|FG002|Overall Study|Withdrawal by Subject|13
7305858|NCT00637377|11529458|FG003|Overall Study|Withdrawal by Subject|11
7305859|NCT00637377|11529455|FG000|Overall Study|Other (no further information available)|7
7305860|NCT00637377|11529456|FG001|Overall Study|Other (no further information available)|6
7305861|NCT00637377|11529457|FG002|Overall Study|Other (no further information available)|10
7305862|NCT00637377|11529458|FG003|Overall Study|Other (no further information available)|5
7305863|NCT00637572|11529479|FG000|Overall Study|Adverse Event|1
7305864|NCT00637572|11529480|FG001|Overall Study|Adverse Event|2
7305865|NCT00637572|11529479|FG000|Overall Study|Death|0
7305866|NCT00637572|11529480|FG001|Overall Study|Death|1
7305867|NCT00637572|11529479|FG000|Overall Study|Lost to Follow-up|0
7305868|NCT00637572|11529480|FG001|Overall Study|Lost to Follow-up|1
7305869|NCT00637572|11529479|FG000|Overall Study|Physician Decision|1
7305870|NCT00637572|11529480|FG001|Overall Study|Physician Decision|1
7305871|NCT00637572|11529479|FG000|Overall Study|Withdrawal by Subject|0
7305872|NCT00637572|11529480|FG001|Overall Study|Withdrawal by Subject|2
7305873|NCT00637572|11529479|FG000|Overall Study|Illicit Drug Use|1
7305874|NCT00637572|11529480|FG001|Overall Study|Illicit Drug Use|0
7305875|NCT00638027|11529510|FG000|Overall Study|Adverse Event|0
7305876|NCT00638027|11529511|FG001|Overall Study|Adverse Event|2
7305877|NCT00638157|11529519|FG000|Overall Study|Adverse Event|0
7305878|NCT00638157|11529520|FG001|Overall Study|Adverse Event|1
7305879|NCT00638157|11529519|FG000|Overall Study|Clinical (symptomatic) failure|1
7305880|NCT00638157|11529520|FG001|Overall Study|Clinical (symptomatic) failure|1
7305881|NCT00638157|11529519|FG000|Overall Study|Microbiological failure|1
7305882|NCT00638157|11529520|FG001|Overall Study|Microbiological failure|0
7305883|NCT00638157|11529519|FG000|Overall Study|Lost to Follow-up|1
7305884|NCT00638157|11529520|FG001|Overall Study|Lost to Follow-up|0
7305885|NCT00638157|11529519|FG000|Overall Study|Physician Decision|1
7305886|NCT00638157|11529520|FG001|Overall Study|Physician Decision|0
7305887|NCT00638157|11529519|FG000|Overall Study|Other|1
7305888|NCT00638157|11529520|FG001|Overall Study|Other|2
7305889|NCT00638157|11529519|FG000|Overall Study|Randomized, not treated|2
7305890|NCT00638157|11529520|FG001|Overall Study|Randomized, not treated|0
7305891|NCT00638183|11529527|FG000|Overall Study|Adverse Event|23
7305892|NCT00638183|11529527|FG000|Overall Study|Lack of Efficacy|14
7305893|NCT00638183|11529527|FG000|Overall Study|Physician Decision|9
7305894|NCT00638183|11529527|FG000|Overall Study|Lost to Follow-up|46
7305895|NCT00638183|11529527|FG000|Overall Study|Other reason not defined above|27
7305896|NCT00638235|11529540|FG000|Overall Study|Lost to Follow-up|31
7305897|NCT00638235|11529541|FG001|Overall Study|Lost to Follow-up|3
7305898|NCT00638235|11529542|FG002|Overall Study|Lost to Follow-up|18
7305899|NCT00638235|11529543|FG003|Overall Study|Lost to Follow-up|10
7305900|NCT00638235|11529544|FG004|Overall Study|Lost to Follow-up|13
7305901|NCT00638235|11529545|FG005|Overall Study|Lost to Follow-up|26
7305902|NCT00638235|11529546|FG006|Overall Study|Lost to Follow-up|0
7305903|NCT00638235|11529547|FG007|Overall Study|Lost to Follow-up|1
7305904|NCT00638235|11529548|FG008|Overall Study|Lost to Follow-up|18
7305905|NCT00638378|11529597|FG000|Overall Study|Death|2
7305906|NCT00638378|11529597|FG000|Overall Study|Adverse Event|1
7305907|NCT00638378|11529597|FG000|Overall Study|Disease progression|15
7305908|NCT00638378|11529597|FG000|Overall Study|Physician Decision|4
7305909|NCT00638404|11529603|FG000|Overall Study|Physician Decision|8
7305910|NCT00638404|11529604|FG001|Overall Study|Physician Decision|0
7305911|NCT00638443|11529614|FG000|First Intervention|Adverse Event|2
7305912|NCT00638443|11529615|FG001|First Intervention|Adverse Event|1
7305913|NCT00638456|11529625|FG000|Overall Study|Withdrawal by Subject|6
7305914|NCT00638456|11529626|FG001|Overall Study|Withdrawal by Subject|2
7305915|NCT00638508|11529634|FG000|Overall Study|Physician Decision|5
7305916|NCT00638508|11529635|FG001|Overall Study|Physician Decision|2
7305917|NCT00638690|11529652|FG000|Overall Study|Death|655
7305918|NCT00638690|11529653|FG001|Overall Study|Death|335
7305919|NCT00638690|11529652|FG000|Overall Study|Withdrawal by Subject|22
7305920|NCT00638690|11529653|FG001|Overall Study|Withdrawal by Subject|5
7305921|NCT00638690|11529652|FG000|Overall Study|Lost to Follow-up|4
7305922|NCT00638690|11529653|FG001|Overall Study|Lost to Follow-up|2
7305923|NCT00638846|11529679|FG000|Overall Study|Adverse Event|0
7305924|NCT00638846|11529680|FG001|Overall Study|Adverse Event|1
7305925|NCT00638846|11529679|FG000|Overall Study|Lost to Follow-up|3
7305926|NCT00638846|11529680|FG001|Overall Study|Lost to Follow-up|2
7305927|NCT00638846|11529679|FG000|Overall Study|lens issue|1
7305928|NCT00638846|11529680|FG001|Overall Study|lens issue|3
7305929|NCT00638963|11529702|FG000|Overall Study|Withdrawal by Subject|1
7305930|NCT00638963|11529703|FG001|Overall Study|Withdrawal by Subject|0
7305931|NCT00638989|11529712|FG000|Overall Study|Lost to Follow-up|0
7305932|NCT00638989|11529713|FG001|Overall Study|Lost to Follow-up|0
7305933|NCT00638989|11529714|FG002|Overall Study|Lost to Follow-up|1
7305934|NCT00639002|11529724|FG000|Overall Study|Death|1
7305935|NCT00639002|11529724|FG000|Overall Study|Adverse Event|1
7305936|NCT00639002|11529724|FG000|Overall Study|Protocol Violation|1
7305937|NCT00639002|11529724|FG000|Overall Study|Disease progression|3
7305938|NCT00639002|11529724|FG000|Overall Study|Physician Decision|6
7305939|NCT00639002|11529724|FG000|Overall Study|Lack of Efficacy|1
7305940|NCT00639223|11529749|FG000|Overall Study|Lost to Follow-up|0
7305941|NCT00639223|11529750|FG001|Overall Study|Lost to Follow-up|2
7305942|NCT00639379|11529756|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
7305943|NCT00639379|11529757|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
7305944|NCT00639379|11529756|FG000|Period 1 - 2 Weeks|lens issue|3
7305945|NCT00639379|11529757|FG001|Period 1 - 2 Weeks|lens issue|0
7305946|NCT00639457|11529786|FG000|Overall Study|Withdrawal by Subject|2
7305947|NCT00639457|11529787|FG001|Overall Study|Withdrawal by Subject|3
7305948|NCT00639509|11529793|FG000|Overall Study|Death|1
7305949|NCT00639678|11529801|FG000|Overall Study|Withdrawal by Subject|3
7305950|NCT00639678|11529802|FG001|Overall Study|Withdrawal by Subject|0
7305951|NCT00639678|11529803|FG002|Overall Study|Withdrawal by Subject|4
7305952|NCT00639678|11529804|FG003|Overall Study|Withdrawal by Subject|0
7305953|NCT00639678|11529801|FG000|Overall Study|Lost to Follow-up|1
7305954|NCT00639678|11529802|FG001|Overall Study|Lost to Follow-up|0
7305955|NCT00639678|11529803|FG002|Overall Study|Lost to Follow-up|6
7305956|NCT00639678|11529804|FG003|Overall Study|Lost to Follow-up|0
7305957|NCT00639678|11529801|FG000|Overall Study|Adverse Event|0
7305958|NCT00639678|11529802|FG001|Overall Study|Adverse Event|1
7305959|NCT00639678|11529803|FG002|Overall Study|Adverse Event|0
7305960|NCT00639678|11529804|FG003|Overall Study|Adverse Event|0
7305961|NCT00639678|11529801|FG000|Overall Study|Lack of Compliance|0
7305962|NCT00639678|11529802|FG001|Overall Study|Lack of Compliance|0
7305963|NCT00639678|11529803|FG002|Overall Study|Lack of Compliance|1
7305964|NCT00639678|11529804|FG003|Overall Study|Lack of Compliance|0
7305965|NCT00639769|11529820|FG000|Overall Study|Death|2
7305966|NCT00639769|11529820|FG000|Overall Study|Adverse Event|7
7305967|NCT00639769|11529820|FG000|Overall Study|Lack of Efficacy|1
7305968|NCT00639769|11529820|FG000|Overall Study|Disease progression|26
7305969|NCT00639769|11529820|FG000|Overall Study|Withdrawal by Subject|4
7305970|NCT00640016|11529832|FG000|Overall Study|Withdrawal by Subject|0
7305971|NCT00640016|11529833|FG001|Overall Study|Withdrawal by Subject|1
7305972|NCT00640016|11529834|FG002|Overall Study|Withdrawal by Subject|0
7305973|NCT00640016|11529835|FG003|Overall Study|Withdrawal by Subject|0
7305974|NCT00640016|11529832|FG000|Overall Study|Study termination|2
7305975|NCT00640016|11529833|FG001|Overall Study|Study termination|1
7305976|NCT00640016|11529834|FG002|Overall Study|Study termination|3
7305977|NCT00640016|11529835|FG003|Overall Study|Study termination|2
7305978|NCT00640016|11529832|FG000|Overall Study|Adverse Event|0
7305979|NCT00640016|11529833|FG001|Overall Study|Adverse Event|0
7305980|NCT00640016|11529834|FG002|Overall Study|Adverse Event|0
7305981|NCT00640016|11529835|FG003|Overall Study|Adverse Event|1
7305982|NCT00640042|11529852|FG000|Enrollment|Did not receive study drug|83
7305983|NCT00640146|11529858|FG000|Overall Study|Adverse Event|2
7305984|NCT00640146|11529859|FG001|Overall Study|Adverse Event|0
7305985|NCT00640146|11529858|FG000|Overall Study|Lost to Follow-up|0
7305986|NCT00640146|11529859|FG001|Overall Study|Lost to Follow-up|1
7305987|NCT00640146|11529858|FG000|Overall Study|Lack of Efficacy|0
7305988|NCT00640146|11529859|FG001|Overall Study|Lack of Efficacy|1
7305989|NCT00640146|11529858|FG000|Overall Study|Withdrawal by Subject|1
7305990|NCT00640146|11529859|FG001|Overall Study|Withdrawal by Subject|1
7305991|NCT00640146|11529858|FG000|Overall Study|Randomized but not treated|1
7305992|NCT00640146|11529859|FG001|Overall Study|Randomized but not treated|3
7305993|NCT00640224|11529869|FG000|Overall Study|Lost to Follow-up|5
7305994|NCT00640224|11529870|FG001|Overall Study|Lost to Follow-up|2
7305995|NCT00640224|11529871|FG002|Overall Study|Lost to Follow-up|0
7305996|NCT00640224|11529872|FG003|Overall Study|Lost to Follow-up|0
7305997|NCT00640224|11529869|FG000|Overall Study|Withdrawal by Subject|1
7305998|NCT00640224|11529870|FG001|Overall Study|Withdrawal by Subject|0
7305999|NCT00640224|11529871|FG002|Overall Study|Withdrawal by Subject|0
7306000|NCT00640224|11529872|FG003|Overall Study|Withdrawal by Subject|0
7306001|NCT00640224|11529869|FG000|Overall Study|Headaches|0
7306002|NCT00640224|11529870|FG001|Overall Study|Headaches|1
7306003|NCT00640224|11529871|FG002|Overall Study|Headaches|0
7306004|NCT00640224|11529872|FG003|Overall Study|Headaches|0
7306005|NCT00640289|11529985|FG000|Overall Study|Death|3
7306006|NCT00640289|11529985|FG000|Overall Study|Withdrawal by Subject|1
7306007|NCT00640289|11529985|FG000|Overall Study|Lost to Follow-up|1
7306008|NCT00640289|11529985|FG000|Overall Study|Data collected under different amendment|2
7306009|NCT00640289|11529985|FG000|Overall Study|Transferred to another center|1
7306010|NCT00640289|11529985|FG000|Overall Study|Missing status|5
7306011|NCT00640315|11529991|FG000|Overall Study|Withdrawal by Subject|0
7306012|NCT00640315|11529992|FG001|Overall Study|Withdrawal by Subject|1
7306013|NCT00640328|11530004|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
7306014|NCT00640328|11530005|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
7306015|NCT00640328|11530006|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
7306016|NCT00640328|11530007|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
7306017|NCT00640328|11530008|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
7306018|NCT00640328|11530009|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
7306019|NCT00640328|11530004|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7306020|NCT00640328|11530005|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7306021|NCT00640328|11530006|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7306022|NCT00640328|11530007|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7306023|NCT00640328|11530008|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
7306024|NCT00640328|11530009|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
7306025|NCT00640328|11530004|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7306026|NCT00640328|11530005|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7306027|NCT00640328|11530006|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
7306028|NCT00640328|11530007|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7306029|NCT00640328|11530008|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7306030|NCT00640328|11530009|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
7306031|NCT00640328|11530004|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7306032|NCT00640328|11530005|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7306033|NCT00640328|11530006|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7306034|NCT00640328|11530007|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
7306035|NCT00640328|11530008|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7306036|NCT00640328|11530009|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
7306037|NCT00640341|11530033|FG000|Overall Study|Adverse Event|0
7306038|NCT00640341|11530034|FG001|Overall Study|Adverse Event|0
7306039|NCT00640341|11530035|FG002|Overall Study|Adverse Event|1
7306040|NCT00640341|11530033|FG000|Overall Study|Positive Slit Lamp Findings|0
7306041|NCT00640341|11530034|FG001|Overall Study|Positive Slit Lamp Findings|0
7306042|NCT00640341|11530035|FG002|Overall Study|Positive Slit Lamp Findings|1
7306043|NCT00640341|11530033|FG000|Overall Study|Study Related Symptoms/Complaints|2
7306044|NCT00640341|11530034|FG001|Overall Study|Study Related Symptoms/Complaints|1
7306045|NCT00640341|11530035|FG002|Overall Study|Study Related Symptoms/Complaints|2
7306046|NCT00640341|11530033|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
7306047|NCT00640341|11530034|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
7306048|NCT00640341|11530035|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
7306049|NCT00640341|11530033|FG000|Overall Study|Failure to Follow Subject Instructions|1
7306050|NCT00640341|11530034|FG001|Overall Study|Failure to Follow Subject Instructions|0
7306051|NCT00640341|11530035|FG002|Overall Study|Failure to Follow Subject Instructions|0
7306052|NCT00640341|11530033|FG000|Overall Study|Lost to Follow-up|2
7306053|NCT00640341|11530034|FG001|Overall Study|Lost to Follow-up|0
7306054|NCT00640341|11530035|FG002|Overall Study|Lost to Follow-up|0
7306055|NCT00640341|11530033|FG000|Overall Study|Withdrawal by Subject|4
7306056|NCT00640341|11530034|FG001|Overall Study|Withdrawal by Subject|0
7306057|NCT00640341|11530035|FG002|Overall Study|Withdrawal by Subject|1
7306058|NCT00640341|11530033|FG000|Overall Study|Unacceptable Lens Movement|1
7306059|NCT00640341|11530034|FG001|Overall Study|Unacceptable Lens Movement|0
7306060|NCT00640341|11530035|FG002|Overall Study|Unacceptable Lens Movement|0
7306061|NCT00640341|11530033|FG000|Overall Study|Poor fit/Uncomfortable|4
7306062|NCT00640341|11530034|FG001|Overall Study|Poor fit/Uncomfortable|0
7306063|NCT00640341|11530035|FG002|Overall Study|Poor fit/Uncomfortable|0
7306064|NCT00640341|11530033|FG000|Overall Study|Ineligable at Baseline|5
7306065|NCT00640341|11530034|FG001|Overall Study|Ineligable at Baseline|3
7306066|NCT00640341|11530035|FG002|Overall Study|Ineligable at Baseline|2
7306067|NCT00640341|11530033|FG000|Overall Study|Adverse event and positive slit lamp|1
7306068|NCT00640341|11530034|FG001|Overall Study|Adverse event and positive slit lamp|0
7306069|NCT00640341|11530035|FG002|Overall Study|Adverse event and positive slit lamp|0
7306070|NCT00640393|11530043|FG000|Part 1|Lost to Follow-up|2
7306071|NCT00640393|11530044|FG001|Part 1|Lost to Follow-up|0
7306072|NCT00640393|11530045|FG002|Part 1|Lost to Follow-up|0
7306073|NCT00640393|11530043|FG000|Part 1|Withdrawal by Subject|3
7306074|NCT00640393|11530044|FG001|Part 1|Withdrawal by Subject|0
7306075|NCT00640393|11530045|FG002|Part 1|Withdrawal by Subject|0
7306076|NCT00640393|11530043|FG000|Randomization|Withdrawn per protocol|17
7306077|NCT00640393|11530044|FG001|Randomization|Withdrawn per protocol|0
7306078|NCT00640393|11530045|FG002|Randomization|Withdrawn per protocol|0
7306079|NCT00640393|11530043|FG000|Randomization|Never randomized by site|2
7306080|NCT00640393|11530044|FG001|Randomization|Never randomized by site|0
7306081|NCT00640393|11530045|FG002|Randomization|Never randomized by site|0
7306082|NCT00640393|11530043|FG000|Part 2|Lost to Follow-up|0
7306083|NCT00640393|11530044|FG001|Part 2|Lost to Follow-up|2
7306084|NCT00640393|11530045|FG002|Part 2|Lost to Follow-up|2
7306085|NCT00640393|11530043|FG000|Part 2|Withdrawal by Subject|0
7306086|NCT00640393|11530044|FG001|Part 2|Withdrawal by Subject|6
7306087|NCT00640393|11530045|FG002|Part 2|Withdrawal by Subject|1
7306088|NCT00640393|11530043|FG000|Part 2|Non-adherence|0
7306089|NCT00640393|11530044|FG001|Part 2|Non-adherence|1
7306090|NCT00640393|11530045|FG002|Part 2|Non-adherence|0
7306091|NCT00640393|11530043|FG000|Part 2|Adverse Event|0
7306092|NCT00640393|11530044|FG001|Part 2|Adverse Event|1
7306093|NCT00640393|11530045|FG002|Part 2|Adverse Event|0
7306094|NCT00640510|11530055|FG000|Overall Study|Lack of Efficacy|0
7306095|NCT00640510|11530056|FG001|Overall Study|Lack of Efficacy|1
7306096|NCT00640510|11530055|FG000|Overall Study|Protocol Violation|1
7306097|NCT00640510|11530056|FG001|Overall Study|Protocol Violation|0
7306098|NCT00640510|11530055|FG000|Overall Study|Physician Decision|0
7306099|NCT00640510|11530056|FG001|Overall Study|Physician Decision|1
7306100|NCT00640562|11530064|FG000|Overall Study|Adverse Event|8
7306101|NCT00640562|11530065|FG001|Overall Study|Adverse Event|5
7306102|NCT00640562|11530064|FG000|Overall Study|Lack of Efficacy|1
7306103|NCT00640562|11530065|FG001|Overall Study|Lack of Efficacy|4
7306104|NCT00640562|11530064|FG000|Overall Study|Protocol Violation|2
7306105|NCT00640562|11530065|FG001|Overall Study|Protocol Violation|4
7306106|NCT00640562|11530064|FG000|Overall Study|Withdrawal by Subject|6
7306107|NCT00640562|11530065|FG001|Overall Study|Withdrawal by Subject|10
7306108|NCT00640562|11530064|FG000|Overall Study|Known risperidone intolerance|0
7306109|NCT00640562|11530065|FG001|Overall Study|Known risperidone intolerance|1
7306195|NCT00641147|11530192|FG001|Completed 16 Months.|Lost to Follow-up|0
7306110|NCT00640562|11530064|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
7306111|NCT00640562|11530065|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
7306112|NCT00640562|11530064|FG000|Overall Study|Low study drug dose|0
7306113|NCT00640562|11530065|FG001|Overall Study|Low study drug dose|1
7306114|NCT00640562|11530064|FG000|Overall Study|Glycosylated Hemoglobin >8|1
7306115|NCT00640562|11530065|FG001|Overall Study|Glycosylated Hemoglobin >8|0
7306116|NCT00640601|11530071|FG000|Overall Study|Adverse Event|43
7306117|NCT00640601|11530071|FG000|Overall Study|Withdrawal by Subject|20
7306118|NCT00640601|11530071|FG000|Overall Study|Protocol Violation|6
7306119|NCT00640601|11530071|FG000|Overall Study|Lack of Efficacy|16
7306120|NCT00640601|11530071|FG000|Overall Study|Lost to Follow-up|9
7306121|NCT00640601|11530071|FG000|Overall Study|Physician Decision|8
7306122|NCT00640601|11530071|FG000|Overall Study|treatment naive, combination therapy|10
7306123|NCT00640614|11530077|FG000|Overall Study|Lost to Follow-up|1
7306124|NCT00640614|11530078|FG001|Overall Study|Lost to Follow-up|0
7306125|NCT00640835|11530143|FG000|Overall Study|Adverse Event|5
7306126|NCT00640835|11530144|FG001|Overall Study|Adverse Event|3
7306127|NCT00640835|11530143|FG000|Overall Study|Withdrawal by Subject|12
7306128|NCT00640835|11530144|FG001|Overall Study|Withdrawal by Subject|14
7306129|NCT00640835|11530143|FG000|Overall Study|Physician Decision|10
7306130|NCT00640835|11530144|FG001|Overall Study|Physician Decision|14
7306131|NCT00640835|11530143|FG000|Overall Study|Sponsor's Decision|11
7306132|NCT00640835|11530144|FG001|Overall Study|Sponsor's Decision|7
7306133|NCT00640835|11530143|FG000|Overall Study|Protocol Violation|2
7306134|NCT00640835|11530144|FG001|Overall Study|Protocol Violation|2
7306135|NCT00640835|11530143|FG000|Overall Study|Lost to Follow-up|17
7306136|NCT00640835|11530144|FG001|Overall Study|Lost to Follow-up|13
7306137|NCT00640835|11530143|FG000|Overall Study|Other Reason|19
7306138|NCT00640835|11530144|FG001|Overall Study|Other Reason|4
7306139|NCT00640926|11530153|FG000|Overall Study|Adverse Event|2
7306140|NCT00640926|11530154|FG001|Overall Study|Adverse Event|3
7306141|NCT00640926|11530155|FG002|Overall Study|Adverse Event|2
7306142|NCT00640926|11530153|FG000|Overall Study|Lack of Efficacy|0
7306143|NCT00640926|11530154|FG001|Overall Study|Lack of Efficacy|2
7306144|NCT00640926|11530155|FG002|Overall Study|Lack of Efficacy|1
7306145|NCT00640926|11530153|FG000|Overall Study|Protocol Violation|2
7306146|NCT00640926|11530154|FG001|Overall Study|Protocol Violation|0
7306147|NCT00640926|11530155|FG002|Overall Study|Protocol Violation|2
7306148|NCT00640926|11530153|FG000|Overall Study|Lost to Follow-up|3
7306149|NCT00640926|11530154|FG001|Overall Study|Lost to Follow-up|1
7306150|NCT00640926|11530155|FG002|Overall Study|Lost to Follow-up|2
7306151|NCT00640926|11530153|FG000|Overall Study|Withdrawal by Subject|1
7306152|NCT00640926|11530154|FG001|Overall Study|Withdrawal by Subject|0
7306153|NCT00640926|11530155|FG002|Overall Study|Withdrawal by Subject|1
7306154|NCT00641043|11530169|FG000|Overall Study|Adverse Event|6
7306155|NCT00641043|11530170|FG001|Overall Study|Adverse Event|4
7306156|NCT00641043|11530169|FG000|Overall Study|Protocol Violation|2
7306157|NCT00641043|11530170|FG001|Overall Study|Protocol Violation|3
7306158|NCT00641043|11530169|FG000|Overall Study|Lost to Follow-up|3
7306159|NCT00641043|11530170|FG001|Overall Study|Lost to Follow-up|2
7306160|NCT00641043|11530169|FG000|Overall Study|Withdrawal by Subject|4
7306161|NCT00641043|11530170|FG001|Overall Study|Withdrawal by Subject|4
7306162|NCT00641043|11530169|FG000|Overall Study|Other incl. lack of efficacy|4
7306163|NCT00641043|11530170|FG001|Overall Study|Other incl. lack of efficacy|2
7306164|NCT00641056|11530178|FG000|Overall Study|Adverse Event|12
7306165|NCT00641056|11530179|FG001|Overall Study|Adverse Event|2
7306166|NCT00641056|11530178|FG000|Overall Study|Lost to Follow-up|2
7306167|NCT00641056|11530179|FG001|Overall Study|Lost to Follow-up|1
7306168|NCT00641056|11530178|FG000|Overall Study|Physician Decision|3
7306169|NCT00641056|11530179|FG001|Overall Study|Physician Decision|1
7306170|NCT00641056|11530178|FG000|Overall Study|Protocol Violation|2
7306171|NCT00641056|11530179|FG001|Overall Study|Protocol Violation|0
7306172|NCT00641056|11530178|FG000|Overall Study|Entry Criteria Not Met|3
7306173|NCT00641056|11530179|FG001|Overall Study|Entry Criteria Not Met|0
7306174|NCT00641056|11530178|FG000|Overall Study|Subject Decision|6
7306175|NCT00641056|11530179|FG001|Overall Study|Subject Decision|19
7306176|NCT00641056|11530178|FG000|Overall Study|Sponsor Decision|1
7306177|NCT00641056|11530179|FG001|Overall Study|Sponsor Decision|2
7306178|NCT00641147|11530191|FG000|Completed 4 Months.|Physician Decision|1
7306179|NCT00641147|11530192|FG001|Completed 4 Months.|Physician Decision|0
7306180|NCT00641147|11530191|FG000|Completed 4 Months.|Adverse Event|1
7306181|NCT00641147|11530192|FG001|Completed 4 Months.|Adverse Event|0
7306182|NCT00641147|11530191|FG000|Completed 8 Months.|Physician Decision|2
7306183|NCT00641147|11530192|FG001|Completed 8 Months.|Physician Decision|1
7306184|NCT00641147|11530191|FG000|Completed 8 Months.|non compliance|1
7306185|NCT00641147|11530192|FG001|Completed 8 Months.|non compliance|0
7306186|NCT00641147|11530191|FG000|Completed 8 Months.|Withdrawal by Subject|0
7306187|NCT00641147|11530192|FG001|Completed 8 Months.|Withdrawal by Subject|1
7306188|NCT00641147|11530191|FG000|Completed 12 Months.|Physician Decision|1
7306189|NCT00641147|11530192|FG001|Completed 12 Months.|Physician Decision|1
7306190|NCT00641147|11530191|FG000|Completed 12 Months.|Withdrawal by Subject|0
7306191|NCT00641147|11530192|FG001|Completed 12 Months.|Withdrawal by Subject|1
7306192|NCT00641147|11530191|FG000|Completed 16 Months.|Physician Decision|1
7306193|NCT00641147|11530192|FG001|Completed 16 Months.|Physician Decision|0
7306194|NCT00641147|11530191|FG000|Completed 16 Months.|Lost to Follow-up|1
7306196|NCT00641667|11530213|FG000|Overall Study|Withdrawal by Subject|1
7306197|NCT00641667|11530213|FG000|Overall Study|Adverse Event|1
7306198|NCT00641667|11530213|FG000|Overall Study|Physician Decision|1
7306199|NCT00641667|11530213|FG000|Overall Study|Worsening of underlying disease|3
7306200|NCT00641706|11530219|FG000|Overall Study|Adverse Event|2
7306201|NCT00641706|11530220|FG001|Overall Study|Adverse Event|1
7306202|NCT00641706|11530219|FG000|Overall Study|Withdrawal by Subject|6
7306203|NCT00641706|11530220|FG001|Overall Study|Withdrawal by Subject|1
7306204|NCT00641706|11530219|FG000|Overall Study|Clinical Decline|1
7306205|NCT00641706|11530220|FG001|Overall Study|Clinical Decline|0
7306206|NCT00641706|11530219|FG000|Overall Study|Lead Investigator Decision|0
7306207|NCT00641706|11530220|FG001|Overall Study|Lead Investigator Decision|1
7306208|NCT00641719|11530228|FG000|Overall Study|Lack of Efficacy|1
7306209|NCT00641719|11530229|FG001|Overall Study|Lack of Efficacy|2
7306210|NCT00641719|11530228|FG000|Overall Study|Adverse Event|24
7306211|NCT00641719|11530229|FG001|Overall Study|Adverse Event|29
7306212|NCT00641719|11530228|FG000|Overall Study|Withdrawal by Subject|4
7306213|NCT00641719|11530229|FG001|Overall Study|Withdrawal by Subject|4
7306214|NCT00641719|11530228|FG000|Overall Study|Reason Not Specified|1
7306215|NCT00641719|11530229|FG001|Overall Study|Reason Not Specified|2
7306216|NCT00642018|11530264|FG000|Overall Study|Adverse Event|11
7306217|NCT00642018|11530265|FG001|Overall Study|Adverse Event|36
7306218|NCT00642018|11530264|FG000|Overall Study|Withdrawal by Subject|4
7306219|NCT00642018|11530265|FG001|Overall Study|Withdrawal by Subject|10
7306220|NCT00642018|11530264|FG000|Overall Study|Progressive Disease|13
7306221|NCT00642018|11530265|FG001|Overall Study|Progressive Disease|18
7306222|NCT00642018|11530264|FG000|Overall Study|Physician Decision|0
7306223|NCT00642018|11530265|FG001|Overall Study|Physician Decision|10
7306224|NCT00642018|11530264|FG000|Overall Study|Protocol Violation|0
7306225|NCT00642018|11530265|FG001|Overall Study|Protocol Violation|1
7306226|NCT00642018|11530264|FG000|Overall Study|Death|0
7306227|NCT00642018|11530265|FG001|Overall Study|Death|3
7306228|NCT00642018|11530264|FG000|Overall Study|Entry Criteria Not Met|0
7306229|NCT00642018|11530265|FG001|Overall Study|Entry Criteria Not Met|1
7306230|NCT00642174|11530274|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
7306231|NCT00642174|11530275|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
7306232|NCT00642278|11530288|FG000|Overall Study|Adverse Event|2
7306233|NCT00642278|11530289|FG001|Overall Study|Adverse Event|1
7306234|NCT00642278|11530290|FG002|Overall Study|Adverse Event|3
7306235|NCT00642278|11530291|FG003|Overall Study|Adverse Event|1
7306236|NCT00642278|11530292|FG004|Overall Study|Adverse Event|2
7306237|NCT00642278|11530293|FG005|Overall Study|Adverse Event|2
7306238|NCT00642278|11530294|FG006|Overall Study|Adverse Event|0
7306239|NCT00642278|11530288|FG000|Overall Study|Lack of Efficacy|0
7306240|NCT00642278|11530289|FG001|Overall Study|Lack of Efficacy|1
7306241|NCT00642278|11530290|FG002|Overall Study|Lack of Efficacy|0
7306242|NCT00642278|11530291|FG003|Overall Study|Lack of Efficacy|0
7306243|NCT00642278|11530292|FG004|Overall Study|Lack of Efficacy|0
7306244|NCT00642278|11530293|FG005|Overall Study|Lack of Efficacy|0
7306245|NCT00642278|11530294|FG006|Overall Study|Lack of Efficacy|0
7306246|NCT00642278|11530288|FG000|Overall Study|Lost to Follow-up|5
7306247|NCT00642278|11530289|FG001|Overall Study|Lost to Follow-up|1
7306248|NCT00642278|11530290|FG002|Overall Study|Lost to Follow-up|0
7306249|NCT00642278|11530291|FG003|Overall Study|Lost to Follow-up|1
7306250|NCT00642278|11530292|FG004|Overall Study|Lost to Follow-up|0
7306251|NCT00642278|11530293|FG005|Overall Study|Lost to Follow-up|1
7306252|NCT00642278|11530294|FG006|Overall Study|Lost to Follow-up|1
7306253|NCT00642278|11530288|FG000|Overall Study|Physician Decision|0
7306254|NCT00642278|11530289|FG001|Overall Study|Physician Decision|0
7306255|NCT00642278|11530290|FG002|Overall Study|Physician Decision|0
7306256|NCT00642278|11530291|FG003|Overall Study|Physician Decision|1
7306257|NCT00642278|11530292|FG004|Overall Study|Physician Decision|0
7306258|NCT00642278|11530293|FG005|Overall Study|Physician Decision|0
7306259|NCT00642278|11530294|FG006|Overall Study|Physician Decision|0
7306260|NCT00642278|11530288|FG000|Overall Study|Protocol Violation|0
7306261|NCT00642278|11530289|FG001|Overall Study|Protocol Violation|0
7306262|NCT00642278|11530290|FG002|Overall Study|Protocol Violation|1
7306263|NCT00642278|11530291|FG003|Overall Study|Protocol Violation|1
7306264|NCT00642278|11530292|FG004|Overall Study|Protocol Violation|0
7306265|NCT00642278|11530293|FG005|Overall Study|Protocol Violation|1
7306266|NCT00642278|11530294|FG006|Overall Study|Protocol Violation|2
7306267|NCT00642278|11530288|FG000|Overall Study|Withdrawal by Subject|1
7306268|NCT00642278|11530289|FG001|Overall Study|Withdrawal by Subject|1
7306269|NCT00642278|11530290|FG002|Overall Study|Withdrawal by Subject|1
7306270|NCT00642278|11530291|FG003|Overall Study|Withdrawal by Subject|3
7306271|NCT00642278|11530292|FG004|Overall Study|Withdrawal by Subject|6
7306272|NCT00642278|11530293|FG005|Overall Study|Withdrawal by Subject|2
7306273|NCT00642278|11530294|FG006|Overall Study|Withdrawal by Subject|2
7306274|NCT00642278|11530288|FG000|Overall Study|Noncompliance with study drug regimen|0
7306275|NCT00642278|11530289|FG001|Overall Study|Noncompliance with study drug regimen|0
7306276|NCT00642278|11530290|FG002|Overall Study|Noncompliance with study drug regimen|0
7306277|NCT00642278|11530291|FG003|Overall Study|Noncompliance with study drug regimen|1
7306278|NCT00642278|11530292|FG004|Overall Study|Noncompliance with study drug regimen|0
7306279|NCT00642278|11530293|FG005|Overall Study|Noncompliance with study drug regimen|0
7306433|NCT00642668|11530392|FG000|Overall Study|Adverse Event|2
7306280|NCT00642278|11530294|FG006|Overall Study|Noncompliance with study drug regimen|0
7306281|NCT00642278|11530288|FG000|Overall Study|Other|2
7306282|NCT00642278|11530289|FG001|Overall Study|Other|1
7306283|NCT00642278|11530290|FG002|Overall Study|Other|0
7306284|NCT00642278|11530291|FG003|Overall Study|Other|1
7306285|NCT00642278|11530292|FG004|Overall Study|Other|0
7306286|NCT00642278|11530293|FG005|Overall Study|Other|1
7306287|NCT00642278|11530294|FG006|Overall Study|Other|0
7306288|NCT00642304|11530310|FG000|Overall Study|Adverse Event|1
7306289|NCT00642304|11530310|FG000|Overall Study|Death|1
7306290|NCT00642304|11530310|FG000|Overall Study|Blood transfusion|2
7306291|NCT00642304|11530310|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
7306292|NCT00642304|11530310|FG000|Overall Study|Transplantation|1
7306293|NCT00642356|11530316|FG000|Overall Study|Adverse Event|1
7306294|NCT00642356|11530317|FG001|Overall Study|Adverse Event|0
7306295|NCT00642356|11530316|FG000|Overall Study|Protocol Violation|0
7306296|NCT00642356|11530317|FG001|Overall Study|Protocol Violation|3
7306297|NCT00642356|11530316|FG000|Overall Study|Lack of Efficacy|1
7306298|NCT00642356|11530317|FG001|Overall Study|Lack of Efficacy|0
7306299|NCT00642369|11530325|FG000|Overall Study|Adverse Event|2
7306300|NCT00642369|11530326|FG001|Overall Study|Adverse Event|3
7306301|NCT00642369|11530325|FG000|Overall Study|Withdrawal by Subject|1
7306302|NCT00642369|11530326|FG001|Overall Study|Withdrawal by Subject|0
7306303|NCT00642369|11530325|FG000|Overall Study|misdiagnosis|0
7306304|NCT00642369|11530326|FG001|Overall Study|misdiagnosis|1
7306305|NCT00642369|11530325|FG000|Overall Study|Lack of Efficacy|2
7306306|NCT00642369|11530326|FG001|Overall Study|Lack of Efficacy|2
7306307|NCT00642460|11530336|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
7306308|NCT00642460|11530337|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
7306309|NCT00642460|11530338|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
7306310|NCT00642460|11530339|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
7306311|NCT00642460|11530340|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
7306312|NCT00642460|11530341|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
7306313|NCT00642460|11530336|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
7306314|NCT00642460|11530337|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
7306315|NCT00642460|11530338|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
7306316|NCT00642460|11530339|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
7306317|NCT00642460|11530340|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
7306318|NCT00642460|11530341|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
7306319|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
7306320|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
7306321|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
7306322|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
7306323|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
7306324|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
7306325|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Death|0
7306326|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Death|1
7306327|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Death|0
7306328|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Death|2
7306329|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Death|0
7306330|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Death|0
7306331|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
7306332|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
7306333|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7306334|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7306335|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7306336|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
7306337|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
7306338|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
7306339|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
7306340|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
7306341|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
7306342|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
7306343|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
7306344|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
7306345|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
7306346|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
7306347|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
7306348|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
7306349|NCT00642460|11530336|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
7306350|NCT00642460|11530337|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
7306351|NCT00642460|11530338|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
7306352|NCT00642460|11530339|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
7306353|NCT00642460|11530340|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
7306354|NCT00642460|11530341|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
7306355|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
7306356|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
7306357|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
7306358|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
7306359|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
7306360|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
7306361|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7306362|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7306363|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7306364|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
7306365|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
7306366|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
7306367|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7306368|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7306369|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7306370|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
7306371|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
7306372|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
7306373|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7306374|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7306375|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7306376|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
7306377|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7306378|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
7306379|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Other|0
7306380|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Other|0
7306381|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Other|0
7306382|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Other|0
7306383|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Other|2
7306384|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Other|2
7306385|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Death|0
7306386|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Death|0
7306387|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Death|0
7306388|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Death|0
7306389|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Death|0
7306390|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Death|3
7306391|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
7306392|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
7306393|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
7306394|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
7306395|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
7306396|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
7306397|NCT00642460|11530336|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
7306398|NCT00642460|11530337|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
7306399|NCT00642460|11530338|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
7306400|NCT00642460|11530339|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
7306401|NCT00642460|11530340|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
7306402|NCT00642460|11530341|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
7306403|NCT00642473|11530353|FG000|Overall Study|Withdrawal by Subject|0
7306404|NCT00642473|11530354|FG001|Overall Study|Withdrawal by Subject|5
7306405|NCT00642473|11530353|FG000|Overall Study|Progression or death|2
7306406|NCT00642473|11530354|FG001|Overall Study|Progression or death|4
7306407|NCT00642473|11530353|FG000|Overall Study|Other|2
7306408|NCT00642473|11530354|FG001|Overall Study|Other|2
7306409|NCT00642616|11530367|FG000|Overall Study|Adverse Event|2
7306410|NCT00642616|11530368|FG001|Overall Study|Adverse Event|0
7306411|NCT00642616|11530369|FG002|Overall Study|Adverse Event|1
7306412|NCT00642616|11530370|FG003|Overall Study|Adverse Event|0
7306413|NCT00642616|11530367|FG000|Overall Study|Study Terminated by Sponsor|7
7306414|NCT00642616|11530368|FG001|Overall Study|Study Terminated by Sponsor|6
7306415|NCT00642616|11530369|FG002|Overall Study|Study Terminated by Sponsor|4
7306416|NCT00642616|11530370|FG003|Overall Study|Study Terminated by Sponsor|5
7306417|NCT00642616|11530367|FG000|Overall Study|Withdrawal by Subject|0
7306418|NCT00642616|11530368|FG001|Overall Study|Withdrawal by Subject|1
7306419|NCT00642616|11530369|FG002|Overall Study|Withdrawal by Subject|1
7306420|NCT00642616|11530370|FG003|Overall Study|Withdrawal by Subject|1
7306421|NCT00642616|11530367|FG000|Overall Study|Protocol Violation|0
7306422|NCT00642616|11530368|FG001|Overall Study|Protocol Violation|0
7306423|NCT00642616|11530369|FG002|Overall Study|Protocol Violation|2
7306424|NCT00642616|11530370|FG003|Overall Study|Protocol Violation|0
7306425|NCT00642616|11530367|FG000|Overall Study|Physician Decision|0
7306426|NCT00642616|11530368|FG001|Overall Study|Physician Decision|0
7306427|NCT00642616|11530369|FG002|Overall Study|Physician Decision|1
7306428|NCT00642616|11530370|FG003|Overall Study|Physician Decision|1
7306429|NCT00642642|11530382|FG000|Treatment & Follow Up|Adverse Event|2
7306430|NCT00642642|11530382|FG000|Treatment & Follow Up|Withdrawal by Subject|5
7306431|NCT00642642|11530382|FG000|Treatment & Follow Up|Lost to Follow-up|10
7306432|NCT00642668|11530392|FG000|Overall Study|Lost to Follow-up|1
7306434|NCT00642668|11530392|FG000|Overall Study|Death|2
7306435|NCT00642668|11530392|FG000|Overall Study|Insufficient Therapeutic Response|1
7306436|NCT00642668|11530392|FG000|Overall Study|Failure to Return|1
7306437|NCT00642668|11530392|FG000|Overall Study|Dialysis Initiation|5
7306438|NCT00642668|11530392|FG000|Overall Study|Blood Transfusion|2
7552081|NCT02980692|11911738|FG003|Overall Study|Physician Decision|1
7552082|NCT02980692|11911739|FG004|Overall Study|Physician Decision|0
7552083|NCT02980692|11911735|FG000|Overall Study|NON COMPLIANCE|1
7552084|NCT02980692|11911736|FG001|Overall Study|NON COMPLIANCE|0
7552085|NCT02980692|11911737|FG002|Overall Study|NON COMPLIANCE|0
7552086|NCT02980692|11911738|FG003|Overall Study|NON COMPLIANCE|0
7552087|NCT02980692|11911739|FG004|Overall Study|NON COMPLIANCE|0
7552088|NCT02980692|11911735|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7552089|NCT02980692|11911736|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
7552090|NCT02980692|11911737|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7552091|NCT02980692|11911738|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7552092|NCT02980692|11911739|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
7552093|NCT02980692|11911735|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7552094|NCT02980692|11911736|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7552095|NCT02980692|11911737|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
7552096|NCT02980692|11911738|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7552097|NCT02980692|11911739|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
7552098|NCT02980692|11911735|FG000|Overall Study|Lack of Efficacy|0
7552099|NCT02980692|11911736|FG001|Overall Study|Lack of Efficacy|0
7552100|NCT02980692|11911737|FG002|Overall Study|Lack of Efficacy|0
7552101|NCT02980692|11911738|FG003|Overall Study|Lack of Efficacy|1
7552102|NCT02980692|11911739|FG004|Overall Study|Lack of Efficacy|0
7552103|NCT02980692|11911735|FG000|Overall Study|RELOCATION|0
7552104|NCT02980692|11911736|FG001|Overall Study|RELOCATION|0
7628241|NCT04426695|12041195|FG000|Overall Study|Death|2
7628242|NCT04426695|12041196|FG001|Overall Study|Death|0
7628243|NCT04426695|12041197|FG002|Overall Study|Death|1
7628244|NCT04426695|12041198|FG003|Overall Study|Death|27
7628245|NCT04426695|12041199|FG004|Overall Study|Death|25
7628246|NCT04426695|12041200|FG005|Overall Study|Death|21
7628247|NCT04426695|12041201|FG006|Overall Study|Death|42
7628248|NCT04426695|12041202|FG007|Overall Study|Death|23
7628249|NCT04426695|12041203|FG008|Overall Study|Death|37
7628250|NCT04426695|12041204|FG009|Overall Study|Death|14
7628251|NCT04426695|12041205|FG010|Overall Study|Death|8
7628252|NCT04426695|12041206|FG011|Overall Study|Death|7
7628253|NCT04426695|12041207|FG012|Overall Study|Death|13
7628254|NCT04426695|12041208|FG013|Overall Study|Death|25
7628255|NCT04426695|12041209|FG014|Overall Study|Death|19
7628256|NCT04426695|12041210|FG015|Overall Study|Death|7
7628257|NCT04426695|12041211|FG016|Overall Study|Death|8
7628258|NCT04426695|12041212|FG017|Overall Study|Death|4
7628259|NCT04426695|12041195|FG000|Overall Study|Lost to Follow-up|2
7628260|NCT04426695|12041196|FG001|Overall Study|Lost to Follow-up|4
7628261|NCT04426695|12041197|FG002|Overall Study|Lost to Follow-up|1
7628262|NCT04426695|12041198|FG003|Overall Study|Lost to Follow-up|19
7628263|NCT04426695|12041199|FG004|Overall Study|Lost to Follow-up|10
7628264|NCT04426695|12041200|FG005|Overall Study|Lost to Follow-up|14
7628265|NCT04426695|12041201|FG006|Overall Study|Lost to Follow-up|5
7628266|NCT04426695|12041202|FG007|Overall Study|Lost to Follow-up|14
7628267|NCT04426695|12041203|FG008|Overall Study|Lost to Follow-up|10
7628268|NCT04426695|12041204|FG009|Overall Study|Lost to Follow-up|11
7628269|NCT04426695|12041205|FG010|Overall Study|Lost to Follow-up|12
7628270|NCT04426695|12041206|FG011|Overall Study|Lost to Follow-up|6
7628271|NCT04426695|12041207|FG012|Overall Study|Lost to Follow-up|2
7628272|NCT04426695|12041208|FG013|Overall Study|Lost to Follow-up|2
7628273|NCT04426695|12041209|FG014|Overall Study|Lost to Follow-up|2
7628274|NCT04426695|12041210|FG015|Overall Study|Lost to Follow-up|0
7628275|NCT04426695|12041211|FG016|Overall Study|Lost to Follow-up|0
7628276|NCT04426695|12041212|FG017|Overall Study|Lost to Follow-up|0
7628277|NCT04426695|12041195|FG000|Overall Study|Participant Decision|1
7628278|NCT04426695|12041196|FG001|Overall Study|Participant Decision|2
7628279|NCT04426695|12041197|FG002|Overall Study|Participant Decision|2
7628280|NCT04426695|12041198|FG003|Overall Study|Participant Decision|12
7628281|NCT04426695|12041199|FG004|Overall Study|Participant Decision|18
7628282|NCT04426695|12041200|FG005|Overall Study|Participant Decision|22
7628283|NCT04426695|12041201|FG006|Overall Study|Participant Decision|13
7628284|NCT04426695|12041202|FG007|Overall Study|Participant Decision|13
7628285|NCT04426695|12041203|FG008|Overall Study|Participant Decision|10
7628286|NCT04426695|12041204|FG009|Overall Study|Participant Decision|15
7628287|NCT04426695|12041205|FG010|Overall Study|Participant Decision|16
7628288|NCT04426695|12041206|FG011|Overall Study|Participant Decision|17
7628289|NCT04426695|12041207|FG012|Overall Study|Participant Decision|2
7628290|NCT04426695|12041208|FG013|Overall Study|Participant Decision|1
7628291|NCT04426695|12041209|FG014|Overall Study|Participant Decision|2
7628292|NCT04426695|12041210|FG015|Overall Study|Participant Decision|0
7628293|NCT04426695|12041211|FG016|Overall Study|Participant Decision|0
7628294|NCT04426695|12041212|FG017|Overall Study|Participant Decision|0
7628295|NCT04426695|12041195|FG000|Overall Study|Adverse Event|0
7628296|NCT04426695|12041196|FG001|Overall Study|Adverse Event|0
7628297|NCT04426695|12041197|FG002|Overall Study|Adverse Event|0
7628298|NCT04426695|12041198|FG003|Overall Study|Adverse Event|0
7628299|NCT04426695|12041199|FG004|Overall Study|Adverse Event|0
7628300|NCT04426695|12041200|FG005|Overall Study|Adverse Event|0
7628301|NCT04426695|12041201|FG006|Overall Study|Adverse Event|0
7628302|NCT04426695|12041202|FG007|Overall Study|Adverse Event|1
7628303|NCT04426695|12041203|FG008|Overall Study|Adverse Event|0
7628304|NCT04426695|12041204|FG009|Overall Study|Adverse Event|0
7628305|NCT04426695|12041205|FG010|Overall Study|Adverse Event|1
7628306|NCT04426695|12041206|FG011|Overall Study|Adverse Event|1
7628307|NCT04426695|12041207|FG012|Overall Study|Adverse Event|0
7628308|NCT04426695|12041208|FG013|Overall Study|Adverse Event|0
7628309|NCT04426695|12041209|FG014|Overall Study|Adverse Event|0
7628310|NCT04426695|12041210|FG015|Overall Study|Adverse Event|0
7628311|NCT04426695|12041211|FG016|Overall Study|Adverse Event|0
7628312|NCT04426695|12041212|FG017|Overall Study|Adverse Event|0
7628313|NCT04426695|12041195|FG000|Overall Study|Sponsor Request|0
7628314|NCT04426695|12041196|FG001|Overall Study|Sponsor Request|0
7628315|NCT04426695|12041197|FG002|Overall Study|Sponsor Request|0
7628316|NCT04426695|12041198|FG003|Overall Study|Sponsor Request|0
7628317|NCT04426695|12041199|FG004|Overall Study|Sponsor Request|0
7628318|NCT04426695|12041200|FG005|Overall Study|Sponsor Request|0
7628319|NCT04426695|12041201|FG006|Overall Study|Sponsor Request|1
7628320|NCT04426695|12041202|FG007|Overall Study|Sponsor Request|0
7628321|NCT04426695|12041203|FG008|Overall Study|Sponsor Request|0
7628322|NCT04426695|12041204|FG009|Overall Study|Sponsor Request|0
7628323|NCT04426695|12041205|FG010|Overall Study|Sponsor Request|0
7628324|NCT04426695|12041206|FG011|Overall Study|Sponsor Request|0
7628325|NCT04426695|12041207|FG012|Overall Study|Sponsor Request|0
7628326|NCT04426695|12041208|FG013|Overall Study|Sponsor Request|0
7628327|NCT04426695|12041209|FG014|Overall Study|Sponsor Request|0
7628328|NCT04426695|12041210|FG015|Overall Study|Sponsor Request|0
7628329|NCT04426695|12041211|FG016|Overall Study|Sponsor Request|0
7628330|NCT04426695|12041212|FG017|Overall Study|Sponsor Request|0
7628331|NCT04426695|12041195|FG000|Overall Study|Physician Decision|0
7628332|NCT04426695|12041196|FG001|Overall Study|Physician Decision|0
7628333|NCT04426695|12041197|FG002|Overall Study|Physician Decision|0
7628334|NCT04426695|12041198|FG003|Overall Study|Physician Decision|0
7628335|NCT04426695|12041199|FG004|Overall Study|Physician Decision|0
7628336|NCT04426695|12041200|FG005|Overall Study|Physician Decision|0
7628337|NCT04426695|12041201|FG006|Overall Study|Physician Decision|0
7628338|NCT04426695|12041202|FG007|Overall Study|Physician Decision|0
7628339|NCT04426695|12041203|FG008|Overall Study|Physician Decision|0
7628340|NCT04426695|12041204|FG009|Overall Study|Physician Decision|1
7628341|NCT04426695|12041205|FG010|Overall Study|Physician Decision|0
7628342|NCT04426695|12041206|FG011|Overall Study|Physician Decision|0
7628343|NCT04426695|12041207|FG012|Overall Study|Physician Decision|1
7628344|NCT04426695|12041208|FG013|Overall Study|Physician Decision|0
7628345|NCT04426695|12041209|FG014|Overall Study|Physician Decision|0
7628346|NCT04426695|12041210|FG015|Overall Study|Physician Decision|0
7628347|NCT04426695|12041211|FG016|Overall Study|Physician Decision|0
7628348|NCT04426695|12041212|FG017|Overall Study|Physician Decision|0
7628349|NCT04426695|12041195|FG000|Overall Study|Randomized but Never Treated|3
7628350|NCT04426695|12041196|FG001|Overall Study|Randomized but Never Treated|1
7628351|NCT04426695|12041197|FG002|Overall Study|Randomized but Never Treated|0
7628352|NCT04426695|12041198|FG003|Overall Study|Randomized but Never Treated|4
7628353|NCT04426695|12041199|FG004|Overall Study|Randomized but Never Treated|5
7628354|NCT04426695|12041200|FG005|Overall Study|Randomized but Never Treated|5
7628355|NCT04426695|12041201|FG006|Overall Study|Randomized but Never Treated|4
7628356|NCT04426695|12041202|FG007|Overall Study|Randomized but Never Treated|6
7628357|NCT04426695|12041203|FG008|Overall Study|Randomized but Never Treated|6
7628358|NCT04426695|12041204|FG009|Overall Study|Randomized but Never Treated|3
7628359|NCT04426695|12041205|FG010|Overall Study|Randomized but Never Treated|3
7628360|NCT04426695|12041206|FG011|Overall Study|Randomized but Never Treated|6
7628361|NCT04426695|12041207|FG012|Overall Study|Randomized but Never Treated|1
7628362|NCT04426695|12041208|FG013|Overall Study|Randomized but Never Treated|2
7628363|NCT04426695|12041209|FG014|Overall Study|Randomized but Never Treated|0
7628364|NCT04426695|12041210|FG015|Overall Study|Randomized but Never Treated|0
7628365|NCT04426695|12041211|FG016|Overall Study|Randomized but Never Treated|0
7628366|NCT04426695|12041212|FG017|Overall Study|Randomized but Never Treated|0
7628367|NCT04209400|12041289|FG000|Overall Study|Withdrawal by Subject|0
7628368|NCT04209400|12041290|FG001|Overall Study|Withdrawal by Subject|1
7628399|NCT04067492|12041348|FG000|Overall Study|Lost to Follow-up|0
7628400|NCT04067492|12041349|FG001|Overall Study|Lost to Follow-up|0
7628401|NCT04067492|12041350|FG002|Overall Study|Lost to Follow-up|0
7628402|NCT04067492|12041351|FG003|Overall Study|Lost to Follow-up|0
7628403|NCT04067492|12041352|FG004|Overall Study|Lost to Follow-up|0
7628404|NCT04067492|12041353|FG005|Overall Study|Lost to Follow-up|1
7628405|NCT04067492|12041348|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628406|NCT04067492|12041349|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1
7628407|NCT04067492|12041350|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628408|NCT04067492|12041351|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628409|NCT04067492|12041352|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628410|NCT04067492|12041353|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0
7628411|NCT04067492|12041348|FG000|Overall Study|COVID-19 epidemiological situation|0
7628412|NCT04067492|12041349|FG001|Overall Study|COVID-19 epidemiological situation|0
7628413|NCT04067492|12041350|FG002|Overall Study|COVID-19 epidemiological situation|0
7628414|NCT04067492|12041351|FG003|Overall Study|COVID-19 epidemiological situation|1
7628415|NCT04067492|12041352|FG004|Overall Study|COVID-19 epidemiological situation|0
7628416|NCT04067492|12041353|FG005|Overall Study|COVID-19 epidemiological situation|0
7628425|NCT03788967|12041379|FG000|Overall Study|Lost to Follow-up|14
7628426|NCT03788967|12041380|FG001|Overall Study|Lost to Follow-up|10
7628427|NCT03788967|12041379|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3
7628428|NCT03788967|12041380|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6
7628429|NCT03788967|12041379|FG000|Overall Study|Participant Withdrawal of Consent|13
7628430|NCT03788967|12041380|FG001|Overall Study|Participant Withdrawal of Consent|5
7628431|NCT03788967|12041379|FG000|Overall Study|Adverse Event|1
7628432|NCT03788967|12041380|FG001|Overall Study|Adverse Event|1
7628433|NCT03788967|12041379|FG000|Overall Study|COVID-19|1
7628434|NCT03788967|12041380|FG001|Overall Study|COVID-19|2
7628435|NCT03721172|12041390|FG000|Placebo-controlled Phase|Adverse Event|7
7628436|NCT03721172|12041391|FG001|Placebo-controlled Phase|Adverse Event|7
7628437|NCT03721172|12041392|FG002|Placebo-controlled Phase|Adverse Event|0
7628438|NCT03721172|12041390|FG000|Placebo-controlled Phase|Lack of Efficacy|4
7628439|NCT03721172|12041391|FG001|Placebo-controlled Phase|Lack of Efficacy|0
7628440|NCT03721172|12041392|FG002|Placebo-controlled Phase|Lack of Efficacy|0
7628441|NCT03721172|12041390|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
7628442|NCT03721172|12041391|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
7628443|NCT03721172|12041392|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
7628444|NCT03721172|12041390|FG000|Placebo-controlled Phase|Lost to Follow-up|15
7628445|NCT03721172|12041391|FG001|Placebo-controlled Phase|Lost to Follow-up|13
7628446|NCT03721172|12041392|FG002|Placebo-controlled Phase|Lost to Follow-up|0
7628447|NCT03721172|12041390|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
7628448|NCT03721172|12041391|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
7628449|NCT03721172|12041392|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
7628450|NCT03721172|12041390|FG000|Placebo-controlled Phase|Other|3
7628451|NCT03721172|12041391|FG001|Placebo-controlled Phase|Other|0
7628452|NCT03721172|12041392|FG002|Placebo-controlled Phase|Other|0
7628453|NCT03721172|12041390|FG000|Apremilast Extension Phase|Adverse Event|0
7628454|NCT03721172|12041391|FG001|Apremilast Extension Phase|Adverse Event|0
7628455|NCT03721172|12041392|FG002|Apremilast Extension Phase|Adverse Event|10
7628456|NCT03721172|12041390|FG000|Apremilast Extension Phase|Lack of Efficacy|0
7628457|NCT03721172|12041391|FG001|Apremilast Extension Phase|Lack of Efficacy|0
7628458|NCT03721172|12041392|FG002|Apremilast Extension Phase|Lack of Efficacy|2
7628459|NCT03721172|12041390|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
7628460|NCT03721172|12041391|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
7628461|NCT03721172|12041392|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
7628462|NCT03721172|12041390|FG000|Apremilast Extension Phase|Lost to Follow-up|0
7628463|NCT03721172|12041391|FG001|Apremilast Extension Phase|Lost to Follow-up|0
7628464|NCT03721172|12041392|FG002|Apremilast Extension Phase|Lost to Follow-up|20
7628465|NCT03721172|12041390|FG000|Apremilast Extension Phase|Protocol Violation|0
7628466|NCT03721172|12041391|FG001|Apremilast Extension Phase|Protocol Violation|0
7628467|NCT03721172|12041392|FG002|Apremilast Extension Phase|Protocol Violation|1
7628468|NCT03721172|12041390|FG000|Apremilast Extension Phase|Physician Decision|0
7628469|NCT03721172|12041391|FG001|Apremilast Extension Phase|Physician Decision|0
7628470|NCT03721172|12041392|FG002|Apremilast Extension Phase|Physician Decision|1
7628471|NCT03721172|12041390|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
7628472|NCT03721172|12041391|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
7628473|NCT03721172|12041392|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
7628474|NCT03721172|12041390|FG000|Apremilast Extension Phase|Other|0
7628475|NCT03721172|12041391|FG001|Apremilast Extension Phase|Other|0
7628476|NCT03721172|12041392|FG002|Apremilast Extension Phase|Other|3
7628477|NCT03721172|12041390|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
7628478|NCT03721172|12041391|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
7628479|NCT03721172|12041392|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
7628480|NCT03692052|12041400|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1
7628481|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1
7628482|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1
7628483|NCT03692052|12041400|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17
7628502|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0
7628503|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5
7628504|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0
7628505|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0
7628506|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0
7628507|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0
7628508|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0
7628509|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0
7628510|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0
7628511|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0
7628512|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0
7628513|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2
7628514|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1
7628515|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628516|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628517|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628518|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628519|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628520|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628521|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628522|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628523|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
7628524|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1
7628525|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3
7628526|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628527|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628528|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628529|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628530|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628531|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628532|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628533|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628534|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
7628535|NCT03410992|12041431|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1
7628536|NCT03410992|12041432|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628537|NCT03410992|12041433|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628538|NCT03410992|12041434|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628539|NCT03410992|12041435|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628540|NCT03410992|12041436|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628541|NCT03410992|12041437|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628542|NCT03410992|12041438|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628543|NCT03410992|12041439|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628544|NCT03410992|12041440|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628545|NCT03410992|12041441|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
7628546|NCT03410992|12041431|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81
7628547|NCT03410992|12041432|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23
7628548|NCT03410992|12041433|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628549|NCT03410992|12041434|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628550|NCT03410992|12041435|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628551|NCT03410992|12041436|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628552|NCT03410992|12041437|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628553|NCT03410992|12041438|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628554|NCT03410992|12041439|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628555|NCT03410992|12041440|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628556|NCT03410992|12041441|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0
7628557|NCT03410992|12041431|FG000|Week 16 Assessment|Incorrect escapers|0
7628558|NCT03410992|12041432|FG001|Week 16 Assessment|Incorrect escapers|6
7628559|NCT03410992|12041433|FG002|Week 16 Assessment|Incorrect escapers|0
7628560|NCT03410992|12041434|FG003|Week 16 Assessment|Incorrect escapers|0
7628561|NCT03410992|12041435|FG004|Week 16 Assessment|Incorrect escapers|0
7628562|NCT03410992|12041436|FG005|Week 16 Assessment|Incorrect escapers|0
7628563|NCT03410992|12041437|FG006|Week 16 Assessment|Incorrect escapers|0
7628564|NCT03410992|12041438|FG007|Week 16 Assessment|Incorrect escapers|0
7628565|NCT03410992|12041439|FG008|Week 16 Assessment|Incorrect escapers|0
7628566|NCT03410992|12041440|FG009|Week 16 Assessment|Incorrect escapers|0
7628567|NCT03410992|12041441|FG010|Week 16 Assessment|Incorrect escapers|0
7628568|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628569|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628570|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628571|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3
7628572|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2
7628573|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628574|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628575|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628576|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628577|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628578|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
7628579|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628580|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628581|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628582|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
7628583|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1
7628584|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
7628585|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628586|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628587|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628588|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628589|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
7628590|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628591|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628592|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628593|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628594|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628595|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3
7628596|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628597|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628598|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628599|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628600|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
7628601|NCT03410992|12041431|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628602|NCT03410992|12041432|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628603|NCT03410992|12041433|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628604|NCT03410992|12041434|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67
7628605|NCT03410992|12041435|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4
7628606|NCT03410992|12041436|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7
7628607|NCT03410992|12041437|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628608|NCT03410992|12041438|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628609|NCT03410992|12041439|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628610|NCT03410992|12041440|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628611|NCT03410992|12041441|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
7628612|NCT03410992|12041431|FG000|Escape Treatment: 12 Weeks|Adverse Event|0
7628613|NCT03410992|12041432|FG001|Escape Treatment: 12 Weeks|Adverse Event|0
7628614|NCT03410992|12041433|FG002|Escape Treatment: 12 Weeks|Adverse Event|0
7628615|NCT03410992|12041434|FG003|Escape Treatment: 12 Weeks|Adverse Event|0
7628616|NCT03410992|12041435|FG004|Escape Treatment: 12 Weeks|Adverse Event|0
7628617|NCT03410992|12041436|FG005|Escape Treatment: 12 Weeks|Adverse Event|0
7628618|NCT03410992|12041437|FG006|Escape Treatment: 12 Weeks|Adverse Event|0
7628619|NCT03410992|12041438|FG007|Escape Treatment: 12 Weeks|Adverse Event|1
7628620|NCT03410992|12041439|FG008|Escape Treatment: 12 Weeks|Adverse Event|0
7628621|NCT03410992|12041440|FG009|Escape Treatment: 12 Weeks|Adverse Event|0
7628622|NCT03410992|12041441|FG010|Escape Treatment: 12 Weeks|Adverse Event|0
7628623|NCT03410992|12041431|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628624|NCT03410992|12041432|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628625|NCT03410992|12041433|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628626|NCT03410992|12041434|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628627|NCT03410992|12041435|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628628|NCT03410992|12041436|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628629|NCT03410992|12041437|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628630|NCT03410992|12041438|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628631|NCT03410992|12041439|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1
7628632|NCT03410992|12041440|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628633|NCT03410992|12041441|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
7628634|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Adverse Event|5
7628635|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Adverse Event|5
7628636|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Adverse Event|2
7628637|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Adverse Event|0
7628638|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Adverse Event|0
7628639|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Adverse Event|0
7628640|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Death|1
7628641|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Death|1
7628642|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Death|1
7628643|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Death|0
7628644|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Death|0
7628645|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Death|0
7628646|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2
7628647|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1
7628648|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628649|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628650|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628651|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0
7628652|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0
7628653|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0
7628654|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2
7628655|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0
7628656|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0
7628657|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0
7628658|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628659|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3
7628660|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628661|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628662|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628663|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0
7628664|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7628665|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2
7628666|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
7628667|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628668|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628669|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
7628670|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Non-compliance|0
7628671|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Non-compliance|1
7628672|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Non-compliance|0
7628673|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Non-compliance|0
7628674|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Non-compliance|0
7628675|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Non-compliance|0
7628676|NCT03370133|12041474|FG000|Initial Treatment Period (WK 16)|Site closed|0
7628677|NCT03370133|12041475|FG001|Initial Treatment Period (WK 16)|Site closed|2
7628678|NCT03370133|12041476|FG002|Initial Treatment Period (WK 16)|Site closed|0
7628679|NCT03370133|12041477|FG003|Initial Treatment Period (WK 16)|Site closed|0
7628680|NCT03370133|12041478|FG004|Initial Treatment Period (WK 16)|Site closed|0
7628681|NCT03370133|12041479|FG005|Initial Treatment Period (WK 16)|Site closed|0
7628682|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628683|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628684|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0
7628685|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3
7628686|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12
7628687|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4
7628688|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628689|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628690|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628691|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
7628692|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1
7628693|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4
7628694|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628695|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628696|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628697|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7628698|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1
7628699|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0
7628700|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628701|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628702|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628703|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
7628704|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4
7628705|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3
7628706|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628707|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628708|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
7628709|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1
7628710|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7628711|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
7628712|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628713|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628714|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628715|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628716|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1
7628717|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0
7628718|NCT03370133|12041474|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628719|NCT03370133|12041475|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628720|NCT03370133|12041476|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628721|NCT03370133|12041477|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628722|NCT03370133|12041478|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
7628723|NCT03370133|12041479|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1
7628724|NCT03291587|12041508|FG000|Overall Study|Lost to Follow-up|62
7628725|NCT03291587|12041509|FG001|Overall Study|Lost to Follow-up|43
7628726|NCT03291587|12041508|FG000|Overall Study|Refused to Answer|5
7628727|NCT03291587|12041509|FG001|Overall Study|Refused to Answer|2
7628728|NCT03291587|12041508|FG000|Overall Study|Death|2
7628729|NCT03291587|12041509|FG001|Overall Study|Death|4
7628730|NCT03291587|12041508|FG000|Overall Study|Not interested in participating|8
7628731|NCT03291587|12041509|FG001|Overall Study|Not interested in participating|6
7628732|NCT03291587|12041508|FG000|Overall Study|Too busy to participate|4
7628733|NCT03291587|12041509|FG001|Overall Study|Too busy to participate|2
7628754|NCT02948829|12041543|FG000|Overall Study|Lost to Follow-up|2
7628755|NCT02948829|12041543|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5
7628756|NCT02948829|12041543|FG000|Overall Study|Pregnancy|1
7628757|NCT02948829|12041543|FG000|Overall Study|Other: Reason not Specified|8
7628758|NCT02819518|12041578|FG000|Overall Study|Death|9
7628759|NCT02819518|12041579|FG001|Overall Study|Death|11
7628760|NCT02819518|12041580|FG002|Overall Study|Death|9
7628761|NCT02819518|12041581|FG003|Overall Study|Death|447
7628762|NCT02819518|12041582|FG004|Overall Study|Death|233
7628763|NCT02819518|12041578|FG000|Overall Study|Withdrawal by Subject|0
7628764|NCT02819518|12041579|FG001|Overall Study|Withdrawal by Subject|0
7628765|NCT02819518|12041580|FG002|Overall Study|Withdrawal by Subject|0
7628766|NCT02819518|12041581|FG003|Overall Study|Withdrawal by Subject|21
7628767|NCT02819518|12041582|FG004|Overall Study|Withdrawal by Subject|6
7628768|NCT02819518|12041578|FG000|Overall Study|Ongoing in Study|2
7628769|NCT02819518|12041579|FG001|Overall Study|Ongoing in Study|3
7628770|NCT02819518|12041580|FG002|Overall Study|Ongoing in Study|1
7628771|NCT02819518|12041581|FG003|Overall Study|Ongoing in Study|98
7628772|NCT02819518|12041582|FG004|Overall Study|Ongoing in Study|42
7628773|NCT02767856|12041598|FG000|Overall Study|Lost to Follow-up|9
7628774|NCT02767856|12041599|FG001|Overall Study|Lost to Follow-up|1
7628775|NCT02767856|12041598|FG000|Overall Study|Withdrawal by Subject|2
7628776|NCT02767856|12041599|FG001|Overall Study|Withdrawal by Subject|1
7628801|NCT02719691|12041621|FG000|Overall Study|Physician Decision|0
7628802|NCT02719691|12041622|FG001|Overall Study|Physician Decision|0
7628803|NCT02719691|12041623|FG002|Overall Study|Physician Decision|1
7628804|NCT02719691|12041624|FG003|Overall Study|Physician Decision|0
7628805|NCT02719691|12041625|FG004|Overall Study|Physician Decision|0
7628806|NCT02719691|12041626|FG005|Overall Study|Physician Decision|0
7628807|NCT02719691|12041627|FG006|Overall Study|Physician Decision|0
7628808|NCT02719691|12041621|FG000|Overall Study|Withdrawal by Subject|0
7628809|NCT02719691|12041622|FG001|Overall Study|Withdrawal by Subject|0
7628810|NCT02719691|12041623|FG002|Overall Study|Withdrawal by Subject|0
7628811|NCT02719691|12041624|FG003|Overall Study|Withdrawal by Subject|0
7628812|NCT02719691|12041625|FG004|Overall Study|Withdrawal by Subject|0
7628813|NCT02719691|12041626|FG005|Overall Study|Withdrawal by Subject|1
7628814|NCT02719691|12041627|FG006|Overall Study|Withdrawal by Subject|0
7628815|NCT02613507|12041646|FG000|Overall Study|Disease Progression|237
7628816|NCT02613507|12041647|FG001|Overall Study|Disease Progression|109
7628817|NCT02613507|12041646|FG000|Overall Study|Study Drug Toxicity|15
7628818|NCT02613507|12041647|FG001|Overall Study|Study Drug Toxicity|14
7628819|NCT02613507|12041646|FG000|Overall Study|Death|3
7628820|NCT02613507|12041647|FG001|Overall Study|Death|0
7628821|NCT02613507|12041646|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
7628822|NCT02613507|12041647|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
7628823|NCT02613507|12041646|FG000|Overall Study|Request to Discontinue Study Treatment|8
7628824|NCT02613507|12041647|FG001|Overall Study|Request to Discontinue Study Treatment|17
7628825|NCT02613507|12041646|FG000|Overall Study|Participant Withdrew Consent|0
7628826|NCT02613507|12041647|FG001|Overall Study|Participant Withdrew Consent|2
7628827|NCT02613507|12041646|FG000|Overall Study|Lost to Follow-up|1
7628828|NCT02613507|12041647|FG001|Overall Study|Lost to Follow-up|0
7628829|NCT02613507|12041646|FG000|Overall Study|Maximum Clinical Benefit|4
7628830|NCT02613507|12041647|FG001|Overall Study|Maximum Clinical Benefit|10
7628831|NCT02613507|12041646|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
7628832|NCT02613507|12041647|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
7628833|NCT02613507|12041646|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
7628834|NCT02613507|12041647|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
7628835|NCT02613507|12041646|FG000|Overall Study|Randomized but not Treated|1
7628836|NCT02613507|12041647|FG001|Overall Study|Randomized but not Treated|10
7628843|NCT02339506|12041684|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
7628844|NCT02339506|12041685|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
7628845|NCT02339506|12041684|FG000|Washout (Period 2)|Withdrawal by Subject|2
7628846|NCT02339506|12041685|FG001|Washout (Period 2)|Withdrawal by Subject|0
7628847|NCT02206048|12041698|FG000|Overall Study|Change in OR schedule and availability of study staff|1
7628848|NCT02068885|12041720|FG000|Overall Study|Withdrew|3
7628849|NCT02068885|12041721|FG001|Overall Study|Withdrew|5
7628850|NCT02068885|12041722|FG002|Overall Study|Withdrew|8
7628851|NCT02005471|12041733|FG000|Overall Study|Ongoing in Study|144
7628852|NCT02005471|12041734|FG001|Overall Study|Ongoing in Study|171
7628853|NCT02005471|12041733|FG000|Overall Study|Adverse Event|1
7628854|NCT02005471|12041734|FG001|Overall Study|Adverse Event|0
7628855|NCT02005471|12041733|FG000|Overall Study|Death|26
7628856|NCT02005471|12041734|FG001|Overall Study|Death|15
7628857|NCT02005471|12041733|FG000|Overall Study|Lost to Follow-up|1
7628858|NCT02005471|12041734|FG001|Overall Study|Lost to Follow-up|0
7628859|NCT02005471|12041733|FG000|Overall Study|Physician Decision|2
7628860|NCT02005471|12041734|FG001|Overall Study|Physician Decision|1
7628861|NCT02005471|12041733|FG000|Overall Study|Progressive Disease|3
7628862|NCT02005471|12041734|FG001|Overall Study|Progressive Disease|0
7628863|NCT02005471|12041733|FG000|Overall Study|Withdrawal by Subject|18
7628864|NCT02005471|12041734|FG001|Overall Study|Withdrawal by Subject|7
7628865|NCT01565941|12041745|FG000|Overall Study|Withdrawn by parent/guardian|3
7628866|NCT01565941|12041746|FG001|Overall Study|Withdrawn by parent/guardian|2
7628867|NCT01565941|12041745|FG000|Overall Study|Randomized; did not receive intevention|8
7628868|NCT01565941|12041746|FG001|Overall Study|Randomized; did not receive intevention|2
7628869|NCT00676715|12041784|FG000|Overall Study|Withdrawal by Subject|7
7628870|NCT00676715|12041785|FG001|Overall Study|Withdrawal by Subject|9
7628871|NCT00676715|12041786|FG002|Overall Study|Withdrawal by Subject|10
7628872|NCT00676715|12041787|FG003|Overall Study|Withdrawal by Subject|10
7628873|NCT00676715|12041784|FG000|Overall Study|Other|2
7628874|NCT00676715|12041785|FG001|Overall Study|Other|6
7628875|NCT00676715|12041786|FG002|Overall Study|Other|4
7628876|NCT00676715|12041787|FG003|Overall Study|Other|3
7628877|NCT00676715|12041784|FG000|Overall Study|Lost to Follow-up|1
7628878|NCT00676715|12041785|FG001|Overall Study|Lost to Follow-up|1
7628879|NCT00676715|12041786|FG002|Overall Study|Lost to Follow-up|7
7628880|NCT00676715|12041787|FG003|Overall Study|Lost to Follow-up|3
7628881|NCT00676715|12041784|FG000|Overall Study|Death|1
7628882|NCT00676715|12041785|FG001|Overall Study|Death|1
7628883|NCT00676715|12041786|FG002|Overall Study|Death|1
7628884|NCT00676715|12041787|FG003|Overall Study|Death|0
7628885|NCT00676715|12041784|FG000|Overall Study|Adverse Event|0
7628886|NCT00676715|12041785|FG001|Overall Study|Adverse Event|1
7628887|NCT00676715|12041786|FG002|Overall Study|Adverse Event|2
7628888|NCT00676715|12041787|FG003|Overall Study|Adverse Event|0
7628889|NCT00676715|12041784|FG000|Overall Study|Participants Ongoing|29
7628890|NCT00676715|12041785|FG001|Overall Study|Participants Ongoing|29
7628891|NCT00676715|12041786|FG002|Overall Study|Participants Ongoing|17
7628892|NCT00676715|12041787|FG003|Overall Study|Participants Ongoing|24
7628893|NCT00443599|12041799|FG000|Overall Study|Physician Decision|2
7628894|NCT00443599|12041800|FG001|Overall Study|Physician Decision|1
7628895|NCT00443599|12041799|FG000|Overall Study|Death|1
7628896|NCT00443599|12041800|FG001|Overall Study|Death|1
7628897|NCT00443599|12041799|FG000|Overall Study|Cardiopulmonary bypass canceled|3
7628898|NCT00443599|12041800|FG001|Overall Study|Cardiopulmonary bypass canceled|1
7628899|NCT04531098|12041827|FG000|Stage I|Adverse Event|0
7628900|NCT04531098|12041828|FG001|Stage I|Adverse Event|0
7628901|NCT04531098|12041829|FG002|Stage I|Adverse Event|3
7628902|NCT04531098|12041827|FG000|Stage I|Protocol Violation|0
7628903|NCT04531098|12041828|FG001|Stage I|Protocol Violation|0
7628904|NCT04531098|12041829|FG002|Stage I|Protocol Violation|5
7628905|NCT04531098|12041827|FG000|Stage I|Withdrawal by Subject|0
7628906|NCT04531098|12041828|FG001|Stage I|Withdrawal by Subject|5
7628907|NCT04531098|12041829|FG002|Stage I|Withdrawal by Subject|10
7628908|NCT04531098|12041827|FG000|Stage II|Adverse Event|1
7628909|NCT04531098|12041828|FG001|Stage II|Adverse Event|2
7628910|NCT04531098|12041829|FG002|Stage II|Adverse Event|0
7628911|NCT04531098|12041827|FG000|Stage II|Protocol Violation|1
7628912|NCT04531098|12041828|FG001|Stage II|Protocol Violation|2
7628913|NCT04531098|12041829|FG002|Stage II|Protocol Violation|0
7628914|NCT04531098|12041827|FG000|Stage II|Withdrawal by Subject|3
7628915|NCT04531098|12041828|FG001|Stage II|Withdrawal by Subject|1
7628916|NCT04531098|12041829|FG002|Stage II|Withdrawal by Subject|0
7628917|NCT04531098|12041827|FG000|Stage II|Moved from study area|8
7628918|NCT04531098|12041828|FG001|Stage II|Moved from study area|5
7628919|NCT04531098|12041829|FG002|Stage II|Moved from study area|0
7628920|NCT04484857|12041837|FG000|Overall Study|Adverse Event|2
7628921|NCT04484857|12041837|FG000|Overall Study|Death|10
7628922|NCT04484857|12041837|FG000|Overall Study|Withdrawal by Subject|3
7628923|NCT04484857|12041837|FG000|Overall Study|Transferred/Relocation|5
7628924|NCT04484857|12041837|FG000|Overall Study|Kidney Transplant|7
7628925|NCT04484857|12041837|FG000|Overall Study|Other than specified|4
7628926|NCT04484857|12041837|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216
7628927|NCT04382053|12041852|FG000|Overall Study|Death|6
7628928|NCT04382053|12041853|FG001|Overall Study|Death|8
7628929|NCT04382053|12041852|FG000|Overall Study|Lost to Follow-up|0
7628930|NCT04382053|12041853|FG001|Overall Study|Lost to Follow-up|2
7628931|NCT04382053|12041852|FG000|Overall Study|Protocol Deviation|1
7628932|NCT04382053|12041853|FG001|Overall Study|Protocol Deviation|2
7628933|NCT04382053|12041852|FG000|Overall Study|Withdrawal by Subject|2
7628934|NCT04382053|12041853|FG001|Overall Study|Withdrawal by Subject|1
7628935|NCT04353817|12041862|FG000|Overall Study|Adverse Event|0
7628936|NCT04353817|12041863|FG001|Overall Study|Adverse Event|1
7628937|NCT04087720|12041883|FG000|Overall Study|Withdrawal by Subject|2
7628938|NCT04087720|12041883|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3
7628939|NCT03951766|12041887|FG000|Treatment Phase|Lost to Follow-up|1
7628940|NCT03951766|12041887|FG000|Follow-up Phase|Lost to Follow-up|10
7628950|NCT03737110|12041919|FG000|Run-in (RI) Period|Lack of Efficacy|3
7628951|NCT03737110|12041920|FG001|Run-in (RI) Period|Lack of Efficacy|0
7628952|NCT03737110|12041921|FG002|Run-in (RI) Period|Lack of Efficacy|0
7628953|NCT03737110|12041919|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
7628954|NCT03737110|12041920|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7628955|NCT03737110|12041921|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
7628956|NCT03737110|12041919|FG000|Run-in (RI) Period|Adverse Event|4
7628957|NCT03737110|12041920|FG001|Run-in (RI) Period|Adverse Event|0
7628958|NCT03737110|12041921|FG002|Run-in (RI) Period|Adverse Event|0
7628959|NCT03737110|12041919|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7628960|NCT03737110|12041920|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
7628961|NCT03737110|12041921|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
7628962|NCT03737110|12041919|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7628963|NCT03737110|12041920|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
7628964|NCT03737110|12041921|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
7628965|NCT03649477|12041961|FG000|Overall Study|Adverse Event|2
7628966|NCT03649477|12041962|FG001|Overall Study|Adverse Event|0
7628967|NCT03649477|12041963|FG002|Overall Study|Adverse Event|0
7628968|NCT03631706|12041973|FG000|Overall Study|Randomized, not treated|1
7628969|NCT03631706|12041974|FG001|Overall Study|Randomized, not treated|0
7628970|NCT03631706|12041973|FG000|Overall Study|Treatment ongoing|26
7628971|NCT03631706|12041974|FG001|Overall Study|Treatment ongoing|57
7628972|NCT03631706|12041973|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65
7628973|NCT03631706|12041974|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41
7628974|NCT03615482|12041982|FG000|Overall Study|Death|1
7628975|NCT03615482|12041983|FG001|Overall Study|Death|0
7628976|NCT03615482|12041982|FG000|Overall Study|Lost to Follow-up|7
7628977|NCT03615482|12041983|FG001|Overall Study|Lost to Follow-up|7
7628978|NCT03615482|12041982|FG000|Overall Study|Physician Decision|2
7628979|NCT03615482|12041983|FG001|Overall Study|Physician Decision|3
7628980|NCT03615482|12041982|FG000|Overall Study|Withdrawal by Subject|7
7628981|NCT03615482|12041983|FG001|Overall Study|Withdrawal by Subject|7
7628982|NCT03572933|12041991|FG000|Overall Study|Adverse Event|4
7628983|NCT03572933|12041992|FG001|Overall Study|Adverse Event|1
7628984|NCT03572933|12041991|FG000|Overall Study|Withdrawal by Subject|0
7628985|NCT03572933|12041992|FG001|Overall Study|Withdrawal by Subject|1
7628986|NCT03526861|12042010|FG000|Initial Treatment Period|Not dosed|1
7628987|NCT03526861|12042011|FG001|Initial Treatment Period|Not dosed|1
7628988|NCT03526861|12042012|FG002|Initial Treatment Period|Not dosed|1
7628989|NCT03526861|12042013|FG003|Initial Treatment Period|Not dosed|0
7628990|NCT03526861|12042014|FG004|Initial Treatment Period|Not dosed|0
7628991|NCT03526861|12042015|FG005|Initial Treatment Period|Not dosed|0
7628992|NCT03526861|12042016|FG006|Initial Treatment Period|Not dosed|0
7628993|NCT03526861|12042017|FG007|Initial Treatment Period|Not dosed|0
7628994|NCT03526861|12042018|FG008|Initial Treatment Period|Not dosed|0
7628995|NCT03526861|12042010|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
7628996|NCT03526861|12042011|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7628997|NCT03526861|12042012|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
7628998|NCT03526861|12042013|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7628999|NCT03526861|12042014|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629000|NCT03526861|12042015|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629001|NCT03526861|12042016|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629002|NCT03526861|12042017|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629003|NCT03526861|12042018|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629004|NCT03526861|12042010|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
7629005|NCT03526861|12042011|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
7629006|NCT03526861|12042012|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
7629007|NCT03526861|12042013|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629008|NCT03526861|12042014|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629009|NCT03526861|12042015|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629010|NCT03526861|12042016|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629011|NCT03526861|12042017|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629012|NCT03526861|12042018|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
7629013|NCT03526861|12042010|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629014|NCT03526861|12042011|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629015|NCT03526861|12042012|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629016|NCT03526861|12042013|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629017|NCT03526861|12042014|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629018|NCT03526861|12042015|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629019|NCT03526861|12042016|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
7629020|NCT03526861|12042017|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629021|NCT03526861|12042018|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629022|NCT03526861|12042010|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629023|NCT03526861|12042011|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629024|NCT03526861|12042012|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629025|NCT03526861|12042013|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
7629026|NCT03526861|12042014|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7629027|NCT03526861|12042015|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
7629028|NCT03526861|12042016|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
7629029|NCT03526861|12042017|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
7629030|NCT03526861|12042018|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
7629031|NCT03526861|12042010|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629032|NCT03526861|12042011|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629033|NCT03526861|12042012|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629034|NCT03526861|12042013|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
7629092|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1
7629035|NCT03526861|12042014|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629036|NCT03526861|12042015|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629037|NCT03526861|12042016|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629038|NCT03526861|12042017|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629039|NCT03526861|12042018|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629040|NCT03526861|12042010|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629041|NCT03526861|12042011|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629042|NCT03526861|12042012|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629043|NCT03526861|12042013|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629044|NCT03526861|12042014|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629045|NCT03526861|12042015|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629046|NCT03526861|12042016|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629047|NCT03526861|12042017|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
7629048|NCT03526861|12042018|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
7629049|NCT03526861|12042010|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629050|NCT03526861|12042011|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629051|NCT03526861|12042012|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629052|NCT03526861|12042013|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629053|NCT03526861|12042014|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629054|NCT03526861|12042015|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629055|NCT03526861|12042016|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629056|NCT03526861|12042017|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
7629057|NCT03526861|12042018|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
7629058|NCT03526861|12042010|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629059|NCT03526861|12042011|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629060|NCT03526861|12042012|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629061|NCT03526861|12042013|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629062|NCT03526861|12042014|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629063|NCT03526861|12042015|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629064|NCT03526861|12042016|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629065|NCT03526861|12042017|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
7629066|NCT03526861|12042018|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
7629067|NCT03429049|12042050|FG000|Overall Study|Adverse Event|2
7629068|NCT03429049|12042051|FG001|Overall Study|Adverse Event|3
7629069|NCT03429049|12042050|FG000|Overall Study|Death|0
7629070|NCT03429049|12042051|FG001|Overall Study|Death|1
7629071|NCT03429049|12042050|FG000|Overall Study|Lack of Efficacy|4
7629072|NCT03429049|12042051|FG001|Overall Study|Lack of Efficacy|2
7629073|NCT03429049|12042050|FG000|Overall Study|Lost to Follow-up|9
7629074|NCT03429049|12042051|FG001|Overall Study|Lost to Follow-up|8
7629075|NCT03429049|12042050|FG000|Overall Study|Physician Decision|1
7629076|NCT03429049|12042051|FG001|Overall Study|Physician Decision|0
7629077|NCT03429049|12042050|FG000|Overall Study|Protocol Violation|3
7629078|NCT03429049|12042051|FG001|Overall Study|Protocol Violation|0
7629079|NCT03429049|12042050|FG000|Overall Study|Sponsor Decision|2
7629080|NCT03429049|12042051|FG001|Overall Study|Sponsor Decision|0
7629081|NCT03429049|12042050|FG000|Overall Study|Withdrawal by Subject|4
7629082|NCT03429049|12042051|FG001|Overall Study|Withdrawal by Subject|20
7629083|NCT03429049|12042050|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3
7629084|NCT03429049|12042051|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8
7629085|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2
7629086|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2
7629087|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0
7629088|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1
7629089|NCT03395639|12042060|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0
7629090|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0
7629091|NCT03395639|12042059|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0
7629093|NCT03395639|12042061|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0
7629094|NCT03395639|12042059|FG000|Extension Period (4-13 Months)|Adverse Event|0
7629095|NCT03395639|12042060|FG001|Extension Period (4-13 Months)|Adverse Event|0
7629096|NCT03395639|12042061|FG002|Extension Period (4-13 Months)|Adverse Event|2
7629097|NCT03395639|12042059|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0
7629098|NCT03395639|12042060|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0
7629099|NCT03395639|12042061|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1
7629100|NCT03381274|12042073|FG000|Overall Study|Death|2
7629101|NCT03381274|12042074|FG001|Overall Study|Death|9
7629102|NCT03381274|12042075|FG002|Overall Study|Death|3
7629103|NCT03381274|12042076|FG003|Overall Study|Death|2
7629104|NCT03381274|12042077|FG004|Overall Study|Death|3
7629105|NCT03381274|12042073|FG000|Overall Study|Lost to Follow-up|0
7629106|NCT03381274|12042074|FG001|Overall Study|Lost to Follow-up|0
7629107|NCT03381274|12042075|FG002|Overall Study|Lost to Follow-up|0
7629108|NCT03381274|12042076|FG003|Overall Study|Lost to Follow-up|1
7629109|NCT03381274|12042077|FG004|Overall Study|Lost to Follow-up|0
7629110|NCT03381274|12042073|FG000|Overall Study|Withdrawal by Subject|2
7629111|NCT03381274|12042074|FG001|Overall Study|Withdrawal by Subject|1
7629112|NCT03381274|12042075|FG002|Overall Study|Withdrawal by Subject|3
7629113|NCT03381274|12042076|FG003|Overall Study|Withdrawal by Subject|1
7629114|NCT03381274|12042077|FG004|Overall Study|Withdrawal by Subject|0
7629115|NCT03381274|12042073|FG000|Overall Study|Other|1
7629116|NCT03381274|12042074|FG001|Overall Study|Other|11
7629117|NCT03381274|12042075|FG002|Overall Study|Other|0
7629118|NCT03381274|12042076|FG003|Overall Study|Other|2
7629119|NCT03381274|12042077|FG004|Overall Study|Other|2
7629123|NCT03338894|12042097|FG000|Overall Study|not able able to attend 9 or more classes|10
7629128|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
7629129|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
7629130|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
7629131|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
7629132|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Adverse Event|10
7629133|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Adverse Event|5
7629134|NCT03199963|12042118|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
7629135|NCT03199963|12042119|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
7629136|NCT03199963|12042118|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
7629137|NCT03199963|12042119|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
7629138|NCT03199963|12042118|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
7629139|NCT03199963|12042119|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
7629140|NCT03132636|12042133|FG000|Overall Study|Adverse Event|1
7629141|NCT03132636|12042134|FG001|Overall Study|Adverse Event|2
7629142|NCT03132636|12042133|FG000|Overall Study|Death|4
7629143|NCT03132636|12042134|FG001|Overall Study|Death|7
7629144|NCT03132636|12042133|FG000|Overall Study|Lost to Follow-up|2
7629145|NCT03132636|12042134|FG001|Overall Study|Lost to Follow-up|2
7629146|NCT03132636|12042133|FG000|Overall Study|Protocol Violation|1
7629147|NCT03132636|12042134|FG001|Overall Study|Protocol Violation|1
7629148|NCT03132636|12042133|FG000|Overall Study|Participant Decision|1
7629149|NCT03132636|12042134|FG001|Overall Study|Participant Decision|9
7629150|NCT03132636|12042133|FG000|Overall Study|Sponsor Decision|0
7629151|NCT03132636|12042134|FG001|Overall Study|Sponsor Decision|1
7629152|NCT03132636|12042133|FG000|Overall Study|Progressive disease|32
7629153|NCT03132636|12042134|FG001|Overall Study|Progressive disease|36
7629154|NCT03132636|12042133|FG000|Overall Study|Withdrawal of consent|2
7629155|NCT03132636|12042134|FG001|Overall Study|Withdrawal of consent|5
7629156|NCT03132636|12042133|FG000|Overall Study|Study ongoing|9
7629157|NCT03132636|12042134|FG001|Overall Study|Study ongoing|10
7629158|NCT03132636|12042133|FG000|Overall Study|Other|1
7629159|NCT03132636|12042134|FG001|Overall Study|Other|2
7629160|NCT03116399|12042142|FG000|Overall Study|Death|8
7629161|NCT03116399|12042143|FG001|Overall Study|Death|3
7629162|NCT03116399|12042142|FG000|Overall Study|Lost to Follow-up|7
7629163|NCT03116399|12042143|FG001|Overall Study|Lost to Follow-up|11
7629164|NCT03116399|12042142|FG000|Overall Study|Investigator Decision|1
7629165|NCT03116399|12042143|FG001|Overall Study|Investigator Decision|1
7629166|NCT03116399|12042142|FG000|Overall Study|Withdrawal by Subject|24
7629167|NCT03116399|12042143|FG001|Overall Study|Withdrawal by Subject|9
7629168|NCT02961374|12042166|FG000|Overall Study|Adverse Event|4
7629169|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
7629170|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
7629171|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
7629172|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
7629173|NCT02904954|12042181|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
7629174|NCT02904954|12042182|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
7629175|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Recurrence|2
7629176|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Recurrence|0
7629177|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Adverse Event|2
7629178|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Adverse Event|6
7629179|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Participant wishes|12
7629180|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Participant wishes|7
7629181|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Physician Decision|2
7629182|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Physician Decision|1
7629183|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
7629184|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
7629185|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Death|0
7629186|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Death|1
7629187|NCT02904954|12042181|FG000|Adjuvant Durvalumab|Prostate cancer|1
7629188|NCT02904954|12042182|FG001|Adjuvant Durvalumab|Prostate cancer|0
7629227|NCT02784431|12042218|FG000|Overall Study|Unsuccessful Implant Attempt|1
7629228|NCT02784431|12042218|FG000|Overall Study|Early Study Termination|19
7629234|NCT02634307|12042229|FG000|Overall Study|Adverse Event|50
7629235|NCT02634307|12042230|FG001|Overall Study|Adverse Event|24
7629236|NCT02634307|12042231|FG002|Overall Study|Adverse Event|14
7629237|NCT02634307|12042229|FG000|Overall Study|Lost to Follow-up|21
7629238|NCT02634307|12042230|FG001|Overall Study|Lost to Follow-up|5
7629239|NCT02634307|12042231|FG002|Overall Study|Lost to Follow-up|6
7629240|NCT02634307|12042229|FG000|Overall Study|Pregnancy|5
7629241|NCT02634307|12042230|FG001|Overall Study|Pregnancy|1
7629242|NCT02634307|12042231|FG002|Overall Study|Pregnancy|3
7629243|NCT02634307|12042229|FG000|Overall Study|Withdrawal by Subject|38
7629244|NCT02634307|12042230|FG001|Overall Study|Withdrawal by Subject|24
7629245|NCT02634307|12042231|FG002|Overall Study|Withdrawal by Subject|18
7629246|NCT02634307|12042229|FG000|Overall Study|Non-Compliance with Study Drug|0
7629247|NCT02634307|12042230|FG001|Overall Study|Non-Compliance with Study Drug|2
7629248|NCT02634307|12042231|FG002|Overall Study|Non-Compliance with Study Drug|2
7629249|NCT02634307|12042229|FG000|Overall Study|Lack of Efficacy|1
7629250|NCT02634307|12042230|FG001|Overall Study|Lack of Efficacy|5
7629251|NCT02634307|12042231|FG002|Overall Study|Lack of Efficacy|3
7629252|NCT02634307|12042229|FG000|Overall Study|Physician Decision|7
7629253|NCT02634307|12042230|FG001|Overall Study|Physician Decision|5
7629254|NCT02634307|12042231|FG002|Overall Study|Physician Decision|5
7629255|NCT02634307|12042229|FG000|Overall Study|Reason not Specified|3
7629256|NCT02634307|12042230|FG001|Overall Study|Reason not Specified|5
7629257|NCT02634307|12042231|FG002|Overall Study|Reason not Specified|10
7629260|NCT02575339|12042246|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1
7629261|NCT02575339|12042247|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0
7629262|NCT02575339|12042248|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0
7629263|NCT02575339|12042246|FG000|Study Treatment|Disease Progression|5
7629264|NCT02575339|12042247|FG001|Study Treatment|Disease Progression|2
7629265|NCT02575339|12042248|FG002|Study Treatment|Disease Progression|0
7629266|NCT02575339|12042246|FG000|Study Treatment|Adverse Event|1
7629267|NCT02575339|12042247|FG001|Study Treatment|Adverse Event|2
7629268|NCT02575339|12042248|FG002|Study Treatment|Adverse Event|0
7629269|NCT02575339|12042246|FG000|Follow up|Death|6
7629270|NCT02575339|12042247|FG001|Follow up|Death|2
7629271|NCT02575339|12042248|FG002|Follow up|Death|0
7629272|NCT02575339|12042246|FG000|Follow up|Study Terminated|0
7629273|NCT02575339|12042247|FG001|Follow up|Study Terminated|2
7629274|NCT02575339|12042248|FG002|Follow up|Study Terminated|0
7629275|NCT02575339|12042246|FG000|Follow up|Death due to progressive disease after coming off treatment early|1
7629276|NCT02575339|12042247|FG001|Follow up|Death due to progressive disease after coming off treatment early|0
7629277|NCT02575339|12042248|FG002|Follow up|Death due to progressive disease after coming off treatment early|0
7629307|NCT02282020|12042323|FG000|Overall Study|Objective Disease Progression|128
7629308|NCT02282020|12042324|FG001|Overall Study|Objective Disease Progression|30
7629309|NCT02282020|12042323|FG000|Overall Study|Adverse Event|18
7629310|NCT02282020|12042324|FG001|Overall Study|Adverse Event|15
7629311|NCT02282020|12042323|FG000|Overall Study|Withdrawal by Subject|7
7629312|NCT02282020|12042324|FG001|Overall Study|Withdrawal by Subject|10
7629313|NCT02282020|12042323|FG000|Overall Study|Miscellaneous|5
7629314|NCT02282020|12042324|FG001|Overall Study|Miscellaneous|19
7629315|NCT02282020|12042323|FG000|Overall Study|Severe Non-compliance to Protocol|1
7629316|NCT02282020|12042324|FG001|Overall Study|Severe Non-compliance to Protocol|0
7629317|NCT02282020|12042323|FG000|Overall Study|Developed Discontinuation Criteria|0
7629318|NCT02282020|12042324|FG001|Overall Study|Developed Discontinuation Criteria|2
7629319|NCT02282020|12042323|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
7629320|NCT02282020|12042324|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
7629322|NCT02243631|12042337|FG000|Overall Study|no synovial fluid on second aspirate|0
7629323|NCT02243631|12042338|FG001|Overall Study|no synovial fluid on second aspirate|1
7629324|NCT02213926|12042344|FG000|Overall Study|Death|59
7629325|NCT02213926|12042344|FG000|Overall Study|Withdrawal by Subject|10
7629326|NCT02213926|12042344|FG000|Overall Study|study terminated by sponsor|51
7629327|NCT02213926|12042344|FG000|Overall Study|Lost to Follow-up|3
7629328|NCT02213926|12042344|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
7629333|NCT02066181|12042354|FG000|Overall Study|Withdrawal by Subject|1
7629334|NCT02066181|12042355|FG001|Overall Study|Withdrawal by Subject|1
7629336|NCT02041533|12042370|FG000|Overall Study|Disease Progression|168
7629337|NCT02041533|12042371|FG001|Overall Study|Disease Progression|142
7629338|NCT02041533|12042370|FG000|Overall Study|Study drug toxicity|27
7629339|NCT02041533|12042371|FG001|Overall Study|Study drug toxicity|30
7629340|NCT02041533|12042370|FG000|Overall Study|Death|1
7629341|NCT02041533|12042371|FG001|Overall Study|Death|0
7629342|NCT02041533|12042370|FG000|Overall Study|Adverse Event unrelated to study drug|20
7629343|NCT02041533|12042371|FG001|Overall Study|Adverse Event unrelated to study drug|21
7629344|NCT02041533|12042370|FG000|Overall Study|Subject request to discontinue treatment|5
7629345|NCT02041533|12042371|FG001|Overall Study|Subject request to discontinue treatment|9
7629346|NCT02041533|12042370|FG000|Overall Study|Withdrawal by Subject|2
7629347|NCT02041533|12042371|FG001|Overall Study|Withdrawal by Subject|1
7629348|NCT02041533|12042370|FG000|Overall Study|Maximum clinical benefit|0
7629349|NCT02041533|12042371|FG001|Overall Study|Maximum clinical benefit|18
7629350|NCT02041533|12042370|FG000|Overall Study|Poor/non-compliance|1
7629351|NCT02041533|12042371|FG001|Overall Study|Poor/non-compliance|0
7629352|NCT02041533|12042370|FG000|Overall Study|Other reasons|0
7629353|NCT02041533|12042371|FG001|Overall Study|Other reasons|1
7629354|NCT02041533|12042370|FG000|Overall Study|Completed max number of chemo cycles|0
7629355|NCT02041533|12042371|FG001|Overall Study|Completed max number of chemo cycles|29
7629356|NCT02041533|12042370|FG000|Overall Study|Randomized, not treated|4
7629357|NCT02041533|12042371|FG001|Overall Study|Randomized, not treated|7
7629358|NCT01963728|12042379|FG000|Overall Study|Study terminated early|0
7629359|NCT01963728|12042380|FG001|Overall Study|Study terminated early|1
7629585|NCT01696981|12042541|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
7629586|NCT01696981|12042542|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
7629587|NCT01696981|12042541|FG000|Overall Study|Died Before Randomization|3
7629588|NCT01696981|12042542|FG001|Overall Study|Died Before Randomization|8
7629589|NCT01696981|12042541|FG000|Overall Study|Died Before ASU (Control)|278
7629590|NCT01696981|12042542|FG001|Overall Study|Died Before ASU (Control)|0
7629591|NCT01696981|12042541|FG000|Overall Study|Refused ASU (Control)|920
7629592|NCT01696981|12042542|FG001|Overall Study|Refused ASU (Control)|0
7629593|NCT01696981|12042541|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
7629594|NCT01696981|12042542|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
7629622|NCT01467466|12042577|FG000|Overall Study|Withdrawal by Subject|15
7629623|NCT01467466|12042578|FG001|Overall Study|Withdrawal by Subject|18
7629624|NCT01467466|12042579|FG002|Overall Study|Withdrawal by Subject|13
7629625|NCT01467466|12042580|FG003|Overall Study|Withdrawal by Subject|11
7629626|NCT01467466|12042577|FG000|Overall Study|Revoked Consent Prior To Procedure|10
7629627|NCT01467466|12042578|FG001|Overall Study|Revoked Consent Prior To Procedure|9
7629628|NCT01467466|12042579|FG002|Overall Study|Revoked Consent Prior To Procedure|15
7629629|NCT01467466|12042580|FG003|Overall Study|Revoked Consent Prior To Procedure|5
7629630|NCT01467466|12042577|FG000|Overall Study|Procedure Cancelled|46
7629631|NCT01467466|12042578|FG001|Overall Study|Procedure Cancelled|45
7629632|NCT01467466|12042579|FG002|Overall Study|Procedure Cancelled|25
7629633|NCT01467466|12042580|FG003|Overall Study|Procedure Cancelled|29
7629634|NCT01467466|12042577|FG000|Overall Study|No Endpoint Blood Draw|38
7629635|NCT01467466|12042578|FG001|Overall Study|No Endpoint Blood Draw|32
7629636|NCT01467466|12042579|FG002|Overall Study|No Endpoint Blood Draw|51
7629637|NCT01467466|12042580|FG003|Overall Study|No Endpoint Blood Draw|43
7629928|NCT01062425|12042859|FG000|Overall Study|Protocol Violation|3
7629929|NCT01062425|12042860|FG001|Overall Study|Protocol Violation|6
7630122|NCT00593840|12043052|FG000|Overall Study|Withdrawal by Subject|1
7630457|NCT00381641|12043121|FG000|Overall Study|Withdrawal by Subject|0
7630458|NCT00381641|12043122|FG001|Overall Study|Withdrawal by Subject|2
7630497|NCT05405244|12043191|FG000|Washout (2 Weeks)|Lost to Follow-up|0
7630498|NCT05405244|12043192|FG001|Washout (2 Weeks)|Lost to Follow-up|1
7630499|NCT05405244|12043191|FG000|Washout (2 Weeks)|Adverse Event|2
7630500|NCT05405244|12043192|FG001|Washout (2 Weeks)|Adverse Event|0
7630501|NCT05405244|12043191|FG000|Washout (2 Weeks)|Withdrawal by Subject|2
7630502|NCT05405244|12043192|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
7630503|NCT05271175|12043205|FG000|One Week Follow up|Lost to Follow-up|10
7630504|NCT05271175|12043206|FG001|One Week Follow up|Lost to Follow-up|7
7630505|NCT05271175|12043207|FG002|One Week Follow up|Lost to Follow-up|5
7630506|NCT05271175|12043205|FG000|One Month Follow up|Lost to Follow-up|12
7630507|NCT05271175|12043206|FG001|One Month Follow up|Lost to Follow-up|7
7630508|NCT05271175|12043207|FG002|One Month Follow up|Lost to Follow-up|9
7630509|NCT05271175|12043205|FG000|Six Months Follow up|Lost to Follow-up|8
7630510|NCT05271175|12043206|FG001|Six Months Follow up|Lost to Follow-up|2
7630511|NCT05271175|12043207|FG002|Six Months Follow up|Lost to Follow-up|2
7630512|NCT05200455|12043215|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4
7630513|NCT05091528|12043228|FG000|Overall Study|Study Termination by Sponsor|0
7630514|NCT05091528|12043229|FG001|Overall Study|Study Termination by Sponsor|1
7630515|NCT05091528|12043230|FG002|Overall Study|Study Termination by Sponsor|0
7630516|NCT05091528|12043231|FG003|Overall Study|Study Termination by Sponsor|1
7630517|NCT05090852|12043239|FG000|Overall Study|Physician Decision|5
7630518|NCT05050318|12043253|FG000|Overall Study|Protocol Deviation|1
7630519|NCT05050318|12043254|FG001|Overall Study|Protocol Deviation|0
7630520|NCT05050318|12043255|FG002|Overall Study|Protocol Deviation|0
7630521|NCT04942925|12043265|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7630522|NCT04942925|12043266|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7630523|NCT04942925|12043265|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0
7630524|NCT04942925|12043266|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1
7630525|NCT04908488|12043277|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
7630526|NCT04908488|12043278|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
7630527|NCT04908488|12043277|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1
7630528|NCT04908488|12043278|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0
7630529|NCT04899232|12043299|FG000|Screening Period|Physician Decision|1
7630530|NCT04899232|12043300|FG001|Screening Period|Physician Decision|0
7630531|NCT04899232|12043301|FG002|Screening Period|Physician Decision|0
7630532|NCT04899232|12043299|FG000|Screening Period|Withdrawal by Subject|1
7630533|NCT04899232|12043300|FG001|Screening Period|Withdrawal by Subject|0
7630534|NCT04899232|12043301|FG002|Screening Period|Withdrawal by Subject|0
7630535|NCT04899232|12043299|FG000|Screening Period|Participant discharged before receiving intervention|3
7630536|NCT04899232|12043300|FG001|Screening Period|Participant discharged before receiving intervention|0
7630537|NCT04899232|12043301|FG002|Screening Period|Participant discharged before receiving intervention|0
7630538|NCT04885296|12043309|FG000|Period 1|Covid-19 Related|1
7630539|NCT04885296|12043310|FG001|Period 1|Covid-19 Related|0
7630540|NCT04885296|12043309|FG000|Period 1|Adverse Event|0
7630541|NCT04885296|12043310|FG001|Period 1|Adverse Event|1
7630542|NCT04885296|12043309|FG000|Period 1|Withdrawal by Subject|1
7630543|NCT04885296|12043310|FG001|Period 1|Withdrawal by Subject|1
7630544|NCT04885296|12043309|FG000|Period 1|Test Article No Longer Available|1
7630545|NCT04885296|12043310|FG001|Period 1|Test Article No Longer Available|0
7630546|NCT04885296|12043309|FG000|Period 1|Dispensed Study lens in Error|1
7630547|NCT04885296|12043310|FG001|Period 1|Dispensed Study lens in Error|0
7630548|NCT04885296|12043309|FG000|Period 1|Lost to Follow-up|1
7630549|NCT04885296|12043310|FG001|Period 1|Lost to Follow-up|0
7630550|NCT04885296|12043309|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0
7630551|NCT04885296|12043310|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1
7630552|NCT04862065|12043319|FG000|Screening|Protocol Violation|54
7630553|NCT04862065|12043320|FG001|Screening|Protocol Violation|0
7630554|NCT04862065|12043321|FG002|Screening|Protocol Violation|0
7630555|NCT04862065|12043319|FG000|Screening|Insufficient Sample|1
7630556|NCT04862065|12043320|FG001|Screening|Insufficient Sample|0
7630557|NCT04862065|12043321|FG002|Screening|Insufficient Sample|0
7630558|NCT04862065|12043319|FG000|Follow-Up|Lost to Follow-up|3
7630559|NCT04862065|12043320|FG001|Follow-Up|Lost to Follow-up|0
7630560|NCT04862065|12043321|FG002|Follow-Up|Lost to Follow-up|0
7630561|NCT04822701|12043338|FG000|Overall Study|Not treated|2
7630562|NCT04822701|12043339|FG001|Overall Study|Not treated|0
7630563|NCT04822701|12043338|FG000|Overall Study|Lost to Follow-up|1
7630564|NCT04822701|12043339|FG001|Overall Study|Lost to Follow-up|0
7630565|NCT04822701|12043338|FG000|Overall Study|Withdrawal by Subject|1
7630566|NCT04822701|12043339|FG001|Overall Study|Withdrawal by Subject|0
7630567|NCT04784897|12043348|FG000|Overall Study|Death|4
7630568|NCT04784897|12043349|FG001|Overall Study|Death|2
7630569|NCT04784897|12043350|FG002|Overall Study|Death|1
7630570|NCT04784897|12043348|FG000|Overall Study|Withdrawal by Subject|0
7630571|NCT04784897|12043349|FG001|Overall Study|Withdrawal by Subject|0
7630572|NCT04784897|12043350|FG002|Overall Study|Withdrawal by Subject|1
7630573|NCT04764669|12043379|FG000|Overall Study|Adverse Event|1
7630574|NCT04764669|12043380|FG001|Overall Study|Adverse Event|0
7630575|NCT04764669|12043381|FG002|Overall Study|Adverse Event|1
7630576|NCT04764669|12043382|FG003|Overall Study|Adverse Event|0
7630577|NCT04764669|12043379|FG000|Overall Study|Subject Choice|0
7630578|NCT04764669|12043380|FG001|Overall Study|Subject Choice|0
7630579|NCT04764669|12043381|FG002|Overall Study|Subject Choice|1
7630580|NCT04764669|12043382|FG003|Overall Study|Subject Choice|0
7630581|NCT04764669|12043379|FG000|Overall Study|Withdrawal by Subject|2
7630582|NCT04764669|12043380|FG001|Overall Study|Withdrawal by Subject|0
7630583|NCT04764669|12043381|FG002|Overall Study|Withdrawal by Subject|0
7630584|NCT04764669|12043382|FG003|Overall Study|Withdrawal by Subject|0
7630585|NCT04741503|12043398|FG000|Initial Enrollment|Failed to meet screening criteria|0
7630586|NCT04741503|12043399|FG001|Initial Enrollment|Failed to meet screening criteria|0
7630587|NCT04741503|12043400|FG002|Initial Enrollment|Failed to meet screening criteria|767
7630588|NCT04741503|12043398|FG000|Initial Enrollment|Overquotas removed|0
7630589|NCT04741503|12043399|FG001|Initial Enrollment|Overquotas removed|0
7630590|NCT04741503|12043400|FG002|Initial Enrollment|Overquotas removed|186
7630591|NCT04741503|12043398|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23
7630592|NCT04741503|12043399|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17
7630593|NCT04741503|12043400|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0
7630594|NCT04734873|12043409|FG000|Overall Study|Lost to Follow-up|1
7630595|NCT04734873|12043410|FG001|Overall Study|Lost to Follow-up|3
7630596|NCT04734873|12043411|FG002|Overall Study|Lost to Follow-up|2
7630597|NCT04734873|12043409|FG000|Overall Study|Randomized but not dosed|1
7630598|NCT04734873|12043410|FG001|Overall Study|Randomized but not dosed|0
7630599|NCT04734873|12043411|FG002|Overall Study|Randomized but not dosed|1
7630600|NCT04724733|12043426|FG000|Overall Study|Lost to Follow-up|1
7630601|NCT04724733|12043427|FG001|Overall Study|Lost to Follow-up|1
7630602|NCT04724733|12043428|FG002|Overall Study|Lost to Follow-up|1
7630603|NCT04713748|12043453|FG000|Overall Study|Not enough kits allocated|35
7630604|NCT04668274|12043487|FG000|Part 1 Study Period 1|Adverse Event|3
7630605|NCT04668274|12043488|FG001|Part 1 Study Period 1|Adverse Event|0
7630606|NCT04668274|12043489|FG002|Part 1 Study Period 1|Adverse Event|0
7630607|NCT04668274|12043490|FG003|Part 1 Study Period 1|Adverse Event|0
7630608|NCT04668274|12043487|FG000|Part 1 Study Period 1|Withdrawal by Subject|2
7630609|NCT04668274|12043488|FG001|Part 1 Study Period 1|Withdrawal by Subject|0
7630610|NCT04668274|12043489|FG002|Part 1 Study Period 1|Withdrawal by Subject|0
7630611|NCT04668274|12043490|FG003|Part 1 Study Period 1|Withdrawal by Subject|0
7630612|NCT04668274|12043487|FG000|Part 1 Study Period 2|Other|0
7630613|NCT04668274|12043488|FG001|Part 1 Study Period 2|Other|1
7630614|NCT04668274|12043489|FG002|Part 1 Study Period 2|Other|0
7630615|NCT04668274|12043490|FG003|Part 1 Study Period 2|Other|0
7630616|NCT04668274|12043487|FG000|Part 1 Study Period 3|Adverse Event|0
7630617|NCT04668274|12043488|FG001|Part 1 Study Period 3|Adverse Event|0
7630618|NCT04668274|12043489|FG002|Part 1 Study Period 3|Adverse Event|1
7630619|NCT04668274|12043490|FG003|Part 1 Study Period 3|Adverse Event|0
7630620|NCT04668274|12043487|FG000|Part 1 Study Period 3|Other|0
7630621|NCT04668274|12043488|FG001|Part 1 Study Period 3|Other|0
7630622|NCT04668274|12043489|FG002|Part 1 Study Period 3|Other|2
7630623|NCT04668274|12043490|FG003|Part 1 Study Period 3|Other|0
7630624|NCT04668274|12043487|FG000|Part 2 Study Period 4|Other|0
7630625|NCT04668274|12043488|FG001|Part 2 Study Period 4|Other|0
7630626|NCT04668274|12043489|FG002|Part 2 Study Period 4|Other|0
7630627|NCT04668274|12043490|FG003|Part 2 Study Period 4|Other|1
7630628|NCT04664153|12043516|FG000|Overall Study|Lack of Efficacy|0
7630629|NCT04664153|12043517|FG001|Overall Study|Lack of Efficacy|0
7630630|NCT04664153|12043518|FG002|Overall Study|Lack of Efficacy|1
7630631|NCT04664153|12043519|FG003|Overall Study|Lack of Efficacy|0
7630632|NCT04664153|12043516|FG000|Overall Study|Physician Decision|0
7630633|NCT04664153|12043517|FG001|Overall Study|Physician Decision|0
7630634|NCT04664153|12043518|FG002|Overall Study|Physician Decision|1
7630635|NCT04664153|12043519|FG003|Overall Study|Physician Decision|0
7630636|NCT04664153|12043516|FG000|Overall Study|Withdrawal by Subject|3
7630637|NCT04664153|12043517|FG001|Overall Study|Withdrawal by Subject|2
7630638|NCT04664153|12043518|FG002|Overall Study|Withdrawal by Subject|1
7630639|NCT04664153|12043519|FG003|Overall Study|Withdrawal by Subject|2
7630640|NCT04664153|12043516|FG000|Overall Study|Other|0
7630641|NCT04664153|12043517|FG001|Overall Study|Other|1
7630642|NCT04664153|12043518|FG002|Overall Study|Other|0
7630643|NCT04664153|12043519|FG003|Overall Study|Other|0
7630644|NCT04664153|12043516|FG000|Overall Study|Adverse Event|4
7630645|NCT04664153|12043517|FG001|Overall Study|Adverse Event|0
7630646|NCT04664153|12043518|FG002|Overall Study|Adverse Event|1
7630647|NCT04664153|12043519|FG003|Overall Study|Adverse Event|0
7630648|NCT04663295|12043531|FG000|Run-in Period|Withdrawal by Subject|3
7630649|NCT04663295|12043531|FG000|Overall Study Period|Pregnancy|1
7630650|NCT04663295|12043531|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1
7630651|NCT04623242|12043662|FG000|Overall Study|Withdrawal by Subject|7
7630652|NCT04623242|12043663|FG001|Overall Study|Withdrawal by Subject|12
7630653|NCT04623242|12043664|FG002|Overall Study|Withdrawal by Subject|5
7630654|NCT04623242|12043665|FG003|Overall Study|Withdrawal by Subject|7
7630655|NCT04623242|12043666|FG004|Overall Study|Withdrawal by Subject|0
7630656|NCT04623242|12043662|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6
7630657|NCT04623242|12043663|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4
7630658|NCT04623242|12043664|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5
7630659|NCT04623242|12043665|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3
7630660|NCT04623242|12043666|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0
7630661|NCT04623242|12043662|FG000|Overall Study|Subject unblinded to mutation status|0
7630662|NCT04623242|12043663|FG001|Overall Study|Subject unblinded to mutation status|0
7630663|NCT04623242|12043664|FG002|Overall Study|Subject unblinded to mutation status|0
7630664|NCT04623242|12043665|FG003|Overall Study|Subject unblinded to mutation status|13
7630665|NCT04623242|12043666|FG004|Overall Study|Subject unblinded to mutation status|0
7630666|NCT04619992|12043683|FG000|Overall Study|Withdrawal by Subject|1
7630667|NCT04619992|12043684|FG001|Overall Study|Withdrawal by Subject|0
7630668|NCT04606199|12043690|FG000|Overall Study|Withdrawal by Subject|2
7630669|NCT04587453|12043711|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0
7630670|NCT04587453|12043712|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1
7630671|NCT04584346|12043731|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0
7630672|NCT04584346|12043732|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1
7630673|NCT04580303|12043746|FG000|Overall Study|Adverse Event|0
7630674|NCT04580303|12043747|FG001|Overall Study|Adverse Event|1
7630675|NCT04580303|12043748|FG002|Overall Study|Adverse Event|0
7630676|NCT04580303|12043749|FG003|Overall Study|Adverse Event|0
7630677|NCT04580303|12043746|FG000|Overall Study|Withdrawal by Subject|0
7630678|NCT04580303|12043747|FG001|Overall Study|Withdrawal by Subject|0
7630679|NCT04580303|12043748|FG002|Overall Study|Withdrawal by Subject|1
7630680|NCT04580303|12043749|FG003|Overall Study|Withdrawal by Subject|0
7630681|NCT04575584|12043765|FG000|Overall Study|Death|6
7630682|NCT04575584|12043766|FG001|Overall Study|Death|4
7630683|NCT04575584|12043767|FG002|Overall Study|Death|6
7630684|NCT04575584|12043768|FG003|Overall Study|Death|2
7630685|NCT04575584|12043769|FG004|Overall Study|Death|0
7630686|NCT04575584|12043770|FG005|Overall Study|Death|0
7630687|NCT04575584|12043765|FG000|Overall Study|Lost to Follow-up|1
7630688|NCT04575584|12043766|FG001|Overall Study|Lost to Follow-up|1
7630689|NCT04575584|12043767|FG002|Overall Study|Lost to Follow-up|1
7630690|NCT04575584|12043768|FG003|Overall Study|Lost to Follow-up|1
7630691|NCT04575584|12043769|FG004|Overall Study|Lost to Follow-up|0
7630692|NCT04575584|12043770|FG005|Overall Study|Lost to Follow-up|0
7630693|NCT04575584|12043765|FG000|Overall Study|Physician Decision|0
7630694|NCT04575584|12043766|FG001|Overall Study|Physician Decision|1
7630695|NCT04575584|12043767|FG002|Overall Study|Physician Decision|1
7630696|NCT04575584|12043768|FG003|Overall Study|Physician Decision|1
7630697|NCT04575584|12043769|FG004|Overall Study|Physician Decision|0
7630698|NCT04575584|12043770|FG005|Overall Study|Physician Decision|0
7630699|NCT04575584|12043765|FG000|Overall Study|Withdrawal by Subject|7
7630700|NCT04575584|12043766|FG001|Overall Study|Withdrawal by Subject|9
7630701|NCT04575584|12043767|FG002|Overall Study|Withdrawal by Subject|5
7630702|NCT04575584|12043768|FG003|Overall Study|Withdrawal by Subject|3
7630703|NCT04575584|12043769|FG004|Overall Study|Withdrawal by Subject|0
7630704|NCT04575584|12043770|FG005|Overall Study|Withdrawal by Subject|0
7630705|NCT04575584|12043765|FG000|Overall Study|Not recorded|0
7630706|NCT04575584|12043766|FG001|Overall Study|Not recorded|0
7630707|NCT04575584|12043767|FG002|Overall Study|Not recorded|0
7630708|NCT04575584|12043768|FG003|Overall Study|Not recorded|1
7630709|NCT04575584|12043769|FG004|Overall Study|Not recorded|0
7630710|NCT04575584|12043770|FG005|Overall Study|Not recorded|0
7630711|NCT04571515|12043789|FG000|Overall Study|Physician Decision|0
7630712|NCT04571515|12043790|FG001|Overall Study|Physician Decision|0
7630713|NCT04571515|12043791|FG002|Overall Study|Physician Decision|0
7630714|NCT04571515|12043792|FG003|Overall Study|Physician Decision|0
7630715|NCT04571515|12043793|FG004|Overall Study|Physician Decision|1
7630716|NCT04571515|12043789|FG000|Overall Study|Withdrawal by Subject|0
7630717|NCT04571515|12043790|FG001|Overall Study|Withdrawal by Subject|0
7630718|NCT04571515|12043791|FG002|Overall Study|Withdrawal by Subject|0
7630719|NCT04571515|12043792|FG003|Overall Study|Withdrawal by Subject|0
7630720|NCT04571515|12043793|FG004|Overall Study|Withdrawal by Subject|1
7630721|NCT04571515|12043789|FG000|Overall Study|insufficient pain|1
7630722|NCT04571515|12043790|FG001|Overall Study|insufficient pain|0
7630723|NCT04571515|12043791|FG002|Overall Study|insufficient pain|0
7630724|NCT04571515|12043792|FG003|Overall Study|insufficient pain|0
7630725|NCT04571515|12043793|FG004|Overall Study|insufficient pain|1
7630726|NCT04562155|12043818|FG000|Overall Study|COVID-19 pandemic|0
7630727|NCT04562155|12043819|FG001|Overall Study|COVID-19 pandemic|0
7630728|NCT04562155|12043820|FG002|Overall Study|COVID-19 pandemic|0
7630729|NCT04562155|12043821|FG003|Overall Study|COVID-19 pandemic|1
7630730|NCT04562155|12043818|FG000|Overall Study|Adverse Event|7
7630731|NCT04562155|12043819|FG001|Overall Study|Adverse Event|3
7630732|NCT04562155|12043820|FG002|Overall Study|Adverse Event|8
7630733|NCT04562155|12043821|FG003|Overall Study|Adverse Event|1
7630734|NCT04562155|12043818|FG000|Overall Study|Withdrawal by Subject|3
7630735|NCT04562155|12043819|FG001|Overall Study|Withdrawal by Subject|6
7630736|NCT04562155|12043820|FG002|Overall Study|Withdrawal by Subject|3
7630737|NCT04562155|12043821|FG003|Overall Study|Withdrawal by Subject|3
7630738|NCT04562155|12043818|FG000|Overall Study|Participant personal reason|1
7630739|NCT04562155|12043819|FG001|Overall Study|Participant personal reason|0
7630740|NCT04562155|12043820|FG002|Overall Study|Participant personal reason|2
7630741|NCT04562155|12043821|FG003|Overall Study|Participant personal reason|1
7630742|NCT04546724|12043851|FG000|Overall Study|Withdrawal by Subject|37
7630743|NCT04546724|12043852|FG001|Overall Study|Withdrawal by Subject|10
7630744|NCT04546724|12043851|FG000|Overall Study|Adverse Event|1
7630745|NCT04546724|12043852|FG001|Overall Study|Adverse Event|1
7630746|NCT04546724|12043851|FG000|Overall Study|Lost to Follow-up|30
7630747|NCT04546724|12043852|FG001|Overall Study|Lost to Follow-up|10
7630748|NCT04546724|12043851|FG000|Overall Study|Physician Decision|4
7630749|NCT04546724|12043852|FG001|Overall Study|Physician Decision|1
7630750|NCT04546724|12043851|FG000|Overall Study|Subject Moved|2
7630751|NCT04546724|12043852|FG001|Overall Study|Subject Moved|0
7630752|NCT04546724|12043851|FG000|Overall Study|Subject Praticipating in another trial|0
7630753|NCT04546724|12043852|FG001|Overall Study|Subject Praticipating in another trial|1
7630754|NCT04546724|12043851|FG000|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|49
7630755|NCT04546724|12043852|FG001|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|12
7630756|NCT04539275|12043871|FG000|Overall Study|Death|2
7630757|NCT04539275|12043872|FG001|Overall Study|Death|4
7630758|NCT04539275|12043871|FG000|Overall Study|Lost to Follow-up|1
7630759|NCT04539275|12043872|FG001|Overall Study|Lost to Follow-up|1
7630760|NCT04539275|12043871|FG000|Overall Study|Withdrawal by Subject|3
7630761|NCT04539275|12043872|FG001|Overall Study|Withdrawal by Subject|0
7630762|NCT04537806|12043880|FG000|Overall Study|Randomized but not treated|1
7630763|NCT04537806|12043881|FG001|Overall Study|Randomized but not treated|0
7630764|NCT04537806|12043880|FG000|Overall Study|Adverse Event|1
7630765|NCT04537806|12043881|FG001|Overall Study|Adverse Event|1
7630766|NCT04535947|12043889|FG000|Overall Study|Adverse Event|1
7630767|NCT04535947|12043890|FG001|Overall Study|Adverse Event|4
7630768|NCT04535947|12043889|FG000|Overall Study|Other reasons not specified|2
7630769|NCT04535947|12043890|FG001|Overall Study|Other reasons not specified|0
7630770|NCT04535947|12043889|FG000|Overall Study|Withdrawal by Subject|1
7630771|NCT04535947|12043890|FG001|Overall Study|Withdrawal by Subject|1
7630772|NCT04529850|12043896|FG000|Overall Study|Death|2
7630773|NCT04529850|12043896|FG000|Overall Study|Physician Decision|1
7630774|NCT04529850|12043896|FG000|Overall Study|Withdrawal by Subject|2
7630775|NCT04529096|12043902|FG000|Overall Study|Adverse Event|6
7630776|NCT04529096|12043903|FG001|Overall Study|Adverse Event|1
7630777|NCT04529096|12043902|FG000|Overall Study|Lack of Efficacy|1
7630778|NCT04529096|12043903|FG001|Overall Study|Lack of Efficacy|0
7630779|NCT04529096|12043902|FG000|Overall Study|Lost to Follow-up|1
7630780|NCT04529096|12043903|FG001|Overall Study|Lost to Follow-up|1
7630781|NCT04529096|12043902|FG000|Overall Study|Non-Compliance With Study Drug|0
7630782|NCT04529096|12043903|FG001|Overall Study|Non-Compliance With Study Drug|1
7630783|NCT04529096|12043902|FG000|Overall Study|Physician Decision|1
7630784|NCT04529096|12043903|FG001|Overall Study|Physician Decision|3
7630785|NCT04529096|12043902|FG000|Overall Study|Withdrawal by Subject|5
7630786|NCT04529096|12043903|FG001|Overall Study|Withdrawal by Subject|0
7630787|NCT04527471|12043911|FG000|Overall Study|Adverse Event|1
7630788|NCT04527471|12043912|FG001|Overall Study|Adverse Event|0
7630789|NCT04527471|12043911|FG000|Overall Study|Lost to Follow-up|1
7630790|NCT04527471|12043912|FG001|Overall Study|Lost to Follow-up|0
7630791|NCT04505722|12043942|FG000|Overall Study|Adverse Event|1
7630792|NCT04505722|12043943|FG001|Overall Study|Adverse Event|2
7630793|NCT04505722|12043942|FG000|Overall Study|Death|34
7630794|NCT04505722|12043943|FG001|Overall Study|Death|63
7630795|NCT04505722|12043942|FG000|Overall Study|Lost to Follow-up|271
7630796|NCT04505722|12043943|FG001|Overall Study|Lost to Follow-up|333
7630797|NCT04505722|12043942|FG000|Overall Study|Physician Decision|17
7630798|NCT04505722|12043943|FG001|Overall Study|Physician Decision|17
7630799|NCT04505722|12043942|FG000|Overall Study|Protocol Violation|0
7630800|NCT04505722|12043943|FG001|Overall Study|Protocol Violation|1
7630801|NCT04505722|12043942|FG000|Overall Study|Withdrawal by Subject|376
7630802|NCT04505722|12043943|FG001|Overall Study|Withdrawal by Subject|714
7630803|NCT04505722|12043942|FG000|Overall Study|Other|61
7630804|NCT04505722|12043943|FG001|Overall Study|Other|98
7630805|NCT04505722|12043942|FG000|Overall Study|Still ongoing|21138
7630806|NCT04505722|12043943|FG001|Overall Study|Still ongoing|20662
7630807|NCT04505722|12043942|FG000|Overall Study|Randomized not vaccinated|276
7630808|NCT04505722|12043943|FG001|Overall Study|Randomized not vaccinated|260
7630809|NCT04498169|12043951|FG000|Study Completion|Adverse Event|1
7630810|NCT04498169|12043952|FG001|Study Completion|Adverse Event|1
7630811|NCT04490499|12043962|FG000|Overall Study|Withdrawal by Subject|2
7630812|NCT04482647|12043966|FG000|Overall Study|Time constraints|2
7630813|NCT04482647|12043966|FG000|Overall Study|Health issues|1
7630814|NCT04482647|12043966|FG000|Overall Study|Death in the family|1
7630815|NCT04482647|12043966|FG000|Overall Study|Disliked the intervention|1
7630816|NCT04482647|12043966|FG000|Overall Study|No reasons specified|7
7630817|NCT04476108|12043972|FG000|Overall Study|Adverse Event|4
7630818|NCT04476108|12043973|FG001|Overall Study|Adverse Event|1
7630819|NCT04476108|12043972|FG000|Overall Study|Lost to Follow-up|1
7630820|NCT04476108|12043973|FG001|Overall Study|Lost to Follow-up|0
7630821|NCT04476108|12043972|FG000|Overall Study|Inadvertent Enrollment|1
7630822|NCT04476108|12043973|FG001|Overall Study|Inadvertent Enrollment|0
7630823|NCT04476108|12043972|FG000|Overall Study|Protocol Violation|1
7630824|NCT04476108|12043973|FG001|Overall Study|Protocol Violation|1
7630825|NCT04476108|12043972|FG000|Overall Study|Withdrawal by Subject|1
7630826|NCT04476108|12043973|FG001|Overall Study|Withdrawal by Subject|1
7630827|NCT04470622|12043981|FG000|Overall Study|Withdrawal by Subject|0
7630828|NCT04470622|12043982|FG001|Overall Study|Withdrawal by Subject|1
7630829|NCT04470622|12043981|FG000|Overall Study|Screen Failure|0
7630830|NCT04470622|12043982|FG001|Overall Study|Screen Failure|1
7630831|NCT04470622|12043981|FG000|Overall Study|Death|0
7630832|NCT04470622|12043982|FG001|Overall Study|Death|1
7630833|NCT04464421|12043990|FG000|Overall Study|Lost to Follow-up|2
7630834|NCT04464421|12043991|FG001|Overall Study|Lost to Follow-up|2
7630835|NCT04456686|12044012|FG000|Overall Study|Adverse Event|2
7630836|NCT04456686|12044013|FG001|Overall Study|Adverse Event|1
7630837|NCT04456686|12044012|FG000|Overall Study|Lack of Efficacy|3
7630838|NCT04456686|12044013|FG001|Overall Study|Lack of Efficacy|1
7630839|NCT04456686|12044012|FG000|Overall Study|Withdrew consent|3
7630840|NCT04456686|12044013|FG001|Overall Study|Withdrew consent|1
7630841|NCT04456686|12044012|FG000|Overall Study|Physician Decision|2
7630842|NCT04456686|12044013|FG001|Overall Study|Physician Decision|2
7630843|NCT04456686|12044012|FG000|Overall Study|Withdrawal by Subject|5
7630844|NCT04456686|12044013|FG001|Overall Study|Withdrawal by Subject|1
7630845|NCT04456686|12044012|FG000|Overall Study|Protocol Violation|0
7630846|NCT04456686|12044013|FG001|Overall Study|Protocol Violation|1
7630847|NCT04447404|12044021|FG000|Overall Study|Death|2
7630848|NCT04447404|12044022|FG001|Overall Study|Death|0
7630849|NCT04439344|12044028|FG000|Overall Study|Never started threapy|3
7630850|NCT04439344|12044028|FG000|Overall Study|Ineligible|3
7630851|NCT04439344|12044028|FG000|Overall Study|Adverse Event|13
7630852|NCT04439344|12044028|FG000|Overall Study|Death|2
7630853|NCT04439344|12044028|FG000|Overall Study|Disease progression|29
7630854|NCT04439344|12044028|FG000|Overall Study|Withdrawal by Subject|2
7630855|NCT04439344|12044028|FG000|Overall Study|Alternative therapy|1
7630856|NCT04439279|12044032|FG000|Overall Study|Adverse Event|7
7630857|NCT04439279|12044032|FG000|Overall Study|Death|4
7630858|NCT04439279|12044032|FG000|Overall Study|Disease progression|17
7630859|NCT04439279|12044032|FG000|Overall Study|Complicating disease|3
7630860|NCT04439279|12044032|FG000|Overall Study|Withdrawal by Subject|2
7630861|NCT04439279|12044032|FG000|Overall Study|Ineligible|1
7630862|NCT04439279|12044032|FG000|Overall Study|Treatment still ongoing|1
7630863|NCT04439266|12044036|FG000|Overall Study|Ineligible|1
7630864|NCT04439266|12044036|FG000|Overall Study|Adverse Event|1
7630865|NCT04439266|12044036|FG000|Overall Study|Death|1
7630866|NCT04439266|12044036|FG000|Overall Study|Disease progression|1
7630867|NCT04439266|12044036|FG000|Overall Study|Still on treatment|1
7630868|NCT04439253|12044040|FG000|Overall Study|Adverse Event|1
7630869|NCT04439253|12044040|FG000|Overall Study|Disease progression|2
7630870|NCT04439253|12044040|FG000|Overall Study|Complicating disease|1
7630871|NCT04439123|12044044|FG000|Overall Study|Adverse Event|11
7630872|NCT04439123|12044044|FG000|Overall Study|Death|1
7630873|NCT04439123|12044044|FG000|Overall Study|Disease progression|19
7630874|NCT04439123|12044044|FG000|Overall Study|Withdrawal by Subject|2
7630875|NCT04439123|12044044|FG000|Overall Study|Still on treatment|2
7630876|NCT04439110|12044048|FG000|Overall Study|Ineligible|2
7630877|NCT04439110|12044048|FG000|Overall Study|Adverse Event|4
7630878|NCT04439110|12044048|FG000|Overall Study|Death|2
7630879|NCT04439110|12044048|FG000|Overall Study|Disease proression|25
7630880|NCT04439110|12044048|FG000|Overall Study|Withdrawal by Subject|1
7630881|NCT04439110|12044048|FG000|Overall Study|Alternative therapy|1
7630882|NCT04439110|12044048|FG000|Overall Study|Other complicating disease|1
7630883|NCT04439110|12044048|FG000|Overall Study|Personal reasons|1
7630884|NCT04439110|12044048|FG000|Overall Study|Still on treatment|1
7630885|NCT04438499|12044052|FG000|Overall Study|Lack of Efficacy|2
7630886|NCT04435665|12044060|FG000|Overall Study|Lost to Follow-up|0
7630887|NCT04435665|12044061|FG001|Overall Study|Lost to Follow-up|0
7630888|NCT04435665|12044062|FG002|Overall Study|Lost to Follow-up|0
7630889|NCT04435665|12044063|FG003|Overall Study|Lost to Follow-up|1
7630890|NCT04427501|12044083|FG000|Overall Study|Death|0
7630891|NCT04427501|12044084|FG001|Overall Study|Death|0
7630892|NCT04427501|12044085|FG002|Overall Study|Death|0
7630893|NCT04427501|12044086|FG003|Overall Study|Death|0
7630894|NCT04427501|12044087|FG004|Overall Study|Death|0
7630895|NCT04427501|12044088|FG005|Overall Study|Death|15
7630896|NCT04427501|12044089|FG006|Overall Study|Death|0
7630897|NCT04427501|12044090|FG007|Overall Study|Death|0
7630898|NCT04427501|12044091|FG008|Overall Study|Death|0
7630899|NCT04427501|12044092|FG009|Overall Study|Death|0
7630900|NCT04427501|12044083|FG000|Overall Study|Lost to Follow-up|5
7630901|NCT04427501|12044084|FG001|Overall Study|Lost to Follow-up|1
7630902|NCT04427501|12044085|FG002|Overall Study|Lost to Follow-up|2
7630903|NCT04427501|12044086|FG003|Overall Study|Lost to Follow-up|0
7630904|NCT04427501|12044087|FG004|Overall Study|Lost to Follow-up|2
7630905|NCT04427501|12044088|FG005|Overall Study|Lost to Follow-up|11
7630906|NCT04427501|12044089|FG006|Overall Study|Lost to Follow-up|10
7630907|NCT04427501|12044090|FG007|Overall Study|Lost to Follow-up|10
7630908|NCT04427501|12044091|FG008|Overall Study|Lost to Follow-up|2
7630909|NCT04427501|12044092|FG009|Overall Study|Lost to Follow-up|5
7630910|NCT04427501|12044083|FG000|Overall Study|Physician Decision|0
7630911|NCT04427501|12044084|FG001|Overall Study|Physician Decision|3
7630912|NCT04427501|12044085|FG002|Overall Study|Physician Decision|0
7630913|NCT04427501|12044086|FG003|Overall Study|Physician Decision|0
7630914|NCT04427501|12044087|FG004|Overall Study|Physician Decision|0
7630915|NCT04427501|12044088|FG005|Overall Study|Physician Decision|0
7630916|NCT04427501|12044089|FG006|Overall Study|Physician Decision|2
7630917|NCT04427501|12044090|FG007|Overall Study|Physician Decision|0
7630918|NCT04427501|12044091|FG008|Overall Study|Physician Decision|0
7630919|NCT04427501|12044092|FG009|Overall Study|Physician Decision|0
7630920|NCT04427501|12044083|FG000|Overall Study|Withdrawal by Subject|9
7630921|NCT04427501|12044084|FG001|Overall Study|Withdrawal by Subject|2
7630922|NCT04427501|12044085|FG002|Overall Study|Withdrawal by Subject|2
7630923|NCT04427501|12044086|FG003|Overall Study|Withdrawal by Subject|3
7630924|NCT04427501|12044087|FG004|Overall Study|Withdrawal by Subject|7
7630925|NCT04427501|12044088|FG005|Overall Study|Withdrawal by Subject|25
7630926|NCT04427501|12044089|FG006|Overall Study|Withdrawal by Subject|15
7630927|NCT04427501|12044090|FG007|Overall Study|Withdrawal by Subject|7
7630928|NCT04427501|12044091|FG008|Overall Study|Withdrawal by Subject|4
7630929|NCT04427501|12044092|FG009|Overall Study|Withdrawal by Subject|1
7630930|NCT04427501|12044083|FG000|Overall Study|Other - as reported by the investigator|1
7630931|NCT04427501|12044084|FG001|Overall Study|Other - as reported by the investigator|0
7630932|NCT04427501|12044085|FG002|Overall Study|Other - as reported by the investigator|0
7630933|NCT04427501|12044086|FG003|Overall Study|Other - as reported by the investigator|0
7630934|NCT04427501|12044087|FG004|Overall Study|Other - as reported by the investigator|0
7630935|NCT04427501|12044088|FG005|Overall Study|Other - as reported by the investigator|6
7630936|NCT04427501|12044089|FG006|Overall Study|Other - as reported by the investigator|6
7630937|NCT04427501|12044090|FG007|Overall Study|Other - as reported by the investigator|0
7630938|NCT04427501|12044091|FG008|Overall Study|Other - as reported by the investigator|0
7630939|NCT04427501|12044092|FG009|Overall Study|Other - as reported by the investigator|0
7630940|NCT04426630|12044125|FG000|Overall Study|Death|4
7630941|NCT04426630|12044125|FG000|Overall Study|Lost to Follow-up|2
7630942|NCT04421027|12044131|FG000|Treatment Period|Adverse Event|5
7630943|NCT04421027|12044132|FG001|Treatment Period|Adverse Event|3
7630944|NCT04421027|12044133|FG002|Treatment Period|Adverse Event|0
7630945|NCT04421027|12044134|FG003|Treatment Period|Adverse Event|0
7630946|NCT04421027|12044131|FG000|Treatment Period|Death|98
7630947|NCT04421027|12044132|FG001|Treatment Period|Death|61
7630948|NCT04421027|12044133|FG002|Treatment Period|Death|0
7630949|NCT04421027|12044134|FG003|Treatment Period|Death|0
7630950|NCT04421027|12044131|FG000|Treatment Period|Lost to Follow-up|22
7630951|NCT04421027|12044132|FG001|Treatment Period|Lost to Follow-up|20
7630952|NCT04421027|12044133|FG002|Treatment Period|Lost to Follow-up|0
7630953|NCT04421027|12044134|FG003|Treatment Period|Lost to Follow-up|0
7630954|NCT04421027|12044131|FG000|Treatment Period|Other-Unknown|15
7630955|NCT04421027|12044132|FG001|Treatment Period|Other-Unknown|9
7630956|NCT04421027|12044133|FG002|Treatment Period|Other-Unknown|0
7630957|NCT04421027|12044134|FG003|Treatment Period|Other-Unknown|0
7630958|NCT04421027|12044131|FG000|Treatment Period|Physician Decision|1
7630959|NCT04421027|12044132|FG001|Treatment Period|Physician Decision|1
7630960|NCT04421027|12044133|FG002|Treatment Period|Physician Decision|0
7630961|NCT04421027|12044134|FG003|Treatment Period|Physician Decision|0
7630962|NCT04421027|12044131|FG000|Treatment Period|Withdrawal by Subject|7
7630963|NCT04421027|12044132|FG001|Treatment Period|Withdrawal by Subject|12
7630964|NCT04421027|12044133|FG002|Treatment Period|Withdrawal by Subject|0
7630965|NCT04421027|12044134|FG003|Treatment Period|Withdrawal by Subject|0
7630966|NCT04421027|12044131|FG000|Treatment Period|Randomized Not Dosed|9
7630967|NCT04421027|12044132|FG001|Treatment Period|Randomized Not Dosed|14
7630968|NCT04421027|12044133|FG002|Treatment Period|Randomized Not Dosed|0
7630969|NCT04421027|12044134|FG003|Treatment Period|Randomized Not Dosed|0
7630970|NCT04421027|12044131|FG000|Follow-Up Period|Adverse Event|0
7630971|NCT04421027|12044132|FG001|Follow-Up Period|Adverse Event|0
7630972|NCT04421027|12044133|FG002|Follow-Up Period|Adverse Event|0
7630973|NCT04421027|12044134|FG003|Follow-Up Period|Adverse Event|3
7630974|NCT04421027|12044131|FG000|Follow-Up Period|Death|0
7630975|NCT04421027|12044132|FG001|Follow-Up Period|Death|0
7630976|NCT04421027|12044133|FG002|Follow-Up Period|Death|16
7630977|NCT04421027|12044134|FG003|Follow-Up Period|Death|17
7630978|NCT04421027|12044131|FG000|Follow-Up Period|Lost to Follow-up|0
7630979|NCT04421027|12044132|FG001|Follow-Up Period|Lost to Follow-up|0
7630980|NCT04421027|12044133|FG002|Follow-Up Period|Lost to Follow-up|7
7630981|NCT04421027|12044134|FG003|Follow-Up Period|Lost to Follow-up|7
7630982|NCT04421027|12044131|FG000|Follow-Up Period|Protocol Deviation|0
7630983|NCT04421027|12044132|FG001|Follow-Up Period|Protocol Deviation|0
7630984|NCT04421027|12044133|FG002|Follow-Up Period|Protocol Deviation|1
7630985|NCT04421027|12044134|FG003|Follow-Up Period|Protocol Deviation|0
7630986|NCT04421027|12044131|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630987|NCT04421027|12044132|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630988|NCT04421027|12044133|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1
7630989|NCT04421027|12044134|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0
7630990|NCT04421027|12044131|FG000|Follow-Up Period|Left message, participant did not call back|0
7630991|NCT04421027|12044132|FG001|Follow-Up Period|Left message, participant did not call back|0
7630992|NCT04421027|12044133|FG002|Follow-Up Period|Left message, participant did not call back|0
7630993|NCT04421027|12044134|FG003|Follow-Up Period|Left message, participant did not call back|1
7630994|NCT04421027|12044131|FG000|Follow-Up Period|Participant died|0
7630995|NCT04421027|12044132|FG001|Follow-Up Period|Participant died|0
7630996|NCT04421027|12044133|FG002|Follow-Up Period|Participant died|0
7630997|NCT04421027|12044134|FG003|Follow-Up Period|Participant died|1
7630998|NCT04421027|12044131|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0
7630999|NCT04421027|12044132|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0
7631000|NCT04421027|12044133|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0
7631001|NCT04421027|12044134|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1
7631002|NCT04413552|12044152|FG000|Overall Study|Adverse Event|0
7631003|NCT04413552|12044153|FG001|Overall Study|Adverse Event|0
7631004|NCT04413552|12044154|FG002|Overall Study|Adverse Event|0
7631005|NCT04413552|12044155|FG003|Overall Study|Adverse Event|0
7631006|NCT04413552|12044156|FG004|Overall Study|Adverse Event|0
7631007|NCT04413552|12044157|FG005|Overall Study|Adverse Event|0
7631008|NCT04413552|12044158|FG006|Overall Study|Adverse Event|1
7631009|NCT04413552|12044159|FG007|Overall Study|Adverse Event|0
7631010|NCT04413552|12044160|FG008|Overall Study|Adverse Event|0
7631011|NCT04413552|12044161|FG009|Overall Study|Adverse Event|0
7631012|NCT04412707|12044189|FG000|Cycle 1|Death|0
7631013|NCT04412707|12044190|FG001|Cycle 1|Death|3
7631014|NCT04412707|12044189|FG000|Cycle 1|Disease progression|1
7631015|NCT04412707|12044190|FG001|Cycle 1|Disease progression|2
7631016|NCT04412707|12044189|FG000|Cycle 2|Death|0
7631017|NCT04412707|12044190|FG001|Cycle 2|Death|1
7631018|NCT04412707|12044189|FG000|Cycle 2|Disease progression|3
7631019|NCT04412707|12044190|FG001|Cycle 2|Disease progression|0
7631020|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Death|1
7631021|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Death|3
7631022|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4
7631023|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2
7631024|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4
7631025|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2
7631026|NCT04412707|12044189|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1
7631027|NCT04412707|12044190|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0
7631028|NCT04410198|12044196|FG000|Overall Study|Death|10
7631029|NCT04410198|12044196|FG000|Overall Study|Withdrawal by Subject|7
7631030|NCT04410198|12044196|FG000|Overall Study|Transferred/Relocation|4
7631031|NCT04410198|12044196|FG000|Overall Study|Kidney Transplant|9
7631032|NCT04410198|12044196|FG000|Overall Study|Adverse Event|4
7631033|NCT04410198|12044196|FG000|Overall Study|Physician Decision|2
7631034|NCT04410198|12044196|FG000|Overall Study|Other than specified|1
7631035|NCT04404010|12044202|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
7631036|NCT04404010|12044203|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
7631037|NCT04401423|12044213|FG000|Overall Study|Withdrawal by Subject|3
7631038|NCT04401423|12044214|FG001|Overall Study|Withdrawal by Subject|1
7631039|NCT04401423|12044213|FG000|Overall Study|Physician Decision|2
7631040|NCT04401423|12044214|FG001|Overall Study|Physician Decision|1
7631041|NCT04398134|12044226|FG000|Overall Study|Adverse Event|0
7631042|NCT04398134|12044227|FG001|Overall Study|Adverse Event|0
7631043|NCT04398134|12044228|FG002|Overall Study|Adverse Event|1
7631044|NCT04398134|12044229|FG003|Overall Study|Adverse Event|0
7631045|NCT04398134|12044226|FG000|Overall Study|Withdrawal by Subject|2
7631046|NCT04398134|12044227|FG001|Overall Study|Withdrawal by Subject|0
7631047|NCT04398134|12044228|FG002|Overall Study|Withdrawal by Subject|0
7631048|NCT04398134|12044229|FG003|Overall Study|Withdrawal by Subject|1
7631049|NCT04398134|12044226|FG000|Overall Study|Study Terminated by Sponsor|30
7631050|NCT04398134|12044227|FG001|Overall Study|Study Terminated by Sponsor|11
7631051|NCT04398134|12044228|FG002|Overall Study|Study Terminated by Sponsor|32
7631052|NCT04398134|12044229|FG003|Overall Study|Study Terminated by Sponsor|11
7631053|NCT04398030|12044239|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0
7631054|NCT04398030|12044240|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1
7631055|NCT04398030|12044239|FG000|Treatment Period 2 (1 Week)|Physician Decision|1
7631056|NCT04398030|12044240|FG001|Treatment Period 2 (1 Week)|Physician Decision|0
7631057|NCT04390191|12044257|FG000|Overall Study|Withdrawal by Subject|1
7631058|NCT04390191|12044258|FG001|Overall Study|Withdrawal by Subject|0
7631059|NCT04389840|12044270|FG000|Overall Study|Adverse Event|0
7631060|NCT04389840|12044271|FG001|Overall Study|Adverse Event|0
7631061|NCT04389840|12044272|FG002|Overall Study|Adverse Event|0
7631062|NCT04389840|12044273|FG003|Overall Study|Adverse Event|1
7631063|NCT04389840|12044274|FG004|Overall Study|Adverse Event|0
7631064|NCT04389840|12044275|FG005|Overall Study|Adverse Event|0
7631065|NCT04389840|12044270|FG000|Overall Study|Subject request and prohibited concomitant medication|2
7631066|NCT04389840|12044271|FG001|Overall Study|Subject request and prohibited concomitant medication|0
7631067|NCT04389840|12044272|FG002|Overall Study|Subject request and prohibited concomitant medication|0
7631068|NCT04389840|12044273|FG003|Overall Study|Subject request and prohibited concomitant medication|0
7631069|NCT04389840|12044274|FG004|Overall Study|Subject request and prohibited concomitant medication|1
7631070|NCT04389840|12044275|FG005|Overall Study|Subject request and prohibited concomitant medication|0
7631071|NCT04389840|12044270|FG000|Overall Study|Death|0
7631072|NCT04389840|12044271|FG001|Overall Study|Death|1
7631073|NCT04389840|12044272|FG002|Overall Study|Death|0
7631074|NCT04389840|12044273|FG003|Overall Study|Death|0
7631075|NCT04389840|12044274|FG004|Overall Study|Death|0
7631076|NCT04389840|12044275|FG005|Overall Study|Death|0
7631077|NCT04388826|12044291|FG000|Overall Study|Lost to Follow-up|3
7631078|NCT04388826|12044292|FG001|Overall Study|Lost to Follow-up|2
7631079|NCT04388826|12044291|FG000|Overall Study|Adverse Event|1
7631080|NCT04388826|12044292|FG001|Overall Study|Adverse Event|0
7631081|NCT04382651|12044300|FG000|Overall Study|Death|26
7631082|NCT04382651|12044301|FG001|Overall Study|Death|23
7631083|NCT04382651|12044300|FG000|Overall Study|Lost to Follow-up|3
7631084|NCT04382651|12044301|FG001|Overall Study|Lost to Follow-up|4
7631085|NCT04382651|12044300|FG000|Overall Study|Withdrawal by Subject|2
7631086|NCT04382651|12044301|FG001|Overall Study|Withdrawal by Subject|0
7631087|NCT04382651|12044300|FG000|Overall Study|Physician Decision|0
7631088|NCT04382651|12044301|FG001|Overall Study|Physician Decision|1
7631089|NCT04382066|12044311|FG000|Overall Study|Adverse Event|1
7631090|NCT04382066|12044312|FG001|Overall Study|Adverse Event|0
7631091|NCT04382066|12044313|FG002|Overall Study|Adverse Event|0
7631092|NCT04382066|12044311|FG000|Overall Study|Death|1
7631093|NCT04382066|12044312|FG001|Overall Study|Death|0
7631094|NCT04382066|12044313|FG002|Overall Study|Death|1
7631095|NCT04375878|12044331|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1
7631096|NCT04375878|12044332|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1
7631097|NCT04375878|12044333|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0
7631098|NCT04375878|12044334|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0
7631099|NCT04375878|12044335|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0
7631100|NCT04375878|12044336|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0
7631101|NCT04375878|12044331|FG000|Crossover First and Second Interventions|Adverse Event|0
7631102|NCT04375878|12044332|FG001|Crossover First and Second Interventions|Adverse Event|0
7631103|NCT04375878|12044333|FG002|Crossover First and Second Interventions|Adverse Event|1
7631104|NCT04375878|12044334|FG003|Crossover First and Second Interventions|Adverse Event|0
7631105|NCT04375878|12044335|FG004|Crossover First and Second Interventions|Adverse Event|0
7631106|NCT04375878|12044336|FG005|Crossover First and Second Interventions|Adverse Event|0
7631107|NCT04375878|12044331|FG000|Extension Phase|Withdrawal by Subject|0
7631108|NCT04375878|12044332|FG001|Extension Phase|Withdrawal by Subject|0
7631109|NCT04375878|12044333|FG002|Extension Phase|Withdrawal by Subject|0
7631110|NCT04375878|12044334|FG003|Extension Phase|Withdrawal by Subject|0
7631111|NCT04375878|12044335|FG004|Extension Phase|Withdrawal by Subject|1
7631112|NCT04375878|12044336|FG005|Extension Phase|Withdrawal by Subject|0
7631113|NCT04363736|12044358|FG000|Overall Study|Withdrawal by Subject|1
7631114|NCT04363736|12044359|FG001|Overall Study|Withdrawal by Subject|0
7631115|NCT04363736|12044358|FG000|Overall Study|Lost to Follow-up|10
7631116|NCT04363736|12044359|FG001|Overall Study|Lost to Follow-up|7
7631117|NCT04363736|12044358|FG000|Overall Study|Death|8
7631118|NCT04363736|12044359|FG001|Overall Study|Death|6
7631119|NCT04353596|12044388|FG000|Overall Study|Protocol Violation|4
7631120|NCT04353596|12044389|FG001|Overall Study|Protocol Violation|4
7631121|NCT04353596|12044388|FG000|Overall Study|no evidence of recent SARS-CoV-2|1
7631122|NCT04353596|12044389|FG001|Overall Study|no evidence of recent SARS-CoV-2|3
7631123|NCT04328077|12044407|FG000|Overall Study|Lost to Follow-up|0
7631124|NCT04328077|12044408|FG001|Overall Study|Lost to Follow-up|1
7631125|NCT04328077|12044409|FG002|Overall Study|Lost to Follow-up|0
7631126|NCT04328077|12044410|FG003|Overall Study|Lost to Follow-up|0
7631127|NCT04328077|12044407|FG000|Overall Study|Withdrawal by Subject|0
7631128|NCT04328077|12044408|FG001|Overall Study|Withdrawal by Subject|1
7631129|NCT04328077|12044409|FG002|Overall Study|Withdrawal by Subject|1
7631130|NCT04328077|12044410|FG003|Overall Study|Withdrawal by Subject|3
7631131|NCT04325828|12044426|FG000|Overall Study|Ongoing|26
7631132|NCT04318093|12044432|FG000|Overall Study|Adverse Event|2
7631133|NCT04318093|12044433|FG001|Overall Study|Adverse Event|2
7631134|NCT04318093|12044432|FG000|Overall Study|Participant withdrew consent|1
7631135|NCT04318093|12044433|FG001|Overall Study|Participant withdrew consent|0
7631136|NCT04318093|12044432|FG000|Overall Study|Other reasons|0
7631137|NCT04318093|12044433|FG001|Overall Study|Other reasons|1
7631138|NCT04314284|12044442|FG000|Overall Study|Withdrawal by Subject|4
7631139|NCT04314284|12044443|FG001|Overall Study|Withdrawal by Subject|7
7631140|NCT04314284|12044442|FG000|Overall Study|Consented but did not complete survey|0
7631141|NCT04314284|12044443|FG001|Overall Study|Consented but did not complete survey|6
7631142|NCT04274686|12044477|FG000|Overall Study|Physician Decision|1
7631143|NCT04274686|12044478|FG001|Overall Study|Physician Decision|0
7631144|NCT04253236|12044486|FG000|Overall Study|Adverse Event|1
7631145|NCT04253236|12044487|FG001|Overall Study|Adverse Event|0
7631146|NCT04253236|12044486|FG000|Overall Study|Safety Concerns|1
7631147|NCT04253236|12044487|FG001|Overall Study|Safety Concerns|0
7631148|NCT04253236|12044486|FG000|Overall Study|Study Terminated by Sponsor|1
7631149|NCT04253236|12044487|FG001|Overall Study|Study Terminated by Sponsor|0
7631150|NCT04252586|12044493|FG000|Overall Study|Withdrawal by parent/guardian|3
7631151|NCT04252586|12044493|FG000|Overall Study|Adverse Event|1
7631152|NCT04252586|12044493|FG000|Overall Study|Death|2
7631153|NCT04252586|12044493|FG000|Overall Study|Study terminated by sponsor|4
7631154|NCT04252586|12044493|FG000|Overall Study|Sponsor request|10
7631155|NCT04252586|12044493|FG000|Overall Study|Did not complete treatment period|1
7631156|NCT04245709|12044502|FG000|Overall Study|Adverse Event|13
7631157|NCT04245709|12044502|FG000|Overall Study|Risk of travel during COVID19 pandemic|1
7631158|NCT04236141|12044512|FG000|Overall Study|Death|11
7631159|NCT04236141|12044513|FG001|Overall Study|Death|9
7631160|NCT04236141|12044512|FG000|Overall Study|Withdrawal by Participant|1
7631161|NCT04236141|12044513|FG001|Overall Study|Withdrawal by Participant|0
7631162|NCT04236141|12044512|FG000|Overall Study|Reason not Specified|1
7631163|NCT04236141|12044513|FG001|Overall Study|Reason not Specified|0
7631164|NCT04233580|12044521|FG000|Overall Study|Adverse Event|3
7631165|NCT04233580|12044522|FG001|Overall Study|Adverse Event|3
7631166|NCT04233580|12044521|FG000|Overall Study|Withdrawal by Subject|2
7631167|NCT04233580|12044522|FG001|Overall Study|Withdrawal by Subject|1
7631168|NCT04232943|12044531|FG000|Overall Study|Enrolled but Treatment not Administered|2
7631169|NCT04232943|12044532|FG001|Overall Study|Enrolled but Treatment not Administered|3
7631170|NCT04232943|12044533|FG002|Overall Study|Enrolled but Treatment not Administered|2
7631171|NCT04232943|12044531|FG000|Overall Study|Withdrawal by Subject|1
7631172|NCT04232943|12044532|FG001|Overall Study|Withdrawal by Subject|1
7631173|NCT04232943|12044533|FG002|Overall Study|Withdrawal by Subject|0
7631174|NCT04230876|12044544|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1
7631175|NCT04230876|12044545|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1
7631176|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8
7631177|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0
7631178|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0
7631179|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7
7631180|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0
7631181|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0
7631182|NCT04230213|12044551|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3
7631183|NCT04230213|12044552|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0
7631184|NCT04230213|12044553|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0
7631185|NCT04230213|12044551|FG000|TP2: Week 10 to Week 16|Other|0
7631186|NCT04230213|12044552|FG001|TP2: Week 10 to Week 16|Other|2
7631187|NCT04230213|12044553|FG002|TP2: Week 10 to Week 16|Other|1
7631188|NCT04230213|12044551|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0
7631189|NCT04230213|12044552|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0
7631190|NCT04230213|12044553|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2
7631191|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0
7631192|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0
7631193|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1
7631194|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0
7631195|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0
7631196|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2
7631197|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Physician Decision|0
7631198|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Physician Decision|0
7631199|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Physician Decision|1
7631200|NCT04230213|12044551|FG000|TP3: Week 16 to Week 22|Other|0
7631201|NCT04230213|12044552|FG001|TP3: Week 16 to Week 22|Other|1
7631202|NCT04230213|12044553|FG002|TP3: Week 16 to Week 22|Other|3
7631203|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Other|0
7631204|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Other|5
7631205|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Other|5
7631206|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0
7631207|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1
7631208|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2
7631209|NCT04230213|12044551|FG000|TP4: Week 22 to Week 32|Physician Decision|0
7631210|NCT04230213|12044552|FG001|TP4: Week 22 to Week 32|Physician Decision|2
7631211|NCT04230213|12044553|FG002|TP4: Week 22 to Week 32|Physician Decision|1
7631212|NCT04230213|12044551|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0
7631213|NCT04230213|12044552|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0
7631214|NCT04230213|12044553|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1
7631215|NCT04230213|12044551|FG000|Follow up: Week 32 to Week 36|Other|0
7631216|NCT04230213|12044552|FG001|Follow up: Week 32 to Week 36|Other|1
7631217|NCT04230213|12044553|FG002|Follow up: Week 32 to Week 36|Other|1
7631218|NCT04223791|12044563|FG000|Overall Study|Lost to Follow-up|0
7631219|NCT04223791|12044564|FG001|Overall Study|Lost to Follow-up|4
7631220|NCT04223791|12044563|FG000|Overall Study|Physician Decision|5
7631221|NCT04223791|12044564|FG001|Overall Study|Physician Decision|1
7631222|NCT04223791|12044563|FG000|Overall Study|Protocol Violation|1
7631223|NCT04223791|12044564|FG001|Overall Study|Protocol Violation|1
7631224|NCT04223791|12044563|FG000|Overall Study|Withdrawal by Subject|10
7631225|NCT04223791|12044564|FG001|Overall Study|Withdrawal by Subject|12
7631226|NCT04223791|12044563|FG000|Overall Study|Pregnancy|1
7631227|NCT04223791|12044564|FG001|Overall Study|Pregnancy|1
7631228|NCT04223791|12044563|FG000|Overall Study|Ongoing in Study|305
7631229|NCT04223791|12044564|FG001|Overall Study|Ongoing in Study|302
7631230|NCT04223778|12044572|FG000|Overall Study|Ongoing|322
7631231|NCT04223778|12044573|FG001|Overall Study|Ongoing|326
7631232|NCT04223778|12044572|FG000|Overall Study|Death|0
7631233|NCT04223778|12044573|FG001|Overall Study|Death|1
7631234|NCT04223778|12044572|FG000|Overall Study|Lost to Follow-up|1
7631235|NCT04223778|12044573|FG001|Overall Study|Lost to Follow-up|5
7631236|NCT04223778|12044572|FG000|Overall Study|Physician Decision|3
7631237|NCT04223778|12044573|FG001|Overall Study|Physician Decision|1
7631238|NCT04223778|12044572|FG000|Overall Study|Withdrawal by Subject|10
7631239|NCT04223778|12044573|FG001|Overall Study|Withdrawal by Subject|1
7631240|NCT04223778|12044572|FG000|Overall Study|Lack of Efficacy|0
7631241|NCT04223778|12044573|FG001|Overall Study|Lack of Efficacy|2
7631242|NCT04218695|12044581|FG000|Overall Study|Adverse Event|1
7631243|NCT04218695|12044582|FG001|Overall Study|Adverse Event|0
7631244|NCT04213989|12044590|FG000|Overall Study|Withdrawal by Subject|3
7631245|NCT04213989|12044591|FG001|Overall Study|Withdrawal by Subject|2
7631246|NCT04213989|12044590|FG000|Overall Study|Physician Decision|1
7631247|NCT04213989|12044591|FG001|Overall Study|Physician Decision|0
7631248|NCT04213989|12044590|FG000|Overall Study|Lost to Follow-up|0
7631249|NCT04213989|12044591|FG001|Overall Study|Lost to Follow-up|4
7631250|NCT04206085|12044611|FG000|Overall Study|Lost to Follow-up|0
7631251|NCT04206085|12044612|FG001|Overall Study|Lost to Follow-up|1
7631252|NCT04206085|12044613|FG002|Overall Study|Lost to Follow-up|0
7631253|NCT04206085|12044611|FG000|Overall Study|Lost to Follow-up|0
7631254|NCT04206085|12044612|FG001|Overall Study|Lost to Follow-up|0
7631255|NCT04206085|12044613|FG002|Overall Study|Lost to Follow-up|1
7631256|NCT04202679|12044623|FG000|Overall Study|Adverse Event|2
7631257|NCT04202679|12044624|FG001|Overall Study|Adverse Event|0
7631258|NCT04202679|12044623|FG000|Overall Study|Lack of Efficacy|11
7631259|NCT04202679|12044624|FG001|Overall Study|Lack of Efficacy|1
7631260|NCT04202679|12044623|FG000|Overall Study|Poor compliance to protocol|2
7631261|NCT04202679|12044624|FG001|Overall Study|Poor compliance to protocol|0
7631262|NCT04202679|12044623|FG000|Overall Study|Withdrawal by Subject|10
7631263|NCT04202679|12044624|FG001|Overall Study|Withdrawal by Subject|1
7631264|NCT04202679|12044623|FG000|Overall Study|Randomized and not exposed|0
7631265|NCT04202679|12044624|FG001|Overall Study|Randomized and not exposed|1
7631266|NCT04189952|12044631|FG000|Follow-up Period|Death|1
7631267|NCT04189952|12044631|FG000|Follow-up Period|Withdrawal by Subject|1
7631268|NCT04182880|12044641|FG000|Overall Study|Pregnancy|1
7631269|NCT04182880|12044642|FG001|Overall Study|Pregnancy|0
7631270|NCT04178967|12044667|FG000|Overall Study|Adverse Event|4
7631271|NCT04178967|12044668|FG001|Overall Study|Adverse Event|6
7631272|NCT04178967|12044667|FG000|Overall Study|Due to Epidemic/Pandemic|0
7631273|NCT04178967|12044668|FG001|Overall Study|Due to Epidemic/Pandemic|1
7631274|NCT04178967|12044667|FG000|Overall Study|Lack of Efficacy|3
7631275|NCT04178967|12044668|FG001|Overall Study|Lack of Efficacy|1
7631276|NCT04178967|12044667|FG000|Overall Study|Protocol Violation|0
7631277|NCT04178967|12044668|FG001|Overall Study|Protocol Violation|7
7631278|NCT04178967|12044667|FG000|Overall Study|Withdrawal by Subject|8
7631279|NCT04178967|12044668|FG001|Overall Study|Withdrawal by Subject|7
7631280|NCT04178967|12044667|FG000|Overall Study|Lost to Follow-up|2
7631281|NCT04178967|12044668|FG001|Overall Study|Lost to Follow-up|0
7631282|NCT04175392|12044680|FG000|Overall Study|Withdrawal by Subject|3
7631283|NCT04175392|12044681|FG001|Overall Study|Withdrawal by Subject|2
7631284|NCT04173572|12044689|FG000|Overall Study|Withdrawal by Subject|1
7631285|NCT04173572|12044690|FG001|Overall Study|Withdrawal by Subject|5
7631286|NCT04173572|12044689|FG000|Overall Study|Lost to Follow-up|3
7631287|NCT04173572|12044690|FG001|Overall Study|Lost to Follow-up|1
7631288|NCT04172831|12044698|FG000|Overall Study|Adverse Event|21
7631289|NCT04172831|12044699|FG001|Overall Study|Adverse Event|9
7631290|NCT04172831|12044698|FG000|Overall Study|Lack of Efficacy|2
7631291|NCT04172831|12044699|FG001|Overall Study|Lack of Efficacy|8
7631292|NCT04172831|12044698|FG000|Overall Study|Physician Decision|0
7631293|NCT04172831|12044699|FG001|Overall Study|Physician Decision|1
7631294|NCT04172831|12044698|FG000|Overall Study|Withdrawal by Subject|12
7631295|NCT04172831|12044699|FG001|Overall Study|Withdrawal by Subject|11
7631296|NCT04172831|12044698|FG000|Overall Study|Lost to Follow-up|4
7631297|NCT04172831|12044699|FG001|Overall Study|Lost to Follow-up|9
7631298|NCT04172831|12044698|FG000|Overall Study|COVID-19 related crisis|3
7631299|NCT04172831|12044699|FG001|Overall Study|COVID-19 related crisis|3
7631300|NCT04172831|12044698|FG000|Overall Study|Subject non-compliance|1
7631301|NCT04172831|12044699|FG001|Overall Study|Subject non-compliance|1
7631302|NCT04172831|12044698|FG000|Overall Study|Family emergency|1
7631303|NCT04172831|12044699|FG001|Overall Study|Family emergency|0
7631304|NCT04169373|12044709|FG000|Overall Study|Adverse Event|1
7631305|NCT04169373|12044710|FG001|Overall Study|Adverse Event|0
7631306|NCT04169373|12044711|FG002|Overall Study|Adverse Event|1
7631307|NCT04169373|12044712|FG003|Overall Study|Adverse Event|2
7631308|NCT04169373|12044709|FG000|Overall Study|Withdrawal by Subject|2
7631309|NCT04169373|12044710|FG001|Overall Study|Withdrawal by Subject|0
7631310|NCT04169373|12044711|FG002|Overall Study|Withdrawal by Subject|5
7631311|NCT04169373|12044712|FG003|Overall Study|Withdrawal by Subject|6
7631312|NCT04169373|12044709|FG000|Overall Study|Lost to Follow-up|1
7631313|NCT04169373|12044710|FG001|Overall Study|Lost to Follow-up|1
7631314|NCT04169373|12044711|FG002|Overall Study|Lost to Follow-up|0
7631315|NCT04169373|12044712|FG003|Overall Study|Lost to Follow-up|1
7631316|NCT04169373|12044709|FG000|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631317|NCT04169373|12044710|FG001|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1
7631318|NCT04169373|12044711|FG002|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631319|NCT04169373|12044712|FG003|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0
7631320|NCT04169373|12044709|FG000|Overall Study|Other|1
7631321|NCT04169373|12044710|FG001|Overall Study|Other|3
7631322|NCT04169373|12044711|FG002|Overall Study|Other|3
7631323|NCT04169373|12044712|FG003|Overall Study|Other|5
7631324|NCT04168190|12044731|FG000|Overall Study|Lost to Follow-up|0
7631325|NCT04168190|12044732|FG001|Overall Study|Lost to Follow-up|1
7631326|NCT04168190|12044733|FG002|Overall Study|Lost to Follow-up|0
7631327|NCT04168190|12044734|FG003|Overall Study|Lost to Follow-up|7
7631328|NCT04168190|12044735|FG004|Overall Study|Lost to Follow-up|5
7631329|NCT04168190|12044731|FG000|Overall Study|Withdrawal by Subject|1
7631330|NCT04168190|12044732|FG001|Overall Study|Withdrawal by Subject|0
7631331|NCT04168190|12044733|FG002|Overall Study|Withdrawal by Subject|0
7631332|NCT04168190|12044734|FG003|Overall Study|Withdrawal by Subject|2
7631333|NCT04168190|12044735|FG004|Overall Study|Withdrawal by Subject|4
7631334|NCT04168190|12044731|FG000|Overall Study|Death|0
7631335|NCT04168190|12044732|FG001|Overall Study|Death|0
7631336|NCT04168190|12044733|FG002|Overall Study|Death|0
7631337|NCT04168190|12044734|FG003|Overall Study|Death|1
7631338|NCT04168190|12044735|FG004|Overall Study|Death|0
7631339|NCT04166630|12044749|FG000|Overall Study|Withdrawal by Subject|0
7631340|NCT04166630|12044750|FG001|Overall Study|Withdrawal by Subject|1
7631341|NCT04165824|12044756|FG000|Overall Study|Adverse Event|23
7631342|NCT04165824|12044756|FG000|Overall Study|Physician Decision|1
7631343|NCT04165824|12044756|FG000|Overall Study|Withdrawal by Subject|17
7631344|NCT04165824|12044756|FG000|Overall Study|Other|5
7631345|NCT04161131|12044760|FG000|Overall Study|Ineligible|2
7631346|NCT04161131|12044760|FG000|Overall Study|Lost to Follow-up|4
7631347|NCT04154293|12044771|FG000|Overall Study|Withdrawal by Subject|2
7631348|NCT04154293|12044772|FG001|Overall Study|Withdrawal by Subject|3
7631349|NCT04154293|12044773|FG002|Overall Study|Withdrawal by Subject|1
7631350|NCT04154293|12044771|FG000|Overall Study|Physician Decision|0
7631351|NCT04154293|12044772|FG001|Overall Study|Physician Decision|0
7631352|NCT04154293|12044773|FG002|Overall Study|Physician Decision|1
7631353|NCT04152200|12044783|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6
7631354|NCT04152200|12044784|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15
7631355|NCT04146363|12044794|FG000|Overall Study|Adverse Event|1
7631356|NCT04146363|12044795|FG001|Overall Study|Adverse Event|2
7631357|NCT04146363|12044794|FG000|Overall Study|Due to Epidemic/Pandemic|1
7631358|NCT04146363|12044795|FG001|Overall Study|Due to Epidemic/Pandemic|1
7631359|NCT04146363|12044794|FG000|Overall Study|Lack of Efficacy|6
7631360|NCT04146363|12044795|FG001|Overall Study|Lack of Efficacy|2
7631361|NCT04146363|12044794|FG000|Overall Study|Lost to Follow-up|1
7631362|NCT04146363|12044795|FG001|Overall Study|Lost to Follow-up|4
7631363|NCT04146363|12044794|FG000|Overall Study|Positive quantiferon test|0
7631364|NCT04146363|12044795|FG001|Overall Study|Positive quantiferon test|1
7631365|NCT04146363|12044794|FG000|Overall Study|Protocol Deviation|5
7631366|NCT04146363|12044795|FG001|Overall Study|Protocol Deviation|6
7631367|NCT04146363|12044794|FG000|Overall Study|Withdrawal by Subject|6
7631368|NCT04146363|12044795|FG001|Overall Study|Withdrawal by Subject|4
7631369|NCT04146363|12044794|FG000|Overall Study|Started systemic dexamethasone|1
7631370|NCT04146363|12044795|FG001|Overall Study|Started systemic dexamethasone|0
7631371|NCT04130919|12044822|FG000|Blinded Treatment Phase|Study terminated by sponsor|1
7631372|NCT04130919|12044823|FG001|Blinded Treatment Phase|Study terminated by sponsor|1
7631373|NCT04130919|12044824|FG002|Blinded Treatment Phase|Study terminated by sponsor|1
7631374|NCT04130919|12044825|FG003|Blinded Treatment Phase|Study terminated by sponsor|0
7631375|NCT04130919|12044826|FG004|Blinded Treatment Phase|Study terminated by sponsor|0
7631376|NCT04130919|12044827|FG005|Blinded Treatment Phase|Study terminated by sponsor|0
7631377|NCT04130919|12044822|FG000|Blinded Treatment Phase|Adverse Event|0
7631378|NCT04130919|12044823|FG001|Blinded Treatment Phase|Adverse Event|0
7631379|NCT04130919|12044824|FG002|Blinded Treatment Phase|Adverse Event|1
7631380|NCT04130919|12044825|FG003|Blinded Treatment Phase|Adverse Event|0
7631381|NCT04130919|12044826|FG004|Blinded Treatment Phase|Adverse Event|0
7631382|NCT04130919|12044827|FG005|Blinded Treatment Phase|Adverse Event|0
7631383|NCT04130919|12044822|FG000|Blinded Treatment Phase|Disease worsening|0
7631384|NCT04130919|12044823|FG001|Blinded Treatment Phase|Disease worsening|0
7631385|NCT04130919|12044824|FG002|Blinded Treatment Phase|Disease worsening|1
7631386|NCT04130919|12044825|FG003|Blinded Treatment Phase|Disease worsening|0
7631387|NCT04130919|12044826|FG004|Blinded Treatment Phase|Disease worsening|0
7631388|NCT04130919|12044827|FG005|Blinded Treatment Phase|Disease worsening|0
7631389|NCT04130919|12044822|FG000|Blinded Treatment Phase|Investigator's decision|0
7631390|NCT04130919|12044823|FG001|Blinded Treatment Phase|Investigator's decision|1
7631391|NCT04130919|12044824|FG002|Blinded Treatment Phase|Investigator's decision|0
7631392|NCT04130919|12044825|FG003|Blinded Treatment Phase|Investigator's decision|0
7631393|NCT04130919|12044826|FG004|Blinded Treatment Phase|Investigator's decision|0
7631394|NCT04130919|12044827|FG005|Blinded Treatment Phase|Investigator's decision|0
7631395|NCT04130919|12044822|FG000|Blinded Treatment Phase|Withdrew consent|1
7631396|NCT04130919|12044823|FG001|Blinded Treatment Phase|Withdrew consent|0
7631397|NCT04130919|12044824|FG002|Blinded Treatment Phase|Withdrew consent|0
7631398|NCT04130919|12044825|FG003|Blinded Treatment Phase|Withdrew consent|0
7631399|NCT04130919|12044826|FG004|Blinded Treatment Phase|Withdrew consent|0
7631400|NCT04130919|12044827|FG005|Blinded Treatment Phase|Withdrew consent|0
7631401|NCT04130919|12044822|FG000|Open-label Treatment Phase|Withdrew consent|0
7631402|NCT04130919|12044823|FG001|Open-label Treatment Phase|Withdrew consent|0
7631403|NCT04130919|12044824|FG002|Open-label Treatment Phase|Withdrew consent|0
7631404|NCT04130919|12044825|FG003|Open-label Treatment Phase|Withdrew consent|1
7631405|NCT04130919|12044826|FG004|Open-label Treatment Phase|Withdrew consent|1
7631406|NCT04130919|12044827|FG005|Open-label Treatment Phase|Withdrew consent|1
7631407|NCT04130919|12044822|FG000|Open-label Treatment Phase|Disease worsening|0
7631408|NCT04130919|12044823|FG001|Open-label Treatment Phase|Disease worsening|0
7631409|NCT04130919|12044824|FG002|Open-label Treatment Phase|Disease worsening|0
7631410|NCT04130919|12044825|FG003|Open-label Treatment Phase|Disease worsening|1
7631411|NCT04130919|12044826|FG004|Open-label Treatment Phase|Disease worsening|0
7631412|NCT04130919|12044827|FG005|Open-label Treatment Phase|Disease worsening|1
7631413|NCT04130919|12044822|FG000|Open-label Treatment Phase|Investigator's decision|0
7631414|NCT04130919|12044823|FG001|Open-label Treatment Phase|Investigator's decision|0
7631415|NCT04130919|12044824|FG002|Open-label Treatment Phase|Investigator's decision|0
7631416|NCT04130919|12044825|FG003|Open-label Treatment Phase|Investigator's decision|1
7631417|NCT04130919|12044826|FG004|Open-label Treatment Phase|Investigator's decision|0
7631418|NCT04130919|12044827|FG005|Open-label Treatment Phase|Investigator's decision|0
7631419|NCT04130919|12044822|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7631420|NCT04130919|12044823|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7631421|NCT04130919|12044824|FG002|Open-label Treatment Phase|Lost to Follow-up|0
7631422|NCT04130919|12044825|FG003|Open-label Treatment Phase|Lost to Follow-up|0
7631423|NCT04130919|12044826|FG004|Open-label Treatment Phase|Lost to Follow-up|0
7631424|NCT04130919|12044827|FG005|Open-label Treatment Phase|Lost to Follow-up|1
7631425|NCT04130919|12044822|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631426|NCT04130919|12044823|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631427|NCT04130919|12044824|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631428|NCT04130919|12044825|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631429|NCT04130919|12044826|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1
7631430|NCT04130919|12044827|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0
7631431|NCT04128696|12044843|FG000|Overall Study|Lost to Follow-up|0
7631432|NCT04128696|12044844|FG001|Overall Study|Lost to Follow-up|1
7631433|NCT04128696|12044843|FG000|Overall Study|Withdrawal by Subject|8
7631434|NCT04128696|12044844|FG001|Overall Study|Withdrawal by Subject|5
7631435|NCT04128696|12044843|FG000|Overall Study|In Follow-up|47
7631436|NCT04128696|12044844|FG001|Overall Study|In Follow-up|51
7631437|NCT04128696|12044843|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52
7631438|NCT04128696|12044844|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62
7631439|NCT04128267|12044850|FG000|Overall Study|Withdrawal by Subject|6
7631440|NCT04128267|12044850|FG000|Overall Study|Death|2
7631441|NCT04128267|12044850|FG000|Overall Study|Disease progression|1
7631442|NCT04128267|12044850|FG000|Overall Study|Participant had other medical issues|4
7631443|NCT04128267|12044850|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2
7631444|NCT04124926|12044856|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3
7631445|NCT04124926|12044857|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7
7631446|NCT04124926|12044858|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631447|NCT04124926|12044859|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631448|NCT04124926|12044860|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0
7631449|NCT04124926|12044856|FG000|Healing Phase|Protocol Violation|0
7631450|NCT04124926|12044857|FG001|Healing Phase|Protocol Violation|1
7631451|NCT04124926|12044858|FG002|Healing Phase|Protocol Violation|0
7631452|NCT04124926|12044859|FG003|Healing Phase|Protocol Violation|0
7631453|NCT04124926|12044860|FG004|Healing Phase|Protocol Violation|0
7631454|NCT04124926|12044856|FG000|Healing Phase|Lost to Follow-up|5
7631455|NCT04124926|12044857|FG001|Healing Phase|Lost to Follow-up|4
7631456|NCT04124926|12044858|FG002|Healing Phase|Lost to Follow-up|0
7631457|NCT04124926|12044859|FG003|Healing Phase|Lost to Follow-up|0
7631458|NCT04124926|12044860|FG004|Healing Phase|Lost to Follow-up|0
7631459|NCT04124926|12044856|FG000|Healing Phase|Voluntary Withdrawal|10
7631460|NCT04124926|12044857|FG001|Healing Phase|Voluntary Withdrawal|7
7631461|NCT04124926|12044858|FG002|Healing Phase|Voluntary Withdrawal|0
7631462|NCT04124926|12044859|FG003|Healing Phase|Voluntary Withdrawal|0
7631463|NCT04124926|12044860|FG004|Healing Phase|Voluntary Withdrawal|0
7631464|NCT04124926|12044856|FG000|Healing Phase|Withdrawal of Consent|5
7631465|NCT04124926|12044857|FG001|Healing Phase|Withdrawal of Consent|3
7631466|NCT04124926|12044858|FG002|Healing Phase|Withdrawal of Consent|0
7631467|NCT04124926|12044859|FG003|Healing Phase|Withdrawal of Consent|0
7631468|NCT04124926|12044860|FG004|Healing Phase|Withdrawal of Consent|0
7631469|NCT04124926|12044856|FG000|Healing Phase|Miscellaneous|8
7631470|NCT04124926|12044857|FG001|Healing Phase|Miscellaneous|7
7631471|NCT04124926|12044858|FG002|Healing Phase|Miscellaneous|0
7631472|NCT04124926|12044859|FG003|Healing Phase|Miscellaneous|0
7631473|NCT04124926|12044860|FG004|Healing Phase|Miscellaneous|0
7631474|NCT04124926|12044856|FG000|Healing Phase|Randomized but not Treated|0
7631475|NCT04124926|12044857|FG001|Healing Phase|Randomized but not Treated|3
7631476|NCT04124926|12044858|FG002|Healing Phase|Randomized but not Treated|0
7631477|NCT04124926|12044859|FG003|Healing Phase|Randomized but not Treated|0
7631478|NCT04124926|12044860|FG004|Healing Phase|Randomized but not Treated|0
7631479|NCT04124926|12044856|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0
7631480|NCT04124926|12044857|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0
7631481|NCT04124926|12044858|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3
7631482|NCT04124926|12044859|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5
7631483|NCT04124926|12044860|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4
7631484|NCT04124926|12044856|FG000|Maintenance Phase|Protocol Violation|0
7631485|NCT04124926|12044857|FG001|Maintenance Phase|Protocol Violation|0
7631486|NCT04124926|12044858|FG002|Maintenance Phase|Protocol Violation|3
7631487|NCT04124926|12044859|FG003|Maintenance Phase|Protocol Violation|0
7631488|NCT04124926|12044860|FG004|Maintenance Phase|Protocol Violation|0
7631489|NCT04124926|12044856|FG000|Maintenance Phase|Lost to Follow-up|0
7631490|NCT04124926|12044857|FG001|Maintenance Phase|Lost to Follow-up|0
7631491|NCT04124926|12044858|FG002|Maintenance Phase|Lost to Follow-up|7
7631492|NCT04124926|12044859|FG003|Maintenance Phase|Lost to Follow-up|8
7631493|NCT04124926|12044860|FG004|Maintenance Phase|Lost to Follow-up|9
7631494|NCT04124926|12044856|FG000|Maintenance Phase|Voluntary Withdrawal|0
7631495|NCT04124926|12044857|FG001|Maintenance Phase|Voluntary Withdrawal|0
7631496|NCT04124926|12044858|FG002|Maintenance Phase|Voluntary Withdrawal|3
7631497|NCT04124926|12044859|FG003|Maintenance Phase|Voluntary Withdrawal|6
7631498|NCT04124926|12044860|FG004|Maintenance Phase|Voluntary Withdrawal|5
7631499|NCT04124926|12044856|FG000|Maintenance Phase|Pregnancy|0
7631500|NCT04124926|12044857|FG001|Maintenance Phase|Pregnancy|0
7631501|NCT04124926|12044858|FG002|Maintenance Phase|Pregnancy|0
7631502|NCT04124926|12044859|FG003|Maintenance Phase|Pregnancy|1
7631503|NCT04124926|12044860|FG004|Maintenance Phase|Pregnancy|0
7631504|NCT04124926|12044856|FG000|Maintenance Phase|Lack of Efficacy|0
7631505|NCT04124926|12044857|FG001|Maintenance Phase|Lack of Efficacy|0
7631506|NCT04124926|12044858|FG002|Maintenance Phase|Lack of Efficacy|0
7631507|NCT04124926|12044859|FG003|Maintenance Phase|Lack of Efficacy|0
7631508|NCT04124926|12044860|FG004|Maintenance Phase|Lack of Efficacy|1
7631509|NCT04124926|12044856|FG000|Maintenance Phase|Withdrawal of Consent|0
7631510|NCT04124926|12044857|FG001|Maintenance Phase|Withdrawal of Consent|0
7631511|NCT04124926|12044858|FG002|Maintenance Phase|Withdrawal of Consent|5
7631512|NCT04124926|12044859|FG003|Maintenance Phase|Withdrawal of Consent|5
7631513|NCT04124926|12044860|FG004|Maintenance Phase|Withdrawal of Consent|5
7631514|NCT04124926|12044856|FG000|Maintenance Phase|Miscellaneous|0
7631515|NCT04124926|12044857|FG001|Maintenance Phase|Miscellaneous|0
7631516|NCT04124926|12044858|FG002|Maintenance Phase|Miscellaneous|1
7631517|NCT04124926|12044859|FG003|Maintenance Phase|Miscellaneous|2
7631518|NCT04124926|12044860|FG004|Maintenance Phase|Miscellaneous|4
7631519|NCT04124926|12044856|FG000|Maintenance Phase|Randomized but not Treated|0
7631520|NCT04124926|12044857|FG001|Maintenance Phase|Randomized but not Treated|0
7631521|NCT04124926|12044858|FG002|Maintenance Phase|Randomized but not Treated|2
7631522|NCT04124926|12044859|FG003|Maintenance Phase|Randomized but not Treated|2
7631523|NCT04124926|12044860|FG004|Maintenance Phase|Randomized but not Treated|0
7631524|NCT04123067|12044874|FG000|Overall Study|Lost to Follow-up|0
7631525|NCT04123067|12044875|FG001|Overall Study|Lost to Follow-up|1
7631526|NCT04093414|12044887|FG000|3 Month Follow up|Physician Decision|0
7631527|NCT04093414|12044888|FG001|3 Month Follow up|Physician Decision|1
7631528|NCT04093414|12044887|FG000|6month Follow up|Physician Decision|1
7631529|NCT04093414|12044888|FG001|6month Follow up|Physician Decision|3
7631530|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631531|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631532|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631533|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631534|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631535|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631536|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631537|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0
7631538|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1
7631539|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1
7631540|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631541|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631542|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631543|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631544|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631545|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631546|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1
7631547|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1
7631548|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631549|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0
7631550|NCT04091360|12044900|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631551|NCT04091360|12044901|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631552|NCT04091360|12044902|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631553|NCT04091360|12044903|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631554|NCT04091360|12044904|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631555|NCT04091360|12044905|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631556|NCT04091360|12044906|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1
7631557|NCT04091360|12044907|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631558|NCT04091360|12044908|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0
7631559|NCT04091360|12044909|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1
7631560|NCT04089553|12044933|FG000|Overall Study|Death|12
7631561|NCT04089553|12044934|FG001|Overall Study|Death|11
7631562|NCT04089553|12044933|FG000|Overall Study|Lost to Follow-up|2
7631563|NCT04089553|12044934|FG001|Overall Study|Lost to Follow-up|2
7631564|NCT04089553|12044933|FG000|Overall Study|Progressive disease|0
7631565|NCT04089553|12044934|FG001|Overall Study|Progressive disease|1
7631566|NCT04089553|12044933|FG000|Overall Study|Withdrawal by Subject|5
7631567|NCT04089553|12044934|FG001|Overall Study|Withdrawal by Subject|2
7631568|NCT04089553|12044933|FG000|Overall Study|Other|6
7631569|NCT04089553|12044934|FG001|Overall Study|Other|2
7631570|NCT04086472|12044946|FG000|Overall Study|Lost to Follow-up|1
7631571|NCT04086472|12044947|FG001|Overall Study|Lost to Follow-up|0
7631572|NCT04086472|12044948|FG002|Overall Study|Lost to Follow-up|0
7631573|NCT04086472|12044949|FG003|Overall Study|Lost to Follow-up|0
7631574|NCT04086472|12044950|FG004|Overall Study|Lost to Follow-up|1
7631575|NCT04086472|12044946|FG000|Overall Study|Physician Decision|0
7631576|NCT04086472|12044947|FG001|Overall Study|Physician Decision|1
7631577|NCT04086472|12044948|FG002|Overall Study|Physician Decision|1
7631578|NCT04086472|12044949|FG003|Overall Study|Physician Decision|0
7631579|NCT04086472|12044950|FG004|Overall Study|Physician Decision|0
7631580|NCT04086472|12044946|FG000|Overall Study|Withdrawal by Subject|1
7631581|NCT04086472|12044947|FG001|Overall Study|Withdrawal by Subject|1
7631582|NCT04086472|12044948|FG002|Overall Study|Withdrawal by Subject|1
7631583|NCT04086472|12044949|FG003|Overall Study|Withdrawal by Subject|0
7631584|NCT04086472|12044950|FG004|Overall Study|Withdrawal by Subject|0
7631585|NCT04086472|12044946|FG000|Overall Study|Various reasons|2
7631586|NCT04086472|12044947|FG001|Overall Study|Various reasons|0
7631587|NCT04086472|12044948|FG002|Overall Study|Various reasons|0
7631588|NCT04086472|12044949|FG003|Overall Study|Various reasons|3
7631589|NCT04086472|12044950|FG004|Overall Study|Various reasons|1
7631590|NCT04075604|12044989|FG000|Overall Study|Adverse Event|0
7631591|NCT04075604|12044990|FG001|Overall Study|Adverse Event|0
7631592|NCT04075604|12044991|FG002|Overall Study|Adverse Event|3
7631593|NCT04075604|12044989|FG000|Overall Study|Participant request to discontinue study treatment|0
7631594|NCT04075604|12044990|FG001|Overall Study|Participant request to discontinue study treatment|0
7631595|NCT04075604|12044991|FG002|Overall Study|Participant request to discontinue study treatment|1
7631596|NCT04075604|12044989|FG000|Overall Study|Participant withdrew consent|0
7631597|NCT04075604|12044990|FG001|Overall Study|Participant withdrew consent|0
7631598|NCT04075604|12044991|FG002|Overall Study|Participant withdrew consent|1
7631599|NCT04075604|12044989|FG000|Overall Study|Other reasons|1
7631600|NCT04075604|12044990|FG001|Overall Study|Other reasons|0
7631601|NCT04075604|12044991|FG002|Overall Study|Other reasons|0
7631602|NCT04075604|12044989|FG000|Overall Study|Disease progression|0
7631603|NCT04075604|12044990|FG001|Overall Study|Disease progression|1
7631604|NCT04075604|12044991|FG002|Overall Study|Disease progression|0
7631605|NCT04075604|12044989|FG000|Overall Study|Study drug toxicity|0
7631606|NCT04075604|12044990|FG001|Overall Study|Study drug toxicity|5
7631607|NCT04075604|12044991|FG002|Overall Study|Study drug toxicity|1
7631608|NCT04073186|12044999|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
7631609|NCT04073186|12044999|FG000|First Wearing Cycle|Withdrawal by Subject|1
7631610|NCT04073186|12044999|FG000|First Wearing Cycle|Protocol Violation|1
7631611|NCT04073186|12044999|FG000|First Wearing Cycle|Lens Discomfort|2
7631612|NCT04073186|12044999|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
7631613|NCT04073186|12044999|FG000|Second Wearing Cycle|Adverse Event|1
7631614|NCT04068181|12045034|FG000|Overall Study|Withdrawal by Subject|2
7631615|NCT04068181|12045035|FG001|Overall Study|Withdrawal by Subject|0
7631616|NCT04068181|12045036|FG002|Overall Study|Withdrawal by Subject|0
7631617|NCT04068181|12045037|FG003|Overall Study|Withdrawal by Subject|0
7631618|NCT04068181|12045034|FG000|Overall Study|Lost to Follow-up|1
7631619|NCT04068181|12045035|FG001|Overall Study|Lost to Follow-up|0
7631620|NCT04068181|12045036|FG002|Overall Study|Lost to Follow-up|0
7631621|NCT04068181|12045037|FG003|Overall Study|Lost to Follow-up|0
7631622|NCT04068181|12045034|FG000|Overall Study|Death|8
7631623|NCT04068181|12045035|FG001|Overall Study|Death|8
7631624|NCT04068181|12045036|FG002|Overall Study|Death|4
7631625|NCT04068181|12045037|FG003|Overall Study|Death|2
7631626|NCT04068181|12045034|FG000|Overall Study|Continuing Study|16
7631627|NCT04068181|12045035|FG001|Overall Study|Continuing Study|7
7631628|NCT04068181|12045036|FG002|Overall Study|Continuing Study|11
7631629|NCT04068181|12045037|FG003|Overall Study|Continuing Study|13
7631630|NCT04067518|12045049|FG000|Overall Study|Screen Failures|0
7631631|NCT04067518|12045050|FG001|Overall Study|Screen Failures|1
7631632|NCT04067518|12045049|FG000|Overall Study|Enrolled but not Treated|0
7631633|NCT04067518|12045050|FG001|Overall Study|Enrolled but not Treated|1
7631634|NCT04067518|12045049|FG000|Overall Study|Adverse Events|0
7631635|NCT04067518|12045050|FG001|Overall Study|Adverse Events|2
7631636|NCT04067518|12045049|FG000|Overall Study|Ongoing|3
7631637|NCT04067518|12045050|FG001|Overall Study|Ongoing|21
7631638|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Adverse Event|2
7631639|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Adverse Event|0
7631640|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Adverse Event|0
7631641|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Adverse Event|0
7631642|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Lack of Efficacy|0
7631643|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
7631644|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Lack of Efficacy|0
7631645|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Lack of Efficacy|0
7631646|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Lost to Follow-up|11
7631647|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Lost to Follow-up|6
7631648|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Lost to Follow-up|0
7631649|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
7631650|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Physician Decision|1
7631651|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Physician Decision|0
7631652|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Physician Decision|0
7631653|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Physician Decision|0
7631654|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Pregnancy|1
7631655|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Pregnancy|0
7631656|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Pregnancy|0
7631657|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Pregnancy|0
7631658|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10
7631659|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8
7631660|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0
7631661|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0
7631662|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3
7631663|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1
7631664|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0
7631665|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0
7631666|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1
7631667|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631668|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631669|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0
7631670|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631671|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1
7631672|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631673|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0
7631674|NCT04057573|12045079|FG000|24-Week Double-Blind Period|Not Treated|1
7631675|NCT04057573|12045080|FG001|24-Week Double-Blind Period|Not Treated|0
7631676|NCT04057573|12045081|FG002|24-Week Double-Blind Period|Not Treated|0
7631677|NCT04057573|12045082|FG003|24-Week Double-Blind Period|Not Treated|0
7631678|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Adverse Event|0
7631679|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Adverse Event|0
7631680|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Adverse Event|1
7631681|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Adverse Event|0
7631682|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0
7631683|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0
7631684|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1
7631685|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0
7631686|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0
7631687|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0
7631688|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9
7631689|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10
7631690|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0
7631691|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0
7631692|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9
7631693|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9
7631694|NCT04057573|12045079|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631695|NCT04057573|12045080|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631696|NCT04057573|12045081|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1
7631697|NCT04057573|12045082|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0
7631698|NCT04057196|12045093|FG000|Overall Study|Withdrawal by Subject|3
7631699|NCT04057196|12045093|FG000|Overall Study|Death|3
7631700|NCT04052425|12045104|FG000|24-Week Double-blind Period|Adverse Event|0
7631701|NCT04052425|12045105|FG001|24-Week Double-blind Period|Adverse Event|1
7631702|NCT04052425|12045106|FG002|24-Week Double-blind Period|Adverse Event|0
7631703|NCT04052425|12045107|FG003|24-Week Double-blind Period|Adverse Event|0
7631704|NCT04052425|12045104|FG000|24-Week Double-blind Period|Lack of Efficacy|0
7631705|NCT04052425|12045105|FG001|24-Week Double-blind Period|Lack of Efficacy|1
7631706|NCT04052425|12045106|FG002|24-Week Double-blind Period|Lack of Efficacy|0
7631707|NCT04052425|12045107|FG003|24-Week Double-blind Period|Lack of Efficacy|0
7631708|NCT04052425|12045104|FG000|24-Week Double-blind Period|Lost to Follow-up|14
7631709|NCT04052425|12045105|FG001|24-Week Double-blind Period|Lost to Follow-up|7
7631710|NCT04052425|12045106|FG002|24-Week Double-blind Period|Lost to Follow-up|0
7631711|NCT04052425|12045107|FG003|24-Week Double-blind Period|Lost to Follow-up|0
7631712|NCT04052425|12045104|FG000|24-Week Double-blind Period|Physician Decision|1
7631713|NCT04052425|12045105|FG001|24-Week Double-blind Period|Physician Decision|0
7631714|NCT04052425|12045106|FG002|24-Week Double-blind Period|Physician Decision|0
7631715|NCT04052425|12045107|FG003|24-Week Double-blind Period|Physician Decision|0
7631716|NCT04052425|12045104|FG000|24-Week Double-blind Period|Protocol Violation|1
7631717|NCT04052425|12045105|FG001|24-Week Double-blind Period|Protocol Violation|0
7631718|NCT04052425|12045106|FG002|24-Week Double-blind Period|Protocol Violation|0
7631719|NCT04052425|12045107|FG003|24-Week Double-blind Period|Protocol Violation|0
7631720|NCT04052425|12045104|FG000|24-Week Double-blind Period|Withdrawal by Subject|9
7631721|NCT04052425|12045105|FG001|24-Week Double-blind Period|Withdrawal by Subject|10
7631722|NCT04052425|12045106|FG002|24-Week Double-blind Period|Withdrawal by Subject|0
7631723|NCT04052425|12045107|FG003|24-Week Double-blind Period|Withdrawal by Subject|0
7631724|NCT04052425|12045104|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3
7631725|NCT04052425|12045105|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631726|NCT04052425|12045106|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631727|NCT04052425|12045107|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0
7631728|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Adverse Event|0
7631729|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Adverse Event|0
7631730|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Adverse Event|1
7631731|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Adverse Event|0
7631732|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631733|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631734|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1
7631735|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0
7631736|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0
7631737|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0
7631738|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5
7631739|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1
7631740|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Physician Decision|0
7631741|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Physician Decision|0
7631742|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Physician Decision|0
7631743|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Physician Decision|1
7631744|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0
7631745|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0
7631746|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10
7631747|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7
7631748|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631749|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631750|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1
7631751|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0
7631752|NCT04052425|12045104|FG000|28-Week Treatment-Extension Period|Participant Moved|0
7631753|NCT04052425|12045105|FG001|28-Week Treatment-Extension Period|Participant Moved|0
7631754|NCT04052425|12045106|FG002|28-Week Treatment-Extension Period|Participant Moved|1
7631755|NCT04052425|12045107|FG003|28-Week Treatment-Extension Period|Participant Moved|1
7631756|NCT04049617|12045132|FG000|Overall Study|Adverse Event|0
7631757|NCT04049617|12045133|FG001|Overall Study|Adverse Event|0
7631758|NCT04049617|12045134|FG002|Overall Study|Adverse Event|0
7631759|NCT04049617|12045135|FG003|Overall Study|Adverse Event|1
7631760|NCT04049617|12045136|FG004|Overall Study|Adverse Event|0
7631761|NCT04049617|12045137|FG005|Overall Study|Adverse Event|0
7631762|NCT04049617|12045132|FG000|Overall Study|Death|0
7631763|NCT04049617|12045133|FG001|Overall Study|Death|0
7631764|NCT04049617|12045134|FG002|Overall Study|Death|0
7631765|NCT04049617|12045135|FG003|Overall Study|Death|0
7631766|NCT04049617|12045136|FG004|Overall Study|Death|0
7631767|NCT04049617|12045137|FG005|Overall Study|Death|1
7631768|NCT04049617|12045132|FG000|Overall Study|Lost to Follow-up|0
7631769|NCT04049617|12045133|FG001|Overall Study|Lost to Follow-up|0
7631770|NCT04049617|12045134|FG002|Overall Study|Lost to Follow-up|0
7631771|NCT04049617|12045135|FG003|Overall Study|Lost to Follow-up|1
7631772|NCT04049617|12045136|FG004|Overall Study|Lost to Follow-up|0
7631773|NCT04049617|12045137|FG005|Overall Study|Lost to Follow-up|0
7631774|NCT04049617|12045132|FG000|Overall Study|Withdrew consent|0
7631775|NCT04049617|12045133|FG001|Overall Study|Withdrew consent|0
7631776|NCT04049617|12045134|FG002|Overall Study|Withdrew consent|1
7631777|NCT04049617|12045135|FG003|Overall Study|Withdrew consent|0
7631778|NCT04049617|12045136|FG004|Overall Study|Withdrew consent|0
7631779|NCT04049617|12045137|FG005|Overall Study|Withdrew consent|0
7631780|NCT04047446|12045171|FG000|Overall Study|Physician Decision|1
7631781|NCT04047446|12045172|FG001|Overall Study|Physician Decision|0
7631782|NCT04030598|12045194|FG000|Overall Study|Voluntary Withdrawal|0
7631783|NCT04030598|12045195|FG001|Overall Study|Voluntary Withdrawal|1
7631784|NCT04030598|12045196|FG002|Overall Study|Voluntary Withdrawal|0
7631785|NCT04026568|12045251|FG000|Overall Study|study terminated|0
7631786|NCT04026568|12045252|FG001|Overall Study|study terminated|1
7631787|NCT04025632|12045260|FG000|Overall Study|Adverse Event|1
7631788|NCT04025632|12045261|FG001|Overall Study|Adverse Event|1
7631789|NCT04025632|12045260|FG000|Overall Study|Withdrawal by Subject|1
7631790|NCT04025632|12045261|FG001|Overall Study|Withdrawal by Subject|1
7631791|NCT04025632|12045260|FG000|Overall Study|Study Terminated by Sponsor|10
7631792|NCT04025632|12045261|FG001|Overall Study|Study Terminated by Sponsor|9
7631793|NCT04025632|12045260|FG000|Overall Study|Physician Decision|3
7631794|NCT04025632|12045261|FG001|Overall Study|Physician Decision|1
7631795|NCT04024891|12045272|FG000|Overall Study|Pregnancy|0
7631796|NCT04024891|12045273|FG001|Overall Study|Pregnancy|1
7631797|NCT04015518|12045297|FG000|Overall Study|Adverse Event|6
7631798|NCT04015518|12045298|FG001|Overall Study|Adverse Event|1
7631799|NCT04015518|12045299|FG002|Overall Study|Adverse Event|1
7631800|NCT04015518|12045300|FG003|Overall Study|Adverse Event|3
7631801|NCT04015518|12045301|FG004|Overall Study|Adverse Event|3
7631802|NCT04015518|12045297|FG000|Overall Study|Lack of Efficacy|1
7631803|NCT04015518|12045298|FG001|Overall Study|Lack of Efficacy|0
7631804|NCT04015518|12045299|FG002|Overall Study|Lack of Efficacy|1
7631805|NCT04015518|12045300|FG003|Overall Study|Lack of Efficacy|0
7631806|NCT04015518|12045301|FG004|Overall Study|Lack of Efficacy|4
7631807|NCT04015518|12045297|FG000|Overall Study|Lost to Follow-up|0
7631808|NCT04015518|12045298|FG001|Overall Study|Lost to Follow-up|0
7631809|NCT04015518|12045299|FG002|Overall Study|Lost to Follow-up|0
7631810|NCT04015518|12045300|FG003|Overall Study|Lost to Follow-up|0
7631811|NCT04015518|12045301|FG004|Overall Study|Lost to Follow-up|1
7631812|NCT04015518|12045297|FG000|Overall Study|Withdrawal by Subject|0
7631813|NCT04015518|12045298|FG001|Overall Study|Withdrawal by Subject|1
7631814|NCT04015518|12045299|FG002|Overall Study|Withdrawal by Subject|0
7631815|NCT04015518|12045300|FG003|Overall Study|Withdrawal by Subject|1
7631816|NCT04015518|12045301|FG004|Overall Study|Withdrawal by Subject|1
7631817|NCT04015518|12045297|FG000|Overall Study|Patient did not come for consecutive visits|0
7631818|NCT04015518|12045298|FG001|Overall Study|Patient did not come for consecutive visits|1
7631819|NCT04015518|12045299|FG002|Overall Study|Patient did not come for consecutive visits|0
7631820|NCT04015518|12045300|FG003|Overall Study|Patient did not come for consecutive visits|0
7631821|NCT04015518|12045301|FG004|Overall Study|Patient did not come for consecutive visits|0
7631822|NCT04015518|12045297|FG000|Overall Study|not willing to travel due to Covid-19|0
7631823|NCT04015518|12045298|FG001|Overall Study|not willing to travel due to Covid-19|0
7631824|NCT04015518|12045299|FG002|Overall Study|not willing to travel due to Covid-19|1
7631825|NCT04015518|12045300|FG003|Overall Study|not willing to travel due to Covid-19|0
7631826|NCT04015518|12045301|FG004|Overall Study|not willing to travel due to Covid-19|0
7631827|NCT04015518|12045297|FG000|Overall Study|Patient wants to discontinue treatment|0
7631828|NCT04015518|12045298|FG001|Overall Study|Patient wants to discontinue treatment|0
7631829|NCT04015518|12045299|FG002|Overall Study|Patient wants to discontinue treatment|0
7631830|NCT04015518|12045300|FG003|Overall Study|Patient wants to discontinue treatment|1
7631831|NCT04015518|12045301|FG004|Overall Study|Patient wants to discontinue treatment|0
7631832|NCT04015518|12045297|FG000|Overall Study|Difficult for patient to come to the hospital|0
7631833|NCT04015518|12045298|FG001|Overall Study|Difficult for patient to come to the hospital|0
7631834|NCT04015518|12045299|FG002|Overall Study|Difficult for patient to come to the hospital|0
7631835|NCT04015518|12045300|FG003|Overall Study|Difficult for patient to come to the hospital|0
7631836|NCT04015518|12045301|FG004|Overall Study|Difficult for patient to come to the hospital|1
7631837|NCT04015518|12045297|FG000|Overall Study|Pregnancy|0
7631838|NCT04015518|12045298|FG001|Overall Study|Pregnancy|0
7631839|NCT04015518|12045299|FG002|Overall Study|Pregnancy|0
7631840|NCT04015518|12045300|FG003|Overall Study|Pregnancy|0
7631841|NCT04015518|12045301|FG004|Overall Study|Pregnancy|1
7631842|NCT04015518|12045297|FG000|Overall Study|Personal reasons|1
7631843|NCT04015518|12045298|FG001|Overall Study|Personal reasons|0
7631844|NCT04015518|12045299|FG002|Overall Study|Personal reasons|0
7631845|NCT04015518|12045300|FG003|Overall Study|Personal reasons|0
7631846|NCT04015518|12045301|FG004|Overall Study|Personal reasons|1
7631847|NCT04015518|12045297|FG000|Overall Study|Withdrew consent|1
7631848|NCT04015518|12045298|FG001|Overall Study|Withdrew consent|0
7631849|NCT04015518|12045299|FG002|Overall Study|Withdrew consent|0
7631850|NCT04015518|12045300|FG003|Overall Study|Withdrew consent|0
7631851|NCT04015518|12045301|FG004|Overall Study|Withdrew consent|0
7631852|NCT04015518|12045297|FG000|Overall Study|Prostate carcinoma|1
7631853|NCT04015518|12045298|FG001|Overall Study|Prostate carcinoma|0
7631854|NCT04015518|12045299|FG002|Overall Study|Prostate carcinoma|0
7631855|NCT04015518|12045300|FG003|Overall Study|Prostate carcinoma|0
7631856|NCT04015518|12045301|FG004|Overall Study|Prostate carcinoma|0
7631857|NCT04015518|12045297|FG000|Overall Study|Could not keep appointments due to work|1
7631858|NCT04015518|12045298|FG001|Overall Study|Could not keep appointments due to work|0
7631859|NCT04015518|12045299|FG002|Overall Study|Could not keep appointments due to work|0
7631860|NCT04015518|12045300|FG003|Overall Study|Could not keep appointments due to work|0
7631861|NCT04015518|12045301|FG004|Overall Study|Could not keep appointments due to work|0
7631862|NCT04014075|12045316|FG000|Overall Study|Progressive Disease|39
7631863|NCT04014075|12045316|FG000|Overall Study|Adverse Event|9
7631864|NCT04014075|12045316|FG000|Overall Study|Clinical Progression|2
7631865|NCT04014075|12045316|FG000|Overall Study|Death|2
7631866|NCT04014075|12045316|FG000|Overall Study|Withdrawal by Subject|2
7631867|NCT04014075|12045316|FG000|Overall Study|Miscellaneous|1
7631868|NCT04014075|12045316|FG000|Overall Study|Physician Decision|1
7631869|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9
7631870|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8
7631871|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5
7631872|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0
7631873|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0
7631874|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3
7631875|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4
7631876|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631877|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631878|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0
7631879|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1
7631880|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3
7631881|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3
7631882|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0
7631883|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0
7631884|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9
7631885|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12
7631886|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
7631887|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0
7631888|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0
7631889|NCT04003155|12045332|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1
7631890|NCT04003155|12045333|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7
7631891|NCT04003155|12045334|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3
7631892|NCT04003155|12045335|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0
7631893|NCT04003155|12045336|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0
7631894|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0
7631895|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5
7631896|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4
7631897|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2
7631898|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2
7631899|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0
7631900|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631901|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3
7631902|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631903|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1
7631904|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0
7631905|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12
7632075|NCT03926169|12045608|FG000|Period A|Other, Not Specified|1
7631906|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7
7631907|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9
7631908|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5
7631909|NCT04003155|12045332|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0
7631910|NCT04003155|12045333|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0
7631911|NCT04003155|12045334|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1
7631912|NCT04003155|12045335|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2
7631913|NCT04003155|12045336|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1
7631914|NCT03999892|12045366|FG000|Overall Study|Lost to Follow-up|1
7631915|NCT03988166|12045370|FG000|Overall Study|Lost to Follow-up|2
7631916|NCT03988166|12045370|FG000|Overall Study|Death|1
7631917|NCT03980808|12045379|FG000|Overall Study|Lost to Follow-up|2
7631918|NCT03980808|12045380|FG001|Overall Study|Lost to Follow-up|2
7631919|NCT03977454|12045388|FG000|Overall Study|immediate postoperative revision|2
7631920|NCT03977454|12045389|FG001|Overall Study|immediate postoperative revision|2
7631921|NCT03976401|12045401|FG000|Overall Study|Adverse Event|2
7631922|NCT03976401|12045402|FG001|Overall Study|Adverse Event|0
7631923|NCT03976401|12045403|FG002|Overall Study|Adverse Event|4
7631924|NCT03976401|12045404|FG003|Overall Study|Adverse Event|1
7631925|NCT03976401|12045405|FG004|Overall Study|Adverse Event|1
7631926|NCT03976401|12045406|FG005|Overall Study|Adverse Event|0
7631927|NCT03976401|12045401|FG000|Overall Study|Withdrawal by Subject|0
7631928|NCT03976401|12045402|FG001|Overall Study|Withdrawal by Subject|1
7631929|NCT03976401|12045403|FG002|Overall Study|Withdrawal by Subject|0
7631930|NCT03976401|12045404|FG003|Overall Study|Withdrawal by Subject|0
7631931|NCT03976401|12045405|FG004|Overall Study|Withdrawal by Subject|0
7631932|NCT03976401|12045406|FG005|Overall Study|Withdrawal by Subject|1
7631933|NCT03976401|12045401|FG000|Overall Study|Physician Decision|0
7631934|NCT03976401|12045402|FG001|Overall Study|Physician Decision|0
7631935|NCT03976401|12045403|FG002|Overall Study|Physician Decision|1
7631936|NCT03976401|12045404|FG003|Overall Study|Physician Decision|0
7631937|NCT03976401|12045405|FG004|Overall Study|Physician Decision|0
7631938|NCT03976401|12045406|FG005|Overall Study|Physician Decision|0
7631939|NCT03976401|12045401|FG000|Overall Study|Lost to Follow-up|1
7631940|NCT03976401|12045402|FG001|Overall Study|Lost to Follow-up|2
7631941|NCT03976401|12045403|FG002|Overall Study|Lost to Follow-up|0
7631942|NCT03976401|12045404|FG003|Overall Study|Lost to Follow-up|0
7631943|NCT03976401|12045405|FG004|Overall Study|Lost to Follow-up|0
7631944|NCT03976401|12045406|FG005|Overall Study|Lost to Follow-up|0
7631945|NCT03976401|12045401|FG000|Overall Study|Protocol Violation|0
7631946|NCT03976401|12045402|FG001|Overall Study|Protocol Violation|1
7631947|NCT03976401|12045403|FG002|Overall Study|Protocol Violation|0
7631948|NCT03976401|12045404|FG003|Overall Study|Protocol Violation|0
7631949|NCT03976401|12045405|FG004|Overall Study|Protocol Violation|0
7631950|NCT03976401|12045406|FG005|Overall Study|Protocol Violation|0
7631951|NCT03976401|12045401|FG000|Overall Study|Withdrew Consent|0
7631952|NCT03976401|12045402|FG001|Overall Study|Withdrew Consent|0
7631953|NCT03976401|12045403|FG002|Overall Study|Withdrew Consent|0
7631954|NCT03976401|12045404|FG003|Overall Study|Withdrew Consent|1
7631955|NCT03976401|12045405|FG004|Overall Study|Withdrew Consent|0
7631956|NCT03976401|12045406|FG005|Overall Study|Withdrew Consent|0
7631957|NCT03967444|12045422|FG000|Overall Study|Lost to Follow-up|1
7631958|NCT03967444|12045423|FG001|Overall Study|Lost to Follow-up|2
7631959|NCT03966885|12045431|FG000|Overall Study|Death|1
7631960|NCT03966885|12045432|FG001|Overall Study|Death|0
7631961|NCT03966885|12045431|FG000|Overall Study|Lost to Follow-up|1
7631962|NCT03966885|12045432|FG001|Overall Study|Lost to Follow-up|2
7631963|NCT03966885|12045431|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20
7631964|NCT03966885|12045432|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16
7631965|NCT03966885|12045431|FG000|Overall Study|Moved from study area.|0
7631966|NCT03966885|12045432|FG001|Overall Study|Moved from study area.|2
7631967|NCT03964974|12045441|FG000|Overall Study|Lost to Follow-up|3
7631968|NCT03964974|12045442|FG001|Overall Study|Lost to Follow-up|2
7631969|NCT03964974|12045441|FG000|Overall Study|Withdrawal by Subject|0
7631970|NCT03964974|12045442|FG001|Overall Study|Withdrawal by Subject|3
7631971|NCT03963232|12045450|FG000|Overall Study|Adverse Event|0
7631972|NCT03963232|12045451|FG001|Overall Study|Adverse Event|6
7631973|NCT03963232|12045450|FG000|Overall Study|Protocol Violation|1
7631974|NCT03963232|12045451|FG001|Overall Study|Protocol Violation|1
7631975|NCT03963232|12045450|FG000|Overall Study|Pregnancy|2
7631976|NCT03963232|12045451|FG001|Overall Study|Pregnancy|1
7631977|NCT03963232|12045450|FG000|Overall Study|Withdrawal by Subject|13
7631978|NCT03963232|12045451|FG001|Overall Study|Withdrawal by Subject|5
7631979|NCT03963232|12045450|FG000|Overall Study|Physician Decision|1
7631980|NCT03963232|12045451|FG001|Overall Study|Physician Decision|3
7631981|NCT03958331|12045470|FG000|Overall Study|Withdrawal by Subject|3
7631982|NCT03958331|12045471|FG001|Overall Study|Withdrawal by Subject|1
7631983|NCT03958331|12045472|FG002|Overall Study|Withdrawal by Subject|5
7631984|NCT03958331|12045470|FG000|Overall Study|Weaned from medicine|2
7631985|NCT03958331|12045471|FG001|Overall Study|Weaned from medicine|0
7631986|NCT03958331|12045472|FG002|Overall Study|Weaned from medicine|0
7631987|NCT03958331|12045470|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2
7631988|NCT03958331|12045471|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1
7631989|NCT03958331|12045472|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12
7631990|NCT03955471|12045478|FG000|Overall Study|Death|22
7631991|NCT03955471|12045478|FG000|Overall Study|Lost to Follow-up|1
7631992|NCT03955471|12045478|FG000|Overall Study|Withdrawal by Subject|6
7631993|NCT03955471|12045478|FG000|Overall Study|Sponsor Decision to Terminate Study|11
7631994|NCT03950674|12045484|FG000|Overall Study|Death|3
7631995|NCT03950674|12045485|FG001|Overall Study|Death|7
7631996|NCT03950674|12045484|FG000|Overall Study|Ongoing in Study|22
7631997|NCT03950674|12045485|FG001|Overall Study|Ongoing in Study|8
7631998|NCT03948581|12045498|FG000|Overall Study|Lost to Follow-up|0
7631999|NCT03948581|12045499|FG001|Overall Study|Lost to Follow-up|1
7632000|NCT03943290|12045514|FG000|Overall Study|Sponsor Terminated Study|6
7632001|NCT03943290|12045515|FG001|Overall Study|Sponsor Terminated Study|1
7632002|NCT03943290|12045516|FG002|Overall Study|Sponsor Terminated Study|11
7632003|NCT03943290|12045517|FG003|Overall Study|Sponsor Terminated Study|6
7632004|NCT03943290|12045518|FG004|Overall Study|Sponsor Terminated Study|7
7632005|NCT03943290|12045519|FG005|Overall Study|Sponsor Terminated Study|6
7632006|NCT03943290|12045520|FG006|Overall Study|Sponsor Terminated Study|6
7632007|NCT03943290|12045521|FG007|Overall Study|Sponsor Terminated Study|7
7632008|NCT03943290|12045522|FG008|Overall Study|Sponsor Terminated Study|8
7632009|NCT03943290|12045514|FG000|Overall Study|Lost to Follow-up|1
7632010|NCT03943290|12045515|FG001|Overall Study|Lost to Follow-up|0
7632011|NCT03943290|12045516|FG002|Overall Study|Lost to Follow-up|1
7632012|NCT03943290|12045517|FG003|Overall Study|Lost to Follow-up|0
7632013|NCT03943290|12045518|FG004|Overall Study|Lost to Follow-up|0
7632014|NCT03943290|12045519|FG005|Overall Study|Lost to Follow-up|0
7632015|NCT03943290|12045520|FG006|Overall Study|Lost to Follow-up|0
7632016|NCT03943290|12045521|FG007|Overall Study|Lost to Follow-up|1
7632017|NCT03943290|12045522|FG008|Overall Study|Lost to Follow-up|0
7632018|NCT03943290|12045514|FG000|Overall Study|Withdrawal by Subject|0
7632019|NCT03943290|12045515|FG001|Overall Study|Withdrawal by Subject|0
7632020|NCT03943290|12045516|FG002|Overall Study|Withdrawal by Subject|1
7632021|NCT03943290|12045517|FG003|Overall Study|Withdrawal by Subject|0
7632022|NCT03943290|12045518|FG004|Overall Study|Withdrawal by Subject|0
7632023|NCT03943290|12045519|FG005|Overall Study|Withdrawal by Subject|0
7632024|NCT03943290|12045520|FG006|Overall Study|Withdrawal by Subject|0
7632025|NCT03943290|12045521|FG007|Overall Study|Withdrawal by Subject|0
7632026|NCT03943290|12045522|FG008|Overall Study|Withdrawal by Subject|0
7632027|NCT03938545|12045559|FG000|Overall Study|Lost to Follow-up|0
7632028|NCT03938545|12045560|FG001|Overall Study|Lost to Follow-up|0
7632029|NCT03938545|12045561|FG002|Overall Study|Lost to Follow-up|0
7632030|NCT03938545|12045562|FG003|Overall Study|Lost to Follow-up|1
7632031|NCT03938545|12045559|FG000|Overall Study|Non-compliance with study drug|0
7632032|NCT03938545|12045560|FG001|Overall Study|Non-compliance with study drug|0
7632033|NCT03938545|12045561|FG002|Overall Study|Non-compliance with study drug|1
7632034|NCT03938545|12045562|FG003|Overall Study|Non-compliance with study drug|0
7632035|NCT03938545|12045559|FG000|Overall Study|Pregnancy|1
7632036|NCT03938545|12045560|FG001|Overall Study|Pregnancy|0
7632037|NCT03938545|12045561|FG002|Overall Study|Pregnancy|0
7632038|NCT03938545|12045562|FG003|Overall Study|Pregnancy|0
7632039|NCT03938545|12045559|FG000|Overall Study|Study terminated by sponsor|6
7632040|NCT03938545|12045560|FG001|Overall Study|Study terminated by sponsor|4
7632041|NCT03938545|12045561|FG002|Overall Study|Study terminated by sponsor|2
7632042|NCT03938545|12045562|FG003|Overall Study|Study terminated by sponsor|4
7632043|NCT03938545|12045559|FG000|Overall Study|Withdrawal by Subject|0
7632044|NCT03938545|12045560|FG001|Overall Study|Withdrawal by Subject|1
7632045|NCT03938545|12045561|FG002|Overall Study|Withdrawal by Subject|0
7632046|NCT03938545|12045562|FG003|Overall Study|Withdrawal by Subject|0
7632047|NCT03938545|12045559|FG000|Overall Study|Adverse Event|1
7632048|NCT03938545|12045560|FG001|Overall Study|Adverse Event|0
7632049|NCT03938545|12045561|FG002|Overall Study|Adverse Event|0
7632050|NCT03938545|12045562|FG003|Overall Study|Adverse Event|0
7632051|NCT03933449|12045574|FG000|Overall Study|Adverse Event|6
7632052|NCT03933449|12045575|FG001|Overall Study|Adverse Event|4
7632053|NCT03933449|12045574|FG000|Overall Study|Death|36
7632054|NCT03933449|12045575|FG001|Overall Study|Death|51
7632055|NCT03933449|12045574|FG000|Overall Study|Ongoing in Study|20
7632056|NCT03933449|12045575|FG001|Overall Study|Ongoing in Study|6
7632057|NCT03926169|12045608|FG000|Period A|Adverse Event|2
7632058|NCT03926169|12045609|FG001|Period A|Adverse Event|2
7632059|NCT03926169|12045610|FG002|Period A|Adverse Event|1
7632060|NCT03926169|12045608|FG000|Period A|Withdrawal by Subject|2
7632061|NCT03926169|12045609|FG001|Period A|Withdrawal by Subject|2
7632062|NCT03926169|12045610|FG002|Period A|Withdrawal by Subject|2
7632063|NCT03926169|12045608|FG000|Period A|Lost to Follow-up|3
7632064|NCT03926169|12045609|FG001|Period A|Lost to Follow-up|1
7632065|NCT03926169|12045610|FG002|Period A|Lost to Follow-up|0
7632066|NCT03926169|12045608|FG000|Period A|Lack of Efficacy|0
7632067|NCT03926169|12045609|FG001|Period A|Lack of Efficacy|2
7632068|NCT03926169|12045610|FG002|Period A|Lack of Efficacy|2
7632069|NCT03926169|12045608|FG000|Period A|COVID-19 Infection|0
7632070|NCT03926169|12045609|FG001|Period A|COVID-19 Infection|1
7632071|NCT03926169|12045610|FG002|Period A|COVID-19 Infection|0
7632072|NCT03926169|12045608|FG000|Period A|COVID-19 Logistical Restrictions|0
7632073|NCT03926169|12045609|FG001|Period A|COVID-19 Logistical Restrictions|2
7632074|NCT03926169|12045610|FG002|Period A|COVID-19 Logistical Restrictions|1
7632076|NCT03926169|12045609|FG001|Period A|Other, Not Specified|0
7632077|NCT03926169|12045610|FG002|Period A|Other, Not Specified|0
7632078|NCT03926169|12045608|FG000|Period B|Adverse Event|3
7632079|NCT03926169|12045609|FG001|Period B|Adverse Event|1
7632080|NCT03926169|12045610|FG002|Period B|Adverse Event|1
7632081|NCT03926169|12045608|FG000|Period B|Withdrawal by Subject|1
7632082|NCT03926169|12045609|FG001|Period B|Withdrawal by Subject|3
7632083|NCT03926169|12045610|FG002|Period B|Withdrawal by Subject|0
7632084|NCT03926169|12045608|FG000|Period B|Lack of Efficacy|3
7632085|NCT03926169|12045609|FG001|Period B|Lack of Efficacy|1
7632086|NCT03926169|12045610|FG002|Period B|Lack of Efficacy|1
7632087|NCT03926169|12045608|FG000|Period B|Lost to Follow-up|1
7632088|NCT03926169|12045609|FG001|Period B|Lost to Follow-up|1
7632089|NCT03926169|12045610|FG002|Period B|Lost to Follow-up|4
7632090|NCT03926169|12045608|FG000|Period B|Other, Not Specified|62
7632091|NCT03926169|12045609|FG001|Period B|Other, Not Specified|57
7632092|NCT03926169|12045610|FG002|Period B|Other, Not Specified|65
7632093|NCT03922945|12045624|FG000|Overall Study|Adverse Event|1
7632094|NCT03922945|12045625|FG001|Overall Study|Adverse Event|1
7632095|NCT03922945|12045626|FG002|Overall Study|Adverse Event|2
7632096|NCT03922945|12045624|FG000|Overall Study|Lost to Follow-up|13
7632097|NCT03922945|12045625|FG001|Overall Study|Lost to Follow-up|9
7632098|NCT03922945|12045626|FG002|Overall Study|Lost to Follow-up|20
7632099|NCT03922945|12045624|FG000|Overall Study|Lack of Efficacy|2
7632100|NCT03922945|12045625|FG001|Overall Study|Lack of Efficacy|0
7632101|NCT03922945|12045626|FG002|Overall Study|Lack of Efficacy|1
7632102|NCT03922945|12045624|FG000|Overall Study|Protocol Non-Compliance|0
7632103|NCT03922945|12045625|FG001|Overall Study|Protocol Non-Compliance|0
7632104|NCT03922945|12045626|FG002|Overall Study|Protocol Non-Compliance|1
7632105|NCT03922945|12045624|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10
7632106|NCT03922945|12045625|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6
7632107|NCT03922945|12045626|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14
7632108|NCT03922945|12045624|FG000|Overall Study|All Other Personal Reasons|1
7632109|NCT03922945|12045625|FG001|Overall Study|All Other Personal Reasons|1
7632110|NCT03922945|12045626|FG002|Overall Study|All Other Personal Reasons|2
7632111|NCT03920280|12045639|FG000|Overall Study|Adverse Event|2
7632112|NCT03920280|12045640|FG001|Overall Study|Adverse Event|3
7632113|NCT03920280|12045639|FG000|Overall Study|Lost to Follow-up|0
7632114|NCT03920280|12045640|FG001|Overall Study|Lost to Follow-up|1
7632115|NCT03920280|12045639|FG000|Overall Study|Withdrawal by Subject|1
7632116|NCT03920280|12045640|FG001|Overall Study|Withdrawal by Subject|1
7632117|NCT03920280|12045639|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
7632118|NCT03920280|12045640|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
7632119|NCT03917654|12045661|FG000|Year 1|Withdrawal by Subject|1
7632120|NCT03917654|12045662|FG001|Year 1|Withdrawal by Subject|0
7632121|NCT03917654|12045663|FG002|Year 1|Withdrawal by Subject|0
7632122|NCT03917654|12045664|FG003|Year 1|Withdrawal by Subject|0
7632123|NCT03917654|12045665|FG004|Year 1|Withdrawal by Subject|0
7632124|NCT03917654|12045666|FG005|Year 1|Withdrawal by Subject|1
7632125|NCT03917654|12045667|FG006|Year 1|Withdrawal by Subject|6
7632126|NCT03917654|12045668|FG007|Year 1|Withdrawal by Subject|2
7632127|NCT03917654|12045669|FG008|Year 1|Withdrawal by Subject|5
7632128|NCT03917654|12045670|FG009|Year 1|Withdrawal by Subject|3
7632129|NCT03917654|12045671|FG010|Year 1|Withdrawal by Subject|1
7632130|NCT03917654|12045672|FG011|Year 1|Withdrawal by Subject|0
7632131|NCT03917654|12045661|FG000|Year 1|Travel|0
7632132|NCT03917654|12045662|FG001|Year 1|Travel|1
7632133|NCT03917654|12045663|FG002|Year 1|Travel|1
7632134|NCT03917654|12045664|FG003|Year 1|Travel|0
7632135|NCT03917654|12045665|FG004|Year 1|Travel|4
7632136|NCT03917654|12045666|FG005|Year 1|Travel|4
7632137|NCT03917654|12045667|FG006|Year 1|Travel|10
7632138|NCT03917654|12045668|FG007|Year 1|Travel|8
7632139|NCT03917654|12045669|FG008|Year 1|Travel|2
7632140|NCT03917654|12045670|FG009|Year 1|Travel|5
7632141|NCT03917654|12045671|FG010|Year 1|Travel|3
7632142|NCT03917654|12045672|FG011|Year 1|Travel|3
7632143|NCT03917654|12045661|FG000|Year 1|Subject moved away from site|0
7632144|NCT03917654|12045662|FG001|Year 1|Subject moved away from site|1
7632145|NCT03917654|12045663|FG002|Year 1|Subject moved away from site|0
7632146|NCT03917654|12045664|FG003|Year 1|Subject moved away from site|0
7632147|NCT03917654|12045665|FG004|Year 1|Subject moved away from site|0
7632148|NCT03917654|12045666|FG005|Year 1|Subject moved away from site|0
7632149|NCT03917654|12045667|FG006|Year 1|Subject moved away from site|1
7632150|NCT03917654|12045668|FG007|Year 1|Subject moved away from site|2
7632151|NCT03917654|12045669|FG008|Year 1|Subject moved away from site|1
7632152|NCT03917654|12045670|FG009|Year 1|Subject moved away from site|0
7632153|NCT03917654|12045671|FG010|Year 1|Subject moved away from site|0
7632154|NCT03917654|12045672|FG011|Year 1|Subject moved away from site|3
7632155|NCT03917654|12045661|FG000|Year 1|Spouse/Family member request|0
7632156|NCT03917654|12045662|FG001|Year 1|Spouse/Family member request|0
7632157|NCT03917654|12045663|FG002|Year 1|Spouse/Family member request|1
7632158|NCT03917654|12045664|FG003|Year 1|Spouse/Family member request|0
7632159|NCT03917654|12045665|FG004|Year 1|Spouse/Family member request|1
7632160|NCT03917654|12045666|FG005|Year 1|Spouse/Family member request|0
7632161|NCT03917654|12045667|FG006|Year 1|Spouse/Family member request|0
7632162|NCT03917654|12045668|FG007|Year 1|Spouse/Family member request|2
7632163|NCT03917654|12045669|FG008|Year 1|Spouse/Family member request|0
7632164|NCT03917654|12045670|FG009|Year 1|Spouse/Family member request|0
7632165|NCT03917654|12045671|FG010|Year 1|Spouse/Family member request|0
7632166|NCT03917654|12045672|FG011|Year 1|Spouse/Family member request|1
7632167|NCT03917654|12045661|FG000|Year 1|Death|0
7632168|NCT03917654|12045662|FG001|Year 1|Death|0
7632169|NCT03917654|12045663|FG002|Year 1|Death|0
7632170|NCT03917654|12045664|FG003|Year 1|Death|0
7632171|NCT03917654|12045665|FG004|Year 1|Death|0
7632172|NCT03917654|12045666|FG005|Year 1|Death|0
7632173|NCT03917654|12045667|FG006|Year 1|Death|0
7632174|NCT03917654|12045668|FG007|Year 1|Death|0
7632175|NCT03917654|12045669|FG008|Year 1|Death|1
7632176|NCT03917654|12045670|FG009|Year 1|Death|1
7632177|NCT03917654|12045671|FG010|Year 1|Death|0
7632178|NCT03917654|12045672|FG011|Year 1|Death|0
7632179|NCT03917654|12045661|FG000|Year 1|Lost to Follow-up|0
7632180|NCT03917654|12045662|FG001|Year 1|Lost to Follow-up|0
7632181|NCT03917654|12045663|FG002|Year 1|Lost to Follow-up|0
7632182|NCT03917654|12045664|FG003|Year 1|Lost to Follow-up|0
7632183|NCT03917654|12045665|FG004|Year 1|Lost to Follow-up|0
7632184|NCT03917654|12045666|FG005|Year 1|Lost to Follow-up|0
7632185|NCT03917654|12045667|FG006|Year 1|Lost to Follow-up|2
7632186|NCT03917654|12045668|FG007|Year 1|Lost to Follow-up|0
7632187|NCT03917654|12045669|FG008|Year 1|Lost to Follow-up|0
7632188|NCT03917654|12045670|FG009|Year 1|Lost to Follow-up|0
7632189|NCT03917654|12045671|FG010|Year 1|Lost to Follow-up|0
7632190|NCT03917654|12045672|FG011|Year 1|Lost to Follow-up|0
7632191|NCT03917654|12045661|FG000|Year 1|Missed visits|0
7632192|NCT03917654|12045662|FG001|Year 1|Missed visits|0
7632193|NCT03917654|12045663|FG002|Year 1|Missed visits|0
7632194|NCT03917654|12045664|FG003|Year 1|Missed visits|0
7632195|NCT03917654|12045665|FG004|Year 1|Missed visits|0
7632196|NCT03917654|12045666|FG005|Year 1|Missed visits|0
7632197|NCT03917654|12045667|FG006|Year 1|Missed visits|0
7632198|NCT03917654|12045668|FG007|Year 1|Missed visits|0
7632199|NCT03917654|12045669|FG008|Year 1|Missed visits|0
7632200|NCT03917654|12045670|FG009|Year 1|Missed visits|0
7632201|NCT03917654|12045671|FG010|Year 1|Missed visits|1
7632202|NCT03917654|12045672|FG011|Year 1|Missed visits|1
7632203|NCT03917654|12045661|FG000|Year 1|Pregnancy|0
7632204|NCT03917654|12045662|FG001|Year 1|Pregnancy|0
7632205|NCT03917654|12045663|FG002|Year 1|Pregnancy|0
7632206|NCT03917654|12045664|FG003|Year 1|Pregnancy|0
7632207|NCT03917654|12045665|FG004|Year 1|Pregnancy|0
7632208|NCT03917654|12045666|FG005|Year 1|Pregnancy|0
7632209|NCT03917654|12045667|FG006|Year 1|Pregnancy|0
7632210|NCT03917654|12045668|FG007|Year 1|Pregnancy|1
7632211|NCT03917654|12045669|FG008|Year 1|Pregnancy|0
7632212|NCT03917654|12045670|FG009|Year 1|Pregnancy|1
7632213|NCT03917654|12045671|FG010|Year 1|Pregnancy|0
7632214|NCT03917654|12045672|FG011|Year 1|Pregnancy|0
7632215|NCT03917654|12045661|FG000|Year 2|Travel|1
7632216|NCT03917654|12045662|FG001|Year 2|Travel|0
7632217|NCT03917654|12045663|FG002|Year 2|Travel|0
7632218|NCT03917654|12045664|FG003|Year 2|Travel|0
7632219|NCT03917654|12045665|FG004|Year 2|Travel|1
7632220|NCT03917654|12045666|FG005|Year 2|Travel|1
7632221|NCT03917654|12045667|FG006|Year 2|Travel|2
7632222|NCT03917654|12045668|FG007|Year 2|Travel|1
7632223|NCT03917654|12045669|FG008|Year 2|Travel|0
7632224|NCT03917654|12045670|FG009|Year 2|Travel|1
7632225|NCT03917654|12045671|FG010|Year 2|Travel|0
7632226|NCT03917654|12045672|FG011|Year 2|Travel|1
7632227|NCT03917654|12045661|FG000|Year 2|Married|1
7632228|NCT03917654|12045662|FG001|Year 2|Married|0
7632229|NCT03917654|12045663|FG002|Year 2|Married|0
7632230|NCT03917654|12045664|FG003|Year 2|Married|0
7632231|NCT03917654|12045665|FG004|Year 2|Married|0
7632232|NCT03917654|12045666|FG005|Year 2|Married|0
7632233|NCT03917654|12045667|FG006|Year 2|Married|1
7632234|NCT03917654|12045668|FG007|Year 2|Married|1
7632235|NCT03917654|12045669|FG008|Year 2|Married|0
7632236|NCT03917654|12045670|FG009|Year 2|Married|0
7632237|NCT03917654|12045671|FG010|Year 2|Married|0
7632238|NCT03917654|12045672|FG011|Year 2|Married|0
7632239|NCT03917654|12045661|FG000|Year 2|Subject moved away from site|1
7632240|NCT03917654|12045662|FG001|Year 2|Subject moved away from site|0
7632241|NCT03917654|12045663|FG002|Year 2|Subject moved away from site|0
7632242|NCT03917654|12045664|FG003|Year 2|Subject moved away from site|0
7632243|NCT03917654|12045665|FG004|Year 2|Subject moved away from site|1
7632244|NCT03917654|12045666|FG005|Year 2|Subject moved away from site|0
7632245|NCT03917654|12045667|FG006|Year 2|Subject moved away from site|2
7632246|NCT03917654|12045668|FG007|Year 2|Subject moved away from site|3
7632247|NCT03917654|12045669|FG008|Year 2|Subject moved away from site|0
7632248|NCT03917654|12045670|FG009|Year 2|Subject moved away from site|2
7632249|NCT03917654|12045671|FG010|Year 2|Subject moved away from site|0
7632250|NCT03917654|12045672|FG011|Year 2|Subject moved away from site|1
7632251|NCT03917654|12045661|FG000|Year 2|Year 2 Screening failure|0
7632252|NCT03917654|12045662|FG001|Year 2|Year 2 Screening failure|1
7632253|NCT03917654|12045663|FG002|Year 2|Year 2 Screening failure|0
7632254|NCT03917654|12045664|FG003|Year 2|Year 2 Screening failure|0
7632255|NCT03917654|12045665|FG004|Year 2|Year 2 Screening failure|2
7632256|NCT03917654|12045666|FG005|Year 2|Year 2 Screening failure|0
7632257|NCT03917654|12045667|FG006|Year 2|Year 2 Screening failure|4
7632258|NCT03917654|12045668|FG007|Year 2|Year 2 Screening failure|3
7632259|NCT03917654|12045669|FG008|Year 2|Year 2 Screening failure|10
7632260|NCT03917654|12045670|FG009|Year 2|Year 2 Screening failure|2
7632261|NCT03917654|12045671|FG010|Year 2|Year 2 Screening failure|1
7632262|NCT03917654|12045672|FG011|Year 2|Year 2 Screening failure|1
7632263|NCT03917654|12045661|FG000|Year 2|Death|0
7632264|NCT03917654|12045662|FG001|Year 2|Death|0
7632265|NCT03917654|12045663|FG002|Year 2|Death|0
7632266|NCT03917654|12045664|FG003|Year 2|Death|0
7632267|NCT03917654|12045665|FG004|Year 2|Death|0
7632268|NCT03917654|12045666|FG005|Year 2|Death|1
7632269|NCT03917654|12045667|FG006|Year 2|Death|0
7632270|NCT03917654|12045668|FG007|Year 2|Death|0
7632271|NCT03917654|12045669|FG008|Year 2|Death|1
7632272|NCT03917654|12045670|FG009|Year 2|Death|1
7632273|NCT03917654|12045671|FG010|Year 2|Death|0
7632274|NCT03917654|12045672|FG011|Year 2|Death|0
7632275|NCT03917654|12045661|FG000|Year 2|Withdrawal by Subject|0
7632276|NCT03917654|12045662|FG001|Year 2|Withdrawal by Subject|0
7632277|NCT03917654|12045663|FG002|Year 2|Withdrawal by Subject|0
7632278|NCT03917654|12045664|FG003|Year 2|Withdrawal by Subject|0
7632279|NCT03917654|12045665|FG004|Year 2|Withdrawal by Subject|0
7632280|NCT03917654|12045666|FG005|Year 2|Withdrawal by Subject|0
7632281|NCT03917654|12045667|FG006|Year 2|Withdrawal by Subject|3
7632282|NCT03917654|12045668|FG007|Year 2|Withdrawal by Subject|0
7632283|NCT03917654|12045669|FG008|Year 2|Withdrawal by Subject|2
7632284|NCT03917654|12045670|FG009|Year 2|Withdrawal by Subject|5
7632285|NCT03917654|12045671|FG010|Year 2|Withdrawal by Subject|0
7632286|NCT03917654|12045672|FG011|Year 2|Withdrawal by Subject|0
7632287|NCT03917654|12045661|FG000|Year 2|Spouse/family member request|0
7632288|NCT03917654|12045662|FG001|Year 2|Spouse/family member request|0
7632289|NCT03917654|12045663|FG002|Year 2|Spouse/family member request|0
7632290|NCT03917654|12045664|FG003|Year 2|Spouse/family member request|0
7632291|NCT03917654|12045665|FG004|Year 2|Spouse/family member request|0
7632292|NCT03917654|12045666|FG005|Year 2|Spouse/family member request|0
7632293|NCT03917654|12045667|FG006|Year 2|Spouse/family member request|1
7632294|NCT03917654|12045668|FG007|Year 2|Spouse/family member request|0
7632295|NCT03917654|12045669|FG008|Year 2|Spouse/family member request|0
7632296|NCT03917654|12045670|FG009|Year 2|Spouse/family member request|0
7632297|NCT03917654|12045671|FG010|Year 2|Spouse/family member request|0
7632298|NCT03917654|12045672|FG011|Year 2|Spouse/family member request|0
7632299|NCT03917654|12045661|FG000|Year 2|Lost to Follow-up|0
7632300|NCT03917654|12045662|FG001|Year 2|Lost to Follow-up|0
7632301|NCT03917654|12045663|FG002|Year 2|Lost to Follow-up|0
7632302|NCT03917654|12045664|FG003|Year 2|Lost to Follow-up|0
7632303|NCT03917654|12045665|FG004|Year 2|Lost to Follow-up|0
7632304|NCT03917654|12045666|FG005|Year 2|Lost to Follow-up|0
7632305|NCT03917654|12045667|FG006|Year 2|Lost to Follow-up|1
7632306|NCT03917654|12045668|FG007|Year 2|Lost to Follow-up|0
7632307|NCT03917654|12045669|FG008|Year 2|Lost to Follow-up|1
7632308|NCT03917654|12045670|FG009|Year 2|Lost to Follow-up|0
7632309|NCT03917654|12045671|FG010|Year 2|Lost to Follow-up|0
7632310|NCT03917654|12045672|FG011|Year 2|Lost to Follow-up|1
7632311|NCT03917654|12045661|FG000|Year 2|Adverse Event|0
7632312|NCT03917654|12045662|FG001|Year 2|Adverse Event|0
7632313|NCT03917654|12045663|FG002|Year 2|Adverse Event|0
7632314|NCT03917654|12045664|FG003|Year 2|Adverse Event|0
7632315|NCT03917654|12045665|FG004|Year 2|Adverse Event|0
7632316|NCT03917654|12045666|FG005|Year 2|Adverse Event|0
7632317|NCT03917654|12045667|FG006|Year 2|Adverse Event|0
7632318|NCT03917654|12045668|FG007|Year 2|Adverse Event|0
7632319|NCT03917654|12045669|FG008|Year 2|Adverse Event|0
7632320|NCT03917654|12045670|FG009|Year 2|Adverse Event|1
7632321|NCT03917654|12045671|FG010|Year 2|Adverse Event|0
7632322|NCT03917654|12045672|FG011|Year 2|Adverse Event|0
7632323|NCT03917472|12045700|FG000|Overall Study|Physician Decision|4
7632324|NCT03917472|12045701|FG001|Overall Study|Physician Decision|0
7632325|NCT03917472|12045700|FG000|Overall Study|Adverse Event|3
7632326|NCT03917472|12045701|FG001|Overall Study|Adverse Event|1
7632327|NCT03917472|12045700|FG000|Overall Study|Death|7
7632328|NCT03917472|12045701|FG001|Overall Study|Death|5
7632329|NCT03917472|12045700|FG000|Overall Study|Withdrawal by Subject|11
7632330|NCT03917472|12045701|FG001|Overall Study|Withdrawal by Subject|4
7632331|NCT03917472|12045700|FG000|Overall Study|Lost to Follow-up|10
7632332|NCT03917472|12045701|FG001|Overall Study|Lost to Follow-up|5
7632333|NCT03911154|12045724|FG000|Overall Study|Withdrawal by Subject|1
7632334|NCT03905694|12045731|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
7632335|NCT03905135|12045737|FG000|Dose Escalation|Adverse Event|1
7632336|NCT03905135|12045738|FG001|Dose Escalation|Adverse Event|1
7632337|NCT03905135|12045737|FG000|Dose Escalation|Progressive disease|3
7632338|NCT03905135|12045738|FG001|Dose Escalation|Progressive disease|1
7632339|NCT03905135|12045737|FG000|Dose Escalation|Intercurrent illness|1
7632340|NCT03905135|12045738|FG001|Dose Escalation|Intercurrent illness|0
7632341|NCT03894540|12045794|FG000|Overall Study|Adverse Event|0
7632342|NCT03894540|12045795|FG001|Overall Study|Adverse Event|0
7632343|NCT03894540|12045796|FG002|Overall Study|Adverse Event|0
7632344|NCT03894540|12045797|FG003|Overall Study|Adverse Event|0
7632345|NCT03894540|12045798|FG004|Overall Study|Adverse Event|1
7632346|NCT03894540|12045799|FG005|Overall Study|Adverse Event|0
7632347|NCT03894540|12045794|FG000|Overall Study|Withdrawal by Subject|0
7632348|NCT03894540|12045795|FG001|Overall Study|Withdrawal by Subject|0
7632349|NCT03894540|12045796|FG002|Overall Study|Withdrawal by Subject|0
7632350|NCT03894540|12045797|FG003|Overall Study|Withdrawal by Subject|0
7632351|NCT03894540|12045798|FG004|Overall Study|Withdrawal by Subject|1
7632352|NCT03894540|12045799|FG005|Overall Study|Withdrawal by Subject|0
7632353|NCT03894540|12045794|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
7632354|NCT03894540|12045795|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
7632355|NCT03894540|12045796|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
7632356|NCT03894540|12045797|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
7632357|NCT03894540|12045798|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
7632358|NCT03894540|12045799|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
7632359|NCT03894540|12045794|FG000|Overall Study|Progressive Disease Clinical|1
7632360|NCT03894540|12045795|FG001|Overall Study|Progressive Disease Clinical|1
7632361|NCT03894540|12045796|FG002|Overall Study|Progressive Disease Clinical|0
7632362|NCT03894540|12045797|FG003|Overall Study|Progressive Disease Clinical|1
7632363|NCT03894540|12045798|FG004|Overall Study|Progressive Disease Clinical|5
7632364|NCT03894540|12045799|FG005|Overall Study|Progressive Disease Clinical|1
7632365|NCT03894540|12045794|FG000|Overall Study|Study termination by sponsor|0
7632366|NCT03894540|12045795|FG001|Overall Study|Study termination by sponsor|0
7632367|NCT03894540|12045796|FG002|Overall Study|Study termination by sponsor|0
7632368|NCT03894540|12045797|FG003|Overall Study|Study termination by sponsor|0
7632369|NCT03894540|12045798|FG004|Overall Study|Study termination by sponsor|2
7632370|NCT03894540|12045799|FG005|Overall Study|Study termination by sponsor|0
7632371|NCT03889886|12045821|FG000|Overall Study|Other|0
7632372|NCT03889886|12045822|FG001|Overall Study|Other|1
7632373|NCT03889886|12045823|FG002|Overall Study|Other|0
7632374|NCT03889886|12045824|FG003|Overall Study|Other|1
7632375|NCT03889886|12045821|FG000|Overall Study|Withdrawal by Subject|0
7632376|NCT03889886|12045822|FG001|Overall Study|Withdrawal by Subject|0
7632377|NCT03889886|12045823|FG002|Overall Study|Withdrawal by Subject|1
7632378|NCT03889886|12045824|FG003|Overall Study|Withdrawal by Subject|0
7632379|NCT03889886|12045821|FG000|Overall Study|Adverse Event|0
7632380|NCT03889886|12045822|FG001|Overall Study|Adverse Event|0
7632381|NCT03889886|12045823|FG002|Overall Study|Adverse Event|0
7632382|NCT03889886|12045824|FG003|Overall Study|Adverse Event|6
7632383|NCT03875092|12045854|FG000|Overall Study|Adverse Event|2
7632384|NCT03875092|12045855|FG001|Overall Study|Adverse Event|5
7632385|NCT03875092|12045854|FG000|Overall Study|Death|28
7632386|NCT03875092|12045855|FG001|Overall Study|Death|41
7632387|NCT03875092|12045854|FG000|Overall Study|Ongoing in Study|35
7632388|NCT03875092|12045855|FG001|Overall Study|Ongoing in Study|14
7632389|NCT03866473|12045905|FG000|Phase 1|Death|1
7632390|NCT03866473|12045906|FG001|Phase 1|Death|0
7632391|NCT03866473|12045905|FG000|Phase 2|Death|0
7632392|NCT03866473|12045906|FG001|Phase 2|Death|2
7632393|NCT03866473|12045905|FG000|Phase 2|Dropped|1
7632394|NCT03866473|12045906|FG001|Phase 2|Dropped|1
7632395|NCT03866473|12045905|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1
7632396|NCT03866473|12045906|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0
7632397|NCT03865732|12045918|FG000|Overall Study|Adverse Event|0
7632398|NCT03865732|12045919|FG001|Overall Study|Adverse Event|1
7632399|NCT03864341|12045930|FG000|Overall Study|Withdrawal by Subject|1
7632400|NCT03863834|12045934|FG000|Overall Study|Lost to Follow-up|3
7632401|NCT03853148|12045951|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5
7632402|NCT03853148|12045952|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8
7632403|NCT03853148|12045953|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8
7632404|NCT03853148|12045954|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5
7632405|NCT03850444|12045970|FG000|Overall Study|Adverse Event|12
7632406|NCT03850444|12045971|FG001|Overall Study|Adverse Event|9
7632407|NCT03850444|12045970|FG000|Overall Study|Death|38
7632408|NCT03850444|12045971|FG001|Overall Study|Death|64
7632409|NCT03850444|12045970|FG000|Overall Study|Lost to Follow-up|0
7632410|NCT03850444|12045971|FG001|Overall Study|Lost to Follow-up|1
7632411|NCT03850444|12045970|FG000|Overall Study|Withdrawal by Subject|0
7632412|NCT03850444|12045971|FG001|Overall Study|Withdrawal by Subject|1
7632413|NCT03850444|12045970|FG000|Overall Study|Ongoing in Study|78
7632414|NCT03850444|12045971|FG001|Overall Study|Ongoing in Study|59
7632415|NCT03848832|12045980|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
7632416|NCT03848832|12045981|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
7632417|NCT03848832|12045982|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
7632418|NCT03848832|12045980|FG000|Overall Study|Withdrawal by Subject|0
7632419|NCT03848832|12045981|FG001|Overall Study|Withdrawal by Subject|0
7632420|NCT03848832|12045982|FG002|Overall Study|Withdrawal by Subject|1
7632421|NCT03848832|12045980|FG000|Overall Study|Withdrawal (Covid-19)|0
7632422|NCT03848832|12045981|FG001|Overall Study|Withdrawal (Covid-19)|2
7632423|NCT03848832|12045982|FG002|Overall Study|Withdrawal (Covid-19)|0
7632424|NCT03848832|12045980|FG000|Overall Study|Physician Decision|2
7632425|NCT03848832|12045981|FG001|Overall Study|Physician Decision|1
7632426|NCT03848832|12045982|FG002|Overall Study|Physician Decision|3
7632427|NCT03848832|12045980|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
7632428|NCT03848832|12045981|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
7632429|NCT03848832|12045982|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
7632430|NCT03848832|12045980|FG000|Overall Study|Adverse Event|1
7632431|NCT03848832|12045981|FG001|Overall Study|Adverse Event|0
7632432|NCT03848832|12045982|FG002|Overall Study|Adverse Event|0
7632433|NCT03839940|12046011|FG000|Overall Study|Withdrawal by Subject|3
7632434|NCT03839940|12046012|FG001|Overall Study|Withdrawal by Subject|0
7632435|NCT03839940|12046011|FG000|Overall Study|Protocol Violation|0
7632436|NCT03839940|12046012|FG001|Overall Study|Protocol Violation|1
7632437|NCT03839940|12046011|FG000|Overall Study|No Post-Baseline Pain Score Data|1
7632438|NCT03839940|12046012|FG001|Overall Study|No Post-Baseline Pain Score Data|1
7632439|NCT03839693|12046023|FG000|Overall Study|Lost to Follow-up|0
7632440|NCT03839693|12046024|FG001|Overall Study|Lost to Follow-up|2
7632441|NCT03839693|12046025|FG002|Overall Study|Lost to Follow-up|2
7632442|NCT03839693|12046023|FG000|Overall Study|Withdrawal by Subject|1
7632443|NCT03839693|12046024|FG001|Overall Study|Withdrawal by Subject|0
7632444|NCT03839693|12046025|FG002|Overall Study|Withdrawal by Subject|2
7632445|NCT03839693|12046023|FG000|Overall Study|subject moved out of the area|1
7632446|NCT03839693|12046024|FG001|Overall Study|subject moved out of the area|0
7632447|NCT03839693|12046025|FG002|Overall Study|subject moved out of the area|0
7632448|NCT03837743|12046035|FG000|Overall Study|Adverse Event|1
7632449|NCT03837743|12046035|FG000|Overall Study|Withdrawal by Subject|2
7632450|NCT03834623|12046049|FG000|Overall Study|Progression|0
7632451|NCT03834623|12046050|FG001|Overall Study|Progression|1
7632452|NCT03833817|12046079|FG000|Overall Study|Withdrawal by Subject|3
7632453|NCT03833817|12046080|FG001|Overall Study|Withdrawal by Subject|3
7632454|NCT03833817|12046079|FG000|Overall Study|Lost to Follow-up|3
7632455|NCT03833817|12046080|FG001|Overall Study|Lost to Follow-up|3
7632456|NCT03823703|12046114|FG000|Overall Study|Sponsor request|0
7632457|NCT03823703|12046115|FG001|Overall Study|Sponsor request|3
7632458|NCT03823703|12046116|FG002|Overall Study|Sponsor request|4
7632459|NCT03823703|12046114|FG000|Overall Study|Adverse Event|3
7632460|NCT03823703|12046115|FG001|Overall Study|Adverse Event|1
7632461|NCT03823703|12046116|FG002|Overall Study|Adverse Event|0
7632462|NCT03823703|12046114|FG000|Overall Study|Withdrawal by Subject|0
7632463|NCT03823703|12046115|FG001|Overall Study|Withdrawal by Subject|1
7632464|NCT03823703|12046116|FG002|Overall Study|Withdrawal by Subject|0
7632465|NCT03823300|12046126|FG000|Overall Study|Withdrawal by Subject|5
7632466|NCT03823300|12046127|FG001|Overall Study|Withdrawal by Subject|8
7632467|NCT03823300|12046126|FG000|Overall Study|Death|2
7632468|NCT03823300|12046127|FG001|Overall Study|Death|5
7632469|NCT03823300|12046126|FG000|Overall Study|Adverse Event|2
7632470|NCT03823300|12046127|FG001|Overall Study|Adverse Event|0
7632471|NCT03823300|12046126|FG000|Overall Study|Physician Decision|0
7632472|NCT03823300|12046127|FG001|Overall Study|Physician Decision|2
7632473|NCT03823300|12046126|FG000|Overall Study|Protocol Violation|1
7632474|NCT03823300|12046127|FG001|Overall Study|Protocol Violation|1
7632475|NCT03823300|12046126|FG000|Overall Study|Lost to Follow-up|0
7632476|NCT03823300|12046127|FG001|Overall Study|Lost to Follow-up|1
7632477|NCT03823300|12046126|FG000|Overall Study|Not Eligible|0
7632478|NCT03823300|12046127|FG001|Overall Study|Not Eligible|1
7632479|NCT03823300|12046126|FG000|Overall Study|Ongoing in the study at Primary Completion Date|321
7632480|NCT03823300|12046127|FG001|Overall Study|Ongoing in the study at Primary Completion Date|309
7632481|NCT03817853|12046133|FG000|Induction Phase|Adverse Event|5
7632482|NCT03817853|12046134|FG001|Induction Phase|Adverse Event|0
7632483|NCT03817853|12046135|FG002|Induction Phase|Adverse Event|0
7632484|NCT03817853|12046133|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
7632485|NCT03817853|12046134|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7632486|NCT03817853|12046135|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
7632487|NCT03817853|12046133|FG000|Induction Phase|Physician Decision|2
7632488|NCT03817853|12046134|FG001|Induction Phase|Physician Decision|0
7632489|NCT03817853|12046135|FG002|Induction Phase|Physician Decision|0
7632490|NCT03817853|12046133|FG000|Induction Phase|Progressive Disease|4
7632491|NCT03817853|12046134|FG001|Induction Phase|Progressive Disease|0
7632492|NCT03817853|12046135|FG002|Induction Phase|Progressive Disease|0
7632493|NCT03817853|12046133|FG000|Induction Phase|Withdrawal by Subject|3
7632494|NCT03817853|12046134|FG001|Induction Phase|Withdrawal by Subject|0
7632495|NCT03817853|12046135|FG002|Induction Phase|Withdrawal by Subject|0
7632496|NCT03817853|12046133|FG000|Induction Phase|Continuing on Study|34
7632497|NCT03817853|12046134|FG001|Induction Phase|Continuing on Study|0
7632498|NCT03817853|12046135|FG002|Induction Phase|Continuing on Study|0
7632499|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
7632500|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
7632501|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
7632502|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Death|0
7632503|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Death|1
7632504|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Death|1
7632505|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
7632506|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
7632507|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
7632508|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7632509|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
7632510|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
7632511|NCT03817853|12046133|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
7632512|NCT03817853|12046134|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
7632513|NCT03817853|12046135|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
7632514|NCT03814590|12046157|FG000|Overall Study|Adverse Event|0
7632515|NCT03814590|12046158|FG001|Overall Study|Adverse Event|0
7632516|NCT03814590|12046159|FG002|Overall Study|Adverse Event|0
7632517|NCT03814590|12046160|FG003|Overall Study|Adverse Event|0
7632518|NCT03814590|12046161|FG004|Overall Study|Adverse Event|0
7632519|NCT03814590|12046162|FG005|Overall Study|Adverse Event|1
7632520|NCT03814590|12046163|FG006|Overall Study|Adverse Event|1
7632521|NCT03814590|12046164|FG007|Overall Study|Adverse Event|1
7632522|NCT03814590|12046165|FG008|Overall Study|Adverse Event|0
7632523|NCT03814590|12046166|FG009|Overall Study|Adverse Event|0
7632524|NCT03814590|12046167|FG010|Overall Study|Adverse Event|1
7632525|NCT03814590|12046168|FG011|Overall Study|Adverse Event|0
7632526|NCT03814590|12046169|FG012|Overall Study|Adverse Event|3
7632527|NCT03814590|12046170|FG013|Overall Study|Adverse Event|0
7632528|NCT03814590|12046157|FG000|Overall Study|Lost to Follow-up|0
7632529|NCT03814590|12046158|FG001|Overall Study|Lost to Follow-up|2
7632530|NCT03814590|12046159|FG002|Overall Study|Lost to Follow-up|1
7632531|NCT03814590|12046160|FG003|Overall Study|Lost to Follow-up|0
7632532|NCT03814590|12046161|FG004|Overall Study|Lost to Follow-up|1
7632533|NCT03814590|12046162|FG005|Overall Study|Lost to Follow-up|1
7632534|NCT03814590|12046163|FG006|Overall Study|Lost to Follow-up|1
7632535|NCT03814590|12046164|FG007|Overall Study|Lost to Follow-up|1
7632536|NCT03814590|12046165|FG008|Overall Study|Lost to Follow-up|0
7632537|NCT03814590|12046166|FG009|Overall Study|Lost to Follow-up|0
7632538|NCT03814590|12046167|FG010|Overall Study|Lost to Follow-up|1
7632539|NCT03814590|12046168|FG011|Overall Study|Lost to Follow-up|0
7632540|NCT03814590|12046169|FG012|Overall Study|Lost to Follow-up|0
7632541|NCT03814590|12046170|FG013|Overall Study|Lost to Follow-up|1
7632542|NCT03814590|12046157|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632543|NCT03814590|12046158|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632544|NCT03814590|12046159|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632545|NCT03814590|12046160|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632546|NCT03814590|12046161|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632547|NCT03814590|12046162|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632548|NCT03814590|12046163|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632549|NCT03814590|12046164|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632550|NCT03814590|12046165|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632551|NCT03814590|12046166|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1
7632552|NCT03814590|12046167|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632553|NCT03814590|12046168|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632554|NCT03814590|12046169|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632555|NCT03814590|12046170|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
7632556|NCT03814590|12046157|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632557|NCT03814590|12046158|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632558|NCT03814590|12046159|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632559|NCT03814590|12046160|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632560|NCT03814590|12046161|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632561|NCT03814590|12046162|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7632562|NCT03814590|12046163|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632563|NCT03814590|12046164|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7632564|NCT03814590|12046165|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632565|NCT03814590|12046166|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
7632566|NCT03814590|12046167|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632567|NCT03814590|12046168|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
7632568|NCT03814590|12046169|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
7632569|NCT03814590|12046170|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
7632570|NCT03814590|12046157|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632571|NCT03814590|12046158|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632572|NCT03814590|12046159|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632573|NCT03814590|12046160|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632574|NCT03814590|12046161|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632575|NCT03814590|12046162|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632576|NCT03814590|12046163|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632577|NCT03814590|12046164|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7632578|NCT03814590|12046165|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632579|NCT03814590|12046166|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
7632580|NCT03814590|12046167|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632581|NCT03814590|12046168|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632582|NCT03814590|12046169|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632583|NCT03814590|12046170|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
7632584|NCT03814590|12046157|FG000|Overall Study|UNKNOWN REASON|0
7632585|NCT03814590|12046158|FG001|Overall Study|UNKNOWN REASON|0
7632586|NCT03814590|12046159|FG002|Overall Study|UNKNOWN REASON|0
7632587|NCT03814590|12046160|FG003|Overall Study|UNKNOWN REASON|0
7632588|NCT03814590|12046161|FG004|Overall Study|UNKNOWN REASON|0
7632589|NCT03814590|12046162|FG005|Overall Study|UNKNOWN REASON|0
7632590|NCT03814590|12046163|FG006|Overall Study|UNKNOWN REASON|0
7632591|NCT03814590|12046164|FG007|Overall Study|UNKNOWN REASON|1
7632592|NCT03814590|12046165|FG008|Overall Study|UNKNOWN REASON|0
7632593|NCT03814590|12046166|FG009|Overall Study|UNKNOWN REASON|0
7632594|NCT03814590|12046167|FG010|Overall Study|UNKNOWN REASON|0
7632595|NCT03814590|12046168|FG011|Overall Study|UNKNOWN REASON|0
7632596|NCT03814590|12046169|FG012|Overall Study|UNKNOWN REASON|0
7632597|NCT03814590|12046170|FG013|Overall Study|UNKNOWN REASON|0
7632598|NCT03812380|12046221|FG000|Overall Study|Protocol Violation|3
7632599|NCT03812380|12046222|FG001|Overall Study|Protocol Violation|3
7632600|NCT03812380|12046221|FG000|Overall Study|Withdrawal by Subject|5
7632601|NCT03812380|12046222|FG001|Overall Study|Withdrawal by Subject|4
7632602|NCT03812380|12046221|FG000|Overall Study|Early termination of study|14
7632603|NCT03812380|12046222|FG001|Overall Study|Early termination of study|14
7632604|NCT03812224|12046230|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
7632605|NCT03812224|12046231|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
7632606|NCT03812224|12046230|FG000|Double-blind Treatment Period|Decision by Sponsor|0
7632607|NCT03812224|12046231|FG001|Double-blind Treatment Period|Decision by Sponsor|1
7632608|NCT03812224|12046230|FG000|Open-label Treatment Period|Withdrawal by Subject|2
7632609|NCT03812224|12046231|FG001|Open-label Treatment Period|Withdrawal by Subject|2
7632610|NCT03812224|12046230|FG000|Open-label Treatment Period|Decision by Sponsor|0
7632611|NCT03812224|12046231|FG001|Open-label Treatment Period|Decision by Sponsor|1
7632612|NCT03811093|12046240|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
7632613|NCT03811093|12046241|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
7632614|NCT03811093|12046240|FG000|Overall Study|Unable to measure body fat percentage|2
7632615|NCT03811093|12046241|FG001|Overall Study|Unable to measure body fat percentage|0
7632616|NCT03810495|12046268|FG000|Overall Study|Lost to Follow-up|2
7632617|NCT03810495|12046268|FG000|Overall Study|Withdrawal by Subject|1
7632618|NCT03810313|12046274|FG000|Overall Study|Study terminated by sponsor|164
7632619|NCT03810313|12046275|FG001|Overall Study|Study terminated by sponsor|159
7632620|NCT03810313|12046274|FG000|Overall Study|Subject decision|10
7632621|NCT03810313|12046275|FG001|Overall Study|Subject decision|11
7632622|NCT03810313|12046274|FG000|Overall Study|Lost to Follow-up|3
7632623|NCT03810313|12046275|FG001|Overall Study|Lost to Follow-up|3
7632624|NCT03810313|12046274|FG000|Overall Study|Adverse Event|2
7632625|NCT03810313|12046275|FG001|Overall Study|Adverse Event|1
7632626|NCT03810313|12046274|FG000|Overall Study|Death|2
7632627|NCT03810313|12046275|FG001|Overall Study|Death|1
7632628|NCT03810313|12046274|FG000|Overall Study|Physician Decision|0
7632629|NCT03810313|12046275|FG001|Overall Study|Physician Decision|1
7632630|NCT03807843|12046284|FG000|Overall Study|Lost to Follow-up|1
7632631|NCT03807843|12046285|FG001|Overall Study|Lost to Follow-up|0
7632632|NCT03804879|12046293|FG000|Overall Study|Adverse Event|3
7632633|NCT03804879|12046294|FG001|Overall Study|Adverse Event|0
7632634|NCT03804879|12046293|FG000|Overall Study|Study Terminated By Sponsor|10
7632635|NCT03804879|12046294|FG001|Overall Study|Study Terminated By Sponsor|12
7632636|NCT03804879|12046293|FG000|Overall Study|Withdrawal by Subject|3
7632637|NCT03804879|12046294|FG001|Overall Study|Withdrawal by Subject|1
7632638|NCT03802630|12046303|FG000|Overall Study|Study terminated by sponsor|130
7632639|NCT03802630|12046304|FG001|Overall Study|Study terminated by sponsor|134
7632640|NCT03802630|12046303|FG000|Overall Study|Subject decision|16
7632641|NCT03802630|12046304|FG001|Overall Study|Subject decision|9
7632642|NCT03802630|12046303|FG000|Overall Study|Adverse Event|3
7632643|NCT03802630|12046304|FG001|Overall Study|Adverse Event|1
7632644|NCT03802630|12046303|FG000|Overall Study|Lost to Follow-up|2
7632645|NCT03802630|12046304|FG001|Overall Study|Lost to Follow-up|2
7632646|NCT03802630|12046303|FG000|Overall Study|Physician Decision|2
7632647|NCT03802630|12046304|FG001|Overall Study|Physician Decision|0
7632648|NCT03802630|12046303|FG000|Overall Study|Death|0
7632649|NCT03802630|12046304|FG001|Overall Study|Death|2
7632650|NCT03789110|12046344|FG000|Overall Study|Adverse Event|2
7632651|NCT03789110|12046344|FG000|Overall Study|Physician Decision|1
7632652|NCT03789110|12046344|FG000|Overall Study|Withdrawal by Subject|2
7632653|NCT03789110|12046344|FG000|Overall Study|Lack of Efficacy|22
7632654|NCT03789110|12046344|FG000|Overall Study|still on treatment|3
7632655|NCT03782064|12046352|FG000|Overall Study|Lack of Efficacy|2
7632656|NCT03782064|12046352|FG000|Overall Study|Progression Prior to Starting Treatment|3
7632657|NCT03777917|12046358|FG000|Overall Study|Withdrawal by Subject|1
7632658|NCT03777917|12046359|FG001|Overall Study|Withdrawal by Subject|0
7632659|NCT03777917|12046358|FG000|Overall Study|Physician Decision|1
7632660|NCT03777917|12046359|FG001|Overall Study|Physician Decision|0
7632661|NCT03777917|12046358|FG000|Overall Study|Lost to Follow-up|6
7632662|NCT03777917|12046359|FG001|Overall Study|Lost to Follow-up|2
7632663|NCT03777917|12046358|FG000|Overall Study|Other|1
7632664|NCT03777917|12046359|FG001|Overall Study|Other|0
7632665|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8
7632666|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16
7632667|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2
7632668|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4
7632669|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12
7632670|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10
7632671|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0
7632672|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2
7632673|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0
7632674|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1
7632675|NCT03774875|12046368|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1
7632676|NCT03774875|12046369|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0
7632677|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6
7632678|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9
7632679|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2
7632680|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11
7632681|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7
7632682|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20
7632683|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0
7632684|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2
7632685|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Other|1
7632686|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Other|1
7632687|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0
7632688|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1
7632689|NCT03774875|12046368|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0
7632690|NCT03774875|12046369|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3
7632691|NCT03773484|12046386|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5
7632692|NCT03773133|12046390|FG000|Overall Study|Screen Failure|8
7632693|NCT03769753|12046395|FG000|Overall Study|Not Treated|6
7632694|NCT03769753|12046395|FG000|Overall Study|Inevaluable - No Evidence of Disease|1
7632695|NCT03769090|12046402|FG000|Overall Study|Randomized and did not receive randomized study treatment|1
7632696|NCT03769090|12046403|FG001|Overall Study|Randomized and did not receive randomized study treatment|2
7632697|NCT03769090|12046404|FG002|Overall Study|Randomized and did not receive randomized study treatment|2
7632698|NCT03769090|12046402|FG000|Overall Study|Withdrawal by Subject|52
7632699|NCT03769090|12046403|FG001|Overall Study|Withdrawal by Subject|62
7632700|NCT03769090|12046404|FG002|Overall Study|Withdrawal by Subject|74
7632701|NCT03769090|12046402|FG000|Overall Study|Death|4
7632702|NCT03769090|12046403|FG001|Overall Study|Death|2
7632703|NCT03769090|12046404|FG002|Overall Study|Death|2
7632704|NCT03769090|12046402|FG000|Overall Study|Adverse Event|7
7632705|NCT03769090|12046403|FG001|Overall Study|Adverse Event|7
7632706|NCT03769090|12046404|FG002|Overall Study|Adverse Event|8
7632707|NCT03769090|12046402|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0
7632708|NCT03769090|12046403|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1
7632709|NCT03769090|12046404|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2
7632710|NCT03769090|12046402|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1
7632711|NCT03769090|12046403|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4
7632712|NCT03769090|12046404|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4
7632713|NCT03769090|12046402|FG000|Overall Study|>= 5 total severe exacerbation events|0
7632714|NCT03769090|12046403|FG001|Overall Study|>= 5 total severe exacerbation events|1
7632715|NCT03769090|12046404|FG002|Overall Study|>= 5 total severe exacerbation events|1
7632716|NCT03769090|12046402|FG000|Overall Study|Protocol Violation|5
7632717|NCT03769090|12046403|FG001|Overall Study|Protocol Violation|6
7632718|NCT03769090|12046404|FG002|Overall Study|Protocol Violation|8
7632719|NCT03769090|12046402|FG000|Overall Study|Pregnancy|1
7632720|NCT03769090|12046403|FG001|Overall Study|Pregnancy|0
7632721|NCT03769090|12046404|FG002|Overall Study|Pregnancy|3
7632722|NCT03769090|12046402|FG000|Overall Study|Lost to Follow-up|19
7632723|NCT03769090|12046403|FG001|Overall Study|Lost to Follow-up|25
7632724|NCT03769090|12046404|FG002|Overall Study|Lost to Follow-up|21
7632725|NCT03769090|12046402|FG000|Overall Study|Condition under investigation worsened|2
7632726|NCT03769090|12046403|FG001|Overall Study|Condition under investigation worsened|0
7632727|NCT03769090|12046404|FG002|Overall Study|Condition under investigation worsened|1
7632728|NCT03769090|12046402|FG000|Overall Study|Lack of Efficacy|1
7632729|NCT03769090|12046403|FG001|Overall Study|Lack of Efficacy|2
7632730|NCT03769090|12046404|FG002|Overall Study|Lack of Efficacy|2
7632731|NCT03769090|12046402|FG000|Overall Study|Other reasons|8
7632732|NCT03769090|12046403|FG001|Overall Study|Other reasons|12
7632733|NCT03769090|12046404|FG002|Overall Study|Other reasons|15
7632734|NCT03764475|12046417|FG000|Overall Study|Adverse Event|11
7632735|NCT03764475|12046418|FG001|Overall Study|Adverse Event|2
7632736|NCT03764475|12046417|FG000|Overall Study|Lost to Follow-up|24
7632737|NCT03764475|12046418|FG001|Overall Study|Lost to Follow-up|10
7632738|NCT03764475|12046417|FG000|Overall Study|Withdrawal by Subject|26
7632739|NCT03764475|12046418|FG001|Overall Study|Withdrawal by Subject|10
7632740|NCT03764475|12046417|FG000|Overall Study|Lack of Efficacy|3
7632741|NCT03764475|12046418|FG001|Overall Study|Lack of Efficacy|0
7632742|NCT03764475|12046417|FG000|Overall Study|COVID-19 Disruption|2
7632743|NCT03764475|12046418|FG001|Overall Study|COVID-19 Disruption|0
7632744|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Adverse Event|7
7632745|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Adverse Event|2
7632746|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1
7632747|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0
7632748|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Physician Decision|1
7632749|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Physician Decision|0
7632750|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2
7632751|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0
7632752|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4
7632753|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0
7632754|NCT03762265|12046430|FG000|BT Period: Weeks 1 to 37|Other|0
7632755|NCT03762265|12046431|FG001|BT Period: Weeks 1 to 37|Other|1
7632756|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1
7632757|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2
7632758|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3
7632759|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2
7632760|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1
7632761|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0
7632762|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8
7632763|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10
7632764|NCT03762265|12046430|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3
7632765|NCT03762265|12046431|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2
7632766|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0
7632767|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1
7632768|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28
7632769|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25
7632770|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0
7632771|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2
7632772|NCT03762265|12046430|FG000|LTE Period: Weeks 61 to 109|Other|1
7632773|NCT03762265|12046431|FG001|LTE Period: Weeks 61 to 109|Other|0
7632774|NCT03760666|12046456|FG000|Overall Study|Adverse Event|2
7632775|NCT03760666|12046457|FG001|Overall Study|Adverse Event|4
7632776|NCT03760666|12046458|FG002|Overall Study|Adverse Event|1
7632777|NCT03760666|12046456|FG000|Overall Study|AML Disease Progression|3
7632778|NCT03760666|12046457|FG001|Overall Study|AML Disease Progression|3
7632779|NCT03760666|12046458|FG002|Overall Study|AML Disease Progression|0
7632780|NCT03760666|12046456|FG000|Overall Study|Physician Decision|0
7632781|NCT03760666|12046457|FG001|Overall Study|Physician Decision|3
7632782|NCT03760666|12046458|FG002|Overall Study|Physician Decision|0
7632783|NCT03760666|12046456|FG000|Overall Study|Withdrawal by Subject|0
7632784|NCT03760666|12046457|FG001|Overall Study|Withdrawal by Subject|1
7632785|NCT03760666|12046458|FG002|Overall Study|Withdrawal by Subject|0
7632786|NCT03759379|12046472|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119
7632787|NCT03759379|12046473|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38
7632788|NCT03759379|12046472|FG000|Treatment Period|Death|2
7632789|NCT03759379|12046473|FG001|Treatment Period|Death|3
7632790|NCT03759379|12046472|FG000|Treatment Period|Lost to Follow-up|1
7632791|NCT03759379|12046473|FG001|Treatment Period|Lost to Follow-up|0
7632792|NCT03759379|12046472|FG000|Treatment Period|Physician Decision|0
7632793|NCT03759379|12046473|FG001|Treatment Period|Physician Decision|1
7632794|NCT03759366|12046479|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1
7632795|NCT03759366|12046479|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10
7632796|NCT03759041|12046486|FG000|Overall Study|Withdrawal by Subject|4
7632797|NCT03759041|12046487|FG001|Overall Study|Withdrawal by Subject|10
7632798|NCT03759041|12046488|FG002|Overall Study|Withdrawal by Subject|10
7632799|NCT03759041|12046486|FG000|Overall Study|Adverse Event|1
7632800|NCT03759041|12046487|FG001|Overall Study|Adverse Event|3
7632801|NCT03759041|12046488|FG002|Overall Study|Adverse Event|4
7632802|NCT03759041|12046486|FG000|Overall Study|Lack of Efficacy|0
7632803|NCT03759041|12046487|FG001|Overall Study|Lack of Efficacy|0
7632804|NCT03759041|12046488|FG002|Overall Study|Lack of Efficacy|1
7632805|NCT03759041|12046486|FG000|Overall Study|Study Terminated by Sponsor|15
7632806|NCT03759041|12046487|FG001|Overall Study|Study Terminated by Sponsor|16
7632807|NCT03759041|12046488|FG002|Overall Study|Study Terminated by Sponsor|10
7632808|NCT03759041|12046486|FG000|Overall Study|Other reason for discontinuation|0
7632809|NCT03759041|12046487|FG001|Overall Study|Other reason for discontinuation|2
7632810|NCT03759041|12046488|FG002|Overall Study|Other reason for discontinuation|1
7632811|NCT03759041|12046486|FG000|Overall Study|Lost to Follow-up|7
7632812|NCT03759041|12046487|FG001|Overall Study|Lost to Follow-up|2
7632813|NCT03759041|12046488|FG002|Overall Study|Lost to Follow-up|2
7632814|NCT03759041|12046486|FG000|Overall Study|Subjects did not have a discontinuation page completed|0
7632815|NCT03759041|12046487|FG001|Overall Study|Subjects did not have a discontinuation page completed|1
7632816|NCT03759041|12046488|FG002|Overall Study|Subjects did not have a discontinuation page completed|0
7632817|NCT03757715|12046498|FG000|Overall Study|Lost to Follow-up|4
7632818|NCT03757715|12046499|FG001|Overall Study|Lost to Follow-up|9
7632819|NCT03757715|12046498|FG000|Overall Study|Withdrawal by Subject|1
7632820|NCT03757715|12046499|FG001|Overall Study|Withdrawal by Subject|1
7632821|NCT03753542|12046507|FG000|Overall Study|Lost to Follow-up|9
7632822|NCT03753542|12046508|FG001|Overall Study|Lost to Follow-up|14
7632823|NCT03750552|12046516|FG000|Overall Study|Adverse Event|5
7632824|NCT03750552|12046517|FG001|Overall Study|Adverse Event|1
7632825|NCT03750552|12046516|FG000|Overall Study|Withdrawal by Subject|1
7632826|NCT03750552|12046517|FG001|Overall Study|Withdrawal by Subject|1
7632827|NCT03750552|12046516|FG000|Overall Study|Other|2
7632828|NCT03750552|12046517|FG001|Overall Study|Other|0
7632829|NCT03750240|12046524|FG000|Overall Study|Technical Difficulties|2
7632830|NCT03749109|12046530|FG000|Overall Study|Adverse Event|2
7632831|NCT03749109|12046531|FG001|Overall Study|Adverse Event|0
7632832|NCT03747302|12046540|FG000|Overall Study|Withdrawal by Subject|1
7632833|NCT03747302|12046541|FG001|Overall Study|Withdrawal by Subject|2
7632834|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6
7632835|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9
7632836|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13
7632837|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7632838|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
7632839|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
7632840|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7632841|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
7632842|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
7632843|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7632844|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
7632845|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6
7632846|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1
7632847|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
7632848|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1
7632849|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1
7632850|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3
7632851|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1
7632852|NCT03739203|12046556|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1
7632853|NCT03739203|12046557|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
7632854|NCT03739203|12046558|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1
7632855|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1
7632856|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2
7632857|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0
7632858|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0
7632859|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0
7632860|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2
7632861|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Death|1
7632862|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Death|0
7632863|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Death|0
7632864|NCT03739203|12046556|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0
7632865|NCT03739203|12046557|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0
7632866|NCT03739203|12046558|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2
7632867|NCT03733444|12046590|FG000|Overall Study|Adverse Event|8
7632868|NCT03733444|12046591|FG001|Overall Study|Adverse Event|10
7632869|NCT03733444|12046592|FG002|Overall Study|Adverse Event|5
7632870|NCT03733444|12046590|FG000|Overall Study|Death|20
7632871|NCT03733444|12046591|FG001|Overall Study|Death|19
7632872|NCT03733444|12046592|FG002|Overall Study|Death|11
7632873|NCT03733444|12046590|FG000|Overall Study|Lost to Follow-up|3
7632874|NCT03733444|12046591|FG001|Overall Study|Lost to Follow-up|0
7632875|NCT03733444|12046592|FG002|Overall Study|Lost to Follow-up|1
7632876|NCT03733444|12046590|FG000|Overall Study|Lack of Efficacy|0
7632877|NCT03733444|12046591|FG001|Overall Study|Lack of Efficacy|1
7632878|NCT03733444|12046592|FG002|Overall Study|Lack of Efficacy|1
7632879|NCT03733444|12046590|FG000|Overall Study|Physician Decision|2
7632880|NCT03733444|12046591|FG001|Overall Study|Physician Decision|1
7632881|NCT03733444|12046592|FG002|Overall Study|Physician Decision|0
7632882|NCT03733444|12046590|FG000|Overall Study|Protocol Violation|2
7632883|NCT03733444|12046591|FG001|Overall Study|Protocol Violation|1
7632884|NCT03733444|12046592|FG002|Overall Study|Protocol Violation|0
7632885|NCT03733444|12046590|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632886|NCT03733444|12046591|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632887|NCT03733444|12046592|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2
7632888|NCT03733444|12046590|FG000|Overall Study|Study Terminated by Sponsor|203
7632889|NCT03733444|12046591|FG001|Overall Study|Study Terminated by Sponsor|209
7632890|NCT03733444|12046592|FG002|Overall Study|Study Terminated by Sponsor|221
7632891|NCT03733444|12046590|FG000|Overall Study|Withdrawal by Subject|19
7632892|NCT03733444|12046591|FG001|Overall Study|Withdrawal by Subject|18
7632893|NCT03733444|12046592|FG002|Overall Study|Withdrawal by Subject|16
7632894|NCT03733444|12046590|FG000|Overall Study|Miscellaneous|1
7632895|NCT03733444|12046591|FG001|Overall Study|Miscellaneous|0
7632896|NCT03733444|12046592|FG002|Overall Study|Miscellaneous|1
7632897|NCT03733444|12046590|FG000|Overall Study|Not Treated|1
7632898|NCT03733444|12046591|FG001|Overall Study|Not Treated|2
7632899|NCT03733444|12046592|FG002|Overall Study|Not Treated|1
7632900|NCT03730012|12046612|FG000|Overall Study|Adverse Event|0
7632901|NCT03730012|12046613|FG001|Overall Study|Adverse Event|1
7632902|NCT03730012|12046612|FG000|Overall Study|Lack of Efficacy|1
7632903|NCT03730012|12046613|FG001|Overall Study|Lack of Efficacy|5
7632904|NCT03730012|12046612|FG000|Overall Study|Withdrawal by Subject|0
7632905|NCT03730012|12046613|FG001|Overall Study|Withdrawal by Subject|1
7632906|NCT03730012|12046612|FG000|Overall Study|Miscellaneous|2
7632907|NCT03730012|12046613|FG001|Overall Study|Miscellaneous|1
7632908|NCT03727841|12046624|FG000|Overall Study|Physician Decision|3
7632909|NCT03727841|12046625|FG001|Overall Study|Physician Decision|1
7632910|NCT03726879|12046633|FG000|Overall Study|Death|6
7632911|NCT03726879|12046634|FG001|Overall Study|Death|4
7632912|NCT03726879|12046633|FG000|Overall Study|Physician Decision|0
7632913|NCT03726879|12046634|FG001|Overall Study|Physician Decision|2
7632914|NCT03726879|12046633|FG000|Overall Study|Protocol Violation|0
7632915|NCT03726879|12046634|FG001|Overall Study|Protocol Violation|1
7632916|NCT03726879|12046633|FG000|Overall Study|Withdrawal by Subject|5
7632917|NCT03726879|12046634|FG001|Overall Study|Withdrawal by Subject|5
7632918|NCT03726879|12046633|FG000|Overall Study|TSH result is unstable|0
7632919|NCT03726879|12046634|FG001|Overall Study|TSH result is unstable|1
7632920|NCT03726879|12046633|FG000|Overall Study|Continuing on Study|215
7632921|NCT03726879|12046634|FG001|Overall Study|Continuing on Study|215
7632922|NCT03712787|12046685|FG000|Overall Study|Adverse Event|2
7632923|NCT03712787|12046686|FG001|Overall Study|Adverse Event|3
7632924|NCT03712787|12046687|FG002|Overall Study|Adverse Event|0
7632925|NCT03712787|12046688|FG003|Overall Study|Adverse Event|4
7632926|NCT03712787|12046685|FG000|Overall Study|Withdrawal by Subject|4
7632927|NCT03712787|12046686|FG001|Overall Study|Withdrawal by Subject|14
7632928|NCT03712787|12046687|FG002|Overall Study|Withdrawal by Subject|12
7632929|NCT03712787|12046688|FG003|Overall Study|Withdrawal by Subject|8
7632930|NCT03712787|12046685|FG000|Overall Study|Lost to Follow-up|1
7632931|NCT03712787|12046686|FG001|Overall Study|Lost to Follow-up|1
7632932|NCT03712787|12046687|FG002|Overall Study|Lost to Follow-up|2
7632933|NCT03712787|12046688|FG003|Overall Study|Lost to Follow-up|1
7632934|NCT03712787|12046685|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7632935|NCT03712787|12046686|FG001|Overall Study|COVID-19 Logistical Restrictions|1
7632936|NCT03712787|12046687|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7632937|NCT03712787|12046688|FG003|Overall Study|COVID-19 Logistical Restrictions|0
7632938|NCT03712787|12046685|FG000|Overall Study|COVID-19 Infection|0
7632939|NCT03712787|12046686|FG001|Overall Study|COVID-19 Infection|1
7632940|NCT03712787|12046687|FG002|Overall Study|COVID-19 Infection|0
7632941|NCT03712787|12046688|FG003|Overall Study|COVID-19 Infection|0
7632942|NCT03712787|12046685|FG000|Overall Study|Other, Not Specified|79
7632943|NCT03712787|12046686|FG001|Overall Study|Other, Not Specified|77
7632944|NCT03712787|12046687|FG002|Overall Study|Other, Not Specified|74
7632945|NCT03712787|12046688|FG003|Overall Study|Other, Not Specified|78
7632946|NCT03711162|12046701|FG000|Overall Study|Adverse Event|5
7632947|NCT03711162|12046702|FG001|Overall Study|Adverse Event|2
7632948|NCT03711162|12046703|FG002|Overall Study|Adverse Event|4
7632949|NCT03711162|12046701|FG000|Overall Study|Death|11
7632950|NCT03711162|12046702|FG001|Overall Study|Death|7
7632951|NCT03711162|12046703|FG002|Overall Study|Death|8
7632952|NCT03711162|12046701|FG000|Overall Study|Lost to Follow-up|1
7632953|NCT03711162|12046702|FG001|Overall Study|Lost to Follow-up|0
7632954|NCT03711162|12046703|FG002|Overall Study|Lost to Follow-up|1
7632955|NCT03711162|12046701|FG000|Overall Study|Study Terminated by Sponsor|139
7632956|NCT03711162|12046702|FG001|Overall Study|Study Terminated by Sponsor|152
7632957|NCT03711162|12046703|FG002|Overall Study|Study Terminated by Sponsor|146
7632958|NCT03711162|12046701|FG000|Overall Study|Withdrawal by Subject|17
7632959|NCT03711162|12046702|FG001|Overall Study|Withdrawal by Subject|10
7632960|NCT03711162|12046703|FG002|Overall Study|Withdrawal by Subject|10
7632961|NCT03711162|12046701|FG000|Overall Study|Miscellaneous|1
7632962|NCT03711162|12046702|FG001|Overall Study|Miscellaneous|2
7632963|NCT03711162|12046703|FG002|Overall Study|Miscellaneous|2
7632964|NCT03711162|12046701|FG000|Overall Study|Not Treated|1
7632965|NCT03711162|12046702|FG001|Overall Study|Not Treated|0
7632966|NCT03711162|12046703|FG002|Overall Study|Not Treated|1
7632967|NCT03711162|12046701|FG000|Overall Study|Physician Decision|0
7632968|NCT03711162|12046702|FG001|Overall Study|Physician Decision|2
7632969|NCT03711162|12046703|FG002|Overall Study|Physician Decision|0
7632970|NCT03711162|12046701|FG000|Overall Study|Lack of Efficacy|0
7632971|NCT03711162|12046702|FG001|Overall Study|Lack of Efficacy|0
7632972|NCT03711162|12046703|FG002|Overall Study|Lack of Efficacy|2
7632973|NCT03711162|12046701|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0
7632974|NCT03711162|12046702|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0
7632975|NCT03711162|12046703|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1
7632976|NCT03706456|12046717|FG000|Overall Study|Lack of Efficacy|1
7632977|NCT03706456|12046717|FG000|Overall Study|Ongoing|21
7632978|NCT03705793|12046723|FG000|Overall Study|Lost to Follow-up|3
7632979|NCT03705793|12046724|FG001|Overall Study|Lost to Follow-up|4
7632980|NCT03705793|12046723|FG000|Overall Study|Withdrawal by Subject|2
7632981|NCT03705793|12046724|FG001|Overall Study|Withdrawal by Subject|1
7632982|NCT03703466|12046733|FG000|Overall Study|Death|2
7632983|NCT03703466|12046734|FG001|Overall Study|Death|1
7632984|NCT03703466|12046735|FG002|Overall Study|Death|0
7632985|NCT03703466|12046733|FG000|Overall Study|Protocol Violation|1
7632986|NCT03703466|12046734|FG001|Overall Study|Protocol Violation|0
7632987|NCT03703466|12046735|FG002|Overall Study|Protocol Violation|0
7632988|NCT03703466|12046733|FG000|Overall Study|Withdrawal by Subject|0
7632989|NCT03703466|12046734|FG001|Overall Study|Withdrawal by Subject|3
7632990|NCT03703466|12046735|FG002|Overall Study|Withdrawal by Subject|0
7632991|NCT03703466|12046733|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
7632992|NCT03703466|12046734|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7632993|NCT03703466|12046735|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
7632994|NCT03693612|12046764|FG000|Overall Study|Lost to Follow-up|0
7632995|NCT03693612|12046765|FG001|Overall Study|Lost to Follow-up|0
7632996|NCT03693612|12046766|FG002|Overall Study|Lost to Follow-up|0
7632997|NCT03693612|12046767|FG003|Overall Study|Lost to Follow-up|0
7632998|NCT03693612|12046768|FG004|Overall Study|Lost to Follow-up|1
7632999|NCT03693612|12046769|FG005|Overall Study|Lost to Follow-up|0
7633000|NCT03693612|12046770|FG006|Overall Study|Lost to Follow-up|0
7633001|NCT03693612|12046764|FG000|Overall Study|Withdrawal by Subject|0
7633002|NCT03693612|12046765|FG001|Overall Study|Withdrawal by Subject|0
7633003|NCT03693612|12046766|FG002|Overall Study|Withdrawal by Subject|1
7633004|NCT03693612|12046767|FG003|Overall Study|Withdrawal by Subject|0
7633005|NCT03693612|12046768|FG004|Overall Study|Withdrawal by Subject|2
7633006|NCT03693612|12046769|FG005|Overall Study|Withdrawal by Subject|0
7633007|NCT03693612|12046770|FG006|Overall Study|Withdrawal by Subject|0
7633008|NCT03693612|12046764|FG000|Overall Study|Study Terminated by Sponsor|0
7633009|NCT03693612|12046765|FG001|Overall Study|Study Terminated by Sponsor|1
7633010|NCT03693612|12046766|FG002|Overall Study|Study Terminated by Sponsor|0
7633011|NCT03693612|12046767|FG003|Overall Study|Study Terminated by Sponsor|0
7633012|NCT03693612|12046768|FG004|Overall Study|Study Terminated by Sponsor|3
7633013|NCT03693612|12046769|FG005|Overall Study|Study Terminated by Sponsor|0
7633014|NCT03693612|12046770|FG006|Overall Study|Study Terminated by Sponsor|0
7633015|NCT03693170|12046786|FG000|Overall Study|Disease Progression|48
7633016|NCT03693170|12046786|FG000|Overall Study|Adverse Event|16
7633017|NCT03693170|12046786|FG000|Overall Study|Physician Decision|6
7633018|NCT03693170|12046786|FG000|Overall Study|Protocol Violation|2
7633019|NCT03693170|12046786|FG000|Overall Study|Death|1
7633020|NCT03693170|12046786|FG000|Overall Study|Non compliance with study drug|1
7633021|NCT03693170|12046786|FG000|Overall Study|Withdrawal by Subject|1
7633022|NCT03692871|12046793|FG000|Overall Study|Death|1
7633023|NCT03692871|12046794|FG001|Overall Study|Death|1
7633024|NCT03692871|12046793|FG000|Overall Study|Lost to Follow-up|24
7633025|NCT03692871|12046794|FG001|Overall Study|Lost to Follow-up|9
7633026|NCT03692871|12046793|FG000|Overall Study|Physician Decision|22
7633027|NCT03692871|12046794|FG001|Overall Study|Physician Decision|7
7633028|NCT03692871|12046793|FG000|Overall Study|Protocol Deviation|1
7633029|NCT03692871|12046794|FG001|Overall Study|Protocol Deviation|0
7633030|NCT03692871|12046793|FG000|Overall Study|Withdrawal by Parent/Guardian|77
7633031|NCT03692871|12046794|FG001|Overall Study|Withdrawal by Parent/Guardian|20
7633032|NCT03689855|12046800|FG000|Overall Study|Adverse Event|3
7633033|NCT03689855|12046800|FG000|Overall Study|Withdrawal by Subject|1
7633034|NCT03687736|12046804|FG000|Overall Study|Lost to Follow-up|7
7633035|NCT03687736|12046804|FG000|Overall Study|Withdrawal by Subject|3
7633036|NCT03682848|12046823|FG000|Overall Study|Withdrawal by Subject|2
7633037|NCT03682848|12046823|FG000|Overall Study|Site closed|5
7633038|NCT03682848|12046823|FG000|Overall Study|Protocol Deviation|1
7633039|NCT03682848|12046823|FG000|Overall Study|Adverse Event|1
7633040|NCT03681691|12046845|FG000|Overall Study|COVID|1
7633041|NCT03681691|12046846|FG001|Overall Study|COVID|0
7633042|NCT03681691|12046845|FG000|Overall Study|prolonged bleeding|1
7633043|NCT03681691|12046846|FG001|Overall Study|prolonged bleeding|0
7633044|NCT03681691|12046845|FG000|Overall Study|veins would not stay open during the PET scan.|0
7633045|NCT03681691|12046846|FG001|Overall Study|veins would not stay open during the PET scan.|1
7633046|NCT03681470|12046854|FG000|Overall Study|Lack of Efficacy|3
7633047|NCT03681470|12046854|FG000|Overall Study|Lost to Follow-up|1
7633048|NCT03681470|12046854|FG000|Overall Study|Protocol Violation|3
7633049|NCT03681470|12046854|FG000|Overall Study|Withdrawal by Subject|1
7633050|NCT03681184|12046860|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
7633051|NCT03681184|12046861|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
7633052|NCT03681184|12046860|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
7633053|NCT03681184|12046861|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
7633054|NCT03681184|12046860|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7633055|NCT03681184|12046861|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
7633056|NCT03679767|12046871|FG000|Overall Study|Death|16
7633057|NCT03679767|12046872|FG001|Overall Study|Death|10
7633058|NCT03679767|12046873|FG002|Overall Study|Death|16
7633059|NCT03679767|12046874|FG003|Overall Study|Death|10
7633060|NCT03679767|12046871|FG000|Overall Study|Lost to Follow-up|1
7633061|NCT03679767|12046872|FG001|Overall Study|Lost to Follow-up|0
7633062|NCT03679767|12046873|FG002|Overall Study|Lost to Follow-up|1
7633063|NCT03679767|12046874|FG003|Overall Study|Lost to Follow-up|1
7633064|NCT03679767|12046871|FG000|Overall Study|Withdrawal by Subject|0
7633065|NCT03679767|12046872|FG001|Overall Study|Withdrawal by Subject|0
7633066|NCT03679767|12046873|FG002|Overall Study|Withdrawal by Subject|0
7633067|NCT03679767|12046874|FG003|Overall Study|Withdrawal by Subject|1
7633068|NCT03679767|12046871|FG000|Overall Study|Follow-up Completed|4
7633069|NCT03679767|12046872|FG001|Overall Study|Follow-up Completed|1
7633070|NCT03679767|12046873|FG002|Overall Study|Follow-up Completed|3
7633071|NCT03679767|12046874|FG003|Overall Study|Follow-up Completed|5
7633072|NCT03679767|12046871|FG000|Overall Study|Ongoing|14
7633073|NCT03679767|12046872|FG001|Overall Study|Ongoing|12
7633074|NCT03679767|12046873|FG002|Overall Study|Ongoing|9
7633075|NCT03679767|12046874|FG003|Overall Study|Ongoing|17
7633076|NCT03677869|12046897|FG000|Overall Study|Withdrawal by Subject|1
7633077|NCT03674112|12046903|FG000|Overall Study|Adverse Event|1
7633078|NCT03674112|12046904|FG001|Overall Study|Adverse Event|0
7633079|NCT03674112|12046903|FG000|Overall Study|Ongoing in the Study|79
7633080|NCT03674112|12046904|FG001|Overall Study|Ongoing in the Study|80
7633081|NCT03673046|12046941|FG000|Overall Study|Adverse Event|1
7633082|NCT03673046|12046942|FG001|Overall Study|Adverse Event|1
7633083|NCT03673046|12046941|FG000|Overall Study|Withdrawal by Subject|8
7633084|NCT03673046|12046942|FG001|Overall Study|Withdrawal by Subject|2
7633085|NCT03670810|12046954|FG000|Main Study|Adverse Event|37
7633086|NCT03670810|12046955|FG001|Main Study|Adverse Event|38
7633087|NCT03670810|12046956|FG002|Main Study|Adverse Event|3
7633088|NCT03670810|12046957|FG003|Main Study|Adverse Event|4
7633089|NCT03670810|12046958|FG004|Main Study|Adverse Event|4
7633090|NCT03670810|12046959|FG005|Main Study|Adverse Event|5
7633091|NCT03670810|12046960|FG006|Main Study|Adverse Event|0
7633092|NCT03670810|12046961|FG007|Main Study|Adverse Event|0
7633093|NCT03670810|12046962|FG008|Main Study|Adverse Event|0
7633094|NCT03670810|12046954|FG000|Main Study|Lack of Efficacy|8
7633095|NCT03670810|12046955|FG001|Main Study|Lack of Efficacy|9
7633096|NCT03670810|12046956|FG002|Main Study|Lack of Efficacy|3
7633097|NCT03670810|12046957|FG003|Main Study|Lack of Efficacy|4
7633098|NCT03670810|12046958|FG004|Main Study|Lack of Efficacy|0
7633099|NCT03670810|12046959|FG005|Main Study|Lack of Efficacy|0
7633100|NCT03670810|12046960|FG006|Main Study|Lack of Efficacy|0
7633101|NCT03670810|12046961|FG007|Main Study|Lack of Efficacy|0
7633102|NCT03670810|12046962|FG008|Main Study|Lack of Efficacy|0
7633103|NCT03670810|12046954|FG000|Main Study|Lost to Follow-up|9
7633104|NCT03670810|12046955|FG001|Main Study|Lost to Follow-up|7
7633105|NCT03670810|12046956|FG002|Main Study|Lost to Follow-up|4
7633106|NCT03670810|12046957|FG003|Main Study|Lost to Follow-up|6
7633107|NCT03670810|12046958|FG004|Main Study|Lost to Follow-up|1
7633108|NCT03670810|12046959|FG005|Main Study|Lost to Follow-up|0
7633109|NCT03670810|12046960|FG006|Main Study|Lost to Follow-up|0
7633110|NCT03670810|12046961|FG007|Main Study|Lost to Follow-up|0
7633111|NCT03670810|12046962|FG008|Main Study|Lost to Follow-up|0
7633112|NCT03670810|12046954|FG000|Main Study|Non-compliance with Study Drug|0
7633113|NCT03670810|12046955|FG001|Main Study|Non-compliance with Study Drug|2
7633114|NCT03670810|12046956|FG002|Main Study|Non-compliance with Study Drug|3
7633115|NCT03670810|12046957|FG003|Main Study|Non-compliance with Study Drug|0
7633116|NCT03670810|12046958|FG004|Main Study|Non-compliance with Study Drug|0
7633117|NCT03670810|12046959|FG005|Main Study|Non-compliance with Study Drug|0
7633118|NCT03670810|12046960|FG006|Main Study|Non-compliance with Study Drug|0
7633119|NCT03670810|12046961|FG007|Main Study|Non-compliance with Study Drug|1
7633120|NCT03670810|12046962|FG008|Main Study|Non-compliance with Study Drug|0
7633121|NCT03670810|12046954|FG000|Main Study|Physician Decision|3
7633122|NCT03670810|12046955|FG001|Main Study|Physician Decision|0
7633123|NCT03670810|12046956|FG002|Main Study|Physician Decision|1
7633124|NCT03670810|12046957|FG003|Main Study|Physician Decision|0
7633125|NCT03670810|12046958|FG004|Main Study|Physician Decision|0
7633126|NCT03670810|12046959|FG005|Main Study|Physician Decision|0
7633127|NCT03670810|12046960|FG006|Main Study|Physician Decision|1
7633128|NCT03670810|12046961|FG007|Main Study|Physician Decision|1
7633129|NCT03670810|12046962|FG008|Main Study|Physician Decision|0
7633130|NCT03670810|12046954|FG000|Main Study|Pregnancy|1
7633131|NCT03670810|12046955|FG001|Main Study|Pregnancy|2
7633132|NCT03670810|12046956|FG002|Main Study|Pregnancy|0
7633133|NCT03670810|12046957|FG003|Main Study|Pregnancy|0
7633134|NCT03670810|12046958|FG004|Main Study|Pregnancy|0
7633135|NCT03670810|12046959|FG005|Main Study|Pregnancy|0
7633136|NCT03670810|12046960|FG006|Main Study|Pregnancy|0
7633137|NCT03670810|12046961|FG007|Main Study|Pregnancy|0
7633138|NCT03670810|12046962|FG008|Main Study|Pregnancy|0
7633139|NCT03670810|12046954|FG000|Main Study|Protocol Deviation|2
7633140|NCT03670810|12046955|FG001|Main Study|Protocol Deviation|12
7633141|NCT03670810|12046956|FG002|Main Study|Protocol Deviation|8
7633142|NCT03670810|12046957|FG003|Main Study|Protocol Deviation|4
7633143|NCT03670810|12046958|FG004|Main Study|Protocol Deviation|0
7633144|NCT03670810|12046959|FG005|Main Study|Protocol Deviation|0
7633145|NCT03670810|12046960|FG006|Main Study|Protocol Deviation|0
7633146|NCT03670810|12046961|FG007|Main Study|Protocol Deviation|0
7633147|NCT03670810|12046962|FG008|Main Study|Protocol Deviation|0
7633148|NCT03670810|12046954|FG000|Main Study|Withdrawal by Subject|21
7633149|NCT03670810|12046955|FG001|Main Study|Withdrawal by Subject|21
7633150|NCT03670810|12046956|FG002|Main Study|Withdrawal by Subject|8
7633151|NCT03670810|12046957|FG003|Main Study|Withdrawal by Subject|9
7633152|NCT03670810|12046958|FG004|Main Study|Withdrawal by Subject|5
7633153|NCT03670810|12046959|FG005|Main Study|Withdrawal by Subject|2
7633154|NCT03670810|12046960|FG006|Main Study|Withdrawal by Subject|1
7633155|NCT03670810|12046961|FG007|Main Study|Withdrawal by Subject|1
7633156|NCT03670810|12046962|FG008|Main Study|Withdrawal by Subject|0
7633157|NCT03670810|12046954|FG000|Main Study|Participant did not want to take the three other treatments|1
7633158|NCT03670810|12046955|FG001|Main Study|Participant did not want to take the three other treatments|0
7633159|NCT03670810|12046956|FG002|Main Study|Participant did not want to take the three other treatments|0
7633160|NCT03670810|12046957|FG003|Main Study|Participant did not want to take the three other treatments|0
7633161|NCT03670810|12046958|FG004|Main Study|Participant did not want to take the three other treatments|0
7633162|NCT03670810|12046959|FG005|Main Study|Participant did not want to take the three other treatments|0
7633163|NCT03670810|12046960|FG006|Main Study|Participant did not want to take the three other treatments|0
7633164|NCT03670810|12046961|FG007|Main Study|Participant did not want to take the three other treatments|0
7633165|NCT03670810|12046962|FG008|Main Study|Participant did not want to take the three other treatments|0
7633166|NCT03670810|12046954|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633167|NCT03670810|12046955|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1
7633168|NCT03670810|12046956|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633169|NCT03670810|12046957|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633170|NCT03670810|12046958|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633171|NCT03670810|12046959|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633172|NCT03670810|12046960|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633173|NCT03670810|12046961|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633174|NCT03670810|12046962|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0
7633175|NCT03670810|12046954|FG000|Main Study|Travel and Coronavirus issues|0
7633176|NCT03670810|12046955|FG001|Main Study|Travel and Coronavirus issues|0
7633177|NCT03670810|12046956|FG002|Main Study|Travel and Coronavirus issues|0
7633178|NCT03670810|12046957|FG003|Main Study|Travel and Coronavirus issues|1
7633179|NCT03670810|12046958|FG004|Main Study|Travel and Coronavirus issues|0
7633180|NCT03670810|12046959|FG005|Main Study|Travel and Coronavirus issues|0
7633181|NCT03670810|12046960|FG006|Main Study|Travel and Coronavirus issues|0
7633182|NCT03670810|12046961|FG007|Main Study|Travel and Coronavirus issues|0
7633183|NCT03670810|12046962|FG008|Main Study|Travel and Coronavirus issues|0
7633184|NCT03670810|12046954|FG000|Open Label Extension|Protocol Deviation|0
7633185|NCT03670810|12046955|FG001|Open Label Extension|Protocol Deviation|0
7633186|NCT03670810|12046956|FG002|Open Label Extension|Protocol Deviation|0
7633187|NCT03670810|12046957|FG003|Open Label Extension|Protocol Deviation|0
7633188|NCT03670810|12046958|FG004|Open Label Extension|Protocol Deviation|0
7633189|NCT03670810|12046959|FG005|Open Label Extension|Protocol Deviation|0
7633190|NCT03670810|12046960|FG006|Open Label Extension|Protocol Deviation|0
7633191|NCT03670810|12046961|FG007|Open Label Extension|Protocol Deviation|0
7633192|NCT03670810|12046962|FG008|Open Label Extension|Protocol Deviation|5
7633193|NCT03670810|12046954|FG000|Open Label Extension|Death|0
7633194|NCT03670810|12046955|FG001|Open Label Extension|Death|0
7633195|NCT03670810|12046956|FG002|Open Label Extension|Death|0
7633196|NCT03670810|12046957|FG003|Open Label Extension|Death|0
7633197|NCT03670810|12046958|FG004|Open Label Extension|Death|0
7633198|NCT03670810|12046959|FG005|Open Label Extension|Death|0
7633199|NCT03670810|12046960|FG006|Open Label Extension|Death|0
7633200|NCT03670810|12046961|FG007|Open Label Extension|Death|0
7633201|NCT03670810|12046962|FG008|Open Label Extension|Death|1
7633202|NCT03670810|12046954|FG000|Open Label Extension|COVID-19|0
7633203|NCT03670810|12046955|FG001|Open Label Extension|COVID-19|0
7633204|NCT03670810|12046956|FG002|Open Label Extension|COVID-19|0
7633205|NCT03670810|12046957|FG003|Open Label Extension|COVID-19|0
7633206|NCT03670810|12046958|FG004|Open Label Extension|COVID-19|0
7633207|NCT03670810|12046959|FG005|Open Label Extension|COVID-19|0
7633208|NCT03670810|12046960|FG006|Open Label Extension|COVID-19|0
7633209|NCT03670810|12046961|FG007|Open Label Extension|COVID-19|0
7633210|NCT03670810|12046962|FG008|Open Label Extension|COVID-19|1
7633211|NCT03670810|12046954|FG000|Open Label Extension|Lack of Efficacy|0
7633212|NCT03670810|12046955|FG001|Open Label Extension|Lack of Efficacy|0
7633213|NCT03670810|12046956|FG002|Open Label Extension|Lack of Efficacy|0
7633214|NCT03670810|12046957|FG003|Open Label Extension|Lack of Efficacy|0
7633215|NCT03670810|12046958|FG004|Open Label Extension|Lack of Efficacy|0
7633216|NCT03670810|12046959|FG005|Open Label Extension|Lack of Efficacy|0
7633217|NCT03670810|12046960|FG006|Open Label Extension|Lack of Efficacy|0
7633218|NCT03670810|12046961|FG007|Open Label Extension|Lack of Efficacy|0
7633219|NCT03670810|12046962|FG008|Open Label Extension|Lack of Efficacy|39
7633220|NCT03670810|12046954|FG000|Open Label Extension|Participant refused to comply with face mask use|0
7633221|NCT03670810|12046955|FG001|Open Label Extension|Participant refused to comply with face mask use|0
7633222|NCT03670810|12046956|FG002|Open Label Extension|Participant refused to comply with face mask use|0
7633223|NCT03670810|12046957|FG003|Open Label Extension|Participant refused to comply with face mask use|0
7633224|NCT03670810|12046958|FG004|Open Label Extension|Participant refused to comply with face mask use|0
7633225|NCT03670810|12046959|FG005|Open Label Extension|Participant refused to comply with face mask use|0
7633226|NCT03670810|12046960|FG006|Open Label Extension|Participant refused to comply with face mask use|0
7633227|NCT03670810|12046961|FG007|Open Label Extension|Participant refused to comply with face mask use|0
7633228|NCT03670810|12046962|FG008|Open Label Extension|Participant refused to comply with face mask use|1
7633229|NCT03670810|12046954|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633230|NCT03670810|12046955|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633231|NCT03670810|12046956|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633232|NCT03670810|12046957|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633233|NCT03670810|12046958|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633234|NCT03670810|12046959|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633235|NCT03670810|12046960|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633236|NCT03670810|12046961|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0
7633237|NCT03670810|12046962|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1
7633238|NCT03670810|12046954|FG000|Open Label Extension|Withdrawal by Subject|0
7633239|NCT03670810|12046955|FG001|Open Label Extension|Withdrawal by Subject|0
7633240|NCT03670810|12046956|FG002|Open Label Extension|Withdrawal by Subject|0
7633241|NCT03670810|12046957|FG003|Open Label Extension|Withdrawal by Subject|0
7633242|NCT03670810|12046958|FG004|Open Label Extension|Withdrawal by Subject|0
7633243|NCT03670810|12046959|FG005|Open Label Extension|Withdrawal by Subject|0
7633244|NCT03670810|12046960|FG006|Open Label Extension|Withdrawal by Subject|0
7633245|NCT03670810|12046961|FG007|Open Label Extension|Withdrawal by Subject|0
7633246|NCT03670810|12046962|FG008|Open Label Extension|Withdrawal by Subject|46
7633247|NCT03670810|12046954|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0
7633248|NCT03670810|12046955|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0
7633249|NCT03670810|12046956|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0
7633250|NCT03670810|12046957|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0
7633251|NCT03670810|12046958|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0
7633252|NCT03670810|12046959|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0
7633253|NCT03670810|12046960|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0
7633254|NCT03670810|12046961|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0
7633255|NCT03670810|12046962|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1
7633256|NCT03670810|12046954|FG000|Open Label Extension|Physician Decision|0
7633257|NCT03670810|12046955|FG001|Open Label Extension|Physician Decision|0
7633258|NCT03670810|12046956|FG002|Open Label Extension|Physician Decision|0
7633259|NCT03670810|12046957|FG003|Open Label Extension|Physician Decision|0
7633260|NCT03670810|12046958|FG004|Open Label Extension|Physician Decision|0
7633261|NCT03670810|12046959|FG005|Open Label Extension|Physician Decision|0
7633262|NCT03670810|12046960|FG006|Open Label Extension|Physician Decision|0
7633263|NCT03670810|12046961|FG007|Open Label Extension|Physician Decision|0
7633264|NCT03670810|12046962|FG008|Open Label Extension|Physician Decision|2
7633265|NCT03670810|12046954|FG000|Open Label Extension|Non-compliance with study drug|0
7633266|NCT03670810|12046955|FG001|Open Label Extension|Non-compliance with study drug|0
7633267|NCT03670810|12046956|FG002|Open Label Extension|Non-compliance with study drug|0
7633268|NCT03670810|12046957|FG003|Open Label Extension|Non-compliance with study drug|0
7633269|NCT03670810|12046958|FG004|Open Label Extension|Non-compliance with study drug|0
7633270|NCT03670810|12046959|FG005|Open Label Extension|Non-compliance with study drug|0
7633271|NCT03670810|12046960|FG006|Open Label Extension|Non-compliance with study drug|0
7633272|NCT03670810|12046961|FG007|Open Label Extension|Non-compliance with study drug|0
7633273|NCT03670810|12046962|FG008|Open Label Extension|Non-compliance with study drug|5
7633274|NCT03670810|12046954|FG000|Open Label Extension|Pregnancy|0
7633275|NCT03670810|12046955|FG001|Open Label Extension|Pregnancy|0
7633276|NCT03670810|12046956|FG002|Open Label Extension|Pregnancy|0
7633277|NCT03670810|12046957|FG003|Open Label Extension|Pregnancy|0
7633278|NCT03670810|12046958|FG004|Open Label Extension|Pregnancy|0
7633279|NCT03670810|12046959|FG005|Open Label Extension|Pregnancy|0
7633280|NCT03670810|12046960|FG006|Open Label Extension|Pregnancy|0
7633281|NCT03670810|12046961|FG007|Open Label Extension|Pregnancy|0
7633282|NCT03670810|12046962|FG008|Open Label Extension|Pregnancy|3
7633283|NCT03670810|12046954|FG000|Open Label Extension|Adverse Event|0
7633284|NCT03670810|12046955|FG001|Open Label Extension|Adverse Event|0
7633285|NCT03670810|12046956|FG002|Open Label Extension|Adverse Event|0
7633286|NCT03670810|12046957|FG003|Open Label Extension|Adverse Event|0
7633287|NCT03670810|12046958|FG004|Open Label Extension|Adverse Event|0
7633288|NCT03670810|12046959|FG005|Open Label Extension|Adverse Event|0
7633289|NCT03670810|12046960|FG006|Open Label Extension|Adverse Event|0
7633290|NCT03670810|12046961|FG007|Open Label Extension|Adverse Event|0
7633291|NCT03670810|12046962|FG008|Open Label Extension|Adverse Event|24
7633292|NCT03670810|12046954|FG000|Open Label Extension|Participant wanted to become pregnant|0
7633293|NCT03670810|12046955|FG001|Open Label Extension|Participant wanted to become pregnant|0
7633375|NCT03655717|12047052|FG001|Overall Study|Physician Decision|3
7633294|NCT03670810|12046956|FG002|Open Label Extension|Participant wanted to become pregnant|0
7633295|NCT03670810|12046957|FG003|Open Label Extension|Participant wanted to become pregnant|0
7633296|NCT03670810|12046958|FG004|Open Label Extension|Participant wanted to become pregnant|0
7633297|NCT03670810|12046959|FG005|Open Label Extension|Participant wanted to become pregnant|0
7633298|NCT03670810|12046960|FG006|Open Label Extension|Participant wanted to become pregnant|0
7633299|NCT03670810|12046961|FG007|Open Label Extension|Participant wanted to become pregnant|0
7633300|NCT03670810|12046962|FG008|Open Label Extension|Participant wanted to become pregnant|1
7633301|NCT03670810|12046954|FG000|Open Label Extension|Lost to Follow-up|0
7633302|NCT03670810|12046955|FG001|Open Label Extension|Lost to Follow-up|0
7633303|NCT03670810|12046956|FG002|Open Label Extension|Lost to Follow-up|0
7633304|NCT03670810|12046957|FG003|Open Label Extension|Lost to Follow-up|0
7633305|NCT03670810|12046958|FG004|Open Label Extension|Lost to Follow-up|0
7633306|NCT03670810|12046959|FG005|Open Label Extension|Lost to Follow-up|0
7633307|NCT03670810|12046960|FG006|Open Label Extension|Lost to Follow-up|0
7633308|NCT03670810|12046961|FG007|Open Label Extension|Lost to Follow-up|0
7633309|NCT03670810|12046962|FG008|Open Label Extension|Lost to Follow-up|23
7633310|NCT03665441|12046978|FG000|Overall Study|survival follow up ongoing|23
7633311|NCT03665441|12046979|FG001|Overall Study|survival follow up ongoing|0
7633312|NCT03665441|12046978|FG000|Overall Study|Patients ongoing on treatment|9
7633313|NCT03665441|12046979|FG001|Overall Study|Patients ongoing on treatment|6
7633314|NCT03665441|12046978|FG000|Overall Study|Randomized but not treated|7
7633315|NCT03665441|12046979|FG001|Overall Study|Randomized but not treated|11
7633316|NCT03665038|12046988|FG000|Overall Study|Lost to Follow-up|0
7633317|NCT03665038|12046989|FG001|Overall Study|Lost to Follow-up|0
7633318|NCT03665038|12046990|FG002|Overall Study|Lost to Follow-up|1
7633319|NCT03663179|12047025|FG000|Overall Study|Withdrawal by Subject|2
7633320|NCT03663179|12047026|FG001|Overall Study|Withdrawal by Subject|0
7633321|NCT03663179|12047025|FG000|Overall Study|Lost to Follow-up|1
7633322|NCT03663179|12047026|FG001|Overall Study|Lost to Follow-up|1
7633323|NCT03663179|12047025|FG000|Overall Study|Revealed exclusionary condition|1
7633324|NCT03663179|12047026|FG001|Overall Study|Revealed exclusionary condition|0
7633325|NCT03662659|12047034|FG000|Pre-treatment|Participant no longer met study criteria|1
7633326|NCT03662659|12047035|FG001|Pre-treatment|Participant no longer met study criteria|1
7633327|NCT03662659|12047034|FG000|Pre-treatment|Other reasons|1
7633328|NCT03662659|12047035|FG001|Pre-treatment|Other reasons|0
7633329|NCT03662659|12047034|FG000|Treatment|Completed Treatment|0
7633330|NCT03662659|12047035|FG001|Treatment|Completed Treatment|3
7633331|NCT03662659|12047034|FG000|Treatment|Disease Progression|69
7633332|NCT03662659|12047035|FG001|Treatment|Disease Progression|78
7633333|NCT03662659|12047034|FG000|Treatment|Study Drug Toxicity|18
7633334|NCT03662659|12047035|FG001|Treatment|Study Drug Toxicity|8
7633335|NCT03662659|12047034|FG000|Treatment|Death|12
7633336|NCT03662659|12047035|FG001|Treatment|Death|7
7633337|NCT03662659|12047034|FG000|Treatment|Adverse Event unrelated to Study Drug|7
7633338|NCT03662659|12047035|FG001|Treatment|Adverse Event unrelated to Study Drug|4
7633339|NCT03662659|12047034|FG000|Treatment|Withdrawal by Subject|1
7633340|NCT03662659|12047035|FG001|Treatment|Withdrawal by Subject|1
7633341|NCT03662659|12047034|FG000|Treatment|Poor/Non-compliance|1
7633342|NCT03662659|12047035|FG001|Treatment|Poor/Non-compliance|0
7633343|NCT03662659|12047034|FG000|Treatment|Participant no longer meets study criteria|1
7633344|NCT03662659|12047035|FG001|Treatment|Participant no longer meets study criteria|0
7633345|NCT03662659|12047034|FG000|Treatment|Other reasons|6
7633346|NCT03662659|12047035|FG001|Treatment|Other reasons|5
7633347|NCT03655756|12047045|FG000|Overall Study|Death|1
7633348|NCT03655717|12047051|FG000|Overall Study|Withdrawal by Subject|4
7633349|NCT03655717|12047052|FG001|Overall Study|Withdrawal by Subject|8
7633350|NCT03655717|12047053|FG002|Overall Study|Withdrawal by Subject|1
7633351|NCT03655717|12047054|FG003|Overall Study|Withdrawal by Subject|0
7633352|NCT03655717|12047055|FG004|Overall Study|Withdrawal by Subject|0
7633353|NCT03655717|12047056|FG005|Overall Study|Withdrawal by Subject|1
7633354|NCT03655717|12047057|FG006|Overall Study|Withdrawal by Subject|3
7633355|NCT03655717|12047058|FG007|Overall Study|Withdrawal by Subject|1
7633356|NCT03655717|12047059|FG008|Overall Study|Withdrawal by Subject|2
7633357|NCT03655717|12047060|FG009|Overall Study|Withdrawal by Subject|0
7633358|NCT03655717|12047061|FG010|Overall Study|Withdrawal by Subject|0
7633359|NCT03655717|12047062|FG011|Overall Study|Withdrawal by Subject|1
7633360|NCT03655717|12047063|FG012|Overall Study|Withdrawal by Subject|0
7633361|NCT03655717|12047064|FG013|Overall Study|Withdrawal by Subject|3
7633362|NCT03655717|12047065|FG014|Overall Study|Withdrawal by Subject|0
7633363|NCT03655717|12047066|FG015|Overall Study|Withdrawal by Subject|1
7633364|NCT03655717|12047067|FG016|Overall Study|Withdrawal by Subject|0
7633365|NCT03655717|12047068|FG017|Overall Study|Withdrawal by Subject|0
7633366|NCT03655717|12047069|FG018|Overall Study|Withdrawal by Subject|1
7633367|NCT03655717|12047070|FG019|Overall Study|Withdrawal by Subject|0
7633368|NCT03655717|12047071|FG020|Overall Study|Withdrawal by Subject|0
7633369|NCT03655717|12047072|FG021|Overall Study|Withdrawal by Subject|1
7633370|NCT03655717|12047073|FG022|Overall Study|Withdrawal by Subject|2
7633371|NCT03655717|12047074|FG023|Overall Study|Withdrawal by Subject|1
7633372|NCT03655717|12047075|FG024|Overall Study|Withdrawal by Subject|1
7633373|NCT03655717|12047076|FG025|Overall Study|Withdrawal by Subject|0
7633374|NCT03655717|12047051|FG000|Overall Study|Physician Decision|3
7633376|NCT03655717|12047053|FG002|Overall Study|Physician Decision|0
7633377|NCT03655717|12047054|FG003|Overall Study|Physician Decision|0
7633378|NCT03655717|12047055|FG004|Overall Study|Physician Decision|0
7633379|NCT03655717|12047056|FG005|Overall Study|Physician Decision|0
7633380|NCT03655717|12047057|FG006|Overall Study|Physician Decision|0
7633381|NCT03655717|12047058|FG007|Overall Study|Physician Decision|0
7633382|NCT03655717|12047059|FG008|Overall Study|Physician Decision|0
7633383|NCT03655717|12047060|FG009|Overall Study|Physician Decision|1
7633384|NCT03655717|12047061|FG010|Overall Study|Physician Decision|0
7633385|NCT03655717|12047062|FG011|Overall Study|Physician Decision|0
7633386|NCT03655717|12047063|FG012|Overall Study|Physician Decision|0
7633387|NCT03655717|12047064|FG013|Overall Study|Physician Decision|0
7633388|NCT03655717|12047065|FG014|Overall Study|Physician Decision|0
7633389|NCT03655717|12047066|FG015|Overall Study|Physician Decision|0
7633390|NCT03655717|12047067|FG016|Overall Study|Physician Decision|0
7633391|NCT03655717|12047068|FG017|Overall Study|Physician Decision|0
7633392|NCT03655717|12047069|FG018|Overall Study|Physician Decision|0
7633393|NCT03655717|12047070|FG019|Overall Study|Physician Decision|1
7633394|NCT03655717|12047071|FG020|Overall Study|Physician Decision|0
7633395|NCT03655717|12047072|FG021|Overall Study|Physician Decision|0
7633396|NCT03655717|12047073|FG022|Overall Study|Physician Decision|0
7633397|NCT03655717|12047074|FG023|Overall Study|Physician Decision|1
7633398|NCT03655717|12047075|FG024|Overall Study|Physician Decision|0
7633399|NCT03655717|12047076|FG025|Overall Study|Physician Decision|0
7633400|NCT03655717|12047051|FG000|Overall Study|Lost to Follow-up|3
7633401|NCT03655717|12047052|FG001|Overall Study|Lost to Follow-up|1
7633402|NCT03655717|12047053|FG002|Overall Study|Lost to Follow-up|0
7633403|NCT03655717|12047054|FG003|Overall Study|Lost to Follow-up|1
7633404|NCT03655717|12047055|FG004|Overall Study|Lost to Follow-up|0
7633405|NCT03655717|12047056|FG005|Overall Study|Lost to Follow-up|1
7633406|NCT03655717|12047057|FG006|Overall Study|Lost to Follow-up|0
7633407|NCT03655717|12047058|FG007|Overall Study|Lost to Follow-up|0
7633408|NCT03655717|12047059|FG008|Overall Study|Lost to Follow-up|0
7633409|NCT03655717|12047060|FG009|Overall Study|Lost to Follow-up|0
7633410|NCT03655717|12047061|FG010|Overall Study|Lost to Follow-up|0
7633411|NCT03655717|12047062|FG011|Overall Study|Lost to Follow-up|1
7633412|NCT03655717|12047063|FG012|Overall Study|Lost to Follow-up|0
7633413|NCT03655717|12047064|FG013|Overall Study|Lost to Follow-up|0
7633414|NCT03655717|12047065|FG014|Overall Study|Lost to Follow-up|0
7633415|NCT03655717|12047066|FG015|Overall Study|Lost to Follow-up|0
7633416|NCT03655717|12047067|FG016|Overall Study|Lost to Follow-up|0
7633417|NCT03655717|12047068|FG017|Overall Study|Lost to Follow-up|0
7633418|NCT03655717|12047069|FG018|Overall Study|Lost to Follow-up|0
7633419|NCT03655717|12047070|FG019|Overall Study|Lost to Follow-up|0
7633420|NCT03655717|12047071|FG020|Overall Study|Lost to Follow-up|0
7633421|NCT03655717|12047072|FG021|Overall Study|Lost to Follow-up|0
7633422|NCT03655717|12047073|FG022|Overall Study|Lost to Follow-up|0
7633423|NCT03655717|12047074|FG023|Overall Study|Lost to Follow-up|0
7633424|NCT03655717|12047075|FG024|Overall Study|Lost to Follow-up|0
7633425|NCT03655717|12047076|FG025|Overall Study|Lost to Follow-up|0
7633426|NCT03647267|12047092|FG000|Overall Study|Lost to Follow-up|1
7633427|NCT03647267|12047093|FG001|Overall Study|Lost to Follow-up|0
7633428|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Adverse Event|1
7633429|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Adverse Event|0
7633430|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Adverse Event|0
7633431|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Adverse Event|0
7633432|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Disease Progression|0
7633433|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Disease Progression|1
7633434|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Disease Progression|0
7633435|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Disease Progression|0
7633436|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633437|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633438|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1
7633439|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0
7633440|NCT03645395|12047126|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1
7633441|NCT03645395|12047127|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2
7633442|NCT03645395|12047128|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2
7633443|NCT03645395|12047129|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0
7633444|NCT03641651|12047140|FG000|Overall Study|organizational issues at one study site|1
7633445|NCT03638258|12047147|FG000|Overall Study|Adverse Event|1
7633446|NCT03638258|12047148|FG001|Overall Study|Adverse Event|0
7633447|NCT03638258|12047149|FG002|Overall Study|Adverse Event|2
7633448|NCT03638258|12047147|FG000|Overall Study|Lost to Follow-up|2
7633449|NCT03638258|12047148|FG001|Overall Study|Lost to Follow-up|4
7633450|NCT03638258|12047149|FG002|Overall Study|Lost to Follow-up|5
7633451|NCT03638258|12047147|FG000|Overall Study|Pregnancy|0
7633452|NCT03638258|12047148|FG001|Overall Study|Pregnancy|0
7633453|NCT03638258|12047149|FG002|Overall Study|Pregnancy|1
7633454|NCT03638258|12047147|FG000|Overall Study|Protocol Violation|0
7633455|NCT03638258|12047148|FG001|Overall Study|Protocol Violation|0
7633456|NCT03638258|12047149|FG002|Overall Study|Protocol Violation|1
7633457|NCT03638258|12047147|FG000|Overall Study|Withdrawal by Subject|4
7633458|NCT03638258|12047148|FG001|Overall Study|Withdrawal by Subject|5
7633459|NCT03638258|12047149|FG002|Overall Study|Withdrawal by Subject|12
7633460|NCT03638258|12047147|FG000|Overall Study|Lack of Efficacy|0
7633461|NCT03638258|12047148|FG001|Overall Study|Lack of Efficacy|0
7633462|NCT03638258|12047149|FG002|Overall Study|Lack of Efficacy|2
7633463|NCT03637374|12047160|FG000|Overall Study|Death|2
7633464|NCT03637374|12047161|FG001|Overall Study|Death|0
7633465|NCT03636906|12047170|FG000|Overall Study|Adverse Event|0
7633466|NCT03636906|12047171|FG001|Overall Study|Adverse Event|0
7633467|NCT03636906|12047172|FG002|Overall Study|Adverse Event|1
7633468|NCT03636906|12047170|FG000|Overall Study|Lost to Follow-up|1
7633469|NCT03636906|12047171|FG001|Overall Study|Lost to Follow-up|0
7633470|NCT03636906|12047172|FG002|Overall Study|Lost to Follow-up|0
7633471|NCT03636906|12047170|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2
7633472|NCT03636906|12047171|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0
7633473|NCT03636906|12047172|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1
7633474|NCT03636906|12047170|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
7633475|NCT03636906|12047171|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
7633476|NCT03636906|12047172|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2
7633477|NCT03636906|12047170|FG000|Overall Study|Other|0
7633478|NCT03636906|12047171|FG001|Overall Study|Other|0
7633479|NCT03636906|12047172|FG002|Overall Study|Other|1
7633480|NCT03635099|12047194|FG000|Period 1|Adverse Event|1
7633481|NCT03635099|12047195|FG001|Period 1|Adverse Event|0
7633482|NCT03635099|12047196|FG002|Period 1|Adverse Event|0
7633483|NCT03635099|12047197|FG003|Period 1|Adverse Event|1
7633484|NCT03635099|12047198|FG004|Period 1|Adverse Event|0
7633485|NCT03635099|12047199|FG005|Period 1|Adverse Event|0
7633486|NCT03635099|12047200|FG006|Period 1|Adverse Event|0
7633487|NCT03635099|12047201|FG007|Period 1|Adverse Event|0
7633488|NCT03635099|12047194|FG000|Period 1|Protocol Violation|0
7633489|NCT03635099|12047195|FG001|Period 1|Protocol Violation|0
7633490|NCT03635099|12047196|FG002|Period 1|Protocol Violation|1
7633491|NCT03635099|12047197|FG003|Period 1|Protocol Violation|0
7633492|NCT03635099|12047198|FG004|Period 1|Protocol Violation|0
7633493|NCT03635099|12047199|FG005|Period 1|Protocol Violation|0
7633494|NCT03635099|12047200|FG006|Period 1|Protocol Violation|0
7633495|NCT03635099|12047201|FG007|Period 1|Protocol Violation|0
7633496|NCT03635099|12047194|FG000|Period 1|Lost to Follow-up|0
7633497|NCT03635099|12047195|FG001|Period 1|Lost to Follow-up|0
7633498|NCT03635099|12047196|FG002|Period 1|Lost to Follow-up|1
7633499|NCT03635099|12047197|FG003|Period 1|Lost to Follow-up|2
7633500|NCT03635099|12047198|FG004|Period 1|Lost to Follow-up|1
7633501|NCT03635099|12047199|FG005|Period 1|Lost to Follow-up|0
7633502|NCT03635099|12047200|FG006|Period 1|Lost to Follow-up|1
7633503|NCT03635099|12047201|FG007|Period 1|Lost to Follow-up|2
7633504|NCT03635099|12047194|FG000|Period 1|Withdrawal by Subject|3
7633505|NCT03635099|12047195|FG001|Period 1|Withdrawal by Subject|3
7633506|NCT03635099|12047196|FG002|Period 1|Withdrawal by Subject|5
7633507|NCT03635099|12047197|FG003|Period 1|Withdrawal by Subject|2
7633508|NCT03635099|12047198|FG004|Period 1|Withdrawal by Subject|2
7633509|NCT03635099|12047199|FG005|Period 1|Withdrawal by Subject|0
7633510|NCT03635099|12047200|FG006|Period 1|Withdrawal by Subject|3
7633511|NCT03635099|12047201|FG007|Period 1|Withdrawal by Subject|0
7633512|NCT03635099|12047194|FG000|Period 1|History of suicidal ideation|0
7633513|NCT03635099|12047195|FG001|Period 1|History of suicidal ideation|0
7633514|NCT03635099|12047196|FG002|Period 1|History of suicidal ideation|1
7633515|NCT03635099|12047197|FG003|Period 1|History of suicidal ideation|0
7633516|NCT03635099|12047198|FG004|Period 1|History of suicidal ideation|0
7633517|NCT03635099|12047199|FG005|Period 1|History of suicidal ideation|0
7633518|NCT03635099|12047200|FG006|Period 1|History of suicidal ideation|0
7633519|NCT03635099|12047201|FG007|Period 1|History of suicidal ideation|0
7633520|NCT03635099|12047194|FG000|Period 1|pursue other treatment options|0
7633521|NCT03635099|12047195|FG001|Period 1|pursue other treatment options|0
7633522|NCT03635099|12047196|FG002|Period 1|pursue other treatment options|0
7633523|NCT03635099|12047197|FG003|Period 1|pursue other treatment options|0
7633524|NCT03635099|12047198|FG004|Period 1|pursue other treatment options|0
7633525|NCT03635099|12047199|FG005|Period 1|pursue other treatment options|1
7633526|NCT03635099|12047200|FG006|Period 1|pursue other treatment options|0
7633527|NCT03635099|12047201|FG007|Period 1|pursue other treatment options|0
7633528|NCT03635099|12047194|FG000|Not Eligible for Period 2|Pregnancy|0
7633529|NCT03635099|12047195|FG001|Not Eligible for Period 2|Pregnancy|0
7633530|NCT03635099|12047196|FG002|Not Eligible for Period 2|Pregnancy|0
7633531|NCT03635099|12047197|FG003|Not Eligible for Period 2|Pregnancy|1
7633532|NCT03635099|12047198|FG004|Not Eligible for Period 2|Pregnancy|0
7633533|NCT03635099|12047199|FG005|Not Eligible for Period 2|Pregnancy|0
7633534|NCT03635099|12047200|FG006|Not Eligible for Period 2|Pregnancy|0
7633535|NCT03635099|12047201|FG007|Not Eligible for Period 2|Pregnancy|0
7633536|NCT03635099|12047194|FG000|Not Eligible for Period 2|Withdrawal by Subject|1
7633537|NCT03635099|12047195|FG001|Not Eligible for Period 2|Withdrawal by Subject|0
7633538|NCT03635099|12047196|FG002|Not Eligible for Period 2|Withdrawal by Subject|0
7633539|NCT03635099|12047197|FG003|Not Eligible for Period 2|Withdrawal by Subject|0
7633540|NCT03635099|12047198|FG004|Not Eligible for Period 2|Withdrawal by Subject|0
7633541|NCT03635099|12047199|FG005|Not Eligible for Period 2|Withdrawal by Subject|0
7633542|NCT03635099|12047200|FG006|Not Eligible for Period 2|Withdrawal by Subject|0
7633543|NCT03635099|12047201|FG007|Not Eligible for Period 2|Withdrawal by Subject|0
7633544|NCT03635099|12047194|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633545|NCT03635099|12047195|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633546|NCT03635099|12047196|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633547|NCT03635099|12047197|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633548|NCT03635099|12047198|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0
7633549|NCT03635099|12047199|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9
7633550|NCT03635099|12047200|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
7633551|NCT03635099|12047201|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40
7633552|NCT03635099|12047194|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15
7633553|NCT03635099|12047195|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35
7633554|NCT03635099|12047196|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21
7633555|NCT03635099|12047197|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25
7633556|NCT03635099|12047198|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633557|NCT03635099|12047199|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633558|NCT03635099|12047200|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633559|NCT03635099|12047201|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0
7633560|NCT03635099|12047194|FG000|Period 2|Adverse Event|0
7633561|NCT03635099|12047195|FG001|Period 2|Adverse Event|0
7633562|NCT03635099|12047196|FG002|Period 2|Adverse Event|1
7633563|NCT03635099|12047197|FG003|Period 2|Adverse Event|0
7633564|NCT03635099|12047198|FG004|Period 2|Adverse Event|1
7633565|NCT03635099|12047199|FG005|Period 2|Adverse Event|0
7633566|NCT03635099|12047200|FG006|Period 2|Adverse Event|0
7633567|NCT03635099|12047201|FG007|Period 2|Adverse Event|0
7633568|NCT03635099|12047194|FG000|Period 2|Lost to Follow-up|0
7633569|NCT03635099|12047195|FG001|Period 2|Lost to Follow-up|0
7633570|NCT03635099|12047196|FG002|Period 2|Lost to Follow-up|1
7633571|NCT03635099|12047197|FG003|Period 2|Lost to Follow-up|0
7633572|NCT03635099|12047198|FG004|Period 2|Lost to Follow-up|4
7633573|NCT03635099|12047199|FG005|Period 2|Lost to Follow-up|0
7633574|NCT03635099|12047200|FG006|Period 2|Lost to Follow-up|0
7633575|NCT03635099|12047201|FG007|Period 2|Lost to Follow-up|0
7633576|NCT03635099|12047194|FG000|Period 2|Withdrawal by Subject|0
7633577|NCT03635099|12047195|FG001|Period 2|Withdrawal by Subject|0
7633578|NCT03635099|12047196|FG002|Period 2|Withdrawal by Subject|7
7633579|NCT03635099|12047197|FG003|Period 2|Withdrawal by Subject|4
7633580|NCT03635099|12047198|FG004|Period 2|Withdrawal by Subject|7
7633581|NCT03635099|12047199|FG005|Period 2|Withdrawal by Subject|0
7633582|NCT03635099|12047200|FG006|Period 2|Withdrawal by Subject|0
7633583|NCT03635099|12047201|FG007|Period 2|Withdrawal by Subject|0
7633584|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1
7633585|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1
7633586|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Death|2
7633587|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Death|1
7633588|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Adverse Event|0
7633589|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Adverse Event|1
7633590|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2
7633591|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1
7633592|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Physician Decision|1
7633593|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Physician Decision|0
7633594|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1
7633595|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0
7633596|NCT03633227|12047229|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1
7633597|NCT03633227|12047230|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0
7633598|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0
7633599|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2
7633600|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Death|0
7633601|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Death|1
7633602|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3
7633603|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2
7633604|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1
7633605|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0
7633606|NCT03633227|12047229|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0
7633607|NCT03633227|12047230|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1
7633608|NCT03624881|12047261|FG000|Overall Study|Screen Failure|14
7633609|NCT03624881|12047262|FG001|Overall Study|Screen Failure|0
7633610|NCT03624881|12047261|FG000|Overall Study|No Catheter Inserted|6
7633611|NCT03624881|12047262|FG001|Overall Study|No Catheter Inserted|1
7633612|NCT03624881|12047261|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2
7633613|NCT03624881|12047262|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0
7633614|NCT03624881|12047261|FG000|Overall Study|Death|2
7633615|NCT03624881|12047262|FG001|Overall Study|Death|0
7633616|NCT03624881|12047261|FG000|Overall Study|Lost to Follow-up|10
7633617|NCT03624881|12047262|FG001|Overall Study|Lost to Follow-up|4
7633618|NCT03624881|12047261|FG000|Overall Study|Withdrawal by Subject|12
7633619|NCT03624881|12047262|FG001|Overall Study|Withdrawal by Subject|1
7633620|NCT03622593|12047271|FG000|Overall Study|Withdrawal by Subject|11
7633621|NCT03622593|12047272|FG001|Overall Study|Withdrawal by Subject|9
7633622|NCT03622593|12047273|FG002|Overall Study|Withdrawal by Subject|13
7633623|NCT03622593|12047271|FG000|Overall Study|Death|12
7633624|NCT03622593|12047272|FG001|Overall Study|Death|9
7633625|NCT03622593|12047273|FG002|Overall Study|Death|10
7633626|NCT03622593|12047271|FG000|Overall Study|Lost to Follow-up|11
7633627|NCT03622593|12047272|FG001|Overall Study|Lost to Follow-up|5
7633628|NCT03622593|12047273|FG002|Overall Study|Lost to Follow-up|8
7633629|NCT03622593|12047271|FG000|Overall Study|Adverse Event|4
7633630|NCT03622593|12047272|FG001|Overall Study|Adverse Event|5
7633631|NCT03622593|12047273|FG002|Overall Study|Adverse Event|6
7633632|NCT03622593|12047271|FG000|Overall Study|Physician Decision|2
7633633|NCT03622593|12047272|FG001|Overall Study|Physician Decision|1
7633634|NCT03622593|12047273|FG002|Overall Study|Physician Decision|6
7633635|NCT03622593|12047271|FG000|Overall Study|Other|2
7633636|NCT03622593|12047272|FG001|Overall Study|Other|2
7633637|NCT03622593|12047273|FG002|Overall Study|Other|3
7633638|NCT03622593|12047271|FG000|Overall Study|Protocol Violation|0
7633639|NCT03622593|12047272|FG001|Overall Study|Protocol Violation|0
7633640|NCT03622593|12047273|FG002|Overall Study|Protocol Violation|1
7633641|NCT03622593|12047271|FG000|Overall Study|Pregnancy|0
7633642|NCT03622593|12047272|FG001|Overall Study|Pregnancy|0
7633643|NCT03622593|12047273|FG002|Overall Study|Pregnancy|1
7633644|NCT03622580|12047285|FG000|Overall Study|Death|16
7633645|NCT03622580|12047286|FG001|Overall Study|Death|21
7633646|NCT03622580|12047287|FG002|Overall Study|Death|13
7633647|NCT03622580|12047285|FG000|Overall Study|Adverse Event|6
7633648|NCT03622580|12047286|FG001|Overall Study|Adverse Event|6
7633649|NCT03622580|12047287|FG002|Overall Study|Adverse Event|5
7633650|NCT03622580|12047285|FG000|Overall Study|Withdrawal by Subject|12
7633651|NCT03622580|12047286|FG001|Overall Study|Withdrawal by Subject|7
7633652|NCT03622580|12047287|FG002|Overall Study|Withdrawal by Subject|19
7633653|NCT03622580|12047285|FG000|Overall Study|Lost to Follow-up|12
7633654|NCT03622580|12047286|FG001|Overall Study|Lost to Follow-up|9
7633655|NCT03622580|12047287|FG002|Overall Study|Lost to Follow-up|9
7633656|NCT03622580|12047285|FG000|Overall Study|Protocol Violation|1
7633657|NCT03622580|12047286|FG001|Overall Study|Protocol Violation|0
7633658|NCT03622580|12047287|FG002|Overall Study|Protocol Violation|1
7633659|NCT03622580|12047285|FG000|Overall Study|Physician Decision|3
7633660|NCT03622580|12047286|FG001|Overall Study|Physician Decision|0
7633661|NCT03622580|12047287|FG002|Overall Study|Physician Decision|1
7633662|NCT03622580|12047285|FG000|Overall Study|Pregnancy|0
7633663|NCT03622580|12047286|FG001|Overall Study|Pregnancy|1
7633664|NCT03622580|12047287|FG002|Overall Study|Pregnancy|0
7633665|NCT03622580|12047285|FG000|Overall Study|Lack of Efficacy|0
7633666|NCT03622580|12047286|FG001|Overall Study|Lack of Efficacy|0
7633667|NCT03622580|12047287|FG002|Overall Study|Lack of Efficacy|1
7633668|NCT03622580|12047285|FG000|Overall Study|Other|2
7633669|NCT03622580|12047286|FG001|Overall Study|Other|0
7633670|NCT03622580|12047287|FG002|Overall Study|Other|3
7633671|NCT03619174|12047298|FG000|Overall Study|Lost to Follow-up|3
7633672|NCT03619174|12047299|FG001|Overall Study|Lost to Follow-up|0
7633673|NCT03619174|12047298|FG000|Overall Study|Withdrawal by Subject|4
7633674|NCT03619174|12047299|FG001|Overall Study|Withdrawal by Subject|3
7633675|NCT03619174|12047298|FG000|Overall Study|Pregnancy|1
7633676|NCT03619174|12047299|FG001|Overall Study|Pregnancy|1
7633677|NCT03619174|12047298|FG000|Overall Study|Discomfort during treatment|1
7633678|NCT03619174|12047299|FG001|Overall Study|Discomfort during treatment|0
7633679|NCT03607487|12047358|FG000|Overall Study|Withdrawal by Subject|2
7633680|NCT03607487|12047359|FG001|Overall Study|Withdrawal by Subject|0
7633681|NCT03607487|12047360|FG002|Overall Study|Withdrawal by Subject|0
7633682|NCT03607487|12047361|FG003|Overall Study|Withdrawal by Subject|1
7633683|NCT03606109|12047375|FG000|Overall Study|Lost to Follow-up|2
7633684|NCT03606109|12047376|FG001|Overall Study|Lost to Follow-up|1
7633685|NCT03595384|12047395|FG000|Overall Study|Other time commitments|8
7633686|NCT03595384|12047395|FG000|Overall Study|Changes to session time|7
7633687|NCT03595384|12047395|FG000|Overall Study|Relocation out of country|1
7633688|NCT03592277|12047417|FG000|Overall Study|Withdrawal by Subject|6
7633689|NCT03592277|12047418|FG001|Overall Study|Withdrawal by Subject|8
7633690|NCT03590366|12047450|FG000|Overall Study|Adverse Event|0
7633691|NCT03590366|12047451|FG001|Overall Study|Adverse Event|3
7633692|NCT03590366|12047450|FG000|Overall Study|Lost to Follow-up|3
7633693|NCT03590366|12047451|FG001|Overall Study|Lost to Follow-up|3
7633694|NCT03590366|12047450|FG000|Overall Study|Withdrawal by Subject|0
7633695|NCT03590366|12047451|FG001|Overall Study|Withdrawal by Subject|2
7633696|NCT03589469|12047457|FG000|Overall Study|Ongoing in study|58
7633697|NCT03589469|12047457|FG000|Overall Study|Withdrawal by Subject|6
7633698|NCT03589469|12047457|FG000|Overall Study|Physician Decision|1
7633699|NCT03589469|12047457|FG000|Overall Study|Death|77
7633700|NCT03589469|12047457|FG000|Overall Study|Lost to Follow-up|3
7633701|NCT03587584|12047463|FG000|Overall Study|SOC deviations|4
7633702|NCT03587584|12047464|FG001|Overall Study|SOC deviations|6
7633703|NCT03587584|12047463|FG000|Overall Study|Incomplete data|0
7633704|NCT03587584|12047464|FG001|Overall Study|Incomplete data|3
7633705|NCT03586427|12047475|FG000|Overall Study|Lost to Follow-up|0
7633706|NCT03586427|12047476|FG001|Overall Study|Lost to Follow-up|3
7633707|NCT03586427|12047477|FG002|Overall Study|Lost to Follow-up|1
7633708|NCT03586427|12047478|FG003|Overall Study|Lost to Follow-up|3
7633709|NCT03586427|12047479|FG004|Overall Study|Lost to Follow-up|3
7633710|NCT03586427|12047475|FG000|Overall Study|Withdrawal by Subject|0
7633711|NCT03586427|12047476|FG001|Overall Study|Withdrawal by Subject|1
7633712|NCT03586427|12047477|FG002|Overall Study|Withdrawal by Subject|2
7633713|NCT03586427|12047478|FG003|Overall Study|Withdrawal by Subject|1
7633714|NCT03586427|12047479|FG004|Overall Study|Withdrawal by Subject|1
7633715|NCT03586427|12047475|FG000|Overall Study|Adverse Event|0
7633716|NCT03586427|12047476|FG001|Overall Study|Adverse Event|0
7633717|NCT03586427|12047477|FG002|Overall Study|Adverse Event|1
7633718|NCT03586427|12047478|FG003|Overall Study|Adverse Event|0
7633719|NCT03586427|12047479|FG004|Overall Study|Adverse Event|0
7633720|NCT03586427|12047475|FG000|Overall Study|Protocol Violation|0
7633721|NCT03586427|12047476|FG001|Overall Study|Protocol Violation|0
7633722|NCT03586427|12047477|FG002|Overall Study|Protocol Violation|1
7633723|NCT03586427|12047478|FG003|Overall Study|Protocol Violation|0
7633724|NCT03586427|12047479|FG004|Overall Study|Protocol Violation|1
7633725|NCT03586427|12047475|FG000|Overall Study|Noncompliance with study drug|0
7633726|NCT03586427|12047476|FG001|Overall Study|Noncompliance with study drug|0
7633727|NCT03586427|12047477|FG002|Overall Study|Noncompliance with study drug|1
7633728|NCT03586427|12047478|FG003|Overall Study|Noncompliance with study drug|0
7633729|NCT03586427|12047479|FG004|Overall Study|Noncompliance with study drug|0
7633730|NCT03584789|12047503|FG000|Overall Study|refused EHR permission|19
7633731|NCT03584789|12047504|FG001|Overall Study|refused EHR permission|28
7633732|NCT03584789|12047505|FG002|Overall Study|refused EHR permission|23
7633733|NCT03584789|12047503|FG000|Overall Study|patients tied to a provider who retired|0
7633734|NCT03584789|12047504|FG001|Overall Study|patients tied to a provider who retired|0
7633735|NCT03584789|12047505|FG002|Overall Study|patients tied to a provider who retired|3
7633736|NCT03575468|12047515|FG000|Overall Study|Withdrawal by Subject|3
7633737|NCT03575468|12047516|FG001|Overall Study|Withdrawal by Subject|0
7633738|NCT03575468|12047515|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10
7633739|NCT03575468|12047516|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4
7633740|NCT03575468|12047515|FG000|Overall Study|Lost to Follow-up|13
7633741|NCT03575468|12047516|FG001|Overall Study|Lost to Follow-up|17
7633742|NCT03575325|12047522|FG000|Overall Study|Death|1
7633743|NCT03575065|12047530|FG000|Overall Study|Death|31
7633744|NCT03575065|12047531|FG001|Overall Study|Death|12
7633745|NCT03575065|12047530|FG000|Overall Study|Sponsor's Decision|28
7633746|NCT03575065|12047531|FG001|Overall Study|Sponsor's Decision|13
7633747|NCT03575065|12047530|FG000|Overall Study|Withdrawal by Subject|2
7633748|NCT03575065|12047531|FG001|Overall Study|Withdrawal by Subject|1
7633749|NCT03575065|12047530|FG000|Overall Study|Lost to Follow-up|1
7633750|NCT03575065|12047531|FG001|Overall Study|Lost to Follow-up|0
7633751|NCT03571581|12047538|FG000|Overall Study|Death|2
7633752|NCT03571581|12047538|FG000|Overall Study|Withdrawal by Subject|2
7633753|NCT03569371|12047590|FG000|Overall Study|Lack of Efficacy|1
7633754|NCT03569371|12047590|FG000|Overall Study|Lost to Follow-up|1
7633755|NCT03569371|12047590|FG000|Overall Study|Adverse Event|1
7633756|NCT03568162|12047609|FG000|Overall Study|Adverse Event|0
7633757|NCT03568162|12047610|FG001|Overall Study|Adverse Event|1
7633758|NCT03568162|12047611|FG002|Overall Study|Adverse Event|2
7633759|NCT03568162|12047612|FG003|Overall Study|Adverse Event|0
7633760|NCT03568162|12047613|FG004|Overall Study|Adverse Event|0
7633761|NCT03568162|12047614|FG005|Overall Study|Adverse Event|1
7633762|NCT03568162|12047609|FG000|Overall Study|Death|0
7633763|NCT03568162|12047610|FG001|Overall Study|Death|0
7633764|NCT03568162|12047611|FG002|Overall Study|Death|0
7633765|NCT03568162|12047612|FG003|Overall Study|Death|0
7633766|NCT03568162|12047613|FG004|Overall Study|Death|1
7633767|NCT03568162|12047614|FG005|Overall Study|Death|0
7633768|NCT03568162|12047609|FG000|Overall Study|Lost to Follow-up|3
7633769|NCT03568162|12047610|FG001|Overall Study|Lost to Follow-up|2
7633770|NCT03568162|12047611|FG002|Overall Study|Lost to Follow-up|4
7633771|NCT03568162|12047612|FG003|Overall Study|Lost to Follow-up|2
7633772|NCT03568162|12047613|FG004|Overall Study|Lost to Follow-up|3
7633773|NCT03568162|12047614|FG005|Overall Study|Lost to Follow-up|2
7633774|NCT03568162|12047609|FG000|Overall Study|Physician Decision|0
7633775|NCT03568162|12047610|FG001|Overall Study|Physician Decision|1
7633776|NCT03568162|12047611|FG002|Overall Study|Physician Decision|1
7633777|NCT03568162|12047612|FG003|Overall Study|Physician Decision|0
7633778|NCT03568162|12047613|FG004|Overall Study|Physician Decision|1
7633779|NCT03568162|12047614|FG005|Overall Study|Physician Decision|0
7633780|NCT03568162|12047609|FG000|Overall Study|Pregnancy|0
7633781|NCT03568162|12047610|FG001|Overall Study|Pregnancy|0
7633782|NCT03568162|12047611|FG002|Overall Study|Pregnancy|0
7633783|NCT03568162|12047612|FG003|Overall Study|Pregnancy|1
7633784|NCT03568162|12047613|FG004|Overall Study|Pregnancy|0
7633785|NCT03568162|12047614|FG005|Overall Study|Pregnancy|0
7633786|NCT03568162|12047609|FG000|Overall Study|Protocol Violation|1
7633787|NCT03568162|12047610|FG001|Overall Study|Protocol Violation|0
7633788|NCT03568162|12047611|FG002|Overall Study|Protocol Violation|1
7633789|NCT03568162|12047612|FG003|Overall Study|Protocol Violation|1
7633790|NCT03568162|12047613|FG004|Overall Study|Protocol Violation|1
7633791|NCT03568162|12047614|FG005|Overall Study|Protocol Violation|1
7633792|NCT03568162|12047609|FG000|Overall Study|Withdrawal by Subject|15
7633793|NCT03568162|12047610|FG001|Overall Study|Withdrawal by Subject|15
7633794|NCT03568162|12047611|FG002|Overall Study|Withdrawal by Subject|26
7633795|NCT03568162|12047612|FG003|Overall Study|Withdrawal by Subject|22
7633796|NCT03568162|12047613|FG004|Overall Study|Withdrawal by Subject|6
7633797|NCT03568162|12047614|FG005|Overall Study|Withdrawal by Subject|9
7633798|NCT03568162|12047609|FG000|Overall Study|Others|3
7633799|NCT03568162|12047610|FG001|Overall Study|Others|4
7633800|NCT03568162|12047611|FG002|Overall Study|Others|1
7633801|NCT03568162|12047612|FG003|Overall Study|Others|4
7633802|NCT03568162|12047613|FG004|Overall Study|Others|2
7633803|NCT03568162|12047614|FG005|Overall Study|Others|1
7633804|NCT03565237|12047640|FG000|Overall Study|Non-compliance of Investigational Product|1
7633805|NCT03565237|12047640|FG000|Overall Study|Physician Decision|1
7633806|NCT03563716|12047646|FG000|Overall Study|Death|20
7633807|NCT03563716|12047647|FG001|Overall Study|Death|14
7633808|NCT03563716|12047646|FG000|Overall Study|Withdrawal by Subject|3
7633809|NCT03563716|12047647|FG001|Overall Study|Withdrawal by Subject|3
7633810|NCT03563716|12047646|FG000|Overall Study|Still on Study|45
7633811|NCT03563716|12047647|FG001|Overall Study|Still on Study|50
7633812|NCT03558503|12047653|FG000|Overall Study|Adverse Event|1
7633813|NCT03558503|12047653|FG000|Overall Study|Death|1
7633814|NCT03558503|12047653|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1
7633815|NCT03557151|12047659|FG000|Randomization to 3 Months|Lost to Follow-up|2
7633816|NCT03557151|12047660|FG001|Randomization to 3 Months|Lost to Follow-up|2
7633817|NCT03557151|12047659|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2
7633818|NCT03557151|12047660|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0
7633819|NCT03557151|12047659|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0
7633820|NCT03557151|12047660|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2
7633821|NCT03538951|12047706|FG000|Overall Study|Withdrawal by Subject|1
7633822|NCT03538951|12047707|FG001|Overall Study|Withdrawal by Subject|2
7633823|NCT03538054|12047713|FG000|Baseline Phase (2 Weeks)|Physician Decision|1
7633824|NCT03538054|12047713|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2
7633825|NCT03538054|12047713|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2
7633826|NCT03538041|12047721|FG000|12-Week Treatment Period|Adverse Event|1
7633827|NCT03538041|12047722|FG001|12-Week Treatment Period|Adverse Event|1
7633828|NCT03538041|12047721|FG000|12-Week Treatment Period|Withdrawal by Subject|0
7633829|NCT03538041|12047722|FG001|12-Week Treatment Period|Withdrawal by Subject|1
7633830|NCT03538041|12047721|FG000|Treatment Extension Period|Adverse Event|4
7633831|NCT03538041|12047722|FG001|Treatment Extension Period|Adverse Event|0
7633832|NCT03538041|12047721|FG000|Treatment Extension Period|Physician Decision|1
7633833|NCT03538041|12047722|FG001|Treatment Extension Period|Physician Decision|0
7633834|NCT03538041|12047721|FG000|Treatment Extension Period|Lack of Efficacy|1
7633835|NCT03538041|12047722|FG001|Treatment Extension Period|Lack of Efficacy|3
7633836|NCT03538041|12047721|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1
7633837|NCT03538041|12047722|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7
7633838|NCT03525678|12047734|FG000|Overall Study|Ongoing at the time of interim analysis|60
7633839|NCT03525678|12047735|FG001|Overall Study|Ongoing at the time of interim analysis|65
7633840|NCT03525678|12047736|FG002|Overall Study|Ongoing at the time of interim analysis|21
7633841|NCT03525678|12047734|FG000|Overall Study|Withdrawal by Subject|3
7633842|NCT03525678|12047735|FG001|Overall Study|Withdrawal by Subject|1
7633843|NCT03525678|12047736|FG002|Overall Study|Withdrawal by Subject|0
7633844|NCT03525678|12047734|FG000|Overall Study|Physician Decision|1
7633845|NCT03525678|12047735|FG001|Overall Study|Physician Decision|2
7633846|NCT03525678|12047736|FG002|Overall Study|Physician Decision|0
7633847|NCT03525678|12047734|FG000|Overall Study|Lost to Follow-up|1
7633848|NCT03525678|12047735|FG001|Overall Study|Lost to Follow-up|0
7633849|NCT03525678|12047736|FG002|Overall Study|Lost to Follow-up|0
7633850|NCT03525678|12047734|FG000|Overall Study|Death|32
7633851|NCT03525678|12047735|FG001|Overall Study|Death|31
7633852|NCT03525678|12047736|FG002|Overall Study|Death|4
7633853|NCT03525119|12047747|FG000|Overall Study|Adverse Event|0
7633854|NCT03525119|12047748|FG001|Overall Study|Adverse Event|1
7633855|NCT03525119|12047749|FG002|Overall Study|Adverse Event|0
7633856|NCT03525119|12047747|FG000|Overall Study|Lost to Follow-up|32
7633857|NCT03525119|12047748|FG001|Overall Study|Lost to Follow-up|33
7633858|NCT03525119|12047749|FG002|Overall Study|Lost to Follow-up|37
7633859|NCT03525119|12047747|FG000|Overall Study|Withdrawal by Subject|5
7633860|NCT03525119|12047748|FG001|Overall Study|Withdrawal by Subject|4
7633861|NCT03525119|12047749|FG002|Overall Study|Withdrawal by Subject|2
7633862|NCT03525119|12047747|FG000|Overall Study|Reason not Specified|2
7633863|NCT03525119|12047748|FG001|Overall Study|Reason not Specified|1
7633864|NCT03525119|12047749|FG002|Overall Study|Reason not Specified|2
7633865|NCT03525119|12047747|FG000|Overall Study|Randomized but not Vaccinated|1
7633866|NCT03525119|12047748|FG001|Overall Study|Randomized but not Vaccinated|0
7633867|NCT03525119|12047749|FG002|Overall Study|Randomized but not Vaccinated|2
7633868|NCT03521193|12047759|FG000|Overall Study|Withdrawal by Subject|8
7633869|NCT03521193|12047760|FG001|Overall Study|Withdrawal by Subject|0
7633870|NCT03521193|12047759|FG000|Overall Study|non compliant to ASA treatment|8
7633871|NCT03521193|12047760|FG001|Overall Study|non compliant to ASA treatment|0
7633872|NCT03518086|12047769|FG000|Overall Study|Adverse Event|23
7633873|NCT03518086|12047770|FG001|Overall Study|Adverse Event|15
7633874|NCT03518086|12047771|FG002|Overall Study|Adverse Event|0
7633875|NCT03518086|12047772|FG003|Overall Study|Adverse Event|0
7633876|NCT03518086|12047769|FG000|Overall Study|Withdrawal by Subject|8
7633877|NCT03518086|12047770|FG001|Overall Study|Withdrawal by Subject|5
7633878|NCT03518086|12047771|FG002|Overall Study|Withdrawal by Subject|0
7633879|NCT03518086|12047772|FG003|Overall Study|Withdrawal by Subject|0
7633880|NCT03518086|12047769|FG000|Overall Study|Lack of Efficacy|5
7633881|NCT03518086|12047770|FG001|Overall Study|Lack of Efficacy|5
7633882|NCT03518086|12047771|FG002|Overall Study|Lack of Efficacy|0
7633883|NCT03518086|12047772|FG003|Overall Study|Lack of Efficacy|0
7633884|NCT03518086|12047769|FG000|Overall Study|Protocol Violation|1
7633885|NCT03518086|12047770|FG001|Overall Study|Protocol Violation|5
7633886|NCT03518086|12047771|FG002|Overall Study|Protocol Violation|0
7633887|NCT03518086|12047772|FG003|Overall Study|Protocol Violation|0
7633888|NCT03518086|12047769|FG000|Overall Study|Lost to Follow-up|0
7633889|NCT03518086|12047770|FG001|Overall Study|Lost to Follow-up|3
7633890|NCT03518086|12047771|FG002|Overall Study|Lost to Follow-up|0
7633891|NCT03518086|12047772|FG003|Overall Study|Lost to Follow-up|0
7633892|NCT03518086|12047769|FG000|Overall Study|Insufficient Diary Data|0
7633893|NCT03518086|12047770|FG001|Overall Study|Insufficient Diary Data|2
7633894|NCT03518086|12047771|FG002|Overall Study|Insufficient Diary Data|0
7633895|NCT03518086|12047772|FG003|Overall Study|Insufficient Diary Data|0
7633896|NCT03518086|12047769|FG000|Overall Study|Non- compliance to Protocol|0
7633897|NCT03518086|12047770|FG001|Overall Study|Non- compliance to Protocol|1
7633898|NCT03518086|12047771|FG002|Overall Study|Non- compliance to Protocol|0
7633899|NCT03518086|12047772|FG003|Overall Study|Non- compliance to Protocol|0
7633900|NCT03518086|12047769|FG000|Overall Study|COVID-19 Related Study Disruption|0
7633901|NCT03518086|12047770|FG001|Overall Study|COVID-19 Related Study Disruption|2
7633902|NCT03518086|12047771|FG002|Overall Study|COVID-19 Related Study Disruption|0
7633903|NCT03518086|12047772|FG003|Overall Study|COVID-19 Related Study Disruption|0
7633904|NCT03518086|12047769|FG000|Overall Study|Site Terminated by Sponsor|0
7633905|NCT03518086|12047770|FG001|Overall Study|Site Terminated by Sponsor|1
7633906|NCT03518086|12047771|FG002|Overall Study|Site Terminated by Sponsor|0
7633907|NCT03518086|12047772|FG003|Overall Study|Site Terminated by Sponsor|0
7633908|NCT03518073|12047782|FG000|Overall Study|Adverse Event|2
7633909|NCT03518073|12047783|FG001|Overall Study|Adverse Event|4
7633910|NCT03518073|12047784|FG002|Overall Study|Adverse Event|2
7633911|NCT03518073|12047782|FG000|Overall Study|Death|2
7633912|NCT03518073|12047783|FG001|Overall Study|Death|1
7633913|NCT03518073|12047784|FG002|Overall Study|Death|3
7633914|NCT03518073|12047782|FG000|Overall Study|Lost to Follow-up|1
7633915|NCT03518073|12047783|FG001|Overall Study|Lost to Follow-up|0
7633916|NCT03518073|12047784|FG002|Overall Study|Lost to Follow-up|1
7633917|NCT03518073|12047782|FG000|Overall Study|Physician Decision|5
7633918|NCT03518073|12047783|FG001|Overall Study|Physician Decision|0
7633919|NCT03518073|12047784|FG002|Overall Study|Physician Decision|2
7633920|NCT03518073|12047782|FG000|Overall Study|Progressive disease|1
7633921|NCT03518073|12047783|FG001|Overall Study|Progressive disease|1
7633922|NCT03518073|12047784|FG002|Overall Study|Progressive disease|1
7633923|NCT03518073|12047782|FG000|Overall Study|Protocol Violation|1
7633924|NCT03518073|12047783|FG001|Overall Study|Protocol Violation|0
7633925|NCT03518073|12047784|FG002|Overall Study|Protocol Violation|0
7633926|NCT03518073|12047782|FG000|Overall Study|Withdrawal by Subject|30
7633927|NCT03518073|12047783|FG001|Overall Study|Withdrawal by Subject|34
7633928|NCT03518073|12047784|FG002|Overall Study|Withdrawal by Subject|29
7633929|NCT03518073|12047782|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1
7633930|NCT03518073|12047783|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6
7633931|NCT03518073|12047784|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7
7633932|NCT03518073|12047782|FG000|Overall Study|Covid-19|1
7633933|NCT03518073|12047783|FG001|Overall Study|Covid-19|2
7633934|NCT03518073|12047784|FG002|Overall Study|Covid-19|1
7633935|NCT03514914|12047796|FG000|Overall Study|Death|3
7633936|NCT03514914|12047797|FG001|Overall Study|Death|3
7633937|NCT03514914|12047796|FG000|Overall Study|Lost to Follow-up|117
7633938|NCT03514914|12047797|FG001|Overall Study|Lost to Follow-up|89
7633939|NCT03511664|12047818|FG000|Overall Study|Treatment ongoing|49
7633940|NCT03511664|12047819|FG001|Overall Study|Treatment ongoing|5
7633941|NCT03511664|12047818|FG000|Overall Study|Entered long-term follow-up|140
7633942|NCT03511664|12047819|FG001|Overall Study|Entered long-term follow-up|50
7633943|NCT03511664|12047818|FG000|Overall Study|Withdrawal by Subject|29
7633944|NCT03511664|12047819|FG001|Overall Study|Withdrawal by Subject|53
7633945|NCT03511664|12047818|FG000|Overall Study|Lost to Follow-up|4
7633946|NCT03511664|12047819|FG001|Overall Study|Lost to Follow-up|4
7633947|NCT03511664|12047818|FG000|Overall Study|Physician Decision|0
7633948|NCT03511664|12047819|FG001|Overall Study|Physician Decision|1
7633949|NCT03498313|12047853|FG000|Experimental Period 1|Adverse Event|1
7633950|NCT03498313|12047854|FG001|Experimental Period 1|Adverse Event|0
7633951|NCT03498313|12047855|FG002|Experimental Period 1|Adverse Event|0
7633952|NCT03498313|12047856|FG003|Experimental Period 1|Adverse Event|1
7633953|NCT03498313|12047857|FG004|Experimental Period 1|Adverse Event|0
7633954|NCT03498313|12047858|FG005|Experimental Period 1|Adverse Event|0
7633955|NCT03498313|12047853|FG000|Experimental Period 1|Withdrawal by Subject|0
7633956|NCT03498313|12047854|FG001|Experimental Period 1|Withdrawal by Subject|1
7633957|NCT03498313|12047855|FG002|Experimental Period 1|Withdrawal by Subject|0
7633958|NCT03498313|12047856|FG003|Experimental Period 1|Withdrawal by Subject|0
7633959|NCT03498313|12047857|FG004|Experimental Period 1|Withdrawal by Subject|0
7633960|NCT03498313|12047858|FG005|Experimental Period 1|Withdrawal by Subject|0
7633961|NCT03498313|12047853|FG000|Washout Period 1|Anovulation|1
7633962|NCT03498313|12047854|FG001|Washout Period 1|Anovulation|0
7633963|NCT03498313|12047855|FG002|Washout Period 1|Anovulation|0
7633964|NCT03498313|12047856|FG003|Washout Period 1|Anovulation|0
7633965|NCT03498313|12047857|FG004|Washout Period 1|Anovulation|0
7633966|NCT03498313|12047858|FG005|Washout Period 1|Anovulation|0
7633967|NCT03498313|12047853|FG000|Washout Period 1|Withdrawal by Subject|0
7633968|NCT03498313|12047854|FG001|Washout Period 1|Withdrawal by Subject|3
7633969|NCT03498313|12047855|FG002|Washout Period 1|Withdrawal by Subject|0
7633970|NCT03498313|12047856|FG003|Washout Period 1|Withdrawal by Subject|1
7633971|NCT03498313|12047857|FG004|Washout Period 1|Withdrawal by Subject|0
7633972|NCT03498313|12047858|FG005|Washout Period 1|Withdrawal by Subject|1
7633973|NCT03498313|12047853|FG000|Experimental Period 2|Adverse Event|0
7633974|NCT03498313|12047854|FG001|Experimental Period 2|Adverse Event|0
7633975|NCT03498313|12047855|FG002|Experimental Period 2|Adverse Event|0
7633976|NCT03498313|12047856|FG003|Experimental Period 2|Adverse Event|0
7633977|NCT03498313|12047857|FG004|Experimental Period 2|Adverse Event|1
7633978|NCT03498313|12047858|FG005|Experimental Period 2|Adverse Event|2
7633979|NCT03498313|12047853|FG000|Washout Period 2|Physician Decision|1
7633980|NCT03498313|12047854|FG001|Washout Period 2|Physician Decision|0
7633981|NCT03498313|12047855|FG002|Washout Period 2|Physician Decision|0
7633982|NCT03498313|12047856|FG003|Washout Period 2|Physician Decision|1
7633983|NCT03498313|12047857|FG004|Washout Period 2|Physician Decision|0
7633984|NCT03498313|12047858|FG005|Washout Period 2|Physician Decision|1
7633985|NCT03498313|12047853|FG000|Washout Period 2|Withdrawal by Subject|3
7633986|NCT03498313|12047854|FG001|Washout Period 2|Withdrawal by Subject|2
7633987|NCT03498313|12047855|FG002|Washout Period 2|Withdrawal by Subject|0
7633988|NCT03498313|12047856|FG003|Washout Period 2|Withdrawal by Subject|0
7633989|NCT03498313|12047857|FG004|Washout Period 2|Withdrawal by Subject|2
7633990|NCT03498313|12047858|FG005|Washout Period 2|Withdrawal by Subject|0
7633991|NCT03498313|12047853|FG000|Washout Period 2|Anovulation|0
7633992|NCT03498313|12047854|FG001|Washout Period 2|Anovulation|0
7633993|NCT03498313|12047855|FG002|Washout Period 2|Anovulation|0
7633994|NCT03498313|12047856|FG003|Washout Period 2|Anovulation|0
7633995|NCT03498313|12047857|FG004|Washout Period 2|Anovulation|0
7633996|NCT03498313|12047858|FG005|Washout Period 2|Anovulation|1
7633997|NCT03495453|12047876|FG000|Overall Study|Withdrawal by Subject|0
7633998|NCT03495453|12047877|FG001|Overall Study|Withdrawal by Subject|1
7633999|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1
7634000|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634001|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634002|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0
7634003|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1
7634004|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634005|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634006|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0
7634007|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4
7634008|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634009|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634010|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0
7634011|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1
7634012|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634013|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634014|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0
7634015|NCT03488251|12047887|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1
7634016|NCT03488251|12047888|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634017|NCT03488251|12047889|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634018|NCT03488251|12047890|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0
7634019|NCT03486899|12047905|FG000|Overall Study|Lost to Follow-up|4
7634020|NCT03486899|12047906|FG001|Overall Study|Lost to Follow-up|1
7634021|NCT03486899|12047907|FG002|Overall Study|Lost to Follow-up|4
7634022|NCT03486899|12047908|FG003|Overall Study|Lost to Follow-up|3
7634023|NCT03486899|12047905|FG000|Overall Study|Death|1
7634024|NCT03486899|12047906|FG001|Overall Study|Death|0
7634025|NCT03486899|12047907|FG002|Overall Study|Death|0
7634026|NCT03486899|12047908|FG003|Overall Study|Death|1
7634027|NCT03486899|12047905|FG000|Overall Study|Adverse Event|0
7634028|NCT03486899|12047906|FG001|Overall Study|Adverse Event|2
7634029|NCT03486899|12047907|FG002|Overall Study|Adverse Event|0
7634030|NCT03486899|12047908|FG003|Overall Study|Adverse Event|2
7634031|NCT03486899|12047905|FG000|Overall Study|Withdrawal by Subject|3
7634032|NCT03486899|12047906|FG001|Overall Study|Withdrawal by Subject|7
7634033|NCT03486899|12047907|FG002|Overall Study|Withdrawal by Subject|4
7634034|NCT03486899|12047908|FG003|Overall Study|Withdrawal by Subject|3
7634035|NCT03486899|12047905|FG000|Overall Study|Other Reasons|0
7634036|NCT03486899|12047906|FG001|Overall Study|Other Reasons|1
7634037|NCT03486899|12047907|FG002|Overall Study|Other Reasons|0
7634038|NCT03486899|12047908|FG003|Overall Study|Other Reasons|1
7634039|NCT03475056|12047956|FG000|Overall Study|Lost to Follow-up|0
7634040|NCT03475056|12047957|FG001|Overall Study|Lost to Follow-up|1
7634041|NCT03475056|12047956|FG000|Overall Study|Moved from Area|0
7634042|NCT03475056|12047957|FG001|Overall Study|Moved from Area|2
7634043|NCT03474107|12047966|FG000|Overall Study|Adverse Event|42
7634044|NCT03474107|12047967|FG001|Overall Study|Adverse Event|46
7634045|NCT03474107|12047966|FG000|Overall Study|Death|2
7634046|NCT03474107|12047967|FG001|Overall Study|Death|2
7634047|NCT03474107|12047966|FG000|Overall Study|Lost to Follow-up|0
7634048|NCT03474107|12047967|FG001|Overall Study|Lost to Follow-up|1
7634049|NCT03474107|12047966|FG000|Overall Study|Progressive Disease|177
7634050|NCT03474107|12047967|FG001|Overall Study|Progressive Disease|180
7634051|NCT03474107|12047966|FG000|Overall Study|Protocol Violation|1
7634052|NCT03474107|12047967|FG001|Overall Study|Protocol Violation|1
7634053|NCT03474107|12047966|FG000|Overall Study|Withdrawal by Subject|15
7634054|NCT03474107|12047967|FG001|Overall Study|Withdrawal by Subject|27
7634055|NCT03474107|12047966|FG000|Overall Study|Physician Decision|7
7634056|NCT03474107|12047967|FG001|Overall Study|Physician Decision|22
7634057|NCT03474107|12047966|FG000|Overall Study|Miscellaneous|1
7634058|NCT03474107|12047967|FG001|Overall Study|Miscellaneous|6
7634059|NCT03473340|12047975|FG000|Overall Study|Follow up not possible due to COVID restrictions|3
7634060|NCT03473340|12047976|FG001|Overall Study|Follow up not possible due to COVID restrictions|0
7634061|NCT03473340|12047975|FG000|Overall Study|Withdrawal by Subject|1
7634062|NCT03473340|12047976|FG001|Overall Study|Withdrawal by Subject|0
7634063|NCT03473340|12047975|FG000|Overall Study|Lost to Follow-up|1
7634064|NCT03473340|12047976|FG001|Overall Study|Lost to Follow-up|2
7634065|NCT03472885|12047982|FG000|Overall Study|Adverse Event|1
7634066|NCT03467152|12047988|FG000|Overall Study|Adverse Event|4
7634067|NCT03467152|12047989|FG001|Overall Study|Adverse Event|5
7634068|NCT03467152|12047990|FG002|Overall Study|Adverse Event|0
7634069|NCT03467152|12047988|FG000|Overall Study|Subject Choice|1
7634070|NCT03467152|12047989|FG001|Overall Study|Subject Choice|3
7634071|NCT03467152|12047990|FG002|Overall Study|Subject Choice|0
7634072|NCT03467152|12047988|FG000|Overall Study|Lost to Follow-up|1
7634073|NCT03467152|12047989|FG001|Overall Study|Lost to Follow-up|0
7634074|NCT03467152|12047990|FG002|Overall Study|Lost to Follow-up|0
7634075|NCT03467152|12047988|FG000|Overall Study|Withdrawal by Subject|4
7634076|NCT03467152|12047989|FG001|Overall Study|Withdrawal by Subject|2
7634077|NCT03467152|12047990|FG002|Overall Study|Withdrawal by Subject|0
7634078|NCT03467152|12047988|FG000|Overall Study|Others|3
7634079|NCT03467152|12047989|FG001|Overall Study|Others|0
7634080|NCT03467152|12047990|FG002|Overall Study|Others|0
7634081|NCT03467152|12047988|FG000|Overall Study|Not treated|3
7634082|NCT03467152|12047989|FG001|Overall Study|Not treated|1
7634083|NCT03467152|12047990|FG002|Overall Study|Not treated|6
7634084|NCT03462719|12048008|FG000|Overall Study|Withdrawal by Subject|2
7634085|NCT03462719|12048009|FG001|Overall Study|Withdrawal by Subject|3
7634086|NCT03462719|12048008|FG000|Overall Study|Ongoing|93
7634087|NCT03462719|12048009|FG001|Overall Study|Ongoing|91
7634088|NCT03462641|12048017|FG000|Visit 1|Failed to complete dopaminergic PET scan|1
7634089|NCT03462641|12048018|FG001|Visit 1|Failed to complete dopaminergic PET scan|0
7634090|NCT03462641|12048017|FG000|Visit 2|Withdrawal by Subject|0
7634091|NCT03462641|12048018|FG001|Visit 2|Withdrawal by Subject|1
7634092|NCT03462563|12048028|FG000|Overall Study|Death|1
7634093|NCT03462563|12048029|FG001|Overall Study|Death|1
7634094|NCT03462563|12048028|FG000|Overall Study|Termination of study|2
7634095|NCT03462563|12048029|FG001|Overall Study|Termination of study|1
7634096|NCT03462563|12048028|FG000|Overall Study|Adverse Event|1
7634097|NCT03462563|12048029|FG001|Overall Study|Adverse Event|3
7634098|NCT03462563|12048028|FG000|Overall Study|Unspecified reason|10
7634099|NCT03462563|12048029|FG001|Overall Study|Unspecified reason|12
7634100|NCT03462563|12048028|FG000|Overall Study|Physician Decision|1
7634101|NCT03462563|12048029|FG001|Overall Study|Physician Decision|0
7634102|NCT03461289|12048035|FG000|Overall Study|Death|1
7634103|NCT03461003|12048041|FG000|Overall Study|Lost to Follow-up|2
7634104|NCT03461003|12048042|FG001|Overall Study|Lost to Follow-up|2
7634105|NCT03461003|12048041|FG000|Overall Study|Withdrawal by Subject|3
7634106|NCT03461003|12048042|FG001|Overall Study|Withdrawal by Subject|1
7634107|NCT03459443|12048048|FG000|Overall Study|Lack of Efficacy|3
7634108|NCT03459443|12048048|FG000|Overall Study|Adverse Event|1
7634109|NCT03459443|12048048|FG000|Overall Study|Sponsor's decision to close the study|18
7634110|NCT03452540|12048061|FG000|Overall Study|Adverse Event|1
7634111|NCT03452540|12048061|FG000|Overall Study|Withdrawal by Subject|1
7634112|NCT03452540|12048061|FG000|Overall Study|Other SAE and AE|2
7634113|NCT03449199|12048068|FG000|Overall Study|Lost to Follow-up|1
7634114|NCT03449199|12048069|FG001|Overall Study|Lost to Follow-up|1
7634115|NCT03449199|12048070|FG002|Overall Study|Lost to Follow-up|0
7634116|NCT03449199|12048068|FG000|Overall Study|Protocol Deviation|0
7634117|NCT03449199|12048069|FG001|Overall Study|Protocol Deviation|0
7634118|NCT03449199|12048070|FG002|Overall Study|Protocol Deviation|1
7634119|NCT03449199|12048068|FG000|Overall Study|Withdrawal by Subject|0
7634120|NCT03449199|12048069|FG001|Overall Study|Withdrawal by Subject|0
7634121|NCT03449199|12048070|FG002|Overall Study|Withdrawal by Subject|1
7634122|NCT03442985|12048084|FG000|Overall Study|Sponsor Request|55
7634123|NCT03442985|12048085|FG001|Overall Study|Sponsor Request|60
7634124|NCT03442985|12048086|FG002|Overall Study|Sponsor Request|54
7634125|NCT03442985|12048084|FG000|Overall Study|Lost to Follow-up|5
7634126|NCT03442985|12048085|FG001|Overall Study|Lost to Follow-up|2
7634127|NCT03442985|12048086|FG002|Overall Study|Lost to Follow-up|7
7634128|NCT03442985|12048084|FG000|Overall Study|Withdrawal by Subject|2
7634129|NCT03442985|12048085|FG001|Overall Study|Withdrawal by Subject|3
7634130|NCT03442985|12048086|FG002|Overall Study|Withdrawal by Subject|4
7634131|NCT03442985|12048084|FG000|Overall Study|Adverse Event|0
7634132|NCT03442985|12048085|FG001|Overall Study|Adverse Event|1
7634133|NCT03442985|12048086|FG002|Overall Study|Adverse Event|0
7634134|NCT03442764|12048099|FG000|Overall Study|Adverse Event|1
7634135|NCT03442764|12048100|FG001|Overall Study|Adverse Event|0
7634136|NCT03442764|12048101|FG002|Overall Study|Adverse Event|0
7634137|NCT03438396|12048110|FG000|Overall Study|Ongoing on study treatment|4
7634138|NCT03438396|12048110|FG000|Overall Study|Ongoing in survival follow-up|33
7634139|NCT03438396|12048110|FG000|Overall Study|Withdrawal by Subject|4
7634140|NCT03438396|12048110|FG000|Overall Study|Lost to Follow-up|2
7634141|NCT03438396|12048110|FG000|Overall Study|Death|58
7634142|NCT03438396|12048110|FG000|Overall Study|Not treated|1
7634143|NCT03435081|12048124|FG000|Week 0 to Week 16|Lack of Efficacy|6
7634144|NCT03435081|12048125|FG001|Week 0 to Week 16|Lack of Efficacy|5
7634145|NCT03435081|12048126|FG002|Week 0 to Week 16|Lack of Efficacy|0
7634146|NCT03435081|12048124|FG000|Week 0 to Week 16|Adverse Event|2
7634147|NCT03435081|12048125|FG001|Week 0 to Week 16|Adverse Event|2
7634148|NCT03435081|12048126|FG002|Week 0 to Week 16|Adverse Event|2
7634149|NCT03435081|12048124|FG000|Week 0 to Week 16|Withdrawal by Subject|8
7634150|NCT03435081|12048125|FG001|Week 0 to Week 16|Withdrawal by Subject|7
7634151|NCT03435081|12048126|FG002|Week 0 to Week 16|Withdrawal by Subject|10
7634152|NCT03435081|12048124|FG000|Week 0 to Week 16|Lost to Follow-up|3
7634153|NCT03435081|12048125|FG001|Week 0 to Week 16|Lost to Follow-up|1
7634154|NCT03435081|12048126|FG002|Week 0 to Week 16|Lost to Follow-up|4
7634155|NCT03435081|12048124|FG000|Week 0 to Week 16|Pregnancy|1
7634156|NCT03435081|12048125|FG001|Week 0 to Week 16|Pregnancy|0
7634157|NCT03435081|12048126|FG002|Week 0 to Week 16|Pregnancy|0
7634158|NCT03435081|12048124|FG000|Week 0 to Week 16|Non-compliance|1
7634159|NCT03435081|12048125|FG001|Week 0 to Week 16|Non-compliance|0
7634160|NCT03435081|12048126|FG002|Week 0 to Week 16|Non-compliance|2
7634161|NCT03435081|12048124|FG000|Week 0 to Week 16|Inadequate Response|0
7634162|NCT03435081|12048125|FG001|Week 0 to Week 16|Inadequate Response|1
7634163|NCT03435081|12048126|FG002|Week 0 to Week 16|Inadequate Response|0
7634164|NCT03435081|12048124|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0
7634165|NCT03435081|12048125|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0
7634166|NCT03435081|12048126|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1
7634167|NCT03435081|12048124|FG000|Week 16 to Week 104|Lack of Efficacy|2
7634168|NCT03435081|12048125|FG001|Week 16 to Week 104|Lack of Efficacy|11
7634169|NCT03435081|12048126|FG002|Week 16 to Week 104|Lack of Efficacy|10
7634170|NCT03435081|12048124|FG000|Week 16 to Week 104|Adverse Event|1
7634171|NCT03435081|12048125|FG001|Week 16 to Week 104|Adverse Event|0
7634172|NCT03435081|12048126|FG002|Week 16 to Week 104|Adverse Event|2
7634173|NCT03435081|12048124|FG000|Week 16 to Week 104|Withdrawal by Subject|0
7634174|NCT03435081|12048125|FG001|Week 16 to Week 104|Withdrawal by Subject|1
7634175|NCT03435081|12048126|FG002|Week 16 to Week 104|Withdrawal by Subject|2
7634176|NCT03435081|12048124|FG000|Week 16 to Week 104|Lost to Follow-up|0
7634177|NCT03435081|12048125|FG001|Week 16 to Week 104|Lost to Follow-up|1
7634178|NCT03435081|12048126|FG002|Week 16 to Week 104|Lost to Follow-up|4
7634179|NCT03435081|12048124|FG000|Week 16 to Week 104|Non--Compliance|0
7634180|NCT03435081|12048125|FG001|Week 16 to Week 104|Non--Compliance|0
7634181|NCT03435081|12048126|FG002|Week 16 to Week 104|Non--Compliance|1
7634182|NCT03434379|12048140|FG000|Global Period|Lost to Follow-up|3
7634183|NCT03434379|12048141|FG001|Global Period|Lost to Follow-up|1
7634184|NCT03434379|12048142|FG002|Global Period|Lost to Follow-up|0
7634185|NCT03434379|12048143|FG003|Global Period|Lost to Follow-up|0
7634186|NCT03434379|12048140|FG000|Global Period|Death|99
7634187|NCT03434379|12048141|FG001|Global Period|Death|179
7634188|NCT03434379|12048142|FG002|Global Period|Death|0
7634189|NCT03434379|12048143|FG003|Global Period|Death|0
7634190|NCT03434379|12048140|FG000|Global Period|Withdrawal by Subject|20
7634191|NCT03434379|12048141|FG001|Global Period|Withdrawal by Subject|20
7634192|NCT03434379|12048142|FG002|Global Period|Withdrawal by Subject|0
7634193|NCT03434379|12048143|FG003|Global Period|Withdrawal by Subject|0
7634194|NCT03434379|12048140|FG000|Global Period|On Study|43
7634195|NCT03434379|12048141|FG001|Global Period|On Study|136
7634196|NCT03434379|12048142|FG002|Global Period|On Study|0
7634197|NCT03434379|12048143|FG003|Global Period|On Study|0
7634198|NCT03434379|12048140|FG000|China Extension Period|Lost to Follow-up|0
7634199|NCT03434379|12048141|FG001|China Extension Period|Lost to Follow-up|0
7634200|NCT03434379|12048142|FG002|China Extension Period|Lost to Follow-up|1
7634201|NCT03434379|12048143|FG003|China Extension Period|Lost to Follow-up|0
7634202|NCT03434379|12048140|FG000|China Extension Period|Death|0
7634203|NCT03434379|12048141|FG001|China Extension Period|Death|0
7634204|NCT03434379|12048142|FG002|China Extension Period|Death|38
7634205|NCT03434379|12048143|FG003|China Extension Period|Death|61
7634206|NCT03434379|12048140|FG000|China Extension Period|Withdrawal by Subject|0
7634207|NCT03434379|12048141|FG001|China Extension Period|Withdrawal by Subject|0
7634208|NCT03434379|12048142|FG002|China Extension Period|Withdrawal by Subject|7
7634209|NCT03434379|12048143|FG003|China Extension Period|Withdrawal by Subject|6
7634210|NCT03434379|12048140|FG000|China Extension Period|On Study|0
7634211|NCT03434379|12048141|FG001|China Extension Period|On Study|0
7634212|NCT03434379|12048142|FG002|China Extension Period|On Study|15
7634213|NCT03434379|12048143|FG003|China Extension Period|On Study|66
7634214|NCT03419364|12048176|FG000|Overall Study|Delivery due to maternal condition|2
7634215|NCT03419364|12048177|FG001|Overall Study|Delivery due to maternal condition|0
7634216|NCT03419364|12048178|FG002|Overall Study|Delivery due to maternal condition|0
7634217|NCT03416374|12048199|FG000|Between Treatment Period I and II|Other|0
7634218|NCT03416374|12048200|FG001|Between Treatment Period I and II|Other|9
7634219|NCT03416374|12048199|FG000|Treatment Period II|Lack of Efficacy|3
7634220|NCT03416374|12048200|FG001|Treatment Period II|Lack of Efficacy|11
7634221|NCT03416374|12048199|FG000|Treatment Period II|Adverse Event|1
7634222|NCT03416374|12048200|FG001|Treatment Period II|Adverse Event|4
7634223|NCT03416374|12048199|FG000|Treatment Period II|Death|0
7634224|NCT03416374|12048200|FG001|Treatment Period II|Death|1
7634225|NCT03416374|12048199|FG000|Treatment Period II|Other|0
7634226|NCT03416374|12048200|FG001|Treatment Period II|Other|2
7634227|NCT03414047|12048213|FG000|Overall Study|Adverse Event|0
7634228|NCT03414047|12048214|FG001|Overall Study|Adverse Event|0
7634229|NCT03414047|12048215|FG002|Overall Study|Adverse Event|1
7634230|NCT03414047|12048216|FG003|Overall Study|Adverse Event|1
7634231|NCT03414047|12048213|FG000|Overall Study|Physician Decision|1
7634232|NCT03414047|12048214|FG001|Overall Study|Physician Decision|0
7634233|NCT03414047|12048215|FG002|Overall Study|Physician Decision|0
7634234|NCT03414047|12048216|FG003|Overall Study|Physician Decision|1
7634235|NCT03414047|12048213|FG000|Overall Study|Withdrawal by Subject|1
7634236|NCT03414047|12048214|FG001|Overall Study|Withdrawal by Subject|0
7634237|NCT03414047|12048215|FG002|Overall Study|Withdrawal by Subject|2
7634238|NCT03414047|12048216|FG003|Overall Study|Withdrawal by Subject|0
7634239|NCT03412604|12048231|FG000|Overall Study|Withdrawal by Subject|1
7634240|NCT03412565|12048239|FG000|Overall Study|Other|0
7634241|NCT03412565|12048240|FG001|Overall Study|Other|0
7634242|NCT03412565|12048241|FG002|Overall Study|Other|0
7634243|NCT03412565|12048242|FG003|Overall Study|Other|3
7634244|NCT03412565|12048239|FG000|Overall Study|Withdrawal by Subject|0
7634245|NCT03412565|12048240|FG001|Overall Study|Withdrawal by Subject|0
7634246|NCT03412565|12048241|FG002|Overall Study|Withdrawal by Subject|1
7634247|NCT03412565|12048242|FG003|Overall Study|Withdrawal by Subject|5
7634248|NCT03412565|12048239|FG000|Overall Study|Physician Decision|0
7634249|NCT03412565|12048240|FG001|Overall Study|Physician Decision|1
7634250|NCT03412565|12048241|FG002|Overall Study|Physician Decision|0
7634251|NCT03412565|12048242|FG003|Overall Study|Physician Decision|1
7634252|NCT03412565|12048239|FG000|Overall Study|Death|1
7634253|NCT03412565|12048240|FG001|Overall Study|Death|2
7634254|NCT03412565|12048241|FG002|Overall Study|Death|2
7634255|NCT03412565|12048242|FG003|Overall Study|Death|4
7634256|NCT03412565|12048239|FG000|Overall Study|Still ongoing|0
7634257|NCT03412565|12048240|FG001|Overall Study|Still ongoing|62
7634258|NCT03412565|12048241|FG002|Overall Study|Still ongoing|59
7634259|NCT03412565|12048242|FG003|Overall Study|Still ongoing|41
7634260|NCT03410693|12048259|FG000|Overall Study|Disc trt: Withdrawal by participant|6
7634261|NCT03410693|12048260|FG001|Overall Study|Disc trt: Withdrawal by participant|4
7634262|NCT03410693|12048259|FG000|Overall Study|Disc trt: Lost to follow up|0
7634263|NCT03410693|12048260|FG001|Overall Study|Disc trt: Lost to follow up|1
7634264|NCT03410693|12048259|FG000|Overall Study|Disc trt: radiological progression|58
7634265|NCT03410693|12048260|FG001|Overall Study|Disc trt: radiological progression|50
7634266|NCT03410693|12048259|FG000|Overall Study|Disc trt: Other|1
7634267|NCT03410693|12048260|FG001|Overall Study|Disc trt: Other|0
7634268|NCT03410693|12048259|FG000|Overall Study|Study drug never administered|1
7634269|NCT03410693|12048260|FG001|Overall Study|Study drug never administered|6
7634270|NCT03410693|12048259|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
7634271|NCT03410693|12048260|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
7634272|NCT03410693|12048259|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
7634273|NCT03410693|12048260|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
7634274|NCT03410693|12048259|FG000|Overall Study|Disc trt: Physician decision|0
7634275|NCT03410693|12048260|FG001|Overall Study|Disc trt: Physician decision|5
7634276|NCT03410693|12048259|FG000|Overall Study|Disc trt: clinical progression|1
7634277|NCT03410693|12048260|FG001|Overall Study|Disc trt: clinical progression|5
7634278|NCT03410693|12048259|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
7634279|NCT03410693|12048260|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
7634280|NCT03406702|12048272|FG000|Overall Study|Missed Day 27 Dosing|1
7634281|NCT03406507|12048290|FG000|Extension Period|Lack of Efficacy|0
7634282|NCT03406507|12048291|FG001|Extension Period|Lack of Efficacy|1
7634283|NCT03406507|12048290|FG000|Extension Period|Ongoing in Extension Period|5
7634284|NCT03406507|12048291|FG001|Extension Period|Ongoing in Extension Period|5
7634285|NCT03394027|12048306|FG000|Overall Study|Ineligible|3
7634286|NCT03394027|12048307|FG001|Overall Study|Ineligible|1
7634287|NCT03394027|12048308|FG002|Overall Study|Ineligible|3
7634288|NCT03394027|12048306|FG000|Overall Study|Participant declined to participate before treatment started|0
7634370|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1
7634289|NCT03394027|12048307|FG001|Overall Study|Participant declined to participate before treatment started|0
7634290|NCT03394027|12048308|FG002|Overall Study|Participant declined to participate before treatment started|1
7634291|NCT03392168|12048361|FG000|Period 2: Cohort 2|Lost to Follow-up|0
7634292|NCT03392168|12048362|FG001|Period 2: Cohort 2|Lost to Follow-up|1
7634293|NCT03392168|12048363|FG002|Period 2: Cohort 2|Lost to Follow-up|1
7634294|NCT03392168|12048364|FG003|Period 2: Cohort 2|Lost to Follow-up|1
7634295|NCT03392168|12048361|FG000|Period 2: Cohort 2|Other|0
7634296|NCT03392168|12048362|FG001|Period 2: Cohort 2|Other|1
7634297|NCT03392168|12048363|FG002|Period 2: Cohort 2|Other|0
7634298|NCT03392168|12048364|FG003|Period 2: Cohort 2|Other|0
7634299|NCT03387735|12048384|FG000|Overall Study|Lost to Follow-up|4
7634300|NCT03387735|12048385|FG001|Overall Study|Lost to Follow-up|8
7634301|NCT03387735|12048384|FG000|Overall Study|Death|4
7634302|NCT03387735|12048385|FG001|Overall Study|Death|8
7634303|NCT03386773|12048407|FG000|Overall Study|Lost to Follow-up|24
7634304|NCT03386773|12048408|FG001|Overall Study|Lost to Follow-up|33
7634305|NCT03386773|12048407|FG000|Overall Study|Withdrawal by Subject|3
7634306|NCT03386773|12048408|FG001|Overall Study|Withdrawal by Subject|2
7634307|NCT03370510|12048437|FG000|Overall Study|COVID-19|2
7634308|NCT03370510|12048438|FG001|Overall Study|COVID-19|0
7634309|NCT03370341|12048446|FG000|Overall Study|Lost to Follow-up|0
7634310|NCT03370341|12048447|FG001|Overall Study|Lost to Follow-up|1
7634311|NCT03364036|12048482|FG000|Overall Study|Adverse Event|1
7634312|NCT03364036|12048482|FG000|Overall Study|Lost to Follow-up|1
7634313|NCT03364036|12048482|FG000|Overall Study|Withdrew Consent|1
7634314|NCT03364036|12048482|FG000|Overall Study|Protocol Non-Compliance|1
7634315|NCT03364036|12048482|FG000|Overall Study|Other|2
7634316|NCT03361306|12048486|FG000|Overall Study|Death|5
7634317|NCT03361306|12048486|FG000|Overall Study|Still On Study (on study treatment)|3
7634318|NCT03361306|12048486|FG000|Overall Study|Still On Study (in follow up)|7
7634319|NCT03358472|12048515|FG000|Overall Study|Death|6
7634320|NCT03358472|12048516|FG001|Overall Study|Death|3
7634321|NCT03358472|12048517|FG002|Overall Study|Death|10
7634322|NCT03358472|12048515|FG000|Overall Study|Physician Decision|0
7634323|NCT03358472|12048516|FG001|Overall Study|Physician Decision|1
7634324|NCT03358472|12048517|FG002|Overall Study|Physician Decision|0
7634325|NCT03358472|12048515|FG000|Overall Study|Withdrawal by Subject|0
7634326|NCT03358472|12048516|FG001|Overall Study|Withdrawal by Subject|0
7634327|NCT03358472|12048517|FG002|Overall Study|Withdrawal by Subject|1
7634328|NCT03358472|12048515|FG000|Overall Study|On-going at clinical cut off date|9
7634329|NCT03358472|12048516|FG001|Overall Study|On-going at clinical cut off date|6
7634330|NCT03358472|12048517|FG002|Overall Study|On-going at clinical cut off date|5
7634331|NCT03350750|12048527|FG000|Overall Study|Death|1
7634332|NCT03350750|12048528|FG001|Overall Study|Death|1
7634333|NCT03346434|12048542|FG000|Overall Study|Randomized in Error|0
7634334|NCT03346434|12048543|FG001|Overall Study|Randomized in Error|0
7634335|NCT03346434|12048544|FG002|Overall Study|Randomized in Error|0
7634336|NCT03346434|12048545|FG003|Overall Study|Randomized in Error|0
7634337|NCT03346434|12048546|FG004|Overall Study|Randomized in Error|1
7634338|NCT03346434|12048547|FG005|Overall Study|Randomized in Error|0
7634339|NCT03346434|12048542|FG000|Overall Study|Withdrawal by Subject|0
7634340|NCT03346434|12048543|FG001|Overall Study|Withdrawal by Subject|0
7634341|NCT03346434|12048544|FG002|Overall Study|Withdrawal by Subject|1
7634342|NCT03346434|12048545|FG003|Overall Study|Withdrawal by Subject|0
7634343|NCT03346434|12048546|FG004|Overall Study|Withdrawal by Subject|1
7634344|NCT03346434|12048547|FG005|Overall Study|Withdrawal by Subject|0
7634345|NCT03346434|12048542|FG000|Overall Study|Lost to Follow-up|0
7634346|NCT03346434|12048543|FG001|Overall Study|Lost to Follow-up|0
7634347|NCT03346434|12048544|FG002|Overall Study|Lost to Follow-up|0
7634348|NCT03346434|12048545|FG003|Overall Study|Lost to Follow-up|0
7634349|NCT03346434|12048546|FG004|Overall Study|Lost to Follow-up|1
7634350|NCT03346434|12048547|FG005|Overall Study|Lost to Follow-up|1
7634351|NCT03346434|12048542|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634352|NCT03346434|12048543|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634353|NCT03346434|12048544|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634354|NCT03346434|12048545|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0
7634355|NCT03346434|12048546|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75
7634356|NCT03346434|12048547|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81
7634357|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5
7634358|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17
7634359|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2
7634360|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634361|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634362|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0
7634363|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8
7634364|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8
7634365|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3
7634366|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634367|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634368|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0
7634369|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634371|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634372|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634373|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634374|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0
7634375|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8
7634376|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4
7634377|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634378|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634379|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634380|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0
7634381|NCT03345836|12048568|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1
7634382|NCT03345836|12048569|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3
7634383|NCT03345836|12048570|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1
7634384|NCT03345836|12048571|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634385|NCT03345836|12048572|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634386|NCT03345836|12048573|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0
7634387|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634388|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634389|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634390|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8
7634391|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5
7634392|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0
7634393|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634394|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634395|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634396|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0
7634397|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5
7634398|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1
7634399|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634400|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634401|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634402|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634403|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0
7634404|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1
7634405|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634406|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634407|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0
7634408|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2
7634409|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6
7634410|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3
7634411|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634412|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634413|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634414|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634415|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1
7634416|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0
7634417|NCT03345836|12048568|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634418|NCT03345836|12048569|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634419|NCT03345836|12048570|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0
7634420|NCT03345836|12048571|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634421|NCT03345836|12048572|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634422|NCT03345836|12048573|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1
7634423|NCT03343054|12048592|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2
7634424|NCT03343054|12048593|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6
7634425|NCT03343054|12048594|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0
7634426|NCT03343054|12048592|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1
7634427|NCT03343054|12048593|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7634428|NCT03343054|12048594|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
7634429|NCT03343054|12048592|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7634430|NCT03343054|12048593|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
7634431|NCT03343054|12048594|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11
7634432|NCT03343054|12048592|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7634433|NCT03343054|12048593|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0
7634434|NCT03343054|12048594|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8
7634435|NCT03342404|12048605|FG000|Overall Study|Withdrawal by Subject|9
7634436|NCT03342404|12048606|FG001|Overall Study|Withdrawal by Subject|10
7634437|NCT03342404|12048605|FG000|Overall Study|Lack of Efficacy|1
7634438|NCT03342404|12048606|FG001|Overall Study|Lack of Efficacy|17
7634439|NCT03342404|12048605|FG000|Overall Study|Adverse Event|3
7634440|NCT03342404|12048606|FG001|Overall Study|Adverse Event|4
7634441|NCT03342404|12048605|FG000|Overall Study|Noncompliance with study drug|1
7634442|NCT03342404|12048606|FG001|Overall Study|Noncompliance with study drug|0
7634443|NCT03342404|12048605|FG000|Overall Study|Other reasons|1
7634444|NCT03342404|12048606|FG001|Overall Study|Other reasons|0
7634445|NCT03338998|12048614|FG000|Treatment Period|Withdrawal by Subject|1
7634446|NCT03338998|12048615|FG001|Treatment Period|Withdrawal by Subject|1
7634447|NCT03338998|12048614|FG000|Treatment Period|Adverse Event|0
7634448|NCT03338998|12048615|FG001|Treatment Period|Adverse Event|2
7634449|NCT03338998|12048614|FG000|Treatment Period|Protocol deviation|1
7634450|NCT03338998|12048615|FG001|Treatment Period|Protocol deviation|0
7634451|NCT03338998|12048614|FG000|Treatment Period|Physician Decision|2
7634452|NCT03338998|12048615|FG001|Treatment Period|Physician Decision|0
7634453|NCT03338998|12048614|FG000|Treatment Period|Subject failed swallow test|4
7634454|NCT03338998|12048615|FG001|Treatment Period|Subject failed swallow test|0
7634455|NCT03338998|12048614|FG000|Safety Follow-Up Period|Adverse Event|0
7634456|NCT03338998|12048615|FG001|Safety Follow-Up Period|Adverse Event|1
7634457|NCT03338998|12048614|FG000|Safety Follow-Up Period|Protocol deviation|1
7634458|NCT03338998|12048615|FG001|Safety Follow-Up Period|Protocol deviation|0
7634459|NCT03338998|12048614|FG000|Safety Follow-Up Period|Lost to Follow-up|1
7634460|NCT03338998|12048615|FG001|Safety Follow-Up Period|Lost to Follow-up|0
7634461|NCT03338972|12048626|FG000|Overall Study|Death|1
7634462|NCT03338972|12048627|FG001|Overall Study|Death|1
7634463|NCT03338972|12048628|FG002|Overall Study|Death|0
7634464|NCT03338972|12048629|FG003|Overall Study|Death|0
7634465|NCT03338972|12048626|FG000|Overall Study|Withdrawal by Subject|1
7634466|NCT03338972|12048627|FG001|Overall Study|Withdrawal by Subject|0
7634467|NCT03338972|12048628|FG002|Overall Study|Withdrawal by Subject|0
7634468|NCT03338972|12048629|FG003|Overall Study|Withdrawal by Subject|0
7634469|NCT03338790|12048643|FG000|Overall Study|Disease Progression|65
7634470|NCT03338790|12048644|FG001|Overall Study|Disease Progression|43
7634471|NCT03338790|12048645|FG002|Overall Study|Disease Progression|50
7634472|NCT03338790|12048646|FG003|Overall Study|Disease Progression|37
7634473|NCT03338790|12048643|FG000|Overall Study|Study Drug Toxicity|9
7634474|NCT03338790|12048644|FG001|Overall Study|Study Drug Toxicity|8
7634475|NCT03338790|12048645|FG002|Overall Study|Study Drug Toxicity|15
7634476|NCT03338790|12048646|FG003|Overall Study|Study Drug Toxicity|0
7634477|NCT03338790|12048643|FG000|Overall Study|Death|1
7634478|NCT03338790|12048644|FG001|Overall Study|Death|1
7634479|NCT03338790|12048645|FG002|Overall Study|Death|1
7634480|NCT03338790|12048646|FG003|Overall Study|Death|0
7634481|NCT03338790|12048643|FG000|Overall Study|Adverse Event unrelated to Study Drug|4
7634482|NCT03338790|12048644|FG001|Overall Study|Adverse Event unrelated to Study Drug|4
7634483|NCT03338790|12048645|FG002|Overall Study|Adverse Event unrelated to Study Drug|6
7634484|NCT03338790|12048646|FG003|Overall Study|Adverse Event unrelated to Study Drug|4
7634485|NCT03338790|12048643|FG000|Overall Study|Participant request to discontinue study treatment|3
7634486|NCT03338790|12048644|FG001|Overall Study|Participant request to discontinue study treatment|3
7634487|NCT03338790|12048645|FG002|Overall Study|Participant request to discontinue study treatment|2
7634488|NCT03338790|12048646|FG003|Overall Study|Participant request to discontinue study treatment|1
7634489|NCT03338790|12048643|FG000|Overall Study|Poor/non-compliance|0
7634490|NCT03338790|12048644|FG001|Overall Study|Poor/non-compliance|1
7634491|NCT03338790|12048645|FG002|Overall Study|Poor/non-compliance|0
7634492|NCT03338790|12048646|FG003|Overall Study|Poor/non-compliance|0
7634493|NCT03338790|12048643|FG000|Overall Study|Participant withdrew consent|1
7634494|NCT03338790|12048644|FG001|Overall Study|Participant withdrew consent|0
7634495|NCT03338790|12048645|FG002|Overall Study|Participant withdrew consent|1
7634496|NCT03338790|12048646|FG003|Overall Study|Participant withdrew consent|1
7634497|NCT03338790|12048643|FG000|Overall Study|Other reasons|0
7634498|NCT03338790|12048644|FG001|Overall Study|Other reasons|5
7634499|NCT03338790|12048645|FG002|Overall Study|Other reasons|0
7634500|NCT03338790|12048646|FG003|Overall Study|Other reasons|2
7634501|NCT03338790|12048643|FG000|Overall Study|Not reported|0
7634502|NCT03338790|12048644|FG001|Overall Study|Not reported|0
7634503|NCT03338790|12048645|FG002|Overall Study|Not reported|1
7634504|NCT03338790|12048646|FG003|Overall Study|Not reported|0
7634505|NCT03338790|12048643|FG000|Overall Study|Completed treatment period|1
7634506|NCT03338790|12048644|FG001|Overall Study|Completed treatment period|2
7634507|NCT03338790|12048645|FG002|Overall Study|Completed treatment period|0
7634508|NCT03338790|12048646|FG003|Overall Study|Completed treatment period|0
7634509|NCT03333837|12048703|FG000|Overall Study|Adverse Event|2
7634510|NCT03333837|12048704|FG001|Overall Study|Adverse Event|1
7634511|NCT03333837|12048705|FG002|Overall Study|Adverse Event|1
7634512|NCT03333837|12048706|FG003|Overall Study|Adverse Event|1
7634513|NCT03333837|12048707|FG004|Overall Study|Adverse Event|0
7634514|NCT03333837|12048703|FG000|Overall Study|Caregiver withdrew|0
7634515|NCT03333837|12048704|FG001|Overall Study|Caregiver withdrew|2
7634516|NCT03333837|12048705|FG002|Overall Study|Caregiver withdrew|1
7634517|NCT03333837|12048706|FG003|Overall Study|Caregiver withdrew|0
7634518|NCT03333837|12048707|FG004|Overall Study|Caregiver withdrew|0
7634519|NCT03333837|12048703|FG000|Overall Study|Withdrawal by Subject|0
7634520|NCT03333837|12048704|FG001|Overall Study|Withdrawal by Subject|0
7634521|NCT03333837|12048705|FG002|Overall Study|Withdrawal by Subject|1
7634522|NCT03333837|12048706|FG003|Overall Study|Withdrawal by Subject|1
7634523|NCT03333837|12048707|FG004|Overall Study|Withdrawal by Subject|3
7634524|NCT03333837|12048703|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634525|NCT03333837|12048704|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634526|NCT03333837|12048705|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2
7634527|NCT03333837|12048706|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634528|NCT03333837|12048707|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0
7634529|NCT03332095|12048736|FG000|Overall Study|Lost to Follow-up|1
7634530|NCT03332095|12048737|FG001|Overall Study|Lost to Follow-up|0
7634531|NCT03332095|12048736|FG000|Overall Study|Pregnancy|0
7634532|NCT03332095|12048737|FG001|Overall Study|Pregnancy|1
7634533|NCT03330847|12048746|FG000|Overall Study|Patients ongoing study|62
7634534|NCT03330847|12048747|FG001|Overall Study|Patients ongoing study|65
7634535|NCT03330847|12048748|FG002|Overall Study|Patients ongoing study|15
7634536|NCT03325712|12048775|FG000|Overall Study|Protocol Violation|0
7634537|NCT03325712|12048776|FG001|Overall Study|Protocol Violation|0
7634538|NCT03325712|12048777|FG002|Overall Study|Protocol Violation|0
7634539|NCT03325712|12048778|FG003|Overall Study|Protocol Violation|0
7634540|NCT03325712|12048779|FG004|Overall Study|Protocol Violation|1
7634541|NCT03325712|12048780|FG005|Overall Study|Protocol Violation|0
7634542|NCT03325712|12048781|FG006|Overall Study|Protocol Violation|0
7634543|NCT03325712|12048782|FG007|Overall Study|Protocol Violation|0
7634544|NCT03325712|12048775|FG000|Overall Study|Adverse Event|0
7634545|NCT03325712|12048776|FG001|Overall Study|Adverse Event|0
7634546|NCT03325712|12048777|FG002|Overall Study|Adverse Event|0
7634547|NCT03325712|12048778|FG003|Overall Study|Adverse Event|0
7634548|NCT03325712|12048779|FG004|Overall Study|Adverse Event|1
7634549|NCT03325712|12048780|FG005|Overall Study|Adverse Event|0
7634550|NCT03325712|12048781|FG006|Overall Study|Adverse Event|0
7634551|NCT03325712|12048782|FG007|Overall Study|Adverse Event|0
7634552|NCT03325166|12048810|FG000|Overall Study|Adverse Event|1
7634553|NCT03323034|12048819|FG000|Overall Study|Lack of Efficacy|5
7634554|NCT03323034|12048820|FG001|Overall Study|Lack of Efficacy|5
7634555|NCT03323034|12048821|FG002|Overall Study|Lack of Efficacy|6
7634556|NCT03323034|12048822|FG003|Overall Study|Lack of Efficacy|5
7634557|NCT03323034|12048823|FG004|Overall Study|Lack of Efficacy|5
7634558|NCT03323034|12048819|FG000|Overall Study|Physician Decision|0
7634559|NCT03323034|12048820|FG001|Overall Study|Physician Decision|0
7634560|NCT03323034|12048821|FG002|Overall Study|Physician Decision|0
7634561|NCT03323034|12048822|FG003|Overall Study|Physician Decision|0
7634562|NCT03323034|12048823|FG004|Overall Study|Physician Decision|1
7634563|NCT03323034|12048819|FG000|Overall Study|Withdrawal by Subject|1
7634564|NCT03323034|12048820|FG001|Overall Study|Withdrawal by Subject|1
7634565|NCT03323034|12048821|FG002|Overall Study|Withdrawal by Subject|0
7634566|NCT03323034|12048822|FG003|Overall Study|Withdrawal by Subject|1
7634567|NCT03323034|12048823|FG004|Overall Study|Withdrawal by Subject|0
7634568|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2
7634569|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2
7634570|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9
7634571|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3
7634572|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1
7634573|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3
7634574|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7
7634575|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8
7634576|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1
7634577|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0
7634578|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3
7634579|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6
7634580|NCT03321526|12048838|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1
7634581|NCT03321526|12048839|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4
7634582|NCT03321526|12048838|FG000|Follow-up Phase (2 Weeks)|Other|24
7634583|NCT03321526|12048839|FG001|Follow-up Phase (2 Weeks)|Other|24
7634584|NCT03320824|12048853|FG000|Overall Study|Withdrawal by Subject|8
7634585|NCT03320824|12048854|FG001|Overall Study|Withdrawal by Subject|1
7634586|NCT03320824|12048853|FG000|Overall Study|Lost to Follow-up|10
7634587|NCT03320824|12048854|FG001|Overall Study|Lost to Follow-up|1
7634588|NCT03320824|12048853|FG000|Overall Study|moved out of state|0
7634589|NCT03320824|12048854|FG001|Overall Study|moved out of state|1
7634590|NCT03320824|12048853|FG000|Overall Study|could not complete final visit|0
7634591|NCT03320824|12048854|FG001|Overall Study|could not complete final visit|1
7634592|NCT03319732|12048873|FG000|Overall Study|Adverse Event|40
7634593|NCT03319732|12048873|FG000|Overall Study|Withdrawal by Subject|50
7634594|NCT03319732|12048873|FG000|Overall Study|MS relapse|10
7634595|NCT03319732|12048873|FG000|Overall Study|reason not specified|5
7634596|NCT03318861|12048883|FG000|Overall Study|Death|1
7634597|NCT03318861|12048884|FG001|Overall Study|Death|2
7634598|NCT03318861|12048885|FG002|Overall Study|Death|2
7634599|NCT03318861|12048886|FG003|Overall Study|Death|1
7634600|NCT03318861|12048887|FG004|Overall Study|Death|1
7634601|NCT03318861|12048883|FG000|Overall Study|Still on Study|2
7634602|NCT03318861|12048884|FG001|Overall Study|Still on Study|1
7634603|NCT03318861|12048885|FG002|Overall Study|Still on Study|1
7634604|NCT03318861|12048886|FG003|Overall Study|Still on Study|2
7634605|NCT03318861|12048887|FG004|Overall Study|Still on Study|1
7634606|NCT03318861|12048883|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7634607|NCT03318861|12048884|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634608|NCT03318861|12048885|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
7634609|NCT03318861|12048886|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634610|NCT03318861|12048887|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
7634611|NCT03315130|12048911|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0
7634612|NCT03315130|12048912|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1
7634613|NCT03315130|12048913|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0
7634614|NCT03315130|12048914|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0
7634615|NCT03315130|12048911|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0
7634616|NCT03315130|12048912|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1
7634617|NCT03315130|12048913|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0
7634618|NCT03315130|12048914|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0
7634619|NCT03315130|12048911|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1
7634620|NCT03315130|12048912|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634621|NCT03315130|12048913|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634622|NCT03315130|12048914|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0
7634623|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634624|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1
7634625|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634626|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0
7634627|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634628|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1
7634629|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634630|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0
7634631|NCT03315130|12048911|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7634632|NCT03315130|12048912|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2
7634633|NCT03315130|12048913|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0
7634634|NCT03315130|12048914|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1
7634635|NCT03314857|12048934|FG000|Overall Study|Death|4
7634636|NCT03314857|12048934|FG000|Overall Study|Physician Decision|1
7634637|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3
7634638|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3
7634639|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2
7634640|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0
7634641|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0
7634642|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11
7634643|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16
7634644|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1
7634645|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0
7634646|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0
7634647|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634648|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1
7634649|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634650|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634651|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0
7634652|NCT03308942|12048943|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3
7634653|NCT03308942|12048944|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1
7634654|NCT03308942|12048945|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634655|NCT03308942|12048946|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634656|NCT03308942|12048947|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0
7634657|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634658|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634659|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634660|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3
7634661|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0
7634662|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634663|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634664|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634665|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6
7634666|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0
7634667|NCT03308942|12048943|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634668|NCT03308942|12048944|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634669|NCT03308942|12048945|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634670|NCT03308942|12048946|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3
7634671|NCT03308942|12048947|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0
7634672|NCT03308786|12048960|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9
7634673|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Disease progression|2
7634674|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Disease progression|0
7634675|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Disease progression|0
7634676|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Disease progression|0
7634677|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Disease progression|0
7634678|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Disease progression|0
7634679|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Disease progression|0
7634680|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Disease progression|0
7634681|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Disease progression|0
7634682|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Disease progression|0
7634683|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Disease progression|0
7634684|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7
7634685|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1
7634686|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634687|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634688|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634689|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634690|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634691|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634692|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634693|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634694|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0
7634695|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Death|4
7634696|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Death|4
7634697|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Death|0
7634698|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Death|0
7634699|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Death|0
7634700|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Death|0
7634701|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Death|0
7634702|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Death|0
7634703|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Death|0
7634704|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Death|0
7634705|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Death|0
7634706|NCT03307785|12048976|FG000|Part A: Up to 28.5 Months|Physician Decision|3
7634707|NCT03307785|12048977|FG001|Part A: Up to 28.5 Months|Physician Decision|1
7634708|NCT03307785|12048978|FG002|Part A: Up to 28.5 Months|Physician Decision|0
7634709|NCT03307785|12048979|FG003|Part A: Up to 28.5 Months|Physician Decision|0
7634710|NCT03307785|12048980|FG004|Part A: Up to 28.5 Months|Physician Decision|0
7634711|NCT03307785|12048981|FG005|Part A: Up to 28.5 Months|Physician Decision|0
7634712|NCT03307785|12048982|FG006|Part A: Up to 28.5 Months|Physician Decision|0
7634713|NCT03307785|12048983|FG007|Part A: Up to 28.5 Months|Physician Decision|0
7634714|NCT03307785|12048984|FG008|Part A: Up to 28.5 Months|Physician Decision|0
7634715|NCT03307785|12048985|FG009|Part A: Up to 28.5 Months|Physician Decision|0
7634716|NCT03307785|12048986|FG010|Part A: Up to 28.5 Months|Physician Decision|0
7634717|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Disease progression|0
7634718|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Disease progression|0
7634719|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Disease progression|1
7634720|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Disease progression|0
7634721|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Disease progression|0
7634722|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Disease progression|0
7634723|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Disease progression|0
7634724|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Disease progression|0
7634725|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Disease progression|0
7634726|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Disease progression|0
7634727|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Disease progression|0
7634728|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Physician Decision|0
7634729|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Physician Decision|0
7634730|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Physician Decision|1
7634731|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Physician Decision|0
7634732|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Physician Decision|0
7634733|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Physician Decision|0
7634734|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Physician Decision|0
7634735|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Physician Decision|0
7634736|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Physician Decision|0
7634737|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Physician Decision|0
7634738|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Physician Decision|0
7634739|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Death|0
7634740|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Death|0
7634741|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Death|7
7634742|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Death|0
7634743|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Death|0
7634744|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Death|0
7634745|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Death|0
7634746|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Death|0
7634747|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Death|0
7634748|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Death|0
7634749|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Death|0
7634750|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634751|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634752|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1
7634753|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634754|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634755|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634756|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634757|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634758|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634759|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634760|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0
7634761|NCT03307785|12048976|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634762|NCT03307785|12048977|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634763|NCT03307785|12048978|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
7634764|NCT03307785|12048979|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634765|NCT03307785|12048980|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634766|NCT03307785|12048981|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634767|NCT03307785|12048982|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634768|NCT03307785|12048983|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634769|NCT03307785|12048984|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634770|NCT03307785|12048985|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634771|NCT03307785|12048986|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
7634772|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Disease progression|0
7634773|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Disease progression|0
7634774|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Disease progression|0
7634775|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Disease progression|0
7634776|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Disease progression|1
7634777|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Disease progression|0
7634778|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Disease progression|0
7634779|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Disease progression|0
7634780|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Disease progression|0
7634781|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Disease progression|0
7634782|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Disease progression|0
7634783|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Physician Decision|0
7634784|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Physician Decision|0
7634785|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Physician Decision|0
7634786|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Physician Decision|3
7634787|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Physician Decision|1
7634788|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Physician Decision|0
7634789|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Physician Decision|0
7634790|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Physician Decision|0
7634791|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Physician Decision|0
7634792|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Physician Decision|0
7634793|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Physician Decision|0
7634794|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Death|0
7634795|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Death|0
7634796|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Death|0
7634797|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Death|1
7634798|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Death|4
7634799|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Death|0
7634800|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Death|0
7634801|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Death|0
7634802|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Death|0
7634803|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Death|0
7634804|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Death|0
7634805|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634806|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634807|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634808|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1
7634809|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634810|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634811|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634812|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634813|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634814|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634815|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0
7634816|NCT03307785|12048976|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634817|NCT03307785|12048977|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634818|NCT03307785|12048978|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634819|NCT03307785|12048979|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7634820|NCT03307785|12048980|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
7634821|NCT03307785|12048981|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634822|NCT03307785|12048982|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634823|NCT03307785|12048983|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634824|NCT03307785|12048984|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634825|NCT03307785|12048985|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634826|NCT03307785|12048986|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
7634827|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Physician Decision|0
7634828|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Physician Decision|0
7634829|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Physician Decision|0
7634830|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Physician Decision|0
7634831|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Physician Decision|0
7634832|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Physician Decision|1
7634833|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Physician Decision|0
7634834|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Physician Decision|0
7634835|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Physician Decision|0
7634836|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Physician Decision|0
7634837|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Physician Decision|0
7634838|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Death|0
7634839|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Death|0
7634840|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Death|0
7634841|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Death|0
7634842|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Death|0
7634843|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Death|1
7634844|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Death|0
7634845|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Death|0
7634846|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Death|0
7634847|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Death|0
7634848|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Death|0
7634849|NCT03307785|12048976|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634850|NCT03307785|12048977|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634851|NCT03307785|12048978|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634852|NCT03307785|12048979|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634853|NCT03307785|12048980|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634854|NCT03307785|12048981|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1
7634855|NCT03307785|12048982|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634856|NCT03307785|12048983|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634857|NCT03307785|12048984|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634858|NCT03307785|12048985|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634859|NCT03307785|12048986|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0
7634860|NCT03307785|12048976|FG000|Part E: Up to 4.4 Months|Death|0
7634861|NCT03307785|12048977|FG001|Part E: Up to 4.4 Months|Death|0
7634862|NCT03307785|12048978|FG002|Part E: Up to 4.4 Months|Death|0
7634863|NCT03307785|12048979|FG003|Part E: Up to 4.4 Months|Death|0
7634864|NCT03307785|12048980|FG004|Part E: Up to 4.4 Months|Death|0
7634865|NCT03307785|12048981|FG005|Part E: Up to 4.4 Months|Death|0
7634866|NCT03307785|12048982|FG006|Part E: Up to 4.4 Months|Death|1
7634867|NCT03307785|12048983|FG007|Part E: Up to 4.4 Months|Death|0
7634868|NCT03307785|12048984|FG008|Part E: Up to 4.4 Months|Death|0
7634869|NCT03307785|12048985|FG009|Part E: Up to 4.4 Months|Death|0
7634870|NCT03307785|12048986|FG010|Part E: Up to 4.4 Months|Death|0
7634871|NCT03307785|12048976|FG000|Part E: Up to 4.4 Months|Physician Decision|0
7634872|NCT03307785|12048977|FG001|Part E: Up to 4.4 Months|Physician Decision|0
7634873|NCT03307785|12048978|FG002|Part E: Up to 4.4 Months|Physician Decision|0
7634874|NCT03307785|12048979|FG003|Part E: Up to 4.4 Months|Physician Decision|0
7634875|NCT03307785|12048980|FG004|Part E: Up to 4.4 Months|Physician Decision|0
7634876|NCT03307785|12048981|FG005|Part E: Up to 4.4 Months|Physician Decision|0
7634877|NCT03307785|12048982|FG006|Part E: Up to 4.4 Months|Physician Decision|1
7634878|NCT03307785|12048983|FG007|Part E: Up to 4.4 Months|Physician Decision|0
7634879|NCT03307785|12048984|FG008|Part E: Up to 4.4 Months|Physician Decision|0
7634880|NCT03307785|12048985|FG009|Part E: Up to 4.4 Months|Physician Decision|0
7634881|NCT03307785|12048986|FG010|Part E: Up to 4.4 Months|Physician Decision|0
7634882|NCT03307785|12048976|FG000|Part F: Up to 3.5 Months|Physician Decision|0
7634883|NCT03307785|12048977|FG001|Part F: Up to 3.5 Months|Physician Decision|0
7634884|NCT03307785|12048978|FG002|Part F: Up to 3.5 Months|Physician Decision|0
7634885|NCT03307785|12048979|FG003|Part F: Up to 3.5 Months|Physician Decision|0
7634886|NCT03307785|12048980|FG004|Part F: Up to 3.5 Months|Physician Decision|0
7634887|NCT03307785|12048981|FG005|Part F: Up to 3.5 Months|Physician Decision|0
7634888|NCT03307785|12048982|FG006|Part F: Up to 3.5 Months|Physician Decision|0
7634889|NCT03307785|12048983|FG007|Part F: Up to 3.5 Months|Physician Decision|1
7634890|NCT03307785|12048984|FG008|Part F: Up to 3.5 Months|Physician Decision|0
7634891|NCT03307785|12048985|FG009|Part F: Up to 3.5 Months|Physician Decision|0
7634892|NCT03307785|12048986|FG010|Part F: Up to 3.5 Months|Physician Decision|0
7634893|NCT03306277|12049007|FG000|Overall Study|Death|1
7634894|NCT03306277|12049007|FG000|Overall Study|Adverse Event|1
7634895|NCT03306277|12049007|FG000|Overall Study|Withdrawal by Subject|1
7634896|NCT03299049|12049044|FG000|Overall Study|On-going|486
7634897|NCT03299049|12049045|FG001|Overall Study|On-going|481
7634898|NCT03299049|12049044|FG000|Overall Study|Withdrawal by Subject|6
7634899|NCT03299049|12049045|FG001|Overall Study|Withdrawal by Subject|21
7634900|NCT03299049|12049044|FG000|Overall Study|Physician Decision|5
7634901|NCT03299049|12049045|FG001|Overall Study|Physician Decision|1
7634902|NCT03299049|12049044|FG000|Overall Study|Lost to Follow-up|2
7634903|NCT03299049|12049045|FG001|Overall Study|Lost to Follow-up|0
7634904|NCT03299049|12049044|FG000|Overall Study|Pregnancy|1
7634905|NCT03299049|12049045|FG001|Overall Study|Pregnancy|3
7634906|NCT03299049|12049044|FG000|Overall Study|Protocol Violation|1
7634907|NCT03299049|12049045|FG001|Overall Study|Protocol Violation|1
7634908|NCT03299049|12049044|FG000|Overall Study|Lack of Efficacy|9
7634909|NCT03299049|12049045|FG001|Overall Study|Lack of Efficacy|3
7634910|NCT03299049|12049044|FG000|Overall Study|Adverse Event|12
7634911|NCT03299049|12049045|FG001|Overall Study|Adverse Event|13
7634912|NCT03292913|12049086|FG000|Overall Study|Death|9
7634913|NCT03292913|12049087|FG001|Overall Study|Death|3
7634914|NCT03292913|12049086|FG000|Overall Study|Lost to Follow-up|49
7634915|NCT03292913|12049087|FG001|Overall Study|Lost to Follow-up|49
7634916|NCT03292913|12049086|FG000|Overall Study|Withdrawal by Subject|2
7634917|NCT03292913|12049087|FG001|Overall Study|Withdrawal by Subject|0
7634918|NCT03292913|12049086|FG000|Overall Study|Clinic closed due to COVID|22
7634919|NCT03292913|12049087|FG001|Overall Study|Clinic closed due to COVID|36
7634920|NCT03291808|12049097|FG000|Overall Study|Lost to Follow-up|6
7634921|NCT03291808|12049097|FG000|Overall Study|Research burden|4
7634922|NCT03290300|12049107|FG000|Overall Study|Lost to Follow-up|3
7634923|NCT03287089|12049137|FG000|Overall Study|Lost to Follow-up|0
7634924|NCT03287089|12049138|FG001|Overall Study|Lost to Follow-up|2
7634925|NCT03287089|12049137|FG000|Overall Study|Physician Decision|0
7634926|NCT03287089|12049138|FG001|Overall Study|Physician Decision|2
7634927|NCT03287089|12049137|FG000|Overall Study|Withdrawal by Subject|0
7634928|NCT03287089|12049138|FG001|Overall Study|Withdrawal by Subject|2
7634929|NCT03281304|12049150|FG000|Overall Study|Adverse Event|5
7634930|NCT03281304|12049151|FG001|Overall Study|Adverse Event|2
7634931|NCT03281304|12049150|FG000|Overall Study|Lack of Efficacy|2
7634932|NCT03281304|12049151|FG001|Overall Study|Lack of Efficacy|0
7634933|NCT03281304|12049150|FG000|Overall Study|Pregnancy|1
7634934|NCT03281304|12049151|FG001|Overall Study|Pregnancy|0
7634935|NCT03281304|12049150|FG000|Overall Study|Withdrawal by Subject|5
7634936|NCT03281304|12049151|FG001|Overall Study|Withdrawal by Subject|10
7634937|NCT03277105|12049168|FG000|Overall Study|Death|77
7634938|NCT03277105|12049169|FG001|Overall Study|Death|73
7634939|NCT03277105|12049168|FG000|Overall Study|Lost to Follow-up|0
7634940|NCT03277105|12049169|FG001|Overall Study|Lost to Follow-up|3
7634941|NCT03277105|12049168|FG000|Overall Study|Withdrawal by Subject|10
7634942|NCT03277105|12049169|FG001|Overall Study|Withdrawal by Subject|9
7634943|NCT03277105|12049168|FG000|Overall Study|Other|1
7634944|NCT03277105|12049169|FG001|Overall Study|Other|3
7634945|NCT03277105|12049168|FG000|Overall Study|Ongoing|171
7634946|NCT03277105|12049169|FG001|Overall Study|Ongoing|175
7634947|NCT03276728|12049183|FG000|Overall Study|Lost to Follow-up|0
7634948|NCT03276728|12049184|FG001|Overall Study|Lost to Follow-up|0
7634949|NCT03276728|12049185|FG002|Overall Study|Lost to Follow-up|2
7634950|NCT03276728|12049186|FG003|Overall Study|Lost to Follow-up|2
7634951|NCT03276728|12049187|FG004|Overall Study|Lost to Follow-up|0
7634952|NCT03276728|12049188|FG005|Overall Study|Lost to Follow-up|0
7634953|NCT03276728|12049189|FG006|Overall Study|Lost to Follow-up|0
7634954|NCT03276728|12049190|FG007|Overall Study|Lost to Follow-up|0
7634955|NCT03276728|12049183|FG000|Overall Study|Withdrawal by Subject|0
7634956|NCT03276728|12049184|FG001|Overall Study|Withdrawal by Subject|0
7634957|NCT03276728|12049185|FG002|Overall Study|Withdrawal by Subject|0
7634958|NCT03276728|12049186|FG003|Overall Study|Withdrawal by Subject|3
7634959|NCT03276728|12049187|FG004|Overall Study|Withdrawal by Subject|0
7634960|NCT03276728|12049188|FG005|Overall Study|Withdrawal by Subject|0
7634961|NCT03276728|12049189|FG006|Overall Study|Withdrawal by Subject|0
7634962|NCT03276728|12049190|FG007|Overall Study|Withdrawal by Subject|0
7634963|NCT03276728|12049183|FG000|Overall Study|Decision by sponsor|0
7634964|NCT03276728|12049184|FG001|Overall Study|Decision by sponsor|0
7634965|NCT03276728|12049185|FG002|Overall Study|Decision by sponsor|0
7634966|NCT03276728|12049186|FG003|Overall Study|Decision by sponsor|0
7634967|NCT03276728|12049187|FG004|Overall Study|Decision by sponsor|1
7634968|NCT03276728|12049188|FG005|Overall Study|Decision by sponsor|0
7634969|NCT03276728|12049189|FG006|Overall Study|Decision by sponsor|2
7634970|NCT03276728|12049190|FG007|Overall Study|Decision by sponsor|1
7634971|NCT03274466|12049212|FG000|Overall Study|Withdrawal by Subject|7
7634972|NCT03274466|12049213|FG001|Overall Study|Withdrawal by Subject|3
7634973|NCT03274466|12049212|FG000|Overall Study|Protocol Specified Withdrawal|5
7634974|NCT03274466|12049213|FG001|Overall Study|Protocol Specified Withdrawal|11
7634975|NCT03274466|12049212|FG000|Overall Study|Lost to Follow-up|5
7634976|NCT03274466|12049213|FG001|Overall Study|Lost to Follow-up|7
7634977|NCT03274466|12049212|FG000|Overall Study|Subject Non-compliance|0
7634978|NCT03274466|12049213|FG001|Overall Study|Subject Non-compliance|1
7634979|NCT03274466|12049212|FG000|Overall Study|Adverse Event|3
7634980|NCT03274466|12049213|FG001|Overall Study|Adverse Event|3
7634981|NCT03274466|12049212|FG000|Overall Study|Physician Decision|0
7634982|NCT03274466|12049213|FG001|Overall Study|Physician Decision|1
7634983|NCT03274466|12049212|FG000|Overall Study|Protocol Violation|3
7634984|NCT03274466|12049213|FG001|Overall Study|Protocol Violation|3
7634985|NCT03273907|12049219|FG000|Overall Study|Death|1
7634986|NCT03273907|12049219|FG000|Overall Study|Lost to Follow-up|4
7634987|NCT03273907|12049219|FG000|Overall Study|Withdrawal by Subject|2
7634988|NCT03273907|12049219|FG000|Overall Study|COVID 19|2
7634989|NCT03273153|12049227|FG000|Overall Study|Adverse Event|1
7634990|NCT03273153|12049228|FG001|Overall Study|Adverse Event|2
7634991|NCT03273153|12049227|FG000|Overall Study|Missing|0
7634992|NCT03273153|12049228|FG001|Overall Study|Missing|2
7634993|NCT03273153|12049227|FG000|Overall Study|Other|3
7634994|NCT03273153|12049228|FG001|Overall Study|Other|2
7634995|NCT03273153|12049227|FG000|Overall Study|Symptomatic Deterioration|0
7634996|NCT03273153|12049228|FG001|Overall Study|Symptomatic Deterioration|1
7634997|NCT03273153|12049227|FG000|Overall Study|Progressive Disease|6
7634998|NCT03273153|12049228|FG001|Overall Study|Progressive Disease|5
7634999|NCT03273153|12049227|FG000|Overall Study|Physician Decision|1
7635000|NCT03273153|12049228|FG001|Overall Study|Physician Decision|3
7635001|NCT03273153|12049227|FG000|Overall Study|Study Terminated by Sponsor|112
7635002|NCT03273153|12049228|FG001|Overall Study|Study Terminated by Sponsor|102
7635003|NCT03273153|12049227|FG000|Overall Study|Withdrawal by Subject|26
7635004|NCT03273153|12049228|FG001|Overall Study|Withdrawal by Subject|25
7635005|NCT03273153|12049227|FG000|Overall Study|Protocol Deviation|3
7635006|NCT03273153|12049228|FG001|Overall Study|Protocol Deviation|0
7635007|NCT03273153|12049227|FG000|Overall Study|Lost to Follow-up|6
7635008|NCT03273153|12049228|FG001|Overall Study|Lost to Follow-up|11
7635009|NCT03273153|12049227|FG000|Overall Study|Death|66
7635010|NCT03273153|12049228|FG001|Overall Study|Death|69
7635011|NCT03268954|12049237|FG000|Overall Study|Ongoing|23
7635012|NCT03268954|12049238|FG001|Overall Study|Ongoing|31
7635013|NCT03268954|12049237|FG000|Overall Study|Adverse Event|53
7635014|NCT03268954|12049238|FG001|Overall Study|Adverse Event|62
7635015|NCT03268954|12049237|FG000|Overall Study|Withdrawal by Subject|25
7635016|NCT03268954|12049238|FG001|Overall Study|Withdrawal by Subject|16
7635017|NCT03268954|12049237|FG000|Overall Study|Progressive Disease|61
7635018|NCT03268954|12049238|FG001|Overall Study|Progressive Disease|48
7635019|NCT03268954|12049237|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25
7635020|NCT03268954|12049238|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30
7635021|NCT03268954|12049237|FG000|Overall Study|Reason not Specified|40
7635022|NCT03268954|12049238|FG001|Overall Study|Reason not Specified|40
7635023|NCT03257631|12049248|FG000|Overall Study|Death|8
7635024|NCT03257631|12049249|FG001|Overall Study|Death|5
7635025|NCT03257631|12049250|FG002|Overall Study|Death|13
7635026|NCT03257631|12049251|FG003|Overall Study|Death|5
7635027|NCT03257631|12049248|FG000|Overall Study|Progressive Disease|0
7635028|NCT03257631|12049249|FG001|Overall Study|Progressive Disease|0
7635029|NCT03257631|12049250|FG002|Overall Study|Progressive Disease|1
7635030|NCT03257631|12049251|FG003|Overall Study|Progressive Disease|0
7635031|NCT03257631|12049248|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7635032|NCT03257631|12049249|FG001|Overall Study|Withdrawal by Parent/Guardian|2
7635033|NCT03257631|12049250|FG002|Overall Study|Withdrawal by Parent/Guardian|4
7635034|NCT03257631|12049251|FG003|Overall Study|Withdrawal by Parent/Guardian|1
7635035|NCT03257631|12049248|FG000|Overall Study|Lost to Follow-up|0
7635036|NCT03257631|12049249|FG001|Overall Study|Lost to Follow-up|0
7635037|NCT03257631|12049250|FG002|Overall Study|Lost to Follow-up|1
7635038|NCT03257631|12049251|FG003|Overall Study|Lost to Follow-up|0
7635039|NCT03257631|12049248|FG000|Overall Study|Still on Study|3
7635040|NCT03257631|12049249|FG001|Overall Study|Still on Study|2
7635041|NCT03257631|12049250|FG002|Overall Study|Still on Study|4
7635042|NCT03257631|12049251|FG003|Overall Study|Still on Study|4
7635043|NCT03255629|12049261|FG000|Overall Study|Adverse Event|1
7635044|NCT03255629|12049262|FG001|Overall Study|Adverse Event|0
7635045|NCT03255629|12049261|FG000|Overall Study|did not experience hypoglycemia|2
7635046|NCT03255629|12049262|FG001|Overall Study|did not experience hypoglycemia|1
7635047|NCT03255187|12049271|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
7635048|NCT03255187|12049272|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
7635049|NCT03255187|12049271|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
7635050|NCT03255187|12049272|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
7635051|NCT03254485|12049282|FG000|Overall Study|Adverse Event|3
7635052|NCT03254485|12049283|FG001|Overall Study|Adverse Event|0
7635053|NCT03254485|12049284|FG002|Overall Study|Adverse Event|0
7635054|NCT03254485|12049285|FG003|Overall Study|Adverse Event|6
7635055|NCT03254485|12049282|FG000|Overall Study|Protocol Violation|6
7635056|NCT03254485|12049283|FG001|Overall Study|Protocol Violation|0
7635057|NCT03254485|12049284|FG002|Overall Study|Protocol Violation|0
7635058|NCT03254485|12049285|FG003|Overall Study|Protocol Violation|2
7635059|NCT03254485|12049282|FG000|Overall Study|Withdrawal by Subject|1
7635060|NCT03254485|12049283|FG001|Overall Study|Withdrawal by Subject|0
7635061|NCT03254485|12049284|FG002|Overall Study|Withdrawal by Subject|0
7635062|NCT03254485|12049285|FG003|Overall Study|Withdrawal by Subject|4
7635063|NCT03254485|12049282|FG000|Overall Study|Death|0
7635064|NCT03254485|12049283|FG001|Overall Study|Death|0
7635065|NCT03254485|12049284|FG002|Overall Study|Death|0
7635066|NCT03254485|12049285|FG003|Overall Study|Death|1
7635067|NCT03254485|12049282|FG000|Overall Study|Lost to Follow-up|1
7635068|NCT03254485|12049283|FG001|Overall Study|Lost to Follow-up|0
7635069|NCT03254485|12049284|FG002|Overall Study|Lost to Follow-up|0
7635070|NCT03254485|12049285|FG003|Overall Study|Lost to Follow-up|0
7635071|NCT03254485|12049282|FG000|Overall Study|Other|1
7635072|NCT03254485|12049283|FG001|Overall Study|Other|0
7635073|NCT03254485|12049284|FG002|Overall Study|Other|0
7635074|NCT03254485|12049285|FG003|Overall Study|Other|2
7635075|NCT03253796|12049301|FG000|Period 1: Run-In|Adverse Event|4
7635076|NCT03253796|12049302|FG001|Period 1: Run-In|Adverse Event|0
7635077|NCT03253796|12049303|FG002|Period 1: Run-In|Adverse Event|0
7635078|NCT03253796|12049304|FG003|Period 1: Run-In|Adverse Event|0
7635079|NCT03253796|12049305|FG004|Period 1: Run-In|Adverse Event|0
7635080|NCT03253796|12049301|FG000|Period 1: Run-In|Lack of Efficacy|1
7635081|NCT03253796|12049302|FG001|Period 1: Run-In|Lack of Efficacy|0
7635082|NCT03253796|12049303|FG002|Period 1: Run-In|Lack of Efficacy|0
7635083|NCT03253796|12049304|FG003|Period 1: Run-In|Lack of Efficacy|0
7635084|NCT03253796|12049305|FG004|Period 1: Run-In|Lack of Efficacy|0
7635085|NCT03253796|12049301|FG000|Period 1: Run-In|Lack of Qualifying Event|98
7635086|NCT03253796|12049302|FG001|Period 1: Run-In|Lack of Qualifying Event|0
7635087|NCT03253796|12049303|FG002|Period 1: Run-In|Lack of Qualifying Event|0
7635088|NCT03253796|12049304|FG003|Period 1: Run-In|Lack of Qualifying Event|0
7635089|NCT03253796|12049305|FG004|Period 1: Run-In|Lack of Qualifying Event|0
7635090|NCT03253796|12049301|FG000|Period 1: Run-In|Protocol Violation|5
7635091|NCT03253796|12049302|FG001|Period 1: Run-In|Protocol Violation|0
7635092|NCT03253796|12049303|FG002|Period 1: Run-In|Protocol Violation|0
7635093|NCT03253796|12049304|FG003|Period 1: Run-In|Protocol Violation|0
7635094|NCT03253796|12049305|FG004|Period 1: Run-In|Protocol Violation|0
7635095|NCT03253796|12049301|FG000|Period 1: Run-In|Withdrawal by Subject|8
7635096|NCT03253796|12049302|FG001|Period 1: Run-In|Withdrawal by Subject|0
7635097|NCT03253796|12049303|FG002|Period 1: Run-In|Withdrawal by Subject|0
7635098|NCT03253796|12049304|FG003|Period 1: Run-In|Withdrawal by Subject|0
7635099|NCT03253796|12049305|FG004|Period 1: Run-In|Withdrawal by Subject|0
7635100|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635101|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635102|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2
7635103|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635104|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0
7635105|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635106|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635107|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1
7635108|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635109|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0
7635110|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635111|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635112|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2
7635113|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3
7635114|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0
7635115|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635116|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635117|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1
7635118|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635119|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0
7635120|NCT03253796|12049301|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
7635121|NCT03253796|12049302|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10
7635122|NCT03253796|12049303|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15
7635123|NCT03253796|12049304|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38
7635124|NCT03253796|12049305|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0
7635125|NCT03253796|12049301|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635126|NCT03253796|12049302|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635127|NCT03253796|12049303|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635128|NCT03253796|12049304|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0
7635129|NCT03253796|12049305|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5
7635130|NCT03252587|12049324|FG000|Overall Study|Adverse Event|3
7635131|NCT03252587|12049325|FG001|Overall Study|Adverse Event|8
7635132|NCT03252587|12049326|FG002|Overall Study|Adverse Event|6
7635133|NCT03252587|12049327|FG003|Overall Study|Adverse Event|12
7635134|NCT03252587|12049324|FG000|Overall Study|Lack of Efficacy|7
7635135|NCT03252587|12049325|FG001|Overall Study|Lack of Efficacy|2
7635136|NCT03252587|12049326|FG002|Overall Study|Lack of Efficacy|2
7635137|NCT03252587|12049327|FG003|Overall Study|Lack of Efficacy|4
7635138|NCT03252587|12049324|FG000|Overall Study|Lost to Follow-up|2
7635139|NCT03252587|12049325|FG001|Overall Study|Lost to Follow-up|0
7635140|NCT03252587|12049326|FG002|Overall Study|Lost to Follow-up|0
7635141|NCT03252587|12049327|FG003|Overall Study|Lost to Follow-up|2
7635142|NCT03252587|12049324|FG000|Overall Study|Pregnancy|2
7635143|NCT03252587|12049325|FG001|Overall Study|Pregnancy|1
7635144|NCT03252587|12049326|FG002|Overall Study|Pregnancy|0
7635145|NCT03252587|12049327|FG003|Overall Study|Pregnancy|1
7635146|NCT03252587|12049324|FG000|Overall Study|Withdrawal by Subject|8
7635147|NCT03252587|12049325|FG001|Overall Study|Withdrawal by Subject|4
7635148|NCT03252587|12049326|FG002|Overall Study|Withdrawal by Subject|4
7635149|NCT03252587|12049327|FG003|Overall Study|Withdrawal by Subject|4
7635150|NCT03252587|12049324|FG000|Overall Study|Other Reasons|2
7635151|NCT03252587|12049325|FG001|Overall Study|Other Reasons|5
7635152|NCT03252587|12049326|FG002|Overall Study|Other Reasons|5
7635153|NCT03252587|12049327|FG003|Overall Study|Other Reasons|4
7635154|NCT03250273|12049342|FG000|Overall Study|Disease Progression|2
7635155|NCT03250273|12049343|FG001|Overall Study|Disease Progression|9
7635156|NCT03250273|12049342|FG000|Overall Study|Adverse Event|0
7635157|NCT03250273|12049343|FG001|Overall Study|Adverse Event|1
7635158|NCT03250273|12049342|FG000|Overall Study|Death|0
7635159|NCT03250273|12049343|FG001|Overall Study|Death|1
7635160|NCT03250273|12049342|FG000|Overall Study|Failed to Maintain Eligibility|0
7635161|NCT03250273|12049343|FG001|Overall Study|Failed to Maintain Eligibility|1
7635162|NCT03246061|12049355|FG000|Overall Study|Still in follow-up|15
7635163|NCT03246061|12049356|FG001|Overall Study|Still in follow-up|21
7635164|NCT03241173|12049375|FG000|Overall Study|Death|3
7635165|NCT03241173|12049376|FG001|Overall Study|Death|2
7635166|NCT03241173|12049377|FG002|Overall Study|Death|4
7635167|NCT03241173|12049378|FG003|Overall Study|Death|4
7635168|NCT03241173|12049379|FG004|Overall Study|Death|2
7635169|NCT03241173|12049380|FG005|Overall Study|Death|2
7635170|NCT03241173|12049381|FG006|Overall Study|Death|3
7635171|NCT03241173|12049382|FG007|Overall Study|Death|1
7635172|NCT03241173|12049383|FG008|Overall Study|Death|0
7635173|NCT03241173|12049384|FG009|Overall Study|Death|5
7635174|NCT03241173|12049385|FG010|Overall Study|Death|4
7635175|NCT03241173|12049386|FG011|Overall Study|Death|3
7635176|NCT03241173|12049387|FG012|Overall Study|Death|0
7635177|NCT03241173|12049388|FG013|Overall Study|Death|0
7635178|NCT03241173|12049389|FG014|Overall Study|Death|0
7635179|NCT03241173|12049375|FG000|Overall Study|Withdrawal by Subject|0
7635180|NCT03241173|12049376|FG001|Overall Study|Withdrawal by Subject|0
7635181|NCT03241173|12049377|FG002|Overall Study|Withdrawal by Subject|1
7635182|NCT03241173|12049378|FG003|Overall Study|Withdrawal by Subject|0
7635183|NCT03241173|12049379|FG004|Overall Study|Withdrawal by Subject|0
7635184|NCT03241173|12049380|FG005|Overall Study|Withdrawal by Subject|1
7635185|NCT03241173|12049381|FG006|Overall Study|Withdrawal by Subject|0
7635186|NCT03241173|12049382|FG007|Overall Study|Withdrawal by Subject|0
7635187|NCT03241173|12049383|FG008|Overall Study|Withdrawal by Subject|0
7635188|NCT03241173|12049384|FG009|Overall Study|Withdrawal by Subject|0
7635189|NCT03241173|12049385|FG010|Overall Study|Withdrawal by Subject|0
7635190|NCT03241173|12049386|FG011|Overall Study|Withdrawal by Subject|0
7635191|NCT03241173|12049387|FG012|Overall Study|Withdrawal by Subject|0
7635192|NCT03241173|12049388|FG013|Overall Study|Withdrawal by Subject|0
7635193|NCT03241173|12049389|FG014|Overall Study|Withdrawal by Subject|0
7635194|NCT03241173|12049375|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635195|NCT03241173|12049376|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635196|NCT03241173|12049377|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635197|NCT03241173|12049378|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635198|NCT03241173|12049379|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635199|NCT03241173|12049380|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635200|NCT03241173|12049381|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1
7635201|NCT03241173|12049382|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635202|NCT03241173|12049383|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635203|NCT03241173|12049384|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635204|NCT03241173|12049385|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2
7635205|NCT03241173|12049386|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3
7635206|NCT03241173|12049387|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635207|NCT03241173|12049388|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635208|NCT03241173|12049389|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0
7635209|NCT03241173|12049375|FG000|Overall Study|Lost to Follow-up|0
7635210|NCT03241173|12049376|FG001|Overall Study|Lost to Follow-up|0
7635211|NCT03241173|12049377|FG002|Overall Study|Lost to Follow-up|0
7635212|NCT03241173|12049378|FG003|Overall Study|Lost to Follow-up|0
7635213|NCT03241173|12049379|FG004|Overall Study|Lost to Follow-up|1
7635214|NCT03241173|12049380|FG005|Overall Study|Lost to Follow-up|0
7635215|NCT03241173|12049381|FG006|Overall Study|Lost to Follow-up|0
7635216|NCT03241173|12049382|FG007|Overall Study|Lost to Follow-up|0
7635217|NCT03241173|12049383|FG008|Overall Study|Lost to Follow-up|0
7635218|NCT03241173|12049384|FG009|Overall Study|Lost to Follow-up|1
7635219|NCT03241173|12049385|FG010|Overall Study|Lost to Follow-up|0
7635220|NCT03241173|12049386|FG011|Overall Study|Lost to Follow-up|0
7635221|NCT03241173|12049387|FG012|Overall Study|Lost to Follow-up|0
7635222|NCT03241173|12049388|FG013|Overall Study|Lost to Follow-up|0
7635223|NCT03241173|12049389|FG014|Overall Study|Lost to Follow-up|0
7635224|NCT03237325|12049419|FG000|Overall Study|Lost to Follow-up|3
7635225|NCT03237325|12049420|FG001|Overall Study|Lost to Follow-up|5
7635226|NCT03237325|12049419|FG000|Overall Study|Physician Decision|2
7635227|NCT03237325|12049420|FG001|Overall Study|Physician Decision|4
7635228|NCT03237325|12049419|FG000|Overall Study|Withdrawal by Subject|9
7635229|NCT03237325|12049420|FG001|Overall Study|Withdrawal by Subject|12
7635230|NCT03237325|12049419|FG000|Overall Study|Noncompliance with Study Procedures|1
7635231|NCT03237325|12049420|FG001|Overall Study|Noncompliance with Study Procedures|1
7635232|NCT03237325|12049419|FG000|Overall Study|Termination by Sponsor|0
7635233|NCT03237325|12049420|FG001|Overall Study|Termination by Sponsor|1
7635234|NCT03237325|12049419|FG000|Overall Study|Reason other than described|0
7635235|NCT03237325|12049420|FG001|Overall Study|Reason other than described|2
7635236|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1
7635237|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1
7635238|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635239|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635240|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635241|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0
7635242|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6
7635243|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4
7635244|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635245|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635246|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635247|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0
7635248|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2
7635249|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635250|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635251|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635252|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635253|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0
7635254|NCT03234907|12049428|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1
7635255|NCT03234907|12049429|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1
7635256|NCT03234907|12049430|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635257|NCT03234907|12049431|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635258|NCT03234907|12049432|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635259|NCT03234907|12049433|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0
7635260|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635261|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635262|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0
7635263|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4
7635264|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3
7635265|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7
7635266|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0
7635267|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0
7635268|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1
7635269|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3
7635270|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3
7635271|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4
7635272|NCT03234907|12049428|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635273|NCT03234907|12049429|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635274|NCT03234907|12049430|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0
7635275|NCT03234907|12049431|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4
7635276|NCT03234907|12049432|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4
7635277|NCT03234907|12049433|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10
7635278|NCT03221842|12049453|FG000|Period 1 (Open-label)|Adverse Event|4
7635279|NCT03221842|12049454|FG001|Period 1 (Open-label)|Adverse Event|0
7635280|NCT03221842|12049453|FG000|Period 1 (Open-label)|Physician Decision|2
7635281|NCT03221842|12049454|FG001|Period 1 (Open-label)|Physician Decision|0
7635282|NCT03221842|12049453|FG000|Period 1 (Open-label)|Lost to Follow-up|1
7635283|NCT03221842|12049454|FG001|Period 1 (Open-label)|Lost to Follow-up|0
7635284|NCT03221842|12049453|FG000|Period 1 (Open-label)|Terminated by sponsor|1
7635285|NCT03221842|12049454|FG001|Period 1 (Open-label)|Terminated by sponsor|0
7635286|NCT03221842|12049453|FG000|Period 1 (Open-label)|Other|2
7635287|NCT03221842|12049454|FG001|Period 1 (Open-label)|Other|0
7635288|NCT03221842|12049453|FG000|Period 2 (Randomized, Blinded)|Death|0
7635289|NCT03221842|12049454|FG001|Period 2 (Randomized, Blinded)|Death|1
7635290|NCT03221842|12049453|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
7635291|NCT03221842|12049454|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
7635292|NCT03217591|12049467|FG000|Overall Study|Adverse Event|1
7635293|NCT03217591|12049468|FG001|Overall Study|Adverse Event|2
7635294|NCT03217591|12049469|FG002|Overall Study|Adverse Event|6
7635295|NCT03217591|12049467|FG000|Overall Study|Withdrawal by Subject|0
7635296|NCT03217591|12049468|FG001|Overall Study|Withdrawal by Subject|1
7635297|NCT03217591|12049469|FG002|Overall Study|Withdrawal by Subject|3
7635298|NCT03217591|12049467|FG000|Overall Study|Lost to Follow-up|1
7635299|NCT03217591|12049468|FG001|Overall Study|Lost to Follow-up|0
7635300|NCT03217591|12049469|FG002|Overall Study|Lost to Follow-up|0
7635301|NCT03217591|12049467|FG000|Overall Study|Protocol Violation|1
7635302|NCT03217591|12049468|FG001|Overall Study|Protocol Violation|0
7635303|NCT03217591|12049469|FG002|Overall Study|Protocol Violation|1
7635304|NCT03214250|12049485|FG000|Overall Study|Death|5
7635305|NCT03214250|12049486|FG001|Overall Study|Death|5
7635306|NCT03214250|12049487|FG002|Overall Study|Death|7
7635307|NCT03214250|12049488|FG003|Overall Study|Death|4
7635308|NCT03214250|12049489|FG004|Overall Study|Death|23
7635309|NCT03214250|12049490|FG005|Overall Study|Death|23
7635310|NCT03214250|12049491|FG006|Overall Study|Death|24
7635311|NCT03214250|12049485|FG000|Overall Study|Lost to Follow-up|0
7635312|NCT03214250|12049486|FG001|Overall Study|Lost to Follow-up|0
7635313|NCT03214250|12049487|FG002|Overall Study|Lost to Follow-up|0
7635314|NCT03214250|12049488|FG003|Overall Study|Lost to Follow-up|1
7635315|NCT03214250|12049489|FG004|Overall Study|Lost to Follow-up|1
7635316|NCT03214250|12049490|FG005|Overall Study|Lost to Follow-up|2
7635317|NCT03214250|12049491|FG006|Overall Study|Lost to Follow-up|0
7635318|NCT03214250|12049485|FG000|Overall Study|Other|0
7635319|NCT03214250|12049486|FG001|Overall Study|Other|0
7635320|NCT03214250|12049487|FG002|Overall Study|Other|0
7635321|NCT03214250|12049488|FG003|Overall Study|Other|0
7635322|NCT03214250|12049489|FG004|Overall Study|Other|1
7635323|NCT03214250|12049490|FG005|Overall Study|Other|1
7635324|NCT03214250|12049491|FG006|Overall Study|Other|2
7635325|NCT03214250|12049485|FG000|Overall Study|Remains on Study|2
7635326|NCT03214250|12049486|FG001|Overall Study|Remains on Study|2
7635327|NCT03214250|12049487|FG002|Overall Study|Remains on Study|0
7635328|NCT03214250|12049488|FG003|Overall Study|Remains on Study|1
7635329|NCT03214250|12049489|FG004|Overall Study|Remains on Study|7
7635330|NCT03214250|12049490|FG005|Overall Study|Remains on Study|5
7635331|NCT03214250|12049491|FG006|Overall Study|Remains on Study|3
7635332|NCT03214250|12049485|FG000|Overall Study|Withdrawal by Subject|0
7635333|NCT03214250|12049486|FG001|Overall Study|Withdrawal by Subject|0
7635334|NCT03214250|12049487|FG002|Overall Study|Withdrawal by Subject|1
7635335|NCT03214250|12049488|FG003|Overall Study|Withdrawal by Subject|2
7635336|NCT03214250|12049489|FG004|Overall Study|Withdrawal by Subject|5
7635337|NCT03214250|12049490|FG005|Overall Study|Withdrawal by Subject|0
7635338|NCT03214250|12049491|FG006|Overall Study|Withdrawal by Subject|2
7635339|NCT03213938|12049513|FG000|Overall Study|Lost to Follow-up|4
7635340|NCT03213938|12049514|FG001|Overall Study|Lost to Follow-up|3
7635341|NCT03213938|12049513|FG000|Overall Study|Lack of Efficacy|1
7635342|NCT03213938|12049514|FG001|Overall Study|Lack of Efficacy|0
7635343|NCT03213938|12049513|FG000|Overall Study|Decline to participate|5
7635344|NCT03213938|12049514|FG001|Overall Study|Decline to participate|4
7635345|NCT03213938|12049513|FG000|Overall Study|Without reason|4
7635346|NCT03213938|12049514|FG001|Overall Study|Without reason|5
7635347|NCT03208127|12049520|FG000|Overall Study|Death|1
7635348|NCT03207451|12049528|FG000|Overall Study|scheduling conflict|1
7635349|NCT03207451|12049529|FG001|Overall Study|scheduling conflict|0
7635350|NCT03207451|12049530|FG002|Overall Study|scheduling conflict|2
7635351|NCT03207451|12049531|FG003|Overall Study|scheduling conflict|2
7635352|NCT03207451|12049528|FG000|Overall Study|Adverse Event|0
7635353|NCT03207451|12049529|FG001|Overall Study|Adverse Event|0
7635354|NCT03207451|12049530|FG002|Overall Study|Adverse Event|0
7635355|NCT03207451|12049531|FG003|Overall Study|Adverse Event|1
7635356|NCT03201965|12049544|FG000|Overall Study|Death|5
7635357|NCT03201965|12049545|FG001|Overall Study|Death|27
7635358|NCT03201965|12049546|FG002|Overall Study|Death|27
7635359|NCT03201965|12049544|FG000|Overall Study|Lost to Follow-up|0
7635360|NCT03201965|12049545|FG001|Overall Study|Lost to Follow-up|1
7635361|NCT03201965|12049546|FG002|Overall Study|Lost to Follow-up|0
7635362|NCT03201965|12049544|FG000|Overall Study|Withdrawal by Subject|3
7635363|NCT03201965|12049545|FG001|Overall Study|Withdrawal by Subject|13
7635364|NCT03201965|12049546|FG002|Overall Study|Withdrawal by Subject|4
7635365|NCT03201965|12049544|FG000|Overall Study|Ongoing|20
7635366|NCT03201965|12049545|FG001|Overall Study|Ongoing|152
7635367|NCT03201965|12049546|FG002|Overall Study|Ongoing|164
7635368|NCT03201562|12049556|FG000|Overall Study|Physician Decision|0
7635369|NCT03201562|12049557|FG001|Overall Study|Physician Decision|0
7635370|NCT03201562|12049558|FG002|Overall Study|Physician Decision|1
7635371|NCT03201562|12049556|FG000|Overall Study|Adverse Event|0
7635372|NCT03201562|12049557|FG001|Overall Study|Adverse Event|0
7635373|NCT03201562|12049558|FG002|Overall Study|Adverse Event|1
7635374|NCT03201562|12049556|FG000|Overall Study|Lost to Follow-up|0
7635375|NCT03201562|12049557|FG001|Overall Study|Lost to Follow-up|1
7635376|NCT03201562|12049558|FG002|Overall Study|Lost to Follow-up|2
7635377|NCT03197935|12049568|FG000|Overall Study|Death due to any cause|9
7635378|NCT03197935|12049569|FG001|Overall Study|Death due to any cause|7
7635379|NCT03197935|12049568|FG000|Overall Study|Lost to Follow-up|0
7635380|NCT03197935|12049569|FG001|Overall Study|Lost to Follow-up|3
7635381|NCT03197935|12049568|FG000|Overall Study|Physician Decision|0
7635382|NCT03197935|12049569|FG001|Overall Study|Physician Decision|1
7635383|NCT03197935|12049568|FG000|Overall Study|Withdrawal by Subject|11
7635384|NCT03197935|12049569|FG001|Overall Study|Withdrawal by Subject|7
7635385|NCT03197935|12049568|FG000|Overall Study|On-Going in Study|147
7635386|NCT03197935|12049569|FG001|Overall Study|On-Going in Study|146
7635387|NCT03197935|12049568|FG000|Overall Study|Did not receive any study treatment|1
7635388|NCT03197935|12049569|FG001|Overall Study|Did not receive any study treatment|1
7635389|NCT03194646|12049580|FG000|Overall Study|Adverse Event|24
7635390|NCT03194646|12049581|FG001|Overall Study|Adverse Event|25
7635391|NCT03194646|12049582|FG002|Overall Study|Adverse Event|14
7635392|NCT03194646|12049583|FG003|Overall Study|Adverse Event|17
7635393|NCT03194646|12049580|FG000|Overall Study|Lack of Efficacy|4
7635394|NCT03194646|12049581|FG001|Overall Study|Lack of Efficacy|2
7635395|NCT03194646|12049582|FG002|Overall Study|Lack of Efficacy|2
7635396|NCT03194646|12049583|FG003|Overall Study|Lack of Efficacy|12
7635397|NCT03194646|12049580|FG000|Overall Study|Lost to Follow-up|30
7635398|NCT03194646|12049581|FG001|Overall Study|Lost to Follow-up|22
7635399|NCT03194646|12049582|FG002|Overall Study|Lost to Follow-up|12
7635400|NCT03194646|12049583|FG003|Overall Study|Lost to Follow-up|35
7635401|NCT03194646|12049580|FG000|Overall Study|Non-compliance with study drug|4
7635402|NCT03194646|12049581|FG001|Overall Study|Non-compliance with study drug|0
7635403|NCT03194646|12049582|FG002|Overall Study|Non-compliance with study drug|1
7635404|NCT03194646|12049583|FG003|Overall Study|Non-compliance with study drug|1
7635405|NCT03194646|12049580|FG000|Overall Study|Other|87
7635406|NCT03194646|12049581|FG001|Overall Study|Other|67
7635407|NCT03194646|12049582|FG002|Overall Study|Other|34
7635408|NCT03194646|12049583|FG003|Overall Study|Other|31
7635409|NCT03194646|12049580|FG000|Overall Study|Physician Decision|7
7635410|NCT03194646|12049581|FG001|Overall Study|Physician Decision|9
7635411|NCT03194646|12049582|FG002|Overall Study|Physician Decision|5
7635412|NCT03194646|12049583|FG003|Overall Study|Physician Decision|4
7635413|NCT03194646|12049580|FG000|Overall Study|Pregnancy|4
7635414|NCT03194646|12049581|FG001|Overall Study|Pregnancy|5
7635415|NCT03194646|12049582|FG002|Overall Study|Pregnancy|1
7635416|NCT03194646|12049583|FG003|Overall Study|Pregnancy|2
7635417|NCT03194646|12049580|FG000|Overall Study|Protocol Violation|4
7635418|NCT03194646|12049581|FG001|Overall Study|Protocol Violation|2
7635419|NCT03194646|12049582|FG002|Overall Study|Protocol Violation|1
7635420|NCT03194646|12049583|FG003|Overall Study|Protocol Violation|1
7635421|NCT03194646|12049580|FG000|Overall Study|Site terminated by sponsor|0
7635422|NCT03194646|12049581|FG001|Overall Study|Site terminated by sponsor|0
7635423|NCT03194646|12049582|FG002|Overall Study|Site terminated by sponsor|2
7635424|NCT03194646|12049583|FG003|Overall Study|Site terminated by sponsor|0
7635425|NCT03194646|12049580|FG000|Overall Study|Study terminated by sponsor|60
7635426|NCT03194646|12049581|FG001|Overall Study|Study terminated by sponsor|61
7635427|NCT03194646|12049582|FG002|Overall Study|Study terminated by sponsor|30
7635428|NCT03194646|12049583|FG003|Overall Study|Study terminated by sponsor|34
7635429|NCT03194646|12049580|FG000|Overall Study|Withdrawal by Subject|74
7635430|NCT03194646|12049581|FG001|Overall Study|Withdrawal by Subject|75
7635431|NCT03194646|12049582|FG002|Overall Study|Withdrawal by Subject|36
7635432|NCT03194646|12049583|FG003|Overall Study|Withdrawal by Subject|131
7635433|NCT03194646|12049580|FG000|Overall Study|Missing|4
7635434|NCT03194646|12049581|FG001|Overall Study|Missing|0
7635435|NCT03194646|12049582|FG002|Overall Study|Missing|1
7635436|NCT03194646|12049583|FG003|Overall Study|Missing|12
7635437|NCT03185949|12049621|FG000|ITT Analysis|Withdrawal by Subject|4
7635438|NCT03185949|12049622|FG001|ITT Analysis|Withdrawal by Subject|3
7635439|NCT03185949|12049621|FG000|PP Analysis|Protocol Violation|2
7635440|NCT03185949|12049622|FG001|PP Analysis|Protocol Violation|2
7635441|NCT03185949|12049621|FG000|PP Analysis|Failed/Incomplete LGA embolization|0
7635442|NCT03185949|12049622|FG001|PP Analysis|Failed/Incomplete LGA embolization|2
7635443|NCT03182686|12049632|FG000|Overall Study|Lost to Follow-up|2
7635444|NCT03182686|12049633|FG001|Overall Study|Lost to Follow-up|0
7635445|NCT03182686|12049632|FG000|Overall Study|Adverse Event|2
7635446|NCT03182686|12049633|FG001|Overall Study|Adverse Event|0
7635447|NCT03182686|12049632|FG000|Overall Study|Withdrawal by Subject|3
7635448|NCT03182686|12049633|FG001|Overall Study|Withdrawal by Subject|0
7635449|NCT03179202|12049648|FG000|Overall Study|Screen Failure|67
7635450|NCT03179202|12049648|FG000|Overall Study|Subject Lost to Follow Up|12
7635451|NCT03179202|12049648|FG000|Overall Study|Withdrawal by Subject|7
7635452|NCT03179202|12049648|FG000|Overall Study|Adverse Event|3
7635453|NCT03179202|12049648|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1
7635454|NCT03179202|12049648|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1
7635455|NCT03175549|12049656|FG000|Overall Study|Lost to Follow-up|2
7635456|NCT03175549|12049657|FG001|Overall Study|Lost to Follow-up|2
7635457|NCT03175549|12049656|FG000|Overall Study|Medication non-compliance|2
7635458|NCT03175549|12049657|FG001|Overall Study|Medication non-compliance|2
7635459|NCT03170349|12049669|FG000|At 30 Days Follow-up|Death|1
7635460|NCT03170349|12049669|FG000|At 6 Months Follow-up|Death|3
7635461|NCT03170349|12049669|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
7635462|NCT03170349|12049669|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
7635463|NCT03170349|12049669|FG000|At 1 Year Follow-up|Death|6
7635464|NCT03170349|12049669|FG000|At 1 Year Follow-up|Exited for Other Reasons|2
7635465|NCT03167619|12049675|FG000|Overall Study|Death|11
7635466|NCT03167619|12049676|FG001|Overall Study|Death|8
7635467|NCT03167619|12049675|FG000|Overall Study|Withdrawal by Subject|1
7635468|NCT03167619|12049676|FG001|Overall Study|Withdrawal by Subject|2
7635469|NCT03167619|12049675|FG000|Overall Study|Physician Decision|0
7635470|NCT03167619|12049676|FG001|Overall Study|Physician Decision|1
7635471|NCT03164772|12049693|FG000|Overall Study|Death|4
7635472|NCT03164772|12049694|FG001|Overall Study|Death|2
7635473|NCT03164772|12049693|FG000|Overall Study|Adverse Event|1
7635474|NCT03164772|12049694|FG001|Overall Study|Adverse Event|4
7635475|NCT03164772|12049693|FG000|Overall Study|Progressive Disease|11
7635476|NCT03164772|12049694|FG001|Overall Study|Progressive Disease|21
7635477|NCT03164772|12049693|FG000|Overall Study|Physician Decision|2
7635478|NCT03164772|12049694|FG001|Overall Study|Physician Decision|0
7635479|NCT03164772|12049693|FG000|Overall Study|Withdrawal by Subject|0
7635480|NCT03164772|12049694|FG001|Overall Study|Withdrawal by Subject|4
7635481|NCT03164616|12049706|FG000|Overall Study|Death|250
7635482|NCT03164616|12049707|FG001|Overall Study|Death|264
7635483|NCT03164616|12049708|FG002|Overall Study|Death|279
7635484|NCT03164616|12049706|FG000|Overall Study|Lost to Follow-up|2
7635485|NCT03164616|12049707|FG001|Overall Study|Lost to Follow-up|2
7635486|NCT03164616|12049708|FG002|Overall Study|Lost to Follow-up|2
7635487|NCT03164616|12049706|FG000|Overall Study|Withdrawal by Subject|6
7635488|NCT03164616|12049707|FG001|Overall Study|Withdrawal by Subject|7
7635489|NCT03164616|12049708|FG002|Overall Study|Withdrawal by Subject|16
7635490|NCT03163667|12049724|FG000|Overall Study|Death|15
7635491|NCT03163667|12049725|FG001|Overall Study|Death|27
7635492|NCT03163667|12049724|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8
7635493|NCT03163667|12049725|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19
7635494|NCT03162224|12049734|FG000|Overall Study|Death|4
7635495|NCT03162224|12049735|FG001|Overall Study|Death|5
7635496|NCT03162224|12049736|FG002|Overall Study|Death|8
7635497|NCT03162224|12049734|FG000|Overall Study|Withdrawal by Subject|1
7635498|NCT03162224|12049735|FG001|Overall Study|Withdrawal by Subject|0
7635499|NCT03162224|12049736|FG002|Overall Study|Withdrawal by Subject|1
7635500|NCT03162224|12049734|FG000|Overall Study|Lost to Follow-up|0
7635501|NCT03162224|12049735|FG001|Overall Study|Lost to Follow-up|1
7635502|NCT03162224|12049736|FG002|Overall Study|Lost to Follow-up|0
7635503|NCT03162224|12049734|FG000|Overall Study|Other|6
7635504|NCT03162224|12049735|FG001|Overall Study|Other|2
7635505|NCT03162224|12049736|FG002|Overall Study|Other|1
7635506|NCT03160716|12049744|FG000|Overall Study|Lost to Follow-up|1
7635507|NCT03158688|12049750|FG000|Overall Study|Continuing in study|107
7635508|NCT03158688|12049751|FG001|Overall Study|Continuing in study|233
7635509|NCT03158688|12049750|FG000|Overall Study|Death|36
7635510|NCT03158688|12049751|FG001|Overall Study|Death|59
7635511|NCT03158688|12049750|FG000|Overall Study|Withdrawal by Subject|9
7635512|NCT03158688|12049751|FG001|Overall Study|Withdrawal by Subject|14
7635513|NCT03158688|12049750|FG000|Overall Study|Decision by sponsor|2
7635514|NCT03158688|12049751|FG001|Overall Study|Decision by sponsor|3
7635515|NCT03158688|12049750|FG000|Overall Study|Lost to Follow-up|0
7635516|NCT03158688|12049751|FG001|Overall Study|Lost to Follow-up|3
7635517|NCT03153137|12049759|FG000|Overall Study|Lost to Follow-up|1
7635518|NCT03153137|12049760|FG001|Overall Study|Lost to Follow-up|0
7635519|NCT03153137|12049759|FG000|Overall Study|Withdrawal by Subject|2
7635520|NCT03153137|12049760|FG001|Overall Study|Withdrawal by Subject|1
7635521|NCT03153137|12049759|FG000|Overall Study|Physician Decision|0
7635522|NCT03153137|12049760|FG001|Overall Study|Physician Decision|3
7635523|NCT03150056|12049781|FG000|Overall Study|Withdrawal by Subject|0
7635524|NCT03150056|12049782|FG001|Overall Study|Withdrawal by Subject|0
7635525|NCT03150056|12049783|FG002|Overall Study|Withdrawal by Subject|0
7635526|NCT03150056|12049784|FG003|Overall Study|Withdrawal by Subject|0
7635527|NCT03150056|12049785|FG004|Overall Study|Withdrawal by Subject|0
7635528|NCT03150056|12049786|FG005|Overall Study|Withdrawal by Subject|2
7635529|NCT03150056|12049781|FG000|Overall Study|Study terminated by Sponsor|1
7635530|NCT03150056|12049782|FG001|Overall Study|Study terminated by Sponsor|3
7635531|NCT03150056|12049783|FG002|Overall Study|Study terminated by Sponsor|1
7635532|NCT03150056|12049784|FG003|Overall Study|Study terminated by Sponsor|1
7635533|NCT03150056|12049785|FG004|Overall Study|Study terminated by Sponsor|5
7635534|NCT03150056|12049786|FG005|Overall Study|Study terminated by Sponsor|6
7635535|NCT03150056|12049781|FG000|Overall Study|Death|9
7635536|NCT03150056|12049782|FG001|Overall Study|Death|2
7635537|NCT03150056|12049783|FG002|Overall Study|Death|2
7635538|NCT03150056|12049784|FG003|Overall Study|Death|7
7635539|NCT03150056|12049785|FG004|Overall Study|Death|8
7635540|NCT03150056|12049786|FG005|Overall Study|Death|10
7635541|NCT03148795|12049803|FG000|Overall Study|Death|6
7635542|NCT03148795|12049803|FG000|Overall Study|Adverse Event|5
7635543|NCT03148795|12049803|FG000|Overall Study|Other|15
7635544|NCT03148795|12049803|FG000|Overall Study|No Longer Clinically Benefitting|2
7635545|NCT03148795|12049803|FG000|Overall Study|Global Deterioration Of Health Status|6
7635546|NCT03148795|12049803|FG000|Overall Study|Withdrawal by Subject|2
7635547|NCT03148795|12049803|FG000|Overall Study|Progressive Disease|62
7635548|NCT03148795|12049803|FG000|Overall Study|Ongoing|30
7635549|NCT03144674|12049811|FG000|Overall Study|Participants Still Ongoing in the Study|1
7635550|NCT03144674|12049812|FG001|Overall Study|Participants Still Ongoing in the Study|4
7635551|NCT03144674|12049813|FG002|Overall Study|Participants Still Ongoing in the Study|24
7635552|NCT03144674|12049814|FG003|Overall Study|Participants Still Ongoing in the Study|54
7635553|NCT03144674|12049811|FG000|Overall Study|Death|3
7635554|NCT03144674|12049812|FG001|Overall Study|Death|1
7635555|NCT03144674|12049813|FG002|Overall Study|Death|1
7635556|NCT03144674|12049814|FG003|Overall Study|Death|10
7635557|NCT03144674|12049811|FG000|Overall Study|Lost to Follow-up|0
7635558|NCT03144674|12049812|FG001|Overall Study|Lost to Follow-up|1
7635559|NCT03144674|12049813|FG002|Overall Study|Lost to Follow-up|1
7635560|NCT03144674|12049814|FG003|Overall Study|Lost to Follow-up|1
7635561|NCT03144674|12049811|FG000|Overall Study|Withdrawal by Participant|0
7635562|NCT03144674|12049812|FG001|Overall Study|Withdrawal by Participant|0
7635563|NCT03144674|12049813|FG002|Overall Study|Withdrawal by Participant|0
7635564|NCT03144674|12049814|FG003|Overall Study|Withdrawal by Participant|3
7635565|NCT03144674|12049811|FG000|Overall Study|Reason not Specified|0
7635566|NCT03144674|12049812|FG001|Overall Study|Reason not Specified|0
7635567|NCT03144674|12049813|FG002|Overall Study|Reason not Specified|2
7635568|NCT03144674|12049814|FG003|Overall Study|Reason not Specified|4
7635569|NCT03141177|12049832|FG000|Overall Study|Death|62
7635570|NCT03141177|12049833|FG001|Overall Study|Death|13
7635571|NCT03141177|12049834|FG002|Overall Study|Death|84
7635572|NCT03141177|12049832|FG000|Overall Study|Participant withdrew consent|9
7635573|NCT03141177|12049833|FG001|Overall Study|Participant withdrew consent|2
7635574|NCT03141177|12049834|FG002|Overall Study|Participant withdrew consent|13
7635575|NCT03141177|12049832|FG000|Overall Study|Not reported|1
7635576|NCT03141177|12049833|FG001|Overall Study|Not reported|0
7635577|NCT03141177|12049834|FG002|Overall Study|Not reported|1
7635578|NCT03141177|12049832|FG000|Overall Study|Lost to Follow-up|2
7635579|NCT03141177|12049833|FG001|Overall Study|Lost to Follow-up|1
7635580|NCT03141177|12049834|FG002|Overall Study|Lost to Follow-up|1
7635581|NCT03141177|12049832|FG000|Overall Study|Other reasons|4
7635582|NCT03141177|12049833|FG001|Overall Study|Other reasons|0
7635583|NCT03141177|12049834|FG002|Overall Study|Other reasons|11
7635584|NCT03141177|12049832|FG000|Overall Study|Participants did not start treatment period|3
7635585|NCT03141177|12049833|FG001|Overall Study|Participants did not start treatment period|0
7635586|NCT03141177|12049834|FG002|Overall Study|Participants did not start treatment period|8
7635587|NCT03132805|12049846|FG000|Overall Study|Lost to Follow-up|142
7635588|NCT03132805|12049847|FG001|Overall Study|Lost to Follow-up|141
7635589|NCT03132805|12049848|FG002|Overall Study|Lost to Follow-up|113
7635590|NCT03132467|12049856|FG000|Overall Study|Adverse Event|2
7635591|NCT03132467|12049856|FG000|Overall Study|Withdrawal by Subject|2
7635592|NCT03131219|12049863|FG000|Initial Evaluation Period|Adverse Event|1
7635593|NCT03131219|12049864|FG001|Initial Evaluation Period|Adverse Event|0
7635594|NCT03131219|12049863|FG000|Initial Evaluation Period|Protocol Violation|1
7635595|NCT03131219|12049864|FG001|Initial Evaluation Period|Protocol Violation|0
7635596|NCT03131219|12049863|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
7635597|NCT03131219|12049864|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
7635598|NCT03130959|12049880|FG000|Overall Study|Disease progression|19
7635599|NCT03130959|12049881|FG001|Overall Study|Disease progression|7
7635600|NCT03130959|12049882|FG002|Overall Study|Disease progression|12
7635601|NCT03130959|12049883|FG003|Overall Study|Disease progression|7
7635602|NCT03130959|12049884|FG004|Overall Study|Disease progression|12
7635603|NCT03130959|12049885|FG005|Overall Study|Disease progression|3
7635604|NCT03130959|12049886|FG006|Overall Study|Disease progression|6
7635605|NCT03130959|12049887|FG007|Overall Study|Disease progression|3
7635606|NCT03130959|12049888|FG008|Overall Study|Disease progression|15
7635607|NCT03130959|12049889|FG009|Overall Study|Disease progression|8
7635608|NCT03130959|12049880|FG000|Overall Study|Study drug toxicity|2
7635609|NCT03130959|12049881|FG001|Overall Study|Study drug toxicity|2
7635610|NCT03130959|12049882|FG002|Overall Study|Study drug toxicity|1
7635611|NCT03130959|12049883|FG003|Overall Study|Study drug toxicity|2
7635612|NCT03130959|12049884|FG004|Overall Study|Study drug toxicity|1
7635613|NCT03130959|12049885|FG005|Overall Study|Study drug toxicity|1
7635614|NCT03130959|12049886|FG006|Overall Study|Study drug toxicity|3
7635615|NCT03130959|12049887|FG007|Overall Study|Study drug toxicity|0
7635616|NCT03130959|12049888|FG008|Overall Study|Study drug toxicity|3
7635617|NCT03130959|12049889|FG009|Overall Study|Study drug toxicity|3
7635618|NCT03130959|12049880|FG000|Overall Study|Other reasons|0
7635619|NCT03130959|12049881|FG001|Overall Study|Other reasons|0
7635620|NCT03130959|12049882|FG002|Overall Study|Other reasons|0
7635621|NCT03130959|12049883|FG003|Overall Study|Other reasons|0
7635622|NCT03130959|12049884|FG004|Overall Study|Other reasons|0
7635623|NCT03130959|12049885|FG005|Overall Study|Other reasons|1
7635624|NCT03130959|12049886|FG006|Overall Study|Other reasons|1
7635625|NCT03130959|12049887|FG007|Overall Study|Other reasons|0
7635626|NCT03130959|12049888|FG008|Overall Study|Other reasons|0
7635627|NCT03130959|12049889|FG009|Overall Study|Other reasons|0
7635628|NCT03130959|12049880|FG000|Overall Study|Subject request to discontinue therapy|0
7635629|NCT03130959|12049881|FG001|Overall Study|Subject request to discontinue therapy|0
7635630|NCT03130959|12049882|FG002|Overall Study|Subject request to discontinue therapy|1
7635631|NCT03130959|12049883|FG003|Overall Study|Subject request to discontinue therapy|1
7635632|NCT03130959|12049884|FG004|Overall Study|Subject request to discontinue therapy|0
7635633|NCT03130959|12049885|FG005|Overall Study|Subject request to discontinue therapy|0
7635634|NCT03130959|12049886|FG006|Overall Study|Subject request to discontinue therapy|1
7635635|NCT03130959|12049887|FG007|Overall Study|Subject request to discontinue therapy|1
7635636|NCT03130959|12049888|FG008|Overall Study|Subject request to discontinue therapy|0
7635637|NCT03130959|12049889|FG009|Overall Study|Subject request to discontinue therapy|0
7635638|NCT03130959|12049880|FG000|Overall Study|Not reported|0
7635639|NCT03130959|12049881|FG001|Overall Study|Not reported|0
7635640|NCT03130959|12049882|FG002|Overall Study|Not reported|0
7635641|NCT03130959|12049883|FG003|Overall Study|Not reported|1
7635642|NCT03130959|12049884|FG004|Overall Study|Not reported|0
7635643|NCT03130959|12049885|FG005|Overall Study|Not reported|1
7635644|NCT03130959|12049886|FG006|Overall Study|Not reported|0
7635645|NCT03130959|12049887|FG007|Overall Study|Not reported|0
7635646|NCT03130959|12049888|FG008|Overall Study|Not reported|0
7635647|NCT03130959|12049889|FG009|Overall Study|Not reported|1
7635648|NCT03130959|12049880|FG000|Overall Study|Adverse Event unrelated to drug|0
7635649|NCT03130959|12049881|FG001|Overall Study|Adverse Event unrelated to drug|0
7635650|NCT03130959|12049882|FG002|Overall Study|Adverse Event unrelated to drug|1
7635651|NCT03130959|12049883|FG003|Overall Study|Adverse Event unrelated to drug|1
7635652|NCT03130959|12049884|FG004|Overall Study|Adverse Event unrelated to drug|1
7635653|NCT03130959|12049885|FG005|Overall Study|Adverse Event unrelated to drug|0
7635654|NCT03130959|12049886|FG006|Overall Study|Adverse Event unrelated to drug|1
7635655|NCT03130959|12049887|FG007|Overall Study|Adverse Event unrelated to drug|0
7635656|NCT03130959|12049888|FG008|Overall Study|Adverse Event unrelated to drug|1
7635657|NCT03130959|12049889|FG009|Overall Study|Adverse Event unrelated to drug|1
7635658|NCT03130959|12049880|FG000|Overall Study|Participant withdrew consent|0
7635659|NCT03130959|12049881|FG001|Overall Study|Participant withdrew consent|1
7635660|NCT03130959|12049882|FG002|Overall Study|Participant withdrew consent|0
7635661|NCT03130959|12049883|FG003|Overall Study|Participant withdrew consent|2
7635662|NCT03130959|12049884|FG004|Overall Study|Participant withdrew consent|1
7635663|NCT03130959|12049885|FG005|Overall Study|Participant withdrew consent|0
7635664|NCT03130959|12049886|FG006|Overall Study|Participant withdrew consent|0
7635665|NCT03130959|12049887|FG007|Overall Study|Participant withdrew consent|0
7635666|NCT03130959|12049888|FG008|Overall Study|Participant withdrew consent|0
7635667|NCT03130959|12049889|FG009|Overall Study|Participant withdrew consent|2
7635668|NCT03130959|12049880|FG000|Overall Study|Administrative reason by sponsor|1
7635669|NCT03130959|12049881|FG001|Overall Study|Administrative reason by sponsor|0
7635670|NCT03130959|12049882|FG002|Overall Study|Administrative reason by sponsor|1
7635671|NCT03130959|12049883|FG003|Overall Study|Administrative reason by sponsor|0
7635672|NCT03130959|12049884|FG004|Overall Study|Administrative reason by sponsor|0
7635673|NCT03130959|12049885|FG005|Overall Study|Administrative reason by sponsor|0
7635674|NCT03130959|12049886|FG006|Overall Study|Administrative reason by sponsor|0
7635675|NCT03130959|12049887|FG007|Overall Study|Administrative reason by sponsor|0
7635676|NCT03130959|12049888|FG008|Overall Study|Administrative reason by sponsor|0
7635677|NCT03130959|12049889|FG009|Overall Study|Administrative reason by sponsor|0
7635678|NCT03130959|12049880|FG000|Overall Study|Lost to Follow-up|1
7635679|NCT03130959|12049881|FG001|Overall Study|Lost to Follow-up|0
7635680|NCT03130959|12049882|FG002|Overall Study|Lost to Follow-up|0
7635681|NCT03130959|12049883|FG003|Overall Study|Lost to Follow-up|0
7635682|NCT03130959|12049884|FG004|Overall Study|Lost to Follow-up|0
7635683|NCT03130959|12049885|FG005|Overall Study|Lost to Follow-up|0
7635684|NCT03130959|12049886|FG006|Overall Study|Lost to Follow-up|0
7635685|NCT03130959|12049887|FG007|Overall Study|Lost to Follow-up|0
7635686|NCT03130959|12049888|FG008|Overall Study|Lost to Follow-up|0
7635687|NCT03130959|12049889|FG009|Overall Study|Lost to Follow-up|0
7635688|NCT03127384|12049932|FG000|Overall Study|Lost to Follow-up|4
7635689|NCT03127384|12049932|FG000|Overall Study|Subject request|2
7635690|NCT03125902|12049940|FG000|Overall Study|Death|52
7635691|NCT03125902|12049941|FG001|Overall Study|Death|123
7635692|NCT03125902|12049940|FG000|Overall Study|Lost to Follow-up|1
7635693|NCT03125902|12049941|FG001|Overall Study|Lost to Follow-up|0
7635694|NCT03125902|12049940|FG000|Overall Study|Mastectomy|0
7635695|NCT03125902|12049941|FG001|Overall Study|Mastectomy|1
7635696|NCT03125902|12049940|FG000|Overall Study|Physician Decision|1
7635697|NCT03125902|12049941|FG001|Overall Study|Physician Decision|0
7635698|NCT03125902|12049940|FG000|Overall Study|Withdrawal by Subject|13
7635699|NCT03125902|12049941|FG001|Overall Study|Withdrawal by Subject|25
7635700|NCT03125902|12049940|FG000|Overall Study|Study is ongoing|153
7635701|NCT03125902|12049941|FG001|Overall Study|Study is ongoing|282
7635702|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635703|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635704|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635705|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635706|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
7635707|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
7635708|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635709|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635710|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635711|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635712|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
7635713|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
7635714|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635715|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635716|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635717|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
7635718|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
7635719|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
7635720|NCT03124459|12049954|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635721|NCT03124459|12049955|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635722|NCT03124459|12049956|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635723|NCT03124459|12049957|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
7635724|NCT03124459|12049958|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
7635725|NCT03124459|12049959|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
7635726|NCT03124459|12049954|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635727|NCT03124459|12049955|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635728|NCT03124459|12049956|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635729|NCT03124459|12049957|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635730|NCT03124459|12049958|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
7635731|NCT03124459|12049959|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
7635732|NCT03124459|12049954|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635733|NCT03124459|12049955|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635734|NCT03124459|12049956|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635735|NCT03124459|12049957|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635736|NCT03124459|12049958|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
7635737|NCT03124459|12049959|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
7635738|NCT03106779|12050009|FG000|Overall Study|Lack of Efficacy|33
7635739|NCT03106779|12050010|FG001|Overall Study|Lack of Efficacy|24
7635740|NCT03106779|12050009|FG000|Overall Study|Adverse Event|8
7635741|NCT03106779|12050010|FG001|Overall Study|Adverse Event|16
7635742|NCT03106779|12050009|FG000|Overall Study|Physician Decision|10
7635743|NCT03106779|12050010|FG001|Overall Study|Physician Decision|6
7635744|NCT03106779|12050009|FG000|Overall Study|Patient/guardian decision|4
7635745|NCT03106779|12050010|FG001|Overall Study|Patient/guardian decision|3
7635746|NCT03106779|12050009|FG000|Overall Study|Progressive disease|1
7635747|NCT03106779|12050010|FG001|Overall Study|Progressive disease|3
7635748|NCT03106779|12050009|FG000|Overall Study|Lost to Follow-up|1
7635749|NCT03106779|12050010|FG001|Overall Study|Lost to Follow-up|2
7635750|NCT03106779|12050009|FG000|Overall Study|Death|1
7635751|NCT03106779|12050010|FG001|Overall Study|Death|0
7635752|NCT03106779|12050009|FG000|Overall Study|Protocol Violation|1
7635753|NCT03106779|12050010|FG001|Overall Study|Protocol Violation|0
7635754|NCT03106779|12050009|FG000|Overall Study|Not treated|1
7635755|NCT03106779|12050010|FG001|Overall Study|Not treated|0
7635756|NCT03101930|12050023|FG000|Overall Study|Withdrawal by Subject|2
7635757|NCT03101930|12050024|FG001|Overall Study|Withdrawal by Subject|1
7635758|NCT03101930|12050025|FG002|Overall Study|Withdrawal by Subject|2
7635759|NCT03100149|12050036|FG000|Overall Study|Adverse Event|0
7635760|NCT03100149|12050037|FG001|Overall Study|Adverse Event|1
7635761|NCT03100149|12050038|FG002|Overall Study|Adverse Event|0
7635762|NCT03100149|12050036|FG000|Overall Study|Participant Moved out of Country|0
7635763|NCT03100149|12050037|FG001|Overall Study|Participant Moved out of Country|0
7635764|NCT03100149|12050038|FG002|Overall Study|Participant Moved out of Country|1
7635765|NCT03100149|12050036|FG000|Overall Study|Withdrawal by Subject|0
7635766|NCT03100149|12050037|FG001|Overall Study|Withdrawal by Subject|3
7635767|NCT03100149|12050038|FG002|Overall Study|Withdrawal by Subject|1
7635768|NCT03095118|12050055|FG000|Overall Study|Adverse Event|1
7635769|NCT03095118|12050055|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
7635770|NCT03093428|12050071|FG000|Overall Study|Not eligible for treatment|2
7635771|NCT03093428|12050072|FG001|Overall Study|Not eligible for treatment|1
7635772|NCT03093428|12050071|FG000|Overall Study|Progression|14
7635773|NCT03093428|12050072|FG001|Overall Study|Progression|4
7635774|NCT03093428|12050071|FG000|Overall Study|Death|1
7635775|NCT03093428|12050072|FG001|Overall Study|Death|0
7635776|NCT03093428|12050071|FG000|Overall Study|Adverse Event|1
7635777|NCT03093428|12050072|FG001|Overall Study|Adverse Event|0
7635778|NCT03093428|12050071|FG000|Overall Study|Withdrawal by Subject|1
7635779|NCT03093428|12050072|FG001|Overall Study|Withdrawal by Subject|1
7635780|NCT03091192|12050080|FG000|Overall Study|Study terminated by sponsor|21
7635781|NCT03091192|12050081|FG001|Overall Study|Study terminated by sponsor|14
7635782|NCT03091192|12050080|FG000|Overall Study|Death|9
7635783|NCT03091192|12050081|FG001|Overall Study|Death|13
7635784|NCT03091192|12050080|FG000|Overall Study|Withdrawal by Subject|2
7635785|NCT03091192|12050081|FG001|Overall Study|Withdrawal by Subject|0
7635786|NCT03091192|12050080|FG000|Overall Study|Lost to Follow-up|1
7635787|NCT03091192|12050081|FG001|Overall Study|Lost to Follow-up|0
7635788|NCT03090152|12050090|FG000|Overall Study|Withdrawal by Subject|0
7635789|NCT03090152|12050091|FG001|Overall Study|Withdrawal by Subject|2
7635790|NCT03090152|12050092|FG002|Overall Study|Withdrawal by Subject|1
7635791|NCT03090152|12050090|FG000|Overall Study|Surgery Canceled|1
7635792|NCT03090152|12050091|FG001|Overall Study|Surgery Canceled|0
7635793|NCT03090152|12050092|FG002|Overall Study|Surgery Canceled|0
7635794|NCT03090152|12050090|FG000|Overall Study|Epidural catheter could not be placed|0
7635795|NCT03090152|12050091|FG001|Overall Study|Epidural catheter could not be placed|2
7635796|NCT03090152|12050092|FG002|Overall Study|Epidural catheter could not be placed|0
7635797|NCT03087058|12050125|FG000|Overall Study|Withdrawal by Subject|2
7635798|NCT03087058|12050126|FG001|Overall Study|Withdrawal by Subject|0
7635799|NCT03087058|12050127|FG002|Overall Study|Withdrawal by Subject|0
7635800|NCT03085914|12050150|FG000|Overall Study|Death|6
7635801|NCT03085914|12050151|FG001|Overall Study|Death|6
7635802|NCT03085914|12050152|FG002|Overall Study|Death|4
7635803|NCT03085914|12050153|FG003|Overall Study|Death|1
7635804|NCT03085914|12050154|FG004|Overall Study|Death|5
7635805|NCT03085914|12050155|FG005|Overall Study|Death|2
7635806|NCT03085914|12050156|FG006|Overall Study|Death|2
7635807|NCT03085914|12050150|FG000|Overall Study|Withdrawal by Subject|1
7635808|NCT03085914|12050151|FG001|Overall Study|Withdrawal by Subject|1
7635809|NCT03085914|12050152|FG002|Overall Study|Withdrawal by Subject|2
7635810|NCT03085914|12050153|FG003|Overall Study|Withdrawal by Subject|2
7635811|NCT03085914|12050154|FG004|Overall Study|Withdrawal by Subject|2
7635812|NCT03085914|12050155|FG005|Overall Study|Withdrawal by Subject|0
7635813|NCT03085914|12050156|FG006|Overall Study|Withdrawal by Subject|1
7635814|NCT03085914|12050150|FG000|Overall Study|Lost to Follow-up|0
7635815|NCT03085914|12050151|FG001|Overall Study|Lost to Follow-up|0
7635816|NCT03085914|12050152|FG002|Overall Study|Lost to Follow-up|1
7635817|NCT03085914|12050153|FG003|Overall Study|Lost to Follow-up|0
7635818|NCT03085914|12050154|FG004|Overall Study|Lost to Follow-up|0
7635819|NCT03085914|12050155|FG005|Overall Study|Lost to Follow-up|1
7635820|NCT03085914|12050156|FG006|Overall Study|Lost to Follow-up|1
7635821|NCT03085914|12050150|FG000|Overall Study|Reason was not specified,|2
7635822|NCT03085914|12050151|FG001|Overall Study|Reason was not specified,|2
7635823|NCT03085914|12050152|FG002|Overall Study|Reason was not specified,|2
7635824|NCT03085914|12050153|FG003|Overall Study|Reason was not specified,|3
7635825|NCT03085914|12050154|FG004|Overall Study|Reason was not specified,|3
7635826|NCT03085914|12050155|FG005|Overall Study|Reason was not specified,|3
7635827|NCT03085914|12050156|FG006|Overall Study|Reason was not specified,|6
7635828|NCT03085914|12050150|FG000|Overall Study|Progressive Disease|0
7635829|NCT03085914|12050151|FG001|Overall Study|Progressive Disease|0
7635830|NCT03085914|12050152|FG002|Overall Study|Progressive Disease|2
7635831|NCT03085914|12050153|FG003|Overall Study|Progressive Disease|2
7635832|NCT03085914|12050154|FG004|Overall Study|Progressive Disease|1
7635833|NCT03085914|12050155|FG005|Overall Study|Progressive Disease|1
7635834|NCT03085914|12050156|FG006|Overall Study|Progressive Disease|1
7635835|NCT03085914|12050150|FG000|Overall Study|Study Terminated by the Sponsor|0
7635836|NCT03085914|12050151|FG001|Overall Study|Study Terminated by the Sponsor|0
7635837|NCT03085914|12050152|FG002|Overall Study|Study Terminated by the Sponsor|0
7635838|NCT03085914|12050153|FG003|Overall Study|Study Terminated by the Sponsor|1
7635839|NCT03085914|12050154|FG004|Overall Study|Study Terminated by the Sponsor|2
7635840|NCT03085914|12050155|FG005|Overall Study|Study Terminated by the Sponsor|1
7635841|NCT03085914|12050156|FG006|Overall Study|Study Terminated by the Sponsor|0
7635842|NCT03084471|12050173|FG000|Overall Study|Development of study specific discontinuation criteria|2
7635843|NCT03084471|12050173|FG000|Overall Study|Condition under investigation worsened|84
7635844|NCT03084471|12050173|FG000|Overall Study|Lack of therapeutic response|2
7635845|NCT03084471|12050173|FG000|Overall Study|Protocol Violation|1
7635846|NCT03084471|12050173|FG000|Overall Study|Adverse Event|73
7635847|NCT03084471|12050173|FG000|Overall Study|Withdrawal by Subject|12
7635848|NCT03084471|12050173|FG000|Overall Study|Disease relapse|181
7635849|NCT03084471|12050173|FG000|Overall Study|Subjective disease progression|359
7635850|NCT03084471|12050173|FG000|Overall Study|Other (as recorded)|33
7635851|NCT03084471|12050173|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
7635852|NCT03082677|12050180|FG000|Overall Study|Not Treated|2
7635853|NCT03078582|12050195|FG000|Overall Study|Adverse Event|0
7635854|NCT03078582|12050196|FG001|Overall Study|Adverse Event|8
7635855|NCT03075527|12050202|FG000|Overall Study|Ongoing treatment|2
7635856|NCT03064126|12050226|FG000|Overall Study|Death|6
7635857|NCT03064126|12050227|FG001|Overall Study|Death|2
7635858|NCT03064126|12050228|FG002|Overall Study|Death|2
7635859|NCT03064126|12050229|FG003|Overall Study|Death|1
7635860|NCT03064126|12050226|FG000|Overall Study|Investigator Discretion|1
7635861|NCT03064126|12050227|FG001|Overall Study|Investigator Discretion|0
7635862|NCT03064126|12050228|FG002|Overall Study|Investigator Discretion|0
7635863|NCT03064126|12050229|FG003|Overall Study|Investigator Discretion|0
7635864|NCT03064126|12050226|FG000|Overall Study|Withdrawal by Subject|7
7635865|NCT03064126|12050227|FG001|Overall Study|Withdrawal by Subject|4
7635866|NCT03064126|12050228|FG002|Overall Study|Withdrawal by Subject|0
7635867|NCT03064126|12050229|FG003|Overall Study|Withdrawal by Subject|0
7635868|NCT03064126|12050226|FG000|Overall Study|Subject moved|1
7635869|NCT03064126|12050227|FG001|Overall Study|Subject moved|0
7635870|NCT03064126|12050228|FG002|Overall Study|Subject moved|0
7635871|NCT03064126|12050229|FG003|Overall Study|Subject moved|0
7635872|NCT03064126|12050226|FG000|Overall Study|Protocol Violation|11
7635873|NCT03064126|12050227|FG001|Overall Study|Protocol Violation|1
7635874|NCT03064126|12050228|FG002|Overall Study|Protocol Violation|1
7635875|NCT03064126|12050229|FG003|Overall Study|Protocol Violation|0
7635876|NCT03063632|12050242|FG000|Overall Study|Death|3
7635877|NCT03063632|12050243|FG001|Overall Study|Death|6
7635878|NCT03063632|12050242|FG000|Overall Study|Lost to Follow-up|0
7635879|NCT03063632|12050243|FG001|Overall Study|Lost to Follow-up|1
7635880|NCT03063632|12050242|FG000|Overall Study|Withdrawal by Subject|0
7635881|NCT03063632|12050243|FG001|Overall Study|Withdrawal by Subject|2
7635882|NCT03063632|12050242|FG000|Overall Study|Physician Decision|2
7635883|NCT03063632|12050243|FG001|Overall Study|Physician Decision|0
7635884|NCT03063632|12050242|FG000|Overall Study|Other: Disease progression; starting another treatment|2
7635885|NCT03063632|12050243|FG001|Overall Study|Other: Disease progression; starting another treatment|1
7635886|NCT03057600|12050262|FG000|Overall Study|Adverse Event|0
7635887|NCT03057600|12050263|FG001|Overall Study|Adverse Event|0
7635888|NCT03057600|12050264|FG002|Overall Study|Adverse Event|4
7635889|NCT03057600|12050265|FG003|Overall Study|Adverse Event|0
7635890|NCT03057600|12050262|FG000|Overall Study|Radiologic Disease Progression|8
7635891|NCT03057600|12050263|FG001|Overall Study|Radiologic Disease Progression|7
7635892|NCT03057600|12050264|FG002|Overall Study|Radiologic Disease Progression|13
7635893|NCT03057600|12050265|FG003|Overall Study|Radiologic Disease Progression|10
7635894|NCT03057600|12050262|FG000|Overall Study|Symptomatic Deterioration|0
7635895|NCT03057600|12050263|FG001|Overall Study|Symptomatic Deterioration|1
7635896|NCT03057600|12050264|FG002|Overall Study|Symptomatic Deterioration|1
7635897|NCT03057600|12050265|FG003|Overall Study|Symptomatic Deterioration|0
7635898|NCT03057600|12050262|FG000|Overall Study|Investigator Decision|0
7635899|NCT03057600|12050263|FG001|Overall Study|Investigator Decision|0
7635900|NCT03057600|12050264|FG002|Overall Study|Investigator Decision|1
7635901|NCT03057600|12050265|FG003|Overall Study|Investigator Decision|0
7635902|NCT03057600|12050262|FG000|Overall Study|Study Termination by Sponsor|0
7635903|NCT03057600|12050263|FG001|Overall Study|Study Termination by Sponsor|0
7635904|NCT03057600|12050264|FG002|Overall Study|Study Termination by Sponsor|0
7635905|NCT03057600|12050265|FG003|Overall Study|Study Termination by Sponsor|2
7635906|NCT03057600|12050262|FG000|Overall Study|Withdrawal by Subject|0
7635907|NCT03057600|12050263|FG001|Overall Study|Withdrawal by Subject|1
7635908|NCT03057600|12050264|FG002|Overall Study|Withdrawal by Subject|0
7635909|NCT03057600|12050265|FG003|Overall Study|Withdrawal by Subject|0
7635910|NCT03057600|12050262|FG000|Overall Study|Other, Not Specified|1
7635911|NCT03057600|12050263|FG001|Overall Study|Other, Not Specified|1
7635912|NCT03057600|12050264|FG002|Overall Study|Other, Not Specified|1
7635913|NCT03057600|12050265|FG003|Overall Study|Other, Not Specified|1
7635914|NCT03055858|12050276|FG000|Overall Study|Death|5
7635915|NCT03055858|12050276|FG000|Overall Study|Adverse Event|1
7635916|NCT03043872|12050283|FG000|Overall Study|Withdrawal by Subject|6
7635917|NCT03043872|12050284|FG001|Overall Study|Withdrawal by Subject|6
7635918|NCT03043872|12050285|FG002|Overall Study|Withdrawal by Subject|15
7635919|NCT03043872|12050283|FG000|Overall Study|Lost to Follow-up|2
7635920|NCT03043872|12050284|FG001|Overall Study|Lost to Follow-up|1
7635921|NCT03043872|12050285|FG002|Overall Study|Lost to Follow-up|1
7635922|NCT03043872|12050283|FG000|Overall Study|Death|270
7635923|NCT03043872|12050284|FG001|Overall Study|Death|269
7635924|NCT03043872|12050285|FG002|Overall Study|Death|296
7635925|NCT03043664|12050303|FG000|Overall Study|Lost to Follow-up|1
7635926|NCT03043664|12050303|FG000|Overall Study|In Observation for Overall Survival|6
7635927|NCT03041467|12050313|FG000|Overall Study|Death|36
7635928|NCT03041467|12050314|FG001|Overall Study|Death|32
7635929|NCT03041467|12050313|FG000|Overall Study|Withdrawal by Subject|26
7635930|NCT03041467|12050314|FG001|Overall Study|Withdrawal by Subject|28
7635931|NCT03041467|12050313|FG000|Overall Study|Lost to Follow-up|6
7635932|NCT03041467|12050314|FG001|Overall Study|Lost to Follow-up|7
7635933|NCT03041467|12050313|FG000|Overall Study|Declined consent for study extension|21
7635934|NCT03041467|12050314|FG001|Overall Study|Declined consent for study extension|33
7635935|NCT03041467|12050313|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4
7635936|NCT03041467|12050314|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2
7635937|NCT03041467|12050313|FG000|Overall Study|36 Month visit not completed|2
7635938|NCT03041467|12050314|FG001|Overall Study|36 Month visit not completed|0
7635939|NCT03035227|12050349|FG000|Overall Study|study stopped due to PI leaving institut|1
7635940|NCT03035227|12050350|FG001|Overall Study|study stopped due to PI leaving institut|1
7635941|NCT03032198|12050358|FG000|Overall Study|Screen Fail|1
7635942|NCT03031847|12050366|FG000|Overall Study|Death|1
7635943|NCT03031847|12050367|FG001|Overall Study|Death|1
7635944|NCT03031847|12050368|FG002|Overall Study|Death|2
7635945|NCT03031847|12050369|FG003|Overall Study|Death|3
7635946|NCT03031847|12050366|FG000|Overall Study|Lost to Follow-up|1
7635947|NCT03031847|12050367|FG001|Overall Study|Lost to Follow-up|1
7635948|NCT03031847|12050368|FG002|Overall Study|Lost to Follow-up|2
7635949|NCT03031847|12050369|FG003|Overall Study|Lost to Follow-up|3
7635950|NCT03031782|12050379|FG000|Treatment Period 1|Lack of Efficacy|3
7635951|NCT03031782|12050380|FG001|Treatment Period 1|Lack of Efficacy|0
7635952|NCT03031782|12050381|FG002|Treatment Period 1|Lack of Efficacy|0
7635953|NCT03031782|12050382|FG003|Treatment Period 1|Lack of Efficacy|0
7635954|NCT03031782|12050383|FG004|Treatment Period 1|Lack of Efficacy|0
7635955|NCT03031782|12050379|FG000|Treatment Period 2|Physician Decision|0
7635956|NCT03031782|12050380|FG001|Treatment Period 2|Physician Decision|1
7635957|NCT03031782|12050381|FG002|Treatment Period 2|Physician Decision|0
7635958|NCT03031782|12050382|FG003|Treatment Period 2|Physician Decision|0
7635959|NCT03031782|12050383|FG004|Treatment Period 2|Physician Decision|3
7635960|NCT03031782|12050379|FG000|Treatment Period 2|Lack of Efficacy|0
7635961|NCT03031782|12050380|FG001|Treatment Period 2|Lack of Efficacy|1
7635962|NCT03031782|12050381|FG002|Treatment Period 2|Lack of Efficacy|0
7635963|NCT03031782|12050382|FG003|Treatment Period 2|Lack of Efficacy|0
7635964|NCT03031782|12050383|FG004|Treatment Period 2|Lack of Efficacy|1
7635965|NCT03031782|12050379|FG000|Treatment Period 2|Withdrawal by Subject|0
7635966|NCT03031782|12050380|FG001|Treatment Period 2|Withdrawal by Subject|3
7635967|NCT03031782|12050381|FG002|Treatment Period 2|Withdrawal by Subject|0
7635968|NCT03031782|12050382|FG003|Treatment Period 2|Withdrawal by Subject|0
7635969|NCT03031782|12050383|FG004|Treatment Period 2|Withdrawal by Subject|1
7635970|NCT03031782|12050379|FG000|Treatment Period 2|Adverse Event|0
7635971|NCT03031782|12050380|FG001|Treatment Period 2|Adverse Event|1
7635972|NCT03031782|12050381|FG002|Treatment Period 2|Adverse Event|2
7635973|NCT03031782|12050382|FG003|Treatment Period 2|Adverse Event|0
7635974|NCT03031782|12050383|FG004|Treatment Period 2|Adverse Event|0
7635975|NCT03031782|12050379|FG000|Treatment Period 3|Withdrawal by Subject|0
7635976|NCT03031782|12050380|FG001|Treatment Period 3|Withdrawal by Subject|0
7635977|NCT03031782|12050381|FG002|Treatment Period 3|Withdrawal by Subject|0
7635978|NCT03031782|12050382|FG003|Treatment Period 3|Withdrawal by Subject|1
7635979|NCT03031782|12050383|FG004|Treatment Period 3|Withdrawal by Subject|0
7635980|NCT03025828|12050401|FG000|Overall Study|Lost to Follow-up|1
7635981|NCT03025542|12050407|FG000|Overall Study|Adverse Event|0
7635982|NCT03025542|12050408|FG001|Overall Study|Adverse Event|2
7635983|NCT03025542|12050407|FG000|Overall Study|Lost to Follow-up|1
7635984|NCT03025542|12050408|FG001|Overall Study|Lost to Follow-up|0
7635985|NCT03025542|12050407|FG000|Overall Study|Withdrawal by Subject|1
7635986|NCT03025542|12050408|FG001|Overall Study|Withdrawal by Subject|0
7635987|NCT03022578|12050418|FG000|Overall Study|Adverse Event|1
7635988|NCT03022578|12050418|FG000|Overall Study|Lack of Efficacy|2
7635989|NCT03022578|12050418|FG000|Overall Study|Withdrawal by Subject|1
7635990|NCT03021642|12050422|FG000|Washout Period (21 Days)|Adverse Event|1
7635991|NCT03021642|12050423|FG001|Washout Period (21 Days)|Adverse Event|1
7635992|NCT03021486|12050432|FG000|Overall Study|Withdrawal by Subject|1
7635993|NCT03021486|12050433|FG001|Overall Study|Withdrawal by Subject|1
7635994|NCT03021486|12050434|FG002|Overall Study|Withdrawal by Subject|3
7635995|NCT03021486|12050432|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7
7635996|NCT03021486|12050433|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5
7635997|NCT03021486|12050434|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6
7635998|NCT03020160|12050445|FG000|Overall Study|Continuing to receive emicizumab|7
7635999|NCT03020160|12050446|FG001|Overall Study|Continuing to receive emicizumab|41
7636000|NCT03016312|12050470|FG000|Overall Study|Death|194
7636001|NCT03016312|12050471|FG001|Overall Study|Death|164
7636002|NCT03016312|12050470|FG000|Overall Study|Lost to Follow-up|11
7636003|NCT03016312|12050471|FG001|Overall Study|Lost to Follow-up|12
7636004|NCT03016312|12050470|FG000|Overall Study|Started new therapy, loss of contact|2
7636005|NCT03016312|12050471|FG001|Overall Study|Started new therapy, loss of contact|1
7636006|NCT03016312|12050470|FG000|Overall Study|Physician Decision|0
7636007|NCT03016312|12050471|FG001|Overall Study|Physician Decision|2
7636008|NCT03016312|12050470|FG000|Overall Study|Withdrawal by Subject|34
7636009|NCT03016312|12050471|FG001|Overall Study|Withdrawal by Subject|39
7636010|NCT03008005|12050502|FG000|Overall Study|Physician Decision|1
7636011|NCT03008005|12050503|FG001|Overall Study|Physician Decision|0
7636012|NCT03008005|12050504|FG002|Overall Study|Physician Decision|0
7636013|NCT03008005|12050502|FG000|Overall Study|Withdrawal by Subject|1
7636014|NCT03008005|12050503|FG001|Overall Study|Withdrawal by Subject|0
7636015|NCT03008005|12050504|FG002|Overall Study|Withdrawal by Subject|0
7636016|NCT03008005|12050502|FG000|Overall Study|Ineligible|0
7636017|NCT03008005|12050503|FG001|Overall Study|Ineligible|1
7636018|NCT03008005|12050504|FG002|Overall Study|Ineligible|0
7636019|NCT03006926|12050514|FG000|Overall Study|Death|0
7636020|NCT03006926|12050515|FG001|Overall Study|Death|33
7636021|NCT03006926|12050514|FG000|Overall Study|Ongoing Survival Follow-up|0
7636022|NCT03006926|12050515|FG001|Overall Study|Ongoing Survival Follow-up|26
7636023|NCT03006926|12050514|FG000|Overall Study|Ongoing-on Treatment|0
7636024|NCT03006926|12050515|FG001|Overall Study|Ongoing-on Treatment|36
7636025|NCT03006926|12050514|FG000|Overall Study|Lost to Follow-up|0
7636026|NCT03006926|12050515|FG001|Overall Study|Lost to Follow-up|1
7636027|NCT03006926|12050514|FG000|Overall Study|Withdrawal by Subject|0
7636028|NCT03006926|12050515|FG001|Overall Study|Withdrawal by Subject|2
7636029|NCT03006848|12050523|FG000|Overall Study|Adverse Event|1
7636030|NCT03006848|12050523|FG000|Overall Study|Physician Decision|1
7636031|NCT03006848|12050523|FG000|Overall Study|Lack of Efficacy|16
7636032|NCT03004976|12050542|FG000|Overall Study|Lost to Follow-up|3
7636033|NCT03004976|12050543|FG001|Overall Study|Lost to Follow-up|1
7636034|NCT03004976|12050542|FG000|Overall Study|Physician Decision|1
7636035|NCT03004976|12050543|FG001|Overall Study|Physician Decision|0
7636036|NCT03004976|12050542|FG000|Overall Study|Withdrawal by Subject|1
7636037|NCT03004976|12050543|FG001|Overall Study|Withdrawal by Subject|0
7636038|NCT03003520|12050551|FG000|Induction|Ongoing|1
7636039|NCT03003520|12050552|FG001|Induction|Ongoing|0
7636040|NCT03003520|12050551|FG000|Induction|Adverse Event|4
7636041|NCT03003520|12050552|FG001|Induction|Adverse Event|0
7636042|NCT03003520|12050551|FG000|Induction|Death|1
7636043|NCT03003520|12050552|FG001|Induction|Death|0
7636044|NCT03003520|12050551|FG000|Induction|Palliative care|1
7636045|NCT03003520|12050552|FG001|Induction|Palliative care|0
7636046|NCT03003520|12050551|FG000|Induction|Physician Decision|2
7636047|NCT03003520|12050552|FG001|Induction|Physician Decision|0
7636048|NCT03003520|12050551|FG000|Induction|Withdrawal by Subject|3
7636049|NCT03003520|12050552|FG001|Induction|Withdrawal by Subject|0
7636050|NCT03003520|12050551|FG000|Induction|Progressive disease|1
7636051|NCT03003520|12050552|FG001|Induction|Progressive disease|0
7636052|NCT03003520|12050551|FG000|Consolidation|Ongoing|18
7636053|NCT03003520|12050552|FG001|Consolidation|Ongoing|0
7636054|NCT03003520|12050551|FG000|Consolidation|Adverse Event|2
7636055|NCT03003520|12050552|FG001|Consolidation|Adverse Event|0
7636056|NCT03003520|12050551|FG000|Consolidation|Progressive disease|3
7636057|NCT03003520|12050552|FG001|Consolidation|Progressive disease|1
7636058|NCT03003520|12050551|FG000|Consolidation|Withdrawal by Subject|1
7636059|NCT03003520|12050552|FG001|Consolidation|Withdrawal by Subject|0
7636060|NCT03003520|12050551|FG000|Follow-up|Death|1
7636061|NCT03003520|12050552|FG001|Follow-up|Death|1
7636062|NCT03003520|12050551|FG000|Follow-up|Ongoing|12
7636063|NCT03003520|12050552|FG001|Follow-up|Ongoing|2
7636064|NCT03003520|12050551|FG000|Follow-up|Withdrawal by Subject|1
7636065|NCT03003520|12050552|FG001|Follow-up|Withdrawal by Subject|0
7636066|NCT02999984|12050575|FG000|Overall Study|Treatment Failure|1
7636067|NCT02998840|12050583|FG000|Overall Study|Lost to Follow-up|1
7636068|NCT02998840|12050584|FG001|Overall Study|Lost to Follow-up|1
7636069|NCT02998840|12050585|FG002|Overall Study|Lost to Follow-up|2
7636070|NCT02998840|12050586|FG003|Overall Study|Lost to Follow-up|3
7636071|NCT02998840|12050583|FG000|Overall Study|Withdrawal by Subject|1
7636072|NCT02998840|12050584|FG001|Overall Study|Withdrawal by Subject|1
7636073|NCT02998840|12050585|FG002|Overall Study|Withdrawal by Subject|0
7636074|NCT02998840|12050586|FG003|Overall Study|Withdrawal by Subject|1
7636075|NCT02998840|12050583|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2
7636076|NCT02998840|12050584|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1
7636077|NCT02998840|12050585|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0
7636078|NCT02998840|12050586|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1
7636079|NCT02998528|12050597|FG000|Randomization Period|Adverse event unrelated to study drug|0
7636080|NCT02998528|12050598|FG001|Randomization Period|Adverse event unrelated to study drug|0
7636081|NCT02998528|12050599|FG002|Randomization Period|Adverse event unrelated to study drug|1
7636082|NCT02998528|12050597|FG000|Randomization Period|Participant withdrew consent|0
7636083|NCT02998528|12050598|FG001|Randomization Period|Participant withdrew consent|3
7636084|NCT02998528|12050599|FG002|Randomization Period|Participant withdrew consent|0
7636085|NCT02998528|12050597|FG000|Randomization Period|Participant no longer meets study criteria|1
7636086|NCT02998528|12050598|FG001|Randomization Period|Participant no longer meets study criteria|3
7636087|NCT02998528|12050599|FG002|Randomization Period|Participant no longer meets study criteria|2
7636088|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0
7636089|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7
7636090|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0
7636091|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0
7636092|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4
7636093|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0
7636094|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0
7636095|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1
7636096|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0
7636097|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Disease progression|3
7636098|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Disease progression|2
7636099|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Disease progression|1
7636100|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6
7636101|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14
7636102|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10
7636103|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Death|1
7636104|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Death|0
7636105|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Death|0
7636106|NCT02998528|12050597|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0
7636107|NCT02998528|12050598|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3
7636108|NCT02998528|12050599|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0
7636109|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Disease progression|1
7636110|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Disease progression|0
7636111|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Disease progression|0
7636112|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4
7636113|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5
7636114|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1
7636115|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1
7636116|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0
7636117|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1
7636118|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3
7636119|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1
7636120|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1
7636121|NCT02998528|12050597|FG000|Systemic Adjuvant Treatment Period|Other reasons|0
7636122|NCT02998528|12050598|FG001|Systemic Adjuvant Treatment Period|Other reasons|0
7636123|NCT02998528|12050599|FG002|Systemic Adjuvant Treatment Period|Other reasons|1
7636124|NCT02994927|12050608|FG000|Overall Study|Withdrawal by parent/guardian|0
7636125|NCT02994927|12050609|FG001|Overall Study|Withdrawal by parent/guardian|1
7636126|NCT02994927|12050608|FG000|Overall Study|Did not meet eligibility criteria|0
7636127|NCT02994927|12050609|FG001|Overall Study|Did not meet eligibility criteria|1
7636128|NCT02994927|12050608|FG000|Overall Study|Physician Decision|4
7636129|NCT02994927|12050609|FG001|Overall Study|Physician Decision|3
7636130|NCT02994927|12050608|FG000|Overall Study|Death|4
7636131|NCT02994927|12050609|FG001|Overall Study|Death|2
7636132|NCT02994927|12050608|FG000|Overall Study|Adverse Event|2
7636133|NCT02994927|12050609|FG001|Overall Study|Adverse Event|1
7636134|NCT02994927|12050608|FG000|Overall Study|Withdrawal by Subject|3
7636135|NCT02994927|12050609|FG001|Overall Study|Withdrawal by Subject|6
7636136|NCT02994927|12050608|FG000|Overall Study|Lost to Follow-up|2
7636137|NCT02994927|12050609|FG001|Overall Study|Lost to Follow-up|1
7636138|NCT02991482|12050617|FG000|Overall Study|Disease progression|56
7636139|NCT02991482|12050618|FG001|Overall Study|Disease progression|47
7636140|NCT02991482|12050617|FG000|Overall Study|Death|4
7636141|NCT02991482|12050618|FG001|Overall Study|Death|4
7636142|NCT02991482|12050617|FG000|Overall Study|Adverse Event|1
7636143|NCT02991482|12050618|FG001|Overall Study|Adverse Event|6
7636144|NCT02991482|12050617|FG000|Overall Study|Patient decision|1
7636145|NCT02991482|12050618|FG001|Overall Study|Patient decision|1
7636146|NCT02991482|12050617|FG000|Overall Study|Physician Decision|0
7636147|NCT02991482|12050618|FG001|Overall Study|Physician Decision|6
7636148|NCT02991482|12050617|FG000|Overall Study|Clinical deterioration|1
7636149|NCT02991482|12050618|FG001|Overall Study|Clinical deterioration|0
7636150|NCT02991482|12050617|FG000|Overall Study|Patient feeling too unwell|1
7636151|NCT02991482|12050618|FG001|Overall Study|Patient feeling too unwell|0
7636152|NCT02991482|12050617|FG000|Overall Study|Worsening of performance status|0
7636153|NCT02991482|12050618|FG001|Overall Study|Worsening of performance status|1
7636154|NCT02991482|12050617|FG000|Overall Study|Death prior to study drug initiation|1
7636155|NCT02991482|12050618|FG001|Overall Study|Death prior to study drug initiation|0
7636156|NCT02991482|12050617|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0
7636157|NCT02991482|12050618|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1
7636158|NCT02989194|12050627|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1
7636159|NCT02989194|12050628|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0
7636160|NCT02989194|12050629|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0
7636161|NCT02989194|12050627|FG000|Overall Study|Lost to Follow-up|0
7636162|NCT02989194|12050628|FG001|Overall Study|Lost to Follow-up|1
7636163|NCT02989194|12050629|FG002|Overall Study|Lost to Follow-up|0
7636164|NCT02989194|12050627|FG000|Overall Study|Withdrawal by Subject|0
7636165|NCT02989194|12050628|FG001|Overall Study|Withdrawal by Subject|1
7636166|NCT02989194|12050629|FG002|Overall Study|Withdrawal by Subject|0
7636167|NCT02987543|12050652|FG000|Overall Study|Ongoing study at data cut off|49
7636168|NCT02987543|12050653|FG001|Overall Study|Ongoing study at data cut off|21
7636169|NCT02987543|12050654|FG002|Overall Study|Ongoing study at data cut off|19
7636170|NCT02987543|12050655|FG003|Overall Study|Ongoing study at data cut off|12
7636171|NCT02987543|12050652|FG000|Overall Study|Death|88
7636172|NCT02987543|12050653|FG001|Overall Study|Death|54
7636173|NCT02987543|12050654|FG002|Overall Study|Death|67
7636174|NCT02987543|12050655|FG003|Overall Study|Death|28
7636175|NCT02987543|12050652|FG000|Overall Study|Lost to Follow-up|3
7636176|NCT02987543|12050653|FG001|Overall Study|Lost to Follow-up|0
7636177|NCT02987543|12050654|FG002|Overall Study|Lost to Follow-up|1
7636178|NCT02987543|12050655|FG003|Overall Study|Lost to Follow-up|0
7636179|NCT02987543|12050652|FG000|Overall Study|Screen failure|0
7636180|NCT02987543|12050653|FG001|Overall Study|Screen failure|0
7636181|NCT02987543|12050654|FG002|Overall Study|Screen failure|0
7636182|NCT02987543|12050655|FG003|Overall Study|Screen failure|1
7636183|NCT02987543|12050652|FG000|Overall Study|Withdrawal by Subject|21
7636184|NCT02987543|12050653|FG001|Overall Study|Withdrawal by Subject|7
7636185|NCT02987543|12050654|FG002|Overall Study|Withdrawal by Subject|7
7636186|NCT02987543|12050655|FG003|Overall Study|Withdrawal by Subject|6
7636187|NCT02987543|12050652|FG000|Overall Study|Study terminated by sponsor|1
7636188|NCT02987543|12050653|FG001|Overall Study|Study terminated by sponsor|0
7636189|NCT02987543|12050654|FG002|Overall Study|Study terminated by sponsor|0
7636190|NCT02987543|12050655|FG003|Overall Study|Study terminated by sponsor|0
7636191|NCT02987543|12050652|FG000|Overall Study|Investigator decision|0
7636192|NCT02987543|12050653|FG001|Overall Study|Investigator decision|1
7636193|NCT02987543|12050654|FG002|Overall Study|Investigator decision|0
7636194|NCT02987543|12050655|FG003|Overall Study|Investigator decision|0
7636195|NCT02987543|12050652|FG000|Overall Study|Disease progression|0
7636196|NCT02987543|12050653|FG001|Overall Study|Disease progression|0
7636197|NCT02987543|12050654|FG002|Overall Study|Disease progression|0
7636198|NCT02987543|12050655|FG003|Overall Study|Disease progression|1
7636199|NCT02973425|12050680|FG000|Overall Study|Lost to Follow-up|49
7636200|NCT02973425|12050681|FG001|Overall Study|Lost to Follow-up|53
7636201|NCT02971683|12050700|FG000|Overall Study|Other reasons|0
7636202|NCT02971683|12050701|FG001|Overall Study|Other reasons|1
7636203|NCT02971683|12050700|FG000|Overall Study|Poor/Non-Compliance|0
7636204|NCT02971683|12050701|FG001|Overall Study|Poor/Non-Compliance|1
7636205|NCT02971683|12050700|FG000|Overall Study|Lost to Follow-up|1
7636206|NCT02971683|12050701|FG001|Overall Study|Lost to Follow-up|0
7636207|NCT02971683|12050700|FG000|Overall Study|Participant withdrew consent|1
7636208|NCT02971683|12050701|FG001|Overall Study|Participant withdrew consent|1
7636209|NCT02971683|12050700|FG000|Overall Study|Participant request to discontinue study treatment|1
7636210|NCT02971683|12050701|FG001|Overall Study|Participant request to discontinue study treatment|1
7636211|NCT02971683|12050700|FG000|Overall Study|Adverse Event|1
7636212|NCT02971683|12050701|FG001|Overall Study|Adverse Event|2
7636213|NCT02971683|12050700|FG000|Overall Study|Lack of Efficacy|2
7636214|NCT02971683|12050701|FG001|Overall Study|Lack of Efficacy|2
7636215|NCT02969356|12050711|FG000|Overall Study|Adverse Event|7
7636216|NCT02969356|12050711|FG000|Overall Study|Consent withdrawn|2
7636217|NCT02969356|12050711|FG000|Overall Study|Lost to Follow-up|3
7636218|NCT02969356|12050711|FG000|Overall Study|Did not need to be reinjected|6
7636219|NCT02969356|12050711|FG000|Overall Study|Personal reasons|5
7636220|NCT02968004|12050717|FG000|Overall Study|Adverse Event|1
7636221|NCT02968004|12050718|FG001|Overall Study|Adverse Event|0
7636222|NCT02968004|12050717|FG000|Overall Study|Withdrawal by Subject|0
7636223|NCT02968004|12050718|FG001|Overall Study|Withdrawal by Subject|1
7636224|NCT02964741|12050749|FG000|Overall Study|Protocol Violation|1
7636225|NCT02964741|12050750|FG001|Overall Study|Protocol Violation|0
7636226|NCT02964741|12050751|FG002|Overall Study|Protocol Violation|0
7636227|NCT02964741|12050749|FG000|Overall Study|Withdrawal by Subject|0
7636228|NCT02964741|12050750|FG001|Overall Study|Withdrawal by Subject|1
7636229|NCT02964741|12050751|FG002|Overall Study|Withdrawal by Subject|0
7636230|NCT02964741|12050749|FG000|Overall Study|claustrophobia|1
7636231|NCT02964741|12050750|FG001|Overall Study|claustrophobia|0
7636232|NCT02964741|12050751|FG002|Overall Study|claustrophobia|0
7636233|NCT02963506|12050762|FG000|Double-Blind Period|Adverse Event|0
7636234|NCT02963506|12050763|FG001|Double-Blind Period|Adverse Event|0
7636235|NCT02963506|12050764|FG002|Double-Blind Period|Adverse Event|1
7636236|NCT02963506|12050765|FG003|Double-Blind Period|Adverse Event|0
7636237|NCT02963506|12050766|FG004|Double-Blind Period|Adverse Event|0
7636238|NCT02963506|12050767|FG005|Double-Blind Period|Adverse Event|0
7636239|NCT02963506|12050768|FG006|Double-Blind Period|Adverse Event|0
7636240|NCT02963506|12050769|FG007|Double-Blind Period|Adverse Event|0
7636241|NCT02963506|12050770|FG008|Double-Blind Period|Adverse Event|0
7636242|NCT02963506|12050771|FG009|Double-Blind Period|Adverse Event|0
7636243|NCT02963506|12050772|FG010|Double-Blind Period|Adverse Event|0
7636244|NCT02963506|12050773|FG011|Double-Blind Period|Adverse Event|0
7636245|NCT02963506|12050774|FG012|Double-Blind Period|Adverse Event|0
7636246|NCT02963506|12050762|FG000|Double-Blind Period|Death|0
7636247|NCT02963506|12050763|FG001|Double-Blind Period|Death|0
7636248|NCT02963506|12050764|FG002|Double-Blind Period|Death|0
7636249|NCT02963506|12050765|FG003|Double-Blind Period|Death|1
7636250|NCT02963506|12050766|FG004|Double-Blind Period|Death|0
7636251|NCT02963506|12050767|FG005|Double-Blind Period|Death|0
7636252|NCT02963506|12050768|FG006|Double-Blind Period|Death|0
7636253|NCT02963506|12050769|FG007|Double-Blind Period|Death|0
7636254|NCT02963506|12050770|FG008|Double-Blind Period|Death|0
7636255|NCT02963506|12050771|FG009|Double-Blind Period|Death|0
7636256|NCT02963506|12050772|FG010|Double-Blind Period|Death|0
7636257|NCT02963506|12050773|FG011|Double-Blind Period|Death|0
7636258|NCT02963506|12050774|FG012|Double-Blind Period|Death|0
7636259|NCT02963506|12050762|FG000|Double-Blind Period|Lost to Follow-up|0
7636260|NCT02963506|12050763|FG001|Double-Blind Period|Lost to Follow-up|1
7636261|NCT02963506|12050764|FG002|Double-Blind Period|Lost to Follow-up|0
7636262|NCT02963506|12050765|FG003|Double-Blind Period|Lost to Follow-up|0
7636263|NCT02963506|12050766|FG004|Double-Blind Period|Lost to Follow-up|0
7636264|NCT02963506|12050767|FG005|Double-Blind Period|Lost to Follow-up|0
7636265|NCT02963506|12050768|FG006|Double-Blind Period|Lost to Follow-up|0
7636266|NCT02963506|12050769|FG007|Double-Blind Period|Lost to Follow-up|0
7636267|NCT02963506|12050770|FG008|Double-Blind Period|Lost to Follow-up|0
7636268|NCT02963506|12050771|FG009|Double-Blind Period|Lost to Follow-up|0
7636269|NCT02963506|12050772|FG010|Double-Blind Period|Lost to Follow-up|0
7636270|NCT02963506|12050773|FG011|Double-Blind Period|Lost to Follow-up|0
7636271|NCT02963506|12050774|FG012|Double-Blind Period|Lost to Follow-up|0
7636272|NCT02963506|12050762|FG000|Double-Blind Period|Withdrawal by Subject|0
7636273|NCT02963506|12050763|FG001|Double-Blind Period|Withdrawal by Subject|0
7636274|NCT02963506|12050764|FG002|Double-Blind Period|Withdrawal by Subject|1
7636275|NCT02963506|12050765|FG003|Double-Blind Period|Withdrawal by Subject|1
7636276|NCT02963506|12050766|FG004|Double-Blind Period|Withdrawal by Subject|0
7636277|NCT02963506|12050767|FG005|Double-Blind Period|Withdrawal by Subject|0
7636278|NCT02963506|12050768|FG006|Double-Blind Period|Withdrawal by Subject|0
7636279|NCT02963506|12050769|FG007|Double-Blind Period|Withdrawal by Subject|0
7636280|NCT02963506|12050770|FG008|Double-Blind Period|Withdrawal by Subject|0
7636281|NCT02963506|12050771|FG009|Double-Blind Period|Withdrawal by Subject|0
7636282|NCT02963506|12050772|FG010|Double-Blind Period|Withdrawal by Subject|0
7636283|NCT02963506|12050773|FG011|Double-Blind Period|Withdrawal by Subject|0
7636284|NCT02963506|12050774|FG012|Double-Blind Period|Withdrawal by Subject|0
7636285|NCT02963506|12050762|FG000|Double-Blind Period|No compliance|0
7636286|NCT02963506|12050763|FG001|Double-Blind Period|No compliance|1
7636287|NCT02963506|12050764|FG002|Double-Blind Period|No compliance|0
7636288|NCT02963506|12050765|FG003|Double-Blind Period|No compliance|0
7636289|NCT02963506|12050766|FG004|Double-Blind Period|No compliance|0
7636290|NCT02963506|12050767|FG005|Double-Blind Period|No compliance|0
7636291|NCT02963506|12050768|FG006|Double-Blind Period|No compliance|0
7636292|NCT02963506|12050769|FG007|Double-Blind Period|No compliance|0
7636293|NCT02963506|12050770|FG008|Double-Blind Period|No compliance|0
7636294|NCT02963506|12050771|FG009|Double-Blind Period|No compliance|0
7636295|NCT02963506|12050772|FG010|Double-Blind Period|No compliance|0
7636296|NCT02963506|12050773|FG011|Double-Blind Period|No compliance|0
7636297|NCT02963506|12050774|FG012|Double-Blind Period|No compliance|0
7636298|NCT02963506|12050762|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636299|NCT02963506|12050763|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
7636300|NCT02963506|12050764|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636301|NCT02963506|12050765|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636302|NCT02963506|12050766|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636303|NCT02963506|12050767|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636304|NCT02963506|12050768|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636305|NCT02963506|12050769|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636306|NCT02963506|12050770|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636307|NCT02963506|12050771|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636308|NCT02963506|12050772|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636309|NCT02963506|12050773|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636310|NCT02963506|12050774|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
7636311|NCT02963506|12050762|FG000|Dose-Blind Period|Adverse Event|0
7636312|NCT02963506|12050763|FG001|Dose-Blind Period|Adverse Event|0
7636313|NCT02963506|12050764|FG002|Dose-Blind Period|Adverse Event|0
7636314|NCT02963506|12050765|FG003|Dose-Blind Period|Adverse Event|0
7636315|NCT02963506|12050766|FG004|Dose-Blind Period|Adverse Event|0
7636316|NCT02963506|12050767|FG005|Dose-Blind Period|Adverse Event|1
7636317|NCT02963506|12050768|FG006|Dose-Blind Period|Adverse Event|3
7636318|NCT02963506|12050769|FG007|Dose-Blind Period|Adverse Event|2
7636319|NCT02963506|12050770|FG008|Dose-Blind Period|Adverse Event|2
7636320|NCT02963506|12050771|FG009|Dose-Blind Period|Adverse Event|2
7636321|NCT02963506|12050772|FG010|Dose-Blind Period|Adverse Event|1
7636322|NCT02963506|12050773|FG011|Dose-Blind Period|Adverse Event|1
7636323|NCT02963506|12050774|FG012|Dose-Blind Period|Adverse Event|6
7636324|NCT02963506|12050762|FG000|Dose-Blind Period|Lack of Efficacy|0
7636325|NCT02963506|12050763|FG001|Dose-Blind Period|Lack of Efficacy|0
7636326|NCT02963506|12050764|FG002|Dose-Blind Period|Lack of Efficacy|0
7636327|NCT02963506|12050765|FG003|Dose-Blind Period|Lack of Efficacy|0
7636328|NCT02963506|12050766|FG004|Dose-Blind Period|Lack of Efficacy|0
7636329|NCT02963506|12050767|FG005|Dose-Blind Period|Lack of Efficacy|0
7636330|NCT02963506|12050768|FG006|Dose-Blind Period|Lack of Efficacy|0
7636331|NCT02963506|12050769|FG007|Dose-Blind Period|Lack of Efficacy|1
7636332|NCT02963506|12050770|FG008|Dose-Blind Period|Lack of Efficacy|0
7636333|NCT02963506|12050771|FG009|Dose-Blind Period|Lack of Efficacy|1
7636334|NCT02963506|12050772|FG010|Dose-Blind Period|Lack of Efficacy|0
7636335|NCT02963506|12050773|FG011|Dose-Blind Period|Lack of Efficacy|0
7636336|NCT02963506|12050774|FG012|Dose-Blind Period|Lack of Efficacy|0
7636337|NCT02963506|12050762|FG000|Dose-Blind Period|Lost to Follow-up|0
7636338|NCT02963506|12050763|FG001|Dose-Blind Period|Lost to Follow-up|0
7636339|NCT02963506|12050764|FG002|Dose-Blind Period|Lost to Follow-up|0
7636340|NCT02963506|12050765|FG003|Dose-Blind Period|Lost to Follow-up|0
7636341|NCT02963506|12050766|FG004|Dose-Blind Period|Lost to Follow-up|0
7636342|NCT02963506|12050767|FG005|Dose-Blind Period|Lost to Follow-up|1
7636343|NCT02963506|12050768|FG006|Dose-Blind Period|Lost to Follow-up|0
7636344|NCT02963506|12050769|FG007|Dose-Blind Period|Lost to Follow-up|0
7636345|NCT02963506|12050770|FG008|Dose-Blind Period|Lost to Follow-up|1
7636346|NCT02963506|12050771|FG009|Dose-Blind Period|Lost to Follow-up|0
7636347|NCT02963506|12050772|FG010|Dose-Blind Period|Lost to Follow-up|0
7636348|NCT02963506|12050773|FG011|Dose-Blind Period|Lost to Follow-up|1
7636349|NCT02963506|12050774|FG012|Dose-Blind Period|Lost to Follow-up|0
7636350|NCT02963506|12050762|FG000|Dose-Blind Period|Withdrawal by Subject|0
7636351|NCT02963506|12050763|FG001|Dose-Blind Period|Withdrawal by Subject|0
7636352|NCT02963506|12050764|FG002|Dose-Blind Period|Withdrawal by Subject|0
7636353|NCT02963506|12050765|FG003|Dose-Blind Period|Withdrawal by Subject|0
7636354|NCT02963506|12050766|FG004|Dose-Blind Period|Withdrawal by Subject|0
7636355|NCT02963506|12050767|FG005|Dose-Blind Period|Withdrawal by Subject|1
7636356|NCT02963506|12050768|FG006|Dose-Blind Period|Withdrawal by Subject|2
7636357|NCT02963506|12050769|FG007|Dose-Blind Period|Withdrawal by Subject|2
7636358|NCT02963506|12050770|FG008|Dose-Blind Period|Withdrawal by Subject|0
7636359|NCT02963506|12050771|FG009|Dose-Blind Period|Withdrawal by Subject|1
7636360|NCT02963506|12050772|FG010|Dose-Blind Period|Withdrawal by Subject|0
7636361|NCT02963506|12050773|FG011|Dose-Blind Period|Withdrawal by Subject|0
7636362|NCT02963506|12050774|FG012|Dose-Blind Period|Withdrawal by Subject|0
7636363|NCT02963506|12050762|FG000|Dose-Blind Period|Sponsor decision|0
7636364|NCT02963506|12050763|FG001|Dose-Blind Period|Sponsor decision|0
7636365|NCT02963506|12050764|FG002|Dose-Blind Period|Sponsor decision|0
7636366|NCT02963506|12050765|FG003|Dose-Blind Period|Sponsor decision|0
7636367|NCT02963506|12050766|FG004|Dose-Blind Period|Sponsor decision|0
7636368|NCT02963506|12050767|FG005|Dose-Blind Period|Sponsor decision|1
7636369|NCT02963506|12050768|FG006|Dose-Blind Period|Sponsor decision|0
7636370|NCT02963506|12050769|FG007|Dose-Blind Period|Sponsor decision|0
7636371|NCT02963506|12050770|FG008|Dose-Blind Period|Sponsor decision|0
7636372|NCT02963506|12050771|FG009|Dose-Blind Period|Sponsor decision|0
7636373|NCT02963506|12050772|FG010|Dose-Blind Period|Sponsor decision|0
7636374|NCT02963506|12050773|FG011|Dose-Blind Period|Sponsor decision|0
7636375|NCT02963506|12050774|FG012|Dose-Blind Period|Sponsor decision|0
7636376|NCT02963506|12050762|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
7636377|NCT02963506|12050763|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
7636378|NCT02963506|12050764|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
7636379|NCT02963506|12050765|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
7636380|NCT02963506|12050766|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
7636381|NCT02963506|12050767|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
7636382|NCT02963506|12050768|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
7636383|NCT02963506|12050769|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
7636384|NCT02963506|12050770|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
7636385|NCT02963506|12050771|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
7636386|NCT02963506|12050772|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
7636387|NCT02963506|12050773|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
7636388|NCT02963506|12050774|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
7636389|NCT02954887|12050803|FG000|Overall Study|Withdrawal by Subject|3
7636390|NCT02954887|12050803|FG000|Overall Study|Lack of Efficacy|3
7636391|NCT02954887|12050803|FG000|Overall Study|Other|1
7636392|NCT02951767|12050815|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
7636393|NCT02951767|12050815|FG000|Overall Study|Withdrawal by Subject|5
7636394|NCT02951767|12050815|FG000|Overall Study|Death|59
7636395|NCT02951767|12050815|FG000|Overall Study|Lost to Follow-up|1
7636396|NCT02949128|12050829|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
7636397|NCT02949128|12050829|FG000|Initial Evaluation Period|Adverse Event|3
7636398|NCT02949128|12050829|FG000|Initial Evaluation Period|Death|2
7636399|NCT02949128|12050829|FG000|Initial Evaluation Period|Physician Decision|1
7636400|NCT02949128|12050829|FG000|Initial Evaluation Period|Protocol Violation|1
7636401|NCT02949128|12050829|FG000|Extension Period|Withdrawal by Subject|5
7636402|NCT02949128|12050829|FG000|Extension Period|Protocol Violation|1
7636403|NCT02949128|12050829|FG000|Extension Period|Physician Decision|2
7636404|NCT02949128|12050829|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41
7636405|NCT02946931|12050833|FG000|Overall Study|Did not require collection of CRFs|588
7636406|NCT02946931|12050833|FG000|Overall Study|Other than listed|37
7636407|NCT02946931|12050833|FG000|Overall Study|Discharge from hospital|118
7636408|NCT02946931|12050833|FG000|Overall Study|Adverse Event|81
7636409|NCT02946931|12050833|FG000|Overall Study|CRFs not valid|1
7636410|NCT02946931|12050833|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
7636411|NCT02946463|12050839|FG000|Primary Evaluation Period|Physician Decision|0
7636412|NCT02946463|12050840|FG001|Primary Evaluation Period|Physician Decision|1
7636413|NCT02946463|12050839|FG000|Primary Evaluation Period|Withdrawal by Subject|0
7636414|NCT02946463|12050840|FG001|Primary Evaluation Period|Withdrawal by Subject|1
7636415|NCT02938520|12050852|FG000|Overall Study|On-going at the time of analysis|258
7636416|NCT02938520|12050853|FG001|Overall Study|On-going at the time of analysis|261
7636417|NCT02938520|12050852|FG000|Overall Study|Physician Decision|2
7636418|NCT02938520|12050853|FG001|Overall Study|Physician Decision|5
7636419|NCT02938520|12050852|FG000|Overall Study|Lost to Follow-up|2
7636420|NCT02938520|12050853|FG001|Overall Study|Lost to Follow-up|2
7636421|NCT02938520|12050852|FG000|Overall Study|Withdrawal by Subject|7
7636422|NCT02938520|12050853|FG001|Overall Study|Withdrawal by Subject|7
7636423|NCT02938520|12050852|FG000|Overall Study|Protocol Violation|0
7636424|NCT02938520|12050853|FG001|Overall Study|Protocol Violation|1
7636425|NCT02938520|12050852|FG000|Overall Study|Lack of Efficacy|5
7636426|NCT02938520|12050853|FG001|Overall Study|Lack of Efficacy|3
7636427|NCT02938520|12050852|FG000|Overall Study|Adverse Event|9
7636428|NCT02938520|12050853|FG001|Overall Study|Adverse Event|4
7636429|NCT02937818|12050866|FG000|Overall Study|Participants decision|1
7636430|NCT02937818|12050867|FG001|Overall Study|Participants decision|0
7636431|NCT02937818|12050868|FG002|Overall Study|Participants decision|1
7636432|NCT02937818|12050869|FG003|Overall Study|Participants decision|1
7636433|NCT02937818|12050866|FG000|Overall Study|Adverse Event|2
7636434|NCT02937818|12050867|FG001|Overall Study|Adverse Event|4
7636435|NCT02937818|12050868|FG002|Overall Study|Adverse Event|1
7636436|NCT02937818|12050869|FG003|Overall Study|Adverse Event|1
7636437|NCT02937818|12050866|FG000|Overall Study|Disease progression|17
7636438|NCT02937818|12050867|FG001|Overall Study|Disease progression|14
7636439|NCT02937818|12050868|FG002|Overall Study|Disease progression|7
7636440|NCT02937818|12050869|FG003|Overall Study|Disease progression|18
7636441|NCT02937818|12050866|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
7636442|NCT02937818|12050867|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
7636443|NCT02937818|12050868|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7636444|NCT02937818|12050869|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
7636445|NCT02937818|12050866|FG000|Overall Study|Condition under investigation worsened|0
7636446|NCT02937818|12050867|FG001|Overall Study|Condition under investigation worsened|0
7636447|NCT02937818|12050868|FG002|Overall Study|Condition under investigation worsened|1
7636448|NCT02937818|12050869|FG003|Overall Study|Condition under investigation worsened|0
7636449|NCT02937818|12050866|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636450|NCT02937818|12050867|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636451|NCT02937818|12050868|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
7636452|NCT02937818|12050869|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
7636453|NCT02933489|12050884|FG000|Overall Study|Ineligible|3
7636454|NCT02933489|12050885|FG001|Overall Study|Ineligible|3
7636455|NCT02933489|12050884|FG000|Overall Study|Withdrawal by Subject|27
7636456|NCT02933489|12050885|FG001|Overall Study|Withdrawal by Subject|18
7636457|NCT02933489|12050884|FG000|Overall Study|Unable to complete exams (other)|14
7636458|NCT02933489|12050885|FG001|Overall Study|Unable to complete exams (other)|7
7636459|NCT02928224|12050900|FG000|Overall Study|Randomized, Not Treated|0
7636460|NCT02928224|12050901|FG001|Overall Study|Randomized, Not Treated|2
7636461|NCT02928224|12050902|FG002|Overall Study|Randomized, Not Treated|4
7636462|NCT02928224|12050903|FG003|Overall Study|Randomized, Not Treated|28
7636463|NCT02928224|12050900|FG000|Overall Study|Treatment Ongoing|6
7636464|NCT02928224|12050901|FG001|Overall Study|Treatment Ongoing|78
7636465|NCT02928224|12050902|FG002|Overall Study|Treatment Ongoing|78
7636466|NCT02928224|12050903|FG003|Overall Study|Treatment Ongoing|37
7636467|NCT02928224|12050900|FG000|Overall Study|Progressive Disease|23
7636468|NCT02928224|12050901|FG001|Overall Study|Progressive Disease|104
7636469|NCT02928224|12050902|FG002|Overall Study|Progressive Disease|101
7636470|NCT02928224|12050903|FG003|Overall Study|Progressive Disease|103
7636471|NCT02928224|12050900|FG000|Overall Study|Adverse Event|2
7636472|NCT02928224|12050901|FG001|Overall Study|Adverse Event|11
7636473|NCT02928224|12050902|FG002|Overall Study|Adverse Event|11
7636474|NCT02928224|12050903|FG003|Overall Study|Adverse Event|10
7636475|NCT02928224|12050900|FG000|Overall Study|Changes in Patient's Condition|3
7636476|NCT02928224|12050901|FG001|Overall Study|Changes in Patient's Condition|9
7636477|NCT02928224|12050902|FG002|Overall Study|Changes in Patient's Condition|9
7636478|NCT02928224|12050903|FG003|Overall Study|Changes in Patient's Condition|13
7636479|NCT02928224|12050900|FG000|Overall Study|Death|1
7636480|NCT02928224|12050901|FG001|Overall Study|Death|7
7636481|NCT02928224|12050902|FG002|Overall Study|Death|5
7636482|NCT02928224|12050903|FG003|Overall Study|Death|11
7636483|NCT02928224|12050900|FG000|Overall Study|Withdrawal by Subject|1
7636484|NCT02928224|12050901|FG001|Overall Study|Withdrawal by Subject|4
7636485|NCT02928224|12050902|FG002|Overall Study|Withdrawal by Subject|3
7636486|NCT02928224|12050903|FG003|Overall Study|Withdrawal by Subject|9
7636487|NCT02928224|12050900|FG000|Overall Study|Dose Interruptions>28|1
7636488|NCT02928224|12050901|FG001|Overall Study|Dose Interruptions>28|2
7636489|NCT02928224|12050902|FG002|Overall Study|Dose Interruptions>28|2
7636490|NCT02928224|12050903|FG003|Overall Study|Dose Interruptions>28|4
7636491|NCT02928224|12050900|FG000|Overall Study|Patient Decision to Discontinue Drug|0
7636492|NCT02928224|12050901|FG001|Overall Study|Patient Decision to Discontinue Drug|2
7636493|NCT02928224|12050902|FG002|Overall Study|Patient Decision to Discontinue Drug|2
7636494|NCT02928224|12050903|FG003|Overall Study|Patient Decision to Discontinue Drug|4
7636495|NCT02928224|12050900|FG000|Overall Study|Physician Decision|0
7636496|NCT02928224|12050901|FG001|Overall Study|Physician Decision|2
7636497|NCT02928224|12050902|FG002|Overall Study|Physician Decision|4
7636498|NCT02928224|12050903|FG003|Overall Study|Physician Decision|2
7636499|NCT02928224|12050900|FG000|Overall Study|not listed|0
7636500|NCT02928224|12050901|FG001|Overall Study|not listed|3
7636501|NCT02928224|12050902|FG002|Overall Study|not listed|1
7636502|NCT02928224|12050903|FG003|Overall Study|not listed|0
7636503|NCT02927301|12050918|FG000|Overall Study|Adverse Event|7
7636504|NCT02927301|12050918|FG000|Overall Study|Withdrawal by Subject|1
7636505|NCT02927301|12050918|FG000|Overall Study|Physician Decision|2
7636506|NCT02927262|12050924|FG000|Overall Study|Adverse Event|7
7636507|NCT02927262|12050925|FG001|Overall Study|Adverse Event|1
7636508|NCT02927262|12050924|FG000|Overall Study|Death|1
7636509|NCT02927262|12050925|FG001|Overall Study|Death|0
7636510|NCT02927262|12050924|FG000|Overall Study|Withdrawal by Subject|3
7636511|NCT02927262|12050925|FG001|Overall Study|Withdrawal by Subject|0
7636512|NCT02927262|12050924|FG000|Overall Study|Disease Relapse|23
7636513|NCT02927262|12050925|FG001|Overall Study|Disease Relapse|18
7636514|NCT02927262|12050924|FG000|Overall Study|Miscellaneous|5
7636515|NCT02927262|12050925|FG001|Overall Study|Miscellaneous|4
7636516|NCT02927262|12050924|FG000|Overall Study|Ongoing|4
7636517|NCT02927262|12050925|FG001|Overall Study|Ongoing|0
7636518|NCT02927080|12050941|FG000|Overall Study|Withdrawal by Subject|0
7636519|NCT02927080|12050942|FG001|Overall Study|Withdrawal by Subject|0
7636520|NCT02927080|12050943|FG002|Overall Study|Withdrawal by Subject|0
7636521|NCT02927080|12050944|FG003|Overall Study|Withdrawal by Subject|0
7636522|NCT02927080|12050945|FG004|Overall Study|Withdrawal by Subject|1
7636523|NCT02927080|12050946|FG005|Overall Study|Withdrawal by Subject|0
7636524|NCT02927080|12050947|FG006|Overall Study|Withdrawal by Subject|1
7636525|NCT02927080|12050948|FG007|Overall Study|Withdrawal by Subject|1
7636526|NCT02927080|12050949|FG008|Overall Study|Withdrawal by Subject|0
7636527|NCT02927080|12050950|FG009|Overall Study|Withdrawal by Subject|2
7636528|NCT02927080|12050941|FG000|Overall Study|Willingness to comply with protocol|0
7636529|NCT02927080|12050942|FG001|Overall Study|Willingness to comply with protocol|0
7636530|NCT02927080|12050943|FG002|Overall Study|Willingness to comply with protocol|0
7636531|NCT02927080|12050944|FG003|Overall Study|Willingness to comply with protocol|0
7636532|NCT02927080|12050945|FG004|Overall Study|Willingness to comply with protocol|0
7636533|NCT02927080|12050946|FG005|Overall Study|Willingness to comply with protocol|0
7636534|NCT02927080|12050947|FG006|Overall Study|Willingness to comply with protocol|0
7636535|NCT02927080|12050948|FG007|Overall Study|Willingness to comply with protocol|0
7636536|NCT02927080|12050949|FG008|Overall Study|Willingness to comply with protocol|0
7636537|NCT02927080|12050950|FG009|Overall Study|Willingness to comply with protocol|1
7636538|NCT02927080|12050941|FG000|Overall Study|Study terminated by Sponsor|0
7636539|NCT02927080|12050942|FG001|Overall Study|Study terminated by Sponsor|0
7636540|NCT02927080|12050943|FG002|Overall Study|Study terminated by Sponsor|0
7636541|NCT02927080|12050944|FG003|Overall Study|Study terminated by Sponsor|0
7636542|NCT02927080|12050945|FG004|Overall Study|Study terminated by Sponsor|0
7636543|NCT02927080|12050946|FG005|Overall Study|Study terminated by Sponsor|0
7636544|NCT02927080|12050947|FG006|Overall Study|Study terminated by Sponsor|6
7636545|NCT02927080|12050948|FG007|Overall Study|Study terminated by Sponsor|7
7636546|NCT02927080|12050949|FG008|Overall Study|Study terminated by Sponsor|2
7636547|NCT02927080|12050950|FG009|Overall Study|Study terminated by Sponsor|3
7636548|NCT02927080|12050941|FG000|Overall Study|Adverse Event|0
7636549|NCT02927080|12050942|FG001|Overall Study|Adverse Event|1
7636550|NCT02927080|12050943|FG002|Overall Study|Adverse Event|0
7636551|NCT02927080|12050944|FG003|Overall Study|Adverse Event|0
7636552|NCT02927080|12050945|FG004|Overall Study|Adverse Event|0
7636553|NCT02927080|12050946|FG005|Overall Study|Adverse Event|0
7636554|NCT02927080|12050947|FG006|Overall Study|Adverse Event|0
7636555|NCT02927080|12050948|FG007|Overall Study|Adverse Event|1
7636556|NCT02927080|12050949|FG008|Overall Study|Adverse Event|0
7636557|NCT02927080|12050950|FG009|Overall Study|Adverse Event|1
7636558|NCT02927080|12050941|FG000|Overall Study|Other|0
7636559|NCT02927080|12050942|FG001|Overall Study|Other|0
7636560|NCT02927080|12050943|FG002|Overall Study|Other|0
7636561|NCT02927080|12050944|FG003|Overall Study|Other|0
7636562|NCT02927080|12050945|FG004|Overall Study|Other|0
7636563|NCT02927080|12050946|FG005|Overall Study|Other|0
7636564|NCT02927080|12050947|FG006|Overall Study|Other|1
7636565|NCT02927080|12050948|FG007|Overall Study|Other|0
7636566|NCT02927080|12050949|FG008|Overall Study|Other|1
7636567|NCT02927080|12050950|FG009|Overall Study|Other|0
7636568|NCT02923180|12050995|FG000|Overall Study|Off Study Due to Detectable PSA|13
7636569|NCT02923180|12050995|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
7636570|NCT02921919|12051001|FG000|Overall Study|Other|5
7636571|NCT02921919|12051002|FG001|Overall Study|Other|6
7636572|NCT02921919|12051001|FG000|Overall Study|Lost to Follow-up|0
7636573|NCT02921919|12051002|FG001|Overall Study|Lost to Follow-up|1
7636574|NCT02921919|12051001|FG000|Overall Study|Withdrawal by Subject|5
7636575|NCT02921919|12051002|FG001|Overall Study|Withdrawal by Subject|1
7636576|NCT02921919|12051001|FG000|Overall Study|Disease Progression|47
7636577|NCT02921919|12051002|FG001|Overall Study|Disease Progression|38
7636578|NCT02921919|12051001|FG000|Overall Study|Physician Decision|3
7636579|NCT02921919|12051002|FG001|Overall Study|Physician Decision|2
7636580|NCT02921919|12051001|FG000|Overall Study|Adverse Event|6
7636581|NCT02921919|12051002|FG001|Overall Study|Adverse Event|4
7636582|NCT02918292|12051013|FG000|Study Enrollment Prior to Transplant|Death|1
7636583|NCT02918292|12051013|FG000|Study Follow up After Transplant|Death|6
7636584|NCT02908685|12051029|FG000|Part 1 Exploratory|Withdrawal by Subject|0
7636585|NCT02908685|12051030|FG001|Part 1 Exploratory|Withdrawal by Subject|1
7636586|NCT02908685|12051031|FG002|Part 1 Exploratory|Withdrawal by Subject|0
7636587|NCT02908685|12051032|FG003|Part 1 Exploratory|Withdrawal by Subject|0
7636588|NCT02908685|12051033|FG004|Part 1 Exploratory|Withdrawal by Subject|0
7636589|NCT02908685|12051034|FG005|Part 1 Exploratory|Withdrawal by Subject|0
7636590|NCT02908685|12051035|FG006|Part 1 Exploratory|Withdrawal by Subject|0
7636591|NCT02908685|12051036|FG007|Part 1 Exploratory|Withdrawal by Subject|0
7636592|NCT02908685|12051037|FG008|Part 1 Exploratory|Withdrawal by Subject|0
7636593|NCT02908685|12051038|FG009|Part 1 Exploratory|Withdrawal by Subject|0
7636594|NCT02908685|12051039|FG010|Part 1 Exploratory|Withdrawal by Subject|0
7636595|NCT02908685|12051040|FG011|Part 1 Exploratory|Withdrawal by Subject|0
7636596|NCT02908685|12051029|FG000|Part 2 Confirmatory|Changed to Spinraza|0
7636597|NCT02908685|12051030|FG001|Part 2 Confirmatory|Changed to Spinraza|0
7636598|NCT02908685|12051031|FG002|Part 2 Confirmatory|Changed to Spinraza|0
7636599|NCT02908685|12051032|FG003|Part 2 Confirmatory|Changed to Spinraza|0
7636600|NCT02908685|12051033|FG004|Part 2 Confirmatory|Changed to Spinraza|0
7636601|NCT02908685|12051034|FG005|Part 2 Confirmatory|Changed to Spinraza|0
7636602|NCT02908685|12051035|FG006|Part 2 Confirmatory|Changed to Spinraza|0
7636603|NCT02908685|12051036|FG007|Part 2 Confirmatory|Changed to Spinraza|0
7636604|NCT02908685|12051037|FG008|Part 2 Confirmatory|Changed to Spinraza|0
7636605|NCT02908685|12051038|FG009|Part 2 Confirmatory|Changed to Spinraza|0
7636606|NCT02908685|12051039|FG010|Part 2 Confirmatory|Changed to Spinraza|2
7636607|NCT02908685|12051040|FG011|Part 2 Confirmatory|Changed to Spinraza|1
7636608|NCT02908685|12051029|FG000|Part 2 Confirmatory|Changed to other treatment|0
7636609|NCT02908685|12051030|FG001|Part 2 Confirmatory|Changed to other treatment|0
7636610|NCT02908685|12051031|FG002|Part 2 Confirmatory|Changed to other treatment|0
7636611|NCT02908685|12051032|FG003|Part 2 Confirmatory|Changed to other treatment|0
7636612|NCT02908685|12051033|FG004|Part 2 Confirmatory|Changed to other treatment|0
7636613|NCT02908685|12051034|FG005|Part 2 Confirmatory|Changed to other treatment|0
7636614|NCT02908685|12051035|FG006|Part 2 Confirmatory|Changed to other treatment|0
7636615|NCT02908685|12051036|FG007|Part 2 Confirmatory|Changed to other treatment|0
7636616|NCT02908685|12051037|FG008|Part 2 Confirmatory|Changed to other treatment|0
7636617|NCT02908685|12051038|FG009|Part 2 Confirmatory|Changed to other treatment|0
7636618|NCT02908685|12051039|FG010|Part 2 Confirmatory|Changed to other treatment|1
7636619|NCT02908685|12051040|FG011|Part 2 Confirmatory|Changed to other treatment|0
7636620|NCT02908672|12051059|FG000|Overall Study|Death|112
7636621|NCT02908672|12051060|FG001|Overall Study|Death|93
7636622|NCT02908672|12051059|FG000|Overall Study|Lost to Follow-up|3
7636623|NCT02908672|12051060|FG001|Overall Study|Lost to Follow-up|3
7636624|NCT02908672|12051059|FG000|Overall Study|Other|2
7636625|NCT02908672|12051060|FG001|Overall Study|Other|0
7636626|NCT02908672|12051059|FG000|Overall Study|Protocol Violation|1
7636627|NCT02908672|12051060|FG001|Overall Study|Protocol Violation|1
7636628|NCT02908672|12051059|FG000|Overall Study|Withdrawal by Subject|13
7636629|NCT02908672|12051060|FG001|Overall Study|Withdrawal by Subject|18
7636630|NCT02908672|12051059|FG000|Overall Study|Study is ongoing|124
7636631|NCT02908672|12051060|FG001|Overall Study|Study is ongoing|141
7636632|NCT02908672|12051059|FG000|Overall Study|Discontinued the study during run-in|3
7636633|NCT02908672|12051060|FG001|Overall Study|Discontinued the study during run-in|0
7636634|NCT02903914|12051074|FG000|Overall Study|Adverse Event|0
7636635|NCT02903914|12051075|FG001|Overall Study|Adverse Event|0
7636636|NCT02903914|12051076|FG002|Overall Study|Adverse Event|1
7636637|NCT02903914|12051077|FG003|Overall Study|Adverse Event|0
7636638|NCT02903914|12051078|FG004|Overall Study|Adverse Event|0
7636639|NCT02903914|12051079|FG005|Overall Study|Adverse Event|1
7636640|NCT02903914|12051080|FG006|Overall Study|Adverse Event|2
7636641|NCT02903914|12051081|FG007|Overall Study|Adverse Event|1
7636642|NCT02903914|12051074|FG000|Overall Study|Withdrawal by Subject|3
7636643|NCT02903914|12051075|FG001|Overall Study|Withdrawal by Subject|1
7636644|NCT02903914|12051076|FG002|Overall Study|Withdrawal by Subject|28
7636645|NCT02903914|12051077|FG003|Overall Study|Withdrawal by Subject|0
7636646|NCT02903914|12051078|FG004|Overall Study|Withdrawal by Subject|1
7636647|NCT02903914|12051079|FG005|Overall Study|Withdrawal by Subject|1
7636648|NCT02903914|12051080|FG006|Overall Study|Withdrawal by Subject|12
7636649|NCT02903914|12051081|FG007|Overall Study|Withdrawal by Subject|0
7636650|NCT02903914|12051074|FG000|Overall Study|Progressive Disease|1
7636651|NCT02903914|12051075|FG001|Overall Study|Progressive Disease|0
7636652|NCT02903914|12051076|FG002|Overall Study|Progressive Disease|4
7636653|NCT02903914|12051077|FG003|Overall Study|Progressive Disease|0
7636654|NCT02903914|12051078|FG004|Overall Study|Progressive Disease|0
7636655|NCT02903914|12051079|FG005|Overall Study|Progressive Disease|0
7636656|NCT02903914|12051080|FG006|Overall Study|Progressive Disease|2
7636657|NCT02903914|12051081|FG007|Overall Study|Progressive Disease|4
7636658|NCT02903914|12051074|FG000|Overall Study|Death|0
7636659|NCT02903914|12051075|FG001|Overall Study|Death|0
7636660|NCT02903914|12051076|FG002|Overall Study|Death|9
7636661|NCT02903914|12051077|FG003|Overall Study|Death|0
7636662|NCT02903914|12051078|FG004|Overall Study|Death|1
7636663|NCT02903914|12051079|FG005|Overall Study|Death|3
7636664|NCT02903914|12051080|FG006|Overall Study|Death|24
7636665|NCT02903914|12051081|FG007|Overall Study|Death|0
7636666|NCT02903914|12051074|FG000|Overall Study|Lost to Follow-up|0
7636667|NCT02903914|12051075|FG001|Overall Study|Lost to Follow-up|1
7636668|NCT02903914|12051076|FG002|Overall Study|Lost to Follow-up|0
7636669|NCT02903914|12051077|FG003|Overall Study|Lost to Follow-up|0
7636670|NCT02903914|12051078|FG004|Overall Study|Lost to Follow-up|2
7636671|NCT02903914|12051079|FG005|Overall Study|Lost to Follow-up|0
7636672|NCT02903914|12051080|FG006|Overall Study|Lost to Follow-up|1
7636673|NCT02903914|12051081|FG007|Overall Study|Lost to Follow-up|0
7636674|NCT02903914|12051074|FG000|Overall Study|Physician Decision|0
7636675|NCT02903914|12051075|FG001|Overall Study|Physician Decision|0
7636676|NCT02903914|12051076|FG002|Overall Study|Physician Decision|1
7636677|NCT02903914|12051077|FG003|Overall Study|Physician Decision|0
7636678|NCT02903914|12051078|FG004|Overall Study|Physician Decision|0
7636679|NCT02903914|12051079|FG005|Overall Study|Physician Decision|0
7636680|NCT02903914|12051080|FG006|Overall Study|Physician Decision|1
7636681|NCT02903914|12051081|FG007|Overall Study|Physician Decision|0
7636682|NCT02903914|12051074|FG000|Overall Study|Symptomatic Deterioration|0
7636683|NCT02903914|12051075|FG001|Overall Study|Symptomatic Deterioration|0
7636684|NCT02903914|12051076|FG002|Overall Study|Symptomatic Deterioration|1
7636685|NCT02903914|12051077|FG003|Overall Study|Symptomatic Deterioration|0
7636686|NCT02903914|12051078|FG004|Overall Study|Symptomatic Deterioration|0
7636687|NCT02903914|12051079|FG005|Overall Study|Symptomatic Deterioration|0
7636688|NCT02903914|12051080|FG006|Overall Study|Symptomatic Deterioration|0
7636689|NCT02903914|12051081|FG007|Overall Study|Symptomatic Deterioration|0
7636690|NCT02903914|12051074|FG000|Overall Study|New Cancer Therapy|2
7636691|NCT02903914|12051075|FG001|Overall Study|New Cancer Therapy|2
7636692|NCT02903914|12051076|FG002|Overall Study|New Cancer Therapy|21
7636693|NCT02903914|12051077|FG003|Overall Study|New Cancer Therapy|4
7636694|NCT02903914|12051078|FG004|Overall Study|New Cancer Therapy|3
7636695|NCT02903914|12051079|FG005|Overall Study|New Cancer Therapy|6
7636696|NCT02903914|12051080|FG006|Overall Study|New Cancer Therapy|55
7636697|NCT02903914|12051081|FG007|Overall Study|New Cancer Therapy|0
7636698|NCT02903914|12051074|FG000|Overall Study|Reasoning not specified|2
7636699|NCT02903914|12051075|FG001|Overall Study|Reasoning not specified|3
7636700|NCT02903914|12051076|FG002|Overall Study|Reasoning not specified|20
7636701|NCT02903914|12051077|FG003|Overall Study|Reasoning not specified|3
7636702|NCT02903914|12051078|FG004|Overall Study|Reasoning not specified|3
7636703|NCT02903914|12051079|FG005|Overall Study|Reasoning not specified|3
7636704|NCT02903914|12051080|FG006|Overall Study|Reasoning not specified|20
7636705|NCT02903914|12051081|FG007|Overall Study|Reasoning not specified|0
7636706|NCT02901548|12051101|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
7636707|NCT02899299|12051107|FG000|Pre-treatment|Participant request to discontinue study treatment|0
7636708|NCT02899299|12051108|FG001|Pre-treatment|Participant request to discontinue study treatment|3
7636709|NCT02899299|12051107|FG000|Pre-treatment|Participant withdrew consent|1
7636710|NCT02899299|12051108|FG001|Pre-treatment|Participant withdrew consent|11
7636711|NCT02899299|12051107|FG000|Pre-treatment|Participant no longer meets study criteria|2
7636712|NCT02899299|12051108|FG001|Pre-treatment|Participant no longer meets study criteria|3
7636713|NCT02899299|12051107|FG000|Pre-treatment|Not reported|0
7636714|NCT02899299|12051108|FG001|Pre-treatment|Not reported|1
7636715|NCT02899299|12051107|FG000|Treatment|Disease Progression|182
7636716|NCT02899299|12051108|FG001|Treatment|Disease Progression|44
7636717|NCT02899299|12051107|FG000|Treatment|Study Drug Toxicity|59
7636718|NCT02899299|12051108|FG001|Treatment|Study Drug Toxicity|24
7636719|NCT02899299|12051107|FG000|Treatment|Adverse Event unrelated to Study Drug|12
7636720|NCT02899299|12051108|FG001|Treatment|Adverse Event unrelated to Study Drug|9
7636721|NCT02899299|12051107|FG000|Treatment|Participant request to discontinue Study treatment|4
7636722|NCT02899299|12051108|FG001|Treatment|Participant request to discontinue Study treatment|10
7636723|NCT02899299|12051107|FG000|Treatment|Participant withdrew consent|6
7636724|NCT02899299|12051108|FG001|Treatment|Participant withdrew consent|3
7636725|NCT02899299|12051107|FG000|Treatment|Lost to Follow-up|0
7636726|NCT02899299|12051108|FG001|Treatment|Lost to Follow-up|1
7636727|NCT02899299|12051107|FG000|Treatment|Maximum Clinical Benefit|10
7636728|NCT02899299|12051108|FG001|Treatment|Maximum Clinical Benefit|2
7636729|NCT02899299|12051107|FG000|Treatment|Poor/Non-compliance|1
7636730|NCT02899299|12051108|FG001|Treatment|Poor/Non-compliance|0
7636731|NCT02899299|12051107|FG000|Treatment|Participant no longer meets Study criteria|4
7636732|NCT02899299|12051108|FG001|Treatment|Participant no longer meets Study criteria|0
7636733|NCT02899299|12051107|FG000|Treatment|Administrative reason by Sponsor|2
7636734|NCT02899299|12051108|FG001|Treatment|Administrative reason by Sponsor|0
7636735|NCT02899299|12051107|FG000|Treatment|Other reasons|11
7636736|NCT02899299|12051108|FG001|Treatment|Other reasons|2
7636737|NCT02899299|12051107|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
7636738|NCT02899299|12051108|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
7636739|NCT02898259|12051119|FG000|Overall Study|Adverse Event|0
7636740|NCT02898259|12051120|FG001|Overall Study|Adverse Event|0
7636741|NCT02898259|12051121|FG002|Overall Study|Adverse Event|1
7636742|NCT02898259|12051122|FG003|Overall Study|Adverse Event|0
7636743|NCT02898259|12051123|FG004|Overall Study|Adverse Event|0
7636744|NCT02898259|12051119|FG000|Overall Study|Lack of Efficacy|1
7636745|NCT02898259|12051120|FG001|Overall Study|Lack of Efficacy|1
7636746|NCT02898259|12051121|FG002|Overall Study|Lack of Efficacy|3
7636747|NCT02898259|12051122|FG003|Overall Study|Lack of Efficacy|0
7636748|NCT02898259|12051123|FG004|Overall Study|Lack of Efficacy|0
7636749|NCT02898259|12051119|FG000|Overall Study|Lost to Follow-up|0
7636750|NCT02898259|12051120|FG001|Overall Study|Lost to Follow-up|0
7636751|NCT02898259|12051121|FG002|Overall Study|Lost to Follow-up|1
7636752|NCT02898259|12051122|FG003|Overall Study|Lost to Follow-up|0
7636753|NCT02898259|12051123|FG004|Overall Study|Lost to Follow-up|0
7636754|NCT02898259|12051119|FG000|Overall Study|Transformation before study began|0
7636755|NCT02898259|12051120|FG001|Overall Study|Transformation before study began|0
7636756|NCT02898259|12051121|FG002|Overall Study|Transformation before study began|0
7636757|NCT02898259|12051122|FG003|Overall Study|Transformation before study began|1
7636758|NCT02898259|12051123|FG004|Overall Study|Transformation before study began|0
7636759|NCT02893930|12051136|FG000|Overall Study|Adverse Event|3
7636760|NCT02893930|12051136|FG000|Overall Study|Death|1
7636761|NCT02893930|12051136|FG000|Overall Study|Disease progression|5
7636762|NCT02893930|12051136|FG000|Overall Study|Withdrawal by Subject|2
7636763|NCT02893930|12051136|FG000|Overall Study|Physician Decision|1
7636764|NCT02893930|12051136|FG000|Overall Study|Ineligible|1
7636765|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4
7636766|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1
7636767|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3
7636768|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636769|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636770|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636771|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636772|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636773|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636774|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636775|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636776|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636777|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636778|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636779|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636780|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0
7636781|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7636782|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
7636783|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636784|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636785|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636786|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636787|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636788|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636789|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636790|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636791|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636792|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636793|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636794|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636795|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636796|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
7636797|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636798|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636799|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636800|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2
7636801|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636802|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636803|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636804|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636805|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636806|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636807|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636808|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636809|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636810|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636811|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636812|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
7636813|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636814|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636815|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1
7636816|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636817|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636818|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636819|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636820|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636821|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636822|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636823|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636824|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636825|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636826|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636827|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636828|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
7636829|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636830|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636831|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636832|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1
7636833|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636834|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636835|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636836|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636837|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636838|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636839|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636840|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636841|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636842|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636843|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636844|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
7636845|NCT02891226|12051157|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636846|NCT02891226|12051158|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636847|NCT02891226|12051159|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636848|NCT02891226|12051160|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1
7636849|NCT02891226|12051161|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636850|NCT02891226|12051162|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636851|NCT02891226|12051163|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636852|NCT02891226|12051164|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636853|NCT02891226|12051165|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636854|NCT02891226|12051166|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636855|NCT02891226|12051167|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636856|NCT02891226|12051168|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636857|NCT02891226|12051169|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636858|NCT02891226|12051170|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636859|NCT02891226|12051171|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636860|NCT02891226|12051172|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
7636861|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636862|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636863|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636864|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636865|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636866|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636867|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1
7636868|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1
7636869|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3
7636870|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7
7636871|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636872|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636873|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636874|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636875|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636876|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0
7636877|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636878|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636879|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636880|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636881|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636882|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
7636883|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636884|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636885|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636886|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
7636887|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636888|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636889|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636890|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636891|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636892|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
7636893|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636894|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636895|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636896|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636897|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636898|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636899|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7636900|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2
7636901|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
7636902|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6
7636903|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636904|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636905|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636906|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636907|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636908|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
7636909|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636910|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636911|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636912|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636913|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1
7636914|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636915|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636916|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636917|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636918|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636919|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636920|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636921|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636922|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636923|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636924|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
7636925|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636926|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636927|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636928|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636929|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636930|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636931|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1
7636932|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636933|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636934|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636935|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636936|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636937|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7637225|NCT02876328|12051277|FG008|Overall Study|Withdrawal by Subject|1
7636938|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636939|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636940|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
7636941|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636942|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636943|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636944|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636945|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636946|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636947|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636948|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636949|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636950|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
7636951|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636952|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636953|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636954|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636955|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636956|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
7636957|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636958|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636959|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636960|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636961|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636962|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636963|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636964|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1
7636965|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636966|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636967|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636968|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636969|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636970|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636971|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636972|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
7636973|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636974|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636975|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636976|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636977|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636978|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636979|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636980|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636981|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1
7636982|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636983|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636984|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636985|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636986|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636987|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636988|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
7636989|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636990|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636991|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636992|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636993|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636994|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636995|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636996|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636997|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7636998|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1
7636999|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637000|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637001|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637002|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637003|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637004|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
7637005|NCT02891226|12051157|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637006|NCT02891226|12051158|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637007|NCT02891226|12051159|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637008|NCT02891226|12051160|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637009|NCT02891226|12051161|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637010|NCT02891226|12051162|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637011|NCT02891226|12051163|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637012|NCT02891226|12051164|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637013|NCT02891226|12051165|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637014|NCT02891226|12051166|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1
7637015|NCT02891226|12051167|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637016|NCT02891226|12051168|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637017|NCT02891226|12051169|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637018|NCT02891226|12051170|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637019|NCT02891226|12051171|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637020|NCT02891226|12051172|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
7637021|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637022|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637023|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637024|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637025|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637026|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637027|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637028|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637029|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637030|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637031|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5
7637032|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637033|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637034|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637035|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637036|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0
7637037|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637038|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637039|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637040|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637041|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637042|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637043|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637044|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637045|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637046|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637047|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1
7637048|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637049|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637050|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637051|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637052|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
7637053|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637054|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637055|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637056|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637057|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637058|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637059|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637060|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637061|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637062|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637063|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14
7637064|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637065|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637066|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637067|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637068|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
7637069|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637070|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637071|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637072|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637073|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637074|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637075|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637076|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637077|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637078|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637079|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108
7637080|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637081|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637082|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637083|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637084|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
7637085|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637086|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637087|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637088|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637089|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637090|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637091|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637092|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637093|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637094|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637095|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2
7637096|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637097|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637098|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637099|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637100|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
7637101|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637102|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637103|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637104|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637105|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637106|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637107|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637108|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637109|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637110|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637111|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3
7637112|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637113|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637114|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637115|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637116|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
7637117|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637118|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637119|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637120|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637121|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637122|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637123|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637124|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637125|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637126|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637127|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2
7637128|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637129|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637130|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637131|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637132|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
7637133|NCT02891226|12051157|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637134|NCT02891226|12051158|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637135|NCT02891226|12051159|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637136|NCT02891226|12051160|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637137|NCT02891226|12051161|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637138|NCT02891226|12051162|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637139|NCT02891226|12051163|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637140|NCT02891226|12051164|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637141|NCT02891226|12051165|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637226|NCT02876328|12051278|FG009|Overall Study|Withdrawal by Subject|2
7637142|NCT02891226|12051166|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637143|NCT02891226|12051167|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2
7637144|NCT02891226|12051168|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637145|NCT02891226|12051169|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637146|NCT02891226|12051170|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637147|NCT02891226|12051171|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637148|NCT02891226|12051172|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
7637149|NCT02891226|12051157|FG000|Follow-up Period|Withdrawal by Subject|0
7637150|NCT02891226|12051158|FG001|Follow-up Period|Withdrawal by Subject|0
7637151|NCT02891226|12051159|FG002|Follow-up Period|Withdrawal by Subject|0
7637152|NCT02891226|12051160|FG003|Follow-up Period|Withdrawal by Subject|0
7637153|NCT02891226|12051161|FG004|Follow-up Period|Withdrawal by Subject|0
7637154|NCT02891226|12051162|FG005|Follow-up Period|Withdrawal by Subject|0
7637155|NCT02891226|12051163|FG006|Follow-up Period|Withdrawal by Subject|0
7637156|NCT02891226|12051164|FG007|Follow-up Period|Withdrawal by Subject|0
7637157|NCT02891226|12051165|FG008|Follow-up Period|Withdrawal by Subject|0
7637158|NCT02891226|12051166|FG009|Follow-up Period|Withdrawal by Subject|0
7637159|NCT02891226|12051167|FG010|Follow-up Period|Withdrawal by Subject|0
7637160|NCT02891226|12051168|FG011|Follow-up Period|Withdrawal by Subject|1
7637161|NCT02891226|12051169|FG012|Follow-up Period|Withdrawal by Subject|0
7637162|NCT02891226|12051170|FG013|Follow-up Period|Withdrawal by Subject|0
7637163|NCT02891226|12051171|FG014|Follow-up Period|Withdrawal by Subject|1
7637164|NCT02891226|12051172|FG015|Follow-up Period|Withdrawal by Subject|1
7637165|NCT02890355|12051198|FG000|Overall Study|Adverse Event|5
7637166|NCT02890355|12051199|FG001|Overall Study|Adverse Event|5
7637167|NCT02890355|12051198|FG000|Overall Study|Refusal unrelated to adverse event|5
7637168|NCT02890355|12051199|FG001|Overall Study|Refusal unrelated to adverse event|10
7637169|NCT02890355|12051198|FG000|Overall Study|Progression/relapse|46
7637170|NCT02890355|12051199|FG001|Overall Study|Progression/relapse|39
7637171|NCT02890355|12051198|FG000|Overall Study|Not protocol specified|3
7637172|NCT02890355|12051199|FG001|Overall Study|Not protocol specified|4
7637173|NCT02880956|12051220|FG000|Overall Study|Adverse Event|3
7637174|NCT02880956|12051221|FG001|Overall Study|Adverse Event|6
7637175|NCT02880956|12051222|FG002|Overall Study|Adverse Event|5
7637176|NCT02880956|12051223|FG003|Overall Study|Adverse Event|4
7637177|NCT02880956|12051220|FG000|Overall Study|Withdrawal by Subject|9
7637178|NCT02880956|12051221|FG001|Overall Study|Withdrawal by Subject|4
7637179|NCT02880956|12051222|FG002|Overall Study|Withdrawal by Subject|6
7637180|NCT02880956|12051223|FG003|Overall Study|Withdrawal by Subject|11
7637181|NCT02880956|12051220|FG000|Overall Study|Lost to Follow-up|0
7637182|NCT02880956|12051221|FG001|Overall Study|Lost to Follow-up|1
7637183|NCT02880956|12051222|FG002|Overall Study|Lost to Follow-up|0
7637184|NCT02880956|12051223|FG003|Overall Study|Lost to Follow-up|0
7637185|NCT02880956|12051220|FG000|Overall Study|COVID-19 Logistical Restrictions|1
7637186|NCT02880956|12051221|FG001|Overall Study|COVID-19 Logistical Restrictions|2
7637187|NCT02880956|12051222|FG002|Overall Study|COVID-19 Logistical Restrictions|0
7637188|NCT02880956|12051223|FG003|Overall Study|COVID-19 Logistical Restrictions|0
7637189|NCT02880956|12051220|FG000|Overall Study|Other, Not Specified|4
7637190|NCT02880956|12051221|FG001|Overall Study|Other, Not Specified|2
7637191|NCT02880956|12051222|FG002|Overall Study|Other, Not Specified|0
7637192|NCT02880956|12051223|FG003|Overall Study|Other, Not Specified|3
7637193|NCT02876328|12051269|FG000|Overall Study|Death|2
7637194|NCT02876328|12051270|FG001|Overall Study|Death|1
7637195|NCT02876328|12051271|FG002|Overall Study|Death|3
7637196|NCT02876328|12051272|FG003|Overall Study|Death|0
7637197|NCT02876328|12051273|FG004|Overall Study|Death|0
7637198|NCT02876328|12051274|FG005|Overall Study|Death|0
7637199|NCT02876328|12051275|FG006|Overall Study|Death|1
7637200|NCT02876328|12051276|FG007|Overall Study|Death|3
7637201|NCT02876328|12051277|FG008|Overall Study|Death|0
7637202|NCT02876328|12051278|FG009|Overall Study|Death|1
7637203|NCT02876328|12051279|FG010|Overall Study|Death|1
7637204|NCT02876328|12051280|FG011|Overall Study|Death|0
7637205|NCT02876328|12051281|FG012|Overall Study|Death|0
7637206|NCT02876328|12051282|FG013|Overall Study|Death|0
7637207|NCT02876328|12051283|FG014|Overall Study|Death|0
7637208|NCT02876328|12051284|FG015|Overall Study|Death|0
7637209|NCT02876328|12051285|FG016|Overall Study|Death|1
7637210|NCT02876328|12051286|FG017|Overall Study|Death|1
7637211|NCT02876328|12051287|FG018|Overall Study|Death|0
7637212|NCT02876328|12051288|FG019|Overall Study|Death|0
7637213|NCT02876328|12051289|FG020|Overall Study|Death|0
7637214|NCT02876328|12051290|FG021|Overall Study|Death|1
7637215|NCT02876328|12051291|FG022|Overall Study|Death|0
7637216|NCT02876328|12051292|FG023|Overall Study|Death|0
7637217|NCT02876328|12051269|FG000|Overall Study|Withdrawal by Subject|0
7637218|NCT02876328|12051270|FG001|Overall Study|Withdrawal by Subject|2
7637219|NCT02876328|12051271|FG002|Overall Study|Withdrawal by Subject|3
7637220|NCT02876328|12051272|FG003|Overall Study|Withdrawal by Subject|3
7637221|NCT02876328|12051273|FG004|Overall Study|Withdrawal by Subject|0
7637222|NCT02876328|12051274|FG005|Overall Study|Withdrawal by Subject|1
7637223|NCT02876328|12051275|FG006|Overall Study|Withdrawal by Subject|0
7637224|NCT02876328|12051276|FG007|Overall Study|Withdrawal by Subject|1
7637227|NCT02876328|12051279|FG010|Overall Study|Withdrawal by Subject|0
7637228|NCT02876328|12051280|FG011|Overall Study|Withdrawal by Subject|0
7637229|NCT02876328|12051281|FG012|Overall Study|Withdrawal by Subject|0
7637230|NCT02876328|12051282|FG013|Overall Study|Withdrawal by Subject|0
7637231|NCT02876328|12051283|FG014|Overall Study|Withdrawal by Subject|0
7637232|NCT02876328|12051284|FG015|Overall Study|Withdrawal by Subject|0
7637233|NCT02876328|12051285|FG016|Overall Study|Withdrawal by Subject|1
7637234|NCT02876328|12051286|FG017|Overall Study|Withdrawal by Subject|3
7637235|NCT02876328|12051287|FG018|Overall Study|Withdrawal by Subject|0
7637236|NCT02876328|12051288|FG019|Overall Study|Withdrawal by Subject|0
7637237|NCT02876328|12051289|FG020|Overall Study|Withdrawal by Subject|1
7637238|NCT02876328|12051290|FG021|Overall Study|Withdrawal by Subject|0
7637239|NCT02876328|12051291|FG022|Overall Study|Withdrawal by Subject|0
7637240|NCT02876328|12051292|FG023|Overall Study|Withdrawal by Subject|0
7637241|NCT02876328|12051269|FG000|Overall Study|Missed 12 Month Visit|15
7637242|NCT02876328|12051270|FG001|Overall Study|Missed 12 Month Visit|10
7637243|NCT02876328|12051271|FG002|Overall Study|Missed 12 Month Visit|11
7637244|NCT02876328|12051272|FG003|Overall Study|Missed 12 Month Visit|6
7637245|NCT02876328|12051273|FG004|Overall Study|Missed 12 Month Visit|10
7637246|NCT02876328|12051274|FG005|Overall Study|Missed 12 Month Visit|14
7637247|NCT02876328|12051275|FG006|Overall Study|Missed 12 Month Visit|3
7637248|NCT02876328|12051276|FG007|Overall Study|Missed 12 Month Visit|8
7637249|NCT02876328|12051277|FG008|Overall Study|Missed 12 Month Visit|9
7637250|NCT02876328|12051278|FG009|Overall Study|Missed 12 Month Visit|5
7637251|NCT02876328|12051279|FG010|Overall Study|Missed 12 Month Visit|4
7637252|NCT02876328|12051280|FG011|Overall Study|Missed 12 Month Visit|1
7637253|NCT02876328|12051281|FG012|Overall Study|Missed 12 Month Visit|5
7637254|NCT02876328|12051282|FG013|Overall Study|Missed 12 Month Visit|4
7637255|NCT02876328|12051283|FG014|Overall Study|Missed 12 Month Visit|4
7637256|NCT02876328|12051284|FG015|Overall Study|Missed 12 Month Visit|4
7637257|NCT02876328|12051285|FG016|Overall Study|Missed 12 Month Visit|3
7637258|NCT02876328|12051286|FG017|Overall Study|Missed 12 Month Visit|6
7637259|NCT02876328|12051287|FG018|Overall Study|Missed 12 Month Visit|2
7637260|NCT02876328|12051288|FG019|Overall Study|Missed 12 Month Visit|2
7637261|NCT02876328|12051289|FG020|Overall Study|Missed 12 Month Visit|11
7637262|NCT02876328|12051290|FG021|Overall Study|Missed 12 Month Visit|7
7637263|NCT02876328|12051291|FG022|Overall Study|Missed 12 Month Visit|1
7637264|NCT02876328|12051292|FG023|Overall Study|Missed 12 Month Visit|0
7637265|NCT02872116|12051334|FG000|Pre-Treatment|Disease Progression|0
7637266|NCT02872116|12051335|FG001|Pre-Treatment|Disease Progression|1
7637267|NCT02872116|12051336|FG002|Pre-Treatment|Disease Progression|0
7637268|NCT02872116|12051334|FG000|Pre-Treatment|Adverse event unrelated to study drug|0
7637269|NCT02872116|12051335|FG001|Pre-Treatment|Adverse event unrelated to study drug|2
7637270|NCT02872116|12051336|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
7637271|NCT02872116|12051334|FG000|Pre-Treatment|Participants request to discontinue study treatment|0
7637272|NCT02872116|12051335|FG001|Pre-Treatment|Participants request to discontinue study treatment|2
7637273|NCT02872116|12051336|FG002|Pre-Treatment|Participants request to discontinue study treatment|0
7637274|NCT02872116|12051334|FG000|Pre-Treatment|Participant withdrew consent|2
7637275|NCT02872116|12051335|FG001|Pre-Treatment|Participant withdrew consent|20
7637276|NCT02872116|12051336|FG002|Pre-Treatment|Participant withdrew consent|3
7637277|NCT02872116|12051334|FG000|Pre-Treatment|Participant no longer meets study criteria|4
7637278|NCT02872116|12051335|FG001|Pre-Treatment|Participant no longer meets study criteria|0
7637279|NCT02872116|12051336|FG002|Pre-Treatment|Participant no longer meets study criteria|0
7637280|NCT02872116|12051334|FG000|Pre-Treatment|Other reasons|1
7637281|NCT02872116|12051335|FG001|Pre-Treatment|Other reasons|2
7637282|NCT02872116|12051336|FG002|Pre-Treatment|Other reasons|2
7637283|NCT02872116|12051334|FG000|Treatment|Death|122
7637284|NCT02872116|12051335|FG001|Treatment|Death|94
7637285|NCT02872116|12051336|FG002|Treatment|Death|68
7637286|NCT02872116|12051334|FG000|Treatment|Lost to Follow-up|5
7637287|NCT02872116|12051335|FG001|Treatment|Lost to Follow-up|7
7637288|NCT02872116|12051336|FG002|Treatment|Lost to Follow-up|3
7637289|NCT02872116|12051334|FG000|Treatment|Participant withdrew consent|20
7637290|NCT02872116|12051335|FG001|Treatment|Participant withdrew consent|40
7637291|NCT02872116|12051336|FG002|Treatment|Participant withdrew consent|8
7637292|NCT02872116|12051334|FG000|Treatment|Other reasons|12
7637293|NCT02872116|12051335|FG001|Treatment|Other reasons|12
7637294|NCT02872116|12051336|FG002|Treatment|Other reasons|5
7637295|NCT02871791|12051351|FG000|Phase 1b|Death|0
7637296|NCT02871791|12051352|FG001|Phase 1b|Death|1
7637297|NCT02871791|12051351|FG000|Phase 1b|progressive disease|6
7637298|NCT02871791|12051352|FG001|Phase 1b|progressive disease|2
7637299|NCT02871791|12051351|FG000|Phase 2|Death|1
7637300|NCT02871791|12051352|FG001|Phase 2|Death|0
7637301|NCT02871791|12051351|FG000|Phase 2|Lost to Follow-up|2
7637302|NCT02871791|12051352|FG001|Phase 2|Lost to Follow-up|0
7637303|NCT02867761|12051360|FG000|Overall Study|Participant withdrawn by investigator|0
7637304|NCT02867761|12051361|FG001|Overall Study|Participant withdrawn by investigator|1
7637305|NCT02867761|12051360|FG000|Overall Study|Lost to Follow-up|25
7637306|NCT02867761|12051361|FG001|Overall Study|Lost to Follow-up|18
7637307|NCT02867761|12051360|FG000|Overall Study|Unable to complete protocol|3
7637308|NCT02867761|12051361|FG001|Overall Study|Unable to complete protocol|7
7637309|NCT02864394|12051374|FG000|Overall Study|Death|135
7637310|NCT02864394|12051375|FG001|Overall Study|Death|150
7637311|NCT02864394|12051374|FG000|Overall Study|Withdrawal by Subject|1
7637312|NCT02864394|12051375|FG001|Overall Study|Withdrawal by Subject|9
7637313|NCT02864394|12051374|FG000|Overall Study|Ongoing In Study|77
7637314|NCT02864394|12051375|FG001|Overall Study|Ongoing In Study|53
7637315|NCT02862457|12051388|FG000|Overall Study|Death|1
7637316|NCT02862457|12051389|FG001|Overall Study|Death|3
7637317|NCT02862457|12051390|FG002|Overall Study|Death|2
7637318|NCT02862457|12051391|FG003|Overall Study|Death|3
7637319|NCT02862457|12051392|FG004|Overall Study|Death|0
7637320|NCT02862457|12051393|FG005|Overall Study|Death|2
7637321|NCT02862457|12051394|FG006|Overall Study|Death|1
7637322|NCT02862457|12051388|FG000|Overall Study|Lost to Follow-up|1
7637323|NCT02862457|12051389|FG001|Overall Study|Lost to Follow-up|0
7637324|NCT02862457|12051390|FG002|Overall Study|Lost to Follow-up|0
7637325|NCT02862457|12051391|FG003|Overall Study|Lost to Follow-up|1
7637326|NCT02862457|12051392|FG004|Overall Study|Lost to Follow-up|0
7637327|NCT02862457|12051393|FG005|Overall Study|Lost to Follow-up|0
7637328|NCT02862457|12051394|FG006|Overall Study|Lost to Follow-up|0
7637329|NCT02862457|12051388|FG000|Overall Study|Withdrawal by Subject|0
7637330|NCT02862457|12051389|FG001|Overall Study|Withdrawal by Subject|0
7637331|NCT02862457|12051390|FG002|Overall Study|Withdrawal by Subject|1
7637332|NCT02862457|12051391|FG003|Overall Study|Withdrawal by Subject|0
7637333|NCT02862457|12051392|FG004|Overall Study|Withdrawal by Subject|0
7637334|NCT02862457|12051393|FG005|Overall Study|Withdrawal by Subject|1
7637335|NCT02862457|12051394|FG006|Overall Study|Withdrawal by Subject|0
7637336|NCT02854436|12051429|FG000|Overall Study|Adverse Event|1
7637337|NCT02854436|12051429|FG000|Overall Study|Death|208
7637338|NCT02854436|12051429|FG000|Overall Study|Lost to Follow-up|5
7637339|NCT02854436|12051429|FG000|Overall Study|Withdrawal by Subject|12
7637340|NCT02854436|12051429|FG000|Overall Study|Other|45
7637341|NCT02854436|12051429|FG000|Overall Study|Ongoing|18
7637342|NCT02853344|12051435|FG000|Overall Study|Death|23
7637343|NCT02853344|12051436|FG001|Overall Study|Death|84
7637344|NCT02853344|12051435|FG000|Overall Study|Withdrawal by Subject|1
7637345|NCT02853344|12051436|FG001|Overall Study|Withdrawal by Subject|3
7637346|NCT02853344|12051435|FG000|Overall Study|Ongoing|86
7637347|NCT02853344|12051436|FG001|Overall Study|Ongoing|78
7637348|NCT02853331|12051446|FG000|Overall Study|Death|59
7637349|NCT02853331|12051447|FG001|Overall Study|Death|95
7637350|NCT02853331|12051446|FG000|Overall Study|Withdrawal by Subject|5
7637351|NCT02853331|12051447|FG001|Overall Study|Withdrawal by Subject|9
7637352|NCT02853331|12051446|FG000|Overall Study|Ongoing in study|368
7637353|NCT02853331|12051447|FG001|Overall Study|Ongoing in study|325
7637354|NCT02853305|12051456|FG000|Overall Study|Death|244
7637355|NCT02853305|12051457|FG001|Overall Study|Death|207
7637356|NCT02853305|12051458|FG002|Overall Study|Death|263
7637357|NCT02853305|12051456|FG000|Overall Study|Withdrawal by Subject|2
7637358|NCT02853305|12051457|FG001|Overall Study|Withdrawal by Subject|4
7637359|NCT02853305|12051458|FG002|Overall Study|Withdrawal by Subject|2
7637360|NCT02853305|12051456|FG000|Overall Study|Ongoing in Trial|105
7637361|NCT02853305|12051457|FG001|Overall Study|Ongoing in Trial|96
7637362|NCT02853305|12051458|FG002|Overall Study|Ongoing in Trial|87
7637363|NCT02852005|12051471|FG000|Overall Study|Lost to Follow-up|0
7637364|NCT02852005|12051472|FG001|Overall Study|Lost to Follow-up|0
7637365|NCT02852005|12051473|FG002|Overall Study|Lost to Follow-up|0
7637366|NCT02852005|12051474|FG003|Overall Study|Lost to Follow-up|0
7637367|NCT02852005|12051475|FG004|Overall Study|Lost to Follow-up|1
7637368|NCT02852005|12051471|FG000|Overall Study|Withdrawal by Subject|1
7637369|NCT02852005|12051472|FG001|Overall Study|Withdrawal by Subject|0
7637370|NCT02852005|12051473|FG002|Overall Study|Withdrawal by Subject|0
7637371|NCT02852005|12051474|FG003|Overall Study|Withdrawal by Subject|0
7637372|NCT02852005|12051475|FG004|Overall Study|Withdrawal by Subject|0
7637373|NCT02836249|12051500|FG000|Overall Study|Randomized but Never Treated|0
7637374|NCT02836249|12051501|FG001|Overall Study|Randomized but Never Treated|1
7637375|NCT02836249|12051500|FG000|Overall Study|Pregnancy|2
7637376|NCT02836249|12051501|FG001|Overall Study|Pregnancy|0
7637377|NCT02836249|12051500|FG000|Overall Study|Withdrew Consent|0
7637378|NCT02836249|12051501|FG001|Overall Study|Withdrew Consent|1
7637379|NCT02836249|12051500|FG000|Overall Study|Lost to Follow-up|0
7637380|NCT02836249|12051501|FG001|Overall Study|Lost to Follow-up|1
7637381|NCT02836249|12051500|FG000|Overall Study|Still on Study|121
7637382|NCT02836249|12051501|FG001|Overall Study|Still on Study|55
7637383|NCT02832063|12051509|FG000|Overall Study|Adverse Event|2
7637384|NCT02832063|12051510|FG001|Overall Study|Adverse Event|1
7637385|NCT02832063|12051509|FG000|Overall Study|Physician Decision|5
7637386|NCT02832063|12051510|FG001|Overall Study|Physician Decision|7
7637387|NCT02832063|12051509|FG000|Overall Study|Lost to Follow-up|15
7637388|NCT02832063|12051510|FG001|Overall Study|Lost to Follow-up|8
7637389|NCT02832063|12051509|FG000|Overall Study|Withdrawal by Subject|10
7637390|NCT02832063|12051510|FG001|Overall Study|Withdrawal by Subject|21
7637391|NCT02832063|12051509|FG000|Overall Study|Other|2
7637392|NCT02832063|12051510|FG001|Overall Study|Other|1
7637393|NCT02831764|12051518|FG000|Overall Study|Protocol specific withdrawal criteria|0
7637394|NCT02831764|12051519|FG001|Overall Study|Protocol specific withdrawal criteria|2
7637395|NCT02831764|12051518|FG000|Overall Study|Withdrawal by Subject|7
7637396|NCT02831764|12051519|FG001|Overall Study|Withdrawal by Subject|6
7637397|NCT02831764|12051518|FG000|Overall Study|Physician Decision|2
7637398|NCT02831764|12051519|FG001|Overall Study|Physician Decision|2
7637399|NCT02831764|12051518|FG000|Overall Study|Lost to Follow-up|6
7637400|NCT02831764|12051519|FG001|Overall Study|Lost to Follow-up|5
7637401|NCT02831764|12051518|FG000|Overall Study|Adverse Event|8
7637402|NCT02831764|12051519|FG001|Overall Study|Adverse Event|5
7637403|NCT02831764|12051518|FG000|Overall Study|Lack of Efficacy|2
7637404|NCT02831764|12051519|FG001|Overall Study|Lack of Efficacy|2
7637405|NCT02831764|12051518|FG000|Overall Study|Protocol Violation|5
7637406|NCT02831764|12051519|FG001|Overall Study|Protocol Violation|2
7637407|NCT02831764|12051518|FG000|Overall Study|Ongoing at the time of the analysis|330
7637408|NCT02831764|12051519|FG001|Overall Study|Ongoing at the time of the analysis|335
7637409|NCT02831673|12051527|FG000|Overall Study|Adverse Event|6
7637410|NCT02831673|12051528|FG001|Overall Study|Adverse Event|4
7637411|NCT02831673|12051527|FG000|Overall Study|Lack of Efficacy|3
7637412|NCT02831673|12051528|FG001|Overall Study|Lack of Efficacy|1
7637413|NCT02831673|12051527|FG000|Overall Study|Protocol Violation|5
7637414|NCT02831673|12051528|FG001|Overall Study|Protocol Violation|4
7637415|NCT02831673|12051527|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
7637416|NCT02831673|12051528|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
7637417|NCT02831673|12051527|FG000|Overall Study|Lost to Follow-up|9
7637418|NCT02831673|12051528|FG001|Overall Study|Lost to Follow-up|6
7637419|NCT02831673|12051527|FG000|Overall Study|Physician Decision|6
7637420|NCT02831673|12051528|FG001|Overall Study|Physician Decision|3
7637421|NCT02831673|12051527|FG000|Overall Study|Withdrawal by Subject|6
7637422|NCT02831673|12051528|FG001|Overall Study|Withdrawal by Subject|4
7637423|NCT02831673|12051527|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
7637424|NCT02831673|12051528|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
7637425|NCT02829918|12051534|FG000|Overall Study|Death|2
7637426|NCT02829918|12051534|FG000|Overall Study|Withdrawal by Subject|4
7637427|NCT02829918|12051534|FG000|Overall Study|Adverse Event|1
7637428|NCT02829918|12051534|FG000|Overall Study|Progression|1
7637429|NCT02824627|12051549|FG000|Overall Study|Adverse Event|1
7637430|NCT02824627|12051550|FG001|Overall Study|Adverse Event|2
7637431|NCT02824627|12051549|FG000|Overall Study|Lost to Follow-up|2
7637432|NCT02824627|12051550|FG001|Overall Study|Lost to Follow-up|1
7637433|NCT02821000|12051556|FG000|Overall Study|Death|44
7637434|NCT02821000|12051556|FG000|Overall Study|Withdrawal by Subject|1
7637435|NCT02821000|12051556|FG000|Overall Study|Ongoing in Study|58
7637436|NCT02815540|12051580|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
7637437|NCT02807493|12051597|FG000|Overall Study|Adverse Event|5
7637438|NCT02807493|12051598|FG001|Overall Study|Adverse Event|2
7637439|NCT02807493|12051597|FG000|Overall Study|Lost to Follow-up|6
7637440|NCT02807493|12051598|FG001|Overall Study|Lost to Follow-up|0
7637441|NCT02807493|12051597|FG000|Overall Study|Physician Decision|4
7637442|NCT02807493|12051598|FG001|Overall Study|Physician Decision|1
7637443|NCT02807493|12051597|FG000|Overall Study|Protocol Violation|7
7637444|NCT02807493|12051598|FG001|Overall Study|Protocol Violation|0
7637445|NCT02807493|12051597|FG000|Overall Study|Withdrawal by Subject|17
7637446|NCT02807493|12051598|FG001|Overall Study|Withdrawal by Subject|10
7637447|NCT02807493|12051597|FG000|Overall Study|Other withdrawal|17
7637448|NCT02807493|12051598|FG001|Overall Study|Other withdrawal|0
7637449|NCT02807493|12051597|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31
7637450|NCT02807493|12051598|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39
7637451|NCT02784535|12051636|FG000|Overall Study|Adverse Event|1
7637452|NCT02784535|12051637|FG001|Overall Study|Adverse Event|0
7637453|NCT02784535|12051636|FG000|Overall Study|Withdrawal by Subject|0
7637454|NCT02784535|12051637|FG001|Overall Study|Withdrawal by Subject|1
7637455|NCT02784535|12051636|FG000|Overall Study|Physician Decision|0
7637456|NCT02784535|12051637|FG001|Overall Study|Physician Decision|1
7637457|NCT02781506|12051655|FG000|Overall Study|Adverse Event|5
7637458|NCT02775903|12051663|FG000|Overall Study|Ongoing|14
7637459|NCT02775903|12051664|FG001|Overall Study|Ongoing|15
7637460|NCT02775903|12051665|FG002|Overall Study|Ongoing|15
7637461|NCT02775903|12051666|FG003|Overall Study|Ongoing|19
7637462|NCT02775903|12051663|FG000|Overall Study|Death|19
7637463|NCT02775903|12051664|FG001|Overall Study|Death|18
7637464|NCT02775903|12051665|FG002|Overall Study|Death|38
7637465|NCT02775903|12051666|FG003|Overall Study|Death|35
7637466|NCT02775903|12051663|FG000|Overall Study|Withdrawal by Subject|5
7637467|NCT02775903|12051664|FG001|Overall Study|Withdrawal by Subject|5
7637468|NCT02775903|12051665|FG002|Overall Study|Withdrawal by Subject|5
7637469|NCT02775903|12051666|FG003|Overall Study|Withdrawal by Subject|4
7637470|NCT02775903|12051663|FG000|Overall Study|Adverse Event|0
7637471|NCT02775903|12051664|FG001|Overall Study|Adverse Event|0
7637472|NCT02775903|12051665|FG002|Overall Study|Adverse Event|1
7637473|NCT02775903|12051666|FG003|Overall Study|Adverse Event|1
7637474|NCT02775903|12051663|FG000|Overall Study|Lost to Follow-up|0
7637475|NCT02775903|12051664|FG001|Overall Study|Lost to Follow-up|0
7637476|NCT02775903|12051665|FG002|Overall Study|Lost to Follow-up|1
7637477|NCT02775903|12051666|FG003|Overall Study|Lost to Follow-up|1
7637478|NCT02775903|12051663|FG000|Overall Study|Other-Miscellaneous|4
7637479|NCT02775903|12051664|FG001|Overall Study|Other-Miscellaneous|3
7637480|NCT02775903|12051665|FG002|Overall Study|Other-Miscellaneous|4
7637481|NCT02775903|12051666|FG003|Overall Study|Other-Miscellaneous|5
7637482|NCT02775435|12051682|FG000|Overall Study|Adverse Event|48
7637483|NCT02775435|12051683|FG001|Overall Study|Adverse Event|25
7637484|NCT02775435|12051682|FG000|Overall Study|Lost to Follow-up|0
7637485|NCT02775435|12051683|FG001|Overall Study|Lost to Follow-up|2
7637486|NCT02775435|12051682|FG000|Overall Study|Physician Decision|5
7637487|NCT02775435|12051683|FG001|Overall Study|Physician Decision|6
7637488|NCT02775435|12051682|FG000|Overall Study|Withdrawal by Subject|5
7637489|NCT02775435|12051683|FG001|Overall Study|Withdrawal by Subject|9
7637490|NCT02775435|12051682|FG000|Overall Study|Progressive Disease|86
7637491|NCT02775435|12051683|FG001|Overall Study|Progressive Disease|140
7637492|NCT02775435|12051682|FG000|Overall Study|Clinical Progression|13
7637493|NCT02775435|12051683|FG001|Overall Study|Clinical Progression|26
7637494|NCT02775435|12051682|FG000|Overall Study|Ongoing in Study|121
7637495|NCT02775435|12051683|FG001|Overall Study|Ongoing in Study|72
7637496|NCT02775435|12051682|FG000|Overall Study|Not Treated|0
7637497|NCT02775435|12051683|FG001|Overall Study|Not Treated|1
7637498|NCT02773849|12051700|FG000|Overall Study|Adverse Event|3
7637499|NCT02773849|12051700|FG000|Overall Study|Lack of Efficacy|89
7637500|NCT02773849|12051700|FG000|Overall Study|Withdrawal by Subject|1
7637501|NCT02773849|12051700|FG000|Overall Study|Withdrawal of Consent|1
7637502|NCT02770716|12051724|FG000|Overall Study|Death|101
7637503|NCT02770716|12051725|FG001|Overall Study|Death|45
7637504|NCT02770716|12051724|FG000|Overall Study|Withdrawal by Subject|4
7637505|NCT02770716|12051725|FG001|Overall Study|Withdrawal by Subject|2
7637506|NCT02770716|12051724|FG000|Overall Study|Lost to Follow-up|1
7637507|NCT02770716|12051725|FG001|Overall Study|Lost to Follow-up|0
7637508|NCT02770716|12051724|FG000|Overall Study|Various reasons|6
7637509|NCT02770716|12051725|FG001|Overall Study|Various reasons|2
7637510|NCT02768792|12051731|FG000|Overall Study|Adverse Event|1
7637511|NCT02766478|12051744|FG000|Overall Study|Withdrawal by Subject|1
7637512|NCT02766478|12051745|FG001|Overall Study|Withdrawal by Subject|1
7637513|NCT02763566|12051755|FG000|Overall Study|Lost to Follow-up|1
7637514|NCT02763566|12051756|FG001|Overall Study|Lost to Follow-up|4
7637515|NCT02763566|12051757|FG002|Overall Study|Lost to Follow-up|0
7637516|NCT02763566|12051758|FG003|Overall Study|Lost to Follow-up|1
7637517|NCT02763566|12051755|FG000|Overall Study|On study treatment at study conclusion|114
7637518|NCT02763566|12051756|FG001|Overall Study|On study treatment at study conclusion|34
7637519|NCT02763566|12051757|FG002|Overall Study|On study treatment at study conclusion|54
7637520|NCT02763566|12051758|FG003|Overall Study|On study treatment at study conclusion|13
7637521|NCT02763566|12051755|FG000|Overall Study|Withdrawal by Subject|3
7637522|NCT02763566|12051756|FG001|Overall Study|Withdrawal by Subject|1
7637523|NCT02763566|12051757|FG002|Overall Study|Withdrawal by Subject|0
7637524|NCT02763566|12051758|FG003|Overall Study|Withdrawal by Subject|0
7637525|NCT02761057|12051776|FG000|Overall Study|Currently On Study Treatment|0
7637526|NCT02761057|12051777|FG001|Overall Study|Currently On Study Treatment|3
7637527|NCT02761057|12051778|FG002|Overall Study|Currently On Study Treatment|0
7637528|NCT02761057|12051779|FG003|Overall Study|Currently On Study Treatment|0
7637529|NCT02761057|12051776|FG000|Overall Study|Adverse Event|11
7637530|NCT02761057|12051777|FG001|Overall Study|Adverse Event|9
7637531|NCT02761057|12051778|FG002|Overall Study|Adverse Event|5
7637532|NCT02761057|12051779|FG003|Overall Study|Adverse Event|3
7637533|NCT02761057|12051776|FG000|Overall Study|Refusal Unrelated to Adverse Event|2
7637534|NCT02761057|12051777|FG001|Overall Study|Refusal Unrelated to Adverse Event|2
7637535|NCT02761057|12051778|FG002|Overall Study|Refusal Unrelated to Adverse Event|0
7637536|NCT02761057|12051779|FG003|Overall Study|Refusal Unrelated to Adverse Event|2
7637537|NCT02761057|12051776|FG000|Overall Study|Progression/Relapse|29
7637538|NCT02761057|12051777|FG001|Overall Study|Progression/Relapse|27
7637539|NCT02761057|12051778|FG002|Overall Study|Progression/Relapse|20
7637540|NCT02761057|12051779|FG003|Overall Study|Progression/Relapse|23
7637541|NCT02761057|12051776|FG000|Overall Study|Death|2
7637542|NCT02761057|12051777|FG001|Overall Study|Death|2
7637543|NCT02761057|12051778|FG002|Overall Study|Death|1
7637544|NCT02761057|12051779|FG003|Overall Study|Death|1
7637545|NCT02761057|12051776|FG000|Overall Study|Other - Not Protocol Specified|2
7637546|NCT02761057|12051777|FG001|Overall Study|Other - Not Protocol Specified|1
7637547|NCT02761057|12051778|FG002|Overall Study|Other - Not Protocol Specified|2
7637548|NCT02761057|12051779|FG003|Overall Study|Other - Not Protocol Specified|0
7637549|NCT02747927|12051800|FG000|Overall Study|Adverse Event|5
7637550|NCT02747927|12051801|FG001|Overall Study|Adverse Event|14
7637551|NCT02747927|12051800|FG000|Overall Study|Lost to Follow-up|22
7637552|NCT02747927|12051801|FG001|Overall Study|Lost to Follow-up|43
7637553|NCT02747927|12051800|FG000|Overall Study|Pregnancy|34
7637554|NCT02747927|12051801|FG001|Overall Study|Pregnancy|66
7637555|NCT02747927|12051800|FG000|Overall Study|Protocol Violation|2
7637556|NCT02747927|12051801|FG001|Overall Study|Protocol Violation|4
7637557|NCT02747927|12051800|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
7637558|NCT02747927|12051801|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
7637559|NCT02747927|12051800|FG000|Overall Study|Reason not Specified|11
7637560|NCT02747927|12051801|FG001|Overall Study|Reason not Specified|27
7637561|NCT02747043|12051809|FG000|Overall Study|Other|1
7637562|NCT02747043|12051810|FG001|Overall Study|Other|1
7637563|NCT02747043|12051809|FG000|Overall Study|Adverse Event|3
7637564|NCT02747043|12051810|FG001|Overall Study|Adverse Event|1
7637565|NCT02747043|12051809|FG000|Overall Study|Withdrawal by Subject|1
7637566|NCT02747043|12051810|FG001|Overall Study|Withdrawal by Subject|1
7637567|NCT02747043|12051809|FG000|Overall Study|Physician Decision|1
7637568|NCT02747043|12051810|FG001|Overall Study|Physician Decision|1
7637569|NCT02747043|12051809|FG000|Overall Study|Protocol Violation|0
7637570|NCT02747043|12051810|FG001|Overall Study|Protocol Violation|1
7637571|NCT02747043|12051809|FG000|Overall Study|Disease progression|4
7637572|NCT02747043|12051810|FG001|Overall Study|Disease progression|0
7637573|NCT02747004|12051819|FG000|Overall Study|Withdrawal by Subject|8
7637574|NCT02747004|12051820|FG001|Overall Study|Withdrawal by Subject|5
7637575|NCT02747004|12051821|FG002|Overall Study|Withdrawal by Subject|4
7637576|NCT02747004|12051819|FG000|Overall Study|Lost to Follow-up|1
7637577|NCT02747004|12051820|FG001|Overall Study|Lost to Follow-up|2
7637578|NCT02747004|12051821|FG002|Overall Study|Lost to Follow-up|2
7637579|NCT02747004|12051819|FG000|Overall Study|on study treatment/follow-up|48
7637580|NCT02747004|12051820|FG001|Overall Study|on study treatment/follow-up|42
7637581|NCT02747004|12051821|FG002|Overall Study|on study treatment/follow-up|41
7637582|NCT02743494|12051835|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
7637583|NCT02743494|12051836|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
7637584|NCT02743494|12051835|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
7637585|NCT02743494|12051836|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
7637586|NCT02743494|12051835|FG000|Treatment Period|Completed treatment|229
7637587|NCT02743494|12051836|FG001|Treatment Period|Completed treatment|99
7637588|NCT02743494|12051835|FG000|Treatment Period|Disease recurrence|149
7637589|NCT02743494|12051836|FG001|Treatment Period|Disease recurrence|113
7637590|NCT02743494|12051835|FG000|Treatment Period|Study drug toxicity|57
7637591|NCT02743494|12051836|FG001|Treatment Period|Study drug toxicity|8
7637592|NCT02743494|12051835|FG000|Treatment Period|Death|1
7637593|NCT02743494|12051836|FG001|Treatment Period|Death|0
7637594|NCT02743494|12051835|FG000|Treatment Period|Adverse event unrelated to study drug|15
7637595|NCT02743494|12051836|FG001|Treatment Period|Adverse event unrelated to study drug|9
7637596|NCT02743494|12051835|FG000|Treatment Period|Participant request to discontinue treatment|30
7637597|NCT02743494|12051836|FG001|Treatment Period|Participant request to discontinue treatment|5
7637598|NCT02743494|12051835|FG000|Treatment Period|Participant withdrew consent|12
7637599|NCT02743494|12051836|FG001|Treatment Period|Participant withdrew consent|4
7637600|NCT02743494|12051835|FG000|Treatment Period|Lost to Follow-up|0
7637601|NCT02743494|12051836|FG001|Treatment Period|Lost to Follow-up|1
7637602|NCT02743494|12051835|FG000|Treatment Period|Poor/Non-compliance|1
7637603|NCT02743494|12051836|FG001|Treatment Period|Poor/Non-compliance|0
7637604|NCT02743494|12051835|FG000|Treatment Period|Other reasons|7
7637605|NCT02743494|12051836|FG001|Treatment Period|Other reasons|2
7637606|NCT02741570|12051844|FG000|Pre-Treatment Period|Other reasons|0
7637607|NCT02741570|12051845|FG001|Pre-Treatment Period|Other reasons|3
7637608|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3
7637609|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6
7637610|NCT02741570|12051844|FG000|Pre-Treatment Period|Poor/non-compliance|0
7637611|NCT02741570|12051845|FG001|Pre-Treatment Period|Poor/non-compliance|1
7637612|NCT02741570|12051844|FG000|Pre-Treatment Period|Lost to Follow-up|0
7637613|NCT02741570|12051845|FG001|Pre-Treatment Period|Lost to Follow-up|2
7637614|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant withdrew consent|0
7637615|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant withdrew consent|18
7637616|NCT02741570|12051844|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0
7637617|NCT02741570|12051845|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2
7637618|NCT02741570|12051844|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1
7637619|NCT02741570|12051845|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0
7637620|NCT02741570|12051844|FG000|Pre-Treatment Period|Death|0
7637621|NCT02741570|12051845|FG001|Pre-Treatment Period|Death|1
7637622|NCT02741570|12051844|FG000|Pre-Treatment Period|Disease progression|0
7637623|NCT02741570|12051845|FG001|Pre-Treatment Period|Disease progression|1
7637624|NCT02741570|12051844|FG000|Treatment Period|Other reasons|47
7637625|NCT02741570|12051845|FG001|Treatment Period|Other reasons|8
7637626|NCT02741570|12051844|FG000|Treatment Period|Poor/non-compliance|0
7637627|NCT02741570|12051845|FG001|Treatment Period|Poor/non-compliance|1
7637628|NCT02741570|12051844|FG000|Treatment Period|Maximum clinical benefit|3
7637629|NCT02741570|12051845|FG001|Treatment Period|Maximum clinical benefit|5
7637630|NCT02741570|12051844|FG000|Treatment Period|Lost to Follow-up|1
7637631|NCT02741570|12051845|FG001|Treatment Period|Lost to Follow-up|3
7637632|NCT02741570|12051844|FG000|Treatment Period|Participant withdrew consent|9
7637633|NCT02741570|12051845|FG001|Treatment Period|Participant withdrew consent|13
7637634|NCT02741570|12051844|FG000|Treatment Period|Participant request to discontinue treatment|8
7637635|NCT02741570|12051845|FG001|Treatment Period|Participant request to discontinue treatment|23
7637636|NCT02741570|12051844|FG000|Treatment Period|Adverse event unrelated to study drug|41
7637637|NCT02741570|12051845|FG001|Treatment Period|Adverse event unrelated to study drug|25
7637638|NCT02741570|12051844|FG000|Treatment Period|Death|9
7637639|NCT02741570|12051845|FG001|Treatment Period|Death|7
7637640|NCT02741570|12051844|FG000|Treatment Period|Study drug toxicity|55
7637641|NCT02741570|12051845|FG001|Treatment Period|Study drug toxicity|45
7637642|NCT02741570|12051844|FG000|Treatment Period|Disease progression|295
7637643|NCT02741570|12051845|FG001|Treatment Period|Disease progression|304
7637644|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2
7637645|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6
7637646|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3
7637647|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1
7637648|NCT02735421|12051851|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1
7637649|NCT02735421|12051851|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1
7637650|NCT02735421|12051851|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3
7637651|NCT02730169|12051871|FG000|Overall Study|Protocol Violation|1
7637652|NCT02730169|12051872|FG001|Overall Study|Protocol Violation|0
7637653|NCT02730169|12051873|FG002|Overall Study|Protocol Violation|0
7637654|NCT02730169|12051874|FG003|Overall Study|Protocol Violation|1
7637655|NCT02730169|12051871|FG000|Overall Study|Adverse Event|2
7637656|NCT02730169|12051872|FG001|Overall Study|Adverse Event|3
7637657|NCT02730169|12051873|FG002|Overall Study|Adverse Event|3
7637658|NCT02730169|12051874|FG003|Overall Study|Adverse Event|0
7637659|NCT02730169|12051871|FG000|Overall Study|Adverse Event of Special Interest|0
7637660|NCT02730169|12051872|FG001|Overall Study|Adverse Event of Special Interest|1
7637661|NCT02730169|12051873|FG002|Overall Study|Adverse Event of Special Interest|2
7637662|NCT02730169|12051874|FG003|Overall Study|Adverse Event of Special Interest|0
7637663|NCT02730169|12051871|FG000|Overall Study|Withdrawal by Subject|6
7637664|NCT02730169|12051872|FG001|Overall Study|Withdrawal by Subject|11
7637665|NCT02730169|12051873|FG002|Overall Study|Withdrawal by Subject|6
7637666|NCT02730169|12051874|FG003|Overall Study|Withdrawal by Subject|8
7637667|NCT02730169|12051871|FG000|Overall Study|Lost to Follow-up|5
7637668|NCT02730169|12051872|FG001|Overall Study|Lost to Follow-up|6
7637669|NCT02730169|12051873|FG002|Overall Study|Lost to Follow-up|5
7637670|NCT02730169|12051874|FG003|Overall Study|Lost to Follow-up|6
7637671|NCT02730169|12051871|FG000|Overall Study|Other|0
7637672|NCT02730169|12051872|FG001|Overall Study|Other|0
7637673|NCT02730169|12051873|FG002|Overall Study|Other|1
7637674|NCT02730169|12051874|FG003|Overall Study|Other|1
7637675|NCT02729025|12051886|FG000|Overall Study|Sponsor Decision|0
7637676|NCT02729025|12051887|FG001|Overall Study|Sponsor Decision|1
7637677|NCT02728102|12051896|FG000|Overall Study|Death|3
7637678|NCT02728102|12051897|FG001|Overall Study|Death|0
7637679|NCT02728102|12051898|FG002|Overall Study|Death|1
7637680|NCT02728102|12051896|FG000|Overall Study|Withdrawal by Subject|0
7637681|NCT02728102|12051897|FG001|Overall Study|Withdrawal by Subject|2
7637682|NCT02728102|12051898|FG002|Overall Study|Withdrawal by Subject|3
7637683|NCT02728102|12051896|FG000|Overall Study|Physician Decision|1
7637684|NCT02728102|12051897|FG001|Overall Study|Physician Decision|1
7637685|NCT02728102|12051898|FG002|Overall Study|Physician Decision|0
7637686|NCT02728102|12051896|FG000|Overall Study|Investigational study drug permanently discontinued|3
7637687|NCT02728102|12051897|FG001|Overall Study|Investigational study drug permanently discontinued|1
7637688|NCT02728102|12051898|FG002|Overall Study|Investigational study drug permanently discontinued|0
7637689|NCT02728102|12051896|FG000|Overall Study|Covid|0
7637690|NCT02728102|12051897|FG001|Overall Study|Covid|0
7637691|NCT02728102|12051898|FG002|Overall Study|Covid|1
7637692|NCT02717611|12051957|FG000|Overall Study|Death|13
7637693|NCT02717611|12051957|FG000|Overall Study|Withdrawal by Subject|6
7637694|NCT02717611|12051957|FG000|Overall Study|Active, not recruiting|40
7637695|NCT02717611|12051957|FG000|Overall Study|Complicating disease|1
7637696|NCT02714062|12051968|FG000|Overall Study|Adverse Event|0
7637697|NCT02714062|12051969|FG001|Overall Study|Adverse Event|0
7637698|NCT02714062|12051970|FG002|Overall Study|Adverse Event|2
7637699|NCT02714062|12051968|FG000|Overall Study|Withdrawal by Subject|1
7637700|NCT02714062|12051969|FG001|Overall Study|Withdrawal by Subject|0
7637701|NCT02714062|12051970|FG002|Overall Study|Withdrawal by Subject|1
7637702|NCT02714062|12051968|FG000|Overall Study|Protocol Violation|0
7637703|NCT02714062|12051969|FG001|Overall Study|Protocol Violation|1
7637704|NCT02714062|12051970|FG002|Overall Study|Protocol Violation|0
7637705|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2
7637706|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637707|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637708|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637709|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0
7637710|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8
7637711|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637712|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637713|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637714|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0
7637715|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3
7637716|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637717|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637718|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637719|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0
7637720|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3
7637721|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637722|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637723|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637724|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0
7637725|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15
7637726|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637727|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637728|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637729|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0
7637730|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1
7637731|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637732|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637733|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637734|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0
7637735|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85
7637736|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637737|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637738|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637739|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0
7637740|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20
7637741|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0
7637742|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0
7637743|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0
7637744|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0
7637745|NCT02709655|12051984|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6
7637746|NCT02709655|12051985|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637747|NCT02709655|12051986|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637748|NCT02709655|12051987|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637749|NCT02709655|12051988|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0
7637750|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0
7637751|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1
7637752|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2
7637753|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3
7637754|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0
7637755|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637756|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2
7637757|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637758|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0
7637759|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1
7637760|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0
7637761|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1
7637762|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3
7637763|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6
7637764|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1
7637765|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637766|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1
7637767|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637768|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637769|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0
7637770|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0
7637771|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637772|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637773|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4
7637774|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1
7637775|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637776|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1
7637777|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637778|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2
7637779|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0
7637780|NCT02709655|12051984|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0
7637781|NCT02709655|12051985|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5
7637782|NCT02709655|12051986|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7
7637783|NCT02709655|12051987|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5
7637784|NCT02709655|12051988|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2
7637785|NCT02706951|12052022|FG000|Overall Study|Adverse Event|1
7637786|NCT02706951|12052023|FG001|Overall Study|Adverse Event|5
7637787|NCT02706951|12052024|FG002|Overall Study|Adverse Event|3
7637788|NCT02706951|12052022|FG000|Overall Study|Withdrawal by Subject|11
7637789|NCT02706951|12052023|FG001|Overall Study|Withdrawal by Subject|6
7637790|NCT02706951|12052024|FG002|Overall Study|Withdrawal by Subject|6
7637791|NCT02706951|12052022|FG000|Overall Study|Lost to Follow-up|0
7637792|NCT02706951|12052023|FG001|Overall Study|Lost to Follow-up|4
7637793|NCT02706951|12052024|FG002|Overall Study|Lost to Follow-up|1
7637794|NCT02706951|12052022|FG000|Overall Study|Other|2
7637795|NCT02706951|12052023|FG001|Overall Study|Other|1
7637796|NCT02706951|12052024|FG002|Overall Study|Other|0
7637797|NCT02706405|12052040|FG000|Overall Study|Death|3
7637798|NCT02706405|12052041|FG001|Overall Study|Death|2
7637799|NCT02706405|12052042|FG002|Overall Study|Death|0
7637800|NCT02706405|12052043|FG003|Overall Study|Death|1
7637801|NCT02706405|12052044|FG004|Overall Study|Death|0
7637802|NCT02706405|12052045|FG005|Overall Study|Death|0
7637803|NCT02706405|12052046|FG006|Overall Study|Death|3
7637804|NCT02706405|12052047|FG007|Overall Study|Death|4
7637805|NCT02706405|12052040|FG000|Overall Study|Disease progression|0
7637806|NCT02706405|12052041|FG001|Overall Study|Disease progression|0
7637807|NCT02706405|12052042|FG002|Overall Study|Disease progression|0
7637808|NCT02706405|12052043|FG003|Overall Study|Disease progression|0
7637809|NCT02706405|12052044|FG004|Overall Study|Disease progression|0
7637810|NCT02706405|12052045|FG005|Overall Study|Disease progression|0
7637811|NCT02706405|12052046|FG006|Overall Study|Disease progression|0
7637812|NCT02706405|12052047|FG007|Overall Study|Disease progression|1
7637813|NCT02706405|12052040|FG000|Overall Study|Pt moved to new therapy|0
7637814|NCT02706405|12052041|FG001|Overall Study|Pt moved to new therapy|0
7637815|NCT02706405|12052042|FG002|Overall Study|Pt moved to new therapy|0
7637816|NCT02706405|12052043|FG003|Overall Study|Pt moved to new therapy|0
7637817|NCT02706405|12052044|FG004|Overall Study|Pt moved to new therapy|0
7637818|NCT02706405|12052045|FG005|Overall Study|Pt moved to new therapy|1
7637819|NCT02706405|12052046|FG006|Overall Study|Pt moved to new therapy|0
7637820|NCT02706405|12052047|FG007|Overall Study|Pt moved to new therapy|1
7637821|NCT02706405|12052040|FG000|Overall Study|Physician Decision|1
7637822|NCT02706405|12052041|FG001|Overall Study|Physician Decision|0
7637823|NCT02706405|12052042|FG002|Overall Study|Physician Decision|0
7637824|NCT02706405|12052043|FG003|Overall Study|Physician Decision|0
7637825|NCT02706405|12052044|FG004|Overall Study|Physician Decision|0
7637826|NCT02706405|12052045|FG005|Overall Study|Physician Decision|0
7637827|NCT02706405|12052046|FG006|Overall Study|Physician Decision|0
7637828|NCT02706405|12052047|FG007|Overall Study|Physician Decision|0
7637829|NCT02706392|12052079|FG000|Overall Study|Death|1
7637830|NCT02706392|12052080|FG001|Overall Study|Death|0
7637831|NCT02706392|12052081|FG002|Overall Study|Death|2
7637832|NCT02706392|12052082|FG003|Overall Study|Death|2
7637833|NCT02706392|12052083|FG004|Overall Study|Death|5
7637834|NCT02706392|12052084|FG005|Overall Study|Death|2
7637835|NCT02705755|12052098|FG000|Part A (6 Days)|Adverse Event|1
7637836|NCT02705755|12052099|FG001|Part A (6 Days)|Adverse Event|0
7637837|NCT02705755|12052100|FG002|Part A (6 Days)|Adverse Event|0
7637838|NCT02705755|12052101|FG003|Part A (6 Days)|Adverse Event|0
7637839|NCT02705755|12052098|FG000|Part A (6 Days)|Physician Decision|3
7637840|NCT02705755|12052099|FG001|Part A (6 Days)|Physician Decision|0
7637841|NCT02705755|12052100|FG002|Part A (6 Days)|Physician Decision|0
7637842|NCT02705755|12052101|FG003|Part A (6 Days)|Physician Decision|0
7637843|NCT02705755|12052098|FG000|Part A (6 Days)|Withdrawal by Subject|1
7637844|NCT02705755|12052099|FG001|Part A (6 Days)|Withdrawal by Subject|0
7637845|NCT02705755|12052100|FG002|Part A (6 Days)|Withdrawal by Subject|0
7637846|NCT02705755|12052101|FG003|Part A (6 Days)|Withdrawal by Subject|0
7637847|NCT02705755|12052098|FG000|Part C (20 Weeks)|Physician Decision|0
7637848|NCT02705755|12052099|FG001|Part C (20 Weeks)|Physician Decision|0
7637849|NCT02705755|12052100|FG002|Part C (20 Weeks)|Physician Decision|0
7637850|NCT02705755|12052101|FG003|Part C (20 Weeks)|Physician Decision|2
7637851|NCT02705755|12052098|FG000|Part C (20 Weeks)|Adverse Event|0
7637852|NCT02705755|12052099|FG001|Part C (20 Weeks)|Adverse Event|0
7637853|NCT02705755|12052100|FG002|Part C (20 Weeks)|Adverse Event|0
7637854|NCT02705755|12052101|FG003|Part C (20 Weeks)|Adverse Event|6
7637855|NCT02705755|12052098|FG000|Part C (20 Weeks)|Withdrawal by Subject|0
7637856|NCT02705755|12052099|FG001|Part C (20 Weeks)|Withdrawal by Subject|0
7637857|NCT02705755|12052100|FG002|Part C (20 Weeks)|Withdrawal by Subject|0
7637858|NCT02705755|12052101|FG003|Part C (20 Weeks)|Withdrawal by Subject|2
7637859|NCT02705105|12052136|FG000|Treatment|Objective Disease Progression|1
7637860|NCT02705105|12052137|FG001|Treatment|Objective Disease Progression|50
7637861|NCT02705105|12052136|FG000|Treatment|Withdrawal by Subject|3
7637862|NCT02705105|12052137|FG001|Treatment|Withdrawal by Subject|5
7637863|NCT02705105|12052136|FG000|Treatment|Adverse Event|0
7637864|NCT02705105|12052137|FG001|Treatment|Adverse Event|17
7637865|NCT02705105|12052136|FG000|Treatment|Clinical Disease Progression|0
7637866|NCT02705105|12052137|FG001|Treatment|Clinical Disease Progression|32
7637867|NCT02705105|12052136|FG000|Treatment|Physician Decision|0
7637868|NCT02705105|12052137|FG001|Treatment|Physician Decision|3
7637869|NCT02705105|12052136|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
7637870|NCT02705105|12052137|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
7637871|NCT02705105|12052136|FG000|Follow-Up|Death|3
7637872|NCT02705105|12052137|FG001|Follow-Up|Death|68
7637873|NCT02705105|12052136|FG000|Follow-Up|Withdrawal by Subject|1
7637874|NCT02705105|12052137|FG001|Follow-Up|Withdrawal by Subject|14
7637875|NCT02705105|12052136|FG000|Follow-Up|Study Terminated|0
7637876|NCT02705105|12052137|FG001|Follow-Up|Study Terminated|26
7637877|NCT02705105|12052136|FG000|Follow-Up|Discontinued per Amendment 3|0
7637878|NCT02705105|12052137|FG001|Follow-Up|Discontinued per Amendment 3|2
7637879|NCT02698189|12052161|FG000|Overall Study|Physician Decision|3
7637880|NCT02698189|12052162|FG001|Overall Study|Physician Decision|0
7637881|NCT02698189|12052161|FG000|Overall Study|Progressive disease|0
7637882|NCT02698189|12052162|FG001|Overall Study|Progressive disease|5
7637883|NCT02698189|12052161|FG000|Overall Study|Study terminated by sponsor|0
7637884|NCT02698189|12052162|FG001|Overall Study|Study terminated by sponsor|1
7637885|NCT02696096|12052179|FG000|Overall Study|ruled out at screening|1
7637886|NCT02696096|12052179|FG000|Overall Study|did not attend second fMRI|1
7637887|NCT02689284|12052189|FG000|Overall Study|Adverse Event|1
7637888|NCT02689284|12052190|FG001|Overall Study|Adverse Event|8
7637889|NCT02689284|12052189|FG000|Overall Study|Death|0
7637890|NCT02689284|12052190|FG001|Overall Study|Death|1
7637891|NCT02689284|12052189|FG000|Overall Study|Physician Decision|1
7637892|NCT02689284|12052190|FG001|Overall Study|Physician Decision|2
7637893|NCT02689284|12052189|FG000|Overall Study|Withdrawal by Subject|0
7637894|NCT02689284|12052190|FG001|Overall Study|Withdrawal by Subject|1
7637895|NCT02689284|12052189|FG000|Overall Study|progression of cancer|1
7637896|NCT02689284|12052190|FG001|Overall Study|progression of cancer|72
7637897|NCT02689284|12052189|FG000|Overall Study|decreased heart function|0
7637898|NCT02689284|12052190|FG001|Overall Study|decreased heart function|1
7637899|NCT02689284|12052189|FG000|Overall Study|concern for anemia|0
7637900|NCT02689284|12052190|FG001|Overall Study|concern for anemia|1
7637901|NCT02689284|12052189|FG000|Overall Study|no measurable cancer for evaluation|0
7637902|NCT02689284|12052190|FG001|Overall Study|no measurable cancer for evaluation|1
7637903|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Death|0
7637904|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Death|1
7637905|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0
7637906|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5
7637907|NCT02688647|12052199|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1
7637908|NCT02688647|12052200|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0
7637909|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Death|7
7637910|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Death|2
7637911|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1
7637912|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0
7637913|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Other|10
7637914|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Other|6
7637915|NCT02688647|12052199|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10
7637916|NCT02688647|12052200|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6
7637917|NCT02685826|12052230|FG000|Overall Study|Adverse Event|2
7637918|NCT02685826|12052231|FG001|Overall Study|Adverse Event|0
7637919|NCT02685826|12052232|FG002|Overall Study|Adverse Event|1
7637920|NCT02685826|12052230|FG000|Overall Study|Progressive Disease|2
7637921|NCT02685826|12052231|FG001|Overall Study|Progressive Disease|1
7637922|NCT02685826|12052232|FG002|Overall Study|Progressive Disease|0
7637923|NCT02685826|12052230|FG000|Overall Study|Withdrawal by Subject|2
7637924|NCT02685826|12052231|FG001|Overall Study|Withdrawal by Subject|0
7637925|NCT02685826|12052232|FG002|Overall Study|Withdrawal by Subject|0
7637926|NCT02685826|12052230|FG000|Overall Study|Full Clinical Hold by FDA|19
7637927|NCT02685826|12052231|FG001|Overall Study|Full Clinical Hold by FDA|9
7637928|NCT02685826|12052232|FG002|Overall Study|Full Clinical Hold by FDA|20
7637929|NCT02680587|12052242|FG000|Overall Study|Withdrawal by Subject|1
7637930|NCT02680587|12052243|FG001|Overall Study|Withdrawal by Subject|0
7637931|NCT02679755|12052264|FG000|Overall Study|Death|0
7637932|NCT02679755|12052265|FG001|Overall Study|Death|3
7637933|NCT02679755|12052264|FG000|Overall Study|Global deterioration of health status|1
7637934|NCT02679755|12052265|FG001|Overall Study|Global deterioration of health status|8
7637935|NCT02679755|12052264|FG000|Overall Study|Lost to Follow-up|1
7637936|NCT02679755|12052265|FG001|Overall Study|Lost to Follow-up|0
7637937|NCT02679755|12052264|FG000|Overall Study|Objective progression or relapse|24
7637938|NCT02679755|12052265|FG001|Overall Study|Objective progression or relapse|83
7637939|NCT02679755|12052264|FG000|Overall Study|Not defined|0
7637940|NCT02679755|12052265|FG001|Overall Study|Not defined|2
7637941|NCT02679755|12052264|FG000|Overall Study|Withdrawal by participant|6
7637942|NCT02679755|12052265|FG001|Overall Study|Withdrawal by participant|3
7637943|NCT02679755|12052264|FG000|Overall Study|Adverse Event|1
7637944|NCT02679755|12052265|FG001|Overall Study|Adverse Event|4
7637945|NCT02679755|12052264|FG000|Overall Study|Adverse events not related to study drug|1
7637946|NCT02679755|12052265|FG001|Overall Study|Adverse events not related to study drug|2
7637947|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Death|113
7637948|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Death|189
7637949|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
7637950|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12
7637951|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3
7637952|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4
7637953|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41
7637954|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69
7637955|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9
7637956|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14
7637957|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365
7637958|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180
7637959|NCT02677896|12052276|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31
7637960|NCT02677896|12052277|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108
7637961|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Death|40
7637962|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Death|14
7637963|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2
7637964|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1
7637965|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3
7637966|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1
7637967|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10
7637968|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9
7637969|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0
7637970|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1
7637971|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261
7637972|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136
7637973|NCT02677896|12052276|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49
7637974|NCT02677896|12052277|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18
7637975|NCT02675231|12052287|FG000|Overall Study|Withdrawal by Subject|1
7637976|NCT02675231|12052288|FG001|Overall Study|Withdrawal by Subject|3
7637977|NCT02675231|12052289|FG002|Overall Study|Withdrawal by Subject|1
7637978|NCT02675231|12052287|FG000|Overall Study|Lost to Follow-up|2
7637979|NCT02675231|12052288|FG001|Overall Study|Lost to Follow-up|2
7637980|NCT02675231|12052289|FG002|Overall Study|Lost to Follow-up|2
7637981|NCT02675231|12052287|FG000|Overall Study|On study treatment/follow up|23
7637982|NCT02675231|12052288|FG001|Overall Study|On study treatment/follow up|31
7637983|NCT02675231|12052289|FG002|Overall Study|On study treatment/follow up|23
7637984|NCT02673697|12052300|FG000|Overall Study|Adverse Event|2
7637985|NCT02673697|12052301|FG001|Overall Study|Adverse Event|0
7637986|NCT02673697|12052300|FG000|Overall Study|Death|32
7637987|NCT02673697|12052301|FG001|Overall Study|Death|24
7637988|NCT02673697|12052300|FG000|Overall Study|Lost to Follow-up|5
7637989|NCT02673697|12052301|FG001|Overall Study|Lost to Follow-up|2
7637990|NCT02673697|12052300|FG000|Overall Study|Physician Decision|2
7637991|NCT02673697|12052301|FG001|Overall Study|Physician Decision|1
7637992|NCT02673697|12052300|FG000|Overall Study|Withdrawal by Subject|10
7637993|NCT02673697|12052301|FG001|Overall Study|Withdrawal by Subject|7
7637994|NCT02673697|12052300|FG000|Overall Study|Change subj medical status|1
7637995|NCT02673697|12052301|FG001|Overall Study|Change subj medical status|2
7637996|NCT02673697|12052300|FG000|Overall Study|Explant|10
7637997|NCT02673697|12052301|FG001|Overall Study|Explant|5
7637998|NCT02673697|12052300|FG000|Overall Study|Sponsor Decision to stop follow up|391
7637999|NCT02673697|12052301|FG001|Overall Study|Sponsor Decision to stop follow up|416
7638000|NCT02667587|12052313|FG000|Pre-Treatment|Not reported|1
7638001|NCT02667587|12052314|FG001|Pre-Treatment|Not reported|0
7638002|NCT02667587|12052313|FG000|Pre-Treatment|Participant no longer meets study criteria|2
7638003|NCT02667587|12052314|FG001|Pre-Treatment|Participant no longer meets study criteria|2
7638004|NCT02667587|12052313|FG000|Pre-Treatment|Participant withdrew consent|0
7638005|NCT02667587|12052314|FG001|Pre-Treatment|Participant withdrew consent|1
7638006|NCT02667587|12052313|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
7638007|NCT02667587|12052314|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
7638008|NCT02667587|12052313|FG000|End of Treatment|Other reasons|11
7638009|NCT02667587|12052314|FG001|End of Treatment|Other reasons|8
7638010|NCT02667587|12052313|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1
7638011|NCT02667587|12052314|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2
7638012|NCT02667587|12052313|FG000|End of Treatment|Poor/Non-Compliance|0
7638013|NCT02667587|12052314|FG001|End of Treatment|Poor/Non-Compliance|1
7638014|NCT02667587|12052313|FG000|End of Treatment|Maximum Clinical Benefit|3
7638015|NCT02667587|12052314|FG001|End of Treatment|Maximum Clinical Benefit|3
7638016|NCT02667587|12052313|FG000|End of Treatment|Participant Withdrew Consent|5
7638017|NCT02667587|12052314|FG001|End of Treatment|Participant Withdrew Consent|6
7638018|NCT02667587|12052313|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25
7638019|NCT02667587|12052314|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26
7638020|NCT02667587|12052313|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19
7638021|NCT02667587|12052314|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20
7638022|NCT02667587|12052313|FG000|End of Treatment|Death|2
7638023|NCT02667587|12052314|FG001|End of Treatment|Death|1
7638024|NCT02667587|12052313|FG000|End of Treatment|Study Drug Toxicity|74
7638025|NCT02667587|12052314|FG001|End of Treatment|Study Drug Toxicity|18
7638026|NCT02667587|12052313|FG000|End of Treatment|Disease progression|177
7638027|NCT02667587|12052314|FG001|End of Treatment|Disease progression|222
7638028|NCT02667587|12052313|FG000|End of Treatment|Lost to Follow-up|1
7638029|NCT02667587|12052314|FG001|End of Treatment|Lost to Follow-up|3
7638030|NCT02667119|12052322|FG000|Overall Study|Lost to Follow-up|3
7638031|NCT02667119|12052323|FG001|Overall Study|Lost to Follow-up|0
7638032|NCT02665338|12052359|FG000|Overall Study|Withdrawal by Subject|0
7638033|NCT02665338|12052360|FG001|Overall Study|Withdrawal by Subject|1
7638034|NCT02660359|12052378|FG000|Overall Study|Protocol Deviation|0
7638035|NCT02660359|12052379|FG001|Overall Study|Protocol Deviation|0
7638036|NCT02660359|12052380|FG002|Overall Study|Protocol Deviation|1
7638037|NCT02660359|12052378|FG000|Overall Study|Sponsor Decision to Terminate Study|73
7638038|NCT02660359|12052379|FG001|Overall Study|Sponsor Decision to Terminate Study|75
7638039|NCT02660359|12052380|FG002|Overall Study|Sponsor Decision to Terminate Study|71
7638040|NCT02660359|12052378|FG000|Overall Study|Lack of Efficacy|1
7638041|NCT02660359|12052379|FG001|Overall Study|Lack of Efficacy|1
7638042|NCT02660359|12052380|FG002|Overall Study|Lack of Efficacy|1
7638043|NCT02660359|12052378|FG000|Overall Study|Adverse Event|0
7638044|NCT02660359|12052379|FG001|Overall Study|Adverse Event|1
7638045|NCT02660359|12052380|FG002|Overall Study|Adverse Event|0
7638046|NCT02660359|12052378|FG000|Overall Study|Other|2
7638047|NCT02660359|12052379|FG001|Overall Study|Other|1
7638048|NCT02660359|12052380|FG002|Overall Study|Other|3
7638049|NCT02660359|12052378|FG000|Overall Study|Withdrawal by Subject|7
7638050|NCT02660359|12052379|FG001|Overall Study|Withdrawal by Subject|5
7638051|NCT02660359|12052380|FG002|Overall Study|Withdrawal by Subject|8
7638052|NCT02660359|12052378|FG000|Overall Study|Lost to Follow-up|3
7638053|NCT02660359|12052379|FG001|Overall Study|Lost to Follow-up|3
7638054|NCT02660359|12052380|FG002|Overall Study|Lost to Follow-up|0
7638055|NCT02660138|12052391|FG000|Overall Study|Adverse Event|0
7638056|NCT02660138|12052392|FG001|Overall Study|Adverse Event|3
7638057|NCT02660138|12052393|FG002|Overall Study|Adverse Event|2
7638058|NCT02660138|12052391|FG000|Overall Study|Lack of Efficacy|1
7638059|NCT02660138|12052392|FG001|Overall Study|Lack of Efficacy|2
7638060|NCT02660138|12052393|FG002|Overall Study|Lack of Efficacy|1
7638061|NCT02660138|12052391|FG000|Overall Study|Withdrawal by Subject|7
7638062|NCT02660138|12052392|FG001|Overall Study|Withdrawal by Subject|6
7638063|NCT02660138|12052393|FG002|Overall Study|Withdrawal by Subject|6
7638064|NCT02660138|12052391|FG000|Overall Study|Lost to Follow-up|4
7638065|NCT02660138|12052392|FG001|Overall Study|Lost to Follow-up|4
7638066|NCT02660138|12052393|FG002|Overall Study|Lost to Follow-up|1
7638067|NCT02660138|12052391|FG000|Overall Study|Sponsor Decision to Terminate Study|57
7638068|NCT02660138|12052392|FG001|Overall Study|Sponsor Decision to Terminate Study|57
7638069|NCT02660138|12052393|FG002|Overall Study|Sponsor Decision to Terminate Study|62
7638070|NCT02660138|12052391|FG000|Overall Study|Other|1
7638071|NCT02660138|12052392|FG001|Overall Study|Other|1
7638072|NCT02660138|12052393|FG002|Overall Study|Other|0
7638073|NCT02660138|12052391|FG000|Overall Study|Not treated|0
7638074|NCT02660138|12052392|FG001|Overall Study|Not treated|1
7638075|NCT02660138|12052393|FG002|Overall Study|Not treated|0
7638076|NCT02659059|12052406|FG000|Overall Study|Completed|1
7638077|NCT02659059|12052407|FG001|Overall Study|Completed|0
7638078|NCT02659059|12052406|FG000|Overall Study|Other reasons|8
7638079|NCT02659059|12052407|FG001|Overall Study|Other reasons|2
7638080|NCT02659059|12052406|FG000|Overall Study|Disease Progression|120
7638081|NCT02659059|12052407|FG001|Overall Study|Disease Progression|16
7638082|NCT02659059|12052406|FG000|Overall Study|Study Drug toxicity|37
7638083|NCT02659059|12052407|FG001|Overall Study|Study Drug toxicity|9
7638084|NCT02659059|12052406|FG000|Overall Study|Death|2
7638085|NCT02659059|12052407|FG001|Overall Study|Death|1
7638086|NCT02659059|12052406|FG000|Overall Study|Adverse Event unrelated to Study drug|22
7638087|NCT02659059|12052407|FG001|Overall Study|Adverse Event unrelated to Study drug|4
7638088|NCT02659059|12052406|FG000|Overall Study|Participant request to discontinue study treatment|5
7638089|NCT02659059|12052407|FG001|Overall Study|Participant request to discontinue study treatment|0
7638090|NCT02659059|12052406|FG000|Overall Study|Participant withdrew consent|4
7638091|NCT02659059|12052407|FG001|Overall Study|Participant withdrew consent|0
7638092|NCT02659059|12052406|FG000|Overall Study|Lost to Follow-up|1
7638093|NCT02659059|12052407|FG001|Overall Study|Lost to Follow-up|0
7638094|NCT02657343|12052420|FG000|Overall Study|Death|0
7638095|NCT02657343|12052421|FG001|Overall Study|Death|2
7638096|NCT02657343|12052422|FG002|Overall Study|Death|0
7638097|NCT02657343|12052423|FG003|Overall Study|Death|0
7638098|NCT02657343|12052424|FG004|Overall Study|Death|0
7638099|NCT02657343|12052425|FG005|Overall Study|Death|0
7638100|NCT02657343|12052420|FG000|Overall Study|Patient went to hospice|1
7638101|NCT02657343|12052421|FG001|Overall Study|Patient went to hospice|0
7638102|NCT02657343|12052422|FG002|Overall Study|Patient went to hospice|0
7638103|NCT02657343|12052423|FG003|Overall Study|Patient went to hospice|0
7638104|NCT02657343|12052424|FG004|Overall Study|Patient went to hospice|0
7638105|NCT02657343|12052425|FG005|Overall Study|Patient went to hospice|0
7638106|NCT02657343|12052420|FG000|Overall Study|Withdrawal by Subject|0
7638107|NCT02657343|12052421|FG001|Overall Study|Withdrawal by Subject|0
7638108|NCT02657343|12052422|FG002|Overall Study|Withdrawal by Subject|0
7638109|NCT02657343|12052423|FG003|Overall Study|Withdrawal by Subject|0
7638110|NCT02657343|12052424|FG004|Overall Study|Withdrawal by Subject|1
7638111|NCT02657343|12052425|FG005|Overall Study|Withdrawal by Subject|0
7638112|NCT02656017|12052441|FG000|Overall Study|Study burden|3
7638113|NCT02656017|12052442|FG001|Overall Study|Study burden|3
7638114|NCT02656017|12052441|FG000|Overall Study|Adverse Event|2
7638115|NCT02656017|12052442|FG001|Overall Study|Adverse Event|1
7638116|NCT02656017|12052441|FG000|Overall Study|Unable/unwilling to take study medication|2
7638117|NCT02656017|12052442|FG001|Overall Study|Unable/unwilling to take study medication|1
7638118|NCT02656017|12052441|FG000|Overall Study|Began Tolvaptan|1
7638119|NCT02656017|12052442|FG001|Overall Study|Began Tolvaptan|1
7638120|NCT02656017|12052441|FG000|Overall Study|Withdrawal by Subject|1
7638121|NCT02656017|12052442|FG001|Overall Study|Withdrawal by Subject|0
7638122|NCT02652767|12052448|FG000|Overall Study|Death|2
7638123|NCT02652767|12052448|FG000|Overall Study|Lost to Follow-up|1
7638124|NCT02652767|12052448|FG000|Overall Study|Withdrawal by Subject|1
7638125|NCT02652260|12052456|FG000|Overall Study|Pregnancy|0
7638126|NCT02652260|12052457|FG001|Overall Study|Pregnancy|1
7638127|NCT02652260|12052456|FG000|Overall Study|Withdrawal by Subject|0
7638128|NCT02652260|12052457|FG001|Overall Study|Withdrawal by Subject|1
7638129|NCT02650921|12052466|FG000|Overall Study|Withdrawal by Subject|4
7638130|NCT02650921|12052466|FG000|Overall Study|Lost to Follow-up|2
7638131|NCT02650921|12052466|FG000|Overall Study|Adverse Event|1
7638132|NCT02650921|12052466|FG000|Overall Study|Due to Medical Condition|1
7638133|NCT02644967|12052472|FG000|Overall Study|Death|26
7638134|NCT02644967|12052472|FG000|Overall Study|Physician Decision|1
7638135|NCT02644967|12052472|FG000|Overall Study|Withdrawal by Subject|2
7638136|NCT02644967|12052472|FG000|Overall Study|Protocol Violation|1
7638137|NCT02644967|12052472|FG000|Overall Study|Progressive Disease|1
7638138|NCT02644967|12052472|FG000|Overall Study|Study Terminated by Sponsor|4
7638139|NCT02642042|12052476|FG000|Overall Study|Adverse Event|22
7638140|NCT02642042|12052476|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7638141|NCT02642042|12052476|FG000|Overall Study|Progression/Relapse|28
7638142|NCT02642042|12052476|FG000|Overall Study|Death|1
7638143|NCT02642042|12052476|FG000|Overall Study|Not Protocol Specified|2
7638144|NCT02639546|12052488|FG000|Overall Study|Death|2
7638145|NCT02639546|12052489|FG001|Overall Study|Death|2
7638146|NCT02639546|12052490|FG002|Overall Study|Death|1
7638147|NCT02639546|12052491|FG003|Overall Study|Death|2
7638148|NCT02639546|12052492|FG004|Overall Study|Death|2
7638149|NCT02639546|12052493|FG005|Overall Study|Death|2
7638150|NCT02639546|12052494|FG006|Overall Study|Death|0
7638151|NCT02639546|12052495|FG007|Overall Study|Death|0
7638152|NCT02639546|12052488|FG000|Overall Study|Lost to Follow-up|0
7638153|NCT02639546|12052489|FG001|Overall Study|Lost to Follow-up|0
7638154|NCT02639546|12052490|FG002|Overall Study|Lost to Follow-up|1
7638155|NCT02639546|12052491|FG003|Overall Study|Lost to Follow-up|0
7638156|NCT02639546|12052492|FG004|Overall Study|Lost to Follow-up|1
7638157|NCT02639546|12052493|FG005|Overall Study|Lost to Follow-up|1
7638158|NCT02639546|12052494|FG006|Overall Study|Lost to Follow-up|0
7638159|NCT02639546|12052495|FG007|Overall Study|Lost to Follow-up|1
7638160|NCT02639546|12052488|FG000|Overall Study|PI, physician decision; no response to trt.|2
7638161|NCT02639546|12052489|FG001|Overall Study|PI, physician decision; no response to trt.|0
7638162|NCT02639546|12052490|FG002|Overall Study|PI, physician decision; no response to trt.|0
7638163|NCT02639546|12052491|FG003|Overall Study|PI, physician decision; no response to trt.|0
7638164|NCT02639546|12052492|FG004|Overall Study|PI, physician decision; no response to trt.|0
7638165|NCT02639546|12052493|FG005|Overall Study|PI, physician decision; no response to trt.|1
7638166|NCT02639546|12052494|FG006|Overall Study|PI, physician decision; no response to trt.|0
7638167|NCT02639546|12052495|FG007|Overall Study|PI, physician decision; no response to trt.|1
7638168|NCT02639546|12052488|FG000|Overall Study|Study Terminated By Sponsor|0
7638169|NCT02639546|12052489|FG001|Overall Study|Study Terminated By Sponsor|2
7638170|NCT02639546|12052490|FG002|Overall Study|Study Terminated By Sponsor|3
7638171|NCT02639546|12052491|FG003|Overall Study|Study Terminated By Sponsor|4
7638172|NCT02639546|12052492|FG004|Overall Study|Study Terminated By Sponsor|4
7638173|NCT02639546|12052493|FG005|Overall Study|Study Terminated By Sponsor|3
7638174|NCT02639546|12052494|FG006|Overall Study|Study Terminated By Sponsor|3
7638175|NCT02639546|12052495|FG007|Overall Study|Study Terminated By Sponsor|9
7638176|NCT02639546|12052488|FG000|Overall Study|Withdrawal by Subject|2
7638177|NCT02639546|12052489|FG001|Overall Study|Withdrawal by Subject|2
7638178|NCT02639546|12052490|FG002|Overall Study|Withdrawal by Subject|1
7638179|NCT02639546|12052491|FG003|Overall Study|Withdrawal by Subject|0
7638180|NCT02639546|12052492|FG004|Overall Study|Withdrawal by Subject|0
7638181|NCT02639546|12052493|FG005|Overall Study|Withdrawal by Subject|1
7638182|NCT02639546|12052494|FG006|Overall Study|Withdrawal by Subject|2
7638183|NCT02639546|12052495|FG007|Overall Study|Withdrawal by Subject|1
7638184|NCT02634333|12052533|FG000|Overall Study|Completed out of Window|3
7638185|NCT02634333|12052534|FG001|Overall Study|Completed out of Window|2
7638186|NCT02634333|12052533|FG000|Overall Study|Missed Visit|5
7638187|NCT02634333|12052534|FG001|Overall Study|Missed Visit|2
7638188|NCT02634333|12052533|FG000|Overall Study|Lost to Follow-up|12
7638189|NCT02634333|12052534|FG001|Overall Study|Lost to Follow-up|7
7638190|NCT02634333|12052533|FG000|Overall Study|Withdrawal by Subject|9
7638191|NCT02634333|12052534|FG001|Overall Study|Withdrawal by Subject|13
7638192|NCT02634333|12052533|FG000|Overall Study|Death|11
7638193|NCT02634333|12052534|FG001|Overall Study|Death|8
7638194|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638195|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
7638196|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638197|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
7638198|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638199|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638200|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638201|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
7638202|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638203|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638204|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
7638205|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638206|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638281|NCT02614066|12052643|FG002|Overall Study|Full Consent Withdrawn|0
7638207|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638208|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638209|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
7638210|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
7638211|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7638212|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
7638213|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
7638214|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638215|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638216|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638217|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
7638218|NCT02630459|12052554|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
7638219|NCT02630459|12052555|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638220|NCT02630459|12052556|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638221|NCT02630459|12052557|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638222|NCT02630459|12052558|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638223|NCT02630459|12052559|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638224|NCT02630459|12052560|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638225|NCT02630459|12052561|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
7638226|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638227|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638228|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638229|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638230|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
7638231|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
7638232|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638233|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
7638234|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638235|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638236|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638237|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638238|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
7638239|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
7638240|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638241|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
7638242|NCT02630459|12052554|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638243|NCT02630459|12052555|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638244|NCT02630459|12052556|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638245|NCT02630459|12052557|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638246|NCT02630459|12052558|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
7638247|NCT02630459|12052559|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638248|NCT02630459|12052560|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638249|NCT02630459|12052561|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
7638250|NCT02622386|12052595|FG000|First Assignment|Withdrawal by Subject|3
7638251|NCT02622386|12052596|FG001|First Assignment|Withdrawal by Subject|2
7638252|NCT02622386|12052595|FG000|Washout|Withdrawal by Subject|4
7638253|NCT02622386|12052596|FG001|Washout|Withdrawal by Subject|4
7638254|NCT02622386|12052595|FG000|Second Assignment|Withdrawal by Subject|0
7638255|NCT02622386|12052596|FG001|Second Assignment|Withdrawal by Subject|2
7638256|NCT02621606|12052605|FG000|Overall Study|Withdrawal by Subject|0
7638257|NCT02621606|12052606|FG001|Overall Study|Withdrawal by Subject|1
7638258|NCT02621606|12052607|FG002|Overall Study|Withdrawal by Subject|0
7638259|NCT02619682|12052624|FG000|Overall Study|Withdrawal by Subject|3
7638260|NCT02619682|12052624|FG000|Overall Study|Lack of Efficacy|8
7638261|NCT02619682|12052624|FG000|Overall Study|new secondary cancer|1
7638262|NCT02619682|12052624|FG000|Overall Study|post surgery complications|2
7638263|NCT02614794|12052630|FG000|Overall Study|On treatment|118
7638264|NCT02614794|12052631|FG001|Overall Study|On treatment|27
7638265|NCT02614794|12052630|FG000|Overall Study|In long term follow up|148
7638266|NCT02614794|12052631|FG001|Overall Study|In long term follow up|85
7638267|NCT02614794|12052630|FG000|Overall Study|Death|126
7638268|NCT02614794|12052631|FG001|Overall Study|Death|84
7638269|NCT02614794|12052630|FG000|Overall Study|Withdrawal by Subject|16
7638270|NCT02614794|12052631|FG001|Overall Study|Withdrawal by Subject|5
7638271|NCT02614794|12052630|FG000|Overall Study|Lost to Follow-up|2
7638272|NCT02614794|12052631|FG001|Overall Study|Lost to Follow-up|0
7638273|NCT02614794|12052630|FG000|Overall Study|Physician Decision|0
7638274|NCT02614794|12052631|FG001|Overall Study|Physician Decision|1
7638275|NCT02614066|12052641|FG000|Overall Study|Initiated KTE-X19 and Died|5
7638276|NCT02614066|12052642|FG001|Overall Study|Initiated KTE-X19 and Died|12
7638277|NCT02614066|12052643|FG002|Overall Study|Initiated KTE-X19 and Died|11
7638278|NCT02614066|12052644|FG003|Overall Study|Initiated KTE-X19 and Died|20
7638279|NCT02614066|12052641|FG000|Overall Study|Full Consent Withdrawn|0
7638280|NCT02614066|12052642|FG001|Overall Study|Full Consent Withdrawn|1
7638282|NCT02614066|12052644|FG003|Overall Study|Full Consent Withdrawn|3
7638283|NCT02614066|12052641|FG000|Overall Study|Lost to Follow-up|0
7638284|NCT02614066|12052642|FG001|Overall Study|Lost to Follow-up|1
7638285|NCT02614066|12052643|FG002|Overall Study|Lost to Follow-up|0
7638286|NCT02614066|12052644|FG003|Overall Study|Lost to Follow-up|0
7638287|NCT02614066|12052641|FG000|Overall Study|Still on-study|1
7638288|NCT02614066|12052642|FG001|Overall Study|Still on-study|9
7638289|NCT02614066|12052643|FG002|Overall Study|Still on-study|5
7638290|NCT02614066|12052644|FG003|Overall Study|Still on-study|32
7638291|NCT02614066|12052641|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
7638292|NCT02614066|12052642|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
7638293|NCT02614066|12052643|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
7638294|NCT02614066|12052644|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
7638295|NCT02610777|12052654|FG000|Overall Study|Lost to Follow-up|1
7638296|NCT02610777|12052655|FG001|Overall Study|Lost to Follow-up|0
7638297|NCT02610777|12052654|FG000|Overall Study|Site Terminated by Sponsor|9
7638298|NCT02610777|12052655|FG001|Overall Study|Site Terminated by Sponsor|8
7638299|NCT02610777|12052654|FG000|Overall Study|Withdrawal by Subject|2
7638300|NCT02610777|12052655|FG001|Overall Study|Withdrawal by Subject|2
7638301|NCT02610777|12052654|FG000|Overall Study|Reason not Specified|0
7638302|NCT02610777|12052655|FG001|Overall Study|Reason not Specified|1
7638303|NCT02610777|12052654|FG000|Overall Study|Death|50
7638304|NCT02610777|12052655|FG001|Overall Study|Death|47
7638305|NCT02604511|12052663|FG000|Overall Study|Adverse Event|3
7638306|NCT02604511|12052663|FG000|Overall Study|Disease Progression|4
7638307|NCT02604511|12052663|FG000|Overall Study|Withdrawal by Subject|3
7638308|NCT02604511|12052663|FG000|Overall Study|Participant ineligible|1
7638309|NCT02604511|12052663|FG000|Overall Study|Intercurrent illness|1
7638310|NCT02603432|12052670|FG000|Overall Study|Ongoing|184
7638311|NCT02603432|12052671|FG001|Overall Study|Ongoing|144
7638312|NCT02603432|12052670|FG000|Overall Study|Adverse Event|1
7638313|NCT02603432|12052671|FG001|Overall Study|Adverse Event|0
7638314|NCT02603432|12052670|FG000|Overall Study|Death|144
7638315|NCT02603432|12052671|FG001|Overall Study|Death|177
7638316|NCT02603432|12052670|FG000|Overall Study|Lost to Follow-up|4
7638317|NCT02603432|12052671|FG001|Overall Study|Lost to Follow-up|6
7638318|NCT02603432|12052670|FG000|Overall Study|Progressive Disease|5
7638319|NCT02603432|12052671|FG001|Overall Study|Progressive Disease|5
7638320|NCT02603432|12052670|FG000|Overall Study|Withdrawal by Subject|9
7638321|NCT02603432|12052671|FG001|Overall Study|Withdrawal by Subject|17
7638322|NCT02603432|12052670|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
7638323|NCT02603432|12052671|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
7638324|NCT02603432|12052670|FG000|Overall Study|Other|0
7638325|NCT02603432|12052671|FG001|Overall Study|Other|1
7638326|NCT02601209|12052684|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638327|NCT02601209|12052685|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638328|NCT02601209|12052686|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
7638329|NCT02601209|12052687|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638330|NCT02601209|12052688|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638331|NCT02601209|12052689|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638332|NCT02601209|12052690|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638333|NCT02601209|12052691|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638334|NCT02601209|12052692|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
7638335|NCT02601209|12052684|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638336|NCT02601209|12052685|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638337|NCT02601209|12052686|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638338|NCT02601209|12052687|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638339|NCT02601209|12052688|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7638340|NCT02601209|12052689|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
7638341|NCT02601209|12052690|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
7638342|NCT02601209|12052691|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638343|NCT02601209|12052692|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
7638344|NCT02594735|12052706|FG000|Overall Study|Adverse Event|1
7638345|NCT02584634|12052723|FG000|Overall Study|Adverse Event|3
7638346|NCT02584634|12052724|FG001|Overall Study|Adverse Event|3
7638347|NCT02584634|12052723|FG000|Overall Study|Death|0
7638348|NCT02584634|12052724|FG001|Overall Study|Death|1
7638349|NCT02584634|12052723|FG000|Overall Study|Lost to Follow-up|0
7638350|NCT02584634|12052724|FG001|Overall Study|Lost to Follow-up|1
7638351|NCT02584634|12052723|FG000|Overall Study|Physician Decision|1
7638352|NCT02584634|12052724|FG001|Overall Study|Physician Decision|1
7638353|NCT02584634|12052723|FG000|Overall Study|Progressive disease|7
7638354|NCT02584634|12052724|FG001|Overall Study|Progressive disease|14
7638355|NCT02584634|12052723|FG000|Overall Study|Withdrawal by Subject|1
7638356|NCT02584634|12052724|FG001|Overall Study|Withdrawal by Subject|1
7638357|NCT02584634|12052723|FG000|Overall Study|Other|0
7638358|NCT02584634|12052724|FG001|Overall Study|Other|2
7638359|NCT02584634|12052723|FG000|Overall Study|Ongoing|0
7638360|NCT02584634|12052724|FG001|Overall Study|Ongoing|8
7638361|NCT02581930|12052733|FG000|Overall Study|Withdrawal by Subject|1
7638362|NCT02581930|12052733|FG000|Overall Study|patient declined further treatment|1
7638363|NCT02580058|12052744|FG000|Overall Study|Lost to Follow-up|4
7638364|NCT02580058|12052745|FG001|Overall Study|Lost to Follow-up|5
7638365|NCT02580058|12052746|FG002|Overall Study|Lost to Follow-up|4
7638366|NCT02580058|12052744|FG000|Overall Study|Ongoing|51
7638367|NCT02580058|12052745|FG001|Overall Study|Ongoing|55
7638368|NCT02580058|12052746|FG002|Overall Study|Ongoing|46
7638369|NCT02580058|12052744|FG000|Overall Study|Withdrawal by Subject|24
7638370|NCT02580058|12052745|FG001|Overall Study|Withdrawal by Subject|26
7638371|NCT02580058|12052746|FG002|Overall Study|Withdrawal by Subject|36
7638372|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
7638373|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
7638374|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
7638375|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
7638376|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
7638377|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
7638378|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
7638379|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
7638380|NCT02579096|12052756|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
7638381|NCT02579096|12052757|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
7638382|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Death|2
7638383|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Death|4
7638384|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
7638385|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
7638386|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
7638387|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
7638388|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
7638389|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
7638390|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
7638391|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
7638392|NCT02579096|12052756|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
7638393|NCT02579096|12052757|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
7638394|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Death|3
7638395|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Death|2
7638396|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
7638397|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
7638398|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
7638399|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
7638400|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
7638401|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
7638402|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
7638403|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
7638404|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
7638405|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
7638406|NCT02579096|12052756|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
7638407|NCT02579096|12052757|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
7638408|NCT02578680|12052765|FG000|Overall Study|Death|124
7638409|NCT02578680|12052766|FG001|Overall Study|Death|104
7638410|NCT02578680|12052765|FG000|Overall Study|Protocol Violation|1
7638411|NCT02578680|12052766|FG001|Overall Study|Protocol Violation|1
7638412|NCT02578680|12052765|FG000|Overall Study|Withdrawal by Parent/Guardian|1
7638413|NCT02578680|12052766|FG001|Overall Study|Withdrawal by Parent/Guardian|0
7638414|NCT02578680|12052765|FG000|Overall Study|Withdrawal by Subject|8
7638415|NCT02578680|12052766|FG001|Overall Study|Withdrawal by Subject|5
7638416|NCT02578680|12052765|FG000|Overall Study|Ongoing in Study|276
7638417|NCT02578680|12052766|FG001|Overall Study|Ongoing in Study|96
7638418|NCT02577406|12052774|FG000|Randomized Period|Death|1
7638419|NCT02577406|12052775|FG001|Randomized Period|Death|0
7638420|NCT02577406|12052774|FG000|Randomized Period|Other reasons|0
7638421|NCT02577406|12052775|FG001|Randomized Period|Other reasons|20
7638422|NCT02577406|12052774|FG000|Treatment Period|Transition to commercially available treatment|1
7638423|NCT02577406|12052775|FG001|Treatment Period|Transition to commercially available treatment|0
7638424|NCT02577406|12052774|FG000|Treatment Period|Progressive disease|47
7638425|NCT02577406|12052775|FG001|Treatment Period|Progressive disease|36
7638426|NCT02577406|12052774|FG000|Treatment Period|Death|36
7638427|NCT02577406|12052775|FG001|Treatment Period|Death|23
7638428|NCT02577406|12052774|FG000|Treatment Period|Other reasons|3
7638429|NCT02577406|12052775|FG001|Treatment Period|Other reasons|37
7638430|NCT02577406|12052774|FG000|Treatment Period|Withdrawal by Subject|10
7638431|NCT02577406|12052775|FG001|Treatment Period|Withdrawal by Subject|24
7638432|NCT02577406|12052774|FG000|Treatment Period|Adverse Event|17
7638433|NCT02577406|12052775|FG001|Treatment Period|Adverse Event|12
7638434|NCT02577406|12052774|FG000|Treatment Period|Disease relapse|27
7638435|NCT02577406|12052775|FG001|Treatment Period|Disease relapse|1
7638436|NCT02577406|12052774|FG000|Treatment Period|HSCT|6
7638437|NCT02577406|12052775|FG001|Treatment Period|HSCT|2
7638438|NCT02577406|12052774|FG000|Treatment Period|Lost to Follow-up|0
7638439|NCT02577406|12052775|FG001|Treatment Period|Lost to Follow-up|1
7638440|NCT02577406|12052774|FG000|Treatment Period|Protocol Violation|0
7638441|NCT02577406|12052775|FG001|Treatment Period|Protocol Violation|1
7638442|NCT02576860|12052787|FG000|Overall Study|Adverse Event|6
7638443|NCT02576860|12052788|FG001|Overall Study|Adverse Event|6
7638444|NCT02576860|12052787|FG000|Overall Study|Lost to Follow-up|5
7638445|NCT02576860|12052788|FG001|Overall Study|Lost to Follow-up|7
7638446|NCT02576860|12052787|FG000|Overall Study|Physician Decision|0
7638447|NCT02576860|12052788|FG001|Overall Study|Physician Decision|1
7638448|NCT02576860|12052787|FG000|Overall Study|Protocol Violation|0
7638449|NCT02576860|12052788|FG001|Overall Study|Protocol Violation|2
7638450|NCT02576860|12052787|FG000|Overall Study|Withdrawal by Subject|13
7638451|NCT02576860|12052788|FG001|Overall Study|Withdrawal by Subject|8
7638452|NCT02576860|12052787|FG000|Overall Study|Disallowed medication|1
7638453|NCT02576860|12052788|FG001|Overall Study|Disallowed medication|0
7638454|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant request to stop therapy|0
7638455|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant request to stop therapy|2
7638456|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant withdrew consent|1
7638457|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant withdrew consent|5
7638458|NCT02576509|12052797|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
7638459|NCT02576509|12052798|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
7638460|NCT02576509|12052797|FG000|Treatment Period|Disease progression|245
7638461|NCT02576509|12052798|FG001|Treatment Period|Disease progression|240
7638462|NCT02576509|12052797|FG000|Treatment Period|Study drug toxicity|32
7638463|NCT02576509|12052798|FG001|Treatment Period|Study drug toxicity|41
7638464|NCT02576509|12052797|FG000|Treatment Period|Death|1
7638465|NCT02576509|12052798|FG001|Treatment Period|Death|1
7638466|NCT02576509|12052797|FG000|Treatment Period|Adverse event unrelated to study drug|37
7638467|NCT02576509|12052798|FG001|Treatment Period|Adverse event unrelated to study drug|40
7638468|NCT02576509|12052797|FG000|Treatment Period|Participant request to stop treatment|8
7638469|NCT02576509|12052798|FG001|Treatment Period|Participant request to stop treatment|17
7638470|NCT02576509|12052797|FG000|Treatment Period|Participant withdrew consent|2
7638471|NCT02576509|12052798|FG001|Treatment Period|Participant withdrew consent|7
7638472|NCT02576509|12052797|FG000|Treatment Period|Lost to Follow-up|0
7638473|NCT02576509|12052798|FG001|Treatment Period|Lost to Follow-up|1
7638474|NCT02576509|12052797|FG000|Treatment Period|Maximum clinical benefit|1
7638475|NCT02576509|12052798|FG001|Treatment Period|Maximum clinical benefit|0
7638476|NCT02576509|12052797|FG000|Treatment Period|Poor/non-compliance|0
7638477|NCT02576509|12052798|FG001|Treatment Period|Poor/non-compliance|1
7638478|NCT02576509|12052797|FG000|Treatment Period|Participant no longer meets criteria|1
7638479|NCT02576509|12052798|FG001|Treatment Period|Participant no longer meets criteria|0
7638480|NCT02576509|12052797|FG000|Treatment Period|Other reason|2
7638481|NCT02576509|12052798|FG001|Treatment Period|Other reason|7
7638482|NCT02576509|12052797|FG000|Follow-up Period|Death|41
7638483|NCT02576509|12052798|FG001|Follow-up Period|Death|35
7638484|NCT02576509|12052797|FG000|Follow-up Period|Participant withdrew consent|7
7638485|NCT02576509|12052798|FG001|Follow-up Period|Participant withdrew consent|14
7638486|NCT02576509|12052797|FG000|Follow-up Period|Lost to Follow-up|0
7638487|NCT02576509|12052798|FG001|Follow-up Period|Lost to Follow-up|1
7638488|NCT02576509|12052797|FG000|Follow-up Period|Other reason|1
7638489|NCT02576509|12052798|FG001|Follow-up Period|Other reason|2
7638490|NCT02574481|12052808|FG000|Overall Study|Withdrawal by Subject|6
7638491|NCT02574481|12052809|FG001|Overall Study|Withdrawal by Subject|4
7638492|NCT02574481|12052810|FG002|Overall Study|Withdrawal by Subject|1
7638493|NCT02574481|12052811|FG003|Overall Study|Withdrawal by Subject|0
7638494|NCT02574481|12052808|FG000|Overall Study|Adverse Event|2
7638495|NCT02574481|12052809|FG001|Overall Study|Adverse Event|0
7638496|NCT02574481|12052810|FG002|Overall Study|Adverse Event|0
7638497|NCT02574481|12052811|FG003|Overall Study|Adverse Event|0
7638498|NCT02574481|12052808|FG000|Overall Study|Visit Missed|12
7638499|NCT02574481|12052809|FG001|Overall Study|Visit Missed|4
7638500|NCT02574481|12052810|FG002|Overall Study|Visit Missed|2
7638501|NCT02574481|12052811|FG003|Overall Study|Visit Missed|0
7638502|NCT02574481|12052808|FG000|Overall Study|Other|1
7638503|NCT02574481|12052809|FG001|Overall Study|Other|0
7638504|NCT02574481|12052810|FG002|Overall Study|Other|0
7638505|NCT02574481|12052811|FG003|Overall Study|Other|0
7638506|NCT02574481|12052808|FG000|Overall Study|Death|6
7638507|NCT02574481|12052809|FG001|Overall Study|Death|6
7638508|NCT02574481|12052810|FG002|Overall Study|Death|0
7638509|NCT02574481|12052811|FG003|Overall Study|Death|0
7638510|NCT02565784|12052837|FG000|First Treatment|Adverse Event|1
7638511|NCT02565784|12052837|FG000|First Treatment|Withdrawal by Subject|1
7638512|NCT02565784|12052837|FG000|Second Treatment|Withdrawal by Subject|2
7638513|NCT02565108|12052847|FG000|Overall Study|Adverse Event|1
7638514|NCT02565108|12052848|FG001|Overall Study|Adverse Event|0
7638515|NCT02565108|12052847|FG000|Overall Study|Withdrew Consent|1
7638516|NCT02565108|12052848|FG001|Overall Study|Withdrew Consent|0
7638517|NCT02564952|12052854|FG000|Overall Study|Adverse Event|6
7638518|NCT02564952|12052854|FG000|Overall Study|Lost to Follow-up|1
7638519|NCT02564952|12052854|FG000|Overall Study|Participant Withdrawn by Investigator|1
7638520|NCT02564952|12052854|FG000|Overall Study|Withdrawal by Subject|1
7638521|NCT02564952|12052854|FG000|Overall Study|Low Efficacy|1
7638522|NCT02564952|12052854|FG000|Overall Study|Participant Met Withdrawal Criteria|1
7638523|NCT02563925|12052858|FG000|Overall Study|Withdrawal by Subject|2
7638524|NCT02563002|12052865|FG000|Overall Study|Death|62
7638525|NCT02563002|12052866|FG001|Overall Study|Death|75
7638526|NCT02563002|12052865|FG000|Overall Study|Lost to Follow-up|1
7638527|NCT02563002|12052866|FG001|Overall Study|Lost to Follow-up|0
7638528|NCT02563002|12052865|FG000|Overall Study|Withdrawal by Subject|0
7638529|NCT02563002|12052866|FG001|Overall Study|Withdrawal by Subject|9
7638530|NCT02563002|12052865|FG000|Overall Study|Ongoing|90
7638531|NCT02563002|12052866|FG001|Overall Study|Ongoing|70
7638532|NCT02562235|12052875|FG000|Overall Study|Adverse Event|3
7638533|NCT02560623|12052897|FG000|Overall Study|Unable to swallow sponge|0
7638534|NCT02560623|12052898|FG001|Overall Study|Unable to swallow sponge|1
7638535|NCT02560623|12052899|FG002|Overall Study|Unable to swallow sponge|0
7638536|NCT02560623|12052900|FG003|Overall Study|Unable to swallow sponge|0
7638537|NCT02560623|12052897|FG000|Overall Study|Intervention prior to sponge administration|0
7638538|NCT02560623|12052898|FG001|Overall Study|Intervention prior to sponge administration|1
7638539|NCT02560623|12052899|FG002|Overall Study|Intervention prior to sponge administration|0
7638540|NCT02560623|12052900|FG003|Overall Study|Intervention prior to sponge administration|0
7638541|NCT02559687|12052910|FG000|Overall Study|Death|112
7638542|NCT02559687|12052910|FG000|Overall Study|Sponsor Decision|5
7638543|NCT02559687|12052910|FG000|Overall Study|Withdrawal by Subject|4
7638544|NCT02556710|12052917|FG000|Overall Study|Surgical treatment|3
7638545|NCT02556710|12052918|FG001|Overall Study|Surgical treatment|0
7638546|NCT02556710|12052917|FG000|Overall Study|Required proscribed pain medication|2
7638547|NCT02556710|12052918|FG001|Overall Study|Required proscribed pain medication|1
7638548|NCT02556710|12052917|FG000|Overall Study|Lack of Efficacy|1
7638549|NCT02556710|12052918|FG001|Overall Study|Lack of Efficacy|0
7638550|NCT02556710|12052917|FG000|Overall Study|Worsening osteoarthritis|1
7638551|NCT02556710|12052918|FG001|Overall Study|Worsening osteoarthritis|0
7638552|NCT02556710|12052917|FG000|Overall Study|Moved out of state|1
7638553|NCT02556710|12052918|FG001|Overall Study|Moved out of state|0
7638554|NCT02556710|12052917|FG000|Overall Study|Missing reason|3
7638555|NCT02556710|12052918|FG001|Overall Study|Missing reason|1
7638556|NCT02556710|12052917|FG000|Overall Study|Pain as lack of efficacy|0
7638557|NCT02556710|12052918|FG001|Overall Study|Pain as lack of efficacy|4
7638558|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
7638559|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
7638560|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
7638561|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7638562|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
7638563|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
7638564|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7638565|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
7638566|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
7638567|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
7638568|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7638569|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
7638570|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
7638571|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
7638572|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
7638573|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7638574|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
7638575|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
7638576|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7638577|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
7638578|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
7638579|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7638580|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
7638581|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
7638582|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
7638583|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
7638584|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
7638585|NCT02552212|12052928|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
7638586|NCT02552212|12052929|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7638587|NCT02552212|12052930|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
7638588|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
7638589|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
7638590|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
7638591|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7638592|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
7638593|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
7638594|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7638595|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
7638596|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
7638597|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7638598|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
7638599|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
7638600|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7638849|NCT02499328|12053188|FG005|Overall Study|Disease Progression|0
7638601|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
7638602|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
7638603|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
7638604|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
7638605|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
7638606|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
7638607|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
7638608|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
7638609|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7638610|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
7638611|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
7638612|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
7638613|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
7638614|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
7638615|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7638616|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
7638617|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
7638618|NCT02552212|12052928|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
7638619|NCT02552212|12052929|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
7638620|NCT02552212|12052930|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
7638621|NCT02550652|12052948|FG000|Overall Study|Death|1
7638622|NCT02550652|12052949|FG001|Overall Study|Death|4
7638623|NCT02550652|12052948|FG000|Overall Study|Lack of Efficacy|1
7638624|NCT02550652|12052949|FG001|Overall Study|Lack of Efficacy|0
7638625|NCT02550652|12052948|FG000|Overall Study|Withdrawal by Subject|3
7638626|NCT02550652|12052949|FG001|Overall Study|Withdrawal by Subject|7
7638627|NCT02550652|12052948|FG000|Overall Study|Post Trial Access|1
7638628|NCT02550652|12052949|FG001|Overall Study|Post Trial Access|0
7638629|NCT02550652|12052948|FG000|Overall Study|Lost to Follow-up|1
7638630|NCT02550652|12052949|FG001|Overall Study|Lost to Follow-up|3
7638631|NCT02550652|12052948|FG000|Overall Study|Physician Decision|0
7638632|NCT02550652|12052949|FG001|Overall Study|Physician Decision|2
7638633|NCT02550652|12052948|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
7638634|NCT02550652|12052949|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
7638635|NCT02547441|12052957|FG000|Double-Blind Study Period|Adverse Event|4
7638636|NCT02547441|12052958|FG001|Double-Blind Study Period|Adverse Event|9
7638637|NCT02547441|12052957|FG000|Double-Blind Study Period|Lost to Follow-up|2
7638638|NCT02547441|12052958|FG001|Double-Blind Study Period|Lost to Follow-up|4
7638639|NCT02547441|12052957|FG000|Double-Blind Study Period|Physician Decision|1
7638640|NCT02547441|12052958|FG001|Double-Blind Study Period|Physician Decision|0
7638641|NCT02547441|12052957|FG000|Double-Blind Study Period|Protocol Violation|1
7638642|NCT02547441|12052958|FG001|Double-Blind Study Period|Protocol Violation|2
7638643|NCT02547441|12052957|FG000|Double-Blind Study Period|Withdrawal by Subject|15
7638644|NCT02547441|12052958|FG001|Double-Blind Study Period|Withdrawal by Subject|17
7638645|NCT02547441|12052957|FG000|Double-Blind Study Period|Sponsor Decision|1
7638646|NCT02547441|12052958|FG001|Double-Blind Study Period|Sponsor Decision|0
7638647|NCT02547441|12052957|FG000|Open-Label Study Period|Adverse Event|10
7638648|NCT02547441|12052958|FG001|Open-Label Study Period|Adverse Event|11
7638649|NCT02547441|12052957|FG000|Open-Label Study Period|Lack of Efficacy|3
7638650|NCT02547441|12052958|FG001|Open-Label Study Period|Lack of Efficacy|2
7638651|NCT02547441|12052957|FG000|Open-Label Study Period|Lost to Follow-up|7
7638652|NCT02547441|12052958|FG001|Open-Label Study Period|Lost to Follow-up|8
7638653|NCT02547441|12052957|FG000|Open-Label Study Period|Physician Decision|1
7638654|NCT02547441|12052958|FG001|Open-Label Study Period|Physician Decision|0
7638655|NCT02547441|12052957|FG000|Open-Label Study Period|Protocol Violation|2
7638656|NCT02547441|12052958|FG001|Open-Label Study Period|Protocol Violation|0
7638657|NCT02547441|12052957|FG000|Open-Label Study Period|Withdrawal by Subject|33
7638658|NCT02547441|12052958|FG001|Open-Label Study Period|Withdrawal by Subject|37
7638659|NCT02547441|12052957|FG000|Open-Label Study Period|Terminated by Sponsor|66
7638660|NCT02547441|12052958|FG001|Open-Label Study Period|Terminated by Sponsor|69
7638661|NCT02546986|12052967|FG000|Treatment Period|Progressive Disease|20
7638662|NCT02546986|12052968|FG001|Treatment Period|Progressive Disease|22
7638663|NCT02546986|12052967|FG000|Treatment Period|Adverse Event|14
7638664|NCT02546986|12052968|FG001|Treatment Period|Adverse Event|6
7638665|NCT02546986|12052967|FG000|Treatment Period|Symptomatic Deterioration|4
7638666|NCT02546986|12052968|FG001|Treatment Period|Symptomatic Deterioration|3
7638667|NCT02546986|12052967|FG000|Treatment Period|Death|3
7638668|NCT02546986|12052968|FG001|Treatment Period|Death|4
7638669|NCT02546986|12052967|FG000|Treatment Period|Physician Decision|1
7638670|NCT02546986|12052968|FG001|Treatment Period|Physician Decision|2
7638671|NCT02546986|12052967|FG000|Treatment Period|Protocol Violation|1
7638672|NCT02546986|12052968|FG001|Treatment Period|Protocol Violation|0
7638673|NCT02546986|12052967|FG000|Treatment Period|Withdrawal by Subject|1
7638674|NCT02546986|12052968|FG001|Treatment Period|Withdrawal by Subject|1
7638675|NCT02546986|12052967|FG000|Treatment Period|Non-compliance with Study Drug|0
7638676|NCT02546986|12052968|FG001|Treatment Period|Non-compliance with Study Drug|1
7638677|NCT02546986|12052967|FG000|Treatment Period|Study Terminated by Sponsor|0
7638678|NCT02546986|12052968|FG001|Treatment Period|Study Terminated by Sponsor|1
7638679|NCT02546986|12052967|FG000|Treatment Period|Miscellaneous|7
7638680|NCT02546986|12052968|FG001|Treatment Period|Miscellaneous|9
7638681|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Missing Status|3
7638682|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Missing Status|5
7638683|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Death|18
7638684|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Death|12
7638685|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Alive|13
7638686|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Alive|16
7638687|NCT02546986|12052967|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
7638688|NCT02546986|12052968|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
7638689|NCT02544763|12052987|FG000|Overall Study|Adverse Event|8
7638690|NCT02544763|12052988|FG001|Overall Study|Adverse Event|8
7638691|NCT02544763|12052989|FG002|Overall Study|Adverse Event|0
7638692|NCT02544763|12052987|FG000|Overall Study|Withdrawn by parent/guardian|1
7638693|NCT02544763|12052988|FG001|Overall Study|Withdrawn by parent/guardian|1
7638694|NCT02544763|12052989|FG002|Overall Study|Withdrawn by parent/guardian|1
7638695|NCT02544763|12052987|FG000|Overall Study|Met withdrawal criteria|0
7638696|NCT02544763|12052988|FG001|Overall Study|Met withdrawal criteria|2
7638697|NCT02544763|12052989|FG002|Overall Study|Met withdrawal criteria|0
7638698|NCT02544763|12052987|FG000|Overall Study|Physician Decision|0
7638699|NCT02544763|12052988|FG001|Overall Study|Physician Decision|1
7638700|NCT02544763|12052989|FG002|Overall Study|Physician Decision|0
7638701|NCT02544763|12052987|FG000|Overall Study|Difficulties taking IMP|1
7638702|NCT02544763|12052988|FG001|Overall Study|Difficulties taking IMP|0
7638703|NCT02544763|12052989|FG002|Overall Study|Difficulties taking IMP|0
7638704|NCT02544503|12052999|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24
7638705|NCT02544503|12053000|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3
7638706|NCT02544503|12052999|FG000|Overall Study|Lost to Follow-up|9
7638707|NCT02544503|12053000|FG001|Overall Study|Lost to Follow-up|0
7638708|NCT02544503|12052999|FG000|Overall Study|Withdrawal by Subject|1
7638709|NCT02544503|12053000|FG001|Overall Study|Withdrawal by Subject|0
7638710|NCT02544373|12053008|FG000|Overall Study|Lost to Follow-up|5
7638711|NCT02544373|12053009|FG001|Overall Study|Lost to Follow-up|3
7638712|NCT02544373|12053008|FG000|Overall Study|Withdrawal by Subject|8
7638713|NCT02544373|12053009|FG001|Overall Study|Withdrawal by Subject|2
7638714|NCT02542293|12053027|FG000|Overall Study|Death|367
7638715|NCT02542293|12053028|FG001|Overall Study|Death|377
7638716|NCT02542293|12053027|FG000|Overall Study|Withdrawal by Subject|8
7638717|NCT02542293|12053028|FG001|Overall Study|Withdrawal by Subject|19
7638718|NCT02533180|12053069|FG000|Overall Study|Death|0
7638719|NCT02533180|12053070|FG001|Overall Study|Death|1
7638720|NCT02533180|12053069|FG000|Overall Study|Lost to Follow-up|0
7638721|NCT02533180|12053070|FG001|Overall Study|Lost to Follow-up|1
7638722|NCT02533180|12053069|FG000|Overall Study|Physician Decision|0
7638723|NCT02533180|12053070|FG001|Overall Study|Physician Decision|1
7638724|NCT02533180|12053069|FG000|Overall Study|Withdrawal by Subject|2
7638725|NCT02533180|12053070|FG001|Overall Study|Withdrawal by Subject|4
7638726|NCT02533180|12053069|FG000|Overall Study|Screen Failure|37
7638727|NCT02533180|12053070|FG001|Overall Study|Screen Failure|0
7638728|NCT02533180|12053069|FG000|Overall Study|Protocol Deviation|0
7638729|NCT02533180|12053070|FG001|Overall Study|Protocol Deviation|1
7638730|NCT02533180|12053069|FG000|Overall Study|On Study|0
7638731|NCT02533180|12053070|FG001|Overall Study|On Study|39
7638732|NCT02527434|12053082|FG000|Overall Study|Lost to Follow-up|2
7638733|NCT02527434|12053083|FG001|Overall Study|Lost to Follow-up|2
7638734|NCT02527434|12053084|FG002|Overall Study|Lost to Follow-up|0
7638735|NCT02527434|12053082|FG000|Overall Study|Death|19
7638736|NCT02527434|12053083|FG001|Overall Study|Death|6
7638737|NCT02527434|12053084|FG002|Overall Study|Death|17
7638738|NCT02527434|12053082|FG000|Overall Study|Withdrawal by Subject|5
7638739|NCT02527434|12053083|FG001|Overall Study|Withdrawal by Subject|3
7638740|NCT02527434|12053084|FG002|Overall Study|Withdrawal by Subject|3
7638741|NCT02527434|12053082|FG000|Overall Study|Reason Not Specified|1
7638742|NCT02527434|12053083|FG001|Overall Study|Reason Not Specified|0
7638743|NCT02527434|12053084|FG002|Overall Study|Reason Not Specified|0
7638744|NCT02527434|12053082|FG000|Overall Study|Site closure|1
7638745|NCT02527434|12053083|FG001|Overall Study|Site closure|0
7638746|NCT02527434|12053084|FG002|Overall Study|Site closure|0
7638747|NCT02524275|12053106|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5
7638748|NCT02522494|12053121|FG000|Overall Study|Lost to Follow-up|6
7638749|NCT02522494|12053122|FG001|Overall Study|Lost to Follow-up|2
7638750|NCT02522494|12053121|FG000|Overall Study|Withdrawal by Subject|1
7638751|NCT02522494|12053122|FG001|Overall Study|Withdrawal by Subject|0
7638752|NCT02522494|12053121|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
7638753|NCT02522494|12053122|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
7638754|NCT02522494|12053121|FG000|Overall Study|Participant did not watch the video|1
7638755|NCT02522494|12053122|FG001|Overall Study|Participant did not watch the video|0
7638756|NCT02522494|12053121|FG000|Overall Study|Death|0
7638757|NCT02522494|12053122|FG001|Overall Study|Death|1
7638758|NCT02513485|12053148|FG000|Overall Study|Adverse Event|1
7638759|NCT02513485|12053149|FG001|Overall Study|Adverse Event|0
7638760|NCT02504151|12053157|FG000|First Intervention (4 Weeks)|Physician Decision|1
7638761|NCT02504151|12053158|FG001|First Intervention (4 Weeks)|Physician Decision|1
7638762|NCT02504151|12053157|FG000|Washout (2 Weeks)|Lost to Follow-up|1
7638763|NCT02504151|12053158|FG001|Washout (2 Weeks)|Lost to Follow-up|0
7638764|NCT02504151|12053157|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
7638765|NCT02504151|12053158|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
7638766|NCT02504151|12053157|FG000|Second Intervention (4 Weeks)|Physician Decision|2
7638767|NCT02504151|12053158|FG001|Second Intervention (4 Weeks)|Physician Decision|1
7638768|NCT02499328|12053183|FG000|Overall Study|Withdrawal by Subject|1
7638769|NCT02499328|12053184|FG001|Overall Study|Withdrawal by Subject|1
7638770|NCT02499328|12053185|FG002|Overall Study|Withdrawal by Subject|5
7638771|NCT02499328|12053186|FG003|Overall Study|Withdrawal by Subject|3
7638772|NCT02499328|12053187|FG004|Overall Study|Withdrawal by Subject|5
7638773|NCT02499328|12053188|FG005|Overall Study|Withdrawal by Subject|0
7638774|NCT02499328|12053189|FG006|Overall Study|Withdrawal by Subject|0
7638775|NCT02499328|12053190|FG007|Overall Study|Withdrawal by Subject|0
7638776|NCT02499328|12053191|FG008|Overall Study|Withdrawal by Subject|2
7638777|NCT02499328|12053192|FG009|Overall Study|Withdrawal by Subject|2
7638778|NCT02499328|12053193|FG010|Overall Study|Withdrawal by Subject|0
7638779|NCT02499328|12053194|FG011|Overall Study|Withdrawal by Subject|3
7638780|NCT02499328|12053195|FG012|Overall Study|Withdrawal by Subject|7
7638781|NCT02499328|12053196|FG013|Overall Study|Withdrawal by Subject|3
7638782|NCT02499328|12053197|FG014|Overall Study|Withdrawal by Subject|1
7638783|NCT02499328|12053198|FG015|Overall Study|Withdrawal by Subject|0
7638784|NCT02499328|12053199|FG016|Overall Study|Withdrawal by Subject|0
7638785|NCT02499328|12053200|FG017|Overall Study|Withdrawal by Subject|3
7638786|NCT02499328|12053201|FG018|Overall Study|Withdrawal by Subject|0
7638787|NCT02499328|12053183|FG000|Overall Study|Lost to Follow-up|0
7638788|NCT02499328|12053184|FG001|Overall Study|Lost to Follow-up|1
7638789|NCT02499328|12053185|FG002|Overall Study|Lost to Follow-up|1
7638790|NCT02499328|12053186|FG003|Overall Study|Lost to Follow-up|2
7638791|NCT02499328|12053187|FG004|Overall Study|Lost to Follow-up|0
7638792|NCT02499328|12053188|FG005|Overall Study|Lost to Follow-up|0
7638793|NCT02499328|12053189|FG006|Overall Study|Lost to Follow-up|0
7638794|NCT02499328|12053190|FG007|Overall Study|Lost to Follow-up|2
7638795|NCT02499328|12053191|FG008|Overall Study|Lost to Follow-up|3
7638796|NCT02499328|12053192|FG009|Overall Study|Lost to Follow-up|0
7638797|NCT02499328|12053193|FG010|Overall Study|Lost to Follow-up|0
7638798|NCT02499328|12053194|FG011|Overall Study|Lost to Follow-up|0
7638799|NCT02499328|12053195|FG012|Overall Study|Lost to Follow-up|0
7638800|NCT02499328|12053196|FG013|Overall Study|Lost to Follow-up|0
7638801|NCT02499328|12053197|FG014|Overall Study|Lost to Follow-up|0
7638802|NCT02499328|12053198|FG015|Overall Study|Lost to Follow-up|0
7638803|NCT02499328|12053199|FG016|Overall Study|Lost to Follow-up|0
7638804|NCT02499328|12053200|FG017|Overall Study|Lost to Follow-up|0
7638805|NCT02499328|12053201|FG018|Overall Study|Lost to Follow-up|1
7638806|NCT02499328|12053183|FG000|Overall Study|Death|0
7638807|NCT02499328|12053184|FG001|Overall Study|Death|3
7638808|NCT02499328|12053185|FG002|Overall Study|Death|3
7638809|NCT02499328|12053186|FG003|Overall Study|Death|2
7638810|NCT02499328|12053187|FG004|Overall Study|Death|4
7638811|NCT02499328|12053188|FG005|Overall Study|Death|7
7638812|NCT02499328|12053189|FG006|Overall Study|Death|3
7638813|NCT02499328|12053190|FG007|Overall Study|Death|0
7638814|NCT02499328|12053191|FG008|Overall Study|Death|2
7638815|NCT02499328|12053192|FG009|Overall Study|Death|6
7638816|NCT02499328|12053193|FG010|Overall Study|Death|6
7638817|NCT02499328|12053194|FG011|Overall Study|Death|20
7638818|NCT02499328|12053195|FG012|Overall Study|Death|9
7638819|NCT02499328|12053196|FG013|Overall Study|Death|7
7638820|NCT02499328|12053197|FG014|Overall Study|Death|3
7638821|NCT02499328|12053198|FG015|Overall Study|Death|1
7638822|NCT02499328|12053199|FG016|Overall Study|Death|1
7638823|NCT02499328|12053200|FG017|Overall Study|Death|16
7638824|NCT02499328|12053201|FG018|Overall Study|Death|5
7638825|NCT02499328|12053183|FG000|Overall Study|"Other"|2
7638826|NCT02499328|12053184|FG001|Overall Study|"Other"|2
7638827|NCT02499328|12053185|FG002|Overall Study|"Other"|1
7638828|NCT02499328|12053186|FG003|Overall Study|"Other"|3
7638829|NCT02499328|12053187|FG004|Overall Study|"Other"|6
7638830|NCT02499328|12053188|FG005|Overall Study|"Other"|2
7638831|NCT02499328|12053189|FG006|Overall Study|"Other"|3
7638832|NCT02499328|12053190|FG007|Overall Study|"Other"|4
7638833|NCT02499328|12053191|FG008|Overall Study|"Other"|6
7638834|NCT02499328|12053192|FG009|Overall Study|"Other"|16
7638835|NCT02499328|12053193|FG010|Overall Study|"Other"|13
7638836|NCT02499328|12053194|FG011|Overall Study|"Other"|31
7638837|NCT02499328|12053195|FG012|Overall Study|"Other"|8
7638838|NCT02499328|12053196|FG013|Overall Study|"Other"|7
7638839|NCT02499328|12053197|FG014|Overall Study|"Other"|6
7638840|NCT02499328|12053198|FG015|Overall Study|"Other"|0
7638841|NCT02499328|12053199|FG016|Overall Study|"Other"|0
7638842|NCT02499328|12053200|FG017|Overall Study|"Other"|34
7638843|NCT02499328|12053201|FG018|Overall Study|"Other"|43
7638844|NCT02499328|12053183|FG000|Overall Study|Disease Progression|0
7638845|NCT02499328|12053184|FG001|Overall Study|Disease Progression|0
7638846|NCT02499328|12053185|FG002|Overall Study|Disease Progression|0
7638847|NCT02499328|12053186|FG003|Overall Study|Disease Progression|0
7638848|NCT02499328|12053187|FG004|Overall Study|Disease Progression|0
7638850|NCT02499328|12053189|FG006|Overall Study|Disease Progression|1
7638851|NCT02499328|12053190|FG007|Overall Study|Disease Progression|0
7638852|NCT02499328|12053191|FG008|Overall Study|Disease Progression|1
7638853|NCT02499328|12053192|FG009|Overall Study|Disease Progression|0
7638854|NCT02499328|12053193|FG010|Overall Study|Disease Progression|1
7638855|NCT02499328|12053194|FG011|Overall Study|Disease Progression|0
7638856|NCT02499328|12053195|FG012|Overall Study|Disease Progression|0
7638857|NCT02499328|12053196|FG013|Overall Study|Disease Progression|0
7638858|NCT02499328|12053197|FG014|Overall Study|Disease Progression|0
7638859|NCT02499328|12053198|FG015|Overall Study|Disease Progression|0
7638860|NCT02499328|12053199|FG016|Overall Study|Disease Progression|0
7638861|NCT02499328|12053200|FG017|Overall Study|Disease Progression|2
7638862|NCT02499328|12053201|FG018|Overall Study|Disease Progression|0
7638863|NCT02499328|12053183|FG000|Overall Study|Adverse Event|1
7638864|NCT02499328|12053184|FG001|Overall Study|Adverse Event|0
7638865|NCT02499328|12053185|FG002|Overall Study|Adverse Event|0
7638866|NCT02499328|12053186|FG003|Overall Study|Adverse Event|1
7638867|NCT02499328|12053187|FG004|Overall Study|Adverse Event|0
7638868|NCT02499328|12053188|FG005|Overall Study|Adverse Event|0
7638869|NCT02499328|12053189|FG006|Overall Study|Adverse Event|0
7638870|NCT02499328|12053190|FG007|Overall Study|Adverse Event|0
7638871|NCT02499328|12053191|FG008|Overall Study|Adverse Event|0
7638872|NCT02499328|12053192|FG009|Overall Study|Adverse Event|0
7638873|NCT02499328|12053193|FG010|Overall Study|Adverse Event|0
7638874|NCT02499328|12053194|FG011|Overall Study|Adverse Event|0
7638875|NCT02499328|12053195|FG012|Overall Study|Adverse Event|1
7638876|NCT02499328|12053196|FG013|Overall Study|Adverse Event|0
7638877|NCT02499328|12053197|FG014|Overall Study|Adverse Event|0
7638878|NCT02499328|12053198|FG015|Overall Study|Adverse Event|0
7638879|NCT02499328|12053199|FG016|Overall Study|Adverse Event|0
7638880|NCT02499328|12053200|FG017|Overall Study|Adverse Event|0
7638881|NCT02499328|12053201|FG018|Overall Study|Adverse Event|0
7638882|NCT02495077|12053295|FG000|Overall Study|Adverse Event|0
7638883|NCT02495077|12053296|FG001|Overall Study|Adverse Event|1
7638884|NCT02495077|12053297|FG002|Overall Study|Adverse Event|1
7638885|NCT02495077|12053298|FG003|Overall Study|Adverse Event|0
7638886|NCT02495077|12053295|FG000|Overall Study|Death|3
7638887|NCT02495077|12053296|FG001|Overall Study|Death|5
7638888|NCT02495077|12053297|FG002|Overall Study|Death|0
7638889|NCT02495077|12053298|FG003|Overall Study|Death|0
7638890|NCT02495077|12053295|FG000|Overall Study|Lost to Follow-up|6
7638891|NCT02495077|12053296|FG001|Overall Study|Lost to Follow-up|4
7638892|NCT02495077|12053297|FG002|Overall Study|Lost to Follow-up|0
7638893|NCT02495077|12053298|FG003|Overall Study|Lost to Follow-up|0
7638894|NCT02495077|12053295|FG000|Overall Study|Physician Decision|2
7638895|NCT02495077|12053296|FG001|Overall Study|Physician Decision|1
7638896|NCT02495077|12053297|FG002|Overall Study|Physician Decision|4
7638897|NCT02495077|12053298|FG003|Overall Study|Physician Decision|0
7638898|NCT02495077|12053295|FG000|Overall Study|Protocol Violation|0
7638899|NCT02495077|12053296|FG001|Overall Study|Protocol Violation|1
7638900|NCT02495077|12053297|FG002|Overall Study|Protocol Violation|0
7638901|NCT02495077|12053298|FG003|Overall Study|Protocol Violation|0
7638902|NCT02495077|12053295|FG000|Overall Study|Screen Failure|0
7638903|NCT02495077|12053296|FG001|Overall Study|Screen Failure|0
7638904|NCT02495077|12053297|FG002|Overall Study|Screen Failure|0
7638905|NCT02495077|12053298|FG003|Overall Study|Screen Failure|48
7638906|NCT02495077|12053295|FG000|Overall Study|Withdrawal by Subject|7
7638907|NCT02495077|12053296|FG001|Overall Study|Withdrawal by Subject|7
7638908|NCT02495077|12053297|FG002|Overall Study|Withdrawal by Subject|7
7638909|NCT02495077|12053298|FG003|Overall Study|Withdrawal by Subject|0
7638910|NCT02495077|12053295|FG000|Overall Study|Covid-19 research restrictions|1
7638911|NCT02495077|12053296|FG001|Overall Study|Covid-19 research restrictions|0
7638912|NCT02495077|12053297|FG002|Overall Study|Covid-19 research restrictions|0
7638913|NCT02495077|12053298|FG003|Overall Study|Covid-19 research restrictions|0
7638914|NCT02495077|12053295|FG000|Overall Study|Visit 14 scheduling difficulties|1
7638915|NCT02495077|12053296|FG001|Overall Study|Visit 14 scheduling difficulties|0
7638916|NCT02495077|12053297|FG002|Overall Study|Visit 14 scheduling difficulties|0
7638917|NCT02495077|12053298|FG003|Overall Study|Visit 14 scheduling difficulties|0
7638918|NCT02495077|12053295|FG000|Overall Study|Incarcerated|0
7638919|NCT02495077|12053296|FG001|Overall Study|Incarcerated|1
7638920|NCT02495077|12053297|FG002|Overall Study|Incarcerated|0
7638921|NCT02495077|12053298|FG003|Overall Study|Incarcerated|0
7638922|NCT02495077|12053295|FG000|Overall Study|Transplant nephrectomy, patient decision|0
7638923|NCT02495077|12053296|FG001|Overall Study|Transplant nephrectomy, patient decision|1
7638924|NCT02495077|12053297|FG002|Overall Study|Transplant nephrectomy, patient decision|0
7638925|NCT02495077|12053298|FG003|Overall Study|Transplant nephrectomy, patient decision|0
7638926|NCT02495077|12053295|FG000|Overall Study|Timing of transplant and randomization|0
7638927|NCT02495077|12053296|FG001|Overall Study|Timing of transplant and randomization|0
7638928|NCT02495077|12053297|FG002|Overall Study|Timing of transplant and randomization|5
7638929|NCT02495077|12053298|FG003|Overall Study|Timing of transplant and randomization|0
7638930|NCT02494921|12053309|FG000|Phase 1b, Dose Level I|Adverse Event|2
7638931|NCT02494921|12053310|FG001|Phase 1b, Dose Level I|Adverse Event|0
7638932|NCT02494921|12053311|FG002|Phase 1b, Dose Level I|Adverse Event|0
7638933|NCT02494921|12053312|FG003|Phase 1b, Dose Level I|Adverse Event|0
7638934|NCT02494921|12053313|FG004|Phase 1b, Dose Level I|Adverse Event|0
7638935|NCT02494921|12053309|FG000|Phase 1b, Dose Level IA|Adverse Event|0
7638936|NCT02494921|12053310|FG001|Phase 1b, Dose Level IA|Adverse Event|1
7638937|NCT02494921|12053311|FG002|Phase 1b, Dose Level IA|Adverse Event|0
7638938|NCT02494921|12053312|FG003|Phase 1b, Dose Level IA|Adverse Event|0
7638939|NCT02494921|12053313|FG004|Phase 1b, Dose Level IA|Adverse Event|0
7638940|NCT02494921|12053309|FG000|Phase 1b, Dose Level IIC|Physician Decision|0
7638941|NCT02494921|12053310|FG001|Phase 1b, Dose Level IIC|Physician Decision|0
7638942|NCT02494921|12053311|FG002|Phase 1b, Dose Level IIC|Physician Decision|1
7638943|NCT02494921|12053312|FG003|Phase 1b, Dose Level IIC|Physician Decision|0
7638944|NCT02494921|12053313|FG004|Phase 1b, Dose Level IIC|Physician Decision|0
7638945|NCT02494583|12053334|FG000|Overall Study|Death|195
7638946|NCT02494583|12053335|FG001|Overall Study|Death|189
7638947|NCT02494583|12053336|FG002|Overall Study|Death|201
7638948|NCT02494583|12053334|FG000|Overall Study|Lost to Follow-up|1
7638949|NCT02494583|12053335|FG001|Overall Study|Lost to Follow-up|0
7638950|NCT02494583|12053336|FG002|Overall Study|Lost to Follow-up|0
7638951|NCT02494583|12053334|FG000|Overall Study|Protocol Violation|1
7638952|NCT02494583|12053335|FG001|Overall Study|Protocol Violation|2
7638953|NCT02494583|12053336|FG002|Overall Study|Protocol Violation|0
7638954|NCT02494583|12053334|FG000|Overall Study|Withdrawal by Subject|3
7638955|NCT02494583|12053335|FG001|Overall Study|Withdrawal by Subject|15
7638956|NCT02494583|12053336|FG002|Overall Study|Withdrawal by Subject|15
7638957|NCT02494583|12053334|FG000|Overall Study|Ongoing in Study|56
7638958|NCT02494583|12053335|FG001|Overall Study|Ongoing in Study|51
7638959|NCT02494583|12053336|FG002|Overall Study|Ongoing in Study|34
7638960|NCT02493946|12053347|FG000|DB Period|Withdrawal by Subject|8
7638961|NCT02493946|12053348|FG001|DB Period|Withdrawal by Subject|5
7638962|NCT02493946|12053349|FG002|DB Period|Withdrawal by Subject|0
7638963|NCT02493946|12053347|FG000|Open Label Period|Withdrawal by Subject|0
7638964|NCT02493946|12053348|FG001|Open Label Period|Withdrawal by Subject|0
7638965|NCT02493946|12053349|FG002|Open Label Period|Withdrawal by Subject|74
7638966|NCT02493946|12053347|FG000|Open Label Period|Adverse Event|0
7638967|NCT02493946|12053348|FG001|Open Label Period|Adverse Event|0
7638968|NCT02493946|12053349|FG002|Open Label Period|Adverse Event|4
7638969|NCT02493946|12053347|FG000|Open Label Period|Lost to Follow-up|0
7638970|NCT02493946|12053348|FG001|Open Label Period|Lost to Follow-up|0
7638971|NCT02493946|12053349|FG002|Open Label Period|Lost to Follow-up|1
7638972|NCT02493946|12053347|FG000|Open Label Period|Investigator decision, non-compliance|0
7638973|NCT02493946|12053348|FG001|Open Label Period|Investigator decision, non-compliance|0
7638974|NCT02493946|12053349|FG002|Open Label Period|Investigator decision, non-compliance|2
7638975|NCT02493946|12053347|FG000|Open Label Period|Investigator decision, non-availability|0
7638976|NCT02493946|12053348|FG001|Open Label Period|Investigator decision, non-availability|0
7638977|NCT02493946|12053349|FG002|Open Label Period|Investigator decision, non-availability|1
7638978|NCT02493946|12053347|FG000|Open Label Period|Pregnancy|0
7638979|NCT02493946|12053348|FG001|Open Label Period|Pregnancy|0
7638980|NCT02493946|12053349|FG002|Open Label Period|Pregnancy|3
7638981|NCT02493946|12053347|FG000|Open Label Period|Site error|0
7638982|NCT02493946|12053348|FG001|Open Label Period|Site error|0
7638983|NCT02493946|12053349|FG002|Open Label Period|Site error|1
7638984|NCT02489318|12053368|FG000|Randomized|Withdrawal by Subject|0
7638985|NCT02489318|12053369|FG001|Randomized|Withdrawal by Subject|1
7638986|NCT02489318|12053368|FG000|Treated|Adverse Event|19
7638987|NCT02489318|12053369|FG001|Treated|Adverse Event|62
7638988|NCT02489318|12053368|FG000|Treated|Death|13
7638989|NCT02489318|12053369|FG001|Treated|Death|11
7638990|NCT02489318|12053368|FG000|Treated|Physician Decision|4
7638991|NCT02489318|12053369|FG001|Treated|Physician Decision|6
7638992|NCT02489318|12053368|FG000|Treated|Protocol Violation|1
7638993|NCT02489318|12053369|FG001|Treated|Protocol Violation|2
7638994|NCT02489318|12053368|FG000|Treated|Withdrawal by Subject|37
7638995|NCT02489318|12053369|FG001|Treated|Withdrawal by Subject|36
7638996|NCT02489318|12053368|FG000|Treated|Other: Progressive Disease|245
7638997|NCT02489318|12053369|FG001|Treated|Other: Progressive Disease|138
7638998|NCT02489318|12053368|FG000|Treated|Other|0
7638999|NCT02489318|12053369|FG001|Treated|Other|2
7639000|NCT02489318|12053368|FG000|Treated|Ongoing|0
7639001|NCT02489318|12053369|FG001|Treated|Ongoing|267
7639002|NCT02488759|12053391|FG000|Overall Study|Disease progression|74
7639003|NCT02488759|12053392|FG001|Overall Study|Disease progression|110
7639004|NCT02488759|12053393|FG002|Overall Study|Disease progression|62
7639005|NCT02488759|12053394|FG003|Overall Study|Disease progression|7
7639006|NCT02488759|12053395|FG004|Overall Study|Disease progression|4
7639007|NCT02488759|12053396|FG005|Overall Study|Disease progression|2
7639008|NCT02488759|12053391|FG000|Overall Study|Study drug toxicity|11
7639009|NCT02488759|12053392|FG001|Overall Study|Study drug toxicity|33
7639010|NCT02488759|12053393|FG002|Overall Study|Study drug toxicity|31
7639011|NCT02488759|12053394|FG003|Overall Study|Study drug toxicity|0
7639012|NCT02488759|12053395|FG004|Overall Study|Study drug toxicity|0
7639013|NCT02488759|12053396|FG005|Overall Study|Study drug toxicity|2
7639014|NCT02488759|12053391|FG000|Overall Study|Adverse event unrelated to study drug|9
7639015|NCT02488759|12053392|FG001|Overall Study|Adverse event unrelated to study drug|11
7639016|NCT02488759|12053393|FG002|Overall Study|Adverse event unrelated to study drug|7
7639017|NCT02488759|12053394|FG003|Overall Study|Adverse event unrelated to study drug|0
7639018|NCT02488759|12053395|FG004|Overall Study|Adverse event unrelated to study drug|1
7639019|NCT02488759|12053396|FG005|Overall Study|Adverse event unrelated to study drug|0
7639020|NCT02488759|12053391|FG000|Overall Study|Participant request to discontinue study treatment|7
7639021|NCT02488759|12053392|FG001|Overall Study|Participant request to discontinue study treatment|8
7639022|NCT02488759|12053393|FG002|Overall Study|Participant request to discontinue study treatment|4
7639023|NCT02488759|12053394|FG003|Overall Study|Participant request to discontinue study treatment|0
7639024|NCT02488759|12053395|FG004|Overall Study|Participant request to discontinue study treatment|0
7639025|NCT02488759|12053396|FG005|Overall Study|Participant request to discontinue study treatment|0
7639026|NCT02488759|12053391|FG000|Overall Study|Withdrawal by Subject|2
7639027|NCT02488759|12053392|FG001|Overall Study|Withdrawal by Subject|0
7639028|NCT02488759|12053393|FG002|Overall Study|Withdrawal by Subject|3
7639029|NCT02488759|12053394|FG003|Overall Study|Withdrawal by Subject|0
7639030|NCT02488759|12053395|FG004|Overall Study|Withdrawal by Subject|0
7639031|NCT02488759|12053396|FG005|Overall Study|Withdrawal by Subject|2
7639032|NCT02488759|12053391|FG000|Overall Study|Lost to Follow-up|0
7639033|NCT02488759|12053392|FG001|Overall Study|Lost to Follow-up|1
7639034|NCT02488759|12053393|FG002|Overall Study|Lost to Follow-up|2
7639035|NCT02488759|12053394|FG003|Overall Study|Lost to Follow-up|0
7639036|NCT02488759|12053395|FG004|Overall Study|Lost to Follow-up|0
7639037|NCT02488759|12053396|FG005|Overall Study|Lost to Follow-up|0
7639038|NCT02488759|12053391|FG000|Overall Study|Maximum clinical benefit|3
7639039|NCT02488759|12053392|FG001|Overall Study|Maximum clinical benefit|0
7639040|NCT02488759|12053393|FG002|Overall Study|Maximum clinical benefit|1
7639041|NCT02488759|12053394|FG003|Overall Study|Maximum clinical benefit|0
7639042|NCT02488759|12053395|FG004|Overall Study|Maximum clinical benefit|0
7639043|NCT02488759|12053396|FG005|Overall Study|Maximum clinical benefit|0
7639044|NCT02488759|12053391|FG000|Overall Study|Completed treatment|0
7639045|NCT02488759|12053392|FG001|Overall Study|Completed treatment|0
7639046|NCT02488759|12053393|FG002|Overall Study|Completed treatment|0
7639047|NCT02488759|12053394|FG003|Overall Study|Completed treatment|0
7639048|NCT02488759|12053395|FG004|Overall Study|Completed treatment|0
7639049|NCT02488759|12053396|FG005|Overall Study|Completed treatment|116
7639050|NCT02488759|12053391|FG000|Overall Study|Other reasons|5
7639051|NCT02488759|12053392|FG001|Overall Study|Other reasons|32
7639052|NCT02488759|12053393|FG002|Overall Study|Other reasons|21
7639053|NCT02488759|12053394|FG003|Overall Study|Other reasons|1
7639054|NCT02488759|12053395|FG004|Overall Study|Other reasons|1
7639055|NCT02488759|12053396|FG005|Overall Study|Other reasons|1
7639056|NCT02488551|12053414|FG000|Overall Study|Lost to Follow-up|4
7639057|NCT02488551|12053415|FG001|Overall Study|Lost to Follow-up|7
7639058|NCT02488551|12053416|FG002|Overall Study|Lost to Follow-up|0
7639059|NCT02488551|12053417|FG003|Overall Study|Lost to Follow-up|0
7639060|NCT02488551|12053414|FG000|Overall Study|Military Deployment|1
7639061|NCT02488551|12053415|FG001|Overall Study|Military Deployment|1
7639062|NCT02488551|12053416|FG002|Overall Study|Military Deployment|0
7639063|NCT02488551|12053417|FG003|Overall Study|Military Deployment|0
7639064|NCT02485899|12053455|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2
7639065|NCT02485899|12053456|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0
7639066|NCT02485899|12053455|FG000|Overall Study|Withdrawal by Subject|1
7639067|NCT02485899|12053456|FG001|Overall Study|Withdrawal by Subject|0
7639068|NCT02485899|12053455|FG000|Overall Study|Withdrawal by Parent/ Guardian|4
7639069|NCT02485899|12053456|FG001|Overall Study|Withdrawal by Parent/ Guardian|0
7639070|NCT02484443|12053462|FG000|Overall Study|Lack of Efficacy|28
7639071|NCT02484443|12053462|FG000|Overall Study|Physician Decision|2
7639072|NCT02484443|12053462|FG000|Overall Study|Ineligible|2
7639073|NCT02477696|12053477|FG000|Overall Study|Adverse Event|40
7639074|NCT02477696|12053478|FG001|Overall Study|Adverse Event|59
7639075|NCT02477696|12053477|FG000|Overall Study|CLL Disease Progression|82
7639076|NCT02477696|12053478|FG001|Overall Study|CLL Disease Progression|68
7639077|NCT02477696|12053477|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
7639078|NCT02477696|12053478|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
7639079|NCT02477696|12053477|FG000|Overall Study|Death|5
7639080|NCT02477696|12053478|FG001|Overall Study|Death|6
7639081|NCT02477696|12053477|FG000|Overall Study|Withdrawal by Subject|7
7639082|NCT02477696|12053478|FG001|Overall Study|Withdrawal by Subject|7
7639083|NCT02477696|12053477|FG000|Overall Study|Physician Decision|5
7639084|NCT02477696|12053478|FG001|Overall Study|Physician Decision|5
7639085|NCT02476968|12053487|FG000|Overall Study|Other|0
7639086|NCT02476968|12053488|FG001|Overall Study|Other|2
7639087|NCT02476968|12053489|FG002|Overall Study|Other|0
7639088|NCT02476968|12053487|FG000|Overall Study|Lost to Follow-up|10
7639089|NCT02476968|12053488|FG001|Overall Study|Lost to Follow-up|0
7639090|NCT02476968|12053489|FG002|Overall Study|Lost to Follow-up|1
7639091|NCT02476968|12053487|FG000|Overall Study|Death|48
7639092|NCT02476968|12053488|FG001|Overall Study|Death|8
7639093|NCT02476968|12053489|FG002|Overall Study|Death|1
7639094|NCT02476968|12053487|FG000|Overall Study|Eligibility criteria not fulfilled|0
7639095|NCT02476968|12053488|FG001|Overall Study|Eligibility criteria not fulfilled|0
7639096|NCT02476968|12053489|FG002|Overall Study|Eligibility criteria not fulfilled|1
7639097|NCT02476968|12053487|FG000|Overall Study|Patient decision|37
7639098|NCT02476968|12053488|FG001|Overall Study|Patient decision|8
7639099|NCT02476968|12053489|FG002|Overall Study|Patient decision|0
7639100|NCT02476916|12053501|FG000|Core Period|Adverse Event|2
7639101|NCT02476916|12053502|FG001|Core Period|Adverse Event|2
7639102|NCT02476916|12053501|FG000|Core Period|Investigator decision|1
7639103|NCT02476916|12053502|FG001|Core Period|Investigator decision|1
7639104|NCT02476916|12053501|FG000|Core Period|Withdrawal by Subject|3
7639105|NCT02476916|12053502|FG001|Core Period|Withdrawal by Subject|0
7639106|NCT02476916|12053501|FG000|Extension Period|Prematurely Discontinued Treatment|6
7639107|NCT02476916|12053502|FG001|Extension Period|Prematurely Discontinued Treatment|1
7639108|NCT02476916|12053501|FG000|Extension Period|On Treatment|12
7639109|NCT02476916|12053502|FG001|Extension Period|On Treatment|17
7639110|NCT02464410|12053528|FG000|Overall Study|Death|3
7639111|NCT02464410|12053529|FG001|Overall Study|Death|4
7639112|NCT02464410|12053528|FG000|Overall Study|Lost to Follow-up|7
7639113|NCT02464410|12053529|FG001|Overall Study|Lost to Follow-up|9
7639114|NCT02464410|12053528|FG000|Overall Study|Withdrawal by Subject|12
7639115|NCT02464410|12053529|FG001|Overall Study|Withdrawal by Subject|3
7639116|NCT02460198|12053563|FG000|Overall Study|Adverse Event|1
7639117|NCT02460198|12053564|FG001|Overall Study|Adverse Event|3
7639118|NCT02460198|12053563|FG000|Overall Study|Death|36
7639119|NCT02460198|12053564|FG001|Overall Study|Death|28
7639120|NCT02460198|12053563|FG000|Overall Study|Lost to Follow-up|1
7639121|NCT02460198|12053564|FG001|Overall Study|Lost to Follow-up|1
7639122|NCT02460198|12053563|FG000|Overall Study|Transferred to Extension Study|15
7639123|NCT02460198|12053564|FG001|Overall Study|Transferred to Extension Study|15
7639124|NCT02460198|12053563|FG000|Overall Study|Withdrawal by Subject|2
7639125|NCT02460198|12053564|FG001|Overall Study|Withdrawal by Subject|4
7639126|NCT02460198|12053563|FG000|Overall Study|Site Terminated By Sponsor|0
7639127|NCT02460198|12053564|FG001|Overall Study|Site Terminated By Sponsor|1
7639128|NCT02460198|12053563|FG000|Overall Study|Did Not Continue on Extension Study|6
7639129|NCT02460198|12053564|FG001|Overall Study|Did Not Continue on Extension Study|11
7639130|NCT02457910|12053578|FG000|Overall Study|Withdrawal by Subject|0
7639131|NCT02457910|12053579|FG001|Overall Study|Withdrawal by Subject|0
7639132|NCT02457910|12053580|FG002|Overall Study|Withdrawal by Subject|0
7639133|NCT02457910|12053581|FG003|Overall Study|Withdrawal by Subject|0
7639134|NCT02457910|12053582|FG004|Overall Study|Withdrawal by Subject|0
7639135|NCT02457910|12053583|FG005|Overall Study|Withdrawal by Subject|1
7639136|NCT02457910|12053578|FG000|Overall Study|Adverse Event|0
7639137|NCT02457910|12053579|FG001|Overall Study|Adverse Event|2
7639138|NCT02457910|12053580|FG002|Overall Study|Adverse Event|1
7639139|NCT02457910|12053581|FG003|Overall Study|Adverse Event|1
7639140|NCT02457910|12053582|FG004|Overall Study|Adverse Event|1
7639141|NCT02457910|12053583|FG005|Overall Study|Adverse Event|3
7639142|NCT02457910|12053578|FG000|Overall Study|Disease progression|3
7639143|NCT02457910|12053579|FG001|Overall Study|Disease progression|3
7639144|NCT02457910|12053580|FG002|Overall Study|Disease progression|1
7639145|NCT02457910|12053581|FG003|Overall Study|Disease progression|1
7639146|NCT02457910|12053582|FG004|Overall Study|Disease progression|4
7639147|NCT02457910|12053583|FG005|Overall Study|Disease progression|6
7639148|NCT02457910|12053578|FG000|Overall Study|Other complicating illness|0
7639149|NCT02457910|12053579|FG001|Overall Study|Other complicating illness|0
7639150|NCT02457910|12053580|FG002|Overall Study|Other complicating illness|0
7639151|NCT02457910|12053581|FG003|Overall Study|Other complicating illness|0
7639152|NCT02457910|12053582|FG004|Overall Study|Other complicating illness|0
7639153|NCT02457910|12053583|FG005|Overall Study|Other complicating illness|1
7639154|NCT02457910|12053578|FG000|Overall Study|Death|0
7639155|NCT02457910|12053579|FG001|Overall Study|Death|0
7639156|NCT02457910|12053580|FG002|Overall Study|Death|1
7639157|NCT02457910|12053581|FG003|Overall Study|Death|0
7639158|NCT02457910|12053582|FG004|Overall Study|Death|0
7639159|NCT02457910|12053583|FG005|Overall Study|Death|0
7639160|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639161|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639162|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
7639163|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639164|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639165|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639166|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639167|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639168|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
7639169|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
7639170|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
7639171|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
7639172|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639173|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639174|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639175|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639176|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639177|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
7639178|NCT02456740|12053603|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
7639179|NCT02456740|12053604|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
7639254|NCT02446600|12053667|FG003|Overall Study|Withdrawal by Subject|0
7639180|NCT02456740|12053605|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
7639181|NCT02456740|12053606|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639182|NCT02456740|12053607|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639183|NCT02456740|12053608|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639184|NCT02456740|12053609|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639185|NCT02456740|12053610|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639186|NCT02456740|12053611|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
7639187|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639188|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639189|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639190|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
7639191|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
7639192|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639193|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639194|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
7639195|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
7639196|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639197|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639198|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
7639199|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
7639200|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
7639201|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7639202|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7639203|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
7639204|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
7639205|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639206|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639207|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639208|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639209|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639210|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639211|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639212|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
7639213|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
7639214|NCT02456740|12053603|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639215|NCT02456740|12053604|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639216|NCT02456740|12053605|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
7639217|NCT02456740|12053606|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7639218|NCT02456740|12053607|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
7639219|NCT02456740|12053608|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7639220|NCT02456740|12053609|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
7639221|NCT02456740|12053610|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
7639222|NCT02456740|12053611|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
7639223|NCT02454933|12053623|FG000|Overall Study|Progressive disease|7
7639224|NCT02454933|12053624|FG001|Overall Study|Progressive disease|5
7639225|NCT02454933|12053623|FG000|Overall Study|Adverse Event|1
7639226|NCT02454933|12053624|FG001|Overall Study|Adverse Event|1
7639227|NCT02454933|12053623|FG000|Overall Study|Withdrawal by Subject|0
7639228|NCT02454933|12053624|FG001|Overall Study|Withdrawal by Subject|2
7639229|NCT02453282|12053632|FG000|Overall Study|Death|275
7639230|NCT02453282|12053633|FG001|Overall Study|Death|277
7639231|NCT02453282|12053634|FG002|Overall Study|Death|296
7639232|NCT02453282|12053632|FG000|Overall Study|Lost to Follow-up|1
7639233|NCT02453282|12053633|FG001|Overall Study|Lost to Follow-up|0
7639234|NCT02453282|12053634|FG002|Overall Study|Lost to Follow-up|2
7639235|NCT02453282|12053632|FG000|Overall Study|Withdrawal by Subject|12
7639236|NCT02453282|12053633|FG001|Overall Study|Withdrawal by Subject|10
7639237|NCT02453282|12053634|FG002|Overall Study|Withdrawal by Subject|11
7639238|NCT02453282|12053632|FG000|Overall Study|Participants ongoing at data cut-off|85
7639239|NCT02453282|12053633|FG001|Overall Study|Participants ongoing at data cut-off|84
7639240|NCT02453282|12053634|FG002|Overall Study|Participants ongoing at data cut-off|62
7639241|NCT02453282|12053632|FG000|Overall Study|Other|1
7639242|NCT02453282|12053633|FG001|Overall Study|Other|1
7639243|NCT02453282|12053634|FG002|Overall Study|Other|1
7639244|NCT02448225|12053653|FG000|Overall Study|Withdrawal by Subject|1
7639245|NCT02448225|12053653|FG000|Overall Study|Did not get FSPG scan|18
7639246|NCT02448225|12053653|FG000|Overall Study|Treated between the FDG and FSPG scan|1
7639247|NCT02446600|12053664|FG000|Overall Study|Never treated|20
7639248|NCT02446600|12053665|FG001|Overall Study|Never treated|2
7639249|NCT02446600|12053666|FG002|Overall Study|Never treated|6
7639250|NCT02446600|12053667|FG003|Overall Study|Never treated|0
7639251|NCT02446600|12053664|FG000|Overall Study|Withdrawal by Subject|19
7639252|NCT02446600|12053665|FG001|Overall Study|Withdrawal by Subject|5
7639253|NCT02446600|12053666|FG002|Overall Study|Withdrawal by Subject|17
7639255|NCT02446600|12053664|FG000|Overall Study|Ineligible|1
7639256|NCT02446600|12053665|FG001|Overall Study|Ineligible|4
7639257|NCT02446600|12053666|FG002|Overall Study|Ineligible|4
7639258|NCT02446600|12053667|FG003|Overall Study|Ineligible|1
7639259|NCT02446600|12053664|FG000|Overall Study|Duplicate Enrollment|0
7639260|NCT02446600|12053665|FG001|Overall Study|Duplicate Enrollment|1
7639261|NCT02446600|12053666|FG002|Overall Study|Duplicate Enrollment|0
7639262|NCT02446600|12053667|FG003|Overall Study|Duplicate Enrollment|0
7639263|NCT02442778|12053680|FG000|Overall Study|Adverse Event|2
7639264|NCT02442778|12053681|FG001|Overall Study|Adverse Event|6
7639265|NCT02442778|12053682|FG002|Overall Study|Adverse Event|6
7639266|NCT02442778|12053680|FG000|Overall Study|Death|0
7639267|NCT02442778|12053681|FG001|Overall Study|Death|2
7639268|NCT02442778|12053682|FG002|Overall Study|Death|0
7639269|NCT02442778|12053680|FG000|Overall Study|Lack of Efficacy|1
7639270|NCT02442778|12053681|FG001|Overall Study|Lack of Efficacy|0
7639271|NCT02442778|12053682|FG002|Overall Study|Lack of Efficacy|0
7639272|NCT02442778|12053680|FG000|Overall Study|Lost to Follow-up|1
7639273|NCT02442778|12053681|FG001|Overall Study|Lost to Follow-up|1
7639274|NCT02442778|12053682|FG002|Overall Study|Lost to Follow-up|1
7639275|NCT02442778|12053680|FG000|Overall Study|Non-compliance with study drug|2
7639276|NCT02442778|12053681|FG001|Overall Study|Non-compliance with study drug|0
7639277|NCT02442778|12053682|FG002|Overall Study|Non-compliance with study drug|1
7639278|NCT02442778|12053680|FG000|Overall Study|Physician Decision|1
7639279|NCT02442778|12053681|FG001|Overall Study|Physician Decision|1
7639280|NCT02442778|12053682|FG002|Overall Study|Physician Decision|1
7639281|NCT02442778|12053680|FG000|Overall Study|Protocol Deviation|3
7639282|NCT02442778|12053681|FG001|Overall Study|Protocol Deviation|0
7639283|NCT02442778|12053682|FG002|Overall Study|Protocol Deviation|1
7639284|NCT02442778|12053680|FG000|Overall Study|Study participant withdrawal by parent or guardian|3
7639285|NCT02442778|12053681|FG001|Overall Study|Study participant withdrawal by parent or guardian|12
7639286|NCT02442778|12053682|FG002|Overall Study|Study participant withdrawal by parent or guardian|2
7639287|NCT02442778|12053680|FG000|Overall Study|Withdrawal by Subject|4
7639288|NCT02442778|12053681|FG001|Overall Study|Withdrawal by Subject|4
7639289|NCT02442778|12053682|FG002|Overall Study|Withdrawal by Subject|3
7639290|NCT02442778|12053680|FG000|Overall Study|Reason not specified|1
7639291|NCT02442778|12053681|FG001|Overall Study|Reason not specified|4
7639292|NCT02442778|12053682|FG002|Overall Study|Reason not specified|0
7639293|NCT02439216|12053696|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1
7639294|NCT02439216|12053697|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639295|NCT02439216|12053698|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639296|NCT02439216|12053699|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639297|NCT02439216|12053700|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639298|NCT02439216|12053701|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639299|NCT02439216|12053702|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639300|NCT02439216|12053703|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639301|NCT02439216|12053704|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0
7639302|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639303|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639304|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639305|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639306|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639307|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639308|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639309|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1
7639310|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0
7639311|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639312|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639313|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639314|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639315|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639316|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639317|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0
7639318|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1
7639319|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2
7639320|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639321|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639322|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639323|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639324|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639325|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639326|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639327|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0
7639328|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3
7639329|NCT02439216|12053696|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639330|NCT02439216|12053697|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639331|NCT02439216|12053698|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639332|NCT02439216|12053699|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639333|NCT02439216|12053700|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639334|NCT02439216|12053701|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639335|NCT02439216|12053702|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0
7639336|NCT02439216|12053703|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5
7639337|NCT02439216|12053704|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6
7639338|NCT02437318|12053730|FG000|Overall Study|Progressive disease|173
7639339|NCT02437318|12053731|FG001|Overall Study|Progressive disease|208
7639340|NCT02437318|12053730|FG000|Overall Study|Subject/guardian decision|22
7639341|NCT02437318|12053731|FG001|Overall Study|Subject/guardian decision|10
7639342|NCT02437318|12053730|FG000|Overall Study|Physician Decision|11
7639343|NCT02437318|12053731|FG001|Overall Study|Physician Decision|10
7639344|NCT02437318|12053730|FG000|Overall Study|Adverse Event|14
7639345|NCT02437318|12053731|FG001|Overall Study|Adverse Event|3
7639346|NCT02437318|12053730|FG000|Overall Study|Death|4
7639347|NCT02437318|12053731|FG001|Overall Study|Death|4
7639348|NCT02437318|12053730|FG000|Overall Study|Protocol Violation|5
7639349|NCT02437318|12053731|FG001|Overall Study|Protocol Violation|6
7639350|NCT02437318|12053730|FG000|Overall Study|Untreated|0
7639351|NCT02437318|12053731|FG001|Overall Study|Untreated|1
7639352|NCT02434081|12053756|FG000|Overall Study|Death (never started treatment)|2
7639353|NCT02434081|12053756|FG000|Overall Study|Death|2
7639354|NCT02434081|12053756|FG000|Overall Study|Progression|20
7639355|NCT02434081|12053756|FG000|Overall Study|Adverse Event|20
7639356|NCT02434081|12053756|FG000|Overall Study|Physician Decision|2
7639357|NCT02434081|12053756|FG000|Overall Study|Withdrawal by Subject|1
7639358|NCT02434081|12053756|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
7639359|NCT02433210|12053763|FG000|Overall Study|Physician Decision|1
7639360|NCT02433210|12053764|FG001|Overall Study|Physician Decision|0
7639361|NCT02433210|12053765|FG002|Overall Study|Physician Decision|0
7639362|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Death|3
7639363|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Death|2
7639364|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Death|4
7639365|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Death|3
7639366|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Death|0
7639367|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Death|0
7639368|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0
7639369|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1
7639370|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1
7639371|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0
7639372|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0
7639373|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0
7639374|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2
7639375|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0
7639376|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0
7639377|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0
7639378|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0
7639379|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0
7639380|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2
7639381|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639382|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1
7639383|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1
7639384|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639385|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0
7639386|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639387|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639388|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2
7639389|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1
7639390|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639391|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0
7639392|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Disease progression|8
7639393|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Disease progression|5
7639394|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Disease progression|15
7639395|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Disease progression|9
7639396|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Disease progression|0
7639397|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Disease progression|0
7639398|NCT02432846|12053857|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639399|NCT02432846|12053858|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639400|NCT02432846|12053859|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1
7639401|NCT02432846|12053860|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639402|NCT02432846|12053861|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639403|NCT02432846|12053862|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0
7639404|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Death|0
7639405|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Death|0
7639406|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Death|0
7639407|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Death|0
7639408|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Death|7
7639409|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Death|5
7639410|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639411|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639412|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639413|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0
7639414|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1
7639415|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1
7639416|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639417|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639418|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639419|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639420|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2
7639421|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0
7639422|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639423|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639424|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639425|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0
7639426|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3
7639427|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1
7639428|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639429|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639430|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639431|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0
7639432|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2
7639433|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1
7639434|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639435|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639436|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639437|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0
7639438|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23
7639439|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14
7639440|NCT02432846|12053857|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639441|NCT02432846|12053858|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639442|NCT02432846|12053859|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639443|NCT02432846|12053860|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639444|NCT02432846|12053861|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1
7639445|NCT02432846|12053862|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0
7639446|NCT02432274|12053892|FG000|Overall Study|Radiological Disease Progression|3
7639447|NCT02432274|12053893|FG001|Overall Study|Radiological Disease Progression|4
7639448|NCT02432274|12053894|FG002|Overall Study|Radiological Disease Progression|7
7639449|NCT02432274|12053895|FG003|Overall Study|Radiological Disease Progression|0
7639450|NCT02432274|12053896|FG004|Overall Study|Radiological Disease Progression|24
7639451|NCT02432274|12053897|FG005|Overall Study|Radiological Disease Progression|6
7639452|NCT02432274|12053898|FG006|Overall Study|Radiological Disease Progression|11
7639453|NCT02432274|12053899|FG007|Overall Study|Radiological Disease Progression|9
7639454|NCT02432274|12053892|FG000|Overall Study|Clinical Disease Progression|0
7639455|NCT02432274|12053893|FG001|Overall Study|Clinical Disease Progression|4
7639456|NCT02432274|12053894|FG002|Overall Study|Clinical Disease Progression|1
7639457|NCT02432274|12053895|FG003|Overall Study|Clinical Disease Progression|0
7639458|NCT02432274|12053896|FG004|Overall Study|Clinical Disease Progression|1
7639459|NCT02432274|12053897|FG005|Overall Study|Clinical Disease Progression|0
7639460|NCT02432274|12053898|FG006|Overall Study|Clinical Disease Progression|0
7639461|NCT02432274|12053899|FG007|Overall Study|Clinical Disease Progression|1
7639462|NCT02432274|12053892|FG000|Overall Study|Adverse Event|0
7639463|NCT02432274|12053893|FG001|Overall Study|Adverse Event|0
7639464|NCT02432274|12053894|FG002|Overall Study|Adverse Event|1
7639465|NCT02432274|12053895|FG003|Overall Study|Adverse Event|0
7639466|NCT02432274|12053896|FG004|Overall Study|Adverse Event|1
7639467|NCT02432274|12053897|FG005|Overall Study|Adverse Event|0
7639468|NCT02432274|12053898|FG006|Overall Study|Adverse Event|2
7639469|NCT02432274|12053899|FG007|Overall Study|Adverse Event|0
7639470|NCT02432274|12053892|FG000|Overall Study|Withdrawal by Subject|0
7639471|NCT02432274|12053893|FG001|Overall Study|Withdrawal by Subject|0
7639472|NCT02432274|12053894|FG002|Overall Study|Withdrawal by Subject|0
7639473|NCT02432274|12053895|FG003|Overall Study|Withdrawal by Subject|0
7639474|NCT02432274|12053896|FG004|Overall Study|Withdrawal by Subject|2
7639475|NCT02432274|12053897|FG005|Overall Study|Withdrawal by Subject|0
7639476|NCT02432274|12053898|FG006|Overall Study|Withdrawal by Subject|1
7639477|NCT02432274|12053899|FG007|Overall Study|Withdrawal by Subject|2
7639478|NCT02432274|12053892|FG000|Overall Study|Participant Choice|0
7639479|NCT02432274|12053893|FG001|Overall Study|Participant Choice|0
7639480|NCT02432274|12053894|FG002|Overall Study|Participant Choice|1
7639481|NCT02432274|12053895|FG003|Overall Study|Participant Choice|0
7639482|NCT02432274|12053896|FG004|Overall Study|Participant Choice|0
7639483|NCT02432274|12053897|FG005|Overall Study|Participant Choice|0
7639484|NCT02432274|12053898|FG006|Overall Study|Participant Choice|1
7639485|NCT02432274|12053899|FG007|Overall Study|Participant Choice|0
7639486|NCT02432274|12053892|FG000|Overall Study|Other than specified|0
7639487|NCT02432274|12053893|FG001|Overall Study|Other than specified|1
7639488|NCT02432274|12053894|FG002|Overall Study|Other than specified|0
7639489|NCT02432274|12053895|FG003|Overall Study|Other than specified|0
7639490|NCT02432274|12053896|FG004|Overall Study|Other than specified|0
7639491|NCT02432274|12053897|FG005|Overall Study|Other than specified|1
7639492|NCT02432274|12053898|FG006|Overall Study|Other than specified|0
7639493|NCT02432274|12053899|FG007|Overall Study|Other than specified|1
7639494|NCT02432274|12053892|FG000|Overall Study|Ongoing|0
7639495|NCT02432274|12053893|FG001|Overall Study|Ongoing|0
7639496|NCT02432274|12053894|FG002|Overall Study|Ongoing|1
7639497|NCT02432274|12053895|FG003|Overall Study|Ongoing|1
7639498|NCT02432274|12053896|FG004|Overall Study|Ongoing|3
7639499|NCT02432274|12053897|FG005|Overall Study|Ongoing|0
7639500|NCT02432274|12053898|FG006|Overall Study|Ongoing|0
7639501|NCT02432274|12053899|FG007|Overall Study|Ongoing|7
7639502|NCT02432196|12053929|FG000|Overall Study|Not Implanted with Device|1
7639503|NCT02432196|12053929|FG000|Overall Study|Death|2
7639504|NCT02432196|12053929|FG000|Overall Study|Reoperation|3
7639505|NCT02432196|12053929|FG000|Overall Study|On Study|20
7639506|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
7639507|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
7639508|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
7639509|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
7639510|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
7639511|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
7639512|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
7639513|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
7639514|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
7639515|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
7639516|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
7639517|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
7639518|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
7639519|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
7639520|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
7639521|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
7639522|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
7639523|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
7639524|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
7639525|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
7639526|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
7639527|NCT02431247|12053935|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
7639528|NCT02431247|12053936|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
7639529|NCT02431247|12053937|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
7639530|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
7639531|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
7639532|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
7639533|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7639534|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
7639535|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
7639536|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7639537|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
7639538|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
7639539|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7639540|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
7639541|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
7639542|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
7639543|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
7639544|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
7639545|NCT02431247|12053935|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7639546|NCT02431247|12053936|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
7639547|NCT02431247|12053937|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
7639548|NCT02429830|12053949|FG000|Overall Study|Lost to Follow-up|1
7639549|NCT02429830|12053949|FG000|Overall Study|Device Explant|2
7639550|NCT02427464|12053955|FG000|Overall Study|Adverse Event|6
7639551|NCT02427464|12053956|FG001|Overall Study|Adverse Event|1
7639552|NCT02427464|12053955|FG000|Overall Study|Lost to Follow-up|16
7639553|NCT02427464|12053956|FG001|Overall Study|Lost to Follow-up|5
7639554|NCT02427464|12053955|FG000|Overall Study|Physician Decision|2
7639555|NCT02427464|12053956|FG001|Overall Study|Physician Decision|0
7639556|NCT02427464|12053955|FG000|Overall Study|Withdrawal by Subject|10
7639557|NCT02427464|12053956|FG001|Overall Study|Withdrawal by Subject|8
7639558|NCT02427464|12053955|FG000|Overall Study|Noncompliance|16
7639559|NCT02427464|12053956|FG001|Overall Study|Noncompliance|10
7639560|NCT02426125|12053964|FG000|Overall Study|Lost to Follow-up|12
7639561|NCT02426125|12053965|FG001|Overall Study|Lost to Follow-up|10
7639562|NCT02426125|12053964|FG000|Overall Study|Protocol Violation|1
7639563|NCT02426125|12053965|FG001|Overall Study|Protocol Violation|0
7639564|NCT02426125|12053964|FG000|Overall Study|Withdrawal by Subject|16
7639565|NCT02426125|12053965|FG001|Overall Study|Withdrawal by Subject|16
7639566|NCT02422615|12053975|FG000|Overall Study|Progressive disease|193
7639567|NCT02422615|12053976|FG001|Overall Study|Progressive disease|142
7639568|NCT02422615|12053975|FG000|Overall Study|Adverse Event|41
7639569|NCT02422615|12053976|FG001|Overall Study|Adverse Event|10
7639570|NCT02422615|12053975|FG000|Overall Study|Physician Decision|22
7639571|NCT02422615|12053976|FG001|Overall Study|Physician Decision|7
7639572|NCT02422615|12053975|FG000|Overall Study|Subject/guardian decision|21
7639573|NCT02422615|12053976|FG001|Overall Study|Subject/guardian decision|5
7639574|NCT02422615|12053975|FG000|Overall Study|Death|2
7639575|NCT02422615|12053976|FG001|Overall Study|Death|0
7639576|NCT02422615|12053975|FG000|Overall Study|Protocol Violation|1
7639577|NCT02422615|12053976|FG001|Overall Study|Protocol Violation|1
7639578|NCT02422615|12053975|FG000|Overall Study|Technical problems|0
7639579|NCT02422615|12053976|FG001|Overall Study|Technical problems|1
7639580|NCT02421939|12053984|FG000|Overall Study|Progressive disease|70
7639581|NCT02421939|12053985|FG001|Overall Study|Progressive disease|16
7639582|NCT02421939|12053984|FG000|Overall Study|Lack of Efficacy|21
7639583|NCT02421939|12053985|FG001|Overall Study|Lack of Efficacy|31
7639584|NCT02421939|12053984|FG000|Overall Study|Death|36
7639585|NCT02421939|12053985|FG001|Overall Study|Death|10
7639586|NCT02421939|12053984|FG000|Overall Study|Disease relapse|33
7639587|NCT02421939|12053985|FG001|Overall Study|Disease relapse|2
7639588|NCT02421939|12053984|FG000|Overall Study|Adverse Event|28
7639589|NCT02421939|12053985|FG001|Overall Study|Adverse Event|5
7639590|NCT02421939|12053984|FG000|Overall Study|Withdrawal by Subject|5
7639591|NCT02421939|12053985|FG001|Overall Study|Withdrawal by Subject|24
7639592|NCT02421939|12053984|FG000|Overall Study|Physician Decision|11
7639593|NCT02421939|12053985|FG001|Overall Study|Physician Decision|11
7639594|NCT02421939|12053984|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
7639595|NCT02421939|12053985|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
7639596|NCT02421939|12053984|FG000|Overall Study|Miscellaneous|4
7639597|NCT02421939|12053985|FG001|Overall Study|Miscellaneous|5
7639598|NCT02421939|12053984|FG000|Overall Study|Protocol deviation|1
7639599|NCT02421939|12053985|FG001|Overall Study|Protocol deviation|1
7639600|NCT02420119|12053991|FG000|Overall Study|insufficient laboratory data|5
7639601|NCT02412878|12054014|FG000|Overall Study|Withdrawal by Subject|19
7639602|NCT02412878|12054015|FG001|Overall Study|Withdrawal by Subject|10
7639603|NCT02412878|12054014|FG000|Overall Study|Lost to Follow-up|2
7639604|NCT02412878|12054015|FG001|Overall Study|Lost to Follow-up|3
7639605|NCT02412670|12054023|FG000|Overall Study|Adverse Event|4
7639606|NCT02412670|12054024|FG001|Overall Study|Adverse Event|1
7639607|NCT02412670|12054023|FG000|Overall Study|Physician Decision|1
7639608|NCT02412670|12054024|FG001|Overall Study|Physician Decision|0
7639609|NCT02412670|12054023|FG000|Overall Study|Withdrawal by Subject|1
7639610|NCT02412670|12054024|FG001|Overall Study|Withdrawal by Subject|0
7639611|NCT02412670|12054023|FG000|Overall Study|Ineligible|1
7639612|NCT02412670|12054024|FG001|Overall Study|Ineligible|0
7639613|NCT02412306|12054035|FG000|Overall Study|Lost to Follow-up|0
7639614|NCT02412306|12054036|FG001|Overall Study|Lost to Follow-up|1
7639615|NCT02412306|12054037|FG002|Overall Study|Lost to Follow-up|0
7639616|NCT02412306|12054038|FG003|Overall Study|Lost to Follow-up|0
7639617|NCT02412306|12054039|FG004|Overall Study|Lost to Follow-up|0
7639618|NCT02412306|12054035|FG000|Overall Study|Withdrawal by Subject|0
7639619|NCT02412306|12054036|FG001|Overall Study|Withdrawal by Subject|0
7639620|NCT02412306|12054037|FG002|Overall Study|Withdrawal by Subject|1
7639621|NCT02412306|12054038|FG003|Overall Study|Withdrawal by Subject|0
7639622|NCT02412306|12054039|FG004|Overall Study|Withdrawal by Subject|0
7639623|NCT02412306|12054035|FG000|Overall Study|Death|5
7639624|NCT02412306|12054036|FG001|Overall Study|Death|7
7639625|NCT02412306|12054037|FG002|Overall Study|Death|15
7639626|NCT02412306|12054038|FG003|Overall Study|Death|0
7639627|NCT02412306|12054039|FG004|Overall Study|Death|2
7639628|NCT02408887|12054062|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1
7639629|NCT02408887|12054063|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0
7639630|NCT02408887|12054062|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0
7639631|NCT02408887|12054063|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1
7639632|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Adverse Event|3
7639633|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Adverse Event|0
7639634|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Adverse Event|1
7639635|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Adverse Event|0
7639636|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Adverse Event|0
7639637|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Adverse Event|0
7639638|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Adverse Event|0
7639639|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Adverse Event|0
7639640|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Death|0
7639641|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Death|0
7639642|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Death|1
7639643|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Death|0
7639644|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Death|0
7639645|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Death|0
7639646|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Death|0
7639647|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Death|0
7639648|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
7639649|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
7639650|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
7639651|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639652|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639653|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639654|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639655|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
7639656|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
7639657|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
7639658|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
7639659|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
7639660|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
7639661|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
7639662|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
7639663|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
7639664|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Physician Decision|1
7639665|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Physician Decision|1
7639666|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Physician Decision|0
7639667|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Physician Decision|0
7639668|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Physician Decision|0
7639669|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Physician Decision|0
7639670|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Physician Decision|0
7639671|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Physician Decision|0
7639672|NCT02407236|12054077|FG000|Induction Study (8 Weeks)|Other|2
7639673|NCT02407236|12054078|FG001|Induction Study (8 Weeks)|Other|1
7639674|NCT02407236|12054079|FG002|Induction Study (8 Weeks)|Other|5
7639675|NCT02407236|12054080|FG003|Induction Study (8 Weeks)|Other|0
7639676|NCT02407236|12054081|FG004|Induction Study (8 Weeks)|Other|0
7639677|NCT02407236|12054082|FG005|Induction Study (8 Weeks)|Other|0
7639678|NCT02407236|12054083|FG006|Induction Study (8 Weeks)|Other|0
7639679|NCT02407236|12054084|FG007|Induction Study (8 Weeks)|Other|0
7639680|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639681|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639682|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639683|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639684|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639685|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639686|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
7639687|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
7639688|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Death|0
7639689|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Death|0
7639690|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Death|0
7639691|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Death|0
7639692|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Death|0
7639693|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Death|0
7639694|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Death|0
7639695|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Death|1
7639696|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639697|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639698|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
7639699|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
7639700|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
7639701|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
7639702|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
7639703|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
7639704|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
7639705|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
7639706|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
7639707|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
7639708|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
7639709|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
7639710|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
7639711|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
7639712|NCT02407236|12054077|FG000|Maintenance Study (44 Weeks)|Other|0
7639713|NCT02407236|12054078|FG001|Maintenance Study (44 Weeks)|Other|0
7639714|NCT02407236|12054079|FG002|Maintenance Study (44 Weeks)|Other|0
7639715|NCT02407236|12054080|FG003|Maintenance Study (44 Weeks)|Other|0
7639716|NCT02407236|12054081|FG004|Maintenance Study (44 Weeks)|Other|1
7639717|NCT02407236|12054082|FG005|Maintenance Study (44 Weeks)|Other|1
7639718|NCT02407236|12054083|FG006|Maintenance Study (44 Weeks)|Other|2
7639719|NCT02407236|12054084|FG007|Maintenance Study (44 Weeks)|Other|1
7639720|NCT02404441|12054112|FG000|Phase 1 Part|Adverse Event|1
7639721|NCT02404441|12054113|FG001|Phase 1 Part|Adverse Event|0
7639722|NCT02404441|12054114|FG002|Phase 1 Part|Adverse Event|0
7639723|NCT02404441|12054115|FG003|Phase 1 Part|Adverse Event|0
7639724|NCT02404441|12054116|FG004|Phase 1 Part|Adverse Event|0
7639725|NCT02404441|12054117|FG005|Phase 1 Part|Adverse Event|0
7639726|NCT02404441|12054118|FG006|Phase 1 Part|Adverse Event|0
7639727|NCT02404441|12054119|FG007|Phase 1 Part|Adverse Event|0
7639728|NCT02404441|12054120|FG008|Phase 1 Part|Adverse Event|0
7639729|NCT02404441|12054121|FG009|Phase 1 Part|Adverse Event|0
7639730|NCT02404441|12054112|FG000|Phase 1 Part|Physician Decision|0
7639731|NCT02404441|12054113|FG001|Phase 1 Part|Physician Decision|1
7639732|NCT02404441|12054114|FG002|Phase 1 Part|Physician Decision|0
7639733|NCT02404441|12054115|FG003|Phase 1 Part|Physician Decision|0
7639734|NCT02404441|12054116|FG004|Phase 1 Part|Physician Decision|0
7639735|NCT02404441|12054117|FG005|Phase 1 Part|Physician Decision|0
7639736|NCT02404441|12054118|FG006|Phase 1 Part|Physician Decision|0
7639737|NCT02404441|12054119|FG007|Phase 1 Part|Physician Decision|0
7639738|NCT02404441|12054120|FG008|Phase 1 Part|Physician Decision|0
7639739|NCT02404441|12054121|FG009|Phase 1 Part|Physician Decision|0
7639740|NCT02404441|12054112|FG000|Phase 1 Part|Progressive Disease|14
7639741|NCT02404441|12054113|FG001|Phase 1 Part|Progressive Disease|11
7639742|NCT02404441|12054114|FG002|Phase 1 Part|Progressive Disease|7
7639743|NCT02404441|12054115|FG003|Phase 1 Part|Progressive Disease|6
7639744|NCT02404441|12054116|FG004|Phase 1 Part|Progressive Disease|9
7639745|NCT02404441|12054117|FG005|Phase 1 Part|Progressive Disease|0
7639746|NCT02404441|12054118|FG006|Phase 1 Part|Progressive Disease|0
7639747|NCT02404441|12054119|FG007|Phase 1 Part|Progressive Disease|0
7639748|NCT02404441|12054120|FG008|Phase 1 Part|Progressive Disease|0
7639749|NCT02404441|12054121|FG009|Phase 1 Part|Progressive Disease|0
7639750|NCT02404441|12054112|FG000|Phase 1 Part|Subject/Guardian Decision|0
7639751|NCT02404441|12054113|FG001|Phase 1 Part|Subject/Guardian Decision|2
7639752|NCT02404441|12054114|FG002|Phase 1 Part|Subject/Guardian Decision|3
7639753|NCT02404441|12054115|FG003|Phase 1 Part|Subject/Guardian Decision|0
7639754|NCT02404441|12054116|FG004|Phase 1 Part|Subject/Guardian Decision|0
7639755|NCT02404441|12054117|FG005|Phase 1 Part|Subject/Guardian Decision|0
7639756|NCT02404441|12054118|FG006|Phase 1 Part|Subject/Guardian Decision|0
7639757|NCT02404441|12054119|FG007|Phase 1 Part|Subject/Guardian Decision|0
7639758|NCT02404441|12054120|FG008|Phase 1 Part|Subject/Guardian Decision|0
7639759|NCT02404441|12054121|FG009|Phase 1 Part|Subject/Guardian Decision|0
7639760|NCT02404441|12054112|FG000|Phase 1 Part|Death|1
7639761|NCT02404441|12054113|FG001|Phase 1 Part|Death|1
7639762|NCT02404441|12054114|FG002|Phase 1 Part|Death|1
7639763|NCT02404441|12054115|FG003|Phase 1 Part|Death|0
7639764|NCT02404441|12054116|FG004|Phase 1 Part|Death|1
7639765|NCT02404441|12054117|FG005|Phase 1 Part|Death|0
7639766|NCT02404441|12054118|FG006|Phase 1 Part|Death|0
7639767|NCT02404441|12054119|FG007|Phase 1 Part|Death|0
7639768|NCT02404441|12054120|FG008|Phase 1 Part|Death|0
7639769|NCT02404441|12054121|FG009|Phase 1 Part|Death|0
7639770|NCT02404441|12054112|FG000|Phase 2 Part|Adverse Event|0
7639771|NCT02404441|12054113|FG001|Phase 2 Part|Adverse Event|0
7639772|NCT02404441|12054114|FG002|Phase 2 Part|Adverse Event|0
7639773|NCT02404441|12054115|FG003|Phase 2 Part|Adverse Event|0
7639774|NCT02404441|12054116|FG004|Phase 2 Part|Adverse Event|0
7639775|NCT02404441|12054117|FG005|Phase 2 Part|Adverse Event|2
7639776|NCT02404441|12054118|FG006|Phase 2 Part|Adverse Event|3
7639777|NCT02404441|12054119|FG007|Phase 2 Part|Adverse Event|3
7639778|NCT02404441|12054120|FG008|Phase 2 Part|Adverse Event|6
7639779|NCT02404441|12054121|FG009|Phase 2 Part|Adverse Event|1
7639780|NCT02404441|12054112|FG000|Phase 2 Part|Physician Decision|0
7639781|NCT02404441|12054113|FG001|Phase 2 Part|Physician Decision|0
7639782|NCT02404441|12054114|FG002|Phase 2 Part|Physician Decision|0
7639783|NCT02404441|12054115|FG003|Phase 2 Part|Physician Decision|0
7639784|NCT02404441|12054116|FG004|Phase 2 Part|Physician Decision|0
7639785|NCT02404441|12054117|FG005|Phase 2 Part|Physician Decision|7
7639786|NCT02404441|12054118|FG006|Phase 2 Part|Physician Decision|9
7639787|NCT02404441|12054119|FG007|Phase 2 Part|Physician Decision|2
7639788|NCT02404441|12054120|FG008|Phase 2 Part|Physician Decision|1
7639789|NCT02404441|12054121|FG009|Phase 2 Part|Physician Decision|3
7639790|NCT02404441|12054112|FG000|Phase 2 Part|Progressive disease|0
7639791|NCT02404441|12054113|FG001|Phase 2 Part|Progressive disease|0
7639792|NCT02404441|12054114|FG002|Phase 2 Part|Progressive disease|0
7639793|NCT02404441|12054115|FG003|Phase 2 Part|Progressive disease|0
7639794|NCT02404441|12054116|FG004|Phase 2 Part|Progressive disease|0
7639795|NCT02404441|12054117|FG005|Phase 2 Part|Progressive disease|43
7639796|NCT02404441|12054118|FG006|Phase 2 Part|Progressive disease|32
7639797|NCT02404441|12054119|FG007|Phase 2 Part|Progressive disease|31
7639798|NCT02404441|12054120|FG008|Phase 2 Part|Progressive disease|39
7639799|NCT02404441|12054121|FG009|Phase 2 Part|Progressive disease|27
7639800|NCT02404441|12054112|FG000|Phase 2 Part|Subject/guardian decision|0
7639801|NCT02404441|12054113|FG001|Phase 2 Part|Subject/guardian decision|0
7639802|NCT02404441|12054114|FG002|Phase 2 Part|Subject/guardian decision|0
7639803|NCT02404441|12054115|FG003|Phase 2 Part|Subject/guardian decision|0
7639804|NCT02404441|12054116|FG004|Phase 2 Part|Subject/guardian decision|0
7639805|NCT02404441|12054117|FG005|Phase 2 Part|Subject/guardian decision|3
7639806|NCT02404441|12054118|FG006|Phase 2 Part|Subject/guardian decision|9
7639807|NCT02404441|12054119|FG007|Phase 2 Part|Subject/guardian decision|0
7639808|NCT02404441|12054120|FG008|Phase 2 Part|Subject/guardian decision|3
7639809|NCT02404441|12054121|FG009|Phase 2 Part|Subject/guardian decision|2
7639810|NCT02404441|12054112|FG000|Phase 2 Part|Death|0
7639811|NCT02404441|12054113|FG001|Phase 2 Part|Death|0
7639812|NCT02404441|12054114|FG002|Phase 2 Part|Death|0
7639813|NCT02404441|12054115|FG003|Phase 2 Part|Death|0
7639814|NCT02404441|12054116|FG004|Phase 2 Part|Death|0
7639815|NCT02404441|12054117|FG005|Phase 2 Part|Death|4
7639816|NCT02404441|12054118|FG006|Phase 2 Part|Death|8
7639817|NCT02404441|12054119|FG007|Phase 2 Part|Death|4
7639818|NCT02404441|12054120|FG008|Phase 2 Part|Death|10
7639819|NCT02404441|12054121|FG009|Phase 2 Part|Death|9
7639820|NCT02403674|12054185|FG000|Overall Study|Adverse Event|10
7639821|NCT02403674|12054186|FG001|Overall Study|Adverse Event|23
7639822|NCT02403674|12054185|FG000|Overall Study|Death|1
7639823|NCT02403674|12054186|FG001|Overall Study|Death|3
7639824|NCT02403674|12054185|FG000|Overall Study|Lack of Efficacy|18
7639825|NCT02403674|12054186|FG001|Overall Study|Lack of Efficacy|10
7639826|NCT02403674|12054185|FG000|Overall Study|Lost to Follow-up|6
7639827|NCT02403674|12054186|FG001|Overall Study|Lost to Follow-up|7
7639828|NCT02403674|12054185|FG000|Overall Study|Noncompliance with study drug|1
7639829|NCT02403674|12054186|FG001|Overall Study|Noncompliance with study drug|2
7639830|NCT02403674|12054185|FG000|Overall Study|Withdrawal by Subject|8
7639831|NCT02403674|12054186|FG001|Overall Study|Withdrawal by Subject|11
7639832|NCT02403674|12054185|FG000|Overall Study|Physician Decision|2
7639833|NCT02403674|12054186|FG001|Overall Study|Physician Decision|2
7639834|NCT02403674|12054185|FG000|Overall Study|Not treated with study drug|4
7639835|NCT02403674|12054186|FG001|Overall Study|Not treated with study drug|2
7639836|NCT02403674|12054185|FG000|Overall Study|Pregnancy|1
7639837|NCT02403674|12054186|FG001|Overall Study|Pregnancy|1
7639838|NCT02403674|12054185|FG000|Overall Study|Protocol Violation|4
7639839|NCT02403674|12054186|FG001|Overall Study|Protocol Violation|2
7639840|NCT02399449|12054194|FG000|Overall Study|Withdrawal by Subject|3
7639841|NCT02399449|12054195|FG001|Overall Study|Withdrawal by Subject|9
7639842|NCT02399449|12054194|FG000|Overall Study|Physician Decision|0
7639843|NCT02399449|12054195|FG001|Overall Study|Physician Decision|1
7639844|NCT02397096|12054203|FG000|Day 1 to Week 24|Adverse Event|7
7639845|NCT02397096|12054204|FG001|Day 1 to Week 24|Adverse Event|1
7639846|NCT02397096|12054203|FG000|Day 1 to Week 24|Death|1
7639847|NCT02397096|12054204|FG001|Day 1 to Week 24|Death|0
7639848|NCT02397096|12054203|FG000|Day 1 to Week 24|Lack of Efficacy|0
7639849|NCT02397096|12054204|FG001|Day 1 to Week 24|Lack of Efficacy|1
7639850|NCT02397096|12054203|FG000|Day 1 to Week 24|Lost to Follow-up|3
7639851|NCT02397096|12054204|FG001|Day 1 to Week 24|Lost to Follow-up|4
7639852|NCT02397096|12054203|FG000|Day 1 to Week 24|Physician Decision|2
7639853|NCT02397096|12054204|FG001|Day 1 to Week 24|Physician Decision|3
7639854|NCT02397096|12054203|FG000|Day 1 to Week 24|Protocol Violation|1
7639855|NCT02397096|12054204|FG001|Day 1 to Week 24|Protocol Violation|4
7639856|NCT02397096|12054203|FG000|Day 1 to Week 24|Withdrawal by Subject|6
7639857|NCT02397096|12054204|FG001|Day 1 to Week 24|Withdrawal by Subject|1
7639858|NCT02397096|12054203|FG000|Week 24 to Week 48|Adverse Event|6
7639859|NCT02397096|12054204|FG001|Week 24 to Week 48|Adverse Event|2
7639860|NCT02397096|12054203|FG000|Week 24 to Week 48|Lack of Efficacy|5
7639861|NCT02397096|12054204|FG001|Week 24 to Week 48|Lack of Efficacy|1
7639862|NCT02397096|12054203|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
7639863|NCT02397096|12054204|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
7639864|NCT02397096|12054203|FG000|Week 24 to Week 48|Physician Decision|2
7639865|NCT02397096|12054204|FG001|Week 24 to Week 48|Physician Decision|1
7639866|NCT02397096|12054203|FG000|Week 24 to Week 48|Withdrawal by Subject|5
7639867|NCT02397096|12054204|FG001|Week 24 to Week 48|Withdrawal by Subject|2
7639868|NCT02397096|12054203|FG000|Week 24 to Week 48|Lost to Follow-up|2
7639869|NCT02397096|12054204|FG001|Week 24 to Week 48|Lost to Follow-up|0
7639870|NCT02397096|12054203|FG000|Study Extensions|Ongoing|399
7639871|NCT02397096|12054204|FG001|Study Extensions|Ongoing|202
7639872|NCT02393859|12054237|FG000|Overall Study|Decision by Sponsor|1
7639873|NCT02393859|12054238|FG001|Overall Study|Decision by Sponsor|1
7639874|NCT02393859|12054237|FG000|Overall Study|Withdrawal by Subject|5
7639875|NCT02393859|12054238|FG001|Overall Study|Withdrawal by Subject|2
7639876|NCT02393859|12054237|FG000|Overall Study|Death|16
7639877|NCT02393859|12054238|FG001|Overall Study|Death|8
7639878|NCT02393859|12054237|FG000|Overall Study|Continuing Study|32
7639879|NCT02393859|12054238|FG001|Overall Study|Continuing Study|43
7639880|NCT02390245|12054259|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0
7639881|NCT02390245|12054260|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103
7639882|NCT02390245|12054261|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104
7639883|NCT02390245|12054259|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0
7639884|NCT02390245|12054260|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95
7639885|NCT02390245|12054261|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106
7639886|NCT02388906|12054281|FG000|Pre-Treatment Period|Participant withdrew consent|1
7639887|NCT02388906|12054282|FG001|Pre-Treatment Period|Participant withdrew consent|0
7639888|NCT02388906|12054281|FG000|Treatment Period|Disease progression|121
7639889|NCT02388906|12054282|FG001|Treatment Period|Disease progression|101
7639890|NCT02388906|12054281|FG000|Treatment Period|Study drug toxicity|41
7639891|NCT02388906|12054282|FG001|Treatment Period|Study drug toxicity|208
7639970|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Other|0
7639892|NCT02388906|12054281|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7639893|NCT02388906|12054282|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
7639894|NCT02388906|12054281|FG000|Treatment Period|Participant request to stop treatment|5
7639895|NCT02388906|12054282|FG001|Treatment Period|Participant request to stop treatment|9
7639896|NCT02388906|12054281|FG000|Treatment Period|Participant withdrew consent|2
7639897|NCT02388906|12054282|FG001|Treatment Period|Participant withdrew consent|3
7639898|NCT02388906|12054281|FG000|Treatment Period|Poor/non-compliance|0
7639899|NCT02388906|12054282|FG001|Treatment Period|Poor/non-compliance|1
7639900|NCT02388906|12054281|FG000|Treatment Period|Participant no longer meets study criteria|0
7639901|NCT02388906|12054282|FG001|Treatment Period|Participant no longer meets study criteria|1
7639902|NCT02388906|12054281|FG000|Treatment Period|Other reasons|3
7639903|NCT02388906|12054282|FG001|Treatment Period|Other reasons|3
7639904|NCT02376790|12054291|FG000|Overall Study|Withdrawal by Subject|43
7639905|NCT02376790|12054292|FG001|Overall Study|Withdrawal by Subject|36
7639906|NCT02376790|12054293|FG002|Overall Study|Withdrawal by Subject|37
7639907|NCT02376790|12054291|FG000|Overall Study|Decision by Sponsor|2
7639908|NCT02376790|12054292|FG001|Overall Study|Decision by Sponsor|1
7639909|NCT02376790|12054293|FG002|Overall Study|Decision by Sponsor|4
7639910|NCT02376790|12054291|FG000|Overall Study|Lost to Follow-up|15
7639911|NCT02376790|12054292|FG001|Overall Study|Lost to Follow-up|10
7639912|NCT02376790|12054293|FG002|Overall Study|Lost to Follow-up|12
7639913|NCT02370914|12054305|FG000|Overall Study|Protocol Violation|2
7639914|NCT02370238|12054311|FG000|Overall Study|Death|42
7639915|NCT02370238|12054312|FG001|Overall Study|Death|35
7639916|NCT02370238|12054311|FG000|Overall Study|Lost to Follow-up|1
7639917|NCT02370238|12054312|FG001|Overall Study|Lost to Follow-up|3
7639918|NCT02370238|12054311|FG000|Overall Study|Withdrawal by Subject|2
7639919|NCT02370238|12054312|FG001|Overall Study|Withdrawal by Subject|6
7639920|NCT02370238|12054311|FG000|Overall Study|Other|2
7639921|NCT02370238|12054312|FG001|Overall Study|Other|1
7639922|NCT02367040|12054328|FG000|Overall Study|Lost to Follow-up|1
7639923|NCT02367040|12054329|FG001|Overall Study|Lost to Follow-up|1
7639924|NCT02367040|12054328|FG000|Overall Study|Lack of Efficacy|1
7639925|NCT02367040|12054329|FG001|Overall Study|Lack of Efficacy|0
7639926|NCT02367040|12054328|FG000|Overall Study|Additional primary malignancy|0
7639927|NCT02367040|12054329|FG001|Overall Study|Additional primary malignancy|1
7639928|NCT02367040|12054328|FG000|Overall Study|AE not associated with clinical disease progression|104
7639929|NCT02367040|12054329|FG001|Overall Study|AE not associated with clinical disease progression|9
7639930|NCT02367040|12054328|FG000|Overall Study|AE associated with clinical disease progression|1
7639931|NCT02367040|12054329|FG001|Overall Study|AE associated with clinical disease progression|3
7639932|NCT02367040|12054328|FG000|Overall Study|Physician Decision|2
7639933|NCT02367040|12054329|FG001|Overall Study|Physician Decision|8
7639934|NCT02367040|12054328|FG000|Overall Study|Non-compliance with study drug|1
7639935|NCT02367040|12054329|FG001|Overall Study|Non-compliance with study drug|0
7639936|NCT02367040|12054328|FG000|Overall Study|Failure to meet continuation criteria|1
7639937|NCT02367040|12054329|FG001|Overall Study|Failure to meet continuation criteria|0
7639938|NCT02367040|12054328|FG000|Overall Study|Switching to other therapy|2
7639939|NCT02367040|12054329|FG001|Overall Study|Switching to other therapy|0
7639940|NCT02367040|12054328|FG000|Overall Study|Withdrawal by Subject|41
7639941|NCT02367040|12054329|FG001|Overall Study|Withdrawal by Subject|14
7639942|NCT02367040|12054328|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
7639943|NCT02367040|12054329|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
7639944|NCT02367040|12054328|FG000|Overall Study|Patient decision|35
7639945|NCT02367040|12054329|FG001|Overall Study|Patient decision|11
7639946|NCT02367040|12054328|FG000|Overall Study|Required procedure failed|1
7639947|NCT02367040|12054329|FG001|Overall Study|Required procedure failed|0
7639948|NCT02367040|12054328|FG000|Overall Study|Randomized by mistake with study treatment|1
7639949|NCT02367040|12054329|FG001|Overall Study|Randomized by mistake with study treatment|0
7639950|NCT02367040|12054328|FG000|Overall Study|Protocol Violation|1
7639951|NCT02367040|12054329|FG001|Overall Study|Protocol Violation|0
7639952|NCT02367040|12054328|FG000|Overall Study|Progressive disease - radiological progression|39
7639953|NCT02367040|12054329|FG001|Overall Study|Progressive disease - radiological progression|67
7639954|NCT02367040|12054328|FG000|Overall Study|Progressive disease - clinical progression|2
7639955|NCT02367040|12054329|FG001|Overall Study|Progressive disease - clinical progression|6
7639956|NCT02367040|12054328|FG000|Overall Study|Drug not administered|3
7639957|NCT02367040|12054329|FG001|Overall Study|Drug not administered|2
7639958|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
7639959|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
7639960|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
7639961|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Death|1
7639962|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Death|0
7639963|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Death|0
7639964|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7639965|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
7639966|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
7639967|NCT02362503|12054347|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7639968|NCT02362503|12054348|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
7639969|NCT02362503|12054349|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
7639971|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Other|1
7639972|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Other|1
7639973|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
7639974|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7639975|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
7639976|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
7639977|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
7639978|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
7639979|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
7639980|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
7639981|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
7639982|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
7639983|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
7639984|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
7639985|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Death|1
7639986|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Death|7
7639987|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Death|15
7639988|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
7639989|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
7639990|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
7639991|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
7639992|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
7639993|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
7639994|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
7639995|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
7639996|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
7639997|NCT02362503|12054347|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
7639998|NCT02362503|12054348|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
7639999|NCT02362503|12054349|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
7640000|NCT02362464|12054360|FG000|Overall Study|Switched to alternative therapy|1
7640001|NCT02362464|12054360|FG000|Overall Study|Refused further treatment|1
7640002|NCT02362464|12054360|FG000|Overall Study|Physician Decision|4
7640003|NCT02361346|12054373|FG000|Part 1 and 2 ( Up to Day 112)|Death|0
7640004|NCT02361346|12054374|FG001|Part 1 and 2 ( Up to Day 112)|Death|0
7640005|NCT02361346|12054375|FG002|Part 1 and 2 ( Up to Day 112)|Death|0
7640006|NCT02361346|12054376|FG003|Part 1 and 2 ( Up to Day 112)|Death|1
7640007|NCT02361346|12054377|FG004|Part 1 and 2 ( Up to Day 112)|Death|0
7640008|NCT02361346|12054378|FG005|Part 1 and 2 ( Up to Day 112)|Death|0
7640009|NCT02361346|12054379|FG006|Part 1 and 2 ( Up to Day 112)|Death|0
7640010|NCT02361346|12054380|FG007|Part 1 and 2 ( Up to Day 112)|Death|0
7640011|NCT02361346|12054381|FG008|Part 1 and 2 ( Up to Day 112)|Death|0
7640012|NCT02361346|12054373|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640013|NCT02361346|12054374|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640014|NCT02361346|12054375|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640015|NCT02361346|12054376|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640016|NCT02361346|12054377|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2
7640017|NCT02361346|12054378|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640018|NCT02361346|12054379|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640019|NCT02361346|12054380|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640020|NCT02361346|12054381|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0
7640021|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Adverse Event|0
7640022|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Adverse Event|0
7640023|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Adverse Event|0
7640024|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Adverse Event|0
7640025|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Adverse Event|0
7640026|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Adverse Event|0
7640027|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Adverse Event|0
7640028|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Adverse Event|1
7640029|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Adverse Event|0
7640030|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640031|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640032|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640033|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640034|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640035|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640036|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640037|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1
7640038|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0
7640039|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640040|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640041|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640042|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640043|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640044|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640045|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640046|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7
7640047|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0
7640048|NCT02361346|12054373|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0
7640049|NCT02361346|12054374|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0
7640050|NCT02361346|12054375|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0
7640051|NCT02361346|12054376|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0
7640052|NCT02361346|12054377|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0
7640053|NCT02361346|12054378|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0
7640054|NCT02361346|12054379|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0
7640055|NCT02361346|12054380|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2
7640056|NCT02361346|12054381|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0
7640057|NCT02358538|12054427|FG000|Through Week 26|Adverse Event|0
7640058|NCT02358538|12054428|FG001|Through Week 26|Adverse Event|1
7640059|NCT02358538|12054429|FG002|Through Week 26|Adverse Event|1
7640060|NCT02358538|12054430|FG003|Through Week 26|Adverse Event|2
7640061|NCT02358538|12054427|FG000|Through Week 26|Lack of Efficacy|1
7640062|NCT02358538|12054428|FG001|Through Week 26|Lack of Efficacy|1
7640063|NCT02358538|12054429|FG002|Through Week 26|Lack of Efficacy|3
7640064|NCT02358538|12054430|FG003|Through Week 26|Lack of Efficacy|3
7640065|NCT02358538|12054427|FG000|Through Week 26|Withdrawal by Subject|1
7640066|NCT02358538|12054428|FG001|Through Week 26|Withdrawal by Subject|0
7640067|NCT02358538|12054429|FG002|Through Week 26|Withdrawal by Subject|0
7640068|NCT02358538|12054430|FG003|Through Week 26|Withdrawal by Subject|0
7640069|NCT02358538|12054427|FG000|Through Week 26|Non-Compliance|0
7640070|NCT02358538|12054428|FG001|Through Week 26|Non-Compliance|0
7640071|NCT02358538|12054429|FG002|Through Week 26|Non-Compliance|1
7640072|NCT02358538|12054430|FG003|Through Week 26|Non-Compliance|0
7640073|NCT02358538|12054427|FG000|Through Week 26|Family did not see benefit from IP|1
7640074|NCT02358538|12054428|FG001|Through Week 26|Family did not see benefit from IP|0
7640075|NCT02358538|12054429|FG002|Through Week 26|Family did not see benefit from IP|0
7640076|NCT02358538|12054430|FG003|Through Week 26|Family did not see benefit from IP|0
7640077|NCT02358538|12054427|FG000|52 Week Extension Period|Lack of Efficacy|0
7640078|NCT02358538|12054428|FG001|52 Week Extension Period|Lack of Efficacy|0
7640079|NCT02358538|12054429|FG002|52 Week Extension Period|Lack of Efficacy|2
7640080|NCT02358538|12054430|FG003|52 Week Extension Period|Lack of Efficacy|4
7640081|NCT02358031|12054447|FG000|Overall Study|Death|226
7640082|NCT02358031|12054448|FG001|Overall Study|Death|204
7640083|NCT02358031|12054449|FG002|Overall Study|Death|249
7640084|NCT02358031|12054447|FG000|Overall Study|Lost to Follow-up|0
7640085|NCT02358031|12054448|FG001|Overall Study|Lost to Follow-up|1
7640086|NCT02358031|12054449|FG002|Overall Study|Lost to Follow-up|1
7640087|NCT02358031|12054447|FG000|Overall Study|Withdrawal by Subject|14
7640088|NCT02358031|12054448|FG001|Overall Study|Withdrawal by Subject|12
7640089|NCT02358031|12054449|FG002|Overall Study|Withdrawal by Subject|17
7640090|NCT02358031|12054447|FG000|Overall Study|Ongoing in Study|61
7640091|NCT02358031|12054448|FG001|Overall Study|Ongoing in Study|64
7640092|NCT02358031|12054449|FG002|Overall Study|Ongoing in Study|33
7640093|NCT02354586|12054466|FG000|Overall Study|Death|230
7640094|NCT02354586|12054466|FG000|Overall Study|Withdrawal by Subject|59
7640095|NCT02354586|12054466|FG000|Overall Study|Lost to Follow-up|11
7640096|NCT02354586|12054466|FG000|Overall Study|Sponsor decision|51
7640097|NCT02354586|12054466|FG000|Overall Study|Site closure|2
7640098|NCT02354586|12054466|FG000|Overall Study|Intercurrent illness|1
7640099|NCT02354586|12054466|FG000|Overall Study|Protocol Violation|3
7640100|NCT02354586|12054466|FG000|Overall Study|Physician Decision|13
7640101|NCT02354586|12054466|FG000|Overall Study|Lack of Efficacy|86
7640102|NCT02354586|12054466|FG000|Overall Study|Adverse Event|7
7640103|NCT02353871|12054481|FG000|Overall Study|Protocol deviation|0
7640104|NCT02353871|12054482|FG001|Overall Study|Protocol deviation|1
7640105|NCT02353871|12054481|FG000|Overall Study|Consent withdrawn|1
7640106|NCT02353871|12054482|FG001|Overall Study|Consent withdrawn|8
7640107|NCT02353871|12054481|FG000|Overall Study|Lost to Follow-up|2
7640108|NCT02353871|12054482|FG001|Overall Study|Lost to Follow-up|0
7640109|NCT02352090|12054491|FG000|Overall Study|general malaise|1
7640110|NCT02352090|12054492|FG001|Overall Study|general malaise|0
7640111|NCT02352090|12054493|FG002|Overall Study|general malaise|0
7640112|NCT02352090|12054491|FG000|Overall Study|non-specified mild side-effects|0
7640113|NCT02352090|12054492|FG001|Overall Study|non-specified mild side-effects|0
7640114|NCT02352090|12054493|FG002|Overall Study|non-specified mild side-effects|2
7640115|NCT02348008|12054503|FG000|Overall Study|Adverse Event|2
7640116|NCT02348008|12054504|FG001|Overall Study|Adverse Event|3
7640117|NCT02348008|12054505|FG002|Overall Study|Adverse Event|3
7640118|NCT02348008|12054503|FG000|Overall Study|Disease Progression|1
7640119|NCT02348008|12054504|FG001|Overall Study|Disease Progression|5
7640120|NCT02348008|12054505|FG002|Overall Study|Disease Progression|16
7640121|NCT02348008|12054503|FG000|Overall Study|Withdrawal by Subject|0
7640122|NCT02348008|12054504|FG001|Overall Study|Withdrawal by Subject|1
7640123|NCT02348008|12054505|FG002|Overall Study|Withdrawal by Subject|0
7640124|NCT02348008|12054503|FG000|Overall Study|Symptomatic Deterioration|0
7640125|NCT02348008|12054504|FG001|Overall Study|Symptomatic Deterioration|1
7640126|NCT02348008|12054505|FG002|Overall Study|Symptomatic Deterioration|0
7640127|NCT02347527|12054515|FG000|Overall Study|MRI not completed due to technical difficulties|1
7640128|NCT02347527|12054516|FG001|Overall Study|MRI not completed due to technical difficulties|0
7640129|NCT02347527|12054517|FG002|Overall Study|MRI not completed due to technical difficulties|0
7640130|NCT02347527|12054518|FG003|Overall Study|MRI not completed due to technical difficulties|0
7640131|NCT02347527|12054515|FG000|Overall Study|MRI stopped due to participant anxiety|0
7640132|NCT02347527|12054516|FG001|Overall Study|MRI stopped due to participant anxiety|1
7640133|NCT02347527|12054517|FG002|Overall Study|MRI stopped due to participant anxiety|0
7640134|NCT02347527|12054518|FG003|Overall Study|MRI stopped due to participant anxiety|0
7640135|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1
7640136|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1
7640137|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0
7640138|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0
7640139|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1
7640140|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0
7640141|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1
7640142|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2
7640143|NCT02347527|12054515|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640144|NCT02347527|12054516|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1
7640145|NCT02347527|12054517|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640146|NCT02347527|12054518|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0
7640147|NCT02341625|12054540|FG000|Overall Study|Disease Progression|2
7640148|NCT02341625|12054541|FG001|Overall Study|Disease Progression|2
7640149|NCT02341625|12054542|FG002|Overall Study|Disease Progression|3
7640150|NCT02341625|12054543|FG003|Overall Study|Disease Progression|6
7640151|NCT02341625|12054544|FG004|Overall Study|Disease Progression|7
7640152|NCT02341625|12054545|FG005|Overall Study|Disease Progression|7
7640153|NCT02341625|12054546|FG006|Overall Study|Disease Progression|28
7640154|NCT02341625|12054547|FG007|Overall Study|Disease Progression|5
7640155|NCT02341625|12054548|FG008|Overall Study|Disease Progression|4
7640156|NCT02341625|12054549|FG009|Overall Study|Disease Progression|19
7640157|NCT02341625|12054540|FG000|Overall Study|Study Drug Toxicity|0
7640158|NCT02341625|12054541|FG001|Overall Study|Study Drug Toxicity|0
7640159|NCT02341625|12054542|FG002|Overall Study|Study Drug Toxicity|0
7640160|NCT02341625|12054543|FG003|Overall Study|Study Drug Toxicity|1
7640161|NCT02341625|12054544|FG004|Overall Study|Study Drug Toxicity|0
7640162|NCT02341625|12054545|FG005|Overall Study|Study Drug Toxicity|3
7640163|NCT02341625|12054546|FG006|Overall Study|Study Drug Toxicity|10
7640164|NCT02341625|12054547|FG007|Overall Study|Study Drug Toxicity|0
7640165|NCT02341625|12054548|FG008|Overall Study|Study Drug Toxicity|0
7640166|NCT02341625|12054549|FG009|Overall Study|Study Drug Toxicity|3
7640167|NCT02341625|12054540|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0
7640168|NCT02341625|12054541|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
7640169|NCT02341625|12054542|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0
7640170|NCT02341625|12054543|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0
7640171|NCT02341625|12054544|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0
7640172|NCT02341625|12054545|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0
7640173|NCT02341625|12054546|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2
7640174|NCT02341625|12054547|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1
7640175|NCT02341625|12054548|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0
7640176|NCT02341625|12054549|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2
7640177|NCT02341625|12054540|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0
7640178|NCT02341625|12054541|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0
7640179|NCT02341625|12054542|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0
7640180|NCT02341625|12054543|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0
7640181|NCT02341625|12054544|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0
7640182|NCT02341625|12054545|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0
7640183|NCT02341625|12054546|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6
7640184|NCT02341625|12054547|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2
7640185|NCT02341625|12054548|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0
7640186|NCT02341625|12054549|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0
7640187|NCT02341625|12054540|FG000|Overall Study|Participant Withdrew Consent|0
7640188|NCT02341625|12054541|FG001|Overall Study|Participant Withdrew Consent|0
7640189|NCT02341625|12054542|FG002|Overall Study|Participant Withdrew Consent|0
7640190|NCT02341625|12054543|FG003|Overall Study|Participant Withdrew Consent|1
7640191|NCT02341625|12054544|FG004|Overall Study|Participant Withdrew Consent|0
7640192|NCT02341625|12054545|FG005|Overall Study|Participant Withdrew Consent|0
7640193|NCT02341625|12054546|FG006|Overall Study|Participant Withdrew Consent|0
7640194|NCT02341625|12054547|FG007|Overall Study|Participant Withdrew Consent|0
7640195|NCT02341625|12054548|FG008|Overall Study|Participant Withdrew Consent|0
7640196|NCT02341625|12054549|FG009|Overall Study|Participant Withdrew Consent|0
7640197|NCT02341625|12054540|FG000|Overall Study|Completed Treatment as per Protocol|0
7640198|NCT02341625|12054541|FG001|Overall Study|Completed Treatment as per Protocol|0
7640199|NCT02341625|12054542|FG002|Overall Study|Completed Treatment as per Protocol|0
7640200|NCT02341625|12054543|FG003|Overall Study|Completed Treatment as per Protocol|0
7640201|NCT02341625|12054544|FG004|Overall Study|Completed Treatment as per Protocol|0
7640202|NCT02341625|12054545|FG005|Overall Study|Completed Treatment as per Protocol|0
7640203|NCT02341625|12054546|FG006|Overall Study|Completed Treatment as per Protocol|0
7640204|NCT02341625|12054547|FG007|Overall Study|Completed Treatment as per Protocol|0
7640205|NCT02341625|12054548|FG008|Overall Study|Completed Treatment as per Protocol|0
7640206|NCT02341625|12054549|FG009|Overall Study|Completed Treatment as per Protocol|1
7640207|NCT02341625|12054540|FG000|Overall Study|Other Reasons|0
7640208|NCT02341625|12054541|FG001|Overall Study|Other Reasons|0
7640209|NCT02341625|12054542|FG002|Overall Study|Other Reasons|0
7640210|NCT02341625|12054543|FG003|Overall Study|Other Reasons|0
7640211|NCT02341625|12054544|FG004|Overall Study|Other Reasons|1
7640212|NCT02341625|12054545|FG005|Overall Study|Other Reasons|0
7640213|NCT02341625|12054546|FG006|Overall Study|Other Reasons|5
7640214|NCT02341625|12054547|FG007|Overall Study|Other Reasons|0
7640215|NCT02341625|12054548|FG008|Overall Study|Other Reasons|0
7640216|NCT02341625|12054549|FG009|Overall Study|Other Reasons|2
7640217|NCT02341625|12054540|FG000|Overall Study|Not Reported|0
7640218|NCT02341625|12054541|FG001|Overall Study|Not Reported|0
7640219|NCT02341625|12054542|FG002|Overall Study|Not Reported|0
7640220|NCT02341625|12054543|FG003|Overall Study|Not Reported|0
7640221|NCT02341625|12054544|FG004|Overall Study|Not Reported|0
7640222|NCT02341625|12054545|FG005|Overall Study|Not Reported|0
7640223|NCT02341625|12054546|FG006|Overall Study|Not Reported|0
7640224|NCT02341625|12054547|FG007|Overall Study|Not Reported|0
7640225|NCT02341625|12054548|FG008|Overall Study|Not Reported|0
7640226|NCT02341625|12054549|FG009|Overall Study|Not Reported|3
7640227|NCT02335424|12054594|FG000|Overall Study|Withdrawal by Subject|12
7640228|NCT02335424|12054594|FG000|Overall Study|Ongoing In Study|89
7640229|NCT02335424|12054594|FG000|Overall Study|Adverse Event|25
7640230|NCT02335424|12054594|FG000|Overall Study|Death|239
7640231|NCT02335424|12054594|FG000|Overall Study|Lost to Follow-up|2
7640232|NCT02335424|12054594|FG000|Overall Study|Physician Decision|3
7640233|NCT02335424|12054594|FG000|Overall Study|Not treated|4
7640234|NCT02335411|12054601|FG000|Overall Study|Death|223
7640235|NCT02335411|12054602|FG001|Overall Study|Death|22
7640236|NCT02335411|12054603|FG002|Overall Study|Death|26
7640237|NCT02335411|12054601|FG000|Overall Study|Physician Decision|3
7640238|NCT02335411|12054602|FG001|Overall Study|Physician Decision|0
7640239|NCT02335411|12054603|FG002|Overall Study|Physician Decision|0
7640240|NCT02335411|12054601|FG000|Overall Study|Protocol Violation|1
7640241|NCT02335411|12054602|FG001|Overall Study|Protocol Violation|0
7640242|NCT02335411|12054603|FG002|Overall Study|Protocol Violation|0
7640243|NCT02335411|12054601|FG000|Overall Study|Withdrawal by Subject|11
7640244|NCT02335411|12054602|FG001|Overall Study|Withdrawal by Subject|0
7640245|NCT02335411|12054603|FG002|Overall Study|Withdrawal by Subject|3
7640246|NCT02335411|12054601|FG000|Overall Study|Sponsor Decision|12
7640247|NCT02335411|12054602|FG001|Overall Study|Sponsor Decision|3
7640248|NCT02335411|12054603|FG002|Overall Study|Sponsor Decision|2
7640249|NCT02335411|12054601|FG000|Overall Study|Adverse Event|9
7640250|NCT02335411|12054602|FG001|Overall Study|Adverse Event|0
7640251|NCT02335411|12054603|FG002|Overall Study|Adverse Event|0
7640252|NCT02328105|12054614|FG000|Overall Study|Death|6
7640253|NCT02328105|12054614|FG000|Overall Study|Withdrawal by Subject|1
7640254|NCT02328105|12054614|FG000|Overall Study|Still On Study in Follow-Up|4
7640255|NCT02321514|12054631|FG000|Overall Study|Death|15
7640256|NCT02321514|12054631|FG000|Overall Study|Missed Visit|7
7640257|NCT02321514|12054631|FG000|Overall Study|Study Exit|3
7640258|NCT02321436|12054637|FG000|Overall Study|Withdrawal by Subject|1
7640259|NCT02321436|12054638|FG001|Overall Study|Withdrawal by Subject|0
7640260|NCT02321436|12054637|FG000|Overall Study|Lost to Follow-up|0
7640261|NCT02321436|12054638|FG001|Overall Study|Lost to Follow-up|1
7640262|NCT02316171|12054647|FG000|Overall Study|difficulties with urinary catheter|1
7640263|NCT02316171|12054648|FG001|Overall Study|difficulties with urinary catheter|0
7640264|NCT02316171|12054649|FG002|Overall Study|difficulties with urinary catheter|0
7640265|NCT02316171|12054650|FG003|Overall Study|difficulties with urinary catheter|0
7640266|NCT02308488|12054656|FG000|Overall Study|Withdrawal by Subject|2
7640267|NCT02306161|12054671|FG000|Overall Study|Death|1
7640268|NCT02306161|12054672|FG001|Overall Study|Death|3
7640269|NCT02306161|12054671|FG000|Overall Study|Lack of Efficacy|20
7640270|NCT02306161|12054672|FG001|Overall Study|Lack of Efficacy|43
7640271|NCT02306161|12054671|FG000|Overall Study|Physician Decision|30
7640272|NCT02306161|12054672|FG001|Overall Study|Physician Decision|18
7640273|NCT02306161|12054671|FG000|Overall Study|Withdrawal by Subject|4
7640274|NCT02306161|12054672|FG001|Overall Study|Withdrawal by Subject|0
7640275|NCT02306161|12054671|FG000|Overall Study|Ineligible|9
7640276|NCT02306161|12054672|FG001|Overall Study|Ineligible|5
7640277|NCT02302222|12054680|FG000|Overall Study|Physician Decision|0
7640278|NCT02302222|12054681|FG001|Overall Study|Physician Decision|4
7640279|NCT02302222|12054680|FG000|Overall Study|Lost to Follow-up|1
7640280|NCT02302222|12054681|FG001|Overall Study|Lost to Follow-up|0
7640281|NCT02302222|12054680|FG000|Overall Study|Treatment discontinued before day 5|0
7640282|NCT02302222|12054681|FG001|Overall Study|Treatment discontinued before day 5|1
7640283|NCT02302222|12054680|FG000|Overall Study|Withdrawn prior to any treatment|0
7640284|NCT02302222|12054681|FG001|Overall Study|Withdrawn prior to any treatment|1
7640285|NCT02297503|12054689|FG000|Overall Study|Withdrawal by Subject|1
7640286|NCT02297503|12054690|FG001|Overall Study|Withdrawal by Subject|1
7640287|NCT02297503|12054689|FG000|Overall Study|Protocol Violation|1
7640288|NCT02297503|12054690|FG001|Overall Study|Protocol Violation|0
7640289|NCT02297503|12054689|FG000|Overall Study|Pregnancy|0
7640290|NCT02297503|12054690|FG001|Overall Study|Pregnancy|1
7640291|NCT02297503|12054689|FG000|Overall Study|Lost to Follow-up|0
7640292|NCT02297503|12054690|FG001|Overall Study|Lost to Follow-up|1
7640293|NCT02297503|12054689|FG000|Overall Study|Medical reason|0
7640294|NCT02297503|12054690|FG001|Overall Study|Medical reason|1
7640295|NCT02296125|12054707|FG000|Overall Study|Withdrawal by Subject|18
7640296|NCT02296125|12054708|FG001|Overall Study|Withdrawal by Subject|8
7640297|NCT02296125|12054709|FG002|Overall Study|Withdrawal by Subject|6
7640298|NCT02296125|12054710|FG003|Overall Study|Withdrawal by Subject|2
7640299|NCT02296125|12054707|FG000|Overall Study|Adverse Event|41
7640300|NCT02296125|12054708|FG001|Overall Study|Adverse Event|52
7640301|NCT02296125|12054709|FG002|Overall Study|Adverse Event|9
7640302|NCT02296125|12054710|FG003|Overall Study|Adverse Event|4
7640303|NCT02296125|12054707|FG000|Overall Study|Severe non-compliance to protocol|0
7640304|NCT02296125|12054708|FG001|Overall Study|Severe non-compliance to protocol|1
7640305|NCT02296125|12054709|FG002|Overall Study|Severe non-compliance to protocol|0
7640306|NCT02296125|12054710|FG003|Overall Study|Severe non-compliance to protocol|0
7640307|NCT02296125|12054707|FG000|Overall Study|Condition under investigation worsened|153
7640308|NCT02296125|12054708|FG001|Overall Study|Condition under investigation worsened|199
7640309|NCT02296125|12054709|FG002|Overall Study|Condition under investigation worsened|39
7640310|NCT02296125|12054710|FG003|Overall Study|Condition under investigation worsened|56
7640311|NCT02296125|12054707|FG000|Overall Study|Any reason not specifically recorded|6
7640312|NCT02296125|12054708|FG001|Overall Study|Any reason not specifically recorded|4
7640313|NCT02296125|12054709|FG002|Overall Study|Any reason not specifically recorded|2
7640314|NCT02296125|12054710|FG003|Overall Study|Any reason not specifically recorded|0
7640315|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Death|6
7640316|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Death|4
7640317|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30
7640318|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66
7640319|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27
7640320|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54
7640321|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0
7640322|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2
7640323|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1
7640324|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0
7640325|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38
7640326|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51
7640327|NCT02294461|12054723|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16
7640328|NCT02294461|12054724|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15
7640329|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19
7640330|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9
7640331|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16
7640332|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12
7640333|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18
7640334|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9
7640335|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2
7640336|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0
7640337|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3
7640338|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1
7640339|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15
7640340|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9
7640341|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Death|6
7640342|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Death|5
7640343|NCT02294461|12054723|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6
7640344|NCT02294461|12054724|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6
7640345|NCT02287233|12054745|FG000|Overall Study|Adverse Event Not Related to Progression|1
7640346|NCT02287233|12054746|FG001|Overall Study|Adverse Event Not Related to Progression|2
7640347|NCT02287233|12054747|FG002|Overall Study|Adverse Event Not Related to Progression|10
7640348|NCT02287233|12054745|FG000|Overall Study|Adverse Event Related to Progression|0
7640349|NCT02287233|12054746|FG001|Overall Study|Adverse Event Related to Progression|2
7640350|NCT02287233|12054747|FG002|Overall Study|Adverse Event Related to Progression|8
7640351|NCT02287233|12054745|FG000|Overall Study|Physician Decision|1
7640352|NCT02287233|12054746|FG001|Overall Study|Physician Decision|2
7640353|NCT02287233|12054747|FG002|Overall Study|Physician Decision|4
7640354|NCT02287233|12054745|FG000|Overall Study|Progressive Disease with Death|0
7640355|NCT02287233|12054746|FG001|Overall Study|Progressive Disease with Death|0
7640356|NCT02287233|12054747|FG002|Overall Study|Progressive Disease with Death|10
7640357|NCT02287233|12054745|FG000|Overall Study|Progressive Disease Without Death|2
7640358|NCT02287233|12054746|FG001|Overall Study|Progressive Disease Without Death|3
7640359|NCT02287233|12054747|FG002|Overall Study|Progressive Disease Without Death|20
7640360|NCT02287233|12054745|FG000|Overall Study|Withdrawal by Subject|1
7640361|NCT02287233|12054746|FG001|Overall Study|Withdrawal by Subject|1
7640362|NCT02287233|12054747|FG002|Overall Study|Withdrawal by Subject|7
7640363|NCT02287233|12054745|FG000|Overall Study|Other|3
7640364|NCT02287233|12054746|FG001|Overall Study|Other|0
7640365|NCT02287233|12054747|FG002|Overall Study|Other|15
7640366|NCT02287233|12054745|FG000|Overall Study|Did Not Receive Treatment|0
7640367|NCT02287233|12054746|FG001|Overall Study|Did Not Receive Treatment|0
7640368|NCT02287233|12054747|FG002|Overall Study|Did Not Receive Treatment|2
7640369|NCT02285062|12054760|FG000|Overall Study|Withdrawal by Subject|12
7640370|NCT02285062|12054761|FG001|Overall Study|Withdrawal by Subject|17
7640371|NCT02285062|12054760|FG000|Overall Study|Death|58
7640372|NCT02285062|12054761|FG001|Overall Study|Death|62
7640373|NCT02285062|12054760|FG000|Overall Study|Lost to Follow-up|8
7640374|NCT02285062|12054761|FG001|Overall Study|Lost to Follow-up|5
7640375|NCT02281084|12054771|FG000|Overall Study|Adverse Event|1
7640376|NCT02281084|12054772|FG001|Overall Study|Adverse Event|0
7640377|NCT02281084|12054773|FG002|Overall Study|Adverse Event|0
7640378|NCT02281084|12054774|FG003|Overall Study|Adverse Event|0
7640379|NCT02281084|12054771|FG000|Overall Study|Withdrawal by Subject|1
7640380|NCT02281084|12054772|FG001|Overall Study|Withdrawal by Subject|2
7640381|NCT02281084|12054773|FG002|Overall Study|Withdrawal by Subject|0
7640382|NCT02281084|12054774|FG003|Overall Study|Withdrawal by Subject|0
7640383|NCT02281084|12054771|FG000|Overall Study|Death|20
7640384|NCT02281084|12054772|FG001|Overall Study|Death|16
7640385|NCT02281084|12054773|FG002|Overall Study|Death|3
7640386|NCT02281084|12054774|FG003|Overall Study|Death|5
7640387|NCT02281084|12054771|FG000|Overall Study|Physician Decision|0
7640388|NCT02281084|12054772|FG001|Overall Study|Physician Decision|0
7640389|NCT02281084|12054773|FG002|Overall Study|Physician Decision|1
7640390|NCT02281084|12054774|FG003|Overall Study|Physician Decision|0
7640391|NCT02278120|12054786|FG000|Overall Study|Progressive disease|122
7640392|NCT02278120|12054787|FG001|Overall Study|Progressive disease|174
7640393|NCT02278120|12054786|FG000|Overall Study|Patient/guardian decision|14
7640394|NCT02278120|12054787|FG001|Overall Study|Patient/guardian decision|8
7640395|NCT02278120|12054786|FG000|Overall Study|Adverse Event|12
7640396|NCT02278120|12054787|FG001|Overall Study|Adverse Event|10
7640397|NCT02278120|12054786|FG000|Overall Study|Physician Decision|8
7640398|NCT02278120|12054787|FG001|Overall Study|Physician Decision|19
7640399|NCT02278120|12054786|FG000|Overall Study|Death|3
7640400|NCT02278120|12054787|FG001|Overall Study|Death|3
7640401|NCT02278120|12054786|FG000|Overall Study|Lost to Follow-up|2
7640402|NCT02278120|12054787|FG001|Overall Study|Lost to Follow-up|0
7640403|NCT02278120|12054786|FG000|Overall Study|Protocol Violation|0
7640404|NCT02278120|12054787|FG001|Overall Study|Protocol Violation|2
7640405|NCT02277444|12054793|FG000|Overall Study|Adverse Event|10
7640406|NCT02277444|12054793|FG000|Overall Study|Withdrawal by Subject|3
7640407|NCT02277444|12054793|FG000|Overall Study|Other|1
7640408|NCT02277444|12054793|FG000|Overall Study|Enrolled and not Treated|3
7640409|NCT02277444|12054793|FG000|Overall Study|Ongoing|113
7640410|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Adverse Event|6
7640411|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Adverse Event|14
7640412|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Death|3
7640413|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Death|1
7640414|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
7640415|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
7640416|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
7640417|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
7640418|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Protocol Violation|1
7640419|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Protocol Violation|6
7640420|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
7640421|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
7640422|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
7640423|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
7640424|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Physician Decision|2
7640425|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Physician Decision|4
7640426|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Pregnancy|2
7640427|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Pregnancy|1
7640428|NCT02275780|12054799|FG000|Base Study: 96 Weeks|Randomized not treated|2
7640429|NCT02275780|12054800|FG001|Base Study: 96 Weeks|Randomized not treated|1
7640430|NCT02275780|12054799|FG000|Extension Study: up to 192 Weeks|Ongoing|260
7640431|NCT02275780|12054800|FG001|Extension Study: up to 192 Weeks|Ongoing|233
7640432|NCT02272790|12054812|FG000|Overall Study|Physician Decision|0
7640433|NCT02272790|12054813|FG001|Overall Study|Physician Decision|1
7640434|NCT02272790|12054814|FG002|Overall Study|Physician Decision|0
7640435|NCT02272790|12054815|FG003|Overall Study|Physician Decision|0
7640436|NCT02272790|12054816|FG004|Overall Study|Physician Decision|0
7640437|NCT02272790|12054817|FG005|Overall Study|Physician Decision|0
7640438|NCT02268916|12054839|FG000|Overall Study|Lost to Follow-up|1
7640439|NCT02268916|12054840|FG001|Overall Study|Lost to Follow-up|1
7640440|NCT02268916|12054839|FG000|Overall Study|Withdrawal by Subject|6
7640441|NCT02268916|12054840|FG001|Overall Study|Withdrawal by Subject|5
7640442|NCT02268916|12054839|FG000|Overall Study|Participant did not have diabetes|1
7640443|NCT02268916|12054840|FG001|Overall Study|Participant did not have diabetes|0
7640444|NCT02268916|12054839|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9
7640445|NCT02268916|12054840|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4
7640446|NCT02268851|12054853|FG000|Overall Study|Death|0
7640447|NCT02268851|12054854|FG001|Overall Study|Death|0
7640448|NCT02268851|12054855|FG002|Overall Study|Death|0
7640449|NCT02268851|12054856|FG003|Overall Study|Death|1
7640450|NCT02268851|12054857|FG004|Overall Study|Death|2
7640451|NCT02268851|12054858|FG005|Overall Study|Death|1
7640452|NCT02268851|12054853|FG000|Overall Study|Adverse Event|0
7640453|NCT02268851|12054854|FG001|Overall Study|Adverse Event|0
7640454|NCT02268851|12054855|FG002|Overall Study|Adverse Event|0
7640455|NCT02268851|12054856|FG003|Overall Study|Adverse Event|0
7640456|NCT02268851|12054857|FG004|Overall Study|Adverse Event|2
7640457|NCT02268851|12054858|FG005|Overall Study|Adverse Event|2
7640458|NCT02268851|12054853|FG000|Overall Study|Withdrawal by Subject|0
7640459|NCT02268851|12054854|FG001|Overall Study|Withdrawal by Subject|0
7640460|NCT02268851|12054855|FG002|Overall Study|Withdrawal by Subject|0
7640461|NCT02268851|12054856|FG003|Overall Study|Withdrawal by Subject|2
7640462|NCT02268851|12054857|FG004|Overall Study|Withdrawal by Subject|0
7640463|NCT02268851|12054858|FG005|Overall Study|Withdrawal by Subject|1
7640464|NCT02268851|12054853|FG000|Overall Study|Progressive Disease|1
7640465|NCT02268851|12054854|FG001|Overall Study|Progressive Disease|3
7640466|NCT02268851|12054855|FG002|Overall Study|Progressive Disease|0
7640467|NCT02268851|12054856|FG003|Overall Study|Progressive Disease|0
7640468|NCT02268851|12054857|FG004|Overall Study|Progressive Disease|1
7640469|NCT02268851|12054858|FG005|Overall Study|Progressive Disease|4
7640470|NCT02268851|12054853|FG000|Overall Study|Physician Decision|0
7640471|NCT02268851|12054854|FG001|Overall Study|Physician Decision|0
7640472|NCT02268851|12054855|FG002|Overall Study|Physician Decision|1
7640473|NCT02268851|12054856|FG003|Overall Study|Physician Decision|0
7640474|NCT02268851|12054857|FG004|Overall Study|Physician Decision|0
7640475|NCT02268851|12054858|FG005|Overall Study|Physician Decision|1
7640476|NCT02268851|12054853|FG000|Overall Study|Patient Compliance|0
7640477|NCT02268851|12054854|FG001|Overall Study|Patient Compliance|0
7640478|NCT02268851|12054855|FG002|Overall Study|Patient Compliance|0
7640479|NCT02268851|12054856|FG003|Overall Study|Patient Compliance|0
7640480|NCT02268851|12054857|FG004|Overall Study|Patient Compliance|1
7640481|NCT02268851|12054858|FG005|Overall Study|Patient Compliance|1
7640482|NCT02268851|12054853|FG000|Overall Study|Co-Morbid Condition|0
7640483|NCT02268851|12054854|FG001|Overall Study|Co-Morbid Condition|0
7640484|NCT02268851|12054855|FG002|Overall Study|Co-Morbid Condition|0
7640485|NCT02268851|12054856|FG003|Overall Study|Co-Morbid Condition|0
7640486|NCT02268851|12054857|FG004|Overall Study|Co-Morbid Condition|1
7640487|NCT02268851|12054858|FG005|Overall Study|Co-Morbid Condition|1
7640488|NCT02264977|12054881|FG000|Overall Study|Death|3
7640489|NCT02264977|12054881|FG000|Overall Study|Physician Decision|1
7640490|NCT02264977|12054881|FG000|Overall Study|Refuse to return|1
7640491|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88
7640492|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95
7640493|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6
7640494|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7
7640495|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8
7640496|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1
7640497|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8
7640498|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6
7640499|NCT02258451|12054887|FG000|Overall Study|Death|4
7640500|NCT02258451|12054888|FG001|Overall Study|Death|3
7640501|NCT02258451|12054887|FG000|Overall Study|Withdrawal by Subject|21
7640502|NCT02258451|12054888|FG001|Overall Study|Withdrawal by Subject|12
7640503|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1
7640504|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0
7640505|NCT02258451|12054887|FG000|Overall Study|Discontinuation all treatment due to event point reached|1
7640506|NCT02258451|12054888|FG001|Overall Study|Discontinuation all treatment due to event point reached|1
7640507|NCT02258451|12054887|FG000|Overall Study|Physician Decision|0
7640508|NCT02258451|12054888|FG001|Overall Study|Physician Decision|2
7640509|NCT02258451|12054887|FG000|Overall Study|Never treated|2
7640510|NCT02258451|12054888|FG001|Overall Study|Never treated|3
7640511|NCT02258451|12054887|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3
7640512|NCT02258451|12054888|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11
7640513|NCT02257736|12054898|FG000|Overall Study|Progressive disease|365
7640514|NCT02257736|12054899|FG001|Overall Study|Progressive disease|327
7640515|NCT02257736|12054898|FG000|Overall Study|Adverse Event|45
7640516|NCT02257736|12054899|FG001|Overall Study|Adverse Event|56
7640517|NCT02257736|12054898|FG000|Overall Study|Withdrawal by Subject|21
7640518|NCT02257736|12054899|FG001|Overall Study|Withdrawal by Subject|38
7640519|NCT02257736|12054898|FG000|Overall Study|Death|11
7640520|NCT02257736|12054899|FG001|Overall Study|Death|6
7640521|NCT02257736|12054898|FG000|Overall Study|Physician Decision|5
7640522|NCT02257736|12054899|FG001|Overall Study|Physician Decision|9
7640523|NCT02257736|12054898|FG000|Overall Study|Non-Compliance with study drug|1
7640524|NCT02257736|12054899|FG001|Overall Study|Non-Compliance with study drug|2
7640525|NCT02257736|12054898|FG000|Overall Study|Protocol Violation|1
7640526|NCT02257736|12054899|FG001|Overall Study|Protocol Violation|0
7640527|NCT02257736|12054898|FG000|Overall Study|Other|1
7640528|NCT02257736|12054899|FG001|Overall Study|Other|7
7640529|NCT02257736|12054898|FG000|Overall Study|Randomized, not treated|1
7640530|NCT02257736|12054899|FG001|Overall Study|Randomized, not treated|2
7640531|NCT02257528|12054905|FG000|Overall Study|Never received study treatment|1
7640532|NCT02257489|12054918|FG000|Overall Study|Withdrawal by Subject|0
7640533|NCT02257489|12054919|FG001|Overall Study|Withdrawal by Subject|0
7640534|NCT02257489|12054920|FG002|Overall Study|Withdrawal by Subject|0
7640535|NCT02257489|12054921|FG003|Overall Study|Withdrawal by Subject|1
7640536|NCT02257489|12054922|FG004|Overall Study|Withdrawal by Subject|0
7640537|NCT02257489|12054923|FG005|Overall Study|Withdrawal by Subject|0
7640538|NCT02257489|12054924|FG006|Overall Study|Withdrawal by Subject|0
7640539|NCT02257489|12054925|FG007|Overall Study|Withdrawal by Subject|0
7640540|NCT02257489|12054926|FG008|Overall Study|Withdrawal by Subject|0
7640541|NCT02254278|12054966|FG000|Overall Study|Protocol Violation|1
7640542|NCT02254278|12054967|FG001|Overall Study|Protocol Violation|1
7640543|NCT02253316|12054989|FG000|Consolidation|Progression|4
7640544|NCT02253316|12054990|FG001|Consolidation|Progression|0
7640545|NCT02253316|12054991|FG002|Consolidation|Progression|0
7640546|NCT02253316|12054989|FG000|Consolidation|Non-Compliance|1
7640547|NCT02253316|12054990|FG001|Consolidation|Non-Compliance|0
7640548|NCT02253316|12054991|FG002|Consolidation|Non-Compliance|0
7640549|NCT02253316|12054989|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
7640550|NCT02253316|12054990|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
7640551|NCT02253316|12054991|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
7640552|NCT02253316|12054989|FG000|Consolidation|Secondary Malignancy|2
7640553|NCT02253316|12054990|FG001|Consolidation|Secondary Malignancy|0
7640554|NCT02253316|12054991|FG002|Consolidation|Secondary Malignancy|0
7640555|NCT02253316|12054989|FG000|Consolidation|Adverse Event|7
7640556|NCT02253316|12054990|FG001|Consolidation|Adverse Event|0
7640557|NCT02253316|12054991|FG002|Consolidation|Adverse Event|0
7640558|NCT02253316|12054989|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
7640559|NCT02253316|12054990|FG001|Maintenance|Patient Withdrew Logistical Concerns|7
7640560|NCT02253316|12054991|FG002|Maintenance|Patient Withdrew Logistical Concerns|7
7640561|NCT02253316|12054989|FG000|Maintenance|Physician Decision|0
7640562|NCT02253316|12054990|FG001|Maintenance|Physician Decision|5
7640563|NCT02253316|12054991|FG002|Maintenance|Physician Decision|16
7640564|NCT02253316|12054989|FG000|Maintenance|Non-Compliance|0
7640565|NCT02253316|12054990|FG001|Maintenance|Non-Compliance|1
7640566|NCT02253316|12054991|FG002|Maintenance|Non-Compliance|0
7640567|NCT02253316|12054989|FG000|Maintenance|Secondary Malignancy|0
7640568|NCT02253316|12054990|FG001|Maintenance|Secondary Malignancy|1
7640569|NCT02253316|12054991|FG002|Maintenance|Secondary Malignancy|5
7640570|NCT02253316|12054989|FG000|Maintenance|Adverse Event|0
7640571|NCT02253316|12054990|FG001|Maintenance|Adverse Event|8
7640572|NCT02253316|12054991|FG002|Maintenance|Adverse Event|12
7640573|NCT02253316|12054989|FG000|Maintenance|Still receiving active treatment|0
7640574|NCT02253316|12054990|FG001|Maintenance|Still receiving active treatment|23
7640575|NCT02253316|12054991|FG002|Maintenance|Still receiving active treatment|26
7640576|NCT02252172|12055001|FG000|Overall Study|Lost to Follow-up|3
7640577|NCT02252172|12055002|FG001|Overall Study|Lost to Follow-up|1
7640578|NCT02252172|12055001|FG000|Overall Study|Ongoing|276
7640579|NCT02252172|12055002|FG001|Overall Study|Ongoing|298
7640580|NCT02252042|12055010|FG000|Overall Study|Death|170
7640581|NCT02252042|12055011|FG001|Overall Study|Death|192
7640582|NCT02252042|12055010|FG000|Overall Study|Physician Decision|0
7640583|NCT02252042|12055011|FG001|Overall Study|Physician Decision|1
7640584|NCT02252042|12055010|FG000|Overall Study|Withdrawal by Subject|13
7640585|NCT02252042|12055011|FG001|Overall Study|Withdrawal by Subject|20
7640586|NCT02252042|12055010|FG000|Overall Study|Ongoing in study|64
7640587|NCT02252042|12055011|FG001|Overall Study|Ongoing in study|35
7640588|NCT02246621|12055027|FG000|Overall Study|Withdrawal by Subject|28
7640589|NCT02246621|12055028|FG001|Overall Study|Withdrawal by Subject|16
7640590|NCT02246621|12055027|FG000|Overall Study|Lost to Follow-up|1
7640591|NCT02246621|12055028|FG001|Overall Study|Lost to Follow-up|0
7640592|NCT02246621|12055027|FG000|Overall Study|On Study Treatment/ Follow Up|236
7640593|NCT02246621|12055028|FG001|Overall Study|On Study Treatment/ Follow Up|119
7640594|NCT02243605|12055036|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
7640595|NCT02243605|12055037|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
7640596|NCT02243605|12055036|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
7640597|NCT02243605|12055037|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
7640598|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
7640599|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
7640600|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
7640601|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
7640602|NCT02243605|12055036|FG000|Stage 2 - Final Analysis Population|Progression|0
7640603|NCT02243605|12055037|FG001|Stage 2 - Final Analysis Population|Progression|1
7640604|NCT02242435|12055054|FG000|Overall Study|Lost to Follow-up|3
7640605|NCT02242435|12055055|FG001|Overall Study|Lost to Follow-up|4
7640606|NCT02242435|12055054|FG000|Overall Study|Adverse Event|3
7640607|NCT02242435|12055055|FG001|Overall Study|Adverse Event|2
7640608|NCT02242435|12055054|FG000|Overall Study|Withdrawal by Subject|13
7640609|NCT02242435|12055055|FG001|Overall Study|Withdrawal by Subject|8
7640610|NCT02242435|12055054|FG000|Overall Study|Death|0
7640611|NCT02242435|12055055|FG001|Overall Study|Death|1
7640612|NCT02242435|12055054|FG000|Overall Study|Protocol Violation|1
7640613|NCT02242435|12055055|FG001|Overall Study|Protocol Violation|0
7640614|NCT02242435|12055054|FG000|Overall Study|Physician Decision|0
7640615|NCT02242435|12055055|FG001|Overall Study|Physician Decision|1
7640616|NCT02230189|12055064|FG000|Overall Study|Withdrawal by Subject|3
7640617|NCT02230189|12055065|FG001|Overall Study|Withdrawal by Subject|0
7640618|NCT02230189|12055066|FG002|Overall Study|Withdrawal by Subject|1
7640619|NCT02230189|12055064|FG000|Overall Study|Lost to Follow-up|1
7640620|NCT02230189|12055065|FG001|Overall Study|Lost to Follow-up|0
7640621|NCT02230189|12055066|FG002|Overall Study|Lost to Follow-up|0
7640622|NCT02230189|12055064|FG000|Overall Study|Physician Decision|1
7640623|NCT02230189|12055065|FG001|Overall Study|Physician Decision|0
7640624|NCT02230189|12055066|FG002|Overall Study|Physician Decision|0
7640625|NCT02224703|12055091|FG000|Overall Study|Adverse Event|0
7640626|NCT02224703|12055092|FG001|Overall Study|Adverse Event|5
7640627|NCT02224703|12055093|FG002|Overall Study|Adverse Event|0
7640628|NCT02224703|12055091|FG000|Overall Study|Withdrawn by investigator|1
7640629|NCT02224703|12055092|FG001|Overall Study|Withdrawn by investigator|0
7640630|NCT02224703|12055093|FG002|Overall Study|Withdrawn by investigator|0
7640631|NCT02224703|12055091|FG000|Overall Study|Advised by medical monitor|1
7640632|NCT02224703|12055092|FG001|Overall Study|Advised by medical monitor|0
7640633|NCT02224703|12055093|FG002|Overall Study|Advised by medical monitor|0
7640634|NCT02224703|12055091|FG000|Overall Study|Withdrawn by parent/guardian|0
7640635|NCT02224703|12055092|FG001|Overall Study|Withdrawn by parent/guardian|1
7640636|NCT02224703|12055093|FG002|Overall Study|Withdrawn by parent/guardian|0
7640637|NCT02224703|12055091|FG000|Overall Study|Lack of Efficacy|1
7640638|NCT02224703|12055092|FG001|Overall Study|Lack of Efficacy|0
7640639|NCT02224703|12055093|FG002|Overall Study|Lack of Efficacy|0
7640640|NCT02224690|12055104|FG000|Overall Study|Adverse Event|8
7640641|NCT02224690|12055105|FG001|Overall Study|Adverse Event|1
7640642|NCT02224690|12055104|FG000|Overall Study|Met Withdrawal Criteria|4
7640643|NCT02224690|12055105|FG001|Overall Study|Met Withdrawal Criteria|0
7640644|NCT02224690|12055104|FG000|Overall Study|Use of G-tube|1
7640645|NCT02224690|12055105|FG001|Overall Study|Use of G-tube|0
7640646|NCT02224690|12055104|FG000|Overall Study|Did not meet eligibility criteria|1
7640647|NCT02224690|12055105|FG001|Overall Study|Did not meet eligibility criteria|0
7640648|NCT02224560|12055114|FG000|Overall Study|Protocol Deviation|1
7640649|NCT02224560|12055115|FG001|Overall Study|Protocol Deviation|0
7640650|NCT02224560|12055116|FG002|Overall Study|Protocol Deviation|0
7640651|NCT02224560|12055114|FG000|Overall Study|Withdrawal by Subject|2
7640652|NCT02224560|12055115|FG001|Overall Study|Withdrawal by Subject|0
7640653|NCT02224560|12055116|FG002|Overall Study|Withdrawal by Subject|1
7640654|NCT02224560|12055114|FG000|Overall Study|Met Withdrawal Criteria|1
7640655|NCT02224560|12055115|FG001|Overall Study|Met Withdrawal Criteria|0
7640656|NCT02224560|12055116|FG002|Overall Study|Met Withdrawal Criteria|0
7640657|NCT02224560|12055114|FG000|Overall Study|Adverse Event|4
7640658|NCT02224560|12055115|FG001|Overall Study|Adverse Event|1
7640659|NCT02224560|12055116|FG002|Overall Study|Adverse Event|1
7640660|NCT02224560|12055114|FG000|Overall Study|Withdrawn by Investigator|1
7640661|NCT02224560|12055115|FG001|Overall Study|Withdrawn by Investigator|1
7640662|NCT02224560|12055116|FG002|Overall Study|Withdrawn by Investigator|0
7640663|NCT02224391|12055126|FG000|Overall Study|Lost to Follow-up|26
7640664|NCT02224391|12055127|FG001|Overall Study|Lost to Follow-up|19
7640665|NCT02224391|12055126|FG000|Overall Study|Withdrawal by Subject|6
7640666|NCT02224391|12055127|FG001|Overall Study|Withdrawal by Subject|5
7640667|NCT02220894|12055135|FG000|Overall Study|Adverse Event|118
7640668|NCT02220894|12055136|FG001|Overall Study|Adverse Event|70
7640669|NCT02220894|12055135|FG000|Overall Study|Death|252
7640670|NCT02220894|12055136|FG001|Overall Study|Death|368
7640671|NCT02220894|12055135|FG000|Overall Study|Lost to Follow-up|0
7640672|NCT02220894|12055136|FG001|Overall Study|Lost to Follow-up|2
7640673|NCT02220894|12055135|FG000|Overall Study|Withdrawal by Parent/Guardian|0
7640674|NCT02220894|12055136|FG001|Overall Study|Withdrawal by Parent/Guardian|1
7640675|NCT02220894|12055135|FG000|Overall Study|Withdrawal by Subject|2
7640676|NCT02220894|12055136|FG001|Overall Study|Withdrawal by Subject|13
7640677|NCT02220894|12055135|FG000|Overall Study|Ongoing in Study|265
7640678|NCT02220894|12055136|FG001|Overall Study|Ongoing in Study|183
7640679|NCT02203513|12055167|FG000|Overall Study|Refused further treatment|2
7640680|NCT02203513|12055168|FG001|Overall Study|Refused further treatment|0
7640681|NCT02203513|12055169|FG002|Overall Study|Refused further treatment|1
7640682|NCT02203513|12055170|FG003|Overall Study|Refused further treatment|0
7640683|NCT02203513|12055171|FG004|Overall Study|Refused further treatment|0
7640684|NCT02203513|12055167|FG000|Overall Study|Switched to alternative treatment|3
7640685|NCT02203513|12055168|FG001|Overall Study|Switched to alternative treatment|4
7640686|NCT02203513|12055169|FG002|Overall Study|Switched to alternative treatment|0
7640687|NCT02203513|12055170|FG003|Overall Study|Switched to alternative treatment|0
7640688|NCT02203513|12055171|FG004|Overall Study|Switched to alternative treatment|4
7640689|NCT02203513|12055167|FG000|Overall Study|Did not receive investigational product (IP)|0
7640690|NCT02203513|12055168|FG001|Overall Study|Did not receive investigational product (IP)|1
7640691|NCT02203513|12055169|FG002|Overall Study|Did not receive investigational product (IP)|0
7640692|NCT02203513|12055170|FG003|Overall Study|Did not receive investigational product (IP)|0
7640693|NCT02203513|12055171|FG004|Overall Study|Did not receive investigational product (IP)|0
7640694|NCT02203513|12055167|FG000|Overall Study|Death (unrelated to study therapy)|1
7640695|NCT02203513|12055168|FG001|Overall Study|Death (unrelated to study therapy)|3
7640696|NCT02203513|12055169|FG002|Overall Study|Death (unrelated to study therapy)|1
7640697|NCT02203513|12055170|FG003|Overall Study|Death (unrelated to study therapy)|0
7640698|NCT02203513|12055171|FG004|Overall Study|Death (unrelated to study therapy)|2
7640699|NCT02203513|12055167|FG000|Overall Study|Lost to Follow-up|0
7640700|NCT02203513|12055168|FG001|Overall Study|Lost to Follow-up|0
7640701|NCT02203513|12055169|FG002|Overall Study|Lost to Follow-up|1
7640702|NCT02203513|12055170|FG003|Overall Study|Lost to Follow-up|1
7640703|NCT02203513|12055171|FG004|Overall Study|Lost to Follow-up|0
7640704|NCT02200445|12055188|FG000|Overall Study|Lack of Efficacy|1
7640705|NCT02200445|12055189|FG001|Overall Study|Lack of Efficacy|2
7640706|NCT02200445|12055190|FG002|Overall Study|Lack of Efficacy|2
7640707|NCT02200445|12055188|FG000|Overall Study|Adverse Event|0
7640708|NCT02200445|12055189|FG001|Overall Study|Adverse Event|2
7640709|NCT02200445|12055190|FG002|Overall Study|Adverse Event|0
7640710|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
7640711|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
7640712|NCT02197234|12055198|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
7640713|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
7640714|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
7640715|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
7640716|NCT02197234|12055198|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
7640717|NCT02195479|12055207|FG000|Overall Study|Lost to Follow-up|3
7640718|NCT02195479|12055208|FG001|Overall Study|Lost to Follow-up|0
7640719|NCT02195479|12055207|FG000|Overall Study|Death|48
7640720|NCT02195479|12055208|FG001|Overall Study|Death|45
7640721|NCT02195479|12055207|FG000|Overall Study|Physician Decision|1
7640722|NCT02195479|12055208|FG001|Overall Study|Physician Decision|0
7640723|NCT02195479|12055207|FG000|Overall Study|Withdrawal by Subject|11
7640724|NCT02195479|12055208|FG001|Overall Study|Withdrawal by Subject|6
7640725|NCT02195479|12055207|FG000|Overall Study|Other|2
7640726|NCT02195479|12055208|FG001|Overall Study|Other|2
7640727|NCT02195479|12055207|FG000|Overall Study|Ongoing|291
7640728|NCT02195479|12055208|FG001|Overall Study|Ongoing|297
7640729|NCT02186834|12055214|FG000|Dose Escalation|Death|0
7640730|NCT02186834|12055215|FG001|Dose Escalation|Death|0
7640731|NCT02186834|12055216|FG002|Dose Escalation|Death|0
7640732|NCT02186834|12055217|FG003|Dose Escalation|Death|1
7640733|NCT02186834|12055218|FG004|Dose Escalation|Death|0
7640734|NCT02186834|12055219|FG005|Dose Escalation|Death|0
7640735|NCT02186834|12055214|FG000|Treatment at RP2D|Died prior to treatment|0
7640736|NCT02186834|12055215|FG001|Treatment at RP2D|Died prior to treatment|0
7640737|NCT02186834|12055216|FG002|Treatment at RP2D|Died prior to treatment|0
7640738|NCT02186834|12055217|FG003|Treatment at RP2D|Died prior to treatment|0
7640739|NCT02186834|12055218|FG004|Treatment at RP2D|Died prior to treatment|0
7640740|NCT02186834|12055219|FG005|Treatment at RP2D|Died prior to treatment|1
7640741|NCT02184195|12055230|FG000|Overall Study|Patients ongoing Study Treatment|19
7640742|NCT02184195|12055231|FG001|Overall Study|Patients ongoing Study Treatment|7
7640743|NCT02180867|12055244|FG000|Overall Study|Adverse Event|3
7640744|NCT02180867|12055245|FG001|Overall Study|Adverse Event|4
7640745|NCT02180867|12055246|FG002|Overall Study|Adverse Event|1
7640746|NCT02180867|12055247|FG003|Overall Study|Adverse Event|5
7640747|NCT02180867|12055248|FG004|Overall Study|Adverse Event|0
7640748|NCT02180867|12055249|FG005|Overall Study|Adverse Event|0
7640749|NCT02180867|12055250|FG006|Overall Study|Adverse Event|0
7640750|NCT02180867|12055244|FG000|Overall Study|Death|0
7640751|NCT02180867|12055245|FG001|Overall Study|Death|0
7640752|NCT02180867|12055246|FG002|Overall Study|Death|0
7640753|NCT02180867|12055247|FG003|Overall Study|Death|0
7640754|NCT02180867|12055248|FG004|Overall Study|Death|1
7640755|NCT02180867|12055249|FG005|Overall Study|Death|0
7640756|NCT02180867|12055250|FG006|Overall Study|Death|0
7640757|NCT02180867|12055244|FG000|Overall Study|Lack of Efficacy|0
7640758|NCT02180867|12055245|FG001|Overall Study|Lack of Efficacy|2
7640759|NCT02180867|12055246|FG002|Overall Study|Lack of Efficacy|0
7640760|NCT02180867|12055247|FG003|Overall Study|Lack of Efficacy|1
7640761|NCT02180867|12055248|FG004|Overall Study|Lack of Efficacy|6
7640762|NCT02180867|12055249|FG005|Overall Study|Lack of Efficacy|0
7640763|NCT02180867|12055250|FG006|Overall Study|Lack of Efficacy|1
7640764|NCT02180867|12055244|FG000|Overall Study|Physician Decision|1
7640765|NCT02180867|12055245|FG001|Overall Study|Physician Decision|3
7640766|NCT02180867|12055246|FG002|Overall Study|Physician Decision|1
7640767|NCT02180867|12055247|FG003|Overall Study|Physician Decision|10
7640768|NCT02180867|12055248|FG004|Overall Study|Physician Decision|9
7640769|NCT02180867|12055249|FG005|Overall Study|Physician Decision|3
7640770|NCT02180867|12055250|FG006|Overall Study|Physician Decision|4
7640771|NCT02180867|12055244|FG000|Overall Study|Withdrawal by Subject|0
7640772|NCT02180867|12055245|FG001|Overall Study|Withdrawal by Subject|0
7640773|NCT02180867|12055246|FG002|Overall Study|Withdrawal by Subject|0
7640774|NCT02180867|12055247|FG003|Overall Study|Withdrawal by Subject|1
7640775|NCT02180867|12055248|FG004|Overall Study|Withdrawal by Subject|1
7640776|NCT02180867|12055249|FG005|Overall Study|Withdrawal by Subject|0
7640777|NCT02180867|12055250|FG006|Overall Study|Withdrawal by Subject|0
7640778|NCT02180867|12055244|FG000|Overall Study|Ineligible|1
7640779|NCT02180867|12055245|FG001|Overall Study|Ineligible|2
7640780|NCT02180867|12055246|FG002|Overall Study|Ineligible|0
7640781|NCT02180867|12055247|FG003|Overall Study|Ineligible|3
7640782|NCT02180867|12055248|FG004|Overall Study|Ineligible|5
7640783|NCT02180867|12055249|FG005|Overall Study|Ineligible|0
7640784|NCT02180867|12055250|FG006|Overall Study|Ineligible|0
7640785|NCT02180867|12055244|FG000|Overall Study|Repeat Eligibility Studies|0
7640786|NCT02180867|12055245|FG001|Overall Study|Repeat Eligibility Studies|0
7640787|NCT02180867|12055246|FG002|Overall Study|Repeat Eligibility Studies|0
7640788|NCT02180867|12055247|FG003|Overall Study|Repeat Eligibility Studies|0
7640789|NCT02180867|12055248|FG004|Overall Study|Repeat Eligibility Studies|1
7640790|NCT02180867|12055249|FG005|Overall Study|Repeat Eligibility Studies|0
7640791|NCT02180867|12055250|FG006|Overall Study|Repeat Eligibility Studies|0
7640792|NCT02180867|12055244|FG000|Overall Study|Refusal of further protocol therapy|1
7640793|NCT02180867|12055245|FG001|Overall Study|Refusal of further protocol therapy|0
7640794|NCT02180867|12055246|FG002|Overall Study|Refusal of further protocol therapy|2
7640795|NCT02180867|12055247|FG003|Overall Study|Refusal of further protocol therapy|6
7640796|NCT02180867|12055248|FG004|Overall Study|Refusal of further protocol therapy|4
7640797|NCT02180867|12055249|FG005|Overall Study|Refusal of further protocol therapy|0
7640798|NCT02180867|12055250|FG006|Overall Study|Refusal of further protocol therapy|0
7640799|NCT02173379|12055280|FG000|Overall Study|Lost to Follow-up|48
7640800|NCT02173379|12055281|FG001|Overall Study|Lost to Follow-up|34
7640801|NCT02173379|12055280|FG000|Overall Study|Withdrawal by Subject|14
7640802|NCT02173379|12055281|FG001|Overall Study|Withdrawal by Subject|17
7640803|NCT02173379|12055280|FG000|Overall Study|Physician Decision|7
7640804|NCT02173379|12055281|FG001|Overall Study|Physician Decision|4
7640805|NCT02173379|12055280|FG000|Overall Study|Death|22
7640806|NCT02173379|12055281|FG001|Overall Study|Death|22
7640807|NCT02163733|12055312|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
7640808|NCT02163733|12055313|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
7640809|NCT02163733|12055314|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
7640810|NCT02163733|12055312|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7640811|NCT02163733|12055313|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
7640812|NCT02163733|12055314|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
7640813|NCT02157883|12055334|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
7640814|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
7640815|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
7640816|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
7640817|NCT02157883|12055334|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
7640818|NCT02155712|12055362|FG000|Primary Objective|Death|3
7640819|NCT02155712|12055363|FG001|Primary Objective|Death|0
7640820|NCT02155712|12055362|FG000|Primary Objective|Lost to Follow-up|22
7640821|NCT02155712|12055363|FG001|Primary Objective|Lost to Follow-up|0
7640822|NCT02155712|12055362|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
7640823|NCT02155712|12055363|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
7640824|NCT02155712|12055362|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
7640825|NCT02155712|12055363|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
7640826|NCT02155712|12055362|FG000|Primary Objective|Withdrawal by Subject|21
7640827|NCT02155712|12055363|FG001|Primary Objective|Withdrawal by Subject|0
7640828|NCT02152631|12055371|FG000|Overall Study|Adverse Event|32
7640829|NCT02152631|12055372|FG001|Overall Study|Adverse Event|4
7640830|NCT02152631|12055371|FG000|Overall Study|Withdrawal by Subject|13
7640831|NCT02152631|12055372|FG001|Overall Study|Withdrawal by Subject|16
7640832|NCT02152631|12055371|FG000|Overall Study|Noncompliance with study drug|1
7640833|NCT02152631|12055372|FG001|Overall Study|Noncompliance with study drug|0
7640834|NCT02152631|12055371|FG000|Overall Study|Physician Decision|1
7640835|NCT02152631|12055372|FG001|Overall Study|Physician Decision|2
7640836|NCT02152631|12055371|FG000|Overall Study|Lost to Follow-up|0
7640837|NCT02152631|12055372|FG001|Overall Study|Lost to Follow-up|1
7640838|NCT02152631|12055371|FG000|Overall Study|On Treatment|19
7640839|NCT02152631|12055372|FG001|Overall Study|On Treatment|3
7640840|NCT02148263|12055380|FG000|Overall Study|Withdrawal by Subject|3
7640841|NCT02148263|12055381|FG001|Overall Study|Withdrawal by Subject|2
7640842|NCT02136134|12055389|FG000|Overall Study|Death|35
7640843|NCT02136134|12055390|FG001|Overall Study|Death|29
7640844|NCT02136134|12055389|FG000|Overall Study|Withdrawal by Subject|14
7640845|NCT02136134|12055390|FG001|Overall Study|Withdrawal by Subject|4
7640846|NCT02136134|12055389|FG000|Overall Study|Other|3
7640847|NCT02136134|12055390|FG001|Overall Study|Other|3
7640848|NCT02136134|12055389|FG000|Overall Study|Ongoing|185
7640849|NCT02136134|12055390|FG001|Overall Study|Ongoing|207
7640850|NCT02136134|12055389|FG000|Overall Study|Subjects randomized but not treated|10
7640851|NCT02136134|12055390|FG001|Overall Study|Subjects randomized but not treated|8
7640852|NCT02134925|12055398|FG000|Overall Study|Withdrawal by Subject|1
7640853|NCT02134925|12055399|FG001|Overall Study|Withdrawal by Subject|0
7640854|NCT02134925|12055398|FG000|Overall Study|Cancel|1
7640855|NCT02134925|12055399|FG001|Overall Study|Cancel|6
7640856|NCT02130466|12055419|FG000|Overall Study|Death|4
7640857|NCT02130466|12055420|FG001|Overall Study|Death|1
7640858|NCT02130466|12055421|FG002|Overall Study|Death|1
7640859|NCT02130466|12055422|FG003|Overall Study|Death|3
7640860|NCT02130466|12055423|FG004|Overall Study|Death|2
7640861|NCT02130466|12055424|FG005|Overall Study|Death|30
7640862|NCT02130466|12055425|FG006|Overall Study|Death|45
7640863|NCT02130466|12055426|FG007|Overall Study|Death|2
7640864|NCT02130466|12055427|FG008|Overall Study|Death|3
7640865|NCT02130466|12055428|FG009|Overall Study|Death|4
7640866|NCT02130466|12055429|FG010|Overall Study|Death|5
7640867|NCT02130466|12055430|FG011|Overall Study|Death|3
7640868|NCT02130466|12055431|FG012|Overall Study|Death|11
7640869|NCT02130466|12055432|FG013|Overall Study|Death|7
7640870|NCT02130466|12055419|FG000|Overall Study|Lost to Follow-up|1
7640871|NCT02130466|12055420|FG001|Overall Study|Lost to Follow-up|0
7640872|NCT02130466|12055421|FG002|Overall Study|Lost to Follow-up|0
7640873|NCT02130466|12055422|FG003|Overall Study|Lost to Follow-up|0
7640874|NCT02130466|12055423|FG004|Overall Study|Lost to Follow-up|0
7640875|NCT02130466|12055424|FG005|Overall Study|Lost to Follow-up|1
7640876|NCT02130466|12055425|FG006|Overall Study|Lost to Follow-up|0
7640877|NCT02130466|12055426|FG007|Overall Study|Lost to Follow-up|0
7640878|NCT02130466|12055427|FG008|Overall Study|Lost to Follow-up|0
7640879|NCT02130466|12055428|FG009|Overall Study|Lost to Follow-up|0
7640880|NCT02130466|12055429|FG010|Overall Study|Lost to Follow-up|0
7640881|NCT02130466|12055430|FG011|Overall Study|Lost to Follow-up|0
7640882|NCT02130466|12055431|FG012|Overall Study|Lost to Follow-up|1
7640883|NCT02130466|12055432|FG013|Overall Study|Lost to Follow-up|0
7640884|NCT02130466|12055419|FG000|Overall Study|Physician Decision|0
7640885|NCT02130466|12055420|FG001|Overall Study|Physician Decision|0
7640886|NCT02130466|12055421|FG002|Overall Study|Physician Decision|0
7640887|NCT02130466|12055422|FG003|Overall Study|Physician Decision|0
7640888|NCT02130466|12055423|FG004|Overall Study|Physician Decision|0
7640889|NCT02130466|12055424|FG005|Overall Study|Physician Decision|1
7640890|NCT02130466|12055425|FG006|Overall Study|Physician Decision|1
7640891|NCT02130466|12055426|FG007|Overall Study|Physician Decision|0
7640892|NCT02130466|12055427|FG008|Overall Study|Physician Decision|0
7640893|NCT02130466|12055428|FG009|Overall Study|Physician Decision|0
7640894|NCT02130466|12055429|FG010|Overall Study|Physician Decision|0
7640895|NCT02130466|12055430|FG011|Overall Study|Physician Decision|0
7640896|NCT02130466|12055431|FG012|Overall Study|Physician Decision|0
7640897|NCT02130466|12055432|FG013|Overall Study|Physician Decision|0
7640898|NCT02130466|12055419|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1
7640899|NCT02130466|12055420|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2
7640900|NCT02130466|12055421|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1
7640901|NCT02130466|12055422|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5
7640902|NCT02130466|12055423|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0
7640903|NCT02130466|12055424|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27
7640904|NCT02130466|12055425|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14
7640905|NCT02130466|12055426|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1
7640906|NCT02130466|12055427|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0
7640907|NCT02130466|12055428|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1
7640908|NCT02130466|12055429|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1
7640909|NCT02130466|12055430|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0
7640910|NCT02130466|12055431|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0
7640911|NCT02130466|12055432|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2
7640912|NCT02130466|12055419|FG000|Overall Study|Withdrawal by Subject|1
7640913|NCT02130466|12055420|FG001|Overall Study|Withdrawal by Subject|0
7640914|NCT02130466|12055421|FG002|Overall Study|Withdrawal by Subject|0
7640915|NCT02130466|12055422|FG003|Overall Study|Withdrawal by Subject|0
7640916|NCT02130466|12055423|FG004|Overall Study|Withdrawal by Subject|0
7640917|NCT02130466|12055424|FG005|Overall Study|Withdrawal by Subject|1
7640918|NCT02130466|12055425|FG006|Overall Study|Withdrawal by Subject|0
7640919|NCT02130466|12055426|FG007|Overall Study|Withdrawal by Subject|0
7640920|NCT02130466|12055427|FG008|Overall Study|Withdrawal by Subject|1
7640921|NCT02130466|12055428|FG009|Overall Study|Withdrawal by Subject|0
7640922|NCT02130466|12055429|FG010|Overall Study|Withdrawal by Subject|0
7640923|NCT02130466|12055430|FG011|Overall Study|Withdrawal by Subject|0
7640924|NCT02130466|12055431|FG012|Overall Study|Withdrawal by Subject|0
7640925|NCT02130466|12055432|FG013|Overall Study|Withdrawal by Subject|0
7640926|NCT02126969|12055485|FG000|Overall Study|Withdrawal by Subject|1
7640927|NCT02126969|12055486|FG001|Overall Study|Withdrawal by Subject|2
7640928|NCT02125461|12055494|FG000|Overall Study|Withdrawal by Subject|30
7640929|NCT02125461|12055495|FG001|Overall Study|Withdrawal by Subject|16
7640930|NCT02125461|12055494|FG000|Overall Study|Lost to Follow-up|8
7640931|NCT02125461|12055495|FG001|Overall Study|Lost to Follow-up|3
7640932|NCT02125461|12055494|FG000|Overall Study|Death|260
7640933|NCT02125461|12055495|FG001|Overall Study|Death|149
7640934|NCT02125461|12055494|FG000|Overall Study|Missing Termination Reason|0
7640935|NCT02125461|12055495|FG001|Overall Study|Missing Termination Reason|1
7640936|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Adverse Event|3
7640937|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Adverse Event|0
7640938|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Adverse Event|0
7640939|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Adverse Event|0
7640940|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
7640941|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
7640942|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
7640943|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
7640944|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Protocol Violation|2
7640945|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Protocol Violation|0
7640946|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Protocol Violation|0
7640947|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Protocol Violation|0
7640948|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
7640949|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640950|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640951|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
7640952|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
7640953|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
7640954|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
7640955|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
7640956|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
7640957|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640958|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640959|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
7640960|NCT02120352|12055510|FG000|Induction Period (20 Weeks)|Physician Decision|1
7640961|NCT02120352|12055511|FG001|Induction Period (20 Weeks)|Physician Decision|0
7640962|NCT02120352|12055512|FG002|Induction Period (20 Weeks)|Physician Decision|0
7640963|NCT02120352|12055513|FG003|Induction Period (20 Weeks)|Physician Decision|0
7640964|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
7640965|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
7640966|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
7640967|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
7640968|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7640969|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7640970|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
7640971|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
7640972|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
7640973|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
7640974|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
7640975|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
7640976|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7640977|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
7640978|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7640979|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
7640980|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640981|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640982|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
7640983|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
7640984|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
7640985|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7640986|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
7640987|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
7640988|NCT02120352|12055510|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
7640989|NCT02120352|12055511|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
7640990|NCT02120352|12055512|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
7640991|NCT02120352|12055513|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
7640992|NCT02119416|12055530|FG000|Overall Study|Protocol Violation|1
7640993|NCT02119416|12055531|FG001|Overall Study|Protocol Violation|1
7640994|NCT02119416|12055532|FG002|Overall Study|Protocol Violation|1
7640995|NCT02119416|12055530|FG000|Overall Study|wrong pubertal stage|1
7640996|NCT02119416|12055531|FG001|Overall Study|wrong pubertal stage|0
7640997|NCT02119416|12055532|FG002|Overall Study|wrong pubertal stage|1
7640998|NCT02108652|12055572|FG000|Overall Study|Death|226
7640999|NCT02108652|12055572|FG000|Overall Study|Lost to Follow-up|2
7641000|NCT02108652|12055572|FG000|Overall Study|Withdrawal by Subject|8
7641001|NCT02108652|12055572|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
7641002|NCT02106351|12055579|FG000|Treatment Cycle 1|Adverse Event|2
7641003|NCT02106351|12055580|FG001|Treatment Cycle 1|Adverse Event|0
7641004|NCT02106351|12055581|FG002|Treatment Cycle 1|Adverse Event|0
7641005|NCT02106351|12055579|FG000|Treatment Cycle 1|Consent withdrawn|1
7641006|NCT02106351|12055580|FG001|Treatment Cycle 1|Consent withdrawn|0
7641007|NCT02106351|12055581|FG002|Treatment Cycle 1|Consent withdrawn|2
7641008|NCT02106351|12055579|FG000|Treatment Cycle 1|Lost to Follow-up|1
7641009|NCT02106351|12055580|FG001|Treatment Cycle 1|Lost to Follow-up|0
7641010|NCT02106351|12055581|FG002|Treatment Cycle 1|Lost to Follow-up|0
7641011|NCT02106351|12055579|FG000|Treatment Cycle 1|Other|0
7641012|NCT02106351|12055580|FG001|Treatment Cycle 1|Other|3
7641013|NCT02106351|12055581|FG002|Treatment Cycle 1|Other|1
7641014|NCT02106351|12055579|FG000|Treatment Cycle 1|Randomised but not treated|1
7641015|NCT02106351|12055580|FG001|Treatment Cycle 1|Randomised but not treated|0
7641016|NCT02106351|12055581|FG002|Treatment Cycle 1|Randomised but not treated|1
7641017|NCT02106351|12055579|FG000|Treatment Cycle 2|Adverse Event|0
7641018|NCT02106351|12055580|FG001|Treatment Cycle 2|Adverse Event|2
7641019|NCT02106351|12055581|FG002|Treatment Cycle 2|Adverse Event|0
7641020|NCT02106351|12055579|FG000|Treatment Cycle 2|Consent withdrawn|0
7641021|NCT02106351|12055580|FG001|Treatment Cycle 2|Consent withdrawn|1
7641022|NCT02106351|12055581|FG002|Treatment Cycle 2|Consent withdrawn|1
7641023|NCT02106351|12055579|FG000|Treatment Cycle 2|Other|0
7641024|NCT02106351|12055580|FG001|Treatment Cycle 2|Other|2
7641025|NCT02106351|12055581|FG002|Treatment Cycle 2|Other|2
7641026|NCT02106351|12055579|FG000|Treatment Cycle 3|Adverse Event|0
7641027|NCT02106351|12055580|FG001|Treatment Cycle 3|Adverse Event|1
7641028|NCT02106351|12055581|FG002|Treatment Cycle 3|Adverse Event|0
7641029|NCT02106351|12055579|FG000|Treatment Cycle 3|Consent withdrawn|0
7641030|NCT02106351|12055580|FG001|Treatment Cycle 3|Consent withdrawn|0
7641031|NCT02106351|12055581|FG002|Treatment Cycle 3|Consent withdrawn|2
7641032|NCT02106351|12055579|FG000|Treatment Cycle 3|Lost to Follow-up|0
7641033|NCT02106351|12055580|FG001|Treatment Cycle 3|Lost to Follow-up|1
7641034|NCT02106351|12055581|FG002|Treatment Cycle 3|Lost to Follow-up|0
7641035|NCT02106351|12055579|FG000|Treatment Cycle 3|Other|0
7641036|NCT02106351|12055580|FG001|Treatment Cycle 3|Other|2
7641037|NCT02106351|12055581|FG002|Treatment Cycle 3|Other|3
7641038|NCT02106351|12055579|FG000|Treatment Cycle 4|Consent withdrawn|0
7641039|NCT02106351|12055580|FG001|Treatment Cycle 4|Consent withdrawn|0
7641040|NCT02106351|12055581|FG002|Treatment Cycle 4|Consent withdrawn|2
7641041|NCT02106351|12055579|FG000|Treatment Cycle 4|Other|0
7641042|NCT02106351|12055580|FG001|Treatment Cycle 4|Other|1
7641043|NCT02106351|12055581|FG002|Treatment Cycle 4|Other|0
7641044|NCT02098876|12055605|FG000|Overall Study|Withdrawal by Subject|5
7641045|NCT02098876|12055606|FG001|Overall Study|Withdrawal by Subject|5
7641046|NCT02094261|12055634|FG000|Overall Study|Death|24
7641047|NCT02094261|12055634|FG000|Overall Study|Lost to Follow-up|1
7641048|NCT02094261|12055634|FG000|Overall Study|Withdrawal by Subject|4
7641049|NCT02094261|12055634|FG000|Overall Study|Ongoing Study at Data Cut-off|181
7641050|NCT02091960|12055638|FG000|Overall Study|Death|7
7641051|NCT02091960|12055638|FG000|Overall Study|Withdrawal by Subject|1
7641052|NCT02091960|12055638|FG000|Overall Study|Miscellaneous Reasons|31
7641053|NCT02091960|12055638|FG000|Overall Study|On Study at Data Cut-off|12
7641054|NCT02091375|12055644|FG000|Overall Study|Adverse Event|8
7641055|NCT02091375|12055645|FG001|Overall Study|Adverse Event|1
7641056|NCT02091375|12055644|FG000|Overall Study|Lost to Follow-up|0
7641057|NCT02091375|12055645|FG001|Overall Study|Lost to Follow-up|1
7641058|NCT02091375|12055644|FG000|Overall Study|Withdrawal by Subject|0
7641059|NCT02091375|12055645|FG001|Overall Study|Withdrawal by Subject|1
7641060|NCT02091375|12055644|FG000|Overall Study|Withdrawn by the investigator|1
7641061|NCT02091375|12055645|FG001|Overall Study|Withdrawn by the investigator|0
7641062|NCT02091206|12055655|FG000|Treatment Period|Adverse Event|0
7641063|NCT02091206|12055656|FG001|Treatment Period|Adverse Event|1
7641064|NCT02091206|12055657|FG002|Treatment Period|Adverse Event|0
7641065|NCT02091206|12055658|FG003|Treatment Period|Adverse Event|0
7641066|NCT02091206|12055655|FG000|Treatment Period|Met withdrawal criteria|0
7641067|NCT02091206|12055656|FG001|Treatment Period|Met withdrawal criteria|0
7641068|NCT02091206|12055657|FG002|Treatment Period|Met withdrawal criteria|1
7641069|NCT02091206|12055658|FG003|Treatment Period|Met withdrawal criteria|0
7641070|NCT02091206|12055655|FG000|Taper Period|Participant refused study drug|1
7641071|NCT02091206|12055656|FG001|Taper Period|Participant refused study drug|0
7641072|NCT02091206|12055657|FG002|Taper Period|Participant refused study drug|0
7641073|NCT02091206|12055658|FG003|Taper Period|Participant refused study drug|1
7641074|NCT02091206|12055655|FG000|Taper Period|Lost to Follow-up|0
7641075|NCT02091206|12055656|FG001|Taper Period|Lost to Follow-up|0
7641076|NCT02091206|12055657|FG002|Taper Period|Lost to Follow-up|0
7641077|NCT02091206|12055658|FG003|Taper Period|Lost to Follow-up|1
7641078|NCT02089685|12055674|FG000|Overall Study|Adverse Event|1
7641079|NCT02089685|12055675|FG001|Overall Study|Adverse Event|0
7641080|NCT02089685|12055676|FG002|Overall Study|Adverse Event|0
7641081|NCT02089685|12055677|FG003|Overall Study|Adverse Event|0
7641082|NCT02089685|12055678|FG004|Overall Study|Adverse Event|1
7641083|NCT02089685|12055679|FG005|Overall Study|Adverse Event|0
7641084|NCT02089685|12055674|FG000|Overall Study|Clinical Progression|4
7641085|NCT02089685|12055675|FG001|Overall Study|Clinical Progression|0
7641086|NCT02089685|12055676|FG002|Overall Study|Clinical Progression|0
7641087|NCT02089685|12055677|FG003|Overall Study|Clinical Progression|5
7641088|NCT02089685|12055678|FG004|Overall Study|Clinical Progression|1
7641089|NCT02089685|12055679|FG005|Overall Study|Clinical Progression|2
7641090|NCT02089685|12055674|FG000|Overall Study|Excluded Medication|1
7641091|NCT02089685|12055675|FG001|Overall Study|Excluded Medication|0
7641092|NCT02089685|12055676|FG002|Overall Study|Excluded Medication|0
7641093|NCT02089685|12055677|FG003|Overall Study|Excluded Medication|11
7641094|NCT02089685|12055678|FG004|Overall Study|Excluded Medication|2
7641095|NCT02089685|12055679|FG005|Overall Study|Excluded Medication|1
7641096|NCT02089685|12055674|FG000|Overall Study|Progressive disease|13
7641097|NCT02089685|12055675|FG001|Overall Study|Progressive disease|10
7641098|NCT02089685|12055676|FG002|Overall Study|Progressive disease|3
7641099|NCT02089685|12055677|FG003|Overall Study|Progressive disease|51
7641100|NCT02089685|12055678|FG004|Overall Study|Progressive disease|17
7641101|NCT02089685|12055679|FG005|Overall Study|Progressive disease|12
7641102|NCT02089685|12055674|FG000|Overall Study|Follow up ended by sponsor|2
7641103|NCT02089685|12055675|FG001|Overall Study|Follow up ended by sponsor|2
7641104|NCT02089685|12055676|FG002|Overall Study|Follow up ended by sponsor|0
7641105|NCT02089685|12055677|FG003|Overall Study|Follow up ended by sponsor|70
7641106|NCT02089685|12055678|FG004|Overall Study|Follow up ended by sponsor|26
7641107|NCT02089685|12055679|FG005|Overall Study|Follow up ended by sponsor|26
7641108|NCT02089685|12055674|FG000|Overall Study|Withdrawal by Subject|0
7641109|NCT02089685|12055675|FG001|Overall Study|Withdrawal by Subject|2
7641110|NCT02089685|12055676|FG002|Overall Study|Withdrawal by Subject|0
7641111|NCT02089685|12055677|FG003|Overall Study|Withdrawal by Subject|8
7641112|NCT02089685|12055678|FG004|Overall Study|Withdrawal by Subject|1
7641113|NCT02089685|12055679|FG005|Overall Study|Withdrawal by Subject|1
7641114|NCT02089685|12055674|FG000|Overall Study|Status not recorded|1
7641115|NCT02089685|12055675|FG001|Overall Study|Status not recorded|0
7641116|NCT02089685|12055676|FG002|Overall Study|Status not recorded|0
7641117|NCT02089685|12055677|FG003|Overall Study|Status not recorded|0
7641118|NCT02089685|12055678|FG004|Overall Study|Status not recorded|1
7641119|NCT02089685|12055679|FG005|Overall Study|Status not recorded|0
7641120|NCT02089685|12055674|FG000|Overall Study|Death|0
7641121|NCT02089685|12055675|FG001|Overall Study|Death|0
7641122|NCT02089685|12055676|FG002|Overall Study|Death|0
7641123|NCT02089685|12055677|FG003|Overall Study|Death|7
7641124|NCT02089685|12055678|FG004|Overall Study|Death|2
7641125|NCT02089685|12055679|FG005|Overall Study|Death|5
7641126|NCT02089685|12055674|FG000|Overall Study|Lost to Follow-up|0
7641127|NCT02089685|12055675|FG001|Overall Study|Lost to Follow-up|0
7641128|NCT02089685|12055676|FG002|Overall Study|Lost to Follow-up|0
7641129|NCT02089685|12055677|FG003|Overall Study|Lost to Follow-up|1
7641130|NCT02089685|12055678|FG004|Overall Study|Lost to Follow-up|0
7641131|NCT02089685|12055679|FG005|Overall Study|Lost to Follow-up|0
7641132|NCT02089685|12055674|FG000|Overall Study|Physician Decision|0
7641133|NCT02089685|12055675|FG001|Overall Study|Physician Decision|0
7641134|NCT02089685|12055676|FG002|Overall Study|Physician Decision|0
7641135|NCT02089685|12055677|FG003|Overall Study|Physician Decision|0
7641136|NCT02089685|12055678|FG004|Overall Study|Physician Decision|0
7641137|NCT02089685|12055679|FG005|Overall Study|Physician Decision|4
7641138|NCT02089685|12055674|FG000|Overall Study|Screen failure|1
7641139|NCT02089685|12055675|FG001|Overall Study|Screen failure|0
7641140|NCT02089685|12055676|FG002|Overall Study|Screen failure|0
7641141|NCT02089685|12055677|FG003|Overall Study|Screen failure|0
7641142|NCT02089685|12055678|FG004|Overall Study|Screen failure|0
7641143|NCT02089685|12055679|FG005|Overall Study|Screen failure|0
7641144|NCT02085941|12055705|FG000|Overall Study|Lack of Efficacy|1
7641145|NCT02085941|12055706|FG001|Overall Study|Lack of Efficacy|0
7641146|NCT02085941|12055705|FG000|Overall Study|Death|6
7641147|NCT02085941|12055706|FG001|Overall Study|Death|1
7641148|NCT02085941|12055705|FG000|Overall Study|Lost to Follow-up|1
7641149|NCT02085941|12055706|FG001|Overall Study|Lost to Follow-up|0
7641150|NCT02085941|12055705|FG000|Overall Study|Physician Decision|0
7641151|NCT02085941|12055706|FG001|Overall Study|Physician Decision|2
7641152|NCT02080403|12055714|FG000|Overall Study|Adverse Event|5
7641153|NCT02080403|12055715|FG001|Overall Study|Adverse Event|1
7641154|NCT02080403|12055714|FG000|Overall Study|Death|0
7641155|NCT02080403|12055715|FG001|Overall Study|Death|2
7641156|NCT02080403|12055714|FG000|Overall Study|Lost to Follow-up|2
7641157|NCT02080403|12055715|FG001|Overall Study|Lost to Follow-up|0
7641158|NCT02080403|12055714|FG000|Overall Study|Pregnancy|0
7641159|NCT02080403|12055715|FG001|Overall Study|Pregnancy|1
7641160|NCT02080403|12055714|FG000|Overall Study|Protocol Violation|3
7641161|NCT02080403|12055715|FG001|Overall Study|Protocol Violation|7
7641162|NCT02080403|12055714|FG000|Overall Study|Withdrawal by Subject|5
7641163|NCT02080403|12055715|FG001|Overall Study|Withdrawal by Subject|1
7641164|NCT02080221|12055721|FG000|Overall Study|Withdrawal by Subject|1
7641165|NCT02080221|12055721|FG000|Overall Study|Clinical Progression of Disease|1
7641166|NCT02076113|12055727|FG000|Overall Study|Lost to Follow-up|4
7641167|NCT02076113|12055728|FG001|Overall Study|Lost to Follow-up|1
7641168|NCT02076113|12055727|FG000|Overall Study|Withdrawal by Subject|2
7641169|NCT02076113|12055728|FG001|Overall Study|Withdrawal by Subject|3
7641170|NCT02076113|12055727|FG000|Overall Study|Death|1
7641171|NCT02076113|12055728|FG001|Overall Study|Death|3
7641172|NCT02076009|12055739|FG000|Overall Study|Death|44
7641173|NCT02076009|12055740|FG001|Overall Study|Death|30
7641174|NCT02076009|12055739|FG000|Overall Study|Withdrawal by Subject|9
7641175|NCT02076009|12055740|FG001|Overall Study|Withdrawal by Subject|3
7641176|NCT02076009|12055739|FG000|Overall Study|Lost to Follow-up|1
7641177|NCT02076009|12055740|FG001|Overall Study|Lost to Follow-up|1
7641178|NCT02076009|12055739|FG000|Overall Study|Progressive disease|1
7641179|NCT02076009|12055740|FG001|Overall Study|Progressive disease|0
7641180|NCT02076009|12055739|FG000|Overall Study|Ongoing|226
7641181|NCT02076009|12055740|FG001|Overall Study|Ongoing|249
7641182|NCT02076009|12055739|FG000|Overall Study|Subjects randomized but not treated|2
7641183|NCT02076009|12055740|FG001|Overall Study|Subjects randomized but not treated|3
7641184|NCT02075840|12055748|FG000|Overall Study|Withdrawal by Subject|13
7641185|NCT02075840|12055749|FG001|Overall Study|Withdrawal by Subject|22
7641186|NCT02075840|12055748|FG000|Overall Study|Reason not specified|1
7641187|NCT02075840|12055749|FG001|Overall Study|Reason not specified|0
7641188|NCT02075840|12055748|FG000|Overall Study|Adverse Event|0
7641189|NCT02075840|12055749|FG001|Overall Study|Adverse Event|2
7641190|NCT02075840|12055748|FG000|Overall Study|Death|35
7641191|NCT02075840|12055749|FG001|Overall Study|Death|40
7641192|NCT02075840|12055748|FG000|Overall Study|Lost to Follow-up|3
7641193|NCT02075840|12055749|FG001|Overall Study|Lost to Follow-up|2
7641194|NCT02075840|12055748|FG000|Overall Study|Physician Decision|1
7641195|NCT02075840|12055749|FG001|Overall Study|Physician Decision|3
7641196|NCT02075840|12055748|FG000|Overall Study|Ongoing at CCOD|99
7641197|NCT02075840|12055749|FG001|Overall Study|Ongoing at CCOD|82
7641198|NCT02069366|12055761|FG000|Overall Study|Lost to Follow-up|0
7641199|NCT02069366|12055762|FG001|Overall Study|Lost to Follow-up|0
7641200|NCT02069366|12055763|FG002|Overall Study|Lost to Follow-up|1
7641201|NCT02069366|12055764|FG003|Overall Study|Lost to Follow-up|0
7641202|NCT02069366|12055765|FG004|Overall Study|Lost to Follow-up|0
7641203|NCT02069366|12055766|FG005|Overall Study|Lost to Follow-up|2
7641204|NCT02069366|12055761|FG000|Overall Study|Protocol Violation|0
7641205|NCT02069366|12055762|FG001|Overall Study|Protocol Violation|0
7641206|NCT02069366|12055763|FG002|Overall Study|Protocol Violation|1
7641207|NCT02069366|12055764|FG003|Overall Study|Protocol Violation|0
7641208|NCT02069366|12055765|FG004|Overall Study|Protocol Violation|0
7641209|NCT02069366|12055766|FG005|Overall Study|Protocol Violation|0
7641210|NCT02069366|12055761|FG000|Overall Study|Withdrawal by Subject|1
7641211|NCT02069366|12055762|FG001|Overall Study|Withdrawal by Subject|0
7641212|NCT02069366|12055763|FG002|Overall Study|Withdrawal by Subject|1
7641213|NCT02069366|12055764|FG003|Overall Study|Withdrawal by Subject|2
7641214|NCT02069366|12055765|FG004|Overall Study|Withdrawal by Subject|0
7641215|NCT02069366|12055766|FG005|Overall Study|Withdrawal by Subject|0
7641216|NCT02066415|12055784|FG000|Overall Study|Decision by Sponsor|5
7641217|NCT02066415|12055785|FG001|Overall Study|Decision by Sponsor|4
7641218|NCT02066415|12055786|FG002|Overall Study|Decision by Sponsor|2
7641219|NCT02066415|12055784|FG000|Overall Study|Withdrawal by Subject|9
7641220|NCT02066415|12055785|FG001|Overall Study|Withdrawal by Subject|1
7641221|NCT02066415|12055786|FG002|Overall Study|Withdrawal by Subject|4
7641222|NCT02066415|12055784|FG000|Overall Study|Lost to Follow-up|7
7641223|NCT02066415|12055785|FG001|Overall Study|Lost to Follow-up|2
7641224|NCT02066415|12055786|FG002|Overall Study|Lost to Follow-up|2
7641225|NCT02064296|12055797|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1
7641226|NCT02064296|12055798|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0
7641227|NCT02064296|12055799|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0
7641228|NCT02064296|12055797|FG000|Intervention|Withdrawal by Subject|0
7641229|NCT02064296|12055798|FG001|Intervention|Withdrawal by Subject|1
7641230|NCT02064296|12055799|FG002|Intervention|Withdrawal by Subject|2
7641231|NCT02063724|12055809|FG000|Overall Study|Disease progression|1
7641232|NCT02059265|12055850|FG000|Overall Study|Ineligible|4
7641233|NCT02043678|12055865|FG000|Overall Study|Never treated|11
7641234|NCT02043678|12055866|FG001|Overall Study|Never treated|9
7641235|NCT02043678|12055865|FG000|Overall Study|AE with clinical progressive disease(PD)|18
7641236|NCT02043678|12055866|FG001|Overall Study|AE with clinical progressive disease(PD)|18
7641237|NCT02043678|12055865|FG000|Overall Study|AE without clinical PD|51
7641238|NCT02043678|12055866|FG001|Overall Study|AE without clinical PD|34
7641239|NCT02043678|12055865|FG000|Overall Study|Lost to Follow-up|1
7641240|NCT02043678|12055866|FG001|Overall Study|Lost to Follow-up|1
7641241|NCT02043678|12055865|FG000|Overall Study|Other|19
7641242|NCT02043678|12055866|FG001|Overall Study|Other|16
7641243|NCT02043678|12055865|FG000|Overall Study|Clinical PD|108
7641244|NCT02043678|12055866|FG001|Overall Study|Clinical PD|138
7641245|NCT02043678|12055865|FG000|Overall Study|Radiological PD|91
7641246|NCT02043678|12055866|FG001|Overall Study|Radiological PD|80
7641247|NCT02043678|12055865|FG000|Overall Study|Protocol-driven decision point|56
7641248|NCT02043678|12055866|FG001|Overall Study|Protocol-driven decision point|56
7641249|NCT02043678|12055865|FG000|Overall Study|Withdrawal by Subject|12
7641250|NCT02043678|12055866|FG001|Overall Study|Withdrawal by Subject|15
7641251|NCT02043678|12055865|FG000|Overall Study|Ongoing with treatment|34
7641252|NCT02043678|12055866|FG001|Overall Study|Ongoing with treatment|38
7641253|NCT02032823|12055874|FG000|Overall Study|Death|59
7641254|NCT02032823|12055875|FG001|Overall Study|Death|86
7641255|NCT02032823|12055874|FG000|Overall Study|Lost to Follow-up|12
7641256|NCT02032823|12055875|FG001|Overall Study|Lost to Follow-up|15
7641257|NCT02032823|12055874|FG000|Overall Study|Withdrawal by Subject|65
7641258|NCT02032823|12055875|FG001|Overall Study|Withdrawal by Subject|49
7641259|NCT02032823|12055874|FG000|Overall Study|Ongoing study at data cut-off|782
7641260|NCT02032823|12055875|FG001|Overall Study|Ongoing study at data cut-off|760
7641261|NCT02032823|12055874|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
7641262|NCT02032823|12055875|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
7641263|NCT02029443|12055886|FG000|Overall Study|Completed 30-Day safety follow-up visit|53
7641264|NCT02029443|12055887|FG001|Overall Study|Completed 30-Day safety follow-up visit|16
7641265|NCT02029443|12055888|FG002|Overall Study|Completed 30-Day safety follow-up visit|12
7641266|NCT02029443|12055889|FG003|Overall Study|Completed 30-Day safety follow-up visit|2
7641267|NCT02029443|12055890|FG004|Overall Study|Completed 30-Day safety follow-up visit|1
7641268|NCT02029443|12055886|FG000|Overall Study|Death|13
7641269|NCT02029443|12055887|FG001|Overall Study|Death|2
7641270|NCT02029443|12055888|FG002|Overall Study|Death|2
7641271|NCT02029443|12055889|FG003|Overall Study|Death|11
7641272|NCT02029443|12055890|FG004|Overall Study|Death|2
7641273|NCT02029443|12055886|FG000|Overall Study|Lost to Follow-up|1
7641274|NCT02029443|12055887|FG001|Overall Study|Lost to Follow-up|0
7641275|NCT02029443|12055888|FG002|Overall Study|Lost to Follow-up|1
7641276|NCT02029443|12055889|FG003|Overall Study|Lost to Follow-up|1
7641277|NCT02029443|12055890|FG004|Overall Study|Lost to Follow-up|0
7641278|NCT02029443|12055886|FG000|Overall Study|Started other anti-cancer therapy|17
7641279|NCT02029443|12055887|FG001|Overall Study|Started other anti-cancer therapy|4
7641280|NCT02029443|12055888|FG002|Overall Study|Started other anti-cancer therapy|7
7641281|NCT02029443|12055889|FG003|Overall Study|Started other anti-cancer therapy|9
7641282|NCT02029443|12055890|FG004|Overall Study|Started other anti-cancer therapy|3
7641283|NCT02029443|12055886|FG000|Overall Study|Withdrawal by Subject|3
7641284|NCT02029443|12055887|FG001|Overall Study|Withdrawal by Subject|1
7641285|NCT02029443|12055888|FG002|Overall Study|Withdrawal by Subject|1
7641286|NCT02029443|12055889|FG003|Overall Study|Withdrawal by Subject|1
7641287|NCT02029443|12055890|FG004|Overall Study|Withdrawal by Subject|0
7641288|NCT02029443|12055886|FG000|Overall Study|Other|6
7641289|NCT02029443|12055887|FG001|Overall Study|Other|6
7641290|NCT02029443|12055888|FG002|Overall Study|Other|4
7641291|NCT02029443|12055889|FG003|Overall Study|Other|2
7641292|NCT02029443|12055890|FG004|Overall Study|Other|0
7641293|NCT02024529|12055926|FG000|Overall Study|Withdrawal by Subject|11
7641294|NCT02024529|12055927|FG001|Overall Study|Withdrawal by Subject|21
7641295|NCT02024529|12055926|FG000|Overall Study|Lost to Follow-up|2
7641296|NCT02024529|12055927|FG001|Overall Study|Lost to Follow-up|4
7641297|NCT02021812|12055945|FG000|Overall Study|Death|8
7641298|NCT02021812|12055945|FG000|Overall Study|Withdrawal by Subject|3
7641299|NCT02021812|12055945|FG000|Overall Study|Lost to Follow-up|2
7641300|NCT02021812|12055945|FG000|Overall Study|Refuse to return, COVD 19|2
7641301|NCT02016781|12055951|FG000|Interim Look for Primary Analysis|Alive and on study|71
7641302|NCT02016781|12055952|FG001|Interim Look for Primary Analysis|Alive and on study|23
7641303|NCT02016781|12055951|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2
7641304|NCT02016781|12055952|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1
7641305|NCT02016781|12055951|FG000|Final Database Lock|Withdrawal by Subject|2
7641306|NCT02016781|12055952|FG001|Final Database Lock|Withdrawal by Subject|1
7641307|NCT02016781|12055951|FG000|Final Database Lock|Lost to Follow-up|11
7641308|NCT02016781|12055952|FG001|Final Database Lock|Lost to Follow-up|4
7641309|NCT02016781|12055951|FG000|Final Database Lock|Missing data|0
7641310|NCT02016781|12055952|FG001|Final Database Lock|Missing data|3
7641311|NCT02006628|12055960|FG000|Overall Study|Adverse Event|1
7641312|NCT02006628|12055961|FG001|Overall Study|Adverse Event|1
7641313|NCT02006628|12055960|FG000|Overall Study|Withdrawal by Subject|2
7641314|NCT02006628|12055961|FG001|Overall Study|Withdrawal by Subject|1
7641315|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Other than specified|2
7641316|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Other than specified|4
7641317|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4
7641318|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5
7641319|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Pregnancy|0
7641320|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Pregnancy|2
7641321|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Physician Decision|1
7641322|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Physician Decision|1
7641323|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Lost to Follow-up|0
7641324|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Lost to Follow-up|1
7641325|NCT02003144|12055969|FG000|Open Label Maintenance Phase|Adverse Event|2
7641326|NCT02003144|12055970|FG001|Open Label Maintenance Phase|Adverse Event|1
7641327|NCT02002182|12055979|FG000|Overall Study|Withdraw from study|3
7641328|NCT02002182|12055980|FG001|Overall Study|Withdraw from study|1
7641329|NCT02002182|12055979|FG000|Overall Study|Health Reasons|1
7641330|NCT02002182|12055980|FG001|Overall Study|Health Reasons|0
7641331|NCT02002182|12055979|FG000|Overall Study|Death|1
7641332|NCT02002182|12055980|FG001|Overall Study|Death|0
7641333|NCT02000427|12055986|FG000|Overall Study|Death|22
7641334|NCT01988493|12056008|FG000|Overall Study|Randomized but not treated|0
7641335|NCT01988493|12056009|FG001|Overall Study|Randomized but not treated|0
7641336|NCT01988493|12056010|FG002|Overall Study|Randomized but not treated|0
7641337|NCT01988493|12056011|FG003|Overall Study|Randomized but not treated|0
7641338|NCT01988493|12056012|FG004|Overall Study|Randomized but not treated|1
7641339|NCT01988233|12056026|FG000|Overall Study|Lost to Follow-up|64
7641340|NCT01988233|12056027|FG001|Overall Study|Lost to Follow-up|51
7641341|NCT01986881|12056036|FG000|Overall Study|Death|228
7641342|NCT01986881|12056037|FG001|Overall Study|Death|233
7641343|NCT01986881|12056038|FG002|Overall Study|Death|247
7641344|NCT01986881|12056036|FG000|Overall Study|Lost to Follow-up|51
7641345|NCT01986881|12056037|FG001|Overall Study|Lost to Follow-up|44
7641346|NCT01986881|12056038|FG002|Overall Study|Lost to Follow-up|55
7641347|NCT01986881|12056036|FG000|Overall Study|Physician Decision|7
7641348|NCT01986881|12056037|FG001|Overall Study|Physician Decision|4
7641349|NCT01986881|12056038|FG002|Overall Study|Physician Decision|6
7641350|NCT01986881|12056036|FG000|Overall Study|Study Site Terminated by Sponsor|2
7641351|NCT01986881|12056037|FG001|Overall Study|Study Site Terminated by Sponsor|2
7641352|NCT01986881|12056038|FG002|Overall Study|Study Site Terminated by Sponsor|3
7641353|NCT01986881|12056036|FG000|Overall Study|Withdrawal by Subject|41
7641354|NCT01986881|12056037|FG001|Overall Study|Withdrawal by Subject|60
7641355|NCT01986881|12056038|FG002|Overall Study|Withdrawal by Subject|45
7641356|NCT01986881|12056036|FG000|Overall Study|Subject Moved|0
7641357|NCT01986881|12056037|FG001|Overall Study|Subject Moved|1
7641358|NCT01986881|12056038|FG002|Overall Study|Subject Moved|0
7641359|NCT01986881|12056036|FG000|Overall Study|Other|1
7641360|NCT01986881|12056037|FG001|Overall Study|Other|2
7641361|NCT01986881|12056038|FG002|Overall Study|Other|2
7641362|NCT01982955|12056074|FG000|Overall Study|Randomized but not treated|0
7641363|NCT01982955|12056075|FG001|Overall Study|Randomized but not treated|0
7641364|NCT01982955|12056076|FG002|Overall Study|Randomized but not treated|0
7641365|NCT01982955|12056077|FG003|Overall Study|Randomized but not treated|1
7641366|NCT01982955|12056078|FG004|Overall Study|Randomized but not treated|0
7641367|NCT01982955|12056074|FG000|Overall Study|Ongoing|0
7641368|NCT01982955|12056075|FG001|Overall Study|Ongoing|0
7641369|NCT01982955|12056076|FG002|Overall Study|Ongoing|4
7641370|NCT01982955|12056077|FG003|Overall Study|Ongoing|0
7641371|NCT01982955|12056078|FG004|Overall Study|Ongoing|0
7641372|NCT01979536|12056097|FG000|Overall Study|Physician Decision|2
7641373|NCT01979536|12056098|FG001|Overall Study|Physician Decision|3
7641374|NCT01979536|12056097|FG000|Overall Study|Withdrawal by Subject|0
7641375|NCT01979536|12056098|FG001|Overall Study|Withdrawal by Subject|1
7641376|NCT01979536|12056097|FG000|Overall Study|Refusal|0
7641377|NCT01979536|12056098|FG001|Overall Study|Refusal|1
7641378|NCT01979536|12056097|FG000|Overall Study|Relapse|0
7641379|NCT01979536|12056098|FG001|Overall Study|Relapse|1
7641380|NCT01979536|12056097|FG000|Overall Study|Study terminated by Sponsor|0
7641381|NCT01979536|12056098|FG001|Overall Study|Study terminated by Sponsor|1
7641382|NCT01979536|12056097|FG000|Overall Study|Did not start treatment|0
7641383|NCT01979536|12056098|FG001|Overall Study|Did not start treatment|1
7641384|NCT01975272|12056124|FG000|Overall Study|Excluded after protocol amendment|1
7641385|NCT01975272|12056125|FG001|Overall Study|Excluded after protocol amendment|1
7641386|NCT01975272|12056126|FG002|Overall Study|Excluded after protocol amendment|2
7641387|NCT01972308|12056136|FG000|Overall Study|Withdrawal by Subject|0
7641388|NCT01972308|12056137|FG001|Overall Study|Withdrawal by Subject|1
7641389|NCT01972308|12056136|FG000|Overall Study|Lost to Follow-up|4
7641390|NCT01972308|12056137|FG001|Overall Study|Lost to Follow-up|6
7641391|NCT01972308|12056136|FG000|Overall Study|Death|4
7641392|NCT01972308|12056137|FG001|Overall Study|Death|1
7641393|NCT01970501|12056147|FG000|Overall Study|Discontinuation of study by sponsor|16
7641394|NCT01970501|12056148|FG001|Overall Study|Discontinuation of study by sponsor|14
7641395|NCT01970501|12056147|FG000|Overall Study|Withdrawal by Subject|6
7641396|NCT01970501|12056148|FG001|Overall Study|Withdrawal by Subject|7
7641397|NCT01970501|12056147|FG000|Overall Study|Adverse Event|2
7641398|NCT01970501|12056148|FG001|Overall Study|Adverse Event|4
7641399|NCT01970501|12056147|FG000|Overall Study|Death|1
7641400|NCT01970501|12056148|FG001|Overall Study|Death|3
7641401|NCT01970501|12056147|FG000|Overall Study|Physician Decision|2
7641402|NCT01970501|12056148|FG001|Overall Study|Physician Decision|0
7641403|NCT01958021|12056156|FG000|Overall Study|Progressive disease|87
7641404|NCT01958021|12056157|FG001|Overall Study|Progressive disease|146
7641405|NCT01958021|12056156|FG000|Overall Study|Adverse Event|25
7641406|NCT01958021|12056157|FG001|Overall Study|Adverse Event|7
7641407|NCT01958021|12056156|FG000|Overall Study|Subject/guardian decision|12
7641408|NCT01958021|12056157|FG001|Overall Study|Subject/guardian decision|13
7641409|NCT01958021|12056156|FG000|Overall Study|Physician Decision|10
7641410|NCT01958021|12056157|FG001|Overall Study|Physician Decision|13
7641411|NCT01958021|12056156|FG000|Overall Study|Protocol Violation|3
7641412|NCT01958021|12056157|FG001|Overall Study|Protocol Violation|1
7641413|NCT01958021|12056156|FG000|Overall Study|Death|2
7641414|NCT01958021|12056157|FG001|Overall Study|Death|0
7641415|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
7641416|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
7641417|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
7641418|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
7641419|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
7641420|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
7641421|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
7641422|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Sponsor Decision|6
7641423|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Sponsor Decision|0
7641424|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Sponsor Decision|5
7641425|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Sponsor Decision|2
7641426|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Sponsor Decision|0
7641427|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Sponsor Decision|0
7641428|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Sponsor Decision|0
7641429|NCT01952574|12056167|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
7641430|NCT01952574|12056168|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
7641431|NCT01952574|12056169|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
7641432|NCT01952574|12056170|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
7641433|NCT01952574|12056171|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
7641434|NCT01952574|12056172|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
7641435|NCT01952574|12056173|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
7641436|NCT01952574|12056167|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
7641437|NCT01952574|12056168|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
7641438|NCT01952574|12056169|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
7641439|NCT01952574|12056170|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
7641440|NCT01952574|12056171|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
7641441|NCT01952574|12056172|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
7641442|NCT01952574|12056173|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
7641443|NCT01952574|12056167|FG000|Open-label Treatment Phase|Decision by Sponsor|0
7641444|NCT01952574|12056168|FG001|Open-label Treatment Phase|Decision by Sponsor|0
7641445|NCT01952574|12056169|FG002|Open-label Treatment Phase|Decision by Sponsor|0
7641446|NCT01952574|12056170|FG003|Open-label Treatment Phase|Decision by Sponsor|0
7641447|NCT01952574|12056171|FG004|Open-label Treatment Phase|Decision by Sponsor|17
7641448|NCT01952574|12056172|FG005|Open-label Treatment Phase|Decision by Sponsor|0
7641449|NCT01952574|12056173|FG006|Open-label Treatment Phase|Decision by Sponsor|0
7641450|NCT01952574|12056167|FG000|Open-label Treatment Phase|Missing|0
7641451|NCT01952574|12056168|FG001|Open-label Treatment Phase|Missing|0
7641452|NCT01952574|12056169|FG002|Open-label Treatment Phase|Missing|0
7641453|NCT01952574|12056170|FG003|Open-label Treatment Phase|Missing|0
7641454|NCT01952574|12056171|FG004|Open-label Treatment Phase|Missing|4
7641455|NCT01952574|12056172|FG005|Open-label Treatment Phase|Missing|0
7641456|NCT01952574|12056173|FG006|Open-label Treatment Phase|Missing|0
7641457|NCT01952574|12056167|FG000|Open-label Treatment Phase|Lost to Follow-up|0
7641458|NCT01952574|12056168|FG001|Open-label Treatment Phase|Lost to Follow-up|0
7641459|NCT01952574|12056169|FG002|Open-label Treatment Phase|Lost to Follow-up|0
7641460|NCT01952574|12056170|FG003|Open-label Treatment Phase|Lost to Follow-up|0
7641461|NCT01952574|12056171|FG004|Open-label Treatment Phase|Lost to Follow-up|19
7641462|NCT01952574|12056172|FG005|Open-label Treatment Phase|Lost to Follow-up|0
7641463|NCT01952574|12056173|FG006|Open-label Treatment Phase|Lost to Follow-up|0
7641464|NCT01952574|12056167|FG000|Open-label Treatment Phase|Death|0
7641465|NCT01952574|12056168|FG001|Open-label Treatment Phase|Death|0
7641466|NCT01952574|12056169|FG002|Open-label Treatment Phase|Death|0
7641467|NCT01952574|12056170|FG003|Open-label Treatment Phase|Death|0
7641468|NCT01952574|12056171|FG004|Open-label Treatment Phase|Death|1
7641469|NCT01952574|12056172|FG005|Open-label Treatment Phase|Death|0
7641470|NCT01952574|12056173|FG006|Open-label Treatment Phase|Death|0
7641471|NCT01952574|12056167|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
7641472|NCT01952574|12056168|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
7641473|NCT01952574|12056169|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
7641474|NCT01952574|12056170|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
7641475|NCT01952574|12056171|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
7641476|NCT01952574|12056172|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
7641477|NCT01952574|12056173|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
7641478|NCT01952574|12056167|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
7641479|NCT01952574|12056168|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
7641480|NCT01952574|12056169|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
7641481|NCT01952574|12056170|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
7641482|NCT01952574|12056171|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
7641483|NCT01952574|12056172|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
7641484|NCT01952574|12056173|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
7641485|NCT01951417|12056198|FG000|Overall Study|Withdrawal by Subject|1
7641486|NCT01951417|12056198|FG000|Overall Study|Protocol Violation|2
7641487|NCT01951417|12056198|FG000|Overall Study|Lost to Follow-up|6
7641488|NCT01949662|12056208|FG000|Overall Study|Death|9
7641489|NCT01949662|12056209|FG001|Overall Study|Death|7
7641490|NCT01949662|12056208|FG000|Overall Study|Discharged before an agitation event|8
7641491|NCT01949662|12056209|FG001|Overall Study|Discharged before an agitation event|3
7641492|NCT01949662|12056208|FG000|Overall Study|Dropped out|1
7641493|NCT01949662|12056209|FG001|Overall Study|Dropped out|3
7641494|NCT01949662|12056208|FG000|Overall Study|Ineligible|0
7641495|NCT01949662|12056209|FG001|Overall Study|Ineligible|1
7641496|NCT01946529|12056227|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
7641497|NCT01946529|12056228|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
7641498|NCT01946529|12056229|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
7641499|NCT01946529|12056227|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
7641500|NCT01946529|12056228|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
7641501|NCT01946529|12056229|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
7641502|NCT01946204|12056238|FG000|Overall Study|Death|38
7641503|NCT01946204|12056239|FG001|Overall Study|Death|59
7641504|NCT01946204|12056238|FG000|Overall Study|Withdrawal by Subject|37
7641505|NCT01946204|12056239|FG001|Overall Study|Withdrawal by Subject|50
7641506|NCT01946204|12056238|FG000|Overall Study|Lost to Follow-up|3
7641507|NCT01946204|12056239|FG001|Overall Study|Lost to Follow-up|7
7641508|NCT01946204|12056238|FG000|Overall Study|Ongoing|316
7641509|NCT01946204|12056239|FG001|Overall Study|Ongoing|687
7641510|NCT01946204|12056238|FG000|Overall Study|Other|7
7641511|NCT01946204|12056239|FG001|Overall Study|Other|3
7641512|NCT01942135|12056256|FG000|Overall Study|Adverse Event|9
7641513|NCT01942135|12056257|FG001|Overall Study|Adverse Event|3
7641514|NCT01942135|12056256|FG000|Overall Study|Global deterioration of health status|8
7641515|NCT01942135|12056257|FG001|Overall Study|Global deterioration of health status|3
7641516|NCT01942135|12056256|FG000|Overall Study|Randomized Not Treated|2
7641517|NCT01942135|12056257|FG001|Overall Study|Randomized Not Treated|2
7641518|NCT01942135|12056256|FG000|Overall Study|Death|0
7641519|NCT01942135|12056257|FG001|Overall Study|Death|1
7641520|NCT01942135|12056256|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
7641521|NCT01942135|12056257|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
7641522|NCT01942135|12056256|FG000|Overall Study|Participant Refused toContinue Treatment|1
7641523|NCT01942135|12056257|FG001|Overall Study|Participant Refused toContinue Treatment|1
7641524|NCT01942135|12056256|FG000|Overall Study|Withdrawal by Subject|4
7641525|NCT01942135|12056257|FG001|Overall Study|Withdrawal by Subject|2
7641526|NCT01942135|12056256|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
7641527|NCT01942135|12056257|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
7641528|NCT01940471|12056265|FG000|Double-Blind Phase|Randomized but Never Treated|1
7641529|NCT01940471|12056266|FG001|Double-Blind Phase|Randomized but Never Treated|1
7641530|NCT01940471|12056265|FG000|Double-Blind Phase|Withdrew Consent|13
7641531|NCT01940471|12056266|FG001|Double-Blind Phase|Withdrew Consent|7
7641532|NCT01940471|12056265|FG000|Double-Blind Phase|Adverse Event|1
7641533|NCT01940471|12056266|FG001|Double-Blind Phase|Adverse Event|2
7641534|NCT01940471|12056265|FG000|Double-Blind Phase|Lost to Follow-up|3
7641535|NCT01940471|12056266|FG001|Double-Blind Phase|Lost to Follow-up|2
7641536|NCT01940471|12056265|FG000|Double-Blind Phase|Pregnancy|2
7641537|NCT01940471|12056266|FG001|Double-Blind Phase|Pregnancy|1
7641538|NCT01940471|12056265|FG000|Double-Blind Phase|Investigator's Discretion|5
7641539|NCT01940471|12056266|FG001|Double-Blind Phase|Investigator's Discretion|0
7641540|NCT01940471|12056265|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
7641541|NCT01940471|12056266|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
7641542|NCT01940471|12056265|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
7641543|NCT01940471|12056266|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
7641544|NCT01940471|12056265|FG000|Double-Blind Phase|Death|1
7641545|NCT01940471|12056266|FG001|Double-Blind Phase|Death|0
7641546|NCT01940471|12056265|FG000|Double-Blind Phase|Lack of Efficacy|1
7641547|NCT01940471|12056266|FG001|Double-Blind Phase|Lack of Efficacy|0
7641548|NCT01940471|12056265|FG000|Double-Blind Phase|Protocol Violation|0
7641549|NCT01940471|12056266|FG001|Double-Blind Phase|Protocol Violation|1
7641550|NCT01940471|12056265|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
7641551|NCT01940471|12056266|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
7641552|NCT01940471|12056265|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
7641553|NCT01940471|12056266|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
7641554|NCT01933932|12056287|FG000|Overall Study|Death|173
7641555|NCT01933932|12056288|FG001|Overall Study|Death|163
7641556|NCT01933932|12056287|FG000|Overall Study|Withdrawal by Subject|11
7641557|NCT01933932|12056288|FG001|Overall Study|Withdrawal by Subject|14
7641558|NCT01933932|12056287|FG000|Overall Study|Eligibility criteria not fulfilled|0
7641559|NCT01933932|12056288|FG001|Overall Study|Eligibility criteria not fulfilled|1
7641560|NCT01930123|12056296|FG000|Overall Study|Adverse Event|1
7641561|NCT01930123|12056297|FG001|Overall Study|Adverse Event|0
7641562|NCT01930123|12056296|FG000|Overall Study|Physician Decision|21
7641563|NCT01930123|12056297|FG001|Overall Study|Physician Decision|8
7641564|NCT01930123|12056296|FG000|Overall Study|Withdrawal by Subject|1
7641565|NCT01930123|12056297|FG001|Overall Study|Withdrawal by Subject|0
7641566|NCT01924533|12056305|FG000|Overall Study|Death|181
7641567|NCT01924533|12056306|FG001|Overall Study|Death|200
7641568|NCT01924533|12056305|FG000|Overall Study|Lost to Follow-up|0
7641569|NCT01924533|12056306|FG001|Overall Study|Lost to Follow-up|1
7641570|NCT01924533|12056305|FG000|Overall Study|Withdrawal by Subject|7
7641571|NCT01924533|12056306|FG001|Overall Study|Withdrawal by Subject|3
7641572|NCT01924533|12056305|FG000|Overall Study|Other Eligibility criteria|1
7641573|NCT01924533|12056306|FG001|Overall Study|Other Eligibility criteria|1
7641574|NCT01920932|12056312|FG000|Overall Study|Death|1
7641575|NCT01920932|12056312|FG000|Overall Study|Withdrawal of consent|1
7641576|NCT01920061|12056353|FG000|Overall Study|Death|1
7641577|NCT01920061|12056354|FG001|Overall Study|Death|1
7641578|NCT01920061|12056355|FG002|Overall Study|Death|0
7641579|NCT01920061|12056356|FG003|Overall Study|Death|1
7641580|NCT01920061|12056357|FG004|Overall Study|Death|1
7641581|NCT01920061|12056358|FG005|Overall Study|Death|0
7641582|NCT01920061|12056359|FG006|Overall Study|Death|0
7641583|NCT01920061|12056360|FG007|Overall Study|Death|1
7641584|NCT01920061|12056361|FG008|Overall Study|Death|0
7641585|NCT01920061|12056362|FG009|Overall Study|Death|1
7641586|NCT01920061|12056363|FG010|Overall Study|Death|0
7641587|NCT01920061|12056364|FG011|Overall Study|Death|1
7641588|NCT01920061|12056365|FG012|Overall Study|Death|0
7641589|NCT01920061|12056366|FG013|Overall Study|Death|2
7641590|NCT01920061|12056367|FG014|Overall Study|Death|0
7641591|NCT01920061|12056368|FG015|Overall Study|Death|0
7641592|NCT01920061|12056369|FG016|Overall Study|Death|0
7641593|NCT01920061|12056370|FG017|Overall Study|Death|0
7641594|NCT01920061|12056371|FG018|Overall Study|Death|1
7641595|NCT01920061|12056372|FG019|Overall Study|Death|0
7641596|NCT01920061|12056353|FG000|Overall Study|Lost to Follow-up|0
7641597|NCT01920061|12056354|FG001|Overall Study|Lost to Follow-up|2
7641598|NCT01920061|12056355|FG002|Overall Study|Lost to Follow-up|0
7641599|NCT01920061|12056356|FG003|Overall Study|Lost to Follow-up|0
7641600|NCT01920061|12056357|FG004|Overall Study|Lost to Follow-up|0
7641601|NCT01920061|12056358|FG005|Overall Study|Lost to Follow-up|0
7641602|NCT01920061|12056359|FG006|Overall Study|Lost to Follow-up|1
7641603|NCT01920061|12056360|FG007|Overall Study|Lost to Follow-up|0
7641604|NCT01920061|12056361|FG008|Overall Study|Lost to Follow-up|0
7641605|NCT01920061|12056362|FG009|Overall Study|Lost to Follow-up|0
7641606|NCT01920061|12056363|FG010|Overall Study|Lost to Follow-up|3
7641607|NCT01920061|12056364|FG011|Overall Study|Lost to Follow-up|0
7641608|NCT01920061|12056365|FG012|Overall Study|Lost to Follow-up|0
7641609|NCT01920061|12056366|FG013|Overall Study|Lost to Follow-up|0
7641610|NCT01920061|12056367|FG014|Overall Study|Lost to Follow-up|0
7641611|NCT01920061|12056368|FG015|Overall Study|Lost to Follow-up|0
7641612|NCT01920061|12056369|FG016|Overall Study|Lost to Follow-up|0
7641613|NCT01920061|12056370|FG017|Overall Study|Lost to Follow-up|1
7641614|NCT01920061|12056371|FG018|Overall Study|Lost to Follow-up|4
7641615|NCT01920061|12056372|FG019|Overall Study|Lost to Follow-up|3
7641616|NCT01920061|12056353|FG000|Overall Study|Other|1
7641617|NCT01920061|12056354|FG001|Overall Study|Other|1
7641618|NCT01920061|12056355|FG002|Overall Study|Other|2
7641619|NCT01920061|12056356|FG003|Overall Study|Other|1
7641620|NCT01920061|12056357|FG004|Overall Study|Other|0
7641621|NCT01920061|12056358|FG005|Overall Study|Other|1
7641622|NCT01920061|12056359|FG006|Overall Study|Other|0
7641623|NCT01920061|12056360|FG007|Overall Study|Other|0
7641624|NCT01920061|12056361|FG008|Overall Study|Other|0
7641625|NCT01920061|12056362|FG009|Overall Study|Other|1
7641626|NCT01920061|12056363|FG010|Overall Study|Other|1
7641627|NCT01920061|12056364|FG011|Overall Study|Other|2
7641628|NCT01920061|12056365|FG012|Overall Study|Other|1
7641629|NCT01920061|12056366|FG013|Overall Study|Other|4
7641630|NCT01920061|12056367|FG014|Overall Study|Other|0
7641631|NCT01920061|12056368|FG015|Overall Study|Other|1
7641632|NCT01920061|12056369|FG016|Overall Study|Other|1
7641633|NCT01920061|12056370|FG017|Overall Study|Other|0
7641634|NCT01920061|12056371|FG018|Overall Study|Other|1
7641635|NCT01920061|12056372|FG019|Overall Study|Other|1
7641636|NCT01920061|12056353|FG000|Overall Study|Participant refused further follow-up|0
7641637|NCT01920061|12056354|FG001|Overall Study|Participant refused further follow-up|0
7641638|NCT01920061|12056355|FG002|Overall Study|Participant refused further follow-up|0
7641639|NCT01920061|12056356|FG003|Overall Study|Participant refused further follow-up|0
7641640|NCT01920061|12056357|FG004|Overall Study|Participant refused further follow-up|1
7641641|NCT01920061|12056358|FG005|Overall Study|Participant refused further follow-up|1
7641642|NCT01920061|12056359|FG006|Overall Study|Participant refused further follow-up|0
7641643|NCT01920061|12056360|FG007|Overall Study|Participant refused further follow-up|0
7641644|NCT01920061|12056361|FG008|Overall Study|Participant refused further follow-up|1
7641645|NCT01920061|12056362|FG009|Overall Study|Participant refused further follow-up|0
7641646|NCT01920061|12056363|FG010|Overall Study|Participant refused further follow-up|1
7641647|NCT01920061|12056364|FG011|Overall Study|Participant refused further follow-up|0
7641648|NCT01920061|12056365|FG012|Overall Study|Participant refused further follow-up|1
7641649|NCT01920061|12056366|FG013|Overall Study|Participant refused further follow-up|0
7641650|NCT01920061|12056367|FG014|Overall Study|Participant refused further follow-up|1
7641651|NCT01920061|12056368|FG015|Overall Study|Participant refused further follow-up|2
7641652|NCT01920061|12056369|FG016|Overall Study|Participant refused further follow-up|1
7641653|NCT01920061|12056370|FG017|Overall Study|Participant refused further follow-up|1
7641654|NCT01920061|12056371|FG018|Overall Study|Participant refused further follow-up|0
7641655|NCT01920061|12056372|FG019|Overall Study|Participant refused further follow-up|0
7641656|NCT01910402|12056437|FG000|Randomized Phase|Adverse Event|10
7641657|NCT01910402|12056438|FG001|Randomized Phase|Adverse Event|18
7641658|NCT01910402|12056437|FG000|Randomized Phase|Physician Decision|1
7641659|NCT01910402|12056438|FG001|Randomized Phase|Physician Decision|0
7641660|NCT01910402|12056437|FG000|Randomized Phase|Lack of Efficacy|5
7641661|NCT01910402|12056438|FG001|Randomized Phase|Lack of Efficacy|4
7641662|NCT01910402|12056437|FG000|Randomized Phase|Lost to Follow-up|11
7641663|NCT01910402|12056438|FG001|Randomized Phase|Lost to Follow-up|13
7641664|NCT01910402|12056437|FG000|Randomized Phase|Protocol Violation|10
7641665|NCT01910402|12056438|FG001|Randomized Phase|Protocol Violation|13
7641666|NCT01910402|12056437|FG000|Randomized Phase|Withdrawal by Subject|5
7641667|NCT01910402|12056438|FG001|Randomized Phase|Withdrawal by Subject|7
7641668|NCT01910402|12056437|FG000|Continuation Phase|Ongoing|84
7641669|NCT01910402|12056438|FG001|Continuation Phase|Ongoing|0
7641670|NCT01910402|12056437|FG000|Continuation Phase|Adverse Event|1
7641671|NCT01910402|12056438|FG001|Continuation Phase|Adverse Event|0
7641672|NCT01910402|12056437|FG000|Continuation Phase|Protocol Violation|3
7641673|NCT01910402|12056438|FG001|Continuation Phase|Protocol Violation|0
7641674|NCT01910402|12056437|FG000|Continuation Phase|Withdrawal by Subject|2
7641675|NCT01910402|12056438|FG001|Continuation Phase|Withdrawal by Subject|0
7641676|NCT01909479|12056473|FG000|From Baseline to Week 26|Adverse Event|3
7641677|NCT01909479|12056474|FG001|From Baseline to Week 26|Adverse Event|2
7641678|NCT01909479|12056473|FG000|From Baseline to Week 26|Withdrawal by Subject|3
7641679|NCT01909479|12056474|FG001|From Baseline to Week 26|Withdrawal by Subject|6
7641680|NCT01909479|12056473|FG000|From Baseline to Week 26|Site and study closed by PI|0
7641681|NCT01909479|12056474|FG001|From Baseline to Week 26|Site and study closed by PI|1
7641682|NCT01909479|12056473|FG000|26 - 52 Weeks|Adverse Event|0
7641683|NCT01909479|12056474|FG001|26 - 52 Weeks|Adverse Event|1
7641684|NCT01909479|12056473|FG000|26 - 52 Weeks|Withdrawal by Subject|2
7641685|NCT01909479|12056474|FG001|26 - 52 Weeks|Withdrawal by Subject|1
7641686|NCT01909479|12056473|FG000|26 - 52 Weeks|Lost to Follow-up|1
7641687|NCT01909479|12056474|FG001|26 - 52 Weeks|Lost to Follow-up|0
7641688|NCT01909479|12056473|FG000|52 Weeks to End of Study|Withdrawal by Subject|18
7641689|NCT01909479|12056474|FG001|52 Weeks to End of Study|Withdrawal by Subject|8
7641690|NCT01909479|12056473|FG000|52 Weeks to End of Study|Adverse Event|2
7641691|NCT01909479|12056474|FG001|52 Weeks to End of Study|Adverse Event|1
7641692|NCT01909479|12056473|FG000|52 Weeks to End of Study|Death|0
7641693|NCT01909479|12056474|FG001|52 Weeks to End of Study|Death|1
7641694|NCT01909479|12056473|FG000|52 Weeks to End of Study|Lost to Follow-up|1
7641695|NCT01909479|12056474|FG001|52 Weeks to End of Study|Lost to Follow-up|0
7641696|NCT01909479|12056473|FG000|52 Weeks to End of Study|Protocol Violation|1
7641697|NCT01909479|12056474|FG001|52 Weeks to End of Study|Protocol Violation|0
7641698|NCT01909479|12056473|FG000|52 Weeks to End of Study|Progressive disease|1
7641699|NCT01909479|12056474|FG001|52 Weeks to End of Study|Progressive disease|1
7641700|NCT01909479|12056473|FG000|52 Weeks to End of Study|Personal reasons|2
7641701|NCT01909479|12056474|FG001|52 Weeks to End of Study|Personal reasons|1
7641702|NCT01909479|12056473|FG000|52 Weeks to End of Study|Sponsor's decision|1
7641703|NCT01909479|12056474|FG001|52 Weeks to End of Study|Sponsor's decision|1
7641704|NCT01909479|12056473|FG000|52 Weeks to End of Study|Study termination by sponsor|0
7641705|NCT01909479|12056474|FG001|52 Weeks to End of Study|Study termination by sponsor|1
7641706|NCT01909479|12056473|FG000|52 Weeks to End of Study|Lack of contact|1
7641707|NCT01909479|12056474|FG001|52 Weeks to End of Study|Lack of contact|0
7641708|NCT01909479|12056473|FG000|52 Weeks to End of Study|Occurrence of malignancy|1
7641709|NCT01909479|12056474|FG001|52 Weeks to End of Study|Occurrence of malignancy|0
7641710|NCT01909479|12056473|FG000|52 Weeks to End of Study|Diabetes not controlled|0
7641711|NCT01909479|12056474|FG001|52 Weeks to End of Study|Diabetes not controlled|1
7641712|NCT01909453|12056489|FG000|Overall Study|Ongoing|118
7641713|NCT01909453|12056490|FG001|Overall Study|Ongoing|103
7641714|NCT01909453|12056491|FG002|Overall Study|Ongoing|83
7641715|NCT01909453|12056492|FG003|Overall Study|Ongoing|164
7641716|NCT01909453|12056493|FG004|Overall Study|Ongoing|50
7641717|NCT01909453|12056489|FG000|Overall Study|Death|69
7641718|NCT01909453|12056490|FG001|Overall Study|Death|74
7641719|NCT01909453|12056491|FG002|Overall Study|Death|88
7641720|NCT01909453|12056492|FG003|Overall Study|Death|86
7641721|NCT01909453|12056493|FG004|Overall Study|Death|29
7641722|NCT01909453|12056489|FG000|Overall Study|Lost to Follow-up|3
7641723|NCT01909453|12056490|FG001|Overall Study|Lost to Follow-up|4
7641724|NCT01909453|12056491|FG002|Overall Study|Lost to Follow-up|4
7641725|NCT01909453|12056492|FG003|Overall Study|Lost to Follow-up|3
7641726|NCT01909453|12056493|FG004|Overall Study|Lost to Follow-up|3
7641727|NCT01909453|12056489|FG000|Overall Study|Withdrawal by Subject|2
7641728|NCT01909453|12056490|FG001|Overall Study|Withdrawal by Subject|13
7641729|NCT01909453|12056491|FG002|Overall Study|Withdrawal by Subject|16
7641730|NCT01909453|12056492|FG003|Overall Study|Withdrawal by Subject|5
7641731|NCT01909453|12056493|FG004|Overall Study|Withdrawal by Subject|4
7641732|NCT01902290|12056524|FG000|Overall Study|Withdrawal by Subject|19
7641733|NCT01902290|12056525|FG001|Overall Study|Withdrawal by Subject|27
7641734|NCT01902290|12056524|FG000|Overall Study|Lost to Follow-up|2
7641735|NCT01902290|12056525|FG001|Overall Study|Lost to Follow-up|2
7641736|NCT01902290|12056524|FG000|Overall Study|Death|1
7641737|NCT01902290|12056525|FG001|Overall Study|Death|0
7641738|NCT01902290|12056524|FG000|Overall Study|Sponsor Decision|26
7641739|NCT01902290|12056525|FG001|Overall Study|Sponsor Decision|24
7641740|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
7641741|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641742|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641743|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641744|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641745|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
7641746|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
7641747|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641748|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641749|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641750|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641751|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
7641752|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641753|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
7641754|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641755|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641756|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641757|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
7641758|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641759|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
7641760|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641761|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641762|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641763|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
7641764|NCT01902173|12056538|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641765|NCT01902173|12056539|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
7641766|NCT01902173|12056540|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641767|NCT01902173|12056541|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641768|NCT01902173|12056542|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641769|NCT01902173|12056543|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
7641770|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641771|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641772|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
7641773|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641774|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641775|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
7641776|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641777|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641778|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
7641779|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641780|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641781|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
7641782|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641783|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641784|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641785|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
7641786|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641787|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
7641788|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641789|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641790|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641791|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
7641792|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641793|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
7641794|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641795|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641796|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641797|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641798|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
7641799|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
7641800|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641801|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641802|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641803|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641804|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
7641805|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
7641806|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641807|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641808|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641809|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641810|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
7641811|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
7641812|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641813|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641814|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641815|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641816|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
7641817|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
7641818|NCT01902173|12056538|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
7641819|NCT01902173|12056539|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
7641820|NCT01902173|12056540|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
7641821|NCT01902173|12056541|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
7641822|NCT01902173|12056542|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
7641823|NCT01902173|12056543|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
7641824|NCT01900691|12056560|FG000|Overall Study|Death|7
7641825|NCT01900691|12056560|FG000|Overall Study|Lost to Follow-up|4
7641826|NCT01900691|12056560|FG000|Overall Study|Study Device Not Placed|3
7641827|NCT01900691|12056560|FG000|Overall Study|Non study stent placed|2
7641828|NCT01900691|12056560|FG000|Overall Study|Six month Follow up completed, stent not removed|2
7641829|NCT01900691|12056560|FG000|Overall Study|Complete stent migration through digestive tract|1
7641830|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641831|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641832|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641833|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0
7641834|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2
7641835|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641836|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641837|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641838|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0
7641839|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1
7641840|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641841|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641842|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641843|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0
7641844|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7
7641845|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641846|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641847|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641848|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0
7641849|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9
7641850|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641851|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641852|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641853|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0
7641854|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2
7641855|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0
7641856|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0
7641857|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0
7641858|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0
7641859|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1
7641860|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641861|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641862|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641863|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0
7641864|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1
7641865|NCT01898494|12056569|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641866|NCT01898494|12056570|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641867|NCT01898494|12056571|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641868|NCT01898494|12056572|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0
7641869|NCT01898494|12056573|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1
7641870|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641871|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641872|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2
7641873|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3
7641874|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0
7641875|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641876|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641877|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6
7641878|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3
7641879|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0
7641880|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Death|0
7641881|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Death|0
7641882|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Death|0
7641883|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Death|1
7641884|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Death|0
7641885|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641886|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1
7641887|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641888|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641889|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0
7641890|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641891|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641892|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1
7641893|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641894|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0
7641895|NCT01898494|12056569|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0
7641896|NCT01898494|12056570|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6
7641897|NCT01898494|12056571|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5
7641898|NCT01898494|12056572|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4
7641899|NCT01898494|12056573|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0
7641900|NCT01892722|12056591|FG000|Overall Study|Protocol deviation|0
7641901|NCT01892722|12056592|FG001|Overall Study|Protocol deviation|1
7641902|NCT01892722|12056591|FG000|Overall Study|Administrative problems|0
7641903|NCT01892722|12056592|FG001|Overall Study|Administrative problems|1
7641904|NCT01892722|12056591|FG000|Overall Study|Patient/guardian decision|0
7641905|NCT01892722|12056592|FG001|Overall Study|Patient/guardian decision|2
7641906|NCT01892722|12056591|FG000|Overall Study|Physician Decision|1
7641907|NCT01892722|12056592|FG001|Overall Study|Physician Decision|2
7641908|NCT01892722|12056591|FG000|Overall Study|Adverse Event|3
7641909|NCT01892722|12056592|FG001|Overall Study|Adverse Event|2
7641910|NCT01892722|12056591|FG000|Overall Study|Lack of Efficacy|0
7641911|NCT01892722|12056592|FG001|Overall Study|Lack of Efficacy|7
7641912|NCT01892722|12056591|FG000|Overall Study|Withdrawal by Subject|3
7641913|NCT01892722|12056592|FG001|Overall Study|Withdrawal by Subject|5
7641914|NCT01892657|12056598|FG000|Overall Study|Withdrawal by Subject|6
7641915|NCT01892657|12056598|FG000|Overall Study|Protocol Violation|12
7641916|NCT01886872|12056626|FG000|Overall Study|Ineligible|7
7641917|NCT01886872|12056627|FG001|Overall Study|Ineligible|4
7641918|NCT01886872|12056628|FG002|Overall Study|Ineligible|12
7641919|NCT01872715|12056653|FG000|Overall Study|Adverse Event|1
7641920|NCT01872715|12056653|FG000|Overall Study|Protocol Violation|1
7641921|NCT01872715|12056653|FG000|Overall Study|Withdrawal by Subject|2
7641922|NCT01867580|12056669|FG000|Overall Study|Withdrawal by Subject|2
7641923|NCT01867580|12056670|FG001|Overall Study|Withdrawal by Subject|3
7641924|NCT01867580|12056669|FG000|Overall Study|Physician Decision|17
7641925|NCT01867580|12056670|FG001|Overall Study|Physician Decision|12
7641926|NCT01867580|12056669|FG000|Overall Study|Lost to Follow-up|3
7641927|NCT01867580|12056670|FG001|Overall Study|Lost to Follow-up|5
7641928|NCT01867580|12056669|FG000|Overall Study|Sponsor terminated study|1
7641929|NCT01867580|12056670|FG001|Overall Study|Sponsor terminated study|0
7641930|NCT01867580|12056669|FG000|Overall Study|Missed follow-up assessment|2
7641931|NCT01867580|12056670|FG001|Overall Study|Missed follow-up assessment|1
7641932|NCT01867580|12056669|FG000|Overall Study|Interruption to therapy|3
7641933|NCT01867580|12056670|FG001|Overall Study|Interruption to therapy|0
7641934|NCT01867580|12056669|FG000|Overall Study|Osteomyelitis|0
7641935|NCT01867580|12056670|FG001|Overall Study|Osteomyelitis|1
7641936|NCT01867580|12056669|FG000|Overall Study|Continuation of therapy|0
7641937|NCT01867580|12056670|FG001|Overall Study|Continuation of therapy|1
7641938|NCT01867580|12056669|FG000|Overall Study|Wound recurrence|0
7641939|NCT01867580|12056670|FG001|Overall Study|Wound recurrence|1
7641940|NCT01865812|12056676|FG000|Primary Treatment Phase|Adverse Event|2
7641941|NCT01865812|12056677|FG001|Primary Treatment Phase|Adverse Event|0
7641942|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0
7641943|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1
7641944|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Pruritus|0
7641945|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Pruritus|3
7641946|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Physician Decision|0
7641947|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Physician Decision|1
7641948|NCT01865812|12056676|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0
7641949|NCT01865812|12056677|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1
7641950|NCT01864018|12056686|FG000|Overall Study|Ineligible|3
7641951|NCT01864018|12056687|FG001|Overall Study|Ineligible|1
7641952|NCT01856192|12056700|FG000|Overall Study|Adverse Event|12
7641953|NCT01856192|12056701|FG001|Overall Study|Adverse Event|4
7641954|NCT01856192|12056700|FG000|Overall Study|Alternative therapy|0
7641955|NCT01856192|12056701|FG001|Overall Study|Alternative therapy|3
7641956|NCT01856192|12056700|FG000|Overall Study|Death|3
7641957|NCT01856192|12056701|FG001|Overall Study|Death|5
7641958|NCT01856192|12056700|FG000|Overall Study|Lack of Efficacy|0
7641959|NCT01856192|12056701|FG001|Overall Study|Lack of Efficacy|5
7641960|NCT01856192|12056700|FG000|Overall Study|Withdrawal by Subject|1
7641961|NCT01856192|12056701|FG001|Overall Study|Withdrawal by Subject|1
7641962|NCT01856192|12056700|FG000|Overall Study|Other diseases|1
7641963|NCT01856192|12056701|FG001|Overall Study|Other diseases|0
7641964|NCT01856192|12056700|FG000|Overall Study|Never started treatment|7
7641965|NCT01856192|12056701|FG001|Overall Study|Never started treatment|5
7641966|NCT01856192|12056700|FG000|Overall Study|Path ineligible|20
7641967|NCT01856192|12056701|FG001|Overall Study|Path ineligible|34
7641968|NCT01856192|12056700|FG000|Overall Study|Non-path ineligible|2
7641969|NCT01856192|12056701|FG001|Overall Study|Non-path ineligible|2
7641970|NCT01856192|12056700|FG000|Overall Study|Physician Decision|1
7641971|NCT01856192|12056701|FG001|Overall Study|Physician Decision|1
7641972|NCT01856192|12056700|FG000|Overall Study|Suspicion of progressive disease|1
7641973|NCT01856192|12056701|FG001|Overall Study|Suspicion of progressive disease|0
7641974|NCT01856192|12056700|FG000|Overall Study|Non-compliance|1
7641975|NCT01856192|12056701|FG001|Overall Study|Non-compliance|0
7641976|NCT01850524|12056743|FG000|Overall Study|Ongoing on Treatment|57
7641977|NCT01850524|12056744|FG001|Overall Study|Ongoing on Treatment|54
7641978|NCT01850524|12056743|FG000|Overall Study|Adverse Event|96
7641979|NCT01850524|12056744|FG001|Overall Study|Adverse Event|122
7641980|NCT01850524|12056743|FG000|Overall Study|Lost to Follow-up|2
7641981|NCT01850524|12056744|FG001|Overall Study|Lost to Follow-up|0
7641982|NCT01850524|12056743|FG000|Overall Study|Progressive Disease|166
7641983|NCT01850524|12056744|FG001|Overall Study|Progressive Disease|123
7641984|NCT01850524|12056743|FG000|Overall Study|Protocol Violation|1
7641985|NCT01850524|12056744|FG001|Overall Study|Protocol Violation|2
7641986|NCT01850524|12056743|FG000|Overall Study|Withdrawal by Subject|8
7641987|NCT01850524|12056744|FG001|Overall Study|Withdrawal by Subject|19
7641988|NCT01850524|12056743|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
7641989|NCT01850524|12056744|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
7641990|NCT01850524|12056743|FG000|Overall Study|Investigator Decision|4
7641991|NCT01850524|12056744|FG001|Overall Study|Investigator Decision|4
7641992|NCT01850524|12056743|FG000|Overall Study|Participants Removed From Study|0
7641993|NCT01850524|12056744|FG001|Overall Study|Participants Removed From Study|1
7641994|NCT01850524|12056743|FG000|Overall Study|Medical Monitor Decision|0
7641995|NCT01850524|12056744|FG001|Overall Study|Medical Monitor Decision|1
7641996|NCT01850524|12056743|FG000|Overall Study|Participants Decision|2
7641997|NCT01850524|12056744|FG001|Overall Study|Participants Decision|2
7641998|NCT01850524|12056743|FG000|Overall Study|Progressive Disease Per Local Lab|1
7641999|NCT01850524|12056744|FG001|Overall Study|Progressive Disease Per Local Lab|0
7642000|NCT01850524|12056743|FG000|Overall Study|Lack of Improvement|0
7642001|NCT01850524|12056744|FG001|Overall Study|Lack of Improvement|1
7642002|NCT01850524|12056743|FG000|Overall Study|Minimal Response|1
7642003|NCT01850524|12056744|FG001|Overall Study|Minimal Response|0
7642004|NCT01850524|12056743|FG000|Overall Study|Comorbidities|1
7642005|NCT01850524|12056744|FG001|Overall Study|Comorbidities|0
7642006|NCT01844986|12056769|FG000|Overall Study|Severe non-compliance to protocol|1
7642007|NCT01844986|12056770|FG001|Overall Study|Severe non-compliance to protocol|0
7642008|NCT01844986|12056769|FG000|Overall Study|Withdrawal by Subject|21
7642009|NCT01844986|12056770|FG001|Overall Study|Withdrawal by Subject|14
7642010|NCT01844986|12056769|FG000|Overall Study|Death|55
7642011|NCT01844986|12056770|FG001|Overall Study|Death|26
7642012|NCT01844518|12056778|FG000|Overall Study|Adverse Event|7
7642013|NCT01844518|12056779|FG001|Overall Study|Adverse Event|1
7642014|NCT01844518|12056778|FG000|Overall Study|Lack of Efficacy|17
7642015|NCT01844518|12056779|FG001|Overall Study|Lack of Efficacy|5
7642016|NCT01844518|12056778|FG000|Overall Study|Participant's request to discontinue|4
7642017|NCT01844518|12056779|FG001|Overall Study|Participant's request to discontinue|1
7642018|NCT01844518|12056778|FG000|Overall Study|Poor/Non-compliance|1
7642019|NCT01844518|12056779|FG001|Overall Study|Poor/Non-compliance|0
7642020|NCT01844518|12056778|FG000|Overall Study|No Longer Met Study Criteria|2
7642021|NCT01844518|12056779|FG001|Overall Study|No Longer Met Study Criteria|0
7642022|NCT01844518|12056778|FG000|Overall Study|Withdrawal by Subject|9
7642023|NCT01844518|12056779|FG001|Overall Study|Withdrawal by Subject|0
7642024|NCT01844518|12056778|FG000|Overall Study|Pregnancy|1
7642025|NCT01844518|12056779|FG001|Overall Study|Pregnancy|0
7642026|NCT01843374|12056790|FG000|Overall Study|Death|155
7642027|NCT01843374|12056791|FG001|Overall Study|Death|313
7642028|NCT01843374|12056790|FG000|Overall Study|Withdrawal by Subject|14
7642029|NCT01843374|12056791|FG001|Overall Study|Withdrawal by Subject|20
7642030|NCT01843374|12056790|FG000|Overall Study|Withdrawing due to Other reason|20
7642031|NCT01843374|12056791|FG001|Overall Study|Withdrawing due to Other reason|46
7642032|NCT01835145|12056830|FG000|Overall Study|Ineligible prior to treatment|1
7642033|NCT01835145|12056831|FG001|Overall Study|Ineligible prior to treatment|0
7642034|NCT01831596|12056839|FG000|Overall Study|Other|8
7642035|NCT01828099|12056845|FG000|Overall Study|Adverse Event|15
7642036|NCT01828099|12056846|FG001|Overall Study|Adverse Event|18
7642037|NCT01828099|12056845|FG000|Overall Study|Death|9
7642038|NCT01828099|12056846|FG001|Overall Study|Death|11
7642039|NCT01828099|12056845|FG000|Overall Study|Lost to Follow-up|2
7642040|NCT01828099|12056846|FG001|Overall Study|Lost to Follow-up|0
7642041|NCT01828099|12056845|FG000|Overall Study|Non-compliance with study treatment|2
7642042|NCT01828099|12056846|FG001|Overall Study|Non-compliance with study treatment|0
7642043|NCT01828099|12056845|FG000|Overall Study|Physician Decision|7
7642044|NCT01828099|12056846|FG001|Overall Study|Physician Decision|11
7642045|NCT01828099|12056845|FG000|Overall Study|Progressive disease|51
7642046|NCT01828099|12056846|FG001|Overall Study|Progressive disease|94
7642047|NCT01828099|12056845|FG000|Overall Study|Protocol Violation|1
7642048|NCT01828099|12056846|FG001|Overall Study|Protocol Violation|0
7642049|NCT01828099|12056845|FG000|Overall Study|Subject/guardian decision|7
7642050|NCT01828099|12056846|FG001|Overall Study|Subject/guardian decision|23
7642051|NCT01809691|12056863|FG000|Overall Study|Currently on Treatment|192
7642052|NCT01809691|12056864|FG001|Overall Study|Currently on Treatment|100
7642053|NCT01809691|12056863|FG000|Overall Study|No Protocol Treatment|10
7642054|NCT01809691|12056864|FG001|Overall Study|No Protocol Treatment|11
7642055|NCT01809691|12056863|FG000|Overall Study|Adverse Event|80
7642056|NCT01809691|12056864|FG001|Overall Study|Adverse Event|21
7642057|NCT01809691|12056863|FG000|Overall Study|Disease Progression|226
7642058|NCT01809691|12056864|FG001|Overall Study|Disease Progression|372
7642059|NCT01809691|12056863|FG000|Overall Study|Death|26
7642060|NCT01809691|12056864|FG001|Overall Study|Death|13
7642061|NCT01809691|12056863|FG000|Overall Study|Participant Refusal|70
7642062|NCT01809691|12056864|FG001|Overall Study|Participant Refusal|72
7642063|NCT01809691|12056863|FG000|Overall Study|Other, Not Specified|34
7642064|NCT01809691|12056864|FG001|Overall Study|Other, Not Specified|52
7642065|NCT01802632|12056880|FG000|Overall Study|Death|28
7642066|NCT01802632|12056881|FG001|Overall Study|Death|1
7642067|NCT01802632|12056882|FG002|Overall Study|Death|38
7642068|NCT01802632|12056883|FG003|Overall Study|Death|0
7642069|NCT01802632|12056884|FG004|Overall Study|Death|2
7642070|NCT01802632|12056885|FG005|Overall Study|Death|0
7642071|NCT01802632|12056880|FG000|Overall Study|Withdrawal by Subject|4
7642072|NCT01802632|12056881|FG001|Overall Study|Withdrawal by Subject|2
7642073|NCT01802632|12056882|FG002|Overall Study|Withdrawal by Subject|7
7642074|NCT01802632|12056883|FG003|Overall Study|Withdrawal by Subject|3
7642075|NCT01802632|12056884|FG004|Overall Study|Withdrawal by Subject|0
7642076|NCT01802632|12056885|FG005|Overall Study|Withdrawal by Subject|1
7642077|NCT01802632|12056880|FG000|Overall Study|Objective Disease Progression|1
7642078|NCT01802632|12056881|FG001|Overall Study|Objective Disease Progression|12
7642079|NCT01802632|12056882|FG002|Overall Study|Objective Disease Progression|104
7642080|NCT01802632|12056883|FG003|Overall Study|Objective Disease Progression|6
7642081|NCT01802632|12056884|FG004|Overall Study|Objective Disease Progression|4
7642082|NCT01802632|12056885|FG005|Overall Study|Objective Disease Progression|4
7642083|NCT01802632|12056880|FG000|Overall Study|Ongoing Study at Data Cut-off|168
7642084|NCT01802632|12056881|FG001|Overall Study|Ongoing Study at Data Cut-off|16
7642085|NCT01802632|12056882|FG002|Overall Study|Ongoing Study at Data Cut-off|115
7642086|NCT01802632|12056883|FG003|Overall Study|Ongoing Study at Data Cut-off|50
7642087|NCT01802632|12056884|FG004|Overall Study|Ongoing Study at Data Cut-off|6
7642088|NCT01802632|12056885|FG005|Overall Study|Ongoing Study at Data Cut-off|22
7642089|NCT01802632|12056880|FG000|Overall Study|Other (not specified)|0
7642090|NCT01802632|12056881|FG001|Overall Study|Other (not specified)|0
7642091|NCT01802632|12056882|FG002|Overall Study|Other (not specified)|7
7642092|NCT01802632|12056883|FG003|Overall Study|Other (not specified)|1
7642093|NCT01802632|12056884|FG004|Overall Study|Other (not specified)|0
7642094|NCT01802632|12056885|FG005|Overall Study|Other (not specified)|1
7642095|NCT01802281|12056899|FG000|Overall Study|Death|1
7642096|NCT01802281|12056900|FG001|Overall Study|Death|2
7642097|NCT01802281|12056899|FG000|Overall Study|Withdrawal by Subject|2
7642098|NCT01802281|12056900|FG001|Overall Study|Withdrawal by Subject|1
7642099|NCT01802281|12056899|FG000|Overall Study|Ineligible|5
7642100|NCT01802281|12056900|FG001|Overall Study|Ineligible|3
7642101|NCT01794338|12056930|FG000|Overall Study|Death|2
7642102|NCT01794338|12056931|FG001|Overall Study|Death|0
7642103|NCT01794338|12056930|FG000|Overall Study|Lost to Follow-up|6
7642104|NCT01794338|12056931|FG001|Overall Study|Lost to Follow-up|9
7642105|NCT01791985|12056937|FG000|Overall Study|Adverse Event|7
7642106|NCT01791985|12056937|FG000|Overall Study|Withdrawal by Subject|1
7642107|NCT01776840|12056974|FG000|Overall Study|Lost to Follow-up|4
7642108|NCT01776840|12056975|FG001|Overall Study|Lost to Follow-up|4
7642109|NCT01776840|12056974|FG000|Overall Study|Withdrawal by Subject|42
7642110|NCT01776840|12056975|FG001|Overall Study|Withdrawal by Subject|22
7642111|NCT01776840|12056974|FG000|Overall Study|Ongoing|112
7642112|NCT01776840|12056975|FG001|Overall Study|Ongoing|129
7642113|NCT01772472|12057008|FG000|Overall Study|Death|56
7642114|NCT01772472|12057009|FG001|Overall Study|Death|42
7642115|NCT01772472|12057008|FG000|Overall Study|Physician Decision|1
7642116|NCT01772472|12057009|FG001|Overall Study|Physician Decision|3
7642117|NCT01772472|12057008|FG000|Overall Study|Other|5
7642118|NCT01772472|12057009|FG001|Overall Study|Other|5
7642119|NCT01772472|12057008|FG000|Overall Study|Lost to Follow-up|12
7642120|NCT01772472|12057009|FG001|Overall Study|Lost to Follow-up|8
7642121|NCT01772472|12057008|FG000|Overall Study|Withdrawal by Subject|72
7642122|NCT01772472|12057009|FG001|Overall Study|Withdrawal by Subject|50
7642123|NCT01772472|12057008|FG000|Overall Study|Ongoing|597
7642124|NCT01772472|12057009|FG001|Overall Study|Ongoing|635
7642125|NCT01767194|12057017|FG000|Overall Study|Adverse Event|1
7642126|NCT01767194|12057018|FG001|Overall Study|Adverse Event|1
7642127|NCT01767194|12057017|FG000|Overall Study|Death|0
7642128|NCT01767194|12057018|FG001|Overall Study|Death|1
7642129|NCT01767194|12057017|FG000|Overall Study|Lack of Efficacy|12
7642130|NCT01767194|12057018|FG001|Overall Study|Lack of Efficacy|11
7642131|NCT01767194|12057017|FG000|Overall Study|Physician Decision|2
7642132|NCT01767194|12057018|FG001|Overall Study|Physician Decision|23
7642133|NCT01767194|12057017|FG000|Overall Study|Withdrawal by Subject|0
7642134|NCT01767194|12057018|FG001|Overall Study|Withdrawal by Subject|1
7642135|NCT01767194|12057017|FG000|Overall Study|Ineligible|1
7642136|NCT01767194|12057018|FG001|Overall Study|Ineligible|1
7642137|NCT01767194|12057017|FG000|Overall Study|Refusal by patient/parent|2
7642138|NCT01767194|12057018|FG001|Overall Study|Refusal by patient/parent|4
7642139|NCT01767194|12057017|FG000|Overall Study|Criteria not met on time for next cycle|0
7642140|NCT01767194|12057018|FG001|Overall Study|Criteria not met on time for next cycle|1
7642141|NCT01760447|12057029|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7642142|NCT01760447|12057030|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
7642143|NCT01760447|12057031|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
7642144|NCT01760447|12057032|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
7642145|NCT01760447|12057029|FG000|Weeks 0-20|Withdrawal by Subject|2
7642146|NCT01760447|12057030|FG001|Weeks 0-20|Withdrawal by Subject|0
7642147|NCT01760447|12057031|FG002|Weeks 0-20|Withdrawal by Subject|1
7642148|NCT01760447|12057032|FG003|Weeks 0-20|Withdrawal by Subject|0
7642149|NCT01760447|12057029|FG000|Weeks 0-20|Lost to Follow-up|1
7642150|NCT01760447|12057030|FG001|Weeks 0-20|Lost to Follow-up|0
7642151|NCT01760447|12057031|FG002|Weeks 0-20|Lost to Follow-up|1
7642152|NCT01760447|12057032|FG003|Weeks 0-20|Lost to Follow-up|1
7642153|NCT01760447|12057029|FG000|Weeks 0-20|Randomized but not treated|0
7642154|NCT01760447|12057030|FG001|Weeks 0-20|Randomized but not treated|0
7642155|NCT01760447|12057031|FG002|Weeks 0-20|Randomized but not treated|2
7642156|NCT01760447|12057032|FG003|Weeks 0-20|Randomized but not treated|0
7642157|NCT01760447|12057029|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642158|NCT01760447|12057030|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642159|NCT01760447|12057031|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
7642160|NCT01760447|12057032|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
7642161|NCT01760447|12057029|FG000|Weeks 20-54|Withdrawal by Subject|2
7642162|NCT01760447|12057030|FG001|Weeks 20-54|Withdrawal by Subject|1
7642163|NCT01760447|12057031|FG002|Weeks 20-54|Withdrawal by Subject|1
7642164|NCT01760447|12057032|FG003|Weeks 20-54|Withdrawal by Subject|2
7642165|NCT01760447|12057029|FG000|Weeks 20-54|Lost to Follow-up|0
7642166|NCT01760447|12057030|FG001|Weeks 20-54|Lost to Follow-up|0
7642167|NCT01760447|12057031|FG002|Weeks 20-54|Lost to Follow-up|1
7642168|NCT01760447|12057032|FG003|Weeks 20-54|Lost to Follow-up|2
7642169|NCT01757535|12057050|FG000|Overall Study|Disease Relapse|143
7642170|NCT01757535|12057051|FG001|Overall Study|Disease Relapse|180
7642171|NCT01757535|12057050|FG000|Overall Study|Adverse Event|29
7642172|NCT01757535|12057051|FG001|Overall Study|Adverse Event|11
7642173|NCT01757535|12057050|FG000|Overall Study|Withdrawal by Subject|9
7642174|NCT01757535|12057051|FG001|Overall Study|Withdrawal by Subject|13
7642175|NCT01757535|12057050|FG000|Overall Study|Miscellaneous|5
7642176|NCT01757535|12057051|FG001|Overall Study|Miscellaneous|2
7642177|NCT01757535|12057050|FG000|Overall Study|Physician Decision|6
7642178|NCT01757535|12057051|FG001|Overall Study|Physician Decision|0
7642179|NCT01757535|12057050|FG000|Overall Study|Death|1
7642180|NCT01757535|12057051|FG001|Overall Study|Death|2
7642181|NCT01750281|12057069|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
7642182|NCT01750281|12057070|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
7642183|NCT01750281|12057071|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
7642184|NCT01750281|12057069|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
7642185|NCT01750281|12057070|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
7642186|NCT01750281|12057071|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
7642187|NCT01750281|12057069|FG000|Overall Study|Did not receive treatment|0
7642188|NCT01750281|12057070|FG001|Overall Study|Did not receive treatment|1
7642189|NCT01750281|12057071|FG002|Overall Study|Did not receive treatment|0
7642190|NCT01740427|12057093|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
7642191|NCT01740427|12057094|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
7642192|NCT01740427|12057093|FG000|Overall Study|Objective progression or relapse|172
7642193|NCT01740427|12057094|FG001|Overall Study|Objective progression or relapse|125
7642194|NCT01740427|12057093|FG000|Overall Study|Adverse Event|20
7642195|NCT01740427|12057094|FG001|Overall Study|Adverse Event|9
7642196|NCT01740427|12057093|FG000|Overall Study|Global deterioration of health status|16
7642197|NCT01740427|12057094|FG001|Overall Study|Global deterioration of health status|9
7642198|NCT01740427|12057093|FG000|Overall Study|Subject refused continued treatment|12
7642199|NCT01740427|12057094|FG001|Overall Study|Subject refused continued treatment|9
7642200|NCT01740427|12057093|FG000|Overall Study|Unspecified reasons|6
7642201|NCT01740427|12057094|FG001|Overall Study|Unspecified reasons|4
7642202|NCT01740427|12057093|FG000|Overall Study|Death|6
7642203|NCT01740427|12057094|FG001|Overall Study|Death|2
7642204|NCT01740427|12057093|FG000|Overall Study|Protocol Violation|5
7642205|NCT01740427|12057094|FG001|Overall Study|Protocol Violation|3
7642206|NCT01740427|12057093|FG000|Overall Study|Lost to Follow-up|1
7642207|NCT01740427|12057094|FG001|Overall Study|Lost to Follow-up|0
7642208|NCT01740427|12057093|FG000|Overall Study|Study terminated by Sponsor|1
7642209|NCT01740427|12057094|FG001|Overall Study|Study terminated by Sponsor|0
7642210|NCT01730118|12057107|FG000|Dose Escalation|Death on study|5
7642211|NCT01730118|12057108|FG001|Dose Escalation|Death on study|7
7642212|NCT01730118|12057109|FG002|Dose Escalation|Death on study|2
7642213|NCT01730118|12057110|FG003|Dose Escalation|Death on study|6
7642214|NCT01730118|12057111|FG004|Dose Escalation|Death on study|0
7642215|NCT01730118|12057112|FG005|Dose Escalation|Death on study|0
7642216|NCT01730118|12057113|FG006|Dose Escalation|Death on study|0
7642217|NCT01730118|12057107|FG000|Dose Escalation|Died before treatment|0
7642218|NCT01730118|12057108|FG001|Dose Escalation|Died before treatment|0
7642219|NCT01730118|12057109|FG002|Dose Escalation|Died before treatment|0
7642220|NCT01730118|12057110|FG003|Dose Escalation|Died before treatment|0
7642221|NCT01730118|12057111|FG004|Dose Escalation|Died before treatment|0
7642222|NCT01730118|12057112|FG005|Dose Escalation|Died before treatment|0
7642223|NCT01730118|12057113|FG006|Dose Escalation|Died before treatment|1
7642224|NCT01730118|12057107|FG000|Dose Escalation|Chose to start a different treatment|1
7642225|NCT01730118|12057108|FG001|Dose Escalation|Chose to start a different treatment|0
7642226|NCT01730118|12057109|FG002|Dose Escalation|Chose to start a different treatment|0
7642227|NCT01730118|12057110|FG003|Dose Escalation|Chose to start a different treatment|0
7642228|NCT01730118|12057111|FG004|Dose Escalation|Chose to start a different treatment|0
7642229|NCT01730118|12057112|FG005|Dose Escalation|Chose to start a different treatment|0
7642230|NCT01730118|12057113|FG006|Dose Escalation|Chose to start a different treatment|0
7642231|NCT01730118|12057107|FG000|Dose Escalation|Withdrawal by Subject|0
7642232|NCT01730118|12057108|FG001|Dose Escalation|Withdrawal by Subject|0
7642233|NCT01730118|12057109|FG002|Dose Escalation|Withdrawal by Subject|1
7642234|NCT01730118|12057110|FG003|Dose Escalation|Withdrawal by Subject|0
7642235|NCT01730118|12057111|FG004|Dose Escalation|Withdrawal by Subject|0
7642236|NCT01730118|12057112|FG005|Dose Escalation|Withdrawal by Subject|0
7642237|NCT01730118|12057113|FG006|Dose Escalation|Withdrawal by Subject|0
7642238|NCT01730118|12057107|FG000|Dose Escalation|Disease progression prior to treatment|0
7642239|NCT01730118|12057108|FG001|Dose Escalation|Disease progression prior to treatment|0
7642240|NCT01730118|12057109|FG002|Dose Escalation|Disease progression prior to treatment|0
7642241|NCT01730118|12057110|FG003|Dose Escalation|Disease progression prior to treatment|0
7642242|NCT01730118|12057111|FG004|Dose Escalation|Disease progression prior to treatment|0
7642243|NCT01730118|12057112|FG005|Dose Escalation|Disease progression prior to treatment|0
7642244|NCT01730118|12057113|FG006|Dose Escalation|Disease progression prior to treatment|1
7642245|NCT01730118|12057107|FG000|Dose Expansion|Death|0
7642246|NCT01730118|12057108|FG001|Dose Expansion|Death|0
7642247|NCT01730118|12057109|FG002|Dose Expansion|Death|0
7642248|NCT01730118|12057110|FG003|Dose Expansion|Death|0
7642249|NCT01730118|12057111|FG004|Dose Expansion|Death|1
7642250|NCT01730118|12057112|FG005|Dose Expansion|Death|0
7642251|NCT01730118|12057113|FG006|Dose Expansion|Death|0
7642252|NCT01730118|12057107|FG000|Dose Expansion|Other medical condition|0
7642253|NCT01730118|12057108|FG001|Dose Expansion|Other medical condition|0
7642254|NCT01730118|12057109|FG002|Dose Expansion|Other medical condition|0
7642255|NCT01730118|12057110|FG003|Dose Expansion|Other medical condition|0
7642256|NCT01730118|12057111|FG004|Dose Expansion|Other medical condition|1
7642257|NCT01730118|12057112|FG005|Dose Expansion|Other medical condition|0
7642258|NCT01730118|12057113|FG006|Dose Expansion|Other medical condition|0
7642259|NCT01730118|12057107|FG000|Dose Expansion|Withdrawal by Subject|0
7642260|NCT01730118|12057108|FG001|Dose Expansion|Withdrawal by Subject|0
7642261|NCT01730118|12057109|FG002|Dose Expansion|Withdrawal by Subject|0
7642262|NCT01730118|12057110|FG003|Dose Expansion|Withdrawal by Subject|0
7642263|NCT01730118|12057111|FG004|Dose Expansion|Withdrawal by Subject|1
7642264|NCT01730118|12057112|FG005|Dose Expansion|Withdrawal by Subject|0
7642265|NCT01730118|12057113|FG006|Dose Expansion|Withdrawal by Subject|0
7642266|NCT01730118|12057107|FG000|Dose Expansion|Disease progression|0
7642267|NCT01730118|12057108|FG001|Dose Expansion|Disease progression|0
7642268|NCT01730118|12057109|FG002|Dose Expansion|Disease progression|0
7642269|NCT01730118|12057110|FG003|Dose Expansion|Disease progression|0
7642270|NCT01730118|12057111|FG004|Dose Expansion|Disease progression|0
7642271|NCT01730118|12057112|FG005|Dose Expansion|Disease progression|1
7642272|NCT01730118|12057113|FG006|Dose Expansion|Disease progression|0
7642273|NCT01730118|12057107|FG000|Dose Expansion|Inability to return|0
7642274|NCT01730118|12057108|FG001|Dose Expansion|Inability to return|0
7642275|NCT01730118|12057109|FG002|Dose Expansion|Inability to return|0
7642276|NCT01730118|12057110|FG003|Dose Expansion|Inability to return|0
7642277|NCT01730118|12057111|FG004|Dose Expansion|Inability to return|0
7642278|NCT01730118|12057112|FG005|Dose Expansion|Inability to return|1
7642279|NCT01730118|12057113|FG006|Dose Expansion|Inability to return|0
7642280|NCT01730118|12057107|FG000|Dose Expansion|Physician Decision|0
7642281|NCT01730118|12057108|FG001|Dose Expansion|Physician Decision|0
7642282|NCT01730118|12057109|FG002|Dose Expansion|Physician Decision|0
7642283|NCT01730118|12057110|FG003|Dose Expansion|Physician Decision|0
7642284|NCT01730118|12057111|FG004|Dose Expansion|Physician Decision|0
7642285|NCT01730118|12057112|FG005|Dose Expansion|Physician Decision|1
7642286|NCT01730118|12057113|FG006|Dose Expansion|Physician Decision|0
7642287|NCT01723774|12057144|FG000|Neoadjuvant|Ki67 > 10%|4
7642288|NCT01723774|12057145|FG001|Neoadjuvant|Ki67 > 10%|0
7642289|NCT01723774|12057146|FG002|Neoadjuvant|Ki67 > 10%|10
7642290|NCT01723774|12057147|FG003|Neoadjuvant|Ki67 > 10%|0
7642291|NCT01723774|12057144|FG000|Neoadjuvant|Withdrawal by Subject|3
7642292|NCT01723774|12057145|FG001|Neoadjuvant|Withdrawal by Subject|1
7642293|NCT01723774|12057146|FG002|Neoadjuvant|Withdrawal by Subject|0
7642294|NCT01723774|12057147|FG003|Neoadjuvant|Withdrawal by Subject|0
7642295|NCT01723774|12057144|FG000|Neoadjuvant|Disease progression|0
7642296|NCT01723774|12057145|FG001|Neoadjuvant|Disease progression|1
7642297|NCT01723774|12057146|FG002|Neoadjuvant|Disease progression|1
7642298|NCT01723774|12057147|FG003|Neoadjuvant|Disease progression|0
7642299|NCT01723774|12057144|FG000|Neoadjuvant|Adverse Event|0
7642300|NCT01723774|12057145|FG001|Neoadjuvant|Adverse Event|1
7642301|NCT01723774|12057146|FG002|Neoadjuvant|Adverse Event|2
7642302|NCT01723774|12057147|FG003|Neoadjuvant|Adverse Event|0
7642303|NCT01723774|12057144|FG000|Neoadjuvant|High estradiol|0
7642304|NCT01723774|12057145|FG001|Neoadjuvant|High estradiol|1
7642305|NCT01723774|12057146|FG002|Neoadjuvant|High estradiol|0
7642306|NCT01723774|12057147|FG003|Neoadjuvant|High estradiol|0
7642307|NCT01723774|12057144|FG000|Adjuvant|Still on active treatment|0
7642308|NCT01723774|12057145|FG001|Adjuvant|Still on active treatment|0
7642309|NCT01723774|12057146|FG002|Adjuvant|Still on active treatment|0
7642310|NCT01723774|12057147|FG003|Adjuvant|Still on active treatment|1
7642311|NCT01719237|12057158|FG000|Overall Study|Physician Decision|0
7642312|NCT01719237|12057159|FG001|Overall Study|Physician Decision|1
7642313|NCT01711541|12057170|FG000|Overall Study|Cancel prior to treatment|0
7642314|NCT01711541|12057171|FG001|Overall Study|Cancel prior to treatment|0
7642315|NCT01711541|12057172|FG002|Overall Study|Cancel prior to treatment|0
7642316|NCT01711541|12057173|FG003|Overall Study|Cancel prior to treatment|1
7642317|NCT01711541|12057174|FG004|Overall Study|Cancel prior to treatment|0
7642318|NCT01711541|12057170|FG000|Overall Study|Ineligible|0
7642319|NCT01711541|12057171|FG001|Overall Study|Ineligible|1
7642320|NCT01711541|12057172|FG002|Overall Study|Ineligible|0
7642321|NCT01711541|12057173|FG003|Overall Study|Ineligible|0
7642322|NCT01711541|12057174|FG004|Overall Study|Ineligible|0
7642323|NCT01708954|12057194|FG000|Step 1|Disease progression|26
7642324|NCT01708954|12057195|FG001|Step 1|Disease progression|17
7642325|NCT01708954|12057196|FG002|Step 1|Disease progression|14
7642326|NCT01708954|12057194|FG000|Step 1|Adverse Event|3
7642327|NCT01708954|12057195|FG001|Step 1|Adverse Event|11
7642328|NCT01708954|12057196|FG002|Step 1|Adverse Event|13
7642329|NCT01708954|12057194|FG000|Step 1|Death|3
7642330|NCT01708954|12057195|FG001|Step 1|Death|2
7642331|NCT01708954|12057196|FG002|Step 1|Death|3
7642332|NCT01708954|12057194|FG000|Step 1|Withdrawal by Subject|2
7642333|NCT01708954|12057195|FG001|Step 1|Withdrawal by Subject|5
7642334|NCT01708954|12057196|FG002|Step 1|Withdrawal by Subject|3
7642335|NCT01708954|12057194|FG000|Step 1|Other complicating disease|0
7642336|NCT01708954|12057195|FG001|Step 1|Other complicating disease|2
7642337|NCT01708954|12057196|FG002|Step 1|Other complicating disease|0
7642338|NCT01708954|12057194|FG000|Step 1|Crossed over to Step 2|2
7642339|NCT01708954|12057195|FG001|Step 1|Crossed over to Step 2|0
7642340|NCT01708954|12057196|FG002|Step 1|Crossed over to Step 2|0
7642341|NCT01708954|12057194|FG000|Step 1|Symptomatic deterioration|1
7642342|NCT01708954|12057195|FG001|Step 1|Symptomatic deterioration|0
7642343|NCT01708954|12057196|FG002|Step 1|Symptomatic deterioration|1
7642344|NCT01708954|12057194|FG000|Step 1|Off-treatment reason not submitted|1
7642345|NCT01708954|12057195|FG001|Step 1|Off-treatment reason not submitted|1
7642346|NCT01708954|12057196|FG002|Step 1|Off-treatment reason not submitted|1
7642347|NCT01708954|12057194|FG000|Step 1|Ineligible or never received treatment|4
7642348|NCT01708954|12057195|FG001|Step 1|Ineligible or never received treatment|2
7642349|NCT01708954|12057196|FG002|Step 1|Ineligible or never received treatment|8
7642350|NCT01708954|12057194|FG000|Step 2|Disease progression|9
7642351|NCT01708954|12057195|FG001|Step 2|Disease progression|4
7642352|NCT01708954|12057196|FG002|Step 2|Disease progression|0
7642353|NCT01708954|12057194|FG000|Step 2|Adverse Event|3
7642354|NCT01708954|12057195|FG001|Step 2|Adverse Event|2
7642355|NCT01708954|12057196|FG002|Step 2|Adverse Event|0
7642356|NCT01708954|12057194|FG000|Step 2|Withdrawal by Subject|1
7642357|NCT01708954|12057195|FG001|Step 2|Withdrawal by Subject|1
7642358|NCT01708954|12057196|FG002|Step 2|Withdrawal by Subject|0
7642359|NCT01708941|12057209|FG000|Overall Study|Adverse Event|4
7642360|NCT01708941|12057210|FG001|Overall Study|Adverse Event|6
7642361|NCT01708941|12057211|FG002|Overall Study|Adverse Event|1
7642362|NCT01708941|12057212|FG003|Overall Study|Adverse Event|0
7642363|NCT01708941|12057209|FG000|Overall Study|Death|1
7642364|NCT01708941|12057210|FG001|Overall Study|Death|1
7642365|NCT01708941|12057211|FG002|Overall Study|Death|2
7642366|NCT01708941|12057212|FG003|Overall Study|Death|14
7642367|NCT01708941|12057209|FG000|Overall Study|Withdrawal by Subject|1
7642368|NCT01708941|12057210|FG001|Overall Study|Withdrawal by Subject|0
7642369|NCT01708941|12057211|FG002|Overall Study|Withdrawal by Subject|3
7642370|NCT01708941|12057212|FG003|Overall Study|Withdrawal by Subject|4
7642371|NCT01708941|12057209|FG000|Overall Study|Disease progression|9
7642372|NCT01708941|12057210|FG001|Overall Study|Disease progression|10
7642373|NCT01708941|12057211|FG002|Overall Study|Disease progression|8
7642374|NCT01708941|12057212|FG003|Overall Study|Disease progression|0
7642375|NCT01708941|12057209|FG000|Overall Study|Alternative therapy|0
7642376|NCT01708941|12057210|FG001|Overall Study|Alternative therapy|0
7642377|NCT01708941|12057211|FG002|Overall Study|Alternative therapy|2
7642378|NCT01708941|12057212|FG003|Overall Study|Alternative therapy|0
7642379|NCT01708941|12057209|FG000|Overall Study|Ineligible and never started treatment|1
7642380|NCT01708941|12057210|FG001|Overall Study|Ineligible and never started treatment|0
7642381|NCT01708941|12057211|FG002|Overall Study|Ineligible and never started treatment|1
7642382|NCT01708941|12057212|FG003|Overall Study|Ineligible and never started treatment|0
7642383|NCT01708941|12057209|FG000|Overall Study|Never started treatment|2
7642384|NCT01708941|12057210|FG001|Overall Study|Never started treatment|1
7642385|NCT01708941|12057211|FG002|Overall Study|Never started treatment|0
7642386|NCT01708941|12057212|FG003|Overall Study|Never started treatment|0
7642387|NCT01708941|12057209|FG000|Overall Study|Ineligible|0
7642388|NCT01708941|12057210|FG001|Overall Study|Ineligible|0
7642389|NCT01708941|12057211|FG002|Overall Study|Ineligible|2
7642390|NCT01708941|12057212|FG003|Overall Study|Ineligible|0
7642391|NCT01706939|12057224|FG000|Pre Randomization|Screen Failure|1
7642392|NCT01706939|12057225|FG001|Pre Randomization|Screen Failure|0
7642393|NCT01706939|12057226|FG002|Pre Randomization|Screen Failure|0
7642394|NCT01706939|12057224|FG000|Pre Randomization|Ineligible for Randomization|1
7642395|NCT01706939|12057225|FG001|Pre Randomization|Ineligible for Randomization|0
7642396|NCT01706939|12057226|FG002|Pre Randomization|Ineligible for Randomization|0
7642397|NCT01706939|12057224|FG000|Pre Randomization|Withdrawal by Subject|1
7642398|NCT01706939|12057225|FG001|Pre Randomization|Withdrawal by Subject|0
7642399|NCT01706939|12057226|FG002|Pre Randomization|Withdrawal by Subject|0
7642400|NCT01706939|12057224|FG000|Randomization|Insufficient QoL survey compliance|0
7642401|NCT01706939|12057225|FG001|Randomization|Insufficient QoL survey compliance|1
7642402|NCT01706939|12057226|FG002|Randomization|Insufficient QoL survey compliance|1
7642403|NCT01706939|12057224|FG000|Randomization|Progression of disease|0
7642404|NCT01706939|12057225|FG001|Randomization|Progression of disease|2
7642405|NCT01706939|12057226|FG002|Randomization|Progression of disease|1
7642406|NCT01700946|12057235|FG000|Overall Study|Lost to Follow-up|1
7642407|NCT01700946|12057236|FG001|Overall Study|Lost to Follow-up|0
7642408|NCT01700946|12057235|FG000|Overall Study|Physician Decision|7
7642409|NCT01700946|12057236|FG001|Overall Study|Physician Decision|12
7642410|NCT01700946|12057235|FG000|Overall Study|Withdrawal by Subject|0
7642411|NCT01700946|12057236|FG001|Overall Study|Withdrawal by Subject|2
7642412|NCT01700946|12057235|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0
7642413|NCT01700946|12057236|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2
7642414|NCT01700946|12057235|FG000|Overall Study|Relapse|2
7642415|NCT01700946|12057236|FG001|Overall Study|Relapse|1
7642416|NCT01700946|12057235|FG000|Overall Study|Unacceptable toxicity|1
7642417|NCT01700946|12057236|FG001|Overall Study|Unacceptable toxicity|0
7642418|NCT01696994|12057248|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
7642419|NCT01696994|12057249|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
7642420|NCT01696994|12057248|FG000|Overall Study|Died Before Randomization|1
7642421|NCT01696994|12057249|FG001|Overall Study|Died Before Randomization|2
7642422|NCT01696994|12057248|FG000|Overall Study|Died Before ASU (Control)|73
7642423|NCT01696994|12057249|FG001|Overall Study|Died Before ASU (Control)|0
7642424|NCT01696994|12057248|FG000|Overall Study|No Ovaries at Baseline|4807
7642425|NCT01696994|12057249|FG001|Overall Study|No Ovaries at Baseline|4851
7642426|NCT01696994|12057248|FG000|Overall Study|Refused ASU (Control)|311
7642427|NCT01696994|12057249|FG001|Overall Study|Refused ASU (Control)|0
7642428|NCT01696994|12057248|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
7642429|NCT01696994|12057249|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
7642430|NCT01696968|12057259|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
7642431|NCT01696968|12057260|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
7642432|NCT01696968|12057259|FG000|Overall Study|Died Before Randomization|3
7642433|NCT01696968|12057260|FG001|Overall Study|Died Before Randomization|8
7642434|NCT01696968|12057259|FG000|Overall Study|Died Before ASU (Control)|278
7642435|NCT01696968|12057260|FG001|Overall Study|Died Before ASU (Control)|0
7642436|NCT01696968|12057259|FG000|Overall Study|Refused ASU (Control)|920
7642437|NCT01696968|12057260|FG001|Overall Study|Refused ASU (Control)|0
7642438|NCT01696968|12057259|FG000|Overall Study|Refused Screen (Lung Screening)|0
7642439|NCT01696968|12057260|FG001|Overall Study|Refused Screen (Lung Screening)|6796
7642440|NCT01682226|12057267|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3
7642441|NCT01682226|12057267|FG000|Overall Study|Participants did not receive treatment|2
7642442|NCT01682226|12057267|FG000|Overall Study|Participants received a transplant under a different protocol|1
7642443|NCT01682148|12057273|FG000|Overall Study|Withdrawal by Subject|2
7642444|NCT01682148|12057274|FG001|Overall Study|Withdrawal by Subject|0
7642445|NCT01682148|12057273|FG000|Overall Study|Lost to Follow-up|1
7642446|NCT01682148|12057274|FG001|Overall Study|Lost to Follow-up|2
7642447|NCT01682148|12057273|FG000|Overall Study|Protocol Violation|1
7642448|NCT01682148|12057274|FG001|Overall Study|Protocol Violation|1
7642449|NCT01682083|12057287|FG000|Overall Study|Lost to Follow-up|11
7642450|NCT01682083|12057288|FG001|Overall Study|Lost to Follow-up|18
7642451|NCT01682083|12057287|FG000|Overall Study|Withdrawal by Subject|31
7642452|NCT01682083|12057288|FG001|Overall Study|Withdrawal by Subject|40
7642453|NCT01682083|12057287|FG000|Overall Study|Death|60
7642454|NCT01682083|12057288|FG001|Overall Study|Death|93
7642455|NCT01682083|12057287|FG000|Overall Study|Physician Decision|5
7642456|NCT01682083|12057288|FG001|Overall Study|Physician Decision|4
7642457|NCT01678131|12057297|FG000|Overall Study|Adverse Event|0
7642458|NCT01678131|12057298|FG001|Overall Study|Adverse Event|1
7642459|NCT01678131|12057299|FG002|Overall Study|Adverse Event|0
7642460|NCT01678131|12057297|FG000|Overall Study|Withdrawal by Subject|0
7642461|NCT01678131|12057298|FG001|Overall Study|Withdrawal by Subject|0
7642462|NCT01678131|12057299|FG002|Overall Study|Withdrawal by Subject|2
7642463|NCT01677858|12057312|FG000|Overall Study|Adverse Event|0
7642464|NCT01677858|12057313|FG001|Overall Study|Adverse Event|0
7642465|NCT01677858|12057314|FG002|Overall Study|Adverse Event|2
7642466|NCT01677858|12057315|FG003|Overall Study|Adverse Event|3
7642467|NCT01677858|12057316|FG004|Overall Study|Adverse Event|13
7642468|NCT01677858|12057312|FG000|Overall Study|Death|0
7642469|NCT01677858|12057313|FG001|Overall Study|Death|0
7642470|NCT01677858|12057314|FG002|Overall Study|Death|0
7642471|NCT01677858|12057315|FG003|Overall Study|Death|0
7642472|NCT01677858|12057316|FG004|Overall Study|Death|1
7642473|NCT01677858|12057312|FG000|Overall Study|Physician Decision|1
7642474|NCT01677858|12057313|FG001|Overall Study|Physician Decision|0
7642475|NCT01677858|12057314|FG002|Overall Study|Physician Decision|2
7642476|NCT01677858|12057315|FG003|Overall Study|Physician Decision|0
7642477|NCT01677858|12057316|FG004|Overall Study|Physician Decision|12
7642478|NCT01677858|12057312|FG000|Overall Study|Progressive Disease|2
7642479|NCT01677858|12057313|FG001|Overall Study|Progressive Disease|1
7642480|NCT01677858|12057314|FG002|Overall Study|Progressive Disease|9
7642481|NCT01677858|12057315|FG003|Overall Study|Progressive Disease|3
7642482|NCT01677858|12057316|FG004|Overall Study|Progressive Disease|43
7642483|NCT01677858|12057312|FG000|Overall Study|Withdrawal by Subject|0
7642484|NCT01677858|12057313|FG001|Overall Study|Withdrawal by Subject|1
7642485|NCT01677858|12057314|FG002|Overall Study|Withdrawal by Subject|1
7642486|NCT01677858|12057315|FG003|Overall Study|Withdrawal by Subject|0
7642487|NCT01677858|12057316|FG004|Overall Study|Withdrawal by Subject|15
7642488|NCT01677858|12057312|FG000|Overall Study|Lost to Follow-up|0
7642489|NCT01677858|12057313|FG001|Overall Study|Lost to Follow-up|0
7642490|NCT01677858|12057314|FG002|Overall Study|Lost to Follow-up|0
7642491|NCT01677858|12057315|FG003|Overall Study|Lost to Follow-up|0
7642492|NCT01677858|12057316|FG004|Overall Study|Lost to Follow-up|1
7642493|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Disease Progression|0
7642494|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Disease Progression|1
7642495|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
7642496|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
7642497|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
7642498|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
7642499|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
7642500|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
7642501|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
7642502|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
7642503|NCT01668784|12057339|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0
7642504|NCT01668784|12057340|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1
7642505|NCT01668784|12057339|FG000|Treatment Period|Disease Progression|316
7642506|NCT01668784|12057340|FG001|Treatment Period|Disease Progression|293
7642507|NCT01668784|12057339|FG000|Treatment Period|Study Drug Toxicity|46
7642508|NCT01668784|12057340|FG001|Treatment Period|Study Drug Toxicity|53
7642509|NCT01668784|12057339|FG000|Treatment Period|Death|1
7642510|NCT01668784|12057340|FG001|Treatment Period|Death|1
7642511|NCT01668784|12057339|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14
7642512|NCT01668784|12057340|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14
7642513|NCT01668784|12057339|FG000|Treatment Period|Request to Discontinue Study Treatment|14
7642514|NCT01668784|12057340|FG001|Treatment Period|Request to Discontinue Study Treatment|21
7642515|NCT01668784|12057339|FG000|Treatment Period|Withdrawal by Subject|5
7642516|NCT01668784|12057340|FG001|Treatment Period|Withdrawal by Subject|3
7642517|NCT01668784|12057339|FG000|Treatment Period|Maximal Clinical Benefit|3
7642518|NCT01668784|12057340|FG001|Treatment Period|Maximal Clinical Benefit|3
7642519|NCT01668784|12057339|FG000|Treatment Period|Other|2
7642520|NCT01668784|12057340|FG001|Treatment Period|Other|8
7642521|NCT01668784|12057339|FG000|Treatment Period|Administrative Reason by Sponsor|5
7642522|NCT01668784|12057340|FG001|Treatment Period|Administrative Reason by Sponsor|1
7642523|NCT01665144|12057348|FG000|Overall Study|New therapy for study indication|2
7642524|NCT01665144|12057349|FG001|Overall Study|New therapy for study indication|1
7642525|NCT01665144|12057348|FG000|Overall Study|Technical problems|2
7642526|NCT01665144|12057349|FG001|Overall Study|Technical problems|0
7642527|NCT01665144|12057348|FG000|Overall Study|Death|3
7642528|NCT01665144|12057349|FG001|Overall Study|Death|1
7642529|NCT01665144|12057348|FG000|Overall Study|Protocol deviation|3
7642530|NCT01665144|12057349|FG001|Overall Study|Protocol deviation|1
7642531|NCT01665144|12057348|FG000|Overall Study|Non-compliance w/study treatment|5
7642532|NCT01665144|12057349|FG001|Overall Study|Non-compliance w/study treatment|0
7642533|NCT01665144|12057348|FG000|Overall Study|Progressive disease|8
7642534|NCT01665144|12057349|FG001|Overall Study|Progressive disease|4
7642535|NCT01665144|12057348|FG000|Overall Study|Lost to Follow-up|9
7642536|NCT01665144|12057349|FG001|Overall Study|Lost to Follow-up|8
7642537|NCT01665144|12057348|FG000|Overall Study|Physician Decision|13
7642538|NCT01665144|12057349|FG001|Overall Study|Physician Decision|1
7642539|NCT01665144|12057348|FG000|Overall Study|Lack of Efficacy|16
7642540|NCT01665144|12057349|FG001|Overall Study|Lack of Efficacy|11
7642541|NCT01665144|12057348|FG000|Overall Study|Adverse Event|45
7642542|NCT01665144|12057349|FG001|Overall Study|Adverse Event|18
7642543|NCT01665144|12057348|FG000|Overall Study|Withdrawal by Subject|96
7642544|NCT01665144|12057349|FG001|Overall Study|Withdrawal by Subject|77
7642545|NCT01660451|12057358|FG000|Overall Study|Protocol Violation|0
7642546|NCT01660451|12057359|FG001|Overall Study|Protocol Violation|1
7642547|NCT01660451|12057360|FG002|Overall Study|Protocol Violation|1
7642548|NCT01660451|12057358|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
7642549|NCT01660451|12057359|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
7642550|NCT01660451|12057360|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
7642551|NCT01660451|12057358|FG000|Overall Study|AE with Clinical PD|1
7642552|NCT01660451|12057359|FG001|Overall Study|AE with Clinical PD|3
7642553|NCT01660451|12057360|FG002|Overall Study|AE with Clinical PD|9
7642554|NCT01660451|12057358|FG000|Overall Study|Sponsor Decision|0
7642555|NCT01660451|12057359|FG001|Overall Study|Sponsor Decision|0
7642556|NCT01660451|12057360|FG002|Overall Study|Sponsor Decision|1
7642557|NCT01660451|12057358|FG000|Overall Study|Protocol Deviation|0
7642558|NCT01660451|12057359|FG001|Overall Study|Protocol Deviation|0
7642559|NCT01660451|12057360|FG002|Overall Study|Protocol Deviation|1
7642560|NCT01660451|12057358|FG000|Overall Study|Physician Decision|1
7642561|NCT01660451|12057359|FG001|Overall Study|Physician Decision|2
7642562|NCT01660451|12057360|FG002|Overall Study|Physician Decision|5
7642563|NCT01660451|12057358|FG000|Overall Study|Withdrawal by Subject|1
7642564|NCT01660451|12057359|FG001|Overall Study|Withdrawal by Subject|0
7642565|NCT01660451|12057360|FG002|Overall Study|Withdrawal by Subject|16
7642566|NCT01660451|12057358|FG000|Overall Study|Ongoing with treatment|3
7642567|NCT01660451|12057359|FG001|Overall Study|Ongoing with treatment|3
7642568|NCT01660451|12057360|FG002|Overall Study|Ongoing with treatment|46
7642569|NCT01659853|12057369|FG000|Washout , 3 to 7 Days|Adverse Event|1
7642570|NCT01659853|12057370|FG001|Washout , 3 to 7 Days|Adverse Event|0
7642571|NCT01659853|12057369|FG000|Washout , 3 to 7 Days|Protocol Violation|1
7642572|NCT01659853|12057370|FG001|Washout , 3 to 7 Days|Protocol Violation|0
7642573|NCT01652872|12057395|FG000|Overall Study|Death|36
7642574|NCT01652872|12057396|FG001|Overall Study|Death|39
7642575|NCT01652872|12057395|FG000|Overall Study|Lost to Follow-up|28
7642576|NCT01652872|12057396|FG001|Overall Study|Lost to Follow-up|23
7642577|NCT01652872|12057395|FG000|Overall Study|Decision by sponsor|5
7642578|NCT01652872|12057396|FG001|Overall Study|Decision by sponsor|7
7642579|NCT01652872|12057395|FG000|Overall Study|Withdrawal by Subject|76
7642580|NCT01652872|12057396|FG001|Overall Study|Withdrawal by Subject|84
7642581|NCT01652469|12057404|FG000|Overall Study|Withdrawal by Subject|1
7642582|NCT01652469|12057405|FG001|Overall Study|Withdrawal by Subject|4
7642583|NCT01652469|12057404|FG000|Overall Study|Lost to Follow-up|0
7642584|NCT01652469|12057405|FG001|Overall Study|Lost to Follow-up|2
7642585|NCT01650558|12057414|FG000|Overall Study|Migration out of study area|61
7642586|NCT01650558|12057415|FG001|Overall Study|Migration out of study area|71
7642587|NCT01650558|12057416|FG002|Overall Study|Migration out of study area|56
7642588|NCT01650558|12057414|FG000|Overall Study|Lost to Follow-up|10
7642589|NCT01650558|12057415|FG001|Overall Study|Lost to Follow-up|13
7642590|NCT01650558|12057416|FG002|Overall Study|Lost to Follow-up|6
7642591|NCT01650558|12057414|FG000|Overall Study|Death|10
7642592|NCT01650558|12057415|FG001|Overall Study|Death|6
7642593|NCT01650558|12057416|FG002|Overall Study|Death|8
7642594|NCT01650558|12057414|FG000|Overall Study|Withdrawal by Subject|1
7642595|NCT01650558|12057415|FG001|Overall Study|Withdrawal by Subject|1
7642596|NCT01650558|12057416|FG002|Overall Study|Withdrawal by Subject|3
7642597|NCT01650558|12057414|FG000|Overall Study|Non-compliant participant|1
7642598|NCT01650558|12057415|FG001|Overall Study|Non-compliant participant|0
7642599|NCT01650558|12057416|FG002|Overall Study|Non-compliant participant|2
7642600|NCT01650558|12057414|FG000|Overall Study|Physician Decision|0
7642601|NCT01650558|12057415|FG001|Overall Study|Physician Decision|1
7642602|NCT01650558|12057416|FG002|Overall Study|Physician Decision|0
7642603|NCT01639131|12057425|FG000|Overall Study|Disease Progression|6
7642604|NCT01626079|12057432|FG000|Overall Study|Death|117
7642605|NCT01626079|12057433|FG001|Overall Study|Death|153
7642606|NCT01626079|12057434|FG002|Overall Study|Death|39
7642607|NCT01626079|12057432|FG000|Overall Study|Withdrawal by Subject|15
7642608|NCT01626079|12057433|FG001|Overall Study|Withdrawal by Subject|39
7642609|NCT01626079|12057434|FG002|Overall Study|Withdrawal by Subject|5
7642610|NCT01626079|12057432|FG000|Overall Study|Lost to Follow-up|5
7642611|NCT01626079|12057433|FG001|Overall Study|Lost to Follow-up|4
7642612|NCT01626079|12057434|FG002|Overall Study|Lost to Follow-up|2
7642613|NCT01626079|12057432|FG000|Overall Study|Missed Visits|13
7642614|NCT01626079|12057433|FG001|Overall Study|Missed Visits|5
7642615|NCT01626079|12057434|FG002|Overall Study|Missed Visits|6
7642616|NCT01625611|12057447|FG000|Overall Study|No adlib drinks Lab 1|3
7642617|NCT01625611|12057448|FG001|Overall Study|No adlib drinks Lab 1|0
7642618|NCT01625611|12057447|FG000|Overall Study|Technical issues with PET|1
7642619|NCT01625611|12057448|FG001|Overall Study|Technical issues with PET|0
7642620|NCT01625611|12057447|FG000|Overall Study|Unable to complete study procedures|1
7642621|NCT01625611|12057448|FG001|Overall Study|Unable to complete study procedures|0
7642622|NCT01625611|12057447|FG000|Overall Study|Withdrawal by Subject|3
7642623|NCT01625611|12057448|FG001|Overall Study|Withdrawal by Subject|0
7642624|NCT01625286|12057462|FG000|Overall Study|Adverse Event|0
7642625|NCT01625286|12057463|FG001|Overall Study|Adverse Event|0
7642626|NCT01625286|12057464|FG002|Overall Study|Adverse Event|0
7642627|NCT01625286|12057465|FG003|Overall Study|Adverse Event|0
7642628|NCT01625286|12057466|FG004|Overall Study|Adverse Event|1
7642629|NCT01625286|12057467|FG005|Overall Study|Adverse Event|2
7642630|NCT01625286|12057468|FG006|Overall Study|Adverse Event|1
7642631|NCT01625286|12057462|FG000|Overall Study|Death|0
7642632|NCT01625286|12057463|FG001|Overall Study|Death|0
7642633|NCT01625286|12057464|FG002|Overall Study|Death|1
7642634|NCT01625286|12057465|FG003|Overall Study|Death|1
7642635|NCT01625286|12057466|FG004|Overall Study|Death|0
7642636|NCT01625286|12057467|FG005|Overall Study|Death|11
7642637|NCT01625286|12057468|FG006|Overall Study|Death|16
7642638|NCT01625286|12057462|FG000|Overall Study|Withdrawal by Subject|0
7642639|NCT01625286|12057463|FG001|Overall Study|Withdrawal by Subject|1
7642640|NCT01625286|12057464|FG002|Overall Study|Withdrawal by Subject|0
7642641|NCT01625286|12057465|FG003|Overall Study|Withdrawal by Subject|1
7642642|NCT01625286|12057466|FG004|Overall Study|Withdrawal by Subject|0
7642643|NCT01625286|12057467|FG005|Overall Study|Withdrawal by Subject|0
7642644|NCT01625286|12057468|FG006|Overall Study|Withdrawal by Subject|1
7642645|NCT01625286|12057462|FG000|Overall Study|Any reason not specifically recorded|0
7642646|NCT01625286|12057463|FG001|Overall Study|Any reason not specifically recorded|0
7642647|NCT01625286|12057464|FG002|Overall Study|Any reason not specifically recorded|0
7642648|NCT01625286|12057465|FG003|Overall Study|Any reason not specifically recorded|0
7642649|NCT01625286|12057466|FG004|Overall Study|Any reason not specifically recorded|0
7642650|NCT01625286|12057467|FG005|Overall Study|Any reason not specifically recorded|1
7642651|NCT01625286|12057468|FG006|Overall Study|Any reason not specifically recorded|0
7642652|NCT01625286|12057462|FG000|Overall Study|Progressive disease|6
7642653|NCT01625286|12057463|FG001|Overall Study|Progressive disease|3
7642654|NCT01625286|12057464|FG002|Overall Study|Progressive disease|4
7642655|NCT01625286|12057465|FG003|Overall Study|Progressive disease|5
7642656|NCT01625286|12057466|FG004|Overall Study|Progressive disease|5
7642657|NCT01625286|12057467|FG005|Overall Study|Progressive disease|0
7642658|NCT01625286|12057468|FG006|Overall Study|Progressive disease|0
7642659|NCT01625286|12057462|FG000|Overall Study|Lost to Follow-up|0
7642660|NCT01625286|12057463|FG001|Overall Study|Lost to Follow-up|0
7642661|NCT01625286|12057464|FG002|Overall Study|Lost to Follow-up|0
7642662|NCT01625286|12057465|FG003|Overall Study|Lost to Follow-up|0
7642663|NCT01625286|12057466|FG004|Overall Study|Lost to Follow-up|0
7642664|NCT01625286|12057467|FG005|Overall Study|Lost to Follow-up|0
7642665|NCT01625286|12057468|FG006|Overall Study|Lost to Follow-up|1
7642666|NCT01625286|12057462|FG000|Overall Study|Ongoing off-treatment at DCO|0
7642667|NCT01625286|12057463|FG001|Overall Study|Ongoing off-treatment at DCO|0
7642668|NCT01625286|12057464|FG002|Overall Study|Ongoing off-treatment at DCO|0
7642669|NCT01625286|12057465|FG003|Overall Study|Ongoing off-treatment at DCO|0
7642670|NCT01625286|12057466|FG004|Overall Study|Ongoing off-treatment at DCO|0
7642671|NCT01625286|12057467|FG005|Overall Study|Ongoing off-treatment at DCO|32
7642672|NCT01625286|12057468|FG006|Overall Study|Ongoing off-treatment at DCO|31
7642673|NCT01625286|12057462|FG000|Overall Study|Ongoing on-treatment at DCO|6
7642674|NCT01625286|12057463|FG001|Overall Study|Ongoing on-treatment at DCO|4
7642675|NCT01625286|12057464|FG002|Overall Study|Ongoing on-treatment at DCO|0
7642676|NCT01625286|12057465|FG003|Overall Study|Ongoing on-treatment at DCO|0
7642677|NCT01625286|12057466|FG004|Overall Study|Ongoing on-treatment at DCO|0
7642678|NCT01625286|12057467|FG005|Overall Study|Ongoing on-treatment at DCO|8
7642679|NCT01625286|12057468|FG006|Overall Study|Ongoing on-treatment at DCO|6
7642680|NCT01615029|12057508|FG000|Overall Study|Adverse Event|0
7642681|NCT01615029|12057509|FG001|Overall Study|Adverse Event|0
7642682|NCT01615029|12057510|FG002|Overall Study|Adverse Event|0
7642683|NCT01615029|12057511|FG003|Overall Study|Adverse Event|0
7642684|NCT01615029|12057512|FG004|Overall Study|Adverse Event|1
7642685|NCT01615029|12057508|FG000|Overall Study|Death|0
7642686|NCT01615029|12057509|FG001|Overall Study|Death|0
7642687|NCT01615029|12057510|FG002|Overall Study|Death|0
7642688|NCT01615029|12057511|FG003|Overall Study|Death|0
7642689|NCT01615029|12057512|FG004|Overall Study|Death|1
7642690|NCT01615029|12057508|FG000|Overall Study|Lost to Follow-up|0
7642691|NCT01615029|12057509|FG001|Overall Study|Lost to Follow-up|0
7642692|NCT01615029|12057510|FG002|Overall Study|Lost to Follow-up|0
7642693|NCT01615029|12057511|FG003|Overall Study|Lost to Follow-up|0
7642694|NCT01615029|12057512|FG004|Overall Study|Lost to Follow-up|1
7642695|NCT01615029|12057508|FG000|Overall Study|Progressive disease|2
7642696|NCT01615029|12057509|FG001|Overall Study|Progressive disease|1
7642697|NCT01615029|12057510|FG002|Overall Study|Progressive disease|1
7642698|NCT01615029|12057511|FG003|Overall Study|Progressive disease|1
7642699|NCT01615029|12057512|FG004|Overall Study|Progressive disease|5
7642700|NCT01615029|12057508|FG000|Overall Study|Physician Decision|0
7642701|NCT01615029|12057509|FG001|Overall Study|Physician Decision|0
7642702|NCT01615029|12057510|FG002|Overall Study|Physician Decision|0
7642703|NCT01615029|12057511|FG003|Overall Study|Physician Decision|0
7642704|NCT01615029|12057512|FG004|Overall Study|Physician Decision|1
7642705|NCT01615029|12057508|FG000|Overall Study|Ongoing|1
7642706|NCT01615029|12057509|FG001|Overall Study|Ongoing|2
7642707|NCT01615029|12057510|FG002|Overall Study|Ongoing|3
7642708|NCT01615029|12057511|FG003|Overall Study|Ongoing|2
7642709|NCT01615029|12057512|FG004|Overall Study|Ongoing|23
7642710|NCT01603407|12057545|FG000|Overall Study|Adverse Event|1
7642711|NCT01603407|12057546|FG001|Overall Study|Adverse Event|1
7642712|NCT01603407|12057547|FG002|Overall Study|Adverse Event|1
7642713|NCT01603407|12057545|FG000|Overall Study|Protocol Violation|2
7642714|NCT01603407|12057546|FG001|Overall Study|Protocol Violation|2
7642715|NCT01603407|12057547|FG002|Overall Study|Protocol Violation|0
7642716|NCT01603407|12057545|FG000|Overall Study|Withdrawal by Subject|8
7642717|NCT01603407|12057546|FG001|Overall Study|Withdrawal by Subject|5
7642718|NCT01603407|12057547|FG002|Overall Study|Withdrawal by Subject|7
7642719|NCT01603407|12057545|FG000|Overall Study|Lost to Follow-up|0
7642720|NCT01603407|12057546|FG001|Overall Study|Lost to Follow-up|3
7642721|NCT01603407|12057547|FG002|Overall Study|Lost to Follow-up|2
7642722|NCT01602380|12057557|FG000|Overall Study|Death|63
7642723|NCT01602380|12057558|FG001|Overall Study|Death|68
7642724|NCT01602380|12057557|FG000|Overall Study|Withdrawal by Subject|22
7642725|NCT01602380|12057558|FG001|Overall Study|Withdrawal by Subject|29
7642726|NCT01602380|12057557|FG000|Overall Study|Lost to Follow-up|6
7642727|NCT01602380|12057558|FG001|Overall Study|Lost to Follow-up|1
7642728|NCT01602380|12057557|FG000|Overall Study|Eligibility criteria not fulfilled|2
7642729|NCT01602380|12057558|FG001|Overall Study|Eligibility criteria not fulfilled|3
7642730|NCT01598311|12057566|FG000|Overall Study|Physician Decision|4
7642731|NCT01598311|12057567|FG001|Overall Study|Physician Decision|5
7642732|NCT01598311|12057566|FG000|Overall Study|Adverse Event|9
7642733|NCT01598311|12057567|FG001|Overall Study|Adverse Event|13
7642734|NCT01598311|12057566|FG000|Overall Study|Lost to Follow-up|7
7642735|NCT01598311|12057567|FG001|Overall Study|Lost to Follow-up|12
7642736|NCT01598311|12057566|FG000|Overall Study|Withdrawal by Subject|9
7642737|NCT01598311|12057567|FG001|Overall Study|Withdrawal by Subject|13
7642738|NCT01598311|12057566|FG000|Overall Study|No reason provided.|0
7642739|NCT01598311|12057567|FG001|Overall Study|No reason provided.|5
7642740|NCT01598311|12057566|FG000|Overall Study|Randomized but never treated|8
7642741|NCT01598311|12057567|FG001|Overall Study|Randomized but never treated|5
7642742|NCT01598311|12057566|FG000|Overall Study|Treated but no confirmed CDAD|9
7642743|NCT01598311|12057567|FG001|Overall Study|Treated but no confirmed CDAD|8
7642744|NCT01598311|12057566|FG000|Overall Study|Assigned to CB but received vancomycin|1
7642745|NCT01598311|12057567|FG001|Overall Study|Assigned to CB but received vancomycin|0
7642746|NCT01593761|12057627|FG000|Overall Study|Lost to Follow-up|1
7642747|NCT01593761|12057627|FG000|Overall Study|culture negative for MRSA at baseline|5
7642748|NCT01593761|12057627|FG000|Overall Study|positive for hepatitis C virus|1
7642749|NCT01593761|12057627|FG000|Overall Study|secondary cellulitis|1
7642750|NCT01593254|12057639|FG000|Treatment Period|Treatment Failure|1
7642751|NCT01593254|12057640|FG001|Treatment Period|Treatment Failure|2
7642752|NCT01593254|12057639|FG000|Treatment Period|Pregnancy|0
7642753|NCT01593254|12057640|FG001|Treatment Period|Pregnancy|1
7642754|NCT01593254|12057639|FG000|Treatment Period|Poor/Non-Compliance|2
7642755|NCT01593254|12057640|FG001|Treatment Period|Poor/Non-Compliance|1
7642756|NCT01593254|12057639|FG000|Treatment Period|Maximum clinical benefit|1
7642757|NCT01593254|12057640|FG001|Treatment Period|Maximum clinical benefit|0
7642758|NCT01593254|12057639|FG000|Treatment Period|Subject withdrew consent|0
7642759|NCT01593254|12057640|FG001|Treatment Period|Subject withdrew consent|5
7642760|NCT01593254|12057639|FG000|Treatment Period|Subject Request to Discontinue|1
7642761|NCT01593254|12057640|FG001|Treatment Period|Subject Request to Discontinue|1
7642762|NCT01593254|12057639|FG000|Treatment Period|AE unrelated to Study Drug|0
7642763|NCT01593254|12057640|FG001|Treatment Period|AE unrelated to Study Drug|1
7642764|NCT01593254|12057639|FG000|Treatment Period|Death|2
7642765|NCT01593254|12057640|FG001|Treatment Period|Death|1
7642766|NCT01593254|12057639|FG000|Treatment Period|Study Drug Toxicity|3
7642767|NCT01593254|12057640|FG001|Treatment Period|Study Drug Toxicity|9
7642768|NCT01593254|12057639|FG000|Treatment Period|Disease Progression|1
7642769|NCT01593254|12057640|FG001|Treatment Period|Disease Progression|6
7642770|NCT01593254|12057639|FG000|Treatment Period|Did Not Achieve RCC|0
7642771|NCT01593254|12057640|FG001|Treatment Period|Did Not Achieve RCC|1
7642772|NCT01593254|12057639|FG000|Treatment Period|Patient Refused to Return|0
7642773|NCT01593254|12057640|FG001|Treatment Period|Patient Refused to Return|1
7642774|NCT01593254|12057639|FG000|Treatment Period|No Response|1
7642775|NCT01593254|12057640|FG001|Treatment Period|No Response|0
7642776|NCT01593254|12057639|FG000|Treatment Period|T315I MUTATION|0
7642777|NCT01593254|12057640|FG001|Treatment Period|T315I MUTATION|1
7642778|NCT01593254|12057639|FG000|Treatment Period|Investigator Decision|2
7642779|NCT01593254|12057640|FG001|Treatment Period|Investigator Decision|1
7642780|NCT01593254|12057639|FG000|Follow-Up Period|Withdrawal by Subject|0
7642781|NCT01593254|12057640|FG001|Follow-Up Period|Withdrawal by Subject|2
7642782|NCT01593254|12057639|FG000|Follow-Up Period|Non-Compliance|1
7642783|NCT01593254|12057640|FG001|Follow-Up Period|Non-Compliance|0
7642784|NCT01593254|12057639|FG000|Follow-Up Period|Death|2
7642785|NCT01593254|12057640|FG001|Follow-Up Period|Death|2
7642786|NCT01593254|12057639|FG000|Follow-Up Period|Subject request to Discontinue|0
7642787|NCT01593254|12057640|FG001|Follow-Up Period|Subject request to Discontinue|1
7642788|NCT01593254|12057639|FG000|Follow-Up Period|Pregnancy|0
7642789|NCT01593254|12057640|FG001|Follow-Up Period|Pregnancy|1
7642790|NCT01593254|12057639|FG000|Follow-Up Period|Study Drug Toxicity|0
7642791|NCT01593254|12057640|FG001|Follow-Up Period|Study Drug Toxicity|1
7642792|NCT01593254|12057639|FG000|Follow-Up Period|Patient refused to return|0
7642793|NCT01593254|12057640|FG001|Follow-Up Period|Patient refused to return|1
7642794|NCT01593254|12057639|FG000|Follow-Up Period|Fundus Hemorrhage|0
7642795|NCT01593254|12057640|FG001|Follow-Up Period|Fundus Hemorrhage|1
7642796|NCT01593254|12057639|FG000|Follow-Up Period|Disease Progression|0
7642797|NCT01593254|12057640|FG001|Follow-Up Period|Disease Progression|1
7642798|NCT01593254|12057639|FG000|Follow-Up Period|Study Drug Side Effects|0
7642799|NCT01593254|12057640|FG001|Follow-Up Period|Study Drug Side Effects|1
7642800|NCT01592721|12057647|FG000|Long-term Follow-up|Death|1
7642801|NCT01592370|12057658|FG000|Overall Study|Disease Progression|62
7642802|NCT01592370|12057659|FG001|Overall Study|Disease Progression|16
7642803|NCT01592370|12057660|FG002|Overall Study|Disease Progression|52
7642804|NCT01592370|12057661|FG003|Overall Study|Disease Progression|3
7642805|NCT01592370|12057662|FG004|Overall Study|Disease Progression|3
7642806|NCT01592370|12057663|FG005|Overall Study|Disease Progression|31
7642807|NCT01592370|12057664|FG006|Overall Study|Disease Progression|14
7642808|NCT01592370|12057658|FG000|Overall Study|Study Drug Toxicity|14
7642809|NCT01592370|12057659|FG001|Overall Study|Study Drug Toxicity|3
7642810|NCT01592370|12057660|FG002|Overall Study|Study Drug Toxicity|0
7642811|NCT01592370|12057661|FG003|Overall Study|Study Drug Toxicity|0
7642812|NCT01592370|12057662|FG004|Overall Study|Study Drug Toxicity|0
7642813|NCT01592370|12057663|FG005|Overall Study|Study Drug Toxicity|0
7642814|NCT01592370|12057664|FG006|Overall Study|Study Drug Toxicity|1
7642815|NCT01592370|12057658|FG000|Overall Study|AE unrelated to study drug|4
7642816|NCT01592370|12057659|FG001|Overall Study|AE unrelated to study drug|3
7642817|NCT01592370|12057660|FG002|Overall Study|AE unrelated to study drug|0
7642818|NCT01592370|12057661|FG003|Overall Study|AE unrelated to study drug|0
7642819|NCT01592370|12057662|FG004|Overall Study|AE unrelated to study drug|0
7642820|NCT01592370|12057663|FG005|Overall Study|AE unrelated to study drug|0
7642821|NCT01592370|12057664|FG006|Overall Study|AE unrelated to study drug|1
7642822|NCT01592370|12057658|FG000|Overall Study|Request to discontinue study treatment|5
7642823|NCT01592370|12057659|FG001|Overall Study|Request to discontinue study treatment|0
7642824|NCT01592370|12057660|FG002|Overall Study|Request to discontinue study treatment|2
7642825|NCT01592370|12057661|FG003|Overall Study|Request to discontinue study treatment|0
7642826|NCT01592370|12057662|FG004|Overall Study|Request to discontinue study treatment|1
7642827|NCT01592370|12057663|FG005|Overall Study|Request to discontinue study treatment|2
7642828|NCT01592370|12057664|FG006|Overall Study|Request to discontinue study treatment|0
7642829|NCT01592370|12057658|FG000|Overall Study|Withdrew consent|1
7642830|NCT01592370|12057659|FG001|Overall Study|Withdrew consent|2
7642831|NCT01592370|12057660|FG002|Overall Study|Withdrew consent|1
7642832|NCT01592370|12057661|FG003|Overall Study|Withdrew consent|1
7642833|NCT01592370|12057662|FG004|Overall Study|Withdrew consent|0
7642834|NCT01592370|12057663|FG005|Overall Study|Withdrew consent|0
7642835|NCT01592370|12057664|FG006|Overall Study|Withdrew consent|0
7642836|NCT01592370|12057658|FG000|Overall Study|Maximum clinical benefit|11
7642837|NCT01592370|12057659|FG001|Overall Study|Maximum clinical benefit|1
7642838|NCT01592370|12057660|FG002|Overall Study|Maximum clinical benefit|7
7642839|NCT01592370|12057661|FG003|Overall Study|Maximum clinical benefit|1
7642840|NCT01592370|12057662|FG004|Overall Study|Maximum clinical benefit|0
7642841|NCT01592370|12057663|FG005|Overall Study|Maximum clinical benefit|0
7642842|NCT01592370|12057664|FG006|Overall Study|Maximum clinical benefit|0
7642843|NCT01592370|12057658|FG000|Overall Study|No longer meets study criteria|1
7642844|NCT01592370|12057659|FG001|Overall Study|No longer meets study criteria|0
7642845|NCT01592370|12057660|FG002|Overall Study|No longer meets study criteria|0
7642846|NCT01592370|12057661|FG003|Overall Study|No longer meets study criteria|0
7642847|NCT01592370|12057662|FG004|Overall Study|No longer meets study criteria|0
7642848|NCT01592370|12057663|FG005|Overall Study|No longer meets study criteria|0
7642849|NCT01592370|12057664|FG006|Overall Study|No longer meets study criteria|0
7642850|NCT01592370|12057658|FG000|Overall Study|Other Reasons|6
7642851|NCT01592370|12057659|FG001|Overall Study|Other Reasons|0
7642852|NCT01592370|12057660|FG002|Overall Study|Other Reasons|10
7642853|NCT01592370|12057661|FG003|Overall Study|Other Reasons|0
7642854|NCT01592370|12057662|FG004|Overall Study|Other Reasons|0
7642855|NCT01592370|12057663|FG005|Overall Study|Other Reasons|1
7642856|NCT01592370|12057664|FG006|Overall Study|Other Reasons|0
7642857|NCT01590017|12057684|FG000|Overall Study|Adverse Event|1
7642858|NCT01590017|12057684|FG000|Overall Study|Withdrawal by Subject|1
7642859|NCT01590017|12057684|FG000|Overall Study|Lack of Efficacy|1
7642860|NCT01590017|12057684|FG000|Overall Study|Physician Decision|1
7642861|NCT01582009|12057688|FG000|Overall Study|Withdrawal by Subject|1
7642862|NCT01582009|12057688|FG000|Overall Study|Physician Decision|1
7642863|NCT01575834|12057694|FG000|Overall Study|Withdrawal by Subject|352
7642864|NCT01575834|12057695|FG001|Overall Study|Withdrawal by Subject|390
7642865|NCT01575834|12057694|FG000|Overall Study|Death|81
7642866|NCT01575834|12057695|FG001|Overall Study|Death|74
7642867|NCT01575834|12057694|FG000|Overall Study|Other|70
7642868|NCT01575834|12057695|FG001|Overall Study|Other|70
7642869|NCT01575834|12057694|FG000|Overall Study|Adverse Event|63
7642870|NCT01575834|12057695|FG001|Overall Study|Adverse Event|61
7642871|NCT01575834|12057694|FG000|Overall Study|Lost to Follow-up|55
7642872|NCT01575834|12057695|FG001|Overall Study|Lost to Follow-up|68
7642873|NCT01575834|12057694|FG000|Overall Study|Noncompliance|52
7642874|NCT01575834|12057695|FG001|Overall Study|Noncompliance|27
7642875|NCT01575834|12057694|FG000|Overall Study|Administrative decision|15
7642876|NCT01575834|12057695|FG001|Overall Study|Administrative decision|33
7642877|NCT01575834|12057694|FG000|Overall Study|Ineligibility Determined|5
7642878|NCT01575834|12057695|FG001|Overall Study|Ineligibility Determined|8
7642879|NCT01575834|12057694|FG000|Overall Study|Protocol Deviation|4
7642880|NCT01575834|12057695|FG001|Overall Study|Protocol Deviation|3
7642881|NCT01575834|12057694|FG000|Overall Study|Requirement for Alternative Therapy|2
7642882|NCT01575834|12057695|FG001|Overall Study|Requirement for Alternative Therapy|4
7642883|NCT01574274|12057707|FG000|Overall Study|Ineligible|0
7642884|NCT01574274|12057708|FG001|Overall Study|Ineligible|1
7642885|NCT01574274|12057707|FG000|Overall Study|Withdrawal of Consent During Induction|1
7642886|NCT01574274|12057708|FG001|Overall Study|Withdrawal of Consent During Induction|1
7642887|NCT01574274|12057707|FG000|Overall Study|Ph+ B-ALL|3
7642888|NCT01574274|12057708|FG001|Overall Study|Ph+ B-ALL|4
7642889|NCT01574274|12057707|FG000|Overall Study|Induction Death|2
7642890|NCT01574274|12057708|FG001|Overall Study|Induction Death|0
7642891|NCT01574274|12057707|FG000|Overall Study|Induction Failure|4
7642892|NCT01574274|12057708|FG001|Overall Study|Induction Failure|1
7642893|NCT01574274|12057707|FG000|Overall Study|Adverse Event|16
7642894|NCT01574274|12057708|FG001|Overall Study|Adverse Event|13
7642895|NCT01574274|12057707|FG000|Overall Study|Remission Death|1
7642896|NCT01574274|12057708|FG001|Overall Study|Remission Death|0
7642897|NCT01574274|12057707|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2
7642898|NCT01574274|12057708|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0
7642899|NCT01574274|12057707|FG000|Overall Study|Other, unknown|3
7642900|NCT01574274|12057708|FG001|Overall Study|Other, unknown|2
7642901|NCT01572480|12057714|FG000|Participants Enrolled|Withdrawal by Subject|1
7642902|NCT01572480|12057714|FG000|Drug Administration|Discontinued drug/Off Study|1
7642903|NCT01572480|12057714|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1
7642904|NCT01572480|12057714|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2
7642905|NCT01568866|12057720|FG000|Overall Study|Disease Progression|208
7642906|NCT01568866|12057721|FG001|Overall Study|Disease Progression|183
7642907|NCT01568866|12057720|FG000|Overall Study|Adverse Event|94
7642908|NCT01568866|12057721|FG001|Overall Study|Adverse Event|96
7642909|NCT01568866|12057720|FG000|Overall Study|Patient Request|55
7642910|NCT01568866|12057721|FG001|Overall Study|Patient Request|71
7642911|NCT01568866|12057720|FG000|Overall Study|Physician Decision|40
7642912|NCT01568866|12057721|FG001|Overall Study|Physician Decision|32
7642913|NCT01568866|12057720|FG000|Overall Study|Withdrawal by Subject|19
7642914|NCT01568866|12057721|FG001|Overall Study|Withdrawal by Subject|11
7642915|NCT01568866|12057720|FG000|Overall Study|Death|10
7642916|NCT01568866|12057721|FG001|Overall Study|Death|18
7642917|NCT01568866|12057720|FG000|Overall Study|Protocol Non-compliance|2
7642918|NCT01568866|12057721|FG001|Overall Study|Protocol Non-compliance|4
7642919|NCT01568866|12057720|FG000|Overall Study|Lost to Follow-up|1
7642920|NCT01568866|12057721|FG001|Overall Study|Lost to Follow-up|0
7642921|NCT01568866|12057720|FG000|Overall Study|Randomized but Not Dosed|9
7642922|NCT01568866|12057721|FG001|Overall Study|Randomized but Not Dosed|1
7642923|NCT01566695|12057729|FG000|Overall Study|Lack of Efficacy|18
7642924|NCT01566695|12057730|FG001|Overall Study|Lack of Efficacy|45
7642925|NCT01566695|12057729|FG000|Overall Study|Adverse Event|28
7642926|NCT01566695|12057730|FG001|Overall Study|Adverse Event|27
7642927|NCT01566695|12057729|FG000|Overall Study|Death|20
7642928|NCT01566695|12057730|FG001|Overall Study|Death|8
7642929|NCT01566695|12057729|FG000|Overall Study|Withdrawal by Subject|14
7642930|NCT01566695|12057730|FG001|Overall Study|Withdrawal by Subject|7
7642931|NCT01566695|12057729|FG000|Overall Study|Progressive Disease|11
7642932|NCT01566695|12057730|FG001|Overall Study|Progressive Disease|6
7642933|NCT01566695|12057729|FG000|Overall Study|Miscellaneous|4
7642934|NCT01566695|12057730|FG001|Overall Study|Miscellaneous|6
7642935|NCT01562028|12057743|FG000|Overall Study|Withdrawal by Subject|1
7642936|NCT01562028|12057744|FG001|Overall Study|Withdrawal by Subject|1
7642937|NCT01562028|12057743|FG000|Overall Study|Lost to Follow-up|2
7642938|NCT01562028|12057744|FG001|Overall Study|Lost to Follow-up|1
7642939|NCT01553149|12057779|FG000|Overall Study|Adverse Event|0
7642940|NCT01553149|12057780|FG001|Overall Study|Adverse Event|9
7642941|NCT01553149|12057779|FG000|Overall Study|Physician Decision|5
7642942|NCT01553149|12057780|FG001|Overall Study|Physician Decision|10
7642943|NCT01553149|12057779|FG000|Overall Study|Ineligible|0
7642944|NCT01553149|12057780|FG001|Overall Study|Ineligible|1
7642945|NCT01535053|12057788|FG000|Overall Study|Ineligible|1
7642946|NCT01535053|12057789|FG001|Overall Study|Ineligible|2
7642947|NCT01522976|12057798|FG000|Overall Study|Ineligible|4
7642948|NCT01522976|12057799|FG001|Overall Study|Ineligible|0
7642949|NCT01522976|12057800|FG002|Overall Study|Ineligible|1
7642950|NCT01522976|12057798|FG000|Overall Study|Death|7
7642951|NCT01522976|12057799|FG001|Overall Study|Death|6
7642952|NCT01522976|12057800|FG002|Overall Study|Death|2
7642953|NCT01522976|12057798|FG000|Overall Study|Still on treatment|9
7642954|NCT01522976|12057799|FG001|Overall Study|Still on treatment|9
7642955|NCT01522976|12057800|FG002|Overall Study|Still on treatment|6
7642956|NCT01522976|12057798|FG000|Overall Study|Disease progression|28
7642957|NCT01522976|12057799|FG001|Overall Study|Disease progression|30
7642958|NCT01522976|12057800|FG002|Overall Study|Disease progression|25
7642959|NCT01522976|12057798|FG000|Overall Study|Adverse Event|17
7642960|NCT01522976|12057799|FG001|Overall Study|Adverse Event|7
7642961|NCT01522976|12057800|FG002|Overall Study|Adverse Event|18
7642962|NCT01522976|12057798|FG000|Overall Study|Refusal unrelated to adverse event|10
7642963|NCT01522976|12057799|FG001|Overall Study|Refusal unrelated to adverse event|13
7642964|NCT01522976|12057800|FG002|Overall Study|Refusal unrelated to adverse event|14
7642965|NCT01522976|12057798|FG000|Overall Study|Not protocol specified|22
7642966|NCT01522976|12057799|FG001|Overall Study|Not protocol specified|27
7642967|NCT01522976|12057800|FG002|Overall Study|Not protocol specified|27
7642968|NCT01522456|12057811|FG000|Overall Study|Adverse Event|2
7642969|NCT01522456|12057811|FG000|Overall Study|Lost to Follow-up|2
7642970|NCT01522456|12057811|FG000|Overall Study|Withdrawal by Subject|2
7642971|NCT01522456|12057811|FG000|Overall Study|Pregnancy|1
7642972|NCT01522456|12057811|FG000|Overall Study|Tolerability Assessment|1
7642973|NCT01522365|12057824|FG000|Overall Study|Withdrawal by Subject|1
7642974|NCT01522365|12057825|FG001|Overall Study|Withdrawal by Subject|1
7642975|NCT01522365|12057824|FG000|Overall Study|Lost to Follow-up|1
7642976|NCT01522365|12057825|FG001|Overall Study|Lost to Follow-up|1
7642977|NCT01496976|12057845|FG000|Overall Study|Withdrew - received stem cell transplant|1
7642978|NCT01485614|12057862|FG000|Randomization|Not Treated|1
7642979|NCT01485614|12057863|FG001|Randomization|Not Treated|0
7642980|NCT01485614|12057864|FG002|Randomization|Not Treated|0
7642981|NCT01485614|12057865|FG003|Randomization|Not Treated|0
7642982|NCT01485614|12057862|FG000|Weeks 0-20|Lost to Follow-up|2
7642983|NCT01485614|12057863|FG001|Weeks 0-20|Lost to Follow-up|0
7642984|NCT01485614|12057864|FG002|Weeks 0-20|Lost to Follow-up|0
7642985|NCT01485614|12057865|FG003|Weeks 0-20|Lost to Follow-up|0
7642986|NCT01485614|12057862|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
7642987|NCT01485614|12057863|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
7642988|NCT01485614|12057864|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
7642989|NCT01485614|12057865|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
7642990|NCT01485614|12057862|FG000|Weeks 0-20|Withdrawal by Subject|3
7642991|NCT01485614|12057863|FG001|Weeks 0-20|Withdrawal by Subject|2
7642992|NCT01485614|12057864|FG002|Weeks 0-20|Withdrawal by Subject|1
7642993|NCT01485614|12057865|FG003|Weeks 0-20|Withdrawal by Subject|0
7642994|NCT01485614|12057862|FG000|Weeks 20-54|Lost to Follow-up|4
7642995|NCT01485614|12057863|FG001|Weeks 20-54|Lost to Follow-up|3
7642996|NCT01485614|12057864|FG002|Weeks 20-54|Lost to Follow-up|1
7642997|NCT01485614|12057865|FG003|Weeks 20-54|Lost to Follow-up|0
7642998|NCT01485614|12057862|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
7642999|NCT01485614|12057863|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
7643000|NCT01485614|12057864|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
7643001|NCT01485614|12057865|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
7643002|NCT01485614|12057862|FG000|Weeks 20-54|Withdrawal by Subject|5
7643003|NCT01485614|12057863|FG001|Weeks 20-54|Withdrawal by Subject|3
7643004|NCT01485614|12057864|FG002|Weeks 20-54|Withdrawal by Subject|0
7643005|NCT01485614|12057865|FG003|Weeks 20-54|Withdrawal by Subject|0
7643006|NCT01471522|12057883|FG000|Overall Study|Withdrawal by Subject|28
7643007|NCT01471522|12057884|FG001|Overall Study|Withdrawal by Subject|22
7643008|NCT01471522|12057883|FG000|Overall Study|Lost to Follow-up|36
7643009|NCT01471522|12057884|FG001|Overall Study|Lost to Follow-up|26
7643010|NCT01462630|12057891|FG000|Overall Study|Did not initiate therapy|3
7643011|NCT01462630|12057891|FG000|Overall Study|Death|1
7643012|NCT01462630|12057891|FG000|Overall Study|Protocol Violation|2
7643013|NCT01462630|12057891|FG000|Overall Study|Adverse Event|1
7643014|NCT01458366|12057900|FG000|Period 1: 70mg/m^2|Physician Decision|2
7643015|NCT01458366|12057901|FG001|Period 1: 70mg/m^2|Physician Decision|0
7643016|NCT01458366|12057902|FG002|Period 1: 70mg/m^2|Physician Decision|0
7643017|NCT01458366|12057903|FG003|Period 1: 70mg/m^2|Physician Decision|0
7643018|NCT01458366|12057904|FG004|Period 1: 70mg/m^2|Physician Decision|0
7643019|NCT01458366|12057900|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643020|NCT01458366|12057901|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643021|NCT01458366|12057902|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643022|NCT01458366|12057903|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
7643023|NCT01458366|12057904|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
7643024|NCT01452919|12057912|FG000|Open-Label Treatment|Adverse Event|5
7643025|NCT01452919|12057913|FG001|Open-Label Treatment|Adverse Event|0
7643026|NCT01452919|12057914|FG002|Open-Label Treatment|Adverse Event|0
7643027|NCT01452919|12057912|FG000|Open-Label Treatment|Lost to Follow-up|4
7643028|NCT01452919|12057913|FG001|Open-Label Treatment|Lost to Follow-up|0
7643029|NCT01452919|12057914|FG002|Open-Label Treatment|Lost to Follow-up|0
7643030|NCT01452919|12057912|FG000|Open-Label Treatment|Perceived lack of efficacy|3
7643031|NCT01452919|12057913|FG001|Open-Label Treatment|Perceived lack of efficacy|0
7643032|NCT01452919|12057914|FG002|Open-Label Treatment|Perceived lack of efficacy|0
7643033|NCT01452919|12057912|FG000|Open-Label Treatment|Protocol Violation|4
7643034|NCT01452919|12057913|FG001|Open-Label Treatment|Protocol Violation|0
7643035|NCT01452919|12057914|FG002|Open-Label Treatment|Protocol Violation|0
7643036|NCT01452919|12057912|FG000|Open-Label Treatment|Sponsor Decision|1
7643037|NCT01452919|12057913|FG001|Open-Label Treatment|Sponsor Decision|0
7643038|NCT01452919|12057914|FG002|Open-Label Treatment|Sponsor Decision|0
7643039|NCT01452919|12057912|FG000|Open-Label Treatment|Withdrawal by Subject|2
7643040|NCT01452919|12057913|FG001|Open-Label Treatment|Withdrawal by Subject|0
7643041|NCT01452919|12057914|FG002|Open-Label Treatment|Withdrawal by Subject|0
7643042|NCT01452919|12057912|FG000|Open-Label Treatment|Subject is moving or has moved|1
7643043|NCT01452919|12057913|FG001|Open-Label Treatment|Subject is moving or has moved|0
7643044|NCT01452919|12057914|FG002|Open-Label Treatment|Subject is moving or has moved|0
7643045|NCT01452919|12057912|FG000|Randomization Treatment|Adverse Event|0
7643046|NCT01452919|12057913|FG001|Randomization Treatment|Adverse Event|0
7643047|NCT01452919|12057914|FG002|Randomization Treatment|Adverse Event|2
7643048|NCT01452919|12057912|FG000|Randomization Treatment|Sponsor Decision|0
7643049|NCT01452919|12057913|FG001|Randomization Treatment|Sponsor Decision|1
7643050|NCT01452919|12057914|FG002|Randomization Treatment|Sponsor Decision|0
7643051|NCT01452919|12057912|FG000|Randomization Treatment|Withdrawal by Subject|0
7643052|NCT01452919|12057913|FG001|Randomization Treatment|Withdrawal by Subject|1
7643053|NCT01452919|12057914|FG002|Randomization Treatment|Withdrawal by Subject|0
7643054|NCT01452919|12057912|FG000|Randomization Treatment|Subject is moving or has moved|0
7643055|NCT01452919|12057913|FG001|Randomization Treatment|Subject is moving or has moved|1
7643056|NCT01452919|12057914|FG002|Randomization Treatment|Subject is moving or has moved|0
7643057|NCT01450631|12057926|FG000|Overall Study|Lost to Follow-up|2
7643058|NCT01450631|12057927|FG001|Overall Study|Lost to Follow-up|4
7643059|NCT01450631|12057926|FG000|Overall Study|Withdrawal by Subject|1
7643060|NCT01450631|12057927|FG001|Overall Study|Withdrawal by Subject|0
7643061|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
7643062|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
7643063|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Death|2
7643064|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Death|1
7643065|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
7643066|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
7643067|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
7643068|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
7643069|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Other|8
7643070|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Other|13
7643071|NCT01439880|12057935|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
7643072|NCT01439880|12057936|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
7643073|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
7643074|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
7643075|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
7643076|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
7643077|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Death|3
7643078|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Death|13
7643079|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
7643080|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
7643081|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Other|14
7643082|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Other|31
7643083|NCT01439880|12057935|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
7643084|NCT01439880|12057936|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
7643085|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Adverse Event|5
7643086|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Adverse Event|0
7643087|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Adverse Event|0
7643088|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
7643089|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
7643090|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
7643091|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Protocol Violation|5
7643092|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Protocol Violation|0
7643093|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Protocol Violation|0
7643094|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
7643095|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
7643096|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
7643097|NCT01426269|12057979|FG000|Period 1: 12 Weeks|Pregnancy|1
7643098|NCT01426269|12057980|FG001|Period 1: 12 Weeks|Pregnancy|0
7643099|NCT01426269|12057981|FG002|Period 1: 12 Weeks|Pregnancy|0
7643100|NCT01426269|12057979|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
7643101|NCT01426269|12057980|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
7643102|NCT01426269|12057981|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
7643103|NCT01426269|12057979|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
7643104|NCT01426269|12057980|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
7643105|NCT01426269|12057981|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
7643106|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Adverse Event|0
7643107|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Adverse Event|1
7643108|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Adverse Event|2
7643109|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
7643110|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
7643111|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
7643112|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Protocol Violation|0
7643113|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Protocol Violation|5
7643114|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Protocol Violation|5
7643115|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
7643116|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
7643117|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
7643118|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Site closed|0
7643119|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Site closed|6
7643120|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Site closed|5
7643121|NCT01426269|12057979|FG000|Period 2: 40 Weeks|Relapsed|0
7643122|NCT01426269|12057980|FG001|Period 2: 40 Weeks|Relapsed|9
7643123|NCT01426269|12057981|FG002|Period 2: 40 Weeks|Relapsed|18
7643124|NCT01420926|12057994|FG000|Overall Study|Adverse Event|6
7643125|NCT01420926|12057995|FG001|Overall Study|Adverse Event|4
7643126|NCT01420926|12057994|FG000|Overall Study|Death|18
7643127|NCT01420926|12057995|FG001|Overall Study|Death|17
7643128|NCT01420926|12057994|FG000|Overall Study|Withdrawal by Subject|11
7643129|NCT01420926|12057995|FG001|Overall Study|Withdrawal by Subject|16
7643130|NCT01420926|12057994|FG000|Overall Study|Non-protocol treatment|17
7643131|NCT01420926|12057995|FG001|Overall Study|Non-protocol treatment|20
7643132|NCT01420926|12057994|FG000|Overall Study|Physician Decision|7
7643133|NCT01420926|12057995|FG001|Overall Study|Physician Decision|5
7643134|NCT01420926|12057994|FG000|Overall Study|Continues on active treatment|1
7643135|NCT01420926|12057995|FG001|Overall Study|Continues on active treatment|3
7643136|NCT01417234|12058001|FG000|Overall Study|Subject non-compliant|3
7643137|NCT01415440|12058008|FG000|Overall Study|Lost to Follow-up|0
7643138|NCT01415440|12058009|FG001|Overall Study|Lost to Follow-up|1
7643139|NCT01415440|12058010|FG002|Overall Study|Lost to Follow-up|2
7643140|NCT01415440|12058008|FG000|Overall Study|Physician Decision|3
7643141|NCT01415440|12058009|FG001|Overall Study|Physician Decision|0
7643142|NCT01415440|12058010|FG002|Overall Study|Physician Decision|0
7643143|NCT01415440|12058008|FG000|Overall Study|Withdrawal by Subject|1
7643144|NCT01415440|12058009|FG001|Overall Study|Withdrawal by Subject|0
7643145|NCT01415440|12058010|FG002|Overall Study|Withdrawal by Subject|0
7643146|NCT01386385|12058041|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
7643147|NCT01386385|12058042|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643148|NCT01386385|12058043|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643149|NCT01386385|12058044|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643150|NCT01386385|12058045|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643151|NCT01386385|12058046|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643152|NCT01386385|12058047|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643153|NCT01386385|12058048|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
7643154|NCT01386385|12058041|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
7643155|NCT01386385|12058042|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643156|NCT01386385|12058043|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643157|NCT01386385|12058044|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643158|NCT01386385|12058045|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643159|NCT01386385|12058046|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643160|NCT01386385|12058047|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643161|NCT01386385|12058048|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
7643162|NCT01386385|12058041|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643163|NCT01386385|12058042|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643164|NCT01386385|12058043|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
7643165|NCT01386385|12058044|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643166|NCT01386385|12058045|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643167|NCT01386385|12058046|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643168|NCT01386385|12058047|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643169|NCT01386385|12058048|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
7643170|NCT01386385|12058041|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643171|NCT01386385|12058042|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643172|NCT01386385|12058043|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643173|NCT01386385|12058044|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643174|NCT01386385|12058045|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
7643175|NCT01386385|12058046|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643176|NCT01386385|12058047|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643177|NCT01386385|12058048|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
7643178|NCT01386385|12058041|FG000|Phase II Concurrent CRT|Adverse Event|0
7643179|NCT01386385|12058042|FG001|Phase II Concurrent CRT|Adverse Event|0
7643180|NCT01386385|12058043|FG002|Phase II Concurrent CRT|Adverse Event|0
7643181|NCT01386385|12058044|FG003|Phase II Concurrent CRT|Adverse Event|0
7643182|NCT01386385|12058045|FG004|Phase II Concurrent CRT|Adverse Event|0
7643183|NCT01386385|12058046|FG005|Phase II Concurrent CRT|Adverse Event|0
7643184|NCT01386385|12058047|FG006|Phase II Concurrent CRT|Adverse Event|3
7643185|NCT01386385|12058048|FG007|Phase II Concurrent CRT|Adverse Event|3
7643186|NCT01386385|12058041|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643187|NCT01386385|12058042|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643188|NCT01386385|12058043|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643189|NCT01386385|12058044|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643190|NCT01386385|12058045|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643191|NCT01386385|12058046|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643192|NCT01386385|12058047|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
7643193|NCT01386385|12058048|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
7643194|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Adverse Event|0
7643195|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Adverse Event|0
7643196|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Adverse Event|0
7643197|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Adverse Event|0
7643198|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Adverse Event|0
7643199|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Adverse Event|0
7643200|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Adverse Event|2
7643201|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Adverse Event|1
7643202|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643203|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643204|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643205|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643206|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643207|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643208|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
7643209|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
7643210|NCT01386385|12058041|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
7643211|NCT01386385|12058042|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
7643212|NCT01386385|12058043|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
7643213|NCT01386385|12058044|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
7643214|NCT01386385|12058045|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
7643215|NCT01386385|12058046|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
7643216|NCT01386385|12058047|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
7643217|NCT01386385|12058048|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
7643218|NCT01385176|12058071|FG000|Randomization Phase|Death|1
7643219|NCT01385176|12058072|FG001|Randomization Phase|Death|2
7643220|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Death|1
7643221|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Death|2
7643222|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Physician Decision|0
7643223|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Physician Decision|1
7643224|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
7643225|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
7643226|NCT01385176|12058071|FG000|6-18 Month All VNS Active|Heart Transplant|1
7643227|NCT01385176|12058072|FG001|6-18 Month All VNS Active|Heart Transplant|0
7643228|NCT01372774|12058085|FG000|Overall Study|Withdrawal prior to treatment|4
7643229|NCT01372774|12058086|FG001|Overall Study|Withdrawal prior to treatment|5
7643230|NCT01371981|12058100|FG000|Overall Study|Adverse Event|12
7643231|NCT01371981|12058101|FG001|Overall Study|Adverse Event|17
7643232|NCT01371981|12058102|FG002|Overall Study|Adverse Event|0
7643233|NCT01371981|12058103|FG003|Overall Study|Adverse Event|4
7643234|NCT01371981|12058104|FG004|Overall Study|Adverse Event|1
7643235|NCT01371981|12058105|FG005|Overall Study|Adverse Event|0
7643236|NCT01371981|12058100|FG000|Overall Study|Death|22
7643237|NCT01371981|12058101|FG001|Overall Study|Death|16
7643238|NCT01371981|12058102|FG002|Overall Study|Death|0
7643239|NCT01371981|12058103|FG003|Overall Study|Death|0
7643240|NCT01371981|12058104|FG004|Overall Study|Death|2
7643241|NCT01371981|12058105|FG005|Overall Study|Death|2
7643242|NCT01371981|12058100|FG000|Overall Study|Lack of Efficacy|69
7643243|NCT01371981|12058101|FG001|Overall Study|Lack of Efficacy|61
7643244|NCT01371981|12058102|FG002|Overall Study|Lack of Efficacy|4
7643245|NCT01371981|12058103|FG003|Overall Study|Lack of Efficacy|8
7643246|NCT01371981|12058104|FG004|Overall Study|Lack of Efficacy|5
7643247|NCT01371981|12058105|FG005|Overall Study|Lack of Efficacy|0
7643248|NCT01371981|12058100|FG000|Overall Study|Physician Decision|48
7643249|NCT01371981|12058101|FG001|Overall Study|Physician Decision|63
7643250|NCT01371981|12058102|FG002|Overall Study|Physician Decision|1
7643251|NCT01371981|12058103|FG003|Overall Study|Physician Decision|7
7643252|NCT01371981|12058104|FG004|Overall Study|Physician Decision|14
7643253|NCT01371981|12058105|FG005|Overall Study|Physician Decision|3
7643254|NCT01371981|12058100|FG000|Overall Study|Withdrawal by Subject|12
7643255|NCT01371981|12058101|FG001|Overall Study|Withdrawal by Subject|19
7643256|NCT01371981|12058102|FG002|Overall Study|Withdrawal by Subject|1
7643257|NCT01371981|12058103|FG003|Overall Study|Withdrawal by Subject|2
7643258|NCT01371981|12058104|FG004|Overall Study|Withdrawal by Subject|10
7643259|NCT01371981|12058105|FG005|Overall Study|Withdrawal by Subject|3
7643260|NCT01371981|12058100|FG000|Overall Study|Ineligible|19
7643261|NCT01371981|12058101|FG001|Overall Study|Ineligible|13
7643262|NCT01371981|12058102|FG002|Overall Study|Ineligible|0
7643263|NCT01371981|12058103|FG003|Overall Study|Ineligible|0
7643264|NCT01371981|12058104|FG004|Overall Study|Ineligible|0
7643265|NCT01371981|12058105|FG005|Overall Study|Ineligible|4
7643266|NCT01371981|12058100|FG000|Overall Study|Did not start treatment|2
7643267|NCT01371981|12058101|FG001|Overall Study|Did not start treatment|3
7643268|NCT01371981|12058102|FG002|Overall Study|Did not start treatment|0
7643269|NCT01371981|12058103|FG003|Overall Study|Did not start treatment|0
7643270|NCT01371981|12058104|FG004|Overall Study|Did not start treatment|0
7643271|NCT01371981|12058105|FG005|Overall Study|Did not start treatment|2
7643272|NCT01364597|12058128|FG000|Overall Study|Adverse Event|4
7643273|NCT01364597|12058129|FG001|Overall Study|Adverse Event|5
7643274|NCT01364597|12058130|FG002|Overall Study|Adverse Event|16
7643275|NCT01364597|12058131|FG003|Overall Study|Adverse Event|7
7643276|NCT01364597|12058128|FG000|Overall Study|Lack of Efficacy|4
7643277|NCT01364597|12058129|FG001|Overall Study|Lack of Efficacy|4
7643278|NCT01364597|12058130|FG002|Overall Study|Lack of Efficacy|23
7643279|NCT01364597|12058131|FG003|Overall Study|Lack of Efficacy|8
7643280|NCT01364597|12058128|FG000|Overall Study|Protocol Violation|0
7643281|NCT01364597|12058129|FG001|Overall Study|Protocol Violation|0
7643282|NCT01364597|12058130|FG002|Overall Study|Protocol Violation|2
7643283|NCT01364597|12058131|FG003|Overall Study|Protocol Violation|0
7643284|NCT01364597|12058128|FG000|Overall Study|Lost to Follow-up|0
7643285|NCT01364597|12058129|FG001|Overall Study|Lost to Follow-up|0
7643286|NCT01364597|12058130|FG002|Overall Study|Lost to Follow-up|5
7643287|NCT01364597|12058131|FG003|Overall Study|Lost to Follow-up|3
7643288|NCT01364597|12058128|FG000|Overall Study|Withdrawal by Subject|4
7643289|NCT01364597|12058129|FG001|Overall Study|Withdrawal by Subject|1
7643290|NCT01364597|12058130|FG002|Overall Study|Withdrawal by Subject|18
7643291|NCT01364597|12058131|FG003|Overall Study|Withdrawal by Subject|6
7643292|NCT01364597|12058128|FG000|Overall Study|Non compliance|1
7643293|NCT01364597|12058129|FG001|Overall Study|Non compliance|0
7643294|NCT01364597|12058130|FG002|Overall Study|Non compliance|1
7643295|NCT01364597|12058131|FG003|Overall Study|Non compliance|0
7643296|NCT01364597|12058128|FG000|Overall Study|Lack of compliance|1
7643297|NCT01364597|12058129|FG001|Overall Study|Lack of compliance|0
7643298|NCT01364597|12058130|FG002|Overall Study|Lack of compliance|0
7643299|NCT01364597|12058131|FG003|Overall Study|Lack of compliance|0
7643300|NCT01364597|12058128|FG000|Overall Study|End of treatment epilepsy|1
7643301|NCT01364597|12058129|FG001|Overall Study|End of treatment epilepsy|0
7643302|NCT01364597|12058130|FG002|Overall Study|End of treatment epilepsy|0
7643303|NCT01364597|12058131|FG003|Overall Study|End of treatment epilepsy|0
7643304|NCT01364597|12058128|FG000|Overall Study|No Seizures|1
7643305|NCT01364597|12058129|FG001|Overall Study|No Seizures|0
7643306|NCT01364597|12058130|FG002|Overall Study|No Seizures|0
7643307|NCT01364597|12058131|FG003|Overall Study|No Seizures|0
7643308|NCT01364597|12058128|FG000|Overall Study|Lack of reliability from the subject's caregiver|1
7643309|NCT01364597|12058129|FG001|Overall Study|Lack of reliability from the subject's caregiver|0
7643310|NCT01364597|12058130|FG002|Overall Study|Lack of reliability from the subject's caregiver|0
7643311|NCT01364597|12058131|FG003|Overall Study|Lack of reliability from the subject's caregiver|0
7643312|NCT01364597|12058128|FG000|Overall Study|Cure|1
7643313|NCT01364597|12058129|FG001|Overall Study|Cure|0
7643314|NCT01364597|12058130|FG002|Overall Study|Cure|0
7643315|NCT01364597|12058131|FG003|Overall Study|Cure|0
7643316|NCT01364597|12058128|FG000|Overall Study|Patient was moving|0
7643317|NCT01364597|12058129|FG001|Overall Study|Patient was moving|1
7643318|NCT01364597|12058130|FG002|Overall Study|Patient was moving|0
7643319|NCT01364597|12058131|FG003|Overall Study|Patient was moving|0
7643320|NCT01364597|12058128|FG000|Overall Study|Seizures resolved|0
7643321|NCT01364597|12058129|FG001|Overall Study|Seizures resolved|0
7643322|NCT01364597|12058130|FG002|Overall Study|Seizures resolved|1
7643323|NCT01364597|12058131|FG003|Overall Study|Seizures resolved|0
7643324|NCT01364597|12058128|FG000|Overall Study|Patient became seizure-free after surgery|0
7643325|NCT01364597|12058129|FG001|Overall Study|Patient became seizure-free after surgery|0
7643326|NCT01364597|12058130|FG002|Overall Study|Patient became seizure-free after surgery|1
7643327|NCT01364597|12058131|FG003|Overall Study|Patient became seizure-free after surgery|0
7643328|NCT01364597|12058128|FG000|Overall Study|5 year without seizures. Treatment is finish|0
7643329|NCT01364597|12058129|FG001|Overall Study|5 year without seizures. Treatment is finish|0
7643330|NCT01364597|12058130|FG002|Overall Study|5 year without seizures. Treatment is finish|1
7643331|NCT01364597|12058131|FG003|Overall Study|5 year without seizures. Treatment is finish|0
7643332|NCT01364597|12058128|FG000|Overall Study|Patient cured from Epilepsy|0
7643333|NCT01364597|12058129|FG001|Overall Study|Patient cured from Epilepsy|0
7643334|NCT01364597|12058130|FG002|Overall Study|Patient cured from Epilepsy|1
7643335|NCT01364597|12058131|FG003|Overall Study|Patient cured from Epilepsy|0
7643336|NCT01364597|12058128|FG000|Overall Study|Investigator decision|0
7643337|NCT01364597|12058129|FG001|Overall Study|Investigator decision|0
7643338|NCT01364597|12058130|FG002|Overall Study|Investigator decision|1
7643339|NCT01364597|12058131|FG003|Overall Study|Investigator decision|0
7643340|NCT01364597|12058128|FG000|Overall Study|Sponsor recommended discontinuation|0
7643341|NCT01364597|12058129|FG001|Overall Study|Sponsor recommended discontinuation|0
7643342|NCT01364597|12058130|FG002|Overall Study|Sponsor recommended discontinuation|0
7643343|NCT01364597|12058131|FG003|Overall Study|Sponsor recommended discontinuation|1
7643344|NCT01364597|12058128|FG000|Overall Study|Parents went abroad with the patient|0
7643345|NCT01364597|12058129|FG001|Overall Study|Parents went abroad with the patient|0
7643346|NCT01364597|12058130|FG002|Overall Study|Parents went abroad with the patient|1
7643347|NCT01364597|12058131|FG003|Overall Study|Parents went abroad with the patient|0
7643348|NCT01364597|12058128|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0
7643349|NCT01364597|12058129|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0
7643350|NCT01364597|12058130|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1
7643351|NCT01364597|12058131|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0
7643352|NCT01364597|12058128|FG000|Overall Study|BRV administration dropout|0
7643353|NCT01364597|12058129|FG001|Overall Study|BRV administration dropout|0
7643354|NCT01364597|12058130|FG002|Overall Study|BRV administration dropout|1
7643355|NCT01364597|12058131|FG003|Overall Study|BRV administration dropout|0
7643356|NCT01364597|12058128|FG000|Overall Study|Dropout|0
7643357|NCT01364597|12058129|FG001|Overall Study|Dropout|0
7643358|NCT01364597|12058130|FG002|Overall Study|Dropout|3
7643359|NCT01364597|12058131|FG003|Overall Study|Dropout|1
7643360|NCT01364597|12058128|FG000|Overall Study|Unreliable subject|0
7643361|NCT01364597|12058129|FG001|Overall Study|Unreliable subject|0
7643362|NCT01364597|12058130|FG002|Overall Study|Unreliable subject|0
7643363|NCT01364597|12058131|FG003|Overall Study|Unreliable subject|1
7643364|NCT01364597|12058128|FG000|Overall Study|Other|0
7643365|NCT01364597|12058129|FG001|Overall Study|Other|0
7643366|NCT01364597|12058130|FG002|Overall Study|Other|0
7643367|NCT01364597|12058131|FG003|Overall Study|Other|1
7643368|NCT01359592|12058144|FG000|Initial Registration|Adverse Event|1
7643369|NCT01359592|12058145|FG001|Initial Registration|Adverse Event|0
7643370|NCT01359592|12058146|FG002|Initial Registration|Adverse Event|0
7643371|NCT01359592|12058147|FG003|Initial Registration|Adverse Event|0
7643372|NCT01359592|12058144|FG000|Initial Registration|Death|1
7643373|NCT01359592|12058145|FG001|Initial Registration|Death|0
7643374|NCT01359592|12058146|FG002|Initial Registration|Death|0
7643375|NCT01359592|12058147|FG003|Initial Registration|Death|0
7643376|NCT01359592|12058144|FG000|Initial Registration|Other reason not protocol specified|1
7643377|NCT01359592|12058145|FG001|Initial Registration|Other reason not protocol specified|0
7643378|NCT01359592|12058146|FG002|Initial Registration|Other reason not protocol specified|0
7643379|NCT01359592|12058147|FG003|Initial Registration|Other reason not protocol specified|0
7643380|NCT01359592|12058144|FG000|Initial Registration|Ineligible|26
7643381|NCT01359592|12058145|FG001|Initial Registration|Ineligible|0
7643382|NCT01359592|12058146|FG002|Initial Registration|Ineligible|0
7643383|NCT01359592|12058147|FG003|Initial Registration|Ineligible|0
7643384|NCT01359592|12058144|FG000|PET-Directed Therapy|Adverse Event|0
7643385|NCT01359592|12058145|FG001|PET-Directed Therapy|Adverse Event|0
7643386|NCT01359592|12058146|FG002|PET-Directed Therapy|Adverse Event|1
7643387|NCT01359592|12058147|FG003|PET-Directed Therapy|Adverse Event|0
7643388|NCT01359592|12058144|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643389|NCT01359592|12058145|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643390|NCT01359592|12058146|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
7643391|NCT01359592|12058147|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
7643392|NCT01359592|12058144|FG000|PET-Directed Therapy|Ineligible|0
7643393|NCT01359592|12058145|FG001|PET-Directed Therapy|Ineligible|0
7643394|NCT01359592|12058146|FG002|PET-Directed Therapy|Ineligible|24
7643395|NCT01359592|12058147|FG003|PET-Directed Therapy|Ineligible|0
7643396|NCT01357980|12058166|FG000|Overall Study|Lack of Efficacy|0
7643397|NCT01357980|12058167|FG001|Overall Study|Lack of Efficacy|1
7643398|NCT01357980|12058168|FG002|Overall Study|Lack of Efficacy|0
7643399|NCT01357980|12058169|FG003|Overall Study|Lack of Efficacy|0
7643400|NCT01357980|12058166|FG000|Overall Study|Consent withdrawn|0
7643401|NCT01357980|12058167|FG001|Overall Study|Consent withdrawn|0
7643402|NCT01357980|12058168|FG002|Overall Study|Consent withdrawn|1
7643403|NCT01357980|12058169|FG003|Overall Study|Consent withdrawn|0
7643404|NCT01354353|12058185|FG000|Overall Study|Adverse Event|1
7643405|NCT01354353|12058186|FG001|Overall Study|Adverse Event|0
7643406|NCT01354353|12058187|FG002|Overall Study|Adverse Event|0
7643407|NCT01354353|12058188|FG003|Overall Study|Adverse Event|4
7643408|NCT01354353|12058189|FG004|Overall Study|Adverse Event|0
7643409|NCT01354353|12058190|FG005|Overall Study|Adverse Event|5
7643410|NCT01354353|12058185|FG000|Overall Study|Entry Criteria Not Met|0
7643411|NCT01354353|12058186|FG001|Overall Study|Entry Criteria Not Met|0
7643412|NCT01354353|12058187|FG002|Overall Study|Entry Criteria Not Met|0
7643413|NCT01354353|12058188|FG003|Overall Study|Entry Criteria Not Met|1
7643414|NCT01354353|12058189|FG004|Overall Study|Entry Criteria Not Met|1
7643415|NCT01354353|12058190|FG005|Overall Study|Entry Criteria Not Met|0
7643416|NCT01354353|12058185|FG000|Overall Study|Physician Decision|0
7643417|NCT01354353|12058186|FG001|Overall Study|Physician Decision|1
7643418|NCT01354353|12058187|FG002|Overall Study|Physician Decision|1
7643419|NCT01354353|12058188|FG003|Overall Study|Physician Decision|0
7643420|NCT01354353|12058189|FG004|Overall Study|Physician Decision|0
7643421|NCT01354353|12058190|FG005|Overall Study|Physician Decision|0
7643422|NCT01354353|12058185|FG000|Overall Study|Withdrawal by Subject|2
7643423|NCT01354353|12058186|FG001|Overall Study|Withdrawal by Subject|0
7643424|NCT01354353|12058187|FG002|Overall Study|Withdrawal by Subject|1
7643425|NCT01354353|12058188|FG003|Overall Study|Withdrawal by Subject|0
7643426|NCT01354353|12058189|FG004|Overall Study|Withdrawal by Subject|0
7643427|NCT01354353|12058190|FG005|Overall Study|Withdrawal by Subject|1
7643428|NCT01353313|12058213|FG000|Overall Study|Lost to Follow-up|22
7643429|NCT01353313|12058214|FG001|Overall Study|Lost to Follow-up|23
7643430|NCT01353313|12058213|FG000|Overall Study|Incomplete Follow-up or No Study Data|12
7643431|NCT01353313|12058214|FG001|Overall Study|Incomplete Follow-up or No Study Data|15
7643432|NCT01333397|12058255|FG000|Overall Study|Lost to Follow-up|1
7643433|NCT01333397|12058256|FG001|Overall Study|Lost to Follow-up|0
7643434|NCT01333397|12058257|FG002|Overall Study|Lost to Follow-up|0
7643435|NCT01333397|12058258|FG003|Overall Study|Lost to Follow-up|1
7643436|NCT01333397|12058259|FG004|Overall Study|Lost to Follow-up|0
7643437|NCT01332968|12058282|FG000|Induction Period|Adverse Event|23
7643438|NCT01332968|12058283|FG001|Induction Period|Adverse Event|26
7643439|NCT01332968|12058284|FG002|Induction Period|Adverse Event|0
7643440|NCT01332968|12058285|FG003|Induction Period|Adverse Event|0
7643441|NCT01332968|12058286|FG004|Induction Period|Adverse Event|0
7643442|NCT01332968|12058287|FG005|Induction Period|Adverse Event|0
7643443|NCT01332968|12058288|FG006|Induction Period|Adverse Event|0
7643444|NCT01332968|12058289|FG007|Induction Period|Adverse Event|0
7643445|NCT01332968|12058282|FG000|Induction Period|Death|1
7643446|NCT01332968|12058283|FG001|Induction Period|Death|4
7643447|NCT01332968|12058284|FG002|Induction Period|Death|0
7643448|NCT01332968|12058285|FG003|Induction Period|Death|0
7643449|NCT01332968|12058286|FG004|Induction Period|Death|0
7643450|NCT01332968|12058287|FG005|Induction Period|Death|0
7643451|NCT01332968|12058288|FG006|Induction Period|Death|0
7643452|NCT01332968|12058289|FG007|Induction Period|Death|0
7643453|NCT01332968|12058282|FG000|Induction Period|Non-compliance|1
7643454|NCT01332968|12058283|FG001|Induction Period|Non-compliance|0
7643455|NCT01332968|12058284|FG002|Induction Period|Non-compliance|0
7643456|NCT01332968|12058285|FG003|Induction Period|Non-compliance|0
7643457|NCT01332968|12058286|FG004|Induction Period|Non-compliance|0
7643458|NCT01332968|12058287|FG005|Induction Period|Non-compliance|0
7643459|NCT01332968|12058288|FG006|Induction Period|Non-compliance|0
7643460|NCT01332968|12058289|FG007|Induction Period|Non-compliance|0
7643461|NCT01332968|12058282|FG000|Induction Period|Other|2
7643462|NCT01332968|12058283|FG001|Induction Period|Other|2
7643463|NCT01332968|12058284|FG002|Induction Period|Other|0
7643464|NCT01332968|12058285|FG003|Induction Period|Other|0
7643465|NCT01332968|12058286|FG004|Induction Period|Other|0
7643466|NCT01332968|12058287|FG005|Induction Period|Other|0
7643467|NCT01332968|12058288|FG006|Induction Period|Other|0
7643468|NCT01332968|12058289|FG007|Induction Period|Other|0
7643469|NCT01332968|12058282|FG000|Induction Period|Physician Decision|6
7643470|NCT01332968|12058283|FG001|Induction Period|Physician Decision|1
7643471|NCT01332968|12058284|FG002|Induction Period|Physician Decision|0
7643472|NCT01332968|12058285|FG003|Induction Period|Physician Decision|0
7643473|NCT01332968|12058286|FG004|Induction Period|Physician Decision|0
7643474|NCT01332968|12058287|FG005|Induction Period|Physician Decision|0
7643475|NCT01332968|12058288|FG006|Induction Period|Physician Decision|0
7643476|NCT01332968|12058289|FG007|Induction Period|Physician Decision|0
7643477|NCT01332968|12058282|FG000|Induction Period|Progressive Disease|15
7643478|NCT01332968|12058283|FG001|Induction Period|Progressive Disease|7
7643479|NCT01332968|12058284|FG002|Induction Period|Progressive Disease|0
7643480|NCT01332968|12058285|FG003|Induction Period|Progressive Disease|0
7643481|NCT01332968|12058286|FG004|Induction Period|Progressive Disease|0
7643482|NCT01332968|12058287|FG005|Induction Period|Progressive Disease|0
7643483|NCT01332968|12058288|FG006|Induction Period|Progressive Disease|0
7643484|NCT01332968|12058289|FG007|Induction Period|Progressive Disease|0
7643485|NCT01332968|12058282|FG000|Induction Period|Protocol Violation|3
7643486|NCT01332968|12058283|FG001|Induction Period|Protocol Violation|4
7643487|NCT01332968|12058284|FG002|Induction Period|Protocol Violation|0
7643488|NCT01332968|12058285|FG003|Induction Period|Protocol Violation|0
7643489|NCT01332968|12058286|FG004|Induction Period|Protocol Violation|0
7643490|NCT01332968|12058287|FG005|Induction Period|Protocol Violation|0
7643491|NCT01332968|12058288|FG006|Induction Period|Protocol Violation|0
7643492|NCT01332968|12058289|FG007|Induction Period|Protocol Violation|0
7643493|NCT01332968|12058282|FG000|Induction Period|Withdrawal by Subject|3
7643494|NCT01332968|12058283|FG001|Induction Period|Withdrawal by Subject|5
7643495|NCT01332968|12058284|FG002|Induction Period|Withdrawal by Subject|0
7643496|NCT01332968|12058285|FG003|Induction Period|Withdrawal by Subject|0
7643497|NCT01332968|12058286|FG004|Induction Period|Withdrawal by Subject|0
7643498|NCT01332968|12058287|FG005|Induction Period|Withdrawal by Subject|0
7643499|NCT01332968|12058288|FG006|Induction Period|Withdrawal by Subject|0
7643500|NCT01332968|12058289|FG007|Induction Period|Withdrawal by Subject|0
7643501|NCT01332968|12058282|FG000|Induction Period|Randomised but not treated|4
7643502|NCT01332968|12058283|FG001|Induction Period|Randomised but not treated|7
7643503|NCT01332968|12058284|FG002|Induction Period|Randomised but not treated|0
7643504|NCT01332968|12058285|FG003|Induction Period|Randomised but not treated|0
7643505|NCT01332968|12058286|FG004|Induction Period|Randomised but not treated|0
7643506|NCT01332968|12058287|FG005|Induction Period|Randomised but not treated|0
7643507|NCT01332968|12058288|FG006|Induction Period|Randomised but not treated|0
7643508|NCT01332968|12058289|FG007|Induction Period|Randomised but not treated|0
7643509|NCT01332968|12058282|FG000|Maintenance/Observation Period|Adverse Event|0
7643510|NCT01332968|12058283|FG001|Maintenance/Observation Period|Adverse Event|0
7643511|NCT01332968|12058284|FG002|Maintenance/Observation Period|Adverse Event|53
7643512|NCT01332968|12058285|FG003|Maintenance/Observation Period|Adverse Event|66
7643513|NCT01332968|12058286|FG004|Maintenance/Observation Period|Adverse Event|0
7643514|NCT01332968|12058287|FG005|Maintenance/Observation Period|Adverse Event|0
7643515|NCT01332968|12058288|FG006|Maintenance/Observation Period|Adverse Event|0
7643516|NCT01332968|12058289|FG007|Maintenance/Observation Period|Adverse Event|0
7643517|NCT01332968|12058282|FG000|Maintenance/Observation Period|Death|0
7643518|NCT01332968|12058283|FG001|Maintenance/Observation Period|Death|0
7643519|NCT01332968|12058284|FG002|Maintenance/Observation Period|Death|5
7643520|NCT01332968|12058285|FG003|Maintenance/Observation Period|Death|6
7643521|NCT01332968|12058286|FG004|Maintenance/Observation Period|Death|0
7643522|NCT01332968|12058287|FG005|Maintenance/Observation Period|Death|0
7643523|NCT01332968|12058288|FG006|Maintenance/Observation Period|Death|0
7643524|NCT01332968|12058289|FG007|Maintenance/Observation Period|Death|0
7643525|NCT01332968|12058282|FG000|Maintenance/Observation Period|Lost to Follow-up|0
7643526|NCT01332968|12058283|FG001|Maintenance/Observation Period|Lost to Follow-up|0
7643527|NCT01332968|12058284|FG002|Maintenance/Observation Period|Lost to Follow-up|1
7643528|NCT01332968|12058285|FG003|Maintenance/Observation Period|Lost to Follow-up|2
7643529|NCT01332968|12058286|FG004|Maintenance/Observation Period|Lost to Follow-up|0
7643530|NCT01332968|12058287|FG005|Maintenance/Observation Period|Lost to Follow-up|0
7643531|NCT01332968|12058288|FG006|Maintenance/Observation Period|Lost to Follow-up|0
7643532|NCT01332968|12058289|FG007|Maintenance/Observation Period|Lost to Follow-up|0
7643533|NCT01332968|12058282|FG000|Maintenance/Observation Period|Non-compliance|0
7643534|NCT01332968|12058283|FG001|Maintenance/Observation Period|Non-compliance|0
7643535|NCT01332968|12058284|FG002|Maintenance/Observation Period|Non-compliance|4
7643536|NCT01332968|12058285|FG003|Maintenance/Observation Period|Non-compliance|3
7643537|NCT01332968|12058286|FG004|Maintenance/Observation Period|Non-compliance|0
7643538|NCT01332968|12058287|FG005|Maintenance/Observation Period|Non-compliance|0
7643539|NCT01332968|12058288|FG006|Maintenance/Observation Period|Non-compliance|0
7643540|NCT01332968|12058289|FG007|Maintenance/Observation Period|Non-compliance|0
7643541|NCT01332968|12058282|FG000|Maintenance/Observation Period|Other|0
7643542|NCT01332968|12058283|FG001|Maintenance/Observation Period|Other|0
7643543|NCT01332968|12058284|FG002|Maintenance/Observation Period|Other|4
7643544|NCT01332968|12058285|FG003|Maintenance/Observation Period|Other|7
7643545|NCT01332968|12058286|FG004|Maintenance/Observation Period|Other|0
7643546|NCT01332968|12058287|FG005|Maintenance/Observation Period|Other|0
7643547|NCT01332968|12058288|FG006|Maintenance/Observation Period|Other|0
7643548|NCT01332968|12058289|FG007|Maintenance/Observation Period|Other|0
7643549|NCT01332968|12058282|FG000|Maintenance/Observation Period|Physician Decision|0
7643550|NCT01332968|12058283|FG001|Maintenance/Observation Period|Physician Decision|0
7643551|NCT01332968|12058284|FG002|Maintenance/Observation Period|Physician Decision|14
7643552|NCT01332968|12058285|FG003|Maintenance/Observation Period|Physician Decision|19
7643553|NCT01332968|12058286|FG004|Maintenance/Observation Period|Physician Decision|0
7643554|NCT01332968|12058287|FG005|Maintenance/Observation Period|Physician Decision|1
7643555|NCT01332968|12058288|FG006|Maintenance/Observation Period|Physician Decision|0
7643556|NCT01332968|12058289|FG007|Maintenance/Observation Period|Physician Decision|0
7643557|NCT01332968|12058282|FG000|Maintenance/Observation Period|Progressive Disease|0
7643558|NCT01332968|12058283|FG001|Maintenance/Observation Period|Progressive Disease|0
7643559|NCT01332968|12058284|FG002|Maintenance/Observation Period|Progressive Disease|72
7643560|NCT01332968|12058285|FG003|Maintenance/Observation Period|Progressive Disease|40
7643561|NCT01332968|12058286|FG004|Maintenance/Observation Period|Progressive Disease|0
7643562|NCT01332968|12058287|FG005|Maintenance/Observation Period|Progressive Disease|0
7643563|NCT01332968|12058288|FG006|Maintenance/Observation Period|Progressive Disease|0
7643564|NCT01332968|12058289|FG007|Maintenance/Observation Period|Progressive Disease|0
7643565|NCT01332968|12058282|FG000|Maintenance/Observation Period|Protocol Violation|0
7643566|NCT01332968|12058283|FG001|Maintenance/Observation Period|Protocol Violation|0
7643567|NCT01332968|12058284|FG002|Maintenance/Observation Period|Protocol Violation|1
7643568|NCT01332968|12058285|FG003|Maintenance/Observation Period|Protocol Violation|1
7643569|NCT01332968|12058286|FG004|Maintenance/Observation Period|Protocol Violation|0
7643570|NCT01332968|12058287|FG005|Maintenance/Observation Period|Protocol Violation|0
7643571|NCT01332968|12058288|FG006|Maintenance/Observation Period|Protocol Violation|0
7643572|NCT01332968|12058289|FG007|Maintenance/Observation Period|Protocol Violation|0
7643573|NCT01332968|12058282|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
7643574|NCT01332968|12058283|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
7643575|NCT01332968|12058284|FG002|Maintenance/Observation Period|Withdrawal by Subject|7
7643576|NCT01332968|12058285|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
7643577|NCT01332968|12058286|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
7643578|NCT01332968|12058287|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
7643579|NCT01332968|12058288|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
7643580|NCT01332968|12058289|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
7643581|NCT01332968|12058282|FG000|Follow-Up Period|Adverse Event|0
7643582|NCT01332968|12058283|FG001|Follow-Up Period|Adverse Event|0
7643583|NCT01332968|12058284|FG002|Follow-Up Period|Adverse Event|0
7643584|NCT01332968|12058285|FG003|Follow-Up Period|Adverse Event|0
7643585|NCT01332968|12058286|FG004|Follow-Up Period|Adverse Event|0
7643586|NCT01332968|12058287|FG005|Follow-Up Period|Adverse Event|0
7643587|NCT01332968|12058288|FG006|Follow-Up Period|Adverse Event|0
7643588|NCT01332968|12058289|FG007|Follow-Up Period|Adverse Event|4
7643589|NCT01332968|12058282|FG000|Follow-Up Period|Death|0
7643590|NCT01332968|12058283|FG001|Follow-Up Period|Death|0
7643591|NCT01332968|12058284|FG002|Follow-Up Period|Death|0
7643592|NCT01332968|12058285|FG003|Follow-Up Period|Death|0
7643593|NCT01332968|12058286|FG004|Follow-Up Period|Death|0
7643594|NCT01332968|12058287|FG005|Follow-Up Period|Death|0
7643595|NCT01332968|12058288|FG006|Follow-Up Period|Death|27
7643596|NCT01332968|12058289|FG007|Follow-Up Period|Death|30
7643597|NCT01332968|12058282|FG000|Follow-Up Period|Lost to Follow-up|0
7643598|NCT01332968|12058283|FG001|Follow-Up Period|Lost to Follow-up|0
7643599|NCT01332968|12058284|FG002|Follow-Up Period|Lost to Follow-up|0
7643600|NCT01332968|12058285|FG003|Follow-Up Period|Lost to Follow-up|0
7643601|NCT01332968|12058286|FG004|Follow-Up Period|Lost to Follow-up|0
7643602|NCT01332968|12058287|FG005|Follow-Up Period|Lost to Follow-up|0
7643603|NCT01332968|12058288|FG006|Follow-Up Period|Lost to Follow-up|11
7643604|NCT01332968|12058289|FG007|Follow-Up Period|Lost to Follow-up|15
7643605|NCT01332968|12058282|FG000|Follow-Up Period|Non-compliance|0
7643606|NCT01332968|12058283|FG001|Follow-Up Period|Non-compliance|0
7643607|NCT01332968|12058284|FG002|Follow-Up Period|Non-compliance|0
7643608|NCT01332968|12058285|FG003|Follow-Up Period|Non-compliance|0
7643609|NCT01332968|12058286|FG004|Follow-Up Period|Non-compliance|0
7643610|NCT01332968|12058287|FG005|Follow-Up Period|Non-compliance|0
7643611|NCT01332968|12058288|FG006|Follow-Up Period|Non-compliance|4
7643612|NCT01332968|12058289|FG007|Follow-Up Period|Non-compliance|9
7643613|NCT01332968|12058282|FG000|Follow-Up Period|Other|0
7643614|NCT01332968|12058283|FG001|Follow-Up Period|Other|0
7643615|NCT01332968|12058284|FG002|Follow-Up Period|Other|0
7643616|NCT01332968|12058285|FG003|Follow-Up Period|Other|0
7643617|NCT01332968|12058286|FG004|Follow-Up Period|Other|0
7643618|NCT01332968|12058287|FG005|Follow-Up Period|Other|0
7643619|NCT01332968|12058288|FG006|Follow-Up Period|Other|18
7643620|NCT01332968|12058289|FG007|Follow-Up Period|Other|21
7643621|NCT01332968|12058282|FG000|Follow-Up Period|Physician Decision|0
7643622|NCT01332968|12058283|FG001|Follow-Up Period|Physician Decision|0
7643623|NCT01332968|12058284|FG002|Follow-Up Period|Physician Decision|0
7643624|NCT01332968|12058285|FG003|Follow-Up Period|Physician Decision|0
7643625|NCT01332968|12058286|FG004|Follow-Up Period|Physician Decision|0
7643626|NCT01332968|12058287|FG005|Follow-Up Period|Physician Decision|0
7643627|NCT01332968|12058288|FG006|Follow-Up Period|Physician Decision|12
7643628|NCT01332968|12058289|FG007|Follow-Up Period|Physician Decision|15
7643629|NCT01332968|12058282|FG000|Follow-Up Period|Progressive Disease|0
7643630|NCT01332968|12058283|FG001|Follow-Up Period|Progressive Disease|0
7643631|NCT01332968|12058284|FG002|Follow-Up Period|Progressive Disease|0
7643632|NCT01332968|12058285|FG003|Follow-Up Period|Progressive Disease|0
7643633|NCT01332968|12058286|FG004|Follow-Up Period|Progressive Disease|0
7643634|NCT01332968|12058287|FG005|Follow-Up Period|Progressive Disease|0
7643635|NCT01332968|12058288|FG006|Follow-Up Period|Progressive Disease|126
7643636|NCT01332968|12058289|FG007|Follow-Up Period|Progressive Disease|106
7643637|NCT01332968|12058282|FG000|Follow-Up Period|Protocol Violation|0
7643638|NCT01332968|12058283|FG001|Follow-Up Period|Protocol Violation|0
7643639|NCT01332968|12058284|FG002|Follow-Up Period|Protocol Violation|0
7643640|NCT01332968|12058285|FG003|Follow-Up Period|Protocol Violation|0
7643641|NCT01332968|12058286|FG004|Follow-Up Period|Protocol Violation|0
7643642|NCT01332968|12058287|FG005|Follow-Up Period|Protocol Violation|0
7643643|NCT01332968|12058288|FG006|Follow-Up Period|Protocol Violation|1
7643644|NCT01332968|12058289|FG007|Follow-Up Period|Protocol Violation|0
7643645|NCT01332968|12058282|FG000|Follow-Up Period|Withdrawal by Subject|0
7643646|NCT01332968|12058283|FG001|Follow-Up Period|Withdrawal by Subject|0
7643647|NCT01332968|12058284|FG002|Follow-Up Period|Withdrawal by Subject|0
7643648|NCT01332968|12058285|FG003|Follow-Up Period|Withdrawal by Subject|0
7643649|NCT01332968|12058286|FG004|Follow-Up Period|Withdrawal by Subject|0
7643650|NCT01332968|12058287|FG005|Follow-Up Period|Withdrawal by Subject|0
7643651|NCT01332968|12058288|FG006|Follow-Up Period|Withdrawal by Subject|29
7643652|NCT01332968|12058289|FG007|Follow-Up Period|Withdrawal by Subject|32
7643653|NCT01332968|12058282|FG000|Follow-Up Period|No reason provided|0
7643654|NCT01332968|12058283|FG001|Follow-Up Period|No reason provided|0
7643655|NCT01332968|12058284|FG002|Follow-Up Period|No reason provided|0
7643656|NCT01332968|12058285|FG003|Follow-Up Period|No reason provided|0
7643657|NCT01332968|12058286|FG004|Follow-Up Period|No reason provided|0
7643658|NCT01332968|12058287|FG005|Follow-Up Period|No reason provided|0
7643659|NCT01332968|12058288|FG006|Follow-Up Period|No reason provided|2
7643660|NCT01332968|12058289|FG007|Follow-Up Period|No reason provided|3
7643661|NCT01328093|12058312|FG000|Double-Blind Phase|Adverse Event|78
7643662|NCT01328093|12058313|FG001|Double-Blind Phase|Adverse Event|15
7643663|NCT01328093|12058312|FG000|Double-Blind Phase|Withdrawal by Subject|42
7643664|NCT01328093|12058313|FG001|Double-Blind Phase|Withdrawal by Subject|14
7643665|NCT01328093|12058312|FG000|Double-Blind Phase|Lost to Follow-up|39
7643666|NCT01328093|12058313|FG001|Double-Blind Phase|Lost to Follow-up|14
7643667|NCT01328093|12058312|FG000|Double-Blind Phase|Protocol Violation|30
7643668|NCT01328093|12058313|FG001|Double-Blind Phase|Protocol Violation|10
7643669|NCT01328093|12058312|FG000|Double-Blind Phase|Lack of Efficacy|55
7643670|NCT01328093|12058313|FG001|Double-Blind Phase|Lack of Efficacy|13
7643671|NCT01328093|12058312|FG000|Double-Blind Phase|Sponsor Decision|17
7643672|NCT01328093|12058313|FG001|Double-Blind Phase|Sponsor Decision|3
7643673|NCT01328093|12058312|FG000|Double-Blind Phase|Entry Criteria Not Met|7
7643674|NCT01328093|12058313|FG001|Double-Blind Phase|Entry Criteria Not Met|5
7643675|NCT01328093|12058312|FG000|Double-Blind Phase|Scheduling conflict|8
7643676|NCT01328093|12058313|FG001|Double-Blind Phase|Scheduling conflict|3
7643677|NCT01328093|12058312|FG000|Double-Blind Phase|Subject is moving or has moved|8
7643678|NCT01328093|12058313|FG001|Double-Blind Phase|Subject is moving or has moved|1
7643679|NCT01328093|12058312|FG000|Double-Blind Phase|Death|1
7643680|NCT01328093|12058313|FG001|Double-Blind Phase|Death|0
7643681|NCT01328093|12058312|FG000|Open-Label Phase|Sponsor Decision|98
7643682|NCT01328093|12058313|FG001|Open-Label Phase|Sponsor Decision|34
7643683|NCT01328093|12058312|FG000|Open-Label Phase|Protocol Violation|8
7643684|NCT01328093|12058313|FG001|Open-Label Phase|Protocol Violation|3
7643685|NCT01328093|12058312|FG000|Open-Label Phase|Lost to Follow-up|10
7643686|NCT01328093|12058313|FG001|Open-Label Phase|Lost to Follow-up|1
7643687|NCT01328093|12058312|FG000|Open-Label Phase|Adverse Event|10
7643688|NCT01328093|12058313|FG001|Open-Label Phase|Adverse Event|4
7643689|NCT01328093|12058312|FG000|Open-Label Phase|Lack of Efficacy|5
7643690|NCT01328093|12058313|FG001|Open-Label Phase|Lack of Efficacy|6
7643691|NCT01328093|12058312|FG000|Open-Label Phase|Withdrawal by Subject|4
7643692|NCT01328093|12058313|FG001|Open-Label Phase|Withdrawal by Subject|1
7643693|NCT01328093|12058312|FG000|Open-Label Phase|Scheduling conflict|2
7643694|NCT01328093|12058313|FG001|Open-Label Phase|Scheduling conflict|1
7643695|NCT01328093|12058312|FG000|Open-Label Phase|Subject is moving or has moved|2
7643696|NCT01328093|12058313|FG001|Open-Label Phase|Subject is moving or has moved|0
7643697|NCT01328093|12058312|FG000|Open-Label Phase|Entry Criteria Not Met|1
7643698|NCT01328093|12058313|FG001|Open-Label Phase|Entry Criteria Not Met|0
7643699|NCT01327651|12058329|FG000|Self-administered Dosing Period|Lost to Follow-up|3
7643700|NCT01327651|12058330|FG001|Self-administered Dosing Period|Lost to Follow-up|2
7643701|NCT01327651|12058331|FG002|Self-administered Dosing Period|Lost to Follow-up|4
7643702|NCT01327651|12058332|FG003|Self-administered Dosing Period|Lost to Follow-up|2
7643703|NCT01327651|12058333|FG004|Self-administered Dosing Period|Lost to Follow-up|3
7643704|NCT01327651|12058334|FG005|Self-administered Dosing Period|Lost to Follow-up|0
7643705|NCT01327651|12058335|FG006|Self-administered Dosing Period|Lost to Follow-up|8
7643706|NCT01327651|12058336|FG007|Self-administered Dosing Period|Lost to Follow-up|9
7643707|NCT01327651|12058337|FG008|Self-administered Dosing Period|Lost to Follow-up|10
7643708|NCT01327651|12058329|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
7643709|NCT01327651|12058330|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643710|NCT01327651|12058331|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643711|NCT01327651|12058332|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643712|NCT01327651|12058333|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643713|NCT01327651|12058334|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643714|NCT01327651|12058335|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643715|NCT01327651|12058336|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643716|NCT01327651|12058337|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
7643717|NCT01327651|12058329|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
7643718|NCT01327651|12058330|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
7643719|NCT01327651|12058331|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
7643720|NCT01327651|12058332|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
7643721|NCT01327651|12058333|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
7643722|NCT01327651|12058334|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
7643723|NCT01327651|12058335|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
7643724|NCT01327651|12058336|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
7643725|NCT01327651|12058337|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
7643726|NCT01327651|12058329|FG000|Post Study Follow-up|Lost to Follow-up|0
7643727|NCT01327651|12058330|FG001|Post Study Follow-up|Lost to Follow-up|1
7643728|NCT01327651|12058331|FG002|Post Study Follow-up|Lost to Follow-up|1
7643729|NCT01327651|12058332|FG003|Post Study Follow-up|Lost to Follow-up|0
7643730|NCT01327651|12058333|FG004|Post Study Follow-up|Lost to Follow-up|0
7643731|NCT01327651|12058334|FG005|Post Study Follow-up|Lost to Follow-up|0
7643732|NCT01327651|12058335|FG006|Post Study Follow-up|Lost to Follow-up|4
7643733|NCT01327651|12058336|FG007|Post Study Follow-up|Lost to Follow-up|1
7643734|NCT01327651|12058337|FG008|Post Study Follow-up|Lost to Follow-up|2
7643735|NCT01314118|12058413|FG000|Overall Study|Adverse Event|9
7643736|NCT01314118|12058413|FG000|Overall Study|Progressive disease|27
7643737|NCT01314118|12058413|FG000|Overall Study|Physician Decision|11
7643738|NCT01314118|12058413|FG000|Overall Study|Death|4
7643739|NCT01314118|12058413|FG000|Overall Study|Protocol Violation|5
7643740|NCT01314118|12058413|FG000|Overall Study|Withdrawal by Subject|11
7643741|NCT01314118|12058413|FG000|Overall Study|Other|2
7643742|NCT01314118|12058413|FG000|Overall Study|Ongoing|62
7643743|NCT01313312|12058417|FG000|Overall Study|Adverse Event|5
7643744|NCT01313312|12058417|FG000|Overall Study|Withdrawal by Subject|18
7643745|NCT01313312|12058417|FG000|Overall Study|Lack of Efficacy|3
7643746|NCT01313312|12058417|FG000|Overall Study|Investigator Decision|1
7643747|NCT01313312|12058417|FG000|Overall Study|Observational Phase|1
7643748|NCT01313312|12058417|FG000|Overall Study|Subject Withdrawn Early in Error|4
7643749|NCT01313312|12058417|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
7643750|NCT01313299|12058424|FG000|Overall Study|Adverse Event|3
7643751|NCT01313299|12058425|FG001|Overall Study|Adverse Event|1
7643752|NCT01313299|12058426|FG002|Overall Study|Adverse Event|1
7643753|NCT01313299|12058424|FG000|Overall Study|Lost to Follow-up|1
7643754|NCT01313299|12058425|FG001|Overall Study|Lost to Follow-up|0
7643755|NCT01313299|12058426|FG002|Overall Study|Lost to Follow-up|0
7643756|NCT01313299|12058424|FG000|Overall Study|Protocol Violation|2
7643757|NCT01313299|12058425|FG001|Overall Study|Protocol Violation|0
7643758|NCT01313299|12058426|FG002|Overall Study|Protocol Violation|0
7643759|NCT01313299|12058424|FG000|Overall Study|Withdrawal by Subject|1
7643760|NCT01313299|12058425|FG001|Overall Study|Withdrawal by Subject|0
7643761|NCT01313299|12058426|FG002|Overall Study|Withdrawal by Subject|2
7643762|NCT01313299|12058424|FG000|Overall Study|Family reason and moved out of state|0
7643763|NCT01313299|12058425|FG001|Overall Study|Family reason and moved out of state|2
7643764|NCT01313299|12058426|FG002|Overall Study|Family reason and moved out of state|0
7643765|NCT01313299|12058424|FG000|Overall Study|Lack of subject compliance|0
7643766|NCT01313299|12058425|FG001|Overall Study|Lack of subject compliance|0
7643767|NCT01313299|12058426|FG002|Overall Study|Lack of subject compliance|1
7643768|NCT01308853|12058443|FG000|Overall Study|Adverse Event|1
7643769|NCT01308853|12058443|FG000|Overall Study|Lost to Follow-up|2
7643770|NCT01308853|12058443|FG000|Overall Study|Insertion of permanent implants|1
7643771|NCT01288911|12058460|FG000|Double-blind Period|Death|11
7643772|NCT01288911|12058461|FG001|Double-blind Period|Death|7
7643773|NCT01288911|12058460|FG000|Double-blind Period|Lost to Follow-up|0
7643774|NCT01288911|12058461|FG001|Double-blind Period|Lost to Follow-up|2
7643775|NCT01288911|12058460|FG000|Double-blind Period|Progressive Disease|75
7643776|NCT01288911|12058461|FG001|Double-blind Period|Progressive Disease|103
7643777|NCT01288911|12058460|FG000|Double-blind Period|Protocol Violation|1
7643778|NCT01288911|12058461|FG001|Double-blind Period|Protocol Violation|0
7643779|NCT01288911|12058460|FG000|Double-blind Period|Withdrawal by Subject|25
7643780|NCT01288911|12058461|FG001|Double-blind Period|Withdrawal by Subject|26
7643781|NCT01288911|12058460|FG000|Double-blind Period|Miscellaneous Reason|29
7643782|NCT01288911|12058461|FG001|Double-blind Period|Miscellaneous Reason|42
7643783|NCT01288911|12058460|FG000|Double-blind Period|Randomized but never received study drug|1
7643784|NCT01288911|12058461|FG001|Double-blind Period|Randomized but never received study drug|2
7643785|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Death|0
7643786|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Death|1
7643787|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
7643788|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
7643789|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
7643790|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
7643791|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
7643792|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
7643793|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
7643794|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
7643795|NCT01288911|12058460|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
7643796|NCT01288911|12058461|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
7643797|NCT01286272|12058472|FG000|Overall Study|Ineligible after beginning treatment|1
7643798|NCT01286272|12058473|FG001|Overall Study|Ineligible after beginning treatment|3
7643799|NCT01275677|12058481|FG000|Overall Study|Not at risk for recurrence.|1
7643800|NCT01275677|12058482|FG001|Overall Study|Not at risk for recurrence.|1
7643801|NCT01275677|12058481|FG000|Overall Study|No follow-up|26
7643802|NCT01275677|12058482|FG001|Overall Study|No follow-up|37
7643803|NCT01275677|12058481|FG000|Overall Study|No clinical follow up.|1
7643804|NCT01275677|12058482|FG001|Overall Study|No clinical follow up.|4
7643805|NCT01267955|12058498|FG000|Stage 1 (6 Months)|Death|3
7643806|NCT01267955|12058498|FG000|Stage 2 (6 Months)|Death|5
7643807|NCT01267955|12058498|FG000|Stage 2 (6 Months)|Protocol Violation|1
7643808|NCT01265849|12058505|FG000|Overall Study|Randomized//Treatment not initiated|1
7643809|NCT01265849|12058506|FG001|Overall Study|Randomized//Treatment not initiated|4
7643810|NCT01265849|12058507|FG002|Overall Study|Randomized//Treatment not initiated|0
7643811|NCT01265849|12058505|FG000|Overall Study|Physician Decision|1
7643812|NCT01265849|12058506|FG001|Overall Study|Physician Decision|2
7643813|NCT01265849|12058507|FG002|Overall Study|Physician Decision|0
7643814|NCT01265849|12058505|FG000|Overall Study|Lost to Follow-up|18
7643815|NCT01265849|12058506|FG001|Overall Study|Lost to Follow-up|15
7643816|NCT01265849|12058507|FG002|Overall Study|Lost to Follow-up|5
7643817|NCT01265849|12058505|FG000|Overall Study|Not otherwise specified|1
7643818|NCT01265849|12058506|FG001|Overall Study|Not otherwise specified|6
7643819|NCT01265849|12058507|FG002|Overall Study|Not otherwise specified|1
7643820|NCT01265849|12058505|FG000|Overall Study|Withdrawal by Subject|25
7643821|NCT01265849|12058506|FG001|Overall Study|Withdrawal by Subject|34
7643822|NCT01265849|12058507|FG002|Overall Study|Withdrawal by Subject|13
7643823|NCT01263769|12058544|FG000|Overall Study|Non-Compliant with treatment|1
7643824|NCT01261611|12058551|FG000|Treatment Cycle 1|Withdrawal by Subject|3
7643825|NCT01261611|12058552|FG001|Treatment Cycle 1|Withdrawal by Subject|2
7643826|NCT01261611|12058553|FG002|Treatment Cycle 1|Withdrawal by Subject|0
7643827|NCT01261611|12058551|FG000|Treatment Cycle 1|Lost to Follow-up|1
7643828|NCT01261611|12058552|FG001|Treatment Cycle 1|Lost to Follow-up|0
7643829|NCT01261611|12058553|FG002|Treatment Cycle 1|Lost to Follow-up|0
7643830|NCT01261611|12058551|FG000|Treatment Cycle 1|Adverse Event|0
7643831|NCT01261611|12058552|FG001|Treatment Cycle 1|Adverse Event|1
7643832|NCT01261611|12058553|FG002|Treatment Cycle 1|Adverse Event|0
7643833|NCT01261611|12058551|FG000|Treatment Cycle 1|Protocol Violation|0
7643834|NCT01261611|12058552|FG001|Treatment Cycle 1|Protocol Violation|0
7643835|NCT01261611|12058553|FG002|Treatment Cycle 1|Protocol Violation|2
7643836|NCT01261611|12058551|FG000|Treatment Cycle 2|Completed study|4
7643837|NCT01261611|12058552|FG001|Treatment Cycle 2|Completed study|0
7643838|NCT01261611|12058553|FG002|Treatment Cycle 2|Completed study|0
7643839|NCT01261611|12058551|FG000|Treatment Cycle 2|Withdrawal by Subject|4
7643840|NCT01261611|12058552|FG001|Treatment Cycle 2|Withdrawal by Subject|0
7643841|NCT01261611|12058553|FG002|Treatment Cycle 2|Withdrawal by Subject|0
7643842|NCT01261611|12058551|FG000|Treatment Cycle 2|Adverse Event|1
7643843|NCT01261611|12058552|FG001|Treatment Cycle 2|Adverse Event|0
7643844|NCT01261611|12058553|FG002|Treatment Cycle 2|Adverse Event|0
7643845|NCT01261611|12058551|FG000|Treatment Cycle 2|Protocol Violation|2
7643846|NCT01261611|12058552|FG001|Treatment Cycle 2|Protocol Violation|0
7643847|NCT01261611|12058553|FG002|Treatment Cycle 2|Protocol Violation|0
7643848|NCT01261611|12058551|FG000|Treatment Cycle 2|Not otherwise specified|2
7643849|NCT01261611|12058552|FG001|Treatment Cycle 2|Not otherwise specified|0
7643850|NCT01261611|12058553|FG002|Treatment Cycle 2|Not otherwise specified|0
7643851|NCT01261611|12058551|FG000|Treatment Cycle 3|Completed study|24
7643852|NCT01261611|12058552|FG001|Treatment Cycle 3|Completed study|0
7643853|NCT01261611|12058553|FG002|Treatment Cycle 3|Completed study|0
7643854|NCT01261611|12058551|FG000|Treatment Cycle 3|Withdrawal by Subject|4
7643855|NCT01261611|12058552|FG001|Treatment Cycle 3|Withdrawal by Subject|0
7643856|NCT01261611|12058553|FG002|Treatment Cycle 3|Withdrawal by Subject|0
7643857|NCT01261611|12058551|FG000|Treatment Cycle 3|Adverse Event|1
7643858|NCT01261611|12058552|FG001|Treatment Cycle 3|Adverse Event|0
7643859|NCT01261611|12058553|FG002|Treatment Cycle 3|Adverse Event|0
7643860|NCT01261611|12058551|FG000|Treatment Cycle 3|Lost to Follow-up|1
7643861|NCT01261611|12058552|FG001|Treatment Cycle 3|Lost to Follow-up|0
7643862|NCT01261611|12058553|FG002|Treatment Cycle 3|Lost to Follow-up|0
7643863|NCT01261611|12058551|FG000|Treatment Cycle 4|Completed study|87
7643864|NCT01261611|12058552|FG001|Treatment Cycle 4|Completed study|0
7643865|NCT01261611|12058553|FG002|Treatment Cycle 4|Completed study|0
7643866|NCT01261611|12058551|FG000|Treatment Cycle 4|Withdrawal by Subject|3
7643867|NCT01261611|12058552|FG001|Treatment Cycle 4|Withdrawal by Subject|0
7643868|NCT01261611|12058553|FG002|Treatment Cycle 4|Withdrawal by Subject|0
7643869|NCT01261611|12058551|FG000|Treatment Cycle 4|Adverse Event|1
7643870|NCT01261611|12058552|FG001|Treatment Cycle 4|Adverse Event|0
7643871|NCT01261611|12058553|FG002|Treatment Cycle 4|Adverse Event|0
7643872|NCT01261611|12058551|FG000|Treatment Cycle 4|Lost to Follow-up|2
7643873|NCT01261611|12058552|FG001|Treatment Cycle 4|Lost to Follow-up|0
7643874|NCT01261611|12058553|FG002|Treatment Cycle 4|Lost to Follow-up|0
7643875|NCT01261611|12058551|FG000|Treatment Cycle 4|Not otherwise specified|3
7643876|NCT01261611|12058552|FG001|Treatment Cycle 4|Not otherwise specified|0
7643877|NCT01261611|12058553|FG002|Treatment Cycle 4|Not otherwise specified|0
7643878|NCT01261611|12058551|FG000|Treatment Cycle 5|Withdrawal by Subject|1
7643879|NCT01261611|12058552|FG001|Treatment Cycle 5|Withdrawal by Subject|0
7643880|NCT01261611|12058553|FG002|Treatment Cycle 5|Withdrawal by Subject|0
7643881|NCT01261611|12058551|FG000|Treatment Cycle 5|Adverse Event|1
7643882|NCT01261611|12058552|FG001|Treatment Cycle 5|Adverse Event|0
7643883|NCT01261611|12058553|FG002|Treatment Cycle 5|Adverse Event|0
7643884|NCT01261611|12058551|FG000|Treatment Cycle 5|Lost to Follow-up|1
7643885|NCT01261611|12058552|FG001|Treatment Cycle 5|Lost to Follow-up|0
7643886|NCT01261611|12058553|FG002|Treatment Cycle 5|Lost to Follow-up|0
7643887|NCT01256398|12058565|FG000|Overall Study|Withdrawal by Subject|1
7643888|NCT01251861|12058585|FG000|Overall Study|Disease progression|6
7643889|NCT01251861|12058586|FG001|Overall Study|Disease progression|6
7643890|NCT01251861|12058585|FG000|Overall Study|Adverse Event|2
7643891|NCT01251861|12058586|FG001|Overall Study|Adverse Event|17
7643892|NCT01251861|12058585|FG000|Overall Study|Withdrawal by Subject|2
7643893|NCT01251861|12058586|FG001|Overall Study|Withdrawal by Subject|2
7643894|NCT01251861|12058585|FG000|Overall Study|Alternative therapy|1
7643895|NCT01251861|12058586|FG001|Overall Study|Alternative therapy|0
7643896|NCT01251861|12058585|FG000|Overall Study|Other complicating disease|0
7643897|NCT01251861|12058586|FG001|Overall Study|Other complicating disease|1
7643898|NCT01251861|12058585|FG000|Overall Study|Physician Decision|1
7643899|NCT01251861|12058586|FG001|Overall Study|Physician Decision|0
7643900|NCT01251861|12058585|FG000|Overall Study|Continued treatment beyond 18 cycles|1
7643901|NCT01251861|12058586|FG001|Overall Study|Continued treatment beyond 18 cycles|0
7643902|NCT01251861|12058585|FG000|Overall Study|Other|1
7643903|NCT01251861|12058586|FG001|Overall Study|Other|0
7643904|NCT01251861|12058585|FG000|Overall Study|Never started therapy|4
7643905|NCT01251861|12058586|FG001|Overall Study|Never started therapy|1
7643906|NCT01251861|12058585|FG000|Overall Study|Potential interaction of drugs|0
7643907|NCT01251861|12058586|FG001|Overall Study|Potential interaction of drugs|1
7643908|NCT01251380|12058592|FG000|Overall Study|Other (Not otherwise specified)|12
7643909|NCT01251380|12058592|FG000|Overall Study|Withdrawal by Subject|6
7643910|NCT01251380|12058592|FG000|Overall Study|Lack of Efficacy|1
7643911|NCT01251380|12058592|FG000|Overall Study|Adverse Event|1
7643912|NCT01251380|12058592|FG000|Overall Study|Lost to Follow-up|2
7643913|NCT01251367|12058601|FG000|Overall Study|Protocol Violation|1
7643914|NCT01251367|12058601|FG000|Overall Study|Lack of Efficacy|2
7643915|NCT01251367|12058601|FG000|Overall Study|Adverse Event|19
7643916|NCT01251367|12058601|FG000|Overall Study|Withdrawal by Subject|36
7643917|NCT01251367|12058601|FG000|Overall Study|Lost to Follow-up|5
7643918|NCT01251367|12058601|FG000|Overall Study|Subject Required Alternative Treatment|7
7643919|NCT01251367|12058601|FG000|Overall Study|No Study Drug Available|1
7643920|NCT01251367|12058601|FG000|Overall Study|Subject had Personal or Medical Issues|4
7643921|NCT01251367|12058601|FG000|Overall Study|End of Study Visit Performed in Error|1
7643922|NCT01251276|12058607|FG000|Overall Study|Protocol Violation|1
7643923|NCT01251276|12058608|FG001|Overall Study|Protocol Violation|0
7643924|NCT01251276|12058607|FG000|Overall Study|Lost to Follow-up|0
7643925|NCT01251276|12058608|FG001|Overall Study|Lost to Follow-up|1
7643926|NCT01249417|12058617|FG000|Randomised Population|Study treatment not received|0
7643927|NCT01249417|12058618|FG001|Randomised Population|Study treatment not received|0
7643928|NCT01249417|12058619|FG002|Randomised Population|Study treatment not received|2
7643929|NCT01249417|12058617|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
7643930|NCT01249417|12058618|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
7643931|NCT01249417|12058619|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
7643932|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Other|0
7643933|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Other|0
7643934|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Other|1
7643935|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Adverse Event|0
7643936|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Adverse Event|0
7643937|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Adverse Event|1
7643938|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
7643939|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
7643940|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
7643941|NCT01249417|12058617|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
7643942|NCT01249417|12058618|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
7643943|NCT01249417|12058619|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
7643944|NCT01249404|12058630|FG000|Overall Study|Study treatment not received|0
7643945|NCT01249404|12058631|FG001|Overall Study|Study treatment not received|1
7643946|NCT01249404|12058632|FG002|Overall Study|Study treatment not received|2
7643947|NCT01249404|12058630|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
7643948|NCT01249404|12058631|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
7643949|NCT01249404|12058632|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
7643950|NCT01249404|12058630|FG000|Overall Study|Adverse Event|2
7643951|NCT01249404|12058631|FG001|Overall Study|Adverse Event|2
7643952|NCT01249404|12058632|FG002|Overall Study|Adverse Event|2
7643953|NCT01249404|12058630|FG000|Overall Study|Withdrawal by Subject|2
7643954|NCT01249404|12058631|FG001|Overall Study|Withdrawal by Subject|2
7643955|NCT01249404|12058632|FG002|Overall Study|Withdrawal by Subject|0
7643956|NCT01249404|12058630|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
7643957|NCT01249404|12058631|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
7643958|NCT01249404|12058632|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
7643959|NCT01249404|12058630|FG000|Overall Study|Non compliance to visit schedule|0
7643960|NCT01249404|12058631|FG001|Overall Study|Non compliance to visit schedule|1
7643961|NCT01249404|12058632|FG002|Overall Study|Non compliance to visit schedule|0
7643962|NCT01238211|12058640|FG000|Overall Study|Continues active treatment|31
7643963|NCT01238211|12058640|FG000|Overall Study|Adverse Event|7
7643964|NCT01238211|12058640|FG000|Overall Study|Death|4
7643965|NCT01238211|12058640|FG000|Overall Study|Relapse/Progression|2
7643966|NCT01238211|12058640|FG000|Overall Study|Withdrawal by Subject|7
7643967|NCT01238211|12058640|FG000|Overall Study|Non-protocol treatment|4
7643968|NCT01238211|12058640|FG000|Overall Study|Investigator/Patient Decision|3
7643969|NCT01236560|12058650|FG000|Overall Study|Adverse Event|0
7643970|NCT01236560|12058651|FG001|Overall Study|Adverse Event|2
7643971|NCT01236560|12058652|FG002|Overall Study|Adverse Event|1
7643972|NCT01236560|12058653|FG003|Overall Study|Adverse Event|3
7643973|NCT01236560|12058654|FG004|Overall Study|Adverse Event|0
7643974|NCT01236560|12058655|FG005|Overall Study|Adverse Event|0
7643975|NCT01236560|12058650|FG000|Overall Study|Death|0
7643976|NCT01236560|12058651|FG001|Overall Study|Death|1
7643977|NCT01236560|12058652|FG002|Overall Study|Death|0
7643978|NCT01236560|12058653|FG003|Overall Study|Death|1
7643979|NCT01236560|12058654|FG004|Overall Study|Death|0
7643980|NCT01236560|12058655|FG005|Overall Study|Death|0
7643981|NCT01236560|12058650|FG000|Overall Study|Lost to Follow-up|0
7643982|NCT01236560|12058651|FG001|Overall Study|Lost to Follow-up|1
7643983|NCT01236560|12058652|FG002|Overall Study|Lost to Follow-up|1
7643984|NCT01236560|12058653|FG003|Overall Study|Lost to Follow-up|0
7643985|NCT01236560|12058654|FG004|Overall Study|Lost to Follow-up|0
7643986|NCT01236560|12058655|FG005|Overall Study|Lost to Follow-up|0
7643987|NCT01236560|12058650|FG000|Overall Study|Physician Decision|0
7643988|NCT01236560|12058651|FG001|Overall Study|Physician Decision|1
7643989|NCT01236560|12058652|FG002|Overall Study|Physician Decision|8
7643990|NCT01236560|12058653|FG003|Overall Study|Physician Decision|0
7643991|NCT01236560|12058654|FG004|Overall Study|Physician Decision|0
7643992|NCT01236560|12058655|FG005|Overall Study|Physician Decision|0
7643993|NCT01236560|12058650|FG000|Overall Study|Withdrawal by Subject|0
7643994|NCT01236560|12058651|FG001|Overall Study|Withdrawal by Subject|0
7643995|NCT01236560|12058652|FG002|Overall Study|Withdrawal by Subject|1
7643996|NCT01236560|12058653|FG003|Overall Study|Withdrawal by Subject|2
7643997|NCT01236560|12058654|FG004|Overall Study|Withdrawal by Subject|0
7643998|NCT01236560|12058655|FG005|Overall Study|Withdrawal by Subject|0
7643999|NCT01236560|12058650|FG000|Overall Study|Progressive disease|5
7644000|NCT01236560|12058651|FG001|Overall Study|Progressive disease|19
7644001|NCT01236560|12058652|FG002|Overall Study|Progressive disease|9
7644002|NCT01236560|12058653|FG003|Overall Study|Progressive disease|16
7644003|NCT01236560|12058654|FG004|Overall Study|Progressive disease|0
7644004|NCT01236560|12058655|FG005|Overall Study|Progressive disease|0
7644005|NCT01209949|12058694|FG000|Overall Study|Lost to Follow-up|3
7644006|NCT01207492|12058698|FG000|Overall Study|Still on study|1
7644007|NCT01207492|12058698|FG000|Overall Study|Withdrawal by Subject|9
7644008|NCT01207492|12058698|FG000|Overall Study|Physician Decision|1
7644009|NCT01207492|12058698|FG000|Overall Study|Progressive disease|3
7644010|NCT01207492|12058698|FG000|Overall Study|Toxicity|1
7644011|NCT01197950|12058705|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7644012|NCT01197950|12058706|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16
7644013|NCT01197950|12058707|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18
7644014|NCT01196390|12058717|FG000|Overall Study|Protocol Violation|4
7644015|NCT01196390|12058718|FG001|Overall Study|Protocol Violation|5
7644016|NCT01171898|12058730|FG000|Overall Study|Death|0
7644017|NCT01171898|12058731|FG001|Overall Study|Death|0
7644018|NCT01171898|12058732|FG002|Overall Study|Death|2
7644019|NCT01171898|12058733|FG003|Overall Study|Death|0
7644020|NCT01171898|12058730|FG000|Overall Study|Lost to Follow-up|0
7644021|NCT01171898|12058731|FG001|Overall Study|Lost to Follow-up|1
7644022|NCT01171898|12058732|FG002|Overall Study|Lost to Follow-up|1
7644023|NCT01171898|12058733|FG003|Overall Study|Lost to Follow-up|1
7644024|NCT01171898|12058730|FG000|Overall Study|Withdrawal by Subject|1
7644025|NCT01171898|12058731|FG001|Overall Study|Withdrawal by Subject|4
7644026|NCT01171898|12058732|FG002|Overall Study|Withdrawal by Subject|6
7644027|NCT01171898|12058733|FG003|Overall Study|Withdrawal by Subject|3
7644028|NCT01171898|12058730|FG000|Overall Study|Terminated by Sponsor|1
7644029|NCT01171898|12058731|FG001|Overall Study|Terminated by Sponsor|0
7644030|NCT01171898|12058732|FG002|Overall Study|Terminated by Sponsor|0
7644031|NCT01171898|12058733|FG003|Overall Study|Terminated by Sponsor|0
7644032|NCT01171898|12058730|FG000|Overall Study|Ongoing|1
7644033|NCT01171898|12058731|FG001|Overall Study|Ongoing|9
7644034|NCT01171898|12058732|FG002|Overall Study|Ongoing|3
7644035|NCT01171898|12058733|FG003|Overall Study|Ongoing|0
7644036|NCT01171898|12058730|FG000|Overall Study|Other|1
7644037|NCT01171898|12058731|FG001|Overall Study|Other|5
7644038|NCT01171898|12058732|FG002|Overall Study|Other|0
7644039|NCT01171898|12058733|FG003|Overall Study|Other|2
7644040|NCT01168219|12058746|FG000|Overall Study|off study before starting treatment|2
7644041|NCT01168219|12058746|FG000|Overall Study|withdrew before transplant|1
7644042|NCT01168219|12058746|FG000|Overall Study|ineligible due to CML|2
7644043|NCT01145495|12058764|FG000|Overall Study|Adverse Event|6
7644044|NCT01145495|12058764|FG000|Overall Study|Withdrawal by Subject|5
7644045|NCT01145495|12058764|FG000|Overall Study|Disease progression after respone|1
7644046|NCT01143038|12058785|FG000|Overall Study|Withdrawal by Subject|4
7644047|NCT01143038|12058785|FG000|Overall Study|Requirement for alternative therapy|5
7644048|NCT01143038|12058785|FG000|Overall Study|Adverse Event|3
7644049|NCT01143038|12058785|FG000|Overall Study|Lost to Follow-up|2
7644050|NCT01143038|12058785|FG000|Overall Study|Protocol Deviation|1
7644051|NCT01143038|12058785|FG000|Overall Study|Death|1
7644052|NCT01142388|12058791|FG000|Overall Study|Lack of Efficacy|21
7644053|NCT01142388|12058792|FG001|Overall Study|Lack of Efficacy|31
7644054|NCT01142388|12058791|FG000|Overall Study|Adverse Event|9
7644055|NCT01142388|12058792|FG001|Overall Study|Adverse Event|5
7644056|NCT01142388|12058791|FG000|Overall Study|Death|3
7644057|NCT01142388|12058792|FG001|Overall Study|Death|2
7644058|NCT01142388|12058791|FG000|Overall Study|Withdrawal by Subject|5
7644059|NCT01142388|12058792|FG001|Overall Study|Withdrawal by Subject|3
7644060|NCT01142388|12058791|FG000|Overall Study|Alternative therapy|1
7644061|NCT01142388|12058792|FG001|Overall Study|Alternative therapy|0
7644062|NCT01142388|12058791|FG000|Overall Study|Other complications|0
7644063|NCT01142388|12058792|FG001|Overall Study|Other complications|2
7644064|NCT01142388|12058791|FG000|Overall Study|Other|1
7644065|NCT01142388|12058792|FG001|Overall Study|Other|1
7644066|NCT01142388|12058791|FG000|Overall Study|Never started therapy|7
7644067|NCT01142388|12058792|FG001|Overall Study|Never started therapy|3
7644068|NCT01139047|12058798|FG000|Overall Study|Withdrawal by Subject|1
7644069|NCT01139008|12058805|FG000|Overall Study|Withdrawal by Subject|5
7644070|NCT01139008|12058805|FG000|Overall Study|Non-compliant, lost product|1
7644071|NCT01134614|12058814|FG000|Overall Study|Still on treatment as of March 2013|21
7644072|NCT01134614|12058815|FG001|Overall Study|Still on treatment as of March 2013|13
7644073|NCT01134614|12058814|FG000|Overall Study|Progressive disease|60
7644074|NCT01134614|12058815|FG001|Overall Study|Progressive disease|54
7644075|NCT01134614|12058814|FG000|Overall Study|Adverse Event|26
7644076|NCT01134614|12058815|FG001|Overall Study|Adverse Event|39
7644077|NCT01134614|12058814|FG000|Overall Study|Death|5
7644078|NCT01134614|12058815|FG001|Overall Study|Death|8
7644079|NCT01134614|12058814|FG000|Overall Study|Withdrawal by Subject|3
7644080|NCT01134614|12058815|FG001|Overall Study|Withdrawal by Subject|2
7644081|NCT01134614|12058814|FG000|Overall Study|Alternative therapy|2
7644082|NCT01134614|12058815|FG001|Overall Study|Alternative therapy|0
7644083|NCT01134614|12058814|FG000|Overall Study|Complicating disease|2
7644084|NCT01134614|12058815|FG001|Overall Study|Complicating disease|1
7644085|NCT01134614|12058814|FG000|Overall Study|Physician's decision|0
7644086|NCT01134614|12058815|FG001|Overall Study|Physician's decision|1
7644087|NCT01134614|12058814|FG000|Overall Study|Never started treatment|4
7644088|NCT01134614|12058815|FG001|Overall Study|Never started treatment|1
7644089|NCT01134614|12058814|FG000|Overall Study|Pt received tx not allowed on study|0
7644090|NCT01134614|12058815|FG001|Overall Study|Pt received tx not allowed on study|1
7644091|NCT01134614|12058814|FG000|Overall Study|Symptomatic deterioration|0
7644092|NCT01134614|12058815|FG001|Overall Study|Symptomatic deterioration|1
7644093|NCT01134614|12058814|FG000|Overall Study|Patient in hospice care|0
7644094|NCT01134614|12058815|FG001|Overall Study|Patient in hospice care|1
7644095|NCT01131182|12058823|FG000|Overall Study|Withdrawal by Subject|1
7644096|NCT01131182|12058824|FG001|Overall Study|Withdrawal by Subject|1
7644097|NCT01131182|12058823|FG000|Overall Study|Lost to Follow-up|14
7644098|NCT01131182|12058824|FG001|Overall Study|Lost to Follow-up|15
7644099|NCT01131182|12058823|FG000|Overall Study|Other Reason|1
7644100|NCT01131182|12058824|FG001|Overall Study|Other Reason|0
7644101|NCT01126736|12058835|FG000|Overall Study|Death|2
7644102|NCT01126736|12058836|FG001|Overall Study|Death|2
7644103|NCT01126736|12058837|FG002|Overall Study|Death|1
7644104|NCT01126736|12058838|FG003|Overall Study|Death|19
7644105|NCT01126736|12058839|FG004|Overall Study|Death|19
7644106|NCT01126736|12058835|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644107|NCT01126736|12058836|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644108|NCT01126736|12058837|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0
7644109|NCT01126736|12058838|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3
7644110|NCT01126736|12058839|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3
7644111|NCT01126736|12058835|FG000|Overall Study|Lost to Follow-up|0
7644112|NCT01126736|12058836|FG001|Overall Study|Lost to Follow-up|0
7644113|NCT01126736|12058837|FG002|Overall Study|Lost to Follow-up|0
7644114|NCT01126736|12058838|FG003|Overall Study|Lost to Follow-up|1
7644115|NCT01126736|12058839|FG004|Overall Study|Lost to Follow-up|1
7644116|NCT01126736|12058835|FG000|Overall Study|Administrative reasons|0
7644117|NCT01126736|12058836|FG001|Overall Study|Administrative reasons|0
7644118|NCT01126736|12058837|FG002|Overall Study|Administrative reasons|0
7644119|NCT01126736|12058838|FG003|Overall Study|Administrative reasons|0
7644120|NCT01126736|12058839|FG004|Overall Study|Administrative reasons|1
7644121|NCT01126736|12058835|FG000|Overall Study|Progressive disease|0
7644122|NCT01126736|12058836|FG001|Overall Study|Progressive disease|0
7644123|NCT01126736|12058837|FG002|Overall Study|Progressive disease|0
7644124|NCT01126736|12058838|FG003|Overall Study|Progressive disease|2
7644125|NCT01126736|12058839|FG004|Overall Study|Progressive disease|1
7644126|NCT01126736|12058835|FG000|Overall Study|Withdrawal by Subject|0
7644127|NCT01126736|12058836|FG001|Overall Study|Withdrawal by Subject|0
7644128|NCT01126736|12058837|FG002|Overall Study|Withdrawal by Subject|0
7644129|NCT01126736|12058838|FG003|Overall Study|Withdrawal by Subject|1
7644130|NCT01126736|12058839|FG004|Overall Study|Withdrawal by Subject|1
7644131|NCT01126736|12058835|FG000|Overall Study|Other|2
7644132|NCT01126736|12058836|FG001|Overall Study|Other|4
7644133|NCT01126736|12058837|FG002|Overall Study|Other|4
7644134|NCT01126736|12058838|FG003|Overall Study|Other|16
7644135|NCT01126736|12058839|FG004|Overall Study|Other|15
7644136|NCT01120964|12058862|FG000|Overall Study|Did not receive full treatment|1
7644137|NCT01120964|12058863|FG001|Overall Study|Did not receive full treatment|0
7644138|NCT01119066|12058873|FG000|Overall Study|Withdrawal by Subject|4
7644139|NCT01119066|12058874|FG001|Overall Study|Withdrawal by Subject|6
7644140|NCT01119066|12058875|FG002|Overall Study|Withdrawal by Subject|0
7644141|NCT01119066|12058876|FG003|Overall Study|Withdrawal by Subject|0
7644142|NCT01119066|12058873|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2
7644143|NCT01119066|12058874|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1
7644144|NCT01119066|12058875|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0
7644145|NCT01119066|12058876|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0
7644146|NCT01119066|12058873|FG000|Overall Study|Relapse identified before transplant|1
7644147|NCT01119066|12058874|FG001|Overall Study|Relapse identified before transplant|0
7644148|NCT01119066|12058875|FG002|Overall Study|Relapse identified before transplant|0
7644149|NCT01119066|12058876|FG003|Overall Study|Relapse identified before transplant|0
7644150|NCT01119066|12058873|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644151|NCT01119066|12058874|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3
7644152|NCT01119066|12058875|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644153|NCT01119066|12058876|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0
7644154|NCT01119066|12058873|FG000|Overall Study|Relapse identified before transplant|0
7644155|NCT01119066|12058874|FG001|Overall Study|Relapse identified before transplant|4
7644156|NCT01119066|12058875|FG002|Overall Study|Relapse identified before transplant|0
7644157|NCT01119066|12058876|FG003|Overall Study|Relapse identified before transplant|0
7644158|NCT01112306|12058886|FG000|Overall Study|Death|175
7644159|NCT01112306|12058886|FG000|Overall Study|Lost to Follow-up|9
7644160|NCT01112306|12058886|FG000|Overall Study|Withdrawal by Subject|31
7644161|NCT01112306|12058886|FG000|Overall Study|Other|70
7644162|NCT01081678|12058898|FG000|Overall Study|Ineligibility Determined|0
7644163|NCT01081678|12058899|FG001|Overall Study|Ineligibility Determined|0
7644164|NCT01081678|12058900|FG002|Overall Study|Ineligibility Determined|1
7644165|NCT01081678|12058901|FG003|Overall Study|Ineligibility Determined|1
7644166|NCT01081678|12058898|FG000|Overall Study|Noncompliance|3
7644167|NCT01081678|12058899|FG001|Overall Study|Noncompliance|4
7644168|NCT01081678|12058900|FG002|Overall Study|Noncompliance|5
7644169|NCT01081678|12058901|FG003|Overall Study|Noncompliance|2
7644170|NCT01081678|12058898|FG000|Overall Study|Adverse Event|2
7644171|NCT01081678|12058899|FG001|Overall Study|Adverse Event|1
7644172|NCT01081678|12058900|FG002|Overall Study|Adverse Event|2
7644173|NCT01081678|12058901|FG003|Overall Study|Adverse Event|2
7644174|NCT01081678|12058898|FG000|Overall Study|Withdrawal by Subject|15
7644175|NCT01081678|12058899|FG001|Overall Study|Withdrawal by Subject|7
7644176|NCT01081678|12058900|FG002|Overall Study|Withdrawal by Subject|17
7644177|NCT01081678|12058901|FG003|Overall Study|Withdrawal by Subject|14
7644178|NCT01081678|12058898|FG000|Overall Study|Administrative Decision|1
7644179|NCT01081678|12058899|FG001|Overall Study|Administrative Decision|0
7644180|NCT01081678|12058900|FG002|Overall Study|Administrative Decision|0
7644181|NCT01081678|12058901|FG003|Overall Study|Administrative Decision|1
7644182|NCT01081678|12058898|FG000|Overall Study|Lost to Follow-up|4
7644183|NCT01081678|12058899|FG001|Overall Study|Lost to Follow-up|1
7644184|NCT01081678|12058900|FG002|Overall Study|Lost to Follow-up|4
7644185|NCT01081678|12058901|FG003|Overall Study|Lost to Follow-up|3
7644186|NCT01081678|12058898|FG000|Overall Study|Death|2
7644187|NCT01081678|12058899|FG001|Overall Study|Death|2
7644188|NCT01081678|12058900|FG002|Overall Study|Death|2
7644189|NCT01081678|12058901|FG003|Overall Study|Death|6
7644190|NCT01081678|12058898|FG000|Overall Study|Other|0
7644191|NCT01081678|12058899|FG001|Overall Study|Other|1
7644192|NCT01081678|12058900|FG002|Overall Study|Other|0
7644193|NCT01081678|12058901|FG003|Overall Study|Other|0
7644194|NCT01080391|12058930|FG000|Overall Study|Randomized but not treated|7
7644195|NCT01080391|12058931|FG001|Overall Study|Randomized but not treated|4
7644196|NCT01065454|12058986|FG000|Treatment|Adverse Event|7
7644197|NCT01065454|12058987|FG001|Treatment|Adverse Event|4
7644198|NCT01065454|12058988|FG002|Treatment|Adverse Event|3
7644199|NCT01065454|12058989|FG003|Treatment|Adverse Event|6
7644200|NCT01065454|12058986|FG000|Treatment|Death|1
7644201|NCT01065454|12058987|FG001|Treatment|Death|0
7644202|NCT01065454|12058988|FG002|Treatment|Death|0
7644203|NCT01065454|12058989|FG003|Treatment|Death|0
7644204|NCT01065454|12058986|FG000|Treatment|Non-compliance|1
7644205|NCT01065454|12058987|FG001|Treatment|Non-compliance|0
7644206|NCT01065454|12058988|FG002|Treatment|Non-compliance|0
7644207|NCT01065454|12058989|FG003|Treatment|Non-compliance|1
7644208|NCT01065454|12058986|FG000|Treatment|Protocol Decision|0
7644209|NCT01065454|12058987|FG001|Treatment|Protocol Decision|0
7644210|NCT01065454|12058988|FG002|Treatment|Protocol Decision|3
7644211|NCT01065454|12058989|FG003|Treatment|Protocol Decision|2
7644212|NCT01065454|12058986|FG000|Treatment|Protocol Violation|1
7644213|NCT01065454|12058987|FG001|Treatment|Protocol Violation|0
7644214|NCT01065454|12058988|FG002|Treatment|Protocol Violation|1
7644215|NCT01065454|12058989|FG003|Treatment|Protocol Violation|0
7644216|NCT01065454|12058986|FG000|Treatment|Withdrawal by Subject|3
7644217|NCT01065454|12058987|FG001|Treatment|Withdrawal by Subject|1
7644218|NCT01065454|12058988|FG002|Treatment|Withdrawal by Subject|2
7644219|NCT01065454|12058989|FG003|Treatment|Withdrawal by Subject|3
7644220|NCT01065454|12058986|FG000|Follow up|Adverse Event|1
7644221|NCT01065454|12058987|FG001|Follow up|Adverse Event|0
7644222|NCT01065454|12058988|FG002|Follow up|Adverse Event|0
7644223|NCT01065454|12058989|FG003|Follow up|Adverse Event|1
7644224|NCT01065454|12058986|FG000|Follow up|Death|0
7644225|NCT01065454|12058987|FG001|Follow up|Death|1
7644226|NCT01065454|12058988|FG002|Follow up|Death|1
7644227|NCT01065454|12058989|FG003|Follow up|Death|0
7644228|NCT01065454|12058986|FG000|Follow up|Lost to Follow-up|0
7644229|NCT01065454|12058987|FG001|Follow up|Lost to Follow-up|0
7644230|NCT01065454|12058988|FG002|Follow up|Lost to Follow-up|0
7644231|NCT01065454|12058989|FG003|Follow up|Lost to Follow-up|1
7644232|NCT01065454|12058986|FG000|Follow up|Progressive disease|0
7644233|NCT01065454|12058987|FG001|Follow up|Progressive disease|0
7644234|NCT01065454|12058988|FG002|Follow up|Progressive disease|0
7644235|NCT01065454|12058989|FG003|Follow up|Progressive disease|1
7644236|NCT01065454|12058986|FG000|Follow up|Withdrawal by Subject|1
7644237|NCT01065454|12058987|FG001|Follow up|Withdrawal by Subject|1
7644238|NCT01065454|12058988|FG002|Follow up|Withdrawal by Subject|1
7644239|NCT01065454|12058989|FG003|Follow up|Withdrawal by Subject|0
7644240|NCT01065454|12058986|FG000|Follow up|study ongoing|37
7644241|NCT01065454|12058987|FG001|Follow up|study ongoing|22
7644242|NCT01065454|12058988|FG002|Follow up|study ongoing|15
7644243|NCT01065454|12058989|FG003|Follow up|study ongoing|41
7644244|NCT01064648|12059002|FG000|Phase I Cohort1: Dose Level 1|Progression|5
7644245|NCT01064648|12059003|FG001|Phase I Cohort1: Dose Level 1|Progression|0
7644246|NCT01064648|12059004|FG002|Phase I Cohort1: Dose Level 1|Progression|0
7644247|NCT01064648|12059005|FG003|Phase I Cohort1: Dose Level 1|Progression|0
7644248|NCT01064648|12059002|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
7644249|NCT01064648|12059003|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644250|NCT01064648|12059004|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644251|NCT01064648|12059005|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
7644252|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644253|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
7644254|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644255|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
7644256|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644257|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
7644258|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644259|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
7644260|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
7644261|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
7644262|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
7644263|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
7644264|NCT01064648|12059002|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644265|NCT01064648|12059003|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
7644266|NCT01064648|12059004|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644267|NCT01064648|12059005|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
7644268|NCT01064648|12059002|FG000|Phase II|Adverse Event|0
7644269|NCT01064648|12059003|FG001|Phase II|Adverse Event|0
7644270|NCT01064648|12059004|FG002|Phase II|Adverse Event|15
7644271|NCT01064648|12059005|FG003|Phase II|Adverse Event|8
7644272|NCT01064648|12059002|FG000|Phase II|Death|0
7644273|NCT01064648|12059003|FG001|Phase II|Death|0
7644274|NCT01064648|12059004|FG002|Phase II|Death|4
7644275|NCT01064648|12059005|FG003|Phase II|Death|5
7644276|NCT01064648|12059002|FG000|Phase II|Withdrawal by Subject|0
7644277|NCT01064648|12059003|FG001|Phase II|Withdrawal by Subject|0
7644278|NCT01064648|12059004|FG002|Phase II|Withdrawal by Subject|2
7644279|NCT01064648|12059005|FG003|Phase II|Withdrawal by Subject|5
7644280|NCT01064648|12059002|FG000|Phase II|Progression|0
7644281|NCT01064648|12059003|FG001|Phase II|Progression|0
7644282|NCT01064648|12059004|FG002|Phase II|Progression|21
7644283|NCT01064648|12059005|FG003|Phase II|Progression|27
7644284|NCT01064648|12059002|FG000|Phase II|Non-protocol specified|0
7644285|NCT01064648|12059003|FG001|Phase II|Non-protocol specified|0
7644286|NCT01064648|12059004|FG002|Phase II|Non-protocol specified|5
7644287|NCT01064648|12059005|FG003|Phase II|Non-protocol specified|3
7644288|NCT01064648|12059002|FG000|Phase II|Under Review|0
7644289|NCT01064648|12059003|FG001|Phase II|Under Review|0
7644290|NCT01064648|12059004|FG002|Phase II|Under Review|2
7644291|NCT01064648|12059005|FG003|Phase II|Under Review|0
7644292|NCT01064479|12059020|FG000|Overall Study|Death|10
7644293|NCT01064479|12059021|FG001|Overall Study|Death|11
7644294|NCT01064479|12059020|FG000|Overall Study|Withdrawal by Subject|2
7644295|NCT01064479|12059021|FG001|Overall Study|Withdrawal by Subject|2
7644296|NCT01064479|12059020|FG000|Overall Study|Disease progression|1
7644297|NCT01064479|12059021|FG001|Overall Study|Disease progression|1
7644298|NCT01064479|12059020|FG000|Overall Study|Toxicity|1
7644299|NCT01064479|12059021|FG001|Overall Study|Toxicity|1
7644300|NCT01064479|12059020|FG000|Overall Study|Other|1
7644301|NCT01064479|12059021|FG001|Overall Study|Other|2
7644302|NCT01063517|12059029|FG000|Overall Study|Consent withdrawal|1
7644303|NCT01063517|12059030|FG001|Overall Study|Consent withdrawal|0
7644304|NCT01063517|12059029|FG000|Overall Study|Study reached data cut-off|19
7644305|NCT01063517|12059030|FG001|Overall Study|Study reached data cut-off|7
7644306|NCT01063517|12059029|FG000|Overall Study|Lost to Follow-up|4
7644307|NCT01063517|12059030|FG001|Overall Study|Lost to Follow-up|3
7644308|NCT01063517|12059029|FG000|Overall Study|Withdrawal by Subject|1
7644309|NCT01063517|12059030|FG001|Overall Study|Withdrawal by Subject|2
7644310|NCT01063517|12059029|FG000|Overall Study|Death|33
7644311|NCT01063517|12059030|FG001|Overall Study|Death|48
7644312|NCT01052103|12059038|FG000|Overall Study|Adverse Event|10
7644313|NCT01052103|12059039|FG001|Overall Study|Adverse Event|6
7644314|NCT01052103|12059038|FG000|Overall Study|Entry Criteria Not Met|3
7644315|NCT01052103|12059039|FG001|Overall Study|Entry Criteria Not Met|1
7644316|NCT01052103|12059038|FG000|Overall Study|Lost to Follow-up|3
7644317|NCT01052103|12059039|FG001|Overall Study|Lost to Follow-up|5
7644318|NCT01052103|12059038|FG000|Overall Study|Protocol Violation|10
7644319|NCT01052103|12059039|FG001|Overall Study|Protocol Violation|4
7644320|NCT01052103|12059038|FG000|Overall Study|Scheduling conflict|2
7644321|NCT01052103|12059039|FG001|Overall Study|Scheduling conflict|1
7644322|NCT01052103|12059038|FG000|Overall Study|Sponsor Decision|2
7644323|NCT01052103|12059039|FG001|Overall Study|Sponsor Decision|0
7644324|NCT01052103|12059038|FG000|Overall Study|Withdrawal by Subject|3
7644325|NCT01052103|12059039|FG001|Overall Study|Withdrawal by Subject|6
7644326|NCT01052103|12059038|FG000|Overall Study|Perceived Lack of Efficacy|1
7644327|NCT01052103|12059039|FG001|Overall Study|Perceived Lack of Efficacy|0
7644328|NCT01046565|12059046|FG000|Overall Study|Adverse Event|2
7644329|NCT01046565|12059046|FG000|Overall Study|Withdrawal by Subject|7
7644330|NCT01046396|12059055|FG000|Overall Study|Withdrawal by Subject|5
7644331|NCT01036087|12059062|FG000|Overall Study|Adverse Event|2
7644332|NCT01036087|12059062|FG000|Overall Study|Lack of Efficacy|1
7644333|NCT01015833|12059081|FG000|Overall Study|Death|1
7644334|NCT01015833|12059082|FG001|Overall Study|Death|0
7644335|NCT01015833|12059081|FG000|Overall Study|Withdrawal by Subject|3
7644336|NCT01015833|12059082|FG001|Overall Study|Withdrawal by Subject|2
7644337|NCT01015833|12059081|FG000|Overall Study|Adverse Event|0
7644338|NCT01015833|12059082|FG001|Overall Study|Adverse Event|1
7644339|NCT01015833|12059081|FG000|Overall Study|Physician Decision|2
7644340|NCT01015833|12059082|FG001|Overall Study|Physician Decision|0
7644341|NCT01015833|12059081|FG000|Overall Study|Symptomatic deterioration|0
7644342|NCT01015833|12059082|FG001|Overall Study|Symptomatic deterioration|1
7644343|NCT01015833|12059081|FG000|Overall Study|Other|5
7644344|NCT01015833|12059082|FG001|Overall Study|Other|1
7644345|NCT01015833|12059081|FG000|Overall Study|Motor Vehicle Accidents|1
7644346|NCT01015833|12059082|FG001|Overall Study|Motor Vehicle Accidents|0
7644347|NCT01015833|12059081|FG000|Overall Study|Did not start treatment|1
7644348|NCT01015833|12059082|FG001|Overall Study|Did not start treatment|0
7644349|NCT01005745|12059159|FG000|Overall Study|No TIL growth|1
7644350|NCT01005745|12059159|FG000|Overall Study|Disease progressed during TIL growth|3
7644351|NCT01005745|12059159|FG000|Overall Study|Death prior to treatment|1
7644352|NCT01005745|12059159|FG000|Overall Study|Inappropriate antidiuretic hormone|1
7644353|NCT01002820|12059163|FG000|Overall Study|Adverse Event|1
7644354|NCT01002820|12059163|FG000|Overall Study|Withdrawal by Subject|2
7644355|NCT01002820|12059163|FG000|Overall Study|Lack of Efficacy|1
7644356|NCT01001377|12059169|FG000|Overall Study|Ineligibility determined|2
7644357|NCT01001377|12059170|FG001|Overall Study|Ineligibility determined|0
7644358|NCT01001377|12059169|FG000|Overall Study|Withdrawal by Subject|19
7644359|NCT01001377|12059170|FG001|Overall Study|Withdrawal by Subject|20
7644360|NCT01001377|12059169|FG000|Overall Study|Lost to Follow-up|14
7644361|NCT01001377|12059170|FG001|Overall Study|Lost to Follow-up|17
7644362|NCT01001377|12059169|FG000|Overall Study|Death|391
7644363|NCT01001377|12059170|FG001|Overall Study|Death|384
7644364|NCT00994162|12059178|FG000|Overall Study|Withdrawal by Subject|1
7644365|NCT00994162|12059178|FG000|Overall Study|Lost to Follow-up|2
7644366|NCT00994162|12059178|FG000|Overall Study|Product Complaint|1
7644367|NCT00994162|12059178|FG000|Overall Study|Poor Compliance|5
7644368|NCT00994162|12059178|FG000|Overall Study|Lack of Response|3
7644369|NCT00994162|12059178|FG000|Overall Study|Discharged from Hospital|4
7644370|NCT00994162|12059178|FG000|Overall Study|Death|2
7644371|NCT00994162|12059178|FG000|Overall Study|Care Transferred to Another Physician|2
7644372|NCT00994162|12059178|FG000|Overall Study|Discontinued and Changed to Iodoflex|1
7644373|NCT00994162|12059178|FG000|Overall Study|Physician Decision|2
7644374|NCT00994162|12059178|FG000|Overall Study|Surrounding Wound Erythematous|1
7644375|NCT00994162|12059178|FG000|Overall Study|Machine Losing Vaccum|1
7644376|NCT00994162|12059178|FG000|Overall Study|Patient Lived Too Far Away|1
7644377|NCT00994162|12059178|FG000|Overall Study|Above Knee Amputation|1
7644378|NCT00994162|12059178|FG000|Overall Study|Reason Not Reported By Site|1
7644379|NCT00988637|12059185|FG000|Overall Study|Lost to Follow-up|2
7644380|NCT00988637|12059186|FG001|Overall Study|Lost to Follow-up|1
7644381|NCT00988637|12059185|FG000|Overall Study|Withdrawal by Subject|1
7644382|NCT00988637|12059186|FG001|Overall Study|Withdrawal by Subject|1
7644383|NCT00988637|12059185|FG000|Overall Study|non-compliance with study drug|0
7644384|NCT00988637|12059186|FG001|Overall Study|non-compliance with study drug|1
7644385|NCT00980538|12059192|FG000|Overall Study|Lost to Follow-up|20
7644386|NCT00980538|12059192|FG000|Overall Study|Sponsor's Decision|4
7644387|NCT00980538|12059192|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
7644388|NCT00980538|12059192|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
7644389|NCT00980538|12059192|FG000|Overall Study|Switch to Commercially Available Medication|25
7644390|NCT00980538|12059192|FG000|Overall Study|Participant Non-Compliant|9
7644391|NCT00980538|12059192|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
7644392|NCT00980538|12059192|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
7644393|NCT00980538|12059192|FG000|Overall Study|Other|60
7644394|NCT00980538|12059192|FG000|Overall Study|Other|1
7644395|NCT00980460|12059201|FG000|Overall Study|Death|0
7644396|NCT00980460|12059202|FG001|Overall Study|Death|0
7644397|NCT00980460|12059203|FG002|Overall Study|Death|1
7644398|NCT00980460|12059204|FG003|Overall Study|Death|2
7644399|NCT00980460|12059205|FG004|Overall Study|Death|1
7644400|NCT00980460|12059201|FG000|Overall Study|Lack of Efficacy|0
7644401|NCT00980460|12059202|FG001|Overall Study|Lack of Efficacy|0
7644402|NCT00980460|12059203|FG002|Overall Study|Lack of Efficacy|10
7644403|NCT00980460|12059204|FG003|Overall Study|Lack of Efficacy|6
7644404|NCT00980460|12059205|FG004|Overall Study|Lack of Efficacy|8
7644405|NCT00980460|12059201|FG000|Overall Study|Lost to Follow-up|0
7644406|NCT00980460|12059202|FG001|Overall Study|Lost to Follow-up|0
7644407|NCT00980460|12059203|FG002|Overall Study|Lost to Follow-up|0
7644408|NCT00980460|12059204|FG003|Overall Study|Lost to Follow-up|1
7644409|NCT00980460|12059205|FG004|Overall Study|Lost to Follow-up|0
7644410|NCT00980460|12059201|FG000|Overall Study|Physician Decision|0
7644411|NCT00980460|12059202|FG001|Overall Study|Physician Decision|0
7644412|NCT00980460|12059203|FG002|Overall Study|Physician Decision|11
7644413|NCT00980460|12059204|FG003|Overall Study|Physician Decision|5
7644414|NCT00980460|12059205|FG004|Overall Study|Physician Decision|3
7644415|NCT00980460|12059201|FG000|Overall Study|Withdrawal by Subject|0
7644416|NCT00980460|12059202|FG001|Overall Study|Withdrawal by Subject|0
7644417|NCT00980460|12059203|FG002|Overall Study|Withdrawal by Subject|1
7644418|NCT00980460|12059204|FG003|Overall Study|Withdrawal by Subject|0
7644419|NCT00980460|12059205|FG004|Overall Study|Withdrawal by Subject|0
7644420|NCT00980460|12059201|FG000|Overall Study|Ineligible|0
7644421|NCT00980460|12059202|FG001|Overall Study|Ineligible|2
7644422|NCT00980460|12059203|FG002|Overall Study|Ineligible|3
7644423|NCT00980460|12059204|FG003|Overall Study|Ineligible|1
7644424|NCT00980460|12059205|FG004|Overall Study|Ineligible|4
7644425|NCT00980460|12059201|FG000|Overall Study|Refusal of further therapy|0
7644426|NCT00980460|12059202|FG001|Overall Study|Refusal of further therapy|2
7644427|NCT00980460|12059203|FG002|Overall Study|Refusal of further therapy|3
7644428|NCT00980460|12059204|FG003|Overall Study|Refusal of further therapy|2
7644429|NCT00980460|12059205|FG004|Overall Study|Refusal of further therapy|0
7644430|NCT00980460|12059201|FG000|Overall Study|No therapy within 42 days of resection|0
7644431|NCT00980460|12059202|FG001|Overall Study|No therapy within 42 days of resection|0
7644432|NCT00980460|12059203|FG002|Overall Study|No therapy within 42 days of resection|3
7644433|NCT00980460|12059204|FG003|Overall Study|No therapy within 42 days of resection|1
7644434|NCT00980460|12059205|FG004|Overall Study|No therapy within 42 days of resection|0
7644435|NCT00980460|12059201|FG000|Overall Study|No transplant by protocol timepoints|0
7644436|NCT00980460|12059202|FG001|Overall Study|No transplant by protocol timepoints|0
7644437|NCT00980460|12059203|FG002|Overall Study|No transplant by protocol timepoints|3
7644438|NCT00980460|12059204|FG003|Overall Study|No transplant by protocol timepoints|0
7644439|NCT00980460|12059205|FG004|Overall Study|No transplant by protocol timepoints|0
7644440|NCT00978562|12059224|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2
7644441|NCT00977574|12059233|FG000|Overall Study|Never Treated|4
7644442|NCT00977574|12059234|FG001|Overall Study|Never Treated|2
7644443|NCT00977574|12059235|FG002|Overall Study|Never Treated|4
7644444|NCT00972478|12059245|FG000|Overall Study|Adverse Event|3
7644445|NCT00972478|12059246|FG001|Overall Study|Adverse Event|16
7644446|NCT00972478|12059245|FG000|Overall Study|Withdrawal by Subject|1
7644447|NCT00972478|12059246|FG001|Overall Study|Withdrawal by Subject|8
7644448|NCT00972478|12059245|FG000|Overall Study|Progression/Relapse|0
7644449|NCT00972478|12059246|FG001|Overall Study|Progression/Relapse|2
7644450|NCT00972478|12059245|FG000|Overall Study|Death|0
7644451|NCT00972478|12059246|FG001|Overall Study|Death|2
7644452|NCT00972478|12059245|FG000|Overall Study|Not protocol specified|1
7644453|NCT00972478|12059246|FG001|Overall Study|Not protocol specified|1
7644454|NCT00972478|12059245|FG000|Overall Study|Ineligible|1
7644455|NCT00972478|12059246|FG001|Overall Study|Ineligible|7
7644456|NCT00972478|12059245|FG000|Overall Study|Not start protocol treatment|1
7644457|NCT00972478|12059246|FG001|Overall Study|Not start protocol treatment|2
7644458|NCT00972179|12059260|FG000|Overall Study|Noncompliance|1
7644459|NCT00972179|12059261|FG001|Overall Study|Noncompliance|0
7644460|NCT00972179|12059262|FG002|Overall Study|Noncompliance|0
7644461|NCT00972179|12059263|FG003|Overall Study|Noncompliance|0
7644462|NCT00972179|12059264|FG004|Overall Study|Noncompliance|1
7644463|NCT00972179|12059265|FG005|Overall Study|Noncompliance|0
7644464|NCT00972179|12059266|FG006|Overall Study|Noncompliance|1
7644465|NCT00972179|12059260|FG000|Overall Study|Withdrawal by Subject|0
7644466|NCT00972179|12059261|FG001|Overall Study|Withdrawal by Subject|3
7644467|NCT00972179|12059262|FG002|Overall Study|Withdrawal by Subject|0
7644468|NCT00972179|12059263|FG003|Overall Study|Withdrawal by Subject|1
7644469|NCT00972179|12059264|FG004|Overall Study|Withdrawal by Subject|0
7644470|NCT00972179|12059265|FG005|Overall Study|Withdrawal by Subject|0
7644471|NCT00972179|12059266|FG006|Overall Study|Withdrawal by Subject|2
7644472|NCT00972179|12059260|FG000|Overall Study|Administrative Decision|0
7644473|NCT00972179|12059261|FG001|Overall Study|Administrative Decision|0
7644474|NCT00972179|12059262|FG002|Overall Study|Administrative Decision|0
7644475|NCT00972179|12059263|FG003|Overall Study|Administrative Decision|0
7644476|NCT00972179|12059264|FG004|Overall Study|Administrative Decision|1
7644477|NCT00972179|12059265|FG005|Overall Study|Administrative Decision|0
7644478|NCT00972179|12059266|FG006|Overall Study|Administrative Decision|0
7644479|NCT00972179|12059260|FG000|Overall Study|Lost to Follow-up|0
7644480|NCT00972179|12059261|FG001|Overall Study|Lost to Follow-up|0
7644481|NCT00972179|12059262|FG002|Overall Study|Lost to Follow-up|1
7644482|NCT00972179|12059263|FG003|Overall Study|Lost to Follow-up|0
7644483|NCT00972179|12059264|FG004|Overall Study|Lost to Follow-up|0
7644484|NCT00972179|12059265|FG005|Overall Study|Lost to Follow-up|3
7644485|NCT00972179|12059266|FG006|Overall Study|Lost to Follow-up|1
7644486|NCT00970684|12059286|FG000|Overall Study|Lack of Efficacy|5
7644487|NCT00970684|12059286|FG000|Overall Study|Adverse Event|4
7644488|NCT00970684|12059286|FG000|Overall Study|Withdrawal by Subject|1
7644489|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11
7644490|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3
7644491|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Death|1
7644492|NCT00961064|12059290|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1
7644493|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3
7644494|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1
7644495|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1
7644496|NCT00961064|12059290|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2
7644497|NCT00951080|12059296|FG000|Overall Study|Adverse Event|3
7644498|NCT00951080|12059297|FG001|Overall Study|Adverse Event|3
7644499|NCT00951080|12059296|FG000|Overall Study|Lost to Follow-up|0
7644500|NCT00951080|12059297|FG001|Overall Study|Lost to Follow-up|1
7644501|NCT00951080|12059296|FG000|Overall Study|Physician Decision|4
7644502|NCT00951080|12059297|FG001|Overall Study|Physician Decision|1
7644503|NCT00951080|12059296|FG000|Overall Study|Other|19
7644504|NCT00951080|12059297|FG001|Overall Study|Other|22
7644505|NCT00942331|12059305|FG000|Overall Study|Did not start treatment|15
7644506|NCT00942331|12059306|FG001|Overall Study|Did not start treatment|22
7644507|NCT00937937|12059312|FG000|Overall Study|Adverse Event|6
7644508|NCT00937937|12059312|FG000|Overall Study|Withdrawal by Subject|2
7644509|NCT00937937|12059312|FG000|Overall Study|Progression/relapse|61
7644510|NCT00937937|12059312|FG000|Overall Study|Death|1
7644511|NCT00937937|12059312|FG000|Overall Study|Other|2
7644512|NCT00931268|12059317|FG000|Overall Study|Lost to Follow-up|6
7644513|NCT00907478|12059324|FG000|Overall Study|Ineligibility determined|0
7644514|NCT00907478|12059325|FG001|Overall Study|Ineligibility determined|0
7644515|NCT00907478|12059326|FG002|Overall Study|Ineligibility determined|1
7644516|NCT00907478|12059324|FG000|Overall Study|Noncompliance|0
7644517|NCT00907478|12059325|FG001|Overall Study|Noncompliance|0
7644518|NCT00907478|12059326|FG002|Overall Study|Noncompliance|1
7644519|NCT00907478|12059324|FG000|Overall Study|Adverse Event|3
7644520|NCT00907478|12059325|FG001|Overall Study|Adverse Event|1
7644521|NCT00907478|12059326|FG002|Overall Study|Adverse Event|2
7644522|NCT00907478|12059324|FG000|Overall Study|Withdrawal by Subject|8
7644523|NCT00907478|12059325|FG001|Overall Study|Withdrawal by Subject|9
7644524|NCT00907478|12059326|FG002|Overall Study|Withdrawal by Subject|6
7644525|NCT00907478|12059324|FG000|Overall Study|Requirement for alternative therapy|1
7644526|NCT00907478|12059325|FG001|Overall Study|Requirement for alternative therapy|2
7644527|NCT00907478|12059326|FG002|Overall Study|Requirement for alternative therapy|3
7644528|NCT00907478|12059324|FG000|Overall Study|Physician Decision|2
7644529|NCT00907478|12059325|FG001|Overall Study|Physician Decision|0
7644530|NCT00907478|12059326|FG002|Overall Study|Physician Decision|3
7644531|NCT00907478|12059324|FG000|Overall Study|Death|4
7644532|NCT00907478|12059325|FG001|Overall Study|Death|2
7644533|NCT00907478|12059326|FG002|Overall Study|Death|1
7644534|NCT00907478|12059324|FG000|Overall Study|Protocol-specified criteria|5
7644535|NCT00907478|12059325|FG001|Overall Study|Protocol-specified criteria|2
7644536|NCT00907478|12059326|FG002|Overall Study|Protocol-specified criteria|3
7644537|NCT00907478|12059324|FG000|Overall Study|Pregnancy|0
7644538|NCT00907478|12059325|FG001|Overall Study|Pregnancy|1
7644539|NCT00907478|12059326|FG002|Overall Study|Pregnancy|1
7644540|NCT00907478|12059324|FG000|Overall Study|Lost to Follow-up|1
7644541|NCT00907478|12059325|FG001|Overall Study|Lost to Follow-up|0
7644542|NCT00907478|12059326|FG002|Overall Study|Lost to Follow-up|0
7644543|NCT00907478|12059324|FG000|Overall Study|Other|3
7644544|NCT00907478|12059325|FG001|Overall Study|Other|0
7644545|NCT00907478|12059326|FG002|Overall Study|Other|1
7644546|NCT00907296|12059346|FG000|Overall Study|Ineligibility Determined|1
7644547|NCT00907296|12059347|FG001|Overall Study|Ineligibility Determined|0
7644548|NCT00907296|12059348|FG002|Overall Study|Ineligibility Determined|0
7644549|NCT00907296|12059349|FG003|Overall Study|Ineligibility Determined|1
7644550|NCT00907296|12059350|FG004|Overall Study|Ineligibility Determined|0
7644551|NCT00907296|12059351|FG005|Overall Study|Ineligibility Determined|0
7644552|NCT00907296|12059352|FG006|Overall Study|Ineligibility Determined|0
7644553|NCT00907296|12059353|FG007|Overall Study|Ineligibility Determined|1
7644554|NCT00907296|12059354|FG008|Overall Study|Ineligibility Determined|0
7644555|NCT00907296|12059355|FG009|Overall Study|Ineligibility Determined|0
7644556|NCT00907296|12059346|FG000|Overall Study|Protocol Deviation|0
7644557|NCT00907296|12059347|FG001|Overall Study|Protocol Deviation|1
7644558|NCT00907296|12059348|FG002|Overall Study|Protocol Deviation|0
7644559|NCT00907296|12059349|FG003|Overall Study|Protocol Deviation|0
7644560|NCT00907296|12059350|FG004|Overall Study|Protocol Deviation|0
7644561|NCT00907296|12059351|FG005|Overall Study|Protocol Deviation|0
7644562|NCT00907296|12059352|FG006|Overall Study|Protocol Deviation|0
7644563|NCT00907296|12059353|FG007|Overall Study|Protocol Deviation|0
7644564|NCT00907296|12059354|FG008|Overall Study|Protocol Deviation|0
7644565|NCT00907296|12059355|FG009|Overall Study|Protocol Deviation|0
7644566|NCT00907296|12059346|FG000|Overall Study|Noncompliance|1
7644567|NCT00907296|12059347|FG001|Overall Study|Noncompliance|1
7644568|NCT00907296|12059348|FG002|Overall Study|Noncompliance|1
7644569|NCT00907296|12059349|FG003|Overall Study|Noncompliance|0
7644570|NCT00907296|12059350|FG004|Overall Study|Noncompliance|0
7644571|NCT00907296|12059351|FG005|Overall Study|Noncompliance|1
7644572|NCT00907296|12059352|FG006|Overall Study|Noncompliance|0
7644573|NCT00907296|12059353|FG007|Overall Study|Noncompliance|2
7644574|NCT00907296|12059354|FG008|Overall Study|Noncompliance|0
7644575|NCT00907296|12059355|FG009|Overall Study|Noncompliance|0
7644576|NCT00907296|12059346|FG000|Overall Study|Adverse Event|2
7644577|NCT00907296|12059347|FG001|Overall Study|Adverse Event|0
7644578|NCT00907296|12059348|FG002|Overall Study|Adverse Event|0
7644579|NCT00907296|12059349|FG003|Overall Study|Adverse Event|0
7644580|NCT00907296|12059350|FG004|Overall Study|Adverse Event|0
7644581|NCT00907296|12059351|FG005|Overall Study|Adverse Event|0
7644582|NCT00907296|12059352|FG006|Overall Study|Adverse Event|1
7644583|NCT00907296|12059353|FG007|Overall Study|Adverse Event|0
7644584|NCT00907296|12059354|FG008|Overall Study|Adverse Event|0
7644585|NCT00907296|12059355|FG009|Overall Study|Adverse Event|1
7644586|NCT00907296|12059346|FG000|Overall Study|Withdrawal by Subject|7
7644587|NCT00907296|12059347|FG001|Overall Study|Withdrawal by Subject|2
7644588|NCT00907296|12059348|FG002|Overall Study|Withdrawal by Subject|1
7644589|NCT00907296|12059349|FG003|Overall Study|Withdrawal by Subject|1
7644590|NCT00907296|12059350|FG004|Overall Study|Withdrawal by Subject|1
7644591|NCT00907296|12059351|FG005|Overall Study|Withdrawal by Subject|5
7644592|NCT00907296|12059352|FG006|Overall Study|Withdrawal by Subject|3
7644593|NCT00907296|12059353|FG007|Overall Study|Withdrawal by Subject|2
7644594|NCT00907296|12059354|FG008|Overall Study|Withdrawal by Subject|4
7644595|NCT00907296|12059355|FG009|Overall Study|Withdrawal by Subject|2
7644596|NCT00907296|12059346|FG000|Overall Study|Lost to Follow-up|9
7644597|NCT00907296|12059347|FG001|Overall Study|Lost to Follow-up|1
7644598|NCT00907296|12059348|FG002|Overall Study|Lost to Follow-up|0
7644599|NCT00907296|12059349|FG003|Overall Study|Lost to Follow-up|2
7644600|NCT00907296|12059350|FG004|Overall Study|Lost to Follow-up|0
7644601|NCT00907296|12059351|FG005|Overall Study|Lost to Follow-up|3
7644602|NCT00907296|12059352|FG006|Overall Study|Lost to Follow-up|2
7644603|NCT00907296|12059353|FG007|Overall Study|Lost to Follow-up|2
7644604|NCT00907296|12059354|FG008|Overall Study|Lost to Follow-up|0
7644605|NCT00907296|12059355|FG009|Overall Study|Lost to Follow-up|4
7644606|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644607|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644608|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644609|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7644610|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644611|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
7644612|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644613|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644614|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644615|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644616|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644617|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644618|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644619|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644620|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644621|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644622|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644623|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644624|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644625|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644626|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644627|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644628|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
7644629|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644630|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7644631|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644632|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
7644633|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644634|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644635|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
7644636|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644637|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644638|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644639|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644640|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644641|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644642|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644643|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644644|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644645|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644646|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644647|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644648|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644649|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644650|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644651|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
7644652|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644653|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
7644654|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644655|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7644656|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
7644657|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
7644658|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644659|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
7644660|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644661|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644662|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644663|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644664|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644665|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644666|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644667|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644668|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644669|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644670|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644671|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644672|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644673|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644674|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
7644675|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644676|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644677|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
7644678|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644679|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
7644680|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644681|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644682|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644683|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644684|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644685|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644686|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644687|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644688|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644689|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644690|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644691|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644692|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644693|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644694|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644695|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644696|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644697|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
7644698|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
7644699|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
7644700|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
7644701|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
7644702|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
7644703|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
7644704|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
7644705|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
7644706|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
7644707|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
7644708|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
7644709|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
7644710|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
7644711|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
7644712|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
7644713|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
7644714|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
7644715|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
7644716|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
7644717|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
7644718|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
7644719|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
7644720|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
7644721|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644722|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644723|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
7644724|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644725|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644726|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644727|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644728|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644729|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644730|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644731|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644732|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644733|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644734|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644735|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644736|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644737|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644738|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644739|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644740|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644741|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644742|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644743|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
7644744|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644745|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644746|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
7644747|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644748|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644749|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644750|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644751|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644752|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644753|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644754|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644755|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644756|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644757|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644758|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644759|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644760|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644761|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644762|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644763|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644764|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644765|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644766|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
7644767|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644768|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644769|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644770|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
7644771|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644772|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644773|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7645050|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Death|0
7644774|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644775|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644776|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644777|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644778|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644779|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644780|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644781|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644782|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644783|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644784|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644785|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644786|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644787|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644788|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644789|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
7644790|NCT00896532|12059389|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
7644791|NCT00896532|12059390|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
7644792|NCT00896532|12059391|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
7644793|NCT00896532|12059392|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
7644794|NCT00896532|12059393|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
7644795|NCT00896532|12059394|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
7644796|NCT00896532|12059395|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
7644797|NCT00896532|12059396|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
7644798|NCT00896532|12059397|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
7644799|NCT00896532|12059398|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
7644800|NCT00896532|12059399|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
7644801|NCT00896532|12059400|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
7644802|NCT00896532|12059401|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
7644803|NCT00896532|12059402|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
7644804|NCT00896532|12059403|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
7644805|NCT00896532|12059404|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
7644806|NCT00896532|12059405|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
7644807|NCT00896532|12059406|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
7644808|NCT00896532|12059407|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
7644809|NCT00896532|12059408|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
7644810|NCT00896532|12059409|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
7644811|NCT00896532|12059410|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
7644812|NCT00896532|12059411|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
7644813|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644814|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644815|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644816|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644817|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644818|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644819|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644820|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644821|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
7644822|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644823|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644824|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644825|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644826|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644827|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644828|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644829|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644830|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644831|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644832|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644833|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644834|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644835|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
7644836|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644837|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644838|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644839|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644840|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644841|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644842|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644843|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644844|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644845|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644846|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644847|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644848|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
7644849|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644850|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644851|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644852|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644853|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644854|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644855|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644856|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644857|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644858|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
7644859|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644860|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644861|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644862|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644863|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644864|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644865|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644866|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644867|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644868|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644869|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7644870|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644871|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
7644872|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644873|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644874|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644875|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644876|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644877|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644878|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644879|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644880|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644881|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
7644882|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644883|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644884|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644885|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644886|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644887|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644888|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644889|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644890|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644891|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644892|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644893|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644894|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7644895|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
7644896|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644897|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644898|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644899|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644900|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644901|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644902|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644903|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644904|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
7644905|NCT00896532|12059389|FG000|Months 24-36: Denosumab Extension Phase|Other|0
7644906|NCT00896532|12059390|FG001|Months 24-36: Denosumab Extension Phase|Other|0
7644907|NCT00896532|12059391|FG002|Months 24-36: Denosumab Extension Phase|Other|0
7644908|NCT00896532|12059392|FG003|Months 24-36: Denosumab Extension Phase|Other|0
7644909|NCT00896532|12059393|FG004|Months 24-36: Denosumab Extension Phase|Other|0
7644910|NCT00896532|12059394|FG005|Months 24-36: Denosumab Extension Phase|Other|0
7644911|NCT00896532|12059395|FG006|Months 24-36: Denosumab Extension Phase|Other|0
7644912|NCT00896532|12059396|FG007|Months 24-36: Denosumab Extension Phase|Other|0
7644913|NCT00896532|12059397|FG008|Months 24-36: Denosumab Extension Phase|Other|0
7644914|NCT00896532|12059398|FG009|Months 24-36: Denosumab Extension Phase|Other|0
7644915|NCT00896532|12059399|FG010|Months 24-36: Denosumab Extension Phase|Other|1
7644916|NCT00896532|12059400|FG011|Months 24-36: Denosumab Extension Phase|Other|2
7644917|NCT00896532|12059401|FG012|Months 24-36: Denosumab Extension Phase|Other|2
7644918|NCT00896532|12059402|FG013|Months 24-36: Denosumab Extension Phase|Other|1
7644919|NCT00896532|12059403|FG014|Months 24-36: Denosumab Extension Phase|Other|0
7644920|NCT00896532|12059404|FG015|Months 24-36: Denosumab Extension Phase|Other|0
7644921|NCT00896532|12059405|FG016|Months 24-36: Denosumab Extension Phase|Other|0
7644922|NCT00896532|12059406|FG017|Months 24-36: Denosumab Extension Phase|Other|0
7644923|NCT00896532|12059407|FG018|Months 24-36: Denosumab Extension Phase|Other|0
7644924|NCT00896532|12059408|FG019|Months 24-36: Denosumab Extension Phase|Other|0
7644925|NCT00896532|12059409|FG020|Months 24-36: Denosumab Extension Phase|Other|0
7644926|NCT00896532|12059410|FG021|Months 24-36: Denosumab Extension Phase|Other|0
7644927|NCT00896532|12059411|FG022|Months 24-36: Denosumab Extension Phase|Other|0
7644928|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644929|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644930|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644931|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644932|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644933|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644934|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644935|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644936|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644937|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644938|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644939|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644940|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644941|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644942|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644943|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
7644944|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
7644945|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644946|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644947|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644948|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644949|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644950|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
7644951|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644952|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644953|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644954|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644955|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644956|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644957|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644958|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644959|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644960|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644961|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644962|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644963|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644964|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644965|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644966|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
7644967|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7644968|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
7644969|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644970|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644971|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644972|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644973|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
7644974|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644975|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644976|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644977|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644978|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644979|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644980|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644981|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644982|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644983|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644984|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644985|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644986|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644987|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644988|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644989|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644990|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
7644991|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644992|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644993|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644994|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644995|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644996|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
7644997|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Other|0
7644998|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Other|0
7644999|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Other|0
7645000|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Other|0
7645001|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Other|0
7645002|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Other|0
7645003|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Other|0
7645004|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Other|0
7645005|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Other|0
7645006|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Other|0
7645007|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Other|0
7645008|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Other|0
7645009|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Other|0
7645010|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Other|0
7645011|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Other|0
7645012|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Other|0
7645013|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Other|0
7645014|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Other|1
7645015|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Other|0
7645016|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Other|0
7645017|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Other|0
7645018|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Other|0
7645019|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Other|0
7645020|NCT00896532|12059389|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645021|NCT00896532|12059390|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645022|NCT00896532|12059391|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645023|NCT00896532|12059392|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645024|NCT00896532|12059393|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645025|NCT00896532|12059394|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645026|NCT00896532|12059395|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645027|NCT00896532|12059396|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645028|NCT00896532|12059397|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645029|NCT00896532|12059398|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645030|NCT00896532|12059399|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645031|NCT00896532|12059400|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645032|NCT00896532|12059401|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645033|NCT00896532|12059402|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645034|NCT00896532|12059403|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645035|NCT00896532|12059404|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645036|NCT00896532|12059405|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
7645037|NCT00896532|12059406|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645038|NCT00896532|12059407|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645039|NCT00896532|12059408|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645040|NCT00896532|12059409|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645041|NCT00896532|12059410|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645042|NCT00896532|12059411|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
7645043|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Death|0
7645044|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Death|0
7645045|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Death|0
7645046|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Death|0
7645047|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Death|0
7645048|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Death|0
7645049|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Death|0
7645051|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Death|0
7645052|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Death|0
7645053|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Death|0
7645054|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Death|0
7645055|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Death|0
7645056|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Death|0
7645057|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Death|0
7645058|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Death|0
7645059|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Death|0
7645060|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Death|0
7645061|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Death|1
7645062|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Death|0
7645063|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Death|0
7645064|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Death|0
7645065|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Death|0
7645066|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645067|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645068|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645069|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645070|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645071|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645072|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645073|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645074|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645075|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645076|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645077|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645078|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645079|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645080|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645081|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645082|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645083|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645084|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645085|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645086|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645087|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
7645088|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
7645089|NCT00896532|12059389|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645090|NCT00896532|12059390|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645091|NCT00896532|12059391|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645092|NCT00896532|12059392|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645093|NCT00896532|12059393|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645094|NCT00896532|12059394|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645095|NCT00896532|12059395|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645096|NCT00896532|12059396|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645097|NCT00896532|12059397|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645098|NCT00896532|12059398|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645099|NCT00896532|12059399|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645100|NCT00896532|12059400|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645101|NCT00896532|12059401|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645102|NCT00896532|12059402|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645103|NCT00896532|12059403|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645104|NCT00896532|12059404|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645105|NCT00896532|12059405|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645106|NCT00896532|12059406|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645107|NCT00896532|12059407|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645108|NCT00896532|12059408|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645109|NCT00896532|12059409|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645110|NCT00896532|12059410|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
7645111|NCT00896532|12059411|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
7645112|NCT00892281|12059460|FG000|Overall Study|Adverse Event|65
7645113|NCT00892281|12059461|FG001|Overall Study|Adverse Event|8
7645114|NCT00892281|12059460|FG000|Overall Study|Lost to Follow-up|81
7645115|NCT00892281|12059461|FG001|Overall Study|Lost to Follow-up|8
7645116|NCT00892281|12059460|FG000|Overall Study|Pregnancy|1
7645117|NCT00892281|12059461|FG001|Overall Study|Pregnancy|0
7645118|NCT00892281|12059460|FG000|Overall Study|Protocol Violation|7
7645119|NCT00892281|12059461|FG001|Overall Study|Protocol Violation|2
7645120|NCT00892281|12059460|FG000|Overall Study|Withdrawal by Subject|86
7645121|NCT00892281|12059461|FG001|Overall Study|Withdrawal by Subject|14
7645122|NCT00892281|12059460|FG000|Overall Study|Subject failed to return for final visit|2
7645123|NCT00892281|12059461|FG001|Overall Study|Subject failed to return for final visit|0
7645124|NCT00892281|12059460|FG000|Overall Study|Subject unable to keep follow-up visits|1
7645125|NCT00892281|12059461|FG001|Overall Study|Subject unable to keep follow-up visits|0
7645126|NCT00892281|12059460|FG000|Overall Study|Final visit completed 4 weeks late|0
7645127|NCT00892281|12059461|FG001|Overall Study|Final visit completed 4 weeks late|1
7645128|NCT00892281|12059460|FG000|Overall Study|Subject completed day after study closed|1
7645129|NCT00892281|12059461|FG001|Overall Study|Subject completed day after study closed|0
7645130|NCT00892281|12059460|FG000|Overall Study|Family emergency|1
7645131|NCT00892281|12059461|FG001|Overall Study|Family emergency|0
7645132|NCT00892281|12059460|FG000|Overall Study|Last visit not done - death in family|1
7645133|NCT00892281|12059461|FG001|Overall Study|Last visit not done - death in family|0
7645134|NCT00892281|12059460|FG000|Overall Study|Did not meet incl/excl criteria|1
7645135|NCT00892281|12059461|FG001|Overall Study|Did not meet incl/excl criteria|0
7645136|NCT00892281|12059460|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
7645137|NCT00892281|12059461|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
7645138|NCT00892281|12059460|FG000|Overall Study|Unable to redeem the drug voucher|1
7645139|NCT00892281|12059461|FG001|Overall Study|Unable to redeem the drug voucher|0
7645140|NCT00892281|12059460|FG000|Overall Study|Subject not good candidate for study|1
7645141|NCT00892281|12059461|FG001|Overall Study|Subject not good candidate for study|0
7645142|NCT00892281|12059460|FG000|Overall Study|Subject did not return for any visits|1
7645143|NCT00892281|12059461|FG001|Overall Study|Subject did not return for any visits|0
7645144|NCT00892281|12059460|FG000|Overall Study|Subject missed several visits/lost meds|1
7645145|NCT00892281|12059461|FG001|Overall Study|Subject missed several visits/lost meds|0
7645146|NCT00892281|12059460|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
7645147|NCT00892281|12059461|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
7645148|NCT00892281|12059460|FG000|Overall Study|Scheduled for knee replacement|0
7645149|NCT00892281|12059461|FG001|Overall Study|Scheduled for knee replacement|1
7645150|NCT00892281|12059460|FG000|Overall Study|PI complained of inadequate compensation|3
7645151|NCT00892281|12059461|FG001|Overall Study|PI complained of inadequate compensation|0
7645152|NCT00892281|12059460|FG000|Overall Study|Subject lost interest in program|0
7645153|NCT00892281|12059461|FG001|Overall Study|Subject lost interest in program|1
7645154|NCT00892281|12059460|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
7645155|NCT00892281|12059461|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
7645156|NCT00892281|12059460|FG000|Overall Study|Death in family|1
7645157|NCT00892281|12059461|FG001|Overall Study|Death in family|0
7645158|NCT00892281|12059460|FG000|Overall Study|Lack of efficacy of study product|2
7645159|NCT00892281|12059461|FG001|Overall Study|Lack of efficacy of study product|0
7645160|NCT00892281|12059460|FG000|Overall Study|Subject not seen by PI at final visit|1
7645161|NCT00892281|12059461|FG001|Overall Study|Subject not seen by PI at final visit|0
7645162|NCT00892281|12059460|FG000|Overall Study|No show Visit 2; prescription not filled|1
7645163|NCT00892281|12059461|FG001|Overall Study|No show Visit 2; prescription not filled|0
7645164|NCT00892281|12059460|FG000|Overall Study|Missed multiple visits|1
7645165|NCT00892281|12059461|FG001|Overall Study|Missed multiple visits|0
7645166|NCT00892281|12059460|FG000|Overall Study|Missed visits rescheduled out of window|1
7645167|NCT00892281|12059461|FG001|Overall Study|Missed visits rescheduled out of window|0
7645168|NCT00892281|12059460|FG000|Overall Study|Non-compliant with visits as scheduled|1
7645169|NCT00892281|12059461|FG001|Overall Study|Non-compliant with visits as scheduled|0
7645170|NCT00892281|12059460|FG000|Overall Study|Subject had history of drug abuse|1
7645171|NCT00892281|12059461|FG001|Overall Study|Subject had history of drug abuse|0
7645172|NCT00892281|12059460|FG000|Overall Study|Rash on hand|1
7645173|NCT00892281|12059461|FG001|Overall Study|Rash on hand|0
7645174|NCT00892281|12059460|FG000|Overall Study|Visit 4 date out of window|1
7645175|NCT00892281|12059461|FG001|Overall Study|Visit 4 date out of window|0
7645176|NCT00881868|12059483|FG000|Overall Study|Adverse Event|0
7645177|NCT00881868|12059484|FG001|Overall Study|Adverse Event|1
7645178|NCT00881868|12059483|FG000|Overall Study|Lost to Follow-up|2
7645179|NCT00881868|12059484|FG001|Overall Study|Lost to Follow-up|1
7645180|NCT00881868|12059483|FG000|Overall Study|Physician Decision|4
7645181|NCT00881868|12059484|FG001|Overall Study|Physician Decision|0
7645182|NCT00881868|12059483|FG000|Overall Study|Protocol Violation|2
7645183|NCT00881868|12059484|FG001|Overall Study|Protocol Violation|0
7645184|NCT00861705|12059498|FG000|Overall Study|Never Began Treatment|7
7645185|NCT00861705|12059499|FG001|Overall Study|Never Began Treatment|3
7645186|NCT00861705|12059500|FG002|Overall Study|Never Began Treatment|0
7645187|NCT00861705|12059501|FG003|Overall Study|Never Began Treatment|1
7645188|NCT00847730|12059519|FG000|Overall Study|Multiple interruptions in therapy|8
7645189|NCT00846742|12059523|FG000|Overall Study|Withdrawal by Subject|1
7645190|NCT00845026|12059530|FG000|Study Period III|Adverse Event|23
7645191|NCT00845026|12059531|FG001|Study Period III|Adverse Event|19
7645192|NCT00845026|12059530|FG000|Study Period III|Perceived lack of efficacy|27
7645193|NCT00845026|12059531|FG001|Study Period III|Perceived lack of efficacy|15
7645194|NCT00845026|12059530|FG000|Study Period III|Withdrawal by Subject|19
7645195|NCT00845026|12059531|FG001|Study Period III|Withdrawal by Subject|15
7645196|NCT00845026|12059530|FG000|Study Period III|Entry Criteria not met|8
7645197|NCT00845026|12059531|FG001|Study Period III|Entry Criteria not met|11
7645198|NCT00845026|12059530|FG000|Study Period III|Lost to Follow-up|4
7645199|NCT00845026|12059531|FG001|Study Period III|Lost to Follow-up|5
7645200|NCT00845026|12059530|FG000|Study Period III|Protocol Violation|8
7645201|NCT00845026|12059531|FG001|Study Period III|Protocol Violation|1
7645202|NCT00845026|12059530|FG000|Study Period III|Scheduled conflict|3
7645203|NCT00845026|12059531|FG001|Study Period III|Scheduled conflict|1
7645204|NCT00845026|12059530|FG000|Study Period III|Subject is moving or has moved|2
7645205|NCT00845026|12059531|FG001|Study Period III|Subject is moving or has moved|4
7645206|NCT00845026|12059530|FG000|Study Period III|Transportation issues|1
7645207|NCT00845026|12059531|FG001|Study Period III|Transportation issues|1
7645208|NCT00845026|12059530|FG000|Study Period IV|Adverse Event|4
7645209|NCT00845026|12059531|FG001|Study Period IV|Adverse Event|0
7645210|NCT00845026|12059530|FG000|Study Period IV|Perceived lack of efficacy|2
7645211|NCT00845026|12059531|FG001|Study Period IV|Perceived lack of efficacy|1
7645212|NCT00845026|12059530|FG000|Study Period IV|Protocol Violation|3
7645213|NCT00845026|12059531|FG001|Study Period IV|Protocol Violation|1
7645214|NCT00845026|12059530|FG000|Study Period IV|Lost to Follow-up|1
7645215|NCT00845026|12059531|FG001|Study Period IV|Lost to Follow-up|0
7645216|NCT00845026|12059530|FG000|Study Period IV|Withdrawal by Subject|4
7645217|NCT00845026|12059531|FG001|Study Period IV|Withdrawal by Subject|1
7645218|NCT00845026|12059530|FG000|Study Period IV|Entry Criteria Not Met|1
7645219|NCT00845026|12059531|FG001|Study Period IV|Entry Criteria Not Met|0
7645220|NCT00845026|12059530|FG000|Study Period IV|Subject is moving or has moved|0
7645221|NCT00845026|12059531|FG001|Study Period IV|Subject is moving or has moved|1
7645222|NCT00845026|12059530|FG000|Study Period IV|Scheduling conflict|1
7645223|NCT00845026|12059531|FG001|Study Period IV|Scheduling conflict|0
7645224|NCT00843882|12059542|FG000|Step 1|Lack of Efficacy|14
7645225|NCT00843882|12059543|FG001|Step 1|Lack of Efficacy|10
7645226|NCT00843882|12059544|FG002|Step 1|Lack of Efficacy|21
7645227|NCT00843882|12059542|FG000|Step 1|Adverse Event|8
7645228|NCT00843882|12059543|FG001|Step 1|Adverse Event|17
7645229|NCT00843882|12059544|FG002|Step 1|Adverse Event|20
7645230|NCT00843882|12059542|FG000|Step 1|Death|1
7645231|NCT00843882|12059543|FG001|Step 1|Death|2
7645232|NCT00843882|12059544|FG002|Step 1|Death|4
7645233|NCT00843882|12059542|FG000|Step 1|Withdrawal by Subject|6
7645234|NCT00843882|12059543|FG001|Step 1|Withdrawal by Subject|12
7645235|NCT00843882|12059544|FG002|Step 1|Withdrawal by Subject|9
7645236|NCT00843882|12059542|FG000|Step 1|Physician Decision|0
7645237|NCT00843882|12059543|FG001|Step 1|Physician Decision|5
7645238|NCT00843882|12059544|FG002|Step 1|Physician Decision|1
7645239|NCT00843882|12059542|FG000|Step 1|Patient and physician's decision|0
7645240|NCT00843882|12059543|FG001|Step 1|Patient and physician's decision|0
7645241|NCT00843882|12059544|FG002|Step 1|Patient and physician's decision|1
7645242|NCT00843882|12059542|FG000|Step 1|Other complicating disease|1
7645243|NCT00843882|12059543|FG001|Step 1|Other complicating disease|3
7645244|NCT00843882|12059544|FG002|Step 1|Other complicating disease|4
7645245|NCT00843882|12059542|FG000|Step 1|Alternative therapy|0
7645246|NCT00843882|12059543|FG001|Step 1|Alternative therapy|1
7645247|NCT00843882|12059544|FG002|Step 1|Alternative therapy|1
7645248|NCT00843882|12059542|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
7645249|NCT00843882|12059543|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
7645250|NCT00843882|12059544|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
7645251|NCT00843882|12059542|FG000|Step 1|Off treatment reason unknown|0
7645252|NCT00843882|12059543|FG001|Step 1|Off treatment reason unknown|1
7645253|NCT00843882|12059544|FG002|Step 1|Off treatment reason unknown|4
7645254|NCT00843882|12059542|FG000|Step 1|Never started treatment|2
7645255|NCT00843882|12059543|FG001|Step 1|Never started treatment|0
7645256|NCT00843882|12059544|FG002|Step 1|Never started treatment|0
7645257|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
7645258|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
7645259|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
7645260|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
7645261|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
7645262|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
7645263|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Death|0
7645264|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Death|3
7645265|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Death|0
7645266|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
7645267|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
7645268|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
7645269|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
7645270|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
7645271|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
7645272|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7645273|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
7645274|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
7645275|NCT00843882|12059542|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7645276|NCT00843882|12059543|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
7645277|NCT00843882|12059544|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
7645278|NCT00837096|12059572|FG000|Overall Study|Physician Decision|1
7645279|NCT00837096|12059573|FG001|Overall Study|Physician Decision|1
7645280|NCT00837096|12059572|FG000|Overall Study|Not reported|9
7645281|NCT00837096|12059573|FG001|Overall Study|Not reported|8
7645282|NCT00836810|12059581|FG000|Overall Study|New diagnosis|1
7645283|NCT00836810|12059582|FG001|Overall Study|New diagnosis|0
7645284|NCT00822120|12059590|FG000|Initial Registration|Adverse Event|1
7645285|NCT00822120|12059591|FG001|Initial Registration|Adverse Event|0
7645286|NCT00822120|12059592|FG002|Initial Registration|Adverse Event|0
7645287|NCT00822120|12059593|FG003|Initial Registration|Adverse Event|0
7645288|NCT00822120|12059594|FG004|Initial Registration|Adverse Event|0
7645289|NCT00822120|12059595|FG005|Initial Registration|Adverse Event|0
7645290|NCT00822120|12059590|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
7645291|NCT00822120|12059591|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
7645292|NCT00822120|12059592|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
7645293|NCT00822120|12059593|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
7645294|NCT00822120|12059594|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
7645295|NCT00822120|12059595|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
7645296|NCT00822120|12059590|FG000|Initial Registration|Reasons not Protocol Specified|2
7645297|NCT00822120|12059591|FG001|Initial Registration|Reasons not Protocol Specified|0
7645298|NCT00822120|12059592|FG002|Initial Registration|Reasons not Protocol Specified|0
7645299|NCT00822120|12059593|FG003|Initial Registration|Reasons not Protocol Specified|0
7645300|NCT00822120|12059594|FG004|Initial Registration|Reasons not Protocol Specified|0
7645301|NCT00822120|12059595|FG005|Initial Registration|Reasons not Protocol Specified|0
7645302|NCT00822120|12059590|FG000|Initial Registration|Ineligible|22
7645303|NCT00822120|12059591|FG001|Initial Registration|Ineligible|1
7645304|NCT00822120|12059592|FG002|Initial Registration|Ineligible|0
7645305|NCT00822120|12059593|FG003|Initial Registration|Ineligible|0
7645306|NCT00822120|12059594|FG004|Initial Registration|Ineligible|0
7645307|NCT00822120|12059595|FG005|Initial Registration|Ineligible|0
7645308|NCT00822120|12059590|FG000|PET-directed Therapy|Adverse Event|0
7645309|NCT00822120|12059591|FG001|PET-directed Therapy|Adverse Event|0
7645310|NCT00822120|12059592|FG002|PET-directed Therapy|Adverse Event|0
7645311|NCT00822120|12059593|FG003|PET-directed Therapy|Adverse Event|1
7645312|NCT00822120|12059594|FG004|PET-directed Therapy|Adverse Event|0
7645313|NCT00822120|12059595|FG005|PET-directed Therapy|Adverse Event|0
7645314|NCT00822120|12059590|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645315|NCT00822120|12059591|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645316|NCT00822120|12059592|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645317|NCT00822120|12059593|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
7645318|NCT00822120|12059594|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645319|NCT00822120|12059595|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
7645320|NCT00822120|12059590|FG000|PET-directed Therapy|Death|0
7645321|NCT00822120|12059591|FG001|PET-directed Therapy|Death|0
7645322|NCT00822120|12059592|FG002|PET-directed Therapy|Death|0
7645323|NCT00822120|12059593|FG003|PET-directed Therapy|Death|2
7645324|NCT00822120|12059594|FG004|PET-directed Therapy|Death|0
7645325|NCT00822120|12059595|FG005|PET-directed Therapy|Death|0
7645326|NCT00822120|12059590|FG000|PET-directed Therapy|Protocol Violation|0
7645327|NCT00822120|12059591|FG001|PET-directed Therapy|Protocol Violation|0
7645328|NCT00822120|12059592|FG002|PET-directed Therapy|Protocol Violation|0
7645329|NCT00822120|12059593|FG003|PET-directed Therapy|Protocol Violation|6
7645330|NCT00822120|12059594|FG004|PET-directed Therapy|Protocol Violation|0
7645331|NCT00822120|12059595|FG005|PET-directed Therapy|Protocol Violation|0
7645332|NCT00819780|12059618|FG000|Overall Study|Did not receive study drug|3
7645333|NCT00819780|12059619|FG001|Overall Study|Did not receive study drug|4
7645334|NCT00819780|12059618|FG000|Overall Study|Still in treatment|25
7645335|NCT00819780|12059619|FG001|Overall Study|Still in treatment|17
7645336|NCT00792948|12059625|FG000|Overall Study|Adverse Event|6
7645337|NCT00792948|12059625|FG000|Overall Study|Death|4
7645338|NCT00792948|12059625|FG000|Overall Study|Withdrawal by Subject|3
7645339|NCT00792948|12059625|FG000|Overall Study|Ineligible|2
7645340|NCT00792948|12059625|FG000|Overall Study|Insurance denial - not treated|1
7645341|NCT00792948|12059625|FG000|Overall Study|Physician Decision|11
7645342|NCT00792948|12059625|FG000|Overall Study|Protocol Violation|1
7645343|NCT00785291|12059644|FG000|Overall Study|Never began treatment|8
7645344|NCT00785291|12059645|FG001|Overall Study|Never began treatment|4
7645345|NCT00785291|12059646|FG002|Overall Study|Never began treatment|4
7645346|NCT00785291|12059644|FG000|Overall Study|Adverse Event|39
7645347|NCT00785291|12059645|FG001|Overall Study|Adverse Event|70
7645348|NCT00785291|12059646|FG002|Overall Study|Adverse Event|56
7645349|NCT00785291|12059644|FG000|Overall Study|Death|7
7645350|NCT00785291|12059645|FG001|Overall Study|Death|4
7645351|NCT00785291|12059646|FG002|Overall Study|Death|3
7645352|NCT00785291|12059644|FG000|Overall Study|Withdrawal by Subject|35
7645353|NCT00785291|12059645|FG001|Overall Study|Withdrawal by Subject|36
7645354|NCT00785291|12059646|FG002|Overall Study|Withdrawal by Subject|17
7645355|NCT00785291|12059644|FG000|Overall Study|Alternative Therapy|12
7645356|NCT00785291|12059645|FG001|Overall Study|Alternative Therapy|6
7645357|NCT00785291|12059646|FG002|Overall Study|Alternative Therapy|7
7645358|NCT00785291|12059644|FG000|Overall Study|Complicating illness|6
7645359|NCT00785291|12059645|FG001|Overall Study|Complicating illness|4
7645360|NCT00785291|12059646|FG002|Overall Study|Complicating illness|4
7645361|NCT00785291|12059644|FG000|Overall Study|Other Medical Reasons|29
7645362|NCT00785291|12059645|FG001|Overall Study|Other Medical Reasons|25
7645363|NCT00785291|12059646|FG002|Overall Study|Other Medical Reasons|15
7645364|NCT00770809|12059678|FG000|Overall Study|Adverse Event|9
7645365|NCT00770809|12059679|FG001|Overall Study|Adverse Event|1
7645366|NCT00770809|12059680|FG002|Overall Study|Adverse Event|12
7645367|NCT00770809|12059678|FG000|Overall Study|Death|1
7645368|NCT00770809|12059679|FG001|Overall Study|Death|0
7645369|NCT00770809|12059680|FG002|Overall Study|Death|0
7645370|NCT00770809|12059678|FG000|Overall Study|Withdrawal by Subject|3
7645371|NCT00770809|12059679|FG001|Overall Study|Withdrawal by Subject|3
7645372|NCT00770809|12059680|FG002|Overall Study|Withdrawal by Subject|7
7645373|NCT00770809|12059678|FG000|Overall Study|Progression|2
7645374|NCT00770809|12059679|FG001|Overall Study|Progression|2
7645375|NCT00770809|12059680|FG002|Overall Study|Progression|0
7645376|NCT00770809|12059678|FG000|Overall Study|Complicating illness|0
7645377|NCT00770809|12059679|FG001|Overall Study|Complicating illness|0
7645378|NCT00770809|12059680|FG002|Overall Study|Complicating illness|1
7645379|NCT00770809|12059678|FG000|Overall Study|Other Medical Reasons|2
7645380|NCT00770809|12059679|FG001|Overall Study|Other Medical Reasons|4
7645381|NCT00770809|12059680|FG002|Overall Study|Other Medical Reasons|3
7645382|NCT00769379|12059690|FG000|Overall Study|No follow up data mapped to Other.|3
7645383|NCT00769379|12059691|FG001|Overall Study|No follow up data mapped to Other.|13
7645384|NCT00763555|12059699|FG000|Overall Study|Adverse Event|2
7645385|NCT00763555|12059700|FG001|Overall Study|Adverse Event|1
7645386|NCT00763555|12059699|FG000|Overall Study|Withdrawal by Subject|2
7645387|NCT00763555|12059700|FG001|Overall Study|Withdrawal by Subject|6
7645388|NCT00763555|12059699|FG000|Overall Study|Lost to Follow-up|0
7645389|NCT00763555|12059700|FG001|Overall Study|Lost to Follow-up|3
7645390|NCT00757042|12059717|FG000|Overall Study|Lost to Follow-up|0
7645391|NCT00757042|12059718|FG001|Overall Study|Lost to Follow-up|0
7645392|NCT00757042|12059719|FG002|Overall Study|Lost to Follow-up|0
7645393|NCT00757042|12059720|FG003|Overall Study|Lost to Follow-up|0
7645394|NCT00757042|12059721|FG004|Overall Study|Lost to Follow-up|0
7645395|NCT00757042|12059722|FG005|Overall Study|Lost to Follow-up|0
7645396|NCT00757042|12059723|FG006|Overall Study|Lost to Follow-up|0
7645397|NCT00757042|12059724|FG007|Overall Study|Lost to Follow-up|0
7645398|NCT00757042|12059725|FG008|Overall Study|Lost to Follow-up|1
7645399|NCT00757042|12059726|FG009|Overall Study|Lost to Follow-up|0
7645400|NCT00757042|12059727|FG010|Overall Study|Lost to Follow-up|0
7645401|NCT00757042|12059717|FG000|Overall Study|Ineligibility Determined|0
7645402|NCT00757042|12059718|FG001|Overall Study|Ineligibility Determined|0
7645403|NCT00757042|12059719|FG002|Overall Study|Ineligibility Determined|0
7645404|NCT00757042|12059720|FG003|Overall Study|Ineligibility Determined|0
7645405|NCT00757042|12059721|FG004|Overall Study|Ineligibility Determined|0
7645406|NCT00757042|12059722|FG005|Overall Study|Ineligibility Determined|0
7645407|NCT00757042|12059723|FG006|Overall Study|Ineligibility Determined|0
7645408|NCT00757042|12059724|FG007|Overall Study|Ineligibility Determined|0
7645409|NCT00757042|12059725|FG008|Overall Study|Ineligibility Determined|0
7645410|NCT00757042|12059726|FG009|Overall Study|Ineligibility Determined|0
7645411|NCT00757042|12059727|FG010|Overall Study|Ineligibility Determined|1
7645412|NCT00757042|12059717|FG000|Overall Study|Withdrawal by Subject|0
7645413|NCT00757042|12059718|FG001|Overall Study|Withdrawal by Subject|0
7645414|NCT00757042|12059719|FG002|Overall Study|Withdrawal by Subject|0
7645415|NCT00757042|12059720|FG003|Overall Study|Withdrawal by Subject|0
7645416|NCT00757042|12059721|FG004|Overall Study|Withdrawal by Subject|0
7645417|NCT00757042|12059722|FG005|Overall Study|Withdrawal by Subject|0
7645418|NCT00757042|12059723|FG006|Overall Study|Withdrawal by Subject|0
7645419|NCT00757042|12059724|FG007|Overall Study|Withdrawal by Subject|0
7645420|NCT00757042|12059725|FG008|Overall Study|Withdrawal by Subject|0
7645421|NCT00757042|12059726|FG009|Overall Study|Withdrawal by Subject|1
7645422|NCT00757042|12059727|FG010|Overall Study|Withdrawal by Subject|0
7645423|NCT00738920|12059761|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8
7645424|NCT00738920|12059762|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9
7645425|NCT00738920|12059763|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8
7645426|NCT00738920|12059761|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8
7645427|NCT00738920|12059762|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14
7645428|NCT00738920|12059763|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7
7645429|NCT00738920|12059761|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3
7645430|NCT00738920|12059762|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5
7645431|NCT00738920|12059763|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6
7645432|NCT00738920|12059761|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5
7645433|NCT00738920|12059762|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7
7645434|NCT00738920|12059763|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6
7645435|NCT00738920|12059761|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3
7645436|NCT00738920|12059762|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0
7645437|NCT00738920|12059763|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2
7645438|NCT00738920|12059761|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1
7645439|NCT00738920|12059762|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0
7645440|NCT00738920|12059763|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1
7645441|NCT00738920|12059761|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2
7645442|NCT00738920|12059762|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4
7645443|NCT00738920|12059763|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7
7645444|NCT00738920|12059761|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2
7645445|NCT00738920|12059762|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3
7645446|NCT00738920|12059763|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5
7645447|NCT00738920|12059761|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1
7645448|NCT00738920|12059762|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0
7645449|NCT00738920|12059763|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1
7645450|NCT00738920|12059761|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0
7645451|NCT00738920|12059762|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1
7645452|NCT00738920|12059763|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0
7645453|NCT00738582|12059771|FG000|Combination Therapy|Completed Combination Therapy|1
7645454|NCT00738582|12059772|FG001|Combination Therapy|Completed Combination Therapy|0
7645455|NCT00738582|12059771|FG000|Combination Therapy|Physician Decision|1
7645456|NCT00738582|12059772|FG001|Combination Therapy|Physician Decision|0
7645457|NCT00738582|12059771|FG000|Combination Therapy|Toxicity to Chemotherapy|1
7645458|NCT00738582|12059772|FG001|Combination Therapy|Toxicity to Chemotherapy|0
7645459|NCT00738582|12059771|FG000|Combination Therapy|Other|5
7645460|NCT00738582|12059772|FG001|Combination Therapy|Other|0
7645461|NCT00738582|12059771|FG000|Combination Therapy|Adverse Event|16
7645462|NCT00738582|12059772|FG001|Combination Therapy|Adverse Event|0
7645463|NCT00738582|12059771|FG000|Combination Therapy|Progressive Disease|9
7645464|NCT00738582|12059772|FG001|Combination Therapy|Progressive Disease|0
7645465|NCT00738582|12059771|FG000|Maintenance Therapy|Other|0
7645466|NCT00738582|12059772|FG001|Maintenance Therapy|Other|2
7645467|NCT00738582|12059771|FG000|Maintenance Therapy|Adverse Event|0
7645468|NCT00738582|12059772|FG001|Maintenance Therapy|Adverse Event|6
7645469|NCT00738582|12059771|FG000|Maintenance Therapy|Progressive Disease|0
7645470|NCT00738582|12059772|FG001|Maintenance Therapy|Progressive Disease|47
7645471|NCT00738582|12059771|FG000|Maintenance Therapy|Withdrawal by Subject|0
7645472|NCT00738582|12059772|FG001|Maintenance Therapy|Withdrawal by Subject|1
7645473|NCT00733954|12059781|FG000|Overall Study|Lost to Follow-up|5
7645474|NCT00733954|12059782|FG001|Overall Study|Lost to Follow-up|2
7645475|NCT00733954|12059781|FG000|Overall Study|Protocol Violation|1
7645476|NCT00733954|12059782|FG001|Overall Study|Protocol Violation|0
7645477|NCT00733954|12059781|FG000|Overall Study|Withdrawal by Subject|2
7645478|NCT00733954|12059782|FG001|Overall Study|Withdrawal by Subject|0
7645479|NCT00731731|12059791|FG000|Overall Study|Protocol Violation|0
7645480|NCT00731731|12059792|FG001|Overall Study|Protocol Violation|0
7645481|NCT00731731|12059793|FG002|Overall Study|Protocol Violation|1
7645482|NCT00731731|12059791|FG000|Overall Study|Cancel prior to treatment|0
7645483|NCT00731731|12059792|FG001|Overall Study|Cancel prior to treatment|0
7645484|NCT00731731|12059793|FG002|Overall Study|Cancel prior to treatment|2
7645485|NCT00728884|12059806|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
7645486|NCT00728884|12059806|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
7645487|NCT00680992|12059827|FG000|Overall Study|Complete Resection (as per protocol)|25
7645488|NCT00680992|12059828|FG001|Overall Study|Complete Resection (as per protocol)|121
7645489|NCT00680992|12059829|FG002|Overall Study|Complete Resection (as per protocol)|0
7645490|NCT00680992|12059827|FG000|Overall Study|Administrative Decision|83
7645491|NCT00680992|12059828|FG001|Overall Study|Administrative Decision|42
7645492|NCT00680992|12059829|FG002|Overall Study|Administrative Decision|5
7645493|NCT00680992|12059827|FG000|Overall Study|End of Trial|32
7645494|NCT00680992|12059828|FG001|Overall Study|End of Trial|12
7645495|NCT00680992|12059829|FG002|Overall Study|End of Trial|3
7645496|NCT00680992|12059827|FG000|Overall Study|Withdrawal by Subject|33
7645497|NCT00680992|12059828|FG001|Overall Study|Withdrawal by Subject|11
7645498|NCT00680992|12059829|FG002|Overall Study|Withdrawal by Subject|1
7645499|NCT00680992|12059827|FG000|Overall Study|Adverse Event|21
7645500|NCT00680992|12059828|FG001|Overall Study|Adverse Event|19
7645501|NCT00680992|12059829|FG002|Overall Study|Adverse Event|1
7645502|NCT00680992|12059827|FG000|Overall Study|Other|19
7645503|NCT00680992|12059828|FG001|Overall Study|Other|14
7645504|NCT00680992|12059829|FG002|Overall Study|Other|1
7645505|NCT00680992|12059827|FG000|Overall Study|Disease Progression|21
7645506|NCT00680992|12059828|FG001|Overall Study|Disease Progression|9
7645507|NCT00680992|12059829|FG002|Overall Study|Disease Progression|0
7645508|NCT00680992|12059827|FG000|Overall Study|Lost to Follow-up|12
7645509|NCT00680992|12059828|FG001|Overall Study|Lost to Follow-up|14
7645510|NCT00680992|12059829|FG002|Overall Study|Lost to Follow-up|0
7645511|NCT00680992|12059827|FG000|Overall Study|Noncompliance|4
7645512|NCT00680992|12059828|FG001|Overall Study|Noncompliance|6
7645513|NCT00680992|12059829|FG002|Overall Study|Noncompliance|0
7645514|NCT00680992|12059827|FG000|Overall Study|Requirement for Alternative Therapy|8
7645515|NCT00680992|12059828|FG001|Overall Study|Requirement for Alternative Therapy|2
7645516|NCT00680992|12059829|FG002|Overall Study|Requirement for Alternative Therapy|0
7645517|NCT00680992|12059827|FG000|Overall Study|Pregnancy|5
7645518|NCT00680992|12059828|FG001|Overall Study|Pregnancy|0
7645519|NCT00680992|12059829|FG002|Overall Study|Pregnancy|1
7645520|NCT00680992|12059827|FG000|Overall Study|Death|5
7645521|NCT00680992|12059828|FG001|Overall Study|Death|1
7645522|NCT00680992|12059829|FG002|Overall Study|Death|0
7645523|NCT00680992|12059827|FG000|Overall Study|Ineligibility Determined|0
7645524|NCT00680992|12059828|FG001|Overall Study|Ineligibility Determined|1
7645525|NCT00680992|12059829|FG002|Overall Study|Ineligibility Determined|0
7645526|NCT00679783|12059845|FG000|Overall Study|Adverse Event|0
7645527|NCT00679783|12059846|FG001|Overall Study|Adverse Event|0
7645528|NCT00679783|12059847|FG002|Overall Study|Adverse Event|0
7645529|NCT00679783|12059848|FG003|Overall Study|Adverse Event|3
7645530|NCT00679783|12059849|FG004|Overall Study|Adverse Event|0
7645531|NCT00679783|12059850|FG005|Overall Study|Adverse Event|0
7645532|NCT00679783|12059851|FG006|Overall Study|Adverse Event|1
7645533|NCT00679783|12059845|FG000|Overall Study|Lack of Efficacy|0
7645534|NCT00679783|12059846|FG001|Overall Study|Lack of Efficacy|1
7645535|NCT00679783|12059847|FG002|Overall Study|Lack of Efficacy|0
7645536|NCT00679783|12059848|FG003|Overall Study|Lack of Efficacy|2
7645537|NCT00679783|12059849|FG004|Overall Study|Lack of Efficacy|0
7645538|NCT00679783|12059850|FG005|Overall Study|Lack of Efficacy|0
7645539|NCT00679783|12059851|FG006|Overall Study|Lack of Efficacy|0
7645540|NCT00679783|12059845|FG000|Overall Study|Withdrawal by Subject|0
7645541|NCT00679783|12059846|FG001|Overall Study|Withdrawal by Subject|0
7645542|NCT00679783|12059847|FG002|Overall Study|Withdrawal by Subject|1
7645543|NCT00679783|12059848|FG003|Overall Study|Withdrawal by Subject|1
7645544|NCT00679783|12059849|FG004|Overall Study|Withdrawal by Subject|0
7645545|NCT00679783|12059850|FG005|Overall Study|Withdrawal by Subject|0
7645546|NCT00679783|12059851|FG006|Overall Study|Withdrawal by Subject|0
7645547|NCT00679783|12059845|FG000|Overall Study|Not Captured|0
7645548|NCT00679783|12059846|FG001|Overall Study|Not Captured|0
7645549|NCT00679783|12059847|FG002|Overall Study|Not Captured|0
7645550|NCT00679783|12059848|FG003|Overall Study|Not Captured|5
7645551|NCT00679783|12059849|FG004|Overall Study|Not Captured|0
7645552|NCT00679783|12059850|FG005|Overall Study|Not Captured|0
7645553|NCT00679783|12059851|FG006|Overall Study|Not Captured|0
7645554|NCT00679783|12059845|FG000|Overall Study|Ongoing at data cut-off|2
7645555|NCT00679783|12059846|FG001|Overall Study|Ongoing at data cut-off|2
7645556|NCT00679783|12059847|FG002|Overall Study|Ongoing at data cut-off|0
7645557|NCT00679783|12059848|FG003|Overall Study|Ongoing at data cut-off|9
7645558|NCT00679783|12059849|FG004|Overall Study|Ongoing at data cut-off|1
7645559|NCT00679783|12059850|FG005|Overall Study|Ongoing at data cut-off|0
7645560|NCT00679783|12059851|FG006|Overall Study|Ongoing at data cut-off|0
7645561|NCT00679042|12059867|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
7645562|NCT00679042|12059867|FG000|5-Year Follow Up|In follow-up (ongoing)|6
7645563|NCT00679042|12059867|FG000|5-Year Follow Up|Death|1
7645564|NCT00679042|12059867|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
7645565|NCT00679042|12059867|FG000|10-Year Follow Up|In follow-up (ongoing)|5
7645566|NCT00671749|12059871|FG000|Overall Study|Adverse Event|2
7645567|NCT00671749|12059871|FG000|Overall Study|Withdrawal by Subject|4
7645568|NCT00671749|12059871|FG000|Overall Study|Protocol Violation|1
7645569|NCT00671749|12059871|FG000|Overall Study|Lost to Follow-up|1
7645570|NCT00669071|12059875|FG000|Overall Study|Lost to Follow-up|3
7645571|NCT00669071|12059875|FG000|Overall Study|Final visit 40 days out of window|1
7645572|NCT00667251|12059883|FG000|Overall Study|Adverse Event|13
7645573|NCT00667251|12059884|FG001|Overall Study|Adverse Event|4
7645574|NCT00667251|12059883|FG000|Overall Study|Withdrawal by Subject|6
7645575|NCT00667251|12059884|FG001|Overall Study|Withdrawal by Subject|2
7645576|NCT00667251|12059883|FG000|Overall Study|Other/missing|46
7645577|NCT00667251|12059884|FG001|Overall Study|Other/missing|84
7645578|NCT00667251|12059883|FG000|Overall Study|Intercurrent Illness|4
7645579|NCT00667251|12059884|FG001|Overall Study|Intercurrent Illness|3
7645580|NCT00667251|12059883|FG000|Overall Study|Symptomatic progression|1
7645581|NCT00667251|12059884|FG001|Overall Study|Symptomatic progression|2
7645582|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Adverse Event|1
7645583|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Adverse Event|3
7645584|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
7645585|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
7645586|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
7645587|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
7645588|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Death|1
7645589|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Death|4
7645590|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Not protocol specified|2
7645591|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Not protocol specified|4
7645592|NCT00658814|12059892|FG000|Remission Induction Chemotherapy|Not eligible|1
7645593|NCT00658814|12059893|FG001|Remission Induction Chemotherapy|Not eligible|2
7645594|NCT00658814|12059892|FG000|Consolidation Therapy|Not protocol specified|0
7645595|NCT00658814|12059893|FG001|Consolidation Therapy|Not protocol specified|1
7645596|NCT00658814|12059892|FG000|Consolidation Therapy|Not eligible|2
7645597|NCT00658814|12059893|FG001|Consolidation Therapy|Not eligible|2
7645598|NCT00658814|12059892|FG000|Maintenance Therapy|Adverse Event|1
7645599|NCT00658814|12059893|FG001|Maintenance Therapy|Adverse Event|1
7645600|NCT00658814|12059892|FG000|Maintenance Therapy|Not protocol specified|1
7645601|NCT00658814|12059893|FG001|Maintenance Therapy|Not protocol specified|0
7645602|NCT00658814|12059892|FG000|Maintenance Therapy|Not eligible|1
7645603|NCT00658814|12059893|FG001|Maintenance Therapy|Not eligible|0
7645604|NCT00658788|12059903|FG000|Overall Study|Adverse Event|11
7645605|NCT00658788|12059903|FG000|Overall Study|Withdrawal by Subject|13
7645606|NCT00658788|12059903|FG000|Overall Study|Lost to Follow-up|18
7645607|NCT00658788|12059903|FG000|Overall Study|Treatment Discontinuation|32
7645608|NCT00647556|12059918|FG000|Overall Study|Adverse Event|0
7645609|NCT00647556|12059919|FG001|Overall Study|Adverse Event|1
7645610|NCT00647556|12059918|FG000|Overall Study|Lost to Follow-up|1
7645611|NCT00647556|12059919|FG001|Overall Study|Lost to Follow-up|0
7645612|NCT00647556|12059918|FG000|Overall Study|Protocol Violation|0
7645613|NCT00647556|12059919|FG001|Overall Study|Protocol Violation|1
7645614|NCT00647556|12059918|FG000|Overall Study|Withdrawal by Subject|1
7645615|NCT00647556|12059919|FG001|Overall Study|Withdrawal by Subject|0
7645616|NCT00647556|12059918|FG000|Overall Study|Surgery for pre-existing neck pain|1
7645617|NCT00647556|12059919|FG001|Overall Study|Surgery for pre-existing neck pain|0
7645618|NCT00641186|12059934|FG000|Overall Study|Adverse Event|3
7645619|NCT00625378|12059949|FG000|Overall Study|Adverse Event|22
7645620|NCT00625378|12059950|FG001|Overall Study|Adverse Event|0
7645621|NCT00625378|12059949|FG000|Overall Study|Withdrawal by Subject|16
7645622|NCT00625378|12059950|FG001|Overall Study|Withdrawal by Subject|0
7645623|NCT00625378|12059949|FG000|Overall Study|Death|38
7645624|NCT00625378|12059950|FG001|Overall Study|Death|0
7645625|NCT00625378|12059949|FG000|Overall Study|Disease progression, recurrence or relapse|88
7645626|NCT00625378|12059950|FG001|Overall Study|Disease progression, recurrence or relapse|0
7645627|NCT00625378|12059949|FG000|Overall Study|Lost to Follow-up|17
7645628|NCT00625378|12059950|FG001|Overall Study|Lost to Follow-up|0
7645629|NCT00625378|12059949|FG000|Overall Study|Non-compliant with study medication|3
7645630|NCT00625378|12059950|FG001|Overall Study|Non-compliant with study medication|0
7645631|NCT00625378|12059949|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1
7645632|NCT00625378|12059950|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0
7645633|NCT00625378|12059949|FG000|Overall Study|Medical decision|1
7645634|NCT00625378|12059950|FG001|Overall Study|Medical decision|0
7645635|NCT00625378|12059949|FG000|Overall Study|Multiple toxicities|1
7645636|NCT00625378|12059950|FG001|Overall Study|Multiple toxicities|0
7645637|NCT00625378|12059949|FG000|Overall Study|New cancer|1
7645638|NCT00625378|12059950|FG001|Overall Study|New cancer|0
7645639|NCT00625378|12059949|FG000|Overall Study|PTA program|2
7645640|NCT00625378|12059950|FG001|Overall Study|PTA program|0
7645641|NCT00625378|12059949|FG000|Overall Study|Recurrent rise in amylase and lipase|1
7645642|NCT00625378|12059950|FG001|Overall Study|Recurrent rise in amylase and lipase|0
7645643|NCT00625378|12059949|FG000|Overall Study|Sponsor decision|1
7645644|NCT00625378|12059950|FG001|Overall Study|Sponsor decision|0
7645645|NCT00625378|12059949|FG000|Overall Study|Sponsor's decision to stop the trial|1
7645646|NCT00625378|12059950|FG001|Overall Study|Sponsor's decision to stop the trial|0
7645647|NCT00625378|12059949|FG000|Overall Study|Switch to commercial drug|6
7645648|NCT00625378|12059950|FG001|Overall Study|Switch to commercial drug|1
7645649|NCT00625378|12059949|FG000|Overall Study|Missing|2
7645650|NCT00625378|12059950|FG001|Overall Study|Missing|0
7645651|NCT00625378|12059949|FG000|Overall Study|End of treatment not available|2
7645652|NCT00625378|12059950|FG001|Overall Study|End of treatment not available|0
7645653|NCT00625378|12059949|FG000|Overall Study|Never treated|2
7645654|NCT00625378|12059950|FG001|Overall Study|Never treated|0
7645655|NCT00609791|12059956|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1
7645656|NCT00605189|12059963|FG000|Overall Study|Adverse Event|1
7645657|NCT00605189|12059964|FG001|Overall Study|Adverse Event|0
7645658|NCT00605189|12059965|FG002|Overall Study|Adverse Event|0
7645659|NCT00605189|12059963|FG000|Overall Study|Other|2
7645660|NCT00605189|12059964|FG001|Overall Study|Other|2
7645661|NCT00605189|12059965|FG002|Overall Study|Other|0
7645662|NCT00602641|12059975|FG000|Overall Study|Never started protocol therapy|6
7645663|NCT00602641|12059976|FG001|Overall Study|Never started protocol therapy|2
7645664|NCT00602641|12059975|FG000|Overall Study|Still on treatment at time of analysis|8
7645665|NCT00602641|12059976|FG001|Overall Study|Still on treatment at time of analysis|15
7645666|NCT00602641|12059975|FG000|Overall Study|Adverse Event|62
7645667|NCT00602641|12059976|FG001|Overall Study|Adverse Event|53
7645668|NCT00602641|12059975|FG000|Overall Study|Disease progression|38
7645669|NCT00602641|12059976|FG001|Overall Study|Disease progression|55
7645670|NCT00602641|12059975|FG000|Overall Study|Death|6
7645671|NCT00602641|12059976|FG001|Overall Study|Death|5
7645672|NCT00602641|12059975|FG000|Overall Study|Withdrawal by Subject|15
7645673|NCT00602641|12059976|FG001|Overall Study|Withdrawal by Subject|12
7645674|NCT00602641|12059975|FG000|Overall Study|Alternative therapy|5
7645675|NCT00602641|12059976|FG001|Overall Study|Alternative therapy|2
7645676|NCT00602641|12059975|FG000|Overall Study|Other Complicating Disease|5
7645677|NCT00602641|12059976|FG001|Overall Study|Other Complicating Disease|2
7645678|NCT00602641|12059975|FG000|Overall Study|Physician Decision|5
7645679|NCT00602641|12059976|FG001|Overall Study|Physician Decision|4
7645680|NCT00602641|12059975|FG000|Overall Study|Administrative Closure|1
7645681|NCT00602641|12059976|FG001|Overall Study|Administrative Closure|1
7645682|NCT00602641|12059975|FG000|Overall Study|Other|3
7645683|NCT00602641|12059976|FG001|Overall Study|Other|1
7645684|NCT00602030|12060009|FG000|Lead-in Phase|Disease Progression|2
7645685|NCT00602030|12060010|FG001|Lead-in Phase|Disease Progression|3
7645686|NCT00602030|12060011|FG002|Lead-in Phase|Disease Progression|0
7645687|NCT00602030|12060012|FG003|Lead-in Phase|Disease Progression|0
7645688|NCT00602030|12060013|FG004|Lead-in Phase|Disease Progression|0
7645689|NCT00602030|12060009|FG000|Lead-in Phase|Adverse Event|0
7645690|NCT00602030|12060010|FG001|Lead-in Phase|Adverse Event|2
7645691|NCT00602030|12060011|FG002|Lead-in Phase|Adverse Event|0
7645692|NCT00602030|12060012|FG003|Lead-in Phase|Adverse Event|0
7645693|NCT00602030|12060013|FG004|Lead-in Phase|Adverse Event|0
7645694|NCT00602030|12060009|FG000|Double-blind Phase|Disease progression|0
7645695|NCT00602030|12060010|FG001|Double-blind Phase|Disease progression|0
7645696|NCT00602030|12060011|FG002|Double-blind Phase|Disease progression|33
7645697|NCT00602030|12060012|FG003|Double-blind Phase|Disease progression|30
7645698|NCT00602030|12060013|FG004|Double-blind Phase|Disease progression|0
7645699|NCT00602030|12060009|FG000|Double-blind Phase|Adverse Event|0
7645700|NCT00602030|12060010|FG001|Double-blind Phase|Adverse Event|0
7645701|NCT00602030|12060011|FG002|Double-blind Phase|Adverse Event|9
7645702|NCT00602030|12060012|FG003|Double-blind Phase|Adverse Event|18
7645703|NCT00602030|12060013|FG004|Double-blind Phase|Adverse Event|0
7645704|NCT00602030|12060009|FG000|Double-blind Phase|Consent withdrawal|0
7645705|NCT00602030|12060010|FG001|Double-blind Phase|Consent withdrawal|0
7645706|NCT00602030|12060011|FG002|Double-blind Phase|Consent withdrawal|4
7645707|NCT00602030|12060012|FG003|Double-blind Phase|Consent withdrawal|3
7645708|NCT00602030|12060013|FG004|Double-blind Phase|Consent withdrawal|0
7645709|NCT00602030|12060009|FG000|Double-blind Phase|Death|0
7645710|NCT00602030|12060010|FG001|Double-blind Phase|Death|0
7645711|NCT00602030|12060011|FG002|Double-blind Phase|Death|3
7645712|NCT00602030|12060012|FG003|Double-blind Phase|Death|3
7645713|NCT00602030|12060013|FG004|Double-blind Phase|Death|0
7645714|NCT00602030|12060009|FG000|Double-blind Phase|Administrative decision|0
7645715|NCT00602030|12060010|FG001|Double-blind Phase|Administrative decision|0
7645716|NCT00602030|12060011|FG002|Double-blind Phase|Administrative decision|0
7645717|NCT00602030|12060012|FG003|Double-blind Phase|Administrative decision|2
7645718|NCT00602030|12060013|FG004|Double-blind Phase|Administrative decision|0
7645719|NCT00602030|12060009|FG000|Double-blind Phase|Ineligibility|0
7645720|NCT00602030|12060010|FG001|Double-blind Phase|Ineligibility|0
7645721|NCT00602030|12060011|FG002|Double-blind Phase|Ineligibility|0
7645722|NCT00602030|12060012|FG003|Double-blind Phase|Ineligibility|1
7645723|NCT00602030|12060013|FG004|Double-blind Phase|Ineligibility|0
7645724|NCT00602030|12060009|FG000|Double-blind Phase|Protocol deviation/noncompliance|0
7645725|NCT00602030|12060010|FG001|Double-blind Phase|Protocol deviation/noncompliance|0
7645726|NCT00602030|12060011|FG002|Double-blind Phase|Protocol deviation/noncompliance|1
7645727|NCT00602030|12060012|FG003|Double-blind Phase|Protocol deviation/noncompliance|0
7645728|NCT00602030|12060013|FG004|Double-blind Phase|Protocol deviation/noncompliance|0
7645729|NCT00602030|12060009|FG000|Double-blind Phase|Reason not specified|0
7645730|NCT00602030|12060010|FG001|Double-blind Phase|Reason not specified|0
7645731|NCT00602030|12060011|FG002|Double-blind Phase|Reason not specified|4
7645732|NCT00602030|12060012|FG003|Double-blind Phase|Reason not specified|2
7645733|NCT00602030|12060013|FG004|Double-blind Phase|Reason not specified|0
7645734|NCT00602030|12060009|FG000|Crossover Phase|Disease Progression|0
7645735|NCT00602030|12060010|FG001|Crossover Phase|Disease Progression|0
7645736|NCT00602030|12060011|FG002|Crossover Phase|Disease Progression|0
7645737|NCT00602030|12060012|FG003|Crossover Phase|Disease Progression|0
7645738|NCT00602030|12060013|FG004|Crossover Phase|Disease Progression|11
7645739|NCT00602030|12060009|FG000|Crossover Phase|Adverse Event|0
7645740|NCT00602030|12060010|FG001|Crossover Phase|Adverse Event|0
7645741|NCT00602030|12060011|FG002|Crossover Phase|Adverse Event|0
7645742|NCT00602030|12060012|FG003|Crossover Phase|Adverse Event|0
7645743|NCT00602030|12060013|FG004|Crossover Phase|Adverse Event|3
7645744|NCT00602030|12060009|FG000|Crossover Phase|Consent withdrawal|0
7645745|NCT00602030|12060010|FG001|Crossover Phase|Consent withdrawal|0
7645746|NCT00602030|12060011|FG002|Crossover Phase|Consent withdrawal|0
7645747|NCT00602030|12060012|FG003|Crossover Phase|Consent withdrawal|0
7645748|NCT00602030|12060013|FG004|Crossover Phase|Consent withdrawal|2
7645749|NCT00601900|12060027|FG000|Overall Study|Withdrawal by Subject|0
7645750|NCT00601900|12060028|FG001|Overall Study|Withdrawal by Subject|3
7645751|NCT00597012|12060036|FG000|Overall Study|Death|1
7645752|NCT00597012|12060037|FG001|Overall Study|Death|1
7645753|NCT00597012|12060036|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
7645754|NCT00597012|12060037|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
7645755|NCT00597012|12060036|FG000|Overall Study|Withdrawal by Subject|7
7645756|NCT00597012|12060037|FG001|Overall Study|Withdrawal by Subject|4
7645757|NCT00597012|12060036|FG000|Overall Study|Ineligible|2
7645758|NCT00597012|12060037|FG001|Overall Study|Ineligible|0
7645759|NCT00597012|12060036|FG000|Overall Study|Lost to Follow-up|0
7645760|NCT00597012|12060037|FG001|Overall Study|Lost to Follow-up|2
7645761|NCT00588770|12060047|FG000|Overall Study|Disease progression|85
7645762|NCT00588770|12060048|FG001|Overall Study|Disease progression|68
7645763|NCT00588770|12060047|FG000|Overall Study|Adverse Event|29
7645764|NCT00588770|12060048|FG001|Overall Study|Adverse Event|58
7645765|NCT00588770|12060047|FG000|Overall Study|Death|13
7645766|NCT00588770|12060048|FG001|Overall Study|Death|22
7645767|NCT00588770|12060047|FG000|Overall Study|Withdrawal by Subject|15
7645768|NCT00588770|12060048|FG001|Overall Study|Withdrawal by Subject|25
7645769|NCT00588770|12060047|FG000|Overall Study|Alternative therapy|2
7645770|NCT00588770|12060048|FG001|Overall Study|Alternative therapy|4
7645771|NCT00588770|12060047|FG000|Overall Study|Other complicating disease|3
7645772|NCT00588770|12060048|FG001|Overall Study|Other complicating disease|2
7645773|NCT00588770|12060047|FG000|Overall Study|Not start protocol therapy|0
7645774|NCT00588770|12060048|FG001|Overall Study|Not start protocol therapy|9
7645775|NCT00588770|12060047|FG000|Overall Study|Lack of Efficacy|8
7645776|NCT00588770|12060048|FG001|Overall Study|Lack of Efficacy|10
7645777|NCT00588770|12060047|FG000|Overall Study|Physician discretion|2
7645778|NCT00588770|12060048|FG001|Overall Study|Physician discretion|0
7645779|NCT00588770|12060047|FG000|Overall Study|Patient non-compliance|2
7645780|NCT00588770|12060048|FG001|Overall Study|Patient non-compliance|2
7645781|NCT00569127|12060067|FG000|Overall Study|Adverse Event|57
7645782|NCT00569127|12060068|FG001|Overall Study|Adverse Event|47
7645783|NCT00569127|12060067|FG000|Overall Study|Withdrawal by Subject|13
7645784|NCT00569127|12060068|FG001|Overall Study|Withdrawal by Subject|27
7645785|NCT00569127|12060067|FG000|Overall Study|Progression|99
7645786|NCT00569127|12060068|FG001|Overall Study|Progression|100
7645787|NCT00569127|12060067|FG000|Overall Study|Death|4
7645788|NCT00569127|12060068|FG001|Overall Study|Death|3
7645789|NCT00569127|12060067|FG000|Overall Study|Other|20
7645790|NCT00569127|12060068|FG001|Overall Study|Other|19
7645791|NCT00569127|12060067|FG000|Overall Study|Lost to Follow-up|0
7645792|NCT00569127|12060068|FG001|Overall Study|Lost to Follow-up|3
7645793|NCT00569127|12060067|FG000|Overall Study|Not Eligible|14
7645794|NCT00569127|12060068|FG001|Overall Study|Not Eligible|11
7645795|NCT00569127|12060067|FG000|Overall Study|Still on Treatment|7
7645796|NCT00569127|12060068|FG001|Overall Study|Still on Treatment|3
7645797|NCT00565851|12060082|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7645798|NCT00565851|12060083|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
7645799|NCT00565851|12060084|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
7645800|NCT00565851|12060085|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
7645801|NCT00565851|12060086|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7645802|NCT00565851|12060087|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7645803|NCT00565851|12060088|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
7645804|NCT00565851|12060089|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
7645805|NCT00565851|12060082|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
7645806|NCT00565851|12060083|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
7645807|NCT00565851|12060084|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
7645808|NCT00565851|12060085|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
7645809|NCT00565851|12060086|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
7645810|NCT00565851|12060087|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
7645811|NCT00565851|12060088|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
7645812|NCT00565851|12060089|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
7645813|NCT00557193|12060111|FG000|Induction|Adverse Event|2
7645814|NCT00557193|12060112|FG001|Induction|Adverse Event|0
7645815|NCT00557193|12060113|FG002|Induction|Adverse Event|0
7645816|NCT00557193|12060114|FG003|Induction|Adverse Event|0
7645817|NCT00557193|12060115|FG004|Induction|Adverse Event|0
7645818|NCT00557193|12060116|FG005|Induction|Adverse Event|0
7645819|NCT00557193|12060111|FG000|Induction|Death|6
7645820|NCT00557193|12060112|FG001|Induction|Death|0
7645821|NCT00557193|12060113|FG002|Induction|Death|0
7645822|NCT00557193|12060114|FG003|Induction|Death|0
7645823|NCT00557193|12060115|FG004|Induction|Death|0
7645824|NCT00557193|12060116|FG005|Induction|Death|0
7645825|NCT00557193|12060111|FG000|Induction|Physician Decision|3
7645826|NCT00557193|12060112|FG001|Induction|Physician Decision|0
7645827|NCT00557193|12060113|FG002|Induction|Physician Decision|0
7645828|NCT00557193|12060114|FG003|Induction|Physician Decision|0
7645829|NCT00557193|12060115|FG004|Induction|Physician Decision|0
7645830|NCT00557193|12060116|FG005|Induction|Physician Decision|0
7645831|NCT00557193|12060111|FG000|Induction|Withdrawal by Subject|1
7645832|NCT00557193|12060112|FG001|Induction|Withdrawal by Subject|0
7645833|NCT00557193|12060113|FG002|Induction|Withdrawal by Subject|0
7645834|NCT00557193|12060114|FG003|Induction|Withdrawal by Subject|0
7645835|NCT00557193|12060115|FG004|Induction|Withdrawal by Subject|0
7645836|NCT00557193|12060116|FG005|Induction|Withdrawal by Subject|0
7645837|NCT00557193|12060111|FG000|Induction|Refusal of Further Protocol Therapy|2
7645838|NCT00557193|12060112|FG001|Induction|Refusal of Further Protocol Therapy|0
7645839|NCT00557193|12060113|FG002|Induction|Refusal of Further Protocol Therapy|0
7645840|NCT00557193|12060114|FG003|Induction|Refusal of Further Protocol Therapy|0
7645841|NCT00557193|12060115|FG004|Induction|Refusal of Further Protocol Therapy|0
7645842|NCT00557193|12060116|FG005|Induction|Refusal of Further Protocol Therapy|0
7645843|NCT00557193|12060111|FG000|Induction|Ineligible|8
7645844|NCT00557193|12060112|FG001|Induction|Ineligible|0
7645845|NCT00557193|12060113|FG002|Induction|Ineligible|0
7645846|NCT00557193|12060114|FG003|Induction|Ineligible|0
7645847|NCT00557193|12060115|FG004|Induction|Ineligible|0
7645848|NCT00557193|12060116|FG005|Induction|Ineligible|0
7645849|NCT00557193|12060111|FG000|Induction|Inevaluable for post Induction|2
7645850|NCT00557193|12060112|FG001|Induction|Inevaluable for post Induction|0
7645851|NCT00557193|12060113|FG002|Induction|Inevaluable for post Induction|0
7645852|NCT00557193|12060114|FG003|Induction|Inevaluable for post Induction|0
7645853|NCT00557193|12060115|FG004|Induction|Inevaluable for post Induction|0
7645854|NCT00557193|12060116|FG005|Induction|Inevaluable for post Induction|0
7645855|NCT00557193|12060111|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
7645856|NCT00557193|12060112|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
7645857|NCT00557193|12060113|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
7645858|NCT00557193|12060114|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
7645859|NCT00557193|12060115|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
7645860|NCT00557193|12060116|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
7645861|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7645862|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
7645863|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
7645864|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
7645865|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
7645866|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
7645867|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Death|0
7645868|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Death|0
7645869|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Death|2
7645870|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Death|0
7645871|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Death|2
7645872|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Death|2
7645873|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7645874|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
7645875|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
7645876|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
7645877|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
7645878|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
7645879|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7645880|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
7645881|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
7645882|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7645883|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
7645884|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
7645885|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
7645886|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
7645887|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
7645888|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
7645889|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
7645890|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
7645891|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645892|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645893|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
7645894|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645895|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645896|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
7645897|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645898|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645899|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
7645900|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645901|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645902|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
7645903|NCT00557193|12060111|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645904|NCT00557193|12060112|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645905|NCT00557193|12060113|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
7645906|NCT00557193|12060114|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645907|NCT00557193|12060115|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
7645908|NCT00557193|12060116|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
7645909|NCT00556374|12060143|FG000|Overall Study|Withdrawal by Subject|190
7645910|NCT00556374|12060144|FG001|Overall Study|Withdrawal by Subject|172
7645911|NCT00556374|12060143|FG000|Overall Study|Death|50
7645912|NCT00556374|12060144|FG001|Overall Study|Death|43
7645913|NCT00556374|12060143|FG000|Overall Study|Lost to Follow-up|7
7645914|NCT00556374|12060144|FG001|Overall Study|Lost to Follow-up|5
7645915|NCT00549848|12060153|FG000|Overall Study|Death|1
7645916|NCT00549848|12060154|FG001|Overall Study|Death|4
7645917|NCT00549848|12060155|FG002|Overall Study|Death|13
7645918|NCT00549848|12060153|FG000|Overall Study|Physician Decision|0
7645919|NCT00549848|12060154|FG001|Overall Study|Physician Decision|0
7645920|NCT00549848|12060155|FG002|Overall Study|Physician Decision|4
7645921|NCT00549848|12060153|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3
7645922|NCT00549848|12060154|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
7645923|NCT00549848|12060155|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
7645924|NCT00549848|12060153|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1
7645925|NCT00549848|12060154|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0
7645926|NCT00549848|12060155|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1
7645927|NCT00549848|12060153|FG000|Overall Study|Participant/Family Withdraw|2
7645928|NCT00549848|12060154|FG001|Overall Study|Participant/Family Withdraw|3
7645929|NCT00549848|12060155|FG002|Overall Study|Participant/Family Withdraw|5
7645930|NCT00549848|12060153|FG000|Overall Study|Second Malignancy|1
7645931|NCT00549848|12060154|FG001|Overall Study|Second Malignancy|0
7645932|NCT00549848|12060155|FG002|Overall Study|Second Malignancy|0
7645933|NCT00549848|12060153|FG000|Overall Study|Transplant|3
7645934|NCT00549848|12060154|FG001|Overall Study|Transplant|3
7645935|NCT00549848|12060155|FG002|Overall Study|Transplant|18
7645936|NCT00549848|12060153|FG000|Overall Study|Unacceptable Toxicity|1
7645937|NCT00549848|12060154|FG001|Overall Study|Unacceptable Toxicity|6
7645938|NCT00549848|12060155|FG002|Overall Study|Unacceptable Toxicity|6
7645939|NCT00523341|12060179|FG000|Overall Study|Withdrawal by Subject|399
7645940|NCT00523341|12060180|FG001|Overall Study|Withdrawal by Subject|427
7645941|NCT00523341|12060179|FG000|Overall Study|Other|181
7645942|NCT00523341|12060180|FG001|Overall Study|Other|198
7645943|NCT00523341|12060179|FG000|Overall Study|Adverse Event|122
7645944|NCT00523341|12060180|FG001|Overall Study|Adverse Event|155
7645945|NCT00523341|12060179|FG000|Overall Study|Death|101
7645946|NCT00523341|12060180|FG001|Overall Study|Death|110
7645947|NCT00523341|12060179|FG000|Overall Study|Lost to Follow-up|73
7645948|NCT00523341|12060180|FG001|Overall Study|Lost to Follow-up|61
7645949|NCT00523341|12060179|FG000|Overall Study|Non-compliance|20
7645950|NCT00523341|12060180|FG001|Overall Study|Non-compliance|13
7645951|NCT00523341|12060179|FG000|Overall Study|Physician Decision|14
7645952|NCT00523341|12060180|FG001|Overall Study|Physician Decision|13
7645953|NCT00523341|12060179|FG000|Overall Study|Requirement for Alternative Therapy|4
7645954|NCT00523341|12060180|FG001|Overall Study|Requirement for Alternative Therapy|14
7645955|NCT00523341|12060179|FG000|Overall Study|Protocol Deviation|6
7645956|NCT00523341|12060180|FG001|Overall Study|Protocol Deviation|5
7645957|NCT00523341|12060179|FG000|Overall Study|Ineligibility Determined|3
7645958|NCT00523341|12060180|FG001|Overall Study|Ineligibility Determined|4
7645959|NCT00523341|12060179|FG000|Overall Study|Disease Progression|1
7645960|NCT00523341|12060180|FG001|Overall Study|Disease Progression|0
7645961|NCT00520767|12060186|FG000|Overall Study|Death|2
7645962|NCT00508820|12060192|FG000|Overall Study|Adverse Event|6
7645963|NCT00508820|12060193|FG001|Overall Study|Adverse Event|10
7645964|NCT00508820|12060192|FG000|Overall Study|Death|6
7645965|NCT00508820|12060193|FG001|Overall Study|Death|8
7645966|NCT00508820|12060192|FG000|Overall Study|Lost to Follow-up|1
7645967|NCT00508820|12060193|FG001|Overall Study|Lost to Follow-up|1
7645968|NCT00508820|12060192|FG000|Overall Study|Physician Decision|8
7645969|NCT00508820|12060193|FG001|Overall Study|Physician Decision|2
7645970|NCT00508820|12060192|FG000|Overall Study|Pregnancy|0
7645971|NCT00508820|12060193|FG001|Overall Study|Pregnancy|2
7645972|NCT00508820|12060192|FG000|Overall Study|Protocol Violation|2
7645973|NCT00508820|12060193|FG001|Overall Study|Protocol Violation|0
7645974|NCT00508820|12060192|FG000|Overall Study|Withdrawal by Subject|10
7645975|NCT00508820|12060193|FG001|Overall Study|Withdrawal by Subject|12
7645976|NCT00508820|12060192|FG000|Overall Study|Other|11
7645977|NCT00508820|12060193|FG001|Overall Study|Other|2
7645978|NCT00508820|12060192|FG000|Overall Study|Noncompliance|1
7645979|NCT00508820|12060193|FG001|Overall Study|Noncompliance|0
7645980|NCT00508820|12060192|FG000|Overall Study|Requirement for alternative therapy|7
7645981|NCT00508820|12060193|FG001|Overall Study|Requirement for alternative therapy|15
7645982|NCT00508820|12060192|FG000|Overall Study|Protocol-specified Criteria|3
7645983|NCT00508820|12060193|FG001|Overall Study|Protocol-specified Criteria|12
7645984|NCT00493467|12060199|FG000|Overall Study|Death|1
7645985|NCT00486889|12060203|FG000|Overall Study|Death|3
7645986|NCT00486889|12060203|FG000|Overall Study|Non-compliant|2
7645987|NCT00486889|12060203|FG000|Overall Study|Withdrawal by Subject|6
7645988|NCT00472212|12060209|FG000|Overall Study|Lost to Follow-up|6
7645989|NCT00472212|12060210|FG001|Overall Study|Lost to Follow-up|4
7645990|NCT00470704|12060218|FG000|Overall Study|Withdrawal by Subject|4
7645991|NCT00470704|12060219|FG001|Overall Study|Withdrawal by Subject|3
7645992|NCT00470704|12060218|FG000|Overall Study|Relapse/Progression|37
7645993|NCT00470704|12060219|FG001|Overall Study|Relapse/Progression|42
7645994|NCT00470704|12060218|FG000|Overall Study|toxicity|0
7645995|NCT00470704|12060219|FG001|Overall Study|toxicity|1
7645996|NCT00436566|12060229|FG000|Overall Study|Withdrawal by Subject|2
7645997|NCT00436566|12060229|FG000|Overall Study|Protocol Violation|1
7645998|NCT00433511|12060236|FG000|Step 1|Adverse Event|50
7645999|NCT00433511|12060237|FG001|Step 1|Adverse Event|157
7646000|NCT00433511|12060238|FG002|Step 1|Adverse Event|153
7646001|NCT00433511|12060236|FG000|Step 1|Withdrawal by Subject|45
7646002|NCT00433511|12060237|FG001|Step 1|Withdrawal by Subject|143
7646003|NCT00433511|12060238|FG002|Step 1|Withdrawal by Subject|154
7646004|NCT00433511|12060236|FG000|Step 1|Death|3
7646005|NCT00433511|12060237|FG001|Step 1|Death|1
7646006|NCT00433511|12060238|FG002|Step 1|Death|1
7646007|NCT00433511|12060236|FG000|Step 1|Physician Decision|1
7646008|NCT00433511|12060237|FG001|Step 1|Physician Decision|4
7646009|NCT00433511|12060238|FG002|Step 1|Physician Decision|3
7646010|NCT00433511|12060236|FG000|Step 1|Never started protocol therapy|28
7646011|NCT00433511|12060237|FG001|Step 1|Never started protocol therapy|64
7646012|NCT00433511|12060238|FG002|Step 1|Never started protocol therapy|66
7646013|NCT00433511|12060236|FG000|Step 1|Alternative therapy|2
7646014|NCT00433511|12060237|FG001|Step 1|Alternative therapy|1
7646015|NCT00433511|12060238|FG002|Step 1|Alternative therapy|3
7646016|NCT00433511|12060236|FG000|Step 1|Disease progression, relapse|5
7646017|NCT00433511|12060237|FG001|Step 1|Disease progression, relapse|3
7646018|NCT00433511|12060238|FG002|Step 1|Disease progression, relapse|3
7646019|NCT00433511|12060236|FG000|Step 1|Other complicating disease|2
7646020|NCT00433511|12060237|FG001|Step 1|Other complicating disease|6
7646021|NCT00433511|12060238|FG002|Step 1|Other complicating disease|3
7646022|NCT00433511|12060236|FG000|Step 1|Non-breast cancer surgery/wound issues|0
7646023|NCT00433511|12060237|FG001|Step 1|Non-breast cancer surgery/wound issues|4
7646024|NCT00433511|12060238|FG002|Step 1|Non-breast cancer surgery/wound issues|1
7646025|NCT00433511|12060236|FG000|Step 1|Suspected recurrence|0
7646026|NCT00433511|12060237|FG001|Step 1|Suspected recurrence|1
7646027|NCT00433511|12060238|FG002|Step 1|Suspected recurrence|0
7646028|NCT00433511|12060236|FG000|Step 1|Insurance/drug distribution issues|0
7646029|NCT00433511|12060237|FG001|Step 1|Insurance/drug distribution issues|1
7646030|NCT00433511|12060238|FG002|Step 1|Insurance/drug distribution issues|2
7646031|NCT00433511|12060236|FG000|Step 1|Patient moved|0
7646032|NCT00433511|12060237|FG001|Step 1|Patient moved|0
7646033|NCT00433511|12060238|FG002|Step 1|Patient moved|1
7646034|NCT00433511|12060236|FG000|Step 2 (Arm D)|Adverse Event|0
7646035|NCT00433511|12060237|FG001|Step 2 (Arm D)|Adverse Event|0
7646036|NCT00433511|12060238|FG002|Step 2 (Arm D)|Adverse Event|135
7646037|NCT00433511|12060236|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
7646038|NCT00433511|12060237|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
7646039|NCT00433511|12060238|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
7646040|NCT00433511|12060236|FG000|Step 2 (Arm D)|Never started protocol therapy|0
7646041|NCT00433511|12060237|FG001|Step 2 (Arm D)|Never started protocol therapy|0
7646042|NCT00433511|12060238|FG002|Step 2 (Arm D)|Never started protocol therapy|148
7646043|NCT00433511|12060236|FG000|Step 2 (Arm D)|Physician Decision|0
7646044|NCT00433511|12060237|FG001|Step 2 (Arm D)|Physician Decision|0
7646045|NCT00433511|12060238|FG002|Step 2 (Arm D)|Physician Decision|9
7646046|NCT00433511|12060236|FG000|Step 2 (Arm D)|Disease progression, relapse|0
7646047|NCT00433511|12060237|FG001|Step 2 (Arm D)|Disease progression, relapse|0
7646048|NCT00433511|12060238|FG002|Step 2 (Arm D)|Disease progression, relapse|7
7646049|NCT00433511|12060236|FG000|Step 2 (Arm D)|Other complicating disease|0
7646050|NCT00433511|12060237|FG001|Step 2 (Arm D)|Other complicating disease|0
7646051|NCT00433511|12060238|FG002|Step 2 (Arm D)|Other complicating disease|3
7646052|NCT00433511|12060236|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7646053|NCT00433511|12060237|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
7646054|NCT00433511|12060238|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
7646055|NCT00433511|12060236|FG000|Step 2 (Arm D)|Suspected recurrence|0
7646056|NCT00433511|12060237|FG001|Step 2 (Arm D)|Suspected recurrence|0
7646057|NCT00433511|12060238|FG002|Step 2 (Arm D)|Suspected recurrence|1
7646058|NCT00433511|12060236|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
7646059|NCT00433511|12060237|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
7646060|NCT00433511|12060238|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
7646061|NCT00433511|12060236|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7646062|NCT00433511|12060237|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
7646063|NCT00433511|12060238|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
7646064|NCT00432965|12060251|FG000|Overall Study|Lost to Follow-up|22
7646065|NCT00432965|12060252|FG001|Overall Study|Lost to Follow-up|19
7646066|NCT00432965|12060251|FG000|Overall Study|Withdrawal by Subject|13
7646067|NCT00432965|12060252|FG001|Overall Study|Withdrawal by Subject|13
7646068|NCT00432965|12060251|FG000|Overall Study|Physician Decision|14
7646069|NCT00432965|12060252|FG001|Overall Study|Physician Decision|13
7646070|NCT00432965|12060251|FG000|Overall Study|Lack of Efficacy|8
7646071|NCT00432965|12060252|FG001|Overall Study|Lack of Efficacy|13
7646072|NCT00432965|12060251|FG000|Overall Study|Non-compliance|7
7646073|NCT00432965|12060252|FG001|Overall Study|Non-compliance|0
7646074|NCT00432965|12060251|FG000|Overall Study|Adverse Event|22
7646075|NCT00432965|12060252|FG001|Overall Study|Adverse Event|19
7646076|NCT00432965|12060251|FG000|Overall Study|Death|3
7646077|NCT00432965|12060252|FG001|Overall Study|Death|4
7646078|NCT00432965|12060251|FG000|Overall Study|Exclusionary Methods|1
7646079|NCT00432965|12060252|FG001|Overall Study|Exclusionary Methods|2
7646080|NCT00432965|12060251|FG000|Overall Study|Incomplete Data|4
7646081|NCT00432965|12060252|FG001|Overall Study|Incomplete Data|3
7646082|NCT00415532|12060260|FG000|Treatment Period|Adverse Event|2
7646083|NCT00415532|12060261|FG001|Treatment Period|Adverse Event|3
7646084|NCT00415532|12060260|FG000|Treatment Period|Death|2
7646085|NCT00415532|12060261|FG001|Treatment Period|Death|1
7646086|NCT00415532|12060260|FG000|Treatment Period|Lost to Follow-up|1
7646087|NCT00415532|12060261|FG001|Treatment Period|Lost to Follow-up|1
7646088|NCT00415532|12060260|FG000|Treatment Period|Protocol Violation|1
7646089|NCT00415532|12060261|FG001|Treatment Period|Protocol Violation|0
7646090|NCT00415532|12060260|FG000|Treatment Period|Withdrawal by Subject|6
7646091|NCT00415532|12060261|FG001|Treatment Period|Withdrawal by Subject|6
7646092|NCT00415532|12060260|FG000|Treatment Period|Other|2
7646093|NCT00415532|12060261|FG001|Treatment Period|Other|2
7646094|NCT00415532|12060260|FG000|Treatment Period|Ineligibility determined|1
7646095|NCT00415532|12060261|FG001|Treatment Period|Ineligibility determined|1
7646096|NCT00415532|12060260|FG000|Treatment Period|Noncompliance|1
7646097|NCT00415532|12060261|FG001|Treatment Period|Noncompliance|1
7646098|NCT00415532|12060260|FG000|Treatment Period|Requirement for alternative therapy|1
7646099|NCT00415532|12060261|FG001|Treatment Period|Requirement for alternative therapy|0
7646100|NCT00415532|12060260|FG000|Safety Follow Up Period|Adverse Event|1
7646101|NCT00415532|12060261|FG001|Safety Follow Up Period|Adverse Event|3
7646102|NCT00415532|12060260|FG000|Safety Follow Up Period|Death|3
7646103|NCT00415532|12060261|FG001|Safety Follow Up Period|Death|0
7646104|NCT00415532|12060260|FG000|Safety Follow Up Period|Withdrawal by Subject|2
7646105|NCT00415532|12060261|FG001|Safety Follow Up Period|Withdrawal by Subject|3
7646106|NCT00415532|12060260|FG000|Safety Follow Up Period|Other|1
7646107|NCT00415532|12060261|FG001|Safety Follow Up Period|Other|4
7646108|NCT00415532|12060260|FG000|Safety Follow Up Period|Ineligibility determined|1
7646109|NCT00415532|12060261|FG001|Safety Follow Up Period|Ineligibility determined|1
7646110|NCT00415532|12060260|FG000|Safety Follow Up Period|Noncompliance|1
7646111|NCT00415532|12060261|FG001|Safety Follow Up Period|Noncompliance|0
7646112|NCT00415532|12060260|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
7646113|NCT00415532|12060261|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
7646114|NCT00408005|12060269|FG000|Induction|Adverse Event|19
7646115|NCT00408005|12060270|FG001|Induction|Adverse Event|3
7646116|NCT00408005|12060271|FG002|Induction|Adverse Event|0
7646117|NCT00408005|12060272|FG003|Induction|Adverse Event|0
7646118|NCT00408005|12060273|FG004|Induction|Adverse Event|0
7646119|NCT00408005|12060274|FG005|Induction|Adverse Event|0
7646120|NCT00408005|12060275|FG006|Induction|Adverse Event|0
7646121|NCT00408005|12060276|FG007|Induction|Adverse Event|0
7646122|NCT00408005|12060269|FG000|Induction|Death|6
7646123|NCT00408005|12060270|FG001|Induction|Death|0
7646124|NCT00408005|12060271|FG002|Induction|Death|0
7646125|NCT00408005|12060272|FG003|Induction|Death|0
7646126|NCT00408005|12060273|FG004|Induction|Death|0
7646127|NCT00408005|12060274|FG005|Induction|Death|0
7646128|NCT00408005|12060275|FG006|Induction|Death|0
7646129|NCT00408005|12060276|FG007|Induction|Death|0
7646130|NCT00408005|12060269|FG000|Induction|Physician Decision|83
7646131|NCT00408005|12060270|FG001|Induction|Physician Decision|9
7646132|NCT00408005|12060271|FG002|Induction|Physician Decision|0
7646133|NCT00408005|12060272|FG003|Induction|Physician Decision|0
7646134|NCT00408005|12060273|FG004|Induction|Physician Decision|0
7646135|NCT00408005|12060274|FG005|Induction|Physician Decision|0
7646136|NCT00408005|12060275|FG006|Induction|Physician Decision|0
7646137|NCT00408005|12060276|FG007|Induction|Physician Decision|0
7646138|NCT00408005|12060269|FG000|Induction|Withdrawal by Subject|2
7646139|NCT00408005|12060270|FG001|Induction|Withdrawal by Subject|4
7646140|NCT00408005|12060271|FG002|Induction|Withdrawal by Subject|0
7646141|NCT00408005|12060272|FG003|Induction|Withdrawal by Subject|0
7646142|NCT00408005|12060273|FG004|Induction|Withdrawal by Subject|0
7646143|NCT00408005|12060274|FG005|Induction|Withdrawal by Subject|0
7646144|NCT00408005|12060275|FG006|Induction|Withdrawal by Subject|0
7646145|NCT00408005|12060276|FG007|Induction|Withdrawal by Subject|0
7646146|NCT00408005|12060269|FG000|Induction|Ineligible|33
7646147|NCT00408005|12060270|FG001|Induction|Ineligible|14
7646148|NCT00408005|12060271|FG002|Induction|Ineligible|0
7646149|NCT00408005|12060272|FG003|Induction|Ineligible|0
7646150|NCT00408005|12060273|FG004|Induction|Ineligible|0
7646151|NCT00408005|12060274|FG005|Induction|Ineligible|0
7646152|NCT00408005|12060275|FG006|Induction|Ineligible|0
7646153|NCT00408005|12060276|FG007|Induction|Ineligible|0
7646154|NCT00408005|12060269|FG000|Induction|Refusal of Further Protocol Therapy|225
7646155|NCT00408005|12060270|FG001|Induction|Refusal of Further Protocol Therapy|44
7646156|NCT00408005|12060271|FG002|Induction|Refusal of Further Protocol Therapy|0
7646157|NCT00408005|12060272|FG003|Induction|Refusal of Further Protocol Therapy|0
7646158|NCT00408005|12060273|FG004|Induction|Refusal of Further Protocol Therapy|0
7646159|NCT00408005|12060274|FG005|Induction|Refusal of Further Protocol Therapy|0
7646160|NCT00408005|12060275|FG006|Induction|Refusal of Further Protocol Therapy|0
7646161|NCT00408005|12060276|FG007|Induction|Refusal of Further Protocol Therapy|0
7646162|NCT00408005|12060269|FG000|Induction|Entered another COG therapeutic protocol|4
7646163|NCT00408005|12060270|FG001|Induction|Entered another COG therapeutic protocol|0
7646164|NCT00408005|12060271|FG002|Induction|Entered another COG therapeutic protocol|0
7646165|NCT00408005|12060272|FG003|Induction|Entered another COG therapeutic protocol|0
7646166|NCT00408005|12060273|FG004|Induction|Entered another COG therapeutic protocol|0
7646167|NCT00408005|12060274|FG005|Induction|Entered another COG therapeutic protocol|0
7646168|NCT00408005|12060275|FG006|Induction|Entered another COG therapeutic protocol|0
7646169|NCT00408005|12060276|FG007|Induction|Entered another COG therapeutic protocol|0
7646170|NCT00408005|12060269|FG000|Induction|Patient transferred Tx to Non-COG Site|3
7646171|NCT00408005|12060270|FG001|Induction|Patient transferred Tx to Non-COG Site|2
7646172|NCT00408005|12060271|FG002|Induction|Patient transferred Tx to Non-COG Site|0
7646173|NCT00408005|12060272|FG003|Induction|Patient transferred Tx to Non-COG Site|0
7646174|NCT00408005|12060273|FG004|Induction|Patient transferred Tx to Non-COG Site|0
7646175|NCT00408005|12060274|FG005|Induction|Patient transferred Tx to Non-COG Site|0
7646176|NCT00408005|12060275|FG006|Induction|Patient transferred Tx to Non-COG Site|0
7646177|NCT00408005|12060276|FG007|Induction|Patient transferred Tx to Non-COG Site|0
7646178|NCT00408005|12060269|FG000|Induction|Identified as Philadelphia Chr. Positive|6
7646179|NCT00408005|12060270|FG001|Induction|Identified as Philadelphia Chr. Positive|0
7646180|NCT00408005|12060271|FG002|Induction|Identified as Philadelphia Chr. Positive|0
7646181|NCT00408005|12060272|FG003|Induction|Identified as Philadelphia Chr. Positive|0
7646182|NCT00408005|12060273|FG004|Induction|Identified as Philadelphia Chr. Positive|0
7646183|NCT00408005|12060274|FG005|Induction|Identified as Philadelphia Chr. Positive|0
7646184|NCT00408005|12060275|FG006|Induction|Identified as Philadelphia Chr. Positive|0
7646185|NCT00408005|12060276|FG007|Induction|Identified as Philadelphia Chr. Positive|0
7646186|NCT00408005|12060269|FG000|Induction|Progressive Disease|0
7646187|NCT00408005|12060270|FG001|Induction|Progressive Disease|1
7646188|NCT00408005|12060271|FG002|Induction|Progressive Disease|0
7646189|NCT00408005|12060272|FG003|Induction|Progressive Disease|0
7646190|NCT00408005|12060273|FG004|Induction|Progressive Disease|0
7646191|NCT00408005|12060274|FG005|Induction|Progressive Disease|0
7646192|NCT00408005|12060275|FG006|Induction|Progressive Disease|0
7646193|NCT00408005|12060276|FG007|Induction|Progressive Disease|0
7646194|NCT00408005|12060269|FG000|Induction|Inevaluable|18
7646195|NCT00408005|12060270|FG001|Induction|Inevaluable|14
7646196|NCT00408005|12060271|FG002|Induction|Inevaluable|0
7646197|NCT00408005|12060272|FG003|Induction|Inevaluable|0
7646198|NCT00408005|12060273|FG004|Induction|Inevaluable|0
7646199|NCT00408005|12060274|FG005|Induction|Inevaluable|0
7646200|NCT00408005|12060275|FG006|Induction|Inevaluable|0
7646201|NCT00408005|12060276|FG007|Induction|Inevaluable|0
7646202|NCT00408005|12060269|FG000|Induction|Failed to Complete Randomization|3
7646203|NCT00408005|12060270|FG001|Induction|Failed to Complete Randomization|2
7646204|NCT00408005|12060271|FG002|Induction|Failed to Complete Randomization|0
7646205|NCT00408005|12060272|FG003|Induction|Failed to Complete Randomization|0
7646206|NCT00408005|12060273|FG004|Induction|Failed to Complete Randomization|0
7646207|NCT00408005|12060274|FG005|Induction|Failed to Complete Randomization|0
7646208|NCT00408005|12060275|FG006|Induction|Failed to Complete Randomization|0
7646209|NCT00408005|12060276|FG007|Induction|Failed to Complete Randomization|0
7646210|NCT00408005|12060269|FG000|Induction|Protocol Deviation|3
7646211|NCT00408005|12060270|FG001|Induction|Protocol Deviation|1
7646212|NCT00408005|12060271|FG002|Induction|Protocol Deviation|0
7646213|NCT00408005|12060272|FG003|Induction|Protocol Deviation|0
7646214|NCT00408005|12060273|FG004|Induction|Protocol Deviation|0
7646215|NCT00408005|12060274|FG005|Induction|Protocol Deviation|0
7646216|NCT00408005|12060275|FG006|Induction|Protocol Deviation|0
7646217|NCT00408005|12060276|FG007|Induction|Protocol Deviation|0
7646218|NCT00408005|12060269|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
7646219|NCT00408005|12060270|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
7646220|NCT00408005|12060271|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
7646221|NCT00408005|12060272|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
7646222|NCT00408005|12060273|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
7646223|NCT00408005|12060274|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
7646224|NCT00408005|12060275|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
7646225|NCT00408005|12060276|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
7646226|NCT00408005|12060269|FG000|Induction|Recurrent leukemia|1
7646227|NCT00408005|12060270|FG001|Induction|Recurrent leukemia|0
7646228|NCT00408005|12060271|FG002|Induction|Recurrent leukemia|0
7646229|NCT00408005|12060272|FG003|Induction|Recurrent leukemia|0
7646230|NCT00408005|12060273|FG004|Induction|Recurrent leukemia|0
7646231|NCT00408005|12060274|FG005|Induction|Recurrent leukemia|0
7646232|NCT00408005|12060275|FG006|Induction|Recurrent leukemia|0
7646233|NCT00408005|12060276|FG007|Induction|Recurrent leukemia|0
7646234|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646235|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646236|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
7646237|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
7646238|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
7646239|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
7646240|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
7646241|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
7646242|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Death|0
7646243|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Death|0
7646244|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Death|3
7646245|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Death|0
7646246|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Death|5
7646247|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Death|5
7646248|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Death|3
7646249|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Death|1
7646250|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646251|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646252|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
7646253|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646254|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
7646255|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646256|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646257|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
7646258|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
7646259|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
7646260|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
7646261|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
7646262|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
7646263|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
7646264|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
7646265|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
7646266|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646267|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646268|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7646269|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
7646270|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646271|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
7646272|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646273|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
7646274|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7646275|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
7646276|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
7646277|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
7646278|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
7646279|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
7646280|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
7646281|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
7646282|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646283|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646284|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646285|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646286|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
7646287|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646288|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646289|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
7646290|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646291|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646292|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
7646293|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646294|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646295|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646296|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
7646297|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
7646298|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646299|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646300|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646301|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646302|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
7646303|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
7646304|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7646305|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
7646306|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646307|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646308|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646309|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646310|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646311|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
7646312|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646313|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
7646314|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646315|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646316|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7646317|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7646318|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
7646319|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
7646320|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646321|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
7646322|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646323|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646324|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646325|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646326|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
7646327|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
7646328|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646329|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
7646330|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646331|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646332|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
7646333|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
7646334|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
7646335|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
7646336|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
7646337|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
7646338|NCT00408005|12060269|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646339|NCT00408005|12060270|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646340|NCT00408005|12060271|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
7646341|NCT00408005|12060272|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646342|NCT00408005|12060273|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646343|NCT00408005|12060274|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
7646344|NCT00408005|12060275|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646345|NCT00408005|12060276|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
7646346|NCT00389610|12060302|FG000|Overall Study|Disease Progression|0
7646347|NCT00389610|12060303|FG001|Overall Study|Disease Progression|19
7646348|NCT00389610|12060302|FG000|Overall Study|Death|0
7646349|NCT00389610|12060303|FG001|Overall Study|Death|1
7646350|NCT00389610|12060302|FG000|Overall Study|Physician Decision|0
7646351|NCT00389610|12060303|FG001|Overall Study|Physician Decision|1
7646352|NCT00389610|12060302|FG000|Overall Study|Withdrawal by Subject|0
7646353|NCT00389610|12060303|FG001|Overall Study|Withdrawal by Subject|1
7646354|NCT00383708|12060309|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1
7646355|NCT00383708|12060309|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32
7646356|NCT00383708|12060309|FG000|Run-in Period|Protocol Violation|4
7646357|NCT00383708|12060309|FG000|Run-in Period|Adverse Event|2
7646358|NCT00383708|12060309|FG000|Run-in Period|Claustrophobia|1
7646359|NCT00383708|12060309|FG000|Co-administration Period|Adverse Event|5
7646360|NCT00377156|12060316|FG000|Overall Study|Death|23
7646361|NCT00377156|12060317|FG001|Overall Study|Death|19
7646362|NCT00377156|12060316|FG000|Overall Study|Withdrawal by Subject|16
7646363|NCT00377156|12060317|FG001|Overall Study|Withdrawal by Subject|24
7646364|NCT00377156|12060316|FG000|Overall Study|Had follow-up <90 d|3
7646365|NCT00377156|12060317|FG001|Overall Study|Had follow-up <90 d|6
7646366|NCT00377156|12060316|FG000|Overall Study|Cancellation|1
7646367|NCT00377156|12060317|FG001|Overall Study|Cancellation|0
7646368|NCT00377156|12060316|FG000|Overall Study|Refused testing|0
7646369|NCT00377156|12060317|FG001|Overall Study|Refused testing|1
7646370|NCT00377156|12060316|FG000|Overall Study|Ineligible|0
7646371|NCT00377156|12060317|FG001|Overall Study|Ineligible|1
7646372|NCT00377156|12060316|FG000|Overall Study|Disability or language problem|0
7646373|NCT00377156|12060317|FG001|Overall Study|Disability or language problem|1
7646374|NCT00377156|12060316|FG000|Overall Study|Other|5
7646375|NCT00377156|12060317|FG001|Overall Study|Other|2
7646376|NCT00364013|12060336|FG000|Overall Study|Ineligibility determined|4
7646377|NCT00364013|12060337|FG001|Overall Study|Ineligibility determined|2
7646378|NCT00364013|12060336|FG000|Overall Study|Adverse Event|4
7646379|NCT00364013|12060337|FG001|Overall Study|Adverse Event|3
7646380|NCT00364013|12060336|FG000|Overall Study|Withdrawal by Subject|13
7646381|NCT00364013|12060337|FG001|Overall Study|Withdrawal by Subject|18
7646382|NCT00364013|12060336|FG000|Overall Study|Physician Decision|3
7646383|NCT00364013|12060337|FG001|Overall Study|Physician Decision|3
7646384|NCT00364013|12060336|FG000|Overall Study|Lost to Follow-up|10
7646385|NCT00364013|12060337|FG001|Overall Study|Lost to Follow-up|3
7646386|NCT00364013|12060336|FG000|Overall Study|Protocol-specified criteria|6
7646387|NCT00364013|12060337|FG001|Overall Study|Protocol-specified criteria|6
7646388|NCT00364013|12060336|FG000|Overall Study|Other|41
7646389|NCT00364013|12060337|FG001|Overall Study|Other|47
7646390|NCT00364013|12060336|FG000|Overall Study|Ongoing|20
7646391|NCT00364013|12060337|FG001|Overall Study|Ongoing|13
7646392|NCT00345839|12060349|FG000|Overall Study|Withdrawal by Subject|91
7646393|NCT00345839|12060350|FG001|Overall Study|Withdrawal by Subject|98
7646394|NCT00345839|12060349|FG000|Overall Study|Lost to Follow-up|58
7646395|NCT00345839|12060350|FG001|Overall Study|Lost to Follow-up|61
7646396|NCT00339183|12060358|FG000|Overall Study|Adverse Event|5
7646397|NCT00339183|12060359|FG001|Overall Study|Adverse Event|3
7646398|NCT00339183|12060358|FG000|Overall Study|Withdrawal by Subject|16
7646399|NCT00339183|12060359|FG001|Overall Study|Withdrawal by Subject|19
7646400|NCT00339183|12060358|FG000|Overall Study|Physician Decision|2
7646401|NCT00339183|12060359|FG001|Overall Study|Physician Decision|4
7646402|NCT00339183|12060358|FG000|Overall Study|Lost to Follow-up|17
7646403|NCT00339183|12060359|FG001|Overall Study|Lost to Follow-up|17
7646404|NCT00339183|12060358|FG000|Overall Study|Protocol-specified criteria|12
7646405|NCT00339183|12060359|FG001|Overall Study|Protocol-specified criteria|8
7646406|NCT00339183|12060358|FG000|Overall Study|Missing reason|3
7646407|NCT00339183|12060359|FG001|Overall Study|Missing reason|1
7646408|NCT00339183|12060358|FG000|Overall Study|Other|46
7646409|NCT00339183|12060359|FG001|Overall Study|Other|40
7646410|NCT00339183|12060358|FG000|Overall Study|Ongoing|20
7646411|NCT00339183|12060359|FG001|Overall Study|Ongoing|13
7646412|NCT00326625|12060384|FG000|Overall Study|Adverse Event|20
7646413|NCT00326625|12060385|FG001|Overall Study|Adverse Event|9
7646414|NCT00326625|12060384|FG000|Overall Study|Withdrawal by Subject|15
7646415|NCT00326625|12060385|FG001|Overall Study|Withdrawal by Subject|12
7646416|NCT00326625|12060384|FG000|Overall Study|Death|18
7646417|NCT00326625|12060385|FG001|Overall Study|Death|16
7646418|NCT00326625|12060384|FG000|Overall Study|Lost to Follow-up|1
7646419|NCT00326625|12060385|FG001|Overall Study|Lost to Follow-up|0
7646420|NCT00326625|12060384|FG000|Overall Study|prescheduled medical intervention|0
7646421|NCT00326625|12060385|FG001|Overall Study|prescheduled medical intervention|1
7646422|NCT00324805|12060393|FG000|Overall Study|Adverse Event|62
7646423|NCT00324805|12060394|FG001|Overall Study|Adverse Event|203
7646424|NCT00324805|12060393|FG000|Overall Study|Progression|7
7646425|NCT00324805|12060394|FG001|Overall Study|Progression|35
7646426|NCT00324805|12060393|FG000|Overall Study|Withdrawal by Subject|51
7646427|NCT00324805|12060394|FG001|Overall Study|Withdrawal by Subject|174
7646428|NCT00324805|12060393|FG000|Overall Study|Death|6
7646429|NCT00324805|12060394|FG001|Overall Study|Death|9
7646430|NCT00324805|12060393|FG000|Overall Study|Alternative therapy|4
7646431|NCT00324805|12060394|FG001|Overall Study|Alternative therapy|8
7646432|NCT00324805|12060393|FG000|Overall Study|Other complicating disease|1
7646433|NCT00324805|12060394|FG001|Overall Study|Other complicating disease|9
7646434|NCT00324805|12060393|FG000|Overall Study|Other reasons|7
7646435|NCT00324805|12060394|FG001|Overall Study|Other reasons|26
7646436|NCT00324805|12060393|FG000|Overall Study|Other|0
7646437|NCT00324805|12060394|FG001|Overall Study|Other|2
7646438|NCT00324805|12060393|FG000|Overall Study|Did not start therapy|12
7646439|NCT00324805|12060394|FG001|Overall Study|Did not start therapy|17
7646440|NCT00323063|12060402|FG000|Overall Study|Adverse Event|1
7646441|NCT00323063|12060403|FG001|Overall Study|Adverse Event|0
7646442|NCT00323063|12060402|FG000|Overall Study|brain mets discovered prior to treatment|1
7646443|NCT00323063|12060403|FG001|Overall Study|brain mets discovered prior to treatment|0
7646444|NCT00302952|12060428|FG000|Overall Study|Physician Decision|1
7646445|NCT00302952|12060429|FG001|Overall Study|Physician Decision|1
7646446|NCT00302952|12060428|FG000|Overall Study|Withdrawal by Subject|2
7646447|NCT00302952|12060429|FG001|Overall Study|Withdrawal by Subject|3
7646448|NCT00302952|12060428|FG000|Overall Study|Elevated SGOT (AST) lab value|0
7646449|NCT00302952|12060429|FG001|Overall Study|Elevated SGOT (AST) lab value|1
7646450|NCT00288509|12060444|FG000|Treatment Cycle 1|Adverse Event|1
7646451|NCT00288509|12060444|FG000|Treatment Cycle 1|Lack of Efficacy|1
7646452|NCT00288509|12060444|FG000|Treatment Cycle 1|Withdrawal by Subject|1
7646453|NCT00288509|12060444|FG000|Treatment Cycle 1|Lost to Follow-up|2
7646454|NCT00288509|12060444|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
7646455|NCT00288509|12060444|FG000|Treatment Cycle 2|Lack of Efficacy|1
7646456|NCT00288509|12060444|FG000|Treatment Cycle 2|Withdrawal by Subject|2
7646457|NCT00288509|12060444|FG000|Treatment Cycle 3|Lack of Efficacy|1
7646458|NCT00288509|12060444|FG000|Treatment Cycle 3|Withdrawal by Subject|1
7646459|NCT00288509|12060444|FG000|Treatment Cycle 3|Lost to Follow-up|2
7646460|NCT00288509|12060444|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
7646461|NCT00288509|12060444|FG000|Treatment Cycle 4|Withdrawal by Subject|3
7646462|NCT00288509|12060444|FG000|Treatment Cycle 4|Physician Decision|4
7646463|NCT00288509|12060444|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
7646464|NCT00278915|12060448|FG000|Overall Study|Lack of Efficacy|1
7646465|NCT00257660|12060454|FG000|Overall Study|Lack of Efficacy|5
7646466|NCT00257660|12060455|FG001|Overall Study|Lack of Efficacy|23
7646467|NCT00257660|12060454|FG000|Overall Study|Withdrawal by Subject|2
7646468|NCT00257660|12060455|FG001|Overall Study|Withdrawal by Subject|0
7646469|NCT00257660|12060454|FG000|Overall Study|Lost to Follow-up|1
7646470|NCT00257660|12060455|FG001|Overall Study|Lost to Follow-up|0
7646471|NCT00257660|12060454|FG000|Overall Study|PI & Subject Schedule Conflicts|1
7646472|NCT00257660|12060455|FG001|Overall Study|PI & Subject Schedule Conflicts|0
7646473|NCT00257660|12060454|FG000|Overall Study|No longer wanted to do blood draws|1
7646474|NCT00257660|12060455|FG001|Overall Study|No longer wanted to do blood draws|0
7646475|NCT00127127|12060474|FG000|Overall Study|Adverse Event|0
7646476|NCT00127127|12060475|FG001|Overall Study|Adverse Event|2
7646477|NCT00127127|12060476|FG002|Overall Study|Adverse Event|0
7646478|NCT00127127|12060477|FG003|Overall Study|Adverse Event|1
7646479|NCT00127127|12060474|FG000|Overall Study|Lack of Efficacy|1
7646480|NCT00127127|12060475|FG001|Overall Study|Lack of Efficacy|3
7646481|NCT00127127|12060476|FG002|Overall Study|Lack of Efficacy|0
7646482|NCT00127127|12060477|FG003|Overall Study|Lack of Efficacy|2
7646483|NCT00113763|12060556|FG000|Overall Study|Adverse Event|5
7646484|NCT00113763|12060557|FG001|Overall Study|Adverse Event|2
7646485|NCT00113763|12060556|FG000|Overall Study|Disease Progression|28
7646486|NCT00113763|12060557|FG001|Overall Study|Disease Progression|14
7646487|NCT00113763|12060556|FG000|Overall Study|Lost to Follow-up|10
7646488|NCT00113763|12060557|FG001|Overall Study|Lost to Follow-up|0
7646489|NCT00113763|12060556|FG000|Overall Study|Withdrawal by Subject|1
7646490|NCT00113763|12060557|FG001|Overall Study|Withdrawal by Subject|4
7646491|NCT00113763|12060556|FG000|Overall Study|Other|27
7646492|NCT00113763|12060557|FG001|Overall Study|Other|6
7646493|NCT00113763|12060556|FG000|Overall Study|Non-compliance|1
7646494|NCT00113763|12060557|FG001|Overall Study|Non-compliance|0
7646495|NCT00113763|12060556|FG000|Overall Study|Ongoing|1
7646496|NCT00113763|12060557|FG001|Overall Study|Ongoing|0
7646497|NCT00101101|12060564|FG000|Overall Study|never received vaccine|20
7646498|NCT00099437|12060570|FG000|Overall Study|Lost to Follow-up|30
7646499|NCT00099437|12060571|FG001|Overall Study|Lost to Follow-up|33
7646500|NCT00099437|12060570|FG000|Overall Study|Death|293
7646501|NCT00099437|12060571|FG001|Overall Study|Death|261
7646502|NCT00099437|12060570|FG000|Overall Study|Withdrawal by Subject|6
7646503|NCT00099437|12060571|FG001|Overall Study|Withdrawal by Subject|10
7646504|NCT00099437|12060570|FG000|Overall Study|Ongoing in FU but not on treatment|37
7646505|NCT00099437|12060571|FG001|Overall Study|Ongoing in FU but not on treatment|45
7646506|NCT00098475|12060579|FG000|Step 1|Progressive disease|33
7646507|NCT00098475|12060580|FG001|Step 1|Progressive disease|35
7646508|NCT00098475|12060581|FG002|Step 1|Progressive disease|2
7646509|NCT00098475|12060582|FG003|Step 1|Progressive disease|1
7646510|NCT00098475|12060579|FG000|Step 1|Adverse Event|56
7646511|NCT00098475|12060580|FG001|Step 1|Adverse Event|37
7646512|NCT00098475|12060581|FG002|Step 1|Adverse Event|0
7646513|NCT00098475|12060582|FG003|Step 1|Adverse Event|1
7646514|NCT00098475|12060579|FG000|Step 1|Death|8
7646515|NCT00098475|12060580|FG001|Step 1|Death|5
7646516|NCT00098475|12060581|FG002|Step 1|Death|0
7646517|NCT00098475|12060582|FG003|Step 1|Death|1
7646518|NCT00098475|12060579|FG000|Step 1|Withdrawal by Subject|14
7646519|NCT00098475|12060580|FG001|Step 1|Withdrawal by Subject|11
7646520|NCT00098475|12060581|FG002|Step 1|Withdrawal by Subject|0
7646521|NCT00098475|12060582|FG003|Step 1|Withdrawal by Subject|0
7646522|NCT00098475|12060579|FG000|Step 1|Physician Decision|5
7646523|NCT00098475|12060580|FG001|Step 1|Physician Decision|2
7646524|NCT00098475|12060581|FG002|Step 1|Physician Decision|0
7646525|NCT00098475|12060582|FG003|Step 1|Physician Decision|0
7646526|NCT00098475|12060579|FG000|Step 1|Alternative therapy|31
7646527|NCT00098475|12060580|FG001|Step 1|Alternative therapy|43
7646528|NCT00098475|12060581|FG002|Step 1|Alternative therapy|1
7646529|NCT00098475|12060582|FG003|Step 1|Alternative therapy|0
7646530|NCT00098475|12060579|FG000|Step 1|Other disease|2
7646531|NCT00098475|12060580|FG001|Step 1|Other disease|1
7646532|NCT00098475|12060581|FG002|Step 1|Other disease|1
7646533|NCT00098475|12060582|FG003|Step 1|Other disease|0
7646534|NCT00098475|12060579|FG000|Step 1|Never started treatment|0
7646535|NCT00098475|12060580|FG001|Step 1|Never started treatment|2
7646536|NCT00098475|12060581|FG002|Step 1|Never started treatment|0
7646537|NCT00098475|12060582|FG003|Step 1|Never started treatment|0
7646538|NCT00098475|12060579|FG000|Step 1|Still on treatment as of this analysis|14
7646539|NCT00098475|12060580|FG001|Step 1|Still on treatment as of this analysis|27
7646540|NCT00098475|12060581|FG002|Step 1|Still on treatment as of this analysis|0
7646541|NCT00098475|12060582|FG003|Step 1|Still on treatment as of this analysis|0
7646542|NCT00098475|12060579|FG000|Step 1|Knee surgery|1
7646543|NCT00098475|12060580|FG001|Step 1|Knee surgery|0
7646544|NCT00098475|12060581|FG002|Step 1|Knee surgery|0
7646545|NCT00098475|12060582|FG003|Step 1|Knee surgery|0
7646546|NCT00098475|12060579|FG000|Step 1|Complications|1
7646547|NCT00098475|12060580|FG001|Step 1|Complications|0
7646548|NCT00098475|12060581|FG002|Step 1|Complications|0
7646549|NCT00098475|12060582|FG003|Step 1|Complications|0
7646550|NCT00098475|12060579|FG000|Step 1|Cannot comply due to other tx|0
7646551|NCT00098475|12060580|FG001|Step 1|Cannot comply due to other tx|1
7646552|NCT00098475|12060581|FG002|Step 1|Cannot comply due to other tx|0
7646553|NCT00098475|12060582|FG003|Step 1|Cannot comply due to other tx|0
7646554|NCT00098475|12060579|FG000|Step 1|Both patient and physician's decision|2
7646555|NCT00098475|12060580|FG001|Step 1|Both patient and physician's decision|1
7646556|NCT00098475|12060581|FG002|Step 1|Both patient and physician's decision|0
7646557|NCT00098475|12060582|FG003|Step 1|Both patient and physician's decision|0
7646558|NCT00098475|12060579|FG000|Step 1|Incorrect disease assessment|2
7646559|NCT00098475|12060580|FG001|Step 1|Incorrect disease assessment|0
7646560|NCT00098475|12060581|FG002|Step 1|Incorrect disease assessment|0
7646561|NCT00098475|12060582|FG003|Step 1|Incorrect disease assessment|0
7646562|NCT00098475|12060579|FG000|Step 1|Off treatment for > specified timeframe|1
7646563|NCT00098475|12060580|FG001|Step 1|Off treatment for > specified timeframe|1
7646564|NCT00098475|12060581|FG002|Step 1|Off treatment for > specified timeframe|0
7646565|NCT00098475|12060582|FG003|Step 1|Off treatment for > specified timeframe|0
7646566|NCT00098475|12060579|FG000|Step 1|Declining performance status|0
7646567|NCT00098475|12060580|FG001|Step 1|Declining performance status|1
7646568|NCT00098475|12060581|FG002|Step 1|Declining performance status|0
7646569|NCT00098475|12060582|FG003|Step 1|Declining performance status|0
7646570|NCT00098475|12060579|FG000|Step 1|Insurance issue|0
7646571|NCT00098475|12060580|FG001|Step 1|Insurance issue|1
7646572|NCT00098475|12060581|FG002|Step 1|Insurance issue|0
7646573|NCT00098475|12060582|FG003|Step 1|Insurance issue|0
7646574|NCT00098475|12060579|FG000|Step 1|Rising paraprotein|0
7646575|NCT00098475|12060580|FG001|Step 1|Rising paraprotein|1
7646576|NCT00098475|12060581|FG002|Step 1|Rising paraprotein|0
7646577|NCT00098475|12060582|FG003|Step 1|Rising paraprotein|0
7646578|NCT00098475|12060579|FG000|Step 1|Referred to other physicians|0
7646579|NCT00098475|12060580|FG001|Step 1|Referred to other physicians|1
7646580|NCT00098475|12060581|FG002|Step 1|Referred to other physicians|0
7646581|NCT00098475|12060582|FG003|Step 1|Referred to other physicians|0
7646582|NCT00098475|12060579|FG000|Step 1|Criteria to continue treatment not met|0
7646583|NCT00098475|12060580|FG001|Step 1|Criteria to continue treatment not met|1
7646584|NCT00098475|12060581|FG002|Step 1|Criteria to continue treatment not met|0
7646585|NCT00098475|12060582|FG003|Step 1|Criteria to continue treatment not met|0
7646586|NCT00098475|12060579|FG000|Step 1|Misinterpretation of lab data|0
7646587|NCT00098475|12060580|FG001|Step 1|Misinterpretation of lab data|1
7646588|NCT00098475|12060581|FG002|Step 1|Misinterpretation of lab data|0
7646589|NCT00098475|12060582|FG003|Step 1|Misinterpretation of lab data|0
7646590|NCT00098475|12060579|FG000|Step 1|Patient fell with fracture|1
7646591|NCT00098475|12060580|FG001|Step 1|Patient fell with fracture|0
7646592|NCT00098475|12060581|FG002|Step 1|Patient fell with fracture|0
7646593|NCT00098475|12060582|FG003|Step 1|Patient fell with fracture|0
7646594|NCT00098475|12060579|FG000|Step 1|Not documented|0
7646595|NCT00098475|12060580|FG001|Step 1|Not documented|1
7646596|NCT00098475|12060581|FG002|Step 1|Not documented|0
7646597|NCT00098475|12060582|FG003|Step 1|Not documented|0
7646598|NCT00098475|12060579|FG000|Step 2|Disease progression|1
7646599|NCT00098475|12060580|FG001|Step 2|Disease progression|4
7646600|NCT00098475|12060581|FG002|Step 2|Disease progression|0
7646601|NCT00098475|12060582|FG003|Step 2|Disease progression|0
7646602|NCT00098475|12060579|FG000|Step 2|Adverse Event|2
7646603|NCT00098475|12060580|FG001|Step 2|Adverse Event|0
7646604|NCT00098475|12060581|FG002|Step 2|Adverse Event|0
7646605|NCT00098475|12060582|FG003|Step 2|Adverse Event|0
7646606|NCT00098475|12060579|FG000|Step 2|Withdrawal by Subject|0
7646607|NCT00098475|12060580|FG001|Step 2|Withdrawal by Subject|2
7646608|NCT00098475|12060581|FG002|Step 2|Withdrawal by Subject|0
7646609|NCT00098475|12060582|FG003|Step 2|Withdrawal by Subject|0
7646610|NCT00098475|12060579|FG000|Step 2|Physician Decision|0
7646611|NCT00098475|12060580|FG001|Step 2|Physician Decision|1
7646612|NCT00098475|12060581|FG002|Step 2|Physician Decision|0
7646613|NCT00098475|12060582|FG003|Step 2|Physician Decision|0
7646614|NCT00098475|12060579|FG000|Step 2|Alternative therapy|1
7646615|NCT00098475|12060580|FG001|Step 2|Alternative therapy|2
7646616|NCT00098475|12060581|FG002|Step 2|Alternative therapy|0
7646617|NCT00098475|12060582|FG003|Step 2|Alternative therapy|0
7646618|NCT00098475|12060579|FG000|Step 2|Never started treatment|1
7646619|NCT00098475|12060580|FG001|Step 2|Never started treatment|1
7646620|NCT00098475|12060581|FG002|Step 2|Never started treatment|0
7646621|NCT00098475|12060582|FG003|Step 2|Never started treatment|0
7646622|NCT00093015|12060594|FG000|Overall Study|Withdrawal by Subject|194
7646623|NCT00093015|12060595|FG001|Overall Study|Withdrawal by Subject|171
7646624|NCT00093015|12060594|FG000|Overall Study|Lost to Follow-up|96
7646625|NCT00093015|12060595|FG001|Overall Study|Lost to Follow-up|108
7646626|NCT00093015|12060594|FG000|Overall Study|Death|375
7646627|NCT00093015|12060595|FG001|Overall Study|Death|385
7646628|NCT00092534|12060603|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
7646629|NCT00092534|12060604|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
7646630|NCT00092534|12060605|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
7646631|NCT00092534|12060606|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
7646632|NCT00092534|12060607|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
7646633|NCT00092534|12060603|FG000|Base Study Vaccination Period|Adverse Event|3
7646634|NCT00092534|12060604|FG001|Base Study Vaccination Period|Adverse Event|1
7646635|NCT00092534|12060605|FG002|Base Study Vaccination Period|Adverse Event|0
7646636|NCT00092534|12060606|FG003|Base Study Vaccination Period|Adverse Event|0
7646637|NCT00092534|12060607|FG004|Base Study Vaccination Period|Adverse Event|0
7646638|NCT00092534|12060603|FG000|Base Study Vaccination Period|Death|5
7646639|NCT00092534|12060604|FG001|Base Study Vaccination Period|Death|4
7646640|NCT00092534|12060605|FG002|Base Study Vaccination Period|Death|0
7646641|NCT00092534|12060606|FG003|Base Study Vaccination Period|Death|0
7646642|NCT00092534|12060607|FG004|Base Study Vaccination Period|Death|0
7646643|NCT00092534|12060603|FG000|Base Study Vaccination Period|Lost to Follow-up|41
7646644|NCT00092534|12060604|FG001|Base Study Vaccination Period|Lost to Follow-up|37
7646645|NCT00092534|12060605|FG002|Base Study Vaccination Period|Lost to Follow-up|0
7646646|NCT00092534|12060606|FG003|Base Study Vaccination Period|Lost to Follow-up|0
7646647|NCT00092534|12060607|FG004|Base Study Vaccination Period|Lost to Follow-up|0
7646648|NCT00092534|12060603|FG000|Base Study Vaccination Period|Physician Decision|1
7646649|NCT00092534|12060604|FG001|Base Study Vaccination Period|Physician Decision|0
7646650|NCT00092534|12060605|FG002|Base Study Vaccination Period|Physician Decision|0
7646651|NCT00092534|12060606|FG003|Base Study Vaccination Period|Physician Decision|0
7646652|NCT00092534|12060607|FG004|Base Study Vaccination Period|Physician Decision|0
7646653|NCT00092534|12060603|FG000|Base Study Vaccination Period|Pregnancy|9
7646654|NCT00092534|12060604|FG001|Base Study Vaccination Period|Pregnancy|7
7646655|NCT00092534|12060605|FG002|Base Study Vaccination Period|Pregnancy|0
7646656|NCT00092534|12060606|FG003|Base Study Vaccination Period|Pregnancy|0
7646657|NCT00092534|12060607|FG004|Base Study Vaccination Period|Pregnancy|0
7646658|NCT00092534|12060603|FG000|Base Study Vaccination Period|Protocol Violation|2
7646659|NCT00092534|12060604|FG001|Base Study Vaccination Period|Protocol Violation|1
7646660|NCT00092534|12060605|FG002|Base Study Vaccination Period|Protocol Violation|0
7646661|NCT00092534|12060606|FG003|Base Study Vaccination Period|Protocol Violation|0
7646662|NCT00092534|12060607|FG004|Base Study Vaccination Period|Protocol Violation|0
7646663|NCT00092534|12060603|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
7646664|NCT00092534|12060604|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
7646665|NCT00092534|12060605|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
7646666|NCT00092534|12060606|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
7646667|NCT00092534|12060607|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
7646668|NCT00092534|12060603|FG000|Base Study Vaccination Period|Moved|14
7646669|NCT00092534|12060604|FG001|Base Study Vaccination Period|Moved|12
7646670|NCT00092534|12060605|FG002|Base Study Vaccination Period|Moved|0
7646671|NCT00092534|12060606|FG003|Base Study Vaccination Period|Moved|0
7646672|NCT00092534|12060607|FG004|Base Study Vaccination Period|Moved|0
7646673|NCT00092534|12060603|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
7646674|NCT00092534|12060604|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646675|NCT00092534|12060605|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646676|NCT00092534|12060606|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646677|NCT00092534|12060607|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
7646678|NCT00092534|12060603|FG000|Base Study Vaccination Period|Travel|1
7646679|NCT00092534|12060604|FG001|Base Study Vaccination Period|Travel|0
7646680|NCT00092534|12060605|FG002|Base Study Vaccination Period|Travel|0
7646681|NCT00092534|12060606|FG003|Base Study Vaccination Period|Travel|0
7646682|NCT00092534|12060607|FG004|Base Study Vaccination Period|Travel|0
7646683|NCT00092534|12060603|FG000|Base Study Vaccination Period|Site Closed|0
7646684|NCT00092534|12060604|FG001|Base Study Vaccination Period|Site Closed|1
7646685|NCT00092534|12060605|FG002|Base Study Vaccination Period|Site Closed|0
7646686|NCT00092534|12060606|FG003|Base Study Vaccination Period|Site Closed|0
7646687|NCT00092534|12060607|FG004|Base Study Vaccination Period|Site Closed|0
7646688|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Adverse Event|2
7646689|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Adverse Event|4
7646690|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Adverse Event|0
7646691|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Adverse Event|0
7646692|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Adverse Event|0
7646693|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Death|2
7646694|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Death|1
7646695|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Death|0
7646696|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Death|0
7646697|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Death|0
7646698|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
7646699|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
7646700|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
7646701|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
7646702|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
7646703|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Pregnancy|6
7646704|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Pregnancy|10
7646705|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Pregnancy|0
7646706|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Pregnancy|0
7646707|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Pregnancy|0
7646708|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Protocol Violation|1
7646709|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Protocol Violation|2
7646710|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Protocol Violation|0
7646711|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Protocol Violation|0
7646712|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Protocol Violation|0
7646713|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
7646714|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
7646715|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
7646716|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
7646717|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
7646718|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Moved|62
7646719|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Moved|58
7646720|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Moved|0
7646721|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Moved|0
7646722|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Moved|0
7646723|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Travel|10
7646724|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Travel|7
7646725|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Travel|0
7646726|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Travel|0
7646727|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Travel|0
7646728|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Site Closed|0
7646729|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Site Closed|2
7646730|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Site Closed|0
7646731|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Site Closed|0
7646732|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Site Closed|0
7646733|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Subjects continuing|27
7646734|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Subjects continuing|31
7646735|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Subjects continuing|0
7646736|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Subjects continuing|0
7646737|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Subjects continuing|0
7646738|NCT00092534|12060603|FG000|Base Study Follow-Up Period|Subjects in extension|15
7646739|NCT00092534|12060604|FG001|Base Study Follow-Up Period|Subjects in extension|371
7646740|NCT00092534|12060605|FG002|Base Study Follow-Up Period|Subjects in extension|0
7646741|NCT00092534|12060606|FG003|Base Study Follow-Up Period|Subjects in extension|0
7646742|NCT00092534|12060607|FG004|Base Study Follow-Up Period|Subjects in extension|0
7646743|NCT00092534|12060603|FG000|Base Study EXT|Lost to Follow-up|0
7646744|NCT00092534|12060604|FG001|Base Study EXT|Lost to Follow-up|0
7646745|NCT00092534|12060605|FG002|Base Study EXT|Lost to Follow-up|41
7646746|NCT00092534|12060606|FG003|Base Study EXT|Lost to Follow-up|0
7646747|NCT00092534|12060607|FG004|Base Study EXT|Lost to Follow-up|0
7646748|NCT00092534|12060603|FG000|Base Study EXT|Physician Decision|0
7646749|NCT00092534|12060604|FG001|Base Study EXT|Physician Decision|0
7646750|NCT00092534|12060605|FG002|Base Study EXT|Physician Decision|1
7646751|NCT00092534|12060606|FG003|Base Study EXT|Physician Decision|0
7646752|NCT00092534|12060607|FG004|Base Study EXT|Physician Decision|0
7646753|NCT00092534|12060603|FG000|Base Study EXT|Pregnancy|0
7646754|NCT00092534|12060604|FG001|Base Study EXT|Pregnancy|0
7646755|NCT00092534|12060605|FG002|Base Study EXT|Pregnancy|12
7646756|NCT00092534|12060606|FG003|Base Study EXT|Pregnancy|0
7646757|NCT00092534|12060607|FG004|Base Study EXT|Pregnancy|0
7646758|NCT00092534|12060603|FG000|Base Study EXT|Withdrawal by Subject|0
7646759|NCT00092534|12060604|FG001|Base Study EXT|Withdrawal by Subject|0
7646760|NCT00092534|12060605|FG002|Base Study EXT|Withdrawal by Subject|18
7646761|NCT00092534|12060606|FG003|Base Study EXT|Withdrawal by Subject|0
7646762|NCT00092534|12060607|FG004|Base Study EXT|Withdrawal by Subject|0
7646763|NCT00092534|12060603|FG000|Base Study EXT|Participant moved|0
7646764|NCT00092534|12060604|FG001|Base Study EXT|Participant moved|0
7646765|NCT00092534|12060605|FG002|Base Study EXT|Participant moved|6
7646766|NCT00092534|12060606|FG003|Base Study EXT|Participant moved|0
7646767|NCT00092534|12060607|FG004|Base Study EXT|Participant moved|0
7646768|NCT00092534|12060603|FG000|Base Study EXT|Travel|0
7646769|NCT00092534|12060604|FG001|Base Study EXT|Travel|0
7646770|NCT00092534|12060605|FG002|Base Study EXT|Travel|2
7646771|NCT00092534|12060606|FG003|Base Study EXT|Travel|0
7646772|NCT00092534|12060607|FG004|Base Study EXT|Travel|0
7646773|NCT00092534|12060603|FG000|Base Study EXT|Site closed|0
7646774|NCT00092534|12060604|FG001|Base Study EXT|Site closed|0
7646775|NCT00092534|12060605|FG002|Base Study EXT|Site closed|21
7646776|NCT00092534|12060606|FG003|Base Study EXT|Site closed|0
7646777|NCT00092534|12060607|FG004|Base Study EXT|Site closed|0
7646778|NCT00092534|12060603|FG000|Base Study EXT|Study ended|0
7646779|NCT00092534|12060604|FG001|Base Study EXT|Study ended|0
7646780|NCT00092534|12060605|FG002|Base Study EXT|Study ended|29
7646781|NCT00092534|12060606|FG003|Base Study EXT|Study ended|0
7646782|NCT00092534|12060607|FG004|Base Study EXT|Study ended|0
7646783|NCT00092534|12060603|FG000|Base Study EXT|Protocol Violation|0
7646784|NCT00092534|12060604|FG001|Base Study EXT|Protocol Violation|0
7646785|NCT00092534|12060605|FG002|Base Study EXT|Protocol Violation|15
7646786|NCT00092534|12060606|FG003|Base Study EXT|Protocol Violation|0
7646787|NCT00092534|12060607|FG004|Base Study EXT|Protocol Violation|0
7646788|NCT00092534|12060603|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646789|NCT00092534|12060604|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646790|NCT00092534|12060605|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646791|NCT00092534|12060606|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
7646792|NCT00092534|12060607|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
7646793|NCT00089791|12060619|FG000|Overall Study|Physician Decision|6
7646794|NCT00089791|12060620|FG001|Overall Study|Physician Decision|3
7646795|NCT00089791|12060619|FG000|Overall Study|Adverse Event|81
7646796|NCT00089791|12060620|FG001|Overall Study|Adverse Event|93
7646797|NCT00089791|12060619|FG000|Overall Study|Withdrawal by Subject|403
7646798|NCT00089791|12060620|FG001|Overall Study|Withdrawal by Subject|344
7646799|NCT00089791|12060619|FG000|Overall Study|Death|78
7646800|NCT00089791|12060620|FG001|Overall Study|Death|62
7646801|NCT00089791|12060619|FG000|Overall Study|Disease progression|7
7646802|NCT00089791|12060620|FG001|Overall Study|Disease progression|3
7646803|NCT00089791|12060619|FG000|Overall Study|Ineligibility determined|12
7646804|NCT00089791|12060620|FG001|Overall Study|Ineligibility determined|9
7646805|NCT00089791|12060619|FG000|Overall Study|Lost to Follow-up|57
7646806|NCT00089791|12060620|FG001|Overall Study|Lost to Follow-up|57
7646807|NCT00089791|12060619|FG000|Overall Study|Noncompliance|17
7646808|NCT00089791|12060620|FG001|Overall Study|Noncompliance|13
7646809|NCT00089791|12060619|FG000|Overall Study|Other|20
7646810|NCT00089791|12060620|FG001|Overall Study|Other|32
7646811|NCT00089791|12060619|FG000|Overall Study|Protocol deviation|12
7646812|NCT00089791|12060620|FG001|Overall Study|Protocol deviation|10
7646813|NCT00089791|12060619|FG000|Overall Study|Requirement for alternative therapy|7
7646814|NCT00089791|12060620|FG001|Overall Study|Requirement for alternative therapy|4
7646815|NCT00087178|12060628|FG000|Overall Study|No follow up data|5
7646816|NCT00087178|12060629|FG001|Overall Study|No follow up data|15
7646817|NCT00087178|12060628|FG000|Overall Study|No clinical assessment|1
7646818|NCT00087178|12060629|FG001|Overall Study|No clinical assessment|2
7646819|NCT00087178|12060628|FG000|Overall Study|Patient not at risk for primary endpoint|0
7646820|NCT00087178|12060629|FG001|Overall Study|Patient not at risk for primary endpoint|1
7646821|NCT00074412|12060637|FG000|Overall Study|Death|30
7646822|NCT00074412|12060638|FG001|Overall Study|Death|26
7646823|NCT00074412|12060637|FG000|Overall Study|Lost to Follow-up|52
7646824|NCT00074412|12060638|FG001|Overall Study|Lost to Follow-up|58
7646825|NCT00070499|12060649|FG000|Overall Study|Adverse Event|6
7646826|NCT00070499|12060650|FG001|Overall Study|Adverse Event|6
7646827|NCT00070499|12060651|FG002|Overall Study|Adverse Event|19
7646828|NCT00070499|12060652|FG003|Overall Study|Adverse Event|15
7646829|NCT00070499|12060649|FG000|Overall Study|Refusal unrelated to adverse effects|7
7646830|NCT00070499|12060650|FG001|Overall Study|Refusal unrelated to adverse effects|5
7646831|NCT00070499|12060651|FG002|Overall Study|Refusal unrelated to adverse effects|5
7646832|NCT00070499|12060652|FG003|Overall Study|Refusal unrelated to adverse effects|8
7646833|NCT00070499|12060649|FG000|Overall Study|Progression/relapse|4
7646834|NCT00070499|12060650|FG001|Overall Study|Progression/relapse|2
7646835|NCT00070499|12060651|FG002|Overall Study|Progression/relapse|1
7646836|NCT00070499|12060652|FG003|Overall Study|Progression/relapse|4
7646837|NCT00070499|12060649|FG000|Overall Study|Death|1
7646838|NCT00070499|12060650|FG001|Overall Study|Death|1
7646839|NCT00070499|12060651|FG002|Overall Study|Death|1
7646840|NCT00070499|12060652|FG003|Overall Study|Death|2
7646841|NCT00070499|12060649|FG000|Overall Study|Other - not protocol specified|7
7646842|NCT00070499|12060650|FG001|Overall Study|Other - not protocol specified|3
7646843|NCT00070499|12060651|FG002|Overall Study|Other - not protocol specified|12
7646844|NCT00070499|12060652|FG003|Overall Study|Other - not protocol specified|20
7646845|NCT00070499|12060649|FG000|Overall Study|Still on protocol treatment|10
7646846|NCT00070499|12060650|FG001|Overall Study|Still on protocol treatment|4
7646847|NCT00070499|12060651|FG002|Overall Study|Still on protocol treatment|79
7646848|NCT00070499|12060652|FG003|Overall Study|Still on protocol treatment|57
7646849|NCT00070499|12060649|FG000|Overall Study|Did not start treatment|1
7646850|NCT00070499|12060650|FG001|Overall Study|Did not start treatment|0
7646851|NCT00070499|12060651|FG002|Overall Study|Did not start treatment|0
7646852|NCT00070499|12060652|FG003|Overall Study|Did not start treatment|2
7646853|NCT00070499|12060649|FG000|Overall Study|Not eligible|2
7646854|NCT00070499|12060650|FG001|Overall Study|Not eligible|5
7646855|NCT00070499|12060651|FG002|Overall Study|Not eligible|3
7646856|NCT00070499|12060652|FG003|Overall Study|Not eligible|2
7646857|NCT00026312|12060672|FG000|Overall Study|Adverse Event|0
7646858|NCT00026312|12060673|FG001|Overall Study|Adverse Event|32
7646859|NCT00026312|12060672|FG000|Overall Study|Death|1
7646860|NCT00026312|12060673|FG001|Overall Study|Death|7
7646861|NCT00026312|12060672|FG000|Overall Study|Lack of Efficacy|19
7646862|NCT00026312|12060673|FG001|Overall Study|Lack of Efficacy|114
7646863|NCT00026312|12060672|FG000|Overall Study|Lost to Follow-up|0
7646864|NCT00026312|12060673|FG001|Overall Study|Lost to Follow-up|5
7646865|NCT00026312|12060672|FG000|Overall Study|Physician Decision|1
7646866|NCT00026312|12060673|FG001|Overall Study|Physician Decision|37
7646867|NCT00026312|12060672|FG000|Overall Study|Protocol Violation|0
7646868|NCT00026312|12060673|FG001|Overall Study|Protocol Violation|3
7646869|NCT00026312|12060672|FG000|Overall Study|Withdrawal by Subject|1
7646870|NCT00026312|12060673|FG001|Overall Study|Withdrawal by Subject|6
7646871|NCT00026312|12060672|FG000|Overall Study|Ineligible|4
7646872|NCT00026312|12060673|FG001|Overall Study|Ineligible|5
7646873|NCT00026312|12060672|FG000|Overall Study|Entry onto another COG study|0
7646874|NCT00026312|12060673|FG001|Overall Study|Entry onto another COG study|1
7646875|NCT00026312|12060672|FG000|Overall Study|Refusal by patient/parent/guardian|8
7646876|NCT00026312|12060673|FG001|Overall Study|Refusal by patient/parent/guardian|59
7646877|NCT00006721|12060686|FG000|Overall Study|Adverse Event|0
7646878|NCT00006721|12060687|FG001|Overall Study|Adverse Event|4
7646879|NCT00006721|12060688|FG002|Overall Study|Adverse Event|4
7646880|NCT00006721|12060686|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
7646881|NCT00006721|12060687|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
7646882|NCT00006721|12060688|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
7646883|NCT00006721|12060686|FG000|Overall Study|Progression/Relapse|0
7646884|NCT00006721|12060687|FG001|Overall Study|Progression/Relapse|1
7646885|NCT00006721|12060688|FG002|Overall Study|Progression/Relapse|2
7646886|NCT00006721|12060686|FG000|Overall Study|Death|0
7646887|NCT00006721|12060687|FG001|Overall Study|Death|1
7646888|NCT00006721|12060688|FG002|Overall Study|Death|2
7646889|NCT00006721|12060686|FG000|Overall Study|Other - Not Protocol Specified|0
7646890|NCT00006721|12060687|FG001|Overall Study|Other - Not Protocol Specified|7
7646891|NCT00006721|12060688|FG002|Overall Study|Other - Not Protocol Specified|7
7646892|NCT00006721|12060686|FG000|Overall Study|Ineligible|2
7646893|NCT00006721|12060687|FG001|Overall Study|Ineligible|12
7646894|NCT00006721|12060688|FG002|Overall Study|Ineligible|10
7646895|NCT00006721|12060686|FG000|Overall Study|Eligible but no Treatment Received|1
7646896|NCT00006721|12060687|FG001|Overall Study|Eligible but no Treatment Received|0
7646897|NCT00006721|12060688|FG002|Overall Study|Eligible but no Treatment Received|0
7646898|NCT00006436|12060698|FG000|Overall Study|Refused further treatment|2
7646899|NCT00006436|12060698|FG000|Overall Study|Declined to participate (before treatment started)|1
7646900|NCT00002540|12060707|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
7646901|NCT00002540|12060708|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
7646902|NCT00002540|12060707|FG000|Overall Study|Died Before Randomization|2
7646903|NCT00002540|12060708|FG001|Overall Study|Died Before Randomization|6
7646904|NCT00002540|12060707|FG000|Overall Study|Died Before ASU (Control)|202
7646905|NCT00002540|12060708|FG001|Overall Study|Died Before ASU (Control)|0
7646906|NCT00002540|12060707|FG000|Overall Study|Refused ASU (Control)|597
7646907|NCT00002540|12060708|FG001|Overall Study|Refused ASU (Control)|0
7646908|NCT00002540|12060707|FG000|Overall Study|Refused Screen (Prostate Screening)|0
7646909|NCT00002540|12060708|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
